data_1e5g_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1e5g _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 26' ' ' ASP . 0.2 OUTLIER . . . . . 0 N--CA 1.446 -0.628 0 CA-C-O 121.166 0.508 . . . . 0.0 111.809 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.45 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 25.7 m -103.6 163.32 17.65 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.647 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.438 ' HD3' ' HB2' ' A' ' 9' ' ' CYS . 38.1 Cg_endo -67.53 171.8 11.32 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.253 1.969 . . . . 0.0 112.052 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.77 104.38 0.42 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.226 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.427 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 2.5 Cg_endo -49.95 156.92 3.05 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.201 1.934 . . . . 0.0 112.058 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.437 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 6.5 mtt180 -76.23 164.39 26.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.305 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.44 -172.62 2.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.198 0.523 . . . . 0.0 111.633 -178.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.412 ' CD1' ' HD3' ' A' ' 64' ' ' PRO . 17.1 tt -145.47 143.26 22.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.891 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.457 ' HB3' ' ND2' ' A' ' 17' ' ' ASN . 2.8 p30 -76.65 160.97 28.92 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.032 0.444 . . . . 0.0 110.352 177.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.457 ' ND2' ' HB3' ' A' ' 16' ' ' ASP . 0.7 OUTLIER 39.01 29.8 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.224 -178.324 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 16' ' ' ASP . . . -151.42 170.54 31.01 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.638 -178.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.36 137.59 39.03 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.769 0.319 . . . . 0.0 110.674 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.517 ' CD2' ' CE2' ' A' ' 33' ' ' TYR . 13.1 mt -82.86 159.68 22.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.041 0.448 . . . . 0.0 111.429 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -126.37 71.32 1.27 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.596 177.657 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.447 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 1.2 mt -69.81 93.44 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.855 -177.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.6 17.85 57.69 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.712 176.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.27 133.78 1.77 Allowed Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.055 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.1 m -119.73 25.9 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.86 0.362 . . . . 0.0 111.055 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 1.4 p-10 -87.11 152.43 22.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.235 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.45 ' CZ ' ' HB2' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -49.98 97.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.746 179.469 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 115.76 6.21 17.23 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.725 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.03 -167.13 1.54 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.833 0.316 . . . . 0.0 110.552 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 47' ' ' SER . 5.5 p -160.28 138.79 10.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.004 0.431 . . . . 0.0 111.675 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.537 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.7 OUTLIER -103.09 150.23 6.81 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.302 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.966 178.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.427 ' O ' ' N ' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -109.38 115.18 29.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.84 0.352 . . . . 0.0 111.144 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.517 ' CE2' ' CD2' ' A' ' 20' ' ' LEU . 13.7 m-85 -88.23 144.24 26.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.627 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -153.55 160.41 42.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.753 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.1 m -82.21 169.36 16.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.092 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -68.25 -84.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.117 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.37 133.25 12.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.821 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.28 22.21 72.66 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.151 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.504 ' CD2' ' HA ' ' A' ' 68' ' ' SER . 2.4 m-85 -113.94 179.0 4.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.754 0.311 . . . . 0.0 110.785 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.515 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.3 OUTLIER -140.98 112.34 7.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.053 0.454 . . . . 0.0 110.678 178.72 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.429 ' CD1' ' HG3' ' A' ' 64' ' ' PRO . 5.1 tt -79.7 126.28 30.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.656 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.515 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 2.1 mm -104.09 163.97 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.992 0.425 . . . . 0.0 111.08 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.15 -133.98 19.15 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.362 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.418 ' O ' ' CB ' ' A' ' 64' ' ' PRO . 0.9 OUTLIER -84.93 -176.19 6.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.957 0.408 . . . . 0.0 110.956 179.657 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.411 ' HB3' HD23 ' A' ' 41' ' ' LEU . 3.2 p -157.38 18.78 0.28 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.698 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 0.5 OUTLIER -145.85 131.31 18.7 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -178.375 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.438 ' OG ' ' CB ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -96.28 147.09 24.14 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.698 176.788 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.474 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 2.2 m-85 -124.85 120.25 31.17 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 119.151 -1.02 . . . . 0.0 112.05 178.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 20.2 t -71.44 107.47 4.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.521 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.38 -174.51 3.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.116 0.484 . . . . 0.0 111.333 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.45 ' HB2' ' CZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.091 -178.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.148 0 CA-C-O 120.825 0.345 . . . . 0.0 110.267 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.4 m -151.99 174.69 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.08 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.537 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 65.0 m95 -129.09 125.75 37.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.3 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.474 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -68.91 165.19 39.95 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.928 178.442 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.448 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 98.5 Cg_exo -17.21 96.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.804 1 C-N-CA 125.408 4.072 . . . . 0.0 114.695 -178.454 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.473 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -93.94 -77.32 0.46 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.212 -178.228 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.489 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -85.16 108.89 17.33 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -175.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.429 ' HG3' ' CD1' ' A' ' 41' ' ' LEU . 1.4 Cg_endo -86.01 -154.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.296 2.664 . . . . 0.0 110.989 176.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.425 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 4.3 mm -86.05 164.15 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.852 0.358 . . . . 0.0 110.766 178.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -168.41 129.81 1.33 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.773 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.58 168.49 26.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.023 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.504 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 53.3 p -83.69 122.76 29.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.17 0.509 . . . . 0.0 110.537 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.486 ' HB ' ' N ' ' A' ' 116' ' ' GLY . 22.5 m -45.79 100.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.052 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -94.12 99.03 11.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.321 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -92.91 116.25 28.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.071 0.462 . . . . 0.0 110.326 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.22 -163.83 0.07 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.678 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -41.64 131.84 2.31 Favored Pre-proline 0 N--CA 1.436 -1.139 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.58 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.481 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 50.0 Cg_exo -54.69 165.71 2.36 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.423 2.082 . . . . 0.0 112.365 -178.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.49 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 80.9 Cg_exo -39.71 161.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.926 2.418 . . . . 0.0 113.021 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.2 t -109.3 88.75 2.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.443 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 19.3 pt -69.32 173.27 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.271 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.6 m -92.96 141.81 27.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.732 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.491 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 7.5 m-80 57.22 30.85 19.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.814 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.435 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . -170.52 -166.06 28.84 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.979 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.63 -175.43 2.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.979 0.418 . . . . 0.0 110.781 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 11.3 p80 -105.81 171.85 7.12 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.969 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.758 179.86 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.81 0.338 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -152.34 164.27 37.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.936 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.2 p -145.76 -175.81 4.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.061 0.458 . . . . 0.0 111.709 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.409 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 6.8 p-10 -50.51 94.36 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.63 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.49 24.64 1.91 Allowed Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.49 176.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.41 152.76 24.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 117.165 0.482 . . . . 0.0 111.132 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 33.2 m -133.47 154.94 39.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.068 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.51 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 13.6 t -148.94 146.54 17.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.094 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.415 ' CG2' ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -100.29 136.76 39.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.625 179.343 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.523 ' CE1' ' CG2' ' A' ' 111' ' ' VAL . 4.4 m-85 -97.32 159.1 15.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.039 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.9 p -157.26 143.05 17.58 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.378 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.435 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 56.9 m -72.55 167.83 19.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.772 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -98.3 -85.89 0.36 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.894 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.4 t -47.26 -29.9 2.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.339 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.06 45.35 0.2 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.508 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.496 ' CE2' HG12 ' A' ' 126' ' ' ILE . 32.9 m-85 -82.83 -172.66 4.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.72 0.295 . . . . 0.0 110.684 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 m -108.4 105.46 15.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.937 0.399 . . . . 0.0 111.307 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.439 HD21 ' CG ' ' A' ' 122' ' ' PRO . 3.1 tp -46.22 113.22 0.59 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.996 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.45 ' HB ' ' CB ' ' A' ' 123' ' ' THR . 33.0 mm -85.97 156.25 3.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.464 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.428 ' N ' HG23 ' A' ' 106' ' ' ILE . . . 57.0 -130.43 50.95 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.364 -0.922 . . . . 0.0 111.478 -178.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 41.1 p-10 -116.09 136.28 53.17 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.087 0.47 . . . . 0.0 111.208 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.462 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 1.2 p -66.78 -26.25 66.87 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.476 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.18 142.67 31.97 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.712 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.523 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 3.3 t -138.66 120.88 17.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.609 0.242 . . . . 0.0 110.909 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.449 ' CD2' ' N ' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -79.14 135.93 36.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.931 0.396 . . . . 0.0 111.408 -179.417 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.493 ' HB2' ' CZ3' ' A' ' 118' ' ' TRP . 35.0 t -107.93 107.93 18.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.866 176.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 12.0 m -161.74 123.9 2.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.883 0.373 . . . . 0.0 111.729 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 91.35 27.33 18.35 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.493 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.486 ' N ' ' HB ' ' A' ' 69' ' ' VAL . . . 71.46 18.02 76.69 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.173 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -147.89 179.28 7.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.222 0.534 . . . . 0.0 111.421 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.51 ' CH2' ' CG2' ' A' ' 95' ' ' VAL . 93.2 m95 -121.06 144.77 48.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.483 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.25 149.49 49.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.029 0.442 . . . . 0.0 111.465 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.489 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.5 OUTLIER 70.67 46.65 0.27 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.956 179.011 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 93.7 Cg_endo -77.6 138.53 17.29 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.509 2.139 . . . . 0.0 111.795 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.462 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 57.2 Cg_endo -89.82 -173.96 0.79 Allowed 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.634 2.223 . . . . 0.0 113.328 -179.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.45 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -135.01 -173.51 3.34 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.019 178.036 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . 0.417 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 17.2 m -144.38 94.74 2.61 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.968 0.413 . . . . 0.0 111.147 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -117.14 163.23 16.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.777 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.496 HG12 ' CE2' ' A' ' 103' ' ' TYR . 35.5 mm . . . . . 0 C--N 1.324 -0.527 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.514 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.443 ' CB ' ' HA ' ' A' ' 26' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 121.113 0.483 . . . . 0.0 111.164 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.518 ' HB2' ' CD ' ' A' ' 10' ' ' PRO . 99.2 m -80.83 175.87 4.39 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.768 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.534 ' HD2' ' CD1' ' A' ' 59' ' ' TRP . 34.0 Cg_endo -89.56 179.46 2.19 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 122.734 2.289 . . . . 0.0 112.0 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.9 t -48.59 104.3 0.41 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.723 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.458 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 31.2 Cg_exo -43.09 167.37 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.176 1.917 . . . . 0.0 112.542 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.403 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -71.54 -175.62 1.36 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.743 177.37 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.406 ' O ' ' CB ' ' A' ' 63' ' ' ALA . 1.6 t0 -139.05 -178.43 5.33 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.329 0.585 . . . . 0.0 111.7 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.433 HG22 ' CD2' ' A' ' 20' ' ' LEU . 13.4 tt -147.11 144.23 19.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.496 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -76.21 -64.02 1.19 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.723 -178.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -90.52 45.47 1.26 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.952 0.406 . . . . 0.0 111.026 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.427 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -164.64 170.63 39.83 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.032 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -131.24 131.13 43.7 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.527 ' CD2' ' CE2' ' A' ' 33' ' ' TYR . 25.7 mt -82.02 160.34 23.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.16 0.505 . . . . 0.0 111.685 -178.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -130.5 79.72 1.91 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.1 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.438 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 52.9 mt -69.72 118.01 13.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.661 -178.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.71 16.99 6.9 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.828 177.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 29' ' ' SER . . . 161.48 120.87 0.55 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.149 -0.548 . . . . 0.0 111.985 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.4 m -109.83 -6.98 11.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.443 ' HA ' ' CB ' ' A' ' 8' ' ' ARG . 1.6 m-20 -70.19 157.77 37.03 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.751 0.31 . . . . 0.0 110.9 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.487 ' CE1' ' HB2' ' A' ' 51' ' ' LEU . 7.2 t80 -50.47 116.04 1.73 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.866 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.14 0.87 48.02 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.83 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' A' ' 24' ' ' GLY . 12.9 m -84.48 166.5 17.22 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-N 116.994 0.397 . . . . 0.0 110.496 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.2 p -139.19 146.95 41.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.952 0.406 . . . . 0.0 111.061 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.491 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.9 OUTLIER -108.09 171.2 2.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.599 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.446 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -129.82 116.3 18.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.048 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.527 ' CE2' ' CD2' ' A' ' 20' ' ' LEU . 11.9 m-85 -94.66 145.49 24.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.489 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.427 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 91.3 p -147.82 161.54 41.05 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.479 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.417 ' HB2' ' HB2' ' A' ' 39' ' ' TYR . 1.2 m -82.26 170.91 14.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.941 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.7 -81.51 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.285 -178.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.1 m -163.6 117.47 1.55 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.899 0.381 . . . . 0.0 110.699 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.04 -10.21 66.63 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.189 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.479 ' CZ ' ' HB2' ' A' ' 68' ' ' SER . 2.6 m-85 -78.5 -173.63 3.44 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.758 0.313 . . . . 0.0 110.706 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.471 ' CG ' HD13 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -143.01 110.43 5.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.012 0.434 . . . . 0.0 110.075 177.409 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.428 ' CD2' ' O ' ' A' ' 44' ' ' GLU . 2.6 tt -74.76 121.87 22.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.682 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.471 HD13 ' CG ' ' A' ' 40' ' ' HIS . 2.1 mm -104.29 147.56 10.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.013 0.435 . . . . 0.0 110.674 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.29 -133.95 12.13 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.52 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.428 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 1.0 OUTLIER -74.85 -177.63 3.37 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.177 0.513 . . . . 0.0 112.083 -178.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.428 ' HB3' HD22 ' A' ' 41' ' ' LEU . 5.6 p -163.15 23.81 0.09 Allowed 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.295 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.446 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 2.5 mtmt -161.54 130.15 4.4 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -177.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.435 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 0.1 OUTLIER -98.06 136.04 38.88 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 176.741 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.474 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.9 m-85 -112.97 118.28 34.41 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 119.182 -1.007 . . . . 0.0 112.292 -178.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 33.1 t -71.15 71.34 0.58 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.066 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.5 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 3.0 tt0 -93.22 172.55 8.23 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.781 -178.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.5 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.61 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.13 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.907 0.385 . . . . 0.0 110.197 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -142.84 169.13 12.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.798 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.534 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 75.5 m95 -117.76 116.4 26.93 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.878 -178.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.474 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -69.89 167.92 21.17 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.949 177.372 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.464 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 76.8 Cg_exo -16.21 101.57 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.816 1 C-N-CA 125.421 4.08 . . . . 0.0 114.847 -178.398 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.504 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.3 OUTLIER -97.88 -69.4 0.76 Allowed 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 115.021 -0.99 . . . . 0.0 113.144 -175.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.406 ' CB ' ' O ' ' A' ' 14' ' ' ASP . . . -102.85 76.02 0.21 Allowed Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -174.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.44 ' CD ' ' O ' ' A' ' 62' ' ' GLU . 37.0 Cg_endo -56.9 -152.4 0.0 OUTLIER 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.225 2.617 . . . . 0.0 111.13 175.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.406 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 5.4 mm -90.74 164.07 2.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.223 0.535 . . . . 0.0 111.927 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -167.89 120.85 0.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.098 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.476 ' O ' ' CD2' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -131.86 174.96 9.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.248 -179.048 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.479 ' HB2' ' CZ ' ' A' ' 39' ' ' TYR . 1.5 p -98.23 123.24 42.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.608 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.434 ' CG2' ' HB3' ' A' ' 91' ' ' ASP . 30.6 m -47.9 101.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.177 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -95.41 99.39 11.31 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.73 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 3.2 m -78.55 130.7 36.27 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 175.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -174.94 0.61 Allowed 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.5 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 t -68.04 109.0 3.23 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.954 -178.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.64 ' HG3' ' CE2' ' A' ' 118' ' ' TRP 0.287 0.6 OUTLIER -37.48 -178.62 0.0 OUTLIER 'Trans proline' 0 CA--C 1.469 -2.745 0 C-N-CA 123.317 2.678 . . . . 0.0 113.389 174.467 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.562 ' CB ' ' CE2' ' A' ' 97' ' ' TYR . 44.0 Cg_endo -68.47 -166.43 2.84 Favored 'Cis proline' 0 C--N 1.316 -1.171 0 N-CA-C 114.094 0.767 . . . . 0.0 114.094 -18.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 38.2 t -134.87 18.6 3.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 113.95 -1.477 . . . . 0.0 108.907 172.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.443 ' CG2' ' HB3' ' A' ' 121' ' ' PRO . 16.2 pt -107.75 -159.05 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.295 -177.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.43 ' N ' HG12 ' A' ' 77' ' ' ILE . 0.9 OUTLIER -132.42 134.92 45.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.664 178.36 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.467 ' N ' ' ND2' ' A' ' 79' ' ' ASN . 0.2 OUTLIER 70.08 28.84 3.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.77 -179.49 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -145.02 -177.68 20.02 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.167 -1.016 . . . . 0.0 113.0 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' ' 98' ' ' SER . 47.3 mtp180 -152.5 -167.81 2.86 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.498 0.666 . . . . 0.0 112.213 -177.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.535 ' CG ' ' HB2' ' A' ' 74' ' ' PRO . 35.5 p-80 -137.87 -178.95 5.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.887 -1.052 . . . . 0.0 111.346 -178.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.605 175.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.428 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 6.7 m-85 . . . . . 0 N--CA 1.456 -0.171 0 CA-C-O 120.672 0.272 . . . . 0.0 110.402 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.436 ' CD2' ' HZ2' ' A' ' 118' ' ' TRP . 45.6 m-85 -144.31 178.59 7.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.358 -178.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 25.4 p -139.15 -179.03 5.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.216 0.531 . . . . 0.0 111.794 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.434 ' HB3' ' CG2' ' A' ' 69' ' ' VAL . 0.7 OUTLIER -57.54 95.53 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.716 -179.179 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 113.94 38.3 1.17 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.709 -0.757 . . . . 0.0 113.493 177.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.462 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -105.66 155.02 19.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.917 0.359 . . . . 0.0 110.658 178.539 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 29.9 m -134.79 146.37 30.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.002 0.429 . . . . 0.0 111.238 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.524 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 1.6 t -149.99 137.0 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.334 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.15 132.24 34.41 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 177.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.562 ' CE2' ' CB ' ' A' ' 75' ' ' PRO . 3.1 m-30 -99.82 149.69 23.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.302 0.572 . . . . 0.0 112.533 -175.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.421 ' O ' ' N ' ' A' ' 81' ' ' ARG . 88.3 p -129.54 139.8 51.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.139 177.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.448 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 87.9 m -69.53 141.63 53.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.153 0.501 . . . . 0.0 111.992 -177.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -56.24 -85.47 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.386 -178.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.93 -16.94 62.7 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -175.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.26 29.63 0.77 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.269 -0.967 . . . . 0.0 113.131 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.464 ' CE1' HG12 ' A' ' 126' ' ' ILE . 32.1 m-85 -68.57 -171.69 0.29 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 125' ' ' GLN . 3.4 p -107.93 108.45 19.61 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.935 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.476 HD21 ' CB ' ' A' ' 109' ' ' SER . 1.8 tp -49.03 102.99 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.191 178.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.455 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 39.1 mm -81.98 155.84 4.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.814 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.429 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 54.59 -130.07 45.16 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.782 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -107.83 132.06 53.82 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.145 0.497 . . . . 0.0 112.177 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.476 ' CB ' HD21 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -68.64 -30.5 69.22 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 174.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -65.5 123.73 25.72 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.282 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.535 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 43.8 t -126.11 124.67 66.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 110.645 -0.131 . . . . 0.0 110.645 -177.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.69 135.28 35.06 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.064 0.459 . . . . 0.0 112.229 -177.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.507 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 12.0 t -97.09 105.89 18.13 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 175.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.78 166.7 23.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.309 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 60.3 14.74 35.01 Favored Glycine 0 CA--C 1.519 0.318 0 CA-C-N 115.524 -0.762 . . . . 0.0 113.294 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.68 8.45 73.46 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.449 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -156.91 -176.08 5.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.87 0.367 . . . . 0.0 110.476 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.64 ' CE2' ' HG3' ' A' ' 74' ' ' PRO . 96.8 m95 -95.78 130.83 42.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.905 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.79 156.09 21.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.251 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.5 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER 55.47 44.39 1.6 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.037 179.834 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 98.5 Cg_endo -78.16 153.45 28.26 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.401 2.067 . . . . 0.0 111.933 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.455 ' CB ' ' O ' ' A' ' 106' ' ' ILE . 74.0 Cg_endo -88.84 -170.01 0.45 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.635 2.223 . . . . 0.0 113.298 -178.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.451 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -131.64 176.91 7.93 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.537 176.841 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . 0.444 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 2.9 m -139.17 97.63 3.34 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.976 0.417 . . . . 0.0 110.87 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.424 ' O ' ' CB ' ' A' ' 104' ' ' SER . 17.1 mt-30 -125.36 163.56 22.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.04 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.464 HG12 ' CE1' ' A' ' 103' ' ' TYR . 17.4 mm . . . . . 0 C--N 1.324 -0.515 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.064 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.43 ' HD3' ' CG2' ' A' ' 25' ' ' VAL . 5.7 mtt180 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.984 0.421 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.45 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 51.7 m -90.35 160.64 39.19 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.974 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.13 177.54 5.73 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.51 2.14 . . . . 0.0 112.122 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.25 112.79 3.94 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.985 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.436 ' CG ' HD12 ' A' ' 22' ' ' ILE . 20.0 Cg_endo -60.34 149.55 85.26 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.353 2.035 . . . . 0.0 112.003 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.434 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 6.6 mtt180 -57.88 173.45 0.32 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -129.89 -174.82 3.42 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.097 0.475 . . . . 0.0 111.623 -178.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.5 tt -141.53 148.62 20.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.866 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.49 -58.25 2.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.245 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.438 ' N ' ' ND2' ' A' ' 17' ' ' ASN . 0.5 OUTLIER -93.65 40.78 1.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.864 -179.503 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.431 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -164.27 -179.93 38.74 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.703 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.25 134.51 32.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.745 0.307 . . . . 0.0 110.524 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.519 ' CD2' ' CE2' ' A' ' 33' ' ' TYR . 13.7 mt -77.83 155.93 30.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.098 0.475 . . . . 0.0 111.687 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.443 ' HB2' ' CB ' ' A' ' 32' ' ' THR . 29.6 t70 -129.3 74.06 1.56 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.114 176.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.49 HD13 HG23 ' A' ' 22' ' ' ILE . 0.8 OUTLIER -76.97 101.83 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.954 -176.447 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.73 16.82 58.26 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.753 -0.736 . . . . 0.0 111.732 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 162.53 132.35 1.33 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.251 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.43 ' CG2' ' HD3' ' A' ' 8' ' ' ARG . 34.0 m -113.62 -8.07 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.429 ' HA ' ' CB ' ' A' ' 8' ' ' ARG . 32.8 t0 -70.18 163.48 26.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.968 0.413 . . . . 0.0 111.074 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.433 ' CE2' ' HB2' ' A' ' 51' ' ' LEU . 11.0 t80 -54.44 113.82 1.42 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.684 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.87 -7.11 33.21 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.664 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.2 m -78.89 158.85 28.0 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.956 0.378 . . . . 0.0 110.647 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.2 p -134.44 136.41 43.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.041 0.448 . . . . 0.0 111.029 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.542 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.9 OUTLIER -96.95 169.7 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.66 178.908 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.443 ' CB ' ' HB2' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -132.7 109.83 9.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.942 0.401 . . . . 0.0 111.148 179.515 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.519 ' CE2' ' CD2' ' A' ' 20' ' ' LEU . 21.5 m-85 -83.59 139.08 33.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.025 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.431 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 41.4 m -144.99 160.31 41.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.711 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 39' ' ' TYR . 36.4 m -84.02 167.31 16.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.863 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -65.3 -84.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.129 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.0 t -152.92 137.61 16.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.702 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 59.11 25.89 60.44 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.843 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.488 ' CE1' ' HB2' ' A' ' 68' ' ' SER . 2.4 m-85 -115.85 172.66 7.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.721 0.296 . . . . 0.0 110.91 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.487 ' CE1' HD13 ' A' ' 42' ' ' ILE . 0.9 OUTLIER -132.49 122.73 25.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.043 0.449 . . . . 0.0 110.674 178.299 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.44 ' CD1' ' HG3' ' A' ' 64' ' ' PRO . 10.1 tt -84.77 127.54 34.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.782 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.487 HD13 ' CE1' ' A' ' 40' ' ' HIS . 1.5 mm -108.49 152.27 10.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.086 0.47 . . . . 0.0 111.023 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.22 -137.24 16.76 Favored Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.31 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.427 ' O ' ' CG ' ' A' ' 64' ' ' PRO . 4.1 pm0 -76.59 178.05 6.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.877 0.37 . . . . 0.0 110.654 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.9 p -156.4 19.11 0.35 Allowed 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.502 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 21.1 mtpt -159.37 121.46 3.43 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.863 0.319 . . . . 0.0 111.863 -177.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.431 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 0.5 OUTLIER -88.51 131.26 34.98 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 177.092 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.476 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 2.0 m-85 -107.14 115.7 30.63 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 119.246 -0.982 . . . . 0.0 111.555 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.436 ' HB3' ' CH2' ' A' ' 59' ' ' TRP . 23.5 t -68.72 80.84 0.28 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.104 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.464 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -97.12 -164.59 1.16 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.626 -179.162 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.464 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.457 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.924 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.245 0 CA-C-O 120.931 0.396 . . . . 0.0 110.399 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.412 HG21 ' HG2' ' A' ' 50' ' ' GLU . 1.3 m -153.72 -177.72 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.527 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.542 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 87.6 m95 -125.14 121.13 33.32 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.104 0.478 . . . . 0.0 112.037 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.476 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 2.4 m120 -72.63 167.05 36.77 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.437 177.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.45 ' HD2' ' HB2' ' A' ' 60' ' ' ASN . 83.3 Cg_exo -18.0 104.29 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 125.142 3.894 . . . . 0.0 114.412 -178.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.48 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -106.92 -81.52 0.55 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.186 -177.235 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.483 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -76.13 107.45 4.49 Favored Pre-proline 0 N--CA 1.463 0.191 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -175.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.44 ' HG3' ' CD1' ' A' ' 41' ' ' LEU . 3.9 Cg_endo -91.52 -155.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 123.459 2.772 . . . . 0.0 111.23 177.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.405 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 2.2 mm -96.65 168.82 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.873 0.368 . . . . 0.0 110.58 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.1 m -167.34 136.59 2.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.206 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.43 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.6 OUTLIER -156.29 175.33 14.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.957 179.703 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.488 ' HB2' ' CE1' ' A' ' 39' ' ' TYR . 3.1 p -93.88 108.76 20.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.94 0.4 . . . . 0.0 111.121 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.461 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 2.7 p -48.58 97.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.263 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.13 121.13 25.18 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.289 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.431 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -103.24 116.79 33.14 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.284 178.798 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.81 -157.68 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.616 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.478 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 1.6 t -47.47 139.01 8.44 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.191 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.486 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 34.5 Cg_exo -58.41 160.93 15.37 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.319 2.013 . . . . 0.0 111.811 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.494 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 88.8 Cg_exo -44.03 157.32 0.15 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.584 2.189 . . . . 0.0 112.784 -178.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 87.7 p -107.32 89.3 2.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.633 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 14.6 pt -69.46 176.55 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.169 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.6 m -92.97 142.4 27.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.84 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 54.99 29.92 13.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.874 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.467 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -163.37 -176.69 35.62 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.294 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -156.43 -174.61 5.02 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.478 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 2.5 p-80 -122.19 161.82 22.49 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.511 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 23.9 m-20 . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.523 179.568 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.418 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 12.8 m-85 . . . . . 0 N--CA 1.446 -0.668 0 CA-C-O 121.138 0.494 . . . . 0.0 111.331 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.431 ' N ' ' O ' ' A' ' 71' ' ' CYS . 9.5 m-85 -141.09 167.64 21.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.038 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.3 p -135.06 -177.45 4.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.153 0.502 . . . . 0.0 111.922 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -62.98 95.05 0.07 Allowed 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.93 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 128.53 12.67 2.71 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.35 -0.841 . . . . 0.0 113.362 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.403 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.5 OUTLIER -90.41 154.51 19.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 117.1 0.45 . . . . 0.0 110.403 179.268 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 26.9 m -133.93 148.23 30.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.075 0.464 . . . . 0.0 110.892 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.469 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 46.3 t -146.9 151.98 13.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.596 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.04 135.01 50.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.595 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.482 ' CE1' HG23 ' A' ' 111' ' ' VAL . 5.2 m-85 -93.73 157.55 16.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.196 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.93 149.66 29.9 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.955 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 72.7 m -85.76 155.14 21.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.899 0.38 . . . . 0.0 111.186 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.467 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 56.1 m-20 -92.31 -72.96 0.57 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.336 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.4 t -51.98 -24.35 6.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.882 0.373 . . . . 0.0 110.805 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.03 29.66 1.46 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.535 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.5 ' CE2' HG12 ' A' ' 126' ' ' ILE . 41.1 m-85 -74.41 -175.83 2.48 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 120.998 0.427 . . . . 0.0 110.55 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 34.3 m -122.34 98.61 6.01 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.592 ' HA ' ' HA ' ' A' ' 124' ' ' CYS . 0.0 OUTLIER -51.93 152.02 3.27 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-O 122.305 1.05 . . . . 0.0 112.504 -175.625 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.472 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 45.1 mm -121.98 145.98 27.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 113.085 -1.87 . . . . 0.0 111.244 -174.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.43 ' O ' ' ND2' ' A' ' 108' ' ' ASN . . . 77.32 39.05 27.56 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.271 -0.966 . . . . 0.0 111.859 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.43 ' ND2' ' O ' ' A' ' 107' ' ' GLY . 8.3 p30 53.5 138.71 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 124.346 1.058 . . . . 0.0 113.117 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.54 ' HA ' ' HG2' ' A' ' 122' ' ' PRO . 0.6 OUTLIER -69.4 -24.61 63.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.583 -179.712 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -64.73 134.06 37.93 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.59 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.482 HG23 ' CE1' ' A' ' 97' ' ' TYR . 2.7 t -132.94 121.76 44.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.657 0.265 . . . . 0.0 110.517 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.12 119.68 27.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.909 0.385 . . . . 0.0 111.388 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.491 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 14.6 t -86.7 102.62 14.39 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 176.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.1 t -156.14 148.1 23.17 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.039 0.447 . . . . 0.0 111.328 -178.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 69.55 24.94 75.98 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.54 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.461 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 74.71 5.74 75.13 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.873 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -137.84 174.42 10.59 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.88 0.372 . . . . 0.0 110.328 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.494 ' CD1' ' HD2' ' A' ' 75' ' ' PRO . 86.4 m95 -107.51 128.93 54.95 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.778 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.27 160.37 14.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.536 -178.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.449 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 2.2 p-10 46.94 48.35 5.57 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.71 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 91.8 Cg_endo -77.26 135.19 14.88 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.431 2.087 . . . . 0.0 110.512 175.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.54 ' HG2' ' HA ' ' A' ' 109' ' ' SER . 73.6 Cg_endo -93.67 -176.49 0.54 Allowed 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.09 1.86 . . . . 0.0 114.526 -175.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 105' ' ' LEU . 0.2 OUTLIER -118.43 -155.45 0.6 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.407 179.039 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . 0.592 ' HA ' ' HA ' ' A' ' 105' ' ' LEU . 1.8 m -153.8 88.31 1.26 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.928 0.394 . . . . 0.0 110.753 177.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -115.41 162.48 17.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.756 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.5 HG12 ' CE2' ' A' ' 103' ' ' TYR . 26.5 mm . . . . . 0 C--N 1.325 -0.488 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.167 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.0 mtm180 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.883 0.373 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.437 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 19.6 m -93.2 162.32 28.59 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.855 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.415 ' HD3' ' HB2' ' A' ' 9' ' ' CYS . 36.4 Cg_endo -66.95 171.97 10.42 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.417 2.078 . . . . 0.0 111.997 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.12 112.63 4.33 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.371 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.416 ' CG ' HD11 ' A' ' 22' ' ' ILE . 11.0 Cg_endo -55.12 151.13 36.19 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.143 1.895 . . . . 0.0 111.933 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.434 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 12.1 mtt180 -65.12 152.83 42.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.622 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -99.41 -178.07 3.79 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.953 -176.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.2 tt -152.44 141.49 14.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.129 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.421 ' HB3' ' ND2' ' A' ' 17' ' ' ASN . 7.3 p30 -80.45 174.64 11.41 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.718 178.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.485 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 0.7 OUTLIER 37.32 31.05 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.809 179.694 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.434 ' HA2' ' N ' ' A' ' 36' ' ' ASN . . . -167.26 -166.89 27.11 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.62 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.96 146.42 21.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.665 0.269 . . . . 0.0 110.932 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.48 HD21 ' CD2' ' A' ' 33' ' ' TYR . 14.5 mt -84.77 157.94 20.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.991 0.424 . . . . 0.0 111.556 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.418 ' HB2' ' CB ' ' A' ' 32' ' ' THR . 1.2 t70 -125.68 76.39 1.57 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.717 177.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.438 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 0.9 OUTLIER -74.85 101.06 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.117 -176.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.47 18.58 50.6 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.631 176.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 160.43 134.94 1.74 Allowed Glycine 0 C--N 1.334 0.444 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.834 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.7 m -128.42 33.16 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -178.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -105.39 163.79 12.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.16 0.505 . . . . 0.0 111.243 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.52 ' CE1' ' CE ' ' A' ' 57' ' ' MET . 0.0 OUTLIER -47.97 95.6 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.349 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.77 -4.74 22.72 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.539 -0.839 . . . . 0.0 113.206 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.3 m -70.23 173.9 6.18 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 117.014 0.407 . . . . 0.0 110.289 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.3 p -145.16 144.22 30.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.002 0.429 . . . . 0.0 111.245 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.533 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.9 OUTLIER -105.97 171.84 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.516 -179.662 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.418 ' CB ' ' HB2' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -133.1 115.17 14.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.876 0.37 . . . . 0.0 110.953 179.633 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.48 ' CD2' HD21 ' A' ' 20' ' ' LEU . 15.3 m-85 -88.77 149.0 23.65 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.218 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 83.4 p -154.78 147.85 24.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.196 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.6 m -76.12 168.44 20.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.816 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.434 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 40.9 m-20 -71.24 -84.86 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.37 -178.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.4 t -151.32 135.18 16.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.897 0.379 . . . . 0.0 110.874 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.77 25.35 71.75 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.066 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.491 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.1 m-85 -118.46 170.13 9.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 0.0 111.083 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.525 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.3 OUTLIER -136.1 112.31 9.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.08 0.467 . . . . 0.0 110.557 177.903 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.44 ' CD1' ' HG3' ' A' ' 64' ' ' PRO . 4.2 tt -80.57 119.48 23.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.8 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.525 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 2.5 mm -94.11 161.96 2.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.186 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.68 -138.01 22.45 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.269 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.416 ' O ' ' CG ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -82.74 -174.65 5.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.84 0.352 . . . . 0.0 110.838 179.508 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.408 ' HB3' HD22 ' A' ' 41' ' ' LEU . 4.7 p -156.16 22.26 0.37 Allowed 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.241 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.422 ' CG ' ' O ' ' A' ' 31' ' ' ILE . 2.9 mtpt -150.76 131.05 13.64 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -177.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.458 ' OG ' ' CB ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -93.42 146.82 23.47 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.286 176.248 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.516 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 1.9 m-85 -120.78 117.12 26.63 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 119.014 -1.074 . . . . 0.0 111.738 178.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 48.8 t -62.86 115.2 4.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.999 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.27 -170.85 3.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.214 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.407 ' HA ' ' HA ' ' A' ' 57' ' ' MET . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.594 0 CA-C-O 120.929 0.395 . . . . 0.0 110.874 -178.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.52 ' CE ' ' CE1' ' A' ' 27' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.454 -0.252 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.526 ' CG2' ' N ' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -118.46 -176.52 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.607 0.717 . . . . 0.0 111.589 -176.834 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.533 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 69.6 m95 -130.87 133.36 45.82 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.636 -1.166 . . . . 0.0 111.448 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.516 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 0.6 OUTLIER -75.67 166.46 45.03 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.944 177.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.477 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 97.3 Cg_exo -17.93 96.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 125.251 3.968 . . . . 0.0 114.494 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.479 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.3 OUTLIER -92.87 -76.84 0.46 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.498 -0.773 . . . . 0.0 112.457 -177.374 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.477 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -88.36 109.3 27.68 Favored Pre-proline 0 C--N 1.331 -0.21 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -175.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.44 ' HG3' ' CD1' ' A' ' 41' ' ' LEU . 1.8 Cg_endo -84.01 -154.96 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.092 2.528 . . . . 0.0 111.073 176.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.411 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 4.0 mm -90.4 165.65 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.897 0.379 . . . . 0.0 110.895 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.2 m -163.41 139.32 6.77 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.063 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -159.94 170.86 20.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.823 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.491 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 13.4 p -82.31 117.07 22.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.954 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.444 ' CG2' ' HB3' ' A' ' 40' ' ' HIS . 0.8 OUTLIER -46.67 93.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.291 179.677 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.6 118.51 15.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.061 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -98.69 117.22 32.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.287 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.76 -159.05 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.713 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.47 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 2.1 t -49.86 139.9 16.25 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.925 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.481 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 26.1 Cg_exo -60.52 160.6 23.46 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.433 2.089 . . . . 0.0 112.062 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.499 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 86.2 Cg_exo -42.18 156.51 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.822 2.348 . . . . 0.0 112.842 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.9 m -109.36 90.68 3.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.438 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 21.6 pt -69.37 171.0 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.418 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.5 m -89.92 139.99 30.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.618 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.488 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 2.9 m-80 60.42 29.27 18.88 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.829 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.415 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -165.43 -165.89 23.5 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.986 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.1 -175.89 2.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.896 0.379 . . . . 0.0 110.805 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.47 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 13.3 p80 -115.24 168.81 9.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.123 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.73 179.542 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.406 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 10.4 m-85 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.828 0.347 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.406 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 41.1 m-85 -147.03 168.1 22.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.603 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 17.7 p -138.06 -175.6 4.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.993 0.425 . . . . 0.0 111.496 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 10.9 m-20 -63.76 96.22 0.13 Allowed 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.304 0.573 . . . . 0.0 111.049 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.93 26.66 1.35 Allowed Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.254 -0.884 . . . . 0.0 113.075 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.41 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.6 OUTLIER -108.26 157.3 18.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.878 0.339 . . . . 0.0 110.494 179.044 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.5 m -135.49 151.65 30.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.156 0.503 . . . . 0.0 111.411 -179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.493 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 18.0 t -147.85 148.06 16.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.404 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.438 ' CG2' ' OG ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -107.52 125.84 51.78 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.067 0.461 . . . . 0.0 110.851 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.521 ' CE1' ' CG2' ' A' ' 111' ' ' VAL . 4.0 m-85 -84.21 164.59 19.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.249 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 51.7 m -156.71 143.33 18.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.504 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.415 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 64.2 m -73.88 157.55 36.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.662 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.417 ' CG ' ' N ' ' A' ' 101' ' ' SER . 1.3 p30 -95.12 -55.5 3.05 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.363 0.602 . . . . 0.0 111.342 -178.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.417 ' N ' ' CG ' ' A' ' 100' ' ' ASN . 6.5 t -75.37 -20.62 58.88 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.4 -178.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 117.96 28.05 2.34 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.446 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.488 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 17.9 m-85 -69.65 -179.83 1.89 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.123 0.487 . . . . 0.0 110.853 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -105.98 96.51 6.54 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.936 178.007 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.458 ' CD2' ' HA ' ' A' ' 109' ' ' SER . 0.3 OUTLIER -47.74 128.86 13.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.588 0.709 . . . . 0.0 111.965 -177.526 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.428 HG21 HD12 ' A' ' 106' ' ' ILE . 36.0 mm -112.51 158.98 12.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.55 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 108' ' ' ASN . . . 66.46 31.85 80.01 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.462 -0.875 . . . . 0.0 113.002 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.43 ' O ' ' O ' ' A' ' 107' ' ' GLY . 8.8 p30 52.03 130.85 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 123.983 0.913 . . . . 0.0 113.052 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.476 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 1.6 p -63.01 -25.39 68.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.388 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -64.14 127.76 35.78 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.466 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.521 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 2.6 t -131.35 123.14 52.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.588 0.233 . . . . 0.0 110.724 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.62 124.06 32.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.946 0.403 . . . . 0.0 111.579 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.494 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 18.4 t -87.23 108.81 19.1 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 176.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.6 OUTLIER -155.77 165.13 37.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.102 0.477 . . . . 0.0 111.508 -178.639 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.67 31.11 7.05 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.604 -0.726 . . . . 0.0 112.889 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.439 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 68.63 12.52 64.35 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.711 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -143.14 176.39 9.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.768 0.318 . . . . 0.0 110.523 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.499 ' CD1' ' HD2' ' A' ' 75' ' ' PRO . 89.3 m95 -110.71 127.54 55.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.824 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.91 148.98 27.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.057 0.456 . . . . 0.0 111.478 -178.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.493 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER 68.08 44.85 0.31 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.121 178.888 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 55.1 Cg_endo -69.63 139.18 40.02 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.175 1.917 . . . . 0.0 111.418 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.476 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 55.6 Cg_endo -88.28 -174.8 1.19 Allowed 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.569 2.179 . . . . 0.0 113.35 -178.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -135.13 -157.48 0.8 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.884 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 1.8 m -156.28 90.21 1.17 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.124 0.488 . . . . 0.0 111.134 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.409 ' O ' ' CB ' ' A' ' 104' ' ' SER . 11.7 mt-30 -115.07 158.97 21.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.6 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.487 HG12 ' CE2' ' A' ' 103' ' ' TYR . 29.4 mm . . . . . 0 C--N 1.323 -0.566 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.987 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.439 ' CB ' ' HA ' ' A' ' 26' ' ' ASP . 5.1 ptt180 . . . . . 0 N--CA 1.457 -0.11 0 CA-C-O 120.973 0.416 . . . . 0.0 111.173 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.458 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 12.3 m -93.12 162.68 27.73 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.999 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.414 ' HD3' ' HB2' ' A' ' 9' ' ' CYS . 51.2 Cg_endo -70.24 178.08 5.24 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.443 2.095 . . . . 0.0 112.172 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.401 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 42.2 t -58.5 107.94 1.13 Allowed Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.072 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.455 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 2.6 Cg_endo -50.29 146.96 17.18 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.147 1.898 . . . . 0.0 112.206 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.423 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 4.4 ttp180 -59.76 151.56 25.02 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.275 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -98.5 -177.82 3.81 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.177 -176.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.42 HG21 ' CD2' ' A' ' 20' ' ' LEU . 8.2 tt -141.38 152.99 19.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.458 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -88.38 -66.98 0.86 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.57 -178.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -91.1 40.33 1.02 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.344 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -160.37 -179.22 35.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.881 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -137.75 125.18 21.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.743 0.306 . . . . 0.0 110.618 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.471 ' CD2' ' CE2' ' A' ' 33' ' ' TYR . 14.9 mt -66.8 154.21 41.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.99 0.424 . . . . 0.0 111.231 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -127.35 74.67 1.53 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.852 178.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.427 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 67.8 mt -70.31 96.28 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.22 -177.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.96 21.48 44.78 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.435 176.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 154.87 140.61 3.05 Favored Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.426 HG22 ' NE ' ' A' ' 8' ' ' ARG . 26.5 m -125.64 -9.21 5.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.439 ' HA ' ' CB ' ' A' ' 8' ' ' ARG . 27.5 t70 -69.68 164.92 22.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.03 0.443 . . . . 0.0 110.95 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.488 ' CZ ' HD13 ' A' ' 51' ' ' LEU . 17.2 t80 -51.9 118.47 3.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.707 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 49' ' ' CYS . . . 100.27 -10.86 59.99 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.659 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.418 ' N ' ' HB2' ' A' ' 49' ' ' CYS . 3.6 m -58.53 179.92 0.07 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.825 0.345 . . . . 0.0 110.964 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.1 p -153.58 133.41 13.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.083 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.532 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.6 OUTLIER -100.97 174.25 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.724 179.584 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.88 106.53 5.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.715 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.496 ' CE2' ' CB ' ' A' ' 63' ' ' ALA . 33.5 m-85 -78.37 138.1 38.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.39 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.0 m -139.46 167.02 23.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.69 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.403 ' HA ' ' HA2' ' A' ' 18' ' ' GLY . 1.3 m -91.8 164.62 13.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.943 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -62.01 -84.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.078 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.63 132.91 9.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.637 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.92 25.94 71.0 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.732 -178.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.525 ' CE1' ' CB ' ' A' ' 68' ' ' SER . 2.6 m-85 -118.34 -179.93 3.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.9 0.381 . . . . 0.0 110.931 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.483 ' CE1' ' HA ' ' A' ' 69' ' ' VAL . 0.0 OUTLIER -136.16 140.47 43.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.841 174.738 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.429 ' CD2' ' O ' ' A' ' 44' ' ' GLU . 9.6 tt -94.11 138.69 31.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.472 -178.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.9 mm -110.73 150.5 13.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.077 0.465 . . . . 0.0 111.275 -178.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.27 -147.14 43.75 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.256 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.434 ' O ' ' CG ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -62.14 177.74 0.44 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.592 0.234 . . . . 0.0 110.679 179.419 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.419 ' HB3' HD22 ' A' ' 41' ' ' LEU . 4.6 p -152.3 26.73 0.6 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.955 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.421 ' CG ' ' O ' ' A' ' 31' ' ' ILE . 0.4 OUTLIER -147.02 -171.11 3.7 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.066 -178.541 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.447 ' O ' HG12 ' A' ' 31' ' ' ILE . 1.1 m -167.07 98.92 0.53 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.168 179.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.424 ' CD1' ' N ' ' A' ' 48' ' ' TYR . 1.5 m-85 -80.51 115.85 20.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.134 0.492 . . . . 0.0 111.781 -177.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.47 ' HB3' ' CH2' ' A' ' 59' ' ' TRP . 34.8 t -65.91 102.96 0.84 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.031 178.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.498 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 3.7 tt0 -134.06 171.63 13.94 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.315 0.579 . . . . 0.0 110.695 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.498 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.744 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.763 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.24 0 CA-C-O 120.996 0.426 . . . . 0.0 110.385 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -148.67 -174.57 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.612 -178.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.532 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 88.5 m95 -128.06 123.2 34.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.805 0.336 . . . . 0.0 111.194 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -140.01 122.01 9.82 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.979 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.29 -166.89 5.25 Favored 'Cis proline' 0 C--N 1.352 0.725 0 C-N-CA 123.858 -1.309 . . . . 0.0 112.375 -0.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -110.34 -152.72 0.5 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.496 ' CB ' ' CE2' ' A' ' 33' ' ' TYR . . . -79.18 112.82 31.09 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.982 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.434 ' CG ' ' O ' ' A' ' 44' ' ' GLU . 16.6 Cg_exo -69.24 -150.54 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.738 2.292 . . . . 0.0 112.318 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -106.66 178.37 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.957 0.408 . . . . 0.0 111.251 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -170.69 127.38 0.76 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.747 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.476 ' O ' ' CD2' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -135.48 175.32 9.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.863 179.724 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.525 ' CB ' ' CE1' ' A' ' 39' ' ' TYR . 1.7 p -98.17 124.26 42.64 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.052 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.483 ' HA ' ' CE1' ' A' ' 40' ' ' HIS . 6.7 p -49.58 92.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.982 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.421 ' CD ' ' HB2' ' A' ' 88' ' ' PHE . 0.8 OUTLIER -81.33 128.77 34.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.807 -178.635 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.433 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -110.62 120.44 42.43 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.867 177.625 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.419 ' HA ' ' HA ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -69.8 -160.19 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.964 -179.242 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.468 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 2.2 t -47.25 136.09 9.0 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.081 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.472 ' HG3' ' CZ2' ' A' ' 118' ' ' TRP . 31.6 Cg_exo -56.81 161.81 9.71 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.347 2.031 . . . . 0.0 111.981 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.47 ' HD2' ' CG ' ' A' ' 118' ' ' TRP . 99.3 Cg_exo -42.75 158.15 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.694 2.262 . . . . 0.0 112.735 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.5 m -110.35 88.61 2.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.852 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 19.4 pt -69.65 -179.0 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.364 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.5 m -98.56 146.47 25.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.619 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.466 ' HB3' ' CD2' ' A' ' 103' ' ' TYR . 8.5 m-80 53.53 30.55 10.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.929 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -174.61 -172.29 39.55 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.874 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -170.72 -174.3 1.56 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.904 0.383 . . . . 0.0 110.673 -179.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.471 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 11.5 p-80 -92.45 174.45 7.28 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.264 178.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.436 ' OD1' ' CG1' ' A' ' 95' ' ' VAL . 17.5 p-10 . . . . . 0 C--N 1.332 -0.183 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.439 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 18.1 m-85 . . . . . 0 N--CA 1.449 -0.493 0 CA-C-O 121.131 0.491 . . . . 0.0 111.612 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.439 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 23.7 m-85 -144.66 169.63 17.63 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.049 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 17.0 p -133.62 178.39 6.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.987 0.423 . . . . 0.0 111.674 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -62.47 100.81 0.2 Allowed 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.539 0.685 . . . . 0.0 110.849 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 122.56 16.71 3.7 Favored Glycine 0 C--N 1.312 -0.792 0 CA-C-N 114.718 -1.128 . . . . 0.0 113.003 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.406 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -99.2 157.7 16.2 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.898 0.349 . . . . 0.0 110.533 179.115 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 34.6 m -136.17 152.01 29.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.164 0.507 . . . . 0.0 111.249 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.436 ' CG1' ' OD1' ' A' ' 83' ' ' ASN . 43.8 t -146.82 150.1 15.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.6 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.419 ' CG2' ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -110.46 126.36 54.25 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.882 -179.537 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.523 ' CE2' ' CG2' ' A' ' 111' ' ' VAL . 3.8 m-85 -83.75 154.61 23.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.465 -178.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.429 ' CA ' HD13 ' A' ' 105' ' ' LEU . 59.9 p -153.58 147.85 25.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.283 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 8.4 m -69.81 160.77 31.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.954 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 21.6 m-20 -85.46 -68.99 0.69 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.249 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 66.9 m -77.56 -45.2 26.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.639 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 154.74 41.84 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.766 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.51 ' CE1' HG12 ' A' ' 126' ' ' ILE . 13.4 m-85 -78.15 -166.19 0.78 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.5 m -117.17 104.99 11.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.703 0.287 . . . . 0.0 111.567 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.429 HD13 ' CA ' ' A' ' 98' ' ' SER . 2.6 tp -47.15 118.26 2.06 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.168 0.509 . . . . 0.0 110.534 178.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.446 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 19.1 mm -94.27 160.71 2.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.917 -178.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.438 ' N ' HG21 ' A' ' 106' ' ' ILE . . . 59.43 -124.18 35.66 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.852 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.28 122.85 38.09 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.79 0.329 . . . . 0.0 110.93 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.458 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 1.4 t -58.15 -27.7 64.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.068 0.461 . . . . 0.0 110.474 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.64 135.38 26.79 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.817 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.523 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 2.7 t -131.07 119.22 44.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.712 0.291 . . . . 0.0 110.594 178.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.0 118.76 24.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.991 0.424 . . . . 0.0 111.588 -178.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.484 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 14.1 t -85.37 100.54 11.91 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.467 176.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.6 t -136.63 161.39 36.04 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.063 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.99 25.58 3.9 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.756 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.432 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 77.16 7.38 86.78 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.655 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -133.53 -176.56 4.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.825 0.345 . . . . 0.0 110.571 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.484 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 94.3 m95 -114.61 145.05 42.45 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.171 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.1 147.39 51.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.286 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.495 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.5 t0 71.0 44.56 0.23 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.289 178.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 62.0 Cg_endo -73.23 137.12 25.5 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.191 1.927 . . . . 0.0 111.254 177.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.458 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 73.0 Cg_endo -89.42 -175.42 1.09 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.467 2.112 . . . . 0.0 113.752 -177.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.445 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -124.93 -162.54 1.11 Allowed 'General case' 0 CA--C 1.501 -0.92 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.509 175.34 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . 0.411 ' SG ' ' CB ' ' A' ' 103' ' ' TYR . 5.2 t -170.69 92.76 0.18 Allowed 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.323 -176.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -118.88 175.93 5.52 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.92 -1.037 . . . . 0.0 111.012 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.51 HG12 ' CE1' ' A' ' 103' ' ' TYR . 16.9 mm . . . . . 0 C--N 1.324 -0.531 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.579 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.4 mtt85 . . . . . 0 N--CA 1.454 -0.238 0 CA-C-O 121.023 0.439 . . . . 0.0 111.92 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.437 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 15.1 m -111.51 161.56 24.86 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.638 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.409 ' HD3' ' HB2' ' A' ' 9' ' ' CYS . 55.8 Cg_endo -66.92 171.54 11.0 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.179 1.919 . . . . 0.0 110.471 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.7 p -51.11 120.47 14.1 Favored Pre-proline 0 N--CA 1.45 -0.45 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.719 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.435 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 6.3 Cg_endo -47.82 144.59 11.15 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.67 2.247 . . . . 0.0 112.395 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.454 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -52.59 -175.88 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.904 177.615 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -144.55 -179.95 6.89 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.46 0.648 . . . . 0.0 111.994 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.411 HG21 ' HA3' ' A' ' 18' ' ' GLY . 7.0 tt -139.77 154.5 24.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.305 -179.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -79.08 -68.72 0.63 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.541 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.484 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 1.2 m120 -93.41 39.08 1.05 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.976 0.417 . . . . 0.0 110.876 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -148.29 178.92 25.55 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.025 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -141.51 134.16 28.53 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.489 HD23 ' CD2' ' A' ' 33' ' ' TYR . 10.5 mt -86.69 152.25 22.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.318 0.58 . . . . 0.0 111.953 -178.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -123.34 80.77 1.81 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.578 177.727 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.47 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 6.3 mt -75.5 116.66 18.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.561 -176.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -108.3 19.36 32.0 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.356 175.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 156.58 164.48 13.51 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 22.5 m -143.82 22.7 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.861 0.33 . . . . 0.0 111.439 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.4 OUTLIER -93.57 159.27 15.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.805 179.762 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.516 ' CZ ' ' CD1' ' A' ' 51' ' ' LEU . 2.9 t80 -56.03 87.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.683 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 134.1 -14.56 4.59 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.417 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.01 -170.94 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.612 0.244 . . . . 0.0 110.348 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 47' ' ' SER . 27.7 p -159.28 139.19 11.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.237 0.541 . . . . 0.0 111.819 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.505 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.5 OUTLIER -103.66 176.27 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.866 178.755 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.435 ' O ' ' N ' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -138.24 113.2 9.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.696 0.284 . . . . 0.0 110.828 179.809 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.545 ' CE2' ' CA ' ' A' ' 63' ' ' ALA . 8.3 m-85 -87.34 149.21 24.65 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.318 0.58 . . . . 0.0 111.751 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.409 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.6 OUTLIER -156.62 164.11 38.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.675 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.427 ' HA ' ' HA2' ' A' ' 18' ' ' GLY . 20.2 m -87.7 165.48 15.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.19 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -66.57 -70.94 0.22 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.92 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.41 141.63 9.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.84 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.401 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 52.46 29.82 32.16 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.171 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.509 ' CE1' ' CB ' ' A' ' 68' ' ' SER . 2.4 m-85 -117.09 175.84 5.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.799 0.333 . . . . 0.0 111.147 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.505 ' CE1' ' HA ' ' A' ' 69' ' ' VAL . 0.1 OUTLIER -131.76 140.5 49.24 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 174.566 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.455 ' CD2' ' O ' ' A' ' 44' ' ' GLU . 0.6 OUTLIER -90.16 138.67 31.33 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.256 -176.501 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.465 ' N ' ' CD1' ' A' ' 42' ' ' ILE . 0.3 OUTLIER -116.38 131.96 67.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 CA-C-O 121.67 0.748 . . . . 0.0 110.552 178.442 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.16 -137.42 13.25 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 114.183 -1.371 . . . . 0.0 111.165 -176.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.457 ' N ' ' HG2' ' A' ' 64' ' ' PRO . 0.6 OUTLIER -87.32 -172.55 3.98 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.843 0.354 . . . . 0.0 110.687 178.333 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.401 ' HB3' HD22 ' A' ' 41' ' ' LEU . 3.0 p -144.77 25.54 1.45 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.979 0.419 . . . . 0.0 110.817 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -160.86 125.92 3.71 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.841 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.44 ' CB ' HD13 ' A' ' 31' ' ' ILE . 1.6 m -95.74 149.54 21.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.008 178.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.498 ' CE2' ' HD2' ' A' ' 61' ' ' PRO . 4.0 m-85 -123.08 126.85 47.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.028 0.442 . . . . 0.0 111.278 -178.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.459 ' HB3' ' CH2' ' A' ' 59' ' ' TRP . 10.5 t -76.21 91.95 3.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.118 179.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -116.4 178.17 4.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.63 -178.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.516 ' CD1' ' CZ ' ' A' ' 27' ' ' PHE . 4.8 mt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.606 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.934 0.397 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.5 m -132.84 -175.78 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.91 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.505 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 88.3 m95 -120.76 139.32 53.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.877 0.37 . . . . 0.0 110.996 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.449 ' O ' ' N ' ' A' ' 48' ' ' TYR . 3.1 m-20 -148.78 140.2 14.16 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.956 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.498 ' HD2' ' CE2' ' A' ' 48' ' ' TYR . 7.3 Cg_exo -75.93 -151.89 0.72 Allowed 'Cis proline' 0 C--N 1.348 0.512 0 C-N-CA 124.163 -1.182 . . . . 0.0 112.738 1.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -65.2 -130.7 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.908 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.545 ' CA ' ' CE2' ' A' ' 33' ' ' TYR . . . -72.26 -82.53 0.04 OUTLIER Pre-proline 0 CA--C 1.48 -1.733 0 CA-C-O 118.503 -0.76 . . . . 0.0 112.132 -178.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.485 ' O ' ' HB1' ' A' ' 63' ' ' ALA . 41.2 Cg_endo -102.92 -144.89 0.03 OUTLIER 'Cis proline' 0 C--N 1.317 -1.095 0 CA-C-N 120.73 1.296 . . . . 0.0 114.285 12.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.425 HG12 ' HB ' ' A' ' 42' ' ' ILE . 2.2 pt -91.22 177.0 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -174.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 1.2 m -158.83 112.12 2.33 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 114.282 -1.327 . . . . 0.0 109.513 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.473 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 1.9 mt-10 -102.13 176.8 5.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.006 0.432 . . . . 0.0 111.335 -178.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.509 ' CB ' ' CE1' ' A' ' 39' ' ' TYR . 2.4 p -97.34 123.02 41.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.802 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.505 ' HA ' ' CE1' ' A' ' 40' ' ' HIS . 3.3 p -45.75 97.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.318 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.41 ' HD3' ' HB2' ' A' ' 88' ' ' PHE . 0.3 OUTLIER -84.78 115.58 22.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.435 -179.139 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -96.38 119.25 34.52 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 177.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -69.81 -157.41 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.577 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.2 t -50.98 138.9 23.92 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.57 0.224 . . . . 0.0 110.736 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.466 ' CG ' HG11 ' A' ' 95' ' ' VAL . 33.9 Cg_exo -58.36 156.36 31.14 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.383 2.055 . . . . 0.0 112.05 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.506 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 76.1 Cg_exo -48.92 156.24 2.2 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.63 2.22 . . . . 0.0 112.921 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 75.4 m -101.63 92.4 4.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.111 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.425 ' CG2' ' O ' ' A' ' 122' ' ' PRO . 6.4 pt -68.97 165.51 2.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.298 -178.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.8 m -77.32 140.09 39.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.871 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.485 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 7.0 m-80 52.72 27.21 5.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.051 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.458 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -161.63 -166.62 20.73 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.757 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.438 ' N ' ' O ' ' A' ' 98' ' ' SER . 9.5 ptt180 -170.32 -174.64 1.74 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.984 0.421 . . . . 0.0 110.918 -178.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.422 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 13.6 p80 -102.14 179.43 4.32 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.549 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.469 ' CB ' ' O ' ' A' ' 96' ' ' THR . 50.2 t30 . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.794 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.438 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 11.1 m-85 . . . . . 0 N--CA 1.453 -0.289 0 CA-C-O 120.637 0.256 . . . . 0.0 110.73 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.451 ' CE2' ' CG2' ' A' ' 95' ' ' VAL . 19.8 m-85 -145.31 164.95 29.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.818 0.342 . . . . 0.0 111.117 -178.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.1 p -147.42 -175.21 4.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.766 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 7.6 p-10 -54.78 94.02 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.676 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.39 25.99 1.24 Allowed Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.543 -0.837 . . . . 0.0 113.512 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.32 152.29 26.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 117.36 0.58 . . . . 0.0 111.176 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 27.3 m -144.34 136.2 22.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.118 0.485 . . . . 0.0 110.949 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.466 HG11 ' CG ' ' A' ' 74' ' ' PRO . 3.8 p -134.8 149.75 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.283 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.469 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 0.2 OUTLIER -91.31 149.72 21.62 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.992 0.425 . . . . 0.0 110.836 -179.658 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.534 ' CE2' ' CG2' ' A' ' 111' ' ' VAL . 2.8 m-85 -107.79 157.39 18.18 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.81 0.338 . . . . 0.0 111.105 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.438 ' O ' ' N ' ' A' ' 81' ' ' ARG . 10.1 p -144.71 146.16 32.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.257 -0.429 . . . . 0.0 112.086 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.496 ' HB2' ' HB3' ' A' ' 103' ' ' TYR . 91.0 m -69.15 161.11 29.81 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.671 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.458 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 0.9 OUTLIER -53.4 -79.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.86 -178.716 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.1 t -110.81 -30.24 7.64 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.706 -176.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 175.45 31.9 0.04 OUTLIER Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.514 -0.85 . . . . 0.0 113.169 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.531 ' CE2' ' CD1' ' A' ' 126' ' ' ILE . 0.2 OUTLIER -69.78 -168.05 0.17 Allowed 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 116.596 0.198 . . . . 0.0 110.681 178.726 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 125' ' ' GLN . 0.2 OUTLIER -125.51 113.95 18.15 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 176.254 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.484 ' CD2' ' HA ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -69.62 143.41 53.26 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.762 0.791 . . . . 0.0 112.17 -176.09 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.445 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 33.8 mm -123.09 156.96 28.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 114.281 -1.327 . . . . 0.0 111.266 -178.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 62.56 32.02 81.81 Favored Glycine 0 CA--C 1.512 -0.137 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.415 178.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.429 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.4 OUTLIER 60.44 135.55 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.313 0.578 . . . . 0.0 111.545 179.218 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.484 ' HA ' ' CD2' ' A' ' 105' ' ' LEU . 1.0 OUTLIER -74.43 -29.96 61.7 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.221 -0.9 . . . . 0.0 112.506 -177.506 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.4 141.45 47.92 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.35 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.534 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 13.9 t -134.86 119.17 26.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.644 0.259 . . . . 0.0 111.303 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.429 ' CD1' ' HB2' ' A' ' 114' ' ' SER . 1.0 OUTLIER -80.18 134.51 36.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.908 0.385 . . . . 0.0 111.194 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.48 ' HB2' ' CZ3' ' A' ' 118' ' ' TRP . 35.9 t -106.17 104.96 14.77 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.122 177.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.429 ' HB2' ' CD1' ' A' ' 112' ' ' LEU . 1.7 t -149.14 131.9 16.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.941 0.401 . . . . 0.0 111.564 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 80.89 24.28 58.24 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.32 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.448 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 75.7 1.53 66.89 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.312 -178.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -124.52 178.73 5.26 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.03 0.443 . . . . 0.0 110.711 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.506 ' CD1' ' HD2' ' A' ' 75' ' ' PRO . 92.9 m95 -120.13 133.52 55.49 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.125 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.404 ' O ' ' HB2' ' A' ' 120' ' ' ASP . 0.8 OUTLIER -109.23 160.36 16.18 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.304 178.41 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.574 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 49.7 t0 67.16 33.39 0.1 OUTLIER Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 32.9 Cg_endo -66.92 124.99 12.97 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 121.993 1.796 . . . . 0.0 110.943 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.499 ' HD3' ' CD1' ' A' ' 97' ' ' TYR . 72.3 Cg_endo -91.38 -174.09 0.6 Allowed 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.603 2.202 . . . . 0.0 114.505 -175.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.5 m -135.81 176.34 8.78 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 113.924 -1.489 . . . . 0.0 108.639 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . 0.507 ' HB3' ' HB2' ' A' ' 103' ' ' TYR . 1.2 m -133.3 103.94 6.22 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.106 -0.638 . . . . 0.0 111.16 177.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.437 ' O ' ' CB ' ' A' ' 104' ' ' SER . 10.2 mt-30 -106.85 153.12 22.96 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.686 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.531 ' CD1' ' CE2' ' A' ' 103' ' ' TYR . 49.2 mm . . . . . 0 C--N 1.315 -0.919 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.839 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.888 0.375 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.435 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 16.7 m -69.67 162.01 70.46 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.725 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.53 169.32 20.18 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.528 2.152 . . . . 0.0 112.218 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -50.29 105.9 0.57 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.939 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.492 ' HG2' ' CZ2' ' A' ' 59' ' ' TRP . 76.5 Cg_exo -46.63 160.96 0.2 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.429 2.086 . . . . 0.0 112.594 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.426 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -66.16 166.38 11.94 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.178 178.532 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -117.03 -178.6 3.48 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.187 0.517 . . . . 0.0 112.187 -176.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.1 tt -144.58 146.74 19.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.378 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -85.81 -61.05 1.84 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.523 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.422 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 0.7 OUTLIER -94.6 34.31 1.34 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.92 -179.142 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.435 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -149.57 -179.18 25.2 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.76 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -138.8 127.99 24.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.769 0.319 . . . . 0.0 110.644 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.5 ' CD2' ' CE1' ' A' ' 33' ' ' TYR . 16.1 mt -76.54 153.74 35.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.096 0.475 . . . . 0.0 111.632 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.432 ' HB2' ' CB ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -127.38 78.82 1.84 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.744 177.838 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.454 ' CD1' ' HG3' ' A' ' 12' ' ' PRO . 3.6 mm -68.85 100.32 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.861 -177.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -103.63 22.86 34.47 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.648 177.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 146.57 133.56 2.48 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 111.741 -0.544 . . . . 0.0 111.741 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.7 m -121.22 22.32 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.697 0.284 . . . . 0.0 111.489 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.12 149.59 26.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.552 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -48.41 113.7 0.81 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.894 0.378 . . . . 0.0 110.853 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.42 6.74 23.39 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.618 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.86 -163.19 0.97 Allowed 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.8 0.3 . . . . 0.0 110.571 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.7 p -168.94 144.02 3.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.935 0.398 . . . . 0.0 111.143 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.519 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -102.6 170.31 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.278 179.413 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.432 ' CB ' ' HB2' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -130.67 114.42 15.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.0 0.429 . . . . 0.0 111.126 179.885 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.5 ' CE1' ' CD2' ' A' ' 20' ' ' LEU . 17.2 m-85 -92.84 137.14 32.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.504 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.435 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 3.5 m -143.86 166.25 25.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.44 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.9 m -82.89 170.44 14.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.784 0.326 . . . . 0.0 110.879 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -70.19 -83.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.851 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.6 m -156.44 132.44 9.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.743 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.51 22.75 73.42 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.067 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.472 ' CE1' ' HB2' ' A' ' 68' ' ' SER . 2.7 m-85 -114.65 -174.78 2.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.795 0.331 . . . . 0.0 110.913 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.526 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.3 OUTLIER -145.35 112.41 6.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.435 178.203 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.439 ' CD1' ' HG3' ' A' ' 64' ' ' PRO . 7.9 tt -77.35 124.17 27.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.768 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.526 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 2.3 mm -100.16 152.23 4.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.994 0.426 . . . . 0.0 110.931 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.71 -137.34 16.58 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.202 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.407 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 0.3 OUTLIER -86.67 -175.84 5.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.02 0.438 . . . . 0.0 110.855 179.432 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.402 ' HB3' HD21 ' A' ' 41' ' ' LEU . 3.5 p -155.86 24.16 0.38 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.23 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.51 130.03 13.94 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.104 0.478 . . . . 0.0 112.221 -178.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.442 ' HB3' ' CB ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -101.15 152.8 20.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.34 178.656 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.476 ' CD2' ' HB2' ' A' ' 60' ' ' ASN . 1.3 m-85 -126.23 120.68 30.66 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 119.7 -0.8 . . . . 0.0 111.902 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.477 ' HB3' ' CH2' ' A' ' 59' ' ' TRP . 32.2 t -70.21 116.73 10.9 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.095 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -153.6 -177.43 6.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.789 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.988 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.873 0.368 . . . . 0.0 110.555 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.6 m -150.64 176.54 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.917 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.519 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 60.0 m95 -128.16 127.98 43.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.944 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.476 ' HB2' ' CD2' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -69.37 163.24 60.19 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.178 179.311 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.446 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 80.1 Cg_exo -16.58 94.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.899 1 C-N-CA 125.574 4.182 . . . . 0.0 114.429 -178.456 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.443 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -101.28 -81.98 0.47 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.958 -177.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.475 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -72.95 106.46 2.26 Favored Pre-proline 0 C--N 1.331 -0.212 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -176.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.473 ' HD2' ' CD1' ' A' ' 33' ' ' TYR . 1.8 Cg_endo -90.05 -156.01 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.469 2.779 . . . . 0.0 111.14 177.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.406 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 3.8 mm -92.43 165.3 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.877 0.37 . . . . 0.0 110.884 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -170.21 136.3 1.39 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.002 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.4 ' C ' ' CD2' ' A' ' 39' ' ' TYR . 1.6 tt0 -159.78 172.37 17.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.909 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.472 ' HB2' ' CE1' ' A' ' 39' ' ' TYR . 4.1 p -89.77 107.88 19.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.431 ' CG2' ' HB3' ' A' ' 40' ' ' HIS . 2.4 p -43.06 94.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.524 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.436 ' HG3' ' CG2' ' A' ' 90' ' ' THR . 2.0 mmtp -75.16 127.23 32.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.375 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.92 113.92 27.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.056 178.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.3 -159.74 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.538 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.482 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 1.4 t -44.52 135.2 4.5 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.234 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.78 161.78 12.03 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.398 2.065 . . . . 0.0 112.116 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.504 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 79.8 Cg_exo -43.14 156.64 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.772 2.314 . . . . 0.0 112.904 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.5 t -104.81 90.56 3.52 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.372 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.1 pt -69.28 175.32 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.395 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.4 p -93.79 141.04 28.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.609 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 58.4 28.58 17.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.036 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.467 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -167.05 -171.32 33.0 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.215 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -158.55 -173.58 4.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.078 0.466 . . . . 0.0 110.614 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.482 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 8.4 p80 -117.5 172.19 7.5 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.173 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.952 178.24 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.432 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 7.4 m-85 . . . . . 0 N--CA 1.456 -0.169 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.432 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 65.6 m-85 -155.64 164.87 38.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.642 0.258 . . . . 0.0 110.9 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.436 ' CG2' ' HG3' ' A' ' 70' ' ' LYS . 19.7 p -148.18 -175.29 4.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.005 0.431 . . . . 0.0 111.567 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 28.8 p-10 -52.92 95.65 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.348 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.04 20.35 2.52 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.231 -0.895 . . . . 0.0 113.261 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -110.24 147.35 33.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 117.051 0.425 . . . . 0.0 110.965 179.508 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.419 HG23 ' N ' ' A' ' 95' ' ' VAL . 33.7 m -128.45 158.44 40.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.005 0.431 . . . . 0.0 111.185 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.518 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 14.0 t -151.67 147.34 15.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.709 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.96 131.41 54.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.852 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.493 ' CE1' ' CG2' ' A' ' 111' ' ' VAL . 5.0 m-85 -88.95 159.08 17.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.516 -178.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 49.7 m -151.97 138.89 19.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.947 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 84.1 m -73.43 156.25 38.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.499 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.467 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 40.8 m-20 -91.35 -71.97 0.61 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.313 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.6 t -53.51 -23.32 10.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.968 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.2 29.03 1.7 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.557 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.49 ' CE1' HG12 ' A' ' 126' ' ' ILE . 24.0 m-85 -73.98 -174.82 1.97 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.021 0.439 . . . . 0.0 110.365 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -123.35 99.19 6.21 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 176.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.541 ' HA ' ' HA ' ' A' ' 124' ' ' CYS . 0.0 OUTLIER -52.57 152.95 3.33 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 122.277 1.036 . . . . 0.0 112.387 -175.285 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.479 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 40.6 mm -119.01 150.3 21.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 113.149 -1.841 . . . . 0.0 111.138 -175.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.416 ' O ' ' ND2' ' A' ' 108' ' ' ASN . . . 72.52 33.99 60.59 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.032 -1.08 . . . . 0.0 111.746 -178.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.416 ' ND2' ' O ' ' A' ' 107' ' ' GLY . 8.6 p30 54.05 145.86 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 124.357 1.063 . . . . 0.0 112.997 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.512 ' HA ' ' HG2' ' A' ' 122' ' ' PRO . 0.7 OUTLIER -71.91 -23.48 61.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.764 -178.756 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -62.14 128.24 41.69 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.764 -0.732 . . . . 0.0 113.009 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.493 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 2.5 t -128.9 125.38 62.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.437 HD22 ' N ' ' A' ' 113' ' ' CYS . 1.2 tm? -85.82 135.53 33.68 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.884 0.373 . . . . 0.0 111.456 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.518 ' HB2' ' CZ3' ' A' ' 118' ' ' TRP . 39.1 t -108.01 104.8 14.32 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.232 177.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.9 OUTLIER -164.83 124.04 1.82 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.923 0.392 . . . . 0.0 111.349 179.865 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.23 26.17 11.57 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.409 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.431 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 68.43 13.51 65.4 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.6 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -145.8 172.3 13.52 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.875 0.369 . . . . 0.0 110.702 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.518 ' CZ3' ' HB2' ' A' ' 113' ' ' CYS . 92.5 m95 -111.27 141.67 44.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.876 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.18 163.81 16.09 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.427 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.448 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 3.7 p-10 46.58 48.66 5.79 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.332 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 91.0 Cg_endo -78.5 146.58 21.82 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.496 2.131 . . . . 0.0 110.572 176.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.512 ' HG2' ' HA ' ' A' ' 109' ' ' SER . 56.6 Cg_endo -97.65 -177.44 0.29 Allowed 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 122.048 1.832 . . . . 0.0 114.357 -176.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -118.21 -156.25 0.63 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.273 -1.331 . . . . 0.0 109.018 177.788 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 105' ' ' LEU . 2.0 m -152.65 89.1 1.38 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.061 0.458 . . . . 0.0 110.788 177.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -121.45 160.13 24.79 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.658 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.49 HG12 ' CE1' ' A' ' 103' ' ' TYR . 16.8 mm . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.053 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 18.6 mtm180 . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 121.11 0.481 . . . . 0.0 111.541 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.522 ' HB2' ' CD ' ' A' ' 10' ' ' PRO . 55.6 m -69.42 179.09 0.79 Allowed Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.5 178.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.522 ' CD ' ' HB2' ' A' ' 9' ' ' CYS . 17.9 Cg_endo -88.84 -171.71 0.61 Allowed 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.637 2.225 . . . . 0.0 111.598 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.6 t -57.23 106.22 0.65 Allowed Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.442 ' CG ' HD11 ' A' ' 22' ' ' ILE . 9.6 Cg_endo -52.44 162.75 2.05 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.107 1.872 . . . . 0.0 112.029 -178.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.427 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -62.27 -175.94 0.09 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.025 179.159 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -143.09 -175.36 4.49 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.165 0.507 . . . . 0.0 111.268 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.7 tt -145.23 158.45 13.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.735 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -93.91 -55.2 3.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.446 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.91 45.79 1.24 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.981 0.419 . . . . 0.0 110.858 -179.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -177.18 -179.14 47.38 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.996 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.74 137.6 40.07 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.8 0.333 . . . . 0.0 110.392 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.525 ' CD2' ' CE2' ' A' ' 33' ' ' TYR . 19.3 mt -82.74 154.87 24.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.033 0.444 . . . . 0.0 111.537 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -124.45 84.06 2.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.089 178.515 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.443 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 3.8 mm -68.68 108.94 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.676 -177.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -112.51 19.99 21.2 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.002 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 147.31 127.14 1.73 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.309 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.9 m -116.52 21.09 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.643 0.258 . . . . 0.0 111.47 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -91.01 151.91 20.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.819 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.439 ' CE2' HD11 ' A' ' 51' ' ' LEU . 9.2 t80 -52.27 96.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.832 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 122.6 13.01 4.83 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.957 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.6 m -101.23 -162.64 0.95 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.862 0.331 . . . . 0.0 110.427 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 47' ' ' SER . 0.9 OUTLIER -166.01 146.62 6.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.05 0.452 . . . . 0.0 111.347 179.12 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.506 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.9 OUTLIER -104.05 172.91 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.364 179.614 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.42 ' O ' ' N ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -134.52 115.14 13.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.922 0.392 . . . . 0.0 111.038 179.722 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.525 ' CE2' ' CD2' ' A' ' 20' ' ' LEU . 19.2 m-85 -88.16 149.45 23.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.034 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 81.4 p -151.24 154.17 36.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.651 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.411 ' HB2' ' HB2' ' A' ' 39' ' ' TYR . 6.3 m -78.04 167.87 20.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.787 0.327 . . . . 0.0 110.868 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -69.01 -83.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.407 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.04 132.08 11.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.889 0.376 . . . . 0.0 110.982 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.48 22.58 76.54 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.98 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.579 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.2 m-85 -117.43 -179.93 3.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.972 0.415 . . . . 0.0 110.908 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.507 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.7 OUTLIER -144.79 114.73 7.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.25 178.338 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.441 HD22 ' CB ' ' A' ' 45' ' ' SER . 7.5 tt -73.91 126.14 29.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.594 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.507 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 1.7 mm -101.99 156.06 4.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.004 0.43 . . . . 0.0 110.945 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.29 -147.32 39.02 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.271 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.413 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 3.4 pt-20 -65.98 -176.22 0.38 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.928 0.394 . . . . 0.0 110.633 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.441 ' CB ' HD22 ' A' ' 41' ' ' LEU . 1.2 t -163.91 25.9 0.08 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.945 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.7 mtpt -152.88 128.16 9.85 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.966 0.412 . . . . 0.0 112.02 -178.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.445 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 1.0 OUTLIER -92.16 142.09 27.88 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 176.572 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.516 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 1.2 m-85 -117.22 120.28 37.79 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 119.099 -1.04 . . . . 0.0 112.255 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 34.8 t -71.57 100.78 2.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.753 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.46 -173.4 2.67 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.014 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.439 HD11 ' CE2' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.873 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.523 -0.077 0 CA-C-O 120.833 0.349 . . . . 0.0 110.186 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.1 m -151.97 173.99 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.975 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.506 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 72.8 m95 -126.82 123.21 36.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.357 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.516 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 1.0 OUTLIER -69.99 166.32 34.12 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.363 178.578 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.461 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 76.7 Cg_exo -21.57 97.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 125.044 3.829 . . . . 0.0 114.163 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.448 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -94.85 -78.34 0.45 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.05 -177.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.485 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -78.07 108.25 7.15 Favored Pre-proline 0 C--N 1.331 -0.216 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -176.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.434 ' HG3' ' CD1' ' A' ' 41' ' ' LEU . 2.4 Cg_endo -87.3 -156.19 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.115 2.543 . . . . 0.0 111.016 177.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.426 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 2.9 mm -88.89 169.25 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.967 0.413 . . . . 0.0 110.67 178.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -169.97 134.29 1.28 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.734 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.467 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 1.4 tt0 -155.06 -177.84 6.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.54 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.579 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 2.7 p -75.02 147.59 40.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.646 0.736 . . . . 0.0 111.336 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.424 HG23 ' N ' ' A' ' 116' ' ' GLY . 0.0 OUTLIER -61.86 100.72 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 114.504 -1.226 . . . . 0.0 110.312 -179.371 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 89' ' ' TYR . 0.3 OUTLIER -105.62 119.42 39.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.3 -178.222 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.27 119.26 38.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.467 176.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.28 -157.93 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.412 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.423 ' OG ' ' NE2' ' A' ' 82' ' ' HIS . 2.4 t -51.66 136.66 34.04 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.625 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.482 ' HD2' ' CD2' ' A' ' 82' ' ' HIS . 52.2 Cg_exo -55.05 159.17 10.12 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.411 2.074 . . . . 0.0 112.302 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.419 ' N ' ' OH ' ' A' ' 97' ' ' TYR . 89.5 Cg_exo -44.39 156.44 0.21 Allowed 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.632 2.221 . . . . 0.0 112.597 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 95.6 p -102.94 89.87 3.59 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.775 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.3 pt -69.61 176.29 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.127 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.79 143.54 26.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.974 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.442 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 12.5 m-80 52.86 29.5 7.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.148 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.461 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -162.15 -169.16 25.11 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.275 -0.964 . . . . 0.0 113.353 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.72 -173.98 3.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.872 0.368 . . . . 0.0 110.489 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.482 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 7.3 p-80 -113.28 167.17 10.78 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.558 -179.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 96' ' ' THR . 16.2 m-20 . . . . . 0 CA--C 1.518 -0.268 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.832 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.433 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 7.3 m-85 . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 120.821 0.343 . . . . 0.0 110.761 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.461 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 22.4 m-85 -141.8 162.33 35.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.13 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.4 p -122.25 174.91 6.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.173 0.511 . . . . 0.0 112.123 -177.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -60.29 95.53 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.163 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 122.46 18.19 3.4 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.291 -0.868 . . . . 0.0 113.075 178.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.09 157.02 16.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.739 0.304 . . . . 0.0 110.595 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 28.6 m -143.52 141.87 25.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.225 0.536 . . . . 0.0 111.152 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.551 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 40.2 t -142.48 142.1 27.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.941 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.444 ' O ' ' N ' ' A' ' 83' ' ' ASN . 0.1 OUTLIER -89.01 149.54 23.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.646 -177.079 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.472 ' CE1' HG23 ' A' ' 111' ' ' VAL . 4.1 m-85 -105.16 159.63 15.71 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.986 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.0 m -157.17 153.65 28.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.039 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 59.5 m -80.02 160.9 25.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.816 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.461 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 60.2 m-20 -87.59 -70.93 0.59 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.418 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.42 -27.62 67.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.24 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.57 35.53 0.49 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.791 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.498 ' CE2' HG12 ' A' ' 126' ' ' ILE . 15.8 m-85 -70.78 -174.68 0.95 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.914 0.387 . . . . 0.0 110.587 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.4 98.16 7.61 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.162 178.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.446 HD22 ' CB ' ' A' ' 122' ' ' PRO . 0.3 OUTLIER -46.47 122.53 4.17 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.507 0.67 . . . . 0.0 112.268 -177.747 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.43 ' HB ' ' CB ' ' A' ' 123' ' ' THR . 5.1 mm -85.06 154.73 3.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.938 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.85 -126.1 33.94 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.209 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -123.48 140.99 52.45 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.936 0.398 . . . . 0.0 111.024 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.428 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 1.8 t -73.05 -29.41 62.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.948 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -78.23 127.83 8.4 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.002 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.472 HG23 ' CE1' ' A' ' 97' ' ' TYR . 3.1 t -118.41 139.97 43.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 178.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.81 131.51 43.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.146 0.498 . . . . 0.0 111.567 -178.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.48 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 12.0 t -97.45 95.16 7.47 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.446 176.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.9 t -151.07 153.14 34.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.455 -178.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.12 -0.56 62.64 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.645 -0.707 . . . . 0.0 113.491 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.424 ' N ' HG23 ' A' ' 69' ' ' VAL . . . 100.24 1.54 55.79 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.902 -177.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -146.3 177.12 9.25 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.821 0.343 . . . . 0.0 110.708 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.551 ' CH2' ' CG2' ' A' ' 95' ' ' VAL . 95.2 m95 -99.01 155.61 17.34 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.717 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.09 155.28 44.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.031 0.444 . . . . 0.0 111.19 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.481 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.7 OUTLIER 66.22 47.0 0.49 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.798 179.599 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 87.0 Cg_endo -79.4 139.3 14.5 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.476 2.117 . . . . 0.0 111.698 178.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.446 ' CB ' HD22 ' A' ' 105' ' ' LEU . 50.3 Cg_endo -90.61 -174.72 0.76 Allowed 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.5 2.133 . . . . 0.0 113.2 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.43 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -128.4 -157.79 0.84 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.499 177.576 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 3.5 m -157.6 89.56 1.04 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.13 0.491 . . . . 0.0 111.133 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.41 ' HB3' ' CD1' ' A' ' 106' ' ' ILE . 16.4 mt-30 -114.5 170.87 7.99 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.783 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.498 HG12 ' CE2' ' A' ' 103' ' ' TYR . 49.1 mm . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.792 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.429 ' CD ' HG23 ' A' ' 25' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.095 0 CA-C-O 120.851 0.358 . . . . 0.0 111.394 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.461 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 15.1 m -78.67 161.62 68.58 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.448 178.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.02 167.32 25.13 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.338 2.025 . . . . 0.0 111.703 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 t -51.02 105.44 0.52 Allowed Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.936 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.414 ' HG2' ' CZ2' ' A' ' 59' ' ' TRP . 51.3 Cg_exo -50.76 151.07 11.46 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.151 1.901 . . . . 0.0 111.731 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.433 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 7.1 mpt_? -55.7 159.24 3.11 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.82 -173.85 2.33 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.2 0.524 . . . . 0.0 111.615 -177.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.429 HG22 ' CD2' ' A' ' 20' ' ' LEU . 9.2 tt -152.57 138.92 12.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.539 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -82.2 -57.31 3.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.676 -177.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.494 ' HB2' ' CE1' ' A' ' 39' ' ' TYR . 1.2 m120 -91.2 45.84 1.27 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.055 0.455 . . . . 0.0 111.069 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -176.65 -179.46 47.09 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.39 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.64 137.36 41.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.815 0.341 . . . . 0.0 110.773 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.476 HD21 ' CD2' ' A' ' 33' ' ' TYR . 14.5 mt -75.9 152.15 37.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.215 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.442 ' HB2' ' CB ' ' A' ' 32' ' ' THR . 19.4 t0 -120.92 69.64 0.89 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.447 177.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.1 mt -80.84 90.95 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.883 -176.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.85 16.13 59.07 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.81 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 165.83 133.21 1.48 Allowed Glycine 0 C--N 1.334 0.435 0 C-N-CA 121.176 -0.535 . . . . 0.0 111.765 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.429 HG23 ' CD ' ' A' ' 8' ' ' ARG . 1.7 m -119.43 -2.54 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -178.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.403 ' HA ' ' HB3' ' A' ' 8' ' ' ARG . 29.3 t0 -75.88 164.13 26.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.986 0.422 . . . . 0.0 110.814 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.425 ' CE2' ' HB2' ' A' ' 51' ' ' LEU . 13.1 t80 -52.03 115.81 1.88 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.09 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.73 -4.59 46.57 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.764 -0.731 . . . . 0.0 113.066 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 57.9 m -74.99 176.83 6.81 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 117.029 0.415 . . . . 0.0 110.602 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 47' ' ' SER . 2.5 p -144.47 149.99 36.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.952 0.406 . . . . 0.0 111.464 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.544 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -118.74 165.83 13.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.468 179.353 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.442 ' CB ' ' HB2' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -135.9 111.75 9.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.896 178.547 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.524 ' CE2' ' CB ' ' A' ' 63' ' ' ALA . 31.6 m-85 -84.06 135.78 34.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.062 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 84.4 p -141.05 146.86 37.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.154 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.45 ' HB2' ' HB2' ' A' ' 39' ' ' TYR . 1.7 m -73.38 174.31 8.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.794 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.68 -82.42 0.06 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.39 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.2 m -155.14 120.16 4.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.476 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.416 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . 77.42 -0.58 68.69 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.475 -177.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.517 ' CZ ' ' CB ' ' A' ' 68' ' ' SER . 5.9 m-85 -89.48 166.43 13.69 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 120.782 0.325 . . . . 0.0 110.832 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.528 ' CE1' ' CG2' ' A' ' 69' ' ' VAL . 0.0 OUTLIER -121.46 127.68 51.34 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 176.578 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.429 ' CD2' ' O ' ' A' ' 44' ' ' GLU . 6.0 tt -86.02 117.2 24.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.135 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.1 mm -92.41 153.83 3.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.475 -177.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.82 -151.29 50.27 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.26 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.439 ' O ' ' CG ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -55.28 178.92 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.534 0.206 . . . . 0.0 110.536 179.504 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.6 p -152.14 18.8 0.66 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.608 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.77 175.72 13.36 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.923 0.392 . . . . 0.0 110.958 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.441 ' HB3' ' CG1' ' A' ' 31' ' ' ILE . 2.6 m -149.63 123.03 9.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.297 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.407 ' O ' ' N ' ' A' ' 50' ' ' GLU . 4.9 m-85 -103.0 114.16 28.23 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.973 0.416 . . . . 0.0 111.452 -178.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.459 ' HB3' ' CH2' ' A' ' 59' ' ' TRP . 42.2 t -64.97 77.44 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.374 0.607 . . . . 0.0 110.076 178.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.5 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 1.9 tt0 -97.33 175.13 6.37 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.907 -177.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.5 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.514 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.106 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.414 ' HA ' ' HA ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.961 0.41 . . . . 0.0 110.71 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.1 m -126.03 -176.79 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.383 -178.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.544 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 97.5 m95 -116.38 125.6 52.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.126 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -150.08 118.73 3.68 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.771 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -73.21 -172.16 9.47 Favored 'Cis proline' 0 C--N 1.35 0.633 0 C-N-CA 124.221 -1.158 . . . . 0.0 112.413 1.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -111.11 -152.5 0.5 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.891 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.524 ' CB ' ' CE2' ' A' ' 33' ' ' TYR . . . -79.38 111.27 19.31 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.651 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.439 ' CG ' ' O ' ' A' ' 44' ' ' GLU . 15.3 Cg_exo -69.07 -150.76 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.662 2.241 . . . . 0.0 112.296 -179.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -108.36 -179.69 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.117 0.484 . . . . 0.0 111.222 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -167.43 118.52 0.87 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.524 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.469 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 0.1 OUTLIER -113.4 166.74 11.2 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.689 179.888 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.517 ' CB ' ' CZ ' ' A' ' 39' ' ' TYR . 1.1 p -107.53 120.42 42.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.993 0.425 . . . . 0.0 111.047 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.528 ' CG2' ' CE1' ' A' ' 40' ' ' HIS . 3.1 p -46.4 94.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.439 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.8 125.44 29.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.276 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.432 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -104.33 126.06 51.1 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.326 178.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -73.62 -169.12 0.65 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.472 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -42.42 135.05 2.59 Favored Pre-proline 0 N--CA 1.438 -1.065 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.436 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.46 ' HA ' ' CD1' ' A' ' 118' ' ' TRP . 34.5 Cg_exo -56.05 159.88 11.45 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.188 1.925 . . . . 0.0 111.923 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.489 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 96.1 Cg_exo -40.85 156.6 0.05 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.757 2.305 . . . . 0.0 112.855 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.3 m -108.5 90.12 3.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.647 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.422 ' CG2' ' O ' ' A' ' 122' ' ' PRO . 16.5 pt -69.41 170.85 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.298 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.39 133.78 35.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.777 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.483 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 0.2 OUTLIER 67.9 26.41 7.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.602 -179.643 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.412 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . -171.44 -170.83 35.96 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.732 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.15 -175.47 2.0 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.958 0.409 . . . . 0.0 110.801 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.452 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 12.3 p80 -95.04 176.11 6.37 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.891 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.43 ' ND2' ' HB ' ' A' ' 96' ' ' THR . 2.7 m-20 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.169 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.414 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 6.0 m-85 . . . . . 0 N--CA 1.457 -0.121 0 CA-C-O 120.976 0.417 . . . . 0.0 111.154 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.432 ' N ' ' O ' ' A' ' 71' ' ' CYS . 33.0 m-85 -145.05 170.32 16.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.613 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.4 p -133.25 175.38 9.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.913 0.387 . . . . 0.0 111.18 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -60.19 94.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.307 0.575 . . . . 0.0 111.038 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 128.31 28.1 0.86 Allowed Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.294 -0.866 . . . . 0.0 113.18 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.11 164.88 12.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.791 0.295 . . . . 0.0 110.661 179.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 33.5 m -138.47 154.81 27.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.067 0.461 . . . . 0.0 111.274 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.501 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 21.7 t -152.42 148.5 14.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.021 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.43 ' HB ' ' ND2' ' A' ' 83' ' ' ASN . 0.1 OUTLIER -104.99 142.94 33.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.306 179.007 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.515 ' CE2' ' CG2' ' A' ' 111' ' ' VAL . 4.6 m-85 -101.43 155.4 18.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.946 0.403 . . . . 0.0 111.279 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 45.9 m -148.57 141.93 25.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.165 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.412 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 73.5 m -72.75 162.35 29.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.759 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.4 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 39.7 m-20 -92.74 -70.59 0.69 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.347 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.5 m -63.79 -23.37 67.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.198 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 122.21 33.0 0.93 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.495 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.491 ' CE2' HG12 ' A' ' 126' ' ' ILE . 22.6 m-85 -69.9 -176.95 1.19 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.022 0.439 . . . . 0.0 110.725 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.2 m -108.11 101.73 10.94 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.185 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.43 HD23 ' CB ' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -46.32 125.18 6.44 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.426 0.631 . . . . 0.0 111.771 -178.255 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.44 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 34.6 mm -90.79 152.1 3.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.931 -1.032 . . . . 0.0 110.282 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 68.86 -127.49 22.33 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.257 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.59 132.48 52.51 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.712 0.291 . . . . 0.0 110.946 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.447 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 1.9 t -62.87 -33.16 74.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.773 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -66.03 139.42 38.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.781 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.515 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 3.0 t -136.44 119.91 23.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.571 0.224 . . . . 0.0 110.705 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.93 128.72 33.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.965 0.412 . . . . 0.0 111.47 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.506 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 17.7 t -92.8 102.29 14.68 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 176.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.1 p -144.54 162.86 35.51 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.074 0.464 . . . . 0.0 111.401 -177.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.2 29.0 4.66 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.778 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.429 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 70.15 16.15 72.78 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.4 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -141.51 -177.76 5.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.869 0.366 . . . . 0.0 110.659 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.506 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 95.1 m95 -117.04 142.19 47.29 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.082 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.18 149.92 47.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.247 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.488 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 2.0 t0 70.14 46.01 0.27 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.036 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 84.1 Cg_endo -78.18 134.43 12.9 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.442 2.095 . . . . 0.0 111.831 178.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.447 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 73.9 Cg_endo -89.05 -173.06 0.74 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.62 2.214 . . . . 0.0 113.432 -178.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.39 -160.76 1.07 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.96 178.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 8.2 m -153.28 91.19 1.49 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.141 0.496 . . . . 0.0 110.957 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -122.39 157.74 31.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.616 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.491 HG12 ' CE2' ' A' ' 103' ' ' TYR . 24.0 mm . . . . . 0 C--N 1.323 -0.584 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.932 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.42 ' HA ' ' HA ' ' A' ' 26' ' ' ASP . 3.1 mtm180 . . . . . 0 N--CA 1.455 -0.184 0 CA-C-O 121.167 0.508 . . . . 0.0 112.363 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.444 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 4.2 m -122.58 164.65 25.24 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.339 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.436 ' HD3' ' HB2' ' A' ' 9' ' ' CYS . 44.3 Cg_endo -66.13 168.05 16.7 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.145 1.897 . . . . 0.0 111.465 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.5 t -52.84 105.95 0.6 Allowed Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.047 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.445 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 17.2 Cg_exo -42.15 158.1 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.212 1.941 . . . . 0.0 112.164 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.428 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -74.87 166.93 22.84 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.155 178.411 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.402 ' HA ' HD11 ' A' ' 20' ' ' LEU . 12.0 p-10 -121.48 -175.21 3.03 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 121.079 0.466 . . . . 0.0 112.022 -176.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.425 ' CD1' ' O ' ' A' ' 64' ' ' PRO . 16.9 tt -151.52 147.21 15.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.715 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.417 ' HB2' ' ND2' ' A' ' 17' ' ' ASN . 4.7 t0 -87.2 156.72 19.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.219 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.523 ' CB ' ' CE1' ' A' ' 39' ' ' TYR . 0.5 OUTLIER 45.44 27.02 0.34 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.096 -179.611 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -147.38 176.96 25.97 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.207 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.54 136.23 34.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.787 0.327 . . . . 0.0 110.812 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.445 HD23 ' CE2' ' A' ' 33' ' ' TYR . 3.5 mt -87.7 159.26 18.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.62 178.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.431 ' CB ' ' HB ' ' A' ' 32' ' ' THR . 5.3 t0 -124.76 71.23 1.16 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.049 177.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.454 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 0.8 OUTLIER -74.19 95.38 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.776 -177.748 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.77 19.14 55.71 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.722 177.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 158.93 132.16 1.34 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.227 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.0 m -118.63 33.35 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.543 0.211 . . . . 0.0 111.521 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 43.9 t0 -105.0 162.87 12.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.043 0.449 . . . . 0.0 111.513 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.464 ' CZ ' HD11 ' A' ' 51' ' ' LEU . 5.2 t80 -59.96 91.73 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.619 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.15 3.56 6.79 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.638 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.77 -165.84 1.39 Allowed 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.843 0.321 . . . . 0.0 110.312 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 67.4 p -162.84 146.81 11.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.298 0.57 . . . . 0.0 111.593 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.537 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.5 OUTLIER -114.17 160.45 13.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.871 179.57 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.431 ' HB ' ' CB ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -123.3 120.48 33.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.919 0.39 . . . . 0.0 110.899 179.184 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.634 ' CZ ' ' O ' ' A' ' 62' ' ' GLU . 2.2 m-85 -91.98 142.32 27.66 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.533 -178.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.91 164.82 37.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.669 -179.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 64.6 m -90.17 172.55 8.72 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.867 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.4 m-20 -78.17 -83.35 0.08 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.205 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.79 135.53 17.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.665 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.423 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . 63.31 26.35 69.34 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.867 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.523 ' CE1' ' CB ' ' A' ' 17' ' ' ASN . 2.4 m-85 -120.11 171.28 8.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.807 0.337 . . . . 0.0 111.171 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.481 ' CE1' HD13 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -133.86 127.86 33.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.289 178.275 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.44 ' CD2' ' HG3' ' A' ' 64' ' ' PRO . 1.7 tt -87.72 124.6 33.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.671 -178.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.481 HD13 ' CE1' ' A' ' 40' ' ' HIS . 0.9 OUTLIER -108.06 131.34 58.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.312 0.577 . . . . 0.0 111.038 -179.432 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 112.86 -146.37 18.34 Favored Glycine 0 C--N 1.321 -0.261 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.204 -177.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.51 ' HG2' ' HG2' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -74.31 -135.59 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 176.912 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.425 ' HB3' ' O ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER 174.02 26.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 117.965 0.348 . . . . 0.0 110.784 177.71 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.474 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 4.3 mttt -160.22 134.49 7.4 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.786 -178.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.435 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 32.1 t -107.69 144.38 34.88 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.908 177.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.493 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 3.4 m-85 -126.41 120.27 29.36 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 119.41 -0.916 . . . . 0.0 112.461 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 32.5 t -64.01 99.28 0.25 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.538 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -124.2 -173.7 2.83 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.112 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.464 HD11 ' CZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.02 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.5 mmt . . . . . 0 N--CA 1.455 -0.186 0 CA-C-O 120.868 0.366 . . . . 0.0 110.433 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.7 m -137.04 179.91 3.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.936 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.537 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 66.5 m95 -124.74 127.18 46.84 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.289 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.493 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -69.53 168.97 13.75 Favored Pre-proline 0 CA--C 1.513 -0.449 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.486 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 1.0 OUTLIER -4.97 85.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.282 1 C-N-CA 125.326 4.017 . . . . 0.0 113.816 -179.107 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.634 ' O ' ' CZ ' ' A' ' 33' ' ' TYR . 15.3 mt-10 -69.09 -53.07 22.21 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-N 113.052 -1.885 . . . . 0.0 111.649 -174.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.569 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -65.31 -148.51 0.0 OUTLIER Pre-proline 0 CA--C 1.487 -1.454 0 CA-C-O 116.708 -1.615 . . . . 0.0 108.043 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.547 ' CA ' ' CB ' ' A' ' 63' ' ' ALA . 3.9 Cg_exo -85.91 -157.44 1.25 Allowed 'Cis proline' 0 N--CA 1.484 0.934 0 CA-C-N 123.772 2.383 . . . . 0.0 115.013 16.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.2 mm -95.68 175.01 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.0 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.6 m -147.67 135.11 20.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.185 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.484 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 3.0 tt0 -140.55 174.06 10.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.755 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.471 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 37.4 p -89.03 118.87 29.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.984 0.421 . . . . 0.0 111.235 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.436 HG12 ' N ' ' A' ' 116' ' ' GLY . 0.1 OUTLIER -40.59 98.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.728 179.773 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.3 mmtp -67.71 137.04 55.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.389 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.03 124.77 50.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.13 178.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -69.26 -156.31 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.319 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.47 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 1.4 t -53.45 145.6 27.15 Favored Pre-proline 0 N--CA 1.45 -0.463 0 CA-C-O 120.59 0.234 . . . . 0.0 110.542 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.448 ' HA ' ' CD1' ' A' ' 118' ' ' TRP . 18.8 Cg_exo -65.29 160.63 41.4 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.53 2.154 . . . . 0.0 112.031 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.493 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 86.8 Cg_exo -40.54 156.68 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.801 2.334 . . . . 0.0 112.892 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.15 91.85 3.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.528 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.407 HG22 ' CD1' ' A' ' 97' ' ' TYR . 15.6 pt -68.98 175.91 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.07 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.9 m -94.49 140.91 29.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.912 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.488 ' HB3' ' CE1' ' A' ' 103' ' ' TYR . 7.0 m-80 57.47 29.25 16.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.989 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.46 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -163.57 -168.03 24.94 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.392 -0.909 . . . . 0.0 112.86 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 7.7 ptt85 -162.48 -175.91 4.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.007 0.432 . . . . 0.0 110.903 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.47 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 4.6 p80 -111.18 172.12 7.07 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.625 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.507 179.426 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.432 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 7.0 m-85 . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.939 0.4 . . . . 0.0 111.333 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.432 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 62.8 m-85 -151.24 164.72 35.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.546 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 19.0 p -128.84 178.47 6.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.912 0.387 . . . . 0.0 111.114 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 14.5 t0 -64.55 101.5 0.46 Allowed 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 121.814 0.816 . . . . 0.0 111.01 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 121.55 21.39 3.01 Favored Glycine 0 C--N 1.311 -0.811 0 CA-C-N 114.312 -1.313 . . . . 0.0 112.993 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.39 160.79 14.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.845 0.322 . . . . 0.0 110.641 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 33.7 m -134.37 152.9 34.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.156 0.503 . . . . 0.0 111.515 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.516 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 27.7 t -146.49 148.71 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.688 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.41 ' CG2' ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -105.51 132.87 51.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.96 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.522 ' CE2' ' CG2' ' A' ' 111' ' ' VAL . 5.2 m-85 -93.29 159.07 15.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.005 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 56.3 p -156.11 143.67 19.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.204 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 62.3 m -72.35 160.49 32.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.305 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.46 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 8.1 m-20 -94.45 -71.01 0.68 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.408 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.95 -21.77 66.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.455 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.65 30.88 1.2 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.694 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.502 ' CE2' HG12 ' A' ' 126' ' ' ILE . 51.1 m-85 -71.27 -172.72 0.76 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.658 0.266 . . . . 0.0 110.469 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -109.62 109.3 20.01 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.011 0.434 . . . . 0.0 111.146 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.42 HD21 ' CG ' ' A' ' 122' ' ' PRO . 2.7 tp -47.56 113.56 0.72 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.662 178.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.446 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 39.0 mm -84.86 149.73 4.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.495 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.409 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 59.93 -132.43 50.92 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.385 -0.912 . . . . 0.0 111.794 -178.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -112.29 133.45 54.4 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.826 0.346 . . . . 0.0 111.477 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.485 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 1.3 t -64.92 -27.31 68.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.44 178.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.34 138.95 31.37 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.836 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.522 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 3.1 t -134.98 123.83 41.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.462 0.173 . . . . 0.0 110.576 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.5 126.94 32.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.964 0.411 . . . . 0.0 111.976 -178.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.501 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 16.4 t -92.4 104.8 17.09 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 176.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 83.1 p -151.79 165.68 33.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.947 -177.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.99 30.71 5.27 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.865 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.436 ' N ' HG12 ' A' ' 69' ' ' VAL . . . 67.9 8.79 54.69 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.51 -179.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -136.98 179.51 6.34 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.817 0.341 . . . . 0.0 110.771 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.516 ' CH2' ' CG2' ' A' ' 95' ' ' VAL . 94.2 m95 -113.5 136.58 52.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.901 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.77 155.86 37.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.134 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.522 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 34.6 t0 67.99 41.94 0.25 Allowed Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 81.4 Cg_endo -78.52 143.21 19.04 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.431 2.087 . . . . 0.0 112.03 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.485 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 57.4 Cg_endo -91.19 -172.66 0.49 Allowed 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.895 2.397 . . . . 0.0 113.353 -179.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.437 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -133.47 -177.19 4.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.274 178.097 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 6.4 m -142.13 96.68 3.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.972 0.415 . . . . 0.0 110.908 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -121.23 170.1 9.91 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.81 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.502 HG12 ' CE2' ' A' ' 103' ' ' TYR . 36.5 mm . . . . . 0 C--N 1.324 -0.515 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.823 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.436 ' CD ' HG22 ' A' ' 25' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.177 0 CA-C-O 120.838 0.352 . . . . 0.0 111.549 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.416 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 6.9 m -87.56 162.29 42.69 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.638 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.402 ' HD3' ' HB2' ' A' ' 9' ' ' CYS . 59.3 Cg_endo -70.29 169.26 20.0 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.275 1.983 . . . . 0.0 111.532 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -50.47 111.81 2.43 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.021 -179.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.53 157.42 58.42 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.495 2.13 . . . . 0.0 112.002 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.437 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 10.4 ttt180 -53.85 -179.74 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.956 178.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.473 ' O ' ' CG2' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -141.3 -3.26 1.2 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -177.662 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.473 ' CG2' ' O ' ' A' ' 14' ' ' ASP . 15.6 tt 56.03 156.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 122.599 0.36 . . . . 0.0 111.114 -177.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -88.37 -63.34 1.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -176.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.425 ' HA ' ' ND2' ' A' ' 36' ' ' ASN . 0.4 OUTLIER -92.42 26.04 2.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.442 -177.797 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.417 ' HA2' ' N ' ' A' ' 36' ' ' ASN . . . -147.8 177.69 25.9 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.955 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -137.61 139.08 40.15 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.504 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -94.6 174.37 7.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.311 0.577 . . . . 0.0 111.532 -178.395 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 32' ' ' THR . 10.0 t0 -133.12 88.34 2.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.562 177.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.448 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 59.9 mt -71.58 115.79 12.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.091 -177.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -122.44 19.06 8.15 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.666 177.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 159.83 131.94 1.3 Allowed Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.436 HG22 ' CD ' ' A' ' 8' ' ' ARG . 6.6 m -124.24 5.36 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -77.33 164.46 25.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.036 0.446 . . . . 0.0 110.983 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.483 ' CZ ' ' CD1' ' A' ' 51' ' ' LEU . 4.8 t80 -57.1 101.83 0.07 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.201 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 115.45 7.7 15.73 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.958 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.2 p -88.76 -169.11 2.41 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.924 0.362 . . . . 0.0 110.62 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.4 p -160.16 151.3 19.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.953 0.406 . . . . 0.0 111.391 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.519 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.8 OUTLIER -115.78 169.84 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.477 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -123.27 113.1 18.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.956 0.408 . . . . 0.0 111.186 179.259 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.491 ' CD2' HD23 ' A' ' 20' ' ' LEU . 17.3 m-85 -88.86 140.92 28.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.218 0.533 . . . . 0.0 111.718 -179.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.92 170.69 15.66 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.231 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.404 ' HB2' ' HB2' ' A' ' 39' ' ' TYR . 1.7 m -89.19 166.14 14.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.716 0.293 . . . . 0.0 110.903 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.425 ' ND2' ' HA ' ' A' ' 17' ' ' ASN . 22.9 m-20 -64.42 -84.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.029 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.86 134.02 13.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.81 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.89 23.62 67.66 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.093 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.483 ' CE2' ' HB2' ' A' ' 68' ' ' SER . 2.5 m-85 -115.88 174.27 6.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.81 0.338 . . . . 0.0 111.007 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.518 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.3 OUTLIER -137.21 112.57 9.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.46 178.142 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.402 HD21 ' HB3' ' A' ' 45' ' ' SER . 4.5 tt -77.51 130.63 37.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.772 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.518 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 2.6 mm -105.52 154.17 6.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.851 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.07 -137.9 17.83 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.273 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.83 -174.21 4.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.948 0.404 . . . . 0.0 110.931 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.402 ' HB3' HD21 ' A' ' 41' ' ' LEU . 5.1 p -160.55 25.48 0.15 Allowed 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.067 -179.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.3 mtpt -152.29 132.11 13.27 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.021 0.438 . . . . 0.0 112.179 -178.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.428 ' HB3' ' HA ' ' A' ' 62' ' ' GLU . 26.4 t -96.83 153.12 18.07 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.766 177.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.487 ' CD1' ' HB2' ' A' ' 60' ' ' ASN . 1.4 m-85 -128.68 114.53 16.75 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 119.248 -0.981 . . . . 0.0 111.895 178.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 29.8 t -63.07 109.29 1.45 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.663 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.97 -176.49 4.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.045 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.483 ' CD1' ' CZ ' ' A' ' 27' ' ' PHE . 5.0 mt . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.199 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.6 mmt . . . . . 0 N--CA 1.456 -0.131 0 CA-C-O 120.835 0.35 . . . . 0.0 110.615 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 51' ' ' LEU . 31.0 m -138.68 -175.17 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.968 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.519 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 68.0 m95 -131.06 134.85 47.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.059 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.487 ' HB2' ' CD1' ' A' ' 48' ' ' TYR . 1.2 m-80 -75.06 166.6 44.13 Favored Pre-proline 0 CA--C 1.517 -0.297 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 177.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.475 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 23.2 Cg_exo -8.96 92.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 0.986 1 C-N-CA 125.568 4.178 . . . . 0.0 114.546 -179.559 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.469 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 3.6 mm-40 -82.91 -87.4 0.1 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.936 -175.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.48 ' HA ' ' CD2' ' A' ' 33' ' ' TYR . . . -96.32 108.18 40.18 Favored Pre-proline 0 C--N 1.332 -0.169 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -176.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -74.71 -151.5 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.797 2.331 . . . . 0.0 111.334 177.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.401 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 4.8 mm -88.8 166.24 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 0.0 110.712 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -165.54 137.17 4.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.884 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.06 169.94 23.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.928 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.483 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 1.1 t -80.59 123.75 28.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.146 0.498 . . . . 0.0 111.008 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.9 p -50.74 104.09 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.984 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.418 ' HD3' ' HB2' ' A' ' 88' ' ' PHE . 46.3 mmtt -71.43 121.65 18.97 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.128 -178.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.418 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -109.2 121.58 45.47 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 176.435 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -69.77 -162.02 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.513 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.477 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 1.1 t -53.32 141.58 41.63 Favored Pre-proline 0 N--CA 1.449 -0.487 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.328 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.488 ' HD2' ' CD2' ' A' ' 82' ' ' HIS . 24.9 Cg_exo -58.3 159.74 18.38 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.204 1.936 . . . . 0.0 111.515 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.402 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 78.1 Cg_exo -39.21 154.56 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.707 2.271 . . . . 0.0 112.799 -178.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.2 t -107.3 89.53 3.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.885 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.7 pt -70.12 -177.92 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.327 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.7 m -104.33 142.32 34.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.583 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.492 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 5.4 m-80 61.9 29.79 17.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.814 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.442 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . -175.78 -168.92 36.78 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.771 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -170.55 -174.66 1.68 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.907 0.384 . . . . 0.0 110.535 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.488 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 2.1 p80 -103.15 170.94 7.66 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.152 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.322 -179.561 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.435 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 10.5 m-85 . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.882 0.372 . . . . 0.0 111.094 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.435 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 59.1 m-85 -148.82 152.74 37.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.665 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.4 p -102.0 175.18 5.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.099 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.9 103.12 2.13 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.652 0.739 . . . . 0.0 110.65 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 120.55 24.66 2.56 Favored Glycine 0 C--N 1.312 -0.778 0 CA-C-N 114.588 -1.187 . . . . 0.0 112.751 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.54 163.57 12.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.711 0.291 . . . . 0.0 110.627 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.416 ' CG2' ' N ' ' A' ' 95' ' ' VAL . 32.6 m -136.27 158.48 38.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.17 0.51 . . . . 0.0 111.333 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.483 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 22.1 t -153.07 150.4 12.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.769 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.4 136.36 48.16 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.355 178.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.481 ' CE1' HG23 ' A' ' 111' ' ' VAL . 4.9 m-85 -93.81 155.57 17.13 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.938 0.399 . . . . 0.0 110.987 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -154.81 144.78 21.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.408 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.442 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 9.5 m -69.95 169.14 13.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.843 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -99.33 -83.81 0.42 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.531 178.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.9 t -54.01 -36.78 63.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.247 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 136.19 47.38 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.548 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.536 ' CE2' HG12 ' A' ' 126' ' ' ILE . 12.4 m-85 -83.77 -170.18 2.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.672 0.272 . . . . 0.0 110.653 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.4 m -116.92 102.3 9.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.726 0.298 . . . . 0.0 110.821 179.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.38 136.95 11.88 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.632 0.729 . . . . 0.0 111.193 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.434 ' HB ' ' CB ' ' A' ' 123' ' ' THR . 33.2 mm -103.43 158.86 4.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.304 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.426 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 62.38 -126.1 37.17 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.309 -0.948 . . . . 0.0 112.021 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -124.12 131.72 53.57 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.981 0.42 . . . . 0.0 111.121 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.426 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 1.2 p -62.77 -26.52 68.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.857 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.2 142.29 31.38 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.821 -0.627 . . . . 0.0 113.014 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.481 HG23 ' CE1' ' A' ' 97' ' ' TYR . 2.8 t -140.05 127.02 23.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.98 122.25 32.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.873 0.368 . . . . 0.0 111.807 -178.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.509 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 15.5 t -85.16 101.26 12.33 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 176.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.45 167.19 25.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.047 0.451 . . . . 0.0 111.527 -178.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.24 25.11 2.61 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.665 -0.698 . . . . 0.0 113.033 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.82 19.7 79.48 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.222 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -151.31 -179.3 7.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.772 0.32 . . . . 0.0 110.297 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.509 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 90.1 m95 -113.23 138.53 49.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.898 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.41 146.63 46.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.236 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.48 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER 69.89 45.98 0.28 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.17 178.819 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 71.7 Cg_endo -76.95 136.77 16.89 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.313 2.009 . . . . 0.0 111.383 177.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.428 ' CB ' ' O ' ' A' ' 106' ' ' ILE . 56.6 Cg_endo -89.7 179.41 2.15 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.383 2.055 . . . . 0.0 113.582 -178.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.434 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -120.13 -159.99 0.81 Allowed 'General case' 0 CA--C 1.503 -0.858 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.955 176.707 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . 0.401 ' SG ' ' HB2' ' A' ' 103' ' ' TYR . 5.5 t -170.7 91.48 0.16 Allowed 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.376 -176.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -118.92 176.57 5.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.812 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.536 HG12 ' CE2' ' A' ' 103' ' ' TYR . 39.1 mm . . . . . 0 C--N 1.322 -0.601 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.846 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.433 ' CB ' ' HA ' ' A' ' 26' ' ' ASP . 7.7 ptt180 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 121.071 0.463 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.53 ' HB2' ' CD ' ' A' ' 10' ' ' PRO . 72.4 m -83.89 177.12 3.17 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.693 178.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.53 ' CD ' ' HB2' ' A' ' 9' ' ' CYS . 38.4 Cg_endo -90.78 -165.93 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.701 2.267 . . . . 0.0 112.025 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.418 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 0.4 OUTLIER -60.39 108.22 1.35 Allowed Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.273 179.037 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.433 ' CG ' HD12 ' A' ' 22' ' ' ILE . 14.0 Cg_endo -56.67 149.31 59.71 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.153 1.902 . . . . 0.0 111.975 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.423 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.8 OUTLIER -59.25 173.43 0.49 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.28 179.645 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.62 -171.71 2.53 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.147 0.498 . . . . 0.0 111.506 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.483 ' HB ' ' CE2' ' A' ' 33' ' ' TYR . 4.1 tt -151.82 147.23 15.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.004 -178.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.428 ' N ' HG13 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -87.72 154.6 20.44 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 177.3 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.463 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 0.3 OUTLIER 48.52 25.44 0.94 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.885 0.374 . . . . 0.0 110.285 -178.521 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -146.3 170.46 27.4 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.658 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -136.46 138.56 41.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.927 0.394 . . . . 0.0 110.689 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.533 ' CD2' ' CE1' ' A' ' 33' ' ' TYR . 8.2 mt -84.62 155.1 22.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.061 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.436 ' CB ' ' HB ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -125.45 71.22 1.2 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.776 177.857 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.433 HD12 ' CG ' ' A' ' 12' ' ' PRO . 0.8 OUTLIER -70.78 95.69 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.041 -177.024 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.8 19.22 52.91 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.591 176.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.46 141.47 3.22 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.206 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.414 ' O ' ' HB3' ' A' ' 8' ' ' ARG . 3.1 m -114.6 -12.54 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.433 ' HA ' ' CB ' ' A' ' 8' ' ' ARG . 0.8 OUTLIER -69.82 160.3 32.01 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.852 0.358 . . . . 0.0 111.738 -179.033 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.473 ' CE2' HD22 ' A' ' 51' ' ' LEU . 24.1 t80 -50.42 127.21 17.0 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.126 178.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.97 -11.06 71.43 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.065 -178.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 74.5 m -65.31 -173.4 0.13 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.955 0.378 . . . . 0.0 110.065 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.0 p -162.12 146.49 12.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.135 0.493 . . . . 0.0 111.808 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.507 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -118.94 151.22 21.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.83 179.157 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.436 ' HB ' ' CB ' ' A' ' 21' ' ' ASP . 3.1 m -115.52 114.61 25.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.037 0.446 . . . . 0.0 111.428 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.619 ' CZ ' ' O ' ' A' ' 62' ' ' GLU . 2.1 m-85 -80.83 135.9 36.02 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.252 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.7 p -148.24 177.65 9.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.146 -177.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.418 ' HA ' ' HA2' ' A' ' 18' ' ' GLY . 71.9 m -94.16 170.17 9.71 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.634 -178.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.26 -77.82 0.17 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.856 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.03 139.23 17.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.593 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 54.35 29.68 46.99 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.725 -178.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.484 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.0 m-85 -121.14 163.12 18.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.948 0.404 . . . . 0.0 111.161 -179.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.508 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 1.4 p80 -127.68 134.65 49.59 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 176.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.46 ' CD2' ' O ' ' A' ' 44' ' ' GLU . 0.9 OUTLIER -82.72 137.62 34.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.959 -174.572 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.508 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 0.2 OUTLIER -114.88 125.26 72.15 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-O 121.344 0.592 . . . . 0.0 110.995 178.827 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 104.69 -145.43 15.97 Favored Glycine 0 C--N 1.318 -0.452 0 CA-C-N 114.539 -1.21 . . . . 0.0 112.378 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.46 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 11.0 mt-10 -60.97 -134.87 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 178.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.4 p 165.32 23.6 0.0 OUTLIER 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 123.712 0.805 . . . . 0.0 111.086 177.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.515 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 1.6 mttt -162.93 146.6 11.08 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -177.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 61' ' ' PRO . 32.9 t -119.85 152.62 37.05 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.75 176.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.517 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 3.4 m-85 -134.2 119.54 18.93 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 118.825 -1.15 . . . . 0.0 113.184 -178.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.493 ' HB3' ' CH2' ' A' ' 59' ' ' TRP . 36.6 t -65.96 120.87 13.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.902 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.486 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 8.4 tt0 -160.68 168.85 24.02 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.565 0.697 . . . . 0.0 110.845 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.486 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 2.8 pp . . . . . 0 C--N 1.317 -0.847 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.074 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.405 ' HA ' ' HA ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.522 -0.099 0 CA-C-O 120.821 0.343 . . . . 0.0 110.341 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.2 m -159.98 -177.65 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.099 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.507 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 75.6 m95 -126.2 135.2 51.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.972 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.517 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 0.3 OUTLIER -69.58 168.57 16.2 Favored Pre-proline 0 CA--C 1.506 -0.722 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 175.208 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.484 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 0.9 OUTLIER -4.28 120.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.949 1 C-N-CA 125.527 4.151 . . . . 0.0 114.873 -177.209 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.619 ' O ' ' CZ ' ' A' ' 33' ' ' TYR . 13.1 mt-10 -89.18 -62.3 1.51 Allowed 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 114.35 -1.295 . . . . 0.0 111.739 -173.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.572 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -65.45 -153.12 0.0 OUTLIER Pre-proline 0 CA--C 1.484 -1.57 0 CA-C-O 116.704 -1.617 . . . . 0.0 108.691 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.548 ' HA ' ' CB ' ' A' ' 63' ' ' ALA . 4.0 Cg_exo -89.51 -155.14 0.78 Allowed 'Cis proline' 0 N--CA 1.483 0.879 0 CA-C-N 123.037 2.12 . . . . 0.0 114.804 19.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -103.15 -167.98 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.072 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.921 -177.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.7 m -164.19 137.42 5.19 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.822 0.344 . . . . 0.0 111.257 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.481 ' HA ' ' CE2' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -141.24 150.89 43.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.524 -179.431 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.484 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 5.0 t -48.3 139.62 8.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.301 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.428 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 0.9 OUTLIER -67.38 108.2 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.261 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.421 ' HG3' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -77.18 127.92 33.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.761 -179.391 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.41 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -107.1 119.34 39.1 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.681 177.532 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.65 -157.09 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.791 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.5 t -49.18 139.61 13.07 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.08 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.482 ' HD2' ' CD2' ' A' ' 82' ' ' HIS . 25.6 Cg_exo -60.23 159.79 25.33 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.474 2.116 . . . . 0.0 111.9 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.479 ' HD2' ' CG ' ' A' ' 118' ' ' TRP . 86.2 Cg_exo -45.81 153.67 0.8 Allowed 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.433 2.089 . . . . 0.0 112.4 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.4 t -106.62 91.81 3.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.635 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 14.1 pt -69.27 167.02 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.091 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.4 p -84.87 139.97 31.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.897 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.433 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 7.2 m-80 58.63 27.9 16.43 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.139 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.455 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -163.05 -163.08 14.86 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.422 -0.894 . . . . 0.0 113.054 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.415 ' N ' ' O ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -170.44 -174.61 1.7 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.874 0.369 . . . . 0.0 110.859 -179.475 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.498 ' HB3' ' CE1' ' A' ' 97' ' ' TYR . 2.3 p80 -111.24 167.3 10.39 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.893 -178.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 96' ' ' THR . 10.4 m-20 . . . . . 0 CA--C 1.515 -0.377 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.452 177.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.427 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 7.3 m-85 . . . . . 0 N--CA 1.454 -0.273 0 CA-C-O 120.833 0.349 . . . . 0.0 110.87 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.427 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 6.5 m-85 -142.54 173.18 11.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.79 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.421 ' CG2' ' HG3' ' A' ' 70' ' ' LYS . 16.7 p -154.02 -175.73 5.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.039 0.447 . . . . 0.0 112.012 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 4.6 m-20 -57.5 96.53 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.358 0.599 . . . . 0.0 111.062 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 128.46 15.54 2.21 Favored Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 115.081 -0.963 . . . . 0.0 113.281 178.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.417 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.4 OUTLIER -104.52 150.61 24.45 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 117.244 0.522 . . . . 0.0 110.698 179.184 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 18.8 m -146.89 132.83 12.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.084 0.469 . . . . 0.0 110.886 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.446 HG11 ' CG ' ' A' ' 74' ' ' PRO . 2.2 p -132.35 148.7 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.009 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.455 ' O ' ' HB2' ' A' ' 83' ' ' ASN . 0.1 OUTLIER -92.1 148.91 21.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.077 0.465 . . . . 0.0 110.732 179.85 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.528 ' CE1' ' CG2' ' A' ' 111' ' ' VAL . 3.0 m-85 -107.17 159.78 16.07 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.846 0.355 . . . . 0.0 110.845 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.425 ' CA ' HD13 ' A' ' 105' ' ' LEU . 50.4 m -155.79 151.44 27.25 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.56 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.413 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 78.4 m -78.38 162.01 26.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.252 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.455 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 17.0 m-20 -91.77 -71.28 0.65 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.488 -179.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.68 -20.96 66.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.434 -179.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.32 31.42 1.17 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.532 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.476 ' CE2' HG12 ' A' ' 126' ' ' ILE . 26.5 m-85 -69.83 -173.47 0.63 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 120.782 0.325 . . . . 0.0 110.539 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.56 103.56 12.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.072 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.439 HD23 ' CG ' ' A' ' 122' ' ' PRO . 3.0 tp -42.62 113.45 0.46 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.135 179.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.44 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 39.0 mm -86.75 155.86 3.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.735 -179.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.428 ' N ' HG21 ' A' ' 106' ' ' ILE . . . 57.18 -128.62 47.86 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.351 -0.928 . . . . 0.0 111.766 -178.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -115.04 134.67 54.98 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.029 0.442 . . . . 0.0 111.573 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.485 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 1.1 t -70.27 -29.83 66.7 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.362 178.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.82 137.28 23.05 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.536 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.528 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 9.9 t -128.75 120.11 51.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.483 0.182 . . . . 0.0 110.527 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.42 HD22 ' N ' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -80.0 133.21 36.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.903 0.382 . . . . 0.0 111.442 -178.906 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.488 ' HB2' ' CZ3' ' A' ' 118' ' ' TRP . 25.5 t -104.68 106.48 16.99 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.851 176.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.2 OUTLIER -167.29 122.02 1.04 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.981 0.42 . . . . 0.0 111.174 179.851 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.406 ' CA ' HG12 ' A' ' 69' ' ' VAL . . . 102.27 26.79 7.19 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.144 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.428 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 69.24 10.09 61.87 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.521 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -148.69 -177.64 5.9 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.981 0.419 . . . . 0.0 110.665 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.488 ' CZ3' ' HB2' ' A' ' 113' ' ' CYS . 92.9 m95 -116.27 151.19 36.31 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.85 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.68 155.63 49.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.073 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.535 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.2 t0 69.49 42.07 0.22 Allowed Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 74.2 Cg_endo -76.7 137.32 17.94 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.48 2.12 . . . . 0.0 111.941 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.486 ' HD3' ' CD2' ' A' ' 97' ' ' TYR . 57.2 Cg_endo -90.83 -172.97 0.55 Allowed 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.853 2.369 . . . . 0.0 113.408 -178.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.433 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.3 OUTLIER -132.36 -163.27 1.32 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.021 177.893 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 7.6 m -151.87 92.2 1.71 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.147 0.498 . . . . 0.0 111.164 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -118.06 164.74 14.67 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.514 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.476 HG12 ' CE2' ' A' ' 103' ' ' TYR . 50.0 mm . . . . . 0 C--N 1.324 -0.523 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.946 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.404 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 13.1 mtm180 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.934 0.397 . . . . 0.0 110.755 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.444 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 19.6 m -89.35 162.06 38.13 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.826 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.41 170.18 16.75 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.413 2.075 . . . . 0.0 111.985 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.8 t -54.33 106.33 0.65 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.226 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.438 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 3.4 Cg_exo -46.76 153.26 1.37 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.118 1.879 . . . . 0.0 112.045 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.43 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 2.4 mtt85 -68.52 163.59 23.12 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.14 178.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -112.35 179.76 3.9 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.18 0.514 . . . . 0.0 112.129 -176.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.402 HG23 HD23 ' A' ' 20' ' ' LEU . 7.3 tt -131.63 152.56 37.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.418 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -80.27 -62.34 1.71 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -177.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -94.57 31.07 1.85 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.867 -178.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.433 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -151.03 -179.98 27.22 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.197 -1.002 . . . . 0.0 113.498 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.34 135.22 33.52 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.529 ' CD2' ' CE2' ' A' ' 33' ' ' TYR . 2.6 mt -79.42 163.29 24.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.218 0.533 . . . . 0.0 111.799 -178.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -131.33 77.75 1.79 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.595 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.46 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 69.1 mt -69.63 104.51 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.018 -177.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -110.2 22.63 22.53 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.519 177.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 153.66 129.78 1.39 Allowed Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -179.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.401 HG22 ' HD3' ' A' ' 8' ' ' ARG . 0.5 OUTLIER -121.33 0.97 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.665 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.404 ' HA ' ' HB3' ' A' ' 8' ' ' ARG . 34.0 t0 -74.22 162.24 29.13 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.844 0.354 . . . . 0.0 110.952 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.488 ' CZ ' HD12 ' A' ' 51' ' ' LEU . 11.0 t80 -52.56 106.19 0.15 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.843 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.57 -0.08 27.7 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.765 -0.731 . . . . 0.0 113.046 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 82.9 p -77.24 178.99 6.64 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.971 0.385 . . . . 0.0 110.964 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 47' ' ' SER . 3.3 p -149.1 144.03 26.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.998 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.536 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.9 OUTLIER -110.64 170.46 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.618 179.819 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.416 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -129.42 113.12 14.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.905 0.383 . . . . 0.0 111.31 179.482 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.529 ' CE2' ' CD2' ' A' ' 20' ' ' LEU . 15.8 m-85 -87.77 140.99 28.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.06 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.433 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 16.6 m -146.36 157.52 43.79 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.677 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.401 ' HB2' ' HB2' ' A' ' 39' ' ' TYR . 62.7 m -80.34 170.01 16.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.748 0.308 . . . . 0.0 110.647 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.09 -75.65 0.11 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.941 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.8 t -160.01 139.69 11.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.835 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 56.97 25.13 52.79 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.063 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.517 ' CD2' ' HA ' ' A' ' 68' ' ' SER . 2.3 m-85 -116.57 171.05 8.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.871 0.367 . . . . 0.0 111.051 -179.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.484 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.3 OUTLIER -131.86 123.25 27.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.426 178.387 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.431 ' CD2' ' O ' ' A' ' 44' ' ' GLU . 4.7 tt -86.47 134.27 33.69 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.502 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.484 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 2.0 mm -112.97 156.98 13.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.02 0.438 . . . . 0.0 111.164 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.4 -128.27 8.36 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.289 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.439 ' O ' ' CG ' ' A' ' 64' ' ' PRO . 1.5 pm0 -83.78 -173.7 4.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.792 0.329 . . . . 0.0 110.648 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.2 p -162.31 24.27 0.11 Allowed 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.159 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.416 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 13.2 mtpt -164.45 126.45 2.28 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.578 -177.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.43 ' OG ' ' CG ' ' A' ' 62' ' ' GLU . 1.9 t -94.06 137.85 32.8 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 176.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.511 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 2.6 m-85 -114.92 118.57 33.85 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.589 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 35.4 t -66.3 92.57 0.19 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.625 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.489 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 1.7 tt0 -123.86 172.12 9.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.518 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.489 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--N 1.32 -0.682 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.521 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.203 0 CA-C-O 121.261 0.553 . . . . 0.0 110.4 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.442 ' N ' ' O ' ' A' ' 50' ' ' GLU . 0.9 OUTLIER -111.99 -175.23 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.432 -179.281 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.536 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 70.7 m95 -125.31 123.73 40.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.916 0.389 . . . . 0.0 111.263 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.511 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 2.7 m-20 -69.04 167.68 19.36 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 10.4 Cg_exo -7.39 89.86 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.008 1 C-N-CA 125.41 4.073 . . . . 0.0 114.796 -179.054 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.479 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 10.7 mt-10 -84.24 -92.58 0.08 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 114.779 -1.101 . . . . 0.0 112.386 -177.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.504 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -91.63 109.01 33.62 Favored Pre-proline 0 C--O 1.231 0.1 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -176.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.439 ' CG ' ' O ' ' A' ' 44' ' ' GLU . 6.1 Cg_exo -79.39 -153.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.892 2.395 . . . . 0.0 111.113 177.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.424 ' CG1' ' HB ' ' A' ' 42' ' ' ILE . 1.5 mm -93.95 168.94 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.859 0.361 . . . . 0.0 110.669 178.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -170.35 138.69 1.6 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.945 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -162.44 173.86 13.51 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.625 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.517 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 54.1 p -79.07 113.64 17.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.301 0.572 . . . . 0.0 110.83 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.475 ' HB ' ' N ' ' A' ' 116' ' ' GLY . 30.9 m -39.2 100.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.425 -179.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 89' ' ' TYR . 0.3 OUTLIER -96.45 103.57 15.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.862 0.363 . . . . 0.0 110.719 178.027 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.94 121.91 35.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.049 179.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.459 ' CG ' ' N ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -69.15 -155.4 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.975 179.402 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.459 ' N ' ' CG ' ' A' ' 72' ' ' GLN . 1.2 t -50.77 142.21 16.79 Favored Pre-proline 0 N--CA 1.449 -0.511 0 CA-C-O 120.642 0.258 . . . . 0.0 110.823 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -59.35 164.1 11.38 Favored 'Trans proline' 0 CA--C 1.528 0.198 0 C-N-CA 122.531 2.154 . . . . 0.0 111.936 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.496 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 89.6 Cg_exo -41.75 158.76 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.56 2.174 . . . . 0.0 112.572 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 83.5 p -109.24 88.6 2.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.528 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.9 pt -69.79 170.55 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.305 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.7 m -90.09 142.59 27.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.675 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.484 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 7.7 m-80 56.26 29.51 15.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.973 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.477 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -161.75 -171.18 27.48 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.27 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.413 ' N ' ' O ' ' A' ' 98' ' ' SER . 9.5 ptt180 -163.75 -175.33 4.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.971 0.415 . . . . 0.0 110.78 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 1.7 p-80 -117.9 169.22 9.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.053 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.691 179.989 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.434 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 7.0 m-85 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.761 0.315 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.434 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 72.5 m-85 -156.39 160.56 39.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.845 -179.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 69' ' ' VAL . 6.7 p -142.63 -177.42 5.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.287 0.565 . . . . 0.0 112.324 -179.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -50.03 94.62 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.489 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 121.96 24.29 2.31 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.373 -0.83 . . . . 0.0 113.37 177.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -110.1 147.4 33.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 117.075 0.437 . . . . 0.0 110.782 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.434 ' CG2' ' N ' ' A' ' 95' ' ' VAL . 35.2 m -128.68 160.0 39.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.1 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.471 HG21 ' CH2' ' A' ' 118' ' ' TRP . 21.5 t -151.8 148.6 14.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.479 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.421 ' CG2' ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -108.01 126.02 52.22 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.228 0.537 . . . . 0.0 111.06 -179.608 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.515 ' CE1' ' CG2' ' A' ' 111' ' ' VAL . 4.6 m-85 -83.87 161.6 20.82 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.657 -178.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.413 ' O ' ' N ' ' A' ' 81' ' ' ARG . 14.8 p -155.24 138.66 15.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.348 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.415 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 73.9 m -69.98 158.39 35.71 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.794 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.477 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 26.8 m-20 -92.0 -70.69 0.68 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.429 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.24 -22.83 67.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.323 -179.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 122.0 31.15 1.13 Allowed Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.63 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.488 ' CE2' HG12 ' A' ' 126' ' ' ILE . 19.9 m-85 -69.61 -175.55 0.87 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.038 0.447 . . . . 0.0 110.898 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.2 m -110.07 98.1 7.45 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.098 178.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.448 ' CD2' ' HA ' ' A' ' 109' ' ' SER . 0.2 OUTLIER -48.77 132.48 17.97 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.555 0.693 . . . . 0.0 111.727 -177.834 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.445 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 38.2 mm -114.23 155.52 15.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.092 -178.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 68.59 23.88 75.32 Favored Glycine 0 C--N 1.328 0.103 0 C-N-CA 120.56 -0.828 . . . . 0.0 113.053 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 60.37 136.66 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.295 0.569 . . . . 0.0 111.531 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.453 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 1.1 p -69.7 -24.13 63.53 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.765 -178.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -63.84 121.72 24.21 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.787 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.515 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 2.7 t -122.14 141.8 41.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 178.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.414 HD22 ' N ' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -102.92 132.43 49.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.841 0.353 . . . . 0.0 111.505 -178.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.499 ' HB2' ' CZ3' ' A' ' 118' ' ' TRP . 41.4 t -104.6 104.59 14.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.034 177.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.4 p -165.93 119.27 1.13 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.922 0.391 . . . . 0.0 111.707 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.33 20.98 11.18 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.686 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.475 ' N ' ' HB ' ' A' ' 69' ' ' VAL . . . 80.88 2.08 90.02 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.498 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -145.51 170.52 16.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.14 0.495 . . . . 0.0 111.317 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.499 ' CZ3' ' HB2' ' A' ' 113' ' ' CYS . 88.5 m95 -104.37 144.98 30.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.355 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.1 149.77 43.1 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.074 0.464 . . . . 0.0 111.491 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.499 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER 65.66 44.7 0.41 Allowed Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.196 178.899 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 56.3 Cg_endo -69.82 142.91 48.93 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.22 1.946 . . . . 0.0 111.467 178.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.493 ' HG2' ' CD2' ' A' ' 97' ' ' TYR . 71.1 Cg_endo -90.23 -172.84 0.6 Allowed 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.641 2.227 . . . . 0.0 113.768 -177.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.37 -158.44 0.87 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.652 178.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 2.3 m -155.76 89.16 1.15 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.089 0.471 . . . . 0.0 110.925 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -113.34 161.11 17.65 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.684 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.488 HG12 ' CE2' ' A' ' 103' ' ' TYR . 21.9 mm . . . . . 0 C--N 1.323 -0.569 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.935 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.425 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 120.946 0.403 . . . . 0.0 111.752 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.461 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 3.5 m -93.24 163.04 26.47 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.672 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -67.62 169.83 15.07 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.205 1.937 . . . . 0.0 111.407 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.03 105.1 0.46 Allowed Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.088 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.44 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 83.1 Cg_exo -38.42 146.35 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.657 2.238 . . . . 0.0 112.739 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.3 152.98 43.83 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.644 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.18 -167.98 1.5 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.118 -178.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.415 ' HB ' ' HB3' ' A' ' 63' ' ' ALA . 19.1 tt -167.88 144.52 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.568 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.403 ' HB2' ' ND2' ' A' ' 17' ' ' ASN . 0.6 OUTLIER -94.28 160.43 14.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.743 177.566 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.403 ' ND2' ' HB2' ' A' ' 16' ' ' ASP . 0.3 OUTLIER 48.1 25.58 0.84 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.879 0.371 . . . . 0.0 110.638 -179.108 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.422 ' HA2' ' N ' ' A' ' 36' ' ' ASN . . . -158.81 -173.91 27.83 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.615 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -132.14 -171.88 2.74 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.313 0.578 . . . . 0.0 111.787 -177.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.3 mt -140.25 139.28 35.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.465 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.426 ' CB ' ' HB ' ' A' ' 32' ' ' THR . 0.3 OUTLIER -118.07 73.56 0.91 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.851 179.109 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.445 HG13 ' CG2' ' A' ' 31' ' ' ILE . 0.2 OUTLIER -82.75 94.21 3.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.947 -176.046 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.38 12.05 63.94 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.048 177.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 156.51 148.12 4.97 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.11 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.7 m -120.37 -1.01 8.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.425 ' HA ' ' HB3' ' A' ' 8' ' ' ARG . 0.7 OUTLIER -69.64 153.78 42.93 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.931 0.395 . . . . 0.0 111.224 -179.292 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.46 110.38 0.37 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.855 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 113.79 -9.16 23.61 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.423 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.73 178.44 4.17 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.845 0.323 . . . . 0.0 110.83 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.4 p -153.82 138.77 17.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.223 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.516 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -103.1 165.78 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.601 179.063 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.426 ' HB ' ' CB ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -130.35 110.5 11.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.633 178.561 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.503 ' CE2' ' HA ' ' A' ' 63' ' ' ALA . 22.9 m-85 -83.2 146.95 28.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.132 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.47 172.2 14.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.926 0.394 . . . . 0.0 111.425 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.412 ' HA ' ' HA2' ' A' ' 18' ' ' GLY . 1.7 m -96.13 156.7 16.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.497 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.422 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 3.6 m-20 -56.1 -85.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.15 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.5 t -152.19 135.67 16.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.934 0.397 . . . . 0.0 110.719 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.51 24.29 63.74 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.865 -179.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.471 ' CG ' ' O ' ' A' ' 67' ' ' GLU . 2.3 m-85 -116.24 174.69 5.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.805 0.336 . . . . 0.0 110.802 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.531 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.6 OUTLIER -136.94 116.17 12.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.036 0.446 . . . . 0.0 110.478 178.241 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.428 ' CD2' ' O ' ' A' ' 44' ' ' GLU . 4.7 tt -77.37 124.62 28.11 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.638 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.531 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 2.7 mm -96.8 152.55 3.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.247 -179.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.09 -149.74 38.04 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.218 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.428 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 4.3 pm0 -61.63 178.65 0.3 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.609 0.242 . . . . 0.0 110.582 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.0 p -152.38 21.44 0.64 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.374 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.415 ' CG ' ' O ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -142.97 -174.6 4.23 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.226 0.536 . . . . 0.0 111.934 -178.299 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.438 ' CB ' HG12 ' A' ' 31' ' ' ILE . 1.7 m -160.96 108.88 1.54 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.831 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -92.15 117.75 30.16 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.229 0.538 . . . . 0.0 111.839 -177.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.484 ' HB3' ' CH2' ' A' ' 59' ' ' TRP . 8.7 t -64.33 90.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.226 179.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.503 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -116.43 175.75 5.42 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.428 -179.51 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.503 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.646 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.235 -178.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.866 0.365 . . . . 0.0 110.11 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.9 m -152.04 -177.66 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.083 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.516 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 93.2 m95 -130.51 124.6 32.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.932 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -143.49 126.51 8.92 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.193 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.78 -162.28 2.13 Favored 'Cis proline' 0 C--N 1.351 0.703 0 C-N-CA 124.06 -1.225 . . . . 0.0 111.928 -0.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.488 ' O ' ' CZ ' ' A' ' 33' ' ' TYR . 4.3 pt-20 -112.25 -113.97 0.33 Allowed 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.401 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.503 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -118.92 86.84 32.06 Favored Pre-proline 0 N--CA 1.45 -0.472 0 C-N-CA 122.658 0.383 . . . . 0.0 110.462 -179.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 63' ' ' ALA . 10.3 Cg_endo -48.58 -158.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.475 0.395 0 C-N-CA 123.863 3.042 . . . . 0.0 113.995 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.0 mm -93.49 165.28 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.109 -177.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -161.42 138.22 8.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.268 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.471 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 1.0 OUTLIER -162.22 -177.1 5.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.898 0.38 . . . . 0.0 111.168 -179.719 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.8 t -83.8 132.27 34.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.108 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -46.21 101.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.553 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.415 ' HD3' ' HB2' ' A' ' 88' ' ' PHE . 0.2 OUTLIER -72.15 123.19 22.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.352 179.951 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.51 122.91 46.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.921 178.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -69.31 -156.28 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.373 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.469 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 1.8 t -52.95 145.6 22.28 Favored Pre-proline 0 N--CA 1.45 -0.426 0 CA-C-O 120.633 0.254 . . . . 0.0 110.377 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.401 ' HG3' HG21 ' A' ' 95' ' ' VAL . 23.4 Cg_exo -62.62 165.33 16.01 Favored 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 122.48 2.12 . . . . 0.0 112.155 -179.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.498 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 81.2 Cg_exo -43.65 160.6 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.713 2.275 . . . . 0.0 112.87 -179.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 86.7 p -108.29 90.16 3.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.497 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.442 HG23 ' CE2' ' A' ' 97' ' ' TYR . 14.1 pt -69.24 175.22 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.243 -178.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.4 p -96.21 143.41 27.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.717 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.489 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 5.3 m-80 55.42 30.23 14.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.925 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -167.41 -170.26 32.01 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.53 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.97 -176.71 4.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.035 0.445 . . . . 0.0 111.091 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.469 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 3.4 p80 -108.37 173.26 6.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.117 -179.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.66 179.408 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.425 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 6.4 m-85 . . . . . 0 N--CA 1.455 -0.196 0 CA-C-O 120.866 0.365 . . . . 0.0 111.521 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.425 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 69.2 m-85 -156.77 165.85 35.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.809 -179.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 19.1 p -149.37 -175.78 5.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.029 0.442 . . . . 0.0 111.62 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.425 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 3.8 p30 -52.86 94.42 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.444 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.14 22.63 2.34 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.273 -0.876 . . . . 0.0 113.13 178.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.21 145.83 36.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.951 0.375 . . . . 0.0 110.789 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 32.7 m -128.58 155.61 40.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.067 0.461 . . . . 0.0 111.249 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.464 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 20.7 t -146.54 146.57 18.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.11 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.425 ' CG2' ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -101.4 134.22 44.82 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.827 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.53 ' CE1' ' CG2' ' A' ' 111' ' ' VAL . 5.0 m-85 -95.39 158.83 15.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.915 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 77.1 p -153.0 140.33 19.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.376 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 68.8 m -71.04 152.46 43.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.891 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.411 ' CG ' ' N ' ' A' ' 101' ' ' SER . 1.5 p30 -92.54 -55.14 3.5 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.419 0.628 . . . . 0.0 111.434 -178.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.411 ' N ' ' CG ' ' A' ' 100' ' ' ASN . 22.4 t -73.98 -14.75 61.08 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.757 -178.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 111.24 24.68 5.32 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.005 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.489 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 30.8 m-85 -69.46 -172.95 0.51 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.855 0.36 . . . . 0.0 110.817 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.1 105.78 15.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.156 -179.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.425 HD23 ' CA ' ' A' ' 109' ' ' SER . 3.1 tp -44.85 113.52 0.57 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.07 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.452 HG23 HD11 ' A' ' 106' ' ' ILE . 30.6 mm -87.13 157.07 3.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.471 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.432 ' N ' HG21 ' A' ' 106' ' ' ILE . . . 58.69 -131.17 51.92 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.767 -178.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.27 126.28 52.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.771 0.32 . . . . 0.0 110.746 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.477 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 1.4 t -57.63 -28.45 63.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.045 0.45 . . . . 0.0 110.242 178.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.9 132.2 15.13 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.558 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.53 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 6.0 t -125.52 126.83 71.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 110.422 -0.214 . . . . 0.0 110.422 178.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.454 ' CD2' ' N ' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -81.14 135.52 35.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.889 0.376 . . . . 0.0 111.48 -178.567 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.507 ' HB2' ' CZ3' ' A' ' 118' ' ' TRP . 39.3 t -108.28 108.04 18.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.051 177.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.2 OUTLIER -164.01 129.67 2.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.868 0.366 . . . . 0.0 111.259 -179.806 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.38 31.04 20.45 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.076 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.16 19.88 62.17 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.018 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -145.53 178.2 8.3 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.104 0.478 . . . . 0.0 111.15 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.507 ' CZ3' ' HB2' ' A' ' 113' ' ' CYS . 92.7 m95 -121.7 145.29 48.17 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.795 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -125.52 167.02 15.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.991 0.424 . . . . 0.0 111.658 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.421 ' N ' ' HD3' ' A' ' 121' ' ' PRO . 6.6 p-10 46.69 52.56 12.06 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.171 179.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.421 ' HD3' ' N ' ' A' ' 120' ' ' ASP . 93.2 Cg_endo -81.28 143.94 14.26 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.666 2.244 . . . . 0.0 111.634 177.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.477 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 73.5 Cg_endo -91.23 -172.29 0.46 Allowed 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.877 2.385 . . . . 0.0 113.856 -177.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.44 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -138.66 -174.7 3.9 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.101 178.321 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . 0.423 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 11.9 m -141.11 96.98 3.08 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.026 0.441 . . . . 0.0 111.097 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -122.54 167.51 13.28 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.863 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.488 HG12 ' CE2' ' A' ' 103' ' ' TYR . 13.0 mm . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.935 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 17.4 mtm180 . . . . . 0 N--CA 1.457 -0.125 0 CA-C-O 120.791 0.329 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.508 ' HB2' ' CD ' ' A' ' 10' ' ' PRO . 69.6 m -77.31 175.86 4.09 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.521 ' HD2' ' CD1' ' A' ' 59' ' ' TRP . 37.9 Cg_endo -91.24 176.29 2.2 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.427 2.084 . . . . 0.0 111.932 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.0 t -53.41 105.6 0.55 Allowed Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.294 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.465 ' HG2' ' CE2' ' A' ' 59' ' ' TRP . 51.5 Cg_exo -52.94 142.2 53.66 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.037 1.825 . . . . 0.0 111.804 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.422 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -49.03 120.8 4.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.925 0.869 . . . . 0.0 111.512 -178.852 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.45 ' HA ' HD11 ' A' ' 20' ' ' LEU . 6.1 p-10 -59.16 -32.09 69.56 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 113.509 -1.678 . . . . 0.0 112.694 -177.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.471 HG23 ' CD2' ' A' ' 20' ' ' LEU . 8.6 tt 58.36 142.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 114.271 -1.331 . . . . 0.0 111.208 -175.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.98 160.41 14.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.0 178.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.482 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 0.3 OUTLIER 50.47 24.07 1.48 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.017 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -154.06 177.61 31.4 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.659 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.43 142.26 39.52 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.74 0.305 . . . . 0.0 110.506 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.472 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 72.2 mt -89.51 155.67 19.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.167 0.508 . . . . 0.0 111.718 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -124.73 72.91 1.24 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.38 177.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.44 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 1.2 mt -76.1 105.71 5.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.992 -176.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.62 13.56 57.99 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.734 176.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 157.19 133.29 1.58 Allowed Glycine 0 C--N 1.335 0.5 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.021 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.0 m -112.41 9.01 8.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -72.82 156.25 39.09 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.836 0.351 . . . . 0.0 111.331 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -54.94 91.45 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.867 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 49' ' ' CYS . . . 130.57 -18.25 5.19 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.456 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.5 p -57.24 -173.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.73 0.3 . . . . 0.0 110.863 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 47' ' ' SER . 81.2 p -150.94 150.85 31.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.25 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.544 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -121.44 167.0 15.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.766 179.493 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.85 108.45 10.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.618 178.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.447 ' CE1' ' HA ' ' A' ' 63' ' ' ALA . 33.4 m-85 -84.59 143.12 29.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.154 -179.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -152.04 157.08 41.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.198 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.3 m -83.8 161.56 20.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.851 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.459 ' ND2' ' HA ' ' A' ' 17' ' ' ASN . 1.2 p30 -55.7 -89.43 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.238 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.8 t -152.08 136.34 16.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.815 0.34 . . . . 0.0 110.524 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.73 17.76 63.09 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.233 -178.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.482 ' CE2' ' HB3' ' A' ' 17' ' ' ASN . 2.1 m-85 -106.87 -173.34 2.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.729 0.299 . . . . 0.0 110.782 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.521 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.3 OUTLIER -147.05 112.46 5.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.983 0.42 . . . . 0.0 110.808 178.86 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.427 ' CD2' ' O ' ' A' ' 44' ' ' GLU . 2.1 tt -78.72 125.47 29.41 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.363 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.521 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 2.9 mm -98.47 167.55 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.049 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.03 -130.02 29.84 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.477 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.427 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 0.8 OUTLIER -83.47 -179.23 7.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.798 0.332 . . . . 0.0 110.925 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.424 ' CB ' HD21 ' A' ' 41' ' ' LEU . 3.0 t -154.98 25.44 0.43 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.924 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -150.14 168.72 23.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.245 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.417 ' O ' HG12 ' A' ' 31' ' ' ILE . 2.6 m -149.56 120.27 7.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.374 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -103.46 116.2 31.96 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.16 0.505 . . . . 0.0 111.193 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.411 ' O ' ' N ' ' A' ' 28' ' ' GLY . 53.6 t -59.16 100.87 0.08 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.098 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.28 -170.96 2.07 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.37 -178.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.848 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.772 0.32 . . . . 0.0 110.601 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.1 m -144.19 -178.45 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.98 0.419 . . . . 0.0 111.333 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.544 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 94.1 m95 -121.03 122.97 41.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.527 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -138.67 118.73 9.71 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.426 -178.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.14 -170.53 7.7 Favored 'Cis proline' 0 C--N 1.351 0.663 0 C-N-CA 124.094 -1.211 . . . . 0.0 112.003 -0.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -110.89 -154.66 0.54 Allowed 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.708 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.447 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -72.62 111.84 12.73 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.582 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.424 ' CG ' ' O ' ' A' ' 44' ' ' GLU . 15.2 Cg_exo -69.78 -150.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.628 2.219 . . . . 0.0 112.452 -178.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.402 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 5.1 mm -100.39 165.73 2.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.6 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.3 m -161.62 137.12 7.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.589 179.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.473 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.2 OUTLIER -163.33 176.62 9.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.931 0.396 . . . . 0.0 110.965 179.784 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.468 ' HB2' ' CE1' ' A' ' 39' ' ' TYR . 12.2 p -94.4 117.37 30.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.917 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.41 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 2.3 p -41.14 93.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.609 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 68' ' ' SER . 0.1 OUTLIER -70.47 121.49 17.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.66 -178.758 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.75 115.49 30.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.695 177.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.409 ' CG ' ' N ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -69.95 -157.99 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.792 -179.504 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.437 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 1.6 t -47.33 136.68 9.07 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.237 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.414 ' HA ' ' CD1' ' A' ' 118' ' ' TRP . 35.3 Cg_exo -58.85 162.03 14.11 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.39 2.06 . . . . 0.0 111.797 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.485 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 80.5 Cg_exo -39.96 156.89 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.764 2.31 . . . . 0.0 112.834 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.9 t -108.15 89.19 2.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.641 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.3 pt -69.81 174.59 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.413 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.8 p -97.67 138.79 34.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.912 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.461 ' N ' ' ND2' ' A' ' 79' ' ' ASN . 0.1 OUTLIER 66.7 27.07 9.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.79 179.458 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.423 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . -172.71 -165.48 29.8 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.897 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 11.1 ptt180 -167.37 -175.26 2.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.873 0.368 . . . . 0.0 110.593 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.437 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 6.1 p80 -105.12 173.46 6.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.082 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.45 179.277 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.433 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 6.5 m-85 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.596 0.236 . . . . 0.0 110.722 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.433 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 60.9 m-85 -151.4 164.04 37.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.866 0.365 . . . . 0.0 111.041 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.4 p -130.45 168.56 16.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.119 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.72 94.76 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.289 0.566 . . . . 0.0 110.886 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 129.88 26.76 0.83 Allowed Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.258 -0.883 . . . . 0.0 113.216 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -110.08 162.27 14.72 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.915 0.358 . . . . 0.0 110.697 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 33.9 m -135.58 154.99 35.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.099 0.476 . . . . 0.0 111.301 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.511 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 20.8 t -150.85 147.49 15.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.823 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.418 ' CG2' ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -105.5 133.05 50.89 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.74 179.436 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.525 ' CE1' ' CG2' ' A' ' 111' ' ' VAL . 4.9 m-85 -91.53 159.29 16.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.169 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.412 ' HA ' ' CD1' ' A' ' 105' ' ' LEU . 62.8 m -157.72 149.62 22.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.052 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.423 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 58.0 m -79.09 159.37 27.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.13 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -83.1 -68.52 0.7 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.632 -178.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.5 -26.17 61.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.383 -178.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.2 37.7 0.45 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.521 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.449 ' CE1' ' HB3' ' A' ' 79' ' ' ASN . 11.2 m-85 -69.78 -173.67 0.64 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.852 0.358 . . . . 0.0 110.35 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.3 m -107.95 98.89 8.4 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.079 178.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.412 ' CD1' ' HA ' ' A' ' 98' ' ' SER . 0.3 OUTLIER -47.94 126.92 11.36 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.623 0.725 . . . . 0.0 111.697 -177.881 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.446 ' HB ' ' CB ' ' A' ' 123' ' ' THR . 31.4 mm -90.6 152.02 3.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.079 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 61.11 -136.53 48.28 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.016 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -112.14 137.59 50.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.945 0.403 . . . . 0.0 111.348 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.433 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 1.6 p -68.06 -26.53 65.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.78 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -72.39 139.46 27.93 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.968 -0.634 . . . . 0.0 113.014 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.525 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 2.5 t -135.21 127.89 48.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.533 0.206 . . . . 0.0 110.56 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.06 126.2 34.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.968 0.414 . . . . 0.0 111.804 -178.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.488 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 13.4 t -90.41 101.2 13.94 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 176.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.67 160.83 39.99 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.065 0.459 . . . . 0.0 111.411 -178.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.0 30.53 5.19 Favored Glycine 0 N--CA 1.453 -0.232 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.665 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.41 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 68.72 19.19 72.96 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.199 -179.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -144.47 179.51 7.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.777 0.322 . . . . 0.0 110.512 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.511 ' CH2' ' CG2' ' A' ' 95' ' ' VAL . 92.7 m95 -115.84 152.24 33.73 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.978 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.67 156.34 48.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.234 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.489 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER 61.83 46.5 0.96 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.881 179.109 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 96.0 Cg_endo -78.36 137.16 14.72 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.421 2.081 . . . . 0.0 111.577 178.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.443 ' CB ' ' O ' ' A' ' 106' ' ' ILE . 73.4 Cg_endo -91.94 -173.91 0.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.587 2.191 . . . . 0.0 113.545 -178.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.446 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.3 OUTLIER -129.17 -171.6 2.53 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.29 177.405 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 5.0 m -144.74 88.37 1.91 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.069 0.461 . . . . 0.0 110.325 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.437 ' NE2' HG21 ' A' ' 123' ' ' THR . 2.0 mp0 -118.11 -179.04 3.65 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.519 -178.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.422 HD13 ' CD2' ' A' ' 103' ' ' TYR . 32.3 mm . . . . . 0 C--N 1.321 -0.657 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.92 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.403 ' HD2' HG22 ' A' ' 25' ' ' VAL . 8.1 mtm180 . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.899 0.381 . . . . 0.0 111.004 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.457 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 28.9 m -91.09 159.85 38.86 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.077 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.0 168.65 23.38 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.661 2.241 . . . . 0.0 111.992 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.0 t -49.39 103.79 0.39 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.733 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.58 157.76 49.52 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.276 1.984 . . . . 0.0 112.051 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.457 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -51.23 -179.55 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.319 179.23 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.461 ' O ' ' CG2' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -140.62 -7.58 1.12 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -178.057 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.461 ' CG2' ' O ' ' A' ' 14' ' ' ASP . 15.1 tt 56.87 142.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 121.223 0.535 . . . . 0.0 111.603 -177.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -81.33 -52.61 7.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.602 -178.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.46 ' N ' ' ND2' ' A' ' 17' ' ' ASN . 0.4 OUTLIER -93.07 45.55 1.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.892 0.377 . . . . 0.0 110.922 -178.419 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 176.48 179.99 47.21 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.51 -0.853 . . . . 0.0 113.249 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -138.44 143.08 39.52 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.51 ' CD1' ' CZ ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -93.63 168.93 10.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.08 0.467 . . . . 0.0 111.125 -179.019 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -126.1 91.73 3.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.843 178.021 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.449 ' CD1' HG23 ' A' ' 31' ' ' ILE . 5.4 mm -68.46 107.08 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.829 -176.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -114.24 22.76 13.37 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.602 177.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 149.67 124.35 1.28 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.068 -0.587 . . . . 0.0 111.945 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.403 HG22 ' HD2' ' A' ' 8' ' ' ARG . 27.8 m -120.54 38.24 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.871 0.367 . . . . 0.0 111.261 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.4 OUTLIER -111.25 150.36 29.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.6 179.302 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.465 ' CE2' HD13 ' A' ' 51' ' ' LEU . 8.0 t80 -49.05 91.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.896 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 130.27 -0.36 5.59 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.764 -0.732 . . . . 0.0 113.021 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -92.17 -168.41 1.99 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 117.038 0.419 . . . . 0.0 110.54 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.6 p -160.63 146.88 15.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.064 0.459 . . . . 0.0 111.27 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.539 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.6 OUTLIER -105.02 170.42 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.34 179.625 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -124.36 112.61 17.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.902 0.382 . . . . 0.0 111.09 179.073 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.51 ' CZ ' ' CD1' ' A' ' 20' ' ' LEU . 12.3 m-85 -87.04 142.5 27.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.602 -179.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.7 m -149.78 159.22 44.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.525 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 16.5 m -77.79 172.9 12.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.814 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -75.4 -83.87 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.262 -179.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.2 t -150.11 137.56 19.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.628 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 59.34 25.57 60.55 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.909 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.489 ' CE1' ' HB2' ' A' ' 68' ' ' SER . 2.4 m-85 -116.16 168.74 9.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.805 0.336 . . . . 0.0 110.875 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.527 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 1.2 p80 -133.74 113.66 12.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.057 177.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.442 ' CD1' ' HG3' ' A' ' 64' ' ' PRO . 8.3 tt -76.11 135.48 39.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.773 -178.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.527 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 1.9 mm -113.89 153.44 15.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.099 0.476 . . . . 0.0 111.16 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.17 -137.48 18.52 Favored Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.135 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.409 ' O ' ' CG ' ' A' ' 64' ' ' PRO . 2.0 pt-20 -80.61 -178.04 6.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.044 0.449 . . . . 0.0 110.879 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.406 ' HB3' HD21 ' A' ' 41' ' ' LEU . 4.6 p -158.46 24.79 0.24 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.891 -179.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -150.73 124.87 9.35 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -177.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.428 ' HB2' HG12 ' A' ' 31' ' ' ILE . 1.7 t -92.51 146.95 23.28 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.593 177.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.499 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 1.1 m-85 -120.74 113.51 20.3 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 119.139 -1.024 . . . . 0.0 111.683 178.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 18.7 t -63.74 95.19 0.1 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.154 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -118.47 -171.28 2.05 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.381 -178.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.465 HD13 ' CE2' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.031 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 120.901 0.382 . . . . 0.0 110.55 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -148.15 -179.35 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.036 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.539 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 78.9 m95 -128.42 122.11 30.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.388 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.499 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -69.11 167.02 23.02 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.82 178.466 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.453 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 84.9 Cg_exo -18.7 93.01 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 125.096 3.864 . . . . 0.0 114.198 -179.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.411 ' CB ' ' OG ' ' A' ' 47' ' ' SER . 0.0 OUTLIER -97.32 -78.79 0.47 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.879 -177.672 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.485 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -75.05 108.4 5.41 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -176.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.442 ' HG3' ' CD1' ' A' ' 41' ' ' LEU . 3.5 Cg_endo -87.95 -156.73 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.307 2.671 . . . . 0.0 111.028 177.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.411 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 1.1 mt -89.2 174.99 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.844 0.354 . . . . 0.0 110.662 178.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -171.16 145.91 2.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.891 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -160.44 163.15 33.25 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.924 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.489 ' HB2' ' CE1' ' A' ' 39' ' ' TYR . 1.4 p -92.82 118.9 31.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.229 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.443 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 1.0 OUTLIER -55.14 93.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.861 179.194 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.401 ' CG ' ' O ' ' A' ' 89' ' ' TYR . 1.3 tttt -77.77 135.91 38.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.897 0.38 . . . . 0.0 111.26 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.431 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -106.64 121.78 45.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.143 178.458 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -69.41 -161.41 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.608 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.418 ' OG ' ' NE2' ' A' ' 82' ' ' HIS . 2.7 t -50.07 137.9 19.96 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.653 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.427 ' HA ' ' CD1' ' A' ' 118' ' ' TRP . 39.6 Cg_exo -57.61 159.13 17.64 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.242 1.961 . . . . 0.0 111.908 -179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.481 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 93.7 Cg_exo -42.54 156.88 0.09 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.653 2.235 . . . . 0.0 112.712 -178.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 75.8 p -106.9 89.13 2.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.789 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.8 pt -69.72 169.91 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.179 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -92.44 137.44 32.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.731 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.475 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 0.4 OUTLIER 65.05 29.18 12.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.71 -179.788 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.409 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -169.43 -167.4 29.94 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.959 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.2 ptt85 -170.18 -174.49 1.75 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.016 0.436 . . . . 0.0 110.462 -179.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 7.5 p80 -108.09 172.43 6.84 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.056 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' A' ' 96' ' ' THR . 63.1 m-20 . . . . . 0 C--N 1.331 -0.222 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.539 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.416 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 12.2 m-85 . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 121.066 0.46 . . . . 0.0 111.308 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.431 ' N ' ' O ' ' A' ' 71' ' ' CYS . 37.7 m-85 -147.03 169.59 18.9 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.761 179.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.1 p -134.21 175.11 9.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.998 0.428 . . . . 0.0 111.647 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 1.3 m-20 -60.25 99.13 0.07 Allowed 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.445 0.641 . . . . 0.0 111.021 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.45 23.36 1.93 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 114.917 -1.038 . . . . 0.0 113.005 178.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.41 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -108.35 161.56 14.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.81 0.338 . . . . 0.0 110.583 179.066 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 32.7 m -138.57 157.62 30.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.079 0.466 . . . . 0.0 111.313 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.467 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 18.8 t -151.13 148.61 14.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.555 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.417 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -105.3 131.91 52.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.397 179.203 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.502 ' CE1' ' CG2' ' A' ' 111' ' ' VAL . 3.6 m-85 -89.25 159.31 17.49 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.052 -178.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.7 m -150.22 133.35 16.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.954 0.407 . . . . 0.0 111.567 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.409 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 74.7 m -69.81 162.67 27.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.745 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -96.81 -84.51 0.36 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.928 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -45.31 -27.38 0.65 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.529 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 124.9 36.0 0.61 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.465 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.487 ' CE2' HG13 ' A' ' 126' ' ' ILE . 18.9 m-85 -75.52 -173.74 2.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.939 0.399 . . . . 0.0 110.915 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.44 107.45 16.23 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.962 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.445 ' CD2' ' HB2' ' A' ' 122' ' ' PRO . 1.1 tp -46.44 118.74 2.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.163 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.465 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 45.2 mm -104.59 160.8 4.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.883 -179.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.419 ' O ' ' ND2' ' A' ' 108' ' ' ASN . . . 52.07 38.44 47.66 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.416 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.419 ' ND2' ' O ' ' A' ' 107' ' ' GLY . 8.1 p30 51.58 124.18 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 123.9 0.88 . . . . 0.0 112.693 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.469 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 1.3 p -56.03 -27.45 53.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.402 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.59 136.06 49.29 Favored Glycine 0 CA--C 1.518 0.239 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.843 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.502 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 2.2 t -136.61 130.2 46.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.27 125.37 37.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.92 0.391 . . . . 0.0 111.826 -178.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.485 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 16.7 t -87.32 107.88 18.71 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 175.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 7.0 t -154.95 166.98 31.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.988 -178.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 45.54 33.16 4.38 Favored Glycine 0 CA--C 1.516 0.146 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.692 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.443 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 64.83 19.41 65.36 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.565 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -149.32 -177.77 6.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.933 0.397 . . . . 0.0 110.989 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.485 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 94.8 m95 -113.27 126.26 55.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.87 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.19 145.84 33.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.261 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.495 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.9 OUTLIER 69.3 44.84 0.26 Allowed Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.123 178.84 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 57.0 Cg_endo -70.14 140.27 40.85 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.166 1.911 . . . . 0.0 111.243 178.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.483 ' HG2' ' CD2' ' A' ' 97' ' ' TYR . 94.7 Cg_endo -89.53 -170.58 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.624 2.216 . . . . 0.0 113.798 -177.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -140.58 -172.07 3.36 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.001 178.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . 0.403 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 11.8 m -142.37 95.72 2.84 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.007 0.432 . . . . 0.0 110.907 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -128.52 156.85 42.63 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.973 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.487 HG13 ' CE2' ' A' ' 103' ' ' TYR . 25.6 mm . . . . . 0 C--N 1.323 -0.544 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.011 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.435 ' CB ' ' HA ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.163 0 CA-C-O 120.736 0.303 . . . . 0.0 110.435 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.428 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 98.3 m -78.6 156.97 77.74 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.203 -179.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.77 177.44 6.94 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.81 2.34 . . . . 0.0 112.533 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 p -48.91 104.67 0.43 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.896 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.457 ' HG2' ' CD1' ' A' ' 22' ' ' ILE . 71.6 Cg_exo -42.71 143.78 1.56 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.396 2.064 . . . . 0.0 112.323 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.425 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 10.1 mtt180 -58.9 152.37 19.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.056 178.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -105.96 178.76 4.47 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 121.338 0.59 . . . . 0.0 112.542 -175.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.415 HG22 ' CD2' ' A' ' 20' ' ' LEU . 6.0 tt -138.86 147.79 24.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.033 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -82.58 -56.2 4.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.779 -177.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -94.48 27.11 3.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.198 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.412 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -149.34 -178.65 24.53 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.383 -0.913 . . . . 0.0 113.297 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -139.13 132.16 29.54 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.449 HD23 ' CE1' ' A' ' 33' ' ' TYR . 3.6 mt -76.89 160.78 28.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.203 0.525 . . . . 0.0 111.897 -178.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.422 ' HB2' ' CB ' ' A' ' 32' ' ' THR . 17.3 t70 -130.44 74.29 1.59 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.515 177.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.457 ' CD1' ' HG2' ' A' ' 12' ' ' PRO . 73.2 mt -72.96 101.45 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.017 -177.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.54 20.72 48.45 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.543 176.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.02 145.42 4.16 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 -179.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.407 ' O ' ' HB3' ' A' ' 8' ' ' ARG . 16.6 m -124.83 -6.79 6.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.435 ' HA ' ' CB ' ' A' ' 8' ' ' ARG . 9.1 m-20 -69.8 156.03 39.65 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.931 0.396 . . . . 0.0 111.698 -178.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.494 ' CZ ' ' HB2' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -48.17 101.48 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.514 178.923 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 119.05 -15.5 11.01 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.441 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.4 m -63.47 166.87 6.07 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.794 0.297 . . . . 0.0 110.293 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.4 p -137.05 147.1 45.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.082 0.467 . . . . 0.0 111.682 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.55 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.4 OUTLIER -113.07 173.77 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.793 -179.807 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.422 ' CB ' ' HB2' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -141.99 106.77 4.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.016 178.645 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.532 ' CE1' ' CB ' ' A' ' 63' ' ' ALA . 20.9 m-85 -76.59 142.37 40.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.043 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.412 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 1.5 m -141.05 165.38 27.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.543 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.416 ' HB2' ' HB2' ' A' ' 39' ' ' TYR . 2.3 m -88.56 165.4 14.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.766 0.317 . . . . 0.0 110.768 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -64.78 -84.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.06 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.6 m -153.93 133.45 12.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.728 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.28 24.59 67.52 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.937 -178.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.485 ' CE1' ' HB3' ' A' ' 68' ' ' SER . 2.6 m-85 -116.72 171.48 7.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.859 0.361 . . . . 0.0 110.906 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.53 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 1.0 OUTLIER -134.57 116.17 14.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.624 178.173 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.43 ' CD2' ' O ' ' A' ' 44' ' ' GLU . 4.6 tt -74.24 127.64 33.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.606 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.53 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 3.1 mm -100.94 151.24 5.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.836 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.45 -140.03 23.9 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.691 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.43 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -70.68 175.38 4.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.948 0.404 . . . . 0.0 110.997 179.857 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.4 ' HA ' ' HG3' ' A' ' 64' ' ' PRO . 0.4 OUTLIER -157.77 26.84 0.27 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.296 179.289 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -149.97 151.84 33.99 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.998 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.4 ' HB3' ' O ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -132.25 143.12 49.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.125 179.51 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.486 ' CE2' ' HD2' ' A' ' 61' ' ' PRO . 2.7 m-85 -117.0 125.8 51.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.176 0.512 . . . . 0.0 111.892 -178.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.502 ' HB3' ' CH2' ' A' ' 59' ' ' TRP . 24.4 t -73.91 117.13 15.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.695 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.491 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 12.9 tt0 -160.38 167.58 27.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.424 0.631 . . . . 0.0 111.016 178.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.494 ' HB2' ' CZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.807 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.433 -178.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.433 ' HA ' ' HA ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.354 0 CA-C-O 121.029 0.442 . . . . 0.0 110.48 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.4 m -160.44 -176.83 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.28 -178.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.55 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 92.2 m95 -133.56 126.01 30.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.137 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -149.61 123.68 4.62 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.589 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.486 ' HD2' ' CE2' ' A' ' 48' ' ' TYR . 23.2 Cg_exo -68.65 -174.69 8.68 Favored 'Cis proline' 0 C--N 1.35 0.633 0 C-N-CA 124.287 -1.13 . . . . 0.0 113.055 2.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.1 -143.05 0.39 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.861 -178.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.532 ' CB ' ' CE1' ' A' ' 33' ' ' TYR . . . -86.4 116.51 66.14 Favored Pre-proline 0 CA--C 1.53 0.187 0 CA-C-O 120.407 0.146 . . . . 0.0 111.008 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.425 ' CG ' ' O ' ' A' ' 44' ' ' GLU . 11.5 Cg_exo -72.95 -151.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.645 2.23 . . . . 0.0 112.582 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.5 mm -101.45 166.34 2.47 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-O 121.02 0.438 . . . . 0.0 111.486 -178.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.3 m -163.61 120.3 1.75 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.379 179.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.32 171.04 15.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.992 0.425 . . . . 0.0 111.318 -178.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.485 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 8.9 p -93.22 103.18 15.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.848 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.7 p -59.46 89.3 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.478 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -63.8 154.22 34.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.558 -0.747 . . . . 0.0 112.184 -177.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.416 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -118.88 127.01 53.1 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.77 177.559 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.413 ' CG ' ' N ' ' A' ' 73' ' ' SER . 0.1 OUTLIER -73.93 -160.48 0.09 Allowed 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.488 179.89 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.413 ' N ' ' CG ' ' A' ' 72' ' ' GLN . 2.7 t -50.21 137.49 21.33 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.505 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.48 ' HD2' ' CD2' ' A' ' 82' ' ' HIS . 37.9 Cg_exo -56.33 162.57 7.64 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.167 1.911 . . . . 0.0 111.574 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.478 ' HD2' ' CG ' ' A' ' 118' ' ' TRP . 82.2 Cg_exo -39.92 156.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.726 2.284 . . . . 0.0 112.571 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.7 m -107.89 89.05 2.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.894 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.408 ' CG2' ' O ' ' A' ' 122' ' ' PRO . 13.5 pt -69.7 173.92 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.002 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.0 m -95.77 138.76 32.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.878 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.48 ' HB3' ' CD2' ' A' ' 103' ' ' TYR . 3.9 m-80 60.16 28.97 18.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.989 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.417 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -160.26 -170.75 25.25 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.149 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.26 -175.15 3.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.046 0.45 . . . . 0.0 110.858 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.48 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 34.8 p-80 -112.92 169.03 9.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.889 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.422 ' ND2' ' HB ' ' A' ' 96' ' ' THR . 1.2 m-20 . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.793 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.419 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 10.7 m-85 . . . . . 0 N--CA 1.456 -0.165 0 CA-C-O 120.911 0.386 . . . . 0.0 110.938 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.419 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 40.6 m-85 -147.0 165.11 30.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.444 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 17.0 p -129.22 172.09 11.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.005 0.431 . . . . 0.0 111.55 -179.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 0.9 OUTLIER -58.74 97.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.889 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.69 14.87 2.75 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.195 -0.911 . . . . 0.0 113.093 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.98 158.31 15.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.909 0.355 . . . . 0.0 110.393 179.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 27.0 m -133.77 156.11 40.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.072 0.463 . . . . 0.0 111.231 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.462 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 38.7 t -149.72 150.86 13.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.615 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.426 ' CG2' ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -108.22 133.6 52.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.963 0.411 . . . . 0.0 110.53 179.112 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.522 ' CE1' ' CG2' ' A' ' 111' ' ' VAL . 5.9 m-85 -93.28 155.84 17.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.044 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 20.0 p -152.83 144.32 23.37 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.147 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.417 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 68.5 m -72.95 158.87 34.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.251 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 -86.91 -71.09 0.57 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.692 -178.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 40.5 t -68.39 -21.72 64.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.612 -178.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 123.85 32.42 0.87 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.66 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.48 ' CD2' ' HB3' ' A' ' 79' ' ' ASN . 30.6 m-85 -69.6 -171.85 0.42 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.768 0.318 . . . . 0.0 110.277 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.7 p -107.35 106.06 16.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.975 0.417 . . . . 0.0 111.168 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.404 HD22 ' CA ' ' A' ' 109' ' ' SER . 3.0 tp -46.92 108.85 0.16 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.702 178.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.451 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 31.8 mm -84.1 158.35 3.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.651 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 59.81 -123.16 32.36 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.258 -0.973 . . . . 0.0 111.795 -178.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -125.82 132.91 52.15 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.796 0.331 . . . . 0.0 110.766 178.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.433 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 1.2 p -66.37 -31.54 72.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.401 179.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.64 136.92 22.69 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.526 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.522 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 2.9 t -126.54 153.37 35.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 179.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.39 118.36 35.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.903 0.382 . . . . 0.0 111.597 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.497 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 15.1 t -85.55 97.75 10.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.615 176.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 1.0 OUTLIER -132.54 151.1 52.03 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.556 -177.982 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 48.01 29.77 6.77 Favored Glycine 0 C--N 1.329 0.187 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.745 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 79.95 -5.06 63.4 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.936 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -121.17 175.11 6.27 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.93 0.395 . . . . 0.0 110.866 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.497 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 87.2 m95 -112.5 152.27 28.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.895 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.27 147.12 49.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.021 0.438 . . . . 0.0 111.466 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.492 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER 70.07 46.11 0.27 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.161 178.546 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.492 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 74.1 Cg_endo -75.37 139.49 23.42 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.382 2.055 . . . . 0.0 111.623 178.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.451 ' CB ' ' O ' ' A' ' 106' ' ' ILE . 57.3 Cg_endo -89.22 -174.52 0.96 Allowed 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.574 2.182 . . . . 0.0 113.559 -178.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.451 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -132.27 -171.75 2.72 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.845 -1.071 . . . . 0.0 109.834 177.829 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 10.4 m -146.3 93.93 2.38 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.0 0.428 . . . . 0.0 111.214 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -119.54 169.54 9.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.878 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.476 HG12 ' CE1' ' A' ' 103' ' ' TYR . 28.3 mm . . . . . 0 C--N 1.323 -0.547 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.944 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.785 0.326 . . . . 0.0 110.507 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.455 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 53.6 m -77.85 159.61 75.94 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.664 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.15 169.86 17.17 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.504 2.136 . . . . 0.0 112.305 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 p -50.55 106.38 0.63 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.832 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.446 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 52.2 Cg_exo -43.23 152.92 0.22 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.262 1.974 . . . . 0.0 112.249 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.425 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -70.05 154.75 41.54 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.056 0.455 . . . . 0.0 110.424 178.685 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -97.59 -176.47 3.49 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.889 -176.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.6 tt -151.45 144.75 16.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.961 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.428 ' HB2' ' ND2' ' A' ' 17' ' ' ASN . 7.4 t0 -86.57 159.25 19.31 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.108 -0.497 . . . . 0.0 109.974 178.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.485 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 0.1 OUTLIER 43.15 29.63 0.22 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.89 0.376 . . . . 0.0 111.051 -179.445 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -155.02 173.42 33.34 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.629 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -137.53 135.18 36.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.763 0.316 . . . . 0.0 110.589 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.479 HD21 ' CD1' ' A' ' 33' ' ' TYR . 14.0 mt -79.27 159.91 27.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.445 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.406 ' HB2' ' CB ' ' A' ' 32' ' ' THR . 34.9 t0 -131.31 75.48 1.66 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.366 178.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.45 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 58.3 mt -70.98 118.38 15.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.134 0.492 . . . . 0.0 111.994 -178.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -128.47 19.83 5.6 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.696 177.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 160.12 117.84 0.48 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.175 -0.536 . . . . 0.0 111.94 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.4 m -114.47 24.85 4.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.692 0.282 . . . . 0.0 111.554 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -100.97 146.47 27.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.703 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.48 ' CZ ' HD11 ' A' ' 51' ' ' LEU . 5.7 t80 -48.23 97.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.062 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.18 5.58 5.59 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.074 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.58 -158.69 0.69 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 117.037 0.419 . . . . 0.0 110.79 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.2 p -168.62 146.63 4.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.048 0.451 . . . . 0.0 111.413 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.543 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.7 OUTLIER -105.89 167.58 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.225 179.51 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.406 ' CB ' ' HB2' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -127.85 121.31 29.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.802 0.334 . . . . 0.0 110.738 179.001 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.479 ' CD1' HD21 ' A' ' 20' ' ' LEU . 14.1 m-85 -95.51 149.09 21.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.519 -179.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.19 155.82 39.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.771 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.404 ' HB2' ' HB2' ' A' ' 39' ' ' TYR . 2.9 m -81.99 169.53 16.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.819 0.342 . . . . 0.0 110.867 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -70.56 -84.97 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.157 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.6 m -153.14 131.91 12.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.933 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.19 21.22 73.74 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.15 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.485 ' CE2' ' HB3' ' A' ' 17' ' ' ASN . 2.5 m-85 -113.46 175.97 5.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.793 0.33 . . . . 0.0 110.868 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.511 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.5 OUTLIER -140.15 113.59 8.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.516 178.662 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.437 ' CD2' ' O ' ' A' ' 44' ' ' GLU . 6.7 tt -79.5 121.33 25.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.829 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.511 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 2.2 mm -99.23 168.43 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.129 -179.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.13 -134.1 26.84 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.374 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.437 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 2.2 pm0 -79.75 -173.05 3.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.766 0.317 . . . . 0.0 110.603 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.432 ' CB ' HD21 ' A' ' 41' ' ' LEU . 2.2 t -166.66 28.84 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.605 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -159.76 127.65 4.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.327 -178.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.436 ' OG ' ' CB ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -93.0 143.67 26.01 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.906 178.323 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.498 ' CD1' ' HB2' ' A' ' 60' ' ' ASN . 1.6 m-85 -118.69 114.5 22.82 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.507 178.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.446 ' HB3' ' CH2' ' A' ' 59' ' ' TRP . 21.8 t -69.86 99.4 1.38 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.565 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -120.38 -172.17 2.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.098 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.48 HD11 ' CZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.953 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 4.6 mmt . . . . . 0 N--CA 1.455 -0.201 0 CA-C-O 120.96 0.41 . . . . 0.0 110.7 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.4 m -155.52 175.34 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.823 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.543 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 79.2 m95 -128.51 121.86 29.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.598 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.498 ' HB2' ' CD1' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -69.52 167.34 23.17 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.342 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.49 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 68.4 Cg_exo -14.58 92.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.872 1 C-N-CA 125.339 4.026 . . . . 0.0 114.622 -178.656 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.479 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -90.81 -75.78 0.46 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.338 -177.4 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.437 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -91.8 108.17 27.87 Favored Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -175.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.437 ' HG3' ' CD1' ' A' ' 41' ' ' LEU . 4.7 Cg_exo -81.47 -154.15 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.083 2.522 . . . . 0.0 111.123 177.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.405 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 3.8 mm -88.81 166.03 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.782 0.325 . . . . 0.0 110.438 177.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -169.32 129.82 1.08 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.605 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -155.74 173.5 16.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.135 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.484 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 5.2 p -85.4 117.25 24.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.627 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.45 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 0.4 OUTLIER -42.44 94.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.344 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.468 ' CD ' ' HB2' ' A' ' 88' ' ' PHE . 4.3 ttpt -80.15 131.72 35.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.285 -178.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.432 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -107.08 130.0 54.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.901 -179.285 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.3 -158.48 0.06 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.443 178.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.479 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 2.0 t -49.98 135.89 21.1 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.842 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.434 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 31.8 Cg_exo -56.69 162.92 7.79 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.393 2.062 . . . . 0.0 112.053 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.492 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 87.8 Cg_exo -42.44 156.68 0.09 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.715 2.277 . . . . 0.0 112.776 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 65.1 p -106.01 90.09 3.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.406 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 25.0 pt -69.32 172.54 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.37 -178.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.0 p -94.98 143.9 26.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.509 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.486 ' HB3' ' CE1' ' A' ' 103' ' ' TYR . 2.7 m-80 58.58 28.59 17.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.86 0.362 . . . . 0.0 111.084 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -171.82 -167.54 32.11 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.498 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 10.2 ptt85 -166.54 -176.6 3.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.966 0.413 . . . . 0.0 111.168 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.479 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 25.3 p-80 -103.08 175.16 5.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.038 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.31 179.047 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.468 ' HB2' ' CD ' ' A' ' 70' ' ' LYS . 19.2 m-85 . . . . . 0 N--CA 1.456 -0.175 0 CA-C-O 120.664 0.269 . . . . 0.0 111.077 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.462 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 84.5 m-85 -157.41 169.95 23.56 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.734 -178.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 11.4 p -134.0 178.59 6.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.909 0.385 . . . . 0.0 111.407 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 28.5 p-10 -62.74 94.77 0.07 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.298 0.571 . . . . 0.0 111.026 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.56 29.53 0.9 Allowed Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.983 179.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.11 163.88 13.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.691 0.282 . . . . 0.0 110.57 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 33.9 m -138.76 150.73 23.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.103 0.478 . . . . 0.0 111.307 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.49 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 20.1 t -145.81 147.06 18.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.635 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.429 ' CG2' ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -105.76 130.59 53.73 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.893 179.956 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.505 ' CE2' ' CG2' ' A' ' 111' ' ' VAL . 5.0 m-85 -89.77 160.55 16.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.069 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 82.4 p -156.47 139.26 15.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.078 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 62.8 m -70.94 160.11 33.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.076 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 -80.85 -81.96 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.299 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.14 -30.99 70.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.214 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 132.57 39.81 0.22 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.645 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.504 ' CD2' HG12 ' A' ' 126' ' ' ILE . 49.7 m-85 -69.51 -174.27 0.67 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.807 0.337 . . . . 0.0 110.545 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 67.3 m -104.97 101.2 10.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.699 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.434 ' HA ' ' O ' ' A' ' 123' ' ' THR . 0.2 OUTLIER -50.69 122.18 6.89 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.475 0.655 . . . . 0.0 111.428 -178.713 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.43 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 30.9 mm -91.3 155.43 3.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.943 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.76 -127.53 36.51 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.922 -178.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -126.19 138.59 53.66 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.799 0.333 . . . . 0.0 111.065 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.429 ' OG ' ' CG2' ' A' ' 96' ' ' THR . 5.7 p -64.79 -32.25 73.85 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.656 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -71.49 138.34 27.37 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.929 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.505 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 2.7 t -133.31 119.66 36.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.543 0.211 . . . . 0.0 110.591 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.5 125.79 30.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.889 0.376 . . . . 0.0 111.554 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.491 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 34.7 t -90.22 102.81 15.53 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 176.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 9.0 t -144.22 161.0 40.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.111 0.482 . . . . 0.0 111.308 -178.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 45.23 33.37 4.0 Favored Glycine 0 CA--C 1.518 0.252 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.912 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.45 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 66.39 16.99 65.83 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.538 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -139.98 178.05 7.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.781 0.324 . . . . 0.0 110.608 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.492 ' CD1' ' HD2' ' A' ' 75' ' ' PRO . 94.5 m95 -116.01 138.18 51.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.926 -179.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.72 146.68 46.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.214 -179.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.475 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 3.2 t0 71.02 46.05 0.25 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.074 178.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 97.2 Cg_endo -78.63 134.69 12.43 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.322 2.015 . . . . 0.0 111.379 177.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.437 ' CG ' ' HB2' ' A' ' 97' ' ' TYR . 53.7 Cg_endo -87.05 -177.65 2.26 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.374 2.05 . . . . 0.0 113.412 -178.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 105' ' ' LEU . 0.2 OUTLIER -134.2 177.85 7.42 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.542 178.312 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 12.5 m -132.93 106.68 7.83 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.312 0.577 . . . . 0.0 110.95 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -114.79 -175.87 2.78 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.437 -178.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.523 ' CD1' ' N ' ' A' ' 126' ' ' ILE . 1.6 mp . . . . . 0 C--N 1.32 -0.68 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.618 -177.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.78 0.324 . . . . 0.0 110.736 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.428 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 60.6 m -104.78 158.74 31.36 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.9 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.91 170.98 14.32 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.362 2.041 . . . . 0.0 110.883 178.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.1 p -53.2 123.53 35.04 Favored Pre-proline 0 N--CA 1.448 -0.525 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.633 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.44 ' CG ' HD13 ' A' ' 22' ' ' ILE . 20.4 Cg_endo -58.61 158.24 24.48 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.737 2.291 . . . . 0.0 112.338 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.81 142.96 51.29 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.474 178.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.62 -171.06 3.38 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.417 -177.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.2 tt -155.97 143.89 11.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.394 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -90.93 158.77 16.55 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.764 177.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.486 ' HB2' ' CE1' ' A' ' 39' ' ' TYR . 0.4 OUTLIER 48.27 26.02 0.99 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.825 0.345 . . . . 0.0 110.656 -179.463 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.408 ' HA3' ' N ' ' A' ' 36' ' ' ASN . . . -157.56 -178.6 31.76 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.589 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -146.06 134.43 21.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.672 0.273 . . . . 0.0 110.887 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 20.1 mt -78.61 155.18 29.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.986 0.422 . . . . 0.0 111.353 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.439 ' CB ' ' HB ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -124.01 72.65 1.17 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.444 177.203 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.44 HD13 ' CG ' ' A' ' 12' ' ' PRO . 1.1 mt -69.93 101.17 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.008 -176.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.9 17.25 57.55 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.718 176.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 154.96 151.5 5.86 Favored Glycine 0 C--N 1.333 0.382 0 N-CA-C 111.659 -0.576 . . . . 0.0 111.659 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.3 m -133.76 13.61 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -85.5 157.18 20.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.849 0.356 . . . . 0.0 111.094 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.479 ' CZ ' HD13 ' A' ' 51' ' ' LEU . 5.9 t80 -51.38 103.34 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.785 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 115.28 -1.51 22.35 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.888 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 94.4 p -78.94 -176.72 5.17 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 116.984 0.392 . . . . 0.0 110.435 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.3 p -151.91 156.36 39.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.936 0.398 . . . . 0.0 111.376 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.507 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.8 OUTLIER -122.37 166.55 16.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.827 -179.713 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.439 ' HB ' ' CB ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -128.89 114.48 16.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.782 179.13 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.464 ' CE2' ' HA ' ' A' ' 63' ' ' ALA . 31.3 m-85 -88.58 145.01 25.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.979 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -148.41 166.17 28.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.113 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.3 m -89.64 158.79 17.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.716 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.418 ' ND2' ' HA ' ' A' ' 17' ' ' ASN . 15.5 m-20 -58.02 -88.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.31 -178.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.9 t -151.86 133.39 14.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.882 0.372 . . . . 0.0 110.822 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.01 18.49 72.81 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.233 -179.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.486 ' CE1' ' HB2' ' A' ' 17' ' ' ASN . 2.7 m-30 -112.6 -177.93 3.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.911 0.386 . . . . 0.0 110.786 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.533 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.3 OUTLIER -142.08 110.85 6.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.008 177.041 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.43 ' CD2' ' O ' ' A' ' 44' ' ' GLU . 2.9 tt -72.57 125.19 26.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.336 -178.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.533 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 1.7 mm -106.2 165.7 3.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.111 0.482 . . . . 0.0 111.274 -178.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.31 -123.16 11.75 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.305 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.43 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 1.3 mt-10 -80.77 174.58 11.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.194 0.521 . . . . 0.0 112.019 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.401 ' HB3' HD22 ' A' ' 41' ' ' LEU . 5.2 p -156.37 19.03 0.35 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.474 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt -159.97 152.05 20.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.059 0.457 . . . . 0.0 112.075 -177.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -121.25 152.73 38.54 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.031 177.986 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.477 ' CD1' ' HB2' ' A' ' 60' ' ' ASN . 1.4 m-85 -131.36 115.13 15.84 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 119.135 -1.026 . . . . 0.0 112.173 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 28.0 t -66.12 109.02 2.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.763 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -133.27 -173.3 3.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.173 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.479 HD13 ' CZ ' ' A' ' 27' ' ' PHE . 7.4 mt . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.242 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.752 0.311 . . . . 0.0 110.801 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.1 -176.95 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.861 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.507 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 65.8 m95 -132.01 131.95 42.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.744 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.477 ' HB2' ' CD1' ' A' ' 48' ' ' TYR . 1.0 OUTLIER -69.92 162.62 67.17 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.08 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.451 ' O ' ' HA ' ' A' ' 47' ' ' SER . 21.4 Cg_exo -7.8 109.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.755 1 C-N-CA 125.888 4.392 . . . . 0.0 115.267 -178.189 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.438 ' HA ' ' OG ' ' A' ' 47' ' ' SER . 3.9 mt-10 -98.09 -113.73 0.15 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 114.901 -1.045 . . . . 0.0 112.513 -176.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.464 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -69.25 107.71 2.41 Favored Pre-proline 0 C--N 1.34 0.168 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -176.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.424 ' CG ' ' O ' ' A' ' 44' ' ' GLU . 2.2 Cg_endo -81.53 -153.98 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.924 2.416 . . . . 0.0 110.298 176.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.443 ' CD1' ' HB ' ' A' ' 42' ' ' ILE . 0.3 OUTLIER -86.04 170.73 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.327 0.584 . . . . 0.0 111.573 -179.976 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -172.24 141.47 1.25 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.042 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -169.7 167.8 9.33 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.801 0.334 . . . . 0.0 111.202 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.484 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 2.8 p -77.54 121.85 24.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.247 178.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.454 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 1.4 p -40.52 96.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.139 0.495 . . . . 0.0 111.582 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.488 ' HG3' ' CD2' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -92.37 127.53 37.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.172 -178.013 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.43 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -100.29 132.02 45.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.998 -179.001 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -75.81 -159.55 0.11 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.599 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.428 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 1.9 t -48.44 136.83 12.29 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.04 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.48 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 25.7 Cg_exo -60.59 159.02 29.6 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.351 2.034 . . . . 0.0 112.225 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.404 ' HG3' ' HD3' ' A' ' 121' ' ' PRO . 81.1 Cg_exo -44.78 159.69 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.982 2.455 . . . . 0.0 113.275 -178.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.6 m -108.8 93.11 4.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.516 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.4 pt -68.5 175.2 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.249 -179.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.2 p -94.32 137.36 33.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.877 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.481 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 0.1 OUTLIER 68.47 26.87 6.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.879 179.521 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.436 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . -171.84 -164.78 27.99 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.263 -0.97 . . . . 0.0 113.216 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' A' ' 98' ' ' SER . 4.9 ptt85 -162.06 -175.1 4.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.044 0.45 . . . . 0.0 110.705 -179.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.428 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 19.6 p-80 -111.14 169.53 8.72 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.71 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.709 179.82 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.488 ' CD2' ' HG3' ' A' ' 70' ' ' LYS . 24.8 m-85 . . . . . 0 N--CA 1.455 -0.217 0 CA-C-O 120.719 0.295 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.468 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 89.2 m-85 -157.17 165.57 35.6 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.419 -178.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.0 p -136.56 -176.4 4.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.072 0.463 . . . . 0.0 111.717 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.407 ' OD2' ' N ' ' A' ' 91' ' ' ASP . 2.1 m-20 -63.03 96.64 0.1 Allowed 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.255 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.94 26.54 1.36 Allowed Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.288 -0.869 . . . . 0.0 113.035 178.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.403 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -110.17 162.92 14.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.817 0.341 . . . . 0.0 110.801 179.374 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 36.0 m -144.29 149.44 17.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.135 0.493 . . . . 0.0 111.125 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.478 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 18.1 t -141.1 146.97 22.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.559 179.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.434 ' CG2' ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -102.08 136.78 41.32 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.816 -179.764 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.531 ' CE2' ' CG2' ' A' ' 111' ' ' VAL . 5.8 m-85 -98.81 156.17 17.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.147 -179.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.4 ' O ' ' N ' ' A' ' 81' ' ' ARG . 1.3 p -148.07 141.42 25.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.57 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.436 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 12.1 m -69.38 162.43 27.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.281 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -97.02 -69.07 0.77 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.092 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.75 -28.81 69.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.01 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.36 36.79 0.48 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.548 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.502 ' CE2' HG12 ' A' ' 126' ' ' ILE . 18.2 m-85 -74.27 -171.77 1.26 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.756 0.312 . . . . 0.0 110.664 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.6 m -117.54 101.05 8.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.759 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.434 HD23 ' CB ' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -49.0 132.79 18.7 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.594 0.711 . . . . 0.0 111.155 -179.739 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.434 ' HB ' ' CB ' ' A' ' 123' ' ' THR . 36.1 mm -101.82 156.98 4.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.59 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.427 ' N ' HG21 ' A' ' 106' ' ' ILE . . . 67.35 -126.47 25.37 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.958 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -125.79 127.06 45.54 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.054 0.454 . . . . 0.0 110.931 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.434 ' OG ' ' CG2' ' A' ' 96' ' ' THR . 3.6 p -59.34 -27.93 66.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.728 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -72.47 121.39 8.08 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.75 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.531 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 11.6 t -113.99 116.03 51.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.5 126.61 31.18 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -177.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.485 ' HB2' ' CZ3' ' A' ' 118' ' ' TRP . 41.8 t -91.07 104.12 16.74 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 19.3 t -141.1 150.72 43.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.078 0.466 . . . . 0.0 111.406 -178.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.68 43.24 15.58 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.767 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.454 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 62.32 14.14 46.7 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.647 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -135.11 173.25 11.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.023 0.44 . . . . 0.0 110.679 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.485 ' CZ3' ' HB2' ' A' ' 113' ' ' CYS . 95.8 m95 -115.48 128.1 55.78 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.527 -178.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.488 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 0.3 OUTLIER -91.81 130.39 37.6 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.663 175.04 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.524 ' CB ' ' CA ' ' A' ' 121' ' ' PRO . 2.8 m-20 108.92 -132.1 0.0 OUTLIER Pre-proline 0 CA--C 1.475 -1.907 0 N-CA-C 100.41 -3.922 . . . . 0.0 100.41 -167.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.524 ' CA ' ' CB ' ' A' ' 120' ' ' ASP . 60.4 Cg_endo -63.52 -179.53 7.77 Favored 'Cis proline' 0 C--N 1.309 -1.54 0 CA-C-N 125.157 2.878 . . . . 0.0 112.717 -17.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.434 ' CB ' HD23 ' A' ' 105' ' ' LEU . 18.0 Cg_endo -87.94 -179.51 2.53 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 123.023 2.482 . . . . 0.0 111.32 176.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.434 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -109.12 -162.6 0.82 Allowed 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.13 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 5.0 t -170.25 85.83 0.12 Allowed 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.904 -176.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -114.61 176.74 4.92 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.909 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.502 HG12 ' CE2' ' A' ' 103' ' ' TYR . 26.4 mm . . . . . 0 C--N 1.322 -0.615 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.718 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.874 0.368 . . . . 0.0 110.731 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.445 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 37.9 m -81.33 160.06 66.02 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.874 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.89 174.44 9.62 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.454 2.103 . . . . 0.0 111.961 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -51.11 109.57 1.41 Allowed Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.794 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.41 162.38 14.85 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.258 1.972 . . . . 0.0 111.977 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.456 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -52.11 -175.02 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.447 179.318 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.418 ' C ' ' CG1' ' A' ' 15' ' ' ILE . 0.4 OUTLIER -140.05 6.53 2.18 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.041 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.537 ' CD1' ' CD2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER 57.8 -165.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.067 -177.635 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -125.79 -70.88 0.72 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.929 0.395 . . . . 0.0 110.613 178.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.471 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -99.2 29.02 4.11 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.941 178.605 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.42 ' HA3' ' N ' ' A' ' 36' ' ' ASN . . . -137.93 -175.66 14.03 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.214 -178.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.431 ' N ' HD11 ' A' ' 15' ' ' ILE . 0.2 OUTLIER -133.75 145.35 49.74 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.672 0.272 . . . . 0.0 110.747 -179.706 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.482 HD23 ' CZ ' ' A' ' 33' ' ' TYR . 4.9 mt -82.67 155.55 24.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.207 0.527 . . . . 0.0 111.797 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.403 ' HB2' ' HB ' ' A' ' 32' ' ' THR . 4.5 t0 -129.91 68.5 1.44 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.92 175.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.463 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 0.9 OUTLIER -74.95 116.95 18.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.49 -175.796 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -116.05 19.57 13.5 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.227 175.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 161.0 125.99 0.8 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.007 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.6 m -112.44 5.79 8.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -88.46 165.42 14.91 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.871 0.367 . . . . 0.0 110.871 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -57.76 116.71 3.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.635 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.45 5.9 36.42 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.833 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 89.7 p -94.14 -169.59 2.1 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.856 0.328 . . . . 0.0 110.307 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.9 p -165.88 141.66 5.0 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.125 0.488 . . . . 0.0 111.1 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.533 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.6 OUTLIER -106.14 164.38 4.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.209 -179.898 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.403 ' HB ' ' HB2' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -121.86 118.18 28.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.952 0.406 . . . . 0.0 110.671 179.034 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.537 ' CD2' ' CD1' ' A' ' 15' ' ' ILE . 6.1 m-85 -90.97 135.63 33.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.784 -178.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.9 m -146.97 157.55 43.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.694 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.9 m -79.58 167.56 20.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.846 0.355 . . . . 0.0 110.869 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.42 ' N ' ' HA3' ' A' ' 18' ' ' GLY . 11.1 m-20 -67.15 -84.13 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.971 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.96 134.52 11.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.699 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.29 24.27 73.47 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.897 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.53 ' CE2' ' CB ' ' A' ' 68' ' ' SER . 2.7 m-30 -119.73 174.52 6.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.887 0.375 . . . . 0.0 110.908 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.517 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.6 OUTLIER -134.53 117.12 15.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.364 177.78 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.401 HD22 ' HB3' ' A' ' 45' ' ' SER . 5.7 tt -81.75 127.47 32.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.337 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.517 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 1.9 mm -106.09 149.49 9.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.275 -178.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.71 -141.4 19.5 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.369 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.427 ' O ' ' CG ' ' A' ' 64' ' ' PRO . 0.9 OUTLIER -74.04 -172.94 1.47 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.903 0.383 . . . . 0.0 110.79 179.53 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.401 ' HB3' HD22 ' A' ' 41' ' ' LEU . 4.8 p -161.69 22.73 0.12 Allowed 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.392 -179.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 1.1 mtpt -153.31 125.47 7.98 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -177.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.45 ' CB ' ' HA ' ' A' ' 62' ' ' GLU . 0.3 OUTLIER -94.61 145.43 24.84 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.092 178.111 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.501 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 1.8 m-85 -120.89 120.5 35.7 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 119.315 -0.954 . . . . 0.0 111.797 178.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 26.5 t -68.74 117.66 10.73 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.156 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -156.61 -179.45 8.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.992 179.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.6 pp . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.656 179.644 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.217 0 CA-C-O 121.088 0.47 . . . . 0.0 110.87 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.1 m -149.28 -176.09 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.541 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.533 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 69.7 m95 -131.48 124.96 31.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.988 0.423 . . . . 0.0 111.261 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.501 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 4.8 m-20 -68.4 166.61 24.03 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.439 178.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.471 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 49.3 Cg_exo -12.63 86.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.008 1 C-N-CA 125.361 4.041 . . . . 0.0 114.211 -178.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.496 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.5 OUTLIER -90.26 -76.58 0.42 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.723 -176.236 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.498 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -94.22 108.23 34.51 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -173.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.427 ' CG ' ' O ' ' A' ' 44' ' ' GLU . 2.3 Cg_endo -81.41 -154.34 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.189 2.592 . . . . 0.0 110.368 175.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.438 ' CD1' ' HB ' ' A' ' 42' ' ' ILE . 1.0 OUTLIER -93.19 175.2 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.602 177.767 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -171.46 144.31 1.92 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.609 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.417 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 1.3 tt0 -166.73 175.08 8.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.86 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.53 ' CB ' ' CE2' ' A' ' 39' ' ' TYR . 0.2 OUTLIER -99.41 123.4 43.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.658 178.944 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.428 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 1.4 p -45.27 92.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.093 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 68' ' ' SER . 2.4 mmtp -63.99 131.95 49.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.199 -177.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.12 121.0 40.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.62 177.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.3 -159.5 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.655 -179.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.465 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 2.7 t -51.33 139.67 25.9 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.589 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.418 ' HA ' ' CD1' ' A' ' 118' ' ' TRP . 26.4 Cg_exo -59.22 159.67 21.81 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.201 1.934 . . . . 0.0 111.918 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.463 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 88.9 Cg_exo -39.79 156.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.934 2.422 . . . . 0.0 113.04 -178.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.1 t -107.97 90.81 3.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.796 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 21.4 pt -69.51 -176.68 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.287 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.6 m -105.25 145.74 30.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.662 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.445 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 7.4 m-80 55.56 28.35 11.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.929 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.471 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -167.52 -163.2 20.99 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.563 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 9.5 ptt180 -170.15 -175.72 2.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.039 0.447 . . . . 0.0 110.971 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.465 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 1.6 p-80 -110.46 168.2 9.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.868 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.636 179.9 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.421 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 7.8 m-85 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.86 0.362 . . . . 0.0 111.106 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.421 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 48.6 m-85 -148.11 165.01 32.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.828 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.1 p -134.5 -175.19 3.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.905 0.383 . . . . 0.0 111.462 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.42 ' OD1' ' CG1' ' A' ' 69' ' ' VAL . 0.7 OUTLIER -64.5 98.45 0.25 Allowed 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.31 0.576 . . . . 0.0 111.069 -179.876 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.86 22.29 2.23 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.164 -0.925 . . . . 0.0 113.13 178.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.426 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.6 OUTLIER -103.18 157.25 17.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.908 0.354 . . . . 0.0 110.631 179.167 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 28.6 m -136.39 149.06 27.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.079 0.466 . . . . 0.0 111.173 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.471 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 21.4 t -144.19 147.39 19.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.747 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.31 129.49 54.32 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.778 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.528 ' CE1' ' CG2' ' A' ' 111' ' ' VAL . 5.5 m-85 -88.56 157.07 18.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.115 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 50.2 m -151.3 141.31 22.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.334 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.405 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 74.0 m -71.89 163.12 28.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.979 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.471 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 18.0 m-20 -96.73 -71.46 0.68 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.513 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.0 t -61.58 -22.57 65.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.23 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 122.37 31.29 1.08 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.534 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.493 ' CD2' HG13 ' A' ' 126' ' ' ILE . 24.8 m-85 -69.96 -174.02 0.72 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 120.959 0.409 . . . . 0.0 110.495 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.0 105.87 14.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.359 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.446 ' CD2' ' HA ' ' A' ' 109' ' ' SER . 0.2 OUTLIER -46.44 123.41 4.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.385 0.612 . . . . 0.0 111.419 -178.809 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.458 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 42.6 mm -91.13 152.61 3.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.457 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.67 -130.44 36.91 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.104 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -114.67 138.8 50.25 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.839 0.352 . . . . 0.0 110.774 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.465 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 0.0 OUTLIER -77.23 -30.08 54.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.756 179.906 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.04 127.41 11.02 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.18 178.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.528 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 2.8 t -120.22 121.86 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.65 0.262 . . . . 0.0 110.642 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.75 122.85 27.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.705 -178.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.484 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 25.6 t -88.85 104.13 16.64 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.6 t -145.39 163.81 33.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.163 -178.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 44.9 30.57 2.44 Favored Glycine 0 CA--C 1.518 0.258 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.928 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.428 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 67.14 19.89 70.55 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.42 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -143.56 175.56 9.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.766 0.317 . . . . 0.0 110.561 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.484 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 95.7 m95 -112.33 142.86 44.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.005 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.9 148.08 50.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.257 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.478 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 26.6 t0 71.74 46.72 0.24 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.082 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 95.4 Cg_endo -78.18 134.03 12.6 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.343 2.029 . . . . 0.0 111.4 177.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.465 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 74.0 Cg_endo -88.66 -173.75 0.92 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.525 2.15 . . . . 0.0 113.532 -177.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.435 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -129.75 -163.42 1.3 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.781 177.756 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 5.1 m -151.97 92.06 1.69 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.047 0.451 . . . . 0.0 110.94 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -122.07 158.11 29.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.852 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.493 HG13 ' CD2' ' A' ' 103' ' ' TYR . 13.6 mm . . . . . 0 C--N 1.324 -0.518 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.859 179.576 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.969 0.414 . . . . 0.0 110.834 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.462 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 4.2 m -93.84 162.94 25.6 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.705 179.506 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.409 ' HD3' ' HB2' ' A' ' 9' ' ' CYS . 15.5 Cg_endo -60.1 -163.28 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.316 2.011 . . . . 0.0 111.452 -179.883 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.409 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 0.9 OUTLIER -78.46 104.94 2.34 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.718 -0.219 . . . . 0.0 110.805 179.92 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.498 ' CG ' ' CD1' ' A' ' 22' ' ' ILE . 13.2 Cg_endo -55.97 142.84 84.47 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.123 1.882 . . . . 0.0 111.677 179.461 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -52.19 169.34 0.08 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.467 -179.556 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.489 ' HA ' ' CD1' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -130.02 -5.27 4.47 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -177.149 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.435 HG23 ' CD2' ' A' ' 20' ' ' LEU . 3.0 tt 55.45 157.42 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 122.864 0.466 . . . . 0.0 111.798 -178.264 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -101.78 -47.33 4.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.432 -178.349 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -94.04 38.71 1.08 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.878 -179.633 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.446 ' HA3' ' N ' ' A' ' 36' ' ' ASN . . . 177.84 -166.07 36.07 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.969 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -136.47 177.21 8.03 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.334 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.489 ' CD1' ' HA ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -126.59 151.5 47.89 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.301 0.572 . . . . 0.0 111.411 -179.836 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 32' ' ' THR . 4.2 t70 -116.25 82.67 1.82 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.528 177.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.498 ' CD1' ' CG ' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -77.39 103.12 4.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.392 -176.908 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.67 19.79 52.95 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.756 177.177 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.07 142.09 3.37 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.06 -0.591 . . . . 0.0 111.955 -179.374 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.0 m -128.6 29.64 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.66 0.266 . . . . 0.0 111.492 -178.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -105.69 164.97 11.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.929 0.395 . . . . 0.0 110.838 179.309 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.491 ' CE1' ' HB2' ' A' ' 51' ' ' LEU . 0.8 OUTLIER -59.93 90.59 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.925 -179.738 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 136.31 -2.88 3.58 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.32 179.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.39 -174.56 3.38 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 117.157 0.479 . . . . 0.0 110.771 179.86 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.4 p -156.58 145.22 19.99 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.016 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.529 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.4 OUTLIER -100.79 166.15 2.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.234 179.525 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -127.48 114.95 18.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.827 0.346 . . . . 0.0 110.864 179.654 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.507 ' CG ' ' O ' ' A' ' 62' ' ' GLU . 15.4 m-85 -91.92 149.2 21.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.258 0.551 . . . . 0.0 112.061 -178.386 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.0 m -151.44 147.02 26.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.188 178.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.3 m -69.15 167.66 15.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.848 0.356 . . . . 0.0 110.829 -179.351 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.446 ' N ' ' HA3' ' A' ' 18' ' ' GLY . 25.4 m-20 -68.69 -85.76 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.239 -178.317 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.73 134.98 15.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.524 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.92 26.42 72.25 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.771 -178.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.482 ' CD2' ' HA ' ' A' ' 68' ' ' SER . 2.1 m-85 -121.41 171.89 8.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.997 0.427 . . . . 0.0 111.179 -179.45 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.527 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.4 OUTLIER -138.26 112.79 8.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.066 177.647 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.433 HD21 ' CB ' ' A' ' 45' ' ' SER . 7.0 tt -75.4 129.93 38.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.856 -178.812 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.527 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 3.0 mm -104.94 157.4 5.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.994 0.426 . . . . 0.0 111.098 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.6 -142.45 31.16 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.05 -179.094 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.424 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -73.0 -172.54 1.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.85 0.357 . . . . 0.0 110.569 179.222 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.433 ' CB ' HD21 ' A' ' 41' ' ' LEU . 0.3 OUTLIER -168.21 30.21 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.534 179.682 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.427 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 25.8 mtpt -151.8 126.02 9.29 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.426 -178.534 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.428 ' OG ' ' CB ' ' A' ' 62' ' ' GLU . 0.3 OUTLIER -93.04 137.47 32.37 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.876 178.819 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.496 ' CD1' ' HB2' ' A' ' 60' ' ' ASN . 1.1 m-85 -114.73 121.77 44.37 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.79 -179.948 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 23.0 t -72.01 117.56 13.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.936 -179.58 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.483 ' HA ' ' CE2' ' A' ' 27' ' ' PHE . 4.6 mt-10 -146.16 -179.47 6.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.034 179.476 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.491 ' HB2' ' CE1' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.424 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.912 -179.673 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.409 ' O ' ' CG1' ' A' ' 58' ' ' VAL . 3.2 mmt . . . . . 0 N--CA 1.455 -0.22 0 CA-C-O 120.839 0.352 . . . . 0.0 110.6 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.409 ' CG1' ' O ' ' A' ' 57' ' ' MET . 2.7 m -163.38 173.95 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.204 -179.484 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.529 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 74.1 m95 -129.25 125.22 36.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.138 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.496 ' HB2' ' CD1' ' A' ' 48' ' ' TYR . 0.7 OUTLIER -69.33 166.06 33.47 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.761 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.48 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 65.7 Cg_exo -11.49 101.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.003 1 C-N-CA 125.647 4.231 . . . . 0.0 114.634 -179.187 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.507 ' O ' ' CG ' ' A' ' 33' ' ' TYR . 0.7 OUTLIER -101.71 -71.1 0.72 Allowed 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 115.159 -0.928 . . . . 0.0 113.159 -175.416 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -102.98 76.93 0.23 Allowed Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -174.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.427 ' HD2' ' O ' ' A' ' 62' ' ' GLU . 33.3 Cg_endo -55.39 -154.42 0.0 OUTLIER 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 123.249 2.633 . . . . 0.0 111.766 176.015 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.408 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 6.8 mm -86.97 166.42 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.964 0.412 . . . . 0.0 111.282 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.1 m -165.34 125.86 1.89 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.762 178.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.16 171.74 13.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.918 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.482 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 96.4 p -84.89 118.53 24.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.552 -179.568 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 116' ' ' GLY . 0.2 OUTLIER -49.98 99.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.036 178.876 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -62.85 138.95 58.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.188 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.419 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -123.18 126.59 47.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.636 179.588 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -74.57 -168.59 0.71 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.841 179.498 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -41.25 133.38 1.98 Allowed Pre-proline 0 N--CA 1.438 -1.056 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.684 179.364 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.479 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 31.8 Cg_exo -57.82 162.9 10.08 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.378 2.052 . . . . 0.0 112.391 -178.704 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.494 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 85.6 Cg_exo -41.32 160.5 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.879 2.386 . . . . 0.0 113.135 -179.469 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.81 89.61 3.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.642 179.399 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.5 pt -69.35 171.99 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.407 -179.025 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.7 m -88.44 141.36 28.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.705 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.418 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 6.2 m-80 57.22 29.46 16.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.926 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.465 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -169.71 -172.52 36.36 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.81 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 9.4 ptt180 -166.69 -175.61 3.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.92 0.39 . . . . 0.0 110.59 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.47 ' CD2' ' O ' ' A' ' 74' ' ' PRO . 16.1 p80 -109.36 167.86 9.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.637 -179.053 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 41.7 p-10 . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.072 178.435 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.42 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 5.1 m-85 . . . . . 0 N--CA 1.455 -0.182 0 CA-C-O 120.769 0.319 . . . . 0.0 110.452 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.42 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 85.9 m-85 -153.62 169.02 24.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.825 -179.232 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.5 p -131.1 179.67 5.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.932 0.396 . . . . 0.0 111.524 -179.059 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 44.6 p-10 -63.67 95.06 0.1 Allowed 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.354 0.597 . . . . 0.0 111.09 -179.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.61 27.95 1.37 Allowed Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.21 -0.905 . . . . 0.0 112.865 179.084 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.52 160.79 15.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.672 0.273 . . . . 0.0 110.458 179.047 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 34.4 m -134.16 155.89 40.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.153 0.501 . . . . 0.0 111.389 -179.657 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.513 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 19.5 t -148.71 148.59 15.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.367 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.29 119.67 40.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.178 0.513 . . . . 0.0 111.12 -179.331 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.515 ' CE2' ' CG2' ' A' ' 111' ' ' VAL . 3.5 m-85 -77.06 164.55 25.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.766 -178.477 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.429 ' HA ' ' CD1' ' A' ' 105' ' ' LEU . 0.7 OUTLIER -155.35 135.35 12.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.671 -179.259 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 61.1 m -69.78 157.52 37.19 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.765 178.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.465 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 78.1 m-20 -85.82 -76.74 0.32 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.426 -179.349 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.7 t -59.02 -26.53 64.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.831 0.348 . . . . 0.0 111.184 -179.345 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 124.39 35.85 0.64 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.402 -179.724 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.418 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 14.3 m-85 -69.58 -174.0 0.65 Allowed 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 120.876 0.37 . . . . 0.0 110.618 179.853 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.5 m -111.9 99.68 8.31 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.181 179.122 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.461 ' CD2' ' HA ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -48.02 144.35 3.7 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.736 0.779 . . . . 0.0 111.682 -177.615 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.475 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 40.5 mm -117.73 159.91 17.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.913 -177.534 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.416 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 51.49 24.69 11.88 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.171 -1.014 . . . . 0.0 112.581 179.728 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 61.04 135.04 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.191 0.52 . . . . 0.0 111.79 178.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.466 ' HA ' ' HG2' ' A' ' 122' ' ' PRO . 1.1 p -62.14 -28.68 69.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.885 -178.776 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -53.44 127.4 36.66 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.883 -179.259 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.515 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 3.1 t -128.11 150.38 33.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 178.72 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.1 129.52 54.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.854 0.359 . . . . 0.0 111.539 -179.201 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.498 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 44.3 t -92.63 106.01 18.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.526 176.228 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.6 t -153.74 164.32 38.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.011 0.434 . . . . 0.0 111.206 -178.425 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 45.25 33.21 3.96 Favored Glycine 0 CA--C 1.518 0.254 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.858 179.604 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.422 ' N ' HG12 ' A' ' 69' ' ' VAL . . . 65.42 19.0 66.17 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.42 -179.641 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -146.89 -176.85 5.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.877 0.37 . . . . 0.0 110.778 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.513 ' CH2' ' CG2' ' A' ' 95' ' ' VAL . 88.8 m95 -118.49 122.96 43.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.95 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.46 147.12 28.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.111 -179.366 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.514 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER 71.85 41.95 0.18 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.489 179.192 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 53.3 Cg_endo -68.69 145.98 65.32 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 121.993 1.796 . . . . 0.0 111.014 177.88 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.475 ' CB ' ' O ' ' A' ' 106' ' ' ILE . 73.3 Cg_endo -96.49 -173.58 0.23 Allowed 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.521 2.147 . . . . 0.0 113.938 -177.096 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.436 HG22 ' NE2' ' A' ' 125' ' ' GLN . 0.2 OUTLIER -132.9 172.2 12.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.446 -1.252 . . . . 0.0 109.195 177.868 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 1.9 m -130.18 91.77 3.17 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.095 0.474 . . . . 0.0 110.433 178.659 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.436 ' NE2' HG22 ' A' ' 123' ' ' THR . 1.3 mp0 -117.11 -179.39 3.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.369 -178.351 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 43.6 mm . . . . . 0 C--N 1.321 -0.645 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.02 -179.462 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.46 ' CB ' ' HA ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 121.022 0.439 . . . . 0.0 111.22 . . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.524 ' HB2' ' CD ' ' A' ' 10' ' ' PRO . 76.6 m -78.47 176.77 3.31 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.645 178.861 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.529 ' HD2' ' CD1' ' A' ' 59' ' ' TRP . 36.8 Cg_endo -92.21 178.71 1.46 Allowed 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 122.75 2.3 . . . . 0.0 112.21 -179.281 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.7 t -48.57 103.82 0.38 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.442 179.12 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.495 ' HG2' ' CZ2' ' A' ' 59' ' ' TRP . 51.2 Cg_exo -48.75 159.65 0.83 Allowed 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.319 2.013 . . . . 0.0 112.751 -178.518 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.444 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 6.2 mtm180 -65.22 -178.43 0.48 Allowed 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.54 177.073 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -141.64 167.2 22.72 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.288 0.566 . . . . 0.0 111.217 -176.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.4 tt -119.29 147.94 22.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.438 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -76.53 -58.82 3.06 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -177.671 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -93.87 32.81 1.39 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.191 -177.945 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -156.86 -171.94 23.55 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.364 -179.579 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -145.56 141.86 28.62 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.291 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.537 ' CD2' ' CE2' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -88.06 166.35 14.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.28 0.562 . . . . 0.0 111.775 -179.153 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.3 OUTLIER -133.05 85.3 2.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.726 177.263 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.452 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 53.6 mt -72.83 105.25 2.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -177.174 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.13 20.96 39.11 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.496 176.414 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 154.39 139.27 2.78 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 -179.135 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.7 m -120.52 -8.06 10.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.9 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.46 ' HA ' ' CB ' ' A' ' 8' ' ' ARG . 25.5 t0 -69.28 164.67 22.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.169 0.509 . . . . 0.0 111.402 -178.816 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.455 ' CZ ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -53.39 119.09 4.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.512 179.751 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.65 -3.9 61.31 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.507 -178.628 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.7 m -70.44 174.21 6.01 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 116.951 0.376 . . . . 0.0 110.592 179.553 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.7 p -148.02 149.22 31.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.108 -179.717 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.477 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -115.6 171.31 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.628 -179.92 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 21' ' ' ASP . 1.4 m -130.83 118.35 20.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.914 0.388 . . . . 0.0 111.091 179.733 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.537 ' CE2' ' CD2' ' A' ' 20' ' ' LEU . 10.0 m-85 -95.76 138.92 32.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.579 -179.212 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.6 m -142.73 157.23 44.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.757 179.416 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.5 m -76.94 170.15 17.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.706 0.289 . . . . 0.0 110.748 179.742 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -65.47 -84.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.968 -179.538 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.0 t -157.32 133.5 9.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.728 179.713 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.93 23.71 72.8 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.054 -179.095 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.501 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.5 m-85 -115.27 -178.25 3.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.933 0.397 . . . . 0.0 110.96 -179.803 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.517 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.4 OUTLIER -141.98 111.63 6.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.882 177.511 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.448 HD21 ' HB3' ' A' ' 45' ' ' SER . 5.3 tt -78.14 127.2 31.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.713 -178.722 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.517 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 2.4 mm -103.72 149.7 7.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.041 0.448 . . . . 0.0 110.975 -179.592 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.66 -131.72 10.88 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.304 -179.15 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.417 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -89.61 -176.55 5.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.771 0.32 . . . . 0.0 110.71 179.686 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.448 ' HB3' HD21 ' A' ' 41' ' ' LEU . 4.3 p -161.26 25.22 0.13 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.049 -179.245 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -153.24 129.65 10.61 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.113 0.483 . . . . 0.0 111.218 -179.171 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -103.38 150.71 23.55 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.0 179.654 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.467 ' CB ' ' HB3' ' A' ' 60' ' ' ASN . 1.9 m-85 -127.04 121.55 31.89 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 119.191 -1.004 . . . . 0.0 113.094 -177.806 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.417 ' HB3' ' CH2' ' A' ' 59' ' ' TRP . 25.4 t -70.16 97.63 1.23 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.258 177.65 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.499 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 2.1 tt0 -131.13 171.92 12.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.448 0.642 . . . . 0.0 111.091 -178.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.499 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.632 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.347 -179.237 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.804 0.335 . . . . 0.0 110.295 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.407 ' N ' ' O ' ' A' ' 50' ' ' GLU . 2.2 m -153.65 -176.94 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.047 -179.422 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.529 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 75.4 m95 -128.83 126.14 39.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.664 -179.285 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.467 ' HB3' ' CB ' ' A' ' 48' ' ' TYR . 2.1 m120 -69.46 164.45 49.54 Favored Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.772 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.48 ' O ' ' HA ' ' A' ' 47' ' ' SER . 67.3 Cg_exo -11.88 121.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 1.003 1 C-N-CA 125.8 4.333 . . . . 0.0 115.309 -175.948 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.512 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 4.9 mm-40 -110.25 -79.78 0.58 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.77 -1.105 . . . . 0.0 113.791 -174.35 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -101.95 79.24 0.25 Allowed Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -174.477 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.433 ' HD2' ' O ' ' A' ' 62' ' ' GLU . 30.7 Cg_endo -54.67 -154.35 0.0 OUTLIER 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.335 2.69 . . . . 0.0 111.811 175.822 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.413 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 5.4 mm -91.15 166.34 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.944 0.402 . . . . 0.0 111.259 -179.879 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -168.98 134.96 1.69 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.451 179.404 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -152.96 171.24 18.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.883 0.373 . . . . 0.0 111.02 -179.828 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.501 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 1.6 p -83.97 130.92 34.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.156 0.503 . . . . 0.0 111.364 -179.37 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.448 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 4.3 m -46.68 100.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.545 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 89' ' ' TYR . 1.4 mmtt -86.91 100.2 12.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.229 179.621 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.421 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -87.57 121.32 29.84 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 177.652 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.454 ' CG ' ' N ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -68.85 -154.13 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -179.848 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.454 ' N ' ' CG ' ' A' ' 72' ' ' GLN . 1.8 t -51.49 148.11 9.74 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-O 120.676 0.274 . . . . 0.0 111.119 -179.318 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.481 ' HD2' ' CD2' ' A' ' 82' ' ' HIS . 12.2 Cg_exo -68.74 157.19 62.87 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.737 2.291 . . . . 0.0 111.909 179.538 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.492 ' HD2' ' CG ' ' A' ' 118' ' ' TRP . 83.0 Cg_exo -44.53 162.03 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.687 2.258 . . . . 0.0 112.741 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 69.4 m -116.63 89.21 3.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.658 179.463 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.6 pt -69.17 176.89 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.274 -179.255 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.3 t -89.81 150.93 22.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.659 179.037 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.488 ' HB3' ' CD2' ' A' ' 103' ' ' TYR . 1.2 m-80 48.74 27.47 1.55 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.277 178.111 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.467 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -166.23 -164.95 22.76 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.776 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.7 ptt180 -170.23 -174.68 1.78 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.923 0.392 . . . . 0.0 110.667 -179.414 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.503 ' HB3' ' CE1' ' A' ' 97' ' ' TYR . 8.9 p80 -107.16 165.96 10.98 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.705 -178.844 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' A' ' 96' ' ' THR . 27.1 m-20 . . . . . 0 C--O 1.223 -0.314 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.857 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.442 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 11.8 m-85 . . . . . 0 N--CA 1.448 -0.564 0 CA-C-O 120.816 0.341 . . . . 0.0 110.817 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.442 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 6.8 m-85 -140.62 166.42 24.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.101 -179.445 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 16.6 p -130.79 175.59 8.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.015 0.436 . . . . 0.0 111.829 -178.46 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.423 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 0.7 OUTLIER -62.88 99.69 0.17 Allowed 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.619 0.724 . . . . 0.0 110.659 179.68 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 125.24 12.86 3.72 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 114.601 -1.181 . . . . 0.0 113.055 179.007 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.438 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -89.04 161.02 16.79 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 117.179 0.49 . . . . 0.0 110.017 178.501 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 20.7 m -150.54 131.16 4.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.11 0.481 . . . . 0.0 110.982 -179.295 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.429 HG11 ' CG ' ' A' ' 74' ' ' PRO . 2.0 p -130.74 143.73 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.698 -179.186 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.41 ' O ' ' HB2' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -94.56 128.61 41.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.365 0.602 . . . . 0.0 111.376 -178.869 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.541 ' CE1' ' CG2' ' A' ' 111' ' ' VAL . 3.1 m-85 -84.36 163.81 19.33 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.298 -179.456 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 89.4 p -153.75 133.42 12.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.768 -178.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.414 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 81.9 m -69.84 159.36 33.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.544 178.629 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.467 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 74.0 m-80 -93.65 -79.1 0.42 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.653 -178.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.55 -31.64 25.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.847 0.356 . . . . 0.0 111.277 -179.106 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 130.65 38.87 0.28 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.446 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.49 ' CE1' HG13 ' A' ' 126' ' ' ILE . 23.9 m-85 -78.66 -172.77 3.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.836 0.35 . . . . 0.0 110.757 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.66 113.97 26.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.494 179.344 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.441 ' CD2' ' HA ' ' A' ' 109' ' ' SER . 1.1 mp -53.51 115.17 1.8 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.006 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.47 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 34.5 mm -99.85 162.11 3.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.856 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.406 ' N ' ' CG2' ' A' ' 106' ' ' ILE . . . 52.64 28.59 30.39 Favored Glycine 0 CA--C 1.508 -0.357 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.541 179.245 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 60.31 128.8 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.935 -0.633 . . . . 0.0 111.465 179.44 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.455 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 1.3 p -60.28 -29.45 68.82 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.81 -178.747 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.76 136.88 49.98 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.908 -178.753 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.541 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 4.0 t -133.31 119.36 35.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 110.439 -0.208 . . . . 0.0 110.439 179.369 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.07 124.09 29.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.952 0.406 . . . . 0.0 111.474 -178.714 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.438 ' HB3' ' HB2' ' A' ' 93' ' ' SER . 10.3 t -88.55 108.09 19.24 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.722 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 52.7 p -155.89 166.41 33.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.189 0.519 . . . . 0.0 111.524 -178.157 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.87 31.99 5.8 Favored Glycine 0 CA--C 1.518 0.279 0 CA-C-N 115.594 -0.73 . . . . 0.0 113.199 179.133 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.448 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 68.61 14.23 66.91 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.569 -179.881 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -147.15 171.63 15.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.016 0.436 . . . . 0.0 110.812 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.492 ' CG ' ' HD2' ' A' ' 75' ' ' PRO . 90.7 m95 -103.61 127.22 51.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.56 179.599 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.98 150.9 28.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.312 -179.037 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.492 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER 69.32 44.2 0.25 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.151 178.919 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.492 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 59.2 Cg_endo -72.64 140.62 32.95 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.154 1.903 . . . . 0.0 111.373 178.372 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.486 ' HG2' ' CD2' ' A' ' 97' ' ' TYR . 96.4 Cg_endo -91.73 -169.73 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.643 2.228 . . . . 0.0 113.98 -177.281 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.41 -159.91 1.0 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.391 -1.277 . . . . 0.0 109.743 178.22 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . 0.422 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 10.2 m -156.5 89.63 1.12 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.068 0.461 . . . . 0.0 110.709 179.033 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -122.69 158.4 30.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.034 -178.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.49 HG13 ' CE1' ' A' ' 103' ' ' TYR . 18.5 mm . . . . . 0 C--N 1.324 -0.536 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.958 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.909 0.385 . . . . 0.0 110.801 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.46 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 14.7 m -94.75 162.09 26.56 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.04 -179.576 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.411 ' HD3' ' HB2' ' A' ' 9' ' ' CYS . 40.2 Cg_endo -67.77 -168.71 0.2 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.605 2.203 . . . . 0.0 112.261 -179.487 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.1 t -67.47 110.83 5.91 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.019 -179.54 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -52.29 132.36 43.85 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.182 1.921 . . . . 0.0 112.161 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.424 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.6 OUTLIER -53.47 161.71 0.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.515 179.248 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -108.37 -176.71 3.12 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.528 -178.138 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.1 tt -146.69 147.96 17.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.942 -179.624 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.43 160.43 15.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.379 -0.373 . . . . 0.0 109.998 178.535 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.473 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 0.2 OUTLIER 47.21 26.6 0.7 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.766 -179.743 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.44 ' HA2' ' N ' ' A' ' 36' ' ' ASN . . . -153.83 -168.07 16.95 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.846 -179.152 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.64 135.42 15.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.806 0.336 . . . . 0.0 111.071 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.478 HD21 ' CE1' ' A' ' 33' ' ' TYR . 8.6 mt -75.17 160.22 30.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.595 -179.746 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.428 ' HB2' ' CB ' ' A' ' 32' ' ' THR . 1.1 t0 -135.39 71.96 1.44 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.774 177.847 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.434 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 18.4 mt -75.09 112.97 13.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.224 -177.437 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -107.48 16.15 37.97 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.628 176.383 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 153.94 136.93 2.37 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.823 -179.31 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.3 m -120.39 29.94 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -178.341 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.83 154.59 18.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.828 0.347 . . . . 0.0 111.002 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.472 ' CE1' ' HB2' ' A' ' 51' ' ' LEU . 10.0 t80 -48.67 108.87 0.2 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.96 -4.98 34.13 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.663 -178.76 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.9 p -69.63 -164.49 0.07 Allowed 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.738 0.304 . . . . 0.0 110.681 179.762 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.3 p -167.02 143.26 4.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.022 0.439 . . . . 0.0 111.225 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.557 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.9 OUTLIER -112.0 174.17 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.497 179.959 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.428 ' CB ' ' HB2' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -135.5 113.11 10.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.948 0.404 . . . . 0.0 110.79 179.319 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.494 ' CE1' ' HA ' ' A' ' 63' ' ' ALA . 26.2 m-85 -88.92 137.09 32.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.935 -179.558 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.6 m -144.19 156.76 44.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.373 -179.085 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.4 m -84.05 166.23 17.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.948 179.74 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.44 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 3.3 m-20 -66.14 -86.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.23 -178.826 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.4 t -151.9 134.67 15.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.871 0.367 . . . . 0.0 110.873 -179.743 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.42 21.99 70.93 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.233 -179.468 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.478 ' CE1' ' HB2' ' A' ' 68' ' ' SER . 2.5 m-30 -114.22 -176.96 3.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.824 0.345 . . . . 0.0 110.832 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.463 ' CD2' ' O ' ' A' ' 40' ' ' HIS . 0.3 OUTLIER -147.92 112.87 5.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.632 178.876 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.431 ' CD2' ' O ' ' A' ' 44' ' ' GLU . 3.1 tt -73.84 131.85 41.94 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.494 -179.782 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.401 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 3.9 mm -103.35 153.83 5.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.975 -179.637 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.72 -133.59 13.3 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.385 -179.514 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.431 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -80.57 174.94 11.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.712 0.292 . . . . 0.0 110.65 179.408 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.29 27.0 0.41 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.408 178.987 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.412 ' O ' ' HD3' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -159.98 121.42 3.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.669 -178.968 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.409 ' HB2' HG12 ' A' ' 31' ' ' ILE . 47.9 t -92.84 157.21 16.5 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.513 179.322 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.494 ' CE1' ' HD2' ' A' ' 61' ' ' PRO . 4.0 m-85 -129.48 110.97 12.3 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.202 0.525 . . . . 0.0 111.648 -179.789 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.486 ' HB3' ' CH2' ' A' ' 59' ' ' TRP . 23.9 t -60.58 84.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.259 178.934 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -97.94 -171.64 2.21 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.995 -178.814 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.472 ' HB2' ' CE1' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.392 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.242 -179.234 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.815 0.34 . . . . 0.0 110.329 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.5 m -153.64 179.69 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.302 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.557 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 95.7 m95 -123.58 123.7 41.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.817 -179.847 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.5 m-20 -148.23 126.82 6.08 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.32 -179.485 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.494 ' HD2' ' CE1' ' A' ' 48' ' ' TYR . 2.9 Cg_exo -76.09 -167.45 5.84 Favored 'Cis proline' 0 C--N 1.35 0.656 0 C-N-CA 124.226 -1.156 . . . . 0.0 112.057 -0.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -110.74 -154.2 0.53 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.945 -179.434 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.494 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -69.61 111.21 8.13 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.911 179.863 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.402 ' HG2' ' HG2' ' A' ' 44' ' ' GLU . 15.3 Cg_exo -69.78 -150.55 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.627 2.218 . . . . 0.0 112.372 -179.165 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 41' ' ' LEU . 6.3 mm -98.45 166.44 2.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.371 -179.07 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.1 m -164.54 126.66 2.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.476 179.296 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.472 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -153.18 178.24 9.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.913 0.387 . . . . 0.0 111.267 -179.081 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.478 ' HB2' ' CE1' ' A' ' 39' ' ' TYR . 27.5 p -90.6 116.12 28.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.746 179.317 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.447 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 2.1 p -43.38 96.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.553 -179.804 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.4 ' HD3' ' HB2' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -78.01 120.64 23.14 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.615 -178.928 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.91 125.33 50.24 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.98 178.245 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -69.47 -158.87 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.429 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.428 ' OG ' ' NE2' ' A' ' 82' ' ' HIS . 1.3 t -54.1 143.39 43.52 Favored Pre-proline 0 N--CA 1.45 -0.442 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 179.612 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.461 ' HD2' ' CD2' ' A' ' 82' ' ' HIS . 25.2 Cg_exo -59.97 159.74 24.5 Favored 'Trans proline' 0 CA--C 1.528 0.207 0 C-N-CA 122.429 2.086 . . . . 0.0 112.092 -179.254 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.49 ' HD2' ' CG ' ' A' ' 118' ' ' TRP . 87.3 Cg_exo -46.56 156.44 0.6 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.762 2.308 . . . . 0.0 113.0 -178.856 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 12.8 t -108.06 91.5 3.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.301 178.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.2 pt -69.03 171.48 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.267 -178.905 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.9 p -89.13 135.17 33.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.021 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.471 ' N ' ' ND2' ' A' ' 79' ' ' ASN . 0.1 OUTLIER 67.41 26.49 8.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.688 179.503 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.415 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -166.67 -163.39 20.32 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.106 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.3 ptt85 -170.29 -175.51 1.96 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.992 0.425 . . . . 0.0 110.982 -179.16 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.461 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 9.0 p-80 -115.99 168.02 10.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.854 179.661 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.895 -179.984 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.432 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 6.4 m-85 . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.792 0.33 . . . . 0.0 111.162 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.432 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 24.6 m-85 -144.32 165.57 27.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.95 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 17.0 p -125.01 -179.66 4.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.128 -179.569 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -67.06 95.36 0.39 Allowed 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.389 0.614 . . . . 0.0 110.933 -179.826 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 128.2 31.23 0.69 Allowed Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.132 -0.94 . . . . 0.0 112.93 179.177 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -110.27 164.16 12.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.689 0.28 . . . . 0.0 110.686 179.476 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 32.5 m -140.55 148.16 22.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.1 0.476 . . . . 0.0 111.276 -179.795 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.464 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 21.7 t -145.08 147.87 18.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.676 179.191 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.439 ' CG2' ' OG ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -101.49 137.05 40.33 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 -179.756 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.537 ' CE1' ' CG2' ' A' ' 111' ' ' VAL . 3.8 m-85 -97.58 157.3 16.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.169 -179.313 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 84.5 p -149.44 140.9 23.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.397 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 73.0 m -70.78 159.02 35.31 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 179.603 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.415 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 17.7 m-20 -92.58 -70.88 0.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.54 -178.808 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.13 -22.1 66.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.368 -179.191 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.29 30.92 1.23 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.604 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.488 ' CE2' HG13 ' A' ' 126' ' ' ILE . 21.9 m-85 -69.71 -175.6 0.9 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.973 0.416 . . . . 0.0 110.754 179.634 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -111.2 104.35 12.85 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.787 177.617 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.442 HD21 ' CB ' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -47.77 129.62 14.17 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.531 0.681 . . . . 0.0 111.799 -177.422 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.438 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 38.1 mm -93.33 158.86 2.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.888 178.726 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.02 -125.83 35.4 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.306 -0.95 . . . . 0.0 111.977 -178.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -129.5 134.89 48.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.812 0.339 . . . . 0.0 111.063 179.526 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.439 ' OG ' ' CG2' ' A' ' 96' ' ' THR . 10.2 p -60.63 -32.26 71.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.115 0.483 . . . . 0.0 110.655 179.286 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -70.63 127.68 16.66 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.795 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.537 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 8.8 t -121.29 124.05 71.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 178.938 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.38 126.16 31.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.007 0.432 . . . . 0.0 111.879 -177.747 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.486 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 30.3 t -94.83 91.72 6.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.739 177.452 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.46 156.84 43.47 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.036 0.446 . . . . 0.0 111.687 -177.892 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.422 ' CA ' HG11 ' A' ' 69' ' ' VAL . . . 46.98 27.7 3.57 Favored Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.856 179.477 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.447 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 77.81 -1.22 68.67 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.811 -179.524 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -123.8 157.45 34.06 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.895 0.379 . . . . 0.0 110.553 179.602 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.49 ' CG ' ' HD2' ' A' ' 75' ' ' PRO . 94.4 m95 -96.41 137.98 34.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.027 -179.654 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 34.0 t -121.82 177.87 5.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.525 0.678 . . . . 0.0 111.478 179.292 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.432 ' N ' ' HD3' ' A' ' 121' ' ' PRO . 1.3 p-10 42.74 50.57 5.69 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.951 -179.521 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.432 ' HD3' ' N ' ' A' ' 120' ' ' ASP . 84.6 Cg_endo -83.25 141.7 10.39 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.642 2.228 . . . . 0.0 112.05 178.975 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.442 ' CB ' HD21 ' A' ' 105' ' ' LEU . 94.7 Cg_endo -91.56 -171.17 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.781 2.321 . . . . 0.0 113.554 -178.733 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.422 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -135.68 -157.94 0.83 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.616 -1.174 . . . . 0.0 109.884 178.601 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 8.6 m -156.6 89.92 1.13 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.077 0.465 . . . . 0.0 110.967 179.065 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -121.39 160.53 23.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.935 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.488 HG13 ' CE2' ' A' ' 103' ' ' TYR . 18.4 mm . . . . . 0 C--N 1.324 -0.518 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.911 179.494 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 26' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.237 0 CA-C-O 120.999 0.428 . . . . 0.0 111.957 . . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.439 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 18.9 m -114.68 159.53 36.8 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.76 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.64 168.59 19.55 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.393 2.062 . . . . 0.0 111.516 179.317 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.1 p -52.59 119.73 16.35 Favored Pre-proline 0 C--N 1.326 -0.447 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.887 -179.204 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.409 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 18.4 Cg_endo -57.79 150.3 63.49 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.55 2.167 . . . . 0.0 112.013 179.739 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.02 136.81 50.76 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.296 0.57 . . . . 0.0 110.701 179.489 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -78.4 -177.38 5.21 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.104 -176.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.4 HG23 ' CD2' ' A' ' 20' ' ' LEU . 18.4 tt -145.75 148.49 17.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.095 -179.637 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.82 162.27 14.17 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.335 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.44 ' N ' ' ND2' ' A' ' 17' ' ' ASN . 0.4 OUTLIER 47.26 27.65 0.89 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.947 0.403 . . . . 0.0 110.586 -179.404 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -175.45 173.79 46.44 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.921 -0.582 . . . . 0.0 112.287 -179.355 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . 0.412 ' N ' ' O ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -136.77 156.94 47.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.729 0.3 . . . . 0.0 110.694 -179.856 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.479 HD23 ' CE1' ' A' ' 33' ' ' TYR . 0.2 OUTLIER -91.11 166.6 12.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.044 0.449 . . . . 0.0 110.976 179.188 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 32' ' ' THR . 15.2 t70 -129.97 78.83 1.87 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.052 178.196 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.443 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 42.5 mt -69.2 118.31 13.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.206 0.527 . . . . 0.0 112.056 -177.237 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -131.66 19.7 4.71 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.747 177.57 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 161.23 114.69 0.34 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 121.148 -0.549 . . . . 0.0 111.963 -179.475 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.7 m -113.58 30.4 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.683 0.278 . . . . 0.0 111.557 -178.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 15.0 t70 -101.55 163.5 12.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.959 0.409 . . . . 0.0 111.158 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.527 ' CZ ' ' CD1' ' A' ' 51' ' ' LEU . 7.8 t80 -60.83 89.45 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.852 -179.892 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.67 10.92 3.44 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.159 179.47 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.1 m -95.43 -160.47 0.79 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 117.039 0.419 . . . . 0.0 110.453 179.258 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 47' ' ' SER . 3.9 p -168.74 141.08 2.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.054 0.454 . . . . 0.0 111.367 179.488 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.53 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.9 OUTLIER -100.87 170.58 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.317 179.444 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.456 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -132.87 110.33 10.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.931 0.396 . . . . 0.0 111.153 179.65 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.483 ' CD1' ' HA ' ' A' ' 63' ' ' ALA . 10.6 m-85 -86.03 156.91 20.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.779 -178.886 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 19' ' ' GLN . 66.5 m -156.02 150.94 26.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.94 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.3 m -76.42 171.08 15.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.974 179.88 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 17' ' ' ASN . 1.4 t-20 -65.35 -76.95 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.061 -179.656 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.93 136.28 5.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.942 -179.704 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 60.39 23.48 60.27 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.063 -179.428 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.488 ' CE1' ' HB3' ' A' ' 68' ' ' SER . 2.4 m-85 -111.35 -176.62 2.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.802 0.334 . . . . 0.0 110.72 -179.539 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.525 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.3 OUTLIER -142.44 113.24 7.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.544 178.45 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.441 ' CD1' ' HG3' ' A' ' 64' ' ' PRO . 7.0 tt -79.21 120.7 24.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.68 -179.293 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.525 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 3.0 mm -98.22 162.17 2.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.216 -179.093 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.76 -140.28 28.77 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.339 -179.762 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.435 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 0.1 OUTLIER -72.26 -173.53 1.11 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.837 0.351 . . . . 0.0 110.473 179.015 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.429 ' CB ' HD21 ' A' ' 41' ' ' LEU . 1.1 t -169.66 29.61 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.457 178.909 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.456 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -163.13 117.26 1.65 Allowed 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.066 -177.801 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.44 ' HB2' HG12 ' A' ' 31' ' ' ILE . 0.6 OUTLIER -84.58 133.53 34.43 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.293 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.498 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 1.9 m-85 -110.45 117.71 34.32 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 119.547 -0.861 . . . . 0.0 111.455 179.527 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 33.0 t -72.6 102.36 3.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.753 -179.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.54 -174.3 2.88 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.145 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.527 ' CD1' ' CZ ' ' A' ' 27' ' ' PHE . 5.1 mt . . . . . 0 C--N 1.327 -0.401 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.296 -179.449 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.428 ' O ' ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.938 0.399 . . . . 0.0 110.554 . . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.428 ' CG1' ' O ' ' A' ' 57' ' ' MET . 2.4 m -165.87 173.6 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.705 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.53 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 75.8 m95 -128.88 122.48 30.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.695 -179.267 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.498 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 0.5 OUTLIER -70.66 167.8 24.78 Favored Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.98 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.478 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 71.6 Cg_exo -17.0 95.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 125.113 3.875 . . . . 0.0 114.387 -179.189 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.424 ' O ' ' HD2' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -96.84 -79.02 0.46 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.179 -177.14 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.483 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . . . -87.94 107.32 15.31 Favored Pre-proline 0 C--N 1.332 -0.189 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -176.506 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.441 ' HG3' ' CD1' ' A' ' 41' ' ' LEU . 1.8 Cg_endo -86.15 -155.88 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.27 2.646 . . . . 0.0 111.444 178.509 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.2 mm -89.75 165.57 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.894 0.378 . . . . 0.0 110.711 178.502 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.1 m -163.05 128.7 3.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.826 179.855 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.478 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -152.81 178.43 9.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.083 -179.652 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.488 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 89.8 p -89.57 117.66 28.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.88 179.591 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.431 ' CG2' ' HB3' ' A' ' 40' ' ' HIS . 2.6 p -44.52 101.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.22 179.754 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.9 mmtt -81.76 125.52 30.74 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.518 -0.764 . . . . 0.0 112.257 -177.623 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -106.86 120.62 42.53 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.733 176.656 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.89 -159.25 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.36 -179.845 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.479 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 2.0 t -54.08 137.81 56.78 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.81 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.471 ' HG3' ' CZ2' ' A' ' 118' ' ' TRP . 52.1 Cg_exo -56.17 162.54 7.37 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.675 2.25 . . . . 0.0 112.211 -179.579 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -43.79 157.05 0.15 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.59 2.193 . . . . 0.0 112.528 -179.454 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.1 t -103.32 90.11 3.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.617 179.585 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 24.5 pt -69.42 168.49 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.188 -179.253 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.96 132.86 39.34 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.882 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.473 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 0.3 OUTLIER 71.18 27.3 3.27 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.76 179.988 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.434 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . -168.36 -168.27 30.21 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.219 179.443 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.84 -175.24 3.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.859 0.361 . . . . 0.0 110.739 -179.231 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.479 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 3.0 p-80 -115.53 166.12 12.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.031 -179.569 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.332 -0.186 0 CA-C-O 120.789 0.328 . . . . 0.0 110.22 179.47 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.436 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 6.2 m-85 . . . . . 0 N--CA 1.455 -0.208 0 CA-C-O 120.701 0.286 . . . . 0.0 110.643 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.436 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 43.8 m-85 -146.85 162.47 38.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.204 -178.69 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.3 p -137.08 -177.86 4.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.476 -179.149 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.413 ' OD2' ' CG1' ' A' ' 69' ' ' VAL . 0.4 OUTLIER -59.43 92.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.252 0.549 . . . . 0.0 111.121 -179.625 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.56 26.8 1.55 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.367 -0.833 . . . . 0.0 113.086 178.571 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.412 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -105.83 154.21 20.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.89 0.345 . . . . 0.0 110.634 179.106 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 17.4 m -139.49 138.07 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.261 0.553 . . . . 0.0 111.472 -179.694 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.562 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 21.5 t -137.94 142.22 36.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.812 179.007 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.431 ' N ' HG12 ' A' ' 95' ' ' VAL . 0.1 OUTLIER -93.2 141.67 28.17 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.553 -178.033 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.52 ' CE2' ' CG2' ' A' ' 111' ' ' VAL . 4.7 m-85 -96.57 161.5 13.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.592 179.234 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.1 m -160.27 139.08 10.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.247 -179.752 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.434 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 59.6 m -69.58 164.87 22.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.037 -179.914 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.404 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 0.3 OUTLIER -97.27 -85.66 0.35 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.12 -179.921 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 41.9 t -47.34 -26.4 1.26 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.351 -179.399 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.27 54.25 0.23 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.088 -179.482 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.473 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 15.0 m-85 -93.1 -173.26 3.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.806 0.336 . . . . 0.0 111.286 -178.696 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -109.58 103.63 12.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.113 179.637 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.445 HD22 ' CG ' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -49.99 129.18 20.18 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.515 0.674 . . . . 0.0 111.556 -178.056 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.491 ' CG1' ' HG3' ' A' ' 125' ' ' GLN . 36.9 mm -95.2 157.68 3.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.294 179.431 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.432 ' N ' HG23 ' A' ' 106' ' ' ILE . . . 60.87 -128.91 45.84 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.319 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -120.04 132.47 55.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.791 0.329 . . . . 0.0 111.086 179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.428 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 3.8 p -68.05 -33.09 73.91 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.904 179.597 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -78.3 119.88 5.27 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.784 -179.721 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.52 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 2.7 t -108.3 141.97 22.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.145 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.35 128.14 46.49 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.939 0.4 . . . . 0.0 111.302 -179.18 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.475 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 20.4 t -90.34 106.04 18.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.392 176.717 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 9.0 p -143.1 146.28 33.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.41 -178.379 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 54.05 34.86 53.06 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.746 179.532 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.424 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 67.75 12.44 62.0 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.848 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -138.58 170.17 16.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.918 0.39 . . . . 0.0 110.778 179.659 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.562 ' CH2' ' CG2' ' A' ' 95' ' ' VAL . 95.7 m95 -107.98 151.86 25.25 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.406 -178.802 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.94 148.92 44.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.158 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.471 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.7 OUTLIER 70.94 47.25 0.26 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.994 178.851 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 96.1 Cg_endo -78.83 136.57 13.47 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.433 2.089 . . . . 0.0 111.647 178.403 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.445 ' CG ' HD22 ' A' ' 105' ' ' LEU . 73.6 Cg_endo -87.16 -174.3 1.29 Allowed 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.533 2.155 . . . . 0.0 113.589 -178.243 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 105' ' ' LEU . 0.6 OUTLIER -134.02 176.79 8.27 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.272 177.305 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 10.9 m -137.67 107.04 6.1 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.511 0.672 . . . . 0.0 111.848 179.726 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.491 ' HG3' ' CG1' ' A' ' 106' ' ' ILE . 2.9 pt20 -148.31 -179.0 6.62 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.117 -179.105 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 22.5 mm . . . . . 0 C--N 1.315 -0.905 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.334 -178.014 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.405 ' HB3' ' O ' ' A' ' 25' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.449 -0.492 0 CA-C-O 121.196 0.522 . . . . 0.0 111.745 . . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 1.226 ' SG ' ' SG ' ' A' ' 49' ' ' CYS . 0.0 OUTLIER -98.57 163.1 19.68 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.684 179.406 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.438 ' HD2' ' CB ' ' A' ' 57' ' ' MET . 37.7 Cg_endo -67.02 170.49 12.92 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.065 1.843 . . . . 0.0 111.851 179.759 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.41 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 14.4 t -51.26 104.56 0.44 Allowed Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.895 -179.332 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.482 ' CB ' ' CD1' ' A' ' 31' ' ' ILE . 12.1 Cg_endo -56.75 147.29 72.8 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.058 1.839 . . . . 0.0 111.76 179.823 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -55.92 174.01 0.13 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.37 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.57 -171.2 2.6 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.989 0.423 . . . . 0.0 111.305 -179.61 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.2 tt -144.1 145.16 22.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.61 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -80.75 -58.68 2.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.256 -178.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.412 ' N ' ' ND2' ' A' ' 17' ' ' ASN . 0.6 OUTLIER -94.0 38.29 1.08 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.852 -179.538 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.411 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -158.37 -177.84 31.84 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.965 -179.804 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -137.71 140.79 40.93 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 179.59 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.531 ' CD2' ' CE2' ' A' ' 33' ' ' TYR . 10.2 mt -86.67 154.75 20.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.081 0.467 . . . . 0.0 111.759 -178.862 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.437 ' HB2' ' CB ' ' A' ' 32' ' ' THR . 15.6 t0 -124.39 71.22 1.13 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.631 177.457 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.478 ' CG2' ' CG1' ' A' ' 25' ' ' VAL . 0.9 OUTLIER -76.58 104.59 4.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.774 -177.836 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -110.6 -15.71 10.89 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.077 178.436 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.416 ' O ' ' CB ' ' A' ' 29' ' ' SER . . . -157.69 110.44 0.44 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.118 179.562 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.478 ' CG1' ' CG2' ' A' ' 22' ' ' ILE . 27.3 m -112.12 51.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.534 0.207 . . . . 0.0 111.534 -179.322 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.408 ' N ' ' OG ' ' A' ' 29' ' ' SER . 25.8 t0 -111.18 163.8 13.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.932 0.396 . . . . 0.0 110.84 178.063 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.451 ' CZ ' ' HB2' ' A' ' 51' ' ' LEU . 1.4 t80 -53.14 95.39 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.904 -179.18 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.17 31.37 5.05 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.148 -179.658 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 24' ' ' GLY . 14.8 m -99.67 -158.42 0.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.285 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 47' ' ' SER . 7.7 p -165.17 139.95 5.08 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 120.273 -0.571 . . . . 0.0 112.288 179.708 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.521 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.8 OUTLIER -105.2 170.68 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.267 178.568 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.437 ' CB ' ' HB2' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -128.48 111.75 13.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.005 0.431 . . . . 0.0 111.11 178.591 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.531 ' CE2' ' CD2' ' A' ' 20' ' ' LEU . 13.6 m-85 -85.13 149.28 25.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.255 -179.604 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.411 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 9.6 p -152.79 165.72 34.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.713 179.475 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.8 m -85.2 168.43 14.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.768 0.318 . . . . 0.0 110.92 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -66.02 -83.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.995 -179.437 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.86 136.23 13.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.476 179.703 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.444 ' HA2' ' CB ' ' A' ' 91' ' ' ASP . . . 59.97 28.84 66.77 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.387 -0.911 . . . . 0.0 111.671 -178.688 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.526 ' CE1' ' CB ' ' A' ' 68' ' ' SER . 2.7 m-85 -120.15 173.07 7.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.816 0.341 . . . . 0.0 110.939 -179.12 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.533 ' CE1' ' CG2' ' A' ' 69' ' ' VAL . 0.0 OUTLIER -129.85 133.45 46.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.106 175.271 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.428 ' CD1' ' HG3' ' A' ' 64' ' ' PRO . 6.7 tt -97.33 120.95 38.63 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.641 -179.333 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.408 ' HB ' ' HB ' ' A' ' 65' ' ' ILE . 1.2 mm -99.13 149.68 5.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.088 -179.302 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.06 -136.01 13.64 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.275 -179.62 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.421 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -84.55 -173.87 4.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.894 0.378 . . . . 0.0 110.653 179.612 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.427 ' HB3' HD23 ' A' ' 41' ' ' LEU . 3.9 p -159.51 22.15 0.18 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.462 -178.899 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.425 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -154.44 125.89 7.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.945 0.402 . . . . 0.0 112.062 -177.796 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 30' ' ' SER . 0.7 OUTLIER -92.4 141.68 28.27 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.673 177.201 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.427 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 1.4 m-85 -122.69 113.41 19.18 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 119.611 -0.836 . . . . 0.0 111.407 179.129 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 1.226 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 1.6 p -79.89 118.54 21.75 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 119.152 -1.019 . . . . 0.0 111.397 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.97 -170.72 2.57 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.842 -179.837 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.451 ' HB2' ' CZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.406 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.04 -179.476 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.438 ' CB ' ' HD2' ' A' ' 10' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.336 0 CA-C-O 121.15 0.5 . . . . 0.0 110.734 . . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 49' ' ' CYS . 1.7 m -157.21 171.31 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.688 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.527 ' CD2' ' HB3' ' A' ' 49' ' ' CYS . 70.7 m95 -131.15 121.01 24.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.042 0.448 . . . . 0.0 111.6 -179.491 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.494 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 6.3 m-20 -69.68 168.03 19.77 Favored Pre-proline 0 C--O 1.223 -0.298 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.148 178.788 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.494 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 76.3 Cg_exo -20.16 96.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 125.081 3.854 . . . . 0.0 114.412 -178.37 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.465 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -96.01 -78.09 0.47 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.817 -178.421 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.496 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -82.13 108.07 10.48 Favored Pre-proline 0 C--N 1.331 -0.2 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -176.565 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.428 ' HG3' ' CD1' ' A' ' 41' ' ' LEU . 1.0 OUTLIER -85.17 -155.1 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.113 2.542 . . . . 0.0 110.754 176.99 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.408 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 1.5 mm -95.85 159.18 2.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.969 0.414 . . . . 0.0 110.402 177.782 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.2 m -157.92 138.27 12.69 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.775 179.834 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.47 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -150.01 177.03 10.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.55 179.991 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.526 ' CB ' ' CE1' ' A' ' 39' ' ' TYR . 1.2 p -104.49 141.32 36.58 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.575 179.088 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.533 ' CG2' ' CE1' ' A' ' 40' ' ' HIS . 2.3 p -67.6 66.84 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.287 0.565 . . . . 0.0 110.384 179.154 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 68' ' ' SER . 1.5 mmpt? -47.75 112.71 0.59 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.159 -178.184 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -97.28 125.79 42.07 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.268 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.04 -166.14 0.97 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.96 -179.342 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.42 ' OG ' ' NE2' ' A' ' 82' ' ' HIS . 1.5 t -42.24 134.21 2.54 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.329 -179.129 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.482 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 37.4 Cg_exo -58.54 161.52 14.42 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.331 2.021 . . . . 0.0 112.158 -179.245 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.436 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 88.2 Cg_exo -40.56 154.61 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.779 2.319 . . . . 0.0 112.867 -179.477 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.0 p -106.38 91.02 3.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.997 -179.641 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 19.9 pt -69.65 175.9 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.066 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.5 t -93.54 149.07 21.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.635 178.869 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.456 ' HB3' ' CE1' ' A' ' 103' ' ' TYR . 1.1 m-80 50.12 28.45 3.04 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.127 177.927 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.47 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -158.34 -163.61 13.07 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.899 179.872 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 98' ' ' SER . 13.2 ptt180 -170.12 -175.65 2.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.095 0.474 . . . . 0.0 110.931 -179.214 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.42 ' NE2' ' OG ' ' A' ' 73' ' ' SER . 4.9 p80 -123.04 166.52 14.98 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.801 179.756 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 46.2 p30 . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.422 178.962 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.425 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 13.9 m-85 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.796 0.332 . . . . 0.0 110.542 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.425 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 65.9 m-85 -152.71 167.84 27.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.713 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 24.9 p -141.05 -175.85 4.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.937 0.398 . . . . 0.0 111.361 -179.339 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.444 ' CB ' ' HA2' ' A' ' 38' ' ' GLY . 1.0 OUTLIER -61.55 96.6 0.06 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.295 0.569 . . . . 0.0 110.967 179.879 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 125.34 19.4 2.36 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.16 -0.927 . . . . 0.0 113.222 178.483 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.429 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.7 OUTLIER -100.64 154.16 18.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 117.049 0.424 . . . . 0.0 110.565 178.989 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.18 148.99 31.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.04 0.448 . . . . 0.0 110.918 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.473 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 17.9 t -145.52 147.45 18.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.651 179.852 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.429 ' N ' HG13 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -107.13 126.58 52.55 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.962 -179.624 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.534 ' CE1' ' CG2' ' A' ' 111' ' ' VAL . 4.6 m-85 -85.51 156.5 20.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.932 -179.742 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 81' ' ' ARG . 72.5 m -149.92 145.55 26.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.17 -179.503 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.416 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 66.7 m -75.16 156.04 36.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.028 179.887 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.47 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 78.9 m-20 -85.06 -78.13 0.26 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.592 -179.03 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.5 m -59.89 -23.49 63.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.378 -178.806 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 123.97 33.73 0.78 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.541 -179.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.495 ' CE2' HG12 ' A' ' 126' ' ' ILE . 40.4 m-85 -69.7 -175.52 0.89 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.967 0.413 . . . . 0.0 110.757 179.697 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.1 m -107.84 101.61 10.88 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.387 179.012 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.452 HD21 ' CG ' ' A' ' 122' ' ' PRO . 0.3 OUTLIER -47.29 127.05 10.31 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 121.367 0.603 . . . . 0.0 111.514 -178.991 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.438 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 40.7 mm -95.76 154.64 3.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.427 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 66.49 -125.42 26.23 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.93 -178.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -127.28 134.24 50.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.878 0.37 . . . . 0.0 110.943 179.167 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.455 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 0.4 OUTLIER -67.65 -30.39 69.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.804 179.621 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -70.11 132.8 23.88 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.554 179.388 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.534 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 2.4 t -127.41 121.64 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.675 0.274 . . . . 0.0 110.453 179.329 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.29 117.31 22.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.005 0.431 . . . . 0.0 111.802 -178.463 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.52 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 17.9 t -82.59 104.33 12.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.438 176.559 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 2.2 p -146.42 163.08 36.77 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.364 -178.17 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.33 30.0 4.03 Favored Glycine 0 N--CA 1.453 -0.219 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.767 179.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.3 16.14 70.9 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.52 -179.464 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -141.45 -177.4 5.13 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.887 0.375 . . . . 0.0 110.599 179.515 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.52 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 93.7 m95 -117.74 144.99 44.78 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.103 -179.391 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.91 147.02 51.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.298 -179.285 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.489 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER 73.38 46.13 0.21 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.163 178.676 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 73.3 Cg_endo -75.84 136.02 18.25 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.361 2.041 . . . . 0.0 111.331 177.951 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.455 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 64.8 Cg_endo -91.12 -173.68 0.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.505 2.137 . . . . 0.0 113.496 -178.135 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.424 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -129.37 -162.7 1.22 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.746 177.833 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 4.9 m -156.43 90.82 1.2 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.069 0.462 . . . . 0.0 110.856 179.378 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -118.12 160.7 21.09 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.932 -179.626 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.495 HG12 ' CE2' ' A' ' 103' ' ' TYR . 15.9 mm . . . . . 0 C--N 1.323 -0.546 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.997 179.912 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.431 ' HD3' ' CG2' ' A' ' 25' ' ' VAL . 32.9 mtm-85 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.915 0.388 . . . . 0.0 110.957 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.415 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 8.5 m -91.08 163.0 31.06 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.625 179.55 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -73.62 167.88 26.15 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.281 1.988 . . . . 0.0 111.719 179.87 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.2 p -52.37 108.97 1.21 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.927 -179.275 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.481 ' HG2' ' CZ2' ' A' ' 59' ' ' TRP . 49.2 Cg_exo -49.34 158.05 1.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.314 2.009 . . . . 0.0 112.335 179.906 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.442 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 4.3 mtt180 -54.11 177.25 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.735 177.354 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.427 ' O ' ' CB ' ' A' ' 63' ' ' ALA . 0.1 OUTLIER -124.9 -177.01 3.7 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.182 0.515 . . . . 0.0 111.678 -178.676 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.404 HD11 ' HA3' ' A' ' 18' ' ' GLY . 5.2 tt -139.47 151.69 22.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.837 -179.397 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -90.34 -64.48 1.13 Allowed 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -177.46 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -92.52 26.92 2.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.775 0.321 . . . . 0.0 111.09 -178.894 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.404 ' HA3' HD11 ' A' ' 15' ' ' ILE . . . -144.15 -160.4 8.45 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.851 179.708 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.85 133.52 10.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.753 0.311 . . . . 0.0 110.489 179.434 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.523 ' CD2' ' CE2' ' A' ' 33' ' ' TYR . 18.7 mt -72.27 150.72 43.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.178 0.513 . . . . 0.0 111.899 -178.37 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -123.36 69.62 1.02 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.266 177.419 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.445 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 0.9 OUTLIER -79.4 100.75 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.069 -176.492 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.36 19.26 54.58 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.575 176.696 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 163.32 141.07 3.02 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 121.192 -0.528 . . . . 0.0 111.87 -179.376 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.431 ' CG2' ' HD3' ' A' ' 8' ' ' ARG . 6.2 m -127.01 -3.77 4.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.898 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.411 ' HA ' ' CB ' ' A' ' 8' ' ' ARG . 1.3 p-10 -69.57 156.58 38.69 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.792 0.33 . . . . 0.0 110.669 179.868 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.439 ' CZ ' ' HG ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -49.26 116.72 1.82 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.021 0.439 . . . . 0.0 111.02 -179.25 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.07 -6.64 47.34 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.585 -178.77 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 m -66.98 -174.29 0.32 Allowed 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.884 0.342 . . . . 0.0 110.762 179.711 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.74 139.16 11.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.964 -179.978 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.542 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.5 OUTLIER -108.2 167.63 3.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.921 0.391 . . . . 0.0 110.854 179.681 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.405 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -132.92 110.6 10.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.695 178.554 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.523 ' CE2' ' CD2' ' A' ' 20' ' ' LEU . 23.8 m-85 -82.76 132.19 35.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.162 -179.272 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.22 159.98 40.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.446 -179.898 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.419 ' HB2' ' HB2' ' A' ' 39' ' ' TYR . 56.4 m -84.69 176.13 8.76 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.625 -179.996 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -84.98 -83.22 0.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.911 0.386 . . . . 0.0 110.769 -179.346 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.23 129.4 9.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.344 179.267 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.441 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . 74.67 28.77 62.52 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.434 -0.888 . . . . 0.0 111.596 -177.842 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.496 ' CE2' ' HB2' ' A' ' 68' ' ' SER . 29.7 m-85 -134.08 157.77 45.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.003 0.43 . . . . 0.0 111.173 -179.734 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.432 ' CE1' HG22 ' A' ' 69' ' ' VAL . 6.3 m-70 -115.13 134.03 55.51 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 173.63 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.433 ' CD2' ' O ' ' A' ' 44' ' ' GLU . 6.3 tt -81.65 107.67 14.58 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.023 -179.613 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.406 HG12 ' HA ' ' A' ' 66' ' ' CYS . 1.3 mm -92.72 146.1 6.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.97 -178.229 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.76 -151.97 32.86 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.011 -178.441 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.433 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 1.3 pm0 -53.22 173.21 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.72 0.26 . . . . 0.0 110.406 179.232 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.424 ' HB3' HD22 ' A' ' 41' ' ' LEU . 8.3 p -153.61 24.07 0.52 Allowed 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.869 0.366 . . . . 0.0 111.522 -178.542 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.405 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 0.8 OUTLIER -157.53 -170.91 3.37 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.947 -178.357 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.428 ' CB ' HG12 ' A' ' 31' ' ' ILE . 1.8 m -164.67 98.87 0.79 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.632 179.182 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.487 ' CD2' ' N ' ' A' ' 48' ' ' TYR . 1.2 m-30 -84.95 118.86 24.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.038 0.447 . . . . 0.0 111.21 -179.303 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 16.2 t -70.2 115.62 9.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.298 179.043 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.503 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 2.8 tt0 -144.56 172.35 13.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.449 0.643 . . . . 0.0 111.214 -178.715 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.503 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 1.0 OUTLIER . . . . . 0 C--N 1.323 -0.584 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.303 -179.683 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.421 ' SD ' ' CE1' ' A' ' 27' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.922 0.391 . . . . 0.0 110.576 . . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.3 m -146.77 -175.65 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.811 -179.891 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.542 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 88.1 m95 -128.51 137.14 51.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.008 -179.454 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -151.86 122.51 3.64 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.016 -179.697 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.65 -167.2 4.8 Favored 'Cis proline' 0 C--N 1.352 0.746 0 C-N-CA 123.744 -1.357 . . . . 0.0 112.259 -0.313 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -110.64 -155.88 0.57 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 -179.306 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.493 ' CB ' ' CE2' ' A' ' 33' ' ' TYR . . . -76.01 112.82 22.46 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.653 179.226 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.468 ' CD ' ' CG ' ' A' ' 33' ' ' TYR . 18.3 Cg_exo -68.26 -150.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.511 2.141 . . . . 0.0 112.192 -179.1 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.5 pt -136.21 -177.95 2.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.841 -179.814 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 40' ' ' HIS . 78.7 m -149.99 157.32 43.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.353 0.597 . . . . 0.0 111.781 179.452 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -129.63 109.18 10.79 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.41 177.659 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.496 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 11.2 p -49.81 131.78 22.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.232 -178.668 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.441 ' CG1' ' O ' ' A' ' 38' ' ' GLY . 4.3 p -53.68 104.83 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.26 -178.479 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.424 ' CD ' ' HB2' ' A' ' 88' ' ' PHE . 2.4 mmtp -89.45 114.21 25.66 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.582 177.867 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.11 125.39 38.72 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.103 0.478 . . . . 0.0 110.266 179.125 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.57 -155.64 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.924 178.777 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.428 ' OG ' ' NE2' ' A' ' 82' ' ' HIS . 1.1 t -53.15 143.77 31.86 Favored Pre-proline 0 N--CA 1.447 -0.584 0 CA-C-O 120.561 0.22 . . . . 0.0 110.536 179.483 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.483 ' HD2' ' CD2' ' A' ' 82' ' ' HIS . 32.4 Cg_exo -60.14 166.28 9.26 Favored 'Trans proline' 0 CA--C 1.53 0.311 0 C-N-CA 122.633 2.222 . . . . 0.0 112.277 -179.263 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.495 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 97.7 Cg_exo -40.97 165.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.795 2.33 . . . . 0.0 112.927 -179.517 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 73.1 m -115.32 87.34 2.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.704 179.551 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.3 pt -69.48 -173.59 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.071 -179.547 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 t -100.8 148.88 24.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.955 179.679 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.474 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 0.9 OUTLIER 47.22 29.4 1.19 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.112 177.937 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -161.51 -171.62 27.79 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.056 179.778 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -170.36 -174.87 1.78 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.992 0.425 . . . . 0.0 111.028 -178.723 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.483 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 2.1 p-80 -117.59 171.95 7.67 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.621 -179.962 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.119 179.625 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.439 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 7.3 m-85 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.81 0.338 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.439 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 49.8 m-85 -152.23 164.32 37.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.0 -179.381 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.423 ' CG2' ' HE3' ' A' ' 70' ' ' LYS . 16.5 p -148.9 -174.93 4.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.004 0.431 . . . . 0.0 111.427 -179.605 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 7.3 p-10 -52.92 93.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.238 0.542 . . . . 0.0 111.566 -179.155 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.09 26.88 1.61 Allowed Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.474 -0.785 . . . . 0.0 113.628 177.549 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.34 152.5 26.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.191 0.495 . . . . 0.0 110.848 178.994 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 34.3 m -134.85 153.62 35.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.156 0.503 . . . . 0.0 111.24 -179.703 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.449 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 25.1 t -147.59 148.14 16.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.636 179.263 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.14 134.09 48.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.698 179.876 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.525 ' CE1' ' CG2' ' A' ' 111' ' ' VAL . 4.5 m-85 -92.4 152.17 19.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.037 -179.754 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 59.0 m -146.52 140.29 26.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.754 179.749 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.45 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 82.0 m -69.75 159.03 34.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.033 -179.666 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -93.03 -87.36 0.23 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.222 -179.821 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.7 t -44.52 -33.2 1.65 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.637 -179.071 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 133.22 40.45 0.19 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.563 179.867 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.49 ' CE2' HG12 ' A' ' 126' ' ' ILE . 37.6 m-85 -82.2 -173.07 4.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.845 0.355 . . . . 0.0 110.781 179.794 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.0 m -112.2 109.98 19.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.016 -179.821 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.432 HD23 ' CG ' ' A' ' 122' ' ' PRO . 2.5 tp -45.43 113.5 0.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.903 179.05 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.432 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 35.2 mm -92.07 154.64 3.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.143 179.83 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 65.69 -125.27 28.11 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.362 -0.923 . . . . 0.0 111.811 -178.299 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -123.3 132.84 54.14 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.795 0.331 . . . . 0.0 110.651 179.052 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.454 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 2.6 t -69.36 -29.94 67.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.49 179.438 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -70.98 135.52 24.48 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.794 179.771 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.525 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 3.1 t -129.44 120.78 51.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.596 0.236 . . . . 0.0 110.717 179.266 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.412 HD21 ' N ' ' A' ' 113' ' ' CYS . 1.0 OUTLIER -80.33 130.49 35.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.903 0.382 . . . . 0.0 111.434 -179.232 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.488 ' HB2' ' CZ3' ' A' ' 118' ' ' TRP . 37.4 t -102.68 104.18 14.5 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.075 177.461 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 5.3 p -152.93 123.01 7.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.898 0.38 . . . . 0.0 111.714 -179.352 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.17 19.79 34.95 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.696 179.148 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.441 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 82.14 -1.27 87.41 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.622 -179.173 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -131.51 -177.42 4.4 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.859 0.361 . . . . 0.0 110.432 179.373 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.495 ' CD1' ' HD2' ' A' ' 75' ' ' PRO . 86.5 m95 -120.08 157.43 28.96 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.035 -178.998 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.72 152.34 47.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.054 0.454 . . . . 0.0 111.298 -179.844 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.498 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.7 OUTLIER 69.52 45.57 0.28 Allowed Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.119 179.241 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.498 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 76.9 Cg_endo -77.45 138.32 17.4 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.384 2.056 . . . . 0.0 111.755 178.564 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.454 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 74.3 Cg_endo -91.25 -171.64 0.42 Allowed 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.786 2.324 . . . . 0.0 113.482 -178.542 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.88 -167.16 1.83 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.819 177.947 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 7.4 m -148.67 92.82 2.04 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.051 0.453 . . . . 0.0 110.801 179.328 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -118.02 163.93 15.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.551 -179.853 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.49 HG12 ' CE2' ' A' ' 103' ' ' TYR . 15.4 mm . . . . . 0 C--N 1.322 -0.594 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.956 -179.789 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' A' ' 26' ' ' ASP . 3.4 ptp180 . . . . . 0 N--CA 1.456 -0.148 0 CA-C-O 120.529 0.204 . . . . 0.0 110.979 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.432 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 20.5 m -116.38 161.58 30.84 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.845 0.355 . . . . 0.0 111.575 -178.454 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.413 ' HD3' ' HB2' ' A' ' 9' ' ' CYS . 57.4 Cg_endo -71.12 174.62 10.39 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.485 2.123 . . . . 0.0 112.02 179.689 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.0 t -54.55 108.25 1.09 Allowed Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.925 -179.683 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.507 ' HG2' ' CZ2' ' A' ' 59' ' ' TRP . 53.3 Cg_exo -46.4 164.56 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.351 2.034 . . . . 0.0 112.123 179.867 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.441 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 14.7 ttt180 -74.07 158.56 34.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.707 178.103 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.9 -175.42 2.76 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.202 0.525 . . . . 0.0 111.516 -178.301 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 19.7 tt -151.05 146.02 16.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.203 -179.492 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -85.03 158.97 20.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.34 -0.391 . . . . 0.0 109.999 177.844 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.471 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 0.4 OUTLIER 46.66 30.77 1.21 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.887 179.974 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -157.93 175.88 35.09 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.705 -179.413 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -141.84 137.82 31.73 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.658 0.266 . . . . 0.0 110.515 -179.869 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.441 ' CD1' ' O ' ' A' ' 13' ' ' ARG . 25.9 mt -83.71 157.88 22.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.11 0.481 . . . . 0.0 111.604 -179.558 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -125.45 75.49 1.48 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.625 177.709 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.448 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 1.1 mt -71.4 104.01 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.105 -177.156 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.39 15.36 56.21 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.789 176.855 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 156.08 130.99 1.34 Allowed Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.077 -179.591 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.454 ' HA ' ' CH2' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -113.24 5.7 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-O 120.768 0.318 . . . . 0.0 110.438 -178.763 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 0.5 OUTLIER -69.37 155.66 40.07 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.907 0.384 . . . . 0.0 111.663 -178.851 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -53.56 90.09 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.711 179.29 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 127.39 -6.92 7.11 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.767 -179.478 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.8 p -72.99 170.89 13.89 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.958 0.379 . . . . 0.0 110.653 179.798 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.2 p -137.13 152.03 49.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.937 179.79 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.509 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 1.1 mt -114.87 170.35 5.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.665 -179.306 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -133.55 115.29 14.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.876 0.369 . . . . 0.0 110.654 179.357 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.495 ' CE2' ' HA ' ' A' ' 63' ' ' ALA . 14.3 m-85 -89.71 154.0 20.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.629 -178.67 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.29 155.98 34.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.536 179.426 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.409 ' HB2' ' HB2' ' A' ' 39' ' ' TYR . 4.0 m -82.11 167.67 18.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.819 0.343 . . . . 0.0 110.958 -179.933 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -68.43 -85.4 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.204 -179.247 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.5 m -153.17 132.61 12.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.832 0.348 . . . . 0.0 111.008 -179.784 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.05 21.84 73.83 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.124 -179.198 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.492 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.6 m-85 -115.16 174.33 6.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.82 0.343 . . . . 0.0 110.86 -179.672 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.526 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.4 OUTLIER -137.82 114.85 10.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.496 177.976 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.437 HD23 ' CB ' ' A' ' 45' ' ' SER . 6.5 tt -78.19 125.36 29.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.502 -179.698 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.526 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 2.2 mm -102.17 160.82 4.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.053 0.454 . . . . 0.0 111.113 -179.398 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.81 -135.24 22.95 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.485 -179.639 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.426 ' O ' ' CB ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -79.96 -173.58 3.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.966 0.413 . . . . 0.0 111.064 -179.952 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.437 ' CB ' HD23 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -167.31 29.18 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.384 179.389 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.8 mtpt -155.08 127.52 7.87 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.962 0.411 . . . . 0.0 111.641 -178.666 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.454 ' OG ' ' CB ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -94.05 148.05 22.54 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.024 178.403 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.471 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 1.6 m-85 -124.45 114.95 20.14 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.603 177.922 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 52.8 t -65.67 98.22 0.37 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.468 179.677 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.503 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 0.6 OUTLIER -122.09 175.01 6.58 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.711 -178.501 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.503 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.595 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.171 -179.292 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.884 0.373 . . . . 0.0 110.359 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -145.34 -175.55 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.491 -179.669 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.509 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 76.6 m95 -129.9 121.43 26.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.068 0.461 . . . . 0.0 111.905 -179.031 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.471 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 2.8 m120 -68.91 165.87 33.33 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.35 177.443 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.442 ' HD2' ' HB2' ' A' ' 60' ' ' ASN . 81.2 Cg_exo -17.09 94.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 125.289 3.993 . . . . 0.0 114.586 -178.475 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.475 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -91.67 -76.13 0.46 Allowed 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.329 -177.871 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.495 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -88.02 109.02 24.49 Favored Pre-proline 0 C--N 1.331 -0.201 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -175.711 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.432 ' HG3' ' CD1' ' A' ' 41' ' ' LEU . 2.3 Cg_endo -83.61 -154.59 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.053 2.502 . . . . 0.0 111.28 177.196 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.42 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 3.0 mm -87.65 165.41 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.917 0.389 . . . . 0.0 110.791 178.64 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -165.83 131.25 2.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.502 179.455 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -154.82 168.32 27.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.184 -179.009 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.492 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 8.6 p -88.1 111.71 21.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.936 179.744 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.48 ' HB ' ' N ' ' A' ' 116' ' ' GLY . 4.9 p -45.08 103.9 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.884 179.253 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.486 ' HD3' ' CD1' ' A' ' 88' ' ' PHE . 2.2 ttpp -104.43 134.63 47.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.957 -176.035 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 1.5 m -90.18 136.87 32.78 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.668 177.791 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.54 -169.85 0.25 Allowed 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.817 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.6 t -74.99 111.57 14.03 Favored Pre-proline 0 C--N 1.314 -0.954 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.744 -179.021 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.585 ' HG3' ' CE2' ' A' ' 118' ' ' TRP 0.321 0.0 OUTLIER -34.23 -175.27 0.0 OUTLIER 'Trans proline' 0 CA--C 1.468 -2.796 0 C-N-CA 123.722 2.948 . . . . 0.0 114.102 173.589 . . . . . . . . 4 4 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.545 ' CB ' ' CE1' ' A' ' 97' ' ' TYR . 23.3 Cg_endo -73.3 -164.0 3.12 Favored 'Cis proline' 0 C--N 1.323 -0.814 0 N-CA-C 113.847 0.672 . . . . 0.0 113.847 -18.854 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.2 t -135.55 21.11 3.36 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.54 172.257 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.454 HG12 ' N ' ' A' ' 78' ' ' SER . 3.3 pt -111.16 -160.03 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.274 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.213 -177.45 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.454 ' N ' HG12 ' A' ' 77' ' ' ILE . 86.2 p -134.24 151.03 51.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.788 177.61 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 55.6 32.46 19.23 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.578 179.327 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -151.08 -160.81 9.64 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.127 -1.035 . . . . 0.0 113.731 179.764 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.42 ' N ' ' O ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -161.95 -172.75 3.39 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.801 0.334 . . . . 0.0 111.121 -178.196 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.516 ' CG ' ' HB3' ' A' ' 74' ' ' PRO . 31.3 p80 -124.52 173.41 8.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.157 0.503 . . . . 0.0 112.257 -175.723 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 . . . . . 0 CA--C 1.534 0.357 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.169 174.021 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.486 ' CD1' ' HD3' ' A' ' 70' ' ' LYS . 9.4 m-85 . . . . . 0 N--CA 1.451 -0.423 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.466 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 17.6 m-85 -147.24 175.53 10.68 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.624 0.249 . . . . 0.0 110.862 -177.661 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.7 p -144.6 169.82 17.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.132 0.492 . . . . 0.0 112.029 -179.28 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.27 94.25 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.307 -179.323 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.53 28.45 0.98 Allowed Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.327 -0.852 . . . . 0.0 113.161 178.376 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.448 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.7 OUTLIER -110.14 157.45 19.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.965 0.383 . . . . 0.0 110.879 179.013 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 35.8 m -138.76 146.08 26.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.759 179.627 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.52 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 4.2 t -147.16 142.8 20.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.026 -178.681 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.55 127.39 44.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.174 0.512 . . . . 0.0 110.132 178.692 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.545 ' CE1' ' CB ' ' A' ' 75' ' ' PRO . 2.8 m-30 -95.49 166.23 11.96 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.496 0.665 . . . . 0.0 112.756 -174.794 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.42 ' O ' ' N ' ' A' ' 81' ' ' ARG . 67.6 m -152.87 145.54 24.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.542 178.75 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.484 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 76.1 m -69.43 155.67 40.08 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.863 0.363 . . . . 0.0 111.538 -178.881 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.6 -86.47 0.19 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.967 178.934 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -47.03 -27.04 1.18 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.511 -179.385 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 125.25 32.26 0.8 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.877 179.866 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.497 ' CE1' HG12 ' A' ' 126' ' ' ILE . 18.5 m-85 -72.54 -170.85 0.72 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.903 0.383 . . . . 0.0 111.25 179.952 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.9 m -118.04 96.81 5.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.205 177.882 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.453 ' CD2' ' HA ' ' A' ' 109' ' ' SER . 0.2 OUTLIER -47.92 139.53 7.7 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.563 0.697 . . . . 0.0 111.81 -178.226 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.45 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 16.8 mm -125.5 160.96 30.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.328 -178.71 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.77 25.18 70.34 Favored Glycine 0 N--CA 1.457 0.082 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.453 177.718 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.449 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.3 OUTLIER 67.05 130.84 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.532 0.682 . . . . 0.0 112.355 178.452 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.453 ' HA ' ' CD2' ' A' ' 105' ' ' LEU . 1.1 p -64.54 -24.68 67.68 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.427 -1.26 . . . . 0.0 111.329 178.906 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.55 130.31 48.24 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.856 179.134 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.541 ' CG1' ' HB2' ' A' ' 118' ' ' TRP . 16.4 t -135.31 123.71 39.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.492 0.187 . . . . 0.0 110.855 -177.819 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.0 127.98 35.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.967 0.413 . . . . 0.0 111.804 -177.932 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.492 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 44.7 t -89.52 98.08 11.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.521 176.386 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 24.0 p -136.76 159.96 40.28 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.672 -179.119 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.439 ' CA ' HG11 ' A' ' 69' ' ' VAL . . . 50.67 29.04 17.53 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.835 -179.074 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.48 ' N ' ' HB ' ' A' ' 69' ' ' VAL . . . 68.39 14.51 66.8 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.085 -0.578 . . . . 0.0 112.575 -179.555 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -141.95 177.02 8.49 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 178.665 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.585 ' CE2' ' HG3' ' A' ' 74' ' ' PRO . 99.4 m95 -98.39 126.5 43.94 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.149 0.5 . . . . 0.0 111.158 -179.586 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.9 150.45 24.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.254 -178.829 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.513 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.9 OUTLIER 53.51 42.46 1.18 Allowed Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.101 -179.987 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 37.7 Cg_endo -64.55 151.5 85.34 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.039 1.826 . . . . 0.0 111.098 177.65 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.452 ' O ' ' CG2' ' A' ' 77' ' ' ILE . 44.4 Cg_endo -80.27 -173.59 1.92 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 121.922 1.748 . . . . 0.0 113.035 -179.06 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.444 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -122.75 -161.57 0.96 Allowed 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 173.765 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . 0.409 ' SG ' ' HB2' ' A' ' 103' ' ' TYR . 2.4 t -170.65 83.6 0.1 Allowed 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.25 -175.61 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -115.01 169.04 9.39 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.583 -1.19 . . . . 0.0 111.676 -175.838 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.497 HG12 ' CE1' ' A' ' 103' ' ' TYR . 37.5 mm . . . . . 0 C--N 1.326 -0.442 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.78 179.342 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.427 ' HD2' ' CG2' ' A' ' 25' ' ' VAL . 7.7 mtm180 . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.821 0.344 . . . . 0.0 110.738 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.433 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 60.8 m -105.33 160.66 25.27 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 -178.956 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.418 ' HD3' ' HB2' ' A' ' 9' ' ' CYS . 32.2 Cg_endo -65.86 173.62 6.72 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.59 2.193 . . . . 0.0 112.192 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.7 t -54.37 108.1 1.05 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.578 179.53 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.51 ' HG2' ' CZ2' ' A' ' 59' ' ' TRP . 72.7 Cg_exo -46.98 160.25 0.27 Allowed 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.302 2.001 . . . . 0.0 112.401 -179.468 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.441 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -75.31 174.01 10.1 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.96 178.325 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -127.33 -177.0 3.9 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.224 0.535 . . . . 0.0 111.691 -178.866 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.429 HG21 ' CD2' ' A' ' 20' ' ' LEU . 17.9 tt -146.47 143.06 20.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.785 -179.339 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -81.86 156.8 24.65 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 177.394 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.485 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 0.5 OUTLIER 49.28 26.14 1.46 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.839 0.352 . . . . 0.0 110.554 -179.239 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -153.21 170.59 32.14 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.698 -179.01 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -138.36 144.01 40.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.699 0.285 . . . . 0.0 110.34 179.526 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.53 ' CD2' ' CE1' ' A' ' 33' ' ' TYR . 0.5 OUTLIER -92.49 163.21 13.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.207 0.527 . . . . 0.0 111.769 -179.312 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 32' ' ' THR . 8.1 t0 -127.47 72.34 1.38 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.875 177.175 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.445 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 1.2 mt -72.76 97.8 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.809 -177.789 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.12 16.7 60.77 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.786 176.979 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 160.26 153.46 6.93 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 -179.278 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.427 ' CG2' ' HD2' ' A' ' 8' ' ' ARG . 17.0 m -134.87 11.58 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.8 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.425 ' O ' ' N ' ' A' ' 28' ' ' GLY . 40.3 t0 -90.02 163.08 15.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.972 0.415 . . . . 0.0 111.377 179.93 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.5 ' CE2' ' HB2' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -50.01 90.27 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.802 -179.599 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 131.99 -9.52 5.43 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.627 -0.796 . . . . 0.0 112.784 -179.566 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.8 m -76.43 157.45 32.23 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 117.107 0.454 . . . . 0.0 110.503 179.536 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.4 p -133.52 142.2 48.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.019 0.437 . . . . 0.0 110.917 179.603 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.523 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -106.81 154.08 7.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.435 -179.789 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.411 ' O ' ' N ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -115.97 119.45 35.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.023 0.44 . . . . 0.0 110.75 179.361 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.53 ' CE1' ' CD2' ' A' ' 20' ' ' LEU . 11.5 m-85 -95.03 137.95 33.4 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.263 -178.927 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.4 m -146.77 159.59 43.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.079 179.793 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.1 m -81.97 173.52 12.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.6 179.452 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.41 -79.88 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.107 -179.447 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.35 134.62 10.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.904 -179.651 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.24 23.52 71.61 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.809 -178.972 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.485 ' CD2' ' HA ' ' A' ' 68' ' ' SER . 2.3 m-85 -118.01 167.88 11.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.842 0.353 . . . . 0.0 110.868 -179.338 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.474 ' CE1' HD12 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -132.97 121.82 23.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.337 177.635 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.45 ' CD2' ' O ' ' A' ' 44' ' ' GLU . 8.7 tt -83.3 127.91 34.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.849 -178.401 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.474 HD12 ' CE1' ' A' ' 40' ' ' HIS . 1.4 mm -106.57 149.46 9.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.051 -179.651 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.08 -142.56 20.71 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.07 -179.102 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.45 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -72.15 -175.8 1.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.869 0.366 . . . . 0.0 110.316 178.469 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -168.1 28.79 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.511 179.431 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -157.08 127.42 6.45 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.973 -179.929 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.426 ' HB3' ' HA ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -102.59 152.36 21.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.74 -179.663 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.487 ' CD1' ' HB2' ' A' ' 60' ' ' ASN . 1.2 m-85 -128.04 124.89 38.22 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.488 0.661 . . . . 0.0 111.672 -179.971 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.483 ' HB3' ' CH2' ' A' ' 59' ' ' TRP . 42.7 t -73.23 118.2 15.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.157 -179.429 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.487 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 9.5 tt0 -159.25 168.45 26.43 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.074 179.018 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.5 ' HB2' ' CE2' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.311 -1.072 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.553 179.729 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.421 ' HA ' ' HA ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 . . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.532 ' CG2' ' N ' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -137.22 -175.97 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 121.823 0.82 . . . . 0.0 112.171 -176.054 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.532 ' N ' ' CG2' ' A' ' 58' ' ' VAL . 59.9 m95 -133.0 134.86 45.02 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.413 179.281 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.487 ' HB2' ' CD1' ' A' ' 48' ' ' TYR . 5.5 m-80 -78.41 163.34 62.22 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.888 178.319 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.431 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 31.6 Cg_exo -11.04 90.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.864 1 C-N-CA 125.758 4.305 . . . . 0.0 114.873 -179.392 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.48 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 39.4 mt-10 -91.27 -93.94 0.13 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.146 -178.284 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.476 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . . . -81.15 108.86 11.54 Favored Pre-proline 0 C--O 1.231 0.131 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -176.124 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.436 ' HG3' ' CD1' ' A' ' 41' ' ' LEU . 2.1 Cg_endo -82.93 -154.6 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.003 2.469 . . . . 0.0 110.756 176.681 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.405 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 2.0 mm -92.88 158.17 2.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.927 0.394 . . . . 0.0 110.508 178.271 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.2 m -164.34 143.37 7.37 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.957 179.905 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -169.88 170.2 7.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.463 179.954 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.485 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 30.2 p -73.92 99.02 3.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.045 0.45 . . . . 0.0 110.219 178.534 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.432 ' O ' ' N ' ' A' ' 116' ' ' GLY . 5.6 p -44.2 93.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.29 179.619 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.439 ' HG3' ' CG2' ' A' ' 90' ' ' THR . 9.0 mttt -69.73 165.05 22.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.0 -177.467 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.416 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -120.88 131.58 54.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.179 179.079 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -69.19 -157.21 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.08 179.205 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.421 ' OG ' ' NE2' ' A' ' 82' ' ' HIS . 1.5 t -52.82 142.65 33.2 Favored Pre-proline 0 N--CA 1.45 -0.446 0 CA-C-O 120.682 0.277 . . . . 0.0 110.276 179.495 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.421 ' O ' ' CE1' ' A' ' 82' ' ' HIS . 37.6 Cg_exo -57.31 162.79 9.22 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.397 2.065 . . . . 0.0 112.036 -179.083 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.484 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 82.4 Cg_exo -39.99 159.06 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.746 2.297 . . . . 0.0 112.947 -179.003 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 86.7 p -109.11 88.45 2.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.635 179.446 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.0 pt -69.85 174.12 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.33 -179.347 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.6 m -97.07 140.64 31.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.532 179.295 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.488 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 4.9 m-80 59.56 29.62 19.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.746 -179.913 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.401 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . -172.83 -170.28 36.36 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.516 179.614 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -170.24 -175.7 2.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.888 0.375 . . . . 0.0 111.095 -179.371 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.421 ' NE2' ' OG ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -99.47 178.24 4.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.022 -179.987 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 96' ' ' THR . 3.4 m-20 . . . . . 0 C--N 1.331 -0.235 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.392 -179.645 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.436 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 2.2 m-85 . . . . . 0 N--CA 1.455 -0.224 0 CA-C-O 120.996 0.427 . . . . 0.0 111.971 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.436 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 71.6 m-85 -151.27 154.51 36.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.028 -179.216 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.439 ' CG2' ' HG3' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -111.4 -174.15 2.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.138 0.494 . . . . 0.0 112.011 -178.617 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 8.7 m-20 -69.97 96.28 1.02 Allowed 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.033 -179.895 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.46 22.77 2.02 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.956 179.074 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -96.73 156.47 16.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.764 0.316 . . . . 0.0 110.635 179.44 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 34.3 m -135.64 151.13 29.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.17 0.51 . . . . 0.0 111.185 -179.816 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.466 HG21 ' CH2' ' A' ' 118' ' ' TRP . 15.1 t -149.2 146.81 17.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.812 179.783 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.421 ' CG2' ' OG ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -100.93 142.0 33.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.261 179.03 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.477 ' CE2' ' CG2' ' A' ' 111' ' ' VAL . 4.0 m-85 -100.4 156.41 17.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.997 0.427 . . . . 0.0 111.202 -179.532 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 36.7 m -150.26 141.61 23.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.133 -179.508 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.401 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 63.2 m -71.96 165.55 23.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.881 179.718 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.32 -86.52 0.34 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.982 179.791 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -46.76 -29.29 1.85 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.403 -179.515 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.19 41.03 0.29 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.539 179.895 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.488 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 43.5 m-85 -80.6 -174.83 4.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.864 0.364 . . . . 0.0 110.817 179.877 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.3 m -112.59 106.99 15.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.173 178.828 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.434 HD23 ' CB ' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -48.26 131.33 16.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.501 0.667 . . . . 0.0 111.683 -178.252 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.445 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 35.4 mm -97.62 155.93 3.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.199 179.16 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.423 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 64.91 -129.32 35.36 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.324 -179.534 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -121.12 129.74 53.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.804 0.335 . . . . 0.0 111.21 -179.771 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.439 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 1.5 p -61.33 -32.13 72.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.82 179.455 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -71.4 135.01 23.29 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.842 -179.592 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.477 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 3.8 t -130.72 120.0 46.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.632 0.253 . . . . 0.0 110.706 179.2 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.435 ' CD1' ' HB2' ' A' ' 114' ' ' SER . 1.1 tm? -82.18 134.32 35.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.86 0.362 . . . . 0.0 111.284 -179.374 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.501 ' HB2' ' CZ3' ' A' ' 118' ' ' TRP . 43.1 t -105.09 102.5 11.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.105 177.999 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.435 ' HB2' ' CD1' ' A' ' 112' ' ' LEU . 4.3 m -135.57 113.12 10.78 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.488 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 81.66 45.21 7.41 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.009 178.06 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 69' ' ' VAL . . . 63.32 12.78 46.77 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.778 179.471 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -134.66 173.74 11.33 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.04 0.447 . . . . 0.0 110.663 179.687 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.501 ' CZ3' ' HB2' ' A' ' 113' ' ' CYS . 94.6 m95 -121.4 156.52 32.49 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.905 -179.41 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.74 149.91 46.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.051 0.453 . . . . 0.0 111.368 -179.767 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.477 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER 67.1 47.07 0.42 Allowed Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.786 179.136 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 84.8 Cg_endo -77.7 133.92 13.17 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.396 2.064 . . . . 0.0 111.642 178.701 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.445 ' CB ' ' O ' ' A' ' 106' ' ' ILE . 63.8 Cg_endo -88.49 -174.27 1.05 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.581 2.187 . . . . 0.0 113.468 -178.301 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.34 -159.39 0.96 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.031 178.431 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 7.6 m -158.62 91.11 1.05 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.087 0.47 . . . . 0.0 110.988 179.255 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -121.24 158.64 27.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.908 -179.922 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.486 HG12 ' CE2' ' A' ' 103' ' ' TYR . 21.0 mm . . . . . 0 C--N 1.324 -0.533 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.111 179.995 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.428 ' HA ' ' HA ' ' A' ' 26' ' ' ASP . 8.2 mtm-85 . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 120.68 0.276 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.431 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 18.3 m -109.27 160.37 27.87 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.084 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -67.94 170.48 14.15 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.318 2.012 . . . . 0.0 111.75 179.748 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -51.43 105.61 0.55 Allowed Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.948 -179.524 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -61.93 159.78 32.36 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.211 1.941 . . . . 0.0 111.881 179.731 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.433 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 4.2 mpt_? -49.34 177.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.513 179.636 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.433 ' O ' ' CG2' ' A' ' 15' ' ' ILE . 0.2 OUTLIER -142.76 -7.74 0.84 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -178.042 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.449 HG22 ' CD2' ' A' ' 20' ' ' LEU . 14.4 tt 53.72 163.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 120.749 0.309 . . . . 0.0 111.105 -177.939 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -104.26 -56.03 2.26 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -177.135 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.475 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 0.2 OUTLIER -94.12 31.01 1.75 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.936 0.398 . . . . 0.0 111.071 -178.412 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -157.47 179.65 33.06 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.517 179.473 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.92 139.42 44.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.793 0.33 . . . . 0.0 110.25 179.864 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.539 ' CD1' ' CZ ' ' A' ' 33' ' ' TYR . 34.0 mt -88.04 159.77 18.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.377 0.608 . . . . 0.0 112.142 -178.462 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 32' ' ' THR . 5.3 t0 -124.04 83.37 2.13 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.225 176.646 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.445 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 1.8 mt -77.44 107.14 8.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.169 -176.678 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.99 19.52 37.85 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.59 176.679 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 152.86 132.77 1.81 Allowed Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.073 -179.373 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.453 ' CG2' ' O ' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -117.38 5.81 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-O 120.811 0.338 . . . . 0.0 110.591 -178.248 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 6.6 p-10 -75.68 153.71 36.97 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-O 120.964 0.412 . . . . 0.0 111.489 -179.11 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -52.51 95.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.767 179.334 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.02 8.49 5.08 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.989 -179.825 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 84.9 p -97.35 -174.1 2.84 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 116.992 0.396 . . . . 0.0 110.483 179.359 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.1 p -155.12 146.53 22.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.036 0.446 . . . . 0.0 111.121 178.44 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.51 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.8 OUTLIER -106.63 172.59 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.418 -179.394 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.431 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -129.64 118.34 21.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.925 0.393 . . . . 0.0 111.2 179.551 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.539 ' CZ ' ' CD1' ' A' ' 20' ' ' LEU . 19.8 m-85 -94.77 140.96 29.19 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.234 0.54 . . . . 0.0 111.604 -179.486 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.8 m -148.82 153.65 38.41 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.458 179.744 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.429 ' HB2' ' HB2' ' A' ' 39' ' ' TYR . 1.7 m -75.17 167.35 22.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.99 -179.628 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -76.04 -82.03 0.08 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.824 -179.589 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -153.95 121.38 5.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.656 179.351 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.432 ' O ' ' CG2' ' A' ' 69' ' ' VAL . . . 77.32 14.19 82.79 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.423 -178.766 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.526 ' CZ ' ' CB ' ' A' ' 68' ' ' SER . 23.1 m-85 -111.7 154.47 24.92 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.586 -0.361 . . . . 0.0 111.0 179.546 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.518 ' CE1' ' CG2' ' A' ' 69' ' ' VAL . 2.3 m-70 -112.86 119.18 37.1 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 175.155 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.417 ' CD2' ' O ' ' A' ' 44' ' ' GLU . 4.1 tt -83.74 109.31 17.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.928 0.394 . . . . 0.0 110.022 -179.842 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.427 ' N ' HD13 ' A' ' 42' ' ' ILE . 1.5 mm -91.94 148.28 4.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.301 -178.255 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.15 -134.36 12.12 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.287 -179.288 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.417 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -84.31 -173.15 4.56 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.655 0.264 . . . . 0.0 110.686 179.422 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.414 ' HB3' HD21 ' A' ' 41' ' ' LEU . 5.2 p -160.46 23.38 0.15 Allowed 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.319 -178.91 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.431 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 8.3 mtpt -159.62 123.13 3.67 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.36 -177.701 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -92.13 145.05 24.82 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.196 178.714 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.516 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 0.4 OUTLIER -119.95 116.03 24.98 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 119.401 -0.919 . . . . 0.0 111.635 178.912 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 15.6 t -69.46 95.66 0.84 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.631 179.628 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -120.18 -168.18 1.57 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.939 -179.79 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.366 0 CA-C-O 121.009 0.433 . . . . 0.0 111.198 -179.693 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.533 0 CA-C-O 120.926 0.393 . . . . 0.0 109.981 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -162.09 176.68 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.136 -179.303 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.51 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 70.9 m95 -128.61 120.93 27.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.396 -179.253 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.516 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -69.0 167.72 18.99 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.754 178.189 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.49 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 56.1 Cg_exo -13.66 90.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.964 1 C-N-CA 125.399 4.066 . . . . 0.0 114.374 -179.16 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.509 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -94.46 -76.23 0.49 Allowed 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 115.273 -0.876 . . . . 0.0 113.231 -175.799 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.494 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -96.56 85.09 0.3 Allowed Pre-proline 0 N--CA 1.45 -0.462 0 N-CA-C 112.883 0.698 . . . . 0.0 112.883 -173.431 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.453 ' CD ' ' O ' ' A' ' 62' ' ' GLU . 22.2 Cg_endo -51.49 -156.28 0.0 OUTLIER 'Trans proline' 0 N--CA 1.473 0.274 0 C-N-CA 123.586 2.858 . . . . 0.0 112.187 174.504 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -100.88 177.59 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.972 0.415 . . . . 0.0 110.726 178.876 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -170.74 133.65 0.98 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.681 179.523 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -137.87 113.18 9.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.078 179.795 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.526 ' CB ' ' CZ ' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -51.65 126.62 18.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.744 179.65 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.518 ' CG2' ' CE1' ' A' ' 40' ' ' HIS . 2.2 p -40.41 96.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.01 -179.674 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.425 ' HE3' ' CG2' ' A' ' 90' ' ' THR . 0.1 OUTLIER -73.15 114.04 10.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.163 179.868 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.428 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -92.14 122.4 34.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.944 0.402 . . . . 0.0 110.133 178.521 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.01 -159.72 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.111 179.85 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.477 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 1.2 t -54.41 143.6 45.87 Favored Pre-proline 0 N--CA 1.449 -0.509 0 CA-C-O 120.589 0.233 . . . . 0.0 110.554 -179.829 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.455 ' HA ' ' CD1' ' A' ' 118' ' ' TRP . 22.4 Cg_exo -62.1 160.77 28.83 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.432 2.088 . . . . 0.0 111.941 -179.855 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.476 ' HD2' ' CG ' ' A' ' 118' ' ' TRP . 74.7 Cg_exo -38.64 156.95 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.885 2.39 . . . . 0.0 112.912 -179.489 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.94 89.97 3.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.749 179.906 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 19.8 pt -69.35 178.65 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.057 -179.816 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.8 m -99.2 142.47 30.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.974 179.941 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.48 ' HB3' ' CE1' ' A' ' 103' ' ' TYR . 2.6 m-80 59.02 28.79 18.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.099 179.524 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.458 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -165.95 -167.49 26.66 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.857 179.834 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 10.1 ptt180 -161.66 -175.49 4.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.032 0.444 . . . . 0.0 110.923 -179.693 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.477 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 9.5 p-80 -108.68 171.35 7.48 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.881 179.88 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.684 179.146 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.431 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 13.5 m-85 . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 120.816 0.341 . . . . 0.0 110.697 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.431 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 32.2 m-85 -145.05 165.66 27.58 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.698 -179.327 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.425 ' CG2' ' HE3' ' A' ' 70' ' ' LYS . 13.3 p -128.5 178.16 6.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.108 0.48 . . . . 0.0 111.764 -178.384 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -62.25 95.58 0.07 Allowed 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.042 179.981 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 125.58 20.35 2.16 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.372 -0.831 . . . . 0.0 113.208 178.453 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.434 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -97.5 159.28 15.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 117.015 0.408 . . . . 0.0 110.439 178.91 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 27.1 m -134.92 146.28 30.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.022 0.439 . . . . 0.0 111.056 -179.626 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.505 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 27.9 t -141.62 148.35 21.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.946 179.699 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.08 131.12 54.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.776 179.663 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.527 ' CE1' ' CG2' ' A' ' 111' ' ' VAL . 6.2 m-85 -90.42 155.89 18.61 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.106 -179.414 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 p -149.86 136.68 19.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.542 -179.482 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.411 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 60.5 m -70.13 159.19 34.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.867 179.27 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.458 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 73.0 m-80 -92.13 -76.49 0.46 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.354 -179.483 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.78 -23.16 28.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.225 -179.351 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.65 32.35 1.03 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.525 -179.932 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.499 ' CE2' HG12 ' A' ' 126' ' ' ILE . 46.2 m-85 -69.99 -171.7 0.46 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 120.64 0.257 . . . . 0.0 110.48 179.709 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.8 m -109.78 108.18 18.44 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.91 0.386 . . . . 0.0 111.349 -178.905 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.457 HD23 ' CB ' ' A' ' 109' ' ' SER . 0.9 OUTLIER -48.14 106.93 0.11 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.374 178.142 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.459 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 43.6 mm -85.2 158.95 3.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.168 -178.47 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.424 ' N ' HG21 ' A' ' 106' ' ' ILE . . . 59.66 -127.42 44.48 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.844 -179.248 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -118.18 132.75 56.31 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.87 0.367 . . . . 0.0 110.669 178.974 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.479 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 0.1 OUTLIER -69.45 -28.9 66.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.119 0.485 . . . . 0.0 110.453 179.549 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.58 131.4 14.44 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.764 -179.927 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.527 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 2.8 t -123.92 121.71 62.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.583 0.23 . . . . 0.0 110.644 179.217 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.67 121.14 25.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.875 0.369 . . . . 0.0 111.443 -178.818 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.483 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 23.3 t -85.73 106.14 16.77 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 176.465 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.81 160.11 43.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.129 0.49 . . . . 0.0 111.394 -178.333 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.28 34.41 6.22 Favored Glycine 0 CA--C 1.518 0.219 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.775 179.611 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 65.91 12.94 58.56 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.641 -179.448 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -136.58 -178.85 5.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.876 0.37 . . . . 0.0 110.704 179.63 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.505 ' CH2' ' CG2' ' A' ' 95' ' ' VAL . 93.2 m95 -119.08 141.63 48.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.969 -179.416 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.08 150.13 50.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.05 0.452 . . . . 0.0 111.535 -179.029 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.478 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.5 OUTLIER 71.26 46.35 0.25 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.125 178.744 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 85.5 Cg_endo -78.22 142.23 19.0 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.376 2.05 . . . . 0.0 111.729 178.424 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.479 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 61.6 Cg_endo -90.13 -172.3 0.56 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.67 2.246 . . . . 0.0 113.476 -178.589 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.432 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -134.71 -178.48 5.09 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.974 178.215 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . 0.432 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 11.1 m -139.51 97.66 3.32 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.965 0.412 . . . . 0.0 111.027 -179.832 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -123.96 155.35 38.34 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.975 -179.683 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.499 HG12 ' CE2' ' A' ' 103' ' ' TYR . 18.1 mm . . . . . 0 C--N 1.324 -0.507 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.99 179.932 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.068 0 CA-C-O 120.838 0.351 . . . . 0.0 111.007 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.409 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 13.1 m -83.93 161.31 55.88 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.733 179.757 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.74 169.19 19.46 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.396 2.064 . . . . 0.0 111.305 179.121 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.81 116.9 9.86 Favored Pre-proline 0 C--N 1.326 -0.436 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.962 -178.794 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.448 ' CG ' HD11 ' A' ' 22' ' ' ILE . 16.3 Cg_endo -57.27 157.58 21.18 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.62 2.214 . . . . 0.0 112.273 179.987 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.439 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 9.2 mtt-85 -64.55 176.05 1.23 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.201 178.974 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.417 ' O ' ' CB ' ' A' ' 63' ' ' ALA . 1.1 t0 -130.89 -172.39 2.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.108 0.48 . . . . 0.0 111.679 -178.895 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.6 tt -145.71 151.48 14.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.727 -179.684 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -80.35 -70.73 0.5 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.672 -178.583 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.433 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 1.2 m120 -91.2 42.9 1.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.929 0.395 . . . . 0.0 110.946 -179.408 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.419 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -153.41 -173.76 22.98 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.956 179.904 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -145.66 135.2 23.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.706 0.289 . . . . 0.0 110.415 179.733 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.519 ' CD2' ' CE1' ' A' ' 33' ' ' TYR . 0.5 OUTLIER -83.73 156.99 22.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.125 0.488 . . . . 0.0 111.677 -179.23 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.436 ' CB ' ' HB ' ' A' ' 32' ' ' THR . 0.3 OUTLIER -127.73 73.75 1.48 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.31 177.061 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.448 HD11 ' CG ' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -80.32 95.58 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.835 -176.674 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.02 16.96 59.24 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.99 177.538 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 164.49 149.67 5.87 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.075 -0.583 . . . . 0.0 111.901 -179.582 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.7 m -135.91 32.85 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.699 0.285 . . . . 0.0 111.354 -179.455 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.2 OUTLIER -102.75 155.81 18.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.125 179.933 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.483 ' CZ ' ' CD1' ' A' ' 51' ' ' LEU . 4.9 t80 -50.71 91.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.771 179.657 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 129.97 -12.2 5.87 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.654 -179.251 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.2 p -70.63 177.04 3.71 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.735 0.302 . . . . 0.0 110.659 179.671 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.8 p -148.51 142.89 26.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.116 179.972 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.532 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.6 OUTLIER -104.64 171.14 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.564 179.858 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.436 ' HB ' ' CB ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -135.73 111.14 9.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.993 0.425 . . . . 0.0 111.337 179.568 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.519 ' CE1' ' CD2' ' A' ' 20' ' ' LEU . 26.5 m-85 -87.37 143.17 27.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.435 -179.755 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.419 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 5.0 m -147.05 168.47 21.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.725 179.442 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.401 ' HB2' ' HB2' ' A' ' 39' ' ' TYR . 1.3 m -87.64 166.14 14.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.828 179.696 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 -67.25 -84.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.996 -179.76 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -154.03 130.8 10.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.109 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.02 19.26 71.68 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.433 -179.534 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.49 ' CE1' ' HB3' ' A' ' 68' ' ' SER . 3.3 m-30 -111.72 178.59 4.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.859 0.361 . . . . 0.0 110.966 -179.604 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.447 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.4 OUTLIER -138.31 113.23 9.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.136 0.493 . . . . 0.0 110.472 177.645 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.445 ' CD1' ' HG3' ' A' ' 64' ' ' PRO . 6.8 tt -77.38 120.26 22.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.96 -179.01 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.447 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 2.6 mm -96.22 153.13 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.734 179.685 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.04 -137.14 15.18 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.975 -178.71 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.424 ' O ' ' CG ' ' A' ' 64' ' ' PRO . 5.1 mt-10 -88.67 -176.84 5.4 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.507 0.67 . . . . 0.0 111.221 179.175 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.406 ' HB3' HD21 ' A' ' 41' ' ' LEU . 3.7 p -155.15 24.16 0.42 Allowed 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 114.592 -1.186 . . . . 0.0 110.332 179.045 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -150.55 128.95 12.1 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.173 0.511 . . . . 0.0 112.068 -178.763 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.489 ' HA ' ' O ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -108.03 151.2 26.16 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.89 178.256 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.503 ' CD1' ' CB ' ' A' ' 60' ' ' ASN . 1.5 m-85 -126.28 122.54 35.8 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 119.456 -0.898 . . . . 0.0 112.598 -177.846 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.457 ' HB3' ' CH2' ' A' ' 59' ' ' TRP . 26.0 t -71.26 102.27 2.52 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.398 178.55 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -129.33 -176.19 3.81 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.317 -179.039 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.483 ' CD1' ' CZ ' ' A' ' 27' ' ' PHE . 6.7 mt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.447 -178.879 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 8.0 mmt . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.863 0.363 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.4 m -143.2 177.94 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.069 -179.909 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.532 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 72.6 m95 -131.84 128.65 39.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.344 -179.429 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.503 ' CB ' ' CD1' ' A' ' 48' ' ' TYR . 0.7 OUTLIER -69.67 164.63 48.86 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.707 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.489 ' O ' ' HA ' ' A' ' 47' ' ' SER . 97.7 Cg_exo -13.78 113.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.826 1 C-N-CA 125.552 4.168 . . . . 0.0 115.08 -176.257 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.474 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 3.7 mt-10 -106.17 -96.56 0.35 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.412 -1.267 . . . . 0.0 112.56 -175.579 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.417 ' CB ' ' O ' ' A' ' 14' ' ' ASP . . . -78.2 108.28 7.31 Favored Pre-proline 0 C--O 1.231 0.11 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -176.457 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.445 ' HG3' ' CD1' ' A' ' 41' ' ' LEU . 1.8 Cg_endo -86.83 -155.28 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.208 2.605 . . . . 0.0 110.881 177.387 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.41 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 5.0 mm -88.95 163.96 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.893 0.378 . . . . 0.0 110.882 178.61 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -170.18 125.46 0.77 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.768 179.589 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -153.6 174.35 14.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.914 -178.873 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.49 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 77.1 p -82.25 94.7 7.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.103 0.478 . . . . 0.0 110.337 178.387 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.43 ' CG2' ' HA3' ' A' ' 116' ' ' GLY . 6.0 p -47.33 102.43 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.214 -179.891 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -70.66 157.0 38.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.516 -177.058 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.409 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -132.02 115.27 15.6 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.882 178.435 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -70.61 -163.59 0.08 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.313 -178.779 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.467 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 1.6 t -46.81 139.92 6.36 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.227 -179.539 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.492 ' HD2' ' CE1' ' A' ' 82' ' ' HIS . 24.2 Cg_exo -62.83 146.36 94.99 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.328 2.019 . . . . 0.0 112.449 -179.125 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.505 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 0.2 OUTLIER -119.71 -159.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 124.742 3.628 . . . . 0.0 114.013 -174.784 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 75' ' ' PRO . 3.4 p 96.0 -66.23 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 171.241 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.506 HG21 ' CD2' ' A' ' 97' ' ' TYR . 0.2 OUTLIER -76.13 176.05 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 122.251 1.024 . . . . 0.0 113.51 -172.144 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.471 ' N ' HG13 ' A' ' 77' ' ' ILE . 2.4 m -139.93 143.36 36.57 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 113.307 -1.769 . . . . 0.0 108.551 176.42 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.406 ' ND2' ' N ' ' A' ' 79' ' ' ASN . 0.7 OUTLIER 77.03 23.12 0.96 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.795 0.331 . . . . 0.0 111.076 -178.091 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -147.9 -161.09 9.31 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.55 178.748 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -161.21 -173.92 4.08 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.92 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.492 ' CE1' ' HD2' ' A' ' 74' ' ' PRO . 2.1 p80 -135.51 150.38 49.75 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.124 0.488 . . . . 0.0 111.927 -178.032 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.416 ' ND2' ' OG1' ' A' ' 96' ' ' THR . 19.3 m-20 . . . . . 0 CA--C 1.533 0.312 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.154 179.106 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 . . . . . 0 N--CA 1.447 -0.588 0 CA-C-O 120.932 0.396 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.409 ' N ' ' O ' ' A' ' 71' ' ' CYS . 31.1 m-85 -140.75 159.1 42.93 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.272 179.813 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.1 p -122.04 177.27 5.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.118 0.485 . . . . 0.0 111.992 -177.466 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.405 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 1.0 OUTLIER -62.9 96.44 0.09 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.918 -179.998 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 125.96 12.54 3.57 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.227 -0.897 . . . . 0.0 113.082 179.107 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.401 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -92.93 155.54 17.5 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.934 0.367 . . . . 0.0 110.433 179.183 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 35.4 m -131.44 157.48 43.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.926 0.393 . . . . 0.0 111.02 -179.946 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.464 HG22 ' CH2' ' A' ' 118' ' ' TRP . 41.9 t -153.59 151.7 11.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.999 179.909 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.426 ' CG2' ' HB3' ' A' ' 109' ' ' SER . 0.0 OUTLIER -111.33 122.45 47.88 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.786 179.922 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.532 ' CE1' ' CG2' ' A' ' 111' ' ' VAL . 6.2 m-85 -81.06 156.1 26.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.651 -178.717 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 81' ' ' ARG . 1.2 p -147.23 134.81 20.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.397 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.4 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 74.8 m -72.0 149.72 44.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.76 0.314 . . . . 0.0 111.454 -179.875 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -96.1 -82.05 0.4 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.931 178.496 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -39.88 -30.99 0.1 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.901 -179.308 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.07 32.7 0.62 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.915 179.597 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.489 ' CD1' HG12 ' A' ' 126' ' ' ILE . 48.2 m-85 -79.96 -171.56 2.97 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.735 0.302 . . . . 0.0 110.779 179.635 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.4 m -118.97 114.5 22.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.967 0.413 . . . . 0.0 110.712 -179.846 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.448 ' CD2' ' HA ' ' A' ' 109' ' ' SER . 0.3 OUTLIER -51.04 102.95 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.001 179.959 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.427 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 22.8 mm -95.62 151.6 3.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.554 179.171 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 69.19 24.96 75.81 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.497 -0.859 . . . . 0.0 113.033 179.173 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.42 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.3 OUTLIER 60.33 136.83 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.471 0.653 . . . . 0.0 111.642 179.745 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.504 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 0.8 OUTLIER -70.21 -20.88 63.07 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.988 -179.179 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -64.65 122.42 24.64 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.695 -179.334 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.532 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 3.2 t -122.63 147.76 26.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 179.175 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.92 115.51 29.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.022 0.439 . . . . 0.0 111.627 -179.003 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.5 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 30.4 t -82.7 98.34 9.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.747 177.167 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.8 OUTLIER -138.48 160.37 39.72 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.362 -178.252 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.73 25.37 3.42 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.69 179.436 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.43 ' HA3' ' CG2' ' A' ' 69' ' ' VAL . . . 83.24 -6.76 70.4 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.945 -179.859 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -126.16 179.8 5.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.866 0.365 . . . . 0.0 110.556 179.834 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.505 ' CD1' ' HD2' ' A' ' 75' ' ' PRO . 79.0 m95 -110.38 143.44 40.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.703 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.05 162.43 23.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.029 0.442 . . . . 0.0 111.536 -178.78 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.475 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 4.3 p-10 47.65 47.82 5.07 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.058 179.526 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 72.0 Cg_endo -76.08 163.55 32.77 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.416 2.077 . . . . 0.0 111.949 178.49 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.504 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 41.3 Cg_endo -94.97 -166.1 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.121 2.547 . . . . 0.0 113.778 -178.133 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.26 170.55 17.64 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.5 177.665 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . 0.439 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 1.6 m -122.97 91.24 3.45 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.971 0.415 . . . . 0.0 111.196 179.846 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.4 ' HB3' HG13 ' A' ' 106' ' ' ILE . 19.2 mt-30 -114.15 159.43 20.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.19 178.96 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.489 HG12 ' CD1' ' A' ' 103' ' ' TYR . 16.9 mm . . . . . 0 C--N 1.321 -0.67 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.224 -179.375 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.96 0.409 . . . . 0.0 110.829 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.51 ' HB2' ' CD ' ' A' ' 10' ' ' PRO . 71.8 m -69.82 176.4 1.77 Allowed Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.174 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.525 ' HD2' ' CD1' ' A' ' 59' ' ' TRP . 30.6 Cg_endo -83.2 175.01 8.75 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 121.792 1.661 . . . . 0.0 110.58 178.261 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.9 p -51.09 104.57 0.44 Allowed Pre-proline 0 C--N 1.324 -0.501 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.611 -179.634 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.467 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 32.3 Cg_exo -38.09 156.02 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.748 2.299 . . . . 0.0 112.723 -178.66 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.44 164.53 20.91 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.379 178.652 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -114.09 -173.54 2.3 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.754 -176.707 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.436 HG22 ' CD2' ' A' ' 20' ' ' LEU . 5.8 tt -132.32 150.14 33.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.502 179.217 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -76.52 -68.5 0.59 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.79 -177.992 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -92.45 41.57 1.08 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.916 0.389 . . . . 0.0 111.076 -178.58 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.432 ' HA2' ' N ' ' A' ' 36' ' ' ASN . . . -162.3 -173.66 31.25 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.999 179.815 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -129.91 168.67 16.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.659 0.266 . . . . 0.0 110.31 179.173 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.512 ' CD2' ' CE2' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -119.85 156.59 30.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.025 0.44 . . . . 0.0 111.38 -179.427 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.42 76.49 1.71 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.979 178.358 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.466 ' CD1' HG22 ' A' ' 31' ' ' ILE . 5.9 mm -69.35 109.81 2.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.72 -177.827 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -112.91 15.72 23.52 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.347 178.465 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 152.58 138.26 2.7 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.994 -179.617 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.431 HG13 ' CD ' ' A' ' 12' ' ' PRO . 30.2 m -124.4 25.66 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -178.705 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -94.58 152.03 18.85 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.994 0.426 . . . . 0.0 111.035 -179.966 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.518 ' CZ ' ' CD1' ' A' ' 51' ' ' LEU . 2.4 t80 -47.25 92.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.088 -179.682 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 126.1 0.51 7.55 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.853 -179.593 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.17 -178.82 7.18 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 116.978 0.389 . . . . 0.0 110.662 179.696 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.0 p -153.84 145.06 22.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.266 0.555 . . . . 0.0 110.862 179.713 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.485 HD12 ' CE3' ' A' ' 59' ' ' TRP . 0.9 OUTLIER -109.98 164.88 5.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.181 -179.169 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.4 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -124.49 107.83 11.49 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.061 0.458 . . . . 0.0 111.157 179.196 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.523 ' CE2' ' HA ' ' A' ' 63' ' ' ALA . 6.5 m-85 -82.24 147.21 29.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.528 -179.461 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.45 168.6 20.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.648 179.471 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -95.36 167.18 11.5 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.645 179.795 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.432 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 25.7 m120 -55.16 -85.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.169 -178.434 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.01 125.59 4.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.258 -179.934 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.427 ' HA2' ' CB ' ' A' ' 91' ' ' ASP . . . 74.02 16.51 79.5 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.284 -0.96 . . . . 0.0 112.12 -178.242 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.532 ' CE1' ' CB ' ' A' ' 68' ' ' SER . 2.2 m-85 -107.21 -173.08 2.21 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.709 0.29 . . . . 0.0 110.503 -179.985 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.492 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.3 OUTLIER -149.65 111.0 4.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.037 0.446 . . . . 0.0 110.762 178.265 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.477 ' CD2' ' HG2' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -79.74 132.05 36.08 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.86 179.761 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.492 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 3.2 mm -97.27 163.13 2.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.605 -176.865 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 63.53 -152.25 47.9 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.531 -178.383 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.409 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -60.23 -171.84 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.199 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.463 ' CB ' ' CD1' ' A' ' 41' ' ' LEU . 91.0 p -171.28 34.19 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 121.307 0.575 . . . . 0.0 109.968 -179.893 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.4 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 1.9 mmmt -151.63 129.0 11.3 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.803 -178.966 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.426 ' HB2' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -95.86 136.32 36.44 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.55 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.499 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 1.8 m-85 -115.89 123.69 48.76 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 119.307 -0.957 . . . . 0.0 112.196 -178.465 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 44.7 t -73.19 107.69 5.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.921 179.562 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -137.43 -175.39 4.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.114 179.929 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.518 ' CD1' ' CZ ' ' A' ' 27' ' ' PHE . 10.9 mt . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.835 -179.891 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.182 0 CA-C-O 121.017 0.437 . . . . 0.0 110.791 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.8 m -148.57 165.34 4.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.176 -179.785 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.525 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 58.3 m95 -121.43 127.04 50.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.141 179.976 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.499 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 6.6 m-80 -69.76 165.21 43.92 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.171 178.883 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.438 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 42.1 Cg_exo -13.27 96.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.055 1 C-N-CA 125.63 4.22 . . . . 0.0 114.398 -179.227 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.488 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.7 OUTLIER -93.17 -70.92 0.68 Allowed 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 114.985 -1.007 . . . . 0.0 113.245 -175.556 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.523 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -106.6 75.39 0.38 Allowed Pre-proline 0 C--N 1.333 -0.143 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -173.861 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.477 ' HG2' ' CD2' ' A' ' 41' ' ' LEU . 11.5 Cg_endo -54.53 -138.76 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 123.95 3.1 . . . . 0.0 112.417 175.849 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.475 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 3.0 mm -103.54 166.14 2.98 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.327 0 O-C-N 121.288 -0.883 . . . . 0.0 112.687 -175.244 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.2 m -158.05 136.01 10.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.779 178.569 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -155.22 167.6 29.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.036 -179.814 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.532 ' CB ' ' CE1' ' A' ' 39' ' ' TYR . 4.9 p -96.27 110.57 22.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.154 179.959 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 116' ' ' GLY . 0.9 OUTLIER -52.17 101.94 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.122 179.405 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.437 ' HB2' ' CD2' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -80.04 117.83 21.22 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.36 -179.729 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.424 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -98.85 115.83 29.71 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.064 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.5 -163.53 0.05 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.843 -179.048 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.435 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 2.3 t -44.89 137.76 4.35 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.945 -179.864 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -56.24 160.93 9.84 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 122.124 1.883 . . . . 0.0 111.791 -179.402 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.484 ' HD2' ' CG ' ' A' ' 118' ' ' TRP . 98.8 Cg_exo -42.17 155.8 0.09 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.839 2.36 . . . . 0.0 112.928 -178.639 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.5 t -107.14 90.23 3.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.43 179.152 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.6 pt -69.47 170.23 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.319 -178.998 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.8 m -89.86 138.44 31.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.727 179.688 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 60.41 28.22 17.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.926 179.782 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.463 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -163.44 -165.68 21.0 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.268 -0.968 . . . . 0.0 113.225 179.828 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.3 -175.07 3.12 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.084 0.469 . . . . 0.0 110.603 -178.952 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.435 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 11.5 p-80 -107.63 178.12 4.62 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.909 179.731 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.597 -179.827 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.437 ' CD2' ' HB2' ' A' ' 70' ' ' LYS . 18.5 m-85 . . . . . 0 N--CA 1.453 -0.294 0 CA-C-O 121.037 0.446 . . . . 0.0 111.704 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.424 ' N ' ' O ' ' A' ' 71' ' ' CYS . 22.3 m-85 -145.75 169.62 18.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.095 178.727 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.428 HG21 ' CE ' ' A' ' 70' ' ' LYS . 5.5 p -134.38 -174.41 3.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.981 0.42 . . . . 0.0 111.729 -178.699 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 0.4 OUTLIER -65.76 103.75 0.95 Allowed 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.6 0.714 . . . . 0.0 111.002 -179.905 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 120.77 17.57 4.19 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.563 179.663 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.46 148.73 25.57 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.825 0.345 . . . . 0.0 110.799 179.746 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 35.5 m -129.06 156.04 41.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.032 -179.522 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.513 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 18.5 t -151.74 148.86 14.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.983 179.918 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.38 138.55 40.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.987 -179.936 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.534 ' CE2' ' CG2' ' A' ' 111' ' ' VAL . 4.4 m-85 -98.8 155.89 17.13 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.342 -179.157 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 74.3 m -151.34 143.28 23.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.066 -179.908 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.425 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 63.7 m -71.78 159.72 33.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.784 179.626 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.463 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 44.5 m-20 -85.85 -70.84 0.57 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.512 -178.944 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.0 t -68.33 -23.62 64.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.384 -179.008 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 124.26 34.79 0.7 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.568 -179.787 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.48 ' CE2' HG12 ' A' ' 126' ' ' ILE . 14.9 m-85 -69.76 -174.46 0.74 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 120.948 0.404 . . . . 0.0 110.573 179.509 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.88 100.66 10.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.424 178.927 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.444 ' CD2' ' HA ' ' A' ' 109' ' ' SER . 0.3 OUTLIER -46.64 125.59 7.31 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.376 0.608 . . . . 0.0 111.602 -178.873 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.44 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 36.8 mm -89.59 153.17 3.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.098 179.391 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 60.37 -132.3 50.07 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.773 -178.594 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -116.26 137.58 52.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.981 0.42 . . . . 0.0 111.318 179.509 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.473 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 0.7 OUTLIER -66.12 -27.64 68.2 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.408 178.7 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -70.9 138.17 27.92 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.545 179.575 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.534 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 2.9 t -131.39 130.46 62.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 179.162 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.417 ' CD1' ' HB2' ' A' ' 114' ' ' SER . 0.6 OUTLIER -89.85 128.18 36.13 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.957 0.408 . . . . 0.0 111.682 -178.576 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.507 ' HB2' ' CZ3' ' A' ' 118' ' ' TRP . 42.6 t -99.21 102.92 14.73 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.678 176.648 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 20.0 p -148.03 111.84 5.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.506 -178.657 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.41 ' CA ' HG12 ' A' ' 69' ' ' VAL . . . 94.25 39.84 4.69 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.262 179.645 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.442 ' N ' HG12 ' A' ' 69' ' ' VAL . . . 58.82 20.2 46.91 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.145 -179.339 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -143.97 -178.06 5.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.916 0.388 . . . . 0.0 110.867 -179.976 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.513 ' CH2' ' CG2' ' A' ' 95' ' ' VAL . 93.5 m95 -125.38 144.07 50.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.184 -179.121 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.48 166.65 15.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.495 -178.984 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.44 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.5 p30 45.73 50.35 7.77 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.437 -0.802 . . . . 0.0 112.361 179.065 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 96.6 Cg_endo -80.05 146.36 18.08 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.558 2.172 . . . . 0.0 111.47 177.572 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.473 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 61.1 Cg_endo -94.6 -173.01 0.29 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.786 2.324 . . . . 0.0 113.489 -178.477 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.439 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -131.69 -161.45 1.13 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.933 177.766 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 6.5 m -154.37 89.07 1.25 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.084 0.468 . . . . 0.0 111.122 179.104 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -118.54 170.86 8.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.436 179.324 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.48 HG12 ' CE2' ' A' ' 103' ' ' TYR . 22.1 mm . . . . . 0 C--N 1.323 -0.575 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.825 -179.976 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.91 0.386 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.435 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 51.1 m -108.54 160.82 25.78 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.751 179.958 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.401 ' HD3' ' HB2' ' A' ' 9' ' ' CYS . 38.6 Cg_endo -67.27 172.96 9.3 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.51 2.14 . . . . 0.0 112.255 -179.777 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.4 t -50.97 111.55 2.36 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.969 -179.57 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.426 ' CB ' HD12 ' A' ' 31' ' ' ILE . 9.9 Cg_endo -56.66 144.26 86.57 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.192 1.928 . . . . 0.0 111.944 179.724 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.423 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 3.0 mtt85 -51.61 159.3 0.78 Allowed 'General case' 0 CA--C 1.517 -0.288 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.071 178.901 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.15 -174.21 2.41 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.179 0.514 . . . . 0.0 111.709 -177.918 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.7 tt -144.36 139.78 24.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.526 -179.726 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -87.08 -48.07 8.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.667 -178.486 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -94.25 25.96 3.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.055 -178.822 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -157.42 -170.37 22.22 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.816 -179.625 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -141.45 130.82 23.69 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.661 0.267 . . . . 0.0 110.638 179.882 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.521 ' CD2' ' CE2' ' A' ' 33' ' ' TYR . 10.6 mt -73.2 156.61 38.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.188 0.518 . . . . 0.0 111.719 -179.496 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.14 73.01 1.51 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.506 177.517 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.447 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 68.5 mt -69.16 101.72 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.722 -177.183 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -103.84 17.11 50.02 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.953 177.735 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 157.43 126.15 0.89 Allowed Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.146 -179.697 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.3 m -116.71 19.02 7.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 111.631 0.234 . . . . 0.0 111.631 -179.298 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -88.03 164.66 15.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.953 0.406 . . . . 0.0 110.847 179.594 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -61.72 91.75 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.787 179.881 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 124.88 12.25 4.08 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.0 179.909 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.2 m -96.0 -172.2 2.51 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.869 0.334 . . . . 0.0 110.479 179.289 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 47' ' ' SER . 19.3 p -155.49 147.27 23.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.054 0.454 . . . . 0.0 111.398 179.852 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.535 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 1.0 OUTLIER -106.82 171.42 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.669 179.631 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.448 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -131.9 113.52 13.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.012 0.434 . . . . 0.0 111.261 179.499 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.521 ' CE2' ' CD2' ' A' ' 20' ' ' LEU . 20.6 m-85 -89.19 136.35 33.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.229 -179.813 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.7 m -139.71 158.05 44.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.796 -179.974 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.431 ' HB2' ' CB ' ' A' ' 39' ' ' TYR . 31.3 m -87.75 157.74 18.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.949 0.404 . . . . 0.0 110.984 179.9 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.48 -92.72 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.88 -179.359 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -147.48 131.0 16.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.824 0.345 . . . . 0.0 110.834 -179.648 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.47 23.21 75.19 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.917 -178.831 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.487 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.0 m-85 -116.18 168.36 10.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.797 0.332 . . . . 0.0 110.994 -179.183 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.521 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.3 OUTLIER -130.56 124.32 31.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.55 178.248 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.442 ' CD2' ' O ' ' A' ' 44' ' ' GLU . 5.4 tt -87.99 124.54 33.83 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.725 -179.622 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.521 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 2.1 mm -102.62 165.09 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.006 0.432 . . . . 0.0 111.071 -179.893 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.65 -136.15 20.47 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.241 -179.458 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.442 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 1.9 pt-20 -74.54 -173.22 1.71 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.767 0.318 . . . . 0.0 110.534 179.197 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.8 p -163.42 24.31 0.08 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.219 -179.502 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.448 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -166.98 125.7 1.37 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.524 -177.554 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.442 ' CB ' ' HA ' ' A' ' 62' ' ' GLU . 0.4 OUTLIER -92.13 138.72 31.3 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 177.492 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.518 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 2.1 m-85 -116.46 119.71 36.49 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 119.446 -0.902 . . . . 0.0 111.765 179.88 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 26.8 t -70.01 112.8 6.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.756 179.537 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.418 ' OE2' ' ND2' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -139.76 -171.55 3.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 179.741 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.034 -179.558 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 6.7 mtt . . . . . 0 N--CA 1.455 -0.178 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.2 m -148.93 176.45 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.188 -178.755 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.535 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 65.7 m95 -132.15 125.73 31.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.02 179.813 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.518 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 3.2 m-20 -68.8 168.38 15.22 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.127 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 19.0 Cg_exo -10.66 88.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.043 1 C-N-CA 125.342 4.028 . . . . 0.0 114.783 -179.032 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.469 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 1.0 OUTLIER -83.82 -97.97 0.05 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.631 -177.381 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.495 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -84.65 110.29 26.34 Favored Pre-proline 0 C--O 1.231 0.096 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -175.903 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.44 ' CG ' ' O ' ' A' ' 44' ' ' GLU . 5.0 Cg_exo -78.53 -153.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.918 2.412 . . . . 0.0 111.086 177.025 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.407 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 3.8 mm -93.83 167.68 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.672 0.272 . . . . 0.0 110.368 177.929 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -165.43 135.07 3.5 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.017 -179.968 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -156.38 178.38 10.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.955 -179.794 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.487 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 52.9 p -86.1 113.2 21.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.981 179.982 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.455 ' CG2' ' HB3' ' A' ' 40' ' ' HIS . 0.1 OUTLIER -43.54 98.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.589 -179.907 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.428 ' HE3' ' CG2' ' A' ' 90' ' ' THR . 1.3 mmtp -72.08 107.93 5.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.1 179.852 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.42 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -93.37 125.26 37.87 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.818 0.342 . . . . 0.0 110.159 178.578 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.88 -156.02 0.06 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.478 179.807 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.427 ' OG ' ' NE2' ' A' ' 82' ' ' HIS . 1.7 t -48.8 138.24 12.54 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.084 -179.854 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.483 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 25.3 Cg_exo -61.11 163.34 17.02 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.372 2.048 . . . . 0.0 112.035 179.764 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.503 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 82.7 Cg_exo -38.75 156.43 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.895 2.396 . . . . 0.0 112.903 -179.274 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.5 m -109.78 89.76 3.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.484 179.315 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.7 pt -69.09 175.22 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.09 -179.318 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.437 ' HB3' ' ND2' ' A' ' 79' ' ' ASN . 0.6 OUTLIER -95.71 145.94 24.9 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.399 178.605 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.507 ' HB3' ' CD2' ' A' ' 103' ' ' TYR . 3.0 m-80 59.46 28.74 18.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.895 0.379 . . . . 0.0 111.104 177.876 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -170.48 -161.68 21.48 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.644 -0.788 . . . . 0.0 113.092 179.634 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' ' 98' ' ' SER . 1.4 ptt85 -170.18 -175.22 1.92 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.972 0.415 . . . . 0.0 110.984 -178.79 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.427 ' NE2' ' OG ' ' A' ' 73' ' ' SER . 12.2 p80 -105.05 176.43 5.16 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.982 179.874 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.427 ' ND2' ' HB ' ' A' ' 96' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.239 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.543 179.138 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 . . . . . 0 N--CA 1.455 -0.212 0 CA-C-O 120.96 0.41 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.42 ' N ' ' O ' ' A' ' 71' ' ' CYS . 62.5 m-85 -144.09 163.52 33.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.491 179.843 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.428 ' CG2' ' HE3' ' A' ' 70' ' ' LYS . 16.0 p -128.22 179.93 5.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.906 0.384 . . . . 0.0 111.349 -179.228 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.1 p-10 -64.48 94.75 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.267 0.556 . . . . 0.0 110.864 -179.926 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.34 28.05 1.04 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.116 179.085 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.421 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -106.0 161.5 14.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.679 0.276 . . . . 0.0 110.522 179.125 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 35.3 m -134.07 152.24 33.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.215 0.531 . . . . 0.0 111.441 -179.567 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.507 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 21.6 t -150.88 147.27 15.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.618 179.27 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.427 ' HB ' ' ND2' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -103.83 144.72 31.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.114 178.574 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.487 ' CE1' HG23 ' A' ' 111' ' ' VAL . 4.7 m-85 -100.5 156.76 17.1 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.596 179.941 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 81' ' ' ARG . 51.8 p -153.18 143.88 22.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.349 -178.82 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.424 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 23.3 m -69.52 164.88 22.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.086 -178.844 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -94.88 -84.78 0.32 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.878 178.913 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.35 -41.07 79.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.495 -179.259 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 147.07 42.56 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.644 -179.978 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.521 ' CE1' HG12 ' A' ' 126' ' ' ILE . 23.3 m-85 -80.14 -165.85 0.92 Allowed 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 122.355 0.262 . . . . 0.0 110.601 179.962 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.3 m -120.64 107.53 12.92 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.798 0.332 . . . . 0.0 111.719 -179.967 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.468 HD22 ' CB ' ' A' ' 109' ' ' SER . 1.4 tp -48.33 117.12 1.82 Allowed 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.334 177.83 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.449 ' HB ' ' CB ' ' A' ' 123' ' ' THR . 44.9 mm -91.53 154.34 3.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.036 -178.859 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.426 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 60.55 -128.88 46.29 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.082 -179.399 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -114.11 127.23 55.82 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.878 0.37 . . . . 0.0 110.819 179.35 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.468 ' CB ' HD22 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -64.01 -28.12 69.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.769 179.741 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.31 144.9 41.72 Favored Glycine 0 N--CA 1.452 -0.256 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.822 -179.919 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.487 HG23 ' CE1' ' A' ' 97' ' ' TYR . 3.4 t -140.52 127.51 22.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.544 0.211 . . . . 0.0 110.989 -179.959 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.45 128.87 34.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.911 0.386 . . . . 0.0 111.524 -179.51 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.5 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 24.7 t -91.98 104.69 17.07 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.513 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.2 t -150.89 163.95 37.47 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.146 0.498 . . . . 0.0 111.596 -177.976 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 45.29 32.21 3.58 Favored Glycine 0 N--CA 1.453 -0.219 0 CA-C-N 115.54 -0.754 . . . . 0.0 113.096 179.557 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.452 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 67.92 13.17 63.65 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.696 -179.994 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -143.17 171.42 14.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.84 0.353 . . . . 0.0 110.267 179.292 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.507 ' CH2' ' CG2' ' A' ' 95' ' ' VAL . 87.8 m95 -108.43 131.92 54.29 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.885 -179.364 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.99 149.81 34.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.066 0.46 . . . . 0.0 111.234 -179.154 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.493 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER 70.43 44.88 0.24 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.231 179.057 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 73.6 Cg_endo -76.9 140.56 20.55 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.266 1.977 . . . . 0.0 111.215 177.834 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.467 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 36.4 Cg_endo -91.78 -179.55 1.29 Allowed 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.453 2.102 . . . . 0.0 113.255 -178.679 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.449 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -118.77 -162.34 0.89 Allowed 'General case' 0 CA--C 1.502 -0.885 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.041 176.278 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 4.9 t -170.39 91.72 0.18 Allowed 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 119.901 -0.72 . . . . 0.0 111.265 -176.486 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -116.2 174.79 5.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.042 -178.685 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.521 HG12 ' CE1' ' A' ' 103' ' ' TYR . 46.7 mm . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.865 -179.881 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.411 ' HA ' ' HA ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.133 0 CA-C-O 121.034 0.445 . . . . 0.0 111.14 . . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.442 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 48.0 m -80.99 161.22 63.95 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.813 179.68 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.422 ' HD3' ' HB2' ' A' ' 9' ' ' CYS . 54.7 Cg_endo -69.77 172.47 12.59 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.355 2.037 . . . . 0.0 111.337 178.773 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.1 p -50.93 117.66 8.97 Favored Pre-proline 0 C--N 1.328 -0.327 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.913 -179.19 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.431 ' CG ' HD11 ' A' ' 22' ' ' ILE . 17.8 Cg_endo -58.71 161.66 14.55 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.708 2.272 . . . . 0.0 112.348 -179.874 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.435 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -61.92 179.92 0.24 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.105 178.744 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.33 -171.07 2.73 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.015 0.436 . . . . 0.0 111.321 -179.678 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.0 tt -152.56 150.15 13.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.798 -179.743 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -95.45 -52.39 4.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.111 -179.519 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -94.17 42.05 1.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.122 0.487 . . . . 0.0 110.819 -179.85 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -169.67 -169.74 33.29 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.429 179.806 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -148.14 130.09 15.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.667 0.27 . . . . 0.0 110.785 -179.505 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.527 ' CD2' ' CE1' ' A' ' 33' ' ' TYR . 19.5 mt -78.52 161.35 27.1 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.271 0.558 . . . . 0.0 111.72 -179.674 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -132.09 74.16 1.57 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.269 177.523 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.443 HG23 HD11 ' A' ' 22' ' ' ILE . 0.7 OUTLIER -80.75 107.55 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.86 -176.794 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.31 14.65 56.75 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.988 177.464 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 158.74 155.23 7.52 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.151 -179.62 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.2 m -132.72 8.42 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -179.52 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.411 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 0.7 OUTLIER -72.72 154.7 40.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.804 0.335 . . . . 0.0 111.009 -179.9 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -50.44 92.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.874 -179.949 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 128.25 -5.16 6.79 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.784 -179.732 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.39 -175.51 0.65 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.903 0.352 . . . . 0.0 110.787 179.92 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.1 p -157.45 139.59 14.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.093 179.776 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.52 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.4 OUTLIER -107.51 170.15 2.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.478 -179.884 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.431 ' O ' ' N ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -134.35 115.92 14.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.893 0.378 . . . . 0.0 110.986 179.58 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.527 ' CE1' ' CD2' ' A' ' 20' ' ' LEU . 23.0 m-85 -93.09 138.02 31.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.361 -179.067 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.83 170.13 16.27 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.782 179.847 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 50.9 m -91.03 163.39 14.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.858 0.361 . . . . 0.0 111.188 -179.639 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -62.69 -82.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.255 -179.655 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.39 136.48 13.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.852 -179.702 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.52 23.05 64.42 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.107 -179.42 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.492 ' CE2' ' HB2' ' A' ' 68' ' ' SER . 2.5 m-30 -116.64 174.25 6.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.95 0.405 . . . . 0.0 111.135 -179.273 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.487 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -134.91 123.67 23.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.995 177.453 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.431 ' CD1' ' HG3' ' A' ' 64' ' ' PRO . 10.2 tt -80.32 144.23 32.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.838 -178.531 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.487 HD11 ' CE1' ' A' ' 40' ' ' HIS . 1.9 mm -124.73 152.12 30.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.942 -179.865 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.62 -127.34 7.99 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.039 -179.165 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.437 ' O ' ' CG ' ' A' ' 64' ' ' PRO . 7.0 pm0 -85.29 167.85 15.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.82 0.343 . . . . 0.0 110.568 178.887 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.8 p -150.8 21.07 0.79 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.898 179.609 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.41 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -163.95 124.37 2.16 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.278 -179.299 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -102.18 156.37 17.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.635 -179.269 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.435 ' CB ' ' HB2' ' A' ' 60' ' ' ASN . 1.7 m-85 -132.45 123.78 27.33 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 119.937 -0.705 . . . . 0.0 112.508 -178.192 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 35.5 t -70.14 95.68 1.0 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.38 178.305 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.5 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 3.7 tt0 -128.01 171.22 12.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.495 0.664 . . . . 0.0 111.033 -179.071 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.5 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 1.3 mt . . . . . 0 C--N 1.321 -0.655 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.366 -179.784 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.941 0.4 . . . . 0.0 111.091 . . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.2 m -125.97 -169.22 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.687 179.457 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.52 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 73.2 m95 -130.45 130.49 44.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.953 0.406 . . . . 0.0 111.819 -179.193 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.471 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.9 OUTLIER -76.45 166.98 40.68 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.483 177.227 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.471 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 42.9 Cg_exo -11.91 96.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.774 1 C-N-CA 125.646 4.231 . . . . 0.0 115.242 -178.574 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.433 ' CG ' ' HB3' ' A' ' 47' ' ' SER . 36.6 mt-10 -100.79 -98.65 0.25 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.951 -178.147 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.482 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -70.67 107.04 2.09 Favored Pre-proline 0 N--CA 1.462 0.167 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -176.545 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.491 ' HD2' ' CD1' ' A' ' 33' ' ' TYR . 2.3 Cg_endo -89.45 -156.94 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.512 2.808 . . . . 0.0 111.223 177.723 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.405 ' CD1' ' HB ' ' A' ' 42' ' ' ILE . 1.0 OUTLIER -93.08 173.26 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.931 0.396 . . . . 0.0 110.393 177.904 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -171.36 142.65 1.72 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.013 179.622 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -169.49 172.09 7.27 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.805 179.458 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.492 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 34.0 p -80.41 126.87 31.73 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.646 179.583 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.439 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 1.3 p -41.51 97.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.584 -179.499 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.415 ' HD3' ' HB2' ' A' ' 88' ' ' PHE . 13.7 mmtp -66.72 129.78 40.99 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.945 -178.468 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.8 115.93 26.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.538 177.166 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.32 -163.41 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.957 -178.658 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.419 ' OG ' ' NE2' ' A' ' 82' ' ' HIS . 1.6 t -45.15 135.27 5.25 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.324 -179.194 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.483 ' HG3' ' CZ2' ' A' ' 118' ' ' TRP . 31.6 Cg_exo -58.96 160.98 16.71 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.364 2.043 . . . . 0.0 112.006 -179.9 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.404 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 87.0 Cg_exo -40.86 156.76 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.795 2.33 . . . . 0.0 112.975 -179.135 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.72 89.84 3.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.783 179.9 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 25.8 pt -69.47 178.75 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.551 -179.201 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.4 m -100.48 145.41 28.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.645 179.411 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' A' ' 124' ' ' CYS . 3.3 m-80 58.55 26.78 14.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.904 179.776 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.464 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -165.87 -164.47 21.41 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.378 179.933 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 98' ' ' SER . 7.7 ptt85 -167.83 -175.86 2.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.151 0.5 . . . . 0.0 111.102 -179.4 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 14.6 p80 -110.76 166.15 11.25 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.661 178.832 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 . . . . . 0 C--N 1.326 -0.436 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.37 179.247 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.436 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 8.2 m-85 . . . . . 0 N--CA 1.456 -0.168 0 CA-C-O 120.824 0.345 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.436 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 62.5 m-85 -151.0 160.47 43.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.593 -179.913 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.434 ' CG2' ' OG ' ' A' ' 68' ' ' SER . 36.9 p -126.81 -177.24 3.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.022 0.439 . . . . 0.0 111.518 -179.048 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -65.47 94.07 0.17 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.007 -179.805 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 127.1 30.59 0.79 Allowed Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.336 -0.847 . . . . 0.0 113.074 178.817 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.418 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.5 OUTLIER -109.92 160.32 16.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.773 0.32 . . . . 0.0 110.632 179.324 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 34.7 m -136.26 150.97 28.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.132 0.491 . . . . 0.0 111.216 -179.603 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.518 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 21.8 t -145.54 148.52 17.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.753 179.686 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.413 ' CG2' ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -110.91 123.38 50.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.012 -179.787 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.513 ' CE2' ' CG2' ' A' ' 111' ' ' VAL . 5.6 m-85 -79.82 156.68 27.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.752 -179.709 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 81' ' ' ARG . 3.9 p -149.86 148.97 29.8 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.914 0.388 . . . . 0.0 112.03 -177.973 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.483 ' HB2' ' HB3' ' A' ' 103' ' ' TYR . 21.2 m -68.8 154.75 41.43 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.541 179.832 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.464 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 85.4 m-20 -73.94 -87.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.111 -177.992 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.43 -43.77 26.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.64 0.257 . . . . 0.0 111.687 -177.642 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 178.44 32.17 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.352 -0.928 . . . . 0.0 113.112 -177.548 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.513 ' CZ ' HG12 ' A' ' 126' ' ' ILE . 0.8 OUTLIER -72.95 -161.81 0.1 Allowed 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.611 -0.295 . . . . 0.0 110.39 -179.524 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.1 t -141.46 117.56 10.62 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.962 0.411 . . . . 0.0 110.77 177.44 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.44 ' CD2' ' HA ' ' A' ' 109' ' ' SER . 0.2 OUTLIER -58.9 140.4 55.44 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.836 0.826 . . . . 0.0 112.063 -178.119 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.4 mm -110.24 158.37 10.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 114.057 -1.429 . . . . 0.0 110.075 179.154 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.96 -125.42 32.43 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.034 -179.158 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -123.33 130.76 53.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.856 0.36 . . . . 0.0 110.837 179.38 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.445 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 2.7 t -66.18 -31.1 71.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.865 179.879 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.4 138.28 30.38 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.049 -179.407 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.513 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 2.9 t -134.4 119.44 30.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.64 0.257 . . . . 0.0 110.744 179.024 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.84 125.71 30.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.923 0.392 . . . . 0.0 111.629 -179.114 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.495 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 14.9 t -91.82 105.76 17.96 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 176.176 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.69 163.09 38.34 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.109 0.48 . . . . 0.0 111.36 -178.495 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.2 30.91 4.3 Favored Glycine 0 CA--C 1.517 0.187 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.731 179.865 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.439 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 68.91 16.03 69.93 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.599 -179.525 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -141.28 -179.18 5.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.905 0.383 . . . . 0.0 110.68 179.72 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.518 ' CH2' ' CG2' ' A' ' 95' ' ' VAL . 94.9 m95 -116.63 142.71 46.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.919 -179.85 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.74 147.35 49.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.142 -179.762 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.487 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER 70.17 45.66 0.26 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.153 179.122 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 98.0 Cg_endo -77.9 133.68 12.72 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.372 2.048 . . . . 0.0 111.295 177.782 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.445 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 93.7 Cg_endo -93.22 -173.15 0.37 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.475 2.117 . . . . 0.0 113.714 -177.824 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.43 -170.01 2.21 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-N 114.054 -1.43 . . . . 0.0 108.582 176.359 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 2.5 t -161.2 105.93 1.34 Allowed 'General case' 0 N--CA 1.424 -1.756 0 CA-C-O 122.127 0.965 . . . . 0.0 110.879 -177.667 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -112.14 152.9 27.77 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 113.491 -1.686 . . . . 0.0 110.329 -179.685 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.513 HG12 ' CZ ' ' A' ' 103' ' ' TYR . 5.0 mm . . . . . 0 C--N 1.32 -0.712 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.953 179.828 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.5 mtm180 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.813 0.34 . . . . 0.0 110.79 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.433 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 29.6 m -84.55 159.82 57.69 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.576 179.56 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.5 169.79 17.75 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.543 2.162 . . . . 0.0 112.527 -179.07 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.4 t -51.38 105.63 0.55 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.836 179.89 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -58.5 144.79 96.54 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.044 1.829 . . . . 0.0 111.768 179.699 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.44 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 3.0 mtt180 -45.45 122.81 3.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.412 0.625 . . . . 0.0 111.343 -179.341 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.449 ' O ' ' CG2' ' A' ' 15' ' ' ILE . 0.2 OUTLIER -73.91 -7.4 52.18 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.213 -178.932 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.46 HG21 ' CD2' ' A' ' 20' ' ' LEU . 18.2 tt 51.72 159.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 121.353 0.597 . . . . 0.0 112.089 -178.803 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.407 ' N ' HG13 ' A' ' 15' ' ' ILE . 7.0 t0 -100.56 159.07 15.45 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.632 177.484 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.476 ' HB2' ' CD2' ' A' ' 39' ' ' TYR . 0.0 OUTLIER 42.82 29.32 0.17 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.77 0.319 . . . . 0.0 111.222 -179.408 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.423 ' HA2' ' N ' ' A' ' 36' ' ' ASN . . . -152.12 176.72 30.3 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.74 -179.42 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -142.56 140.12 31.63 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.673 0.273 . . . . 0.0 110.696 179.938 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.46 ' CD2' HG21 ' A' ' 15' ' ' ILE . 52.0 mt -88.99 155.52 19.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.305 0.574 . . . . 0.0 112.096 -178.888 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -124.11 79.03 1.69 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.268 177.181 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.455 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 1.3 mt -75.29 107.71 6.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.36 -176.096 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -109.75 20.8 26.55 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.191 175.869 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 154.63 124.8 0.94 Allowed Glycine 0 C--N 1.334 0.444 0 N-CA-C 111.799 -0.52 . . . . 0.0 111.799 -178.948 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.431 ' CG1' ' CG2' ' A' ' 22' ' ' ILE . 28.7 m -120.4 32.49 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -178.504 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.3 OUTLIER -100.9 151.05 22.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.843 0.354 . . . . 0.0 110.921 179.372 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.416 ' CE2' HD12 ' A' ' 51' ' ' LEU . 8.1 t80 -49.57 91.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.938 179.996 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 129.5 1.73 5.53 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.997 -179.807 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.37 -164.27 1.16 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 117.052 0.426 . . . . 0.0 110.669 179.677 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.4 p -160.01 153.19 21.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.958 0.409 . . . . 0.0 111.164 179.475 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.53 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.8 OUTLIER -114.01 175.0 2.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.442 -179.972 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -130.74 120.31 23.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.79 0.329 . . . . 0.0 110.706 178.638 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.401 ' OH ' ' HB2' ' A' ' 62' ' ' GLU . 19.4 m-85 -96.69 144.67 26.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.301 0.572 . . . . 0.0 112.215 -177.897 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.02 165.33 31.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.287 179.224 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.3 m -85.17 159.41 20.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.878 0.37 . . . . 0.0 110.928 -179.6 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.423 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 8.7 m-20 -59.76 -86.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.272 -178.68 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.3 t -153.02 132.22 12.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.896 0.379 . . . . 0.0 110.938 -179.979 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.72 22.6 73.69 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.036 -179.396 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.476 ' CD2' ' HB2' ' A' ' 17' ' ' ASN . 2.5 m-30 -114.81 -174.14 2.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.96 0.409 . . . . 0.0 110.902 -179.649 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.513 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.3 OUTLIER -145.1 113.59 6.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.878 177.635 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.436 ' CD2' ' O ' ' A' ' 44' ' ' GLU . 6.5 tt -79.4 119.2 22.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.824 -178.631 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.513 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 2.0 mm -103.89 153.11 6.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.513 179.248 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.11 -127.46 8.21 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.989 179.626 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.438 ' O ' ' CG ' ' A' ' 64' ' ' PRO . 1.3 mt-10 -79.7 179.53 7.47 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.484 0.659 . . . . 0.0 112.618 -177.899 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.416 ' O ' ' CG ' ' A' ' 46' ' ' LYS . 4.8 p -165.84 27.52 0.05 OUTLIER 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.005 -179.857 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.416 ' CG ' ' O ' ' A' ' 45' ' ' SER . 3.0 mtpt -166.83 123.73 1.24 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -177.774 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.44 ' HB3' ' HA ' ' A' ' 62' ' ' GLU . 5.8 t -94.07 152.23 18.93 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.103 177.496 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.516 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 1.1 m-85 -124.63 105.36 9.27 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.736 177.539 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.449 ' HB3' ' CH2' ' A' ' 59' ' ' TRP . 27.6 t -58.59 101.05 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.509 179.677 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.01 -171.08 2.22 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.164 -179.172 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.416 HD12 ' CE2' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.385 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.055 -179.375 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.4 mmt . . . . . 0 N--CA 1.456 -0.145 0 CA-C-O 120.804 0.335 . . . . 0.0 110.448 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.4 m -148.4 173.88 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.959 -179.537 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.53 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 74.0 m95 -126.29 124.68 40.88 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.147 -179.907 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.516 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 0.7 OUTLIER -68.98 166.84 24.06 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 177.368 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.481 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 78.3 Cg_exo -15.07 88.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 125.229 3.953 . . . . 0.0 114.253 -179.408 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.44 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 1.0 OUTLIER -92.73 -93.41 0.15 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.244 -177.43 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.23 106.06 1.32 Allowed Pre-proline 0 C--O 1.231 0.125 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -177.118 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.438 ' CG ' ' O ' ' A' ' 44' ' ' GLU . 1.9 Cg_endo -84.43 -153.6 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.993 2.462 . . . . 0.0 110.576 178.059 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.434 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 3.4 mm -86.77 161.32 2.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.994 0.426 . . . . 0.0 111.105 179.911 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -169.76 130.9 1.05 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.965 179.491 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -154.92 175.61 13.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.665 179.576 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.469 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 1.7 p -87.39 121.75 30.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.295 179.053 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.46 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 1.6 p -41.92 94.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 120.971 0.415 . . . . 0.0 111.299 -179.591 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 68' ' ' SER . 2.7 mmtt -79.63 140.37 37.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.835 -177.85 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.424 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -116.89 122.34 44.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.977 178.544 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.36 -164.66 0.06 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.935 -178.993 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.0 t -49.1 136.16 14.86 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.814 -179.504 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.486 ' HG3' ' CZ2' ' A' ' 118' ' ' TRP . 24.3 Cg_exo -59.48 155.71 40.19 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.119 1.879 . . . . 0.0 111.675 179.905 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.405 ' HG3' ' HD3' ' A' ' 121' ' ' PRO . 95.9 Cg_exo -44.17 164.46 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.984 2.456 . . . . 0.0 113.237 -178.458 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 83.0 p -113.04 90.49 3.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.592 179.697 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.2 pt -68.74 172.88 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.942 -179.623 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.0 133.77 35.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.086 -179.555 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.485 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 0.2 OUTLIER 66.78 28.09 9.01 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.707 179.872 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.421 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -163.64 -177.99 36.93 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.287 -0.959 . . . . 0.0 113.187 -179.833 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.71 -175.76 5.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.815 0.34 . . . . 0.0 110.301 179.757 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.48 ' HB3' ' CE2' ' A' ' 97' ' ' TYR . 4.0 p-80 -120.78 161.6 21.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.07 0.462 . . . . 0.0 111.545 179.993 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.905 -179.904 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.422 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 9.7 m-85 . . . . . 0 N--CA 1.448 -0.559 0 CA-C-O 121.104 0.478 . . . . 0.0 111.239 . . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.424 ' N ' ' O ' ' A' ' 71' ' ' CYS . 21.1 m-85 -141.43 163.39 33.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.797 179.358 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.7 p -122.77 165.57 16.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.042 0.449 . . . . 0.0 111.901 -177.758 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -56.55 98.32 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.697 179.767 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 128.44 12.47 2.79 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.097 -0.956 . . . . 0.0 113.071 179.555 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.79 161.58 13.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.945 0.372 . . . . 0.0 110.399 179.211 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 30.2 m -141.35 147.39 22.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.113 0.482 . . . . 0.0 110.782 -179.913 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.454 HG22 ' CH2' ' A' ' 118' ' ' TRP . 43.7 t -136.94 151.32 27.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.56 179.561 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.425 ' CG2' ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -108.2 129.29 55.2 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.977 -179.565 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.53 ' CE2' ' CG2' ' A' ' 111' ' ' VAL . 6.0 m-85 -92.97 155.65 17.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.081 -179.525 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.1 p -149.16 139.33 22.21 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.443 -179.308 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 52.0 m -69.67 152.87 44.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.676 179.178 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.421 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 26.9 m-20 -92.67 -70.41 0.7 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.237 -179.383 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 36.8 m -55.5 -23.36 25.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.151 -179.683 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 118.77 30.7 1.59 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.344 -179.752 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.485 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 18.8 m-85 -71.39 -173.13 0.84 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.882 0.372 . . . . 0.0 110.774 179.986 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.69 103.89 11.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.296 -179.386 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.425 ' CD2' ' HB2' ' A' ' 122' ' ' PRO . 2.1 tp -42.62 115.89 0.78 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.419 179.21 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.44 ' HB ' ' CB ' ' A' ' 123' ' ' THR . 46.7 mm -91.01 153.58 3.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.277 179.555 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.427 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 65.41 -121.83 21.52 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.084 -1.055 . . . . 0.0 111.502 -178.09 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -136.91 120.81 17.55 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.059 0.457 . . . . 0.0 111.207 178.759 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.437 ' HA ' ' CG ' ' A' ' 122' ' ' PRO . 2.0 p -51.21 -26.6 7.29 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.95 179.326 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.46 119.13 10.86 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.849 -179.376 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.53 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 2.5 t -113.53 116.19 51.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 178.796 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.25 120.1 23.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.006 0.432 . . . . 0.0 111.828 -177.382 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.46 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 16.1 t -89.35 94.86 10.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.502 176.591 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.17 159.43 41.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.33 -178.123 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.68 29.51 4.2 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.702 179.85 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.46 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 70.09 20.94 76.81 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.267 -179.42 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -142.85 170.85 14.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.833 0.349 . . . . 0.0 110.376 179.299 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.486 ' CZ2' ' HG3' ' A' ' 74' ' ' PRO . 97.4 m95 -112.34 126.64 55.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.35 -179.192 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.48 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -92.97 131.62 37.81 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.489 174.804 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.529 ' HB2' ' CA ' ' A' ' 121' ' ' PRO . 2.3 m-20 109.42 -135.87 0.0 OUTLIER Pre-proline 0 CA--C 1.474 -1.945 0 N-CA-C 100.432 -3.914 . . . . 0.0 100.432 -166.987 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.529 ' CA ' ' HB2' ' A' ' 120' ' ' ASP . 64.4 Cg_endo -65.41 179.23 12.83 Favored 'Cis proline' 0 C--N 1.308 -1.566 0 CA-C-N 125.258 2.914 . . . . 0.0 113.36 -14.08 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.437 ' CG ' ' HA ' ' A' ' 109' ' ' SER . 10.4 Cg_endo -89.56 -174.9 0.97 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.692 2.928 . . . . 0.0 111.463 176.75 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.44 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -121.61 -179.51 4.12 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.83 179.045 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . 0.419 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 4.9 m -139.95 94.59 2.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.743 179.947 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -123.33 163.69 20.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.971 -179.474 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.479 HG12 ' CE2' ' A' ' 103' ' ' TYR . 41.1 mm . . . . . 0 C--N 1.325 -0.478 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.927 -179.917 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 80.2 mtm180 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.915 0.388 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.439 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 48.7 m -92.4 159.86 36.09 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.839 179.864 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' A' ' 9' ' ' CYS . 36.9 Cg_endo -66.45 173.85 7.1 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.491 2.127 . . . . 0.0 112.156 -179.695 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -49.28 107.64 0.82 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.126 -179.47 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.487 ' CG ' ' CD1' ' A' ' 22' ' ' ILE . 9.4 Cg_endo -52.64 154.98 11.06 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.282 1.988 . . . . 0.0 111.824 179.728 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 18.8 mtt180 -80.24 164.91 22.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.257 0.551 . . . . 0.0 111.502 -178.794 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -118.88 -166.71 1.27 Allowed 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.042 -178.023 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.441 HG21 ' CD2' ' A' ' 20' ' ' LEU . 8.5 tt -142.8 155.51 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.566 179.113 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -85.81 -55.45 3.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -176.882 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.71 28.3 2.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.632 0.254 . . . . 0.0 111.551 -177.352 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -167.16 -165.23 24.21 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.784 179.482 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -132.91 175.36 9.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.621 0.248 . . . . 0.0 110.345 179.031 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.477 HD22 ' CE1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -122.46 157.83 31.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.153 0.501 . . . . 0.0 111.224 -179.964 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -126.94 84.77 2.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.926 178.805 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.487 ' CD1' ' CG ' ' A' ' 12' ' ' PRO . 0.4 OUTLIER -82.98 97.1 4.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.992 -177.01 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.2 11.73 70.08 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.033 177.436 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 165.27 148.69 5.58 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.297 -179.72 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.0 m -129.88 13.87 2.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.948 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -93.52 151.06 19.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.694 0.283 . . . . 0.0 110.578 179.534 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -49.28 100.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.952 0.406 . . . . 0.0 110.758 179.96 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.26 0.41 6.89 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.603 -178.885 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.1 p -99.56 169.54 9.22 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.877 0.339 . . . . 0.0 110.481 179.443 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 47' ' ' SER . 4.4 p -143.27 138.74 29.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.078 0.466 . . . . 0.0 111.015 179.948 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.522 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 1.0 OUTLIER -92.84 173.67 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.634 178.949 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.412 ' O ' ' N ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -135.92 113.2 10.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.982 0.42 . . . . 0.0 111.331 -179.667 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.489 ' CE1' ' HA ' ' A' ' 63' ' ' ALA . 22.2 m-85 -89.27 140.87 29.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.883 179.696 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -147.14 146.31 29.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.731 -179.918 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.405 ' HB2' ' HB2' ' A' ' 39' ' ' TYR . 23.1 m -69.81 167.98 16.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.89 0.376 . . . . 0.0 111.001 -179.682 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -66.48 -78.5 0.06 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.006 -179.776 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -158.84 139.13 12.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.607 179.867 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.11 28.39 61.18 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.883 -179.002 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.486 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.1 m-85 -119.37 168.13 11.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.828 0.347 . . . . 0.0 111.09 -179.28 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.517 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.4 OUTLIER -127.39 117.08 21.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.404 177.806 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.459 ' CD1' ' HG3' ' A' ' 64' ' ' PRO . 8.5 tt -81.97 126.03 31.47 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.778 -179.349 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.517 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 2.1 mm -105.62 164.46 4.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.116 -179.434 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.92 -132.26 16.94 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.507 179.986 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.431 ' O ' ' CG ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -81.92 -175.41 5.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.966 0.412 . . . . 0.0 110.759 179.575 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.419 ' O ' ' CG ' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -169.83 30.73 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.43 179.327 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.419 ' CG ' ' O ' ' A' ' 45' ' ' SER . 10.9 mtpt -166.91 114.47 0.82 Allowed 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.021 -178.315 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.451 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 0.4 OUTLIER -84.67 132.31 34.49 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 178.643 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.492 ' CD1' ' HB2' ' A' ' 60' ' ' ASN . 1.6 m-85 -107.1 120.74 42.91 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 119.514 -0.875 . . . . 0.0 111.516 -179.484 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.6 t -67.72 116.94 8.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.318 -179.035 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -158.5 179.66 8.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.371 179.413 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.326 -0.432 0 CA-C-O 120.746 0.308 . . . . 0.0 110.818 179.6 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.451 -0.397 0 CA-C-O 121.318 0.58 . . . . 0.0 111.529 . . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.2 m -135.16 -175.47 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.458 179.868 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.522 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 59.5 m95 -128.41 128.18 43.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.837 0.351 . . . . 0.0 110.975 179.61 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.492 ' HB2' ' CD1' ' A' ' 48' ' ' TYR . 0.7 OUTLIER -69.69 164.93 46.23 Favored Pre-proline 0 C--O 1.224 -0.271 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.971 178.515 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.449 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 79.2 Cg_exo -16.73 100.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.741 1 C-N-CA 125.32 4.014 . . . . 0.0 114.498 -178.932 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.471 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -104.22 -82.15 0.51 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.753 -177.916 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.489 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -77.08 107.13 4.37 Favored Pre-proline 0 N--CA 1.463 0.185 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -176.355 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.459 ' HG3' ' CD1' ' A' ' 41' ' ' LEU . 3.1 Cg_endo -90.52 -155.54 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.345 2.697 . . . . 0.0 111.172 178.257 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.9 mm -97.23 165.82 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.872 0.367 . . . . 0.0 110.847 178.803 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.2 m -162.32 136.92 6.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.944 179.904 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.22 173.23 16.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.758 179.793 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.486 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 80.8 p -81.42 112.63 18.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.999 179.954 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.45 ' CG2' ' HB3' ' A' ' 40' ' ' HIS . 6.3 p -44.62 97.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.429 179.844 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -79.76 127.59 32.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.617 -179.024 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.441 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -113.48 119.86 39.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.917 178.336 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.57 -159.63 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.775 0.322 . . . . 0.0 110.597 -179.067 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.463 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 2.3 t -49.06 137.75 13.76 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.818 -179.864 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.442 ' HA ' ' CD1' ' A' ' 118' ' ' TRP . 37.0 Cg_exo -56.77 161.64 9.88 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.168 1.912 . . . . 0.0 111.589 -179.874 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.477 ' HD2' ' CG ' ' A' ' 118' ' ' TRP . 79.7 Cg_exo -39.55 156.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.701 2.267 . . . . 0.0 112.785 -179.231 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.7 m -108.38 88.21 2.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.645 179.756 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.404 ' CG2' ' O ' ' A' ' 122' ' ' PRO . 13.5 pt -70.08 -177.68 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.299 -179.357 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.6 m -103.43 147.34 27.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.781 179.657 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.409 ' HB3' ' CD2' ' A' ' 103' ' ' TYR . 24.8 m-80 51.43 29.83 5.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.161 179.698 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.465 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -160.36 -165.27 16.87 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.395 -0.907 . . . . 0.0 113.098 179.798 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.407 ' N ' ' O ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -164.18 -175.34 3.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.857 0.36 . . . . 0.0 110.463 -179.463 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.463 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 1.8 p-80 -120.37 166.14 13.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.617 -178.999 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.592 179.945 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.428 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 11.3 m-85 . . . . . 0 N--CA 1.449 -0.519 0 CA-C-O 121.091 0.472 . . . . 0.0 110.995 . . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.441 ' N ' ' O ' ' A' ' 71' ' ' CYS . 16.5 m-85 -141.69 166.89 23.5 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.922 179.569 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.2 p -131.29 179.64 5.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.127 0.489 . . . . 0.0 112.013 -177.97 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -63.26 96.22 0.1 Allowed 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.904 179.888 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.49 14.49 2.9 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.297 -0.865 . . . . 0.0 113.152 179.157 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.67 156.58 16.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.906 0.353 . . . . 0.0 110.349 179.005 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.9 m -135.38 151.51 30.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.174 0.511 . . . . 0.0 111.095 -179.475 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.501 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 14.4 t -148.79 145.43 18.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.028 179.937 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.424 ' N ' HG11 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -105.69 128.44 53.66 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.637 179.341 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.529 ' CE1' ' CG2' ' A' ' 111' ' ' VAL . 5.4 m-85 -89.0 157.83 18.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.154 -179.242 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.407 ' O ' ' N ' ' A' ' 81' ' ' ARG . 39.6 m -153.57 148.12 26.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.226 179.974 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.408 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 63.0 m -74.03 162.04 29.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.91 179.686 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.465 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 65.3 m-20 -84.9 -72.57 0.47 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.587 -179.055 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.0 m -70.84 -28.21 64.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.344 -178.67 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 132.08 36.78 0.3 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.712 179.854 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.496 ' CE1' HG12 ' A' ' 126' ' ' ILE . 33.8 m-85 -69.97 -174.82 0.82 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.893 0.378 . . . . 0.0 110.586 179.266 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.6 m -106.31 101.32 10.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.291 178.677 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.405 HD21 ' HA ' ' A' ' 109' ' ' SER . 0.3 OUTLIER -48.81 128.04 14.91 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.438 0.637 . . . . 0.0 111.508 -178.466 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.446 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 35.7 mm -91.56 153.31 3.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.955 179.078 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.47 -128.13 38.15 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.994 -178.926 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -123.79 143.86 50.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.828 0.347 . . . . 0.0 110.982 179.432 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.435 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 1.4 t -72.19 -32.57 66.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.703 179.638 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.13 137.42 29.66 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.747 -179.701 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.529 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 2.5 t -132.32 118.62 36.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.648 0.261 . . . . 0.0 110.554 179.247 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.71 114.95 21.94 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.916 0.389 . . . . 0.0 111.538 -178.848 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.492 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 26.3 t -82.5 100.93 10.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.659 176.881 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.8 t -138.61 154.58 48.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.113 0.482 . . . . 0.0 111.473 -178.2 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 53.09 21.02 9.84 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.934 179.489 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.446 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 82.8 8.05 86.46 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.8 -179.917 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.95 176.56 8.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.98 0.419 . . . . 0.0 110.692 179.737 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.501 ' CH2' ' CG2' ' A' ' 95' ' ' VAL . 96.3 m95 -113.58 134.97 54.41 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.847 -179.763 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.3 147.22 44.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.343 -179.232 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.473 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER 71.23 46.08 0.24 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.123 178.843 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 98.0 Cg_endo -78.49 133.23 11.63 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.364 2.043 . . . . 0.0 111.453 178.179 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.446 ' CB ' ' O ' ' A' ' 106' ' ' ILE . 74.2 Cg_endo -91.25 -173.88 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.664 2.243 . . . . 0.0 113.513 -178.04 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.429 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -131.33 -161.23 1.11 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.878 177.689 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 6.6 m -157.4 92.03 1.21 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.199 0.523 . . . . 0.0 110.879 179.074 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -122.94 160.15 26.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.927 -179.652 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.496 HG12 ' CE1' ' A' ' 103' ' ' TYR . 46.5 mm . . . . . 0 C--N 1.324 -0.529 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.816 179.693 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 32.4 mtm180 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.851 0.358 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.446 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 32.7 m -86.62 160.93 49.48 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.908 -179.965 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.12 169.14 18.77 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.496 2.131 . . . . 0.0 112.02 179.92 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.402 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 33.3 t -50.59 104.52 0.43 Allowed Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.982 -179.351 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.407 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 2.7 Cg_exo -45.41 166.32 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.197 1.932 . . . . 0.0 111.919 -179.67 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.425 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 2.5 ttt-85 -73.84 170.03 16.18 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.0 178.321 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.4 ' HA ' HD11 ' A' ' 20' ' ' LEU . 2.9 p30 -125.4 -177.95 4.06 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.161 0.505 . . . . 0.0 112.055 -176.347 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.3 tt -148.54 142.73 18.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.338 179.372 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -79.89 -60.68 2.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.54 -178.33 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -91.03 45.37 1.24 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.961 0.41 . . . . 0.0 110.911 -179.251 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.418 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -167.01 -179.73 40.24 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.92 179.957 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -138.86 137.77 36.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.671 0.272 . . . . 0.0 110.525 179.641 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.514 ' CD2' ' CE2' ' A' ' 33' ' ' TYR . 0.5 OUTLIER -87.17 154.2 20.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.006 0.431 . . . . 0.0 111.443 -179.653 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -123.97 82.1 1.99 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.902 177.574 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.439 ' CD1' HG23 ' A' ' 31' ' ' ILE . 4.0 mm -68.93 105.08 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.495 -177.529 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.3 15.03 47.28 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.165 178.079 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.424 ' O ' ' CB ' ' A' ' 29' ' ' SER . . . 154.12 121.43 0.8 Allowed Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.206 -179.765 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.2 m -108.96 22.24 4.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.754 0.312 . . . . 0.0 111.442 -179.599 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -99.0 158.69 15.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.923 0.392 . . . . 0.0 110.855 179.502 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.419 ' CE1' HD11 ' A' ' 51' ' ' LEU . 8.3 t80 -56.27 92.1 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.899 -179.957 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 130.93 -0.22 5.3 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.77 -0.728 . . . . 0.0 113.072 -179.859 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 24' ' ' GLY . 58.2 m -89.87 -174.04 4.12 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.969 0.384 . . . . 0.0 110.75 179.848 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.4 p -155.71 145.4 21.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.068 0.461 . . . . 0.0 111.456 -179.561 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.517 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.4 OUTLIER -104.68 167.57 2.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.444 179.445 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.81 108.83 9.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.948 0.404 . . . . 0.0 110.701 179.147 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.514 ' CE2' ' CD2' ' A' ' 20' ' ' LEU . 20.4 m-85 -81.5 149.5 28.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.177 -179.323 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.418 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 5.5 m -153.48 168.28 26.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.801 -179.61 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.432 ' HB2' ' HB2' ' A' ' 39' ' ' TYR . 1.6 m -88.08 171.99 9.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.833 179.912 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -70.23 -84.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.084 -179.4 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.44 130.5 10.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.524 179.858 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.8 23.63 69.29 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.864 -178.618 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.492 ' CZ ' ' HB2' ' A' ' 68' ' ' SER . 3.4 m-85 -113.85 175.34 5.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.681 0.277 . . . . 0.0 110.842 -179.085 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.526 ' CE1' ' CG2' ' A' ' 69' ' ' VAL . 0.0 OUTLIER -131.16 132.57 44.85 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 175.731 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.438 ' CD2' ' O ' ' A' ' 44' ' ' GLU . 7.8 tt -95.35 118.43 32.08 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.886 -178.914 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.41 ' HB ' ' HB ' ' A' ' 65' ' ' ILE . 1.1 mm -97.67 147.26 6.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.666 179.841 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.15 -149.5 23.04 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.21 -179.047 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.438 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 1.2 pt-20 -67.14 -177.12 0.61 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.071 0.463 . . . . 0.0 110.786 179.361 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.417 ' CB ' HD21 ' A' ' 41' ' ' LEU . 0.3 OUTLIER -170.45 30.09 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.336 179.846 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.31 123.37 2.59 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.773 -179.725 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.433 ' HB3' ' HA ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -105.47 155.04 19.54 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.536 -179.384 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.494 ' CD2' ' HB2' ' A' ' 60' ' ' ASN . 1.4 m-85 -130.86 125.06 32.61 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 119.686 -0.806 . . . . 0.0 112.283 -179.46 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.429 ' HB3' ' CH2' ' A' ' 59' ' ' TRP . 20.5 t -75.75 98.19 4.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.386 178.786 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.65 -173.33 2.62 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.107 -179.689 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.419 HD11 ' CE1' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.815 -179.68 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 13.2 mtt . . . . . 0 N--CA 1.455 -0.202 0 CA-C-O 120.872 0.368 . . . . 0.0 110.548 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.4 m -157.76 163.52 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.94 -179.41 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.517 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 69.4 m95 -124.06 123.13 39.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.342 -179.489 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.494 ' HB2' ' CD2' ' A' ' 48' ' ' TYR . 3.2 m-20 -69.7 165.99 36.0 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.911 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 48.7 Cg_exo -9.61 95.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.029 1 C-N-CA 125.74 4.293 . . . . 0.0 115.074 -178.57 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.473 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 42.7 mt-10 -98.08 -99.27 0.21 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.482 -177.772 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.487 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -74.9 108.66 5.73 Favored Pre-proline 0 C--O 1.232 0.135 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -175.343 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.432 ' HG3' ' CD1' ' A' ' 41' ' ' LEU . 2.5 Cg_endo -87.01 -155.31 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.216 2.61 . . . . 0.0 110.757 176.668 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.41 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 2.1 mm -99.73 161.1 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.87 0.367 . . . . 0.0 110.786 178.685 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.1 m -155.65 137.53 14.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 -179.908 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.479 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -141.42 172.88 12.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.644 179.896 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.492 ' HB2' ' CZ ' ' A' ' 39' ' ' TYR . 1.1 p -108.38 123.72 49.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.283 -179.813 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.526 ' CG2' ' CE1' ' A' ' 40' ' ' HIS . 5.1 p -52.12 90.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.596 178.494 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 68' ' ' SER . 0.6 OUTLIER -68.8 132.62 47.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.893 -178.129 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.422 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -112.75 118.56 35.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.585 177.164 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.471 ' CG ' ' N ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -69.29 -157.97 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.358 -179.532 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.471 ' N ' ' CG ' ' A' ' 72' ' ' GLN . 0.8 OUTLIER -52.38 142.36 30.08 Favored Pre-proline 0 N--CA 1.447 -0.593 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.781 179.919 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.48 ' HA ' ' CD1' ' A' ' 118' ' ' TRP . 23.8 Cg_exo -60.67 157.87 35.34 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.326 2.017 . . . . 0.0 111.813 179.741 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.472 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 81.0 Cg_exo -43.79 156.19 0.17 Allowed 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.62 2.214 . . . . 0.0 112.594 -179.429 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.7 t -105.79 90.27 3.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.771 179.905 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.2 pt -69.56 176.32 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.297 -179.477 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.8 m -94.01 143.39 26.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.416 178.898 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.488 ' HB3' ' CD2' ' A' ' 103' ' ' TYR . 4.3 m-80 57.34 30.01 17.81 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.758 -179.829 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.424 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . 178.88 -175.79 47.56 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.689 179.953 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.25 -175.06 1.86 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.765 0.316 . . . . 0.0 110.348 -179.893 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.472 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 12.3 p80 -85.83 174.78 9.07 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.855 179.8 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.417 ' OD1' ' CG1' ' A' ' 95' ' ' VAL . 21.0 p-10 . . . . . 0 C--N 1.332 -0.186 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -178.254 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.425 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 12.7 m-85 . . . . . 0 N--CA 1.446 -0.651 0 CA-C-O 121.186 0.517 . . . . 0.0 111.614 . . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.425 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 12.3 m-85 -142.28 166.91 23.39 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.017 179.661 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.4 p -127.16 169.56 13.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.969 0.414 . . . . 0.0 111.573 -178.783 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.418 ' OD1' ' CG1' ' A' ' 69' ' ' VAL . 0.1 OUTLIER -58.55 100.79 0.07 Allowed 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.49 0.662 . . . . 0.0 110.689 179.461 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.76 14.28 3.9 Favored Glycine 0 C--N 1.313 -0.745 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.916 179.287 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.7 OUTLIER -95.97 158.63 15.36 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.957 0.379 . . . . 0.0 110.327 178.808 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.0 m -134.37 156.17 40.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.055 0.455 . . . . 0.0 111.043 -179.355 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.518 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 40.1 t -148.94 152.14 12.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.646 179.95 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.435 ' CG2' ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -112.25 121.02 43.72 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.097 0.475 . . . . 0.0 111.01 -179.673 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.527 ' CE2' ' CG2' ' A' ' 111' ' ' VAL . 4.9 m-85 -80.74 155.36 26.75 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.568 -178.986 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.421 ' HA ' ' CD1' ' A' ' 105' ' ' LEU . 90.3 p -153.42 143.97 22.53 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.378 -179.729 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.424 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 6.3 m -69.54 164.86 22.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.442 -179.886 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -93.25 -67.44 0.86 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.883 179.268 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.68 -34.47 72.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.247 -179.716 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 133.63 43.94 0.13 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.491 -179.952 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.517 ' CE1' HG12 ' A' ' 126' ' ' ILE . 6.4 m-85 -78.46 -171.05 2.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.832 0.348 . . . . 0.0 110.644 179.809 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -113.57 98.86 7.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.489 179.051 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.474 ' CD2' ' HA ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -49.83 144.67 6.14 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.534 0.683 . . . . 0.0 111.254 -179.091 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.461 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 23.8 mm -121.67 162.12 21.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.999 -178.096 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.453 ' O ' ' ND2' ' A' ' 108' ' ' ASN . . . 47.7 45.82 24.3 Favored Glycine 0 C--O 1.226 -0.402 0 C-N-CA 120.574 -0.822 . . . . 0.0 113.237 178.619 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.453 ' ND2' ' O ' ' A' ' 107' ' ' GLY . 0.7 OUTLIER 46.51 128.39 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 124.577 1.151 . . . . 0.0 114.09 177.556 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.474 ' HA ' ' CD2' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -55.07 -33.16 62.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.769 179.207 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -55.43 130.1 47.38 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.2 -178.534 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.527 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 2.4 t -127.31 150.19 32.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.024 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.28 122.23 47.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.951 0.405 . . . . 0.0 111.668 -179.149 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.491 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 15.3 t -87.76 100.88 13.17 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 176.733 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -150.66 171.22 17.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.984 -178.654 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.418 ' N ' ' OD1' ' A' ' 91' ' ' ASP . . . 46.61 26.16 2.48 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.871 -179.935 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.12 18.82 76.82 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.281 -179.331 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -152.78 -176.68 5.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.895 0.379 . . . . 0.0 110.536 179.889 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.518 ' CH2' ' CG2' ' A' ' 95' ' ' VAL . 91.6 m95 -111.39 126.32 54.8 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.069 -179.425 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.8 161.09 14.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.263 -179.273 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.478 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 3.6 p30 48.46 46.04 3.33 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.434 179.161 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 57.5 Cg_endo -69.99 150.21 66.5 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.221 1.947 . . . . 0.0 110.691 176.51 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.461 ' CB ' ' O ' ' A' ' 106' ' ' ILE . 57.0 Cg_endo -95.99 177.51 0.7 Allowed 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.223 1.948 . . . . 0.0 114.089 -176.856 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.433 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -119.46 -160.8 0.83 Allowed 'General case' 0 CA--C 1.505 -0.784 0 CA-C-N 114.343 -1.298 . . . . 0.0 109.044 176.566 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 5.0 t -170.32 91.02 0.18 Allowed 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.891 -175.98 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -122.16 175.76 6.19 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.355 -177.415 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.517 HG12 ' CE1' ' A' ' 103' ' ' TYR . 46.3 mm . . . . . 0 C--N 1.326 -0.437 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.677 179.37 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.4 mtm180 . . . . . 0 N--CA 1.455 -0.211 0 CA-C-O 120.986 0.422 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.498 ' HB2' ' CD ' ' A' ' 10' ' ' PRO . 65.9 m -69.82 175.91 2.04 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.596 178.565 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.526 ' HD2' ' CD1' ' A' ' 59' ' ' TRP . 35.6 Cg_endo -88.66 177.96 2.97 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.532 2.155 . . . . 0.0 111.452 179.047 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.8 t -51.31 105.54 0.54 Allowed Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.427 179.551 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.486 ' HG2' ' CZ2' ' A' ' 59' ' ' TRP . 53.5 Cg_exo -46.55 161.38 0.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.137 1.891 . . . . 0.0 112.366 -179.049 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.421 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -62.15 -173.42 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.849 177.673 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.22 -175.95 4.82 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.288 179.524 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.438 HG21 ' CD2' ' A' ' 20' ' ' LEU . 9.2 tt -146.71 142.98 20.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.571 179.739 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -73.94 -60.82 2.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.014 -177.63 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.409 ' O ' ' N ' ' A' ' 36' ' ' ASN . 0.1 OUTLIER -94.09 30.47 1.88 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.188 -178.133 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.406 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -147.17 177.43 25.47 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.896 -179.932 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -135.9 130.66 34.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.689 0.281 . . . . 0.0 110.365 179.01 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.527 ' CD2' ' CE2' ' A' ' 33' ' ' TYR . 24.6 mt -82.91 157.45 23.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.056 0.455 . . . . 0.0 111.726 -178.75 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.03 78.75 1.85 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.163 178.823 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.455 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 67.8 mt -69.93 100.27 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.843 -177.993 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.69 17.19 59.71 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.792 177.073 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 150.46 139.73 3.08 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.218 -179.601 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.8 m -124.1 31.15 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.915 0.388 . . . . 0.0 111.253 -179.477 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.41 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.4 OUTLIER -101.06 148.93 24.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.574 179.335 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.468 ' CZ ' HD11 ' A' ' 51' ' ' LEU . 4.7 t80 -49.99 92.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.92 0.39 . . . . 0.0 110.79 179.909 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 131.44 -2.28 5.35 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.78 -179.094 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 65.6 p -89.15 -173.14 3.93 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 117.003 0.402 . . . . 0.0 110.444 179.468 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.3 p -155.11 154.36 32.26 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.002 0.43 . . . . 0.0 111.064 179.872 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.522 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.8 OUTLIER -115.65 164.6 11.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.491 -179.987 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -124.19 120.41 32.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.954 0.406 . . . . 0.0 111.253 -179.867 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.527 ' CE2' ' CD2' ' A' ' 20' ' ' LEU . 16.2 m-85 -97.77 135.28 39.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.182 -179.882 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.406 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -143.65 158.54 43.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.682 179.67 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.404 ' HB2' ' HB2' ' A' ' 39' ' ' TYR . 3.0 m -76.45 167.95 20.94 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.737 179.841 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 17' ' ' ASN . 0.6 OUTLIER -63.93 -81.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.898 -179.764 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -158.27 133.68 8.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.81 179.851 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.427 ' O ' ' CG2' ' A' ' 69' ' ' VAL . . . 64.43 23.61 68.61 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.107 -179.374 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.524 ' CE1' ' CB ' ' A' ' 68' ' ' SER . 2.6 m-85 -114.58 179.84 3.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.793 0.33 . . . . 0.0 110.862 -179.622 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.522 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.5 OUTLIER -136.17 112.54 9.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.006 0.431 . . . . 0.0 110.55 178.135 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.443 ' CD1' ' HG3' ' A' ' 64' ' ' PRO . 4.6 tt -78.58 123.93 27.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.251 -179.981 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.522 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 1.9 mm -100.17 152.33 4.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.072 0.463 . . . . 0.0 111.059 -179.207 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.77 -137.92 17.4 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.117 -179.211 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.75 -175.86 5.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.943 0.402 . . . . 0.0 110.806 179.439 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.402 ' HB3' HD21 ' A' ' 41' ' ' LEU . 3.7 p -156.55 21.41 0.34 Allowed 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.458 -178.995 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -148.13 139.16 23.25 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.246 0.546 . . . . 0.0 112.304 -178.377 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.434 ' HB2' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -107.96 145.23 34.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.875 178.212 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.468 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 1.6 m-85 -123.61 119.99 31.5 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 119.179 -1.008 . . . . 0.0 112.405 -179.928 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.406 ' HB3' ' CH2' ' A' ' 59' ' ' TRP . 19.0 t -71.4 96.83 1.52 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.517 178.935 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.7 -173.96 2.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.167 -179.463 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.468 HD11 ' CZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.998 -179.851 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 4.1 mmt . . . . . 0 N--CA 1.455 -0.194 0 CA-C-O 120.882 0.372 . . . . 0.0 110.513 . . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.4 m -158.78 172.91 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.1 -179.822 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.526 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 69.9 m95 -123.24 124.66 43.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.1 -179.976 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.468 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 3.1 m120 -69.28 163.98 52.98 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.333 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.432 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 38.9 Cg_exo -10.86 99.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.944 1 C-N-CA 125.735 4.29 . . . . 0.0 114.925 -178.618 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.476 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 7.9 mt-10 -91.62 -92.62 0.15 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.167 -0.924 . . . . 0.0 113.146 -176.43 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.496 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -81.93 110.47 20.41 Favored Pre-proline 0 CA--C 1.528 0.109 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -174.953 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.443 ' HG3' ' CD1' ' A' ' 41' ' ' LEU . 5.1 Cg_exo -80.05 -153.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.942 2.428 . . . . 0.0 110.95 176.395 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.437 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 3.5 mm -94.57 167.38 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.825 0.345 . . . . 0.0 110.919 178.833 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.2 m -166.44 132.9 2.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.171 179.24 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.9 164.56 35.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.761 -178.909 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.524 ' CB ' ' CE1' ' A' ' 39' ' ' TYR . 1.7 p -88.86 120.09 29.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.362 0.601 . . . . 0.0 111.248 -179.906 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.474 ' HB ' ' N ' ' A' ' 116' ' ' GLY . 0.6 OUTLIER -39.55 91.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.39 179.478 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.517 ' CD ' ' CD2' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -101.4 151.38 21.99 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.85 178.016 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.61 136.06 52.86 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.412 -177.63 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.419 ' O ' ' NE1' ' A' ' 118' ' ' TRP . 0.0 OUTLIER -67.23 -173.18 0.26 Allowed 'General case' 0 N--CA 1.432 -1.354 0 CA-C-O 121.904 0.859 . . . . 0.0 113.115 -178.12 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -48.19 124.4 11.07 Favored Pre-proline 0 N--CA 1.441 -0.894 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.09 175.051 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.505 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 31.7 Cg_exo -46.09 153.33 1.01 Allowed 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.593 1.529 . . . . 0.0 111.88 -175.702 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.468 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 86.3 Cg_exo -45.59 154.34 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.741 2.294 . . . . 0.0 112.679 -177.492 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 12.8 t -103.1 91.02 3.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.666 -179.881 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.9 pt -69.16 172.37 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.808 -179.962 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -93.29 134.04 35.9 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.892 -179.86 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.493 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 0.1 OUTLIER 66.95 27.76 8.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.543 -179.945 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -170.56 176.46 44.1 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.78 179.746 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.5 mtp85 -148.49 -167.37 2.8 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.505 0.669 . . . . 0.0 111.706 -178.512 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 10.3 p-80 -127.37 160.28 31.87 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.843 178.993 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.611 -179.926 . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.517 ' CD2' ' CD ' ' A' ' 70' ' ' LYS . 6.5 m-30 . . . . . 0 N--CA 1.448 -0.568 0 CA-C-O 121.096 0.474 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.485 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 54.4 m-85 -152.61 166.45 32.04 Favored 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.647 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 12.2 p -147.47 -177.46 5.71 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.53 -0.868 . . . . 0.0 112.927 -178.416 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -49.94 95.53 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.391 -179.575 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.01 10.04 5.9 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.43 -0.891 . . . . 0.0 113.269 177.467 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.433 ' O ' ' N ' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -95.16 143.77 26.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 117.253 0.526 . . . . 0.0 110.652 179.61 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 27.2 m -130.31 150.48 34.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.586 -179.736 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.47 HG21 ' CH2' ' A' ' 118' ' ' TRP . 24.3 t -142.96 147.07 21.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.039 179.877 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.68 130.59 51.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.929 -179.64 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.53 ' CE1' ' CG2' ' A' ' 111' ' ' VAL . 6.8 m-85 -91.68 154.78 18.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.153 -179.575 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.39 134.95 22.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.494 -179.471 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.406 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 81.1 m -69.34 158.39 35.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.908 179.864 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.91 -86.77 0.3 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.31 -179.702 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.0 t -43.6 -28.11 0.36 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.825 -178.944 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.05 38.45 0.43 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.361 -179.872 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.493 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 54.6 m-85 -81.6 -172.95 4.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.759 0.314 . . . . 0.0 110.852 -179.87 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.45 113.68 25.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.11 0.481 . . . . 0.0 110.985 -179.801 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.437 HD22 ' CB ' ' A' ' 109' ' ' SER . 0.6 OUTLIER -47.51 109.78 0.25 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.509 178.554 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.46 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 47.5 mm -84.31 156.58 3.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.917 -178.947 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 59.06 -127.52 45.43 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.677 -178.736 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -117.18 133.68 55.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.012 0.434 . . . . 0.0 110.574 178.446 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.478 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 0.1 OUTLIER -67.79 -29.56 68.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.376 179.6 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -77.0 125.61 7.5 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.673 179.622 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.53 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 10.9 t -115.86 124.94 72.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 178.771 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.409 HD23 ' N ' ' A' ' 113' ' ' CYS . 1.3 tm? -80.75 136.04 36.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.041 0.448 . . . . 0.0 111.527 -178.621 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.488 ' HB2' ' CZ3' ' A' ' 118' ' ' TRP . 18.4 t -108.95 107.2 17.48 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.702 177.116 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.8 t -164.34 134.13 3.94 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.992 0.425 . . . . 0.0 111.349 -179.717 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 89.76 16.4 56.57 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.477 -179.863 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.474 ' N ' ' HB ' ' A' ' 69' ' ' VAL . . . 86.33 1.83 85.81 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.064 -179.062 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -138.28 -170.66 2.86 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.755 0.788 . . . . 0.0 111.768 -178.809 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.505 ' CH2' ' HG3' ' A' ' 74' ' ' PRO . 97.0 m95 -117.5 159.67 22.46 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.381 179.055 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.15 161.16 38.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.075 0.464 . . . . 0.0 111.785 -179.506 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.4 p30 46.87 53.67 13.99 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.423 179.069 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -80.5 147.29 17.7 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.633 2.222 . . . . 0.0 111.37 177.227 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.478 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 72.6 Cg_endo -92.05 -172.32 0.41 Allowed 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.71 2.273 . . . . 0.0 114.068 -177.339 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.426 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -136.63 -170.12 2.61 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.878 178.063 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 15.6 m -145.46 95.71 2.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.111 0.481 . . . . 0.0 111.211 -179.85 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -124.66 155.76 38.66 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.708 179.706 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.488 HG12 ' CE2' ' A' ' 103' ' ' TYR . 27.9 mm . . . . . 0 C--N 1.323 -0.572 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.914 179.961 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.433 ' CB ' ' HA ' ' A' ' 26' ' ' ASP . 70.0 mtm180 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.874 0.369 . . . . 0.0 111.012 . . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.43 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 52.1 m -94.23 159.92 33.07 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.353 179.15 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.405 ' HD3' ' HB2' ' A' ' 9' ' ' CYS . 57.4 Cg_endo -68.31 166.38 25.55 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.271 1.981 . . . . 0.0 111.333 178.919 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 4.4 p -51.71 104.95 0.46 Allowed Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.178 -178.738 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.433 ' HG2' ' CZ2' ' A' ' 59' ' ' TRP . 12.7 Cg_exo -40.62 160.97 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.493 2.129 . . . . 0.0 112.517 -179.429 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.443 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -68.61 169.42 11.12 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.068 178.737 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -114.49 -173.98 2.4 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.253 0.549 . . . . 0.0 111.759 -178.192 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.9 tt -148.22 149.79 14.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.855 -179.435 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.19 159.82 16.54 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.643 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.433 ' N ' ' ND2' ' A' ' 17' ' ' ASN . 0.3 OUTLIER 46.45 27.51 0.62 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.86 0.362 . . . . 0.0 110.508 -179.138 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.74 170.25 39.76 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.024 -0.607 . . . . 0.0 112.471 -178.974 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -136.57 155.56 49.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.882 0.372 . . . . 0.0 110.41 179.831 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.477 HD22 ' CE2' ' A' ' 33' ' ' TYR . 0.3 OUTLIER -93.05 162.43 14.04 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.256 -179.638 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 32' ' ' THR . 12.8 t0 -128.9 74.61 1.59 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.538 177.962 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.43 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 1.5 mt -75.02 102.95 2.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.394 -176.086 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.3 13.1 58.61 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.612 175.893 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 166.46 138.05 2.35 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 -179.495 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.7 m -125.52 1.96 4.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.49 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.433 ' HA ' ' CB ' ' A' ' 8' ' ' ARG . 37.3 t70 -71.79 165.12 24.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.879 0.371 . . . . 0.0 110.816 179.943 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.518 ' CZ ' ' CD1' ' A' ' 51' ' ' LEU . 6.7 t80 -57.68 90.59 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.967 -179.501 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.81 -2.59 6.01 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.007 179.819 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.7 m -82.04 162.32 22.63 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 117.004 0.402 . . . . 0.0 110.485 179.561 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.5 p -131.55 148.92 52.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.94 0.4 . . . . 0.0 110.973 179.785 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.516 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.9 OUTLIER -108.67 170.64 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.668 -179.598 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.439 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -133.15 111.55 11.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.984 0.421 . . . . 0.0 110.874 179.015 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.482 ' CD2' ' HA ' ' A' ' 63' ' ' ALA . 12.1 m-85 -85.83 149.66 25.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.677 -178.475 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.1 m -149.52 160.64 43.3 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.134 179.821 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.5 m -84.27 169.18 14.97 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.068 179.939 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -67.76 -85.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.247 -178.972 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.23 132.67 12.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.742 -179.833 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.36 21.22 74.07 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.912 -178.718 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.534 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.7 m-85 -116.72 176.12 5.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.719 0.295 . . . . 0.0 110.598 -179.903 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.515 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 1.3 p80 -139.93 118.1 11.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.082 0.468 . . . . 0.0 110.243 177.754 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.448 HD22 ' CB ' ' A' ' 45' ' ' SER . 7.9 tt -78.22 123.31 26.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.736 -178.877 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.515 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 2.0 mm -102.04 165.51 2.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.038 0.447 . . . . 0.0 111.052 -179.343 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.69 -142.56 40.51 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.163 -179.198 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.413 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 1.0 OUTLIER -66.96 -175.56 0.43 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.006 0.431 . . . . 0.0 110.767 179.414 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.448 ' CB ' HD22 ' A' ' 41' ' ' LEU . 1.2 t -171.44 31.38 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.409 179.362 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.439 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -160.41 126.79 4.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.468 -178.153 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.448 ' OG ' ' CB ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -93.5 145.81 24.24 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.063 178.265 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.519 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 1.6 m-85 -122.18 115.29 22.14 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 119.414 -0.914 . . . . 0.0 111.583 178.579 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 39.1 t -68.04 100.18 0.96 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.845 -179.89 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.498 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -126.46 175.47 7.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.447 -179.686 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.518 ' CD1' ' CZ ' ' A' ' 27' ' ' PHE . 7.8 mt . . . . . 0 C--N 1.324 -0.535 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.127 -179.345 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.918 0.389 . . . . 0.0 110.79 . . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.4 m -113.31 -169.39 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.767 179.808 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.516 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 73.6 m95 -130.7 146.58 52.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.977 0.418 . . . . 0.0 111.423 -179.543 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.519 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 0.6 OUTLIER -92.1 166.64 16.95 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.632 177.427 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.486 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 93.6 Cg_exo -16.22 97.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.811 1 C-N-CA 125.387 4.058 . . . . 0.0 114.639 -178.802 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.481 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -93.92 -76.54 0.48 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.088 -178.054 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.482 ' HA ' ' CD2' ' A' ' 33' ' ' TYR . . . -85.53 108.38 16.02 Favored Pre-proline 0 N--CA 1.463 0.176 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -175.896 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.446 ' HG3' ' CD1' ' A' ' 41' ' ' LEU . 3.5 Cg_exo -82.82 -153.88 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.148 2.565 . . . . 0.0 111.038 177.078 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.415 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 4.2 mm -90.29 167.38 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.771 0.319 . . . . 0.0 110.541 178.064 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.1 m -167.53 127.93 1.44 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.037 179.462 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -148.45 173.25 13.29 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.579 179.618 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.534 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 67.6 p -77.41 130.55 37.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.441 0.639 . . . . 0.0 111.368 -179.495 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.441 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 2.7 m -36.39 104.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 114.934 -1.03 . . . . 0.0 112.95 -178.985 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.437 ' CE ' HG21 ' A' ' 90' ' ' THR . 0.1 OUTLIER -86.77 97.06 10.4 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.271 177.132 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.403 ' N ' ' O ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -83.15 128.35 34.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.991 0.424 . . . . 0.0 110.246 179.264 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.44 -158.24 0.07 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.253 178.993 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.479 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 1.8 t -48.92 137.79 13.15 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.035 -179.997 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.489 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 35.5 Cg_exo -59.71 165.58 9.61 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.43 2.086 . . . . 0.0 112.348 -179.662 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.506 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 84.0 Cg_exo -45.77 157.38 0.34 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.769 2.312 . . . . 0.0 112.781 -179.669 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.7 t -109.87 90.21 3.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.461 179.047 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.1 pt -69.26 167.84 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.286 -179.0 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.8 m -81.29 139.45 35.41 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.717 179.684 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 56.5 28.84 14.39 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 -179.821 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.464 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -157.09 -170.29 21.87 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.344 -0.932 . . . . 0.0 113.268 -179.851 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -170.16 -175.32 1.95 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.068 0.461 . . . . 0.0 110.976 -179.307 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.479 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 9.3 p80 -115.84 170.64 8.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.971 -179.74 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 120.948 0.404 . . . . 0.0 111.035 179.012 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.435 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 11.6 m-85 . . . . . 0 N--CA 1.457 -0.103 0 CA-C-O 120.784 0.326 . . . . 0.0 110.817 . . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.435 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 72.7 m-85 -156.62 164.14 38.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.67 -179.126 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.437 HG21 ' CE ' ' A' ' 70' ' ' LYS . 17.3 p -148.49 -177.04 5.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.087 0.47 . . . . 0.0 112.017 -179.242 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.426 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 56.4 m-20 -52.19 94.01 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.249 -179.503 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 122.43 20.5 2.94 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.184 -0.916 . . . . 0.0 113.044 178.455 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.411 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -106.11 150.02 26.19 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 117.087 0.443 . . . . 0.0 110.554 178.994 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 31.1 m -131.36 153.67 39.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.158 0.504 . . . . 0.0 111.359 -179.245 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.455 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 23.0 t -145.78 149.17 16.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.374 179.132 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.31 130.41 53.44 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.09 0.471 . . . . 0.0 110.796 -179.966 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.52 ' CE2' ' CG2' ' A' ' 111' ' ' VAL . 3.2 m-85 -87.52 157.41 19.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.252 -179.115 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 61.0 p -144.29 131.42 20.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.524 -179.746 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.423 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 87.8 m -69.26 151.88 45.72 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.019 179.761 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.464 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 6.4 m-20 -90.62 -71.69 0.61 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.706 -178.384 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.7 t -58.39 -17.95 24.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.512 -179.279 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 115.3 27.23 3.19 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.082 -179.298 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.483 ' CE2' HG12 ' A' ' 126' ' ' ILE . 31.3 m-85 -69.61 -173.72 0.62 Allowed 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 120.886 0.374 . . . . 0.0 110.923 -179.676 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.57 112.4 23.9 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.396 179.126 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.422 HD21 ' CB ' ' A' ' 97' ' ' TYR . 1.1 tp -50.1 112.49 0.68 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.074 -179.737 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.448 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 47.5 mm -99.34 155.88 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.729 179.957 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 60.53 28.13 67.1 Favored Glycine 0 CA--C 1.508 -0.363 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.437 179.497 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 60.22 129.11 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.001 -0.599 . . . . 0.0 111.495 179.65 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.475 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 1.2 p -61.47 -26.64 68.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.452 -179.059 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -58.66 136.83 50.81 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.788 -179.356 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.52 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 3.2 t -136.81 123.48 29.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.613 0.244 . . . . 0.0 110.936 179.734 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.458 ' CD2' ' N ' ' A' ' 113' ' ' CYS . 0.7 OUTLIER -81.72 136.16 35.47 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.886 0.374 . . . . 0.0 111.226 -179.73 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.497 ' HB2' ' CZ3' ' A' ' 118' ' ' TRP . 36.5 t -107.11 108.46 19.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.991 176.835 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 10.2 p -162.0 129.23 3.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.043 0.449 . . . . 0.0 111.848 -179.932 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.412 ' N ' ' OD1' ' A' ' 91' ' ' ASP . . . 86.58 30.22 22.08 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.508 179.309 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.441 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 68.75 14.15 67.12 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.212 -178.923 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -143.08 -178.15 5.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.181 0.515 . . . . 0.0 111.365 -179.552 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.506 ' CD1' ' HD2' ' A' ' 75' ' ' PRO . 90.4 m95 -123.73 133.05 53.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.525 179.989 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.89 157.21 20.9 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.085 0.469 . . . . 0.0 111.356 -179.428 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.495 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER 62.63 44.22 0.6 Allowed Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.256 179.21 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 55.2 Cg_endo -69.13 137.24 36.79 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.174 1.916 . . . . 0.0 111.273 178.008 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.485 ' HG2' ' CD1' ' A' ' 97' ' ' TYR . 71.0 Cg_endo -86.43 -173.99 1.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.404 2.069 . . . . 0.0 113.772 -177.631 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.58 -175.5 3.97 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.549 178.123 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . 0.419 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 3.8 m -139.29 94.87 2.85 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.972 0.415 . . . . 0.0 110.897 179.688 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -123.26 159.17 29.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.86 -179.666 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.483 HG12 ' CE2' ' A' ' 103' ' ' TYR . 27.3 mm . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.993 179.935 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 66.0 mtm-85 . . . . . 0 C--O 1.232 0.154 0 CA-C-O 121.039 0.447 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.5 ' HB2' ' CD ' ' A' ' 10' ' ' PRO . 36.2 m -73.53 175.83 3.23 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.808 178.592 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.531 ' HD2' ' CD1' ' A' ' 59' ' ' TRP . 18.6 Cg_endo -87.2 -174.83 1.41 Allowed 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.791 2.327 . . . . 0.0 111.406 178.882 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.9 t -58.18 106.53 0.71 Allowed Pre-proline 0 C--N 1.325 -0.479 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.402 179.242 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.433 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 1.8 Cg_endo -49.91 148.11 13.41 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.09 1.86 . . . . 0.0 111.849 -179.203 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.433 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -58.16 159.47 5.87 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.126 178.981 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -108.33 -178.96 3.75 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.149 0.5 . . . . 0.0 112.021 -176.29 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.5 tt -138.85 144.23 30.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.71 179.585 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.02 -68.95 0.58 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.557 -178.483 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.411 ' HA ' ' ND2' ' A' ' 36' ' ' ASN . 66.5 m-80 -90.02 43.4 1.14 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.222 -179.134 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.418 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -160.5 -174.81 30.78 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.093 179.981 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -143.53 128.62 18.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.742 0.306 . . . . 0.0 110.624 -179.598 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.53 ' CD2' ' CE2' ' A' ' 33' ' ' TYR . 13.8 mt -73.11 157.88 36.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.072 0.463 . . . . 0.0 111.497 -179.571 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.98 75.37 1.65 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.643 177.657 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.447 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 68.0 mt -69.25 106.32 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.65 -177.643 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -115.87 21.05 12.69 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.66 177.557 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 158.31 119.91 0.58 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.136 -179.512 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.84 28.92 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.774 0.321 . . . . 0.0 111.295 -179.596 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -104.89 147.85 27.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.852 179.86 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 51' ' ' LEU . 8.4 t80 -47.34 96.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.088 -179.693 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 122.33 16.68 3.8 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.83 -179.951 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.16 -161.0 0.75 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.696 0.284 . . . . 0.0 110.749 179.632 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.4 p -167.68 148.82 5.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.986 0.422 . . . . 0.0 111.318 179.42 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.532 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 1.0 OUTLIER -106.94 173.33 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.591 -179.977 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.445 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -130.92 116.35 17.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.99 0.424 . . . . 0.0 111.384 179.375 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.53 ' CE2' ' CD2' ' A' ' 20' ' ' LEU . 18.7 m-85 -92.29 138.83 31.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.968 179.758 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.418 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 85.3 p -144.01 166.41 25.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.981 -179.74 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.416 ' HB2' ' HB2' ' A' ' 39' ' ' TYR . 3.9 m -90.2 165.72 13.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.728 179.915 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.411 ' ND2' ' HA ' ' A' ' 17' ' ' ASN . 34.6 m-80 -64.28 -83.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.851 0.358 . . . . 0.0 111.015 -179.612 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.18 136.81 15.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.624 179.906 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 60.77 26.92 65.75 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.862 -178.913 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.486 ' CD2' ' HA ' ' A' ' 68' ' ' SER . 2.3 m-85 -119.26 171.41 8.32 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.725 0.298 . . . . 0.0 110.811 -179.328 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.504 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.5 OUTLIER -132.3 120.37 22.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.955 0.407 . . . . 0.0 110.516 177.865 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.436 ' CD1' ' HG3' ' A' ' 64' ' ' PRO . 6.7 tt -83.46 124.07 30.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.765 -179.294 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.504 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 1.9 mm -103.8 167.79 2.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.984 -179.625 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.59 -134.37 19.06 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.097 -179.16 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.431 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 1.2 pt-20 -80.71 -175.69 5.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.868 0.366 . . . . 0.0 110.688 178.978 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.9 p -160.19 22.31 0.16 Allowed 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.423 -179.258 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.445 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -163.2 124.29 2.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.85 0.357 . . . . 0.0 111.691 -177.984 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 30' ' ' SER . 1.4 t -91.89 138.77 31.28 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 177.233 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.493 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 1.7 m-85 -113.38 121.53 44.61 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 119.146 -1.022 . . . . 0.0 112.17 -179.473 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 33.9 t -73.28 102.78 3.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.576 179.174 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.01 -172.33 2.43 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.311 -179.543 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.387 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.03 -179.353 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.966 0.412 . . . . 0.0 110.628 . . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.2 m -156.46 163.48 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.879 179.692 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.532 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 78.4 m95 -124.75 120.42 31.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.937 0.399 . . . . 0.0 111.528 -179.325 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.493 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -69.9 165.9 37.84 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.14 178.155 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.442 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 89.3 Cg_exo -19.35 98.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 125.216 3.944 . . . . 0.0 114.164 -179.004 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.474 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -100.48 -78.76 0.51 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.344 -177.096 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.497 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -76.55 108.3 6.16 Favored Pre-proline 0 N--CA 1.463 0.19 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -175.032 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.436 ' HG3' ' CD1' ' A' ' 41' ' ' LEU . 1.0 OUTLIER -88.22 -153.99 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.388 2.725 . . . . 0.0 110.993 176.814 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.42 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 3.0 mm -98.76 169.57 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.875 0.369 . . . . 0.0 110.76 178.629 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.1 m -160.51 145.77 14.7 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 179.556 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.471 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.3 OUTLIER -164.56 172.38 13.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.039 -179.951 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.486 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 12.1 p -90.22 112.61 24.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.086 0.469 . . . . 0.0 111.078 179.967 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.449 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 0.4 OUTLIER -47.79 99.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.344 179.863 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.88 116.13 21.39 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.075 179.923 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.407 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -97.68 129.75 44.72 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.308 179.283 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.85 -156.33 0.12 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.362 179.306 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.421 ' OG ' ' NE2' ' A' ' 82' ' ' HIS . 2.1 t -49.26 137.58 15.14 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.854 179.933 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.479 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 27.4 Cg_exo -59.9 163.79 13.15 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.405 2.07 . . . . 0.0 112.062 -179.989 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.492 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 86.1 Cg_exo -39.38 156.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.812 2.341 . . . . 0.0 112.894 -179.605 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.6 t -108.8 90.49 3.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.551 179.449 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 35.7 pt -69.43 175.22 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.326 -179.182 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.36 138.18 39.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.622 179.309 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.478 ' HB3' ' CD2' ' A' ' 103' ' ' TYR . 0.3 OUTLIER 68.65 28.07 5.8 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.676 -179.958 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.438 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . -170.21 -159.99 17.47 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.76 179.694 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.4 ptt85 -170.13 -176.2 2.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.091 0.472 . . . . 0.0 111.022 -179.226 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.446 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 21.4 p-80 -110.25 170.9 7.78 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.918 179.795 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.775 179.88 . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.42 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 5.3 m-85 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.889 0.376 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.42 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 66.4 m-85 -152.77 161.6 42.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.928 -179.689 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.1 p -128.36 -175.92 3.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.214 -179.252 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -64.85 94.83 0.14 Allowed 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.271 0.558 . . . . 0.0 110.988 -179.843 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.55 18.72 2.18 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.317 178.656 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -95.34 162.86 13.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.934 0.367 . . . . 0.0 110.573 179.246 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.6 m -138.27 149.64 24.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.13 0.49 . . . . 0.0 111.335 -179.608 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.505 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 23.6 t -146.09 148.68 16.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.743 179.526 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.43 ' CG2' ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -106.97 130.89 54.55 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.987 -179.973 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.527 ' CE1' ' CG2' ' A' ' 111' ' ' VAL . 4.9 m-85 -89.88 160.74 16.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.985 -179.67 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.3 p -157.37 138.86 13.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.557 -179.941 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.438 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 68.5 m -70.27 164.5 24.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.815 179.4 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -101.68 -85.24 0.43 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.84 0.352 . . . . 0.0 111.207 179.636 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -45.01 -31.36 1.28 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.522 -179.198 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 130.29 45.12 0.17 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.681 179.777 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.496 ' CE1' HG12 ' A' ' 126' ' ' ILE . 29.7 m-85 -87.04 -173.54 4.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.833 0.349 . . . . 0.0 110.836 179.972 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 41.2 m -111.49 108.17 17.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.108 -179.519 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.428 HD23 ' CG ' ' A' ' 122' ' ' PRO . 2.9 tp -44.94 113.16 0.52 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.146 178.935 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.446 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 40.0 mm -85.93 156.33 3.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.465 179.79 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.411 ' N ' HG21 ' A' ' 106' ' ' ILE . . . 60.44 -125.62 39.09 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.558 -178.333 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -124.2 135.37 53.4 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.849 0.357 . . . . 0.0 110.584 178.55 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.456 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 1.2 p -65.94 -29.8 70.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.701 -180.0 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -71.91 137.08 24.97 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.578 179.892 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.527 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 2.7 t -131.08 119.16 43.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.757 0.313 . . . . 0.0 110.837 179.712 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.03 119.57 23.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.522 -179.006 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.51 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 31.7 t -85.57 101.88 13.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.623 176.996 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.9 t -139.31 153.85 47.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.193 0.52 . . . . 0.0 111.568 -178.143 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.15 33.94 7.71 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.911 179.482 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.449 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 69.94 11.07 65.97 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.746 -179.999 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -131.15 175.15 9.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.899 0.381 . . . . 0.0 110.391 179.225 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.51 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 93.3 m95 -117.12 128.62 55.32 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.787 -179.43 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.38 146.63 35.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.4 -178.852 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.486 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.5 t0 71.53 46.46 0.24 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.207 178.646 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 74.0 Cg_endo -75.32 130.66 13.15 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.319 2.013 . . . . 0.0 111.324 177.934 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.456 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 58.0 Cg_endo -86.15 -174.7 1.58 Allowed 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.448 2.099 . . . . 0.0 113.387 -178.229 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.443 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.3 OUTLIER -135.81 -173.62 3.42 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.071 178.392 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . 0.432 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 16.5 m -141.61 94.62 2.71 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.94 0.4 . . . . 0.0 111.108 -179.5 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -118.83 169.42 9.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.713 179.921 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.496 HG12 ' CE1' ' A' ' 103' ' ' TYR . 19.5 mm . . . . . 0 C--N 1.325 -0.491 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.806 -179.796 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.3 mtm180 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.812 0.339 . . . . 0.0 110.798 . . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.451 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 69.4 m -77.67 159.24 77.19 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.577 179.606 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' A' ' 9' ' ' CYS . 51.1 Cg_endo -68.85 169.98 16.49 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.345 2.03 . . . . 0.0 111.964 -179.718 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.17 105.91 0.58 Allowed Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.777 -179.745 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.497 ' HG2' ' CZ2' ' A' ' 59' ' ' TRP . 53.0 Cg_exo -53.67 160.16 5.8 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.278 1.985 . . . . 0.0 112.517 -179.759 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.439 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -52.86 -174.58 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.156 177.811 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.451 ' O ' HG21 ' A' ' 15' ' ' ILE . 11.8 p-10 -135.66 -40.88 0.7 Allowed 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -176.314 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.451 HG21 ' O ' ' A' ' 14' ' ' ASP . 5.1 tt 66.08 139.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.777 -177.084 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -94.47 -40.03 10.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.855 -177.736 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -93.83 24.71 4.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.8 0.333 . . . . 0.0 111.116 -179.016 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.421 ' CA ' HG23 ' A' ' 15' ' ' ILE . . . -164.08 176.29 40.08 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.544 179.838 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -129.49 129.7 44.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.702 0.287 . . . . 0.0 110.564 179.718 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.513 ' CG ' ' CE1' ' A' ' 33' ' ' TYR . 49.1 mt -82.63 162.51 21.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.151 0.5 . . . . 0.0 111.632 -179.14 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -130.71 80.59 1.95 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.166 179.259 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.424 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 56.3 mt -71.33 103.33 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.441 -178.583 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.31 15.22 50.7 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.303 178.451 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 157.11 127.86 1.01 Allowed Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.772 -179.538 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.1 m -115.32 26.22 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -178.213 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -101.18 162.09 13.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.986 0.422 . . . . 0.0 110.996 179.08 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -57.18 92.01 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.986 -179.31 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 132.51 -11.87 5.21 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.884 179.87 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.3 m -75.37 -175.74 2.87 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.819 0.309 . . . . 0.0 110.805 179.87 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 47' ' ' SER . 0.3 OUTLIER -154.07 143.45 21.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.493 -179.717 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.54 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.5 OUTLIER -104.51 171.25 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.938 179.222 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.426 ' O ' ' N ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -132.25 120.19 21.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.891 178.933 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.534 ' CE1' ' CB ' ' A' ' 63' ' ' ALA . 28.5 m-85 -99.65 135.22 41.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.197 -179.624 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 64.3 m -143.33 159.38 42.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.765 179.628 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.401 ' HB2' ' HB2' ' A' ' 39' ' ' TYR . 57.0 m -83.87 166.02 18.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.002 -179.947 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.85 -83.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.082 -179.705 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 t -155.44 136.48 13.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.787 -179.895 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.01 23.25 65.7 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.124 -179.294 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.484 ' CE1' ' HB2' ' A' ' 68' ' ' SER . 2.3 m-85 -113.63 -179.02 3.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.918 0.389 . . . . 0.0 110.98 -179.386 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.466 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.3 OUTLIER -143.98 114.56 7.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.393 178.095 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.425 ' CD2' ' O ' ' A' ' 44' ' ' GLU . 2.3 tt -75.25 136.47 40.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.675 -179.105 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.466 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 3.1 mm -108.39 153.94 9.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.199 -179.01 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.64 -135.95 19.1 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.554 -179.948 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.425 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 4.3 pm0 -75.47 -179.14 4.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.624 0.25 . . . . 0.0 110.691 179.733 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.1 p -152.23 21.04 0.65 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.181 -179.784 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.415 ' CE ' ' O ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -151.91 163.06 40.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.896 -178.882 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.444 ' O ' HG12 ' A' ' 31' ' ' ILE . 2.8 m -137.44 112.05 8.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.643 179.99 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.419 ' CD1' ' N ' ' A' ' 48' ' ' TYR . 2.0 m-30 -90.01 121.2 31.87 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.897 0.38 . . . . 0.0 111.334 -179.258 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.489 ' HB3' ' CH2' ' A' ' 59' ' ' TRP . 35.1 t -71.56 97.49 1.7 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.55 179.396 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -124.58 -176.49 3.54 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.128 -179.514 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.01 -179.314 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 4.0 mmt . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.679 0.276 . . . . 0.0 110.443 . . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.0 m -149.7 -178.13 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.87 0.367 . . . . 0.0 111.275 -179.296 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.54 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 95.2 m95 -128.77 123.86 34.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.774 -179.733 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -148.45 119.71 4.34 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.769 -179.459 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -67.72 -176.28 9.64 Favored 'Cis proline' 0 C--N 1.351 0.7 0 C-N-CA 124.135 -1.194 . . . . 0.0 112.718 1.787 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.435 ' O ' ' CD ' ' A' ' 64' ' ' PRO . 0.6 OUTLIER -111.6 -140.77 0.38 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.102 -178.654 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.534 ' CB ' ' CE1' ' A' ' 33' ' ' TYR . . . -95.6 86.17 0.32 Allowed Pre-proline 0 N--CA 1.448 -0.567 0 C-N-CA 122.878 0.471 . . . . 0.0 110.759 179.464 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 63' ' ' ALA . 9.8 Cg_endo -45.68 -159.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.476 0.451 0 C-N-CA 124.313 3.342 . . . . 0.0 114.53 178.703 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.5 mm -97.59 165.76 2.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.854 -178.267 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.2 m -164.83 117.35 1.24 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.342 179.017 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.19 177.68 7.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.893 0.377 . . . . 0.0 111.353 -179.417 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.484 ' HB2' ' CE1' ' A' ' 39' ' ' TYR . 49.7 p -88.71 99.35 12.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.22 -179.965 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.439 ' CG2' ' HA3' ' A' ' 116' ' ' GLY . 6.8 p -60.99 103.89 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.302 178.489 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.428 ' HG2' ' CG2' ' A' ' 90' ' ' THR . 2.7 mttp -82.21 167.44 18.66 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -176.297 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.421 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -125.96 122.69 36.67 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.525 177.3 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.444 ' CG ' ' N ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -69.43 -155.48 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.988 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.444 ' N ' ' CG ' ' A' ' 72' ' ' GLN . 1.4 t -52.8 144.52 25.6 Favored Pre-proline 0 N--CA 1.448 -0.556 0 C-N-CA 121.081 -0.248 . . . . 0.0 110.373 179.091 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.473 ' HD2' ' CD2' ' A' ' 82' ' ' HIS . 39.0 Cg_exo -60.78 160.36 25.31 Favored 'Trans proline' 0 C--O 1.231 0.129 0 C-N-CA 122.561 2.174 . . . . 0.0 112.159 -179.327 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -42.39 155.89 0.1 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.568 2.179 . . . . 0.0 112.41 -179.315 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.3 t -103.94 86.39 2.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.828 -179.793 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.43 ' CD1' ' HA3' ' A' ' 80' ' ' GLY . 8.2 pt -69.85 169.98 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.953 -179.959 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.5 m -91.59 137.91 31.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.81 179.651 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.482 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 4.8 m-80 57.62 29.84 17.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.725 -179.901 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.43 ' HA3' ' CD1' ' A' ' 77' ' ' ILE . . . -165.5 169.36 39.91 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.531 -0.843 . . . . 0.0 112.807 179.685 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' A' ' 80' ' ' GLY . 19.8 mtt180 -147.19 -166.38 2.5 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.483 0.659 . . . . 0.0 111.622 -178.082 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 1.9 p-80 -130.6 157.24 43.25 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.442 179.911 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.429 ' OD1' ' N ' ' A' ' 96' ' ' THR . 1.8 p30 . . . . . 0 CA--C 1.511 -0.524 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.109 177.867 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.403 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 4.2 m-85 . . . . . 0 N--CA 1.455 -0.204 0 CA-C-O 120.725 0.297 . . . . 0.0 110.535 . . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.421 ' N ' ' O ' ' A' ' 71' ' ' CYS . 26.2 m-85 -140.22 158.45 44.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.034 -179.746 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.428 ' CG2' ' HG2' ' A' ' 70' ' ' LYS . 5.5 p -122.71 176.34 6.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.572 -178.32 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -60.85 93.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.76 179.495 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 125.56 19.1 2.35 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.126 179.134 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -98.82 158.85 15.36 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.868 0.334 . . . . 0.0 110.33 178.865 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 27.8 m -145.57 142.27 22.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.421 0.629 . . . . 0.0 111.972 -179.491 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.545 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 40.7 t -144.46 148.12 18.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.488 178.167 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.429 ' N ' ' OD1' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -95.68 159.92 14.75 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.083 0.468 . . . . 0.0 111.796 -177.5 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.518 ' CE1' ' CG2' ' A' ' 111' ' ' VAL . 4.9 m-85 -110.7 155.66 22.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.997 179.223 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.1 p -150.25 140.18 21.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.339 -178.958 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.402 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 83.9 m -75.24 146.92 40.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.222 -179.951 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -78.78 -83.2 0.09 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.622 -179.057 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.2 t -52.47 -22.96 5.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.538 -178.647 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 123.1 30.55 1.09 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.808 179.971 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.497 ' CE2' HG12 ' A' ' 126' ' ' ILE . 48.9 m-85 -69.32 -172.19 0.42 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.724 0.297 . . . . 0.0 110.51 179.413 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.2 m -110.45 107.32 16.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.999 0.428 . . . . 0.0 111.302 -179.257 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.456 HD23 ' CB ' ' A' ' 109' ' ' SER . 1.9 tp -45.52 112.96 0.52 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.944 178.734 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.453 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 20.1 mm -90.6 160.85 2.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.051 -178.874 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.423 ' N ' HG21 ' A' ' 106' ' ' ILE . . . 56.5 -129.29 48.25 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.148 -179.641 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -110.4 125.0 52.77 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.8 0.333 . . . . 0.0 110.932 179.873 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.457 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 0.1 OUTLIER -67.67 -34.57 77.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.203 178.661 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -79.08 130.83 10.17 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.982 178.479 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.518 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 3.2 t -117.63 141.33 36.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 179.786 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.07 122.73 44.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.99 0.424 . . . . 0.0 111.712 -178.469 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.413 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 10.9 t -85.88 105.99 16.77 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.055 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.34 154.6 42.49 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.183 0.516 . . . . 0.0 111.349 -178.422 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 54.36 22.09 21.89 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.73 179.548 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.439 ' HA3' ' CG2' ' A' ' 69' ' ' VAL . . . 87.55 -6.44 83.4 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.533 -0.842 . . . . 0.0 113.005 179.996 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -128.66 -176.81 3.95 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.09 0.472 . . . . 0.0 110.932 -179.698 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.545 ' CH2' ' CG2' ' A' ' 95' ' ' VAL . 95.3 m95 -108.92 157.62 18.46 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.831 -179.71 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.47 149.11 42.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.061 0.458 . . . . 0.0 111.324 -179.369 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.471 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.7 OUTLIER 68.21 47.67 0.39 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.786 178.69 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 74.0 Cg_endo -75.31 137.68 21.34 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.314 2.009 . . . . 0.0 111.534 178.422 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.457 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 59.5 Cg_endo -89.29 -174.13 0.89 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.543 2.162 . . . . 0.0 113.561 -178.212 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.433 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -133.6 -174.06 3.41 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.913 177.997 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 8.3 m -143.3 96.5 2.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.143 0.497 . . . . 0.0 111.146 -179.811 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -121.62 157.72 30.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.775 -179.998 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.497 HG12 ' CE2' ' A' ' 103' ' ' TYR . 37.3 mm . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.93 179.918 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.418 ' CB ' ' O ' ' A' ' 25' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 121.004 0.43 . . . . 0.0 111.085 . . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.449 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 55.6 m -93.01 160.17 34.21 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.202 -179.126 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.04 176.56 7.56 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.714 2.276 . . . . 0.0 112.531 -179.338 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -50.14 106.58 0.65 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.701 179.662 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.493 ' HG2' ' CZ2' ' A' ' 59' ' ' TRP . 76.2 Cg_exo -48.68 144.22 14.97 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.466 2.111 . . . . 0.0 112.676 -179.323 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.427 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -54.94 164.74 0.75 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.882 178.651 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.6 -174.17 2.52 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.322 0.582 . . . . 0.0 112.025 -177.785 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.7 tt -142.06 145.07 24.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.263 -179.768 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -74.9 -66.84 0.7 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -177.106 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -91.74 26.62 2.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.336 -177.998 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.421 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -142.47 -175.5 15.78 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.241 -0.981 . . . . 0.0 113.279 -179.399 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -140.45 137.54 34.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.691 0.282 . . . . 0.0 110.357 179.294 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.473 HD23 ' CE1' ' A' ' 33' ' ' TYR . 3.7 mt -80.45 163.85 23.48 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.154 0.502 . . . . 0.0 111.794 -179.009 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.69 71.06 1.42 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.536 177.283 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.431 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 62.2 mt -69.9 103.56 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.84 -177.758 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.18 18.21 42.78 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.985 177.843 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 156.02 131.74 1.44 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 121.14 -0.552 . . . . 0.0 111.936 -179.586 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.418 ' O ' ' CB ' ' A' ' 8' ' ' ARG . 32.3 m -116.43 25.97 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.686 0.279 . . . . 0.0 111.683 -178.822 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.2 152.23 19.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.042 179.792 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.405 ' CZ ' ' HB2' ' A' ' 51' ' ' LEU . 2.2 t80 -55.51 91.31 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.979 0.419 . . . . 0.0 110.441 179.327 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 131.92 -10.09 5.43 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.515 -178.825 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 92.2 p -75.11 -167.73 0.66 Allowed 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 179.326 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.1 p -157.7 152.05 24.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.073 0.463 . . . . 0.0 111.668 179.857 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.517 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -113.84 169.36 5.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.327 179.332 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.31 112.81 11.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.9 0.381 . . . . 0.0 111.062 178.621 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.478 ' CE1' ' HA ' ' A' ' 63' ' ' ALA . 17.0 m-85 -85.3 138.53 32.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.946 179.955 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.421 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.2 OUTLIER -138.35 168.75 19.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.668 -179.982 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.423 ' HB2' ' HB2' ' A' ' 39' ' ' TYR . 3.8 m -91.65 160.81 15.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.733 179.872 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -60.96 -79.68 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.184 -179.303 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.03 133.65 10.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.724 -179.786 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 60.72 25.39 63.52 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.79 -178.907 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.487 ' CD2' ' HA ' ' A' ' 68' ' ' SER . 2.3 m-85 -116.53 171.37 7.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.709 0.29 . . . . 0.0 110.78 -179.354 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.478 ' CE1' HD13 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -130.66 131.62 44.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.019 0.438 . . . . 0.0 110.718 178.764 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.434 ' CD2' ' HB2' ' A' ' 64' ' ' PRO . 3.3 tt -87.7 131.01 34.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.816 -179.054 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.478 HD13 ' CE1' ' A' ' 40' ' ' HIS . 2.1 mm -105.45 154.23 6.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.982 0.42 . . . . 0.0 111.143 -179.365 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.09 -136.35 23.85 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.61 -178.469 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.421 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 0.8 OUTLIER -81.45 -178.12 6.8 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.33 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.409 ' HA ' ' HG3' ' A' ' 64' ' ' PRO . 6.4 p -155.17 23.6 0.42 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.104 -179.313 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt -147.48 141.57 26.04 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.199 -178.642 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.429 ' CB ' HD13 ' A' ' 31' ' ' ILE . 2.5 m -113.01 147.16 37.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.105 178.924 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.427 ' CD1' ' HD2' ' A' ' 61' ' ' PRO . 1.7 m-85 -119.16 121.78 40.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.014 0.435 . . . . 0.0 111.424 -179.597 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.503 ' HB3' ' CH2' ' A' ' 59' ' ' TRP . 18.8 t -70.26 77.09 0.53 Allowed 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.03 178.474 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -102.64 179.63 4.24 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.371 -178.491 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.405 ' HB2' ' CZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.212 -178.821 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.522 -0.113 0 CA-C-O 120.914 0.387 . . . . 0.0 110.457 . . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.6 m -139.8 165.76 21.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.216 -179.199 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.517 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 92.2 m95 -102.24 127.62 49.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.17 178.629 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -159.67 127.59 2.81 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.745 -176.873 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.427 ' HD2' ' CD1' ' A' ' 48' ' ' TYR . 21.4 Cg_exo -68.77 -174.38 8.51 Favored 'Cis proline' 0 C--N 1.351 0.677 0 C-N-CA 124.236 -1.152 . . . . 0.0 112.697 1.364 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -110.7 -152.15 0.49 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.128 -178.38 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.478 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -75.27 110.96 11.66 Favored Pre-proline 0 CA--C 1.53 0.181 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.176 -179.717 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.434 ' HB2' ' CD2' ' A' ' 41' ' ' LEU . 23.6 Cg_exo -66.42 -145.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.832 2.355 . . . . 0.0 112.174 -179.871 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.423 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 3.4 mm -106.39 165.59 4.01 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 120.762 0.315 . . . . 0.0 111.312 -178.73 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -164.18 124.46 2.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.92 179.632 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.478 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 3.8 tt0 -143.73 -179.64 6.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.938 179.96 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.487 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 1.3 p -86.43 119.44 26.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.021 0.439 . . . . 0.0 111.125 -179.894 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.435 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 3.8 p -49.3 96.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.278 179.778 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -71.31 139.87 50.08 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.863 179.752 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.2 128.11 55.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.922 0.391 . . . . 0.0 110.781 179.58 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.412 ' O ' ' NE1' ' A' ' 118' ' ' TRP . 0.0 OUTLIER -67.42 -175.54 0.5 Allowed 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 121.912 0.863 . . . . 0.0 113.176 -177.677 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.465 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 0.3 OUTLIER -51.82 119.09 12.99 Favored Pre-proline 0 N--CA 1.439 -0.98 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.484 176.388 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.492 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 51.4 Cg_exo -41.71 155.04 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.063 1.842 . . . . 0.0 112.416 -176.564 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -45.31 157.08 0.28 Allowed 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.88 2.387 . . . . 0.0 112.854 -179.015 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.31 90.79 3.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.845 -179.933 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.411 ' CG2' ' O ' ' A' ' 122' ' ' PRO . 18.4 pt -69.5 171.72 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.361 -179.484 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.7 p -88.12 136.66 32.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.707 179.242 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.476 ' HB3' ' CD2' ' A' ' 103' ' ' TYR . 0.1 OUTLIER 66.34 26.53 10.24 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.52 -179.576 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.426 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . 178.03 -178.66 48.53 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.625 179.978 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.406 ' NE ' ' OD1' ' A' ' 100' ' ' ASN . 0.1 OUTLIER -170.25 -175.84 2.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.784 0.326 . . . . 0.0 110.605 -179.714 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.481 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 42.6 p-80 -95.35 168.91 10.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.038 179.831 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.706 179.392 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.431 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 6.4 m-85 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.767 0.318 . . . . 0.0 110.841 . . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.431 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 39.0 m-85 -145.52 165.01 29.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.972 -179.429 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.8 p -130.32 163.02 27.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.998 0.428 . . . . 0.0 111.47 -178.901 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -50.22 95.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.009 -179.91 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.69 26.53 1.14 Allowed Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.32 -0.855 . . . . 0.0 113.114 178.809 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.403 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -110.28 161.93 15.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.837 0.319 . . . . 0.0 110.6 179.065 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.405 ' CG2' ' N ' ' A' ' 95' ' ' VAL . 34.1 m -135.2 157.83 40.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.061 0.457 . . . . 0.0 111.058 -179.996 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.475 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 25.4 t -148.99 148.24 15.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.299 179.52 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.62 120.93 44.02 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.349 0.595 . . . . 0.0 111.126 -179.372 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.531 ' CE2' ' CG2' ' A' ' 111' ' ' VAL . 4.4 m-85 -77.26 158.12 30.42 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.69 -178.671 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.0 p -154.37 139.11 17.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.551 -179.929 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.426 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 6.9 m -69.85 164.02 24.61 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.51 179.971 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.406 ' OD1' ' NE ' ' A' ' 81' ' ' ARG . 28.9 m-20 -95.12 -69.93 0.73 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.314 -179.543 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.6 t -68.74 -34.45 75.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.345 -178.928 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 137.14 41.77 0.1 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.574 -179.925 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.518 ' CD1' ' CD1' ' A' ' 126' ' ' ILE . 15.4 m-85 -80.8 -168.14 1.66 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 179.479 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.8 m -117.15 105.42 12.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.804 0.335 . . . . 0.0 111.538 -179.642 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.446 ' CD2' ' HB2' ' A' ' 122' ' ' PRO . 1.6 tp -48.97 121.84 5.17 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.107 0.48 . . . . 0.0 110.615 178.509 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.44 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 33.7 mm -103.12 159.31 4.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.566 -177.298 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 52.37 30.32 32.74 Favored Glycine 0 CA--C 1.509 -0.343 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.546 179.468 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.401 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.6 OUTLIER 59.65 127.9 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.984 -0.608 . . . . 0.0 111.394 179.679 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.439 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 1.2 p -58.56 -29.21 66.2 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.97 -178.332 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -52.69 131.39 39.79 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.706 -0.759 . . . . 0.0 113.154 -178.651 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.531 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 2.3 t -130.72 144.28 38.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.39 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.1 tt -104.93 125.24 50.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.963 0.411 . . . . 0.0 112.076 -177.803 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.429 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 11.2 t -88.59 95.47 10.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.436 176.547 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 p -139.06 163.64 31.88 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.208 -178.45 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.2 26.18 2.15 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.773 179.802 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.435 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 76.11 1.51 69.01 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.955 -179.633 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -131.64 179.71 5.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.808 0.337 . . . . 0.0 110.61 179.525 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.492 ' CH2' ' HG3' ' A' ' 74' ' ' PRO . 93.5 m95 -107.79 125.65 51.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 -179.898 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.56 145.07 36.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.145 -179.474 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.486 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 2.0 t70 66.89 44.5 0.35 Allowed Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.256 178.71 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 52.9 Cg_endo -67.44 149.83 80.42 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 121.893 1.728 . . . . 0.0 110.354 176.912 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.446 ' HB2' ' CD2' ' A' ' 105' ' ' LEU . 42.0 Cg_endo -95.71 -178.19 0.45 Allowed 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 122.129 1.886 . . . . 0.0 114.039 -176.925 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.412 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -124.34 -159.81 0.89 Allowed 'General case' 0 CA--C 1.502 -0.867 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.009 176.796 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . 0.404 ' SG ' ' CB ' ' A' ' 103' ' ' TYR . 3.8 t -170.34 93.8 0.22 Allowed 'General case' 0 N--CA 1.433 -1.288 0 CA-C-O 121.772 0.796 . . . . 0.0 110.87 -175.906 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -106.88 -169.33 1.53 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.303 -1.317 . . . . 0.0 112.096 -176.891 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.518 ' CD1' ' CD1' ' A' ' 103' ' ' TYR . 19.1 mm . . . . . 0 C--N 1.313 -1.012 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.11 179.51 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.403 ' HA ' ' HA ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.982 0.42 . . . . 0.0 110.833 . . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.449 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 60.3 m -90.24 161.25 38.01 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.681 179.85 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.415 ' HD3' ' HB2' ' A' ' 9' ' ' CYS . 37.2 Cg_endo -67.34 176.52 4.71 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.549 2.166 . . . . 0.0 112.393 -179.345 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.3 t -51.78 109.39 1.38 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.06 -179.368 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -52.33 152.97 14.21 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.16 1.907 . . . . 0.0 111.894 179.757 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.442 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 14.6 mtt180 -66.4 160.2 25.31 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.191 179.24 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -110.86 -178.69 3.54 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-O 121.223 0.535 . . . . 0.0 112.17 -176.129 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.442 HG22 ' CD2' ' A' ' 20' ' ' LEU . 6.0 tt -142.14 145.32 24.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.539 179.673 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -80.36 -65.0 1.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.829 -178.026 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.425 ' ND2' ' N ' ' A' ' 17' ' ' ASN . 0.5 OUTLIER -93.47 36.46 1.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.878 0.371 . . . . 0.0 110.961 -178.909 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.426 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -150.06 176.95 28.48 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.813 179.69 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -136.55 123.66 21.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.779 0.323 . . . . 0.0 110.75 179.595 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.517 ' CD2' ' CE1' ' A' ' 33' ' ' TYR . 14.6 mt -74.41 159.03 32.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.164 0.506 . . . . 0.0 111.92 -179.124 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.431 ' HB2' ' CB ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -130.52 74.3 1.59 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.914 177.608 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.426 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 62.6 mt -69.78 93.2 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.735 -178.174 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.73 20.9 47.61 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.932 178.078 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 151.89 133.32 1.96 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.942 -179.455 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.9 m -118.37 8.95 6.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.134 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.409 ' N ' ' OG ' ' A' ' 29' ' ' SER . 16.0 t70 -74.46 163.45 27.75 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.011 0.434 . . . . 0.0 110.825 179.481 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.475 ' CE1' ' HB2' ' A' ' 51' ' ' LEU . 7.9 t80 -59.79 93.6 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.535 179.987 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.17 -7.73 7.15 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.494 -178.804 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.409 ' OG ' ' N ' ' A' ' 26' ' ' ASP . 1.3 m -71.67 174.32 6.92 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.841 0.32 . . . . 0.0 110.626 179.589 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -143.83 145.3 32.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.018 -179.973 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.444 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -107.34 164.22 4.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.629 179.996 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.431 ' CB ' ' HB2' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -126.48 113.61 17.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.845 179.467 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.517 ' CE1' ' CD2' ' A' ' 20' ' ' LEU . 21.5 m-85 -91.4 138.56 31.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.556 -179.421 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.426 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.4 OUTLIER -139.87 173.81 11.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.512 179.313 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.2 m -92.83 169.92 10.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.347 . . . . 0.0 111.027 -179.915 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.97 -85.45 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.333 -178.844 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.73 116.6 2.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.289 179.917 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.16 -8.08 68.79 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.129 -177.282 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.491 ' CZ ' ' HB2' ' A' ' 68' ' ' SER . 4.0 m-85 -82.25 176.27 9.6 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 120.912 0.387 . . . . 0.0 110.84 179.678 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.534 ' CE1' ' CG2' ' A' ' 69' ' ' VAL . 0.0 OUTLIER -129.54 129.46 44.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.122 175.983 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.438 ' CD1' ' HG3' ' A' ' 64' ' ' PRO . 9.2 tt -93.92 112.1 23.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.523 -179.624 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.407 ' HB ' ' HB ' ' A' ' 65' ' ' ILE . 1.2 mm -85.77 149.27 4.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.085 0.469 . . . . 0.0 110.955 -179.009 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.36 -149.77 30.98 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.121 -178.892 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -77.78 176.89 8.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.043 0.449 . . . . 0.0 110.856 179.297 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.5 p -147.05 28.14 1.03 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.014 -179.306 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.55 138.32 23.4 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.971 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.461 ' HB3' ' HA ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -110.73 159.44 17.62 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.978 178.191 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.477 ' CD1' ' HB2' ' A' ' 60' ' ' ASN . 1.7 m-85 -134.27 119.22 18.47 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 119.509 -0.876 . . . . 0.0 112.38 -179.217 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 37.2 t -69.75 84.83 0.47 Allowed 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.286 178.81 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.499 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 1.9 tt0 -109.45 173.72 6.19 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.49 -179.178 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.499 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.667 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.095 -179.284 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.0 mmt . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.999 0.428 . . . . 0.0 110.576 . . . . . . . . . 0 0 . 1 . 042 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.1 m -127.05 177.18 5.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.648 -179.982 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.449 ' NE1' ' HB2' ' A' ' 9' ' ' CYS . 68.7 m95 -118.07 121.13 39.79 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.672 -178.896 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.477 ' HB2' ' CD1' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -70.39 162.98 66.68 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.005 178.011 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.451 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 80.5 Cg_exo -16.64 97.64 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.83 1 C-N-CA 125.534 4.156 . . . . 0.0 114.76 -177.773 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.496 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 6.1 mt-10 -98.49 -81.71 0.44 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.313 -178.309 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.41 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -75.49 108.34 5.59 Favored Pre-proline 0 CA--C 1.529 0.151 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -176.419 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.486 ' HD2' ' CD1' ' A' ' 33' ' ' TYR . 1.3 Cg_endo -85.5 -154.84 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.222 2.615 . . . . 0.0 110.855 177.071 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.407 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 2.0 mm -97.66 161.17 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.057 0.456 . . . . 0.0 110.756 178.606 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -154.09 138.45 16.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.888 179.988 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.478 ' O ' ' CD2' ' A' ' 39' ' ' TYR . 0.6 OUTLIER -144.54 167.9 21.41 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.354 179.639 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.491 ' HB2' ' CZ ' ' A' ' 39' ' ' TYR . 1.2 p -108.4 118.56 37.09 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.12 0.486 . . . . 0.0 111.511 -179.396 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.534 ' CG2' ' CE1' ' A' ' 40' ' ' HIS . 2.6 p -46.95 97.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.309 179.364 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.408 ' HG2' ' CG2' ' A' ' 90' ' ' THR . 0.3 OUTLIER -78.89 131.06 36.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.546 -179.221 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -113.96 117.86 32.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.957 178.527 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -163.75 0.09 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.127 0.489 . . . . 0.0 110.978 -179.493 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -41.09 132.92 1.91 Allowed Pre-proline 0 N--CA 1.436 -1.142 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.926 179.111 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.487 ' HG3' ' CZ2' ' A' ' 118' ' ' TRP . 26.2 Cg_exo -60.78 158.16 34.43 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.321 2.014 . . . . 0.0 112.146 -179.625 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -44.95 156.93 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.905 2.403 . . . . 0.0 113.291 -178.923 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.0 t -104.99 93.41 4.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.464 179.195 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 24.3 pt -68.88 177.16 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.576 -178.556 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.6 m -92.9 144.47 25.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.681 179.478 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.473 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 5.0 m-80 58.25 27.94 15.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.033 179.706 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.451 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -173.93 -168.14 34.49 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.962 179.69 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.11 -175.23 4.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.971 0.415 . . . . 0.0 110.415 -179.386 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.468 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 12.8 p-80 -108.47 166.0 11.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.907 179.411 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.704 179.912 . . . . . . . . 0 0 . 1 . 042 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.404 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 14.1 m-85 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.851 0.357 . . . . 0.0 111.173 . . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.404 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 69.6 m-85 -154.27 167.0 31.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.677 -179.655 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.408 ' CG2' ' HG2' ' A' ' 70' ' ' LYS . 21.4 p -151.68 -176.18 5.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.12 0.486 . . . . 0.0 111.845 -179.162 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.438 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 25.7 m-20 -50.13 94.56 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.488 -179.554 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.32 20.29 2.46 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.273 177.938 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -110.32 152.83 25.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 117.216 0.508 . . . . 0.0 110.757 179.224 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 32.9 m -138.26 156.11 29.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.081 0.467 . . . . 0.0 111.03 -179.718 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.523 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 7.4 t -146.58 145.17 19.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.597 -179.926 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.421 ' CG2' ' OG ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -104.65 125.6 50.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.134 0.492 . . . . 0.0 110.693 179.938 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.504 ' CE1' ' CG2' ' A' ' 111' ' ' VAL . 5.2 m-85 -84.27 160.88 20.66 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.498 -178.172 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.1 p -154.05 140.55 18.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.973 0.416 . . . . 0.0 111.775 -178.838 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.436 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 9.9 m -69.29 165.79 19.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.453 179.83 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.451 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 51.1 m-20 -91.03 -68.67 0.78 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.136 179.956 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.74 -38.42 62.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.293 -179.36 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 143.71 41.17 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.842 179.572 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.503 ' CE2' HG12 ' A' ' 126' ' ' ILE . 12.4 m-85 -75.36 -167.63 0.68 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 178.698 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.3 p -115.39 106.15 13.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.851 0.357 . . . . 0.0 111.369 179.635 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.431 ' CD2' ' HA ' ' A' ' 109' ' ' SER . 1.6 tp -51.54 119.76 4.47 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.431 178.469 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.448 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 26.6 mm -100.14 163.01 3.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.349 -177.709 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 50.54 27.89 13.51 Favored Glycine 0 CA--C 1.508 -0.353 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.679 179.237 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.406 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.3 OUTLIER 60.51 132.64 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.406 0.622 . . . . 0.0 111.293 179.99 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.444 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 1.3 p -57.61 -25.79 60.59 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.155 -178.441 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -58.77 132.81 52.74 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.78 -177.631 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.504 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 3.0 t -133.54 119.56 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 177.807 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.428 HD21 ' N ' ' A' ' 113' ' ' CYS . 1.2 tm? -83.18 136.54 34.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.612 0.244 . . . . 0.0 111.344 -178.709 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.522 ' HB2' ' CZ3' ' A' ' 118' ' ' TRP . 42.8 t -106.84 105.86 16.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.455 177.69 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 5.9 t -160.94 135.82 7.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.981 0.419 . . . . 0.0 111.333 179.259 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 83.32 25.27 48.43 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.07 -179.658 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.434 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 70.85 14.84 73.38 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.231 -178.867 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -142.66 -179.65 6.44 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.05 0.452 . . . . 0.0 111.162 179.958 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.523 ' CH2' ' CG2' ' A' ' 95' ' ' VAL . 94.2 m95 -120.65 123.57 43.11 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.253 -179.75 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.483 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -83.36 128.14 34.26 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.112 175.016 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.539 ' CB ' ' CA ' ' A' ' 121' ' ' PRO . 70.0 m-20 109.55 -124.65 0.0 OUTLIER Pre-proline 0 CA--C 1.476 -1.878 0 N-CA-C 100.339 -3.948 . . . . 0.0 100.339 -166.533 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.539 ' CA ' ' CB ' ' A' ' 120' ' ' ASP . 67.6 Cg_endo -60.77 178.24 6.14 Favored 'Cis proline' 0 C--N 1.315 -1.235 0 CA-C-N 125.038 2.835 . . . . 0.0 112.553 -21.243 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.448 ' CB ' ' O ' ' A' ' 106' ' ' ILE . 43.4 Cg_endo -85.97 179.93 3.53 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.401 2.067 . . . . 0.0 113.006 179.71 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.77 -162.74 0.83 Allowed 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.168 176.157 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . 0.405 ' SG ' ' HB2' ' A' ' 103' ' ' TYR . 4.7 t -170.44 88.91 0.14 Allowed 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 120.109 -0.637 . . . . 0.0 110.828 -175.72 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -117.57 173.64 6.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.27 -177.756 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.503 HG12 ' CE2' ' A' ' 103' ' ' TYR . 47.8 mm . . . . . 0 C--N 1.322 -0.602 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.897 -179.751 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.6 mtm-85 . . . . . 0 N--CA 1.457 -0.118 0 CA-C-O 120.829 0.347 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 043 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.432 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 26.7 m -85.08 160.72 54.43 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.297 -179.165 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.42 171.98 16.59 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.675 2.25 . . . . 0.0 112.237 179.824 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.8 t -51.23 106.45 0.65 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.922 -179.962 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.488 ' HG2' ' CE2' ' A' ' 59' ' ' TRP . 76.7 Cg_exo -46.92 149.98 2.96 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.331 2.021 . . . . 0.0 112.135 179.643 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.43 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -69.85 143.69 52.78 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.215 0.531 . . . . 0.0 110.321 179.031 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.4 ' HA ' HD11 ' A' ' 20' ' ' LEU . 1.9 p-10 -93.67 -176.86 4.2 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.061 -176.541 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.402 HG23 ' CA ' ' A' ' 18' ' ' GLY . 6.5 tt -135.71 151.04 29.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.599 179.588 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -75.93 -68.83 0.54 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.808 -177.631 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.434 ' N ' ' ND2' ' A' ' 17' ' ' ASN . 0.7 OUTLIER -89.87 44.8 1.23 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.862 0.363 . . . . 0.0 110.985 -179.056 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.429 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -167.36 179.84 40.67 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.957 179.939 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.9 134.54 28.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.823 0.344 . . . . 0.0 110.934 179.645 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.493 ' CD2' ' CE1' ' A' ' 33' ' ' TYR . 18.6 mt -80.02 158.5 26.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.116 0.484 . . . . 0.0 111.924 -178.855 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.1 76.93 1.76 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.866 177.602 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.44 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 28.8 mt -70.16 112.6 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.265 -177.607 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -108.47 18.25 32.89 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.926 -0.655 . . . . 0.0 111.693 176.675 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 151.18 136.85 2.56 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 111.759 -0.537 . . . . 0.0 111.759 -179.148 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.9 m -118.06 12.21 7.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -178.915 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -69.86 157.48 37.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.8 0.333 . . . . 0.0 110.824 179.415 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.474 ' CE2' ' HB2' ' A' ' 51' ' ' LEU . 7.5 t80 -55.62 91.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.628 179.759 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 49' ' ' CYS . . . 127.22 -10.75 6.9 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.677 -179.394 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 61.1 m -58.71 -174.52 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.748 0.309 . . . . 0.0 110.743 179.898 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.0 p -151.59 140.21 20.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.232 179.736 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.535 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -107.87 166.58 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.551 179.661 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.407 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -129.1 108.6 10.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.885 179.522 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.493 ' CE1' ' CD2' ' A' ' 20' ' ' LEU . 18.2 m-85 -82.47 149.58 27.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.017 0.436 . . . . 0.0 111.043 -179.814 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.429 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.3 OUTLIER -150.91 164.79 35.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.681 -179.949 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 39' ' ' TYR . 3.7 m -87.28 161.57 17.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.855 -179.925 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -57.72 -84.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.078 -179.683 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.74 135.65 14.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.634 179.95 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 60.16 25.94 62.96 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.522 -0.846 . . . . 0.0 111.732 -178.84 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.478 ' CD2' ' HA ' ' A' ' 68' ' ' SER . 2.1 m-85 -117.0 172.08 7.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.836 0.35 . . . . 0.0 111.088 -179.045 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.478 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -133.27 120.44 21.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.491 178.017 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.439 HD21 ' CB ' ' A' ' 45' ' ' SER . 3.6 tt -81.86 132.76 35.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.245 -179.844 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.478 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.5 mm -101.7 151.54 5.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.219 -178.551 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.39 -147.08 38.48 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.064 -179.044 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.423 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 0.6 OUTLIER -66.2 -177.92 0.58 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.88 0.371 . . . . 0.0 110.766 179.289 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.439 ' CB ' HD21 ' A' ' 41' ' ' LEU . 0.3 OUTLIER -160.57 27.93 0.16 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.289 178.72 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.407 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -147.79 132.45 17.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.324 -179.047 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.1 m -104.21 150.04 24.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.152 178.641 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.429 ' CE1' ' HD3' ' A' ' 61' ' ' PRO . 6.8 m-85 -124.18 125.6 44.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.047 0.451 . . . . 0.0 111.51 -178.879 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.484 ' HB3' ' CH2' ' A' ' 59' ' ' TRP . 28.3 t -74.58 86.26 2.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.356 179.106 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.498 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 1.1 tt0 -105.13 175.4 5.51 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.425 -179.243 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.498 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.653 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.948 -179.94 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.8 mmt . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 120.825 0.345 . . . . 0.0 110.345 . . . . . . . . . 0 0 . 1 . 043 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.9 m -140.68 -176.81 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.12 -179.076 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.535 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 90.9 m95 -123.02 124.81 43.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.289 -179.246 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.427 ' O ' ' CD1' ' A' ' 48' ' ' TYR . 14.5 m-80 -146.88 126.92 6.77 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.886 179.851 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.429 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 71.6 Cg_endo -75.89 -163.64 3.33 Favored 'Cis proline' 0 C--N 1.351 0.685 0 C-N-CA 123.892 -1.295 . . . . 0.0 112.206 -0.34 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.49 ' O ' ' CZ ' ' A' ' 33' ' ' TYR . 28.6 mm-40 -110.13 -107.9 0.35 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.095 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.446 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -122.0 100.0 43.39 Favored Pre-proline 0 N--CA 1.445 -0.714 0 C-N-CA 122.514 0.325 . . . . 0.0 110.722 -177.937 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 63' ' ' ALA . 20.7 Cg_endo -50.59 -158.02 0.0 OUTLIER 'Trans proline' 0 N--CA 1.476 0.448 0 C-N-CA 123.286 2.657 . . . . 0.0 112.939 177.652 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -93.0 174.94 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.505 -179.136 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -170.34 133.32 1.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.695 -179.983 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.472 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -150.65 179.59 8.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.872 -179.94 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.478 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 73.0 p -86.81 120.1 27.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.99 179.862 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.442 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 1.2 p -48.0 99.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.289 179.876 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -82.69 115.75 21.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.432 -179.344 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.428 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -97.54 123.11 41.3 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.284 -0.416 . . . . 0.0 109.919 178.179 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -74.04 -150.99 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.953 179.694 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.464 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 2.4 t -56.62 144.81 63.46 Favored Pre-proline 0 C--N 1.324 -0.516 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.647 -179.661 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -61.87 163.41 19.14 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.544 2.162 . . . . 0.0 111.817 179.732 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.486 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 97.8 Cg_exo -41.11 156.66 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.722 2.281 . . . . 0.0 112.742 -179.315 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 12.3 t -105.96 90.03 3.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.48 179.15 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 20.7 pt -69.48 -178.32 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.21 -179.195 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.1 m -104.02 145.56 29.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.809 179.635 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.484 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 13.2 m-20 56.7 29.57 16.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.214 179.448 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -166.85 -165.49 24.33 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.794 179.716 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.96 -175.63 4.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.097 0.475 . . . . 0.0 111.005 -179.73 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.464 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 35.1 p-80 -108.51 173.77 6.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.933 179.681 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.493 178.71 . . . . . . . . 0 0 . 1 . 043 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.425 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 8.5 m-85 . . . . . 0 N--CA 1.456 -0.141 0 CA-C-O 120.923 0.392 . . . . 0.0 111.003 . . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.428 ' N ' ' O ' ' A' ' 71' ' ' CYS . 55.0 m-85 -151.76 164.0 37.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.761 -179.523 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.6 p -131.27 -175.89 3.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.231 -179.502 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 5.0 m-20 -65.95 94.47 0.23 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.19 0.519 . . . . 0.0 111.126 -179.767 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.86 31.1 0.77 Allowed Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.973 178.753 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.437 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.6 OUTLIER -110.19 159.0 17.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.74 0.305 . . . . 0.0 110.83 179.418 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 34.6 m -134.72 149.48 29.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.075 0.464 . . . . 0.0 111.191 -179.741 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.484 HG22 ' CZ3' ' A' ' 118' ' ' TRP . 26.2 t -144.77 148.0 18.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.841 179.592 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.35 128.5 54.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.033 -179.849 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.525 ' CE1' ' CG2' ' A' ' 111' ' ' VAL . 7.0 m-85 -89.13 155.77 19.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.953 -179.943 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 77.3 p -149.15 137.84 21.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.086 179.543 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.404 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 83.1 m -69.73 157.87 36.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.057 -179.737 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.3 m-20 -90.03 -71.79 0.6 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.564 -178.898 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.0 t -63.77 -19.68 65.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.555 -178.862 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 119.46 31.04 1.43 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.376 -179.733 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.495 ' CE2' HG12 ' A' ' 126' ' ' ILE . 35.5 m-85 -69.59 -171.55 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.698 0.285 . . . . 0.0 110.476 179.61 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.72 106.53 16.2 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.907 0.384 . . . . 0.0 111.274 -179.078 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.477 HD22 ' CB ' ' A' ' 109' ' ' SER . 1.6 tp -45.18 108.95 0.14 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.633 178.476 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.469 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 24.3 mm -83.25 160.75 3.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.067 -178.366 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.428 ' N ' HG23 ' A' ' 106' ' ' ILE . . . 54.68 -128.29 42.29 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.902 -179.257 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -115.52 134.39 55.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.975 0.417 . . . . 0.0 110.898 179.018 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.479 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 0.0 OUTLIER -68.3 -30.6 69.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.377 179.322 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -75.45 133.16 14.21 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.542 179.807 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.525 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 3.3 t -125.6 124.2 66.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.506 0.194 . . . . 0.0 110.49 179.393 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.76 123.71 30.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.895 0.379 . . . . 0.0 111.799 -178.269 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.522 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 27.2 t -88.95 104.36 16.89 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 176.354 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 53.3 p -142.99 154.6 44.18 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.042 0.448 . . . . 0.0 111.605 -177.772 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.43 35.49 7.13 Favored Glycine 0 N--CA 1.453 -0.194 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.748 179.519 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.442 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 68.28 11.44 61.66 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.74 -179.439 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -132.87 178.29 6.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.865 0.364 . . . . 0.0 110.558 179.418 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.522 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 93.1 m95 -117.4 148.13 42.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.882 -179.458 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.28 164.06 23.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.111 0.481 . . . . 0.0 111.635 -178.654 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.425 ' N ' ' HD3' ' A' ' 121' ' ' PRO . 1.7 p-10 45.97 52.13 10.71 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.233 179.219 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.425 ' HD3' ' N ' ' A' ' 120' ' ' ASP . 84.0 Cg_endo -82.18 145.64 13.81 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.547 2.164 . . . . 0.0 111.562 177.527 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.479 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 90.5 Cg_endo -93.7 -170.1 0.23 Allowed 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.888 2.392 . . . . 0.0 114.177 -177.458 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.435 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -140.54 -170.03 2.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.004 177.806 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . 0.408 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 14.5 m -143.49 95.39 2.74 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.039 0.447 . . . . 0.0 111.11 -179.662 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.43 ' HB3' ' CD1' ' A' ' 106' ' ' ILE . 23.6 mt-30 -122.78 158.07 31.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.797 179.921 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.495 HG12 ' CE2' ' A' ' 103' ' ' TYR . 28.8 mm . . . . . 0 C--N 1.324 -0.506 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.08 -179.754 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.4 mtm180 . . . . . 0 N--CA 1.447 -0.6 0 CA-C-O 121.011 0.434 . . . . 0.0 111.59 . . . . . . . . . 0 0 . 1 . 044 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.442 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 95.3 m -87.44 158.69 51.44 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.965 -179.824 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.409 ' HD3' ' HB2' ' A' ' 9' ' ' CYS . 41.0 Cg_endo -68.56 173.49 9.79 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.604 2.203 . . . . 0.0 112.274 -179.971 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -50.65 107.31 0.78 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.783 179.871 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.8 141.93 75.52 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.202 1.935 . . . . 0.0 112.147 -179.29 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.416 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -52.32 150.83 4.39 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.379 179.259 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.83 -176.06 2.99 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.269 0.556 . . . . 0.0 111.588 -178.038 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.1 tt -135.58 148.91 28.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.621 -179.585 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -81.02 -62.35 1.69 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.917 -177.635 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -93.15 27.04 2.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.16 -178.549 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.431 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -146.26 -176.58 20.23 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.097 -179.693 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -139.77 127.65 22.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.644 0.259 . . . . 0.0 110.667 179.544 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.534 ' CD2' ' CE2' ' A' ' 33' ' ' TYR . 11.1 mt -72.76 154.14 40.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.11 0.481 . . . . 0.0 111.712 -179.49 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.427 ' CB ' ' HB ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -130.58 76.22 1.71 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.561 177.061 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.442 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 54.8 mt -69.97 107.76 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.826 -177.702 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -109.44 15.07 32.7 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.167 178.119 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 162.29 122.9 0.63 Allowed Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.911 -179.639 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.9 m -112.94 28.06 2.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.482 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -102.45 162.69 12.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.043 0.449 . . . . 0.0 111.271 179.534 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.483 ' CZ ' HD13 ' A' ' 51' ' ' LEU . 7.3 t80 -59.61 93.5 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.911 -179.502 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 123.94 3.27 8.35 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.812 -179.963 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.6 m -84.92 -159.0 0.39 Allowed 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 116.892 0.346 . . . . 0.0 110.134 179.161 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 51.9 p -168.18 153.98 7.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.116 0.484 . . . . 0.0 111.451 179.361 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.517 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.6 OUTLIER -114.82 172.84 3.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.383 179.663 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.427 ' HB ' ' CB ' ' A' ' 21' ' ' ASP . 2.6 m -132.86 109.23 9.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.996 0.427 . . . . 0.0 110.962 178.661 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.534 ' CE2' ' CD2' ' A' ' 20' ' ' LEU . 22.4 m-85 -84.31 132.12 34.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.828 179.836 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.431 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.7 OUTLIER -135.61 162.71 31.94 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.652 -179.42 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.413 ' HB2' ' HB2' ' A' ' 39' ' ' TYR . 5.4 m -84.57 168.01 15.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.789 0.328 . . . . 0.0 110.83 179.875 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -63.66 -78.62 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.013 -179.319 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -156.36 135.76 12.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.743 179.72 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.421 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . 55.83 26.49 47.61 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.693 -178.939 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.498 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.1 m-85 -115.15 165.84 12.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.707 0.289 . . . . 0.0 110.805 -179.23 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.475 ' NE2' ' CG2' ' A' ' 69' ' ' VAL . 95.3 m-70 -117.88 122.01 42.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.457 178.255 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.414 ' CD2' ' O ' ' A' ' 44' ' ' GLU . 10.1 tt -86.2 110.18 19.42 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.294 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.403 ' HB ' ' HB ' ' A' ' 65' ' ' ILE . 2.2 mm -84.07 155.13 3.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.934 0.397 . . . . 0.0 111.314 -177.801 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.5 -145.64 36.07 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.057 -179.053 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.443 ' O ' ' CG ' ' A' ' 64' ' ' PRO . 1.0 OUTLIER -74.31 165.92 24.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.628 0.251 . . . . 0.0 110.473 179.009 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.2 p -141.66 24.39 2.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.003 -179.883 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -148.37 135.77 20.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.447 -178.416 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.427 ' C ' ' CD2' ' A' ' 48' ' ' TYR . 1.0 OUTLIER -106.07 161.07 14.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.498 178.605 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.492 ' CE1' ' HD3' ' A' ' 61' ' ' PRO . 3.6 m-85 -134.29 122.14 22.26 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.056 0.455 . . . . 0.0 111.811 -177.569 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.499 ' HB3' ' CH2' ' A' ' 59' ' ' TRP . 35.7 t -76.96 94.42 3.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.806 179.484 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -115.19 -172.83 2.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.531 179.641 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.483 HD13 ' CZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.554 179.105 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 120.871 0.367 . . . . 0.0 110.678 . . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.4 m -152.09 173.87 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.264 -179.128 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.517 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 89.9 m95 -129.54 130.99 46.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.06 -179.874 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.471 ' O ' ' CD1' ' A' ' 48' ' ' TYR . 0.9 OUTLIER -160.6 135.14 5.36 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.053 179.897 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.492 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 61.4 Cg_endo -71.33 -165.8 3.5 Favored 'Cis proline' 0 C--N 1.353 0.786 0 C-N-CA 123.984 -1.257 . . . . 0.0 112.691 0.013 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -111.49 -152.3 0.5 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.064 -179.012 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.488 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -73.46 115.24 39.38 Favored Pre-proline 0 C--O 1.231 0.128 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.672 179.213 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.443 ' CG ' ' O ' ' A' ' 44' ' ' GLU . 15.2 Cg_exo -71.22 -150.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.7 2.267 . . . . 0.0 112.54 -178.826 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.403 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 1.5 mm -103.56 170.64 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.058 -179.162 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.3 m -159.31 134.69 8.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.109 -179.952 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.73 157.25 44.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.984 179.809 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.498 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 1.4 p -78.67 129.22 34.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.253 0.549 . . . . 0.0 111.553 -179.274 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.475 ' CG2' ' NE2' ' A' ' 40' ' ' HIS . 3.9 p -50.6 94.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.208 179.458 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.42 116.95 20.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.128 -179.846 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -98.17 119.84 37.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.376 179.074 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -158.63 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.662 179.764 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.42 ' OG ' ' NE2' ' A' ' 82' ' ' HIS . 2.2 t -48.64 139.99 10.88 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.96 -179.704 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.499 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 26.5 Cg_exo -60.72 161.93 19.93 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.426 2.084 . . . . 0.0 112.154 -179.862 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.499 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 80.9 Cg_exo -42.88 157.48 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.786 2.324 . . . . 0.0 112.85 -179.692 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.3 m -108.16 89.85 3.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.551 179.094 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.8 pt -69.35 173.75 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.242 -179.176 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.1 m -95.31 142.91 27.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.582 179.332 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 60.74 28.44 18.18 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.003 179.815 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.465 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -166.49 -166.99 26.47 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.813 -179.882 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.423 ' N ' ' O ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -166.26 -175.75 3.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.001 0.429 . . . . 0.0 110.798 -179.934 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 3.1 p80 -114.63 167.42 10.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.25 -179.515 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.778 179.812 . . . . . . . . 0 0 . 1 . 044 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.433 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 6.1 m-85 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.786 0.326 . . . . 0.0 110.946 . . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.433 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 31.2 m-85 -147.03 167.62 23.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.04 -179.635 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 21.7 p -139.25 -175.13 4.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.114 -179.78 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.42 ' OD2' ' CG1' ' A' ' 69' ' ' VAL . 0.4 OUTLIER -62.05 95.06 0.06 Allowed 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.197 0.523 . . . . 0.0 110.94 179.937 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.7 26.94 1.34 Allowed Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.496 -0.775 . . . . 0.0 113.151 178.592 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -108.3 152.17 24.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.769 0.285 . . . . 0.0 110.384 178.679 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 35.5 m -130.53 154.41 40.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.02 0.438 . . . . 0.0 111.251 -179.494 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.527 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 43.8 t -148.14 151.15 13.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.763 179.32 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.424 ' CG2' ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -109.12 125.62 52.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.172 0.51 . . . . 0.0 110.957 179.905 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.534 ' CE2' ' CG2' ' A' ' 111' ' ' VAL . 4.5 m-85 -83.35 162.19 21.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.12 -179.043 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 81' ' ' ARG . 2.6 p -150.94 130.39 12.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.853 0.359 . . . . 0.0 111.689 -178.82 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 71.8 m -69.93 155.28 40.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.699 178.831 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.465 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 12.6 m-20 -92.76 -72.16 0.61 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.594 -178.598 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.5 t -57.2 -20.59 27.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.771 0.32 . . . . 0.0 111.261 -179.365 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 117.81 29.75 1.96 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.29 -179.846 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.467 ' CE2' HG12 ' A' ' 126' ' ' ILE . 43.9 m-85 -70.7 -174.18 0.87 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.876 0.37 . . . . 0.0 110.643 179.898 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -109.99 110.45 21.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.702 179.56 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.455 ' CD2' ' HB2' ' A' ' 122' ' ' PRO . 1.1 tp -48.08 113.62 0.77 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.936 179.401 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.455 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 30.1 mm -94.78 161.06 2.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.031 -179.029 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.4 ' N ' HG21 ' A' ' 106' ' ' ILE . . . 51.63 25.8 15.09 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.333 -0.937 . . . . 0.0 112.346 -179.48 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.403 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.3 OUTLIER 60.24 133.42 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.028 -0.586 . . . . 0.0 111.342 -179.567 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.46 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 1.3 p -60.64 -26.65 67.21 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.485 -179.156 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.84 128.68 47.0 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.115 -178.692 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.534 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 2.3 t -123.67 149.79 27.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 178.279 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.8 108.41 17.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.821 0.343 . . . . 0.0 111.441 -179.93 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.495 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 11.6 t -73.68 103.93 4.43 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 176.536 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.5 p -145.9 159.45 43.2 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.212 -178.619 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.67 32.31 8.01 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.739 179.782 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.424 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 71.81 6.41 63.34 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.824 -179.65 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -136.84 173.52 11.62 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.876 0.369 . . . . 0.0 110.624 179.746 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.527 ' CH2' ' CG2' ' A' ' 95' ' ' VAL . 83.1 m95 -106.39 124.86 50.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.031 -179.461 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.78 159.05 15.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.517 -178.926 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.472 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 3.6 p-10 49.44 46.58 3.87 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.465 179.076 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 52.9 Cg_endo -68.36 144.44 61.9 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.32 2.013 . . . . 0.0 111.132 177.215 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.46 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 74.1 Cg_endo -89.73 -172.6 0.62 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.528 2.152 . . . . 0.0 114.3 -176.761 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.41 -158.81 0.9 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.363 -1.289 . . . . 0.0 109.822 178.465 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 7.8 m -155.5 90.54 1.25 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.998 0.427 . . . . 0.0 110.894 179.241 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -117.37 173.34 6.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.779 -179.851 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.467 HG12 ' CE2' ' A' ' 103' ' ' TYR . 29.1 mm . . . . . 0 C--N 1.325 -0.479 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.971 -179.424 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.419 ' HD2' ' CG2' ' A' ' 25' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.344 0 CA-C-O 121.232 0.539 . . . . 0.0 112.057 . . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.526 ' HB2' ' CD ' ' A' ' 10' ' ' PRO . 89.4 m -94.32 177.54 1.86 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.696 179.708 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.526 ' CD ' ' HB2' ' A' ' 9' ' ' CYS . 28.1 Cg_endo -91.33 179.9 1.51 Allowed 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.706 2.27 . . . . 0.0 111.974 -179.538 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.1 t -51.81 105.51 0.53 Allowed Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.567 179.497 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.468 ' HG2' ' CZ2' ' A' ' 59' ' ' TRP . 77.8 Cg_exo -49.47 153.3 5.21 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.304 2.003 . . . . 0.0 112.4 -179.447 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.428 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 1.0 OUTLIER -62.97 168.5 3.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.981 179.124 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.426 ' O ' ' CB ' ' A' ' 63' ' ' ALA . 1.0 OUTLIER -118.93 -175.1 2.84 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.303 0.573 . . . . 0.0 111.752 -178.24 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.9 tt -145.19 139.37 22.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.317 -179.692 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -65.34 -72.96 0.14 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.86 -177.568 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -90.02 45.64 1.29 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.933 0.397 . . . . 0.0 110.884 -179.129 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.428 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -157.08 171.93 34.54 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.352 -0.928 . . . . 0.0 113.292 179.767 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -133.55 131.03 39.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.775 0.321 . . . . 0.0 110.36 179.323 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.479 HD22 ' CE1' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -78.54 166.62 22.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.171 0.51 . . . . 0.0 111.748 -178.788 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.44 ' CB ' ' HB ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -135.55 73.39 1.47 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.634 177.127 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.485 HG22 HD13 ' A' ' 22' ' ' ILE . 45.4 mt -71.53 92.62 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.582 -178.058 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -97.49 18.42 57.38 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.161 178.212 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 158.51 129.51 1.09 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.109 -0.567 . . . . 0.0 111.887 -179.585 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.419 ' CG2' ' HD2' ' A' ' 8' ' ' ARG . 32.6 m -115.35 0.91 8.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.553 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -69.6 153.6 43.22 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.923 0.392 . . . . 0.0 111.069 -179.764 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.476 ' CE1' ' HB2' ' A' ' 51' ' ' LEU . 12.1 t80 -50.48 106.54 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.935 -179.939 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.18 -7.07 23.23 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.913 179.988 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 99.7 p -71.78 -171.65 0.71 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.791 0.329 . . . . 0.0 110.807 179.971 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.2 p -153.48 156.05 37.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.026 179.727 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.525 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.5 OUTLIER -119.71 168.05 12.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.492 -179.869 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.44 ' HB ' ' CB ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -128.93 111.1 12.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.918 0.39 . . . . 0.0 110.977 179.054 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.492 ' CE1' ' HA ' ' A' ' 63' ' ' ALA . 27.8 m-85 -88.84 134.93 33.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.211 -179.645 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.428 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 21.3 p -138.42 167.97 20.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.703 179.908 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.417 ' HB2' ' HB2' ' A' ' 39' ' ' TYR . 1.6 m -88.18 162.68 16.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.86 -179.991 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.16 -80.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.849 0.357 . . . . 0.0 111.123 -179.324 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.1 m -158.63 133.72 8.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.773 -179.814 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 60.06 24.74 61.11 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.789 -178.959 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.477 ' CG ' ' O ' ' A' ' 67' ' ' GLU . 2.0 m-85 -112.47 -179.58 3.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.78 0.324 . . . . 0.0 110.766 -179.662 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.524 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.3 OUTLIER -138.7 113.8 9.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.011 0.434 . . . . 0.0 110.613 178.49 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.406 HD22 ' HB3' ' A' ' 45' ' ' SER . 4.7 tt -78.99 126.36 30.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.514 -179.595 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.524 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 2.6 mm -100.2 153.51 4.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.401 -178.688 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.9 -145.35 31.05 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.328 -179.711 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -70.02 171.56 9.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.576 0.227 . . . . 0.0 110.695 179.477 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.406 ' HB3' HD22 ' A' ' 41' ' ' LEU . 4.0 p -146.96 18.98 1.26 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.437 -179.599 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.41 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -148.15 134.15 19.2 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.925 0.393 . . . . 0.0 111.495 -178.768 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.431 ' CB ' HD12 ' A' ' 31' ' ' ILE . 1.5 m -102.89 152.52 21.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.992 178.51 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.48 ' CE1' ' HD3' ' A' ' 61' ' ' PRO . 4.5 m-85 -125.3 121.05 32.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.135 0.493 . . . . 0.0 111.601 -178.74 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.435 ' HB3' ' CH2' ' A' ' 59' ' ' TRP . 41.0 t -72.32 93.77 1.53 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.301 179.216 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.493 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 0.7 OUTLIER -111.93 176.4 5.04 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.372 -178.78 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.493 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.579 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.811 179.79 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.982 0.42 . . . . 0.0 110.397 . . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.0 m -125.62 -176.62 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.074 -179.046 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.526 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 86.0 m95 -127.69 127.05 43.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.666 179.976 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -151.87 128.92 5.53 Favored Pre-proline 0 CA--C 1.532 0.285 0 C-N-CA 121.086 -0.246 . . . . 0.0 111.322 -179.416 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.48 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 72.8 Cg_endo -75.7 -165.92 4.63 Favored 'Cis proline' 0 C--N 1.351 0.701 0 C-N-CA 123.864 -1.306 . . . . 0.0 112.335 -0.516 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.79 -153.87 0.53 Allowed 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.014 -179.474 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.492 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -73.63 112.67 17.19 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.819 179.63 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -68.75 -150.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.669 2.246 . . . . 0.0 112.452 -179.075 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.7 mm -99.6 166.35 2.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.91 0.386 . . . . 0.0 111.459 -178.842 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -165.94 123.8 1.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.692 179.381 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.477 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -136.24 176.64 8.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.0 -179.739 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.464 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 4.2 p -94.2 122.48 36.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.15 -179.736 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.0 p -46.85 99.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.399 179.569 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.0 mmtt -70.99 114.88 9.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.177 179.958 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -97.01 121.44 38.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.095 178.73 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -158.74 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.925 -179.643 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.472 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 2.1 t -48.54 138.08 11.9 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.113 -179.556 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.485 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 24.6 Cg_exo -61.22 162.3 20.38 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.389 2.059 . . . . 0.0 112.001 179.746 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.486 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 91.9 Cg_exo -40.72 158.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.852 2.368 . . . . 0.0 113.01 -179.158 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.7 m -108.91 90.99 3.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.588 179.328 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 23.0 pt -69.14 -177.11 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.23 -179.139 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.0 p -101.37 146.74 27.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.752 179.639 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.486 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 3.3 m-80 53.54 29.62 9.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.12 179.449 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.466 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -171.55 -171.69 36.9 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.543 179.612 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.54 -176.17 4.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.966 0.412 . . . . 0.0 110.914 179.417 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.472 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 8.6 p-80 -100.93 173.03 6.67 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.018 -179.956 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.393 179.223 . . . . . . . . 0 0 . 1 . 045 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.43 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 6.3 m-85 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.827 0.346 . . . . 0.0 111.182 . . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.43 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 70.4 m-85 -151.27 165.15 34.86 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.895 -179.913 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.3 p -127.4 173.57 9.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.97 0.414 . . . . 0.0 111.214 -179.159 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -60.26 95.31 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.303 0.573 . . . . 0.0 110.82 179.744 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 125.81 28.28 1.07 Allowed Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.943 179.34 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.2 158.14 18.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.696 0.284 . . . . 0.0 110.567 179.208 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 32.8 m -131.43 150.43 34.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.066 0.46 . . . . 0.0 111.361 -179.514 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.502 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 33.2 t -143.12 148.67 19.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.563 178.854 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.428 ' CG2' ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -104.45 134.42 47.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.936 -179.873 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.536 ' CE1' ' CG2' ' A' ' 111' ' ' VAL . 4.7 m-85 -94.27 158.59 15.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.263 -179.354 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 84.7 p -154.3 139.91 17.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.39 -179.856 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.4 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 66.3 m -70.54 162.73 28.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.224 -179.862 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.466 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 73.6 m-80 -92.05 -78.26 0.41 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.45 -179.232 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.7 m -56.53 -27.33 57.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.855 0.36 . . . . 0.0 110.985 -179.312 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.61 34.09 0.58 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.768 179.679 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.494 ' CE2' HG12 ' A' ' 126' ' ' ILE . 32.4 m-85 -70.4 -173.06 0.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.763 0.316 . . . . 0.0 110.175 178.939 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.98 109.97 20.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.139 0.495 . . . . 0.0 110.853 179.563 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.44 HD21 ' CG ' ' A' ' 122' ' ' PRO . 2.6 tp -46.65 113.5 0.66 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.936 179.145 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.446 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 38.7 mm -89.06 157.29 3.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.785 -179.265 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 62.77 -121.58 25.38 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.462 -0.875 . . . . 0.0 111.587 -178.335 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -127.48 130.52 49.37 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.878 0.37 . . . . 0.0 110.711 178.523 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.474 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 1.1 p -63.72 -28.48 69.92 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.107 179.123 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -74.33 130.96 12.76 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.594 179.477 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.536 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 4.3 t -122.95 134.13 67.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.152 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.02 124.79 35.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.019 0.438 . . . . 0.0 111.785 -178.2 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.508 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 14.5 t -91.02 100.44 13.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.521 176.909 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.9 166.54 27.33 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.098 0.475 . . . . 0.0 111.591 -178.217 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.98 26.93 3.16 Favored Glycine 0 CA--C 1.517 0.214 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.841 179.589 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.83 10.88 80.84 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.597 -179.425 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -142.14 -177.74 5.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.753 0.311 . . . . 0.0 110.459 179.705 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.508 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 85.0 m95 -114.57 149.33 36.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.072 -179.264 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.02 168.87 16.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.444 -179.121 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.456 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 5.0 p-10 46.67 49.62 7.21 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.975 179.801 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 75.5 Cg_endo -77.85 143.01 20.5 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.632 2.221 . . . . 0.0 111.681 178.045 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.474 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 70.0 Cg_endo -90.8 -171.54 0.44 Allowed 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.841 2.36 . . . . 0.0 113.819 -178.053 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.408 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -133.96 -161.3 1.13 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.252 178.592 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 10.7 m -153.53 90.14 1.39 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.016 0.436 . . . . 0.0 110.996 179.599 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -118.35 160.84 20.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.651 179.793 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.494 HG12 ' CE2' ' A' ' 103' ' ' TYR . 20.5 mm . . . . . 0 C--N 1.322 -0.618 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.103 -179.852 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.45 0 CA-C-O 121.078 0.465 . . . . 0.0 111.501 . . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.418 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 18.4 m -72.73 160.82 81.91 Favored Pre-proline 0 N--CA 1.452 -0.346 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.51 179.817 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.45 167.61 16.46 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.171 1.914 . . . . 0.0 111.175 179.517 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.5 p -53.64 107.74 0.93 Allowed Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.152 -178.376 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.49 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 50.0 Cg_exo -44.87 167.41 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.312 2.008 . . . . 0.0 112.765 179.724 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.36 176.51 1.79 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.593 176.416 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.48 ' O ' ' CG2' ' A' ' 15' ' ' ILE . 0.2 OUTLIER -130.46 -7.06 4.19 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -177.279 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.48 ' CG2' ' O ' ' A' ' 14' ' ' ASP . 17.4 tt 51.67 156.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 123.498 0.719 . . . . 0.0 112.533 -178.685 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.429 ' HB2' ' ND2' ' A' ' 17' ' ' ASN . 3.9 t0 -103.97 157.52 17.04 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.141 178.858 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.429 ' ND2' ' HB2' ' A' ' 16' ' ' ASP . 0.1 OUTLIER 42.97 28.0 0.12 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.293 -179.516 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.433 ' HA2' ' N ' ' A' ' 36' ' ' ASN . . . -151.25 -163.42 11.38 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.341 -179.781 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.93 175.37 9.64 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.85 0.357 . . . . 0.0 111.132 179.964 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.529 ' CD2' ' CE2' ' A' ' 33' ' ' TYR . 0.8 OUTLIER -125.13 150.65 46.68 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.57 179.514 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.445 ' HB2' ' CB ' ' A' ' 32' ' ' THR . 60.5 t0 -125.97 67.08 1.19 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 177.913 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.436 HG13 ' CG2' ' A' ' 31' ' ' ILE . 0.2 OUTLIER -82.33 101.63 7.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.026 -176.613 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.22 7.97 72.48 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.982 176.908 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 175.53 160.36 23.1 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.926 -179.928 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.41 ' HA ' ' CH2' ' A' ' 59' ' ' TRP . 31.9 m -143.13 33.73 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.873 0.368 . . . . 0.0 111.205 -179.689 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.17 156.9 17.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.081 -179.906 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.505 ' CE2' ' HG ' ' A' ' 51' ' ' LEU . 0.6 OUTLIER -54.23 91.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.723 179.56 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 132.54 -10.47 5.25 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.797 -179.796 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.3 -179.27 5.59 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.804 0.335 . . . . 0.0 110.561 179.565 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 47' ' ' SER . 3.0 p -155.13 141.63 18.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.076 0.465 . . . . 0.0 110.558 179.277 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.517 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 1.1 mt -101.95 166.12 2.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.56 -179.239 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.445 ' CB ' ' HB2' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -127.98 104.81 8.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.942 0.401 . . . . 0.0 110.214 178.842 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.529 ' CE2' ' CD2' ' A' ' 20' ' ' LEU . 9.5 m-85 -79.76 157.83 27.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.695 -178.02 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.6 t -162.81 176.59 10.09 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.697 179.99 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.446 ' HB2' ' CB ' ' A' ' 39' ' ' TYR . 45.2 m -98.43 173.78 6.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.876 179.916 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.433 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 30.6 m-20 -72.81 -83.63 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.289 -179.279 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.4 t -149.48 139.04 21.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.631 -179.867 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 55.89 27.02 49.5 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.811 -179.056 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.539 ' CD2' ' HA ' ' A' ' 68' ' ' SER . 2.4 m-85 -115.82 171.62 7.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.681 0.277 . . . . 0.0 110.763 -179.147 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.519 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.4 OUTLIER -137.5 117.52 13.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.978 0.418 . . . . 0.0 110.608 178.677 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.43 HD23 ' CB ' ' A' ' 45' ' ' SER . 5.9 tt -81.52 125.8 30.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.64 -179.542 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.519 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 2.0 mm -102.16 153.33 5.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.09 -179.3 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.08 -142.82 26.79 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.452 -179.681 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.438 ' O ' ' CG ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -68.43 -172.39 0.33 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.063 0.458 . . . . 0.0 110.882 179.68 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.43 ' CB ' HD23 ' A' ' 41' ' ' LEU . 0.4 OUTLIER -174.77 32.23 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.202 178.992 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 mtpt -157.34 118.8 3.68 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.033 0.444 . . . . 0.0 111.577 -179.426 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.434 ' CB ' HD11 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -91.83 139.47 30.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.109 179.214 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.517 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 2.1 m-85 -115.74 118.4 32.95 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 119.43 -0.908 . . . . 0.0 111.439 178.82 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 22.6 t -67.33 116.2 7.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.855 -179.575 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.49 ' HA ' ' CE1' ' A' ' 27' ' ' PHE . 2.7 mt-10 -148.85 177.87 9.16 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.127 0.489 . . . . 0.0 111.338 179.678 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.505 ' HG ' ' CE2' ' A' ' 27' ' ' PHE . 1.0 OUTLIER . . . . . 0 C--N 1.326 -0.421 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.702 -179.065 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 121.227 0.537 . . . . 0.0 111.164 . . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.8 m -122.23 -172.37 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.645 179.669 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.517 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 73.3 m95 -132.66 128.88 37.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.865 0.364 . . . . 0.0 111.439 -179.317 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.517 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 5.3 m-80 -69.18 166.98 23.62 Favored Pre-proline 0 C--O 1.223 -0.323 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.538 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.473 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 57.4 Cg_exo -12.66 90.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 125.228 3.952 . . . . 0.0 114.224 -179.103 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.476 ' O ' ' CG ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -92.8 -72.68 0.59 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.584 -175.826 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.507 ' HA ' ' CD2' ' A' ' 33' ' ' TYR . . . -97.25 106.64 33.28 Favored Pre-proline 0 N--CA 1.463 0.189 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -174.885 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.438 ' CG ' ' O ' ' A' ' 44' ' ' GLU . 5.7 Cg_exo -82.64 -152.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.251 2.634 . . . . 0.0 111.335 177.138 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.2 mm -90.8 169.98 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.825 0.345 . . . . 0.0 110.744 178.648 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -167.37 139.82 3.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.488 179.313 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -161.09 170.7 19.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.266 -179.098 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.539 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 54.9 p -81.09 120.87 25.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.235 0.541 . . . . 0.0 111.124 179.713 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.494 ' HB ' ' N ' ' A' ' 116' ' ' GLY . 16.3 m -46.86 107.89 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.829 -179.72 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.502 ' HG2' ' CD1' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -101.7 122.09 43.25 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.313 0.578 . . . . 0.0 110.388 177.409 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.38 128.84 55.12 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.597 -178.759 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.49 -156.17 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.148 179.103 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.423 ' OG ' ' NE2' ' A' ' 82' ' ' HIS . 0.3 OUTLIER -54.97 139.59 62.99 Favored Pre-proline 0 N--CA 1.445 -0.678 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.408 179.212 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.496 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 38.5 Cg_exo -58.27 162.94 10.94 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.558 2.172 . . . . 0.0 112.192 -179.487 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.496 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 94.5 Cg_exo -42.09 155.49 0.09 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.671 2.247 . . . . 0.0 112.647 -179.647 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.4 m -109.57 89.75 3.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.538 179.559 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.1 pt -69.38 172.04 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.047 -179.45 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -89.58 131.41 35.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.935 179.99 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.28 26.86 8.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.618 -179.869 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -158.4 178.46 34.62 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.329 -179.754 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.3 mtm180 -149.27 -166.57 2.59 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.358 0.599 . . . . 0.0 110.991 -179.214 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 4.3 p-80 -132.2 157.42 44.36 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.561 -179.889 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 . . . . . 0 CA--C 1.537 0.465 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.399 -179.887 . . . . . . . . 0 0 . 1 . 046 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.502 ' CD1' ' HG2' ' A' ' 70' ' ' LYS . 45.6 m-85 . . . . . 0 N--CA 1.446 -0.627 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 . . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.464 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 73.5 m-85 -158.94 163.62 36.35 Favored 'General case' 0 C--O 1.223 -0.309 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.896 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.1 p -144.2 -177.3 5.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.365 0.602 . . . . 0.0 112.59 -178.493 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 41.1 p-10 -50.91 95.2 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.373 -179.302 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 121.01 25.4 2.28 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.282 -0.872 . . . . 0.0 113.076 178.15 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.17 145.46 37.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.936 0.368 . . . . 0.0 110.75 179.068 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.406 ' CG2' ' N ' ' A' ' 95' ' ' VAL . 33.5 m -127.33 158.58 38.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.043 0.449 . . . . 0.0 111.043 -179.777 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.473 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 15.5 t -151.95 147.77 14.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.641 179.79 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.432 ' CG2' ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -108.1 127.59 53.93 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.142 0.496 . . . . 0.0 110.868 -179.899 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.527 ' CE2' ' CG2' ' A' ' 111' ' ' VAL . 3.9 m-85 -84.81 159.61 20.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.445 -178.963 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.441 ' CA ' HD12 ' A' ' 105' ' ' LEU . 19.1 p -147.58 130.28 16.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.84 -179.589 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.402 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 93.8 m -69.5 150.11 47.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.907 179.376 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -87.11 -72.7 0.5 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.832 -178.383 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.38 -18.49 28.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.557 -178.831 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 116.05 28.5 2.63 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.262 -179.472 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.478 ' CD2' HD13 ' A' ' 126' ' ' ILE . 45.5 m-85 -69.56 -173.45 0.58 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 120.779 0.323 . . . . 0.0 110.555 179.964 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 125' ' ' GLN . 1.4 m -110.44 109.18 19.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 -179.97 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.441 HD12 ' CA ' ' A' ' 98' ' ' SER . 1.1 mp -46.93 107.91 0.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.96 179.189 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.445 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 43.7 mm -93.8 153.18 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.939 -179.424 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 60.48 25.94 63.71 Favored Glycine 0 CA--C 1.51 -0.228 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.591 -179.916 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.405 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.4 OUTLIER 60.79 135.73 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.288 0.566 . . . . 0.0 111.212 -179.713 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.486 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 1.2 p -65.52 -24.67 67.18 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.692 -178.678 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -58.93 131.58 52.12 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.022 -179.037 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.527 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 2.3 t -133.59 125.49 50.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.626 0.251 . . . . 0.0 110.551 178.927 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.423 ' CD1' ' HB2' ' A' ' 114' ' ' SER . 0.8 OUTLIER -89.92 130.86 36.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.942 0.401 . . . . 0.0 111.562 -179.234 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.521 ' HB2' ' CZ3' ' A' ' 118' ' ' TRP . 48.7 t -100.84 104.81 16.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.665 176.866 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.423 ' HB2' ' CD1' ' A' ' 112' ' ' LEU . 71.1 m -152.85 126.18 8.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.896 0.379 . . . . 0.0 111.777 -178.907 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.3 22.13 55.09 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.575 178.994 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.494 ' N ' ' HB ' ' A' ' 69' ' ' VAL . . . 84.37 -4.22 84.44 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.43 179.995 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -124.81 173.38 8.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.421 0.629 . . . . 0.0 111.892 -178.669 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.521 ' CZ3' ' HB2' ' A' ' 113' ' ' CYS . 95.2 m95 -115.75 125.93 53.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.008 178.812 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.92 148.34 30.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.232 0.539 . . . . 0.0 111.64 -178.711 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.497 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER 68.8 44.86 0.28 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.299 178.374 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 56.9 Cg_endo -70.59 140.99 40.79 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.078 1.852 . . . . 0.0 111.331 177.859 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.486 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 67.5 Cg_endo -88.51 -173.82 0.96 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.58 2.186 . . . . 0.0 114.007 -177.25 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.46 -160.82 1.08 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.58 177.661 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . 0.404 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 6.6 m -152.99 90.96 1.49 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.091 0.472 . . . . 0.0 111.028 179.144 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.426 ' O ' ' CB ' ' A' ' 104' ' ' SER . 8.9 mt-30 -121.06 158.4 27.93 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.712 -179.852 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.478 HD13 ' CD2' ' A' ' 103' ' ' TYR . 35.3 mm . . . . . 0 C--N 1.323 -0.568 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.909 179.933 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.409 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 20.6 mtm180 . . . . . 0 N--CA 1.453 -0.319 0 CA-C-O 121.178 0.513 . . . . 0.0 111.834 . . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.521 ' HB2' ' CD ' ' A' ' 10' ' ' PRO . 80.7 m -87.8 176.4 3.42 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.839 179.738 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.53 ' HD2' ' CD1' ' A' ' 59' ' ' TRP . 26.4 Cg_endo -88.37 -167.49 0.31 Allowed 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.556 2.171 . . . . 0.0 111.814 179.626 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.414 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 1.1 p -56.79 105.81 0.58 Allowed Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.554 179.603 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.432 ' CB ' HD12 ' A' ' 31' ' ' ILE . 10.1 Cg_endo -52.43 138.99 56.52 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.253 1.969 . . . . 0.0 112.111 -179.194 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.22 160.87 0.99 Allowed 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.581 179.963 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -117.2 -175.1 2.73 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.785 -176.567 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.7 tt -139.44 145.19 27.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.437 179.395 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -76.14 -65.73 0.88 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.459 -178.463 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.424 ' N ' ' ND2' ' A' ' 17' ' ' ASN . 0.6 OUTLIER -91.77 42.07 1.09 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.861 -179.34 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.439 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -160.88 -179.87 35.91 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.392 -0.908 . . . . 0.0 113.3 -179.89 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -137.95 140.28 40.17 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 179.166 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.527 ' CD2' ' CE2' ' A' ' 33' ' ' TYR . 10.7 mt -84.38 158.26 21.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.216 0.531 . . . . 0.0 111.875 -179.013 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -131.46 72.76 1.51 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.114 176.741 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.44 HG13 ' CG2' ' A' ' 31' ' ' ILE . 0.5 OUTLIER -73.95 106.09 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.238 -176.135 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.1 -5.04 73.77 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.668 175.632 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 172.39 153.03 8.97 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 121.16 -0.543 . . . . 0.0 111.818 -179.95 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.405 ' O ' ' HB3' ' A' ' 8' ' ' ARG . 24.3 m -121.86 3.4 6.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.271 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.409 ' HA ' ' HB3' ' A' ' 8' ' ' ARG . 0.6 OUTLIER -72.54 162.14 29.86 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 121.081 0.467 . . . . 0.0 111.517 -179.349 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.478 ' CE1' ' HA ' ' A' ' 50' ' ' GLU . 0.6 OUTLIER -51.91 98.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.202 178.744 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 117.86 -9.24 14.31 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.561 -179.097 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.4 m -75.31 138.23 41.67 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 117.068 0.434 . . . . 0.0 109.985 178.93 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 47' ' ' SER . 2.1 p -115.96 140.54 49.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.251 0.548 . . . . 0.0 111.397 -178.778 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.505 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.9 OUTLIER -98.06 164.32 2.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.946 179.196 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.76 110.4 14.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.957 0.408 . . . . 0.0 110.856 179.574 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.527 ' CE2' ' CD2' ' A' ' 20' ' ' LEU . 13.8 m-85 -83.23 142.64 31.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.231 -179.372 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.439 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 26.5 p -143.61 158.91 43.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.206 179.235 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.2 m -84.62 167.84 15.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.754 0.312 . . . . 0.0 110.936 -179.763 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.49 -82.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.003 -179.597 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -159.61 129.91 5.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.798 179.948 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.92 21.21 76.68 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.078 -179.016 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.479 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.9 m-30 -114.51 178.51 4.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.846 0.355 . . . . 0.0 110.833 -179.637 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.524 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.3 OUTLIER -138.88 119.41 13.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.568 178.244 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.44 ' CD1' ' HG3' ' A' ' 64' ' ' PRO . 7.6 tt -83.25 122.27 28.19 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.647 -179.65 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.524 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 1.7 mm -99.65 160.49 3.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.119 0.485 . . . . 0.0 111.313 -178.644 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.89 -145.05 40.97 Favored Glycine 0 N--CA 1.453 -0.191 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.43 -179.758 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.429 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 0.5 OUTLIER -60.74 -174.38 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.863 0.363 . . . . 0.0 110.538 179.28 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.409 ' CB ' HD21 ' A' ' 41' ' ' LEU . 2.0 t -172.88 29.96 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.792 178.786 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.9 mtpt -162.21 119.94 2.15 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 120.751 0.31 . . . . 0.0 111.287 -179.329 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.429 ' OG ' ' CG ' ' A' ' 62' ' ' GLU . 1.0 OUTLIER -87.52 136.79 32.8 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.026 178.919 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.508 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 1.1 m-85 -111.9 120.71 42.84 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 119.482 -0.887 . . . . 0.0 111.703 179.916 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.411 ' HB3' ' CH2' ' A' ' 59' ' ' TRP . 18.5 t -72.45 118.46 15.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.849 -179.973 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.488 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 10.3 tt0 -156.62 169.21 25.2 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.429 0.633 . . . . 0.0 110.782 179.326 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.488 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.76 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.039 -178.956 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.803 0.335 . . . . 0.0 110.434 . . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.4 m -153.68 173.45 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.247 -179.493 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.53 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 64.6 m95 -126.4 129.73 49.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.853 179.874 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.508 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 6.1 m-20 -73.69 166.15 46.77 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.489 179.184 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.46 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 90.1 Cg_exo -18.4 96.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 125.247 3.965 . . . . 0.0 114.112 -179.366 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.463 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -97.81 -78.52 0.48 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.268 -176.943 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.483 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -85.46 108.38 15.9 Favored Pre-proline 0 C--N 1.332 -0.168 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -175.726 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.44 ' HG3' ' CD1' ' A' ' 41' ' ' LEU . 3.5 Cg_exo -84.08 -153.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.201 2.601 . . . . 0.0 111.073 177.211 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.41 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 3.6 mm -90.79 166.33 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.768 0.318 . . . . 0.0 110.594 178.259 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -166.66 137.94 3.41 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.947 179.631 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.427 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -161.99 177.0 10.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.047 179.716 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.479 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 6.5 p -89.44 112.16 23.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.118 -179.7 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.484 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 3.2 p -48.43 104.88 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.997 179.602 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.427 ' CG ' ' O ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -87.54 145.67 26.12 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.021 -177.988 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 1.8 m -105.47 137.16 43.75 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.57 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.407 ' CG ' ' N ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -69.32 -170.56 0.28 Allowed 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 120.469 -0.492 . . . . 0.0 109.849 179.967 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.407 ' N ' ' CG ' ' A' ' 72' ' ' GLN . 2.0 t -72.91 108.94 5.13 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.251 -178.039 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.669 ' HG3' ' CE2' ' A' ' 118' ' ' TRP 0.302 0.2 OUTLIER -35.82 -177.96 0.0 OUTLIER 'Trans proline' 0 CA--C 1.467 -2.864 0 C-N-CA 123.481 2.788 . . . . 0.0 113.553 173.807 . . . . . . . . 4 4 . 1 . 047 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.581 ' CB ' ' CE1' ' A' ' 97' ' ' TYR . 26.7 Cg_endo -71.78 -165.14 3.24 Favored 'Cis proline' 0 C--N 1.315 -1.187 0 N-CA-C 113.994 0.728 . . . . 0.0 113.994 -19.258 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.3 p -132.57 20.28 4.29 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 114.178 -1.374 . . . . 0.0 108.795 172.395 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.439 ' CG2' ' O ' ' A' ' 122' ' ' PRO . 17.5 pt -106.43 -159.32 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.265 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.14 -177.952 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.427 ' HB3' ' ND2' ' A' ' 79' ' ' ASN . 0.4 OUTLIER -131.24 148.34 52.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.869 177.199 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.427 ' ND2' ' HB3' ' A' ' 78' ' ' SER . 2.1 m-80 55.46 30.26 14.75 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.882 178.8 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.462 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -144.52 -168.38 12.57 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.417 -0.896 . . . . 0.0 113.039 -179.531 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.418 ' CG ' ' O ' ' A' ' 98' ' ' SER . 4.2 ptt180 -166.81 -174.49 2.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.069 0.462 . . . . 0.0 111.592 -178.789 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.523 ' CG ' ' HB2' ' A' ' 74' ' ' PRO . 41.1 p-80 -120.31 175.86 5.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.759 -177.858 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.425 ' ND2' ' O ' ' A' ' 96' ' ' THR . 1.2 m-20 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.282 178.216 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.434 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 7.5 m-85 . . . . . 0 N--CA 1.455 -0.184 0 CA-C-O 120.802 0.334 . . . . 0.0 110.885 . . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.483 ' CE2' ' HD2' ' A' ' 74' ' ' PRO . 37.9 m-85 -144.9 159.4 42.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.182 -178.811 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.2 p -119.11 172.5 7.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.374 -179.055 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 48.8 p-10 -59.81 94.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.14 -179.782 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.94 32.88 0.67 Allowed Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.959 178.681 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.44 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -110.07 160.39 16.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.843 0.354 . . . . 0.0 110.944 179.49 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 29.9 m -139.72 148.21 23.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.044 179.981 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.476 HG21 ' CH2' ' A' ' 118' ' ' TRP . 3.5 t -150.93 144.27 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.365 -179.148 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.425 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -93.67 135.19 35.21 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.146 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.581 ' CE1' ' CB ' ' A' ' 75' ' ' PRO . 3.3 m-30 -104.04 158.65 16.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.341 0.591 . . . . 0.0 112.282 -175.21 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.418 ' O ' ' CG ' ' A' ' 81' ' ' ARG . 61.0 m -142.24 144.77 33.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.391 178.766 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.428 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 93.3 m -71.25 148.03 47.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.912 0.387 . . . . 0.0 111.596 -178.893 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.462 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 62.5 m-20 -75.6 -77.42 0.13 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.973 -178.501 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.0 t -62.19 -18.73 61.87 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.641 0.258 . . . . 0.0 111.624 -178.285 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.95 27.46 1.88 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.653 -179.993 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.461 ' CD2' HD12 ' A' ' 126' ' ' ILE . 34.9 m-85 -69.0 -173.35 0.48 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.867 0.365 . . . . 0.0 110.428 179.26 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -112.06 109.52 19.31 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.855 178.026 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.439 ' CD2' ' HA ' ' A' ' 109' ' ' SER . 0.2 OUTLIER -52.2 123.42 10.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.457 0.646 . . . . 0.0 111.059 -178.656 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.463 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 28.3 mm -95.57 162.14 2.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.247 179.783 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.431 ' N ' ' CG2' ' A' ' 106' ' ' ILE . . . 57.28 -128.66 47.97 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.235 -0.984 . . . . 0.0 112.253 -179.572 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -110.68 135.64 50.98 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.025 0.44 . . . . 0.0 112.118 -178.913 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.439 ' HA ' ' CD2' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -77.33 -32.52 55.29 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 174.481 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -68.3 117.4 8.38 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 110.536 -1.025 . . . . 0.0 110.536 175.332 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.545 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 32.4 t -117.36 127.01 74.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 C-N-CA 121.977 0.111 . . . . 0.0 110.787 -175.832 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.42 133.32 34.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.43 . . . . 0.0 111.857 -177.744 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.49 ' HB2' ' CZ3' ' A' ' 118' ' ' TRP . 23.0 t -97.0 100.01 11.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.441 176.384 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.33 170.47 16.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.128 -178.45 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.38 26.13 2.28 Favored Glycine 0 CA--C 1.517 0.214 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.727 179.762 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.484 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 71.58 19.47 77.86 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.516 -179.613 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -153.09 179.64 8.52 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.188 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.669 ' CE2' ' HG3' ' A' ' 74' ' ' PRO . 97.1 m95 -100.7 129.47 46.61 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.046 0.45 . . . . 0.0 111.023 -179.703 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.38 156.49 19.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.237 -178.787 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.511 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER 54.53 42.81 1.19 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.13 179.868 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.511 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 72.4 Cg_endo -75.01 154.13 42.21 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.146 1.897 . . . . 0.0 111.748 178.649 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.463 ' CB ' ' O ' ' A' ' 106' ' ' ILE . 57.6 Cg_endo -88.24 -169.73 0.46 Allowed 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.544 2.162 . . . . 0.0 113.191 -179.46 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.446 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -133.32 173.52 11.38 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.962 176.498 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 1.4 m -134.06 97.34 3.84 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.989 179.964 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -129.35 163.65 25.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.937 -179.228 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.461 HD12 ' CD2' ' A' ' 103' ' ' TYR . 23.2 mm . . . . . 0 C--N 1.324 -0.524 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.07 -179.937 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.946 0.403 . . . . 0.0 111.002 . . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.428 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 34.1 m -79.47 161.41 67.33 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.15 -179.7 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -70.65 172.81 12.78 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.55 2.167 . . . . 0.0 112.18 179.794 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.8 t -54.13 108.73 1.21 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.856 -179.889 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.486 ' HG2' ' CZ2' ' A' ' 59' ' ' TRP . 53.9 Cg_exo -50.55 143.72 27.26 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.321 2.014 . . . . 0.0 112.263 179.905 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -56.91 151.15 15.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.221 179.047 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.56 -171.75 2.71 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.536 -177.719 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.423 HG22 ' CD2' ' A' ' 20' ' ' LEU . 14.9 tt -147.99 146.39 18.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.914 -179.448 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -86.29 156.43 20.25 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.018 178.446 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.447 ' N ' ' ND2' ' A' ' 17' ' ' ASN . 0.0 OUTLIER 43.28 29.11 0.2 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.964 -179.15 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.43 ' HA2' ' N ' ' A' ' 36' ' ' ASN . . . -157.71 177.91 34.27 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.536 -179.57 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.88 153.97 51.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.768 0.318 . . . . 0.0 110.605 -179.874 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.496 HD21 ' CE1' ' A' ' 33' ' ' TYR . 4.8 mt -91.57 153.15 19.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.002 0.429 . . . . 0.0 111.164 179.76 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.441 ' HB2' ' CB ' ' A' ' 32' ' ' THR . 19.6 t0 -123.96 67.4 1.04 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.337 177.526 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.437 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 0.9 OUTLIER -79.77 95.82 2.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.77 -176.667 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.11 15.94 61.7 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.025 177.662 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 161.62 128.19 0.93 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.054 -179.6 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.413 ' HA ' ' CH2' ' A' ' 59' ' ' TRP . 2.8 m -114.8 15.76 8.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -179.077 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 28' ' ' GLY . 5.2 m-20 -79.59 157.18 27.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.913 0.387 . . . . 0.0 111.312 -179.573 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -54.34 86.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.019 179.705 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 132.79 -5.41 5.12 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.024 179.974 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.9 m -77.87 -178.01 5.23 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.926 0.363 . . . . 0.0 110.787 179.999 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 47' ' ' SER . 5.4 p -146.15 154.09 41.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.871 0.367 . . . . 0.0 111.427 -179.924 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.537 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.5 OUTLIER -115.84 170.89 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.113 179.749 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.441 ' CB ' ' HB2' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -137.91 106.87 5.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.735 178.41 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.496 ' CE1' HD21 ' A' ' 20' ' ' LEU . 34.3 m-85 -79.09 148.25 32.47 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.86 -179.79 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.8 p -152.23 158.3 42.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.222 -179.703 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.9 m -84.92 163.88 18.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.958 179.78 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.43 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 5.9 m-20 -64.57 -84.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.295 -179.168 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -153.3 134.48 14.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.85 -179.594 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.12 23.41 69.7 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.945 -178.929 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.484 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.3 m-85 -117.0 175.43 5.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.37 . . . . 0.0 110.906 -179.292 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.443 ' HB3' ' CG2' ' A' ' 69' ' ' VAL . 0.5 OUTLIER -141.05 115.73 9.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.427 177.549 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.413 ' CD2' ' O ' ' A' ' 44' ' ' GLU . 2.0 tt -77.33 131.66 38.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.493 -179.448 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.8 mm -100.15 162.13 3.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.15 -179.218 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.9 -137.25 26.6 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.24 -179.355 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.413 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -76.82 177.47 7.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.729 0.299 . . . . 0.0 110.825 179.621 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.401 ' HB3' HD23 ' A' ' 41' ' ' LEU . 4.5 p -147.31 22.65 1.18 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.054 179.885 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.406 ' CG ' ' O ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -145.92 -177.91 5.84 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.214 0.531 . . . . 0.0 111.527 -178.626 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.436 ' CB ' HG12 ' A' ' 31' ' ' ILE . 0.5 OUTLIER -155.06 147.79 24.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.486 178.567 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.469 ' CD1' ' O ' ' A' ' 60' ' ' ASN . 2.4 m-85 -125.03 118.95 27.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.983 0.42 . . . . 0.0 111.934 -177.652 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.488 ' HB3' ' CH2' ' A' ' 59' ' ' TRP . 34.6 t -70.93 112.57 7.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.407 178.417 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.48 -176.77 4.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.15 0.5 . . . . 0.0 111.553 -179.432 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.853 -179.626 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.1 mmt . . . . . 0 N--CA 1.456 -0.14 0 CA-C-O 120.774 0.321 . . . . 0.0 110.58 . . . . . . . . . 0 0 . 1 . 048 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.1 m -154.01 178.71 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.246 -179.303 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.537 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 86.4 m95 -135.1 125.87 27.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.027 -179.427 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.469 ' O ' ' CD1' ' A' ' 48' ' ' TYR . 13.6 m-80 -146.43 127.13 7.13 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.219 -179.636 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 47' ' ' SER . 74.3 Cg_endo -75.36 -165.51 4.28 Favored 'Cis proline' 0 C--N 1.352 0.76 0 C-N-CA 123.849 -1.313 . . . . 0.0 112.394 -0.652 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.8 -151.81 0.49 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.249 -178.819 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.493 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -79.03 116.9 63.59 Favored Pre-proline 0 C--N 1.333 -0.119 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.058 -179.654 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -72.21 -151.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.645 2.23 . . . . 0.0 112.499 -179.257 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.3 mm -99.99 167.22 2.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.403 -178.858 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.2 m -161.13 128.5 4.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.752 179.219 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.475 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -152.49 178.6 9.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.956 -179.727 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.484 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 87.4 p -80.41 119.62 23.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.185 0.517 . . . . 0.0 111.094 -179.883 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.451 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 2.3 p -45.63 96.35 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.526 179.82 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -82.79 118.02 23.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.067 179.888 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.65 117.28 34.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.129 179.047 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.56 -157.01 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.837 -179.605 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.458 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 2.1 t -49.02 138.56 13.01 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.06 -179.656 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.475 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 26.8 Cg_exo -60.32 161.35 20.32 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.349 2.033 . . . . 0.0 111.973 179.807 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.484 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 88.3 Cg_exo -42.39 156.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.675 2.25 . . . . 0.0 112.744 -179.821 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.2 t -108.46 90.91 3.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.552 179.378 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.7 pt -69.16 178.33 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.305 -179.163 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -99.23 140.2 33.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.756 179.624 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.49 ' HB3' ' CE2' ' A' ' 103' ' ' TYR . 0.1 OUTLIER 63.92 29.21 14.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.555 -179.992 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.418 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . -169.51 -165.46 26.93 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.814 179.627 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' A' ' 98' ' ' SER . 6.7 ptt180 -168.69 -175.63 2.5 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.85 0.357 . . . . 0.0 110.611 -179.584 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.458 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 10.5 p80 -111.61 167.91 9.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.282 -179.651 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.738 179.889 . . . . . . . . 0 0 . 1 . 048 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.416 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 11.0 m-85 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.733 0.302 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.416 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 46.5 m-85 -148.18 162.71 38.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.101 179.924 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 16.5 p -136.3 -174.92 3.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.058 -179.616 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.425 ' OD1' ' CG1' ' A' ' 69' ' ' VAL . 1.6 m-20 -62.25 93.78 0.05 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.193 0.52 . . . . 0.0 111.246 -179.679 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.48 30.42 0.84 Allowed Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.514 -0.766 . . . . 0.0 113.143 178.175 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.421 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.5 OUTLIER -109.83 155.46 21.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.823 0.311 . . . . 0.0 110.62 179.135 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 28.8 m -133.5 150.7 32.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.171 0.51 . . . . 0.0 111.285 -179.719 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.492 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 22.1 t -147.22 149.19 15.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.495 179.612 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.63 123.06 49.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.176 0.512 . . . . 0.0 111.117 -179.991 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.504 ' CE1' ' CG2' ' A' ' 111' ' ' VAL . 4.7 m-85 -79.14 161.82 26.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.48 -179.244 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.4 ' O ' ' N ' ' A' ' 81' ' ' ARG . 49.3 m -152.41 133.54 14.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.442 -179.872 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.418 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 73.4 m -69.62 163.92 24.47 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.77 179.415 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.46 -84.93 0.4 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.917 179.514 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.8 t -44.41 -28.68 0.58 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.445 -179.696 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 126.74 35.74 0.54 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.769 179.605 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.5 ' CE1' HG12 ' A' ' 126' ' ' ILE . 52.0 m-85 -76.46 -173.86 2.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.793 0.33 . . . . 0.0 110.467 179.364 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.401 ' O ' HG12 ' A' ' 106' ' ' ILE . 0.2 OUTLIER -111.58 113.67 26.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.079 0.466 . . . . 0.0 111.04 -179.696 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.447 ' CD2' ' HA ' ' A' ' 109' ' ' SER . 0.3 OUTLIER -50.63 112.14 0.65 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.74 179.078 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.456 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 49.9 mm -97.61 158.58 3.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.976 -179.583 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 108' ' ' ASN . . . 52.87 34.55 45.56 Favored Glycine 0 CA--C 1.509 -0.294 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.632 179.3 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.422 ' O ' ' O ' ' A' ' 107' ' ' GLY . 8.6 p30 52.88 138.32 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 124.158 0.983 . . . . 0.0 112.974 179.43 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.483 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 0.9 OUTLIER -66.9 -23.9 66.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.686 -179.435 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.36 125.37 39.28 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.702 -179.543 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.504 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 2.2 t -129.32 121.56 53.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 179.515 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.98 123.56 32.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.827 0.346 . . . . 0.0 111.525 -178.787 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.492 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 19.8 t -88.83 103.5 16.05 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 176.55 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.37 158.83 43.28 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.048 0.451 . . . . 0.0 111.271 -178.772 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.11 31.39 5.94 Favored Glycine 0 N--CA 1.453 -0.195 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.715 179.824 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.451 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 70.2 12.08 68.36 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.646 -179.369 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -136.04 174.89 10.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.981 0.419 . . . . 0.0 110.67 179.522 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.492 ' CH2' ' CG2' ' A' ' 95' ' ' VAL . 91.2 m95 -113.22 129.57 56.48 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.731 -179.732 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.07 145.85 39.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.087 0.47 . . . . 0.0 111.443 -178.822 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.482 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER 69.63 44.63 0.25 Allowed Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.288 178.675 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 55.6 Cg_endo -69.93 143.91 51.5 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.174 1.916 . . . . 0.0 111.27 177.874 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.483 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 62.3 Cg_endo -90.91 -173.22 0.56 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.519 2.146 . . . . 0.0 113.719 -177.732 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.55 -159.13 0.93 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.778 178.672 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . 0.419 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 7.6 m -154.82 88.99 1.21 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.949 0.404 . . . . 0.0 110.992 179.337 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -112.57 160.96 17.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.737 179.877 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.5 HG12 ' CE1' ' A' ' 103' ' ' TYR . 15.9 mm . . . . . 0 C--N 1.323 -0.576 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.285 -179.631 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.409 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 2.5 mtt180 . . . . . 0 CA--C 1.528 0.134 0 CA-C-O 120.91 0.386 . . . . 0.0 111.827 . . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.438 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 66.4 m -116.0 160.23 36.21 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.697 -179.967 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.17 172.64 9.69 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.419 2.079 . . . . 0.0 111.928 179.464 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.39 110.62 1.62 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.874 -179.778 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.432 ' CB ' HD11 ' A' ' 31' ' ' ILE . 13.8 Cg_endo -57.32 159.31 16.15 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.209 1.939 . . . . 0.0 112.061 -179.761 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.424 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 6.2 ttt180 -63.66 174.79 1.25 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.807 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -136.87 -175.69 4.11 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.304 0.573 . . . . 0.0 111.62 -179.534 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.4 tt -131.68 152.45 37.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.363 179.801 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -77.92 -66.75 0.8 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.391 -178.567 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -93.37 36.72 1.06 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.746 -179.932 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.43 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -149.89 176.88 28.36 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.813 -179.824 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -138.04 134.55 34.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.785 0.326 . . . . 0.0 110.419 179.64 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.536 ' CD2' ' CZ ' ' A' ' 33' ' ' TYR . 11.5 mt -83.71 156.22 22.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.062 0.458 . . . . 0.0 111.486 -179.508 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.83 73.72 0.91 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.679 177.569 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.443 HG13 ' CG2' ' A' ' 31' ' ' ILE . 2.5 mt -70.34 92.76 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.972 -177.395 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.26 10.9 67.1 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.522 -0.846 . . . . 0.0 111.904 176.712 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 150.69 145.65 4.17 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 -179.347 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.1 m -119.29 6.15 6.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.489 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.409 ' HA ' ' HB3' ' A' ' 8' ' ' ARG . 2.7 p-10 -69.6 155.58 40.27 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.974 0.416 . . . . 0.0 111.31 -179.417 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.46 ' CE1' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -49.74 102.47 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.932 179.823 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.27 5.82 24.46 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.516 -179.09 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.96 -178.82 7.05 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.934 0.367 . . . . 0.0 110.448 179.366 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 88.1 p -151.77 147.64 26.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.253 0.549 . . . . 0.0 111.547 -179.551 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.483 HD13 ' CE3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -118.4 150.16 20.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.058 179.466 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.31 119.0 36.18 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.76 0.314 . . . . 0.0 111.182 -179.756 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.609 ' CZ ' ' O ' ' A' ' 62' ' ' GLU . 3.8 m-85 -85.57 138.56 32.1 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.048 0.452 . . . . 0.0 111.025 179.826 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.43 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.5 OUTLIER -149.58 169.22 21.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.017 -178.933 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.402 ' HA ' ' HA2' ' A' ' 18' ' ' GLY . 92.8 m -90.57 166.71 13.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.505 -179.055 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.71 -75.61 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.893 179.96 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -161.55 139.81 9.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.737 179.784 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.423 ' HA3' ' CB ' ' A' ' 91' ' ' ASP . . . 53.76 26.6 33.25 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.118 -179.327 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.497 ' CE2' ' CB ' ' A' ' 68' ' ' SER . 2.2 m-85 -113.6 -179.81 3.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.07 0.462 . . . . 0.0 111.184 -179.492 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.492 ' CE1' HD12 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -137.12 134.54 36.52 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.208 176.385 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.45 ' CD2' ' HG3' ' A' ' 64' ' ' PRO . 2.6 tt -88.69 135.13 33.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.542 -175.603 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.492 HD12 ' CE1' ' A' ' 40' ' ' HIS . 0.1 OUTLIER -110.57 123.62 66.64 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 CA-C-O 121.424 0.631 . . . . 0.0 111.329 -179.752 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.99 -145.99 16.01 Favored Glycine 0 C--N 1.316 -0.558 0 CA-C-N 114.553 -1.203 . . . . 0.0 112.621 179.527 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.446 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 3.5 mm-40 -61.96 -137.71 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.4 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.8 p 167.56 39.43 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 122.925 0.49 . . . . 0.0 110.806 179.272 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.471 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . 0.7 OUTLIER -168.49 170.18 9.91 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.537 0.685 . . . . 0.0 112.461 -178.013 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.529 ' HA ' ' O ' ' A' ' 61' ' ' PRO . 20.7 m -148.78 139.71 22.95 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.767 178.591 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.545 ' CD2' ' N ' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -132.42 129.54 39.44 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 117.752 -1.579 . . . . 0.0 113.836 -176.78 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 30.2 t -74.88 96.68 3.16 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.154 -1.385 . . . . 0.0 110.763 179.171 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.51 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 2.2 tt0 -130.35 173.26 10.98 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.661 -179.967 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.51 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.669 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.435 -178.648 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.521 -0.135 0 CA-C-O 120.844 0.354 . . . . 0.0 110.142 . . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.6 m -142.81 -175.78 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.872 -178.51 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.483 ' CE3' HD13 ' A' ' 31' ' ' ILE . 73.2 m95 -128.81 125.79 38.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.973 0.416 . . . . 0.0 111.707 -179.69 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.533 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 1.7 m-20 -67.82 171.76 4.98 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 174.729 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.533 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 0.3 OUTLIER 4.16 118.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.256 1 C-N-CA 125.467 4.111 . . . . 0.0 115.527 -176.024 . . . . . . . . 4 4 . 1 . 049 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.609 ' O ' ' CZ ' ' A' ' 33' ' ' TYR . 6.1 mm-40 -84.95 -77.6 0.27 Allowed 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 114.536 -1.211 . . . . 0.0 112.05 -174.105 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.589 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -65.54 -139.13 0.0 OUTLIER Pre-proline 0 CA--C 1.499 -1.016 0 CA-C-O 116.477 -1.725 . . . . 0.0 109.48 -177.991 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.557 ' CA ' ' CB ' ' A' ' 63' ' ' ALA . 4.3 Cg_exo -88.76 -158.7 1.19 Allowed 'Cis proline' 0 N--CA 1.483 0.91 0 CA-C-N 124.213 2.54 . . . . 0.0 114.856 15.441 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.3 pt -97.4 -176.47 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.366 -178.024 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.5 m -157.79 116.7 3.2 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.745 -179.052 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -105.46 172.82 6.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.588 178.433 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.497 ' CB ' ' CE2' ' A' ' 39' ' ' TYR . 2.0 p -97.09 113.07 24.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.058 179.896 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.441 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 0.6 OUTLIER -49.42 99.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.063 179.523 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.453 ' CE ' ' CG2' ' A' ' 90' ' ' THR . 0.3 OUTLIER -79.37 124.07 28.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.511 -179.356 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.28 117.58 34.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.924 178.039 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.8 -156.89 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.849 -179.15 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.431 ' OG ' ' NE2' ' A' ' 82' ' ' HIS . 1.8 t -47.75 136.56 10.35 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.119 -179.794 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.423 ' HG3' ' CZ2' ' A' ' 118' ' ' TRP . 30.6 Cg_exo -58.41 161.72 13.71 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.223 1.948 . . . . 0.0 111.461 179.487 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.45 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 93.3 Cg_exo -40.16 156.3 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.57 2.18 . . . . 0.0 112.631 -178.978 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.4 t -106.13 88.62 2.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.855 179.971 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 21.4 pt -69.83 174.7 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.121 -179.804 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.4 m -99.22 142.72 30.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.753 179.405 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.482 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 8.9 m-80 60.3 28.51 18.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.193 179.687 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.421 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -166.44 -167.45 27.13 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.908 179.848 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.412 ' CD ' ' OD1' ' A' ' 100' ' ' ASN . 9.4 ptt85 -163.92 -175.81 4.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.897 0.379 . . . . 0.0 110.708 -179.534 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 15.7 p80 -114.07 167.17 10.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.984 -179.883 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 . . . . . 0 CA--C 1.534 0.349 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.614 179.785 . . . . . . . . 0 0 . 1 . 049 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.415 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 9.1 m-85 . . . . . 0 N--CA 1.451 -0.378 0 CA-C-O 120.854 0.359 . . . . 0.0 110.872 . . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.415 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 60.6 m-85 -149.26 159.92 43.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.479 179.516 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.453 ' CG2' ' CE ' ' A' ' 70' ' ' LYS . 9.5 p -122.55 -177.48 3.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.002 0.43 . . . . 0.0 111.64 -178.537 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.423 ' CB ' ' HA3' ' A' ' 38' ' ' GLY . 4.3 p-10 -68.58 96.49 0.71 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.867 179.948 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.67 18.3 2.21 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.286 -0.87 . . . . 0.0 113.182 178.882 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.35 162.06 13.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.871 0.336 . . . . 0.0 110.542 179.121 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.3 m -138.08 153.52 27.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.144 0.497 . . . . 0.0 111.198 -179.736 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.466 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 21.3 t -147.93 149.4 15.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.924 179.705 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.425 ' CG2' ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -108.41 128.37 54.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.855 179.751 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.523 ' CE2' ' CG2' ' A' ' 111' ' ' VAL . 5.9 m-85 -88.96 157.58 18.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.201 -179.294 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 22.8 m -154.57 142.11 19.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.458 -179.661 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 69.0 m -73.51 159.39 33.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.797 179.217 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.421 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 69.8 m-20 -93.04 -70.75 0.69 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.32 -179.404 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.9 t -61.05 -23.48 65.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.224 -179.358 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.56 32.86 1.07 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.452 -179.821 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.486 ' CE2' HG12 ' A' ' 126' ' ' ILE . 16.0 m-85 -69.92 -175.41 0.91 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.057 0.456 . . . . 0.0 110.934 -179.903 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.75 100.47 9.47 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.206 178.47 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.436 HD23 ' CB ' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -44.76 126.21 5.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.442 0.639 . . . . 0.0 111.957 -177.927 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.453 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 35.4 mm -87.72 153.86 3.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.749 178.43 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.03 -129.2 40.89 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.314 -0.946 . . . . 0.0 112.06 -179.04 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -122.62 142.47 50.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.865 0.364 . . . . 0.0 110.874 179.417 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.428 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 1.6 t -70.19 -29.87 66.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.893 179.985 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -72.57 135.34 21.92 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.818 -179.665 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.523 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 2.4 t -131.6 118.51 39.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.703 0.287 . . . . 0.0 110.812 179.44 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.92 122.92 28.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.521 -179.017 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.515 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 16.3 t -89.56 102.09 14.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.569 176.982 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.12 157.99 44.53 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.04 -178.608 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.05 33.87 7.28 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.703 -179.965 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.441 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 66.02 10.29 50.86 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.522 -179.115 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -129.8 168.96 15.77 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.894 0.378 . . . . 0.0 110.578 179.407 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.515 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 94.9 m95 -109.98 134.5 52.05 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.929 -179.82 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.7 153.66 32.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.931 179.89 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.55 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 61.2 t0 66.04 37.17 0.2 Allowed Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 179.326 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.55 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 65.1 Cg_endo -75.78 134.89 17.05 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.12 1.88 . . . . 0.0 111.587 179.229 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.453 ' CB ' ' O ' ' A' ' 106' ' ' ILE . 87.0 Cg_endo -92.11 -172.3 0.4 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.812 2.341 . . . . 0.0 113.889 -177.33 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.435 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -133.11 -158.59 0.9 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.722 178.042 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 8.1 m -153.85 90.49 1.38 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.13 0.491 . . . . 0.0 111.012 179.129 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -122.33 157.31 32.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.778 179.966 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.486 HG12 ' CE2' ' A' ' 103' ' ' TYR . 19.0 mm . . . . . 0 C--N 1.323 -0.564 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.941 -179.87 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.162 0 CA-C-O 120.896 0.379 . . . . 0.0 112.01 . . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.475 ' O ' ' O ' ' A' ' 10' ' ' PRO . 1.3 m -100.35 171.35 5.62 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.347 -179.504 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 9' ' ' CYS . 75.5 Cg_exo -51.44 -147.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.262 2.641 . . . . 0.0 113.037 179.298 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.433 ' HB2' ' C ' ' A' ' 12' ' ' PRO . 40.7 t -37.26 -85.25 0.0 OUTLIER Pre-proline 0 CA--C 1.499 -1.011 0 CA-C-O 117.117 -1.42 . . . . 0.0 113.882 -177.216 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.5 ' HB3' ' CE2' ' A' ' 59' ' ' TRP . 63.7 Cg_endo -77.38 157.58 96.13 Favored 'Cis proline' 0 N--CA 1.481 0.764 0 CA-C-N 123.757 2.378 . . . . 0.0 115.083 -0.969 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.455 ' HG2' ' N ' ' A' ' 14' ' ' ASP . 17.1 tpp180 -50.64 156.7 0.87 Allowed 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.779 178.883 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.455 ' N ' ' HG2' ' A' ' 13' ' ' ARG . 0.3 OUTLIER -109.57 -175.73 2.83 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.99 -179.779 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.8 tt -128.01 147.74 32.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.723 179.759 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -83.94 -42.31 16.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.343 -178.521 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . 0.408 ' ND2' ' N ' ' A' ' 17' ' ' ASN . 0.8 OUTLIER -103.07 39.32 1.58 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.849 -179.233 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.415 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -175.5 -172.69 40.59 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.781 179.864 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -139.17 140.24 37.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.756 0.312 . . . . 0.0 110.407 179.732 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.543 ' CD2' ' CE1' ' A' ' 33' ' ' TYR . 11.3 mt -85.35 150.91 24.42 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.16 0.505 . . . . 0.0 112.12 -179.091 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.437 ' CB ' ' HB ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -120.51 72.32 0.95 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.23 175.275 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.466 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 1.7 mt -69.13 97.84 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.636 -176.974 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -88.94 7.45 82.11 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.282 178.002 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 159.07 136.95 2.14 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.528 179.972 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.1 m -113.73 25.23 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.785 0.326 . . . . 0.0 111.189 -179.817 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.407 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.5 OUTLIER -100.88 142.69 31.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.036 179.973 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.465 ' CE2' HD12 ' A' ' 51' ' ' LEU . 9.4 t80 -47.51 93.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.18 0.514 . . . . 0.0 110.715 179.302 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 134.32 -4.84 4.53 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.556 -178.959 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.91 -162.23 0.91 Allowed 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.975 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -168.41 150.56 5.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.089 0.471 . . . . 0.0 111.046 179.58 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . 0.466 ' CG2' ' HA ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -104.49 160.16 5.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.908 179.243 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.437 ' HB ' ' CB ' ' A' ' 21' ' ' ASP . 1.7 m -125.3 114.91 19.54 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.803 0.335 . . . . 0.0 110.447 179.307 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.543 ' CE1' ' CD2' ' A' ' 20' ' ' LEU . 11.2 m-85 -91.53 149.68 21.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.184 0.516 . . . . 0.0 111.962 -178.048 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.415 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.6 OUTLIER -153.99 145.89 23.51 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.699 179.498 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 39' ' ' TYR . 10.8 m -70.47 167.45 18.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.714 0.292 . . . . 0.0 110.629 179.816 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -68.97 -84.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.003 -179.44 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.2 m -153.3 134.31 14.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.695 179.716 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.76 26.02 73.03 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.852 -178.93 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.495 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.1 m-85 -118.99 170.25 9.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.868 0.366 . . . . 0.0 111.104 -179.382 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.522 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.4 OUTLIER -134.13 113.52 12.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.376 178.169 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.442 HD22 ' CB ' ' A' ' 45' ' ' SER . 4.8 tt -79.64 122.59 26.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.794 -179.438 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.522 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 2.3 mm -95.64 157.08 3.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.015 0.436 . . . . 0.0 111.284 -179.179 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.54 -135.23 19.11 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.159 -179.379 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.431 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -85.95 -174.09 4.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.784 0.326 . . . . 0.0 110.822 179.469 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.442 ' CB ' HD22 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -160.53 27.27 0.16 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.403 179.616 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 6.5 mtpt -151.32 129.95 12.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.332 -179.467 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.442 ' OG ' ' CD1' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -101.28 159.29 15.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.168 179.316 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.467 ' CD1' ' CB ' ' A' ' 60' ' ' ASN . 1.1 m-85 -132.16 121.54 23.89 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.58 -0.848 . . . . 0.0 112.222 -179.642 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 8.4 t -75.23 83.84 2.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.886 178.747 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -103.6 -177.86 3.49 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.622 -178.468 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.465 HD12 ' CE2' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.014 -179.262 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.4 ' HB2' ' HA ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.319 0 CA-C-O 121.001 0.429 . . . . 0.0 109.879 . . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.5 m -127.21 163.48 30.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.869 -178.773 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.5 ' CE2' ' HB3' ' A' ' 12' ' ' PRO . 63.5 m95 -116.01 118.06 31.86 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.647 -178.666 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.472 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 1.2 m-80 -72.26 165.46 50.53 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.27 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.472 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 87.3 Cg_exo -15.91 98.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.644 1 C-N-CA 125.681 4.254 . . . . 0.0 115.014 -178.39 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.505 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 4.2 mt-10 -99.35 -68.44 0.8 Allowed 'General case' 0 C--O 1.221 -0.426 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -176.487 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.428 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -102.14 77.68 0.22 Allowed Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -174.053 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 62' ' ' GLU . 36.5 Cg_endo -55.87 -154.37 0.01 OUTLIER 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 123.327 2.684 . . . . 0.0 111.575 175.352 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.409 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 4.2 mm -93.56 165.32 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.051 0.453 . . . . 0.0 111.42 179.654 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -165.03 135.25 3.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.662 179.277 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.3 OUTLIER -153.86 176.18 12.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.014 -179.786 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.495 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 26.4 p -85.17 123.48 30.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.16 179.894 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.448 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 1.3 p -55.82 96.54 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.246 179.973 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.15 124.0 27.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.522 -179.522 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.441 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -104.57 125.94 51.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.957 178.234 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -75.75 -151.38 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.165 -179.962 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.412 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 2.8 t -55.3 138.67 66.96 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-O 120.636 0.255 . . . . 0.0 110.883 -179.568 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.483 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 29.2 Cg_exo -59.51 161.36 17.62 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.373 2.049 . . . . 0.0 112.078 179.969 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.5 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 87.0 Cg_exo -43.07 158.36 0.08 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.725 2.283 . . . . 0.0 112.798 -179.142 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 85.9 p -112.27 89.56 3.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.235 178.548 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.3 pt -69.24 167.82 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.206 -178.742 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 p -86.48 134.21 33.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.86 179.811 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.479 ' HB3' ' CE1' ' A' ' 103' ' ' TYR . 0.1 OUTLIER 67.77 28.37 7.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.486 -179.977 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -167.2 -166.04 25.61 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.141 179.661 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 98' ' ' SER . 0.4 OUTLIER -170.19 -174.11 1.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.091 0.472 . . . . 0.0 110.858 -178.829 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 15.3 p80 -104.89 172.37 6.82 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.945 179.537 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.4 ' ND2' ' HB ' ' A' ' 96' ' ' THR . 30.1 m-20 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.711 -179.979 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.428 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 5.6 m-85 . . . . . 0 N--CA 1.454 -0.241 0 CA-C-O 121.078 0.466 . . . . 0.0 111.499 . . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.441 ' N ' ' O ' ' A' ' 71' ' ' CYS . 46.5 m-85 -149.08 166.08 29.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.41 -179.551 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.8 p -126.08 -178.62 4.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.967 0.413 . . . . 0.0 111.483 -179.444 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -67.12 96.29 0.45 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.926 -179.867 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.18 23.93 1.52 Allowed Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.236 -0.893 . . . . 0.0 113.061 179.112 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.68 159.22 16.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.645 0.26 . . . . 0.0 110.425 179.254 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 33.0 m -132.69 156.27 42.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.29 0.567 . . . . 0.0 111.501 -179.644 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.49 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 22.8 t -151.11 149.38 14.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.341 179.078 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.4 ' HB ' ' ND2' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -103.7 139.47 38.91 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.029 0.442 . . . . 0.0 110.562 179.242 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.523 ' CE1' ' CG2' ' A' ' 111' ' ' VAL . 3.2 m-85 -95.94 158.57 15.39 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.814 -179.434 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 81' ' ' ARG . 1.2 p -147.78 133.05 18.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.659 -178.681 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 99' ' ' CYS . . . . . 0.429 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 81.9 m -70.19 160.41 32.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.46 178.401 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.58 -85.33 0.36 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.776 0.322 . . . . 0.0 110.987 179.572 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -43.7 -28.82 0.44 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.642 -179.498 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 126.61 36.24 0.53 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.719 179.662 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.491 ' CE2' HG12 ' A' ' 126' ' ' ILE . 47.8 m-85 -77.52 -173.91 3.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.884 0.373 . . . . 0.0 110.923 179.958 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.402 ' O ' HG12 ' A' ' 106' ' ' ILE . 0.9 OUTLIER -113.06 107.26 15.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.799 179.917 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.434 ' CD2' ' HB2' ' A' ' 122' ' ' PRO . 1.1 mp -45.21 117.08 1.26 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.296 179.842 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.454 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 47.1 mm -106.25 155.54 7.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.935 -179.512 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . 0.415 ' O ' ' ND2' ' A' ' 108' ' ' ASN . . . 60.34 37.61 93.38 Favored Glycine 0 CA--C 1.508 -0.396 0 C-N-CA 120.321 -0.942 . . . . 0.0 112.243 179.835 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 107' ' ' GLY . 8.4 p30 51.36 120.3 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.45 -0.875 . . . . 0.0 112.507 179.777 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.458 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 1.3 p -54.4 -27.64 38.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.307 179.83 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.22 137.16 49.27 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.697 -179.465 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.523 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 2.9 t -134.87 137.15 51.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.454 0.169 . . . . 0.0 110.621 179.983 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.76 125.78 42.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.878 0.371 . . . . 0.0 111.478 -179.455 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.516 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 34.6 t -90.66 100.67 13.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.662 176.883 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.27 159.55 42.0 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.129 -178.495 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.18 32.06 6.52 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.655 -179.912 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . 0.448 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 70.52 6.16 57.7 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.916 -179.759 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -129.8 -178.46 4.72 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.861 0.362 . . . . 0.0 110.498 179.261 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.516 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 92.0 m95 -117.36 122.72 44.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.932 -179.52 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.07 152.65 21.83 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.28 -179.049 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.513 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.5 OUTLIER 67.0 43.27 0.3 Allowed Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.205 179.27 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 56.4 Cg_endo -69.75 141.42 45.22 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.158 1.905 . . . . 0.0 111.261 178.117 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.482 ' HG2' ' CD2' ' A' ' 97' ' ' TYR . 87.4 Cg_endo -92.25 -169.8 0.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.554 2.169 . . . . 0.0 113.636 -177.594 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.28 -168.03 2.37 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.151 178.853 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 124' ' ' CYS . . . . . 0.422 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 6.7 m -145.84 94.81 2.54 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.006 0.431 . . . . 0.0 110.962 179.95 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -118.93 157.9 26.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.85 -179.772 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.491 HG12 ' CE2' ' A' ' 103' ' ' TYR . 22.9 mm . . . . . 0 C--N 1.324 -0.533 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.229 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.732 0.301 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 26' ' ' ASP . 0.2 OUTLIER 54.98 166.7 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 121.166 0.508 . . . . 0.0 111.809 178.863 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.45 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 25.7 m -103.6 163.32 17.65 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.647 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.438 ' HD3' ' HB2' ' A' ' 9' ' ' CYS . 38.1 Cg_endo -67.53 171.8 11.32 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.253 1.969 . . . . 0.0 112.052 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.77 104.38 0.42 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.226 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.427 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 2.5 Cg_endo -49.95 156.92 3.05 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.201 1.934 . . . . 0.0 112.058 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.437 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 6.5 mtt180 -76.23 164.39 26.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.305 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.44 -172.62 2.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.198 0.523 . . . . 0.0 111.633 -178.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.412 ' CD1' ' HD3' ' A' ' 64' ' ' PRO . 17.1 tt -145.47 143.26 22.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.891 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.457 ' HB3' ' ND2' ' A' ' 17' ' ' ASN . 2.8 p30 -76.65 160.97 28.92 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.032 0.444 . . . . 0.0 110.352 177.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.457 ' ND2' ' HB3' ' A' ' 16' ' ' ASP . 0.7 OUTLIER 39.01 29.8 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.224 -178.324 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 16' ' ' ASP . . . -151.42 170.54 31.01 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.638 -178.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.36 137.59 39.03 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.769 0.319 . . . . 0.0 110.674 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.517 ' CD2' ' CE2' ' A' ' 33' ' ' TYR . 13.1 mt -82.86 159.68 22.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.041 0.448 . . . . 0.0 111.429 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -126.37 71.32 1.27 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.596 177.657 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.447 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 1.2 mt -69.81 93.44 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.855 -177.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.6 17.85 57.69 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.712 176.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.27 133.78 1.77 Allowed Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.055 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.1 m -119.73 25.9 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.86 0.362 . . . . 0.0 111.055 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 1.4 p-10 -87.11 152.43 22.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.235 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.45 ' CZ ' ' HB2' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -49.98 97.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.746 179.469 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 115.76 6.21 17.23 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.725 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.03 -167.13 1.54 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.833 0.316 . . . . 0.0 110.552 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 47' ' ' SER . 5.5 p -160.28 138.79 10.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.004 0.431 . . . . 0.0 111.675 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.537 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.7 OUTLIER -103.09 150.23 6.81 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.302 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.966 178.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.427 ' O ' ' N ' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -109.38 115.18 29.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.84 0.352 . . . . 0.0 111.144 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.517 ' CE2' ' CD2' ' A' ' 20' ' ' LEU . 13.7 m-85 -88.23 144.24 26.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.627 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -153.55 160.41 42.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.753 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.1 m -82.21 169.36 16.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.092 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -68.25 -84.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.117 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.37 133.25 12.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.821 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.28 22.21 72.66 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.151 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.504 ' CD2' ' HA ' ' A' ' 68' ' ' SER . 2.4 m-85 -113.94 179.0 4.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.754 0.311 . . . . 0.0 110.785 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.515 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.3 OUTLIER -140.98 112.34 7.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.053 0.454 . . . . 0.0 110.678 178.72 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.429 ' CD1' ' HG3' ' A' ' 64' ' ' PRO . 5.1 tt -79.7 126.28 30.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.656 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.515 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 2.1 mm -104.09 163.97 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.992 0.425 . . . . 0.0 111.08 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.15 -133.98 19.15 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.362 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.418 ' O ' ' CB ' ' A' ' 64' ' ' PRO . 0.9 OUTLIER -84.93 -176.19 6.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.957 0.408 . . . . 0.0 110.956 179.657 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.411 ' HB3' HD23 ' A' ' 41' ' ' LEU . 3.2 p -157.38 18.78 0.28 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.698 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 0.5 OUTLIER -145.85 131.31 18.7 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -178.375 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.438 ' OG ' ' CB ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -96.28 147.09 24.14 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.698 176.788 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.474 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 2.2 m-85 -124.85 120.25 31.17 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 119.151 -1.02 . . . . 0.0 112.05 178.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 20.2 t -71.44 107.47 4.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.521 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.38 -174.51 3.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.116 0.484 . . . . 0.0 111.333 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.45 ' HB2' ' CZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -95.07 149.59 21.1 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.091 -178.806 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.35 -143.37 0.46 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.563 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.1 t -94.14 -33.83 13.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.815 0.341 . . . . 0.0 110.913 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 81.4 p -103.49 25.45 9.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.778 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.04 21.3 65.77 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.274 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.6 -175.93 6.0 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.017 0.437 . . . . 0.0 111.243 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.83 131.9 50.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.267 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.4 m -151.99 174.69 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.08 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.537 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 65.0 m95 -129.09 125.75 37.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.3 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.474 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -68.91 165.19 39.95 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.928 178.442 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.448 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 98.5 Cg_exo -17.21 96.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.804 1 C-N-CA 125.408 4.072 . . . . 0.0 114.695 -178.454 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.473 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -93.94 -77.32 0.46 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.212 -178.228 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.489 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -85.16 108.89 17.33 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -175.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.429 ' HG3' ' CD1' ' A' ' 41' ' ' LEU . 1.4 Cg_endo -86.01 -154.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.296 2.664 . . . . 0.0 110.989 176.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.425 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 4.3 mm -86.05 164.15 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.852 0.358 . . . . 0.0 110.766 178.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -168.41 129.81 1.33 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.773 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.58 168.49 26.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.023 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.504 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 53.3 p -83.69 122.76 29.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.17 0.509 . . . . 0.0 110.537 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.486 ' HB ' ' N ' ' A' ' 116' ' ' GLY . 22.5 m -45.79 100.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.052 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -94.12 99.03 11.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.321 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -92.91 116.25 28.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.071 0.462 . . . . 0.0 110.326 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.22 -163.83 0.07 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.678 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -41.64 131.84 2.31 Favored Pre-proline 0 N--CA 1.436 -1.139 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.58 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.481 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 50.0 Cg_exo -54.69 165.71 2.36 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.423 2.082 . . . . 0.0 112.365 -178.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.49 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 80.9 Cg_exo -39.71 161.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.926 2.418 . . . . 0.0 113.021 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.2 t -109.3 88.75 2.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.443 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 19.3 pt -69.32 173.27 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.271 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.6 m -92.96 141.81 27.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.732 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.491 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 7.5 m-80 57.22 30.85 19.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.814 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.435 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . -170.52 -166.06 28.84 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.979 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.63 -175.43 2.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.979 0.418 . . . . 0.0 110.781 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 11.3 p80 -105.81 171.85 7.12 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.969 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -104.53 -87.84 0.44 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.758 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.405 ' HA3' ' OH ' ' A' ' 89' ' ' TYR . . . 59.57 153.5 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.814 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.472 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -111.03 -33.56 6.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.052 0.453 . . . . 0.0 110.5 179.628 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.43 -172.07 2.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.91 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -106.47 -23.03 12.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.174 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -129.65 170.87 13.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.111 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.405 ' OH ' ' HA3' ' A' ' 84' ' ' GLY . 69.3 m-85 -152.34 164.27 37.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.936 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.2 p -145.76 -175.81 4.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.061 0.458 . . . . 0.0 111.709 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.409 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 6.8 p-10 -50.51 94.36 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.63 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.49 24.64 1.91 Allowed Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.49 176.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.41 152.76 24.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 117.165 0.482 . . . . 0.0 111.132 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 33.2 m -133.47 154.94 39.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.068 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.51 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 13.6 t -148.94 146.54 17.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.094 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.415 ' CG2' ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -100.29 136.76 39.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.625 179.343 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.523 ' CE1' ' CG2' ' A' ' 111' ' ' VAL . 4.4 m-85 -97.32 159.1 15.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.039 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.9 p -157.26 143.05 17.58 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.378 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.435 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 56.9 m -72.55 167.83 19.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.772 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -98.3 -85.89 0.36 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.894 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.4 t -47.26 -29.9 2.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.339 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.06 45.35 0.2 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.508 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.496 ' CE2' HG12 ' A' ' 126' ' ' ILE . 32.9 m-85 -82.83 -172.66 4.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.72 0.295 . . . . 0.0 110.684 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 m -108.4 105.46 15.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.937 0.399 . . . . 0.0 111.307 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.439 HD21 ' CG ' ' A' ' 122' ' ' PRO . 3.1 tp -46.22 113.22 0.59 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.996 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.45 ' HB ' ' CB ' ' A' ' 123' ' ' THR . 33.0 mm -85.97 156.25 3.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.464 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.428 ' N ' HG23 ' A' ' 106' ' ' ILE . . . 57.0 -130.43 50.95 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.364 -0.922 . . . . 0.0 111.478 -178.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 41.1 p-10 -116.09 136.28 53.17 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.087 0.47 . . . . 0.0 111.208 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.462 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 1.2 p -66.78 -26.25 66.87 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.476 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.18 142.67 31.97 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.712 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.523 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 3.3 t -138.66 120.88 17.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.609 0.242 . . . . 0.0 110.909 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.449 ' CD2' ' N ' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -79.14 135.93 36.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.931 0.396 . . . . 0.0 111.408 -179.417 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.493 ' HB2' ' CZ3' ' A' ' 118' ' ' TRP . 35.0 t -107.93 107.93 18.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.866 176.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 12.0 m -161.74 123.9 2.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.883 0.373 . . . . 0.0 111.729 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 91.35 27.33 18.35 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.493 179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.486 ' N ' ' HB ' ' A' ' 69' ' ' VAL . . . 71.46 18.02 76.69 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.173 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -147.89 179.28 7.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.222 0.534 . . . . 0.0 111.421 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.51 ' CH2' ' CG2' ' A' ' 95' ' ' VAL . 93.2 m95 -121.06 144.77 48.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.483 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.25 149.49 49.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.029 0.442 . . . . 0.0 111.465 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.489 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.5 OUTLIER 70.67 46.65 0.27 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.956 179.011 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 93.7 Cg_endo -77.6 138.53 17.29 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.509 2.139 . . . . 0.0 111.795 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.462 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 57.2 Cg_endo -89.82 -173.96 0.79 Allowed 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.634 2.223 . . . . 0.0 113.328 -179.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.45 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -135.01 -173.51 3.34 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.019 178.036 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . 0.417 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 17.2 m -144.38 94.74 2.61 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.968 0.413 . . . . 0.0 111.147 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -117.14 163.23 16.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.777 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.496 HG12 ' CE2' ' A' ' 103' ' ' TYR . 35.5 mm . . . . . 0 C--N 1.324 -0.527 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.514 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.402 ' HA ' ' CZ ' ' A' ' 7' ' ' ARG . 1.6 mmp_? . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.898 0.38 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.443 ' CB ' ' HA ' ' A' ' 26' ' ' ASP . 0.1 OUTLIER -88.17 171.47 10.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.164 -179.733 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.518 ' HB2' ' CD ' ' A' ' 10' ' ' PRO . 99.2 m -80.83 175.87 4.39 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.768 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.534 ' HD2' ' CD1' ' A' ' 59' ' ' TRP . 34.0 Cg_endo -89.56 179.46 2.19 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 122.734 2.289 . . . . 0.0 112.0 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.9 t -48.59 104.3 0.41 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.723 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.458 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 31.2 Cg_exo -43.09 167.37 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.176 1.917 . . . . 0.0 112.542 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.403 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -71.54 -175.62 1.36 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.743 177.37 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.406 ' O ' ' CB ' ' A' ' 63' ' ' ALA . 1.6 t0 -139.05 -178.43 5.33 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.329 0.585 . . . . 0.0 111.7 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.433 HG22 ' CD2' ' A' ' 20' ' ' LEU . 13.4 tt -147.11 144.23 19.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.496 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -76.21 -64.02 1.19 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.723 -178.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -90.52 45.47 1.26 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.952 0.406 . . . . 0.0 111.026 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.427 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -164.64 170.63 39.83 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.032 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -131.24 131.13 43.7 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.527 ' CD2' ' CE2' ' A' ' 33' ' ' TYR . 25.7 mt -82.02 160.34 23.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.16 0.505 . . . . 0.0 111.685 -178.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -130.5 79.72 1.91 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.1 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.438 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 52.9 mt -69.72 118.01 13.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.661 -178.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.71 16.99 6.9 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.828 177.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 29' ' ' SER . . . 161.48 120.87 0.55 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.149 -0.548 . . . . 0.0 111.985 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.4 m -109.83 -6.98 11.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.443 ' HA ' ' CB ' ' A' ' 8' ' ' ARG . 1.6 m-20 -70.19 157.77 37.03 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.751 0.31 . . . . 0.0 110.9 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.487 ' CE1' ' HB2' ' A' ' 51' ' ' LEU . 7.2 t80 -50.47 116.04 1.73 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.866 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.14 0.87 48.02 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.83 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' A' ' 24' ' ' GLY . 12.9 m -84.48 166.5 17.22 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-N 116.994 0.397 . . . . 0.0 110.496 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.2 p -139.19 146.95 41.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.952 0.406 . . . . 0.0 111.061 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.491 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.9 OUTLIER -108.09 171.2 2.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.599 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.446 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -129.82 116.3 18.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.048 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.527 ' CE2' ' CD2' ' A' ' 20' ' ' LEU . 11.9 m-85 -94.66 145.49 24.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.489 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.427 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 91.3 p -147.82 161.54 41.05 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.479 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.417 ' HB2' ' HB2' ' A' ' 39' ' ' TYR . 1.2 m -82.26 170.91 14.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.941 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.7 -81.51 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.285 -178.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.1 m -163.6 117.47 1.55 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.899 0.381 . . . . 0.0 110.699 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.04 -10.21 66.63 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.189 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.479 ' CZ ' ' HB2' ' A' ' 68' ' ' SER . 2.6 m-85 -78.5 -173.63 3.44 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.758 0.313 . . . . 0.0 110.706 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.471 ' CG ' HD13 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -143.01 110.43 5.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.012 0.434 . . . . 0.0 110.075 177.409 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.428 ' CD2' ' O ' ' A' ' 44' ' ' GLU . 2.6 tt -74.76 121.87 22.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.682 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.471 HD13 ' CG ' ' A' ' 40' ' ' HIS . 2.1 mm -104.29 147.56 10.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.013 0.435 . . . . 0.0 110.674 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.29 -133.95 12.13 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.52 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.428 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 1.0 OUTLIER -74.85 -177.63 3.37 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.177 0.513 . . . . 0.0 112.083 -178.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.428 ' HB3' HD22 ' A' ' 41' ' ' LEU . 5.6 p -163.15 23.81 0.09 Allowed 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.295 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.446 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 2.5 mtmt -161.54 130.15 4.4 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -177.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.435 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 0.1 OUTLIER -98.06 136.04 38.88 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 176.741 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.474 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.9 m-85 -112.97 118.28 34.41 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 119.182 -1.007 . . . . 0.0 112.292 -178.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 33.1 t -71.15 71.34 0.58 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.066 177.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.5 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 3.0 tt0 -93.22 172.55 8.23 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.781 -178.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.5 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -82.6 148.46 28.0 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.13 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.65 -123.21 0.11 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.468 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.0 t -114.93 -33.14 5.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.856 0.36 . . . . 0.0 111.019 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.4 p -102.54 32.77 3.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.035 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.7 18.75 80.05 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.704 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.3 t -83.78 -164.99 1.0 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.873 0.368 . . . . 0.0 111.006 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.28 134.23 55.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.197 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -142.84 169.13 12.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.798 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.534 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 75.5 m95 -117.76 116.4 26.93 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.878 -178.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.474 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -69.89 167.92 21.17 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.949 177.372 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.464 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 76.8 Cg_exo -16.21 101.57 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.816 1 C-N-CA 125.421 4.08 . . . . 0.0 114.847 -178.398 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.504 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.3 OUTLIER -97.88 -69.4 0.76 Allowed 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 115.021 -0.99 . . . . 0.0 113.144 -175.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.406 ' CB ' ' O ' ' A' ' 14' ' ' ASP . . . -102.85 76.02 0.21 Allowed Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -174.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.44 ' CD ' ' O ' ' A' ' 62' ' ' GLU . 37.0 Cg_endo -56.9 -152.4 0.0 OUTLIER 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.225 2.617 . . . . 0.0 111.13 175.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.406 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 5.4 mm -90.74 164.07 2.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.223 0.535 . . . . 0.0 111.927 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -167.89 120.85 0.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.098 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.476 ' O ' ' CD2' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -131.86 174.96 9.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.248 -179.048 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.479 ' HB2' ' CZ ' ' A' ' 39' ' ' TYR . 1.5 p -98.23 123.24 42.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.608 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.434 ' CG2' ' HB3' ' A' ' 91' ' ' ASP . 30.6 m -47.9 101.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.177 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -95.41 99.39 11.31 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.73 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 3.2 m -78.55 130.7 36.27 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 175.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -174.94 0.61 Allowed 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.5 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 t -68.04 109.0 3.23 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.954 -178.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.64 ' HG3' ' CE2' ' A' ' 118' ' ' TRP 0.287 0.6 OUTLIER -37.48 -178.62 0.0 OUTLIER 'Trans proline' 0 CA--C 1.469 -2.745 0 C-N-CA 123.317 2.678 . . . . 0.0 113.389 174.467 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.562 ' CB ' ' CE2' ' A' ' 97' ' ' TYR . 44.0 Cg_endo -68.47 -166.43 2.84 Favored 'Cis proline' 0 C--N 1.316 -1.171 0 N-CA-C 114.094 0.767 . . . . 0.0 114.094 -18.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 38.2 t -134.87 18.6 3.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 113.95 -1.477 . . . . 0.0 108.907 172.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.443 ' CG2' ' HB3' ' A' ' 121' ' ' PRO . 16.2 pt -107.75 -159.05 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.295 -177.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.43 ' N ' HG12 ' A' ' 77' ' ' ILE . 0.9 OUTLIER -132.42 134.92 45.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.664 178.36 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.467 ' N ' ' ND2' ' A' ' 79' ' ' ASN . 0.2 OUTLIER 70.08 28.84 3.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.77 -179.49 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -145.02 -177.68 20.02 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.167 -1.016 . . . . 0.0 113.0 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.421 ' N ' ' O ' ' A' ' 98' ' ' SER . 47.3 mtp180 -152.5 -167.81 2.86 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.498 0.666 . . . . 0.0 112.213 -177.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.535 ' CG ' ' HB2' ' A' ' 74' ' ' PRO . 35.5 p-80 -137.87 -178.95 5.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.887 -1.052 . . . . 0.0 111.346 -178.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -123.61 -68.7 0.86 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.605 175.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 49.93 174.29 0.01 OUTLIER Glycine 0 C--N 1.332 0.317 0 CA-C-N 116.013 -0.539 . . . . 0.0 113.58 177.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.427 ' CD2' ' N ' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -119.57 -30.01 4.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.856 0.36 . . . . 0.0 110.838 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.92 -174.47 2.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.399 -178.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.1 -28.83 12.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.27 178.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.428 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 6.7 m-85 -127.55 175.92 7.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.402 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.436 ' CD2' ' HZ2' ' A' ' 118' ' ' TRP . 45.6 m-85 -144.31 178.59 7.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.358 -178.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 25.4 p -139.15 -179.03 5.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.216 0.531 . . . . 0.0 111.794 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.434 ' HB3' ' CG2' ' A' ' 69' ' ' VAL . 0.7 OUTLIER -57.54 95.53 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.716 -179.179 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 113.94 38.3 1.17 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.709 -0.757 . . . . 0.0 113.493 177.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.462 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -105.66 155.02 19.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.917 0.359 . . . . 0.0 110.658 178.539 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 29.9 m -134.79 146.37 30.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.002 0.429 . . . . 0.0 111.238 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.524 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 1.6 t -149.99 137.0 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.334 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.15 132.24 34.41 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 177.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.562 ' CE2' ' CB ' ' A' ' 75' ' ' PRO . 3.1 m-30 -99.82 149.69 23.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.302 0.572 . . . . 0.0 112.533 -175.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.421 ' O ' ' N ' ' A' ' 81' ' ' ARG . 88.3 p -129.54 139.8 51.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.139 177.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.448 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 87.9 m -69.53 141.63 53.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.153 0.501 . . . . 0.0 111.992 -177.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -56.24 -85.47 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.386 -178.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.93 -16.94 62.7 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -175.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.26 29.63 0.77 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.269 -0.967 . . . . 0.0 113.131 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.464 ' CE1' HG12 ' A' ' 126' ' ' ILE . 32.1 m-85 -68.57 -171.69 0.29 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 125' ' ' GLN . 3.4 p -107.93 108.45 19.61 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.935 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.476 HD21 ' CB ' ' A' ' 109' ' ' SER . 1.8 tp -49.03 102.99 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.191 178.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.455 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 39.1 mm -81.98 155.84 4.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.814 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.429 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 54.59 -130.07 45.16 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.782 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -107.83 132.06 53.82 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.145 0.497 . . . . 0.0 112.177 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.476 ' CB ' HD21 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -68.64 -30.5 69.22 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 174.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -65.5 123.73 25.72 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.282 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.535 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 43.8 t -126.11 124.67 66.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 110.645 -0.131 . . . . 0.0 110.645 -177.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.69 135.28 35.06 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.064 0.459 . . . . 0.0 112.229 -177.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.507 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 12.0 t -97.09 105.89 18.13 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 175.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.78 166.7 23.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.309 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 60.3 14.74 35.01 Favored Glycine 0 CA--C 1.519 0.318 0 CA-C-N 115.524 -0.762 . . . . 0.0 113.294 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.68 8.45 73.46 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.449 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -156.91 -176.08 5.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.87 0.367 . . . . 0.0 110.476 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.64 ' CE2' ' HG3' ' A' ' 74' ' ' PRO . 96.8 m95 -95.78 130.83 42.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.905 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.79 156.09 21.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.251 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.5 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER 55.47 44.39 1.6 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.037 179.834 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 98.5 Cg_endo -78.16 153.45 28.26 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.401 2.067 . . . . 0.0 111.933 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.455 ' CB ' ' O ' ' A' ' 106' ' ' ILE . 74.0 Cg_endo -88.84 -170.01 0.45 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.635 2.223 . . . . 0.0 113.298 -178.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.451 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -131.64 176.91 7.93 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.537 176.841 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . 0.444 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 2.9 m -139.17 97.63 3.34 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.976 0.417 . . . . 0.0 110.87 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.424 ' O ' ' CB ' ' A' ' 104' ' ' SER . 17.1 mt-30 -125.36 163.56 22.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.04 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.464 HG12 ' CE1' ' A' ' 103' ' ' TYR . 17.4 mm . . . . . 0 C--N 1.324 -0.515 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.064 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.799 0.333 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.43 ' HD3' ' CG2' ' A' ' 25' ' ' VAL . 5.7 mtt180 -78.59 -171.45 2.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.102 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.45 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 51.7 m -90.35 160.64 39.19 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.974 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.13 177.54 5.73 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.51 2.14 . . . . 0.0 112.122 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.25 112.79 3.94 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.985 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.436 ' CG ' HD12 ' A' ' 22' ' ' ILE . 20.0 Cg_endo -60.34 149.55 85.26 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.353 2.035 . . . . 0.0 112.003 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.434 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 6.6 mtt180 -57.88 173.45 0.32 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -129.89 -174.82 3.42 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.097 0.475 . . . . 0.0 111.623 -178.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.5 tt -141.53 148.62 20.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.866 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.49 -58.25 2.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.245 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.438 ' N ' ' ND2' ' A' ' 17' ' ' ASN . 0.5 OUTLIER -93.65 40.78 1.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.864 -179.503 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.431 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -164.27 -179.93 38.74 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.703 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.25 134.51 32.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.745 0.307 . . . . 0.0 110.524 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.519 ' CD2' ' CE2' ' A' ' 33' ' ' TYR . 13.7 mt -77.83 155.93 30.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.098 0.475 . . . . 0.0 111.687 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.443 ' HB2' ' CB ' ' A' ' 32' ' ' THR . 29.6 t70 -129.3 74.06 1.56 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.114 176.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.49 HD13 HG23 ' A' ' 22' ' ' ILE . 0.8 OUTLIER -76.97 101.83 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.954 -176.447 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.73 16.82 58.26 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.753 -0.736 . . . . 0.0 111.732 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 162.53 132.35 1.33 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.251 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.43 ' CG2' ' HD3' ' A' ' 8' ' ' ARG . 34.0 m -113.62 -8.07 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.429 ' HA ' ' CB ' ' A' ' 8' ' ' ARG . 32.8 t0 -70.18 163.48 26.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.968 0.413 . . . . 0.0 111.074 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.433 ' CE2' ' HB2' ' A' ' 51' ' ' LEU . 11.0 t80 -54.44 113.82 1.42 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.684 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.87 -7.11 33.21 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.664 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.2 m -78.89 158.85 28.0 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.956 0.378 . . . . 0.0 110.647 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.2 p -134.44 136.41 43.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.041 0.448 . . . . 0.0 111.029 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.542 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.9 OUTLIER -96.95 169.7 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.66 178.908 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.443 ' CB ' ' HB2' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -132.7 109.83 9.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.942 0.401 . . . . 0.0 111.148 179.515 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.519 ' CE2' ' CD2' ' A' ' 20' ' ' LEU . 21.5 m-85 -83.59 139.08 33.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.025 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.431 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 41.4 m -144.99 160.31 41.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.711 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 39' ' ' TYR . 36.4 m -84.02 167.31 16.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.863 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -65.3 -84.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.129 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.0 t -152.92 137.61 16.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.702 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 59.11 25.89 60.44 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.843 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.488 ' CE1' ' HB2' ' A' ' 68' ' ' SER . 2.4 m-85 -115.85 172.66 7.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.721 0.296 . . . . 0.0 110.91 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.487 ' CE1' HD13 ' A' ' 42' ' ' ILE . 0.9 OUTLIER -132.49 122.73 25.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.043 0.449 . . . . 0.0 110.674 178.299 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.44 ' CD1' ' HG3' ' A' ' 64' ' ' PRO . 10.1 tt -84.77 127.54 34.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.782 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.487 HD13 ' CE1' ' A' ' 40' ' ' HIS . 1.5 mm -108.49 152.27 10.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.086 0.47 . . . . 0.0 111.023 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.22 -137.24 16.76 Favored Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.31 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.427 ' O ' ' CG ' ' A' ' 64' ' ' PRO . 4.1 pm0 -76.59 178.05 6.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.877 0.37 . . . . 0.0 110.654 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.9 p -156.4 19.11 0.35 Allowed 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.502 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 21.1 mtpt -159.37 121.46 3.43 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.863 0.319 . . . . 0.0 111.863 -177.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.431 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 0.5 OUTLIER -88.51 131.26 34.98 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 177.092 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.476 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 2.0 m-85 -107.14 115.7 30.63 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 119.246 -0.982 . . . . 0.0 111.555 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.436 ' HB3' ' CH2' ' A' ' 59' ' ' TRP . 23.5 t -68.72 80.84 0.28 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.104 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.464 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -97.12 -164.59 1.16 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.626 -179.162 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.464 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -105.87 147.98 28.1 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.924 -179.679 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.35 -129.78 0.11 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.564 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.8 t -112.73 -32.03 6.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.78 0.324 . . . . 0.0 110.988 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.07 33.41 2.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.899 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.46 16.76 77.49 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.584 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.58 -164.28 1.03 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.692 0.282 . . . . 0.0 110.71 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.46 148.26 43.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.399 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.412 HG21 ' HG2' ' A' ' 50' ' ' GLU . 1.3 m -153.72 -177.72 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.527 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.542 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 87.6 m95 -125.14 121.13 33.32 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.104 0.478 . . . . 0.0 112.037 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.476 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 2.4 m120 -72.63 167.05 36.77 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.437 177.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.45 ' HD2' ' HB2' ' A' ' 60' ' ' ASN . 83.3 Cg_exo -18.0 104.29 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 125.142 3.894 . . . . 0.0 114.412 -178.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.48 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -106.92 -81.52 0.55 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.186 -177.235 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.483 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -76.13 107.45 4.49 Favored Pre-proline 0 N--CA 1.463 0.191 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -175.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.44 ' HG3' ' CD1' ' A' ' 41' ' ' LEU . 3.9 Cg_endo -91.52 -155.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 123.459 2.772 . . . . 0.0 111.23 177.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.405 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 2.2 mm -96.65 168.82 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.873 0.368 . . . . 0.0 110.58 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.1 m -167.34 136.59 2.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.206 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.43 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.6 OUTLIER -156.29 175.33 14.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.957 179.703 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.488 ' HB2' ' CE1' ' A' ' 39' ' ' TYR . 3.1 p -93.88 108.76 20.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.94 0.4 . . . . 0.0 111.121 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.461 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 2.7 p -48.58 97.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.263 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.13 121.13 25.18 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.289 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.431 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -103.24 116.79 33.14 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.284 178.798 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.81 -157.68 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.616 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.478 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 1.6 t -47.47 139.01 8.44 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.191 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.486 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 34.5 Cg_exo -58.41 160.93 15.37 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.319 2.013 . . . . 0.0 111.811 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.494 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 88.8 Cg_exo -44.03 157.32 0.15 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.584 2.189 . . . . 0.0 112.784 -178.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 87.7 p -107.32 89.3 2.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.633 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 14.6 pt -69.46 176.55 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.169 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.6 m -92.97 142.4 27.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.84 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 54.99 29.92 13.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.874 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.467 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -163.37 -176.69 35.62 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.294 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -156.43 -174.61 5.02 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.478 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 2.5 p-80 -122.19 161.82 22.49 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.511 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 23.9 m-20 -88.86 -165.1 1.25 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.523 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.453 ' C ' ' CG ' ' A' ' 85' ' ' TYR . . . 72.65 -63.05 1.53 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.684 -178.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.526 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 0.0 OUTLIER 51.62 36.19 16.68 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 122.146 0.974 . . . . 0.0 110.03 -179.832 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.48 ' HB3' ' CZ ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -74.28 -165.92 0.37 Allowed 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 113.572 -1.649 . . . . 0.0 109.897 179.609 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.442 ' O ' ' CD2' ' A' ' 88' ' ' PHE . 1.5 m-20 -110.43 -25.33 10.11 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.712 178.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.442 ' CD2' ' O ' ' A' ' 87' ' ' ASP . 12.8 m-85 -158.62 159.61 35.61 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.331 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.48 ' CZ ' ' HB3' ' A' ' 86' ' ' GLU . 9.5 m-85 -141.09 167.64 21.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.038 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.3 p -135.06 -177.45 4.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.153 0.502 . . . . 0.0 111.922 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -62.98 95.05 0.07 Allowed 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.93 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 128.53 12.67 2.71 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.35 -0.841 . . . . 0.0 113.362 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.403 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.5 OUTLIER -90.41 154.51 19.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 117.1 0.45 . . . . 0.0 110.403 179.268 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 26.9 m -133.93 148.23 30.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.075 0.464 . . . . 0.0 110.892 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.469 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 46.3 t -146.9 151.98 13.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.596 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.04 135.01 50.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.595 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.482 ' CE1' HG23 ' A' ' 111' ' ' VAL . 5.2 m-85 -93.73 157.55 16.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.196 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.93 149.66 29.9 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.955 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 72.7 m -85.76 155.14 21.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.899 0.38 . . . . 0.0 111.186 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.467 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 56.1 m-20 -92.31 -72.96 0.57 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.336 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.4 t -51.98 -24.35 6.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.882 0.373 . . . . 0.0 110.805 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.03 29.66 1.46 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.535 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.5 ' CE2' HG12 ' A' ' 126' ' ' ILE . 41.1 m-85 -74.41 -175.83 2.48 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 120.998 0.427 . . . . 0.0 110.55 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 34.3 m -122.34 98.61 6.01 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.592 ' HA ' ' HA ' ' A' ' 124' ' ' CYS . 0.0 OUTLIER -51.93 152.02 3.27 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-O 122.305 1.05 . . . . 0.0 112.504 -175.625 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.472 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 45.1 mm -121.98 145.98 27.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 113.085 -1.87 . . . . 0.0 111.244 -174.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.43 ' O ' ' ND2' ' A' ' 108' ' ' ASN . . . 77.32 39.05 27.56 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.271 -0.966 . . . . 0.0 111.859 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.43 ' ND2' ' O ' ' A' ' 107' ' ' GLY . 8.3 p30 53.5 138.71 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 124.346 1.058 . . . . 0.0 113.117 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.54 ' HA ' ' HG2' ' A' ' 122' ' ' PRO . 0.6 OUTLIER -69.4 -24.61 63.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.583 -179.712 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -64.73 134.06 37.93 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.59 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.482 HG23 ' CE1' ' A' ' 97' ' ' TYR . 2.7 t -132.94 121.76 44.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.657 0.265 . . . . 0.0 110.517 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.12 119.68 27.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.909 0.385 . . . . 0.0 111.388 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.491 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 14.6 t -86.7 102.62 14.39 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 176.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.1 t -156.14 148.1 23.17 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.039 0.447 . . . . 0.0 111.328 -178.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 69.55 24.94 75.98 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.54 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.461 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 74.71 5.74 75.13 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.873 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -137.84 174.42 10.59 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.88 0.372 . . . . 0.0 110.328 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.494 ' CD1' ' HD2' ' A' ' 75' ' ' PRO . 86.4 m95 -107.51 128.93 54.95 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.778 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.27 160.37 14.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.536 -178.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.449 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 2.2 p-10 46.94 48.35 5.57 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.71 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 91.8 Cg_endo -77.26 135.19 14.88 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.431 2.087 . . . . 0.0 110.512 175.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.54 ' HG2' ' HA ' ' A' ' 109' ' ' SER . 73.6 Cg_endo -93.67 -176.49 0.54 Allowed 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.09 1.86 . . . . 0.0 114.526 -175.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 105' ' ' LEU . 0.2 OUTLIER -118.43 -155.45 0.6 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.407 179.039 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . 0.592 ' HA ' ' HA ' ' A' ' 105' ' ' LEU . 1.8 m -153.8 88.31 1.26 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.928 0.394 . . . . 0.0 110.753 177.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -115.41 162.48 17.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.756 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.5 HG12 ' CE2' ' A' ' 103' ' ' TYR . 26.5 mm . . . . . 0 C--N 1.325 -0.488 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.167 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.904 0.383 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.0 mtm180 -83.51 174.1 10.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.977 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.437 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 19.6 m -93.2 162.32 28.59 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.855 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.415 ' HD3' ' HB2' ' A' ' 9' ' ' CYS . 36.4 Cg_endo -66.95 171.97 10.42 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.417 2.078 . . . . 0.0 111.997 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.12 112.63 4.33 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.371 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.416 ' CG ' HD11 ' A' ' 22' ' ' ILE . 11.0 Cg_endo -55.12 151.13 36.19 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.143 1.895 . . . . 0.0 111.933 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.434 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 12.1 mtt180 -65.12 152.83 42.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.622 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -99.41 -178.07 3.79 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.953 -176.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.2 tt -152.44 141.49 14.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.129 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.421 ' HB3' ' ND2' ' A' ' 17' ' ' ASN . 7.3 p30 -80.45 174.64 11.41 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.718 178.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.485 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 0.7 OUTLIER 37.32 31.05 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.809 179.694 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.434 ' HA2' ' N ' ' A' ' 36' ' ' ASN . . . -167.26 -166.89 27.11 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.62 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.96 146.42 21.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.665 0.269 . . . . 0.0 110.932 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.48 HD21 ' CD2' ' A' ' 33' ' ' TYR . 14.5 mt -84.77 157.94 20.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.991 0.424 . . . . 0.0 111.556 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.418 ' HB2' ' CB ' ' A' ' 32' ' ' THR . 1.2 t70 -125.68 76.39 1.57 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.717 177.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.438 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 0.9 OUTLIER -74.85 101.06 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.117 -176.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.47 18.58 50.6 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.631 176.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 160.43 134.94 1.74 Allowed Glycine 0 C--N 1.334 0.444 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.834 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.7 m -128.42 33.16 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -178.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -105.39 163.79 12.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.16 0.505 . . . . 0.0 111.243 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.52 ' CE1' ' CE ' ' A' ' 57' ' ' MET . 0.0 OUTLIER -47.97 95.6 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.349 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.77 -4.74 22.72 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.539 -0.839 . . . . 0.0 113.206 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.3 m -70.23 173.9 6.18 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 117.014 0.407 . . . . 0.0 110.289 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.3 p -145.16 144.22 30.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.002 0.429 . . . . 0.0 111.245 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.533 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.9 OUTLIER -105.97 171.84 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.516 -179.662 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.418 ' CB ' ' HB2' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -133.1 115.17 14.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.876 0.37 . . . . 0.0 110.953 179.633 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.48 ' CD2' HD21 ' A' ' 20' ' ' LEU . 15.3 m-85 -88.77 149.0 23.65 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.218 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 83.4 p -154.78 147.85 24.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.196 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.6 m -76.12 168.44 20.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.816 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.434 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 40.9 m-20 -71.24 -84.86 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.37 -178.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.4 t -151.32 135.18 16.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.897 0.379 . . . . 0.0 110.874 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.77 25.35 71.75 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.066 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.491 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.1 m-85 -118.46 170.13 9.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 0.0 111.083 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.525 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.3 OUTLIER -136.1 112.31 9.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.08 0.467 . . . . 0.0 110.557 177.903 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.44 ' CD1' ' HG3' ' A' ' 64' ' ' PRO . 4.2 tt -80.57 119.48 23.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.8 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.525 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 2.5 mm -94.11 161.96 2.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.186 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.68 -138.01 22.45 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.269 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.416 ' O ' ' CG ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -82.74 -174.65 5.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.84 0.352 . . . . 0.0 110.838 179.508 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.408 ' HB3' HD22 ' A' ' 41' ' ' LEU . 4.7 p -156.16 22.26 0.37 Allowed 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.241 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.422 ' CG ' ' O ' ' A' ' 31' ' ' ILE . 2.9 mtpt -150.76 131.05 13.64 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -177.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.458 ' OG ' ' CB ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -93.42 146.82 23.47 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.286 176.248 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.516 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 1.9 m-85 -120.78 117.12 26.63 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 119.014 -1.074 . . . . 0.0 111.738 178.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 48.8 t -62.86 115.2 4.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.999 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.27 -170.85 3.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.214 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.429 HD23 ' N ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -102.59 141.34 35.58 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.929 0.395 . . . . 0.0 110.874 -178.761 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.429 ' N ' HD23 ' A' ' 51' ' ' LEU . . . -61.18 -127.55 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.579 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.3 m -121.51 -39.62 2.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.777 0.322 . . . . 0.0 111.365 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 30.1 p -91.24 43.33 1.14 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.195 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.18 25.21 69.48 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.402 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.402 ' O ' HD23 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -94.65 -158.26 0.62 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.702 0.287 . . . . 0.0 110.404 179.672 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.52 ' CE ' ' CE1' ' A' ' 27' ' ' PHE . 0.3 OUTLIER -129.73 116.79 19.29 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.477 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.526 ' CG2' ' N ' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -118.46 -176.52 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.607 0.717 . . . . 0.0 111.589 -176.834 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.533 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 69.6 m95 -130.87 133.36 45.82 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.636 -1.166 . . . . 0.0 111.448 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.516 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 0.6 OUTLIER -75.67 166.46 45.03 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.944 177.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.477 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 97.3 Cg_exo -17.93 96.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 125.251 3.968 . . . . 0.0 114.494 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.479 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.3 OUTLIER -92.87 -76.84 0.46 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.498 -0.773 . . . . 0.0 112.457 -177.374 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.477 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -88.36 109.3 27.68 Favored Pre-proline 0 C--N 1.331 -0.21 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -175.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.44 ' HG3' ' CD1' ' A' ' 41' ' ' LEU . 1.8 Cg_endo -84.01 -154.96 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.092 2.528 . . . . 0.0 111.073 176.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.411 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 4.0 mm -90.4 165.65 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.897 0.379 . . . . 0.0 110.895 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.2 m -163.41 139.32 6.77 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.063 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -159.94 170.86 20.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.823 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.491 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 13.4 p -82.31 117.07 22.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.954 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.444 ' CG2' ' HB3' ' A' ' 40' ' ' HIS . 0.8 OUTLIER -46.67 93.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.291 179.677 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.6 118.51 15.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.061 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -98.69 117.22 32.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.287 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.76 -159.05 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.713 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.47 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 2.1 t -49.86 139.9 16.25 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.925 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.481 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 26.1 Cg_exo -60.52 160.6 23.46 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.433 2.089 . . . . 0.0 112.062 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.499 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 86.2 Cg_exo -42.18 156.51 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.822 2.348 . . . . 0.0 112.842 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.9 m -109.36 90.68 3.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.438 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 21.6 pt -69.37 171.0 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.418 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.5 m -89.92 139.99 30.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.618 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.488 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 2.9 m-80 60.42 29.27 18.88 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.829 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.415 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -165.43 -165.89 23.5 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.986 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.1 -175.89 2.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.896 0.379 . . . . 0.0 110.805 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.47 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 13.3 p80 -115.24 168.81 9.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.123 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -93.92 -85.28 0.29 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.73 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 61.22 141.46 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.835 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.423 ' N ' ' CD2' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -112.63 -33.87 6.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.055 0.455 . . . . 0.0 110.514 179.864 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.76 -171.86 2.46 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.852 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -103.1 -21.77 13.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.136 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.406 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 10.4 m-85 -134.08 169.72 16.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.16 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.406 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 41.1 m-85 -147.03 168.1 22.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.603 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 17.7 p -138.06 -175.6 4.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.993 0.425 . . . . 0.0 111.496 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 10.9 m-20 -63.76 96.22 0.13 Allowed 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.304 0.573 . . . . 0.0 111.049 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.93 26.66 1.35 Allowed Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.254 -0.884 . . . . 0.0 113.075 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.41 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.6 OUTLIER -108.26 157.3 18.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.878 0.339 . . . . 0.0 110.494 179.044 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.5 m -135.49 151.65 30.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.156 0.503 . . . . 0.0 111.411 -179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.493 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 18.0 t -147.85 148.06 16.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.404 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.438 ' CG2' ' OG ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -107.52 125.84 51.78 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.067 0.461 . . . . 0.0 110.851 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.521 ' CE1' ' CG2' ' A' ' 111' ' ' VAL . 4.0 m-85 -84.21 164.59 19.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.249 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 51.7 m -156.71 143.33 18.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.504 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.415 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 64.2 m -73.88 157.55 36.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.662 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.417 ' CG ' ' N ' ' A' ' 101' ' ' SER . 1.3 p30 -95.12 -55.5 3.05 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.363 0.602 . . . . 0.0 111.342 -178.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.417 ' N ' ' CG ' ' A' ' 100' ' ' ASN . 6.5 t -75.37 -20.62 58.88 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.4 -178.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 117.96 28.05 2.34 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.446 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.488 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 17.9 m-85 -69.65 -179.83 1.89 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.123 0.487 . . . . 0.0 110.853 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -105.98 96.51 6.54 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.936 178.007 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.458 ' CD2' ' HA ' ' A' ' 109' ' ' SER . 0.3 OUTLIER -47.74 128.86 13.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.588 0.709 . . . . 0.0 111.965 -177.526 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.428 HG21 HD12 ' A' ' 106' ' ' ILE . 36.0 mm -112.51 158.98 12.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.55 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 108' ' ' ASN . . . 66.46 31.85 80.01 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.462 -0.875 . . . . 0.0 113.002 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.43 ' O ' ' O ' ' A' ' 107' ' ' GLY . 8.8 p30 52.03 130.85 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 123.983 0.913 . . . . 0.0 113.052 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.476 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 1.6 p -63.01 -25.39 68.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.388 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -64.14 127.76 35.78 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.466 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.521 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 2.6 t -131.35 123.14 52.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.588 0.233 . . . . 0.0 110.724 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.62 124.06 32.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.946 0.403 . . . . 0.0 111.579 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.494 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 18.4 t -87.23 108.81 19.1 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 176.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.6 OUTLIER -155.77 165.13 37.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.102 0.477 . . . . 0.0 111.508 -178.639 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.67 31.11 7.05 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.604 -0.726 . . . . 0.0 112.889 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.439 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 68.63 12.52 64.35 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.711 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -143.14 176.39 9.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.768 0.318 . . . . 0.0 110.523 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.499 ' CD1' ' HD2' ' A' ' 75' ' ' PRO . 89.3 m95 -110.71 127.54 55.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.824 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.91 148.98 27.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.057 0.456 . . . . 0.0 111.478 -178.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.493 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER 68.08 44.85 0.31 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.121 178.888 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 55.1 Cg_endo -69.63 139.18 40.02 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.175 1.917 . . . . 0.0 111.418 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.476 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 55.6 Cg_endo -88.28 -174.8 1.19 Allowed 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.569 2.179 . . . . 0.0 113.35 -178.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -135.13 -157.48 0.8 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.884 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 1.8 m -156.28 90.21 1.17 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.124 0.488 . . . . 0.0 111.134 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.409 ' O ' ' CB ' ' A' ' 104' ' ' SER . 11.7 mt-30 -115.07 158.97 21.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.6 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.487 HG12 ' CE2' ' A' ' 103' ' ' TYR . 29.4 mm . . . . . 0 C--N 1.323 -0.566 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.987 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 27.4 mtm-85 . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.777 0.323 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.439 ' CB ' ' HA ' ' A' ' 26' ' ' ASP . 5.1 ptt180 -85.42 -170.97 3.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.973 0.416 . . . . 0.0 111.173 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.458 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 12.3 m -93.12 162.68 27.73 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.999 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.414 ' HD3' ' HB2' ' A' ' 9' ' ' CYS . 51.2 Cg_endo -70.24 178.08 5.24 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.443 2.095 . . . . 0.0 112.172 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.401 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 42.2 t -58.5 107.94 1.13 Allowed Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.072 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.455 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 2.6 Cg_endo -50.29 146.96 17.18 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.147 1.898 . . . . 0.0 112.206 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.423 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 4.4 ttp180 -59.76 151.56 25.02 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.275 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -98.5 -177.82 3.81 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.177 -176.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.42 HG21 ' CD2' ' A' ' 20' ' ' LEU . 8.2 tt -141.38 152.99 19.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.458 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -88.38 -66.98 0.86 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.57 -178.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -91.1 40.33 1.02 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.344 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -160.37 -179.22 35.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.881 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -137.75 125.18 21.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.743 0.306 . . . . 0.0 110.618 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.471 ' CD2' ' CE2' ' A' ' 33' ' ' TYR . 14.9 mt -66.8 154.21 41.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.99 0.424 . . . . 0.0 111.231 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -127.35 74.67 1.53 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.852 178.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.427 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 67.8 mt -70.31 96.28 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.22 -177.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.96 21.48 44.78 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.435 176.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 154.87 140.61 3.05 Favored Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.426 HG22 ' NE ' ' A' ' 8' ' ' ARG . 26.5 m -125.64 -9.21 5.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.439 ' HA ' ' CB ' ' A' ' 8' ' ' ARG . 27.5 t70 -69.68 164.92 22.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.03 0.443 . . . . 0.0 110.95 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.488 ' CZ ' HD13 ' A' ' 51' ' ' LEU . 17.2 t80 -51.9 118.47 3.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.707 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 49' ' ' CYS . . . 100.27 -10.86 59.99 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.659 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.418 ' N ' ' HB2' ' A' ' 49' ' ' CYS . 3.6 m -58.53 179.92 0.07 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.825 0.345 . . . . 0.0 110.964 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.1 p -153.58 133.41 13.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.083 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.532 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.6 OUTLIER -100.97 174.25 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.724 179.584 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.88 106.53 5.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.715 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.496 ' CE2' ' CB ' ' A' ' 63' ' ' ALA . 33.5 m-85 -78.37 138.1 38.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.39 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.0 m -139.46 167.02 23.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.69 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.403 ' HA ' ' HA2' ' A' ' 18' ' ' GLY . 1.3 m -91.8 164.62 13.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.943 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -62.01 -84.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.078 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.63 132.91 9.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.637 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.92 25.94 71.0 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.732 -178.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.525 ' CE1' ' CB ' ' A' ' 68' ' ' SER . 2.6 m-85 -118.34 -179.93 3.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.9 0.381 . . . . 0.0 110.931 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.483 ' CE1' ' HA ' ' A' ' 69' ' ' VAL . 0.0 OUTLIER -136.16 140.47 43.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.841 174.738 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.429 ' CD2' ' O ' ' A' ' 44' ' ' GLU . 9.6 tt -94.11 138.69 31.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.472 -178.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.9 mm -110.73 150.5 13.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.077 0.465 . . . . 0.0 111.275 -178.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.27 -147.14 43.75 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.256 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.434 ' O ' ' CG ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -62.14 177.74 0.44 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.592 0.234 . . . . 0.0 110.679 179.419 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.419 ' HB3' HD22 ' A' ' 41' ' ' LEU . 4.6 p -152.3 26.73 0.6 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.955 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.421 ' CG ' ' O ' ' A' ' 31' ' ' ILE . 0.4 OUTLIER -147.02 -171.11 3.7 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.066 -178.541 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.447 ' O ' HG12 ' A' ' 31' ' ' ILE . 1.1 m -167.07 98.92 0.53 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.168 179.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.424 ' CD1' ' N ' ' A' ' 48' ' ' TYR . 1.5 m-85 -80.51 115.85 20.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.134 0.492 . . . . 0.0 111.781 -177.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.47 ' HB3' ' CH2' ' A' ' 59' ' ' TRP . 34.8 t -65.91 102.96 0.84 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.031 178.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.498 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 3.7 tt0 -134.06 171.63 13.94 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.315 0.579 . . . . 0.0 110.695 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.498 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -95.18 141.62 28.58 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.763 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 173.99 45.06 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.348 -0.93 . . . . 0.0 113.043 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.423 ' HB2' ' CB ' ' A' ' 56' ' ' SER . 0.2 OUTLIER -140.26 59.22 1.57 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.914 0.388 . . . . 0.0 110.825 179.666 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.3 p 63.15 27.67 15.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.715 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 104.91 27.99 5.77 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.138 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.423 ' CB ' ' HB2' ' A' ' 53' ' ' SER . 0.2 OUTLIER -120.07 -160.42 0.83 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.899 0.38 . . . . 0.0 111.031 -179.302 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.96 147.37 44.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.385 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -148.67 -174.57 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.612 -178.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.532 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 88.5 m95 -128.06 123.2 34.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.805 0.336 . . . . 0.0 111.194 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -140.01 122.01 9.82 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.979 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.29 -166.89 5.25 Favored 'Cis proline' 0 C--N 1.352 0.725 0 C-N-CA 123.858 -1.309 . . . . 0.0 112.375 -0.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -110.34 -152.72 0.5 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.496 ' CB ' ' CE2' ' A' ' 33' ' ' TYR . . . -79.18 112.82 31.09 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.982 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.434 ' CG ' ' O ' ' A' ' 44' ' ' GLU . 16.6 Cg_exo -69.24 -150.54 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.738 2.292 . . . . 0.0 112.318 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -106.66 178.37 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.957 0.408 . . . . 0.0 111.251 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -170.69 127.38 0.76 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.747 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.476 ' O ' ' CD2' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -135.48 175.32 9.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.863 179.724 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.525 ' CB ' ' CE1' ' A' ' 39' ' ' TYR . 1.7 p -98.17 124.26 42.64 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.052 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.483 ' HA ' ' CE1' ' A' ' 40' ' ' HIS . 6.7 p -49.58 92.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.982 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.421 ' CD ' ' HB2' ' A' ' 88' ' ' PHE . 0.8 OUTLIER -81.33 128.77 34.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.807 -178.635 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.433 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -110.62 120.44 42.43 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.867 177.625 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.419 ' HA ' ' HA ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -69.8 -160.19 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.964 -179.242 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.468 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 2.2 t -47.25 136.09 9.0 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.081 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.472 ' HG3' ' CZ2' ' A' ' 118' ' ' TRP . 31.6 Cg_exo -56.81 161.81 9.71 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.347 2.031 . . . . 0.0 111.981 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.47 ' HD2' ' CG ' ' A' ' 118' ' ' TRP . 99.3 Cg_exo -42.75 158.15 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.694 2.262 . . . . 0.0 112.735 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.5 m -110.35 88.61 2.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.852 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 19.4 pt -69.65 -179.0 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.364 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.5 m -98.56 146.47 25.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.619 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.466 ' HB3' ' CD2' ' A' ' 103' ' ' TYR . 8.5 m-80 53.53 30.55 10.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.929 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -174.61 -172.29 39.55 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.874 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -170.72 -174.3 1.56 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.904 0.383 . . . . 0.0 110.673 -179.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.471 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 11.5 p-80 -92.45 174.45 7.28 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.264 178.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.436 ' OD1' ' CG1' ' A' ' 95' ' ' VAL . 17.5 p-10 -106.34 -37.89 6.39 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -178.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -44.42 -71.18 0.49 Allowed Glycine 0 CA--C 1.516 0.136 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.985 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.404 ' CD2' ' CD2' ' A' ' 82' ' ' HIS . 3.4 m-85 65.2 28.49 12.08 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 121.264 0.554 . . . . 0.0 110.065 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -69.85 -98.46 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.4 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -174.4 -36.72 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.372 0.606 . . . . 0.0 109.642 178.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.439 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 18.1 m-85 -152.75 159.63 43.12 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.612 -178.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.439 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 23.7 m-85 -144.66 169.63 17.63 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.049 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 17.0 p -133.62 178.39 6.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.987 0.423 . . . . 0.0 111.674 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -62.47 100.81 0.2 Allowed 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.539 0.685 . . . . 0.0 110.849 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 122.56 16.71 3.7 Favored Glycine 0 C--N 1.312 -0.792 0 CA-C-N 114.718 -1.128 . . . . 0.0 113.003 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.406 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -99.2 157.7 16.2 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.898 0.349 . . . . 0.0 110.533 179.115 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 34.6 m -136.17 152.01 29.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.164 0.507 . . . . 0.0 111.249 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.436 ' CG1' ' OD1' ' A' ' 83' ' ' ASN . 43.8 t -146.82 150.1 15.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.6 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.419 ' CG2' ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -110.46 126.36 54.25 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.882 -179.537 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.523 ' CE2' ' CG2' ' A' ' 111' ' ' VAL . 3.8 m-85 -83.75 154.61 23.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.465 -178.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.429 ' CA ' HD13 ' A' ' 105' ' ' LEU . 59.9 p -153.58 147.85 25.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.283 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 8.4 m -69.81 160.77 31.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.954 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 21.6 m-20 -85.46 -68.99 0.69 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.249 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 66.9 m -77.56 -45.2 26.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.639 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 154.74 41.84 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.766 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.51 ' CE1' HG12 ' A' ' 126' ' ' ILE . 13.4 m-85 -78.15 -166.19 0.78 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.5 m -117.17 104.99 11.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.703 0.287 . . . . 0.0 111.567 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.429 HD13 ' CA ' ' A' ' 98' ' ' SER . 2.6 tp -47.15 118.26 2.06 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.168 0.509 . . . . 0.0 110.534 178.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.446 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 19.1 mm -94.27 160.71 2.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.917 -178.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.438 ' N ' HG21 ' A' ' 106' ' ' ILE . . . 59.43 -124.18 35.66 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.852 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.28 122.85 38.09 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.79 0.329 . . . . 0.0 110.93 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.458 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 1.4 t -58.15 -27.7 64.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.068 0.461 . . . . 0.0 110.474 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.64 135.38 26.79 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.817 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.523 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 2.7 t -131.07 119.22 44.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.712 0.291 . . . . 0.0 110.594 178.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.0 118.76 24.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.991 0.424 . . . . 0.0 111.588 -178.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.484 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 14.1 t -85.37 100.54 11.91 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.467 176.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.6 t -136.63 161.39 36.04 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.063 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.99 25.58 3.9 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.756 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.432 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 77.16 7.38 86.78 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.655 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -133.53 -176.56 4.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.825 0.345 . . . . 0.0 110.571 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.484 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 94.3 m95 -114.61 145.05 42.45 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.171 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.1 147.39 51.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.286 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.495 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.5 t0 71.0 44.56 0.23 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.289 178.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 62.0 Cg_endo -73.23 137.12 25.5 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.191 1.927 . . . . 0.0 111.254 177.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.458 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 73.0 Cg_endo -89.42 -175.42 1.09 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.467 2.112 . . . . 0.0 113.752 -177.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.445 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -124.93 -162.54 1.11 Allowed 'General case' 0 CA--C 1.501 -0.92 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.509 175.34 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . 0.411 ' SG ' ' CB ' ' A' ' 103' ' ' TYR . 5.2 t -170.69 92.76 0.18 Allowed 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.323 -176.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -118.88 175.93 5.52 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.92 -1.037 . . . . 0.0 111.012 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.51 HG12 ' CE1' ' A' ' 103' ' ' TYR . 16.9 mm . . . . . 0 C--N 1.324 -0.531 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.579 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 28.8 mtm-85 . . . . . 0 CA--C 1.529 0.145 0 CA-C-O 120.701 0.286 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.4 mtt85 43.34 -167.89 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.023 0.439 . . . . 0.0 111.92 179.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.437 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 15.1 m -111.51 161.56 24.86 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.638 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.409 ' HD3' ' HB2' ' A' ' 9' ' ' CYS . 55.8 Cg_endo -66.92 171.54 11.0 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.179 1.919 . . . . 0.0 110.471 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.7 p -51.11 120.47 14.1 Favored Pre-proline 0 N--CA 1.45 -0.45 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.719 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.435 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 6.3 Cg_endo -47.82 144.59 11.15 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.67 2.247 . . . . 0.0 112.395 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.454 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -52.59 -175.88 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.904 177.615 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -144.55 -179.95 6.89 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.46 0.648 . . . . 0.0 111.994 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.411 HG21 ' HA3' ' A' ' 18' ' ' GLY . 7.0 tt -139.77 154.5 24.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.305 -179.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -79.08 -68.72 0.63 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.541 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.484 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 1.2 m120 -93.41 39.08 1.05 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.976 0.417 . . . . 0.0 110.876 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -148.29 178.92 25.55 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.025 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -141.51 134.16 28.53 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.489 HD23 ' CD2' ' A' ' 33' ' ' TYR . 10.5 mt -86.69 152.25 22.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.318 0.58 . . . . 0.0 111.953 -178.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -123.34 80.77 1.81 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.578 177.727 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.47 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 6.3 mt -75.5 116.66 18.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.561 -176.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -108.3 19.36 32.0 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.356 175.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 156.58 164.48 13.51 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 22.5 m -143.82 22.7 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.861 0.33 . . . . 0.0 111.439 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.4 OUTLIER -93.57 159.27 15.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.805 179.762 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.516 ' CZ ' ' CD1' ' A' ' 51' ' ' LEU . 2.9 t80 -56.03 87.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.683 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 134.1 -14.56 4.59 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.417 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.01 -170.94 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.612 0.244 . . . . 0.0 110.348 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.405 ' HA ' ' O ' ' A' ' 47' ' ' SER . 27.7 p -159.28 139.19 11.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.237 0.541 . . . . 0.0 111.819 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.505 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.5 OUTLIER -103.66 176.27 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.866 178.755 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.435 ' O ' ' N ' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -138.24 113.2 9.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.696 0.284 . . . . 0.0 110.828 179.809 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.545 ' CE2' ' CA ' ' A' ' 63' ' ' ALA . 8.3 m-85 -87.34 149.21 24.65 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.318 0.58 . . . . 0.0 111.751 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.409 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.6 OUTLIER -156.62 164.11 38.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.675 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.427 ' HA ' ' HA2' ' A' ' 18' ' ' GLY . 20.2 m -87.7 165.48 15.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.19 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -66.57 -70.94 0.22 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.92 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.41 141.63 9.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.84 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.401 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 52.46 29.82 32.16 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.171 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.509 ' CE1' ' CB ' ' A' ' 68' ' ' SER . 2.4 m-85 -117.09 175.84 5.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.799 0.333 . . . . 0.0 111.147 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.505 ' CE1' ' HA ' ' A' ' 69' ' ' VAL . 0.1 OUTLIER -131.76 140.5 49.24 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 174.566 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.455 ' CD2' ' O ' ' A' ' 44' ' ' GLU . 0.6 OUTLIER -90.16 138.67 31.33 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.256 -176.501 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.465 ' N ' ' CD1' ' A' ' 42' ' ' ILE . 0.3 OUTLIER -116.38 131.96 67.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 CA-C-O 121.67 0.748 . . . . 0.0 110.552 178.442 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.16 -137.42 13.25 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 114.183 -1.371 . . . . 0.0 111.165 -176.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.457 ' N ' ' HG2' ' A' ' 64' ' ' PRO . 0.6 OUTLIER -87.32 -172.55 3.98 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.843 0.354 . . . . 0.0 110.687 178.333 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.401 ' HB3' HD22 ' A' ' 41' ' ' LEU . 3.0 p -144.77 25.54 1.45 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.979 0.419 . . . . 0.0 110.817 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -160.86 125.92 3.71 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.841 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.44 ' CB ' HD13 ' A' ' 31' ' ' ILE . 1.6 m -95.74 149.54 21.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.008 178.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.498 ' CE2' ' HD2' ' A' ' 61' ' ' PRO . 4.0 m-85 -123.08 126.85 47.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.028 0.442 . . . . 0.0 111.278 -178.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.459 ' HB3' ' CH2' ' A' ' 59' ' ' TRP . 10.5 t -76.21 91.95 3.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.118 179.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -116.4 178.17 4.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.63 -178.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.516 ' CD1' ' CZ ' ' A' ' 27' ' ' PHE . 4.8 mt -80.84 155.91 26.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.606 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 166.18 178.09 38.7 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.465 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.8 t 70.81 55.82 0.24 Allowed 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.394 0.616 . . . . 0.0 111.158 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 p 71.59 16.99 5.72 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.557 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 105.33 39.79 2.19 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.716 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.416 ' O ' ' CD2' ' A' ' 51' ' ' LEU . 33.3 t -121.61 -169.16 1.81 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.734 0.302 . . . . 0.0 110.675 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -96.84 118.38 33.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.934 0.397 . . . . 0.0 110.867 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.5 m -132.84 -175.78 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.91 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.505 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 88.3 m95 -120.76 139.32 53.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.877 0.37 . . . . 0.0 110.996 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.449 ' O ' ' N ' ' A' ' 48' ' ' TYR . 3.1 m-20 -148.78 140.2 14.16 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.956 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.498 ' HD2' ' CE2' ' A' ' 48' ' ' TYR . 7.3 Cg_exo -75.93 -151.89 0.72 Allowed 'Cis proline' 0 C--N 1.348 0.512 0 C-N-CA 124.163 -1.182 . . . . 0.0 112.738 1.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -65.2 -130.7 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.908 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.545 ' CA ' ' CE2' ' A' ' 33' ' ' TYR . . . -72.26 -82.53 0.04 OUTLIER Pre-proline 0 CA--C 1.48 -1.733 0 CA-C-O 118.503 -0.76 . . . . 0.0 112.132 -178.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.485 ' O ' ' HB1' ' A' ' 63' ' ' ALA . 41.2 Cg_endo -102.92 -144.89 0.03 OUTLIER 'Cis proline' 0 C--N 1.317 -1.095 0 CA-C-N 120.73 1.296 . . . . 0.0 114.285 12.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.425 HG12 ' HB ' ' A' ' 42' ' ' ILE . 2.2 pt -91.22 177.0 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -174.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 41' ' ' LEU . 1.2 m -158.83 112.12 2.33 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 114.282 -1.327 . . . . 0.0 109.513 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.473 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 1.9 mt-10 -102.13 176.8 5.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.006 0.432 . . . . 0.0 111.335 -178.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.509 ' CB ' ' CE1' ' A' ' 39' ' ' TYR . 2.4 p -97.34 123.02 41.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.802 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.505 ' HA ' ' CE1' ' A' ' 40' ' ' HIS . 3.3 p -45.75 97.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.318 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.41 ' HD3' ' HB2' ' A' ' 88' ' ' PHE . 0.3 OUTLIER -84.78 115.58 22.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.435 -179.139 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -96.38 119.25 34.52 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 177.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -69.81 -157.41 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.577 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.2 t -50.98 138.9 23.92 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.57 0.224 . . . . 0.0 110.736 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.466 ' CG ' HG11 ' A' ' 95' ' ' VAL . 33.9 Cg_exo -58.36 156.36 31.14 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.383 2.055 . . . . 0.0 112.05 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.506 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 76.1 Cg_exo -48.92 156.24 2.2 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.63 2.22 . . . . 0.0 112.921 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 75.4 m -101.63 92.4 4.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.111 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.425 ' CG2' ' O ' ' A' ' 122' ' ' PRO . 6.4 pt -68.97 165.51 2.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.298 -178.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.8 m -77.32 140.09 39.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.871 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.485 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 7.0 m-80 52.72 27.21 5.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.051 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.458 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -161.63 -166.62 20.73 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.757 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.438 ' N ' ' O ' ' A' ' 98' ' ' SER . 9.5 ptt180 -170.32 -174.64 1.74 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.984 0.421 . . . . 0.0 110.918 -178.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.422 ' HA ' ' CD2' ' A' ' 97' ' ' TYR . 13.6 p80 -102.14 179.43 4.32 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.549 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.469 ' CB ' ' O ' ' A' ' 96' ' ' THR . 50.2 t30 -131.13 24.77 4.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.794 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.448 ' CA ' ' OH ' ' A' ' 89' ' ' TYR . . . -40.39 147.87 0.23 Allowed Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 121.028 -0.606 . . . . 0.0 113.829 -175.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.477 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -101.09 -43.31 6.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.155 0.502 . . . . 0.0 110.523 -179.549 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.23 -176.42 3.15 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.988 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.72 -26.48 17.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.411 178.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.438 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 11.1 m-85 -132.67 166.32 22.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.73 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.451 ' CE2' ' CG2' ' A' ' 95' ' ' VAL . 19.8 m-85 -145.31 164.95 29.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.818 0.342 . . . . 0.0 111.117 -178.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.1 p -147.42 -175.21 4.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.766 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 7.6 p-10 -54.78 94.02 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.676 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.39 25.99 1.24 Allowed Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.543 -0.837 . . . . 0.0 113.512 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.32 152.29 26.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 117.36 0.58 . . . . 0.0 111.176 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 27.3 m -144.34 136.2 22.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.118 0.485 . . . . 0.0 110.949 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.466 HG11 ' CG ' ' A' ' 74' ' ' PRO . 3.8 p -134.8 149.75 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.283 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.469 ' O ' ' CB ' ' A' ' 83' ' ' ASN . 0.2 OUTLIER -91.31 149.72 21.62 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.992 0.425 . . . . 0.0 110.836 -179.658 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.534 ' CE2' ' CG2' ' A' ' 111' ' ' VAL . 2.8 m-85 -107.79 157.39 18.18 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.81 0.338 . . . . 0.0 111.105 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.438 ' O ' ' N ' ' A' ' 81' ' ' ARG . 10.1 p -144.71 146.16 32.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.257 -0.429 . . . . 0.0 112.086 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.496 ' HB2' ' HB3' ' A' ' 103' ' ' TYR . 91.0 m -69.15 161.11 29.81 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.671 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.458 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 0.9 OUTLIER -53.4 -79.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.86 -178.716 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.1 t -110.81 -30.24 7.64 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.706 -176.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 175.45 31.9 0.04 OUTLIER Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.514 -0.85 . . . . 0.0 113.169 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.531 ' CE2' ' CD1' ' A' ' 126' ' ' ILE . 0.2 OUTLIER -69.78 -168.05 0.17 Allowed 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 116.596 0.198 . . . . 0.0 110.681 178.726 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 125' ' ' GLN . 0.2 OUTLIER -125.51 113.95 18.15 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 176.254 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.484 ' CD2' ' HA ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -69.62 143.41 53.26 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.762 0.791 . . . . 0.0 112.17 -176.09 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.445 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 33.8 mm -123.09 156.96 28.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 114.281 -1.327 . . . . 0.0 111.266 -178.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 62.56 32.02 81.81 Favored Glycine 0 CA--C 1.512 -0.137 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.415 178.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.429 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.4 OUTLIER 60.44 135.55 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.313 0.578 . . . . 0.0 111.545 179.218 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.484 ' HA ' ' CD2' ' A' ' 105' ' ' LEU . 1.0 OUTLIER -74.43 -29.96 61.7 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.221 -0.9 . . . . 0.0 112.506 -177.506 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.4 141.45 47.92 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.35 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.534 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 13.9 t -134.86 119.17 26.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.644 0.259 . . . . 0.0 111.303 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.429 ' CD1' ' HB2' ' A' ' 114' ' ' SER . 1.0 OUTLIER -80.18 134.51 36.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.908 0.385 . . . . 0.0 111.194 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.48 ' HB2' ' CZ3' ' A' ' 118' ' ' TRP . 35.9 t -106.17 104.96 14.77 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.122 177.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.429 ' HB2' ' CD1' ' A' ' 112' ' ' LEU . 1.7 t -149.14 131.9 16.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.941 0.401 . . . . 0.0 111.564 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 80.89 24.28 58.24 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.32 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.448 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 75.7 1.53 66.89 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.312 -178.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -124.52 178.73 5.26 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.03 0.443 . . . . 0.0 110.711 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.506 ' CD1' ' HD2' ' A' ' 75' ' ' PRO . 92.9 m95 -120.13 133.52 55.49 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.125 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.404 ' O ' ' HB2' ' A' ' 120' ' ' ASP . 0.8 OUTLIER -109.23 160.36 16.18 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.304 178.41 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.574 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 49.7 t0 67.16 33.39 0.1 OUTLIER Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 32.9 Cg_endo -66.92 124.99 12.97 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 121.993 1.796 . . . . 0.0 110.943 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.499 ' HD3' ' CD1' ' A' ' 97' ' ' TYR . 72.3 Cg_endo -91.38 -174.09 0.6 Allowed 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.603 2.202 . . . . 0.0 114.505 -175.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 2.5 m -135.81 176.34 8.78 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 113.924 -1.489 . . . . 0.0 108.639 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . 0.507 ' HB3' ' HB2' ' A' ' 103' ' ' TYR . 1.2 m -133.3 103.94 6.22 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.106 -0.638 . . . . 0.0 111.16 177.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.437 ' O ' ' CB ' ' A' ' 104' ' ' SER . 10.2 mt-30 -106.85 153.12 22.96 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.686 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.531 ' CD1' ' CE2' ' A' ' 103' ' ' TYR . 49.2 mm . . . . . 0 C--N 1.315 -0.919 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.839 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.4 mtt180 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.789 0.328 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -81.13 156.94 25.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.174 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.435 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 16.7 m -69.67 162.01 70.46 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.725 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.53 169.32 20.18 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.528 2.152 . . . . 0.0 112.218 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -50.29 105.9 0.57 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.939 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.492 ' HG2' ' CZ2' ' A' ' 59' ' ' TRP . 76.5 Cg_exo -46.63 160.96 0.2 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.429 2.086 . . . . 0.0 112.594 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.426 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -66.16 166.38 11.94 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.178 178.532 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -117.03 -178.6 3.48 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.187 0.517 . . . . 0.0 112.187 -176.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.1 tt -144.58 146.74 19.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.378 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -85.81 -61.05 1.84 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.523 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.422 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 0.7 OUTLIER -94.6 34.31 1.34 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.92 -179.142 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.435 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -149.57 -179.18 25.2 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.76 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -138.8 127.99 24.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.769 0.319 . . . . 0.0 110.644 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.5 ' CD2' ' CE1' ' A' ' 33' ' ' TYR . 16.1 mt -76.54 153.74 35.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.096 0.475 . . . . 0.0 111.632 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.432 ' HB2' ' CB ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -127.38 78.82 1.84 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.744 177.838 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.454 ' CD1' ' HG3' ' A' ' 12' ' ' PRO . 3.6 mm -68.85 100.32 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.861 -177.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -103.63 22.86 34.47 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.648 177.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 146.57 133.56 2.48 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 111.741 -0.544 . . . . 0.0 111.741 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.7 m -121.22 22.32 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.697 0.284 . . . . 0.0 111.489 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.12 149.59 26.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.552 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -48.41 113.7 0.81 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.894 0.378 . . . . 0.0 110.853 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.42 6.74 23.39 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.618 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.86 -163.19 0.97 Allowed 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.8 0.3 . . . . 0.0 110.571 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.7 p -168.94 144.02 3.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.935 0.398 . . . . 0.0 111.143 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.519 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -102.6 170.31 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.278 179.413 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.432 ' CB ' ' HB2' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -130.67 114.42 15.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.0 0.429 . . . . 0.0 111.126 179.885 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.5 ' CE1' ' CD2' ' A' ' 20' ' ' LEU . 17.2 m-85 -92.84 137.14 32.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.504 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.435 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 3.5 m -143.86 166.25 25.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.44 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.9 m -82.89 170.44 14.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.784 0.326 . . . . 0.0 110.879 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -70.19 -83.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.851 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.6 m -156.44 132.44 9.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.743 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.51 22.75 73.42 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.067 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.472 ' CE1' ' HB2' ' A' ' 68' ' ' SER . 2.7 m-85 -114.65 -174.78 2.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.795 0.331 . . . . 0.0 110.913 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.526 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.3 OUTLIER -145.35 112.41 6.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.435 178.203 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.439 ' CD1' ' HG3' ' A' ' 64' ' ' PRO . 7.9 tt -77.35 124.17 27.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.768 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.526 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 2.3 mm -100.16 152.23 4.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.994 0.426 . . . . 0.0 110.931 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.71 -137.34 16.58 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.202 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.407 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 0.3 OUTLIER -86.67 -175.84 5.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.02 0.438 . . . . 0.0 110.855 179.432 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.402 ' HB3' HD21 ' A' ' 41' ' ' LEU . 3.5 p -155.86 24.16 0.38 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.23 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.51 130.03 13.94 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.104 0.478 . . . . 0.0 112.221 -178.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.442 ' HB3' ' CB ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -101.15 152.8 20.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.34 178.656 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.476 ' CD2' ' HB2' ' A' ' 60' ' ' ASN . 1.3 m-85 -126.23 120.68 30.66 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 119.7 -0.8 . . . . 0.0 111.902 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.477 ' HB3' ' CH2' ' A' ' 59' ' ' TRP . 32.2 t -70.21 116.73 10.9 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.095 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -153.6 -177.43 6.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.789 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.81 165.6 12.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.988 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.28 -135.52 5.6 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.57 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -93.04 -40.67 10.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.753 0.311 . . . . 0.0 111.011 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.1 p -95.29 44.02 1.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.028 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.13 19.32 30.91 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.654 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.6 t -79.53 -170.21 2.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.763 0.316 . . . . 0.0 110.904 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.66 134.05 54.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.555 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.6 m -150.64 176.54 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.917 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.519 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 60.0 m95 -128.16 127.98 43.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.944 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.476 ' HB2' ' CD2' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -69.37 163.24 60.19 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.178 179.311 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.446 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 80.1 Cg_exo -16.58 94.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.899 1 C-N-CA 125.574 4.182 . . . . 0.0 114.429 -178.456 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.443 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -101.28 -81.98 0.47 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.958 -177.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.475 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -72.95 106.46 2.26 Favored Pre-proline 0 C--N 1.331 -0.212 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -176.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.473 ' HD2' ' CD1' ' A' ' 33' ' ' TYR . 1.8 Cg_endo -90.05 -156.01 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.469 2.779 . . . . 0.0 111.14 177.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.406 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 3.8 mm -92.43 165.3 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.877 0.37 . . . . 0.0 110.884 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -170.21 136.3 1.39 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.002 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.4 ' C ' ' CD2' ' A' ' 39' ' ' TYR . 1.6 tt0 -159.78 172.37 17.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.909 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.472 ' HB2' ' CE1' ' A' ' 39' ' ' TYR . 4.1 p -89.77 107.88 19.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.431 ' CG2' ' HB3' ' A' ' 40' ' ' HIS . 2.4 p -43.06 94.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.524 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.436 ' HG3' ' CG2' ' A' ' 90' ' ' THR . 2.0 mmtp -75.16 127.23 32.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.375 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.92 113.92 27.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.056 178.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.3 -159.74 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.538 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.482 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 1.4 t -44.52 135.2 4.5 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.234 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.78 161.78 12.03 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.398 2.065 . . . . 0.0 112.116 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.504 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 79.8 Cg_exo -43.14 156.64 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.772 2.314 . . . . 0.0 112.904 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.5 t -104.81 90.56 3.52 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.372 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.1 pt -69.28 175.32 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.395 -178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.4 p -93.79 141.04 28.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.609 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 58.4 28.58 17.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.036 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.467 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -167.05 -171.32 33.0 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.215 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -158.55 -173.58 4.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.078 0.466 . . . . 0.0 110.614 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.482 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 8.4 p80 -117.5 172.19 7.5 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.173 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -117.86 -155.75 0.61 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.952 178.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 129.59 162.16 10.76 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.628 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.507 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -110.75 -39.54 4.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.138 0.494 . . . . 0.0 110.523 179.752 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -84.61 -177.15 6.53 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.455 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.66 -15.01 15.09 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.585 177.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.432 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 7.4 m-85 -138.88 178.52 7.1 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.35 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.432 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 65.6 m-85 -155.64 164.87 38.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.642 0.258 . . . . 0.0 110.9 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.436 ' CG2' ' HG3' ' A' ' 70' ' ' LYS . 19.7 p -148.18 -175.29 4.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.005 0.431 . . . . 0.0 111.567 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 28.8 p-10 -52.92 95.65 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.348 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.04 20.35 2.52 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.231 -0.895 . . . . 0.0 113.261 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -110.24 147.35 33.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 117.051 0.425 . . . . 0.0 110.965 179.508 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.419 HG23 ' N ' ' A' ' 95' ' ' VAL . 33.7 m -128.45 158.44 40.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.005 0.431 . . . . 0.0 111.185 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.518 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 14.0 t -151.67 147.34 15.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.709 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.96 131.41 54.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.852 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.493 ' CE1' ' CG2' ' A' ' 111' ' ' VAL . 5.0 m-85 -88.95 159.08 17.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.516 -178.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 49.7 m -151.97 138.89 19.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.947 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 84.1 m -73.43 156.25 38.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.499 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.467 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 40.8 m-20 -91.35 -71.97 0.61 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.313 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.6 t -53.51 -23.32 10.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.968 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.2 29.03 1.7 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.557 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.49 ' CE1' HG12 ' A' ' 126' ' ' ILE . 24.0 m-85 -73.98 -174.82 1.97 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.021 0.439 . . . . 0.0 110.365 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -123.35 99.19 6.21 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 176.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.541 ' HA ' ' HA ' ' A' ' 124' ' ' CYS . 0.0 OUTLIER -52.57 152.95 3.33 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 122.277 1.036 . . . . 0.0 112.387 -175.285 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.479 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 40.6 mm -119.01 150.3 21.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 113.149 -1.841 . . . . 0.0 111.138 -175.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.416 ' O ' ' ND2' ' A' ' 108' ' ' ASN . . . 72.52 33.99 60.59 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.032 -1.08 . . . . 0.0 111.746 -178.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.416 ' ND2' ' O ' ' A' ' 107' ' ' GLY . 8.6 p30 54.05 145.86 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 124.357 1.063 . . . . 0.0 112.997 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.512 ' HA ' ' HG2' ' A' ' 122' ' ' PRO . 0.7 OUTLIER -71.91 -23.48 61.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.764 -178.756 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -62.14 128.24 41.69 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.764 -0.732 . . . . 0.0 113.009 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.493 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 2.5 t -128.9 125.38 62.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.437 HD22 ' N ' ' A' ' 113' ' ' CYS . 1.2 tm? -85.82 135.53 33.68 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.884 0.373 . . . . 0.0 111.456 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.518 ' HB2' ' CZ3' ' A' ' 118' ' ' TRP . 39.1 t -108.01 104.8 14.32 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.232 177.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.9 OUTLIER -164.83 124.04 1.82 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.923 0.392 . . . . 0.0 111.349 179.865 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.23 26.17 11.57 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.409 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.431 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 68.43 13.51 65.4 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.6 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -145.8 172.3 13.52 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.875 0.369 . . . . 0.0 110.702 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.518 ' CZ3' ' HB2' ' A' ' 113' ' ' CYS . 92.5 m95 -111.27 141.67 44.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.876 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.18 163.81 16.09 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.427 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.448 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 3.7 p-10 46.58 48.66 5.79 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.332 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.448 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 91.0 Cg_endo -78.5 146.58 21.82 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.496 2.131 . . . . 0.0 110.572 176.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.512 ' HG2' ' HA ' ' A' ' 109' ' ' SER . 56.6 Cg_endo -97.65 -177.44 0.29 Allowed 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 122.048 1.832 . . . . 0.0 114.357 -176.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.47 ' O ' ' HA ' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -118.21 -156.25 0.63 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.273 -1.331 . . . . 0.0 109.018 177.788 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 105' ' ' LEU . 2.0 m -152.65 89.1 1.38 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.061 0.458 . . . . 0.0 110.788 177.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -121.45 160.13 24.79 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.658 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.49 HG12 ' CE1' ' A' ' 103' ' ' TYR . 16.8 mm . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.053 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.927 0.394 . . . . 0.0 110.785 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 18.6 mtm180 -61.81 150.51 36.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.541 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.522 ' HB2' ' CD ' ' A' ' 10' ' ' PRO . 55.6 m -69.42 179.09 0.79 Allowed Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.5 178.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.522 ' CD ' ' HB2' ' A' ' 9' ' ' CYS . 17.9 Cg_endo -88.84 -171.71 0.61 Allowed 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.637 2.225 . . . . 0.0 111.598 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.6 t -57.23 106.22 0.65 Allowed Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.442 ' CG ' HD11 ' A' ' 22' ' ' ILE . 9.6 Cg_endo -52.44 162.75 2.05 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.107 1.872 . . . . 0.0 112.029 -178.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.427 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -62.27 -175.94 0.09 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.025 179.159 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -143.09 -175.36 4.49 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.165 0.507 . . . . 0.0 111.268 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.7 tt -145.23 158.45 13.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.735 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -93.91 -55.2 3.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.446 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.91 45.79 1.24 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.981 0.419 . . . . 0.0 110.858 -179.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -177.18 -179.14 47.38 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.996 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.74 137.6 40.07 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.8 0.333 . . . . 0.0 110.392 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.525 ' CD2' ' CE2' ' A' ' 33' ' ' TYR . 19.3 mt -82.74 154.87 24.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.033 0.444 . . . . 0.0 111.537 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -124.45 84.06 2.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.089 178.515 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.443 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 3.8 mm -68.68 108.94 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.676 -177.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -112.51 19.99 21.2 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.002 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 147.31 127.14 1.73 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.309 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.9 m -116.52 21.09 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.643 0.258 . . . . 0.0 111.47 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -91.01 151.91 20.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.819 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.439 ' CE2' HD11 ' A' ' 51' ' ' LEU . 9.2 t80 -52.27 96.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.832 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 122.6 13.01 4.83 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.957 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.6 m -101.23 -162.64 0.95 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.862 0.331 . . . . 0.0 110.427 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 47' ' ' SER . 0.9 OUTLIER -166.01 146.62 6.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.05 0.452 . . . . 0.0 111.347 179.12 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.506 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.9 OUTLIER -104.05 172.91 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.364 179.614 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.42 ' O ' ' N ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -134.52 115.14 13.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.922 0.392 . . . . 0.0 111.038 179.722 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.525 ' CE2' ' CD2' ' A' ' 20' ' ' LEU . 19.2 m-85 -88.16 149.45 23.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.034 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 81.4 p -151.24 154.17 36.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.651 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.411 ' HB2' ' HB2' ' A' ' 39' ' ' TYR . 6.3 m -78.04 167.87 20.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.787 0.327 . . . . 0.0 110.868 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -69.01 -83.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.407 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.04 132.08 11.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.889 0.376 . . . . 0.0 110.982 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.48 22.58 76.54 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.98 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.579 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.2 m-85 -117.43 -179.93 3.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.972 0.415 . . . . 0.0 110.908 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.507 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.7 OUTLIER -144.79 114.73 7.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.25 178.338 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.441 HD22 ' CB ' ' A' ' 45' ' ' SER . 7.5 tt -73.91 126.14 29.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.594 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.507 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 1.7 mm -101.99 156.06 4.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.004 0.43 . . . . 0.0 110.945 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.29 -147.32 39.02 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.271 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.413 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 3.4 pt-20 -65.98 -176.22 0.38 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.928 0.394 . . . . 0.0 110.633 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.441 ' CB ' HD22 ' A' ' 41' ' ' LEU . 1.2 t -163.91 25.9 0.08 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.945 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.7 mtpt -152.88 128.16 9.85 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.966 0.412 . . . . 0.0 112.02 -178.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.445 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 1.0 OUTLIER -92.16 142.09 27.88 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 176.572 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.516 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 1.2 m-85 -117.22 120.28 37.79 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 119.099 -1.04 . . . . 0.0 112.255 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 34.8 t -71.57 100.78 2.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.753 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.46 -173.4 2.67 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.014 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.439 HD11 ' CE2' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -100.44 150.6 22.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.873 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.19 -147.88 1.32 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.432 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.8 -38.23 13.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.759 0.314 . . . . 0.0 110.948 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 72.7 p -102.33 45.62 0.96 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.983 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 63.22 20.52 63.05 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.647 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.22 -161.73 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.787 0.327 . . . . 0.0 110.886 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.8 140.76 51.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.186 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.1 m -151.97 173.99 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.975 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.506 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 72.8 m95 -126.82 123.21 36.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.357 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.516 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 1.0 OUTLIER -69.99 166.32 34.12 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.363 178.578 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.461 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 76.7 Cg_exo -21.57 97.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 125.044 3.829 . . . . 0.0 114.163 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.448 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -94.85 -78.34 0.45 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.05 -177.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.485 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -78.07 108.25 7.15 Favored Pre-proline 0 C--N 1.331 -0.216 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -176.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.434 ' HG3' ' CD1' ' A' ' 41' ' ' LEU . 2.4 Cg_endo -87.3 -156.19 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.115 2.543 . . . . 0.0 111.016 177.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.426 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 2.9 mm -88.89 169.25 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.967 0.413 . . . . 0.0 110.67 178.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -169.97 134.29 1.28 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.734 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.467 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 1.4 tt0 -155.06 -177.84 6.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.54 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.579 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 2.7 p -75.02 147.59 40.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.646 0.736 . . . . 0.0 111.336 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.424 HG23 ' N ' ' A' ' 116' ' ' GLY . 0.0 OUTLIER -61.86 100.72 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 114.504 -1.226 . . . . 0.0 110.312 -179.371 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 89' ' ' TYR . 0.3 OUTLIER -105.62 119.42 39.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.3 -178.222 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.27 119.26 38.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.467 176.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.28 -157.93 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.412 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.423 ' OG ' ' NE2' ' A' ' 82' ' ' HIS . 2.4 t -51.66 136.66 34.04 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.625 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.482 ' HD2' ' CD2' ' A' ' 82' ' ' HIS . 52.2 Cg_exo -55.05 159.17 10.12 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.411 2.074 . . . . 0.0 112.302 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.419 ' N ' ' OH ' ' A' ' 97' ' ' TYR . 89.5 Cg_exo -44.39 156.44 0.21 Allowed 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.632 2.221 . . . . 0.0 112.597 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 95.6 p -102.94 89.87 3.59 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.775 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.3 pt -69.61 176.29 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.127 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.79 143.54 26.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.974 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.442 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 12.5 m-80 52.86 29.5 7.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.148 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.461 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -162.15 -169.16 25.11 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.275 -0.964 . . . . 0.0 113.353 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.72 -173.98 3.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.872 0.368 . . . . 0.0 110.489 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.482 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 7.3 p-80 -113.28 167.17 10.78 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.558 -179.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 96' ' ' THR . 16.2 m-20 -94.23 17.12 13.27 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.832 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.431 ' N ' HG13 ' A' ' 95' ' ' VAL . . . -48.76 136.41 18.88 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.028 -1.082 . . . . 0.0 112.961 -176.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -108.3 -37.22 6.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.964 0.411 . . . . 0.0 111.01 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.87 -175.99 3.32 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.043 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.11 -24.6 16.22 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.78 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.433 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 7.3 m-85 -135.6 169.67 17.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.761 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.461 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 22.4 m-85 -141.8 162.33 35.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.13 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.4 p -122.25 174.91 6.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.173 0.511 . . . . 0.0 112.123 -177.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -60.29 95.53 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.163 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 122.46 18.19 3.4 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.291 -0.868 . . . . 0.0 113.075 178.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.09 157.02 16.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.739 0.304 . . . . 0.0 110.595 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 28.6 m -143.52 141.87 25.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.225 0.536 . . . . 0.0 111.152 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.551 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 40.2 t -142.48 142.1 27.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.941 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.444 ' O ' ' N ' ' A' ' 83' ' ' ASN . 0.1 OUTLIER -89.01 149.54 23.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.646 -177.079 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.472 ' CE1' HG23 ' A' ' 111' ' ' VAL . 4.1 m-85 -105.16 159.63 15.71 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.986 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.0 m -157.17 153.65 28.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.039 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 59.5 m -80.02 160.9 25.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.816 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.461 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 60.2 m-20 -87.59 -70.93 0.59 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.418 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.42 -27.62 67.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.24 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.57 35.53 0.49 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.791 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.498 ' CE2' HG12 ' A' ' 126' ' ' ILE . 15.8 m-85 -70.78 -174.68 0.95 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.914 0.387 . . . . 0.0 110.587 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.4 98.16 7.61 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.162 178.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.446 HD22 ' CB ' ' A' ' 122' ' ' PRO . 0.3 OUTLIER -46.47 122.53 4.17 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.507 0.67 . . . . 0.0 112.268 -177.747 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.43 ' HB ' ' CB ' ' A' ' 123' ' ' THR . 5.1 mm -85.06 154.73 3.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.938 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.85 -126.1 33.94 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.209 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -123.48 140.99 52.45 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.936 0.398 . . . . 0.0 111.024 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.428 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 1.8 t -73.05 -29.41 62.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.948 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -78.23 127.83 8.4 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.002 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.472 HG23 ' CE1' ' A' ' 97' ' ' TYR . 3.1 t -118.41 139.97 43.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 178.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.81 131.51 43.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.146 0.498 . . . . 0.0 111.567 -178.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.48 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 12.0 t -97.45 95.16 7.47 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.446 176.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.9 t -151.07 153.14 34.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.455 -178.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.12 -0.56 62.64 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.645 -0.707 . . . . 0.0 113.491 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.424 ' N ' HG23 ' A' ' 69' ' ' VAL . . . 100.24 1.54 55.79 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.902 -177.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -146.3 177.12 9.25 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.821 0.343 . . . . 0.0 110.708 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.551 ' CH2' ' CG2' ' A' ' 95' ' ' VAL . 95.2 m95 -99.01 155.61 17.34 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.717 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.09 155.28 44.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.031 0.444 . . . . 0.0 111.19 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.481 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.7 OUTLIER 66.22 47.0 0.49 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.798 179.599 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 87.0 Cg_endo -79.4 139.3 14.5 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.476 2.117 . . . . 0.0 111.698 178.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.446 ' CB ' HD22 ' A' ' 105' ' ' LEU . 50.3 Cg_endo -90.61 -174.72 0.76 Allowed 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.5 2.133 . . . . 0.0 113.2 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.43 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -128.4 -157.79 0.84 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.499 177.576 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 3.5 m -157.6 89.56 1.04 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.13 0.491 . . . . 0.0 111.133 178.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.41 ' HB3' ' CD1' ' A' ' 106' ' ' ILE . 16.4 mt-30 -114.5 170.87 7.99 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.783 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.498 HG12 ' CE2' ' A' ' 103' ' ' TYR . 49.1 mm . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.792 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? . . . . . 0 C--O 1.231 0.13 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.429 ' CD ' HG23 ' A' ' 25' ' ' VAL . 0.0 OUTLIER 42.88 -164.13 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.851 0.358 . . . . 0.0 111.394 178.767 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.461 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 15.1 m -78.67 161.62 68.58 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.448 178.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.02 167.32 25.13 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.338 2.025 . . . . 0.0 111.703 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 t -51.02 105.44 0.52 Allowed Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.936 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.414 ' HG2' ' CZ2' ' A' ' 59' ' ' TRP . 51.3 Cg_exo -50.76 151.07 11.46 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.151 1.901 . . . . 0.0 111.731 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.433 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 7.1 mpt_? -55.7 159.24 3.11 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.82 -173.85 2.33 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.2 0.524 . . . . 0.0 111.615 -177.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.429 HG22 ' CD2' ' A' ' 20' ' ' LEU . 9.2 tt -152.57 138.92 12.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.539 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -82.2 -57.31 3.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.676 -177.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.494 ' HB2' ' CE1' ' A' ' 39' ' ' TYR . 1.2 m120 -91.2 45.84 1.27 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.055 0.455 . . . . 0.0 111.069 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -176.65 -179.46 47.09 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.39 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.64 137.36 41.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.815 0.341 . . . . 0.0 110.773 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.476 HD21 ' CD2' ' A' ' 33' ' ' TYR . 14.5 mt -75.9 152.15 37.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.215 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.442 ' HB2' ' CB ' ' A' ' 32' ' ' THR . 19.4 t0 -120.92 69.64 0.89 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.447 177.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.1 mt -80.84 90.95 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.883 -176.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.85 16.13 59.07 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.81 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 165.83 133.21 1.48 Allowed Glycine 0 C--N 1.334 0.435 0 C-N-CA 121.176 -0.535 . . . . 0.0 111.765 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.429 HG23 ' CD ' ' A' ' 8' ' ' ARG . 1.7 m -119.43 -2.54 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -178.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.403 ' HA ' ' HB3' ' A' ' 8' ' ' ARG . 29.3 t0 -75.88 164.13 26.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.986 0.422 . . . . 0.0 110.814 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.425 ' CE2' ' HB2' ' A' ' 51' ' ' LEU . 13.1 t80 -52.03 115.81 1.88 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.09 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.73 -4.59 46.57 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.764 -0.731 . . . . 0.0 113.066 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 57.9 m -74.99 176.83 6.81 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 117.029 0.415 . . . . 0.0 110.602 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 47' ' ' SER . 2.5 p -144.47 149.99 36.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.952 0.406 . . . . 0.0 111.464 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.544 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -118.74 165.83 13.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.468 179.353 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.442 ' CB ' ' HB2' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -135.9 111.75 9.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.896 178.547 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.524 ' CE2' ' CB ' ' A' ' 63' ' ' ALA . 31.6 m-85 -84.06 135.78 34.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.062 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 84.4 p -141.05 146.86 37.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.154 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.45 ' HB2' ' HB2' ' A' ' 39' ' ' TYR . 1.7 m -73.38 174.31 8.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.794 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.68 -82.42 0.06 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.39 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.2 m -155.14 120.16 4.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.476 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.416 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . 77.42 -0.58 68.69 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.475 -177.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.517 ' CZ ' ' CB ' ' A' ' 68' ' ' SER . 5.9 m-85 -89.48 166.43 13.69 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 120.782 0.325 . . . . 0.0 110.832 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.528 ' CE1' ' CG2' ' A' ' 69' ' ' VAL . 0.0 OUTLIER -121.46 127.68 51.34 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 176.578 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.429 ' CD2' ' O ' ' A' ' 44' ' ' GLU . 6.0 tt -86.02 117.2 24.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.135 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.1 mm -92.41 153.83 3.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.475 -177.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.82 -151.29 50.27 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.26 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.439 ' O ' ' CG ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -55.28 178.92 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.534 0.206 . . . . 0.0 110.536 179.504 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.6 p -152.14 18.8 0.66 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.608 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.77 175.72 13.36 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.923 0.392 . . . . 0.0 110.958 -178.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.441 ' HB3' ' CG1' ' A' ' 31' ' ' ILE . 2.6 m -149.63 123.03 9.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.297 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.407 ' O ' ' N ' ' A' ' 50' ' ' GLU . 4.9 m-85 -103.0 114.16 28.23 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.973 0.416 . . . . 0.0 111.452 -178.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.459 ' HB3' ' CH2' ' A' ' 59' ' ' TRP . 42.2 t -64.97 77.44 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.374 0.607 . . . . 0.0 110.076 178.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.5 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 1.9 tt0 -97.33 175.13 6.37 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.907 -177.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.5 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -88.0 138.57 31.33 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.106 -179.551 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.29 -148.07 0.55 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.754 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -92.04 -38.73 12.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.712 0.292 . . . . 0.0 111.186 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.0 p -91.67 40.57 1.04 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.183 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 62.19 19.24 59.19 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.551 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.08 -161.36 0.63 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.702 0.287 . . . . 0.0 110.725 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.414 ' HA ' ' HA ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -134.16 116.99 16.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.71 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.1 m -126.03 -176.79 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.383 -178.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.544 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 97.5 m95 -116.38 125.6 52.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.126 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -150.08 118.73 3.68 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.771 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_exo -73.21 -172.16 9.47 Favored 'Cis proline' 0 C--N 1.35 0.633 0 C-N-CA 124.221 -1.158 . . . . 0.0 112.413 1.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -111.11 -152.5 0.5 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.891 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.524 ' CB ' ' CE2' ' A' ' 33' ' ' TYR . . . -79.38 111.27 19.31 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.651 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.439 ' CG ' ' O ' ' A' ' 44' ' ' GLU . 15.3 Cg_exo -69.07 -150.76 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.662 2.241 . . . . 0.0 112.296 -179.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -108.36 -179.69 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.117 0.484 . . . . 0.0 111.222 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -167.43 118.52 0.87 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.524 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.469 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 0.1 OUTLIER -113.4 166.74 11.2 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.689 179.888 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.517 ' CB ' ' CZ ' ' A' ' 39' ' ' TYR . 1.1 p -107.53 120.42 42.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.993 0.425 . . . . 0.0 111.047 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.528 ' CG2' ' CE1' ' A' ' 40' ' ' HIS . 3.1 p -46.4 94.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.439 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.8 125.44 29.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.276 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.432 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -104.33 126.06 51.1 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.326 178.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -73.62 -169.12 0.65 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.472 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -42.42 135.05 2.59 Favored Pre-proline 0 N--CA 1.438 -1.065 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.436 178.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.46 ' HA ' ' CD1' ' A' ' 118' ' ' TRP . 34.5 Cg_exo -56.05 159.88 11.45 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.188 1.925 . . . . 0.0 111.923 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.489 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 96.1 Cg_exo -40.85 156.6 0.05 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.757 2.305 . . . . 0.0 112.855 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.3 m -108.5 90.12 3.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.647 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.422 ' CG2' ' O ' ' A' ' 122' ' ' PRO . 16.5 pt -69.41 170.85 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.298 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.39 133.78 35.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.777 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.483 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 0.2 OUTLIER 67.9 26.41 7.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.602 -179.643 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.412 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . -171.44 -170.83 35.96 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.732 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.15 -175.47 2.0 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.958 0.409 . . . . 0.0 110.801 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.452 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 12.3 p80 -95.04 176.11 6.37 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.891 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.43 ' ND2' ' HB ' ' A' ' 96' ' ' THR . 2.7 m-20 -121.8 21.75 10.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.169 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -52.26 150.76 8.27 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.618 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -107.65 -28.65 9.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.067 0.46 . . . . 0.0 110.529 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.57 -172.2 2.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.637 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.75 -21.8 12.72 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.125 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.414 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 6.0 m-85 -139.07 168.98 18.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.976 0.417 . . . . 0.0 111.154 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.432 ' N ' ' O ' ' A' ' 71' ' ' CYS . 33.0 m-85 -145.05 170.32 16.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.613 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.4 p -133.25 175.38 9.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.913 0.387 . . . . 0.0 111.18 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -60.19 94.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.307 0.575 . . . . 0.0 111.038 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 128.31 28.1 0.86 Allowed Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.294 -0.866 . . . . 0.0 113.18 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.11 164.88 12.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.791 0.295 . . . . 0.0 110.661 179.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 33.5 m -138.47 154.81 27.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.067 0.461 . . . . 0.0 111.274 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.501 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 21.7 t -152.42 148.5 14.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.021 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.43 ' HB ' ' ND2' ' A' ' 83' ' ' ASN . 0.1 OUTLIER -104.99 142.94 33.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.306 179.007 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.515 ' CE2' ' CG2' ' A' ' 111' ' ' VAL . 4.6 m-85 -101.43 155.4 18.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.946 0.403 . . . . 0.0 111.279 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 45.9 m -148.57 141.93 25.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.165 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.412 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 73.5 m -72.75 162.35 29.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.759 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.4 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 39.7 m-20 -92.74 -70.59 0.69 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.347 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.5 m -63.79 -23.37 67.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.198 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 122.21 33.0 0.93 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.495 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.491 ' CE2' HG12 ' A' ' 126' ' ' ILE . 22.6 m-85 -69.9 -176.95 1.19 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.022 0.439 . . . . 0.0 110.725 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.2 m -108.11 101.73 10.94 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.185 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.43 HD23 ' CB ' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -46.32 125.18 6.44 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.426 0.631 . . . . 0.0 111.771 -178.255 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.44 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 34.6 mm -90.79 152.1 3.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.931 -1.032 . . . . 0.0 110.282 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 68.86 -127.49 22.33 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.257 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.59 132.48 52.51 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.712 0.291 . . . . 0.0 110.946 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.447 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 1.9 t -62.87 -33.16 74.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.773 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -66.03 139.42 38.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.781 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.515 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 3.0 t -136.44 119.91 23.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.571 0.224 . . . . 0.0 110.705 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.93 128.72 33.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.965 0.412 . . . . 0.0 111.47 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.506 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 17.7 t -92.8 102.29 14.68 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 176.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.1 p -144.54 162.86 35.51 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.074 0.464 . . . . 0.0 111.401 -177.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.2 29.0 4.66 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.778 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.429 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 70.15 16.15 72.78 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.4 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -141.51 -177.76 5.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.869 0.366 . . . . 0.0 110.659 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.506 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 95.1 m95 -117.04 142.19 47.29 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.082 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.18 149.92 47.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.247 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.488 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 2.0 t0 70.14 46.01 0.27 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.036 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 84.1 Cg_endo -78.18 134.43 12.9 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.442 2.095 . . . . 0.0 111.831 178.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.447 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 73.9 Cg_endo -89.05 -173.06 0.74 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.62 2.214 . . . . 0.0 113.432 -178.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.39 -160.76 1.07 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.96 178.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 8.2 m -153.28 91.19 1.49 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.141 0.496 . . . . 0.0 110.957 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -122.39 157.74 31.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.616 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.491 HG12 ' CE2' ' A' ' 103' ' ' TYR . 24.0 mm . . . . . 0 C--N 1.323 -0.584 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.932 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 29.1 mtt180 . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.969 0.414 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.42 ' HA ' ' HA ' ' A' ' 26' ' ' ASP . 3.1 mtm180 40.04 -163.66 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.363 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.444 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 4.2 m -122.58 164.65 25.24 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.339 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.436 ' HD3' ' HB2' ' A' ' 9' ' ' CYS . 44.3 Cg_endo -66.13 168.05 16.7 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.145 1.897 . . . . 0.0 111.465 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.5 t -52.84 105.95 0.6 Allowed Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.047 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.445 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 17.2 Cg_exo -42.15 158.1 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.212 1.941 . . . . 0.0 112.164 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.428 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -74.87 166.93 22.84 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.155 178.411 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.402 ' HA ' HD11 ' A' ' 20' ' ' LEU . 12.0 p-10 -121.48 -175.21 3.03 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 121.079 0.466 . . . . 0.0 112.022 -176.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.425 ' CD1' ' O ' ' A' ' 64' ' ' PRO . 16.9 tt -151.52 147.21 15.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.715 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.417 ' HB2' ' ND2' ' A' ' 17' ' ' ASN . 4.7 t0 -87.2 156.72 19.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.219 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.523 ' CB ' ' CE1' ' A' ' 39' ' ' TYR . 0.5 OUTLIER 45.44 27.02 0.34 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.096 -179.611 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -147.38 176.96 25.97 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.207 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.54 136.23 34.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.787 0.327 . . . . 0.0 110.812 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.445 HD23 ' CE2' ' A' ' 33' ' ' TYR . 3.5 mt -87.7 159.26 18.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.62 178.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.431 ' CB ' ' HB ' ' A' ' 32' ' ' THR . 5.3 t0 -124.76 71.23 1.16 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.049 177.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.454 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 0.8 OUTLIER -74.19 95.38 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.776 -177.748 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.77 19.14 55.71 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.722 177.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 158.93 132.16 1.34 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.227 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.0 m -118.63 33.35 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.543 0.211 . . . . 0.0 111.521 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 43.9 t0 -105.0 162.87 12.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.043 0.449 . . . . 0.0 111.513 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.464 ' CZ ' HD11 ' A' ' 51' ' ' LEU . 5.2 t80 -59.96 91.73 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.619 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.15 3.56 6.79 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.638 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.77 -165.84 1.39 Allowed 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.843 0.321 . . . . 0.0 110.312 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 67.4 p -162.84 146.81 11.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.298 0.57 . . . . 0.0 111.593 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.537 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.5 OUTLIER -114.17 160.45 13.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.871 179.57 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.431 ' HB ' ' CB ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -123.3 120.48 33.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.919 0.39 . . . . 0.0 110.899 179.184 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.634 ' CZ ' ' O ' ' A' ' 62' ' ' GLU . 2.2 m-85 -91.98 142.32 27.66 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.533 -178.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.91 164.82 37.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.669 -179.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 64.6 m -90.17 172.55 8.72 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.867 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.4 m-20 -78.17 -83.35 0.08 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.205 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.79 135.53 17.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.665 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.423 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . 63.31 26.35 69.34 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.867 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.523 ' CE1' ' CB ' ' A' ' 17' ' ' ASN . 2.4 m-85 -120.11 171.28 8.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.807 0.337 . . . . 0.0 111.171 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.481 ' CE1' HD13 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -133.86 127.86 33.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.289 178.275 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.44 ' CD2' ' HG3' ' A' ' 64' ' ' PRO . 1.7 tt -87.72 124.6 33.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.671 -178.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.481 HD13 ' CE1' ' A' ' 40' ' ' HIS . 0.9 OUTLIER -108.06 131.34 58.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.312 0.577 . . . . 0.0 111.038 -179.432 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 112.86 -146.37 18.34 Favored Glycine 0 C--N 1.321 -0.261 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.204 -177.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.51 ' HG2' ' HG2' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -74.31 -135.59 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 176.912 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.425 ' HB3' ' O ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER 174.02 26.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 117.965 0.348 . . . . 0.0 110.784 177.71 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.474 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 4.3 mttt -160.22 134.49 7.4 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.786 -178.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.435 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 32.1 t -107.69 144.38 34.88 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.908 177.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.493 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 3.4 m-85 -126.41 120.27 29.36 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 119.41 -0.916 . . . . 0.0 112.461 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 32.5 t -64.01 99.28 0.25 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.538 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -124.2 -173.7 2.83 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.112 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.464 HD11 ' CZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -100.44 151.67 21.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.02 -179.348 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.41 -125.74 0.23 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.487 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.4 m -110.93 -32.37 6.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.87 0.367 . . . . 0.0 110.884 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 80.8 p -99.21 29.64 3.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.742 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.78 22.38 78.73 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.311 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.3 t -80.48 -161.63 0.39 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.916 0.389 . . . . 0.0 110.994 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.5 mmt -124.58 123.72 40.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.433 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.7 m -137.04 179.91 3.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.936 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.537 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 66.5 m95 -124.74 127.18 46.84 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.289 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.493 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -69.53 168.97 13.75 Favored Pre-proline 0 CA--C 1.513 -0.449 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.486 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 1.0 OUTLIER -4.97 85.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.282 1 C-N-CA 125.326 4.017 . . . . 0.0 113.816 -179.107 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.634 ' O ' ' CZ ' ' A' ' 33' ' ' TYR . 15.3 mt-10 -69.09 -53.07 22.21 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-N 113.052 -1.885 . . . . 0.0 111.649 -174.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.569 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -65.31 -148.51 0.0 OUTLIER Pre-proline 0 CA--C 1.487 -1.454 0 CA-C-O 116.708 -1.615 . . . . 0.0 108.043 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.547 ' CA ' ' CB ' ' A' ' 63' ' ' ALA . 3.9 Cg_exo -85.91 -157.44 1.25 Allowed 'Cis proline' 0 N--CA 1.484 0.934 0 CA-C-N 123.772 2.383 . . . . 0.0 115.013 16.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.2 mm -95.68 175.01 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.0 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.6 m -147.67 135.11 20.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.185 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.484 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 3.0 tt0 -140.55 174.06 10.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.755 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.471 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 37.4 p -89.03 118.87 29.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.984 0.421 . . . . 0.0 111.235 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.436 HG12 ' N ' ' A' ' 116' ' ' GLY . 0.1 OUTLIER -40.59 98.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.728 179.773 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.3 mmtp -67.71 137.04 55.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.389 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.03 124.77 50.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.13 178.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -69.26 -156.31 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.319 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.47 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 1.4 t -53.45 145.6 27.15 Favored Pre-proline 0 N--CA 1.45 -0.463 0 CA-C-O 120.59 0.234 . . . . 0.0 110.542 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.448 ' HA ' ' CD1' ' A' ' 118' ' ' TRP . 18.8 Cg_exo -65.29 160.63 41.4 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.53 2.154 . . . . 0.0 112.031 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.493 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 86.8 Cg_exo -40.54 156.68 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.801 2.334 . . . . 0.0 112.892 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.15 91.85 3.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.528 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.407 HG22 ' CD1' ' A' ' 97' ' ' TYR . 15.6 pt -68.98 175.91 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.07 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.9 m -94.49 140.91 29.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.912 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.488 ' HB3' ' CE1' ' A' ' 103' ' ' TYR . 7.0 m-80 57.47 29.25 16.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.989 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.46 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -163.57 -168.03 24.94 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.392 -0.909 . . . . 0.0 112.86 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 7.7 ptt85 -162.48 -175.91 4.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.007 0.432 . . . . 0.0 110.903 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.47 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 4.6 p80 -111.18 172.12 7.07 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.625 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -96.91 -85.13 0.35 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.507 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.415 ' CA ' ' OH ' ' A' ' 89' ' ' TYR . . . 60.92 142.74 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.959 178.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -113.71 -33.15 5.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.001 0.429 . . . . 0.0 110.724 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.16 -171.93 2.25 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.739 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.26 -22.27 15.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.272 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.432 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 7.0 m-85 -134.34 176.97 8.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.939 0.4 . . . . 0.0 111.333 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.432 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 62.8 m-85 -151.24 164.72 35.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.546 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 19.0 p -128.84 178.47 6.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.912 0.387 . . . . 0.0 111.114 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 14.5 t0 -64.55 101.5 0.46 Allowed 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 121.814 0.816 . . . . 0.0 111.01 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 121.55 21.39 3.01 Favored Glycine 0 C--N 1.311 -0.811 0 CA-C-N 114.312 -1.313 . . . . 0.0 112.993 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.39 160.79 14.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.845 0.322 . . . . 0.0 110.641 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 33.7 m -134.37 152.9 34.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.156 0.503 . . . . 0.0 111.515 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.516 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 27.7 t -146.49 148.71 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.688 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.41 ' CG2' ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -105.51 132.87 51.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.96 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.522 ' CE2' ' CG2' ' A' ' 111' ' ' VAL . 5.2 m-85 -93.29 159.07 15.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.005 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 56.3 p -156.11 143.67 19.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.204 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 62.3 m -72.35 160.49 32.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.305 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.46 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 8.1 m-20 -94.45 -71.01 0.68 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.408 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.95 -21.77 66.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.455 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.65 30.88 1.2 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.694 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.502 ' CE2' HG12 ' A' ' 126' ' ' ILE . 51.1 m-85 -71.27 -172.72 0.76 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.658 0.266 . . . . 0.0 110.469 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -109.62 109.3 20.01 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.011 0.434 . . . . 0.0 111.146 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.42 HD21 ' CG ' ' A' ' 122' ' ' PRO . 2.7 tp -47.56 113.56 0.72 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.662 178.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.446 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 39.0 mm -84.86 149.73 4.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.495 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.409 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 59.93 -132.43 50.92 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.385 -0.912 . . . . 0.0 111.794 -178.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -112.29 133.45 54.4 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.826 0.346 . . . . 0.0 111.477 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.485 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 1.3 t -64.92 -27.31 68.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.44 178.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.34 138.95 31.37 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.836 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.522 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 3.1 t -134.98 123.83 41.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.462 0.173 . . . . 0.0 110.576 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.5 126.94 32.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.964 0.411 . . . . 0.0 111.976 -178.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.501 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 16.4 t -92.4 104.8 17.09 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 176.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 83.1 p -151.79 165.68 33.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.947 -177.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.99 30.71 5.27 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.865 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.436 ' N ' HG12 ' A' ' 69' ' ' VAL . . . 67.9 8.79 54.69 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.51 -179.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -136.98 179.51 6.34 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.817 0.341 . . . . 0.0 110.771 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.516 ' CH2' ' CG2' ' A' ' 95' ' ' VAL . 94.2 m95 -113.5 136.58 52.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.901 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.77 155.86 37.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.134 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.522 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 34.6 t0 67.99 41.94 0.25 Allowed Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 81.4 Cg_endo -78.52 143.21 19.04 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.431 2.087 . . . . 0.0 112.03 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.485 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 57.4 Cg_endo -91.19 -172.66 0.49 Allowed 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.895 2.397 . . . . 0.0 113.353 -179.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.437 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -133.47 -177.19 4.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.274 178.097 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 6.4 m -142.13 96.68 3.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.972 0.415 . . . . 0.0 110.908 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -121.23 170.1 9.91 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.81 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.502 HG12 ' CE2' ' A' ' 103' ' ' TYR . 36.5 mm . . . . . 0 C--N 1.324 -0.515 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.823 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.622 0.248 . . . . 0.0 110.661 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.436 ' CD ' HG22 ' A' ' 25' ' ' VAL . 0.0 OUTLIER 42.11 -162.26 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.549 178.866 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.416 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 6.9 m -87.56 162.29 42.69 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.638 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.402 ' HD3' ' HB2' ' A' ' 9' ' ' CYS . 59.3 Cg_endo -70.29 169.26 20.0 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.275 1.983 . . . . 0.0 111.532 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -50.47 111.81 2.43 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.021 -179.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.53 157.42 58.42 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.495 2.13 . . . . 0.0 112.002 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.437 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 10.4 ttt180 -53.85 -179.74 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.956 178.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.473 ' O ' ' CG2' ' A' ' 15' ' ' ILE . 0.5 OUTLIER -141.3 -3.26 1.2 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -177.662 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.473 ' CG2' ' O ' ' A' ' 14' ' ' ASP . 15.6 tt 56.03 156.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 122.599 0.36 . . . . 0.0 111.114 -177.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -88.37 -63.34 1.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -176.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.425 ' HA ' ' ND2' ' A' ' 36' ' ' ASN . 0.4 OUTLIER -92.42 26.04 2.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.442 -177.797 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.417 ' HA2' ' N ' ' A' ' 36' ' ' ASN . . . -147.8 177.69 25.9 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.955 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -137.61 139.08 40.15 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.504 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -94.6 174.37 7.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.311 0.577 . . . . 0.0 111.532 -178.395 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 32' ' ' THR . 10.0 t0 -133.12 88.34 2.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.562 177.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.448 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 59.9 mt -71.58 115.79 12.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.091 -177.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -122.44 19.06 8.15 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.666 177.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 159.83 131.94 1.3 Allowed Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.436 HG22 ' CD ' ' A' ' 8' ' ' ARG . 6.6 m -124.24 5.36 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -77.33 164.46 25.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.036 0.446 . . . . 0.0 110.983 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.483 ' CZ ' ' CD1' ' A' ' 51' ' ' LEU . 4.8 t80 -57.1 101.83 0.07 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.201 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 115.45 7.7 15.73 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.958 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.2 p -88.76 -169.11 2.41 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.924 0.362 . . . . 0.0 110.62 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.4 p -160.16 151.3 19.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.953 0.406 . . . . 0.0 111.391 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.519 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.8 OUTLIER -115.78 169.84 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.477 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -123.27 113.1 18.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.956 0.408 . . . . 0.0 111.186 179.259 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.491 ' CD2' HD23 ' A' ' 20' ' ' LEU . 17.3 m-85 -88.86 140.92 28.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.218 0.533 . . . . 0.0 111.718 -179.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.92 170.69 15.66 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.231 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.404 ' HB2' ' HB2' ' A' ' 39' ' ' TYR . 1.7 m -89.19 166.14 14.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.716 0.293 . . . . 0.0 110.903 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.425 ' ND2' ' HA ' ' A' ' 17' ' ' ASN . 22.9 m-20 -64.42 -84.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.029 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.86 134.02 13.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.81 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.89 23.62 67.66 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.093 -179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.483 ' CE2' ' HB2' ' A' ' 68' ' ' SER . 2.5 m-85 -115.88 174.27 6.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.81 0.338 . . . . 0.0 111.007 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.518 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.3 OUTLIER -137.21 112.57 9.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.46 178.142 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.402 HD21 ' HB3' ' A' ' 45' ' ' SER . 4.5 tt -77.51 130.63 37.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.772 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.518 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 2.6 mm -105.52 154.17 6.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.851 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.07 -137.9 17.83 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.273 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.83 -174.21 4.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.948 0.404 . . . . 0.0 110.931 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.402 ' HB3' HD21 ' A' ' 41' ' ' LEU . 5.1 p -160.55 25.48 0.15 Allowed 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.067 -179.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.3 mtpt -152.29 132.11 13.27 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.021 0.438 . . . . 0.0 112.179 -178.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.428 ' HB3' ' HA ' ' A' ' 62' ' ' GLU . 26.4 t -96.83 153.12 18.07 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.766 177.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.487 ' CD1' ' HB2' ' A' ' 60' ' ' ASN . 1.4 m-85 -128.68 114.53 16.75 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 119.248 -0.981 . . . . 0.0 111.895 178.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 29.8 t -63.07 109.29 1.45 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.663 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.97 -176.49 4.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.045 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.483 ' CD1' ' CZ ' ' A' ' 27' ' ' PHE . 5.0 mt -82.85 167.89 17.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.199 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -94.34 -107.31 2.01 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.455 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.0 t -131.67 -44.97 0.97 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.844 0.354 . . . . 0.0 110.923 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.3 p -97.11 27.13 4.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.722 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.28 17.66 58.63 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.485 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.423 ' O ' ' CD2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -84.53 176.41 8.65 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 120.848 0.356 . . . . 0.0 111.194 -179.416 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.6 mmt -107.09 129.49 54.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.615 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 51' ' ' LEU . 31.0 m -138.68 -175.17 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.968 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.519 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 68.0 m95 -131.06 134.85 47.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.059 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.487 ' HB2' ' CD1' ' A' ' 48' ' ' TYR . 1.2 m-80 -75.06 166.6 44.13 Favored Pre-proline 0 CA--C 1.517 -0.297 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 177.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.475 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 23.2 Cg_exo -8.96 92.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 0.986 1 C-N-CA 125.568 4.178 . . . . 0.0 114.546 -179.559 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.469 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 3.6 mm-40 -82.91 -87.4 0.1 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.936 -175.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.48 ' HA ' ' CD2' ' A' ' 33' ' ' TYR . . . -96.32 108.18 40.18 Favored Pre-proline 0 C--N 1.332 -0.169 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -176.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -74.71 -151.5 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.797 2.331 . . . . 0.0 111.334 177.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.401 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 4.8 mm -88.8 166.24 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 0.0 110.712 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -165.54 137.17 4.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.884 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.06 169.94 23.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.928 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.483 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 1.1 t -80.59 123.75 28.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.146 0.498 . . . . 0.0 111.008 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.9 p -50.74 104.09 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.984 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.418 ' HD3' ' HB2' ' A' ' 88' ' ' PHE . 46.3 mmtt -71.43 121.65 18.97 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.128 -178.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.418 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -109.2 121.58 45.47 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 176.435 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -69.77 -162.02 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.513 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.477 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 1.1 t -53.32 141.58 41.63 Favored Pre-proline 0 N--CA 1.449 -0.487 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.328 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.488 ' HD2' ' CD2' ' A' ' 82' ' ' HIS . 24.9 Cg_exo -58.3 159.74 18.38 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.204 1.936 . . . . 0.0 111.515 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.402 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 78.1 Cg_exo -39.21 154.56 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.707 2.271 . . . . 0.0 112.799 -178.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.2 t -107.3 89.53 3.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.885 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.7 pt -70.12 -177.92 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.327 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.7 m -104.33 142.32 34.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.583 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.492 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 5.4 m-80 61.9 29.79 17.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.814 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.442 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . -175.78 -168.92 36.78 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.771 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -170.55 -174.66 1.68 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.907 0.384 . . . . 0.0 110.535 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.488 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 2.1 p80 -103.15 170.94 7.66 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.152 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -103.93 18.86 21.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.322 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.42 ' CA ' ' OH ' ' A' ' 89' ' ' TYR . . . -55.07 140.93 38.14 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.232 -0.985 . . . . 0.0 112.498 -179.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -108.31 -27.81 9.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.978 0.418 . . . . 0.0 110.675 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.75 -172.24 2.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.722 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -104.11 -24.79 13.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.968 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.435 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 10.5 m-85 -134.65 175.98 9.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.094 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.435 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 59.1 m-85 -148.82 152.74 37.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.665 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.4 p -102.0 175.18 5.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.099 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.9 103.12 2.13 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.652 0.739 . . . . 0.0 110.65 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 120.55 24.66 2.56 Favored Glycine 0 C--N 1.312 -0.778 0 CA-C-N 114.588 -1.187 . . . . 0.0 112.751 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.54 163.57 12.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.711 0.291 . . . . 0.0 110.627 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.416 ' CG2' ' N ' ' A' ' 95' ' ' VAL . 32.6 m -136.27 158.48 38.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.17 0.51 . . . . 0.0 111.333 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.483 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 22.1 t -153.07 150.4 12.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.769 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.4 136.36 48.16 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.355 178.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.481 ' CE1' HG23 ' A' ' 111' ' ' VAL . 4.9 m-85 -93.81 155.57 17.13 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.938 0.399 . . . . 0.0 110.987 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -154.81 144.78 21.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.408 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.442 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 9.5 m -69.95 169.14 13.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.843 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -99.33 -83.81 0.42 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.531 178.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.9 t -54.01 -36.78 63.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.247 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 136.19 47.38 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.548 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.536 ' CE2' HG12 ' A' ' 126' ' ' ILE . 12.4 m-85 -83.77 -170.18 2.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.672 0.272 . . . . 0.0 110.653 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.4 m -116.92 102.3 9.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.726 0.298 . . . . 0.0 110.821 179.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.38 136.95 11.88 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.632 0.729 . . . . 0.0 111.193 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.434 ' HB ' ' CB ' ' A' ' 123' ' ' THR . 33.2 mm -103.43 158.86 4.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.304 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.426 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 62.38 -126.1 37.17 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.309 -0.948 . . . . 0.0 112.021 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -124.12 131.72 53.57 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.981 0.42 . . . . 0.0 111.121 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.426 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 1.2 p -62.77 -26.52 68.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.857 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.2 142.29 31.38 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.821 -0.627 . . . . 0.0 113.014 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.481 HG23 ' CE1' ' A' ' 97' ' ' TYR . 2.8 t -140.05 127.02 23.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.98 122.25 32.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.873 0.368 . . . . 0.0 111.807 -178.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.509 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 15.5 t -85.16 101.26 12.33 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 176.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.45 167.19 25.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.047 0.451 . . . . 0.0 111.527 -178.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.24 25.11 2.61 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.665 -0.698 . . . . 0.0 113.033 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.82 19.7 79.48 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.222 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -151.31 -179.3 7.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.772 0.32 . . . . 0.0 110.297 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.509 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 90.1 m95 -113.23 138.53 49.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.898 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.41 146.63 46.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.236 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.48 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER 69.89 45.98 0.28 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.17 178.819 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 71.7 Cg_endo -76.95 136.77 16.89 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.313 2.009 . . . . 0.0 111.383 177.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.428 ' CB ' ' O ' ' A' ' 106' ' ' ILE . 56.6 Cg_endo -89.7 179.41 2.15 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.383 2.055 . . . . 0.0 113.582 -178.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.434 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -120.13 -159.99 0.81 Allowed 'General case' 0 CA--C 1.503 -0.858 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.955 176.707 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . 0.401 ' SG ' ' HB2' ' A' ' 103' ' ' TYR . 5.5 t -170.7 91.48 0.16 Allowed 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.376 -176.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -118.92 176.57 5.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.812 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.536 HG12 ' CE2' ' A' ' 103' ' ' TYR . 39.1 mm . . . . . 0 C--N 1.322 -0.601 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.846 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.854 0.359 . . . . 0.0 111.002 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.433 ' CB ' ' HA ' ' A' ' 26' ' ' ASP . 7.7 ptt180 -65.8 -172.35 0.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.121 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.53 ' HB2' ' CD ' ' A' ' 10' ' ' PRO . 72.4 m -83.89 177.12 3.17 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.693 178.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.53 ' CD ' ' HB2' ' A' ' 9' ' ' CYS . 38.4 Cg_endo -90.78 -165.93 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.701 2.267 . . . . 0.0 112.025 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.418 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 0.4 OUTLIER -60.39 108.22 1.35 Allowed Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.273 179.037 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.433 ' CG ' HD12 ' A' ' 22' ' ' ILE . 14.0 Cg_endo -56.67 149.31 59.71 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.153 1.902 . . . . 0.0 111.975 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.423 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.8 OUTLIER -59.25 173.43 0.49 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.28 179.645 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.62 -171.71 2.53 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.147 0.498 . . . . 0.0 111.506 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.483 ' HB ' ' CE2' ' A' ' 33' ' ' TYR . 4.1 tt -151.82 147.23 15.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.004 -178.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.428 ' N ' HG13 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -87.72 154.6 20.44 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 177.3 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.463 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 0.3 OUTLIER 48.52 25.44 0.94 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.885 0.374 . . . . 0.0 110.285 -178.521 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -146.3 170.46 27.4 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.658 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -136.46 138.56 41.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.927 0.394 . . . . 0.0 110.689 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.533 ' CD2' ' CE1' ' A' ' 33' ' ' TYR . 8.2 mt -84.62 155.1 22.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.061 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.436 ' CB ' ' HB ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -125.45 71.22 1.2 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.776 177.857 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.433 HD12 ' CG ' ' A' ' 12' ' ' PRO . 0.8 OUTLIER -70.78 95.69 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.041 -177.024 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.8 19.22 52.91 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.591 176.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.46 141.47 3.22 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.206 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.414 ' O ' ' HB3' ' A' ' 8' ' ' ARG . 3.1 m -114.6 -12.54 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.433 ' HA ' ' CB ' ' A' ' 8' ' ' ARG . 0.8 OUTLIER -69.82 160.3 32.01 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.852 0.358 . . . . 0.0 111.738 -179.033 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.473 ' CE2' HD22 ' A' ' 51' ' ' LEU . 24.1 t80 -50.42 127.21 17.0 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.126 178.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.97 -11.06 71.43 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.065 -178.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 74.5 m -65.31 -173.4 0.13 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.955 0.378 . . . . 0.0 110.065 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.0 p -162.12 146.49 12.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.135 0.493 . . . . 0.0 111.808 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.507 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -118.94 151.22 21.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.83 179.157 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.436 ' HB ' ' CB ' ' A' ' 21' ' ' ASP . 3.1 m -115.52 114.61 25.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.037 0.446 . . . . 0.0 111.428 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.619 ' CZ ' ' O ' ' A' ' 62' ' ' GLU . 2.1 m-85 -80.83 135.9 36.02 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.252 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.7 p -148.24 177.65 9.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.146 -177.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.418 ' HA ' ' HA2' ' A' ' 18' ' ' GLY . 71.9 m -94.16 170.17 9.71 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.634 -178.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.26 -77.82 0.17 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.856 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.03 139.23 17.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.593 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 54.35 29.68 46.99 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.725 -178.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.484 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.0 m-85 -121.14 163.12 18.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.948 0.404 . . . . 0.0 111.161 -179.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.508 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 1.4 p80 -127.68 134.65 49.59 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 176.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.46 ' CD2' ' O ' ' A' ' 44' ' ' GLU . 0.9 OUTLIER -82.72 137.62 34.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.959 -174.572 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.508 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 0.2 OUTLIER -114.88 125.26 72.15 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-O 121.344 0.592 . . . . 0.0 110.995 178.827 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 104.69 -145.43 15.97 Favored Glycine 0 C--N 1.318 -0.452 0 CA-C-N 114.539 -1.21 . . . . 0.0 112.378 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.46 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 11.0 mt-10 -60.97 -134.87 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 178.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.4 p 165.32 23.6 0.0 OUTLIER 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 123.712 0.805 . . . . 0.0 111.086 177.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.515 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 1.6 mttt -162.93 146.6 11.08 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -177.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.475 ' CB ' ' O ' ' A' ' 61' ' ' PRO . 32.9 t -119.85 152.62 37.05 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.75 176.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.517 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 3.4 m-85 -134.2 119.54 18.93 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 118.825 -1.15 . . . . 0.0 113.184 -178.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.493 ' HB3' ' CH2' ' A' ' 59' ' ' TRP . 36.6 t -65.96 120.87 13.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.902 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.486 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 8.4 tt0 -160.68 168.85 24.02 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.565 0.697 . . . . 0.0 110.845 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.486 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 2.8 pp -75.17 155.99 36.36 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.074 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -79.05 -125.93 0.47 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.396 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 36.3 t -113.15 -33.08 6.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.754 0.312 . . . . 0.0 111.14 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 81.8 p -97.51 33.0 2.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.937 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.27 18.48 78.15 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.587 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.07 -161.33 0.62 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.752 0.31 . . . . 0.0 110.877 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.405 ' HA ' ' HA ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -125.54 142.6 51.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.341 179.494 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.2 m -159.98 -177.65 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.099 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.507 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 75.6 m95 -126.2 135.2 51.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.972 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.517 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 0.3 OUTLIER -69.58 168.57 16.2 Favored Pre-proline 0 CA--C 1.506 -0.722 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 175.208 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.484 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 0.9 OUTLIER -4.28 120.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.949 1 C-N-CA 125.527 4.151 . . . . 0.0 114.873 -177.209 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.619 ' O ' ' CZ ' ' A' ' 33' ' ' TYR . 13.1 mt-10 -89.18 -62.3 1.51 Allowed 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 114.35 -1.295 . . . . 0.0 111.739 -173.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.572 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -65.45 -153.12 0.0 OUTLIER Pre-proline 0 CA--C 1.484 -1.57 0 CA-C-O 116.704 -1.617 . . . . 0.0 108.691 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.548 ' HA ' ' CB ' ' A' ' 63' ' ' ALA . 4.0 Cg_exo -89.51 -155.14 0.78 Allowed 'Cis proline' 0 N--CA 1.483 0.879 0 CA-C-N 123.037 2.12 . . . . 0.0 114.804 19.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -103.15 -167.98 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.072 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.921 -177.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.7 m -164.19 137.42 5.19 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.822 0.344 . . . . 0.0 111.257 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.481 ' HA ' ' CE2' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -141.24 150.89 43.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.524 -179.431 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.484 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 5.0 t -48.3 139.62 8.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.301 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.428 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 0.9 OUTLIER -67.38 108.2 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.261 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.421 ' HG3' ' CG2' ' A' ' 90' ' ' THR . 0.0 OUTLIER -77.18 127.92 33.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.761 -179.391 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.41 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -107.1 119.34 39.1 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.681 177.532 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.65 -157.09 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.791 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.5 t -49.18 139.61 13.07 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.08 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.482 ' HD2' ' CD2' ' A' ' 82' ' ' HIS . 25.6 Cg_exo -60.23 159.79 25.33 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.474 2.116 . . . . 0.0 111.9 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.479 ' HD2' ' CG ' ' A' ' 118' ' ' TRP . 86.2 Cg_exo -45.81 153.67 0.8 Allowed 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.433 2.089 . . . . 0.0 112.4 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.4 t -106.62 91.81 3.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.635 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 14.1 pt -69.27 167.02 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.091 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.4 p -84.87 139.97 31.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.897 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.433 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 7.2 m-80 58.63 27.9 16.43 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.139 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.455 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -163.05 -163.08 14.86 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.422 -0.894 . . . . 0.0 113.054 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.415 ' N ' ' O ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -170.44 -174.61 1.7 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.874 0.369 . . . . 0.0 110.859 -179.475 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.498 ' HB3' ' CE1' ' A' ' 97' ' ' TYR . 2.3 p80 -111.24 167.3 10.39 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.893 -178.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 96' ' ' THR . 10.4 m-20 -97.48 19.55 13.18 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.452 177.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.427 ' CA ' ' OH ' ' A' ' 89' ' ' TYR . . . -43.68 127.9 6.03 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.312 -0.947 . . . . 0.0 112.795 -176.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -99.7 -39.08 8.43 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.084 0.468 . . . . 0.0 111.194 -177.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.04 178.11 5.2 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.144 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -90.2 -24.82 20.9 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.346 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.427 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 7.3 m-85 -137.56 163.32 31.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.87 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.427 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 6.5 m-85 -142.54 173.18 11.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.79 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.421 ' CG2' ' HG3' ' A' ' 70' ' ' LYS . 16.7 p -154.02 -175.73 5.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.039 0.447 . . . . 0.0 112.012 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.446 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 4.6 m-20 -57.5 96.53 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.358 0.599 . . . . 0.0 111.062 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 128.46 15.54 2.21 Favored Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 115.081 -0.963 . . . . 0.0 113.281 178.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.417 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.4 OUTLIER -104.52 150.61 24.45 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 117.244 0.522 . . . . 0.0 110.698 179.184 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 18.8 m -146.89 132.83 12.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.084 0.469 . . . . 0.0 110.886 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.446 HG11 ' CG ' ' A' ' 74' ' ' PRO . 2.2 p -132.35 148.7 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.009 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.455 ' O ' ' HB2' ' A' ' 83' ' ' ASN . 0.1 OUTLIER -92.1 148.91 21.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.077 0.465 . . . . 0.0 110.732 179.85 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.528 ' CE1' ' CG2' ' A' ' 111' ' ' VAL . 3.0 m-85 -107.17 159.78 16.07 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.846 0.355 . . . . 0.0 110.845 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.425 ' CA ' HD13 ' A' ' 105' ' ' LEU . 50.4 m -155.79 151.44 27.25 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.56 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.413 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 78.4 m -78.38 162.01 26.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.252 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.455 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 17.0 m-20 -91.77 -71.28 0.65 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.488 -179.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.68 -20.96 66.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.434 -179.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.32 31.42 1.17 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.532 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.476 ' CE2' HG12 ' A' ' 126' ' ' ILE . 26.5 m-85 -69.83 -173.47 0.63 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 120.782 0.325 . . . . 0.0 110.539 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.56 103.56 12.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.072 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.439 HD23 ' CG ' ' A' ' 122' ' ' PRO . 3.0 tp -42.62 113.45 0.46 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.135 179.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.44 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 39.0 mm -86.75 155.86 3.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.735 -179.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.428 ' N ' HG21 ' A' ' 106' ' ' ILE . . . 57.18 -128.62 47.86 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.351 -0.928 . . . . 0.0 111.766 -178.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -115.04 134.67 54.98 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.029 0.442 . . . . 0.0 111.573 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.485 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 1.1 t -70.27 -29.83 66.7 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.362 178.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.82 137.28 23.05 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.536 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.528 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 9.9 t -128.75 120.11 51.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.483 0.182 . . . . 0.0 110.527 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.42 HD22 ' N ' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -80.0 133.21 36.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.903 0.382 . . . . 0.0 111.442 -178.906 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.488 ' HB2' ' CZ3' ' A' ' 118' ' ' TRP . 25.5 t -104.68 106.48 16.99 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.851 176.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.2 OUTLIER -167.29 122.02 1.04 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.981 0.42 . . . . 0.0 111.174 179.851 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.406 ' CA ' HG12 ' A' ' 69' ' ' VAL . . . 102.27 26.79 7.19 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.144 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.428 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 69.24 10.09 61.87 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.521 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -148.69 -177.64 5.9 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.981 0.419 . . . . 0.0 110.665 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.488 ' CZ3' ' HB2' ' A' ' 113' ' ' CYS . 92.9 m95 -116.27 151.19 36.31 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.85 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.68 155.63 49.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.073 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.535 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.2 t0 69.49 42.07 0.22 Allowed Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 74.2 Cg_endo -76.7 137.32 17.94 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.48 2.12 . . . . 0.0 111.941 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.486 ' HD3' ' CD2' ' A' ' 97' ' ' TYR . 57.2 Cg_endo -90.83 -172.97 0.55 Allowed 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.853 2.369 . . . . 0.0 113.408 -178.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.433 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.3 OUTLIER -132.36 -163.27 1.32 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.021 177.893 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 7.6 m -151.87 92.2 1.71 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.147 0.498 . . . . 0.0 111.164 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -118.06 164.74 14.67 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.514 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.476 HG12 ' CE2' ' A' ' 103' ' ' TYR . 50.0 mm . . . . . 0 C--N 1.324 -0.523 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.946 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.897 0.379 . . . . 0.0 110.859 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.404 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 13.1 mtm180 -79.49 -169.01 1.74 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.755 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.444 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 19.6 m -89.35 162.06 38.13 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.826 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.41 170.18 16.75 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.413 2.075 . . . . 0.0 111.985 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 12.8 t -54.33 106.33 0.65 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.226 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.438 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 3.4 Cg_exo -46.76 153.26 1.37 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.118 1.879 . . . . 0.0 112.045 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.43 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 2.4 mtt85 -68.52 163.59 23.12 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.14 178.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -112.35 179.76 3.9 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.18 0.514 . . . . 0.0 112.129 -176.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.402 HG23 HD23 ' A' ' 20' ' ' LEU . 7.3 tt -131.63 152.56 37.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.418 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -80.27 -62.34 1.71 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -177.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -94.57 31.07 1.85 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.867 -178.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.433 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -151.03 -179.98 27.22 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.197 -1.002 . . . . 0.0 113.498 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.34 135.22 33.52 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.529 ' CD2' ' CE2' ' A' ' 33' ' ' TYR . 2.6 mt -79.42 163.29 24.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.218 0.533 . . . . 0.0 111.799 -178.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -131.33 77.75 1.79 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.595 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.46 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 69.1 mt -69.63 104.51 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.018 -177.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -110.2 22.63 22.53 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.519 177.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 153.66 129.78 1.39 Allowed Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -179.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.401 HG22 ' HD3' ' A' ' 8' ' ' ARG . 0.5 OUTLIER -121.33 0.97 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.665 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.404 ' HA ' ' HB3' ' A' ' 8' ' ' ARG . 34.0 t0 -74.22 162.24 29.13 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.844 0.354 . . . . 0.0 110.952 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.488 ' CZ ' HD12 ' A' ' 51' ' ' LEU . 11.0 t80 -52.56 106.19 0.15 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.843 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.57 -0.08 27.7 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.765 -0.731 . . . . 0.0 113.046 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 82.9 p -77.24 178.99 6.64 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.971 0.385 . . . . 0.0 110.964 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 47' ' ' SER . 3.3 p -149.1 144.03 26.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.998 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.536 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.9 OUTLIER -110.64 170.46 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.618 179.819 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.416 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -129.42 113.12 14.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.905 0.383 . . . . 0.0 111.31 179.482 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.529 ' CE2' ' CD2' ' A' ' 20' ' ' LEU . 15.8 m-85 -87.77 140.99 28.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.06 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.433 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 16.6 m -146.36 157.52 43.79 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.677 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.401 ' HB2' ' HB2' ' A' ' 39' ' ' TYR . 62.7 m -80.34 170.01 16.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.748 0.308 . . . . 0.0 110.647 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.09 -75.65 0.11 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.941 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.8 t -160.01 139.69 11.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.835 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 56.97 25.13 52.79 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.063 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.517 ' CD2' ' HA ' ' A' ' 68' ' ' SER . 2.3 m-85 -116.57 171.05 8.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.871 0.367 . . . . 0.0 111.051 -179.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.484 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.3 OUTLIER -131.86 123.25 27.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.426 178.387 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.431 ' CD2' ' O ' ' A' ' 44' ' ' GLU . 4.7 tt -86.47 134.27 33.69 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.502 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.484 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 2.0 mm -112.97 156.98 13.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.02 0.438 . . . . 0.0 111.164 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.4 -128.27 8.36 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.289 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.439 ' O ' ' CG ' ' A' ' 64' ' ' PRO . 1.5 pm0 -83.78 -173.7 4.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.792 0.329 . . . . 0.0 110.648 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.2 p -162.31 24.27 0.11 Allowed 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.159 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.416 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 13.2 mtpt -164.45 126.45 2.28 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.578 -177.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.43 ' OG ' ' CG ' ' A' ' 62' ' ' GLU . 1.9 t -94.06 137.85 32.8 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 176.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.511 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 2.6 m-85 -114.92 118.57 33.85 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.589 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 35.4 t -66.3 92.57 0.19 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.625 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.489 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 1.7 tt0 -123.86 172.12 9.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.518 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.489 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 0.1 OUTLIER -102.86 152.0 21.78 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.521 179.474 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -171.1 -36.6 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.279 -0.962 . . . . 0.0 113.237 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.431 ' CB ' ' HB2' ' A' ' 56' ' ' SER . 0.2 OUTLIER -65.73 72.72 0.06 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.034 0.445 . . . . 0.0 111.113 -179.17 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.1 p 49.94 28.26 2.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.258 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 114.92 2.2 22.31 Favored Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.708 -0.758 . . . . 0.0 113.129 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.431 ' HB2' ' CB ' ' A' ' 53' ' ' SER . 1.9 t -82.9 -159.4 0.33 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.773 0.32 . . . . 0.0 110.75 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.8 113.13 14.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.261 0.553 . . . . 0.0 110.4 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.442 ' N ' ' O ' ' A' ' 50' ' ' GLU . 0.9 OUTLIER -111.99 -175.23 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.432 -179.281 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.536 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 70.7 m95 -125.31 123.73 40.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.916 0.389 . . . . 0.0 111.263 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.511 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 2.7 m-20 -69.04 167.68 19.36 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 10.4 Cg_exo -7.39 89.86 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.008 1 C-N-CA 125.41 4.073 . . . . 0.0 114.796 -179.054 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.479 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 10.7 mt-10 -84.24 -92.58 0.08 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 114.779 -1.101 . . . . 0.0 112.386 -177.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.504 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -91.63 109.01 33.62 Favored Pre-proline 0 C--O 1.231 0.1 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -176.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.439 ' CG ' ' O ' ' A' ' 44' ' ' GLU . 6.1 Cg_exo -79.39 -153.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.892 2.395 . . . . 0.0 111.113 177.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.424 ' CG1' ' HB ' ' A' ' 42' ' ' ILE . 1.5 mm -93.95 168.94 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.859 0.361 . . . . 0.0 110.669 178.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -170.35 138.69 1.6 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.945 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -162.44 173.86 13.51 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.625 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.517 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 54.1 p -79.07 113.64 17.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.301 0.572 . . . . 0.0 110.83 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.475 ' HB ' ' N ' ' A' ' 116' ' ' GLY . 30.9 m -39.2 100.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.425 -179.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 89' ' ' TYR . 0.3 OUTLIER -96.45 103.57 15.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.862 0.363 . . . . 0.0 110.719 178.027 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.94 121.91 35.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.049 179.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.459 ' CG ' ' N ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -69.15 -155.4 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.975 179.402 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.459 ' N ' ' CG ' ' A' ' 72' ' ' GLN . 1.2 t -50.77 142.21 16.79 Favored Pre-proline 0 N--CA 1.449 -0.511 0 CA-C-O 120.642 0.258 . . . . 0.0 110.823 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -59.35 164.1 11.38 Favored 'Trans proline' 0 CA--C 1.528 0.198 0 C-N-CA 122.531 2.154 . . . . 0.0 111.936 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.496 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 89.6 Cg_exo -41.75 158.76 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.56 2.174 . . . . 0.0 112.572 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 83.5 p -109.24 88.6 2.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.528 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.9 pt -69.79 170.55 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.305 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.7 m -90.09 142.59 27.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.675 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.484 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 7.7 m-80 56.26 29.51 15.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.973 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.477 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -161.75 -171.18 27.48 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.27 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.413 ' N ' ' O ' ' A' ' 98' ' ' SER . 9.5 ptt180 -163.75 -175.33 4.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.971 0.415 . . . . 0.0 110.78 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 1.7 p-80 -117.9 169.22 9.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.053 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -98.54 -84.27 0.4 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.691 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.407 ' HA3' ' OH ' ' A' ' 89' ' ' TYR . . . 63.99 147.54 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.667 -0.777 . . . . 0.0 113.007 178.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -112.02 -35.76 5.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.089 0.471 . . . . 0.0 110.705 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -97.05 -172.26 2.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.072 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.7 -23.72 14.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.194 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.434 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 7.0 m-85 -131.36 -179.94 5.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.434 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 72.5 m-85 -156.39 160.56 39.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.845 -179.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 69' ' ' VAL . 6.7 p -142.63 -177.42 5.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.287 0.565 . . . . 0.0 112.324 -179.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -50.03 94.62 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.489 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 121.96 24.29 2.31 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.373 -0.83 . . . . 0.0 113.37 177.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -110.1 147.4 33.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 117.075 0.437 . . . . 0.0 110.782 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.434 ' CG2' ' N ' ' A' ' 95' ' ' VAL . 35.2 m -128.68 160.0 39.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.1 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.471 HG21 ' CH2' ' A' ' 118' ' ' TRP . 21.5 t -151.8 148.6 14.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.479 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.421 ' CG2' ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -108.01 126.02 52.22 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.228 0.537 . . . . 0.0 111.06 -179.608 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.515 ' CE1' ' CG2' ' A' ' 111' ' ' VAL . 4.6 m-85 -83.87 161.6 20.82 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.657 -178.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.413 ' O ' ' N ' ' A' ' 81' ' ' ARG . 14.8 p -155.24 138.66 15.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.348 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.415 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 73.9 m -69.98 158.39 35.71 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.794 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.477 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 26.8 m-20 -92.0 -70.69 0.68 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.429 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.24 -22.83 67.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.323 -179.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 122.0 31.15 1.13 Allowed Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.63 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.488 ' CE2' HG12 ' A' ' 126' ' ' ILE . 19.9 m-85 -69.61 -175.55 0.87 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.038 0.447 . . . . 0.0 110.898 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.2 m -110.07 98.1 7.45 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.098 178.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.448 ' CD2' ' HA ' ' A' ' 109' ' ' SER . 0.2 OUTLIER -48.77 132.48 17.97 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.555 0.693 . . . . 0.0 111.727 -177.834 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.445 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 38.2 mm -114.23 155.52 15.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.092 -178.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 68.59 23.88 75.32 Favored Glycine 0 C--N 1.328 0.103 0 C-N-CA 120.56 -0.828 . . . . 0.0 113.053 179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 60.37 136.66 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.295 0.569 . . . . 0.0 111.531 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.453 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 1.1 p -69.7 -24.13 63.53 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.765 -178.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -63.84 121.72 24.21 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.787 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.515 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 2.7 t -122.14 141.8 41.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 178.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.414 HD22 ' N ' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -102.92 132.43 49.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.841 0.353 . . . . 0.0 111.505 -178.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.499 ' HB2' ' CZ3' ' A' ' 118' ' ' TRP . 41.4 t -104.6 104.59 14.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.034 177.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.4 p -165.93 119.27 1.13 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.922 0.391 . . . . 0.0 111.707 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.33 20.98 11.18 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.686 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.475 ' N ' ' HB ' ' A' ' 69' ' ' VAL . . . 80.88 2.08 90.02 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.498 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -145.51 170.52 16.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.14 0.495 . . . . 0.0 111.317 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.499 ' CZ3' ' HB2' ' A' ' 113' ' ' CYS . 88.5 m95 -104.37 144.98 30.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.355 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.1 149.77 43.1 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.074 0.464 . . . . 0.0 111.491 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.499 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER 65.66 44.7 0.41 Allowed Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.196 178.899 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 56.3 Cg_endo -69.82 142.91 48.93 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.22 1.946 . . . . 0.0 111.467 178.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.493 ' HG2' ' CD2' ' A' ' 97' ' ' TYR . 71.1 Cg_endo -90.23 -172.84 0.6 Allowed 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.641 2.227 . . . . 0.0 113.768 -177.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.37 -158.44 0.87 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.652 178.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 2.3 m -155.76 89.16 1.15 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.089 0.471 . . . . 0.0 110.925 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -113.34 161.11 17.65 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.684 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.488 HG12 ' CE2' ' A' ' 103' ' ' TYR . 21.9 mm . . . . . 0 C--N 1.323 -0.569 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.935 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.603 0.239 . . . . 0.0 110.773 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.425 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 0.1 OUTLIER 41.25 -162.08 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.946 0.403 . . . . 0.0 111.752 179.202 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.461 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 3.5 m -93.24 163.04 26.47 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.672 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -67.62 169.83 15.07 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.205 1.937 . . . . 0.0 111.407 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.03 105.1 0.46 Allowed Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.088 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.44 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 83.1 Cg_exo -38.42 146.35 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.657 2.238 . . . . 0.0 112.739 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.3 152.98 43.83 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.644 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.18 -167.98 1.5 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.118 -178.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.415 ' HB ' ' HB3' ' A' ' 63' ' ' ALA . 19.1 tt -167.88 144.52 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.568 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.403 ' HB2' ' ND2' ' A' ' 17' ' ' ASN . 0.6 OUTLIER -94.28 160.43 14.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.743 177.566 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.403 ' ND2' ' HB2' ' A' ' 16' ' ' ASP . 0.3 OUTLIER 48.1 25.58 0.84 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.879 0.371 . . . . 0.0 110.638 -179.108 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.422 ' HA2' ' N ' ' A' ' 36' ' ' ASN . . . -158.81 -173.91 27.83 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.615 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -132.14 -171.88 2.74 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.313 0.578 . . . . 0.0 111.787 -177.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.3 mt -140.25 139.28 35.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.465 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.426 ' CB ' ' HB ' ' A' ' 32' ' ' THR . 0.3 OUTLIER -118.07 73.56 0.91 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.851 179.109 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.445 HG13 ' CG2' ' A' ' 31' ' ' ILE . 0.2 OUTLIER -82.75 94.21 3.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.947 -176.046 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.38 12.05 63.94 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.048 177.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 156.51 148.12 4.97 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.11 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.7 m -120.37 -1.01 8.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.425 ' HA ' ' HB3' ' A' ' 8' ' ' ARG . 0.7 OUTLIER -69.64 153.78 42.93 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.931 0.395 . . . . 0.0 111.224 -179.292 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.46 110.38 0.37 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.855 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 113.79 -9.16 23.61 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.423 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.73 178.44 4.17 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.845 0.323 . . . . 0.0 110.83 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.4 p -153.82 138.77 17.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.223 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.516 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -103.1 165.78 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.601 179.063 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.426 ' HB ' ' CB ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -130.35 110.5 11.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.633 178.561 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.503 ' CE2' ' HA ' ' A' ' 63' ' ' ALA . 22.9 m-85 -83.2 146.95 28.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.132 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.47 172.2 14.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.926 0.394 . . . . 0.0 111.425 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.412 ' HA ' ' HA2' ' A' ' 18' ' ' GLY . 1.7 m -96.13 156.7 16.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.497 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.422 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 3.6 m-20 -56.1 -85.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.15 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.5 t -152.19 135.67 16.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.934 0.397 . . . . 0.0 110.719 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 61.51 24.29 63.74 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.865 -179.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.471 ' CG ' ' O ' ' A' ' 67' ' ' GLU . 2.3 m-85 -116.24 174.69 5.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.805 0.336 . . . . 0.0 110.802 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.531 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.6 OUTLIER -136.94 116.17 12.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.036 0.446 . . . . 0.0 110.478 178.241 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.428 ' CD2' ' O ' ' A' ' 44' ' ' GLU . 4.7 tt -77.37 124.62 28.11 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.638 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.531 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 2.7 mm -96.8 152.55 3.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.247 -179.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.09 -149.74 38.04 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.218 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.428 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 4.3 pm0 -61.63 178.65 0.3 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.609 0.242 . . . . 0.0 110.582 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.0 p -152.38 21.44 0.64 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.374 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.415 ' CG ' ' O ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -142.97 -174.6 4.23 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.226 0.536 . . . . 0.0 111.934 -178.299 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.438 ' CB ' HG12 ' A' ' 31' ' ' ILE . 1.7 m -160.96 108.88 1.54 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.831 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -92.15 117.75 30.16 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.229 0.538 . . . . 0.0 111.839 -177.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.484 ' HB3' ' CH2' ' A' ' 59' ' ' TRP . 8.7 t -64.33 90.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.226 179.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.503 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -116.43 175.75 5.42 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.428 -179.51 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.503 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -88.55 145.56 25.65 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.235 -178.326 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -73.2 -112.11 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.475 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.1 t -128.11 -41.58 1.59 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.752 0.31 . . . . 0.0 111.091 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 43.0 p -92.07 49.23 1.5 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.096 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 55.97 33.87 61.04 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.444 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.9 t -106.2 -174.37 2.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.851 0.358 . . . . 0.0 111.03 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.29 146.31 41.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.11 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.9 m -152.04 -177.66 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.083 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.516 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 93.2 m95 -130.51 124.6 32.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.932 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -143.49 126.51 8.92 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.193 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.78 -162.28 2.13 Favored 'Cis proline' 0 C--N 1.351 0.703 0 C-N-CA 124.06 -1.225 . . . . 0.0 111.928 -0.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.488 ' O ' ' CZ ' ' A' ' 33' ' ' TYR . 4.3 pt-20 -112.25 -113.97 0.33 Allowed 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.401 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.503 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -118.92 86.84 32.06 Favored Pre-proline 0 N--CA 1.45 -0.472 0 C-N-CA 122.658 0.383 . . . . 0.0 110.462 -179.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 63' ' ' ALA . 10.3 Cg_endo -48.58 -158.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.475 0.395 0 C-N-CA 123.863 3.042 . . . . 0.0 113.995 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.0 mm -93.49 165.28 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.109 -177.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -161.42 138.22 8.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.268 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.471 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 1.0 OUTLIER -162.22 -177.1 5.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.898 0.38 . . . . 0.0 111.168 -179.719 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.8 t -83.8 132.27 34.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.108 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -46.21 101.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.553 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.415 ' HD3' ' HB2' ' A' ' 88' ' ' PHE . 0.2 OUTLIER -72.15 123.19 22.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.352 179.951 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.51 122.91 46.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.921 178.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -69.31 -156.28 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.373 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.469 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 1.8 t -52.95 145.6 22.28 Favored Pre-proline 0 N--CA 1.45 -0.426 0 CA-C-O 120.633 0.254 . . . . 0.0 110.377 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.401 ' HG3' HG21 ' A' ' 95' ' ' VAL . 23.4 Cg_exo -62.62 165.33 16.01 Favored 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 122.48 2.12 . . . . 0.0 112.155 -179.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.498 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 81.2 Cg_exo -43.65 160.6 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.713 2.275 . . . . 0.0 112.87 -179.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 86.7 p -108.29 90.16 3.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.497 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.442 HG23 ' CE2' ' A' ' 97' ' ' TYR . 14.1 pt -69.24 175.22 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.243 -178.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.4 p -96.21 143.41 27.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.717 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.489 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 5.3 m-80 55.42 30.23 14.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.925 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -167.41 -170.26 32.01 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.53 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.97 -176.71 4.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.035 0.445 . . . . 0.0 111.091 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.469 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 3.4 p80 -108.37 173.26 6.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.117 -179.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -103.99 -85.45 0.46 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.66 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 60.91 141.58 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.901 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -110.82 -31.44 7.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.048 0.451 . . . . 0.0 110.602 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.93 -171.91 2.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.741 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.05 -14.98 15.23 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.528 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.425 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 6.4 m-85 -140.58 177.87 7.72 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.866 0.365 . . . . 0.0 111.521 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.425 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 69.2 m-85 -156.77 165.85 35.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.809 -179.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 19.1 p -149.37 -175.78 5.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.029 0.442 . . . . 0.0 111.62 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.425 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 3.8 p30 -52.86 94.42 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.444 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.14 22.63 2.34 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.273 -0.876 . . . . 0.0 113.13 178.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.21 145.83 36.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.951 0.375 . . . . 0.0 110.789 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 32.7 m -128.58 155.61 40.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.067 0.461 . . . . 0.0 111.249 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.464 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 20.7 t -146.54 146.57 18.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.11 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.425 ' CG2' ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -101.4 134.22 44.82 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.827 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.53 ' CE1' ' CG2' ' A' ' 111' ' ' VAL . 5.0 m-85 -95.39 158.83 15.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.915 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 77.1 p -153.0 140.33 19.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.376 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 68.8 m -71.04 152.46 43.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.891 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.411 ' CG ' ' N ' ' A' ' 101' ' ' SER . 1.5 p30 -92.54 -55.14 3.5 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.419 0.628 . . . . 0.0 111.434 -178.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.411 ' N ' ' CG ' ' A' ' 100' ' ' ASN . 22.4 t -73.98 -14.75 61.08 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.757 -178.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 111.24 24.68 5.32 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.005 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.489 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 30.8 m-85 -69.46 -172.95 0.51 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.855 0.36 . . . . 0.0 110.817 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.1 105.78 15.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.156 -179.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.425 HD23 ' CA ' ' A' ' 109' ' ' SER . 3.1 tp -44.85 113.52 0.57 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.07 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.452 HG23 HD11 ' A' ' 106' ' ' ILE . 30.6 mm -87.13 157.07 3.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.471 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.432 ' N ' HG21 ' A' ' 106' ' ' ILE . . . 58.69 -131.17 51.92 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.767 -178.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.27 126.28 52.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.771 0.32 . . . . 0.0 110.746 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.477 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 1.4 t -57.63 -28.45 63.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.045 0.45 . . . . 0.0 110.242 178.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.9 132.2 15.13 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.558 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.53 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 6.0 t -125.52 126.83 71.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 110.422 -0.214 . . . . 0.0 110.422 178.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.454 ' CD2' ' N ' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -81.14 135.52 35.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.889 0.376 . . . . 0.0 111.48 -178.567 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.507 ' HB2' ' CZ3' ' A' ' 118' ' ' TRP . 39.3 t -108.28 108.04 18.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.051 177.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.2 OUTLIER -164.01 129.67 2.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.868 0.366 . . . . 0.0 111.259 -179.806 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.38 31.04 20.45 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.076 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.16 19.88 62.17 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.018 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -145.53 178.2 8.3 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.104 0.478 . . . . 0.0 111.15 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.507 ' CZ3' ' HB2' ' A' ' 113' ' ' CYS . 92.7 m95 -121.7 145.29 48.17 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.795 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -125.52 167.02 15.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.991 0.424 . . . . 0.0 111.658 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.421 ' N ' ' HD3' ' A' ' 121' ' ' PRO . 6.6 p-10 46.69 52.56 12.06 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.171 179.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.421 ' HD3' ' N ' ' A' ' 120' ' ' ASP . 93.2 Cg_endo -81.28 143.94 14.26 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.666 2.244 . . . . 0.0 111.634 177.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.477 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 73.5 Cg_endo -91.23 -172.29 0.46 Allowed 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.877 2.385 . . . . 0.0 113.856 -177.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.44 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -138.66 -174.7 3.9 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.101 178.321 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . 0.423 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 11.9 m -141.11 96.98 3.08 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.026 0.441 . . . . 0.0 111.097 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -122.54 167.51 13.28 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.863 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.488 HG12 ' CE2' ' A' ' 103' ' ' TYR . 13.0 mm . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.935 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.906 0.384 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 17.4 mtm180 -106.17 -177.74 3.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.758 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.508 ' HB2' ' CD ' ' A' ' 10' ' ' PRO . 69.6 m -77.31 175.86 4.09 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.521 ' HD2' ' CD1' ' A' ' 59' ' ' TRP . 37.9 Cg_endo -91.24 176.29 2.2 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.427 2.084 . . . . 0.0 111.932 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.0 t -53.41 105.6 0.55 Allowed Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.294 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.465 ' HG2' ' CE2' ' A' ' 59' ' ' TRP . 51.5 Cg_exo -52.94 142.2 53.66 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.037 1.825 . . . . 0.0 111.804 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.422 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -49.03 120.8 4.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.925 0.869 . . . . 0.0 111.512 -178.852 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.45 ' HA ' HD11 ' A' ' 20' ' ' LEU . 6.1 p-10 -59.16 -32.09 69.56 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 113.509 -1.678 . . . . 0.0 112.694 -177.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.471 HG23 ' CD2' ' A' ' 20' ' ' LEU . 8.6 tt 58.36 142.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 114.271 -1.331 . . . . 0.0 111.208 -175.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.98 160.41 14.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.0 178.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.482 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 0.3 OUTLIER 50.47 24.07 1.48 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.017 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -154.06 177.61 31.4 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.659 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.43 142.26 39.52 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.74 0.305 . . . . 0.0 110.506 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.472 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 72.2 mt -89.51 155.67 19.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.167 0.508 . . . . 0.0 111.718 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -124.73 72.91 1.24 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.38 177.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.44 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 1.2 mt -76.1 105.71 5.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.992 -176.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.62 13.56 57.99 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.734 176.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 157.19 133.29 1.58 Allowed Glycine 0 C--N 1.335 0.5 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.021 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.0 m -112.41 9.01 8.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -72.82 156.25 39.09 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.836 0.351 . . . . 0.0 111.331 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -54.94 91.45 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.867 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 49' ' ' CYS . . . 130.57 -18.25 5.19 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.456 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.5 p -57.24 -173.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.73 0.3 . . . . 0.0 110.863 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 47' ' ' SER . 81.2 p -150.94 150.85 31.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.25 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.544 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -121.44 167.0 15.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.766 179.493 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.85 108.45 10.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.618 178.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.447 ' CE1' ' HA ' ' A' ' 63' ' ' ALA . 33.4 m-85 -84.59 143.12 29.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.154 -179.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -152.04 157.08 41.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.198 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.3 m -83.8 161.56 20.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.851 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.459 ' ND2' ' HA ' ' A' ' 17' ' ' ASN . 1.2 p30 -55.7 -89.43 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.238 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.8 t -152.08 136.34 16.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.815 0.34 . . . . 0.0 110.524 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.73 17.76 63.09 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.233 -178.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.482 ' CE2' ' HB3' ' A' ' 17' ' ' ASN . 2.1 m-85 -106.87 -173.34 2.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.729 0.299 . . . . 0.0 110.782 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.521 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.3 OUTLIER -147.05 112.46 5.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.983 0.42 . . . . 0.0 110.808 178.86 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.427 ' CD2' ' O ' ' A' ' 44' ' ' GLU . 2.1 tt -78.72 125.47 29.41 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.363 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.521 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 2.9 mm -98.47 167.55 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.049 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.03 -130.02 29.84 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.477 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.427 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 0.8 OUTLIER -83.47 -179.23 7.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.798 0.332 . . . . 0.0 110.925 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.424 ' CB ' HD21 ' A' ' 41' ' ' LEU . 3.0 t -154.98 25.44 0.43 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.924 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -150.14 168.72 23.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.245 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.417 ' O ' HG12 ' A' ' 31' ' ' ILE . 2.6 m -149.56 120.27 7.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.374 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -103.46 116.2 31.96 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.16 0.505 . . . . 0.0 111.193 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.411 ' O ' ' N ' ' A' ' 28' ' ' GLY . 53.6 t -59.16 100.87 0.08 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.098 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.28 -170.96 2.07 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.37 -178.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -101.92 146.2 28.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.848 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.413 ' N ' HG21 ' A' ' 58' ' ' VAL . . . -74.47 -145.21 1.01 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.577 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.5 m -93.19 -37.88 11.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.755 0.312 . . . . 0.0 111.049 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.8 p -95.74 41.41 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.275 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 63.71 19.82 63.32 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.825 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.24 -161.45 0.59 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.763 0.316 . . . . 0.0 110.752 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -123.88 133.8 53.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.601 179.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.413 HG21 ' N ' ' A' ' 52' ' ' GLY . 1.1 m -144.19 -178.45 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.98 0.419 . . . . 0.0 111.333 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.544 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 94.1 m95 -121.03 122.97 41.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.527 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -138.67 118.73 9.71 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.426 -178.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.14 -170.53 7.7 Favored 'Cis proline' 0 C--N 1.351 0.663 0 C-N-CA 124.094 -1.211 . . . . 0.0 112.003 -0.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -110.89 -154.66 0.54 Allowed 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.708 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.447 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -72.62 111.84 12.73 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.582 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.424 ' CG ' ' O ' ' A' ' 44' ' ' GLU . 15.2 Cg_exo -69.78 -150.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.628 2.219 . . . . 0.0 112.452 -178.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.402 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 5.1 mm -100.39 165.73 2.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.6 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.3 m -161.62 137.12 7.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.589 179.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.473 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.2 OUTLIER -163.33 176.62 9.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.931 0.396 . . . . 0.0 110.965 179.784 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.468 ' HB2' ' CE1' ' A' ' 39' ' ' TYR . 12.2 p -94.4 117.37 30.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.917 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.41 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 2.3 p -41.14 93.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.609 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 68' ' ' SER . 0.1 OUTLIER -70.47 121.49 17.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.66 -178.758 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.75 115.49 30.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.695 177.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.409 ' CG ' ' N ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -69.95 -157.99 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.792 -179.504 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.437 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 1.6 t -47.33 136.68 9.07 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.237 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.414 ' HA ' ' CD1' ' A' ' 118' ' ' TRP . 35.3 Cg_exo -58.85 162.03 14.11 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.39 2.06 . . . . 0.0 111.797 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.485 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 80.5 Cg_exo -39.96 156.89 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.764 2.31 . . . . 0.0 112.834 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.9 t -108.15 89.19 2.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.641 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.3 pt -69.81 174.59 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.413 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.8 p -97.67 138.79 34.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.912 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.461 ' N ' ' ND2' ' A' ' 79' ' ' ASN . 0.1 OUTLIER 66.7 27.07 9.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.79 179.458 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.423 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . -172.71 -165.48 29.8 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.897 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 11.1 ptt180 -167.37 -175.26 2.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.873 0.368 . . . . 0.0 110.593 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.437 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 6.1 p80 -105.12 173.46 6.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.082 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -99.91 -84.28 0.42 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.45 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.4 ' HA3' ' OH ' ' A' ' 89' ' ' TYR . . . 60.96 150.5 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.779 -0.724 . . . . 0.0 113.068 178.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -112.87 -33.87 5.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.079 0.466 . . . . 0.0 110.634 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.76 -172.47 2.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.991 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -102.95 -23.41 13.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.016 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.433 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 6.5 m-85 -129.96 175.51 8.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.722 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.433 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 60.9 m-85 -151.4 164.04 37.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.866 0.365 . . . . 0.0 111.041 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.4 p -130.45 168.56 16.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.119 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.72 94.76 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.289 0.566 . . . . 0.0 110.886 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 129.88 26.76 0.83 Allowed Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.258 -0.883 . . . . 0.0 113.216 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -110.08 162.27 14.72 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.915 0.358 . . . . 0.0 110.697 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 33.9 m -135.58 154.99 35.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.099 0.476 . . . . 0.0 111.301 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.511 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 20.8 t -150.85 147.49 15.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.823 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.418 ' CG2' ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -105.5 133.05 50.89 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.74 179.436 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.525 ' CE1' ' CG2' ' A' ' 111' ' ' VAL . 4.9 m-85 -91.53 159.29 16.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.169 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.412 ' HA ' ' CD1' ' A' ' 105' ' ' LEU . 62.8 m -157.72 149.62 22.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.052 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.423 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 58.0 m -79.09 159.37 27.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.13 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -83.1 -68.52 0.7 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.632 -178.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.5 -26.17 61.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.383 -178.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.2 37.7 0.45 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.521 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.449 ' CE1' ' HB3' ' A' ' 79' ' ' ASN . 11.2 m-85 -69.78 -173.67 0.64 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.852 0.358 . . . . 0.0 110.35 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.3 m -107.95 98.89 8.4 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.079 178.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.412 ' CD1' ' HA ' ' A' ' 98' ' ' SER . 0.3 OUTLIER -47.94 126.92 11.36 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.623 0.725 . . . . 0.0 111.697 -177.881 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.446 ' HB ' ' CB ' ' A' ' 123' ' ' THR . 31.4 mm -90.6 152.02 3.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.079 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 61.11 -136.53 48.28 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.016 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -112.14 137.59 50.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.945 0.403 . . . . 0.0 111.348 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.433 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 1.6 p -68.06 -26.53 65.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.78 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -72.39 139.46 27.93 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.968 -0.634 . . . . 0.0 113.014 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.525 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 2.5 t -135.21 127.89 48.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.533 0.206 . . . . 0.0 110.56 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.06 126.2 34.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.968 0.414 . . . . 0.0 111.804 -178.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.488 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 13.4 t -90.41 101.2 13.94 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 176.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.67 160.83 39.99 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.065 0.459 . . . . 0.0 111.411 -178.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.0 30.53 5.19 Favored Glycine 0 N--CA 1.453 -0.232 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.665 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.41 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 68.72 19.19 72.96 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.199 -179.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -144.47 179.51 7.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.777 0.322 . . . . 0.0 110.512 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.511 ' CH2' ' CG2' ' A' ' 95' ' ' VAL . 92.7 m95 -115.84 152.24 33.73 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.978 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.67 156.34 48.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.234 -179.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.489 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER 61.83 46.5 0.96 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.881 179.109 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 96.0 Cg_endo -78.36 137.16 14.72 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.421 2.081 . . . . 0.0 111.577 178.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.443 ' CB ' ' O ' ' A' ' 106' ' ' ILE . 73.4 Cg_endo -91.94 -173.91 0.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.587 2.191 . . . . 0.0 113.545 -178.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.446 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.3 OUTLIER -129.17 -171.6 2.53 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.29 177.405 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 5.0 m -144.74 88.37 1.91 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.069 0.461 . . . . 0.0 110.325 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.437 ' NE2' HG21 ' A' ' 123' ' ' THR . 2.0 mp0 -118.11 -179.04 3.65 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.519 -178.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.422 HD13 ' CD2' ' A' ' 103' ' ' TYR . 32.3 mm . . . . . 0 C--N 1.321 -0.657 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.92 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.865 0.364 . . . . 0.0 110.894 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.403 ' HD2' HG22 ' A' ' 25' ' ' VAL . 8.1 mtm180 -60.29 176.79 0.31 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.004 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.457 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 28.9 m -91.09 159.85 38.86 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.077 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.0 168.65 23.38 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.661 2.241 . . . . 0.0 111.992 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.0 t -49.39 103.79 0.39 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.733 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.58 157.76 49.52 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.276 1.984 . . . . 0.0 112.051 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.457 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -51.23 -179.55 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.319 179.23 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.461 ' O ' ' CG2' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -140.62 -7.58 1.12 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -178.057 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.461 ' CG2' ' O ' ' A' ' 14' ' ' ASP . 15.1 tt 56.87 142.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 121.223 0.535 . . . . 0.0 111.603 -177.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -81.33 -52.61 7.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.602 -178.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.46 ' N ' ' ND2' ' A' ' 17' ' ' ASN . 0.4 OUTLIER -93.07 45.55 1.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.892 0.377 . . . . 0.0 110.922 -178.419 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 176.48 179.99 47.21 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.51 -0.853 . . . . 0.0 113.249 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -138.44 143.08 39.52 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.51 ' CD1' ' CZ ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -93.63 168.93 10.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.08 0.467 . . . . 0.0 111.125 -179.019 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -126.1 91.73 3.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.843 178.021 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.449 ' CD1' HG23 ' A' ' 31' ' ' ILE . 5.4 mm -68.46 107.08 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.829 -176.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -114.24 22.76 13.37 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.602 177.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 149.67 124.35 1.28 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.068 -0.587 . . . . 0.0 111.945 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.403 HG22 ' HD2' ' A' ' 8' ' ' ARG . 27.8 m -120.54 38.24 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.871 0.367 . . . . 0.0 111.261 -179.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.4 OUTLIER -111.25 150.36 29.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.6 179.302 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.465 ' CE2' HD13 ' A' ' 51' ' ' LEU . 8.0 t80 -49.05 91.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.896 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 130.27 -0.36 5.59 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.764 -0.732 . . . . 0.0 113.021 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -92.17 -168.41 1.99 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 117.038 0.419 . . . . 0.0 110.54 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.6 p -160.63 146.88 15.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.064 0.459 . . . . 0.0 111.27 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.539 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.6 OUTLIER -105.02 170.42 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.34 179.625 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -124.36 112.61 17.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.902 0.382 . . . . 0.0 111.09 179.073 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.51 ' CZ ' ' CD1' ' A' ' 20' ' ' LEU . 12.3 m-85 -87.04 142.5 27.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.602 -179.22 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.7 m -149.78 159.22 44.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.525 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 16.5 m -77.79 172.9 12.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.814 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -75.4 -83.87 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.262 -179.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.2 t -150.11 137.56 19.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.628 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 59.34 25.57 60.55 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.909 -179.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.489 ' CE1' ' HB2' ' A' ' 68' ' ' SER . 2.4 m-85 -116.16 168.74 9.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.805 0.336 . . . . 0.0 110.875 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.527 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 1.2 p80 -133.74 113.66 12.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.057 177.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.442 ' CD1' ' HG3' ' A' ' 64' ' ' PRO . 8.3 tt -76.11 135.48 39.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.773 -178.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.527 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 1.9 mm -113.89 153.44 15.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.099 0.476 . . . . 0.0 111.16 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.17 -137.48 18.52 Favored Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.135 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.409 ' O ' ' CG ' ' A' ' 64' ' ' PRO . 2.0 pt-20 -80.61 -178.04 6.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.044 0.449 . . . . 0.0 110.879 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.406 ' HB3' HD21 ' A' ' 41' ' ' LEU . 4.6 p -158.46 24.79 0.24 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.891 -179.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.6 mtmt -150.73 124.87 9.35 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -177.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.428 ' HB2' HG12 ' A' ' 31' ' ' ILE . 1.7 t -92.51 146.95 23.28 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.593 177.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.499 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 1.1 m-85 -120.74 113.51 20.3 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 119.139 -1.024 . . . . 0.0 111.683 178.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 18.7 t -63.74 95.19 0.1 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.154 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -118.47 -171.28 2.05 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.381 -178.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.465 HD13 ' CE2' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -97.2 148.19 23.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.031 -179.423 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -81.35 -144.8 4.41 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.437 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.3 m -85.43 -47.37 10.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.902 0.382 . . . . 0.0 110.905 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.0 p -91.23 47.4 1.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.843 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 51.37 29.14 22.4 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.416 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.82 -168.2 2.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.855 0.36 . . . . 0.0 111.007 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.94 133.86 51.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.55 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -148.15 -179.35 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.036 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.539 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 78.9 m95 -128.42 122.11 30.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.388 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.499 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -69.11 167.02 23.02 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.82 178.466 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.453 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 84.9 Cg_exo -18.7 93.01 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 125.096 3.864 . . . . 0.0 114.198 -179.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.411 ' CB ' ' OG ' ' A' ' 47' ' ' SER . 0.0 OUTLIER -97.32 -78.79 0.47 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.879 -177.672 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.485 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -75.05 108.4 5.41 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -176.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.442 ' HG3' ' CD1' ' A' ' 41' ' ' LEU . 3.5 Cg_endo -87.95 -156.73 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.307 2.671 . . . . 0.0 111.028 177.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.411 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 1.1 mt -89.2 174.99 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.844 0.354 . . . . 0.0 110.662 178.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -171.16 145.91 2.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.891 179.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -160.44 163.15 33.25 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.924 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.489 ' HB2' ' CE1' ' A' ' 39' ' ' TYR . 1.4 p -92.82 118.9 31.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.229 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.443 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 1.0 OUTLIER -55.14 93.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.861 179.194 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.401 ' CG ' ' O ' ' A' ' 89' ' ' TYR . 1.3 tttt -77.77 135.91 38.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.897 0.38 . . . . 0.0 111.26 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.431 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -106.64 121.78 45.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.143 178.458 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -69.41 -161.41 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.608 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.418 ' OG ' ' NE2' ' A' ' 82' ' ' HIS . 2.7 t -50.07 137.9 19.96 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.653 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.427 ' HA ' ' CD1' ' A' ' 118' ' ' TRP . 39.6 Cg_exo -57.61 159.13 17.64 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.242 1.961 . . . . 0.0 111.908 -179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.481 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 93.7 Cg_exo -42.54 156.88 0.09 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.653 2.235 . . . . 0.0 112.712 -178.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 75.8 p -106.9 89.13 2.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.789 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.8 pt -69.72 169.91 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.179 -179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -92.44 137.44 32.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.731 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.475 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 0.4 OUTLIER 65.05 29.18 12.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.71 -179.788 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.409 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -169.43 -167.4 29.94 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.959 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.2 ptt85 -170.18 -174.49 1.75 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.016 0.436 . . . . 0.0 110.462 -179.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 7.5 p80 -108.09 172.43 6.84 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.056 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' A' ' 96' ' ' THR . 63.1 m-20 -107.75 8.75 29.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.539 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -50.62 134.77 29.82 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.341 -0.933 . . . . 0.0 112.604 -179.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -105.68 -26.93 11.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.057 0.456 . . . . 0.0 110.611 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.27 -172.59 4.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.601 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.62 -23.06 11.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.952 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.416 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 12.2 m-85 -137.72 169.95 16.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.066 0.46 . . . . 0.0 111.308 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.431 ' N ' ' O ' ' A' ' 71' ' ' CYS . 37.7 m-85 -147.03 169.59 18.9 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.761 179.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.1 p -134.21 175.11 9.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.998 0.428 . . . . 0.0 111.647 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 1.3 m-20 -60.25 99.13 0.07 Allowed 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.445 0.641 . . . . 0.0 111.021 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.45 23.36 1.93 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 114.917 -1.038 . . . . 0.0 113.005 178.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.41 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -108.35 161.56 14.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.81 0.338 . . . . 0.0 110.583 179.066 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 32.7 m -138.57 157.62 30.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.079 0.466 . . . . 0.0 111.313 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.467 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 18.8 t -151.13 148.61 14.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.555 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.417 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -105.3 131.91 52.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.397 179.203 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.502 ' CE1' ' CG2' ' A' ' 111' ' ' VAL . 3.6 m-85 -89.25 159.31 17.49 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.052 -178.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.7 m -150.22 133.35 16.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.954 0.407 . . . . 0.0 111.567 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.409 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 74.7 m -69.81 162.67 27.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.745 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -96.81 -84.51 0.36 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.928 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -45.31 -27.38 0.65 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.529 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 124.9 36.0 0.61 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.465 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.487 ' CE2' HG13 ' A' ' 126' ' ' ILE . 18.9 m-85 -75.52 -173.74 2.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.939 0.399 . . . . 0.0 110.915 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.44 107.45 16.23 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.962 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.445 ' CD2' ' HB2' ' A' ' 122' ' ' PRO . 1.1 tp -46.44 118.74 2.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.163 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.465 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 45.2 mm -104.59 160.8 4.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.883 -179.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.419 ' O ' ' ND2' ' A' ' 108' ' ' ASN . . . 52.07 38.44 47.66 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.416 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.419 ' ND2' ' O ' ' A' ' 107' ' ' GLY . 8.1 p30 51.58 124.18 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 123.9 0.88 . . . . 0.0 112.693 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.469 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 1.3 p -56.03 -27.45 53.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.402 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.59 136.06 49.29 Favored Glycine 0 CA--C 1.518 0.239 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.843 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.502 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 2.2 t -136.61 130.2 46.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.27 125.37 37.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.92 0.391 . . . . 0.0 111.826 -178.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.485 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 16.7 t -87.32 107.88 18.71 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 175.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 7.0 t -154.95 166.98 31.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.988 -178.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 45.54 33.16 4.38 Favored Glycine 0 CA--C 1.516 0.146 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.692 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.443 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 64.83 19.41 65.36 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.565 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -149.32 -177.77 6.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.933 0.397 . . . . 0.0 110.989 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.485 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 94.8 m95 -113.27 126.26 55.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.87 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.19 145.84 33.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.261 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.495 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.9 OUTLIER 69.3 44.84 0.26 Allowed Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.123 178.84 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 57.0 Cg_endo -70.14 140.27 40.85 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.166 1.911 . . . . 0.0 111.243 178.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.483 ' HG2' ' CD2' ' A' ' 97' ' ' TYR . 94.7 Cg_endo -89.53 -170.58 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.624 2.216 . . . . 0.0 113.798 -177.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -140.58 -172.07 3.36 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.001 178.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . 0.403 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 11.8 m -142.37 95.72 2.84 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.007 0.432 . . . . 0.0 110.907 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -128.52 156.85 42.63 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.973 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.487 HG13 ' CE2' ' A' ' 103' ' ' TYR . 25.6 mm . . . . . 0 C--N 1.323 -0.544 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.011 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.0 mtm-85 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.938 0.399 . . . . 0.0 111.73 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.435 ' CB ' ' HA ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -93.29 171.08 9.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.435 178.627 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.428 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 98.3 m -78.6 156.97 77.74 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.203 -179.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.77 177.44 6.94 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.81 2.34 . . . . 0.0 112.533 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 p -48.91 104.67 0.43 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.896 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.457 ' HG2' ' CD1' ' A' ' 22' ' ' ILE . 71.6 Cg_exo -42.71 143.78 1.56 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.396 2.064 . . . . 0.0 112.323 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.425 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 10.1 mtt180 -58.9 152.37 19.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.056 178.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -105.96 178.76 4.47 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 121.338 0.59 . . . . 0.0 112.542 -175.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.415 HG22 ' CD2' ' A' ' 20' ' ' LEU . 6.0 tt -138.86 147.79 24.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.033 178.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -82.58 -56.2 4.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.779 -177.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -94.48 27.11 3.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.198 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.412 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -149.34 -178.65 24.53 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.383 -0.913 . . . . 0.0 113.297 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -139.13 132.16 29.54 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.449 HD23 ' CE1' ' A' ' 33' ' ' TYR . 3.6 mt -76.89 160.78 28.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.203 0.525 . . . . 0.0 111.897 -178.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.422 ' HB2' ' CB ' ' A' ' 32' ' ' THR . 17.3 t70 -130.44 74.29 1.59 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.515 177.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.457 ' CD1' ' HG2' ' A' ' 12' ' ' PRO . 73.2 mt -72.96 101.45 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.017 -177.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.54 20.72 48.45 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.543 176.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.02 145.42 4.16 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 -179.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.407 ' O ' ' HB3' ' A' ' 8' ' ' ARG . 16.6 m -124.83 -6.79 6.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.435 ' HA ' ' CB ' ' A' ' 8' ' ' ARG . 9.1 m-20 -69.8 156.03 39.65 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.931 0.396 . . . . 0.0 111.698 -178.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.494 ' CZ ' ' HB2' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -48.17 101.48 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.514 178.923 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 119.05 -15.5 11.01 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.441 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.4 m -63.47 166.87 6.07 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.794 0.297 . . . . 0.0 110.293 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.4 p -137.05 147.1 45.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.082 0.467 . . . . 0.0 111.682 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.55 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.4 OUTLIER -113.07 173.77 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.793 -179.807 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.422 ' CB ' ' HB2' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -141.99 106.77 4.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.016 178.645 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.532 ' CE1' ' CB ' ' A' ' 63' ' ' ALA . 20.9 m-85 -76.59 142.37 40.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.043 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.412 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 1.5 m -141.05 165.38 27.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.543 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.416 ' HB2' ' HB2' ' A' ' 39' ' ' TYR . 2.3 m -88.56 165.4 14.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.766 0.317 . . . . 0.0 110.768 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -64.78 -84.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.06 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.6 m -153.93 133.45 12.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.728 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.28 24.59 67.52 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.937 -178.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.485 ' CE1' ' HB3' ' A' ' 68' ' ' SER . 2.6 m-85 -116.72 171.48 7.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.859 0.361 . . . . 0.0 110.906 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.53 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 1.0 OUTLIER -134.57 116.17 14.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.624 178.173 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.43 ' CD2' ' O ' ' A' ' 44' ' ' GLU . 4.6 tt -74.24 127.64 33.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.606 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.53 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 3.1 mm -100.94 151.24 5.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.836 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.45 -140.03 23.9 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.691 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.43 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -70.68 175.38 4.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.948 0.404 . . . . 0.0 110.997 179.857 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.4 ' HA ' ' HG3' ' A' ' 64' ' ' PRO . 0.4 OUTLIER -157.77 26.84 0.27 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.296 179.289 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -149.97 151.84 33.99 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.998 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.4 ' HB3' ' O ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -132.25 143.12 49.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.125 179.51 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.486 ' CE2' ' HD2' ' A' ' 61' ' ' PRO . 2.7 m-85 -117.0 125.8 51.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.176 0.512 . . . . 0.0 111.892 -178.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.502 ' HB3' ' CH2' ' A' ' 59' ' ' TRP . 24.4 t -73.91 117.13 15.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.695 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.491 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 12.9 tt0 -160.38 167.58 27.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.424 0.631 . . . . 0.0 111.016 178.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.494 ' HB2' ' CZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -82.86 139.95 33.18 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.433 -178.733 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.43 ' N ' HG21 ' A' ' 58' ' ' VAL . . . 177.87 76.29 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.43 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 t -176.04 58.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.931 0.396 . . . . 0.0 110.609 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.2 p 63.61 13.97 7.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.131 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 121.01 33.78 0.95 Allowed Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.604 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.07 -174.13 3.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.116 0.484 . . . . 0.0 111.335 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.433 ' HA ' ' HA ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -94.77 156.39 16.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.48 179.91 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.43 HG21 ' N ' ' A' ' 52' ' ' GLY . 2.4 m -160.44 -176.83 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.28 -178.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.55 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 92.2 m95 -133.56 126.01 30.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.137 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -149.61 123.68 4.62 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.589 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.486 ' HD2' ' CE2' ' A' ' 48' ' ' TYR . 23.2 Cg_exo -68.65 -174.69 8.68 Favored 'Cis proline' 0 C--N 1.35 0.633 0 C-N-CA 124.287 -1.13 . . . . 0.0 113.055 2.077 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.1 -143.05 0.39 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.861 -178.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.532 ' CB ' ' CE1' ' A' ' 33' ' ' TYR . . . -86.4 116.51 66.14 Favored Pre-proline 0 CA--C 1.53 0.187 0 CA-C-O 120.407 0.146 . . . . 0.0 111.008 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.425 ' CG ' ' O ' ' A' ' 44' ' ' GLU . 11.5 Cg_exo -72.95 -151.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.645 2.23 . . . . 0.0 112.582 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.5 mm -101.45 166.34 2.47 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-O 121.02 0.438 . . . . 0.0 111.486 -178.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.3 m -163.61 120.3 1.75 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.379 179.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.32 171.04 15.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.992 0.425 . . . . 0.0 111.318 -178.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.485 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 8.9 p -93.22 103.18 15.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.848 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.7 p -59.46 89.3 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.478 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -63.8 154.22 34.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.558 -0.747 . . . . 0.0 112.184 -177.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.416 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -118.88 127.01 53.1 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.77 177.559 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.413 ' CG ' ' N ' ' A' ' 73' ' ' SER . 0.1 OUTLIER -73.93 -160.48 0.09 Allowed 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.488 179.89 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.413 ' N ' ' CG ' ' A' ' 72' ' ' GLN . 2.7 t -50.21 137.49 21.33 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.505 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.48 ' HD2' ' CD2' ' A' ' 82' ' ' HIS . 37.9 Cg_exo -56.33 162.57 7.64 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.167 1.911 . . . . 0.0 111.574 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.478 ' HD2' ' CG ' ' A' ' 118' ' ' TRP . 82.2 Cg_exo -39.92 156.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.726 2.284 . . . . 0.0 112.571 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.7 m -107.89 89.05 2.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.894 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.408 ' CG2' ' O ' ' A' ' 122' ' ' PRO . 13.5 pt -69.7 173.92 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.002 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.0 m -95.77 138.76 32.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.878 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.48 ' HB3' ' CD2' ' A' ' 103' ' ' TYR . 3.9 m-80 60.16 28.97 18.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.989 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.417 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -160.26 -170.75 25.25 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.149 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.26 -175.15 3.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.046 0.45 . . . . 0.0 110.858 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.48 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 34.8 p-80 -112.92 169.03 9.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.889 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.422 ' ND2' ' HB ' ' A' ' 96' ' ' THR . 1.2 m-20 -116.97 63.75 0.72 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.793 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -92.12 151.74 20.9 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.043 -1.075 . . . . 0.0 112.484 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.447 ' CD2' ' N ' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -108.79 -30.31 8.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.16 0.505 . . . . 0.0 110.632 -179.969 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.5 -172.37 2.49 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.845 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.33 -24.48 12.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.928 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.419 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 10.7 m-85 -134.08 174.78 10.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.938 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.419 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 40.6 m-85 -147.0 165.11 30.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.444 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 17.0 p -129.22 172.09 11.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.005 0.431 . . . . 0.0 111.55 -179.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 0.9 OUTLIER -58.74 97.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.889 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.69 14.87 2.75 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.195 -0.911 . . . . 0.0 113.093 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.98 158.31 15.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.909 0.355 . . . . 0.0 110.393 179.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 27.0 m -133.77 156.11 40.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.072 0.463 . . . . 0.0 111.231 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.462 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 38.7 t -149.72 150.86 13.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.615 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.426 ' CG2' ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -108.22 133.6 52.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.963 0.411 . . . . 0.0 110.53 179.112 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.522 ' CE1' ' CG2' ' A' ' 111' ' ' VAL . 5.9 m-85 -93.28 155.84 17.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.044 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 20.0 p -152.83 144.32 23.37 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.147 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.417 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 68.5 m -72.95 158.87 34.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.251 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 -86.91 -71.09 0.57 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.692 -178.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 40.5 t -68.39 -21.72 64.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.612 -178.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 123.85 32.42 0.87 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.66 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.48 ' CD2' ' HB3' ' A' ' 79' ' ' ASN . 30.6 m-85 -69.6 -171.85 0.42 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.768 0.318 . . . . 0.0 110.277 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.7 p -107.35 106.06 16.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.975 0.417 . . . . 0.0 111.168 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.404 HD22 ' CA ' ' A' ' 109' ' ' SER . 3.0 tp -46.92 108.85 0.16 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.702 178.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.451 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 31.8 mm -84.1 158.35 3.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.651 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 59.81 -123.16 32.36 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.258 -0.973 . . . . 0.0 111.795 -178.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -125.82 132.91 52.15 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.796 0.331 . . . . 0.0 110.766 178.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.433 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 1.2 p -66.37 -31.54 72.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.401 179.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.64 136.92 22.69 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.526 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.522 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 2.9 t -126.54 153.37 35.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 179.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.39 118.36 35.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.903 0.382 . . . . 0.0 111.597 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.497 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 15.1 t -85.55 97.75 10.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.615 176.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 1.0 OUTLIER -132.54 151.1 52.03 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.556 -177.982 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 48.01 29.77 6.77 Favored Glycine 0 C--N 1.329 0.187 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.745 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 79.95 -5.06 63.4 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.936 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -121.17 175.11 6.27 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.93 0.395 . . . . 0.0 110.866 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.497 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 87.2 m95 -112.5 152.27 28.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.895 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.27 147.12 49.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.021 0.438 . . . . 0.0 111.466 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.492 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER 70.07 46.11 0.27 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.161 178.546 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.492 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 74.1 Cg_endo -75.37 139.49 23.42 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.382 2.055 . . . . 0.0 111.623 178.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.451 ' CB ' ' O ' ' A' ' 106' ' ' ILE . 57.3 Cg_endo -89.22 -174.52 0.96 Allowed 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.574 2.182 . . . . 0.0 113.559 -178.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.451 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -132.27 -171.75 2.72 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.845 -1.071 . . . . 0.0 109.834 177.829 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 10.4 m -146.3 93.93 2.38 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.0 0.428 . . . . 0.0 111.214 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -119.54 169.54 9.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.878 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.476 HG12 ' CE1' ' A' ' 103' ' ' TYR . 28.3 mm . . . . . 0 C--N 1.323 -0.547 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.944 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.6 mtt-85 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.821 0.343 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.22 171.46 8.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.507 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.455 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 53.6 m -77.85 159.61 75.94 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.664 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.15 169.86 17.17 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.504 2.136 . . . . 0.0 112.305 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 p -50.55 106.38 0.63 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.832 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.446 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 52.2 Cg_exo -43.23 152.92 0.22 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.262 1.974 . . . . 0.0 112.249 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.425 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -70.05 154.75 41.54 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.056 0.455 . . . . 0.0 110.424 178.685 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -97.59 -176.47 3.49 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.889 -176.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 18.6 tt -151.45 144.75 16.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.961 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.428 ' HB2' ' ND2' ' A' ' 17' ' ' ASN . 7.4 t0 -86.57 159.25 19.31 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.108 -0.497 . . . . 0.0 109.974 178.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.485 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 0.1 OUTLIER 43.15 29.63 0.22 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.89 0.376 . . . . 0.0 111.051 -179.445 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -155.02 173.42 33.34 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.629 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -137.53 135.18 36.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.763 0.316 . . . . 0.0 110.589 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.479 HD21 ' CD1' ' A' ' 33' ' ' TYR . 14.0 mt -79.27 159.91 27.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.445 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.406 ' HB2' ' CB ' ' A' ' 32' ' ' THR . 34.9 t0 -131.31 75.48 1.66 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.366 178.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.45 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 58.3 mt -70.98 118.38 15.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.134 0.492 . . . . 0.0 111.994 -178.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -128.47 19.83 5.6 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.696 177.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 160.12 117.84 0.48 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.175 -0.536 . . . . 0.0 111.94 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.4 m -114.47 24.85 4.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.692 0.282 . . . . 0.0 111.554 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -100.97 146.47 27.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.703 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.48 ' CZ ' HD11 ' A' ' 51' ' ' LEU . 5.7 t80 -48.23 97.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.062 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.18 5.58 5.59 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.074 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.58 -158.69 0.69 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 117.037 0.419 . . . . 0.0 110.79 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.2 p -168.62 146.63 4.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.048 0.451 . . . . 0.0 111.413 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.543 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.7 OUTLIER -105.89 167.58 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.225 179.51 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.406 ' CB ' ' HB2' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -127.85 121.31 29.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.802 0.334 . . . . 0.0 110.738 179.001 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.479 ' CD1' HD21 ' A' ' 20' ' ' LEU . 14.1 m-85 -95.51 149.09 21.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.519 -179.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.19 155.82 39.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.771 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.404 ' HB2' ' HB2' ' A' ' 39' ' ' TYR . 2.9 m -81.99 169.53 16.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.819 0.342 . . . . 0.0 110.867 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -70.56 -84.97 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.157 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.6 m -153.14 131.91 12.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.933 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.19 21.22 73.74 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.15 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.485 ' CE2' ' HB3' ' A' ' 17' ' ' ASN . 2.5 m-85 -113.46 175.97 5.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.793 0.33 . . . . 0.0 110.868 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.511 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.5 OUTLIER -140.15 113.59 8.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.516 178.662 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.437 ' CD2' ' O ' ' A' ' 44' ' ' GLU . 6.7 tt -79.5 121.33 25.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.829 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.511 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 2.2 mm -99.23 168.43 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.129 -179.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.13 -134.1 26.84 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.374 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.437 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 2.2 pm0 -79.75 -173.05 3.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.766 0.317 . . . . 0.0 110.603 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.432 ' CB ' HD21 ' A' ' 41' ' ' LEU . 2.2 t -166.66 28.84 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.605 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -159.76 127.65 4.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.327 -178.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.436 ' OG ' ' CB ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -93.0 143.67 26.01 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.906 178.323 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.498 ' CD1' ' HB2' ' A' ' 60' ' ' ASN . 1.6 m-85 -118.69 114.5 22.82 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.507 178.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.446 ' HB3' ' CH2' ' A' ' 59' ' ' TRP . 21.8 t -69.86 99.4 1.38 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.565 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -120.38 -172.17 2.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.098 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.48 HD11 ' CZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -93.18 145.33 24.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.953 -179.608 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.71 -137.5 0.2 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.534 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.0 m -92.43 -44.6 8.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.802 0.334 . . . . 0.0 110.959 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 80.4 p -99.57 43.52 1.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.973 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.67 19.25 66.96 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.58 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.88 -161.58 0.36 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.849 0.357 . . . . 0.0 110.803 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 4.6 mmt -114.87 141.83 47.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.7 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.4 m -155.52 175.34 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.823 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.543 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 79.2 m95 -128.51 121.86 29.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.598 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.498 ' HB2' ' CD1' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -69.52 167.34 23.17 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.342 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.49 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 68.4 Cg_exo -14.58 92.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.872 1 C-N-CA 125.339 4.026 . . . . 0.0 114.622 -178.656 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.479 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -90.81 -75.78 0.46 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.338 -177.4 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.437 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -91.8 108.17 27.87 Favored Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -175.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.437 ' HG3' ' CD1' ' A' ' 41' ' ' LEU . 4.7 Cg_exo -81.47 -154.15 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.083 2.522 . . . . 0.0 111.123 177.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.405 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 3.8 mm -88.81 166.03 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.782 0.325 . . . . 0.0 110.438 177.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -169.32 129.82 1.08 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.605 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -155.74 173.5 16.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.135 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.484 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 5.2 p -85.4 117.25 24.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.627 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.45 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 0.4 OUTLIER -42.44 94.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.344 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.468 ' CD ' ' HB2' ' A' ' 88' ' ' PHE . 4.3 ttpt -80.15 131.72 35.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.285 -178.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.432 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -107.08 130.0 54.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.901 -179.285 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.3 -158.48 0.06 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.443 178.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.479 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 2.0 t -49.98 135.89 21.1 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.842 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.434 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 31.8 Cg_exo -56.69 162.92 7.79 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.393 2.062 . . . . 0.0 112.053 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.492 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 87.8 Cg_exo -42.44 156.68 0.09 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.715 2.277 . . . . 0.0 112.776 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 65.1 p -106.01 90.09 3.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.406 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 25.0 pt -69.32 172.54 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.37 -178.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.0 p -94.98 143.9 26.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.509 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.486 ' HB3' ' CE1' ' A' ' 103' ' ' TYR . 2.7 m-80 58.58 28.59 17.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.86 0.362 . . . . 0.0 111.084 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -171.82 -167.54 32.11 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.498 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 10.2 ptt85 -166.54 -176.6 3.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.966 0.413 . . . . 0.0 111.168 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.479 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 25.3 p-80 -103.08 175.16 5.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.038 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -107.18 -86.37 0.5 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.31 179.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.406 ' HA3' ' OH ' ' A' ' 89' ' ' TYR . . . 58.56 154.42 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.117 178.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -114.44 -34.02 5.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.027 0.441 . . . . 0.0 110.793 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.12 -171.73 2.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.801 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -102.25 -27.12 13.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.202 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.468 ' HB2' ' CD ' ' A' ' 70' ' ' LYS . 19.2 m-85 -128.86 -176.85 3.98 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.077 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.462 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 84.5 m-85 -157.41 169.95 23.56 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.734 -178.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 11.4 p -134.0 178.59 6.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.909 0.385 . . . . 0.0 111.407 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 28.5 p-10 -62.74 94.77 0.07 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.298 0.571 . . . . 0.0 111.026 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.56 29.53 0.9 Allowed Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.983 179.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.11 163.88 13.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.691 0.282 . . . . 0.0 110.57 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 33.9 m -138.76 150.73 23.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.103 0.478 . . . . 0.0 111.307 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.49 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 20.1 t -145.81 147.06 18.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.635 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.429 ' CG2' ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -105.76 130.59 53.73 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.893 179.956 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.505 ' CE2' ' CG2' ' A' ' 111' ' ' VAL . 5.0 m-85 -89.77 160.55 16.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.069 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 82.4 p -156.47 139.26 15.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.078 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 62.8 m -70.94 160.11 33.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.076 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 -80.85 -81.96 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.299 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.14 -30.99 70.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.214 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 132.57 39.81 0.22 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.645 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.504 ' CD2' HG12 ' A' ' 126' ' ' ILE . 49.7 m-85 -69.51 -174.27 0.67 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.807 0.337 . . . . 0.0 110.545 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 67.3 m -104.97 101.2 10.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.699 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.434 ' HA ' ' O ' ' A' ' 123' ' ' THR . 0.2 OUTLIER -50.69 122.18 6.89 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.475 0.655 . . . . 0.0 111.428 -178.713 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.43 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 30.9 mm -91.3 155.43 3.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.943 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.76 -127.53 36.51 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.922 -178.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -126.19 138.59 53.66 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.799 0.333 . . . . 0.0 111.065 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.429 ' OG ' ' CG2' ' A' ' 96' ' ' THR . 5.7 p -64.79 -32.25 73.85 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.656 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -71.49 138.34 27.37 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.929 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.505 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 2.7 t -133.31 119.66 36.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.543 0.211 . . . . 0.0 110.591 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.5 125.79 30.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.889 0.376 . . . . 0.0 111.554 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.491 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 34.7 t -90.22 102.81 15.53 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 176.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 9.0 t -144.22 161.0 40.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.111 0.482 . . . . 0.0 111.308 -178.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 45.23 33.37 4.0 Favored Glycine 0 CA--C 1.518 0.252 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.912 179.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.45 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 66.39 16.99 65.83 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.538 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -139.98 178.05 7.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.781 0.324 . . . . 0.0 110.608 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.492 ' CD1' ' HD2' ' A' ' 75' ' ' PRO . 94.5 m95 -116.01 138.18 51.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.926 -179.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.72 146.68 46.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.214 -179.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.475 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 3.2 t0 71.02 46.05 0.25 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.074 178.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 97.2 Cg_endo -78.63 134.69 12.43 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.322 2.015 . . . . 0.0 111.379 177.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.437 ' CG ' ' HB2' ' A' ' 97' ' ' TYR . 53.7 Cg_endo -87.05 -177.65 2.26 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.374 2.05 . . . . 0.0 113.412 -178.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 105' ' ' LEU . 0.2 OUTLIER -134.2 177.85 7.42 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.542 178.312 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 12.5 m -132.93 106.68 7.83 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.312 0.577 . . . . 0.0 110.95 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -114.79 -175.87 2.78 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.437 -178.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.523 ' CD1' ' N ' ' A' ' 126' ' ' ILE . 1.6 mp . . . . . 0 C--N 1.32 -0.68 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.618 -177.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.782 0.325 . . . . 0.0 111.214 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.94 -174.91 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.736 179.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.428 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 60.6 m -104.78 158.74 31.36 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.9 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.91 170.98 14.32 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.362 2.041 . . . . 0.0 110.883 178.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.1 p -53.2 123.53 35.04 Favored Pre-proline 0 N--CA 1.448 -0.525 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.633 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.44 ' CG ' HD13 ' A' ' 22' ' ' ILE . 20.4 Cg_endo -58.61 158.24 24.48 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.737 2.291 . . . . 0.0 112.338 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -70.81 142.96 51.29 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.474 178.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.62 -171.06 3.38 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.417 -177.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 20.2 tt -155.97 143.89 11.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.394 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -90.93 158.77 16.55 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.764 177.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.486 ' HB2' ' CE1' ' A' ' 39' ' ' TYR . 0.4 OUTLIER 48.27 26.02 0.99 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.825 0.345 . . . . 0.0 110.656 -179.463 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.408 ' HA3' ' N ' ' A' ' 36' ' ' ASN . . . -157.56 -178.6 31.76 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.589 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -146.06 134.43 21.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.672 0.273 . . . . 0.0 110.887 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 20.1 mt -78.61 155.18 29.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.986 0.422 . . . . 0.0 111.353 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.439 ' CB ' ' HB ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -124.01 72.65 1.17 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.444 177.203 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.44 HD13 ' CG ' ' A' ' 12' ' ' PRO . 1.1 mt -69.93 101.17 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.008 -176.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.9 17.25 57.55 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.718 176.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 154.96 151.5 5.86 Favored Glycine 0 C--N 1.333 0.382 0 N-CA-C 111.659 -0.576 . . . . 0.0 111.659 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.3 m -133.76 13.61 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -85.5 157.18 20.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.849 0.356 . . . . 0.0 111.094 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.479 ' CZ ' HD13 ' A' ' 51' ' ' LEU . 5.9 t80 -51.38 103.34 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.785 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 115.28 -1.51 22.35 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.888 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 94.4 p -78.94 -176.72 5.17 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 116.984 0.392 . . . . 0.0 110.435 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.3 p -151.91 156.36 39.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.936 0.398 . . . . 0.0 111.376 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.507 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.8 OUTLIER -122.37 166.55 16.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.827 -179.713 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.439 ' HB ' ' CB ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -128.89 114.48 16.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.782 179.13 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.464 ' CE2' ' HA ' ' A' ' 63' ' ' ALA . 31.3 m-85 -88.58 145.01 25.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.979 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -148.41 166.17 28.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.113 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.3 m -89.64 158.79 17.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.716 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.418 ' ND2' ' HA ' ' A' ' 17' ' ' ASN . 15.5 m-20 -58.02 -88.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.31 -178.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.9 t -151.86 133.39 14.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.882 0.372 . . . . 0.0 110.822 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.01 18.49 72.81 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.233 -179.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.486 ' CE1' ' HB2' ' A' ' 17' ' ' ASN . 2.7 m-30 -112.6 -177.93 3.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.911 0.386 . . . . 0.0 110.786 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.533 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.3 OUTLIER -142.08 110.85 6.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.008 177.041 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.43 ' CD2' ' O ' ' A' ' 44' ' ' GLU . 2.9 tt -72.57 125.19 26.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.336 -178.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.533 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 1.7 mm -106.2 165.7 3.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.111 0.482 . . . . 0.0 111.274 -178.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.31 -123.16 11.75 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.305 -179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.43 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 1.3 mt-10 -80.77 174.58 11.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.194 0.521 . . . . 0.0 112.019 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.401 ' HB3' HD22 ' A' ' 41' ' ' LEU . 5.2 p -156.37 19.03 0.35 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.474 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.8 mtpt -159.97 152.05 20.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.059 0.457 . . . . 0.0 112.075 -177.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -121.25 152.73 38.54 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.031 177.986 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.477 ' CD1' ' HB2' ' A' ' 60' ' ' ASN . 1.4 m-85 -131.36 115.13 15.84 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 119.135 -1.026 . . . . 0.0 112.173 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 28.0 t -66.12 109.02 2.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.763 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -133.27 -173.3 3.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.173 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.479 HD13 ' CZ ' ' A' ' 27' ' ' PHE . 7.4 mt -85.63 160.85 19.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.242 -179.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.42 -143.27 3.26 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.532 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.3 t -101.28 -31.41 10.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.792 0.33 . . . . 0.0 110.891 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 26.7 p -113.28 25.56 11.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.852 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.26 32.51 11.99 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.444 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -102.45 -171.4 1.96 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.988 0.423 . . . . 0.0 111.131 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.31 125.61 52.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.801 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.1 -176.95 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.861 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.507 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 65.8 m95 -132.01 131.95 42.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.744 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.477 ' HB2' ' CD1' ' A' ' 48' ' ' TYR . 1.0 OUTLIER -69.92 162.62 67.17 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.08 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.451 ' O ' ' HA ' ' A' ' 47' ' ' SER . 21.4 Cg_exo -7.8 109.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.755 1 C-N-CA 125.888 4.392 . . . . 0.0 115.267 -178.189 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.438 ' HA ' ' OG ' ' A' ' 47' ' ' SER . 3.9 mt-10 -98.09 -113.73 0.15 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 114.901 -1.045 . . . . 0.0 112.513 -176.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.464 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -69.25 107.71 2.41 Favored Pre-proline 0 C--N 1.34 0.168 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -176.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.424 ' CG ' ' O ' ' A' ' 44' ' ' GLU . 2.2 Cg_endo -81.53 -153.98 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.924 2.416 . . . . 0.0 110.298 176.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.443 ' CD1' ' HB ' ' A' ' 42' ' ' ILE . 0.3 OUTLIER -86.04 170.73 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.327 0.584 . . . . 0.0 111.573 -179.976 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -172.24 141.47 1.25 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.042 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -169.7 167.8 9.33 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.801 0.334 . . . . 0.0 111.202 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.484 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 2.8 p -77.54 121.85 24.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.247 178.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.454 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 1.4 p -40.52 96.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.139 0.495 . . . . 0.0 111.582 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.488 ' HG3' ' CD2' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -92.37 127.53 37.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.172 -178.013 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.43 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -100.29 132.02 45.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.998 -179.001 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -75.81 -159.55 0.11 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.599 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.428 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 1.9 t -48.44 136.83 12.29 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.04 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.48 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 25.7 Cg_exo -60.59 159.02 29.6 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.351 2.034 . . . . 0.0 112.225 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.404 ' HG3' ' HD3' ' A' ' 121' ' ' PRO . 81.1 Cg_exo -44.78 159.69 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.982 2.455 . . . . 0.0 113.275 -178.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.6 m -108.8 93.11 4.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.516 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.4 pt -68.5 175.2 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.249 -179.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.2 p -94.32 137.36 33.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.877 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.481 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 0.1 OUTLIER 68.47 26.87 6.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.879 179.521 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.436 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . -171.84 -164.78 27.99 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.263 -0.97 . . . . 0.0 113.216 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' A' ' 98' ' ' SER . 4.9 ptt85 -162.06 -175.1 4.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.044 0.45 . . . . 0.0 110.705 -179.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.428 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 19.6 p-80 -111.14 169.53 8.72 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.71 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -100.52 -83.72 0.44 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.709 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.41 ' CA ' ' OH ' ' A' ' 89' ' ' TYR . . . 60.74 148.61 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.617 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -115.66 -36.27 4.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.099 0.475 . . . . 0.0 110.613 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.79 -171.38 2.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.611 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -100.89 -25.94 13.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.058 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.488 ' CD2' ' HG3' ' A' ' 70' ' ' LYS . 24.8 m-85 -130.19 -176.67 4.02 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.161 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.468 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 89.2 m-85 -157.17 165.57 35.6 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.419 -178.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.0 p -136.56 -176.4 4.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.072 0.463 . . . . 0.0 111.717 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.407 ' OD2' ' N ' ' A' ' 91' ' ' ASP . 2.1 m-20 -63.03 96.64 0.1 Allowed 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.255 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.94 26.54 1.36 Allowed Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.288 -0.869 . . . . 0.0 113.035 178.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.403 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -110.17 162.92 14.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.817 0.341 . . . . 0.0 110.801 179.374 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.406 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 36.0 m -144.29 149.44 17.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.135 0.493 . . . . 0.0 111.125 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.478 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 18.1 t -141.1 146.97 22.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.559 179.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.434 ' CG2' ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -102.08 136.78 41.32 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.816 -179.764 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.531 ' CE2' ' CG2' ' A' ' 111' ' ' VAL . 5.8 m-85 -98.81 156.17 17.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.147 -179.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.4 ' O ' ' N ' ' A' ' 81' ' ' ARG . 1.3 p -148.07 141.42 25.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.57 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.436 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 12.1 m -69.38 162.43 27.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.281 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -97.02 -69.07 0.77 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.092 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.75 -28.81 69.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.01 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.36 36.79 0.48 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.548 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.502 ' CE2' HG12 ' A' ' 126' ' ' ILE . 18.2 m-85 -74.27 -171.77 1.26 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.756 0.312 . . . . 0.0 110.664 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.6 m -117.54 101.05 8.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.759 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.434 HD23 ' CB ' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -49.0 132.79 18.7 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.594 0.711 . . . . 0.0 111.155 -179.739 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.434 ' HB ' ' CB ' ' A' ' 123' ' ' THR . 36.1 mm -101.82 156.98 4.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.59 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.427 ' N ' HG21 ' A' ' 106' ' ' ILE . . . 67.35 -126.47 25.37 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.958 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -125.79 127.06 45.54 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.054 0.454 . . . . 0.0 110.931 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.434 ' OG ' ' CG2' ' A' ' 96' ' ' THR . 3.6 p -59.34 -27.93 66.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.728 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -72.47 121.39 8.08 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.75 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.531 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 11.6 t -113.99 116.03 51.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.5 126.61 31.18 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -177.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.485 ' HB2' ' CZ3' ' A' ' 118' ' ' TRP . 41.8 t -91.07 104.12 16.74 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 19.3 t -141.1 150.72 43.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.078 0.466 . . . . 0.0 111.406 -178.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.68 43.24 15.58 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.767 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.454 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 62.32 14.14 46.7 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.647 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -135.11 173.25 11.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.023 0.44 . . . . 0.0 110.679 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.485 ' CZ3' ' HB2' ' A' ' 113' ' ' CYS . 95.8 m95 -115.48 128.1 55.78 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.527 -178.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.488 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 0.3 OUTLIER -91.81 130.39 37.6 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.663 175.04 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.524 ' CB ' ' CA ' ' A' ' 121' ' ' PRO . 2.8 m-20 108.92 -132.1 0.0 OUTLIER Pre-proline 0 CA--C 1.475 -1.907 0 N-CA-C 100.41 -3.922 . . . . 0.0 100.41 -167.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.524 ' CA ' ' CB ' ' A' ' 120' ' ' ASP . 60.4 Cg_endo -63.52 -179.53 7.77 Favored 'Cis proline' 0 C--N 1.309 -1.54 0 CA-C-N 125.157 2.878 . . . . 0.0 112.717 -17.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.434 ' CB ' HD23 ' A' ' 105' ' ' LEU . 18.0 Cg_endo -87.94 -179.51 2.53 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 123.023 2.482 . . . . 0.0 111.32 176.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.434 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -109.12 -162.6 0.82 Allowed 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.13 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 5.0 t -170.25 85.83 0.12 Allowed 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.904 -176.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -114.61 176.74 4.92 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.909 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.502 HG12 ' CE2' ' A' ' 103' ' ' TYR . 26.4 mm . . . . . 0 C--N 1.322 -0.615 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.718 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.816 0.341 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.34 175.21 7.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.731 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.445 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 37.9 m -81.33 160.06 66.02 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.874 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.89 174.44 9.62 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.454 2.103 . . . . 0.0 111.961 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -51.11 109.57 1.41 Allowed Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.794 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.41 162.38 14.85 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.258 1.972 . . . . 0.0 111.977 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.456 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -52.11 -175.02 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.447 179.318 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.418 ' C ' ' CG1' ' A' ' 15' ' ' ILE . 0.4 OUTLIER -140.05 6.53 2.18 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.041 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.537 ' CD1' ' CD2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER 57.8 -165.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.067 -177.635 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -125.79 -70.88 0.72 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.929 0.395 . . . . 0.0 110.613 178.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.471 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -99.2 29.02 4.11 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.941 178.605 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.42 ' HA3' ' N ' ' A' ' 36' ' ' ASN . . . -137.93 -175.66 14.03 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.214 -178.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.431 ' N ' HD11 ' A' ' 15' ' ' ILE . 0.2 OUTLIER -133.75 145.35 49.74 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.672 0.272 . . . . 0.0 110.747 -179.706 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.482 HD23 ' CZ ' ' A' ' 33' ' ' TYR . 4.9 mt -82.67 155.55 24.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.207 0.527 . . . . 0.0 111.797 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.403 ' HB2' ' HB ' ' A' ' 32' ' ' THR . 4.5 t0 -129.91 68.5 1.44 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.92 175.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.463 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 0.9 OUTLIER -74.95 116.95 18.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.49 -175.796 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -116.05 19.57 13.5 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.227 175.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 161.0 125.99 0.8 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.007 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.6 m -112.44 5.79 8.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -88.46 165.42 14.91 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.871 0.367 . . . . 0.0 110.871 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -57.76 116.71 3.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.635 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.45 5.9 36.42 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.833 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 89.7 p -94.14 -169.59 2.1 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.856 0.328 . . . . 0.0 110.307 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.9 p -165.88 141.66 5.0 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.125 0.488 . . . . 0.0 111.1 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.533 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.6 OUTLIER -106.14 164.38 4.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.209 -179.898 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.403 ' HB ' ' HB2' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -121.86 118.18 28.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.952 0.406 . . . . 0.0 110.671 179.034 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.537 ' CD2' ' CD1' ' A' ' 15' ' ' ILE . 6.1 m-85 -90.97 135.63 33.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.784 -178.109 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.9 m -146.97 157.55 43.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.694 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.9 m -79.58 167.56 20.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.846 0.355 . . . . 0.0 110.869 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.42 ' N ' ' HA3' ' A' ' 18' ' ' GLY . 11.1 m-20 -67.15 -84.13 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.971 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.96 134.52 11.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.699 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.29 24.27 73.47 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.897 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.53 ' CE2' ' CB ' ' A' ' 68' ' ' SER . 2.7 m-30 -119.73 174.52 6.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.887 0.375 . . . . 0.0 110.908 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.517 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.6 OUTLIER -134.53 117.12 15.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.364 177.78 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.401 HD22 ' HB3' ' A' ' 45' ' ' SER . 5.7 tt -81.75 127.47 32.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.337 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.517 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 1.9 mm -106.09 149.49 9.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.275 -178.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.71 -141.4 19.5 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.369 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.427 ' O ' ' CG ' ' A' ' 64' ' ' PRO . 0.9 OUTLIER -74.04 -172.94 1.47 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.903 0.383 . . . . 0.0 110.79 179.53 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.401 ' HB3' HD22 ' A' ' 41' ' ' LEU . 4.8 p -161.69 22.73 0.12 Allowed 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.392 -179.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 1.1 mtpt -153.31 125.47 7.98 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -177.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.45 ' CB ' ' HA ' ' A' ' 62' ' ' GLU . 0.3 OUTLIER -94.61 145.43 24.84 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.092 178.111 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.501 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 1.8 m-85 -120.89 120.5 35.7 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 119.315 -0.954 . . . . 0.0 111.797 178.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 26.5 t -68.74 117.66 10.73 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.156 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -156.61 -179.45 8.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.992 179.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.4 ' CB ' ' O ' ' A' ' 56' ' ' SER . 4.6 pp -94.09 158.42 15.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.656 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.417 ' O ' ' N ' ' A' ' 54' ' ' THR . . . -155.41 -56.25 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.012 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.42 ' CB ' ' HB2' ' A' ' 56' ' ' SER . 0.1 OUTLIER -63.27 77.18 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.99 0.424 . . . . 0.0 111.22 -178.943 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.417 ' N ' ' O ' ' A' ' 52' ' ' GLY . 2.5 p 51.14 27.28 3.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.124 179.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 121.56 -17.8 8.83 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.535 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.42 ' HB2' ' CB ' ' A' ' 53' ' ' SER . 6.6 t -57.49 -159.56 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.916 0.389 . . . . 0.0 110.998 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.87 140.06 49.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.87 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.1 m -149.28 -176.09 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.541 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.533 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 69.7 m95 -131.48 124.96 31.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.988 0.423 . . . . 0.0 111.261 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.501 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 4.8 m-20 -68.4 166.61 24.03 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.439 178.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.471 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 49.3 Cg_exo -12.63 86.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.008 1 C-N-CA 125.361 4.041 . . . . 0.0 114.211 -178.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.496 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.5 OUTLIER -90.26 -76.58 0.42 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.723 -176.236 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.498 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -94.22 108.23 34.51 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -173.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.427 ' CG ' ' O ' ' A' ' 44' ' ' GLU . 2.3 Cg_endo -81.41 -154.34 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.189 2.592 . . . . 0.0 110.368 175.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.438 ' CD1' ' HB ' ' A' ' 42' ' ' ILE . 1.0 OUTLIER -93.19 175.2 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.602 177.767 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -171.46 144.31 1.92 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.609 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.417 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 1.3 tt0 -166.73 175.08 8.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.86 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.53 ' CB ' ' CE2' ' A' ' 39' ' ' TYR . 0.2 OUTLIER -99.41 123.4 43.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.658 178.944 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.428 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 1.4 p -45.27 92.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.093 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 68' ' ' SER . 2.4 mmtp -63.99 131.95 49.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.199 -177.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.12 121.0 40.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.62 177.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.3 -159.5 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.655 -179.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.465 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 2.7 t -51.33 139.67 25.9 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.589 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.418 ' HA ' ' CD1' ' A' ' 118' ' ' TRP . 26.4 Cg_exo -59.22 159.67 21.81 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.201 1.934 . . . . 0.0 111.918 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.463 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 88.9 Cg_exo -39.79 156.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.934 2.422 . . . . 0.0 113.04 -178.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.1 t -107.97 90.81 3.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.796 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 21.4 pt -69.51 -176.68 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.287 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.6 m -105.25 145.74 30.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.662 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.445 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 7.4 m-80 55.56 28.35 11.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.929 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.471 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -167.52 -163.2 20.99 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.563 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 9.5 ptt180 -170.15 -175.72 2.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.039 0.447 . . . . 0.0 110.971 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.465 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 1.6 p-80 -110.46 168.2 9.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.868 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -92.95 -87.01 0.24 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.636 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 60.69 142.96 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.049 178.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.478 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -113.51 -35.74 5.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.091 0.472 . . . . 0.0 110.587 179.423 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.36 -171.53 2.97 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.819 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.91 -21.9 13.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.14 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.421 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 7.8 m-85 -134.02 172.48 12.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.106 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.421 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 48.6 m-85 -148.11 165.01 32.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.828 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.1 p -134.5 -175.19 3.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.905 0.383 . . . . 0.0 111.462 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.42 ' OD1' ' CG1' ' A' ' 69' ' ' VAL . 0.7 OUTLIER -64.5 98.45 0.25 Allowed 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.31 0.576 . . . . 0.0 111.069 -179.876 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.86 22.29 2.23 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.164 -0.925 . . . . 0.0 113.13 178.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.426 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.6 OUTLIER -103.18 157.25 17.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.908 0.354 . . . . 0.0 110.631 179.167 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 28.6 m -136.39 149.06 27.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.079 0.466 . . . . 0.0 111.173 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.471 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 21.4 t -144.19 147.39 19.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.747 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.31 129.49 54.32 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.778 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.528 ' CE1' ' CG2' ' A' ' 111' ' ' VAL . 5.5 m-85 -88.56 157.07 18.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.115 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 50.2 m -151.3 141.31 22.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.334 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.405 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 74.0 m -71.89 163.12 28.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.979 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.471 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 18.0 m-20 -96.73 -71.46 0.68 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.513 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.0 t -61.58 -22.57 65.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.23 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 122.37 31.29 1.08 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.534 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.493 ' CD2' HG13 ' A' ' 126' ' ' ILE . 24.8 m-85 -69.96 -174.02 0.72 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 120.959 0.409 . . . . 0.0 110.495 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.0 105.87 14.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.359 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.446 ' CD2' ' HA ' ' A' ' 109' ' ' SER . 0.2 OUTLIER -46.44 123.41 4.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.385 0.612 . . . . 0.0 111.419 -178.809 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.458 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 42.6 mm -91.13 152.61 3.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.457 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.67 -130.44 36.91 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.104 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -114.67 138.8 50.25 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.839 0.352 . . . . 0.0 110.774 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.465 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 0.0 OUTLIER -77.23 -30.08 54.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.756 179.906 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.04 127.41 11.02 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.18 178.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.528 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 2.8 t -120.22 121.86 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.65 0.262 . . . . 0.0 110.642 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.75 122.85 27.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.705 -178.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.484 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 25.6 t -88.85 104.13 16.64 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.6 t -145.39 163.81 33.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.163 -178.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 44.9 30.57 2.44 Favored Glycine 0 CA--C 1.518 0.258 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.928 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.428 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 67.14 19.89 70.55 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.42 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -143.56 175.56 9.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.766 0.317 . . . . 0.0 110.561 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.484 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 95.7 m95 -112.33 142.86 44.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.005 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.9 148.08 50.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.257 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.478 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 26.6 t0 71.74 46.72 0.24 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.082 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 95.4 Cg_endo -78.18 134.03 12.6 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.343 2.029 . . . . 0.0 111.4 177.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.465 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 74.0 Cg_endo -88.66 -173.75 0.92 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.525 2.15 . . . . 0.0 113.532 -177.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.435 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -129.75 -163.42 1.3 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.781 177.756 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 5.1 m -151.97 92.06 1.69 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.047 0.451 . . . . 0.0 110.94 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -122.07 158.11 29.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.852 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.493 HG13 ' CD2' ' A' ' 103' ' ' TYR . 13.6 mm . . . . . 0 C--N 1.324 -0.518 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.859 179.576 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.907 0.384 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.34 -175.94 3.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.834 179.754 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.462 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 4.2 m -93.84 162.94 25.6 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.705 179.506 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.409 ' HD3' ' HB2' ' A' ' 9' ' ' CYS . 15.5 Cg_endo -60.1 -163.28 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.316 2.011 . . . . 0.0 111.452 -179.883 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.409 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 0.9 OUTLIER -78.46 104.94 2.34 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.718 -0.219 . . . . 0.0 110.805 179.92 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.498 ' CG ' ' CD1' ' A' ' 22' ' ' ILE . 13.2 Cg_endo -55.97 142.84 84.47 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.123 1.882 . . . . 0.0 111.677 179.461 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -52.19 169.34 0.08 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.467 -179.556 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.489 ' HA ' ' CD1' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -130.02 -5.27 4.47 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -177.149 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.435 HG23 ' CD2' ' A' ' 20' ' ' LEU . 3.0 tt 55.45 157.42 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 122.864 0.466 . . . . 0.0 111.798 -178.264 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -101.78 -47.33 4.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.432 -178.349 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -94.04 38.71 1.08 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.878 -179.633 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.446 ' HA3' ' N ' ' A' ' 36' ' ' ASN . . . 177.84 -166.07 36.07 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.969 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -136.47 177.21 8.03 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.334 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.489 ' CD1' ' HA ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -126.59 151.5 47.89 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.301 0.572 . . . . 0.0 111.411 -179.836 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 32' ' ' THR . 4.2 t70 -116.25 82.67 1.82 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.528 177.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.498 ' CD1' ' CG ' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -77.39 103.12 4.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.392 -176.908 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.67 19.79 52.95 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.756 177.177 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.07 142.09 3.37 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.06 -0.591 . . . . 0.0 111.955 -179.374 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.0 m -128.6 29.64 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.66 0.266 . . . . 0.0 111.492 -178.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -105.69 164.97 11.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.929 0.395 . . . . 0.0 110.838 179.309 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.491 ' CE1' ' HB2' ' A' ' 51' ' ' LEU . 0.8 OUTLIER -59.93 90.59 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.925 -179.738 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 136.31 -2.88 3.58 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.32 179.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.39 -174.56 3.38 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 117.157 0.479 . . . . 0.0 110.771 179.86 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.4 p -156.58 145.22 19.99 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.016 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.529 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.4 OUTLIER -100.79 166.15 2.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.234 179.525 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -127.48 114.95 18.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.827 0.346 . . . . 0.0 110.864 179.654 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.507 ' CG ' ' O ' ' A' ' 62' ' ' GLU . 15.4 m-85 -91.92 149.2 21.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.258 0.551 . . . . 0.0 112.061 -178.386 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 46.0 m -151.44 147.02 26.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.188 178.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.3 m -69.15 167.66 15.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.848 0.356 . . . . 0.0 110.829 -179.351 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.446 ' N ' ' HA3' ' A' ' 18' ' ' GLY . 25.4 m-20 -68.69 -85.76 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.239 -178.317 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.73 134.98 15.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.524 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.92 26.42 72.25 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.771 -178.79 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.482 ' CD2' ' HA ' ' A' ' 68' ' ' SER . 2.1 m-85 -121.41 171.89 8.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.997 0.427 . . . . 0.0 111.179 -179.45 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.527 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.4 OUTLIER -138.26 112.79 8.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.066 177.647 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.433 HD21 ' CB ' ' A' ' 45' ' ' SER . 7.0 tt -75.4 129.93 38.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.856 -178.812 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.527 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 3.0 mm -104.94 157.4 5.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.994 0.426 . . . . 0.0 111.098 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.6 -142.45 31.16 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.05 -179.094 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.424 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -73.0 -172.54 1.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.85 0.357 . . . . 0.0 110.569 179.222 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.433 ' CB ' HD21 ' A' ' 41' ' ' LEU . 0.3 OUTLIER -168.21 30.21 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.534 179.682 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.427 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 25.8 mtpt -151.8 126.02 9.29 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.426 -178.534 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.428 ' OG ' ' CB ' ' A' ' 62' ' ' GLU . 0.3 OUTLIER -93.04 137.47 32.37 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.876 178.819 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.496 ' CD1' ' HB2' ' A' ' 60' ' ' ASN . 1.1 m-85 -114.73 121.77 44.37 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.79 -179.948 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 23.0 t -72.01 117.56 13.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.936 -179.58 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.483 ' HA ' ' CE2' ' A' ' 27' ' ' PHE . 4.6 mt-10 -146.16 -179.47 6.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.034 179.476 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.491 ' HB2' ' CE1' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -94.46 143.15 26.66 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.912 -179.673 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -63.21 -125.47 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.368 179.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.8 t -123.0 -34.22 3.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.767 0.318 . . . . 0.0 111.263 -179.723 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.73 24.77 3.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.242 -179.516 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.56 18.58 61.73 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.679 179.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.1 t -95.3 -161.7 0.88 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.785 0.326 . . . . 0.0 111.059 179.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.409 ' O ' ' CG1' ' A' ' 58' ' ' VAL . 3.2 mmt -119.37 159.33 24.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.6 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.409 ' CG1' ' O ' ' A' ' 57' ' ' MET . 2.7 m -163.38 173.95 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.204 -179.484 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.529 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 74.1 m95 -129.25 125.22 36.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.138 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.496 ' HB2' ' CD1' ' A' ' 48' ' ' TYR . 0.7 OUTLIER -69.33 166.06 33.47 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.761 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.48 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 65.7 Cg_exo -11.49 101.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.003 1 C-N-CA 125.647 4.231 . . . . 0.0 114.634 -179.187 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.507 ' O ' ' CG ' ' A' ' 33' ' ' TYR . 0.7 OUTLIER -101.71 -71.1 0.72 Allowed 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 115.159 -0.928 . . . . 0.0 113.159 -175.416 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -102.98 76.93 0.23 Allowed Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -174.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.427 ' HD2' ' O ' ' A' ' 62' ' ' GLU . 33.3 Cg_endo -55.39 -154.42 0.0 OUTLIER 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 123.249 2.633 . . . . 0.0 111.766 176.015 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.408 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 6.8 mm -86.97 166.42 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.964 0.412 . . . . 0.0 111.282 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.1 m -165.34 125.86 1.89 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.762 178.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.16 171.74 13.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.918 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.482 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 96.4 p -84.89 118.53 24.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.552 -179.568 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 116' ' ' GLY . 0.2 OUTLIER -49.98 99.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.036 178.876 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -62.85 138.95 58.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.188 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.419 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -123.18 126.59 47.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.636 179.588 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -74.57 -168.59 0.71 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.841 179.498 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -41.25 133.38 1.98 Allowed Pre-proline 0 N--CA 1.438 -1.056 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.684 179.364 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.479 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 31.8 Cg_exo -57.82 162.9 10.08 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.378 2.052 . . . . 0.0 112.391 -178.704 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.494 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 85.6 Cg_exo -41.32 160.5 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.879 2.386 . . . . 0.0 113.135 -179.469 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.81 89.61 3.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.642 179.399 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.5 pt -69.35 171.99 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.407 -179.025 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.7 m -88.44 141.36 28.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.705 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.418 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 6.2 m-80 57.22 29.46 16.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.926 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.465 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -169.71 -172.52 36.36 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.81 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 9.4 ptt180 -166.69 -175.61 3.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.92 0.39 . . . . 0.0 110.59 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.47 ' CD2' ' O ' ' A' ' 74' ' ' PRO . 16.1 p80 -109.36 167.86 9.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.637 -179.053 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 41.7 p-10 -122.66 -157.92 0.76 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.072 178.435 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 134.81 175.33 13.81 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.297 -0.954 . . . . 0.0 112.783 179.453 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.08 -27.15 8.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.04 0.448 . . . . 0.0 110.744 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.74 -175.72 2.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.354 -179.024 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.55 -25.57 11.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.494 178.654 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.42 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 5.1 m-85 -125.14 178.93 5.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.452 179.112 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.42 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 85.9 m-85 -153.62 169.02 24.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.825 -179.232 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.5 p -131.1 179.67 5.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.932 0.396 . . . . 0.0 111.524 -179.059 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 44.6 p-10 -63.67 95.06 0.1 Allowed 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.354 0.597 . . . . 0.0 111.09 -179.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.61 27.95 1.37 Allowed Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.21 -0.905 . . . . 0.0 112.865 179.084 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.52 160.79 15.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.672 0.273 . . . . 0.0 110.458 179.047 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 34.4 m -134.16 155.89 40.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.153 0.501 . . . . 0.0 111.389 -179.657 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.513 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 19.5 t -148.71 148.59 15.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.367 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.29 119.67 40.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.178 0.513 . . . . 0.0 111.12 -179.331 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.515 ' CE2' ' CG2' ' A' ' 111' ' ' VAL . 3.5 m-85 -77.06 164.55 25.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.766 -178.477 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.429 ' HA ' ' CD1' ' A' ' 105' ' ' LEU . 0.7 OUTLIER -155.35 135.35 12.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.671 -179.259 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 61.1 m -69.78 157.52 37.19 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.765 178.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.465 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 78.1 m-20 -85.82 -76.74 0.32 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.426 -179.349 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.7 t -59.02 -26.53 64.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.831 0.348 . . . . 0.0 111.184 -179.345 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 124.39 35.85 0.64 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.402 -179.724 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.418 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 14.3 m-85 -69.58 -174.0 0.65 Allowed 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 120.876 0.37 . . . . 0.0 110.618 179.853 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.5 m -111.9 99.68 8.31 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.181 179.122 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.461 ' CD2' ' HA ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -48.02 144.35 3.7 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.736 0.779 . . . . 0.0 111.682 -177.615 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.475 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 40.5 mm -117.73 159.91 17.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.913 -177.534 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.416 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 51.49 24.69 11.88 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.171 -1.014 . . . . 0.0 112.581 179.728 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 61.04 135.04 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.191 0.52 . . . . 0.0 111.79 178.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.466 ' HA ' ' HG2' ' A' ' 122' ' ' PRO . 1.1 p -62.14 -28.68 69.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.885 -178.776 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -53.44 127.4 36.66 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.883 -179.259 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.515 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 3.1 t -128.11 150.38 33.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 178.72 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.1 129.52 54.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.854 0.359 . . . . 0.0 111.539 -179.201 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.498 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 44.3 t -92.63 106.01 18.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.526 176.228 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.6 t -153.74 164.32 38.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.011 0.434 . . . . 0.0 111.206 -178.425 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 45.25 33.21 3.96 Favored Glycine 0 CA--C 1.518 0.254 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.858 179.604 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.422 ' N ' HG12 ' A' ' 69' ' ' VAL . . . 65.42 19.0 66.17 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.42 -179.641 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -146.89 -176.85 5.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.877 0.37 . . . . 0.0 110.778 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.513 ' CH2' ' CG2' ' A' ' 95' ' ' VAL . 88.8 m95 -118.49 122.96 43.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.95 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.46 147.12 28.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.111 -179.366 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.514 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER 71.85 41.95 0.18 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.489 179.192 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 53.3 Cg_endo -68.69 145.98 65.32 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 121.993 1.796 . . . . 0.0 111.014 177.88 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.475 ' CB ' ' O ' ' A' ' 106' ' ' ILE . 73.3 Cg_endo -96.49 -173.58 0.23 Allowed 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.521 2.147 . . . . 0.0 113.938 -177.096 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.436 HG22 ' NE2' ' A' ' 125' ' ' GLN . 0.2 OUTLIER -132.9 172.2 12.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.446 -1.252 . . . . 0.0 109.195 177.868 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 1.9 m -130.18 91.77 3.17 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.095 0.474 . . . . 0.0 110.433 178.659 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.436 ' NE2' HG22 ' A' ' 123' ' ' THR . 1.3 mp0 -117.11 -179.39 3.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.369 -178.351 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 43.6 mm . . . . . 0 C--N 1.321 -0.645 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.02 -179.462 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.866 0.365 . . . . 0.0 110.956 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.46 ' CB ' ' HA ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -93.93 168.98 10.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.22 -179.734 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.524 ' HB2' ' CD ' ' A' ' 10' ' ' PRO . 76.6 m -78.47 176.77 3.31 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.645 178.861 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.529 ' HD2' ' CD1' ' A' ' 59' ' ' TRP . 36.8 Cg_endo -92.21 178.71 1.46 Allowed 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 122.75 2.3 . . . . 0.0 112.21 -179.281 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.7 t -48.57 103.82 0.38 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.442 179.12 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.495 ' HG2' ' CZ2' ' A' ' 59' ' ' TRP . 51.2 Cg_exo -48.75 159.65 0.83 Allowed 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.319 2.013 . . . . 0.0 112.751 -178.518 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.444 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 6.2 mtm180 -65.22 -178.43 0.48 Allowed 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.54 177.073 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -141.64 167.2 22.72 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.288 0.566 . . . . 0.0 111.217 -176.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 7.4 tt -119.29 147.94 22.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.438 -179.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -76.53 -58.82 3.06 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -177.671 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -93.87 32.81 1.39 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.191 -177.945 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -156.86 -171.94 23.55 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.364 -179.579 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -145.56 141.86 28.62 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.291 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.537 ' CD2' ' CE2' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -88.06 166.35 14.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.28 0.562 . . . . 0.0 111.775 -179.153 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.3 OUTLIER -133.05 85.3 2.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.726 177.263 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.452 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 53.6 mt -72.83 105.25 2.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -177.174 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.13 20.96 39.11 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.496 176.414 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 154.39 139.27 2.78 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 -179.135 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.7 m -120.52 -8.06 10.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.9 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.46 ' HA ' ' CB ' ' A' ' 8' ' ' ARG . 25.5 t0 -69.28 164.67 22.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.169 0.509 . . . . 0.0 111.402 -178.816 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.455 ' CZ ' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -53.39 119.09 4.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.512 179.751 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.65 -3.9 61.31 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.507 -178.628 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.7 m -70.44 174.21 6.01 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 116.951 0.376 . . . . 0.0 110.592 179.553 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.7 p -148.02 149.22 31.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.108 -179.717 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.477 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -115.6 171.31 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.628 -179.92 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 21' ' ' ASP . 1.4 m -130.83 118.35 20.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.914 0.388 . . . . 0.0 111.091 179.733 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.537 ' CE2' ' CD2' ' A' ' 20' ' ' LEU . 10.0 m-85 -95.76 138.92 32.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.579 -179.212 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 22.6 m -142.73 157.23 44.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.757 179.416 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.5 m -76.94 170.15 17.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.706 0.289 . . . . 0.0 110.748 179.742 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -65.47 -84.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.968 -179.538 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.0 t -157.32 133.5 9.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.728 179.713 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.93 23.71 72.8 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.054 -179.095 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.501 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.5 m-85 -115.27 -178.25 3.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.933 0.397 . . . . 0.0 110.96 -179.803 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.517 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.4 OUTLIER -141.98 111.63 6.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.882 177.511 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.448 HD21 ' HB3' ' A' ' 45' ' ' SER . 5.3 tt -78.14 127.2 31.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.713 -178.722 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.517 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 2.4 mm -103.72 149.7 7.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.041 0.448 . . . . 0.0 110.975 -179.592 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.66 -131.72 10.88 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.304 -179.15 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.417 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -89.61 -176.55 5.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.771 0.32 . . . . 0.0 110.71 179.686 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.448 ' HB3' HD21 ' A' ' 41' ' ' LEU . 4.3 p -161.26 25.22 0.13 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.049 -179.245 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -153.24 129.65 10.61 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.113 0.483 . . . . 0.0 111.218 -179.171 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -103.38 150.71 23.55 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.0 179.654 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.467 ' CB ' ' HB3' ' A' ' 60' ' ' ASN . 1.9 m-85 -127.04 121.55 31.89 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 119.191 -1.004 . . . . 0.0 113.094 -177.806 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.417 ' HB3' ' CH2' ' A' ' 59' ' ' TRP . 25.4 t -70.16 97.63 1.23 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.258 177.65 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.499 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 2.1 tt0 -131.13 171.92 12.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.448 0.642 . . . . 0.0 111.091 -178.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.499 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -74.36 153.05 39.45 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.347 -179.237 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.5 -126.97 1.51 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.704 -179.833 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.4 t -107.95 -40.81 5.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.73 0.3 . . . . 0.0 111.149 -179.444 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 71.0 p -93.95 36.37 1.12 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.039 -179.742 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.76 19.63 71.52 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.622 179.834 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.35 -161.35 0.69 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.821 0.343 . . . . 0.0 110.782 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.55 143.24 47.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.295 -179.938 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.407 ' N ' ' O ' ' A' ' 50' ' ' GLU . 2.2 m -153.65 -176.94 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.047 -179.422 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.529 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 75.4 m95 -128.83 126.14 39.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.664 -179.285 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.467 ' HB3' ' CB ' ' A' ' 48' ' ' TYR . 2.1 m120 -69.46 164.45 49.54 Favored Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.772 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.48 ' O ' ' HA ' ' A' ' 47' ' ' SER . 67.3 Cg_exo -11.88 121.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 1.003 1 C-N-CA 125.8 4.333 . . . . 0.0 115.309 -175.948 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.512 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 4.9 mm-40 -110.25 -79.78 0.58 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.77 -1.105 . . . . 0.0 113.791 -174.35 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -101.95 79.24 0.25 Allowed Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -174.477 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.433 ' HD2' ' O ' ' A' ' 62' ' ' GLU . 30.7 Cg_endo -54.67 -154.35 0.0 OUTLIER 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.335 2.69 . . . . 0.0 111.811 175.822 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.413 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 5.4 mm -91.15 166.34 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.944 0.402 . . . . 0.0 111.259 -179.879 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -168.98 134.96 1.69 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.451 179.404 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -152.96 171.24 18.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.883 0.373 . . . . 0.0 111.02 -179.828 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.501 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 1.6 p -83.97 130.92 34.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.156 0.503 . . . . 0.0 111.364 -179.37 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.448 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 4.3 m -46.68 100.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.545 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 89' ' ' TYR . 1.4 mmtt -86.91 100.2 12.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.229 179.621 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.421 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -87.57 121.32 29.84 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 177.652 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.454 ' CG ' ' N ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -68.85 -154.13 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -179.848 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.454 ' N ' ' CG ' ' A' ' 72' ' ' GLN . 1.8 t -51.49 148.11 9.74 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-O 120.676 0.274 . . . . 0.0 111.119 -179.318 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.481 ' HD2' ' CD2' ' A' ' 82' ' ' HIS . 12.2 Cg_exo -68.74 157.19 62.87 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.737 2.291 . . . . 0.0 111.909 179.538 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.492 ' HD2' ' CG ' ' A' ' 118' ' ' TRP . 83.0 Cg_exo -44.53 162.03 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.687 2.258 . . . . 0.0 112.741 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 69.4 m -116.63 89.21 3.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.658 179.463 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.6 pt -69.17 176.89 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.274 -179.255 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.3 t -89.81 150.93 22.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.659 179.037 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.488 ' HB3' ' CD2' ' A' ' 103' ' ' TYR . 1.2 m-80 48.74 27.47 1.55 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.277 178.111 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.467 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -166.23 -164.95 22.76 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.776 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.7 ptt180 -170.23 -174.68 1.78 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.923 0.392 . . . . 0.0 110.667 -179.414 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.503 ' HB3' ' CE1' ' A' ' 97' ' ' TYR . 8.9 p80 -107.16 165.96 10.98 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.705 -178.844 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.502 ' O ' ' CD1' ' A' ' 85' ' ' TYR . 27.1 m-20 -89.38 -91.04 0.13 Allowed 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.857 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.434 ' O ' ' HB3' ' A' ' 85' ' ' TYR . . . 37.31 -87.04 0.01 OUTLIER Glycine 0 C--N 1.338 0.671 0 N-CA-C 114.134 0.414 . . . . 0.0 114.134 177.439 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.502 ' CD1' ' O ' ' A' ' 83' ' ' ASN . 22.6 m-85 72.89 29.39 1.87 Allowed 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 123.745 0.818 . . . . 0.0 110.177 -179.573 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.41 ' HB3' ' CZ ' ' A' ' 89' ' ' TYR . 0.4 OUTLIER -101.28 -171.02 1.92 Allowed 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.069 178.286 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -109.01 -27.32 9.71 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.013 0.435 . . . . 0.0 110.64 178.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.442 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 11.8 m-85 -153.01 162.86 40.82 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.817 179.824 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.442 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 6.8 m-85 -140.62 166.42 24.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.101 -179.445 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 16.6 p -130.79 175.59 8.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.015 0.436 . . . . 0.0 111.829 -178.46 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.423 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 0.7 OUTLIER -62.88 99.69 0.17 Allowed 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.619 0.724 . . . . 0.0 110.659 179.68 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 125.24 12.86 3.72 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 114.601 -1.181 . . . . 0.0 113.055 179.007 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.438 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -89.04 161.02 16.79 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 117.179 0.49 . . . . 0.0 110.017 178.501 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 20.7 m -150.54 131.16 4.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.11 0.481 . . . . 0.0 110.982 -179.295 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.429 HG11 ' CG ' ' A' ' 74' ' ' PRO . 2.0 p -130.74 143.73 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.698 -179.186 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.41 ' O ' ' HB2' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -94.56 128.61 41.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.365 0.602 . . . . 0.0 111.376 -178.869 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.541 ' CE1' ' CG2' ' A' ' 111' ' ' VAL . 3.1 m-85 -84.36 163.81 19.33 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.298 -179.456 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 89.4 p -153.75 133.42 12.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.768 -178.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.414 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 81.9 m -69.84 159.36 33.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.544 178.629 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.467 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 74.0 m-80 -93.65 -79.1 0.42 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.653 -178.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.55 -31.64 25.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.847 0.356 . . . . 0.0 111.277 -179.106 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 130.65 38.87 0.28 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.446 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.49 ' CE1' HG13 ' A' ' 126' ' ' ILE . 23.9 m-85 -78.66 -172.77 3.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.836 0.35 . . . . 0.0 110.757 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.66 113.97 26.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.494 179.344 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.441 ' CD2' ' HA ' ' A' ' 109' ' ' SER . 1.1 mp -53.51 115.17 1.8 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.006 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.47 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 34.5 mm -99.85 162.11 3.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.856 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.406 ' N ' ' CG2' ' A' ' 106' ' ' ILE . . . 52.64 28.59 30.39 Favored Glycine 0 CA--C 1.508 -0.357 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.541 179.245 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 60.31 128.8 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.935 -0.633 . . . . 0.0 111.465 179.44 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.455 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 1.3 p -60.28 -29.45 68.82 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.81 -178.747 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.76 136.88 49.98 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.908 -178.753 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.541 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 4.0 t -133.31 119.36 35.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 110.439 -0.208 . . . . 0.0 110.439 179.369 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.07 124.09 29.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.952 0.406 . . . . 0.0 111.474 -178.714 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.438 ' HB3' ' HB2' ' A' ' 93' ' ' SER . 10.3 t -88.55 108.09 19.24 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.722 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 52.7 p -155.89 166.41 33.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.189 0.519 . . . . 0.0 111.524 -178.157 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.87 31.99 5.8 Favored Glycine 0 CA--C 1.518 0.279 0 CA-C-N 115.594 -0.73 . . . . 0.0 113.199 179.133 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.448 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 68.61 14.23 66.91 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.569 -179.881 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -147.15 171.63 15.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.016 0.436 . . . . 0.0 110.812 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.492 ' CG ' ' HD2' ' A' ' 75' ' ' PRO . 90.7 m95 -103.61 127.22 51.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.56 179.599 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.98 150.9 28.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.312 -179.037 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.492 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER 69.32 44.2 0.25 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.151 178.919 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.492 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 59.2 Cg_endo -72.64 140.62 32.95 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.154 1.903 . . . . 0.0 111.373 178.372 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.486 ' HG2' ' CD2' ' A' ' 97' ' ' TYR . 96.4 Cg_endo -91.73 -169.73 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.643 2.228 . . . . 0.0 113.98 -177.281 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.41 -159.91 1.0 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.391 -1.277 . . . . 0.0 109.743 178.22 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . 0.422 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 10.2 m -156.5 89.63 1.12 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.068 0.461 . . . . 0.0 110.709 179.033 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -122.69 158.4 30.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.034 -178.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.49 HG13 ' CE1' ' A' ' 103' ' ' TYR . 18.5 mm . . . . . 0 C--N 1.324 -0.536 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.958 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.805 0.336 . . . . 0.0 110.938 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.64 -174.84 2.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.801 179.617 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.46 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 14.7 m -94.75 162.09 26.56 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.04 -179.576 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.411 ' HD3' ' HB2' ' A' ' 9' ' ' CYS . 40.2 Cg_endo -67.77 -168.71 0.2 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.605 2.203 . . . . 0.0 112.261 -179.487 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.1 t -67.47 110.83 5.91 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.019 -179.54 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -52.29 132.36 43.85 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.182 1.921 . . . . 0.0 112.161 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.424 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.6 OUTLIER -53.47 161.71 0.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.515 179.248 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -108.37 -176.71 3.12 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.528 -178.138 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 14.1 tt -146.69 147.96 17.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.942 -179.624 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.43 160.43 15.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.379 -0.373 . . . . 0.0 109.998 178.535 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.473 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 0.2 OUTLIER 47.21 26.6 0.7 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.766 -179.743 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.44 ' HA2' ' N ' ' A' ' 36' ' ' ASN . . . -153.83 -168.07 16.95 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.846 -179.152 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.64 135.42 15.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.806 0.336 . . . . 0.0 111.071 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.478 HD21 ' CE1' ' A' ' 33' ' ' TYR . 8.6 mt -75.17 160.22 30.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.595 -179.746 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.428 ' HB2' ' CB ' ' A' ' 32' ' ' THR . 1.1 t0 -135.39 71.96 1.44 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.774 177.847 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.434 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 18.4 mt -75.09 112.97 13.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.224 -177.437 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -107.48 16.15 37.97 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.628 176.383 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 153.94 136.93 2.37 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.823 -179.31 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.3 m -120.39 29.94 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -178.341 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.83 154.59 18.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.828 0.347 . . . . 0.0 111.002 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.472 ' CE1' ' HB2' ' A' ' 51' ' ' LEU . 10.0 t80 -48.67 108.87 0.2 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.96 -4.98 34.13 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.663 -178.76 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.9 p -69.63 -164.49 0.07 Allowed 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.738 0.304 . . . . 0.0 110.681 179.762 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.3 p -167.02 143.26 4.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.022 0.439 . . . . 0.0 111.225 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.557 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.9 OUTLIER -112.0 174.17 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.497 179.959 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.428 ' CB ' ' HB2' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -135.5 113.11 10.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.948 0.404 . . . . 0.0 110.79 179.319 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.494 ' CE1' ' HA ' ' A' ' 63' ' ' ALA . 26.2 m-85 -88.92 137.09 32.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.935 -179.558 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.6 m -144.19 156.76 44.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.373 -179.085 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 59.4 m -84.05 166.23 17.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.948 179.74 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.44 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 3.3 m-20 -66.14 -86.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.23 -178.826 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.4 t -151.9 134.67 15.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.871 0.367 . . . . 0.0 110.873 -179.743 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.42 21.99 70.93 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.233 -179.468 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.478 ' CE1' ' HB2' ' A' ' 68' ' ' SER . 2.5 m-30 -114.22 -176.96 3.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.824 0.345 . . . . 0.0 110.832 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.463 ' CD2' ' O ' ' A' ' 40' ' ' HIS . 0.3 OUTLIER -147.92 112.87 5.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.632 178.876 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.431 ' CD2' ' O ' ' A' ' 44' ' ' GLU . 3.1 tt -73.84 131.85 41.94 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.494 -179.782 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.401 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 3.9 mm -103.35 153.83 5.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.975 -179.637 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.72 -133.59 13.3 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.385 -179.514 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.431 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -80.57 174.94 11.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.712 0.292 . . . . 0.0 110.65 179.408 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.29 27.0 0.41 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.408 178.987 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.412 ' O ' ' HD3' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -159.98 121.42 3.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.669 -178.968 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.409 ' HB2' HG12 ' A' ' 31' ' ' ILE . 47.9 t -92.84 157.21 16.5 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.513 179.322 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.494 ' CE1' ' HD2' ' A' ' 61' ' ' PRO . 4.0 m-85 -129.48 110.97 12.3 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.202 0.525 . . . . 0.0 111.648 -179.789 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.486 ' HB3' ' CH2' ' A' ' 59' ' ' TRP . 23.9 t -60.58 84.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.259 178.934 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -97.94 -171.64 2.21 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.995 -178.814 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.472 ' HB2' ' CE1' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -108.17 136.2 48.24 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.242 -179.234 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 56' ' ' SER . . . -125.38 -172.86 13.53 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.939 179.226 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.9 t 47.52 27.59 1.01 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.969 0.414 . . . . 0.0 111.084 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 p 78.15 -53.55 0.5 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.422 -179.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -131.5 41.22 1.54 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.616 -179.591 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 52' ' ' GLY . 9.1 t -125.69 -168.24 1.81 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.862 0.363 . . . . 0.0 110.991 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.21 144.63 47.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.329 179.574 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.5 m -153.64 179.69 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.302 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.557 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 95.7 m95 -123.58 123.7 41.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.817 -179.847 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.5 m-20 -148.23 126.82 6.08 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.32 -179.485 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.494 ' HD2' ' CE1' ' A' ' 48' ' ' TYR . 2.9 Cg_exo -76.09 -167.45 5.84 Favored 'Cis proline' 0 C--N 1.35 0.656 0 C-N-CA 124.226 -1.156 . . . . 0.0 112.057 -0.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -110.74 -154.2 0.53 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.945 -179.434 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.494 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -69.61 111.21 8.13 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.911 179.863 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.402 ' HG2' ' HG2' ' A' ' 44' ' ' GLU . 15.3 Cg_exo -69.78 -150.55 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.627 2.218 . . . . 0.0 112.372 -179.165 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 41' ' ' LEU . 6.3 mm -98.45 166.44 2.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.371 -179.07 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.1 m -164.54 126.66 2.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.476 179.296 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.472 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -153.18 178.24 9.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.913 0.387 . . . . 0.0 111.267 -179.081 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.478 ' HB2' ' CE1' ' A' ' 39' ' ' TYR . 27.5 p -90.6 116.12 28.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.746 179.317 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.447 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 2.1 p -43.38 96.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.553 -179.804 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.4 ' HD3' ' HB2' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -78.01 120.64 23.14 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.615 -178.928 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.91 125.33 50.24 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.98 178.245 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -69.47 -158.87 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.429 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.428 ' OG ' ' NE2' ' A' ' 82' ' ' HIS . 1.3 t -54.1 143.39 43.52 Favored Pre-proline 0 N--CA 1.45 -0.442 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 179.612 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.461 ' HD2' ' CD2' ' A' ' 82' ' ' HIS . 25.2 Cg_exo -59.97 159.74 24.5 Favored 'Trans proline' 0 CA--C 1.528 0.207 0 C-N-CA 122.429 2.086 . . . . 0.0 112.092 -179.254 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.49 ' HD2' ' CG ' ' A' ' 118' ' ' TRP . 87.3 Cg_exo -46.56 156.44 0.6 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.762 2.308 . . . . 0.0 113.0 -178.856 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 12.8 t -108.06 91.5 3.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.301 178.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.2 pt -69.03 171.48 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.267 -178.905 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.9 p -89.13 135.17 33.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.021 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.471 ' N ' ' ND2' ' A' ' 79' ' ' ASN . 0.1 OUTLIER 67.41 26.49 8.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.688 179.503 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.415 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -166.67 -163.39 20.32 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.106 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.3 ptt85 -170.29 -175.51 1.96 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.992 0.425 . . . . 0.0 110.982 -179.16 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.461 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 9.0 p-80 -115.99 168.02 10.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.854 179.661 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -93.07 -88.66 0.21 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.895 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 61.06 137.04 0.01 OUTLIER Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.903 179.423 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -111.26 -26.52 9.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.957 0.408 . . . . 0.0 110.714 179.384 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -92.91 -171.83 2.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.786 179.785 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -106.09 -22.08 12.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.135 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.432 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 6.4 m-85 -139.56 170.19 16.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.162 -179.449 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.432 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 24.6 m-85 -144.32 165.57 27.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.95 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 17.0 p -125.01 -179.66 4.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.128 -179.569 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -67.06 95.36 0.39 Allowed 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.389 0.614 . . . . 0.0 110.933 -179.826 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 128.2 31.23 0.69 Allowed Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.132 -0.94 . . . . 0.0 112.93 179.177 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -110.27 164.16 12.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.689 0.28 . . . . 0.0 110.686 179.476 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 32.5 m -140.55 148.16 22.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.1 0.476 . . . . 0.0 111.276 -179.795 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.464 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 21.7 t -145.08 147.87 18.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.676 179.191 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.439 ' CG2' ' OG ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -101.49 137.05 40.33 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 -179.756 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.537 ' CE1' ' CG2' ' A' ' 111' ' ' VAL . 3.8 m-85 -97.58 157.3 16.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.169 -179.313 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 84.5 p -149.44 140.9 23.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.397 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 73.0 m -70.78 159.02 35.31 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 179.603 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.415 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 17.7 m-20 -92.58 -70.88 0.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.54 -178.808 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.13 -22.1 66.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.368 -179.191 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.29 30.92 1.23 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.604 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.488 ' CE2' HG13 ' A' ' 126' ' ' ILE . 21.9 m-85 -69.71 -175.6 0.9 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.973 0.416 . . . . 0.0 110.754 179.634 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -111.2 104.35 12.85 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.787 177.617 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.442 HD21 ' CB ' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -47.77 129.62 14.17 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.531 0.681 . . . . 0.0 111.799 -177.422 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.438 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 38.1 mm -93.33 158.86 2.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.888 178.726 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.02 -125.83 35.4 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.306 -0.95 . . . . 0.0 111.977 -178.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -129.5 134.89 48.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.812 0.339 . . . . 0.0 111.063 179.526 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.439 ' OG ' ' CG2' ' A' ' 96' ' ' THR . 10.2 p -60.63 -32.26 71.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.115 0.483 . . . . 0.0 110.655 179.286 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -70.63 127.68 16.66 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.795 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.537 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 8.8 t -121.29 124.05 71.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 178.938 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.38 126.16 31.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.007 0.432 . . . . 0.0 111.879 -177.747 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.486 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 30.3 t -94.83 91.72 6.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.739 177.452 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -129.46 156.84 43.47 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.036 0.446 . . . . 0.0 111.687 -177.892 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.422 ' CA ' HG11 ' A' ' 69' ' ' VAL . . . 46.98 27.7 3.57 Favored Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.856 179.477 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.447 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 77.81 -1.22 68.67 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.811 -179.524 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -123.8 157.45 34.06 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.895 0.379 . . . . 0.0 110.553 179.602 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.49 ' CG ' ' HD2' ' A' ' 75' ' ' PRO . 94.4 m95 -96.41 137.98 34.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.027 -179.654 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 34.0 t -121.82 177.87 5.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.525 0.678 . . . . 0.0 111.478 179.292 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.432 ' N ' ' HD3' ' A' ' 121' ' ' PRO . 1.3 p-10 42.74 50.57 5.69 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.951 -179.521 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.432 ' HD3' ' N ' ' A' ' 120' ' ' ASP . 84.6 Cg_endo -83.25 141.7 10.39 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.642 2.228 . . . . 0.0 112.05 178.975 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.442 ' CB ' HD21 ' A' ' 105' ' ' LEU . 94.7 Cg_endo -91.56 -171.17 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.781 2.321 . . . . 0.0 113.554 -178.733 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.422 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -135.68 -157.94 0.83 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.616 -1.174 . . . . 0.0 109.884 178.601 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 8.6 m -156.6 89.92 1.13 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.077 0.465 . . . . 0.0 110.967 179.065 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -121.39 160.53 23.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.935 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.488 HG13 ' CE2' ' A' ' 103' ' ' TYR . 18.4 mm . . . . . 0 C--N 1.324 -0.518 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.911 179.494 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.79 0.329 . . . . 0.0 110.979 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 26' ' ' ASP . 0.1 OUTLIER 41.82 -165.32 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.957 178.981 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.439 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 18.9 m -114.68 159.53 36.8 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.76 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.64 168.59 19.55 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.393 2.062 . . . . 0.0 111.516 179.317 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.1 p -52.59 119.73 16.35 Favored Pre-proline 0 C--N 1.326 -0.447 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.887 -179.204 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.409 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 18.4 Cg_endo -57.79 150.3 63.49 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.55 2.167 . . . . 0.0 112.013 179.739 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.02 136.81 50.76 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.296 0.57 . . . . 0.0 110.701 179.489 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -78.4 -177.38 5.21 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.104 -176.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.4 HG23 ' CD2' ' A' ' 20' ' ' LEU . 18.4 tt -145.75 148.49 17.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.095 -179.637 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.82 162.27 14.17 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.335 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.44 ' N ' ' ND2' ' A' ' 17' ' ' ASN . 0.4 OUTLIER 47.26 27.65 0.89 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.947 0.403 . . . . 0.0 110.586 -179.404 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -175.45 173.79 46.44 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.921 -0.582 . . . . 0.0 112.287 -179.355 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.412 ' N ' ' O ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -136.77 156.94 47.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.729 0.3 . . . . 0.0 110.694 -179.856 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.479 HD23 ' CE1' ' A' ' 33' ' ' TYR . 0.2 OUTLIER -91.11 166.6 12.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.044 0.449 . . . . 0.0 110.976 179.188 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 32' ' ' THR . 15.2 t70 -129.97 78.83 1.87 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.052 178.196 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.443 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 42.5 mt -69.2 118.31 13.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.206 0.527 . . . . 0.0 112.056 -177.237 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -131.66 19.7 4.71 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.747 177.57 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 161.23 114.69 0.34 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 121.148 -0.549 . . . . 0.0 111.963 -179.475 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.7 m -113.58 30.4 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.683 0.278 . . . . 0.0 111.557 -178.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.408 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 15.0 t70 -101.55 163.5 12.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.959 0.409 . . . . 0.0 111.158 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.527 ' CZ ' ' CD1' ' A' ' 51' ' ' LEU . 7.8 t80 -60.83 89.45 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.852 -179.892 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.67 10.92 3.44 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.159 179.47 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.1 m -95.43 -160.47 0.79 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 117.039 0.419 . . . . 0.0 110.453 179.258 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 47' ' ' SER . 3.9 p -168.74 141.08 2.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.054 0.454 . . . . 0.0 111.367 179.488 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.53 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.9 OUTLIER -100.87 170.58 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.317 179.444 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.456 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -132.87 110.33 10.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.931 0.396 . . . . 0.0 111.153 179.65 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.483 ' CD1' ' HA ' ' A' ' 63' ' ' ALA . 10.6 m-85 -86.03 156.91 20.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.779 -178.886 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 19' ' ' GLN . 66.5 m -156.02 150.94 26.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.94 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 14.3 m -76.42 171.08 15.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.974 179.88 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 17' ' ' ASN . 1.4 t-20 -65.35 -76.95 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.061 -179.656 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.93 136.28 5.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.942 -179.704 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 60.39 23.48 60.27 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.063 -179.428 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.488 ' CE1' ' HB3' ' A' ' 68' ' ' SER . 2.4 m-85 -111.35 -176.62 2.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.802 0.334 . . . . 0.0 110.72 -179.539 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.525 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.3 OUTLIER -142.44 113.24 7.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.544 178.45 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.441 ' CD1' ' HG3' ' A' ' 64' ' ' PRO . 7.0 tt -79.21 120.7 24.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.68 -179.293 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.525 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 3.0 mm -98.22 162.17 2.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.216 -179.093 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.76 -140.28 28.77 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.339 -179.762 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.435 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 0.1 OUTLIER -72.26 -173.53 1.11 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.837 0.351 . . . . 0.0 110.473 179.015 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.429 ' CB ' HD21 ' A' ' 41' ' ' LEU . 1.1 t -169.66 29.61 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.457 178.909 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.456 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -163.13 117.26 1.65 Allowed 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.066 -177.801 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.44 ' HB2' HG12 ' A' ' 31' ' ' ILE . 0.6 OUTLIER -84.58 133.53 34.43 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.293 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.498 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 1.9 m-85 -110.45 117.71 34.32 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 119.547 -0.861 . . . . 0.0 111.455 179.527 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 33.0 t -72.6 102.36 3.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.753 -179.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.54 -174.3 2.88 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.145 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.527 ' CD1' ' CZ ' ' A' ' 27' ' ' PHE . 5.1 mt -80.39 140.49 36.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.296 -179.449 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.01 -102.89 0.5 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.867 -0.683 . . . . 0.0 112.434 179.604 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.8 t -89.1 50.23 1.91 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.694 0.283 . . . . 0.0 110.827 179.672 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.3 p 79.5 -50.83 0.41 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.332 -179.568 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.92 32.49 5.62 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.587 -0.815 . . . . 0.0 112.715 -179.633 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 5.0 t -135.68 -173.22 3.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.876 0.369 . . . . 0.0 110.98 179.806 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.428 ' O ' ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -119.36 158.17 26.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.554 -179.751 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.428 ' CG1' ' O ' ' A' ' 57' ' ' MET . 2.4 m -165.87 173.6 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.705 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.53 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 75.8 m95 -128.88 122.48 30.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.695 -179.267 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.498 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 0.5 OUTLIER -70.66 167.8 24.78 Favored Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.98 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.478 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 71.6 Cg_exo -17.0 95.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 125.113 3.875 . . . . 0.0 114.387 -179.189 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.424 ' O ' ' HD2' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -96.84 -79.02 0.46 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.179 -177.14 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.483 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . . . -87.94 107.32 15.31 Favored Pre-proline 0 C--N 1.332 -0.189 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -176.506 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.441 ' HG3' ' CD1' ' A' ' 41' ' ' LEU . 1.8 Cg_endo -86.15 -155.88 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.27 2.646 . . . . 0.0 111.444 178.509 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.2 mm -89.75 165.57 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.894 0.378 . . . . 0.0 110.711 178.502 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.1 m -163.05 128.7 3.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.826 179.855 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.478 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -152.81 178.43 9.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.083 -179.652 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.488 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 89.8 p -89.57 117.66 28.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.88 179.591 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.431 ' CG2' ' HB3' ' A' ' 40' ' ' HIS . 2.6 p -44.52 101.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.22 179.754 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.9 mmtt -81.76 125.52 30.74 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.518 -0.764 . . . . 0.0 112.257 -177.623 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -106.86 120.62 42.53 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.733 176.656 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.89 -159.25 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.36 -179.845 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.479 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 2.0 t -54.08 137.81 56.78 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.81 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.471 ' HG3' ' CZ2' ' A' ' 118' ' ' TRP . 52.1 Cg_exo -56.17 162.54 7.37 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.675 2.25 . . . . 0.0 112.211 -179.579 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -43.79 157.05 0.15 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.59 2.193 . . . . 0.0 112.528 -179.454 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.1 t -103.32 90.11 3.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.617 179.585 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 24.5 pt -69.42 168.49 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.188 -179.253 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.96 132.86 39.34 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.882 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.473 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 0.3 OUTLIER 71.18 27.3 3.27 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.76 179.988 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.434 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . -168.36 -168.27 30.21 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.219 179.443 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.84 -175.24 3.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.859 0.361 . . . . 0.0 110.739 -179.231 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.479 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 3.0 p-80 -115.53 166.12 12.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.031 -179.569 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -105.3 -71.42 0.74 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.789 0.328 . . . . 0.0 110.22 179.47 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.435 ' N ' HG11 ' A' ' 95' ' ' VAL . . . 70.93 160.82 3.77 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.167 177.718 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -111.63 -39.39 4.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.095 0.474 . . . . 0.0 110.721 179.369 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -106.45 -174.65 2.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.239 -179.462 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.02 -37.46 14.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.696 177.152 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.436 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 6.2 m-85 -119.54 177.48 4.92 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.643 179.07 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.436 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 43.8 m-85 -146.85 162.47 38.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.204 -178.69 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.3 p -137.08 -177.86 4.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.476 -179.149 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.413 ' OD2' ' CG1' ' A' ' 69' ' ' VAL . 0.4 OUTLIER -59.43 92.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.252 0.549 . . . . 0.0 111.121 -179.625 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.56 26.8 1.55 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.367 -0.833 . . . . 0.0 113.086 178.571 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.412 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -105.83 154.21 20.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.89 0.345 . . . . 0.0 110.634 179.106 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 17.4 m -139.49 138.07 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.261 0.553 . . . . 0.0 111.472 -179.694 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.562 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 21.5 t -137.94 142.22 36.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.812 179.007 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.431 ' N ' HG12 ' A' ' 95' ' ' VAL . 0.1 OUTLIER -93.2 141.67 28.17 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.553 -178.033 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.52 ' CE2' ' CG2' ' A' ' 111' ' ' VAL . 4.7 m-85 -96.57 161.5 13.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.592 179.234 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.1 m -160.27 139.08 10.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.247 -179.752 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.434 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 59.6 m -69.58 164.87 22.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.037 -179.914 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.404 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 0.3 OUTLIER -97.27 -85.66 0.35 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.12 -179.921 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 41.9 t -47.34 -26.4 1.26 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.351 -179.399 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.27 54.25 0.23 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.088 -179.482 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.473 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 15.0 m-85 -93.1 -173.26 3.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.806 0.336 . . . . 0.0 111.286 -178.696 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -109.58 103.63 12.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.113 179.637 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.445 HD22 ' CG ' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -49.99 129.18 20.18 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.515 0.674 . . . . 0.0 111.556 -178.056 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.491 ' CG1' ' HG3' ' A' ' 125' ' ' GLN . 36.9 mm -95.2 157.68 3.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.294 179.431 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.432 ' N ' HG23 ' A' ' 106' ' ' ILE . . . 60.87 -128.91 45.84 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.319 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -120.04 132.47 55.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.791 0.329 . . . . 0.0 111.086 179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.428 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 3.8 p -68.05 -33.09 73.91 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.904 179.597 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -78.3 119.88 5.27 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.784 -179.721 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.52 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 2.7 t -108.3 141.97 22.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.145 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.35 128.14 46.49 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.939 0.4 . . . . 0.0 111.302 -179.18 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.475 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 20.4 t -90.34 106.04 18.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.392 176.717 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 9.0 p -143.1 146.28 33.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.41 -178.379 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 54.05 34.86 53.06 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.746 179.532 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.424 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 67.75 12.44 62.0 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.848 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -138.58 170.17 16.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.918 0.39 . . . . 0.0 110.778 179.659 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.562 ' CH2' ' CG2' ' A' ' 95' ' ' VAL . 95.7 m95 -107.98 151.86 25.25 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.406 -178.802 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.94 148.92 44.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.158 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.471 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.7 OUTLIER 70.94 47.25 0.26 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.994 178.851 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 96.1 Cg_endo -78.83 136.57 13.47 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.433 2.089 . . . . 0.0 111.647 178.403 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.445 ' CG ' HD22 ' A' ' 105' ' ' LEU . 73.6 Cg_endo -87.16 -174.3 1.29 Allowed 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.533 2.155 . . . . 0.0 113.589 -178.243 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 105' ' ' LEU . 0.6 OUTLIER -134.02 176.79 8.27 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.272 177.305 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 10.9 m -137.67 107.04 6.1 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.511 0.672 . . . . 0.0 111.848 179.726 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.491 ' HG3' ' CG1' ' A' ' 106' ' ' ILE . 2.9 pt20 -148.31 -179.0 6.62 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.117 -179.105 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 22.5 mm . . . . . 0 C--N 1.315 -0.905 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.334 -178.014 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.3 mtt-85 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.683 0.278 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.405 ' HB3' ' O ' ' A' ' 25' ' ' VAL . 0.2 OUTLIER 48.41 -179.16 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.196 0.522 . . . . 0.0 111.745 178.298 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 1.226 ' SG ' ' SG ' ' A' ' 49' ' ' CYS . 0.0 OUTLIER -98.57 163.1 19.68 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.684 179.406 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.438 ' HD2' ' CB ' ' A' ' 57' ' ' MET . 37.7 Cg_endo -67.02 170.49 12.92 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.065 1.843 . . . . 0.0 111.851 179.759 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.41 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 14.4 t -51.26 104.56 0.44 Allowed Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.895 -179.332 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.482 ' CB ' ' CD1' ' A' ' 31' ' ' ILE . 12.1 Cg_endo -56.75 147.29 72.8 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.058 1.839 . . . . 0.0 111.76 179.823 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -55.92 174.01 0.13 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.37 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.57 -171.2 2.6 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.989 0.423 . . . . 0.0 111.305 -179.61 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 5.2 tt -144.1 145.16 22.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.61 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -80.75 -58.68 2.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.256 -178.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.412 ' N ' ' ND2' ' A' ' 17' ' ' ASN . 0.6 OUTLIER -94.0 38.29 1.08 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.852 -179.538 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.411 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -158.37 -177.84 31.84 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.965 -179.804 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -137.71 140.79 40.93 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 179.59 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.531 ' CD2' ' CE2' ' A' ' 33' ' ' TYR . 10.2 mt -86.67 154.75 20.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.081 0.467 . . . . 0.0 111.759 -178.862 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.437 ' HB2' ' CB ' ' A' ' 32' ' ' THR . 15.6 t0 -124.39 71.22 1.13 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.631 177.457 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.478 ' CG2' ' CG1' ' A' ' 25' ' ' VAL . 0.9 OUTLIER -76.58 104.59 4.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.774 -177.836 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -110.6 -15.71 10.89 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.077 178.436 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.416 ' O ' ' CB ' ' A' ' 29' ' ' SER . . . -157.69 110.44 0.44 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.118 179.562 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.478 ' CG1' ' CG2' ' A' ' 22' ' ' ILE . 27.3 m -112.12 51.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.534 0.207 . . . . 0.0 111.534 -179.322 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.408 ' N ' ' OG ' ' A' ' 29' ' ' SER . 25.8 t0 -111.18 163.8 13.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.932 0.396 . . . . 0.0 110.84 178.063 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.451 ' CZ ' ' HB2' ' A' ' 51' ' ' LEU . 1.4 t80 -53.14 95.39 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.904 -179.18 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.17 31.37 5.05 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.148 -179.658 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 24' ' ' GLY . 14.8 m -99.67 -158.42 0.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.285 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 47' ' ' SER . 7.7 p -165.17 139.95 5.08 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 120.273 -0.571 . . . . 0.0 112.288 179.708 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.521 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.8 OUTLIER -105.2 170.68 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.267 178.568 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.437 ' CB ' ' HB2' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -128.48 111.75 13.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.005 0.431 . . . . 0.0 111.11 178.591 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.531 ' CE2' ' CD2' ' A' ' 20' ' ' LEU . 13.6 m-85 -85.13 149.28 25.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.255 -179.604 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.411 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 9.6 p -152.79 165.72 34.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.713 179.475 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 9.8 m -85.2 168.43 14.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.768 0.318 . . . . 0.0 110.92 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -66.02 -83.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.995 -179.437 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.86 136.23 13.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.476 179.703 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.444 ' HA2' ' CB ' ' A' ' 91' ' ' ASP . . . 59.97 28.84 66.77 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.387 -0.911 . . . . 0.0 111.671 -178.688 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.526 ' CE1' ' CB ' ' A' ' 68' ' ' SER . 2.7 m-85 -120.15 173.07 7.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.816 0.341 . . . . 0.0 110.939 -179.12 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.533 ' CE1' ' CG2' ' A' ' 69' ' ' VAL . 0.0 OUTLIER -129.85 133.45 46.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.106 175.271 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.428 ' CD1' ' HG3' ' A' ' 64' ' ' PRO . 6.7 tt -97.33 120.95 38.63 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.641 -179.333 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.408 ' HB ' ' HB ' ' A' ' 65' ' ' ILE . 1.2 mm -99.13 149.68 5.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.088 -179.302 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.06 -136.01 13.64 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.275 -179.62 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.421 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -84.55 -173.87 4.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.894 0.378 . . . . 0.0 110.653 179.612 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.427 ' HB3' HD23 ' A' ' 41' ' ' LEU . 3.9 p -159.51 22.15 0.18 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.462 -178.899 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.425 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -154.44 125.89 7.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.945 0.402 . . . . 0.0 112.062 -177.796 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 30' ' ' SER . 0.7 OUTLIER -92.4 141.68 28.27 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.673 177.201 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.427 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 1.4 m-85 -122.69 113.41 19.18 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 119.611 -0.836 . . . . 0.0 111.407 179.129 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 1.226 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 1.6 p -79.89 118.54 21.75 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 119.152 -1.019 . . . . 0.0 111.397 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.97 -170.72 2.57 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.842 -179.837 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.451 ' HB2' ' CZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -85.95 126.21 33.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.04 -179.476 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -93.54 -58.87 1.24 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.659 -179.686 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.4 48.01 1.55 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.846 0.355 . . . . 0.0 111.063 -179.683 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.9 p 58.31 28.14 16.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.791 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 163.12 -28.73 0.24 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.228 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.41 -163.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.738 0.304 . . . . 0.0 110.664 179.514 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.438 ' CB ' ' HD2' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -120.61 144.08 48.32 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.15 0.5 . . . . 0.0 110.734 179.736 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 49' ' ' CYS . 1.7 m -157.21 171.31 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.688 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.527 ' CD2' ' HB3' ' A' ' 49' ' ' CYS . 70.7 m95 -131.15 121.01 24.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.042 0.448 . . . . 0.0 111.6 -179.491 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.494 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 6.3 m-20 -69.68 168.03 19.77 Favored Pre-proline 0 C--O 1.223 -0.298 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.148 178.788 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.494 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 76.3 Cg_exo -20.16 96.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 125.081 3.854 . . . . 0.0 114.412 -178.37 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.465 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -96.01 -78.09 0.47 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.817 -178.421 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.496 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -82.13 108.07 10.48 Favored Pre-proline 0 C--N 1.331 -0.2 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -176.565 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.428 ' HG3' ' CD1' ' A' ' 41' ' ' LEU . 1.0 OUTLIER -85.17 -155.1 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.113 2.542 . . . . 0.0 110.754 176.99 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.408 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 1.5 mm -95.85 159.18 2.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.969 0.414 . . . . 0.0 110.402 177.782 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.2 m -157.92 138.27 12.69 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.775 179.834 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.47 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -150.01 177.03 10.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.55 179.991 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.526 ' CB ' ' CE1' ' A' ' 39' ' ' TYR . 1.2 p -104.49 141.32 36.58 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.575 179.088 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.533 ' CG2' ' CE1' ' A' ' 40' ' ' HIS . 2.3 p -67.6 66.84 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.287 0.565 . . . . 0.0 110.384 179.154 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 68' ' ' SER . 1.5 mmpt? -47.75 112.71 0.59 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.159 -178.184 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -97.28 125.79 42.07 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.268 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.04 -166.14 0.97 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.96 -179.342 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.42 ' OG ' ' NE2' ' A' ' 82' ' ' HIS . 1.5 t -42.24 134.21 2.54 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.329 -179.129 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.482 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 37.4 Cg_exo -58.54 161.52 14.42 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.331 2.021 . . . . 0.0 112.158 -179.245 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.436 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 88.2 Cg_exo -40.56 154.61 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.779 2.319 . . . . 0.0 112.867 -179.477 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.0 p -106.38 91.02 3.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.997 -179.641 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 19.9 pt -69.65 175.9 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.066 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.5 t -93.54 149.07 21.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.635 178.869 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.456 ' HB3' ' CE1' ' A' ' 103' ' ' TYR . 1.1 m-80 50.12 28.45 3.04 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.127 177.927 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.47 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -158.34 -163.61 13.07 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.899 179.872 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 98' ' ' SER . 13.2 ptt180 -170.12 -175.65 2.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.095 0.474 . . . . 0.0 110.931 -179.214 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.42 ' NE2' ' OG ' ' A' ' 73' ' ' SER . 4.9 p80 -123.04 166.52 14.98 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.801 179.756 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 46.2 p30 -116.96 -158.21 0.69 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.422 178.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 138.05 168.2 11.24 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.551 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -113.69 -30.57 6.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.921 0.391 . . . . 0.0 111.122 -179.712 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.54 -173.81 2.56 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.169 -179.541 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.56 -26.64 12.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.667 179.247 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.425 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 13.9 m-85 -125.62 -179.28 4.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.542 179.315 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.425 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 65.9 m-85 -152.71 167.84 27.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.713 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 24.9 p -141.05 -175.85 4.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.937 0.398 . . . . 0.0 111.361 -179.339 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.444 ' CB ' ' HA2' ' A' ' 38' ' ' GLY . 1.0 OUTLIER -61.55 96.6 0.06 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.295 0.569 . . . . 0.0 110.967 179.879 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 125.34 19.4 2.36 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.16 -0.927 . . . . 0.0 113.222 178.483 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.429 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.7 OUTLIER -100.64 154.16 18.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 117.049 0.424 . . . . 0.0 110.565 178.989 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.18 148.99 31.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.04 0.448 . . . . 0.0 110.918 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.473 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 17.9 t -145.52 147.45 18.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.651 179.852 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.429 ' N ' HG13 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -107.13 126.58 52.55 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.962 -179.624 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.534 ' CE1' ' CG2' ' A' ' 111' ' ' VAL . 4.6 m-85 -85.51 156.5 20.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.932 -179.742 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 81' ' ' ARG . 72.5 m -149.92 145.55 26.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.17 -179.503 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.416 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 66.7 m -75.16 156.04 36.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.028 179.887 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.47 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 78.9 m-20 -85.06 -78.13 0.26 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.592 -179.03 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.5 m -59.89 -23.49 63.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.378 -178.806 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 123.97 33.73 0.78 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.541 -179.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.495 ' CE2' HG12 ' A' ' 126' ' ' ILE . 40.4 m-85 -69.7 -175.52 0.89 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.967 0.413 . . . . 0.0 110.757 179.697 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.1 m -107.84 101.61 10.88 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.387 179.012 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.452 HD21 ' CG ' ' A' ' 122' ' ' PRO . 0.3 OUTLIER -47.29 127.05 10.31 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 121.367 0.603 . . . . 0.0 111.514 -178.991 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.438 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 40.7 mm -95.76 154.64 3.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.427 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 66.49 -125.42 26.23 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.93 -178.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -127.28 134.24 50.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.878 0.37 . . . . 0.0 110.943 179.167 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.455 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 0.4 OUTLIER -67.65 -30.39 69.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.804 179.621 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -70.11 132.8 23.88 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.554 179.388 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.534 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 2.4 t -127.41 121.64 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.675 0.274 . . . . 0.0 110.453 179.329 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.29 117.31 22.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.005 0.431 . . . . 0.0 111.802 -178.463 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.52 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 17.9 t -82.59 104.33 12.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.438 176.559 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 2.2 p -146.42 163.08 36.77 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.364 -178.17 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.33 30.0 4.03 Favored Glycine 0 N--CA 1.453 -0.219 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.767 179.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.3 16.14 70.9 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.52 -179.464 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -141.45 -177.4 5.13 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.887 0.375 . . . . 0.0 110.599 179.515 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.52 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 93.7 m95 -117.74 144.99 44.78 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.103 -179.391 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.91 147.02 51.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.298 -179.285 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.489 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER 73.38 46.13 0.21 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.163 178.676 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 73.3 Cg_endo -75.84 136.02 18.25 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.361 2.041 . . . . 0.0 111.331 177.951 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.455 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 64.8 Cg_endo -91.12 -173.68 0.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.505 2.137 . . . . 0.0 113.496 -178.135 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.424 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -129.37 -162.7 1.22 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.746 177.833 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 4.9 m -156.43 90.82 1.2 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.069 0.462 . . . . 0.0 110.856 179.378 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -118.12 160.7 21.09 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.932 -179.626 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.495 HG12 ' CE2' ' A' ' 103' ' ' TYR . 15.9 mm . . . . . 0 C--N 1.323 -0.546 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.997 179.912 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.898 0.38 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.431 ' HD3' ' CG2' ' A' ' 25' ' ' VAL . 32.9 mtm-85 -86.26 -169.01 2.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.957 179.814 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.415 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 8.5 m -91.08 163.0 31.06 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.625 179.55 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -73.62 167.88 26.15 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.281 1.988 . . . . 0.0 111.719 179.87 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.2 p -52.37 108.97 1.21 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.927 -179.275 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.481 ' HG2' ' CZ2' ' A' ' 59' ' ' TRP . 49.2 Cg_exo -49.34 158.05 1.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.314 2.009 . . . . 0.0 112.335 179.906 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.442 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 4.3 mtt180 -54.11 177.25 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.735 177.354 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.427 ' O ' ' CB ' ' A' ' 63' ' ' ALA . 0.1 OUTLIER -124.9 -177.01 3.7 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.182 0.515 . . . . 0.0 111.678 -178.676 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.404 HD11 ' HA3' ' A' ' 18' ' ' GLY . 5.2 tt -139.47 151.69 22.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.837 -179.397 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -90.34 -64.48 1.13 Allowed 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -177.46 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -92.52 26.92 2.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.775 0.321 . . . . 0.0 111.09 -178.894 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.404 ' HA3' HD11 ' A' ' 15' ' ' ILE . . . -144.15 -160.4 8.45 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.851 179.708 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.85 133.52 10.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.753 0.311 . . . . 0.0 110.489 179.434 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.523 ' CD2' ' CE2' ' A' ' 33' ' ' TYR . 18.7 mt -72.27 150.72 43.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.178 0.513 . . . . 0.0 111.899 -178.37 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -123.36 69.62 1.02 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.266 177.419 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.445 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 0.9 OUTLIER -79.4 100.75 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.069 -176.492 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.36 19.26 54.58 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.575 176.696 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 163.32 141.07 3.02 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 121.192 -0.528 . . . . 0.0 111.87 -179.376 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.431 ' CG2' ' HD3' ' A' ' 8' ' ' ARG . 6.2 m -127.01 -3.77 4.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.898 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.411 ' HA ' ' CB ' ' A' ' 8' ' ' ARG . 1.3 p-10 -69.57 156.58 38.69 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.792 0.33 . . . . 0.0 110.669 179.868 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.439 ' CZ ' ' HG ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -49.26 116.72 1.82 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.021 0.439 . . . . 0.0 111.02 -179.25 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.07 -6.64 47.34 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.585 -178.77 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 m -66.98 -174.29 0.32 Allowed 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.884 0.342 . . . . 0.0 110.762 179.711 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.74 139.16 11.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.964 -179.978 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.542 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.5 OUTLIER -108.2 167.63 3.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.921 0.391 . . . . 0.0 110.854 179.681 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.405 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -132.92 110.6 10.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.695 178.554 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.523 ' CE2' ' CD2' ' A' ' 20' ' ' LEU . 23.8 m-85 -82.76 132.19 35.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.162 -179.272 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.22 159.98 40.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.446 -179.898 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.419 ' HB2' ' HB2' ' A' ' 39' ' ' TYR . 56.4 m -84.69 176.13 8.76 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.625 -179.996 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -84.98 -83.22 0.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.911 0.386 . . . . 0.0 110.769 -179.346 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.23 129.4 9.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.344 179.267 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.441 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . 74.67 28.77 62.52 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.434 -0.888 . . . . 0.0 111.596 -177.842 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.496 ' CE2' ' HB2' ' A' ' 68' ' ' SER . 29.7 m-85 -134.08 157.77 45.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.003 0.43 . . . . 0.0 111.173 -179.734 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.432 ' CE1' HG22 ' A' ' 69' ' ' VAL . 6.3 m-70 -115.13 134.03 55.51 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 173.63 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.433 ' CD2' ' O ' ' A' ' 44' ' ' GLU . 6.3 tt -81.65 107.67 14.58 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.023 -179.613 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.406 HG12 ' HA ' ' A' ' 66' ' ' CYS . 1.3 mm -92.72 146.1 6.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.97 -178.229 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.76 -151.97 32.86 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.011 -178.441 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.433 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 1.3 pm0 -53.22 173.21 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.72 0.26 . . . . 0.0 110.406 179.232 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.424 ' HB3' HD22 ' A' ' 41' ' ' LEU . 8.3 p -153.61 24.07 0.52 Allowed 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.869 0.366 . . . . 0.0 111.522 -178.542 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.405 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 0.8 OUTLIER -157.53 -170.91 3.37 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.947 -178.357 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.428 ' CB ' HG12 ' A' ' 31' ' ' ILE . 1.8 m -164.67 98.87 0.79 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.632 179.182 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.487 ' CD2' ' N ' ' A' ' 48' ' ' TYR . 1.2 m-30 -84.95 118.86 24.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.038 0.447 . . . . 0.0 111.21 -179.303 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 16.2 t -70.2 115.62 9.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.298 179.043 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.503 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 2.8 tt0 -144.56 172.35 13.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.449 0.643 . . . . 0.0 111.214 -178.715 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.503 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 1.0 OUTLIER -58.76 153.38 16.94 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.303 -179.683 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -94.63 -104.81 1.9 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.503 -179.711 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.3 t -126.43 -61.81 1.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.847 0.356 . . . . 0.0 110.931 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.1 p -89.94 52.6 2.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.922 179.844 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 60.18 39.54 96.04 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.51 -179.994 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.0 t -108.76 -170.36 1.65 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.78 0.324 . . . . 0.0 110.983 -179.906 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.421 ' SD ' ' CE1' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -116.49 136.2 53.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.576 179.798 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.3 m -146.77 -175.65 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.811 -179.891 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.542 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 88.1 m95 -128.51 137.14 51.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.008 -179.454 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -151.86 122.51 3.64 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.016 -179.697 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.65 -167.2 4.8 Favored 'Cis proline' 0 C--N 1.352 0.746 0 C-N-CA 123.744 -1.357 . . . . 0.0 112.259 -0.313 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -110.64 -155.88 0.57 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 -179.306 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.493 ' CB ' ' CE2' ' A' ' 33' ' ' TYR . . . -76.01 112.82 22.46 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.653 179.226 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.468 ' CD ' ' CG ' ' A' ' 33' ' ' TYR . 18.3 Cg_exo -68.26 -150.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.511 2.141 . . . . 0.0 112.192 -179.1 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.5 pt -136.21 -177.95 2.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.841 -179.814 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 40' ' ' HIS . 78.7 m -149.99 157.32 43.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.353 0.597 . . . . 0.0 111.781 179.452 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -129.63 109.18 10.79 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.41 177.659 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.496 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 11.2 p -49.81 131.78 22.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.232 -178.668 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.441 ' CG1' ' O ' ' A' ' 38' ' ' GLY . 4.3 p -53.68 104.83 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.26 -178.479 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.424 ' CD ' ' HB2' ' A' ' 88' ' ' PHE . 2.4 mmtp -89.45 114.21 25.66 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.582 177.867 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.11 125.39 38.72 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.103 0.478 . . . . 0.0 110.266 179.125 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.57 -155.64 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.924 178.777 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.428 ' OG ' ' NE2' ' A' ' 82' ' ' HIS . 1.1 t -53.15 143.77 31.86 Favored Pre-proline 0 N--CA 1.447 -0.584 0 CA-C-O 120.561 0.22 . . . . 0.0 110.536 179.483 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.483 ' HD2' ' CD2' ' A' ' 82' ' ' HIS . 32.4 Cg_exo -60.14 166.28 9.26 Favored 'Trans proline' 0 CA--C 1.53 0.311 0 C-N-CA 122.633 2.222 . . . . 0.0 112.277 -179.263 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.495 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 97.7 Cg_exo -40.97 165.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.795 2.33 . . . . 0.0 112.927 -179.517 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 73.1 m -115.32 87.34 2.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.704 179.551 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.3 pt -69.48 -173.59 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.071 -179.547 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 t -100.8 148.88 24.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.955 179.679 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.474 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 0.9 OUTLIER 47.22 29.4 1.19 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.112 177.937 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -161.51 -171.62 27.79 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.056 179.778 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -170.36 -174.87 1.78 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.992 0.425 . . . . 0.0 111.028 -178.723 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.483 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 2.1 p-80 -117.59 171.95 7.67 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.621 -179.962 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -109.95 -75.88 0.62 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.119 179.625 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 69.72 154.78 1.05 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.664 179.773 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.461 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -110.24 -35.81 5.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.14 0.495 . . . . 0.0 110.63 179.61 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.3 -172.71 2.4 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.948 -179.79 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.7 -24.35 14.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.891 179.338 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.439 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 7.3 m-85 -130.27 178.13 6.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.897 179.856 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.439 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 49.8 m-85 -152.23 164.32 37.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.0 -179.381 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.423 ' CG2' ' HE3' ' A' ' 70' ' ' LYS . 16.5 p -148.9 -174.93 4.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.004 0.431 . . . . 0.0 111.427 -179.605 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 7.3 p-10 -52.92 93.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.238 0.542 . . . . 0.0 111.566 -179.155 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.09 26.88 1.61 Allowed Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.474 -0.785 . . . . 0.0 113.628 177.549 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.34 152.5 26.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.191 0.495 . . . . 0.0 110.848 178.994 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 34.3 m -134.85 153.62 35.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.156 0.503 . . . . 0.0 111.24 -179.703 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.449 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 25.1 t -147.59 148.14 16.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.636 179.263 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.14 134.09 48.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.698 179.876 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.525 ' CE1' ' CG2' ' A' ' 111' ' ' VAL . 4.5 m-85 -92.4 152.17 19.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.037 -179.754 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 59.0 m -146.52 140.29 26.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.754 179.749 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.45 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 82.0 m -69.75 159.03 34.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.033 -179.666 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -93.03 -87.36 0.23 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.222 -179.821 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.7 t -44.52 -33.2 1.65 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.637 -179.071 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 133.22 40.45 0.19 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.563 179.867 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.49 ' CE2' HG12 ' A' ' 126' ' ' ILE . 37.6 m-85 -82.2 -173.07 4.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.845 0.355 . . . . 0.0 110.781 179.794 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.0 m -112.2 109.98 19.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.016 -179.821 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.432 HD23 ' CG ' ' A' ' 122' ' ' PRO . 2.5 tp -45.43 113.5 0.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.903 179.05 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.432 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 35.2 mm -92.07 154.64 3.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.143 179.83 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 65.69 -125.27 28.11 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.362 -0.923 . . . . 0.0 111.811 -178.299 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -123.3 132.84 54.14 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.795 0.331 . . . . 0.0 110.651 179.052 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.454 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 2.6 t -69.36 -29.94 67.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.49 179.438 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -70.98 135.52 24.48 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.794 179.771 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.525 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 3.1 t -129.44 120.78 51.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.596 0.236 . . . . 0.0 110.717 179.266 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.412 HD21 ' N ' ' A' ' 113' ' ' CYS . 1.0 OUTLIER -80.33 130.49 35.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.903 0.382 . . . . 0.0 111.434 -179.232 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.488 ' HB2' ' CZ3' ' A' ' 118' ' ' TRP . 37.4 t -102.68 104.18 14.5 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.075 177.461 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 5.3 p -152.93 123.01 7.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.898 0.38 . . . . 0.0 111.714 -179.352 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 93.17 19.79 34.95 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.696 179.148 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.441 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 82.14 -1.27 87.41 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.622 -179.173 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -131.51 -177.42 4.4 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.859 0.361 . . . . 0.0 110.432 179.373 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.495 ' CD1' ' HD2' ' A' ' 75' ' ' PRO . 86.5 m95 -120.08 157.43 28.96 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.035 -178.998 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.72 152.34 47.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.054 0.454 . . . . 0.0 111.298 -179.844 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.498 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.7 OUTLIER 69.52 45.57 0.28 Allowed Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.119 179.241 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.498 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 76.9 Cg_endo -77.45 138.32 17.4 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.384 2.056 . . . . 0.0 111.755 178.564 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.454 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 74.3 Cg_endo -91.25 -171.64 0.42 Allowed 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.786 2.324 . . . . 0.0 113.482 -178.542 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.88 -167.16 1.83 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.819 177.947 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 7.4 m -148.67 92.82 2.04 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.051 0.453 . . . . 0.0 110.801 179.328 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -118.02 163.93 15.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.551 -179.853 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.49 HG12 ' CE2' ' A' ' 103' ' ' TYR . 15.4 mm . . . . . 0 C--N 1.322 -0.594 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.956 -179.789 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.716 0.293 . . . . 0.0 110.773 . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' A' ' 26' ' ' ASP . 3.4 ptp180 -86.55 -158.36 0.41 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.979 -179.78 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.432 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 20.5 m -116.38 161.58 30.84 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.845 0.355 . . . . 0.0 111.575 -178.454 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.413 ' HD3' ' HB2' ' A' ' 9' ' ' CYS . 57.4 Cg_endo -71.12 174.62 10.39 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.485 2.123 . . . . 0.0 112.02 179.689 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.0 t -54.55 108.25 1.09 Allowed Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.925 -179.683 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.507 ' HG2' ' CZ2' ' A' ' 59' ' ' TRP . 53.3 Cg_exo -46.4 164.56 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.351 2.034 . . . . 0.0 112.123 179.867 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.441 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 14.7 ttt180 -74.07 158.56 34.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.707 178.103 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.9 -175.42 2.76 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.202 0.525 . . . . 0.0 111.516 -178.301 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 19.7 tt -151.05 146.02 16.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.203 -179.492 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -85.03 158.97 20.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.34 -0.391 . . . . 0.0 109.999 177.844 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.471 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 0.4 OUTLIER 46.66 30.77 1.21 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.887 179.974 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -157.93 175.88 35.09 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.705 -179.413 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -141.84 137.82 31.73 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.658 0.266 . . . . 0.0 110.515 -179.869 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.441 ' CD1' ' O ' ' A' ' 13' ' ' ARG . 25.9 mt -83.71 157.88 22.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.11 0.481 . . . . 0.0 111.604 -179.558 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -125.45 75.49 1.48 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.625 177.709 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.448 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 1.1 mt -71.4 104.01 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.105 -177.156 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.39 15.36 56.21 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.789 176.855 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 156.08 130.99 1.34 Allowed Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.077 -179.591 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.454 ' HA ' ' CH2' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -113.24 5.7 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-O 120.768 0.318 . . . . 0.0 110.438 -178.763 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 0.5 OUTLIER -69.37 155.66 40.07 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.907 0.384 . . . . 0.0 111.663 -178.851 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -53.56 90.09 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.711 179.29 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 127.39 -6.92 7.11 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.767 -179.478 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.8 p -72.99 170.89 13.89 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.958 0.379 . . . . 0.0 110.653 179.798 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.2 p -137.13 152.03 49.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.937 179.79 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.509 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 1.1 mt -114.87 170.35 5.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.665 -179.306 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -133.55 115.29 14.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.876 0.369 . . . . 0.0 110.654 179.357 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.495 ' CE2' ' HA ' ' A' ' 63' ' ' ALA . 14.3 m-85 -89.71 154.0 20.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.629 -178.67 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.29 155.98 34.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.536 179.426 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.409 ' HB2' ' HB2' ' A' ' 39' ' ' TYR . 4.0 m -82.11 167.67 18.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.819 0.343 . . . . 0.0 110.958 -179.933 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -68.43 -85.4 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.204 -179.247 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.5 m -153.17 132.61 12.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.832 0.348 . . . . 0.0 111.008 -179.784 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.05 21.84 73.83 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.124 -179.198 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.492 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.6 m-85 -115.16 174.33 6.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.82 0.343 . . . . 0.0 110.86 -179.672 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.526 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.4 OUTLIER -137.82 114.85 10.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.496 177.976 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.437 HD23 ' CB ' ' A' ' 45' ' ' SER . 6.5 tt -78.19 125.36 29.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.502 -179.698 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.526 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 2.2 mm -102.17 160.82 4.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.053 0.454 . . . . 0.0 111.113 -179.398 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.81 -135.24 22.95 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.485 -179.639 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.426 ' O ' ' CB ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -79.96 -173.58 3.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.966 0.413 . . . . 0.0 111.064 -179.952 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.437 ' CB ' HD23 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -167.31 29.18 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.384 179.389 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 15.8 mtpt -155.08 127.52 7.87 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.962 0.411 . . . . 0.0 111.641 -178.666 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.454 ' OG ' ' CB ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -94.05 148.05 22.54 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.024 178.403 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.471 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 1.6 m-85 -124.45 114.95 20.14 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.603 177.922 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 52.8 t -65.67 98.22 0.37 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.468 179.677 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.503 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 0.6 OUTLIER -122.09 175.01 6.58 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.711 -178.501 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.503 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -83.19 147.65 27.9 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.171 -179.292 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.421 ' N ' HG23 ' A' ' 58' ' ' VAL . . . -75.59 -130.63 0.3 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.661 -179.849 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.9 t -109.35 -30.93 7.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.782 0.325 . . . . 0.0 111.014 -179.785 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 68.1 p -102.63 36.67 2.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.972 -179.884 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.83 20.85 72.78 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.452 -179.942 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.04 -162.44 0.86 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.856 0.36 . . . . 0.0 110.913 -179.976 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.0 138.52 52.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.359 179.656 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.421 HG23 ' N ' ' A' ' 52' ' ' GLY . 0.4 OUTLIER -145.34 -175.55 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.491 -179.669 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.509 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 76.6 m95 -129.9 121.43 26.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.068 0.461 . . . . 0.0 111.905 -179.031 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.471 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 2.8 m120 -68.91 165.87 33.33 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.35 177.443 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.442 ' HD2' ' HB2' ' A' ' 60' ' ' ASN . 81.2 Cg_exo -17.09 94.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 125.289 3.993 . . . . 0.0 114.586 -178.475 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.475 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -91.67 -76.13 0.46 Allowed 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.329 -177.871 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.495 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -88.02 109.02 24.49 Favored Pre-proline 0 C--N 1.331 -0.201 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -175.711 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.432 ' HG3' ' CD1' ' A' ' 41' ' ' LEU . 2.3 Cg_endo -83.61 -154.59 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.053 2.502 . . . . 0.0 111.28 177.196 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.42 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 3.0 mm -87.65 165.41 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.917 0.389 . . . . 0.0 110.791 178.64 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -165.83 131.25 2.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.502 179.455 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -154.82 168.32 27.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.184 -179.009 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.492 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 8.6 p -88.1 111.71 21.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.936 179.744 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.48 ' HB ' ' N ' ' A' ' 116' ' ' GLY . 4.9 p -45.08 103.9 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.884 179.253 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.486 ' HD3' ' CD1' ' A' ' 88' ' ' PHE . 2.2 ttpp -104.43 134.63 47.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.957 -176.035 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 1.5 m -90.18 136.87 32.78 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.668 177.791 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.54 -169.85 0.25 Allowed 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.817 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.6 t -74.99 111.57 14.03 Favored Pre-proline 0 C--N 1.314 -0.954 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.744 -179.021 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.585 ' HG3' ' CE2' ' A' ' 118' ' ' TRP 0.321 0.0 OUTLIER -34.23 -175.27 0.0 OUTLIER 'Trans proline' 0 CA--C 1.468 -2.796 0 C-N-CA 123.722 2.948 . . . . 0.0 114.102 173.589 . . . . . . . . 4 4 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.545 ' CB ' ' CE1' ' A' ' 97' ' ' TYR . 23.3 Cg_endo -73.3 -164.0 3.12 Favored 'Cis proline' 0 C--N 1.323 -0.814 0 N-CA-C 113.847 0.672 . . . . 0.0 113.847 -18.854 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.2 t -135.55 21.11 3.36 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.54 172.257 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.454 HG12 ' N ' ' A' ' 78' ' ' SER . 3.3 pt -111.16 -160.03 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.274 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.213 -177.45 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.454 ' N ' HG12 ' A' ' 77' ' ' ILE . 86.2 p -134.24 151.03 51.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.788 177.61 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 55.6 32.46 19.23 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.578 179.327 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -151.08 -160.81 9.64 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.127 -1.035 . . . . 0.0 113.731 179.764 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.42 ' N ' ' O ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -161.95 -172.75 3.39 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.801 0.334 . . . . 0.0 111.121 -178.196 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.516 ' CG ' ' HB3' ' A' ' 74' ' ' PRO . 31.3 p80 -124.52 173.41 8.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.157 0.503 . . . . 0.0 112.257 -175.723 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.455 ' O ' ' N ' ' A' ' 85' ' ' TYR . 80.8 m-20 -107.65 -98.15 0.37 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.169 174.021 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.469 ' O ' ' CG ' ' A' ' 85' ' ' TYR . . . 57.14 -80.41 0.01 OUTLIER Glycine 0 C--N 1.342 0.87 0 C-N-CA 121.039 -0.601 . . . . 0.0 113.241 177.826 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.475 ' N ' ' CD2' ' A' ' 85' ' ' TYR . 2.8 m-30 98.42 11.72 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.593 1.557 . . . . 0.0 111.293 179.488 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.87 -173.7 2.36 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.517 178.204 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.26 -24.08 10.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.733 178.651 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.486 ' CD1' ' HD3' ' A' ' 70' ' ' LYS . 9.4 m-85 -147.71 171.41 15.69 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.423 179.413 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.466 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 17.6 m-85 -147.24 175.53 10.68 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.624 0.249 . . . . 0.0 110.862 -177.661 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 14.7 p -144.6 169.82 17.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.132 0.492 . . . . 0.0 112.029 -179.28 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.27 94.25 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.307 -179.323 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.53 28.45 0.98 Allowed Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.327 -0.852 . . . . 0.0 113.161 178.376 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.448 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.7 OUTLIER -110.14 157.45 19.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.965 0.383 . . . . 0.0 110.879 179.013 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 35.8 m -138.76 146.08 26.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.759 179.627 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.52 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 4.2 t -147.16 142.8 20.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.026 -178.681 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.55 127.39 44.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.174 0.512 . . . . 0.0 110.132 178.692 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.545 ' CE1' ' CB ' ' A' ' 75' ' ' PRO . 2.8 m-30 -95.49 166.23 11.96 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.496 0.665 . . . . 0.0 112.756 -174.794 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.42 ' O ' ' N ' ' A' ' 81' ' ' ARG . 67.6 m -152.87 145.54 24.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.542 178.75 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.484 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 76.1 m -69.43 155.67 40.08 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.863 0.363 . . . . 0.0 111.538 -178.881 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.6 -86.47 0.19 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.967 178.934 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -47.03 -27.04 1.18 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.511 -179.385 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 125.25 32.26 0.8 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.877 179.866 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.497 ' CE1' HG12 ' A' ' 126' ' ' ILE . 18.5 m-85 -72.54 -170.85 0.72 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.903 0.383 . . . . 0.0 111.25 179.952 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.9 m -118.04 96.81 5.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.205 177.882 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.453 ' CD2' ' HA ' ' A' ' 109' ' ' SER . 0.2 OUTLIER -47.92 139.53 7.7 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.563 0.697 . . . . 0.0 111.81 -178.226 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.45 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 16.8 mm -125.5 160.96 30.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.328 -178.71 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.77 25.18 70.34 Favored Glycine 0 N--CA 1.457 0.082 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.453 177.718 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.449 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.3 OUTLIER 67.05 130.84 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.532 0.682 . . . . 0.0 112.355 178.452 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.453 ' HA ' ' CD2' ' A' ' 105' ' ' LEU . 1.1 p -64.54 -24.68 67.68 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.427 -1.26 . . . . 0.0 111.329 178.906 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.55 130.31 48.24 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.856 179.134 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.541 ' CG1' ' HB2' ' A' ' 118' ' ' TRP . 16.4 t -135.31 123.71 39.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.492 0.187 . . . . 0.0 110.855 -177.819 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.0 127.98 35.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.967 0.413 . . . . 0.0 111.804 -177.932 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.492 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 44.7 t -89.52 98.08 11.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.521 176.386 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 24.0 p -136.76 159.96 40.28 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.672 -179.119 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.439 ' CA ' HG11 ' A' ' 69' ' ' VAL . . . 50.67 29.04 17.53 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.835 -179.074 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.48 ' N ' ' HB ' ' A' ' 69' ' ' VAL . . . 68.39 14.51 66.8 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.085 -0.578 . . . . 0.0 112.575 -179.555 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -141.95 177.02 8.49 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 178.665 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.585 ' CE2' ' HG3' ' A' ' 74' ' ' PRO . 99.4 m95 -98.39 126.5 43.94 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.149 0.5 . . . . 0.0 111.158 -179.586 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.9 150.45 24.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.254 -178.829 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.513 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.9 OUTLIER 53.51 42.46 1.18 Allowed Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.101 -179.987 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 37.7 Cg_endo -64.55 151.5 85.34 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.039 1.826 . . . . 0.0 111.098 177.65 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.452 ' O ' ' CG2' ' A' ' 77' ' ' ILE . 44.4 Cg_endo -80.27 -173.59 1.92 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 121.922 1.748 . . . . 0.0 113.035 -179.06 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.444 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -122.75 -161.57 0.96 Allowed 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 173.765 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . 0.409 ' SG ' ' HB2' ' A' ' 103' ' ' TYR . 2.4 t -170.65 83.6 0.1 Allowed 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.25 -175.61 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -115.01 169.04 9.39 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.583 -1.19 . . . . 0.0 111.676 -175.838 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.497 HG12 ' CE1' ' A' ' 103' ' ' TYR . 37.5 mm . . . . . 0 C--N 1.326 -0.442 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.78 179.342 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.5 mtt180 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.764 0.316 . . . . 0.0 110.829 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.427 ' HD2' ' CG2' ' A' ' 25' ' ' VAL . 7.7 mtm180 -92.47 -159.92 0.7 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.738 179.953 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.433 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 60.8 m -105.33 160.66 25.27 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 -178.956 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.418 ' HD3' ' HB2' ' A' ' 9' ' ' CYS . 32.2 Cg_endo -65.86 173.62 6.72 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.59 2.193 . . . . 0.0 112.192 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.7 t -54.37 108.1 1.05 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.578 179.53 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.51 ' HG2' ' CZ2' ' A' ' 59' ' ' TRP . 72.7 Cg_exo -46.98 160.25 0.27 Allowed 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.302 2.001 . . . . 0.0 112.401 -179.468 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.441 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -75.31 174.01 10.1 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.96 178.325 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -127.33 -177.0 3.9 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.224 0.535 . . . . 0.0 111.691 -178.866 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.429 HG21 ' CD2' ' A' ' 20' ' ' LEU . 17.9 tt -146.47 143.06 20.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.785 -179.339 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -81.86 156.8 24.65 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 177.394 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.485 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 0.5 OUTLIER 49.28 26.14 1.46 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.839 0.352 . . . . 0.0 110.554 -179.239 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -153.21 170.59 32.14 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.698 -179.01 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -138.36 144.01 40.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.699 0.285 . . . . 0.0 110.34 179.526 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.53 ' CD2' ' CE1' ' A' ' 33' ' ' TYR . 0.5 OUTLIER -92.49 163.21 13.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.207 0.527 . . . . 0.0 111.769 -179.312 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 32' ' ' THR . 8.1 t0 -127.47 72.34 1.38 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.875 177.175 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.445 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 1.2 mt -72.76 97.8 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.809 -177.789 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.12 16.7 60.77 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.786 176.979 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 160.26 153.46 6.93 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 -179.278 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.427 ' CG2' ' HD2' ' A' ' 8' ' ' ARG . 17.0 m -134.87 11.58 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.8 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.425 ' O ' ' N ' ' A' ' 28' ' ' GLY . 40.3 t0 -90.02 163.08 15.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.972 0.415 . . . . 0.0 111.377 179.93 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.5 ' CE2' ' HB2' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -50.01 90.27 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.802 -179.599 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 131.99 -9.52 5.43 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.627 -0.796 . . . . 0.0 112.784 -179.566 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.8 m -76.43 157.45 32.23 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 117.107 0.454 . . . . 0.0 110.503 179.536 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.4 p -133.52 142.2 48.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.019 0.437 . . . . 0.0 110.917 179.603 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.523 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -106.81 154.08 7.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.435 -179.789 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.411 ' O ' ' N ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -115.97 119.45 35.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.023 0.44 . . . . 0.0 110.75 179.361 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.53 ' CE1' ' CD2' ' A' ' 20' ' ' LEU . 11.5 m-85 -95.03 137.95 33.4 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.263 -178.927 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.4 m -146.77 159.59 43.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.079 179.793 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.1 m -81.97 173.52 12.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.6 179.452 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.41 -79.88 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.107 -179.447 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.35 134.62 10.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.904 -179.651 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.24 23.52 71.61 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.809 -178.972 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.485 ' CD2' ' HA ' ' A' ' 68' ' ' SER . 2.3 m-85 -118.01 167.88 11.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.842 0.353 . . . . 0.0 110.868 -179.338 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.474 ' CE1' HD12 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -132.97 121.82 23.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.337 177.635 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.45 ' CD2' ' O ' ' A' ' 44' ' ' GLU . 8.7 tt -83.3 127.91 34.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.849 -178.401 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.474 HD12 ' CE1' ' A' ' 40' ' ' HIS . 1.4 mm -106.57 149.46 9.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.051 -179.651 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.08 -142.56 20.71 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.07 -179.102 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.45 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -72.15 -175.8 1.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.869 0.366 . . . . 0.0 110.316 178.469 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -168.1 28.79 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.511 179.431 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -157.08 127.42 6.45 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.973 -179.929 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.426 ' HB3' ' HA ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -102.59 152.36 21.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.74 -179.663 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.487 ' CD1' ' HB2' ' A' ' 60' ' ' ASN . 1.2 m-85 -128.04 124.89 38.22 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.488 0.661 . . . . 0.0 111.672 -179.971 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.483 ' HB3' ' CH2' ' A' ' 59' ' ' TRP . 42.7 t -73.23 118.2 15.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.157 -179.429 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.487 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 9.5 tt0 -159.25 168.45 26.43 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.074 179.018 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.5 ' HB2' ' CE2' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -95.76 130.65 42.61 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.553 179.729 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -176.94 93.41 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.013 -179.4 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.434 ' HB2' ' CB ' ' A' ' 56' ' ' SER . 9.6 t -179.09 40.52 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -179.142 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 79.51 29.54 0.31 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.149 -178.89 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 103.7 15.59 22.15 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.115 -179.325 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.434 ' CB ' ' HB2' ' A' ' 53' ' ' SER . 0.1 OUTLIER -105.31 -159.59 0.71 Allowed 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.97 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.421 ' HA ' ' HA ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -118.24 136.46 53.65 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.538 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.532 ' CG2' ' N ' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -137.22 -175.97 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 121.823 0.82 . . . . 0.0 112.171 -176.054 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.532 ' N ' ' CG2' ' A' ' 58' ' ' VAL . 59.9 m95 -133.0 134.86 45.02 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.413 179.281 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.487 ' HB2' ' CD1' ' A' ' 48' ' ' TYR . 5.5 m-80 -78.41 163.34 62.22 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.888 178.319 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.431 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 31.6 Cg_exo -11.04 90.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.864 1 C-N-CA 125.758 4.305 . . . . 0.0 114.873 -179.392 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.48 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 39.4 mt-10 -91.27 -93.94 0.13 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.146 -178.284 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.476 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . . . -81.15 108.86 11.54 Favored Pre-proline 0 C--O 1.231 0.131 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -176.124 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.436 ' HG3' ' CD1' ' A' ' 41' ' ' LEU . 2.1 Cg_endo -82.93 -154.6 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.003 2.469 . . . . 0.0 110.756 176.681 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.405 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 2.0 mm -92.88 158.17 2.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.927 0.394 . . . . 0.0 110.508 178.271 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.2 m -164.34 143.37 7.37 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.957 179.905 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -169.88 170.2 7.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.463 179.954 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.485 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 30.2 p -73.92 99.02 3.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.045 0.45 . . . . 0.0 110.219 178.534 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.432 ' O ' ' N ' ' A' ' 116' ' ' GLY . 5.6 p -44.2 93.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.29 179.619 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.439 ' HG3' ' CG2' ' A' ' 90' ' ' THR . 9.0 mttt -69.73 165.05 22.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.0 -177.467 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.416 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -120.88 131.58 54.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.179 179.079 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -69.19 -157.21 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.08 179.205 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.421 ' OG ' ' NE2' ' A' ' 82' ' ' HIS . 1.5 t -52.82 142.65 33.2 Favored Pre-proline 0 N--CA 1.45 -0.446 0 CA-C-O 120.682 0.277 . . . . 0.0 110.276 179.495 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.421 ' O ' ' CE1' ' A' ' 82' ' ' HIS . 37.6 Cg_exo -57.31 162.79 9.22 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.397 2.065 . . . . 0.0 112.036 -179.083 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.484 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 82.4 Cg_exo -39.99 159.06 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.746 2.297 . . . . 0.0 112.947 -179.003 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 86.7 p -109.11 88.45 2.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.635 179.446 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.0 pt -69.85 174.12 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.33 -179.347 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.6 m -97.07 140.64 31.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.532 179.295 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.488 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 4.9 m-80 59.56 29.62 19.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.746 -179.913 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.401 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . -172.83 -170.28 36.36 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.516 179.614 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -170.24 -175.7 2.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.888 0.375 . . . . 0.0 111.095 -179.371 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.421 ' NE2' ' OG ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -99.47 178.24 4.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.022 -179.987 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 96' ' ' THR . 3.4 m-20 -122.17 18.3 10.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.392 -179.645 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -51.76 153.4 5.39 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.281 -0.961 . . . . 0.0 112.282 -179.878 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.466 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 0.6 OUTLIER -106.53 -30.67 8.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.143 0.497 . . . . 0.0 110.426 179.816 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.18 -173.54 2.45 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.761 179.87 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -107.02 -14.78 14.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.242 179.248 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.436 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 2.2 m-85 -134.74 165.61 24.86 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.996 0.427 . . . . 0.0 111.971 -178.351 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.436 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 71.6 m-85 -151.27 154.51 36.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.028 -179.216 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.439 ' CG2' ' HG3' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -111.4 -174.15 2.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.138 0.494 . . . . 0.0 112.011 -178.617 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 8.7 m-20 -69.97 96.28 1.02 Allowed 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.033 -179.895 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.46 22.77 2.02 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.956 179.074 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -96.73 156.47 16.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.764 0.316 . . . . 0.0 110.635 179.44 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 34.3 m -135.64 151.13 29.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.17 0.51 . . . . 0.0 111.185 -179.816 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.466 HG21 ' CH2' ' A' ' 118' ' ' TRP . 15.1 t -149.2 146.81 17.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.812 179.783 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.421 ' CG2' ' OG ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -100.93 142.0 33.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.261 179.03 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.477 ' CE2' ' CG2' ' A' ' 111' ' ' VAL . 4.0 m-85 -100.4 156.41 17.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.997 0.427 . . . . 0.0 111.202 -179.532 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 36.7 m -150.26 141.61 23.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.133 -179.508 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.401 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 63.2 m -71.96 165.55 23.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.881 179.718 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.32 -86.52 0.34 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.982 179.791 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -46.76 -29.29 1.85 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.403 -179.515 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.19 41.03 0.29 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.539 179.895 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.488 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 43.5 m-85 -80.6 -174.83 4.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.864 0.364 . . . . 0.0 110.817 179.877 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.3 m -112.59 106.99 15.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.173 178.828 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.434 HD23 ' CB ' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -48.26 131.33 16.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.501 0.667 . . . . 0.0 111.683 -178.252 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.445 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 35.4 mm -97.62 155.93 3.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.199 179.16 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.423 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 64.91 -129.32 35.36 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.324 -179.534 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -121.12 129.74 53.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.804 0.335 . . . . 0.0 111.21 -179.771 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.439 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 1.5 p -61.33 -32.13 72.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.82 179.455 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -71.4 135.01 23.29 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.842 -179.592 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.477 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 3.8 t -130.72 120.0 46.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.632 0.253 . . . . 0.0 110.706 179.2 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.435 ' CD1' ' HB2' ' A' ' 114' ' ' SER . 1.1 tm? -82.18 134.32 35.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.86 0.362 . . . . 0.0 111.284 -179.374 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.501 ' HB2' ' CZ3' ' A' ' 118' ' ' TRP . 43.1 t -105.09 102.5 11.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.105 177.999 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.435 ' HB2' ' CD1' ' A' ' 112' ' ' LEU . 4.3 m -135.57 113.12 10.78 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.488 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 81.66 45.21 7.41 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.009 178.06 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 69' ' ' VAL . . . 63.32 12.78 46.77 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.778 179.471 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -134.66 173.74 11.33 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.04 0.447 . . . . 0.0 110.663 179.687 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.501 ' CZ3' ' HB2' ' A' ' 113' ' ' CYS . 94.6 m95 -121.4 156.52 32.49 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.905 -179.41 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.74 149.91 46.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.051 0.453 . . . . 0.0 111.368 -179.767 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.477 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER 67.1 47.07 0.42 Allowed Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.786 179.136 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 84.8 Cg_endo -77.7 133.92 13.17 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.396 2.064 . . . . 0.0 111.642 178.701 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.445 ' CB ' ' O ' ' A' ' 106' ' ' ILE . 63.8 Cg_endo -88.49 -174.27 1.05 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.581 2.187 . . . . 0.0 113.468 -178.301 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.34 -159.39 0.96 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.031 178.431 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 7.6 m -158.62 91.11 1.05 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.087 0.47 . . . . 0.0 110.988 179.255 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -121.24 158.64 27.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.908 -179.922 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.486 HG12 ' CE2' ' A' ' 103' ' ' TYR . 21.0 mm . . . . . 0 C--N 1.324 -0.533 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.111 179.995 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.79 0.329 . . . . 0.0 110.998 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.428 ' HA ' ' HA ' ' A' ' 26' ' ' ASP . 8.2 mtm-85 -94.69 -176.68 3.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.925 179.796 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.431 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 18.3 m -109.27 160.37 27.87 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.084 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -67.94 170.48 14.15 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.318 2.012 . . . . 0.0 111.75 179.748 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -51.43 105.61 0.55 Allowed Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.948 -179.524 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -61.93 159.78 32.36 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.211 1.941 . . . . 0.0 111.881 179.731 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.433 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 4.2 mpt_? -49.34 177.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.513 179.636 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.433 ' O ' ' CG2' ' A' ' 15' ' ' ILE . 0.2 OUTLIER -142.76 -7.74 0.84 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -178.042 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.449 HG22 ' CD2' ' A' ' 20' ' ' LEU . 14.4 tt 53.72 163.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 120.749 0.309 . . . . 0.0 111.105 -177.939 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -104.26 -56.03 2.26 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -177.135 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.475 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 0.2 OUTLIER -94.12 31.01 1.75 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.936 0.398 . . . . 0.0 111.071 -178.412 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -157.47 179.65 33.06 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.517 179.473 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.92 139.42 44.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.793 0.33 . . . . 0.0 110.25 179.864 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.539 ' CD1' ' CZ ' ' A' ' 33' ' ' TYR . 34.0 mt -88.04 159.77 18.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.377 0.608 . . . . 0.0 112.142 -178.462 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 32' ' ' THR . 5.3 t0 -124.04 83.37 2.13 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.225 176.646 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.445 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 1.8 mt -77.44 107.14 8.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.169 -176.678 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.99 19.52 37.85 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.59 176.679 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 152.86 132.77 1.81 Allowed Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.073 -179.373 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.453 ' CG2' ' O ' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -117.38 5.81 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-O 120.811 0.338 . . . . 0.0 110.591 -178.248 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 6.6 p-10 -75.68 153.71 36.97 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-O 120.964 0.412 . . . . 0.0 111.489 -179.11 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -52.51 95.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.767 179.334 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.02 8.49 5.08 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.989 -179.825 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 84.9 p -97.35 -174.1 2.84 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 116.992 0.396 . . . . 0.0 110.483 179.359 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.1 p -155.12 146.53 22.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.036 0.446 . . . . 0.0 111.121 178.44 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.51 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.8 OUTLIER -106.63 172.59 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.418 -179.394 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.431 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -129.64 118.34 21.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.925 0.393 . . . . 0.0 111.2 179.551 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.539 ' CZ ' ' CD1' ' A' ' 20' ' ' LEU . 19.8 m-85 -94.77 140.96 29.19 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.234 0.54 . . . . 0.0 111.604 -179.486 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 16.8 m -148.82 153.65 38.41 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.458 179.744 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.429 ' HB2' ' HB2' ' A' ' 39' ' ' TYR . 1.7 m -75.17 167.35 22.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.99 -179.628 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -76.04 -82.03 0.08 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.824 -179.589 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -153.95 121.38 5.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.656 179.351 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.432 ' O ' ' CG2' ' A' ' 69' ' ' VAL . . . 77.32 14.19 82.79 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.423 -178.766 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.526 ' CZ ' ' CB ' ' A' ' 68' ' ' SER . 23.1 m-85 -111.7 154.47 24.92 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.586 -0.361 . . . . 0.0 111.0 179.546 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.518 ' CE1' ' CG2' ' A' ' 69' ' ' VAL . 2.3 m-70 -112.86 119.18 37.1 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 175.155 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.417 ' CD2' ' O ' ' A' ' 44' ' ' GLU . 4.1 tt -83.74 109.31 17.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.928 0.394 . . . . 0.0 110.022 -179.842 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.427 ' N ' HD13 ' A' ' 42' ' ' ILE . 1.5 mm -91.94 148.28 4.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.301 -178.255 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.15 -134.36 12.12 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.287 -179.288 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.417 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -84.31 -173.15 4.56 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.655 0.264 . . . . 0.0 110.686 179.422 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.414 ' HB3' HD21 ' A' ' 41' ' ' LEU . 5.2 p -160.46 23.38 0.15 Allowed 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.319 -178.91 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.431 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 8.3 mtpt -159.62 123.13 3.67 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.36 -177.701 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.439 ' O ' ' HA ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -92.13 145.05 24.82 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.196 178.714 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.516 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 0.4 OUTLIER -119.95 116.03 24.98 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 119.401 -0.919 . . . . 0.0 111.635 178.912 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 15.6 t -69.46 95.66 0.84 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.631 179.628 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -120.18 -168.18 1.57 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.939 -179.79 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -105.2 142.02 35.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.009 0.433 . . . . 0.0 111.198 -179.693 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.435 ' O ' ' N ' ' A' ' 56' ' ' SER . . . -125.26 -171.6 13.29 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.681 178.99 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.5 t 44.87 27.26 0.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.899 0.38 . . . . 0.0 111.59 179.41 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.5 p 67.7 19.75 9.65 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.695 179.025 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 169.9 -28.56 0.13 Allowed Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.124 -1.036 . . . . 0.0 113.384 179.475 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 52' ' ' GLY . 19.7 t -69.49 -176.63 1.02 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.908 0.385 . . . . 0.0 111.064 -179.596 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.58 151.53 21.87 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.981 179.409 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.434 HG23 ' N ' ' A' ' 52' ' ' GLY . 0.9 OUTLIER -162.09 176.68 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.136 -179.303 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.51 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 70.9 m95 -128.61 120.93 27.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.396 -179.253 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.516 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -69.0 167.72 18.99 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.754 178.189 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.49 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 56.1 Cg_exo -13.66 90.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.964 1 C-N-CA 125.399 4.066 . . . . 0.0 114.374 -179.16 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.509 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -94.46 -76.23 0.49 Allowed 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 115.273 -0.876 . . . . 0.0 113.231 -175.799 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.494 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -96.56 85.09 0.3 Allowed Pre-proline 0 N--CA 1.45 -0.462 0 N-CA-C 112.883 0.698 . . . . 0.0 112.883 -173.431 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.453 ' CD ' ' O ' ' A' ' 62' ' ' GLU . 22.2 Cg_endo -51.49 -156.28 0.0 OUTLIER 'Trans proline' 0 N--CA 1.473 0.274 0 C-N-CA 123.586 2.858 . . . . 0.0 112.187 174.504 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -100.88 177.59 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.972 0.415 . . . . 0.0 110.726 178.876 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -170.74 133.65 0.98 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.681 179.523 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -137.87 113.18 9.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.078 179.795 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.526 ' CB ' ' CZ ' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -51.65 126.62 18.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.744 179.65 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.518 ' CG2' ' CE1' ' A' ' 40' ' ' HIS . 2.2 p -40.41 96.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.01 -179.674 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.425 ' HE3' ' CG2' ' A' ' 90' ' ' THR . 0.1 OUTLIER -73.15 114.04 10.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.163 179.868 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.428 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -92.14 122.4 34.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.944 0.402 . . . . 0.0 110.133 178.521 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.01 -159.72 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.111 179.85 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.477 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 1.2 t -54.41 143.6 45.87 Favored Pre-proline 0 N--CA 1.449 -0.509 0 CA-C-O 120.589 0.233 . . . . 0.0 110.554 -179.829 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.455 ' HA ' ' CD1' ' A' ' 118' ' ' TRP . 22.4 Cg_exo -62.1 160.77 28.83 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.432 2.088 . . . . 0.0 111.941 -179.855 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.476 ' HD2' ' CG ' ' A' ' 118' ' ' TRP . 74.7 Cg_exo -38.64 156.95 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.885 2.39 . . . . 0.0 112.912 -179.489 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.94 89.97 3.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.749 179.906 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 19.8 pt -69.35 178.65 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.057 -179.816 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.8 m -99.2 142.47 30.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.974 179.941 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.48 ' HB3' ' CE1' ' A' ' 103' ' ' TYR . 2.6 m-80 59.02 28.79 18.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.099 179.524 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.458 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -165.95 -167.49 26.66 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.857 179.834 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 10.1 ptt180 -161.66 -175.49 4.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.032 0.444 . . . . 0.0 110.923 -179.693 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.477 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 9.5 p-80 -108.68 171.35 7.48 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.881 179.88 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.435 ' O ' ' N ' ' A' ' 85' ' ' TYR . 95.5 m-20 -106.97 -96.77 0.36 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.684 179.146 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.446 ' O ' ' CB ' ' A' ' 85' ' ' TYR . . . 59.93 -81.48 0.01 OUTLIER Glycine 0 C--N 1.337 0.596 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.878 179.34 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.472 ' N ' ' CD2' ' A' ' 85' ' ' TYR . 3.7 m-30 93.66 10.72 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.287 1.435 . . . . 0.0 111.374 -179.783 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.53 -174.06 2.45 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.593 178.456 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -110.28 -25.01 10.35 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.631 178.649 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.431 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 13.5 m-85 -145.95 166.93 24.57 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.697 179.847 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.431 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 32.2 m-85 -145.05 165.66 27.58 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.698 -179.327 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.425 ' CG2' ' HE3' ' A' ' 70' ' ' LYS . 13.3 p -128.5 178.16 6.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.108 0.48 . . . . 0.0 111.764 -178.384 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -62.25 95.58 0.07 Allowed 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.042 179.981 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 125.58 20.35 2.16 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.372 -0.831 . . . . 0.0 113.208 178.453 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.434 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -97.5 159.28 15.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 117.015 0.408 . . . . 0.0 110.439 178.91 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 27.1 m -134.92 146.28 30.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.022 0.439 . . . . 0.0 111.056 -179.626 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.505 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 27.9 t -141.62 148.35 21.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.946 179.699 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.08 131.12 54.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.776 179.663 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.527 ' CE1' ' CG2' ' A' ' 111' ' ' VAL . 6.2 m-85 -90.42 155.89 18.61 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.106 -179.414 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 p -149.86 136.68 19.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.542 -179.482 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.411 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 60.5 m -70.13 159.19 34.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.867 179.27 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.458 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 73.0 m-80 -92.13 -76.49 0.46 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.354 -179.483 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.78 -23.16 28.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.225 -179.351 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.65 32.35 1.03 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.525 -179.932 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.499 ' CE2' HG12 ' A' ' 126' ' ' ILE . 46.2 m-85 -69.99 -171.7 0.46 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 120.64 0.257 . . . . 0.0 110.48 179.709 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.8 m -109.78 108.18 18.44 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.91 0.386 . . . . 0.0 111.349 -178.905 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.457 HD23 ' CB ' ' A' ' 109' ' ' SER . 0.9 OUTLIER -48.14 106.93 0.11 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.374 178.142 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.459 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 43.6 mm -85.2 158.95 3.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.168 -178.47 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.424 ' N ' HG21 ' A' ' 106' ' ' ILE . . . 59.66 -127.42 44.48 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.844 -179.248 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -118.18 132.75 56.31 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.87 0.367 . . . . 0.0 110.669 178.974 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.479 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 0.1 OUTLIER -69.45 -28.9 66.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.119 0.485 . . . . 0.0 110.453 179.549 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.58 131.4 14.44 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.764 -179.927 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.527 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 2.8 t -123.92 121.71 62.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.583 0.23 . . . . 0.0 110.644 179.217 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.67 121.14 25.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.875 0.369 . . . . 0.0 111.443 -178.818 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.483 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 23.3 t -85.73 106.14 16.77 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 176.465 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.81 160.11 43.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.129 0.49 . . . . 0.0 111.394 -178.333 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.28 34.41 6.22 Favored Glycine 0 CA--C 1.518 0.219 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.775 179.611 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 65.91 12.94 58.56 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.641 -179.448 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -136.58 -178.85 5.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.876 0.37 . . . . 0.0 110.704 179.63 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.505 ' CH2' ' CG2' ' A' ' 95' ' ' VAL . 93.2 m95 -119.08 141.63 48.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.969 -179.416 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.08 150.13 50.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.05 0.452 . . . . 0.0 111.535 -179.029 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.478 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.5 OUTLIER 71.26 46.35 0.25 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.125 178.744 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 85.5 Cg_endo -78.22 142.23 19.0 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.376 2.05 . . . . 0.0 111.729 178.424 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.479 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 61.6 Cg_endo -90.13 -172.3 0.56 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.67 2.246 . . . . 0.0 113.476 -178.589 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.432 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -134.71 -178.48 5.09 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.974 178.215 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . 0.432 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 11.1 m -139.51 97.66 3.32 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.965 0.412 . . . . 0.0 111.027 -179.832 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -123.96 155.35 38.34 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.975 -179.683 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.499 HG12 ' CE2' ' A' ' 103' ' ' TYR . 18.1 mm . . . . . 0 C--N 1.324 -0.507 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.99 179.932 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 120.975 0.417 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.73 176.4 4.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.007 -179.788 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.409 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 13.1 m -83.93 161.31 55.88 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.733 179.757 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.74 169.19 19.46 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.396 2.064 . . . . 0.0 111.305 179.121 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -52.81 116.9 9.86 Favored Pre-proline 0 C--N 1.326 -0.436 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.962 -178.794 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.448 ' CG ' HD11 ' A' ' 22' ' ' ILE . 16.3 Cg_endo -57.27 157.58 21.18 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.62 2.214 . . . . 0.0 112.273 179.987 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.439 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 9.2 mtt-85 -64.55 176.05 1.23 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.201 178.974 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.417 ' O ' ' CB ' ' A' ' 63' ' ' ALA . 1.1 t0 -130.89 -172.39 2.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.108 0.48 . . . . 0.0 111.679 -178.895 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.6 tt -145.71 151.48 14.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.727 -179.684 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -80.35 -70.73 0.5 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.672 -178.583 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.433 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 1.2 m120 -91.2 42.9 1.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.929 0.395 . . . . 0.0 110.946 -179.408 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.419 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -153.41 -173.76 22.98 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.956 179.904 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -145.66 135.2 23.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.706 0.289 . . . . 0.0 110.415 179.733 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.519 ' CD2' ' CE1' ' A' ' 33' ' ' TYR . 0.5 OUTLIER -83.73 156.99 22.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.125 0.488 . . . . 0.0 111.677 -179.23 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.436 ' CB ' ' HB ' ' A' ' 32' ' ' THR . 0.3 OUTLIER -127.73 73.75 1.48 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.31 177.061 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.448 HD11 ' CG ' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -80.32 95.58 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.835 -176.674 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.02 16.96 59.24 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.99 177.538 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 164.49 149.67 5.87 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.075 -0.583 . . . . 0.0 111.901 -179.582 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.7 m -135.91 32.85 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.699 0.285 . . . . 0.0 111.354 -179.455 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.2 OUTLIER -102.75 155.81 18.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.125 179.933 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.483 ' CZ ' ' CD1' ' A' ' 51' ' ' LEU . 4.9 t80 -50.71 91.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.771 179.657 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 129.97 -12.2 5.87 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.654 -179.251 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.2 p -70.63 177.04 3.71 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.735 0.302 . . . . 0.0 110.659 179.671 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.8 p -148.51 142.89 26.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.116 179.972 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.532 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.6 OUTLIER -104.64 171.14 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.564 179.858 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.436 ' HB ' ' CB ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -135.73 111.14 9.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.993 0.425 . . . . 0.0 111.337 179.568 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.519 ' CE1' ' CD2' ' A' ' 20' ' ' LEU . 26.5 m-85 -87.37 143.17 27.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.435 -179.755 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.419 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 5.0 m -147.05 168.47 21.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.725 179.442 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.401 ' HB2' ' HB2' ' A' ' 39' ' ' TYR . 1.3 m -87.64 166.14 14.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.828 179.696 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 -67.25 -84.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.996 -179.76 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -154.03 130.8 10.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.109 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.02 19.26 71.68 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.433 -179.534 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.49 ' CE1' ' HB3' ' A' ' 68' ' ' SER . 3.3 m-30 -111.72 178.59 4.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.859 0.361 . . . . 0.0 110.966 -179.604 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.447 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.4 OUTLIER -138.31 113.23 9.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.136 0.493 . . . . 0.0 110.472 177.645 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.445 ' CD1' ' HG3' ' A' ' 64' ' ' PRO . 6.8 tt -77.38 120.26 22.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.96 -179.01 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.447 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 2.6 mm -96.22 153.13 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.734 179.685 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.04 -137.14 15.18 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.975 -178.71 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.424 ' O ' ' CG ' ' A' ' 64' ' ' PRO . 5.1 mt-10 -88.67 -176.84 5.4 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.507 0.67 . . . . 0.0 111.221 179.175 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.406 ' HB3' HD21 ' A' ' 41' ' ' LEU . 3.7 p -155.15 24.16 0.42 Allowed 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 114.592 -1.186 . . . . 0.0 110.332 179.045 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -150.55 128.95 12.1 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.173 0.511 . . . . 0.0 112.068 -178.763 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.489 ' HA ' ' O ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -108.03 151.2 26.16 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.89 178.256 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.503 ' CD1' ' CB ' ' A' ' 60' ' ' ASN . 1.5 m-85 -126.28 122.54 35.8 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 119.456 -0.898 . . . . 0.0 112.598 -177.846 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.457 ' HB3' ' CH2' ' A' ' 59' ' ' TRP . 26.0 t -71.26 102.27 2.52 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.398 178.55 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -129.33 -176.19 3.81 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.317 -179.039 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.483 ' CD1' ' CZ ' ' A' ' 27' ' ' PHE . 6.7 mt -83.13 157.84 22.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.447 -178.879 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.04 -157.57 23.75 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.618 179.933 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 m -83.83 -32.48 25.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.77 0.319 . . . . 0.0 110.992 -179.874 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.9 p -108.38 24.55 12.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.022 179.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.2 25.89 42.41 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.569 179.944 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.36 -165.04 1.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.832 0.349 . . . . 0.0 110.92 179.962 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 8.0 mmt -109.98 129.82 55.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.768 179.683 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.4 m -143.2 177.94 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.069 -179.909 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.532 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 72.6 m95 -131.84 128.65 39.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.344 -179.429 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.503 ' CB ' ' CD1' ' A' ' 48' ' ' TYR . 0.7 OUTLIER -69.67 164.63 48.86 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.707 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.489 ' O ' ' HA ' ' A' ' 47' ' ' SER . 97.7 Cg_exo -13.78 113.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.826 1 C-N-CA 125.552 4.168 . . . . 0.0 115.08 -176.257 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.474 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 3.7 mt-10 -106.17 -96.56 0.35 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.412 -1.267 . . . . 0.0 112.56 -175.579 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.417 ' CB ' ' O ' ' A' ' 14' ' ' ASP . . . -78.2 108.28 7.31 Favored Pre-proline 0 C--O 1.231 0.11 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -176.457 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.445 ' HG3' ' CD1' ' A' ' 41' ' ' LEU . 1.8 Cg_endo -86.83 -155.28 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.208 2.605 . . . . 0.0 110.881 177.387 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.41 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 5.0 mm -88.95 163.96 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.893 0.378 . . . . 0.0 110.882 178.61 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -170.18 125.46 0.77 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.768 179.589 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -153.6 174.35 14.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.914 -178.873 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.49 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 77.1 p -82.25 94.7 7.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.103 0.478 . . . . 0.0 110.337 178.387 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.43 ' CG2' ' HA3' ' A' ' 116' ' ' GLY . 6.0 p -47.33 102.43 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.214 -179.891 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -70.66 157.0 38.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.516 -177.058 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.409 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -132.02 115.27 15.6 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.882 178.435 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -70.61 -163.59 0.08 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.313 -178.779 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.467 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 1.6 t -46.81 139.92 6.36 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.227 -179.539 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.492 ' HD2' ' CE1' ' A' ' 82' ' ' HIS . 24.2 Cg_exo -62.83 146.36 94.99 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.328 2.019 . . . . 0.0 112.449 -179.125 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.505 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 0.2 OUTLIER -119.71 -159.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 124.742 3.628 . . . . 0.0 114.013 -174.784 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 75' ' ' PRO . 3.4 p 96.0 -66.23 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 171.241 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.506 HG21 ' CD2' ' A' ' 97' ' ' TYR . 0.2 OUTLIER -76.13 176.05 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 122.251 1.024 . . . . 0.0 113.51 -172.144 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.471 ' N ' HG13 ' A' ' 77' ' ' ILE . 2.4 m -139.93 143.36 36.57 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 113.307 -1.769 . . . . 0.0 108.551 176.42 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.406 ' ND2' ' N ' ' A' ' 79' ' ' ASN . 0.7 OUTLIER 77.03 23.12 0.96 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.795 0.331 . . . . 0.0 111.076 -178.091 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -147.9 -161.09 9.31 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.55 178.748 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -161.21 -173.92 4.08 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.92 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.492 ' CE1' ' HD2' ' A' ' 74' ' ' PRO . 2.1 p80 -135.51 150.38 49.75 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.124 0.488 . . . . 0.0 111.927 -178.032 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.416 ' ND2' ' OG1' ' A' ' 96' ' ' THR . 19.3 m-20 -76.54 -146.15 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.154 179.106 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.428 ' O ' ' HB3' ' A' ' 85' ' ' TYR . . . 79.4 -66.01 3.55 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.102 -1.046 . . . . 0.0 111.314 -178.352 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.428 ' HB3' ' O ' ' A' ' 84' ' ' GLY . 3.7 m-85 66.18 28.62 10.07 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 121.456 0.646 . . . . 0.0 110.075 179.363 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.91 -173.43 2.61 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.173 178.648 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -109.9 -23.82 11.15 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.897 0.38 . . . . 0.0 110.644 178.553 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -151.47 163.38 39.12 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.187 -179.652 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.409 ' N ' ' O ' ' A' ' 71' ' ' CYS . 31.1 m-85 -140.75 159.1 42.93 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.272 179.813 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.1 p -122.04 177.27 5.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.118 0.485 . . . . 0.0 111.992 -177.466 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.405 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 1.0 OUTLIER -62.9 96.44 0.09 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.918 -179.998 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 125.96 12.54 3.57 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.227 -0.897 . . . . 0.0 113.082 179.107 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.401 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -92.93 155.54 17.5 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.934 0.367 . . . . 0.0 110.433 179.183 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 35.4 m -131.44 157.48 43.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.926 0.393 . . . . 0.0 111.02 -179.946 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.464 HG22 ' CH2' ' A' ' 118' ' ' TRP . 41.9 t -153.59 151.7 11.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.999 179.909 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.426 ' CG2' ' HB3' ' A' ' 109' ' ' SER . 0.0 OUTLIER -111.33 122.45 47.88 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.786 179.922 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.532 ' CE1' ' CG2' ' A' ' 111' ' ' VAL . 6.2 m-85 -81.06 156.1 26.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.651 -178.717 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 81' ' ' ARG . 1.2 p -147.23 134.81 20.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.397 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.4 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 74.8 m -72.0 149.72 44.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.76 0.314 . . . . 0.0 111.454 -179.875 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -96.1 -82.05 0.4 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.931 178.496 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -39.88 -30.99 0.1 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.901 -179.308 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.07 32.7 0.62 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.915 179.597 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.489 ' CD1' HG12 ' A' ' 126' ' ' ILE . 48.2 m-85 -79.96 -171.56 2.97 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.735 0.302 . . . . 0.0 110.779 179.635 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.4 m -118.97 114.5 22.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.967 0.413 . . . . 0.0 110.712 -179.846 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.448 ' CD2' ' HA ' ' A' ' 109' ' ' SER . 0.3 OUTLIER -51.04 102.95 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.001 179.959 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.427 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 22.8 mm -95.62 151.6 3.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.554 179.171 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 69.19 24.96 75.81 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.497 -0.859 . . . . 0.0 113.033 179.173 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.42 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.3 OUTLIER 60.33 136.83 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.471 0.653 . . . . 0.0 111.642 179.745 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.504 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 0.8 OUTLIER -70.21 -20.88 63.07 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.988 -179.179 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -64.65 122.42 24.64 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.695 -179.334 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.532 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 3.2 t -122.63 147.76 26.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 179.175 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.92 115.51 29.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.022 0.439 . . . . 0.0 111.627 -179.003 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.5 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 30.4 t -82.7 98.34 9.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.747 177.167 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.8 OUTLIER -138.48 160.37 39.72 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.362 -178.252 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.73 25.37 3.42 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.69 179.436 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.43 ' HA3' ' CG2' ' A' ' 69' ' ' VAL . . . 83.24 -6.76 70.4 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.945 -179.859 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -126.16 179.8 5.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.866 0.365 . . . . 0.0 110.556 179.834 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.505 ' CD1' ' HD2' ' A' ' 75' ' ' PRO . 79.0 m95 -110.38 143.44 40.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.703 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.05 162.43 23.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.029 0.442 . . . . 0.0 111.536 -178.78 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.475 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 4.3 p-10 47.65 47.82 5.07 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.058 179.526 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 72.0 Cg_endo -76.08 163.55 32.77 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.416 2.077 . . . . 0.0 111.949 178.49 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.504 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 41.3 Cg_endo -94.97 -166.1 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.121 2.547 . . . . 0.0 113.778 -178.133 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.26 170.55 17.64 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.5 177.665 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . 0.439 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 1.6 m -122.97 91.24 3.45 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.971 0.415 . . . . 0.0 111.196 179.846 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.4 ' HB3' HG13 ' A' ' 106' ' ' ILE . 19.2 mt-30 -114.15 159.43 20.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.19 178.96 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.489 HG12 ' CD1' ' A' ' 103' ' ' TYR . 16.9 mm . . . . . 0 C--N 1.321 -0.67 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.224 -179.375 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 22.5 mmm-85 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.917 0.389 . . . . 0.0 111.087 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.14 164.99 11.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.829 -179.97 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.51 ' HB2' ' CD ' ' A' ' 10' ' ' PRO . 71.8 m -69.82 176.4 1.77 Allowed Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.174 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.525 ' HD2' ' CD1' ' A' ' 59' ' ' TRP . 30.6 Cg_endo -83.2 175.01 8.75 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 121.792 1.661 . . . . 0.0 110.58 178.261 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.9 p -51.09 104.57 0.44 Allowed Pre-proline 0 C--N 1.324 -0.501 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.611 -179.634 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.467 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 32.3 Cg_exo -38.09 156.02 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.748 2.299 . . . . 0.0 112.723 -178.66 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.44 164.53 20.91 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.379 178.652 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -114.09 -173.54 2.3 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.754 -176.707 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.436 HG22 ' CD2' ' A' ' 20' ' ' LEU . 5.8 tt -132.32 150.14 33.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.502 179.217 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -76.52 -68.5 0.59 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.79 -177.992 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -92.45 41.57 1.08 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.916 0.389 . . . . 0.0 111.076 -178.58 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.432 ' HA2' ' N ' ' A' ' 36' ' ' ASN . . . -162.3 -173.66 31.25 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.999 179.815 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -129.91 168.67 16.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.659 0.266 . . . . 0.0 110.31 179.173 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.512 ' CD2' ' CE2' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -119.85 156.59 30.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.025 0.44 . . . . 0.0 111.38 -179.427 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.42 76.49 1.71 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.979 178.358 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.466 ' CD1' HG22 ' A' ' 31' ' ' ILE . 5.9 mm -69.35 109.81 2.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.72 -177.827 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -112.91 15.72 23.52 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.347 178.465 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 152.58 138.26 2.7 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.994 -179.617 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.431 HG13 ' CD ' ' A' ' 12' ' ' PRO . 30.2 m -124.4 25.66 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -178.705 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -94.58 152.03 18.85 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.994 0.426 . . . . 0.0 111.035 -179.966 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.518 ' CZ ' ' CD1' ' A' ' 51' ' ' LEU . 2.4 t80 -47.25 92.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.088 -179.682 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 126.1 0.51 7.55 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.853 -179.593 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.17 -178.82 7.18 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 116.978 0.389 . . . . 0.0 110.662 179.696 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.0 p -153.84 145.06 22.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.266 0.555 . . . . 0.0 110.862 179.713 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.485 HD12 ' CE3' ' A' ' 59' ' ' TRP . 0.9 OUTLIER -109.98 164.88 5.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.181 -179.169 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.4 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -124.49 107.83 11.49 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.061 0.458 . . . . 0.0 111.157 179.196 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.523 ' CE2' ' HA ' ' A' ' 63' ' ' ALA . 6.5 m-85 -82.24 147.21 29.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.528 -179.461 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.45 168.6 20.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.648 179.471 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -95.36 167.18 11.5 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.645 179.795 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.432 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 25.7 m120 -55.16 -85.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.169 -178.434 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.01 125.59 4.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.258 -179.934 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.427 ' HA2' ' CB ' ' A' ' 91' ' ' ASP . . . 74.02 16.51 79.5 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.284 -0.96 . . . . 0.0 112.12 -178.242 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.532 ' CE1' ' CB ' ' A' ' 68' ' ' SER . 2.2 m-85 -107.21 -173.08 2.21 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.709 0.29 . . . . 0.0 110.503 -179.985 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.492 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.3 OUTLIER -149.65 111.0 4.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.037 0.446 . . . . 0.0 110.762 178.265 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.477 ' CD2' ' HG2' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -79.74 132.05 36.08 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.86 179.761 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.492 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 3.2 mm -97.27 163.13 2.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.605 -176.865 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 63.53 -152.25 47.9 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.531 -178.383 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.409 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -60.23 -171.84 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.199 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.463 ' CB ' ' CD1' ' A' ' 41' ' ' LEU . 91.0 p -171.28 34.19 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 121.307 0.575 . . . . 0.0 109.968 -179.893 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.4 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 1.9 mmmt -151.63 129.0 11.3 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.803 -178.966 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.426 ' HB2' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -95.86 136.32 36.44 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.55 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.499 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 1.8 m-85 -115.89 123.69 48.76 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 119.307 -0.957 . . . . 0.0 112.196 -178.465 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 44.7 t -73.19 107.69 5.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.921 179.562 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -137.43 -175.39 4.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.114 179.929 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.518 ' CD1' ' CZ ' ' A' ' 27' ' ' PHE . 10.9 mt -86.71 161.4 18.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.835 -179.891 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -103.35 -87.83 2.02 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.832 -179.566 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.71 47.79 1.25 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.826 0.346 . . . . 0.0 111.242 -179.19 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 1.2 p 68.14 27.38 6.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.905 179.195 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.92 -31.87 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.652 -179.697 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.0 t -78.28 167.34 21.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.885 0.374 . . . . 0.0 110.821 179.882 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.49 135.2 43.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.791 -179.073 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.8 m -148.57 165.34 4.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.176 -179.785 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.525 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 58.3 m95 -121.43 127.04 50.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.141 179.976 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.499 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 6.6 m-80 -69.76 165.21 43.92 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.171 178.883 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.438 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 42.1 Cg_exo -13.27 96.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.055 1 C-N-CA 125.63 4.22 . . . . 0.0 114.398 -179.227 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.488 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.7 OUTLIER -93.17 -70.92 0.68 Allowed 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 114.985 -1.007 . . . . 0.0 113.245 -175.556 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.523 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -106.6 75.39 0.38 Allowed Pre-proline 0 C--N 1.333 -0.143 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -173.861 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.477 ' HG2' ' CD2' ' A' ' 41' ' ' LEU . 11.5 Cg_endo -54.53 -138.76 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 123.95 3.1 . . . . 0.0 112.417 175.849 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.475 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 3.0 mm -103.54 166.14 2.98 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.327 0 O-C-N 121.288 -0.883 . . . . 0.0 112.687 -175.244 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.2 m -158.05 136.01 10.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.779 178.569 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -155.22 167.6 29.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.036 -179.814 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.532 ' CB ' ' CE1' ' A' ' 39' ' ' TYR . 4.9 p -96.27 110.57 22.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.154 179.959 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 116' ' ' GLY . 0.9 OUTLIER -52.17 101.94 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.122 179.405 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.437 ' HB2' ' CD2' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -80.04 117.83 21.22 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.36 -179.729 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.424 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -98.85 115.83 29.71 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.064 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.5 -163.53 0.05 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.843 -179.048 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.435 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 2.3 t -44.89 137.76 4.35 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.945 -179.864 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -56.24 160.93 9.84 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 122.124 1.883 . . . . 0.0 111.791 -179.402 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.484 ' HD2' ' CG ' ' A' ' 118' ' ' TRP . 98.8 Cg_exo -42.17 155.8 0.09 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.839 2.36 . . . . 0.0 112.928 -178.639 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.5 t -107.14 90.23 3.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.43 179.152 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.6 pt -69.47 170.23 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.319 -178.998 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.8 m -89.86 138.44 31.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.727 179.688 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 60.41 28.22 17.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.926 179.782 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.463 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -163.44 -165.68 21.0 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.268 -0.968 . . . . 0.0 113.225 179.828 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.3 -175.07 3.12 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.084 0.469 . . . . 0.0 110.603 -178.952 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.435 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 11.5 p-80 -107.63 178.12 4.62 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.909 179.731 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -107.4 -14.51 14.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.597 -179.827 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -45.65 138.31 6.63 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.936 -178.741 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -109.76 -25.51 10.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.907 0.385 . . . . 0.0 110.967 -179.743 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.31 -170.81 2.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.678 179.791 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -110.36 -21.17 12.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.399 -179.649 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.437 ' CD2' ' HB2' ' A' ' 70' ' ' LYS . 18.5 m-85 -143.6 164.32 30.73 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.037 0.446 . . . . 0.0 111.704 -178.591 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.424 ' N ' ' O ' ' A' ' 71' ' ' CYS . 22.3 m-85 -145.75 169.62 18.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.095 178.727 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.428 HG21 ' CE ' ' A' ' 70' ' ' LYS . 5.5 p -134.38 -174.41 3.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.981 0.42 . . . . 0.0 111.729 -178.699 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 0.4 OUTLIER -65.76 103.75 0.95 Allowed 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.6 0.714 . . . . 0.0 111.002 -179.905 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 120.77 17.57 4.19 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.563 179.663 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.46 148.73 25.57 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.825 0.345 . . . . 0.0 110.799 179.746 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 35.5 m -129.06 156.04 41.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.032 -179.522 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.513 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 18.5 t -151.74 148.86 14.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.983 179.918 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -104.38 138.55 40.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.987 -179.936 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.534 ' CE2' ' CG2' ' A' ' 111' ' ' VAL . 4.4 m-85 -98.8 155.89 17.13 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.342 -179.157 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 74.3 m -151.34 143.28 23.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.066 -179.908 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.425 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 63.7 m -71.78 159.72 33.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.784 179.626 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.463 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 44.5 m-20 -85.85 -70.84 0.57 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.512 -178.944 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.0 t -68.33 -23.62 64.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.384 -179.008 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 124.26 34.79 0.7 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.568 -179.787 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.48 ' CE2' HG12 ' A' ' 126' ' ' ILE . 14.9 m-85 -69.76 -174.46 0.74 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 120.948 0.404 . . . . 0.0 110.573 179.509 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.88 100.66 10.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.424 178.927 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.444 ' CD2' ' HA ' ' A' ' 109' ' ' SER . 0.3 OUTLIER -46.64 125.59 7.31 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.376 0.608 . . . . 0.0 111.602 -178.873 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.44 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 36.8 mm -89.59 153.17 3.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.098 179.391 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 60.37 -132.3 50.07 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.773 -178.594 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -116.26 137.58 52.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.981 0.42 . . . . 0.0 111.318 179.509 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.473 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 0.7 OUTLIER -66.12 -27.64 68.2 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.408 178.7 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -70.9 138.17 27.92 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.545 179.575 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.534 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 2.9 t -131.39 130.46 62.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 179.162 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.417 ' CD1' ' HB2' ' A' ' 114' ' ' SER . 0.6 OUTLIER -89.85 128.18 36.13 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.957 0.408 . . . . 0.0 111.682 -178.576 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.507 ' HB2' ' CZ3' ' A' ' 118' ' ' TRP . 42.6 t -99.21 102.92 14.73 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.678 176.648 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 20.0 p -148.03 111.84 5.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.506 -178.657 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.41 ' CA ' HG12 ' A' ' 69' ' ' VAL . . . 94.25 39.84 4.69 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.262 179.645 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.442 ' N ' HG12 ' A' ' 69' ' ' VAL . . . 58.82 20.2 46.91 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.145 -179.339 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -143.97 -178.06 5.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.916 0.388 . . . . 0.0 110.867 -179.976 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.513 ' CH2' ' CG2' ' A' ' 95' ' ' VAL . 93.5 m95 -125.38 144.07 50.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.184 -179.121 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.48 166.65 15.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.495 -178.984 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.44 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.5 p30 45.73 50.35 7.77 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.437 -0.802 . . . . 0.0 112.361 179.065 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 96.6 Cg_endo -80.05 146.36 18.08 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.558 2.172 . . . . 0.0 111.47 177.572 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.473 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 61.1 Cg_endo -94.6 -173.01 0.29 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.786 2.324 . . . . 0.0 113.489 -178.477 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.439 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -131.69 -161.45 1.13 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.933 177.766 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 6.5 m -154.37 89.07 1.25 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.084 0.468 . . . . 0.0 111.122 179.104 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -118.54 170.86 8.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.436 179.324 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.48 HG12 ' CE2' ' A' ' 103' ' ' TYR . 22.1 mm . . . . . 0 C--N 1.323 -0.575 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.825 -179.976 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.9 mtm180 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.885 0.374 . . . . 0.0 110.772 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.85 -176.38 1.32 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.071 -179.716 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.435 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 51.1 m -108.54 160.82 25.78 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.751 179.958 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.401 ' HD3' ' HB2' ' A' ' 9' ' ' CYS . 38.6 Cg_endo -67.27 172.96 9.3 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.51 2.14 . . . . 0.0 112.255 -179.777 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.4 t -50.97 111.55 2.36 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.969 -179.57 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.426 ' CB ' HD12 ' A' ' 31' ' ' ILE . 9.9 Cg_endo -56.66 144.26 86.57 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.192 1.928 . . . . 0.0 111.944 179.724 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.423 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 3.0 mtt85 -51.61 159.3 0.78 Allowed 'General case' 0 CA--C 1.517 -0.288 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.071 178.901 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.15 -174.21 2.41 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.179 0.514 . . . . 0.0 111.709 -177.918 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.7 tt -144.36 139.78 24.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.526 -179.726 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -87.08 -48.07 8.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.667 -178.486 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -94.25 25.96 3.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.055 -178.822 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -157.42 -170.37 22.22 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.816 -179.625 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -141.45 130.82 23.69 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.661 0.267 . . . . 0.0 110.638 179.882 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.521 ' CD2' ' CE2' ' A' ' 33' ' ' TYR . 10.6 mt -73.2 156.61 38.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.188 0.518 . . . . 0.0 111.719 -179.496 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.14 73.01 1.51 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.506 177.517 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.447 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 68.5 mt -69.16 101.72 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.722 -177.183 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -103.84 17.11 50.02 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.953 177.735 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 157.43 126.15 0.89 Allowed Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.146 -179.697 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.3 m -116.71 19.02 7.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 111.631 0.234 . . . . 0.0 111.631 -179.298 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -88.03 164.66 15.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.953 0.406 . . . . 0.0 110.847 179.594 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -61.72 91.75 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.787 179.881 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 124.88 12.25 4.08 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.0 179.909 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.2 m -96.0 -172.2 2.51 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.869 0.334 . . . . 0.0 110.479 179.289 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 47' ' ' SER . 19.3 p -155.49 147.27 23.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.054 0.454 . . . . 0.0 111.398 179.852 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.535 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 1.0 OUTLIER -106.82 171.42 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.669 179.631 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.448 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -131.9 113.52 13.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.012 0.434 . . . . 0.0 111.261 179.499 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.521 ' CE2' ' CD2' ' A' ' 20' ' ' LEU . 20.6 m-85 -89.19 136.35 33.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.229 -179.813 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.7 m -139.71 158.05 44.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.796 -179.974 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.431 ' HB2' ' CB ' ' A' ' 39' ' ' TYR . 31.3 m -87.75 157.74 18.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.949 0.404 . . . . 0.0 110.984 179.9 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.48 -92.72 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.88 -179.359 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -147.48 131.0 16.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.824 0.345 . . . . 0.0 110.834 -179.648 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.47 23.21 75.19 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.917 -178.831 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.487 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.0 m-85 -116.18 168.36 10.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.797 0.332 . . . . 0.0 110.994 -179.183 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.521 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.3 OUTLIER -130.56 124.32 31.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.55 178.248 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.442 ' CD2' ' O ' ' A' ' 44' ' ' GLU . 5.4 tt -87.99 124.54 33.83 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.725 -179.622 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.521 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 2.1 mm -102.62 165.09 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.006 0.432 . . . . 0.0 111.071 -179.893 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.65 -136.15 20.47 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.241 -179.458 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.442 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 1.9 pt-20 -74.54 -173.22 1.71 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.767 0.318 . . . . 0.0 110.534 179.197 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.8 p -163.42 24.31 0.08 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.219 -179.502 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.448 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -166.98 125.7 1.37 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.524 -177.554 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.442 ' CB ' ' HA ' ' A' ' 62' ' ' GLU . 0.4 OUTLIER -92.13 138.72 31.3 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 177.492 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.518 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 2.1 m-85 -116.46 119.71 36.49 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 119.446 -0.902 . . . . 0.0 111.765 179.88 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 26.8 t -70.01 112.8 6.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.756 179.537 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.418 ' OE2' ' ND2' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -139.76 -171.55 3.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 179.741 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -100.78 143.12 31.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.034 -179.558 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -64.9 -148.02 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.421 179.76 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.09 -38.19 12.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.824 0.345 . . . . 0.0 110.861 179.922 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.6 p -97.9 25.28 6.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.835 179.797 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.14 21.95 64.19 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.218 -179.517 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.7 -175.03 5.34 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.063 0.459 . . . . 0.0 111.433 -179.047 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 6.7 mtt -105.68 129.66 53.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.096 178.474 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.2 m -148.93 176.45 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.188 -178.755 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.535 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 65.7 m95 -132.15 125.73 31.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.02 179.813 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.518 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 3.2 m-20 -68.8 168.38 15.22 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.127 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 19.0 Cg_exo -10.66 88.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.043 1 C-N-CA 125.342 4.028 . . . . 0.0 114.783 -179.032 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.469 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 1.0 OUTLIER -83.82 -97.97 0.05 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.631 -177.381 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.495 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -84.65 110.29 26.34 Favored Pre-proline 0 C--O 1.231 0.096 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -175.903 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.44 ' CG ' ' O ' ' A' ' 44' ' ' GLU . 5.0 Cg_exo -78.53 -153.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.918 2.412 . . . . 0.0 111.086 177.025 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.407 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 3.8 mm -93.83 167.68 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.672 0.272 . . . . 0.0 110.368 177.929 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -165.43 135.07 3.5 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.017 -179.968 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -156.38 178.38 10.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.955 -179.794 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.487 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 52.9 p -86.1 113.2 21.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.981 179.982 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.455 ' CG2' ' HB3' ' A' ' 40' ' ' HIS . 0.1 OUTLIER -43.54 98.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.589 -179.907 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.428 ' HE3' ' CG2' ' A' ' 90' ' ' THR . 1.3 mmtp -72.08 107.93 5.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.1 179.852 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.42 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -93.37 125.26 37.87 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.818 0.342 . . . . 0.0 110.159 178.578 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.88 -156.02 0.06 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.478 179.807 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.427 ' OG ' ' NE2' ' A' ' 82' ' ' HIS . 1.7 t -48.8 138.24 12.54 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.084 -179.854 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.483 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 25.3 Cg_exo -61.11 163.34 17.02 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.372 2.048 . . . . 0.0 112.035 179.764 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.503 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 82.7 Cg_exo -38.75 156.43 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.895 2.396 . . . . 0.0 112.903 -179.274 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.5 m -109.78 89.76 3.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.484 179.315 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.7 pt -69.09 175.22 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.09 -179.318 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.437 ' HB3' ' ND2' ' A' ' 79' ' ' ASN . 0.6 OUTLIER -95.71 145.94 24.9 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.399 178.605 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.507 ' HB3' ' CD2' ' A' ' 103' ' ' TYR . 3.0 m-80 59.46 28.74 18.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.895 0.379 . . . . 0.0 111.104 177.876 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -170.48 -161.68 21.48 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.644 -0.788 . . . . 0.0 113.092 179.634 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' ' 98' ' ' SER . 1.4 ptt85 -170.18 -175.22 1.92 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.972 0.415 . . . . 0.0 110.984 -178.79 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.427 ' NE2' ' OG ' ' A' ' 73' ' ' SER . 12.2 p80 -105.05 176.43 5.16 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.982 179.874 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.427 ' ND2' ' HB ' ' A' ' 96' ' ' THR . 0.2 OUTLIER -131.73 80.62 1.93 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.543 179.138 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -110.88 150.93 17.77 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.189 -1.005 . . . . 0.0 112.53 -179.845 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -106.35 -27.95 10.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.033 0.444 . . . . 0.0 110.546 179.747 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.27 -172.15 2.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.814 179.852 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -111.46 -19.84 12.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.084 179.324 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -138.27 167.72 21.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.96 0.41 . . . . 0.0 111.251 -179.557 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.42 ' N ' ' O ' ' A' ' 71' ' ' CYS . 62.5 m-85 -144.09 163.52 33.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.491 179.843 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.428 ' CG2' ' HE3' ' A' ' 70' ' ' LYS . 16.0 p -128.22 179.93 5.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.906 0.384 . . . . 0.0 111.349 -179.228 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.1 p-10 -64.48 94.75 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.267 0.556 . . . . 0.0 110.864 -179.926 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.34 28.05 1.04 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.116 179.085 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.421 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -106.0 161.5 14.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.679 0.276 . . . . 0.0 110.522 179.125 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 35.3 m -134.07 152.24 33.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.215 0.531 . . . . 0.0 111.441 -179.567 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.507 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 21.6 t -150.88 147.27 15.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.618 179.27 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.427 ' HB ' ' ND2' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -103.83 144.72 31.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.114 178.574 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.487 ' CE1' HG23 ' A' ' 111' ' ' VAL . 4.7 m-85 -100.5 156.76 17.1 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.596 179.941 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 81' ' ' ARG . 51.8 p -153.18 143.88 22.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.349 -178.82 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.424 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 23.3 m -69.52 164.88 22.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.086 -178.844 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -94.88 -84.78 0.32 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.878 178.913 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.35 -41.07 79.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.495 -179.259 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 147.07 42.56 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.644 -179.978 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.521 ' CE1' HG12 ' A' ' 126' ' ' ILE . 23.3 m-85 -80.14 -165.85 0.92 Allowed 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 122.355 0.262 . . . . 0.0 110.601 179.962 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.3 m -120.64 107.53 12.92 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.798 0.332 . . . . 0.0 111.719 -179.967 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.468 HD22 ' CB ' ' A' ' 109' ' ' SER . 1.4 tp -48.33 117.12 1.82 Allowed 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.334 177.83 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.449 ' HB ' ' CB ' ' A' ' 123' ' ' THR . 44.9 mm -91.53 154.34 3.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.036 -178.859 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.426 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 60.55 -128.88 46.29 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.082 -179.399 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -114.11 127.23 55.82 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.878 0.37 . . . . 0.0 110.819 179.35 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.468 ' CB ' HD22 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -64.01 -28.12 69.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.769 179.741 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.31 144.9 41.72 Favored Glycine 0 N--CA 1.452 -0.256 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.822 -179.919 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.487 HG23 ' CE1' ' A' ' 97' ' ' TYR . 3.4 t -140.52 127.51 22.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.544 0.211 . . . . 0.0 110.989 -179.959 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.45 128.87 34.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.911 0.386 . . . . 0.0 111.524 -179.51 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.5 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 24.7 t -91.98 104.69 17.07 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.513 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.2 t -150.89 163.95 37.47 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.146 0.498 . . . . 0.0 111.596 -177.976 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 45.29 32.21 3.58 Favored Glycine 0 N--CA 1.453 -0.219 0 CA-C-N 115.54 -0.754 . . . . 0.0 113.096 179.557 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.452 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 67.92 13.17 63.65 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.696 -179.994 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -143.17 171.42 14.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.84 0.353 . . . . 0.0 110.267 179.292 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.507 ' CH2' ' CG2' ' A' ' 95' ' ' VAL . 87.8 m95 -108.43 131.92 54.29 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.885 -179.364 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.99 149.81 34.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.066 0.46 . . . . 0.0 111.234 -179.154 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.493 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER 70.43 44.88 0.24 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.231 179.057 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 73.6 Cg_endo -76.9 140.56 20.55 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.266 1.977 . . . . 0.0 111.215 177.834 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.467 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 36.4 Cg_endo -91.78 -179.55 1.29 Allowed 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.453 2.102 . . . . 0.0 113.255 -178.679 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.449 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -118.77 -162.34 0.89 Allowed 'General case' 0 CA--C 1.502 -0.885 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.041 176.278 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 4.9 t -170.39 91.72 0.18 Allowed 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 119.901 -0.72 . . . . 0.0 111.265 -176.486 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -116.2 174.79 5.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.042 -178.685 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.521 HG12 ' CE1' ' A' ' 103' ' ' TYR . 46.7 mm . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.865 -179.881 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.81 0.338 . . . . 0.0 110.712 . . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.411 ' HA ' ' HA ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -86.75 170.1 12.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.14 -178.875 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.442 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 48.0 m -80.99 161.22 63.95 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.813 179.68 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.422 ' HD3' ' HB2' ' A' ' 9' ' ' CYS . 54.7 Cg_endo -69.77 172.47 12.59 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.355 2.037 . . . . 0.0 111.337 178.773 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.1 p -50.93 117.66 8.97 Favored Pre-proline 0 C--N 1.328 -0.327 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.913 -179.19 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.431 ' CG ' HD11 ' A' ' 22' ' ' ILE . 17.8 Cg_endo -58.71 161.66 14.55 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.708 2.272 . . . . 0.0 112.348 -179.874 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.435 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -61.92 179.92 0.24 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.105 178.744 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.33 -171.07 2.73 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.015 0.436 . . . . 0.0 111.321 -179.678 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.0 tt -152.56 150.15 13.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.798 -179.743 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -95.45 -52.39 4.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.111 -179.519 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -94.17 42.05 1.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.122 0.487 . . . . 0.0 110.819 -179.85 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -169.67 -169.74 33.29 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.429 179.806 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -148.14 130.09 15.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.667 0.27 . . . . 0.0 110.785 -179.505 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.527 ' CD2' ' CE1' ' A' ' 33' ' ' TYR . 19.5 mt -78.52 161.35 27.1 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.271 0.558 . . . . 0.0 111.72 -179.674 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -132.09 74.16 1.57 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.269 177.523 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.443 HG23 HD11 ' A' ' 22' ' ' ILE . 0.7 OUTLIER -80.75 107.55 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.86 -176.794 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.31 14.65 56.75 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.988 177.464 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 158.74 155.23 7.52 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.151 -179.62 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.2 m -132.72 8.42 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -179.52 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.411 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 0.7 OUTLIER -72.72 154.7 40.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.804 0.335 . . . . 0.0 111.009 -179.9 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -50.44 92.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.874 -179.949 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 128.25 -5.16 6.79 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.784 -179.732 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.39 -175.51 0.65 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.903 0.352 . . . . 0.0 110.787 179.92 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.1 p -157.45 139.59 14.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.093 179.776 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.52 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.4 OUTLIER -107.51 170.15 2.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.478 -179.884 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.431 ' O ' ' N ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -134.35 115.92 14.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.893 0.378 . . . . 0.0 110.986 179.58 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.527 ' CE1' ' CD2' ' A' ' 20' ' ' LEU . 23.0 m-85 -93.09 138.02 31.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.361 -179.067 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.83 170.13 16.27 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.782 179.847 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 50.9 m -91.03 163.39 14.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.858 0.361 . . . . 0.0 111.188 -179.639 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -62.69 -82.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.255 -179.655 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.39 136.48 13.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.852 -179.702 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.52 23.05 64.42 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.107 -179.42 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.492 ' CE2' ' HB2' ' A' ' 68' ' ' SER . 2.5 m-30 -116.64 174.25 6.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.95 0.405 . . . . 0.0 111.135 -179.273 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.487 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -134.91 123.67 23.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.995 177.453 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.431 ' CD1' ' HG3' ' A' ' 64' ' ' PRO . 10.2 tt -80.32 144.23 32.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.838 -178.531 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.487 HD11 ' CE1' ' A' ' 40' ' ' HIS . 1.9 mm -124.73 152.12 30.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.942 -179.865 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.62 -127.34 7.99 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.039 -179.165 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.437 ' O ' ' CG ' ' A' ' 64' ' ' PRO . 7.0 pm0 -85.29 167.85 15.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.82 0.343 . . . . 0.0 110.568 178.887 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.8 p -150.8 21.07 0.79 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.898 179.609 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.41 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -163.95 124.37 2.16 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.278 -179.299 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -102.18 156.37 17.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.635 -179.269 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.435 ' CB ' ' HB2' ' A' ' 60' ' ' ASN . 1.7 m-85 -132.45 123.78 27.33 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 119.937 -0.705 . . . . 0.0 112.508 -178.192 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 35.5 t -70.14 95.68 1.0 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.38 178.305 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.5 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 3.7 tt0 -128.01 171.22 12.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.495 0.664 . . . . 0.0 111.033 -179.071 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.5 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 1.3 mt -65.36 161.54 19.48 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.366 -179.784 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -102.23 -116.23 4.1 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.509 179.891 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.6 t -122.56 -46.16 2.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.773 0.32 . . . . 0.0 110.897 179.88 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.8 p -93.34 51.01 1.56 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.842 179.936 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 52.32 39.95 52.35 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.474 -179.952 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.4 t -117.56 170.81 8.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.791 0.329 . . . . 0.0 110.849 179.855 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -98.53 125.28 43.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.091 -179.307 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.2 m -125.97 -169.22 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.687 179.457 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.52 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 73.2 m95 -130.45 130.49 44.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.953 0.406 . . . . 0.0 111.819 -179.193 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.471 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.9 OUTLIER -76.45 166.98 40.68 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.483 177.227 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.471 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 42.9 Cg_exo -11.91 96.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.774 1 C-N-CA 125.646 4.231 . . . . 0.0 115.242 -178.574 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.433 ' CG ' ' HB3' ' A' ' 47' ' ' SER . 36.6 mt-10 -100.79 -98.65 0.25 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.951 -178.147 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.482 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -70.67 107.04 2.09 Favored Pre-proline 0 N--CA 1.462 0.167 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -176.545 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.491 ' HD2' ' CD1' ' A' ' 33' ' ' TYR . 2.3 Cg_endo -89.45 -156.94 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.512 2.808 . . . . 0.0 111.223 177.723 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.405 ' CD1' ' HB ' ' A' ' 42' ' ' ILE . 1.0 OUTLIER -93.08 173.26 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.931 0.396 . . . . 0.0 110.393 177.904 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -171.36 142.65 1.72 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.013 179.622 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -169.49 172.09 7.27 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.805 179.458 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.492 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 34.0 p -80.41 126.87 31.73 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.646 179.583 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.439 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 1.3 p -41.51 97.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.584 -179.499 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.415 ' HD3' ' HB2' ' A' ' 88' ' ' PHE . 13.7 mmtp -66.72 129.78 40.99 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.945 -178.468 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.8 115.93 26.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.538 177.166 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.32 -163.41 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.957 -178.658 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.419 ' OG ' ' NE2' ' A' ' 82' ' ' HIS . 1.6 t -45.15 135.27 5.25 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.324 -179.194 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.483 ' HG3' ' CZ2' ' A' ' 118' ' ' TRP . 31.6 Cg_exo -58.96 160.98 16.71 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.364 2.043 . . . . 0.0 112.006 -179.9 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.404 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 87.0 Cg_exo -40.86 156.76 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.795 2.33 . . . . 0.0 112.975 -179.135 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.72 89.84 3.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.783 179.9 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 25.8 pt -69.47 178.75 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.551 -179.201 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.4 m -100.48 145.41 28.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.645 179.411 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.404 ' HB2' ' O ' ' A' ' 124' ' ' CYS . 3.3 m-80 58.55 26.78 14.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.904 179.776 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.464 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -165.87 -164.47 21.41 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.378 179.933 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 98' ' ' SER . 7.7 ptt85 -167.83 -175.86 2.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.151 0.5 . . . . 0.0 111.102 -179.4 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 14.6 p80 -110.76 166.15 11.25 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.661 178.832 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -92.02 -86.48 0.23 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.37 179.247 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.421 ' CA ' ' OH ' ' A' ' 89' ' ' TYR . . . 60.62 139.51 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.261 178.3 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -112.29 -29.78 7.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.1 0.476 . . . . 0.0 110.652 179.137 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.62 -172.26 2.21 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.763 179.682 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -102.45 -20.92 14.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.168 179.694 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.436 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 8.2 m-85 -133.84 176.56 8.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.194 -179.993 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.436 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 62.5 m-85 -151.0 160.47 43.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.593 -179.913 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.434 ' CG2' ' OG ' ' A' ' 68' ' ' SER . 36.9 p -126.81 -177.24 3.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.022 0.439 . . . . 0.0 111.518 -179.048 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -65.47 94.07 0.17 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.007 -179.805 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 127.1 30.59 0.79 Allowed Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.336 -0.847 . . . . 0.0 113.074 178.817 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.418 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.5 OUTLIER -109.92 160.32 16.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.773 0.32 . . . . 0.0 110.632 179.324 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 34.7 m -136.26 150.97 28.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.132 0.491 . . . . 0.0 111.216 -179.603 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.518 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 21.8 t -145.54 148.52 17.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.753 179.686 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.413 ' CG2' ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -110.91 123.38 50.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.012 -179.787 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.513 ' CE2' ' CG2' ' A' ' 111' ' ' VAL . 5.6 m-85 -79.82 156.68 27.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.752 -179.709 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 81' ' ' ARG . 3.9 p -149.86 148.97 29.8 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.914 0.388 . . . . 0.0 112.03 -177.973 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.483 ' HB2' ' HB3' ' A' ' 103' ' ' TYR . 21.2 m -68.8 154.75 41.43 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.541 179.832 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.464 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 85.4 m-20 -73.94 -87.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.111 -177.992 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.43 -43.77 26.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.64 0.257 . . . . 0.0 111.687 -177.642 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 178.44 32.17 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.352 -0.928 . . . . 0.0 113.112 -177.548 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.513 ' CZ ' HG12 ' A' ' 126' ' ' ILE . 0.8 OUTLIER -72.95 -161.81 0.1 Allowed 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.611 -0.295 . . . . 0.0 110.39 -179.524 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.1 t -141.46 117.56 10.62 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.962 0.411 . . . . 0.0 110.77 177.44 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.44 ' CD2' ' HA ' ' A' ' 109' ' ' SER . 0.2 OUTLIER -58.9 140.4 55.44 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.836 0.826 . . . . 0.0 112.063 -178.119 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 37.4 mm -110.24 158.37 10.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 114.057 -1.429 . . . . 0.0 110.075 179.154 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.96 -125.42 32.43 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.034 -179.158 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -123.33 130.76 53.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.856 0.36 . . . . 0.0 110.837 179.38 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.445 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 2.7 t -66.18 -31.1 71.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.865 179.879 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.4 138.28 30.38 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.049 -179.407 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.513 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 2.9 t -134.4 119.44 30.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.64 0.257 . . . . 0.0 110.744 179.024 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.84 125.71 30.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.923 0.392 . . . . 0.0 111.629 -179.114 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.495 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 14.9 t -91.82 105.76 17.96 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 176.176 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.69 163.09 38.34 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.109 0.48 . . . . 0.0 111.36 -178.495 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.2 30.91 4.3 Favored Glycine 0 CA--C 1.517 0.187 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.731 179.865 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.439 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 68.91 16.03 69.93 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.599 -179.525 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -141.28 -179.18 5.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.905 0.383 . . . . 0.0 110.68 179.72 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.518 ' CH2' ' CG2' ' A' ' 95' ' ' VAL . 94.9 m95 -116.63 142.71 46.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.919 -179.85 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.74 147.35 49.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.142 -179.762 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.487 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER 70.17 45.66 0.26 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.153 179.122 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 98.0 Cg_endo -77.9 133.68 12.72 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.372 2.048 . . . . 0.0 111.295 177.782 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.445 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 93.7 Cg_endo -93.22 -173.15 0.37 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.475 2.117 . . . . 0.0 113.714 -177.824 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.43 -170.01 2.21 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-N 114.054 -1.43 . . . . 0.0 108.582 176.359 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 79' ' ' ASN . 2.5 t -161.2 105.93 1.34 Allowed 'General case' 0 N--CA 1.424 -1.756 0 CA-C-O 122.127 0.965 . . . . 0.0 110.879 -177.667 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -112.14 152.9 27.77 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 113.491 -1.686 . . . . 0.0 110.329 -179.685 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.513 HG12 ' CZ ' ' A' ' 103' ' ' TYR . 5.0 mm . . . . . 0 C--N 1.32 -0.712 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.953 179.828 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 121.015 0.436 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 35.5 mtm180 -76.67 171.38 14.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.79 179.705 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.433 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 29.6 m -84.55 159.82 57.69 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.576 179.56 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.5 169.79 17.75 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.543 2.162 . . . . 0.0 112.527 -179.07 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.4 t -51.38 105.63 0.55 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.836 179.89 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -58.5 144.79 96.54 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.044 1.829 . . . . 0.0 111.768 179.699 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.44 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 3.0 mtt180 -45.45 122.81 3.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.412 0.625 . . . . 0.0 111.343 -179.341 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.449 ' O ' ' CG2' ' A' ' 15' ' ' ILE . 0.2 OUTLIER -73.91 -7.4 52.18 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.213 -178.932 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.46 HG21 ' CD2' ' A' ' 20' ' ' LEU . 18.2 tt 51.72 159.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 121.353 0.597 . . . . 0.0 112.089 -178.803 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.407 ' N ' HG13 ' A' ' 15' ' ' ILE . 7.0 t0 -100.56 159.07 15.45 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.632 177.484 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.476 ' HB2' ' CD2' ' A' ' 39' ' ' TYR . 0.0 OUTLIER 42.82 29.32 0.17 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.77 0.319 . . . . 0.0 111.222 -179.408 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.423 ' HA2' ' N ' ' A' ' 36' ' ' ASN . . . -152.12 176.72 30.3 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.74 -179.42 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -142.56 140.12 31.63 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.673 0.273 . . . . 0.0 110.696 179.938 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.46 ' CD2' HG21 ' A' ' 15' ' ' ILE . 52.0 mt -88.99 155.52 19.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.305 0.574 . . . . 0.0 112.096 -178.888 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -124.11 79.03 1.69 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.268 177.181 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.455 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 1.3 mt -75.29 107.71 6.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.36 -176.096 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -109.75 20.8 26.55 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.191 175.869 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 154.63 124.8 0.94 Allowed Glycine 0 C--N 1.334 0.444 0 N-CA-C 111.799 -0.52 . . . . 0.0 111.799 -178.948 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.431 ' CG1' ' CG2' ' A' ' 22' ' ' ILE . 28.7 m -120.4 32.49 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -178.504 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.3 OUTLIER -100.9 151.05 22.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.843 0.354 . . . . 0.0 110.921 179.372 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.416 ' CE2' HD12 ' A' ' 51' ' ' LEU . 8.1 t80 -49.57 91.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.938 179.996 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 129.5 1.73 5.53 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.997 -179.807 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.37 -164.27 1.16 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 117.052 0.426 . . . . 0.0 110.669 179.677 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.4 p -160.01 153.19 21.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.958 0.409 . . . . 0.0 111.164 179.475 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.53 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.8 OUTLIER -114.01 175.0 2.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.442 -179.972 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -130.74 120.31 23.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.79 0.329 . . . . 0.0 110.706 178.638 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.401 ' OH ' ' HB2' ' A' ' 62' ' ' GLU . 19.4 m-85 -96.69 144.67 26.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.301 0.572 . . . . 0.0 112.215 -177.897 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.02 165.33 31.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.287 179.224 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.3 m -85.17 159.41 20.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.878 0.37 . . . . 0.0 110.928 -179.6 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.423 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 8.7 m-20 -59.76 -86.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.272 -178.68 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.3 t -153.02 132.22 12.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.896 0.379 . . . . 0.0 110.938 -179.979 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.72 22.6 73.69 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.036 -179.396 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.476 ' CD2' ' HB2' ' A' ' 17' ' ' ASN . 2.5 m-30 -114.81 -174.14 2.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.96 0.409 . . . . 0.0 110.902 -179.649 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.513 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.3 OUTLIER -145.1 113.59 6.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.878 177.635 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.436 ' CD2' ' O ' ' A' ' 44' ' ' GLU . 6.5 tt -79.4 119.2 22.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.824 -178.631 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.513 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 2.0 mm -103.89 153.11 6.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.513 179.248 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.11 -127.46 8.21 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.989 179.626 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.438 ' O ' ' CG ' ' A' ' 64' ' ' PRO . 1.3 mt-10 -79.7 179.53 7.47 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.484 0.659 . . . . 0.0 112.618 -177.899 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.416 ' O ' ' CG ' ' A' ' 46' ' ' LYS . 4.8 p -165.84 27.52 0.05 OUTLIER 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.005 -179.857 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.416 ' CG ' ' O ' ' A' ' 45' ' ' SER . 3.0 mtpt -166.83 123.73 1.24 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -177.774 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.44 ' HB3' ' HA ' ' A' ' 62' ' ' GLU . 5.8 t -94.07 152.23 18.93 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.103 177.496 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.516 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 1.1 m-85 -124.63 105.36 9.27 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.736 177.539 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.449 ' HB3' ' CH2' ' A' ' 59' ' ' TRP . 27.6 t -58.59 101.05 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.509 179.677 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.01 -171.08 2.22 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.164 -179.172 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.416 HD12 ' CE2' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -96.21 151.73 19.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.055 -179.375 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -75.84 -143.07 1.18 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.437 179.921 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.3 t -95.19 -40.19 9.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.794 0.33 . . . . 0.0 110.924 179.894 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.5 p -101.63 36.63 2.0 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.905 179.778 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.8 24.39 76.72 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.373 -179.823 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.94 -162.01 0.64 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.848 0.356 . . . . 0.0 110.891 -179.991 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.4 mmt -117.2 134.0 55.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.448 179.438 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.4 m -148.4 173.88 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.959 -179.537 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.53 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 74.0 m95 -126.29 124.68 40.88 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.147 -179.907 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.516 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 0.7 OUTLIER -68.98 166.84 24.06 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 177.368 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.481 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 78.3 Cg_exo -15.07 88.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 125.229 3.953 . . . . 0.0 114.253 -179.408 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.44 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 1.0 OUTLIER -92.73 -93.41 0.15 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.244 -177.43 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.23 106.06 1.32 Allowed Pre-proline 0 C--O 1.231 0.125 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -177.118 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.438 ' CG ' ' O ' ' A' ' 44' ' ' GLU . 1.9 Cg_endo -84.43 -153.6 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.993 2.462 . . . . 0.0 110.576 178.059 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.434 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 3.4 mm -86.77 161.32 2.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.994 0.426 . . . . 0.0 111.105 179.911 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -169.76 130.9 1.05 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.965 179.491 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -154.92 175.61 13.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.665 179.576 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.469 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 1.7 p -87.39 121.75 30.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.295 179.053 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.46 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 1.6 p -41.92 94.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 120.971 0.415 . . . . 0.0 111.299 -179.591 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 68' ' ' SER . 2.7 mmtt -79.63 140.37 37.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.835 -177.85 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.424 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -116.89 122.34 44.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.977 178.544 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.36 -164.66 0.06 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.935 -178.993 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.0 t -49.1 136.16 14.86 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.814 -179.504 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.486 ' HG3' ' CZ2' ' A' ' 118' ' ' TRP . 24.3 Cg_exo -59.48 155.71 40.19 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.119 1.879 . . . . 0.0 111.675 179.905 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.405 ' HG3' ' HD3' ' A' ' 121' ' ' PRO . 95.9 Cg_exo -44.17 164.46 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.984 2.456 . . . . 0.0 113.237 -178.458 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 83.0 p -113.04 90.49 3.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.592 179.697 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.2 pt -68.74 172.88 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.942 -179.623 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.0 133.77 35.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.086 -179.555 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.485 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 0.2 OUTLIER 66.78 28.09 9.01 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.707 179.872 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.421 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -163.64 -177.99 36.93 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.287 -0.959 . . . . 0.0 113.187 -179.833 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.71 -175.76 5.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.815 0.34 . . . . 0.0 110.301 179.757 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.48 ' HB3' ' CE2' ' A' ' 97' ' ' TYR . 4.0 p-80 -120.78 161.6 21.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.07 0.462 . . . . 0.0 111.545 179.993 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -92.37 -171.7 2.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.905 -179.904 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 85' ' ' TYR . . . 88.79 -66.52 3.12 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.686 -0.769 . . . . 0.0 111.884 -178.994 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.443 ' HB3' ' O ' ' A' ' 84' ' ' GLY . 4.0 m-85 66.56 30.36 8.49 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-O 121.483 0.658 . . . . 0.0 109.985 179.732 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.424 ' HB3' ' CZ ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -87.97 -173.47 4.28 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.014 179.014 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.09 -23.27 11.38 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.847 0.356 . . . . 0.0 110.812 178.947 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.422 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 9.7 m-85 -153.74 161.34 42.19 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.239 -179.72 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.424 ' N ' ' O ' ' A' ' 71' ' ' CYS . 21.1 m-85 -141.43 163.39 33.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.797 179.358 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.7 p -122.77 165.57 16.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.042 0.449 . . . . 0.0 111.901 -177.758 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -56.55 98.32 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.697 179.767 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 128.44 12.47 2.79 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.097 -0.956 . . . . 0.0 113.071 179.555 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.79 161.58 13.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.945 0.372 . . . . 0.0 110.399 179.211 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 30.2 m -141.35 147.39 22.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.113 0.482 . . . . 0.0 110.782 -179.913 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.454 HG22 ' CH2' ' A' ' 118' ' ' TRP . 43.7 t -136.94 151.32 27.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.56 179.561 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.425 ' CG2' ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -108.2 129.29 55.2 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.977 -179.565 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.53 ' CE2' ' CG2' ' A' ' 111' ' ' VAL . 6.0 m-85 -92.97 155.65 17.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.081 -179.525 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.1 p -149.16 139.33 22.21 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.443 -179.308 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 52.0 m -69.67 152.87 44.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.676 179.178 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.421 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 26.9 m-20 -92.67 -70.41 0.7 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.237 -179.383 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 36.8 m -55.5 -23.36 25.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.151 -179.683 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 118.77 30.7 1.59 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.344 -179.752 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.485 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 18.8 m-85 -71.39 -173.13 0.84 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.882 0.372 . . . . 0.0 110.774 179.986 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.69 103.89 11.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.296 -179.386 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.425 ' CD2' ' HB2' ' A' ' 122' ' ' PRO . 2.1 tp -42.62 115.89 0.78 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.419 179.21 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.44 ' HB ' ' CB ' ' A' ' 123' ' ' THR . 46.7 mm -91.01 153.58 3.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.277 179.555 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.427 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 65.41 -121.83 21.52 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.084 -1.055 . . . . 0.0 111.502 -178.09 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -136.91 120.81 17.55 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.059 0.457 . . . . 0.0 111.207 178.759 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.437 ' HA ' ' CG ' ' A' ' 122' ' ' PRO . 2.0 p -51.21 -26.6 7.29 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.95 179.326 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.46 119.13 10.86 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.849 -179.376 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.53 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 2.5 t -113.53 116.19 51.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 178.796 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.25 120.1 23.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.006 0.432 . . . . 0.0 111.828 -177.382 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.46 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 16.1 t -89.35 94.86 10.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.502 176.591 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.17 159.43 41.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.33 -178.123 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.68 29.51 4.2 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.702 179.85 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.46 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 70.09 20.94 76.81 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.267 -179.42 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -142.85 170.85 14.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.833 0.349 . . . . 0.0 110.376 179.299 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.486 ' CZ2' ' HG3' ' A' ' 74' ' ' PRO . 97.4 m95 -112.34 126.64 55.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.35 -179.192 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.48 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -92.97 131.62 37.81 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.489 174.804 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.529 ' HB2' ' CA ' ' A' ' 121' ' ' PRO . 2.3 m-20 109.42 -135.87 0.0 OUTLIER Pre-proline 0 CA--C 1.474 -1.945 0 N-CA-C 100.432 -3.914 . . . . 0.0 100.432 -166.987 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.529 ' CA ' ' HB2' ' A' ' 120' ' ' ASP . 64.4 Cg_endo -65.41 179.23 12.83 Favored 'Cis proline' 0 C--N 1.308 -1.566 0 CA-C-N 125.258 2.914 . . . . 0.0 113.36 -14.08 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.437 ' CG ' ' HA ' ' A' ' 109' ' ' SER . 10.4 Cg_endo -89.56 -174.9 0.97 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.692 2.928 . . . . 0.0 111.463 176.75 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.44 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -121.61 -179.51 4.12 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.83 179.045 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . 0.419 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 4.9 m -139.95 94.59 2.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.743 179.947 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -123.33 163.69 20.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.971 -179.474 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.479 HG12 ' CE2' ' A' ' 103' ' ' TYR . 41.1 mm . . . . . 0 C--N 1.325 -0.478 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.927 -179.917 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.774 0.321 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 80.2 mtm180 -89.12 168.55 12.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.952 179.826 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.439 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 48.7 m -92.4 159.86 36.09 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.839 179.864 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' A' ' 9' ' ' CYS . 36.9 Cg_endo -66.45 173.85 7.1 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.491 2.127 . . . . 0.0 112.156 -179.695 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -49.28 107.64 0.82 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.126 -179.47 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.487 ' CG ' ' CD1' ' A' ' 22' ' ' ILE . 9.4 Cg_endo -52.64 154.98 11.06 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.282 1.988 . . . . 0.0 111.824 179.728 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 18.8 mtt180 -80.24 164.91 22.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.257 0.551 . . . . 0.0 111.502 -178.794 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -118.88 -166.71 1.27 Allowed 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.042 -178.023 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.441 HG21 ' CD2' ' A' ' 20' ' ' LEU . 8.5 tt -142.8 155.51 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.566 179.113 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -85.81 -55.45 3.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -176.882 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.71 28.3 2.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.632 0.254 . . . . 0.0 111.551 -177.352 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -167.16 -165.23 24.21 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.784 179.482 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -132.91 175.36 9.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.621 0.248 . . . . 0.0 110.345 179.031 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.477 HD22 ' CE1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -122.46 157.83 31.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.153 0.501 . . . . 0.0 111.224 -179.964 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -126.94 84.77 2.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.926 178.805 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.487 ' CD1' ' CG ' ' A' ' 12' ' ' PRO . 0.4 OUTLIER -82.98 97.1 4.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.992 -177.01 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.2 11.73 70.08 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.033 177.436 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 165.27 148.69 5.58 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.297 -179.72 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.0 m -129.88 13.87 2.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.948 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -93.52 151.06 19.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.694 0.283 . . . . 0.0 110.578 179.534 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -49.28 100.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.952 0.406 . . . . 0.0 110.758 179.96 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.26 0.41 6.89 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.603 -178.885 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.1 p -99.56 169.54 9.22 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.877 0.339 . . . . 0.0 110.481 179.443 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 47' ' ' SER . 4.4 p -143.27 138.74 29.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.078 0.466 . . . . 0.0 111.015 179.948 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.522 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 1.0 OUTLIER -92.84 173.67 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.634 178.949 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.412 ' O ' ' N ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -135.92 113.2 10.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.982 0.42 . . . . 0.0 111.331 -179.667 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.489 ' CE1' ' HA ' ' A' ' 63' ' ' ALA . 22.2 m-85 -89.27 140.87 29.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.883 179.696 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -147.14 146.31 29.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.731 -179.918 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.405 ' HB2' ' HB2' ' A' ' 39' ' ' TYR . 23.1 m -69.81 167.98 16.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.89 0.376 . . . . 0.0 111.001 -179.682 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -66.48 -78.5 0.06 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.006 -179.776 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -158.84 139.13 12.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.607 179.867 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 58.11 28.39 61.18 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.883 -179.002 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.486 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.1 m-85 -119.37 168.13 11.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.828 0.347 . . . . 0.0 111.09 -179.28 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.517 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.4 OUTLIER -127.39 117.08 21.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.404 177.806 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.459 ' CD1' ' HG3' ' A' ' 64' ' ' PRO . 8.5 tt -81.97 126.03 31.47 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.778 -179.349 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.517 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 2.1 mm -105.62 164.46 4.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.116 -179.434 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.92 -132.26 16.94 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.507 179.986 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.431 ' O ' ' CG ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -81.92 -175.41 5.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.966 0.412 . . . . 0.0 110.759 179.575 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.419 ' O ' ' CG ' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -169.83 30.73 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.43 179.327 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.419 ' CG ' ' O ' ' A' ' 45' ' ' SER . 10.9 mtpt -166.91 114.47 0.82 Allowed 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.021 -178.315 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.451 ' HB2' ' CD1' ' A' ' 31' ' ' ILE . 0.4 OUTLIER -84.67 132.31 34.49 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 178.643 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.492 ' CD1' ' HB2' ' A' ' 60' ' ' ASN . 1.6 m-85 -107.1 120.74 42.91 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 119.514 -0.875 . . . . 0.0 111.516 -179.484 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.6 t -67.72 116.94 8.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.318 -179.035 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -158.5 179.66 8.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.371 179.413 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.56 148.72 49.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.746 0.308 . . . . 0.0 110.818 179.6 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 174.83 33.95 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.306 -0.949 . . . . 0.0 113.313 -179.498 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.97 71.41 0.94 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.069 0.461 . . . . 0.0 110.464 179.304 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.3 p 62.14 25.1 15.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.455 -178.842 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 104.3 18.44 13.32 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.462 -179.531 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.5 t -115.57 163.24 16.07 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.054 0.454 . . . . 0.0 111.089 179.903 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -87.77 137.83 31.99 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.529 -178.998 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.2 m -135.16 -175.47 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.458 179.868 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.522 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 59.5 m95 -128.41 128.18 43.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.837 0.351 . . . . 0.0 110.975 179.61 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.492 ' HB2' ' CD1' ' A' ' 48' ' ' TYR . 0.7 OUTLIER -69.69 164.93 46.23 Favored Pre-proline 0 C--O 1.224 -0.271 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.971 178.515 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.449 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 79.2 Cg_exo -16.73 100.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.741 1 C-N-CA 125.32 4.014 . . . . 0.0 114.498 -178.932 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.471 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -104.22 -82.15 0.51 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.753 -177.916 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.489 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -77.08 107.13 4.37 Favored Pre-proline 0 N--CA 1.463 0.185 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -176.355 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.459 ' HG3' ' CD1' ' A' ' 41' ' ' LEU . 3.1 Cg_endo -90.52 -155.54 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.345 2.697 . . . . 0.0 111.172 178.257 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.9 mm -97.23 165.82 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.872 0.367 . . . . 0.0 110.847 178.803 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.2 m -162.32 136.92 6.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.944 179.904 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.22 173.23 16.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.758 179.793 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.486 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 80.8 p -81.42 112.63 18.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.999 179.954 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.45 ' CG2' ' HB3' ' A' ' 40' ' ' HIS . 6.3 p -44.62 97.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.429 179.844 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -79.76 127.59 32.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.617 -179.024 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.441 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -113.48 119.86 39.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.917 178.336 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.57 -159.63 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.775 0.322 . . . . 0.0 110.597 -179.067 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.463 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 2.3 t -49.06 137.75 13.76 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.818 -179.864 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.442 ' HA ' ' CD1' ' A' ' 118' ' ' TRP . 37.0 Cg_exo -56.77 161.64 9.88 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.168 1.912 . . . . 0.0 111.589 -179.874 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.477 ' HD2' ' CG ' ' A' ' 118' ' ' TRP . 79.7 Cg_exo -39.55 156.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.701 2.267 . . . . 0.0 112.785 -179.231 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.7 m -108.38 88.21 2.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.645 179.756 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.404 ' CG2' ' O ' ' A' ' 122' ' ' PRO . 13.5 pt -70.08 -177.68 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.299 -179.357 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.6 m -103.43 147.34 27.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.781 179.657 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.409 ' HB3' ' CD2' ' A' ' 103' ' ' TYR . 24.8 m-80 51.43 29.83 5.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.161 179.698 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.465 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -160.36 -165.27 16.87 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.395 -0.907 . . . . 0.0 113.098 179.798 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.407 ' N ' ' O ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -164.18 -175.34 3.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.857 0.36 . . . . 0.0 110.463 -179.463 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.463 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 1.8 p-80 -120.37 166.14 13.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.617 -178.999 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -98.0 -170.72 2.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.592 179.945 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' A' ' 85' ' ' TYR . . . 90.71 -68.87 2.28 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.533 -0.842 . . . . 0.0 111.72 -178.796 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.436 ' HB3' ' O ' ' A' ' 84' ' ' GLY . 15.0 m-30 71.37 28.52 2.92 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 123.542 0.737 . . . . 0.0 110.173 179.308 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.464 ' HB3' ' CZ ' ' A' ' 89' ' ' TYR . 0.2 OUTLIER -87.19 -173.35 4.37 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.915 178.641 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -111.64 -22.92 10.96 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.802 0.334 . . . . 0.0 110.831 178.97 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.428 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 11.3 m-85 -154.08 160.87 42.16 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.995 -179.776 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.464 ' CZ ' ' HB3' ' A' ' 86' ' ' GLU . 16.5 m-85 -141.69 166.89 23.5 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.922 179.569 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.2 p -131.29 179.64 5.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.127 0.489 . . . . 0.0 112.013 -177.97 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -63.26 96.22 0.1 Allowed 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.904 179.888 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.49 14.49 2.9 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.297 -0.865 . . . . 0.0 113.152 179.157 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.67 156.58 16.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.906 0.353 . . . . 0.0 110.349 179.005 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.9 m -135.38 151.51 30.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.174 0.511 . . . . 0.0 111.095 -179.475 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.501 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 14.4 t -148.79 145.43 18.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.028 179.937 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.424 ' N ' HG11 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -105.69 128.44 53.66 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.637 179.341 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.529 ' CE1' ' CG2' ' A' ' 111' ' ' VAL . 5.4 m-85 -89.0 157.83 18.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.154 -179.242 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.407 ' O ' ' N ' ' A' ' 81' ' ' ARG . 39.6 m -153.57 148.12 26.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.226 179.974 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.408 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 63.0 m -74.03 162.04 29.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.91 179.686 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.465 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 65.3 m-20 -84.9 -72.57 0.47 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.587 -179.055 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.0 m -70.84 -28.21 64.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.344 -178.67 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 132.08 36.78 0.3 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.712 179.854 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.496 ' CE1' HG12 ' A' ' 126' ' ' ILE . 33.8 m-85 -69.97 -174.82 0.82 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.893 0.378 . . . . 0.0 110.586 179.266 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.6 m -106.31 101.32 10.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.291 178.677 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.405 HD21 ' HA ' ' A' ' 109' ' ' SER . 0.3 OUTLIER -48.81 128.04 14.91 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.438 0.637 . . . . 0.0 111.508 -178.466 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.446 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 35.7 mm -91.56 153.31 3.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.955 179.078 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.47 -128.13 38.15 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.994 -178.926 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -123.79 143.86 50.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.828 0.347 . . . . 0.0 110.982 179.432 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.435 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 1.4 t -72.19 -32.57 66.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.703 179.638 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.13 137.42 29.66 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.747 -179.701 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.529 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 2.5 t -132.32 118.62 36.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.648 0.261 . . . . 0.0 110.554 179.247 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.71 114.95 21.94 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.916 0.389 . . . . 0.0 111.538 -178.848 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.492 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 26.3 t -82.5 100.93 10.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.659 176.881 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.8 t -138.61 154.58 48.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.113 0.482 . . . . 0.0 111.473 -178.2 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 53.09 21.02 9.84 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.934 179.489 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.446 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 82.8 8.05 86.46 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.8 -179.917 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.95 176.56 8.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.98 0.419 . . . . 0.0 110.692 179.737 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.501 ' CH2' ' CG2' ' A' ' 95' ' ' VAL . 96.3 m95 -113.58 134.97 54.41 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.847 -179.763 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.3 147.22 44.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.343 -179.232 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.473 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER 71.23 46.08 0.24 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.123 178.843 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 98.0 Cg_endo -78.49 133.23 11.63 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.364 2.043 . . . . 0.0 111.453 178.179 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.446 ' CB ' ' O ' ' A' ' 106' ' ' ILE . 74.2 Cg_endo -91.25 -173.88 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.664 2.243 . . . . 0.0 113.513 -178.04 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.429 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -131.33 -161.23 1.11 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.878 177.689 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 6.6 m -157.4 92.03 1.21 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.199 0.523 . . . . 0.0 110.879 179.074 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -122.94 160.15 26.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.927 -179.652 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.496 HG12 ' CE1' ' A' ' 103' ' ' TYR . 46.5 mm . . . . . 0 C--N 1.324 -0.529 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.816 179.693 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.9 mtm180 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.826 0.346 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 32.4 mtm180 -49.9 172.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.923 179.827 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.446 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 32.7 m -86.62 160.93 49.48 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.908 -179.965 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.12 169.14 18.77 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.496 2.131 . . . . 0.0 112.02 179.92 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.402 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 33.3 t -50.59 104.52 0.43 Allowed Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.982 -179.351 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.407 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 2.7 Cg_exo -45.41 166.32 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.197 1.932 . . . . 0.0 111.919 -179.67 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.425 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 2.5 ttt-85 -73.84 170.03 16.18 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.0 178.321 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.4 ' HA ' HD11 ' A' ' 20' ' ' LEU . 2.9 p30 -125.4 -177.95 4.06 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.161 0.505 . . . . 0.0 112.055 -176.347 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 4.3 tt -148.54 142.73 18.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.338 179.372 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -79.89 -60.68 2.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.54 -178.33 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -91.03 45.37 1.24 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.961 0.41 . . . . 0.0 110.911 -179.251 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.418 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -167.01 -179.73 40.24 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.92 179.957 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -138.86 137.77 36.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.671 0.272 . . . . 0.0 110.525 179.641 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.514 ' CD2' ' CE2' ' A' ' 33' ' ' TYR . 0.5 OUTLIER -87.17 154.2 20.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.006 0.431 . . . . 0.0 111.443 -179.653 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -123.97 82.1 1.99 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.902 177.574 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.439 ' CD1' HG23 ' A' ' 31' ' ' ILE . 4.0 mm -68.93 105.08 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.495 -177.529 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.3 15.03 47.28 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.165 178.079 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.424 ' O ' ' CB ' ' A' ' 29' ' ' SER . . . 154.12 121.43 0.8 Allowed Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.206 -179.765 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.2 m -108.96 22.24 4.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.754 0.312 . . . . 0.0 111.442 -179.599 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -99.0 158.69 15.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.923 0.392 . . . . 0.0 110.855 179.502 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.419 ' CE1' HD11 ' A' ' 51' ' ' LEU . 8.3 t80 -56.27 92.1 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.899 -179.957 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 130.93 -0.22 5.3 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.77 -0.728 . . . . 0.0 113.072 -179.859 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 24' ' ' GLY . 58.2 m -89.87 -174.04 4.12 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.969 0.384 . . . . 0.0 110.75 179.848 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.4 p -155.71 145.4 21.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.068 0.461 . . . . 0.0 111.456 -179.561 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.517 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.4 OUTLIER -104.68 167.57 2.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.444 179.445 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.81 108.83 9.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.948 0.404 . . . . 0.0 110.701 179.147 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.514 ' CE2' ' CD2' ' A' ' 20' ' ' LEU . 20.4 m-85 -81.5 149.5 28.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.177 -179.323 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.418 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 5.5 m -153.48 168.28 26.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.801 -179.61 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.432 ' HB2' ' HB2' ' A' ' 39' ' ' TYR . 1.6 m -88.08 171.99 9.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.833 179.912 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -70.23 -84.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.084 -179.4 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.44 130.5 10.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.524 179.858 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.8 23.63 69.29 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.864 -178.618 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.492 ' CZ ' ' HB2' ' A' ' 68' ' ' SER . 3.4 m-85 -113.85 175.34 5.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.681 0.277 . . . . 0.0 110.842 -179.085 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.526 ' CE1' ' CG2' ' A' ' 69' ' ' VAL . 0.0 OUTLIER -131.16 132.57 44.85 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 175.731 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.438 ' CD2' ' O ' ' A' ' 44' ' ' GLU . 7.8 tt -95.35 118.43 32.08 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.886 -178.914 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.41 ' HB ' ' HB ' ' A' ' 65' ' ' ILE . 1.1 mm -97.67 147.26 6.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.666 179.841 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.15 -149.5 23.04 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.21 -179.047 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.438 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 1.2 pt-20 -67.14 -177.12 0.61 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.071 0.463 . . . . 0.0 110.786 179.361 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.417 ' CB ' HD21 ' A' ' 41' ' ' LEU . 0.3 OUTLIER -170.45 30.09 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.336 179.846 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.31 123.37 2.59 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.773 -179.725 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.433 ' HB3' ' HA ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -105.47 155.04 19.54 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.536 -179.384 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.494 ' CD2' ' HB2' ' A' ' 60' ' ' ASN . 1.4 m-85 -130.86 125.06 32.61 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 119.686 -0.806 . . . . 0.0 112.283 -179.46 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.429 ' HB3' ' CH2' ' A' ' 59' ' ' TRP . 20.5 t -75.75 98.19 4.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.386 178.786 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.65 -173.33 2.62 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.107 -179.689 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.419 HD11 ' CE1' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -93.42 145.09 24.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.815 -179.68 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -64.21 -121.68 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.425 179.957 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.32 -32.16 6.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.796 0.332 . . . . 0.0 110.897 -179.962 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 33.6 p -115.71 38.51 3.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.955 179.912 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.5 22.51 69.92 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.386 -179.719 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.5 t -83.9 -161.65 0.56 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.869 0.366 . . . . 0.0 111.068 -179.796 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 13.2 mtt -117.29 140.0 50.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.548 179.712 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.4 m -157.76 163.52 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.94 -179.41 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.517 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 69.4 m95 -124.06 123.13 39.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.342 -179.489 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.494 ' HB2' ' CD2' ' A' ' 48' ' ' TYR . 3.2 m-20 -69.7 165.99 36.0 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.911 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 48.7 Cg_exo -9.61 95.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.029 1 C-N-CA 125.74 4.293 . . . . 0.0 115.074 -178.57 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.473 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 42.7 mt-10 -98.08 -99.27 0.21 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.482 -177.772 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.487 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -74.9 108.66 5.73 Favored Pre-proline 0 C--O 1.232 0.135 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -175.343 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.432 ' HG3' ' CD1' ' A' ' 41' ' ' LEU . 2.5 Cg_endo -87.01 -155.31 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.216 2.61 . . . . 0.0 110.757 176.668 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.41 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 2.1 mm -99.73 161.1 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.87 0.367 . . . . 0.0 110.786 178.685 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.1 m -155.65 137.53 14.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 -179.908 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.479 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -141.42 172.88 12.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.644 179.896 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.492 ' HB2' ' CZ ' ' A' ' 39' ' ' TYR . 1.1 p -108.38 123.72 49.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.283 -179.813 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.526 ' CG2' ' CE1' ' A' ' 40' ' ' HIS . 5.1 p -52.12 90.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.596 178.494 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 68' ' ' SER . 0.6 OUTLIER -68.8 132.62 47.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.893 -178.129 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.422 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -112.75 118.56 35.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.585 177.164 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.471 ' CG ' ' N ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -69.29 -157.97 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.358 -179.532 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.471 ' N ' ' CG ' ' A' ' 72' ' ' GLN . 0.8 OUTLIER -52.38 142.36 30.08 Favored Pre-proline 0 N--CA 1.447 -0.593 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.781 179.919 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.48 ' HA ' ' CD1' ' A' ' 118' ' ' TRP . 23.8 Cg_exo -60.67 157.87 35.34 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.326 2.017 . . . . 0.0 111.813 179.741 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.472 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 81.0 Cg_exo -43.79 156.19 0.17 Allowed 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.62 2.214 . . . . 0.0 112.594 -179.429 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.7 t -105.79 90.27 3.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.771 179.905 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.2 pt -69.56 176.32 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.297 -179.477 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.8 m -94.01 143.39 26.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.416 178.898 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.488 ' HB3' ' CD2' ' A' ' 103' ' ' TYR . 4.3 m-80 57.34 30.01 17.81 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.758 -179.829 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.424 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . 178.88 -175.79 47.56 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.689 179.953 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.25 -175.06 1.86 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.765 0.316 . . . . 0.0 110.348 -179.893 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.472 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 12.3 p80 -85.83 174.78 9.07 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.855 179.8 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.417 ' OD1' ' CG1' ' A' ' 95' ' ' VAL . 21.0 p-10 -109.22 -37.94 5.65 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -178.254 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.436 ' O ' ' HB3' ' A' ' 85' ' ' TYR . . . -41.06 -62.44 1.75 Allowed Glycine 0 C--N 1.331 0.286 0 C-N-CA 121.044 -0.598 . . . . 0.0 113.302 -178.129 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.448 ' CE1' ' O ' ' A' ' 82' ' ' HIS . 21.2 m-30 66.21 27.39 10.31 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-O 121.319 0.58 . . . . 0.0 110.134 -179.779 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.442 ' HB3' ' CZ ' ' A' ' 89' ' ' TYR . 0.4 OUTLIER -79.36 -167.27 1.14 Allowed 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.317 177.76 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -112.63 -23.06 10.44 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.241 179.487 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.425 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 12.7 m-85 -158.87 159.74 35.35 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.186 0.517 . . . . 0.0 111.614 -179.447 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.442 ' CZ ' ' HB3' ' A' ' 86' ' ' GLU . 12.3 m-85 -142.28 166.91 23.39 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.017 179.661 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.4 p -127.16 169.56 13.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.969 0.414 . . . . 0.0 111.573 -178.783 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.418 ' OD1' ' CG1' ' A' ' 69' ' ' VAL . 0.1 OUTLIER -58.55 100.79 0.07 Allowed 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.49 0.662 . . . . 0.0 110.689 179.461 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.76 14.28 3.9 Favored Glycine 0 C--N 1.313 -0.745 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.916 179.287 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.7 OUTLIER -95.97 158.63 15.36 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.957 0.379 . . . . 0.0 110.327 178.808 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.0 m -134.37 156.17 40.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.055 0.455 . . . . 0.0 111.043 -179.355 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.518 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 40.1 t -148.94 152.14 12.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.646 179.95 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.435 ' CG2' ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -112.25 121.02 43.72 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.097 0.475 . . . . 0.0 111.01 -179.673 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.527 ' CE2' ' CG2' ' A' ' 111' ' ' VAL . 4.9 m-85 -80.74 155.36 26.75 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.568 -178.986 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.421 ' HA ' ' CD1' ' A' ' 105' ' ' LEU . 90.3 p -153.42 143.97 22.53 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.378 -179.729 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.424 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 6.3 m -69.54 164.86 22.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.442 -179.886 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -93.25 -67.44 0.86 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.883 179.268 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.68 -34.47 72.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.247 -179.716 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 133.63 43.94 0.13 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.491 -179.952 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.517 ' CE1' HG12 ' A' ' 126' ' ' ILE . 6.4 m-85 -78.46 -171.05 2.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.832 0.348 . . . . 0.0 110.644 179.809 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -113.57 98.86 7.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.489 179.051 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.474 ' CD2' ' HA ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -49.83 144.67 6.14 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.534 0.683 . . . . 0.0 111.254 -179.091 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.461 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 23.8 mm -121.67 162.12 21.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.999 -178.096 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.453 ' O ' ' ND2' ' A' ' 108' ' ' ASN . . . 47.7 45.82 24.3 Favored Glycine 0 C--O 1.226 -0.402 0 C-N-CA 120.574 -0.822 . . . . 0.0 113.237 178.619 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.453 ' ND2' ' O ' ' A' ' 107' ' ' GLY . 0.7 OUTLIER 46.51 128.39 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 124.577 1.151 . . . . 0.0 114.09 177.556 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.474 ' HA ' ' CD2' ' A' ' 105' ' ' LEU . 0.1 OUTLIER -55.07 -33.16 62.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.769 179.207 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -55.43 130.1 47.38 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.2 -178.534 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.527 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 2.4 t -127.31 150.19 32.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.024 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.28 122.23 47.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.951 0.405 . . . . 0.0 111.668 -179.149 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.491 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 15.3 t -87.76 100.88 13.17 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 176.733 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -150.66 171.22 17.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.984 -178.654 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.418 ' N ' ' OD1' ' A' ' 91' ' ' ASP . . . 46.61 26.16 2.48 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.871 -179.935 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.12 18.82 76.82 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.281 -179.331 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -152.78 -176.68 5.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.895 0.379 . . . . 0.0 110.536 179.889 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.518 ' CH2' ' CG2' ' A' ' 95' ' ' VAL . 91.6 m95 -111.39 126.32 54.8 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.069 -179.425 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.8 161.09 14.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.263 -179.273 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.478 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 3.6 p30 48.46 46.04 3.33 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.434 179.161 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 57.5 Cg_endo -69.99 150.21 66.5 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.221 1.947 . . . . 0.0 110.691 176.51 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.461 ' CB ' ' O ' ' A' ' 106' ' ' ILE . 57.0 Cg_endo -95.99 177.51 0.7 Allowed 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.223 1.948 . . . . 0.0 114.089 -176.856 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.433 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -119.46 -160.8 0.83 Allowed 'General case' 0 CA--C 1.505 -0.784 0 CA-C-N 114.343 -1.298 . . . . 0.0 109.044 176.566 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 5.0 t -170.32 91.02 0.18 Allowed 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.891 -175.98 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -122.16 175.76 6.19 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.355 -177.415 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.517 HG12 ' CE1' ' A' ' 103' ' ' TYR . 46.3 mm . . . . . 0 C--N 1.326 -0.437 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.677 179.37 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.896 0.379 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.4 mtm180 -97.22 157.25 16.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.183 -179.591 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.498 ' HB2' ' CD ' ' A' ' 10' ' ' PRO . 65.9 m -69.82 175.91 2.04 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.596 178.565 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.526 ' HD2' ' CD1' ' A' ' 59' ' ' TRP . 35.6 Cg_endo -88.66 177.96 2.97 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.532 2.155 . . . . 0.0 111.452 179.047 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.8 t -51.31 105.54 0.54 Allowed Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.427 179.551 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.486 ' HG2' ' CZ2' ' A' ' 59' ' ' TRP . 53.5 Cg_exo -46.55 161.38 0.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.137 1.891 . . . . 0.0 112.366 -179.049 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.421 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -62.15 -173.42 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.849 177.673 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.22 -175.95 4.82 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.288 179.524 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.438 HG21 ' CD2' ' A' ' 20' ' ' LEU . 9.2 tt -146.71 142.98 20.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.571 179.739 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -73.94 -60.82 2.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.014 -177.63 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.409 ' O ' ' N ' ' A' ' 36' ' ' ASN . 0.1 OUTLIER -94.09 30.47 1.88 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.188 -178.133 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.406 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -147.17 177.43 25.47 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.896 -179.932 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -135.9 130.66 34.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.689 0.281 . . . . 0.0 110.365 179.01 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.527 ' CD2' ' CE2' ' A' ' 33' ' ' TYR . 24.6 mt -82.91 157.45 23.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.056 0.455 . . . . 0.0 111.726 -178.75 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.03 78.75 1.85 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.163 178.823 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.455 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 67.8 mt -69.93 100.27 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.843 -177.993 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.69 17.19 59.71 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.792 177.073 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 150.46 139.73 3.08 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.218 -179.601 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.8 m -124.1 31.15 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.915 0.388 . . . . 0.0 111.253 -179.477 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.41 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.4 OUTLIER -101.06 148.93 24.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.574 179.335 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.468 ' CZ ' HD11 ' A' ' 51' ' ' LEU . 4.7 t80 -49.99 92.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.92 0.39 . . . . 0.0 110.79 179.909 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 131.44 -2.28 5.35 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.78 -179.094 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 65.6 p -89.15 -173.14 3.93 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 117.003 0.402 . . . . 0.0 110.444 179.468 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.3 p -155.11 154.36 32.26 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.002 0.43 . . . . 0.0 111.064 179.872 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.522 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.8 OUTLIER -115.65 164.6 11.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.491 -179.987 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -124.19 120.41 32.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.954 0.406 . . . . 0.0 111.253 -179.867 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.527 ' CE2' ' CD2' ' A' ' 20' ' ' LEU . 16.2 m-85 -97.77 135.28 39.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.182 -179.882 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.406 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -143.65 158.54 43.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.682 179.67 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.404 ' HB2' ' HB2' ' A' ' 39' ' ' TYR . 3.0 m -76.45 167.95 20.94 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.737 179.841 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 17' ' ' ASN . 0.6 OUTLIER -63.93 -81.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.898 -179.764 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -158.27 133.68 8.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.81 179.851 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.427 ' O ' ' CG2' ' A' ' 69' ' ' VAL . . . 64.43 23.61 68.61 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.107 -179.374 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.524 ' CE1' ' CB ' ' A' ' 68' ' ' SER . 2.6 m-85 -114.58 179.84 3.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.793 0.33 . . . . 0.0 110.862 -179.622 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.522 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.5 OUTLIER -136.17 112.54 9.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.006 0.431 . . . . 0.0 110.55 178.135 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.443 ' CD1' ' HG3' ' A' ' 64' ' ' PRO . 4.6 tt -78.58 123.93 27.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.251 -179.981 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.522 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 1.9 mm -100.17 152.33 4.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.072 0.463 . . . . 0.0 111.059 -179.207 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.77 -137.92 17.4 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.117 -179.211 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.75 -175.86 5.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.943 0.402 . . . . 0.0 110.806 179.439 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.402 ' HB3' HD21 ' A' ' 41' ' ' LEU . 3.7 p -156.55 21.41 0.34 Allowed 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.458 -178.995 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -148.13 139.16 23.25 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.246 0.546 . . . . 0.0 112.304 -178.377 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.434 ' HB2' HG12 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -107.96 145.23 34.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.875 178.212 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.468 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 1.6 m-85 -123.61 119.99 31.5 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 119.179 -1.008 . . . . 0.0 112.405 -179.928 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.406 ' HB3' ' CH2' ' A' ' 59' ' ' TRP . 19.0 t -71.4 96.83 1.52 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.517 178.935 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.7 -173.96 2.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.167 -179.463 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.468 HD11 ' CZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -95.87 153.61 17.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.998 -179.851 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -73.69 -129.26 0.15 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.517 179.848 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.6 t -114.64 -33.33 5.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.876 0.37 . . . . 0.0 110.953 179.992 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 60.6 p -99.75 33.4 2.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.864 179.91 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.7 26.43 74.06 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.427 -179.812 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.7 t -94.04 -161.98 0.9 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.87 0.367 . . . . 0.0 110.901 -179.942 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 4.1 mmt -117.44 144.6 44.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.513 179.536 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.4 m -158.78 172.91 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.1 -179.822 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.526 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 69.9 m95 -123.24 124.66 43.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.1 -179.976 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.468 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 3.1 m120 -69.28 163.98 52.98 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.333 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.432 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 38.9 Cg_exo -10.86 99.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.944 1 C-N-CA 125.735 4.29 . . . . 0.0 114.925 -178.618 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.476 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 7.9 mt-10 -91.62 -92.62 0.15 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.167 -0.924 . . . . 0.0 113.146 -176.43 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.496 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -81.93 110.47 20.41 Favored Pre-proline 0 CA--C 1.528 0.109 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -174.953 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.443 ' HG3' ' CD1' ' A' ' 41' ' ' LEU . 5.1 Cg_exo -80.05 -153.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.942 2.428 . . . . 0.0 110.95 176.395 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.437 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 3.5 mm -94.57 167.38 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.825 0.345 . . . . 0.0 110.919 178.833 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.2 m -166.44 132.9 2.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.171 179.24 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.9 164.56 35.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.761 -178.909 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.524 ' CB ' ' CE1' ' A' ' 39' ' ' TYR . 1.7 p -88.86 120.09 29.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.362 0.601 . . . . 0.0 111.248 -179.906 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.474 ' HB ' ' N ' ' A' ' 116' ' ' GLY . 0.6 OUTLIER -39.55 91.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.39 179.478 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.517 ' CD ' ' CD2' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -101.4 151.38 21.99 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.85 178.016 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.61 136.06 52.86 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.412 -177.63 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.419 ' O ' ' NE1' ' A' ' 118' ' ' TRP . 0.0 OUTLIER -67.23 -173.18 0.26 Allowed 'General case' 0 N--CA 1.432 -1.354 0 CA-C-O 121.904 0.859 . . . . 0.0 113.115 -178.12 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -48.19 124.4 11.07 Favored Pre-proline 0 N--CA 1.441 -0.894 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.09 175.051 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.505 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 31.7 Cg_exo -46.09 153.33 1.01 Allowed 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.593 1.529 . . . . 0.0 111.88 -175.702 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.468 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 86.3 Cg_exo -45.59 154.34 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.741 2.294 . . . . 0.0 112.679 -177.492 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 12.8 t -103.1 91.02 3.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.666 -179.881 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.9 pt -69.16 172.37 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.808 -179.962 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -93.29 134.04 35.9 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.892 -179.86 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.493 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 0.1 OUTLIER 66.95 27.76 8.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.543 -179.945 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -170.56 176.46 44.1 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.78 179.746 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 3.5 mtp85 -148.49 -167.37 2.8 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.505 0.669 . . . . 0.0 111.706 -178.512 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 10.3 p-80 -127.37 160.28 31.87 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.843 178.993 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -85.21 -87.66 0.12 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.611 -179.926 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.401 ' HA3' ' OH ' ' A' ' 89' ' ' TYR . . . 59.2 151.39 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.801 179.117 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -116.07 -33.65 4.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.982 0.42 . . . . 0.0 110.871 179.824 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.52 -175.94 2.94 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.137 -179.83 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -97.9 -33.07 11.37 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.554 177.157 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.517 ' CD2' ' CD ' ' A' ' 70' ' ' LYS . 6.5 m-30 -103.69 163.75 12.12 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.149 179.585 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.485 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 54.4 m-85 -152.61 166.45 32.04 Favored 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.647 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 12.2 p -147.47 -177.46 5.71 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.53 -0.868 . . . . 0.0 112.927 -178.416 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -49.94 95.53 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.391 -179.575 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.01 10.04 5.9 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.43 -0.891 . . . . 0.0 113.269 177.467 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.433 ' O ' ' N ' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -95.16 143.77 26.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 117.253 0.526 . . . . 0.0 110.652 179.61 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 27.2 m -130.31 150.48 34.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.586 -179.736 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.47 HG21 ' CH2' ' A' ' 118' ' ' TRP . 24.3 t -142.96 147.07 21.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.039 179.877 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.68 130.59 51.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.929 -179.64 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.53 ' CE1' ' CG2' ' A' ' 111' ' ' VAL . 6.8 m-85 -91.68 154.78 18.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.153 -179.575 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.39 134.95 22.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.494 -179.471 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.406 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 81.1 m -69.34 158.39 35.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.908 179.864 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.91 -86.77 0.3 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.31 -179.702 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.0 t -43.6 -28.11 0.36 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.825 -178.944 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.05 38.45 0.43 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.361 -179.872 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.493 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 54.6 m-85 -81.6 -172.95 4.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.759 0.314 . . . . 0.0 110.852 -179.87 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.45 113.68 25.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.11 0.481 . . . . 0.0 110.985 -179.801 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.437 HD22 ' CB ' ' A' ' 109' ' ' SER . 0.6 OUTLIER -47.51 109.78 0.25 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.509 178.554 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.46 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 47.5 mm -84.31 156.58 3.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.917 -178.947 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 59.06 -127.52 45.43 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.677 -178.736 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -117.18 133.68 55.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.012 0.434 . . . . 0.0 110.574 178.446 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.478 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 0.1 OUTLIER -67.79 -29.56 68.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.376 179.6 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -77.0 125.61 7.5 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.673 179.622 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.53 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 10.9 t -115.86 124.94 72.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 178.771 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.409 HD23 ' N ' ' A' ' 113' ' ' CYS . 1.3 tm? -80.75 136.04 36.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.041 0.448 . . . . 0.0 111.527 -178.621 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.488 ' HB2' ' CZ3' ' A' ' 118' ' ' TRP . 18.4 t -108.95 107.2 17.48 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.702 177.116 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.8 t -164.34 134.13 3.94 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.992 0.425 . . . . 0.0 111.349 -179.717 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 89.76 16.4 56.57 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.477 -179.863 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.474 ' N ' ' HB ' ' A' ' 69' ' ' VAL . . . 86.33 1.83 85.81 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.064 -179.062 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -138.28 -170.66 2.86 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.755 0.788 . . . . 0.0 111.768 -178.809 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.505 ' CH2' ' HG3' ' A' ' 74' ' ' PRO . 97.0 m95 -117.5 159.67 22.46 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.381 179.055 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.15 161.16 38.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.075 0.464 . . . . 0.0 111.785 -179.506 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.4 p30 46.87 53.67 13.99 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.423 179.069 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -80.5 147.29 17.7 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.633 2.222 . . . . 0.0 111.37 177.227 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.478 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 72.6 Cg_endo -92.05 -172.32 0.41 Allowed 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.71 2.273 . . . . 0.0 114.068 -177.339 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.426 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -136.63 -170.12 2.61 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.878 178.063 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 15.6 m -145.46 95.71 2.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.111 0.481 . . . . 0.0 111.211 -179.85 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -124.66 155.76 38.66 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.708 179.706 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.488 HG12 ' CE2' ' A' ' 103' ' ' TYR . 27.9 mm . . . . . 0 C--N 1.323 -0.572 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.914 179.961 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.94 0.4 . . . . 0.0 111.177 . . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.433 ' CB ' ' HA ' ' A' ' 26' ' ' ASP . 70.0 mtm180 -57.11 -171.71 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.012 -179.864 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.43 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 52.1 m -94.23 159.92 33.07 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.353 179.15 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.405 ' HD3' ' HB2' ' A' ' 9' ' ' CYS . 57.4 Cg_endo -68.31 166.38 25.55 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.271 1.981 . . . . 0.0 111.333 178.919 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 4.4 p -51.71 104.95 0.46 Allowed Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.178 -178.738 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.433 ' HG2' ' CZ2' ' A' ' 59' ' ' TRP . 12.7 Cg_exo -40.62 160.97 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.493 2.129 . . . . 0.0 112.517 -179.429 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.443 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -68.61 169.42 11.12 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.068 178.737 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -114.49 -173.98 2.4 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.253 0.549 . . . . 0.0 111.759 -178.192 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 13.9 tt -148.22 149.79 14.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.855 -179.435 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -90.19 159.82 16.54 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.643 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.433 ' N ' ' ND2' ' A' ' 17' ' ' ASN . 0.3 OUTLIER 46.45 27.51 0.62 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.86 0.362 . . . . 0.0 110.508 -179.138 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.74 170.25 39.76 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.024 -0.607 . . . . 0.0 112.471 -178.974 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -136.57 155.56 49.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.882 0.372 . . . . 0.0 110.41 179.831 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.477 HD22 ' CE2' ' A' ' 33' ' ' TYR . 0.3 OUTLIER -93.05 162.43 14.04 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.256 -179.638 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 32' ' ' THR . 12.8 t0 -128.9 74.61 1.59 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.538 177.962 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.43 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 1.5 mt -75.02 102.95 2.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.394 -176.086 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.3 13.1 58.61 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.612 175.893 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 166.46 138.05 2.35 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 -179.495 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 13.7 m -125.52 1.96 4.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.49 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.433 ' HA ' ' CB ' ' A' ' 8' ' ' ARG . 37.3 t70 -71.79 165.12 24.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.879 0.371 . . . . 0.0 110.816 179.943 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.518 ' CZ ' ' CD1' ' A' ' 51' ' ' LEU . 6.7 t80 -57.68 90.59 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.967 -179.501 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.81 -2.59 6.01 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.007 179.819 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.7 m -82.04 162.32 22.63 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 117.004 0.402 . . . . 0.0 110.485 179.561 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.5 p -131.55 148.92 52.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.94 0.4 . . . . 0.0 110.973 179.785 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.516 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.9 OUTLIER -108.67 170.64 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.668 -179.598 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.439 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -133.15 111.55 11.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.984 0.421 . . . . 0.0 110.874 179.015 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.482 ' CD2' ' HA ' ' A' ' 63' ' ' ALA . 12.1 m-85 -85.83 149.66 25.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.677 -178.475 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.1 m -149.52 160.64 43.3 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.134 179.821 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.5 m -84.27 169.18 14.97 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.068 179.939 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -67.76 -85.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.247 -178.972 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.23 132.67 12.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.742 -179.833 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.36 21.22 74.07 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.912 -178.718 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.534 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.7 m-85 -116.72 176.12 5.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.719 0.295 . . . . 0.0 110.598 -179.903 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.515 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 1.3 p80 -139.93 118.1 11.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.082 0.468 . . . . 0.0 110.243 177.754 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.448 HD22 ' CB ' ' A' ' 45' ' ' SER . 7.9 tt -78.22 123.31 26.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.736 -178.877 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.515 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 2.0 mm -102.04 165.51 2.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.038 0.447 . . . . 0.0 111.052 -179.343 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.69 -142.56 40.51 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.163 -179.198 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.413 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 1.0 OUTLIER -66.96 -175.56 0.43 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.006 0.431 . . . . 0.0 110.767 179.414 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.448 ' CB ' HD22 ' A' ' 41' ' ' LEU . 1.2 t -171.44 31.38 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.409 179.362 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.439 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -160.41 126.79 4.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.468 -178.153 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.448 ' OG ' ' CB ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -93.5 145.81 24.24 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.063 178.265 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.519 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 1.6 m-85 -122.18 115.29 22.14 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 119.414 -0.914 . . . . 0.0 111.583 178.579 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 39.1 t -68.04 100.18 0.96 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.845 -179.89 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.498 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -126.46 175.47 7.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.447 -179.686 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.518 ' CD1' ' CZ ' ' A' ' 27' ' ' PHE . 7.8 mt -79.87 160.06 26.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.127 -179.345 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.81 -86.01 0.94 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.55 -179.801 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.0 t -153.26 -45.48 0.09 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.805 0.336 . . . . 0.0 111.023 -179.771 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 81.5 p -95.71 16.25 17.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.435 -179.816 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 103.04 11.28 34.72 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.983 179.671 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.423 ' O ' ' CD2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -84.27 159.14 21.01 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.754 0.277 . . . . 0.0 110.649 179.644 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.4 111.14 23.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.918 0.389 . . . . 0.0 110.79 179.984 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.4 m -113.31 -169.39 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.767 179.808 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.516 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 73.6 m95 -130.7 146.58 52.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.977 0.418 . . . . 0.0 111.423 -179.543 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.519 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 0.6 OUTLIER -92.1 166.64 16.95 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.632 177.427 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.486 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 93.6 Cg_exo -16.22 97.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.811 1 C-N-CA 125.387 4.058 . . . . 0.0 114.639 -178.802 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.481 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -93.92 -76.54 0.48 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.088 -178.054 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.482 ' HA ' ' CD2' ' A' ' 33' ' ' TYR . . . -85.53 108.38 16.02 Favored Pre-proline 0 N--CA 1.463 0.176 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -175.896 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.446 ' HG3' ' CD1' ' A' ' 41' ' ' LEU . 3.5 Cg_exo -82.82 -153.88 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.148 2.565 . . . . 0.0 111.038 177.078 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.415 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 4.2 mm -90.29 167.38 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.771 0.319 . . . . 0.0 110.541 178.064 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.1 m -167.53 127.93 1.44 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.037 179.462 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -148.45 173.25 13.29 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.579 179.618 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.534 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 67.6 p -77.41 130.55 37.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.441 0.639 . . . . 0.0 111.368 -179.495 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.441 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 2.7 m -36.39 104.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 114.934 -1.03 . . . . 0.0 112.95 -178.985 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.437 ' CE ' HG21 ' A' ' 90' ' ' THR . 0.1 OUTLIER -86.77 97.06 10.4 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.271 177.132 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.403 ' N ' ' O ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -83.15 128.35 34.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.991 0.424 . . . . 0.0 110.246 179.264 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.44 -158.24 0.07 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.253 178.993 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.479 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 1.8 t -48.92 137.79 13.15 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.035 -179.997 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.489 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 35.5 Cg_exo -59.71 165.58 9.61 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.43 2.086 . . . . 0.0 112.348 -179.662 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.506 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 84.0 Cg_exo -45.77 157.38 0.34 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.769 2.312 . . . . 0.0 112.781 -179.669 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.7 t -109.87 90.21 3.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.461 179.047 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.1 pt -69.26 167.84 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.286 -179.0 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.8 m -81.29 139.45 35.41 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.717 179.684 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 56.5 28.84 14.39 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 -179.821 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.464 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -157.09 -170.29 21.87 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.344 -0.932 . . . . 0.0 113.268 -179.851 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -170.16 -175.32 1.95 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.068 0.461 . . . . 0.0 110.976 -179.307 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.479 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 9.3 p80 -115.84 170.64 8.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.971 -179.74 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -151.89 103.35 2.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.948 0.404 . . . . 0.0 111.035 179.012 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -122.06 176.91 16.49 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.268 179.568 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.404 ' CD2' ' N ' ' A' ' 85' ' ' TYR . 2.7 m-85 -107.85 -24.57 11.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.973 0.416 . . . . 0.0 110.813 179.643 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.37 -173.15 2.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.928 -179.853 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -109.91 -24.92 10.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.907 179.451 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.435 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 11.6 m-85 -129.13 -179.68 5.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.817 179.9 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.435 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 72.7 m-85 -156.62 164.14 38.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.67 -179.126 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.437 HG21 ' CE ' ' A' ' 70' ' ' LYS . 17.3 p -148.49 -177.04 5.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.087 0.47 . . . . 0.0 112.017 -179.242 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.426 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 56.4 m-20 -52.19 94.01 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.249 -179.503 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 122.43 20.5 2.94 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.184 -0.916 . . . . 0.0 113.044 178.455 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.411 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -106.11 150.02 26.19 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 117.087 0.443 . . . . 0.0 110.554 178.994 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 31.1 m -131.36 153.67 39.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.158 0.504 . . . . 0.0 111.359 -179.245 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.455 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 23.0 t -145.78 149.17 16.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.374 179.132 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.31 130.41 53.44 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.09 0.471 . . . . 0.0 110.796 -179.966 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.52 ' CE2' ' CG2' ' A' ' 111' ' ' VAL . 3.2 m-85 -87.52 157.41 19.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.252 -179.115 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 61.0 p -144.29 131.42 20.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.524 -179.746 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.423 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 87.8 m -69.26 151.88 45.72 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.019 179.761 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.464 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 6.4 m-20 -90.62 -71.69 0.61 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.706 -178.384 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.7 t -58.39 -17.95 24.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.512 -179.279 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 115.3 27.23 3.19 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.082 -179.298 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.483 ' CE2' HG12 ' A' ' 126' ' ' ILE . 31.3 m-85 -69.61 -173.72 0.62 Allowed 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 120.886 0.374 . . . . 0.0 110.923 -179.676 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.57 112.4 23.9 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.396 179.126 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.422 HD21 ' CB ' ' A' ' 97' ' ' TYR . 1.1 tp -50.1 112.49 0.68 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.074 -179.737 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.448 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 47.5 mm -99.34 155.88 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.729 179.957 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 60.53 28.13 67.1 Favored Glycine 0 CA--C 1.508 -0.363 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.437 179.497 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 60.22 129.11 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.001 -0.599 . . . . 0.0 111.495 179.65 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.475 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 1.2 p -61.47 -26.64 68.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.452 -179.059 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -58.66 136.83 50.81 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.788 -179.356 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.52 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 3.2 t -136.81 123.48 29.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.613 0.244 . . . . 0.0 110.936 179.734 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.458 ' CD2' ' N ' ' A' ' 113' ' ' CYS . 0.7 OUTLIER -81.72 136.16 35.47 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.886 0.374 . . . . 0.0 111.226 -179.73 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.497 ' HB2' ' CZ3' ' A' ' 118' ' ' TRP . 36.5 t -107.11 108.46 19.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.991 176.835 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 10.2 p -162.0 129.23 3.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.043 0.449 . . . . 0.0 111.848 -179.932 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.412 ' N ' ' OD1' ' A' ' 91' ' ' ASP . . . 86.58 30.22 22.08 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.508 179.309 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.441 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 68.75 14.15 67.12 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.212 -178.923 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -143.08 -178.15 5.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.181 0.515 . . . . 0.0 111.365 -179.552 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.506 ' CD1' ' HD2' ' A' ' 75' ' ' PRO . 90.4 m95 -123.73 133.05 53.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.525 179.989 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -111.89 157.21 20.9 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.085 0.469 . . . . 0.0 111.356 -179.428 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.495 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER 62.63 44.22 0.6 Allowed Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.256 179.21 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 55.2 Cg_endo -69.13 137.24 36.79 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.174 1.916 . . . . 0.0 111.273 178.008 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.485 ' HG2' ' CD1' ' A' ' 97' ' ' TYR . 71.0 Cg_endo -86.43 -173.99 1.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.404 2.069 . . . . 0.0 113.772 -177.631 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.58 -175.5 3.97 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.549 178.123 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . 0.419 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 3.8 m -139.29 94.87 2.85 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.972 0.415 . . . . 0.0 110.897 179.688 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -123.26 159.17 29.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.86 -179.666 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.483 HG12 ' CE2' ' A' ' 103' ' ' TYR . 27.3 mm . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.993 179.935 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.0 ttp180 . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.827 0.346 . . . . 0.0 110.811 . . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 66.0 mtm-85 -48.93 157.7 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.243 -179.803 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.5 ' HB2' ' CD ' ' A' ' 10' ' ' PRO . 36.2 m -73.53 175.83 3.23 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.808 178.592 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.531 ' HD2' ' CD1' ' A' ' 59' ' ' TRP . 18.6 Cg_endo -87.2 -174.83 1.41 Allowed 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.791 2.327 . . . . 0.0 111.406 178.882 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.9 t -58.18 106.53 0.71 Allowed Pre-proline 0 C--N 1.325 -0.479 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.402 179.242 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.433 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 1.8 Cg_endo -49.91 148.11 13.41 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.09 1.86 . . . . 0.0 111.849 -179.203 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.433 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -58.16 159.47 5.87 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.126 178.981 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -108.33 -178.96 3.75 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.149 0.5 . . . . 0.0 112.021 -176.29 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.5 tt -138.85 144.23 30.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.71 179.585 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.02 -68.95 0.58 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.557 -178.483 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.411 ' HA ' ' ND2' ' A' ' 36' ' ' ASN . 66.5 m-80 -90.02 43.4 1.14 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.222 -179.134 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.418 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -160.5 -174.81 30.78 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.093 179.981 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -143.53 128.62 18.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.742 0.306 . . . . 0.0 110.624 -179.598 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.53 ' CD2' ' CE2' ' A' ' 33' ' ' TYR . 13.8 mt -73.11 157.88 36.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.072 0.463 . . . . 0.0 111.497 -179.571 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.98 75.37 1.65 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.643 177.657 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.447 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 68.0 mt -69.25 106.32 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.65 -177.643 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -115.87 21.05 12.69 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.66 177.557 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 158.31 119.91 0.58 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.136 -179.512 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.8 m -117.84 28.92 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.774 0.321 . . . . 0.0 111.295 -179.596 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -104.89 147.85 27.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.852 179.86 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.449 ' CZ ' ' HB2' ' A' ' 51' ' ' LEU . 8.4 t80 -47.34 96.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.088 -179.693 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 122.33 16.68 3.8 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.83 -179.951 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.16 -161.0 0.75 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.696 0.284 . . . . 0.0 110.749 179.632 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.4 p -167.68 148.82 5.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.986 0.422 . . . . 0.0 111.318 179.42 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.532 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 1.0 OUTLIER -106.94 173.33 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.591 -179.977 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.445 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -130.92 116.35 17.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.99 0.424 . . . . 0.0 111.384 179.375 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.53 ' CE2' ' CD2' ' A' ' 20' ' ' LEU . 18.7 m-85 -92.29 138.83 31.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.968 179.758 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.418 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 85.3 p -144.01 166.41 25.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.981 -179.74 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.416 ' HB2' ' HB2' ' A' ' 39' ' ' TYR . 3.9 m -90.2 165.72 13.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.728 179.915 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.411 ' ND2' ' HA ' ' A' ' 17' ' ' ASN . 34.6 m-80 -64.28 -83.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.851 0.358 . . . . 0.0 111.015 -179.612 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.18 136.81 15.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.624 179.906 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 60.77 26.92 65.75 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.862 -178.913 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.486 ' CD2' ' HA ' ' A' ' 68' ' ' SER . 2.3 m-85 -119.26 171.41 8.32 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.725 0.298 . . . . 0.0 110.811 -179.328 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.504 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.5 OUTLIER -132.3 120.37 22.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.955 0.407 . . . . 0.0 110.516 177.865 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.436 ' CD1' ' HG3' ' A' ' 64' ' ' PRO . 6.7 tt -83.46 124.07 30.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.765 -179.294 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.504 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 1.9 mm -103.8 167.79 2.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.984 -179.625 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.59 -134.37 19.06 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.097 -179.16 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.431 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 1.2 pt-20 -80.71 -175.69 5.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.868 0.366 . . . . 0.0 110.688 178.978 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.9 p -160.19 22.31 0.16 Allowed 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.423 -179.258 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.445 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -163.2 124.29 2.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.85 0.357 . . . . 0.0 111.691 -177.984 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 30' ' ' SER . 1.4 t -91.89 138.77 31.28 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 177.233 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.493 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 1.7 m-85 -113.38 121.53 44.61 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 119.146 -1.022 . . . . 0.0 112.17 -179.473 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 33.9 t -73.28 102.78 3.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.576 179.174 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.01 -172.33 2.43 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.311 -179.543 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -92.47 143.58 26.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.03 -179.353 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -93.57 -94.24 1.53 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.672 -179.793 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.22 60.12 1.05 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.957 0.408 . . . . 0.0 111.211 -179.262 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.403 ' HA ' ' CD2' ' A' ' 51' ' ' LEU . 2.9 p 59.57 29.49 19.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.064 179.369 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.0 -25.98 0.24 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.526 -179.95 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.98 -162.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.865 0.364 . . . . 0.0 111.022 -179.849 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.69 139.86 50.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.628 -179.518 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.2 m -156.46 163.48 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.879 179.692 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.532 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 78.4 m95 -124.75 120.42 31.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.937 0.399 . . . . 0.0 111.528 -179.325 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.493 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -69.9 165.9 37.84 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.14 178.155 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.442 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 89.3 Cg_exo -19.35 98.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 125.216 3.944 . . . . 0.0 114.164 -179.004 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.474 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -100.48 -78.76 0.51 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.344 -177.096 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.497 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -76.55 108.3 6.16 Favored Pre-proline 0 N--CA 1.463 0.19 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -175.032 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.436 ' HG3' ' CD1' ' A' ' 41' ' ' LEU . 1.0 OUTLIER -88.22 -153.99 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.388 2.725 . . . . 0.0 110.993 176.814 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.42 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 3.0 mm -98.76 169.57 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.875 0.369 . . . . 0.0 110.76 178.629 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.1 m -160.51 145.77 14.7 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 179.556 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.471 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.3 OUTLIER -164.56 172.38 13.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.039 -179.951 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.486 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 12.1 p -90.22 112.61 24.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.086 0.469 . . . . 0.0 111.078 179.967 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.449 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 0.4 OUTLIER -47.79 99.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.344 179.863 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.88 116.13 21.39 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.075 179.923 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.407 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -97.68 129.75 44.72 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.308 179.283 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.85 -156.33 0.12 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.362 179.306 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.421 ' OG ' ' NE2' ' A' ' 82' ' ' HIS . 2.1 t -49.26 137.58 15.14 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.854 179.933 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.479 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 27.4 Cg_exo -59.9 163.79 13.15 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.405 2.07 . . . . 0.0 112.062 -179.989 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.492 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 86.1 Cg_exo -39.38 156.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.812 2.341 . . . . 0.0 112.894 -179.605 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.6 t -108.8 90.49 3.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.551 179.449 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 35.7 pt -69.43 175.22 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.326 -179.182 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.36 138.18 39.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.622 179.309 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.478 ' HB3' ' CD2' ' A' ' 103' ' ' TYR . 0.3 OUTLIER 68.65 28.07 5.8 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.676 -179.958 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.438 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . -170.21 -159.99 17.47 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.76 179.694 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.4 ptt85 -170.13 -176.2 2.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.091 0.472 . . . . 0.0 111.022 -179.226 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.446 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 21.4 p-80 -110.25 170.9 7.78 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.918 179.795 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -104.55 -88.09 0.43 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.775 179.88 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 65.9 153.57 0.19 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.036 178.729 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -114.14 -35.72 4.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.006 0.432 . . . . 0.0 110.813 179.588 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.05 -172.76 2.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.141 -179.532 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -99.99 -21.13 15.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.295 179.987 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.42 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 5.3 m-85 -133.08 176.72 8.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.205 -179.727 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.42 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 66.4 m-85 -152.77 161.6 42.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.928 -179.689 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.1 p -128.36 -175.92 3.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.214 -179.252 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -64.85 94.83 0.14 Allowed 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.271 0.558 . . . . 0.0 110.988 -179.843 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.55 18.72 2.18 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.317 178.656 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -95.34 162.86 13.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.934 0.367 . . . . 0.0 110.573 179.246 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.6 m -138.27 149.64 24.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.13 0.49 . . . . 0.0 111.335 -179.608 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.505 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 23.6 t -146.09 148.68 16.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.743 179.526 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.43 ' CG2' ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -106.97 130.89 54.55 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.987 -179.973 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.527 ' CE1' ' CG2' ' A' ' 111' ' ' VAL . 4.9 m-85 -89.88 160.74 16.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.985 -179.67 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.3 p -157.37 138.86 13.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.557 -179.941 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.438 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 68.5 m -70.27 164.5 24.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.815 179.4 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -101.68 -85.24 0.43 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.84 0.352 . . . . 0.0 111.207 179.636 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -45.01 -31.36 1.28 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.522 -179.198 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 130.29 45.12 0.17 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.681 179.777 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.496 ' CE1' HG12 ' A' ' 126' ' ' ILE . 29.7 m-85 -87.04 -173.54 4.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.833 0.349 . . . . 0.0 110.836 179.972 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 41.2 m -111.49 108.17 17.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.108 -179.519 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.428 HD23 ' CG ' ' A' ' 122' ' ' PRO . 2.9 tp -44.94 113.16 0.52 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.146 178.935 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.446 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 40.0 mm -85.93 156.33 3.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.465 179.79 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.411 ' N ' HG21 ' A' ' 106' ' ' ILE . . . 60.44 -125.62 39.09 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.558 -178.333 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -124.2 135.37 53.4 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.849 0.357 . . . . 0.0 110.584 178.55 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.456 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 1.2 p -65.94 -29.8 70.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.701 -180.0 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -71.91 137.08 24.97 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.578 179.892 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.527 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 2.7 t -131.08 119.16 43.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.757 0.313 . . . . 0.0 110.837 179.712 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.03 119.57 23.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.522 -179.006 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.51 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 31.7 t -85.57 101.88 13.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.623 176.996 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.9 t -139.31 153.85 47.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.193 0.52 . . . . 0.0 111.568 -178.143 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.15 33.94 7.71 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.911 179.482 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.449 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 69.94 11.07 65.97 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.746 -179.999 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -131.15 175.15 9.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.899 0.381 . . . . 0.0 110.391 179.225 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.51 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 93.3 m95 -117.12 128.62 55.32 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.787 -179.43 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.38 146.63 35.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.4 -178.852 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.486 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.5 t0 71.53 46.46 0.24 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.207 178.646 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 74.0 Cg_endo -75.32 130.66 13.15 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.319 2.013 . . . . 0.0 111.324 177.934 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.456 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 58.0 Cg_endo -86.15 -174.7 1.58 Allowed 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.448 2.099 . . . . 0.0 113.387 -178.229 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.443 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.3 OUTLIER -135.81 -173.62 3.42 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.071 178.392 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . 0.432 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 16.5 m -141.61 94.62 2.71 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.94 0.4 . . . . 0.0 111.108 -179.5 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -118.83 169.42 9.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.713 179.921 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.496 HG12 ' CE1' ' A' ' 103' ' ' TYR . 19.5 mm . . . . . 0 C--N 1.325 -0.491 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.806 -179.796 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.457 -0.084 0 CA-C-O 120.896 0.379 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.3 mtm180 -71.93 157.14 38.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.798 179.394 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.451 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 69.4 m -77.67 159.24 77.19 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.577 179.606 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' A' ' 9' ' ' CYS . 51.1 Cg_endo -68.85 169.98 16.49 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.345 2.03 . . . . 0.0 111.964 -179.718 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.17 105.91 0.58 Allowed Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.777 -179.745 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.497 ' HG2' ' CZ2' ' A' ' 59' ' ' TRP . 53.0 Cg_exo -53.67 160.16 5.8 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.278 1.985 . . . . 0.0 112.517 -179.759 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.439 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -52.86 -174.58 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.156 177.811 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.451 ' O ' HG21 ' A' ' 15' ' ' ILE . 11.8 p-10 -135.66 -40.88 0.7 Allowed 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -176.314 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.451 HG21 ' O ' ' A' ' 14' ' ' ASP . 5.1 tt 66.08 139.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.777 -177.084 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -94.47 -40.03 10.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.855 -177.736 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -93.83 24.71 4.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.8 0.333 . . . . 0.0 111.116 -179.016 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.421 ' CA ' HG23 ' A' ' 15' ' ' ILE . . . -164.08 176.29 40.08 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.544 179.838 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -129.49 129.7 44.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.702 0.287 . . . . 0.0 110.564 179.718 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.513 ' CG ' ' CE1' ' A' ' 33' ' ' TYR . 49.1 mt -82.63 162.51 21.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.151 0.5 . . . . 0.0 111.632 -179.14 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -130.71 80.59 1.95 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.166 179.259 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.424 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 56.3 mt -71.33 103.33 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.441 -178.583 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.31 15.22 50.7 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.303 178.451 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 157.11 127.86 1.01 Allowed Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.772 -179.538 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 30.1 m -115.32 26.22 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -178.213 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -101.18 162.09 13.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.986 0.422 . . . . 0.0 110.996 179.08 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -57.18 92.01 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.986 -179.31 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 132.51 -11.87 5.21 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.884 179.87 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.3 m -75.37 -175.74 2.87 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.819 0.309 . . . . 0.0 110.805 179.87 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 47' ' ' SER . 0.3 OUTLIER -154.07 143.45 21.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.493 -179.717 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.54 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.5 OUTLIER -104.51 171.25 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.938 179.222 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.426 ' O ' ' N ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -132.25 120.19 21.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.891 178.933 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.534 ' CE1' ' CB ' ' A' ' 63' ' ' ALA . 28.5 m-85 -99.65 135.22 41.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.197 -179.624 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 64.3 m -143.33 159.38 42.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.765 179.628 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.401 ' HB2' ' HB2' ' A' ' 39' ' ' TYR . 57.0 m -83.87 166.02 18.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.002 -179.947 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.85 -83.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.082 -179.705 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 t -155.44 136.48 13.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.787 -179.895 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.01 23.25 65.7 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.124 -179.294 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.484 ' CE1' ' HB2' ' A' ' 68' ' ' SER . 2.3 m-85 -113.63 -179.02 3.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.918 0.389 . . . . 0.0 110.98 -179.386 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.466 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.3 OUTLIER -143.98 114.56 7.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.393 178.095 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.425 ' CD2' ' O ' ' A' ' 44' ' ' GLU . 2.3 tt -75.25 136.47 40.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.675 -179.105 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.466 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 3.1 mm -108.39 153.94 9.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.199 -179.01 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.64 -135.95 19.1 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.554 -179.948 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.425 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 4.3 pm0 -75.47 -179.14 4.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.624 0.25 . . . . 0.0 110.691 179.733 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.1 p -152.23 21.04 0.65 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.181 -179.784 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.415 ' CE ' ' O ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -151.91 163.06 40.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.896 -178.882 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.444 ' O ' HG12 ' A' ' 31' ' ' ILE . 2.8 m -137.44 112.05 8.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.643 179.99 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.419 ' CD1' ' N ' ' A' ' 48' ' ' TYR . 2.0 m-30 -90.01 121.2 31.87 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.897 0.38 . . . . 0.0 111.334 -179.258 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.489 ' HB3' ' CH2' ' A' ' 59' ' ' TRP . 35.1 t -71.56 97.49 1.7 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.55 179.396 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -124.58 -176.49 3.54 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.128 -179.514 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -90.16 150.26 22.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.01 -179.314 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -77.24 -118.48 0.18 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.486 -179.889 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.81 -42.04 3.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.859 0.362 . . . . 0.0 110.948 -179.947 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 59.2 p -99.08 56.6 1.04 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.854 -179.888 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 52.84 26.15 25.05 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.373 -179.795 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.85 -165.01 1.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.892 0.377 . . . . 0.0 111.052 -179.851 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 4.0 mmt -124.06 139.08 54.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.443 179.716 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.0 m -149.7 -178.13 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.87 0.367 . . . . 0.0 111.275 -179.296 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.54 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 95.2 m95 -128.77 123.86 34.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.774 -179.733 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -148.45 119.71 4.34 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.769 -179.459 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -67.72 -176.28 9.64 Favored 'Cis proline' 0 C--N 1.351 0.7 0 C-N-CA 124.135 -1.194 . . . . 0.0 112.718 1.787 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.435 ' O ' ' CD ' ' A' ' 64' ' ' PRO . 0.6 OUTLIER -111.6 -140.77 0.38 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.102 -178.654 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.534 ' CB ' ' CE1' ' A' ' 33' ' ' TYR . . . -95.6 86.17 0.32 Allowed Pre-proline 0 N--CA 1.448 -0.567 0 C-N-CA 122.878 0.471 . . . . 0.0 110.759 179.464 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 63' ' ' ALA . 9.8 Cg_endo -45.68 -159.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.476 0.451 0 C-N-CA 124.313 3.342 . . . . 0.0 114.53 178.703 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.5 mm -97.59 165.76 2.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.854 -178.267 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.2 m -164.83 117.35 1.24 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.342 179.017 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.19 177.68 7.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.893 0.377 . . . . 0.0 111.353 -179.417 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.484 ' HB2' ' CE1' ' A' ' 39' ' ' TYR . 49.7 p -88.71 99.35 12.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.22 -179.965 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.439 ' CG2' ' HA3' ' A' ' 116' ' ' GLY . 6.8 p -60.99 103.89 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.302 178.489 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.428 ' HG2' ' CG2' ' A' ' 90' ' ' THR . 2.7 mttp -82.21 167.44 18.66 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -176.297 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.421 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -125.96 122.69 36.67 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.525 177.3 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.444 ' CG ' ' N ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -69.43 -155.48 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.988 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.444 ' N ' ' CG ' ' A' ' 72' ' ' GLN . 1.4 t -52.8 144.52 25.6 Favored Pre-proline 0 N--CA 1.448 -0.556 0 C-N-CA 121.081 -0.248 . . . . 0.0 110.373 179.091 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.473 ' HD2' ' CD2' ' A' ' 82' ' ' HIS . 39.0 Cg_exo -60.78 160.36 25.31 Favored 'Trans proline' 0 C--O 1.231 0.129 0 C-N-CA 122.561 2.174 . . . . 0.0 112.159 -179.327 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -42.39 155.89 0.1 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.568 2.179 . . . . 0.0 112.41 -179.315 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.3 t -103.94 86.39 2.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.828 -179.793 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.43 ' CD1' ' HA3' ' A' ' 80' ' ' GLY . 8.2 pt -69.85 169.98 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.953 -179.959 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.5 m -91.59 137.91 31.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.81 179.651 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.482 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 4.8 m-80 57.62 29.84 17.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.725 -179.901 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.43 ' HA3' ' CD1' ' A' ' 77' ' ' ILE . . . -165.5 169.36 39.91 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.531 -0.843 . . . . 0.0 112.807 179.685 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' A' ' 80' ' ' GLY . 19.8 mtt180 -147.19 -166.38 2.5 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.483 0.659 . . . . 0.0 111.622 -178.082 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 1.9 p-80 -130.6 157.24 43.25 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.442 179.911 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.429 ' OD1' ' N ' ' A' ' 96' ' ' THR . 1.8 p30 -109.36 86.44 2.29 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.109 177.867 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.415 ' CA ' ' OH ' ' A' ' 89' ' ' TYR . . . -90.96 153.49 22.39 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 119.478 -1.344 . . . . 0.0 112.522 -179.149 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.05 -36.97 8.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.172 0.51 . . . . 0.0 110.377 -179.395 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.76 -176.3 3.0 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.262 -179.482 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.88 -26.49 18.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.193 177.809 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.403 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 4.2 m-85 -134.11 171.85 13.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.535 179.22 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.421 ' N ' ' O ' ' A' ' 71' ' ' CYS . 26.2 m-85 -140.22 158.45 44.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.034 -179.746 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.428 ' CG2' ' HG2' ' A' ' 70' ' ' LYS . 5.5 p -122.71 176.34 6.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.572 -178.32 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -60.85 93.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.76 179.495 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 125.56 19.1 2.35 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.126 179.134 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -98.82 158.85 15.36 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.868 0.334 . . . . 0.0 110.33 178.865 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 27.8 m -145.57 142.27 22.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.421 0.629 . . . . 0.0 111.972 -179.491 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.545 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 40.7 t -144.46 148.12 18.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.488 178.167 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.429 ' N ' ' OD1' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -95.68 159.92 14.75 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.083 0.468 . . . . 0.0 111.796 -177.5 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.518 ' CE1' ' CG2' ' A' ' 111' ' ' VAL . 4.9 m-85 -110.7 155.66 22.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.997 179.223 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.1 p -150.25 140.18 21.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.339 -178.958 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.402 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 83.9 m -75.24 146.92 40.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.222 -179.951 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -78.78 -83.2 0.09 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.622 -179.057 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.2 t -52.47 -22.96 5.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.538 -178.647 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 123.1 30.55 1.09 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.808 179.971 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.497 ' CE2' HG12 ' A' ' 126' ' ' ILE . 48.9 m-85 -69.32 -172.19 0.42 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.724 0.297 . . . . 0.0 110.51 179.413 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.2 m -110.45 107.32 16.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.999 0.428 . . . . 0.0 111.302 -179.257 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.456 HD23 ' CB ' ' A' ' 109' ' ' SER . 1.9 tp -45.52 112.96 0.52 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.944 178.734 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.453 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 20.1 mm -90.6 160.85 2.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.051 -178.874 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.423 ' N ' HG21 ' A' ' 106' ' ' ILE . . . 56.5 -129.29 48.25 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.148 -179.641 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -110.4 125.0 52.77 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.8 0.333 . . . . 0.0 110.932 179.873 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.457 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 0.1 OUTLIER -67.67 -34.57 77.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.203 178.661 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -79.08 130.83 10.17 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.982 178.479 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.518 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 3.2 t -117.63 141.33 36.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 179.786 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.07 122.73 44.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.99 0.424 . . . . 0.0 111.712 -178.469 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.413 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 10.9 t -85.88 105.99 16.77 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.055 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.34 154.6 42.49 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.183 0.516 . . . . 0.0 111.349 -178.422 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 54.36 22.09 21.89 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.73 179.548 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.439 ' HA3' ' CG2' ' A' ' 69' ' ' VAL . . . 87.55 -6.44 83.4 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.533 -0.842 . . . . 0.0 113.005 179.996 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -128.66 -176.81 3.95 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.09 0.472 . . . . 0.0 110.932 -179.698 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.545 ' CH2' ' CG2' ' A' ' 95' ' ' VAL . 95.3 m95 -108.92 157.62 18.46 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.831 -179.71 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.47 149.11 42.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.061 0.458 . . . . 0.0 111.324 -179.369 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.471 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.7 OUTLIER 68.21 47.67 0.39 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.786 178.69 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 74.0 Cg_endo -75.31 137.68 21.34 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.314 2.009 . . . . 0.0 111.534 178.422 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.457 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 59.5 Cg_endo -89.29 -174.13 0.89 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.543 2.162 . . . . 0.0 113.561 -178.212 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.433 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -133.6 -174.06 3.41 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.913 177.997 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 8.3 m -143.3 96.5 2.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.143 0.497 . . . . 0.0 111.146 -179.811 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -121.62 157.72 30.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.775 -179.998 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.497 HG12 ' CE2' ' A' ' 103' ' ' TYR . 37.3 mm . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.93 179.918 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 23.1 mmt85 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.788 0.327 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.418 ' CB ' ' O ' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -118.3 178.3 4.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.085 -179.693 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.449 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 55.6 m -93.01 160.17 34.21 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.202 -179.126 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.04 176.56 7.56 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.714 2.276 . . . . 0.0 112.531 -179.338 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -50.14 106.58 0.65 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.701 179.662 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.493 ' HG2' ' CZ2' ' A' ' 59' ' ' TRP . 76.2 Cg_exo -48.68 144.22 14.97 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.466 2.111 . . . . 0.0 112.676 -179.323 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.427 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -54.94 164.74 0.75 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.882 178.651 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.6 -174.17 2.52 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.322 0.582 . . . . 0.0 112.025 -177.785 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.7 tt -142.06 145.07 24.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.263 -179.768 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -74.9 -66.84 0.7 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -177.106 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -91.74 26.62 2.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.336 -177.998 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.421 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -142.47 -175.5 15.78 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.241 -0.981 . . . . 0.0 113.279 -179.399 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -140.45 137.54 34.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.691 0.282 . . . . 0.0 110.357 179.294 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.473 HD23 ' CE1' ' A' ' 33' ' ' TYR . 3.7 mt -80.45 163.85 23.48 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.154 0.502 . . . . 0.0 111.794 -179.009 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.69 71.06 1.42 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.536 177.283 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.431 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 62.2 mt -69.9 103.56 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.84 -177.758 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.18 18.21 42.78 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.985 177.843 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 156.02 131.74 1.44 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 121.14 -0.552 . . . . 0.0 111.936 -179.586 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.418 ' O ' ' CB ' ' A' ' 8' ' ' ARG . 32.3 m -116.43 25.97 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.686 0.279 . . . . 0.0 111.683 -178.822 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.2 152.23 19.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.042 179.792 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.405 ' CZ ' ' HB2' ' A' ' 51' ' ' LEU . 2.2 t80 -55.51 91.31 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.979 0.419 . . . . 0.0 110.441 179.327 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 131.92 -10.09 5.43 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.515 -178.825 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 92.2 p -75.11 -167.73 0.66 Allowed 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 179.326 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.1 p -157.7 152.05 24.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.073 0.463 . . . . 0.0 111.668 179.857 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.517 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -113.84 169.36 5.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.327 179.332 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.31 112.81 11.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.9 0.381 . . . . 0.0 111.062 178.621 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.478 ' CE1' ' HA ' ' A' ' 63' ' ' ALA . 17.0 m-85 -85.3 138.53 32.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.946 179.955 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.421 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.2 OUTLIER -138.35 168.75 19.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.668 -179.982 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.423 ' HB2' ' HB2' ' A' ' 39' ' ' TYR . 3.8 m -91.65 160.81 15.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.733 179.872 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -60.96 -79.68 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.184 -179.303 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.03 133.65 10.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.724 -179.786 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 60.72 25.39 63.52 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.79 -178.907 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.487 ' CD2' ' HA ' ' A' ' 68' ' ' SER . 2.3 m-85 -116.53 171.37 7.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.709 0.29 . . . . 0.0 110.78 -179.354 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.478 ' CE1' HD13 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -130.66 131.62 44.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.019 0.438 . . . . 0.0 110.718 178.764 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.434 ' CD2' ' HB2' ' A' ' 64' ' ' PRO . 3.3 tt -87.7 131.01 34.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.816 -179.054 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.478 HD13 ' CE1' ' A' ' 40' ' ' HIS . 2.1 mm -105.45 154.23 6.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.982 0.42 . . . . 0.0 111.143 -179.365 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.09 -136.35 23.85 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.61 -178.469 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.421 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 0.8 OUTLIER -81.45 -178.12 6.8 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.33 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.409 ' HA ' ' HG3' ' A' ' 64' ' ' PRO . 6.4 p -155.17 23.6 0.42 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.104 -179.313 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt -147.48 141.57 26.04 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.199 -178.642 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.429 ' CB ' HD13 ' A' ' 31' ' ' ILE . 2.5 m -113.01 147.16 37.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.105 178.924 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.427 ' CD1' ' HD2' ' A' ' 61' ' ' PRO . 1.7 m-85 -119.16 121.78 40.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.014 0.435 . . . . 0.0 111.424 -179.597 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.503 ' HB3' ' CH2' ' A' ' 59' ' ' TRP . 18.8 t -70.26 77.09 0.53 Allowed 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.03 178.474 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -102.64 179.63 4.24 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.371 -178.491 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.405 ' HB2' ' CZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -88.43 162.12 16.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.212 -178.821 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.58 -136.77 6.2 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.552 -179.987 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.1 m -93.87 -40.75 9.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.78 0.324 . . . . 0.0 111.102 -179.74 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 61.8 p -98.65 46.19 1.0 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.16 -179.672 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 61.74 15.62 48.59 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.884 179.507 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.0 t -76.67 -163.35 0.32 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.69 0.281 . . . . 0.0 110.763 179.679 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.97 124.53 37.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.914 0.387 . . . . 0.0 110.457 179.808 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.6 m -139.8 165.76 21.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.216 -179.199 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.517 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 92.2 m95 -102.24 127.62 49.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.17 178.629 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -159.67 127.59 2.81 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.745 -176.873 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.427 ' HD2' ' CD1' ' A' ' 48' ' ' TYR . 21.4 Cg_exo -68.77 -174.38 8.51 Favored 'Cis proline' 0 C--N 1.351 0.677 0 C-N-CA 124.236 -1.152 . . . . 0.0 112.697 1.364 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -110.7 -152.15 0.49 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.128 -178.38 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.478 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -75.27 110.96 11.66 Favored Pre-proline 0 CA--C 1.53 0.181 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.176 -179.717 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.434 ' HB2' ' CD2' ' A' ' 41' ' ' LEU . 23.6 Cg_exo -66.42 -145.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.832 2.355 . . . . 0.0 112.174 -179.871 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.423 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 3.4 mm -106.39 165.59 4.01 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 120.762 0.315 . . . . 0.0 111.312 -178.73 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -164.18 124.46 2.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.92 179.632 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.478 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 3.8 tt0 -143.73 -179.64 6.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.938 179.96 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.487 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 1.3 p -86.43 119.44 26.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.021 0.439 . . . . 0.0 111.125 -179.894 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.435 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 3.8 p -49.3 96.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.278 179.778 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -71.31 139.87 50.08 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.863 179.752 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.2 128.11 55.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.922 0.391 . . . . 0.0 110.781 179.58 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.412 ' O ' ' NE1' ' A' ' 118' ' ' TRP . 0.0 OUTLIER -67.42 -175.54 0.5 Allowed 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 121.912 0.863 . . . . 0.0 113.176 -177.677 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.465 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 0.3 OUTLIER -51.82 119.09 12.99 Favored Pre-proline 0 N--CA 1.439 -0.98 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.484 176.388 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.492 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 51.4 Cg_exo -41.71 155.04 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.063 1.842 . . . . 0.0 112.416 -176.564 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -45.31 157.08 0.28 Allowed 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.88 2.387 . . . . 0.0 112.854 -179.015 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.31 90.79 3.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.845 -179.933 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.411 ' CG2' ' O ' ' A' ' 122' ' ' PRO . 18.4 pt -69.5 171.72 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.361 -179.484 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.7 p -88.12 136.66 32.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.707 179.242 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.476 ' HB3' ' CD2' ' A' ' 103' ' ' TYR . 0.1 OUTLIER 66.34 26.53 10.24 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.52 -179.576 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.426 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . 178.03 -178.66 48.53 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.625 179.978 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.406 ' NE ' ' OD1' ' A' ' 100' ' ' ASN . 0.1 OUTLIER -170.25 -175.84 2.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.784 0.326 . . . . 0.0 110.605 -179.714 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.481 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 42.6 p-80 -95.35 168.91 10.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.038 179.831 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -105.53 -72.32 0.72 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.706 179.392 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.41 ' HA3' ' OH ' ' A' ' 89' ' ' TYR . . . 59.72 153.36 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.996 178.911 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -112.36 -26.33 8.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.996 0.427 . . . . 0.0 110.863 179.521 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.8 -173.46 2.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.236 -179.315 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.59 -23.46 13.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.854 178.973 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.431 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 6.4 m-85 -135.13 175.07 9.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.841 179.876 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.431 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 39.0 m-85 -145.52 165.01 29.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.972 -179.429 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.8 p -130.32 163.02 27.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.998 0.428 . . . . 0.0 111.47 -178.901 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -50.22 95.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.009 -179.91 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.69 26.53 1.14 Allowed Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.32 -0.855 . . . . 0.0 113.114 178.809 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.403 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -110.28 161.93 15.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.837 0.319 . . . . 0.0 110.6 179.065 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.405 ' CG2' ' N ' ' A' ' 95' ' ' VAL . 34.1 m -135.2 157.83 40.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.061 0.457 . . . . 0.0 111.058 -179.996 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.475 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 25.4 t -148.99 148.24 15.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.299 179.52 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.62 120.93 44.02 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.349 0.595 . . . . 0.0 111.126 -179.372 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.531 ' CE2' ' CG2' ' A' ' 111' ' ' VAL . 4.4 m-85 -77.26 158.12 30.42 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.69 -178.671 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.0 p -154.37 139.11 17.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.551 -179.929 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.426 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 6.9 m -69.85 164.02 24.61 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.51 179.971 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.406 ' OD1' ' NE ' ' A' ' 81' ' ' ARG . 28.9 m-20 -95.12 -69.93 0.73 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.314 -179.543 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.6 t -68.74 -34.45 75.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.345 -178.928 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 137.14 41.77 0.1 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.574 -179.925 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.518 ' CD1' ' CD1' ' A' ' 126' ' ' ILE . 15.4 m-85 -80.8 -168.14 1.66 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 179.479 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.8 m -117.15 105.42 12.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.804 0.335 . . . . 0.0 111.538 -179.642 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.446 ' CD2' ' HB2' ' A' ' 122' ' ' PRO . 1.6 tp -48.97 121.84 5.17 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.107 0.48 . . . . 0.0 110.615 178.509 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.44 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 33.7 mm -103.12 159.31 4.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.566 -177.298 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 52.37 30.32 32.74 Favored Glycine 0 CA--C 1.509 -0.343 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.546 179.468 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.401 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.6 OUTLIER 59.65 127.9 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.984 -0.608 . . . . 0.0 111.394 179.679 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.439 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 1.2 p -58.56 -29.21 66.2 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.97 -178.332 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -52.69 131.39 39.79 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.706 -0.759 . . . . 0.0 113.154 -178.651 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.531 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 2.3 t -130.72 144.28 38.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.39 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.1 tt -104.93 125.24 50.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.963 0.411 . . . . 0.0 112.076 -177.803 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.429 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 11.2 t -88.59 95.47 10.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.436 176.547 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 p -139.06 163.64 31.88 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.208 -178.45 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.2 26.18 2.15 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.773 179.802 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.435 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 76.11 1.51 69.01 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.955 -179.633 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -131.64 179.71 5.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.808 0.337 . . . . 0.0 110.61 179.525 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.492 ' CH2' ' HG3' ' A' ' 74' ' ' PRO . 93.5 m95 -107.79 125.65 51.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 -179.898 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.56 145.07 36.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.145 -179.474 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.486 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 2.0 t70 66.89 44.5 0.35 Allowed Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.256 178.71 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 52.9 Cg_endo -67.44 149.83 80.42 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 121.893 1.728 . . . . 0.0 110.354 176.912 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.446 ' HB2' ' CD2' ' A' ' 105' ' ' LEU . 42.0 Cg_endo -95.71 -178.19 0.45 Allowed 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 122.129 1.886 . . . . 0.0 114.039 -176.925 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.412 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -124.34 -159.81 0.89 Allowed 'General case' 0 CA--C 1.502 -0.867 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.009 176.796 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . 0.404 ' SG ' ' CB ' ' A' ' 103' ' ' TYR . 3.8 t -170.34 93.8 0.22 Allowed 'General case' 0 N--CA 1.433 -1.288 0 CA-C-O 121.772 0.796 . . . . 0.0 110.87 -175.906 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -106.88 -169.33 1.53 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.303 -1.317 . . . . 0.0 112.096 -176.891 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.518 ' CD1' ' CD1' ' A' ' 103' ' ' TYR . 19.1 mm . . . . . 0 C--N 1.313 -1.012 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.11 179.51 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.822 0.344 . . . . 0.0 110.938 . . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.403 ' HA ' ' HA ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -98.89 176.76 5.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.833 -179.859 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.449 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 60.3 m -90.24 161.25 38.01 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.681 179.85 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.415 ' HD3' ' HB2' ' A' ' 9' ' ' CYS . 37.2 Cg_endo -67.34 176.52 4.71 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.549 2.166 . . . . 0.0 112.393 -179.345 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.3 t -51.78 109.39 1.38 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.06 -179.368 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -52.33 152.97 14.21 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.16 1.907 . . . . 0.0 111.894 179.757 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.442 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 14.6 mtt180 -66.4 160.2 25.31 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.191 179.24 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -110.86 -178.69 3.54 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-O 121.223 0.535 . . . . 0.0 112.17 -176.129 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.442 HG22 ' CD2' ' A' ' 20' ' ' LEU . 6.0 tt -142.14 145.32 24.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.539 179.673 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -80.36 -65.0 1.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.829 -178.026 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.425 ' ND2' ' N ' ' A' ' 17' ' ' ASN . 0.5 OUTLIER -93.47 36.46 1.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.878 0.371 . . . . 0.0 110.961 -178.909 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.426 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -150.06 176.95 28.48 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.813 179.69 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -136.55 123.66 21.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.779 0.323 . . . . 0.0 110.75 179.595 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.517 ' CD2' ' CE1' ' A' ' 33' ' ' TYR . 14.6 mt -74.41 159.03 32.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.164 0.506 . . . . 0.0 111.92 -179.124 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.431 ' HB2' ' CB ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -130.52 74.3 1.59 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.914 177.608 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.426 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 62.6 mt -69.78 93.2 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.735 -178.174 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.73 20.9 47.61 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.932 178.078 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 151.89 133.32 1.96 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.942 -179.455 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.9 m -118.37 8.95 6.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.134 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.409 ' N ' ' OG ' ' A' ' 29' ' ' SER . 16.0 t70 -74.46 163.45 27.75 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.011 0.434 . . . . 0.0 110.825 179.481 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.475 ' CE1' ' HB2' ' A' ' 51' ' ' LEU . 7.9 t80 -59.79 93.6 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.535 179.987 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.17 -7.73 7.15 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.494 -178.804 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.409 ' OG ' ' N ' ' A' ' 26' ' ' ASP . 1.3 m -71.67 174.32 6.92 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.841 0.32 . . . . 0.0 110.626 179.589 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -143.83 145.3 32.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.018 -179.973 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.444 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -107.34 164.22 4.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.629 179.996 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.431 ' CB ' ' HB2' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -126.48 113.61 17.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.845 179.467 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.517 ' CE1' ' CD2' ' A' ' 20' ' ' LEU . 21.5 m-85 -91.4 138.56 31.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.556 -179.421 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.426 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.4 OUTLIER -139.87 173.81 11.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.512 179.313 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.2 m -92.83 169.92 10.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.347 . . . . 0.0 111.027 -179.915 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.97 -85.45 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.333 -178.844 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.73 116.6 2.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.289 179.917 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.16 -8.08 68.79 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.129 -177.282 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.491 ' CZ ' ' HB2' ' A' ' 68' ' ' SER . 4.0 m-85 -82.25 176.27 9.6 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 120.912 0.387 . . . . 0.0 110.84 179.678 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.534 ' CE1' ' CG2' ' A' ' 69' ' ' VAL . 0.0 OUTLIER -129.54 129.46 44.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.122 175.983 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.438 ' CD1' ' HG3' ' A' ' 64' ' ' PRO . 9.2 tt -93.92 112.1 23.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.523 -179.624 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.407 ' HB ' ' HB ' ' A' ' 65' ' ' ILE . 1.2 mm -85.77 149.27 4.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.085 0.469 . . . . 0.0 110.955 -179.009 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.36 -149.77 30.98 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.121 -178.892 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -77.78 176.89 8.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.043 0.449 . . . . 0.0 110.856 179.297 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.5 p -147.05 28.14 1.03 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.014 -179.306 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.55 138.32 23.4 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.971 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.461 ' HB3' ' HA ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -110.73 159.44 17.62 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.978 178.191 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.477 ' CD1' ' HB2' ' A' ' 60' ' ' ASN . 1.7 m-85 -134.27 119.22 18.47 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 119.509 -0.876 . . . . 0.0 112.38 -179.217 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 37.2 t -69.75 84.83 0.47 Allowed 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.286 178.81 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.499 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 1.9 tt0 -109.45 173.72 6.19 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.49 -179.178 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.499 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -86.81 155.85 20.13 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.095 -179.284 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.33 -140.01 5.67 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.506 179.844 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.4 m -91.41 -38.06 12.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.765 0.317 . . . . 0.0 111.133 -179.754 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.2 p -97.43 44.28 1.05 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.123 -179.678 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.88 19.61 37.49 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.689 179.705 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.0 t -79.13 -162.6 0.41 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.766 0.317 . . . . 0.0 110.828 179.801 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.0 mmt -128.49 119.6 25.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.576 179.479 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.1 m -127.05 177.18 5.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.648 -179.982 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.449 ' NE1' ' HB2' ' A' ' 9' ' ' CYS . 68.7 m95 -118.07 121.13 39.79 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.672 -178.896 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.477 ' HB2' ' CD1' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -70.39 162.98 66.68 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.005 178.011 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.451 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 80.5 Cg_exo -16.64 97.64 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.83 1 C-N-CA 125.534 4.156 . . . . 0.0 114.76 -177.773 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.496 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 6.1 mt-10 -98.49 -81.71 0.44 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.313 -178.309 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.41 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -75.49 108.34 5.59 Favored Pre-proline 0 CA--C 1.529 0.151 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -176.419 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.486 ' HD2' ' CD1' ' A' ' 33' ' ' TYR . 1.3 Cg_endo -85.5 -154.84 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.222 2.615 . . . . 0.0 110.855 177.071 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.407 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 2.0 mm -97.66 161.17 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.057 0.456 . . . . 0.0 110.756 178.606 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -154.09 138.45 16.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.888 179.988 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.478 ' O ' ' CD2' ' A' ' 39' ' ' TYR . 0.6 OUTLIER -144.54 167.9 21.41 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.354 179.639 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.491 ' HB2' ' CZ ' ' A' ' 39' ' ' TYR . 1.2 p -108.4 118.56 37.09 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.12 0.486 . . . . 0.0 111.511 -179.396 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.534 ' CG2' ' CE1' ' A' ' 40' ' ' HIS . 2.6 p -46.95 97.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.309 179.364 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.408 ' HG2' ' CG2' ' A' ' 90' ' ' THR . 0.3 OUTLIER -78.89 131.06 36.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.546 -179.221 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -113.96 117.86 32.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.957 178.527 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -163.75 0.09 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.127 0.489 . . . . 0.0 110.978 -179.493 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -41.09 132.92 1.91 Allowed Pre-proline 0 N--CA 1.436 -1.142 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.926 179.111 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.487 ' HG3' ' CZ2' ' A' ' 118' ' ' TRP . 26.2 Cg_exo -60.78 158.16 34.43 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.321 2.014 . . . . 0.0 112.146 -179.625 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -44.95 156.93 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.905 2.403 . . . . 0.0 113.291 -178.923 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.0 t -104.99 93.41 4.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.464 179.195 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 24.3 pt -68.88 177.16 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.576 -178.556 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.6 m -92.9 144.47 25.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.681 179.478 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.473 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 5.0 m-80 58.25 27.94 15.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.033 179.706 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.451 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -173.93 -168.14 34.49 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.962 179.69 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.11 -175.23 4.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.971 0.415 . . . . 0.0 110.415 -179.386 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.468 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 12.8 p-80 -108.47 166.0 11.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.907 179.411 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -97.86 -85.14 0.37 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.704 179.912 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.4 ' HA3' ' OH ' ' A' ' 89' ' ' TYR . . . 65.06 148.86 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.699 179.22 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.482 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -111.38 -38.4 4.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.14 0.495 . . . . 0.0 110.564 179.724 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.13 -172.55 2.46 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.837 179.721 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -100.1 -21.44 15.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.148 179.737 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.404 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 14.1 m-85 -131.26 173.53 10.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.173 -179.83 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.404 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 69.6 m-85 -154.27 167.0 31.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.677 -179.655 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.408 ' CG2' ' HG2' ' A' ' 70' ' ' LYS . 21.4 p -151.68 -176.18 5.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.12 0.486 . . . . 0.0 111.845 -179.162 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.438 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 25.7 m-20 -50.13 94.56 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.488 -179.554 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.32 20.29 2.46 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.273 177.938 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -110.32 152.83 25.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 117.216 0.508 . . . . 0.0 110.757 179.224 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 32.9 m -138.26 156.11 29.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.081 0.467 . . . . 0.0 111.03 -179.718 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.523 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 7.4 t -146.58 145.17 19.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.597 -179.926 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.421 ' CG2' ' OG ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -104.65 125.6 50.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.134 0.492 . . . . 0.0 110.693 179.938 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.504 ' CE1' ' CG2' ' A' ' 111' ' ' VAL . 5.2 m-85 -84.27 160.88 20.66 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.498 -178.172 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.1 p -154.05 140.55 18.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.973 0.416 . . . . 0.0 111.775 -178.838 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.436 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 9.9 m -69.29 165.79 19.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.453 179.83 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.451 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 51.1 m-20 -91.03 -68.67 0.78 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.136 179.956 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.74 -38.42 62.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.293 -179.36 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 143.71 41.17 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.842 179.572 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.503 ' CE2' HG12 ' A' ' 126' ' ' ILE . 12.4 m-85 -75.36 -167.63 0.68 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 178.698 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.3 p -115.39 106.15 13.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.851 0.357 . . . . 0.0 111.369 179.635 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.431 ' CD2' ' HA ' ' A' ' 109' ' ' SER . 1.6 tp -51.54 119.76 4.47 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.431 178.469 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.448 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 26.6 mm -100.14 163.01 3.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.349 -177.709 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 50.54 27.89 13.51 Favored Glycine 0 CA--C 1.508 -0.353 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.679 179.237 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.406 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.3 OUTLIER 60.51 132.64 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.406 0.622 . . . . 0.0 111.293 179.99 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.444 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 1.3 p -57.61 -25.79 60.59 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.155 -178.441 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -58.77 132.81 52.74 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.78 -177.631 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.504 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 3.0 t -133.54 119.56 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 177.807 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.428 HD21 ' N ' ' A' ' 113' ' ' CYS . 1.2 tm? -83.18 136.54 34.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.612 0.244 . . . . 0.0 111.344 -178.709 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.522 ' HB2' ' CZ3' ' A' ' 118' ' ' TRP . 42.8 t -106.84 105.86 16.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.455 177.69 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 5.9 t -160.94 135.82 7.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.981 0.419 . . . . 0.0 111.333 179.259 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 83.32 25.27 48.43 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.07 -179.658 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.434 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 70.85 14.84 73.38 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.231 -178.867 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -142.66 -179.65 6.44 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.05 0.452 . . . . 0.0 111.162 179.958 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.523 ' CH2' ' CG2' ' A' ' 95' ' ' VAL . 94.2 m95 -120.65 123.57 43.11 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.253 -179.75 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.483 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -83.36 128.14 34.26 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.112 175.016 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.539 ' CB ' ' CA ' ' A' ' 121' ' ' PRO . 70.0 m-20 109.55 -124.65 0.0 OUTLIER Pre-proline 0 CA--C 1.476 -1.878 0 N-CA-C 100.339 -3.948 . . . . 0.0 100.339 -166.533 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.539 ' CA ' ' CB ' ' A' ' 120' ' ' ASP . 67.6 Cg_endo -60.77 178.24 6.14 Favored 'Cis proline' 0 C--N 1.315 -1.235 0 CA-C-N 125.038 2.835 . . . . 0.0 112.553 -21.243 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.448 ' CB ' ' O ' ' A' ' 106' ' ' ILE . 43.4 Cg_endo -85.97 179.93 3.53 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.401 2.067 . . . . 0.0 113.006 179.71 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.77 -162.74 0.83 Allowed 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.168 176.157 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . 0.405 ' SG ' ' HB2' ' A' ' 103' ' ' TYR . 4.7 t -170.44 88.91 0.14 Allowed 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 120.109 -0.637 . . . . 0.0 110.828 -175.72 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -117.57 173.64 6.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.27 -177.756 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.503 HG12 ' CE2' ' A' ' 103' ' ' TYR . 47.8 mm . . . . . 0 C--N 1.322 -0.602 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.897 -179.751 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.832 0.348 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.6 mtm-85 -87.03 -173.44 4.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.839 179.679 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.432 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 26.7 m -85.08 160.72 54.43 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.297 -179.165 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.42 171.98 16.59 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.675 2.25 . . . . 0.0 112.237 179.824 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.8 t -51.23 106.45 0.65 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.922 -179.962 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.488 ' HG2' ' CE2' ' A' ' 59' ' ' TRP . 76.7 Cg_exo -46.92 149.98 2.96 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.331 2.021 . . . . 0.0 112.135 179.643 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.43 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -69.85 143.69 52.78 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.215 0.531 . . . . 0.0 110.321 179.031 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.4 ' HA ' HD11 ' A' ' 20' ' ' LEU . 1.9 p-10 -93.67 -176.86 4.2 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.061 -176.541 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.402 HG23 ' CA ' ' A' ' 18' ' ' GLY . 6.5 tt -135.71 151.04 29.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.599 179.588 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -75.93 -68.83 0.54 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.808 -177.631 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.434 ' N ' ' ND2' ' A' ' 17' ' ' ASN . 0.7 OUTLIER -89.87 44.8 1.23 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.862 0.363 . . . . 0.0 110.985 -179.056 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.429 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -167.36 179.84 40.67 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.957 179.939 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.9 134.54 28.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.823 0.344 . . . . 0.0 110.934 179.645 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.493 ' CD2' ' CE1' ' A' ' 33' ' ' TYR . 18.6 mt -80.02 158.5 26.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.116 0.484 . . . . 0.0 111.924 -178.855 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -129.1 76.93 1.76 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.866 177.602 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.44 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 28.8 mt -70.16 112.6 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.265 -177.607 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -108.47 18.25 32.89 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.926 -0.655 . . . . 0.0 111.693 176.675 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 151.18 136.85 2.56 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 111.759 -0.537 . . . . 0.0 111.759 -179.148 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.9 m -118.06 12.21 7.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -178.915 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -69.86 157.48 37.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.8 0.333 . . . . 0.0 110.824 179.415 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.474 ' CE2' ' HB2' ' A' ' 51' ' ' LEU . 7.5 t80 -55.62 91.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.628 179.759 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 49' ' ' CYS . . . 127.22 -10.75 6.9 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.677 -179.394 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 61.1 m -58.71 -174.52 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.748 0.309 . . . . 0.0 110.743 179.898 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.0 p -151.59 140.21 20.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.232 179.736 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.535 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.3 OUTLIER -107.87 166.58 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.551 179.661 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.407 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -129.1 108.6 10.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.885 179.522 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.493 ' CE1' ' CD2' ' A' ' 20' ' ' LEU . 18.2 m-85 -82.47 149.58 27.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.017 0.436 . . . . 0.0 111.043 -179.814 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.429 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.3 OUTLIER -150.91 164.79 35.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.681 -179.949 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 39' ' ' TYR . 3.7 m -87.28 161.57 17.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.855 -179.925 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -57.72 -84.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.078 -179.683 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.74 135.65 14.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.634 179.95 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 60.16 25.94 62.96 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.522 -0.846 . . . . 0.0 111.732 -178.84 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.478 ' CD2' ' HA ' ' A' ' 68' ' ' SER . 2.1 m-85 -117.0 172.08 7.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.836 0.35 . . . . 0.0 111.088 -179.045 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.478 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -133.27 120.44 21.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.491 178.017 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.439 HD21 ' CB ' ' A' ' 45' ' ' SER . 3.6 tt -81.86 132.76 35.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.245 -179.844 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.478 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.5 mm -101.7 151.54 5.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.219 -178.551 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.39 -147.08 38.48 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.064 -179.044 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.423 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 0.6 OUTLIER -66.2 -177.92 0.58 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.88 0.371 . . . . 0.0 110.766 179.289 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.439 ' CB ' HD21 ' A' ' 41' ' ' LEU . 0.3 OUTLIER -160.57 27.93 0.16 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.289 178.72 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.407 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -147.79 132.45 17.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.324 -179.047 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 2.1 m -104.21 150.04 24.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.152 178.641 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.429 ' CE1' ' HD3' ' A' ' 61' ' ' PRO . 6.8 m-85 -124.18 125.6 44.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.047 0.451 . . . . 0.0 111.51 -178.879 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.484 ' HB3' ' CH2' ' A' ' 59' ' ' TRP . 28.3 t -74.58 86.26 2.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.356 179.106 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.498 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 1.1 tt0 -105.13 175.4 5.51 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.425 -179.243 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.498 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -89.11 154.07 20.47 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.948 -179.94 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -82.22 -141.12 3.63 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.546 -179.961 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.3 m -99.42 -35.78 9.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.82 0.343 . . . . 0.0 111.023 -179.8 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.7 p -94.13 37.6 1.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.928 -179.986 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 63.22 26.13 69.01 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.35 -179.733 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.8 t -91.86 -167.8 1.86 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.897 0.38 . . . . 0.0 111.02 -179.943 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.8 mmt -122.39 129.24 51.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.345 179.364 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.9 m -140.68 -176.81 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.12 -179.076 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.535 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 90.9 m95 -123.02 124.81 43.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.289 -179.246 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.427 ' O ' ' CD1' ' A' ' 48' ' ' TYR . 14.5 m-80 -146.88 126.92 6.77 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.886 179.851 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.429 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 71.6 Cg_endo -75.89 -163.64 3.33 Favored 'Cis proline' 0 C--N 1.351 0.685 0 C-N-CA 123.892 -1.295 . . . . 0.0 112.206 -0.34 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.49 ' O ' ' CZ ' ' A' ' 33' ' ' TYR . 28.6 mm-40 -110.13 -107.9 0.35 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.095 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.446 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -122.0 100.0 43.39 Favored Pre-proline 0 N--CA 1.445 -0.714 0 C-N-CA 122.514 0.325 . . . . 0.0 110.722 -177.937 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 63' ' ' ALA . 20.7 Cg_endo -50.59 -158.02 0.0 OUTLIER 'Trans proline' 0 N--CA 1.476 0.448 0 C-N-CA 123.286 2.657 . . . . 0.0 112.939 177.652 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -93.0 174.94 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.505 -179.136 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -170.34 133.32 1.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.695 -179.983 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.472 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -150.65 179.59 8.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.872 -179.94 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.478 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 73.0 p -86.81 120.1 27.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.99 179.862 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.442 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 1.2 p -48.0 99.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.289 179.876 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -82.69 115.75 21.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.432 -179.344 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.428 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -97.54 123.11 41.3 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.284 -0.416 . . . . 0.0 109.919 178.179 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -74.04 -150.99 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.953 179.694 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.464 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 2.4 t -56.62 144.81 63.46 Favored Pre-proline 0 C--N 1.324 -0.516 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.647 -179.661 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -61.87 163.41 19.14 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.544 2.162 . . . . 0.0 111.817 179.732 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.486 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 97.8 Cg_exo -41.11 156.66 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.722 2.281 . . . . 0.0 112.742 -179.315 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 12.3 t -105.96 90.03 3.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.48 179.15 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 20.7 pt -69.48 -178.32 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.21 -179.195 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.1 m -104.02 145.56 29.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.809 179.635 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.484 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 13.2 m-20 56.7 29.57 16.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.214 179.448 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -166.85 -165.49 24.33 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.794 179.716 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.96 -175.63 4.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.097 0.475 . . . . 0.0 111.005 -179.73 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.464 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 35.1 p-80 -108.51 173.77 6.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.933 179.681 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -107.71 -87.28 0.49 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.493 178.71 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 56.67 159.78 0.01 OUTLIER Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.964 178.996 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -120.67 -35.23 3.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.91 0.386 . . . . 0.0 111.203 -179.757 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.57 -173.04 3.43 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.942 -179.767 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.93 -24.95 13.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.905 179.518 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.425 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 8.5 m-85 -129.49 176.91 7.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.003 179.969 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.428 ' N ' ' O ' ' A' ' 71' ' ' CYS . 55.0 m-85 -151.76 164.0 37.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.761 -179.523 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.6 p -131.27 -175.89 3.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.231 -179.502 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 5.0 m-20 -65.95 94.47 0.23 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.19 0.519 . . . . 0.0 111.126 -179.767 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.86 31.1 0.77 Allowed Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.973 178.753 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.437 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.6 OUTLIER -110.19 159.0 17.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.74 0.305 . . . . 0.0 110.83 179.418 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 34.6 m -134.72 149.48 29.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.075 0.464 . . . . 0.0 111.191 -179.741 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.484 HG22 ' CZ3' ' A' ' 118' ' ' TRP . 26.2 t -144.77 148.0 18.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.841 179.592 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.35 128.5 54.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.033 -179.849 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.525 ' CE1' ' CG2' ' A' ' 111' ' ' VAL . 7.0 m-85 -89.13 155.77 19.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.953 -179.943 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 77.3 p -149.15 137.84 21.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.086 179.543 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.404 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 83.1 m -69.73 157.87 36.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.057 -179.737 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.3 m-20 -90.03 -71.79 0.6 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.564 -178.898 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.0 t -63.77 -19.68 65.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.555 -178.862 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 119.46 31.04 1.43 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.376 -179.733 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.495 ' CE2' HG12 ' A' ' 126' ' ' ILE . 35.5 m-85 -69.59 -171.55 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.698 0.285 . . . . 0.0 110.476 179.61 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.72 106.53 16.2 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.907 0.384 . . . . 0.0 111.274 -179.078 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.477 HD22 ' CB ' ' A' ' 109' ' ' SER . 1.6 tp -45.18 108.95 0.14 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.633 178.476 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.469 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 24.3 mm -83.25 160.75 3.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.067 -178.366 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.428 ' N ' HG23 ' A' ' 106' ' ' ILE . . . 54.68 -128.29 42.29 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.902 -179.257 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -115.52 134.39 55.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.975 0.417 . . . . 0.0 110.898 179.018 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.479 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 0.0 OUTLIER -68.3 -30.6 69.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.377 179.322 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -75.45 133.16 14.21 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.542 179.807 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.525 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 3.3 t -125.6 124.2 66.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.506 0.194 . . . . 0.0 110.49 179.393 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.76 123.71 30.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.895 0.379 . . . . 0.0 111.799 -178.269 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.522 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 27.2 t -88.95 104.36 16.89 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 176.354 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 53.3 p -142.99 154.6 44.18 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.042 0.448 . . . . 0.0 111.605 -177.772 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.43 35.49 7.13 Favored Glycine 0 N--CA 1.453 -0.194 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.748 179.519 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.442 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 68.28 11.44 61.66 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.74 -179.439 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -132.87 178.29 6.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.865 0.364 . . . . 0.0 110.558 179.418 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.522 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 93.1 m95 -117.4 148.13 42.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.882 -179.458 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.28 164.06 23.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.111 0.481 . . . . 0.0 111.635 -178.654 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.425 ' N ' ' HD3' ' A' ' 121' ' ' PRO . 1.7 p-10 45.97 52.13 10.71 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.233 179.219 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.425 ' HD3' ' N ' ' A' ' 120' ' ' ASP . 84.0 Cg_endo -82.18 145.64 13.81 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.547 2.164 . . . . 0.0 111.562 177.527 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.479 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 90.5 Cg_endo -93.7 -170.1 0.23 Allowed 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.888 2.392 . . . . 0.0 114.177 -177.458 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.435 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -140.54 -170.03 2.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.004 177.806 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . 0.408 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 14.5 m -143.49 95.39 2.74 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.039 0.447 . . . . 0.0 111.11 -179.662 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.43 ' HB3' ' CD1' ' A' ' 106' ' ' ILE . 23.6 mt-30 -122.78 158.07 31.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.797 179.921 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.495 HG12 ' CE2' ' A' ' 103' ' ' TYR . 28.8 mm . . . . . 0 C--N 1.324 -0.506 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.08 -179.754 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.531 0.205 . . . . 0.0 110.673 . . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.4 mtm180 56.72 162.23 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.011 0.434 . . . . 0.0 111.59 178.525 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.442 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 95.3 m -87.44 158.69 51.44 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.965 -179.824 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.409 ' HD3' ' HB2' ' A' ' 9' ' ' CYS . 41.0 Cg_endo -68.56 173.49 9.79 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.604 2.203 . . . . 0.0 112.274 -179.971 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -50.65 107.31 0.78 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.783 179.871 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -54.8 141.93 75.52 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.202 1.935 . . . . 0.0 112.147 -179.29 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.416 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -52.32 150.83 4.39 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.379 179.259 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.83 -176.06 2.99 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.269 0.556 . . . . 0.0 111.588 -178.038 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.1 tt -135.58 148.91 28.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.621 -179.585 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -81.02 -62.35 1.69 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.917 -177.635 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -93.15 27.04 2.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.16 -178.549 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.431 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -146.26 -176.58 20.23 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.097 -179.693 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -139.77 127.65 22.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.644 0.259 . . . . 0.0 110.667 179.544 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.534 ' CD2' ' CE2' ' A' ' 33' ' ' TYR . 11.1 mt -72.76 154.14 40.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.11 0.481 . . . . 0.0 111.712 -179.49 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.427 ' CB ' ' HB ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -130.58 76.22 1.71 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.561 177.061 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.442 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 54.8 mt -69.97 107.76 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.826 -177.702 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -109.44 15.07 32.7 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.167 178.119 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 162.29 122.9 0.63 Allowed Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.911 -179.639 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.9 m -112.94 28.06 2.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.482 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -102.45 162.69 12.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.043 0.449 . . . . 0.0 111.271 179.534 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.483 ' CZ ' HD13 ' A' ' 51' ' ' LEU . 7.3 t80 -59.61 93.5 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.911 -179.502 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 123.94 3.27 8.35 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.812 -179.963 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.6 m -84.92 -159.0 0.39 Allowed 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 116.892 0.346 . . . . 0.0 110.134 179.161 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 51.9 p -168.18 153.98 7.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.116 0.484 . . . . 0.0 111.451 179.361 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.517 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.6 OUTLIER -114.82 172.84 3.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.383 179.663 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.427 ' HB ' ' CB ' ' A' ' 21' ' ' ASP . 2.6 m -132.86 109.23 9.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.996 0.427 . . . . 0.0 110.962 178.661 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.534 ' CE2' ' CD2' ' A' ' 20' ' ' LEU . 22.4 m-85 -84.31 132.12 34.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.828 179.836 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.431 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.7 OUTLIER -135.61 162.71 31.94 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.652 -179.42 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.413 ' HB2' ' HB2' ' A' ' 39' ' ' TYR . 5.4 m -84.57 168.01 15.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.789 0.328 . . . . 0.0 110.83 179.875 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -63.66 -78.62 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.013 -179.319 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -156.36 135.76 12.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.743 179.72 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.421 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . 55.83 26.49 47.61 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.693 -178.939 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.498 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.1 m-85 -115.15 165.84 12.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.707 0.289 . . . . 0.0 110.805 -179.23 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.475 ' NE2' ' CG2' ' A' ' 69' ' ' VAL . 95.3 m-70 -117.88 122.01 42.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.457 178.255 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.414 ' CD2' ' O ' ' A' ' 44' ' ' GLU . 10.1 tt -86.2 110.18 19.42 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.294 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.403 ' HB ' ' HB ' ' A' ' 65' ' ' ILE . 2.2 mm -84.07 155.13 3.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.934 0.397 . . . . 0.0 111.314 -177.801 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.5 -145.64 36.07 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.057 -179.053 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.443 ' O ' ' CG ' ' A' ' 64' ' ' PRO . 1.0 OUTLIER -74.31 165.92 24.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.628 0.251 . . . . 0.0 110.473 179.009 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.2 p -141.66 24.39 2.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.003 -179.883 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -148.37 135.77 20.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.447 -178.416 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.427 ' C ' ' CD2' ' A' ' 48' ' ' TYR . 1.0 OUTLIER -106.07 161.07 14.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.498 178.605 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.492 ' CE1' ' HD3' ' A' ' 61' ' ' PRO . 3.6 m-85 -134.29 122.14 22.26 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.056 0.455 . . . . 0.0 111.811 -177.569 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.499 ' HB3' ' CH2' ' A' ' 59' ' ' TRP . 35.7 t -76.96 94.42 3.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.806 179.484 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -115.19 -172.83 2.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.531 179.641 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.483 HD13 ' CZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -102.45 152.12 21.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.554 179.105 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -110.04 -51.03 0.65 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.751 -179.542 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.3 t -89.61 48.74 1.63 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.82 0.343 . . . . 0.0 110.936 -179.767 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.4 p 53.21 28.01 6.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.642 -179.94 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 169.41 -30.81 0.16 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.008 -179.66 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.78 -160.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.835 0.35 . . . . 0.0 110.877 179.515 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.66 137.38 51.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.678 179.911 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.4 m -152.09 173.87 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.264 -179.128 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.517 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 89.9 m95 -129.54 130.99 46.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.06 -179.874 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.471 ' O ' ' CD1' ' A' ' 48' ' ' TYR . 0.9 OUTLIER -160.6 135.14 5.36 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.053 179.897 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.492 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 61.4 Cg_endo -71.33 -165.8 3.5 Favored 'Cis proline' 0 C--N 1.353 0.786 0 C-N-CA 123.984 -1.257 . . . . 0.0 112.691 0.013 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -111.49 -152.3 0.5 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.064 -179.012 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.488 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -73.46 115.24 39.38 Favored Pre-proline 0 C--O 1.231 0.128 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.672 179.213 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.443 ' CG ' ' O ' ' A' ' 44' ' ' GLU . 15.2 Cg_exo -71.22 -150.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.7 2.267 . . . . 0.0 112.54 -178.826 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.403 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 1.5 mm -103.56 170.64 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.058 -179.162 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.3 m -159.31 134.69 8.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.109 -179.952 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.73 157.25 44.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.984 179.809 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.498 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 1.4 p -78.67 129.22 34.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.253 0.549 . . . . 0.0 111.553 -179.274 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.475 ' CG2' ' NE2' ' A' ' 40' ' ' HIS . 3.9 p -50.6 94.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.208 179.458 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.42 116.95 20.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.128 -179.846 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -98.17 119.84 37.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.376 179.074 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -158.63 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.662 179.764 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.42 ' OG ' ' NE2' ' A' ' 82' ' ' HIS . 2.2 t -48.64 139.99 10.88 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.96 -179.704 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.499 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 26.5 Cg_exo -60.72 161.93 19.93 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.426 2.084 . . . . 0.0 112.154 -179.862 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.499 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 80.9 Cg_exo -42.88 157.48 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.786 2.324 . . . . 0.0 112.85 -179.692 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.3 m -108.16 89.85 3.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.551 179.094 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.8 pt -69.35 173.75 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.242 -179.176 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.1 m -95.31 142.91 27.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.582 179.332 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 60.74 28.44 18.18 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.003 179.815 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.465 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -166.49 -166.99 26.47 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.813 -179.882 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.423 ' N ' ' O ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -166.26 -175.75 3.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.001 0.429 . . . . 0.0 110.798 -179.934 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 3.1 p80 -114.63 167.42 10.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.25 -179.515 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -99.94 -86.77 0.38 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.778 179.812 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.56 144.87 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.836 179.238 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.505 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -111.44 -31.22 7.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.997 0.427 . . . . 0.0 110.512 179.448 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.69 -171.53 2.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.027 -179.788 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -104.39 -25.21 12.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.025 179.753 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.433 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 6.1 m-85 -132.53 172.27 12.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.946 -179.967 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.433 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 31.2 m-85 -147.03 167.62 23.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.04 -179.635 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 21.7 p -139.25 -175.13 4.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.114 -179.78 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.42 ' OD2' ' CG1' ' A' ' 69' ' ' VAL . 0.4 OUTLIER -62.05 95.06 0.06 Allowed 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.197 0.523 . . . . 0.0 110.94 179.937 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.7 26.94 1.34 Allowed Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.496 -0.775 . . . . 0.0 113.151 178.592 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -108.3 152.17 24.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.769 0.285 . . . . 0.0 110.384 178.679 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 35.5 m -130.53 154.41 40.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.02 0.438 . . . . 0.0 111.251 -179.494 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.527 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 43.8 t -148.14 151.15 13.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.763 179.32 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.424 ' CG2' ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -109.12 125.62 52.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.172 0.51 . . . . 0.0 110.957 179.905 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.534 ' CE2' ' CG2' ' A' ' 111' ' ' VAL . 4.5 m-85 -83.35 162.19 21.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.12 -179.043 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 81' ' ' ARG . 2.6 p -150.94 130.39 12.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.853 0.359 . . . . 0.0 111.689 -178.82 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 71.8 m -69.93 155.28 40.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.699 178.831 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.465 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 12.6 m-20 -92.76 -72.16 0.61 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.594 -178.598 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.5 t -57.2 -20.59 27.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.771 0.32 . . . . 0.0 111.261 -179.365 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 117.81 29.75 1.96 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.29 -179.846 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.467 ' CE2' HG12 ' A' ' 126' ' ' ILE . 43.9 m-85 -70.7 -174.18 0.87 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.876 0.37 . . . . 0.0 110.643 179.898 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -109.99 110.45 21.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.702 179.56 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.455 ' CD2' ' HB2' ' A' ' 122' ' ' PRO . 1.1 tp -48.08 113.62 0.77 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.936 179.401 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.455 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 30.1 mm -94.78 161.06 2.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.031 -179.029 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.4 ' N ' HG21 ' A' ' 106' ' ' ILE . . . 51.63 25.8 15.09 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.333 -0.937 . . . . 0.0 112.346 -179.48 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.403 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.3 OUTLIER 60.24 133.42 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.028 -0.586 . . . . 0.0 111.342 -179.567 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.46 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 1.3 p -60.64 -26.65 67.21 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.485 -179.156 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.84 128.68 47.0 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.115 -178.692 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.534 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 2.3 t -123.67 149.79 27.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 178.279 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.8 108.41 17.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.821 0.343 . . . . 0.0 111.441 -179.93 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.495 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 11.6 t -73.68 103.93 4.43 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 176.536 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.5 p -145.9 159.45 43.2 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.212 -178.619 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.67 32.31 8.01 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.739 179.782 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.424 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 71.81 6.41 63.34 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.824 -179.65 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -136.84 173.52 11.62 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.876 0.369 . . . . 0.0 110.624 179.746 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.527 ' CH2' ' CG2' ' A' ' 95' ' ' VAL . 83.1 m95 -106.39 124.86 50.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.031 -179.461 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.78 159.05 15.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.517 -178.926 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.472 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 3.6 p-10 49.44 46.58 3.87 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.465 179.076 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 52.9 Cg_endo -68.36 144.44 61.9 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.32 2.013 . . . . 0.0 111.132 177.215 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.46 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 74.1 Cg_endo -89.73 -172.6 0.62 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.528 2.152 . . . . 0.0 114.3 -176.761 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.41 -158.81 0.9 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.363 -1.289 . . . . 0.0 109.822 178.465 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 7.8 m -155.5 90.54 1.25 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.998 0.427 . . . . 0.0 110.894 179.241 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -117.37 173.34 6.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.779 -179.851 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.467 HG12 ' CE2' ' A' ' 103' ' ' TYR . 29.1 mm . . . . . 0 C--N 1.325 -0.479 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.971 -179.424 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.843 0.354 . . . . 0.0 111.256 . . . . . . . . . 0 0 . 1 . 045 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.419 ' HD2' ' CG2' ' A' ' 25' ' ' VAL . 0.5 OUTLIER 45.16 -171.89 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.982 -0.553 . . . . 0.0 112.057 178.213 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.526 ' HB2' ' CD ' ' A' ' 10' ' ' PRO . 89.4 m -94.32 177.54 1.86 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.696 179.708 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.526 ' CD ' ' HB2' ' A' ' 9' ' ' CYS . 28.1 Cg_endo -91.33 179.9 1.51 Allowed 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.706 2.27 . . . . 0.0 111.974 -179.538 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.1 t -51.81 105.51 0.53 Allowed Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.567 179.497 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.468 ' HG2' ' CZ2' ' A' ' 59' ' ' TRP . 77.8 Cg_exo -49.47 153.3 5.21 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.304 2.003 . . . . 0.0 112.4 -179.447 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.428 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 1.0 OUTLIER -62.97 168.5 3.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.981 179.124 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.426 ' O ' ' CB ' ' A' ' 63' ' ' ALA . 1.0 OUTLIER -118.93 -175.1 2.84 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.303 0.573 . . . . 0.0 111.752 -178.24 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.9 tt -145.19 139.37 22.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.317 -179.692 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -65.34 -72.96 0.14 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.86 -177.568 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -90.02 45.64 1.29 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.933 0.397 . . . . 0.0 110.884 -179.129 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.428 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -157.08 171.93 34.54 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.352 -0.928 . . . . 0.0 113.292 179.767 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -133.55 131.03 39.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.775 0.321 . . . . 0.0 110.36 179.323 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.479 HD22 ' CE1' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -78.54 166.62 22.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.171 0.51 . . . . 0.0 111.748 -178.788 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.44 ' CB ' ' HB ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -135.55 73.39 1.47 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.634 177.127 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.485 HG22 HD13 ' A' ' 22' ' ' ILE . 45.4 mt -71.53 92.62 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.582 -178.058 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -97.49 18.42 57.38 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.161 178.212 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 158.51 129.51 1.09 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.109 -0.567 . . . . 0.0 111.887 -179.585 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.419 ' CG2' ' HD2' ' A' ' 8' ' ' ARG . 32.6 m -115.35 0.91 8.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.553 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -69.6 153.6 43.22 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.923 0.392 . . . . 0.0 111.069 -179.764 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.476 ' CE1' ' HB2' ' A' ' 51' ' ' LEU . 12.1 t80 -50.48 106.54 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.935 -179.939 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.18 -7.07 23.23 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.913 179.988 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 99.7 p -71.78 -171.65 0.71 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.791 0.329 . . . . 0.0 110.807 179.971 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.2 p -153.48 156.05 37.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.026 179.727 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.525 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.5 OUTLIER -119.71 168.05 12.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.492 -179.869 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.44 ' HB ' ' CB ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -128.93 111.1 12.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.918 0.39 . . . . 0.0 110.977 179.054 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.492 ' CE1' ' HA ' ' A' ' 63' ' ' ALA . 27.8 m-85 -88.84 134.93 33.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.211 -179.645 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.428 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 21.3 p -138.42 167.97 20.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.703 179.908 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.417 ' HB2' ' HB2' ' A' ' 39' ' ' TYR . 1.6 m -88.18 162.68 16.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.86 -179.991 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.16 -80.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.849 0.357 . . . . 0.0 111.123 -179.324 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.1 m -158.63 133.72 8.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.773 -179.814 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 60.06 24.74 61.11 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.789 -178.959 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.477 ' CG ' ' O ' ' A' ' 67' ' ' GLU . 2.0 m-85 -112.47 -179.58 3.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.78 0.324 . . . . 0.0 110.766 -179.662 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.524 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.3 OUTLIER -138.7 113.8 9.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.011 0.434 . . . . 0.0 110.613 178.49 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.406 HD22 ' HB3' ' A' ' 45' ' ' SER . 4.7 tt -78.99 126.36 30.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.514 -179.595 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.524 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 2.6 mm -100.2 153.51 4.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.401 -178.688 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.9 -145.35 31.05 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.328 -179.711 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -70.02 171.56 9.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.576 0.227 . . . . 0.0 110.695 179.477 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.406 ' HB3' HD22 ' A' ' 41' ' ' LEU . 4.0 p -146.96 18.98 1.26 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.437 -179.599 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.41 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -148.15 134.15 19.2 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.925 0.393 . . . . 0.0 111.495 -178.768 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.431 ' CB ' HD12 ' A' ' 31' ' ' ILE . 1.5 m -102.89 152.52 21.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.992 178.51 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.48 ' CE1' ' HD3' ' A' ' 61' ' ' PRO . 4.5 m-85 -125.3 121.05 32.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.135 0.493 . . . . 0.0 111.601 -178.74 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.435 ' HB3' ' CH2' ' A' ' 59' ' ' TRP . 41.0 t -72.32 93.77 1.53 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.301 179.216 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.493 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 0.7 OUTLIER -111.93 176.4 5.04 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.372 -178.78 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.493 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -91.73 157.33 16.98 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.811 179.79 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.69 -126.74 2.41 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.592 -179.815 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.02 -40.93 5.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.81 0.338 . . . . 0.0 111.019 -179.8 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 27.8 p -97.9 56.84 1.27 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 179.961 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 50.24 24.86 7.39 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.344 -179.709 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.4 t -84.12 -164.46 0.94 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.894 0.378 . . . . 0.0 111.066 -179.681 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.19 120.83 20.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.397 179.407 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.0 m -125.62 -176.62 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.074 -179.046 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.526 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 86.0 m95 -127.69 127.05 43.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.666 179.976 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -151.87 128.92 5.53 Favored Pre-proline 0 CA--C 1.532 0.285 0 C-N-CA 121.086 -0.246 . . . . 0.0 111.322 -179.416 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.48 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 72.8 Cg_endo -75.7 -165.92 4.63 Favored 'Cis proline' 0 C--N 1.351 0.701 0 C-N-CA 123.864 -1.306 . . . . 0.0 112.335 -0.516 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.79 -153.87 0.53 Allowed 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.014 -179.474 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.492 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -73.63 112.67 17.19 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.819 179.63 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -68.75 -150.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.669 2.246 . . . . 0.0 112.452 -179.075 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.7 mm -99.6 166.35 2.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.91 0.386 . . . . 0.0 111.459 -178.842 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -165.94 123.8 1.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.692 179.381 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.477 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -136.24 176.64 8.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.0 -179.739 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.464 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 4.2 p -94.2 122.48 36.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.15 -179.736 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.0 p -46.85 99.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.399 179.569 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.0 mmtt -70.99 114.88 9.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.177 179.958 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -97.01 121.44 38.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.095 178.73 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -158.74 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.925 -179.643 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.472 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 2.1 t -48.54 138.08 11.9 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.113 -179.556 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.485 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 24.6 Cg_exo -61.22 162.3 20.38 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.389 2.059 . . . . 0.0 112.001 179.746 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.486 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 91.9 Cg_exo -40.72 158.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.852 2.368 . . . . 0.0 113.01 -179.158 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.7 m -108.91 90.99 3.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.588 179.328 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 23.0 pt -69.14 -177.11 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.23 -179.139 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.0 p -101.37 146.74 27.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.752 179.639 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.486 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 3.3 m-80 53.54 29.62 9.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.12 179.449 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.466 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -171.55 -171.69 36.9 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.543 179.612 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.54 -176.17 4.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.966 0.412 . . . . 0.0 110.914 179.417 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.472 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 8.6 p-80 -100.93 173.03 6.67 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.018 -179.956 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -102.0 -84.11 0.45 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.393 179.223 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 60.22 147.74 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.098 178.351 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -112.45 -32.83 6.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.141 0.496 . . . . 0.0 110.629 179.104 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.3 -171.61 2.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.707 179.629 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -104.64 -19.06 14.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.367 -179.954 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.43 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 6.3 m-85 -134.29 174.93 9.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.827 0.346 . . . . 0.0 111.182 -179.552 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.43 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 70.4 m-85 -151.27 165.15 34.86 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.895 -179.913 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.3 p -127.4 173.57 9.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.97 0.414 . . . . 0.0 111.214 -179.159 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -60.26 95.31 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.303 0.573 . . . . 0.0 110.82 179.744 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 125.81 28.28 1.07 Allowed Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.943 179.34 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.2 158.14 18.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.696 0.284 . . . . 0.0 110.567 179.208 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 32.8 m -131.43 150.43 34.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.066 0.46 . . . . 0.0 111.361 -179.514 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.502 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 33.2 t -143.12 148.67 19.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.563 178.854 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.428 ' CG2' ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -104.45 134.42 47.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.936 -179.873 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.536 ' CE1' ' CG2' ' A' ' 111' ' ' VAL . 4.7 m-85 -94.27 158.59 15.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.263 -179.354 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 84.7 p -154.3 139.91 17.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.39 -179.856 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.4 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 66.3 m -70.54 162.73 28.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.224 -179.862 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.466 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 73.6 m-80 -92.05 -78.26 0.41 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.45 -179.232 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.7 m -56.53 -27.33 57.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.855 0.36 . . . . 0.0 110.985 -179.312 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.61 34.09 0.58 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.768 179.679 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.494 ' CE2' HG12 ' A' ' 126' ' ' ILE . 32.4 m-85 -70.4 -173.06 0.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.763 0.316 . . . . 0.0 110.175 178.939 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.98 109.97 20.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.139 0.495 . . . . 0.0 110.853 179.563 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.44 HD21 ' CG ' ' A' ' 122' ' ' PRO . 2.6 tp -46.65 113.5 0.66 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.936 179.145 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.446 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 38.7 mm -89.06 157.29 3.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.785 -179.265 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 62.77 -121.58 25.38 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.462 -0.875 . . . . 0.0 111.587 -178.335 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -127.48 130.52 49.37 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.878 0.37 . . . . 0.0 110.711 178.523 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.474 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 1.1 p -63.72 -28.48 69.92 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.107 179.123 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -74.33 130.96 12.76 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.594 179.477 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.536 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 4.3 t -122.95 134.13 67.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.152 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.02 124.79 35.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.019 0.438 . . . . 0.0 111.785 -178.2 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.508 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 14.5 t -91.02 100.44 13.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.521 176.909 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.9 166.54 27.33 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.098 0.475 . . . . 0.0 111.591 -178.217 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.98 26.93 3.16 Favored Glycine 0 CA--C 1.517 0.214 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.841 179.589 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.83 10.88 80.84 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.597 -179.425 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -142.14 -177.74 5.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.753 0.311 . . . . 0.0 110.459 179.705 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.508 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 85.0 m95 -114.57 149.33 36.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.072 -179.264 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.02 168.87 16.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.444 -179.121 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.456 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 5.0 p-10 46.67 49.62 7.21 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.975 179.801 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 75.5 Cg_endo -77.85 143.01 20.5 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.632 2.221 . . . . 0.0 111.681 178.045 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.474 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 70.0 Cg_endo -90.8 -171.54 0.44 Allowed 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.841 2.36 . . . . 0.0 113.819 -178.053 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.408 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -133.96 -161.3 1.13 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.252 178.592 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 10.7 m -153.53 90.14 1.39 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.016 0.436 . . . . 0.0 110.996 179.599 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -118.35 160.84 20.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.651 179.793 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.494 HG12 ' CE2' ' A' ' 103' ' ' TYR . 20.5 mm . . . . . 0 C--N 1.322 -0.618 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.103 -179.852 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.9 mtm-85 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.719 0.295 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 046 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.68 168.54 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.501 178.561 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.418 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 18.4 m -72.73 160.82 81.91 Favored Pre-proline 0 N--CA 1.452 -0.346 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.51 179.817 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.45 167.61 16.46 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.171 1.914 . . . . 0.0 111.175 179.517 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.5 p -53.64 107.74 0.93 Allowed Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.152 -178.376 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.49 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 50.0 Cg_exo -44.87 167.41 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.312 2.008 . . . . 0.0 112.765 179.724 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.36 176.51 1.79 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.593 176.416 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.48 ' O ' ' CG2' ' A' ' 15' ' ' ILE . 0.2 OUTLIER -130.46 -7.06 4.19 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -177.279 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.48 ' CG2' ' O ' ' A' ' 14' ' ' ASP . 17.4 tt 51.67 156.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 123.498 0.719 . . . . 0.0 112.533 -178.685 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.429 ' HB2' ' ND2' ' A' ' 17' ' ' ASN . 3.9 t0 -103.97 157.52 17.04 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.141 178.858 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.429 ' ND2' ' HB2' ' A' ' 16' ' ' ASP . 0.1 OUTLIER 42.97 28.0 0.12 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.293 -179.516 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.433 ' HA2' ' N ' ' A' ' 36' ' ' ASN . . . -151.25 -163.42 11.38 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.341 -179.781 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.93 175.37 9.64 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.85 0.357 . . . . 0.0 111.132 179.964 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.529 ' CD2' ' CE2' ' A' ' 33' ' ' TYR . 0.8 OUTLIER -125.13 150.65 46.68 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.57 179.514 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.445 ' HB2' ' CB ' ' A' ' 32' ' ' THR . 60.5 t0 -125.97 67.08 1.19 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 177.913 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.436 HG13 ' CG2' ' A' ' 31' ' ' ILE . 0.2 OUTLIER -82.33 101.63 7.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.026 -176.613 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.22 7.97 72.48 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.982 176.908 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 175.53 160.36 23.1 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.926 -179.928 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.41 ' HA ' ' CH2' ' A' ' 59' ' ' TRP . 31.9 m -143.13 33.73 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.873 0.368 . . . . 0.0 111.205 -179.689 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.17 156.9 17.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.081 -179.906 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.505 ' CE2' ' HG ' ' A' ' 51' ' ' LEU . 0.6 OUTLIER -54.23 91.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.723 179.56 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 132.54 -10.47 5.25 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.797 -179.796 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.3 -179.27 5.59 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.804 0.335 . . . . 0.0 110.561 179.565 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 47' ' ' SER . 3.0 p -155.13 141.63 18.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.076 0.465 . . . . 0.0 110.558 179.277 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.517 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 1.1 mt -101.95 166.12 2.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.56 -179.239 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.445 ' CB ' ' HB2' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -127.98 104.81 8.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.942 0.401 . . . . 0.0 110.214 178.842 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.529 ' CE2' ' CD2' ' A' ' 20' ' ' LEU . 9.5 m-85 -79.76 157.83 27.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.695 -178.02 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.6 t -162.81 176.59 10.09 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.697 179.99 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.446 ' HB2' ' CB ' ' A' ' 39' ' ' TYR . 45.2 m -98.43 173.78 6.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.876 179.916 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.433 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 30.6 m-20 -72.81 -83.63 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.289 -179.279 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.4 t -149.48 139.04 21.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.631 -179.867 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 55.89 27.02 49.5 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.811 -179.056 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.539 ' CD2' ' HA ' ' A' ' 68' ' ' SER . 2.4 m-85 -115.82 171.62 7.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.681 0.277 . . . . 0.0 110.763 -179.147 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.519 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.4 OUTLIER -137.5 117.52 13.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.978 0.418 . . . . 0.0 110.608 178.677 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.43 HD23 ' CB ' ' A' ' 45' ' ' SER . 5.9 tt -81.52 125.8 30.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.64 -179.542 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.519 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 2.0 mm -102.16 153.33 5.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.09 -179.3 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.08 -142.82 26.79 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.452 -179.681 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.438 ' O ' ' CG ' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -68.43 -172.39 0.33 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.063 0.458 . . . . 0.0 110.882 179.68 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.43 ' CB ' HD23 ' A' ' 41' ' ' LEU . 0.4 OUTLIER -174.77 32.23 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.202 178.992 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 mtpt -157.34 118.8 3.68 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.033 0.444 . . . . 0.0 111.577 -179.426 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.434 ' CB ' HD11 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -91.83 139.47 30.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.109 179.214 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.517 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 2.1 m-85 -115.74 118.4 32.95 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 119.43 -0.908 . . . . 0.0 111.439 178.82 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 22.6 t -67.33 116.2 7.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.855 -179.575 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.49 ' HA ' ' CE1' ' A' ' 27' ' ' PHE . 2.7 mt-10 -148.85 177.87 9.16 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.127 0.489 . . . . 0.0 111.338 179.678 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.505 ' HG ' ' CE2' ' A' ' 27' ' ' PHE . 1.0 OUTLIER -65.37 167.38 8.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.702 -179.065 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -115.85 -93.54 1.84 Allowed Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.326 179.739 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.35 -48.54 0.48 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.752 0.311 . . . . 0.0 110.827 179.676 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 57.8 p -113.47 28.25 8.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.046 179.911 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.424 ' HA3' ' CD2' ' A' ' 51' ' ' LEU . . . 75.09 36.02 47.53 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.466 -179.907 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.51 -1.93 46.21 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 179.983 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 57.47 121.14 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.164 179.653 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 25.8 m -122.23 -172.37 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.645 179.669 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.517 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 73.3 m95 -132.66 128.88 37.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.865 0.364 . . . . 0.0 111.439 -179.317 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.517 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 5.3 m-80 -69.18 166.98 23.62 Favored Pre-proline 0 C--O 1.223 -0.323 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.538 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.473 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 57.4 Cg_exo -12.66 90.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 125.228 3.952 . . . . 0.0 114.224 -179.103 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.476 ' O ' ' CG ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -92.8 -72.68 0.59 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.584 -175.826 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.507 ' HA ' ' CD2' ' A' ' 33' ' ' TYR . . . -97.25 106.64 33.28 Favored Pre-proline 0 N--CA 1.463 0.189 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -174.885 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.438 ' CG ' ' O ' ' A' ' 44' ' ' GLU . 5.7 Cg_exo -82.64 -152.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.251 2.634 . . . . 0.0 111.335 177.138 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.2 mm -90.8 169.98 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.825 0.345 . . . . 0.0 110.744 178.648 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -167.37 139.82 3.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.488 179.313 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -161.09 170.7 19.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.266 -179.098 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.539 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 54.9 p -81.09 120.87 25.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.235 0.541 . . . . 0.0 111.124 179.713 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.494 ' HB ' ' N ' ' A' ' 116' ' ' GLY . 16.3 m -46.86 107.89 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.829 -179.72 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.502 ' HG2' ' CD1' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -101.7 122.09 43.25 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.313 0.578 . . . . 0.0 110.388 177.409 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.38 128.84 55.12 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.597 -178.759 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.49 -156.17 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.148 179.103 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.423 ' OG ' ' NE2' ' A' ' 82' ' ' HIS . 0.3 OUTLIER -54.97 139.59 62.99 Favored Pre-proline 0 N--CA 1.445 -0.678 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.408 179.212 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.496 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 38.5 Cg_exo -58.27 162.94 10.94 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.558 2.172 . . . . 0.0 112.192 -179.487 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.496 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 94.5 Cg_exo -42.09 155.49 0.09 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.671 2.247 . . . . 0.0 112.647 -179.647 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.4 m -109.57 89.75 3.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.538 179.559 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.1 pt -69.38 172.04 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.047 -179.45 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -89.58 131.41 35.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.935 179.99 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.28 26.86 8.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.618 -179.869 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -158.4 178.46 34.62 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.329 -179.754 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.3 mtm180 -149.27 -166.57 2.59 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.358 0.599 . . . . 0.0 110.991 -179.214 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 4.3 p-80 -132.2 157.42 44.36 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.561 -179.889 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 -96.74 -139.74 0.27 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.399 -179.887 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 85' ' ' TYR . . . 75.68 -67.96 2.23 Favored Glycine 0 C--N 1.337 0.635 0 C-N-CA 120.112 -1.042 . . . . 0.0 111.311 -178.225 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.422 ' HB3' ' O ' ' A' ' 84' ' ' GLY . 3.3 m-85 66.89 29.45 8.27 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-O 121.439 0.638 . . . . 0.0 110.232 178.697 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.49 ' HB3' ' CZ ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -89.15 -172.92 3.84 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.743 178.085 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.473 ' O ' ' CD2' ' A' ' 88' ' ' PHE . 6.9 m-20 -102.74 -29.64 11.37 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.122 0.486 . . . . 0.0 110.352 178.648 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.502 ' CD1' ' HG2' ' A' ' 70' ' ' LYS . 45.6 m-85 -155.61 -175.08 5.25 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.401 179.835 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.49 ' CZ ' ' HB3' ' A' ' 86' ' ' GLU . 73.5 m-85 -158.94 163.62 36.35 Favored 'General case' 0 C--O 1.223 -0.309 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.896 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.1 p -144.2 -177.3 5.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.365 0.602 . . . . 0.0 112.59 -178.493 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 41.1 p-10 -50.91 95.2 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.373 -179.302 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 121.01 25.4 2.28 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.282 -0.872 . . . . 0.0 113.076 178.15 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.17 145.46 37.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.936 0.368 . . . . 0.0 110.75 179.068 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.406 ' CG2' ' N ' ' A' ' 95' ' ' VAL . 33.5 m -127.33 158.58 38.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.043 0.449 . . . . 0.0 111.043 -179.777 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.473 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 15.5 t -151.95 147.77 14.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.641 179.79 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.432 ' CG2' ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -108.1 127.59 53.93 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.142 0.496 . . . . 0.0 110.868 -179.899 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.527 ' CE2' ' CG2' ' A' ' 111' ' ' VAL . 3.9 m-85 -84.81 159.61 20.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.445 -178.963 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.441 ' CA ' HD12 ' A' ' 105' ' ' LEU . 19.1 p -147.58 130.28 16.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.84 -179.589 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.402 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 93.8 m -69.5 150.11 47.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.907 179.376 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -87.11 -72.7 0.5 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.832 -178.383 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.38 -18.49 28.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.557 -178.831 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 116.05 28.5 2.63 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.262 -179.472 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.478 ' CD2' HD13 ' A' ' 126' ' ' ILE . 45.5 m-85 -69.56 -173.45 0.58 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 120.779 0.323 . . . . 0.0 110.555 179.964 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 125' ' ' GLN . 1.4 m -110.44 109.18 19.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 -179.97 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.441 HD12 ' CA ' ' A' ' 98' ' ' SER . 1.1 mp -46.93 107.91 0.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.96 179.189 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.445 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 43.7 mm -93.8 153.18 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.939 -179.424 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 60.48 25.94 63.71 Favored Glycine 0 CA--C 1.51 -0.228 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.591 -179.916 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.405 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.4 OUTLIER 60.79 135.73 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.288 0.566 . . . . 0.0 111.212 -179.713 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.486 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 1.2 p -65.52 -24.67 67.18 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.692 -178.678 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -58.93 131.58 52.12 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.022 -179.037 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.527 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 2.3 t -133.59 125.49 50.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.626 0.251 . . . . 0.0 110.551 178.927 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.423 ' CD1' ' HB2' ' A' ' 114' ' ' SER . 0.8 OUTLIER -89.92 130.86 36.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.942 0.401 . . . . 0.0 111.562 -179.234 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.521 ' HB2' ' CZ3' ' A' ' 118' ' ' TRP . 48.7 t -100.84 104.81 16.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.665 176.866 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.423 ' HB2' ' CD1' ' A' ' 112' ' ' LEU . 71.1 m -152.85 126.18 8.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.896 0.379 . . . . 0.0 111.777 -178.907 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 84.3 22.13 55.09 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.575 178.994 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.494 ' N ' ' HB ' ' A' ' 69' ' ' VAL . . . 84.37 -4.22 84.44 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.43 179.995 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -124.81 173.38 8.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.421 0.629 . . . . 0.0 111.892 -178.669 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.521 ' CZ3' ' HB2' ' A' ' 113' ' ' CYS . 95.2 m95 -115.75 125.93 53.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.008 178.812 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.92 148.34 30.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.232 0.539 . . . . 0.0 111.64 -178.711 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.497 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER 68.8 44.86 0.28 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.299 178.374 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 56.9 Cg_endo -70.59 140.99 40.79 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.078 1.852 . . . . 0.0 111.331 177.859 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.486 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 67.5 Cg_endo -88.51 -173.82 0.96 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.58 2.186 . . . . 0.0 114.007 -177.25 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.46 -160.82 1.08 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.58 177.661 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . 0.404 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 6.6 m -152.99 90.96 1.49 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.091 0.472 . . . . 0.0 111.028 179.144 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.426 ' O ' ' CB ' ' A' ' 104' ' ' SER . 8.9 mt-30 -121.06 158.4 27.93 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.712 -179.852 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.478 HD13 ' CD2' ' A' ' 103' ' ' TYR . 35.3 mm . . . . . 0 C--N 1.323 -0.568 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.909 179.933 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.817 0.341 . . . . 0.0 111.198 . . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.409 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 20.6 mtm180 45.06 -171.43 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.178 0.513 . . . . 0.0 111.834 178.437 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.521 ' HB2' ' CD ' ' A' ' 10' ' ' PRO . 80.7 m -87.8 176.4 3.42 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.839 179.738 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.53 ' HD2' ' CD1' ' A' ' 59' ' ' TRP . 26.4 Cg_endo -88.37 -167.49 0.31 Allowed 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.556 2.171 . . . . 0.0 111.814 179.626 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.414 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 1.1 p -56.79 105.81 0.58 Allowed Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.554 179.603 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.432 ' CB ' HD12 ' A' ' 31' ' ' ILE . 10.1 Cg_endo -52.43 138.99 56.52 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.253 1.969 . . . . 0.0 112.111 -179.194 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.22 160.87 0.99 Allowed 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.581 179.963 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -117.2 -175.1 2.73 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.785 -176.567 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.7 tt -139.44 145.19 27.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.437 179.395 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -76.14 -65.73 0.88 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.459 -178.463 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.424 ' N ' ' ND2' ' A' ' 17' ' ' ASN . 0.6 OUTLIER -91.77 42.07 1.09 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.861 -179.34 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.439 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -160.88 -179.87 35.91 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.392 -0.908 . . . . 0.0 113.3 -179.89 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -137.95 140.28 40.17 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 179.166 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.527 ' CD2' ' CE2' ' A' ' 33' ' ' TYR . 10.7 mt -84.38 158.26 21.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.216 0.531 . . . . 0.0 111.875 -179.013 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -131.46 72.76 1.51 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.114 176.741 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.44 HG13 ' CG2' ' A' ' 31' ' ' ILE . 0.5 OUTLIER -73.95 106.09 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.238 -176.135 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.1 -5.04 73.77 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.668 175.632 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 172.39 153.03 8.97 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 121.16 -0.543 . . . . 0.0 111.818 -179.95 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.405 ' O ' ' HB3' ' A' ' 8' ' ' ARG . 24.3 m -121.86 3.4 6.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.271 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.409 ' HA ' ' HB3' ' A' ' 8' ' ' ARG . 0.6 OUTLIER -72.54 162.14 29.86 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 121.081 0.467 . . . . 0.0 111.517 -179.349 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.478 ' CE1' ' HA ' ' A' ' 50' ' ' GLU . 0.6 OUTLIER -51.91 98.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.202 178.744 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 117.86 -9.24 14.31 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.561 -179.097 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.4 m -75.31 138.23 41.67 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 117.068 0.434 . . . . 0.0 109.985 178.93 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 47' ' ' SER . 2.1 p -115.96 140.54 49.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.251 0.548 . . . . 0.0 111.397 -178.778 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.505 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.9 OUTLIER -98.06 164.32 2.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.946 179.196 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -124.76 110.4 14.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.957 0.408 . . . . 0.0 110.856 179.574 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.527 ' CE2' ' CD2' ' A' ' 20' ' ' LEU . 13.8 m-85 -83.23 142.64 31.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.231 -179.372 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.439 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 26.5 p -143.61 158.91 43.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.206 179.235 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.2 m -84.62 167.84 15.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.754 0.312 . . . . 0.0 110.936 -179.763 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.49 -82.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.003 -179.597 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -159.61 129.91 5.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.798 179.948 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.92 21.21 76.68 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.078 -179.016 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.479 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.9 m-30 -114.51 178.51 4.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.846 0.355 . . . . 0.0 110.833 -179.637 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.524 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.3 OUTLIER -138.88 119.41 13.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.568 178.244 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.44 ' CD1' ' HG3' ' A' ' 64' ' ' PRO . 7.6 tt -83.25 122.27 28.19 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.647 -179.65 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.524 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 1.7 mm -99.65 160.49 3.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.119 0.485 . . . . 0.0 111.313 -178.644 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.89 -145.05 40.97 Favored Glycine 0 N--CA 1.453 -0.191 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.43 -179.758 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.429 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 0.5 OUTLIER -60.74 -174.38 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.863 0.363 . . . . 0.0 110.538 179.28 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.409 ' CB ' HD21 ' A' ' 41' ' ' LEU . 2.0 t -172.88 29.96 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.792 178.786 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 11.9 mtpt -162.21 119.94 2.15 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 120.751 0.31 . . . . 0.0 111.287 -179.329 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.429 ' OG ' ' CG ' ' A' ' 62' ' ' GLU . 1.0 OUTLIER -87.52 136.79 32.8 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.026 178.919 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.508 ' HB2' ' HB3' ' A' ' 60' ' ' ASN . 1.1 m-85 -111.9 120.71 42.84 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 119.482 -0.887 . . . . 0.0 111.703 179.916 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.411 ' HB3' ' CH2' ' A' ' 59' ' ' TRP . 18.5 t -72.45 118.46 15.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.849 -179.973 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.488 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 10.3 tt0 -156.62 169.21 25.2 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.429 0.633 . . . . 0.0 110.782 179.326 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.488 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -79.82 155.37 27.89 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.039 -178.956 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -73.48 -123.01 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.407 179.907 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.13 -35.25 3.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.863 0.364 . . . . 0.0 111.0 -179.964 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 82.4 p -97.8 31.55 2.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.894 179.981 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.2 20.4 77.36 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.502 -179.777 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.8 t -88.5 -171.32 3.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.851 0.358 . . . . 0.0 110.917 -179.964 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.31 138.69 50.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.434 179.892 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.4 m -153.68 173.45 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.247 -179.493 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.53 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 64.6 m95 -126.4 129.73 49.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.853 179.874 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.508 ' HB3' ' HB2' ' A' ' 48' ' ' TYR . 6.1 m-20 -73.69 166.15 46.77 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.489 179.184 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.46 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 90.1 Cg_exo -18.4 96.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 125.247 3.965 . . . . 0.0 114.112 -179.366 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.463 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -97.81 -78.52 0.48 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.268 -176.943 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.483 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -85.46 108.38 15.9 Favored Pre-proline 0 C--N 1.332 -0.168 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -175.726 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.44 ' HG3' ' CD1' ' A' ' 41' ' ' LEU . 3.5 Cg_exo -84.08 -153.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.201 2.601 . . . . 0.0 111.073 177.211 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.41 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 3.6 mm -90.79 166.33 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.768 0.318 . . . . 0.0 110.594 178.259 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -166.66 137.94 3.41 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.947 179.631 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.427 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -161.99 177.0 10.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.047 179.716 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.479 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 6.5 p -89.44 112.16 23.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.118 -179.7 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.484 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 3.2 p -48.43 104.88 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.997 179.602 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.427 ' CG ' ' O ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -87.54 145.67 26.12 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.021 -177.988 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 1.8 m -105.47 137.16 43.75 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.57 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.407 ' CG ' ' N ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -69.32 -170.56 0.28 Allowed 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 120.469 -0.492 . . . . 0.0 109.849 179.967 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.407 ' N ' ' CG ' ' A' ' 72' ' ' GLN . 2.0 t -72.91 108.94 5.13 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.251 -178.039 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.669 ' HG3' ' CE2' ' A' ' 118' ' ' TRP 0.302 0.2 OUTLIER -35.82 -177.96 0.0 OUTLIER 'Trans proline' 0 CA--C 1.467 -2.864 0 C-N-CA 123.481 2.788 . . . . 0.0 113.553 173.807 . . . . . . . . 4 4 . 1 . 047 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.581 ' CB ' ' CE1' ' A' ' 97' ' ' TYR . 26.7 Cg_endo -71.78 -165.14 3.24 Favored 'Cis proline' 0 C--N 1.315 -1.187 0 N-CA-C 113.994 0.728 . . . . 0.0 113.994 -19.258 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.3 p -132.57 20.28 4.29 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 114.178 -1.374 . . . . 0.0 108.795 172.395 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.439 ' CG2' ' O ' ' A' ' 122' ' ' PRO . 17.5 pt -106.43 -159.32 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.265 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.14 -177.952 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.427 ' HB3' ' ND2' ' A' ' 79' ' ' ASN . 0.4 OUTLIER -131.24 148.34 52.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.869 177.199 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.427 ' ND2' ' HB3' ' A' ' 78' ' ' SER . 2.1 m-80 55.46 30.26 14.75 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.882 178.8 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.462 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -144.52 -168.38 12.57 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.417 -0.896 . . . . 0.0 113.039 -179.531 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.418 ' CG ' ' O ' ' A' ' 98' ' ' SER . 4.2 ptt180 -166.81 -174.49 2.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.069 0.462 . . . . 0.0 111.592 -178.789 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.523 ' CG ' ' HB2' ' A' ' 74' ' ' PRO . 41.1 p-80 -120.31 175.86 5.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.759 -177.858 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.425 ' ND2' ' O ' ' A' ' 96' ' ' THR . 1.2 m-20 -124.37 9.1 8.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.282 178.216 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -51.16 168.96 0.39 Allowed Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.719 -179.59 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.505 ' N ' ' CD2' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -114.86 -24.3 8.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.751 0.31 . . . . 0.0 111.086 -179.534 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.85 -173.21 3.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.097 -179.35 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.54 -25.1 11.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.932 179.689 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.434 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 7.5 m-85 -134.56 172.43 12.93 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.885 179.962 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.483 ' CE2' ' HD2' ' A' ' 74' ' ' PRO . 37.9 m-85 -144.9 159.4 42.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.182 -178.811 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 3.2 p -119.11 172.5 7.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.374 -179.055 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 48.8 p-10 -59.81 94.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.14 -179.782 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.94 32.88 0.67 Allowed Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.959 178.681 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.44 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -110.07 160.39 16.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.843 0.354 . . . . 0.0 110.944 179.49 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 29.9 m -139.72 148.21 23.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.044 179.981 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.476 HG21 ' CH2' ' A' ' 118' ' ' TRP . 3.5 t -150.93 144.27 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.365 -179.148 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.425 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -93.67 135.19 35.21 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.146 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.581 ' CE1' ' CB ' ' A' ' 75' ' ' PRO . 3.3 m-30 -104.04 158.65 16.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.341 0.591 . . . . 0.0 112.282 -175.21 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.418 ' O ' ' CG ' ' A' ' 81' ' ' ARG . 61.0 m -142.24 144.77 33.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.391 178.766 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.428 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 93.3 m -71.25 148.03 47.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.912 0.387 . . . . 0.0 111.596 -178.893 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.462 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 62.5 m-20 -75.6 -77.42 0.13 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.973 -178.501 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.0 t -62.19 -18.73 61.87 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.641 0.258 . . . . 0.0 111.624 -178.285 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.95 27.46 1.88 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.653 -179.993 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.461 ' CD2' HD12 ' A' ' 126' ' ' ILE . 34.9 m-85 -69.0 -173.35 0.48 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.867 0.365 . . . . 0.0 110.428 179.26 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -112.06 109.52 19.31 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.855 178.026 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.439 ' CD2' ' HA ' ' A' ' 109' ' ' SER . 0.2 OUTLIER -52.2 123.42 10.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.457 0.646 . . . . 0.0 111.059 -178.656 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.463 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 28.3 mm -95.57 162.14 2.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.247 179.783 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.431 ' N ' ' CG2' ' A' ' 106' ' ' ILE . . . 57.28 -128.66 47.97 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.235 -0.984 . . . . 0.0 112.253 -179.572 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -110.68 135.64 50.98 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.025 0.44 . . . . 0.0 112.118 -178.913 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.439 ' HA ' ' CD2' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -77.33 -32.52 55.29 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 174.481 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -68.3 117.4 8.38 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 110.536 -1.025 . . . . 0.0 110.536 175.332 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.545 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 32.4 t -117.36 127.01 74.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 C-N-CA 121.977 0.111 . . . . 0.0 110.787 -175.832 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.42 133.32 34.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.43 . . . . 0.0 111.857 -177.744 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.49 ' HB2' ' CZ3' ' A' ' 118' ' ' TRP . 23.0 t -97.0 100.01 11.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.441 176.384 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.33 170.47 16.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.128 -178.45 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.38 26.13 2.28 Favored Glycine 0 CA--C 1.517 0.214 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.727 179.762 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.484 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 71.58 19.47 77.86 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.516 -179.613 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -153.09 179.64 8.52 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.188 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.669 ' CE2' ' HG3' ' A' ' 74' ' ' PRO . 97.1 m95 -100.7 129.47 46.61 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.046 0.45 . . . . 0.0 111.023 -179.703 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.38 156.49 19.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.237 -178.787 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.511 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER 54.53 42.81 1.19 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.13 179.868 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.511 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 72.4 Cg_endo -75.01 154.13 42.21 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.146 1.897 . . . . 0.0 111.748 178.649 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.463 ' CB ' ' O ' ' A' ' 106' ' ' ILE . 57.6 Cg_endo -88.24 -169.73 0.46 Allowed 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.544 2.162 . . . . 0.0 113.191 -179.46 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.446 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -133.32 173.52 11.38 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.962 176.498 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 1.4 m -134.06 97.34 3.84 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.989 179.964 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -129.35 163.65 25.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.937 -179.228 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.461 HD12 ' CD2' ' A' ' 103' ' ' TYR . 23.2 mm . . . . . 0 C--N 1.324 -0.524 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.07 -179.937 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 . . . . . 0 N--CA 1.457 -0.098 0 CA-C-O 120.912 0.387 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 048 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.82 173.62 11.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.002 -179.86 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.428 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 34.1 m -79.47 161.41 67.33 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.15 -179.7 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -70.65 172.81 12.78 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.55 2.167 . . . . 0.0 112.18 179.794 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.8 t -54.13 108.73 1.21 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.856 -179.889 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.486 ' HG2' ' CZ2' ' A' ' 59' ' ' TRP . 53.9 Cg_exo -50.55 143.72 27.26 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.321 2.014 . . . . 0.0 112.263 179.905 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -56.91 151.15 15.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.221 179.047 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.56 -171.75 2.71 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.536 -177.719 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.423 HG22 ' CD2' ' A' ' 20' ' ' LEU . 14.9 tt -147.99 146.39 18.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.914 -179.448 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -86.29 156.43 20.25 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.018 178.446 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.447 ' N ' ' ND2' ' A' ' 17' ' ' ASN . 0.0 OUTLIER 43.28 29.11 0.2 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.964 -179.15 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.43 ' HA2' ' N ' ' A' ' 36' ' ' ASN . . . -157.71 177.91 34.27 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.536 -179.57 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.88 153.97 51.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.768 0.318 . . . . 0.0 110.605 -179.874 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.496 HD21 ' CE1' ' A' ' 33' ' ' TYR . 4.8 mt -91.57 153.15 19.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.002 0.429 . . . . 0.0 111.164 179.76 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.441 ' HB2' ' CB ' ' A' ' 32' ' ' THR . 19.6 t0 -123.96 67.4 1.04 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.337 177.526 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.437 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 0.9 OUTLIER -79.77 95.82 2.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.77 -176.667 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.11 15.94 61.7 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.025 177.662 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 161.62 128.19 0.93 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.054 -179.6 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.413 ' HA ' ' CH2' ' A' ' 59' ' ' TRP . 2.8 m -114.8 15.76 8.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -179.077 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 28' ' ' GLY . 5.2 m-20 -79.59 157.18 27.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.913 0.387 . . . . 0.0 111.312 -179.573 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -54.34 86.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.019 179.705 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 132.79 -5.41 5.12 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.024 179.974 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.9 m -77.87 -178.01 5.23 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.926 0.363 . . . . 0.0 110.787 179.999 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 47' ' ' SER . 5.4 p -146.15 154.09 41.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.871 0.367 . . . . 0.0 111.427 -179.924 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.537 ' CG1' ' CZ3' ' A' ' 59' ' ' TRP . 0.5 OUTLIER -115.84 170.89 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.113 179.749 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.441 ' CB ' ' HB2' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -137.91 106.87 5.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.735 178.41 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.496 ' CE1' HD21 ' A' ' 20' ' ' LEU . 34.3 m-85 -79.09 148.25 32.47 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.86 -179.79 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.8 p -152.23 158.3 42.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.222 -179.703 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.9 m -84.92 163.88 18.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.958 179.78 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.43 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 5.9 m-20 -64.57 -84.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.295 -179.168 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -153.3 134.48 14.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.85 -179.594 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.12 23.41 69.7 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.945 -178.929 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.484 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.3 m-85 -117.0 175.43 5.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.37 . . . . 0.0 110.906 -179.292 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.443 ' HB3' ' CG2' ' A' ' 69' ' ' VAL . 0.5 OUTLIER -141.05 115.73 9.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.427 177.549 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.413 ' CD2' ' O ' ' A' ' 44' ' ' GLU . 2.0 tt -77.33 131.66 38.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.493 -179.448 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.8 mm -100.15 162.13 3.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.15 -179.218 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.9 -137.25 26.6 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.24 -179.355 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.413 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -76.82 177.47 7.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.729 0.299 . . . . 0.0 110.825 179.621 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.401 ' HB3' HD23 ' A' ' 41' ' ' LEU . 4.5 p -147.31 22.65 1.18 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.054 179.885 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.406 ' CG ' ' O ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -145.92 -177.91 5.84 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.214 0.531 . . . . 0.0 111.527 -178.626 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.436 ' CB ' HG12 ' A' ' 31' ' ' ILE . 0.5 OUTLIER -155.06 147.79 24.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.486 178.567 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.469 ' CD1' ' O ' ' A' ' 60' ' ' ASN . 2.4 m-85 -125.03 118.95 27.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.983 0.42 . . . . 0.0 111.934 -177.652 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.488 ' HB3' ' CH2' ' A' ' 59' ' ' TRP . 34.6 t -70.93 112.57 7.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.407 178.417 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.48 -176.77 4.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.15 0.5 . . . . 0.0 111.553 -179.432 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.73 139.5 30.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.853 -179.626 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -105.29 -61.01 0.64 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.808 -179.57 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.71 50.14 1.95 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.764 0.316 . . . . 0.0 111.256 -179.397 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.0 p 53.89 30.82 12.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.829 179.65 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 163.19 -27.15 0.23 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.176 -179.693 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.4 t -66.19 -161.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.873 0.368 . . . . 0.0 110.885 179.572 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.1 mmt -125.07 139.74 53.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.58 179.829 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.1 m -154.01 178.71 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.246 -179.303 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.537 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 86.4 m95 -135.1 125.87 27.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.027 -179.427 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.469 ' O ' ' CD1' ' A' ' 48' ' ' TYR . 13.6 m-80 -146.43 127.13 7.13 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.219 -179.636 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 47' ' ' SER . 74.3 Cg_endo -75.36 -165.51 4.28 Favored 'Cis proline' 0 C--N 1.352 0.76 0 C-N-CA 123.849 -1.313 . . . . 0.0 112.394 -0.652 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.8 -151.81 0.49 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.249 -178.819 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.493 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -79.03 116.9 63.59 Favored Pre-proline 0 C--N 1.333 -0.119 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.058 -179.654 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -72.21 -151.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.645 2.23 . . . . 0.0 112.499 -179.257 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 7.3 mm -99.99 167.22 2.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.403 -178.858 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.2 m -161.13 128.5 4.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.752 179.219 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.475 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -152.49 178.6 9.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.956 -179.727 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.484 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 87.4 p -80.41 119.62 23.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.185 0.517 . . . . 0.0 111.094 -179.883 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.451 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 2.3 p -45.63 96.35 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.526 179.82 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -82.79 118.02 23.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.067 179.888 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.65 117.28 34.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.129 179.047 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.56 -157.01 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.837 -179.605 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.458 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 2.1 t -49.02 138.56 13.01 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.06 -179.656 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.475 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 26.8 Cg_exo -60.32 161.35 20.32 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.349 2.033 . . . . 0.0 111.973 179.807 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.484 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 88.3 Cg_exo -42.39 156.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.675 2.25 . . . . 0.0 112.744 -179.821 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.2 t -108.46 90.91 3.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.552 179.378 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.7 pt -69.16 178.33 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.305 -179.163 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -99.23 140.2 33.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.756 179.624 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.49 ' HB3' ' CE2' ' A' ' 103' ' ' TYR . 0.1 OUTLIER 63.92 29.21 14.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.555 -179.992 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.418 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . -169.51 -165.46 26.93 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.814 179.627 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' A' ' 98' ' ' SER . 6.7 ptt180 -168.69 -175.63 2.5 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.85 0.357 . . . . 0.0 110.611 -179.584 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.458 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 10.5 p80 -111.61 167.91 9.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.282 -179.651 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -98.3 -83.95 0.4 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.738 179.889 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.4 ' HA3' ' OH ' ' A' ' 89' ' ' TYR . . . 61.05 145.37 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.823 179.369 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -112.29 -30.37 7.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.063 0.459 . . . . 0.0 110.752 179.632 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.28 -171.66 2.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.983 -179.768 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.83 -25.81 12.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.069 179.959 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.416 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 11.0 m-85 -131.9 174.5 10.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.889 -179.864 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.416 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 46.5 m-85 -148.18 162.71 38.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.101 179.924 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 16.5 p -136.3 -174.92 3.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.058 -179.616 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.425 ' OD1' ' CG1' ' A' ' 69' ' ' VAL . 1.6 m-20 -62.25 93.78 0.05 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.193 0.52 . . . . 0.0 111.246 -179.679 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.48 30.42 0.84 Allowed Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.514 -0.766 . . . . 0.0 113.143 178.175 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.421 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.5 OUTLIER -109.83 155.46 21.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.823 0.311 . . . . 0.0 110.62 179.135 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 28.8 m -133.5 150.7 32.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.171 0.51 . . . . 0.0 111.285 -179.719 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.492 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 22.1 t -147.22 149.19 15.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.495 179.612 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -111.63 123.06 49.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.176 0.512 . . . . 0.0 111.117 -179.991 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.504 ' CE1' ' CG2' ' A' ' 111' ' ' VAL . 4.7 m-85 -79.14 161.82 26.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.48 -179.244 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.4 ' O ' ' N ' ' A' ' 81' ' ' ARG . 49.3 m -152.41 133.54 14.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.442 -179.872 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.418 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 73.4 m -69.62 163.92 24.47 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.77 179.415 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.46 -84.93 0.4 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.917 179.514 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.8 t -44.41 -28.68 0.58 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.445 -179.696 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 126.74 35.74 0.54 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.769 179.605 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.5 ' CE1' HG12 ' A' ' 126' ' ' ILE . 52.0 m-85 -76.46 -173.86 2.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.793 0.33 . . . . 0.0 110.467 179.364 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.401 ' O ' HG12 ' A' ' 106' ' ' ILE . 0.2 OUTLIER -111.58 113.67 26.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.079 0.466 . . . . 0.0 111.04 -179.696 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.447 ' CD2' ' HA ' ' A' ' 109' ' ' SER . 0.3 OUTLIER -50.63 112.14 0.65 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.74 179.078 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.456 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 49.9 mm -97.61 158.58 3.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.976 -179.583 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 108' ' ' ASN . . . 52.87 34.55 45.56 Favored Glycine 0 CA--C 1.509 -0.294 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.632 179.3 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.422 ' O ' ' O ' ' A' ' 107' ' ' GLY . 8.6 p30 52.88 138.32 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 124.158 0.983 . . . . 0.0 112.974 179.43 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.483 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 0.9 OUTLIER -66.9 -23.9 66.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.686 -179.435 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.36 125.37 39.28 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.702 -179.543 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.504 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 2.2 t -129.32 121.56 53.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 179.515 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.98 123.56 32.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.827 0.346 . . . . 0.0 111.525 -178.787 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.492 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 19.8 t -88.83 103.5 16.05 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 176.55 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.37 158.83 43.28 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.048 0.451 . . . . 0.0 111.271 -178.772 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.11 31.39 5.94 Favored Glycine 0 N--CA 1.453 -0.195 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.715 179.824 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.451 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 70.2 12.08 68.36 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.646 -179.369 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -136.04 174.89 10.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.981 0.419 . . . . 0.0 110.67 179.522 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.492 ' CH2' ' CG2' ' A' ' 95' ' ' VAL . 91.2 m95 -113.22 129.57 56.48 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.731 -179.732 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.07 145.85 39.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.087 0.47 . . . . 0.0 111.443 -178.822 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.482 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER 69.63 44.63 0.25 Allowed Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.288 178.675 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 55.6 Cg_endo -69.93 143.91 51.5 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.174 1.916 . . . . 0.0 111.27 177.874 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.483 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 62.3 Cg_endo -90.91 -173.22 0.56 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.519 2.146 . . . . 0.0 113.719 -177.732 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.55 -159.13 0.93 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.778 178.672 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . 0.419 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 7.6 m -154.82 88.99 1.21 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.949 0.404 . . . . 0.0 110.992 179.337 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -112.57 160.96 17.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.737 179.877 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.5 HG12 ' CE1' ' A' ' 103' ' ' TYR . 15.9 mm . . . . . 0 C--N 1.323 -0.576 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.285 -179.631 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.647 0.261 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.409 ' HB3' ' HA ' ' A' ' 26' ' ' ASP . 2.5 mtt180 40.04 -161.05 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.827 179.308 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.438 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 66.4 m -116.0 160.23 36.21 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.697 -179.967 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.17 172.64 9.69 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.419 2.079 . . . . 0.0 111.928 179.464 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.39 110.62 1.62 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.874 -179.778 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.432 ' CB ' HD11 ' A' ' 31' ' ' ILE . 13.8 Cg_endo -57.32 159.31 16.15 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.209 1.939 . . . . 0.0 112.061 -179.761 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.424 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 6.2 ttt180 -63.66 174.79 1.25 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.807 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -136.87 -175.69 4.11 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.304 0.573 . . . . 0.0 111.62 -179.534 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 10.4 tt -131.68 152.45 37.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.363 179.801 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -77.92 -66.75 0.8 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.391 -178.567 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -93.37 36.72 1.06 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.746 -179.932 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.43 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -149.89 176.88 28.36 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.813 -179.824 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -138.04 134.55 34.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.785 0.326 . . . . 0.0 110.419 179.64 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.536 ' CD2' ' CZ ' ' A' ' 33' ' ' TYR . 11.5 mt -83.71 156.22 22.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.062 0.458 . . . . 0.0 111.486 -179.508 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.83 73.72 0.91 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.679 177.569 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.443 HG13 ' CG2' ' A' ' 31' ' ' ILE . 2.5 mt -70.34 92.76 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.972 -177.395 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.26 10.9 67.1 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.522 -0.846 . . . . 0.0 111.904 176.712 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 150.69 145.65 4.17 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 -179.347 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.1 m -119.29 6.15 6.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.489 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.409 ' HA ' ' HB3' ' A' ' 8' ' ' ARG . 2.7 p-10 -69.6 155.58 40.27 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.974 0.416 . . . . 0.0 111.31 -179.417 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.46 ' CE1' ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -49.74 102.47 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.932 179.823 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.27 5.82 24.46 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.516 -179.09 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.96 -178.82 7.05 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.934 0.367 . . . . 0.0 110.448 179.366 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 88.1 p -151.77 147.64 26.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.253 0.549 . . . . 0.0 111.547 -179.551 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.483 HD13 ' CE3' ' A' ' 59' ' ' TRP . 0.2 OUTLIER -118.4 150.16 20.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.058 179.466 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.31 119.0 36.18 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.76 0.314 . . . . 0.0 111.182 -179.756 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.609 ' CZ ' ' O ' ' A' ' 62' ' ' GLU . 3.8 m-85 -85.57 138.56 32.1 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.048 0.452 . . . . 0.0 111.025 179.826 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.43 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.5 OUTLIER -149.58 169.22 21.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.017 -178.933 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.402 ' HA ' ' HA2' ' A' ' 18' ' ' GLY . 92.8 m -90.57 166.71 13.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.505 -179.055 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.71 -75.61 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.893 179.96 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -161.55 139.81 9.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.737 179.784 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.423 ' HA3' ' CB ' ' A' ' 91' ' ' ASP . . . 53.76 26.6 33.25 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.118 -179.327 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.497 ' CE2' ' CB ' ' A' ' 68' ' ' SER . 2.2 m-85 -113.6 -179.81 3.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.07 0.462 . . . . 0.0 111.184 -179.492 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.492 ' CE1' HD12 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -137.12 134.54 36.52 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.208 176.385 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.45 ' CD2' ' HG3' ' A' ' 64' ' ' PRO . 2.6 tt -88.69 135.13 33.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.542 -175.603 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.492 HD12 ' CE1' ' A' ' 40' ' ' HIS . 0.1 OUTLIER -110.57 123.62 66.64 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 CA-C-O 121.424 0.631 . . . . 0.0 111.329 -179.752 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.99 -145.99 16.01 Favored Glycine 0 C--N 1.316 -0.558 0 CA-C-N 114.553 -1.203 . . . . 0.0 112.621 179.527 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.446 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 3.5 mm-40 -61.96 -137.71 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.4 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.8 p 167.56 39.43 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 122.925 0.49 . . . . 0.0 110.806 179.272 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.471 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . 0.7 OUTLIER -168.49 170.18 9.91 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.537 0.685 . . . . 0.0 112.461 -178.013 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.529 ' HA ' ' O ' ' A' ' 61' ' ' PRO . 20.7 m -148.78 139.71 22.95 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.767 178.591 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.545 ' CD2' ' N ' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -132.42 129.54 39.44 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 117.752 -1.579 . . . . 0.0 113.836 -176.78 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 30.2 t -74.88 96.68 3.16 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.154 -1.385 . . . . 0.0 110.763 179.171 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.51 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 2.2 tt0 -130.35 173.26 10.98 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.661 -179.967 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.51 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -77.21 157.15 31.04 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.435 -178.648 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -88.05 -149.65 18.33 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.644 179.833 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.4 m -84.47 -52.42 6.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.86 0.362 . . . . 0.0 111.033 -179.623 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 34.8 p -71.71 -19.54 62.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.221 -179.921 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 120.7 12.93 5.82 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.665 -179.602 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.62 -165.93 1.08 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.707 0.289 . . . . 0.0 110.771 179.948 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.16 130.52 55.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.142 179.627 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.6 m -142.81 -175.78 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.872 -178.51 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.483 ' CE3' HD13 ' A' ' 31' ' ' ILE . 73.2 m95 -128.81 125.79 38.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.973 0.416 . . . . 0.0 111.707 -179.69 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.533 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 1.7 m-20 -67.82 171.76 4.98 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 174.729 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.533 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 0.3 OUTLIER 4.16 118.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.256 1 C-N-CA 125.467 4.111 . . . . 0.0 115.527 -176.024 . . . . . . . . 4 4 . 1 . 049 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.609 ' O ' ' CZ ' ' A' ' 33' ' ' TYR . 6.1 mm-40 -84.95 -77.6 0.27 Allowed 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 114.536 -1.211 . . . . 0.0 112.05 -174.105 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.589 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -65.54 -139.13 0.0 OUTLIER Pre-proline 0 CA--C 1.499 -1.016 0 CA-C-O 116.477 -1.725 . . . . 0.0 109.48 -177.991 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.557 ' CA ' ' CB ' ' A' ' 63' ' ' ALA . 4.3 Cg_exo -88.76 -158.7 1.19 Allowed 'Cis proline' 0 N--CA 1.483 0.91 0 CA-C-N 124.213 2.54 . . . . 0.0 114.856 15.441 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.3 pt -97.4 -176.47 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.366 -178.024 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.5 m -157.79 116.7 3.2 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.745 -179.052 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -105.46 172.82 6.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.588 178.433 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.497 ' CB ' ' CE2' ' A' ' 39' ' ' TYR . 2.0 p -97.09 113.07 24.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.058 179.896 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.441 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 0.6 OUTLIER -49.42 99.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.063 179.523 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.453 ' CE ' ' CG2' ' A' ' 90' ' ' THR . 0.3 OUTLIER -79.37 124.07 28.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.511 -179.356 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.28 117.58 34.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.924 178.039 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.8 -156.89 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.849 -179.15 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.431 ' OG ' ' NE2' ' A' ' 82' ' ' HIS . 1.8 t -47.75 136.56 10.35 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.119 -179.794 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.423 ' HG3' ' CZ2' ' A' ' 118' ' ' TRP . 30.6 Cg_exo -58.41 161.72 13.71 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.223 1.948 . . . . 0.0 111.461 179.487 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.45 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 93.3 Cg_exo -40.16 156.3 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.57 2.18 . . . . 0.0 112.631 -178.978 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.4 t -106.13 88.62 2.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.855 179.971 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 21.4 pt -69.83 174.7 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.121 -179.804 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.4 m -99.22 142.72 30.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.753 179.405 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.482 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 8.9 m-80 60.3 28.51 18.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.193 179.687 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.421 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -166.44 -167.45 27.13 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.908 179.848 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.412 ' CD ' ' OD1' ' A' ' 100' ' ' ASN . 9.4 ptt85 -163.92 -175.81 4.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.897 0.379 . . . . 0.0 110.708 -179.534 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 15.7 p80 -114.07 167.17 10.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.984 -179.883 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 85' ' ' TYR . 92.5 m-20 -98.21 -97.12 0.22 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.614 179.785 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 85' ' ' TYR . . . 58.73 -83.05 0.01 OUTLIER Glycine 0 C--N 1.337 0.588 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.836 179.14 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.448 ' CB ' ' O ' ' A' ' 84' ' ' GLY . 4.1 m-30 93.05 13.32 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.2 1.4 . . . . 0.0 111.382 179.819 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.07 -174.54 2.55 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.836 179.012 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -110.33 -24.41 10.66 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.605 178.635 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.415 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 9.1 m-85 -143.16 169.69 17.13 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.872 -179.948 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.415 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 60.6 m-85 -149.26 159.92 43.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.479 179.516 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.453 ' CG2' ' CE ' ' A' ' 70' ' ' LYS . 9.5 p -122.55 -177.48 3.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.002 0.43 . . . . 0.0 111.64 -178.537 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.423 ' CB ' ' HA3' ' A' ' 38' ' ' GLY . 4.3 p-10 -68.58 96.49 0.71 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.867 179.948 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.67 18.3 2.21 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.286 -0.87 . . . . 0.0 113.182 178.882 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.35 162.06 13.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.871 0.336 . . . . 0.0 110.542 179.121 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.3 m -138.08 153.52 27.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.144 0.497 . . . . 0.0 111.198 -179.736 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.466 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 21.3 t -147.93 149.4 15.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.924 179.705 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.425 ' CG2' ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -108.41 128.37 54.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.855 179.751 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.523 ' CE2' ' CG2' ' A' ' 111' ' ' VAL . 5.9 m-85 -88.96 157.58 18.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.201 -179.294 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 22.8 m -154.57 142.11 19.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.458 -179.661 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 69.0 m -73.51 159.39 33.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.797 179.217 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.421 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 69.8 m-20 -93.04 -70.75 0.69 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.32 -179.404 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.9 t -61.05 -23.48 65.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.224 -179.358 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.56 32.86 1.07 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.452 -179.821 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.486 ' CE2' HG12 ' A' ' 126' ' ' ILE . 16.0 m-85 -69.92 -175.41 0.91 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.057 0.456 . . . . 0.0 110.934 -179.903 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.75 100.47 9.47 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.206 178.47 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.436 HD23 ' CB ' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -44.76 126.21 5.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.442 0.639 . . . . 0.0 111.957 -177.927 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.453 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 35.4 mm -87.72 153.86 3.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.749 178.43 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.03 -129.2 40.89 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.314 -0.946 . . . . 0.0 112.06 -179.04 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -122.62 142.47 50.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.865 0.364 . . . . 0.0 110.874 179.417 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.428 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 1.6 t -70.19 -29.87 66.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.893 179.985 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -72.57 135.34 21.92 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.818 -179.665 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.523 ' CG2' ' CE2' ' A' ' 97' ' ' TYR . 2.4 t -131.6 118.51 39.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.703 0.287 . . . . 0.0 110.812 179.44 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.92 122.92 28.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.521 -179.017 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.515 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 16.3 t -89.56 102.09 14.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.569 176.982 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.12 157.99 44.53 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.04 -178.608 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.05 33.87 7.28 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.703 -179.965 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.441 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 66.02 10.29 50.86 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.522 -179.115 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -129.8 168.96 15.77 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.894 0.378 . . . . 0.0 110.578 179.407 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.515 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 94.9 m95 -109.98 134.5 52.05 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.929 -179.82 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.7 153.66 32.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.931 179.89 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.55 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 61.2 t0 66.04 37.17 0.2 Allowed Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 179.326 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.55 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 65.1 Cg_endo -75.78 134.89 17.05 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.12 1.88 . . . . 0.0 111.587 179.229 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.453 ' CB ' ' O ' ' A' ' 106' ' ' ILE . 87.0 Cg_endo -92.11 -172.3 0.4 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.812 2.341 . . . . 0.0 113.889 -177.33 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.435 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -133.11 -158.59 0.9 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.722 178.042 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 8.1 m -153.85 90.49 1.38 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.13 0.491 . . . . 0.0 111.012 179.129 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -122.33 157.31 32.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.778 179.966 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.486 HG12 ' CE2' ' A' ' 103' ' ' TYR . 19.0 mm . . . . . 0 C--N 1.323 -0.564 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.941 -179.87 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.792 0.33 . . . . 0.0 110.873 . . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 40.61 -162.0 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.01 178.648 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.475 ' O ' ' O ' ' A' ' 10' ' ' PRO . 1.3 m -100.35 171.35 5.62 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.347 -179.504 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 9' ' ' CYS . 75.5 Cg_exo -51.44 -147.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.262 2.641 . . . . 0.0 113.037 179.298 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.433 ' HB2' ' C ' ' A' ' 12' ' ' PRO . 40.7 t -37.26 -85.25 0.0 OUTLIER Pre-proline 0 CA--C 1.499 -1.011 0 CA-C-O 117.117 -1.42 . . . . 0.0 113.882 -177.216 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.5 ' HB3' ' CE2' ' A' ' 59' ' ' TRP . 63.7 Cg_endo -77.38 157.58 96.13 Favored 'Cis proline' 0 N--CA 1.481 0.764 0 CA-C-N 123.757 2.378 . . . . 0.0 115.083 -0.969 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.455 ' HG2' ' N ' ' A' ' 14' ' ' ASP . 17.1 tpp180 -50.64 156.7 0.87 Allowed 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.779 178.883 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.455 ' N ' ' HG2' ' A' ' 13' ' ' ARG . 0.3 OUTLIER -109.57 -175.73 2.83 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.99 -179.779 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.8 tt -128.01 147.74 32.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.723 179.759 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -83.94 -42.31 16.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.343 -178.521 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . 0.408 ' ND2' ' N ' ' A' ' 17' ' ' ASN . 0.8 OUTLIER -103.07 39.32 1.58 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.849 -179.233 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.415 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -175.5 -172.69 40.59 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.781 179.864 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -139.17 140.24 37.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.756 0.312 . . . . 0.0 110.407 179.732 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.543 ' CD2' ' CE1' ' A' ' 33' ' ' TYR . 11.3 mt -85.35 150.91 24.42 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.16 0.505 . . . . 0.0 112.12 -179.091 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.437 ' CB ' ' HB ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -120.51 72.32 0.95 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.23 175.275 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.466 ' HA ' ' CG2' ' A' ' 31' ' ' ILE . 1.7 mt -69.13 97.84 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.636 -176.974 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -88.94 7.45 82.11 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.282 178.002 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 159.07 136.95 2.14 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.528 179.972 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.1 m -113.73 25.23 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.785 0.326 . . . . 0.0 111.189 -179.817 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.407 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.5 OUTLIER -100.88 142.69 31.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.036 179.973 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.465 ' CE2' HD12 ' A' ' 51' ' ' LEU . 9.4 t80 -47.51 93.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.18 0.514 . . . . 0.0 110.715 179.302 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 134.32 -4.84 4.53 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.556 -178.959 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.91 -162.23 0.91 Allowed 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.975 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -168.41 150.56 5.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.089 0.471 . . . . 0.0 111.046 179.58 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.466 ' CG2' ' HA ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -104.49 160.16 5.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.908 179.243 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.437 ' HB ' ' CB ' ' A' ' 21' ' ' ASP . 1.7 m -125.3 114.91 19.54 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.803 0.335 . . . . 0.0 110.447 179.307 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.543 ' CE1' ' CD2' ' A' ' 20' ' ' LEU . 11.2 m-85 -91.53 149.68 21.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.184 0.516 . . . . 0.0 111.962 -178.048 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.415 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.6 OUTLIER -153.99 145.89 23.51 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.699 179.498 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 39' ' ' TYR . 10.8 m -70.47 167.45 18.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.714 0.292 . . . . 0.0 110.629 179.816 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -68.97 -84.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.003 -179.44 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.2 m -153.3 134.31 14.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.695 179.716 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.76 26.02 73.03 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.852 -178.93 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.495 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.1 m-85 -118.99 170.25 9.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.868 0.366 . . . . 0.0 111.104 -179.382 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.522 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 0.4 OUTLIER -134.13 113.52 12.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.376 178.169 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.442 HD22 ' CB ' ' A' ' 45' ' ' SER . 4.8 tt -79.64 122.59 26.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.794 -179.438 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.522 ' CD1' ' CE1' ' A' ' 40' ' ' HIS . 2.3 mm -95.64 157.08 3.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.015 0.436 . . . . 0.0 111.284 -179.179 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.54 -135.23 19.11 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.159 -179.379 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.431 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -85.95 -174.09 4.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.784 0.326 . . . . 0.0 110.822 179.469 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.442 ' CB ' HD22 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -160.53 27.27 0.16 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.403 179.616 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 6.5 mtpt -151.32 129.95 12.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.332 -179.467 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.442 ' OG ' ' CD1' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -101.28 159.29 15.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.168 179.316 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.467 ' CD1' ' CB ' ' A' ' 60' ' ' ASN . 1.1 m-85 -132.16 121.54 23.89 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.58 -0.848 . . . . 0.0 112.222 -179.642 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 8.4 t -75.23 83.84 2.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.886 178.747 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -103.6 -177.86 3.49 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.622 -178.468 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.465 HD12 ' CE2' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -89.11 143.86 26.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.014 -179.262 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.87 -120.58 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.389 179.829 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.2 t -105.98 -41.67 5.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.86 0.362 . . . . 0.0 110.894 179.633 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.91 43.39 1.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.852 179.924 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.73 18.76 74.36 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.598 -179.891 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.75 -162.79 0.09 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.795 0.331 . . . . 0.0 110.815 179.668 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.4 ' HB2' ' HA ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER -123.29 117.14 24.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.879 -179.978 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.5 m -127.21 163.48 30.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.869 -178.773 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.5 ' CE2' ' HB3' ' A' ' 12' ' ' PRO . 63.5 m95 -116.01 118.06 31.86 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.647 -178.666 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.472 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 1.2 m-80 -72.26 165.46 50.53 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.27 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.472 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 87.3 Cg_exo -15.91 98.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.644 1 C-N-CA 125.681 4.254 . . . . 0.0 115.014 -178.39 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.505 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 4.2 mt-10 -99.35 -68.44 0.8 Allowed 'General case' 0 C--O 1.221 -0.426 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -176.487 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.428 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -102.14 77.68 0.22 Allowed Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -174.053 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 62' ' ' GLU . 36.5 Cg_endo -55.87 -154.37 0.01 OUTLIER 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 123.327 2.684 . . . . 0.0 111.575 175.352 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.409 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 4.2 mm -93.56 165.32 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.051 0.453 . . . . 0.0 111.42 179.654 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -165.03 135.25 3.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.662 179.277 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.3 OUTLIER -153.86 176.18 12.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.014 -179.786 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.495 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 26.4 p -85.17 123.48 30.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.16 179.894 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.448 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 1.3 p -55.82 96.54 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.246 179.973 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.15 124.0 27.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.522 -179.522 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.441 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -104.57 125.94 51.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.957 178.234 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -75.75 -151.38 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.165 -179.962 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.412 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 2.8 t -55.3 138.67 66.96 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-O 120.636 0.255 . . . . 0.0 110.883 -179.568 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.483 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 29.2 Cg_exo -59.51 161.36 17.62 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.373 2.049 . . . . 0.0 112.078 179.969 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.5 ' HD2' ' CD1' ' A' ' 118' ' ' TRP . 87.0 Cg_exo -43.07 158.36 0.08 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.725 2.283 . . . . 0.0 112.798 -179.142 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 85.9 p -112.27 89.56 3.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.235 178.548 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.3 pt -69.24 167.82 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.206 -178.742 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 p -86.48 134.21 33.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.86 179.811 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.479 ' HB3' ' CE1' ' A' ' 103' ' ' TYR . 0.1 OUTLIER 67.77 28.37 7.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.486 -179.977 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -167.2 -166.04 25.61 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.141 179.661 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 98' ' ' SER . 0.4 OUTLIER -170.19 -174.11 1.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.091 0.472 . . . . 0.0 110.858 -178.829 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 15.3 p80 -104.89 172.37 6.82 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.945 179.537 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.4 ' ND2' ' HB ' ' A' ' 96' ' ' THR . 30.1 m-20 -112.23 1.03 15.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.711 -179.979 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -48.57 140.26 10.94 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.658 -179.456 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -108.77 -26.46 10.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.949 0.404 . . . . 0.0 110.832 -179.9 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.92 -170.44 2.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.634 179.472 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -112.61 -18.3 12.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.437 179.951 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.428 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 5.6 m-85 -145.4 169.88 17.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.078 0.466 . . . . 0.0 111.499 -179.448 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.441 ' N ' ' O ' ' A' ' 71' ' ' CYS . 46.5 m-85 -149.08 166.08 29.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.41 -179.551 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.8 p -126.08 -178.62 4.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.967 0.413 . . . . 0.0 111.483 -179.444 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -67.12 96.29 0.45 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.926 -179.867 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.18 23.93 1.52 Allowed Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.236 -0.893 . . . . 0.0 113.061 179.112 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.68 159.22 16.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.645 0.26 . . . . 0.0 110.425 179.254 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 33.0 m -132.69 156.27 42.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.29 0.567 . . . . 0.0 111.501 -179.644 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.49 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 22.8 t -151.11 149.38 14.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.341 179.078 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.4 ' HB ' ' ND2' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -103.7 139.47 38.91 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.029 0.442 . . . . 0.0 110.562 179.242 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.523 ' CE1' ' CG2' ' A' ' 111' ' ' VAL . 3.2 m-85 -95.94 158.57 15.39 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.814 -179.434 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 81' ' ' ARG . 1.2 p -147.78 133.05 18.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.659 -178.681 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.429 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 81.9 m -70.19 160.41 32.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.46 178.401 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.58 -85.33 0.36 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.776 0.322 . . . . 0.0 110.987 179.572 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -43.7 -28.82 0.44 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.642 -179.498 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 126.61 36.24 0.53 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.719 179.662 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.491 ' CE2' HG12 ' A' ' 126' ' ' ILE . 47.8 m-85 -77.52 -173.91 3.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.884 0.373 . . . . 0.0 110.923 179.958 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.402 ' O ' HG12 ' A' ' 106' ' ' ILE . 0.9 OUTLIER -113.06 107.26 15.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.799 179.917 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.434 ' CD2' ' HB2' ' A' ' 122' ' ' PRO . 1.1 mp -45.21 117.08 1.26 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.296 179.842 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.454 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 47.1 mm -106.25 155.54 7.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.935 -179.512 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.415 ' O ' ' ND2' ' A' ' 108' ' ' ASN . . . 60.34 37.61 93.38 Favored Glycine 0 CA--C 1.508 -0.396 0 C-N-CA 120.321 -0.942 . . . . 0.0 112.243 179.835 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 107' ' ' GLY . 8.4 p30 51.36 120.3 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.45 -0.875 . . . . 0.0 112.507 179.777 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.458 ' HA ' ' HG3' ' A' ' 122' ' ' PRO . 1.3 p -54.4 -27.64 38.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.307 179.83 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.22 137.16 49.27 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.697 -179.465 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.523 ' CG2' ' CE1' ' A' ' 97' ' ' TYR . 2.9 t -134.87 137.15 51.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.454 0.169 . . . . 0.0 110.621 179.983 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.76 125.78 42.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.878 0.371 . . . . 0.0 111.478 -179.455 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.516 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 34.6 t -90.66 100.67 13.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.662 176.883 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.27 159.55 42.0 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.129 -178.495 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.18 32.06 6.52 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.655 -179.912 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.448 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 70.52 6.16 57.7 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.916 -179.759 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -129.8 -178.46 4.72 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.861 0.362 . . . . 0.0 110.498 179.261 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.516 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 92.0 m95 -117.36 122.72 44.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.932 -179.52 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.07 152.65 21.83 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.28 -179.049 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.513 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.5 OUTLIER 67.0 43.27 0.3 Allowed Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.205 179.27 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 56.4 Cg_endo -69.75 141.42 45.22 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.158 1.905 . . . . 0.0 111.261 178.117 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.482 ' HG2' ' CD2' ' A' ' 97' ' ' TYR . 87.4 Cg_endo -92.25 -169.8 0.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.554 2.169 . . . . 0.0 113.636 -177.594 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.28 -168.03 2.37 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.151 178.853 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 124' ' ' CYS . . . . . 0.422 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 6.7 m -145.84 94.81 2.54 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.006 0.431 . . . . 0.0 110.962 179.95 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -118.93 157.9 26.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.85 -179.772 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.491 HG12 ' CE2' ' A' ' 103' ' ' TYR . 22.9 mm . . . . . 0 C--N 1.324 -0.533 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.229 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.433 ' HB3' HG23 ' A' ' 25' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.446 -0.628 0 CA-C-O 121.166 0.508 . . . . 0.0 111.809 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.47 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 25.7 m -103.6 163.32 17.65 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.647 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 38.1 Cg_endo -67.53 171.8 11.32 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.253 1.969 . . . . 0.0 112.052 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.77 104.38 0.42 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.226 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.557 ' HB3' HD11 ' A' ' 31' ' ' ILE . 2.5 Cg_endo -49.95 156.92 3.05 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.201 1.934 . . . . 0.0 112.058 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.753 ' O ' HD11 ' A' ' 20' ' ' LEU . 6.5 mtt180 -76.23 164.39 26.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.305 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.44 -172.62 2.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.198 0.523 . . . . 0.0 111.633 -178.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.661 HD12 ' HD2' ' A' ' 64' ' ' PRO . 17.1 tt -145.47 143.26 22.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.891 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.4 ' O ' ' N ' ' A' ' 18' ' ' GLY . 2.8 p30 -76.65 160.97 28.92 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.032 0.444 . . . . 0.0 110.352 177.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.466 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 2.0 m120 39.01 29.8 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.224 -178.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 16' ' ' ASP . . . -151.42 170.54 31.01 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.638 -178.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.36 137.59 39.03 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.769 0.319 . . . . 0.0 110.674 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.953 HD21 ' CE2' ' A' ' 33' ' ' TYR . 13.1 mt -82.86 159.68 22.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.041 0.448 . . . . 0.0 111.429 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -126.37 71.32 1.27 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.596 177.657 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.918 ' HA ' HG23 ' A' ' 31' ' ' ILE . 1.2 mt -69.81 93.44 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.855 -177.225 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.6 17.85 57.69 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.712 176.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.27 133.78 1.77 Allowed Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.055 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.433 HG23 ' HB3' ' A' ' 8' ' ' ARG . 17.1 m -119.73 25.9 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.86 0.362 . . . . 0.0 111.055 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 1.4 p-10 -87.11 152.43 22.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.235 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.464 ' CZ ' ' HB3' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -49.98 97.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.746 179.469 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 115.76 6.21 17.23 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.725 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.03 -167.13 1.54 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.833 0.316 . . . . 0.0 110.552 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 47' ' ' SER . 5.5 p -160.28 138.79 10.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.004 0.431 . . . . 0.0 111.675 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.918 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.7 OUTLIER -103.09 150.23 6.81 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.302 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.966 178.649 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.427 ' O ' ' N ' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -109.38 115.18 29.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.84 0.352 . . . . 0.0 111.144 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.953 ' CE2' HD21 ' A' ' 20' ' ' LEU . 13.7 m-85 -88.23 144.24 26.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.627 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -153.55 160.41 42.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.753 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.436 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 9.1 m -82.21 169.36 16.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.092 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -68.25 -84.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.117 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.37 133.25 12.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.821 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.48 ' O ' HG22 ' A' ' 69' ' ' VAL . . . 67.28 22.21 72.66 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.151 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.518 ' CD2' ' HA ' ' A' ' 68' ' ' SER . 2.4 m-85 -113.94 179.0 4.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.754 0.311 . . . . 0.0 110.785 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.922 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -140.98 112.34 7.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.053 0.454 . . . . 0.0 110.678 178.72 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.933 HD11 ' HG2' ' A' ' 64' ' ' PRO . 5.1 tt -79.7 126.28 30.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.656 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.922 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.1 mm -104.09 163.97 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.992 0.425 . . . . 0.0 111.08 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.434 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 73.15 -133.98 19.15 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.362 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.795 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.9 OUTLIER -84.93 -176.19 6.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.957 0.408 . . . . 0.0 110.956 179.657 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.2 p -157.38 18.78 0.28 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.698 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 0.5 OUTLIER -145.85 131.31 18.7 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -178.375 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.438 ' OG ' ' CB ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -96.28 147.09 24.14 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.698 176.788 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.499 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 2.2 m-85 -124.85 120.25 31.17 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 119.151 -1.02 . . . . 0.0 112.05 178.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 20.2 t -71.44 107.47 4.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.521 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.38 -174.51 3.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.116 0.484 . . . . 0.0 111.333 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.542 HD13 ' H ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.091 -178.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.416 ' HB2' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.148 0 CA-C-O 120.825 0.345 . . . . 0.0 110.267 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.4 m -151.99 174.69 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.08 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.537 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 65.0 m95 -129.09 125.75 37.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.3 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.499 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -68.91 165.19 39.95 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.928 178.442 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.44 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 98.5 Cg_exo -17.21 96.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.804 1 C-N-CA 125.408 4.072 . . . . 0.0 114.695 -178.454 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.473 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -93.94 -77.32 0.46 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.212 -178.228 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.468 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -85.16 108.89 17.33 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -175.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.933 ' HG2' HD11 ' A' ' 41' ' ' LEU . 1.4 Cg_endo -86.01 -154.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.296 2.664 . . . . 0.0 110.989 176.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.478 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 4.3 mm -86.05 164.15 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.852 0.358 . . . . 0.0 110.766 178.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.458 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.8 OUTLIER -168.41 129.81 1.33 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.773 179.446 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.58 168.49 26.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.023 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.518 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 53.3 p -83.69 122.76 29.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.17 0.509 . . . . 0.0 110.537 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 69' ' ' VAL . 22.5 m -45.79 100.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.052 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -94.12 99.03 11.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.321 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.425 ' N ' ' O ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -92.91 116.25 28.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.071 0.462 . . . . 0.0 110.326 179.775 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.22 -163.83 0.07 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.678 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.437 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -41.64 131.84 2.31 Favored Pre-proline 0 N--CA 1.436 -1.139 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.58 179.369 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.49 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 50.0 Cg_exo -54.69 165.71 2.36 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.423 2.082 . . . . 0.0 112.365 -178.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.512 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 80.9 Cg_exo -39.71 161.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.926 2.418 . . . . 0.0 113.021 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.2 t -109.3 88.75 2.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.443 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.683 HG23 ' HE2' ' A' ' 97' ' ' TYR . 19.3 pt -69.32 173.27 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.271 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.6 m -92.96 141.81 27.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.732 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.515 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 7.5 m-80 57.22 30.85 19.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.814 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.447 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . -170.52 -166.06 28.84 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.979 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.404 ' N ' ' O ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -169.63 -175.43 2.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.979 0.418 . . . . 0.0 110.781 -179.378 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 11.3 p80 -105.81 171.85 7.12 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.969 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.758 179.86 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.81 0.338 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.425 ' O ' ' N ' ' A' ' 71' ' ' CYS . 69.3 m-85 -152.34 164.27 37.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.936 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.469 HG22 ' O ' ' A' ' 69' ' ' VAL . 7.2 p -145.76 -175.81 4.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.061 0.458 . . . . 0.0 111.709 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 6.8 p-10 -50.51 94.36 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.63 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.49 24.64 1.91 Allowed Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.49 176.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.41 152.76 24.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 117.165 0.482 . . . . 0.0 111.132 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.433 HG22 ' N ' ' A' ' 95' ' ' VAL . 33.2 m -133.47 154.94 39.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.068 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.547 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 13.6 t -148.94 146.54 17.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.094 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.967 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -100.29 136.76 39.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.625 179.343 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.963 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.4 m-85 -97.32 159.1 15.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.039 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 81' ' ' ARG . 17.9 p -157.26 143.05 17.58 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.378 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.447 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 56.9 m -72.55 167.83 19.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.772 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -98.3 -85.89 0.36 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.894 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.4 t -47.26 -29.9 2.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.339 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.06 45.35 0.2 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.508 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.515 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 32.9 m-85 -82.83 -172.66 4.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.72 0.295 . . . . 0.0 110.684 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 m -108.4 105.46 15.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.937 0.399 . . . . 0.0 111.307 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.626 HD23 ' HB2' ' A' ' 122' ' ' PRO . 3.1 tp -46.22 113.22 0.59 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.996 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.511 HD11 ' HB2' ' A' ' 125' ' ' GLN . 33.0 mm -85.97 156.25 3.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.464 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.438 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 57.0 -130.43 50.95 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.364 -0.922 . . . . 0.0 111.478 -178.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 41.1 p-10 -116.09 136.28 53.17 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.087 0.47 . . . . 0.0 111.208 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.967 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.2 p -66.78 -26.25 66.87 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.476 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.18 142.67 31.97 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.712 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.963 HG21 ' CE1' ' A' ' 97' ' ' TYR . 3.3 t -138.66 120.88 17.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.609 0.242 . . . . 0.0 110.909 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.936 HD22 ' N ' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -79.14 135.93 36.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.931 0.396 . . . . 0.0 111.408 -179.417 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.936 ' N ' HD22 ' A' ' 112' ' ' LEU . 35.0 t -107.93 107.93 18.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.866 176.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.613 ' OG ' HD21 ' A' ' 112' ' ' LEU . 12.0 m -161.74 123.9 2.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.883 0.373 . . . . 0.0 111.729 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.501 ' H ' HG21 ' A' ' 69' ' ' VAL . . . 91.35 27.33 18.35 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.493 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.499 ' N ' ' HB ' ' A' ' 69' ' ' VAL . . . 71.46 18.02 76.69 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.173 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -147.89 179.28 7.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.222 0.534 . . . . 0.0 111.421 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.547 ' CZ3' HG23 ' A' ' 95' ' ' VAL . 93.2 m95 -121.06 144.77 48.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.483 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.435 ' OG ' HD12 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -127.25 149.49 49.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.029 0.442 . . . . 0.0 111.465 -179.279 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.489 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.5 OUTLIER 70.67 46.65 0.27 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.956 179.011 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 93.7 Cg_endo -77.6 138.53 17.29 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.509 2.139 . . . . 0.0 111.795 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.626 ' HB2' HD23 ' A' ' 105' ' ' LEU . 57.2 Cg_endo -89.82 -173.96 0.79 Allowed 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.634 2.223 . . . . 0.0 113.328 -179.028 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.467 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -135.01 -173.51 3.34 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.019 178.036 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 124' ' ' CYS . . . . . 0.42 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 17.2 m -144.38 94.74 2.61 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.968 0.413 . . . . 0.0 111.147 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.511 ' HB2' HD11 ' A' ' 106' ' ' ILE . 20.3 mt-30 -117.14 163.23 16.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.777 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.618 ' O ' HG22 ' A' ' 126' ' ' ILE . 35.5 mm . . . . . 0 C--N 1.324 -0.527 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.514 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.452 ' CB ' ' HA ' ' A' ' 26' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 121.113 0.483 . . . . 0.0 111.164 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.544 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 99.2 m -80.83 175.87 4.39 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.768 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.563 ' HD2' ' CD1' ' A' ' 59' ' ' TRP . 34.0 Cg_endo -89.56 179.46 2.19 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 122.734 2.289 . . . . 0.0 112.0 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.9 t -48.59 104.3 0.41 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.723 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.488 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 31.2 Cg_exo -43.09 167.37 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.176 1.917 . . . . 0.0 112.542 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.54 -175.62 1.36 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.743 177.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.661 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 1.6 t0 -139.05 -178.43 5.33 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.329 0.585 . . . . 0.0 111.7 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.558 HG22 ' CD2' ' A' ' 20' ' ' LEU . 13.4 tt -147.11 144.23 19.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.496 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -76.21 -64.02 1.19 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.723 -178.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -90.52 45.47 1.26 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.952 0.406 . . . . 0.0 111.026 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.427 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -164.64 170.63 39.83 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.032 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -131.24 131.13 43.7 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.829 HD21 ' CE2' ' A' ' 33' ' ' TYR . 25.7 mt -82.02 160.34 23.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.16 0.505 . . . . 0.0 111.685 -178.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -130.5 79.72 1.91 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.1 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.899 ' HA ' HG23 ' A' ' 31' ' ' ILE . 52.9 mt -69.72 118.01 13.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.661 -178.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.71 16.99 6.9 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.828 177.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 29' ' ' SER . . . 161.48 120.87 0.55 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.149 -0.548 . . . . 0.0 111.985 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.4 m -109.83 -6.98 11.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.452 ' HA ' ' CB ' ' A' ' 8' ' ' ARG . 1.6 m-20 -70.19 157.77 37.03 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.751 0.31 . . . . 0.0 110.9 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.556 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 7.2 t80 -50.47 116.04 1.73 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.866 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.14 0.87 48.02 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.83 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' A' ' 24' ' ' GLY . 12.9 m -84.48 166.5 17.22 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-N 116.994 0.397 . . . . 0.0 110.496 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.2 p -139.19 146.95 41.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.952 0.406 . . . . 0.0 111.061 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.899 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -108.09 171.2 2.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.599 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.473 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -129.82 116.3 18.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.048 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.829 ' CE2' HD21 ' A' ' 20' ' ' LEU . 11.9 m-85 -94.66 145.49 24.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.489 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.427 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 91.3 p -147.82 161.54 41.05 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.479 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.445 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 1.2 m -82.26 170.91 14.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.941 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.7 -81.51 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.285 -178.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.1 m -163.6 117.47 1.55 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.899 0.381 . . . . 0.0 110.699 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.427 ' HA3' ' HB2' ' A' ' 91' ' ' ASP . . . 86.04 -10.21 66.63 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.189 -177.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.506 ' CZ ' ' HB3' ' A' ' 68' ' ' SER . 2.6 m-85 -78.5 -173.63 3.44 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.758 0.313 . . . . 0.0 110.706 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.792 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -143.01 110.43 5.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.012 0.434 . . . . 0.0 110.075 177.409 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.969 HD21 ' O ' ' A' ' 44' ' ' GLU . 2.6 tt -74.76 121.87 22.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.682 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.792 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.1 mm -104.29 147.56 10.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.013 0.435 . . . . 0.0 110.674 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.29 -133.95 12.13 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.52 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.969 ' O ' HD21 ' A' ' 41' ' ' LEU . 1.0 OUTLIER -74.85 -177.63 3.37 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.177 0.513 . . . . 0.0 112.083 -178.938 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.6 p -163.15 23.81 0.09 Allowed 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.295 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.473 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 2.5 mtmt -161.54 130.15 4.4 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -177.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.463 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 0.1 OUTLIER -98.06 136.04 38.88 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 176.741 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.497 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.9 m-85 -112.97 118.28 34.41 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 119.182 -1.007 . . . . 0.0 112.292 -178.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.407 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 33.1 t -71.15 71.34 0.58 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.066 177.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.5 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 3.0 tt0 -93.22 172.55 8.23 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.781 -178.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.556 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.61 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.13 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.907 0.385 . . . . 0.0 110.197 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -142.84 169.13 12.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.798 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.563 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 75.5 m95 -117.76 116.4 26.93 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.878 -178.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.497 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -69.89 167.92 21.17 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.949 177.372 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.46 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 76.8 Cg_exo -16.21 101.57 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.816 1 C-N-CA 125.421 4.08 . . . . 0.0 114.847 -178.398 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.504 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.3 OUTLIER -97.88 -69.4 0.76 Allowed 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 115.021 -0.99 . . . . 0.0 113.144 -175.996 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.661 ' HB2' ' O ' ' A' ' 14' ' ' ASP . . . -102.85 76.02 0.21 Allowed Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -174.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.493 ' HG2' HD11 ' A' ' 41' ' ' LEU . 37.0 Cg_endo -56.9 -152.4 0.0 OUTLIER 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.225 2.617 . . . . 0.0 111.13 175.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.475 HG22 ' N ' ' A' ' 66' ' ' CYS . 5.4 mm -90.74 164.07 2.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.223 0.535 . . . . 0.0 111.927 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.475 ' N ' HG22 ' A' ' 65' ' ' ILE . 0.8 OUTLIER -167.89 120.85 0.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.098 179.338 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.476 ' O ' ' CD2' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -131.86 174.96 9.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.248 -179.048 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.506 ' HB3' ' CZ ' ' A' ' 39' ' ' TYR . 1.5 p -98.23 123.24 42.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.608 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 69' ' ' VAL . 30.6 m -47.9 101.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.177 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -95.41 99.39 11.31 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.73 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 3.2 m -78.55 130.7 36.27 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 175.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.405 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -68.61 -174.94 0.61 Allowed 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.5 -179.544 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 t -68.04 109.0 3.23 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.954 -178.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.71 ' HG3' ' CE2' ' A' ' 118' ' ' TRP 0.287 0.6 OUTLIER -37.48 -178.62 0.0 OUTLIER 'Trans proline' 0 CA--C 1.469 -2.745 0 C-N-CA 123.317 2.678 . . . . 0.0 113.389 174.467 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.562 ' CB ' ' CE2' ' A' ' 97' ' ' TYR . 44.0 Cg_endo -68.47 -166.43 2.84 Favored 'Cis proline' 0 C--N 1.316 -1.171 0 N-CA-C 114.094 0.767 . . . . 0.0 114.094 -18.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 38.2 t -134.87 18.6 3.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 113.95 -1.477 . . . . 0.0 108.907 172.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.666 HD11 ' HA3' ' A' ' 80' ' ' GLY . 16.2 pt -107.75 -159.05 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.295 -177.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.443 ' N ' HG13 ' A' ' 77' ' ' ILE . 0.9 OUTLIER -132.42 134.92 45.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.664 178.36 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 70.08 28.84 3.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.77 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.666 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -145.02 -177.68 20.02 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.167 -1.016 . . . . 0.0 113.0 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.546 ' HD2' ' ND2' ' A' ' 100' ' ' ASN . 47.3 mtp180 -152.5 -167.81 2.86 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.498 0.666 . . . . 0.0 112.213 -177.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.553 ' CG ' ' HB2' ' A' ' 74' ' ' PRO . 35.5 p-80 -137.87 -178.95 5.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.887 -1.052 . . . . 0.0 111.346 -178.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.574 ' OD1' HG12 ' A' ' 95' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.605 175.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.428 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 6.7 m-85 . . . . . 0 N--CA 1.456 -0.171 0 CA-C-O 120.672 0.272 . . . . 0.0 110.402 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.443 ' CD2' ' HZ2' ' A' ' 118' ' ' TRP . 45.6 m-85 -144.31 178.59 7.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.358 -178.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 25.4 p -139.15 -179.03 5.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.216 0.531 . . . . 0.0 111.794 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.622 ' HB3' HG22 ' A' ' 69' ' ' VAL . 0.7 OUTLIER -57.54 95.53 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.716 -179.179 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 113.94 38.3 1.17 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.709 -0.757 . . . . 0.0 113.493 177.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.484 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -105.66 155.02 19.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.917 0.359 . . . . 0.0 110.658 178.539 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 29.9 m -134.79 146.37 30.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.002 0.429 . . . . 0.0 111.238 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.579 HG23 ' CH2' ' A' ' 118' ' ' TRP . 1.6 t -149.99 137.0 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.334 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.816 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -88.15 132.24 34.41 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 177.98 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.775 ' CZ ' HG21 ' A' ' 111' ' ' VAL . 3.1 m-30 -99.82 149.69 23.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.302 0.572 . . . . 0.0 112.533 -175.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.421 ' O ' ' N ' ' A' ' 81' ' ' ARG . 88.3 p -129.54 139.8 51.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.139 177.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.492 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 87.9 m -69.53 141.63 53.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.153 0.501 . . . . 0.0 111.992 -177.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.546 ' ND2' ' HD2' ' A' ' 81' ' ' ARG . 5.2 m120 -56.24 -85.47 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.386 -178.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.93 -16.94 62.7 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -175.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.26 29.63 0.77 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.269 -0.967 . . . . 0.0 113.131 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.469 ' CE1' HG12 ' A' ' 126' ' ' ILE . 32.1 m-85 -68.57 -171.69 0.29 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 125' ' ' GLN . 3.4 p -107.93 108.45 19.61 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.935 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.488 HD12 ' HA ' ' A' ' 105' ' ' LEU . 1.8 tp -49.03 102.99 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.191 178.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.47 ' HB ' ' CB ' ' A' ' 123' ' ' THR . 39.1 mm -81.98 155.84 4.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.814 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.462 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 54.59 -130.07 45.16 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.782 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.538 ' ND2' ' O ' ' A' ' 120' ' ' ASP . 1.5 p-10 -107.83 132.06 53.82 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.145 0.497 . . . . 0.0 112.177 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.816 ' HB2' HG22 ' A' ' 96' ' ' THR . 0.1 OUTLIER -68.64 -30.5 69.22 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 174.98 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -65.5 123.73 25.72 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.282 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.775 HG21 ' CZ ' ' A' ' 97' ' ' TYR . 43.8 t -126.11 124.67 66.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 110.645 -0.131 . . . . 0.0 110.645 -177.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.69 135.28 35.06 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.064 0.459 . . . . 0.0 112.229 -177.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.525 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 12.0 t -97.09 105.89 18.13 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 175.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.78 166.7 23.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.309 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 60.3 14.74 35.01 Favored Glycine 0 CA--C 1.519 0.318 0 CA-C-N 115.524 -0.762 . . . . 0.0 113.294 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.402 ' O ' ' HG2' ' A' ' 117' ' ' GLU . . . 87.68 8.45 73.46 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.449 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 116' ' ' GLY . 25.8 mt-10 -156.91 -176.08 5.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.87 0.367 . . . . 0.0 110.476 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.71 ' CE2' ' HG3' ' A' ' 74' ' ' PRO . 96.8 m95 -95.78 130.83 42.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.905 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.79 156.09 21.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.251 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.538 ' O ' ' ND2' ' A' ' 108' ' ' ASN . 0.3 OUTLIER 55.47 44.39 1.6 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.037 179.834 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 98.5 Cg_endo -78.16 153.45 28.26 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.401 2.067 . . . . 0.0 111.933 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.587 ' HD3' HG22 ' A' ' 111' ' ' VAL . 74.0 Cg_endo -88.84 -170.01 0.45 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.635 2.223 . . . . 0.0 113.298 -178.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.47 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -131.64 176.91 7.93 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.537 176.841 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 124' ' ' CYS . . . . . 0.444 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 2.9 m -139.17 97.63 3.34 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.976 0.417 . . . . 0.0 110.87 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.424 ' O ' ' CB ' ' A' ' 104' ' ' SER . 17.1 mt-30 -125.36 163.56 22.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.04 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.469 HG12 ' CE1' ' A' ' 103' ' ' TYR . 17.4 mm . . . . . 0 C--N 1.324 -0.515 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.064 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.475 ' HD3' HG23 ' A' ' 25' ' ' VAL . 5.7 mtt180 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.984 0.421 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.471 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 51.7 m -90.35 160.64 39.19 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.974 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 56.0 Cg_endo -70.13 177.54 5.73 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.51 2.14 . . . . 0.0 112.122 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.412 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -53.25 112.79 3.94 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.985 -179.84 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.642 ' HG3' HD13 ' A' ' 22' ' ' ILE . 20.0 Cg_endo -60.34 149.55 85.26 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.353 2.035 . . . . 0.0 112.003 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.778 ' O ' HD11 ' A' ' 20' ' ' LEU . 6.6 mtt180 -57.88 173.45 0.32 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -129.89 -174.82 3.42 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.097 0.475 . . . . 0.0 111.623 -178.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.445 HG23 ' O ' ' A' ' 18' ' ' GLY . 4.5 tt -141.53 148.62 20.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.866 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.49 -58.25 2.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.245 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.422 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 0.7 OUTLIER -93.65 40.78 1.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.864 -179.503 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.445 ' O ' HG23 ' A' ' 15' ' ' ILE . . . -164.27 -179.93 38.74 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.703 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.25 134.51 32.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.745 0.307 . . . . 0.0 110.524 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.909 HD21 ' CE2' ' A' ' 33' ' ' TYR . 13.7 mt -77.83 155.93 30.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.098 0.475 . . . . 0.0 111.687 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.459 ' HB3' ' CB ' ' A' ' 32' ' ' THR . 29.6 t70 -129.3 74.06 1.56 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.114 176.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.915 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.8 OUTLIER -76.97 101.83 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.954 -176.447 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.73 16.82 58.26 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.753 -0.736 . . . . 0.0 111.732 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 162.53 132.35 1.33 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.251 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.475 HG23 ' HD3' ' A' ' 8' ' ' ARG . 34.0 m -113.62 -8.07 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.44 ' HA ' ' CB ' ' A' ' 8' ' ' ARG . 32.8 t0 -70.18 163.48 26.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.968 0.413 . . . . 0.0 111.074 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.518 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 11.0 t80 -54.44 113.82 1.42 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.684 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.87 -7.11 33.21 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.664 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.2 m -78.89 158.85 28.0 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.956 0.378 . . . . 0.0 110.647 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.2 p -134.44 136.41 43.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.041 0.448 . . . . 0.0 111.029 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.915 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -96.95 169.7 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.66 178.908 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.459 ' CB ' ' HB3' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -132.7 109.83 9.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.942 0.401 . . . . 0.0 111.148 179.515 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.909 ' CE2' HD21 ' A' ' 20' ' ' LEU . 21.5 m-85 -83.59 139.08 33.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.025 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.431 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 41.4 m -144.99 160.31 41.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.711 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.443 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 36.4 m -84.02 167.31 16.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.863 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.3 -84.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.129 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.0 t -152.92 137.61 16.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.702 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 59.11 25.89 60.44 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.843 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.512 ' CE1' ' HB3' ' A' ' 68' ' ' SER . 2.4 m-85 -115.85 172.66 7.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.721 0.296 . . . . 0.0 110.91 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.87 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.9 OUTLIER -132.49 122.73 25.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.043 0.449 . . . . 0.0 110.674 178.299 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.87 HD11 ' HG2' ' A' ' 64' ' ' PRO . 10.1 tt -84.77 127.54 34.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.782 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.87 HD11 ' CE1' ' A' ' 40' ' ' HIS . 1.5 mm -108.49 152.27 10.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.086 0.47 . . . . 0.0 111.023 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.22 -137.24 16.76 Favored Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.31 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.828 ' O ' HD21 ' A' ' 41' ' ' LEU . 4.1 pm0 -76.59 178.05 6.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.877 0.37 . . . . 0.0 110.654 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.9 p -156.4 19.11 0.35 Allowed 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.502 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.435 ' HG3' ' HA ' ' A' ' 32' ' ' THR . 21.1 mtpt -159.37 121.46 3.43 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.863 0.319 . . . . 0.0 111.863 -177.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.46 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 0.5 OUTLIER -88.51 131.26 34.98 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 177.092 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.496 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 2.0 m-85 -107.14 115.7 30.63 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 119.246 -0.982 . . . . 0.0 111.555 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.455 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 23.5 t -68.72 80.84 0.28 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.104 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.464 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -97.12 -164.59 1.16 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.626 -179.162 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.518 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.457 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.924 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.245 0 CA-C-O 120.931 0.396 . . . . 0.0 110.399 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.461 HG23 ' HG2' ' A' ' 50' ' ' GLU . 1.3 m -153.72 -177.72 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.527 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.542 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 87.6 m95 -125.14 121.13 33.32 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.104 0.478 . . . . 0.0 112.037 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.496 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 2.4 m120 -72.63 167.05 36.77 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.437 177.034 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.446 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 83.3 Cg_exo -18.0 104.29 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 125.142 3.894 . . . . 0.0 114.412 -178.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.48 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -106.92 -81.52 0.55 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.186 -177.235 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.471 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -76.13 107.45 4.49 Favored Pre-proline 0 N--CA 1.463 0.191 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -175.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.87 ' HG2' HD11 ' A' ' 41' ' ' LEU . 3.9 Cg_endo -91.52 -155.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 123.459 2.772 . . . . 0.0 111.23 177.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.565 HG22 ' H ' ' A' ' 66' ' ' CYS . 2.2 mm -96.65 168.82 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.873 0.368 . . . . 0.0 110.58 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.565 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.1 m -167.34 136.59 2.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.206 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.43 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.6 OUTLIER -156.29 175.33 14.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.957 179.703 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.512 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 3.1 p -93.88 108.76 20.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.94 0.4 . . . . 0.0 111.121 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.494 ' O ' HG13 ' A' ' 69' ' ' VAL . 2.7 p -48.58 97.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.263 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.13 121.13 25.18 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.289 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.431 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -103.24 116.79 33.14 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.284 178.798 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -70.81 -157.68 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.616 179.537 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.478 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 1.6 t -47.47 139.01 8.44 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.191 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.495 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 34.5 Cg_exo -58.41 160.93 15.37 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.319 2.013 . . . . 0.0 111.811 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.516 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 88.8 Cg_exo -44.03 157.32 0.15 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.584 2.189 . . . . 0.0 112.784 -178.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 87.7 p -107.32 89.3 2.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.633 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.663 HG21 ' O ' ' A' ' 122' ' ' PRO . 14.6 pt -69.46 176.55 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.169 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.6 m -92.97 142.4 27.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.84 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 54.99 29.92 13.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.874 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.467 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -163.37 -176.69 35.62 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.294 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -156.43 -174.61 5.02 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.478 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 2.5 p-80 -122.19 161.82 22.49 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.511 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.8 m120 . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.523 179.568 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 72' ' ' GLN . 12.8 m-85 . . . . . 0 N--CA 1.446 -0.668 0 CA-C-O 121.138 0.494 . . . . 0.0 111.331 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.431 ' N ' ' O ' ' A' ' 71' ' ' CYS . 9.5 m-85 -141.09 167.64 21.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.038 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.3 p -135.06 -177.45 4.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.153 0.502 . . . . 0.0 111.922 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -62.98 95.05 0.07 Allowed 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.93 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 128.53 12.67 2.71 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.35 -0.841 . . . . 0.0 113.362 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.419 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.5 OUTLIER -90.41 154.51 19.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 117.1 0.45 . . . . 0.0 110.403 179.268 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 26.9 m -133.93 148.23 30.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.075 0.464 . . . . 0.0 110.892 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.513 HG23 ' CH2' ' A' ' 118' ' ' TRP . 46.3 t -146.9 151.98 13.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.596 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.781 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -109.04 135.01 50.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.595 179.712 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.973 ' CE1' HG21 ' A' ' 111' ' ' VAL . 5.2 m-85 -93.73 157.55 16.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.196 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.93 149.66 29.9 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.955 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.411 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 72.7 m -85.76 155.14 21.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.899 0.38 . . . . 0.0 111.186 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.467 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 56.1 m-20 -92.31 -72.96 0.57 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.336 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.4 t -51.98 -24.35 6.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.882 0.373 . . . . 0.0 110.805 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.03 29.66 1.46 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.535 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.509 ' CE2' HG12 ' A' ' 126' ' ' ILE . 41.1 m-85 -74.41 -175.83 2.48 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 120.998 0.427 . . . . 0.0 110.55 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 34.3 m -122.34 98.61 6.01 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.63 ' HA ' ' HA ' ' A' ' 124' ' ' CYS . 0.0 OUTLIER -51.93 152.02 3.27 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-O 122.305 1.05 . . . . 0.0 112.504 -175.625 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.472 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 45.1 mm -121.98 145.98 27.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 113.085 -1.87 . . . . 0.0 111.244 -174.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.43 ' O ' ' ND2' ' A' ' 108' ' ' ASN . . . 77.32 39.05 27.56 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.271 -0.966 . . . . 0.0 111.859 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.43 ' ND2' ' O ' ' A' ' 107' ' ' GLY . 8.3 p30 53.5 138.71 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 124.346 1.058 . . . . 0.0 113.117 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.781 ' HB2' HG22 ' A' ' 96' ' ' THR . 0.6 OUTLIER -69.4 -24.61 63.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.583 -179.712 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -64.73 134.06 37.93 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.59 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.973 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.7 t -132.94 121.76 44.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.657 0.265 . . . . 0.0 110.517 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.12 119.68 27.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.909 0.385 . . . . 0.0 111.388 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.501 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 14.6 t -86.7 102.62 14.39 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 176.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.1 t -156.14 148.1 23.17 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.039 0.447 . . . . 0.0 111.328 -178.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 69.55 24.94 75.98 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.54 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.474 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 74.71 5.74 75.13 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.873 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -137.84 174.42 10.59 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.88 0.372 . . . . 0.0 110.328 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.516 ' CD1' ' HD3' ' A' ' 75' ' ' PRO . 86.4 m95 -107.51 128.93 54.95 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.778 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.454 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -100.27 160.37 14.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.536 -178.479 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.449 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 2.2 p-10 46.94 48.35 5.57 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.71 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 91.8 Cg_endo -77.26 135.19 14.88 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.431 2.087 . . . . 0.0 110.512 175.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.663 ' O ' HG21 ' A' ' 77' ' ' ILE . 73.6 Cg_endo -93.67 -176.49 0.54 Allowed 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.09 1.86 . . . . 0.0 114.526 -175.227 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' A' ' 105' ' ' LEU . 0.2 OUTLIER -118.43 -155.45 0.6 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.407 179.039 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 124' ' ' CYS . . . . . 0.63 ' HA ' ' HA ' ' A' ' 105' ' ' LEU . 1.8 m -153.8 88.31 1.26 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.928 0.394 . . . . 0.0 110.753 177.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -115.41 162.48 17.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.756 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.509 HG12 ' CE2' ' A' ' 103' ' ' TYR . 26.5 mm . . . . . 0 C--N 1.325 -0.488 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.167 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.493 ' HB3' HG23 ' A' ' 25' ' ' VAL . 9.0 mtm180 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.883 0.373 . . . . 0.0 110.977 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.457 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 19.6 m -93.2 162.32 28.59 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.855 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 36.4 Cg_endo -66.95 171.97 10.42 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.417 2.078 . . . . 0.0 111.997 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.414 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -55.12 112.63 4.33 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.371 179.67 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 11' ' ' SER . 11.0 Cg_endo -55.12 151.13 36.19 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.143 1.895 . . . . 0.0 111.933 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.862 ' O ' HD11 ' A' ' 20' ' ' LEU . 12.1 mtt180 -65.12 152.83 42.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.622 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -99.41 -178.07 3.79 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.953 -176.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.495 HG22 ' CD2' ' A' ' 20' ' ' LEU . 14.2 tt -152.44 141.49 14.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.129 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.407 ' O ' ' N ' ' A' ' 18' ' ' GLY . 7.3 p30 -80.45 174.64 11.41 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.718 178.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.496 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 2.0 m120 37.32 31.05 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.809 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.447 ' HA2' ' N ' ' A' ' 36' ' ' ASN . . . -167.26 -166.89 27.11 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.62 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -155.96 146.42 21.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.665 0.269 . . . . 0.0 110.932 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.862 HD11 ' O ' ' A' ' 13' ' ' ARG . 14.5 mt -84.77 157.94 20.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.991 0.424 . . . . 0.0 111.556 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.439 ' HB3' ' CB ' ' A' ' 32' ' ' THR . 1.2 t70 -125.68 76.39 1.57 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.717 177.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.901 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.9 OUTLIER -74.85 101.06 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.117 -176.922 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.47 18.58 50.6 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.631 176.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 160.43 134.94 1.74 Allowed Glycine 0 C--N 1.334 0.444 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.834 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.493 HG23 ' HB3' ' A' ' 8' ' ' ARG . 33.7 m -128.42 33.16 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -105.39 163.79 12.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.16 0.505 . . . . 0.0 111.243 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.55 ' CE1' ' HE3' ' A' ' 57' ' ' MET . 0.0 OUTLIER -47.97 95.6 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.349 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.77 -4.74 22.72 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.539 -0.839 . . . . 0.0 113.206 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.3 m -70.23 173.9 6.18 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 117.014 0.407 . . . . 0.0 110.289 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.3 p -145.16 144.22 30.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.002 0.429 . . . . 0.0 111.245 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.901 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -105.97 171.84 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.516 -179.662 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.439 ' CB ' ' HB3' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -133.1 115.17 14.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.876 0.37 . . . . 0.0 110.953 179.633 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.831 ' CE2' HD21 ' A' ' 20' ' ' LEU . 15.3 m-85 -88.77 149.0 23.65 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.218 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 83.4 p -154.78 147.85 24.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.196 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.418 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 8.6 m -76.12 168.44 20.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.816 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.447 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 40.9 m-20 -71.24 -84.86 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.37 -178.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.4 t -151.32 135.18 16.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.897 0.379 . . . . 0.0 110.874 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.744 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 65.77 25.35 71.75 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.066 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.498 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.1 m-85 -118.46 170.13 9.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 0.0 111.083 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.795 ' CD2' HD11 ' A' ' 42' ' ' ILE . 3.2 p-80 -136.1 112.31 9.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.08 0.467 . . . . 0.0 110.557 177.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.897 HD21 ' O ' ' A' ' 44' ' ' GLU . 4.2 tt -80.57 119.48 23.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.8 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.795 HD11 ' CD2' ' A' ' 40' ' ' HIS . 2.5 mm -94.11 161.96 2.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.186 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.68 -138.01 22.45 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.269 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.897 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -82.74 -174.65 5.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.84 0.352 . . . . 0.0 110.838 179.508 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.7 p -156.16 22.26 0.37 Allowed 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.241 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.438 ' HG3' ' HA ' ' A' ' 32' ' ' THR . 2.9 mtpt -150.76 131.05 13.64 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -177.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.458 ' OG ' ' CB ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -93.42 146.82 23.47 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.286 176.248 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.547 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.9 m-85 -120.78 117.12 26.63 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 119.014 -1.074 . . . . 0.0 111.738 178.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 48.8 t -62.86 115.2 4.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.999 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.27 -170.85 3.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.214 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.514 HD22 ' C ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.594 0 CA-C-O 120.929 0.395 . . . . 0.0 110.874 -178.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.55 ' HE3' ' CE1' ' A' ' 27' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.454 -0.252 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.658 HG23 ' N ' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -118.46 -176.52 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.607 0.717 . . . . 0.0 111.589 -176.834 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.658 ' N ' HG23 ' A' ' 58' ' ' VAL . 69.6 m95 -130.87 133.36 45.82 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.636 -1.166 . . . . 0.0 111.448 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.547 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.6 OUTLIER -75.67 166.46 45.03 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.944 177.906 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.474 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 97.3 Cg_exo -17.93 96.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 125.251 3.968 . . . . 0.0 114.494 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.479 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.3 OUTLIER -92.87 -76.84 0.46 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.498 -0.773 . . . . 0.0 112.457 -177.374 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.45 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -88.36 109.3 27.68 Favored Pre-proline 0 C--N 1.331 -0.21 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -175.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.88 ' HG2' HD11 ' A' ' 41' ' ' LEU . 1.8 Cg_endo -84.01 -154.96 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.092 2.528 . . . . 0.0 111.073 176.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.499 HG22 ' H ' ' A' ' 66' ' ' CYS . 4.0 mm -90.4 165.65 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.897 0.379 . . . . 0.0 110.895 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.499 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.2 m -163.41 139.32 6.77 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.063 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -159.94 170.86 20.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.823 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.498 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 13.4 p -82.31 117.07 22.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.954 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.744 HG12 ' O ' ' A' ' 38' ' ' GLY . 0.8 OUTLIER -46.67 93.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.291 179.677 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.495 ' HE2' HG23 ' A' ' 90' ' ' THR . 0.3 OUTLIER -72.6 118.51 15.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.061 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -98.69 117.22 32.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.287 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.76 -159.05 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.713 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.47 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 2.1 t -49.86 139.9 16.25 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.925 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.491 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 26.1 Cg_exo -60.52 160.6 23.46 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.433 2.089 . . . . 0.0 112.062 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.527 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 86.2 Cg_exo -42.18 156.51 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.822 2.348 . . . . 0.0 112.842 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.9 m -109.36 90.68 3.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.438 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.575 HG23 ' HE2' ' A' ' 97' ' ' TYR . 21.6 pt -69.37 171.0 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.418 -178.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.5 m -89.92 139.99 30.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.618 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.515 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 2.9 m-80 60.42 29.27 18.88 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.829 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -165.43 -165.89 23.5 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.986 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -168.1 -175.89 2.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.896 0.379 . . . . 0.0 110.805 -179.537 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.47 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 13.3 p80 -115.24 168.81 9.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.123 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.73 179.542 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.406 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 10.4 m-85 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.828 0.347 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.406 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 41.1 m-85 -147.03 168.1 22.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.603 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.495 HG23 ' HE2' ' A' ' 70' ' ' LYS . 17.7 p -138.06 -175.6 4.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.993 0.425 . . . . 0.0 111.496 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.426 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 10.9 m-20 -63.76 96.22 0.13 Allowed 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.304 0.573 . . . . 0.0 111.049 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.93 26.66 1.35 Allowed Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.254 -0.884 . . . . 0.0 113.075 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.425 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.6 OUTLIER -108.26 157.3 18.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.878 0.339 . . . . 0.0 110.494 179.044 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 35.5 m -135.49 151.65 30.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.156 0.503 . . . . 0.0 111.411 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.526 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 18.0 t -147.85 148.06 16.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.404 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.939 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -107.52 125.84 51.78 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.067 0.461 . . . . 0.0 110.851 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 1.004 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.0 m-85 -84.21 164.59 19.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.249 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.52 ' HA ' HD13 ' A' ' 105' ' ' LEU . 51.7 m -156.71 143.33 18.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.504 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.452 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 64.2 m -73.88 157.55 36.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.662 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.417 ' CG ' ' N ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -95.12 -55.5 3.05 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.363 0.602 . . . . 0.0 111.342 -178.493 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.417 ' N ' ' CG ' ' A' ' 100' ' ' ASN . 6.5 t -75.37 -20.62 58.88 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.4 -178.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 117.96 28.05 2.34 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.446 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.515 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 17.9 m-85 -69.65 -179.83 1.89 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.123 0.487 . . . . 0.0 110.853 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -105.98 96.51 6.54 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.936 178.007 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.52 HD13 ' HA ' ' A' ' 98' ' ' SER . 0.3 OUTLIER -47.74 128.86 13.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.588 0.709 . . . . 0.0 111.965 -177.526 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.48 HG22 ' N ' ' A' ' 107' ' ' GLY . 36.0 mm -112.51 158.98 12.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.55 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.48 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 66.46 31.85 80.01 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.462 -0.875 . . . . 0.0 113.002 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.43 ' O ' ' O ' ' A' ' 107' ' ' GLY . 8.8 p30 52.03 130.85 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 123.983 0.913 . . . . 0.0 113.052 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.939 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.6 p -63.01 -25.39 68.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.388 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -64.14 127.76 35.78 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.466 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 1.004 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.6 t -131.35 123.14 52.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.588 0.233 . . . . 0.0 110.724 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.62 124.06 32.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.946 0.403 . . . . 0.0 111.579 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.506 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 18.4 t -87.23 108.81 19.1 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 176.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.6 OUTLIER -155.77 165.13 37.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.102 0.477 . . . . 0.0 111.508 -178.639 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.67 31.11 7.05 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.604 -0.726 . . . . 0.0 112.889 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.45 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 68.63 12.52 64.35 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.711 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -143.14 176.39 9.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.768 0.318 . . . . 0.0 110.523 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.527 ' CD1' ' HD3' ' A' ' 75' ' ' PRO . 89.3 m95 -110.71 127.54 55.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.824 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.91 148.98 27.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.057 0.456 . . . . 0.0 111.478 -178.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.493 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER 68.08 44.85 0.31 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.121 178.888 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 55.1 Cg_endo -69.63 139.18 40.02 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.175 1.917 . . . . 0.0 111.418 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.538 ' O ' HG21 ' A' ' 77' ' ' ILE . 55.6 Cg_endo -88.28 -174.8 1.19 Allowed 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.569 2.179 . . . . 0.0 113.35 -178.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.41 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -135.13 -157.48 0.8 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.884 179.002 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 1.8 m -156.28 90.21 1.17 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.124 0.488 . . . . 0.0 111.134 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.409 ' O ' ' CB ' ' A' ' 104' ' ' SER . 11.7 mt-30 -115.07 158.97 21.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.6 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.542 ' O ' HG22 ' A' ' 126' ' ' ILE . 29.4 mm . . . . . 0 C--N 1.323 -0.566 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.987 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.449 ' CB ' ' HA ' ' A' ' 26' ' ' ASP . 5.1 ptt180 . . . . . 0 N--CA 1.457 -0.11 0 CA-C-O 120.973 0.416 . . . . 0.0 111.173 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.483 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 12.3 m -93.12 162.68 27.73 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.999 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 51.2 Cg_endo -70.24 178.08 5.24 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.443 2.095 . . . . 0.0 112.172 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 42.2 t -58.5 107.94 1.13 Allowed Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.072 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.486 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 2.6 Cg_endo -50.29 146.96 17.18 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.147 1.898 . . . . 0.0 112.206 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.927 ' O ' HD11 ' A' ' 20' ' ' LEU . 4.4 ttp180 -59.76 151.56 25.02 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.275 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -98.5 -177.82 3.81 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.177 -176.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.608 HG22 ' CD2' ' A' ' 20' ' ' LEU . 8.2 tt -141.38 152.99 19.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.458 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -88.38 -66.98 0.86 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.57 -178.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -91.1 40.33 1.02 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.344 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.44 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -160.37 -179.22 35.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.881 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -137.75 125.18 21.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.743 0.306 . . . . 0.0 110.618 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.927 HD11 ' O ' ' A' ' 13' ' ' ARG . 14.9 mt -66.8 154.21 41.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.99 0.424 . . . . 0.0 111.231 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 32' ' ' THR . 3.9 t0 -127.35 74.67 1.53 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.852 178.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.865 ' HA ' HG23 ' A' ' 31' ' ' ILE . 67.8 mt -70.31 96.28 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.22 -177.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.96 21.48 44.78 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.435 176.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 154.87 140.61 3.05 Favored Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.437 HG23 ' HD2' ' A' ' 8' ' ' ARG . 26.5 m -125.64 -9.21 5.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.05 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.449 ' HA ' ' CB ' ' A' ' 8' ' ' ARG . 27.5 t70 -69.68 164.92 22.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.03 0.443 . . . . 0.0 110.95 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.452 ' CZ ' HD12 ' A' ' 51' ' ' LEU . 17.2 t80 -51.9 118.47 3.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.707 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 49' ' ' CYS . . . 100.27 -10.86 59.99 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.659 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.425 ' N ' ' HB3' ' A' ' 49' ' ' CYS . 3.6 m -58.53 179.92 0.07 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.825 0.345 . . . . 0.0 110.964 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.1 p -153.58 133.41 13.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.083 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.865 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.6 OUTLIER -100.97 174.25 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.724 179.584 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.47 ' H ' HG22 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -140.88 106.53 5.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.715 178.778 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.701 ' CE2' HD21 ' A' ' 20' ' ' LEU . 33.5 m-85 -78.37 138.1 38.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.39 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.0 m -139.46 167.02 23.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.69 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.44 ' HA ' ' HA2' ' A' ' 18' ' ' GLY . 1.3 m -91.8 164.62 13.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.943 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.01 -84.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.078 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.63 132.91 9.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.637 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.814 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 64.92 25.94 71.0 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.732 -178.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.525 ' CE1' ' CB ' ' A' ' 68' ' ' SER . 2.6 m-85 -118.34 -179.93 3.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.9 0.381 . . . . 0.0 110.931 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -136.16 140.47 43.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.841 174.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.836 HD21 ' O ' ' A' ' 44' ' ' GLU . 9.6 tt -94.11 138.69 31.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.472 -178.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.577 HD13 ' C ' ' A' ' 41' ' ' LEU . 1.9 mm -110.73 150.5 13.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.077 0.465 . . . . 0.0 111.275 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.27 -147.14 43.75 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.256 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.836 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -62.14 177.74 0.44 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.592 0.234 . . . . 0.0 110.679 179.419 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.6 p -152.3 26.73 0.6 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.955 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.421 ' CG ' ' O ' ' A' ' 31' ' ' ILE . 0.4 OUTLIER -147.02 -171.11 3.7 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.066 -178.541 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.471 ' O ' HG13 ' A' ' 31' ' ' ILE . 1.1 m -167.07 98.92 0.53 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.168 179.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.424 ' CD1' ' N ' ' A' ' 48' ' ' TYR . 1.5 m-85 -80.51 115.85 20.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.134 0.492 . . . . 0.0 111.781 -177.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.482 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 34.8 t -65.91 102.96 0.84 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.031 178.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.498 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 3.7 tt0 -134.06 171.63 13.94 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.315 0.579 . . . . 0.0 110.695 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.498 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.744 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.763 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.24 0 CA-C-O 120.996 0.426 . . . . 0.0 110.385 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -148.67 -174.57 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.612 -178.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.532 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 88.5 m95 -128.06 123.2 34.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.805 0.336 . . . . 0.0 111.194 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -140.01 122.01 9.82 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.979 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.29 -166.89 5.25 Favored 'Cis proline' 0 C--N 1.352 0.725 0 C-N-CA 123.858 -1.309 . . . . 0.0 112.375 -0.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -110.34 -152.72 0.5 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.496 ' CB ' ' CE2' ' A' ' 33' ' ' TYR . . . -79.18 112.82 31.09 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.982 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.434 ' CG ' ' O ' ' A' ' 44' ' ' GLU . 16.6 Cg_exo -69.24 -150.54 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.738 2.292 . . . . 0.0 112.318 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.601 HG22 ' H ' ' A' ' 66' ' ' CYS . 0.5 OUTLIER -106.66 178.37 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.957 0.408 . . . . 0.0 111.251 -179.245 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.601 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.5 OUTLIER -170.69 127.38 0.76 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.747 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.476 ' O ' ' CD2' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -135.48 175.32 9.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.863 179.724 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.525 ' CB ' ' CE1' ' A' ' 39' ' ' TYR . 1.7 p -98.17 124.26 42.64 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.052 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.814 HG12 ' O ' ' A' ' 38' ' ' GLY . 6.7 p -49.58 92.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.982 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.434 ' CD ' ' HB3' ' A' ' 88' ' ' PHE . 0.8 OUTLIER -81.33 128.77 34.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.807 -178.635 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.433 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -110.62 120.44 42.43 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.867 177.625 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.443 ' HA ' ' HA ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -69.8 -160.19 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.964 -179.242 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.576 ' HG ' ' CE1' ' A' ' 82' ' ' HIS . 2.2 t -47.25 136.09 9.0 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.081 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.476 ' HD2' ' CD2' ' A' ' 82' ' ' HIS . 31.6 Cg_exo -56.81 161.81 9.71 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.347 2.031 . . . . 0.0 111.981 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.5 ' HD3' ' CG ' ' A' ' 118' ' ' TRP . 99.3 Cg_exo -42.75 158.15 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.694 2.262 . . . . 0.0 112.735 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.5 m -110.35 88.61 2.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.852 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.667 HG23 ' HE1' ' A' ' 97' ' ' TYR . 19.4 pt -69.65 -179.0 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.364 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.5 m -98.56 146.47 25.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.619 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.484 ' HB3' ' CD2' ' A' ' 103' ' ' TYR . 8.5 m-80 53.53 30.55 10.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.929 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -174.61 -172.29 39.55 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.874 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -170.72 -174.3 1.56 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.904 0.383 . . . . 0.0 110.673 -179.082 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.576 ' CE1' ' HG ' ' A' ' 73' ' ' SER . 11.5 p-80 -92.45 174.45 7.28 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.264 178.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.436 ' OD1' ' CG1' ' A' ' 95' ' ' VAL . 17.5 p-10 . . . . . 0 C--N 1.332 -0.183 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 72' ' ' GLN . 18.1 m-85 . . . . . 0 N--CA 1.449 -0.493 0 CA-C-O 121.131 0.491 . . . . 0.0 111.612 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.439 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 23.7 m-85 -144.66 169.63 17.63 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.049 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 17.0 p -133.62 178.39 6.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.987 0.423 . . . . 0.0 111.674 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -62.47 100.81 0.2 Allowed 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.539 0.685 . . . . 0.0 110.849 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 122.56 16.71 3.7 Favored Glycine 0 C--N 1.312 -0.792 0 CA-C-N 114.718 -1.128 . . . . 0.0 113.003 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.411 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -99.2 157.7 16.2 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.898 0.349 . . . . 0.0 110.533 179.115 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 34.6 m -136.17 152.01 29.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.164 0.507 . . . . 0.0 111.249 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.47 HG23 ' CH2' ' A' ' 118' ' ' TRP . 43.8 t -146.82 150.1 15.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.6 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.809 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -110.46 126.36 54.25 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.882 -179.537 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.977 ' CE2' HG21 ' A' ' 111' ' ' VAL . 3.8 m-85 -83.75 154.61 23.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.465 -178.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 59.9 p -153.58 147.85 25.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.283 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.454 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 8.4 m -69.81 160.77 31.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.954 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 21.6 m-20 -85.46 -68.99 0.69 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.249 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 66.9 m -77.56 -45.2 26.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.639 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 154.74 41.84 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.766 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.528 ' CE1' HG12 ' A' ' 126' ' ' ILE . 13.4 m-85 -78.15 -166.19 0.78 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' A' ' 124' ' ' CYS . 3.5 m -117.17 104.99 11.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.703 0.287 . . . . 0.0 111.567 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 105' ' ' LEU . 2.6 tp -47.15 118.26 2.06 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.168 0.509 . . . . 0.0 110.534 178.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.523 HG22 ' N ' ' A' ' 107' ' ' GLY . 19.1 mm -94.27 160.71 2.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.917 -178.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.523 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 59.43 -124.18 35.66 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.852 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -125.28 122.85 38.09 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.79 0.329 . . . . 0.0 110.93 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.809 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.4 t -58.15 -27.7 64.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.068 0.461 . . . . 0.0 110.474 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.64 135.38 26.79 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.817 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.977 HG21 ' CE2' ' A' ' 97' ' ' TYR . 2.7 t -131.07 119.22 44.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.712 0.291 . . . . 0.0 110.594 178.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.0 118.76 24.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.991 0.424 . . . . 0.0 111.588 -178.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.496 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 14.1 t -85.37 100.54 11.91 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.467 176.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.6 t -136.63 161.39 36.04 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.063 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.99 25.58 3.9 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.756 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.434 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 77.16 7.38 86.78 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.655 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -133.53 -176.56 4.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.825 0.345 . . . . 0.0 110.571 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.5 ' CG ' ' HD3' ' A' ' 75' ' ' PRO . 94.3 m95 -114.61 145.05 42.45 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.171 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.1 147.39 51.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.286 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.495 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.5 t0 71.0 44.56 0.23 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.289 178.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 62.0 Cg_endo -73.23 137.12 25.5 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.191 1.927 . . . . 0.0 111.254 177.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.484 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 73.0 Cg_endo -89.42 -175.42 1.09 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.467 2.112 . . . . 0.0 113.752 -177.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.468 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -124.93 -162.54 1.11 Allowed 'General case' 0 CA--C 1.501 -0.92 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.509 175.34 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 124' ' ' CYS . . . . . 0.411 ' SG ' ' CB ' ' A' ' 103' ' ' TYR . 5.2 t -170.69 92.76 0.18 Allowed 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.323 -176.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -118.88 175.93 5.52 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.92 -1.037 . . . . 0.0 111.012 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.618 ' O ' HG22 ' A' ' 126' ' ' ILE . 16.9 mm . . . . . 0 C--N 1.324 -0.531 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.579 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.445 ' HB3' HG23 ' A' ' 25' ' ' VAL . 2.4 mtt85 . . . . . 0 N--CA 1.454 -0.238 0 CA-C-O 121.023 0.439 . . . . 0.0 111.92 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.457 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 15.1 m -111.51 161.56 24.86 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.638 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.408 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 55.8 Cg_endo -66.92 171.54 11.0 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.179 1.919 . . . . 0.0 110.471 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.408 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 5.7 p -51.11 120.47 14.1 Favored Pre-proline 0 N--CA 1.45 -0.45 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.719 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.509 ' HB3' HD13 ' A' ' 31' ' ' ILE . 6.3 Cg_endo -47.82 144.59 11.15 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.67 2.247 . . . . 0.0 112.395 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.454 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -52.59 -175.88 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.904 177.615 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -144.55 -179.95 6.89 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.46 0.648 . . . . 0.0 111.994 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.752 HD12 ' O ' ' A' ' 64' ' ' PRO . 7.0 tt -139.77 154.5 24.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.305 -179.053 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -79.08 -68.72 0.63 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.541 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.496 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 1.9 m-20 -93.41 39.08 1.05 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.976 0.417 . . . . 0.0 110.876 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -148.29 178.92 25.55 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.025 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -141.51 134.16 28.53 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.953 HD21 ' CE2' ' A' ' 33' ' ' TYR . 10.5 mt -86.69 152.25 22.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.318 0.58 . . . . 0.0 111.953 -178.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -123.34 80.77 1.81 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.578 177.727 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.819 ' HA ' HG23 ' A' ' 31' ' ' ILE . 6.3 mt -75.5 116.66 18.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.561 -176.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -108.3 19.36 32.0 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.356 175.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.499 ' H ' HG22 ' A' ' 22' ' ' ILE . . . 156.58 164.48 13.51 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -179.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.445 HG23 ' HB3' ' A' ' 8' ' ' ARG . 22.5 m -143.82 22.7 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.861 0.33 . . . . 0.0 111.439 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.4 OUTLIER -93.57 159.27 15.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.805 179.762 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.641 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 2.9 t80 -56.03 87.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.683 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 134.1 -14.56 4.59 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.417 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.01 -170.94 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.612 0.244 . . . . 0.0 110.348 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 47' ' ' SER . 27.7 p -159.28 139.19 11.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.237 0.541 . . . . 0.0 111.819 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.819 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -103.66 176.27 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.866 178.755 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.545 HG23 ' HG2' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -138.24 113.2 9.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.696 0.284 . . . . 0.0 110.828 179.809 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.953 ' CE2' HD21 ' A' ' 20' ' ' LEU . 8.3 m-85 -87.34 149.21 24.65 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.318 0.58 . . . . 0.0 111.751 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.409 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.6 OUTLIER -156.62 164.11 38.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.675 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.467 ' HA ' ' HA2' ' A' ' 18' ' ' GLY . 20.2 m -87.7 165.48 15.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.19 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -66.57 -70.94 0.22 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.92 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.41 141.63 9.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.84 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.797 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 52.46 29.82 32.16 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.171 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.512 ' CZ ' ' HB3' ' A' ' 68' ' ' SER . 2.4 m-85 -117.09 175.84 5.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.799 0.333 . . . . 0.0 111.147 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -131.76 140.5 49.24 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 174.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.972 HD21 ' O ' ' A' ' 44' ' ' GLU . 0.6 OUTLIER -90.16 138.67 31.33 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.256 -176.501 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.86 HD13 ' C ' ' A' ' 41' ' ' LEU . 0.3 OUTLIER -116.38 131.96 67.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 CA-C-O 121.67 0.748 . . . . 0.0 110.552 178.442 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.16 -137.42 13.25 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 114.183 -1.371 . . . . 0.0 111.165 -176.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.972 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.6 OUTLIER -87.32 -172.55 3.98 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.843 0.354 . . . . 0.0 110.687 178.333 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.0 p -144.77 25.54 1.45 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.979 0.419 . . . . 0.0 110.817 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.545 ' HG2' HG23 ' A' ' 32' ' ' THR . 0.2 OUTLIER -160.86 125.92 3.71 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.841 -179.117 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' A' ' 30' ' ' SER . 1.6 m -95.74 149.54 21.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.008 178.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.512 ' CE2' ' HD3' ' A' ' 61' ' ' PRO . 4.0 m-85 -123.08 126.85 47.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.028 0.442 . . . . 0.0 111.278 -178.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.477 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 10.5 t -76.21 91.95 3.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.118 179.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -116.4 178.17 4.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.63 -178.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.641 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 4.8 mt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.606 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.934 0.397 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.5 m -132.84 -175.78 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.91 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.631 ' CE3' HD11 ' A' ' 31' ' ' ILE . 88.3 m95 -120.76 139.32 53.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.877 0.37 . . . . 0.0 110.996 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.424 ' O ' ' N ' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -148.78 140.2 14.16 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.956 -179.372 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.512 ' HD3' ' CE2' ' A' ' 48' ' ' TYR . 7.3 Cg_exo -75.93 -151.89 0.72 Allowed 'Cis proline' 0 C--N 1.348 0.512 0 C-N-CA 124.163 -1.182 . . . . 0.0 112.738 1.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -65.2 -130.7 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.908 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.642 ' HB3' ' CA ' ' A' ' 64' ' ' PRO . . . -72.26 -82.53 0.04 OUTLIER Pre-proline 0 CA--C 1.48 -1.733 0 CA-C-O 118.503 -0.76 . . . . 0.0 112.132 -178.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.752 ' O ' HD12 ' A' ' 15' ' ' ILE . 41.2 Cg_endo -102.92 -144.89 0.03 OUTLIER 'Cis proline' 0 C--N 1.317 -1.095 0 CA-C-N 120.73 1.296 . . . . 0.0 114.285 12.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.451 HG13 ' HB ' ' A' ' 42' ' ' ILE . 2.2 pt -91.22 177.0 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -174.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.631 ' HB2' HD11 ' A' ' 15' ' ' ILE . 1.2 m -158.83 112.12 2.33 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 114.282 -1.327 . . . . 0.0 109.513 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.473 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 1.9 mt-10 -102.13 176.8 5.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.006 0.432 . . . . 0.0 111.335 -178.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.512 ' HB3' ' CZ ' ' A' ' 39' ' ' TYR . 2.4 p -97.34 123.02 41.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.802 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.797 HG12 ' O ' ' A' ' 38' ' ' GLY . 3.3 p -45.75 97.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.318 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.619 ' HE2' HG23 ' A' ' 90' ' ' THR . 0.3 OUTLIER -84.78 115.58 22.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.435 -179.139 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -96.38 119.25 34.52 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 177.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -69.81 -157.41 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.577 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.413 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 2.2 t -50.98 138.9 23.92 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.57 0.224 . . . . 0.0 110.736 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.935 ' HG2' HG11 ' A' ' 95' ' ' VAL . 33.9 Cg_exo -58.36 156.36 31.14 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.383 2.055 . . . . 0.0 112.05 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.533 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 76.1 Cg_exo -48.92 156.24 2.2 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.63 2.22 . . . . 0.0 112.921 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 75.4 m -101.63 92.4 4.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.111 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.539 HG23 ' HE1' ' A' ' 97' ' ' TYR . 6.4 pt -68.97 165.51 2.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.298 -178.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.8 m -77.32 140.09 39.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.871 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.503 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 7.0 m-80 52.72 27.21 5.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.051 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -161.63 -166.62 20.73 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.757 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.438 ' N ' ' O ' ' A' ' 98' ' ' SER . 9.5 ptt180 -170.32 -174.64 1.74 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.984 0.421 . . . . 0.0 110.918 -178.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.429 ' HB3' ' CE2' ' A' ' 97' ' ' TYR . 13.6 p80 -102.14 179.43 4.32 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.549 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.469 ' CB ' ' O ' ' A' ' 96' ' ' THR . 50.2 t30 . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.794 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.438 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 11.1 m-85 . . . . . 0 N--CA 1.453 -0.289 0 CA-C-O 120.637 0.256 . . . . 0.0 110.73 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.451 ' CE2' ' CG2' ' A' ' 95' ' ' VAL . 19.8 m-85 -145.31 164.95 29.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.818 0.342 . . . . 0.0 111.117 -178.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.619 HG23 ' HE2' ' A' ' 70' ' ' LYS . 11.1 p -147.42 -175.21 4.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.766 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 7.6 p-10 -54.78 94.02 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.676 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.39 25.99 1.24 Allowed Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.543 -0.837 . . . . 0.0 113.512 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.32 152.29 26.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 117.36 0.58 . . . . 0.0 111.176 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 27.3 m -144.34 136.2 22.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.118 0.485 . . . . 0.0 110.949 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.935 HG11 ' HG2' ' A' ' 74' ' ' PRO . 3.8 p -134.8 149.75 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.283 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.917 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.2 OUTLIER -91.31 149.72 21.62 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.992 0.425 . . . . 0.0 110.836 -179.658 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.876 ' CE2' HG21 ' A' ' 111' ' ' VAL . 2.8 m-85 -107.79 157.39 18.18 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.81 0.338 . . . . 0.0 111.105 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.438 ' O ' ' N ' ' A' ' 81' ' ' ARG . 10.1 p -144.71 146.16 32.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.257 -0.429 . . . . 0.0 112.086 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.551 ' HB3' ' HB2' ' A' ' 103' ' ' TYR . 91.0 m -69.15 161.11 29.81 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.671 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -53.4 -79.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.86 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.1 t -110.81 -30.24 7.64 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.706 -176.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 175.45 31.9 0.04 OUTLIER Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.514 -0.85 . . . . 0.0 113.169 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.555 ' CZ ' HD11 ' A' ' 126' ' ' ILE . 0.2 OUTLIER -69.78 -168.05 0.17 Allowed 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 116.596 0.198 . . . . 0.0 110.681 178.726 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 125' ' ' GLN . 0.2 OUTLIER -125.51 113.95 18.15 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 176.254 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.78 HD12 ' SG ' ' A' ' 124' ' ' CYS . 0.1 OUTLIER -69.62 143.41 53.26 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.762 0.791 . . . . 0.0 112.17 -176.09 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.445 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 33.8 mm -123.09 156.96 28.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 114.281 -1.327 . . . . 0.0 111.266 -178.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.438 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 62.56 32.02 81.81 Favored Glycine 0 CA--C 1.512 -0.137 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.415 178.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.45 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.4 OUTLIER 60.44 135.55 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.313 0.578 . . . . 0.0 111.545 179.218 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.917 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.0 OUTLIER -74.43 -29.96 61.7 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.221 -0.9 . . . . 0.0 112.506 -177.506 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.4 141.45 47.92 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.35 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.876 HG21 ' CE2' ' A' ' 97' ' ' TYR . 13.9 t -134.86 119.17 26.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.644 0.259 . . . . 0.0 111.303 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.92 HD11 ' HB2' ' A' ' 114' ' ' SER . 1.0 OUTLIER -80.18 134.51 36.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.908 0.385 . . . . 0.0 111.194 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.896 ' N ' HD22 ' A' ' 112' ' ' LEU . 35.9 t -106.17 104.96 14.77 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.122 177.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.92 ' HB2' HD11 ' A' ' 112' ' ' LEU . 1.7 t -149.14 131.9 16.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.941 0.401 . . . . 0.0 111.564 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.59 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 80.89 24.28 58.24 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.32 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.458 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 75.7 1.53 66.89 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.312 -178.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -124.52 178.73 5.26 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.03 0.443 . . . . 0.0 110.711 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.608 ' HE3' HG12 ' A' ' 111' ' ' VAL . 92.9 m95 -120.13 133.52 55.49 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.125 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.401 ' O ' ' HB3' ' A' ' 120' ' ' ASP . 0.8 OUTLIER -109.23 160.36 16.18 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.304 178.41 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.574 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 49.7 t0 67.16 33.39 0.1 OUTLIER Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 32.9 Cg_endo -66.92 124.99 12.97 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 121.993 1.796 . . . . 0.0 110.943 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.509 ' HD2' ' CD1' ' A' ' 97' ' ' TYR . 72.3 Cg_endo -91.38 -174.09 0.6 Allowed 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.603 2.202 . . . . 0.0 114.505 -175.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.522 HG22 ' H ' ' A' ' 124' ' ' CYS . 2.5 m -135.81 176.34 8.78 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 113.924 -1.489 . . . . 0.0 108.639 177.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' CYS . . . . . 0.78 ' SG ' HD12 ' A' ' 105' ' ' LEU . 1.2 m -133.3 103.94 6.22 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.106 -0.638 . . . . 0.0 111.16 177.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.437 ' O ' ' CB ' ' A' ' 104' ' ' SER . 10.2 mt-30 -106.85 153.12 22.96 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.686 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.568 ' O ' HG22 ' A' ' 126' ' ' ILE . 49.2 mm . . . . . 0 C--N 1.315 -0.919 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.839 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.659 ' HD2' HG23 ' A' ' 25' ' ' VAL . 14.4 mtm180 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.888 0.375 . . . . 0.0 111.174 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.454 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 16.7 m -69.67 162.01 70.46 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.725 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' A' ' 57' ' ' MET . 57.5 Cg_endo -70.53 169.32 20.18 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.528 2.152 . . . . 0.0 112.218 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -50.29 105.9 0.57 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.939 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.513 ' HG3' ' CZ2' ' A' ' 59' ' ' TRP . 76.5 Cg_exo -46.63 160.96 0.2 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.429 2.086 . . . . 0.0 112.594 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.859 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -66.16 166.38 11.94 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.178 178.532 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -117.03 -178.6 3.48 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.187 0.517 . . . . 0.0 112.187 -176.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.482 HG22 ' CD2' ' A' ' 20' ' ' LEU . 4.1 tt -144.58 146.74 19.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.378 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -85.81 -61.05 1.84 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.523 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.435 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -94.6 34.31 1.34 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.92 -179.142 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.435 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -149.57 -179.18 25.2 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.76 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -138.8 127.99 24.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.769 0.319 . . . . 0.0 110.644 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.859 HD11 ' O ' ' A' ' 13' ' ' ARG . 16.1 mt -76.54 153.74 35.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.096 0.475 . . . . 0.0 111.632 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.454 ' HB3' ' CB ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -127.38 78.82 1.84 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.744 177.838 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.848 ' HA ' HG23 ' A' ' 31' ' ' ILE . 3.6 mm -68.85 100.32 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.861 -177.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -103.63 22.86 34.47 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.648 177.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 146.57 133.56 2.48 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 111.741 -0.544 . . . . 0.0 111.741 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.659 HG23 ' HD2' ' A' ' 8' ' ' ARG . 6.7 m -121.22 22.32 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.697 0.284 . . . . 0.0 111.489 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.12 149.59 26.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.552 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.594 ' CE2' HD13 ' A' ' 51' ' ' LEU . 3.7 t80 -48.41 113.7 0.81 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.894 0.378 . . . . 0.0 110.853 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.42 6.74 23.39 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.618 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.86 -163.19 0.97 Allowed 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.8 0.3 . . . . 0.0 110.571 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.7 p -168.94 144.02 3.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.935 0.398 . . . . 0.0 111.143 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.848 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -102.6 170.31 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.278 179.413 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.569 HG23 ' HD2' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -130.67 114.42 15.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.0 0.429 . . . . 0.0 111.126 179.885 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.779 ' CE1' HD21 ' A' ' 20' ' ' LEU . 17.2 m-85 -92.84 137.14 32.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.504 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.435 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 3.5 m -143.86 166.25 25.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.44 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.428 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 3.9 m -82.89 170.44 14.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.784 0.326 . . . . 0.0 110.879 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.19 -83.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.851 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.6 m -156.44 132.44 9.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.743 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.51 22.75 73.42 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.067 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.494 ' CE1' ' HB3' ' A' ' 68' ' ' SER . 2.7 m-85 -114.65 -174.78 2.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.795 0.331 . . . . 0.0 110.913 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.714 ' CD2' HD11 ' A' ' 42' ' ' ILE . 3.6 p-80 -145.35 112.41 6.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.435 178.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.95 HD11 ' HG2' ' A' ' 64' ' ' PRO . 7.9 tt -77.35 124.17 27.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.768 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.714 HD11 ' CD2' ' A' ' 40' ' ' HIS . 2.3 mm -100.16 152.23 4.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.994 0.426 . . . . 0.0 110.931 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.71 -137.34 16.58 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.202 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.902 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.3 OUTLIER -86.67 -175.84 5.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.02 0.438 . . . . 0.0 110.855 179.432 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.5 p -155.86 24.16 0.38 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.23 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.569 ' HD2' HG23 ' A' ' 32' ' ' THR . 0.0 OUTLIER -149.51 130.03 13.94 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.104 0.478 . . . . 0.0 112.221 -178.598 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.447 ' HB3' ' CB ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -101.15 152.8 20.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.34 178.656 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.494 ' CD2' ' HB3' ' A' ' 60' ' ' ASN . 1.3 m-85 -126.23 120.68 30.66 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 119.7 -0.8 . . . . 0.0 111.902 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.487 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 32.2 t -70.21 116.73 10.9 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.095 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -153.6 -177.43 6.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.789 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.594 HD13 ' CE2' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.988 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.403 ' HB2' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.873 0.368 . . . . 0.0 110.555 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.6 m -150.64 176.54 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.917 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.523 ' CE3' HD11 ' A' ' 31' ' ' ILE . 60.0 m95 -128.16 127.98 43.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.944 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.494 ' HB3' ' CD2' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -69.37 163.24 60.19 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.178 179.311 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.432 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 80.1 Cg_exo -16.58 94.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.899 1 C-N-CA 125.574 4.182 . . . . 0.0 114.429 -178.456 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.447 ' CB ' ' HB3' ' A' ' 47' ' ' SER . 0.0 OUTLIER -101.28 -81.98 0.47 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.958 -177.87 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.462 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -72.95 106.46 2.26 Favored Pre-proline 0 C--N 1.331 -0.212 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -176.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.95 ' HG2' HD11 ' A' ' 41' ' ' LEU . 1.8 Cg_endo -90.05 -156.01 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.469 2.779 . . . . 0.0 111.14 177.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.49 HG22 ' H ' ' A' ' 66' ' ' CYS . 3.8 mm -92.43 165.3 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.877 0.37 . . . . 0.0 110.884 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.49 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.8 OUTLIER -170.21 136.3 1.39 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.002 179.666 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.4 ' C ' ' CD2' ' A' ' 39' ' ' TYR . 1.6 tt0 -159.78 172.37 17.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.909 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.494 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 4.1 p -89.77 107.88 19.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.447 ' O ' HG13 ' A' ' 69' ' ' VAL . 2.4 p -43.06 94.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.524 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.432 ' HG2' ' CG2' ' A' ' 90' ' ' THR . 2.0 mmtp -75.16 127.23 32.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.375 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.92 113.92 27.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.056 178.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.3 -159.74 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.538 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.482 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 1.4 t -44.52 135.2 4.5 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.234 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.489 ' HG2' HG11 ' A' ' 95' ' ' VAL . 31.6 Cg_exo -57.78 161.78 12.03 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.398 2.065 . . . . 0.0 112.116 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.53 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 79.8 Cg_exo -43.14 156.64 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.772 2.314 . . . . 0.0 112.904 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.5 t -104.81 90.56 3.52 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.372 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.66 HG23 ' HE2' ' A' ' 97' ' ' TYR . 10.1 pt -69.28 175.32 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.395 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.4 p -93.79 141.04 28.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.609 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.4 m120 58.4 28.58 17.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.036 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.467 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -167.05 -171.32 33.0 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.215 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -158.55 -173.58 4.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.078 0.466 . . . . 0.0 110.614 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.482 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 8.4 p80 -117.5 172.19 7.5 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.173 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.952 178.24 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.432 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 7.4 m-85 . . . . . 0 N--CA 1.456 -0.169 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.432 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 65.6 m-85 -155.64 164.87 38.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.642 0.258 . . . . 0.0 110.9 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.432 ' CG2' ' HG2' ' A' ' 70' ' ' LYS . 19.7 p -148.18 -175.29 4.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.005 0.431 . . . . 0.0 111.567 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.441 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 28.8 p-10 -52.92 95.65 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.348 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.04 20.35 2.52 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.231 -0.895 . . . . 0.0 113.261 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.24 147.35 33.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 117.051 0.425 . . . . 0.0 110.965 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.494 HG22 ' N ' ' A' ' 95' ' ' VAL . 33.7 m -128.45 158.44 40.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.005 0.431 . . . . 0.0 111.185 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.533 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 14.0 t -151.67 147.34 15.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.709 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.874 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -106.96 131.41 54.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.852 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 1.001 ' CE1' HG21 ' A' ' 111' ' ' VAL . 5.0 m-85 -88.95 159.08 17.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.516 -178.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 49.7 m -151.97 138.89 19.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.947 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.436 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 84.1 m -73.43 156.25 38.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.499 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.467 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 40.8 m-20 -91.35 -71.97 0.61 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.313 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.6 t -53.51 -23.32 10.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.968 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.2 29.03 1.7 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.557 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.497 ' CE1' HG12 ' A' ' 126' ' ' ILE . 24.0 m-85 -73.98 -174.82 1.97 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.021 0.439 . . . . 0.0 110.365 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -123.35 99.19 6.21 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 176.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.666 HD21 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -52.57 152.95 3.33 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 122.277 1.036 . . . . 0.0 112.387 -175.285 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.479 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 40.6 mm -119.01 150.3 21.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 113.149 -1.841 . . . . 0.0 111.138 -175.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.52 33.99 60.59 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.032 -1.08 . . . . 0.0 111.746 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 54.05 145.86 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 124.357 1.063 . . . . 0.0 112.997 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.874 ' HB2' HG22 ' A' ' 96' ' ' THR . 0.7 OUTLIER -71.91 -23.48 61.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.764 -178.756 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -62.14 128.24 41.69 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.764 -0.732 . . . . 0.0 113.009 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 1.001 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.5 t -128.9 125.38 62.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.885 HD22 ' N ' ' A' ' 113' ' ' CYS . 1.2 tm? -85.82 135.53 33.68 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.884 0.373 . . . . 0.0 111.456 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.885 ' N ' HD22 ' A' ' 112' ' ' LEU . 39.1 t -108.01 104.8 14.32 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.232 177.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.689 ' OG ' HD11 ' A' ' 112' ' ' LEU . 0.9 OUTLIER -164.83 124.04 1.82 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.923 0.392 . . . . 0.0 111.349 179.865 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.23 26.17 11.57 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.409 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.44 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 68.43 13.51 65.4 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.6 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -145.8 172.3 13.52 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.875 0.369 . . . . 0.0 110.702 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.54 ' CZ3' ' HB2' ' A' ' 113' ' ' CYS . 92.5 m95 -111.27 141.67 44.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.876 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.18 163.81 16.09 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.427 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.448 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 3.7 p-10 46.58 48.66 5.79 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.332 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.47 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 91.0 Cg_endo -78.5 146.58 21.82 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.496 2.131 . . . . 0.0 110.572 176.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.567 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 56.6 Cg_endo -97.65 -177.44 0.29 Allowed 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 122.048 1.832 . . . . 0.0 114.357 -176.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -118.21 -156.25 0.63 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.273 -1.331 . . . . 0.0 109.018 177.788 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 124' ' ' CYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 105' ' ' LEU . 2.0 m -152.65 89.1 1.38 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.061 0.458 . . . . 0.0 110.788 177.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -121.45 160.13 24.79 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.658 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.511 ' O ' HG22 ' A' ' 126' ' ' ILE . 16.8 mm . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.053 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.512 ' HD2' HG23 ' A' ' 25' ' ' VAL . 18.6 mtm180 . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 121.11 0.481 . . . . 0.0 111.541 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.554 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 55.6 m -69.42 179.09 0.79 Allowed Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.5 178.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.554 ' CD ' ' HB3' ' A' ' 9' ' ' CYS . 17.9 Cg_endo -88.84 -171.71 0.61 Allowed 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.637 2.225 . . . . 0.0 111.598 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.433 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 2.6 t -57.23 106.22 0.65 Allowed Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.452 ' HG3' ' CD1' ' A' ' 22' ' ' ILE . 9.6 Cg_endo -52.44 162.75 2.05 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.107 1.872 . . . . 0.0 112.029 -178.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.427 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -62.27 -175.94 0.09 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.025 179.159 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -143.09 -175.36 4.49 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.165 0.507 . . . . 0.0 111.268 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.451 HG22 ' CD2' ' A' ' 20' ' ' LEU . 13.7 tt -145.23 158.45 13.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.735 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -93.91 -55.2 3.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.446 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -91.91 45.79 1.24 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.981 0.419 . . . . 0.0 110.858 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 34' ' ' SER . . . -177.18 -179.14 47.38 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.996 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -136.74 137.6 40.07 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.8 0.333 . . . . 0.0 110.392 179.626 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.887 HD21 ' CE2' ' A' ' 33' ' ' TYR . 19.3 mt -82.74 154.87 24.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.033 0.444 . . . . 0.0 111.537 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -124.45 84.06 2.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.089 178.515 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.873 ' HA ' HG23 ' A' ' 31' ' ' ILE . 3.8 mm -68.68 108.94 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.676 -177.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -112.51 19.99 21.2 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.002 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 147.31 127.14 1.73 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.309 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.512 HG23 ' HD2' ' A' ' 8' ' ' ARG . 35.9 m -116.52 21.09 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.643 0.258 . . . . 0.0 111.47 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -91.01 151.91 20.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.819 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.509 ' CZ ' HD12 ' A' ' 51' ' ' LEU . 9.2 t80 -52.27 96.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.832 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 122.6 13.01 4.83 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.957 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.6 m -101.23 -162.64 0.95 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.862 0.331 . . . . 0.0 110.427 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 47' ' ' SER . 0.9 OUTLIER -166.01 146.62 6.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.05 0.452 . . . . 0.0 111.347 179.12 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.873 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -104.05 172.91 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.364 179.614 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.468 ' H ' HG22 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -134.52 115.14 13.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.922 0.392 . . . . 0.0 111.038 179.722 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.887 ' CE2' HD21 ' A' ' 20' ' ' LEU . 19.2 m-85 -88.16 149.45 23.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.034 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.42 ' O ' ' N ' ' A' ' 19' ' ' GLN . 81.4 p -151.24 154.17 36.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.651 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.442 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 6.3 m -78.04 167.87 20.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.787 0.327 . . . . 0.0 110.868 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.01 -83.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.407 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.04 132.08 11.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.889 0.376 . . . . 0.0 110.982 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.48 22.58 76.54 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.98 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.603 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.2 m-85 -117.43 -179.93 3.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.972 0.415 . . . . 0.0 110.908 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.557 ' NE2' HD11 ' A' ' 42' ' ' ILE . 5.2 p-80 -144.79 114.73 7.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.25 178.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.923 HD21 ' O ' ' A' ' 44' ' ' GLU . 7.5 tt -73.91 126.14 29.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.594 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.557 HD11 ' NE2' ' A' ' 40' ' ' HIS . 1.7 mm -101.99 156.06 4.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.004 0.43 . . . . 0.0 110.945 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.29 -147.32 39.02 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.271 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.923 ' O ' HD21 ' A' ' 41' ' ' LEU . 3.4 pt-20 -65.98 -176.22 0.38 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.928 0.394 . . . . 0.0 110.633 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.2 t -163.91 25.9 0.08 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.945 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.402 ' HG3' ' HA ' ' A' ' 32' ' ' THR . 10.7 mtpt -152.88 128.16 9.85 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.966 0.412 . . . . 0.0 112.02 -178.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.478 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 1.0 OUTLIER -92.16 142.09 27.88 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 176.572 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.548 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.2 m-85 -117.22 120.28 37.79 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 119.099 -1.04 . . . . 0.0 112.255 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 34.8 t -71.57 100.78 2.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.753 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.46 -173.4 2.67 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.014 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.509 HD12 ' CZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.873 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.523 -0.077 0 CA-C-O 120.833 0.349 . . . . 0.0 110.186 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.1 m -151.97 173.99 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.975 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.533 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 72.8 m95 -126.82 123.21 36.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.357 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.548 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 1.0 OUTLIER -69.99 166.32 34.12 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.363 178.578 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.459 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 76.7 Cg_exo -21.57 97.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 125.044 3.829 . . . . 0.0 114.163 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.448 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -94.85 -78.34 0.45 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.05 -177.933 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.463 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -78.07 108.25 7.15 Favored Pre-proline 0 C--N 1.331 -0.216 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -176.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.91 ' HG2' HD11 ' A' ' 41' ' ' LEU . 2.4 Cg_endo -87.3 -156.19 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.115 2.543 . . . . 0.0 111.016 177.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.554 HG22 ' H ' ' A' ' 66' ' ' CYS . 2.9 mm -88.89 169.25 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.967 0.413 . . . . 0.0 110.67 178.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.554 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.0 OUTLIER -169.97 134.29 1.28 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.734 179.273 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.467 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 1.4 tt0 -155.06 -177.84 6.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.54 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.603 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 2.7 p -75.02 147.59 40.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.646 0.736 . . . . 0.0 111.336 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.646 HG23 ' N ' ' A' ' 116' ' ' GLY . 0.0 OUTLIER -61.86 100.72 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 114.504 -1.226 . . . . 0.0 110.312 -179.371 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 89' ' ' TYR . 0.3 OUTLIER -105.62 119.42 39.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.3 -178.222 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.27 119.26 38.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.467 176.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -69.28 -157.93 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.412 -179.513 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.405 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 2.4 t -51.66 136.66 34.04 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.625 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.756 ' CG ' HG21 ' A' ' 95' ' ' VAL . 52.2 Cg_exo -55.05 159.17 10.12 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.411 2.074 . . . . 0.0 112.302 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.419 ' N ' ' OH ' ' A' ' 97' ' ' TYR . 89.5 Cg_exo -44.39 156.44 0.21 Allowed 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.632 2.221 . . . . 0.0 112.597 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 95.6 p -102.94 89.87 3.59 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.775 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.567 HG23 ' HE2' ' A' ' 97' ' ' TYR . 10.3 pt -69.61 176.29 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.127 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.79 143.54 26.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.974 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.465 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 12.5 m-80 52.86 29.5 7.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.148 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.461 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -162.15 -169.16 25.11 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.275 -0.964 . . . . 0.0 113.353 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.72 -173.98 3.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.872 0.368 . . . . 0.0 110.489 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.484 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 7.3 p-80 -113.28 167.17 10.78 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.558 -179.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 96' ' ' THR . 16.2 m-20 . . . . . 0 CA--C 1.518 -0.268 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.832 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.433 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 7.3 m-85 . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 120.821 0.343 . . . . 0.0 110.761 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.472 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 22.4 m-85 -141.8 162.33 35.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.13 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.4 p -122.25 174.91 6.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.173 0.511 . . . . 0.0 112.123 -177.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.436 ' HB3' ' HB ' ' A' ' 69' ' ' VAL . 10.2 p-10 -60.29 95.53 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.163 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 122.46 18.19 3.4 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.291 -0.868 . . . . 0.0 113.075 178.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.09 157.02 16.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.739 0.304 . . . . 0.0 110.595 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 28.6 m -143.52 141.87 25.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.225 0.536 . . . . 0.0 111.152 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.83 HG22 ' CH2' ' A' ' 118' ' ' TRP . 40.2 t -142.48 142.1 27.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.941 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.512 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -89.01 149.54 23.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.646 -177.079 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.756 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.1 m-85 -105.16 159.63 15.71 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.986 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.691 ' HA ' HD13 ' A' ' 105' ' ' LEU . 58.0 m -157.17 153.65 28.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.039 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.414 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 59.5 m -80.02 160.9 25.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.816 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.461 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 60.2 m-20 -87.59 -70.93 0.59 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.418 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.42 -27.62 67.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.24 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.57 35.53 0.49 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.791 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.502 ' CE2' HG12 ' A' ' 126' ' ' ILE . 15.8 m-85 -70.78 -174.68 0.95 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.914 0.387 . . . . 0.0 110.587 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.4 98.16 7.61 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.162 178.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.691 HD13 ' HA ' ' A' ' 98' ' ' SER . 0.3 OUTLIER -46.47 122.53 4.17 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.507 0.67 . . . . 0.0 112.268 -177.747 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.843 HD11 ' HB2' ' A' ' 125' ' ' GLN . 5.1 mm -85.06 154.73 3.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.938 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.85 -126.1 33.94 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.209 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -123.48 140.99 52.45 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.936 0.398 . . . . 0.0 111.024 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.618 ' HB2' HD22 ' A' ' 105' ' ' LEU . 1.8 t -73.05 -29.41 62.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.948 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -78.23 127.83 8.4 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.002 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.756 HG21 ' CE1' ' A' ' 97' ' ' TYR . 3.1 t -118.41 139.97 43.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 178.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.81 131.51 43.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.146 0.498 . . . . 0.0 111.567 -178.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.494 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 12.0 t -97.45 95.16 7.47 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.446 176.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.9 t -151.07 153.14 34.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.455 -178.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.12 -0.56 62.64 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.645 -0.707 . . . . 0.0 113.491 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.646 ' N ' HG23 ' A' ' 69' ' ' VAL . . . 100.24 1.54 55.79 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.902 -177.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -146.3 177.12 9.25 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.821 0.343 . . . . 0.0 110.708 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.83 ' CH2' HG22 ' A' ' 95' ' ' VAL . 95.2 m95 -99.01 155.61 17.34 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.717 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.585 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -143.09 155.28 44.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.031 0.444 . . . . 0.0 111.19 -179.844 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.481 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.7 OUTLIER 66.22 47.0 0.49 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.798 179.599 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 87.0 Cg_endo -79.4 139.3 14.5 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.476 2.117 . . . . 0.0 111.698 178.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.513 ' CG ' HD21 ' A' ' 105' ' ' LEU . 50.3 Cg_endo -90.61 -174.72 0.76 Allowed 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.5 2.133 . . . . 0.0 113.2 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.449 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -128.4 -157.79 0.84 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.499 177.576 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 124' ' ' CYS . . . . . 0.483 ' SG ' HD12 ' A' ' 105' ' ' LEU . 3.5 m -157.6 89.56 1.04 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.13 0.491 . . . . 0.0 111.133 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.843 ' HB2' HD11 ' A' ' 106' ' ' ILE . 16.4 mt-30 -114.5 170.87 7.99 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.783 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.502 HG12 ' CE2' ' A' ' 103' ' ' TYR . 49.1 mm . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.792 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.448 ' CD ' HG23 ' A' ' 25' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.095 0 CA-C-O 120.851 0.358 . . . . 0.0 111.394 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.486 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 15.1 m -78.67 161.62 68.58 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.448 178.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.02 167.32 25.13 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.338 2.025 . . . . 0.0 111.703 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 t -51.02 105.44 0.52 Allowed Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.936 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.68 ' HG2' HD13 ' A' ' 22' ' ' ILE . 51.3 Cg_exo -50.76 151.07 11.46 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.151 1.901 . . . . 0.0 111.731 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.933 ' O ' HD11 ' A' ' 20' ' ' LEU . 7.1 mpt_? -55.7 159.24 3.11 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.82 -173.85 2.33 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.2 0.524 . . . . 0.0 111.615 -177.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.2 tt -152.57 138.92 12.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.539 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -82.2 -57.31 3.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.676 -177.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.504 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 1.9 m-20 -91.2 45.84 1.27 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.055 0.455 . . . . 0.0 111.069 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -176.65 -179.46 47.09 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.39 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.64 137.36 41.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.815 0.341 . . . . 0.0 110.773 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.933 HD11 ' O ' ' A' ' 13' ' ' ARG . 14.5 mt -75.9 152.15 37.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.215 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.462 ' HB3' ' CB ' ' A' ' 32' ' ' THR . 19.4 t0 -120.92 69.64 0.89 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.447 177.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.821 ' HA ' HG23 ' A' ' 31' ' ' ILE . 1.1 mt -80.84 90.95 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.883 -176.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.85 16.13 59.07 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.81 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 29' ' ' SER . . . 165.83 133.21 1.48 Allowed Glycine 0 C--N 1.334 0.435 0 C-N-CA 121.176 -0.535 . . . . 0.0 111.765 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.448 HG23 ' CD ' ' A' ' 8' ' ' ARG . 1.7 m -119.43 -2.54 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -178.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -75.88 164.13 26.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.986 0.422 . . . . 0.0 110.814 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.54 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 13.1 t80 -52.03 115.81 1.88 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.09 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.73 -4.59 46.57 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.764 -0.731 . . . . 0.0 113.066 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 24' ' ' GLY . 57.9 m -74.99 176.83 6.81 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 117.029 0.415 . . . . 0.0 110.602 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 47' ' ' SER . 2.5 p -144.47 149.99 36.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.952 0.406 . . . . 0.0 111.464 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.821 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -118.74 165.83 13.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.468 179.353 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.462 ' CB ' ' HB3' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -135.9 111.75 9.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.896 178.547 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.697 ' CE2' HD21 ' A' ' 20' ' ' LEU . 31.6 m-85 -84.06 135.78 34.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.062 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 84.4 p -141.05 146.86 37.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.154 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.479 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 1.7 m -73.38 174.31 8.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.794 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.68 -82.42 0.06 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.39 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.2 m -155.14 120.16 4.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.476 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.579 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 77.42 -0.58 68.69 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.475 -177.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.517 ' CZ ' ' CB ' ' A' ' 68' ' ' SER . 5.9 m-85 -89.48 166.43 13.69 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 120.782 0.325 . . . . 0.0 110.832 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.599 ' NE2' HG22 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -121.46 127.68 51.34 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 176.578 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.849 HD21 ' O ' ' A' ' 44' ' ' GLU . 6.0 tt -86.02 117.2 24.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.135 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.448 ' HB ' ' HB ' ' A' ' 65' ' ' ILE . 2.1 mm -92.41 153.83 3.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.475 -177.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.82 -151.29 50.27 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.26 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.849 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -55.28 178.92 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.534 0.206 . . . . 0.0 110.536 179.504 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.447 ' HB3' HD22 ' A' ' 41' ' ' LEU . 6.6 p -152.14 18.8 0.66 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.608 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.411 ' HG3' ' HA ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -154.77 175.72 13.36 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.923 0.392 . . . . 0.0 110.958 -178.648 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.469 ' HB2' ' CG1' ' A' ' 31' ' ' ILE . 2.6 m -149.63 123.03 9.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.297 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.408 ' CE1' ' HD3' ' A' ' 61' ' ' PRO . 4.9 m-85 -103.0 114.16 28.23 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.973 0.416 . . . . 0.0 111.452 -178.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.471 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 42.2 t -64.97 77.44 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.374 0.607 . . . . 0.0 110.076 178.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.5 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 1.9 tt0 -97.33 175.13 6.37 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.907 -177.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.54 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.514 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.106 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.442 ' HA ' ' HA ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.961 0.41 . . . . 0.0 110.71 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.1 m -126.03 -176.79 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.383 -178.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.668 ' CE3' HD11 ' A' ' 31' ' ' ILE . 97.5 m95 -116.38 125.6 52.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.126 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -150.08 118.73 3.68 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.771 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.408 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 8.9 Cg_exo -73.21 -172.16 9.47 Favored 'Cis proline' 0 C--N 1.35 0.633 0 C-N-CA 124.221 -1.158 . . . . 0.0 112.413 1.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -111.11 -152.5 0.5 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.891 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.524 ' CB ' ' CE2' ' A' ' 33' ' ' TYR . . . -79.38 111.27 19.31 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.651 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.439 ' CG ' ' O ' ' A' ' 44' ' ' GLU . 15.3 Cg_exo -69.07 -150.76 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.662 2.241 . . . . 0.0 112.296 -179.051 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.569 HG22 ' H ' ' A' ' 66' ' ' CYS . 0.4 OUTLIER -108.36 -179.69 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.117 0.484 . . . . 0.0 111.222 -179.324 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.569 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.0 OUTLIER -167.43 118.52 0.87 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.524 179.454 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.469 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 0.1 OUTLIER -113.4 166.74 11.2 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.689 179.888 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.517 ' CB ' ' CZ ' ' A' ' 39' ' ' TYR . 1.1 p -107.53 120.42 42.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.993 0.425 . . . . 0.0 111.047 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.599 HG22 ' NE2' ' A' ' 40' ' ' HIS . 3.1 p -46.4 94.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.439 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.44 ' HE2' HG23 ' A' ' 90' ' ' THR . 0.2 OUTLIER -76.8 125.44 29.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.276 -179.581 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.432 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -104.33 126.06 51.1 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.326 178.953 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -73.62 -169.12 0.65 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.472 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -42.42 135.05 2.59 Favored Pre-proline 0 N--CA 1.438 -1.065 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.436 178.948 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.513 ' HG2' HG11 ' A' ' 95' ' ' VAL . 34.5 Cg_exo -56.05 159.88 11.45 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.188 1.925 . . . . 0.0 111.923 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.516 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 96.1 Cg_exo -40.85 156.6 0.05 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.757 2.305 . . . . 0.0 112.855 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.3 m -108.5 90.12 3.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.647 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.647 HG21 ' O ' ' A' ' 122' ' ' PRO . 16.5 pt -69.41 170.85 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.298 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.39 133.78 35.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.777 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.508 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 0.1 OUTLIER 67.9 26.41 7.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.602 -179.643 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -171.44 -170.83 35.96 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.732 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.15 -175.47 2.0 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.958 0.409 . . . . 0.0 110.801 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.442 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 12.3 p80 -95.04 176.11 6.37 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.891 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.7 m120 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.169 -179.992 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.414 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 6.0 m-85 . . . . . 0 N--CA 1.457 -0.121 0 CA-C-O 120.976 0.417 . . . . 0.0 111.154 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.432 ' N ' ' O ' ' A' ' 71' ' ' CYS . 33.0 m-85 -145.05 170.32 16.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.613 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.44 HG23 ' HE2' ' A' ' 70' ' ' LYS . 14.4 p -133.25 175.38 9.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.913 0.387 . . . . 0.0 111.18 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 23.1 p-10 -60.19 94.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.307 0.575 . . . . 0.0 111.038 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 128.31 28.1 0.86 Allowed Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.294 -0.866 . . . . 0.0 113.18 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.405 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -110.11 164.88 12.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.791 0.295 . . . . 0.0 110.661 179.24 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.429 HG22 ' N ' ' A' ' 95' ' ' VAL . 33.5 m -138.47 154.81 27.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.067 0.461 . . . . 0.0 111.274 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.513 HG11 ' HG2' ' A' ' 74' ' ' PRO . 21.7 t -152.42 148.5 14.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.021 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.706 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -104.99 142.94 33.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.306 179.007 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.972 ' CE2' HG21 ' A' ' 111' ' ' VAL . 4.6 m-85 -101.43 155.4 18.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.946 0.403 . . . . 0.0 111.279 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.416 ' HA ' HD13 ' A' ' 105' ' ' LEU . 45.9 m -148.57 141.93 25.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.165 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.431 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 73.5 m -72.75 162.35 29.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.759 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.4 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 39.7 m-20 -92.74 -70.59 0.69 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.347 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.5 m -63.79 -23.37 67.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.198 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 122.21 33.0 0.93 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.495 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.508 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 22.6 m-85 -69.9 -176.95 1.19 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.022 0.439 . . . . 0.0 110.725 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.2 m -108.11 101.73 10.94 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.185 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.649 HD22 ' HB2' ' A' ' 109' ' ' SER . 0.2 OUTLIER -46.32 125.18 6.44 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.426 0.631 . . . . 0.0 111.771 -178.255 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.44 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 34.6 mm -90.79 152.1 3.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.931 -1.032 . . . . 0.0 110.282 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 68.86 -127.49 22.33 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.257 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -125.59 132.48 52.51 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.712 0.291 . . . . 0.0 110.946 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.706 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.9 t -62.87 -33.16 74.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.773 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -66.03 139.42 38.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.781 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.972 HG21 ' CE2' ' A' ' 97' ' ' TYR . 3.0 t -136.44 119.91 23.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.571 0.224 . . . . 0.0 110.705 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.93 128.72 33.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.965 0.412 . . . . 0.0 111.47 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.52 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 17.7 t -92.8 102.29 14.68 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 176.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 3.1 p -144.54 162.86 35.51 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.074 0.464 . . . . 0.0 111.401 -177.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.2 29.0 4.66 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.778 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.436 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 70.15 16.15 72.78 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.4 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -141.51 -177.76 5.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.869 0.366 . . . . 0.0 110.659 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.52 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 95.1 m95 -117.04 142.19 47.29 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.082 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.18 149.92 47.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.247 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.488 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 2.0 t0 70.14 46.01 0.27 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.036 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 84.1 Cg_endo -78.18 134.43 12.9 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.442 2.095 . . . . 0.0 111.831 178.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.647 ' O ' HG21 ' A' ' 77' ' ' ILE . 73.9 Cg_endo -89.05 -173.06 0.74 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.62 2.214 . . . . 0.0 113.432 -178.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.401 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -131.39 -160.76 1.07 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.96 178.468 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 8.2 m -153.28 91.19 1.49 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.141 0.496 . . . . 0.0 110.957 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -122.39 157.74 31.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.616 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.551 ' O ' HG22 ' A' ' 126' ' ' ILE . 24.0 mm . . . . . 0 C--N 1.323 -0.584 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.932 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 26' ' ' ASP . 3.1 mtm180 . . . . . 0 N--CA 1.455 -0.184 0 CA-C-O 121.167 0.508 . . . . 0.0 112.363 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.462 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 4.2 m -122.58 164.65 25.24 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.339 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 44.3 Cg_endo -66.13 168.05 16.7 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.145 1.897 . . . . 0.0 111.465 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.5 t -52.84 105.95 0.6 Allowed Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.047 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.76 ' HG2' HD13 ' A' ' 22' ' ' ILE . 17.2 Cg_exo -42.15 158.1 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.212 1.941 . . . . 0.0 112.164 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.452 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -74.87 166.93 22.84 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.155 178.411 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.735 ' HA ' HD11 ' A' ' 20' ' ' LEU . 12.0 p-10 -121.48 -175.21 3.03 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 121.079 0.466 . . . . 0.0 112.022 -176.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.848 HD12 ' O ' ' A' ' 64' ' ' PRO . 16.9 tt -151.52 147.21 15.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.715 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -87.2 156.72 19.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.219 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.523 ' CB ' ' CE1' ' A' ' 39' ' ' TYR . 0.9 OUTLIER 45.44 27.02 0.34 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.096 -179.611 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -147.38 176.96 25.97 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.207 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.54 136.23 34.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.787 0.327 . . . . 0.0 110.812 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.783 HD22 ' CE2' ' A' ' 33' ' ' TYR . 3.5 mt -87.7 159.26 18.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.62 178.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.424 ' CB ' ' HB ' ' A' ' 32' ' ' THR . 5.3 t0 -124.76 71.23 1.16 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.049 177.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.941 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.8 OUTLIER -74.19 95.38 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.776 -177.748 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.77 19.14 55.71 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.722 177.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 158.93 132.16 1.34 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.227 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.0 m -118.63 33.35 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.543 0.211 . . . . 0.0 111.521 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.443 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 43.9 t0 -105.0 162.87 12.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.043 0.449 . . . . 0.0 111.513 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.655 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 5.2 t80 -59.96 91.73 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.619 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.15 3.56 6.79 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.638 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.77 -165.84 1.39 Allowed 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.843 0.321 . . . . 0.0 110.312 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 67.4 p -162.84 146.81 11.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.298 0.57 . . . . 0.0 111.593 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.941 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -114.17 160.45 13.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.871 179.57 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.43 ' HA ' ' HG3' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -123.3 120.48 33.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.919 0.39 . . . . 0.0 110.899 179.184 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.783 ' CE2' HD22 ' A' ' 20' ' ' LEU . 2.2 m-85 -91.98 142.32 27.66 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.533 -178.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.91 164.82 37.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.669 -179.046 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.429 ' HA ' ' HA2' ' A' ' 18' ' ' GLY . 64.6 m -90.17 172.55 8.72 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.867 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.4 m-20 -78.17 -83.35 0.08 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.205 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.79 135.53 17.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.665 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.784 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 63.31 26.35 69.34 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.867 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.523 ' CE1' ' CB ' ' A' ' 17' ' ' ASN . 2.4 m-85 -120.11 171.28 8.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.807 0.337 . . . . 0.0 111.171 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.791 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -133.86 127.86 33.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.289 178.275 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.816 HD21 ' HG2' ' A' ' 64' ' ' PRO . 1.7 tt -87.72 124.6 33.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.671 -178.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.791 HD11 ' CE1' ' A' ' 40' ' ' HIS . 0.9 OUTLIER -108.06 131.34 58.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.312 0.577 . . . . 0.0 111.038 -179.432 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 112.86 -146.37 18.34 Favored Glycine 0 C--N 1.321 -0.261 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.204 -177.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.752 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -74.31 -135.59 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 176.912 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.42 ' HB2' ' O ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER 174.02 26.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 117.965 0.348 . . . . 0.0 110.784 177.71 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.493 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 4.3 mttt -160.22 134.49 7.4 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.786 -178.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.504 ' HB3' HD12 ' A' ' 31' ' ' ILE . 32.1 t -107.69 144.38 34.88 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.908 177.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.516 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 3.4 m-85 -126.41 120.27 29.36 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 119.41 -0.916 . . . . 0.0 112.461 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 32.5 t -64.01 99.28 0.25 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.538 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -124.2 -173.7 2.83 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.112 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.655 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.02 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.5 mmt . . . . . 0 N--CA 1.455 -0.186 0 CA-C-O 120.868 0.366 . . . . 0.0 110.433 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.7 m -137.04 179.91 3.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.936 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.669 ' CZ3' HD11 ' A' ' 31' ' ' ILE . 66.5 m95 -124.74 127.18 46.84 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.289 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.516 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -69.53 168.97 13.75 Favored Pre-proline 0 CA--C 1.513 -0.449 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.923 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.487 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 1.0 OUTLIER -4.97 85.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.282 1 C-N-CA 125.326 4.017 . . . . 0.0 113.816 -179.107 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.634 ' O ' ' CZ ' ' A' ' 33' ' ' TYR . 15.3 mt-10 -69.09 -53.07 22.21 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-N 113.052 -1.885 . . . . 0.0 111.649 -174.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.649 ' CB ' ' HA ' ' A' ' 64' ' ' PRO . . . -65.31 -148.51 0.0 OUTLIER Pre-proline 0 CA--C 1.487 -1.454 0 CA-C-O 116.708 -1.615 . . . . 0.0 108.043 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.848 ' O ' HD12 ' A' ' 15' ' ' ILE . 3.9 Cg_exo -85.91 -157.44 1.25 Allowed 'Cis proline' 0 N--CA 1.484 0.934 0 CA-C-N 123.772 2.383 . . . . 0.0 115.013 16.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.601 ' N ' HD13 ' A' ' 65' ' ' ILE . 1.2 mm -95.68 175.01 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.0 -178.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.588 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.6 m -147.67 135.11 20.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.185 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.484 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 3.0 tt0 -140.55 174.06 10.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.755 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.472 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 37.4 p -89.03 118.87 29.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.984 0.421 . . . . 0.0 111.235 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.784 HG12 ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -40.59 98.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.728 179.773 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.415 ' HG2' HG22 ' A' ' 90' ' ' THR . 1.3 mmtp -67.71 137.04 55.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.389 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.03 124.77 50.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.13 178.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -69.26 -156.31 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.319 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.555 ' HG ' ' CE1' ' A' ' 82' ' ' HIS . 1.4 t -53.45 145.6 27.15 Favored Pre-proline 0 N--CA 1.45 -0.463 0 CA-C-O 120.59 0.234 . . . . 0.0 110.542 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.57 ' HG2' HG11 ' A' ' 95' ' ' VAL . 18.8 Cg_exo -65.29 160.63 41.4 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.53 2.154 . . . . 0.0 112.031 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.52 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 86.8 Cg_exo -40.54 156.68 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.801 2.334 . . . . 0.0 112.892 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.15 91.85 3.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.528 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.694 HG23 ' HE1' ' A' ' 97' ' ' TYR . 15.6 pt -68.98 175.91 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.07 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.9 m -94.49 140.91 29.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.912 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.5 ' HB3' ' CE1' ' A' ' 103' ' ' TYR . 7.0 m-80 57.47 29.25 16.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.989 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.46 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -163.57 -168.03 24.94 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.392 -0.909 . . . . 0.0 112.86 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 7.7 ptt85 -162.48 -175.91 4.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.007 0.432 . . . . 0.0 110.903 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.555 ' CE1' ' HG ' ' A' ' 73' ' ' SER . 4.6 p80 -111.18 172.12 7.07 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.625 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.507 179.426 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.432 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 7.0 m-85 . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.939 0.4 . . . . 0.0 111.333 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.432 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 62.8 m-85 -151.24 164.72 35.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.546 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.415 HG22 ' HG2' ' A' ' 70' ' ' LYS . 19.0 p -128.84 178.47 6.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.912 0.387 . . . . 0.0 111.114 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 14.5 t0 -64.55 101.5 0.46 Allowed 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 121.814 0.816 . . . . 0.0 111.01 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 121.55 21.39 3.01 Favored Glycine 0 C--N 1.311 -0.811 0 CA-C-N 114.312 -1.313 . . . . 0.0 112.993 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.39 160.79 14.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.845 0.322 . . . . 0.0 110.641 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 33.7 m -134.37 152.9 34.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.156 0.503 . . . . 0.0 111.515 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.57 HG11 ' HG2' ' A' ' 74' ' ' PRO . 27.7 t -146.49 148.71 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.688 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.734 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -105.51 132.87 51.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.96 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 1.005 ' CE2' HG21 ' A' ' 111' ' ' VAL . 5.2 m-85 -93.29 159.07 15.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.005 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 56.3 p -156.11 143.67 19.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.204 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.415 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 62.3 m -72.35 160.49 32.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.305 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.46 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 8.1 m-20 -94.45 -71.01 0.68 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.408 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.95 -21.77 66.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.455 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.65 30.88 1.2 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.694 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.505 ' CE2' HG12 ' A' ' 126' ' ' ILE . 51.1 m-85 -71.27 -172.72 0.76 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.658 0.266 . . . . 0.0 110.469 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -109.62 109.3 20.01 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.011 0.434 . . . . 0.0 111.146 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.564 HD23 ' HB2' ' A' ' 122' ' ' PRO . 2.7 tp -47.56 113.56 0.72 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.662 178.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.453 ' HB ' ' CB ' ' A' ' 123' ' ' THR . 39.0 mm -84.86 149.73 4.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.495 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 59.93 -132.43 50.92 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.385 -0.912 . . . . 0.0 111.794 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -112.29 133.45 54.4 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.826 0.346 . . . . 0.0 111.477 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.734 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.3 t -64.92 -27.31 68.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.44 178.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.34 138.95 31.37 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.836 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 1.005 HG21 ' CE2' ' A' ' 97' ' ' TYR . 3.1 t -134.98 123.83 41.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.462 0.173 . . . . 0.0 110.576 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.5 126.94 32.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.964 0.411 . . . . 0.0 111.976 -178.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.516 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 16.4 t -92.4 104.8 17.09 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 176.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 83.1 p -151.79 165.68 33.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.947 -177.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.99 30.71 5.27 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.865 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.434 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 67.9 8.79 54.69 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.51 -179.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -136.98 179.51 6.34 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.817 0.341 . . . . 0.0 110.771 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.52 ' CD1' ' HD3' ' A' ' 75' ' ' PRO . 94.2 m95 -113.5 136.58 52.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.901 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.77 155.86 37.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.134 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.522 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 34.6 t0 67.99 41.94 0.25 Allowed Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 81.4 Cg_endo -78.52 143.21 19.04 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.431 2.087 . . . . 0.0 112.03 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.564 ' HB2' HD23 ' A' ' 105' ' ' LEU . 57.4 Cg_endo -91.19 -172.66 0.49 Allowed 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.895 2.397 . . . . 0.0 113.353 -179.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.453 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -133.47 -177.19 4.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.274 178.097 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 6.4 m -142.13 96.68 3.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.972 0.415 . . . . 0.0 110.908 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -121.23 170.1 9.91 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.81 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.565 ' O ' HG22 ' A' ' 126' ' ' ILE . 36.5 mm . . . . . 0 C--N 1.324 -0.515 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.823 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.423 ' CD ' HG23 ' A' ' 25' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.177 0 CA-C-O 120.838 0.352 . . . . 0.0 111.549 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.433 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 6.9 m -87.56 162.29 42.69 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.638 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.29 169.26 20.0 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.275 1.983 . . . . 0.0 111.532 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -50.47 111.81 2.43 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.021 -179.342 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.53 157.42 58.42 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.495 2.13 . . . . 0.0 112.002 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.779 ' O ' HD11 ' A' ' 20' ' ' LEU . 10.4 ttt180 -53.85 -179.74 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.956 178.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.74 ' O ' HG22 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -141.3 -3.26 1.2 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -177.662 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.74 HG22 ' O ' ' A' ' 14' ' ' ASP . 15.6 tt 56.03 156.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 122.599 0.36 . . . . 0.0 111.114 -177.432 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -88.37 -63.34 1.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -176.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.418 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 0.7 OUTLIER -92.42 26.04 2.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.442 -177.797 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.425 ' HA2' ' N ' ' A' ' 36' ' ' ASN . . . -147.8 177.69 25.9 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.955 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 34' ' ' SER . 1.2 mt-30 -137.61 139.08 40.15 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.815 HD13 ' CZ ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -94.6 174.37 7.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.311 0.577 . . . . 0.0 111.532 -178.395 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 32' ' ' THR . 10.0 t0 -133.12 88.34 2.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.562 177.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.902 ' HA ' HG23 ' A' ' 31' ' ' ILE . 59.9 mt -71.58 115.79 12.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.091 -177.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -122.44 19.06 8.15 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.666 177.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 159.83 131.94 1.3 Allowed Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.423 HG23 ' CD ' ' A' ' 8' ' ' ARG . 6.6 m -124.24 5.36 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -77.33 164.46 25.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.036 0.446 . . . . 0.0 110.983 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.635 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 4.8 t80 -57.1 101.83 0.07 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.201 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 115.45 7.7 15.73 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.958 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.2 p -88.76 -169.11 2.41 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.924 0.362 . . . . 0.0 110.62 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.4 p -160.16 151.3 19.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.953 0.406 . . . . 0.0 111.391 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.902 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.8 OUTLIER -115.78 169.84 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.477 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -123.27 113.1 18.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.956 0.408 . . . . 0.0 111.186 179.259 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.815 ' CZ ' HD13 ' A' ' 20' ' ' LEU . 17.3 m-85 -88.86 140.92 28.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.218 0.533 . . . . 0.0 111.718 -179.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 19' ' ' GLN . 0.4 OUTLIER -144.92 170.69 15.66 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.231 179.151 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.429 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 1.7 m -89.19 166.14 14.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.716 0.293 . . . . 0.0 110.903 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.425 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 1.6 m120 -64.42 -84.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.029 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.86 134.02 13.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.81 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.731 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 63.89 23.62 67.66 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.093 -179.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.496 ' CE2' ' HB2' ' A' ' 68' ' ' SER . 2.5 m-85 -115.88 174.27 6.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.81 0.338 . . . . 0.0 111.007 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.686 ' NE2' HD11 ' A' ' 42' ' ' ILE . 3.2 p-80 -137.21 112.57 9.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.46 178.142 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.917 HD21 ' O ' ' A' ' 44' ' ' GLU . 4.5 tt -77.51 130.63 37.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.772 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.686 HD11 ' NE2' ' A' ' 40' ' ' HIS . 2.6 mm -105.52 154.17 6.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.851 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.07 -137.9 17.83 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.273 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.917 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -79.83 -174.21 4.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.948 0.404 . . . . 0.0 110.931 179.599 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.1 p -160.55 25.48 0.15 Allowed 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.067 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.41 ' HG3' ' HA ' ' A' ' 32' ' ' THR . 6.3 mtpt -152.29 132.11 13.27 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.021 0.438 . . . . 0.0 112.179 -178.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.452 ' HB2' ' HA ' ' A' ' 62' ' ' GLU . 26.4 t -96.83 153.12 18.07 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.766 177.324 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.5 ' CD1' ' HB3' ' A' ' 60' ' ' ASN . 1.4 m-85 -128.68 114.53 16.75 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 119.248 -0.981 . . . . 0.0 111.895 178.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 29.8 t -63.07 109.29 1.45 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.663 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.97 -176.49 4.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.045 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.635 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 5.0 mt . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.199 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.6 mmt . . . . . 0 N--CA 1.456 -0.131 0 CA-C-O 120.835 0.35 . . . . 0.0 110.615 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.519 HG22 ' C ' ' A' ' 51' ' ' LEU . 31.0 m -138.68 -175.17 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.968 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.519 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 68.0 m95 -131.06 134.85 47.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.059 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.5 ' HB3' ' CD1' ' A' ' 48' ' ' TYR . 1.2 m-80 -75.06 166.6 44.13 Favored Pre-proline 0 CA--C 1.517 -0.297 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 177.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.467 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 23.2 Cg_exo -8.96 92.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 0.986 1 C-N-CA 125.568 4.178 . . . . 0.0 114.546 -179.559 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.469 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 3.6 mm-40 -82.91 -87.4 0.1 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.936 -175.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.506 ' HB1' HG13 ' A' ' 15' ' ' ILE . . . -96.32 108.18 40.18 Favored Pre-proline 0 C--N 1.332 -0.169 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -176.165 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.811 ' HG2' HD11 ' A' ' 41' ' ' LEU . 5.7 Cg_exo -74.71 -151.5 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.797 2.331 . . . . 0.0 111.334 177.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.507 HG22 ' H ' ' A' ' 66' ' ' CYS . 4.8 mm -88.8 166.24 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 0.0 110.712 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.507 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.8 OUTLIER -165.54 137.17 4.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.884 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.06 169.94 23.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.928 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.496 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 1.1 t -80.59 123.75 28.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.146 0.498 . . . . 0.0 111.008 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.731 HG12 ' O ' ' A' ' 38' ' ' GLY . 1.9 p -50.74 104.09 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.984 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.446 ' HD2' ' HB3' ' A' ' 88' ' ' PHE . 46.3 mmtt -71.43 121.65 18.97 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.128 -178.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.418 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -109.2 121.58 45.47 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 176.435 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -69.77 -162.02 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.513 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.599 ' HG ' ' CE1' ' A' ' 82' ' ' HIS . 1.1 t -53.32 141.58 41.63 Favored Pre-proline 0 N--CA 1.449 -0.487 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.328 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.474 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 24.9 Cg_exo -58.3 159.74 18.38 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.204 1.936 . . . . 0.0 111.515 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.426 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 78.1 Cg_exo -39.21 154.56 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.707 2.271 . . . . 0.0 112.799 -178.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.2 t -107.3 89.53 3.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.885 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.621 HG23 ' HE2' ' A' ' 97' ' ' TYR . 22.7 pt -70.12 -177.92 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.327 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.7 m -104.33 142.32 34.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.583 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.514 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 5.4 m-80 61.9 29.79 17.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.814 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.466 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . -175.78 -168.92 36.78 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.771 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -170.55 -174.66 1.68 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.907 0.384 . . . . 0.0 110.535 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.599 ' CE1' ' HG ' ' A' ' 73' ' ' SER . 2.1 p80 -103.15 170.94 7.66 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.152 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.322 -179.561 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.446 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 10.5 m-85 . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.882 0.372 . . . . 0.0 111.094 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.435 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 59.1 m-85 -148.82 152.74 37.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.665 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.4 p -102.0 175.18 5.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.099 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.9 103.12 2.13 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.652 0.739 . . . . 0.0 110.65 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 120.55 24.66 2.56 Favored Glycine 0 C--N 1.312 -0.778 0 CA-C-N 114.588 -1.187 . . . . 0.0 112.751 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.54 163.57 12.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.711 0.291 . . . . 0.0 110.627 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.507 HG22 ' N ' ' A' ' 95' ' ' VAL . 32.6 m -136.27 158.48 38.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.17 0.51 . . . . 0.0 111.333 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.507 ' N ' HG22 ' A' ' 94' ' ' VAL . 22.1 t -153.07 150.4 12.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.769 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.941 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -108.4 136.36 48.16 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.355 178.994 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.875 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.9 m-85 -93.81 155.57 17.13 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.938 0.399 . . . . 0.0 110.987 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -154.81 144.78 21.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.408 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.466 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 9.5 m -69.95 169.14 13.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.843 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -99.33 -83.81 0.42 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.531 178.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.9 t -54.01 -36.78 63.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.247 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 136.19 47.38 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.548 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.55 ' CE2' HG12 ' A' ' 126' ' ' ILE . 12.4 m-85 -83.77 -170.18 2.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.672 0.272 . . . . 0.0 110.653 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.4 m -116.92 102.3 9.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.726 0.298 . . . . 0.0 110.821 179.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.529 HD11 ' HB3' ' A' ' 97' ' ' TYR . 0.2 OUTLIER -48.38 136.95 11.88 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.632 0.729 . . . . 0.0 111.193 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.481 HG22 ' N ' ' A' ' 107' ' ' GLY . 33.2 mm -103.43 158.86 4.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.304 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.481 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 62.38 -126.1 37.17 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.309 -0.948 . . . . 0.0 112.021 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -124.12 131.72 53.57 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.981 0.42 . . . . 0.0 111.121 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.941 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.2 p -62.77 -26.52 68.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.857 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.2 142.29 31.38 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.821 -0.627 . . . . 0.0 113.014 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.875 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.8 t -140.05 127.02 23.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.98 122.25 32.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.873 0.368 . . . . 0.0 111.807 -178.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.521 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 15.5 t -85.16 101.26 12.33 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 176.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.45 167.19 25.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.047 0.451 . . . . 0.0 111.527 -178.141 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.24 25.11 2.61 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.665 -0.698 . . . . 0.0 113.033 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.82 19.7 79.48 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.222 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -151.31 -179.3 7.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.772 0.32 . . . . 0.0 110.297 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.521 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 90.1 m95 -113.23 138.53 49.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.898 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.41 146.63 46.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.236 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.48 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER 69.89 45.98 0.28 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.17 178.819 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 71.7 Cg_endo -76.95 136.77 16.89 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.313 2.009 . . . . 0.0 111.383 177.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.527 ' O ' HG21 ' A' ' 77' ' ' ILE . 56.6 Cg_endo -89.7 179.41 2.15 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.383 2.055 . . . . 0.0 113.582 -178.213 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.45 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -120.13 -159.99 0.81 Allowed 'General case' 0 CA--C 1.503 -0.858 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.955 176.707 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 124' ' ' CYS . . . . . 0.437 ' SG ' ' HB2' ' A' ' 103' ' ' TYR . 5.5 t -170.7 91.48 0.16 Allowed 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.376 -176.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -118.92 176.57 5.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.812 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.595 ' O ' HG22 ' A' ' 126' ' ' ILE . 39.1 mm . . . . . 0 C--N 1.322 -0.601 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.846 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.459 ' HB2' ' HA ' ' A' ' 26' ' ' ASP . 7.7 ptt180 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 121.071 0.463 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.558 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 72.4 m -83.89 177.12 3.17 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.693 178.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.558 ' CD ' ' HB3' ' A' ' 9' ' ' CYS . 38.4 Cg_endo -90.78 -165.93 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.701 2.267 . . . . 0.0 112.025 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.39 108.22 1.35 Allowed Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.273 179.037 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.469 ' HB3' HD11 ' A' ' 31' ' ' ILE . 14.0 Cg_endo -56.67 149.31 59.71 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.153 1.902 . . . . 0.0 111.975 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.82 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.8 OUTLIER -59.25 173.43 0.49 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.28 179.645 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.62 -171.71 2.53 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.147 0.498 . . . . 0.0 111.506 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.582 HD12 ' O ' ' A' ' 64' ' ' PRO . 4.1 tt -151.82 147.23 15.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.004 -178.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.451 ' N ' HG12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -87.72 154.6 20.44 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 177.3 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.477 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 0.2 OUTLIER 48.52 25.44 0.94 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.885 0.374 . . . . 0.0 110.285 -178.521 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -146.3 170.46 27.4 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.658 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -136.46 138.56 41.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.927 0.394 . . . . 0.0 110.689 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.911 HD21 ' CZ ' ' A' ' 33' ' ' TYR . 8.2 mt -84.62 155.1 22.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.061 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.441 ' CB ' ' HB ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -125.45 71.22 1.2 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.776 177.857 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.888 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.8 OUTLIER -70.78 95.69 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.041 -177.024 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.8 19.22 52.91 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.591 176.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.4 ' O ' ' HB3' ' A' ' 29' ' ' SER . . . 155.46 141.47 3.22 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.206 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.42 ' O ' ' HB2' ' A' ' 8' ' ' ARG . 3.1 m -114.6 -12.54 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.459 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 0.8 OUTLIER -69.82 160.3 32.01 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.852 0.358 . . . . 0.0 111.738 -179.033 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.672 ' CE2' HD23 ' A' ' 51' ' ' LEU . 24.1 t80 -50.42 127.21 17.0 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.126 178.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.97 -11.06 71.43 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.065 -178.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.4 ' HB3' ' O ' ' A' ' 24' ' ' GLY . 74.5 m -65.31 -173.4 0.13 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.955 0.378 . . . . 0.0 110.065 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 48' ' ' TYR . 11.0 p -162.12 146.49 12.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.135 0.493 . . . . 0.0 111.808 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.888 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -118.94 151.22 21.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.83 179.157 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.444 ' HA ' ' HG3' ' A' ' 46' ' ' LYS . 3.1 m -115.52 114.61 25.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.037 0.446 . . . . 0.0 111.428 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.911 ' CZ ' HD21 ' A' ' 20' ' ' LEU . 2.1 m-85 -80.83 135.9 36.02 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.252 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.467 ' HA ' HD13 ' A' ' 41' ' ' LEU . 3.7 p -148.24 177.65 9.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.146 -177.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.466 ' HA ' ' HA2' ' A' ' 18' ' ' GLY . 71.9 m -94.16 170.17 9.71 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.634 -178.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.26 -77.82 0.17 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.856 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.03 139.23 17.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.593 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.487 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 54.35 29.68 46.99 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.725 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.5 ' CE2' ' HA ' ' A' ' 67' ' ' GLU . 2.0 m-85 -121.14 163.12 18.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.948 0.404 . . . . 0.0 111.161 -179.126 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.419 ' CE1' HD11 ' A' ' 42' ' ' ILE . 5.5 p-80 -127.68 134.65 49.59 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 176.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.837 HD21 ' HG2' ' A' ' 64' ' ' PRO . 0.9 OUTLIER -82.72 137.62 34.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.959 -174.572 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.531 HD13 ' C ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -114.88 125.26 72.15 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-O 121.344 0.592 . . . . 0.0 110.995 178.827 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 104.69 -145.43 15.97 Favored Glycine 0 C--N 1.318 -0.452 0 CA-C-N 114.539 -1.21 . . . . 0.0 112.378 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.46 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 11.0 mt-10 -60.97 -134.87 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 178.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.507 ' HB3' HD22 ' A' ' 41' ' ' LEU . 6.4 p 165.32 23.6 0.0 OUTLIER 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 123.712 0.805 . . . . 0.0 111.086 177.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.533 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 1.6 mttt -162.93 146.6 11.08 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -177.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.489 ' HA ' ' O ' ' A' ' 61' ' ' PRO . 32.9 t -119.85 152.62 37.05 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.75 176.243 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.546 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 3.4 m-85 -134.2 119.54 18.93 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 118.825 -1.15 . . . . 0.0 113.184 -178.347 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.51 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 36.6 t -65.96 120.87 13.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.902 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.486 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 8.4 tt0 -160.68 168.85 24.02 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.565 0.697 . . . . 0.0 110.845 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.672 HD23 ' CE2' ' A' ' 27' ' ' PHE . 2.8 pp . . . . . 0 C--N 1.317 -0.847 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.074 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.565 ' O ' HG13 ' A' ' 58' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.522 -0.099 0 CA-C-O 120.821 0.343 . . . . 0.0 110.341 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.565 HG13 ' O ' ' A' ' 57' ' ' MET . 8.2 m -159.98 -177.65 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.099 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.53 ' CE3' HD11 ' A' ' 31' ' ' ILE . 75.6 m95 -126.2 135.2 51.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.972 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.546 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.3 OUTLIER -69.58 168.57 16.2 Favored Pre-proline 0 CA--C 1.506 -0.722 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 175.208 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.49 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 0.9 OUTLIER -4.28 120.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.949 1 C-N-CA 125.527 4.151 . . . . 0.0 114.873 -177.209 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.619 ' O ' ' CZ ' ' A' ' 33' ' ' TYR . 13.1 mt-10 -89.18 -62.3 1.51 Allowed 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 114.35 -1.295 . . . . 0.0 111.739 -173.061 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.677 ' HB1' ' CA ' ' A' ' 64' ' ' PRO . . . -65.45 -153.12 0.0 OUTLIER Pre-proline 0 CA--C 1.484 -1.57 0 CA-C-O 116.704 -1.617 . . . . 0.0 108.691 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.837 ' HG2' HD21 ' A' ' 41' ' ' LEU . 4.0 Cg_exo -89.51 -155.14 0.78 Allowed 'Cis proline' 0 N--CA 1.483 0.879 0 CA-C-N 123.037 2.12 . . . . 0.0 114.804 19.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.545 HG22 ' H ' ' A' ' 66' ' ' CYS . 0.4 OUTLIER -103.15 -167.98 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.072 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.921 -177.905 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.649 ' SG ' HD12 ' A' ' 41' ' ' LEU . 1.7 m -164.19 137.42 5.19 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.822 0.344 . . . . 0.0 111.257 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.5 ' HA ' ' CE2' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -141.24 150.89 43.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.524 -179.431 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.486 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 5.0 t -48.3 139.62 8.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.301 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.487 HG12 ' O ' ' A' ' 38' ' ' GLY . 0.9 OUTLIER -67.38 108.2 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.261 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.427 ' HA ' HG22 ' A' ' 90' ' ' THR . 0.0 OUTLIER -77.18 127.92 33.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.761 -179.391 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.41 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -107.1 119.34 39.1 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.681 177.532 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.65 -157.09 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.791 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.5 t -49.18 139.61 13.07 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.08 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.807 ' HG2' HG11 ' A' ' 95' ' ' VAL . 25.6 Cg_exo -60.23 159.79 25.33 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.474 2.116 . . . . 0.0 111.9 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.51 ' HD3' ' CG ' ' A' ' 118' ' ' TRP . 86.2 Cg_exo -45.81 153.67 0.8 Allowed 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.433 2.089 . . . . 0.0 112.4 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.4 t -106.62 91.81 3.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.635 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.534 HG21 ' O ' ' A' ' 122' ' ' PRO . 14.1 pt -69.27 167.02 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.091 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.4 p -84.87 139.97 31.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.897 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.455 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 5.9 m120 58.63 27.9 16.43 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.139 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.455 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -163.05 -163.08 14.86 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.422 -0.894 . . . . 0.0 113.054 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.415 ' N ' ' O ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -170.44 -174.61 1.7 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.874 0.369 . . . . 0.0 110.859 -179.475 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.526 ' HB3' ' CE1' ' A' ' 97' ' ' TYR . 2.3 p80 -111.24 167.3 10.39 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.893 -178.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 96' ' ' THR . 10.4 m-20 . . . . . 0 CA--C 1.515 -0.377 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.452 177.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.427 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 7.3 m-85 . . . . . 0 N--CA 1.454 -0.273 0 CA-C-O 120.833 0.349 . . . . 0.0 110.87 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.427 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 6.5 m-85 -142.54 173.18 11.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.79 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.427 HG22 ' HA ' ' A' ' 70' ' ' LYS . 16.7 p -154.02 -175.73 5.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.039 0.447 . . . . 0.0 112.012 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.467 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 4.6 m-20 -57.5 96.53 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.358 0.599 . . . . 0.0 111.062 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 128.46 15.54 2.21 Favored Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 115.081 -0.963 . . . . 0.0 113.281 178.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.431 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.4 OUTLIER -104.52 150.61 24.45 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 117.244 0.522 . . . . 0.0 110.698 179.184 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.484 HG12 ' HA ' ' A' ' 112' ' ' LEU . 18.8 m -146.89 132.83 12.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.084 0.469 . . . . 0.0 110.886 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.807 HG11 ' HG2' ' A' ' 74' ' ' PRO . 2.2 p -132.35 148.7 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.009 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.574 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -92.1 148.91 21.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.077 0.465 . . . . 0.0 110.732 179.85 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.883 ' CE1' HG21 ' A' ' 111' ' ' VAL . 3.0 m-85 -107.17 159.78 16.07 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.846 0.355 . . . . 0.0 110.845 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.415 ' O ' ' N ' ' A' ' 81' ' ' ARG . 50.4 m -155.79 151.44 27.25 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.56 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.452 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 78.4 m -78.38 162.01 26.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.252 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.455 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 17.0 m-20 -91.77 -71.28 0.65 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.488 -179.054 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.68 -20.96 66.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.434 -179.214 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.32 31.42 1.17 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.532 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.484 ' CE2' HG12 ' A' ' 126' ' ' ILE . 26.5 m-85 -69.83 -173.47 0.63 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 120.782 0.325 . . . . 0.0 110.539 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.56 103.56 12.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.072 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.591 HD23 ' HB2' ' A' ' 122' ' ' PRO . 3.0 tp -42.62 113.45 0.46 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.135 179.088 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.734 HD11 ' HB2' ' A' ' 125' ' ' GLN . 39.0 mm -86.75 155.86 3.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.735 -179.375 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.439 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 57.18 -128.62 47.86 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.351 -0.928 . . . . 0.0 111.766 -178.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -115.04 134.67 54.98 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.029 0.442 . . . . 0.0 111.573 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.574 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.1 t -70.27 -29.83 66.7 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.362 178.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.82 137.28 23.05 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.536 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.883 HG21 ' CE1' ' A' ' 97' ' ' TYR . 9.9 t -128.75 120.11 51.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.483 0.182 . . . . 0.0 110.527 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.883 HD22 ' N ' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -80.0 133.21 36.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.903 0.382 . . . . 0.0 111.442 -178.906 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.883 ' N ' HD22 ' A' ' 112' ' ' LEU . 25.5 t -104.68 106.48 16.99 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.851 176.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.645 ' HB2' HD11 ' A' ' 112' ' ' LEU . 0.2 OUTLIER -167.29 122.02 1.04 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.981 0.42 . . . . 0.0 111.174 179.851 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.27 26.79 7.19 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.144 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.438 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 69.24 10.09 61.87 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.521 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -148.69 -177.64 5.9 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.981 0.419 . . . . 0.0 110.665 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.579 ' HE3' HG12 ' A' ' 111' ' ' VAL . 92.9 m95 -116.27 151.19 36.31 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.85 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.68 155.63 49.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.073 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.535 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.2 t0 69.49 42.07 0.22 Allowed Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 74.2 Cg_endo -76.7 137.32 17.94 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.48 2.12 . . . . 0.0 111.941 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.591 ' HB2' HD23 ' A' ' 105' ' ' LEU . 57.2 Cg_endo -90.83 -172.97 0.55 Allowed 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.853 2.369 . . . . 0.0 113.408 -178.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.453 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.3 OUTLIER -132.36 -163.27 1.32 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.021 177.893 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 7.6 m -151.87 92.2 1.71 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.147 0.498 . . . . 0.0 111.164 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.734 ' HB2' HD11 ' A' ' 106' ' ' ILE . 10.1 mt-30 -118.06 164.74 14.67 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.514 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.557 ' O ' HG22 ' A' ' 126' ' ' ILE . 50.0 mm . . . . . 0 C--N 1.324 -0.523 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.946 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.84 ' HD2' HG23 ' A' ' 25' ' ' VAL . 13.1 mtm180 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.934 0.397 . . . . 0.0 110.755 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.463 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 19.6 m -89.35 162.06 38.13 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.826 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.41 170.18 16.75 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.413 2.075 . . . . 0.0 111.985 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.429 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 12.8 t -54.33 106.33 0.65 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.226 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.468 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 3.4 Cg_exo -46.76 153.26 1.37 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.118 1.879 . . . . 0.0 112.045 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.703 ' O ' HD11 ' A' ' 20' ' ' LEU . 2.4 mtt85 -68.52 163.59 23.12 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.14 178.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.454 ' HA ' HD11 ' A' ' 20' ' ' LEU . 2.0 p30 -112.35 179.76 3.9 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.18 0.514 . . . . 0.0 112.129 -176.222 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.461 HG23 ' C ' ' A' ' 18' ' ' GLY . 7.3 tt -131.63 152.56 37.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.418 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -80.27 -62.34 1.71 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -177.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -94.57 31.07 1.85 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.867 -178.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.461 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -151.03 -179.98 27.22 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.197 -1.002 . . . . 0.0 113.498 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -139.34 135.22 33.52 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.146 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.703 HD11 ' O ' ' A' ' 13' ' ' ARG . 2.6 mt -79.42 163.29 24.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.218 0.533 . . . . 0.0 111.799 -178.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -131.33 77.75 1.79 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.595 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.921 ' HA ' HG23 ' A' ' 31' ' ' ILE . 69.1 mt -69.63 104.51 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.018 -177.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -110.2 22.63 22.53 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.519 177.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 153.66 129.78 1.39 Allowed Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -179.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.84 HG23 ' HD2' ' A' ' 8' ' ' ARG . 0.5 OUTLIER -121.33 0.97 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.665 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 27' ' ' PHE . 34.0 t0 -74.22 162.24 29.13 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.844 0.354 . . . . 0.0 110.952 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.88 ' CZ ' HD13 ' A' ' 51' ' ' LEU . 11.0 t80 -52.56 106.19 0.15 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.843 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.57 -0.08 27.7 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.765 -0.731 . . . . 0.0 113.046 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 82.9 p -77.24 178.99 6.64 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.971 0.385 . . . . 0.0 110.964 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 47' ' ' SER . 3.3 p -149.1 144.03 26.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.998 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.921 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -110.64 170.46 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.618 179.819 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.441 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -129.42 113.12 14.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.905 0.383 . . . . 0.0 111.31 179.482 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.673 ' CE2' HD22 ' A' ' 20' ' ' LEU . 15.8 m-85 -87.77 140.99 28.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.06 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.433 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 16.6 m -146.36 157.52 43.79 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.677 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.437 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 62.7 m -80.34 170.01 16.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.748 0.308 . . . . 0.0 110.647 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.09 -75.65 0.11 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.941 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.8 t -160.01 139.69 11.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.835 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 56.97 25.13 52.79 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.063 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.531 ' CD2' ' HA ' ' A' ' 68' ' ' SER . 2.3 m-85 -116.57 171.05 8.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.871 0.367 . . . . 0.0 111.051 -179.256 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.744 ' CD2' HD11 ' A' ' 42' ' ' ILE . 1.6 p-80 -131.86 123.25 27.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.426 178.387 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.941 HD21 ' O ' ' A' ' 44' ' ' GLU . 4.7 tt -86.47 134.27 33.69 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.502 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.744 HD11 ' CD2' ' A' ' 40' ' ' HIS . 2.0 mm -112.97 156.98 13.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.02 0.438 . . . . 0.0 111.164 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.4 -128.27 8.36 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.289 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.941 ' O ' HD21 ' A' ' 41' ' ' LEU . 1.5 pm0 -83.78 -173.7 4.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.792 0.329 . . . . 0.0 110.648 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.2 p -162.31 24.27 0.11 Allowed 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.159 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.441 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 13.2 mtpt -164.45 126.45 2.28 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.578 -177.093 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.455 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 1.9 t -94.06 137.85 32.8 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 176.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.552 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 2.6 m-85 -114.92 118.57 33.85 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.589 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 35.4 t -66.3 92.57 0.19 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.625 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.489 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 1.7 tt0 -123.86 172.12 9.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.518 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.88 HD13 ' CZ ' ' A' ' 27' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.32 -0.682 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.521 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.203 0 CA-C-O 121.261 0.553 . . . . 0.0 110.4 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.442 ' N ' ' O ' ' A' ' 50' ' ' GLU . 0.9 OUTLIER -111.99 -175.23 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.432 -179.281 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.536 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 70.7 m95 -125.31 123.73 40.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.916 0.389 . . . . 0.0 111.263 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.552 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 2.7 m-20 -69.04 167.68 19.36 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.49 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 10.4 Cg_exo -7.39 89.86 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.008 1 C-N-CA 125.41 4.073 . . . . 0.0 114.796 -179.054 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.479 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 10.7 mt-10 -84.24 -92.58 0.08 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 114.779 -1.101 . . . . 0.0 112.386 -177.154 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.48 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -91.63 109.01 33.62 Favored Pre-proline 0 C--O 1.231 0.1 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -176.393 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.893 ' HG2' HD11 ' A' ' 41' ' ' LEU . 6.1 Cg_exo -79.39 -153.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.892 2.395 . . . . 0.0 111.113 177.192 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.515 HG22 ' H ' ' A' ' 66' ' ' CYS . 1.5 mm -93.95 168.94 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.859 0.361 . . . . 0.0 110.669 178.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.515 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.8 OUTLIER -170.35 138.69 1.6 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.945 179.759 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -162.44 173.86 13.51 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.625 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.531 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 54.1 p -79.07 113.64 17.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.301 0.572 . . . . 0.0 110.83 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.684 HG21 ' H ' ' A' ' 115' ' ' GLY . 30.9 m -39.2 100.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.425 -179.252 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 89' ' ' TYR . 0.3 OUTLIER -96.45 103.57 15.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.862 0.363 . . . . 0.0 110.719 178.027 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.94 121.91 35.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.049 179.094 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.459 ' CG ' ' N ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -69.15 -155.4 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.975 179.402 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.459 ' N ' ' CG ' ' A' ' 72' ' ' GLN . 1.2 t -50.77 142.21 16.79 Favored Pre-proline 0 N--CA 1.449 -0.511 0 CA-C-O 120.642 0.258 . . . . 0.0 110.823 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.496 ' HG2' HG11 ' A' ' 95' ' ' VAL . 26.8 Cg_exo -59.35 164.1 11.38 Favored 'Trans proline' 0 CA--C 1.528 0.198 0 C-N-CA 122.531 2.154 . . . . 0.0 111.936 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.521 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 89.6 Cg_exo -41.75 158.76 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.56 2.174 . . . . 0.0 112.572 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 83.5 p -109.24 88.6 2.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.528 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.645 HG23 ' HE2' ' A' ' 97' ' ' TYR . 15.9 pt -69.79 170.55 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.305 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.7 m -90.09 142.59 27.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.675 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.506 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 7.7 m-80 56.26 29.51 15.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.973 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.477 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -161.75 -171.18 27.48 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.27 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.413 ' N ' ' O ' ' A' ' 98' ' ' SER . 9.5 ptt180 -163.75 -175.33 4.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.971 0.415 . . . . 0.0 110.78 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 1.7 p-80 -117.9 169.22 9.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.053 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.691 179.989 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.434 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 7.0 m-85 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.761 0.315 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.434 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 72.5 m-85 -156.39 160.56 39.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.845 -179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 69' ' ' VAL . 6.7 p -142.63 -177.42 5.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.287 0.565 . . . . 0.0 112.324 -179.295 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 6.9 p-10 -50.03 94.62 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.489 -179.088 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 121.96 24.29 2.31 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.373 -0.83 . . . . 0.0 113.37 177.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -110.1 147.4 33.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 117.075 0.437 . . . . 0.0 110.782 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.517 HG22 ' N ' ' A' ' 95' ' ' VAL . 35.2 m -128.68 160.0 39.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.1 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.517 ' N ' HG22 ' A' ' 94' ' ' VAL . 21.5 t -151.8 148.6 14.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.479 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.9 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -108.01 126.02 52.22 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.228 0.537 . . . . 0.0 111.06 -179.608 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.955 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.6 m-85 -83.87 161.6 20.82 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.657 -178.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.432 ' HA ' HD13 ' A' ' 105' ' ' LEU . 14.8 p -155.24 138.66 15.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.348 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.453 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 73.9 m -69.98 158.39 35.71 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.794 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.477 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 26.8 m-20 -92.0 -70.69 0.68 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.429 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.24 -22.83 67.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.323 -179.117 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 122.0 31.15 1.13 Allowed Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.63 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.506 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 19.9 m-85 -69.61 -175.55 0.87 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.038 0.447 . . . . 0.0 110.898 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.2 m -110.07 98.1 7.45 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.098 178.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.527 HD11 ' HB3' ' A' ' 97' ' ' TYR . 0.2 OUTLIER -48.77 132.48 17.97 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.555 0.693 . . . . 0.0 111.727 -177.834 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.445 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 38.2 mm -114.23 155.52 15.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.092 -178.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.41 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 68.59 23.88 75.32 Favored Glycine 0 C--N 1.328 0.103 0 C-N-CA 120.56 -0.828 . . . . 0.0 113.053 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.41 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.3 OUTLIER 60.37 136.66 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.295 0.569 . . . . 0.0 111.531 179.759 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.9 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.1 p -69.7 -24.13 63.53 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.765 -178.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -63.84 121.72 24.21 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.787 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.955 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.7 t -122.14 141.8 41.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 178.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.895 HD22 ' N ' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -102.92 132.43 49.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.841 0.353 . . . . 0.0 111.505 -178.955 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.895 ' N ' HD22 ' A' ' 112' ' ' LEU . 41.4 t -104.6 104.59 14.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.034 177.325 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.798 ' OG ' HD11 ' A' ' 112' ' ' LEU . 12.4 p -165.93 119.27 1.13 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.922 0.391 . . . . 0.0 111.707 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.684 ' H ' HG21 ' A' ' 69' ' ' VAL . . . 102.33 20.98 11.18 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.686 179.124 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.489 ' N ' ' HB ' ' A' ' 69' ' ' VAL . . . 80.88 2.08 90.02 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.498 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -145.51 170.52 16.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.14 0.495 . . . . 0.0 111.317 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.521 ' CD1' ' HD3' ' A' ' 75' ' ' PRO . 88.5 m95 -104.37 144.98 30.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.355 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.1 149.77 43.1 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.074 0.464 . . . . 0.0 111.491 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.499 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER 65.66 44.7 0.41 Allowed Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.196 178.899 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 56.3 Cg_endo -69.82 142.91 48.93 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.22 1.946 . . . . 0.0 111.467 178.045 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.508 ' HG2' ' CD2' ' A' ' 97' ' ' TYR . 71.1 Cg_endo -90.23 -172.84 0.6 Allowed 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.641 2.227 . . . . 0.0 113.768 -177.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.37 -158.44 0.87 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.652 178.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 2.3 m -155.76 89.16 1.15 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.089 0.471 . . . . 0.0 110.925 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -113.34 161.11 17.65 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.684 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.582 ' O ' HG22 ' A' ' 126' ' ' ILE . 21.9 mm . . . . . 0 C--N 1.323 -0.569 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.935 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.426 ' CB ' HG23 ' A' ' 25' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 120.946 0.403 . . . . 0.0 111.752 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.481 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 3.5 m -93.24 163.04 26.47 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.672 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -67.62 169.83 15.07 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.205 1.937 . . . . 0.0 111.407 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.03 105.1 0.46 Allowed Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.088 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.6 ' HB3' HD13 ' A' ' 31' ' ' ILE . 83.1 Cg_exo -38.42 146.35 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.657 2.238 . . . . 0.0 112.739 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.3 152.98 43.83 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.644 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.415 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -101.18 -167.98 1.5 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.118 -178.701 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 19.1 tt -167.88 144.52 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.568 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -94.28 160.43 14.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.743 177.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 48.1 25.58 0.84 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.879 0.371 . . . . 0.0 110.638 -179.108 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -158.81 -173.91 27.83 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.615 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -132.14 -171.88 2.74 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.313 0.578 . . . . 0.0 111.787 -177.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.3 mt -140.25 139.28 35.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.465 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.422 ' CB ' ' HB ' ' A' ' 32' ' ' THR . 0.3 OUTLIER -118.07 73.56 0.91 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.851 179.109 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.763 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -82.75 94.21 3.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.947 -176.046 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.38 12.05 63.94 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.048 177.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 29' ' ' SER . . . 156.51 148.12 4.97 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.11 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.426 HG23 ' CB ' ' A' ' 8' ' ' ARG . 29.7 m -120.37 -1.01 8.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.424 ' HA ' ' HB3' ' A' ' 8' ' ' ARG . 0.7 OUTLIER -69.64 153.78 42.93 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.931 0.395 . . . . 0.0 111.224 -179.292 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.46 110.38 0.37 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.855 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 113.79 -9.16 23.61 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.423 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 24' ' ' GLY . 0.4 OUTLIER -72.73 178.44 4.17 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.845 0.323 . . . . 0.0 110.83 179.777 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 47' ' ' SER . 11.4 p -153.82 138.77 17.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.223 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.763 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -103.1 165.78 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.601 179.063 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.423 ' HA ' ' HG3' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -130.35 110.5 11.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.633 178.561 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.491 ' CE2' ' HA ' ' A' ' 63' ' ' ALA . 22.9 m-85 -83.2 146.95 28.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.132 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.47 172.2 14.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.926 0.394 . . . . 0.0 111.425 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.444 ' HA ' ' HA2' ' A' ' 18' ' ' GLY . 1.7 m -96.13 156.7 16.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.497 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.423 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 3.6 m-20 -56.1 -85.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.15 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.5 t -152.19 135.67 16.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.934 0.397 . . . . 0.0 110.719 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.439 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 61.51 24.29 63.74 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.865 -179.016 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.471 ' CG ' ' O ' ' A' ' 67' ' ' GLU . 2.3 m-85 -116.24 174.69 5.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.805 0.336 . . . . 0.0 110.802 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.618 ' NE2' HD11 ' A' ' 42' ' ' ILE . 4.7 p-80 -136.94 116.17 12.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.036 0.446 . . . . 0.0 110.478 178.241 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.917 HD21 ' O ' ' A' ' 44' ' ' GLU . 4.7 tt -77.37 124.62 28.11 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.638 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.618 HD11 ' NE2' ' A' ' 40' ' ' HIS . 2.7 mm -96.8 152.55 3.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.247 -179.011 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.09 -149.74 38.04 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.218 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.917 ' O ' HD21 ' A' ' 41' ' ' LEU . 4.3 pm0 -61.63 178.65 0.3 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.609 0.242 . . . . 0.0 110.582 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.0 p -152.38 21.44 0.64 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.374 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.423 ' HG3' ' HA ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -142.97 -174.6 4.23 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.226 0.536 . . . . 0.0 111.934 -178.299 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.456 ' O ' HG13 ' A' ' 31' ' ' ILE . 1.7 m -160.96 108.88 1.54 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.831 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -92.15 117.75 30.16 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.229 0.538 . . . . 0.0 111.839 -177.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.499 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 8.7 t -64.33 90.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.226 179.129 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.503 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -116.43 175.75 5.42 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.428 -179.51 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.503 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.646 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.235 -178.326 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.866 0.365 . . . . 0.0 110.11 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.9 m -152.04 -177.66 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.083 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.526 ' CE3' HD11 ' A' ' 31' ' ' ILE . 93.2 m95 -130.51 124.6 32.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.932 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -143.49 126.51 8.92 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.193 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.78 -162.28 2.13 Favored 'Cis proline' 0 C--N 1.351 0.703 0 C-N-CA 124.06 -1.225 . . . . 0.0 111.928 -0.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.488 ' O ' ' CZ ' ' A' ' 33' ' ' TYR . 4.3 pt-20 -112.25 -113.97 0.33 Allowed 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.401 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.491 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -118.92 86.84 32.06 Favored Pre-proline 0 N--CA 1.45 -0.472 0 C-N-CA 122.658 0.383 . . . . 0.0 110.462 -179.362 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.549 ' HG2' HD11 ' A' ' 41' ' ' LEU . 10.3 Cg_endo -48.58 -158.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.475 0.395 0 C-N-CA 123.863 3.042 . . . . 0.0 113.995 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.487 HG22 ' N ' ' A' ' 66' ' ' CYS . 5.0 mm -93.49 165.28 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.109 -177.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.487 ' N ' HG22 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -161.42 138.22 8.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.268 179.074 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.471 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 1.0 OUTLIER -162.22 -177.1 5.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.898 0.38 . . . . 0.0 111.168 -179.719 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.8 t -83.8 132.27 34.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.108 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -46.21 101.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.553 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.526 ' HE2' HG23 ' A' ' 90' ' ' THR . 0.2 OUTLIER -72.15 123.19 22.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.352 179.951 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.51 122.91 46.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.921 178.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -69.31 -156.28 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.373 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.544 ' HG ' ' CE1' ' A' ' 82' ' ' HIS . 1.8 t -52.95 145.6 22.28 Favored Pre-proline 0 N--CA 1.45 -0.426 0 CA-C-O 120.633 0.254 . . . . 0.0 110.377 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.464 ' HG2' HG11 ' A' ' 95' ' ' VAL . 23.4 Cg_exo -62.62 165.33 16.01 Favored 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 122.48 2.12 . . . . 0.0 112.155 -179.268 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.518 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 81.2 Cg_exo -43.65 160.6 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.713 2.275 . . . . 0.0 112.87 -179.004 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 86.7 p -108.29 90.16 3.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.497 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.692 HG23 ' HE2' ' A' ' 97' ' ' TYR . 14.1 pt -69.24 175.22 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.243 -178.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.4 p -96.21 143.41 27.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.717 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.514 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 4.9 m120 55.42 30.23 14.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.925 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.439 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -167.41 -170.26 32.01 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.53 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.97 -176.71 4.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.035 0.445 . . . . 0.0 111.091 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.544 ' CE1' ' HG ' ' A' ' 73' ' ' SER . 3.4 p80 -108.37 173.26 6.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.117 -179.297 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.66 179.408 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.434 ' HB3' ' HD3' ' A' ' 70' ' ' LYS . 6.4 m-85 . . . . . 0 N--CA 1.455 -0.196 0 CA-C-O 120.866 0.365 . . . . 0.0 111.521 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.425 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 69.2 m-85 -156.77 165.85 35.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.809 -179.262 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.526 HG23 ' HE2' ' A' ' 70' ' ' LYS . 19.1 p -149.37 -175.78 5.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.029 0.442 . . . . 0.0 111.62 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 3.8 p30 -52.86 94.42 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.444 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.14 22.63 2.34 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.273 -0.876 . . . . 0.0 113.13 178.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.401 ' HB2' ' HB3' ' A' ' 89' ' ' TYR . 0.9 OUTLIER -110.21 145.83 36.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.951 0.375 . . . . 0.0 110.789 179.104 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 32.7 m -128.58 155.61 40.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.067 0.461 . . . . 0.0 111.249 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.509 HG23 ' CH2' ' A' ' 118' ' ' TRP . 20.7 t -146.54 146.57 18.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.11 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.802 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -101.4 134.22 44.82 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.827 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.911 ' CE1' HG21 ' A' ' 111' ' ' VAL . 5.0 m-85 -95.39 158.83 15.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.915 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 77.1 p -153.0 140.33 19.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.376 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.431 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 68.8 m -71.04 152.46 43.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.891 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.411 ' CG ' ' N ' ' A' ' 101' ' ' SER . 0.2 OUTLIER -92.54 -55.14 3.5 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.419 0.628 . . . . 0.0 111.434 -178.334 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.411 ' N ' ' CG ' ' A' ' 100' ' ' ASN . 22.4 t -73.98 -14.75 61.08 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.757 -178.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 111.24 24.68 5.32 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.005 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.514 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 30.8 m-85 -69.46 -172.95 0.51 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.855 0.36 . . . . 0.0 110.817 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.1 105.78 15.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.156 -179.277 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.639 HD23 ' HB2' ' A' ' 122' ' ' PRO . 3.1 tp -44.85 113.52 0.57 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.07 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.453 ' HB ' ' CB ' ' A' ' 123' ' ' THR . 30.6 mm -87.13 157.07 3.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.471 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.438 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 58.69 -131.17 51.92 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.767 -178.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.27 126.28 52.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.771 0.32 . . . . 0.0 110.746 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.802 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.4 t -57.63 -28.45 63.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.045 0.45 . . . . 0.0 110.242 178.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.9 132.2 15.13 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.558 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.911 HG21 ' CE1' ' A' ' 97' ' ' TYR . 6.0 t -125.52 126.83 71.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 110.422 -0.214 . . . . 0.0 110.422 178.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.93 HD22 ' N ' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -81.14 135.52 35.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.889 0.376 . . . . 0.0 111.48 -178.567 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.93 ' N ' HD22 ' A' ' 112' ' ' LEU . 39.3 t -108.28 108.04 18.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.051 177.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.711 ' HB2' HD11 ' A' ' 112' ' ' LEU . 0.2 OUTLIER -164.01 129.67 2.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.868 0.366 . . . . 0.0 111.259 -179.806 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.38 31.04 20.45 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.076 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.16 19.88 62.17 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.018 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -145.53 178.2 8.3 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.104 0.478 . . . . 0.0 111.15 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.528 ' CZ3' ' HB2' ' A' ' 113' ' ' CYS . 92.7 m95 -121.7 145.29 48.17 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.795 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.578 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -125.52 167.02 15.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.991 0.424 . . . . 0.0 111.658 -179.095 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.44 ' N ' ' HD3' ' A' ' 121' ' ' PRO . 6.6 p-10 46.69 52.56 12.06 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.171 179.303 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.44 ' HD3' ' N ' ' A' ' 120' ' ' ASP . 93.2 Cg_endo -81.28 143.94 14.26 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.666 2.244 . . . . 0.0 111.634 177.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.639 ' HB2' HD23 ' A' ' 105' ' ' LEU . 73.5 Cg_endo -91.23 -172.29 0.46 Allowed 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.877 2.385 . . . . 0.0 113.856 -177.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.453 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -138.66 -174.7 3.9 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.101 178.321 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 124' ' ' CYS . . . . . 0.424 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 11.9 m -141.11 96.98 3.08 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.026 0.441 . . . . 0.0 111.097 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.429 ' HB2' HD11 ' A' ' 106' ' ' ILE . 20.6 mt-30 -122.54 167.51 13.28 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.863 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.497 HG12 ' CE2' ' A' ' 103' ' ' TYR . 13.0 mm . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.935 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.543 ' HD2' HG23 ' A' ' 25' ' ' VAL . 17.4 mtm180 . . . . . 0 N--CA 1.457 -0.125 0 CA-C-O 120.791 0.329 . . . . 0.0 110.758 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.528 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 69.6 m -77.31 175.86 4.09 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.545 ' HD2' ' CD1' ' A' ' 59' ' ' TRP . 37.9 Cg_endo -91.24 176.29 2.2 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.427 2.084 . . . . 0.0 111.932 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.0 t -53.41 105.6 0.55 Allowed Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.294 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.49 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 51.5 Cg_exo -52.94 142.2 53.66 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.037 1.825 . . . . 0.0 111.804 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.945 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -49.03 120.8 4.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.925 0.869 . . . . 0.0 111.512 -178.852 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.747 ' O ' HG22 ' A' ' 15' ' ' ILE . 6.1 p-10 -59.16 -32.09 69.56 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 113.509 -1.678 . . . . 0.0 112.694 -177.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.747 HG22 ' O ' ' A' ' 14' ' ' ASP . 8.6 tt 58.36 142.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 114.271 -1.331 . . . . 0.0 111.208 -175.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.98 160.41 14.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.0 178.492 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.494 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 0.3 OUTLIER 50.47 24.07 1.48 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.017 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -154.06 177.61 31.4 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.659 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.43 142.26 39.52 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.74 0.305 . . . . 0.0 110.506 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.945 HD11 ' O ' ' A' ' 13' ' ' ARG . 72.2 mt -89.51 155.67 19.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.167 0.508 . . . . 0.0 111.718 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.412 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 11.1 t0 -124.73 72.91 1.24 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.38 177.243 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.879 ' HA ' HG23 ' A' ' 31' ' ' ILE . 1.2 mt -76.1 105.71 5.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.992 -176.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.62 13.56 57.99 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.734 176.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 157.19 133.29 1.58 Allowed Glycine 0 C--N 1.335 0.5 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.021 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.543 HG23 ' HD2' ' A' ' 8' ' ' ARG . 15.0 m -112.41 9.01 8.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.097 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -72.82 156.25 39.09 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.836 0.351 . . . . 0.0 111.331 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.598 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 8.4 t80 -54.94 91.45 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.867 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 49' ' ' CYS . . . 130.57 -18.25 5.19 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.456 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.5 p -57.24 -173.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.73 0.3 . . . . 0.0 110.863 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 47' ' ' SER . 81.2 p -150.94 150.85 31.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.25 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.879 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -121.44 167.0 15.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.766 179.493 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.412 ' HB ' ' HB3' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -129.85 108.45 10.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.618 178.243 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.436 ' CE1' ' HA ' ' A' ' 63' ' ' ALA . 33.4 m-85 -84.59 143.12 29.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.154 -179.239 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -152.04 157.08 41.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.198 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 21.3 m -83.8 161.56 20.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.851 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.465 ' ND2' ' HA ' ' A' ' 17' ' ' ASN . 1.2 p30 -55.7 -89.43 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.238 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.8 t -152.08 136.34 16.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.815 0.34 . . . . 0.0 110.524 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.73 17.76 63.09 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.233 -178.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.494 ' CE2' ' HB3' ' A' ' 17' ' ' ASN . 2.1 m-85 -106.87 -173.34 2.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.729 0.299 . . . . 0.0 110.782 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.696 ' NE2' HD11 ' A' ' 42' ' ' ILE . 2.2 p-80 -147.05 112.46 5.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.983 0.42 . . . . 0.0 110.808 178.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.954 HD21 ' O ' ' A' ' 44' ' ' GLU . 2.1 tt -78.72 125.47 29.41 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.363 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.696 HD11 ' NE2' ' A' ' 40' ' ' HIS . 2.9 mm -98.47 167.55 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.049 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.532 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 67.03 -130.02 29.84 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.477 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.954 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.8 OUTLIER -83.47 -179.23 7.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.798 0.332 . . . . 0.0 110.925 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.438 ' HA ' ' HG2' ' A' ' 64' ' ' PRO . 3.0 t -154.98 25.44 0.43 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.924 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -150.14 168.72 23.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.245 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.444 ' O ' HG13 ' A' ' 31' ' ' ILE . 2.6 m -149.56 120.27 7.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.374 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -103.46 116.2 31.96 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.16 0.505 . . . . 0.0 111.193 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.411 ' O ' ' N ' ' A' ' 28' ' ' GLY . 53.6 t -59.16 100.87 0.08 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.098 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.28 -170.96 2.07 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.37 -178.197 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.598 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.848 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.772 0.32 . . . . 0.0 110.601 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.1 m -144.19 -178.45 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.98 0.419 . . . . 0.0 111.333 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.668 ' CE3' HD11 ' A' ' 31' ' ' ILE . 94.1 m95 -121.03 122.97 41.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.527 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -138.67 118.73 9.71 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.426 -178.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.14 -170.53 7.7 Favored 'Cis proline' 0 C--N 1.351 0.663 0 C-N-CA 124.094 -1.211 . . . . 0.0 112.003 -0.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -110.89 -154.66 0.54 Allowed 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.708 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.454 ' HB2' ' HB3' ' A' ' 13' ' ' ARG . . . -72.62 111.84 12.73 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.582 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.438 ' HG2' ' HA ' ' A' ' 45' ' ' SER . 15.2 Cg_exo -69.78 -150.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.628 2.219 . . . . 0.0 112.452 -178.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.501 HG22 ' H ' ' A' ' 66' ' ' CYS . 5.1 mm -100.39 165.73 2.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.6 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.501 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.3 m -161.62 137.12 7.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.589 179.093 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.473 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.2 OUTLIER -163.33 176.62 9.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.931 0.396 . . . . 0.0 110.965 179.784 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.49 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 12.2 p -94.4 117.37 30.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.917 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.419 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 2.3 p -41.14 93.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.609 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 68' ' ' SER . 0.1 OUTLIER -70.47 121.49 17.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.66 -178.758 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.402 ' N ' ' O ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -104.75 115.49 30.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.695 177.487 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.409 ' CG ' ' N ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -69.95 -157.99 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.792 -179.504 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.437 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 1.6 t -47.33 136.68 9.07 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.237 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.477 ' HG2' HG11 ' A' ' 95' ' ' VAL . 35.3 Cg_exo -58.85 162.03 14.11 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.39 2.06 . . . . 0.0 111.797 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.509 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 80.5 Cg_exo -39.96 156.89 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.764 2.31 . . . . 0.0 112.834 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.9 t -108.15 89.19 2.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.641 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.651 HG23 ' HE2' ' A' ' 97' ' ' TYR . 26.3 pt -69.81 174.59 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.413 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.8 p -97.67 138.79 34.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.912 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.465 ' HB3' ' CE1' ' A' ' 103' ' ' TYR . 0.1 OUTLIER 66.7 27.07 9.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.79 179.458 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.438 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . -172.71 -165.48 29.8 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.897 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 11.1 ptt180 -167.37 -175.26 2.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.873 0.368 . . . . 0.0 110.593 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.437 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 6.1 p80 -105.12 173.46 6.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.082 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.45 179.277 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.433 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 6.5 m-85 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.596 0.236 . . . . 0.0 110.722 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.433 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 60.9 m-85 -151.4 164.04 37.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.866 0.365 . . . . 0.0 111.041 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.443 HG22 ' OG ' ' A' ' 68' ' ' SER . 8.4 p -130.45 168.56 16.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.119 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 0.9 OUTLIER -54.72 94.76 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.289 0.566 . . . . 0.0 110.886 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 129.88 26.76 0.83 Allowed Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.258 -0.883 . . . . 0.0 113.216 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -110.08 162.27 14.72 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.915 0.358 . . . . 0.0 110.697 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 33.9 m -135.58 154.99 35.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.099 0.476 . . . . 0.0 111.301 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.546 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 20.8 t -150.85 147.49 15.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.823 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.98 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -105.5 133.05 50.89 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.74 179.436 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.977 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.9 m-85 -91.53 159.29 16.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.169 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.546 ' HA ' HD13 ' A' ' 105' ' ' LEU . 62.8 m -157.72 149.62 22.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.052 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.438 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 58.0 m -79.09 159.37 27.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.13 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -83.1 -68.52 0.7 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.632 -178.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.5 -26.17 61.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.383 -178.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.2 37.7 0.45 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.521 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.465 ' CE1' ' HB3' ' A' ' 79' ' ' ASN . 11.2 m-85 -69.78 -173.67 0.64 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.852 0.358 . . . . 0.0 110.35 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.3 m -107.95 98.89 8.4 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.079 178.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.546 HD13 ' HA ' ' A' ' 98' ' ' SER . 0.3 OUTLIER -47.94 126.92 11.36 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.623 0.725 . . . . 0.0 111.697 -177.881 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.455 ' HB ' ' CB ' ' A' ' 123' ' ' THR . 31.4 mm -90.6 152.02 3.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.079 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 61.11 -136.53 48.28 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.016 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -112.14 137.59 50.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.945 0.403 . . . . 0.0 111.348 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.98 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.6 p -68.06 -26.53 65.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.78 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -72.39 139.46 27.93 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.968 -0.634 . . . . 0.0 113.014 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.977 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.5 t -135.21 127.89 48.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.533 0.206 . . . . 0.0 110.56 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.06 126.2 34.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.968 0.414 . . . . 0.0 111.804 -178.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.504 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 13.4 t -90.41 101.2 13.94 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 176.485 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.1 OUTLIER -143.67 160.83 39.99 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.065 0.459 . . . . 0.0 111.411 -178.181 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.0 30.53 5.19 Favored Glycine 0 N--CA 1.453 -0.232 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.665 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.419 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 68.72 19.19 72.96 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.199 -179.249 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -144.47 179.51 7.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.777 0.322 . . . . 0.0 110.512 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.546 ' CZ3' HG23 ' A' ' 95' ' ' VAL . 92.7 m95 -115.84 152.24 33.73 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.978 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.41 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -133.67 156.34 48.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.234 -179.413 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.489 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER 61.83 46.5 0.96 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.881 179.109 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 96.0 Cg_endo -78.36 137.16 14.72 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.421 2.081 . . . . 0.0 111.577 178.211 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.54 ' O ' HG21 ' A' ' 77' ' ' ILE . 73.4 Cg_endo -91.94 -173.91 0.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.587 2.191 . . . . 0.0 113.545 -178.35 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.455 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.3 OUTLIER -129.17 -171.6 2.53 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.29 177.405 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 5.0 m -144.74 88.37 1.91 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.069 0.461 . . . . 0.0 110.325 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -118.11 -179.04 3.65 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.519 -178.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 32.3 mm . . . . . 0 C--N 1.321 -0.657 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.92 -179.612 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.1 mtm180 . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.899 0.381 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.479 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 28.9 m -91.09 159.85 38.86 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.077 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.0 168.65 23.38 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.661 2.241 . . . . 0.0 111.992 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.0 t -49.39 103.79 0.39 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.733 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.58 157.76 49.52 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.276 1.984 . . . . 0.0 112.051 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.752 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -51.23 -179.55 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.319 179.23 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.745 ' O ' HG22 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -140.62 -7.58 1.12 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -178.057 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 14' ' ' ASP . 15.1 tt 56.87 142.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 121.223 0.535 . . . . 0.0 111.603 -177.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -81.33 -52.61 7.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.602 -178.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -93.07 45.55 1.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.892 0.377 . . . . 0.0 110.922 -178.419 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 176.48 179.99 47.21 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.51 -0.853 . . . . 0.0 113.249 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -138.44 143.08 39.52 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.826 HD13 ' CZ ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -93.63 168.93 10.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.08 0.467 . . . . 0.0 111.125 -179.019 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -126.1 91.73 3.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.843 178.021 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.865 ' HA ' HG23 ' A' ' 31' ' ' ILE . 5.4 mm -68.46 107.08 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.829 -176.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -114.24 22.76 13.37 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.602 177.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 149.67 124.35 1.28 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.068 -0.587 . . . . 0.0 111.945 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.8 m -120.54 38.24 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.871 0.367 . . . . 0.0 111.261 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.4 OUTLIER -111.25 150.36 29.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.6 179.302 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.561 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 8.0 t80 -49.05 91.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.896 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 130.27 -0.36 5.59 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.764 -0.732 . . . . 0.0 113.021 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -92.17 -168.41 1.99 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 117.038 0.419 . . . . 0.0 110.54 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.6 p -160.63 146.88 15.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.064 0.459 . . . . 0.0 111.27 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.865 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.6 OUTLIER -105.02 170.42 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.34 179.625 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -124.36 112.61 17.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.902 0.382 . . . . 0.0 111.09 179.073 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.826 ' CZ ' HD13 ' A' ' 20' ' ' LEU . 12.3 m-85 -87.04 142.5 27.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.602 -179.22 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.7 m -149.78 159.22 44.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.525 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 16.5 m -77.79 172.9 12.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.814 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -75.4 -83.87 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.262 -179.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.2 t -150.11 137.56 19.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.628 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.461 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 59.34 25.57 60.55 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.909 -179.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.515 ' CE1' ' HB3' ' A' ' 68' ' ' SER . 2.4 m-85 -116.16 168.74 9.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.805 0.336 . . . . 0.0 110.875 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.662 ' CD2' HD11 ' A' ' 42' ' ' ILE . 7.6 p-80 -133.74 113.66 12.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.057 177.404 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.939 HD11 ' HG2' ' A' ' 64' ' ' PRO . 8.3 tt -76.11 135.48 39.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.773 -178.41 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.662 HD11 ' CD2' ' A' ' 40' ' ' HIS . 1.9 mm -113.89 153.44 15.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.099 0.476 . . . . 0.0 111.16 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.17 -137.48 18.52 Favored Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.135 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.782 ' O ' HD21 ' A' ' 41' ' ' LEU . 2.0 pt-20 -80.61 -178.04 6.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.044 0.449 . . . . 0.0 110.879 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.6 p -158.46 24.79 0.24 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.891 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.416 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 1.6 mtmt -150.73 124.87 9.35 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -177.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.443 ' HB3' HG13 ' A' ' 31' ' ' ILE . 1.7 t -92.51 146.95 23.28 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.593 177.051 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.525 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.1 m-85 -120.74 113.51 20.3 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 119.139 -1.024 . . . . 0.0 111.683 178.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.409 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 18.7 t -63.74 95.19 0.1 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.154 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -118.47 -171.28 2.05 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.381 -178.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.561 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.031 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 120.901 0.382 . . . . 0.0 110.55 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -148.15 -179.35 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.036 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.539 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 78.9 m95 -128.42 122.11 30.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.388 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.525 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -69.11 167.02 23.02 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.82 178.466 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.451 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 84.9 Cg_exo -18.7 93.01 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 125.096 3.864 . . . . 0.0 114.198 -179.248 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.411 ' CB ' ' OG ' ' A' ' 47' ' ' SER . 0.0 OUTLIER -97.32 -78.79 0.47 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.879 -177.672 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.471 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -75.05 108.4 5.41 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -176.056 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.939 ' HG2' HD11 ' A' ' 41' ' ' LEU . 3.5 Cg_endo -87.95 -156.73 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.307 2.671 . . . . 0.0 111.028 177.057 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.662 HD12 ' HB ' ' A' ' 42' ' ' ILE . 1.1 mt -89.2 174.99 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.844 0.354 . . . . 0.0 110.662 178.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.621 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.7 OUTLIER -171.16 145.91 2.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.891 179.45 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.55 ' HB3' ' CE1' ' A' ' 40' ' ' HIS . 31.2 tt0 -160.44 163.15 33.25 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.924 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.515 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 1.4 p -92.82 118.9 31.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.229 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.52 HG13 ' OD2' ' A' ' 91' ' ' ASP . 1.0 OUTLIER -55.14 93.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.861 179.194 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.401 ' CG ' ' O ' ' A' ' 89' ' ' TYR . 1.3 tttt -77.77 135.91 38.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.897 0.38 . . . . 0.0 111.26 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.431 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -106.64 121.78 45.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.143 178.458 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -69.41 -161.41 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.608 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.418 ' OG ' ' NE2' ' A' ' 82' ' ' HIS . 2.7 t -50.07 137.9 19.96 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.653 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.435 ' HA ' ' CD1' ' A' ' 118' ' ' TRP . 39.6 Cg_exo -57.61 159.13 17.64 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.242 1.961 . . . . 0.0 111.908 -179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.504 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 93.7 Cg_exo -42.54 156.88 0.09 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.653 2.235 . . . . 0.0 112.712 -178.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 75.8 p -106.9 89.13 2.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.789 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.603 HG23 ' HE2' ' A' ' 97' ' ' TYR . 33.8 pt -69.72 169.91 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.179 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -92.44 137.44 32.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.731 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.495 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 0.4 OUTLIER 65.05 29.18 12.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.71 -179.788 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -169.43 -167.4 29.94 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.959 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.2 ptt85 -170.18 -174.49 1.75 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.016 0.436 . . . . 0.0 110.462 -179.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 7.5 p80 -108.09 172.43 6.84 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.056 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' A' ' 96' ' ' THR . 63.1 m-20 . . . . . 0 C--N 1.331 -0.222 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.539 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.416 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 12.2 m-85 . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 121.066 0.46 . . . . 0.0 111.308 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.431 ' N ' ' O ' ' A' ' 71' ' ' CYS . 37.7 m-85 -147.03 169.59 18.9 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.761 179.254 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.1 p -134.21 175.11 9.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.998 0.428 . . . . 0.0 111.647 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.52 ' OD2' HG13 ' A' ' 69' ' ' VAL . 1.3 m-20 -60.25 99.13 0.07 Allowed 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.445 0.641 . . . . 0.0 111.021 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.45 23.36 1.93 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 114.917 -1.038 . . . . 0.0 113.005 178.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.416 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -108.35 161.56 14.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.81 0.338 . . . . 0.0 110.583 179.066 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.489 HG22 ' N ' ' A' ' 95' ' ' VAL . 32.7 m -138.57 157.62 30.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.079 0.466 . . . . 0.0 111.313 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.493 HG23 ' CH2' ' A' ' 118' ' ' TRP . 18.8 t -151.13 148.61 14.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.555 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.776 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -105.3 131.91 52.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.397 179.203 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.958 ' CE1' HG21 ' A' ' 111' ' ' VAL . 3.6 m-85 -89.25 159.31 17.49 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.052 -178.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.7 m -150.22 133.35 16.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.954 0.407 . . . . 0.0 111.567 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.444 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 74.7 m -69.81 162.67 27.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.745 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -96.81 -84.51 0.36 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.928 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -45.31 -27.38 0.65 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.529 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 124.9 36.0 0.61 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.465 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.495 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 18.9 m-85 -75.52 -173.74 2.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.939 0.399 . . . . 0.0 110.915 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.44 107.45 16.23 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.962 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.514 HD22 ' HA ' ' A' ' 109' ' ' SER . 1.1 tp -46.44 118.74 2.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.163 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.526 HG22 ' N ' ' A' ' 107' ' ' GLY . 45.2 mm -104.59 160.8 4.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.883 -179.184 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.526 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 52.07 38.44 47.66 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.416 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.411 ' O ' ' O ' ' A' ' 107' ' ' GLY . 4.1 p-10 51.58 124.18 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 123.9 0.88 . . . . 0.0 112.693 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.776 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.3 p -56.03 -27.45 53.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.402 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.59 136.06 49.29 Favored Glycine 0 CA--C 1.518 0.239 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.843 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.958 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.2 t -136.61 130.2 46.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.27 125.37 37.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.92 0.391 . . . . 0.0 111.826 -178.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.498 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 16.7 t -87.32 107.88 18.71 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 175.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 7.0 t -154.95 166.98 31.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.988 -178.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 45.54 33.16 4.38 Favored Glycine 0 CA--C 1.516 0.146 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.692 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.453 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 64.83 19.41 65.36 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.565 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -149.32 -177.77 6.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.933 0.397 . . . . 0.0 110.989 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.504 ' CD1' ' HD3' ' A' ' 75' ' ' PRO . 94.8 m95 -113.27 126.26 55.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.87 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.19 145.84 33.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.261 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.495 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.9 OUTLIER 69.3 44.84 0.26 Allowed Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.123 178.84 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 57.0 Cg_endo -70.14 140.27 40.85 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.166 1.911 . . . . 0.0 111.243 178.091 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.504 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 94.7 Cg_endo -89.53 -170.58 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.624 2.216 . . . . 0.0 113.798 -177.244 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -140.58 -172.07 3.36 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.001 178.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' CYS . . . . . 0.403 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 11.8 m -142.37 95.72 2.84 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.007 0.432 . . . . 0.0 110.907 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -128.52 156.85 42.63 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.973 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.494 HG12 ' CE2' ' A' ' 103' ' ' TYR . 25.6 mm . . . . . 0 C--N 1.323 -0.544 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.011 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.446 ' CB ' ' HA ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.163 0 CA-C-O 120.736 0.303 . . . . 0.0 110.435 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.449 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 98.3 m -78.6 156.97 77.74 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.203 -179.133 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.444 ' HD3' ' HB2' ' A' ' 57' ' ' MET . 60.4 Cg_endo -71.77 177.44 6.94 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.81 2.34 . . . . 0.0 112.533 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 p -48.91 104.67 0.43 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.896 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.459 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 71.6 Cg_exo -42.71 143.78 1.56 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.396 2.064 . . . . 0.0 112.323 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.569 ' O ' HD11 ' A' ' 20' ' ' LEU . 10.1 mtt180 -58.9 152.37 19.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.056 178.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.539 ' HA ' HD11 ' A' ' 20' ' ' LEU . 1.7 p30 -105.96 178.76 4.47 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 121.338 0.59 . . . . 0.0 112.542 -175.484 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.0 tt -138.86 147.79 24.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.033 178.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -82.58 -56.2 4.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.779 -177.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.411 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 0.7 OUTLIER -94.48 27.11 3.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.198 -178.303 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.412 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -149.34 -178.65 24.53 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.383 -0.913 . . . . 0.0 113.297 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -139.13 132.16 29.54 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.569 HD11 ' O ' ' A' ' 13' ' ' ARG . 3.6 mt -76.89 160.78 28.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.203 0.525 . . . . 0.0 111.897 -178.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.437 ' HB3' ' CB ' ' A' ' 32' ' ' THR . 17.3 t70 -130.44 74.29 1.59 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.515 177.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.857 ' HA ' HG23 ' A' ' 31' ' ' ILE . 73.2 mt -72.96 101.45 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.017 -177.09 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.54 20.72 48.45 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.543 176.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.02 145.42 4.16 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 -179.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.42 ' O ' ' HB2' ' A' ' 8' ' ' ARG . 16.6 m -124.83 -6.79 6.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.446 ' HA ' ' CB ' ' A' ' 8' ' ' ARG . 9.1 m-20 -69.8 156.03 39.65 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.931 0.396 . . . . 0.0 111.698 -178.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.74 ' HZ ' HD13 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -48.17 101.48 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.514 178.923 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 119.05 -15.5 11.01 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.441 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.4 m -63.47 166.87 6.07 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.794 0.297 . . . . 0.0 110.293 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 47' ' ' SER . 12.4 p -137.05 147.1 45.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.082 0.467 . . . . 0.0 111.682 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.857 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.4 OUTLIER -113.07 173.77 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.793 -179.807 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.505 HG23 ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -141.99 106.77 4.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.016 178.645 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.557 ' CE1' HD22 ' A' ' 20' ' ' LEU . 20.9 m-85 -76.59 142.37 40.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.043 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.412 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 1.5 m -141.05 165.38 27.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.543 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.445 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 2.3 m -88.56 165.4 14.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.766 0.317 . . . . 0.0 110.768 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -64.78 -84.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.06 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.6 m -153.93 133.45 12.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.728 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.4 ' HA3' ' CB ' ' A' ' 91' ' ' ASP . . . 63.28 24.59 67.52 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.937 -178.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.509 ' CE1' ' HB3' ' A' ' 68' ' ' SER . 2.6 m-85 -116.72 171.48 7.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.859 0.361 . . . . 0.0 110.906 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.61 ' NE2' HD11 ' A' ' 42' ' ' ILE . 6.5 p-80 -134.57 116.17 14.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.624 178.173 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.954 HD21 ' O ' ' A' ' 44' ' ' GLU . 4.6 tt -74.24 127.64 33.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.606 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.61 HD11 ' NE2' ' A' ' 40' ' ' HIS . 3.1 mm -100.94 151.24 5.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.836 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.45 -140.03 23.9 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.691 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.954 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -70.68 175.38 4.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.948 0.404 . . . . 0.0 110.997 179.857 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.431 ' HA ' ' HG2' ' A' ' 64' ' ' PRO . 0.4 OUTLIER -157.77 26.84 0.27 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.296 179.289 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.505 ' HG2' HG23 ' A' ' 32' ' ' THR . 6.6 mtpt -149.97 151.84 33.99 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.998 -179.065 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.417 ' OG ' ' HB ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -132.25 143.12 49.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.125 179.51 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.511 ' CE2' ' HD3' ' A' ' 61' ' ' PRO . 2.7 m-85 -117.0 125.8 51.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.176 0.512 . . . . 0.0 111.892 -178.066 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.515 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 24.4 t -73.91 117.13 15.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.695 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.495 ' HA ' ' CE2' ' A' ' 27' ' ' PHE . 12.9 tt0 -160.38 167.58 27.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.424 0.631 . . . . 0.0 111.016 178.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.74 HD13 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.807 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.433 -178.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.592 ' O ' HG13 ' A' ' 58' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.354 0 CA-C-O 121.029 0.442 . . . . 0.0 110.48 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.592 HG13 ' O ' ' A' ' 57' ' ' MET . 2.4 m -160.44 -176.83 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.28 -178.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.82 ' CE3' HD11 ' A' ' 31' ' ' ILE . 92.2 m95 -133.56 126.01 30.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.137 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -149.61 123.68 4.62 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.589 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.511 ' HD3' ' CE2' ' A' ' 48' ' ' TYR . 23.2 Cg_exo -68.65 -174.69 8.68 Favored 'Cis proline' 0 C--N 1.35 0.633 0 C-N-CA 124.287 -1.13 . . . . 0.0 113.055 2.077 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.1 -143.05 0.39 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.861 -178.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.532 ' CB ' ' CE1' ' A' ' 33' ' ' TYR . . . -86.4 116.51 66.14 Favored Pre-proline 0 CA--C 1.53 0.187 0 CA-C-O 120.407 0.146 . . . . 0.0 111.008 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.545 ' HG2' HD11 ' A' ' 41' ' ' LEU . 11.5 Cg_exo -72.95 -151.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.645 2.23 . . . . 0.0 112.582 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.488 HG22 ' H ' ' A' ' 66' ' ' CYS . 4.5 mm -101.45 166.34 2.47 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-O 121.02 0.438 . . . . 0.0 111.486 -178.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.488 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.3 m -163.61 120.3 1.75 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.379 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.32 171.04 15.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.992 0.425 . . . . 0.0 111.318 -178.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.509 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 8.9 p -93.22 103.18 15.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.848 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.791 HG22 ' HA3' ' A' ' 116' ' ' GLY . 2.7 p -59.46 89.3 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.478 179.21 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 89' ' ' TYR . 5.4 tttt -63.8 154.22 34.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.558 -0.747 . . . . 0.0 112.184 -177.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.416 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -118.88 127.01 53.1 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.77 177.559 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.413 ' CG ' ' N ' ' A' ' 73' ' ' SER . 0.1 OUTLIER -73.93 -160.48 0.09 Allowed 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.488 179.89 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.413 ' N ' ' CG ' ' A' ' 72' ' ' GLN . 2.7 t -50.21 137.49 21.33 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.505 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.483 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 37.9 Cg_exo -56.33 162.57 7.64 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.167 1.911 . . . . 0.0 111.574 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.507 ' HD3' ' CG ' ' A' ' 118' ' ' TRP . 82.2 Cg_exo -39.92 156.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.726 2.284 . . . . 0.0 112.571 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.7 m -107.89 89.05 2.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.894 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.571 HG21 ' O ' ' A' ' 122' ' ' PRO . 13.5 pt -69.7 173.92 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.002 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.0 m -95.77 138.76 32.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.878 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.506 ' HB3' ' CD2' ' A' ' 103' ' ' TYR . 3.9 m-80 60.16 28.97 18.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.989 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.498 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -160.26 -170.75 25.25 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.149 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.26 -175.15 3.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.046 0.45 . . . . 0.0 110.858 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -112.92 169.03 9.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.889 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.793 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.419 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 10.7 m-85 . . . . . 0 N--CA 1.456 -0.165 0 CA-C-O 120.911 0.386 . . . . 0.0 110.938 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.423 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 40.6 m-85 -147.0 165.11 30.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.444 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 17.0 p -129.22 172.09 11.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.005 0.431 . . . . 0.0 111.55 -179.066 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 0.9 OUTLIER -58.74 97.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.889 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.69 14.87 2.75 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.195 -0.911 . . . . 0.0 113.093 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.98 158.31 15.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.909 0.355 . . . . 0.0 110.393 179.086 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.419 HG22 ' N ' ' A' ' 95' ' ' VAL . 27.0 m -133.77 156.11 40.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.072 0.463 . . . . 0.0 111.231 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.474 HG23 ' CH2' ' A' ' 118' ' ' TRP . 38.7 t -149.72 150.86 13.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.615 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.983 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -108.22 133.6 52.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.963 0.411 . . . . 0.0 110.53 179.112 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.944 ' CE1' HG21 ' A' ' 111' ' ' VAL . 5.9 m-85 -93.28 155.84 17.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.044 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 20.0 p -152.83 144.32 23.37 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.147 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.459 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 68.5 m -72.95 158.87 34.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.251 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 -86.91 -71.09 0.57 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.692 -178.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 40.5 t -68.39 -21.72 64.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.612 -178.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 123.85 32.42 0.87 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.66 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.506 ' CD2' ' HB3' ' A' ' 79' ' ' ASN . 30.6 m-85 -69.6 -171.85 0.42 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.768 0.318 . . . . 0.0 110.277 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.7 p -107.35 106.06 16.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.975 0.417 . . . . 0.0 111.168 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.598 HD23 ' HB2' ' A' ' 122' ' ' PRO . 3.0 tp -46.92 108.85 0.16 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.702 178.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.488 HG22 ' N ' ' A' ' 107' ' ' GLY . 31.8 mm -84.1 158.35 3.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.651 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.488 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 59.81 -123.16 32.36 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.258 -0.973 . . . . 0.0 111.795 -178.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -125.82 132.91 52.15 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.796 0.331 . . . . 0.0 110.766 178.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.983 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.2 p -66.37 -31.54 72.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.401 179.469 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.64 136.92 22.69 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.526 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.944 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.9 t -126.54 153.37 35.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 179.215 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.39 118.36 35.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.903 0.382 . . . . 0.0 111.597 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.508 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 15.1 t -85.55 97.75 10.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.615 176.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 1.0 OUTLIER -132.54 151.1 52.03 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.556 -177.982 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 48.01 29.77 6.77 Favored Glycine 0 C--N 1.329 0.187 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.745 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.791 ' HA3' HG22 ' A' ' 69' ' ' VAL . . . 79.95 -5.06 63.4 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.936 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -121.17 175.11 6.27 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.93 0.395 . . . . 0.0 110.866 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.508 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 87.2 m95 -112.5 152.27 28.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.895 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.27 147.12 49.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.021 0.438 . . . . 0.0 111.466 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.492 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER 70.07 46.11 0.27 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.161 178.546 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.492 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 74.1 Cg_endo -75.37 139.49 23.42 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.382 2.055 . . . . 0.0 111.623 178.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.598 ' HB2' HD23 ' A' ' 105' ' ' LEU . 57.3 Cg_endo -89.22 -174.52 0.96 Allowed 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.574 2.182 . . . . 0.0 113.559 -178.295 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.469 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -132.27 -171.75 2.72 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.845 -1.071 . . . . 0.0 109.834 177.829 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 10.4 m -146.3 93.93 2.38 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.0 0.428 . . . . 0.0 111.214 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -119.54 169.54 9.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.878 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.479 HG12 ' CE1' ' A' ' 103' ' ' TYR . 28.3 mm . . . . . 0 C--N 1.323 -0.547 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.944 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.419 ' HD3' HG23 ' A' ' 25' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.785 0.326 . . . . 0.0 110.507 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.477 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 53.6 m -77.85 159.61 75.94 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.664 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.15 169.86 17.17 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.504 2.136 . . . . 0.0 112.305 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 p -50.55 106.38 0.63 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.832 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.47 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 52.2 Cg_exo -43.23 152.92 0.22 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.262 1.974 . . . . 0.0 112.249 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.905 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -70.05 154.75 41.54 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.056 0.455 . . . . 0.0 110.424 178.685 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -97.59 -176.47 3.49 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.889 -176.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.591 HG22 ' CD2' ' A' ' 20' ' ' LEU . 18.6 tt -151.45 144.75 16.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.961 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -86.57 159.25 19.31 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.108 -0.497 . . . . 0.0 109.974 178.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.499 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 0.3 OUTLIER 43.15 29.63 0.22 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.89 0.376 . . . . 0.0 111.051 -179.445 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -155.02 173.42 33.34 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.629 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -137.53 135.18 36.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.763 0.316 . . . . 0.0 110.589 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.905 HD11 ' O ' ' A' ' 13' ' ' ARG . 14.0 mt -79.27 159.91 27.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.445 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.42 ' HB3' ' CB ' ' A' ' 32' ' ' THR . 34.9 t0 -131.31 75.48 1.66 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.366 178.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.876 ' HA ' HG23 ' A' ' 31' ' ' ILE . 58.3 mt -70.98 118.38 15.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.134 0.492 . . . . 0.0 111.994 -178.247 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -128.47 19.83 5.6 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.696 177.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 160.12 117.84 0.48 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.175 -0.536 . . . . 0.0 111.94 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.419 HG23 ' HD3' ' A' ' 8' ' ' ARG . 17.4 m -114.47 24.85 4.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.692 0.282 . . . . 0.0 111.554 -178.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -100.97 146.47 27.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.703 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.539 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 5.7 t80 -48.23 97.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.062 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.18 5.58 5.59 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.074 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.58 -158.69 0.69 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 117.037 0.419 . . . . 0.0 110.79 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.2 p -168.62 146.63 4.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.048 0.451 . . . . 0.0 111.413 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.876 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.7 OUTLIER -105.89 167.58 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.225 179.51 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.42 ' CB ' ' HB3' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -127.85 121.31 29.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.802 0.334 . . . . 0.0 110.738 179.001 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.693 ' CE1' HD21 ' A' ' 20' ' ' LEU . 14.1 m-85 -95.51 149.09 21.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.519 -179.056 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.19 155.82 39.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.771 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.432 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 2.9 m -81.99 169.53 16.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.819 0.342 . . . . 0.0 110.867 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -70.56 -84.97 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.157 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.6 m -153.14 131.91 12.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.933 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.71 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 68.19 21.22 73.74 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.15 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.499 ' CE2' ' HB3' ' A' ' 17' ' ' ASN . 2.5 m-85 -113.46 175.97 5.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.793 0.33 . . . . 0.0 110.868 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.929 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.5 OUTLIER -140.15 113.59 8.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.516 178.662 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.936 HD21 ' O ' ' A' ' 44' ' ' GLU . 6.7 tt -79.5 121.33 25.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.829 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.929 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.2 mm -99.23 168.43 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.129 -179.465 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.544 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 69.13 -134.1 26.84 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.374 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.936 ' O ' HD21 ' A' ' 41' ' ' LEU . 2.2 pm0 -79.75 -173.05 3.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.766 0.317 . . . . 0.0 110.603 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.2 t -166.66 28.84 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.605 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.409 ' HG3' ' HA ' ' A' ' 32' ' ' THR . 1.1 mtpt -159.76 127.65 4.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.327 -178.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.436 ' OG ' ' CB ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -93.0 143.67 26.01 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.906 178.323 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.534 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.6 m-85 -118.69 114.5 22.82 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.507 178.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.463 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 21.8 t -69.86 99.4 1.38 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.565 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -120.38 -172.17 2.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.098 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.539 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.953 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.412 ' O ' HG13 ' A' ' 58' ' ' VAL . 4.6 mmt . . . . . 0 N--CA 1.455 -0.201 0 CA-C-O 120.96 0.41 . . . . 0.0 110.7 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 57' ' ' MET . 1.4 m -155.52 175.34 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.823 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.549 ' CE3' HD11 ' A' ' 31' ' ' ILE . 79.2 m95 -128.51 121.86 29.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.598 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.534 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -69.52 167.34 23.17 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.342 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.489 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 68.4 Cg_exo -14.58 92.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.872 1 C-N-CA 125.339 4.026 . . . . 0.0 114.622 -178.656 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.479 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -90.81 -75.78 0.46 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.338 -177.4 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.419 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . . . -91.8 108.17 27.87 Favored Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -175.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.897 ' HG2' HD11 ' A' ' 41' ' ' LEU . 4.7 Cg_exo -81.47 -154.15 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.083 2.522 . . . . 0.0 111.123 177.303 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.504 HG22 ' H ' ' A' ' 66' ' ' CYS . 3.8 mm -88.81 166.03 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.782 0.325 . . . . 0.0 110.438 177.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.504 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.8 OUTLIER -169.32 129.82 1.08 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.605 179.783 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -155.74 173.5 16.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.135 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.493 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 5.2 p -85.4 117.25 24.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.627 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.71 HG12 ' O ' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -42.44 94.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.344 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.489 ' CD ' ' HB3' ' A' ' 88' ' ' PHE . 4.3 ttpt -80.15 131.72 35.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.285 -178.091 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.432 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -107.08 130.0 54.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.901 -179.285 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.3 -158.48 0.06 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.443 178.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.567 ' HG ' ' CE1' ' A' ' 82' ' ' HIS . 2.0 t -49.98 135.89 21.1 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.842 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.499 ' HG2' HG11 ' A' ' 95' ' ' VAL . 31.8 Cg_exo -56.69 162.92 7.79 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.393 2.062 . . . . 0.0 112.053 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.516 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 87.8 Cg_exo -42.44 156.68 0.09 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.715 2.277 . . . . 0.0 112.776 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 65.1 p -106.01 90.09 3.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.406 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.688 HG23 ' HE1' ' A' ' 97' ' ' TYR . 25.0 pt -69.32 172.54 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.37 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 124' ' ' CYS . 3.0 p -94.98 143.9 26.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.509 179.055 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.501 ' HB3' ' CE1' ' A' ' 103' ' ' TYR . 2.9 m120 58.58 28.59 17.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.86 0.362 . . . . 0.0 111.084 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -171.82 -167.54 32.11 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.498 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 10.2 ptt85 -166.54 -176.6 3.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.966 0.413 . . . . 0.0 111.168 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.567 ' CE1' ' HG ' ' A' ' 73' ' ' SER . 25.3 p-80 -103.08 175.16 5.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.038 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.31 179.047 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.489 ' HB3' ' CD ' ' A' ' 70' ' ' LYS . 19.2 m-85 . . . . . 0 N--CA 1.456 -0.175 0 CA-C-O 120.664 0.269 . . . . 0.0 111.077 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.462 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 84.5 m-85 -157.41 169.95 23.56 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.734 -178.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 11.4 p -134.0 178.59 6.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.909 0.385 . . . . 0.0 111.407 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.409 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 28.5 p-10 -62.74 94.77 0.07 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.298 0.571 . . . . 0.0 111.026 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.56 29.53 0.9 Allowed Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.983 179.002 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.11 163.88 13.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.691 0.282 . . . . 0.0 110.57 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 33.9 m -138.76 150.73 23.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.103 0.478 . . . . 0.0 111.307 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.51 HG23 ' CH2' ' A' ' 118' ' ' TRP . 20.1 t -145.81 147.06 18.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.635 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.963 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -105.76 130.59 53.73 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.893 179.956 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.94 ' CE2' HG21 ' A' ' 111' ' ' VAL . 5.0 m-85 -89.77 160.55 16.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.069 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 82.4 p -156.47 139.26 15.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.078 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.426 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 62.8 m -70.94 160.11 33.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.076 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 -80.85 -81.96 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.299 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.14 -30.99 70.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.214 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 132.57 39.81 0.22 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.645 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.523 ' HE2' HD11 ' A' ' 126' ' ' ILE . 49.7 m-85 -69.51 -174.27 0.67 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.807 0.337 . . . . 0.0 110.545 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 67.3 m -104.97 101.2 10.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.699 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.494 HD21 ' HA ' ' A' ' 109' ' ' SER . 0.2 OUTLIER -50.69 122.18 6.89 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.475 0.655 . . . . 0.0 111.428 -178.713 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.43 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 30.9 mm -91.3 155.43 3.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.943 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.76 -127.53 36.51 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.922 -178.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -126.19 138.59 53.66 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.799 0.333 . . . . 0.0 111.065 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.963 ' OG ' HG22 ' A' ' 96' ' ' THR . 5.7 p -64.79 -32.25 73.85 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.656 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -71.49 138.34 27.37 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.929 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.94 HG21 ' CE2' ' A' ' 97' ' ' TYR . 2.7 t -133.31 119.66 36.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.543 0.211 . . . . 0.0 110.591 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.5 125.79 30.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.889 0.376 . . . . 0.0 111.554 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.504 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 34.7 t -90.22 102.81 15.53 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 176.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 9.0 t -144.22 161.0 40.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.111 0.482 . . . . 0.0 111.308 -178.352 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.433 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 45.23 33.37 4.0 Favored Glycine 0 CA--C 1.518 0.252 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.912 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.463 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 66.39 16.99 65.83 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.538 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -139.98 178.05 7.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.781 0.324 . . . . 0.0 110.608 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.516 ' CD1' ' HD3' ' A' ' 75' ' ' PRO . 94.5 m95 -116.01 138.18 51.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.926 -179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.72 146.68 46.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.214 -179.301 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.475 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 3.2 t0 71.02 46.05 0.25 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.074 178.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 97.2 Cg_endo -78.63 134.69 12.43 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.322 2.015 . . . . 0.0 111.379 177.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.459 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 53.7 Cg_endo -87.05 -177.65 2.26 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.374 2.05 . . . . 0.0 113.412 -178.361 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 105' ' ' LEU . 0.2 OUTLIER -134.2 177.85 7.42 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.542 178.312 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 124' ' ' CYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 78' ' ' SER . 12.5 m -132.93 106.68 7.83 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.312 0.577 . . . . 0.0 110.95 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.497 ' C ' HD12 ' A' ' 126' ' ' ILE . 13.7 mt-30 -114.79 -175.87 2.78 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.437 -178.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.791 ' N ' HD12 ' A' ' 126' ' ' ILE . 1.6 mp . . . . . 0 C--N 1.32 -0.68 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.618 -177.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.402 ' HA ' ' HA ' ' A' ' 26' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.78 0.324 . . . . 0.0 110.736 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.449 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 60.6 m -104.78 158.74 31.36 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.9 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.444 ' HD3' ' HB2' ' A' ' 57' ' ' MET . 57.8 Cg_endo -68.91 170.98 14.32 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.362 2.041 . . . . 0.0 110.883 178.385 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.1 p -53.2 123.53 35.04 Favored Pre-proline 0 N--CA 1.448 -0.525 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.633 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -58.61 158.24 24.48 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.737 2.291 . . . . 0.0 112.338 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.809 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -70.81 142.96 51.29 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.474 178.779 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.417 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 0.7 OUTLIER -83.62 -171.06 3.38 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.417 -177.624 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.671 HG22 ' CD2' ' A' ' 20' ' ' LEU . 20.2 tt -155.97 143.89 11.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.394 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -90.93 158.77 16.55 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.764 177.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.498 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 0.4 OUTLIER 48.27 26.02 0.99 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.825 0.345 . . . . 0.0 110.656 -179.463 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.413 ' HA2' ' N ' ' A' ' 36' ' ' ASN . . . -157.56 -178.6 31.76 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.589 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -146.06 134.43 21.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.672 0.273 . . . . 0.0 110.887 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.809 HD11 ' O ' ' A' ' 13' ' ' ARG . 20.1 mt -78.61 155.18 29.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.986 0.422 . . . . 0.0 111.353 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.44 ' CB ' ' HB ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -124.01 72.65 1.17 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.444 177.203 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.889 ' HA ' HG23 ' A' ' 31' ' ' ILE . 1.1 mt -69.93 101.17 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.008 -176.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.9 17.25 57.55 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.718 176.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 154.96 151.5 5.86 Favored Glycine 0 C--N 1.333 0.382 0 N-CA-C 111.659 -0.576 . . . . 0.0 111.659 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.402 ' O ' ' HB2' ' A' ' 8' ' ' ARG . 23.3 m -133.76 13.61 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.011 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 1.8 p-10 -85.5 157.18 20.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.849 0.356 . . . . 0.0 111.094 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.485 ' CZ ' ' HG ' ' A' ' 51' ' ' LEU . 5.9 t80 -51.38 103.34 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.785 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 115.28 -1.51 22.35 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.888 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 94.4 p -78.94 -176.72 5.17 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 116.984 0.392 . . . . 0.0 110.435 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.3 p -151.91 156.36 39.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.936 0.398 . . . . 0.0 111.376 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.889 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.8 OUTLIER -122.37 166.55 16.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.827 -179.713 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.44 ' HB ' ' CB ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -128.89 114.48 16.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.782 179.13 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.474 ' CE2' HD21 ' A' ' 20' ' ' LEU . 31.3 m-85 -88.58 145.01 25.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.979 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -148.41 166.17 28.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.113 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.414 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 1.3 m -89.64 158.79 17.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.716 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.424 ' ND2' ' HA ' ' A' ' 17' ' ' ASN . 15.5 m-20 -58.02 -88.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.31 -178.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.9 t -151.86 133.39 14.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.882 0.372 . . . . 0.0 110.822 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.41 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 69.01 18.49 72.81 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.233 -179.075 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.498 ' CE1' ' HB3' ' A' ' 17' ' ' ASN . 2.7 m-30 -112.6 -177.93 3.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.911 0.386 . . . . 0.0 110.786 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.733 ' CE1' HD11 ' A' ' 42' ' ' ILE . 1.2 p-80 -142.08 110.85 6.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.008 177.041 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.941 HD21 ' O ' ' A' ' 44' ' ' GLU . 2.9 tt -72.57 125.19 26.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.336 -178.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.733 HD11 ' CE1' ' A' ' 40' ' ' HIS . 1.7 mm -106.2 165.7 3.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.111 0.482 . . . . 0.0 111.274 -178.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.487 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 70.31 -123.16 11.75 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.305 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.941 ' O ' HD21 ' A' ' 41' ' ' LEU . 1.3 mt-10 -80.77 174.58 11.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.194 0.521 . . . . 0.0 112.019 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.2 p -156.37 19.03 0.35 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.474 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.412 ' HG2' ' O ' ' A' ' 31' ' ' ILE . 8.8 mtpt -159.97 152.05 20.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.059 0.457 . . . . 0.0 112.075 -177.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -121.25 152.73 38.54 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.031 177.986 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.502 ' CB ' ' HB2' ' A' ' 60' ' ' ASN . 1.4 m-85 -131.36 115.13 15.84 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 119.135 -1.026 . . . . 0.0 112.173 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 28.0 t -66.12 109.02 2.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.763 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -133.27 -173.3 3.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.173 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.485 ' HG ' ' CZ ' ' A' ' 27' ' ' PHE . 7.4 mt . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.242 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.444 ' HB2' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.752 0.311 . . . . 0.0 110.801 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.1 -176.95 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.861 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.644 ' CE3' HD11 ' A' ' 31' ' ' ILE . 65.8 m95 -132.01 131.95 42.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.744 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.502 ' HB2' ' CB ' ' A' ' 48' ' ' TYR . 1.0 OUTLIER -69.92 162.62 67.17 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.08 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.474 ' O ' ' HA ' ' A' ' 47' ' ' SER . 21.4 Cg_exo -7.8 109.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.755 1 C-N-CA 125.888 4.392 . . . . 0.0 115.267 -178.189 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.424 ' HA ' ' OG ' ' A' ' 47' ' ' SER . 3.9 mt-10 -98.09 -113.73 0.15 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 114.901 -1.045 . . . . 0.0 112.513 -176.279 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.449 ' HA ' ' CD2' ' A' ' 33' ' ' TYR . . . -69.25 107.71 2.41 Favored Pre-proline 0 C--N 1.34 0.168 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -176.254 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.577 ' HG2' HD11 ' A' ' 41' ' ' LEU . 2.2 Cg_endo -81.53 -153.98 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.924 2.416 . . . . 0.0 110.298 176.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.661 HD12 ' HB ' ' A' ' 42' ' ' ILE . 0.3 OUTLIER -86.04 170.73 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.327 0.584 . . . . 0.0 111.573 -179.976 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.568 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.5 OUTLIER -172.24 141.47 1.25 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.042 179.805 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -169.7 167.8 9.33 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.801 0.334 . . . . 0.0 111.202 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.496 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 2.8 p -77.54 121.85 24.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.247 178.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.702 HG13 ' OD2' ' A' ' 91' ' ' ASP . 1.4 p -40.52 96.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.139 0.495 . . . . 0.0 111.582 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.521 ' HG2' ' CD2' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -92.37 127.53 37.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.172 -178.013 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.43 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -100.29 132.02 45.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.998 -179.001 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -75.81 -159.55 0.11 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.599 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.433 ' HG ' ' CE1' ' A' ' 82' ' ' HIS . 1.9 t -48.44 136.83 12.29 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.04 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.487 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 25.7 Cg_exo -60.59 159.02 29.6 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.351 2.034 . . . . 0.0 112.225 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.427 ' HG2' ' HD3' ' A' ' 121' ' ' PRO . 81.1 Cg_exo -44.78 159.69 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.982 2.455 . . . . 0.0 113.275 -178.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.6 m -108.8 93.11 4.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.516 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.493 HG23 ' CE1' ' A' ' 97' ' ' TYR . 22.4 pt -68.5 175.2 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.249 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.2 p -94.32 137.36 33.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.877 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.503 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 0.1 OUTLIER 68.47 26.87 6.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.879 179.521 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.454 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . -171.84 -164.78 27.99 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.263 -0.97 . . . . 0.0 113.216 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.422 ' N ' ' O ' ' A' ' 98' ' ' SER . 4.9 ptt85 -162.06 -175.1 4.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.044 0.45 . . . . 0.0 110.705 -179.12 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.433 ' CE1' ' HG ' ' A' ' 73' ' ' SER . 19.6 p-80 -111.14 169.53 8.72 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.71 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.709 179.82 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.521 ' CD2' ' HG2' ' A' ' 70' ' ' LYS . 24.8 m-85 . . . . . 0 N--CA 1.455 -0.217 0 CA-C-O 120.719 0.295 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.468 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 89.2 m-85 -157.17 165.57 35.6 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.419 -178.244 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.0 p -136.56 -176.4 4.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.072 0.463 . . . . 0.0 111.717 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.702 ' OD2' HG13 ' A' ' 69' ' ' VAL . 2.1 m-20 -63.03 96.64 0.1 Allowed 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.255 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.94 26.54 1.36 Allowed Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.288 -0.869 . . . . 0.0 113.035 178.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.408 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -110.17 162.92 14.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.817 0.341 . . . . 0.0 110.801 179.374 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 36.0 m -144.29 149.44 17.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.135 0.493 . . . . 0.0 111.125 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.514 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 18.1 t -141.1 146.97 22.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.559 179.492 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.99 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -102.08 136.78 41.32 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.816 -179.764 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.883 ' CE2' HG21 ' A' ' 111' ' ' VAL . 5.8 m-85 -98.81 156.17 17.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.147 -179.233 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.422 ' O ' ' N ' ' A' ' 81' ' ' ARG . 1.3 p -148.07 141.42 25.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.57 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.454 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 12.1 m -69.38 162.43 27.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.281 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -97.02 -69.07 0.77 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.092 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.75 -28.81 69.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.01 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.36 36.79 0.48 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.548 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.519 ' CE2' HG12 ' A' ' 126' ' ' ILE . 18.2 m-85 -74.27 -171.77 1.26 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.756 0.312 . . . . 0.0 110.664 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.6 m -117.54 101.05 8.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.759 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.691 HD21 ' HG2' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -49.0 132.79 18.7 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.594 0.711 . . . . 0.0 111.155 -179.739 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.449 ' HB ' ' CB ' ' A' ' 123' ' ' THR . 36.1 mm -101.82 156.98 4.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.59 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.434 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 67.35 -126.47 25.37 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.958 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -125.79 127.06 45.54 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.054 0.454 . . . . 0.0 110.931 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.99 ' OG ' HG22 ' A' ' 96' ' ' THR . 3.6 p -59.34 -27.93 66.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.728 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -72.47 121.39 8.08 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.75 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.883 HG21 ' CE2' ' A' ' 97' ' ' TYR . 11.6 t -113.99 116.03 51.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.5 126.61 31.18 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -177.339 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.5 ' HB2' ' CZ3' ' A' ' 118' ' ' TRP . 41.8 t -91.07 104.12 16.74 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.234 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 19.3 t -141.1 150.72 43.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.078 0.466 . . . . 0.0 111.406 -178.125 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.598 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 46.68 43.24 15.58 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.767 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.468 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 62.32 14.14 46.7 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.647 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -135.11 173.25 11.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.023 0.44 . . . . 0.0 110.679 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.514 ' CZ3' HG23 ' A' ' 95' ' ' VAL . 95.8 m95 -115.48 128.1 55.78 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.527 -178.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.488 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 0.3 OUTLIER -91.81 130.39 37.6 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.663 175.04 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.626 ' HB2' HG13 ' A' ' 111' ' ' VAL . 2.8 m-20 108.92 -132.1 0.0 OUTLIER Pre-proline 0 CA--C 1.475 -1.907 0 N-CA-C 100.41 -3.922 . . . . 0.0 100.41 -167.105 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.553 ' HA ' ' CB ' ' A' ' 120' ' ' ASP . 60.4 Cg_endo -63.52 -179.53 7.77 Favored 'Cis proline' 0 C--N 1.309 -1.54 0 CA-C-N 125.157 2.878 . . . . 0.0 112.717 -17.346 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.691 ' HG2' HD21 ' A' ' 105' ' ' LEU . 18.0 Cg_endo -87.94 -179.51 2.53 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 123.023 2.482 . . . . 0.0 111.32 176.324 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.449 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -109.12 -162.6 0.82 Allowed 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.13 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 124' ' ' CYS . . . . . 0.427 ' SG ' ' HB2' ' A' ' 103' ' ' TYR . 5.0 t -170.25 85.83 0.12 Allowed 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.904 -176.311 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -114.61 176.74 4.92 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.909 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.66 ' O ' HG22 ' A' ' 126' ' ' ILE . 26.4 mm . . . . . 0 C--N 1.322 -0.615 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.718 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.874 0.368 . . . . 0.0 110.731 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.467 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 37.9 m -81.33 160.06 66.02 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.874 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.89 174.44 9.62 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.454 2.103 . . . . 0.0 111.961 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -51.11 109.57 1.41 Allowed Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.794 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.41 162.38 14.85 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.258 1.972 . . . . 0.0 111.977 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.575 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -52.11 -175.02 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.447 179.318 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.422 ' O ' HG13 ' A' ' 15' ' ' ILE . 0.4 OUTLIER -140.05 6.53 2.18 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.041 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.936 HD13 ' CD2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER 57.8 -165.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.067 -177.635 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -125.79 -70.88 0.72 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.929 0.395 . . . . 0.0 110.613 178.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.482 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -99.2 29.02 4.11 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.941 178.605 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.43 ' HA2' ' N ' ' A' ' 36' ' ' ASN . . . -137.93 -175.66 14.03 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.214 -178.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -133.75 145.35 49.74 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.672 0.272 . . . . 0.0 110.747 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.789 HD22 HD11 ' A' ' 15' ' ' ILE . 4.9 mt -82.67 155.55 24.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.207 0.527 . . . . 0.0 111.797 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.416 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 4.5 t0 -129.91 68.5 1.44 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.92 175.433 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.879 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.9 OUTLIER -74.95 116.95 18.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.49 -175.796 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -116.05 19.57 13.5 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.227 175.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 161.0 125.99 0.8 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.007 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.6 m -112.44 5.79 8.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 15.8 t70 -88.46 165.42 14.91 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.871 0.367 . . . . 0.0 110.871 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -57.76 116.71 3.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.635 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.45 5.9 36.42 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.833 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 89.7 p -94.14 -169.59 2.1 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.856 0.328 . . . . 0.0 110.307 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.9 p -165.88 141.66 5.0 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.125 0.488 . . . . 0.0 111.1 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.879 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.6 OUTLIER -106.14 164.38 4.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.209 -179.898 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.424 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -121.86 118.18 28.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.952 0.406 . . . . 0.0 110.671 179.034 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.936 ' CD2' HD13 ' A' ' 15' ' ' ILE . 6.1 m-85 -90.97 135.63 33.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.784 -178.109 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.9 m -146.97 157.55 43.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.694 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.42 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 1.9 m -79.58 167.56 20.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.846 0.355 . . . . 0.0 110.869 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.43 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 2.7 m120 -67.15 -84.13 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.971 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.96 134.52 11.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.699 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.29 24.27 73.47 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.897 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.53 ' CE2' ' CB ' ' A' ' 68' ' ' SER . 2.7 m-30 -119.73 174.52 6.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.887 0.375 . . . . 0.0 110.908 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.905 ' CD2' HD11 ' A' ' 42' ' ' ILE . 4.9 p-80 -134.53 117.12 15.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.364 177.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.84 HD21 ' O ' ' A' ' 44' ' ' GLU . 5.7 tt -81.75 127.47 32.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.337 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.905 HD11 ' CD2' ' A' ' 40' ' ' HIS . 1.9 mm -106.09 149.49 9.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.275 -178.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.71 -141.4 19.5 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.369 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.84 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.9 OUTLIER -74.04 -172.94 1.47 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.903 0.383 . . . . 0.0 110.79 179.53 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.8 p -161.69 22.73 0.12 Allowed 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.392 -179.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.424 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 1.1 mtpt -153.31 125.47 7.98 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -177.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.453 ' CB ' ' HA ' ' A' ' 62' ' ' GLU . 0.3 OUTLIER -94.61 145.43 24.84 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.092 178.111 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.537 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.8 m-85 -120.89 120.5 35.7 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 119.315 -0.954 . . . . 0.0 111.797 178.383 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 26.5 t -68.74 117.66 10.73 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.156 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -156.61 -179.45 8.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.992 179.289 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.5 ' C ' HD12 ' A' ' 51' ' ' LEU . 4.6 pp . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.656 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.217 0 CA-C-O 121.088 0.47 . . . . 0.0 110.87 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.1 m -149.28 -176.09 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.541 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.56 ' CZ3' HD11 ' A' ' 31' ' ' ILE . 69.7 m95 -131.48 124.96 31.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.988 0.423 . . . . 0.0 111.261 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.537 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 4.8 m-20 -68.4 166.61 24.03 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.439 178.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.47 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 49.3 Cg_exo -12.63 86.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.008 1 C-N-CA 125.361 4.041 . . . . 0.0 114.211 -178.958 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.496 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.5 OUTLIER -90.26 -76.58 0.42 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.723 -176.236 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.464 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -94.22 108.23 34.51 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -173.232 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.787 ' HG2' HD11 ' A' ' 41' ' ' LEU . 2.3 Cg_endo -81.41 -154.34 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.189 2.592 . . . . 0.0 110.368 175.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.677 HD12 ' HB ' ' A' ' 42' ' ' ILE . 1.0 OUTLIER -93.19 175.2 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.602 177.767 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.61 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.8 OUTLIER -171.46 144.31 1.92 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.609 179.718 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.417 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 1.3 tt0 -166.73 175.08 8.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.86 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.53 ' CB ' ' CE2' ' A' ' 39' ' ' TYR . 0.2 OUTLIER -99.41 123.4 43.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.658 178.944 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.438 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 1.4 p -45.27 92.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.093 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 68' ' ' SER . 2.4 mmtp -63.99 131.95 49.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.199 -177.464 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.12 121.0 40.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.62 177.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.3 -159.5 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.655 -179.16 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.465 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 2.7 t -51.33 139.67 25.9 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.589 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.466 ' HG2' HG11 ' A' ' 95' ' ' VAL . 26.4 Cg_exo -59.22 159.67 21.81 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.201 1.934 . . . . 0.0 111.918 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.492 ' HD3' ' CG ' ' A' ' 118' ' ' TRP . 88.9 Cg_exo -39.79 156.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.934 2.422 . . . . 0.0 113.04 -178.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.1 t -107.97 90.81 3.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.796 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.597 HG23 ' HE2' ' A' ' 97' ' ' TYR . 21.4 pt -69.51 -176.68 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.287 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.6 m -105.25 145.74 30.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.662 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.47 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 7.4 m-80 55.56 28.35 11.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.929 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.471 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -167.52 -163.2 20.99 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.563 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 9.5 ptt180 -170.15 -175.72 2.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.039 0.447 . . . . 0.0 110.971 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.465 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 1.6 p-80 -110.46 168.2 9.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.868 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.636 179.9 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.421 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 7.8 m-85 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.86 0.362 . . . . 0.0 111.106 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.421 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 48.6 m-85 -148.11 165.01 32.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.828 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.415 ' CG2' ' HE3' ' A' ' 70' ' ' LYS . 12.1 p -134.5 -175.19 3.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.905 0.383 . . . . 0.0 111.462 -178.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.42 ' OD1' ' CG1' ' A' ' 69' ' ' VAL . 0.7 OUTLIER -64.5 98.45 0.25 Allowed 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.31 0.576 . . . . 0.0 111.069 -179.876 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.86 22.29 2.23 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.164 -0.925 . . . . 0.0 113.13 178.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.438 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.6 OUTLIER -103.18 157.25 17.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.908 0.354 . . . . 0.0 110.631 179.167 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 28.6 m -136.39 149.06 27.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.079 0.466 . . . . 0.0 111.173 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.475 HG23 ' CH2' ' A' ' 118' ' ' TRP . 21.4 t -144.19 147.39 19.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.747 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.694 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -106.31 129.49 54.32 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.778 -179.984 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.955 ' CE1' HG21 ' A' ' 111' ' ' VAL . 5.5 m-85 -88.56 157.07 18.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.115 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.4 ' HA ' HD13 ' A' ' 105' ' ' LEU . 50.2 m -151.3 141.31 22.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.334 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.425 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 74.0 m -71.89 163.12 28.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.979 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.471 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 18.0 m-20 -96.73 -71.46 0.68 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.513 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.0 t -61.58 -22.57 65.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.23 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 122.37 31.29 1.08 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.534 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.494 ' CD2' HG12 ' A' ' 126' ' ' ILE . 24.8 m-85 -69.96 -174.02 0.72 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 120.959 0.409 . . . . 0.0 110.495 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.0 105.87 14.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.359 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.674 HD22 ' HB3' ' A' ' 109' ' ' SER . 0.2 OUTLIER -46.44 123.41 4.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.385 0.612 . . . . 0.0 111.419 -178.809 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.458 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 42.6 mm -91.13 152.61 3.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.457 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.67 -130.44 36.91 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.104 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -114.67 138.8 50.25 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.839 0.352 . . . . 0.0 110.774 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.694 ' HB2' HG22 ' A' ' 96' ' ' THR . 0.0 OUTLIER -77.23 -30.08 54.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.756 179.906 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.04 127.41 11.02 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.18 178.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.955 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.8 t -120.22 121.86 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.65 0.262 . . . . 0.0 110.642 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.75 122.85 27.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.705 -178.582 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.496 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 25.6 t -88.85 104.13 16.64 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.067 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.6 t -145.39 163.81 33.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.163 -178.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 44.9 30.57 2.44 Favored Glycine 0 CA--C 1.518 0.258 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.928 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.438 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 67.14 19.89 70.55 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.42 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -143.56 175.56 9.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.766 0.317 . . . . 0.0 110.561 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.496 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 95.7 m95 -112.33 142.86 44.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.005 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.9 148.08 50.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.257 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.478 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 26.6 t0 71.74 46.72 0.24 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.082 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 95.4 Cg_endo -78.18 134.03 12.6 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.343 2.029 . . . . 0.0 111.4 177.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.495 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 74.0 Cg_endo -88.66 -173.75 0.92 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.525 2.15 . . . . 0.0 113.532 -177.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.448 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -129.75 -163.42 1.3 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.781 177.756 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 5.1 m -151.97 92.06 1.69 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.047 0.451 . . . . 0.0 110.94 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -122.07 158.11 29.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.852 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.494 HG12 ' CD2' ' A' ' 103' ' ' TYR . 13.6 mm . . . . . 0 C--N 1.324 -0.518 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.859 179.576 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.785 ' HD3' HG23 ' A' ' 25' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.969 0.414 . . . . 0.0 110.834 . . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.482 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 4.2 m -93.84 162.94 25.6 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.705 179.506 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.42 ' O ' ' HD3' ' A' ' 12' ' ' PRO . 15.5 Cg_endo -60.1 -163.28 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.316 2.011 . . . . 0.0 111.452 -179.883 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.44 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 0.9 OUTLIER -78.46 104.94 2.34 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.718 -0.219 . . . . 0.0 110.805 179.92 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.498 ' CG ' ' CD1' ' A' ' 22' ' ' ILE . 13.2 Cg_endo -55.97 142.84 84.47 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.123 1.882 . . . . 0.0 111.677 179.461 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.42 ' HB3' ' OH ' ' A' ' 33' ' ' TYR . 0.5 OUTLIER -52.19 169.34 0.08 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.467 -179.556 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.747 ' C ' HD21 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -130.02 -5.27 4.47 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -177.149 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.692 HG22 ' O ' ' A' ' 14' ' ' ASP . 3.0 tt 55.45 157.42 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 122.864 0.466 . . . . 0.0 111.798 -178.264 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -101.78 -47.33 4.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.432 -178.349 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -94.04 38.71 1.08 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.878 -179.633 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.464 ' HA2' ' N ' ' A' ' 36' ' ' ASN . . . 177.84 -166.07 36.07 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.969 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.893 ' C ' HD23 ' A' ' 20' ' ' LEU . 0.9 OUTLIER -136.47 177.21 8.03 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.334 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.893 HD23 ' C ' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -126.59 151.5 47.89 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.301 0.572 . . . . 0.0 111.411 -179.836 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 32' ' ' THR . 4.2 t70 -116.25 82.67 1.82 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.528 177.909 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.806 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.7 OUTLIER -77.39 103.12 4.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.392 -176.908 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.67 19.79 52.95 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.756 177.177 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.07 142.09 3.37 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.06 -0.591 . . . . 0.0 111.955 -179.374 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.785 HG23 ' HD3' ' A' ' 8' ' ' ARG . 11.0 m -128.6 29.64 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.66 0.266 . . . . 0.0 111.492 -178.891 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -105.69 164.97 11.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.929 0.395 . . . . 0.0 110.838 179.309 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.763 ' HZ ' HD13 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -59.93 90.59 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.925 -179.738 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 136.31 -2.88 3.58 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.32 179.63 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.39 -174.56 3.38 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 117.157 0.479 . . . . 0.0 110.771 179.86 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.427 ' HB2' ' HE2' ' A' ' 46' ' ' LYS . 1.4 p -156.58 145.22 19.99 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.016 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.806 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.4 OUTLIER -100.79 166.15 2.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.234 179.525 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.456 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -127.48 114.95 18.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.827 0.346 . . . . 0.0 110.864 179.654 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.789 ' CE1' HD22 ' A' ' 20' ' ' LEU . 15.4 m-85 -91.92 149.2 21.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.258 0.551 . . . . 0.0 112.061 -178.386 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.406 ' O ' ' HA3' ' A' ' 18' ' ' GLY . 46.0 m -151.44 147.02 26.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.188 178.901 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.417 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 6.3 m -69.15 167.66 15.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.848 0.356 . . . . 0.0 110.829 -179.351 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.464 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 25.4 m-20 -68.69 -85.76 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.239 -178.317 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.73 134.98 15.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.524 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.535 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 65.92 26.42 72.25 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.771 -178.79 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.499 ' CE2' ' HB3' ' A' ' 68' ' ' SER . 2.1 m-85 -121.41 171.89 8.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.997 0.427 . . . . 0.0 111.179 -179.45 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.664 ' NE2' HD11 ' A' ' 42' ' ' ILE . 4.4 p-80 -138.26 112.79 8.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.066 177.647 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.932 HD21 ' O ' ' A' ' 44' ' ' GLU . 7.0 tt -75.4 129.93 38.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.856 -178.812 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.664 HD11 ' NE2' ' A' ' 40' ' ' HIS . 3.0 mm -104.94 157.4 5.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.994 0.426 . . . . 0.0 111.098 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.6 -142.45 31.16 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.05 -179.094 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.932 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -73.0 -172.54 1.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.85 0.357 . . . . 0.0 110.569 179.222 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.417 ' HA ' ' HG3' ' A' ' 64' ' ' PRO . 0.3 OUTLIER -168.21 30.21 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.534 179.682 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.456 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 25.8 mtpt -151.8 126.02 9.29 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.426 -178.534 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.428 ' OG ' ' CB ' ' A' ' 62' ' ' GLU . 0.3 OUTLIER -93.04 137.47 32.37 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.876 178.819 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.515 ' CD1' ' HB3' ' A' ' 60' ' ' ASN . 1.1 m-85 -114.73 121.77 44.37 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.79 -179.948 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 23.0 t -72.01 117.56 13.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.936 -179.58 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.497 ' HA ' ' CE2' ' A' ' 27' ' ' PHE . 4.6 mt-10 -146.16 -179.47 6.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.034 179.476 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.763 HD13 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.424 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.912 -179.673 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.684 ' O ' HG13 ' A' ' 58' ' ' VAL . 3.2 mmt . . . . . 0 N--CA 1.455 -0.22 0 CA-C-O 120.839 0.352 . . . . 0.0 110.6 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.684 HG13 ' O ' ' A' ' 57' ' ' MET . 2.7 m -163.38 173.95 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.204 -179.484 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.529 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 74.1 m95 -129.25 125.22 36.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.138 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.515 ' HB3' ' CD1' ' A' ' 48' ' ' TYR . 0.7 OUTLIER -69.33 166.06 33.47 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.761 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.47 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 65.7 Cg_exo -11.49 101.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.003 1 C-N-CA 125.647 4.231 . . . . 0.0 114.634 -179.187 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.507 ' O ' ' CG ' ' A' ' 33' ' ' TYR . 0.7 OUTLIER -101.71 -71.1 0.72 Allowed 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 115.159 -0.928 . . . . 0.0 113.159 -175.416 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.438 ' HA ' HD12 ' A' ' 15' ' ' ILE . . . -102.98 76.93 0.23 Allowed Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -174.858 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.795 ' HG2' HD11 ' A' ' 41' ' ' LEU . 33.3 Cg_endo -55.39 -154.42 0.0 OUTLIER 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 123.249 2.633 . . . . 0.0 111.766 176.015 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.51 HG22 ' H ' ' A' ' 66' ' ' CYS . 6.8 mm -86.97 166.42 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.964 0.412 . . . . 0.0 111.282 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.51 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.1 m -165.34 125.86 1.89 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.762 178.907 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.16 171.74 13.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.918 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.499 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 96.4 p -84.89 118.53 24.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.552 -179.568 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.559 HG23 ' HB3' ' A' ' 40' ' ' HIS . 0.2 OUTLIER -49.98 99.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.036 178.876 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -62.85 138.95 58.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.188 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.419 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -123.18 126.59 47.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.636 179.588 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -74.57 -168.59 0.71 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.841 179.498 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -41.25 133.38 1.98 Allowed Pre-proline 0 N--CA 1.438 -1.056 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.684 179.364 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.492 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 31.8 Cg_exo -57.82 162.9 10.08 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.378 2.052 . . . . 0.0 112.391 -178.704 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.52 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 85.6 Cg_exo -41.32 160.5 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.879 2.386 . . . . 0.0 113.135 -179.469 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.81 89.61 3.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.642 179.399 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.565 HG23 ' HE1' ' A' ' 97' ' ' TYR . 22.5 pt -69.35 171.99 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.407 -179.025 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.404 ' O ' ' HB2' ' A' ' 124' ' ' CYS . 3.7 m -88.44 141.36 28.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.705 179.645 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.438 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 6.2 m-80 57.22 29.46 16.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.926 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.465 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -169.71 -172.52 36.36 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.81 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 9.4 ptt180 -166.69 -175.61 3.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.92 0.39 . . . . 0.0 110.59 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 16.1 p80 -109.36 167.86 9.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.637 -179.053 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 41.7 p-10 . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.072 178.435 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.42 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 5.1 m-85 . . . . . 0 N--CA 1.455 -0.182 0 CA-C-O 120.769 0.319 . . . . 0.0 110.452 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.42 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 85.9 m-85 -153.62 169.02 24.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.825 -179.232 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.5 p -131.1 179.67 5.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.932 0.396 . . . . 0.0 111.524 -179.059 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.403 ' OD1' ' HB2' ' A' ' 68' ' ' SER . 44.6 p-10 -63.67 95.06 0.1 Allowed 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.354 0.597 . . . . 0.0 111.09 -179.865 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.61 27.95 1.37 Allowed Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.21 -0.905 . . . . 0.0 112.865 179.084 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.412 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -107.52 160.79 15.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.672 0.273 . . . . 0.0 110.458 179.047 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.442 HG22 ' N ' ' A' ' 95' ' ' VAL . 34.4 m -134.16 155.89 40.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.153 0.501 . . . . 0.0 111.389 -179.657 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.553 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 19.5 t -148.71 148.59 15.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.367 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.824 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -108.29 119.67 40.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.178 0.513 . . . . 0.0 111.12 -179.331 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.951 ' CE2' HG21 ' A' ' 111' ' ' VAL . 3.5 m-85 -77.06 164.55 25.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.766 -178.477 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.448 ' HA ' ' CD1' ' A' ' 105' ' ' LEU . 0.7 OUTLIER -155.35 135.35 12.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.671 -179.259 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.414 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 61.1 m -69.78 157.52 37.19 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.765 178.921 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.465 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 78.1 m-20 -85.82 -76.74 0.32 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.426 -179.349 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.7 t -59.02 -26.53 64.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.831 0.348 . . . . 0.0 111.184 -179.345 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 124.39 35.85 0.64 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.402 -179.724 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.438 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 14.3 m-85 -69.58 -174.0 0.65 Allowed 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 120.876 0.37 . . . . 0.0 110.618 179.853 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.5 m -111.9 99.68 8.31 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.181 179.122 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.588 HD23 ' HB2' ' A' ' 122' ' ' PRO . 0.0 OUTLIER -48.02 144.35 3.7 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.736 0.779 . . . . 0.0 111.682 -177.615 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.475 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 40.5 mm -117.73 159.91 17.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.913 -177.534 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.464 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 51.49 24.69 11.88 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.171 -1.014 . . . . 0.0 112.581 179.728 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.409 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.5 OUTLIER 61.04 135.04 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.191 0.52 . . . . 0.0 111.79 178.898 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.824 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.1 p -62.14 -28.68 69.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.885 -178.776 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -53.44 127.4 36.66 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.883 -179.259 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.951 HG21 ' CE2' ' A' ' 97' ' ' TYR . 3.1 t -128.11 150.38 33.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 178.72 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 118' ' ' TRP . 0.3 OUTLIER -107.1 129.52 54.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.854 0.359 . . . . 0.0 111.539 -179.201 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.508 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 44.3 t -92.63 106.01 18.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.526 176.228 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.6 t -153.74 164.32 38.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.011 0.434 . . . . 0.0 111.206 -178.425 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 45.25 33.21 3.96 Favored Glycine 0 CA--C 1.518 0.254 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.858 179.604 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 65.42 19.0 66.17 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.42 -179.641 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -146.89 -176.85 5.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.877 0.37 . . . . 0.0 110.778 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.553 ' CZ3' HG23 ' A' ' 95' ' ' VAL . 88.8 m95 -118.49 122.96 43.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.95 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.46 147.12 28.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.111 -179.366 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.514 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER 71.85 41.95 0.18 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.489 179.192 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 53.3 Cg_endo -68.69 145.98 65.32 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 121.993 1.796 . . . . 0.0 111.014 177.88 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.588 ' HB2' HD23 ' A' ' 105' ' ' LEU . 73.3 Cg_endo -96.49 -173.58 0.23 Allowed 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.521 2.147 . . . . 0.0 113.938 -177.096 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 105' ' ' LEU . 0.2 OUTLIER -132.9 172.2 12.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.446 -1.252 . . . . 0.0 109.195 177.868 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 124' ' ' CYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 78' ' ' SER . 1.9 m -130.18 91.77 3.17 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.095 0.474 . . . . 0.0 110.433 178.659 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -117.11 -179.39 3.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.369 -178.351 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.48 ' O ' HG22 ' A' ' 126' ' ' ILE . 43.6 mm . . . . . 0 C--N 1.321 -0.645 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.02 -179.462 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.472 ' CB ' ' HA ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 121.022 0.439 . . . . 0.0 111.22 . . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.551 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 76.6 m -78.47 176.77 3.31 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.645 178.861 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.555 ' HD2' ' CD1' ' A' ' 59' ' ' TRP . 36.8 Cg_endo -92.21 178.71 1.46 Allowed 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 122.75 2.3 . . . . 0.0 112.21 -179.281 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.7 t -48.57 103.82 0.38 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.442 179.12 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.514 ' HG3' ' CZ2' ' A' ' 59' ' ' TRP . 51.2 Cg_exo -48.75 159.65 0.83 Allowed 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.319 2.013 . . . . 0.0 112.751 -178.518 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.654 ' O ' HD11 ' A' ' 20' ' ' LEU . 6.2 mtm180 -65.22 -178.43 0.48 Allowed 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.54 177.073 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.489 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 2.7 t70 -141.64 167.2 22.72 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.288 0.566 . . . . 0.0 111.217 -176.865 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.404 HG23 ' C ' ' A' ' 18' ' ' GLY . 7.4 tt -119.29 147.94 22.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.438 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -76.53 -58.82 3.06 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -177.671 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.407 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 0.1 OUTLIER -93.87 32.81 1.39 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.191 -177.945 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.404 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -156.86 -171.94 23.55 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.364 -179.579 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -145.56 141.86 28.62 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.291 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.876 HD22 ' CE2' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -88.06 166.35 14.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.28 0.562 . . . . 0.0 111.775 -179.153 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.3 OUTLIER -133.05 85.3 2.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.726 177.263 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.861 ' HA ' HG23 ' A' ' 31' ' ' ILE . 53.6 mt -72.83 105.25 2.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -177.174 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.13 20.96 39.11 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.496 176.414 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 29' ' ' SER . . . 154.39 139.27 2.78 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 -179.135 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.401 ' O ' ' HB2' ' A' ' 8' ' ' ARG . 15.7 m -120.52 -8.06 10.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.9 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.472 ' HA ' ' CB ' ' A' ' 8' ' ' ARG . 25.5 t0 -69.28 164.67 22.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.169 0.509 . . . . 0.0 111.402 -178.816 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.465 ' CZ ' ' HB3' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -53.39 119.09 4.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.512 179.751 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.65 -3.9 61.31 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.507 -178.628 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 24' ' ' GLY . 22.7 m -70.44 174.21 6.01 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 116.951 0.376 . . . . 0.0 110.592 179.553 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.7 p -148.02 149.22 31.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.108 -179.717 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.861 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -115.6 171.31 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.628 -179.92 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 21' ' ' ASP . 1.4 m -130.83 118.35 20.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.914 0.388 . . . . 0.0 111.091 179.733 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.876 ' CE2' HD22 ' A' ' 20' ' ' LEU . 10.0 m-85 -95.76 138.92 32.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.579 -179.212 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.403 ' O ' ' HA3' ' A' ' 18' ' ' GLY . 22.6 m -142.73 157.23 44.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.757 179.416 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.4 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 1.5 m -76.94 170.15 17.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.706 0.289 . . . . 0.0 110.748 179.742 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -65.47 -84.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.968 -179.538 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.0 t -157.32 133.5 9.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.728 179.713 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.6 ' O ' HG22 ' A' ' 69' ' ' VAL . . . 66.93 23.71 72.8 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.054 -179.095 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.507 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.5 m-85 -115.27 -178.25 3.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.933 0.397 . . . . 0.0 110.96 -179.803 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.789 ' CD2' HD11 ' A' ' 42' ' ' ILE . 4.1 p-80 -141.98 111.63 6.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.882 177.511 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.951 HD21 ' O ' ' A' ' 44' ' ' GLU . 5.3 tt -78.14 127.2 31.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.713 -178.722 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.789 HD11 ' CD2' ' A' ' 40' ' ' HIS . 2.4 mm -103.72 149.7 7.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.041 0.448 . . . . 0.0 110.975 -179.592 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.66 -131.72 10.88 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.304 -179.15 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.951 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -89.61 -176.55 5.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.771 0.32 . . . . 0.0 110.71 179.686 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.3 p -161.26 25.22 0.13 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.049 -179.245 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.413 ' HG3' ' HA ' ' A' ' 32' ' ' THR . 1.4 mtpt -153.24 129.65 10.61 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.113 0.483 . . . . 0.0 111.218 -179.171 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -103.38 150.71 23.55 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.0 179.654 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.492 ' CB ' ' HB2' ' A' ' 60' ' ' ASN . 1.9 m-85 -127.04 121.55 31.89 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 119.191 -1.004 . . . . 0.0 113.094 -177.806 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.432 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 25.4 t -70.16 97.63 1.23 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.258 177.65 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.499 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 2.1 tt0 -131.13 171.92 12.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.448 0.642 . . . . 0.0 111.091 -178.991 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.499 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.632 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.347 -179.237 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.804 0.335 . . . . 0.0 110.295 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.2 m -153.65 -176.94 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.047 -179.422 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.555 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 75.4 m95 -128.83 126.14 39.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.664 -179.285 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.492 ' HB2' ' CB ' ' A' ' 48' ' ' TYR . 2.1 m120 -69.46 164.45 49.54 Favored Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.772 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.493 ' O ' ' HA ' ' A' ' 47' ' ' SER . 67.3 Cg_exo -11.88 121.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 1.003 1 C-N-CA 125.8 4.333 . . . . 0.0 115.309 -175.948 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.512 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 4.9 mm-40 -110.25 -79.78 0.58 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.77 -1.105 . . . . 0.0 113.791 -174.35 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' A' ' 14' ' ' ASP . . . -101.95 79.24 0.25 Allowed Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -174.477 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.589 ' HG2' HD11 ' A' ' 41' ' ' LEU . 30.7 Cg_endo -54.67 -154.35 0.0 OUTLIER 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.335 2.69 . . . . 0.0 111.811 175.822 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.501 HG22 ' H ' ' A' ' 66' ' ' CYS . 5.4 mm -91.15 166.34 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.944 0.402 . . . . 0.0 111.259 -179.879 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.501 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -168.98 134.96 1.69 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.451 179.404 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -152.96 171.24 18.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.883 0.373 . . . . 0.0 111.02 -179.828 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.507 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 1.6 p -83.97 130.92 34.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.156 0.503 . . . . 0.0 111.364 -179.37 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 38' ' ' GLY . 4.3 m -46.68 100.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.545 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.488 ' HE2' HG23 ' A' ' 90' ' ' THR . 1.4 mmtt -86.91 100.2 12.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.229 179.621 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.421 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -87.57 121.32 29.84 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 177.652 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.454 ' CG ' ' N ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -68.85 -154.13 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -179.848 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.454 ' N ' ' CG ' ' A' ' 72' ' ' GLN . 1.8 t -51.49 148.11 9.74 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-O 120.676 0.274 . . . . 0.0 111.119 -179.318 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.483 ' CG ' HG11 ' A' ' 95' ' ' VAL . 12.2 Cg_exo -68.74 157.19 62.87 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.737 2.291 . . . . 0.0 111.909 179.538 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.524 ' HD3' ' CG ' ' A' ' 118' ' ' TRP . 83.0 Cg_exo -44.53 162.03 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.687 2.258 . . . . 0.0 112.741 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 69.4 m -116.63 89.21 3.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.658 179.463 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.628 HG23 ' HE2' ' A' ' 97' ' ' TYR . 17.6 pt -69.17 176.89 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.274 -179.255 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.3 t -89.81 150.93 22.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.659 179.037 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.514 ' HB3' ' CD2' ' A' ' 103' ' ' TYR . 2.0 m120 48.74 27.47 1.55 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.277 178.111 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.467 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -166.23 -164.95 22.76 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.776 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.7 ptt180 -170.23 -174.68 1.78 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.923 0.392 . . . . 0.0 110.667 -179.414 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.532 ' HB3' ' CE1' ' A' ' 97' ' ' TYR . 8.9 p80 -107.16 165.96 10.98 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.705 -178.844 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.4 ' HB2' ' O ' ' A' ' 96' ' ' THR . 27.1 m-20 . . . . . 0 C--O 1.223 -0.314 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.857 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.442 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 11.8 m-85 . . . . . 0 N--CA 1.448 -0.564 0 CA-C-O 120.816 0.341 . . . . 0.0 110.817 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.442 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 6.8 m-85 -140.62 166.42 24.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.101 -179.445 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.488 HG23 ' HE2' ' A' ' 70' ' ' LYS . 16.6 p -130.79 175.59 8.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.015 0.436 . . . . 0.0 111.829 -178.46 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.584 ' OD2' HG21 ' A' ' 69' ' ' VAL . 0.7 OUTLIER -62.88 99.69 0.17 Allowed 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.619 0.724 . . . . 0.0 110.659 179.68 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 125.24 12.86 3.72 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 114.601 -1.181 . . . . 0.0 113.055 179.007 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -89.04 161.02 16.79 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 117.179 0.49 . . . . 0.0 110.017 178.501 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 20.7 m -150.54 131.16 4.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.11 0.481 . . . . 0.0 110.982 -179.295 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.483 HG11 ' CG ' ' A' ' 74' ' ' PRO . 2.0 p -130.74 143.73 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.698 -179.186 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.795 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -94.56 128.61 41.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.365 0.602 . . . . 0.0 111.376 -178.869 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.911 ' CE1' HG21 ' A' ' 111' ' ' VAL . 3.1 m-85 -84.36 163.81 19.33 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.298 -179.456 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 89.4 p -153.75 133.42 12.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.768 -178.947 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.445 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 81.9 m -69.84 159.36 33.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.544 178.629 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.467 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 74.0 m-80 -93.65 -79.1 0.42 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.653 -178.969 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.55 -31.64 25.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.847 0.356 . . . . 0.0 111.277 -179.106 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 130.65 38.87 0.28 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.446 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.514 ' CD2' ' HB3' ' A' ' 79' ' ' ASN . 23.9 m-85 -78.66 -172.77 3.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.836 0.35 . . . . 0.0 110.757 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 125' ' ' GLN . 0.3 OUTLIER -111.66 113.97 26.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.494 179.344 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.535 HD22 ' HA ' ' A' ' 109' ' ' SER . 1.1 mp -53.51 115.17 1.8 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.006 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.543 HG22 ' N ' ' A' ' 107' ' ' GLY . 34.5 mm -99.85 162.11 3.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.856 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.543 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 52.64 28.59 30.39 Favored Glycine 0 CA--C 1.508 -0.357 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.541 179.245 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.403 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.7 OUTLIER 60.31 128.8 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.935 -0.633 . . . . 0.0 111.465 179.44 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.795 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.3 p -60.28 -29.45 68.82 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.81 -178.747 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.76 136.88 49.98 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.908 -178.753 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.911 HG21 ' CE1' ' A' ' 97' ' ' TYR . 4.0 t -133.31 119.36 35.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 110.439 -0.208 . . . . 0.0 110.439 179.369 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.07 124.09 29.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.952 0.406 . . . . 0.0 111.474 -178.714 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 93' ' ' SER . 10.3 t -88.55 108.09 19.24 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.722 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 52.7 p -155.89 166.41 33.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.189 0.519 . . . . 0.0 111.524 -178.157 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.87 31.99 5.8 Favored Glycine 0 CA--C 1.518 0.279 0 CA-C-N 115.594 -0.73 . . . . 0.0 113.199 179.133 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.46 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 68.61 14.23 66.91 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.569 -179.881 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -147.15 171.63 15.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.016 0.436 . . . . 0.0 110.812 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.524 ' CG ' ' HD3' ' A' ' 75' ' ' PRO . 90.7 m95 -103.61 127.22 51.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.56 179.599 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.98 150.9 28.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.312 -179.037 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.492 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER 69.32 44.2 0.25 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.151 178.919 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.492 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 59.2 Cg_endo -72.64 140.62 32.95 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.154 1.903 . . . . 0.0 111.373 178.372 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.505 ' HG2' ' CD2' ' A' ' 97' ' ' TYR . 96.4 Cg_endo -91.73 -169.73 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.643 2.228 . . . . 0.0 113.98 -177.281 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.41 -159.91 1.0 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.391 -1.277 . . . . 0.0 109.743 178.22 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 124' ' ' CYS . . . . . 0.422 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 10.2 m -156.5 89.63 1.12 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.068 0.461 . . . . 0.0 110.709 179.033 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.414 ' O ' ' HB2' ' A' ' 104' ' ' SER . 15.6 mt-30 -122.69 158.4 30.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.034 -178.949 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.499 HG12 ' CE1' ' A' ' 103' ' ' TYR . 18.5 mm . . . . . 0 C--N 1.324 -0.536 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.958 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 25' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.909 0.385 . . . . 0.0 110.801 . . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.481 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 14.7 m -94.75 162.09 26.56 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.04 -179.576 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 40.2 Cg_endo -67.77 -168.71 0.2 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.605 2.203 . . . . 0.0 112.261 -179.487 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 3.1 t -67.47 110.83 5.91 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.019 -179.54 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 11' ' ' SER . 1.5 Cg_endo -52.29 132.36 43.85 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.182 1.921 . . . . 0.0 112.161 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.942 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -53.47 161.71 0.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.515 179.248 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -108.37 -176.71 3.12 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.528 -178.138 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.477 HG22 ' CD2' ' A' ' 20' ' ' LEU . 14.1 tt -146.69 147.96 17.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.942 -179.624 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.43 160.43 15.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.379 -0.373 . . . . 0.0 109.998 178.535 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.486 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 0.2 OUTLIER 47.21 26.6 0.7 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.766 -179.743 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.45 ' HA2' ' N ' ' A' ' 36' ' ' ASN . . . -153.83 -168.07 16.95 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.846 -179.152 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.64 135.42 15.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.806 0.336 . . . . 0.0 111.071 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.942 HD11 ' O ' ' A' ' 13' ' ' ARG . 8.6 mt -75.17 160.22 30.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.595 -179.746 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.449 ' HB3' ' CB ' ' A' ' 32' ' ' THR . 1.1 t0 -135.39 71.96 1.44 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.774 177.847 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.895 ' HA ' HG23 ' A' ' 31' ' ' ILE . 18.4 mt -75.09 112.97 13.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.224 -177.437 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -107.48 16.15 37.97 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.628 176.383 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 153.94 136.93 2.37 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.823 -179.31 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.412 ' O ' ' HB2' ' A' ' 8' ' ' ARG . 28.3 m -120.39 29.94 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -178.341 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.83 154.59 18.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.828 0.347 . . . . 0.0 111.002 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.478 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 10.0 t80 -48.67 108.87 0.2 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.96 -4.98 34.13 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.663 -178.76 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.9 p -69.63 -164.49 0.07 Allowed 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.738 0.304 . . . . 0.0 110.681 179.762 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.3 p -167.02 143.26 4.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.022 0.439 . . . . 0.0 111.225 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.895 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -112.0 174.17 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.497 179.959 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.573 HG23 ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -135.5 113.11 10.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.948 0.404 . . . . 0.0 110.79 179.319 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.77 ' CE1' HD21 ' A' ' 20' ' ' LEU . 26.2 m-85 -88.92 137.09 32.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.935 -179.558 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.6 m -144.19 156.76 44.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.373 -179.085 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 59.4 m -84.05 166.23 17.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.948 179.74 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.45 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 3.3 m-20 -66.14 -86.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.23 -178.826 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.4 t -151.9 134.67 15.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.871 0.367 . . . . 0.0 110.873 -179.743 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.42 21.99 70.93 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.233 -179.468 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.497 ' CE1' ' HB3' ' A' ' 68' ' ' SER . 2.5 m-30 -114.22 -176.96 3.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.824 0.345 . . . . 0.0 110.832 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.557 ' CE1' HD11 ' A' ' 42' ' ' ILE . 1.8 p-80 -147.92 112.87 5.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.632 178.876 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.957 HD21 ' O ' ' A' ' 44' ' ' GLU . 3.1 tt -73.84 131.85 41.94 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.494 -179.782 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.557 HD11 ' CE1' ' A' ' 40' ' ' HIS . 3.9 mm -103.35 153.83 5.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.975 -179.637 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.72 -133.59 13.3 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.385 -179.514 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.957 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -80.57 174.94 11.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.712 0.292 . . . . 0.0 110.65 179.408 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.537 ' OG ' HD13 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -155.29 27.0 0.41 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.408 178.987 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.573 ' HG2' HG23 ' A' ' 32' ' ' THR . 0.0 OUTLIER -159.98 121.42 3.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.669 -178.968 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.426 ' HA ' ' HD2' ' A' ' 61' ' ' PRO . 47.9 t -92.84 157.21 16.5 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.513 179.322 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.52 ' CE1' ' HD3' ' A' ' 61' ' ' PRO . 4.0 m-85 -129.48 110.97 12.3 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.202 0.525 . . . . 0.0 111.648 -179.789 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.502 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 23.9 t -60.58 84.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.259 178.934 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -97.94 -171.64 2.21 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.995 -178.814 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.478 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.392 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.242 -179.234 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.815 0.34 . . . . 0.0 110.329 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.5 m -153.64 179.69 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.302 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.672 ' CE3' HD11 ' A' ' 31' ' ' ILE . 95.7 m95 -123.58 123.7 41.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.817 -179.847 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.5 m-20 -148.23 126.82 6.08 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.32 -179.485 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.52 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 2.9 Cg_exo -76.09 -167.45 5.84 Favored 'Cis proline' 0 C--N 1.35 0.656 0 C-N-CA 124.226 -1.156 . . . . 0.0 112.057 -0.983 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -110.74 -154.2 0.53 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.945 -179.434 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.482 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -69.61 111.21 8.13 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.911 179.863 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.533 ' HG2' HD11 ' A' ' 41' ' ' LEU . 15.3 Cg_exo -69.78 -150.55 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.627 2.218 . . . . 0.0 112.372 -179.165 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.506 HG22 ' H ' ' A' ' 66' ' ' CYS . 6.3 mm -98.45 166.44 2.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.371 -179.07 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.506 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.1 m -164.54 126.66 2.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.476 179.296 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.472 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -153.18 178.24 9.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.913 0.387 . . . . 0.0 111.267 -179.081 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.497 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 27.5 p -90.6 116.12 28.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.746 179.317 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.458 HG11 ' HA2' ' A' ' 115' ' ' GLY . 2.1 p -43.38 96.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.553 -179.804 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.421 ' HD3' ' HB3' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -78.01 120.64 23.14 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.615 -178.928 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.91 125.33 50.24 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.98 178.245 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -69.47 -158.87 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.429 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.406 ' HG ' ' HE2' ' A' ' 82' ' ' HIS . 1.3 t -54.1 143.39 43.52 Favored Pre-proline 0 N--CA 1.45 -0.442 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 179.612 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.459 ' HD2' ' CD2' ' A' ' 82' ' ' HIS . 25.2 Cg_exo -59.97 159.74 24.5 Favored 'Trans proline' 0 CA--C 1.528 0.207 0 C-N-CA 122.429 2.086 . . . . 0.0 112.092 -179.254 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.521 ' HD3' ' CG ' ' A' ' 118' ' ' TRP . 87.3 Cg_exo -46.56 156.44 0.6 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.762 2.308 . . . . 0.0 113.0 -178.856 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 12.8 t -108.06 91.5 3.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.301 178.89 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.748 HG23 ' HE2' ' A' ' 97' ' ' TYR . 22.2 pt -69.03 171.48 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.267 -178.905 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.9 p -89.13 135.17 33.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.021 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.463 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 0.0 OUTLIER 67.41 26.49 8.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.688 179.503 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -166.67 -163.39 20.32 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.106 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.3 ptt85 -170.29 -175.51 1.96 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.992 0.425 . . . . 0.0 110.982 -179.16 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.459 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 9.0 p-80 -115.99 168.02 10.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.854 179.661 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 23.0 m120 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.895 -179.984 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.432 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 6.4 m-85 . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.792 0.33 . . . . 0.0 111.162 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.432 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 24.6 m-85 -144.32 165.57 27.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.95 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 17.0 p -125.01 -179.66 4.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.128 -179.569 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 5.4 p-10 -67.06 95.36 0.39 Allowed 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.389 0.614 . . . . 0.0 110.933 -179.826 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 128.2 31.23 0.69 Allowed Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.132 -0.94 . . . . 0.0 112.93 179.177 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.415 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -110.27 164.16 12.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.689 0.28 . . . . 0.0 110.686 179.476 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 32.5 m -140.55 148.16 22.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.1 0.476 . . . . 0.0 111.276 -179.795 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.529 HG23 ' CH2' ' A' ' 118' ' ' TRP . 21.7 t -145.08 147.87 18.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.676 179.191 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.991 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -101.49 137.05 40.33 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 -179.756 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.95 ' CE1' HG21 ' A' ' 111' ' ' VAL . 3.8 m-85 -97.58 157.3 16.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.169 -179.313 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 84.5 p -149.44 140.9 23.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.397 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.433 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 73.0 m -70.78 159.02 35.31 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.415 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 17.7 m-20 -92.58 -70.88 0.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.54 -178.808 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.13 -22.1 66.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.368 -179.191 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.29 30.92 1.23 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.604 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.496 ' CE2' HG12 ' A' ' 126' ' ' ILE . 21.9 m-85 -69.71 -175.6 0.9 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.973 0.416 . . . . 0.0 110.754 179.634 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 125' ' ' GLN . 0.8 OUTLIER -111.2 104.35 12.85 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.787 177.617 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.55 HD21 ' CG ' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -47.77 129.62 14.17 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.531 0.681 . . . . 0.0 111.799 -177.422 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.438 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 38.1 mm -93.33 158.86 2.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.888 178.726 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.429 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 63.02 -125.83 35.4 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.306 -0.95 . . . . 0.0 111.977 -178.959 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -129.5 134.89 48.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.812 0.339 . . . . 0.0 111.063 179.526 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.991 ' OG ' HG22 ' A' ' 96' ' ' THR . 10.2 p -60.63 -32.26 71.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.115 0.483 . . . . 0.0 110.655 179.286 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -70.63 127.68 16.66 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.795 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.95 HG21 ' CE1' ' A' ' 97' ' ' TYR . 8.8 t -121.29 124.05 71.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 178.938 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.38 126.16 31.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.007 0.432 . . . . 0.0 111.879 -177.747 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.495 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 30.3 t -94.83 91.72 6.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.739 177.452 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.2 OUTLIER -129.46 156.84 43.47 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.036 0.446 . . . . 0.0 111.687 -177.892 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.458 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 46.98 27.7 3.57 Favored Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.856 179.477 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.456 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 77.81 -1.22 68.67 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.811 -179.524 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -123.8 157.45 34.06 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.895 0.379 . . . . 0.0 110.553 179.602 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.529 ' CH2' HG23 ' A' ' 95' ' ' VAL . 94.4 m95 -96.41 137.98 34.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.027 -179.654 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.633 ' O ' HG13 ' A' ' 111' ' ' VAL . 34.0 t -121.82 177.87 5.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.525 0.678 . . . . 0.0 111.478 179.292 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.457 ' N ' ' HD3' ' A' ' 121' ' ' PRO . 1.3 p-10 42.74 50.57 5.69 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.951 -179.521 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.457 ' HD3' ' N ' ' A' ' 120' ' ' ASP . 84.6 Cg_endo -83.25 141.7 10.39 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.642 2.228 . . . . 0.0 112.05 178.975 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.55 ' CG ' HD21 ' A' ' 105' ' ' LEU . 94.7 Cg_endo -91.56 -171.17 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.781 2.321 . . . . 0.0 113.554 -178.733 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.433 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -135.68 -157.94 0.83 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.616 -1.174 . . . . 0.0 109.884 178.601 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 8.6 m -156.6 89.92 1.13 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.077 0.465 . . . . 0.0 110.967 179.065 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.406 ' O ' ' HB2' ' A' ' 104' ' ' SER . 15.6 mt-30 -121.39 160.53 23.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.935 -179.767 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.496 HG12 ' CE2' ' A' ' 103' ' ' TYR . 18.4 mm . . . . . 0 C--N 1.324 -0.518 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.911 179.494 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.55 ' HB3' HG23 ' A' ' 25' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.237 0 CA-C-O 120.999 0.428 . . . . 0.0 111.957 . . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.46 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 18.9 m -114.68 159.53 36.8 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.76 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.64 168.59 19.55 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.393 2.062 . . . . 0.0 111.516 179.317 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.1 p -52.59 119.73 16.35 Favored Pre-proline 0 C--N 1.326 -0.447 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.887 -179.204 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.442 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 18.4 Cg_endo -57.79 150.3 63.49 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.55 2.167 . . . . 0.0 112.013 179.739 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.02 136.81 50.76 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.296 0.57 . . . . 0.0 110.701 179.489 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.474 ' HA ' HD11 ' A' ' 20' ' ' LEU . 2.9 p-10 -78.4 -177.38 5.21 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.104 -176.948 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.702 HG22 ' CD2' ' A' ' 20' ' ' LEU . 18.4 tt -145.75 148.49 17.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.095 -179.637 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.82 162.27 14.17 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.335 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.412 ' O ' ' N ' ' A' ' 36' ' ' ASN . 0.5 OUTLIER 47.26 27.65 0.89 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.947 0.403 . . . . 0.0 110.586 -179.404 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -175.45 173.79 46.44 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.921 -0.582 . . . . 0.0 112.287 -179.355 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.412 ' N ' ' O ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -136.77 156.94 47.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.729 0.3 . . . . 0.0 110.694 -179.856 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.931 HD22 ' CE1' ' A' ' 33' ' ' TYR . 0.2 OUTLIER -91.11 166.6 12.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.044 0.449 . . . . 0.0 110.976 179.188 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 32' ' ' THR . 15.2 t70 -129.97 78.83 1.87 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.052 178.196 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.887 ' HA ' HG23 ' A' ' 31' ' ' ILE . 42.5 mt -69.2 118.31 13.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.206 0.527 . . . . 0.0 112.056 -177.237 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -131.66 19.7 4.71 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.747 177.57 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 161.23 114.69 0.34 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 121.148 -0.549 . . . . 0.0 111.963 -179.475 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.55 HG23 ' HB3' ' A' ' 8' ' ' ARG . 18.7 m -113.58 30.4 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.683 0.278 . . . . 0.0 111.557 -178.837 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.423 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 15.0 t70 -101.55 163.5 12.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.959 0.409 . . . . 0.0 111.158 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.603 ' CZ ' HD12 ' A' ' 51' ' ' LEU . 7.8 t80 -60.83 89.45 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.852 -179.892 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.67 10.92 3.44 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.159 179.47 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.1 m -95.43 -160.47 0.79 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 117.039 0.419 . . . . 0.0 110.453 179.258 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 47' ' ' SER . 3.9 p -168.74 141.08 2.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.054 0.454 . . . . 0.0 111.367 179.488 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.887 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -100.87 170.58 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.317 179.444 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.494 ' HA ' ' HG3' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -132.87 110.33 10.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.931 0.396 . . . . 0.0 111.153 179.65 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.931 ' CE1' HD22 ' A' ' 20' ' ' LEU . 10.6 m-85 -86.03 156.91 20.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.779 -178.886 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 19' ' ' GLN . 66.5 m -156.02 150.94 26.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.94 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 14.3 m -76.42 171.08 15.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.974 179.88 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 17' ' ' ASN . 1.4 t-20 -65.35 -76.95 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.061 -179.656 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.93 136.28 5.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.942 -179.704 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 60.39 23.48 60.27 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.063 -179.428 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.504 ' CE1' ' HB3' ' A' ' 68' ' ' SER . 2.4 m-85 -111.35 -176.62 2.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.802 0.334 . . . . 0.0 110.72 -179.539 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.889 ' CD2' HD11 ' A' ' 42' ' ' ILE . 2.6 p-80 -142.44 113.24 7.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.544 178.45 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.908 HD21 ' O ' ' A' ' 44' ' ' GLU . 7.0 tt -79.21 120.7 24.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.68 -179.293 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.889 HD11 ' CD2' ' A' ' 40' ' ' HIS . 3.0 mm -98.22 162.17 2.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.216 -179.093 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.4 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 72.76 -140.28 28.77 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.339 -179.762 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.908 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -72.26 -173.53 1.11 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.837 0.351 . . . . 0.0 110.473 179.015 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.1 t -169.66 29.61 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.457 178.909 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.494 ' HG3' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -163.13 117.26 1.65 Allowed 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.066 -177.801 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.466 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 0.6 OUTLIER -84.58 133.53 34.43 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.293 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.53 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.9 m-85 -110.45 117.71 34.32 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 119.547 -0.861 . . . . 0.0 111.455 179.527 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 33.0 t -72.6 102.36 3.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.753 -179.984 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.54 -174.3 2.88 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.145 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.603 HD12 ' CZ ' ' A' ' 27' ' ' PHE . 5.1 mt . . . . . 0 C--N 1.327 -0.401 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.296 -179.449 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.717 ' O ' HG13 ' A' ' 58' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.938 0.399 . . . . 0.0 110.554 . . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.717 HG13 ' O ' ' A' ' 57' ' ' MET . 2.4 m -165.87 173.6 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.705 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.53 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 75.8 m95 -128.88 122.48 30.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.695 -179.267 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.53 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.5 OUTLIER -70.66 167.8 24.78 Favored Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.98 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.476 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 71.6 Cg_exo -17.0 95.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 125.113 3.875 . . . . 0.0 114.387 -179.189 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.422 ' CB ' ' OH ' ' A' ' 33' ' ' TYR . 0.2 OUTLIER -96.84 -79.02 0.46 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.179 -177.14 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.482 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . . . -87.94 107.32 15.31 Favored Pre-proline 0 C--N 1.332 -0.189 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -176.506 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.87 ' HG2' HD11 ' A' ' 41' ' ' LEU . 1.8 Cg_endo -86.15 -155.88 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.27 2.646 . . . . 0.0 111.444 178.509 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.489 HG22 ' H ' ' A' ' 66' ' ' CYS . 5.2 mm -89.75 165.57 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.894 0.378 . . . . 0.0 110.711 178.502 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.489 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.1 m -163.05 128.7 3.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.826 179.855 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.478 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -152.81 178.43 9.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.083 -179.652 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.504 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 89.8 p -89.57 117.66 28.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.88 179.591 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.439 ' CG2' ' HB3' ' A' ' 40' ' ' HIS . 2.6 p -44.52 101.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.22 179.754 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.418 ' HD2' ' HB3' ' A' ' 88' ' ' PHE . 38.9 mmtt -81.76 125.52 30.74 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.518 -0.764 . . . . 0.0 112.257 -177.623 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -106.86 120.62 42.53 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.733 176.656 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.89 -159.25 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.36 -179.845 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.479 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 2.0 t -54.08 137.81 56.78 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.81 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.805 ' CG ' HG21 ' A' ' 95' ' ' VAL . 52.1 Cg_exo -56.17 162.54 7.37 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.675 2.25 . . . . 0.0 112.211 -179.579 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -43.79 157.05 0.15 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.59 2.193 . . . . 0.0 112.528 -179.454 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.1 t -103.32 90.11 3.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.617 179.585 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.672 HG23 ' HE1' ' A' ' 97' ' ' TYR . 24.5 pt -69.42 168.49 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.188 -179.253 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.96 132.86 39.34 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.882 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.496 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 0.3 OUTLIER 71.18 27.3 3.27 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.76 179.988 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -168.36 -168.27 30.21 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.219 179.443 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.84 -175.24 3.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.859 0.361 . . . . 0.0 110.739 -179.231 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.479 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 3.0 p-80 -115.53 166.12 12.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.031 -179.569 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.332 -0.186 0 CA-C-O 120.789 0.328 . . . . 0.0 110.22 179.47 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.436 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 6.2 m-85 . . . . . 0 N--CA 1.455 -0.208 0 CA-C-O 120.701 0.286 . . . . 0.0 110.643 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.436 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 43.8 m-85 -146.85 162.47 38.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.204 -178.69 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.3 p -137.08 -177.86 4.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.476 -179.149 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 0.4 OUTLIER -59.43 92.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.252 0.549 . . . . 0.0 111.121 -179.625 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.56 26.8 1.55 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.367 -0.833 . . . . 0.0 113.086 178.571 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.426 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -105.83 154.21 20.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.89 0.345 . . . . 0.0 110.634 179.106 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 17.4 m -139.49 138.07 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.261 0.553 . . . . 0.0 111.472 -179.694 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.805 HG21 ' CG ' ' A' ' 74' ' ' PRO . 21.5 t -137.94 142.22 36.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.812 179.007 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.77 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -93.2 141.67 28.17 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.553 -178.033 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.82 ' CE2' HG21 ' A' ' 111' ' ' VAL . 4.7 m-85 -96.57 161.5 13.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.592 179.234 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.1 m -160.27 139.08 10.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.247 -179.752 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.459 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 59.6 m -69.58 164.87 22.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.037 -179.914 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.404 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 0.3 OUTLIER -97.27 -85.66 0.35 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.12 -179.921 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 41.9 t -47.34 -26.4 1.26 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.351 -179.399 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.27 54.25 0.23 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.088 -179.482 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.496 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 15.0 m-85 -93.1 -173.26 3.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.806 0.336 . . . . 0.0 111.286 -178.696 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -109.58 103.63 12.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.113 179.637 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.456 HD21 ' HA ' ' A' ' 109' ' ' SER . 0.2 OUTLIER -49.99 129.18 20.18 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.515 0.674 . . . . 0.0 111.556 -178.056 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.678 HD11 ' HG3' ' A' ' 125' ' ' GLN . 36.9 mm -95.2 157.68 3.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.294 179.431 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.473 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 60.87 -128.91 45.84 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.319 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -120.04 132.47 55.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.791 0.329 . . . . 0.0 111.086 179.954 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.77 ' OG ' HG22 ' A' ' 96' ' ' THR . 3.8 p -68.05 -33.09 73.91 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.904 179.597 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -78.3 119.88 5.27 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.784 -179.721 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.82 HG21 ' CE2' ' A' ' 97' ' ' TYR . 2.7 t -108.3 141.97 22.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.145 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.35 128.14 46.49 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.939 0.4 . . . . 0.0 111.302 -179.18 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.492 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 20.4 t -90.34 106.04 18.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.392 176.717 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 9.0 p -143.1 146.28 33.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.41 -178.379 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.402 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 54.05 34.86 53.06 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.746 179.532 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.436 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 67.75 12.44 62.0 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.848 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -138.58 170.17 16.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.918 0.39 . . . . 0.0 110.778 179.659 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.792 ' CH2' HG22 ' A' ' 95' ' ' VAL . 95.7 m95 -107.98 151.86 25.25 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.406 -178.802 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.94 148.92 44.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.158 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.471 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.7 OUTLIER 70.94 47.25 0.26 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.994 178.851 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 96.1 Cg_endo -78.83 136.57 13.47 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.433 2.089 . . . . 0.0 111.647 178.403 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.454 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 73.6 Cg_endo -87.16 -174.3 1.29 Allowed 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.533 2.155 . . . . 0.0 113.589 -178.243 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.481 HG22 ' H ' ' A' ' 124' ' ' CYS . 0.6 OUTLIER -134.02 176.79 8.27 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.272 177.305 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 124' ' ' CYS . . . . . 0.481 ' H ' HG22 ' A' ' 123' ' ' THR . 10.9 m -137.67 107.04 6.1 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.511 0.672 . . . . 0.0 111.848 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.678 ' HG3' HD11 ' A' ' 106' ' ' ILE . 2.9 pt20 -148.31 -179.0 6.62 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.117 -179.105 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 22.5 mm . . . . . 0 C--N 1.315 -0.905 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.334 -178.014 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.457 ' HD2' HG23 ' A' ' 25' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.449 -0.492 0 CA-C-O 121.196 0.522 . . . . 0.0 111.745 . . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 1.226 ' SG ' ' SG ' ' A' ' 49' ' ' CYS . 0.0 OUTLIER -98.57 163.1 19.68 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.684 179.406 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.47 ' HD3' ' CB ' ' A' ' 57' ' ' MET . 37.7 Cg_endo -67.02 170.49 12.92 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.065 1.843 . . . . 0.0 111.851 179.759 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.4 t -51.26 104.56 0.44 Allowed Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.895 -179.332 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.742 ' HB3' HD11 ' A' ' 31' ' ' ILE . 12.1 Cg_endo -56.75 147.29 72.8 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.058 1.839 . . . . 0.0 111.76 179.823 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -55.92 174.01 0.13 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.37 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.745 ' HA ' HD11 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -132.57 -171.2 2.6 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.989 0.423 . . . . 0.0 111.305 -179.61 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.432 HG23 ' C ' ' A' ' 18' ' ' GLY . 5.2 tt -144.1 145.16 22.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.61 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -80.75 -58.68 2.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.256 -178.988 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -94.0 38.29 1.08 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.852 -179.538 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.432 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -158.37 -177.84 31.84 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.965 -179.804 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.41 ' N ' ' O ' ' A' ' 34' ' ' SER . 0.7 OUTLIER -137.71 140.79 40.93 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 179.59 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.745 HD11 ' HA ' ' A' ' 14' ' ' ASP . 10.2 mt -86.67 154.75 20.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.081 0.467 . . . . 0.0 111.759 -178.862 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.461 ' HB3' ' CB ' ' A' ' 32' ' ' THR . 15.6 t0 -124.39 71.22 1.13 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.631 177.457 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.86 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.9 OUTLIER -76.58 104.59 4.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.774 -177.836 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -110.6 -15.71 10.89 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.077 178.436 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.416 ' O ' ' CB ' ' A' ' 29' ' ' SER . . . -157.69 110.44 0.44 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.118 179.562 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.555 HG13 ' CG2' ' A' ' 22' ' ' ILE . 27.3 m -112.12 51.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.534 0.207 . . . . 0.0 111.534 -179.322 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 25.8 t0 -111.18 163.8 13.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.932 0.396 . . . . 0.0 110.84 178.063 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.456 ' CZ ' ' HB3' ' A' ' 51' ' ' LEU . 1.4 t80 -53.14 95.39 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.904 -179.18 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.17 31.37 5.05 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.148 -179.658 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 24' ' ' GLY . 14.8 m -99.67 -158.42 0.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.285 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 47' ' ' SER . 7.7 p -165.17 139.95 5.08 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 120.273 -0.571 . . . . 0.0 112.288 179.708 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.86 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.8 OUTLIER -105.2 170.68 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.267 178.568 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.463 ' HA ' ' HG3' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -128.48 111.75 13.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.005 0.431 . . . . 0.0 111.11 178.591 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.531 ' CE2' ' CD2' ' A' ' 20' ' ' LEU . 13.6 m-85 -85.13 149.28 25.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.255 -179.604 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.411 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 9.6 p -152.79 165.72 34.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.713 179.475 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.415 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 9.8 m -85.2 168.43 14.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.768 0.318 . . . . 0.0 110.92 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -66.02 -83.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.995 -179.437 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.86 136.23 13.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.476 179.703 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.464 ' HA3' ' CB ' ' A' ' 91' ' ' ASP . . . 59.97 28.84 66.77 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.387 -0.911 . . . . 0.0 111.671 -178.688 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.526 ' CE1' ' CB ' ' A' ' 68' ' ' SER . 2.7 m-85 -120.15 173.07 7.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.816 0.341 . . . . 0.0 110.939 -179.12 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.553 ' NE2' HG22 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -129.85 133.45 46.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.106 175.271 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.933 HD21 ' O ' ' A' ' 44' ' ' GLU . 6.7 tt -97.33 120.95 38.63 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.641 -179.333 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.591 ' N ' HD13 ' A' ' 42' ' ' ILE . 1.2 mm -99.13 149.68 5.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.088 -179.302 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.06 -136.01 13.64 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.275 -179.62 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.933 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -84.55 -173.87 4.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.894 0.378 . . . . 0.0 110.653 179.612 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.9 p -159.51 22.15 0.18 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.462 -178.899 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.463 ' HG3' ' HA ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -154.44 125.89 7.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.945 0.402 . . . . 0.0 112.062 -177.796 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' A' ' 30' ' ' SER . 0.7 OUTLIER -92.4 141.68 28.27 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.673 177.201 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.441 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.4 m-85 -122.69 113.41 19.18 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 119.611 -0.836 . . . . 0.0 111.407 179.129 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 1.226 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 1.6 p -79.89 118.54 21.75 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 119.152 -1.019 . . . . 0.0 111.397 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.97 -170.72 2.57 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.842 -179.837 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.487 HD13 ' H ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.406 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.04 -179.476 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.47 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.336 0 CA-C-O 121.15 0.5 . . . . 0.0 110.734 . . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 49' ' ' CYS . 1.7 m -157.21 171.31 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.688 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.555 ' CD2' ' HB3' ' A' ' 49' ' ' CYS . 70.7 m95 -131.15 121.01 24.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.042 0.448 . . . . 0.0 111.6 -179.491 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.495 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 6.3 m-20 -69.68 168.03 19.77 Favored Pre-proline 0 C--O 1.223 -0.298 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.148 178.788 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.495 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 76.3 Cg_exo -20.16 96.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 125.081 3.854 . . . . 0.0 114.412 -178.37 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.465 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -96.01 -78.09 0.47 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.817 -178.421 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.506 ' HB2' ' O ' ' A' ' 14' ' ' ASP . . . -82.13 108.07 10.48 Favored Pre-proline 0 C--N 1.331 -0.2 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -176.565 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.88 ' HG2' HD11 ' A' ' 41' ' ' LEU . 1.0 OUTLIER -85.17 -155.1 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.113 2.542 . . . . 0.0 110.754 176.99 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.461 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 1.5 mm -95.85 159.18 2.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.969 0.414 . . . . 0.0 110.402 177.782 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.2 m -157.92 138.27 12.69 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.775 179.834 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.47 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -150.01 177.03 10.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.55 179.991 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.526 ' CB ' ' CE1' ' A' ' 39' ' ' TYR . 1.2 p -104.49 141.32 36.58 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.575 179.088 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.553 HG22 ' NE2' ' A' ' 40' ' ' HIS . 2.3 p -67.6 66.84 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.287 0.565 . . . . 0.0 110.384 179.154 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.559 ' HE2' HG23 ' A' ' 90' ' ' THR . 1.5 mmpt? -47.75 112.71 0.59 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.159 -178.184 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -97.28 125.79 42.07 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.268 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.04 -166.14 0.97 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.96 -179.342 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 1.5 t -42.24 134.21 2.54 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.329 -179.129 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.495 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 37.4 Cg_exo -58.54 161.52 14.42 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.331 2.021 . . . . 0.0 112.158 -179.245 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.462 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 88.2 Cg_exo -40.56 154.61 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.779 2.319 . . . . 0.0 112.867 -179.477 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.0 p -106.38 91.02 3.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.997 -179.641 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.549 HG21 ' O ' ' A' ' 122' ' ' PRO . 19.9 pt -69.65 175.9 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.066 179.917 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.5 t -93.54 149.07 21.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.635 178.869 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.47 ' HB3' ' CE1' ' A' ' 103' ' ' TYR . 1.6 m120 50.12 28.45 3.04 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.127 177.927 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.47 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -158.34 -163.61 13.07 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.899 179.872 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 98' ' ' SER . 13.2 ptt180 -170.12 -175.65 2.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.095 0.474 . . . . 0.0 110.931 -179.214 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 4.9 p80 -123.04 166.52 14.98 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.801 179.756 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.434 ' OD1' HG13 ' A' ' 95' ' ' VAL . 46.2 p30 . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.422 178.962 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.425 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 13.9 m-85 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.796 0.332 . . . . 0.0 110.542 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.425 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 65.9 m-85 -152.71 167.84 27.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.713 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.559 HG23 ' HE2' ' A' ' 70' ' ' LYS . 24.9 p -141.05 -175.85 4.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.937 0.398 . . . . 0.0 111.361 -179.339 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.464 ' CB ' ' HA3' ' A' ' 38' ' ' GLY . 1.0 OUTLIER -61.55 96.6 0.06 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.295 0.569 . . . . 0.0 110.967 179.879 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 125.34 19.4 2.36 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.16 -0.927 . . . . 0.0 113.222 178.483 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.441 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.7 OUTLIER -100.64 154.16 18.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 117.049 0.424 . . . . 0.0 110.565 178.989 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.18 148.99 31.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.04 0.448 . . . . 0.0 110.918 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.473 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 17.9 t -145.52 147.45 18.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.651 179.852 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.794 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -107.13 126.58 52.55 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.962 -179.624 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.977 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.6 m-85 -85.51 156.5 20.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.932 -179.742 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.432 ' HA ' HD13 ' A' ' 105' ' ' LEU . 72.5 m -149.92 145.55 26.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.17 -179.503 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.457 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 66.7 m -75.16 156.04 36.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.028 179.887 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.47 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 78.9 m-20 -85.06 -78.13 0.26 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.592 -179.03 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.5 m -59.89 -23.49 63.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.378 -178.806 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 123.97 33.73 0.78 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.541 -179.811 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.503 ' CE2' HG12 ' A' ' 126' ' ' ILE . 40.4 m-85 -69.7 -175.52 0.89 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.967 0.413 . . . . 0.0 110.757 179.697 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.1 m -107.84 101.61 10.88 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.387 179.012 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.512 HD21 ' HA ' ' A' ' 109' ' ' SER . 0.3 OUTLIER -47.29 127.05 10.31 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 121.367 0.603 . . . . 0.0 111.514 -178.991 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.438 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 40.7 mm -95.76 154.64 3.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.427 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 66.49 -125.42 26.23 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.93 -178.891 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -127.28 134.24 50.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.878 0.37 . . . . 0.0 110.943 179.167 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.794 ' HB2' HG22 ' A' ' 96' ' ' THR . 0.4 OUTLIER -67.65 -30.39 69.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.804 179.621 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -70.11 132.8 23.88 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.554 179.388 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.977 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.4 t -127.41 121.64 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.675 0.274 . . . . 0.0 110.453 179.329 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.29 117.31 22.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.005 0.431 . . . . 0.0 111.802 -178.463 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.534 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 17.9 t -82.59 104.33 12.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.438 176.559 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 2.2 p -146.42 163.08 36.77 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.364 -178.17 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.33 30.0 4.03 Favored Glycine 0 N--CA 1.453 -0.219 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.767 179.898 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.3 16.14 70.9 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.52 -179.464 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -141.45 -177.4 5.13 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.887 0.375 . . . . 0.0 110.599 179.515 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.534 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 93.7 m95 -117.74 144.99 44.78 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.103 -179.391 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.91 147.02 51.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.298 -179.285 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.489 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER 73.38 46.13 0.21 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.163 178.676 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 73.3 Cg_endo -75.84 136.02 18.25 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.361 2.041 . . . . 0.0 111.331 177.951 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.549 ' O ' HG21 ' A' ' 77' ' ' ILE . 64.8 Cg_endo -91.12 -173.68 0.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.505 2.137 . . . . 0.0 113.496 -178.135 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.436 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -129.37 -162.7 1.22 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.746 177.833 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 4.9 m -156.43 90.82 1.2 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.069 0.462 . . . . 0.0 110.856 179.378 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -118.12 160.7 21.09 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.932 -179.626 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.563 ' O ' HG22 ' A' ' 126' ' ' ILE . 15.9 mm . . . . . 0 C--N 1.323 -0.546 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.997 179.912 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.844 ' HD2' HG23 ' A' ' 25' ' ' VAL . 32.9 mtm-85 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.915 0.388 . . . . 0.0 110.957 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.432 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 8.5 m -91.08 163.0 31.06 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.625 179.55 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -73.62 167.88 26.15 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.281 1.988 . . . . 0.0 111.719 179.87 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.2 p -52.37 108.97 1.21 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.927 -179.275 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.592 ' HG2' HD13 ' A' ' 22' ' ' ILE . 49.2 Cg_exo -49.34 158.05 1.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.314 2.009 . . . . 0.0 112.335 179.906 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.876 ' O ' HD11 ' A' ' 20' ' ' LEU . 4.3 mtt180 -54.11 177.25 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.735 177.354 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.427 ' O ' ' CB ' ' A' ' 63' ' ' ALA . 0.1 OUTLIER -124.9 -177.01 3.7 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.182 0.515 . . . . 0.0 111.678 -178.676 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.501 HG22 ' CD2' ' A' ' 20' ' ' LEU . 5.2 tt -139.47 151.69 22.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.837 -179.397 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -90.34 -64.48 1.13 Allowed 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -177.46 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -92.52 26.92 2.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.775 0.321 . . . . 0.0 111.09 -178.894 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -144.15 -160.4 8.45 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.851 179.708 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.85 133.52 10.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.753 0.311 . . . . 0.0 110.489 179.434 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.876 HD11 ' O ' ' A' ' 13' ' ' ARG . 18.7 mt -72.27 150.72 43.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.178 0.513 . . . . 0.0 111.899 -178.37 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.412 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 5.5 t0 -123.36 69.62 1.02 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.266 177.419 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.894 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.9 OUTLIER -79.4 100.75 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.069 -176.492 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.36 19.26 54.58 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.575 176.696 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 163.32 141.07 3.02 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 121.192 -0.528 . . . . 0.0 111.87 -179.376 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.844 HG23 ' HD2' ' A' ' 8' ' ' ARG . 6.2 m -127.01 -3.77 4.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.898 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.421 ' HA ' ' CB ' ' A' ' 8' ' ' ARG . 1.3 p-10 -69.57 156.58 38.69 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.792 0.33 . . . . 0.0 110.669 179.868 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.451 ' CZ ' ' HG ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -49.26 116.72 1.82 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.021 0.439 . . . . 0.0 111.02 -179.25 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.07 -6.64 47.34 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.585 -178.77 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 m -66.98 -174.29 0.32 Allowed 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.884 0.342 . . . . 0.0 110.762 179.711 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 47' ' ' SER . 0.3 OUTLIER -159.74 139.16 11.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.964 -179.978 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.894 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -108.2 167.63 3.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.921 0.391 . . . . 0.0 110.854 179.681 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.423 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -132.92 110.6 10.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.695 178.554 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.713 ' CE2' HD21 ' A' ' 20' ' ' LEU . 23.8 m-85 -82.76 132.19 35.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.162 -179.272 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.22 159.98 40.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.446 -179.898 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.449 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 56.4 m -84.69 176.13 8.76 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.625 -179.996 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -84.98 -83.22 0.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.911 0.386 . . . . 0.0 110.769 -179.346 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.23 129.4 9.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.344 179.267 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.905 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 74.67 28.77 62.52 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.434 -0.888 . . . . 0.0 111.596 -177.842 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.508 ' CE2' ' HB3' ' A' ' 68' ' ' SER . 29.7 m-85 -134.08 157.77 45.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.003 0.43 . . . . 0.0 111.173 -179.734 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.843 ' CE1' HG22 ' A' ' 69' ' ' VAL . 6.3 m-70 -115.13 134.03 55.51 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 173.63 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.848 HD21 ' O ' ' A' ' 44' ' ' GLU . 6.3 tt -81.65 107.67 14.58 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.023 -179.613 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.431 HG12 ' HA ' ' A' ' 66' ' ' CYS . 1.3 mm -92.72 146.1 6.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.97 -178.229 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.76 -151.97 32.86 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.011 -178.441 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.848 ' O ' HD21 ' A' ' 41' ' ' LEU . 1.3 pm0 -53.22 173.21 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.72 0.26 . . . . 0.0 110.406 179.232 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.519 ' HB3' HD22 ' A' ' 41' ' ' LEU . 8.3 p -153.61 24.07 0.52 Allowed 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.869 0.366 . . . . 0.0 111.522 -178.542 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.423 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 0.8 OUTLIER -157.53 -170.91 3.37 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.947 -178.357 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.447 ' O ' HG13 ' A' ' 31' ' ' ILE . 1.8 m -164.67 98.87 0.79 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.632 179.182 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.487 ' CD2' ' N ' ' A' ' 48' ' ' TYR . 1.2 m-30 -84.95 118.86 24.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.038 0.447 . . . . 0.0 111.21 -179.303 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 16.2 t -70.2 115.62 9.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.298 179.043 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.503 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 2.8 tt0 -144.56 172.35 13.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.449 0.643 . . . . 0.0 111.214 -178.715 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.503 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 1.0 OUTLIER . . . . . 0 C--N 1.323 -0.584 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.303 -179.683 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.421 ' SD ' ' CE1' ' A' ' 27' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.922 0.391 . . . . 0.0 110.576 . . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.3 m -146.77 -175.65 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.811 -179.891 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.542 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 88.1 m95 -128.51 137.14 51.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.008 -179.454 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -151.86 122.51 3.64 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.016 -179.697 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.4 ' HG2' ' O ' ' A' ' 46' ' ' LYS . 58.2 Cg_endo -72.65 -167.2 4.8 Favored 'Cis proline' 0 C--N 1.352 0.746 0 C-N-CA 123.744 -1.357 . . . . 0.0 112.259 -0.313 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -110.64 -155.88 0.57 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 -179.306 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.493 ' CB ' ' CE2' ' A' ' 33' ' ' TYR . . . -76.01 112.82 22.46 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.653 179.226 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.474 ' HD2' ' CG ' ' A' ' 33' ' ' TYR . 18.3 Cg_exo -68.26 -150.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.511 2.141 . . . . 0.0 112.192 -179.1 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.5 pt -136.21 -177.95 2.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.841 -179.814 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.431 ' HA ' HG12 ' A' ' 42' ' ' ILE . 78.7 m -149.99 157.32 43.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.353 0.597 . . . . 0.0 111.781 179.452 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -129.63 109.18 10.79 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.41 177.659 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.508 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 11.2 p -49.81 131.78 22.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.232 -178.668 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.905 HG12 ' O ' ' A' ' 38' ' ' GLY . 4.3 p -53.68 104.83 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.26 -178.479 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.467 ' CE ' HG23 ' A' ' 90' ' ' THR . 2.4 mmtp -89.45 114.21 25.66 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.582 177.867 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.11 125.39 38.72 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.103 0.478 . . . . 0.0 110.266 179.125 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.57 -155.64 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.924 178.777 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.408 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 1.1 t -53.15 143.77 31.86 Favored Pre-proline 0 N--CA 1.447 -0.584 0 CA-C-O 120.561 0.22 . . . . 0.0 110.536 179.483 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.488 ' HD2' ' CD2' ' A' ' 82' ' ' HIS . 32.4 Cg_exo -60.14 166.28 9.26 Favored 'Trans proline' 0 CA--C 1.53 0.311 0 C-N-CA 122.633 2.222 . . . . 0.0 112.277 -179.263 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.526 ' HD3' ' CG ' ' A' ' 118' ' ' TRP . 97.7 Cg_exo -40.97 165.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.795 2.33 . . . . 0.0 112.927 -179.517 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 73.1 m -115.32 87.34 2.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.704 179.551 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.632 HG23 ' HE2' ' A' ' 97' ' ' TYR . 7.3 pt -69.48 -173.59 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.071 -179.547 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 t -100.8 148.88 24.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.955 179.679 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.497 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 1.5 m120 47.22 29.4 1.19 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.112 177.937 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.494 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -161.51 -171.62 27.79 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.056 179.778 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -170.36 -174.87 1.78 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.992 0.425 . . . . 0.0 111.028 -178.723 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.488 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 2.1 p-80 -117.59 171.95 7.67 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.621 -179.962 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.119 179.625 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.439 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 7.3 m-85 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.81 0.338 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.439 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 49.8 m-85 -152.23 164.32 37.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.0 -179.381 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.467 HG23 ' CE ' ' A' ' 70' ' ' LYS . 16.5 p -148.9 -174.93 4.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.004 0.431 . . . . 0.0 111.427 -179.605 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 7.3 p-10 -52.92 93.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.238 0.542 . . . . 0.0 111.566 -179.155 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.09 26.88 1.61 Allowed Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.474 -0.785 . . . . 0.0 113.628 177.549 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.34 152.5 26.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.191 0.495 . . . . 0.0 110.848 178.994 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.41 HG22 ' N ' ' A' ' 95' ' ' VAL . 34.3 m -134.85 153.62 35.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.156 0.503 . . . . 0.0 111.24 -179.703 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.517 HG23 ' CH2' ' A' ' 118' ' ' TRP . 25.1 t -147.59 148.14 16.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.636 179.263 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.488 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -105.14 134.09 48.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.698 179.876 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.953 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.5 m-85 -92.4 152.17 19.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.037 -179.754 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 59.0 m -146.52 140.29 26.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.754 179.749 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.494 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 82.0 m -69.75 159.03 34.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.033 -179.666 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -93.03 -87.36 0.23 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.222 -179.821 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.7 t -44.52 -33.2 1.65 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.637 -179.071 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 133.22 40.45 0.19 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.563 179.867 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.498 ' CE2' HG12 ' A' ' 126' ' ' ILE . 37.6 m-85 -82.2 -173.07 4.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.845 0.355 . . . . 0.0 110.781 179.794 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.0 m -112.2 109.98 19.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.016 -179.821 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.51 HD23 ' HB2' ' A' ' 122' ' ' PRO . 2.5 tp -45.43 113.5 0.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.903 179.05 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.432 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 35.2 mm -92.07 154.64 3.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.143 179.83 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 65.69 -125.27 28.11 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.362 -0.923 . . . . 0.0 111.811 -178.299 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -123.3 132.84 54.14 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.795 0.331 . . . . 0.0 110.651 179.052 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.488 ' OG ' HG22 ' A' ' 96' ' ' THR . 2.6 t -69.36 -29.94 67.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.49 179.438 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -70.98 135.52 24.48 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.794 179.771 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.953 HG21 ' CE1' ' A' ' 97' ' ' TYR . 3.1 t -129.44 120.78 51.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.596 0.236 . . . . 0.0 110.717 179.266 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.859 HD22 ' N ' ' A' ' 113' ' ' CYS . 1.0 OUTLIER -80.33 130.49 35.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.903 0.382 . . . . 0.0 111.434 -179.232 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.859 ' N ' HD22 ' A' ' 112' ' ' LEU . 37.4 t -102.68 104.18 14.5 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.075 177.461 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.727 ' HB3' HD11 ' A' ' 112' ' ' LEU . 5.3 p -152.93 123.01 7.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.898 0.38 . . . . 0.0 111.714 -179.352 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.42 ' CA ' HG11 ' A' ' 69' ' ' VAL . . . 93.17 19.79 34.95 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.696 179.148 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.449 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 82.14 -1.27 87.41 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.622 -179.173 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -131.51 -177.42 4.4 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.859 0.361 . . . . 0.0 110.432 179.373 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.526 ' CG ' ' HD3' ' A' ' 75' ' ' PRO . 86.5 m95 -120.08 157.43 28.96 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.035 -178.998 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.72 152.34 47.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.054 0.454 . . . . 0.0 111.298 -179.844 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.498 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.7 OUTLIER 69.52 45.57 0.28 Allowed Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.119 179.241 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.498 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 76.9 Cg_endo -77.45 138.32 17.4 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.384 2.056 . . . . 0.0 111.755 178.564 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.51 ' HB2' HD23 ' A' ' 105' ' ' LEU . 74.3 Cg_endo -91.25 -171.64 0.42 Allowed 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.786 2.324 . . . . 0.0 113.482 -178.542 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.88 -167.16 1.83 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.819 177.947 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 7.4 m -148.67 92.82 2.04 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.051 0.453 . . . . 0.0 110.801 179.328 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -118.02 163.93 15.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.551 -179.853 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.551 ' O ' HG22 ' A' ' 126' ' ' ILE . 15.4 mm . . . . . 0 C--N 1.322 -0.594 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.956 -179.789 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.499 ' CD ' HG22 ' A' ' 25' ' ' VAL . 3.4 ptp180 . . . . . 0 N--CA 1.456 -0.148 0 CA-C-O 120.529 0.204 . . . . 0.0 110.979 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.45 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 20.5 m -116.38 161.58 30.84 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.845 0.355 . . . . 0.0 111.575 -178.454 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 57.4 Cg_endo -71.12 174.62 10.39 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.485 2.123 . . . . 0.0 112.02 179.689 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.0 t -54.55 108.25 1.09 Allowed Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.925 -179.683 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.519 ' HG3' ' CZ2' ' A' ' 59' ' ' TRP . 53.3 Cg_exo -46.4 164.56 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.351 2.034 . . . . 0.0 112.123 179.867 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.849 ' O ' HD11 ' A' ' 20' ' ' LEU . 14.7 ttt180 -74.07 158.56 34.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.707 178.103 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.9 -175.42 2.76 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.202 0.525 . . . . 0.0 111.516 -178.301 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.452 HG22 ' CD2' ' A' ' 20' ' ' LEU . 19.7 tt -151.05 146.02 16.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.203 -179.492 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -85.03 158.97 20.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.34 -0.391 . . . . 0.0 109.999 177.844 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.483 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 0.4 OUTLIER 46.66 30.77 1.21 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.887 179.974 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -157.93 175.88 35.09 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.705 -179.413 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -141.84 137.82 31.73 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.658 0.266 . . . . 0.0 110.515 -179.869 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.849 HD11 ' O ' ' A' ' 13' ' ' ARG . 25.9 mt -83.71 157.88 22.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.11 0.481 . . . . 0.0 111.604 -179.558 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -125.45 75.49 1.48 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.625 177.709 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.918 ' HA ' HG23 ' A' ' 31' ' ' ILE . 1.1 mt -71.4 104.01 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.105 -177.156 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.39 15.36 56.21 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.789 176.855 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 156.08 130.99 1.34 Allowed Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.077 -179.591 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.781 HG12 ' HZ2' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -113.24 5.7 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-O 120.768 0.318 . . . . 0.0 110.438 -178.763 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 0.5 OUTLIER -69.37 155.66 40.07 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.907 0.384 . . . . 0.0 111.663 -178.851 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.599 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 5.8 t80 -53.56 90.09 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.711 179.29 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 127.39 -6.92 7.11 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.767 -179.478 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.8 p -72.99 170.89 13.89 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.958 0.379 . . . . 0.0 110.653 179.798 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.2 p -137.13 152.03 49.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.937 179.79 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.918 HG23 ' HA ' ' A' ' 22' ' ' ILE . 1.1 mt -114.87 170.35 5.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.665 -179.306 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.448 ' H ' HG22 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -133.55 115.29 14.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.876 0.369 . . . . 0.0 110.654 179.357 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.578 ' CE2' HD21 ' A' ' 20' ' ' LEU . 14.3 m-85 -89.71 154.0 20.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.629 -178.67 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.29 155.98 34.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.536 179.426 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.437 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 4.0 m -82.11 167.67 18.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.819 0.343 . . . . 0.0 110.958 -179.933 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -68.43 -85.4 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.204 -179.247 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.5 m -153.17 132.61 12.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.832 0.348 . . . . 0.0 111.008 -179.784 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.622 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 68.05 21.84 73.83 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.124 -179.198 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.5 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.6 m-85 -115.16 174.33 6.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.82 0.343 . . . . 0.0 110.86 -179.672 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.741 ' CD2' HD11 ' A' ' 42' ' ' ILE . 3.3 p-80 -137.82 114.85 10.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.496 177.976 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.927 HD21 ' O ' ' A' ' 44' ' ' GLU . 6.5 tt -78.19 125.36 29.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.502 -179.698 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.741 HD11 ' CD2' ' A' ' 40' ' ' HIS . 2.2 mm -102.17 160.82 4.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.053 0.454 . . . . 0.0 111.113 -179.398 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.81 -135.24 22.95 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.485 -179.639 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.927 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -79.96 -173.58 3.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.966 0.413 . . . . 0.0 111.064 -179.952 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -167.31 29.18 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.384 179.389 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.425 ' HG3' ' HA ' ' A' ' 32' ' ' THR . 15.8 mtpt -155.08 127.52 7.87 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.962 0.411 . . . . 0.0 111.641 -178.666 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.454 ' OG ' ' CB ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -94.05 148.05 22.54 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.024 178.403 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.501 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.6 m-85 -124.45 114.95 20.14 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.603 177.922 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 52.8 t -65.67 98.22 0.37 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.468 179.677 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.503 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 0.6 OUTLIER -122.09 175.01 6.58 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.711 -178.501 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.599 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.595 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.171 -179.292 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.884 0.373 . . . . 0.0 110.359 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -145.34 -175.55 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.491 -179.669 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.781 ' HZ2' HG12 ' A' ' 25' ' ' VAL . 76.6 m95 -129.9 121.43 26.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.068 0.461 . . . . 0.0 111.905 -179.031 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.501 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 2.8 m120 -68.91 165.87 33.33 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.35 177.443 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.435 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 81.2 Cg_exo -17.09 94.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 125.289 3.993 . . . . 0.0 114.586 -178.475 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.475 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -91.67 -76.13 0.46 Allowed 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.329 -177.871 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.477 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -88.02 109.02 24.49 Favored Pre-proline 0 C--N 1.331 -0.201 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -175.711 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.92 ' HG2' HD11 ' A' ' 41' ' ' LEU . 2.3 Cg_endo -83.61 -154.59 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.053 2.502 . . . . 0.0 111.28 177.196 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.476 HG22 ' H ' ' A' ' 66' ' ' CYS . 3.0 mm -87.65 165.41 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.917 0.389 . . . . 0.0 110.791 178.64 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.476 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -165.83 131.25 2.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.502 179.455 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -154.82 168.32 27.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.184 -179.009 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.5 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 8.6 p -88.1 111.71 21.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.936 179.744 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.622 HG12 ' O ' ' A' ' 38' ' ' GLY . 4.9 p -45.08 103.9 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.884 179.253 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.492 ' HD2' ' CD1' ' A' ' 88' ' ' PHE . 2.2 ttpp -104.43 134.63 47.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.957 -176.035 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 1.5 m -90.18 136.87 32.78 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.668 177.791 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.54 -169.85 0.25 Allowed 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.817 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.6 t -74.99 111.57 14.03 Favored Pre-proline 0 C--N 1.314 -0.954 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.744 -179.021 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.642 ' HG3' ' CE2' ' A' ' 118' ' ' TRP 0.321 0.0 OUTLIER -34.23 -175.27 0.0 OUTLIER 'Trans proline' 0 CA--C 1.468 -2.796 0 C-N-CA 123.722 2.948 . . . . 0.0 114.102 173.589 . . . . . . . . 4 4 . 1 . 027 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.545 ' CB ' ' CE1' ' A' ' 97' ' ' TYR . 23.3 Cg_endo -73.3 -164.0 3.12 Favored 'Cis proline' 0 C--N 1.323 -0.814 0 N-CA-C 113.847 0.672 . . . . 0.0 113.847 -18.854 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.2 t -135.55 21.11 3.36 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.54 172.257 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.612 HD12 ' HB2' ' A' ' 124' ' ' CYS . 3.3 pt -111.16 -160.03 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.274 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.213 -177.45 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.472 ' N ' HG13 ' A' ' 77' ' ' ILE . 86.2 p -134.24 151.03 51.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.788 177.61 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.9 m120 55.6 32.46 19.23 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.578 179.327 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.573 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -151.08 -160.81 9.64 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.127 -1.035 . . . . 0.0 113.731 179.764 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.42 ' N ' ' O ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -161.95 -172.75 3.39 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.801 0.334 . . . . 0.0 111.121 -178.196 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.563 ' CG ' ' HB2' ' A' ' 74' ' ' PRO . 31.3 p80 -124.52 173.41 8.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.157 0.503 . . . . 0.0 112.257 -175.723 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.474 ' H ' HG12 ' A' ' 95' ' ' VAL . 80.8 m-20 . . . . . 0 CA--C 1.534 0.357 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.169 174.021 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.492 ' CD1' ' HD2' ' A' ' 70' ' ' LYS . 9.4 m-85 . . . . . 0 N--CA 1.451 -0.423 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.494 ' CE1' ' HD2' ' A' ' 74' ' ' PRO . 17.6 m-85 -147.24 175.53 10.68 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.624 0.249 . . . . 0.0 110.862 -177.661 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.424 HG22 ' HB2' ' A' ' 70' ' ' LYS . 14.7 p -144.6 169.82 17.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.132 0.492 . . . . 0.0 112.029 -179.28 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.27 94.25 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.307 -179.323 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.53 28.45 0.98 Allowed Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.327 -0.852 . . . . 0.0 113.161 178.376 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.469 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.7 OUTLIER -110.14 157.45 19.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.965 0.383 . . . . 0.0 110.879 179.013 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 35.8 m -138.76 146.08 26.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.759 179.627 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.629 HG23 ' CH2' ' A' ' 118' ' ' TRP . 4.2 t -147.16 142.8 20.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.026 -178.681 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.846 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -98.55 127.39 44.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.174 0.512 . . . . 0.0 110.132 178.692 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.731 ' CZ ' HG21 ' A' ' 111' ' ' VAL . 2.8 m-30 -95.49 166.23 11.96 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.496 0.665 . . . . 0.0 112.756 -174.794 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.42 ' O ' ' N ' ' A' ' 81' ' ' ARG . 67.6 m -152.87 145.54 24.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.542 178.75 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.542 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 76.1 m -69.43 155.67 40.08 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.863 0.363 . . . . 0.0 111.538 -178.881 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.6 -86.47 0.19 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.967 178.934 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -47.03 -27.04 1.18 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.511 -179.385 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 125.25 32.26 0.8 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.877 179.866 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.502 ' CE1' HG12 ' A' ' 126' ' ' ILE . 18.5 m-85 -72.54 -170.85 0.72 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.903 0.383 . . . . 0.0 111.25 179.952 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.9 m -118.04 96.81 5.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.205 177.882 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.439 ' CD2' ' HA ' ' A' ' 109' ' ' SER . 0.2 OUTLIER -47.92 139.53 7.7 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.563 0.697 . . . . 0.0 111.81 -178.226 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.555 HG22 ' N ' ' A' ' 107' ' ' GLY . 16.8 mm -125.5 160.96 30.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.328 -178.71 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.555 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 64.77 25.18 70.34 Favored Glycine 0 N--CA 1.457 0.082 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.453 177.718 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.455 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.3 OUTLIER 67.05 130.84 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.532 0.682 . . . . 0.0 112.355 178.452 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.846 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.1 p -64.54 -24.68 67.68 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.427 -1.26 . . . . 0.0 111.329 178.906 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.55 130.31 48.24 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.856 179.134 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.731 HG21 ' CZ ' ' A' ' 97' ' ' TYR . 16.4 t -135.31 123.71 39.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.492 0.187 . . . . 0.0 110.855 -177.819 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.0 127.98 35.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.967 0.413 . . . . 0.0 111.804 -177.932 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.506 ' HB2' ' CZ3' ' A' ' 118' ' ' TRP . 44.7 t -89.52 98.08 11.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.521 176.386 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 24.0 p -136.76 159.96 40.28 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.672 -179.119 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.498 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 50.67 29.04 17.53 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.835 -179.074 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.487 ' N ' ' HB ' ' A' ' 69' ' ' VAL . . . 68.39 14.51 66.8 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.085 -0.578 . . . . 0.0 112.575 -179.555 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -141.95 177.02 8.49 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 178.665 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.642 ' CE2' ' HG3' ' A' ' 74' ' ' PRO . 99.4 m95 -98.39 126.5 43.94 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.149 0.5 . . . . 0.0 111.158 -179.586 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.9 150.45 24.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.254 -178.829 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.513 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.9 OUTLIER 53.51 42.46 1.18 Allowed Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.101 -179.987 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 37.7 Cg_endo -64.55 151.5 85.34 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.039 1.826 . . . . 0.0 111.098 177.65 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.664 ' HD3' HG22 ' A' ' 111' ' ' VAL . 44.4 Cg_endo -80.27 -173.59 1.92 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 121.922 1.748 . . . . 0.0 113.035 -179.06 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.461 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -122.75 -161.57 0.96 Allowed 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 173.765 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 124' ' ' CYS . . . . . 0.612 ' HB2' HD12 ' A' ' 77' ' ' ILE . 2.4 t -170.65 83.6 0.1 Allowed 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.25 -175.61 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -115.01 169.04 9.39 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.583 -1.19 . . . . 0.0 111.676 -175.838 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.502 HG12 ' CE1' ' A' ' 103' ' ' TYR . 37.5 mm . . . . . 0 C--N 1.326 -0.442 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.78 179.342 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.75 ' HD2' HG23 ' A' ' 25' ' ' VAL . 7.7 mtm180 . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.821 0.344 . . . . 0.0 110.738 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.45 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 60.8 m -105.33 160.66 25.27 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 -178.956 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.45 ' HD3' ' HB2' ' A' ' 57' ' ' MET . 32.2 Cg_endo -65.86 173.62 6.72 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.59 2.193 . . . . 0.0 112.192 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.7 t -54.37 108.1 1.05 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.578 179.53 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.678 ' HG2' HD13 ' A' ' 22' ' ' ILE . 72.7 Cg_exo -46.98 160.25 0.27 Allowed 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.302 2.001 . . . . 0.0 112.401 -179.468 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.525 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -75.31 174.01 10.1 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.96 178.325 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.582 ' HA ' HD11 ' A' ' 20' ' ' LEU . 1.7 t0 -127.33 -177.0 3.9 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.224 0.535 . . . . 0.0 111.691 -178.866 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.484 HG22 HD21 ' A' ' 20' ' ' LEU . 17.9 tt -146.47 143.06 20.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.785 -179.339 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -81.86 156.8 24.65 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 177.394 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.496 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 0.5 OUTLIER 49.28 26.14 1.46 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.839 0.352 . . . . 0.0 110.554 -179.239 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -153.21 170.59 32.14 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.698 -179.01 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 34' ' ' SER . 0.2 OUTLIER -138.36 144.01 40.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.699 0.285 . . . . 0.0 110.34 179.526 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.781 HD22 ' CE1' ' A' ' 33' ' ' TYR . 0.5 OUTLIER -92.49 163.21 13.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.207 0.527 . . . . 0.0 111.769 -179.312 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 32' ' ' THR . 8.1 t0 -127.47 72.34 1.38 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.875 177.175 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.891 ' HA ' HG23 ' A' ' 31' ' ' ILE . 1.2 mt -72.76 97.8 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.809 -177.789 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.12 16.7 60.77 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.786 176.979 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 160.26 153.46 6.93 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 -179.278 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.75 HG23 ' HD2' ' A' ' 8' ' ' ARG . 17.0 m -134.87 11.58 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.8 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 40.3 t0 -90.02 163.08 15.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.972 0.415 . . . . 0.0 111.377 179.93 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.518 ' CE2' ' HB3' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -50.01 90.27 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.802 -179.599 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 131.99 -9.52 5.43 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.627 -0.796 . . . . 0.0 112.784 -179.566 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.8 m -76.43 157.45 32.23 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 117.107 0.454 . . . . 0.0 110.503 179.536 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.4 p -133.52 142.2 48.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.019 0.437 . . . . 0.0 110.917 179.603 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.891 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -106.81 154.08 7.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.435 -179.789 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.411 ' O ' ' N ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -115.97 119.45 35.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.023 0.44 . . . . 0.0 110.75 179.361 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.781 ' CE1' HD22 ' A' ' 20' ' ' LEU . 11.5 m-85 -95.03 137.95 33.4 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.263 -178.927 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 19' ' ' GLN . 4.4 m -146.77 159.59 43.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.079 179.793 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.414 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 11.1 m -81.97 173.52 12.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.6 179.452 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.415 ' N ' ' O ' ' A' ' 17' ' ' ASN . 0.4 OUTLIER -75.41 -79.88 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.107 -179.447 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.35 134.62 10.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.904 -179.651 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.24 23.52 71.61 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.809 -178.972 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.498 ' CE2' ' HB3' ' A' ' 68' ' ' SER . 2.3 m-85 -118.01 167.88 11.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.842 0.353 . . . . 0.0 110.868 -179.338 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.596 ' CD2' HD11 ' A' ' 42' ' ' ILE . 2.5 p-80 -132.97 121.82 23.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.337 177.635 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.932 HD21 ' O ' ' A' ' 44' ' ' GLU . 8.7 tt -83.3 127.91 34.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.849 -178.401 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.596 HD11 ' CD2' ' A' ' 40' ' ' HIS . 1.4 mm -106.57 149.46 9.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.051 -179.651 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.08 -142.56 20.71 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.07 -179.102 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.932 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -72.15 -175.8 1.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.869 0.366 . . . . 0.0 110.316 178.469 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -168.1 28.79 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.511 179.431 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -157.08 127.42 6.45 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.973 -179.929 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.432 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -102.59 152.36 21.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.74 -179.663 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.499 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.2 m-85 -128.04 124.89 38.22 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.488 0.661 . . . . 0.0 111.672 -179.971 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.491 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 42.7 t -73.23 118.2 15.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.157 -179.429 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.487 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 9.5 tt0 -159.25 168.45 26.43 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.074 179.018 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.518 ' HB3' ' CE2' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.311 -1.072 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.553 179.729 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.45 ' HB2' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 . . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.661 HG23 ' N ' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -137.22 -175.97 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 121.823 0.82 . . . . 0.0 112.171 -176.054 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.672 ' CE3' HD11 ' A' ' 31' ' ' ILE . 59.9 m95 -133.0 134.86 45.02 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.413 179.281 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.499 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 5.5 m-80 -78.41 163.34 62.22 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.888 178.319 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.42 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 31.6 Cg_exo -11.04 90.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.864 1 C-N-CA 125.758 4.305 . . . . 0.0 114.873 -179.392 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.48 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 39.4 mt-10 -91.27 -93.94 0.13 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.146 -178.284 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.479 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . . . -81.15 108.86 11.54 Favored Pre-proline 0 C--O 1.231 0.131 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -176.124 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.878 ' HG2' HD11 ' A' ' 41' ' ' LEU . 2.1 Cg_endo -82.93 -154.6 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.003 2.469 . . . . 0.0 110.756 176.681 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.446 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 2.0 mm -92.88 158.17 2.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.927 0.394 . . . . 0.0 110.508 178.271 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.2 m -164.34 143.37 7.37 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.957 179.905 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -169.88 170.2 7.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.463 179.954 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.498 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 30.2 p -73.92 99.02 3.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.045 0.45 . . . . 0.0 110.219 178.534 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.548 ' O ' HG13 ' A' ' 69' ' ' VAL . 5.6 p -44.2 93.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.29 179.619 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.468 ' CD ' HG23 ' A' ' 90' ' ' THR . 9.0 mttt -69.73 165.05 22.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.0 -177.467 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.416 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -120.88 131.58 54.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.179 179.079 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -69.19 -157.21 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.08 179.205 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.432 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 1.5 t -52.82 142.65 33.2 Favored Pre-proline 0 N--CA 1.45 -0.446 0 CA-C-O 120.682 0.277 . . . . 0.0 110.276 179.495 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 73' ' ' SER . 37.6 Cg_exo -57.31 162.79 9.22 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.397 2.065 . . . . 0.0 112.036 -179.083 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.507 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 82.4 Cg_exo -39.99 159.06 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.746 2.297 . . . . 0.0 112.947 -179.003 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 86.7 p -109.11 88.45 2.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.635 179.446 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.632 HG23 ' HE1' ' A' ' 97' ' ' TYR . 18.0 pt -69.85 174.12 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.33 -179.347 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.6 m -97.07 140.64 31.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.532 179.295 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.513 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 4.9 m-80 59.56 29.62 19.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.746 -179.913 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -172.83 -170.28 36.36 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.516 179.614 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -170.24 -175.7 2.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.888 0.375 . . . . 0.0 111.095 -179.371 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 0.7 OUTLIER -99.47 178.24 4.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.022 -179.987 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.8 m120 . . . . . 0 C--N 1.331 -0.235 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.392 -179.645 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.462 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 2.2 m-85 . . . . . 0 N--CA 1.455 -0.224 0 CA-C-O 120.996 0.427 . . . . 0.0 111.971 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.436 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 71.6 m-85 -151.27 154.51 36.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.028 -179.216 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.468 HG23 ' CD ' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -111.4 -174.15 2.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.138 0.494 . . . . 0.0 112.011 -178.617 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.452 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 8.7 m-20 -69.97 96.28 1.02 Allowed 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.033 -179.895 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.46 22.77 2.02 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.956 179.074 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -96.73 156.47 16.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.764 0.316 . . . . 0.0 110.635 179.44 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 34.3 m -135.64 151.13 29.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.17 0.51 . . . . 0.0 111.185 -179.816 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.457 HG23 ' CH2' ' A' ' 118' ' ' TRP . 15.1 t -149.2 146.81 17.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.812 179.783 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.974 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -100.93 142.0 33.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.261 179.03 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.895 ' CE2' HG21 ' A' ' 111' ' ' VAL . 4.0 m-85 -100.4 156.41 17.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.997 0.427 . . . . 0.0 111.202 -179.532 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.434 ' HA ' HD13 ' A' ' 105' ' ' LEU . 36.7 m -150.26 141.61 23.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.133 -179.508 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.419 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 63.2 m -71.96 165.55 23.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.881 179.718 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.32 -86.52 0.34 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.982 179.791 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -46.76 -29.29 1.85 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.403 -179.515 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.19 41.03 0.29 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.539 179.895 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.513 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 43.5 m-85 -80.6 -174.83 4.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.864 0.364 . . . . 0.0 110.817 179.877 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.3 m -112.59 106.99 15.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.173 178.828 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.474 HD11 ' HB3' ' A' ' 97' ' ' TYR . 0.2 OUTLIER -48.26 131.33 16.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.501 0.667 . . . . 0.0 111.683 -178.252 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.445 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 35.4 mm -97.62 155.93 3.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.199 179.16 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.91 -129.32 35.36 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.324 -179.534 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -121.12 129.74 53.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.804 0.335 . . . . 0.0 111.21 -179.771 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.974 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.5 p -61.33 -32.13 72.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.82 179.455 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -71.4 135.01 23.29 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.842 -179.592 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.895 HG21 ' CE2' ' A' ' 97' ' ' TYR . 3.8 t -130.72 120.0 46.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.632 0.253 . . . . 0.0 110.706 179.2 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.878 HD22 ' N ' ' A' ' 113' ' ' CYS . 1.1 tm? -82.18 134.32 35.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.86 0.362 . . . . 0.0 111.284 -179.374 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.878 ' N ' HD22 ' A' ' 112' ' ' LEU . 43.1 t -105.09 102.5 11.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.105 177.999 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.693 ' CB ' HD11 ' A' ' 112' ' ' LEU . 4.3 m -135.57 113.12 10.78 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.488 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 81.66 45.21 7.41 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.009 178.06 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.432 ' HA3' HG22 ' A' ' 69' ' ' VAL . . . 63.32 12.78 46.77 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.778 179.471 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -134.66 173.74 11.33 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.04 0.447 . . . . 0.0 110.663 179.687 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.52 ' CZ3' ' HB2' ' A' ' 113' ' ' CYS . 94.6 m95 -121.4 156.52 32.49 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.905 -179.41 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.74 149.91 46.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.051 0.453 . . . . 0.0 111.368 -179.767 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.477 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER 67.1 47.07 0.42 Allowed Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.786 179.136 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 84.8 Cg_endo -77.7 133.92 13.17 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.396 2.064 . . . . 0.0 111.642 178.701 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.509 ' O ' HG21 ' A' ' 77' ' ' ILE . 63.8 Cg_endo -88.49 -174.27 1.05 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.581 2.187 . . . . 0.0 113.468 -178.301 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.406 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -130.34 -159.39 0.96 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.031 178.431 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 7.6 m -158.62 91.11 1.05 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.087 0.47 . . . . 0.0 110.988 179.255 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -121.24 158.64 27.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.908 -179.922 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.498 HG12 ' CE2' ' A' ' 103' ' ' TYR . 21.0 mm . . . . . 0 C--N 1.324 -0.533 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.111 179.995 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.454 ' HA ' ' HA ' ' A' ' 26' ' ' ASP . 8.2 mtm-85 . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 120.68 0.276 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.452 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 18.3 m -109.27 160.37 27.87 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.084 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -67.94 170.48 14.15 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.318 2.012 . . . . 0.0 111.75 179.748 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.415 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 0.8 OUTLIER -51.43 105.61 0.55 Allowed Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.948 -179.524 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 11' ' ' SER . 19.8 Cg_endo -61.93 159.78 32.36 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.211 1.941 . . . . 0.0 111.881 179.731 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.441 ' O ' HD12 ' A' ' 20' ' ' LEU . 4.2 mpt_? -49.34 177.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.513 179.636 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.7 ' O ' HG22 ' A' ' 15' ' ' ILE . 0.2 OUTLIER -142.76 -7.74 0.84 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -178.042 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.7 HG22 ' O ' ' A' ' 14' ' ' ASP . 14.4 tt 53.72 163.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 120.749 0.309 . . . . 0.0 111.105 -177.939 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -104.26 -56.03 2.26 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -177.135 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.486 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 0.4 OUTLIER -94.12 31.01 1.75 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.936 0.398 . . . . 0.0 111.071 -178.412 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 34' ' ' SER . . . -157.47 179.65 33.06 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.517 179.473 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -134.92 139.42 44.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.793 0.33 . . . . 0.0 110.25 179.864 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.832 HD21 ' CE1' ' A' ' 33' ' ' TYR . 34.0 mt -88.04 159.77 18.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.377 0.608 . . . . 0.0 112.142 -178.462 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 32' ' ' THR . 5.3 t0 -124.04 83.37 2.13 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.225 176.646 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.892 ' HA ' HG23 ' A' ' 31' ' ' ILE . 1.8 mt -77.44 107.14 8.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.169 -176.678 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.99 19.52 37.85 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.59 176.679 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 152.86 132.77 1.81 Allowed Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.073 -179.373 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.824 HG12 ' CZ2' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -117.38 5.81 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-O 120.811 0.338 . . . . 0.0 110.591 -178.248 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.454 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 6.6 p-10 -75.68 153.71 36.97 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-O 120.964 0.412 . . . . 0.0 111.489 -179.11 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.59 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 3.7 t80 -52.51 95.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.767 179.334 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.02 8.49 5.08 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.989 -179.825 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 84.9 p -97.35 -174.1 2.84 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 116.992 0.396 . . . . 0.0 110.483 179.359 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.1 p -155.12 146.53 22.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.036 0.446 . . . . 0.0 111.121 178.44 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.892 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.8 OUTLIER -106.63 172.59 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.418 -179.394 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.463 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -129.64 118.34 21.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.925 0.393 . . . . 0.0 111.2 179.551 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.832 ' CE1' HD21 ' A' ' 20' ' ' LEU . 19.8 m-85 -94.77 140.96 29.19 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.234 0.54 . . . . 0.0 111.604 -179.486 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 19' ' ' GLN . 16.8 m -148.82 153.65 38.41 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.458 179.744 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.444 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 1.7 m -75.17 167.35 22.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.99 -179.628 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -76.04 -82.03 0.08 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.824 -179.589 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -153.95 121.38 5.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.656 179.351 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.743 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 77.32 14.19 82.79 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.423 -178.766 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.526 ' CZ ' ' CB ' ' A' ' 68' ' ' SER . 23.1 m-85 -111.7 154.47 24.92 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.586 -0.361 . . . . 0.0 111.0 179.546 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.841 ' CE1' HG22 ' A' ' 69' ' ' VAL . 2.3 m-70 -112.86 119.18 37.1 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 175.155 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.957 HD21 ' O ' ' A' ' 44' ' ' GLU . 4.1 tt -83.74 109.31 17.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.928 0.394 . . . . 0.0 110.022 -179.842 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.572 ' N ' HD13 ' A' ' 42' ' ' ILE . 1.5 mm -91.94 148.28 4.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.301 -178.255 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.15 -134.36 12.12 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.287 -179.288 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.957 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -84.31 -173.15 4.56 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.655 0.264 . . . . 0.0 110.686 179.422 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.2 p -160.46 23.38 0.15 Allowed 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.319 -178.91 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.463 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 8.3 mtpt -159.62 123.13 3.67 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.36 -177.701 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -92.13 145.05 24.82 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.196 178.714 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.556 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 0.4 OUTLIER -119.95 116.03 24.98 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 119.401 -0.919 . . . . 0.0 111.635 178.912 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.413 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 15.6 t -69.46 95.66 0.84 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.631 179.628 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -120.18 -168.18 1.57 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.939 -179.79 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.59 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.366 0 CA-C-O 121.009 0.433 . . . . 0.0 111.198 -179.693 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.625 ' O ' HG13 ' A' ' 58' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.533 0 CA-C-O 120.926 0.393 . . . . 0.0 109.981 . . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.625 HG13 ' O ' ' A' ' 57' ' ' MET . 0.9 OUTLIER -162.09 176.68 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.136 -179.303 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.824 ' CZ2' HG12 ' A' ' 25' ' ' VAL . 70.9 m95 -128.61 120.93 27.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.396 -179.253 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.556 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -69.0 167.72 18.99 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.754 178.189 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.487 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 56.1 Cg_exo -13.66 90.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.964 1 C-N-CA 125.399 4.066 . . . . 0.0 114.374 -179.16 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.509 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -94.46 -76.23 0.49 Allowed 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 115.273 -0.876 . . . . 0.0 113.231 -175.799 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.469 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -96.56 85.09 0.3 Allowed Pre-proline 0 N--CA 1.45 -0.462 0 N-CA-C 112.883 0.698 . . . . 0.0 112.883 -173.431 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.684 ' CG ' HD11 ' A' ' 41' ' ' LEU . 22.2 Cg_endo -51.49 -156.28 0.0 OUTLIER 'Trans proline' 0 N--CA 1.473 0.274 0 C-N-CA 123.586 2.858 . . . . 0.0 112.187 174.504 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.576 HG22 ' H ' ' A' ' 66' ' ' CYS . 0.7 OUTLIER -100.88 177.59 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.972 0.415 . . . . 0.0 110.726 178.876 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.576 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -170.74 133.65 0.98 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.681 179.523 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -137.87 113.18 9.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.078 179.795 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.526 ' CB ' ' CZ ' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -51.65 126.62 18.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.744 179.65 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.841 HG22 ' CE1' ' A' ' 40' ' ' HIS . 2.2 p -40.41 96.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.01 -179.674 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.498 ' HE3' HG23 ' A' ' 90' ' ' THR . 0.1 OUTLIER -73.15 114.04 10.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.163 179.868 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.428 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -92.14 122.4 34.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.944 0.402 . . . . 0.0 110.133 178.521 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.01 -159.72 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.111 179.85 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.663 ' HG ' ' CE1' ' A' ' 82' ' ' HIS . 1.2 t -54.41 143.6 45.87 Favored Pre-proline 0 N--CA 1.449 -0.509 0 CA-C-O 120.589 0.233 . . . . 0.0 110.554 -179.829 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.519 ' HG2' HG11 ' A' ' 95' ' ' VAL . 22.4 Cg_exo -62.1 160.77 28.83 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.432 2.088 . . . . 0.0 111.941 -179.855 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.508 ' HD3' ' CG ' ' A' ' 118' ' ' TRP . 74.7 Cg_exo -38.64 156.95 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.885 2.39 . . . . 0.0 112.912 -179.489 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.94 89.97 3.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.749 179.906 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.605 HG23 ' HE2' ' A' ' 97' ' ' TYR . 19.8 pt -69.35 178.65 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.057 -179.816 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.8 m -99.2 142.47 30.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.974 179.941 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.504 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 2.6 m-80 59.02 28.79 18.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.099 179.524 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.458 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -165.95 -167.49 26.66 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.857 179.834 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.427 ' N ' ' O ' ' A' ' 98' ' ' SER . 10.1 ptt180 -161.66 -175.49 4.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.032 0.444 . . . . 0.0 110.923 -179.693 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.663 ' CE1' ' HG ' ' A' ' 73' ' ' SER . 19.7 p80 -108.68 171.35 7.48 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.881 179.88 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.684 179.146 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.431 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 13.5 m-85 . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 120.816 0.341 . . . . 0.0 110.697 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.431 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 32.2 m-85 -145.05 165.66 27.58 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.698 -179.327 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.498 HG23 ' HE3' ' A' ' 70' ' ' LYS . 13.3 p -128.5 178.16 6.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.108 0.48 . . . . 0.0 111.764 -178.384 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 71.3 m-20 -62.25 95.58 0.07 Allowed 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.042 179.981 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 125.58 20.35 2.16 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.372 -0.831 . . . . 0.0 113.208 178.453 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.449 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -97.5 159.28 15.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 117.015 0.408 . . . . 0.0 110.439 178.91 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 27.1 m -134.92 146.28 30.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.022 0.439 . . . . 0.0 111.056 -179.626 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.519 HG11 ' HG2' ' A' ' 74' ' ' PRO . 27.9 t -141.62 148.35 21.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.946 179.699 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.741 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -107.08 131.12 54.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.776 179.663 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.973 ' CE1' HG21 ' A' ' 111' ' ' VAL . 6.2 m-85 -90.42 155.89 18.61 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.106 -179.414 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.427 ' O ' ' N ' ' A' ' 81' ' ' ARG . 1.3 p -149.86 136.68 19.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.542 -179.482 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.423 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 60.5 m -70.13 159.19 34.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.867 179.27 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.458 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 73.0 m-80 -92.13 -76.49 0.46 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.354 -179.483 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.78 -23.16 28.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.225 -179.351 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.65 32.35 1.03 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.525 -179.932 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.509 ' CE2' HG12 ' A' ' 126' ' ' ILE . 46.2 m-85 -69.99 -171.7 0.46 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 120.64 0.257 . . . . 0.0 110.48 179.709 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.8 m -109.78 108.18 18.44 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.91 0.386 . . . . 0.0 111.349 -178.905 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 105' ' ' LEU . 0.9 OUTLIER -48.14 106.93 0.11 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.374 178.142 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.506 HG22 ' N ' ' A' ' 107' ' ' GLY . 43.6 mm -85.2 158.95 3.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.168 -178.47 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.506 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 59.66 -127.42 44.48 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.844 -179.248 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -118.18 132.75 56.31 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.87 0.367 . . . . 0.0 110.669 178.974 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.741 ' HB2' HG22 ' A' ' 96' ' ' THR . 0.1 OUTLIER -69.45 -28.9 66.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.119 0.485 . . . . 0.0 110.453 179.549 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.58 131.4 14.44 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.764 -179.927 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.973 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.8 t -123.92 121.71 62.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.583 0.23 . . . . 0.0 110.644 179.217 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.67 121.14 25.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.875 0.369 . . . . 0.0 111.443 -178.818 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.494 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 23.3 t -85.73 106.14 16.77 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 176.465 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.414 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.3 OUTLIER -147.81 160.11 43.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.129 0.49 . . . . 0.0 111.394 -178.333 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.28 34.41 6.22 Favored Glycine 0 CA--C 1.518 0.219 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.775 179.611 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 65.91 12.94 58.56 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.641 -179.448 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -136.58 -178.85 5.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.876 0.37 . . . . 0.0 110.704 179.63 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.508 ' CG ' ' HD3' ' A' ' 75' ' ' PRO . 93.2 m95 -119.08 141.63 48.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.969 -179.416 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.08 150.13 50.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.05 0.452 . . . . 0.0 111.535 -179.029 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.478 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.5 OUTLIER 71.26 46.35 0.25 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.125 178.744 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 85.5 Cg_endo -78.22 142.23 19.0 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.376 2.05 . . . . 0.0 111.729 178.424 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.507 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 61.6 Cg_endo -90.13 -172.3 0.56 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.67 2.246 . . . . 0.0 113.476 -178.589 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.452 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -134.71 -178.48 5.09 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.974 178.215 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 124' ' ' CYS . . . . . 0.435 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 11.1 m -139.51 97.66 3.32 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.965 0.412 . . . . 0.0 111.027 -179.832 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -123.96 155.35 38.34 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.975 -179.683 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.565 ' O ' HG22 ' A' ' 126' ' ' ILE . 18.1 mm . . . . . 0 C--N 1.324 -0.507 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.99 179.932 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.683 ' HD3' HG23 ' A' ' 25' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.068 0 CA-C-O 120.838 0.351 . . . . 0.0 111.007 . . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.426 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 13.1 m -83.93 161.31 55.88 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.733 179.757 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.74 169.19 19.46 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.396 2.064 . . . . 0.0 111.305 179.121 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.43 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -52.81 116.9 9.86 Favored Pre-proline 0 C--N 1.326 -0.436 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.962 -178.794 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.795 ' HG3' HD13 ' A' ' 22' ' ' ILE . 16.3 Cg_endo -57.27 157.58 21.18 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.62 2.214 . . . . 0.0 112.273 179.987 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.439 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 9.2 mtt-85 -64.55 176.05 1.23 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.201 178.974 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.783 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 1.1 t0 -130.89 -172.39 2.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.108 0.48 . . . . 0.0 111.679 -178.895 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.434 HG22 HD21 ' A' ' 20' ' ' LEU . 3.6 tt -145.71 151.48 14.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.727 -179.684 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -80.35 -70.73 0.5 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.672 -178.583 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.442 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 1.9 m-20 -91.2 42.9 1.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.929 0.395 . . . . 0.0 110.946 -179.408 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -153.41 -173.76 22.98 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.956 179.904 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -145.66 135.2 23.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.706 0.289 . . . . 0.0 110.415 179.733 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.863 HD22 ' CE1' ' A' ' 33' ' ' TYR . 0.5 OUTLIER -83.73 156.99 22.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.125 0.488 . . . . 0.0 111.677 -179.23 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.433 ' CB ' ' HB ' ' A' ' 32' ' ' THR . 0.3 OUTLIER -127.73 73.75 1.48 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.31 177.061 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.824 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.5 OUTLIER -80.32 95.58 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.835 -176.674 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.02 16.96 59.24 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.99 177.538 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 164.49 149.67 5.87 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.075 -0.583 . . . . 0.0 111.901 -179.582 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.683 HG23 ' HD3' ' A' ' 8' ' ' ARG . 8.7 m -135.91 32.85 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.699 0.285 . . . . 0.0 111.354 -179.455 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.2 OUTLIER -102.75 155.81 18.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.125 179.933 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.571 ' CZ ' HD12 ' A' ' 51' ' ' LEU . 4.9 t80 -50.71 91.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.771 179.657 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 129.97 -12.2 5.87 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.654 -179.251 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.2 p -70.63 177.04 3.71 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.735 0.302 . . . . 0.0 110.659 179.671 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.8 p -148.51 142.89 26.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.116 179.972 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.824 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.6 OUTLIER -104.64 171.14 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.564 179.858 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.433 ' HB ' ' CB ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -135.73 111.14 9.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.993 0.425 . . . . 0.0 111.337 179.568 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.863 ' CE1' HD22 ' A' ' 20' ' ' LEU . 26.5 m-85 -87.37 143.17 27.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.435 -179.755 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.419 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 5.0 m -147.05 168.47 21.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.725 179.442 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.427 ' HA ' ' HA2' ' A' ' 18' ' ' GLY . 1.3 m -87.64 166.14 14.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.828 179.696 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.408 ' ND2' ' HA ' ' A' ' 17' ' ' ASN . 15.0 m-20 -67.25 -84.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.996 -179.76 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -154.03 130.8 10.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.109 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.02 19.26 71.68 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.433 -179.534 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.506 ' CE1' ' HB3' ' A' ' 68' ' ' SER . 3.3 m-30 -111.72 178.59 4.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.859 0.361 . . . . 0.0 110.966 -179.604 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.77 ' CD2' HD11 ' A' ' 42' ' ' ILE . 3.1 p-80 -138.31 113.23 9.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.136 0.493 . . . . 0.0 110.472 177.645 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.943 HD21 ' O ' ' A' ' 44' ' ' GLU . 6.8 tt -77.38 120.26 22.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.96 -179.01 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.77 HD11 ' CD2' ' A' ' 40' ' ' HIS . 2.6 mm -96.22 153.13 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.734 179.685 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.04 -137.14 15.18 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.975 -178.71 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.943 ' O ' HD21 ' A' ' 41' ' ' LEU . 5.1 mt-10 -88.67 -176.84 5.4 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.507 0.67 . . . . 0.0 111.221 179.175 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.7 p -155.15 24.16 0.42 Allowed 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 114.592 -1.186 . . . . 0.0 110.332 179.045 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -150.55 128.95 12.1 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.173 0.511 . . . . 0.0 112.068 -178.763 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -108.03 151.2 26.16 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.89 178.256 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.503 ' CD1' ' CB ' ' A' ' 60' ' ' ASN . 1.5 m-85 -126.28 122.54 35.8 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 119.456 -0.898 . . . . 0.0 112.598 -177.846 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.47 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 26.0 t -71.26 102.27 2.52 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.398 178.55 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -129.33 -176.19 3.81 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.317 -179.039 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.571 HD12 ' CZ ' ' A' ' 27' ' ' PHE . 6.7 mt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.447 -178.879 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 8.0 mmt . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.863 0.363 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.4 m -143.2 177.94 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.069 -179.909 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.532 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 72.6 m95 -131.84 128.65 39.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.344 -179.429 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.503 ' CB ' ' CD1' ' A' ' 48' ' ' TYR . 0.7 OUTLIER -69.67 164.63 48.86 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.707 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.505 ' O ' ' HA ' ' A' ' 47' ' ' SER . 97.7 Cg_exo -13.78 113.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.826 1 C-N-CA 125.552 4.168 . . . . 0.0 115.08 -176.257 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.474 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 3.7 mt-10 -106.17 -96.56 0.35 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.412 -1.267 . . . . 0.0 112.56 -175.579 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.783 ' HB2' ' O ' ' A' ' 14' ' ' ASP . . . -78.2 108.28 7.31 Favored Pre-proline 0 C--O 1.231 0.11 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -176.457 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.898 ' HG2' HD11 ' A' ' 41' ' ' LEU . 1.8 Cg_endo -86.83 -155.28 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.208 2.605 . . . . 0.0 110.881 177.387 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.457 HG22 ' H ' ' A' ' 66' ' ' CYS . 5.0 mm -88.95 163.96 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.893 0.378 . . . . 0.0 110.882 178.61 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.457 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -170.18 125.46 0.77 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.768 179.589 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -153.6 174.35 14.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.914 -178.873 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.506 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 77.1 p -82.25 94.7 7.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.103 0.478 . . . . 0.0 110.337 178.387 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.705 HG22 ' HA3' ' A' ' 116' ' ' GLY . 6.0 p -47.33 102.43 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.214 -179.891 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.428 ' HD2' ' HB3' ' A' ' 88' ' ' PHE . 6.0 mmtp -70.66 157.0 38.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.516 -177.058 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.409 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -132.02 115.27 15.6 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.882 178.435 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -70.61 -163.59 0.08 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.313 -178.779 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.467 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 1.6 t -46.81 139.92 6.36 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.227 -179.539 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.501 ' HD2' ' CE1' ' A' ' 82' ' ' HIS . 24.2 Cg_exo -62.83 146.36 94.99 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.328 2.019 . . . . 0.0 112.449 -179.125 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.537 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 0.2 OUTLIER -119.71 -159.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 124.742 3.628 . . . . 0.0 114.013 -174.784 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 75' ' ' PRO . 3.4 p 96.0 -66.23 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 171.241 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.83 HG22 ' O ' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -76.13 176.05 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 122.251 1.024 . . . . 0.0 113.51 -172.144 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.494 ' N ' HG13 ' A' ' 77' ' ' ILE . 2.4 m -139.93 143.36 36.57 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 113.307 -1.769 . . . . 0.0 108.551 176.42 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 77.03 23.12 0.96 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.795 0.331 . . . . 0.0 111.076 -178.091 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.705 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -147.9 -161.09 9.31 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.55 178.748 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -161.21 -173.92 4.08 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.92 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.514 ' HB2' HG11 ' A' ' 95' ' ' VAL . 2.1 p80 -135.51 150.38 49.75 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.124 0.488 . . . . 0.0 111.927 -178.032 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.8 m120 . . . . . 0 CA--C 1.533 0.312 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.154 179.106 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.428 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 9.6 m-85 . . . . . 0 N--CA 1.447 -0.588 0 CA-C-O 120.932 0.396 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.409 ' N ' ' O ' ' A' ' 71' ' ' CYS . 31.1 m-85 -140.75 159.1 42.93 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.272 179.813 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.1 p -122.04 177.27 5.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.118 0.485 . . . . 0.0 111.992 -177.466 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 1.0 OUTLIER -62.9 96.44 0.09 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.918 -179.998 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 125.96 12.54 3.57 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.227 -0.897 . . . . 0.0 113.082 179.107 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.406 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -92.93 155.54 17.5 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.934 0.367 . . . . 0.0 110.433 179.183 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.46 HG22 ' N ' ' A' ' 95' ' ' VAL . 35.4 m -131.44 157.48 43.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.926 0.393 . . . . 0.0 111.02 -179.946 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.514 HG11 ' HB2' ' A' ' 82' ' ' HIS . 41.9 t -153.59 151.7 11.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.999 179.909 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.933 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -111.33 122.45 47.88 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.786 179.922 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 1.035 ' CE1' HG21 ' A' ' 111' ' ' VAL . 6.2 m-85 -81.06 156.1 26.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.651 -178.717 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 81' ' ' ARG . 1.2 p -147.23 134.81 20.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.397 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.441 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 74.8 m -72.0 149.72 44.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.76 0.314 . . . . 0.0 111.454 -179.875 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -96.1 -82.05 0.4 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.931 178.496 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -39.88 -30.99 0.1 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.901 -179.308 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.07 32.7 0.62 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.915 179.597 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.482 ' CD1' HG12 ' A' ' 126' ' ' ILE . 48.2 m-85 -79.96 -171.56 2.97 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.735 0.302 . . . . 0.0 110.779 179.635 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.4 m -118.97 114.5 22.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.967 0.413 . . . . 0.0 110.712 -179.846 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.634 HD21 ' HB2' ' A' ' 97' ' ' TYR . 0.3 OUTLIER -51.04 102.95 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.001 179.959 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.44 HG13 ' HB2' ' A' ' 125' ' ' GLN . 22.8 mm -95.62 151.6 3.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.554 179.171 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 69.19 24.96 75.81 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.497 -0.859 . . . . 0.0 113.033 179.173 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.429 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.3 OUTLIER 60.33 136.83 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.471 0.653 . . . . 0.0 111.642 179.745 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.933 ' HB2' HG22 ' A' ' 96' ' ' THR . 0.8 OUTLIER -70.21 -20.88 63.07 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.988 -179.179 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -64.65 122.42 24.64 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.695 -179.334 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 1.035 HG21 ' CE1' ' A' ' 97' ' ' TYR . 3.2 t -122.63 147.76 26.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 179.175 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.92 115.51 29.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.022 0.439 . . . . 0.0 111.627 -179.003 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.513 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 30.4 t -82.7 98.34 9.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.747 177.167 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.8 OUTLIER -138.48 160.37 39.72 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.362 -178.252 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.73 25.37 3.42 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.69 179.436 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.705 ' HA3' HG22 ' A' ' 69' ' ' VAL . . . 83.24 -6.76 70.4 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.945 -179.859 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -126.16 179.8 5.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.866 0.365 . . . . 0.0 110.556 179.834 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.537 ' CD1' ' HD3' ' A' ' 75' ' ' PRO . 79.0 m95 -110.38 143.44 40.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.703 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.05 162.43 23.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.029 0.442 . . . . 0.0 111.536 -178.78 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.475 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 4.3 p-10 47.65 47.82 5.07 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.058 179.526 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 72.0 Cg_endo -76.08 163.55 32.77 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.416 2.077 . . . . 0.0 111.949 178.49 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.83 ' O ' HG22 ' A' ' 77' ' ' ILE . 41.3 Cg_endo -94.97 -166.1 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.121 2.547 . . . . 0.0 113.778 -178.133 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.26 170.55 17.64 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.5 177.665 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 124' ' ' CYS . . . . . 0.433 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 1.6 m -122.97 91.24 3.45 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.971 0.415 . . . . 0.0 111.196 179.846 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.44 ' HB2' HG13 ' A' ' 106' ' ' ILE . 19.2 mt-30 -114.15 159.43 20.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.19 178.96 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.539 ' O ' HG22 ' A' ' 126' ' ' ILE . 16.9 mm . . . . . 0 C--N 1.321 -0.67 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.224 -179.375 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 25' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.96 0.409 . . . . 0.0 110.829 . . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.536 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 71.8 m -69.82 176.4 1.77 Allowed Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.174 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.546 ' HD2' ' CD1' ' A' ' 59' ' ' TRP . 30.6 Cg_endo -83.2 175.01 8.75 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 121.792 1.661 . . . . 0.0 110.58 178.261 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.9 p -51.09 104.57 0.44 Allowed Pre-proline 0 C--N 1.324 -0.501 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.611 -179.634 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.883 ' HG2' HD12 ' A' ' 22' ' ' ILE . 32.3 Cg_exo -38.09 156.02 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.748 2.299 . . . . 0.0 112.723 -178.66 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.44 164.53 20.91 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.379 178.652 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -114.09 -173.54 2.3 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.754 -176.707 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.467 HG23 ' C ' ' A' ' 18' ' ' GLY . 5.8 tt -132.32 150.14 33.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.502 179.217 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -76.52 -68.5 0.59 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.79 -177.992 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.417 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 1.9 m-20 -92.45 41.57 1.08 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.916 0.389 . . . . 0.0 111.076 -178.58 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.467 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -162.3 -173.66 31.25 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.999 179.815 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -129.91 168.67 16.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.659 0.266 . . . . 0.0 110.31 179.173 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.728 ' N ' HD12 ' A' ' 20' ' ' LEU . 0.4 OUTLIER -119.85 156.59 30.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.025 0.44 . . . . 0.0 111.38 -179.427 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.42 76.49 1.71 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.979 178.358 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.905 ' HA ' HG23 ' A' ' 31' ' ' ILE . 5.9 mm -69.35 109.81 2.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.72 -177.827 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -112.91 15.72 23.52 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.347 178.465 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 152.58 138.26 2.7 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.994 -179.617 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.437 HG12 ' HG3' ' A' ' 12' ' ' PRO . 30.2 m -124.4 25.66 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -178.705 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -94.58 152.03 18.85 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.994 0.426 . . . . 0.0 111.035 -179.966 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.634 ' CZ ' HD12 ' A' ' 51' ' ' LEU . 2.4 t80 -47.25 92.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.088 -179.682 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 126.1 0.51 7.55 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.853 -179.593 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.17 -178.82 7.18 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 116.978 0.389 . . . . 0.0 110.662 179.696 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.0 p -153.84 145.06 22.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.266 0.555 . . . . 0.0 110.862 179.713 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.905 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -109.98 164.88 5.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.181 -179.169 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.673 HG23 ' HD3' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -124.49 107.83 11.49 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.061 0.458 . . . . 0.0 111.157 179.196 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.571 ' CZ ' HD22 ' A' ' 20' ' ' LEU . 6.5 m-85 -82.24 147.21 29.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.528 -179.461 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.45 168.6 20.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.648 179.471 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.423 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 0.8 OUTLIER -95.36 167.18 11.5 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.645 179.795 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.44 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 25.7 m120 -55.16 -85.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.169 -178.434 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.01 125.59 4.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.258 -179.934 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.542 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 74.02 16.51 79.5 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.284 -0.96 . . . . 0.0 112.12 -178.242 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.532 ' CE1' ' CB ' ' A' ' 68' ' ' SER . 2.2 m-85 -107.21 -173.08 2.21 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.709 0.29 . . . . 0.0 110.503 -179.985 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.563 ' HB3' HG23 ' A' ' 69' ' ' VAL . 3.4 p-80 -149.65 111.0 4.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.037 0.446 . . . . 0.0 110.762 178.265 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.865 HD11 ' CB ' ' A' ' 45' ' ' SER . 0.0 OUTLIER -79.74 132.05 36.08 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.86 179.761 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.528 HD11 ' NE2' ' A' ' 40' ' ' HIS . 3.2 mm -97.27 163.13 2.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.605 -176.865 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.43 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 63.53 -152.25 47.9 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.531 -178.383 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.412 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -60.23 -171.84 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.199 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.865 ' CB ' HD11 ' A' ' 41' ' ' LEU . 91.0 p -171.28 34.19 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 121.307 0.575 . . . . 0.0 109.968 -179.893 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.673 ' HD3' HG23 ' A' ' 32' ' ' THR . 1.9 mmmt -151.63 129.0 11.3 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.803 -178.966 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.447 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 0.2 OUTLIER -95.86 136.32 36.44 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.55 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.526 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.8 m-85 -115.89 123.69 48.76 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 119.307 -0.957 . . . . 0.0 112.196 -178.465 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.404 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 44.7 t -73.19 107.69 5.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.921 179.562 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -137.43 -175.39 4.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.114 179.929 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.634 HD12 ' CZ ' ' A' ' 27' ' ' PHE . 10.9 mt . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.835 -179.891 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.182 0 CA-C-O 121.017 0.437 . . . . 0.0 110.791 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.511 HG22 ' C ' ' A' ' 51' ' ' LEU . 30.8 m -148.57 165.34 4.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.176 -179.785 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.568 ' CZ3' HD11 ' A' ' 31' ' ' ILE . 58.3 m95 -121.43 127.04 50.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.141 179.976 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.526 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 6.6 m-80 -69.76 165.21 43.92 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.171 178.883 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.442 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 42.1 Cg_exo -13.27 96.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.055 1 C-N-CA 125.63 4.22 . . . . 0.0 114.398 -179.227 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.502 ' O ' ' HD2' ' A' ' 64' ' ' PRO . 0.7 OUTLIER -93.17 -70.92 0.68 Allowed 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 114.985 -1.007 . . . . 0.0 113.245 -175.556 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.504 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -106.6 75.39 0.38 Allowed Pre-proline 0 C--N 1.333 -0.143 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -173.861 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.506 ' HG2' ' CD2' ' A' ' 41' ' ' LEU . 11.5 Cg_endo -54.53 -138.76 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 123.95 3.1 . . . . 0.0 112.417 175.849 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.492 HG22 ' H ' ' A' ' 66' ' ' CYS . 3.0 mm -103.54 166.14 2.98 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.327 0 O-C-N 121.288 -0.883 . . . . 0.0 112.687 -175.244 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.492 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.2 m -158.05 136.01 10.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.779 178.569 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -155.22 167.6 29.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.036 -179.814 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.532 ' CB ' ' CE1' ' A' ' 39' ' ' TYR . 4.9 p -96.27 110.57 22.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.154 179.959 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.693 HG11 ' HA2' ' A' ' 115' ' ' GLY . 0.9 OUTLIER -52.17 101.94 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.122 179.405 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.542 ' HE3' HG23 ' A' ' 90' ' ' THR . 0.0 OUTLIER -80.04 117.83 21.22 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.36 -179.729 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.419 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -98.85 115.83 29.71 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.064 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.5 -163.53 0.05 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.843 -179.048 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.452 ' HG ' ' CE1' ' A' ' 82' ' ' HIS . 2.3 t -44.89 137.76 4.35 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.945 -179.864 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.5 ' HG2' HG11 ' A' ' 95' ' ' VAL . 32.1 Cg_exo -56.24 160.93 9.84 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 122.124 1.883 . . . . 0.0 111.791 -179.402 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.516 ' HD3' ' CG ' ' A' ' 118' ' ' TRP . 98.8 Cg_exo -42.17 155.8 0.09 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.839 2.36 . . . . 0.0 112.928 -178.639 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.5 t -107.14 90.23 3.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.43 179.152 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.666 HG23 ' HE1' ' A' ' 97' ' ' TYR . 17.6 pt -69.47 170.23 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.319 -178.998 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.8 m -89.86 138.44 31.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.727 179.688 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 60.41 28.22 17.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.926 179.782 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -163.44 -165.68 21.0 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.268 -0.968 . . . . 0.0 113.225 179.828 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.3 -175.07 3.12 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.084 0.469 . . . . 0.0 110.603 -178.952 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.452 ' CE1' ' HG ' ' A' ' 73' ' ' SER . 11.5 p-80 -107.63 178.12 4.62 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.909 179.731 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.597 -179.827 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.447 ' CD2' ' HB3' ' A' ' 70' ' ' LYS . 18.5 m-85 . . . . . 0 N--CA 1.453 -0.294 0 CA-C-O 121.037 0.446 . . . . 0.0 111.704 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.419 ' N ' ' O ' ' A' ' 71' ' ' CYS . 22.3 m-85 -145.75 169.62 18.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.095 178.727 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.542 HG23 ' HE3' ' A' ' 70' ' ' LYS . 5.5 p -134.38 -174.41 3.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.981 0.42 . . . . 0.0 111.729 -178.699 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.486 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 0.4 OUTLIER -65.76 103.75 0.95 Allowed 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.6 0.714 . . . . 0.0 111.002 -179.905 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 120.77 17.57 4.19 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.563 179.663 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.46 148.73 25.57 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.825 0.345 . . . . 0.0 110.799 179.746 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 35.5 m -129.06 156.04 41.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.032 -179.522 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.526 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 18.5 t -151.74 148.86 14.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.983 179.918 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.429 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.1 OUTLIER -104.38 138.55 40.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.987 -179.936 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.969 ' CE2' HG21 ' A' ' 111' ' ' VAL . 4.4 m-85 -98.8 155.89 17.13 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.342 -179.157 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.475 ' HA ' HD13 ' A' ' 105' ' ' LEU . 74.3 m -151.34 143.28 23.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.066 -179.908 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.466 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 63.7 m -71.78 159.72 33.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.784 179.626 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.463 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 44.5 m-20 -85.85 -70.84 0.57 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.512 -178.944 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.0 t -68.33 -23.62 64.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.384 -179.008 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 124.26 34.79 0.7 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.568 -179.787 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.49 ' CE2' HG12 ' A' ' 126' ' ' ILE . 14.9 m-85 -69.76 -174.46 0.74 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 120.948 0.404 . . . . 0.0 110.573 179.509 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.88 100.66 10.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.424 178.927 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.629 HD21 ' HA ' ' A' ' 109' ' ' SER . 0.3 OUTLIER -46.64 125.59 7.31 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.376 0.608 . . . . 0.0 111.602 -178.873 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.451 ' HB ' ' CB ' ' A' ' 123' ' ' THR . 36.8 mm -89.59 153.17 3.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.098 179.391 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 60.37 -132.3 50.07 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.773 -178.594 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -116.26 137.58 52.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.981 0.42 . . . . 0.0 111.318 179.509 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.629 ' HA ' HD21 ' A' ' 105' ' ' LEU . 0.7 OUTLIER -66.12 -27.64 68.2 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.408 178.7 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -70.9 138.17 27.92 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.545 179.575 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.969 HG21 ' CE2' ' A' ' 97' ' ' TYR . 2.9 t -131.39 130.46 62.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 179.162 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.916 HD22 ' N ' ' A' ' 113' ' ' CYS . 0.6 OUTLIER -89.85 128.18 36.13 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.957 0.408 . . . . 0.0 111.682 -178.576 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.916 ' N ' HD22 ' A' ' 112' ' ' LEU . 42.6 t -99.21 102.92 14.73 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.678 176.648 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.779 ' HB3' HD11 ' A' ' 112' ' ' LEU . 20.0 p -148.03 111.84 5.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.506 -178.657 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.693 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 94.25 39.84 4.69 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.262 179.645 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.434 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 58.82 20.2 46.91 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.145 -179.339 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -143.97 -178.06 5.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.916 0.388 . . . . 0.0 110.867 -179.976 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.53 ' CZ3' ' HB2' ' A' ' 113' ' ' CYS . 93.5 m95 -125.38 144.07 50.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.184 -179.121 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.426 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.9 OUTLIER -123.48 166.65 15.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.495 -178.984 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.446 ' N ' ' HD3' ' A' ' 121' ' ' PRO . 1.5 p30 45.73 50.35 7.77 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.437 -0.802 . . . . 0.0 112.361 179.065 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.468 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 96.6 Cg_endo -80.05 146.36 18.08 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.558 2.172 . . . . 0.0 111.47 177.572 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.507 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 61.1 Cg_endo -94.6 -173.01 0.29 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.786 2.324 . . . . 0.0 113.489 -178.477 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.451 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -131.69 -161.45 1.13 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.933 177.766 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 6.5 m -154.37 89.07 1.25 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.084 0.468 . . . . 0.0 111.122 179.104 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -118.54 170.86 8.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.436 179.324 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.561 ' O ' HG22 ' A' ' 126' ' ' ILE . 22.1 mm . . . . . 0 C--N 1.323 -0.575 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.825 -179.976 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.658 ' HD3' HG23 ' A' ' 25' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.91 0.386 . . . . 0.0 111.071 . . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.457 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 51.1 m -108.54 160.82 25.78 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.751 179.958 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 38.6 Cg_endo -67.27 172.96 9.3 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.51 2.14 . . . . 0.0 112.255 -179.777 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.425 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 2.4 t -50.97 111.55 2.36 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.969 -179.57 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.546 ' HB3' HD11 ' A' ' 31' ' ' ILE . 9.9 Cg_endo -56.66 144.26 86.57 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.192 1.928 . . . . 0.0 111.944 179.724 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.902 ' O ' HD11 ' A' ' 20' ' ' LEU . 3.0 mtt85 -51.61 159.3 0.78 Allowed 'General case' 0 CA--C 1.517 -0.288 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.071 178.901 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.15 -174.21 2.41 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.179 0.514 . . . . 0.0 111.709 -177.918 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.441 HG23 ' C ' ' A' ' 18' ' ' GLY . 2.7 tt -144.36 139.78 24.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.526 -179.726 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -87.08 -48.07 8.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.667 -178.486 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.442 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 1.3 m120 -94.25 25.96 3.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.055 -178.822 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.441 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -157.42 -170.37 22.22 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.816 -179.625 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -141.45 130.82 23.69 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.661 0.267 . . . . 0.0 110.638 179.882 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.902 HD11 ' O ' ' A' ' 13' ' ' ARG . 10.6 mt -73.2 156.61 38.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.188 0.518 . . . . 0.0 111.719 -179.496 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 32' ' ' THR . 0.8 OUTLIER -132.14 73.01 1.51 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.506 177.517 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.924 ' HA ' HG23 ' A' ' 31' ' ' ILE . 68.5 mt -69.16 101.72 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.722 -177.183 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -103.84 17.11 50.02 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.953 177.735 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 29' ' ' SER . . . 157.43 126.15 0.89 Allowed Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.146 -179.697 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.658 HG23 ' HD3' ' A' ' 8' ' ' ARG . 33.3 m -116.71 19.02 7.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 111.631 0.234 . . . . 0.0 111.631 -179.298 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 14.0 t70 -88.03 164.66 15.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.953 0.406 . . . . 0.0 110.847 179.594 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.653 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 4.0 t80 -61.72 91.75 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.787 179.881 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 124.88 12.25 4.08 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.0 179.909 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 1.2 m -96.0 -172.2 2.51 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.869 0.334 . . . . 0.0 110.479 179.289 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 47' ' ' SER . 19.3 p -155.49 147.27 23.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.054 0.454 . . . . 0.0 111.398 179.852 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.924 HG23 ' HA ' ' A' ' 22' ' ' ILE . 1.0 OUTLIER -106.82 171.42 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.669 179.631 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.489 ' H ' HG22 ' A' ' 31' ' ' ILE . 0.1 OUTLIER -131.9 113.52 13.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.012 0.434 . . . . 0.0 111.261 179.499 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.83 ' CE2' HD21 ' A' ' 20' ' ' LEU . 20.6 m-85 -89.19 136.35 33.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.229 -179.813 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.401 ' O ' ' HA3' ' A' ' 18' ' ' GLY . 6.7 m -139.71 158.05 44.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.796 -179.974 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.462 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 31.3 m -87.75 157.74 18.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.949 0.404 . . . . 0.0 110.984 179.9 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.48 -92.72 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.88 -179.359 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -147.48 131.0 16.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.824 0.345 . . . . 0.0 110.834 -179.648 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.586 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 68.47 23.21 75.19 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.917 -178.831 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.491 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.0 m-85 -116.18 168.36 10.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.797 0.332 . . . . 0.0 110.994 -179.183 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.892 ' CD2' HD11 ' A' ' 42' ' ' ILE . 2.2 p-80 -130.56 124.32 31.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.55 178.248 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.918 HD21 ' O ' ' A' ' 44' ' ' GLU . 5.4 tt -87.99 124.54 33.83 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.725 -179.622 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.892 HD11 ' CD2' ' A' ' 40' ' ' HIS . 2.1 mm -102.62 165.09 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.006 0.432 . . . . 0.0 111.071 -179.893 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.463 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 74.65 -136.15 20.47 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.241 -179.458 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.918 ' O ' HD21 ' A' ' 41' ' ' LEU . 1.9 pt-20 -74.54 -173.22 1.71 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.767 0.318 . . . . 0.0 110.534 179.197 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.8 p -163.42 24.31 0.08 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.219 -179.502 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.471 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -166.98 125.7 1.37 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.524 -177.554 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.456 ' CB ' ' HA ' ' A' ' 62' ' ' GLU . 0.4 OUTLIER -92.13 138.72 31.3 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 177.492 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.552 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 2.1 m-85 -116.46 119.71 36.49 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 119.446 -0.902 . . . . 0.0 111.765 179.88 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 26.8 t -70.01 112.8 6.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.756 179.537 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.418 ' OE2' ' ND2' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -139.76 -171.55 3.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 179.741 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.653 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.034 -179.558 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 6.7 mtt . . . . . 0 N--CA 1.455 -0.178 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.2 m -148.93 176.45 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.188 -178.755 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.535 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 65.7 m95 -132.15 125.73 31.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.02 179.813 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.552 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 3.2 m-20 -68.8 168.38 15.22 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.127 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.494 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 19.0 Cg_exo -10.66 88.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.043 1 C-N-CA 125.342 4.028 . . . . 0.0 114.783 -179.032 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.469 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 1.0 OUTLIER -83.82 -97.97 0.05 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.631 -177.381 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.474 ' HA ' ' CD2' ' A' ' 33' ' ' TYR . . . -84.65 110.29 26.34 Favored Pre-proline 0 C--O 1.231 0.096 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -175.903 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.849 ' HG2' HD11 ' A' ' 41' ' ' LEU . 5.0 Cg_exo -78.53 -153.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.918 2.412 . . . . 0.0 111.086 177.025 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.527 HG22 ' H ' ' A' ' 66' ' ' CYS . 3.8 mm -93.83 167.68 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.672 0.272 . . . . 0.0 110.368 177.929 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.527 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -165.43 135.07 3.5 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.017 -179.968 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -156.38 178.38 10.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.955 -179.794 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.491 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 52.9 p -86.1 113.2 21.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.981 179.982 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.726 HG23 ' HB3' ' A' ' 40' ' ' HIS . 0.1 OUTLIER -43.54 98.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.589 -179.907 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.443 ' HE3' ' CG2' ' A' ' 90' ' ' THR . 1.3 mmtp -72.08 107.93 5.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.1 179.852 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.419 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -93.37 125.26 37.87 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.818 0.342 . . . . 0.0 110.159 178.578 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.88 -156.02 0.06 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.478 179.807 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.426 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 1.7 t -48.8 138.24 12.54 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.084 -179.854 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.512 ' HG2' HG11 ' A' ' 95' ' ' VAL . 25.3 Cg_exo -61.11 163.34 17.02 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.372 2.048 . . . . 0.0 112.035 179.764 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.532 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 82.7 Cg_exo -38.75 156.43 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.895 2.396 . . . . 0.0 112.903 -179.274 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.5 m -109.78 89.76 3.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.484 179.315 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.678 HG23 ' HE2' ' A' ' 97' ' ' TYR . 32.7 pt -69.09 175.22 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.09 -179.318 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.71 145.94 24.9 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.399 178.605 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.533 ' HB3' ' CD2' ' A' ' 103' ' ' TYR . 3.0 m120 59.46 28.74 18.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.895 0.379 . . . . 0.0 111.104 177.876 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -170.48 -161.68 21.48 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.644 -0.788 . . . . 0.0 113.092 179.634 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' ' 98' ' ' SER . 1.4 ptt85 -170.18 -175.22 1.92 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.972 0.415 . . . . 0.0 110.984 -178.79 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 12.2 p80 -105.05 176.43 5.16 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.982 179.874 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.424 ' ND2' ' HB ' ' A' ' 96' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.239 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.543 179.138 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.414 ' HB3' ' HD3' ' A' ' 70' ' ' LYS . 7.3 m-85 . . . . . 0 N--CA 1.455 -0.212 0 CA-C-O 120.96 0.41 . . . . 0.0 111.251 . . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.419 ' N ' ' O ' ' A' ' 71' ' ' CYS . 62.5 m-85 -144.09 163.52 33.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.491 179.843 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.443 ' CG2' ' HE3' ' A' ' 70' ' ' LYS . 16.0 p -128.22 179.93 5.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.906 0.384 . . . . 0.0 111.349 -179.228 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.1 p-10 -64.48 94.75 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.267 0.556 . . . . 0.0 110.864 -179.926 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.34 28.05 1.04 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.116 179.085 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.433 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -106.0 161.5 14.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.679 0.276 . . . . 0.0 110.522 179.125 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 35.3 m -134.07 152.24 33.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.215 0.531 . . . . 0.0 111.441 -179.567 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.542 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 21.6 t -150.88 147.27 15.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.618 179.27 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.516 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -103.83 144.72 31.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.114 178.574 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.92 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.7 m-85 -100.5 156.76 17.1 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.596 179.941 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 81' ' ' ARG . 51.8 p -153.18 143.88 22.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.349 -178.82 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.482 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 23.3 m -69.52 164.88 22.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.086 -178.844 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -94.88 -84.78 0.32 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.878 178.913 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.35 -41.07 79.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.495 -179.259 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 147.07 42.56 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.644 -179.978 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.533 ' CD2' ' HB3' ' A' ' 79' ' ' ASN . 23.3 m-85 -80.14 -165.85 0.92 Allowed 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 122.355 0.262 . . . . 0.0 110.601 179.962 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 124' ' ' CYS . 4.3 m -120.64 107.53 12.92 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.798 0.332 . . . . 0.0 111.719 -179.967 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.446 HD23 ' HB2' ' A' ' 122' ' ' PRO . 1.4 tp -48.33 117.12 1.82 Allowed 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.334 177.83 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.469 ' HB ' ' CB ' ' A' ' 123' ' ' THR . 44.9 mm -91.53 154.34 3.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.036 -178.859 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.424 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 60.55 -128.88 46.29 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.082 -179.399 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -114.11 127.23 55.82 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.878 0.37 . . . . 0.0 110.819 179.35 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.516 ' HB2' HG22 ' A' ' 96' ' ' THR . 0.1 OUTLIER -64.01 -28.12 69.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.769 179.741 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.31 144.9 41.72 Favored Glycine 0 N--CA 1.452 -0.256 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.822 -179.919 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.92 HG21 ' CE1' ' A' ' 97' ' ' TYR . 3.4 t -140.52 127.51 22.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.544 0.211 . . . . 0.0 110.989 -179.959 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.45 128.87 34.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.911 0.386 . . . . 0.0 111.524 -179.51 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.511 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 24.7 t -91.98 104.69 17.07 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.513 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.2 t -150.89 163.95 37.47 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.146 0.498 . . . . 0.0 111.596 -177.976 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 45.29 32.21 3.58 Favored Glycine 0 N--CA 1.453 -0.219 0 CA-C-N 115.54 -0.754 . . . . 0.0 113.096 179.557 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.464 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 67.92 13.17 63.65 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.696 -179.994 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -143.17 171.42 14.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.84 0.353 . . . . 0.0 110.267 179.292 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.542 ' CZ3' HG23 ' A' ' 95' ' ' VAL . 87.8 m95 -108.43 131.92 54.29 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.885 -179.364 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.99 149.81 34.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.066 0.46 . . . . 0.0 111.234 -179.154 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.493 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER 70.43 44.88 0.24 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.231 179.057 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 73.6 Cg_endo -76.9 140.56 20.55 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.266 1.977 . . . . 0.0 111.215 177.834 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.509 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 36.4 Cg_endo -91.78 -179.55 1.29 Allowed 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.453 2.102 . . . . 0.0 113.255 -178.679 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.469 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -118.77 -162.34 0.89 Allowed 'General case' 0 CA--C 1.502 -0.885 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.041 176.278 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 124' ' ' CYS . . . . . 0.44 ' SG ' ' HB2' ' A' ' 103' ' ' TYR . 4.9 t -170.39 91.72 0.18 Allowed 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 119.901 -0.72 . . . . 0.0 111.265 -176.486 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -116.2 174.79 5.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.042 -178.685 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.527 HG12 ' CE1' ' A' ' 103' ' ' TYR . 46.7 mm . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.865 -179.881 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.486 ' HB3' HG23 ' A' ' 25' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.133 0 CA-C-O 121.034 0.445 . . . . 0.0 111.14 . . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.46 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 48.0 m -80.99 161.22 63.95 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.813 179.68 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 54.7 Cg_endo -69.77 172.47 12.59 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.355 2.037 . . . . 0.0 111.337 178.773 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.428 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 3.1 p -50.93 117.66 8.97 Favored Pre-proline 0 C--N 1.328 -0.327 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.913 -179.19 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.552 ' HB3' HD11 ' A' ' 31' ' ' ILE . 17.8 Cg_endo -58.71 161.66 14.55 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.708 2.272 . . . . 0.0 112.348 -179.874 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.562 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -61.92 179.92 0.24 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.105 178.744 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.33 -171.07 2.73 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.015 0.436 . . . . 0.0 111.321 -179.678 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.573 HG22 ' CD2' ' A' ' 20' ' ' LEU . 11.0 tt -152.56 150.15 13.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.798 -179.743 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -95.45 -52.39 4.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.111 -179.519 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.43 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 2.3 m-20 -94.17 42.05 1.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.122 0.487 . . . . 0.0 110.819 -179.85 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.409 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -169.67 -169.74 33.29 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.429 179.806 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -148.14 130.09 15.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.667 0.27 . . . . 0.0 110.785 -179.505 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.815 HD21 ' CE1' ' A' ' 33' ' ' TYR . 19.5 mt -78.52 161.35 27.1 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.271 0.558 . . . . 0.0 111.72 -179.674 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -132.09 74.16 1.57 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.269 177.523 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.853 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.7 OUTLIER -80.75 107.55 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.86 -176.794 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.31 14.65 56.75 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.988 177.464 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 158.74 155.23 7.52 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.151 -179.62 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.486 HG23 ' HB3' ' A' ' 8' ' ' ARG . 31.2 m -132.72 8.42 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -179.52 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 0.7 OUTLIER -72.72 154.7 40.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.804 0.335 . . . . 0.0 111.009 -179.9 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.595 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 6.0 t80 -50.44 92.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.874 -179.949 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 128.25 -5.16 6.79 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.784 -179.732 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.39 -175.51 0.65 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.903 0.352 . . . . 0.0 110.787 179.92 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.1 p -157.45 139.59 14.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.093 179.776 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.853 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.4 OUTLIER -107.51 170.15 2.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.478 -179.884 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.702 HG23 ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -134.35 115.92 14.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.893 0.378 . . . . 0.0 110.986 179.58 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.815 ' CE1' HD21 ' A' ' 20' ' ' LEU . 23.0 m-85 -93.09 138.02 31.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.361 -179.067 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.83 170.13 16.27 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.782 179.847 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.429 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 50.9 m -91.03 163.39 14.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.858 0.361 . . . . 0.0 111.188 -179.639 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.405 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 1.5 m-20 -62.69 -82.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.255 -179.655 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.39 136.48 13.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.852 -179.702 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.52 23.05 64.42 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.107 -179.42 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.512 ' CE2' ' HB3' ' A' ' 68' ' ' SER . 2.5 m-30 -116.64 174.25 6.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.95 0.405 . . . . 0.0 111.135 -179.273 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.503 ' CE1' HD11 ' A' ' 42' ' ' ILE . 1.5 p-80 -134.91 123.67 23.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.995 177.453 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.947 HD11 ' HG2' ' A' ' 64' ' ' PRO . 10.2 tt -80.32 144.23 32.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.838 -178.531 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.709 HD13 ' C ' ' A' ' 41' ' ' LEU . 1.9 mm -124.73 152.12 30.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.942 -179.865 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.62 -127.34 7.99 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.039 -179.165 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.852 ' O ' HD21 ' A' ' 41' ' ' LEU . 7.0 pm0 -85.29 167.85 15.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.82 0.343 . . . . 0.0 110.568 178.887 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.8 p -150.8 21.07 0.79 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.898 179.609 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.702 ' HG2' HG23 ' A' ' 32' ' ' THR . 0.0 OUTLIER -163.95 124.37 2.16 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.278 -179.299 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.45 ' HB3' ' CG ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -102.18 156.37 17.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.635 -179.269 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.462 ' CB ' ' HB2' ' A' ' 60' ' ' ASN . 1.7 m-85 -132.45 123.78 27.33 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 119.937 -0.705 . . . . 0.0 112.508 -178.192 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 35.5 t -70.14 95.68 1.0 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.38 178.305 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.5 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 3.7 tt0 -128.01 171.22 12.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.495 0.664 . . . . 0.0 111.033 -179.071 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.595 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 1.3 mt . . . . . 0 C--N 1.321 -0.655 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.366 -179.784 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.941 0.4 . . . . 0.0 111.091 . . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.2 m -125.97 -169.22 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.687 179.457 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.52 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 73.2 m95 -130.45 130.49 44.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.953 0.406 . . . . 0.0 111.819 -179.193 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.469 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.9 OUTLIER -76.45 166.98 40.68 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.483 177.227 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.469 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 42.9 Cg_exo -11.91 96.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.774 1 C-N-CA 125.646 4.231 . . . . 0.0 115.242 -178.574 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.45 ' CG ' ' HB3' ' A' ' 47' ' ' SER . 36.6 mt-10 -100.79 -98.65 0.25 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.951 -178.147 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.468 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -70.67 107.04 2.09 Favored Pre-proline 0 N--CA 1.462 0.167 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -176.545 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.947 ' HG2' HD11 ' A' ' 41' ' ' LEU . 2.3 Cg_endo -89.45 -156.94 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.512 2.808 . . . . 0.0 111.223 177.723 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.63 HD12 ' HB ' ' A' ' 42' ' ' ILE . 1.0 OUTLIER -93.08 173.26 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.931 0.396 . . . . 0.0 110.393 177.904 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.591 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -171.36 142.65 1.72 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.013 179.622 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -169.49 172.09 7.27 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.805 179.458 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.512 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 34.0 p -80.41 126.87 31.73 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.646 179.583 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.448 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 1.3 p -41.51 97.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.584 -179.499 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.437 ' HD2' ' HB3' ' A' ' 88' ' ' PHE . 13.7 mmtp -66.72 129.78 40.99 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.945 -178.468 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.8 115.93 26.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.538 177.166 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.32 -163.41 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.957 -178.658 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.432 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 1.6 t -45.15 135.27 5.25 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.324 -179.194 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.595 ' HG2' HG11 ' A' ' 95' ' ' VAL . 31.6 Cg_exo -58.96 160.98 16.71 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.364 2.043 . . . . 0.0 112.006 -179.9 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.43 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 87.0 Cg_exo -40.86 156.76 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.795 2.33 . . . . 0.0 112.975 -179.135 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.72 89.84 3.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.783 179.9 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.67 HG21 ' O ' ' A' ' 122' ' ' PRO . 25.8 pt -69.47 178.75 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.551 -179.201 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.4 m -100.48 145.41 28.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.645 179.411 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' ' 124' ' ' CYS . 3.3 m-80 58.55 26.78 14.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.904 179.776 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.464 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -165.87 -164.47 21.41 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.378 179.933 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 98' ' ' SER . 7.7 ptt85 -167.83 -175.86 2.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.151 0.5 . . . . 0.0 111.102 -179.4 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 14.6 p80 -110.76 166.15 11.25 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.661 178.832 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 . . . . . 0 C--N 1.326 -0.436 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.37 179.247 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.437 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 8.2 m-85 . . . . . 0 N--CA 1.456 -0.168 0 CA-C-O 120.824 0.345 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.436 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 62.5 m-85 -151.0 160.47 43.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.593 -179.913 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.434 ' CG2' ' OG ' ' A' ' 68' ' ' SER . 36.9 p -126.81 -177.24 3.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.022 0.439 . . . . 0.0 111.518 -179.048 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 20.4 p-10 -65.47 94.07 0.17 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.007 -179.805 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 127.1 30.59 0.79 Allowed Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.336 -0.847 . . . . 0.0 113.074 178.817 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.434 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.5 OUTLIER -109.92 160.32 16.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.773 0.32 . . . . 0.0 110.632 179.324 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 34.7 m -136.26 150.97 28.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.132 0.491 . . . . 0.0 111.216 -179.603 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.595 HG11 ' HG2' ' A' ' 74' ' ' PRO . 21.8 t -145.54 148.52 17.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.753 179.686 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.786 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -110.91 123.38 50.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.012 -179.787 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.972 ' CE2' HG21 ' A' ' 111' ' ' VAL . 5.6 m-85 -79.82 156.68 27.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.752 -179.709 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 81' ' ' ARG . 3.9 p -149.86 148.97 29.8 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.914 0.388 . . . . 0.0 112.03 -177.973 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.538 ' HB3' ' HB2' ' A' ' 103' ' ' TYR . 21.2 m -68.8 154.75 41.43 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.541 179.832 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.464 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 85.4 m-20 -73.94 -87.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.111 -177.992 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.43 -43.77 26.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.64 0.257 . . . . 0.0 111.687 -177.642 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 178.44 32.17 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.352 -0.928 . . . . 0.0 113.112 -177.548 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.546 ' CZ ' HG12 ' A' ' 126' ' ' ILE . 0.8 OUTLIER -72.95 -161.81 0.1 Allowed 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.611 -0.295 . . . . 0.0 110.39 -179.524 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' A' ' 124' ' ' CYS . 3.1 t -141.46 117.56 10.62 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.962 0.411 . . . . 0.0 110.77 177.44 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.745 HD22 ' HB2' ' A' ' 109' ' ' SER . 0.2 OUTLIER -58.9 140.4 55.44 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.836 0.826 . . . . 0.0 112.063 -178.119 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.445 HG22 ' N ' ' A' ' 107' ' ' GLY . 37.4 mm -110.24 158.37 10.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 114.057 -1.429 . . . . 0.0 110.075 179.154 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.445 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 63.96 -125.42 32.43 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.034 -179.158 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -123.33 130.76 53.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.856 0.36 . . . . 0.0 110.837 179.38 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.786 ' OG ' HG22 ' A' ' 96' ' ' THR . 2.7 t -66.18 -31.1 71.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.865 179.879 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.4 138.28 30.38 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.049 -179.407 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.972 HG21 ' CE2' ' A' ' 97' ' ' TYR . 2.9 t -134.4 119.44 30.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.64 0.257 . . . . 0.0 110.744 179.024 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.84 125.71 30.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.923 0.392 . . . . 0.0 111.629 -179.114 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.507 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 14.9 t -91.82 105.76 17.96 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 176.176 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.1 OUTLIER -148.69 163.09 38.34 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.109 0.48 . . . . 0.0 111.36 -178.495 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.2 30.91 4.3 Favored Glycine 0 CA--C 1.517 0.187 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.731 179.865 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.448 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 68.91 16.03 69.93 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.599 -179.525 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -141.28 -179.18 5.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.905 0.383 . . . . 0.0 110.68 179.72 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.536 ' CZ3' HG23 ' A' ' 95' ' ' VAL . 94.9 m95 -116.63 142.71 46.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.919 -179.85 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.74 147.35 49.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.142 -179.762 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.487 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER 70.17 45.66 0.26 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.153 179.122 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 98.0 Cg_endo -77.9 133.68 12.72 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.372 2.048 . . . . 0.0 111.295 177.782 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.67 ' O ' HG21 ' A' ' 77' ' ' ILE . 93.7 Cg_endo -93.22 -173.15 0.37 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.475 2.117 . . . . 0.0 113.714 -177.824 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.43 -170.01 2.21 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-N 114.054 -1.43 . . . . 0.0 108.582 176.359 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 124' ' ' CYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 104' ' ' SER . 2.5 t -161.2 105.93 1.34 Allowed 'General case' 0 N--CA 1.424 -1.756 0 CA-C-O 122.127 0.965 . . . . 0.0 110.879 -177.667 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -112.14 152.9 27.77 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 113.491 -1.686 . . . . 0.0 110.329 -179.685 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.682 ' O ' HG22 ' A' ' 126' ' ' ILE . 5.0 mm . . . . . 0 C--N 1.32 -0.712 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.953 179.828 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.415 ' HD2' HG23 ' A' ' 25' ' ' VAL . 35.5 mtm180 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.813 0.34 . . . . 0.0 110.79 . . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.457 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 29.6 m -84.55 159.82 57.69 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.576 179.56 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.5 169.79 17.75 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.543 2.162 . . . . 0.0 112.527 -179.07 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.425 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 3.4 t -51.38 105.63 0.55 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.836 179.89 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 11' ' ' SER . 12.7 Cg_endo -58.5 144.79 96.54 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.044 1.829 . . . . 0.0 111.768 179.699 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.928 ' O ' HD11 ' A' ' 20' ' ' LEU . 3.0 mtt180 -45.45 122.81 3.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.412 0.625 . . . . 0.0 111.343 -179.341 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.663 ' O ' HG22 ' A' ' 15' ' ' ILE . 0.2 OUTLIER -73.91 -7.4 52.18 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.213 -178.932 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.663 HG22 ' O ' ' A' ' 14' ' ' ASP . 18.2 tt 51.72 159.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 121.353 0.597 . . . . 0.0 112.089 -178.803 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.433 ' N ' HG12 ' A' ' 15' ' ' ILE . 7.0 t0 -100.56 159.07 15.45 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.632 177.484 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.496 ' HB2' ' CD2' ' A' ' 39' ' ' TYR . 0.0 OUTLIER 42.82 29.32 0.17 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.77 0.319 . . . . 0.0 111.222 -179.408 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.425 ' HA2' ' N ' ' A' ' 36' ' ' ASN . . . -152.12 176.72 30.3 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.74 -179.42 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -142.56 140.12 31.63 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.673 0.273 . . . . 0.0 110.696 179.938 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.928 HD11 ' O ' ' A' ' 13' ' ' ARG . 52.0 mt -88.99 155.52 19.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.305 0.574 . . . . 0.0 112.096 -178.888 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -124.11 79.03 1.69 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.268 177.181 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.908 ' HA ' HG23 ' A' ' 31' ' ' ILE . 1.3 mt -75.29 107.71 6.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.36 -176.096 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -109.75 20.8 26.55 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.191 175.869 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 154.63 124.8 0.94 Allowed Glycine 0 C--N 1.334 0.444 0 N-CA-C 111.799 -0.52 . . . . 0.0 111.799 -178.948 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.495 HG13 ' CG2' ' A' ' 22' ' ' ILE . 28.7 m -120.4 32.49 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -178.504 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.3 OUTLIER -100.9 151.05 22.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.843 0.354 . . . . 0.0 110.921 179.372 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.523 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 8.1 t80 -49.57 91.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.938 179.996 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 129.5 1.73 5.53 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.997 -179.807 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.37 -164.27 1.16 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 117.052 0.426 . . . . 0.0 110.669 179.677 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.4 p -160.01 153.19 21.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.958 0.409 . . . . 0.0 111.164 179.475 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.908 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.8 OUTLIER -114.01 175.0 2.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.442 -179.972 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.458 ' H ' HG22 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -130.74 120.31 23.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.79 0.329 . . . . 0.0 110.706 178.638 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.461 ' CE2' HD21 ' A' ' 20' ' ' LEU . 19.4 m-85 -96.69 144.67 26.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.301 0.572 . . . . 0.0 112.215 -177.897 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.02 165.33 31.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.287 179.224 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.416 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 1.3 m -85.17 159.41 20.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.878 0.37 . . . . 0.0 110.928 -179.6 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.429 ' ND2' ' HA ' ' A' ' 17' ' ' ASN . 8.7 m-20 -59.76 -86.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.272 -178.68 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.3 t -153.02 132.22 12.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.896 0.379 . . . . 0.0 110.938 -179.979 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.72 22.6 73.69 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.036 -179.396 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.496 ' CD2' ' HB2' ' A' ' 17' ' ' ASN . 2.5 m-30 -114.81 -174.14 2.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.96 0.409 . . . . 0.0 110.902 -179.649 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 1.067 ' CD2' HD11 ' A' ' 42' ' ' ILE . 1.9 p-80 -145.1 113.59 6.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.878 177.635 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.98 HD21 ' O ' ' A' ' 44' ' ' GLU . 6.5 tt -79.4 119.2 22.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.824 -178.631 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 1.067 HD11 ' CD2' ' A' ' 40' ' ' HIS . 2.0 mm -103.89 153.11 6.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.513 179.248 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.11 -127.46 8.21 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.989 179.626 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.98 ' O ' HD21 ' A' ' 41' ' ' LEU . 1.3 mt-10 -79.7 179.53 7.47 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.484 0.659 . . . . 0.0 112.618 -177.899 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.425 ' HA ' ' HB2' ' A' ' 33' ' ' TYR . 4.8 p -165.84 27.52 0.05 OUTLIER 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.005 -179.857 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.416 ' CG ' ' O ' ' A' ' 45' ' ' SER . 3.0 mtpt -166.83 123.73 1.24 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -177.774 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.45 ' HB3' HG13 ' A' ' 31' ' ' ILE . 5.8 t -94.07 152.23 18.93 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.103 177.496 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.547 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.1 m-85 -124.63 105.36 9.27 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.736 177.539 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.464 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 27.6 t -58.59 101.05 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.509 179.677 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.01 -171.08 2.22 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.164 -179.172 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.523 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.385 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.055 -179.375 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.4 mmt . . . . . 0 N--CA 1.456 -0.145 0 CA-C-O 120.804 0.335 . . . . 0.0 110.448 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.4 m -148.4 173.88 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.959 -179.537 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.622 ' CZ3' HD11 ' A' ' 31' ' ' ILE . 74.0 m95 -126.29 124.68 40.88 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.147 -179.907 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.547 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.7 OUTLIER -68.98 166.84 24.06 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 177.368 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.478 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 78.3 Cg_exo -15.07 88.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 125.229 3.953 . . . . 0.0 114.253 -179.408 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.446 ' HA ' ' HB2' ' A' ' 47' ' ' SER . 1.0 OUTLIER -92.73 -93.41 0.15 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.244 -177.43 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.23 106.06 1.32 Allowed Pre-proline 0 C--O 1.231 0.125 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -177.118 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.667 ' HG2' HD11 ' A' ' 41' ' ' LEU . 1.9 Cg_endo -84.43 -153.6 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.993 2.462 . . . . 0.0 110.576 178.059 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.466 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 3.4 mm -86.77 161.32 2.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.994 0.426 . . . . 0.0 111.105 179.911 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.406 ' HB3' ' OD1' ' A' ' 17' ' ' ASN . 0.8 OUTLIER -169.76 130.9 1.05 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.965 179.491 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -154.92 175.61 13.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.665 179.576 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.476 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 1.7 p -87.39 121.75 30.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.295 179.053 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.471 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 1.6 p -41.92 94.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 120.971 0.415 . . . . 0.0 111.299 -179.591 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.427 ' HD2' ' HB3' ' A' ' 88' ' ' PHE . 2.7 mmtt -79.63 140.37 37.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.835 -177.85 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.424 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -116.89 122.34 44.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.977 178.544 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -69.36 -164.66 0.06 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.935 -178.993 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 2.0 t -49.1 136.16 14.86 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.814 -179.504 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.48 ' HG3' ' CZ2' ' A' ' 118' ' ' TRP . 24.3 Cg_exo -59.48 155.71 40.19 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.119 1.879 . . . . 0.0 111.675 179.905 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.434 ' HG2' ' HD3' ' A' ' 121' ' ' PRO . 95.9 Cg_exo -44.17 164.46 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.984 2.456 . . . . 0.0 113.237 -178.458 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 83.0 p -113.04 90.49 3.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.592 179.697 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.2 pt -68.74 172.88 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.942 -179.623 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.0 133.77 35.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.086 -179.555 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.504 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 0.1 OUTLIER 66.78 28.09 9.01 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.707 179.872 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.421 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -163.64 -177.99 36.93 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.287 -0.959 . . . . 0.0 113.187 -179.833 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.71 -175.76 5.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.815 0.34 . . . . 0.0 110.301 179.757 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.503 ' HB3' ' CE2' ' A' ' 97' ' ' TYR . 4.0 p-80 -120.78 161.6 21.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.07 0.462 . . . . 0.0 111.545 179.993 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.0 m120 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.905 -179.904 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.427 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 9.7 m-85 . . . . . 0 N--CA 1.448 -0.559 0 CA-C-O 121.104 0.478 . . . . 0.0 111.239 . . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.424 ' N ' ' O ' ' A' ' 71' ' ' CYS . 21.1 m-85 -141.43 163.39 33.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.797 179.358 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.7 p -122.77 165.57 16.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.042 0.449 . . . . 0.0 111.901 -177.758 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 5.6 p-10 -56.55 98.32 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.697 179.767 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 128.44 12.47 2.79 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.097 -0.956 . . . . 0.0 113.071 179.555 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.79 161.58 13.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.945 0.372 . . . . 0.0 110.399 179.211 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 30.2 m -141.35 147.39 22.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.113 0.482 . . . . 0.0 110.782 -179.913 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.55 HG23 ' CH2' ' A' ' 118' ' ' TRP . 43.7 t -136.94 151.32 27.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.56 179.561 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.972 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -108.2 129.29 55.2 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.977 -179.565 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.977 ' CE2' HG21 ' A' ' 111' ' ' VAL . 6.0 m-85 -92.97 155.65 17.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.081 -179.525 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.1 p -149.16 139.33 22.21 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.443 -179.308 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 52.0 m -69.67 152.87 44.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.676 179.178 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.421 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 26.9 m-20 -92.67 -70.41 0.7 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.237 -179.383 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 36.8 m -55.5 -23.36 25.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.151 -179.683 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 118.77 30.7 1.59 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.344 -179.752 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.504 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 18.8 m-85 -71.39 -173.13 0.84 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.882 0.372 . . . . 0.0 110.774 179.986 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.69 103.89 11.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.296 -179.386 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.637 HD21 ' HG2' ' A' ' 122' ' ' PRO . 2.1 tp -42.62 115.89 0.78 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.419 179.21 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.456 ' HB ' ' CB ' ' A' ' 123' ' ' THR . 46.7 mm -91.01 153.58 3.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.277 179.555 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 65.41 -121.83 21.52 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.084 -1.055 . . . . 0.0 111.502 -178.09 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.0 m-20 -136.91 120.81 17.55 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.059 0.457 . . . . 0.0 111.207 178.759 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.972 ' OG ' HG22 ' A' ' 96' ' ' THR . 2.0 p -51.21 -26.6 7.29 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.95 179.326 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.46 119.13 10.86 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.849 -179.376 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.977 HG21 ' CE2' ' A' ' 97' ' ' TYR . 2.5 t -113.53 116.19 51.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 178.796 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.25 120.1 23.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.006 0.432 . . . . 0.0 111.828 -177.382 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.469 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 16.1 t -89.35 94.86 10.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.502 176.591 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.4 OUTLIER -136.17 159.43 41.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.33 -178.123 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.449 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 46.68 29.51 4.2 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.702 179.85 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.471 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 70.09 20.94 76.81 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.267 -179.42 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -142.85 170.85 14.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.833 0.349 . . . . 0.0 110.376 179.299 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.55 ' CH2' HG23 ' A' ' 95' ' ' VAL . 97.4 m95 -112.34 126.64 55.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.35 -179.192 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.48 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -92.97 131.62 37.81 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.489 174.804 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.604 ' HB2' HG13 ' A' ' 111' ' ' VAL . 2.3 m-20 109.42 -135.87 0.0 OUTLIER Pre-proline 0 CA--C 1.474 -1.945 0 N-CA-C 100.432 -3.914 . . . . 0.0 100.432 -166.987 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.566 ' CA ' ' HB3' ' A' ' 120' ' ' ASP . 64.4 Cg_endo -65.41 179.23 12.83 Favored 'Cis proline' 0 C--N 1.308 -1.566 0 CA-C-N 125.258 2.914 . . . . 0.0 113.36 -14.08 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.637 ' HG2' HD21 ' A' ' 105' ' ' LEU . 10.4 Cg_endo -89.56 -174.9 0.97 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.692 2.928 . . . . 0.0 111.463 176.75 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.456 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -121.61 -179.51 4.12 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.83 179.045 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 124' ' ' CYS . . . . . 0.42 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 4.9 m -139.95 94.59 2.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.743 179.947 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -123.33 163.69 20.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.971 -179.474 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.48 HG12 ' CE2' ' A' ' 103' ' ' TYR . 41.1 mm . . . . . 0 C--N 1.325 -0.478 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.927 -179.917 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 80.2 mtm180 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.915 0.388 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.46 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 48.7 m -92.4 159.86 36.09 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.839 179.864 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 36.9 Cg_endo -66.45 173.85 7.1 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.491 2.127 . . . . 0.0 112.156 -179.695 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.404 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -49.28 107.64 0.82 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.126 -179.47 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.487 ' CG ' ' CD1' ' A' ' 22' ' ' ILE . 9.4 Cg_endo -52.64 154.98 11.06 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.282 1.988 . . . . 0.0 111.824 179.728 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 18.8 mtt180 -80.24 164.91 22.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.257 0.551 . . . . 0.0 111.502 -178.794 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -118.88 -166.71 1.27 Allowed 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.042 -178.023 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.531 HD12 ' HD2' ' A' ' 64' ' ' PRO . 8.5 tt -142.8 155.51 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.566 179.113 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -85.81 -55.45 3.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -176.882 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.415 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 0.3 OUTLIER -92.71 28.3 2.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.632 0.254 . . . . 0.0 111.551 -177.352 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.429 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -167.16 -165.23 24.21 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.784 179.482 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.894 ' C ' HD23 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -132.91 175.36 9.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.621 0.248 . . . . 0.0 110.345 179.031 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.894 HD23 ' C ' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -122.46 157.83 31.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.153 0.501 . . . . 0.0 111.224 -179.964 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -126.94 84.77 2.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.926 178.805 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.854 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -82.98 97.1 4.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.992 -177.01 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.2 11.73 70.08 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.033 177.436 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 165.27 148.69 5.58 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.297 -179.72 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.0 m -129.88 13.87 2.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.948 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -93.52 151.06 19.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.694 0.283 . . . . 0.0 110.578 179.534 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -49.28 100.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.952 0.406 . . . . 0.0 110.758 179.96 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.26 0.41 6.89 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.603 -178.885 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.1 p -99.56 169.54 9.22 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.877 0.339 . . . . 0.0 110.481 179.443 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 47' ' ' SER . 4.4 p -143.27 138.74 29.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.078 0.466 . . . . 0.0 111.015 179.948 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.854 HG23 ' HA ' ' A' ' 22' ' ' ILE . 1.0 OUTLIER -92.84 173.67 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.634 178.949 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.45 ' H ' HG22 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -135.92 113.2 10.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.982 0.42 . . . . 0.0 111.331 -179.667 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.585 ' CE1' HD22 ' A' ' 20' ' ' LEU . 22.2 m-85 -89.27 140.87 29.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.883 179.696 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -147.14 146.31 29.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.731 -179.918 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.441 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 23.1 m -69.81 167.98 16.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.89 0.376 . . . . 0.0 111.001 -179.682 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -66.48 -78.5 0.06 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.006 -179.776 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -158.84 139.13 12.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.607 179.867 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.543 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 58.11 28.39 61.18 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.883 -179.002 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.491 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.1 m-85 -119.37 168.13 11.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.828 0.347 . . . . 0.0 111.09 -179.28 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.907 ' CD2' HD11 ' A' ' 42' ' ' ILE . 3.5 p-80 -127.39 117.08 21.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.404 177.806 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.919 HD21 ' O ' ' A' ' 44' ' ' GLU . 8.5 tt -81.97 126.03 31.47 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.778 -179.349 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.907 HD11 ' CD2' ' A' ' 40' ' ' HIS . 2.1 mm -105.62 164.46 4.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.116 -179.434 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.447 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 72.92 -132.26 16.94 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.507 179.986 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.919 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -81.92 -175.41 5.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.966 0.412 . . . . 0.0 110.759 179.575 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.419 ' O ' ' CG ' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -169.83 30.73 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.43 179.327 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.419 ' CG ' ' O ' ' A' ' 45' ' ' SER . 10.9 mtpt -166.91 114.47 0.82 Allowed 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.021 -178.315 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.486 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 0.4 OUTLIER -84.67 132.31 34.49 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 178.643 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.517 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.6 m-85 -107.1 120.74 42.91 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 119.514 -0.875 . . . . 0.0 111.516 -179.484 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.6 t -67.72 116.94 8.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.318 -179.035 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -158.5 179.66 8.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.371 179.413 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.633 ' C ' HD12 ' A' ' 51' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.326 -0.432 0 CA-C-O 120.746 0.308 . . . . 0.0 110.818 179.6 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.42 ' HA ' ' HA ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.451 -0.397 0 CA-C-O 121.318 0.58 . . . . 0.0 111.529 . . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.2 m -135.16 -175.47 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.458 179.868 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.522 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 59.5 m95 -128.41 128.18 43.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.837 0.351 . . . . 0.0 110.975 179.61 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.517 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.7 OUTLIER -69.69 164.93 46.23 Favored Pre-proline 0 C--O 1.224 -0.271 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.971 178.515 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.447 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 79.2 Cg_exo -16.73 100.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.741 1 C-N-CA 125.32 4.014 . . . . 0.0 114.498 -178.932 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.471 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -104.22 -82.15 0.51 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.753 -177.916 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.476 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -77.08 107.13 4.37 Favored Pre-proline 0 N--CA 1.463 0.185 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -176.355 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.893 ' HG2' HD11 ' A' ' 41' ' ' LEU . 3.1 Cg_endo -90.52 -155.54 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.345 2.697 . . . . 0.0 111.172 178.257 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.512 HG22 ' H ' ' A' ' 66' ' ' CYS . 3.9 mm -97.23 165.82 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.872 0.367 . . . . 0.0 110.847 178.803 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.512 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.2 m -162.32 136.92 6.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.944 179.904 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.22 173.23 16.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.758 179.793 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.491 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 80.8 p -81.42 112.63 18.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.999 179.954 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.756 HG22 ' HB3' ' A' ' 40' ' ' HIS . 6.3 p -44.62 97.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.429 179.844 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -79.76 127.59 32.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.617 -179.024 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.441 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -113.48 119.86 39.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.917 178.336 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.57 -159.63 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.775 0.322 . . . . 0.0 110.597 -179.067 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.463 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 2.3 t -49.06 137.75 13.76 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.818 -179.864 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.449 ' HA ' ' CD1' ' A' ' 118' ' ' TRP . 37.0 Cg_exo -56.77 161.64 9.88 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.168 1.912 . . . . 0.0 111.589 -179.874 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.507 ' HD3' ' CG ' ' A' ' 118' ' ' TRP . 79.7 Cg_exo -39.55 156.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.701 2.267 . . . . 0.0 112.785 -179.231 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.7 m -108.38 88.21 2.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.645 179.756 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.571 HG21 ' O ' ' A' ' 122' ' ' PRO . 13.5 pt -70.08 -177.68 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.299 -179.357 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.6 m -103.43 147.34 27.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.781 179.657 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.43 ' HB3' ' CD2' ' A' ' 103' ' ' TYR . 24.8 m-80 51.43 29.83 5.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.161 179.698 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.465 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -160.36 -165.27 16.87 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.395 -0.907 . . . . 0.0 113.098 179.798 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -164.18 -175.34 3.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.857 0.36 . . . . 0.0 110.463 -179.463 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.463 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 1.8 p-80 -120.37 166.14 13.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.617 -178.999 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.592 179.945 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.428 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 11.3 m-85 . . . . . 0 N--CA 1.449 -0.519 0 CA-C-O 121.091 0.472 . . . . 0.0 110.995 . . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.441 ' N ' ' O ' ' A' ' 71' ' ' CYS . 16.5 m-85 -141.69 166.89 23.5 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.922 179.569 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.2 p -131.29 179.64 5.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.127 0.489 . . . . 0.0 112.013 -177.97 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 5.4 p-10 -63.26 96.22 0.1 Allowed 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.904 179.888 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.49 14.49 2.9 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.297 -0.865 . . . . 0.0 113.152 179.157 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.67 156.58 16.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.906 0.353 . . . . 0.0 110.349 179.005 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.9 m -135.38 151.51 30.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.174 0.511 . . . . 0.0 111.095 -179.475 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.529 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 14.4 t -148.79 145.43 18.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.028 179.937 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.769 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -105.69 128.44 53.66 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.637 179.341 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.978 ' CE1' HG21 ' A' ' 111' ' ' VAL . 5.4 m-85 -89.0 157.83 18.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.154 -179.242 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.435 ' HA ' HD13 ' A' ' 105' ' ' LEU . 39.6 m -153.57 148.12 26.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.226 179.974 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.444 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 63.0 m -74.03 162.04 29.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.91 179.686 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.465 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 65.3 m-20 -84.9 -72.57 0.47 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.587 -179.055 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.0 m -70.84 -28.21 64.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.344 -178.67 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 132.08 36.78 0.3 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.712 179.854 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.501 ' CE1' HG12 ' A' ' 126' ' ' ILE . 33.8 m-85 -69.97 -174.82 0.82 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.893 0.378 . . . . 0.0 110.586 179.266 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.6 m -106.31 101.32 10.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.291 178.677 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.447 HD21 ' CG ' ' A' ' 122' ' ' PRO . 0.3 OUTLIER -48.81 128.04 14.91 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.438 0.637 . . . . 0.0 111.508 -178.466 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.446 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 35.7 mm -91.56 153.31 3.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.955 179.078 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.47 -128.13 38.15 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.994 -178.926 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -123.79 143.86 50.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.828 0.347 . . . . 0.0 110.982 179.432 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.769 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.4 t -72.19 -32.57 66.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.703 179.638 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.13 137.42 29.66 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.747 -179.701 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.978 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.5 t -132.32 118.62 36.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.648 0.261 . . . . 0.0 110.554 179.247 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.71 114.95 21.94 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.916 0.389 . . . . 0.0 111.538 -178.848 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.504 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 26.3 t -82.5 100.93 10.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.659 176.881 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 1.8 t -138.61 154.58 48.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.113 0.482 . . . . 0.0 111.473 -178.2 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.519 ' CA ' HG11 ' A' ' 69' ' ' VAL . . . 53.09 21.02 9.84 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.934 179.489 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.452 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 82.8 8.05 86.46 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.8 -179.917 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.95 176.56 8.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.98 0.419 . . . . 0.0 110.692 179.737 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.529 ' CZ3' HG23 ' A' ' 95' ' ' VAL . 96.3 m95 -113.58 134.97 54.41 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.847 -179.763 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.3 147.22 44.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.343 -179.232 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.473 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER 71.23 46.08 0.24 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.123 178.843 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 98.0 Cg_endo -78.49 133.23 11.63 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.364 2.043 . . . . 0.0 111.453 178.179 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.571 ' O ' HG21 ' A' ' 77' ' ' ILE . 74.2 Cg_endo -91.25 -173.88 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.664 2.243 . . . . 0.0 113.513 -178.04 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.438 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -131.33 -161.23 1.11 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.878 177.689 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 6.6 m -157.4 92.03 1.21 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.199 0.523 . . . . 0.0 110.879 179.074 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -122.94 160.15 26.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.927 -179.652 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.501 HG12 ' CE1' ' A' ' 103' ' ' TYR . 46.5 mm . . . . . 0 C--N 1.324 -0.529 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.816 179.693 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.473 ' HD2' HG23 ' A' ' 25' ' ' VAL . 32.4 mtm180 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.851 0.358 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.468 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 32.7 m -86.62 160.93 49.48 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.908 -179.965 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.12 169.14 18.77 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.496 2.131 . . . . 0.0 112.02 179.92 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.3 t -50.59 104.52 0.43 Allowed Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.982 -179.351 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.469 ' HG2' HD11 ' A' ' 22' ' ' ILE . 2.7 Cg_exo -45.41 166.32 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.197 1.932 . . . . 0.0 111.919 -179.67 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.623 ' NH1' ' HB3' ' A' ' 63' ' ' ALA . 2.5 ttt-85 -73.84 170.03 16.18 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.0 178.321 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.648 ' HA ' HD11 ' A' ' 20' ' ' LEU . 2.9 p30 -125.4 -177.95 4.06 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.161 0.505 . . . . 0.0 112.055 -176.347 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.628 HG22 HD21 ' A' ' 20' ' ' LEU . 4.3 tt -148.54 142.73 18.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.338 179.372 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -79.89 -60.68 2.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.54 -178.33 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.437 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 2.6 m-20 -91.03 45.37 1.24 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.961 0.41 . . . . 0.0 110.911 -179.251 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -167.01 -179.73 40.24 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.92 179.957 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -138.86 137.77 36.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.671 0.272 . . . . 0.0 110.525 179.641 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.856 HD22 ' CE2' ' A' ' 33' ' ' TYR . 0.5 OUTLIER -87.17 154.2 20.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.006 0.431 . . . . 0.0 111.443 -179.653 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -123.97 82.1 1.99 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.902 177.574 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.81 ' HA ' HG23 ' A' ' 31' ' ' ILE . 4.0 mm -68.93 105.08 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.495 -177.529 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.3 15.03 47.28 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.165 178.079 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.424 ' O ' ' CB ' ' A' ' 29' ' ' SER . . . 154.12 121.43 0.8 Allowed Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.206 -179.765 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.473 HG23 ' HD2' ' A' ' 8' ' ' ARG . 31.2 m -108.96 22.24 4.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.754 0.312 . . . . 0.0 111.442 -179.599 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -99.0 158.69 15.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.923 0.392 . . . . 0.0 110.855 179.502 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.562 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 8.3 t80 -56.27 92.1 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.899 -179.957 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 130.93 -0.22 5.3 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.77 -0.728 . . . . 0.0 113.072 -179.859 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 24' ' ' GLY . 58.2 m -89.87 -174.04 4.12 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.969 0.384 . . . . 0.0 110.75 179.848 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 48' ' ' TYR . 7.4 p -155.71 145.4 21.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.068 0.461 . . . . 0.0 111.456 -179.561 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.81 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.4 OUTLIER -104.68 167.57 2.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.444 179.445 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.553 HG23 ' HG3' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -132.81 108.83 9.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.948 0.404 . . . . 0.0 110.701 179.147 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.856 ' CE2' HD22 ' A' ' 20' ' ' LEU . 20.4 m-85 -81.5 149.5 28.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.177 -179.323 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.418 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 5.5 m -153.48 168.28 26.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.801 -179.61 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 1.6 m -88.08 171.99 9.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.833 179.912 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.23 -84.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.084 -179.4 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.44 130.5 10.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.524 179.858 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.712 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 64.8 23.63 69.29 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.864 -178.618 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.521 ' CZ ' ' HB3' ' A' ' 68' ' ' SER . 3.4 m-85 -113.85 175.34 5.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.681 0.277 . . . . 0.0 110.842 -179.085 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.591 ' NE2' HG22 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -131.16 132.57 44.85 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 175.731 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.927 HD21 ' O ' ' A' ' 44' ' ' GLU . 7.8 tt -95.35 118.43 32.08 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.886 -178.914 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.579 ' N ' HD13 ' A' ' 42' ' ' ILE . 1.1 mm -97.67 147.26 6.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.666 179.841 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.15 -149.5 23.04 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.21 -179.047 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.927 ' O ' HD21 ' A' ' 41' ' ' LEU . 1.2 pt-20 -67.14 -177.12 0.61 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.071 0.463 . . . . 0.0 110.786 179.361 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.45 30.09 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.336 179.846 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.553 ' HG3' HG23 ' A' ' 32' ' ' THR . 0.0 OUTLIER -162.31 123.37 2.59 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.773 -179.725 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.453 ' HB3' ' CG ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -105.47 155.04 19.54 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.536 -179.384 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.51 ' CD2' ' HB3' ' A' ' 60' ' ' ASN . 1.4 m-85 -130.86 125.06 32.61 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 119.686 -0.806 . . . . 0.0 112.283 -179.46 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.447 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 20.5 t -75.75 98.19 4.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.386 178.786 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.65 -173.33 2.62 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.107 -179.689 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.562 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.815 -179.68 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.496 ' O ' HG13 ' A' ' 58' ' ' VAL . 13.2 mtt . . . . . 0 N--CA 1.455 -0.202 0 CA-C-O 120.872 0.368 . . . . 0.0 110.548 . . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.496 HG13 ' O ' ' A' ' 57' ' ' MET . 3.4 m -157.76 163.52 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.94 -179.41 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.517 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 69.4 m95 -124.06 123.13 39.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.342 -179.489 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.51 ' HB3' ' CD2' ' A' ' 48' ' ' TYR . 3.2 m-20 -69.7 165.99 36.0 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.911 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 48.7 Cg_exo -9.61 95.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.029 1 C-N-CA 125.74 4.293 . . . . 0.0 115.074 -178.57 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.473 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 42.7 mt-10 -98.08 -99.27 0.21 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.482 -177.772 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.623 ' HB3' ' NH1' ' A' ' 13' ' ' ARG . . . -74.9 108.66 5.73 Favored Pre-proline 0 C--O 1.232 0.135 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -175.343 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.887 ' HG2' HD11 ' A' ' 41' ' ' LEU . 2.5 Cg_endo -87.01 -155.31 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.216 2.61 . . . . 0.0 110.757 176.668 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.466 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 2.1 mm -99.73 161.1 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.87 0.367 . . . . 0.0 110.786 178.685 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.437 ' HB3' ' HB2' ' A' ' 17' ' ' ASN . 1.1 m -155.65 137.53 14.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 -179.908 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.479 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -141.42 172.88 12.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.644 179.896 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.521 ' HB3' ' CZ ' ' A' ' 39' ' ' TYR . 1.1 p -108.38 123.72 49.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.283 -179.813 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.712 HG12 ' O ' ' A' ' 38' ' ' GLY . 5.1 p -52.12 90.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.596 178.494 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 68' ' ' SER . 0.6 OUTLIER -68.8 132.62 47.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.893 -178.129 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.422 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -112.75 118.56 35.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.585 177.164 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.471 ' CG ' ' N ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -69.29 -157.97 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.358 -179.532 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.585 ' HG ' ' CE1' ' A' ' 82' ' ' HIS . 0.8 OUTLIER -52.38 142.36 30.08 Favored Pre-proline 0 N--CA 1.447 -0.593 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.781 179.919 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.493 ' HA ' ' CD1' ' A' ' 118' ' ' TRP . 23.8 Cg_exo -60.67 157.87 35.34 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.326 2.017 . . . . 0.0 111.813 179.741 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.492 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 81.0 Cg_exo -43.79 156.19 0.17 Allowed 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.62 2.214 . . . . 0.0 112.594 -179.429 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.7 t -105.79 90.27 3.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.771 179.905 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.586 HG23 ' HE1' ' A' ' 97' ' ' TYR . 22.2 pt -69.56 176.32 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.297 -179.477 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.8 m -94.01 143.39 26.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.416 178.898 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.506 ' HB3' ' CD2' ' A' ' 103' ' ' TYR . 4.3 m-80 57.34 30.01 17.81 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.758 -179.829 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.44 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . 178.88 -175.79 47.56 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.689 179.953 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.25 -175.06 1.86 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.765 0.316 . . . . 0.0 110.348 -179.893 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.585 ' CE1' ' HG ' ' A' ' 73' ' ' SER . 12.3 p80 -85.83 174.78 9.07 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.855 179.8 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.417 ' OD1' ' CG1' ' A' ' 95' ' ' VAL . 21.0 p-10 . . . . . 0 C--N 1.332 -0.186 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -178.254 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.425 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 12.7 m-85 . . . . . 0 N--CA 1.446 -0.651 0 CA-C-O 121.186 0.517 . . . . 0.0 111.614 . . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.425 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 12.3 m-85 -142.28 166.91 23.39 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.017 179.661 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.4 p -127.16 169.56 13.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.969 0.414 . . . . 0.0 111.573 -178.783 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.418 ' OD1' ' CG1' ' A' ' 69' ' ' VAL . 0.1 OUTLIER -58.55 100.79 0.07 Allowed 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.49 0.662 . . . . 0.0 110.689 179.461 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.76 14.28 3.9 Favored Glycine 0 C--N 1.313 -0.745 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.916 179.287 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.424 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.7 OUTLIER -95.97 158.63 15.36 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.957 0.379 . . . . 0.0 110.327 178.808 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.431 HG22 ' N ' ' A' ' 95' ' ' VAL . 35.0 m -134.37 156.17 40.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.055 0.455 . . . . 0.0 111.043 -179.355 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.533 HG23 ' CH2' ' A' ' 118' ' ' TRP . 40.1 t -148.94 152.14 12.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.646 179.95 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.771 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -112.25 121.02 43.72 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.097 0.475 . . . . 0.0 111.01 -179.673 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 1.005 ' CE2' HG21 ' A' ' 111' ' ' VAL . 4.9 m-85 -80.74 155.36 26.75 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.568 -178.986 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.431 ' HA ' ' CD1' ' A' ' 105' ' ' LEU . 90.3 p -153.42 143.97 22.53 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.378 -179.729 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.44 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 6.3 m -69.54 164.86 22.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.442 -179.886 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -93.25 -67.44 0.86 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.883 179.268 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.68 -34.47 72.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.247 -179.716 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 133.63 43.94 0.13 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.491 -179.952 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.524 ' CE1' HG12 ' A' ' 126' ' ' ILE . 6.4 m-85 -78.46 -171.05 2.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.832 0.348 . . . . 0.0 110.644 179.809 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -113.57 98.86 7.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.489 179.051 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.482 HD23 ' HB2' ' A' ' 122' ' ' PRO . 0.1 OUTLIER -49.83 144.67 6.14 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.534 0.683 . . . . 0.0 111.254 -179.091 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.553 HG22 ' N ' ' A' ' 107' ' ' GLY . 23.8 mm -121.67 162.12 21.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.999 -178.096 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.553 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 47.7 45.82 24.3 Favored Glycine 0 C--O 1.226 -0.402 0 C-N-CA 120.574 -0.822 . . . . 0.0 113.237 178.619 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.435 ' O ' ' O ' ' A' ' 107' ' ' GLY . 9.2 p30 46.51 128.39 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 124.577 1.151 . . . . 0.0 114.09 177.556 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.771 ' OG ' HG22 ' A' ' 96' ' ' THR . 0.1 OUTLIER -55.07 -33.16 62.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.769 179.207 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -55.43 130.1 47.38 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.2 -178.534 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 1.005 HG21 ' CE2' ' A' ' 97' ' ' TYR . 2.4 t -127.31 150.19 32.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.024 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.28 122.23 47.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.951 0.405 . . . . 0.0 111.668 -179.149 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.504 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 15.3 t -87.76 100.88 13.17 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 176.733 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.6 OUTLIER -150.66 171.22 17.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.984 -178.654 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.418 ' N ' ' OD1' ' A' ' 91' ' ' ASP . . . 46.61 26.16 2.48 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.871 -179.935 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.12 18.82 76.82 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.281 -179.331 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -152.78 -176.68 5.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.895 0.379 . . . . 0.0 110.536 179.889 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.533 ' CH2' HG23 ' A' ' 95' ' ' VAL . 91.6 m95 -111.39 126.32 54.8 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.069 -179.425 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.8 161.09 14.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.263 -179.273 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.478 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 3.6 p30 48.46 46.04 3.33 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.434 179.161 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 57.5 Cg_endo -69.99 150.21 66.5 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.221 1.947 . . . . 0.0 110.691 176.51 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.566 ' O ' HG21 ' A' ' 77' ' ' ILE . 57.0 Cg_endo -95.99 177.51 0.7 Allowed 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.223 1.948 . . . . 0.0 114.089 -176.856 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.451 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -119.46 -160.8 0.83 Allowed 'General case' 0 CA--C 1.505 -0.784 0 CA-C-N 114.343 -1.298 . . . . 0.0 109.044 176.566 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 124' ' ' CYS . . . . . 0.425 ' SG ' ' HB2' ' A' ' 103' ' ' TYR . 5.0 t -170.32 91.02 0.18 Allowed 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.891 -175.98 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -122.16 175.76 6.19 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.355 -177.415 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.524 HG12 ' CE1' ' A' ' 103' ' ' TYR . 46.3 mm . . . . . 0 C--N 1.326 -0.437 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.677 179.37 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.445 ' HD2' HG23 ' A' ' 25' ' ' VAL . 6.4 mtm180 . . . . . 0 N--CA 1.455 -0.211 0 CA-C-O 120.986 0.422 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.524 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 65.9 m -69.82 175.91 2.04 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.596 178.565 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.553 ' HD2' ' CD1' ' A' ' 59' ' ' TRP . 35.6 Cg_endo -88.66 177.96 2.97 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.532 2.155 . . . . 0.0 111.452 179.047 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.8 t -51.31 105.54 0.54 Allowed Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.427 179.551 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.498 ' HG3' ' CZ2' ' A' ' 59' ' ' TRP . 53.5 Cg_exo -46.55 161.38 0.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.137 1.891 . . . . 0.0 112.366 -179.049 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.421 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -62.15 -173.42 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.849 177.673 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.508 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 0.4 OUTLIER -144.22 -175.95 4.82 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.288 179.524 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.412 HG23 ' C ' ' A' ' 18' ' ' GLY . 9.2 tt -146.71 142.98 20.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.571 179.739 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -73.94 -60.82 2.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.014 -177.63 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.409 ' O ' ' N ' ' A' ' 36' ' ' ASN . 0.2 OUTLIER -94.09 30.47 1.88 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.188 -178.133 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.412 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -147.17 177.43 25.47 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.896 -179.932 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -135.9 130.66 34.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.689 0.281 . . . . 0.0 110.365 179.01 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.868 HD21 ' CE2' ' A' ' 33' ' ' TYR . 24.6 mt -82.91 157.45 23.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.056 0.455 . . . . 0.0 111.726 -178.75 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.03 78.75 1.85 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.163 178.823 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.931 ' HA ' HG23 ' A' ' 31' ' ' ILE . 67.8 mt -69.93 100.27 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.843 -177.993 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.69 17.19 59.71 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.792 177.073 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 150.46 139.73 3.08 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.218 -179.601 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.445 HG23 ' HD2' ' A' ' 8' ' ' ARG . 35.8 m -124.1 31.15 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.915 0.388 . . . . 0.0 111.253 -179.477 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.41 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.4 OUTLIER -101.06 148.93 24.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.574 179.335 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.667 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 4.7 t80 -49.99 92.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.92 0.39 . . . . 0.0 110.79 179.909 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 131.44 -2.28 5.35 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.78 -179.094 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 65.6 p -89.15 -173.14 3.93 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 117.003 0.402 . . . . 0.0 110.444 179.468 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.3 p -155.11 154.36 32.26 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.002 0.43 . . . . 0.0 111.064 179.872 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.931 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.8 OUTLIER -115.65 164.6 11.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.491 -179.987 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -124.19 120.41 32.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.954 0.406 . . . . 0.0 111.253 -179.867 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.868 ' CE2' HD21 ' A' ' 20' ' ' LEU . 16.2 m-85 -97.77 135.28 39.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.182 -179.882 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.406 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -143.65 158.54 43.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.682 179.67 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.435 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 3.0 m -76.45 167.95 20.94 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.737 179.841 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 17' ' ' ASN . 0.8 OUTLIER -63.93 -81.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.898 -179.764 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -158.27 133.68 8.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.81 179.851 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.833 ' O ' HG22 ' A' ' 69' ' ' VAL . . . 64.43 23.61 68.61 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.107 -179.374 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.537 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.6 m-85 -114.58 179.84 3.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.793 0.33 . . . . 0.0 110.862 -179.622 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.882 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.5 OUTLIER -136.17 112.54 9.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.006 0.431 . . . . 0.0 110.55 178.135 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.934 HD11 ' HG2' ' A' ' 64' ' ' PRO . 4.6 tt -78.58 123.93 27.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.251 -179.981 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.882 HD11 ' CE1' ' A' ' 40' ' ' HIS . 1.9 mm -100.17 152.33 4.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.072 0.463 . . . . 0.0 111.059 -179.207 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.77 -137.92 17.4 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.117 -179.211 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.897 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -82.75 -175.86 5.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.943 0.402 . . . . 0.0 110.806 179.439 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.7 p -156.55 21.41 0.34 Allowed 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.458 -178.995 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -148.13 139.16 23.25 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.246 0.546 . . . . 0.0 112.304 -178.377 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.444 ' HB3' HG13 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -107.96 145.23 34.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.875 178.212 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.492 ' CB ' ' HB2' ' A' ' 60' ' ' ASN . 1.6 m-85 -123.61 119.99 31.5 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 119.179 -1.008 . . . . 0.0 112.405 -179.928 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.419 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 19.0 t -71.4 96.83 1.52 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.517 178.935 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.7 -173.96 2.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.167 -179.463 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.667 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.998 -179.851 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.528 ' O ' HG13 ' A' ' 58' ' ' VAL . 4.1 mmt . . . . . 0 N--CA 1.455 -0.194 0 CA-C-O 120.882 0.372 . . . . 0.0 110.513 . . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.528 HG13 ' O ' ' A' ' 57' ' ' MET . 2.4 m -158.78 172.91 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.1 -179.822 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.627 ' CE3' HD11 ' A' ' 31' ' ' ILE . 69.9 m95 -123.24 124.66 43.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.1 -179.976 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.492 ' HB2' ' CB ' ' A' ' 48' ' ' TYR . 3.1 m120 -69.28 163.98 52.98 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.333 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.439 ' O ' ' HA ' ' A' ' 47' ' ' SER . 38.9 Cg_exo -10.86 99.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.944 1 C-N-CA 125.735 4.29 . . . . 0.0 114.925 -178.618 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.476 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 7.9 mt-10 -91.62 -92.62 0.15 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.167 -0.924 . . . . 0.0 113.146 -176.43 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.508 ' HB2' ' O ' ' A' ' 14' ' ' ASP . . . -81.93 110.47 20.41 Favored Pre-proline 0 CA--C 1.528 0.109 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -174.953 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.934 ' HG2' HD11 ' A' ' 41' ' ' LEU . 5.1 Cg_exo -80.05 -153.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.942 2.428 . . . . 0.0 110.95 176.395 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.522 HG22 ' H ' ' A' ' 66' ' ' CYS . 3.5 mm -94.57 167.38 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.825 0.345 . . . . 0.0 110.919 178.833 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.522 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.2 m -166.44 132.9 2.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.171 179.24 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.9 164.56 35.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.761 -178.909 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.537 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 1.7 p -88.86 120.09 29.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.362 0.601 . . . . 0.0 111.248 -179.906 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.833 HG22 ' O ' ' A' ' 38' ' ' GLY . 0.6 OUTLIER -39.55 91.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.39 179.478 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.659 ' HZ1' ' HA ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -101.4 151.38 21.99 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.85 178.016 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.413 ' C ' ' HE3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -125.61 136.06 52.86 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.412 -177.63 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.659 ' HA ' ' HZ1' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -67.23 -173.18 0.26 Allowed 'General case' 0 N--CA 1.432 -1.354 0 CA-C-O 121.904 0.859 . . . . 0.0 113.115 -178.12 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -48.19 124.4 11.07 Favored Pre-proline 0 N--CA 1.441 -0.894 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.09 175.051 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.528 ' HG2' HG11 ' A' ' 95' ' ' VAL . 31.7 Cg_exo -46.09 153.33 1.01 Allowed 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.593 1.529 . . . . 0.0 111.88 -175.702 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.487 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 86.3 Cg_exo -45.59 154.34 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.741 2.294 . . . . 0.0 112.679 -177.492 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 12.8 t -103.1 91.02 3.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.666 -179.881 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.524 HG21 ' O ' ' A' ' 122' ' ' PRO . 18.9 pt -69.16 172.37 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.808 -179.962 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -93.29 134.04 35.9 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.892 -179.86 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.517 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 0.1 OUTLIER 66.95 27.76 8.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.543 -179.945 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -170.56 176.46 44.1 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.78 179.746 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 80' ' ' GLY . 3.5 mtp85 -148.49 -167.37 2.8 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.505 0.669 . . . . 0.0 111.706 -178.512 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 10.3 p-80 -127.37 160.28 31.87 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.843 178.993 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.611 -179.926 . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.517 ' CD2' ' CD ' ' A' ' 70' ' ' LYS . 6.5 m-30 . . . . . 0 N--CA 1.448 -0.568 0 CA-C-O 121.096 0.474 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.519 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 54.4 m-85 -152.61 166.45 32.04 Favored 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.647 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 12.2 p -147.47 -177.46 5.71 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.53 -0.868 . . . . 0.0 112.927 -178.416 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 7.9 p-10 -49.94 95.53 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.391 -179.575 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.01 10.04 5.9 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.43 -0.891 . . . . 0.0 113.269 177.467 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.422 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -95.16 143.77 26.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 117.253 0.526 . . . . 0.0 110.652 179.61 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 27.2 m -130.31 150.48 34.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.586 -179.736 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.528 HG11 ' HG2' ' A' ' 74' ' ' PRO . 24.3 t -142.96 147.07 21.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.039 179.877 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.714 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -103.68 130.59 51.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.929 -179.64 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.875 ' CE1' HG21 ' A' ' 111' ' ' VAL . 6.8 m-85 -91.68 154.78 18.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.153 -179.575 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.39 134.95 22.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.494 -179.471 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.444 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 81.1 m -69.34 158.39 35.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.908 179.864 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.91 -86.77 0.3 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.31 -179.702 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.0 t -43.6 -28.11 0.36 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.825 -178.944 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.05 38.45 0.43 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.361 -179.872 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.517 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 54.6 m-85 -81.6 -172.95 4.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.759 0.314 . . . . 0.0 110.852 -179.87 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 125' ' ' GLN . 0.3 OUTLIER -112.45 113.68 25.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.11 0.481 . . . . 0.0 110.985 -179.801 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.47 HD12 ' HA ' ' A' ' 105' ' ' LEU . 0.6 OUTLIER -47.51 109.78 0.25 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.509 178.554 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.46 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 47.5 mm -84.31 156.58 3.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.917 -178.947 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.445 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 59.06 -127.52 45.43 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.677 -178.736 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -117.18 133.68 55.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.012 0.434 . . . . 0.0 110.574 178.446 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.714 ' HB2' HG22 ' A' ' 96' ' ' THR . 0.1 OUTLIER -67.79 -29.56 68.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.376 179.6 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -77.0 125.61 7.5 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.673 179.622 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.875 HG21 ' CE1' ' A' ' 97' ' ' TYR . 10.9 t -115.86 124.94 72.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 178.771 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.864 HD22 ' N ' ' A' ' 113' ' ' CYS . 1.3 tm? -80.75 136.04 36.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.041 0.448 . . . . 0.0 111.527 -178.621 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.864 ' N ' HD22 ' A' ' 112' ' ' LEU . 18.4 t -108.95 107.2 17.48 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.702 177.116 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.606 ' CB ' HD11 ' A' ' 112' ' ' LEU . 2.8 t -164.34 134.13 3.94 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.992 0.425 . . . . 0.0 111.349 -179.717 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.49 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 89.76 16.4 56.57 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.477 -179.863 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.488 ' N ' ' HB ' ' A' ' 69' ' ' VAL . . . 86.33 1.83 85.81 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.064 -179.062 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -138.28 -170.66 2.86 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.755 0.788 . . . . 0.0 111.768 -178.809 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.507 ' CH2' ' HG3' ' A' ' 74' ' ' PRO . 97.0 m95 -117.5 159.67 22.46 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.381 179.055 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.544 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.2 OUTLIER -141.15 161.16 38.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.075 0.464 . . . . 0.0 111.785 -179.506 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.4 p30 46.87 53.67 13.99 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.423 179.069 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.448 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 87.3 Cg_endo -80.5 147.29 17.7 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.633 2.222 . . . . 0.0 111.37 177.227 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.524 ' O ' HG21 ' A' ' 77' ' ' ILE . 72.6 Cg_endo -92.05 -172.32 0.41 Allowed 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.71 2.273 . . . . 0.0 114.068 -177.339 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.444 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -136.63 -170.12 2.61 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.878 178.063 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 15.6 m -145.46 95.71 2.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.111 0.481 . . . . 0.0 111.211 -179.85 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.411 ' O ' ' HB2' ' A' ' 104' ' ' SER . 17.4 mt-30 -124.66 155.76 38.66 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.708 179.706 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.496 HG12 ' CE2' ' A' ' 103' ' ' TYR . 27.9 mm . . . . . 0 C--N 1.323 -0.572 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.914 179.961 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.662 ' HD2' HG23 ' A' ' 25' ' ' VAL . 70.0 mtm180 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.874 0.369 . . . . 0.0 111.012 . . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.448 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 52.1 m -94.23 159.92 33.07 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.353 179.15 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.406 ' O ' ' HD3' ' A' ' 12' ' ' PRO . 57.4 Cg_endo -68.31 166.38 25.55 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.271 1.981 . . . . 0.0 111.333 178.919 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.4 p -51.71 104.95 0.46 Allowed Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.178 -178.738 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.67 ' HG2' HD13 ' A' ' 22' ' ' ILE . 12.7 Cg_exo -40.62 160.97 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.493 2.129 . . . . 0.0 112.517 -179.429 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.527 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -68.61 169.42 11.12 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.068 178.737 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.52 ' HA ' HD11 ' A' ' 20' ' ' LEU . 1.4 t0 -114.49 -173.98 2.4 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.253 0.549 . . . . 0.0 111.759 -178.192 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.552 HG22 ' CD2' ' A' ' 20' ' ' LEU . 13.9 tt -148.22 149.79 14.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.855 -179.435 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.401 ' O ' HG12 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -90.19 159.82 16.54 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.643 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 46.45 27.51 0.62 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.86 0.362 . . . . 0.0 110.508 -179.138 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.74 170.25 39.76 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.024 -0.607 . . . . 0.0 112.471 -178.974 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -136.57 155.56 49.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.882 0.372 . . . . 0.0 110.41 179.831 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.807 HD22 ' CE2' ' A' ' 33' ' ' TYR . 0.3 OUTLIER -93.05 162.43 14.04 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.256 -179.638 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 32' ' ' THR . 12.8 t0 -128.9 74.61 1.59 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.538 177.962 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.898 ' HA ' HG23 ' A' ' 31' ' ' ILE . 1.5 mt -75.02 102.95 2.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.394 -176.086 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.3 13.1 58.61 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.612 175.893 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 166.46 138.05 2.35 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 -179.495 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.662 HG23 ' HD2' ' A' ' 8' ' ' ARG . 13.7 m -125.52 1.96 4.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.49 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.443 ' HA ' ' CB ' ' A' ' 8' ' ' ARG . 37.3 t70 -71.79 165.12 24.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.879 0.371 . . . . 0.0 110.816 179.943 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.588 ' CZ ' HD12 ' A' ' 51' ' ' LEU . 6.7 t80 -57.68 90.59 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.967 -179.501 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.81 -2.59 6.01 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.007 179.819 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.7 m -82.04 162.32 22.63 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 117.004 0.402 . . . . 0.0 110.485 179.561 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.5 p -131.55 148.92 52.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.94 0.4 . . . . 0.0 110.973 179.785 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.898 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -108.67 170.64 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.668 -179.598 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.463 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -133.15 111.55 11.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.984 0.421 . . . . 0.0 110.874 179.015 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.807 ' CE2' HD22 ' A' ' 20' ' ' LEU . 12.1 m-85 -85.83 149.66 25.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.677 -178.475 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.1 m -149.52 160.64 43.3 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.134 179.821 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.403 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 3.5 m -84.27 169.18 14.97 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.068 179.939 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -67.76 -85.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.247 -178.972 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.23 132.67 12.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.742 -179.833 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.755 ' O ' HG22 ' A' ' 69' ' ' VAL . . . 68.36 21.22 74.07 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.912 -178.718 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.545 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.7 m-85 -116.72 176.12 5.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.719 0.295 . . . . 0.0 110.598 -179.903 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.816 ' CD2' HD11 ' A' ' 42' ' ' ILE . 7.7 p-80 -139.93 118.1 11.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.082 0.468 . . . . 0.0 110.243 177.754 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.886 HD21 ' O ' ' A' ' 44' ' ' GLU . 7.9 tt -78.22 123.31 26.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.736 -178.877 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.816 HD11 ' CD2' ' A' ' 40' ' ' HIS . 2.0 mm -102.04 165.51 2.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.038 0.447 . . . . 0.0 111.052 -179.343 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.481 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 67.69 -142.56 40.51 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.163 -179.198 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.886 ' O ' HD21 ' A' ' 41' ' ' LEU . 1.0 OUTLIER -66.96 -175.56 0.43 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.006 0.431 . . . . 0.0 110.767 179.414 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.2 t -171.44 31.38 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.409 179.362 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.463 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -160.41 126.79 4.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.468 -178.153 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.458 ' CB ' HD12 ' A' ' 31' ' ' ILE . 0.1 OUTLIER -93.5 145.81 24.24 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.063 178.265 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.545 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.6 m-85 -122.18 115.29 22.14 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 119.414 -0.914 . . . . 0.0 111.583 178.579 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 39.1 t -68.04 100.18 0.96 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.845 -179.89 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.498 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -126.46 175.47 7.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.447 -179.686 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.588 HD12 ' CZ ' ' A' ' 27' ' ' PHE . 7.8 mt . . . . . 0 C--N 1.324 -0.535 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.127 -179.345 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.918 0.389 . . . . 0.0 110.79 . . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.4 m -113.31 -169.39 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.767 179.808 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.516 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 73.6 m95 -130.7 146.58 52.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.977 0.418 . . . . 0.0 111.423 -179.543 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.545 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.6 OUTLIER -92.1 166.64 16.95 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.632 177.427 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.482 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 93.6 Cg_exo -16.22 97.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.811 1 C-N-CA 125.387 4.058 . . . . 0.0 114.639 -178.802 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.481 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -93.92 -76.54 0.48 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.088 -178.054 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.488 ' HA ' ' CD2' ' A' ' 33' ' ' TYR . . . -85.53 108.38 16.02 Favored Pre-proline 0 N--CA 1.463 0.176 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -175.896 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.884 ' HG2' HD11 ' A' ' 41' ' ' LEU . 3.5 Cg_exo -82.82 -153.88 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.148 2.565 . . . . 0.0 111.038 177.078 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.538 HG22 ' H ' ' A' ' 66' ' ' CYS . 4.2 mm -90.29 167.38 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.771 0.319 . . . . 0.0 110.541 178.064 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.538 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.1 m -167.53 127.93 1.44 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.037 179.462 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -148.45 173.25 13.29 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.579 179.618 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.545 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 67.6 p -77.41 130.55 37.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.441 0.639 . . . . 0.0 111.368 -179.495 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.755 HG22 ' O ' ' A' ' 38' ' ' GLY . 2.7 m -36.39 104.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 114.934 -1.03 . . . . 0.0 112.95 -178.985 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.57 ' CE ' HG23 ' A' ' 90' ' ' THR . 0.1 OUTLIER -86.77 97.06 10.4 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.271 177.132 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.447 ' N ' ' O ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -83.15 128.35 34.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.991 0.424 . . . . 0.0 110.246 179.264 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.44 -158.24 0.07 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.253 178.993 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.479 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 1.8 t -48.92 137.79 13.15 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.035 -179.997 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.495 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 35.5 Cg_exo -59.71 165.58 9.61 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.43 2.086 . . . . 0.0 112.348 -179.662 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.529 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 84.0 Cg_exo -45.77 157.38 0.34 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.769 2.312 . . . . 0.0 112.781 -179.669 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.7 t -109.87 90.21 3.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.461 179.047 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.727 HG23 ' HE1' ' A' ' 97' ' ' TYR . 17.1 pt -69.26 167.84 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.286 -179.0 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.8 m -81.29 139.45 35.41 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.717 179.684 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.411 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 5.4 m-80 56.5 28.84 14.39 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 -179.821 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.464 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -157.09 -170.29 21.87 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.344 -0.932 . . . . 0.0 113.268 -179.851 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -170.16 -175.32 1.95 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.068 0.461 . . . . 0.0 110.976 -179.307 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.479 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 9.3 p80 -115.84 170.64 8.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.971 -179.74 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 120.948 0.404 . . . . 0.0 111.035 179.012 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.435 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 11.6 m-85 . . . . . 0 N--CA 1.457 -0.103 0 CA-C-O 120.784 0.326 . . . . 0.0 110.817 . . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.447 ' O ' ' N ' ' A' ' 71' ' ' CYS . 72.7 m-85 -156.62 164.14 38.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.67 -179.126 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.57 HG23 ' CE ' ' A' ' 70' ' ' LYS . 17.3 p -148.49 -177.04 5.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.087 0.47 . . . . 0.0 112.017 -179.242 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.441 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 56.4 m-20 -52.19 94.01 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.249 -179.503 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 122.43 20.5 2.94 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.184 -0.916 . . . . 0.0 113.044 178.455 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.417 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -106.11 150.02 26.19 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 117.087 0.443 . . . . 0.0 110.554 178.994 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.415 HG22 ' N ' ' A' ' 95' ' ' VAL . 31.1 m -131.36 153.67 39.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.158 0.504 . . . . 0.0 111.359 -179.245 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.521 HG23 ' CH2' ' A' ' 118' ' ' TRP . 23.0 t -145.78 149.17 16.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.374 179.132 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.871 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -105.31 130.41 53.44 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.09 0.471 . . . . 0.0 110.796 -179.966 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.967 ' CE2' HG21 ' A' ' 111' ' ' VAL . 3.2 m-85 -87.52 157.41 19.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.252 -179.115 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 61.0 p -144.29 131.42 20.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.524 -179.746 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.46 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 87.8 m -69.26 151.88 45.72 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.019 179.761 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.464 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 6.4 m-20 -90.62 -71.69 0.61 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.706 -178.384 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.7 t -58.39 -17.95 24.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.512 -179.279 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 115.3 27.23 3.19 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.082 -179.298 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.487 ' CE2' HG12 ' A' ' 126' ' ' ILE . 31.3 m-85 -69.61 -173.72 0.62 Allowed 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 120.886 0.374 . . . . 0.0 110.923 -179.676 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.57 112.4 23.9 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.396 179.126 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.492 HD22 ' HA ' ' A' ' 109' ' ' SER . 1.1 tp -50.1 112.49 0.68 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.074 -179.737 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.448 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 47.5 mm -99.34 155.88 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.729 179.957 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.434 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 60.53 28.13 67.1 Favored Glycine 0 CA--C 1.508 -0.363 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.437 179.497 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 60.22 129.11 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.001 -0.599 . . . . 0.0 111.495 179.65 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.871 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.2 p -61.47 -26.64 68.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.452 -179.059 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -58.66 136.83 50.81 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.788 -179.356 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.967 HG21 ' CE2' ' A' ' 97' ' ' TYR . 3.2 t -136.81 123.48 29.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.613 0.244 . . . . 0.0 110.936 179.734 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.954 HD22 ' N ' ' A' ' 113' ' ' CYS . 0.7 OUTLIER -81.72 136.16 35.47 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.886 0.374 . . . . 0.0 111.226 -179.73 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.954 ' N ' HD22 ' A' ' 112' ' ' LEU . 36.5 t -107.11 108.46 19.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.991 176.835 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.579 ' OG ' HD11 ' A' ' 112' ' ' LEU . 10.2 p -162.0 129.23 3.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.043 0.449 . . . . 0.0 111.848 -179.932 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.519 ' H ' HG21 ' A' ' 69' ' ' VAL . . . 86.58 30.22 22.08 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.508 179.309 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.453 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 68.75 14.15 67.12 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.212 -178.923 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -143.08 -178.15 5.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.181 0.515 . . . . 0.0 111.365 -179.552 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.529 ' CD1' ' HD3' ' A' ' 75' ' ' PRO . 90.4 m95 -123.73 133.05 53.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.525 179.989 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.455 ' OG ' HD12 ' A' ' 112' ' ' LEU . 0.4 OUTLIER -111.89 157.21 20.9 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.085 0.469 . . . . 0.0 111.356 -179.428 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.495 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER 62.63 44.22 0.6 Allowed Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.256 179.21 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 55.2 Cg_endo -69.13 137.24 36.79 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.174 1.916 . . . . 0.0 111.273 178.008 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.513 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 71.0 Cg_endo -86.43 -173.99 1.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.404 2.069 . . . . 0.0 113.772 -177.631 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.58 -175.5 3.97 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.549 178.123 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 124' ' ' CYS . . . . . 0.415 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 3.8 m -139.29 94.87 2.85 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.972 0.415 . . . . 0.0 110.897 179.688 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -123.26 159.17 29.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.86 -179.666 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.487 HG12 ' CE2' ' A' ' 103' ' ' TYR . 27.3 mm . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.993 179.935 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.47 ' HD2' HG23 ' A' ' 25' ' ' VAL . 66.0 mtm-85 . . . . . 0 C--O 1.232 0.154 0 CA-C-O 121.039 0.447 . . . . 0.0 111.243 . . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.527 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 36.2 m -73.53 175.83 3.23 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.808 178.592 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.56 ' HD2' ' CD1' ' A' ' 59' ' ' TRP . 18.6 Cg_endo -87.2 -174.83 1.41 Allowed 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.791 2.327 . . . . 0.0 111.406 178.882 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.435 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 2.9 t -58.18 106.53 0.71 Allowed Pre-proline 0 C--N 1.325 -0.479 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.402 179.242 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.471 ' HG2' HD11 ' A' ' 22' ' ' ILE . 1.8 Cg_endo -49.91 148.11 13.41 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.09 1.86 . . . . 0.0 111.849 -179.203 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.906 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -58.16 159.47 5.87 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.126 178.981 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -108.33 -178.96 3.75 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.149 0.5 . . . . 0.0 112.021 -176.29 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.5 tt -138.85 144.23 30.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.71 179.585 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.02 -68.95 0.58 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.557 -178.483 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -90.02 43.4 1.14 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.222 -179.134 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -160.5 -174.81 30.78 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.093 179.981 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -143.53 128.62 18.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.742 0.306 . . . . 0.0 110.624 -179.598 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.906 HD11 ' O ' ' A' ' 13' ' ' ARG . 13.8 mt -73.11 157.88 36.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.072 0.463 . . . . 0.0 111.497 -179.571 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.98 75.37 1.65 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.643 177.657 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.931 ' HA ' HG23 ' A' ' 31' ' ' ILE . 68.0 mt -69.25 106.32 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.65 -177.643 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -115.87 21.05 12.69 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.66 177.557 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 158.31 119.91 0.58 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.136 -179.512 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.47 HG23 ' HD2' ' A' ' 8' ' ' ARG . 32.8 m -117.84 28.92 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.774 0.321 . . . . 0.0 111.295 -179.596 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -104.89 147.85 27.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.852 179.86 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.482 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 8.4 t80 -47.34 96.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.088 -179.693 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 122.33 16.68 3.8 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.83 -179.951 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.16 -161.0 0.75 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.696 0.284 . . . . 0.0 110.749 179.632 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.4 p -167.68 148.82 5.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.986 0.422 . . . . 0.0 111.318 179.42 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.931 HG23 ' HA ' ' A' ' 22' ' ' ILE . 1.0 OUTLIER -106.94 173.33 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.591 -179.977 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.492 ' H ' HG22 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -130.92 116.35 17.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.99 0.424 . . . . 0.0 111.384 179.375 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.833 ' CE2' HD21 ' A' ' 20' ' ' LEU . 18.7 m-85 -92.29 138.83 31.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.968 179.758 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.418 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 85.3 p -144.01 166.41 25.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.981 -179.74 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.448 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 3.9 m -90.2 165.72 13.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.728 179.915 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -64.28 -83.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.851 0.358 . . . . 0.0 111.015 -179.612 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.18 136.81 15.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.624 179.906 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.627 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 60.77 26.92 65.75 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.862 -178.913 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.491 ' CD2' ' HA ' ' A' ' 68' ' ' SER . 2.3 m-85 -119.26 171.41 8.32 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.725 0.298 . . . . 0.0 110.811 -179.328 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.891 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.5 OUTLIER -132.3 120.37 22.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.955 0.407 . . . . 0.0 110.516 177.865 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.902 HD11 ' HG2' ' A' ' 64' ' ' PRO . 6.7 tt -83.46 124.07 30.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.765 -179.294 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.891 HD11 ' CE1' ' A' ' 40' ' ' HIS . 1.9 mm -103.8 167.79 2.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.984 -179.625 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.519 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 73.59 -134.37 19.06 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.097 -179.16 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.894 ' O ' HD21 ' A' ' 41' ' ' LEU . 1.2 pt-20 -80.71 -175.69 5.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.868 0.366 . . . . 0.0 110.688 178.978 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.9 p -160.19 22.31 0.16 Allowed 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.423 -179.258 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.464 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -163.2 124.29 2.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.85 0.357 . . . . 0.0 111.691 -177.984 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 30' ' ' SER . 1.4 t -91.89 138.77 31.28 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 177.233 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.517 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.7 m-85 -113.38 121.53 44.61 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 119.146 -1.022 . . . . 0.0 112.17 -179.473 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 33.9 t -73.28 102.78 3.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.576 179.174 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.01 -172.33 2.43 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.311 -179.543 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.482 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.387 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.03 -179.353 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.446 ' O ' HG13 ' A' ' 58' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.966 0.412 . . . . 0.0 110.628 . . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 57' ' ' MET . 2.2 m -156.46 163.48 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.879 179.692 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.56 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 78.4 m95 -124.75 120.42 31.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.937 0.399 . . . . 0.0 111.528 -179.325 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.517 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -69.9 165.9 37.84 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.14 178.155 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.445 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 89.3 Cg_exo -19.35 98.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 125.216 3.944 . . . . 0.0 114.164 -179.004 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.474 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -100.48 -78.76 0.51 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.344 -177.096 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.478 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -76.55 108.3 6.16 Favored Pre-proline 0 N--CA 1.463 0.19 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -175.032 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.902 ' HG2' HD11 ' A' ' 41' ' ' LEU . 1.0 OUTLIER -88.22 -153.99 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.388 2.725 . . . . 0.0 110.993 176.814 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.573 HG22 ' H ' ' A' ' 66' ' ' CYS . 3.0 mm -98.76 169.57 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.875 0.369 . . . . 0.0 110.76 178.629 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.573 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.1 m -160.51 145.77 14.7 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 179.556 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.471 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.3 OUTLIER -164.56 172.38 13.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.039 -179.951 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.491 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 12.1 p -90.22 112.61 24.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.086 0.469 . . . . 0.0 111.078 179.967 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.627 HG12 ' O ' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -47.79 99.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.344 179.863 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.492 ' HE2' HG23 ' A' ' 90' ' ' THR . 0.1 OUTLIER -81.88 116.13 21.39 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.075 179.923 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.407 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -97.68 129.75 44.72 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.308 179.283 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.85 -156.33 0.12 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.362 179.306 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.443 ' HG ' ' CE1' ' A' ' 82' ' ' HIS . 2.1 t -49.26 137.58 15.14 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.854 179.933 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.52 ' HG2' HG11 ' A' ' 95' ' ' VAL . 27.4 Cg_exo -59.9 163.79 13.15 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.405 2.07 . . . . 0.0 112.062 -179.989 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.517 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 86.1 Cg_exo -39.38 156.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.812 2.341 . . . . 0.0 112.894 -179.605 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.6 t -108.8 90.49 3.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.551 179.449 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.721 HG23 ' HE2' ' A' ' 97' ' ' TYR . 35.7 pt -69.43 175.22 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.326 -179.182 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.36 138.18 39.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.622 179.309 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.498 ' HB3' ' CD2' ' A' ' 103' ' ' TYR . 0.3 OUTLIER 68.65 28.07 5.8 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.676 -179.958 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.452 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . -170.21 -159.99 17.47 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.76 179.694 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.417 ' N ' ' O ' ' A' ' 98' ' ' SER . 1.4 ptt85 -170.13 -176.2 2.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.091 0.472 . . . . 0.0 111.022 -179.226 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.457 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 21.4 p-80 -110.25 170.9 7.78 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.918 179.795 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.775 179.88 . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.42 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 5.3 m-85 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.889 0.376 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.42 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 66.4 m-85 -152.77 161.6 42.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.928 -179.689 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.492 HG23 ' HE2' ' A' ' 70' ' ' LYS . 8.1 p -128.36 -175.92 3.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.214 -179.252 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -64.85 94.83 0.14 Allowed 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.271 0.558 . . . . 0.0 110.988 -179.843 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.55 18.72 2.18 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.317 178.656 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.4 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -95.34 162.86 13.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.934 0.367 . . . . 0.0 110.573 179.246 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 35.6 m -138.27 149.64 24.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.13 0.49 . . . . 0.0 111.335 -179.608 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.525 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 23.6 t -146.09 148.68 16.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.743 179.526 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.968 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -106.97 130.89 54.55 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.987 -179.973 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.972 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.9 m-85 -89.88 160.74 16.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.985 -179.67 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.417 ' O ' ' N ' ' A' ' 81' ' ' ARG . 21.3 p -157.37 138.86 13.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.557 -179.941 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.452 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 68.5 m -70.27 164.5 24.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.815 179.4 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -101.68 -85.24 0.43 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.84 0.352 . . . . 0.0 111.207 179.636 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -45.01 -31.36 1.28 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.522 -179.198 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 130.29 45.12 0.17 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.681 179.777 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.504 ' CE1' HG12 ' A' ' 126' ' ' ILE . 29.7 m-85 -87.04 -173.54 4.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.833 0.349 . . . . 0.0 110.836 179.972 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 41.2 m -111.49 108.17 17.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.108 -179.519 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.648 HD23 ' HB2' ' A' ' 122' ' ' PRO . 2.9 tp -44.94 113.16 0.52 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.146 178.935 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.592 HD11 ' HB2' ' A' ' 125' ' ' GLN . 40.0 mm -85.93 156.33 3.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.465 179.79 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.438 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 60.44 -125.62 39.09 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.558 -178.333 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -124.2 135.37 53.4 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.849 0.357 . . . . 0.0 110.584 178.55 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.968 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.2 p -65.94 -29.8 70.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.701 -180.0 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -71.91 137.08 24.97 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.578 179.892 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.972 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.7 t -131.08 119.16 43.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.757 0.313 . . . . 0.0 110.837 179.712 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.03 119.57 23.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.522 -179.006 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.523 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 31.7 t -85.57 101.88 13.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.623 176.996 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.9 t -139.31 153.85 47.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.193 0.52 . . . . 0.0 111.568 -178.143 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.448 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 47.15 33.94 7.71 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.911 179.482 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.461 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 69.94 11.07 65.97 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.746 -179.999 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -131.15 175.15 9.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.899 0.381 . . . . 0.0 110.391 179.225 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.525 ' CZ3' HG23 ' A' ' 95' ' ' VAL . 93.3 m95 -117.12 128.62 55.32 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.787 -179.43 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.38 146.63 35.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.4 -178.852 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.486 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.5 t0 71.53 46.46 0.24 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.207 178.646 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 74.0 Cg_endo -75.32 130.66 13.15 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.319 2.013 . . . . 0.0 111.324 177.934 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.648 ' HB2' HD23 ' A' ' 105' ' ' LEU . 58.0 Cg_endo -86.15 -174.7 1.58 Allowed 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.448 2.099 . . . . 0.0 113.387 -178.229 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.458 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.3 OUTLIER -135.81 -173.62 3.42 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.071 178.392 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 124' ' ' CYS . . . . . 0.435 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 16.5 m -141.61 94.62 2.71 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.94 0.4 . . . . 0.0 111.108 -179.5 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.592 ' HB2' HD11 ' A' ' 106' ' ' ILE . 20.6 mt-30 -118.83 169.42 9.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.713 179.921 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.504 HG12 ' CE1' ' A' ' 103' ' ' TYR . 19.5 mm . . . . . 0 C--N 1.325 -0.491 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.806 -179.796 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.701 ' HD2' HG23 ' A' ' 25' ' ' VAL . 4.3 mtm180 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.812 0.339 . . . . 0.0 110.798 . . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.473 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 69.4 m -77.67 159.24 77.19 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.577 179.606 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 51.1 Cg_endo -68.85 169.98 16.49 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.345 2.03 . . . . 0.0 111.964 -179.718 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.17 105.91 0.58 Allowed Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.777 -179.745 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.522 ' HG3' ' CZ2' ' A' ' 59' ' ' TRP . 53.0 Cg_exo -53.67 160.16 5.8 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.278 1.985 . . . . 0.0 112.517 -179.759 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.571 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -52.86 -174.58 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.156 177.811 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.767 ' O ' HG22 ' A' ' 15' ' ' ILE . 11.8 p-10 -135.66 -40.88 0.7 Allowed 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -176.314 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.767 HG22 ' O ' ' A' ' 14' ' ' ASP . 5.1 tt 66.08 139.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.777 -177.084 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -94.47 -40.03 10.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.855 -177.736 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.445 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 1.3 m120 -93.83 24.71 4.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.8 0.333 . . . . 0.0 111.116 -179.016 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.08 176.29 40.08 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.544 179.838 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.424 ' N ' ' O ' ' A' ' 34' ' ' SER . 2.2 mt-30 -129.49 129.7 44.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.702 0.287 . . . . 0.0 110.564 179.718 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.699 HD21 ' CE1' ' A' ' 33' ' ' TYR . 49.1 mt -82.63 162.51 21.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.151 0.5 . . . . 0.0 111.632 -179.14 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -130.71 80.59 1.95 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.166 179.259 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.876 ' HA ' HG23 ' A' ' 31' ' ' ILE . 56.3 mt -71.33 103.33 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.441 -178.583 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.31 15.22 50.7 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.303 178.451 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.402 ' O ' ' HB3' ' A' ' 29' ' ' SER . . . 157.11 127.86 1.01 Allowed Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.772 -179.538 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.701 HG23 ' HD2' ' A' ' 8' ' ' ARG . 30.1 m -115.32 26.22 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -178.213 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -101.18 162.09 13.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.986 0.422 . . . . 0.0 110.996 179.08 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.439 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 2.5 t80 -57.18 92.01 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.986 -179.31 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 132.51 -11.87 5.21 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.884 179.87 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.402 ' HB3' ' O ' ' A' ' 24' ' ' GLY . 9.3 m -75.37 -175.74 2.87 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.819 0.309 . . . . 0.0 110.805 179.87 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 47' ' ' SER . 0.3 OUTLIER -154.07 143.45 21.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.493 -179.717 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.876 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -104.51 171.25 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.938 179.222 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.426 ' O ' ' N ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -132.25 120.19 21.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.891 178.933 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.699 ' CE1' HD21 ' A' ' 20' ' ' LEU . 28.5 m-85 -99.65 135.22 41.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.197 -179.624 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.424 ' O ' ' N ' ' A' ' 19' ' ' GLN . 64.3 m -143.33 159.38 42.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.765 179.628 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.438 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 57.0 m -83.87 166.02 18.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.002 -179.947 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.85 -83.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.082 -179.705 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 t -155.44 136.48 13.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.787 -179.895 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.01 23.25 65.7 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.124 -179.294 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.503 ' CE1' ' HB3' ' A' ' 68' ' ' SER . 2.3 m-85 -113.63 -179.02 3.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.918 0.389 . . . . 0.0 110.98 -179.386 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.567 ' CE1' HD11 ' A' ' 42' ' ' ILE . 3.2 p-80 -143.98 114.56 7.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.393 178.095 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.969 HD21 ' O ' ' A' ' 44' ' ' GLU . 2.3 tt -75.25 136.47 40.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.675 -179.105 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.567 HD11 ' CE1' ' A' ' 40' ' ' HIS . 3.1 mm -108.39 153.94 9.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.199 -179.01 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.64 -135.95 19.1 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.554 -179.948 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.969 ' O ' HD21 ' A' ' 41' ' ' LEU . 4.3 pm0 -75.47 -179.14 4.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.624 0.25 . . . . 0.0 110.691 179.733 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.1 p -152.23 21.04 0.65 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.181 -179.784 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.415 ' CE ' ' O ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -151.91 163.06 40.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.896 -178.882 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.472 ' O ' HG13 ' A' ' 31' ' ' ILE . 2.8 m -137.44 112.05 8.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.643 179.99 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.419 ' CD1' ' N ' ' A' ' 48' ' ' TYR . 2.0 m-30 -90.01 121.2 31.87 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.897 0.38 . . . . 0.0 111.334 -179.258 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.502 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 35.1 t -71.56 97.49 1.7 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.55 179.396 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -124.58 -176.49 3.54 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.128 -179.514 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.599 HD13 ' H ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.01 -179.314 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 4.0 mmt . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.679 0.276 . . . . 0.0 110.443 . . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.0 m -149.7 -178.13 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.87 0.367 . . . . 0.0 111.275 -179.296 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.564 ' CE3' HD11 ' A' ' 31' ' ' ILE . 95.2 m95 -128.77 123.86 34.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.774 -179.733 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -148.45 119.71 4.34 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.769 -179.459 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -67.72 -176.28 9.64 Favored 'Cis proline' 0 C--N 1.351 0.7 0 C-N-CA 124.135 -1.194 . . . . 0.0 112.718 1.787 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.435 ' O ' ' CD ' ' A' ' 64' ' ' PRO . 0.6 OUTLIER -111.6 -140.77 0.38 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.102 -178.654 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.534 ' CB ' ' CE1' ' A' ' 33' ' ' TYR . . . -95.6 86.17 0.32 Allowed Pre-proline 0 N--CA 1.448 -0.567 0 C-N-CA 122.878 0.471 . . . . 0.0 110.759 179.464 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.713 ' HG2' HD11 ' A' ' 41' ' ' LEU . 9.8 Cg_endo -45.68 -159.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.476 0.451 0 C-N-CA 124.313 3.342 . . . . 0.0 114.53 178.703 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.495 HG22 ' H ' ' A' ' 66' ' ' CYS . 5.5 mm -97.59 165.76 2.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.854 -178.267 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.495 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.2 m -164.83 117.35 1.24 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.342 179.017 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.19 177.68 7.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.893 0.377 . . . . 0.0 111.353 -179.417 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.503 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 49.7 p -88.71 99.35 12.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.22 -179.965 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.765 HG22 ' HA3' ' A' ' 116' ' ' GLY . 6.8 p -60.99 103.89 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.302 178.489 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.5 ' HG2' HG22 ' A' ' 90' ' ' THR . 2.7 mttp -82.21 167.44 18.66 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -176.297 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.421 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -125.96 122.69 36.67 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.525 177.3 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.444 ' CG ' ' N ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -69.43 -155.48 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.988 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.444 ' N ' ' CG ' ' A' ' 72' ' ' GLN . 1.4 t -52.8 144.52 25.6 Favored Pre-proline 0 N--CA 1.448 -0.556 0 C-N-CA 121.081 -0.248 . . . . 0.0 110.373 179.091 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.775 ' HG3' HG21 ' A' ' 95' ' ' VAL . 39.0 Cg_exo -60.78 160.36 25.31 Favored 'Trans proline' 0 C--O 1.231 0.129 0 C-N-CA 122.561 2.174 . . . . 0.0 112.159 -179.327 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -42.39 155.89 0.1 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.568 2.179 . . . . 0.0 112.41 -179.315 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.3 t -103.94 86.39 2.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.828 -179.793 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.642 HD11 ' HA3' ' A' ' 80' ' ' GLY . 8.2 pt -69.85 169.98 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.953 -179.959 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.5 m -91.59 137.91 31.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.81 179.651 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.506 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 4.8 m-80 57.62 29.84 17.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.725 -179.901 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.642 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -165.5 169.36 39.91 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.531 -0.843 . . . . 0.0 112.807 179.685 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 80' ' ' GLY . 19.8 mtt180 -147.19 -166.38 2.5 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.483 0.659 . . . . 0.0 111.622 -178.082 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 1.9 p-80 -130.6 157.24 43.25 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.442 179.911 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.745 ' O ' HG13 ' A' ' 95' ' ' VAL . 1.8 p30 . . . . . 0 CA--C 1.511 -0.524 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.109 177.867 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.407 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 4.2 m-85 . . . . . 0 N--CA 1.455 -0.204 0 CA-C-O 120.725 0.297 . . . . 0.0 110.535 . . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.421 ' N ' ' O ' ' A' ' 71' ' ' CYS . 26.2 m-85 -140.22 158.45 44.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.034 -179.746 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.5 HG22 ' HG2' ' A' ' 70' ' ' LYS . 5.5 p -122.71 176.34 6.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.572 -178.32 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 7.5 p-10 -60.85 93.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.76 179.495 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 125.56 19.1 2.35 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.126 179.134 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -98.82 158.85 15.36 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.868 0.334 . . . . 0.0 110.33 178.865 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 27.8 m -145.57 142.27 22.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.421 0.629 . . . . 0.0 111.972 -179.491 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.853 HG22 ' CH2' ' A' ' 118' ' ' TRP . 40.7 t -144.46 148.12 18.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.488 178.167 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.461 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -95.68 159.92 14.75 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.083 0.468 . . . . 0.0 111.796 -177.5 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.827 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.9 m-85 -110.7 155.66 22.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.997 179.223 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.1 p -150.25 140.18 21.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.339 -178.958 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.442 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 83.9 m -75.24 146.92 40.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.222 -179.951 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -78.78 -83.2 0.09 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.622 -179.057 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.2 t -52.47 -22.96 5.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.538 -178.647 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 123.1 30.55 1.09 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.808 179.971 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.506 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 48.9 m-85 -69.32 -172.19 0.42 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.724 0.297 . . . . 0.0 110.51 179.413 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.2 m -110.45 107.32 16.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.999 0.428 . . . . 0.0 111.302 -179.257 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.539 HD23 ' HB2' ' A' ' 122' ' ' PRO . 1.9 tp -45.52 112.96 0.52 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.944 178.734 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.534 HG22 ' N ' ' A' ' 107' ' ' GLY . 20.1 mm -90.6 160.85 2.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.051 -178.874 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.534 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 56.5 -129.29 48.25 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.148 -179.641 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -110.4 125.0 52.77 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.8 0.333 . . . . 0.0 110.932 179.873 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.511 ' HA ' HD21 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -67.67 -34.57 77.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.203 178.661 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -79.08 130.83 10.17 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.982 178.479 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.827 HG21 ' CE1' ' A' ' 97' ' ' TYR . 3.2 t -117.63 141.33 36.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 179.786 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.07 122.73 44.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.99 0.424 . . . . 0.0 111.712 -178.469 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.428 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 10.9 t -85.88 105.99 16.77 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.055 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.6 OUTLIER -145.34 154.6 42.49 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.183 0.516 . . . . 0.0 111.349 -178.422 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 54.36 22.09 21.89 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.73 179.548 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.765 ' HA3' HG22 ' A' ' 69' ' ' VAL . . . 87.55 -6.44 83.4 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.533 -0.842 . . . . 0.0 113.005 179.996 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -128.66 -176.81 3.95 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.09 0.472 . . . . 0.0 110.932 -179.698 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.853 ' CH2' HG22 ' A' ' 95' ' ' VAL . 95.3 m95 -108.92 157.62 18.46 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.831 -179.71 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.47 149.11 42.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.061 0.458 . . . . 0.0 111.324 -179.369 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.471 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.7 OUTLIER 68.21 47.67 0.39 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.786 178.69 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 74.0 Cg_endo -75.31 137.68 21.34 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.314 2.009 . . . . 0.0 111.534 178.422 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.539 ' HB2' HD23 ' A' ' 105' ' ' LEU . 59.5 Cg_endo -89.29 -174.13 0.89 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.543 2.162 . . . . 0.0 113.561 -178.212 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.45 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -133.6 -174.06 3.41 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.913 177.997 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 8.3 m -143.3 96.5 2.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.143 0.497 . . . . 0.0 111.146 -179.811 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.495 ' HB2' HD11 ' A' ' 106' ' ' ILE . 13.2 mt-30 -121.62 157.72 30.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.775 -179.998 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.549 ' O ' HG22 ' A' ' 126' ' ' ILE . 37.3 mm . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.93 179.918 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.428 ' HD2' HG23 ' A' ' 25' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 121.004 0.43 . . . . 0.0 111.085 . . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.47 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 55.6 m -93.01 160.17 34.21 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.202 -179.126 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.04 176.56 7.56 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.714 2.276 . . . . 0.0 112.531 -179.338 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -50.14 106.58 0.65 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.701 179.662 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.514 ' HG3' ' CZ2' ' A' ' 59' ' ' TRP . 76.2 Cg_exo -48.68 144.22 14.97 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.466 2.111 . . . . 0.0 112.676 -179.323 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.508 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -54.94 164.74 0.75 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.882 178.651 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.569 ' HA ' HD11 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -116.6 -174.17 2.52 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.322 0.582 . . . . 0.0 112.025 -177.785 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.436 HG23 ' C ' ' A' ' 18' ' ' GLY . 2.7 tt -142.06 145.07 24.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.263 -179.768 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -74.9 -66.84 0.7 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -177.106 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.419 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 0.7 OUTLIER -91.74 26.62 2.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.336 -177.998 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.436 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -142.47 -175.5 15.78 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.241 -0.981 . . . . 0.0 113.279 -179.399 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -140.45 137.54 34.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.691 0.282 . . . . 0.0 110.357 179.294 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.569 HD11 ' HA ' ' A' ' 14' ' ' ASP . 3.7 mt -80.45 163.85 23.48 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.154 0.502 . . . . 0.0 111.794 -179.009 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -135.69 71.06 1.42 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.536 177.283 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.846 ' HA ' HG23 ' A' ' 31' ' ' ILE . 62.2 mt -69.9 103.56 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.84 -177.758 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.18 18.21 42.78 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.985 177.843 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 156.02 131.74 1.44 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 121.14 -0.552 . . . . 0.0 111.936 -179.586 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.428 HG23 ' HD2' ' A' ' 8' ' ' ARG . 32.3 m -116.43 25.97 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.686 0.279 . . . . 0.0 111.683 -178.822 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.2 152.23 19.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.042 179.792 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.412 ' CZ ' ' HB3' ' A' ' 51' ' ' LEU . 2.2 t80 -55.51 91.31 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.979 0.419 . . . . 0.0 110.441 179.327 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 131.92 -10.09 5.43 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.515 -178.825 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 92.2 p -75.11 -167.73 0.66 Allowed 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 179.326 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.1 p -157.7 152.05 24.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.073 0.463 . . . . 0.0 111.668 179.857 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.846 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -113.84 169.36 5.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.327 179.332 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.42 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -133.31 112.81 11.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.9 0.381 . . . . 0.0 111.062 178.621 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.535 ' CE1' HD22 ' A' ' 20' ' ' LEU . 17.0 m-85 -85.3 138.53 32.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.946 179.955 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.421 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.2 OUTLIER -138.35 168.75 19.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.668 -179.982 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.458 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 3.8 m -91.65 160.81 15.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.733 179.872 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.96 -79.68 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.184 -179.303 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.03 133.65 10.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.724 -179.786 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.599 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 60.72 25.39 63.52 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.79 -178.907 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.488 ' CD2' ' HA ' ' A' ' 68' ' ' SER . 2.3 m-85 -116.53 171.37 7.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.709 0.29 . . . . 0.0 110.78 -179.354 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.612 ' HB3' HG22 ' A' ' 69' ' ' VAL . 1.8 p-80 -130.66 131.62 44.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.019 0.438 . . . . 0.0 110.718 178.764 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.755 HD21 ' HB2' ' A' ' 64' ' ' PRO . 3.3 tt -87.7 131.01 34.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.816 -179.054 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.536 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.1 mm -105.45 154.23 6.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.982 0.42 . . . . 0.0 111.143 -179.365 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.09 -136.35 23.85 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.61 -178.469 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.421 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 0.8 OUTLIER -81.45 -178.12 6.8 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.33 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.442 ' HA ' ' HG2' ' A' ' 64' ' ' PRO . 6.4 p -155.17 23.6 0.42 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.104 -179.313 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.42 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 3.4 mtpt -147.48 141.57 26.04 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.199 -178.642 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.45 ' HB2' ' CG1' ' A' ' 31' ' ' ILE . 2.5 m -113.01 147.16 37.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.105 178.924 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.452 ' CD1' ' HD3' ' A' ' 61' ' ' PRO . 1.7 m-85 -119.16 121.78 40.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.014 0.435 . . . . 0.0 111.424 -179.597 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.524 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 18.8 t -70.26 77.09 0.53 Allowed 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.03 178.474 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -102.64 179.63 4.24 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.371 -178.491 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.212 -178.821 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.522 -0.113 0 CA-C-O 120.914 0.387 . . . . 0.0 110.457 . . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.6 m -139.8 165.76 21.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.216 -179.199 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.82 ' CE3' HD11 ' A' ' 31' ' ' ILE . 92.2 m95 -102.24 127.62 49.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.17 178.629 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.404 ' HA ' ' C ' ' A' ' 61' ' ' PRO . 14.0 t30 -159.67 127.59 2.81 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.745 -176.873 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.452 ' HD3' ' CD1' ' A' ' 48' ' ' TYR . 21.4 Cg_exo -68.77 -174.38 8.51 Favored 'Cis proline' 0 C--N 1.351 0.677 0 C-N-CA 124.236 -1.152 . . . . 0.0 112.697 1.364 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -110.7 -152.15 0.49 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.128 -178.38 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.457 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -75.27 110.96 11.66 Favored Pre-proline 0 CA--C 1.53 0.181 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.176 -179.717 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.755 ' HB2' HD21 ' A' ' 41' ' ' LEU . 23.6 Cg_exo -66.42 -145.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.832 2.355 . . . . 0.0 112.174 -179.871 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.489 HG22 ' H ' ' A' ' 66' ' ' CYS . 3.4 mm -106.39 165.59 4.01 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 120.762 0.315 . . . . 0.0 111.312 -178.73 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.489 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.8 OUTLIER -164.18 124.46 2.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.92 179.632 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.478 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 3.8 tt0 -143.73 -179.64 6.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.938 179.96 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.488 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 1.3 p -86.43 119.44 26.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.021 0.439 . . . . 0.0 111.125 -179.894 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.612 HG22 ' HB3' ' A' ' 40' ' ' HIS . 3.8 p -49.3 96.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.278 179.778 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 89' ' ' TYR . 1.4 mmtp -71.31 139.87 50.08 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.863 179.752 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.2 128.11 55.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.922 0.391 . . . . 0.0 110.781 179.58 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.412 ' O ' ' NE1' ' A' ' 118' ' ' TRP . 0.0 OUTLIER -67.42 -175.54 0.5 Allowed 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 121.912 0.863 . . . . 0.0 113.176 -177.677 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.558 ' HG ' ' CE1' ' A' ' 82' ' ' HIS . 0.3 OUTLIER -51.82 119.09 12.99 Favored Pre-proline 0 N--CA 1.439 -0.98 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.484 176.388 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.498 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 51.4 Cg_exo -41.71 155.04 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.063 1.842 . . . . 0.0 112.416 -176.564 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.412 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 85.6 Cg_exo -45.31 157.08 0.28 Allowed 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.88 2.387 . . . . 0.0 112.854 -179.015 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.31 90.79 3.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.845 -179.933 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.662 HG21 ' O ' ' A' ' 122' ' ' PRO . 18.4 pt -69.5 171.72 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.361 -179.484 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.7 p -88.12 136.66 32.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.707 179.242 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.497 ' HB3' ' CD2' ' A' ' 103' ' ' TYR . 0.0 OUTLIER 66.34 26.53 10.24 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.52 -179.576 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.446 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . 178.03 -178.66 48.53 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.625 179.978 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.406 ' NE ' ' OD1' ' A' ' 100' ' ' ASN . 0.1 OUTLIER -170.25 -175.84 2.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.784 0.326 . . . . 0.0 110.605 -179.714 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.558 ' CE1' ' HG ' ' A' ' 73' ' ' SER . 42.6 p-80 -95.35 168.91 10.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.038 179.831 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.706 179.392 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.431 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 6.4 m-85 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.767 0.318 . . . . 0.0 110.841 . . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.431 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 39.0 m-85 -145.52 165.01 29.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.972 -179.429 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.8 p -130.32 163.02 27.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.998 0.428 . . . . 0.0 111.47 -178.901 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -50.22 95.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.009 -179.91 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.69 26.53 1.14 Allowed Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.32 -0.855 . . . . 0.0 113.114 178.809 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.407 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -110.28 161.93 15.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.837 0.319 . . . . 0.0 110.6 179.065 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.485 HG22 ' N ' ' A' ' 95' ' ' VAL . 34.1 m -135.2 157.83 40.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.061 0.457 . . . . 0.0 111.058 -179.996 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.496 HG11 ' HB2' ' A' ' 82' ' ' HIS . 25.4 t -148.99 148.24 15.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.299 179.52 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.857 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -109.62 120.93 44.02 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.349 0.595 . . . . 0.0 111.126 -179.372 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.971 ' CE2' HG21 ' A' ' 111' ' ' VAL . 4.4 m-85 -77.26 158.12 30.42 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.69 -178.671 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.0 p -154.37 139.11 17.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.551 -179.929 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.446 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 6.9 m -69.85 164.02 24.61 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.51 179.971 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.406 ' OD1' ' NE ' ' A' ' 81' ' ' ARG . 28.9 m-20 -95.12 -69.93 0.73 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.314 -179.543 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.6 t -68.74 -34.45 75.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.345 -178.928 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 137.14 41.77 0.1 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.574 -179.925 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.518 ' CD1' ' CD1' ' A' ' 126' ' ' ILE . 15.4 m-85 -80.8 -168.14 1.66 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 179.479 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.8 m -117.15 105.42 12.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.804 0.335 . . . . 0.0 111.538 -179.642 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.477 ' CD2' ' HB2' ' A' ' 122' ' ' PRO . 1.6 tp -48.97 121.84 5.17 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.107 0.48 . . . . 0.0 110.615 178.509 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.473 HG22 ' N ' ' A' ' 107' ' ' GLY . 33.7 mm -103.12 159.31 4.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.566 -177.298 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.473 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 52.37 30.32 32.74 Favored Glycine 0 CA--C 1.509 -0.343 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.546 179.468 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.418 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.6 OUTLIER 59.65 127.9 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.984 -0.608 . . . . 0.0 111.394 179.679 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.857 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.2 p -58.56 -29.21 66.2 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.97 -178.332 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -52.69 131.39 39.79 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.706 -0.759 . . . . 0.0 113.154 -178.651 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.971 HG21 ' CE2' ' A' ' 97' ' ' TYR . 2.3 t -130.72 144.28 38.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.39 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.1 tt -104.93 125.24 50.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.963 0.411 . . . . 0.0 112.076 -177.803 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.438 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 11.2 t -88.59 95.47 10.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.436 176.547 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 p -139.06 163.64 31.88 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.208 -178.45 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.2 26.18 2.15 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.773 179.802 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.441 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 76.11 1.51 69.01 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.955 -179.633 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -131.64 179.71 5.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.808 0.337 . . . . 0.0 110.61 179.525 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.498 ' CH2' ' HG3' ' A' ' 74' ' ' PRO . 93.5 m95 -107.79 125.65 51.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 -179.898 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.56 145.07 36.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.145 -179.474 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.486 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 2.0 t70 66.89 44.5 0.35 Allowed Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.256 178.71 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 52.9 Cg_endo -67.44 149.83 80.42 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 121.893 1.728 . . . . 0.0 110.354 176.912 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.662 ' O ' HG21 ' A' ' 77' ' ' ILE . 42.0 Cg_endo -95.71 -178.19 0.45 Allowed 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 122.129 1.886 . . . . 0.0 114.039 -176.925 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.427 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -124.34 -159.81 0.89 Allowed 'General case' 0 CA--C 1.502 -0.867 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.009 176.796 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 124' ' ' CYS . . . . . 0.579 ' HB2' HD12 ' A' ' 77' ' ' ILE . 3.8 t -170.34 93.8 0.22 Allowed 'General case' 0 N--CA 1.433 -1.288 0 CA-C-O 121.772 0.796 . . . . 0.0 110.87 -175.906 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -106.88 -169.33 1.53 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.303 -1.317 . . . . 0.0 112.096 -176.891 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.662 ' O ' HG22 ' A' ' 126' ' ' ILE . 19.1 mm . . . . . 0 C--N 1.313 -1.012 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.11 179.51 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.68 ' HD3' HG23 ' A' ' 25' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.982 0.42 . . . . 0.0 110.833 . . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.472 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 60.3 m -90.24 161.25 38.01 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.681 179.85 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 37.2 Cg_endo -67.34 176.52 4.71 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.549 2.166 . . . . 0.0 112.393 -179.345 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.3 t -51.78 109.39 1.38 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.06 -179.368 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.409 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 2.3 Cg_endo -52.33 152.97 14.21 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.16 1.907 . . . . 0.0 111.894 179.757 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.825 ' O ' HD11 ' A' ' 20' ' ' LEU . 14.6 mtt180 -66.4 160.2 25.31 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.191 179.24 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -110.86 -178.69 3.54 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-O 121.223 0.535 . . . . 0.0 112.17 -176.129 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.491 HG22 ' CD2' ' A' ' 20' ' ' LEU . 6.0 tt -142.14 145.32 24.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.539 179.673 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -80.36 -65.0 1.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.829 -178.026 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -93.47 36.46 1.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.878 0.371 . . . . 0.0 110.961 -178.909 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.426 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -150.06 176.95 28.48 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.813 179.69 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -136.55 123.66 21.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.779 0.323 . . . . 0.0 110.75 179.595 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.825 HD11 ' O ' ' A' ' 13' ' ' ARG . 14.6 mt -74.41 159.03 32.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.164 0.506 . . . . 0.0 111.92 -179.124 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.453 ' HB3' ' CB ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -130.52 74.3 1.59 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.914 177.608 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.845 ' HA ' HG23 ' A' ' 31' ' ' ILE . 62.6 mt -69.78 93.2 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.735 -178.174 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.73 20.9 47.61 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.932 178.078 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 29' ' ' SER . . . 151.89 133.32 1.96 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.942 -179.455 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.68 HG23 ' HD3' ' A' ' 8' ' ' ARG . 11.9 m -118.37 8.95 6.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.134 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 16.0 t70 -74.46 163.45 27.75 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.011 0.434 . . . . 0.0 110.825 179.481 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.561 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 7.9 t80 -59.79 93.6 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.535 179.987 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.17 -7.73 7.15 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.494 -178.804 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.409 ' OG ' ' N ' ' A' ' 26' ' ' ASP . 1.3 m -71.67 174.32 6.92 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.841 0.32 . . . . 0.0 110.626 179.589 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -143.83 145.3 32.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.018 -179.973 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.845 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -107.34 164.22 4.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.629 179.996 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.453 ' CB ' ' HB3' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -126.48 113.61 17.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.845 179.467 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.824 ' CE1' HD21 ' A' ' 20' ' ' LEU . 21.5 m-85 -91.4 138.56 31.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.556 -179.421 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.426 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.4 OUTLIER -139.87 173.81 11.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.512 179.313 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 1.2 m -92.83 169.92 10.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.347 . . . . 0.0 111.027 -179.915 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -61.97 -85.45 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.333 -178.844 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.73 116.6 2.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.289 179.917 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.541 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 84.16 -8.08 68.79 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.129 -177.282 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.52 ' CZ ' ' HB3' ' A' ' 68' ' ' SER . 4.0 m-85 -82.25 176.27 9.6 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 120.912 0.387 . . . . 0.0 110.84 179.678 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.533 ' NE2' HG22 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -129.54 129.46 44.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.122 175.983 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.937 HD11 ' HG2' ' A' ' 64' ' ' PRO . 9.2 tt -93.92 112.1 23.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.523 -179.624 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.553 ' N ' HD13 ' A' ' 42' ' ' ILE . 1.2 mm -85.77 149.27 4.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.085 0.469 . . . . 0.0 110.955 -179.009 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.36 -149.77 30.98 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.121 -178.892 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.754 ' O ' HD21 ' A' ' 41' ' ' LEU . 7.4 pt-20 -77.78 176.89 8.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.043 0.449 . . . . 0.0 110.856 179.297 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 33' ' ' TYR . 2.5 p -147.05 28.14 1.03 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.014 -179.306 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.55 138.32 23.4 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.971 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -110.73 159.44 17.62 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.978 178.191 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.492 ' CD1' ' HB3' ' A' ' 60' ' ' ASN . 1.7 m-85 -134.27 119.22 18.47 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 119.509 -0.876 . . . . 0.0 112.38 -179.217 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.412 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 37.2 t -69.75 84.83 0.47 Allowed 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.286 178.81 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.499 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 1.9 tt0 -109.45 173.72 6.19 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.49 -179.178 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.561 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.667 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.095 -179.284 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.0 mmt . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.999 0.428 . . . . 0.0 110.576 . . . . . . . . . 0 0 . 1 . 042 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.1 m -127.05 177.18 5.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.648 -179.982 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.529 ' CE3' HD11 ' A' ' 31' ' ' ILE . 68.7 m95 -118.07 121.13 39.79 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.672 -178.896 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.492 ' HB3' ' CD1' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -70.39 162.98 66.68 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.005 178.011 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.441 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 80.5 Cg_exo -16.64 97.64 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.83 1 C-N-CA 125.534 4.156 . . . . 0.0 114.76 -177.773 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.501 ' HB3' ' CE2' ' A' ' 33' ' ' TYR . 6.1 mt-10 -98.49 -81.71 0.44 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.313 -178.309 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . . . -75.49 108.34 5.59 Favored Pre-proline 0 CA--C 1.529 0.151 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -176.419 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.937 ' HG2' HD11 ' A' ' 41' ' ' LEU . 1.3 Cg_endo -85.5 -154.84 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.222 2.615 . . . . 0.0 110.855 177.071 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.466 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 2.0 mm -97.66 161.17 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.057 0.456 . . . . 0.0 110.756 178.606 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -154.09 138.45 16.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.888 179.988 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.478 ' O ' ' CD2' ' A' ' 39' ' ' TYR . 0.6 OUTLIER -144.54 167.9 21.41 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.354 179.639 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.52 ' HB3' ' CZ ' ' A' ' 39' ' ' TYR . 1.2 p -108.4 118.56 37.09 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.12 0.486 . . . . 0.0 111.511 -179.396 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.541 HG12 ' O ' ' A' ' 38' ' ' GLY . 2.6 p -46.95 97.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.309 179.364 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.475 ' HA ' HG22 ' A' ' 90' ' ' THR . 0.3 OUTLIER -78.89 131.06 36.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.546 -179.221 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -113.96 117.86 32.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.957 178.527 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -163.75 0.09 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.127 0.489 . . . . 0.0 110.978 -179.493 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -41.09 132.92 1.91 Allowed Pre-proline 0 N--CA 1.436 -1.142 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.926 179.111 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.48 ' HG3' ' CZ2' ' A' ' 118' ' ' TRP . 26.2 Cg_exo -60.78 158.16 34.43 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.321 2.014 . . . . 0.0 112.146 -179.625 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -44.95 156.93 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.905 2.403 . . . . 0.0 113.291 -178.923 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.0 t -104.99 93.41 4.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.464 179.195 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.579 HG23 ' HE2' ' A' ' 97' ' ' TYR . 24.3 pt -68.88 177.16 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.576 -178.556 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.6 m -92.9 144.47 25.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.681 179.478 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.492 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 5.0 m-80 58.25 27.94 15.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.033 179.706 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.457 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . -173.93 -168.14 34.49 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.962 179.69 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.11 -175.23 4.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.971 0.415 . . . . 0.0 110.415 -179.386 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.473 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 12.8 p-80 -108.47 166.0 11.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.907 179.411 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.704 179.912 . . . . . . . . 0 0 . 1 . 042 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.404 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 14.1 m-85 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.851 0.357 . . . . 0.0 111.173 . . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.404 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 69.6 m-85 -154.27 167.0 31.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.677 -179.655 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.475 HG22 ' HA ' ' A' ' 70' ' ' LYS . 21.4 p -151.68 -176.18 5.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.12 0.486 . . . . 0.0 111.845 -179.162 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 25.7 m-20 -50.13 94.56 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.488 -179.554 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.32 20.29 2.46 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.273 177.938 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -110.32 152.83 25.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 117.216 0.508 . . . . 0.0 110.757 179.224 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.457 HG22 ' N ' ' A' ' 95' ' ' VAL . 32.9 m -138.26 156.11 29.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.081 0.467 . . . . 0.0 111.03 -179.718 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.602 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 7.4 t -146.58 145.17 19.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.597 -179.926 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.893 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -104.65 125.6 50.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.134 0.492 . . . . 0.0 110.693 179.938 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.943 ' CE1' HG21 ' A' ' 111' ' ' VAL . 5.2 m-85 -84.27 160.88 20.66 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.498 -178.172 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.1 p -154.05 140.55 18.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.973 0.416 . . . . 0.0 111.775 -178.838 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.457 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 9.9 m -69.29 165.79 19.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.453 179.83 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -91.03 -68.67 0.78 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.136 179.956 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.74 -38.42 62.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.293 -179.36 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 143.71 41.17 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.842 179.572 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.509 ' CE2' HG12 ' A' ' 126' ' ' ILE . 12.4 m-85 -75.36 -167.63 0.68 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 178.698 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 124' ' ' CYS . 4.3 p -115.39 106.15 13.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.851 0.357 . . . . 0.0 111.369 179.635 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.485 HD22 ' HA ' ' A' ' 109' ' ' SER . 1.6 tp -51.54 119.76 4.47 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.431 178.469 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.547 HG22 ' N ' ' A' ' 107' ' ' GLY . 26.6 mm -100.14 163.01 3.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.349 -177.709 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.547 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 50.54 27.89 13.51 Favored Glycine 0 CA--C 1.508 -0.353 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.679 179.237 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.43 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.3 OUTLIER 60.51 132.64 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.406 0.622 . . . . 0.0 111.293 179.99 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.893 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.3 p -57.61 -25.79 60.59 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.155 -178.441 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -58.77 132.81 52.74 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.78 -177.631 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.943 HG21 ' CE1' ' A' ' 97' ' ' TYR . 3.0 t -133.54 119.56 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 177.807 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.874 HD22 ' N ' ' A' ' 113' ' ' CYS . 1.2 tm? -83.18 136.54 34.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.612 0.244 . . . . 0.0 111.344 -178.709 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.874 ' N ' HD22 ' A' ' 112' ' ' LEU . 42.8 t -106.84 105.86 16.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.455 177.69 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.584 ' CB ' HD11 ' A' ' 112' ' ' LEU . 5.9 t -160.94 135.82 7.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.981 0.419 . . . . 0.0 111.333 179.259 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.424 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 83.32 25.27 48.43 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.07 -179.658 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.444 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 70.85 14.84 73.38 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.231 -178.867 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -142.66 -179.65 6.44 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.05 0.452 . . . . 0.0 111.162 179.958 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.602 ' CZ3' HG23 ' A' ' 95' ' ' VAL . 94.2 m95 -120.65 123.57 43.11 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.253 -179.75 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.559 ' OG ' HD12 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -83.36 128.14 34.26 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.112 175.016 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.663 ' HB2' HG13 ' A' ' 111' ' ' VAL . 70.0 m-20 109.55 -124.65 0.0 OUTLIER Pre-proline 0 CA--C 1.476 -1.878 0 N-CA-C 100.339 -3.948 . . . . 0.0 100.339 -166.533 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.539 ' CA ' ' CB ' ' A' ' 120' ' ' ASP . 67.6 Cg_endo -60.77 178.24 6.14 Favored 'Cis proline' 0 C--N 1.315 -1.235 0 CA-C-N 125.038 2.835 . . . . 0.0 112.553 -21.243 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.599 ' HD3' HG22 ' A' ' 111' ' ' VAL . 43.4 Cg_endo -85.97 179.93 3.53 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.401 2.067 . . . . 0.0 113.006 179.71 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.413 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -114.77 -162.74 0.83 Allowed 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.168 176.157 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 124' ' ' CYS . . . . . 0.442 ' SG ' ' HB2' ' A' ' 103' ' ' TYR . 4.7 t -170.44 88.91 0.14 Allowed 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 120.109 -0.637 . . . . 0.0 110.828 -175.72 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -117.57 173.64 6.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.27 -177.756 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.651 ' O ' HG22 ' A' ' 126' ' ' ILE . 47.8 mm . . . . . 0 C--N 1.322 -0.602 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.897 -179.751 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.456 ' HD2' HG23 ' A' ' 25' ' ' VAL . 11.6 mtm-85 . . . . . 0 N--CA 1.457 -0.118 0 CA-C-O 120.829 0.347 . . . . 0.0 110.839 . . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.451 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 26.7 m -85.08 160.72 54.43 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.297 -179.165 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.42 171.98 16.59 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.675 2.25 . . . . 0.0 112.237 179.824 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.8 t -51.23 106.45 0.65 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.922 -179.962 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.498 ' HG3' ' CZ2' ' A' ' 59' ' ' TRP . 76.7 Cg_exo -46.92 149.98 2.96 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.331 2.021 . . . . 0.0 112.135 179.643 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.792 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -69.85 143.69 52.78 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.215 0.531 . . . . 0.0 110.321 179.031 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -93.67 -176.86 4.2 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.061 -176.541 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.453 HD12 ' HB1' ' A' ' 63' ' ' ALA . 6.5 tt -135.71 151.04 29.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.599 179.588 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -75.93 -68.83 0.54 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.808 -177.631 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.432 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 1.0 OUTLIER -89.87 44.8 1.23 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.862 0.363 . . . . 0.0 110.985 -179.056 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.437 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -167.36 179.84 40.67 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.957 179.939 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.9 134.54 28.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.823 0.344 . . . . 0.0 110.934 179.645 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.899 HD21 ' CE1' ' A' ' 33' ' ' TYR . 18.6 mt -80.02 158.5 26.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.116 0.484 . . . . 0.0 111.924 -178.855 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 32' ' ' THR . 0.7 OUTLIER -129.1 76.93 1.76 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.866 177.602 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.838 ' HA ' HG23 ' A' ' 31' ' ' ILE . 28.8 mt -70.16 112.6 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.265 -177.607 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -108.47 18.25 32.89 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.926 -0.655 . . . . 0.0 111.693 176.675 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 29' ' ' SER . . . 151.18 136.85 2.56 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 111.759 -0.537 . . . . 0.0 111.759 -179.148 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.456 HG23 ' HD2' ' A' ' 8' ' ' ARG . 18.9 m -118.06 12.21 7.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -178.915 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -69.86 157.48 37.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.8 0.333 . . . . 0.0 110.824 179.415 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.586 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 7.5 t80 -55.62 91.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.628 179.759 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 49' ' ' CYS . . . 127.22 -10.75 6.9 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.677 -179.394 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.407 ' HB3' ' O ' ' A' ' 24' ' ' GLY . 61.1 m -58.71 -174.52 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.748 0.309 . . . . 0.0 110.743 179.898 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 47' ' ' SER . 23.0 p -151.59 140.21 20.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.232 179.736 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.838 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -107.87 166.58 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.551 179.661 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.424 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -129.1 108.6 10.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.885 179.522 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.899 ' CE1' HD21 ' A' ' 20' ' ' LEU . 18.2 m-85 -82.47 149.58 27.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.017 0.436 . . . . 0.0 111.043 -179.814 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.429 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.3 OUTLIER -150.91 164.79 35.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.681 -179.949 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.432 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 3.7 m -87.28 161.57 17.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.855 -179.925 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -57.72 -84.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.078 -179.683 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.74 135.65 14.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.634 179.95 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.779 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 60.16 25.94 62.96 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.522 -0.846 . . . . 0.0 111.732 -178.84 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.481 ' CD2' ' HA ' ' A' ' 68' ' ' SER . 2.1 m-85 -117.0 172.08 7.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.836 0.35 . . . . 0.0 111.088 -179.045 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.535 ' CE1' HD11 ' A' ' 42' ' ' ILE . 1.6 p-80 -133.27 120.44 21.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.491 178.017 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.972 HD21 ' O ' ' A' ' 44' ' ' GLU . 3.6 tt -81.86 132.76 35.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.245 -179.844 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.553 ' HB ' HD12 ' A' ' 65' ' ' ILE . 2.5 mm -101.7 151.54 5.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.219 -178.551 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.39 -147.08 38.48 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.064 -179.044 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.972 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.6 OUTLIER -66.2 -177.92 0.58 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.88 0.371 . . . . 0.0 110.766 179.289 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.57 27.93 0.16 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.289 178.72 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.424 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -147.79 132.45 17.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.324 -179.047 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.403 ' O ' ' HA ' ' A' ' 30' ' ' SER . 2.1 m -104.21 150.04 24.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.152 178.641 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.463 ' CE1' ' HD3' ' A' ' 61' ' ' PRO . 6.8 m-85 -124.18 125.6 44.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.047 0.451 . . . . 0.0 111.51 -178.879 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.502 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 28.3 t -74.58 86.26 2.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.356 179.106 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.498 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 1.1 tt0 -105.13 175.4 5.51 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.425 -179.243 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.586 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.653 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.948 -179.94 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.8 mmt . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 120.825 0.345 . . . . 0.0 110.345 . . . . . . . . . 0 0 . 1 . 043 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.9 m -140.68 -176.81 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.12 -179.076 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.756 ' CE3' HD11 ' A' ' 31' ' ' ILE . 90.9 m95 -123.02 124.81 43.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.289 -179.246 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.427 ' O ' ' CD1' ' A' ' 48' ' ' TYR . 14.5 m-80 -146.88 126.92 6.77 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.886 179.851 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.463 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 71.6 Cg_endo -75.89 -163.64 3.33 Favored 'Cis proline' 0 C--N 1.351 0.685 0 C-N-CA 123.892 -1.295 . . . . 0.0 112.206 -0.34 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.49 ' O ' ' CZ ' ' A' ' 33' ' ' TYR . 28.6 mm-40 -110.13 -107.9 0.35 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.095 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.547 ' HB2' ' HE1' ' A' ' 33' ' ' TYR . . . -122.0 100.0 43.39 Favored Pre-proline 0 N--CA 1.445 -0.714 0 C-N-CA 122.514 0.325 . . . . 0.0 110.722 -177.937 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.78 ' HG2' HD11 ' A' ' 41' ' ' LEU . 20.7 Cg_endo -50.59 -158.02 0.0 OUTLIER 'Trans proline' 0 N--CA 1.476 0.448 0 C-N-CA 123.286 2.657 . . . . 0.0 112.939 177.652 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.64 HG22 ' H ' ' A' ' 66' ' ' CYS . 1.0 OUTLIER -93.0 174.94 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.505 -179.136 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.64 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.7 OUTLIER -170.34 133.32 1.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.695 -179.983 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.472 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -150.65 179.59 8.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.872 -179.94 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.481 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 73.0 p -86.81 120.1 27.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.99 179.862 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.779 HG12 ' O ' ' A' ' 38' ' ' GLY . 1.2 p -48.0 99.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.289 179.876 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -82.69 115.75 21.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.432 -179.344 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.428 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -97.54 123.11 41.3 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.284 -0.416 . . . . 0.0 109.919 178.179 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -74.04 -150.99 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.953 179.694 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.464 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 2.4 t -56.62 144.81 63.46 Favored Pre-proline 0 C--N 1.324 -0.516 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.647 -179.661 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.579 ' HG2' HG11 ' A' ' 95' ' ' VAL . 23.7 Cg_exo -61.87 163.41 19.14 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.544 2.162 . . . . 0.0 111.817 179.732 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.504 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 97.8 Cg_exo -41.11 156.66 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.722 2.281 . . . . 0.0 112.742 -179.315 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 12.3 t -105.96 90.03 3.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.48 179.15 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.661 HG23 ' HE2' ' A' ' 97' ' ' TYR . 20.7 pt -69.48 -178.32 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.21 -179.195 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.1 m -104.02 145.56 29.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.809 179.635 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.508 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 13.2 m-20 56.7 29.57 16.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.214 179.448 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.44 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -166.85 -165.49 24.33 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.794 179.716 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.96 -175.63 4.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.097 0.475 . . . . 0.0 111.005 -179.73 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.464 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 35.1 p-80 -108.51 173.77 6.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.933 179.681 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.493 178.71 . . . . . . . . 0 0 . 1 . 043 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.425 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 8.5 m-85 . . . . . 0 N--CA 1.456 -0.141 0 CA-C-O 120.923 0.392 . . . . 0.0 111.003 . . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.428 ' N ' ' O ' ' A' ' 71' ' ' CYS . 55.0 m-85 -151.76 164.0 37.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.761 -179.523 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.6 p -131.27 -175.89 3.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.231 -179.502 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 5.0 m-20 -65.95 94.47 0.23 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.19 0.519 . . . . 0.0 111.126 -179.767 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.86 31.1 0.77 Allowed Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.973 178.753 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.449 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.6 OUTLIER -110.19 159.0 17.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.74 0.305 . . . . 0.0 110.83 179.418 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 34.6 m -134.72 149.48 29.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.075 0.464 . . . . 0.0 111.191 -179.741 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.579 HG11 ' HG2' ' A' ' 74' ' ' PRO . 26.2 t -144.77 148.0 18.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.841 179.592 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.689 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -108.35 128.5 54.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.033 -179.849 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.961 ' CE1' HG21 ' A' ' 111' ' ' VAL . 7.0 m-85 -89.13 155.77 19.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.953 -179.943 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 77.3 p -149.15 137.84 21.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.086 179.543 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.44 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 83.1 m -69.73 157.87 36.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.057 -179.737 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.3 m-20 -90.03 -71.79 0.6 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.564 -178.898 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.0 t -63.77 -19.68 65.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.555 -178.862 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 119.46 31.04 1.43 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.376 -179.733 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.508 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 35.5 m-85 -69.59 -171.55 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.698 0.285 . . . . 0.0 110.476 179.61 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.72 106.53 16.2 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.907 0.384 . . . . 0.0 111.274 -179.078 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.542 HD23 ' HB2' ' A' ' 122' ' ' PRO . 1.6 tp -45.18 108.95 0.14 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.633 178.476 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.782 HD11 ' HB2' ' A' ' 125' ' ' GLN . 24.3 mm -83.25 160.75 3.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.067 -178.366 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.539 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 54.68 -128.29 42.29 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.902 -179.257 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -115.52 134.39 55.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.975 0.417 . . . . 0.0 110.898 179.018 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.689 ' HB2' HG22 ' A' ' 96' ' ' THR . 0.0 OUTLIER -68.3 -30.6 69.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.377 179.322 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -75.45 133.16 14.21 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.542 179.807 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.961 HG21 ' CE1' ' A' ' 97' ' ' TYR . 3.3 t -125.6 124.2 66.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.506 0.194 . . . . 0.0 110.49 179.393 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.76 123.71 30.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.895 0.379 . . . . 0.0 111.799 -178.269 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.536 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 27.2 t -88.95 104.36 16.89 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 176.354 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 53.3 p -142.99 154.6 44.18 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.042 0.448 . . . . 0.0 111.605 -177.772 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.43 35.49 7.13 Favored Glycine 0 N--CA 1.453 -0.194 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.748 179.519 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.454 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 68.28 11.44 61.66 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.74 -179.439 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -132.87 178.29 6.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.865 0.364 . . . . 0.0 110.558 179.418 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.536 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 93.1 m95 -117.4 148.13 42.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.882 -179.458 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.498 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.1 OUTLIER -128.28 164.06 23.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.111 0.481 . . . . 0.0 111.635 -178.654 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.442 ' N ' ' HD3' ' A' ' 121' ' ' PRO . 1.7 p-10 45.97 52.13 10.71 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.233 179.219 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.442 ' HD3' ' N ' ' A' ' 120' ' ' ASP . 84.0 Cg_endo -82.18 145.64 13.81 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.547 2.164 . . . . 0.0 111.562 177.527 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.542 ' HB2' HD23 ' A' ' 105' ' ' LEU . 90.5 Cg_endo -93.7 -170.1 0.23 Allowed 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.888 2.392 . . . . 0.0 114.177 -177.458 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.452 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -140.54 -170.03 2.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.004 177.806 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 124' ' ' CYS . . . . . 0.408 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 14.5 m -143.49 95.39 2.74 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.039 0.447 . . . . 0.0 111.11 -179.662 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.782 ' HB2' HD11 ' A' ' 106' ' ' ILE . 23.6 mt-30 -122.78 158.07 31.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.797 179.921 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.503 HG12 ' CE2' ' A' ' 103' ' ' TYR . 28.8 mm . . . . . 0 C--N 1.324 -0.506 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.08 -179.754 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.575 ' HB3' HG23 ' A' ' 25' ' ' VAL . 1.4 mtm180 . . . . . 0 N--CA 1.447 -0.6 0 CA-C-O 121.011 0.434 . . . . 0.0 111.59 . . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.464 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 95.3 m -87.44 158.69 51.44 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.965 -179.824 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 41.0 Cg_endo -68.56 173.49 9.79 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.604 2.203 . . . . 0.0 112.274 -179.971 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -50.65 107.31 0.78 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.783 179.871 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.415 ' HG2' HD11 ' A' ' 22' ' ' ILE . 9.9 Cg_endo -54.8 141.93 75.52 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.202 1.935 . . . . 0.0 112.147 -179.29 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.88 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -52.32 150.83 4.39 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.379 179.259 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.83 -176.06 2.99 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.269 0.556 . . . . 0.0 111.588 -178.038 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.452 HG23 ' C ' ' A' ' 18' ' ' GLY . 11.1 tt -135.58 148.91 28.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.621 -179.585 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -81.02 -62.35 1.69 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.917 -177.635 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.415 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 0.6 OUTLIER -93.15 27.04 2.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.16 -178.549 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.452 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -146.26 -176.58 20.23 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.097 -179.693 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -139.77 127.65 22.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.644 0.259 . . . . 0.0 110.667 179.544 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.88 HD11 ' O ' ' A' ' 13' ' ' ARG . 11.1 mt -72.76 154.14 40.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.11 0.481 . . . . 0.0 111.712 -179.49 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.441 ' CB ' ' HB ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -130.58 76.22 1.71 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.561 177.061 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.917 ' HA ' HG23 ' A' ' 31' ' ' ILE . 54.8 mt -69.97 107.76 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.826 -177.702 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -109.44 15.07 32.7 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.167 178.119 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 29' ' ' SER . . . 162.29 122.9 0.63 Allowed Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.911 -179.639 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.575 HG23 ' HB3' ' A' ' 8' ' ' ARG . 34.9 m -112.94 28.06 2.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.482 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 12.6 t70 -102.45 162.69 12.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.043 0.449 . . . . 0.0 111.271 179.534 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.91 ' CZ ' HD13 ' A' ' 51' ' ' LEU . 7.3 t80 -59.61 93.5 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.911 -179.502 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 123.94 3.27 8.35 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.812 -179.963 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 1.6 m -84.92 -159.0 0.39 Allowed 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 116.892 0.346 . . . . 0.0 110.134 179.161 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 47' ' ' SER . 51.9 p -168.18 153.98 7.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.116 0.484 . . . . 0.0 111.451 179.361 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.917 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.6 OUTLIER -114.82 172.84 3.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.383 179.663 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.441 ' HB ' ' CB ' ' A' ' 21' ' ' ASP . 2.6 m -132.86 109.23 9.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.996 0.427 . . . . 0.0 110.962 178.661 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.869 ' CE2' HD21 ' A' ' 20' ' ' LEU . 22.4 m-85 -84.31 132.12 34.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.828 179.836 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.431 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.7 OUTLIER -135.61 162.71 31.94 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.652 -179.42 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.449 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 5.4 m -84.57 168.01 15.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.789 0.328 . . . . 0.0 110.83 179.875 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -63.66 -78.62 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.013 -179.319 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -156.36 135.76 12.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.743 179.72 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.806 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 55.83 26.49 47.61 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.693 -178.939 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.502 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.1 m-85 -115.15 165.84 12.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.707 0.289 . . . . 0.0 110.805 -179.23 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.974 ' NE2' HG22 ' A' ' 69' ' ' VAL . 95.3 m-70 -117.88 122.01 42.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.457 178.255 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.735 HD21 ' O ' ' A' ' 44' ' ' GLU . 10.1 tt -86.2 110.18 19.42 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.294 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.454 ' HB ' ' HB ' ' A' ' 65' ' ' ILE . 2.2 mm -84.07 155.13 3.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.934 0.397 . . . . 0.0 111.314 -177.801 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.5 -145.64 36.07 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.057 -179.053 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.735 ' O ' HD21 ' A' ' 41' ' ' LEU . 1.0 OUTLIER -74.31 165.92 24.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.628 0.251 . . . . 0.0 110.473 179.009 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.678 ' HB3' HD22 ' A' ' 41' ' ' LEU . 3.2 p -141.66 24.39 2.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.003 -179.883 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.408 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -148.37 135.77 20.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.447 -178.416 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.427 ' C ' ' CD2' ' A' ' 48' ' ' TYR . 1.0 OUTLIER -106.07 161.07 14.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.498 178.605 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.535 ' CE1' ' HD3' ' A' ' 61' ' ' PRO . 3.6 m-85 -134.29 122.14 22.26 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.056 0.455 . . . . 0.0 111.811 -177.569 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.514 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 35.7 t -76.96 94.42 3.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.806 179.484 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -115.19 -172.83 2.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.531 179.641 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.91 HD13 ' CZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.554 179.105 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 120.871 0.367 . . . . 0.0 110.678 . . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.456 HG22 ' C ' ' A' ' 51' ' ' LEU . 8.4 m -152.09 173.87 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.264 -179.128 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.704 ' CE3' HD11 ' A' ' 31' ' ' ILE . 89.9 m95 -129.54 130.99 46.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.06 -179.874 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.471 ' O ' ' CD1' ' A' ' 48' ' ' TYR . 0.9 OUTLIER -160.6 135.14 5.36 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.053 179.897 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.535 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 61.4 Cg_endo -71.33 -165.8 3.5 Favored 'Cis proline' 0 C--N 1.353 0.786 0 C-N-CA 123.984 -1.257 . . . . 0.0 112.691 0.013 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -111.49 -152.3 0.5 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.064 -179.012 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.478 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -73.46 115.24 39.38 Favored Pre-proline 0 C--O 1.231 0.128 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.672 179.213 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.443 ' CG ' ' O ' ' A' ' 44' ' ' GLU . 15.2 Cg_exo -71.22 -150.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.7 2.267 . . . . 0.0 112.54 -178.826 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.585 HG22 ' H ' ' A' ' 66' ' ' CYS . 1.5 mm -103.56 170.64 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.058 -179.162 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.585 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.3 m -159.31 134.69 8.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.109 -179.952 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.73 157.25 44.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.984 179.809 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.502 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 1.4 p -78.67 129.22 34.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.253 0.549 . . . . 0.0 111.553 -179.274 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.974 HG22 ' NE2' ' A' ' 40' ' ' HIS . 3.9 p -50.6 94.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.208 179.458 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.413 ' HE2' HG23 ' A' ' 90' ' ' THR . 0.8 OUTLIER -80.42 116.95 20.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.128 -179.846 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -98.17 119.84 37.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.376 179.074 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -158.63 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.662 179.764 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.432 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 2.2 t -48.64 139.99 10.88 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.96 -179.704 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.509 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 26.5 Cg_exo -60.72 161.93 19.93 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.426 2.084 . . . . 0.0 112.154 -179.862 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.525 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 80.9 Cg_exo -42.88 157.48 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.786 2.324 . . . . 0.0 112.85 -179.692 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.3 m -108.16 89.85 3.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.551 179.094 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.73 HG23 ' HE1' ' A' ' 97' ' ' TYR . 33.8 pt -69.35 173.75 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.242 -179.176 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.1 m -95.31 142.91 27.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.582 179.332 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.418 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 7.0 m-80 60.74 28.44 18.18 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.003 179.815 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.465 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -166.49 -166.99 26.47 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.813 -179.882 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.423 ' N ' ' O ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -166.26 -175.75 3.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.001 0.429 . . . . 0.0 110.798 -179.934 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 3.1 p80 -114.63 167.42 10.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.25 -179.515 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.778 179.812 . . . . . . . . 0 0 . 1 . 044 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.433 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 6.1 m-85 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.786 0.326 . . . . 0.0 110.946 . . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.433 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 31.2 m-85 -147.03 167.62 23.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.04 -179.635 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.413 HG23 ' HE2' ' A' ' 70' ' ' LYS . 21.7 p -139.25 -175.13 4.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.114 -179.78 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.42 ' OD2' ' CG1' ' A' ' 69' ' ' VAL . 0.4 OUTLIER -62.05 95.06 0.06 Allowed 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.197 0.523 . . . . 0.0 110.94 179.937 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.7 26.94 1.34 Allowed Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.496 -0.775 . . . . 0.0 113.151 178.592 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -108.3 152.17 24.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.769 0.285 . . . . 0.0 110.384 178.679 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 35.5 m -130.53 154.41 40.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.02 0.438 . . . . 0.0 111.251 -179.494 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.55 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 43.8 t -148.14 151.15 13.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.763 179.32 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.926 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -109.12 125.62 52.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.172 0.51 . . . . 0.0 110.957 179.905 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.967 ' CE2' HG21 ' A' ' 111' ' ' VAL . 4.5 m-85 -83.35 162.19 21.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.12 -179.043 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 81' ' ' ARG . 2.6 p -150.94 130.39 12.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.853 0.359 . . . . 0.0 111.689 -178.82 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.409 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 71.8 m -69.93 155.28 40.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.699 178.831 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.465 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 12.6 m-20 -92.76 -72.16 0.61 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.594 -178.598 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.5 t -57.2 -20.59 27.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.771 0.32 . . . . 0.0 111.261 -179.365 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 117.81 29.75 1.96 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.29 -179.846 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.472 ' CE2' HG12 ' A' ' 126' ' ' ILE . 43.9 m-85 -70.7 -174.18 0.87 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.876 0.37 . . . . 0.0 110.643 179.898 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 125' ' ' GLN . 0.5 OUTLIER -109.99 110.45 21.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.702 179.56 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.494 ' CD2' ' HB2' ' A' ' 122' ' ' PRO . 1.1 tp -48.08 113.62 0.77 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.936 179.401 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.525 HG22 ' N ' ' A' ' 107' ' ' GLY . 30.1 mm -94.78 161.06 2.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.031 -179.029 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.525 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 51.63 25.8 15.09 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.333 -0.937 . . . . 0.0 112.346 -179.48 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.417 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.3 OUTLIER 60.24 133.42 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.028 -0.586 . . . . 0.0 111.342 -179.567 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.926 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.3 p -60.64 -26.65 67.21 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.485 -179.156 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.84 128.68 47.0 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.115 -178.692 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.967 HG21 ' CE2' ' A' ' 97' ' ' TYR . 2.3 t -123.67 149.79 27.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 178.279 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.8 108.41 17.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.821 0.343 . . . . 0.0 111.441 -179.93 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.512 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 11.6 t -73.68 103.93 4.43 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 176.536 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.5 p -145.9 159.45 43.2 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.212 -178.619 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.67 32.31 8.01 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.739 179.782 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.43 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 71.81 6.41 63.34 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.824 -179.65 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -136.84 173.52 11.62 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.876 0.369 . . . . 0.0 110.624 179.746 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.55 ' CZ3' HG23 ' A' ' 95' ' ' VAL . 83.1 m95 -106.39 124.86 50.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.031 -179.461 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.78 159.05 15.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.517 -178.926 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.472 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 3.6 p-10 49.44 46.58 3.87 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.465 179.076 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 52.9 Cg_endo -68.36 144.44 61.9 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.32 2.013 . . . . 0.0 111.132 177.215 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.505 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 74.1 Cg_endo -89.73 -172.6 0.62 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.528 2.152 . . . . 0.0 114.3 -176.761 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.41 -158.81 0.9 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.363 -1.289 . . . . 0.0 109.822 178.465 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 7.8 m -155.5 90.54 1.25 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.998 0.427 . . . . 0.0 110.894 179.241 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.402 ' O ' ' HB2' ' A' ' 104' ' ' SER . 22.6 mt-30 -117.37 173.34 6.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.779 -179.851 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.472 HG12 ' CE2' ' A' ' 103' ' ' TYR . 29.1 mm . . . . . 0 C--N 1.325 -0.479 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.971 -179.424 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.682 ' HD2' HG23 ' A' ' 25' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.344 0 CA-C-O 121.232 0.539 . . . . 0.0 112.057 . . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.55 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 89.4 m -94.32 177.54 1.86 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.696 179.708 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.55 ' CD ' ' HB3' ' A' ' 9' ' ' CYS . 28.1 Cg_endo -91.33 179.9 1.51 Allowed 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.706 2.27 . . . . 0.0 111.974 -179.538 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.1 t -51.81 105.51 0.53 Allowed Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.567 179.497 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.483 ' HG3' ' CZ2' ' A' ' 59' ' ' TRP . 77.8 Cg_exo -49.47 153.3 5.21 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.304 2.003 . . . . 0.0 112.4 -179.447 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.428 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 1.0 OUTLIER -62.97 168.5 3.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.981 179.124 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.554 ' HA ' HD11 ' A' ' 20' ' ' LEU . 1.0 OUTLIER -118.93 -175.1 2.84 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.303 0.573 . . . . 0.0 111.752 -178.24 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.9 tt -145.19 139.37 22.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.317 -179.692 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -65.34 -72.96 0.14 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.86 -177.568 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.426 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 2.2 m-20 -90.02 45.64 1.29 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.933 0.397 . . . . 0.0 110.884 -179.129 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -157.08 171.93 34.54 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.352 -0.928 . . . . 0.0 113.292 179.767 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.403 ' N ' ' O ' ' A' ' 34' ' ' SER . 0.3 OUTLIER -133.55 131.03 39.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.775 0.321 . . . . 0.0 110.36 179.323 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.734 HD22 ' CE1' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -78.54 166.62 22.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.171 0.51 . . . . 0.0 111.748 -178.788 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.452 ' HB3' ' CB ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -135.55 73.39 1.47 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.634 177.127 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.805 ' HA ' HG23 ' A' ' 31' ' ' ILE . 45.4 mt -71.53 92.62 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.582 -178.058 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -97.49 18.42 57.38 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.161 178.212 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 158.51 129.51 1.09 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.109 -0.567 . . . . 0.0 111.887 -179.585 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.682 HG23 ' HD2' ' A' ' 8' ' ' ARG . 32.6 m -115.35 0.91 8.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.553 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -69.6 153.6 43.22 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.923 0.392 . . . . 0.0 111.069 -179.764 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.526 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 12.1 t80 -50.48 106.54 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.935 -179.939 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.18 -7.07 23.23 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.913 179.988 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 99.7 p -71.78 -171.65 0.71 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.791 0.329 . . . . 0.0 110.807 179.971 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 47' ' ' SER . 3.2 p -153.48 156.05 37.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.026 179.727 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.805 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -119.71 168.05 12.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.492 -179.869 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.452 ' CB ' ' HB3' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -128.93 111.1 12.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.918 0.39 . . . . 0.0 110.977 179.054 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.734 ' CE1' HD22 ' A' ' 20' ' ' LEU . 27.8 m-85 -88.84 134.93 33.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.211 -179.645 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.428 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 21.3 p -138.42 167.97 20.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.703 179.908 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.448 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 1.6 m -88.18 162.68 16.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.86 -179.991 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.16 -80.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.849 0.357 . . . . 0.0 111.123 -179.324 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.1 m -158.63 133.72 8.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.773 -179.814 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.727 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 60.06 24.74 61.11 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.789 -178.959 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.477 ' CG ' ' O ' ' A' ' 67' ' ' GLU . 2.0 m-85 -112.47 -179.58 3.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.78 0.324 . . . . 0.0 110.766 -179.662 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.678 ' CD2' HD11 ' A' ' 42' ' ' ILE . 3.6 p-80 -138.7 113.8 9.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.011 0.434 . . . . 0.0 110.613 178.49 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.713 HD21 ' O ' ' A' ' 44' ' ' GLU . 4.7 tt -78.99 126.36 30.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.514 -179.595 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.678 HD11 ' CD2' ' A' ' 40' ' ' HIS . 2.6 mm -100.2 153.51 4.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.401 -178.688 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.9 -145.35 31.05 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.328 -179.711 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.713 ' O ' HD21 ' A' ' 41' ' ' LEU . 3.7 pm0 -70.02 171.56 9.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.576 0.227 . . . . 0.0 110.695 179.477 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.0 p -146.96 18.98 1.26 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.437 -179.599 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.431 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -148.15 134.15 19.2 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.925 0.393 . . . . 0.0 111.495 -178.768 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.45 ' HB2' ' CG1' ' A' ' 31' ' ' ILE . 1.5 m -102.89 152.52 21.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.992 178.51 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.515 ' CE1' ' HD3' ' A' ' 61' ' ' PRO . 4.5 m-85 -125.3 121.05 32.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.135 0.493 . . . . 0.0 111.601 -178.74 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.447 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 41.0 t -72.32 93.77 1.53 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.301 179.216 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.493 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 0.7 OUTLIER -111.93 176.4 5.04 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.372 -178.78 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.526 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.579 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.811 179.79 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.982 0.42 . . . . 0.0 110.397 . . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.0 m -125.62 -176.62 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.074 -179.046 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.698 ' CE3' HD11 ' A' ' 31' ' ' ILE . 86.0 m95 -127.69 127.05 43.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.666 179.976 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -151.87 128.92 5.53 Favored Pre-proline 0 CA--C 1.532 0.285 0 C-N-CA 121.086 -0.246 . . . . 0.0 111.322 -179.416 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.515 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 72.8 Cg_endo -75.7 -165.92 4.63 Favored 'Cis proline' 0 C--N 1.351 0.701 0 C-N-CA 123.864 -1.306 . . . . 0.0 112.335 -0.516 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.79 -153.87 0.53 Allowed 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.014 -179.474 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.475 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -73.63 112.67 17.19 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.819 179.63 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 63' ' ' ALA . 17.3 Cg_exo -68.75 -150.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.669 2.246 . . . . 0.0 112.452 -179.075 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.509 HG22 ' H ' ' A' ' 66' ' ' CYS . 5.7 mm -99.6 166.35 2.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.91 0.386 . . . . 0.0 111.459 -178.842 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.509 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -165.94 123.8 1.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.692 179.381 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.477 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -136.24 176.64 8.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.0 -179.739 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.467 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 4.2 p -94.2 122.48 36.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.15 -179.736 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.727 HG12 ' O ' ' A' ' 38' ' ' GLY . 3.0 p -46.85 99.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.399 179.569 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.408 ' HD2' ' HB3' ' A' ' 88' ' ' PHE . 23.0 mmtt -70.99 114.88 9.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.177 179.958 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.426 ' N ' ' O ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -97.01 121.44 38.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.095 178.73 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -158.74 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.925 -179.643 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.543 ' HG ' ' CE1' ' A' ' 82' ' ' HIS . 2.1 t -48.54 138.08 11.9 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.113 -179.556 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.491 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 24.6 Cg_exo -61.22 162.3 20.38 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.389 2.059 . . . . 0.0 112.001 179.746 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.512 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 91.9 Cg_exo -40.72 158.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.852 2.368 . . . . 0.0 113.01 -179.158 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.7 m -108.91 90.99 3.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.588 179.328 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.719 HG23 ' HE2' ' A' ' 97' ' ' TYR . 23.0 pt -69.14 -177.11 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.23 -179.139 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.0 p -101.37 146.74 27.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.752 179.639 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.512 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 3.5 m120 53.54 29.62 9.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.12 179.449 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.466 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -171.55 -171.69 36.9 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.543 179.612 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.54 -176.17 4.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.966 0.412 . . . . 0.0 110.914 179.417 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.543 ' CE1' ' HG ' ' A' ' 73' ' ' SER . 8.6 p-80 -100.93 173.03 6.67 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.018 -179.956 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.393 179.223 . . . . . . . . 0 0 . 1 . 045 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.43 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 6.3 m-85 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.827 0.346 . . . . 0.0 111.182 . . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.43 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 70.4 m-85 -151.27 165.15 34.86 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.895 -179.913 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.3 p -127.4 173.57 9.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.97 0.414 . . . . 0.0 111.214 -179.159 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -60.26 95.31 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.303 0.573 . . . . 0.0 110.82 179.744 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 125.81 28.28 1.07 Allowed Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.943 179.34 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.2 158.14 18.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.696 0.284 . . . . 0.0 110.567 179.208 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 32.8 m -131.43 150.43 34.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.066 0.46 . . . . 0.0 111.361 -179.514 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.542 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 33.2 t -143.12 148.67 19.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.563 178.854 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.983 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -104.45 134.42 47.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.936 -179.873 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.962 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.7 m-85 -94.27 158.59 15.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.263 -179.354 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 84.7 p -154.3 139.91 17.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.39 -179.856 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.415 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 66.3 m -70.54 162.73 28.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.224 -179.862 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.466 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 73.6 m-80 -92.05 -78.26 0.41 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.45 -179.232 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.7 m -56.53 -27.33 57.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.855 0.36 . . . . 0.0 110.985 -179.312 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.61 34.09 0.58 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.768 179.679 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.512 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 32.4 m-85 -70.4 -173.06 0.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.763 0.316 . . . . 0.0 110.175 178.939 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.98 109.97 20.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.139 0.495 . . . . 0.0 110.853 179.563 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.644 HD23 ' HB2' ' A' ' 122' ' ' PRO . 2.6 tp -46.65 113.5 0.66 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.936 179.145 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.464 HG22 ' N ' ' A' ' 107' ' ' GLY . 38.7 mm -89.06 157.29 3.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.785 -179.265 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.464 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 62.77 -121.58 25.38 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.462 -0.875 . . . . 0.0 111.587 -178.335 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -127.48 130.52 49.37 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.878 0.37 . . . . 0.0 110.711 178.523 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.983 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.1 p -63.72 -28.48 69.92 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.107 179.123 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -74.33 130.96 12.76 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.594 179.477 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.962 HG21 ' CE1' ' A' ' 97' ' ' TYR . 4.3 t -122.95 134.13 67.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.152 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 118' ' ' TRP . 0.3 OUTLIER -90.02 124.79 35.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.019 0.438 . . . . 0.0 111.785 -178.2 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.521 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 14.5 t -91.02 100.44 13.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.521 176.909 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.9 166.54 27.33 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.098 0.475 . . . . 0.0 111.591 -178.217 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.98 26.93 3.16 Favored Glycine 0 CA--C 1.517 0.214 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.841 179.589 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.421 ' N ' HG11 ' A' ' 69' ' ' VAL . . . 73.83 10.88 80.84 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.597 -179.425 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -142.14 -177.74 5.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.753 0.311 . . . . 0.0 110.459 179.705 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.542 ' CZ3' HG23 ' A' ' 95' ' ' VAL . 85.0 m95 -114.57 149.33 36.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.072 -179.264 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.549 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -130.02 168.87 16.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.444 -179.121 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.456 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 5.0 p-10 46.67 49.62 7.21 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.975 179.801 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 75.5 Cg_endo -77.85 143.01 20.5 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.632 2.221 . . . . 0.0 111.681 178.045 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.644 ' HB2' HD23 ' A' ' 105' ' ' LEU . 70.0 Cg_endo -90.8 -171.54 0.44 Allowed 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.841 2.36 . . . . 0.0 113.819 -178.053 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.424 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -133.96 -161.3 1.13 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.252 178.592 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 10.7 m -153.53 90.14 1.39 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.016 0.436 . . . . 0.0 110.996 179.599 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -118.35 160.84 20.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.651 179.793 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.62 ' O ' HG22 ' A' ' 126' ' ' ILE . 20.5 mm . . . . . 0 C--N 1.322 -0.618 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.103 -179.852 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.622 ' HB3' HG23 ' A' ' 25' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.45 0 CA-C-O 121.078 0.465 . . . . 0.0 111.501 . . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.438 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 18.4 m -72.73 160.82 81.91 Favored Pre-proline 0 N--CA 1.452 -0.346 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.51 179.817 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.45 167.61 16.46 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.171 1.914 . . . . 0.0 111.175 179.517 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.5 p -53.64 107.74 0.93 Allowed Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.152 -178.376 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.564 ' HG2' HD13 ' A' ' 22' ' ' ILE . 50.0 Cg_exo -44.87 167.41 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.312 2.008 . . . . 0.0 112.765 179.724 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.413 ' HB3' ' OH ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -66.36 176.51 1.79 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.593 176.416 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.919 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -130.46 -7.06 4.19 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -177.279 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.698 HD12 ' HD2' ' A' ' 64' ' ' PRO . 17.4 tt 51.67 156.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 123.498 0.719 . . . . 0.0 112.533 -178.685 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -103.97 157.52 17.04 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.141 178.858 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 42.97 28.0 0.12 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.293 -179.516 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.447 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -151.25 -163.42 11.38 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.341 -179.781 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.694 ' C ' HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -137.93 175.37 9.64 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.85 0.357 . . . . 0.0 111.132 179.964 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.919 HD11 ' O ' ' A' ' 14' ' ' ASP . 0.8 OUTLIER -125.13 150.65 46.68 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.57 179.514 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.457 ' HB3' ' CB ' ' A' ' 32' ' ' THR . 60.5 t0 -125.97 67.08 1.19 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 177.913 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.94 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -82.33 101.63 7.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.026 -176.613 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.22 7.97 72.48 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.982 176.908 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 175.53 160.36 23.1 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.926 -179.928 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.622 HG23 ' HB3' ' A' ' 8' ' ' ARG . 31.9 m -143.13 33.73 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.873 0.368 . . . . 0.0 111.205 -179.689 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.17 156.9 17.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.081 -179.906 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.518 ' CE2' ' HG ' ' A' ' 51' ' ' LEU . 0.6 OUTLIER -54.23 91.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.723 179.56 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 132.54 -10.47 5.25 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.797 -179.796 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.3 -179.27 5.59 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.804 0.335 . . . . 0.0 110.561 179.565 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 47' ' ' SER . 3.0 p -155.13 141.63 18.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.076 0.465 . . . . 0.0 110.558 179.277 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.94 HG23 ' HA ' ' A' ' 22' ' ' ILE . 1.1 mt -101.95 166.12 2.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.56 -179.239 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.457 ' CB ' ' HB3' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -127.98 104.81 8.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.942 0.401 . . . . 0.0 110.214 178.842 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.529 ' CE2' ' CD2' ' A' ' 20' ' ' LEU . 9.5 m-85 -79.76 157.83 27.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.695 -178.02 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.6 t -162.81 176.59 10.09 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.697 179.99 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.455 ' HB3' ' CB ' ' A' ' 39' ' ' TYR . 45.2 m -98.43 173.78 6.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.876 179.916 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.439 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 4.9 m120 -72.81 -83.63 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.289 -179.279 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.4 t -149.48 139.04 21.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.631 -179.867 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.877 ' O ' HG22 ' A' ' 69' ' ' VAL . . . 55.89 27.02 49.5 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.811 -179.056 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.555 ' CD2' ' HA ' ' A' ' 68' ' ' SER . 2.4 m-85 -115.82 171.62 7.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.681 0.277 . . . . 0.0 110.763 -179.147 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.759 ' CD2' HD11 ' A' ' 42' ' ' ILE . 3.3 p-80 -137.5 117.52 13.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.978 0.418 . . . . 0.0 110.608 178.677 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.931 HD21 ' O ' ' A' ' 44' ' ' GLU . 5.9 tt -81.52 125.8 30.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.64 -179.542 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.759 HD11 ' CD2' ' A' ' 40' ' ' HIS . 2.0 mm -102.16 153.33 5.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.09 -179.3 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.08 -142.82 26.79 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.452 -179.681 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.931 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -68.43 -172.39 0.33 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.063 0.458 . . . . 0.0 110.882 179.68 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -174.77 32.23 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.202 178.992 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 mtpt -157.34 118.8 3.68 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.033 0.444 . . . . 0.0 111.577 -179.426 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.442 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 0.4 OUTLIER -91.83 139.47 30.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.109 179.214 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.548 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 2.1 m-85 -115.74 118.4 32.95 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 119.43 -0.908 . . . . 0.0 111.439 178.82 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 22.6 t -67.33 116.2 7.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.855 -179.575 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.5 ' HA ' ' CE1' ' A' ' 27' ' ' PHE . 2.7 mt-10 -148.85 177.87 9.16 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.127 0.489 . . . . 0.0 111.338 179.678 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.736 ' O ' HG22 ' A' ' 58' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--N 1.326 -0.421 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.702 -179.065 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.408 ' HB2' ' HA ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 121.227 0.537 . . . . 0.0 111.164 . . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.736 HG22 ' O ' ' A' ' 51' ' ' LEU . 25.8 m -122.23 -172.37 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.645 179.669 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.526 ' CE3' HD11 ' A' ' 31' ' ' ILE . 73.3 m95 -132.66 128.88 37.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.865 0.364 . . . . 0.0 111.439 -179.317 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.548 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 5.3 m-80 -69.18 166.98 23.62 Favored Pre-proline 0 C--O 1.223 -0.323 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.538 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.471 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 57.4 Cg_exo -12.66 90.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 125.228 3.952 . . . . 0.0 114.224 -179.103 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.476 ' O ' ' CG ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -92.8 -72.68 0.59 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.584 -175.826 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.512 ' HA ' ' CD2' ' A' ' 33' ' ' TYR . . . -97.25 106.64 33.28 Favored Pre-proline 0 N--CA 1.463 0.189 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -174.885 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.792 ' HG2' HD11 ' A' ' 41' ' ' LEU . 5.7 Cg_exo -82.64 -152.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.251 2.634 . . . . 0.0 111.335 177.138 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.576 HG22 ' H ' ' A' ' 66' ' ' CYS . 3.2 mm -90.8 169.98 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.825 0.345 . . . . 0.0 110.744 178.648 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.576 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -167.37 139.82 3.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.488 179.313 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -161.09 170.7 19.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.266 -179.098 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.555 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 54.9 p -81.09 120.87 25.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.235 0.541 . . . . 0.0 111.124 179.713 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.877 HG22 ' O ' ' A' ' 38' ' ' GLY . 16.3 m -46.86 107.89 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.829 -179.72 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.53 ' HG2' ' CD1' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -101.7 122.09 43.25 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.313 0.578 . . . . 0.0 110.388 177.409 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.38 128.84 55.12 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.597 -178.759 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.49 -156.17 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.148 179.103 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.444 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.3 OUTLIER -54.97 139.59 62.99 Favored Pre-proline 0 N--CA 1.445 -0.678 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.408 179.212 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.507 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 38.5 Cg_exo -58.27 162.94 10.94 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.558 2.172 . . . . 0.0 112.192 -179.487 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.519 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 94.5 Cg_exo -42.09 155.49 0.09 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.671 2.247 . . . . 0.0 112.647 -179.647 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.4 m -109.57 89.75 3.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.538 179.559 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.626 HG23 ' HE1' ' A' ' 97' ' ' TYR . 16.1 pt -69.38 172.04 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.047 -179.45 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -89.58 131.41 35.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.935 179.99 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.28 26.86 8.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.618 -179.869 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.449 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -158.4 178.46 34.62 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.329 -179.754 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 98' ' ' SER . 5.3 mtm180 -149.27 -166.57 2.59 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.358 0.599 . . . . 0.0 110.991 -179.214 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 4.3 p-80 -132.2 157.42 44.36 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.561 -179.889 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 . . . . . 0 CA--C 1.537 0.465 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.399 -179.887 . . . . . . . . 0 0 . 1 . 046 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.53 ' CD1' ' HG2' ' A' ' 70' ' ' LYS . 45.6 m-85 . . . . . 0 N--CA 1.446 -0.627 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 . . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.474 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 73.5 m-85 -158.94 163.62 36.35 Favored 'General case' 0 C--O 1.223 -0.309 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.896 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.1 p -144.2 -177.3 5.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.365 0.602 . . . . 0.0 112.59 -178.493 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 41.1 p-10 -50.91 95.2 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.373 -179.302 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 121.01 25.4 2.28 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.282 -0.872 . . . . 0.0 113.076 178.15 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.17 145.46 37.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.936 0.368 . . . . 0.0 110.75 179.068 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.488 HG22 ' N ' ' A' ' 95' ' ' VAL . 33.5 m -127.33 158.58 38.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.043 0.449 . . . . 0.0 111.043 -179.777 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.488 ' N ' HG22 ' A' ' 94' ' ' VAL . 15.5 t -151.95 147.77 14.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.641 179.79 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.908 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -108.1 127.59 53.93 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.142 0.496 . . . . 0.0 110.868 -179.899 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.996 ' CE2' HG21 ' A' ' 111' ' ' VAL . 3.9 m-85 -84.81 159.61 20.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.445 -178.963 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 81' ' ' ARG . 19.1 p -147.58 130.28 16.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.84 -179.589 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.455 ' SG ' HD12 ' A' ' 105' ' ' LEU . 93.8 m -69.5 150.11 47.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.907 179.376 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.4 ' OD1' ' HG3' ' A' ' 81' ' ' ARG . 4.9 m-20 -87.11 -72.7 0.5 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.832 -178.383 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.38 -18.49 28.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.557 -178.831 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 116.05 28.5 2.63 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.262 -179.472 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.61 ' HA ' HD13 ' A' ' 126' ' ' ILE . 45.5 m-85 -69.56 -173.45 0.58 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 120.779 0.323 . . . . 0.0 110.555 179.964 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 125' ' ' GLN . 1.4 m -110.44 109.18 19.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 -179.97 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.455 HD12 ' SG ' ' A' ' 99' ' ' CYS . 1.1 mp -46.93 107.91 0.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.96 179.189 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.445 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 43.7 mm -93.8 153.18 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.939 -179.424 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 60.48 25.94 63.71 Favored Glycine 0 CA--C 1.51 -0.228 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.591 -179.916 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.419 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.4 OUTLIER 60.79 135.73 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.288 0.566 . . . . 0.0 111.212 -179.713 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.908 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.2 p -65.52 -24.67 67.18 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.692 -178.678 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -58.93 131.58 52.12 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.022 -179.037 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.996 HG21 ' CE2' ' A' ' 97' ' ' TYR . 2.3 t -133.59 125.49 50.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.626 0.251 . . . . 0.0 110.551 178.927 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.896 HD22 ' N ' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -89.92 130.86 36.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.942 0.401 . . . . 0.0 111.562 -179.234 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.896 ' N ' HD22 ' A' ' 112' ' ' LEU . 48.7 t -100.84 104.81 16.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.665 176.866 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.784 ' HB2' HD11 ' A' ' 112' ' ' LEU . 71.1 m -152.85 126.18 8.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.896 0.379 . . . . 0.0 111.777 -178.907 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.487 ' H ' HG21 ' A' ' 69' ' ' VAL . . . 84.3 22.13 55.09 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.575 178.994 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.509 ' N ' ' HB ' ' A' ' 69' ' ' VAL . . . 84.37 -4.22 84.44 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.43 179.995 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -124.81 173.38 8.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.421 0.629 . . . . 0.0 111.892 -178.669 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.54 ' CZ3' ' HB2' ' A' ' 113' ' ' CYS . 95.2 m95 -115.75 125.93 53.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.008 178.812 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.92 148.34 30.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.232 0.539 . . . . 0.0 111.64 -178.711 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.497 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER 68.8 44.86 0.28 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.299 178.374 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 56.9 Cg_endo -70.59 140.99 40.79 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.078 1.852 . . . . 0.0 111.331 177.859 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.572 ' O ' HG21 ' A' ' 77' ' ' ILE . 67.5 Cg_endo -88.51 -173.82 0.96 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.58 2.186 . . . . 0.0 114.007 -177.25 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.46 -160.82 1.08 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.58 177.661 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 124' ' ' CYS . . . . . 0.402 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 6.6 m -152.99 90.96 1.49 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.091 0.472 . . . . 0.0 111.028 179.144 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.426 ' O ' ' CB ' ' A' ' 104' ' ' SER . 8.9 mt-30 -121.06 158.4 27.93 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.712 -179.852 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.61 HD13 ' HA ' ' A' ' 103' ' ' TYR . 35.3 mm . . . . . 0 C--N 1.323 -0.568 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.909 179.933 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.425 ' HB3' ' O ' ' A' ' 25' ' ' VAL . 20.6 mtm180 . . . . . 0 N--CA 1.453 -0.319 0 CA-C-O 121.178 0.513 . . . . 0.0 111.834 . . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.547 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 80.7 m -87.8 176.4 3.42 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.839 179.738 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.554 ' HD2' ' CD1' ' A' ' 59' ' ' TRP . 26.4 Cg_endo -88.37 -167.49 0.31 Allowed 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.556 2.171 . . . . 0.0 111.814 179.626 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.448 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 1.1 p -56.79 105.81 0.58 Allowed Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.554 179.603 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.619 ' HB3' HD11 ' A' ' 31' ' ' ILE . 10.1 Cg_endo -52.43 138.99 56.52 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.253 1.969 . . . . 0.0 112.111 -179.194 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.529 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -53.22 160.87 0.99 Allowed 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.581 179.963 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.611 ' HA ' HD11 ' A' ' 20' ' ' LEU . 3.9 p-10 -117.2 -175.1 2.73 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.785 -176.567 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.442 HG23 ' C ' ' A' ' 18' ' ' GLY . 2.7 tt -139.44 145.19 27.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.437 179.395 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -76.14 -65.73 0.88 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.459 -178.463 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -91.77 42.07 1.09 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.861 -179.34 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.442 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -160.88 -179.87 35.91 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.392 -0.908 . . . . 0.0 113.3 -179.89 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -137.95 140.28 40.17 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 179.166 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.611 HD11 ' HA ' ' A' ' 14' ' ' ASP . 10.7 mt -84.38 158.26 21.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.216 0.531 . . . . 0.0 111.875 -179.013 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -131.46 72.76 1.51 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.114 176.741 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.894 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.5 OUTLIER -73.95 106.09 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.238 -176.135 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.1 -5.04 73.77 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.668 175.632 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 172.39 153.03 8.97 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 121.16 -0.543 . . . . 0.0 111.818 -179.95 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.425 ' O ' ' HB3' ' A' ' 8' ' ' ARG . 24.3 m -121.86 3.4 6.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.271 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.414 ' HA ' ' HB3' ' A' ' 8' ' ' ARG . 0.6 OUTLIER -72.54 162.14 29.86 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 121.081 0.467 . . . . 0.0 111.517 -179.349 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.74 ' HZ ' HD13 ' A' ' 51' ' ' LEU . 0.6 OUTLIER -51.91 98.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.202 178.744 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 117.86 -9.24 14.31 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.561 -179.097 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.4 m -75.31 138.23 41.67 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 117.068 0.434 . . . . 0.0 109.985 178.93 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 47' ' ' SER . 2.1 p -115.96 140.54 49.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.251 0.548 . . . . 0.0 111.397 -178.778 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.894 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -98.06 164.32 2.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.946 179.196 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.413 ' HA ' ' HG3' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -124.76 110.4 14.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.957 0.408 . . . . 0.0 110.856 179.574 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.527 ' CE2' ' CD2' ' A' ' 20' ' ' LEU . 13.8 m-85 -83.23 142.64 31.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.231 -179.372 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.439 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 26.5 p -143.61 158.91 43.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.206 179.235 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.2 m -84.62 167.84 15.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.754 0.312 . . . . 0.0 110.936 -179.763 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -63.49 -82.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.003 -179.597 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -159.61 129.91 5.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.798 179.948 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.402 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 69.92 21.21 76.68 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.078 -179.016 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.482 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.9 m-30 -114.51 178.51 4.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.846 0.355 . . . . 0.0 110.833 -179.637 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.864 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -138.88 119.41 13.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.568 178.244 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.856 HD21 ' O ' ' A' ' 44' ' ' GLU . 7.6 tt -83.25 122.27 28.19 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.647 -179.65 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.864 HD11 ' CE1' ' A' ' 40' ' ' HIS . 1.7 mm -99.65 160.49 3.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.119 0.485 . . . . 0.0 111.313 -178.644 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.89 -145.05 40.97 Favored Glycine 0 N--CA 1.453 -0.191 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.43 -179.758 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.856 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -60.74 -174.38 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.863 0.363 . . . . 0.0 110.538 179.28 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.0 t -172.88 29.96 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.792 178.786 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.413 ' HG3' ' HA ' ' A' ' 32' ' ' THR . 11.9 mtpt -162.21 119.94 2.15 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 120.751 0.31 . . . . 0.0 111.287 -179.329 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.429 ' HB3' HG13 ' A' ' 31' ' ' ILE . 1.0 OUTLIER -87.52 136.79 32.8 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.026 178.919 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.534 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.1 m-85 -111.9 120.71 42.84 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 119.482 -0.887 . . . . 0.0 111.703 179.916 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.421 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 18.5 t -72.45 118.46 15.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.849 -179.973 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.507 ' HA ' ' CE1' ' A' ' 27' ' ' PHE . 10.3 tt0 -156.62 169.21 25.2 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.429 0.633 . . . . 0.0 110.782 179.326 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.74 HD13 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.76 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.039 -178.956 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.803 0.335 . . . . 0.0 110.434 . . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.4 m -153.68 173.45 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.247 -179.493 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.554 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 64.6 m95 -126.4 129.73 49.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.853 179.874 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.534 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 6.1 m-20 -73.69 166.15 46.77 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.489 179.184 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.447 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 90.1 Cg_exo -18.4 96.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 125.247 3.965 . . . . 0.0 114.112 -179.366 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.463 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -97.81 -78.52 0.48 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.268 -176.943 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.469 ' HA ' ' CD2' ' A' ' 33' ' ' TYR . . . -85.46 108.38 15.9 Favored Pre-proline 0 C--N 1.332 -0.168 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -175.726 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.808 ' HG2' HD11 ' A' ' 41' ' ' LEU . 3.5 Cg_exo -84.08 -153.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.201 2.601 . . . . 0.0 111.073 177.211 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.507 HG22 ' H ' ' A' ' 66' ' ' CYS . 3.6 mm -90.79 166.33 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.768 0.318 . . . . 0.0 110.594 178.259 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.507 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -166.66 137.94 3.41 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.947 179.631 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.427 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -161.99 177.0 10.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.047 179.716 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.482 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 6.5 p -89.44 112.16 23.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.118 -179.7 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.497 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 3.2 p -48.43 104.88 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.997 179.602 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.429 ' HD2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -87.54 145.67 26.12 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.021 -177.988 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 1.8 m -105.47 137.16 43.75 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.57 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.407 ' CG ' ' N ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -69.32 -170.56 0.28 Allowed 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 120.469 -0.492 . . . . 0.0 109.849 179.967 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.407 ' N ' ' CG ' ' A' ' 72' ' ' GLN . 2.0 t -72.91 108.94 5.13 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.251 -178.039 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.734 ' HG3' ' CE2' ' A' ' 118' ' ' TRP 0.302 0.2 OUTLIER -35.82 -177.96 0.0 OUTLIER 'Trans proline' 0 CA--C 1.467 -2.864 0 C-N-CA 123.481 2.788 . . . . 0.0 113.553 173.807 . . . . . . . . 4 4 . 1 . 047 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.581 ' CB ' ' CE1' ' A' ' 97' ' ' TYR . 26.7 Cg_endo -71.78 -165.14 3.24 Favored 'Cis proline' 0 C--N 1.315 -1.187 0 N-CA-C 113.994 0.728 . . . . 0.0 113.994 -19.258 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.3 p -132.57 20.28 4.29 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 114.178 -1.374 . . . . 0.0 108.795 172.395 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.835 HD11 ' HA3' ' A' ' 80' ' ' GLY . 17.5 pt -106.43 -159.32 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.265 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.14 -177.952 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.429 ' N ' HG13 ' A' ' 77' ' ' ILE . 0.4 OUTLIER -131.24 148.34 52.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.869 177.199 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.3 m120 55.46 30.26 14.75 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.882 178.8 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.835 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -144.52 -168.38 12.57 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.417 -0.896 . . . . 0.0 113.039 -179.531 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.419 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 4.2 ptt180 -166.81 -174.49 2.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.069 0.462 . . . . 0.0 111.592 -178.789 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.548 ' CG ' ' HB2' ' A' ' 74' ' ' PRO . 41.1 p-80 -120.31 175.86 5.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.759 -177.858 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.282 178.216 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.434 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 7.5 m-85 . . . . . 0 N--CA 1.455 -0.184 0 CA-C-O 120.802 0.334 . . . . 0.0 110.885 . . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.515 ' CE2' ' HD2' ' A' ' 74' ' ' PRO . 37.9 m-85 -144.9 159.4 42.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.182 -178.811 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.414 ' CG2' ' HG2' ' A' ' 70' ' ' LYS . 3.2 p -119.11 172.5 7.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.374 -179.055 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 48.8 p-10 -59.81 94.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.14 -179.782 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.94 32.88 0.67 Allowed Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.959 178.681 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.459 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -110.07 160.39 16.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.843 0.354 . . . . 0.0 110.944 179.49 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 29.9 m -139.72 148.21 23.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.044 179.981 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.559 HG23 ' CH2' ' A' ' 118' ' ' TRP . 3.5 t -150.93 144.27 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.365 -179.148 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.67 135.19 35.21 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.146 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.766 ' CZ ' HG21 ' A' ' 111' ' ' VAL . 3.3 m-30 -104.04 158.65 16.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.341 0.591 . . . . 0.0 112.282 -175.21 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.418 ' O ' ' CG ' ' A' ' 81' ' ' ARG . 61.0 m -142.24 144.77 33.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.391 178.766 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.471 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 93.3 m -71.25 148.03 47.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.912 0.387 . . . . 0.0 111.596 -178.893 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.462 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 62.5 m-20 -75.6 -77.42 0.13 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.973 -178.501 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.0 t -62.19 -18.73 61.87 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.641 0.258 . . . . 0.0 111.624 -178.285 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.95 27.46 1.88 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.653 -179.993 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.42 ' CE2' HG12 ' A' ' 126' ' ' ILE . 34.9 m-85 -69.0 -173.35 0.48 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.867 0.365 . . . . 0.0 110.428 179.26 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 125' ' ' GLN . 0.5 OUTLIER -112.06 109.52 19.31 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.855 178.026 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.662 HD22 ' HB3' ' A' ' 109' ' ' SER . 0.2 OUTLIER -52.2 123.42 10.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.457 0.646 . . . . 0.0 111.059 -178.656 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.531 HG22 ' N ' ' A' ' 107' ' ' GLY . 28.3 mm -95.57 162.14 2.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.247 179.783 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.531 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 57.28 -128.66 47.97 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.235 -0.984 . . . . 0.0 112.253 -179.572 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -110.68 135.64 50.98 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.025 0.44 . . . . 0.0 112.118 -178.913 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.662 ' HB3' HD22 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -77.33 -32.52 55.29 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 174.481 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -68.3 117.4 8.38 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 110.536 -1.025 . . . . 0.0 110.536 175.332 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.766 HG21 ' CZ ' ' A' ' 97' ' ' TYR . 32.4 t -117.36 127.01 74.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 C-N-CA 121.977 0.111 . . . . 0.0 110.787 -175.832 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 118' ' ' TRP . 0.6 OUTLIER -84.42 133.32 34.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.43 . . . . 0.0 111.857 -177.744 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.51 ' HB2' ' CZ3' ' A' ' 118' ' ' TRP . 23.0 t -97.0 100.01 11.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.441 176.384 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.33 170.47 16.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.128 -178.45 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.38 26.13 2.28 Favored Glycine 0 CA--C 1.517 0.214 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.727 179.762 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.497 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 71.58 19.47 77.86 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.516 -179.613 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -153.09 179.64 8.52 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.188 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.734 ' CE2' ' HG3' ' A' ' 74' ' ' PRO . 97.1 m95 -100.7 129.47 46.61 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.046 0.45 . . . . 0.0 111.023 -179.703 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.38 156.49 19.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.237 -178.787 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.511 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER 54.53 42.81 1.19 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.13 179.868 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.511 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 72.4 Cg_endo -75.01 154.13 42.21 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.146 1.897 . . . . 0.0 111.748 178.649 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.463 ' CB ' ' O ' ' A' ' 106' ' ' ILE . 57.6 Cg_endo -88.24 -169.73 0.46 Allowed 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.544 2.162 . . . . 0.0 113.191 -179.46 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.459 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -133.32 173.52 11.38 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.962 176.498 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 1.4 m -134.06 97.34 3.84 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.989 179.964 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.4 ' O ' ' HB2' ' A' ' 104' ' ' SER . 22.9 mt-30 -129.35 163.65 25.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.937 -179.228 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.42 HG12 ' CE2' ' A' ' 103' ' ' TYR . 23.2 mm . . . . . 0 C--N 1.324 -0.524 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.07 -179.937 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.946 0.403 . . . . 0.0 111.002 . . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.447 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 34.1 m -79.47 161.41 67.33 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.15 -179.7 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -70.65 172.81 12.78 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.55 2.167 . . . . 0.0 112.18 179.794 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.8 t -54.13 108.73 1.21 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.856 -179.889 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.877 ' HG2' HD13 ' A' ' 22' ' ' ILE . 53.9 Cg_exo -50.55 143.72 27.26 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.321 2.014 . . . . 0.0 112.263 179.905 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -56.91 151.15 15.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.221 179.047 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.602 ' HA ' HD11 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -93.56 -171.75 2.71 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.536 -177.719 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.436 HG22 ' CD2' ' A' ' 20' ' ' LEU . 14.9 tt -147.99 146.39 18.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.914 -179.448 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -86.29 156.43 20.25 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.018 178.446 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.447 ' N ' ' ND2' ' A' ' 17' ' ' ASN . 0.0 OUTLIER 43.28 29.11 0.2 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.964 -179.15 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.436 ' HA2' ' N ' ' A' ' 36' ' ' ASN . . . -157.71 177.91 34.27 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.536 -179.57 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.88 153.97 51.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.768 0.318 . . . . 0.0 110.605 -179.874 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.602 HD11 ' HA ' ' A' ' 14' ' ' ASP . 4.8 mt -91.57 153.15 19.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.002 0.429 . . . . 0.0 111.164 179.76 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.464 ' HB3' ' CB ' ' A' ' 32' ' ' THR . 19.6 t0 -123.96 67.4 1.04 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.337 177.526 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.881 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.9 OUTLIER -79.77 95.82 2.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.77 -176.667 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.11 15.94 61.7 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.025 177.662 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 161.62 128.19 0.93 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.054 -179.6 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.617 HG12 ' CZ2' ' A' ' 59' ' ' TRP . 2.8 m -114.8 15.76 8.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -179.077 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 28' ' ' GLY . 5.2 m-20 -79.59 157.18 27.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.913 0.387 . . . . 0.0 111.312 -179.573 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.596 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 2.0 t80 -54.34 86.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.019 179.705 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 132.79 -5.41 5.12 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.024 179.974 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.9 m -77.87 -178.01 5.23 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.926 0.363 . . . . 0.0 110.787 179.999 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 47' ' ' SER . 5.4 p -146.15 154.09 41.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.871 0.367 . . . . 0.0 111.427 -179.924 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.881 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -115.84 170.89 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.113 179.749 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.489 HG23 ' HG2' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -137.91 106.87 5.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.735 178.41 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.474 ' CE1' ' HA ' ' A' ' 63' ' ' ALA . 34.3 m-85 -79.09 148.25 32.47 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.86 -179.79 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.8 p -152.23 158.3 42.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.222 -179.703 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 6.9 m -84.92 163.88 18.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.958 179.78 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.436 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 5.9 m-20 -64.57 -84.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.295 -179.168 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -153.3 134.48 14.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.85 -179.594 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.691 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 65.12 23.41 69.7 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.945 -178.929 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.492 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.3 m-85 -117.0 175.43 5.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.37 . . . . 0.0 110.906 -179.292 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.739 ' HB3' HG22 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -141.05 115.73 9.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.427 177.549 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.965 HD21 ' O ' ' A' ' 44' ' ' GLU . 2.0 tt -77.33 131.66 38.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.493 -179.448 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.454 ' N ' HD13 ' A' ' 42' ' ' ILE . 2.8 mm -100.15 162.13 3.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.15 -179.218 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.415 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 70.9 -137.25 26.6 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.24 -179.355 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.965 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -76.82 177.47 7.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.729 0.299 . . . . 0.0 110.825 179.621 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.5 p -147.31 22.65 1.18 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.054 179.885 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.489 ' HG2' HG23 ' A' ' 32' ' ' THR . 0.0 OUTLIER -145.92 -177.91 5.84 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.214 0.531 . . . . 0.0 111.527 -178.626 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.421 ' CB ' HG13 ' A' ' 31' ' ' ILE . 0.5 OUTLIER -155.06 147.79 24.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.486 178.567 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.469 ' CD1' ' O ' ' A' ' 60' ' ' ASN . 2.4 m-85 -125.03 118.95 27.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.983 0.42 . . . . 0.0 111.934 -177.652 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.5 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 34.6 t -70.93 112.57 7.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.407 178.417 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.48 -176.77 4.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.15 0.5 . . . . 0.0 111.553 -179.432 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.596 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.853 -179.626 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.1 mmt . . . . . 0 N--CA 1.456 -0.14 0 CA-C-O 120.774 0.321 . . . . 0.0 110.58 . . . . . . . . . 0 0 . 1 . 048 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.1 m -154.01 178.71 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.246 -179.303 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.679 ' CE3' HD11 ' A' ' 31' ' ' ILE . 86.4 m95 -135.1 125.87 27.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.027 -179.427 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.469 ' O ' ' CD1' ' A' ' 48' ' ' TYR . 8.3 m120 -146.43 127.13 7.13 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.219 -179.636 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.402 ' HG2' ' O ' ' A' ' 46' ' ' LYS . 74.3 Cg_endo -75.36 -165.51 4.28 Favored 'Cis proline' 0 C--N 1.352 0.76 0 C-N-CA 123.849 -1.313 . . . . 0.0 112.394 -0.652 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.8 -151.81 0.49 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.249 -178.819 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.474 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -79.03 116.9 63.59 Favored Pre-proline 0 C--N 1.333 -0.119 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.058 -179.654 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.491 ' HG2' HD11 ' A' ' 41' ' ' LEU . 13.6 Cg_exo -72.21 -151.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.645 2.23 . . . . 0.0 112.499 -179.257 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.519 HG22 ' H ' ' A' ' 66' ' ' CYS . 7.3 mm -99.99 167.22 2.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.403 -178.858 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.519 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.2 m -161.13 128.5 4.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.752 179.219 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.475 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -152.49 178.6 9.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.956 -179.727 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.492 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 87.4 p -80.41 119.62 23.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.185 0.517 . . . . 0.0 111.094 -179.883 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.739 HG22 ' HB3' ' A' ' 40' ' ' HIS . 2.3 p -45.63 96.35 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.526 179.82 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -82.79 118.02 23.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.067 179.888 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.65 117.28 34.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.129 179.047 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.56 -157.01 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.837 -179.605 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.458 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 2.1 t -49.02 138.56 13.01 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.06 -179.656 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.484 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 26.8 Cg_exo -60.32 161.35 20.32 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.349 2.033 . . . . 0.0 111.973 179.807 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.51 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 88.3 Cg_exo -42.39 156.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.675 2.25 . . . . 0.0 112.744 -179.821 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.2 t -108.46 90.91 3.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.552 179.378 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.719 HG23 ' HE2' ' A' ' 97' ' ' TYR . 26.7 pt -69.16 178.33 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.305 -179.163 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -99.23 140.2 33.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.756 179.624 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.502 ' HB3' ' CE2' ' A' ' 103' ' ' TYR . 0.1 OUTLIER 63.92 29.21 14.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.555 -179.992 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.431 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . -169.51 -165.46 26.93 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.814 179.627 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' A' ' 98' ' ' SER . 6.7 ptt180 -168.69 -175.63 2.5 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.85 0.357 . . . . 0.0 110.611 -179.584 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 10.5 p80 -111.61 167.91 9.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.282 -179.651 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.738 179.889 . . . . . . . . 0 0 . 1 . 048 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.416 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 11.0 m-85 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.733 0.302 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.416 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 46.5 m-85 -148.18 162.71 38.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.101 179.924 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 16.5 p -136.3 -174.92 3.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.058 -179.616 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.425 ' OD1' ' CG1' ' A' ' 69' ' ' VAL . 1.6 m-20 -62.25 93.78 0.05 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.193 0.52 . . . . 0.0 111.246 -179.679 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.48 30.42 0.84 Allowed Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.514 -0.766 . . . . 0.0 113.143 178.175 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.436 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.5 OUTLIER -109.83 155.46 21.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.823 0.311 . . . . 0.0 110.62 179.135 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 28.8 m -133.5 150.7 32.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.171 0.51 . . . . 0.0 111.285 -179.719 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.517 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 22.1 t -147.22 149.19 15.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.495 179.612 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.897 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -111.63 123.06 49.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.176 0.512 . . . . 0.0 111.117 -179.991 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 1.013 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.7 m-85 -79.14 161.82 26.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.48 -179.244 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.4 ' O ' ' N ' ' A' ' 81' ' ' ARG . 49.3 m -152.41 133.54 14.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.442 -179.872 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.431 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 73.4 m -69.62 163.92 24.47 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.77 179.415 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.46 -84.93 0.4 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.917 179.514 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.8 t -44.41 -28.68 0.58 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.445 -179.696 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 126.74 35.74 0.54 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.769 179.605 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.507 ' CE1' HG12 ' A' ' 126' ' ' ILE . 52.0 m-85 -76.46 -173.86 2.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.793 0.33 . . . . 0.0 110.467 179.364 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.58 113.67 26.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.079 0.466 . . . . 0.0 111.04 -179.696 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.622 HD21 ' HB2' ' A' ' 97' ' ' TYR . 0.3 OUTLIER -50.63 112.14 0.65 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.74 179.078 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.483 HG22 ' N ' ' A' ' 107' ' ' GLY . 49.9 mm -97.61 158.58 3.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.976 -179.583 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.483 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 52.87 34.55 45.56 Favored Glycine 0 CA--C 1.509 -0.294 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.632 179.3 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.422 ' O ' ' O ' ' A' ' 107' ' ' GLY . 3.8 p-10 52.88 138.32 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 124.158 0.983 . . . . 0.0 112.974 179.43 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.897 ' HB2' HG22 ' A' ' 96' ' ' THR . 0.9 OUTLIER -66.9 -23.9 66.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.686 -179.435 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.36 125.37 39.28 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.702 -179.543 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 1.013 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.2 t -129.32 121.56 53.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 179.515 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.98 123.56 32.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.827 0.346 . . . . 0.0 111.525 -178.787 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.506 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 19.8 t -88.83 103.5 16.05 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 176.55 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.37 158.83 43.28 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.048 0.451 . . . . 0.0 111.271 -178.772 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.11 31.39 5.94 Favored Glycine 0 N--CA 1.453 -0.195 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.715 179.824 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.461 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 70.2 12.08 68.36 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.646 -179.369 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -136.04 174.89 10.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.981 0.419 . . . . 0.0 110.67 179.522 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.517 ' CZ3' HG23 ' A' ' 95' ' ' VAL . 91.2 m95 -113.22 129.57 56.48 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.731 -179.732 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.07 145.85 39.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.087 0.47 . . . . 0.0 111.443 -178.822 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.482 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER 69.63 44.63 0.25 Allowed Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.288 178.675 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 55.6 Cg_endo -69.93 143.91 51.5 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.174 1.916 . . . . 0.0 111.27 177.874 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.525 ' HB2' HD23 ' A' ' 105' ' ' LEU . 62.3 Cg_endo -90.91 -173.22 0.56 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.519 2.146 . . . . 0.0 113.719 -177.732 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.55 -159.13 0.93 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.778 178.672 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 124' ' ' CYS . . . . . 0.417 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 7.6 m -154.82 88.99 1.21 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.949 0.404 . . . . 0.0 110.992 179.337 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -112.57 160.96 17.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.737 179.877 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.507 HG12 ' CE1' ' A' ' 103' ' ' TYR . 15.9 mm . . . . . 0 C--N 1.323 -0.576 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.285 -179.631 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.544 ' HD3' HG23 ' A' ' 25' ' ' VAL . 2.5 mtt180 . . . . . 0 CA--C 1.528 0.134 0 CA-C-O 120.91 0.386 . . . . 0.0 111.827 . . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.455 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 66.4 m -116.0 160.23 36.21 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.697 -179.967 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 40.0 Cg_endo -67.17 172.64 9.69 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.419 2.079 . . . . 0.0 111.928 179.464 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.4 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -49.39 110.62 1.62 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.874 -179.778 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.525 ' HB3' HD11 ' A' ' 31' ' ' ILE . 13.8 Cg_endo -57.32 159.31 16.15 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.209 1.939 . . . . 0.0 112.061 -179.761 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.434 ' O ' HD11 ' A' ' 20' ' ' LEU . 6.2 ttt180 -63.66 174.79 1.25 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.807 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -136.87 -175.69 4.11 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.304 0.573 . . . . 0.0 111.62 -179.534 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.79 HD12 ' O ' ' A' ' 64' ' ' PRO . 10.4 tt -131.68 152.45 37.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.363 179.801 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -77.92 -66.75 0.8 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.391 -178.567 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -93.37 36.72 1.06 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.746 -179.932 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.498 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -149.89 176.88 28.36 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.813 -179.824 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -138.04 134.55 34.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.785 0.326 . . . . 0.0 110.419 179.64 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 1.024 HD21 ' CZ ' ' A' ' 33' ' ' TYR . 11.5 mt -83.71 156.22 22.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.062 0.458 . . . . 0.0 111.486 -179.508 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.83 73.72 0.91 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.679 177.569 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.883 ' HA ' HG23 ' A' ' 31' ' ' ILE . 2.5 mt -70.34 92.76 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.972 -177.395 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.26 10.9 67.1 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.522 -0.846 . . . . 0.0 111.904 176.712 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 150.69 145.65 4.17 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 -179.347 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.544 HG23 ' HD3' ' A' ' 8' ' ' ARG . 35.1 m -119.29 6.15 6.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.489 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.4 ' HA ' ' HB3' ' A' ' 8' ' ' ARG . 2.7 p-10 -69.6 155.58 40.27 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.974 0.416 . . . . 0.0 111.31 -179.417 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.472 ' CZ ' ' HB3' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -49.74 102.47 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.932 179.823 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.27 5.82 24.46 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.516 -179.09 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.96 -178.82 7.05 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.934 0.367 . . . . 0.0 110.448 179.366 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 88.1 p -151.77 147.64 26.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.253 0.549 . . . . 0.0 111.547 -179.551 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.883 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -118.4 150.16 20.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.058 179.466 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.429 ' HA ' ' HG3' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -113.31 119.0 36.18 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.76 0.314 . . . . 0.0 111.182 -179.756 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 1.024 ' CZ ' HD21 ' A' ' 20' ' ' LEU . 3.8 m-85 -85.57 138.56 32.1 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.048 0.452 . . . . 0.0 111.025 179.826 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.43 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.5 OUTLIER -149.58 169.22 21.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.017 -178.933 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.447 ' HA ' ' HA2' ' A' ' 18' ' ' GLY . 92.8 m -90.57 166.71 13.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.505 -179.055 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.71 -75.61 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.893 179.96 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -161.55 139.81 9.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.737 179.784 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.494 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 53.76 26.6 33.25 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.118 -179.327 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.497 ' CE2' ' CB ' ' A' ' 68' ' ' SER . 2.2 m-85 -113.6 -179.81 3.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.07 0.462 . . . . 0.0 111.184 -179.492 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.63 ' HB3' HG23 ' A' ' 69' ' ' VAL . 0.3 OUTLIER -137.12 134.54 36.52 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.208 176.385 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.918 HD21 ' HG2' ' A' ' 64' ' ' PRO . 2.6 tt -88.69 135.13 33.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.542 -175.603 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.676 ' N ' HD13 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -110.57 123.62 66.64 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 CA-C-O 121.424 0.631 . . . . 0.0 111.329 -179.752 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.99 -145.99 16.01 Favored Glycine 0 C--N 1.316 -0.558 0 CA-C-N 114.553 -1.203 . . . . 0.0 112.621 179.527 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.449 ' O ' ' HG2' ' A' ' 64' ' ' PRO . 3.5 mm-40 -61.96 -137.71 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.4 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.8 p 167.56 39.43 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 122.925 0.49 . . . . 0.0 110.806 179.272 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.489 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . 0.7 OUTLIER -168.49 170.18 9.91 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.537 0.685 . . . . 0.0 112.461 -178.013 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.566 ' HA ' ' O ' ' A' ' 61' ' ' PRO . 20.7 m -148.78 139.71 22.95 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.767 178.591 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.546 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -132.42 129.54 39.44 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 117.752 -1.579 . . . . 0.0 113.836 -176.78 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.416 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 30.2 t -74.88 96.68 3.16 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.154 -1.385 . . . . 0.0 110.763 179.171 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.51 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 2.2 tt0 -130.35 173.26 10.98 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.661 -179.967 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.51 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.669 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.435 -178.648 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.521 -0.135 0 CA-C-O 120.844 0.354 . . . . 0.0 110.142 . . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.6 m -142.81 -175.78 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.872 -178.51 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.61 ' CZ3' HD11 ' A' ' 31' ' ' ILE . 73.2 m95 -128.81 125.79 38.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.973 0.416 . . . . 0.0 111.707 -179.69 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.546 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 1.7 m-20 -67.82 171.76 4.98 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 174.729 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.566 ' O ' ' HA ' ' A' ' 47' ' ' SER . 0.3 OUTLIER 4.16 118.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.256 1 C-N-CA 125.467 4.111 . . . . 0.0 115.527 -176.024 . . . . . . . . 4 4 . 1 . 049 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.609 ' O ' ' CZ ' ' A' ' 33' ' ' TYR . 6.1 mm-40 -84.95 -77.6 0.27 Allowed 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 114.536 -1.211 . . . . 0.0 112.05 -174.105 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.629 ' CB ' ' HA ' ' A' ' 64' ' ' PRO . . . -65.54 -139.13 0.0 OUTLIER Pre-proline 0 CA--C 1.499 -1.016 0 CA-C-O 116.477 -1.725 . . . . 0.0 109.48 -177.991 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.918 ' HG2' HD21 ' A' ' 41' ' ' LEU . 4.3 Cg_exo -88.76 -158.7 1.19 Allowed 'Cis proline' 0 N--CA 1.483 0.91 0 CA-C-N 124.213 2.54 . . . . 0.0 114.856 15.441 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.3 pt -97.4 -176.47 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.366 -178.024 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.495 ' SG ' HD12 ' A' ' 41' ' ' LEU . 1.5 m -157.79 116.7 3.2 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.745 -179.052 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -105.46 172.82 6.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.588 178.433 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.497 ' CB ' ' CE2' ' A' ' 39' ' ' TYR . 2.0 p -97.09 113.07 24.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.058 179.896 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.63 HG23 ' HB3' ' A' ' 40' ' ' HIS . 0.6 OUTLIER -49.42 99.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.063 179.523 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.763 ' HE2' HG23 ' A' ' 90' ' ' THR . 0.3 OUTLIER -79.37 124.07 28.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.511 -179.356 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.28 117.58 34.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.924 178.039 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.8 -156.89 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.849 -179.15 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.418 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 1.8 t -47.75 136.56 10.35 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.119 -179.794 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.421 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 30.6 Cg_exo -58.41 161.72 13.71 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.223 1.948 . . . . 0.0 111.461 179.487 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.474 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 93.3 Cg_exo -40.16 156.3 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.57 2.18 . . . . 0.0 112.631 -178.978 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.4 t -106.13 88.62 2.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.855 179.971 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.588 HG21 ' O ' ' A' ' 122' ' ' PRO . 21.4 pt -69.83 174.7 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.121 -179.804 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.4 m -99.22 142.72 30.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.753 179.405 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.504 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 8.9 m-80 60.3 28.51 18.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.193 179.687 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -166.44 -167.45 27.13 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.908 179.848 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.412 ' CD ' ' OD1' ' A' ' 100' ' ' ASN . 9.4 ptt85 -163.92 -175.81 4.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.897 0.379 . . . . 0.0 110.708 -179.534 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 15.7 p80 -114.07 167.17 10.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.984 -179.883 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 . . . . . 0 CA--C 1.534 0.349 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.614 179.785 . . . . . . . . 0 0 . 1 . 049 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.415 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 9.1 m-85 . . . . . 0 N--CA 1.451 -0.378 0 CA-C-O 120.854 0.359 . . . . 0.0 110.872 . . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.415 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 60.6 m-85 -149.26 159.92 43.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.479 179.516 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.763 HG23 ' HE2' ' A' ' 70' ' ' LYS . 9.5 p -122.55 -177.48 3.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.002 0.43 . . . . 0.0 111.64 -178.537 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.433 ' CB ' ' HA3' ' A' ' 38' ' ' GLY . 4.3 p-10 -68.58 96.49 0.71 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.867 179.948 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.67 18.3 2.21 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.286 -0.87 . . . . 0.0 113.182 178.882 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.35 162.06 13.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.871 0.336 . . . . 0.0 110.542 179.121 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 35.3 m -138.08 153.52 27.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.144 0.497 . . . . 0.0 111.198 -179.736 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.466 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 21.3 t -147.93 149.4 15.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.924 179.705 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.855 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -108.41 128.37 54.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.855 179.751 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.971 ' CE2' HG21 ' A' ' 111' ' ' VAL . 5.9 m-85 -88.96 157.58 18.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.201 -179.294 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.434 ' HA ' HD13 ' A' ' 105' ' ' LEU . 22.8 m -154.57 142.11 19.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.458 -179.661 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.43 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 69.0 m -73.51 159.39 33.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.797 179.217 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.421 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 69.8 m-20 -93.04 -70.75 0.69 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.32 -179.404 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.9 t -61.05 -23.48 65.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.224 -179.358 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.56 32.86 1.07 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.452 -179.821 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.504 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 16.0 m-85 -69.92 -175.41 0.91 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.057 0.456 . . . . 0.0 110.934 -179.903 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.75 100.47 9.47 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.206 178.47 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.589 HD22 ' HB2' ' A' ' 109' ' ' SER . 0.2 OUTLIER -44.76 126.21 5.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.442 0.639 . . . . 0.0 111.957 -177.927 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.453 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 35.4 mm -87.72 153.86 3.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.749 178.43 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.03 -129.2 40.89 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.314 -0.946 . . . . 0.0 112.06 -179.04 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -122.62 142.47 50.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.865 0.364 . . . . 0.0 110.874 179.417 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.855 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.6 t -70.19 -29.87 66.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.893 179.985 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -72.57 135.34 21.92 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.818 -179.665 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.971 HG21 ' CE2' ' A' ' 97' ' ' TYR . 2.4 t -131.6 118.51 39.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.703 0.287 . . . . 0.0 110.812 179.44 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.92 122.92 28.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.521 -179.017 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.532 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 16.3 t -89.56 102.09 14.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.569 176.982 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.2 OUTLIER -141.12 157.99 44.53 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.04 -178.608 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.418 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 47.05 33.87 7.28 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.703 -179.965 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.451 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 66.02 10.29 50.86 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.522 -179.115 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -129.8 168.96 15.77 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.894 0.378 . . . . 0.0 110.578 179.407 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.532 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 94.9 m95 -109.98 134.5 52.05 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.929 -179.82 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.7 153.66 32.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.931 179.89 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.55 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 61.2 t0 66.04 37.17 0.2 Allowed Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 179.326 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.55 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 65.1 Cg_endo -75.78 134.89 17.05 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.12 1.88 . . . . 0.0 111.587 179.229 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.588 ' O ' HG21 ' A' ' 77' ' ' ILE . 87.0 Cg_endo -92.11 -172.3 0.4 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.812 2.341 . . . . 0.0 113.889 -177.33 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.446 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -133.11 -158.59 0.9 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.722 178.042 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 8.1 m -153.85 90.49 1.38 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.13 0.491 . . . . 0.0 111.012 179.129 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.429 ' HB2' HD11 ' A' ' 106' ' ' ILE . 10.4 mt-30 -122.33 157.31 32.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.778 179.966 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.576 ' O ' HG22 ' A' ' 126' ' ' ILE . 19.0 mm . . . . . 0 C--N 1.323 -0.564 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.941 -179.87 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.696 ' HD3' HG23 ' A' ' 25' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.162 0 CA-C-O 120.896 0.379 . . . . 0.0 112.01 . . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.475 ' O ' ' O ' ' A' ' 10' ' ' PRO . 1.3 m -100.35 171.35 5.62 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.347 -179.504 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 9' ' ' CYS . 75.5 Cg_exo -51.44 -147.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.262 2.641 . . . . 0.0 113.037 179.298 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.516 ' HG ' ' C ' ' A' ' 12' ' ' PRO . 40.7 t -37.26 -85.25 0.0 OUTLIER Pre-proline 0 CA--C 1.499 -1.011 0 CA-C-O 117.117 -1.42 . . . . 0.0 113.882 -177.216 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.602 ' HG3' HD13 ' A' ' 31' ' ' ILE . 63.7 Cg_endo -77.38 157.58 96.13 Favored 'Cis proline' 0 N--CA 1.481 0.764 0 CA-C-N 123.757 2.378 . . . . 0.0 115.083 -0.969 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.76 ' O ' HD11 ' A' ' 20' ' ' LEU . 17.1 tpp180 -50.64 156.7 0.87 Allowed 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.779 178.883 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.437 ' N ' ' HG3' ' A' ' 13' ' ' ARG . 0.3 OUTLIER -109.57 -175.73 2.83 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.99 -179.779 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.501 HG23 ' C ' ' A' ' 18' ' ' GLY . 6.8 tt -128.01 147.74 32.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.723 179.759 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -83.94 -42.31 16.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.343 -178.521 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 17' ' ' ASN . . . . . 0.434 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 1.2 m-20 -103.07 39.32 1.58 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.849 -179.233 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.501 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -175.5 -172.69 40.59 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.781 179.864 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.428 ' N ' ' O ' ' A' ' 34' ' ' SER . 0.4 OUTLIER -139.17 140.24 37.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.756 0.312 . . . . 0.0 110.407 179.732 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.906 HD21 ' CE1' ' A' ' 33' ' ' TYR . 11.3 mt -85.35 150.91 24.42 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.16 0.505 . . . . 0.0 112.12 -179.091 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.455 ' CB ' ' HB ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -120.51 72.32 0.95 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.23 175.275 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.94 ' HA ' HG23 ' A' ' 31' ' ' ILE . 1.7 mt -69.13 97.84 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.636 -176.974 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -88.94 7.45 82.11 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.282 178.002 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 159.07 136.95 2.14 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.528 179.972 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.696 HG23 ' HD3' ' A' ' 8' ' ' ARG . 15.1 m -113.73 25.23 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.785 0.326 . . . . 0.0 111.189 -179.817 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.407 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.5 OUTLIER -100.88 142.69 31.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.036 179.973 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.535 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 9.4 t80 -47.51 93.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.18 0.514 . . . . 0.0 110.715 179.302 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 134.32 -4.84 4.53 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.556 -178.959 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.91 -162.23 0.91 Allowed 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.975 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -168.41 150.56 5.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.089 0.471 . . . . 0.0 111.046 179.58 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.94 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -104.49 160.16 5.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.908 179.243 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.455 ' HB ' ' CB ' ' A' ' 21' ' ' ASP . 1.7 m -125.3 114.91 19.54 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.803 0.335 . . . . 0.0 110.447 179.307 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.906 ' CE1' HD21 ' A' ' 20' ' ' LEU . 11.2 m-85 -91.53 149.68 21.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.184 0.516 . . . . 0.0 111.962 -178.048 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.428 ' O ' ' N ' ' A' ' 19' ' ' GLN . 0.6 OUTLIER -153.99 145.89 23.51 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.699 179.498 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 10.8 m -70.47 167.45 18.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.714 0.292 . . . . 0.0 110.629 179.816 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -68.97 -84.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.003 -179.44 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.2 m -153.3 134.31 14.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.695 179.716 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.74 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 66.76 26.02 73.03 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.852 -178.93 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.5 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.1 m-85 -118.99 170.25 9.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.868 0.366 . . . . 0.0 111.104 -179.382 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.882 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -134.13 113.52 12.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.376 178.169 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.967 HD21 ' O ' ' A' ' 44' ' ' GLU . 4.8 tt -79.64 122.59 26.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.794 -179.438 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.882 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.3 mm -95.64 157.08 3.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.015 0.436 . . . . 0.0 111.284 -179.179 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.54 -135.23 19.11 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.159 -179.379 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.967 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -85.95 -174.09 4.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.784 0.326 . . . . 0.0 110.822 179.469 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.422 ' HA ' ' HG3' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -160.53 27.27 0.16 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.403 179.616 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 6.5 mtpt -151.32 129.95 12.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.332 -179.467 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.451 ' HB2' ' HA ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -101.28 159.29 15.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.168 179.316 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.488 ' CB ' ' HB2' ' A' ' 60' ' ' ASN . 1.1 m-85 -132.16 121.54 23.89 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.58 -0.848 . . . . 0.0 112.222 -179.642 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 8.4 t -75.23 83.84 2.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.886 178.747 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -103.6 -177.86 3.49 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.622 -178.468 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.535 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.014 -179.262 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.427 ' HB2' ' HA ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.319 0 CA-C-O 121.001 0.429 . . . . 0.0 109.879 . . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.431 HG22 ' C ' ' A' ' 51' ' ' LEU . 1.5 m -127.21 163.48 30.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.869 -178.773 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.497 ' CE2' ' HB3' ' A' ' 12' ' ' PRO . 63.5 m95 -116.01 118.06 31.86 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.647 -178.666 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.488 ' HB2' ' CB ' ' A' ' 48' ' ' TYR . 1.2 m-80 -72.26 165.46 50.53 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.27 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.466 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 87.3 Cg_exo -15.91 98.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.644 1 C-N-CA 125.681 4.254 . . . . 0.0 115.014 -178.39 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.505 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 4.2 mt-10 -99.35 -68.44 0.8 Allowed 'General case' 0 C--O 1.221 -0.426 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -176.487 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.425 ' HA ' ' HD2' ' A' ' 64' ' ' PRO . . . -102.14 77.68 0.22 Allowed Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -174.053 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.57 ' HG2' HD11 ' A' ' 41' ' ' LEU . 36.5 Cg_endo -55.87 -154.37 0.01 OUTLIER 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 123.327 2.684 . . . . 0.0 111.575 175.352 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.489 HG22 ' H ' ' A' ' 66' ' ' CYS . 4.2 mm -93.56 165.32 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.051 0.453 . . . . 0.0 111.42 179.654 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.489 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -165.03 135.25 3.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.662 179.277 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.3 OUTLIER -153.86 176.18 12.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.014 -179.786 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.5 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 26.4 p -85.17 123.48 30.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.16 179.894 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.74 HG12 ' O ' ' A' ' 38' ' ' GLY . 1.3 p -55.82 96.54 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.246 179.973 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.15 124.0 27.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.522 -179.522 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.441 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -104.57 125.94 51.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.957 178.234 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -75.75 -151.38 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.165 -179.962 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.446 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 2.8 t -55.3 138.67 66.96 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-O 120.636 0.255 . . . . 0.0 110.883 -179.568 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.487 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 29.2 Cg_exo -59.51 161.36 17.62 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.373 2.049 . . . . 0.0 112.078 179.969 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.525 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 87.0 Cg_exo -43.07 158.36 0.08 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.725 2.283 . . . . 0.0 112.798 -179.142 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 85.9 p -112.27 89.56 3.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.235 178.548 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.718 HG23 ' HE2' ' A' ' 97' ' ' TYR . 22.3 pt -69.24 167.82 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.206 -178.742 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 p -86.48 134.21 33.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.86 179.811 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.494 ' HB3' ' CE1' ' A' ' 103' ' ' TYR . 0.1 OUTLIER 67.77 28.37 7.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.486 -179.977 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -167.2 -166.04 25.61 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.141 179.661 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 98' ' ' SER . 0.4 OUTLIER -170.19 -174.11 1.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.091 0.472 . . . . 0.0 110.858 -178.829 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 15.3 p80 -104.89 172.37 6.82 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.945 179.537 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 30.1 m-20 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.711 -179.979 . . . . . . . . 0 0 . 1 . 050 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.428 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 5.6 m-85 . . . . . 0 N--CA 1.454 -0.241 0 CA-C-O 121.078 0.466 . . . . 0.0 111.499 . . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.441 ' N ' ' O ' ' A' ' 71' ' ' CYS . 46.5 m-85 -149.08 166.08 29.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.41 -179.551 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.8 p -126.08 -178.62 4.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.967 0.413 . . . . 0.0 111.483 -179.444 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 9.0 p-10 -67.12 96.29 0.45 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.926 -179.867 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.18 23.93 1.52 Allowed Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.236 -0.893 . . . . 0.0 113.061 179.112 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.68 159.22 16.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.645 0.26 . . . . 0.0 110.425 179.254 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.474 HG22 ' N ' ' A' ' 95' ' ' VAL . 33.0 m -132.69 156.27 42.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.29 0.567 . . . . 0.0 111.501 -179.644 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.518 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 22.8 t -151.11 149.38 14.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.341 179.078 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.721 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -103.7 139.47 38.91 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.029 0.442 . . . . 0.0 110.562 179.242 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.98 ' CE1' HG21 ' A' ' 111' ' ' VAL . 3.2 m-85 -95.94 158.57 15.39 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.814 -179.434 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 81' ' ' ARG . 1.2 p -147.78 133.05 18.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.659 -178.681 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 99' ' ' CYS . . . . . 0.466 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 81.9 m -70.19 160.41 32.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.46 178.401 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.58 -85.33 0.36 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.776 0.322 . . . . 0.0 110.987 179.572 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -43.7 -28.82 0.44 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.642 -179.498 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 126.61 36.24 0.53 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.719 179.662 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.499 ' CE2' HG12 ' A' ' 126' ' ' ILE . 47.8 m-85 -77.52 -173.91 3.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.884 0.373 . . . . 0.0 110.923 179.958 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -113.06 107.26 15.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.799 179.917 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.546 HD22 ' HA ' ' A' ' 109' ' ' SER . 1.1 mp -45.21 117.08 1.26 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.296 179.842 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.46 HG22 ' N ' ' A' ' 107' ' ' GLY . 47.1 mm -106.25 155.54 7.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.935 -179.512 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 107' ' ' GLY . . . . . 0.46 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 60.34 37.61 93.38 Favored Glycine 0 CA--C 1.508 -0.396 0 C-N-CA 120.321 -0.942 . . . . 0.0 112.243 179.835 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 51.36 120.3 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.45 -0.875 . . . . 0.0 112.507 179.777 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.721 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.3 p -54.4 -27.64 38.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.307 179.83 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.22 137.16 49.27 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.697 -179.465 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.98 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.9 t -134.87 137.15 51.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.454 0.169 . . . . 0.0 110.621 179.983 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.76 125.78 42.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.878 0.371 . . . . 0.0 111.478 -179.455 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.528 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 34.6 t -90.66 100.67 13.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.662 176.883 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.3 OUTLIER -142.27 159.55 42.0 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.129 -178.495 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.433 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 47.18 32.06 6.52 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.655 -179.912 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.46 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 70.52 6.16 57.7 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.916 -179.759 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -129.8 -178.46 4.72 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.861 0.362 . . . . 0.0 110.498 179.261 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.528 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 92.0 m95 -117.36 122.72 44.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.932 -179.52 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.07 152.65 21.83 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.28 -179.049 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.513 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.5 OUTLIER 67.0 43.27 0.3 Allowed Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.205 179.27 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 56.4 Cg_endo -69.75 141.42 45.22 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.158 1.905 . . . . 0.0 111.261 178.117 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.51 ' HB2' HD23 ' A' ' 105' ' ' LEU . 87.4 Cg_endo -92.25 -169.8 0.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.554 2.169 . . . . 0.0 113.636 -177.594 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.28 -168.03 2.37 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.151 178.853 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 124' ' ' CYS . . . . . 0.424 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 6.7 m -145.84 94.81 2.54 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.006 0.431 . . . . 0.0 110.962 179.95 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -118.93 157.9 26.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.85 -179.772 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.499 HG12 ' CE2' ' A' ' 103' ' ' TYR . 22.9 mm . . . . . 0 C--N 1.324 -0.533 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.229 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.732 0.301 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.433 ' HB3' HG23 ' A' ' 25' ' ' VAL . 0.2 OUTLIER 54.98 166.7 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 121.166 0.508 . . . . 0.0 111.809 178.863 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.47 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 25.7 m -103.6 163.32 17.65 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.647 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 38.1 Cg_endo -67.53 171.8 11.32 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.253 1.969 . . . . 0.0 112.052 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.77 104.38 0.42 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.226 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.557 ' HB3' HD11 ' A' ' 31' ' ' ILE . 2.5 Cg_endo -49.95 156.92 3.05 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.201 1.934 . . . . 0.0 112.058 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.753 ' O ' HD11 ' A' ' 20' ' ' LEU . 6.5 mtt180 -76.23 164.39 26.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.305 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.44 -172.62 2.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.198 0.523 . . . . 0.0 111.633 -178.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.661 HD12 ' HD2' ' A' ' 64' ' ' PRO . 17.1 tt -145.47 143.26 22.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.891 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.4 ' O ' ' N ' ' A' ' 18' ' ' GLY . 2.8 p30 -76.65 160.97 28.92 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.032 0.444 . . . . 0.0 110.352 177.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.466 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 2.0 m120 39.01 29.8 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.224 -178.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 16' ' ' ASP . . . -151.42 170.54 31.01 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.638 -178.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.36 137.59 39.03 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.769 0.319 . . . . 0.0 110.674 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.953 HD21 ' CE2' ' A' ' 33' ' ' TYR . 13.1 mt -82.86 159.68 22.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.041 0.448 . . . . 0.0 111.429 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -126.37 71.32 1.27 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.596 177.657 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.918 ' HA ' HG23 ' A' ' 31' ' ' ILE . 1.2 mt -69.81 93.44 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.855 -177.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.6 17.85 57.69 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.712 176.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.27 133.78 1.77 Allowed Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.055 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.433 HG23 ' HB3' ' A' ' 8' ' ' ARG . 17.1 m -119.73 25.9 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.86 0.362 . . . . 0.0 111.055 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 1.4 p-10 -87.11 152.43 22.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.235 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.464 ' CZ ' ' HB3' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -49.98 97.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.746 179.469 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 115.76 6.21 17.23 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.725 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.03 -167.13 1.54 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.833 0.316 . . . . 0.0 110.552 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 47' ' ' SER . 5.5 p -160.28 138.79 10.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.004 0.431 . . . . 0.0 111.675 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.918 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.7 OUTLIER -103.09 150.23 6.81 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.302 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.966 178.649 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.427 ' O ' ' N ' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -109.38 115.18 29.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.84 0.352 . . . . 0.0 111.144 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.953 ' CE2' HD21 ' A' ' 20' ' ' LEU . 13.7 m-85 -88.23 144.24 26.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.627 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -153.55 160.41 42.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.753 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.436 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 9.1 m -82.21 169.36 16.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.092 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -68.25 -84.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.117 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.37 133.25 12.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.821 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.48 ' O ' HG22 ' A' ' 69' ' ' VAL . . . 67.28 22.21 72.66 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.151 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.518 ' CD2' ' HA ' ' A' ' 68' ' ' SER . 2.4 m-85 -113.94 179.0 4.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.754 0.311 . . . . 0.0 110.785 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.922 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -140.98 112.34 7.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.053 0.454 . . . . 0.0 110.678 178.72 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.933 HD11 ' HG2' ' A' ' 64' ' ' PRO . 5.1 tt -79.7 126.28 30.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.656 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.922 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.1 mm -104.09 163.97 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.992 0.425 . . . . 0.0 111.08 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.434 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 73.15 -133.98 19.15 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.362 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.795 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.9 OUTLIER -84.93 -176.19 6.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.957 0.408 . . . . 0.0 110.956 179.657 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.2 p -157.38 18.78 0.28 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.698 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 0.5 OUTLIER -145.85 131.31 18.7 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -178.375 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.438 ' OG ' ' CB ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -96.28 147.09 24.14 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.698 176.788 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.499 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 2.2 m-85 -124.85 120.25 31.17 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 119.151 -1.02 . . . . 0.0 112.05 178.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 20.2 t -71.44 107.47 4.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.521 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.38 -174.51 3.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.116 0.484 . . . . 0.0 111.333 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.542 HD13 ' H ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -95.07 149.59 21.1 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.091 -178.806 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.35 -143.37 0.46 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.563 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.1 t -94.14 -33.83 13.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.815 0.341 . . . . 0.0 110.913 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 81.4 p -103.49 25.45 9.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.778 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.04 21.3 65.77 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.274 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.6 -175.93 6.0 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.017 0.437 . . . . 0.0 111.243 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.416 ' HB2' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -103.83 131.9 50.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.267 179.661 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.4 m -151.99 174.69 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.08 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.537 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 65.0 m95 -129.09 125.75 37.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.3 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.499 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -68.91 165.19 39.95 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.928 178.442 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.44 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 98.5 Cg_exo -17.21 96.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.804 1 C-N-CA 125.408 4.072 . . . . 0.0 114.695 -178.454 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.473 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -93.94 -77.32 0.46 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.212 -178.228 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.468 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -85.16 108.89 17.33 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -175.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.933 ' HG2' HD11 ' A' ' 41' ' ' LEU . 1.4 Cg_endo -86.01 -154.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.296 2.664 . . . . 0.0 110.989 176.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.478 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 4.3 mm -86.05 164.15 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.852 0.358 . . . . 0.0 110.766 178.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.458 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.8 OUTLIER -168.41 129.81 1.33 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.773 179.446 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.58 168.49 26.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.023 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.518 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 53.3 p -83.69 122.76 29.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.17 0.509 . . . . 0.0 110.537 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 69' ' ' VAL . 22.5 m -45.79 100.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.052 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -94.12 99.03 11.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.321 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.425 ' N ' ' O ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -92.91 116.25 28.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.071 0.462 . . . . 0.0 110.326 179.775 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.22 -163.83 0.07 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.678 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.437 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -41.64 131.84 2.31 Favored Pre-proline 0 N--CA 1.436 -1.139 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.58 179.369 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.49 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 50.0 Cg_exo -54.69 165.71 2.36 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.423 2.082 . . . . 0.0 112.365 -178.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.512 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 80.9 Cg_exo -39.71 161.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.926 2.418 . . . . 0.0 113.021 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.2 t -109.3 88.75 2.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.443 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.683 HG23 ' HE2' ' A' ' 97' ' ' TYR . 19.3 pt -69.32 173.27 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.271 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.6 m -92.96 141.81 27.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.732 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.515 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 7.5 m-80 57.22 30.85 19.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.814 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.447 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . -170.52 -166.06 28.84 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.979 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.404 ' N ' ' O ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -169.63 -175.43 2.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.979 0.418 . . . . 0.0 110.781 -179.378 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 11.3 p80 -105.81 171.85 7.12 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.969 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -104.53 -87.84 0.44 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.758 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.513 ' N ' HG13 ' A' ' 95' ' ' VAL . . . 59.57 153.5 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.814 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.472 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -111.03 -33.56 6.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.052 0.453 . . . . 0.0 110.5 179.628 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.43 -172.07 2.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.91 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -106.47 -23.03 12.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.174 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -129.65 170.87 13.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.111 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.425 ' O ' ' N ' ' A' ' 71' ' ' CYS . 69.3 m-85 -152.34 164.27 37.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.936 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.469 HG22 ' O ' ' A' ' 69' ' ' VAL . 7.2 p -145.76 -175.81 4.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.061 0.458 . . . . 0.0 111.709 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 6.8 p-10 -50.51 94.36 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.63 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.49 24.64 1.91 Allowed Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.49 176.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.41 152.76 24.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 117.165 0.482 . . . . 0.0 111.132 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.433 HG22 ' N ' ' A' ' 95' ' ' VAL . 33.2 m -133.47 154.94 39.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.068 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.547 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 13.6 t -148.94 146.54 17.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.094 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.967 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -100.29 136.76 39.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.625 179.343 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.963 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.4 m-85 -97.32 159.1 15.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.039 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 81' ' ' ARG . 17.9 p -157.26 143.05 17.58 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.378 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.447 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 56.9 m -72.55 167.83 19.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.772 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -98.3 -85.89 0.36 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.894 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.4 t -47.26 -29.9 2.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.339 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.06 45.35 0.2 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.508 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.515 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 32.9 m-85 -82.83 -172.66 4.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.72 0.295 . . . . 0.0 110.684 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 m -108.4 105.46 15.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.937 0.399 . . . . 0.0 111.307 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.626 HD23 ' HB2' ' A' ' 122' ' ' PRO . 3.1 tp -46.22 113.22 0.59 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.996 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.511 HD11 ' HB2' ' A' ' 125' ' ' GLN . 33.0 mm -85.97 156.25 3.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.464 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.438 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 57.0 -130.43 50.95 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.364 -0.922 . . . . 0.0 111.478 -178.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 41.1 p-10 -116.09 136.28 53.17 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.087 0.47 . . . . 0.0 111.208 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.967 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.2 p -66.78 -26.25 66.87 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.476 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.18 142.67 31.97 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.712 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.963 HG21 ' CE1' ' A' ' 97' ' ' TYR . 3.3 t -138.66 120.88 17.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.609 0.242 . . . . 0.0 110.909 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.936 HD22 ' N ' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -79.14 135.93 36.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.931 0.396 . . . . 0.0 111.408 -179.417 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.936 ' N ' HD22 ' A' ' 112' ' ' LEU . 35.0 t -107.93 107.93 18.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.866 176.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.613 ' OG ' HD21 ' A' ' 112' ' ' LEU . 12.0 m -161.74 123.9 2.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.883 0.373 . . . . 0.0 111.729 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.501 ' H ' HG21 ' A' ' 69' ' ' VAL . . . 91.35 27.33 18.35 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.493 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.499 ' N ' ' HB ' ' A' ' 69' ' ' VAL . . . 71.46 18.02 76.69 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.173 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -147.89 179.28 7.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.222 0.534 . . . . 0.0 111.421 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.547 ' CZ3' HG23 ' A' ' 95' ' ' VAL . 93.2 m95 -121.06 144.77 48.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.483 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.435 ' OG ' HD12 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -127.25 149.49 49.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.029 0.442 . . . . 0.0 111.465 -179.279 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.489 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.5 OUTLIER 70.67 46.65 0.27 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.956 179.011 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 93.7 Cg_endo -77.6 138.53 17.29 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.509 2.139 . . . . 0.0 111.795 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.626 ' HB2' HD23 ' A' ' 105' ' ' LEU . 57.2 Cg_endo -89.82 -173.96 0.79 Allowed 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.634 2.223 . . . . 0.0 113.328 -179.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.467 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -135.01 -173.51 3.34 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.019 178.036 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 124' ' ' CYS . . . . . 0.42 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 17.2 m -144.38 94.74 2.61 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.968 0.413 . . . . 0.0 111.147 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.511 ' HB2' HD11 ' A' ' 106' ' ' ILE . 20.3 mt-30 -117.14 163.23 16.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.777 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.618 ' O ' HG22 ' A' ' 126' ' ' ILE . 35.5 mm . . . . . 0 C--N 1.324 -0.527 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.514 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.41 ' HA ' ' CZ ' ' A' ' 7' ' ' ARG . 1.6 mmp_? . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.898 0.38 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.452 ' CB ' ' HA ' ' A' ' 26' ' ' ASP . 0.1 OUTLIER -88.17 171.47 10.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.164 -179.733 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.544 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 99.2 m -80.83 175.87 4.39 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.768 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.563 ' HD2' ' CD1' ' A' ' 59' ' ' TRP . 34.0 Cg_endo -89.56 179.46 2.19 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 122.734 2.289 . . . . 0.0 112.0 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.9 t -48.59 104.3 0.41 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.723 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.488 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 31.2 Cg_exo -43.09 167.37 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.176 1.917 . . . . 0.0 112.542 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.54 -175.62 1.36 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.743 177.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.661 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 1.6 t0 -139.05 -178.43 5.33 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.329 0.585 . . . . 0.0 111.7 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.558 HG22 ' CD2' ' A' ' 20' ' ' LEU . 13.4 tt -147.11 144.23 19.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.496 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -76.21 -64.02 1.19 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.723 -178.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -90.52 45.47 1.26 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.952 0.406 . . . . 0.0 111.026 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.427 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -164.64 170.63 39.83 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.032 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -131.24 131.13 43.7 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.829 HD21 ' CE2' ' A' ' 33' ' ' TYR . 25.7 mt -82.02 160.34 23.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.16 0.505 . . . . 0.0 111.685 -178.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -130.5 79.72 1.91 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.1 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.899 ' HA ' HG23 ' A' ' 31' ' ' ILE . 52.9 mt -69.72 118.01 13.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.661 -178.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.71 16.99 6.9 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.828 177.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 29' ' ' SER . . . 161.48 120.87 0.55 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.149 -0.548 . . . . 0.0 111.985 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.4 m -109.83 -6.98 11.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.452 ' HA ' ' CB ' ' A' ' 8' ' ' ARG . 1.6 m-20 -70.19 157.77 37.03 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.751 0.31 . . . . 0.0 110.9 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.556 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 7.2 t80 -50.47 116.04 1.73 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.866 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.14 0.87 48.02 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.83 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' A' ' 24' ' ' GLY . 12.9 m -84.48 166.5 17.22 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-N 116.994 0.397 . . . . 0.0 110.496 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.2 p -139.19 146.95 41.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.952 0.406 . . . . 0.0 111.061 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.899 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -108.09 171.2 2.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.599 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.473 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -129.82 116.3 18.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.048 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.829 ' CE2' HD21 ' A' ' 20' ' ' LEU . 11.9 m-85 -94.66 145.49 24.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.489 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.427 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 91.3 p -147.82 161.54 41.05 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.479 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.445 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 1.2 m -82.26 170.91 14.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.941 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.7 -81.51 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.285 -178.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.1 m -163.6 117.47 1.55 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.899 0.381 . . . . 0.0 110.699 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.427 ' HA3' ' HB2' ' A' ' 91' ' ' ASP . . . 86.04 -10.21 66.63 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.189 -177.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.506 ' CZ ' ' HB3' ' A' ' 68' ' ' SER . 2.6 m-85 -78.5 -173.63 3.44 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.758 0.313 . . . . 0.0 110.706 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.792 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -143.01 110.43 5.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.012 0.434 . . . . 0.0 110.075 177.409 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.969 HD21 ' O ' ' A' ' 44' ' ' GLU . 2.6 tt -74.76 121.87 22.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.682 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.792 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.1 mm -104.29 147.56 10.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.013 0.435 . . . . 0.0 110.674 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.29 -133.95 12.13 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.52 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.969 ' O ' HD21 ' A' ' 41' ' ' LEU . 1.0 OUTLIER -74.85 -177.63 3.37 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.177 0.513 . . . . 0.0 112.083 -178.938 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.6 p -163.15 23.81 0.09 Allowed 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.295 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.473 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 2.5 mtmt -161.54 130.15 4.4 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -177.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.463 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 0.1 OUTLIER -98.06 136.04 38.88 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 176.741 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.497 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.9 m-85 -112.97 118.28 34.41 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 119.182 -1.007 . . . . 0.0 112.292 -178.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.407 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 33.1 t -71.15 71.34 0.58 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.066 177.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.5 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 3.0 tt0 -93.22 172.55 8.23 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.781 -178.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.556 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -82.6 148.46 28.0 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.13 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.65 -123.21 0.11 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.468 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.0 t -114.93 -33.14 5.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.856 0.36 . . . . 0.0 111.019 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.4 p -102.54 32.77 3.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.035 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.7 18.75 80.05 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.704 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.3 t -83.78 -164.99 1.0 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.873 0.368 . . . . 0.0 111.006 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.28 134.23 55.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.197 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -142.84 169.13 12.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.798 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.563 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 75.5 m95 -117.76 116.4 26.93 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.878 -178.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.497 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -69.89 167.92 21.17 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.949 177.372 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.46 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 76.8 Cg_exo -16.21 101.57 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.816 1 C-N-CA 125.421 4.08 . . . . 0.0 114.847 -178.398 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.504 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.3 OUTLIER -97.88 -69.4 0.76 Allowed 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 115.021 -0.99 . . . . 0.0 113.144 -175.996 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.661 ' HB2' ' O ' ' A' ' 14' ' ' ASP . . . -102.85 76.02 0.21 Allowed Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -174.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.493 ' HG2' HD11 ' A' ' 41' ' ' LEU . 37.0 Cg_endo -56.9 -152.4 0.0 OUTLIER 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.225 2.617 . . . . 0.0 111.13 175.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.475 HG22 ' N ' ' A' ' 66' ' ' CYS . 5.4 mm -90.74 164.07 2.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.223 0.535 . . . . 0.0 111.927 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.475 ' N ' HG22 ' A' ' 65' ' ' ILE . 0.8 OUTLIER -167.89 120.85 0.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.098 179.338 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.476 ' O ' ' CD2' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -131.86 174.96 9.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.248 -179.048 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.506 ' HB3' ' CZ ' ' A' ' 39' ' ' TYR . 1.5 p -98.23 123.24 42.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.608 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 69' ' ' VAL . 30.6 m -47.9 101.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.177 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -95.41 99.39 11.31 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.73 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 3.2 m -78.55 130.7 36.27 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 175.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.405 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -68.61 -174.94 0.61 Allowed 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.5 -179.544 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 t -68.04 109.0 3.23 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.954 -178.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.71 ' HG3' ' CE2' ' A' ' 118' ' ' TRP 0.287 0.6 OUTLIER -37.48 -178.62 0.0 OUTLIER 'Trans proline' 0 CA--C 1.469 -2.745 0 C-N-CA 123.317 2.678 . . . . 0.0 113.389 174.467 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.562 ' CB ' ' CE2' ' A' ' 97' ' ' TYR . 44.0 Cg_endo -68.47 -166.43 2.84 Favored 'Cis proline' 0 C--N 1.316 -1.171 0 N-CA-C 114.094 0.767 . . . . 0.0 114.094 -18.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 38.2 t -134.87 18.6 3.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 113.95 -1.477 . . . . 0.0 108.907 172.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.666 HD11 ' HA3' ' A' ' 80' ' ' GLY . 16.2 pt -107.75 -159.05 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.295 -177.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.443 ' N ' HG13 ' A' ' 77' ' ' ILE . 0.9 OUTLIER -132.42 134.92 45.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.664 178.36 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 70.08 28.84 3.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.77 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.666 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -145.02 -177.68 20.02 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.167 -1.016 . . . . 0.0 113.0 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.546 ' HD2' ' ND2' ' A' ' 100' ' ' ASN . 47.3 mtp180 -152.5 -167.81 2.86 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.498 0.666 . . . . 0.0 112.213 -177.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.553 ' CG ' ' HB2' ' A' ' 74' ' ' PRO . 35.5 p-80 -137.87 -178.95 5.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.887 -1.052 . . . . 0.0 111.346 -178.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.574 ' OD1' HG12 ' A' ' 95' ' ' VAL . 0.9 OUTLIER -123.61 -68.7 0.86 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.605 175.591 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 49.93 174.29 0.01 OUTLIER Glycine 0 C--N 1.332 0.317 0 CA-C-N 116.013 -0.539 . . . . 0.0 113.58 177.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.427 ' CD2' ' N ' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -119.57 -30.01 4.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.856 0.36 . . . . 0.0 110.838 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.92 -174.47 2.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.399 -178.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.1 -28.83 12.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.27 178.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.428 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 6.7 m-85 -127.55 175.92 7.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.402 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.443 ' CD2' ' HZ2' ' A' ' 118' ' ' TRP . 45.6 m-85 -144.31 178.59 7.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.358 -178.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 25.4 p -139.15 -179.03 5.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.216 0.531 . . . . 0.0 111.794 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.622 ' HB3' HG22 ' A' ' 69' ' ' VAL . 0.7 OUTLIER -57.54 95.53 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.716 -179.179 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 113.94 38.3 1.17 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.709 -0.757 . . . . 0.0 113.493 177.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.484 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -105.66 155.02 19.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.917 0.359 . . . . 0.0 110.658 178.539 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 29.9 m -134.79 146.37 30.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.002 0.429 . . . . 0.0 111.238 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.579 HG23 ' CH2' ' A' ' 118' ' ' TRP . 1.6 t -149.99 137.0 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.334 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.816 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -88.15 132.24 34.41 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 177.98 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.775 ' CZ ' HG21 ' A' ' 111' ' ' VAL . 3.1 m-30 -99.82 149.69 23.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.302 0.572 . . . . 0.0 112.533 -175.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.421 ' O ' ' N ' ' A' ' 81' ' ' ARG . 88.3 p -129.54 139.8 51.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.139 177.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.492 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 87.9 m -69.53 141.63 53.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.153 0.501 . . . . 0.0 111.992 -177.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.546 ' ND2' ' HD2' ' A' ' 81' ' ' ARG . 5.2 m120 -56.24 -85.47 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.386 -178.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.93 -16.94 62.7 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -175.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.26 29.63 0.77 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.269 -0.967 . . . . 0.0 113.131 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.469 ' CE1' HG12 ' A' ' 126' ' ' ILE . 32.1 m-85 -68.57 -171.69 0.29 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 125' ' ' GLN . 3.4 p -107.93 108.45 19.61 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.935 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.488 HD12 ' HA ' ' A' ' 105' ' ' LEU . 1.8 tp -49.03 102.99 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.191 178.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.47 ' HB ' ' CB ' ' A' ' 123' ' ' THR . 39.1 mm -81.98 155.84 4.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.814 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.462 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 54.59 -130.07 45.16 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.782 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.538 ' ND2' ' O ' ' A' ' 120' ' ' ASP . 1.5 p-10 -107.83 132.06 53.82 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.145 0.497 . . . . 0.0 112.177 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.816 ' HB2' HG22 ' A' ' 96' ' ' THR . 0.1 OUTLIER -68.64 -30.5 69.22 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 174.98 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -65.5 123.73 25.72 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.282 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.775 HG21 ' CZ ' ' A' ' 97' ' ' TYR . 43.8 t -126.11 124.67 66.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 110.645 -0.131 . . . . 0.0 110.645 -177.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.69 135.28 35.06 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.064 0.459 . . . . 0.0 112.229 -177.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.525 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 12.0 t -97.09 105.89 18.13 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 175.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.78 166.7 23.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.309 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 60.3 14.74 35.01 Favored Glycine 0 CA--C 1.519 0.318 0 CA-C-N 115.524 -0.762 . . . . 0.0 113.294 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.402 ' O ' ' HG2' ' A' ' 117' ' ' GLU . . . 87.68 8.45 73.46 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.449 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 116' ' ' GLY . 25.8 mt-10 -156.91 -176.08 5.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.87 0.367 . . . . 0.0 110.476 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.71 ' CE2' ' HG3' ' A' ' 74' ' ' PRO . 96.8 m95 -95.78 130.83 42.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.905 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.79 156.09 21.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.251 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.538 ' O ' ' ND2' ' A' ' 108' ' ' ASN . 0.3 OUTLIER 55.47 44.39 1.6 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.037 179.834 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 98.5 Cg_endo -78.16 153.45 28.26 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.401 2.067 . . . . 0.0 111.933 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.587 ' HD3' HG22 ' A' ' 111' ' ' VAL . 74.0 Cg_endo -88.84 -170.01 0.45 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.635 2.223 . . . . 0.0 113.298 -178.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.47 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -131.64 176.91 7.93 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.537 176.841 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 124' ' ' CYS . . . . . 0.444 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 2.9 m -139.17 97.63 3.34 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.976 0.417 . . . . 0.0 110.87 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.424 ' O ' ' CB ' ' A' ' 104' ' ' SER . 17.1 mt-30 -125.36 163.56 22.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.04 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.469 HG12 ' CE1' ' A' ' 103' ' ' TYR . 17.4 mm . . . . . 0 C--N 1.324 -0.515 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.064 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.799 0.333 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.475 ' HD3' HG23 ' A' ' 25' ' ' VAL . 5.7 mtt180 -78.59 -171.45 2.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.102 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.471 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 51.7 m -90.35 160.64 39.19 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.974 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 56.0 Cg_endo -70.13 177.54 5.73 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.51 2.14 . . . . 0.0 112.122 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.412 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -53.25 112.79 3.94 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.985 -179.84 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.642 ' HG3' HD13 ' A' ' 22' ' ' ILE . 20.0 Cg_endo -60.34 149.55 85.26 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.353 2.035 . . . . 0.0 112.003 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.778 ' O ' HD11 ' A' ' 20' ' ' LEU . 6.6 mtt180 -57.88 173.45 0.32 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -129.89 -174.82 3.42 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.097 0.475 . . . . 0.0 111.623 -178.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.445 HG23 ' O ' ' A' ' 18' ' ' GLY . 4.5 tt -141.53 148.62 20.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.866 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.49 -58.25 2.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.245 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.422 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 0.7 OUTLIER -93.65 40.78 1.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.864 -179.503 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.445 ' O ' HG23 ' A' ' 15' ' ' ILE . . . -164.27 -179.93 38.74 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.703 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.25 134.51 32.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.745 0.307 . . . . 0.0 110.524 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.909 HD21 ' CE2' ' A' ' 33' ' ' TYR . 13.7 mt -77.83 155.93 30.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.098 0.475 . . . . 0.0 111.687 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.459 ' HB3' ' CB ' ' A' ' 32' ' ' THR . 29.6 t70 -129.3 74.06 1.56 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.114 176.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.915 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.8 OUTLIER -76.97 101.83 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.954 -176.447 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.73 16.82 58.26 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.753 -0.736 . . . . 0.0 111.732 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 162.53 132.35 1.33 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.251 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.475 HG23 ' HD3' ' A' ' 8' ' ' ARG . 34.0 m -113.62 -8.07 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.44 ' HA ' ' CB ' ' A' ' 8' ' ' ARG . 32.8 t0 -70.18 163.48 26.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.968 0.413 . . . . 0.0 111.074 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.518 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 11.0 t80 -54.44 113.82 1.42 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.684 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.87 -7.11 33.21 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.664 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.2 m -78.89 158.85 28.0 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.956 0.378 . . . . 0.0 110.647 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.2 p -134.44 136.41 43.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.041 0.448 . . . . 0.0 111.029 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.915 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -96.95 169.7 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.66 178.908 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.459 ' CB ' ' HB3' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -132.7 109.83 9.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.942 0.401 . . . . 0.0 111.148 179.515 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.909 ' CE2' HD21 ' A' ' 20' ' ' LEU . 21.5 m-85 -83.59 139.08 33.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.025 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.431 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 41.4 m -144.99 160.31 41.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.711 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.443 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 36.4 m -84.02 167.31 16.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.863 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.3 -84.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.129 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.0 t -152.92 137.61 16.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.702 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 59.11 25.89 60.44 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.843 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.512 ' CE1' ' HB3' ' A' ' 68' ' ' SER . 2.4 m-85 -115.85 172.66 7.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.721 0.296 . . . . 0.0 110.91 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.87 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.9 OUTLIER -132.49 122.73 25.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.043 0.449 . . . . 0.0 110.674 178.299 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.87 HD11 ' HG2' ' A' ' 64' ' ' PRO . 10.1 tt -84.77 127.54 34.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.782 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.87 HD11 ' CE1' ' A' ' 40' ' ' HIS . 1.5 mm -108.49 152.27 10.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.086 0.47 . . . . 0.0 111.023 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.22 -137.24 16.76 Favored Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.31 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.828 ' O ' HD21 ' A' ' 41' ' ' LEU . 4.1 pm0 -76.59 178.05 6.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.877 0.37 . . . . 0.0 110.654 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.9 p -156.4 19.11 0.35 Allowed 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.502 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.435 ' HG3' ' HA ' ' A' ' 32' ' ' THR . 21.1 mtpt -159.37 121.46 3.43 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.863 0.319 . . . . 0.0 111.863 -177.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.46 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 0.5 OUTLIER -88.51 131.26 34.98 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 177.092 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.496 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 2.0 m-85 -107.14 115.7 30.63 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 119.246 -0.982 . . . . 0.0 111.555 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.455 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 23.5 t -68.72 80.84 0.28 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.104 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.464 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -97.12 -164.59 1.16 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.626 -179.162 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.518 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -105.87 147.98 28.1 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.924 -179.679 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.35 -129.78 0.11 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.564 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.8 t -112.73 -32.03 6.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.78 0.324 . . . . 0.0 110.988 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.07 33.41 2.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.899 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.46 16.76 77.49 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.584 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -86.58 -164.28 1.03 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.692 0.282 . . . . 0.0 110.71 179.646 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.46 148.26 43.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.399 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.461 HG23 ' HG2' ' A' ' 50' ' ' GLU . 1.3 m -153.72 -177.72 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.527 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.542 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 87.6 m95 -125.14 121.13 33.32 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.104 0.478 . . . . 0.0 112.037 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.496 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 2.4 m120 -72.63 167.05 36.77 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.437 177.034 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.446 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 83.3 Cg_exo -18.0 104.29 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 125.142 3.894 . . . . 0.0 114.412 -178.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.48 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -106.92 -81.52 0.55 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.186 -177.235 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.471 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -76.13 107.45 4.49 Favored Pre-proline 0 N--CA 1.463 0.191 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -175.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.87 ' HG2' HD11 ' A' ' 41' ' ' LEU . 3.9 Cg_endo -91.52 -155.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 123.459 2.772 . . . . 0.0 111.23 177.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.565 HG22 ' H ' ' A' ' 66' ' ' CYS . 2.2 mm -96.65 168.82 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.873 0.368 . . . . 0.0 110.58 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.565 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.1 m -167.34 136.59 2.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.206 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.43 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.6 OUTLIER -156.29 175.33 14.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.957 179.703 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.512 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 3.1 p -93.88 108.76 20.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.94 0.4 . . . . 0.0 111.121 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.494 ' O ' HG13 ' A' ' 69' ' ' VAL . 2.7 p -48.58 97.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.263 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.13 121.13 25.18 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.289 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.431 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -103.24 116.79 33.14 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.284 178.798 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -70.81 -157.68 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.616 179.537 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.478 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 1.6 t -47.47 139.01 8.44 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.191 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.495 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 34.5 Cg_exo -58.41 160.93 15.37 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.319 2.013 . . . . 0.0 111.811 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.516 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 88.8 Cg_exo -44.03 157.32 0.15 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.584 2.189 . . . . 0.0 112.784 -178.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 87.7 p -107.32 89.3 2.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.633 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.663 HG21 ' O ' ' A' ' 122' ' ' PRO . 14.6 pt -69.46 176.55 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.169 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.6 m -92.97 142.4 27.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.84 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 54.99 29.92 13.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.874 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.467 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -163.37 -176.69 35.62 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.294 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -156.43 -174.61 5.02 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.478 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 2.5 p-80 -122.19 161.82 22.49 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.511 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -88.86 -165.1 1.25 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.523 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.453 ' C ' ' CG ' ' A' ' 85' ' ' TYR . . . 72.65 -63.05 1.53 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.684 -178.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.526 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 0.0 OUTLIER 51.62 36.19 16.68 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 122.146 0.974 . . . . 0.0 110.03 -179.832 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.507 ' HB2' ' CZ ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -74.28 -165.92 0.37 Allowed 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 113.572 -1.649 . . . . 0.0 109.897 179.609 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.442 ' O ' ' CD2' ' A' ' 88' ' ' PHE . 1.5 m-20 -110.43 -25.33 10.11 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.712 178.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.442 ' CD2' ' O ' ' A' ' 87' ' ' ASP . 12.8 m-85 -158.62 159.61 35.61 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.331 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.507 ' CZ ' ' HB2' ' A' ' 86' ' ' GLU . 9.5 m-85 -141.09 167.64 21.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.038 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.3 p -135.06 -177.45 4.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.153 0.502 . . . . 0.0 111.922 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -62.98 95.05 0.07 Allowed 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.93 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 128.53 12.67 2.71 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.35 -0.841 . . . . 0.0 113.362 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.419 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.5 OUTLIER -90.41 154.51 19.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 117.1 0.45 . . . . 0.0 110.403 179.268 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 26.9 m -133.93 148.23 30.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.075 0.464 . . . . 0.0 110.892 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.513 HG23 ' CH2' ' A' ' 118' ' ' TRP . 46.3 t -146.9 151.98 13.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.596 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.781 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -109.04 135.01 50.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.595 179.712 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.973 ' CE1' HG21 ' A' ' 111' ' ' VAL . 5.2 m-85 -93.73 157.55 16.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.196 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.93 149.66 29.9 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.955 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.411 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 72.7 m -85.76 155.14 21.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.899 0.38 . . . . 0.0 111.186 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.467 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 56.1 m-20 -92.31 -72.96 0.57 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.336 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.4 t -51.98 -24.35 6.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.882 0.373 . . . . 0.0 110.805 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.03 29.66 1.46 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.535 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.509 ' CE2' HG12 ' A' ' 126' ' ' ILE . 41.1 m-85 -74.41 -175.83 2.48 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 120.998 0.427 . . . . 0.0 110.55 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 34.3 m -122.34 98.61 6.01 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.63 ' HA ' ' HA ' ' A' ' 124' ' ' CYS . 0.0 OUTLIER -51.93 152.02 3.27 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-O 122.305 1.05 . . . . 0.0 112.504 -175.625 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.472 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 45.1 mm -121.98 145.98 27.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 113.085 -1.87 . . . . 0.0 111.244 -174.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.43 ' O ' ' ND2' ' A' ' 108' ' ' ASN . . . 77.32 39.05 27.56 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.271 -0.966 . . . . 0.0 111.859 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.43 ' ND2' ' O ' ' A' ' 107' ' ' GLY . 8.3 p30 53.5 138.71 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 124.346 1.058 . . . . 0.0 113.117 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.781 ' HB2' HG22 ' A' ' 96' ' ' THR . 0.6 OUTLIER -69.4 -24.61 63.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.583 -179.712 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -64.73 134.06 37.93 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.59 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.973 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.7 t -132.94 121.76 44.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.657 0.265 . . . . 0.0 110.517 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.12 119.68 27.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.909 0.385 . . . . 0.0 111.388 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.501 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 14.6 t -86.7 102.62 14.39 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 176.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.1 t -156.14 148.1 23.17 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.039 0.447 . . . . 0.0 111.328 -178.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 69.55 24.94 75.98 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.54 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.474 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 74.71 5.74 75.13 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.873 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -137.84 174.42 10.59 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.88 0.372 . . . . 0.0 110.328 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.516 ' CD1' ' HD3' ' A' ' 75' ' ' PRO . 86.4 m95 -107.51 128.93 54.95 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.778 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.454 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -100.27 160.37 14.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.536 -178.479 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.449 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 2.2 p-10 46.94 48.35 5.57 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.71 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 91.8 Cg_endo -77.26 135.19 14.88 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.431 2.087 . . . . 0.0 110.512 175.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.663 ' O ' HG21 ' A' ' 77' ' ' ILE . 73.6 Cg_endo -93.67 -176.49 0.54 Allowed 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.09 1.86 . . . . 0.0 114.526 -175.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' A' ' 105' ' ' LEU . 0.2 OUTLIER -118.43 -155.45 0.6 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.407 179.039 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 124' ' ' CYS . . . . . 0.63 ' HA ' ' HA ' ' A' ' 105' ' ' LEU . 1.8 m -153.8 88.31 1.26 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.928 0.394 . . . . 0.0 110.753 177.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -115.41 162.48 17.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.756 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.509 HG12 ' CE2' ' A' ' 103' ' ' TYR . 26.5 mm . . . . . 0 C--N 1.325 -0.488 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.167 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.904 0.383 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.493 ' HB3' HG23 ' A' ' 25' ' ' VAL . 9.0 mtm180 -83.51 174.1 10.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.977 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.457 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 19.6 m -93.2 162.32 28.59 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.855 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 36.4 Cg_endo -66.95 171.97 10.42 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.417 2.078 . . . . 0.0 111.997 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.414 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -55.12 112.63 4.33 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.371 179.67 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 11' ' ' SER . 11.0 Cg_endo -55.12 151.13 36.19 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.143 1.895 . . . . 0.0 111.933 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.862 ' O ' HD11 ' A' ' 20' ' ' LEU . 12.1 mtt180 -65.12 152.83 42.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.622 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -99.41 -178.07 3.79 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.953 -176.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.495 HG22 ' CD2' ' A' ' 20' ' ' LEU . 14.2 tt -152.44 141.49 14.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.129 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.407 ' O ' ' N ' ' A' ' 18' ' ' GLY . 7.3 p30 -80.45 174.64 11.41 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.718 178.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.496 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 2.0 m120 37.32 31.05 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.809 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.447 ' HA2' ' N ' ' A' ' 36' ' ' ASN . . . -167.26 -166.89 27.11 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.62 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -155.96 146.42 21.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.665 0.269 . . . . 0.0 110.932 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.862 HD11 ' O ' ' A' ' 13' ' ' ARG . 14.5 mt -84.77 157.94 20.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.991 0.424 . . . . 0.0 111.556 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.439 ' HB3' ' CB ' ' A' ' 32' ' ' THR . 1.2 t70 -125.68 76.39 1.57 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.717 177.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.901 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.9 OUTLIER -74.85 101.06 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.117 -176.922 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.47 18.58 50.6 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.631 176.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 160.43 134.94 1.74 Allowed Glycine 0 C--N 1.334 0.444 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.834 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.493 HG23 ' HB3' ' A' ' 8' ' ' ARG . 33.7 m -128.42 33.16 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -105.39 163.79 12.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.16 0.505 . . . . 0.0 111.243 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.55 ' CE1' ' HE3' ' A' ' 57' ' ' MET . 0.0 OUTLIER -47.97 95.6 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.349 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.77 -4.74 22.72 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.539 -0.839 . . . . 0.0 113.206 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.3 m -70.23 173.9 6.18 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 117.014 0.407 . . . . 0.0 110.289 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.3 p -145.16 144.22 30.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.002 0.429 . . . . 0.0 111.245 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.901 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -105.97 171.84 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.516 -179.662 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.439 ' CB ' ' HB3' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -133.1 115.17 14.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.876 0.37 . . . . 0.0 110.953 179.633 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.831 ' CE2' HD21 ' A' ' 20' ' ' LEU . 15.3 m-85 -88.77 149.0 23.65 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.218 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 83.4 p -154.78 147.85 24.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.196 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.418 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 8.6 m -76.12 168.44 20.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.816 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.447 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 40.9 m-20 -71.24 -84.86 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.37 -178.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.4 t -151.32 135.18 16.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.897 0.379 . . . . 0.0 110.874 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.744 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 65.77 25.35 71.75 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.066 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.498 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.1 m-85 -118.46 170.13 9.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 0.0 111.083 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.795 ' CD2' HD11 ' A' ' 42' ' ' ILE . 3.2 p-80 -136.1 112.31 9.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.08 0.467 . . . . 0.0 110.557 177.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.897 HD21 ' O ' ' A' ' 44' ' ' GLU . 4.2 tt -80.57 119.48 23.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.8 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.795 HD11 ' CD2' ' A' ' 40' ' ' HIS . 2.5 mm -94.11 161.96 2.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.186 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.68 -138.01 22.45 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.269 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.897 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -82.74 -174.65 5.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.84 0.352 . . . . 0.0 110.838 179.508 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.7 p -156.16 22.26 0.37 Allowed 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.241 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.438 ' HG3' ' HA ' ' A' ' 32' ' ' THR . 2.9 mtpt -150.76 131.05 13.64 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -177.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.458 ' OG ' ' CB ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -93.42 146.82 23.47 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.286 176.248 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.547 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.9 m-85 -120.78 117.12 26.63 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 119.014 -1.074 . . . . 0.0 111.738 178.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 48.8 t -62.86 115.2 4.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.999 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.27 -170.85 3.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.214 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.741 HD22 ' N ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -102.59 141.34 35.58 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.929 0.395 . . . . 0.0 110.874 -178.761 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.741 ' N ' HD22 ' A' ' 51' ' ' LEU . . . -61.18 -127.55 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.579 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.3 m -121.51 -39.62 2.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.777 0.322 . . . . 0.0 111.365 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 30.1 p -91.24 43.33 1.14 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.195 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.18 25.21 69.48 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.402 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.65 -158.26 0.62 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.702 0.287 . . . . 0.0 110.404 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.55 ' HE3' ' CE1' ' A' ' 27' ' ' PHE . 0.3 OUTLIER -129.73 116.79 19.29 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.477 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.658 HG23 ' N ' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -118.46 -176.52 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.607 0.717 . . . . 0.0 111.589 -176.834 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.658 ' N ' HG23 ' A' ' 58' ' ' VAL . 69.6 m95 -130.87 133.36 45.82 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.636 -1.166 . . . . 0.0 111.448 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.547 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.6 OUTLIER -75.67 166.46 45.03 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.944 177.906 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.474 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 97.3 Cg_exo -17.93 96.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 125.251 3.968 . . . . 0.0 114.494 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.479 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.3 OUTLIER -92.87 -76.84 0.46 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.498 -0.773 . . . . 0.0 112.457 -177.374 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.45 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -88.36 109.3 27.68 Favored Pre-proline 0 C--N 1.331 -0.21 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -175.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.88 ' HG2' HD11 ' A' ' 41' ' ' LEU . 1.8 Cg_endo -84.01 -154.96 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.092 2.528 . . . . 0.0 111.073 176.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.499 HG22 ' H ' ' A' ' 66' ' ' CYS . 4.0 mm -90.4 165.65 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.897 0.379 . . . . 0.0 110.895 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.499 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.2 m -163.41 139.32 6.77 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.063 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -159.94 170.86 20.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.823 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.498 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 13.4 p -82.31 117.07 22.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.954 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.744 HG12 ' O ' ' A' ' 38' ' ' GLY . 0.8 OUTLIER -46.67 93.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.291 179.677 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.495 ' HE2' HG23 ' A' ' 90' ' ' THR . 0.3 OUTLIER -72.6 118.51 15.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.061 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -98.69 117.22 32.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.287 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.76 -159.05 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.713 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.47 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 2.1 t -49.86 139.9 16.25 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.925 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.491 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 26.1 Cg_exo -60.52 160.6 23.46 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.433 2.089 . . . . 0.0 112.062 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.527 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 86.2 Cg_exo -42.18 156.51 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.822 2.348 . . . . 0.0 112.842 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.9 m -109.36 90.68 3.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.438 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.575 HG23 ' HE2' ' A' ' 97' ' ' TYR . 21.6 pt -69.37 171.0 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.418 -178.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.5 m -89.92 139.99 30.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.618 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.515 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 2.9 m-80 60.42 29.27 18.88 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.829 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -165.43 -165.89 23.5 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.986 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -168.1 -175.89 2.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.896 0.379 . . . . 0.0 110.805 -179.537 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.47 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 13.3 p80 -115.24 168.81 9.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.123 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -93.92 -85.28 0.29 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.73 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.574 ' H ' HG13 ' A' ' 95' ' ' VAL . . . 61.22 141.46 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.835 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.423 ' N ' ' CD2' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -112.63 -33.87 6.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.055 0.455 . . . . 0.0 110.514 179.864 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.76 -171.86 2.46 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.852 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -103.1 -21.77 13.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.136 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.406 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 10.4 m-85 -134.08 169.72 16.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.16 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.406 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 41.1 m-85 -147.03 168.1 22.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.603 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.495 HG23 ' HE2' ' A' ' 70' ' ' LYS . 17.7 p -138.06 -175.6 4.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.993 0.425 . . . . 0.0 111.496 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.426 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 10.9 m-20 -63.76 96.22 0.13 Allowed 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.304 0.573 . . . . 0.0 111.049 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.93 26.66 1.35 Allowed Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.254 -0.884 . . . . 0.0 113.075 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.425 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.6 OUTLIER -108.26 157.3 18.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.878 0.339 . . . . 0.0 110.494 179.044 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 35.5 m -135.49 151.65 30.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.156 0.503 . . . . 0.0 111.411 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.574 HG13 ' H ' ' A' ' 84' ' ' GLY . 18.0 t -147.85 148.06 16.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.404 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.939 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -107.52 125.84 51.78 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.067 0.461 . . . . 0.0 110.851 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 1.004 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.0 m-85 -84.21 164.59 19.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.249 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.52 ' HA ' HD13 ' A' ' 105' ' ' LEU . 51.7 m -156.71 143.33 18.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.504 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.452 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 64.2 m -73.88 157.55 36.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.662 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.417 ' CG ' ' N ' ' A' ' 101' ' ' SER . 0.1 OUTLIER -95.12 -55.5 3.05 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.363 0.602 . . . . 0.0 111.342 -178.493 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.417 ' N ' ' CG ' ' A' ' 100' ' ' ASN . 6.5 t -75.37 -20.62 58.88 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.4 -178.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 117.96 28.05 2.34 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.446 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.515 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 17.9 m-85 -69.65 -179.83 1.89 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.123 0.487 . . . . 0.0 110.853 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -105.98 96.51 6.54 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.936 178.007 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.52 HD13 ' HA ' ' A' ' 98' ' ' SER . 0.3 OUTLIER -47.74 128.86 13.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.588 0.709 . . . . 0.0 111.965 -177.526 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.48 HG22 ' N ' ' A' ' 107' ' ' GLY . 36.0 mm -112.51 158.98 12.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.55 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.48 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 66.46 31.85 80.01 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.462 -0.875 . . . . 0.0 113.002 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.43 ' O ' ' O ' ' A' ' 107' ' ' GLY . 8.8 p30 52.03 130.85 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 123.983 0.913 . . . . 0.0 113.052 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.939 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.6 p -63.01 -25.39 68.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.388 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -64.14 127.76 35.78 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.466 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 1.004 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.6 t -131.35 123.14 52.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.588 0.233 . . . . 0.0 110.724 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.62 124.06 32.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.946 0.403 . . . . 0.0 111.579 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.506 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 18.4 t -87.23 108.81 19.1 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 176.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.6 OUTLIER -155.77 165.13 37.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.102 0.477 . . . . 0.0 111.508 -178.639 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.67 31.11 7.05 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.604 -0.726 . . . . 0.0 112.889 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.45 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 68.63 12.52 64.35 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.711 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -143.14 176.39 9.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.768 0.318 . . . . 0.0 110.523 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.527 ' CD1' ' HD3' ' A' ' 75' ' ' PRO . 89.3 m95 -110.71 127.54 55.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.824 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.91 148.98 27.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.057 0.456 . . . . 0.0 111.478 -178.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.493 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER 68.08 44.85 0.31 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.121 178.888 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 55.1 Cg_endo -69.63 139.18 40.02 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.175 1.917 . . . . 0.0 111.418 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.538 ' O ' HG21 ' A' ' 77' ' ' ILE . 55.6 Cg_endo -88.28 -174.8 1.19 Allowed 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.569 2.179 . . . . 0.0 113.35 -178.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.41 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -135.13 -157.48 0.8 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.884 179.002 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 1.8 m -156.28 90.21 1.17 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.124 0.488 . . . . 0.0 111.134 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.409 ' O ' ' CB ' ' A' ' 104' ' ' SER . 11.7 mt-30 -115.07 158.97 21.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.6 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.542 ' O ' HG22 ' A' ' 126' ' ' ILE . 29.4 mm . . . . . 0 C--N 1.323 -0.566 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.987 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 27.4 mtm-85 . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.777 0.323 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.449 ' CB ' ' HA ' ' A' ' 26' ' ' ASP . 5.1 ptt180 -85.42 -170.97 3.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.973 0.416 . . . . 0.0 111.173 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.483 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 12.3 m -93.12 162.68 27.73 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.999 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 51.2 Cg_endo -70.24 178.08 5.24 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.443 2.095 . . . . 0.0 112.172 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 42.2 t -58.5 107.94 1.13 Allowed Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.072 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.486 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 2.6 Cg_endo -50.29 146.96 17.18 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.147 1.898 . . . . 0.0 112.206 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.927 ' O ' HD11 ' A' ' 20' ' ' LEU . 4.4 ttp180 -59.76 151.56 25.02 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.275 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -98.5 -177.82 3.81 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.177 -176.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.608 HG22 ' CD2' ' A' ' 20' ' ' LEU . 8.2 tt -141.38 152.99 19.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.458 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -88.38 -66.98 0.86 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.57 -178.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -91.1 40.33 1.02 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.344 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.44 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -160.37 -179.22 35.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.881 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -137.75 125.18 21.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.743 0.306 . . . . 0.0 110.618 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.927 HD11 ' O ' ' A' ' 13' ' ' ARG . 14.9 mt -66.8 154.21 41.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.99 0.424 . . . . 0.0 111.231 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 32' ' ' THR . 3.9 t0 -127.35 74.67 1.53 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.852 178.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.865 ' HA ' HG23 ' A' ' 31' ' ' ILE . 67.8 mt -70.31 96.28 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.22 -177.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.96 21.48 44.78 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.435 176.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 154.87 140.61 3.05 Favored Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.437 HG23 ' HD2' ' A' ' 8' ' ' ARG . 26.5 m -125.64 -9.21 5.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.449 ' HA ' ' CB ' ' A' ' 8' ' ' ARG . 27.5 t70 -69.68 164.92 22.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.03 0.443 . . . . 0.0 110.95 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.452 ' CZ ' HD12 ' A' ' 51' ' ' LEU . 17.2 t80 -51.9 118.47 3.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.707 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 49' ' ' CYS . . . 100.27 -10.86 59.99 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.659 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.425 ' N ' ' HB3' ' A' ' 49' ' ' CYS . 3.6 m -58.53 179.92 0.07 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.825 0.345 . . . . 0.0 110.964 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.1 p -153.58 133.41 13.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.083 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.865 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.6 OUTLIER -100.97 174.25 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.724 179.584 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.47 ' H ' HG22 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -140.88 106.53 5.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.715 178.778 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.701 ' CE2' HD21 ' A' ' 20' ' ' LEU . 33.5 m-85 -78.37 138.1 38.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.39 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.0 m -139.46 167.02 23.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.69 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.44 ' HA ' ' HA2' ' A' ' 18' ' ' GLY . 1.3 m -91.8 164.62 13.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.943 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.01 -84.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.078 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.63 132.91 9.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.637 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.814 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 64.92 25.94 71.0 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.732 -178.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.525 ' CE1' ' CB ' ' A' ' 68' ' ' SER . 2.6 m-85 -118.34 -179.93 3.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.9 0.381 . . . . 0.0 110.931 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -136.16 140.47 43.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.841 174.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.836 HD21 ' O ' ' A' ' 44' ' ' GLU . 9.6 tt -94.11 138.69 31.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.472 -178.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.577 HD13 ' C ' ' A' ' 41' ' ' LEU . 1.9 mm -110.73 150.5 13.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.077 0.465 . . . . 0.0 111.275 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.27 -147.14 43.75 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.256 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.836 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -62.14 177.74 0.44 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.592 0.234 . . . . 0.0 110.679 179.419 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.6 p -152.3 26.73 0.6 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.955 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.421 ' CG ' ' O ' ' A' ' 31' ' ' ILE . 0.4 OUTLIER -147.02 -171.11 3.7 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.066 -178.541 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.471 ' O ' HG13 ' A' ' 31' ' ' ILE . 1.1 m -167.07 98.92 0.53 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.168 179.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.424 ' CD1' ' N ' ' A' ' 48' ' ' TYR . 1.5 m-85 -80.51 115.85 20.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.134 0.492 . . . . 0.0 111.781 -177.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.482 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 34.8 t -65.91 102.96 0.84 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.031 178.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.498 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 3.7 tt0 -134.06 171.63 13.94 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.315 0.579 . . . . 0.0 110.695 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.498 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -95.18 141.62 28.58 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.763 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 173.99 45.06 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.348 -0.93 . . . . 0.0 113.043 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.448 ' HB3' ' CB ' ' A' ' 56' ' ' SER . 0.2 OUTLIER -140.26 59.22 1.57 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.914 0.388 . . . . 0.0 110.825 179.666 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.3 p 63.15 27.67 15.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.715 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 104.91 27.99 5.77 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.138 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.448 ' CB ' ' HB3' ' A' ' 53' ' ' SER . 0.2 OUTLIER -120.07 -160.42 0.83 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.899 0.38 . . . . 0.0 111.031 -179.302 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.96 147.37 44.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.385 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -148.67 -174.57 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.612 -178.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.532 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 88.5 m95 -128.06 123.2 34.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.805 0.336 . . . . 0.0 111.194 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -140.01 122.01 9.82 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.979 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.29 -166.89 5.25 Favored 'Cis proline' 0 C--N 1.352 0.725 0 C-N-CA 123.858 -1.309 . . . . 0.0 112.375 -0.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -110.34 -152.72 0.5 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.496 ' CB ' ' CE2' ' A' ' 33' ' ' TYR . . . -79.18 112.82 31.09 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.982 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.434 ' CG ' ' O ' ' A' ' 44' ' ' GLU . 16.6 Cg_exo -69.24 -150.54 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.738 2.292 . . . . 0.0 112.318 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.601 HG22 ' H ' ' A' ' 66' ' ' CYS . 0.5 OUTLIER -106.66 178.37 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.957 0.408 . . . . 0.0 111.251 -179.245 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.601 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.5 OUTLIER -170.69 127.38 0.76 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.747 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.476 ' O ' ' CD2' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -135.48 175.32 9.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.863 179.724 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.525 ' CB ' ' CE1' ' A' ' 39' ' ' TYR . 1.7 p -98.17 124.26 42.64 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.052 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.814 HG12 ' O ' ' A' ' 38' ' ' GLY . 6.7 p -49.58 92.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.982 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.434 ' CD ' ' HB3' ' A' ' 88' ' ' PHE . 0.8 OUTLIER -81.33 128.77 34.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.807 -178.635 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.433 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -110.62 120.44 42.43 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.867 177.625 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.443 ' HA ' ' HA ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -69.8 -160.19 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.964 -179.242 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.576 ' HG ' ' CE1' ' A' ' 82' ' ' HIS . 2.2 t -47.25 136.09 9.0 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.081 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.476 ' HD2' ' CD2' ' A' ' 82' ' ' HIS . 31.6 Cg_exo -56.81 161.81 9.71 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.347 2.031 . . . . 0.0 111.981 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.5 ' HD3' ' CG ' ' A' ' 118' ' ' TRP . 99.3 Cg_exo -42.75 158.15 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.694 2.262 . . . . 0.0 112.735 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.5 m -110.35 88.61 2.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.852 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.667 HG23 ' HE1' ' A' ' 97' ' ' TYR . 19.4 pt -69.65 -179.0 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.364 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.5 m -98.56 146.47 25.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.619 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.484 ' HB3' ' CD2' ' A' ' 103' ' ' TYR . 8.5 m-80 53.53 30.55 10.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.929 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -174.61 -172.29 39.55 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.874 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -170.72 -174.3 1.56 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.904 0.383 . . . . 0.0 110.673 -179.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.576 ' CE1' ' HG ' ' A' ' 73' ' ' SER . 11.5 p-80 -92.45 174.45 7.28 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.264 178.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.436 ' OD1' ' CG1' ' A' ' 95' ' ' VAL . 17.5 p-10 -106.34 -37.89 6.39 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -178.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' A' ' 85' ' ' TYR . . . -44.42 -71.18 0.49 Allowed Glycine 0 CA--C 1.516 0.136 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.985 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.413 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 3.4 m-85 65.2 28.49 12.08 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 121.264 0.554 . . . . 0.0 110.065 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -69.85 -98.46 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.4 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -174.4 -36.72 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.372 0.606 . . . . 0.0 109.642 178.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 72' ' ' GLN . 18.1 m-85 -152.75 159.63 43.12 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.612 -178.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.439 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 23.7 m-85 -144.66 169.63 17.63 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.049 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 17.0 p -133.62 178.39 6.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.987 0.423 . . . . 0.0 111.674 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -62.47 100.81 0.2 Allowed 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.539 0.685 . . . . 0.0 110.849 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 122.56 16.71 3.7 Favored Glycine 0 C--N 1.312 -0.792 0 CA-C-N 114.718 -1.128 . . . . 0.0 113.003 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.411 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -99.2 157.7 16.2 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.898 0.349 . . . . 0.0 110.533 179.115 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 34.6 m -136.17 152.01 29.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.164 0.507 . . . . 0.0 111.249 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.47 HG23 ' CH2' ' A' ' 118' ' ' TRP . 43.8 t -146.82 150.1 15.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.6 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.809 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -110.46 126.36 54.25 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.882 -179.537 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.977 ' CE2' HG21 ' A' ' 111' ' ' VAL . 3.8 m-85 -83.75 154.61 23.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.465 -178.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 59.9 p -153.58 147.85 25.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.283 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.454 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 8.4 m -69.81 160.77 31.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.954 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 21.6 m-20 -85.46 -68.99 0.69 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.249 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 66.9 m -77.56 -45.2 26.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.639 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 154.74 41.84 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.766 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.528 ' CE1' HG12 ' A' ' 126' ' ' ILE . 13.4 m-85 -78.15 -166.19 0.78 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' A' ' 124' ' ' CYS . 3.5 m -117.17 104.99 11.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.703 0.287 . . . . 0.0 111.567 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 105' ' ' LEU . 2.6 tp -47.15 118.26 2.06 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.168 0.509 . . . . 0.0 110.534 178.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.523 HG22 ' N ' ' A' ' 107' ' ' GLY . 19.1 mm -94.27 160.71 2.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.917 -178.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.523 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 59.43 -124.18 35.66 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.852 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -125.28 122.85 38.09 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.79 0.329 . . . . 0.0 110.93 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.809 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.4 t -58.15 -27.7 64.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.068 0.461 . . . . 0.0 110.474 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.64 135.38 26.79 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.817 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.977 HG21 ' CE2' ' A' ' 97' ' ' TYR . 2.7 t -131.07 119.22 44.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.712 0.291 . . . . 0.0 110.594 178.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.0 118.76 24.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.991 0.424 . . . . 0.0 111.588 -178.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.496 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 14.1 t -85.37 100.54 11.91 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.467 176.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.6 t -136.63 161.39 36.04 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.063 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.99 25.58 3.9 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.756 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.434 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 77.16 7.38 86.78 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.655 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -133.53 -176.56 4.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.825 0.345 . . . . 0.0 110.571 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.5 ' CG ' ' HD3' ' A' ' 75' ' ' PRO . 94.3 m95 -114.61 145.05 42.45 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.171 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.1 147.39 51.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.286 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.495 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.5 t0 71.0 44.56 0.23 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.289 178.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 62.0 Cg_endo -73.23 137.12 25.5 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.191 1.927 . . . . 0.0 111.254 177.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.484 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 73.0 Cg_endo -89.42 -175.42 1.09 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.467 2.112 . . . . 0.0 113.752 -177.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.468 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -124.93 -162.54 1.11 Allowed 'General case' 0 CA--C 1.501 -0.92 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.509 175.34 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 124' ' ' CYS . . . . . 0.411 ' SG ' ' CB ' ' A' ' 103' ' ' TYR . 5.2 t -170.69 92.76 0.18 Allowed 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.323 -176.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -118.88 175.93 5.52 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.92 -1.037 . . . . 0.0 111.012 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.618 ' O ' HG22 ' A' ' 126' ' ' ILE . 16.9 mm . . . . . 0 C--N 1.324 -0.531 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.579 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 28.8 mtm-85 . . . . . 0 CA--C 1.529 0.145 0 CA-C-O 120.701 0.286 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.445 ' HB3' HG23 ' A' ' 25' ' ' VAL . 2.4 mtt85 43.34 -167.89 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.023 0.439 . . . . 0.0 111.92 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.457 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 15.1 m -111.51 161.56 24.86 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.638 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.408 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 55.8 Cg_endo -66.92 171.54 11.0 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.179 1.919 . . . . 0.0 110.471 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.408 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 5.7 p -51.11 120.47 14.1 Favored Pre-proline 0 N--CA 1.45 -0.45 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.719 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.509 ' HB3' HD13 ' A' ' 31' ' ' ILE . 6.3 Cg_endo -47.82 144.59 11.15 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.67 2.247 . . . . 0.0 112.395 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.454 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -52.59 -175.88 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.904 177.615 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -144.55 -179.95 6.89 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.46 0.648 . . . . 0.0 111.994 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.752 HD12 ' O ' ' A' ' 64' ' ' PRO . 7.0 tt -139.77 154.5 24.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.305 -179.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -79.08 -68.72 0.63 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.541 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.496 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 1.9 m-20 -93.41 39.08 1.05 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.976 0.417 . . . . 0.0 110.876 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -148.29 178.92 25.55 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.025 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -141.51 134.16 28.53 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.953 HD21 ' CE2' ' A' ' 33' ' ' TYR . 10.5 mt -86.69 152.25 22.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.318 0.58 . . . . 0.0 111.953 -178.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -123.34 80.77 1.81 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.578 177.727 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.819 ' HA ' HG23 ' A' ' 31' ' ' ILE . 6.3 mt -75.5 116.66 18.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.561 -176.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -108.3 19.36 32.0 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.356 175.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.499 ' H ' HG22 ' A' ' 22' ' ' ILE . . . 156.58 164.48 13.51 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -179.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.445 HG23 ' HB3' ' A' ' 8' ' ' ARG . 22.5 m -143.82 22.7 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.861 0.33 . . . . 0.0 111.439 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.4 OUTLIER -93.57 159.27 15.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.805 179.762 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.641 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 2.9 t80 -56.03 87.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.683 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 134.1 -14.56 4.59 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.417 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.01 -170.94 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.612 0.244 . . . . 0.0 110.348 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 47' ' ' SER . 27.7 p -159.28 139.19 11.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.237 0.541 . . . . 0.0 111.819 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.819 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -103.66 176.27 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.866 178.755 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.545 HG23 ' HG2' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -138.24 113.2 9.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.696 0.284 . . . . 0.0 110.828 179.809 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.953 ' CE2' HD21 ' A' ' 20' ' ' LEU . 8.3 m-85 -87.34 149.21 24.65 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.318 0.58 . . . . 0.0 111.751 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.409 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.6 OUTLIER -156.62 164.11 38.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.675 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.467 ' HA ' ' HA2' ' A' ' 18' ' ' GLY . 20.2 m -87.7 165.48 15.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.19 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -66.57 -70.94 0.22 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.92 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.41 141.63 9.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.84 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.797 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 52.46 29.82 32.16 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.171 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.512 ' CZ ' ' HB3' ' A' ' 68' ' ' SER . 2.4 m-85 -117.09 175.84 5.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.799 0.333 . . . . 0.0 111.147 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -131.76 140.5 49.24 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 174.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.972 HD21 ' O ' ' A' ' 44' ' ' GLU . 0.6 OUTLIER -90.16 138.67 31.33 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.256 -176.501 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.86 HD13 ' C ' ' A' ' 41' ' ' LEU . 0.3 OUTLIER -116.38 131.96 67.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 CA-C-O 121.67 0.748 . . . . 0.0 110.552 178.442 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.16 -137.42 13.25 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 114.183 -1.371 . . . . 0.0 111.165 -176.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.972 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.6 OUTLIER -87.32 -172.55 3.98 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.843 0.354 . . . . 0.0 110.687 178.333 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.0 p -144.77 25.54 1.45 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.979 0.419 . . . . 0.0 110.817 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.545 ' HG2' HG23 ' A' ' 32' ' ' THR . 0.2 OUTLIER -160.86 125.92 3.71 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.841 -179.117 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' A' ' 30' ' ' SER . 1.6 m -95.74 149.54 21.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.008 178.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.512 ' CE2' ' HD3' ' A' ' 61' ' ' PRO . 4.0 m-85 -123.08 126.85 47.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.028 0.442 . . . . 0.0 111.278 -178.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.477 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 10.5 t -76.21 91.95 3.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.118 179.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -116.4 178.17 4.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.63 -178.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.901 HD23 ' O ' ' A' ' 56' ' ' SER . 4.8 mt -80.84 155.91 26.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.606 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 53' ' ' SER . . . 166.18 178.09 38.7 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.465 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.524 ' C ' HG23 ' A' ' 54' ' ' THR . 15.8 t 70.81 55.82 0.24 Allowed 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.394 0.616 . . . . 0.0 111.158 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.524 HG23 ' C ' ' A' ' 53' ' ' SER . 1.3 p 71.59 16.99 5.72 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.557 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 105.33 39.79 2.19 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.716 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.901 ' O ' HD23 ' A' ' 51' ' ' LEU . 33.3 t -121.61 -169.16 1.81 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.734 0.302 . . . . 0.0 110.675 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -96.84 118.38 33.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.934 0.397 . . . . 0.0 110.867 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.5 m -132.84 -175.78 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.91 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.631 ' CE3' HD11 ' A' ' 31' ' ' ILE . 88.3 m95 -120.76 139.32 53.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.877 0.37 . . . . 0.0 110.996 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.424 ' O ' ' N ' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -148.78 140.2 14.16 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.956 -179.372 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.512 ' HD3' ' CE2' ' A' ' 48' ' ' TYR . 7.3 Cg_exo -75.93 -151.89 0.72 Allowed 'Cis proline' 0 C--N 1.348 0.512 0 C-N-CA 124.163 -1.182 . . . . 0.0 112.738 1.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -65.2 -130.7 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.908 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.642 ' HB3' ' CA ' ' A' ' 64' ' ' PRO . . . -72.26 -82.53 0.04 OUTLIER Pre-proline 0 CA--C 1.48 -1.733 0 CA-C-O 118.503 -0.76 . . . . 0.0 112.132 -178.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.752 ' O ' HD12 ' A' ' 15' ' ' ILE . 41.2 Cg_endo -102.92 -144.89 0.03 OUTLIER 'Cis proline' 0 C--N 1.317 -1.095 0 CA-C-N 120.73 1.296 . . . . 0.0 114.285 12.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.451 HG13 ' HB ' ' A' ' 42' ' ' ILE . 2.2 pt -91.22 177.0 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -174.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.631 ' HB2' HD11 ' A' ' 15' ' ' ILE . 1.2 m -158.83 112.12 2.33 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 114.282 -1.327 . . . . 0.0 109.513 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.473 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 1.9 mt-10 -102.13 176.8 5.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.006 0.432 . . . . 0.0 111.335 -178.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.512 ' HB3' ' CZ ' ' A' ' 39' ' ' TYR . 2.4 p -97.34 123.02 41.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.802 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.797 HG12 ' O ' ' A' ' 38' ' ' GLY . 3.3 p -45.75 97.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.318 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.619 ' HE2' HG23 ' A' ' 90' ' ' THR . 0.3 OUTLIER -84.78 115.58 22.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.435 -179.139 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -96.38 119.25 34.52 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 177.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -69.81 -157.41 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.577 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.413 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 2.2 t -50.98 138.9 23.92 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.57 0.224 . . . . 0.0 110.736 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.935 ' HG2' HG11 ' A' ' 95' ' ' VAL . 33.9 Cg_exo -58.36 156.36 31.14 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.383 2.055 . . . . 0.0 112.05 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.533 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 76.1 Cg_exo -48.92 156.24 2.2 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.63 2.22 . . . . 0.0 112.921 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 75.4 m -101.63 92.4 4.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.111 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.539 HG23 ' HE1' ' A' ' 97' ' ' TYR . 6.4 pt -68.97 165.51 2.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.298 -178.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.8 m -77.32 140.09 39.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.871 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.503 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 7.0 m-80 52.72 27.21 5.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.051 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -161.63 -166.62 20.73 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.757 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.438 ' N ' ' O ' ' A' ' 98' ' ' SER . 9.5 ptt180 -170.32 -174.64 1.74 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.984 0.421 . . . . 0.0 110.918 -178.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.429 ' HB3' ' CE2' ' A' ' 97' ' ' TYR . 13.6 p80 -102.14 179.43 4.32 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.549 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.469 ' CB ' ' O ' ' A' ' 96' ' ' THR . 50.2 t30 -131.13 24.77 4.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.794 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.448 ' CA ' ' OH ' ' A' ' 89' ' ' TYR . . . -40.39 147.87 0.23 Allowed Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 121.028 -0.606 . . . . 0.0 113.829 -175.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.477 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -101.09 -43.31 6.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.155 0.502 . . . . 0.0 110.523 -179.549 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.23 -176.42 3.15 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.988 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.72 -26.48 17.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.411 178.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.438 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 11.1 m-85 -132.67 166.32 22.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.73 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.451 ' CE2' ' CG2' ' A' ' 95' ' ' VAL . 19.8 m-85 -145.31 164.95 29.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.818 0.342 . . . . 0.0 111.117 -178.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.619 HG23 ' HE2' ' A' ' 70' ' ' LYS . 11.1 p -147.42 -175.21 4.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.766 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 7.6 p-10 -54.78 94.02 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.676 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.39 25.99 1.24 Allowed Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.543 -0.837 . . . . 0.0 113.512 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.32 152.29 26.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 117.36 0.58 . . . . 0.0 111.176 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 27.3 m -144.34 136.2 22.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.118 0.485 . . . . 0.0 110.949 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.935 HG11 ' HG2' ' A' ' 74' ' ' PRO . 3.8 p -134.8 149.75 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.283 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.917 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.2 OUTLIER -91.31 149.72 21.62 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.992 0.425 . . . . 0.0 110.836 -179.658 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.876 ' CE2' HG21 ' A' ' 111' ' ' VAL . 2.8 m-85 -107.79 157.39 18.18 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.81 0.338 . . . . 0.0 111.105 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.438 ' O ' ' N ' ' A' ' 81' ' ' ARG . 10.1 p -144.71 146.16 32.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.257 -0.429 . . . . 0.0 112.086 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.551 ' HB3' ' HB2' ' A' ' 103' ' ' TYR . 91.0 m -69.15 161.11 29.81 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.671 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -53.4 -79.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.86 -178.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.1 t -110.81 -30.24 7.64 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.706 -176.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 175.45 31.9 0.04 OUTLIER Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.514 -0.85 . . . . 0.0 113.169 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.555 ' CZ ' HD11 ' A' ' 126' ' ' ILE . 0.2 OUTLIER -69.78 -168.05 0.17 Allowed 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 116.596 0.198 . . . . 0.0 110.681 178.726 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 125' ' ' GLN . 0.2 OUTLIER -125.51 113.95 18.15 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 176.254 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.78 HD12 ' SG ' ' A' ' 124' ' ' CYS . 0.1 OUTLIER -69.62 143.41 53.26 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.762 0.791 . . . . 0.0 112.17 -176.09 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.445 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 33.8 mm -123.09 156.96 28.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 114.281 -1.327 . . . . 0.0 111.266 -178.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.438 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 62.56 32.02 81.81 Favored Glycine 0 CA--C 1.512 -0.137 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.415 178.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.45 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.4 OUTLIER 60.44 135.55 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.313 0.578 . . . . 0.0 111.545 179.218 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.917 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.0 OUTLIER -74.43 -29.96 61.7 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.221 -0.9 . . . . 0.0 112.506 -177.506 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.4 141.45 47.92 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.35 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.876 HG21 ' CE2' ' A' ' 97' ' ' TYR . 13.9 t -134.86 119.17 26.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.644 0.259 . . . . 0.0 111.303 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.92 HD11 ' HB2' ' A' ' 114' ' ' SER . 1.0 OUTLIER -80.18 134.51 36.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.908 0.385 . . . . 0.0 111.194 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.896 ' N ' HD22 ' A' ' 112' ' ' LEU . 35.9 t -106.17 104.96 14.77 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.122 177.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.92 ' HB2' HD11 ' A' ' 112' ' ' LEU . 1.7 t -149.14 131.9 16.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.941 0.401 . . . . 0.0 111.564 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.59 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 80.89 24.28 58.24 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.32 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.458 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 75.7 1.53 66.89 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.312 -178.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -124.52 178.73 5.26 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.03 0.443 . . . . 0.0 110.711 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.608 ' HE3' HG12 ' A' ' 111' ' ' VAL . 92.9 m95 -120.13 133.52 55.49 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.125 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.401 ' O ' ' HB3' ' A' ' 120' ' ' ASP . 0.8 OUTLIER -109.23 160.36 16.18 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.304 178.41 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.574 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 49.7 t0 67.16 33.39 0.1 OUTLIER Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 32.9 Cg_endo -66.92 124.99 12.97 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 121.993 1.796 . . . . 0.0 110.943 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.509 ' HD2' ' CD1' ' A' ' 97' ' ' TYR . 72.3 Cg_endo -91.38 -174.09 0.6 Allowed 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.603 2.202 . . . . 0.0 114.505 -175.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.522 HG22 ' H ' ' A' ' 124' ' ' CYS . 2.5 m -135.81 176.34 8.78 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 113.924 -1.489 . . . . 0.0 108.639 177.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' CYS . . . . . 0.78 ' SG ' HD12 ' A' ' 105' ' ' LEU . 1.2 m -133.3 103.94 6.22 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.106 -0.638 . . . . 0.0 111.16 177.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.437 ' O ' ' CB ' ' A' ' 104' ' ' SER . 10.2 mt-30 -106.85 153.12 22.96 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.686 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.568 ' O ' HG22 ' A' ' 126' ' ' ILE . 49.2 mm . . . . . 0 C--N 1.315 -0.919 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.839 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.4 mtt180 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.789 0.328 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.659 ' HD2' HG23 ' A' ' 25' ' ' VAL . 14.4 mtm180 -81.13 156.94 25.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.174 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.454 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 16.7 m -69.67 162.01 70.46 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.725 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' A' ' 57' ' ' MET . 57.5 Cg_endo -70.53 169.32 20.18 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.528 2.152 . . . . 0.0 112.218 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -50.29 105.9 0.57 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.939 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.513 ' HG3' ' CZ2' ' A' ' 59' ' ' TRP . 76.5 Cg_exo -46.63 160.96 0.2 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.429 2.086 . . . . 0.0 112.594 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.859 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -66.16 166.38 11.94 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.178 178.532 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -117.03 -178.6 3.48 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.187 0.517 . . . . 0.0 112.187 -176.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.482 HG22 ' CD2' ' A' ' 20' ' ' LEU . 4.1 tt -144.58 146.74 19.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.378 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -85.81 -61.05 1.84 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.523 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.435 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -94.6 34.31 1.34 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.92 -179.142 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.435 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -149.57 -179.18 25.2 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.76 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -138.8 127.99 24.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.769 0.319 . . . . 0.0 110.644 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.859 HD11 ' O ' ' A' ' 13' ' ' ARG . 16.1 mt -76.54 153.74 35.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.096 0.475 . . . . 0.0 111.632 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.454 ' HB3' ' CB ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -127.38 78.82 1.84 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.744 177.838 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.848 ' HA ' HG23 ' A' ' 31' ' ' ILE . 3.6 mm -68.85 100.32 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.861 -177.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -103.63 22.86 34.47 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.648 177.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 146.57 133.56 2.48 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 111.741 -0.544 . . . . 0.0 111.741 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.659 HG23 ' HD2' ' A' ' 8' ' ' ARG . 6.7 m -121.22 22.32 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.697 0.284 . . . . 0.0 111.489 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.12 149.59 26.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.552 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.594 ' CE2' HD13 ' A' ' 51' ' ' LEU . 3.7 t80 -48.41 113.7 0.81 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.894 0.378 . . . . 0.0 110.853 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.42 6.74 23.39 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.618 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.86 -163.19 0.97 Allowed 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.8 0.3 . . . . 0.0 110.571 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.7 p -168.94 144.02 3.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.935 0.398 . . . . 0.0 111.143 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.848 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -102.6 170.31 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.278 179.413 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.569 HG23 ' HD2' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -130.67 114.42 15.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.0 0.429 . . . . 0.0 111.126 179.885 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.779 ' CE1' HD21 ' A' ' 20' ' ' LEU . 17.2 m-85 -92.84 137.14 32.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.504 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.435 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 3.5 m -143.86 166.25 25.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.44 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.428 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 3.9 m -82.89 170.44 14.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.784 0.326 . . . . 0.0 110.879 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.19 -83.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.851 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.6 m -156.44 132.44 9.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.743 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.51 22.75 73.42 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.067 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.494 ' CE1' ' HB3' ' A' ' 68' ' ' SER . 2.7 m-85 -114.65 -174.78 2.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.795 0.331 . . . . 0.0 110.913 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.714 ' CD2' HD11 ' A' ' 42' ' ' ILE . 3.6 p-80 -145.35 112.41 6.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.435 178.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.95 HD11 ' HG2' ' A' ' 64' ' ' PRO . 7.9 tt -77.35 124.17 27.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.768 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.714 HD11 ' CD2' ' A' ' 40' ' ' HIS . 2.3 mm -100.16 152.23 4.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.994 0.426 . . . . 0.0 110.931 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.71 -137.34 16.58 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.202 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.902 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.3 OUTLIER -86.67 -175.84 5.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.02 0.438 . . . . 0.0 110.855 179.432 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.5 p -155.86 24.16 0.38 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.23 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.569 ' HD2' HG23 ' A' ' 32' ' ' THR . 0.0 OUTLIER -149.51 130.03 13.94 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.104 0.478 . . . . 0.0 112.221 -178.598 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.447 ' HB3' ' CB ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -101.15 152.8 20.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.34 178.656 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.494 ' CD2' ' HB3' ' A' ' 60' ' ' ASN . 1.3 m-85 -126.23 120.68 30.66 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 119.7 -0.8 . . . . 0.0 111.902 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.487 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 32.2 t -70.21 116.73 10.9 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.095 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -153.6 -177.43 6.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.789 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.594 HD13 ' CE2' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -95.81 165.6 12.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.988 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.592 ' O ' HD22 ' A' ' 51' ' ' LEU . . . -89.28 -135.52 5.6 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.57 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -93.04 -40.67 10.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.753 0.311 . . . . 0.0 111.011 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.1 p -95.29 44.02 1.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.028 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.13 19.32 30.91 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.654 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.6 t -79.53 -170.21 2.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.763 0.316 . . . . 0.0 110.904 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.403 ' HB2' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -112.66 134.05 54.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.555 -179.572 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.6 m -150.64 176.54 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.917 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.523 ' CE3' HD11 ' A' ' 31' ' ' ILE . 60.0 m95 -128.16 127.98 43.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.944 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.494 ' HB3' ' CD2' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -69.37 163.24 60.19 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.178 179.311 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.432 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 80.1 Cg_exo -16.58 94.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.899 1 C-N-CA 125.574 4.182 . . . . 0.0 114.429 -178.456 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.447 ' CB ' ' HB3' ' A' ' 47' ' ' SER . 0.0 OUTLIER -101.28 -81.98 0.47 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.958 -177.87 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.462 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -72.95 106.46 2.26 Favored Pre-proline 0 C--N 1.331 -0.212 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -176.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.95 ' HG2' HD11 ' A' ' 41' ' ' LEU . 1.8 Cg_endo -90.05 -156.01 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.469 2.779 . . . . 0.0 111.14 177.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.49 HG22 ' H ' ' A' ' 66' ' ' CYS . 3.8 mm -92.43 165.3 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.877 0.37 . . . . 0.0 110.884 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.49 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.8 OUTLIER -170.21 136.3 1.39 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.002 179.666 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.4 ' C ' ' CD2' ' A' ' 39' ' ' TYR . 1.6 tt0 -159.78 172.37 17.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.909 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.494 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 4.1 p -89.77 107.88 19.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.447 ' O ' HG13 ' A' ' 69' ' ' VAL . 2.4 p -43.06 94.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.524 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.432 ' HG2' ' CG2' ' A' ' 90' ' ' THR . 2.0 mmtp -75.16 127.23 32.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.375 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.92 113.92 27.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.056 178.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.3 -159.74 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.538 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.482 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 1.4 t -44.52 135.2 4.5 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.234 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.489 ' HG2' HG11 ' A' ' 95' ' ' VAL . 31.6 Cg_exo -57.78 161.78 12.03 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.398 2.065 . . . . 0.0 112.116 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.53 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 79.8 Cg_exo -43.14 156.64 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.772 2.314 . . . . 0.0 112.904 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.5 t -104.81 90.56 3.52 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.372 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.66 HG23 ' HE2' ' A' ' 97' ' ' TYR . 10.1 pt -69.28 175.32 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.395 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.4 p -93.79 141.04 28.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.609 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.4 m120 58.4 28.58 17.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.036 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.467 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -167.05 -171.32 33.0 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.215 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -158.55 -173.58 4.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.078 0.466 . . . . 0.0 110.614 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.482 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 8.4 p80 -117.5 172.19 7.5 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.173 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -117.86 -155.75 0.61 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.952 178.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 129.59 162.16 10.76 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.628 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.507 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -110.75 -39.54 4.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.138 0.494 . . . . 0.0 110.523 179.752 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -84.61 -177.15 6.53 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.455 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.66 -15.01 15.09 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.585 177.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.432 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 7.4 m-85 -138.88 178.52 7.1 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.35 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.432 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 65.6 m-85 -155.64 164.87 38.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.642 0.258 . . . . 0.0 110.9 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.432 ' CG2' ' HG2' ' A' ' 70' ' ' LYS . 19.7 p -148.18 -175.29 4.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.005 0.431 . . . . 0.0 111.567 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.441 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 28.8 p-10 -52.92 95.65 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.348 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.04 20.35 2.52 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.231 -0.895 . . . . 0.0 113.261 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.24 147.35 33.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 117.051 0.425 . . . . 0.0 110.965 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.494 HG22 ' N ' ' A' ' 95' ' ' VAL . 33.7 m -128.45 158.44 40.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.005 0.431 . . . . 0.0 111.185 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.533 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 14.0 t -151.67 147.34 15.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.709 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.874 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -106.96 131.41 54.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.852 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 1.001 ' CE1' HG21 ' A' ' 111' ' ' VAL . 5.0 m-85 -88.95 159.08 17.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.516 -178.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 49.7 m -151.97 138.89 19.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.947 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.436 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 84.1 m -73.43 156.25 38.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.499 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.467 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 40.8 m-20 -91.35 -71.97 0.61 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.313 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.6 t -53.51 -23.32 10.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.968 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.2 29.03 1.7 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.557 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.497 ' CE1' HG12 ' A' ' 126' ' ' ILE . 24.0 m-85 -73.98 -174.82 1.97 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.021 0.439 . . . . 0.0 110.365 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -123.35 99.19 6.21 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 176.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.666 HD21 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -52.57 152.95 3.33 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 122.277 1.036 . . . . 0.0 112.387 -175.285 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.479 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 40.6 mm -119.01 150.3 21.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 113.149 -1.841 . . . . 0.0 111.138 -175.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 72.52 33.99 60.59 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.032 -1.08 . . . . 0.0 111.746 -178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 54.05 145.86 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 124.357 1.063 . . . . 0.0 112.997 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.874 ' HB2' HG22 ' A' ' 96' ' ' THR . 0.7 OUTLIER -71.91 -23.48 61.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.764 -178.756 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -62.14 128.24 41.69 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.764 -0.732 . . . . 0.0 113.009 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 1.001 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.5 t -128.9 125.38 62.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.885 HD22 ' N ' ' A' ' 113' ' ' CYS . 1.2 tm? -85.82 135.53 33.68 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.884 0.373 . . . . 0.0 111.456 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.885 ' N ' HD22 ' A' ' 112' ' ' LEU . 39.1 t -108.01 104.8 14.32 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.232 177.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.689 ' OG ' HD11 ' A' ' 112' ' ' LEU . 0.9 OUTLIER -164.83 124.04 1.82 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.923 0.392 . . . . 0.0 111.349 179.865 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.23 26.17 11.57 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.409 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.44 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 68.43 13.51 65.4 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.6 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -145.8 172.3 13.52 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.875 0.369 . . . . 0.0 110.702 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.54 ' CZ3' ' HB2' ' A' ' 113' ' ' CYS . 92.5 m95 -111.27 141.67 44.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.876 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.18 163.81 16.09 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.427 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.448 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 3.7 p-10 46.58 48.66 5.79 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.332 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.47 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 91.0 Cg_endo -78.5 146.58 21.82 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.496 2.131 . . . . 0.0 110.572 176.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.567 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 56.6 Cg_endo -97.65 -177.44 0.29 Allowed 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 122.048 1.832 . . . . 0.0 114.357 -176.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -118.21 -156.25 0.63 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.273 -1.331 . . . . 0.0 109.018 177.788 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 124' ' ' CYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 105' ' ' LEU . 2.0 m -152.65 89.1 1.38 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.061 0.458 . . . . 0.0 110.788 177.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -121.45 160.13 24.79 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.658 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.511 ' O ' HG22 ' A' ' 126' ' ' ILE . 16.8 mm . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.053 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.927 0.394 . . . . 0.0 110.785 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.512 ' HD2' HG23 ' A' ' 25' ' ' VAL . 18.6 mtm180 -61.81 150.51 36.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.541 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.554 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 55.6 m -69.42 179.09 0.79 Allowed Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.5 178.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.554 ' CD ' ' HB3' ' A' ' 9' ' ' CYS . 17.9 Cg_endo -88.84 -171.71 0.61 Allowed 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.637 2.225 . . . . 0.0 111.598 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.433 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 2.6 t -57.23 106.22 0.65 Allowed Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.452 ' HG3' ' CD1' ' A' ' 22' ' ' ILE . 9.6 Cg_endo -52.44 162.75 2.05 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.107 1.872 . . . . 0.0 112.029 -178.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.427 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -62.27 -175.94 0.09 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.025 179.159 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -143.09 -175.36 4.49 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.165 0.507 . . . . 0.0 111.268 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.451 HG22 ' CD2' ' A' ' 20' ' ' LEU . 13.7 tt -145.23 158.45 13.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.735 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -93.91 -55.2 3.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.446 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -91.91 45.79 1.24 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.981 0.419 . . . . 0.0 110.858 -179.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 34' ' ' SER . . . -177.18 -179.14 47.38 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.996 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -136.74 137.6 40.07 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.8 0.333 . . . . 0.0 110.392 179.626 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.887 HD21 ' CE2' ' A' ' 33' ' ' TYR . 19.3 mt -82.74 154.87 24.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.033 0.444 . . . . 0.0 111.537 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -124.45 84.06 2.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.089 178.515 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.873 ' HA ' HG23 ' A' ' 31' ' ' ILE . 3.8 mm -68.68 108.94 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.676 -177.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -112.51 19.99 21.2 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.002 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 147.31 127.14 1.73 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.309 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.512 HG23 ' HD2' ' A' ' 8' ' ' ARG . 35.9 m -116.52 21.09 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.643 0.258 . . . . 0.0 111.47 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -91.01 151.91 20.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.819 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.509 ' CZ ' HD12 ' A' ' 51' ' ' LEU . 9.2 t80 -52.27 96.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.832 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 122.6 13.01 4.83 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.957 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.6 m -101.23 -162.64 0.95 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.862 0.331 . . . . 0.0 110.427 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 47' ' ' SER . 0.9 OUTLIER -166.01 146.62 6.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.05 0.452 . . . . 0.0 111.347 179.12 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.873 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -104.05 172.91 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.364 179.614 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.468 ' H ' HG22 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -134.52 115.14 13.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.922 0.392 . . . . 0.0 111.038 179.722 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.887 ' CE2' HD21 ' A' ' 20' ' ' LEU . 19.2 m-85 -88.16 149.45 23.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.034 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.42 ' O ' ' N ' ' A' ' 19' ' ' GLN . 81.4 p -151.24 154.17 36.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.651 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.442 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 6.3 m -78.04 167.87 20.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.787 0.327 . . . . 0.0 110.868 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -69.01 -83.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.407 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.04 132.08 11.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.889 0.376 . . . . 0.0 110.982 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.48 22.58 76.54 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.98 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.603 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.2 m-85 -117.43 -179.93 3.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.972 0.415 . . . . 0.0 110.908 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.557 ' NE2' HD11 ' A' ' 42' ' ' ILE . 5.2 p-80 -144.79 114.73 7.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.25 178.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.923 HD21 ' O ' ' A' ' 44' ' ' GLU . 7.5 tt -73.91 126.14 29.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.594 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.557 HD11 ' NE2' ' A' ' 40' ' ' HIS . 1.7 mm -101.99 156.06 4.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.004 0.43 . . . . 0.0 110.945 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.29 -147.32 39.02 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.271 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.923 ' O ' HD21 ' A' ' 41' ' ' LEU . 3.4 pt-20 -65.98 -176.22 0.38 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.928 0.394 . . . . 0.0 110.633 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.2 t -163.91 25.9 0.08 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.945 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.402 ' HG3' ' HA ' ' A' ' 32' ' ' THR . 10.7 mtpt -152.88 128.16 9.85 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.966 0.412 . . . . 0.0 112.02 -178.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.478 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 1.0 OUTLIER -92.16 142.09 27.88 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 176.572 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.548 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.2 m-85 -117.22 120.28 37.79 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 119.099 -1.04 . . . . 0.0 112.255 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 34.8 t -71.57 100.78 2.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.753 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.46 -173.4 2.67 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.014 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.509 HD12 ' CZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -100.44 150.6 22.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.873 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.19 -147.88 1.32 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.432 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.8 -38.23 13.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.759 0.314 . . . . 0.0 110.948 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 72.7 p -102.33 45.62 0.96 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.983 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 63.22 20.52 63.05 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.647 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.22 -161.73 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.787 0.327 . . . . 0.0 110.886 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.8 140.76 51.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.186 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.1 m -151.97 173.99 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.975 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.533 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 72.8 m95 -126.82 123.21 36.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.357 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.548 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 1.0 OUTLIER -69.99 166.32 34.12 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.363 178.578 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.459 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 76.7 Cg_exo -21.57 97.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 125.044 3.829 . . . . 0.0 114.163 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.448 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -94.85 -78.34 0.45 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.05 -177.933 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.463 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -78.07 108.25 7.15 Favored Pre-proline 0 C--N 1.331 -0.216 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -176.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.91 ' HG2' HD11 ' A' ' 41' ' ' LEU . 2.4 Cg_endo -87.3 -156.19 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.115 2.543 . . . . 0.0 111.016 177.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.554 HG22 ' H ' ' A' ' 66' ' ' CYS . 2.9 mm -88.89 169.25 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.967 0.413 . . . . 0.0 110.67 178.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.554 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.0 OUTLIER -169.97 134.29 1.28 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.734 179.273 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.467 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 1.4 tt0 -155.06 -177.84 6.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.54 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.603 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 2.7 p -75.02 147.59 40.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.646 0.736 . . . . 0.0 111.336 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.646 HG23 ' N ' ' A' ' 116' ' ' GLY . 0.0 OUTLIER -61.86 100.72 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 114.504 -1.226 . . . . 0.0 110.312 -179.371 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 89' ' ' TYR . 0.3 OUTLIER -105.62 119.42 39.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.3 -178.222 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.27 119.26 38.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.467 176.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -69.28 -157.93 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.412 -179.513 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.405 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 2.4 t -51.66 136.66 34.04 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.625 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.756 ' CG ' HG21 ' A' ' 95' ' ' VAL . 52.2 Cg_exo -55.05 159.17 10.12 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.411 2.074 . . . . 0.0 112.302 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.419 ' N ' ' OH ' ' A' ' 97' ' ' TYR . 89.5 Cg_exo -44.39 156.44 0.21 Allowed 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.632 2.221 . . . . 0.0 112.597 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 95.6 p -102.94 89.87 3.59 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.775 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.567 HG23 ' HE2' ' A' ' 97' ' ' TYR . 10.3 pt -69.61 176.29 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.127 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.79 143.54 26.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.974 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.465 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 12.5 m-80 52.86 29.5 7.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.148 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.461 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -162.15 -169.16 25.11 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.275 -0.964 . . . . 0.0 113.353 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.72 -173.98 3.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.872 0.368 . . . . 0.0 110.489 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.484 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 7.3 p-80 -113.28 167.17 10.78 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.558 -179.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 96' ' ' THR . 16.2 m-20 -94.23 17.12 13.27 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.832 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.452 ' HA2' ' OH ' ' A' ' 89' ' ' TYR . . . -48.76 136.41 18.88 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.028 -1.082 . . . . 0.0 112.961 -176.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -108.3 -37.22 6.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.964 0.411 . . . . 0.0 111.01 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.87 -175.99 3.32 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.043 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.11 -24.6 16.22 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.78 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.433 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 7.3 m-85 -135.6 169.67 17.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.761 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.472 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 22.4 m-85 -141.8 162.33 35.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.13 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.4 p -122.25 174.91 6.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.173 0.511 . . . . 0.0 112.123 -177.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.436 ' HB3' ' HB ' ' A' ' 69' ' ' VAL . 10.2 p-10 -60.29 95.53 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.163 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 122.46 18.19 3.4 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.291 -0.868 . . . . 0.0 113.075 178.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.09 157.02 16.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.739 0.304 . . . . 0.0 110.595 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 28.6 m -143.52 141.87 25.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.225 0.536 . . . . 0.0 111.152 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.83 HG22 ' CH2' ' A' ' 118' ' ' TRP . 40.2 t -142.48 142.1 27.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.941 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.512 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -89.01 149.54 23.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.646 -177.079 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.756 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.1 m-85 -105.16 159.63 15.71 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.986 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.691 ' HA ' HD13 ' A' ' 105' ' ' LEU . 58.0 m -157.17 153.65 28.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.039 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.414 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 59.5 m -80.02 160.9 25.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.816 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.461 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 60.2 m-20 -87.59 -70.93 0.59 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.418 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.42 -27.62 67.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.24 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.57 35.53 0.49 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.791 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.502 ' CE2' HG12 ' A' ' 126' ' ' ILE . 15.8 m-85 -70.78 -174.68 0.95 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.914 0.387 . . . . 0.0 110.587 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.4 98.16 7.61 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.162 178.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.691 HD13 ' HA ' ' A' ' 98' ' ' SER . 0.3 OUTLIER -46.47 122.53 4.17 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.507 0.67 . . . . 0.0 112.268 -177.747 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.843 HD11 ' HB2' ' A' ' 125' ' ' GLN . 5.1 mm -85.06 154.73 3.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.938 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.85 -126.1 33.94 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.209 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -123.48 140.99 52.45 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.936 0.398 . . . . 0.0 111.024 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.618 ' HB2' HD22 ' A' ' 105' ' ' LEU . 1.8 t -73.05 -29.41 62.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.948 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -78.23 127.83 8.4 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.002 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.756 HG21 ' CE1' ' A' ' 97' ' ' TYR . 3.1 t -118.41 139.97 43.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 178.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.81 131.51 43.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.146 0.498 . . . . 0.0 111.567 -178.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.494 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 12.0 t -97.45 95.16 7.47 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.446 176.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.9 t -151.07 153.14 34.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.455 -178.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.12 -0.56 62.64 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.645 -0.707 . . . . 0.0 113.491 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.646 ' N ' HG23 ' A' ' 69' ' ' VAL . . . 100.24 1.54 55.79 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.902 -177.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -146.3 177.12 9.25 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.821 0.343 . . . . 0.0 110.708 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.83 ' CH2' HG22 ' A' ' 95' ' ' VAL . 95.2 m95 -99.01 155.61 17.34 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.717 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.585 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -143.09 155.28 44.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.031 0.444 . . . . 0.0 111.19 -179.844 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.481 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.7 OUTLIER 66.22 47.0 0.49 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.798 179.599 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 87.0 Cg_endo -79.4 139.3 14.5 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.476 2.117 . . . . 0.0 111.698 178.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.513 ' CG ' HD21 ' A' ' 105' ' ' LEU . 50.3 Cg_endo -90.61 -174.72 0.76 Allowed 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.5 2.133 . . . . 0.0 113.2 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.449 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -128.4 -157.79 0.84 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.499 177.576 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 124' ' ' CYS . . . . . 0.483 ' SG ' HD12 ' A' ' 105' ' ' LEU . 3.5 m -157.6 89.56 1.04 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.13 0.491 . . . . 0.0 111.133 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.843 ' HB2' HD11 ' A' ' 106' ' ' ILE . 16.4 mt-30 -114.5 170.87 7.99 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.783 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.502 HG12 ' CE2' ' A' ' 103' ' ' TYR . 49.1 mm . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.792 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? . . . . . 0 C--O 1.231 0.13 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.448 ' CD ' HG23 ' A' ' 25' ' ' VAL . 0.0 OUTLIER 42.88 -164.13 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.851 0.358 . . . . 0.0 111.394 178.767 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.486 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 15.1 m -78.67 161.62 68.58 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.448 178.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.02 167.32 25.13 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.338 2.025 . . . . 0.0 111.703 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 t -51.02 105.44 0.52 Allowed Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.936 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.68 ' HG2' HD13 ' A' ' 22' ' ' ILE . 51.3 Cg_exo -50.76 151.07 11.46 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.151 1.901 . . . . 0.0 111.731 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.933 ' O ' HD11 ' A' ' 20' ' ' LEU . 7.1 mpt_? -55.7 159.24 3.11 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.82 -173.85 2.33 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.2 0.524 . . . . 0.0 111.615 -177.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.2 tt -152.57 138.92 12.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.539 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -82.2 -57.31 3.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.676 -177.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.504 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 1.9 m-20 -91.2 45.84 1.27 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.055 0.455 . . . . 0.0 111.069 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -176.65 -179.46 47.09 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.39 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.64 137.36 41.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.815 0.341 . . . . 0.0 110.773 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.933 HD11 ' O ' ' A' ' 13' ' ' ARG . 14.5 mt -75.9 152.15 37.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.215 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.462 ' HB3' ' CB ' ' A' ' 32' ' ' THR . 19.4 t0 -120.92 69.64 0.89 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.447 177.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.821 ' HA ' HG23 ' A' ' 31' ' ' ILE . 1.1 mt -80.84 90.95 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.883 -176.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.85 16.13 59.07 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.81 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 29' ' ' SER . . . 165.83 133.21 1.48 Allowed Glycine 0 C--N 1.334 0.435 0 C-N-CA 121.176 -0.535 . . . . 0.0 111.765 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.448 HG23 ' CD ' ' A' ' 8' ' ' ARG . 1.7 m -119.43 -2.54 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -178.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -75.88 164.13 26.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.986 0.422 . . . . 0.0 110.814 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.54 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 13.1 t80 -52.03 115.81 1.88 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.09 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.73 -4.59 46.57 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.764 -0.731 . . . . 0.0 113.066 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 24' ' ' GLY . 57.9 m -74.99 176.83 6.81 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 117.029 0.415 . . . . 0.0 110.602 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 47' ' ' SER . 2.5 p -144.47 149.99 36.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.952 0.406 . . . . 0.0 111.464 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.821 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -118.74 165.83 13.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.468 179.353 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.462 ' CB ' ' HB3' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -135.9 111.75 9.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.896 178.547 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.697 ' CE2' HD21 ' A' ' 20' ' ' LEU . 31.6 m-85 -84.06 135.78 34.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.062 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 84.4 p -141.05 146.86 37.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.154 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.479 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 1.7 m -73.38 174.31 8.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.794 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.68 -82.42 0.06 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.39 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.2 m -155.14 120.16 4.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.476 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.579 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 77.42 -0.58 68.69 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.475 -177.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.517 ' CZ ' ' CB ' ' A' ' 68' ' ' SER . 5.9 m-85 -89.48 166.43 13.69 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 120.782 0.325 . . . . 0.0 110.832 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.599 ' NE2' HG22 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -121.46 127.68 51.34 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 176.578 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.849 HD21 ' O ' ' A' ' 44' ' ' GLU . 6.0 tt -86.02 117.2 24.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.135 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.448 ' HB ' ' HB ' ' A' ' 65' ' ' ILE . 2.1 mm -92.41 153.83 3.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.475 -177.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.82 -151.29 50.27 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.26 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.849 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -55.28 178.92 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.534 0.206 . . . . 0.0 110.536 179.504 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.447 ' HB3' HD22 ' A' ' 41' ' ' LEU . 6.6 p -152.14 18.8 0.66 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.608 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.411 ' HG3' ' HA ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -154.77 175.72 13.36 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.923 0.392 . . . . 0.0 110.958 -178.648 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.469 ' HB2' ' CG1' ' A' ' 31' ' ' ILE . 2.6 m -149.63 123.03 9.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.297 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.408 ' CE1' ' HD3' ' A' ' 61' ' ' PRO . 4.9 m-85 -103.0 114.16 28.23 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.973 0.416 . . . . 0.0 111.452 -178.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.471 ' HB2' ' CZ3' ' A' ' 59' ' ' TRP . 42.2 t -64.97 77.44 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.374 0.607 . . . . 0.0 110.076 178.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.5 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 1.9 tt0 -97.33 175.13 6.37 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.907 -177.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.54 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -88.0 138.57 31.33 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.106 -179.551 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.29 -148.07 0.55 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.754 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -92.04 -38.73 12.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.712 0.292 . . . . 0.0 111.186 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.0 p -91.67 40.57 1.04 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.183 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 62.19 19.24 59.19 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.551 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.08 -161.36 0.63 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.702 0.287 . . . . 0.0 110.725 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.442 ' HA ' ' HA ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -134.16 116.99 16.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.71 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.1 m -126.03 -176.79 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.383 -178.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.668 ' CE3' HD11 ' A' ' 31' ' ' ILE . 97.5 m95 -116.38 125.6 52.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.126 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -150.08 118.73 3.68 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.771 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.408 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 8.9 Cg_exo -73.21 -172.16 9.47 Favored 'Cis proline' 0 C--N 1.35 0.633 0 C-N-CA 124.221 -1.158 . . . . 0.0 112.413 1.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -111.11 -152.5 0.5 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.891 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.524 ' CB ' ' CE2' ' A' ' 33' ' ' TYR . . . -79.38 111.27 19.31 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.651 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.439 ' CG ' ' O ' ' A' ' 44' ' ' GLU . 15.3 Cg_exo -69.07 -150.76 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.662 2.241 . . . . 0.0 112.296 -179.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.569 HG22 ' H ' ' A' ' 66' ' ' CYS . 0.4 OUTLIER -108.36 -179.69 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.117 0.484 . . . . 0.0 111.222 -179.324 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.569 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.0 OUTLIER -167.43 118.52 0.87 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.524 179.454 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.469 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 0.1 OUTLIER -113.4 166.74 11.2 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.689 179.888 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.517 ' CB ' ' CZ ' ' A' ' 39' ' ' TYR . 1.1 p -107.53 120.42 42.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.993 0.425 . . . . 0.0 111.047 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.599 HG22 ' NE2' ' A' ' 40' ' ' HIS . 3.1 p -46.4 94.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.439 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.44 ' HE2' HG23 ' A' ' 90' ' ' THR . 0.2 OUTLIER -76.8 125.44 29.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.276 -179.581 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.432 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -104.33 126.06 51.1 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.326 178.953 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -73.62 -169.12 0.65 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.472 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -42.42 135.05 2.59 Favored Pre-proline 0 N--CA 1.438 -1.065 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.436 178.948 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.513 ' HG2' HG11 ' A' ' 95' ' ' VAL . 34.5 Cg_exo -56.05 159.88 11.45 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.188 1.925 . . . . 0.0 111.923 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.516 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 96.1 Cg_exo -40.85 156.6 0.05 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.757 2.305 . . . . 0.0 112.855 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.3 m -108.5 90.12 3.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.647 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.647 HG21 ' O ' ' A' ' 122' ' ' PRO . 16.5 pt -69.41 170.85 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.298 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.39 133.78 35.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.777 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.508 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 0.1 OUTLIER 67.9 26.41 7.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.602 -179.643 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -171.44 -170.83 35.96 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.732 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.15 -175.47 2.0 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.958 0.409 . . . . 0.0 110.801 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.442 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 12.3 p80 -95.04 176.11 6.37 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.891 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -121.8 21.75 10.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.169 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.402 ' HA3' ' OH ' ' A' ' 89' ' ' TYR . . . -52.26 150.76 8.27 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.618 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -107.65 -28.65 9.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.067 0.46 . . . . 0.0 110.529 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.57 -172.2 2.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.637 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.75 -21.8 12.72 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.125 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.414 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 6.0 m-85 -139.07 168.98 18.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.976 0.417 . . . . 0.0 111.154 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.432 ' N ' ' O ' ' A' ' 71' ' ' CYS . 33.0 m-85 -145.05 170.32 16.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.613 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.44 HG23 ' HE2' ' A' ' 70' ' ' LYS . 14.4 p -133.25 175.38 9.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.913 0.387 . . . . 0.0 111.18 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 23.1 p-10 -60.19 94.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.307 0.575 . . . . 0.0 111.038 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 128.31 28.1 0.86 Allowed Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.294 -0.866 . . . . 0.0 113.18 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.405 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -110.11 164.88 12.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.791 0.295 . . . . 0.0 110.661 179.24 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.429 HG22 ' N ' ' A' ' 95' ' ' VAL . 33.5 m -138.47 154.81 27.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.067 0.461 . . . . 0.0 111.274 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.513 HG11 ' HG2' ' A' ' 74' ' ' PRO . 21.7 t -152.42 148.5 14.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.021 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.706 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -104.99 142.94 33.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.306 179.007 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.972 ' CE2' HG21 ' A' ' 111' ' ' VAL . 4.6 m-85 -101.43 155.4 18.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.946 0.403 . . . . 0.0 111.279 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.416 ' HA ' HD13 ' A' ' 105' ' ' LEU . 45.9 m -148.57 141.93 25.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.165 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.431 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 73.5 m -72.75 162.35 29.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.759 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.4 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 39.7 m-20 -92.74 -70.59 0.69 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.347 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.5 m -63.79 -23.37 67.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.198 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 122.21 33.0 0.93 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.495 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.508 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 22.6 m-85 -69.9 -176.95 1.19 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.022 0.439 . . . . 0.0 110.725 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.2 m -108.11 101.73 10.94 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.185 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.649 HD22 ' HB2' ' A' ' 109' ' ' SER . 0.2 OUTLIER -46.32 125.18 6.44 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.426 0.631 . . . . 0.0 111.771 -178.255 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.44 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 34.6 mm -90.79 152.1 3.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.931 -1.032 . . . . 0.0 110.282 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 68.86 -127.49 22.33 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.257 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -125.59 132.48 52.51 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.712 0.291 . . . . 0.0 110.946 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.706 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.9 t -62.87 -33.16 74.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.773 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -66.03 139.42 38.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.781 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.972 HG21 ' CE2' ' A' ' 97' ' ' TYR . 3.0 t -136.44 119.91 23.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.571 0.224 . . . . 0.0 110.705 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.93 128.72 33.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.965 0.412 . . . . 0.0 111.47 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.52 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 17.7 t -92.8 102.29 14.68 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 176.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 3.1 p -144.54 162.86 35.51 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.074 0.464 . . . . 0.0 111.401 -177.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.2 29.0 4.66 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.778 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.436 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 70.15 16.15 72.78 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.4 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -141.51 -177.76 5.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.869 0.366 . . . . 0.0 110.659 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.52 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 95.1 m95 -117.04 142.19 47.29 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.082 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.18 149.92 47.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.247 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.488 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 2.0 t0 70.14 46.01 0.27 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.036 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 84.1 Cg_endo -78.18 134.43 12.9 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.442 2.095 . . . . 0.0 111.831 178.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.647 ' O ' HG21 ' A' ' 77' ' ' ILE . 73.9 Cg_endo -89.05 -173.06 0.74 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.62 2.214 . . . . 0.0 113.432 -178.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.401 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -131.39 -160.76 1.07 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.96 178.468 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 8.2 m -153.28 91.19 1.49 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.141 0.496 . . . . 0.0 110.957 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -122.39 157.74 31.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.616 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.551 ' O ' HG22 ' A' ' 126' ' ' ILE . 24.0 mm . . . . . 0 C--N 1.323 -0.584 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.932 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 29.1 mtt180 . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.969 0.414 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 26' ' ' ASP . 3.1 mtm180 40.04 -163.66 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.363 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.462 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 4.2 m -122.58 164.65 25.24 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.339 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 44.3 Cg_endo -66.13 168.05 16.7 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.145 1.897 . . . . 0.0 111.465 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.5 t -52.84 105.95 0.6 Allowed Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.047 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.76 ' HG2' HD13 ' A' ' 22' ' ' ILE . 17.2 Cg_exo -42.15 158.1 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.212 1.941 . . . . 0.0 112.164 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.452 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -74.87 166.93 22.84 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.155 178.411 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.735 ' HA ' HD11 ' A' ' 20' ' ' LEU . 12.0 p-10 -121.48 -175.21 3.03 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 121.079 0.466 . . . . 0.0 112.022 -176.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.848 HD12 ' O ' ' A' ' 64' ' ' PRO . 16.9 tt -151.52 147.21 15.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.715 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -87.2 156.72 19.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.219 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.523 ' CB ' ' CE1' ' A' ' 39' ' ' TYR . 0.9 OUTLIER 45.44 27.02 0.34 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.096 -179.611 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -147.38 176.96 25.97 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.207 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.54 136.23 34.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.787 0.327 . . . . 0.0 110.812 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.783 HD22 ' CE2' ' A' ' 33' ' ' TYR . 3.5 mt -87.7 159.26 18.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.62 178.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.424 ' CB ' ' HB ' ' A' ' 32' ' ' THR . 5.3 t0 -124.76 71.23 1.16 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.049 177.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.941 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.8 OUTLIER -74.19 95.38 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.776 -177.748 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.77 19.14 55.71 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.722 177.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 158.93 132.16 1.34 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.227 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.0 m -118.63 33.35 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.543 0.211 . . . . 0.0 111.521 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.443 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 43.9 t0 -105.0 162.87 12.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.043 0.449 . . . . 0.0 111.513 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.655 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 5.2 t80 -59.96 91.73 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.619 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.15 3.56 6.79 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.638 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.77 -165.84 1.39 Allowed 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.843 0.321 . . . . 0.0 110.312 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 67.4 p -162.84 146.81 11.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.298 0.57 . . . . 0.0 111.593 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.941 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -114.17 160.45 13.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.871 179.57 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.43 ' HA ' ' HG3' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -123.3 120.48 33.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.919 0.39 . . . . 0.0 110.899 179.184 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.783 ' CE2' HD22 ' A' ' 20' ' ' LEU . 2.2 m-85 -91.98 142.32 27.66 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.533 -178.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.91 164.82 37.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.669 -179.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.429 ' HA ' ' HA2' ' A' ' 18' ' ' GLY . 64.6 m -90.17 172.55 8.72 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.867 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.4 m-20 -78.17 -83.35 0.08 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.205 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.79 135.53 17.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.665 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.784 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 63.31 26.35 69.34 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.867 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.523 ' CE1' ' CB ' ' A' ' 17' ' ' ASN . 2.4 m-85 -120.11 171.28 8.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.807 0.337 . . . . 0.0 111.171 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.791 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -133.86 127.86 33.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.289 178.275 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.816 HD21 ' HG2' ' A' ' 64' ' ' PRO . 1.7 tt -87.72 124.6 33.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.671 -178.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.791 HD11 ' CE1' ' A' ' 40' ' ' HIS . 0.9 OUTLIER -108.06 131.34 58.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.312 0.577 . . . . 0.0 111.038 -179.432 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 112.86 -146.37 18.34 Favored Glycine 0 C--N 1.321 -0.261 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.204 -177.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.752 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -74.31 -135.59 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 176.912 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.42 ' HB2' ' O ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER 174.02 26.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 117.965 0.348 . . . . 0.0 110.784 177.71 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.493 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 4.3 mttt -160.22 134.49 7.4 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.786 -178.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.504 ' HB3' HD12 ' A' ' 31' ' ' ILE . 32.1 t -107.69 144.38 34.88 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.908 177.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.516 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 3.4 m-85 -126.41 120.27 29.36 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 119.41 -0.916 . . . . 0.0 112.461 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 32.5 t -64.01 99.28 0.25 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.538 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -124.2 -173.7 2.83 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.112 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.655 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -100.44 151.67 21.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.02 -179.348 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.41 -125.74 0.23 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.487 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.4 m -110.93 -32.37 6.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.87 0.367 . . . . 0.0 110.884 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 80.8 p -99.21 29.64 3.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.742 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.78 22.38 78.73 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.311 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.3 t -80.48 -161.63 0.39 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.916 0.389 . . . . 0.0 110.994 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.5 mmt -124.58 123.72 40.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.433 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.7 m -137.04 179.91 3.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.936 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.669 ' CZ3' HD11 ' A' ' 31' ' ' ILE . 66.5 m95 -124.74 127.18 46.84 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.289 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.516 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -69.53 168.97 13.75 Favored Pre-proline 0 CA--C 1.513 -0.449 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.923 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.487 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 1.0 OUTLIER -4.97 85.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.282 1 C-N-CA 125.326 4.017 . . . . 0.0 113.816 -179.107 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.634 ' O ' ' CZ ' ' A' ' 33' ' ' TYR . 15.3 mt-10 -69.09 -53.07 22.21 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-N 113.052 -1.885 . . . . 0.0 111.649 -174.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.649 ' CB ' ' HA ' ' A' ' 64' ' ' PRO . . . -65.31 -148.51 0.0 OUTLIER Pre-proline 0 CA--C 1.487 -1.454 0 CA-C-O 116.708 -1.615 . . . . 0.0 108.043 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.848 ' O ' HD12 ' A' ' 15' ' ' ILE . 3.9 Cg_exo -85.91 -157.44 1.25 Allowed 'Cis proline' 0 N--CA 1.484 0.934 0 CA-C-N 123.772 2.383 . . . . 0.0 115.013 16.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.601 ' N ' HD13 ' A' ' 65' ' ' ILE . 1.2 mm -95.68 175.01 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.0 -178.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.588 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.6 m -147.67 135.11 20.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.185 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.484 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 3.0 tt0 -140.55 174.06 10.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.755 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.472 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 37.4 p -89.03 118.87 29.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.984 0.421 . . . . 0.0 111.235 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.784 HG12 ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -40.59 98.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.728 179.773 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.415 ' HG2' HG22 ' A' ' 90' ' ' THR . 1.3 mmtp -67.71 137.04 55.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.389 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.03 124.77 50.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.13 178.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -69.26 -156.31 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.319 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.555 ' HG ' ' CE1' ' A' ' 82' ' ' HIS . 1.4 t -53.45 145.6 27.15 Favored Pre-proline 0 N--CA 1.45 -0.463 0 CA-C-O 120.59 0.234 . . . . 0.0 110.542 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.57 ' HG2' HG11 ' A' ' 95' ' ' VAL . 18.8 Cg_exo -65.29 160.63 41.4 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.53 2.154 . . . . 0.0 112.031 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.52 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 86.8 Cg_exo -40.54 156.68 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.801 2.334 . . . . 0.0 112.892 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.15 91.85 3.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.528 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.694 HG23 ' HE1' ' A' ' 97' ' ' TYR . 15.6 pt -68.98 175.91 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.07 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.9 m -94.49 140.91 29.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.912 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.5 ' HB3' ' CE1' ' A' ' 103' ' ' TYR . 7.0 m-80 57.47 29.25 16.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.989 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.46 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -163.57 -168.03 24.94 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.392 -0.909 . . . . 0.0 112.86 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 7.7 ptt85 -162.48 -175.91 4.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.007 0.432 . . . . 0.0 110.903 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.555 ' CE1' ' HG ' ' A' ' 73' ' ' SER . 4.6 p80 -111.18 172.12 7.07 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.625 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -96.91 -85.13 0.35 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.507 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.485 ' H ' HG13 ' A' ' 95' ' ' VAL . . . 60.92 142.74 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.959 178.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -113.71 -33.15 5.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.001 0.429 . . . . 0.0 110.724 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.16 -171.93 2.25 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.739 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.26 -22.27 15.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.272 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.432 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 7.0 m-85 -134.34 176.97 8.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.939 0.4 . . . . 0.0 111.333 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.432 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 62.8 m-85 -151.24 164.72 35.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.546 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.415 HG22 ' HG2' ' A' ' 70' ' ' LYS . 19.0 p -128.84 178.47 6.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.912 0.387 . . . . 0.0 111.114 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 14.5 t0 -64.55 101.5 0.46 Allowed 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 121.814 0.816 . . . . 0.0 111.01 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 121.55 21.39 3.01 Favored Glycine 0 C--N 1.311 -0.811 0 CA-C-N 114.312 -1.313 . . . . 0.0 112.993 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.39 160.79 14.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.845 0.322 . . . . 0.0 110.641 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 33.7 m -134.37 152.9 34.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.156 0.503 . . . . 0.0 111.515 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.57 HG11 ' HG2' ' A' ' 74' ' ' PRO . 27.7 t -146.49 148.71 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.688 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.734 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -105.51 132.87 51.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.96 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 1.005 ' CE2' HG21 ' A' ' 111' ' ' VAL . 5.2 m-85 -93.29 159.07 15.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.005 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 56.3 p -156.11 143.67 19.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.204 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.415 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 62.3 m -72.35 160.49 32.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.305 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.46 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 8.1 m-20 -94.45 -71.01 0.68 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.408 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.95 -21.77 66.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.455 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.65 30.88 1.2 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.694 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.505 ' CE2' HG12 ' A' ' 126' ' ' ILE . 51.1 m-85 -71.27 -172.72 0.76 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.658 0.266 . . . . 0.0 110.469 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -109.62 109.3 20.01 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.011 0.434 . . . . 0.0 111.146 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.564 HD23 ' HB2' ' A' ' 122' ' ' PRO . 2.7 tp -47.56 113.56 0.72 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.662 178.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.453 ' HB ' ' CB ' ' A' ' 123' ' ' THR . 39.0 mm -84.86 149.73 4.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.495 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 59.93 -132.43 50.92 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.385 -0.912 . . . . 0.0 111.794 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -112.29 133.45 54.4 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.826 0.346 . . . . 0.0 111.477 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.734 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.3 t -64.92 -27.31 68.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.44 178.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.34 138.95 31.37 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.836 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 1.005 HG21 ' CE2' ' A' ' 97' ' ' TYR . 3.1 t -134.98 123.83 41.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.462 0.173 . . . . 0.0 110.576 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.5 126.94 32.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.964 0.411 . . . . 0.0 111.976 -178.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.516 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 16.4 t -92.4 104.8 17.09 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 176.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 83.1 p -151.79 165.68 33.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.947 -177.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.99 30.71 5.27 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.865 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.434 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 67.9 8.79 54.69 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.51 -179.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -136.98 179.51 6.34 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.817 0.341 . . . . 0.0 110.771 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.52 ' CD1' ' HD3' ' A' ' 75' ' ' PRO . 94.2 m95 -113.5 136.58 52.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.901 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.77 155.86 37.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.134 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.522 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 34.6 t0 67.99 41.94 0.25 Allowed Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 81.4 Cg_endo -78.52 143.21 19.04 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.431 2.087 . . . . 0.0 112.03 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.564 ' HB2' HD23 ' A' ' 105' ' ' LEU . 57.4 Cg_endo -91.19 -172.66 0.49 Allowed 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.895 2.397 . . . . 0.0 113.353 -179.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.453 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -133.47 -177.19 4.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.274 178.097 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 6.4 m -142.13 96.68 3.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.972 0.415 . . . . 0.0 110.908 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -121.23 170.1 9.91 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.81 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.565 ' O ' HG22 ' A' ' 126' ' ' ILE . 36.5 mm . . . . . 0 C--N 1.324 -0.515 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.823 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.622 0.248 . . . . 0.0 110.661 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.423 ' CD ' HG23 ' A' ' 25' ' ' VAL . 0.0 OUTLIER 42.11 -162.26 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.549 178.866 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.433 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 6.9 m -87.56 162.29 42.69 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.638 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.29 169.26 20.0 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.275 1.983 . . . . 0.0 111.532 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -50.47 111.81 2.43 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.021 -179.342 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.53 157.42 58.42 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.495 2.13 . . . . 0.0 112.002 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.779 ' O ' HD11 ' A' ' 20' ' ' LEU . 10.4 ttt180 -53.85 -179.74 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.956 178.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.74 ' O ' HG22 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -141.3 -3.26 1.2 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -177.662 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.74 HG22 ' O ' ' A' ' 14' ' ' ASP . 15.6 tt 56.03 156.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 122.599 0.36 . . . . 0.0 111.114 -177.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -88.37 -63.34 1.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -176.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.418 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 0.7 OUTLIER -92.42 26.04 2.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.442 -177.797 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.425 ' HA2' ' N ' ' A' ' 36' ' ' ASN . . . -147.8 177.69 25.9 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.955 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 34' ' ' SER . 1.2 mt-30 -137.61 139.08 40.15 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.815 HD13 ' CZ ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -94.6 174.37 7.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.311 0.577 . . . . 0.0 111.532 -178.395 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 32' ' ' THR . 10.0 t0 -133.12 88.34 2.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.562 177.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.902 ' HA ' HG23 ' A' ' 31' ' ' ILE . 59.9 mt -71.58 115.79 12.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.091 -177.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -122.44 19.06 8.15 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.666 177.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 159.83 131.94 1.3 Allowed Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.423 HG23 ' CD ' ' A' ' 8' ' ' ARG . 6.6 m -124.24 5.36 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -77.33 164.46 25.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.036 0.446 . . . . 0.0 110.983 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.635 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 4.8 t80 -57.1 101.83 0.07 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.201 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 115.45 7.7 15.73 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.958 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.2 p -88.76 -169.11 2.41 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.924 0.362 . . . . 0.0 110.62 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.4 p -160.16 151.3 19.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.953 0.406 . . . . 0.0 111.391 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.902 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.8 OUTLIER -115.78 169.84 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.477 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -123.27 113.1 18.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.956 0.408 . . . . 0.0 111.186 179.259 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.815 ' CZ ' HD13 ' A' ' 20' ' ' LEU . 17.3 m-85 -88.86 140.92 28.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.218 0.533 . . . . 0.0 111.718 -179.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 19' ' ' GLN . 0.4 OUTLIER -144.92 170.69 15.66 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.231 179.151 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.429 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 1.7 m -89.19 166.14 14.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.716 0.293 . . . . 0.0 110.903 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.425 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 1.6 m120 -64.42 -84.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.029 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.86 134.02 13.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.81 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.731 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 63.89 23.62 67.66 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.093 -179.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.496 ' CE2' ' HB2' ' A' ' 68' ' ' SER . 2.5 m-85 -115.88 174.27 6.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.81 0.338 . . . . 0.0 111.007 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.686 ' NE2' HD11 ' A' ' 42' ' ' ILE . 3.2 p-80 -137.21 112.57 9.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.46 178.142 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.917 HD21 ' O ' ' A' ' 44' ' ' GLU . 4.5 tt -77.51 130.63 37.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.772 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.686 HD11 ' NE2' ' A' ' 40' ' ' HIS . 2.6 mm -105.52 154.17 6.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.851 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.07 -137.9 17.83 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.273 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.917 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -79.83 -174.21 4.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.948 0.404 . . . . 0.0 110.931 179.599 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.1 p -160.55 25.48 0.15 Allowed 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.067 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.41 ' HG3' ' HA ' ' A' ' 32' ' ' THR . 6.3 mtpt -152.29 132.11 13.27 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.021 0.438 . . . . 0.0 112.179 -178.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.452 ' HB2' ' HA ' ' A' ' 62' ' ' GLU . 26.4 t -96.83 153.12 18.07 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.766 177.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.5 ' CD1' ' HB3' ' A' ' 60' ' ' ASN . 1.4 m-85 -128.68 114.53 16.75 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 119.248 -0.981 . . . . 0.0 111.895 178.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 29.8 t -63.07 109.29 1.45 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.663 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.97 -176.49 4.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.045 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.904 HD23 ' O ' ' A' ' 56' ' ' SER . 5.0 mt -82.85 167.89 17.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.199 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -94.34 -107.31 2.01 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.455 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.0 t -131.67 -44.97 0.97 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.844 0.354 . . . . 0.0 110.923 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.3 p -97.11 27.13 4.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.722 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.28 17.66 58.63 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.485 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.904 ' O ' HD23 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -84.53 176.41 8.65 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 120.848 0.356 . . . . 0.0 111.194 -179.416 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.6 mmt -107.09 129.49 54.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.615 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.519 HG22 ' C ' ' A' ' 51' ' ' LEU . 31.0 m -138.68 -175.17 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.968 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.519 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 68.0 m95 -131.06 134.85 47.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.059 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.5 ' HB3' ' CD1' ' A' ' 48' ' ' TYR . 1.2 m-80 -75.06 166.6 44.13 Favored Pre-proline 0 CA--C 1.517 -0.297 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 177.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.467 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 23.2 Cg_exo -8.96 92.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 0.986 1 C-N-CA 125.568 4.178 . . . . 0.0 114.546 -179.559 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.469 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 3.6 mm-40 -82.91 -87.4 0.1 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.936 -175.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.506 ' HB1' HG13 ' A' ' 15' ' ' ILE . . . -96.32 108.18 40.18 Favored Pre-proline 0 C--N 1.332 -0.169 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -176.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.811 ' HG2' HD11 ' A' ' 41' ' ' LEU . 5.7 Cg_exo -74.71 -151.5 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.797 2.331 . . . . 0.0 111.334 177.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.507 HG22 ' H ' ' A' ' 66' ' ' CYS . 4.8 mm -88.8 166.24 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 0.0 110.712 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.507 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.8 OUTLIER -165.54 137.17 4.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.884 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.06 169.94 23.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.928 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.496 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 1.1 t -80.59 123.75 28.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.146 0.498 . . . . 0.0 111.008 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.731 HG12 ' O ' ' A' ' 38' ' ' GLY . 1.9 p -50.74 104.09 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.984 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.446 ' HD2' ' HB3' ' A' ' 88' ' ' PHE . 46.3 mmtt -71.43 121.65 18.97 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.128 -178.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.418 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -109.2 121.58 45.47 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 176.435 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -69.77 -162.02 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.513 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.599 ' HG ' ' CE1' ' A' ' 82' ' ' HIS . 1.1 t -53.32 141.58 41.63 Favored Pre-proline 0 N--CA 1.449 -0.487 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.328 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.474 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 24.9 Cg_exo -58.3 159.74 18.38 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.204 1.936 . . . . 0.0 111.515 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.426 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 78.1 Cg_exo -39.21 154.56 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.707 2.271 . . . . 0.0 112.799 -178.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.2 t -107.3 89.53 3.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.885 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.621 HG23 ' HE2' ' A' ' 97' ' ' TYR . 22.7 pt -70.12 -177.92 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.327 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.7 m -104.33 142.32 34.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.583 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.514 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 5.4 m-80 61.9 29.79 17.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.814 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.466 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . -175.78 -168.92 36.78 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.771 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -170.55 -174.66 1.68 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.907 0.384 . . . . 0.0 110.535 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.599 ' CE1' ' HG ' ' A' ' 73' ' ' SER . 2.1 p80 -103.15 170.94 7.66 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.152 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -103.93 18.86 21.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.322 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.42 ' CA ' ' OH ' ' A' ' 89' ' ' TYR . . . -55.07 140.93 38.14 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.232 -0.985 . . . . 0.0 112.498 -179.201 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -108.31 -27.81 9.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.978 0.418 . . . . 0.0 110.675 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.75 -172.24 2.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.722 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -104.11 -24.79 13.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.968 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.446 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 10.5 m-85 -134.65 175.98 9.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.094 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.435 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 59.1 m-85 -148.82 152.74 37.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.665 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.4 p -102.0 175.18 5.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.099 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.9 103.12 2.13 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.652 0.739 . . . . 0.0 110.65 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 120.55 24.66 2.56 Favored Glycine 0 C--N 1.312 -0.778 0 CA-C-N 114.588 -1.187 . . . . 0.0 112.751 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.54 163.57 12.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.711 0.291 . . . . 0.0 110.627 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.507 HG22 ' N ' ' A' ' 95' ' ' VAL . 32.6 m -136.27 158.48 38.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.17 0.51 . . . . 0.0 111.333 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.507 ' N ' HG22 ' A' ' 94' ' ' VAL . 22.1 t -153.07 150.4 12.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.769 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.941 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -108.4 136.36 48.16 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.355 178.994 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.875 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.9 m-85 -93.81 155.57 17.13 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.938 0.399 . . . . 0.0 110.987 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -154.81 144.78 21.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.408 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.466 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 9.5 m -69.95 169.14 13.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.843 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -99.33 -83.81 0.42 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.531 178.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.9 t -54.01 -36.78 63.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.247 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 136.19 47.38 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.548 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.55 ' CE2' HG12 ' A' ' 126' ' ' ILE . 12.4 m-85 -83.77 -170.18 2.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.672 0.272 . . . . 0.0 110.653 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.4 m -116.92 102.3 9.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.726 0.298 . . . . 0.0 110.821 179.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.529 HD11 ' HB3' ' A' ' 97' ' ' TYR . 0.2 OUTLIER -48.38 136.95 11.88 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.632 0.729 . . . . 0.0 111.193 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.481 HG22 ' N ' ' A' ' 107' ' ' GLY . 33.2 mm -103.43 158.86 4.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.304 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.481 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 62.38 -126.1 37.17 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.309 -0.948 . . . . 0.0 112.021 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -124.12 131.72 53.57 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.981 0.42 . . . . 0.0 111.121 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.941 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.2 p -62.77 -26.52 68.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.857 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.2 142.29 31.38 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.821 -0.627 . . . . 0.0 113.014 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.875 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.8 t -140.05 127.02 23.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.98 122.25 32.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.873 0.368 . . . . 0.0 111.807 -178.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.521 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 15.5 t -85.16 101.26 12.33 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 176.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.45 167.19 25.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.047 0.451 . . . . 0.0 111.527 -178.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.24 25.11 2.61 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.665 -0.698 . . . . 0.0 113.033 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.82 19.7 79.48 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.222 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -151.31 -179.3 7.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.772 0.32 . . . . 0.0 110.297 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.521 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 90.1 m95 -113.23 138.53 49.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.898 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.41 146.63 46.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.236 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.48 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER 69.89 45.98 0.28 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.17 178.819 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 71.7 Cg_endo -76.95 136.77 16.89 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.313 2.009 . . . . 0.0 111.383 177.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.527 ' O ' HG21 ' A' ' 77' ' ' ILE . 56.6 Cg_endo -89.7 179.41 2.15 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.383 2.055 . . . . 0.0 113.582 -178.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.45 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -120.13 -159.99 0.81 Allowed 'General case' 0 CA--C 1.503 -0.858 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.955 176.707 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 124' ' ' CYS . . . . . 0.437 ' SG ' ' HB2' ' A' ' 103' ' ' TYR . 5.5 t -170.7 91.48 0.16 Allowed 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.376 -176.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -118.92 176.57 5.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.812 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.595 ' O ' HG22 ' A' ' 126' ' ' ILE . 39.1 mm . . . . . 0 C--N 1.322 -0.601 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.846 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.854 0.359 . . . . 0.0 111.002 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.459 ' HB2' ' HA ' ' A' ' 26' ' ' ASP . 7.7 ptt180 -65.8 -172.35 0.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.121 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.558 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 72.4 m -83.89 177.12 3.17 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.693 178.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.558 ' CD ' ' HB3' ' A' ' 9' ' ' CYS . 38.4 Cg_endo -90.78 -165.93 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.701 2.267 . . . . 0.0 112.025 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.39 108.22 1.35 Allowed Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.273 179.037 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.469 ' HB3' HD11 ' A' ' 31' ' ' ILE . 14.0 Cg_endo -56.67 149.31 59.71 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.153 1.902 . . . . 0.0 111.975 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.82 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.8 OUTLIER -59.25 173.43 0.49 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.28 179.645 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.62 -171.71 2.53 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.147 0.498 . . . . 0.0 111.506 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.582 HD12 ' O ' ' A' ' 64' ' ' PRO . 4.1 tt -151.82 147.23 15.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.004 -178.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.451 ' N ' HG12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -87.72 154.6 20.44 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 177.3 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.477 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 0.2 OUTLIER 48.52 25.44 0.94 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.885 0.374 . . . . 0.0 110.285 -178.521 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -146.3 170.46 27.4 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.658 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -136.46 138.56 41.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.927 0.394 . . . . 0.0 110.689 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.911 HD21 ' CZ ' ' A' ' 33' ' ' TYR . 8.2 mt -84.62 155.1 22.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.061 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.441 ' CB ' ' HB ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -125.45 71.22 1.2 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.776 177.857 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.888 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.8 OUTLIER -70.78 95.69 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.041 -177.024 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.8 19.22 52.91 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.591 176.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.4 ' O ' ' HB3' ' A' ' 29' ' ' SER . . . 155.46 141.47 3.22 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.206 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.42 ' O ' ' HB2' ' A' ' 8' ' ' ARG . 3.1 m -114.6 -12.54 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.459 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 0.8 OUTLIER -69.82 160.3 32.01 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.852 0.358 . . . . 0.0 111.738 -179.033 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.672 ' CE2' HD23 ' A' ' 51' ' ' LEU . 24.1 t80 -50.42 127.21 17.0 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.126 178.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.97 -11.06 71.43 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.065 -178.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.4 ' HB3' ' O ' ' A' ' 24' ' ' GLY . 74.5 m -65.31 -173.4 0.13 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.955 0.378 . . . . 0.0 110.065 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 48' ' ' TYR . 11.0 p -162.12 146.49 12.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.135 0.493 . . . . 0.0 111.808 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.888 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -118.94 151.22 21.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.83 179.157 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.444 ' HA ' ' HG3' ' A' ' 46' ' ' LYS . 3.1 m -115.52 114.61 25.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.037 0.446 . . . . 0.0 111.428 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.911 ' CZ ' HD21 ' A' ' 20' ' ' LEU . 2.1 m-85 -80.83 135.9 36.02 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.252 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.467 ' HA ' HD13 ' A' ' 41' ' ' LEU . 3.7 p -148.24 177.65 9.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.146 -177.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.466 ' HA ' ' HA2' ' A' ' 18' ' ' GLY . 71.9 m -94.16 170.17 9.71 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.634 -178.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.26 -77.82 0.17 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.856 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.03 139.23 17.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.593 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.487 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 54.35 29.68 46.99 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.725 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.5 ' CE2' ' HA ' ' A' ' 67' ' ' GLU . 2.0 m-85 -121.14 163.12 18.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.948 0.404 . . . . 0.0 111.161 -179.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.419 ' CE1' HD11 ' A' ' 42' ' ' ILE . 5.5 p-80 -127.68 134.65 49.59 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 176.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.837 HD21 ' HG2' ' A' ' 64' ' ' PRO . 0.9 OUTLIER -82.72 137.62 34.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.959 -174.572 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.531 HD13 ' C ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -114.88 125.26 72.15 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-O 121.344 0.592 . . . . 0.0 110.995 178.827 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 104.69 -145.43 15.97 Favored Glycine 0 C--N 1.318 -0.452 0 CA-C-N 114.539 -1.21 . . . . 0.0 112.378 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.46 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 11.0 mt-10 -60.97 -134.87 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 178.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.507 ' HB3' HD22 ' A' ' 41' ' ' LEU . 6.4 p 165.32 23.6 0.0 OUTLIER 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 123.712 0.805 . . . . 0.0 111.086 177.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.533 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 1.6 mttt -162.93 146.6 11.08 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -177.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.489 ' HA ' ' O ' ' A' ' 61' ' ' PRO . 32.9 t -119.85 152.62 37.05 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.75 176.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.546 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 3.4 m-85 -134.2 119.54 18.93 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 118.825 -1.15 . . . . 0.0 113.184 -178.347 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.51 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 36.6 t -65.96 120.87 13.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.902 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.486 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 8.4 tt0 -160.68 168.85 24.02 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.565 0.697 . . . . 0.0 110.845 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.672 HD23 ' CE2' ' A' ' 27' ' ' PHE . 2.8 pp -75.17 155.99 36.36 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.074 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.523 ' O ' HD12 ' A' ' 51' ' ' LEU . . . -79.05 -125.93 0.47 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.396 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 36.3 t -113.15 -33.08 6.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.754 0.312 . . . . 0.0 111.14 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 81.8 p -97.51 33.0 2.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.937 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.27 18.48 78.15 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.587 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.07 -161.33 0.62 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.752 0.31 . . . . 0.0 110.877 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.565 ' O ' HG13 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -125.54 142.6 51.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.341 179.494 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.565 HG13 ' O ' ' A' ' 57' ' ' MET . 8.2 m -159.98 -177.65 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.099 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.53 ' CE3' HD11 ' A' ' 31' ' ' ILE . 75.6 m95 -126.2 135.2 51.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.972 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.546 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.3 OUTLIER -69.58 168.57 16.2 Favored Pre-proline 0 CA--C 1.506 -0.722 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 175.208 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.49 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 0.9 OUTLIER -4.28 120.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.949 1 C-N-CA 125.527 4.151 . . . . 0.0 114.873 -177.209 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.619 ' O ' ' CZ ' ' A' ' 33' ' ' TYR . 13.1 mt-10 -89.18 -62.3 1.51 Allowed 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 114.35 -1.295 . . . . 0.0 111.739 -173.061 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.677 ' HB1' ' CA ' ' A' ' 64' ' ' PRO . . . -65.45 -153.12 0.0 OUTLIER Pre-proline 0 CA--C 1.484 -1.57 0 CA-C-O 116.704 -1.617 . . . . 0.0 108.691 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.837 ' HG2' HD21 ' A' ' 41' ' ' LEU . 4.0 Cg_exo -89.51 -155.14 0.78 Allowed 'Cis proline' 0 N--CA 1.483 0.879 0 CA-C-N 123.037 2.12 . . . . 0.0 114.804 19.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.545 HG22 ' H ' ' A' ' 66' ' ' CYS . 0.4 OUTLIER -103.15 -167.98 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.072 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.921 -177.905 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.649 ' SG ' HD12 ' A' ' 41' ' ' LEU . 1.7 m -164.19 137.42 5.19 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.822 0.344 . . . . 0.0 111.257 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.5 ' HA ' ' CE2' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -141.24 150.89 43.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.524 -179.431 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.486 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 5.0 t -48.3 139.62 8.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.301 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.487 HG12 ' O ' ' A' ' 38' ' ' GLY . 0.9 OUTLIER -67.38 108.2 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.261 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.427 ' HA ' HG22 ' A' ' 90' ' ' THR . 0.0 OUTLIER -77.18 127.92 33.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.761 -179.391 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.41 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -107.1 119.34 39.1 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.681 177.532 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.65 -157.09 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.791 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.5 t -49.18 139.61 13.07 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.08 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.807 ' HG2' HG11 ' A' ' 95' ' ' VAL . 25.6 Cg_exo -60.23 159.79 25.33 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.474 2.116 . . . . 0.0 111.9 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.51 ' HD3' ' CG ' ' A' ' 118' ' ' TRP . 86.2 Cg_exo -45.81 153.67 0.8 Allowed 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.433 2.089 . . . . 0.0 112.4 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.4 t -106.62 91.81 3.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.635 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.534 HG21 ' O ' ' A' ' 122' ' ' PRO . 14.1 pt -69.27 167.02 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.091 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.4 p -84.87 139.97 31.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.897 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.455 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 5.9 m120 58.63 27.9 16.43 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.139 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.455 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -163.05 -163.08 14.86 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.422 -0.894 . . . . 0.0 113.054 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.415 ' N ' ' O ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -170.44 -174.61 1.7 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.874 0.369 . . . . 0.0 110.859 -179.475 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.526 ' HB3' ' CE1' ' A' ' 97' ' ' TYR . 2.3 p80 -111.24 167.3 10.39 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.893 -178.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 96' ' ' THR . 10.4 m-20 -97.48 19.55 13.18 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.452 177.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.427 ' CA ' ' OH ' ' A' ' 89' ' ' TYR . . . -43.68 127.9 6.03 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.312 -0.947 . . . . 0.0 112.795 -176.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -99.7 -39.08 8.43 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.084 0.468 . . . . 0.0 111.194 -177.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.04 178.11 5.2 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.144 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -90.2 -24.82 20.9 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.346 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.427 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 7.3 m-85 -137.56 163.32 31.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.87 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.427 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 6.5 m-85 -142.54 173.18 11.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.79 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.427 HG22 ' HA ' ' A' ' 70' ' ' LYS . 16.7 p -154.02 -175.73 5.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.039 0.447 . . . . 0.0 112.012 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.467 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 4.6 m-20 -57.5 96.53 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.358 0.599 . . . . 0.0 111.062 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 128.46 15.54 2.21 Favored Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 115.081 -0.963 . . . . 0.0 113.281 178.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.431 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.4 OUTLIER -104.52 150.61 24.45 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 117.244 0.522 . . . . 0.0 110.698 179.184 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.484 HG12 ' HA ' ' A' ' 112' ' ' LEU . 18.8 m -146.89 132.83 12.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.084 0.469 . . . . 0.0 110.886 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.807 HG11 ' HG2' ' A' ' 74' ' ' PRO . 2.2 p -132.35 148.7 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.009 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.574 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -92.1 148.91 21.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.077 0.465 . . . . 0.0 110.732 179.85 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.883 ' CE1' HG21 ' A' ' 111' ' ' VAL . 3.0 m-85 -107.17 159.78 16.07 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.846 0.355 . . . . 0.0 110.845 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.415 ' O ' ' N ' ' A' ' 81' ' ' ARG . 50.4 m -155.79 151.44 27.25 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.56 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.452 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 78.4 m -78.38 162.01 26.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.252 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.455 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 17.0 m-20 -91.77 -71.28 0.65 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.488 -179.054 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.68 -20.96 66.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.434 -179.214 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.32 31.42 1.17 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.532 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.484 ' CE2' HG12 ' A' ' 126' ' ' ILE . 26.5 m-85 -69.83 -173.47 0.63 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 120.782 0.325 . . . . 0.0 110.539 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.56 103.56 12.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.072 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.591 HD23 ' HB2' ' A' ' 122' ' ' PRO . 3.0 tp -42.62 113.45 0.46 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.135 179.088 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.734 HD11 ' HB2' ' A' ' 125' ' ' GLN . 39.0 mm -86.75 155.86 3.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.735 -179.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.439 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 57.18 -128.62 47.86 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.351 -0.928 . . . . 0.0 111.766 -178.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -115.04 134.67 54.98 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.029 0.442 . . . . 0.0 111.573 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.574 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.1 t -70.27 -29.83 66.7 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.362 178.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.82 137.28 23.05 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.536 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.883 HG21 ' CE1' ' A' ' 97' ' ' TYR . 9.9 t -128.75 120.11 51.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.483 0.182 . . . . 0.0 110.527 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.883 HD22 ' N ' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -80.0 133.21 36.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.903 0.382 . . . . 0.0 111.442 -178.906 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.883 ' N ' HD22 ' A' ' 112' ' ' LEU . 25.5 t -104.68 106.48 16.99 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.851 176.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.645 ' HB2' HD11 ' A' ' 112' ' ' LEU . 0.2 OUTLIER -167.29 122.02 1.04 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.981 0.42 . . . . 0.0 111.174 179.851 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.27 26.79 7.19 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.144 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.438 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 69.24 10.09 61.87 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.521 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -148.69 -177.64 5.9 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.981 0.419 . . . . 0.0 110.665 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.579 ' HE3' HG12 ' A' ' 111' ' ' VAL . 92.9 m95 -116.27 151.19 36.31 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.85 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.68 155.63 49.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.073 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.535 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.2 t0 69.49 42.07 0.22 Allowed Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 74.2 Cg_endo -76.7 137.32 17.94 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.48 2.12 . . . . 0.0 111.941 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.591 ' HB2' HD23 ' A' ' 105' ' ' LEU . 57.2 Cg_endo -90.83 -172.97 0.55 Allowed 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.853 2.369 . . . . 0.0 113.408 -178.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.453 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.3 OUTLIER -132.36 -163.27 1.32 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.021 177.893 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 7.6 m -151.87 92.2 1.71 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.147 0.498 . . . . 0.0 111.164 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.734 ' HB2' HD11 ' A' ' 106' ' ' ILE . 10.1 mt-30 -118.06 164.74 14.67 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.514 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.557 ' O ' HG22 ' A' ' 126' ' ' ILE . 50.0 mm . . . . . 0 C--N 1.324 -0.523 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.946 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.897 0.379 . . . . 0.0 110.859 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.84 ' HD2' HG23 ' A' ' 25' ' ' VAL . 13.1 mtm180 -79.49 -169.01 1.74 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.755 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.463 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 19.6 m -89.35 162.06 38.13 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.826 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.41 170.18 16.75 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.413 2.075 . . . . 0.0 111.985 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.429 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 12.8 t -54.33 106.33 0.65 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.226 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.468 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 3.4 Cg_exo -46.76 153.26 1.37 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.118 1.879 . . . . 0.0 112.045 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.703 ' O ' HD11 ' A' ' 20' ' ' LEU . 2.4 mtt85 -68.52 163.59 23.12 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.14 178.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.454 ' HA ' HD11 ' A' ' 20' ' ' LEU . 2.0 p30 -112.35 179.76 3.9 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.18 0.514 . . . . 0.0 112.129 -176.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.461 HG23 ' C ' ' A' ' 18' ' ' GLY . 7.3 tt -131.63 152.56 37.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.418 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -80.27 -62.34 1.71 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -177.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -94.57 31.07 1.85 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.867 -178.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.461 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -151.03 -179.98 27.22 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.197 -1.002 . . . . 0.0 113.498 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -139.34 135.22 33.52 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.146 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.703 HD11 ' O ' ' A' ' 13' ' ' ARG . 2.6 mt -79.42 163.29 24.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.218 0.533 . . . . 0.0 111.799 -178.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -131.33 77.75 1.79 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.595 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.921 ' HA ' HG23 ' A' ' 31' ' ' ILE . 69.1 mt -69.63 104.51 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.018 -177.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -110.2 22.63 22.53 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.519 177.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 153.66 129.78 1.39 Allowed Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -179.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.84 HG23 ' HD2' ' A' ' 8' ' ' ARG . 0.5 OUTLIER -121.33 0.97 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.665 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 27' ' ' PHE . 34.0 t0 -74.22 162.24 29.13 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.844 0.354 . . . . 0.0 110.952 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.88 ' CZ ' HD13 ' A' ' 51' ' ' LEU . 11.0 t80 -52.56 106.19 0.15 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.843 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.57 -0.08 27.7 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.765 -0.731 . . . . 0.0 113.046 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 82.9 p -77.24 178.99 6.64 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.971 0.385 . . . . 0.0 110.964 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 47' ' ' SER . 3.3 p -149.1 144.03 26.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.998 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.921 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -110.64 170.46 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.618 179.819 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.441 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -129.42 113.12 14.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.905 0.383 . . . . 0.0 111.31 179.482 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.673 ' CE2' HD22 ' A' ' 20' ' ' LEU . 15.8 m-85 -87.77 140.99 28.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.06 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.433 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 16.6 m -146.36 157.52 43.79 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.677 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.437 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 62.7 m -80.34 170.01 16.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.748 0.308 . . . . 0.0 110.647 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.09 -75.65 0.11 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.941 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.8 t -160.01 139.69 11.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.835 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 56.97 25.13 52.79 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.063 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.531 ' CD2' ' HA ' ' A' ' 68' ' ' SER . 2.3 m-85 -116.57 171.05 8.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.871 0.367 . . . . 0.0 111.051 -179.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.744 ' CD2' HD11 ' A' ' 42' ' ' ILE . 1.6 p-80 -131.86 123.25 27.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.426 178.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.941 HD21 ' O ' ' A' ' 44' ' ' GLU . 4.7 tt -86.47 134.27 33.69 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.502 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.744 HD11 ' CD2' ' A' ' 40' ' ' HIS . 2.0 mm -112.97 156.98 13.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.02 0.438 . . . . 0.0 111.164 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.4 -128.27 8.36 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.289 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.941 ' O ' HD21 ' A' ' 41' ' ' LEU . 1.5 pm0 -83.78 -173.7 4.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.792 0.329 . . . . 0.0 110.648 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.2 p -162.31 24.27 0.11 Allowed 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.159 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.441 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 13.2 mtpt -164.45 126.45 2.28 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.578 -177.093 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.455 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 1.9 t -94.06 137.85 32.8 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 176.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.552 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 2.6 m-85 -114.92 118.57 33.85 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.589 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 35.4 t -66.3 92.57 0.19 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.625 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.489 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 1.7 tt0 -123.86 172.12 9.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.518 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.88 HD13 ' CZ ' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -102.86 152.0 21.78 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.521 179.474 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.407 ' O ' ' N ' ' A' ' 54' ' ' THR . . . -171.1 -36.6 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.279 -0.962 . . . . 0.0 113.237 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.458 ' CB ' ' HB3' ' A' ' 56' ' ' SER . 0.2 OUTLIER -65.73 72.72 0.06 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.034 0.445 . . . . 0.0 111.113 -179.17 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.407 ' N ' ' O ' ' A' ' 52' ' ' GLY . 2.1 p 49.94 28.26 2.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.258 179.341 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 114.92 2.2 22.31 Favored Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.708 -0.758 . . . . 0.0 113.129 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.458 ' HB3' ' CB ' ' A' ' 53' ' ' SER . 1.9 t -82.9 -159.4 0.33 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.773 0.32 . . . . 0.0 110.75 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.8 113.13 14.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.261 0.553 . . . . 0.0 110.4 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.442 ' N ' ' O ' ' A' ' 50' ' ' GLU . 0.9 OUTLIER -111.99 -175.23 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.432 -179.281 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.536 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 70.7 m95 -125.31 123.73 40.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.916 0.389 . . . . 0.0 111.263 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.552 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 2.7 m-20 -69.04 167.68 19.36 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.49 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 10.4 Cg_exo -7.39 89.86 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.008 1 C-N-CA 125.41 4.073 . . . . 0.0 114.796 -179.054 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.479 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 10.7 mt-10 -84.24 -92.58 0.08 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 114.779 -1.101 . . . . 0.0 112.386 -177.154 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.48 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -91.63 109.01 33.62 Favored Pre-proline 0 C--O 1.231 0.1 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -176.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.893 ' HG2' HD11 ' A' ' 41' ' ' LEU . 6.1 Cg_exo -79.39 -153.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.892 2.395 . . . . 0.0 111.113 177.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.515 HG22 ' H ' ' A' ' 66' ' ' CYS . 1.5 mm -93.95 168.94 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.859 0.361 . . . . 0.0 110.669 178.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.515 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.8 OUTLIER -170.35 138.69 1.6 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.945 179.759 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -162.44 173.86 13.51 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.625 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.531 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 54.1 p -79.07 113.64 17.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.301 0.572 . . . . 0.0 110.83 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.684 HG21 ' H ' ' A' ' 115' ' ' GLY . 30.9 m -39.2 100.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.425 -179.252 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 89' ' ' TYR . 0.3 OUTLIER -96.45 103.57 15.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.862 0.363 . . . . 0.0 110.719 178.027 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.94 121.91 35.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.049 179.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.459 ' CG ' ' N ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -69.15 -155.4 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.975 179.402 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.459 ' N ' ' CG ' ' A' ' 72' ' ' GLN . 1.2 t -50.77 142.21 16.79 Favored Pre-proline 0 N--CA 1.449 -0.511 0 CA-C-O 120.642 0.258 . . . . 0.0 110.823 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.496 ' HG2' HG11 ' A' ' 95' ' ' VAL . 26.8 Cg_exo -59.35 164.1 11.38 Favored 'Trans proline' 0 CA--C 1.528 0.198 0 C-N-CA 122.531 2.154 . . . . 0.0 111.936 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.521 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 89.6 Cg_exo -41.75 158.76 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.56 2.174 . . . . 0.0 112.572 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 83.5 p -109.24 88.6 2.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.528 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.645 HG23 ' HE2' ' A' ' 97' ' ' TYR . 15.9 pt -69.79 170.55 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.305 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.7 m -90.09 142.59 27.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.675 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.506 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 7.7 m-80 56.26 29.51 15.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.973 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.477 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -161.75 -171.18 27.48 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.27 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.413 ' N ' ' O ' ' A' ' 98' ' ' SER . 9.5 ptt180 -163.75 -175.33 4.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.971 0.415 . . . . 0.0 110.78 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 1.7 p-80 -117.9 169.22 9.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.053 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -98.54 -84.27 0.4 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.691 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.43 ' HA3' ' OH ' ' A' ' 89' ' ' TYR . . . 63.99 147.54 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.667 -0.777 . . . . 0.0 113.007 178.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -112.02 -35.76 5.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.089 0.471 . . . . 0.0 110.705 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -97.05 -172.26 2.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.072 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.7 -23.72 14.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.194 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.434 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 7.0 m-85 -131.36 -179.94 5.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.434 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 72.5 m-85 -156.39 160.56 39.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.845 -179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 69' ' ' VAL . 6.7 p -142.63 -177.42 5.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.287 0.565 . . . . 0.0 112.324 -179.295 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 6.9 p-10 -50.03 94.62 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.489 -179.088 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 121.96 24.29 2.31 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.373 -0.83 . . . . 0.0 113.37 177.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -110.1 147.4 33.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 117.075 0.437 . . . . 0.0 110.782 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.517 HG22 ' N ' ' A' ' 95' ' ' VAL . 35.2 m -128.68 160.0 39.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.1 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.517 ' N ' HG22 ' A' ' 94' ' ' VAL . 21.5 t -151.8 148.6 14.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.479 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.9 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -108.01 126.02 52.22 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.228 0.537 . . . . 0.0 111.06 -179.608 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.955 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.6 m-85 -83.87 161.6 20.82 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.657 -178.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.432 ' HA ' HD13 ' A' ' 105' ' ' LEU . 14.8 p -155.24 138.66 15.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.348 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.453 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 73.9 m -69.98 158.39 35.71 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.794 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.477 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 26.8 m-20 -92.0 -70.69 0.68 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.429 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.24 -22.83 67.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.323 -179.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 122.0 31.15 1.13 Allowed Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.63 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.506 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 19.9 m-85 -69.61 -175.55 0.87 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.038 0.447 . . . . 0.0 110.898 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.2 m -110.07 98.1 7.45 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.098 178.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.527 HD11 ' HB3' ' A' ' 97' ' ' TYR . 0.2 OUTLIER -48.77 132.48 17.97 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.555 0.693 . . . . 0.0 111.727 -177.834 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.445 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 38.2 mm -114.23 155.52 15.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.092 -178.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.41 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 68.59 23.88 75.32 Favored Glycine 0 C--N 1.328 0.103 0 C-N-CA 120.56 -0.828 . . . . 0.0 113.053 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.41 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.3 OUTLIER 60.37 136.66 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.295 0.569 . . . . 0.0 111.531 179.759 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.9 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.1 p -69.7 -24.13 63.53 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.765 -178.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -63.84 121.72 24.21 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.787 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.955 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.7 t -122.14 141.8 41.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 178.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.895 HD22 ' N ' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -102.92 132.43 49.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.841 0.353 . . . . 0.0 111.505 -178.955 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.895 ' N ' HD22 ' A' ' 112' ' ' LEU . 41.4 t -104.6 104.59 14.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.034 177.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.798 ' OG ' HD11 ' A' ' 112' ' ' LEU . 12.4 p -165.93 119.27 1.13 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.922 0.391 . . . . 0.0 111.707 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.684 ' H ' HG21 ' A' ' 69' ' ' VAL . . . 102.33 20.98 11.18 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.686 179.124 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.489 ' N ' ' HB ' ' A' ' 69' ' ' VAL . . . 80.88 2.08 90.02 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.498 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -145.51 170.52 16.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.14 0.495 . . . . 0.0 111.317 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.521 ' CD1' ' HD3' ' A' ' 75' ' ' PRO . 88.5 m95 -104.37 144.98 30.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.355 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.1 149.77 43.1 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.074 0.464 . . . . 0.0 111.491 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.499 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER 65.66 44.7 0.41 Allowed Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.196 178.899 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 56.3 Cg_endo -69.82 142.91 48.93 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.22 1.946 . . . . 0.0 111.467 178.045 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.508 ' HG2' ' CD2' ' A' ' 97' ' ' TYR . 71.1 Cg_endo -90.23 -172.84 0.6 Allowed 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.641 2.227 . . . . 0.0 113.768 -177.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.37 -158.44 0.87 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.652 178.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 2.3 m -155.76 89.16 1.15 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.089 0.471 . . . . 0.0 110.925 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -113.34 161.11 17.65 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.684 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.582 ' O ' HG22 ' A' ' 126' ' ' ILE . 21.9 mm . . . . . 0 C--N 1.323 -0.569 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.935 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.603 0.239 . . . . 0.0 110.773 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.426 ' CB ' HG23 ' A' ' 25' ' ' VAL . 0.1 OUTLIER 41.25 -162.08 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.946 0.403 . . . . 0.0 111.752 179.202 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.481 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 3.5 m -93.24 163.04 26.47 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.672 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -67.62 169.83 15.07 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.205 1.937 . . . . 0.0 111.407 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.03 105.1 0.46 Allowed Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.088 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.6 ' HB3' HD13 ' A' ' 31' ' ' ILE . 83.1 Cg_exo -38.42 146.35 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.657 2.238 . . . . 0.0 112.739 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.3 152.98 43.83 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.644 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.415 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -101.18 -167.98 1.5 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.118 -178.701 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 19.1 tt -167.88 144.52 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.568 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -94.28 160.43 14.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.743 177.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 48.1 25.58 0.84 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.879 0.371 . . . . 0.0 110.638 -179.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -158.81 -173.91 27.83 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.615 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -132.14 -171.88 2.74 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.313 0.578 . . . . 0.0 111.787 -177.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.3 mt -140.25 139.28 35.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.465 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.422 ' CB ' ' HB ' ' A' ' 32' ' ' THR . 0.3 OUTLIER -118.07 73.56 0.91 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.851 179.109 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.763 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -82.75 94.21 3.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.947 -176.046 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.38 12.05 63.94 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.048 177.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 29' ' ' SER . . . 156.51 148.12 4.97 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.11 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.426 HG23 ' CB ' ' A' ' 8' ' ' ARG . 29.7 m -120.37 -1.01 8.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.424 ' HA ' ' HB3' ' A' ' 8' ' ' ARG . 0.7 OUTLIER -69.64 153.78 42.93 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.931 0.395 . . . . 0.0 111.224 -179.292 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.46 110.38 0.37 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.855 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 113.79 -9.16 23.61 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.423 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 24' ' ' GLY . 0.4 OUTLIER -72.73 178.44 4.17 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.845 0.323 . . . . 0.0 110.83 179.777 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 47' ' ' SER . 11.4 p -153.82 138.77 17.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.223 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.763 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -103.1 165.78 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.601 179.063 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.423 ' HA ' ' HG3' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -130.35 110.5 11.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.633 178.561 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.491 ' CE2' ' HA ' ' A' ' 63' ' ' ALA . 22.9 m-85 -83.2 146.95 28.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.132 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.47 172.2 14.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.926 0.394 . . . . 0.0 111.425 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.444 ' HA ' ' HA2' ' A' ' 18' ' ' GLY . 1.7 m -96.13 156.7 16.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.497 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.423 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 3.6 m-20 -56.1 -85.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.15 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.5 t -152.19 135.67 16.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.934 0.397 . . . . 0.0 110.719 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.439 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 61.51 24.29 63.74 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.865 -179.016 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.471 ' CG ' ' O ' ' A' ' 67' ' ' GLU . 2.3 m-85 -116.24 174.69 5.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.805 0.336 . . . . 0.0 110.802 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.618 ' NE2' HD11 ' A' ' 42' ' ' ILE . 4.7 p-80 -136.94 116.17 12.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.036 0.446 . . . . 0.0 110.478 178.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.917 HD21 ' O ' ' A' ' 44' ' ' GLU . 4.7 tt -77.37 124.62 28.11 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.638 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.618 HD11 ' NE2' ' A' ' 40' ' ' HIS . 2.7 mm -96.8 152.55 3.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.247 -179.011 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.09 -149.74 38.04 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.218 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.917 ' O ' HD21 ' A' ' 41' ' ' LEU . 4.3 pm0 -61.63 178.65 0.3 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.609 0.242 . . . . 0.0 110.582 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.0 p -152.38 21.44 0.64 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.374 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.423 ' HG3' ' HA ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -142.97 -174.6 4.23 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.226 0.536 . . . . 0.0 111.934 -178.299 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.456 ' O ' HG13 ' A' ' 31' ' ' ILE . 1.7 m -160.96 108.88 1.54 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.831 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -92.15 117.75 30.16 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.229 0.538 . . . . 0.0 111.839 -177.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.499 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 8.7 t -64.33 90.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.226 179.129 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.503 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -116.43 175.75 5.42 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.428 -179.51 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.503 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -88.55 145.56 25.65 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.235 -178.326 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -73.2 -112.11 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.475 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.1 t -128.11 -41.58 1.59 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.752 0.31 . . . . 0.0 111.091 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 43.0 p -92.07 49.23 1.5 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.096 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 55.97 33.87 61.04 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.444 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 46.9 t -106.2 -174.37 2.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.851 0.358 . . . . 0.0 111.03 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.29 146.31 41.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.11 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.9 m -152.04 -177.66 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.083 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.526 ' CE3' HD11 ' A' ' 31' ' ' ILE . 93.2 m95 -130.51 124.6 32.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.932 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -143.49 126.51 8.92 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.193 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.78 -162.28 2.13 Favored 'Cis proline' 0 C--N 1.351 0.703 0 C-N-CA 124.06 -1.225 . . . . 0.0 111.928 -0.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.488 ' O ' ' CZ ' ' A' ' 33' ' ' TYR . 4.3 pt-20 -112.25 -113.97 0.33 Allowed 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.401 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.491 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -118.92 86.84 32.06 Favored Pre-proline 0 N--CA 1.45 -0.472 0 C-N-CA 122.658 0.383 . . . . 0.0 110.462 -179.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.549 ' HG2' HD11 ' A' ' 41' ' ' LEU . 10.3 Cg_endo -48.58 -158.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.475 0.395 0 C-N-CA 123.863 3.042 . . . . 0.0 113.995 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.487 HG22 ' N ' ' A' ' 66' ' ' CYS . 5.0 mm -93.49 165.28 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.109 -177.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.487 ' N ' HG22 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -161.42 138.22 8.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.268 179.074 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.471 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 1.0 OUTLIER -162.22 -177.1 5.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.898 0.38 . . . . 0.0 111.168 -179.719 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.8 t -83.8 132.27 34.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.108 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -46.21 101.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.553 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.526 ' HE2' HG23 ' A' ' 90' ' ' THR . 0.2 OUTLIER -72.15 123.19 22.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.352 179.951 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.51 122.91 46.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.921 178.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -69.31 -156.28 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.373 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.544 ' HG ' ' CE1' ' A' ' 82' ' ' HIS . 1.8 t -52.95 145.6 22.28 Favored Pre-proline 0 N--CA 1.45 -0.426 0 CA-C-O 120.633 0.254 . . . . 0.0 110.377 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.464 ' HG2' HG11 ' A' ' 95' ' ' VAL . 23.4 Cg_exo -62.62 165.33 16.01 Favored 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 122.48 2.12 . . . . 0.0 112.155 -179.268 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.518 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 81.2 Cg_exo -43.65 160.6 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.713 2.275 . . . . 0.0 112.87 -179.004 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 86.7 p -108.29 90.16 3.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.497 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.692 HG23 ' HE2' ' A' ' 97' ' ' TYR . 14.1 pt -69.24 175.22 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.243 -178.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.4 p -96.21 143.41 27.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.717 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.514 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 4.9 m120 55.42 30.23 14.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.925 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.439 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -167.41 -170.26 32.01 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.53 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.97 -176.71 4.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.035 0.445 . . . . 0.0 111.091 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.544 ' CE1' ' HG ' ' A' ' 73' ' ' SER . 3.4 p80 -108.37 173.26 6.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.117 -179.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -103.99 -85.45 0.46 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.66 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.43 ' H ' HG13 ' A' ' 95' ' ' VAL . . . 60.91 141.58 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.901 179.068 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -110.82 -31.44 7.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.048 0.451 . . . . 0.0 110.602 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.93 -171.91 2.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.741 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.05 -14.98 15.23 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.528 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.434 ' HB3' ' HD3' ' A' ' 70' ' ' LYS . 6.4 m-85 -140.58 177.87 7.72 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.866 0.365 . . . . 0.0 111.521 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.425 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 69.2 m-85 -156.77 165.85 35.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.809 -179.262 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.526 HG23 ' HE2' ' A' ' 70' ' ' LYS . 19.1 p -149.37 -175.78 5.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.029 0.442 . . . . 0.0 111.62 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 3.8 p30 -52.86 94.42 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.444 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.14 22.63 2.34 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.273 -0.876 . . . . 0.0 113.13 178.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.401 ' HB2' ' HB3' ' A' ' 89' ' ' TYR . 0.9 OUTLIER -110.21 145.83 36.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.951 0.375 . . . . 0.0 110.789 179.104 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 32.7 m -128.58 155.61 40.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.067 0.461 . . . . 0.0 111.249 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.509 HG23 ' CH2' ' A' ' 118' ' ' TRP . 20.7 t -146.54 146.57 18.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.11 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.802 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -101.4 134.22 44.82 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.827 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.911 ' CE1' HG21 ' A' ' 111' ' ' VAL . 5.0 m-85 -95.39 158.83 15.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.915 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 77.1 p -153.0 140.33 19.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.376 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.431 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 68.8 m -71.04 152.46 43.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.891 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.411 ' CG ' ' N ' ' A' ' 101' ' ' SER . 0.2 OUTLIER -92.54 -55.14 3.5 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.419 0.628 . . . . 0.0 111.434 -178.334 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.411 ' N ' ' CG ' ' A' ' 100' ' ' ASN . 22.4 t -73.98 -14.75 61.08 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.757 -178.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 111.24 24.68 5.32 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.005 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.514 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 30.8 m-85 -69.46 -172.95 0.51 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.855 0.36 . . . . 0.0 110.817 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.1 105.78 15.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.156 -179.277 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.639 HD23 ' HB2' ' A' ' 122' ' ' PRO . 3.1 tp -44.85 113.52 0.57 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.07 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.453 ' HB ' ' CB ' ' A' ' 123' ' ' THR . 30.6 mm -87.13 157.07 3.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.471 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.438 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 58.69 -131.17 51.92 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.767 -178.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.27 126.28 52.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.771 0.32 . . . . 0.0 110.746 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.802 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.4 t -57.63 -28.45 63.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.045 0.45 . . . . 0.0 110.242 178.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.9 132.2 15.13 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.558 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.911 HG21 ' CE1' ' A' ' 97' ' ' TYR . 6.0 t -125.52 126.83 71.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 110.422 -0.214 . . . . 0.0 110.422 178.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.93 HD22 ' N ' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -81.14 135.52 35.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.889 0.376 . . . . 0.0 111.48 -178.567 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.93 ' N ' HD22 ' A' ' 112' ' ' LEU . 39.3 t -108.28 108.04 18.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.051 177.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.711 ' HB2' HD11 ' A' ' 112' ' ' LEU . 0.2 OUTLIER -164.01 129.67 2.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.868 0.366 . . . . 0.0 111.259 -179.806 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.38 31.04 20.45 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.076 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.16 19.88 62.17 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.018 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -145.53 178.2 8.3 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.104 0.478 . . . . 0.0 111.15 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.528 ' CZ3' ' HB2' ' A' ' 113' ' ' CYS . 92.7 m95 -121.7 145.29 48.17 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.795 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.578 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -125.52 167.02 15.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.991 0.424 . . . . 0.0 111.658 -179.095 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.44 ' N ' ' HD3' ' A' ' 121' ' ' PRO . 6.6 p-10 46.69 52.56 12.06 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.171 179.303 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.44 ' HD3' ' N ' ' A' ' 120' ' ' ASP . 93.2 Cg_endo -81.28 143.94 14.26 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.666 2.244 . . . . 0.0 111.634 177.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.639 ' HB2' HD23 ' A' ' 105' ' ' LEU . 73.5 Cg_endo -91.23 -172.29 0.46 Allowed 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.877 2.385 . . . . 0.0 113.856 -177.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.453 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -138.66 -174.7 3.9 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.101 178.321 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 124' ' ' CYS . . . . . 0.424 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 11.9 m -141.11 96.98 3.08 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.026 0.441 . . . . 0.0 111.097 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.429 ' HB2' HD11 ' A' ' 106' ' ' ILE . 20.6 mt-30 -122.54 167.51 13.28 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.863 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.497 HG12 ' CE2' ' A' ' 103' ' ' TYR . 13.0 mm . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.935 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.906 0.384 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.543 ' HD2' HG23 ' A' ' 25' ' ' VAL . 17.4 mtm180 -106.17 -177.74 3.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.758 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.528 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 69.6 m -77.31 175.86 4.09 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.545 ' HD2' ' CD1' ' A' ' 59' ' ' TRP . 37.9 Cg_endo -91.24 176.29 2.2 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.427 2.084 . . . . 0.0 111.932 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.0 t -53.41 105.6 0.55 Allowed Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.294 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.49 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 51.5 Cg_exo -52.94 142.2 53.66 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.037 1.825 . . . . 0.0 111.804 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.945 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -49.03 120.8 4.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.925 0.869 . . . . 0.0 111.512 -178.852 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.747 ' O ' HG22 ' A' ' 15' ' ' ILE . 6.1 p-10 -59.16 -32.09 69.56 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 113.509 -1.678 . . . . 0.0 112.694 -177.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.747 HG22 ' O ' ' A' ' 14' ' ' ASP . 8.6 tt 58.36 142.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 114.271 -1.331 . . . . 0.0 111.208 -175.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.98 160.41 14.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.0 178.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.494 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 0.3 OUTLIER 50.47 24.07 1.48 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.017 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -154.06 177.61 31.4 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.659 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.43 142.26 39.52 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.74 0.305 . . . . 0.0 110.506 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.945 HD11 ' O ' ' A' ' 13' ' ' ARG . 72.2 mt -89.51 155.67 19.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.167 0.508 . . . . 0.0 111.718 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.412 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 11.1 t0 -124.73 72.91 1.24 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.38 177.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.879 ' HA ' HG23 ' A' ' 31' ' ' ILE . 1.2 mt -76.1 105.71 5.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.992 -176.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.62 13.56 57.99 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.734 176.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 157.19 133.29 1.58 Allowed Glycine 0 C--N 1.335 0.5 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.021 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.543 HG23 ' HD2' ' A' ' 8' ' ' ARG . 15.0 m -112.41 9.01 8.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.097 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -72.82 156.25 39.09 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.836 0.351 . . . . 0.0 111.331 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.598 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 8.4 t80 -54.94 91.45 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.867 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 49' ' ' CYS . . . 130.57 -18.25 5.19 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.456 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.5 p -57.24 -173.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.73 0.3 . . . . 0.0 110.863 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 47' ' ' SER . 81.2 p -150.94 150.85 31.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.25 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.879 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -121.44 167.0 15.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.766 179.493 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.412 ' HB ' ' HB3' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -129.85 108.45 10.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.618 178.243 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.436 ' CE1' ' HA ' ' A' ' 63' ' ' ALA . 33.4 m-85 -84.59 143.12 29.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.154 -179.239 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -152.04 157.08 41.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.198 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 21.3 m -83.8 161.56 20.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.851 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.465 ' ND2' ' HA ' ' A' ' 17' ' ' ASN . 1.2 p30 -55.7 -89.43 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.238 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.8 t -152.08 136.34 16.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.815 0.34 . . . . 0.0 110.524 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.73 17.76 63.09 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.233 -178.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.494 ' CE2' ' HB3' ' A' ' 17' ' ' ASN . 2.1 m-85 -106.87 -173.34 2.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.729 0.299 . . . . 0.0 110.782 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.696 ' NE2' HD11 ' A' ' 42' ' ' ILE . 2.2 p-80 -147.05 112.46 5.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.983 0.42 . . . . 0.0 110.808 178.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.954 HD21 ' O ' ' A' ' 44' ' ' GLU . 2.1 tt -78.72 125.47 29.41 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.363 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.696 HD11 ' NE2' ' A' ' 40' ' ' HIS . 2.9 mm -98.47 167.55 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.049 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.532 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 67.03 -130.02 29.84 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.477 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.954 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.8 OUTLIER -83.47 -179.23 7.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.798 0.332 . . . . 0.0 110.925 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.438 ' HA ' ' HG2' ' A' ' 64' ' ' PRO . 3.0 t -154.98 25.44 0.43 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.924 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -150.14 168.72 23.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.245 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.444 ' O ' HG13 ' A' ' 31' ' ' ILE . 2.6 m -149.56 120.27 7.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.374 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -103.46 116.2 31.96 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.16 0.505 . . . . 0.0 111.193 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.411 ' O ' ' N ' ' A' ' 28' ' ' GLY . 53.6 t -59.16 100.87 0.08 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.098 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.28 -170.96 2.07 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.37 -178.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.598 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -101.92 146.2 28.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.848 -179.716 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.45 ' N ' HG22 ' A' ' 58' ' ' VAL . . . -74.47 -145.21 1.01 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.577 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.5 m -93.19 -37.88 11.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.755 0.312 . . . . 0.0 111.049 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.8 p -95.74 41.41 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.275 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 63.71 19.82 63.32 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.825 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.24 -161.45 0.59 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.763 0.316 . . . . 0.0 110.752 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -123.88 133.8 53.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.601 179.016 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.45 HG22 ' N ' ' A' ' 52' ' ' GLY . 1.1 m -144.19 -178.45 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.98 0.419 . . . . 0.0 111.333 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.668 ' CE3' HD11 ' A' ' 31' ' ' ILE . 94.1 m95 -121.03 122.97 41.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.527 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 63.6 m-20 -138.67 118.73 9.71 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.426 -178.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.14 -170.53 7.7 Favored 'Cis proline' 0 C--N 1.351 0.663 0 C-N-CA 124.094 -1.211 . . . . 0.0 112.003 -0.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -110.89 -154.66 0.54 Allowed 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.708 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.454 ' HB2' ' HB3' ' A' ' 13' ' ' ARG . . . -72.62 111.84 12.73 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.582 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.438 ' HG2' ' HA ' ' A' ' 45' ' ' SER . 15.2 Cg_exo -69.78 -150.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.628 2.219 . . . . 0.0 112.452 -178.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.501 HG22 ' H ' ' A' ' 66' ' ' CYS . 5.1 mm -100.39 165.73 2.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.6 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.501 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.3 m -161.62 137.12 7.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.589 179.093 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.473 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.2 OUTLIER -163.33 176.62 9.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.931 0.396 . . . . 0.0 110.965 179.784 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.49 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 12.2 p -94.4 117.37 30.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.917 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.419 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 2.3 p -41.14 93.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.609 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 68' ' ' SER . 0.1 OUTLIER -70.47 121.49 17.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.66 -178.758 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.402 ' N ' ' O ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -104.75 115.49 30.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.695 177.487 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.409 ' CG ' ' N ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -69.95 -157.99 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.792 -179.504 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.437 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 1.6 t -47.33 136.68 9.07 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.237 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.477 ' HG2' HG11 ' A' ' 95' ' ' VAL . 35.3 Cg_exo -58.85 162.03 14.11 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.39 2.06 . . . . 0.0 111.797 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.509 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 80.5 Cg_exo -39.96 156.89 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.764 2.31 . . . . 0.0 112.834 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.9 t -108.15 89.19 2.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.641 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.651 HG23 ' HE2' ' A' ' 97' ' ' TYR . 26.3 pt -69.81 174.59 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.413 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.8 p -97.67 138.79 34.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.912 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.465 ' HB3' ' CE1' ' A' ' 103' ' ' TYR . 0.1 OUTLIER 66.7 27.07 9.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.79 179.458 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.438 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . -172.71 -165.48 29.8 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.897 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 11.1 ptt180 -167.37 -175.26 2.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.873 0.368 . . . . 0.0 110.593 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.437 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 6.1 p80 -105.12 173.46 6.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.082 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -99.91 -84.28 0.42 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.45 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.472 ' H ' HG13 ' A' ' 95' ' ' VAL . . . 60.96 150.5 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.779 -0.724 . . . . 0.0 113.068 178.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -112.87 -33.87 5.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.079 0.466 . . . . 0.0 110.634 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.76 -172.47 2.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.991 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -102.95 -23.41 13.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.016 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.433 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 6.5 m-85 -129.96 175.51 8.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.722 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.433 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 60.9 m-85 -151.4 164.04 37.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.866 0.365 . . . . 0.0 111.041 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.443 HG22 ' OG ' ' A' ' 68' ' ' SER . 8.4 p -130.45 168.56 16.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.119 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 0.9 OUTLIER -54.72 94.76 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.289 0.566 . . . . 0.0 110.886 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 129.88 26.76 0.83 Allowed Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.258 -0.883 . . . . 0.0 113.216 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -110.08 162.27 14.72 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.915 0.358 . . . . 0.0 110.697 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 33.9 m -135.58 154.99 35.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.099 0.476 . . . . 0.0 111.301 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.546 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 20.8 t -150.85 147.49 15.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.823 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.98 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -105.5 133.05 50.89 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.74 179.436 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.977 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.9 m-85 -91.53 159.29 16.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.169 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.546 ' HA ' HD13 ' A' ' 105' ' ' LEU . 62.8 m -157.72 149.62 22.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.052 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.438 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 58.0 m -79.09 159.37 27.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.13 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -83.1 -68.52 0.7 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.632 -178.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.5 -26.17 61.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.383 -178.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.2 37.7 0.45 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.521 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.465 ' CE1' ' HB3' ' A' ' 79' ' ' ASN . 11.2 m-85 -69.78 -173.67 0.64 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.852 0.358 . . . . 0.0 110.35 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.3 m -107.95 98.89 8.4 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.079 178.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.546 HD13 ' HA ' ' A' ' 98' ' ' SER . 0.3 OUTLIER -47.94 126.92 11.36 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.623 0.725 . . . . 0.0 111.697 -177.881 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.455 ' HB ' ' CB ' ' A' ' 123' ' ' THR . 31.4 mm -90.6 152.02 3.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.079 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 61.11 -136.53 48.28 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.016 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -112.14 137.59 50.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.945 0.403 . . . . 0.0 111.348 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.98 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.6 p -68.06 -26.53 65.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.78 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -72.39 139.46 27.93 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.968 -0.634 . . . . 0.0 113.014 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.977 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.5 t -135.21 127.89 48.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.533 0.206 . . . . 0.0 110.56 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.06 126.2 34.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.968 0.414 . . . . 0.0 111.804 -178.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.504 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 13.4 t -90.41 101.2 13.94 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 176.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.1 OUTLIER -143.67 160.83 39.99 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.065 0.459 . . . . 0.0 111.411 -178.181 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.0 30.53 5.19 Favored Glycine 0 N--CA 1.453 -0.232 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.665 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.419 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 68.72 19.19 72.96 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.199 -179.249 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -144.47 179.51 7.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.777 0.322 . . . . 0.0 110.512 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.546 ' CZ3' HG23 ' A' ' 95' ' ' VAL . 92.7 m95 -115.84 152.24 33.73 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.978 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.41 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -133.67 156.34 48.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.234 -179.413 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.489 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER 61.83 46.5 0.96 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.881 179.109 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 96.0 Cg_endo -78.36 137.16 14.72 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.421 2.081 . . . . 0.0 111.577 178.211 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.54 ' O ' HG21 ' A' ' 77' ' ' ILE . 73.4 Cg_endo -91.94 -173.91 0.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.587 2.191 . . . . 0.0 113.545 -178.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.455 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.3 OUTLIER -129.17 -171.6 2.53 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.29 177.405 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 5.0 m -144.74 88.37 1.91 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.069 0.461 . . . . 0.0 110.325 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -118.11 -179.04 3.65 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.519 -178.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 32.3 mm . . . . . 0 C--N 1.321 -0.657 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.92 -179.612 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.865 0.364 . . . . 0.0 110.894 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.1 mtm180 -60.29 176.79 0.31 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.004 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.479 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 28.9 m -91.09 159.85 38.86 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.077 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.0 168.65 23.38 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.661 2.241 . . . . 0.0 111.992 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.0 t -49.39 103.79 0.39 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.733 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.58 157.76 49.52 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.276 1.984 . . . . 0.0 112.051 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.752 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -51.23 -179.55 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.319 179.23 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.745 ' O ' HG22 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -140.62 -7.58 1.12 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -178.057 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 14' ' ' ASP . 15.1 tt 56.87 142.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 121.223 0.535 . . . . 0.0 111.603 -177.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -81.33 -52.61 7.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.602 -178.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -93.07 45.55 1.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.892 0.377 . . . . 0.0 110.922 -178.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 176.48 179.99 47.21 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.51 -0.853 . . . . 0.0 113.249 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -138.44 143.08 39.52 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.826 HD13 ' CZ ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -93.63 168.93 10.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.08 0.467 . . . . 0.0 111.125 -179.019 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -126.1 91.73 3.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.843 178.021 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.865 ' HA ' HG23 ' A' ' 31' ' ' ILE . 5.4 mm -68.46 107.08 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.829 -176.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -114.24 22.76 13.37 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.602 177.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 149.67 124.35 1.28 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.068 -0.587 . . . . 0.0 111.945 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.8 m -120.54 38.24 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.871 0.367 . . . . 0.0 111.261 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.4 OUTLIER -111.25 150.36 29.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.6 179.302 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.561 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 8.0 t80 -49.05 91.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.896 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 130.27 -0.36 5.59 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.764 -0.732 . . . . 0.0 113.021 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -92.17 -168.41 1.99 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 117.038 0.419 . . . . 0.0 110.54 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.6 p -160.63 146.88 15.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.064 0.459 . . . . 0.0 111.27 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.865 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.6 OUTLIER -105.02 170.42 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.34 179.625 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -124.36 112.61 17.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.902 0.382 . . . . 0.0 111.09 179.073 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.826 ' CZ ' HD13 ' A' ' 20' ' ' LEU . 12.3 m-85 -87.04 142.5 27.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.602 -179.22 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.7 m -149.78 159.22 44.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.525 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 16.5 m -77.79 172.9 12.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.814 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -75.4 -83.87 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.262 -179.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.2 t -150.11 137.56 19.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.628 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.461 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 59.34 25.57 60.55 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.909 -179.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.515 ' CE1' ' HB3' ' A' ' 68' ' ' SER . 2.4 m-85 -116.16 168.74 9.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.805 0.336 . . . . 0.0 110.875 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.662 ' CD2' HD11 ' A' ' 42' ' ' ILE . 7.6 p-80 -133.74 113.66 12.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.057 177.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.939 HD11 ' HG2' ' A' ' 64' ' ' PRO . 8.3 tt -76.11 135.48 39.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.773 -178.41 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.662 HD11 ' CD2' ' A' ' 40' ' ' HIS . 1.9 mm -113.89 153.44 15.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.099 0.476 . . . . 0.0 111.16 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.17 -137.48 18.52 Favored Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.135 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.782 ' O ' HD21 ' A' ' 41' ' ' LEU . 2.0 pt-20 -80.61 -178.04 6.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.044 0.449 . . . . 0.0 110.879 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.6 p -158.46 24.79 0.24 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.891 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.416 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 1.6 mtmt -150.73 124.87 9.35 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -177.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.443 ' HB3' HG13 ' A' ' 31' ' ' ILE . 1.7 t -92.51 146.95 23.28 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.593 177.051 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.525 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.1 m-85 -120.74 113.51 20.3 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 119.139 -1.024 . . . . 0.0 111.683 178.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.409 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 18.7 t -63.74 95.19 0.1 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.154 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -118.47 -171.28 2.05 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.381 -178.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.561 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -97.2 148.19 23.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.031 -179.423 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.415 ' N ' HG22 ' A' ' 58' ' ' VAL . . . -81.35 -144.8 4.41 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.437 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.3 m -85.43 -47.37 10.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.902 0.382 . . . . 0.0 110.905 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.0 p -91.23 47.4 1.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.843 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 51.37 29.14 22.4 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.416 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.82 -168.2 2.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.855 0.36 . . . . 0.0 111.007 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.94 133.86 51.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.55 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.415 HG22 ' N ' ' A' ' 52' ' ' GLY . 0.8 OUTLIER -148.15 -179.35 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.036 -179.736 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.539 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 78.9 m95 -128.42 122.11 30.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.388 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.525 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -69.11 167.02 23.02 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.82 178.466 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.451 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 84.9 Cg_exo -18.7 93.01 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 125.096 3.864 . . . . 0.0 114.198 -179.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.411 ' CB ' ' OG ' ' A' ' 47' ' ' SER . 0.0 OUTLIER -97.32 -78.79 0.47 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.879 -177.672 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.471 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -75.05 108.4 5.41 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -176.056 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.939 ' HG2' HD11 ' A' ' 41' ' ' LEU . 3.5 Cg_endo -87.95 -156.73 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.307 2.671 . . . . 0.0 111.028 177.057 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.662 HD12 ' HB ' ' A' ' 42' ' ' ILE . 1.1 mt -89.2 174.99 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.844 0.354 . . . . 0.0 110.662 178.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.621 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.7 OUTLIER -171.16 145.91 2.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.891 179.45 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.55 ' HB3' ' CE1' ' A' ' 40' ' ' HIS . 31.2 tt0 -160.44 163.15 33.25 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.924 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.515 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 1.4 p -92.82 118.9 31.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.229 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.52 HG13 ' OD2' ' A' ' 91' ' ' ASP . 1.0 OUTLIER -55.14 93.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.861 179.194 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.401 ' CG ' ' O ' ' A' ' 89' ' ' TYR . 1.3 tttt -77.77 135.91 38.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.897 0.38 . . . . 0.0 111.26 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.431 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -106.64 121.78 45.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.143 178.458 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -69.41 -161.41 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.608 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.418 ' OG ' ' NE2' ' A' ' 82' ' ' HIS . 2.7 t -50.07 137.9 19.96 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.653 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.435 ' HA ' ' CD1' ' A' ' 118' ' ' TRP . 39.6 Cg_exo -57.61 159.13 17.64 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.242 1.961 . . . . 0.0 111.908 -179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.504 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 93.7 Cg_exo -42.54 156.88 0.09 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.653 2.235 . . . . 0.0 112.712 -178.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 75.8 p -106.9 89.13 2.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.789 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.603 HG23 ' HE2' ' A' ' 97' ' ' TYR . 33.8 pt -69.72 169.91 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.179 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -92.44 137.44 32.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.731 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.495 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 0.4 OUTLIER 65.05 29.18 12.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.71 -179.788 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -169.43 -167.4 29.94 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.959 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.2 ptt85 -170.18 -174.49 1.75 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.016 0.436 . . . . 0.0 110.462 -179.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 7.5 p80 -108.09 172.43 6.84 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.056 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' A' ' 96' ' ' THR . 63.1 m-20 -107.75 8.75 29.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.539 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -50.62 134.77 29.82 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.341 -0.933 . . . . 0.0 112.604 -179.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -105.68 -26.93 11.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.057 0.456 . . . . 0.0 110.611 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.27 -172.59 4.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.601 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.62 -23.06 11.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.952 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.416 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 12.2 m-85 -137.72 169.95 16.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.066 0.46 . . . . 0.0 111.308 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.431 ' N ' ' O ' ' A' ' 71' ' ' CYS . 37.7 m-85 -147.03 169.59 18.9 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.761 179.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.1 p -134.21 175.11 9.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.998 0.428 . . . . 0.0 111.647 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.52 ' OD2' HG13 ' A' ' 69' ' ' VAL . 1.3 m-20 -60.25 99.13 0.07 Allowed 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.445 0.641 . . . . 0.0 111.021 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.45 23.36 1.93 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 114.917 -1.038 . . . . 0.0 113.005 178.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.416 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -108.35 161.56 14.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.81 0.338 . . . . 0.0 110.583 179.066 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.489 HG22 ' N ' ' A' ' 95' ' ' VAL . 32.7 m -138.57 157.62 30.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.079 0.466 . . . . 0.0 111.313 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.493 HG23 ' CH2' ' A' ' 118' ' ' TRP . 18.8 t -151.13 148.61 14.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.555 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.776 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -105.3 131.91 52.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.397 179.203 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.958 ' CE1' HG21 ' A' ' 111' ' ' VAL . 3.6 m-85 -89.25 159.31 17.49 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.052 -178.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.7 m -150.22 133.35 16.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.954 0.407 . . . . 0.0 111.567 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.444 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 74.7 m -69.81 162.67 27.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.745 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -96.81 -84.51 0.36 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.928 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -45.31 -27.38 0.65 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.529 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 124.9 36.0 0.61 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.465 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.495 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 18.9 m-85 -75.52 -173.74 2.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.939 0.399 . . . . 0.0 110.915 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.44 107.45 16.23 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.962 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.514 HD22 ' HA ' ' A' ' 109' ' ' SER . 1.1 tp -46.44 118.74 2.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.163 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.526 HG22 ' N ' ' A' ' 107' ' ' GLY . 45.2 mm -104.59 160.8 4.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.883 -179.184 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.526 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 52.07 38.44 47.66 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.416 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.411 ' O ' ' O ' ' A' ' 107' ' ' GLY . 4.1 p-10 51.58 124.18 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 123.9 0.88 . . . . 0.0 112.693 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.776 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.3 p -56.03 -27.45 53.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.402 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.59 136.06 49.29 Favored Glycine 0 CA--C 1.518 0.239 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.843 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.958 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.2 t -136.61 130.2 46.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.27 125.37 37.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.92 0.391 . . . . 0.0 111.826 -178.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.498 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 16.7 t -87.32 107.88 18.71 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 175.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 7.0 t -154.95 166.98 31.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.988 -178.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 45.54 33.16 4.38 Favored Glycine 0 CA--C 1.516 0.146 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.692 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.453 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 64.83 19.41 65.36 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.565 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -149.32 -177.77 6.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.933 0.397 . . . . 0.0 110.989 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.504 ' CD1' ' HD3' ' A' ' 75' ' ' PRO . 94.8 m95 -113.27 126.26 55.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.87 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.19 145.84 33.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.261 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.495 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.9 OUTLIER 69.3 44.84 0.26 Allowed Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.123 178.84 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 57.0 Cg_endo -70.14 140.27 40.85 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.166 1.911 . . . . 0.0 111.243 178.091 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.504 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 94.7 Cg_endo -89.53 -170.58 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.624 2.216 . . . . 0.0 113.798 -177.244 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -140.58 -172.07 3.36 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.001 178.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' CYS . . . . . 0.403 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 11.8 m -142.37 95.72 2.84 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.007 0.432 . . . . 0.0 110.907 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -128.52 156.85 42.63 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.973 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.494 HG12 ' CE2' ' A' ' 103' ' ' TYR . 25.6 mm . . . . . 0 C--N 1.323 -0.544 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.011 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.0 mtm-85 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.938 0.399 . . . . 0.0 111.73 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.446 ' CB ' ' HA ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -93.29 171.08 9.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.435 178.627 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.449 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 98.3 m -78.6 156.97 77.74 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.203 -179.133 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.444 ' HD3' ' HB2' ' A' ' 57' ' ' MET . 60.4 Cg_endo -71.77 177.44 6.94 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.81 2.34 . . . . 0.0 112.533 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 p -48.91 104.67 0.43 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.896 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.459 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 71.6 Cg_exo -42.71 143.78 1.56 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.396 2.064 . . . . 0.0 112.323 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.569 ' O ' HD11 ' A' ' 20' ' ' LEU . 10.1 mtt180 -58.9 152.37 19.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.056 178.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.539 ' HA ' HD11 ' A' ' 20' ' ' LEU . 1.7 p30 -105.96 178.76 4.47 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 121.338 0.59 . . . . 0.0 112.542 -175.484 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.0 tt -138.86 147.79 24.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.033 178.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -82.58 -56.2 4.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.779 -177.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.411 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 0.7 OUTLIER -94.48 27.11 3.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.198 -178.303 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.412 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -149.34 -178.65 24.53 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.383 -0.913 . . . . 0.0 113.297 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -139.13 132.16 29.54 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.569 HD11 ' O ' ' A' ' 13' ' ' ARG . 3.6 mt -76.89 160.78 28.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.203 0.525 . . . . 0.0 111.897 -178.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.437 ' HB3' ' CB ' ' A' ' 32' ' ' THR . 17.3 t70 -130.44 74.29 1.59 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.515 177.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.857 ' HA ' HG23 ' A' ' 31' ' ' ILE . 73.2 mt -72.96 101.45 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.017 -177.09 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.54 20.72 48.45 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.543 176.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.02 145.42 4.16 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 -179.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.42 ' O ' ' HB2' ' A' ' 8' ' ' ARG . 16.6 m -124.83 -6.79 6.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.446 ' HA ' ' CB ' ' A' ' 8' ' ' ARG . 9.1 m-20 -69.8 156.03 39.65 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.931 0.396 . . . . 0.0 111.698 -178.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.74 ' HZ ' HD13 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -48.17 101.48 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.514 178.923 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 119.05 -15.5 11.01 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.441 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.4 m -63.47 166.87 6.07 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.794 0.297 . . . . 0.0 110.293 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 47' ' ' SER . 12.4 p -137.05 147.1 45.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.082 0.467 . . . . 0.0 111.682 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.857 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.4 OUTLIER -113.07 173.77 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.793 -179.807 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.505 HG23 ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -141.99 106.77 4.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.016 178.645 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.557 ' CE1' HD22 ' A' ' 20' ' ' LEU . 20.9 m-85 -76.59 142.37 40.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.043 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.412 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 1.5 m -141.05 165.38 27.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.543 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.445 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 2.3 m -88.56 165.4 14.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.766 0.317 . . . . 0.0 110.768 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -64.78 -84.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.06 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.6 m -153.93 133.45 12.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.728 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.4 ' HA3' ' CB ' ' A' ' 91' ' ' ASP . . . 63.28 24.59 67.52 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.937 -178.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.509 ' CE1' ' HB3' ' A' ' 68' ' ' SER . 2.6 m-85 -116.72 171.48 7.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.859 0.361 . . . . 0.0 110.906 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.61 ' NE2' HD11 ' A' ' 42' ' ' ILE . 6.5 p-80 -134.57 116.17 14.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.624 178.173 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.954 HD21 ' O ' ' A' ' 44' ' ' GLU . 4.6 tt -74.24 127.64 33.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.606 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.61 HD11 ' NE2' ' A' ' 40' ' ' HIS . 3.1 mm -100.94 151.24 5.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.836 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.45 -140.03 23.9 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.691 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.954 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -70.68 175.38 4.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.948 0.404 . . . . 0.0 110.997 179.857 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.431 ' HA ' ' HG2' ' A' ' 64' ' ' PRO . 0.4 OUTLIER -157.77 26.84 0.27 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.296 179.289 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.505 ' HG2' HG23 ' A' ' 32' ' ' THR . 6.6 mtpt -149.97 151.84 33.99 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.998 -179.065 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.417 ' OG ' ' HB ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -132.25 143.12 49.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.125 179.51 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.511 ' CE2' ' HD3' ' A' ' 61' ' ' PRO . 2.7 m-85 -117.0 125.8 51.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.176 0.512 . . . . 0.0 111.892 -178.066 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.515 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 24.4 t -73.91 117.13 15.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.695 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.495 ' HA ' ' CE2' ' A' ' 27' ' ' PHE . 12.9 tt0 -160.38 167.58 27.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.424 0.631 . . . . 0.0 111.016 178.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.74 HD13 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -82.86 139.95 33.18 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.433 -178.733 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.507 ' N ' HG22 ' A' ' 58' ' ' VAL . . . 177.87 76.29 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.43 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.406 ' HB3' ' HB3' ' A' ' 56' ' ' SER . 23.0 t -176.04 58.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.931 0.396 . . . . 0.0 110.609 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.2 p 63.61 13.97 7.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.131 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 121.01 33.78 0.95 Allowed Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.604 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.406 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 0.2 OUTLIER -132.07 -174.13 3.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.116 0.484 . . . . 0.0 111.335 -179.885 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.592 ' O ' HG13 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -94.77 156.39 16.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.48 179.91 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.592 HG13 ' O ' ' A' ' 57' ' ' MET . 2.4 m -160.44 -176.83 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.28 -178.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.82 ' CE3' HD11 ' A' ' 31' ' ' ILE . 92.2 m95 -133.56 126.01 30.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.137 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -149.61 123.68 4.62 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.589 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.511 ' HD3' ' CE2' ' A' ' 48' ' ' TYR . 23.2 Cg_exo -68.65 -174.69 8.68 Favored 'Cis proline' 0 C--N 1.35 0.633 0 C-N-CA 124.287 -1.13 . . . . 0.0 113.055 2.077 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.1 -143.05 0.39 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.861 -178.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.532 ' CB ' ' CE1' ' A' ' 33' ' ' TYR . . . -86.4 116.51 66.14 Favored Pre-proline 0 CA--C 1.53 0.187 0 CA-C-O 120.407 0.146 . . . . 0.0 111.008 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.545 ' HG2' HD11 ' A' ' 41' ' ' LEU . 11.5 Cg_exo -72.95 -151.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.645 2.23 . . . . 0.0 112.582 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.488 HG22 ' H ' ' A' ' 66' ' ' CYS . 4.5 mm -101.45 166.34 2.47 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-O 121.02 0.438 . . . . 0.0 111.486 -178.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.488 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.3 m -163.61 120.3 1.75 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.379 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.32 171.04 15.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.992 0.425 . . . . 0.0 111.318 -178.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.509 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 8.9 p -93.22 103.18 15.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.848 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.791 HG22 ' HA3' ' A' ' 116' ' ' GLY . 2.7 p -59.46 89.3 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.478 179.21 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 89' ' ' TYR . 5.4 tttt -63.8 154.22 34.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.558 -0.747 . . . . 0.0 112.184 -177.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.416 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -118.88 127.01 53.1 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.77 177.559 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.413 ' CG ' ' N ' ' A' ' 73' ' ' SER . 0.1 OUTLIER -73.93 -160.48 0.09 Allowed 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.488 179.89 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.413 ' N ' ' CG ' ' A' ' 72' ' ' GLN . 2.7 t -50.21 137.49 21.33 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.505 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.483 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 37.9 Cg_exo -56.33 162.57 7.64 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.167 1.911 . . . . 0.0 111.574 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.507 ' HD3' ' CG ' ' A' ' 118' ' ' TRP . 82.2 Cg_exo -39.92 156.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.726 2.284 . . . . 0.0 112.571 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.7 m -107.89 89.05 2.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.894 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.571 HG21 ' O ' ' A' ' 122' ' ' PRO . 13.5 pt -69.7 173.92 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.002 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.0 m -95.77 138.76 32.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.878 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.506 ' HB3' ' CD2' ' A' ' 103' ' ' TYR . 3.9 m-80 60.16 28.97 18.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.989 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.498 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -160.26 -170.75 25.25 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.149 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.26 -175.15 3.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.046 0.45 . . . . 0.0 110.858 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -112.92 169.03 9.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.889 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -116.97 63.75 0.72 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.793 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -92.12 151.74 20.9 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.043 -1.075 . . . . 0.0 112.484 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.447 ' CD2' ' N ' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -108.79 -30.31 8.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.16 0.505 . . . . 0.0 110.632 -179.969 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.5 -172.37 2.49 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.845 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.33 -24.48 12.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.928 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.419 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 10.7 m-85 -134.08 174.78 10.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.938 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.423 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 40.6 m-85 -147.0 165.11 30.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.444 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 17.0 p -129.22 172.09 11.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.005 0.431 . . . . 0.0 111.55 -179.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 0.9 OUTLIER -58.74 97.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.889 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.69 14.87 2.75 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.195 -0.911 . . . . 0.0 113.093 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.98 158.31 15.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.909 0.355 . . . . 0.0 110.393 179.086 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.419 HG22 ' N ' ' A' ' 95' ' ' VAL . 27.0 m -133.77 156.11 40.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.072 0.463 . . . . 0.0 111.231 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.474 HG23 ' CH2' ' A' ' 118' ' ' TRP . 38.7 t -149.72 150.86 13.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.615 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.983 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -108.22 133.6 52.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.963 0.411 . . . . 0.0 110.53 179.112 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.944 ' CE1' HG21 ' A' ' 111' ' ' VAL . 5.9 m-85 -93.28 155.84 17.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.044 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 20.0 p -152.83 144.32 23.37 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.147 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.459 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 68.5 m -72.95 158.87 34.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.251 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 -86.91 -71.09 0.57 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.692 -178.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 40.5 t -68.39 -21.72 64.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.612 -178.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 123.85 32.42 0.87 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.66 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.506 ' CD2' ' HB3' ' A' ' 79' ' ' ASN . 30.6 m-85 -69.6 -171.85 0.42 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.768 0.318 . . . . 0.0 110.277 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.7 p -107.35 106.06 16.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.975 0.417 . . . . 0.0 111.168 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.598 HD23 ' HB2' ' A' ' 122' ' ' PRO . 3.0 tp -46.92 108.85 0.16 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.702 178.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.488 HG22 ' N ' ' A' ' 107' ' ' GLY . 31.8 mm -84.1 158.35 3.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.651 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.488 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 59.81 -123.16 32.36 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.258 -0.973 . . . . 0.0 111.795 -178.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -125.82 132.91 52.15 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.796 0.331 . . . . 0.0 110.766 178.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.983 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.2 p -66.37 -31.54 72.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.401 179.469 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.64 136.92 22.69 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.526 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.944 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.9 t -126.54 153.37 35.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 179.215 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.39 118.36 35.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.903 0.382 . . . . 0.0 111.597 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.508 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 15.1 t -85.55 97.75 10.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.615 176.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 1.0 OUTLIER -132.54 151.1 52.03 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.556 -177.982 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 48.01 29.77 6.77 Favored Glycine 0 C--N 1.329 0.187 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.745 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.791 ' HA3' HG22 ' A' ' 69' ' ' VAL . . . 79.95 -5.06 63.4 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.936 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -121.17 175.11 6.27 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.93 0.395 . . . . 0.0 110.866 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.508 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 87.2 m95 -112.5 152.27 28.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.895 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.27 147.12 49.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.021 0.438 . . . . 0.0 111.466 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.492 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER 70.07 46.11 0.27 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.161 178.546 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.492 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 74.1 Cg_endo -75.37 139.49 23.42 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.382 2.055 . . . . 0.0 111.623 178.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.598 ' HB2' HD23 ' A' ' 105' ' ' LEU . 57.3 Cg_endo -89.22 -174.52 0.96 Allowed 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.574 2.182 . . . . 0.0 113.559 -178.295 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.469 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -132.27 -171.75 2.72 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.845 -1.071 . . . . 0.0 109.834 177.829 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 10.4 m -146.3 93.93 2.38 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.0 0.428 . . . . 0.0 111.214 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -119.54 169.54 9.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.878 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.479 HG12 ' CE1' ' A' ' 103' ' ' TYR . 28.3 mm . . . . . 0 C--N 1.323 -0.547 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.944 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.6 mtt-85 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.821 0.343 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.419 ' HD3' HG23 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -69.22 171.46 8.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.507 179.488 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.477 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 53.6 m -77.85 159.61 75.94 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.664 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.15 169.86 17.17 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.504 2.136 . . . . 0.0 112.305 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 p -50.55 106.38 0.63 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.832 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.47 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 52.2 Cg_exo -43.23 152.92 0.22 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.262 1.974 . . . . 0.0 112.249 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.905 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -70.05 154.75 41.54 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.056 0.455 . . . . 0.0 110.424 178.685 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -97.59 -176.47 3.49 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.889 -176.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.591 HG22 ' CD2' ' A' ' 20' ' ' LEU . 18.6 tt -151.45 144.75 16.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.961 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -86.57 159.25 19.31 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.108 -0.497 . . . . 0.0 109.974 178.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.499 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 0.3 OUTLIER 43.15 29.63 0.22 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.89 0.376 . . . . 0.0 111.051 -179.445 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -155.02 173.42 33.34 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.629 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -137.53 135.18 36.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.763 0.316 . . . . 0.0 110.589 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.905 HD11 ' O ' ' A' ' 13' ' ' ARG . 14.0 mt -79.27 159.91 27.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.445 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.42 ' HB3' ' CB ' ' A' ' 32' ' ' THR . 34.9 t0 -131.31 75.48 1.66 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.366 178.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.876 ' HA ' HG23 ' A' ' 31' ' ' ILE . 58.3 mt -70.98 118.38 15.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.134 0.492 . . . . 0.0 111.994 -178.247 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -128.47 19.83 5.6 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.696 177.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 160.12 117.84 0.48 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.175 -0.536 . . . . 0.0 111.94 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.419 HG23 ' HD3' ' A' ' 8' ' ' ARG . 17.4 m -114.47 24.85 4.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.692 0.282 . . . . 0.0 111.554 -178.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -100.97 146.47 27.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.703 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.539 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 5.7 t80 -48.23 97.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.062 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.18 5.58 5.59 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.074 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.58 -158.69 0.69 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 117.037 0.419 . . . . 0.0 110.79 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.2 p -168.62 146.63 4.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.048 0.451 . . . . 0.0 111.413 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.876 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.7 OUTLIER -105.89 167.58 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.225 179.51 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.42 ' CB ' ' HB3' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -127.85 121.31 29.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.802 0.334 . . . . 0.0 110.738 179.001 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.693 ' CE1' HD21 ' A' ' 20' ' ' LEU . 14.1 m-85 -95.51 149.09 21.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.519 -179.056 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.19 155.82 39.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.771 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.432 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 2.9 m -81.99 169.53 16.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.819 0.342 . . . . 0.0 110.867 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -70.56 -84.97 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.157 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.6 m -153.14 131.91 12.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.933 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.71 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 68.19 21.22 73.74 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.15 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.499 ' CE2' ' HB3' ' A' ' 17' ' ' ASN . 2.5 m-85 -113.46 175.97 5.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.793 0.33 . . . . 0.0 110.868 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.929 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.5 OUTLIER -140.15 113.59 8.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.516 178.662 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.936 HD21 ' O ' ' A' ' 44' ' ' GLU . 6.7 tt -79.5 121.33 25.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.829 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.929 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.2 mm -99.23 168.43 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.129 -179.465 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.544 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 69.13 -134.1 26.84 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.374 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.936 ' O ' HD21 ' A' ' 41' ' ' LEU . 2.2 pm0 -79.75 -173.05 3.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.766 0.317 . . . . 0.0 110.603 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.2 t -166.66 28.84 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.605 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.409 ' HG3' ' HA ' ' A' ' 32' ' ' THR . 1.1 mtpt -159.76 127.65 4.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.327 -178.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.436 ' OG ' ' CB ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -93.0 143.67 26.01 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.906 178.323 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.534 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.6 m-85 -118.69 114.5 22.82 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.507 178.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.463 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 21.8 t -69.86 99.4 1.38 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.565 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -120.38 -172.17 2.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.098 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.539 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -93.18 145.33 24.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.953 -179.608 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.71 -137.5 0.2 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.534 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.0 m -92.43 -44.6 8.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.802 0.334 . . . . 0.0 110.959 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 80.4 p -99.57 43.52 1.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.973 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.67 19.25 66.96 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.58 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.88 -161.58 0.36 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.849 0.357 . . . . 0.0 110.803 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.412 ' O ' HG13 ' A' ' 58' ' ' VAL . 4.6 mmt -114.87 141.83 47.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.7 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 57' ' ' MET . 1.4 m -155.52 175.34 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.823 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.549 ' CE3' HD11 ' A' ' 31' ' ' ILE . 79.2 m95 -128.51 121.86 29.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.598 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.534 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -69.52 167.34 23.17 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.342 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.489 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 68.4 Cg_exo -14.58 92.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.872 1 C-N-CA 125.339 4.026 . . . . 0.0 114.622 -178.656 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.479 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -90.81 -75.78 0.46 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.338 -177.4 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.419 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . . . -91.8 108.17 27.87 Favored Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -175.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.897 ' HG2' HD11 ' A' ' 41' ' ' LEU . 4.7 Cg_exo -81.47 -154.15 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.083 2.522 . . . . 0.0 111.123 177.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.504 HG22 ' H ' ' A' ' 66' ' ' CYS . 3.8 mm -88.81 166.03 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.782 0.325 . . . . 0.0 110.438 177.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.504 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.8 OUTLIER -169.32 129.82 1.08 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.605 179.783 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -155.74 173.5 16.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.135 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.493 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 5.2 p -85.4 117.25 24.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.627 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.71 HG12 ' O ' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -42.44 94.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.344 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.489 ' CD ' ' HB3' ' A' ' 88' ' ' PHE . 4.3 ttpt -80.15 131.72 35.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.285 -178.091 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.432 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -107.08 130.0 54.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.901 -179.285 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.3 -158.48 0.06 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.443 178.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.567 ' HG ' ' CE1' ' A' ' 82' ' ' HIS . 2.0 t -49.98 135.89 21.1 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.842 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.499 ' HG2' HG11 ' A' ' 95' ' ' VAL . 31.8 Cg_exo -56.69 162.92 7.79 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.393 2.062 . . . . 0.0 112.053 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.516 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 87.8 Cg_exo -42.44 156.68 0.09 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.715 2.277 . . . . 0.0 112.776 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 65.1 p -106.01 90.09 3.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.406 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.688 HG23 ' HE1' ' A' ' 97' ' ' TYR . 25.0 pt -69.32 172.54 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.37 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 124' ' ' CYS . 3.0 p -94.98 143.9 26.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.509 179.055 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.501 ' HB3' ' CE1' ' A' ' 103' ' ' TYR . 2.9 m120 58.58 28.59 17.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.86 0.362 . . . . 0.0 111.084 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -171.82 -167.54 32.11 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.498 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 10.2 ptt85 -166.54 -176.6 3.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.966 0.413 . . . . 0.0 111.168 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.567 ' CE1' ' HG ' ' A' ' 73' ' ' SER . 25.3 p-80 -103.08 175.16 5.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.038 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -107.18 -86.37 0.5 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.31 179.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.429 ' HA3' ' OH ' ' A' ' 89' ' ' TYR . . . 58.56 154.42 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.117 178.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -114.44 -34.02 5.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.027 0.441 . . . . 0.0 110.793 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.12 -171.73 2.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.801 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -102.25 -27.12 13.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.202 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.489 ' HB3' ' CD ' ' A' ' 70' ' ' LYS . 19.2 m-85 -128.86 -176.85 3.98 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.077 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.462 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 84.5 m-85 -157.41 169.95 23.56 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.734 -178.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 11.4 p -134.0 178.59 6.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.909 0.385 . . . . 0.0 111.407 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.409 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 28.5 p-10 -62.74 94.77 0.07 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.298 0.571 . . . . 0.0 111.026 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.56 29.53 0.9 Allowed Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.983 179.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.11 163.88 13.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.691 0.282 . . . . 0.0 110.57 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 33.9 m -138.76 150.73 23.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.103 0.478 . . . . 0.0 111.307 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.51 HG23 ' CH2' ' A' ' 118' ' ' TRP . 20.1 t -145.81 147.06 18.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.635 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.963 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -105.76 130.59 53.73 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.893 179.956 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.94 ' CE2' HG21 ' A' ' 111' ' ' VAL . 5.0 m-85 -89.77 160.55 16.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.069 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 82.4 p -156.47 139.26 15.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.078 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.426 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 62.8 m -70.94 160.11 33.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.076 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 -80.85 -81.96 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.299 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.14 -30.99 70.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.214 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 132.57 39.81 0.22 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.645 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.523 ' HE2' HD11 ' A' ' 126' ' ' ILE . 49.7 m-85 -69.51 -174.27 0.67 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.807 0.337 . . . . 0.0 110.545 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 67.3 m -104.97 101.2 10.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.699 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.494 HD21 ' HA ' ' A' ' 109' ' ' SER . 0.2 OUTLIER -50.69 122.18 6.89 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.475 0.655 . . . . 0.0 111.428 -178.713 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.43 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 30.9 mm -91.3 155.43 3.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.943 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.76 -127.53 36.51 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.922 -178.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -126.19 138.59 53.66 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.799 0.333 . . . . 0.0 111.065 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.963 ' OG ' HG22 ' A' ' 96' ' ' THR . 5.7 p -64.79 -32.25 73.85 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.656 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -71.49 138.34 27.37 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.929 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.94 HG21 ' CE2' ' A' ' 97' ' ' TYR . 2.7 t -133.31 119.66 36.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.543 0.211 . . . . 0.0 110.591 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.5 125.79 30.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.889 0.376 . . . . 0.0 111.554 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.504 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 34.7 t -90.22 102.81 15.53 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 176.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 9.0 t -144.22 161.0 40.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.111 0.482 . . . . 0.0 111.308 -178.352 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.433 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 45.23 33.37 4.0 Favored Glycine 0 CA--C 1.518 0.252 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.912 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.463 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 66.39 16.99 65.83 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.538 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -139.98 178.05 7.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.781 0.324 . . . . 0.0 110.608 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.516 ' CD1' ' HD3' ' A' ' 75' ' ' PRO . 94.5 m95 -116.01 138.18 51.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.926 -179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.72 146.68 46.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.214 -179.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.475 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 3.2 t0 71.02 46.05 0.25 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.074 178.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 97.2 Cg_endo -78.63 134.69 12.43 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.322 2.015 . . . . 0.0 111.379 177.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.459 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 53.7 Cg_endo -87.05 -177.65 2.26 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.374 2.05 . . . . 0.0 113.412 -178.361 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 105' ' ' LEU . 0.2 OUTLIER -134.2 177.85 7.42 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.542 178.312 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 124' ' ' CYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 78' ' ' SER . 12.5 m -132.93 106.68 7.83 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.312 0.577 . . . . 0.0 110.95 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.497 ' C ' HD12 ' A' ' 126' ' ' ILE . 13.7 mt-30 -114.79 -175.87 2.78 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.437 -178.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.791 ' N ' HD12 ' A' ' 126' ' ' ILE . 1.6 mp . . . . . 0 C--N 1.32 -0.68 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.618 -177.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.782 0.325 . . . . 0.0 111.214 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.402 ' HA ' ' HA ' ' A' ' 26' ' ' ASP . 0.1 OUTLIER -61.94 -174.91 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.736 179.291 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.449 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 60.6 m -104.78 158.74 31.36 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.9 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.444 ' HD3' ' HB2' ' A' ' 57' ' ' MET . 57.8 Cg_endo -68.91 170.98 14.32 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.362 2.041 . . . . 0.0 110.883 178.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.1 p -53.2 123.53 35.04 Favored Pre-proline 0 N--CA 1.448 -0.525 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.633 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -58.61 158.24 24.48 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.737 2.291 . . . . 0.0 112.338 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.809 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -70.81 142.96 51.29 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.474 178.779 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.417 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 0.7 OUTLIER -83.62 -171.06 3.38 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.417 -177.624 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.671 HG22 ' CD2' ' A' ' 20' ' ' LEU . 20.2 tt -155.97 143.89 11.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.394 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -90.93 158.77 16.55 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.764 177.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.498 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 0.4 OUTLIER 48.27 26.02 0.99 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.825 0.345 . . . . 0.0 110.656 -179.463 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.413 ' HA2' ' N ' ' A' ' 36' ' ' ASN . . . -157.56 -178.6 31.76 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.589 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -146.06 134.43 21.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.672 0.273 . . . . 0.0 110.887 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.809 HD11 ' O ' ' A' ' 13' ' ' ARG . 20.1 mt -78.61 155.18 29.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.986 0.422 . . . . 0.0 111.353 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.44 ' CB ' ' HB ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -124.01 72.65 1.17 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.444 177.203 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.889 ' HA ' HG23 ' A' ' 31' ' ' ILE . 1.1 mt -69.93 101.17 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.008 -176.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.9 17.25 57.55 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.718 176.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 154.96 151.5 5.86 Favored Glycine 0 C--N 1.333 0.382 0 N-CA-C 111.659 -0.576 . . . . 0.0 111.659 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.402 ' O ' ' HB2' ' A' ' 8' ' ' ARG . 23.3 m -133.76 13.61 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.011 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 1.8 p-10 -85.5 157.18 20.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.849 0.356 . . . . 0.0 111.094 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.485 ' CZ ' ' HG ' ' A' ' 51' ' ' LEU . 5.9 t80 -51.38 103.34 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.785 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 115.28 -1.51 22.35 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.888 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 94.4 p -78.94 -176.72 5.17 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 116.984 0.392 . . . . 0.0 110.435 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.3 p -151.91 156.36 39.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.936 0.398 . . . . 0.0 111.376 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.889 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.8 OUTLIER -122.37 166.55 16.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.827 -179.713 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.44 ' HB ' ' CB ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -128.89 114.48 16.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.782 179.13 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.474 ' CE2' HD21 ' A' ' 20' ' ' LEU . 31.3 m-85 -88.58 145.01 25.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.979 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -148.41 166.17 28.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.113 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.414 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 1.3 m -89.64 158.79 17.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.716 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.424 ' ND2' ' HA ' ' A' ' 17' ' ' ASN . 15.5 m-20 -58.02 -88.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.31 -178.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.9 t -151.86 133.39 14.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.882 0.372 . . . . 0.0 110.822 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.41 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 69.01 18.49 72.81 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.233 -179.075 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.498 ' CE1' ' HB3' ' A' ' 17' ' ' ASN . 2.7 m-30 -112.6 -177.93 3.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.911 0.386 . . . . 0.0 110.786 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.733 ' CE1' HD11 ' A' ' 42' ' ' ILE . 1.2 p-80 -142.08 110.85 6.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.008 177.041 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.941 HD21 ' O ' ' A' ' 44' ' ' GLU . 2.9 tt -72.57 125.19 26.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.336 -178.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.733 HD11 ' CE1' ' A' ' 40' ' ' HIS . 1.7 mm -106.2 165.7 3.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.111 0.482 . . . . 0.0 111.274 -178.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.487 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 70.31 -123.16 11.75 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.305 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.941 ' O ' HD21 ' A' ' 41' ' ' LEU . 1.3 mt-10 -80.77 174.58 11.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.194 0.521 . . . . 0.0 112.019 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.2 p -156.37 19.03 0.35 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.474 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.412 ' HG2' ' O ' ' A' ' 31' ' ' ILE . 8.8 mtpt -159.97 152.05 20.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.059 0.457 . . . . 0.0 112.075 -177.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -121.25 152.73 38.54 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.031 177.986 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.502 ' CB ' ' HB2' ' A' ' 60' ' ' ASN . 1.4 m-85 -131.36 115.13 15.84 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 119.135 -1.026 . . . . 0.0 112.173 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 28.0 t -66.12 109.02 2.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.763 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -133.27 -173.3 3.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.173 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.664 HD23 ' O ' ' A' ' 56' ' ' SER . 7.4 mt -85.63 160.85 19.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.242 -179.312 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.42 -143.27 3.26 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.532 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.3 t -101.28 -31.41 10.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.792 0.33 . . . . 0.0 110.891 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 26.7 p -113.28 25.56 11.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.852 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.26 32.51 11.99 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.444 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.664 ' O ' HD23 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -102.45 -171.4 1.96 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.988 0.423 . . . . 0.0 111.131 -179.861 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.444 ' HB2' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -109.31 125.61 52.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.801 -179.411 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.1 -176.95 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.861 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.644 ' CE3' HD11 ' A' ' 31' ' ' ILE . 65.8 m95 -132.01 131.95 42.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.744 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.502 ' HB2' ' CB ' ' A' ' 48' ' ' TYR . 1.0 OUTLIER -69.92 162.62 67.17 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.08 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.474 ' O ' ' HA ' ' A' ' 47' ' ' SER . 21.4 Cg_exo -7.8 109.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.755 1 C-N-CA 125.888 4.392 . . . . 0.0 115.267 -178.189 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.424 ' HA ' ' OG ' ' A' ' 47' ' ' SER . 3.9 mt-10 -98.09 -113.73 0.15 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 114.901 -1.045 . . . . 0.0 112.513 -176.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.449 ' HA ' ' CD2' ' A' ' 33' ' ' TYR . . . -69.25 107.71 2.41 Favored Pre-proline 0 C--N 1.34 0.168 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -176.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.577 ' HG2' HD11 ' A' ' 41' ' ' LEU . 2.2 Cg_endo -81.53 -153.98 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.924 2.416 . . . . 0.0 110.298 176.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.661 HD12 ' HB ' ' A' ' 42' ' ' ILE . 0.3 OUTLIER -86.04 170.73 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.327 0.584 . . . . 0.0 111.573 -179.976 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.568 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.5 OUTLIER -172.24 141.47 1.25 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.042 179.805 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -169.7 167.8 9.33 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.801 0.334 . . . . 0.0 111.202 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.496 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 2.8 p -77.54 121.85 24.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.247 178.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.702 HG13 ' OD2' ' A' ' 91' ' ' ASP . 1.4 p -40.52 96.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.139 0.495 . . . . 0.0 111.582 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.521 ' HG2' ' CD2' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -92.37 127.53 37.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.172 -178.013 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.43 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -100.29 132.02 45.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.998 -179.001 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -75.81 -159.55 0.11 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.599 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.433 ' HG ' ' CE1' ' A' ' 82' ' ' HIS . 1.9 t -48.44 136.83 12.29 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.04 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.487 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 25.7 Cg_exo -60.59 159.02 29.6 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.351 2.034 . . . . 0.0 112.225 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.427 ' HG2' ' HD3' ' A' ' 121' ' ' PRO . 81.1 Cg_exo -44.78 159.69 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.982 2.455 . . . . 0.0 113.275 -178.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.6 m -108.8 93.11 4.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.516 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.493 HG23 ' CE1' ' A' ' 97' ' ' TYR . 22.4 pt -68.5 175.2 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.249 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.2 p -94.32 137.36 33.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.877 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.503 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 0.1 OUTLIER 68.47 26.87 6.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.879 179.521 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.454 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . -171.84 -164.78 27.99 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.263 -0.97 . . . . 0.0 113.216 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.422 ' N ' ' O ' ' A' ' 98' ' ' SER . 4.9 ptt85 -162.06 -175.1 4.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.044 0.45 . . . . 0.0 110.705 -179.12 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.433 ' CE1' ' HG ' ' A' ' 73' ' ' SER . 19.6 p-80 -111.14 169.53 8.72 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.71 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -100.52 -83.72 0.44 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.709 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.519 ' H ' HG13 ' A' ' 95' ' ' VAL . . . 60.74 148.61 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.617 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -115.66 -36.27 4.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.099 0.475 . . . . 0.0 110.613 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.79 -171.38 2.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.611 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -100.89 -25.94 13.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.058 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.521 ' CD2' ' HG2' ' A' ' 70' ' ' LYS . 24.8 m-85 -130.19 -176.67 4.02 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.161 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.468 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 89.2 m-85 -157.17 165.57 35.6 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.419 -178.244 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.0 p -136.56 -176.4 4.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.072 0.463 . . . . 0.0 111.717 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.702 ' OD2' HG13 ' A' ' 69' ' ' VAL . 2.1 m-20 -63.03 96.64 0.1 Allowed 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.255 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.94 26.54 1.36 Allowed Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.288 -0.869 . . . . 0.0 113.035 178.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.408 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -110.17 162.92 14.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.817 0.341 . . . . 0.0 110.801 179.374 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 36.0 m -144.29 149.44 17.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.135 0.493 . . . . 0.0 111.125 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.519 HG13 ' H ' ' A' ' 84' ' ' GLY . 18.1 t -141.1 146.97 22.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.559 179.492 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.99 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -102.08 136.78 41.32 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.816 -179.764 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.883 ' CE2' HG21 ' A' ' 111' ' ' VAL . 5.8 m-85 -98.81 156.17 17.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.147 -179.233 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.422 ' O ' ' N ' ' A' ' 81' ' ' ARG . 1.3 p -148.07 141.42 25.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.57 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.454 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 12.1 m -69.38 162.43 27.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.281 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -97.02 -69.07 0.77 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.092 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.75 -28.81 69.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.01 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.36 36.79 0.48 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.548 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.519 ' CE2' HG12 ' A' ' 126' ' ' ILE . 18.2 m-85 -74.27 -171.77 1.26 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.756 0.312 . . . . 0.0 110.664 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.6 m -117.54 101.05 8.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.759 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.691 HD21 ' HG2' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -49.0 132.79 18.7 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.594 0.711 . . . . 0.0 111.155 -179.739 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.449 ' HB ' ' CB ' ' A' ' 123' ' ' THR . 36.1 mm -101.82 156.98 4.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.59 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.434 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 67.35 -126.47 25.37 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.958 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -125.79 127.06 45.54 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.054 0.454 . . . . 0.0 110.931 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.99 ' OG ' HG22 ' A' ' 96' ' ' THR . 3.6 p -59.34 -27.93 66.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.728 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -72.47 121.39 8.08 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.75 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.883 HG21 ' CE2' ' A' ' 97' ' ' TYR . 11.6 t -113.99 116.03 51.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.5 126.61 31.18 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -177.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.5 ' HB2' ' CZ3' ' A' ' 118' ' ' TRP . 41.8 t -91.07 104.12 16.74 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.234 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 19.3 t -141.1 150.72 43.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.078 0.466 . . . . 0.0 111.406 -178.125 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.598 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 46.68 43.24 15.58 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.767 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.468 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 62.32 14.14 46.7 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.647 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -135.11 173.25 11.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.023 0.44 . . . . 0.0 110.679 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.514 ' CZ3' HG23 ' A' ' 95' ' ' VAL . 95.8 m95 -115.48 128.1 55.78 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.527 -178.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.488 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 0.3 OUTLIER -91.81 130.39 37.6 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.663 175.04 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.626 ' HB2' HG13 ' A' ' 111' ' ' VAL . 2.8 m-20 108.92 -132.1 0.0 OUTLIER Pre-proline 0 CA--C 1.475 -1.907 0 N-CA-C 100.41 -3.922 . . . . 0.0 100.41 -167.105 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.553 ' HA ' ' CB ' ' A' ' 120' ' ' ASP . 60.4 Cg_endo -63.52 -179.53 7.77 Favored 'Cis proline' 0 C--N 1.309 -1.54 0 CA-C-N 125.157 2.878 . . . . 0.0 112.717 -17.346 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.691 ' HG2' HD21 ' A' ' 105' ' ' LEU . 18.0 Cg_endo -87.94 -179.51 2.53 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 123.023 2.482 . . . . 0.0 111.32 176.324 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.449 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -109.12 -162.6 0.82 Allowed 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.13 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 124' ' ' CYS . . . . . 0.427 ' SG ' ' HB2' ' A' ' 103' ' ' TYR . 5.0 t -170.25 85.83 0.12 Allowed 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.904 -176.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -114.61 176.74 4.92 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.909 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.66 ' O ' HG22 ' A' ' 126' ' ' ILE . 26.4 mm . . . . . 0 C--N 1.322 -0.615 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.718 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.816 0.341 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -74.34 175.21 7.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.731 179.594 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.467 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 37.9 m -81.33 160.06 66.02 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.874 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.89 174.44 9.62 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.454 2.103 . . . . 0.0 111.961 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -51.11 109.57 1.41 Allowed Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.794 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.41 162.38 14.85 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.258 1.972 . . . . 0.0 111.977 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.575 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -52.11 -175.02 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.447 179.318 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.422 ' O ' HG13 ' A' ' 15' ' ' ILE . 0.4 OUTLIER -140.05 6.53 2.18 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.041 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.936 HD13 ' CD2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER 57.8 -165.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.067 -177.635 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -125.79 -70.88 0.72 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.929 0.395 . . . . 0.0 110.613 178.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.482 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -99.2 29.02 4.11 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.941 178.605 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.43 ' HA2' ' N ' ' A' ' 36' ' ' ASN . . . -137.93 -175.66 14.03 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.214 -178.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -133.75 145.35 49.74 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.672 0.272 . . . . 0.0 110.747 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.789 HD22 HD11 ' A' ' 15' ' ' ILE . 4.9 mt -82.67 155.55 24.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.207 0.527 . . . . 0.0 111.797 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.416 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 4.5 t0 -129.91 68.5 1.44 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.92 175.433 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.879 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.9 OUTLIER -74.95 116.95 18.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.49 -175.796 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -116.05 19.57 13.5 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.227 175.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 161.0 125.99 0.8 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.007 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.6 m -112.44 5.79 8.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 15.8 t70 -88.46 165.42 14.91 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.871 0.367 . . . . 0.0 110.871 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -57.76 116.71 3.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.635 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.45 5.9 36.42 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.833 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 89.7 p -94.14 -169.59 2.1 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.856 0.328 . . . . 0.0 110.307 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.9 p -165.88 141.66 5.0 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.125 0.488 . . . . 0.0 111.1 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.879 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.6 OUTLIER -106.14 164.38 4.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.209 -179.898 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.424 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -121.86 118.18 28.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.952 0.406 . . . . 0.0 110.671 179.034 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.936 ' CD2' HD13 ' A' ' 15' ' ' ILE . 6.1 m-85 -90.97 135.63 33.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.784 -178.109 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.9 m -146.97 157.55 43.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.694 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.42 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 1.9 m -79.58 167.56 20.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.846 0.355 . . . . 0.0 110.869 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.43 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 2.7 m120 -67.15 -84.13 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.971 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.96 134.52 11.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.699 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.29 24.27 73.47 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.897 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.53 ' CE2' ' CB ' ' A' ' 68' ' ' SER . 2.7 m-30 -119.73 174.52 6.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.887 0.375 . . . . 0.0 110.908 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.905 ' CD2' HD11 ' A' ' 42' ' ' ILE . 4.9 p-80 -134.53 117.12 15.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.364 177.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.84 HD21 ' O ' ' A' ' 44' ' ' GLU . 5.7 tt -81.75 127.47 32.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.337 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.905 HD11 ' CD2' ' A' ' 40' ' ' HIS . 1.9 mm -106.09 149.49 9.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.275 -178.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.71 -141.4 19.5 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.369 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.84 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.9 OUTLIER -74.04 -172.94 1.47 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.903 0.383 . . . . 0.0 110.79 179.53 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.8 p -161.69 22.73 0.12 Allowed 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.392 -179.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.424 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 1.1 mtpt -153.31 125.47 7.98 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -177.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.453 ' CB ' ' HA ' ' A' ' 62' ' ' GLU . 0.3 OUTLIER -94.61 145.43 24.84 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.092 178.111 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.537 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.8 m-85 -120.89 120.5 35.7 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 119.315 -0.954 . . . . 0.0 111.797 178.383 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 26.5 t -68.74 117.66 10.73 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.156 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -156.61 -179.45 8.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.992 179.289 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.5 ' C ' HD12 ' A' ' 51' ' ' LEU . 4.6 pp -94.09 158.42 15.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.656 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.417 ' O ' ' N ' ' A' ' 54' ' ' THR . . . -155.41 -56.25 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.012 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.448 ' HB2' ' HB3' ' A' ' 56' ' ' SER . 0.1 OUTLIER -63.27 77.18 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.99 0.424 . . . . 0.0 111.22 -178.943 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.417 ' N ' ' O ' ' A' ' 52' ' ' GLY . 2.5 p 51.14 27.28 3.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.124 179.152 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 121.56 -17.8 8.83 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.535 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.448 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 6.6 t -57.49 -159.56 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.916 0.389 . . . . 0.0 110.998 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.87 140.06 49.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.87 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.1 m -149.28 -176.09 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.541 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.56 ' CZ3' HD11 ' A' ' 31' ' ' ILE . 69.7 m95 -131.48 124.96 31.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.988 0.423 . . . . 0.0 111.261 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.537 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 4.8 m-20 -68.4 166.61 24.03 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.439 178.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.47 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 49.3 Cg_exo -12.63 86.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.008 1 C-N-CA 125.361 4.041 . . . . 0.0 114.211 -178.958 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.496 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.5 OUTLIER -90.26 -76.58 0.42 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.723 -176.236 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.464 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -94.22 108.23 34.51 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -173.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.787 ' HG2' HD11 ' A' ' 41' ' ' LEU . 2.3 Cg_endo -81.41 -154.34 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.189 2.592 . . . . 0.0 110.368 175.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.677 HD12 ' HB ' ' A' ' 42' ' ' ILE . 1.0 OUTLIER -93.19 175.2 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.602 177.767 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.61 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.8 OUTLIER -171.46 144.31 1.92 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.609 179.718 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.417 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 1.3 tt0 -166.73 175.08 8.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.86 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.53 ' CB ' ' CE2' ' A' ' 39' ' ' TYR . 0.2 OUTLIER -99.41 123.4 43.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.658 178.944 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.438 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 1.4 p -45.27 92.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.093 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 68' ' ' SER . 2.4 mmtp -63.99 131.95 49.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.199 -177.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.12 121.0 40.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.62 177.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.3 -159.5 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.655 -179.16 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.465 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 2.7 t -51.33 139.67 25.9 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.589 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.466 ' HG2' HG11 ' A' ' 95' ' ' VAL . 26.4 Cg_exo -59.22 159.67 21.81 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.201 1.934 . . . . 0.0 111.918 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.492 ' HD3' ' CG ' ' A' ' 118' ' ' TRP . 88.9 Cg_exo -39.79 156.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.934 2.422 . . . . 0.0 113.04 -178.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.1 t -107.97 90.81 3.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.796 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.597 HG23 ' HE2' ' A' ' 97' ' ' TYR . 21.4 pt -69.51 -176.68 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.287 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.6 m -105.25 145.74 30.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.662 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.47 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 7.4 m-80 55.56 28.35 11.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.929 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.471 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -167.52 -163.2 20.99 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.563 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 9.5 ptt180 -170.15 -175.72 2.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.039 0.447 . . . . 0.0 110.971 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.465 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 1.6 p-80 -110.46 168.2 9.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.868 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -92.95 -87.01 0.24 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.636 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.47 ' H ' HG13 ' A' ' 95' ' ' VAL . . . 60.69 142.96 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.049 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.478 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -113.51 -35.74 5.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.091 0.472 . . . . 0.0 110.587 179.423 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.36 -171.53 2.97 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.819 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.91 -21.9 13.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.14 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.421 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 7.8 m-85 -134.02 172.48 12.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.106 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.421 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 48.6 m-85 -148.11 165.01 32.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.828 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.415 ' CG2' ' HE3' ' A' ' 70' ' ' LYS . 12.1 p -134.5 -175.19 3.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.905 0.383 . . . . 0.0 111.462 -178.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.42 ' OD1' ' CG1' ' A' ' 69' ' ' VAL . 0.7 OUTLIER -64.5 98.45 0.25 Allowed 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.31 0.576 . . . . 0.0 111.069 -179.876 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.86 22.29 2.23 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.164 -0.925 . . . . 0.0 113.13 178.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.438 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.6 OUTLIER -103.18 157.25 17.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.908 0.354 . . . . 0.0 110.631 179.167 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 28.6 m -136.39 149.06 27.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.079 0.466 . . . . 0.0 111.173 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.475 HG23 ' CH2' ' A' ' 118' ' ' TRP . 21.4 t -144.19 147.39 19.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.747 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.694 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -106.31 129.49 54.32 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.778 -179.984 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.955 ' CE1' HG21 ' A' ' 111' ' ' VAL . 5.5 m-85 -88.56 157.07 18.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.115 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.4 ' HA ' HD13 ' A' ' 105' ' ' LEU . 50.2 m -151.3 141.31 22.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.334 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.425 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 74.0 m -71.89 163.12 28.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.979 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.471 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 18.0 m-20 -96.73 -71.46 0.68 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.513 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.0 t -61.58 -22.57 65.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.23 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 122.37 31.29 1.08 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.534 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.494 ' CD2' HG12 ' A' ' 126' ' ' ILE . 24.8 m-85 -69.96 -174.02 0.72 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 120.959 0.409 . . . . 0.0 110.495 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.0 105.87 14.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.359 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.674 HD22 ' HB3' ' A' ' 109' ' ' SER . 0.2 OUTLIER -46.44 123.41 4.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.385 0.612 . . . . 0.0 111.419 -178.809 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.458 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 42.6 mm -91.13 152.61 3.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.457 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.67 -130.44 36.91 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.104 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -114.67 138.8 50.25 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.839 0.352 . . . . 0.0 110.774 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.694 ' HB2' HG22 ' A' ' 96' ' ' THR . 0.0 OUTLIER -77.23 -30.08 54.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.756 179.906 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.04 127.41 11.02 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.18 178.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.955 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.8 t -120.22 121.86 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.65 0.262 . . . . 0.0 110.642 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.75 122.85 27.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.705 -178.582 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.496 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 25.6 t -88.85 104.13 16.64 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.067 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.6 t -145.39 163.81 33.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.163 -178.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 44.9 30.57 2.44 Favored Glycine 0 CA--C 1.518 0.258 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.928 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.438 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 67.14 19.89 70.55 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.42 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -143.56 175.56 9.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.766 0.317 . . . . 0.0 110.561 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.496 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 95.7 m95 -112.33 142.86 44.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.005 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.9 148.08 50.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.257 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.478 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 26.6 t0 71.74 46.72 0.24 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.082 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 95.4 Cg_endo -78.18 134.03 12.6 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.343 2.029 . . . . 0.0 111.4 177.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.495 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 74.0 Cg_endo -88.66 -173.75 0.92 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.525 2.15 . . . . 0.0 113.532 -177.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.448 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -129.75 -163.42 1.3 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.781 177.756 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 5.1 m -151.97 92.06 1.69 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.047 0.451 . . . . 0.0 110.94 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -122.07 158.11 29.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.852 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.494 HG12 ' CD2' ' A' ' 103' ' ' TYR . 13.6 mm . . . . . 0 C--N 1.324 -0.518 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.859 179.576 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.907 0.384 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.785 ' HD3' HG23 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -77.34 -175.94 3.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.834 179.754 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.482 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 4.2 m -93.84 162.94 25.6 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.705 179.506 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.42 ' O ' ' HD3' ' A' ' 12' ' ' PRO . 15.5 Cg_endo -60.1 -163.28 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.316 2.011 . . . . 0.0 111.452 -179.883 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.44 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 0.9 OUTLIER -78.46 104.94 2.34 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.718 -0.219 . . . . 0.0 110.805 179.92 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.498 ' CG ' ' CD1' ' A' ' 22' ' ' ILE . 13.2 Cg_endo -55.97 142.84 84.47 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.123 1.882 . . . . 0.0 111.677 179.461 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.42 ' HB3' ' OH ' ' A' ' 33' ' ' TYR . 0.5 OUTLIER -52.19 169.34 0.08 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.467 -179.556 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.747 ' C ' HD21 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -130.02 -5.27 4.47 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -177.149 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.692 HG22 ' O ' ' A' ' 14' ' ' ASP . 3.0 tt 55.45 157.42 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 122.864 0.466 . . . . 0.0 111.798 -178.264 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -101.78 -47.33 4.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.432 -178.349 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -94.04 38.71 1.08 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.878 -179.633 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.464 ' HA2' ' N ' ' A' ' 36' ' ' ASN . . . 177.84 -166.07 36.07 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.969 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.893 ' C ' HD23 ' A' ' 20' ' ' LEU . 0.9 OUTLIER -136.47 177.21 8.03 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.334 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.893 HD23 ' C ' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -126.59 151.5 47.89 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.301 0.572 . . . . 0.0 111.411 -179.836 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 32' ' ' THR . 4.2 t70 -116.25 82.67 1.82 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.528 177.909 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.806 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.7 OUTLIER -77.39 103.12 4.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.392 -176.908 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.67 19.79 52.95 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.756 177.177 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.07 142.09 3.37 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.06 -0.591 . . . . 0.0 111.955 -179.374 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.785 HG23 ' HD3' ' A' ' 8' ' ' ARG . 11.0 m -128.6 29.64 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.66 0.266 . . . . 0.0 111.492 -178.891 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -105.69 164.97 11.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.929 0.395 . . . . 0.0 110.838 179.309 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.763 ' HZ ' HD13 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -59.93 90.59 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.925 -179.738 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 136.31 -2.88 3.58 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.32 179.63 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.39 -174.56 3.38 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 117.157 0.479 . . . . 0.0 110.771 179.86 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.427 ' HB2' ' HE2' ' A' ' 46' ' ' LYS . 1.4 p -156.58 145.22 19.99 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.016 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.806 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.4 OUTLIER -100.79 166.15 2.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.234 179.525 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.456 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -127.48 114.95 18.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.827 0.346 . . . . 0.0 110.864 179.654 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.789 ' CE1' HD22 ' A' ' 20' ' ' LEU . 15.4 m-85 -91.92 149.2 21.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.258 0.551 . . . . 0.0 112.061 -178.386 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.406 ' O ' ' HA3' ' A' ' 18' ' ' GLY . 46.0 m -151.44 147.02 26.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.188 178.901 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.417 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 6.3 m -69.15 167.66 15.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.848 0.356 . . . . 0.0 110.829 -179.351 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.464 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 25.4 m-20 -68.69 -85.76 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.239 -178.317 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.73 134.98 15.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.524 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.535 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 65.92 26.42 72.25 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.771 -178.79 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.499 ' CE2' ' HB3' ' A' ' 68' ' ' SER . 2.1 m-85 -121.41 171.89 8.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.997 0.427 . . . . 0.0 111.179 -179.45 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.664 ' NE2' HD11 ' A' ' 42' ' ' ILE . 4.4 p-80 -138.26 112.79 8.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.066 177.647 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.932 HD21 ' O ' ' A' ' 44' ' ' GLU . 7.0 tt -75.4 129.93 38.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.856 -178.812 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.664 HD11 ' NE2' ' A' ' 40' ' ' HIS . 3.0 mm -104.94 157.4 5.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.994 0.426 . . . . 0.0 111.098 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.6 -142.45 31.16 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.05 -179.094 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.932 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -73.0 -172.54 1.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.85 0.357 . . . . 0.0 110.569 179.222 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.417 ' HA ' ' HG3' ' A' ' 64' ' ' PRO . 0.3 OUTLIER -168.21 30.21 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.534 179.682 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.456 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 25.8 mtpt -151.8 126.02 9.29 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.426 -178.534 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.428 ' OG ' ' CB ' ' A' ' 62' ' ' GLU . 0.3 OUTLIER -93.04 137.47 32.37 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.876 178.819 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.515 ' CD1' ' HB3' ' A' ' 60' ' ' ASN . 1.1 m-85 -114.73 121.77 44.37 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.79 -179.948 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 23.0 t -72.01 117.56 13.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.936 -179.58 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.497 ' HA ' ' CE2' ' A' ' 27' ' ' PHE . 4.6 mt-10 -146.16 -179.47 6.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.034 179.476 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.763 HD13 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -94.46 143.15 26.66 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.912 -179.673 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -63.21 -125.47 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.368 179.722 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.8 t -123.0 -34.22 3.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.767 0.318 . . . . 0.0 111.263 -179.723 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.73 24.77 3.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.242 -179.516 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.56 18.58 61.73 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.679 179.755 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.1 t -95.3 -161.7 0.88 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.785 0.326 . . . . 0.0 111.059 179.889 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.684 ' O ' HG13 ' A' ' 58' ' ' VAL . 3.2 mmt -119.37 159.33 24.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.6 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.684 HG13 ' O ' ' A' ' 57' ' ' MET . 2.7 m -163.38 173.95 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.204 -179.484 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.529 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 74.1 m95 -129.25 125.22 36.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.138 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.515 ' HB3' ' CD1' ' A' ' 48' ' ' TYR . 0.7 OUTLIER -69.33 166.06 33.47 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.761 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.47 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 65.7 Cg_exo -11.49 101.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.003 1 C-N-CA 125.647 4.231 . . . . 0.0 114.634 -179.187 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.507 ' O ' ' CG ' ' A' ' 33' ' ' TYR . 0.7 OUTLIER -101.71 -71.1 0.72 Allowed 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 115.159 -0.928 . . . . 0.0 113.159 -175.416 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.438 ' HA ' HD12 ' A' ' 15' ' ' ILE . . . -102.98 76.93 0.23 Allowed Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -174.858 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.795 ' HG2' HD11 ' A' ' 41' ' ' LEU . 33.3 Cg_endo -55.39 -154.42 0.0 OUTLIER 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 123.249 2.633 . . . . 0.0 111.766 176.015 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.51 HG22 ' H ' ' A' ' 66' ' ' CYS . 6.8 mm -86.97 166.42 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.964 0.412 . . . . 0.0 111.282 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.51 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.1 m -165.34 125.86 1.89 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.762 178.907 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.16 171.74 13.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.918 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.499 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 96.4 p -84.89 118.53 24.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.552 -179.568 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.559 HG23 ' HB3' ' A' ' 40' ' ' HIS . 0.2 OUTLIER -49.98 99.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.036 178.876 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -62.85 138.95 58.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.188 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.419 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -123.18 126.59 47.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.636 179.588 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -74.57 -168.59 0.71 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.841 179.498 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -41.25 133.38 1.98 Allowed Pre-proline 0 N--CA 1.438 -1.056 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.684 179.364 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.492 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 31.8 Cg_exo -57.82 162.9 10.08 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.378 2.052 . . . . 0.0 112.391 -178.704 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.52 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 85.6 Cg_exo -41.32 160.5 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.879 2.386 . . . . 0.0 113.135 -179.469 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.81 89.61 3.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.642 179.399 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.565 HG23 ' HE1' ' A' ' 97' ' ' TYR . 22.5 pt -69.35 171.99 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.407 -179.025 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.404 ' O ' ' HB2' ' A' ' 124' ' ' CYS . 3.7 m -88.44 141.36 28.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.705 179.645 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.438 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 6.2 m-80 57.22 29.46 16.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.926 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.465 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -169.71 -172.52 36.36 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.81 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 9.4 ptt180 -166.69 -175.61 3.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.92 0.39 . . . . 0.0 110.59 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 16.1 p80 -109.36 167.86 9.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.637 -179.053 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 41.7 p-10 -122.66 -157.92 0.76 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.072 178.435 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 134.81 175.33 13.81 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.297 -0.954 . . . . 0.0 112.783 179.453 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.08 -27.15 8.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.04 0.448 . . . . 0.0 110.744 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.74 -175.72 2.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.354 -179.024 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.55 -25.57 11.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.494 178.654 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.42 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 5.1 m-85 -125.14 178.93 5.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.452 179.112 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.42 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 85.9 m-85 -153.62 169.02 24.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.825 -179.232 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.5 p -131.1 179.67 5.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.932 0.396 . . . . 0.0 111.524 -179.059 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.403 ' OD1' ' HB2' ' A' ' 68' ' ' SER . 44.6 p-10 -63.67 95.06 0.1 Allowed 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.354 0.597 . . . . 0.0 111.09 -179.865 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.61 27.95 1.37 Allowed Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.21 -0.905 . . . . 0.0 112.865 179.084 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.412 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -107.52 160.79 15.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.672 0.273 . . . . 0.0 110.458 179.047 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.442 HG22 ' N ' ' A' ' 95' ' ' VAL . 34.4 m -134.16 155.89 40.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.153 0.501 . . . . 0.0 111.389 -179.657 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.553 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 19.5 t -148.71 148.59 15.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.367 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.824 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -108.29 119.67 40.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.178 0.513 . . . . 0.0 111.12 -179.331 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.951 ' CE2' HG21 ' A' ' 111' ' ' VAL . 3.5 m-85 -77.06 164.55 25.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.766 -178.477 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.448 ' HA ' ' CD1' ' A' ' 105' ' ' LEU . 0.7 OUTLIER -155.35 135.35 12.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.671 -179.259 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.414 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 61.1 m -69.78 157.52 37.19 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.765 178.921 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.465 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 78.1 m-20 -85.82 -76.74 0.32 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.426 -179.349 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.7 t -59.02 -26.53 64.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.831 0.348 . . . . 0.0 111.184 -179.345 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 124.39 35.85 0.64 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.402 -179.724 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.438 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 14.3 m-85 -69.58 -174.0 0.65 Allowed 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 120.876 0.37 . . . . 0.0 110.618 179.853 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.5 m -111.9 99.68 8.31 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.181 179.122 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.588 HD23 ' HB2' ' A' ' 122' ' ' PRO . 0.0 OUTLIER -48.02 144.35 3.7 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.736 0.779 . . . . 0.0 111.682 -177.615 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.475 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 40.5 mm -117.73 159.91 17.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.913 -177.534 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.464 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 51.49 24.69 11.88 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.171 -1.014 . . . . 0.0 112.581 179.728 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.409 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.5 OUTLIER 61.04 135.04 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.191 0.52 . . . . 0.0 111.79 178.898 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.824 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.1 p -62.14 -28.68 69.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.885 -178.776 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -53.44 127.4 36.66 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.883 -179.259 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.951 HG21 ' CE2' ' A' ' 97' ' ' TYR . 3.1 t -128.11 150.38 33.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 178.72 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 118' ' ' TRP . 0.3 OUTLIER -107.1 129.52 54.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.854 0.359 . . . . 0.0 111.539 -179.201 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.508 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 44.3 t -92.63 106.01 18.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.526 176.228 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.6 t -153.74 164.32 38.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.011 0.434 . . . . 0.0 111.206 -178.425 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 45.25 33.21 3.96 Favored Glycine 0 CA--C 1.518 0.254 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.858 179.604 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 65.42 19.0 66.17 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.42 -179.641 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -146.89 -176.85 5.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.877 0.37 . . . . 0.0 110.778 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.553 ' CZ3' HG23 ' A' ' 95' ' ' VAL . 88.8 m95 -118.49 122.96 43.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.95 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.46 147.12 28.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.111 -179.366 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.514 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER 71.85 41.95 0.18 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.489 179.192 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 53.3 Cg_endo -68.69 145.98 65.32 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 121.993 1.796 . . . . 0.0 111.014 177.88 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.588 ' HB2' HD23 ' A' ' 105' ' ' LEU . 73.3 Cg_endo -96.49 -173.58 0.23 Allowed 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.521 2.147 . . . . 0.0 113.938 -177.096 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 105' ' ' LEU . 0.2 OUTLIER -132.9 172.2 12.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.446 -1.252 . . . . 0.0 109.195 177.868 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 124' ' ' CYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 78' ' ' SER . 1.9 m -130.18 91.77 3.17 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.095 0.474 . . . . 0.0 110.433 178.659 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -117.11 -179.39 3.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.369 -178.351 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.48 ' O ' HG22 ' A' ' 126' ' ' ILE . 43.6 mm . . . . . 0 C--N 1.321 -0.645 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.02 -179.462 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.866 0.365 . . . . 0.0 110.956 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.472 ' CB ' ' HA ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -93.93 168.98 10.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.22 -179.734 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.551 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 76.6 m -78.47 176.77 3.31 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.645 178.861 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.555 ' HD2' ' CD1' ' A' ' 59' ' ' TRP . 36.8 Cg_endo -92.21 178.71 1.46 Allowed 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 122.75 2.3 . . . . 0.0 112.21 -179.281 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.7 t -48.57 103.82 0.38 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.442 179.12 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.514 ' HG3' ' CZ2' ' A' ' 59' ' ' TRP . 51.2 Cg_exo -48.75 159.65 0.83 Allowed 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.319 2.013 . . . . 0.0 112.751 -178.518 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.654 ' O ' HD11 ' A' ' 20' ' ' LEU . 6.2 mtm180 -65.22 -178.43 0.48 Allowed 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.54 177.073 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.489 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 2.7 t70 -141.64 167.2 22.72 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.288 0.566 . . . . 0.0 111.217 -176.865 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.404 HG23 ' C ' ' A' ' 18' ' ' GLY . 7.4 tt -119.29 147.94 22.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.438 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -76.53 -58.82 3.06 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -177.671 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.407 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 0.1 OUTLIER -93.87 32.81 1.39 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.191 -177.945 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.404 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -156.86 -171.94 23.55 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.364 -179.579 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -145.56 141.86 28.62 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.291 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.876 HD22 ' CE2' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -88.06 166.35 14.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.28 0.562 . . . . 0.0 111.775 -179.153 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.3 OUTLIER -133.05 85.3 2.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.726 177.263 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.861 ' HA ' HG23 ' A' ' 31' ' ' ILE . 53.6 mt -72.83 105.25 2.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -177.174 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.13 20.96 39.11 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.496 176.414 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 29' ' ' SER . . . 154.39 139.27 2.78 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 -179.135 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.401 ' O ' ' HB2' ' A' ' 8' ' ' ARG . 15.7 m -120.52 -8.06 10.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.9 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.472 ' HA ' ' CB ' ' A' ' 8' ' ' ARG . 25.5 t0 -69.28 164.67 22.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.169 0.509 . . . . 0.0 111.402 -178.816 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.465 ' CZ ' ' HB3' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -53.39 119.09 4.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.512 179.751 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.65 -3.9 61.31 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.507 -178.628 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 24' ' ' GLY . 22.7 m -70.44 174.21 6.01 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 116.951 0.376 . . . . 0.0 110.592 179.553 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.7 p -148.02 149.22 31.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.108 -179.717 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.861 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -115.6 171.31 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.628 -179.92 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 21' ' ' ASP . 1.4 m -130.83 118.35 20.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.914 0.388 . . . . 0.0 111.091 179.733 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.876 ' CE2' HD22 ' A' ' 20' ' ' LEU . 10.0 m-85 -95.76 138.92 32.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.579 -179.212 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.403 ' O ' ' HA3' ' A' ' 18' ' ' GLY . 22.6 m -142.73 157.23 44.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.757 179.416 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.4 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 1.5 m -76.94 170.15 17.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.706 0.289 . . . . 0.0 110.748 179.742 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -65.47 -84.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.968 -179.538 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.0 t -157.32 133.5 9.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.728 179.713 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.6 ' O ' HG22 ' A' ' 69' ' ' VAL . . . 66.93 23.71 72.8 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.054 -179.095 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.507 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.5 m-85 -115.27 -178.25 3.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.933 0.397 . . . . 0.0 110.96 -179.803 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.789 ' CD2' HD11 ' A' ' 42' ' ' ILE . 4.1 p-80 -141.98 111.63 6.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.882 177.511 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.951 HD21 ' O ' ' A' ' 44' ' ' GLU . 5.3 tt -78.14 127.2 31.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.713 -178.722 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.789 HD11 ' CD2' ' A' ' 40' ' ' HIS . 2.4 mm -103.72 149.7 7.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.041 0.448 . . . . 0.0 110.975 -179.592 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.66 -131.72 10.88 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.304 -179.15 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.951 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -89.61 -176.55 5.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.771 0.32 . . . . 0.0 110.71 179.686 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.3 p -161.26 25.22 0.13 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.049 -179.245 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.413 ' HG3' ' HA ' ' A' ' 32' ' ' THR . 1.4 mtpt -153.24 129.65 10.61 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.113 0.483 . . . . 0.0 111.218 -179.171 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -103.38 150.71 23.55 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.0 179.654 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.492 ' CB ' ' HB2' ' A' ' 60' ' ' ASN . 1.9 m-85 -127.04 121.55 31.89 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 119.191 -1.004 . . . . 0.0 113.094 -177.806 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.432 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 25.4 t -70.16 97.63 1.23 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.258 177.65 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.499 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 2.1 tt0 -131.13 171.92 12.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.448 0.642 . . . . 0.0 111.091 -178.991 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.499 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -74.36 153.05 39.45 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.347 -179.237 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.5 -126.97 1.51 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.704 -179.833 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.4 t -107.95 -40.81 5.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.73 0.3 . . . . 0.0 111.149 -179.444 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 71.0 p -93.95 36.37 1.12 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.039 -179.742 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.76 19.63 71.52 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.622 179.834 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.35 -161.35 0.69 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.821 0.343 . . . . 0.0 110.782 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.55 143.24 47.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.295 -179.938 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.2 m -153.65 -176.94 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.047 -179.422 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.555 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 75.4 m95 -128.83 126.14 39.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.664 -179.285 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.492 ' HB2' ' CB ' ' A' ' 48' ' ' TYR . 2.1 m120 -69.46 164.45 49.54 Favored Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.772 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.493 ' O ' ' HA ' ' A' ' 47' ' ' SER . 67.3 Cg_exo -11.88 121.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 1.003 1 C-N-CA 125.8 4.333 . . . . 0.0 115.309 -175.948 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.512 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 4.9 mm-40 -110.25 -79.78 0.58 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.77 -1.105 . . . . 0.0 113.791 -174.35 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' A' ' 14' ' ' ASP . . . -101.95 79.24 0.25 Allowed Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -174.477 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.589 ' HG2' HD11 ' A' ' 41' ' ' LEU . 30.7 Cg_endo -54.67 -154.35 0.0 OUTLIER 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.335 2.69 . . . . 0.0 111.811 175.822 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.501 HG22 ' H ' ' A' ' 66' ' ' CYS . 5.4 mm -91.15 166.34 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.944 0.402 . . . . 0.0 111.259 -179.879 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.501 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -168.98 134.96 1.69 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.451 179.404 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -152.96 171.24 18.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.883 0.373 . . . . 0.0 111.02 -179.828 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.507 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 1.6 p -83.97 130.92 34.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.156 0.503 . . . . 0.0 111.364 -179.37 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 38' ' ' GLY . 4.3 m -46.68 100.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.545 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.488 ' HE2' HG23 ' A' ' 90' ' ' THR . 1.4 mmtt -86.91 100.2 12.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.229 179.621 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.421 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -87.57 121.32 29.84 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 177.652 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.454 ' CG ' ' N ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -68.85 -154.13 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -179.848 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.454 ' N ' ' CG ' ' A' ' 72' ' ' GLN . 1.8 t -51.49 148.11 9.74 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-O 120.676 0.274 . . . . 0.0 111.119 -179.318 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.483 ' CG ' HG11 ' A' ' 95' ' ' VAL . 12.2 Cg_exo -68.74 157.19 62.87 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.737 2.291 . . . . 0.0 111.909 179.538 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.524 ' HD3' ' CG ' ' A' ' 118' ' ' TRP . 83.0 Cg_exo -44.53 162.03 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.687 2.258 . . . . 0.0 112.741 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 69.4 m -116.63 89.21 3.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.658 179.463 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.628 HG23 ' HE2' ' A' ' 97' ' ' TYR . 17.6 pt -69.17 176.89 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.274 -179.255 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.3 t -89.81 150.93 22.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.659 179.037 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.514 ' HB3' ' CD2' ' A' ' 103' ' ' TYR . 2.0 m120 48.74 27.47 1.55 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.277 178.111 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.467 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -166.23 -164.95 22.76 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.776 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.7 ptt180 -170.23 -174.68 1.78 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.923 0.392 . . . . 0.0 110.667 -179.414 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.532 ' HB3' ' CE1' ' A' ' 97' ' ' TYR . 8.9 p80 -107.16 165.96 10.98 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.705 -178.844 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.502 ' O ' ' CD1' ' A' ' 85' ' ' TYR . 27.1 m-20 -89.38 -91.04 0.13 Allowed 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.857 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 85' ' ' TYR . . . 37.31 -87.04 0.01 OUTLIER Glycine 0 C--N 1.338 0.671 0 N-CA-C 114.134 0.414 . . . . 0.0 114.134 177.439 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.502 ' CD1' ' O ' ' A' ' 83' ' ' ASN . 22.6 m-85 72.89 29.39 1.87 Allowed 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 123.745 0.818 . . . . 0.0 110.177 -179.573 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.428 ' HB2' ' CZ ' ' A' ' 89' ' ' TYR . 0.4 OUTLIER -101.28 -171.02 1.92 Allowed 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.069 178.286 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -109.01 -27.32 9.71 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.013 0.435 . . . . 0.0 110.64 178.811 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.442 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 11.8 m-85 -153.01 162.86 40.82 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.817 179.824 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.442 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 6.8 m-85 -140.62 166.42 24.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.101 -179.445 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.488 HG23 ' HE2' ' A' ' 70' ' ' LYS . 16.6 p -130.79 175.59 8.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.015 0.436 . . . . 0.0 111.829 -178.46 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.584 ' OD2' HG21 ' A' ' 69' ' ' VAL . 0.7 OUTLIER -62.88 99.69 0.17 Allowed 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.619 0.724 . . . . 0.0 110.659 179.68 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 125.24 12.86 3.72 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 114.601 -1.181 . . . . 0.0 113.055 179.007 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -89.04 161.02 16.79 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 117.179 0.49 . . . . 0.0 110.017 178.501 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 20.7 m -150.54 131.16 4.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.11 0.481 . . . . 0.0 110.982 -179.295 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.483 HG11 ' CG ' ' A' ' 74' ' ' PRO . 2.0 p -130.74 143.73 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.698 -179.186 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.795 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -94.56 128.61 41.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.365 0.602 . . . . 0.0 111.376 -178.869 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.911 ' CE1' HG21 ' A' ' 111' ' ' VAL . 3.1 m-85 -84.36 163.81 19.33 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.298 -179.456 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 89.4 p -153.75 133.42 12.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.768 -178.947 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.445 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 81.9 m -69.84 159.36 33.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.544 178.629 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.467 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 74.0 m-80 -93.65 -79.1 0.42 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.653 -178.969 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.55 -31.64 25.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.847 0.356 . . . . 0.0 111.277 -179.106 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 130.65 38.87 0.28 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.446 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.514 ' CD2' ' HB3' ' A' ' 79' ' ' ASN . 23.9 m-85 -78.66 -172.77 3.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.836 0.35 . . . . 0.0 110.757 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 125' ' ' GLN . 0.3 OUTLIER -111.66 113.97 26.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.494 179.344 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.535 HD22 ' HA ' ' A' ' 109' ' ' SER . 1.1 mp -53.51 115.17 1.8 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.006 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.543 HG22 ' N ' ' A' ' 107' ' ' GLY . 34.5 mm -99.85 162.11 3.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.856 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.543 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 52.64 28.59 30.39 Favored Glycine 0 CA--C 1.508 -0.357 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.541 179.245 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.403 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.7 OUTLIER 60.31 128.8 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.935 -0.633 . . . . 0.0 111.465 179.44 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.795 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.3 p -60.28 -29.45 68.82 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.81 -178.747 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.76 136.88 49.98 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.908 -178.753 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.911 HG21 ' CE1' ' A' ' 97' ' ' TYR . 4.0 t -133.31 119.36 35.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 110.439 -0.208 . . . . 0.0 110.439 179.369 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.07 124.09 29.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.952 0.406 . . . . 0.0 111.474 -178.714 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 93' ' ' SER . 10.3 t -88.55 108.09 19.24 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.722 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 52.7 p -155.89 166.41 33.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.189 0.519 . . . . 0.0 111.524 -178.157 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.87 31.99 5.8 Favored Glycine 0 CA--C 1.518 0.279 0 CA-C-N 115.594 -0.73 . . . . 0.0 113.199 179.133 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.46 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 68.61 14.23 66.91 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.569 -179.881 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -147.15 171.63 15.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.016 0.436 . . . . 0.0 110.812 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.524 ' CG ' ' HD3' ' A' ' 75' ' ' PRO . 90.7 m95 -103.61 127.22 51.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.56 179.599 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.98 150.9 28.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.312 -179.037 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.492 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER 69.32 44.2 0.25 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.151 178.919 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.492 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 59.2 Cg_endo -72.64 140.62 32.95 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.154 1.903 . . . . 0.0 111.373 178.372 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.505 ' HG2' ' CD2' ' A' ' 97' ' ' TYR . 96.4 Cg_endo -91.73 -169.73 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.643 2.228 . . . . 0.0 113.98 -177.281 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.41 -159.91 1.0 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.391 -1.277 . . . . 0.0 109.743 178.22 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 124' ' ' CYS . . . . . 0.422 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 10.2 m -156.5 89.63 1.12 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.068 0.461 . . . . 0.0 110.709 179.033 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.414 ' O ' ' HB2' ' A' ' 104' ' ' SER . 15.6 mt-30 -122.69 158.4 30.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.034 -178.949 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.499 HG12 ' CE1' ' A' ' 103' ' ' TYR . 18.5 mm . . . . . 0 C--N 1.324 -0.536 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.958 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.805 0.336 . . . . 0.0 110.938 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -115.64 -174.84 2.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.801 179.617 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.481 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 14.7 m -94.75 162.09 26.56 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.04 -179.576 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 40.2 Cg_endo -67.77 -168.71 0.2 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.605 2.203 . . . . 0.0 112.261 -179.487 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 3.1 t -67.47 110.83 5.91 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.019 -179.54 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 11' ' ' SER . 1.5 Cg_endo -52.29 132.36 43.85 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.182 1.921 . . . . 0.0 112.161 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.942 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -53.47 161.71 0.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.515 179.248 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -108.37 -176.71 3.12 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.528 -178.138 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.477 HG22 ' CD2' ' A' ' 20' ' ' LEU . 14.1 tt -146.69 147.96 17.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.942 -179.624 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.43 160.43 15.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.379 -0.373 . . . . 0.0 109.998 178.535 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.486 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 0.2 OUTLIER 47.21 26.6 0.7 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.766 -179.743 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.45 ' HA2' ' N ' ' A' ' 36' ' ' ASN . . . -153.83 -168.07 16.95 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.846 -179.152 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.64 135.42 15.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.806 0.336 . . . . 0.0 111.071 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.942 HD11 ' O ' ' A' ' 13' ' ' ARG . 8.6 mt -75.17 160.22 30.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.595 -179.746 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.449 ' HB3' ' CB ' ' A' ' 32' ' ' THR . 1.1 t0 -135.39 71.96 1.44 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.774 177.847 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.895 ' HA ' HG23 ' A' ' 31' ' ' ILE . 18.4 mt -75.09 112.97 13.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.224 -177.437 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -107.48 16.15 37.97 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.628 176.383 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 153.94 136.93 2.37 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.823 -179.31 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.412 ' O ' ' HB2' ' A' ' 8' ' ' ARG . 28.3 m -120.39 29.94 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -178.341 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.83 154.59 18.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.828 0.347 . . . . 0.0 111.002 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.478 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 10.0 t80 -48.67 108.87 0.2 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.96 -4.98 34.13 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.663 -178.76 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.9 p -69.63 -164.49 0.07 Allowed 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.738 0.304 . . . . 0.0 110.681 179.762 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.3 p -167.02 143.26 4.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.022 0.439 . . . . 0.0 111.225 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.895 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -112.0 174.17 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.497 179.959 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.573 HG23 ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -135.5 113.11 10.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.948 0.404 . . . . 0.0 110.79 179.319 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.77 ' CE1' HD21 ' A' ' 20' ' ' LEU . 26.2 m-85 -88.92 137.09 32.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.935 -179.558 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.6 m -144.19 156.76 44.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.373 -179.085 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 59.4 m -84.05 166.23 17.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.948 179.74 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.45 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 3.3 m-20 -66.14 -86.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.23 -178.826 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.4 t -151.9 134.67 15.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.871 0.367 . . . . 0.0 110.873 -179.743 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.42 21.99 70.93 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.233 -179.468 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.497 ' CE1' ' HB3' ' A' ' 68' ' ' SER . 2.5 m-30 -114.22 -176.96 3.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.824 0.345 . . . . 0.0 110.832 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.557 ' CE1' HD11 ' A' ' 42' ' ' ILE . 1.8 p-80 -147.92 112.87 5.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.632 178.876 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.957 HD21 ' O ' ' A' ' 44' ' ' GLU . 3.1 tt -73.84 131.85 41.94 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.494 -179.782 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.557 HD11 ' CE1' ' A' ' 40' ' ' HIS . 3.9 mm -103.35 153.83 5.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.975 -179.637 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.72 -133.59 13.3 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.385 -179.514 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.957 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -80.57 174.94 11.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.712 0.292 . . . . 0.0 110.65 179.408 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.537 ' OG ' HD13 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -155.29 27.0 0.41 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.408 178.987 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.573 ' HG2' HG23 ' A' ' 32' ' ' THR . 0.0 OUTLIER -159.98 121.42 3.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.669 -178.968 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.426 ' HA ' ' HD2' ' A' ' 61' ' ' PRO . 47.9 t -92.84 157.21 16.5 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.513 179.322 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.52 ' CE1' ' HD3' ' A' ' 61' ' ' PRO . 4.0 m-85 -129.48 110.97 12.3 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.202 0.525 . . . . 0.0 111.648 -179.789 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.502 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 23.9 t -60.58 84.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.259 178.934 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -97.94 -171.64 2.21 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.995 -178.814 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.478 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -108.17 136.2 48.24 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.242 -179.234 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.476 ' N ' HG22 ' A' ' 58' ' ' VAL . . . -125.38 -172.86 13.53 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.939 179.226 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.604 ' C ' HG23 ' A' ' 54' ' ' THR . 5.9 t 47.52 27.59 1.01 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.969 0.414 . . . . 0.0 111.084 179.854 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.604 HG23 ' C ' ' A' ' 53' ' ' SER . 1.3 p 78.15 -53.55 0.5 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.422 -179.881 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -131.5 41.22 1.54 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.616 -179.591 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 52' ' ' GLY . 9.1 t -125.69 -168.24 1.81 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.862 0.363 . . . . 0.0 110.991 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.21 144.63 47.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.329 179.574 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.476 HG22 ' N ' ' A' ' 52' ' ' GLY . 1.5 m -153.64 179.69 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.302 -179.809 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.672 ' CE3' HD11 ' A' ' 31' ' ' ILE . 95.7 m95 -123.58 123.7 41.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.817 -179.847 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.5 m-20 -148.23 126.82 6.08 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.32 -179.485 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.52 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 2.9 Cg_exo -76.09 -167.45 5.84 Favored 'Cis proline' 0 C--N 1.35 0.656 0 C-N-CA 124.226 -1.156 . . . . 0.0 112.057 -0.983 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -110.74 -154.2 0.53 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.945 -179.434 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.482 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -69.61 111.21 8.13 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.911 179.863 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.533 ' HG2' HD11 ' A' ' 41' ' ' LEU . 15.3 Cg_exo -69.78 -150.55 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.627 2.218 . . . . 0.0 112.372 -179.165 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.506 HG22 ' H ' ' A' ' 66' ' ' CYS . 6.3 mm -98.45 166.44 2.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.371 -179.07 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.506 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.1 m -164.54 126.66 2.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.476 179.296 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.472 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -153.18 178.24 9.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.913 0.387 . . . . 0.0 111.267 -179.081 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.497 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 27.5 p -90.6 116.12 28.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.746 179.317 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.458 HG11 ' HA2' ' A' ' 115' ' ' GLY . 2.1 p -43.38 96.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.553 -179.804 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.421 ' HD3' ' HB3' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -78.01 120.64 23.14 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.615 -178.928 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.91 125.33 50.24 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.98 178.245 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -69.47 -158.87 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.429 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.406 ' HG ' ' HE2' ' A' ' 82' ' ' HIS . 1.3 t -54.1 143.39 43.52 Favored Pre-proline 0 N--CA 1.45 -0.442 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 179.612 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.459 ' HD2' ' CD2' ' A' ' 82' ' ' HIS . 25.2 Cg_exo -59.97 159.74 24.5 Favored 'Trans proline' 0 CA--C 1.528 0.207 0 C-N-CA 122.429 2.086 . . . . 0.0 112.092 -179.254 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.521 ' HD3' ' CG ' ' A' ' 118' ' ' TRP . 87.3 Cg_exo -46.56 156.44 0.6 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.762 2.308 . . . . 0.0 113.0 -178.856 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 12.8 t -108.06 91.5 3.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.301 178.89 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.748 HG23 ' HE2' ' A' ' 97' ' ' TYR . 22.2 pt -69.03 171.48 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.267 -178.905 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.9 p -89.13 135.17 33.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.021 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.463 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 0.0 OUTLIER 67.41 26.49 8.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.688 179.503 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -166.67 -163.39 20.32 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.106 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.3 ptt85 -170.29 -175.51 1.96 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.992 0.425 . . . . 0.0 110.982 -179.16 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.459 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 9.0 p-80 -115.99 168.02 10.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.854 179.661 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -93.07 -88.66 0.21 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.895 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.402 ' HA3' ' OH ' ' A' ' 89' ' ' TYR . . . 61.06 137.04 0.01 OUTLIER Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.903 179.423 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -111.26 -26.52 9.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.957 0.408 . . . . 0.0 110.714 179.384 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -92.91 -171.83 2.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.786 179.785 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -106.09 -22.08 12.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.135 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.432 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 6.4 m-85 -139.56 170.19 16.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.162 -179.449 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.432 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 24.6 m-85 -144.32 165.57 27.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.95 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 17.0 p -125.01 -179.66 4.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.128 -179.569 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 5.4 p-10 -67.06 95.36 0.39 Allowed 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.389 0.614 . . . . 0.0 110.933 -179.826 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 128.2 31.23 0.69 Allowed Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.132 -0.94 . . . . 0.0 112.93 179.177 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.415 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -110.27 164.16 12.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.689 0.28 . . . . 0.0 110.686 179.476 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 32.5 m -140.55 148.16 22.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.1 0.476 . . . . 0.0 111.276 -179.795 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.529 HG23 ' CH2' ' A' ' 118' ' ' TRP . 21.7 t -145.08 147.87 18.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.676 179.191 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.991 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -101.49 137.05 40.33 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 -179.756 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.95 ' CE1' HG21 ' A' ' 111' ' ' VAL . 3.8 m-85 -97.58 157.3 16.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.169 -179.313 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 84.5 p -149.44 140.9 23.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.397 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.433 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 73.0 m -70.78 159.02 35.31 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.415 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 17.7 m-20 -92.58 -70.88 0.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.54 -178.808 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.13 -22.1 66.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.368 -179.191 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.29 30.92 1.23 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.604 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.496 ' CE2' HG12 ' A' ' 126' ' ' ILE . 21.9 m-85 -69.71 -175.6 0.9 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.973 0.416 . . . . 0.0 110.754 179.634 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 125' ' ' GLN . 0.8 OUTLIER -111.2 104.35 12.85 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.787 177.617 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.55 HD21 ' CG ' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -47.77 129.62 14.17 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.531 0.681 . . . . 0.0 111.799 -177.422 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.438 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 38.1 mm -93.33 158.86 2.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.888 178.726 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.429 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 63.02 -125.83 35.4 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.306 -0.95 . . . . 0.0 111.977 -178.959 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -129.5 134.89 48.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.812 0.339 . . . . 0.0 111.063 179.526 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.991 ' OG ' HG22 ' A' ' 96' ' ' THR . 10.2 p -60.63 -32.26 71.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.115 0.483 . . . . 0.0 110.655 179.286 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -70.63 127.68 16.66 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.795 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.95 HG21 ' CE1' ' A' ' 97' ' ' TYR . 8.8 t -121.29 124.05 71.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 178.938 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.38 126.16 31.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.007 0.432 . . . . 0.0 111.879 -177.747 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.495 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 30.3 t -94.83 91.72 6.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.739 177.452 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.2 OUTLIER -129.46 156.84 43.47 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.036 0.446 . . . . 0.0 111.687 -177.892 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.458 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 46.98 27.7 3.57 Favored Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.856 179.477 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.456 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 77.81 -1.22 68.67 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.811 -179.524 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -123.8 157.45 34.06 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.895 0.379 . . . . 0.0 110.553 179.602 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.529 ' CH2' HG23 ' A' ' 95' ' ' VAL . 94.4 m95 -96.41 137.98 34.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.027 -179.654 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.633 ' O ' HG13 ' A' ' 111' ' ' VAL . 34.0 t -121.82 177.87 5.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.525 0.678 . . . . 0.0 111.478 179.292 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.457 ' N ' ' HD3' ' A' ' 121' ' ' PRO . 1.3 p-10 42.74 50.57 5.69 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.951 -179.521 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.457 ' HD3' ' N ' ' A' ' 120' ' ' ASP . 84.6 Cg_endo -83.25 141.7 10.39 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.642 2.228 . . . . 0.0 112.05 178.975 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.55 ' CG ' HD21 ' A' ' 105' ' ' LEU . 94.7 Cg_endo -91.56 -171.17 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.781 2.321 . . . . 0.0 113.554 -178.733 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.433 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -135.68 -157.94 0.83 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.616 -1.174 . . . . 0.0 109.884 178.601 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 8.6 m -156.6 89.92 1.13 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.077 0.465 . . . . 0.0 110.967 179.065 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.406 ' O ' ' HB2' ' A' ' 104' ' ' SER . 15.6 mt-30 -121.39 160.53 23.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.935 -179.767 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.496 HG12 ' CE2' ' A' ' 103' ' ' TYR . 18.4 mm . . . . . 0 C--N 1.324 -0.518 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.911 179.494 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.79 0.329 . . . . 0.0 110.979 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.55 ' HB3' HG23 ' A' ' 25' ' ' VAL . 0.1 OUTLIER 41.82 -165.32 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.957 178.981 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.46 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 18.9 m -114.68 159.53 36.8 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.76 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.64 168.59 19.55 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.393 2.062 . . . . 0.0 111.516 179.317 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.1 p -52.59 119.73 16.35 Favored Pre-proline 0 C--N 1.326 -0.447 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.887 -179.204 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.442 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 18.4 Cg_endo -57.79 150.3 63.49 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.55 2.167 . . . . 0.0 112.013 179.739 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.02 136.81 50.76 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.296 0.57 . . . . 0.0 110.701 179.489 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.474 ' HA ' HD11 ' A' ' 20' ' ' LEU . 2.9 p-10 -78.4 -177.38 5.21 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.104 -176.948 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.702 HG22 ' CD2' ' A' ' 20' ' ' LEU . 18.4 tt -145.75 148.49 17.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.095 -179.637 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.82 162.27 14.17 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.335 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.412 ' O ' ' N ' ' A' ' 36' ' ' ASN . 0.5 OUTLIER 47.26 27.65 0.89 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.947 0.403 . . . . 0.0 110.586 -179.404 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -175.45 173.79 46.44 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.921 -0.582 . . . . 0.0 112.287 -179.355 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.412 ' N ' ' O ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -136.77 156.94 47.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.729 0.3 . . . . 0.0 110.694 -179.856 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.931 HD22 ' CE1' ' A' ' 33' ' ' TYR . 0.2 OUTLIER -91.11 166.6 12.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.044 0.449 . . . . 0.0 110.976 179.188 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 32' ' ' THR . 15.2 t70 -129.97 78.83 1.87 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.052 178.196 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.887 ' HA ' HG23 ' A' ' 31' ' ' ILE . 42.5 mt -69.2 118.31 13.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.206 0.527 . . . . 0.0 112.056 -177.237 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -131.66 19.7 4.71 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.747 177.57 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 161.23 114.69 0.34 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 121.148 -0.549 . . . . 0.0 111.963 -179.475 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.55 HG23 ' HB3' ' A' ' 8' ' ' ARG . 18.7 m -113.58 30.4 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.683 0.278 . . . . 0.0 111.557 -178.837 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.423 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 15.0 t70 -101.55 163.5 12.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.959 0.409 . . . . 0.0 111.158 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.603 ' CZ ' HD12 ' A' ' 51' ' ' LEU . 7.8 t80 -60.83 89.45 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.852 -179.892 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.67 10.92 3.44 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.159 179.47 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.1 m -95.43 -160.47 0.79 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 117.039 0.419 . . . . 0.0 110.453 179.258 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 47' ' ' SER . 3.9 p -168.74 141.08 2.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.054 0.454 . . . . 0.0 111.367 179.488 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.887 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -100.87 170.58 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.317 179.444 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.494 ' HA ' ' HG3' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -132.87 110.33 10.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.931 0.396 . . . . 0.0 111.153 179.65 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.931 ' CE1' HD22 ' A' ' 20' ' ' LEU . 10.6 m-85 -86.03 156.91 20.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.779 -178.886 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 19' ' ' GLN . 66.5 m -156.02 150.94 26.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.94 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 14.3 m -76.42 171.08 15.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.974 179.88 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 17' ' ' ASN . 1.4 t-20 -65.35 -76.95 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.061 -179.656 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.93 136.28 5.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.942 -179.704 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 60.39 23.48 60.27 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.063 -179.428 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.504 ' CE1' ' HB3' ' A' ' 68' ' ' SER . 2.4 m-85 -111.35 -176.62 2.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.802 0.334 . . . . 0.0 110.72 -179.539 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.889 ' CD2' HD11 ' A' ' 42' ' ' ILE . 2.6 p-80 -142.44 113.24 7.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.544 178.45 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.908 HD21 ' O ' ' A' ' 44' ' ' GLU . 7.0 tt -79.21 120.7 24.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.68 -179.293 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.889 HD11 ' CD2' ' A' ' 40' ' ' HIS . 3.0 mm -98.22 162.17 2.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.216 -179.093 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.4 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 72.76 -140.28 28.77 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.339 -179.762 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.908 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -72.26 -173.53 1.11 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.837 0.351 . . . . 0.0 110.473 179.015 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.1 t -169.66 29.61 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.457 178.909 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.494 ' HG3' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -163.13 117.26 1.65 Allowed 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.066 -177.801 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.466 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 0.6 OUTLIER -84.58 133.53 34.43 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.293 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.53 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.9 m-85 -110.45 117.71 34.32 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 119.547 -0.861 . . . . 0.0 111.455 179.527 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 33.0 t -72.6 102.36 3.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.753 -179.984 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.54 -174.3 2.88 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.145 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.734 HD23 ' O ' ' A' ' 56' ' ' SER . 5.1 mt -80.39 140.49 36.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.296 -179.449 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.01 -102.89 0.5 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.867 -0.683 . . . . 0.0 112.434 179.604 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.605 ' C ' HG23 ' A' ' 54' ' ' THR . 1.8 t -89.1 50.23 1.91 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.694 0.283 . . . . 0.0 110.827 179.672 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.617 ' O ' HD22 ' A' ' 51' ' ' LEU . 1.3 p 79.5 -50.83 0.41 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.332 -179.568 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.92 32.49 5.62 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.587 -0.815 . . . . 0.0 112.715 -179.633 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.734 ' O ' HD23 ' A' ' 51' ' ' LEU . 5.0 t -135.68 -173.22 3.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.876 0.369 . . . . 0.0 110.98 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.717 ' O ' HG13 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -119.36 158.17 26.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.554 -179.751 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.717 HG13 ' O ' ' A' ' 57' ' ' MET . 2.4 m -165.87 173.6 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.705 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.53 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 75.8 m95 -128.88 122.48 30.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.695 -179.267 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.53 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.5 OUTLIER -70.66 167.8 24.78 Favored Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.98 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.476 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 71.6 Cg_exo -17.0 95.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 125.113 3.875 . . . . 0.0 114.387 -179.189 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.422 ' CB ' ' OH ' ' A' ' 33' ' ' TYR . 0.2 OUTLIER -96.84 -79.02 0.46 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.179 -177.14 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.482 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . . . -87.94 107.32 15.31 Favored Pre-proline 0 C--N 1.332 -0.189 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -176.506 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.87 ' HG2' HD11 ' A' ' 41' ' ' LEU . 1.8 Cg_endo -86.15 -155.88 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.27 2.646 . . . . 0.0 111.444 178.509 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.489 HG22 ' H ' ' A' ' 66' ' ' CYS . 5.2 mm -89.75 165.57 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.894 0.378 . . . . 0.0 110.711 178.502 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.489 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.1 m -163.05 128.7 3.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.826 179.855 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.478 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -152.81 178.43 9.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.083 -179.652 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.504 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 89.8 p -89.57 117.66 28.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.88 179.591 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.439 ' CG2' ' HB3' ' A' ' 40' ' ' HIS . 2.6 p -44.52 101.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.22 179.754 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.418 ' HD2' ' HB3' ' A' ' 88' ' ' PHE . 38.9 mmtt -81.76 125.52 30.74 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.518 -0.764 . . . . 0.0 112.257 -177.623 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -106.86 120.62 42.53 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.733 176.656 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.89 -159.25 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.36 -179.845 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.479 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 2.0 t -54.08 137.81 56.78 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.81 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.805 ' CG ' HG21 ' A' ' 95' ' ' VAL . 52.1 Cg_exo -56.17 162.54 7.37 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.675 2.25 . . . . 0.0 112.211 -179.579 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -43.79 157.05 0.15 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.59 2.193 . . . . 0.0 112.528 -179.454 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.1 t -103.32 90.11 3.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.617 179.585 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.672 HG23 ' HE1' ' A' ' 97' ' ' TYR . 24.5 pt -69.42 168.49 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.188 -179.253 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.96 132.86 39.34 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.882 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.496 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 0.3 OUTLIER 71.18 27.3 3.27 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.76 179.988 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -168.36 -168.27 30.21 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.219 179.443 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.84 -175.24 3.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.859 0.361 . . . . 0.0 110.739 -179.231 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.479 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 3.0 p-80 -115.53 166.12 12.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.031 -179.569 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -105.3 -71.42 0.74 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.789 0.328 . . . . 0.0 110.22 179.47 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.756 ' N ' HG13 ' A' ' 95' ' ' VAL . . . 70.93 160.82 3.77 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.167 177.718 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -111.63 -39.39 4.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.095 0.474 . . . . 0.0 110.721 179.369 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -106.45 -174.65 2.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.239 -179.462 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.02 -37.46 14.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.696 177.152 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.436 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 6.2 m-85 -119.54 177.48 4.92 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.643 179.07 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.436 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 43.8 m-85 -146.85 162.47 38.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.204 -178.69 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.3 p -137.08 -177.86 4.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.476 -179.149 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 0.4 OUTLIER -59.43 92.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.252 0.549 . . . . 0.0 111.121 -179.625 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.56 26.8 1.55 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.367 -0.833 . . . . 0.0 113.086 178.571 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.426 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -105.83 154.21 20.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.89 0.345 . . . . 0.0 110.634 179.106 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 17.4 m -139.49 138.07 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.261 0.553 . . . . 0.0 111.472 -179.694 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.805 HG21 ' CG ' ' A' ' 74' ' ' PRO . 21.5 t -137.94 142.22 36.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.812 179.007 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.77 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -93.2 141.67 28.17 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.553 -178.033 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.82 ' CE2' HG21 ' A' ' 111' ' ' VAL . 4.7 m-85 -96.57 161.5 13.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.592 179.234 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.1 m -160.27 139.08 10.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.247 -179.752 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.459 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 59.6 m -69.58 164.87 22.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.037 -179.914 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.404 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 0.3 OUTLIER -97.27 -85.66 0.35 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.12 -179.921 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 41.9 t -47.34 -26.4 1.26 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.351 -179.399 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.27 54.25 0.23 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.088 -179.482 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.496 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 15.0 m-85 -93.1 -173.26 3.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.806 0.336 . . . . 0.0 111.286 -178.696 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -109.58 103.63 12.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.113 179.637 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.456 HD21 ' HA ' ' A' ' 109' ' ' SER . 0.2 OUTLIER -49.99 129.18 20.18 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.515 0.674 . . . . 0.0 111.556 -178.056 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.678 HD11 ' HG3' ' A' ' 125' ' ' GLN . 36.9 mm -95.2 157.68 3.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.294 179.431 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.473 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 60.87 -128.91 45.84 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.319 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -120.04 132.47 55.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.791 0.329 . . . . 0.0 111.086 179.954 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.77 ' OG ' HG22 ' A' ' 96' ' ' THR . 3.8 p -68.05 -33.09 73.91 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.904 179.597 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -78.3 119.88 5.27 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.784 -179.721 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.82 HG21 ' CE2' ' A' ' 97' ' ' TYR . 2.7 t -108.3 141.97 22.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.145 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.35 128.14 46.49 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.939 0.4 . . . . 0.0 111.302 -179.18 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.492 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 20.4 t -90.34 106.04 18.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.392 176.717 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 9.0 p -143.1 146.28 33.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.41 -178.379 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.402 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 54.05 34.86 53.06 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.746 179.532 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.436 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 67.75 12.44 62.0 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.848 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -138.58 170.17 16.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.918 0.39 . . . . 0.0 110.778 179.659 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.792 ' CH2' HG22 ' A' ' 95' ' ' VAL . 95.7 m95 -107.98 151.86 25.25 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.406 -178.802 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.94 148.92 44.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.158 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.471 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.7 OUTLIER 70.94 47.25 0.26 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.994 178.851 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 96.1 Cg_endo -78.83 136.57 13.47 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.433 2.089 . . . . 0.0 111.647 178.403 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.454 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 73.6 Cg_endo -87.16 -174.3 1.29 Allowed 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.533 2.155 . . . . 0.0 113.589 -178.243 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.481 HG22 ' H ' ' A' ' 124' ' ' CYS . 0.6 OUTLIER -134.02 176.79 8.27 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.272 177.305 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 124' ' ' CYS . . . . . 0.481 ' H ' HG22 ' A' ' 123' ' ' THR . 10.9 m -137.67 107.04 6.1 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.511 0.672 . . . . 0.0 111.848 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.678 ' HG3' HD11 ' A' ' 106' ' ' ILE . 2.9 pt20 -148.31 -179.0 6.62 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.117 -179.105 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 22.5 mm . . . . . 0 C--N 1.315 -0.905 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.334 -178.014 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.3 mtt-85 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.683 0.278 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.457 ' HD2' HG23 ' A' ' 25' ' ' VAL . 0.2 OUTLIER 48.41 -179.16 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.196 0.522 . . . . 0.0 111.745 178.298 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 1.226 ' SG ' ' SG ' ' A' ' 49' ' ' CYS . 0.0 OUTLIER -98.57 163.1 19.68 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.684 179.406 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.47 ' HD3' ' CB ' ' A' ' 57' ' ' MET . 37.7 Cg_endo -67.02 170.49 12.92 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.065 1.843 . . . . 0.0 111.851 179.759 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.4 t -51.26 104.56 0.44 Allowed Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.895 -179.332 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.742 ' HB3' HD11 ' A' ' 31' ' ' ILE . 12.1 Cg_endo -56.75 147.29 72.8 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.058 1.839 . . . . 0.0 111.76 179.823 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -55.92 174.01 0.13 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.37 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.745 ' HA ' HD11 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -132.57 -171.2 2.6 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.989 0.423 . . . . 0.0 111.305 -179.61 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.432 HG23 ' C ' ' A' ' 18' ' ' GLY . 5.2 tt -144.1 145.16 22.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.61 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -80.75 -58.68 2.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.256 -178.988 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -94.0 38.29 1.08 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.852 -179.538 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.432 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -158.37 -177.84 31.84 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.965 -179.804 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.41 ' N ' ' O ' ' A' ' 34' ' ' SER . 0.7 OUTLIER -137.71 140.79 40.93 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 179.59 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.745 HD11 ' HA ' ' A' ' 14' ' ' ASP . 10.2 mt -86.67 154.75 20.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.081 0.467 . . . . 0.0 111.759 -178.862 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.461 ' HB3' ' CB ' ' A' ' 32' ' ' THR . 15.6 t0 -124.39 71.22 1.13 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.631 177.457 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.86 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.9 OUTLIER -76.58 104.59 4.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.774 -177.836 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -110.6 -15.71 10.89 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.077 178.436 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.416 ' O ' ' CB ' ' A' ' 29' ' ' SER . . . -157.69 110.44 0.44 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.118 179.562 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.555 HG13 ' CG2' ' A' ' 22' ' ' ILE . 27.3 m -112.12 51.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.534 0.207 . . . . 0.0 111.534 -179.322 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 25.8 t0 -111.18 163.8 13.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.932 0.396 . . . . 0.0 110.84 178.063 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.456 ' CZ ' ' HB3' ' A' ' 51' ' ' LEU . 1.4 t80 -53.14 95.39 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.904 -179.18 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.17 31.37 5.05 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.148 -179.658 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 24' ' ' GLY . 14.8 m -99.67 -158.42 0.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.285 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 47' ' ' SER . 7.7 p -165.17 139.95 5.08 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 120.273 -0.571 . . . . 0.0 112.288 179.708 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.86 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.8 OUTLIER -105.2 170.68 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.267 178.568 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.463 ' HA ' ' HG3' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -128.48 111.75 13.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.005 0.431 . . . . 0.0 111.11 178.591 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.531 ' CE2' ' CD2' ' A' ' 20' ' ' LEU . 13.6 m-85 -85.13 149.28 25.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.255 -179.604 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.411 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 9.6 p -152.79 165.72 34.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.713 179.475 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.415 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 9.8 m -85.2 168.43 14.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.768 0.318 . . . . 0.0 110.92 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -66.02 -83.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.995 -179.437 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.86 136.23 13.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.476 179.703 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.464 ' HA3' ' CB ' ' A' ' 91' ' ' ASP . . . 59.97 28.84 66.77 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.387 -0.911 . . . . 0.0 111.671 -178.688 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.526 ' CE1' ' CB ' ' A' ' 68' ' ' SER . 2.7 m-85 -120.15 173.07 7.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.816 0.341 . . . . 0.0 110.939 -179.12 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.553 ' NE2' HG22 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -129.85 133.45 46.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.106 175.271 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.933 HD21 ' O ' ' A' ' 44' ' ' GLU . 6.7 tt -97.33 120.95 38.63 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.641 -179.333 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.591 ' N ' HD13 ' A' ' 42' ' ' ILE . 1.2 mm -99.13 149.68 5.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.088 -179.302 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.06 -136.01 13.64 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.275 -179.62 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.933 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -84.55 -173.87 4.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.894 0.378 . . . . 0.0 110.653 179.612 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.9 p -159.51 22.15 0.18 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.462 -178.899 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.463 ' HG3' ' HA ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -154.44 125.89 7.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.945 0.402 . . . . 0.0 112.062 -177.796 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' A' ' 30' ' ' SER . 0.7 OUTLIER -92.4 141.68 28.27 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.673 177.201 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.441 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.4 m-85 -122.69 113.41 19.18 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 119.611 -0.836 . . . . 0.0 111.407 179.129 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 1.226 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 1.6 p -79.89 118.54 21.75 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 119.152 -1.019 . . . . 0.0 111.397 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.97 -170.72 2.57 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.842 -179.837 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.511 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -85.95 126.21 33.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.04 -179.476 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.422 ' N ' HG22 ' A' ' 58' ' ' VAL . . . -93.54 -58.87 1.24 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.659 -179.686 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.4 48.01 1.55 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.846 0.355 . . . . 0.0 111.063 -179.683 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.511 ' HA ' HD22 ' A' ' 51' ' ' LEU . 3.9 p 58.31 28.14 16.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.791 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 163.12 -28.73 0.24 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.228 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.41 -163.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.738 0.304 . . . . 0.0 110.664 179.514 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.47 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -120.61 144.08 48.32 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.15 0.5 . . . . 0.0 110.734 179.736 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 49' ' ' CYS . 1.7 m -157.21 171.31 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.688 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.555 ' CD2' ' HB3' ' A' ' 49' ' ' CYS . 70.7 m95 -131.15 121.01 24.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.042 0.448 . . . . 0.0 111.6 -179.491 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.495 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 6.3 m-20 -69.68 168.03 19.77 Favored Pre-proline 0 C--O 1.223 -0.298 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.148 178.788 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.495 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 76.3 Cg_exo -20.16 96.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 125.081 3.854 . . . . 0.0 114.412 -178.37 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.465 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -96.01 -78.09 0.47 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.817 -178.421 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.506 ' HB2' ' O ' ' A' ' 14' ' ' ASP . . . -82.13 108.07 10.48 Favored Pre-proline 0 C--N 1.331 -0.2 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -176.565 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.88 ' HG2' HD11 ' A' ' 41' ' ' LEU . 1.0 OUTLIER -85.17 -155.1 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.113 2.542 . . . . 0.0 110.754 176.99 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.461 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 1.5 mm -95.85 159.18 2.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.969 0.414 . . . . 0.0 110.402 177.782 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.2 m -157.92 138.27 12.69 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.775 179.834 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.47 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -150.01 177.03 10.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.55 179.991 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.526 ' CB ' ' CE1' ' A' ' 39' ' ' TYR . 1.2 p -104.49 141.32 36.58 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.575 179.088 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.553 HG22 ' NE2' ' A' ' 40' ' ' HIS . 2.3 p -67.6 66.84 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.287 0.565 . . . . 0.0 110.384 179.154 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.559 ' HE2' HG23 ' A' ' 90' ' ' THR . 1.5 mmpt? -47.75 112.71 0.59 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.159 -178.184 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -97.28 125.79 42.07 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.268 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.04 -166.14 0.97 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.96 -179.342 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 1.5 t -42.24 134.21 2.54 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.329 -179.129 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.495 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 37.4 Cg_exo -58.54 161.52 14.42 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.331 2.021 . . . . 0.0 112.158 -179.245 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.462 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 88.2 Cg_exo -40.56 154.61 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.779 2.319 . . . . 0.0 112.867 -179.477 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.0 p -106.38 91.02 3.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.997 -179.641 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.549 HG21 ' O ' ' A' ' 122' ' ' PRO . 19.9 pt -69.65 175.9 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.066 179.917 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.5 t -93.54 149.07 21.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.635 178.869 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.47 ' HB3' ' CE1' ' A' ' 103' ' ' TYR . 1.6 m120 50.12 28.45 3.04 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.127 177.927 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.47 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -158.34 -163.61 13.07 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.899 179.872 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 98' ' ' SER . 13.2 ptt180 -170.12 -175.65 2.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.095 0.474 . . . . 0.0 110.931 -179.214 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 4.9 p80 -123.04 166.52 14.98 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.801 179.756 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.434 ' OD1' HG13 ' A' ' 95' ' ' VAL . 46.2 p30 -116.96 -158.21 0.69 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.422 178.962 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 138.05 168.2 11.24 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.551 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -113.69 -30.57 6.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.921 0.391 . . . . 0.0 111.122 -179.712 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.54 -173.81 2.56 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.169 -179.541 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.56 -26.64 12.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.667 179.247 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.425 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 13.9 m-85 -125.62 -179.28 4.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.542 179.315 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.425 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 65.9 m-85 -152.71 167.84 27.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.713 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.559 HG23 ' HE2' ' A' ' 70' ' ' LYS . 24.9 p -141.05 -175.85 4.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.937 0.398 . . . . 0.0 111.361 -179.339 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.464 ' CB ' ' HA3' ' A' ' 38' ' ' GLY . 1.0 OUTLIER -61.55 96.6 0.06 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.295 0.569 . . . . 0.0 110.967 179.879 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 125.34 19.4 2.36 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.16 -0.927 . . . . 0.0 113.222 178.483 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.441 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.7 OUTLIER -100.64 154.16 18.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 117.049 0.424 . . . . 0.0 110.565 178.989 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.18 148.99 31.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.04 0.448 . . . . 0.0 110.918 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.473 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 17.9 t -145.52 147.45 18.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.651 179.852 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.794 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -107.13 126.58 52.55 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.962 -179.624 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.977 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.6 m-85 -85.51 156.5 20.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.932 -179.742 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.432 ' HA ' HD13 ' A' ' 105' ' ' LEU . 72.5 m -149.92 145.55 26.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.17 -179.503 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.457 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 66.7 m -75.16 156.04 36.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.028 179.887 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.47 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 78.9 m-20 -85.06 -78.13 0.26 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.592 -179.03 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.5 m -59.89 -23.49 63.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.378 -178.806 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 123.97 33.73 0.78 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.541 -179.811 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.503 ' CE2' HG12 ' A' ' 126' ' ' ILE . 40.4 m-85 -69.7 -175.52 0.89 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.967 0.413 . . . . 0.0 110.757 179.697 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.1 m -107.84 101.61 10.88 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.387 179.012 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.512 HD21 ' HA ' ' A' ' 109' ' ' SER . 0.3 OUTLIER -47.29 127.05 10.31 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 121.367 0.603 . . . . 0.0 111.514 -178.991 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.438 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 40.7 mm -95.76 154.64 3.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.427 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 66.49 -125.42 26.23 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.93 -178.891 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -127.28 134.24 50.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.878 0.37 . . . . 0.0 110.943 179.167 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.794 ' HB2' HG22 ' A' ' 96' ' ' THR . 0.4 OUTLIER -67.65 -30.39 69.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.804 179.621 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -70.11 132.8 23.88 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.554 179.388 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.977 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.4 t -127.41 121.64 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.675 0.274 . . . . 0.0 110.453 179.329 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.29 117.31 22.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.005 0.431 . . . . 0.0 111.802 -178.463 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.534 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 17.9 t -82.59 104.33 12.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.438 176.559 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 2.2 p -146.42 163.08 36.77 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.364 -178.17 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.33 30.0 4.03 Favored Glycine 0 N--CA 1.453 -0.219 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.767 179.898 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.3 16.14 70.9 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.52 -179.464 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -141.45 -177.4 5.13 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.887 0.375 . . . . 0.0 110.599 179.515 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.534 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 93.7 m95 -117.74 144.99 44.78 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.103 -179.391 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.91 147.02 51.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.298 -179.285 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.489 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER 73.38 46.13 0.21 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.163 178.676 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 73.3 Cg_endo -75.84 136.02 18.25 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.361 2.041 . . . . 0.0 111.331 177.951 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.549 ' O ' HG21 ' A' ' 77' ' ' ILE . 64.8 Cg_endo -91.12 -173.68 0.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.505 2.137 . . . . 0.0 113.496 -178.135 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.436 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -129.37 -162.7 1.22 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.746 177.833 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 4.9 m -156.43 90.82 1.2 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.069 0.462 . . . . 0.0 110.856 179.378 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -118.12 160.7 21.09 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.932 -179.626 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.563 ' O ' HG22 ' A' ' 126' ' ' ILE . 15.9 mm . . . . . 0 C--N 1.323 -0.546 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.997 179.912 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.898 0.38 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.844 ' HD2' HG23 ' A' ' 25' ' ' VAL . 32.9 mtm-85 -86.26 -169.01 2.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.957 179.814 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.432 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 8.5 m -91.08 163.0 31.06 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.625 179.55 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -73.62 167.88 26.15 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.281 1.988 . . . . 0.0 111.719 179.87 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.2 p -52.37 108.97 1.21 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.927 -179.275 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.592 ' HG2' HD13 ' A' ' 22' ' ' ILE . 49.2 Cg_exo -49.34 158.05 1.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.314 2.009 . . . . 0.0 112.335 179.906 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.876 ' O ' HD11 ' A' ' 20' ' ' LEU . 4.3 mtt180 -54.11 177.25 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.735 177.354 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.427 ' O ' ' CB ' ' A' ' 63' ' ' ALA . 0.1 OUTLIER -124.9 -177.01 3.7 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.182 0.515 . . . . 0.0 111.678 -178.676 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.501 HG22 ' CD2' ' A' ' 20' ' ' LEU . 5.2 tt -139.47 151.69 22.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.837 -179.397 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -90.34 -64.48 1.13 Allowed 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -177.46 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -92.52 26.92 2.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.775 0.321 . . . . 0.0 111.09 -178.894 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -144.15 -160.4 8.45 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.851 179.708 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.85 133.52 10.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.753 0.311 . . . . 0.0 110.489 179.434 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.876 HD11 ' O ' ' A' ' 13' ' ' ARG . 18.7 mt -72.27 150.72 43.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.178 0.513 . . . . 0.0 111.899 -178.37 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.412 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 5.5 t0 -123.36 69.62 1.02 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.266 177.419 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.894 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.9 OUTLIER -79.4 100.75 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.069 -176.492 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.36 19.26 54.58 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.575 176.696 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 163.32 141.07 3.02 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 121.192 -0.528 . . . . 0.0 111.87 -179.376 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.844 HG23 ' HD2' ' A' ' 8' ' ' ARG . 6.2 m -127.01 -3.77 4.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.898 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.421 ' HA ' ' CB ' ' A' ' 8' ' ' ARG . 1.3 p-10 -69.57 156.58 38.69 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.792 0.33 . . . . 0.0 110.669 179.868 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.451 ' CZ ' ' HG ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -49.26 116.72 1.82 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.021 0.439 . . . . 0.0 111.02 -179.25 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.07 -6.64 47.34 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.585 -178.77 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 m -66.98 -174.29 0.32 Allowed 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.884 0.342 . . . . 0.0 110.762 179.711 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 47' ' ' SER . 0.3 OUTLIER -159.74 139.16 11.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.964 -179.978 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.894 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -108.2 167.63 3.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.921 0.391 . . . . 0.0 110.854 179.681 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.423 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -132.92 110.6 10.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.695 178.554 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.713 ' CE2' HD21 ' A' ' 20' ' ' LEU . 23.8 m-85 -82.76 132.19 35.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.162 -179.272 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.22 159.98 40.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.446 -179.898 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.449 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 56.4 m -84.69 176.13 8.76 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.625 -179.996 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -84.98 -83.22 0.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.911 0.386 . . . . 0.0 110.769 -179.346 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.23 129.4 9.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.344 179.267 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.905 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 74.67 28.77 62.52 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.434 -0.888 . . . . 0.0 111.596 -177.842 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.508 ' CE2' ' HB3' ' A' ' 68' ' ' SER . 29.7 m-85 -134.08 157.77 45.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.003 0.43 . . . . 0.0 111.173 -179.734 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.843 ' CE1' HG22 ' A' ' 69' ' ' VAL . 6.3 m-70 -115.13 134.03 55.51 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 173.63 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.848 HD21 ' O ' ' A' ' 44' ' ' GLU . 6.3 tt -81.65 107.67 14.58 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.023 -179.613 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.431 HG12 ' HA ' ' A' ' 66' ' ' CYS . 1.3 mm -92.72 146.1 6.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.97 -178.229 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.76 -151.97 32.86 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.011 -178.441 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.848 ' O ' HD21 ' A' ' 41' ' ' LEU . 1.3 pm0 -53.22 173.21 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.72 0.26 . . . . 0.0 110.406 179.232 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.519 ' HB3' HD22 ' A' ' 41' ' ' LEU . 8.3 p -153.61 24.07 0.52 Allowed 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.869 0.366 . . . . 0.0 111.522 -178.542 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.423 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 0.8 OUTLIER -157.53 -170.91 3.37 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.947 -178.357 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.447 ' O ' HG13 ' A' ' 31' ' ' ILE . 1.8 m -164.67 98.87 0.79 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.632 179.182 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.487 ' CD2' ' N ' ' A' ' 48' ' ' TYR . 1.2 m-30 -84.95 118.86 24.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.038 0.447 . . . . 0.0 111.21 -179.303 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 16.2 t -70.2 115.62 9.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.298 179.043 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.503 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 2.8 tt0 -144.56 172.35 13.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.449 0.643 . . . . 0.0 111.214 -178.715 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.697 HD23 ' O ' ' A' ' 56' ' ' SER . 1.0 OUTLIER -58.76 153.38 16.94 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.303 -179.683 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -94.63 -104.81 1.9 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.503 -179.711 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.3 t -126.43 -61.81 1.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.847 0.356 . . . . 0.0 110.931 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.1 p -89.94 52.6 2.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.922 179.844 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 60.18 39.54 96.04 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.51 -179.994 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.697 ' O ' HD23 ' A' ' 51' ' ' LEU . 10.0 t -108.76 -170.36 1.65 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.78 0.324 . . . . 0.0 110.983 -179.906 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.421 ' SD ' ' CE1' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -116.49 136.2 53.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.576 179.798 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.3 m -146.77 -175.65 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.811 -179.891 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.542 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 88.1 m95 -128.51 137.14 51.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.008 -179.454 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -151.86 122.51 3.64 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.016 -179.697 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.4 ' HG2' ' O ' ' A' ' 46' ' ' LYS . 58.2 Cg_endo -72.65 -167.2 4.8 Favored 'Cis proline' 0 C--N 1.352 0.746 0 C-N-CA 123.744 -1.357 . . . . 0.0 112.259 -0.313 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -110.64 -155.88 0.57 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 -179.306 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.493 ' CB ' ' CE2' ' A' ' 33' ' ' TYR . . . -76.01 112.82 22.46 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.653 179.226 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.474 ' HD2' ' CG ' ' A' ' 33' ' ' TYR . 18.3 Cg_exo -68.26 -150.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.511 2.141 . . . . 0.0 112.192 -179.1 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.5 pt -136.21 -177.95 2.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.841 -179.814 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.431 ' HA ' HG12 ' A' ' 42' ' ' ILE . 78.7 m -149.99 157.32 43.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.353 0.597 . . . . 0.0 111.781 179.452 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -129.63 109.18 10.79 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.41 177.659 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.508 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 11.2 p -49.81 131.78 22.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.232 -178.668 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.905 HG12 ' O ' ' A' ' 38' ' ' GLY . 4.3 p -53.68 104.83 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.26 -178.479 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.467 ' CE ' HG23 ' A' ' 90' ' ' THR . 2.4 mmtp -89.45 114.21 25.66 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.582 177.867 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.11 125.39 38.72 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.103 0.478 . . . . 0.0 110.266 179.125 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.57 -155.64 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.924 178.777 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.408 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 1.1 t -53.15 143.77 31.86 Favored Pre-proline 0 N--CA 1.447 -0.584 0 CA-C-O 120.561 0.22 . . . . 0.0 110.536 179.483 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.488 ' HD2' ' CD2' ' A' ' 82' ' ' HIS . 32.4 Cg_exo -60.14 166.28 9.26 Favored 'Trans proline' 0 CA--C 1.53 0.311 0 C-N-CA 122.633 2.222 . . . . 0.0 112.277 -179.263 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.526 ' HD3' ' CG ' ' A' ' 118' ' ' TRP . 97.7 Cg_exo -40.97 165.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.795 2.33 . . . . 0.0 112.927 -179.517 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 73.1 m -115.32 87.34 2.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.704 179.551 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.632 HG23 ' HE2' ' A' ' 97' ' ' TYR . 7.3 pt -69.48 -173.59 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.071 -179.547 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 t -100.8 148.88 24.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.955 179.679 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.497 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 1.5 m120 47.22 29.4 1.19 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.112 177.937 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.494 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -161.51 -171.62 27.79 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.056 179.778 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -170.36 -174.87 1.78 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.992 0.425 . . . . 0.0 111.028 -178.723 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.488 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 2.1 p-80 -117.59 171.95 7.67 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.621 -179.962 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -109.95 -75.88 0.62 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.119 179.625 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.406 ' HA3' ' OH ' ' A' ' 89' ' ' TYR . . . 69.72 154.78 1.05 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.664 179.773 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.461 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -110.24 -35.81 5.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.14 0.495 . . . . 0.0 110.63 179.61 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.3 -172.71 2.4 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.948 -179.79 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.7 -24.35 14.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.891 179.338 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.439 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 7.3 m-85 -130.27 178.13 6.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.897 179.856 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.439 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 49.8 m-85 -152.23 164.32 37.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.0 -179.381 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.467 HG23 ' CE ' ' A' ' 70' ' ' LYS . 16.5 p -148.9 -174.93 4.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.004 0.431 . . . . 0.0 111.427 -179.605 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 7.3 p-10 -52.92 93.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.238 0.542 . . . . 0.0 111.566 -179.155 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.09 26.88 1.61 Allowed Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.474 -0.785 . . . . 0.0 113.628 177.549 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.34 152.5 26.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.191 0.495 . . . . 0.0 110.848 178.994 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.41 HG22 ' N ' ' A' ' 95' ' ' VAL . 34.3 m -134.85 153.62 35.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.156 0.503 . . . . 0.0 111.24 -179.703 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.517 HG23 ' CH2' ' A' ' 118' ' ' TRP . 25.1 t -147.59 148.14 16.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.636 179.263 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.488 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -105.14 134.09 48.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.698 179.876 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.953 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.5 m-85 -92.4 152.17 19.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.037 -179.754 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 59.0 m -146.52 140.29 26.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.754 179.749 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.494 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 82.0 m -69.75 159.03 34.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.033 -179.666 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -93.03 -87.36 0.23 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.222 -179.821 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.7 t -44.52 -33.2 1.65 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.637 -179.071 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 133.22 40.45 0.19 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.563 179.867 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.498 ' CE2' HG12 ' A' ' 126' ' ' ILE . 37.6 m-85 -82.2 -173.07 4.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.845 0.355 . . . . 0.0 110.781 179.794 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.0 m -112.2 109.98 19.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.016 -179.821 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.51 HD23 ' HB2' ' A' ' 122' ' ' PRO . 2.5 tp -45.43 113.5 0.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.903 179.05 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.432 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 35.2 mm -92.07 154.64 3.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.143 179.83 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 65.69 -125.27 28.11 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.362 -0.923 . . . . 0.0 111.811 -178.299 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -123.3 132.84 54.14 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.795 0.331 . . . . 0.0 110.651 179.052 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.488 ' OG ' HG22 ' A' ' 96' ' ' THR . 2.6 t -69.36 -29.94 67.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.49 179.438 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -70.98 135.52 24.48 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.794 179.771 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.953 HG21 ' CE1' ' A' ' 97' ' ' TYR . 3.1 t -129.44 120.78 51.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.596 0.236 . . . . 0.0 110.717 179.266 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.859 HD22 ' N ' ' A' ' 113' ' ' CYS . 1.0 OUTLIER -80.33 130.49 35.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.903 0.382 . . . . 0.0 111.434 -179.232 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.859 ' N ' HD22 ' A' ' 112' ' ' LEU . 37.4 t -102.68 104.18 14.5 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.075 177.461 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.727 ' HB3' HD11 ' A' ' 112' ' ' LEU . 5.3 p -152.93 123.01 7.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.898 0.38 . . . . 0.0 111.714 -179.352 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.42 ' CA ' HG11 ' A' ' 69' ' ' VAL . . . 93.17 19.79 34.95 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.696 179.148 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.449 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 82.14 -1.27 87.41 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.622 -179.173 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -131.51 -177.42 4.4 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.859 0.361 . . . . 0.0 110.432 179.373 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.526 ' CG ' ' HD3' ' A' ' 75' ' ' PRO . 86.5 m95 -120.08 157.43 28.96 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.035 -178.998 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.72 152.34 47.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.054 0.454 . . . . 0.0 111.298 -179.844 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.498 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.7 OUTLIER 69.52 45.57 0.28 Allowed Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.119 179.241 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.498 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 76.9 Cg_endo -77.45 138.32 17.4 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.384 2.056 . . . . 0.0 111.755 178.564 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.51 ' HB2' HD23 ' A' ' 105' ' ' LEU . 74.3 Cg_endo -91.25 -171.64 0.42 Allowed 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.786 2.324 . . . . 0.0 113.482 -178.542 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.88 -167.16 1.83 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.819 177.947 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 7.4 m -148.67 92.82 2.04 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.051 0.453 . . . . 0.0 110.801 179.328 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -118.02 163.93 15.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.551 -179.853 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.551 ' O ' HG22 ' A' ' 126' ' ' ILE . 15.4 mm . . . . . 0 C--N 1.322 -0.594 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.956 -179.789 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.716 0.293 . . . . 0.0 110.773 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.499 ' CD ' HG22 ' A' ' 25' ' ' VAL . 3.4 ptp180 -86.55 -158.36 0.41 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.979 -179.78 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.45 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 20.5 m -116.38 161.58 30.84 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.845 0.355 . . . . 0.0 111.575 -178.454 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 57.4 Cg_endo -71.12 174.62 10.39 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.485 2.123 . . . . 0.0 112.02 179.689 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.0 t -54.55 108.25 1.09 Allowed Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.925 -179.683 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.519 ' HG3' ' CZ2' ' A' ' 59' ' ' TRP . 53.3 Cg_exo -46.4 164.56 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.351 2.034 . . . . 0.0 112.123 179.867 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.849 ' O ' HD11 ' A' ' 20' ' ' LEU . 14.7 ttt180 -74.07 158.56 34.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.707 178.103 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.9 -175.42 2.76 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.202 0.525 . . . . 0.0 111.516 -178.301 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.452 HG22 ' CD2' ' A' ' 20' ' ' LEU . 19.7 tt -151.05 146.02 16.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.203 -179.492 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -85.03 158.97 20.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.34 -0.391 . . . . 0.0 109.999 177.844 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.483 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 0.4 OUTLIER 46.66 30.77 1.21 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.887 179.974 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -157.93 175.88 35.09 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.705 -179.413 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -141.84 137.82 31.73 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.658 0.266 . . . . 0.0 110.515 -179.869 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.849 HD11 ' O ' ' A' ' 13' ' ' ARG . 25.9 mt -83.71 157.88 22.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.11 0.481 . . . . 0.0 111.604 -179.558 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -125.45 75.49 1.48 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.625 177.709 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.918 ' HA ' HG23 ' A' ' 31' ' ' ILE . 1.1 mt -71.4 104.01 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.105 -177.156 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.39 15.36 56.21 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.789 176.855 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 156.08 130.99 1.34 Allowed Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.077 -179.591 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.781 HG12 ' HZ2' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -113.24 5.7 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-O 120.768 0.318 . . . . 0.0 110.438 -178.763 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 0.5 OUTLIER -69.37 155.66 40.07 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.907 0.384 . . . . 0.0 111.663 -178.851 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.599 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 5.8 t80 -53.56 90.09 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.711 179.29 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 127.39 -6.92 7.11 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.767 -179.478 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.8 p -72.99 170.89 13.89 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.958 0.379 . . . . 0.0 110.653 179.798 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.2 p -137.13 152.03 49.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.937 179.79 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.918 HG23 ' HA ' ' A' ' 22' ' ' ILE . 1.1 mt -114.87 170.35 5.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.665 -179.306 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.448 ' H ' HG22 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -133.55 115.29 14.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.876 0.369 . . . . 0.0 110.654 179.357 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.578 ' CE2' HD21 ' A' ' 20' ' ' LEU . 14.3 m-85 -89.71 154.0 20.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.629 -178.67 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.29 155.98 34.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.536 179.426 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.437 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 4.0 m -82.11 167.67 18.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.819 0.343 . . . . 0.0 110.958 -179.933 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -68.43 -85.4 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.204 -179.247 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.5 m -153.17 132.61 12.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.832 0.348 . . . . 0.0 111.008 -179.784 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.622 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 68.05 21.84 73.83 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.124 -179.198 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.5 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.6 m-85 -115.16 174.33 6.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.82 0.343 . . . . 0.0 110.86 -179.672 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.741 ' CD2' HD11 ' A' ' 42' ' ' ILE . 3.3 p-80 -137.82 114.85 10.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.496 177.976 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.927 HD21 ' O ' ' A' ' 44' ' ' GLU . 6.5 tt -78.19 125.36 29.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.502 -179.698 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.741 HD11 ' CD2' ' A' ' 40' ' ' HIS . 2.2 mm -102.17 160.82 4.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.053 0.454 . . . . 0.0 111.113 -179.398 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.81 -135.24 22.95 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.485 -179.639 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.927 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -79.96 -173.58 3.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.966 0.413 . . . . 0.0 111.064 -179.952 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -167.31 29.18 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.384 179.389 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.425 ' HG3' ' HA ' ' A' ' 32' ' ' THR . 15.8 mtpt -155.08 127.52 7.87 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.962 0.411 . . . . 0.0 111.641 -178.666 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.454 ' OG ' ' CB ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -94.05 148.05 22.54 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.024 178.403 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.501 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.6 m-85 -124.45 114.95 20.14 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.603 177.922 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 52.8 t -65.67 98.22 0.37 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.468 179.677 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.503 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 0.6 OUTLIER -122.09 175.01 6.58 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.711 -178.501 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.599 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -83.19 147.65 27.9 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.171 -179.292 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.446 ' N ' HG22 ' A' ' 58' ' ' VAL . . . -75.59 -130.63 0.3 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.661 -179.849 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.9 t -109.35 -30.93 7.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.782 0.325 . . . . 0.0 111.014 -179.785 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 68.1 p -102.63 36.67 2.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.972 -179.884 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.83 20.85 72.78 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.452 -179.942 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.04 -162.44 0.86 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.856 0.36 . . . . 0.0 110.913 -179.976 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.0 138.52 52.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.359 179.656 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.446 HG22 ' N ' ' A' ' 52' ' ' GLY . 0.4 OUTLIER -145.34 -175.55 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.491 -179.669 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.781 ' HZ2' HG12 ' A' ' 25' ' ' VAL . 76.6 m95 -129.9 121.43 26.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.068 0.461 . . . . 0.0 111.905 -179.031 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.501 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 2.8 m120 -68.91 165.87 33.33 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.35 177.443 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.435 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 81.2 Cg_exo -17.09 94.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 125.289 3.993 . . . . 0.0 114.586 -178.475 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.475 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -91.67 -76.13 0.46 Allowed 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.329 -177.871 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.477 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -88.02 109.02 24.49 Favored Pre-proline 0 C--N 1.331 -0.201 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -175.711 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.92 ' HG2' HD11 ' A' ' 41' ' ' LEU . 2.3 Cg_endo -83.61 -154.59 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.053 2.502 . . . . 0.0 111.28 177.196 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.476 HG22 ' H ' ' A' ' 66' ' ' CYS . 3.0 mm -87.65 165.41 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.917 0.389 . . . . 0.0 110.791 178.64 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.476 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -165.83 131.25 2.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.502 179.455 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -154.82 168.32 27.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.184 -179.009 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.5 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 8.6 p -88.1 111.71 21.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.936 179.744 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.622 HG12 ' O ' ' A' ' 38' ' ' GLY . 4.9 p -45.08 103.9 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.884 179.253 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.492 ' HD2' ' CD1' ' A' ' 88' ' ' PHE . 2.2 ttpp -104.43 134.63 47.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.957 -176.035 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 1.5 m -90.18 136.87 32.78 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.668 177.791 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.54 -169.85 0.25 Allowed 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.817 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.6 t -74.99 111.57 14.03 Favored Pre-proline 0 C--N 1.314 -0.954 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.744 -179.021 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.642 ' HG3' ' CE2' ' A' ' 118' ' ' TRP 0.321 0.0 OUTLIER -34.23 -175.27 0.0 OUTLIER 'Trans proline' 0 CA--C 1.468 -2.796 0 C-N-CA 123.722 2.948 . . . . 0.0 114.102 173.589 . . . . . . . . 4 4 . 1 . 027 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.545 ' CB ' ' CE1' ' A' ' 97' ' ' TYR . 23.3 Cg_endo -73.3 -164.0 3.12 Favored 'Cis proline' 0 C--N 1.323 -0.814 0 N-CA-C 113.847 0.672 . . . . 0.0 113.847 -18.854 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.2 t -135.55 21.11 3.36 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.54 172.257 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.612 HD12 ' HB2' ' A' ' 124' ' ' CYS . 3.3 pt -111.16 -160.03 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.274 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.213 -177.45 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.472 ' N ' HG13 ' A' ' 77' ' ' ILE . 86.2 p -134.24 151.03 51.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.788 177.61 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.9 m120 55.6 32.46 19.23 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.578 179.327 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.573 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -151.08 -160.81 9.64 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.127 -1.035 . . . . 0.0 113.731 179.764 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.42 ' N ' ' O ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -161.95 -172.75 3.39 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.801 0.334 . . . . 0.0 111.121 -178.196 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.563 ' CG ' ' HB2' ' A' ' 74' ' ' PRO . 31.3 p80 -124.52 173.41 8.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.157 0.503 . . . . 0.0 112.257 -175.723 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.474 ' H ' HG12 ' A' ' 95' ' ' VAL . 80.8 m-20 -107.65 -98.15 0.37 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.169 174.021 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.758 ' N ' HG13 ' A' ' 95' ' ' VAL . . . 57.14 -80.41 0.01 OUTLIER Glycine 0 C--N 1.342 0.87 0 C-N-CA 121.039 -0.601 . . . . 0.0 113.241 177.826 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.475 ' N ' ' CD2' ' A' ' 85' ' ' TYR . 2.8 m-30 98.42 11.72 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.593 1.557 . . . . 0.0 111.293 179.488 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.87 -173.7 2.36 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.517 178.204 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.26 -24.08 10.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.733 178.651 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.492 ' CD1' ' HD2' ' A' ' 70' ' ' LYS . 9.4 m-85 -147.71 171.41 15.69 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.423 179.413 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.494 ' CE1' ' HD2' ' A' ' 74' ' ' PRO . 17.6 m-85 -147.24 175.53 10.68 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.624 0.249 . . . . 0.0 110.862 -177.661 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.424 HG22 ' HB2' ' A' ' 70' ' ' LYS . 14.7 p -144.6 169.82 17.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.132 0.492 . . . . 0.0 112.029 -179.28 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.27 94.25 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.307 -179.323 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.53 28.45 0.98 Allowed Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.327 -0.852 . . . . 0.0 113.161 178.376 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.469 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.7 OUTLIER -110.14 157.45 19.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.965 0.383 . . . . 0.0 110.879 179.013 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 35.8 m -138.76 146.08 26.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.759 179.627 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.758 HG13 ' N ' ' A' ' 84' ' ' GLY . 4.2 t -147.16 142.8 20.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.026 -178.681 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.846 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -98.55 127.39 44.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.174 0.512 . . . . 0.0 110.132 178.692 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.731 ' CZ ' HG21 ' A' ' 111' ' ' VAL . 2.8 m-30 -95.49 166.23 11.96 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.496 0.665 . . . . 0.0 112.756 -174.794 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.42 ' O ' ' N ' ' A' ' 81' ' ' ARG . 67.6 m -152.87 145.54 24.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.542 178.75 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.542 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 76.1 m -69.43 155.67 40.08 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.863 0.363 . . . . 0.0 111.538 -178.881 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.6 -86.47 0.19 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.967 178.934 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -47.03 -27.04 1.18 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.511 -179.385 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 125.25 32.26 0.8 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.877 179.866 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.502 ' CE1' HG12 ' A' ' 126' ' ' ILE . 18.5 m-85 -72.54 -170.85 0.72 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.903 0.383 . . . . 0.0 111.25 179.952 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.9 m -118.04 96.81 5.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.205 177.882 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.439 ' CD2' ' HA ' ' A' ' 109' ' ' SER . 0.2 OUTLIER -47.92 139.53 7.7 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.563 0.697 . . . . 0.0 111.81 -178.226 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.555 HG22 ' N ' ' A' ' 107' ' ' GLY . 16.8 mm -125.5 160.96 30.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.328 -178.71 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.555 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 64.77 25.18 70.34 Favored Glycine 0 N--CA 1.457 0.082 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.453 177.718 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.455 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.3 OUTLIER 67.05 130.84 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.532 0.682 . . . . 0.0 112.355 178.452 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.846 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.1 p -64.54 -24.68 67.68 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.427 -1.26 . . . . 0.0 111.329 178.906 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.55 130.31 48.24 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.856 179.134 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.731 HG21 ' CZ ' ' A' ' 97' ' ' TYR . 16.4 t -135.31 123.71 39.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.492 0.187 . . . . 0.0 110.855 -177.819 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.0 127.98 35.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.967 0.413 . . . . 0.0 111.804 -177.932 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.506 ' HB2' ' CZ3' ' A' ' 118' ' ' TRP . 44.7 t -89.52 98.08 11.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.521 176.386 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 24.0 p -136.76 159.96 40.28 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.672 -179.119 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.498 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 50.67 29.04 17.53 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.835 -179.074 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.487 ' N ' ' HB ' ' A' ' 69' ' ' VAL . . . 68.39 14.51 66.8 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.085 -0.578 . . . . 0.0 112.575 -179.555 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -141.95 177.02 8.49 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 178.665 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.642 ' CE2' ' HG3' ' A' ' 74' ' ' PRO . 99.4 m95 -98.39 126.5 43.94 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.149 0.5 . . . . 0.0 111.158 -179.586 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.9 150.45 24.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.254 -178.829 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.513 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.9 OUTLIER 53.51 42.46 1.18 Allowed Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.101 -179.987 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 37.7 Cg_endo -64.55 151.5 85.34 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.039 1.826 . . . . 0.0 111.098 177.65 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.664 ' HD3' HG22 ' A' ' 111' ' ' VAL . 44.4 Cg_endo -80.27 -173.59 1.92 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 121.922 1.748 . . . . 0.0 113.035 -179.06 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.461 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -122.75 -161.57 0.96 Allowed 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 173.765 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 124' ' ' CYS . . . . . 0.612 ' HB2' HD12 ' A' ' 77' ' ' ILE . 2.4 t -170.65 83.6 0.1 Allowed 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.25 -175.61 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -115.01 169.04 9.39 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.583 -1.19 . . . . 0.0 111.676 -175.838 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.502 HG12 ' CE1' ' A' ' 103' ' ' TYR . 37.5 mm . . . . . 0 C--N 1.326 -0.442 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.78 179.342 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.5 mtt180 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.764 0.316 . . . . 0.0 110.829 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.75 ' HD2' HG23 ' A' ' 25' ' ' VAL . 7.7 mtm180 -92.47 -159.92 0.7 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.738 179.953 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.45 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 60.8 m -105.33 160.66 25.27 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 -178.956 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.45 ' HD3' ' HB2' ' A' ' 57' ' ' MET . 32.2 Cg_endo -65.86 173.62 6.72 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.59 2.193 . . . . 0.0 112.192 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.7 t -54.37 108.1 1.05 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.578 179.53 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.678 ' HG2' HD13 ' A' ' 22' ' ' ILE . 72.7 Cg_exo -46.98 160.25 0.27 Allowed 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.302 2.001 . . . . 0.0 112.401 -179.468 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.525 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -75.31 174.01 10.1 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.96 178.325 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.582 ' HA ' HD11 ' A' ' 20' ' ' LEU . 1.7 t0 -127.33 -177.0 3.9 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.224 0.535 . . . . 0.0 111.691 -178.866 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.484 HG22 HD21 ' A' ' 20' ' ' LEU . 17.9 tt -146.47 143.06 20.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.785 -179.339 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -81.86 156.8 24.65 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 177.394 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.496 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 0.5 OUTLIER 49.28 26.14 1.46 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.839 0.352 . . . . 0.0 110.554 -179.239 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -153.21 170.59 32.14 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.698 -179.01 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 34' ' ' SER . 0.2 OUTLIER -138.36 144.01 40.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.699 0.285 . . . . 0.0 110.34 179.526 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.781 HD22 ' CE1' ' A' ' 33' ' ' TYR . 0.5 OUTLIER -92.49 163.21 13.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.207 0.527 . . . . 0.0 111.769 -179.312 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 32' ' ' THR . 8.1 t0 -127.47 72.34 1.38 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.875 177.175 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.891 ' HA ' HG23 ' A' ' 31' ' ' ILE . 1.2 mt -72.76 97.8 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.809 -177.789 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.12 16.7 60.77 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.786 176.979 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 160.26 153.46 6.93 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 -179.278 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.75 HG23 ' HD2' ' A' ' 8' ' ' ARG . 17.0 m -134.87 11.58 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.8 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 40.3 t0 -90.02 163.08 15.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.972 0.415 . . . . 0.0 111.377 179.93 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.518 ' CE2' ' HB3' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -50.01 90.27 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.802 -179.599 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 131.99 -9.52 5.43 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.627 -0.796 . . . . 0.0 112.784 -179.566 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.8 m -76.43 157.45 32.23 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 117.107 0.454 . . . . 0.0 110.503 179.536 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.4 p -133.52 142.2 48.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.019 0.437 . . . . 0.0 110.917 179.603 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.891 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -106.81 154.08 7.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.435 -179.789 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.411 ' O ' ' N ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -115.97 119.45 35.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.023 0.44 . . . . 0.0 110.75 179.361 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.781 ' CE1' HD22 ' A' ' 20' ' ' LEU . 11.5 m-85 -95.03 137.95 33.4 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.263 -178.927 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 19' ' ' GLN . 4.4 m -146.77 159.59 43.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.079 179.793 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.414 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 11.1 m -81.97 173.52 12.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.6 179.452 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.415 ' N ' ' O ' ' A' ' 17' ' ' ASN . 0.4 OUTLIER -75.41 -79.88 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.107 -179.447 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.35 134.62 10.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.904 -179.651 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.24 23.52 71.61 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.809 -178.972 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.498 ' CE2' ' HB3' ' A' ' 68' ' ' SER . 2.3 m-85 -118.01 167.88 11.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.842 0.353 . . . . 0.0 110.868 -179.338 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.596 ' CD2' HD11 ' A' ' 42' ' ' ILE . 2.5 p-80 -132.97 121.82 23.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.337 177.635 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.932 HD21 ' O ' ' A' ' 44' ' ' GLU . 8.7 tt -83.3 127.91 34.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.849 -178.401 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.596 HD11 ' CD2' ' A' ' 40' ' ' HIS . 1.4 mm -106.57 149.46 9.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.051 -179.651 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.08 -142.56 20.71 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.07 -179.102 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.932 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -72.15 -175.8 1.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.869 0.366 . . . . 0.0 110.316 178.469 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -168.1 28.79 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.511 179.431 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -157.08 127.42 6.45 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.973 -179.929 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.432 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -102.59 152.36 21.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.74 -179.663 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.499 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.2 m-85 -128.04 124.89 38.22 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.488 0.661 . . . . 0.0 111.672 -179.971 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.491 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 42.7 t -73.23 118.2 15.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.157 -179.429 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.487 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 9.5 tt0 -159.25 168.45 26.43 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.074 179.018 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.518 ' HB3' ' CE2' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -95.76 130.65 42.61 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.553 179.729 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -176.94 93.41 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.013 -179.4 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.444 ' HB3' ' CB ' ' A' ' 56' ' ' SER . 9.6 t -179.09 40.52 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -179.142 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 79.51 29.54 0.31 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.149 -178.89 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 103.7 15.59 22.15 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.115 -179.325 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.461 ' O ' HD23 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -105.31 -159.59 0.71 Allowed 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.97 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.45 ' HB2' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -118.24 136.46 53.65 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.538 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.661 HG23 ' N ' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -137.22 -175.97 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 121.823 0.82 . . . . 0.0 112.171 -176.054 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.672 ' CE3' HD11 ' A' ' 31' ' ' ILE . 59.9 m95 -133.0 134.86 45.02 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.413 179.281 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.499 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 5.5 m-80 -78.41 163.34 62.22 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.888 178.319 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.42 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 31.6 Cg_exo -11.04 90.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.864 1 C-N-CA 125.758 4.305 . . . . 0.0 114.873 -179.392 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.48 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 39.4 mt-10 -91.27 -93.94 0.13 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.146 -178.284 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.479 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . . . -81.15 108.86 11.54 Favored Pre-proline 0 C--O 1.231 0.131 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -176.124 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.878 ' HG2' HD11 ' A' ' 41' ' ' LEU . 2.1 Cg_endo -82.93 -154.6 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.003 2.469 . . . . 0.0 110.756 176.681 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.446 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 2.0 mm -92.88 158.17 2.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.927 0.394 . . . . 0.0 110.508 178.271 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.2 m -164.34 143.37 7.37 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.957 179.905 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -169.88 170.2 7.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.463 179.954 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.498 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 30.2 p -73.92 99.02 3.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.045 0.45 . . . . 0.0 110.219 178.534 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.548 ' O ' HG13 ' A' ' 69' ' ' VAL . 5.6 p -44.2 93.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.29 179.619 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.468 ' CD ' HG23 ' A' ' 90' ' ' THR . 9.0 mttt -69.73 165.05 22.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.0 -177.467 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.416 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -120.88 131.58 54.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.179 179.079 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -69.19 -157.21 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.08 179.205 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.432 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 1.5 t -52.82 142.65 33.2 Favored Pre-proline 0 N--CA 1.45 -0.446 0 CA-C-O 120.682 0.277 . . . . 0.0 110.276 179.495 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 73' ' ' SER . 37.6 Cg_exo -57.31 162.79 9.22 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.397 2.065 . . . . 0.0 112.036 -179.083 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.507 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 82.4 Cg_exo -39.99 159.06 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.746 2.297 . . . . 0.0 112.947 -179.003 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 86.7 p -109.11 88.45 2.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.635 179.446 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.632 HG23 ' HE1' ' A' ' 97' ' ' TYR . 18.0 pt -69.85 174.12 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.33 -179.347 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.6 m -97.07 140.64 31.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.532 179.295 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.513 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 4.9 m-80 59.56 29.62 19.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.746 -179.913 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -172.83 -170.28 36.36 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.516 179.614 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -170.24 -175.7 2.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.888 0.375 . . . . 0.0 111.095 -179.371 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 0.7 OUTLIER -99.47 178.24 4.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.022 -179.987 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -122.17 18.3 10.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.392 -179.645 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -51.76 153.4 5.39 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.281 -0.961 . . . . 0.0 112.282 -179.878 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.466 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 0.6 OUTLIER -106.53 -30.67 8.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.143 0.497 . . . . 0.0 110.426 179.816 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.18 -173.54 2.45 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.761 179.87 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -107.02 -14.78 14.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.242 179.248 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.462 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 2.2 m-85 -134.74 165.61 24.86 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.996 0.427 . . . . 0.0 111.971 -178.351 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.436 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 71.6 m-85 -151.27 154.51 36.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.028 -179.216 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.468 HG23 ' CD ' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -111.4 -174.15 2.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.138 0.494 . . . . 0.0 112.011 -178.617 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.452 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 8.7 m-20 -69.97 96.28 1.02 Allowed 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.033 -179.895 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.46 22.77 2.02 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.956 179.074 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -96.73 156.47 16.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.764 0.316 . . . . 0.0 110.635 179.44 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 34.3 m -135.64 151.13 29.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.17 0.51 . . . . 0.0 111.185 -179.816 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.457 HG23 ' CH2' ' A' ' 118' ' ' TRP . 15.1 t -149.2 146.81 17.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.812 179.783 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.974 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -100.93 142.0 33.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.261 179.03 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.895 ' CE2' HG21 ' A' ' 111' ' ' VAL . 4.0 m-85 -100.4 156.41 17.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.997 0.427 . . . . 0.0 111.202 -179.532 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.434 ' HA ' HD13 ' A' ' 105' ' ' LEU . 36.7 m -150.26 141.61 23.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.133 -179.508 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.419 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 63.2 m -71.96 165.55 23.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.881 179.718 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.32 -86.52 0.34 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.982 179.791 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -46.76 -29.29 1.85 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.403 -179.515 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.19 41.03 0.29 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.539 179.895 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.513 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 43.5 m-85 -80.6 -174.83 4.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.864 0.364 . . . . 0.0 110.817 179.877 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.3 m -112.59 106.99 15.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.173 178.828 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.474 HD11 ' HB3' ' A' ' 97' ' ' TYR . 0.2 OUTLIER -48.26 131.33 16.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.501 0.667 . . . . 0.0 111.683 -178.252 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.445 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 35.4 mm -97.62 155.93 3.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.199 179.16 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.91 -129.32 35.36 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.324 -179.534 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 -121.12 129.74 53.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.804 0.335 . . . . 0.0 111.21 -179.771 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.974 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.5 p -61.33 -32.13 72.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.82 179.455 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -71.4 135.01 23.29 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.842 -179.592 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.895 HG21 ' CE2' ' A' ' 97' ' ' TYR . 3.8 t -130.72 120.0 46.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.632 0.253 . . . . 0.0 110.706 179.2 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.878 HD22 ' N ' ' A' ' 113' ' ' CYS . 1.1 tm? -82.18 134.32 35.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.86 0.362 . . . . 0.0 111.284 -179.374 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.878 ' N ' HD22 ' A' ' 112' ' ' LEU . 43.1 t -105.09 102.5 11.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.105 177.999 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.693 ' CB ' HD11 ' A' ' 112' ' ' LEU . 4.3 m -135.57 113.12 10.78 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.488 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 81.66 45.21 7.41 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.009 178.06 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.432 ' HA3' HG22 ' A' ' 69' ' ' VAL . . . 63.32 12.78 46.77 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.778 179.471 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -134.66 173.74 11.33 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.04 0.447 . . . . 0.0 110.663 179.687 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.52 ' CZ3' ' HB2' ' A' ' 113' ' ' CYS . 94.6 m95 -121.4 156.52 32.49 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.905 -179.41 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.74 149.91 46.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.051 0.453 . . . . 0.0 111.368 -179.767 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.477 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER 67.1 47.07 0.42 Allowed Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.786 179.136 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 84.8 Cg_endo -77.7 133.92 13.17 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.396 2.064 . . . . 0.0 111.642 178.701 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.509 ' O ' HG21 ' A' ' 77' ' ' ILE . 63.8 Cg_endo -88.49 -174.27 1.05 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.581 2.187 . . . . 0.0 113.468 -178.301 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.406 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -130.34 -159.39 0.96 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.031 178.431 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 7.6 m -158.62 91.11 1.05 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.087 0.47 . . . . 0.0 110.988 179.255 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -121.24 158.64 27.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.908 -179.922 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.498 HG12 ' CE2' ' A' ' 103' ' ' TYR . 21.0 mm . . . . . 0 C--N 1.324 -0.533 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.111 179.995 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.79 0.329 . . . . 0.0 110.998 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.454 ' HA ' ' HA ' ' A' ' 26' ' ' ASP . 8.2 mtm-85 -94.69 -176.68 3.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.925 179.796 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.452 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 18.3 m -109.27 160.37 27.87 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.084 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -67.94 170.48 14.15 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.318 2.012 . . . . 0.0 111.75 179.748 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.415 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 0.8 OUTLIER -51.43 105.61 0.55 Allowed Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.948 -179.524 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 11' ' ' SER . 19.8 Cg_endo -61.93 159.78 32.36 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.211 1.941 . . . . 0.0 111.881 179.731 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.441 ' O ' HD12 ' A' ' 20' ' ' LEU . 4.2 mpt_? -49.34 177.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.513 179.636 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.7 ' O ' HG22 ' A' ' 15' ' ' ILE . 0.2 OUTLIER -142.76 -7.74 0.84 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -178.042 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.7 HG22 ' O ' ' A' ' 14' ' ' ASP . 14.4 tt 53.72 163.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 120.749 0.309 . . . . 0.0 111.105 -177.939 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -104.26 -56.03 2.26 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -177.135 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.486 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 0.4 OUTLIER -94.12 31.01 1.75 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.936 0.398 . . . . 0.0 111.071 -178.412 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 34' ' ' SER . . . -157.47 179.65 33.06 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.517 179.473 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -134.92 139.42 44.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.793 0.33 . . . . 0.0 110.25 179.864 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.832 HD21 ' CE1' ' A' ' 33' ' ' TYR . 34.0 mt -88.04 159.77 18.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.377 0.608 . . . . 0.0 112.142 -178.462 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 32' ' ' THR . 5.3 t0 -124.04 83.37 2.13 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.225 176.646 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.892 ' HA ' HG23 ' A' ' 31' ' ' ILE . 1.8 mt -77.44 107.14 8.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.169 -176.678 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.99 19.52 37.85 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.59 176.679 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 152.86 132.77 1.81 Allowed Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.073 -179.373 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.824 HG12 ' CZ2' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -117.38 5.81 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-O 120.811 0.338 . . . . 0.0 110.591 -178.248 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.454 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 6.6 p-10 -75.68 153.71 36.97 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-O 120.964 0.412 . . . . 0.0 111.489 -179.11 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.59 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 3.7 t80 -52.51 95.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.767 179.334 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.02 8.49 5.08 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.989 -179.825 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 84.9 p -97.35 -174.1 2.84 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 116.992 0.396 . . . . 0.0 110.483 179.359 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.1 p -155.12 146.53 22.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.036 0.446 . . . . 0.0 111.121 178.44 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.892 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.8 OUTLIER -106.63 172.59 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.418 -179.394 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.463 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -129.64 118.34 21.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.925 0.393 . . . . 0.0 111.2 179.551 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.832 ' CE1' HD21 ' A' ' 20' ' ' LEU . 19.8 m-85 -94.77 140.96 29.19 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.234 0.54 . . . . 0.0 111.604 -179.486 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 19' ' ' GLN . 16.8 m -148.82 153.65 38.41 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.458 179.744 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.444 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 1.7 m -75.17 167.35 22.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.99 -179.628 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -76.04 -82.03 0.08 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.824 -179.589 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -153.95 121.38 5.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.656 179.351 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.743 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 77.32 14.19 82.79 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.423 -178.766 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.526 ' CZ ' ' CB ' ' A' ' 68' ' ' SER . 23.1 m-85 -111.7 154.47 24.92 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.586 -0.361 . . . . 0.0 111.0 179.546 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.841 ' CE1' HG22 ' A' ' 69' ' ' VAL . 2.3 m-70 -112.86 119.18 37.1 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 175.155 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.957 HD21 ' O ' ' A' ' 44' ' ' GLU . 4.1 tt -83.74 109.31 17.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.928 0.394 . . . . 0.0 110.022 -179.842 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.572 ' N ' HD13 ' A' ' 42' ' ' ILE . 1.5 mm -91.94 148.28 4.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.301 -178.255 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.15 -134.36 12.12 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.287 -179.288 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.957 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -84.31 -173.15 4.56 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.655 0.264 . . . . 0.0 110.686 179.422 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.2 p -160.46 23.38 0.15 Allowed 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.319 -178.91 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.463 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 8.3 mtpt -159.62 123.13 3.67 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.36 -177.701 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -92.13 145.05 24.82 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.196 178.714 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.556 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 0.4 OUTLIER -119.95 116.03 24.98 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 119.401 -0.919 . . . . 0.0 111.635 178.912 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.413 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 15.6 t -69.46 95.66 0.84 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.631 179.628 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -120.18 -168.18 1.57 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.939 -179.79 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.59 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -105.2 142.02 35.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.009 0.433 . . . . 0.0 111.198 -179.693 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.587 ' N ' HG22 ' A' ' 58' ' ' VAL . . . -125.26 -171.6 13.29 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.681 178.99 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.437 ' C ' HG23 ' A' ' 54' ' ' THR . 3.5 t 44.87 27.26 0.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.899 0.38 . . . . 0.0 111.59 179.41 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.437 HG23 ' C ' ' A' ' 53' ' ' SER . 1.5 p 67.7 19.75 9.65 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.695 179.025 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 169.9 -28.56 0.13 Allowed Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.124 -1.036 . . . . 0.0 113.384 179.475 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 52' ' ' GLY . 19.7 t -69.49 -176.63 1.02 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.908 0.385 . . . . 0.0 111.064 -179.596 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.625 ' O ' HG13 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -101.58 151.53 21.87 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.981 179.409 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.625 HG13 ' O ' ' A' ' 57' ' ' MET . 0.9 OUTLIER -162.09 176.68 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.136 -179.303 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.824 ' CZ2' HG12 ' A' ' 25' ' ' VAL . 70.9 m95 -128.61 120.93 27.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.396 -179.253 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.556 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -69.0 167.72 18.99 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.754 178.189 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.487 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 56.1 Cg_exo -13.66 90.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.964 1 C-N-CA 125.399 4.066 . . . . 0.0 114.374 -179.16 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.509 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -94.46 -76.23 0.49 Allowed 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 115.273 -0.876 . . . . 0.0 113.231 -175.799 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.469 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -96.56 85.09 0.3 Allowed Pre-proline 0 N--CA 1.45 -0.462 0 N-CA-C 112.883 0.698 . . . . 0.0 112.883 -173.431 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.684 ' CG ' HD11 ' A' ' 41' ' ' LEU . 22.2 Cg_endo -51.49 -156.28 0.0 OUTLIER 'Trans proline' 0 N--CA 1.473 0.274 0 C-N-CA 123.586 2.858 . . . . 0.0 112.187 174.504 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.576 HG22 ' H ' ' A' ' 66' ' ' CYS . 0.7 OUTLIER -100.88 177.59 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.972 0.415 . . . . 0.0 110.726 178.876 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.576 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -170.74 133.65 0.98 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.681 179.523 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -137.87 113.18 9.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.078 179.795 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.526 ' CB ' ' CZ ' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -51.65 126.62 18.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.744 179.65 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.841 HG22 ' CE1' ' A' ' 40' ' ' HIS . 2.2 p -40.41 96.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.01 -179.674 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.498 ' HE3' HG23 ' A' ' 90' ' ' THR . 0.1 OUTLIER -73.15 114.04 10.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.163 179.868 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.428 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -92.14 122.4 34.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.944 0.402 . . . . 0.0 110.133 178.521 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.01 -159.72 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.111 179.85 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.663 ' HG ' ' CE1' ' A' ' 82' ' ' HIS . 1.2 t -54.41 143.6 45.87 Favored Pre-proline 0 N--CA 1.449 -0.509 0 CA-C-O 120.589 0.233 . . . . 0.0 110.554 -179.829 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.519 ' HG2' HG11 ' A' ' 95' ' ' VAL . 22.4 Cg_exo -62.1 160.77 28.83 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.432 2.088 . . . . 0.0 111.941 -179.855 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.508 ' HD3' ' CG ' ' A' ' 118' ' ' TRP . 74.7 Cg_exo -38.64 156.95 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.885 2.39 . . . . 0.0 112.912 -179.489 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.94 89.97 3.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.749 179.906 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.605 HG23 ' HE2' ' A' ' 97' ' ' TYR . 19.8 pt -69.35 178.65 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.057 -179.816 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.8 m -99.2 142.47 30.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.974 179.941 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.504 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 2.6 m-80 59.02 28.79 18.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.099 179.524 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.458 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -165.95 -167.49 26.66 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.857 179.834 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.427 ' N ' ' O ' ' A' ' 98' ' ' SER . 10.1 ptt180 -161.66 -175.49 4.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.032 0.444 . . . . 0.0 110.923 -179.693 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.663 ' CE1' ' HG ' ' A' ' 73' ' ' SER . 19.7 p80 -108.68 171.35 7.48 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.881 179.88 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.435 ' O ' ' N ' ' A' ' 85' ' ' TYR . 95.5 m-20 -106.97 -96.77 0.36 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.684 179.146 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.641 ' N ' HG13 ' A' ' 95' ' ' VAL . . . 59.93 -81.48 0.01 OUTLIER Glycine 0 C--N 1.337 0.596 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.878 179.34 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.472 ' N ' ' CD2' ' A' ' 85' ' ' TYR . 3.7 m-30 93.66 10.72 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.287 1.435 . . . . 0.0 111.374 -179.783 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.53 -174.06 2.45 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.593 178.456 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -110.28 -25.01 10.35 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.631 178.649 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.431 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 13.5 m-85 -145.95 166.93 24.57 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.697 179.847 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.431 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 32.2 m-85 -145.05 165.66 27.58 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.698 -179.327 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.498 HG23 ' HE3' ' A' ' 70' ' ' LYS . 13.3 p -128.5 178.16 6.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.108 0.48 . . . . 0.0 111.764 -178.384 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 71.3 m-20 -62.25 95.58 0.07 Allowed 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.042 179.981 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 125.58 20.35 2.16 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.372 -0.831 . . . . 0.0 113.208 178.453 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.449 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -97.5 159.28 15.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 117.015 0.408 . . . . 0.0 110.439 178.91 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 27.1 m -134.92 146.28 30.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.022 0.439 . . . . 0.0 111.056 -179.626 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.641 HG13 ' N ' ' A' ' 84' ' ' GLY . 27.9 t -141.62 148.35 21.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.946 179.699 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.741 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -107.08 131.12 54.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.776 179.663 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.973 ' CE1' HG21 ' A' ' 111' ' ' VAL . 6.2 m-85 -90.42 155.89 18.61 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.106 -179.414 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.427 ' O ' ' N ' ' A' ' 81' ' ' ARG . 1.3 p -149.86 136.68 19.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.542 -179.482 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.423 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 60.5 m -70.13 159.19 34.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.867 179.27 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.458 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 73.0 m-80 -92.13 -76.49 0.46 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.354 -179.483 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.78 -23.16 28.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.225 -179.351 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.65 32.35 1.03 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.525 -179.932 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.509 ' CE2' HG12 ' A' ' 126' ' ' ILE . 46.2 m-85 -69.99 -171.7 0.46 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 120.64 0.257 . . . . 0.0 110.48 179.709 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.8 m -109.78 108.18 18.44 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.91 0.386 . . . . 0.0 111.349 -178.905 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 105' ' ' LEU . 0.9 OUTLIER -48.14 106.93 0.11 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.374 178.142 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.506 HG22 ' N ' ' A' ' 107' ' ' GLY . 43.6 mm -85.2 158.95 3.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.168 -178.47 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.506 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 59.66 -127.42 44.48 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.844 -179.248 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -118.18 132.75 56.31 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.87 0.367 . . . . 0.0 110.669 178.974 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.741 ' HB2' HG22 ' A' ' 96' ' ' THR . 0.1 OUTLIER -69.45 -28.9 66.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.119 0.485 . . . . 0.0 110.453 179.549 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.58 131.4 14.44 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.764 -179.927 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.973 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.8 t -123.92 121.71 62.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.583 0.23 . . . . 0.0 110.644 179.217 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.67 121.14 25.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.875 0.369 . . . . 0.0 111.443 -178.818 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.494 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 23.3 t -85.73 106.14 16.77 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 176.465 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.414 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.3 OUTLIER -147.81 160.11 43.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.129 0.49 . . . . 0.0 111.394 -178.333 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.28 34.41 6.22 Favored Glycine 0 CA--C 1.518 0.219 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.775 179.611 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 65.91 12.94 58.56 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.641 -179.448 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -136.58 -178.85 5.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.876 0.37 . . . . 0.0 110.704 179.63 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.508 ' CG ' ' HD3' ' A' ' 75' ' ' PRO . 93.2 m95 -119.08 141.63 48.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.969 -179.416 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.08 150.13 50.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.05 0.452 . . . . 0.0 111.535 -179.029 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.478 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.5 OUTLIER 71.26 46.35 0.25 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.125 178.744 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 85.5 Cg_endo -78.22 142.23 19.0 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.376 2.05 . . . . 0.0 111.729 178.424 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.507 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 61.6 Cg_endo -90.13 -172.3 0.56 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.67 2.246 . . . . 0.0 113.476 -178.589 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.452 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -134.71 -178.48 5.09 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.974 178.215 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 124' ' ' CYS . . . . . 0.435 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 11.1 m -139.51 97.66 3.32 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.965 0.412 . . . . 0.0 111.027 -179.832 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -123.96 155.35 38.34 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.975 -179.683 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.565 ' O ' HG22 ' A' ' 126' ' ' ILE . 18.1 mm . . . . . 0 C--N 1.324 -0.507 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.99 179.932 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 120.975 0.417 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.683 ' HD3' HG23 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -71.73 176.4 4.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.007 -179.788 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.426 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 13.1 m -83.93 161.31 55.88 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.733 179.757 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.74 169.19 19.46 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.396 2.064 . . . . 0.0 111.305 179.121 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.43 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -52.81 116.9 9.86 Favored Pre-proline 0 C--N 1.326 -0.436 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.962 -178.794 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.795 ' HG3' HD13 ' A' ' 22' ' ' ILE . 16.3 Cg_endo -57.27 157.58 21.18 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.62 2.214 . . . . 0.0 112.273 179.987 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.439 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 9.2 mtt-85 -64.55 176.05 1.23 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.201 178.974 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.783 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 1.1 t0 -130.89 -172.39 2.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.108 0.48 . . . . 0.0 111.679 -178.895 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.434 HG22 HD21 ' A' ' 20' ' ' LEU . 3.6 tt -145.71 151.48 14.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.727 -179.684 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -80.35 -70.73 0.5 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.672 -178.583 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.442 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 1.9 m-20 -91.2 42.9 1.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.929 0.395 . . . . 0.0 110.946 -179.408 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -153.41 -173.76 22.98 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.956 179.904 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -145.66 135.2 23.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.706 0.289 . . . . 0.0 110.415 179.733 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.863 HD22 ' CE1' ' A' ' 33' ' ' TYR . 0.5 OUTLIER -83.73 156.99 22.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.125 0.488 . . . . 0.0 111.677 -179.23 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.433 ' CB ' ' HB ' ' A' ' 32' ' ' THR . 0.3 OUTLIER -127.73 73.75 1.48 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.31 177.061 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.824 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.5 OUTLIER -80.32 95.58 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.835 -176.674 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.02 16.96 59.24 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.99 177.538 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 164.49 149.67 5.87 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.075 -0.583 . . . . 0.0 111.901 -179.582 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.683 HG23 ' HD3' ' A' ' 8' ' ' ARG . 8.7 m -135.91 32.85 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.699 0.285 . . . . 0.0 111.354 -179.455 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.2 OUTLIER -102.75 155.81 18.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.125 179.933 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.571 ' CZ ' HD12 ' A' ' 51' ' ' LEU . 4.9 t80 -50.71 91.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.771 179.657 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 129.97 -12.2 5.87 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.654 -179.251 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.2 p -70.63 177.04 3.71 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.735 0.302 . . . . 0.0 110.659 179.671 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.8 p -148.51 142.89 26.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.116 179.972 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.824 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.6 OUTLIER -104.64 171.14 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.564 179.858 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.433 ' HB ' ' CB ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -135.73 111.14 9.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.993 0.425 . . . . 0.0 111.337 179.568 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.863 ' CE1' HD22 ' A' ' 20' ' ' LEU . 26.5 m-85 -87.37 143.17 27.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.435 -179.755 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.419 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 5.0 m -147.05 168.47 21.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.725 179.442 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.427 ' HA ' ' HA2' ' A' ' 18' ' ' GLY . 1.3 m -87.64 166.14 14.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.828 179.696 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.408 ' ND2' ' HA ' ' A' ' 17' ' ' ASN . 15.0 m-20 -67.25 -84.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.996 -179.76 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -154.03 130.8 10.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.109 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.02 19.26 71.68 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.433 -179.534 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.506 ' CE1' ' HB3' ' A' ' 68' ' ' SER . 3.3 m-30 -111.72 178.59 4.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.859 0.361 . . . . 0.0 110.966 -179.604 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.77 ' CD2' HD11 ' A' ' 42' ' ' ILE . 3.1 p-80 -138.31 113.23 9.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.136 0.493 . . . . 0.0 110.472 177.645 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.943 HD21 ' O ' ' A' ' 44' ' ' GLU . 6.8 tt -77.38 120.26 22.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.96 -179.01 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.77 HD11 ' CD2' ' A' ' 40' ' ' HIS . 2.6 mm -96.22 153.13 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.734 179.685 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.04 -137.14 15.18 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.975 -178.71 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.943 ' O ' HD21 ' A' ' 41' ' ' LEU . 5.1 mt-10 -88.67 -176.84 5.4 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.507 0.67 . . . . 0.0 111.221 179.175 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.7 p -155.15 24.16 0.42 Allowed 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 114.592 -1.186 . . . . 0.0 110.332 179.045 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -150.55 128.95 12.1 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.173 0.511 . . . . 0.0 112.068 -178.763 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -108.03 151.2 26.16 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.89 178.256 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.503 ' CD1' ' CB ' ' A' ' 60' ' ' ASN . 1.5 m-85 -126.28 122.54 35.8 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 119.456 -0.898 . . . . 0.0 112.598 -177.846 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.47 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 26.0 t -71.26 102.27 2.52 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.398 178.55 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -129.33 -176.19 3.81 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.317 -179.039 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.841 HD23 ' O ' ' A' ' 56' ' ' SER . 6.7 mt -83.13 157.84 22.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.447 -178.879 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.04 -157.57 23.75 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.618 179.933 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 m -83.83 -32.48 25.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.77 0.319 . . . . 0.0 110.992 -179.874 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.9 p -108.38 24.55 12.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.022 179.985 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.2 25.89 42.41 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.569 179.944 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.841 ' O ' HD23 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -93.36 -165.04 1.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.832 0.349 . . . . 0.0 110.92 179.962 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 8.0 mmt -109.98 129.82 55.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.768 179.683 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.4 m -143.2 177.94 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.069 -179.909 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.532 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 72.6 m95 -131.84 128.65 39.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.344 -179.429 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.503 ' CB ' ' CD1' ' A' ' 48' ' ' TYR . 0.7 OUTLIER -69.67 164.63 48.86 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.707 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.505 ' O ' ' HA ' ' A' ' 47' ' ' SER . 97.7 Cg_exo -13.78 113.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.826 1 C-N-CA 125.552 4.168 . . . . 0.0 115.08 -176.257 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.474 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 3.7 mt-10 -106.17 -96.56 0.35 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.412 -1.267 . . . . 0.0 112.56 -175.579 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.783 ' HB2' ' O ' ' A' ' 14' ' ' ASP . . . -78.2 108.28 7.31 Favored Pre-proline 0 C--O 1.231 0.11 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -176.457 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.898 ' HG2' HD11 ' A' ' 41' ' ' LEU . 1.8 Cg_endo -86.83 -155.28 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.208 2.605 . . . . 0.0 110.881 177.387 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.457 HG22 ' H ' ' A' ' 66' ' ' CYS . 5.0 mm -88.95 163.96 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.893 0.378 . . . . 0.0 110.882 178.61 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.457 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -170.18 125.46 0.77 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.768 179.589 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -153.6 174.35 14.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.914 -178.873 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.506 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 77.1 p -82.25 94.7 7.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.103 0.478 . . . . 0.0 110.337 178.387 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.705 HG22 ' HA3' ' A' ' 116' ' ' GLY . 6.0 p -47.33 102.43 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.214 -179.891 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.428 ' HD2' ' HB3' ' A' ' 88' ' ' PHE . 6.0 mmtp -70.66 157.0 38.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.516 -177.058 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.409 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -132.02 115.27 15.6 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.882 178.435 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -70.61 -163.59 0.08 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.313 -178.779 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.467 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 1.6 t -46.81 139.92 6.36 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.227 -179.539 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.501 ' HD2' ' CE1' ' A' ' 82' ' ' HIS . 24.2 Cg_exo -62.83 146.36 94.99 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.328 2.019 . . . . 0.0 112.449 -179.125 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.537 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 0.2 OUTLIER -119.71 -159.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 124.742 3.628 . . . . 0.0 114.013 -174.784 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 75' ' ' PRO . 3.4 p 96.0 -66.23 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 171.241 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.83 HG22 ' O ' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -76.13 176.05 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 122.251 1.024 . . . . 0.0 113.51 -172.144 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.494 ' N ' HG13 ' A' ' 77' ' ' ILE . 2.4 m -139.93 143.36 36.57 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 113.307 -1.769 . . . . 0.0 108.551 176.42 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 77.03 23.12 0.96 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.795 0.331 . . . . 0.0 111.076 -178.091 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.705 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -147.9 -161.09 9.31 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.55 178.748 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -161.21 -173.92 4.08 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.92 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.514 ' HB2' HG11 ' A' ' 95' ' ' VAL . 2.1 p80 -135.51 150.38 49.75 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.124 0.488 . . . . 0.0 111.927 -178.032 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -76.54 -146.15 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.154 179.106 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 85' ' ' TYR . . . 79.4 -66.01 3.55 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.102 -1.046 . . . . 0.0 111.314 -178.352 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.435 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 3.7 m-85 66.18 28.62 10.07 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 121.456 0.646 . . . . 0.0 110.075 179.363 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.91 -173.43 2.61 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.173 178.648 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -109.9 -23.82 11.15 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.897 0.38 . . . . 0.0 110.644 178.553 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.428 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 9.6 m-85 -151.47 163.38 39.12 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.187 -179.652 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.409 ' N ' ' O ' ' A' ' 71' ' ' CYS . 31.1 m-85 -140.75 159.1 42.93 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.272 179.813 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.1 p -122.04 177.27 5.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.118 0.485 . . . . 0.0 111.992 -177.466 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 1.0 OUTLIER -62.9 96.44 0.09 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.918 -179.998 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 125.96 12.54 3.57 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.227 -0.897 . . . . 0.0 113.082 179.107 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.406 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -92.93 155.54 17.5 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.934 0.367 . . . . 0.0 110.433 179.183 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.46 HG22 ' N ' ' A' ' 95' ' ' VAL . 35.4 m -131.44 157.48 43.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.926 0.393 . . . . 0.0 111.02 -179.946 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.514 HG11 ' HB2' ' A' ' 82' ' ' HIS . 41.9 t -153.59 151.7 11.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.999 179.909 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.933 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -111.33 122.45 47.88 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.786 179.922 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 1.035 ' CE1' HG21 ' A' ' 111' ' ' VAL . 6.2 m-85 -81.06 156.1 26.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.651 -178.717 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 81' ' ' ARG . 1.2 p -147.23 134.81 20.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.397 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.441 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 74.8 m -72.0 149.72 44.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.76 0.314 . . . . 0.0 111.454 -179.875 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -96.1 -82.05 0.4 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.931 178.496 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -39.88 -30.99 0.1 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.901 -179.308 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.07 32.7 0.62 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.915 179.597 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.482 ' CD1' HG12 ' A' ' 126' ' ' ILE . 48.2 m-85 -79.96 -171.56 2.97 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.735 0.302 . . . . 0.0 110.779 179.635 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.4 m -118.97 114.5 22.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.967 0.413 . . . . 0.0 110.712 -179.846 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.634 HD21 ' HB2' ' A' ' 97' ' ' TYR . 0.3 OUTLIER -51.04 102.95 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.001 179.959 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.44 HG13 ' HB2' ' A' ' 125' ' ' GLN . 22.8 mm -95.62 151.6 3.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.554 179.171 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 69.19 24.96 75.81 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.497 -0.859 . . . . 0.0 113.033 179.173 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.429 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.3 OUTLIER 60.33 136.83 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.471 0.653 . . . . 0.0 111.642 179.745 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.933 ' HB2' HG22 ' A' ' 96' ' ' THR . 0.8 OUTLIER -70.21 -20.88 63.07 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.988 -179.179 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -64.65 122.42 24.64 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.695 -179.334 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 1.035 HG21 ' CE1' ' A' ' 97' ' ' TYR . 3.2 t -122.63 147.76 26.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 179.175 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.92 115.51 29.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.022 0.439 . . . . 0.0 111.627 -179.003 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.513 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 30.4 t -82.7 98.34 9.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.747 177.167 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.8 OUTLIER -138.48 160.37 39.72 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.362 -178.252 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.73 25.37 3.42 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.69 179.436 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.705 ' HA3' HG22 ' A' ' 69' ' ' VAL . . . 83.24 -6.76 70.4 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.945 -179.859 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -126.16 179.8 5.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.866 0.365 . . . . 0.0 110.556 179.834 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.537 ' CD1' ' HD3' ' A' ' 75' ' ' PRO . 79.0 m95 -110.38 143.44 40.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.703 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.05 162.43 23.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.029 0.442 . . . . 0.0 111.536 -178.78 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.475 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 4.3 p-10 47.65 47.82 5.07 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.058 179.526 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 72.0 Cg_endo -76.08 163.55 32.77 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.416 2.077 . . . . 0.0 111.949 178.49 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.83 ' O ' HG22 ' A' ' 77' ' ' ILE . 41.3 Cg_endo -94.97 -166.1 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.121 2.547 . . . . 0.0 113.778 -178.133 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.26 170.55 17.64 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.5 177.665 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 124' ' ' CYS . . . . . 0.433 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 1.6 m -122.97 91.24 3.45 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.971 0.415 . . . . 0.0 111.196 179.846 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.44 ' HB2' HG13 ' A' ' 106' ' ' ILE . 19.2 mt-30 -114.15 159.43 20.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.19 178.96 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.539 ' O ' HG22 ' A' ' 126' ' ' ILE . 16.9 mm . . . . . 0 C--N 1.321 -0.67 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.224 -179.375 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 22.5 mmm-85 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.917 0.389 . . . . 0.0 111.087 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -105.14 164.99 11.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.829 -179.97 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.536 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 71.8 m -69.82 176.4 1.77 Allowed Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.174 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.546 ' HD2' ' CD1' ' A' ' 59' ' ' TRP . 30.6 Cg_endo -83.2 175.01 8.75 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 121.792 1.661 . . . . 0.0 110.58 178.261 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.9 p -51.09 104.57 0.44 Allowed Pre-proline 0 C--N 1.324 -0.501 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.611 -179.634 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.883 ' HG2' HD12 ' A' ' 22' ' ' ILE . 32.3 Cg_exo -38.09 156.02 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.748 2.299 . . . . 0.0 112.723 -178.66 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.44 164.53 20.91 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.379 178.652 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -114.09 -173.54 2.3 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.754 -176.707 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.467 HG23 ' C ' ' A' ' 18' ' ' GLY . 5.8 tt -132.32 150.14 33.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.502 179.217 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -76.52 -68.5 0.59 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.79 -177.992 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.417 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 1.9 m-20 -92.45 41.57 1.08 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.916 0.389 . . . . 0.0 111.076 -178.58 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.467 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -162.3 -173.66 31.25 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.999 179.815 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -129.91 168.67 16.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.659 0.266 . . . . 0.0 110.31 179.173 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.728 ' N ' HD12 ' A' ' 20' ' ' LEU . 0.4 OUTLIER -119.85 156.59 30.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.025 0.44 . . . . 0.0 111.38 -179.427 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.42 76.49 1.71 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.979 178.358 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.905 ' HA ' HG23 ' A' ' 31' ' ' ILE . 5.9 mm -69.35 109.81 2.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.72 -177.827 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -112.91 15.72 23.52 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.347 178.465 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 152.58 138.26 2.7 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.994 -179.617 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.437 HG12 ' HG3' ' A' ' 12' ' ' PRO . 30.2 m -124.4 25.66 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -178.705 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -94.58 152.03 18.85 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.994 0.426 . . . . 0.0 111.035 -179.966 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.634 ' CZ ' HD12 ' A' ' 51' ' ' LEU . 2.4 t80 -47.25 92.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.088 -179.682 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 126.1 0.51 7.55 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.853 -179.593 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.17 -178.82 7.18 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 116.978 0.389 . . . . 0.0 110.662 179.696 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.0 p -153.84 145.06 22.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.266 0.555 . . . . 0.0 110.862 179.713 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.905 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -109.98 164.88 5.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.181 -179.169 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.673 HG23 ' HD3' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -124.49 107.83 11.49 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.061 0.458 . . . . 0.0 111.157 179.196 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.571 ' CZ ' HD22 ' A' ' 20' ' ' LEU . 6.5 m-85 -82.24 147.21 29.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.528 -179.461 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.45 168.6 20.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.648 179.471 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.423 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 0.8 OUTLIER -95.36 167.18 11.5 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.645 179.795 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.44 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 25.7 m120 -55.16 -85.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.169 -178.434 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.01 125.59 4.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.258 -179.934 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.542 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 74.02 16.51 79.5 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.284 -0.96 . . . . 0.0 112.12 -178.242 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.532 ' CE1' ' CB ' ' A' ' 68' ' ' SER . 2.2 m-85 -107.21 -173.08 2.21 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.709 0.29 . . . . 0.0 110.503 -179.985 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.563 ' HB3' HG23 ' A' ' 69' ' ' VAL . 3.4 p-80 -149.65 111.0 4.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.037 0.446 . . . . 0.0 110.762 178.265 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.865 HD11 ' CB ' ' A' ' 45' ' ' SER . 0.0 OUTLIER -79.74 132.05 36.08 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.86 179.761 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.528 HD11 ' NE2' ' A' ' 40' ' ' HIS . 3.2 mm -97.27 163.13 2.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.605 -176.865 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.43 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 63.53 -152.25 47.9 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.531 -178.383 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.412 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -60.23 -171.84 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.199 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.865 ' CB ' HD11 ' A' ' 41' ' ' LEU . 91.0 p -171.28 34.19 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 121.307 0.575 . . . . 0.0 109.968 -179.893 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.673 ' HD3' HG23 ' A' ' 32' ' ' THR . 1.9 mmmt -151.63 129.0 11.3 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.803 -178.966 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.447 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 0.2 OUTLIER -95.86 136.32 36.44 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.55 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.526 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.8 m-85 -115.89 123.69 48.76 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 119.307 -0.957 . . . . 0.0 112.196 -178.465 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.404 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 44.7 t -73.19 107.69 5.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.921 179.562 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -137.43 -175.39 4.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.114 179.929 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.661 HD23 ' O ' ' A' ' 56' ' ' SER . 10.9 mt -86.71 161.4 18.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.835 -179.891 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -103.35 -87.83 2.02 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.832 -179.566 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.496 ' C ' HG23 ' A' ' 54' ' ' THR . 0.1 OUTLIER -93.71 47.79 1.25 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.826 0.346 . . . . 0.0 111.242 -179.19 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.496 HG23 ' C ' ' A' ' 53' ' ' SER . 1.2 p 68.14 27.38 6.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.905 179.195 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.92 -31.87 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.652 -179.697 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.661 ' O ' HD23 ' A' ' 51' ' ' LEU . 18.0 t -78.28 167.34 21.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.885 0.374 . . . . 0.0 110.821 179.882 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.49 135.2 43.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.791 -179.073 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.511 HG22 ' C ' ' A' ' 51' ' ' LEU . 30.8 m -148.57 165.34 4.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.176 -179.785 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.568 ' CZ3' HD11 ' A' ' 31' ' ' ILE . 58.3 m95 -121.43 127.04 50.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.141 179.976 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.526 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 6.6 m-80 -69.76 165.21 43.92 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.171 178.883 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.442 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 42.1 Cg_exo -13.27 96.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.055 1 C-N-CA 125.63 4.22 . . . . 0.0 114.398 -179.227 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.502 ' O ' ' HD2' ' A' ' 64' ' ' PRO . 0.7 OUTLIER -93.17 -70.92 0.68 Allowed 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 114.985 -1.007 . . . . 0.0 113.245 -175.556 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.504 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -106.6 75.39 0.38 Allowed Pre-proline 0 C--N 1.333 -0.143 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -173.861 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.506 ' HG2' ' CD2' ' A' ' 41' ' ' LEU . 11.5 Cg_endo -54.53 -138.76 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 123.95 3.1 . . . . 0.0 112.417 175.849 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.492 HG22 ' H ' ' A' ' 66' ' ' CYS . 3.0 mm -103.54 166.14 2.98 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.327 0 O-C-N 121.288 -0.883 . . . . 0.0 112.687 -175.244 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.492 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.2 m -158.05 136.01 10.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.779 178.569 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -155.22 167.6 29.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.036 -179.814 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.532 ' CB ' ' CE1' ' A' ' 39' ' ' TYR . 4.9 p -96.27 110.57 22.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.154 179.959 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.693 HG11 ' HA2' ' A' ' 115' ' ' GLY . 0.9 OUTLIER -52.17 101.94 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.122 179.405 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.542 ' HE3' HG23 ' A' ' 90' ' ' THR . 0.0 OUTLIER -80.04 117.83 21.22 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.36 -179.729 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.419 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -98.85 115.83 29.71 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.064 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.5 -163.53 0.05 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.843 -179.048 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.452 ' HG ' ' CE1' ' A' ' 82' ' ' HIS . 2.3 t -44.89 137.76 4.35 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.945 -179.864 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.5 ' HG2' HG11 ' A' ' 95' ' ' VAL . 32.1 Cg_exo -56.24 160.93 9.84 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 122.124 1.883 . . . . 0.0 111.791 -179.402 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.516 ' HD3' ' CG ' ' A' ' 118' ' ' TRP . 98.8 Cg_exo -42.17 155.8 0.09 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.839 2.36 . . . . 0.0 112.928 -178.639 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.5 t -107.14 90.23 3.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.43 179.152 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.666 HG23 ' HE1' ' A' ' 97' ' ' TYR . 17.6 pt -69.47 170.23 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.319 -178.998 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.8 m -89.86 138.44 31.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.727 179.688 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 60.41 28.22 17.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.926 179.782 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -163.44 -165.68 21.0 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.268 -0.968 . . . . 0.0 113.225 179.828 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.3 -175.07 3.12 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.084 0.469 . . . . 0.0 110.603 -178.952 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.452 ' CE1' ' HG ' ' A' ' 73' ' ' SER . 11.5 p-80 -107.63 178.12 4.62 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.909 179.731 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -107.4 -14.51 14.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.597 -179.827 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -45.65 138.31 6.63 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.936 -178.741 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -109.76 -25.51 10.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.907 0.385 . . . . 0.0 110.967 -179.743 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.31 -170.81 2.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.678 179.791 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -110.36 -21.17 12.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.399 -179.649 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.447 ' CD2' ' HB3' ' A' ' 70' ' ' LYS . 18.5 m-85 -143.6 164.32 30.73 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.037 0.446 . . . . 0.0 111.704 -178.591 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.419 ' N ' ' O ' ' A' ' 71' ' ' CYS . 22.3 m-85 -145.75 169.62 18.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.095 178.727 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.542 HG23 ' HE3' ' A' ' 70' ' ' LYS . 5.5 p -134.38 -174.41 3.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.981 0.42 . . . . 0.0 111.729 -178.699 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.486 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 0.4 OUTLIER -65.76 103.75 0.95 Allowed 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.6 0.714 . . . . 0.0 111.002 -179.905 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 120.77 17.57 4.19 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.563 179.663 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.46 148.73 25.57 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.825 0.345 . . . . 0.0 110.799 179.746 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 35.5 m -129.06 156.04 41.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.032 -179.522 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.526 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 18.5 t -151.74 148.86 14.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.983 179.918 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.429 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.1 OUTLIER -104.38 138.55 40.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.987 -179.936 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.969 ' CE2' HG21 ' A' ' 111' ' ' VAL . 4.4 m-85 -98.8 155.89 17.13 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.342 -179.157 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.475 ' HA ' HD13 ' A' ' 105' ' ' LEU . 74.3 m -151.34 143.28 23.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.066 -179.908 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.466 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 63.7 m -71.78 159.72 33.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.784 179.626 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.463 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 44.5 m-20 -85.85 -70.84 0.57 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.512 -178.944 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.0 t -68.33 -23.62 64.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.384 -179.008 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 124.26 34.79 0.7 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.568 -179.787 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.49 ' CE2' HG12 ' A' ' 126' ' ' ILE . 14.9 m-85 -69.76 -174.46 0.74 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 120.948 0.404 . . . . 0.0 110.573 179.509 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.88 100.66 10.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.424 178.927 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.629 HD21 ' HA ' ' A' ' 109' ' ' SER . 0.3 OUTLIER -46.64 125.59 7.31 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.376 0.608 . . . . 0.0 111.602 -178.873 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.451 ' HB ' ' CB ' ' A' ' 123' ' ' THR . 36.8 mm -89.59 153.17 3.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.098 179.391 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 60.37 -132.3 50.07 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.773 -178.594 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -116.26 137.58 52.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.981 0.42 . . . . 0.0 111.318 179.509 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.629 ' HA ' HD21 ' A' ' 105' ' ' LEU . 0.7 OUTLIER -66.12 -27.64 68.2 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.408 178.7 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -70.9 138.17 27.92 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.545 179.575 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.969 HG21 ' CE2' ' A' ' 97' ' ' TYR . 2.9 t -131.39 130.46 62.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 179.162 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.916 HD22 ' N ' ' A' ' 113' ' ' CYS . 0.6 OUTLIER -89.85 128.18 36.13 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.957 0.408 . . . . 0.0 111.682 -178.576 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.916 ' N ' HD22 ' A' ' 112' ' ' LEU . 42.6 t -99.21 102.92 14.73 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.678 176.648 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.779 ' HB3' HD11 ' A' ' 112' ' ' LEU . 20.0 p -148.03 111.84 5.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.506 -178.657 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.693 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 94.25 39.84 4.69 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.262 179.645 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.434 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 58.82 20.2 46.91 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.145 -179.339 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -143.97 -178.06 5.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.916 0.388 . . . . 0.0 110.867 -179.976 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.53 ' CZ3' ' HB2' ' A' ' 113' ' ' CYS . 93.5 m95 -125.38 144.07 50.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.184 -179.121 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.426 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.9 OUTLIER -123.48 166.65 15.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.495 -178.984 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.446 ' N ' ' HD3' ' A' ' 121' ' ' PRO . 1.5 p30 45.73 50.35 7.77 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.437 -0.802 . . . . 0.0 112.361 179.065 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.468 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 96.6 Cg_endo -80.05 146.36 18.08 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.558 2.172 . . . . 0.0 111.47 177.572 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.507 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 61.1 Cg_endo -94.6 -173.01 0.29 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.786 2.324 . . . . 0.0 113.489 -178.477 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.451 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -131.69 -161.45 1.13 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.933 177.766 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 6.5 m -154.37 89.07 1.25 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.084 0.468 . . . . 0.0 111.122 179.104 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -118.54 170.86 8.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.436 179.324 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.561 ' O ' HG22 ' A' ' 126' ' ' ILE . 22.1 mm . . . . . 0 C--N 1.323 -0.575 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.825 -179.976 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.9 mtm180 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.885 0.374 . . . . 0.0 110.772 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.658 ' HD3' HG23 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -70.85 -176.38 1.32 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.071 -179.716 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.457 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 51.1 m -108.54 160.82 25.78 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.751 179.958 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 38.6 Cg_endo -67.27 172.96 9.3 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.51 2.14 . . . . 0.0 112.255 -179.777 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.425 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 2.4 t -50.97 111.55 2.36 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.969 -179.57 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.546 ' HB3' HD11 ' A' ' 31' ' ' ILE . 9.9 Cg_endo -56.66 144.26 86.57 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.192 1.928 . . . . 0.0 111.944 179.724 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.902 ' O ' HD11 ' A' ' 20' ' ' LEU . 3.0 mtt85 -51.61 159.3 0.78 Allowed 'General case' 0 CA--C 1.517 -0.288 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.071 178.901 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.15 -174.21 2.41 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.179 0.514 . . . . 0.0 111.709 -177.918 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.441 HG23 ' C ' ' A' ' 18' ' ' GLY . 2.7 tt -144.36 139.78 24.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.526 -179.726 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -87.08 -48.07 8.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.667 -178.486 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.442 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 1.3 m120 -94.25 25.96 3.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.055 -178.822 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.441 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -157.42 -170.37 22.22 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.816 -179.625 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -141.45 130.82 23.69 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.661 0.267 . . . . 0.0 110.638 179.882 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.902 HD11 ' O ' ' A' ' 13' ' ' ARG . 10.6 mt -73.2 156.61 38.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.188 0.518 . . . . 0.0 111.719 -179.496 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 32' ' ' THR . 0.8 OUTLIER -132.14 73.01 1.51 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.506 177.517 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.924 ' HA ' HG23 ' A' ' 31' ' ' ILE . 68.5 mt -69.16 101.72 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.722 -177.183 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -103.84 17.11 50.02 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.953 177.735 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 29' ' ' SER . . . 157.43 126.15 0.89 Allowed Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.146 -179.697 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.658 HG23 ' HD3' ' A' ' 8' ' ' ARG . 33.3 m -116.71 19.02 7.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 111.631 0.234 . . . . 0.0 111.631 -179.298 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 14.0 t70 -88.03 164.66 15.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.953 0.406 . . . . 0.0 110.847 179.594 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.653 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 4.0 t80 -61.72 91.75 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.787 179.881 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 124.88 12.25 4.08 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.0 179.909 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 1.2 m -96.0 -172.2 2.51 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.869 0.334 . . . . 0.0 110.479 179.289 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 47' ' ' SER . 19.3 p -155.49 147.27 23.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.054 0.454 . . . . 0.0 111.398 179.852 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.924 HG23 ' HA ' ' A' ' 22' ' ' ILE . 1.0 OUTLIER -106.82 171.42 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.669 179.631 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.489 ' H ' HG22 ' A' ' 31' ' ' ILE . 0.1 OUTLIER -131.9 113.52 13.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.012 0.434 . . . . 0.0 111.261 179.499 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.83 ' CE2' HD21 ' A' ' 20' ' ' LEU . 20.6 m-85 -89.19 136.35 33.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.229 -179.813 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.401 ' O ' ' HA3' ' A' ' 18' ' ' GLY . 6.7 m -139.71 158.05 44.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.796 -179.974 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.462 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 31.3 m -87.75 157.74 18.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.949 0.404 . . . . 0.0 110.984 179.9 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.48 -92.72 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.88 -179.359 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -147.48 131.0 16.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.824 0.345 . . . . 0.0 110.834 -179.648 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.586 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 68.47 23.21 75.19 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.917 -178.831 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.491 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.0 m-85 -116.18 168.36 10.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.797 0.332 . . . . 0.0 110.994 -179.183 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.892 ' CD2' HD11 ' A' ' 42' ' ' ILE . 2.2 p-80 -130.56 124.32 31.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.55 178.248 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.918 HD21 ' O ' ' A' ' 44' ' ' GLU . 5.4 tt -87.99 124.54 33.83 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.725 -179.622 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.892 HD11 ' CD2' ' A' ' 40' ' ' HIS . 2.1 mm -102.62 165.09 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.006 0.432 . . . . 0.0 111.071 -179.893 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.463 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 74.65 -136.15 20.47 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.241 -179.458 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.918 ' O ' HD21 ' A' ' 41' ' ' LEU . 1.9 pt-20 -74.54 -173.22 1.71 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.767 0.318 . . . . 0.0 110.534 179.197 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.8 p -163.42 24.31 0.08 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.219 -179.502 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.471 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -166.98 125.7 1.37 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.524 -177.554 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.456 ' CB ' ' HA ' ' A' ' 62' ' ' GLU . 0.4 OUTLIER -92.13 138.72 31.3 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 177.492 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.552 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 2.1 m-85 -116.46 119.71 36.49 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 119.446 -0.902 . . . . 0.0 111.765 179.88 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 26.8 t -70.01 112.8 6.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.756 179.537 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.418 ' OE2' ' ND2' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -139.76 -171.55 3.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 179.741 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.653 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -100.78 143.12 31.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.034 -179.558 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -64.9 -148.02 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.421 179.76 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.09 -38.19 12.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.824 0.345 . . . . 0.0 110.861 179.922 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.6 p -97.9 25.28 6.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.835 179.797 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.14 21.95 64.19 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.218 -179.517 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.7 -175.03 5.34 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.063 0.459 . . . . 0.0 111.433 -179.047 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 6.7 mtt -105.68 129.66 53.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.096 178.474 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.2 m -148.93 176.45 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.188 -178.755 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.535 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 65.7 m95 -132.15 125.73 31.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.02 179.813 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.552 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 3.2 m-20 -68.8 168.38 15.22 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.127 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.494 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 19.0 Cg_exo -10.66 88.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.043 1 C-N-CA 125.342 4.028 . . . . 0.0 114.783 -179.032 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.469 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 1.0 OUTLIER -83.82 -97.97 0.05 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.631 -177.381 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.474 ' HA ' ' CD2' ' A' ' 33' ' ' TYR . . . -84.65 110.29 26.34 Favored Pre-proline 0 C--O 1.231 0.096 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -175.903 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.849 ' HG2' HD11 ' A' ' 41' ' ' LEU . 5.0 Cg_exo -78.53 -153.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.918 2.412 . . . . 0.0 111.086 177.025 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.527 HG22 ' H ' ' A' ' 66' ' ' CYS . 3.8 mm -93.83 167.68 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.672 0.272 . . . . 0.0 110.368 177.929 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.527 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -165.43 135.07 3.5 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.017 -179.968 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -156.38 178.38 10.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.955 -179.794 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.491 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 52.9 p -86.1 113.2 21.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.981 179.982 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.726 HG23 ' HB3' ' A' ' 40' ' ' HIS . 0.1 OUTLIER -43.54 98.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.589 -179.907 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.443 ' HE3' ' CG2' ' A' ' 90' ' ' THR . 1.3 mmtp -72.08 107.93 5.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.1 179.852 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.419 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -93.37 125.26 37.87 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.818 0.342 . . . . 0.0 110.159 178.578 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.88 -156.02 0.06 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.478 179.807 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.426 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 1.7 t -48.8 138.24 12.54 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.084 -179.854 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.512 ' HG2' HG11 ' A' ' 95' ' ' VAL . 25.3 Cg_exo -61.11 163.34 17.02 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.372 2.048 . . . . 0.0 112.035 179.764 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.532 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 82.7 Cg_exo -38.75 156.43 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.895 2.396 . . . . 0.0 112.903 -179.274 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.5 m -109.78 89.76 3.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.484 179.315 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.678 HG23 ' HE2' ' A' ' 97' ' ' TYR . 32.7 pt -69.09 175.22 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.09 -179.318 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.71 145.94 24.9 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.399 178.605 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.533 ' HB3' ' CD2' ' A' ' 103' ' ' TYR . 3.0 m120 59.46 28.74 18.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.895 0.379 . . . . 0.0 111.104 177.876 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -170.48 -161.68 21.48 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.644 -0.788 . . . . 0.0 113.092 179.634 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' ' 98' ' ' SER . 1.4 ptt85 -170.18 -175.22 1.92 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.972 0.415 . . . . 0.0 110.984 -178.79 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 12.2 p80 -105.05 176.43 5.16 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.982 179.874 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.424 ' ND2' ' HB ' ' A' ' 96' ' ' THR . 0.2 OUTLIER -131.73 80.62 1.93 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.543 179.138 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -110.88 150.93 17.77 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.189 -1.005 . . . . 0.0 112.53 -179.845 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -106.35 -27.95 10.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.033 0.444 . . . . 0.0 110.546 179.747 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.27 -172.15 2.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.814 179.852 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -111.46 -19.84 12.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.084 179.324 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.414 ' HB3' ' HD3' ' A' ' 70' ' ' LYS . 7.3 m-85 -138.27 167.72 21.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.96 0.41 . . . . 0.0 111.251 -179.557 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.419 ' N ' ' O ' ' A' ' 71' ' ' CYS . 62.5 m-85 -144.09 163.52 33.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.491 179.843 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.443 ' CG2' ' HE3' ' A' ' 70' ' ' LYS . 16.0 p -128.22 179.93 5.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.906 0.384 . . . . 0.0 111.349 -179.228 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.1 p-10 -64.48 94.75 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.267 0.556 . . . . 0.0 110.864 -179.926 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.34 28.05 1.04 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.116 179.085 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.433 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -106.0 161.5 14.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.679 0.276 . . . . 0.0 110.522 179.125 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 35.3 m -134.07 152.24 33.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.215 0.531 . . . . 0.0 111.441 -179.567 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.542 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 21.6 t -150.88 147.27 15.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.618 179.27 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.516 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -103.83 144.72 31.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.114 178.574 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.92 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.7 m-85 -100.5 156.76 17.1 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.596 179.941 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 81' ' ' ARG . 51.8 p -153.18 143.88 22.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.349 -178.82 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.482 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 23.3 m -69.52 164.88 22.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.086 -178.844 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -94.88 -84.78 0.32 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.878 178.913 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.35 -41.07 79.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.495 -179.259 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 147.07 42.56 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.644 -179.978 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.533 ' CD2' ' HB3' ' A' ' 79' ' ' ASN . 23.3 m-85 -80.14 -165.85 0.92 Allowed 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 122.355 0.262 . . . . 0.0 110.601 179.962 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 124' ' ' CYS . 4.3 m -120.64 107.53 12.92 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.798 0.332 . . . . 0.0 111.719 -179.967 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.446 HD23 ' HB2' ' A' ' 122' ' ' PRO . 1.4 tp -48.33 117.12 1.82 Allowed 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.334 177.83 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.469 ' HB ' ' CB ' ' A' ' 123' ' ' THR . 44.9 mm -91.53 154.34 3.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.036 -178.859 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.424 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 60.55 -128.88 46.29 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.082 -179.399 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -114.11 127.23 55.82 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.878 0.37 . . . . 0.0 110.819 179.35 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.516 ' HB2' HG22 ' A' ' 96' ' ' THR . 0.1 OUTLIER -64.01 -28.12 69.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.769 179.741 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.31 144.9 41.72 Favored Glycine 0 N--CA 1.452 -0.256 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.822 -179.919 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.92 HG21 ' CE1' ' A' ' 97' ' ' TYR . 3.4 t -140.52 127.51 22.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.544 0.211 . . . . 0.0 110.989 -179.959 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.45 128.87 34.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.911 0.386 . . . . 0.0 111.524 -179.51 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.511 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 24.7 t -91.98 104.69 17.07 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.513 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.2 t -150.89 163.95 37.47 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.146 0.498 . . . . 0.0 111.596 -177.976 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 45.29 32.21 3.58 Favored Glycine 0 N--CA 1.453 -0.219 0 CA-C-N 115.54 -0.754 . . . . 0.0 113.096 179.557 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.464 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 67.92 13.17 63.65 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.696 -179.994 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -143.17 171.42 14.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.84 0.353 . . . . 0.0 110.267 179.292 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.542 ' CZ3' HG23 ' A' ' 95' ' ' VAL . 87.8 m95 -108.43 131.92 54.29 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.885 -179.364 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.99 149.81 34.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.066 0.46 . . . . 0.0 111.234 -179.154 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.493 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER 70.43 44.88 0.24 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.231 179.057 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 73.6 Cg_endo -76.9 140.56 20.55 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.266 1.977 . . . . 0.0 111.215 177.834 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.509 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 36.4 Cg_endo -91.78 -179.55 1.29 Allowed 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.453 2.102 . . . . 0.0 113.255 -178.679 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.469 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -118.77 -162.34 0.89 Allowed 'General case' 0 CA--C 1.502 -0.885 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.041 176.278 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 124' ' ' CYS . . . . . 0.44 ' SG ' ' HB2' ' A' ' 103' ' ' TYR . 4.9 t -170.39 91.72 0.18 Allowed 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 119.901 -0.72 . . . . 0.0 111.265 -176.486 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -116.2 174.79 5.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.042 -178.685 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.527 HG12 ' CE1' ' A' ' 103' ' ' TYR . 46.7 mm . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.865 -179.881 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.81 0.338 . . . . 0.0 110.712 . . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.486 ' HB3' HG23 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -86.75 170.1 12.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.14 -178.875 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.46 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 48.0 m -80.99 161.22 63.95 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.813 179.68 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 54.7 Cg_endo -69.77 172.47 12.59 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.355 2.037 . . . . 0.0 111.337 178.773 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.428 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 3.1 p -50.93 117.66 8.97 Favored Pre-proline 0 C--N 1.328 -0.327 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.913 -179.19 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.552 ' HB3' HD11 ' A' ' 31' ' ' ILE . 17.8 Cg_endo -58.71 161.66 14.55 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.708 2.272 . . . . 0.0 112.348 -179.874 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.562 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -61.92 179.92 0.24 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.105 178.744 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.33 -171.07 2.73 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.015 0.436 . . . . 0.0 111.321 -179.678 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.573 HG22 ' CD2' ' A' ' 20' ' ' LEU . 11.0 tt -152.56 150.15 13.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.798 -179.743 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -95.45 -52.39 4.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.111 -179.519 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.43 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 2.3 m-20 -94.17 42.05 1.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.122 0.487 . . . . 0.0 110.819 -179.85 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.409 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -169.67 -169.74 33.29 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.429 179.806 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -148.14 130.09 15.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.667 0.27 . . . . 0.0 110.785 -179.505 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.815 HD21 ' CE1' ' A' ' 33' ' ' TYR . 19.5 mt -78.52 161.35 27.1 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.271 0.558 . . . . 0.0 111.72 -179.674 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -132.09 74.16 1.57 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.269 177.523 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.853 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.7 OUTLIER -80.75 107.55 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.86 -176.794 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.31 14.65 56.75 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.988 177.464 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 158.74 155.23 7.52 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.151 -179.62 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.486 HG23 ' HB3' ' A' ' 8' ' ' ARG . 31.2 m -132.72 8.42 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -179.52 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 0.7 OUTLIER -72.72 154.7 40.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.804 0.335 . . . . 0.0 111.009 -179.9 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.595 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 6.0 t80 -50.44 92.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.874 -179.949 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 128.25 -5.16 6.79 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.784 -179.732 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.39 -175.51 0.65 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.903 0.352 . . . . 0.0 110.787 179.92 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.1 p -157.45 139.59 14.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.093 179.776 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.853 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.4 OUTLIER -107.51 170.15 2.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.478 -179.884 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.702 HG23 ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -134.35 115.92 14.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.893 0.378 . . . . 0.0 110.986 179.58 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.815 ' CE1' HD21 ' A' ' 20' ' ' LEU . 23.0 m-85 -93.09 138.02 31.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.361 -179.067 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.83 170.13 16.27 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.782 179.847 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.429 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 50.9 m -91.03 163.39 14.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.858 0.361 . . . . 0.0 111.188 -179.639 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.405 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 1.5 m-20 -62.69 -82.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.255 -179.655 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.39 136.48 13.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.852 -179.702 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.52 23.05 64.42 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.107 -179.42 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.512 ' CE2' ' HB3' ' A' ' 68' ' ' SER . 2.5 m-30 -116.64 174.25 6.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.95 0.405 . . . . 0.0 111.135 -179.273 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.503 ' CE1' HD11 ' A' ' 42' ' ' ILE . 1.5 p-80 -134.91 123.67 23.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.995 177.453 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.947 HD11 ' HG2' ' A' ' 64' ' ' PRO . 10.2 tt -80.32 144.23 32.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.838 -178.531 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.709 HD13 ' C ' ' A' ' 41' ' ' LEU . 1.9 mm -124.73 152.12 30.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.942 -179.865 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.62 -127.34 7.99 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.039 -179.165 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.852 ' O ' HD21 ' A' ' 41' ' ' LEU . 7.0 pm0 -85.29 167.85 15.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.82 0.343 . . . . 0.0 110.568 178.887 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.8 p -150.8 21.07 0.79 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.898 179.609 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.702 ' HG2' HG23 ' A' ' 32' ' ' THR . 0.0 OUTLIER -163.95 124.37 2.16 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.278 -179.299 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.45 ' HB3' ' CG ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -102.18 156.37 17.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.635 -179.269 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.462 ' CB ' ' HB2' ' A' ' 60' ' ' ASN . 1.7 m-85 -132.45 123.78 27.33 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 119.937 -0.705 . . . . 0.0 112.508 -178.192 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 35.5 t -70.14 95.68 1.0 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.38 178.305 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.5 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 3.7 tt0 -128.01 171.22 12.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.495 0.664 . . . . 0.0 111.033 -179.071 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.745 HD23 ' O ' ' A' ' 56' ' ' SER . 1.3 mt -65.36 161.54 19.48 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.366 -179.784 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 56' ' ' SER . . . -102.23 -116.23 4.1 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.509 179.891 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.6 t -122.56 -46.16 2.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.773 0.32 . . . . 0.0 110.897 179.88 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.8 p -93.34 51.01 1.56 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.842 179.936 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 52.32 39.95 52.35 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.474 -179.952 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.745 ' O ' HD23 ' A' ' 51' ' ' LEU . 25.4 t -117.56 170.81 8.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.791 0.329 . . . . 0.0 110.849 179.855 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -98.53 125.28 43.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.091 -179.307 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.2 m -125.97 -169.22 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.687 179.457 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.52 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 73.2 m95 -130.45 130.49 44.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.953 0.406 . . . . 0.0 111.819 -179.193 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.469 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.9 OUTLIER -76.45 166.98 40.68 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.483 177.227 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.469 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 42.9 Cg_exo -11.91 96.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.774 1 C-N-CA 125.646 4.231 . . . . 0.0 115.242 -178.574 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.45 ' CG ' ' HB3' ' A' ' 47' ' ' SER . 36.6 mt-10 -100.79 -98.65 0.25 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.951 -178.147 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.468 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -70.67 107.04 2.09 Favored Pre-proline 0 N--CA 1.462 0.167 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -176.545 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.947 ' HG2' HD11 ' A' ' 41' ' ' LEU . 2.3 Cg_endo -89.45 -156.94 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.512 2.808 . . . . 0.0 111.223 177.723 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.63 HD12 ' HB ' ' A' ' 42' ' ' ILE . 1.0 OUTLIER -93.08 173.26 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.931 0.396 . . . . 0.0 110.393 177.904 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.591 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -171.36 142.65 1.72 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.013 179.622 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -169.49 172.09 7.27 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.805 179.458 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.512 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 34.0 p -80.41 126.87 31.73 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.646 179.583 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.448 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 1.3 p -41.51 97.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.584 -179.499 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.437 ' HD2' ' HB3' ' A' ' 88' ' ' PHE . 13.7 mmtp -66.72 129.78 40.99 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.945 -178.468 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.8 115.93 26.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.538 177.166 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.32 -163.41 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.957 -178.658 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.432 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 1.6 t -45.15 135.27 5.25 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.324 -179.194 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.595 ' HG2' HG11 ' A' ' 95' ' ' VAL . 31.6 Cg_exo -58.96 160.98 16.71 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.364 2.043 . . . . 0.0 112.006 -179.9 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.43 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 87.0 Cg_exo -40.86 156.76 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.795 2.33 . . . . 0.0 112.975 -179.135 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.72 89.84 3.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.783 179.9 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.67 HG21 ' O ' ' A' ' 122' ' ' PRO . 25.8 pt -69.47 178.75 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.551 -179.201 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.4 m -100.48 145.41 28.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.645 179.411 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' ' 124' ' ' CYS . 3.3 m-80 58.55 26.78 14.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.904 179.776 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.464 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -165.87 -164.47 21.41 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.378 179.933 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 98' ' ' SER . 7.7 ptt85 -167.83 -175.86 2.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.151 0.5 . . . . 0.0 111.102 -179.4 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 14.6 p80 -110.76 166.15 11.25 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.661 178.832 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -92.02 -86.48 0.23 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.37 179.247 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.432 ' HA3' ' OH ' ' A' ' 89' ' ' TYR . . . 60.62 139.51 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.261 178.3 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -112.29 -29.78 7.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.1 0.476 . . . . 0.0 110.652 179.137 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.62 -172.26 2.21 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.763 179.682 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -102.45 -20.92 14.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.168 179.694 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.437 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 8.2 m-85 -133.84 176.56 8.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.194 -179.993 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.436 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 62.5 m-85 -151.0 160.47 43.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.593 -179.913 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.434 ' CG2' ' OG ' ' A' ' 68' ' ' SER . 36.9 p -126.81 -177.24 3.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.022 0.439 . . . . 0.0 111.518 -179.048 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 20.4 p-10 -65.47 94.07 0.17 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.007 -179.805 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 127.1 30.59 0.79 Allowed Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.336 -0.847 . . . . 0.0 113.074 178.817 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.434 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.5 OUTLIER -109.92 160.32 16.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.773 0.32 . . . . 0.0 110.632 179.324 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 34.7 m -136.26 150.97 28.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.132 0.491 . . . . 0.0 111.216 -179.603 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.595 HG11 ' HG2' ' A' ' 74' ' ' PRO . 21.8 t -145.54 148.52 17.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.753 179.686 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.786 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -110.91 123.38 50.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.012 -179.787 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.972 ' CE2' HG21 ' A' ' 111' ' ' VAL . 5.6 m-85 -79.82 156.68 27.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.752 -179.709 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 81' ' ' ARG . 3.9 p -149.86 148.97 29.8 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.914 0.388 . . . . 0.0 112.03 -177.973 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.538 ' HB3' ' HB2' ' A' ' 103' ' ' TYR . 21.2 m -68.8 154.75 41.43 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.541 179.832 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.464 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 85.4 m-20 -73.94 -87.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.111 -177.992 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.43 -43.77 26.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.64 0.257 . . . . 0.0 111.687 -177.642 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 178.44 32.17 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.352 -0.928 . . . . 0.0 113.112 -177.548 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.546 ' CZ ' HG12 ' A' ' 126' ' ' ILE . 0.8 OUTLIER -72.95 -161.81 0.1 Allowed 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.611 -0.295 . . . . 0.0 110.39 -179.524 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' A' ' 124' ' ' CYS . 3.1 t -141.46 117.56 10.62 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.962 0.411 . . . . 0.0 110.77 177.44 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.745 HD22 ' HB2' ' A' ' 109' ' ' SER . 0.2 OUTLIER -58.9 140.4 55.44 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.836 0.826 . . . . 0.0 112.063 -178.119 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.445 HG22 ' N ' ' A' ' 107' ' ' GLY . 37.4 mm -110.24 158.37 10.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 114.057 -1.429 . . . . 0.0 110.075 179.154 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.445 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 63.96 -125.42 32.43 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.034 -179.158 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -123.33 130.76 53.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.856 0.36 . . . . 0.0 110.837 179.38 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.786 ' OG ' HG22 ' A' ' 96' ' ' THR . 2.7 t -66.18 -31.1 71.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.865 179.879 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.4 138.28 30.38 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.049 -179.407 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.972 HG21 ' CE2' ' A' ' 97' ' ' TYR . 2.9 t -134.4 119.44 30.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.64 0.257 . . . . 0.0 110.744 179.024 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.84 125.71 30.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.923 0.392 . . . . 0.0 111.629 -179.114 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.507 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 14.9 t -91.82 105.76 17.96 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 176.176 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.1 OUTLIER -148.69 163.09 38.34 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.109 0.48 . . . . 0.0 111.36 -178.495 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.2 30.91 4.3 Favored Glycine 0 CA--C 1.517 0.187 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.731 179.865 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.448 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 68.91 16.03 69.93 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.599 -179.525 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -141.28 -179.18 5.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.905 0.383 . . . . 0.0 110.68 179.72 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.536 ' CZ3' HG23 ' A' ' 95' ' ' VAL . 94.9 m95 -116.63 142.71 46.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.919 -179.85 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.74 147.35 49.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.142 -179.762 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.487 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER 70.17 45.66 0.26 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.153 179.122 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 98.0 Cg_endo -77.9 133.68 12.72 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.372 2.048 . . . . 0.0 111.295 177.782 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.67 ' O ' HG21 ' A' ' 77' ' ' ILE . 93.7 Cg_endo -93.22 -173.15 0.37 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.475 2.117 . . . . 0.0 113.714 -177.824 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.43 -170.01 2.21 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-N 114.054 -1.43 . . . . 0.0 108.582 176.359 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 124' ' ' CYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 104' ' ' SER . 2.5 t -161.2 105.93 1.34 Allowed 'General case' 0 N--CA 1.424 -1.756 0 CA-C-O 122.127 0.965 . . . . 0.0 110.879 -177.667 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -112.14 152.9 27.77 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 113.491 -1.686 . . . . 0.0 110.329 -179.685 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.682 ' O ' HG22 ' A' ' 126' ' ' ILE . 5.0 mm . . . . . 0 C--N 1.32 -0.712 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.953 179.828 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 121.015 0.436 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.415 ' HD2' HG23 ' A' ' 25' ' ' VAL . 35.5 mtm180 -76.67 171.38 14.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.79 179.705 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.457 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 29.6 m -84.55 159.82 57.69 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.576 179.56 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.5 169.79 17.75 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.543 2.162 . . . . 0.0 112.527 -179.07 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.425 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 3.4 t -51.38 105.63 0.55 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.836 179.89 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 11' ' ' SER . 12.7 Cg_endo -58.5 144.79 96.54 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.044 1.829 . . . . 0.0 111.768 179.699 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.928 ' O ' HD11 ' A' ' 20' ' ' LEU . 3.0 mtt180 -45.45 122.81 3.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.412 0.625 . . . . 0.0 111.343 -179.341 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.663 ' O ' HG22 ' A' ' 15' ' ' ILE . 0.2 OUTLIER -73.91 -7.4 52.18 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.213 -178.932 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.663 HG22 ' O ' ' A' ' 14' ' ' ASP . 18.2 tt 51.72 159.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 121.353 0.597 . . . . 0.0 112.089 -178.803 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.433 ' N ' HG12 ' A' ' 15' ' ' ILE . 7.0 t0 -100.56 159.07 15.45 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.632 177.484 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.496 ' HB2' ' CD2' ' A' ' 39' ' ' TYR . 0.0 OUTLIER 42.82 29.32 0.17 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.77 0.319 . . . . 0.0 111.222 -179.408 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.425 ' HA2' ' N ' ' A' ' 36' ' ' ASN . . . -152.12 176.72 30.3 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.74 -179.42 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -142.56 140.12 31.63 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.673 0.273 . . . . 0.0 110.696 179.938 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.928 HD11 ' O ' ' A' ' 13' ' ' ARG . 52.0 mt -88.99 155.52 19.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.305 0.574 . . . . 0.0 112.096 -178.888 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -124.11 79.03 1.69 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.268 177.181 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.908 ' HA ' HG23 ' A' ' 31' ' ' ILE . 1.3 mt -75.29 107.71 6.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.36 -176.096 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -109.75 20.8 26.55 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.191 175.869 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 154.63 124.8 0.94 Allowed Glycine 0 C--N 1.334 0.444 0 N-CA-C 111.799 -0.52 . . . . 0.0 111.799 -178.948 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.495 HG13 ' CG2' ' A' ' 22' ' ' ILE . 28.7 m -120.4 32.49 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -178.504 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.3 OUTLIER -100.9 151.05 22.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.843 0.354 . . . . 0.0 110.921 179.372 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.523 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 8.1 t80 -49.57 91.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.938 179.996 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 129.5 1.73 5.53 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.997 -179.807 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.37 -164.27 1.16 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 117.052 0.426 . . . . 0.0 110.669 179.677 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.4 p -160.01 153.19 21.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.958 0.409 . . . . 0.0 111.164 179.475 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.908 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.8 OUTLIER -114.01 175.0 2.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.442 -179.972 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.458 ' H ' HG22 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -130.74 120.31 23.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.79 0.329 . . . . 0.0 110.706 178.638 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.461 ' CE2' HD21 ' A' ' 20' ' ' LEU . 19.4 m-85 -96.69 144.67 26.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.301 0.572 . . . . 0.0 112.215 -177.897 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.02 165.33 31.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.287 179.224 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.416 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 1.3 m -85.17 159.41 20.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.878 0.37 . . . . 0.0 110.928 -179.6 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.429 ' ND2' ' HA ' ' A' ' 17' ' ' ASN . 8.7 m-20 -59.76 -86.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.272 -178.68 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.3 t -153.02 132.22 12.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.896 0.379 . . . . 0.0 110.938 -179.979 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.72 22.6 73.69 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.036 -179.396 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.496 ' CD2' ' HB2' ' A' ' 17' ' ' ASN . 2.5 m-30 -114.81 -174.14 2.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.96 0.409 . . . . 0.0 110.902 -179.649 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 1.067 ' CD2' HD11 ' A' ' 42' ' ' ILE . 1.9 p-80 -145.1 113.59 6.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.878 177.635 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.98 HD21 ' O ' ' A' ' 44' ' ' GLU . 6.5 tt -79.4 119.2 22.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.824 -178.631 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 1.067 HD11 ' CD2' ' A' ' 40' ' ' HIS . 2.0 mm -103.89 153.11 6.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.513 179.248 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.11 -127.46 8.21 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.989 179.626 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.98 ' O ' HD21 ' A' ' 41' ' ' LEU . 1.3 mt-10 -79.7 179.53 7.47 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.484 0.659 . . . . 0.0 112.618 -177.899 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.425 ' HA ' ' HB2' ' A' ' 33' ' ' TYR . 4.8 p -165.84 27.52 0.05 OUTLIER 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.005 -179.857 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.416 ' CG ' ' O ' ' A' ' 45' ' ' SER . 3.0 mtpt -166.83 123.73 1.24 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -177.774 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.45 ' HB3' HG13 ' A' ' 31' ' ' ILE . 5.8 t -94.07 152.23 18.93 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.103 177.496 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.547 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.1 m-85 -124.63 105.36 9.27 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.736 177.539 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.464 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 27.6 t -58.59 101.05 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.509 179.677 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.01 -171.08 2.22 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.164 -179.172 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.523 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -96.21 151.73 19.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.055 -179.375 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -75.84 -143.07 1.18 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.437 179.921 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.3 t -95.19 -40.19 9.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.794 0.33 . . . . 0.0 110.924 179.894 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.5 p -101.63 36.63 2.0 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.905 179.778 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.8 24.39 76.72 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.373 -179.823 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.94 -162.01 0.64 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.848 0.356 . . . . 0.0 110.891 -179.991 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.4 mmt -117.2 134.0 55.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.448 179.438 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.4 m -148.4 173.88 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.959 -179.537 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.622 ' CZ3' HD11 ' A' ' 31' ' ' ILE . 74.0 m95 -126.29 124.68 40.88 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.147 -179.907 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.547 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.7 OUTLIER -68.98 166.84 24.06 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 177.368 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.478 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 78.3 Cg_exo -15.07 88.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 125.229 3.953 . . . . 0.0 114.253 -179.408 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.446 ' HA ' ' HB2' ' A' ' 47' ' ' SER . 1.0 OUTLIER -92.73 -93.41 0.15 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.244 -177.43 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.23 106.06 1.32 Allowed Pre-proline 0 C--O 1.231 0.125 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -177.118 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.667 ' HG2' HD11 ' A' ' 41' ' ' LEU . 1.9 Cg_endo -84.43 -153.6 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.993 2.462 . . . . 0.0 110.576 178.059 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.466 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 3.4 mm -86.77 161.32 2.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.994 0.426 . . . . 0.0 111.105 179.911 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.406 ' HB3' ' OD1' ' A' ' 17' ' ' ASN . 0.8 OUTLIER -169.76 130.9 1.05 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.965 179.491 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -154.92 175.61 13.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.665 179.576 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.476 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 1.7 p -87.39 121.75 30.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.295 179.053 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.471 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 1.6 p -41.92 94.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 120.971 0.415 . . . . 0.0 111.299 -179.591 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.427 ' HD2' ' HB3' ' A' ' 88' ' ' PHE . 2.7 mmtt -79.63 140.37 37.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.835 -177.85 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.424 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -116.89 122.34 44.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.977 178.544 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -69.36 -164.66 0.06 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.935 -178.993 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 2.0 t -49.1 136.16 14.86 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.814 -179.504 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.48 ' HG3' ' CZ2' ' A' ' 118' ' ' TRP . 24.3 Cg_exo -59.48 155.71 40.19 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.119 1.879 . . . . 0.0 111.675 179.905 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.434 ' HG2' ' HD3' ' A' ' 121' ' ' PRO . 95.9 Cg_exo -44.17 164.46 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.984 2.456 . . . . 0.0 113.237 -178.458 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 83.0 p -113.04 90.49 3.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.592 179.697 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.2 pt -68.74 172.88 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.942 -179.623 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.0 133.77 35.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.086 -179.555 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.504 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 0.1 OUTLIER 66.78 28.09 9.01 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.707 179.872 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.421 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -163.64 -177.99 36.93 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.287 -0.959 . . . . 0.0 113.187 -179.833 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.71 -175.76 5.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.815 0.34 . . . . 0.0 110.301 179.757 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.503 ' HB3' ' CE2' ' A' ' 97' ' ' TYR . 4.0 p-80 -120.78 161.6 21.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.07 0.462 . . . . 0.0 111.545 179.993 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -92.37 -171.7 2.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.905 -179.904 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 85' ' ' TYR . . . 88.79 -66.52 3.12 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.686 -0.769 . . . . 0.0 111.884 -178.994 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.451 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 4.0 m-85 66.56 30.36 8.49 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-O 121.483 0.658 . . . . 0.0 109.985 179.732 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -87.97 -173.47 4.28 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.014 179.014 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.09 -23.27 11.38 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.847 0.356 . . . . 0.0 110.812 178.947 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.427 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 9.7 m-85 -153.74 161.34 42.19 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.239 -179.72 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.443 ' CZ ' ' HB2' ' A' ' 86' ' ' GLU . 21.1 m-85 -141.43 163.39 33.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.797 179.358 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.7 p -122.77 165.57 16.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.042 0.449 . . . . 0.0 111.901 -177.758 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 5.6 p-10 -56.55 98.32 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.697 179.767 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 128.44 12.47 2.79 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.097 -0.956 . . . . 0.0 113.071 179.555 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.79 161.58 13.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.945 0.372 . . . . 0.0 110.399 179.211 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 30.2 m -141.35 147.39 22.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.113 0.482 . . . . 0.0 110.782 -179.913 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.55 HG23 ' CH2' ' A' ' 118' ' ' TRP . 43.7 t -136.94 151.32 27.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.56 179.561 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.972 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -108.2 129.29 55.2 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.977 -179.565 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.977 ' CE2' HG21 ' A' ' 111' ' ' VAL . 6.0 m-85 -92.97 155.65 17.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.081 -179.525 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.1 p -149.16 139.33 22.21 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.443 -179.308 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 52.0 m -69.67 152.87 44.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.676 179.178 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.421 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 26.9 m-20 -92.67 -70.41 0.7 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.237 -179.383 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 36.8 m -55.5 -23.36 25.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.151 -179.683 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 118.77 30.7 1.59 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.344 -179.752 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.504 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 18.8 m-85 -71.39 -173.13 0.84 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.882 0.372 . . . . 0.0 110.774 179.986 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.69 103.89 11.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.296 -179.386 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.637 HD21 ' HG2' ' A' ' 122' ' ' PRO . 2.1 tp -42.62 115.89 0.78 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.419 179.21 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.456 ' HB ' ' CB ' ' A' ' 123' ' ' THR . 46.7 mm -91.01 153.58 3.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.277 179.555 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 65.41 -121.83 21.52 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.084 -1.055 . . . . 0.0 111.502 -178.09 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.0 m-20 -136.91 120.81 17.55 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.059 0.457 . . . . 0.0 111.207 178.759 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.972 ' OG ' HG22 ' A' ' 96' ' ' THR . 2.0 p -51.21 -26.6 7.29 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.95 179.326 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.46 119.13 10.86 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.849 -179.376 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.977 HG21 ' CE2' ' A' ' 97' ' ' TYR . 2.5 t -113.53 116.19 51.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 178.796 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.25 120.1 23.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.006 0.432 . . . . 0.0 111.828 -177.382 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.469 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 16.1 t -89.35 94.86 10.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.502 176.591 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.4 OUTLIER -136.17 159.43 41.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.33 -178.123 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.449 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 46.68 29.51 4.2 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.702 179.85 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.471 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 70.09 20.94 76.81 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.267 -179.42 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -142.85 170.85 14.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.833 0.349 . . . . 0.0 110.376 179.299 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.55 ' CH2' HG23 ' A' ' 95' ' ' VAL . 97.4 m95 -112.34 126.64 55.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.35 -179.192 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.48 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -92.97 131.62 37.81 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.489 174.804 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.604 ' HB2' HG13 ' A' ' 111' ' ' VAL . 2.3 m-20 109.42 -135.87 0.0 OUTLIER Pre-proline 0 CA--C 1.474 -1.945 0 N-CA-C 100.432 -3.914 . . . . 0.0 100.432 -166.987 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.566 ' CA ' ' HB3' ' A' ' 120' ' ' ASP . 64.4 Cg_endo -65.41 179.23 12.83 Favored 'Cis proline' 0 C--N 1.308 -1.566 0 CA-C-N 125.258 2.914 . . . . 0.0 113.36 -14.08 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.637 ' HG2' HD21 ' A' ' 105' ' ' LEU . 10.4 Cg_endo -89.56 -174.9 0.97 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.692 2.928 . . . . 0.0 111.463 176.75 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.456 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -121.61 -179.51 4.12 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.83 179.045 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 124' ' ' CYS . . . . . 0.42 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 4.9 m -139.95 94.59 2.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.743 179.947 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -123.33 163.69 20.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.971 -179.474 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.48 HG12 ' CE2' ' A' ' 103' ' ' TYR . 41.1 mm . . . . . 0 C--N 1.325 -0.478 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.927 -179.917 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.774 0.321 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 80.2 mtm180 -89.12 168.55 12.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.952 179.826 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.46 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 48.7 m -92.4 159.86 36.09 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.839 179.864 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 36.9 Cg_endo -66.45 173.85 7.1 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.491 2.127 . . . . 0.0 112.156 -179.695 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.404 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -49.28 107.64 0.82 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.126 -179.47 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.487 ' CG ' ' CD1' ' A' ' 22' ' ' ILE . 9.4 Cg_endo -52.64 154.98 11.06 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.282 1.988 . . . . 0.0 111.824 179.728 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 18.8 mtt180 -80.24 164.91 22.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.257 0.551 . . . . 0.0 111.502 -178.794 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -118.88 -166.71 1.27 Allowed 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.042 -178.023 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.531 HD12 ' HD2' ' A' ' 64' ' ' PRO . 8.5 tt -142.8 155.51 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.566 179.113 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -85.81 -55.45 3.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -176.882 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.415 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 0.3 OUTLIER -92.71 28.3 2.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.632 0.254 . . . . 0.0 111.551 -177.352 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.429 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -167.16 -165.23 24.21 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.784 179.482 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.894 ' C ' HD23 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -132.91 175.36 9.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.621 0.248 . . . . 0.0 110.345 179.031 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.894 HD23 ' C ' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -122.46 157.83 31.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.153 0.501 . . . . 0.0 111.224 -179.964 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -126.94 84.77 2.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.926 178.805 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.854 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -82.98 97.1 4.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.992 -177.01 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.2 11.73 70.08 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.033 177.436 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 165.27 148.69 5.58 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.297 -179.72 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.0 m -129.88 13.87 2.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.948 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -93.52 151.06 19.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.694 0.283 . . . . 0.0 110.578 179.534 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -49.28 100.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.952 0.406 . . . . 0.0 110.758 179.96 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.26 0.41 6.89 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.603 -178.885 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.1 p -99.56 169.54 9.22 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.877 0.339 . . . . 0.0 110.481 179.443 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 47' ' ' SER . 4.4 p -143.27 138.74 29.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.078 0.466 . . . . 0.0 111.015 179.948 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.854 HG23 ' HA ' ' A' ' 22' ' ' ILE . 1.0 OUTLIER -92.84 173.67 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.634 178.949 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.45 ' H ' HG22 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -135.92 113.2 10.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.982 0.42 . . . . 0.0 111.331 -179.667 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.585 ' CE1' HD22 ' A' ' 20' ' ' LEU . 22.2 m-85 -89.27 140.87 29.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.883 179.696 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -147.14 146.31 29.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.731 -179.918 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.441 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 23.1 m -69.81 167.98 16.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.89 0.376 . . . . 0.0 111.001 -179.682 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -66.48 -78.5 0.06 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.006 -179.776 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -158.84 139.13 12.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.607 179.867 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.543 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 58.11 28.39 61.18 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.883 -179.002 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.491 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.1 m-85 -119.37 168.13 11.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.828 0.347 . . . . 0.0 111.09 -179.28 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.907 ' CD2' HD11 ' A' ' 42' ' ' ILE . 3.5 p-80 -127.39 117.08 21.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.404 177.806 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.919 HD21 ' O ' ' A' ' 44' ' ' GLU . 8.5 tt -81.97 126.03 31.47 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.778 -179.349 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.907 HD11 ' CD2' ' A' ' 40' ' ' HIS . 2.1 mm -105.62 164.46 4.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.116 -179.434 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.447 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 72.92 -132.26 16.94 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.507 179.986 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.919 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -81.92 -175.41 5.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.966 0.412 . . . . 0.0 110.759 179.575 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.419 ' O ' ' CG ' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -169.83 30.73 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.43 179.327 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.419 ' CG ' ' O ' ' A' ' 45' ' ' SER . 10.9 mtpt -166.91 114.47 0.82 Allowed 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.021 -178.315 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.486 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 0.4 OUTLIER -84.67 132.31 34.49 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 178.643 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.517 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.6 m-85 -107.1 120.74 42.91 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 119.514 -0.875 . . . . 0.0 111.516 -179.484 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.6 t -67.72 116.94 8.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.318 -179.035 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -158.5 179.66 8.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.371 179.413 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.633 ' C ' HD12 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -126.56 148.72 49.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.746 0.308 . . . . 0.0 110.818 179.6 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.616 ' N ' HD12 ' A' ' 51' ' ' LEU . . . 174.83 33.95 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.306 -0.949 . . . . 0.0 113.313 -179.498 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.42 ' HB3' ' HB3' ' A' ' 56' ' ' SER . 0.1 OUTLIER -120.97 71.41 0.94 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.069 0.461 . . . . 0.0 110.464 179.304 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.3 p 62.14 25.1 15.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.455 -178.842 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 104.3 18.44 13.32 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.462 -179.531 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.42 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 15.5 t -115.57 163.24 16.07 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.054 0.454 . . . . 0.0 111.089 179.903 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.42 ' HA ' ' HA ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -87.77 137.83 31.99 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.529 -178.998 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.2 m -135.16 -175.47 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.458 179.868 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.522 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 59.5 m95 -128.41 128.18 43.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.837 0.351 . . . . 0.0 110.975 179.61 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.517 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.7 OUTLIER -69.69 164.93 46.23 Favored Pre-proline 0 C--O 1.224 -0.271 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.971 178.515 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.447 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 79.2 Cg_exo -16.73 100.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.741 1 C-N-CA 125.32 4.014 . . . . 0.0 114.498 -178.932 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.471 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -104.22 -82.15 0.51 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.753 -177.916 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.476 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -77.08 107.13 4.37 Favored Pre-proline 0 N--CA 1.463 0.185 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -176.355 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.893 ' HG2' HD11 ' A' ' 41' ' ' LEU . 3.1 Cg_endo -90.52 -155.54 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.345 2.697 . . . . 0.0 111.172 178.257 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.512 HG22 ' H ' ' A' ' 66' ' ' CYS . 3.9 mm -97.23 165.82 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.872 0.367 . . . . 0.0 110.847 178.803 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.512 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.2 m -162.32 136.92 6.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.944 179.904 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.22 173.23 16.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.758 179.793 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.491 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 80.8 p -81.42 112.63 18.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.999 179.954 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.756 HG22 ' HB3' ' A' ' 40' ' ' HIS . 6.3 p -44.62 97.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.429 179.844 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -79.76 127.59 32.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.617 -179.024 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.441 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -113.48 119.86 39.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.917 178.336 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.57 -159.63 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.775 0.322 . . . . 0.0 110.597 -179.067 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.463 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 2.3 t -49.06 137.75 13.76 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.818 -179.864 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.449 ' HA ' ' CD1' ' A' ' 118' ' ' TRP . 37.0 Cg_exo -56.77 161.64 9.88 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.168 1.912 . . . . 0.0 111.589 -179.874 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.507 ' HD3' ' CG ' ' A' ' 118' ' ' TRP . 79.7 Cg_exo -39.55 156.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.701 2.267 . . . . 0.0 112.785 -179.231 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.7 m -108.38 88.21 2.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.645 179.756 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.571 HG21 ' O ' ' A' ' 122' ' ' PRO . 13.5 pt -70.08 -177.68 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.299 -179.357 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.6 m -103.43 147.34 27.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.781 179.657 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.43 ' HB3' ' CD2' ' A' ' 103' ' ' TYR . 24.8 m-80 51.43 29.83 5.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.161 179.698 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.465 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -160.36 -165.27 16.87 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.395 -0.907 . . . . 0.0 113.098 179.798 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -164.18 -175.34 3.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.857 0.36 . . . . 0.0 110.463 -179.463 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.463 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 1.8 p-80 -120.37 166.14 13.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.617 -178.999 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -98.0 -170.72 2.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.592 179.945 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' A' ' 85' ' ' TYR . . . 90.71 -68.87 2.28 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.533 -0.842 . . . . 0.0 111.72 -178.796 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.424 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 15.0 m-30 71.37 28.52 2.92 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 123.542 0.737 . . . . 0.0 110.173 179.308 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.48 ' HB2' ' CZ ' ' A' ' 89' ' ' TYR . 0.2 OUTLIER -87.19 -173.35 4.37 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.915 178.641 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -111.64 -22.92 10.96 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.802 0.334 . . . . 0.0 110.831 178.97 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.428 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 11.3 m-85 -154.08 160.87 42.16 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.995 -179.776 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.48 ' CZ ' ' HB2' ' A' ' 86' ' ' GLU . 16.5 m-85 -141.69 166.89 23.5 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.922 179.569 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.2 p -131.29 179.64 5.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.127 0.489 . . . . 0.0 112.013 -177.97 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 5.4 p-10 -63.26 96.22 0.1 Allowed 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.904 179.888 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.49 14.49 2.9 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.297 -0.865 . . . . 0.0 113.152 179.157 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.67 156.58 16.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.906 0.353 . . . . 0.0 110.349 179.005 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.9 m -135.38 151.51 30.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.174 0.511 . . . . 0.0 111.095 -179.475 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.529 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 14.4 t -148.79 145.43 18.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.028 179.937 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.769 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -105.69 128.44 53.66 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.637 179.341 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.978 ' CE1' HG21 ' A' ' 111' ' ' VAL . 5.4 m-85 -89.0 157.83 18.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.154 -179.242 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.435 ' HA ' HD13 ' A' ' 105' ' ' LEU . 39.6 m -153.57 148.12 26.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.226 179.974 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.444 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 63.0 m -74.03 162.04 29.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.91 179.686 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.465 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 65.3 m-20 -84.9 -72.57 0.47 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.587 -179.055 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.0 m -70.84 -28.21 64.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.344 -178.67 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 132.08 36.78 0.3 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.712 179.854 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.501 ' CE1' HG12 ' A' ' 126' ' ' ILE . 33.8 m-85 -69.97 -174.82 0.82 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.893 0.378 . . . . 0.0 110.586 179.266 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.6 m -106.31 101.32 10.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.291 178.677 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.447 HD21 ' CG ' ' A' ' 122' ' ' PRO . 0.3 OUTLIER -48.81 128.04 14.91 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.438 0.637 . . . . 0.0 111.508 -178.466 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.446 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 35.7 mm -91.56 153.31 3.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.955 179.078 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.47 -128.13 38.15 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.994 -178.926 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -123.79 143.86 50.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.828 0.347 . . . . 0.0 110.982 179.432 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.769 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.4 t -72.19 -32.57 66.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.703 179.638 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.13 137.42 29.66 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.747 -179.701 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.978 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.5 t -132.32 118.62 36.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.648 0.261 . . . . 0.0 110.554 179.247 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.71 114.95 21.94 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.916 0.389 . . . . 0.0 111.538 -178.848 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.504 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 26.3 t -82.5 100.93 10.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.659 176.881 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 1.8 t -138.61 154.58 48.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.113 0.482 . . . . 0.0 111.473 -178.2 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.519 ' CA ' HG11 ' A' ' 69' ' ' VAL . . . 53.09 21.02 9.84 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.934 179.489 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.452 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 82.8 8.05 86.46 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.8 -179.917 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.95 176.56 8.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.98 0.419 . . . . 0.0 110.692 179.737 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.529 ' CZ3' HG23 ' A' ' 95' ' ' VAL . 96.3 m95 -113.58 134.97 54.41 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.847 -179.763 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.3 147.22 44.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.343 -179.232 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.473 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER 71.23 46.08 0.24 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.123 178.843 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 98.0 Cg_endo -78.49 133.23 11.63 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.364 2.043 . . . . 0.0 111.453 178.179 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.571 ' O ' HG21 ' A' ' 77' ' ' ILE . 74.2 Cg_endo -91.25 -173.88 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.664 2.243 . . . . 0.0 113.513 -178.04 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.438 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -131.33 -161.23 1.11 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.878 177.689 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 6.6 m -157.4 92.03 1.21 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.199 0.523 . . . . 0.0 110.879 179.074 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -122.94 160.15 26.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.927 -179.652 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.501 HG12 ' CE1' ' A' ' 103' ' ' TYR . 46.5 mm . . . . . 0 C--N 1.324 -0.529 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.816 179.693 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.9 mtm180 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.826 0.346 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.473 ' HD2' HG23 ' A' ' 25' ' ' VAL . 32.4 mtm180 -49.9 172.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.923 179.827 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.468 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 32.7 m -86.62 160.93 49.48 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.908 -179.965 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.12 169.14 18.77 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.496 2.131 . . . . 0.0 112.02 179.92 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.3 t -50.59 104.52 0.43 Allowed Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.982 -179.351 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.469 ' HG2' HD11 ' A' ' 22' ' ' ILE . 2.7 Cg_exo -45.41 166.32 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.197 1.932 . . . . 0.0 111.919 -179.67 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.623 ' NH1' ' HB3' ' A' ' 63' ' ' ALA . 2.5 ttt-85 -73.84 170.03 16.18 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.0 178.321 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.648 ' HA ' HD11 ' A' ' 20' ' ' LEU . 2.9 p30 -125.4 -177.95 4.06 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.161 0.505 . . . . 0.0 112.055 -176.347 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.628 HG22 HD21 ' A' ' 20' ' ' LEU . 4.3 tt -148.54 142.73 18.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.338 179.372 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -79.89 -60.68 2.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.54 -178.33 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.437 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 2.6 m-20 -91.03 45.37 1.24 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.961 0.41 . . . . 0.0 110.911 -179.251 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -167.01 -179.73 40.24 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.92 179.957 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -138.86 137.77 36.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.671 0.272 . . . . 0.0 110.525 179.641 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.856 HD22 ' CE2' ' A' ' 33' ' ' TYR . 0.5 OUTLIER -87.17 154.2 20.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.006 0.431 . . . . 0.0 111.443 -179.653 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -123.97 82.1 1.99 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.902 177.574 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.81 ' HA ' HG23 ' A' ' 31' ' ' ILE . 4.0 mm -68.93 105.08 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.495 -177.529 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.3 15.03 47.28 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.165 178.079 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.424 ' O ' ' CB ' ' A' ' 29' ' ' SER . . . 154.12 121.43 0.8 Allowed Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.206 -179.765 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.473 HG23 ' HD2' ' A' ' 8' ' ' ARG . 31.2 m -108.96 22.24 4.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.754 0.312 . . . . 0.0 111.442 -179.599 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -99.0 158.69 15.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.923 0.392 . . . . 0.0 110.855 179.502 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.562 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 8.3 t80 -56.27 92.1 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.899 -179.957 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 130.93 -0.22 5.3 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.77 -0.728 . . . . 0.0 113.072 -179.859 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 24' ' ' GLY . 58.2 m -89.87 -174.04 4.12 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.969 0.384 . . . . 0.0 110.75 179.848 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 48' ' ' TYR . 7.4 p -155.71 145.4 21.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.068 0.461 . . . . 0.0 111.456 -179.561 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.81 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.4 OUTLIER -104.68 167.57 2.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.444 179.445 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.553 HG23 ' HG3' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -132.81 108.83 9.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.948 0.404 . . . . 0.0 110.701 179.147 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.856 ' CE2' HD22 ' A' ' 20' ' ' LEU . 20.4 m-85 -81.5 149.5 28.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.177 -179.323 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.418 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 5.5 m -153.48 168.28 26.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.801 -179.61 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 1.6 m -88.08 171.99 9.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.833 179.912 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.23 -84.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.084 -179.4 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.44 130.5 10.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.524 179.858 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.712 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 64.8 23.63 69.29 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.864 -178.618 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.521 ' CZ ' ' HB3' ' A' ' 68' ' ' SER . 3.4 m-85 -113.85 175.34 5.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.681 0.277 . . . . 0.0 110.842 -179.085 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.591 ' NE2' HG22 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -131.16 132.57 44.85 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 175.731 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.927 HD21 ' O ' ' A' ' 44' ' ' GLU . 7.8 tt -95.35 118.43 32.08 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.886 -178.914 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.579 ' N ' HD13 ' A' ' 42' ' ' ILE . 1.1 mm -97.67 147.26 6.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.666 179.841 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.15 -149.5 23.04 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.21 -179.047 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.927 ' O ' HD21 ' A' ' 41' ' ' LEU . 1.2 pt-20 -67.14 -177.12 0.61 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.071 0.463 . . . . 0.0 110.786 179.361 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.45 30.09 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.336 179.846 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.553 ' HG3' HG23 ' A' ' 32' ' ' THR . 0.0 OUTLIER -162.31 123.37 2.59 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.773 -179.725 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.453 ' HB3' ' CG ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -105.47 155.04 19.54 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.536 -179.384 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.51 ' CD2' ' HB3' ' A' ' 60' ' ' ASN . 1.4 m-85 -130.86 125.06 32.61 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 119.686 -0.806 . . . . 0.0 112.283 -179.46 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.447 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 20.5 t -75.75 98.19 4.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.386 178.786 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.65 -173.33 2.62 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.107 -179.689 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.562 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -93.42 145.09 24.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.815 -179.68 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -64.21 -121.68 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.425 179.957 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.32 -32.16 6.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.796 0.332 . . . . 0.0 110.897 -179.962 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 33.6 p -115.71 38.51 3.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.955 179.912 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.5 22.51 69.92 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.386 -179.719 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.5 t -83.9 -161.65 0.56 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.869 0.366 . . . . 0.0 111.068 -179.796 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.496 ' O ' HG13 ' A' ' 58' ' ' VAL . 13.2 mtt -117.29 140.0 50.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.548 179.712 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.496 HG13 ' O ' ' A' ' 57' ' ' MET . 3.4 m -157.76 163.52 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.94 -179.41 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.517 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 69.4 m95 -124.06 123.13 39.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.342 -179.489 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.51 ' HB3' ' CD2' ' A' ' 48' ' ' TYR . 3.2 m-20 -69.7 165.99 36.0 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.911 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 48.7 Cg_exo -9.61 95.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.029 1 C-N-CA 125.74 4.293 . . . . 0.0 115.074 -178.57 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.473 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 42.7 mt-10 -98.08 -99.27 0.21 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.482 -177.772 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.623 ' HB3' ' NH1' ' A' ' 13' ' ' ARG . . . -74.9 108.66 5.73 Favored Pre-proline 0 C--O 1.232 0.135 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -175.343 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.887 ' HG2' HD11 ' A' ' 41' ' ' LEU . 2.5 Cg_endo -87.01 -155.31 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.216 2.61 . . . . 0.0 110.757 176.668 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.466 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 2.1 mm -99.73 161.1 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.87 0.367 . . . . 0.0 110.786 178.685 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.437 ' HB3' ' HB2' ' A' ' 17' ' ' ASN . 1.1 m -155.65 137.53 14.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 -179.908 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.479 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -141.42 172.88 12.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.644 179.896 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.521 ' HB3' ' CZ ' ' A' ' 39' ' ' TYR . 1.1 p -108.38 123.72 49.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.283 -179.813 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.712 HG12 ' O ' ' A' ' 38' ' ' GLY . 5.1 p -52.12 90.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.596 178.494 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 68' ' ' SER . 0.6 OUTLIER -68.8 132.62 47.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.893 -178.129 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.422 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -112.75 118.56 35.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.585 177.164 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.471 ' CG ' ' N ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -69.29 -157.97 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.358 -179.532 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.585 ' HG ' ' CE1' ' A' ' 82' ' ' HIS . 0.8 OUTLIER -52.38 142.36 30.08 Favored Pre-proline 0 N--CA 1.447 -0.593 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.781 179.919 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.493 ' HA ' ' CD1' ' A' ' 118' ' ' TRP . 23.8 Cg_exo -60.67 157.87 35.34 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.326 2.017 . . . . 0.0 111.813 179.741 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.492 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 81.0 Cg_exo -43.79 156.19 0.17 Allowed 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.62 2.214 . . . . 0.0 112.594 -179.429 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.7 t -105.79 90.27 3.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.771 179.905 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.586 HG23 ' HE1' ' A' ' 97' ' ' TYR . 22.2 pt -69.56 176.32 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.297 -179.477 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.8 m -94.01 143.39 26.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.416 178.898 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.506 ' HB3' ' CD2' ' A' ' 103' ' ' TYR . 4.3 m-80 57.34 30.01 17.81 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.758 -179.829 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.44 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . 178.88 -175.79 47.56 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.689 179.953 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.25 -175.06 1.86 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.765 0.316 . . . . 0.0 110.348 -179.893 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.585 ' CE1' ' HG ' ' A' ' 73' ' ' SER . 12.3 p80 -85.83 174.78 9.07 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.855 179.8 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.417 ' OD1' ' CG1' ' A' ' 95' ' ' VAL . 21.0 p-10 -109.22 -37.94 5.65 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -178.254 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 85' ' ' TYR . . . -41.06 -62.44 1.75 Allowed Glycine 0 C--N 1.331 0.286 0 C-N-CA 121.044 -0.598 . . . . 0.0 113.302 -178.129 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.448 ' CE1' ' O ' ' A' ' 82' ' ' HIS . 21.2 m-30 66.21 27.39 10.31 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-O 121.319 0.58 . . . . 0.0 110.134 -179.779 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.465 ' HB2' ' CZ ' ' A' ' 89' ' ' TYR . 0.4 OUTLIER -79.36 -167.27 1.14 Allowed 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.317 177.76 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -112.63 -23.06 10.44 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.241 179.487 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.425 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 12.7 m-85 -158.87 159.74 35.35 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.186 0.517 . . . . 0.0 111.614 -179.447 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.465 ' CZ ' ' HB2' ' A' ' 86' ' ' GLU . 12.3 m-85 -142.28 166.91 23.39 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.017 179.661 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.4 p -127.16 169.56 13.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.969 0.414 . . . . 0.0 111.573 -178.783 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.418 ' OD1' ' CG1' ' A' ' 69' ' ' VAL . 0.1 OUTLIER -58.55 100.79 0.07 Allowed 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.49 0.662 . . . . 0.0 110.689 179.461 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.76 14.28 3.9 Favored Glycine 0 C--N 1.313 -0.745 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.916 179.287 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.424 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.7 OUTLIER -95.97 158.63 15.36 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.957 0.379 . . . . 0.0 110.327 178.808 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.431 HG22 ' N ' ' A' ' 95' ' ' VAL . 35.0 m -134.37 156.17 40.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.055 0.455 . . . . 0.0 111.043 -179.355 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.533 HG23 ' CH2' ' A' ' 118' ' ' TRP . 40.1 t -148.94 152.14 12.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.646 179.95 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.771 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -112.25 121.02 43.72 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.097 0.475 . . . . 0.0 111.01 -179.673 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 1.005 ' CE2' HG21 ' A' ' 111' ' ' VAL . 4.9 m-85 -80.74 155.36 26.75 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.568 -178.986 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.431 ' HA ' ' CD1' ' A' ' 105' ' ' LEU . 90.3 p -153.42 143.97 22.53 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.378 -179.729 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.44 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 6.3 m -69.54 164.86 22.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.442 -179.886 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -93.25 -67.44 0.86 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.883 179.268 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.68 -34.47 72.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.247 -179.716 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 133.63 43.94 0.13 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.491 -179.952 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.524 ' CE1' HG12 ' A' ' 126' ' ' ILE . 6.4 m-85 -78.46 -171.05 2.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.832 0.348 . . . . 0.0 110.644 179.809 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -113.57 98.86 7.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.489 179.051 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.482 HD23 ' HB2' ' A' ' 122' ' ' PRO . 0.1 OUTLIER -49.83 144.67 6.14 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.534 0.683 . . . . 0.0 111.254 -179.091 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.553 HG22 ' N ' ' A' ' 107' ' ' GLY . 23.8 mm -121.67 162.12 21.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.999 -178.096 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.553 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 47.7 45.82 24.3 Favored Glycine 0 C--O 1.226 -0.402 0 C-N-CA 120.574 -0.822 . . . . 0.0 113.237 178.619 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.435 ' O ' ' O ' ' A' ' 107' ' ' GLY . 9.2 p30 46.51 128.39 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 124.577 1.151 . . . . 0.0 114.09 177.556 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.771 ' OG ' HG22 ' A' ' 96' ' ' THR . 0.1 OUTLIER -55.07 -33.16 62.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.769 179.207 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -55.43 130.1 47.38 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.2 -178.534 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 1.005 HG21 ' CE2' ' A' ' 97' ' ' TYR . 2.4 t -127.31 150.19 32.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.024 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.28 122.23 47.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.951 0.405 . . . . 0.0 111.668 -179.149 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.504 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 15.3 t -87.76 100.88 13.17 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 176.733 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.6 OUTLIER -150.66 171.22 17.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.984 -178.654 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.418 ' N ' ' OD1' ' A' ' 91' ' ' ASP . . . 46.61 26.16 2.48 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.871 -179.935 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.12 18.82 76.82 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.281 -179.331 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -152.78 -176.68 5.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.895 0.379 . . . . 0.0 110.536 179.889 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.533 ' CH2' HG23 ' A' ' 95' ' ' VAL . 91.6 m95 -111.39 126.32 54.8 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.069 -179.425 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.8 161.09 14.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.263 -179.273 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.478 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 3.6 p30 48.46 46.04 3.33 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.434 179.161 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 57.5 Cg_endo -69.99 150.21 66.5 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.221 1.947 . . . . 0.0 110.691 176.51 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.566 ' O ' HG21 ' A' ' 77' ' ' ILE . 57.0 Cg_endo -95.99 177.51 0.7 Allowed 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.223 1.948 . . . . 0.0 114.089 -176.856 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.451 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -119.46 -160.8 0.83 Allowed 'General case' 0 CA--C 1.505 -0.784 0 CA-C-N 114.343 -1.298 . . . . 0.0 109.044 176.566 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 124' ' ' CYS . . . . . 0.425 ' SG ' ' HB2' ' A' ' 103' ' ' TYR . 5.0 t -170.32 91.02 0.18 Allowed 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.891 -175.98 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -122.16 175.76 6.19 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.355 -177.415 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.524 HG12 ' CE1' ' A' ' 103' ' ' TYR . 46.3 mm . . . . . 0 C--N 1.326 -0.437 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.677 179.37 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.896 0.379 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.445 ' HD2' HG23 ' A' ' 25' ' ' VAL . 6.4 mtm180 -97.22 157.25 16.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.183 -179.591 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.524 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 65.9 m -69.82 175.91 2.04 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.596 178.565 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.553 ' HD2' ' CD1' ' A' ' 59' ' ' TRP . 35.6 Cg_endo -88.66 177.96 2.97 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.532 2.155 . . . . 0.0 111.452 179.047 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.8 t -51.31 105.54 0.54 Allowed Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.427 179.551 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.498 ' HG3' ' CZ2' ' A' ' 59' ' ' TRP . 53.5 Cg_exo -46.55 161.38 0.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.137 1.891 . . . . 0.0 112.366 -179.049 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.421 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -62.15 -173.42 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.849 177.673 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.508 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 0.4 OUTLIER -144.22 -175.95 4.82 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.288 179.524 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.412 HG23 ' C ' ' A' ' 18' ' ' GLY . 9.2 tt -146.71 142.98 20.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.571 179.739 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -73.94 -60.82 2.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.014 -177.63 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.409 ' O ' ' N ' ' A' ' 36' ' ' ASN . 0.2 OUTLIER -94.09 30.47 1.88 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.188 -178.133 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.412 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -147.17 177.43 25.47 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.896 -179.932 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -135.9 130.66 34.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.689 0.281 . . . . 0.0 110.365 179.01 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.868 HD21 ' CE2' ' A' ' 33' ' ' TYR . 24.6 mt -82.91 157.45 23.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.056 0.455 . . . . 0.0 111.726 -178.75 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.03 78.75 1.85 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.163 178.823 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.931 ' HA ' HG23 ' A' ' 31' ' ' ILE . 67.8 mt -69.93 100.27 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.843 -177.993 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.69 17.19 59.71 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.792 177.073 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 150.46 139.73 3.08 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.218 -179.601 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.445 HG23 ' HD2' ' A' ' 8' ' ' ARG . 35.8 m -124.1 31.15 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.915 0.388 . . . . 0.0 111.253 -179.477 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.41 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.4 OUTLIER -101.06 148.93 24.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.574 179.335 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.667 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 4.7 t80 -49.99 92.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.92 0.39 . . . . 0.0 110.79 179.909 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 131.44 -2.28 5.35 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.78 -179.094 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 65.6 p -89.15 -173.14 3.93 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 117.003 0.402 . . . . 0.0 110.444 179.468 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.3 p -155.11 154.36 32.26 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.002 0.43 . . . . 0.0 111.064 179.872 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.931 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.8 OUTLIER -115.65 164.6 11.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.491 -179.987 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -124.19 120.41 32.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.954 0.406 . . . . 0.0 111.253 -179.867 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.868 ' CE2' HD21 ' A' ' 20' ' ' LEU . 16.2 m-85 -97.77 135.28 39.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.182 -179.882 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.406 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -143.65 158.54 43.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.682 179.67 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.435 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 3.0 m -76.45 167.95 20.94 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.737 179.841 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 17' ' ' ASN . 0.8 OUTLIER -63.93 -81.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.898 -179.764 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -158.27 133.68 8.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.81 179.851 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.833 ' O ' HG22 ' A' ' 69' ' ' VAL . . . 64.43 23.61 68.61 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.107 -179.374 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.537 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.6 m-85 -114.58 179.84 3.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.793 0.33 . . . . 0.0 110.862 -179.622 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.882 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.5 OUTLIER -136.17 112.54 9.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.006 0.431 . . . . 0.0 110.55 178.135 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.934 HD11 ' HG2' ' A' ' 64' ' ' PRO . 4.6 tt -78.58 123.93 27.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.251 -179.981 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.882 HD11 ' CE1' ' A' ' 40' ' ' HIS . 1.9 mm -100.17 152.33 4.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.072 0.463 . . . . 0.0 111.059 -179.207 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.77 -137.92 17.4 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.117 -179.211 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.897 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -82.75 -175.86 5.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.943 0.402 . . . . 0.0 110.806 179.439 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.7 p -156.55 21.41 0.34 Allowed 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.458 -178.995 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -148.13 139.16 23.25 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.246 0.546 . . . . 0.0 112.304 -178.377 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.444 ' HB3' HG13 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -107.96 145.23 34.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.875 178.212 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.492 ' CB ' ' HB2' ' A' ' 60' ' ' ASN . 1.6 m-85 -123.61 119.99 31.5 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 119.179 -1.008 . . . . 0.0 112.405 -179.928 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.419 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 19.0 t -71.4 96.83 1.52 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.517 178.935 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.7 -173.96 2.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.167 -179.463 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.667 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -95.87 153.61 17.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.998 -179.851 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -73.69 -129.26 0.15 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.517 179.848 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.6 t -114.64 -33.33 5.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.876 0.37 . . . . 0.0 110.953 179.992 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 60.6 p -99.75 33.4 2.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.864 179.91 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.7 26.43 74.06 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.427 -179.812 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.7 t -94.04 -161.98 0.9 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.87 0.367 . . . . 0.0 110.901 -179.942 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.528 ' O ' HG13 ' A' ' 58' ' ' VAL . 4.1 mmt -117.44 144.6 44.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.513 179.536 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.528 HG13 ' O ' ' A' ' 57' ' ' MET . 2.4 m -158.78 172.91 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.1 -179.822 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.627 ' CE3' HD11 ' A' ' 31' ' ' ILE . 69.9 m95 -123.24 124.66 43.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.1 -179.976 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.492 ' HB2' ' CB ' ' A' ' 48' ' ' TYR . 3.1 m120 -69.28 163.98 52.98 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.333 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.439 ' O ' ' HA ' ' A' ' 47' ' ' SER . 38.9 Cg_exo -10.86 99.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.944 1 C-N-CA 125.735 4.29 . . . . 0.0 114.925 -178.618 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.476 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 7.9 mt-10 -91.62 -92.62 0.15 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.167 -0.924 . . . . 0.0 113.146 -176.43 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.508 ' HB2' ' O ' ' A' ' 14' ' ' ASP . . . -81.93 110.47 20.41 Favored Pre-proline 0 CA--C 1.528 0.109 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -174.953 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.934 ' HG2' HD11 ' A' ' 41' ' ' LEU . 5.1 Cg_exo -80.05 -153.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.942 2.428 . . . . 0.0 110.95 176.395 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.522 HG22 ' H ' ' A' ' 66' ' ' CYS . 3.5 mm -94.57 167.38 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.825 0.345 . . . . 0.0 110.919 178.833 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.522 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.2 m -166.44 132.9 2.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.171 179.24 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.9 164.56 35.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.761 -178.909 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.537 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 1.7 p -88.86 120.09 29.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.362 0.601 . . . . 0.0 111.248 -179.906 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.833 HG22 ' O ' ' A' ' 38' ' ' GLY . 0.6 OUTLIER -39.55 91.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.39 179.478 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.659 ' HZ1' ' HA ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -101.4 151.38 21.99 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.85 178.016 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.413 ' C ' ' HE3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -125.61 136.06 52.86 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.412 -177.63 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.659 ' HA ' ' HZ1' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -67.23 -173.18 0.26 Allowed 'General case' 0 N--CA 1.432 -1.354 0 CA-C-O 121.904 0.859 . . . . 0.0 113.115 -178.12 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -48.19 124.4 11.07 Favored Pre-proline 0 N--CA 1.441 -0.894 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.09 175.051 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.528 ' HG2' HG11 ' A' ' 95' ' ' VAL . 31.7 Cg_exo -46.09 153.33 1.01 Allowed 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.593 1.529 . . . . 0.0 111.88 -175.702 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.487 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 86.3 Cg_exo -45.59 154.34 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.741 2.294 . . . . 0.0 112.679 -177.492 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 12.8 t -103.1 91.02 3.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.666 -179.881 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.524 HG21 ' O ' ' A' ' 122' ' ' PRO . 18.9 pt -69.16 172.37 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.808 -179.962 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -93.29 134.04 35.9 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.892 -179.86 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.517 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 0.1 OUTLIER 66.95 27.76 8.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.543 -179.945 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -170.56 176.46 44.1 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.78 179.746 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 80' ' ' GLY . 3.5 mtp85 -148.49 -167.37 2.8 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.505 0.669 . . . . 0.0 111.706 -178.512 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 10.3 p-80 -127.37 160.28 31.87 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.843 178.993 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -85.21 -87.66 0.12 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.611 -179.926 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.421 ' HA3' ' OH ' ' A' ' 89' ' ' TYR . . . 59.2 151.39 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.801 179.117 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -116.07 -33.65 4.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.982 0.42 . . . . 0.0 110.871 179.824 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.52 -175.94 2.94 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.137 -179.83 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -97.9 -33.07 11.37 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.554 177.157 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.517 ' CD2' ' CD ' ' A' ' 70' ' ' LYS . 6.5 m-30 -103.69 163.75 12.12 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.149 179.585 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.519 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 54.4 m-85 -152.61 166.45 32.04 Favored 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.647 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 12.2 p -147.47 -177.46 5.71 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.53 -0.868 . . . . 0.0 112.927 -178.416 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 7.9 p-10 -49.94 95.53 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.391 -179.575 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.01 10.04 5.9 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.43 -0.891 . . . . 0.0 113.269 177.467 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.422 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -95.16 143.77 26.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 117.253 0.526 . . . . 0.0 110.652 179.61 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 27.2 m -130.31 150.48 34.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.586 -179.736 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.528 HG11 ' HG2' ' A' ' 74' ' ' PRO . 24.3 t -142.96 147.07 21.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.039 179.877 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.714 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -103.68 130.59 51.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.929 -179.64 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.875 ' CE1' HG21 ' A' ' 111' ' ' VAL . 6.8 m-85 -91.68 154.78 18.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.153 -179.575 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.39 134.95 22.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.494 -179.471 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.444 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 81.1 m -69.34 158.39 35.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.908 179.864 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.91 -86.77 0.3 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.31 -179.702 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.0 t -43.6 -28.11 0.36 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.825 -178.944 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.05 38.45 0.43 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.361 -179.872 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.517 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 54.6 m-85 -81.6 -172.95 4.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.759 0.314 . . . . 0.0 110.852 -179.87 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 125' ' ' GLN . 0.3 OUTLIER -112.45 113.68 25.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.11 0.481 . . . . 0.0 110.985 -179.801 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.47 HD12 ' HA ' ' A' ' 105' ' ' LEU . 0.6 OUTLIER -47.51 109.78 0.25 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.509 178.554 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.46 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 47.5 mm -84.31 156.58 3.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.917 -178.947 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.445 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 59.06 -127.52 45.43 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.677 -178.736 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -117.18 133.68 55.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.012 0.434 . . . . 0.0 110.574 178.446 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.714 ' HB2' HG22 ' A' ' 96' ' ' THR . 0.1 OUTLIER -67.79 -29.56 68.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.376 179.6 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -77.0 125.61 7.5 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.673 179.622 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.875 HG21 ' CE1' ' A' ' 97' ' ' TYR . 10.9 t -115.86 124.94 72.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 178.771 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.864 HD22 ' N ' ' A' ' 113' ' ' CYS . 1.3 tm? -80.75 136.04 36.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.041 0.448 . . . . 0.0 111.527 -178.621 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.864 ' N ' HD22 ' A' ' 112' ' ' LEU . 18.4 t -108.95 107.2 17.48 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.702 177.116 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.606 ' CB ' HD11 ' A' ' 112' ' ' LEU . 2.8 t -164.34 134.13 3.94 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.992 0.425 . . . . 0.0 111.349 -179.717 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.49 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 89.76 16.4 56.57 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.477 -179.863 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.488 ' N ' ' HB ' ' A' ' 69' ' ' VAL . . . 86.33 1.83 85.81 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.064 -179.062 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -138.28 -170.66 2.86 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.755 0.788 . . . . 0.0 111.768 -178.809 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.507 ' CH2' ' HG3' ' A' ' 74' ' ' PRO . 97.0 m95 -117.5 159.67 22.46 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.381 179.055 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.544 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.2 OUTLIER -141.15 161.16 38.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.075 0.464 . . . . 0.0 111.785 -179.506 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.4 p30 46.87 53.67 13.99 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.423 179.069 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.448 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 87.3 Cg_endo -80.5 147.29 17.7 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.633 2.222 . . . . 0.0 111.37 177.227 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.524 ' O ' HG21 ' A' ' 77' ' ' ILE . 72.6 Cg_endo -92.05 -172.32 0.41 Allowed 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.71 2.273 . . . . 0.0 114.068 -177.339 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.444 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -136.63 -170.12 2.61 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.878 178.063 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 15.6 m -145.46 95.71 2.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.111 0.481 . . . . 0.0 111.211 -179.85 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.411 ' O ' ' HB2' ' A' ' 104' ' ' SER . 17.4 mt-30 -124.66 155.76 38.66 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.708 179.706 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.496 HG12 ' CE2' ' A' ' 103' ' ' TYR . 27.9 mm . . . . . 0 C--N 1.323 -0.572 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.914 179.961 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.94 0.4 . . . . 0.0 111.177 . . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.662 ' HD2' HG23 ' A' ' 25' ' ' VAL . 70.0 mtm180 -57.11 -171.71 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.012 -179.864 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.448 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 52.1 m -94.23 159.92 33.07 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.353 179.15 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.406 ' O ' ' HD3' ' A' ' 12' ' ' PRO . 57.4 Cg_endo -68.31 166.38 25.55 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.271 1.981 . . . . 0.0 111.333 178.919 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.4 p -51.71 104.95 0.46 Allowed Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.178 -178.738 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.67 ' HG2' HD13 ' A' ' 22' ' ' ILE . 12.7 Cg_exo -40.62 160.97 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.493 2.129 . . . . 0.0 112.517 -179.429 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.527 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -68.61 169.42 11.12 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.068 178.737 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.52 ' HA ' HD11 ' A' ' 20' ' ' LEU . 1.4 t0 -114.49 -173.98 2.4 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.253 0.549 . . . . 0.0 111.759 -178.192 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.552 HG22 ' CD2' ' A' ' 20' ' ' LEU . 13.9 tt -148.22 149.79 14.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.855 -179.435 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.401 ' O ' HG12 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -90.19 159.82 16.54 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.643 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 46.45 27.51 0.62 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.86 0.362 . . . . 0.0 110.508 -179.138 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.74 170.25 39.76 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.024 -0.607 . . . . 0.0 112.471 -178.974 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -136.57 155.56 49.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.882 0.372 . . . . 0.0 110.41 179.831 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.807 HD22 ' CE2' ' A' ' 33' ' ' TYR . 0.3 OUTLIER -93.05 162.43 14.04 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.256 -179.638 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 32' ' ' THR . 12.8 t0 -128.9 74.61 1.59 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.538 177.962 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.898 ' HA ' HG23 ' A' ' 31' ' ' ILE . 1.5 mt -75.02 102.95 2.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.394 -176.086 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.3 13.1 58.61 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.612 175.893 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 166.46 138.05 2.35 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 -179.495 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.662 HG23 ' HD2' ' A' ' 8' ' ' ARG . 13.7 m -125.52 1.96 4.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.49 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.443 ' HA ' ' CB ' ' A' ' 8' ' ' ARG . 37.3 t70 -71.79 165.12 24.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.879 0.371 . . . . 0.0 110.816 179.943 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.588 ' CZ ' HD12 ' A' ' 51' ' ' LEU . 6.7 t80 -57.68 90.59 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.967 -179.501 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.81 -2.59 6.01 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.007 179.819 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.7 m -82.04 162.32 22.63 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 117.004 0.402 . . . . 0.0 110.485 179.561 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.5 p -131.55 148.92 52.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.94 0.4 . . . . 0.0 110.973 179.785 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.898 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -108.67 170.64 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.668 -179.598 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.463 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -133.15 111.55 11.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.984 0.421 . . . . 0.0 110.874 179.015 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.807 ' CE2' HD22 ' A' ' 20' ' ' LEU . 12.1 m-85 -85.83 149.66 25.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.677 -178.475 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.1 m -149.52 160.64 43.3 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.134 179.821 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.403 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 3.5 m -84.27 169.18 14.97 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.068 179.939 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -67.76 -85.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.247 -178.972 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.23 132.67 12.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.742 -179.833 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.755 ' O ' HG22 ' A' ' 69' ' ' VAL . . . 68.36 21.22 74.07 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.912 -178.718 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.545 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.7 m-85 -116.72 176.12 5.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.719 0.295 . . . . 0.0 110.598 -179.903 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.816 ' CD2' HD11 ' A' ' 42' ' ' ILE . 7.7 p-80 -139.93 118.1 11.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.082 0.468 . . . . 0.0 110.243 177.754 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.886 HD21 ' O ' ' A' ' 44' ' ' GLU . 7.9 tt -78.22 123.31 26.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.736 -178.877 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.816 HD11 ' CD2' ' A' ' 40' ' ' HIS . 2.0 mm -102.04 165.51 2.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.038 0.447 . . . . 0.0 111.052 -179.343 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.481 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 67.69 -142.56 40.51 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.163 -179.198 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.886 ' O ' HD21 ' A' ' 41' ' ' LEU . 1.0 OUTLIER -66.96 -175.56 0.43 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.006 0.431 . . . . 0.0 110.767 179.414 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.2 t -171.44 31.38 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.409 179.362 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.463 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -160.41 126.79 4.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.468 -178.153 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.458 ' CB ' HD12 ' A' ' 31' ' ' ILE . 0.1 OUTLIER -93.5 145.81 24.24 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.063 178.265 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.545 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.6 m-85 -122.18 115.29 22.14 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 119.414 -0.914 . . . . 0.0 111.583 178.579 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 39.1 t -68.04 100.18 0.96 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.845 -179.89 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.498 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -126.46 175.47 7.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.447 -179.686 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.845 HD23 ' O ' ' A' ' 56' ' ' SER . 7.8 mt -79.87 160.06 26.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.127 -179.345 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.81 -86.01 0.94 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.55 -179.801 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.0 t -153.26 -45.48 0.09 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.805 0.336 . . . . 0.0 111.023 -179.771 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 81.5 p -95.71 16.25 17.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.435 -179.816 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 103.04 11.28 34.72 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.983 179.671 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.845 ' O ' HD23 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -84.27 159.14 21.01 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.754 0.277 . . . . 0.0 110.649 179.644 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.4 111.14 23.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.918 0.389 . . . . 0.0 110.79 179.984 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.4 m -113.31 -169.39 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.767 179.808 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.516 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 73.6 m95 -130.7 146.58 52.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.977 0.418 . . . . 0.0 111.423 -179.543 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.545 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.6 OUTLIER -92.1 166.64 16.95 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.632 177.427 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.482 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 93.6 Cg_exo -16.22 97.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.811 1 C-N-CA 125.387 4.058 . . . . 0.0 114.639 -178.802 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.481 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -93.92 -76.54 0.48 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.088 -178.054 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.488 ' HA ' ' CD2' ' A' ' 33' ' ' TYR . . . -85.53 108.38 16.02 Favored Pre-proline 0 N--CA 1.463 0.176 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -175.896 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.884 ' HG2' HD11 ' A' ' 41' ' ' LEU . 3.5 Cg_exo -82.82 -153.88 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.148 2.565 . . . . 0.0 111.038 177.078 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.538 HG22 ' H ' ' A' ' 66' ' ' CYS . 4.2 mm -90.29 167.38 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.771 0.319 . . . . 0.0 110.541 178.064 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.538 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.1 m -167.53 127.93 1.44 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.037 179.462 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -148.45 173.25 13.29 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.579 179.618 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.545 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 67.6 p -77.41 130.55 37.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.441 0.639 . . . . 0.0 111.368 -179.495 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.755 HG22 ' O ' ' A' ' 38' ' ' GLY . 2.7 m -36.39 104.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 114.934 -1.03 . . . . 0.0 112.95 -178.985 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.57 ' CE ' HG23 ' A' ' 90' ' ' THR . 0.1 OUTLIER -86.77 97.06 10.4 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.271 177.132 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.447 ' N ' ' O ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -83.15 128.35 34.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.991 0.424 . . . . 0.0 110.246 179.264 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.44 -158.24 0.07 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.253 178.993 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.479 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 1.8 t -48.92 137.79 13.15 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.035 -179.997 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.495 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 35.5 Cg_exo -59.71 165.58 9.61 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.43 2.086 . . . . 0.0 112.348 -179.662 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.529 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 84.0 Cg_exo -45.77 157.38 0.34 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.769 2.312 . . . . 0.0 112.781 -179.669 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.7 t -109.87 90.21 3.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.461 179.047 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.727 HG23 ' HE1' ' A' ' 97' ' ' TYR . 17.1 pt -69.26 167.84 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.286 -179.0 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.8 m -81.29 139.45 35.41 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.717 179.684 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.411 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 5.4 m-80 56.5 28.84 14.39 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 -179.821 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.464 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -157.09 -170.29 21.87 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.344 -0.932 . . . . 0.0 113.268 -179.851 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -170.16 -175.32 1.95 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.068 0.461 . . . . 0.0 110.976 -179.307 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.479 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 9.3 p80 -115.84 170.64 8.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.971 -179.74 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -151.89 103.35 2.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.948 0.404 . . . . 0.0 111.035 179.012 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -122.06 176.91 16.49 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.268 179.568 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.404 ' CD2' ' N ' ' A' ' 85' ' ' TYR . 2.7 m-85 -107.85 -24.57 11.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.973 0.416 . . . . 0.0 110.813 179.643 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.37 -173.15 2.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.928 -179.853 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -109.91 -24.92 10.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.907 179.451 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.435 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 11.6 m-85 -129.13 -179.68 5.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.817 179.9 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.447 ' O ' ' N ' ' A' ' 71' ' ' CYS . 72.7 m-85 -156.62 164.14 38.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.67 -179.126 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.57 HG23 ' CE ' ' A' ' 70' ' ' LYS . 17.3 p -148.49 -177.04 5.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.087 0.47 . . . . 0.0 112.017 -179.242 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.441 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 56.4 m-20 -52.19 94.01 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.249 -179.503 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 122.43 20.5 2.94 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.184 -0.916 . . . . 0.0 113.044 178.455 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.417 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -106.11 150.02 26.19 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 117.087 0.443 . . . . 0.0 110.554 178.994 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.415 HG22 ' N ' ' A' ' 95' ' ' VAL . 31.1 m -131.36 153.67 39.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.158 0.504 . . . . 0.0 111.359 -179.245 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.521 HG23 ' CH2' ' A' ' 118' ' ' TRP . 23.0 t -145.78 149.17 16.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.374 179.132 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.871 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -105.31 130.41 53.44 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.09 0.471 . . . . 0.0 110.796 -179.966 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.967 ' CE2' HG21 ' A' ' 111' ' ' VAL . 3.2 m-85 -87.52 157.41 19.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.252 -179.115 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 61.0 p -144.29 131.42 20.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.524 -179.746 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.46 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 87.8 m -69.26 151.88 45.72 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.019 179.761 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.464 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 6.4 m-20 -90.62 -71.69 0.61 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.706 -178.384 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.7 t -58.39 -17.95 24.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.512 -179.279 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 115.3 27.23 3.19 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.082 -179.298 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.487 ' CE2' HG12 ' A' ' 126' ' ' ILE . 31.3 m-85 -69.61 -173.72 0.62 Allowed 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 120.886 0.374 . . . . 0.0 110.923 -179.676 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.57 112.4 23.9 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.396 179.126 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.492 HD22 ' HA ' ' A' ' 109' ' ' SER . 1.1 tp -50.1 112.49 0.68 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.074 -179.737 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.448 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 47.5 mm -99.34 155.88 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.729 179.957 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.434 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 60.53 28.13 67.1 Favored Glycine 0 CA--C 1.508 -0.363 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.437 179.497 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 60.22 129.11 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.001 -0.599 . . . . 0.0 111.495 179.65 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.871 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.2 p -61.47 -26.64 68.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.452 -179.059 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -58.66 136.83 50.81 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.788 -179.356 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.967 HG21 ' CE2' ' A' ' 97' ' ' TYR . 3.2 t -136.81 123.48 29.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.613 0.244 . . . . 0.0 110.936 179.734 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.954 HD22 ' N ' ' A' ' 113' ' ' CYS . 0.7 OUTLIER -81.72 136.16 35.47 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.886 0.374 . . . . 0.0 111.226 -179.73 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.954 ' N ' HD22 ' A' ' 112' ' ' LEU . 36.5 t -107.11 108.46 19.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.991 176.835 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.579 ' OG ' HD11 ' A' ' 112' ' ' LEU . 10.2 p -162.0 129.23 3.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.043 0.449 . . . . 0.0 111.848 -179.932 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.519 ' H ' HG21 ' A' ' 69' ' ' VAL . . . 86.58 30.22 22.08 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.508 179.309 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.453 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 68.75 14.15 67.12 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.212 -178.923 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -143.08 -178.15 5.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.181 0.515 . . . . 0.0 111.365 -179.552 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.529 ' CD1' ' HD3' ' A' ' 75' ' ' PRO . 90.4 m95 -123.73 133.05 53.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.525 179.989 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.455 ' OG ' HD12 ' A' ' 112' ' ' LEU . 0.4 OUTLIER -111.89 157.21 20.9 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.085 0.469 . . . . 0.0 111.356 -179.428 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.495 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER 62.63 44.22 0.6 Allowed Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.256 179.21 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 55.2 Cg_endo -69.13 137.24 36.79 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.174 1.916 . . . . 0.0 111.273 178.008 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.513 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 71.0 Cg_endo -86.43 -173.99 1.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.404 2.069 . . . . 0.0 113.772 -177.631 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.58 -175.5 3.97 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.549 178.123 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 124' ' ' CYS . . . . . 0.415 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 3.8 m -139.29 94.87 2.85 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.972 0.415 . . . . 0.0 110.897 179.688 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -123.26 159.17 29.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.86 -179.666 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.487 HG12 ' CE2' ' A' ' 103' ' ' TYR . 27.3 mm . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.993 179.935 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.0 ttp180 . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.827 0.346 . . . . 0.0 110.811 . . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.47 ' HD2' HG23 ' A' ' 25' ' ' VAL . 66.0 mtm-85 -48.93 157.7 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.243 -179.803 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.527 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 36.2 m -73.53 175.83 3.23 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.808 178.592 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.56 ' HD2' ' CD1' ' A' ' 59' ' ' TRP . 18.6 Cg_endo -87.2 -174.83 1.41 Allowed 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.791 2.327 . . . . 0.0 111.406 178.882 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.435 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 2.9 t -58.18 106.53 0.71 Allowed Pre-proline 0 C--N 1.325 -0.479 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.402 179.242 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.471 ' HG2' HD11 ' A' ' 22' ' ' ILE . 1.8 Cg_endo -49.91 148.11 13.41 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.09 1.86 . . . . 0.0 111.849 -179.203 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.906 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -58.16 159.47 5.87 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.126 178.981 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -108.33 -178.96 3.75 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.149 0.5 . . . . 0.0 112.021 -176.29 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.5 tt -138.85 144.23 30.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.71 179.585 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.02 -68.95 0.58 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.557 -178.483 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -90.02 43.4 1.14 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.222 -179.134 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -160.5 -174.81 30.78 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.093 179.981 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -143.53 128.62 18.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.742 0.306 . . . . 0.0 110.624 -179.598 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.906 HD11 ' O ' ' A' ' 13' ' ' ARG . 13.8 mt -73.11 157.88 36.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.072 0.463 . . . . 0.0 111.497 -179.571 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.98 75.37 1.65 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.643 177.657 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.931 ' HA ' HG23 ' A' ' 31' ' ' ILE . 68.0 mt -69.25 106.32 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.65 -177.643 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -115.87 21.05 12.69 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.66 177.557 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 158.31 119.91 0.58 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.136 -179.512 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.47 HG23 ' HD2' ' A' ' 8' ' ' ARG . 32.8 m -117.84 28.92 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.774 0.321 . . . . 0.0 111.295 -179.596 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -104.89 147.85 27.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.852 179.86 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.482 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 8.4 t80 -47.34 96.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.088 -179.693 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 122.33 16.68 3.8 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.83 -179.951 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.16 -161.0 0.75 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.696 0.284 . . . . 0.0 110.749 179.632 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.4 p -167.68 148.82 5.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.986 0.422 . . . . 0.0 111.318 179.42 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.931 HG23 ' HA ' ' A' ' 22' ' ' ILE . 1.0 OUTLIER -106.94 173.33 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.591 -179.977 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.492 ' H ' HG22 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -130.92 116.35 17.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.99 0.424 . . . . 0.0 111.384 179.375 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.833 ' CE2' HD21 ' A' ' 20' ' ' LEU . 18.7 m-85 -92.29 138.83 31.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.968 179.758 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.418 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 85.3 p -144.01 166.41 25.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.981 -179.74 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.448 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 3.9 m -90.2 165.72 13.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.728 179.915 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -64.28 -83.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.851 0.358 . . . . 0.0 111.015 -179.612 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.18 136.81 15.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.624 179.906 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.627 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 60.77 26.92 65.75 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.862 -178.913 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.491 ' CD2' ' HA ' ' A' ' 68' ' ' SER . 2.3 m-85 -119.26 171.41 8.32 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.725 0.298 . . . . 0.0 110.811 -179.328 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.891 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.5 OUTLIER -132.3 120.37 22.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.955 0.407 . . . . 0.0 110.516 177.865 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.902 HD11 ' HG2' ' A' ' 64' ' ' PRO . 6.7 tt -83.46 124.07 30.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.765 -179.294 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.891 HD11 ' CE1' ' A' ' 40' ' ' HIS . 1.9 mm -103.8 167.79 2.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.984 -179.625 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.519 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 73.59 -134.37 19.06 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.097 -179.16 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.894 ' O ' HD21 ' A' ' 41' ' ' LEU . 1.2 pt-20 -80.71 -175.69 5.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.868 0.366 . . . . 0.0 110.688 178.978 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.9 p -160.19 22.31 0.16 Allowed 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.423 -179.258 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.464 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -163.2 124.29 2.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.85 0.357 . . . . 0.0 111.691 -177.984 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 30' ' ' SER . 1.4 t -91.89 138.77 31.28 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 177.233 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.517 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.7 m-85 -113.38 121.53 44.61 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 119.146 -1.022 . . . . 0.0 112.17 -179.473 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 33.9 t -73.28 102.78 3.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.576 179.174 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.01 -172.33 2.43 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.311 -179.543 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.482 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -92.47 143.58 26.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.03 -179.353 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -93.57 -94.24 1.53 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.672 -179.793 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.22 60.12 1.05 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.957 0.408 . . . . 0.0 111.211 -179.262 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.416 ' HA ' ' CD2' ' A' ' 51' ' ' LEU . 2.9 p 59.57 29.49 19.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.064 179.369 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.0 -25.98 0.24 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.526 -179.95 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.98 -162.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.865 0.364 . . . . 0.0 111.022 -179.849 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.446 ' O ' HG13 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -117.69 139.86 50.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.628 -179.518 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 57' ' ' MET . 2.2 m -156.46 163.48 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.879 179.692 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.56 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 78.4 m95 -124.75 120.42 31.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.937 0.399 . . . . 0.0 111.528 -179.325 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.517 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -69.9 165.9 37.84 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.14 178.155 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.445 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 89.3 Cg_exo -19.35 98.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 125.216 3.944 . . . . 0.0 114.164 -179.004 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.474 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -100.48 -78.76 0.51 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.344 -177.096 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.478 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -76.55 108.3 6.16 Favored Pre-proline 0 N--CA 1.463 0.19 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -175.032 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.902 ' HG2' HD11 ' A' ' 41' ' ' LEU . 1.0 OUTLIER -88.22 -153.99 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.388 2.725 . . . . 0.0 110.993 176.814 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.573 HG22 ' H ' ' A' ' 66' ' ' CYS . 3.0 mm -98.76 169.57 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.875 0.369 . . . . 0.0 110.76 178.629 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.573 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.1 m -160.51 145.77 14.7 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 179.556 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.471 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.3 OUTLIER -164.56 172.38 13.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.039 -179.951 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.491 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 12.1 p -90.22 112.61 24.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.086 0.469 . . . . 0.0 111.078 179.967 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.627 HG12 ' O ' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -47.79 99.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.344 179.863 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.492 ' HE2' HG23 ' A' ' 90' ' ' THR . 0.1 OUTLIER -81.88 116.13 21.39 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.075 179.923 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.407 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -97.68 129.75 44.72 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.308 179.283 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.85 -156.33 0.12 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.362 179.306 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.443 ' HG ' ' CE1' ' A' ' 82' ' ' HIS . 2.1 t -49.26 137.58 15.14 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.854 179.933 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.52 ' HG2' HG11 ' A' ' 95' ' ' VAL . 27.4 Cg_exo -59.9 163.79 13.15 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.405 2.07 . . . . 0.0 112.062 -179.989 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.517 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 86.1 Cg_exo -39.38 156.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.812 2.341 . . . . 0.0 112.894 -179.605 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.6 t -108.8 90.49 3.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.551 179.449 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.721 HG23 ' HE2' ' A' ' 97' ' ' TYR . 35.7 pt -69.43 175.22 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.326 -179.182 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.36 138.18 39.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.622 179.309 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.498 ' HB3' ' CD2' ' A' ' 103' ' ' TYR . 0.3 OUTLIER 68.65 28.07 5.8 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.676 -179.958 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.452 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . -170.21 -159.99 17.47 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.76 179.694 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.417 ' N ' ' O ' ' A' ' 98' ' ' SER . 1.4 ptt85 -170.13 -176.2 2.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.091 0.472 . . . . 0.0 111.022 -179.226 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.457 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 21.4 p-80 -110.25 170.9 7.78 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.918 179.795 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -104.55 -88.09 0.43 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.775 179.88 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.462 ' N ' HG13 ' A' ' 95' ' ' VAL . . . 65.9 153.57 0.19 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.036 178.729 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -114.14 -35.72 4.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.006 0.432 . . . . 0.0 110.813 179.588 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.05 -172.76 2.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.141 -179.532 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -99.99 -21.13 15.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.295 179.987 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.42 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 5.3 m-85 -133.08 176.72 8.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.205 -179.727 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.421 ' OH ' ' HA3' ' A' ' 84' ' ' GLY . 66.4 m-85 -152.77 161.6 42.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.928 -179.689 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.492 HG23 ' HE2' ' A' ' 70' ' ' LYS . 8.1 p -128.36 -175.92 3.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.214 -179.252 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -64.85 94.83 0.14 Allowed 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.271 0.558 . . . . 0.0 110.988 -179.843 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.55 18.72 2.18 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.317 178.656 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.4 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -95.34 162.86 13.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.934 0.367 . . . . 0.0 110.573 179.246 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 35.6 m -138.27 149.64 24.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.13 0.49 . . . . 0.0 111.335 -179.608 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.525 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 23.6 t -146.09 148.68 16.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.743 179.526 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.968 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -106.97 130.89 54.55 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.987 -179.973 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.972 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.9 m-85 -89.88 160.74 16.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.985 -179.67 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.417 ' O ' ' N ' ' A' ' 81' ' ' ARG . 21.3 p -157.37 138.86 13.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.557 -179.941 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.452 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 68.5 m -70.27 164.5 24.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.815 179.4 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -101.68 -85.24 0.43 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.84 0.352 . . . . 0.0 111.207 179.636 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -45.01 -31.36 1.28 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.522 -179.198 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 130.29 45.12 0.17 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.681 179.777 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.504 ' CE1' HG12 ' A' ' 126' ' ' ILE . 29.7 m-85 -87.04 -173.54 4.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.833 0.349 . . . . 0.0 110.836 179.972 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 41.2 m -111.49 108.17 17.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.108 -179.519 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.648 HD23 ' HB2' ' A' ' 122' ' ' PRO . 2.9 tp -44.94 113.16 0.52 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.146 178.935 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.592 HD11 ' HB2' ' A' ' 125' ' ' GLN . 40.0 mm -85.93 156.33 3.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.465 179.79 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.438 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 60.44 -125.62 39.09 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.558 -178.333 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -124.2 135.37 53.4 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.849 0.357 . . . . 0.0 110.584 178.55 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.968 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.2 p -65.94 -29.8 70.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.701 -180.0 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -71.91 137.08 24.97 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.578 179.892 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.972 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.7 t -131.08 119.16 43.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.757 0.313 . . . . 0.0 110.837 179.712 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.03 119.57 23.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.522 -179.006 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.523 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 31.7 t -85.57 101.88 13.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.623 176.996 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.9 t -139.31 153.85 47.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.193 0.52 . . . . 0.0 111.568 -178.143 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.448 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 47.15 33.94 7.71 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.911 179.482 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.461 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 69.94 11.07 65.97 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.746 -179.999 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -131.15 175.15 9.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.899 0.381 . . . . 0.0 110.391 179.225 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.525 ' CZ3' HG23 ' A' ' 95' ' ' VAL . 93.3 m95 -117.12 128.62 55.32 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.787 -179.43 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.38 146.63 35.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.4 -178.852 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.486 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.5 t0 71.53 46.46 0.24 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.207 178.646 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 74.0 Cg_endo -75.32 130.66 13.15 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.319 2.013 . . . . 0.0 111.324 177.934 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.648 ' HB2' HD23 ' A' ' 105' ' ' LEU . 58.0 Cg_endo -86.15 -174.7 1.58 Allowed 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.448 2.099 . . . . 0.0 113.387 -178.229 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.458 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.3 OUTLIER -135.81 -173.62 3.42 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.071 178.392 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 124' ' ' CYS . . . . . 0.435 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 16.5 m -141.61 94.62 2.71 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.94 0.4 . . . . 0.0 111.108 -179.5 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.592 ' HB2' HD11 ' A' ' 106' ' ' ILE . 20.6 mt-30 -118.83 169.42 9.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.713 179.921 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.504 HG12 ' CE1' ' A' ' 103' ' ' TYR . 19.5 mm . . . . . 0 C--N 1.325 -0.491 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.806 -179.796 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.457 -0.084 0 CA-C-O 120.896 0.379 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.701 ' HD2' HG23 ' A' ' 25' ' ' VAL . 4.3 mtm180 -71.93 157.14 38.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.798 179.394 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.473 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 69.4 m -77.67 159.24 77.19 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.577 179.606 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 51.1 Cg_endo -68.85 169.98 16.49 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.345 2.03 . . . . 0.0 111.964 -179.718 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.17 105.91 0.58 Allowed Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.777 -179.745 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.522 ' HG3' ' CZ2' ' A' ' 59' ' ' TRP . 53.0 Cg_exo -53.67 160.16 5.8 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.278 1.985 . . . . 0.0 112.517 -179.759 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.571 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -52.86 -174.58 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.156 177.811 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.767 ' O ' HG22 ' A' ' 15' ' ' ILE . 11.8 p-10 -135.66 -40.88 0.7 Allowed 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -176.314 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.767 HG22 ' O ' ' A' ' 14' ' ' ASP . 5.1 tt 66.08 139.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.777 -177.084 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -94.47 -40.03 10.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.855 -177.736 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.445 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 1.3 m120 -93.83 24.71 4.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.8 0.333 . . . . 0.0 111.116 -179.016 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.08 176.29 40.08 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.544 179.838 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.424 ' N ' ' O ' ' A' ' 34' ' ' SER . 2.2 mt-30 -129.49 129.7 44.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.702 0.287 . . . . 0.0 110.564 179.718 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.699 HD21 ' CE1' ' A' ' 33' ' ' TYR . 49.1 mt -82.63 162.51 21.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.151 0.5 . . . . 0.0 111.632 -179.14 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -130.71 80.59 1.95 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.166 179.259 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.876 ' HA ' HG23 ' A' ' 31' ' ' ILE . 56.3 mt -71.33 103.33 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.441 -178.583 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.31 15.22 50.7 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.303 178.451 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.402 ' O ' ' HB3' ' A' ' 29' ' ' SER . . . 157.11 127.86 1.01 Allowed Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.772 -179.538 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.701 HG23 ' HD2' ' A' ' 8' ' ' ARG . 30.1 m -115.32 26.22 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -178.213 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -101.18 162.09 13.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.986 0.422 . . . . 0.0 110.996 179.08 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.439 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 2.5 t80 -57.18 92.01 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.986 -179.31 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 132.51 -11.87 5.21 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.884 179.87 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.402 ' HB3' ' O ' ' A' ' 24' ' ' GLY . 9.3 m -75.37 -175.74 2.87 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.819 0.309 . . . . 0.0 110.805 179.87 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 47' ' ' SER . 0.3 OUTLIER -154.07 143.45 21.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.493 -179.717 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.876 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -104.51 171.25 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.938 179.222 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.426 ' O ' ' N ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -132.25 120.19 21.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.891 178.933 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.699 ' CE1' HD21 ' A' ' 20' ' ' LEU . 28.5 m-85 -99.65 135.22 41.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.197 -179.624 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.424 ' O ' ' N ' ' A' ' 19' ' ' GLN . 64.3 m -143.33 159.38 42.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.765 179.628 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.438 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 57.0 m -83.87 166.02 18.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.002 -179.947 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.85 -83.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.082 -179.705 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 t -155.44 136.48 13.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.787 -179.895 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.01 23.25 65.7 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.124 -179.294 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.503 ' CE1' ' HB3' ' A' ' 68' ' ' SER . 2.3 m-85 -113.63 -179.02 3.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.918 0.389 . . . . 0.0 110.98 -179.386 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.567 ' CE1' HD11 ' A' ' 42' ' ' ILE . 3.2 p-80 -143.98 114.56 7.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.393 178.095 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.969 HD21 ' O ' ' A' ' 44' ' ' GLU . 2.3 tt -75.25 136.47 40.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.675 -179.105 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.567 HD11 ' CE1' ' A' ' 40' ' ' HIS . 3.1 mm -108.39 153.94 9.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.199 -179.01 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.64 -135.95 19.1 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.554 -179.948 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.969 ' O ' HD21 ' A' ' 41' ' ' LEU . 4.3 pm0 -75.47 -179.14 4.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.624 0.25 . . . . 0.0 110.691 179.733 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.1 p -152.23 21.04 0.65 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.181 -179.784 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.415 ' CE ' ' O ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -151.91 163.06 40.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.896 -178.882 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.472 ' O ' HG13 ' A' ' 31' ' ' ILE . 2.8 m -137.44 112.05 8.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.643 179.99 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.419 ' CD1' ' N ' ' A' ' 48' ' ' TYR . 2.0 m-30 -90.01 121.2 31.87 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.897 0.38 . . . . 0.0 111.334 -179.258 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.502 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 35.1 t -71.56 97.49 1.7 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.55 179.396 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -124.58 -176.49 3.54 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.128 -179.514 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.599 HD13 ' H ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -90.16 150.26 22.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.01 -179.314 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.414 ' HA2' HG21 ' A' ' 58' ' ' VAL . . . -77.24 -118.48 0.18 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.486 -179.889 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.81 -42.04 3.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.859 0.362 . . . . 0.0 110.948 -179.947 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 59.2 p -99.08 56.6 1.04 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.854 -179.888 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 52.84 26.15 25.05 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.373 -179.795 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.85 -165.01 1.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.892 0.377 . . . . 0.0 111.052 -179.851 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 4.0 mmt -124.06 139.08 54.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.443 179.716 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.414 HG21 ' HA2' ' A' ' 52' ' ' GLY . 2.0 m -149.7 -178.13 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.87 0.367 . . . . 0.0 111.275 -179.296 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.564 ' CE3' HD11 ' A' ' 31' ' ' ILE . 95.2 m95 -128.77 123.86 34.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.774 -179.733 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -148.45 119.71 4.34 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.769 -179.459 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -67.72 -176.28 9.64 Favored 'Cis proline' 0 C--N 1.351 0.7 0 C-N-CA 124.135 -1.194 . . . . 0.0 112.718 1.787 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.435 ' O ' ' CD ' ' A' ' 64' ' ' PRO . 0.6 OUTLIER -111.6 -140.77 0.38 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.102 -178.654 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.534 ' CB ' ' CE1' ' A' ' 33' ' ' TYR . . . -95.6 86.17 0.32 Allowed Pre-proline 0 N--CA 1.448 -0.567 0 C-N-CA 122.878 0.471 . . . . 0.0 110.759 179.464 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.713 ' HG2' HD11 ' A' ' 41' ' ' LEU . 9.8 Cg_endo -45.68 -159.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.476 0.451 0 C-N-CA 124.313 3.342 . . . . 0.0 114.53 178.703 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.495 HG22 ' H ' ' A' ' 66' ' ' CYS . 5.5 mm -97.59 165.76 2.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.854 -178.267 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.495 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.2 m -164.83 117.35 1.24 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.342 179.017 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.19 177.68 7.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.893 0.377 . . . . 0.0 111.353 -179.417 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.503 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 49.7 p -88.71 99.35 12.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.22 -179.965 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.765 HG22 ' HA3' ' A' ' 116' ' ' GLY . 6.8 p -60.99 103.89 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.302 178.489 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.5 ' HG2' HG22 ' A' ' 90' ' ' THR . 2.7 mttp -82.21 167.44 18.66 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -176.297 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.421 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -125.96 122.69 36.67 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.525 177.3 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.444 ' CG ' ' N ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -69.43 -155.48 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.988 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.444 ' N ' ' CG ' ' A' ' 72' ' ' GLN . 1.4 t -52.8 144.52 25.6 Favored Pre-proline 0 N--CA 1.448 -0.556 0 C-N-CA 121.081 -0.248 . . . . 0.0 110.373 179.091 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.775 ' HG3' HG21 ' A' ' 95' ' ' VAL . 39.0 Cg_exo -60.78 160.36 25.31 Favored 'Trans proline' 0 C--O 1.231 0.129 0 C-N-CA 122.561 2.174 . . . . 0.0 112.159 -179.327 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -42.39 155.89 0.1 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.568 2.179 . . . . 0.0 112.41 -179.315 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.3 t -103.94 86.39 2.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.828 -179.793 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.642 HD11 ' HA3' ' A' ' 80' ' ' GLY . 8.2 pt -69.85 169.98 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.953 -179.959 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.5 m -91.59 137.91 31.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.81 179.651 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.506 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 4.8 m-80 57.62 29.84 17.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.725 -179.901 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.642 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -165.5 169.36 39.91 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.531 -0.843 . . . . 0.0 112.807 179.685 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 80' ' ' GLY . 19.8 mtt180 -147.19 -166.38 2.5 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.483 0.659 . . . . 0.0 111.622 -178.082 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 1.9 p-80 -130.6 157.24 43.25 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.442 179.911 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.745 ' O ' HG13 ' A' ' 95' ' ' VAL . 1.8 p30 -109.36 86.44 2.29 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.109 177.867 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.418 ' HA3' ' OH ' ' A' ' 89' ' ' TYR . . . -90.96 153.49 22.39 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 119.478 -1.344 . . . . 0.0 112.522 -179.149 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.05 -36.97 8.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.172 0.51 . . . . 0.0 110.377 -179.395 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.76 -176.3 3.0 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.262 -179.482 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.88 -26.49 18.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.193 177.809 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.407 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 4.2 m-85 -134.11 171.85 13.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.535 179.22 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.421 ' N ' ' O ' ' A' ' 71' ' ' CYS . 26.2 m-85 -140.22 158.45 44.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.034 -179.746 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.5 HG22 ' HG2' ' A' ' 70' ' ' LYS . 5.5 p -122.71 176.34 6.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.572 -178.32 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 7.5 p-10 -60.85 93.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.76 179.495 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 125.56 19.1 2.35 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.126 179.134 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -98.82 158.85 15.36 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.868 0.334 . . . . 0.0 110.33 178.865 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 27.8 m -145.57 142.27 22.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.421 0.629 . . . . 0.0 111.972 -179.491 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.853 HG22 ' CH2' ' A' ' 118' ' ' TRP . 40.7 t -144.46 148.12 18.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.488 178.167 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.461 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -95.68 159.92 14.75 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.083 0.468 . . . . 0.0 111.796 -177.5 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.827 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.9 m-85 -110.7 155.66 22.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.997 179.223 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.1 p -150.25 140.18 21.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.339 -178.958 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.442 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 83.9 m -75.24 146.92 40.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.222 -179.951 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -78.78 -83.2 0.09 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.622 -179.057 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.2 t -52.47 -22.96 5.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.538 -178.647 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 123.1 30.55 1.09 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.808 179.971 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.506 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 48.9 m-85 -69.32 -172.19 0.42 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.724 0.297 . . . . 0.0 110.51 179.413 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.2 m -110.45 107.32 16.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.999 0.428 . . . . 0.0 111.302 -179.257 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.539 HD23 ' HB2' ' A' ' 122' ' ' PRO . 1.9 tp -45.52 112.96 0.52 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.944 178.734 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.534 HG22 ' N ' ' A' ' 107' ' ' GLY . 20.1 mm -90.6 160.85 2.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.051 -178.874 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.534 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 56.5 -129.29 48.25 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.148 -179.641 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -110.4 125.0 52.77 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.8 0.333 . . . . 0.0 110.932 179.873 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.511 ' HA ' HD21 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -67.67 -34.57 77.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.203 178.661 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -79.08 130.83 10.17 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.982 178.479 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.827 HG21 ' CE1' ' A' ' 97' ' ' TYR . 3.2 t -117.63 141.33 36.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 179.786 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.07 122.73 44.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.99 0.424 . . . . 0.0 111.712 -178.469 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.428 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 10.9 t -85.88 105.99 16.77 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.055 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.6 OUTLIER -145.34 154.6 42.49 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.183 0.516 . . . . 0.0 111.349 -178.422 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 54.36 22.09 21.89 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.73 179.548 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.765 ' HA3' HG22 ' A' ' 69' ' ' VAL . . . 87.55 -6.44 83.4 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.533 -0.842 . . . . 0.0 113.005 179.996 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -128.66 -176.81 3.95 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.09 0.472 . . . . 0.0 110.932 -179.698 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.853 ' CH2' HG22 ' A' ' 95' ' ' VAL . 95.3 m95 -108.92 157.62 18.46 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.831 -179.71 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.47 149.11 42.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.061 0.458 . . . . 0.0 111.324 -179.369 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.471 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.7 OUTLIER 68.21 47.67 0.39 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.786 178.69 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 74.0 Cg_endo -75.31 137.68 21.34 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.314 2.009 . . . . 0.0 111.534 178.422 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.539 ' HB2' HD23 ' A' ' 105' ' ' LEU . 59.5 Cg_endo -89.29 -174.13 0.89 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.543 2.162 . . . . 0.0 113.561 -178.212 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.45 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -133.6 -174.06 3.41 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.913 177.997 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 8.3 m -143.3 96.5 2.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.143 0.497 . . . . 0.0 111.146 -179.811 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.495 ' HB2' HD11 ' A' ' 106' ' ' ILE . 13.2 mt-30 -121.62 157.72 30.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.775 -179.998 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.549 ' O ' HG22 ' A' ' 126' ' ' ILE . 37.3 mm . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.93 179.918 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 23.1 mmt85 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.788 0.327 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 041 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.428 ' HD2' HG23 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -118.3 178.3 4.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.085 -179.693 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.47 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 55.6 m -93.01 160.17 34.21 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.202 -179.126 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.04 176.56 7.56 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.714 2.276 . . . . 0.0 112.531 -179.338 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -50.14 106.58 0.65 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.701 179.662 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.514 ' HG3' ' CZ2' ' A' ' 59' ' ' TRP . 76.2 Cg_exo -48.68 144.22 14.97 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.466 2.111 . . . . 0.0 112.676 -179.323 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.508 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -54.94 164.74 0.75 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.882 178.651 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.569 ' HA ' HD11 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -116.6 -174.17 2.52 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.322 0.582 . . . . 0.0 112.025 -177.785 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.436 HG23 ' C ' ' A' ' 18' ' ' GLY . 2.7 tt -142.06 145.07 24.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.263 -179.768 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -74.9 -66.84 0.7 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -177.106 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.419 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 0.7 OUTLIER -91.74 26.62 2.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.336 -177.998 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.436 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -142.47 -175.5 15.78 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.241 -0.981 . . . . 0.0 113.279 -179.399 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -140.45 137.54 34.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.691 0.282 . . . . 0.0 110.357 179.294 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.569 HD11 ' HA ' ' A' ' 14' ' ' ASP . 3.7 mt -80.45 163.85 23.48 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.154 0.502 . . . . 0.0 111.794 -179.009 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -135.69 71.06 1.42 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.536 177.283 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.846 ' HA ' HG23 ' A' ' 31' ' ' ILE . 62.2 mt -69.9 103.56 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.84 -177.758 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.18 18.21 42.78 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.985 177.843 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 156.02 131.74 1.44 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 121.14 -0.552 . . . . 0.0 111.936 -179.586 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.428 HG23 ' HD2' ' A' ' 8' ' ' ARG . 32.3 m -116.43 25.97 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.686 0.279 . . . . 0.0 111.683 -178.822 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.2 152.23 19.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.042 179.792 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.412 ' CZ ' ' HB3' ' A' ' 51' ' ' LEU . 2.2 t80 -55.51 91.31 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.979 0.419 . . . . 0.0 110.441 179.327 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 131.92 -10.09 5.43 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.515 -178.825 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 92.2 p -75.11 -167.73 0.66 Allowed 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 179.326 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.1 p -157.7 152.05 24.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.073 0.463 . . . . 0.0 111.668 179.857 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.846 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -113.84 169.36 5.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.327 179.332 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.42 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -133.31 112.81 11.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.9 0.381 . . . . 0.0 111.062 178.621 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.535 ' CE1' HD22 ' A' ' 20' ' ' LEU . 17.0 m-85 -85.3 138.53 32.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.946 179.955 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.421 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.2 OUTLIER -138.35 168.75 19.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.668 -179.982 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.458 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 3.8 m -91.65 160.81 15.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.733 179.872 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.96 -79.68 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.184 -179.303 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.03 133.65 10.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.724 -179.786 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.599 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 60.72 25.39 63.52 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.79 -178.907 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.488 ' CD2' ' HA ' ' A' ' 68' ' ' SER . 2.3 m-85 -116.53 171.37 7.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.709 0.29 . . . . 0.0 110.78 -179.354 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.612 ' HB3' HG22 ' A' ' 69' ' ' VAL . 1.8 p-80 -130.66 131.62 44.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.019 0.438 . . . . 0.0 110.718 178.764 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.755 HD21 ' HB2' ' A' ' 64' ' ' PRO . 3.3 tt -87.7 131.01 34.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.816 -179.054 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.536 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.1 mm -105.45 154.23 6.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.982 0.42 . . . . 0.0 111.143 -179.365 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.09 -136.35 23.85 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.61 -178.469 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.421 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 0.8 OUTLIER -81.45 -178.12 6.8 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.33 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.442 ' HA ' ' HG2' ' A' ' 64' ' ' PRO . 6.4 p -155.17 23.6 0.42 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.104 -179.313 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.42 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 3.4 mtpt -147.48 141.57 26.04 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.199 -178.642 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.45 ' HB2' ' CG1' ' A' ' 31' ' ' ILE . 2.5 m -113.01 147.16 37.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.105 178.924 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.452 ' CD1' ' HD3' ' A' ' 61' ' ' PRO . 1.7 m-85 -119.16 121.78 40.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.014 0.435 . . . . 0.0 111.424 -179.597 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.524 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 18.8 t -70.26 77.09 0.53 Allowed 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.03 178.474 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -102.64 179.63 4.24 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.371 -178.491 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -88.43 162.12 16.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.212 -178.821 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.58 -136.77 6.2 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.552 -179.987 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.1 m -93.87 -40.75 9.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.78 0.324 . . . . 0.0 111.102 -179.74 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 61.8 p -98.65 46.19 1.0 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.16 -179.672 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 61.74 15.62 48.59 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.884 179.507 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.0 t -76.67 -163.35 0.32 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.69 0.281 . . . . 0.0 110.763 179.679 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.97 124.53 37.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.914 0.387 . . . . 0.0 110.457 179.808 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.6 m -139.8 165.76 21.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.216 -179.199 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.82 ' CE3' HD11 ' A' ' 31' ' ' ILE . 92.2 m95 -102.24 127.62 49.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.17 178.629 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.404 ' HA ' ' C ' ' A' ' 61' ' ' PRO . 14.0 t30 -159.67 127.59 2.81 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.745 -176.873 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.452 ' HD3' ' CD1' ' A' ' 48' ' ' TYR . 21.4 Cg_exo -68.77 -174.38 8.51 Favored 'Cis proline' 0 C--N 1.351 0.677 0 C-N-CA 124.236 -1.152 . . . . 0.0 112.697 1.364 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -110.7 -152.15 0.49 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.128 -178.38 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.457 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -75.27 110.96 11.66 Favored Pre-proline 0 CA--C 1.53 0.181 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.176 -179.717 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.755 ' HB2' HD21 ' A' ' 41' ' ' LEU . 23.6 Cg_exo -66.42 -145.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.832 2.355 . . . . 0.0 112.174 -179.871 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.489 HG22 ' H ' ' A' ' 66' ' ' CYS . 3.4 mm -106.39 165.59 4.01 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 120.762 0.315 . . . . 0.0 111.312 -178.73 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.489 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.8 OUTLIER -164.18 124.46 2.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.92 179.632 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.478 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 3.8 tt0 -143.73 -179.64 6.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.938 179.96 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.488 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 1.3 p -86.43 119.44 26.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.021 0.439 . . . . 0.0 111.125 -179.894 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.612 HG22 ' HB3' ' A' ' 40' ' ' HIS . 3.8 p -49.3 96.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.278 179.778 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 89' ' ' TYR . 1.4 mmtp -71.31 139.87 50.08 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.863 179.752 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.2 128.11 55.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.922 0.391 . . . . 0.0 110.781 179.58 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.412 ' O ' ' NE1' ' A' ' 118' ' ' TRP . 0.0 OUTLIER -67.42 -175.54 0.5 Allowed 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 121.912 0.863 . . . . 0.0 113.176 -177.677 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.558 ' HG ' ' CE1' ' A' ' 82' ' ' HIS . 0.3 OUTLIER -51.82 119.09 12.99 Favored Pre-proline 0 N--CA 1.439 -0.98 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.484 176.388 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.498 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 51.4 Cg_exo -41.71 155.04 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.063 1.842 . . . . 0.0 112.416 -176.564 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.412 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 85.6 Cg_exo -45.31 157.08 0.28 Allowed 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.88 2.387 . . . . 0.0 112.854 -179.015 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.31 90.79 3.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.845 -179.933 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.662 HG21 ' O ' ' A' ' 122' ' ' PRO . 18.4 pt -69.5 171.72 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.361 -179.484 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.7 p -88.12 136.66 32.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.707 179.242 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.497 ' HB3' ' CD2' ' A' ' 103' ' ' TYR . 0.0 OUTLIER 66.34 26.53 10.24 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.52 -179.576 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.446 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . 178.03 -178.66 48.53 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.625 179.978 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.406 ' NE ' ' OD1' ' A' ' 100' ' ' ASN . 0.1 OUTLIER -170.25 -175.84 2.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.784 0.326 . . . . 0.0 110.605 -179.714 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.558 ' CE1' ' HG ' ' A' ' 73' ' ' SER . 42.6 p-80 -95.35 168.91 10.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.038 179.831 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -105.53 -72.32 0.72 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.706 179.392 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.433 ' HA3' ' OH ' ' A' ' 89' ' ' TYR . . . 59.72 153.36 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.996 178.911 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -112.36 -26.33 8.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.996 0.427 . . . . 0.0 110.863 179.521 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.8 -173.46 2.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.236 -179.315 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.59 -23.46 13.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.854 178.973 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.431 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 6.4 m-85 -135.13 175.07 9.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.841 179.876 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.433 ' OH ' ' HA3' ' A' ' 84' ' ' GLY . 39.0 m-85 -145.52 165.01 29.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.972 -179.429 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.8 p -130.32 163.02 27.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.998 0.428 . . . . 0.0 111.47 -178.901 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -50.22 95.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.009 -179.91 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.69 26.53 1.14 Allowed Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.32 -0.855 . . . . 0.0 113.114 178.809 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.407 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -110.28 161.93 15.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.837 0.319 . . . . 0.0 110.6 179.065 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.485 HG22 ' N ' ' A' ' 95' ' ' VAL . 34.1 m -135.2 157.83 40.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.061 0.457 . . . . 0.0 111.058 -179.996 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.496 HG11 ' HB2' ' A' ' 82' ' ' HIS . 25.4 t -148.99 148.24 15.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.299 179.52 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.857 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -109.62 120.93 44.02 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.349 0.595 . . . . 0.0 111.126 -179.372 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.971 ' CE2' HG21 ' A' ' 111' ' ' VAL . 4.4 m-85 -77.26 158.12 30.42 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.69 -178.671 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.0 p -154.37 139.11 17.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.551 -179.929 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.446 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 6.9 m -69.85 164.02 24.61 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.51 179.971 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.406 ' OD1' ' NE ' ' A' ' 81' ' ' ARG . 28.9 m-20 -95.12 -69.93 0.73 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.314 -179.543 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.6 t -68.74 -34.45 75.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.345 -178.928 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 137.14 41.77 0.1 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.574 -179.925 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.518 ' CD1' ' CD1' ' A' ' 126' ' ' ILE . 15.4 m-85 -80.8 -168.14 1.66 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 179.479 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.8 m -117.15 105.42 12.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.804 0.335 . . . . 0.0 111.538 -179.642 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.477 ' CD2' ' HB2' ' A' ' 122' ' ' PRO . 1.6 tp -48.97 121.84 5.17 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.107 0.48 . . . . 0.0 110.615 178.509 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.473 HG22 ' N ' ' A' ' 107' ' ' GLY . 33.7 mm -103.12 159.31 4.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.566 -177.298 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.473 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 52.37 30.32 32.74 Favored Glycine 0 CA--C 1.509 -0.343 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.546 179.468 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.418 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.6 OUTLIER 59.65 127.9 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.984 -0.608 . . . . 0.0 111.394 179.679 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.857 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.2 p -58.56 -29.21 66.2 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.97 -178.332 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -52.69 131.39 39.79 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.706 -0.759 . . . . 0.0 113.154 -178.651 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.971 HG21 ' CE2' ' A' ' 97' ' ' TYR . 2.3 t -130.72 144.28 38.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.39 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.1 tt -104.93 125.24 50.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.963 0.411 . . . . 0.0 112.076 -177.803 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.438 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 11.2 t -88.59 95.47 10.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.436 176.547 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 p -139.06 163.64 31.88 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.208 -178.45 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.2 26.18 2.15 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.773 179.802 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.441 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 76.11 1.51 69.01 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.955 -179.633 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -131.64 179.71 5.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.808 0.337 . . . . 0.0 110.61 179.525 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.498 ' CH2' ' HG3' ' A' ' 74' ' ' PRO . 93.5 m95 -107.79 125.65 51.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 -179.898 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.56 145.07 36.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.145 -179.474 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.486 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 2.0 t70 66.89 44.5 0.35 Allowed Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.256 178.71 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 52.9 Cg_endo -67.44 149.83 80.42 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 121.893 1.728 . . . . 0.0 110.354 176.912 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.662 ' O ' HG21 ' A' ' 77' ' ' ILE . 42.0 Cg_endo -95.71 -178.19 0.45 Allowed 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 122.129 1.886 . . . . 0.0 114.039 -176.925 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.427 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -124.34 -159.81 0.89 Allowed 'General case' 0 CA--C 1.502 -0.867 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.009 176.796 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 124' ' ' CYS . . . . . 0.579 ' HB2' HD12 ' A' ' 77' ' ' ILE . 3.8 t -170.34 93.8 0.22 Allowed 'General case' 0 N--CA 1.433 -1.288 0 CA-C-O 121.772 0.796 . . . . 0.0 110.87 -175.906 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -106.88 -169.33 1.53 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.303 -1.317 . . . . 0.0 112.096 -176.891 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.662 ' O ' HG22 ' A' ' 126' ' ' ILE . 19.1 mm . . . . . 0 C--N 1.313 -1.012 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.11 179.51 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.822 0.344 . . . . 0.0 110.938 . . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.68 ' HD3' HG23 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -98.89 176.76 5.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.833 -179.859 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.472 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 60.3 m -90.24 161.25 38.01 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.681 179.85 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 37.2 Cg_endo -67.34 176.52 4.71 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.549 2.166 . . . . 0.0 112.393 -179.345 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.3 t -51.78 109.39 1.38 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.06 -179.368 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.409 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 2.3 Cg_endo -52.33 152.97 14.21 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.16 1.907 . . . . 0.0 111.894 179.757 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.825 ' O ' HD11 ' A' ' 20' ' ' LEU . 14.6 mtt180 -66.4 160.2 25.31 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.191 179.24 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -110.86 -178.69 3.54 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-O 121.223 0.535 . . . . 0.0 112.17 -176.129 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.491 HG22 ' CD2' ' A' ' 20' ' ' LEU . 6.0 tt -142.14 145.32 24.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.539 179.673 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -80.36 -65.0 1.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.829 -178.026 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -93.47 36.46 1.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.878 0.371 . . . . 0.0 110.961 -178.909 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.426 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -150.06 176.95 28.48 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.813 179.69 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -136.55 123.66 21.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.779 0.323 . . . . 0.0 110.75 179.595 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.825 HD11 ' O ' ' A' ' 13' ' ' ARG . 14.6 mt -74.41 159.03 32.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.164 0.506 . . . . 0.0 111.92 -179.124 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.453 ' HB3' ' CB ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -130.52 74.3 1.59 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.914 177.608 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.845 ' HA ' HG23 ' A' ' 31' ' ' ILE . 62.6 mt -69.78 93.2 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.735 -178.174 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.73 20.9 47.61 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.932 178.078 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 29' ' ' SER . . . 151.89 133.32 1.96 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.942 -179.455 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.68 HG23 ' HD3' ' A' ' 8' ' ' ARG . 11.9 m -118.37 8.95 6.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.134 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 16.0 t70 -74.46 163.45 27.75 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.011 0.434 . . . . 0.0 110.825 179.481 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.561 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 7.9 t80 -59.79 93.6 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.535 179.987 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.17 -7.73 7.15 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.494 -178.804 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.409 ' OG ' ' N ' ' A' ' 26' ' ' ASP . 1.3 m -71.67 174.32 6.92 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.841 0.32 . . . . 0.0 110.626 179.589 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -143.83 145.3 32.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.018 -179.973 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.845 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -107.34 164.22 4.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.629 179.996 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.453 ' CB ' ' HB3' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -126.48 113.61 17.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.845 179.467 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.824 ' CE1' HD21 ' A' ' 20' ' ' LEU . 21.5 m-85 -91.4 138.56 31.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.556 -179.421 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.426 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.4 OUTLIER -139.87 173.81 11.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.512 179.313 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 1.2 m -92.83 169.92 10.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.347 . . . . 0.0 111.027 -179.915 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -61.97 -85.45 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.333 -178.844 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.73 116.6 2.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.289 179.917 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.541 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 84.16 -8.08 68.79 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.129 -177.282 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.52 ' CZ ' ' HB3' ' A' ' 68' ' ' SER . 4.0 m-85 -82.25 176.27 9.6 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 120.912 0.387 . . . . 0.0 110.84 179.678 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.533 ' NE2' HG22 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -129.54 129.46 44.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.122 175.983 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.937 HD11 ' HG2' ' A' ' 64' ' ' PRO . 9.2 tt -93.92 112.1 23.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.523 -179.624 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.553 ' N ' HD13 ' A' ' 42' ' ' ILE . 1.2 mm -85.77 149.27 4.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.085 0.469 . . . . 0.0 110.955 -179.009 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.36 -149.77 30.98 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.121 -178.892 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.754 ' O ' HD21 ' A' ' 41' ' ' LEU . 7.4 pt-20 -77.78 176.89 8.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.043 0.449 . . . . 0.0 110.856 179.297 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 33' ' ' TYR . 2.5 p -147.05 28.14 1.03 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.014 -179.306 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.55 138.32 23.4 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.971 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -110.73 159.44 17.62 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.978 178.191 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.492 ' CD1' ' HB3' ' A' ' 60' ' ' ASN . 1.7 m-85 -134.27 119.22 18.47 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 119.509 -0.876 . . . . 0.0 112.38 -179.217 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.412 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 37.2 t -69.75 84.83 0.47 Allowed 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.286 178.81 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.499 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 1.9 tt0 -109.45 173.72 6.19 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.49 -179.178 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.561 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -86.81 155.85 20.13 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.095 -179.284 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.33 -140.01 5.67 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.506 179.844 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.4 m -91.41 -38.06 12.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.765 0.317 . . . . 0.0 111.133 -179.754 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.2 p -97.43 44.28 1.05 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.123 -179.678 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.88 19.61 37.49 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.689 179.705 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.0 t -79.13 -162.6 0.41 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.766 0.317 . . . . 0.0 110.828 179.801 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.0 mmt -128.49 119.6 25.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.576 179.479 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.1 m -127.05 177.18 5.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.648 -179.982 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.529 ' CE3' HD11 ' A' ' 31' ' ' ILE . 68.7 m95 -118.07 121.13 39.79 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.672 -178.896 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.492 ' HB3' ' CD1' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -70.39 162.98 66.68 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.005 178.011 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.441 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 80.5 Cg_exo -16.64 97.64 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.83 1 C-N-CA 125.534 4.156 . . . . 0.0 114.76 -177.773 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.501 ' HB3' ' CE2' ' A' ' 33' ' ' TYR . 6.1 mt-10 -98.49 -81.71 0.44 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.313 -178.309 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . . . -75.49 108.34 5.59 Favored Pre-proline 0 CA--C 1.529 0.151 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -176.419 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.937 ' HG2' HD11 ' A' ' 41' ' ' LEU . 1.3 Cg_endo -85.5 -154.84 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.222 2.615 . . . . 0.0 110.855 177.071 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.466 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 2.0 mm -97.66 161.17 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.057 0.456 . . . . 0.0 110.756 178.606 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -154.09 138.45 16.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.888 179.988 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.478 ' O ' ' CD2' ' A' ' 39' ' ' TYR . 0.6 OUTLIER -144.54 167.9 21.41 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.354 179.639 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.52 ' HB3' ' CZ ' ' A' ' 39' ' ' TYR . 1.2 p -108.4 118.56 37.09 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.12 0.486 . . . . 0.0 111.511 -179.396 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.541 HG12 ' O ' ' A' ' 38' ' ' GLY . 2.6 p -46.95 97.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.309 179.364 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.475 ' HA ' HG22 ' A' ' 90' ' ' THR . 0.3 OUTLIER -78.89 131.06 36.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.546 -179.221 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -113.96 117.86 32.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.957 178.527 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -163.75 0.09 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.127 0.489 . . . . 0.0 110.978 -179.493 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -41.09 132.92 1.91 Allowed Pre-proline 0 N--CA 1.436 -1.142 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.926 179.111 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.48 ' HG3' ' CZ2' ' A' ' 118' ' ' TRP . 26.2 Cg_exo -60.78 158.16 34.43 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.321 2.014 . . . . 0.0 112.146 -179.625 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -44.95 156.93 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.905 2.403 . . . . 0.0 113.291 -178.923 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.0 t -104.99 93.41 4.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.464 179.195 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.579 HG23 ' HE2' ' A' ' 97' ' ' TYR . 24.3 pt -68.88 177.16 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.576 -178.556 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.6 m -92.9 144.47 25.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.681 179.478 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.492 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 5.0 m-80 58.25 27.94 15.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.033 179.706 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.457 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . -173.93 -168.14 34.49 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.962 179.69 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.11 -175.23 4.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.971 0.415 . . . . 0.0 110.415 -179.386 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.473 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 12.8 p-80 -108.47 166.0 11.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.907 179.411 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -97.86 -85.14 0.37 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.704 179.912 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.575 ' H ' HG13 ' A' ' 95' ' ' VAL . . . 65.06 148.86 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.699 179.22 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.482 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -111.38 -38.4 4.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.14 0.495 . . . . 0.0 110.564 179.724 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.13 -172.55 2.46 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.837 179.721 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -100.1 -21.44 15.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.148 179.737 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.404 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 14.1 m-85 -131.26 173.53 10.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.173 -179.83 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.42 ' OH ' ' HA3' ' A' ' 84' ' ' GLY . 69.6 m-85 -154.27 167.0 31.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.677 -179.655 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.475 HG22 ' HA ' ' A' ' 70' ' ' LYS . 21.4 p -151.68 -176.18 5.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.12 0.486 . . . . 0.0 111.845 -179.162 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 25.7 m-20 -50.13 94.56 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.488 -179.554 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.32 20.29 2.46 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.273 177.938 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -110.32 152.83 25.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 117.216 0.508 . . . . 0.0 110.757 179.224 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.457 HG22 ' N ' ' A' ' 95' ' ' VAL . 32.9 m -138.26 156.11 29.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.081 0.467 . . . . 0.0 111.03 -179.718 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.602 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 7.4 t -146.58 145.17 19.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.597 -179.926 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.893 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -104.65 125.6 50.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.134 0.492 . . . . 0.0 110.693 179.938 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.943 ' CE1' HG21 ' A' ' 111' ' ' VAL . 5.2 m-85 -84.27 160.88 20.66 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.498 -178.172 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.1 p -154.05 140.55 18.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.973 0.416 . . . . 0.0 111.775 -178.838 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.457 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 9.9 m -69.29 165.79 19.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.453 179.83 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -91.03 -68.67 0.78 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.136 179.956 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.74 -38.42 62.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.293 -179.36 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 143.71 41.17 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.842 179.572 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.509 ' CE2' HG12 ' A' ' 126' ' ' ILE . 12.4 m-85 -75.36 -167.63 0.68 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 178.698 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 124' ' ' CYS . 4.3 p -115.39 106.15 13.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.851 0.357 . . . . 0.0 111.369 179.635 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.485 HD22 ' HA ' ' A' ' 109' ' ' SER . 1.6 tp -51.54 119.76 4.47 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.431 178.469 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.547 HG22 ' N ' ' A' ' 107' ' ' GLY . 26.6 mm -100.14 163.01 3.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.349 -177.709 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.547 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 50.54 27.89 13.51 Favored Glycine 0 CA--C 1.508 -0.353 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.679 179.237 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.43 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.3 OUTLIER 60.51 132.64 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.406 0.622 . . . . 0.0 111.293 179.99 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.893 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.3 p -57.61 -25.79 60.59 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.155 -178.441 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -58.77 132.81 52.74 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.78 -177.631 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.943 HG21 ' CE1' ' A' ' 97' ' ' TYR . 3.0 t -133.54 119.56 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 177.807 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.874 HD22 ' N ' ' A' ' 113' ' ' CYS . 1.2 tm? -83.18 136.54 34.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.612 0.244 . . . . 0.0 111.344 -178.709 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.874 ' N ' HD22 ' A' ' 112' ' ' LEU . 42.8 t -106.84 105.86 16.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.455 177.69 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.584 ' CB ' HD11 ' A' ' 112' ' ' LEU . 5.9 t -160.94 135.82 7.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.981 0.419 . . . . 0.0 111.333 179.259 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.424 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 83.32 25.27 48.43 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.07 -179.658 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.444 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 70.85 14.84 73.38 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.231 -178.867 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -142.66 -179.65 6.44 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.05 0.452 . . . . 0.0 111.162 179.958 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.602 ' CZ3' HG23 ' A' ' 95' ' ' VAL . 94.2 m95 -120.65 123.57 43.11 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.253 -179.75 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.559 ' OG ' HD12 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -83.36 128.14 34.26 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.112 175.016 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.663 ' HB2' HG13 ' A' ' 111' ' ' VAL . 70.0 m-20 109.55 -124.65 0.0 OUTLIER Pre-proline 0 CA--C 1.476 -1.878 0 N-CA-C 100.339 -3.948 . . . . 0.0 100.339 -166.533 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.539 ' CA ' ' CB ' ' A' ' 120' ' ' ASP . 67.6 Cg_endo -60.77 178.24 6.14 Favored 'Cis proline' 0 C--N 1.315 -1.235 0 CA-C-N 125.038 2.835 . . . . 0.0 112.553 -21.243 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.599 ' HD3' HG22 ' A' ' 111' ' ' VAL . 43.4 Cg_endo -85.97 179.93 3.53 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.401 2.067 . . . . 0.0 113.006 179.71 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.413 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -114.77 -162.74 0.83 Allowed 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.168 176.157 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 124' ' ' CYS . . . . . 0.442 ' SG ' ' HB2' ' A' ' 103' ' ' TYR . 4.7 t -170.44 88.91 0.14 Allowed 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 120.109 -0.637 . . . . 0.0 110.828 -175.72 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -117.57 173.64 6.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.27 -177.756 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.651 ' O ' HG22 ' A' ' 126' ' ' ILE . 47.8 mm . . . . . 0 C--N 1.322 -0.602 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.897 -179.751 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.832 0.348 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.456 ' HD2' HG23 ' A' ' 25' ' ' VAL . 11.6 mtm-85 -87.03 -173.44 4.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.839 179.679 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.451 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 26.7 m -85.08 160.72 54.43 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.297 -179.165 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.42 171.98 16.59 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.675 2.25 . . . . 0.0 112.237 179.824 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.8 t -51.23 106.45 0.65 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.922 -179.962 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.498 ' HG3' ' CZ2' ' A' ' 59' ' ' TRP . 76.7 Cg_exo -46.92 149.98 2.96 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.331 2.021 . . . . 0.0 112.135 179.643 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.792 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -69.85 143.69 52.78 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.215 0.531 . . . . 0.0 110.321 179.031 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -93.67 -176.86 4.2 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.061 -176.541 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.453 HD12 ' HB1' ' A' ' 63' ' ' ALA . 6.5 tt -135.71 151.04 29.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.599 179.588 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -75.93 -68.83 0.54 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.808 -177.631 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.432 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 1.0 OUTLIER -89.87 44.8 1.23 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.862 0.363 . . . . 0.0 110.985 -179.056 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.437 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -167.36 179.84 40.67 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.957 179.939 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.9 134.54 28.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.823 0.344 . . . . 0.0 110.934 179.645 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.899 HD21 ' CE1' ' A' ' 33' ' ' TYR . 18.6 mt -80.02 158.5 26.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.116 0.484 . . . . 0.0 111.924 -178.855 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 32' ' ' THR . 0.7 OUTLIER -129.1 76.93 1.76 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.866 177.602 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.838 ' HA ' HG23 ' A' ' 31' ' ' ILE . 28.8 mt -70.16 112.6 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.265 -177.607 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -108.47 18.25 32.89 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.926 -0.655 . . . . 0.0 111.693 176.675 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 29' ' ' SER . . . 151.18 136.85 2.56 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 111.759 -0.537 . . . . 0.0 111.759 -179.148 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.456 HG23 ' HD2' ' A' ' 8' ' ' ARG . 18.9 m -118.06 12.21 7.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -178.915 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -69.86 157.48 37.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.8 0.333 . . . . 0.0 110.824 179.415 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.586 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 7.5 t80 -55.62 91.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.628 179.759 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 49' ' ' CYS . . . 127.22 -10.75 6.9 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.677 -179.394 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.407 ' HB3' ' O ' ' A' ' 24' ' ' GLY . 61.1 m -58.71 -174.52 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.748 0.309 . . . . 0.0 110.743 179.898 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 47' ' ' SER . 23.0 p -151.59 140.21 20.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.232 179.736 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.838 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -107.87 166.58 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.551 179.661 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.424 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -129.1 108.6 10.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.885 179.522 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.899 ' CE1' HD21 ' A' ' 20' ' ' LEU . 18.2 m-85 -82.47 149.58 27.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.017 0.436 . . . . 0.0 111.043 -179.814 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.429 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.3 OUTLIER -150.91 164.79 35.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.681 -179.949 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.432 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 3.7 m -87.28 161.57 17.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.855 -179.925 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -57.72 -84.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.078 -179.683 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.74 135.65 14.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.634 179.95 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.779 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 60.16 25.94 62.96 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.522 -0.846 . . . . 0.0 111.732 -178.84 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.481 ' CD2' ' HA ' ' A' ' 68' ' ' SER . 2.1 m-85 -117.0 172.08 7.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.836 0.35 . . . . 0.0 111.088 -179.045 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.535 ' CE1' HD11 ' A' ' 42' ' ' ILE . 1.6 p-80 -133.27 120.44 21.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.491 178.017 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.972 HD21 ' O ' ' A' ' 44' ' ' GLU . 3.6 tt -81.86 132.76 35.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.245 -179.844 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.553 ' HB ' HD12 ' A' ' 65' ' ' ILE . 2.5 mm -101.7 151.54 5.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.219 -178.551 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.39 -147.08 38.48 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.064 -179.044 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.972 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.6 OUTLIER -66.2 -177.92 0.58 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.88 0.371 . . . . 0.0 110.766 179.289 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.57 27.93 0.16 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.289 178.72 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.424 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -147.79 132.45 17.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.324 -179.047 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.403 ' O ' ' HA ' ' A' ' 30' ' ' SER . 2.1 m -104.21 150.04 24.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.152 178.641 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.463 ' CE1' ' HD3' ' A' ' 61' ' ' PRO . 6.8 m-85 -124.18 125.6 44.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.047 0.451 . . . . 0.0 111.51 -178.879 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.502 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 28.3 t -74.58 86.26 2.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.356 179.106 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.498 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 1.1 tt0 -105.13 175.4 5.51 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.425 -179.243 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.586 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -89.11 154.07 20.47 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.948 -179.94 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -82.22 -141.12 3.63 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.546 -179.961 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.3 m -99.42 -35.78 9.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.82 0.343 . . . . 0.0 111.023 -179.8 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.7 p -94.13 37.6 1.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.928 -179.986 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 63.22 26.13 69.01 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.35 -179.733 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.8 t -91.86 -167.8 1.86 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.897 0.38 . . . . 0.0 111.02 -179.943 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.8 mmt -122.39 129.24 51.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.345 179.364 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.9 m -140.68 -176.81 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.12 -179.076 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.756 ' CE3' HD11 ' A' ' 31' ' ' ILE . 90.9 m95 -123.02 124.81 43.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.289 -179.246 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.427 ' O ' ' CD1' ' A' ' 48' ' ' TYR . 14.5 m-80 -146.88 126.92 6.77 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.886 179.851 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.463 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 71.6 Cg_endo -75.89 -163.64 3.33 Favored 'Cis proline' 0 C--N 1.351 0.685 0 C-N-CA 123.892 -1.295 . . . . 0.0 112.206 -0.34 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.49 ' O ' ' CZ ' ' A' ' 33' ' ' TYR . 28.6 mm-40 -110.13 -107.9 0.35 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.095 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.547 ' HB2' ' HE1' ' A' ' 33' ' ' TYR . . . -122.0 100.0 43.39 Favored Pre-proline 0 N--CA 1.445 -0.714 0 C-N-CA 122.514 0.325 . . . . 0.0 110.722 -177.937 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.78 ' HG2' HD11 ' A' ' 41' ' ' LEU . 20.7 Cg_endo -50.59 -158.02 0.0 OUTLIER 'Trans proline' 0 N--CA 1.476 0.448 0 C-N-CA 123.286 2.657 . . . . 0.0 112.939 177.652 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.64 HG22 ' H ' ' A' ' 66' ' ' CYS . 1.0 OUTLIER -93.0 174.94 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.505 -179.136 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.64 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.7 OUTLIER -170.34 133.32 1.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.695 -179.983 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.472 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -150.65 179.59 8.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.872 -179.94 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.481 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 73.0 p -86.81 120.1 27.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.99 179.862 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.779 HG12 ' O ' ' A' ' 38' ' ' GLY . 1.2 p -48.0 99.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.289 179.876 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -82.69 115.75 21.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.432 -179.344 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.428 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -97.54 123.11 41.3 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.284 -0.416 . . . . 0.0 109.919 178.179 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -74.04 -150.99 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.953 179.694 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.464 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 2.4 t -56.62 144.81 63.46 Favored Pre-proline 0 C--N 1.324 -0.516 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.647 -179.661 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.579 ' HG2' HG11 ' A' ' 95' ' ' VAL . 23.7 Cg_exo -61.87 163.41 19.14 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.544 2.162 . . . . 0.0 111.817 179.732 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.504 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 97.8 Cg_exo -41.11 156.66 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.722 2.281 . . . . 0.0 112.742 -179.315 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 12.3 t -105.96 90.03 3.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.48 179.15 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.661 HG23 ' HE2' ' A' ' 97' ' ' TYR . 20.7 pt -69.48 -178.32 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.21 -179.195 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.1 m -104.02 145.56 29.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.809 179.635 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.508 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 13.2 m-20 56.7 29.57 16.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.214 179.448 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.44 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -166.85 -165.49 24.33 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.794 179.716 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.96 -175.63 4.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.097 0.475 . . . . 0.0 111.005 -179.73 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.464 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 35.1 p-80 -108.51 173.77 6.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.933 179.681 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -107.71 -87.28 0.49 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.493 178.71 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.434 ' N ' HG13 ' A' ' 95' ' ' VAL . . . 56.67 159.78 0.01 OUTLIER Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.964 178.996 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -120.67 -35.23 3.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.91 0.386 . . . . 0.0 111.203 -179.757 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.57 -173.04 3.43 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.942 -179.767 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.93 -24.95 13.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.905 179.518 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.425 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 8.5 m-85 -129.49 176.91 7.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.003 179.969 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.428 ' N ' ' O ' ' A' ' 71' ' ' CYS . 55.0 m-85 -151.76 164.0 37.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.761 -179.523 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.6 p -131.27 -175.89 3.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.231 -179.502 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 5.0 m-20 -65.95 94.47 0.23 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.19 0.519 . . . . 0.0 111.126 -179.767 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.86 31.1 0.77 Allowed Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.973 178.753 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.449 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.6 OUTLIER -110.19 159.0 17.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.74 0.305 . . . . 0.0 110.83 179.418 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 34.6 m -134.72 149.48 29.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.075 0.464 . . . . 0.0 111.191 -179.741 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.579 HG11 ' HG2' ' A' ' 74' ' ' PRO . 26.2 t -144.77 148.0 18.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.841 179.592 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.689 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -108.35 128.5 54.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.033 -179.849 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.961 ' CE1' HG21 ' A' ' 111' ' ' VAL . 7.0 m-85 -89.13 155.77 19.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.953 -179.943 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 77.3 p -149.15 137.84 21.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.086 179.543 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.44 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 83.1 m -69.73 157.87 36.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.057 -179.737 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.3 m-20 -90.03 -71.79 0.6 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.564 -178.898 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.0 t -63.77 -19.68 65.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.555 -178.862 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 119.46 31.04 1.43 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.376 -179.733 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.508 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 35.5 m-85 -69.59 -171.55 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.698 0.285 . . . . 0.0 110.476 179.61 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.72 106.53 16.2 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.907 0.384 . . . . 0.0 111.274 -179.078 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.542 HD23 ' HB2' ' A' ' 122' ' ' PRO . 1.6 tp -45.18 108.95 0.14 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.633 178.476 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.782 HD11 ' HB2' ' A' ' 125' ' ' GLN . 24.3 mm -83.25 160.75 3.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.067 -178.366 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.539 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 54.68 -128.29 42.29 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.902 -179.257 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -115.52 134.39 55.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.975 0.417 . . . . 0.0 110.898 179.018 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.689 ' HB2' HG22 ' A' ' 96' ' ' THR . 0.0 OUTLIER -68.3 -30.6 69.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.377 179.322 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -75.45 133.16 14.21 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.542 179.807 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.961 HG21 ' CE1' ' A' ' 97' ' ' TYR . 3.3 t -125.6 124.2 66.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.506 0.194 . . . . 0.0 110.49 179.393 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.76 123.71 30.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.895 0.379 . . . . 0.0 111.799 -178.269 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.536 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 27.2 t -88.95 104.36 16.89 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 176.354 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 53.3 p -142.99 154.6 44.18 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.042 0.448 . . . . 0.0 111.605 -177.772 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.43 35.49 7.13 Favored Glycine 0 N--CA 1.453 -0.194 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.748 179.519 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.454 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 68.28 11.44 61.66 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.74 -179.439 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -132.87 178.29 6.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.865 0.364 . . . . 0.0 110.558 179.418 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.536 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 93.1 m95 -117.4 148.13 42.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.882 -179.458 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.498 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.1 OUTLIER -128.28 164.06 23.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.111 0.481 . . . . 0.0 111.635 -178.654 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.442 ' N ' ' HD3' ' A' ' 121' ' ' PRO . 1.7 p-10 45.97 52.13 10.71 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.233 179.219 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.442 ' HD3' ' N ' ' A' ' 120' ' ' ASP . 84.0 Cg_endo -82.18 145.64 13.81 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.547 2.164 . . . . 0.0 111.562 177.527 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.542 ' HB2' HD23 ' A' ' 105' ' ' LEU . 90.5 Cg_endo -93.7 -170.1 0.23 Allowed 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.888 2.392 . . . . 0.0 114.177 -177.458 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.452 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -140.54 -170.03 2.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.004 177.806 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 124' ' ' CYS . . . . . 0.408 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 14.5 m -143.49 95.39 2.74 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.039 0.447 . . . . 0.0 111.11 -179.662 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.782 ' HB2' HD11 ' A' ' 106' ' ' ILE . 23.6 mt-30 -122.78 158.07 31.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.797 179.921 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.503 HG12 ' CE2' ' A' ' 103' ' ' TYR . 28.8 mm . . . . . 0 C--N 1.324 -0.506 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.08 -179.754 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.531 0.205 . . . . 0.0 110.673 . . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.575 ' HB3' HG23 ' A' ' 25' ' ' VAL . 1.4 mtm180 56.72 162.23 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.011 0.434 . . . . 0.0 111.59 178.525 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.464 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 95.3 m -87.44 158.69 51.44 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.965 -179.824 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 41.0 Cg_endo -68.56 173.49 9.79 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.604 2.203 . . . . 0.0 112.274 -179.971 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -50.65 107.31 0.78 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.783 179.871 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.415 ' HG2' HD11 ' A' ' 22' ' ' ILE . 9.9 Cg_endo -54.8 141.93 75.52 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.202 1.935 . . . . 0.0 112.147 -179.29 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.88 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -52.32 150.83 4.39 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.379 179.259 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.83 -176.06 2.99 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.269 0.556 . . . . 0.0 111.588 -178.038 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.452 HG23 ' C ' ' A' ' 18' ' ' GLY . 11.1 tt -135.58 148.91 28.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.621 -179.585 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -81.02 -62.35 1.69 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.917 -177.635 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.415 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 0.6 OUTLIER -93.15 27.04 2.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.16 -178.549 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.452 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -146.26 -176.58 20.23 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.097 -179.693 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -139.77 127.65 22.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.644 0.259 . . . . 0.0 110.667 179.544 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.88 HD11 ' O ' ' A' ' 13' ' ' ARG . 11.1 mt -72.76 154.14 40.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.11 0.481 . . . . 0.0 111.712 -179.49 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.441 ' CB ' ' HB ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -130.58 76.22 1.71 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.561 177.061 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.917 ' HA ' HG23 ' A' ' 31' ' ' ILE . 54.8 mt -69.97 107.76 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.826 -177.702 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -109.44 15.07 32.7 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.167 178.119 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 29' ' ' SER . . . 162.29 122.9 0.63 Allowed Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.911 -179.639 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.575 HG23 ' HB3' ' A' ' 8' ' ' ARG . 34.9 m -112.94 28.06 2.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.482 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 12.6 t70 -102.45 162.69 12.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.043 0.449 . . . . 0.0 111.271 179.534 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.91 ' CZ ' HD13 ' A' ' 51' ' ' LEU . 7.3 t80 -59.61 93.5 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.911 -179.502 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 123.94 3.27 8.35 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.812 -179.963 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 1.6 m -84.92 -159.0 0.39 Allowed 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 116.892 0.346 . . . . 0.0 110.134 179.161 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 47' ' ' SER . 51.9 p -168.18 153.98 7.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.116 0.484 . . . . 0.0 111.451 179.361 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.917 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.6 OUTLIER -114.82 172.84 3.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.383 179.663 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.441 ' HB ' ' CB ' ' A' ' 21' ' ' ASP . 2.6 m -132.86 109.23 9.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.996 0.427 . . . . 0.0 110.962 178.661 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.869 ' CE2' HD21 ' A' ' 20' ' ' LEU . 22.4 m-85 -84.31 132.12 34.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.828 179.836 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.431 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.7 OUTLIER -135.61 162.71 31.94 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.652 -179.42 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.449 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 5.4 m -84.57 168.01 15.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.789 0.328 . . . . 0.0 110.83 179.875 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -63.66 -78.62 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.013 -179.319 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -156.36 135.76 12.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.743 179.72 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.806 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 55.83 26.49 47.61 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.693 -178.939 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.502 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.1 m-85 -115.15 165.84 12.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.707 0.289 . . . . 0.0 110.805 -179.23 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.974 ' NE2' HG22 ' A' ' 69' ' ' VAL . 95.3 m-70 -117.88 122.01 42.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.457 178.255 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.735 HD21 ' O ' ' A' ' 44' ' ' GLU . 10.1 tt -86.2 110.18 19.42 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.294 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.454 ' HB ' ' HB ' ' A' ' 65' ' ' ILE . 2.2 mm -84.07 155.13 3.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.934 0.397 . . . . 0.0 111.314 -177.801 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.5 -145.64 36.07 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.057 -179.053 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.735 ' O ' HD21 ' A' ' 41' ' ' LEU . 1.0 OUTLIER -74.31 165.92 24.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.628 0.251 . . . . 0.0 110.473 179.009 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.678 ' HB3' HD22 ' A' ' 41' ' ' LEU . 3.2 p -141.66 24.39 2.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.003 -179.883 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.408 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -148.37 135.77 20.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.447 -178.416 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.427 ' C ' ' CD2' ' A' ' 48' ' ' TYR . 1.0 OUTLIER -106.07 161.07 14.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.498 178.605 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.535 ' CE1' ' HD3' ' A' ' 61' ' ' PRO . 3.6 m-85 -134.29 122.14 22.26 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.056 0.455 . . . . 0.0 111.811 -177.569 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.514 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 35.7 t -76.96 94.42 3.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.806 179.484 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -115.19 -172.83 2.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.531 179.641 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.91 HD13 ' CZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -102.45 152.12 21.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.554 179.105 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -110.04 -51.03 0.65 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.751 -179.542 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.3 t -89.61 48.74 1.63 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.82 0.343 . . . . 0.0 110.936 -179.767 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.434 ' CA ' HD23 ' A' ' 51' ' ' LEU . 2.4 p 53.21 28.01 6.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.642 -179.94 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 169.41 -30.81 0.16 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.008 -179.66 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.78 -160.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.835 0.35 . . . . 0.0 110.877 179.515 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.66 137.38 51.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.678 179.911 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.456 HG22 ' C ' ' A' ' 51' ' ' LEU . 8.4 m -152.09 173.87 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.264 -179.128 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.704 ' CE3' HD11 ' A' ' 31' ' ' ILE . 89.9 m95 -129.54 130.99 46.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.06 -179.874 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.471 ' O ' ' CD1' ' A' ' 48' ' ' TYR . 0.9 OUTLIER -160.6 135.14 5.36 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.053 179.897 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.535 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 61.4 Cg_endo -71.33 -165.8 3.5 Favored 'Cis proline' 0 C--N 1.353 0.786 0 C-N-CA 123.984 -1.257 . . . . 0.0 112.691 0.013 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -111.49 -152.3 0.5 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.064 -179.012 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.478 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -73.46 115.24 39.38 Favored Pre-proline 0 C--O 1.231 0.128 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.672 179.213 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.443 ' CG ' ' O ' ' A' ' 44' ' ' GLU . 15.2 Cg_exo -71.22 -150.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.7 2.267 . . . . 0.0 112.54 -178.826 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.585 HG22 ' H ' ' A' ' 66' ' ' CYS . 1.5 mm -103.56 170.64 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.058 -179.162 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.585 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.3 m -159.31 134.69 8.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.109 -179.952 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.73 157.25 44.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.984 179.809 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.502 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 1.4 p -78.67 129.22 34.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.253 0.549 . . . . 0.0 111.553 -179.274 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.974 HG22 ' NE2' ' A' ' 40' ' ' HIS . 3.9 p -50.6 94.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.208 179.458 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.413 ' HE2' HG23 ' A' ' 90' ' ' THR . 0.8 OUTLIER -80.42 116.95 20.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.128 -179.846 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -98.17 119.84 37.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.376 179.074 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -158.63 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.662 179.764 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.432 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 2.2 t -48.64 139.99 10.88 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.96 -179.704 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.509 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 26.5 Cg_exo -60.72 161.93 19.93 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.426 2.084 . . . . 0.0 112.154 -179.862 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.525 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 80.9 Cg_exo -42.88 157.48 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.786 2.324 . . . . 0.0 112.85 -179.692 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.3 m -108.16 89.85 3.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.551 179.094 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.73 HG23 ' HE1' ' A' ' 97' ' ' TYR . 33.8 pt -69.35 173.75 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.242 -179.176 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.1 m -95.31 142.91 27.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.582 179.332 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.418 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 7.0 m-80 60.74 28.44 18.18 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.003 179.815 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.465 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -166.49 -166.99 26.47 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.813 -179.882 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.423 ' N ' ' O ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -166.26 -175.75 3.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.001 0.429 . . . . 0.0 110.798 -179.934 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 3.1 p80 -114.63 167.42 10.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.25 -179.515 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -99.94 -86.77 0.38 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.778 179.812 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.416 ' HA3' ' OH ' ' A' ' 89' ' ' TYR . . . 64.56 144.87 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.836 179.238 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.505 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -111.44 -31.22 7.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.997 0.427 . . . . 0.0 110.512 179.448 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.69 -171.53 2.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.027 -179.788 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -104.39 -25.21 12.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.025 179.753 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.433 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 6.1 m-85 -132.53 172.27 12.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.946 -179.967 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.433 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 31.2 m-85 -147.03 167.62 23.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.04 -179.635 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.413 HG23 ' HE2' ' A' ' 70' ' ' LYS . 21.7 p -139.25 -175.13 4.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.114 -179.78 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.42 ' OD2' ' CG1' ' A' ' 69' ' ' VAL . 0.4 OUTLIER -62.05 95.06 0.06 Allowed 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.197 0.523 . . . . 0.0 110.94 179.937 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.7 26.94 1.34 Allowed Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.496 -0.775 . . . . 0.0 113.151 178.592 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -108.3 152.17 24.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.769 0.285 . . . . 0.0 110.384 178.679 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 35.5 m -130.53 154.41 40.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.02 0.438 . . . . 0.0 111.251 -179.494 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.55 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 43.8 t -148.14 151.15 13.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.763 179.32 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.926 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -109.12 125.62 52.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.172 0.51 . . . . 0.0 110.957 179.905 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.967 ' CE2' HG21 ' A' ' 111' ' ' VAL . 4.5 m-85 -83.35 162.19 21.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.12 -179.043 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 81' ' ' ARG . 2.6 p -150.94 130.39 12.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.853 0.359 . . . . 0.0 111.689 -178.82 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.409 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 71.8 m -69.93 155.28 40.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.699 178.831 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.465 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 12.6 m-20 -92.76 -72.16 0.61 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.594 -178.598 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.5 t -57.2 -20.59 27.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.771 0.32 . . . . 0.0 111.261 -179.365 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 117.81 29.75 1.96 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.29 -179.846 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.472 ' CE2' HG12 ' A' ' 126' ' ' ILE . 43.9 m-85 -70.7 -174.18 0.87 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.876 0.37 . . . . 0.0 110.643 179.898 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 125' ' ' GLN . 0.5 OUTLIER -109.99 110.45 21.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.702 179.56 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.494 ' CD2' ' HB2' ' A' ' 122' ' ' PRO . 1.1 tp -48.08 113.62 0.77 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.936 179.401 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.525 HG22 ' N ' ' A' ' 107' ' ' GLY . 30.1 mm -94.78 161.06 2.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.031 -179.029 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.525 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 51.63 25.8 15.09 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.333 -0.937 . . . . 0.0 112.346 -179.48 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.417 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.3 OUTLIER 60.24 133.42 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.028 -0.586 . . . . 0.0 111.342 -179.567 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.926 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.3 p -60.64 -26.65 67.21 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.485 -179.156 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.84 128.68 47.0 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.115 -178.692 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.967 HG21 ' CE2' ' A' ' 97' ' ' TYR . 2.3 t -123.67 149.79 27.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 178.279 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.8 108.41 17.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.821 0.343 . . . . 0.0 111.441 -179.93 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.512 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 11.6 t -73.68 103.93 4.43 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 176.536 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.5 p -145.9 159.45 43.2 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.212 -178.619 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.67 32.31 8.01 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.739 179.782 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.43 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 71.81 6.41 63.34 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.824 -179.65 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -136.84 173.52 11.62 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.876 0.369 . . . . 0.0 110.624 179.746 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.55 ' CZ3' HG23 ' A' ' 95' ' ' VAL . 83.1 m95 -106.39 124.86 50.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.031 -179.461 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.78 159.05 15.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.517 -178.926 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.472 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 3.6 p-10 49.44 46.58 3.87 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.465 179.076 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 52.9 Cg_endo -68.36 144.44 61.9 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.32 2.013 . . . . 0.0 111.132 177.215 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.505 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 74.1 Cg_endo -89.73 -172.6 0.62 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.528 2.152 . . . . 0.0 114.3 -176.761 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.41 -158.81 0.9 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.363 -1.289 . . . . 0.0 109.822 178.465 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 7.8 m -155.5 90.54 1.25 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.998 0.427 . . . . 0.0 110.894 179.241 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.402 ' O ' ' HB2' ' A' ' 104' ' ' SER . 22.6 mt-30 -117.37 173.34 6.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.779 -179.851 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.472 HG12 ' CE2' ' A' ' 103' ' ' TYR . 29.1 mm . . . . . 0 C--N 1.325 -0.479 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.971 -179.424 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.843 0.354 . . . . 0.0 111.256 . . . . . . . . . 0 0 . 1 . 045 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.682 ' HD2' HG23 ' A' ' 25' ' ' VAL . 0.5 OUTLIER 45.16 -171.89 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.982 -0.553 . . . . 0.0 112.057 178.213 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.55 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 89.4 m -94.32 177.54 1.86 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.696 179.708 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.55 ' CD ' ' HB3' ' A' ' 9' ' ' CYS . 28.1 Cg_endo -91.33 179.9 1.51 Allowed 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.706 2.27 . . . . 0.0 111.974 -179.538 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.1 t -51.81 105.51 0.53 Allowed Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.567 179.497 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.483 ' HG3' ' CZ2' ' A' ' 59' ' ' TRP . 77.8 Cg_exo -49.47 153.3 5.21 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.304 2.003 . . . . 0.0 112.4 -179.447 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.428 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 1.0 OUTLIER -62.97 168.5 3.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.981 179.124 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.554 ' HA ' HD11 ' A' ' 20' ' ' LEU . 1.0 OUTLIER -118.93 -175.1 2.84 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.303 0.573 . . . . 0.0 111.752 -178.24 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.9 tt -145.19 139.37 22.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.317 -179.692 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -65.34 -72.96 0.14 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.86 -177.568 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.426 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 2.2 m-20 -90.02 45.64 1.29 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.933 0.397 . . . . 0.0 110.884 -179.129 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -157.08 171.93 34.54 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.352 -0.928 . . . . 0.0 113.292 179.767 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.403 ' N ' ' O ' ' A' ' 34' ' ' SER . 0.3 OUTLIER -133.55 131.03 39.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.775 0.321 . . . . 0.0 110.36 179.323 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.734 HD22 ' CE1' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -78.54 166.62 22.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.171 0.51 . . . . 0.0 111.748 -178.788 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.452 ' HB3' ' CB ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -135.55 73.39 1.47 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.634 177.127 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.805 ' HA ' HG23 ' A' ' 31' ' ' ILE . 45.4 mt -71.53 92.62 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.582 -178.058 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -97.49 18.42 57.38 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.161 178.212 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 158.51 129.51 1.09 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.109 -0.567 . . . . 0.0 111.887 -179.585 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.682 HG23 ' HD2' ' A' ' 8' ' ' ARG . 32.6 m -115.35 0.91 8.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.553 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -69.6 153.6 43.22 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.923 0.392 . . . . 0.0 111.069 -179.764 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.526 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 12.1 t80 -50.48 106.54 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.935 -179.939 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.18 -7.07 23.23 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.913 179.988 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 99.7 p -71.78 -171.65 0.71 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.791 0.329 . . . . 0.0 110.807 179.971 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 47' ' ' SER . 3.2 p -153.48 156.05 37.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.026 179.727 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.805 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -119.71 168.05 12.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.492 -179.869 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.452 ' CB ' ' HB3' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -128.93 111.1 12.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.918 0.39 . . . . 0.0 110.977 179.054 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.734 ' CE1' HD22 ' A' ' 20' ' ' LEU . 27.8 m-85 -88.84 134.93 33.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.211 -179.645 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.428 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 21.3 p -138.42 167.97 20.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.703 179.908 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.448 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 1.6 m -88.18 162.68 16.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.86 -179.991 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.16 -80.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.849 0.357 . . . . 0.0 111.123 -179.324 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.1 m -158.63 133.72 8.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.773 -179.814 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.727 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 60.06 24.74 61.11 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.789 -178.959 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.477 ' CG ' ' O ' ' A' ' 67' ' ' GLU . 2.0 m-85 -112.47 -179.58 3.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.78 0.324 . . . . 0.0 110.766 -179.662 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.678 ' CD2' HD11 ' A' ' 42' ' ' ILE . 3.6 p-80 -138.7 113.8 9.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.011 0.434 . . . . 0.0 110.613 178.49 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.713 HD21 ' O ' ' A' ' 44' ' ' GLU . 4.7 tt -78.99 126.36 30.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.514 -179.595 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.678 HD11 ' CD2' ' A' ' 40' ' ' HIS . 2.6 mm -100.2 153.51 4.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.401 -178.688 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.9 -145.35 31.05 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.328 -179.711 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.713 ' O ' HD21 ' A' ' 41' ' ' LEU . 3.7 pm0 -70.02 171.56 9.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.576 0.227 . . . . 0.0 110.695 179.477 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.0 p -146.96 18.98 1.26 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.437 -179.599 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.431 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -148.15 134.15 19.2 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.925 0.393 . . . . 0.0 111.495 -178.768 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.45 ' HB2' ' CG1' ' A' ' 31' ' ' ILE . 1.5 m -102.89 152.52 21.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.992 178.51 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.515 ' CE1' ' HD3' ' A' ' 61' ' ' PRO . 4.5 m-85 -125.3 121.05 32.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.135 0.493 . . . . 0.0 111.601 -178.74 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.447 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 41.0 t -72.32 93.77 1.53 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.301 179.216 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.493 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 0.7 OUTLIER -111.93 176.4 5.04 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.372 -178.78 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.526 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -91.73 157.33 16.98 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.811 179.79 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.69 -126.74 2.41 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.592 -179.815 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.02 -40.93 5.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.81 0.338 . . . . 0.0 111.019 -179.8 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 27.8 p -97.9 56.84 1.27 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 179.961 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 50.24 24.86 7.39 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.344 -179.709 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.4 t -84.12 -164.46 0.94 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.894 0.378 . . . . 0.0 111.066 -179.681 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.19 120.83 20.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.397 179.407 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.0 m -125.62 -176.62 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.074 -179.046 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.698 ' CE3' HD11 ' A' ' 31' ' ' ILE . 86.0 m95 -127.69 127.05 43.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.666 179.976 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -151.87 128.92 5.53 Favored Pre-proline 0 CA--C 1.532 0.285 0 C-N-CA 121.086 -0.246 . . . . 0.0 111.322 -179.416 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.515 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 72.8 Cg_endo -75.7 -165.92 4.63 Favored 'Cis proline' 0 C--N 1.351 0.701 0 C-N-CA 123.864 -1.306 . . . . 0.0 112.335 -0.516 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.79 -153.87 0.53 Allowed 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.014 -179.474 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.475 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -73.63 112.67 17.19 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.819 179.63 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 63' ' ' ALA . 17.3 Cg_exo -68.75 -150.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.669 2.246 . . . . 0.0 112.452 -179.075 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.509 HG22 ' H ' ' A' ' 66' ' ' CYS . 5.7 mm -99.6 166.35 2.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.91 0.386 . . . . 0.0 111.459 -178.842 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.509 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -165.94 123.8 1.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.692 179.381 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.477 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -136.24 176.64 8.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.0 -179.739 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.467 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 4.2 p -94.2 122.48 36.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.15 -179.736 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.727 HG12 ' O ' ' A' ' 38' ' ' GLY . 3.0 p -46.85 99.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.399 179.569 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.408 ' HD2' ' HB3' ' A' ' 88' ' ' PHE . 23.0 mmtt -70.99 114.88 9.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.177 179.958 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.426 ' N ' ' O ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -97.01 121.44 38.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.095 178.73 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -158.74 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.925 -179.643 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.543 ' HG ' ' CE1' ' A' ' 82' ' ' HIS . 2.1 t -48.54 138.08 11.9 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.113 -179.556 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.491 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 24.6 Cg_exo -61.22 162.3 20.38 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.389 2.059 . . . . 0.0 112.001 179.746 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.512 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 91.9 Cg_exo -40.72 158.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.852 2.368 . . . . 0.0 113.01 -179.158 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.7 m -108.91 90.99 3.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.588 179.328 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.719 HG23 ' HE2' ' A' ' 97' ' ' TYR . 23.0 pt -69.14 -177.11 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.23 -179.139 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.0 p -101.37 146.74 27.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.752 179.639 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.512 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 3.5 m120 53.54 29.62 9.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.12 179.449 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.466 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -171.55 -171.69 36.9 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.543 179.612 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.54 -176.17 4.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.966 0.412 . . . . 0.0 110.914 179.417 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.543 ' CE1' ' HG ' ' A' ' 73' ' ' SER . 8.6 p-80 -100.93 173.03 6.67 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.018 -179.956 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -102.0 -84.11 0.45 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.393 179.223 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.419 ' HA3' ' OH ' ' A' ' 89' ' ' TYR . . . 60.22 147.74 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.098 178.351 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -112.45 -32.83 6.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.141 0.496 . . . . 0.0 110.629 179.104 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.3 -171.61 2.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.707 179.629 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -104.64 -19.06 14.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.367 -179.954 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.43 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 6.3 m-85 -134.29 174.93 9.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.827 0.346 . . . . 0.0 111.182 -179.552 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.43 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 70.4 m-85 -151.27 165.15 34.86 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.895 -179.913 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.3 p -127.4 173.57 9.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.97 0.414 . . . . 0.0 111.214 -179.159 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -60.26 95.31 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.303 0.573 . . . . 0.0 110.82 179.744 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 125.81 28.28 1.07 Allowed Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.943 179.34 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.2 158.14 18.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.696 0.284 . . . . 0.0 110.567 179.208 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 32.8 m -131.43 150.43 34.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.066 0.46 . . . . 0.0 111.361 -179.514 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.542 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 33.2 t -143.12 148.67 19.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.563 178.854 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.983 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -104.45 134.42 47.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.936 -179.873 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.962 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.7 m-85 -94.27 158.59 15.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.263 -179.354 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 84.7 p -154.3 139.91 17.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.39 -179.856 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.415 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 66.3 m -70.54 162.73 28.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.224 -179.862 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.466 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 73.6 m-80 -92.05 -78.26 0.41 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.45 -179.232 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.7 m -56.53 -27.33 57.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.855 0.36 . . . . 0.0 110.985 -179.312 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.61 34.09 0.58 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.768 179.679 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.512 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 32.4 m-85 -70.4 -173.06 0.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.763 0.316 . . . . 0.0 110.175 178.939 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.98 109.97 20.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.139 0.495 . . . . 0.0 110.853 179.563 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.644 HD23 ' HB2' ' A' ' 122' ' ' PRO . 2.6 tp -46.65 113.5 0.66 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.936 179.145 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.464 HG22 ' N ' ' A' ' 107' ' ' GLY . 38.7 mm -89.06 157.29 3.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.785 -179.265 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.464 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 62.77 -121.58 25.38 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.462 -0.875 . . . . 0.0 111.587 -178.335 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -127.48 130.52 49.37 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.878 0.37 . . . . 0.0 110.711 178.523 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.983 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.1 p -63.72 -28.48 69.92 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.107 179.123 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -74.33 130.96 12.76 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.594 179.477 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.962 HG21 ' CE1' ' A' ' 97' ' ' TYR . 4.3 t -122.95 134.13 67.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.152 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 118' ' ' TRP . 0.3 OUTLIER -90.02 124.79 35.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.019 0.438 . . . . 0.0 111.785 -178.2 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.521 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 14.5 t -91.02 100.44 13.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.521 176.909 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.9 166.54 27.33 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.098 0.475 . . . . 0.0 111.591 -178.217 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.98 26.93 3.16 Favored Glycine 0 CA--C 1.517 0.214 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.841 179.589 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.421 ' N ' HG11 ' A' ' 69' ' ' VAL . . . 73.83 10.88 80.84 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.597 -179.425 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -142.14 -177.74 5.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.753 0.311 . . . . 0.0 110.459 179.705 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.542 ' CZ3' HG23 ' A' ' 95' ' ' VAL . 85.0 m95 -114.57 149.33 36.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.072 -179.264 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.549 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -130.02 168.87 16.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.444 -179.121 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.456 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 5.0 p-10 46.67 49.62 7.21 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.975 179.801 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 75.5 Cg_endo -77.85 143.01 20.5 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.632 2.221 . . . . 0.0 111.681 178.045 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.644 ' HB2' HD23 ' A' ' 105' ' ' LEU . 70.0 Cg_endo -90.8 -171.54 0.44 Allowed 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.841 2.36 . . . . 0.0 113.819 -178.053 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.424 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -133.96 -161.3 1.13 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.252 178.592 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 10.7 m -153.53 90.14 1.39 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.016 0.436 . . . . 0.0 110.996 179.599 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -118.35 160.84 20.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.651 179.793 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.62 ' O ' HG22 ' A' ' 126' ' ' ILE . 20.5 mm . . . . . 0 C--N 1.322 -0.618 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.103 -179.852 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.9 mtm-85 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.719 0.295 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 046 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.622 ' HB3' HG23 ' A' ' 25' ' ' VAL . 0.0 OUTLIER 53.68 168.54 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.501 178.561 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.438 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 18.4 m -72.73 160.82 81.91 Favored Pre-proline 0 N--CA 1.452 -0.346 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.51 179.817 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.45 167.61 16.46 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.171 1.914 . . . . 0.0 111.175 179.517 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.5 p -53.64 107.74 0.93 Allowed Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.152 -178.376 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.564 ' HG2' HD13 ' A' ' 22' ' ' ILE . 50.0 Cg_exo -44.87 167.41 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.312 2.008 . . . . 0.0 112.765 179.724 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.413 ' HB3' ' OH ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -66.36 176.51 1.79 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.593 176.416 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.919 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -130.46 -7.06 4.19 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -177.279 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.698 HD12 ' HD2' ' A' ' 64' ' ' PRO . 17.4 tt 51.67 156.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 123.498 0.719 . . . . 0.0 112.533 -178.685 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -103.97 157.52 17.04 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.141 178.858 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 42.97 28.0 0.12 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.293 -179.516 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.447 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -151.25 -163.42 11.38 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.341 -179.781 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.694 ' C ' HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -137.93 175.37 9.64 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.85 0.357 . . . . 0.0 111.132 179.964 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.919 HD11 ' O ' ' A' ' 14' ' ' ASP . 0.8 OUTLIER -125.13 150.65 46.68 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.57 179.514 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.457 ' HB3' ' CB ' ' A' ' 32' ' ' THR . 60.5 t0 -125.97 67.08 1.19 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 177.913 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.94 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -82.33 101.63 7.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.026 -176.613 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.22 7.97 72.48 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.982 176.908 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 175.53 160.36 23.1 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.926 -179.928 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.622 HG23 ' HB3' ' A' ' 8' ' ' ARG . 31.9 m -143.13 33.73 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.873 0.368 . . . . 0.0 111.205 -179.689 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.17 156.9 17.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.081 -179.906 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.518 ' CE2' ' HG ' ' A' ' 51' ' ' LEU . 0.6 OUTLIER -54.23 91.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.723 179.56 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 132.54 -10.47 5.25 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.797 -179.796 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.3 -179.27 5.59 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.804 0.335 . . . . 0.0 110.561 179.565 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 47' ' ' SER . 3.0 p -155.13 141.63 18.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.076 0.465 . . . . 0.0 110.558 179.277 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.94 HG23 ' HA ' ' A' ' 22' ' ' ILE . 1.1 mt -101.95 166.12 2.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.56 -179.239 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.457 ' CB ' ' HB3' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -127.98 104.81 8.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.942 0.401 . . . . 0.0 110.214 178.842 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.529 ' CE2' ' CD2' ' A' ' 20' ' ' LEU . 9.5 m-85 -79.76 157.83 27.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.695 -178.02 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.6 t -162.81 176.59 10.09 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.697 179.99 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.455 ' HB3' ' CB ' ' A' ' 39' ' ' TYR . 45.2 m -98.43 173.78 6.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.876 179.916 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.439 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 4.9 m120 -72.81 -83.63 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.289 -179.279 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.4 t -149.48 139.04 21.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.631 -179.867 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.877 ' O ' HG22 ' A' ' 69' ' ' VAL . . . 55.89 27.02 49.5 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.811 -179.056 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.555 ' CD2' ' HA ' ' A' ' 68' ' ' SER . 2.4 m-85 -115.82 171.62 7.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.681 0.277 . . . . 0.0 110.763 -179.147 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.759 ' CD2' HD11 ' A' ' 42' ' ' ILE . 3.3 p-80 -137.5 117.52 13.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.978 0.418 . . . . 0.0 110.608 178.677 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.931 HD21 ' O ' ' A' ' 44' ' ' GLU . 5.9 tt -81.52 125.8 30.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.64 -179.542 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.759 HD11 ' CD2' ' A' ' 40' ' ' HIS . 2.0 mm -102.16 153.33 5.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.09 -179.3 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.08 -142.82 26.79 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.452 -179.681 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.931 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -68.43 -172.39 0.33 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.063 0.458 . . . . 0.0 110.882 179.68 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -174.77 32.23 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.202 178.992 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 mtpt -157.34 118.8 3.68 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.033 0.444 . . . . 0.0 111.577 -179.426 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.442 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 0.4 OUTLIER -91.83 139.47 30.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.109 179.214 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.548 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 2.1 m-85 -115.74 118.4 32.95 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 119.43 -0.908 . . . . 0.0 111.439 178.82 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 22.6 t -67.33 116.2 7.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.855 -179.575 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.5 ' HA ' ' CE1' ' A' ' 27' ' ' PHE . 2.7 mt-10 -148.85 177.87 9.16 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.127 0.489 . . . . 0.0 111.338 179.678 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.736 ' O ' HG22 ' A' ' 58' ' ' VAL . 1.0 OUTLIER -65.37 167.38 8.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.702 -179.065 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -115.85 -93.54 1.84 Allowed Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.326 179.739 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.35 -48.54 0.48 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.752 0.311 . . . . 0.0 110.827 179.676 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 57.8 p -113.47 28.25 8.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.046 179.911 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.432 ' HA2' ' CD2' ' A' ' 51' ' ' LEU . . . 75.09 36.02 47.53 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.466 -179.907 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.51 -1.93 46.21 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 179.983 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.408 ' HB2' ' HA ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER 57.47 121.14 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.164 179.653 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.736 HG22 ' O ' ' A' ' 51' ' ' LEU . 25.8 m -122.23 -172.37 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.645 179.669 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.526 ' CE3' HD11 ' A' ' 31' ' ' ILE . 73.3 m95 -132.66 128.88 37.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.865 0.364 . . . . 0.0 111.439 -179.317 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.548 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 5.3 m-80 -69.18 166.98 23.62 Favored Pre-proline 0 C--O 1.223 -0.323 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.538 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.471 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 57.4 Cg_exo -12.66 90.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 125.228 3.952 . . . . 0.0 114.224 -179.103 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.476 ' O ' ' CG ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -92.8 -72.68 0.59 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.584 -175.826 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.512 ' HA ' ' CD2' ' A' ' 33' ' ' TYR . . . -97.25 106.64 33.28 Favored Pre-proline 0 N--CA 1.463 0.189 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -174.885 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.792 ' HG2' HD11 ' A' ' 41' ' ' LEU . 5.7 Cg_exo -82.64 -152.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.251 2.634 . . . . 0.0 111.335 177.138 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.576 HG22 ' H ' ' A' ' 66' ' ' CYS . 3.2 mm -90.8 169.98 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.825 0.345 . . . . 0.0 110.744 178.648 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.576 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -167.37 139.82 3.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.488 179.313 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -161.09 170.7 19.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.266 -179.098 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.555 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 54.9 p -81.09 120.87 25.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.235 0.541 . . . . 0.0 111.124 179.713 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.877 HG22 ' O ' ' A' ' 38' ' ' GLY . 16.3 m -46.86 107.89 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.829 -179.72 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.53 ' HG2' ' CD1' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -101.7 122.09 43.25 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.313 0.578 . . . . 0.0 110.388 177.409 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.38 128.84 55.12 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.597 -178.759 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.49 -156.17 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.148 179.103 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.444 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.3 OUTLIER -54.97 139.59 62.99 Favored Pre-proline 0 N--CA 1.445 -0.678 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.408 179.212 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.507 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 38.5 Cg_exo -58.27 162.94 10.94 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.558 2.172 . . . . 0.0 112.192 -179.487 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.519 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 94.5 Cg_exo -42.09 155.49 0.09 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.671 2.247 . . . . 0.0 112.647 -179.647 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.4 m -109.57 89.75 3.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.538 179.559 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.626 HG23 ' HE1' ' A' ' 97' ' ' TYR . 16.1 pt -69.38 172.04 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.047 -179.45 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -89.58 131.41 35.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.935 179.99 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.28 26.86 8.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.618 -179.869 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.449 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -158.4 178.46 34.62 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.329 -179.754 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 98' ' ' SER . 5.3 mtm180 -149.27 -166.57 2.59 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.358 0.599 . . . . 0.0 110.991 -179.214 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 4.3 p-80 -132.2 157.42 44.36 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.561 -179.889 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 -96.74 -139.74 0.27 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.399 -179.887 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 85' ' ' TYR . . . 75.68 -67.96 2.23 Favored Glycine 0 C--N 1.337 0.635 0 C-N-CA 120.112 -1.042 . . . . 0.0 111.311 -178.225 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.432 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 3.3 m-85 66.89 29.45 8.27 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-O 121.439 0.638 . . . . 0.0 110.232 178.697 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.512 ' HB2' ' CZ ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -89.15 -172.92 3.84 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.743 178.085 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.473 ' O ' ' CD2' ' A' ' 88' ' ' PHE . 6.9 m-20 -102.74 -29.64 11.37 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.122 0.486 . . . . 0.0 110.352 178.648 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.53 ' CD1' ' HG2' ' A' ' 70' ' ' LYS . 45.6 m-85 -155.61 -175.08 5.25 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.401 179.835 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.512 ' CZ ' ' HB2' ' A' ' 86' ' ' GLU . 73.5 m-85 -158.94 163.62 36.35 Favored 'General case' 0 C--O 1.223 -0.309 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.896 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.1 p -144.2 -177.3 5.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.365 0.602 . . . . 0.0 112.59 -178.493 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 41.1 p-10 -50.91 95.2 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.373 -179.302 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 121.01 25.4 2.28 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.282 -0.872 . . . . 0.0 113.076 178.15 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.17 145.46 37.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.936 0.368 . . . . 0.0 110.75 179.068 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.488 HG22 ' N ' ' A' ' 95' ' ' VAL . 33.5 m -127.33 158.58 38.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.043 0.449 . . . . 0.0 111.043 -179.777 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.488 ' N ' HG22 ' A' ' 94' ' ' VAL . 15.5 t -151.95 147.77 14.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.641 179.79 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.908 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -108.1 127.59 53.93 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.142 0.496 . . . . 0.0 110.868 -179.899 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.996 ' CE2' HG21 ' A' ' 111' ' ' VAL . 3.9 m-85 -84.81 159.61 20.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.445 -178.963 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 81' ' ' ARG . 19.1 p -147.58 130.28 16.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.84 -179.589 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.455 ' SG ' HD12 ' A' ' 105' ' ' LEU . 93.8 m -69.5 150.11 47.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.907 179.376 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.4 ' OD1' ' HG3' ' A' ' 81' ' ' ARG . 4.9 m-20 -87.11 -72.7 0.5 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.832 -178.383 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.38 -18.49 28.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.557 -178.831 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 116.05 28.5 2.63 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.262 -179.472 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.61 ' HA ' HD13 ' A' ' 126' ' ' ILE . 45.5 m-85 -69.56 -173.45 0.58 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 120.779 0.323 . . . . 0.0 110.555 179.964 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 125' ' ' GLN . 1.4 m -110.44 109.18 19.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 -179.97 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.455 HD12 ' SG ' ' A' ' 99' ' ' CYS . 1.1 mp -46.93 107.91 0.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.96 179.189 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.445 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 43.7 mm -93.8 153.18 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.939 -179.424 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 60.48 25.94 63.71 Favored Glycine 0 CA--C 1.51 -0.228 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.591 -179.916 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.419 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.4 OUTLIER 60.79 135.73 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.288 0.566 . . . . 0.0 111.212 -179.713 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.908 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.2 p -65.52 -24.67 67.18 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.692 -178.678 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -58.93 131.58 52.12 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.022 -179.037 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.996 HG21 ' CE2' ' A' ' 97' ' ' TYR . 2.3 t -133.59 125.49 50.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.626 0.251 . . . . 0.0 110.551 178.927 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.896 HD22 ' N ' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -89.92 130.86 36.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.942 0.401 . . . . 0.0 111.562 -179.234 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.896 ' N ' HD22 ' A' ' 112' ' ' LEU . 48.7 t -100.84 104.81 16.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.665 176.866 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.784 ' HB2' HD11 ' A' ' 112' ' ' LEU . 71.1 m -152.85 126.18 8.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.896 0.379 . . . . 0.0 111.777 -178.907 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.487 ' H ' HG21 ' A' ' 69' ' ' VAL . . . 84.3 22.13 55.09 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.575 178.994 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.509 ' N ' ' HB ' ' A' ' 69' ' ' VAL . . . 84.37 -4.22 84.44 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.43 179.995 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -124.81 173.38 8.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.421 0.629 . . . . 0.0 111.892 -178.669 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.54 ' CZ3' ' HB2' ' A' ' 113' ' ' CYS . 95.2 m95 -115.75 125.93 53.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.008 178.812 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.92 148.34 30.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.232 0.539 . . . . 0.0 111.64 -178.711 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.497 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER 68.8 44.86 0.28 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.299 178.374 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 56.9 Cg_endo -70.59 140.99 40.79 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.078 1.852 . . . . 0.0 111.331 177.859 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.572 ' O ' HG21 ' A' ' 77' ' ' ILE . 67.5 Cg_endo -88.51 -173.82 0.96 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.58 2.186 . . . . 0.0 114.007 -177.25 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.46 -160.82 1.08 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.58 177.661 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 124' ' ' CYS . . . . . 0.402 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 6.6 m -152.99 90.96 1.49 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.091 0.472 . . . . 0.0 111.028 179.144 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.426 ' O ' ' CB ' ' A' ' 104' ' ' SER . 8.9 mt-30 -121.06 158.4 27.93 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.712 -179.852 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.61 HD13 ' HA ' ' A' ' 103' ' ' TYR . 35.3 mm . . . . . 0 C--N 1.323 -0.568 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.909 179.933 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.817 0.341 . . . . 0.0 111.198 . . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.425 ' HB3' ' O ' ' A' ' 25' ' ' VAL . 20.6 mtm180 45.06 -171.43 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.178 0.513 . . . . 0.0 111.834 178.437 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.547 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 80.7 m -87.8 176.4 3.42 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.839 179.738 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.554 ' HD2' ' CD1' ' A' ' 59' ' ' TRP . 26.4 Cg_endo -88.37 -167.49 0.31 Allowed 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.556 2.171 . . . . 0.0 111.814 179.626 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.448 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 1.1 p -56.79 105.81 0.58 Allowed Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.554 179.603 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.619 ' HB3' HD11 ' A' ' 31' ' ' ILE . 10.1 Cg_endo -52.43 138.99 56.52 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.253 1.969 . . . . 0.0 112.111 -179.194 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.529 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -53.22 160.87 0.99 Allowed 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.581 179.963 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.611 ' HA ' HD11 ' A' ' 20' ' ' LEU . 3.9 p-10 -117.2 -175.1 2.73 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.785 -176.567 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.442 HG23 ' C ' ' A' ' 18' ' ' GLY . 2.7 tt -139.44 145.19 27.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.437 179.395 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -76.14 -65.73 0.88 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.459 -178.463 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -91.77 42.07 1.09 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.861 -179.34 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.442 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -160.88 -179.87 35.91 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.392 -0.908 . . . . 0.0 113.3 -179.89 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -137.95 140.28 40.17 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 179.166 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.611 HD11 ' HA ' ' A' ' 14' ' ' ASP . 10.7 mt -84.38 158.26 21.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.216 0.531 . . . . 0.0 111.875 -179.013 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -131.46 72.76 1.51 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.114 176.741 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.894 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.5 OUTLIER -73.95 106.09 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.238 -176.135 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.1 -5.04 73.77 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.668 175.632 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 172.39 153.03 8.97 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 121.16 -0.543 . . . . 0.0 111.818 -179.95 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.425 ' O ' ' HB3' ' A' ' 8' ' ' ARG . 24.3 m -121.86 3.4 6.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.271 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.414 ' HA ' ' HB3' ' A' ' 8' ' ' ARG . 0.6 OUTLIER -72.54 162.14 29.86 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 121.081 0.467 . . . . 0.0 111.517 -179.349 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.74 ' HZ ' HD13 ' A' ' 51' ' ' LEU . 0.6 OUTLIER -51.91 98.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.202 178.744 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 117.86 -9.24 14.31 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.561 -179.097 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.4 m -75.31 138.23 41.67 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 117.068 0.434 . . . . 0.0 109.985 178.93 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 47' ' ' SER . 2.1 p -115.96 140.54 49.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.251 0.548 . . . . 0.0 111.397 -178.778 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.894 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -98.06 164.32 2.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.946 179.196 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.413 ' HA ' ' HG3' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -124.76 110.4 14.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.957 0.408 . . . . 0.0 110.856 179.574 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.527 ' CE2' ' CD2' ' A' ' 20' ' ' LEU . 13.8 m-85 -83.23 142.64 31.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.231 -179.372 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.439 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 26.5 p -143.61 158.91 43.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.206 179.235 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.2 m -84.62 167.84 15.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.754 0.312 . . . . 0.0 110.936 -179.763 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -63.49 -82.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.003 -179.597 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -159.61 129.91 5.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.798 179.948 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.402 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 69.92 21.21 76.68 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.078 -179.016 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.482 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.9 m-30 -114.51 178.51 4.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.846 0.355 . . . . 0.0 110.833 -179.637 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.864 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -138.88 119.41 13.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.568 178.244 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.856 HD21 ' O ' ' A' ' 44' ' ' GLU . 7.6 tt -83.25 122.27 28.19 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.647 -179.65 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.864 HD11 ' CE1' ' A' ' 40' ' ' HIS . 1.7 mm -99.65 160.49 3.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.119 0.485 . . . . 0.0 111.313 -178.644 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.89 -145.05 40.97 Favored Glycine 0 N--CA 1.453 -0.191 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.43 -179.758 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.856 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -60.74 -174.38 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.863 0.363 . . . . 0.0 110.538 179.28 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.0 t -172.88 29.96 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.792 178.786 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.413 ' HG3' ' HA ' ' A' ' 32' ' ' THR . 11.9 mtpt -162.21 119.94 2.15 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 120.751 0.31 . . . . 0.0 111.287 -179.329 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.429 ' HB3' HG13 ' A' ' 31' ' ' ILE . 1.0 OUTLIER -87.52 136.79 32.8 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.026 178.919 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.534 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.1 m-85 -111.9 120.71 42.84 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 119.482 -0.887 . . . . 0.0 111.703 179.916 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.421 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 18.5 t -72.45 118.46 15.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.849 -179.973 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.507 ' HA ' ' CE1' ' A' ' 27' ' ' PHE . 10.3 tt0 -156.62 169.21 25.2 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.429 0.633 . . . . 0.0 110.782 179.326 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.74 HD13 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -79.82 155.37 27.89 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.039 -178.956 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -73.48 -123.01 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.407 179.907 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.13 -35.25 3.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.863 0.364 . . . . 0.0 111.0 -179.964 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 82.4 p -97.8 31.55 2.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.894 179.981 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.735 ' HA2' HD23 ' A' ' 51' ' ' LEU . . . 76.2 20.4 77.36 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.502 -179.777 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.8 t -88.5 -171.32 3.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.851 0.358 . . . . 0.0 110.917 -179.964 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.31 138.69 50.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.434 179.892 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.4 m -153.68 173.45 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.247 -179.493 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.554 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 64.6 m95 -126.4 129.73 49.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.853 179.874 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.534 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 6.1 m-20 -73.69 166.15 46.77 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.489 179.184 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.447 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 90.1 Cg_exo -18.4 96.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 125.247 3.965 . . . . 0.0 114.112 -179.366 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.463 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -97.81 -78.52 0.48 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.268 -176.943 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.469 ' HA ' ' CD2' ' A' ' 33' ' ' TYR . . . -85.46 108.38 15.9 Favored Pre-proline 0 C--N 1.332 -0.168 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -175.726 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.808 ' HG2' HD11 ' A' ' 41' ' ' LEU . 3.5 Cg_exo -84.08 -153.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.201 2.601 . . . . 0.0 111.073 177.211 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.507 HG22 ' H ' ' A' ' 66' ' ' CYS . 3.6 mm -90.79 166.33 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.768 0.318 . . . . 0.0 110.594 178.259 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.507 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -166.66 137.94 3.41 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.947 179.631 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.427 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -161.99 177.0 10.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.047 179.716 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.482 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 6.5 p -89.44 112.16 23.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.118 -179.7 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.497 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 3.2 p -48.43 104.88 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.997 179.602 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.429 ' HD2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -87.54 145.67 26.12 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.021 -177.988 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 1.8 m -105.47 137.16 43.75 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.57 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.407 ' CG ' ' N ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -69.32 -170.56 0.28 Allowed 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 120.469 -0.492 . . . . 0.0 109.849 179.967 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.407 ' N ' ' CG ' ' A' ' 72' ' ' GLN . 2.0 t -72.91 108.94 5.13 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.251 -178.039 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.734 ' HG3' ' CE2' ' A' ' 118' ' ' TRP 0.302 0.2 OUTLIER -35.82 -177.96 0.0 OUTLIER 'Trans proline' 0 CA--C 1.467 -2.864 0 C-N-CA 123.481 2.788 . . . . 0.0 113.553 173.807 . . . . . . . . 4 4 . 1 . 047 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.581 ' CB ' ' CE1' ' A' ' 97' ' ' TYR . 26.7 Cg_endo -71.78 -165.14 3.24 Favored 'Cis proline' 0 C--N 1.315 -1.187 0 N-CA-C 113.994 0.728 . . . . 0.0 113.994 -19.258 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.3 p -132.57 20.28 4.29 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 114.178 -1.374 . . . . 0.0 108.795 172.395 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.835 HD11 ' HA3' ' A' ' 80' ' ' GLY . 17.5 pt -106.43 -159.32 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.265 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.14 -177.952 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.429 ' N ' HG13 ' A' ' 77' ' ' ILE . 0.4 OUTLIER -131.24 148.34 52.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.869 177.199 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.3 m120 55.46 30.26 14.75 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.882 178.8 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.835 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -144.52 -168.38 12.57 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.417 -0.896 . . . . 0.0 113.039 -179.531 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.419 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 4.2 ptt180 -166.81 -174.49 2.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.069 0.462 . . . . 0.0 111.592 -178.789 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.548 ' CG ' ' HB2' ' A' ' 74' ' ' PRO . 41.1 p-80 -120.31 175.86 5.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.759 -177.858 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -124.37 9.1 8.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.282 178.216 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -51.16 168.96 0.39 Allowed Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.719 -179.59 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.505 ' N ' ' CD2' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -114.86 -24.3 8.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.751 0.31 . . . . 0.0 111.086 -179.534 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.85 -173.21 3.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.097 -179.35 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.54 -25.1 11.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.932 179.689 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.434 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 7.5 m-85 -134.56 172.43 12.93 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.885 179.962 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.515 ' CE2' ' HD2' ' A' ' 74' ' ' PRO . 37.9 m-85 -144.9 159.4 42.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.182 -178.811 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.414 ' CG2' ' HG2' ' A' ' 70' ' ' LYS . 3.2 p -119.11 172.5 7.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.374 -179.055 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 48.8 p-10 -59.81 94.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.14 -179.782 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.94 32.88 0.67 Allowed Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.959 178.681 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.459 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -110.07 160.39 16.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.843 0.354 . . . . 0.0 110.944 179.49 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 29.9 m -139.72 148.21 23.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.044 179.981 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.559 HG23 ' CH2' ' A' ' 118' ' ' TRP . 3.5 t -150.93 144.27 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.365 -179.148 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.67 135.19 35.21 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.146 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.766 ' CZ ' HG21 ' A' ' 111' ' ' VAL . 3.3 m-30 -104.04 158.65 16.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.341 0.591 . . . . 0.0 112.282 -175.21 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.418 ' O ' ' CG ' ' A' ' 81' ' ' ARG . 61.0 m -142.24 144.77 33.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.391 178.766 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.471 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 93.3 m -71.25 148.03 47.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.912 0.387 . . . . 0.0 111.596 -178.893 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.462 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 62.5 m-20 -75.6 -77.42 0.13 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.973 -178.501 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.0 t -62.19 -18.73 61.87 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.641 0.258 . . . . 0.0 111.624 -178.285 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.95 27.46 1.88 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.653 -179.993 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.42 ' CE2' HG12 ' A' ' 126' ' ' ILE . 34.9 m-85 -69.0 -173.35 0.48 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.867 0.365 . . . . 0.0 110.428 179.26 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 125' ' ' GLN . 0.5 OUTLIER -112.06 109.52 19.31 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.855 178.026 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.662 HD22 ' HB3' ' A' ' 109' ' ' SER . 0.2 OUTLIER -52.2 123.42 10.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.457 0.646 . . . . 0.0 111.059 -178.656 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.531 HG22 ' N ' ' A' ' 107' ' ' GLY . 28.3 mm -95.57 162.14 2.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.247 179.783 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.531 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 57.28 -128.66 47.97 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.235 -0.984 . . . . 0.0 112.253 -179.572 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -110.68 135.64 50.98 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.025 0.44 . . . . 0.0 112.118 -178.913 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.662 ' HB3' HD22 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -77.33 -32.52 55.29 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 174.481 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -68.3 117.4 8.38 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 110.536 -1.025 . . . . 0.0 110.536 175.332 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.766 HG21 ' CZ ' ' A' ' 97' ' ' TYR . 32.4 t -117.36 127.01 74.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 C-N-CA 121.977 0.111 . . . . 0.0 110.787 -175.832 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 118' ' ' TRP . 0.6 OUTLIER -84.42 133.32 34.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.43 . . . . 0.0 111.857 -177.744 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.51 ' HB2' ' CZ3' ' A' ' 118' ' ' TRP . 23.0 t -97.0 100.01 11.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.441 176.384 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.33 170.47 16.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.128 -178.45 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.38 26.13 2.28 Favored Glycine 0 CA--C 1.517 0.214 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.727 179.762 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.497 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 71.58 19.47 77.86 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.516 -179.613 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -153.09 179.64 8.52 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.188 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.734 ' CE2' ' HG3' ' A' ' 74' ' ' PRO . 97.1 m95 -100.7 129.47 46.61 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.046 0.45 . . . . 0.0 111.023 -179.703 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.38 156.49 19.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.237 -178.787 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.511 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER 54.53 42.81 1.19 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.13 179.868 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.511 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 72.4 Cg_endo -75.01 154.13 42.21 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.146 1.897 . . . . 0.0 111.748 178.649 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.463 ' CB ' ' O ' ' A' ' 106' ' ' ILE . 57.6 Cg_endo -88.24 -169.73 0.46 Allowed 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.544 2.162 . . . . 0.0 113.191 -179.46 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.459 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -133.32 173.52 11.38 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.962 176.498 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 1.4 m -134.06 97.34 3.84 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.989 179.964 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.4 ' O ' ' HB2' ' A' ' 104' ' ' SER . 22.9 mt-30 -129.35 163.65 25.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.937 -179.228 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.42 HG12 ' CE2' ' A' ' 103' ' ' TYR . 23.2 mm . . . . . 0 C--N 1.324 -0.524 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.07 -179.937 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 . . . . . 0 N--CA 1.457 -0.098 0 CA-C-O 120.912 0.387 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 048 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.82 173.62 11.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.002 -179.86 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.447 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 34.1 m -79.47 161.41 67.33 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.15 -179.7 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -70.65 172.81 12.78 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.55 2.167 . . . . 0.0 112.18 179.794 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.8 t -54.13 108.73 1.21 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.856 -179.889 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.877 ' HG2' HD13 ' A' ' 22' ' ' ILE . 53.9 Cg_exo -50.55 143.72 27.26 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.321 2.014 . . . . 0.0 112.263 179.905 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -56.91 151.15 15.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.221 179.047 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.602 ' HA ' HD11 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -93.56 -171.75 2.71 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.536 -177.719 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.436 HG22 ' CD2' ' A' ' 20' ' ' LEU . 14.9 tt -147.99 146.39 18.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.914 -179.448 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -86.29 156.43 20.25 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.018 178.446 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.447 ' N ' ' ND2' ' A' ' 17' ' ' ASN . 0.0 OUTLIER 43.28 29.11 0.2 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.964 -179.15 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.436 ' HA2' ' N ' ' A' ' 36' ' ' ASN . . . -157.71 177.91 34.27 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.536 -179.57 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.88 153.97 51.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.768 0.318 . . . . 0.0 110.605 -179.874 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.602 HD11 ' HA ' ' A' ' 14' ' ' ASP . 4.8 mt -91.57 153.15 19.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.002 0.429 . . . . 0.0 111.164 179.76 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.464 ' HB3' ' CB ' ' A' ' 32' ' ' THR . 19.6 t0 -123.96 67.4 1.04 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.337 177.526 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.881 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.9 OUTLIER -79.77 95.82 2.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.77 -176.667 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.11 15.94 61.7 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.025 177.662 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 161.62 128.19 0.93 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.054 -179.6 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.617 HG12 ' CZ2' ' A' ' 59' ' ' TRP . 2.8 m -114.8 15.76 8.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -179.077 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 28' ' ' GLY . 5.2 m-20 -79.59 157.18 27.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.913 0.387 . . . . 0.0 111.312 -179.573 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.596 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 2.0 t80 -54.34 86.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.019 179.705 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 132.79 -5.41 5.12 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.024 179.974 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.9 m -77.87 -178.01 5.23 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.926 0.363 . . . . 0.0 110.787 179.999 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 47' ' ' SER . 5.4 p -146.15 154.09 41.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.871 0.367 . . . . 0.0 111.427 -179.924 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.881 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -115.84 170.89 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.113 179.749 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.489 HG23 ' HG2' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -137.91 106.87 5.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.735 178.41 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.474 ' CE1' ' HA ' ' A' ' 63' ' ' ALA . 34.3 m-85 -79.09 148.25 32.47 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.86 -179.79 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.8 p -152.23 158.3 42.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.222 -179.703 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 6.9 m -84.92 163.88 18.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.958 179.78 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.436 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 5.9 m-20 -64.57 -84.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.295 -179.168 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -153.3 134.48 14.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.85 -179.594 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.691 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 65.12 23.41 69.7 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.945 -178.929 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.492 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.3 m-85 -117.0 175.43 5.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.37 . . . . 0.0 110.906 -179.292 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.739 ' HB3' HG22 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -141.05 115.73 9.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.427 177.549 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.965 HD21 ' O ' ' A' ' 44' ' ' GLU . 2.0 tt -77.33 131.66 38.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.493 -179.448 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.454 ' N ' HD13 ' A' ' 42' ' ' ILE . 2.8 mm -100.15 162.13 3.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.15 -179.218 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.415 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 70.9 -137.25 26.6 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.24 -179.355 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.965 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -76.82 177.47 7.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.729 0.299 . . . . 0.0 110.825 179.621 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.5 p -147.31 22.65 1.18 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.054 179.885 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.489 ' HG2' HG23 ' A' ' 32' ' ' THR . 0.0 OUTLIER -145.92 -177.91 5.84 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.214 0.531 . . . . 0.0 111.527 -178.626 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.421 ' CB ' HG13 ' A' ' 31' ' ' ILE . 0.5 OUTLIER -155.06 147.79 24.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.486 178.567 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.469 ' CD1' ' O ' ' A' ' 60' ' ' ASN . 2.4 m-85 -125.03 118.95 27.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.983 0.42 . . . . 0.0 111.934 -177.652 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.5 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 34.6 t -70.93 112.57 7.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.407 178.417 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.48 -176.77 4.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.15 0.5 . . . . 0.0 111.553 -179.432 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.596 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -88.73 139.5 30.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.853 -179.626 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.435 ' N ' HG22 ' A' ' 58' ' ' VAL . . . -105.29 -61.01 0.64 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.808 -179.57 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.71 50.14 1.95 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.764 0.316 . . . . 0.0 111.256 -179.397 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.0 p 53.89 30.82 12.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.829 179.65 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 163.19 -27.15 0.23 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.176 -179.693 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.4 t -66.19 -161.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.873 0.368 . . . . 0.0 110.885 179.572 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.1 mmt -125.07 139.74 53.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.58 179.829 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.435 HG22 ' N ' ' A' ' 52' ' ' GLY . 3.1 m -154.01 178.71 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.246 -179.303 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.679 ' CE3' HD11 ' A' ' 31' ' ' ILE . 86.4 m95 -135.1 125.87 27.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.027 -179.427 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.469 ' O ' ' CD1' ' A' ' 48' ' ' TYR . 8.3 m120 -146.43 127.13 7.13 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.219 -179.636 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.402 ' HG2' ' O ' ' A' ' 46' ' ' LYS . 74.3 Cg_endo -75.36 -165.51 4.28 Favored 'Cis proline' 0 C--N 1.352 0.76 0 C-N-CA 123.849 -1.313 . . . . 0.0 112.394 -0.652 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.8 -151.81 0.49 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.249 -178.819 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.474 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -79.03 116.9 63.59 Favored Pre-proline 0 C--N 1.333 -0.119 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.058 -179.654 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.491 ' HG2' HD11 ' A' ' 41' ' ' LEU . 13.6 Cg_exo -72.21 -151.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.645 2.23 . . . . 0.0 112.499 -179.257 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.519 HG22 ' H ' ' A' ' 66' ' ' CYS . 7.3 mm -99.99 167.22 2.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.403 -178.858 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.519 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.2 m -161.13 128.5 4.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.752 179.219 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.475 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -152.49 178.6 9.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.956 -179.727 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.492 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 87.4 p -80.41 119.62 23.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.185 0.517 . . . . 0.0 111.094 -179.883 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.739 HG22 ' HB3' ' A' ' 40' ' ' HIS . 2.3 p -45.63 96.35 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.526 179.82 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -82.79 118.02 23.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.067 179.888 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.65 117.28 34.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.129 179.047 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.56 -157.01 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.837 -179.605 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.458 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 2.1 t -49.02 138.56 13.01 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.06 -179.656 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.484 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 26.8 Cg_exo -60.32 161.35 20.32 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.349 2.033 . . . . 0.0 111.973 179.807 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.51 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 88.3 Cg_exo -42.39 156.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.675 2.25 . . . . 0.0 112.744 -179.821 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.2 t -108.46 90.91 3.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.552 179.378 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.719 HG23 ' HE2' ' A' ' 97' ' ' TYR . 26.7 pt -69.16 178.33 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.305 -179.163 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -99.23 140.2 33.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.756 179.624 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.502 ' HB3' ' CE2' ' A' ' 103' ' ' TYR . 0.1 OUTLIER 63.92 29.21 14.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.555 -179.992 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.431 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . -169.51 -165.46 26.93 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.814 179.627 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' A' ' 98' ' ' SER . 6.7 ptt180 -168.69 -175.63 2.5 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.85 0.357 . . . . 0.0 110.611 -179.584 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 10.5 p80 -111.61 167.91 9.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.282 -179.651 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -98.3 -83.95 0.4 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.738 179.889 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.435 ' H ' HG13 ' A' ' 95' ' ' VAL . . . 61.05 145.37 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.823 179.369 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -112.29 -30.37 7.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.063 0.459 . . . . 0.0 110.752 179.632 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.28 -171.66 2.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.983 -179.768 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.83 -25.81 12.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.069 179.959 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.416 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 11.0 m-85 -131.9 174.5 10.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.889 -179.864 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.422 ' OH ' ' HA3' ' A' ' 84' ' ' GLY . 46.5 m-85 -148.18 162.71 38.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.101 179.924 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 16.5 p -136.3 -174.92 3.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.058 -179.616 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.425 ' OD1' ' CG1' ' A' ' 69' ' ' VAL . 1.6 m-20 -62.25 93.78 0.05 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.193 0.52 . . . . 0.0 111.246 -179.679 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.48 30.42 0.84 Allowed Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.514 -0.766 . . . . 0.0 113.143 178.175 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.436 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.5 OUTLIER -109.83 155.46 21.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.823 0.311 . . . . 0.0 110.62 179.135 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 28.8 m -133.5 150.7 32.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.171 0.51 . . . . 0.0 111.285 -179.719 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.517 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 22.1 t -147.22 149.19 15.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.495 179.612 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.897 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -111.63 123.06 49.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.176 0.512 . . . . 0.0 111.117 -179.991 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 1.013 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.7 m-85 -79.14 161.82 26.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.48 -179.244 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.4 ' O ' ' N ' ' A' ' 81' ' ' ARG . 49.3 m -152.41 133.54 14.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.442 -179.872 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.431 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 73.4 m -69.62 163.92 24.47 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.77 179.415 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.46 -84.93 0.4 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.917 179.514 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.8 t -44.41 -28.68 0.58 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.445 -179.696 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 126.74 35.74 0.54 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.769 179.605 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.507 ' CE1' HG12 ' A' ' 126' ' ' ILE . 52.0 m-85 -76.46 -173.86 2.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.793 0.33 . . . . 0.0 110.467 179.364 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.58 113.67 26.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.079 0.466 . . . . 0.0 111.04 -179.696 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.622 HD21 ' HB2' ' A' ' 97' ' ' TYR . 0.3 OUTLIER -50.63 112.14 0.65 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.74 179.078 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.483 HG22 ' N ' ' A' ' 107' ' ' GLY . 49.9 mm -97.61 158.58 3.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.976 -179.583 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.483 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 52.87 34.55 45.56 Favored Glycine 0 CA--C 1.509 -0.294 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.632 179.3 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.422 ' O ' ' O ' ' A' ' 107' ' ' GLY . 3.8 p-10 52.88 138.32 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 124.158 0.983 . . . . 0.0 112.974 179.43 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.897 ' HB2' HG22 ' A' ' 96' ' ' THR . 0.9 OUTLIER -66.9 -23.9 66.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.686 -179.435 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.36 125.37 39.28 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.702 -179.543 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 1.013 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.2 t -129.32 121.56 53.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 179.515 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.98 123.56 32.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.827 0.346 . . . . 0.0 111.525 -178.787 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.506 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 19.8 t -88.83 103.5 16.05 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 176.55 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.37 158.83 43.28 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.048 0.451 . . . . 0.0 111.271 -178.772 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.11 31.39 5.94 Favored Glycine 0 N--CA 1.453 -0.195 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.715 179.824 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.461 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 70.2 12.08 68.36 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.646 -179.369 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -136.04 174.89 10.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.981 0.419 . . . . 0.0 110.67 179.522 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.517 ' CZ3' HG23 ' A' ' 95' ' ' VAL . 91.2 m95 -113.22 129.57 56.48 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.731 -179.732 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.07 145.85 39.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.087 0.47 . . . . 0.0 111.443 -178.822 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.482 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER 69.63 44.63 0.25 Allowed Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.288 178.675 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 55.6 Cg_endo -69.93 143.91 51.5 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.174 1.916 . . . . 0.0 111.27 177.874 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.525 ' HB2' HD23 ' A' ' 105' ' ' LEU . 62.3 Cg_endo -90.91 -173.22 0.56 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.519 2.146 . . . . 0.0 113.719 -177.732 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.55 -159.13 0.93 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.778 178.672 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 124' ' ' CYS . . . . . 0.417 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 7.6 m -154.82 88.99 1.21 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.949 0.404 . . . . 0.0 110.992 179.337 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -112.57 160.96 17.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.737 179.877 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.507 HG12 ' CE1' ' A' ' 103' ' ' TYR . 15.9 mm . . . . . 0 C--N 1.323 -0.576 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.285 -179.631 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.647 0.261 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.544 ' HD3' HG23 ' A' ' 25' ' ' VAL . 2.5 mtt180 40.04 -161.05 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.827 179.308 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.455 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 66.4 m -116.0 160.23 36.21 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.697 -179.967 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 40.0 Cg_endo -67.17 172.64 9.69 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.419 2.079 . . . . 0.0 111.928 179.464 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.4 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -49.39 110.62 1.62 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.874 -179.778 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.525 ' HB3' HD11 ' A' ' 31' ' ' ILE . 13.8 Cg_endo -57.32 159.31 16.15 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.209 1.939 . . . . 0.0 112.061 -179.761 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.434 ' O ' HD11 ' A' ' 20' ' ' LEU . 6.2 ttt180 -63.66 174.79 1.25 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.807 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -136.87 -175.69 4.11 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.304 0.573 . . . . 0.0 111.62 -179.534 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.79 HD12 ' O ' ' A' ' 64' ' ' PRO . 10.4 tt -131.68 152.45 37.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.363 179.801 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -77.92 -66.75 0.8 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.391 -178.567 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -93.37 36.72 1.06 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.746 -179.932 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.498 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -149.89 176.88 28.36 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.813 -179.824 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -138.04 134.55 34.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.785 0.326 . . . . 0.0 110.419 179.64 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 1.024 HD21 ' CZ ' ' A' ' 33' ' ' TYR . 11.5 mt -83.71 156.22 22.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.062 0.458 . . . . 0.0 111.486 -179.508 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.83 73.72 0.91 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.679 177.569 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.883 ' HA ' HG23 ' A' ' 31' ' ' ILE . 2.5 mt -70.34 92.76 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.972 -177.395 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.26 10.9 67.1 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.522 -0.846 . . . . 0.0 111.904 176.712 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 150.69 145.65 4.17 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 -179.347 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.544 HG23 ' HD3' ' A' ' 8' ' ' ARG . 35.1 m -119.29 6.15 6.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.489 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.4 ' HA ' ' HB3' ' A' ' 8' ' ' ARG . 2.7 p-10 -69.6 155.58 40.27 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.974 0.416 . . . . 0.0 111.31 -179.417 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.472 ' CZ ' ' HB3' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -49.74 102.47 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.932 179.823 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.27 5.82 24.46 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.516 -179.09 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.96 -178.82 7.05 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.934 0.367 . . . . 0.0 110.448 179.366 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 88.1 p -151.77 147.64 26.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.253 0.549 . . . . 0.0 111.547 -179.551 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.883 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -118.4 150.16 20.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.058 179.466 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.429 ' HA ' ' HG3' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -113.31 119.0 36.18 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.76 0.314 . . . . 0.0 111.182 -179.756 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 1.024 ' CZ ' HD21 ' A' ' 20' ' ' LEU . 3.8 m-85 -85.57 138.56 32.1 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.048 0.452 . . . . 0.0 111.025 179.826 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.43 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.5 OUTLIER -149.58 169.22 21.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.017 -178.933 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.447 ' HA ' ' HA2' ' A' ' 18' ' ' GLY . 92.8 m -90.57 166.71 13.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.505 -179.055 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.71 -75.61 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.893 179.96 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -161.55 139.81 9.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.737 179.784 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.494 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 53.76 26.6 33.25 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.118 -179.327 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.497 ' CE2' ' CB ' ' A' ' 68' ' ' SER . 2.2 m-85 -113.6 -179.81 3.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.07 0.462 . . . . 0.0 111.184 -179.492 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.63 ' HB3' HG23 ' A' ' 69' ' ' VAL . 0.3 OUTLIER -137.12 134.54 36.52 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.208 176.385 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.918 HD21 ' HG2' ' A' ' 64' ' ' PRO . 2.6 tt -88.69 135.13 33.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.542 -175.603 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.676 ' N ' HD13 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -110.57 123.62 66.64 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 CA-C-O 121.424 0.631 . . . . 0.0 111.329 -179.752 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.99 -145.99 16.01 Favored Glycine 0 C--N 1.316 -0.558 0 CA-C-N 114.553 -1.203 . . . . 0.0 112.621 179.527 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.449 ' O ' ' HG2' ' A' ' 64' ' ' PRO . 3.5 mm-40 -61.96 -137.71 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.4 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.8 p 167.56 39.43 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 122.925 0.49 . . . . 0.0 110.806 179.272 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.489 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . 0.7 OUTLIER -168.49 170.18 9.91 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.537 0.685 . . . . 0.0 112.461 -178.013 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.566 ' HA ' ' O ' ' A' ' 61' ' ' PRO . 20.7 m -148.78 139.71 22.95 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.767 178.591 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.546 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -132.42 129.54 39.44 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 117.752 -1.579 . . . . 0.0 113.836 -176.78 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.416 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 30.2 t -74.88 96.68 3.16 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.154 -1.385 . . . . 0.0 110.763 179.171 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.51 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 2.2 tt0 -130.35 173.26 10.98 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.661 -179.967 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.51 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -77.21 157.15 31.04 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.435 -178.648 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.459 ' HA2' HG21 ' A' ' 58' ' ' VAL . . . -88.05 -149.65 18.33 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.644 179.833 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.4 m -84.47 -52.42 6.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.86 0.362 . . . . 0.0 111.033 -179.623 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 34.8 p -71.71 -19.54 62.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.221 -179.921 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 120.7 12.93 5.82 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.665 -179.602 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.409 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -81.62 -165.93 1.08 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.707 0.289 . . . . 0.0 110.771 179.948 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.16 130.52 55.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.142 179.627 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.459 HG21 ' HA2' ' A' ' 52' ' ' GLY . 1.6 m -142.81 -175.78 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.872 -178.51 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.61 ' CZ3' HD11 ' A' ' 31' ' ' ILE . 73.2 m95 -128.81 125.79 38.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.973 0.416 . . . . 0.0 111.707 -179.69 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.546 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 1.7 m-20 -67.82 171.76 4.98 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 174.729 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.566 ' O ' ' HA ' ' A' ' 47' ' ' SER . 0.3 OUTLIER 4.16 118.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.256 1 C-N-CA 125.467 4.111 . . . . 0.0 115.527 -176.024 . . . . . . . . 4 4 . 1 . 049 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.609 ' O ' ' CZ ' ' A' ' 33' ' ' TYR . 6.1 mm-40 -84.95 -77.6 0.27 Allowed 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 114.536 -1.211 . . . . 0.0 112.05 -174.105 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.629 ' CB ' ' HA ' ' A' ' 64' ' ' PRO . . . -65.54 -139.13 0.0 OUTLIER Pre-proline 0 CA--C 1.499 -1.016 0 CA-C-O 116.477 -1.725 . . . . 0.0 109.48 -177.991 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.918 ' HG2' HD21 ' A' ' 41' ' ' LEU . 4.3 Cg_exo -88.76 -158.7 1.19 Allowed 'Cis proline' 0 N--CA 1.483 0.91 0 CA-C-N 124.213 2.54 . . . . 0.0 114.856 15.441 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.3 pt -97.4 -176.47 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.366 -178.024 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.495 ' SG ' HD12 ' A' ' 41' ' ' LEU . 1.5 m -157.79 116.7 3.2 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.745 -179.052 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -105.46 172.82 6.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.588 178.433 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.497 ' CB ' ' CE2' ' A' ' 39' ' ' TYR . 2.0 p -97.09 113.07 24.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.058 179.896 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.63 HG23 ' HB3' ' A' ' 40' ' ' HIS . 0.6 OUTLIER -49.42 99.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.063 179.523 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.763 ' HE2' HG23 ' A' ' 90' ' ' THR . 0.3 OUTLIER -79.37 124.07 28.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.511 -179.356 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.28 117.58 34.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.924 178.039 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.8 -156.89 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.849 -179.15 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.418 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 1.8 t -47.75 136.56 10.35 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.119 -179.794 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.421 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 30.6 Cg_exo -58.41 161.72 13.71 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.223 1.948 . . . . 0.0 111.461 179.487 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.474 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 93.3 Cg_exo -40.16 156.3 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.57 2.18 . . . . 0.0 112.631 -178.978 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.4 t -106.13 88.62 2.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.855 179.971 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.588 HG21 ' O ' ' A' ' 122' ' ' PRO . 21.4 pt -69.83 174.7 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.121 -179.804 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.4 m -99.22 142.72 30.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.753 179.405 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.504 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 8.9 m-80 60.3 28.51 18.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.193 179.687 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -166.44 -167.45 27.13 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.908 179.848 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.412 ' CD ' ' OD1' ' A' ' 100' ' ' ASN . 9.4 ptt85 -163.92 -175.81 4.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.897 0.379 . . . . 0.0 110.708 -179.534 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 15.7 p80 -114.07 167.17 10.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.984 -179.883 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 85' ' ' TYR . 92.5 m-20 -98.21 -97.12 0.22 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.614 179.785 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.638 ' N ' HG13 ' A' ' 95' ' ' VAL . . . 58.73 -83.05 0.01 OUTLIER Glycine 0 C--N 1.337 0.588 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.836 179.14 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.448 ' CB ' ' O ' ' A' ' 84' ' ' GLY . 4.1 m-30 93.05 13.32 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.2 1.4 . . . . 0.0 111.382 179.819 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.07 -174.54 2.55 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.836 179.012 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -110.33 -24.41 10.66 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.605 178.635 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.415 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 9.1 m-85 -143.16 169.69 17.13 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.872 -179.948 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.415 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 60.6 m-85 -149.26 159.92 43.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.479 179.516 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.763 HG23 ' HE2' ' A' ' 70' ' ' LYS . 9.5 p -122.55 -177.48 3.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.002 0.43 . . . . 0.0 111.64 -178.537 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.433 ' CB ' ' HA3' ' A' ' 38' ' ' GLY . 4.3 p-10 -68.58 96.49 0.71 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.867 179.948 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.67 18.3 2.21 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.286 -0.87 . . . . 0.0 113.182 178.882 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.35 162.06 13.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.871 0.336 . . . . 0.0 110.542 179.121 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 35.3 m -138.08 153.52 27.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.144 0.497 . . . . 0.0 111.198 -179.736 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.638 HG13 ' N ' ' A' ' 84' ' ' GLY . 21.3 t -147.93 149.4 15.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.924 179.705 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.855 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -108.41 128.37 54.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.855 179.751 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.971 ' CE2' HG21 ' A' ' 111' ' ' VAL . 5.9 m-85 -88.96 157.58 18.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.201 -179.294 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.434 ' HA ' HD13 ' A' ' 105' ' ' LEU . 22.8 m -154.57 142.11 19.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.458 -179.661 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.43 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 69.0 m -73.51 159.39 33.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.797 179.217 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.421 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 69.8 m-20 -93.04 -70.75 0.69 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.32 -179.404 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.9 t -61.05 -23.48 65.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.224 -179.358 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.56 32.86 1.07 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.452 -179.821 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.504 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 16.0 m-85 -69.92 -175.41 0.91 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.057 0.456 . . . . 0.0 110.934 -179.903 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.75 100.47 9.47 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.206 178.47 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.589 HD22 ' HB2' ' A' ' 109' ' ' SER . 0.2 OUTLIER -44.76 126.21 5.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.442 0.639 . . . . 0.0 111.957 -177.927 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.453 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 35.4 mm -87.72 153.86 3.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.749 178.43 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.03 -129.2 40.89 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.314 -0.946 . . . . 0.0 112.06 -179.04 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -122.62 142.47 50.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.865 0.364 . . . . 0.0 110.874 179.417 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.855 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.6 t -70.19 -29.87 66.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.893 179.985 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -72.57 135.34 21.92 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.818 -179.665 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.971 HG21 ' CE2' ' A' ' 97' ' ' TYR . 2.4 t -131.6 118.51 39.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.703 0.287 . . . . 0.0 110.812 179.44 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.92 122.92 28.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.521 -179.017 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.532 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 16.3 t -89.56 102.09 14.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.569 176.982 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.2 OUTLIER -141.12 157.99 44.53 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.04 -178.608 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.418 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 47.05 33.87 7.28 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.703 -179.965 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.451 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 66.02 10.29 50.86 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.522 -179.115 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -129.8 168.96 15.77 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.894 0.378 . . . . 0.0 110.578 179.407 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.532 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 94.9 m95 -109.98 134.5 52.05 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.929 -179.82 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.7 153.66 32.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.931 179.89 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.55 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 61.2 t0 66.04 37.17 0.2 Allowed Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 179.326 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.55 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 65.1 Cg_endo -75.78 134.89 17.05 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.12 1.88 . . . . 0.0 111.587 179.229 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.588 ' O ' HG21 ' A' ' 77' ' ' ILE . 87.0 Cg_endo -92.11 -172.3 0.4 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.812 2.341 . . . . 0.0 113.889 -177.33 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.446 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -133.11 -158.59 0.9 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.722 178.042 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 8.1 m -153.85 90.49 1.38 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.13 0.491 . . . . 0.0 111.012 179.129 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.429 ' HB2' HD11 ' A' ' 106' ' ' ILE . 10.4 mt-30 -122.33 157.31 32.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.778 179.966 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.576 ' O ' HG22 ' A' ' 126' ' ' ILE . 19.0 mm . . . . . 0 C--N 1.323 -0.564 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.941 -179.87 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.792 0.33 . . . . 0.0 110.873 . . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.696 ' HD3' HG23 ' A' ' 25' ' ' VAL . 0.0 OUTLIER 40.61 -162.0 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.01 178.648 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.475 ' O ' ' O ' ' A' ' 10' ' ' PRO . 1.3 m -100.35 171.35 5.62 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.347 -179.504 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 9' ' ' CYS . 75.5 Cg_exo -51.44 -147.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.262 2.641 . . . . 0.0 113.037 179.298 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.516 ' HG ' ' C ' ' A' ' 12' ' ' PRO . 40.7 t -37.26 -85.25 0.0 OUTLIER Pre-proline 0 CA--C 1.499 -1.011 0 CA-C-O 117.117 -1.42 . . . . 0.0 113.882 -177.216 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.602 ' HG3' HD13 ' A' ' 31' ' ' ILE . 63.7 Cg_endo -77.38 157.58 96.13 Favored 'Cis proline' 0 N--CA 1.481 0.764 0 CA-C-N 123.757 2.378 . . . . 0.0 115.083 -0.969 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.76 ' O ' HD11 ' A' ' 20' ' ' LEU . 17.1 tpp180 -50.64 156.7 0.87 Allowed 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.779 178.883 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.437 ' N ' ' HG3' ' A' ' 13' ' ' ARG . 0.3 OUTLIER -109.57 -175.73 2.83 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.99 -179.779 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.501 HG23 ' C ' ' A' ' 18' ' ' GLY . 6.8 tt -128.01 147.74 32.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.723 179.759 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -83.94 -42.31 16.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.343 -178.521 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 17' ' ' ASN . . . . . 0.434 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 1.2 m-20 -103.07 39.32 1.58 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.849 -179.233 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.501 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -175.5 -172.69 40.59 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.781 179.864 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.428 ' N ' ' O ' ' A' ' 34' ' ' SER . 0.4 OUTLIER -139.17 140.24 37.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.756 0.312 . . . . 0.0 110.407 179.732 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.906 HD21 ' CE1' ' A' ' 33' ' ' TYR . 11.3 mt -85.35 150.91 24.42 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.16 0.505 . . . . 0.0 112.12 -179.091 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.455 ' CB ' ' HB ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -120.51 72.32 0.95 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.23 175.275 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.94 ' HA ' HG23 ' A' ' 31' ' ' ILE . 1.7 mt -69.13 97.84 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.636 -176.974 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -88.94 7.45 82.11 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.282 178.002 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 159.07 136.95 2.14 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.528 179.972 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.696 HG23 ' HD3' ' A' ' 8' ' ' ARG . 15.1 m -113.73 25.23 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.785 0.326 . . . . 0.0 111.189 -179.817 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.407 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.5 OUTLIER -100.88 142.69 31.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.036 179.973 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.535 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 9.4 t80 -47.51 93.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.18 0.514 . . . . 0.0 110.715 179.302 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 134.32 -4.84 4.53 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.556 -178.959 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.91 -162.23 0.91 Allowed 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.975 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -168.41 150.56 5.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.089 0.471 . . . . 0.0 111.046 179.58 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.94 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -104.49 160.16 5.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.908 179.243 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.455 ' HB ' ' CB ' ' A' ' 21' ' ' ASP . 1.7 m -125.3 114.91 19.54 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.803 0.335 . . . . 0.0 110.447 179.307 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.906 ' CE1' HD21 ' A' ' 20' ' ' LEU . 11.2 m-85 -91.53 149.68 21.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.184 0.516 . . . . 0.0 111.962 -178.048 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.428 ' O ' ' N ' ' A' ' 19' ' ' GLN . 0.6 OUTLIER -153.99 145.89 23.51 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.699 179.498 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 10.8 m -70.47 167.45 18.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.714 0.292 . . . . 0.0 110.629 179.816 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -68.97 -84.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.003 -179.44 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.2 m -153.3 134.31 14.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.695 179.716 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.74 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 66.76 26.02 73.03 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.852 -178.93 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.5 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.1 m-85 -118.99 170.25 9.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.868 0.366 . . . . 0.0 111.104 -179.382 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.882 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -134.13 113.52 12.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.376 178.169 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.967 HD21 ' O ' ' A' ' 44' ' ' GLU . 4.8 tt -79.64 122.59 26.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.794 -179.438 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.882 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.3 mm -95.64 157.08 3.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.015 0.436 . . . . 0.0 111.284 -179.179 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.54 -135.23 19.11 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.159 -179.379 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.967 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -85.95 -174.09 4.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.784 0.326 . . . . 0.0 110.822 179.469 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.422 ' HA ' ' HG3' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -160.53 27.27 0.16 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.403 179.616 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 6.5 mtpt -151.32 129.95 12.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.332 -179.467 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.451 ' HB2' ' HA ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -101.28 159.29 15.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.168 179.316 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.488 ' CB ' ' HB2' ' A' ' 60' ' ' ASN . 1.1 m-85 -132.16 121.54 23.89 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.58 -0.848 . . . . 0.0 112.222 -179.642 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 8.4 t -75.23 83.84 2.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.886 178.747 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -103.6 -177.86 3.49 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.622 -178.468 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.535 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -89.11 143.86 26.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.014 -179.262 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.87 -120.58 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.389 179.829 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.2 t -105.98 -41.67 5.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.86 0.362 . . . . 0.0 110.894 179.633 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.91 43.39 1.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.852 179.924 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.73 18.76 74.36 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.598 -179.891 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.75 -162.79 0.09 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.795 0.331 . . . . 0.0 110.815 179.668 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.427 ' HB2' ' HA ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER -123.29 117.14 24.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.879 -179.978 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.431 HG22 ' C ' ' A' ' 51' ' ' LEU . 1.5 m -127.21 163.48 30.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.869 -178.773 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.497 ' CE2' ' HB3' ' A' ' 12' ' ' PRO . 63.5 m95 -116.01 118.06 31.86 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.647 -178.666 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.488 ' HB2' ' CB ' ' A' ' 48' ' ' TYR . 1.2 m-80 -72.26 165.46 50.53 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.27 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.466 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 87.3 Cg_exo -15.91 98.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.644 1 C-N-CA 125.681 4.254 . . . . 0.0 115.014 -178.39 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.505 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 4.2 mt-10 -99.35 -68.44 0.8 Allowed 'General case' 0 C--O 1.221 -0.426 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -176.487 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.425 ' HA ' ' HD2' ' A' ' 64' ' ' PRO . . . -102.14 77.68 0.22 Allowed Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -174.053 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.57 ' HG2' HD11 ' A' ' 41' ' ' LEU . 36.5 Cg_endo -55.87 -154.37 0.01 OUTLIER 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 123.327 2.684 . . . . 0.0 111.575 175.352 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.489 HG22 ' H ' ' A' ' 66' ' ' CYS . 4.2 mm -93.56 165.32 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.051 0.453 . . . . 0.0 111.42 179.654 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.489 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -165.03 135.25 3.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.662 179.277 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.3 OUTLIER -153.86 176.18 12.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.014 -179.786 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.5 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 26.4 p -85.17 123.48 30.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.16 179.894 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.74 HG12 ' O ' ' A' ' 38' ' ' GLY . 1.3 p -55.82 96.54 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.246 179.973 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.15 124.0 27.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.522 -179.522 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.441 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -104.57 125.94 51.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.957 178.234 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -75.75 -151.38 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.165 -179.962 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.446 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 2.8 t -55.3 138.67 66.96 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-O 120.636 0.255 . . . . 0.0 110.883 -179.568 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.487 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 29.2 Cg_exo -59.51 161.36 17.62 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.373 2.049 . . . . 0.0 112.078 179.969 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.525 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 87.0 Cg_exo -43.07 158.36 0.08 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.725 2.283 . . . . 0.0 112.798 -179.142 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 85.9 p -112.27 89.56 3.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.235 178.548 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.718 HG23 ' HE2' ' A' ' 97' ' ' TYR . 22.3 pt -69.24 167.82 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.206 -178.742 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 p -86.48 134.21 33.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.86 179.811 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.494 ' HB3' ' CE1' ' A' ' 103' ' ' TYR . 0.1 OUTLIER 67.77 28.37 7.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.486 -179.977 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -167.2 -166.04 25.61 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.141 179.661 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 98' ' ' SER . 0.4 OUTLIER -170.19 -174.11 1.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.091 0.472 . . . . 0.0 110.858 -178.829 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 15.3 p80 -104.89 172.37 6.82 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.945 179.537 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 30.1 m-20 -112.23 1.03 15.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.711 -179.979 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -48.57 140.26 10.94 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.658 -179.456 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -108.77 -26.46 10.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.949 0.404 . . . . 0.0 110.832 -179.9 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.92 -170.44 2.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.634 179.472 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -112.61 -18.3 12.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.437 179.951 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.428 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 5.6 m-85 -145.4 169.88 17.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.078 0.466 . . . . 0.0 111.499 -179.448 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.441 ' N ' ' O ' ' A' ' 71' ' ' CYS . 46.5 m-85 -149.08 166.08 29.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.41 -179.551 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.8 p -126.08 -178.62 4.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.967 0.413 . . . . 0.0 111.483 -179.444 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 9.0 p-10 -67.12 96.29 0.45 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.926 -179.867 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.18 23.93 1.52 Allowed Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.236 -0.893 . . . . 0.0 113.061 179.112 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.68 159.22 16.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.645 0.26 . . . . 0.0 110.425 179.254 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.474 HG22 ' N ' ' A' ' 95' ' ' VAL . 33.0 m -132.69 156.27 42.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.29 0.567 . . . . 0.0 111.501 -179.644 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.518 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 22.8 t -151.11 149.38 14.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.341 179.078 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.721 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -103.7 139.47 38.91 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.029 0.442 . . . . 0.0 110.562 179.242 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.98 ' CE1' HG21 ' A' ' 111' ' ' VAL . 3.2 m-85 -95.94 158.57 15.39 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.814 -179.434 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 81' ' ' ARG . 1.2 p -147.78 133.05 18.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.659 -178.681 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.466 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 81.9 m -70.19 160.41 32.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.46 178.401 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.58 -85.33 0.36 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.776 0.322 . . . . 0.0 110.987 179.572 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -43.7 -28.82 0.44 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.642 -179.498 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 126.61 36.24 0.53 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.719 179.662 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.499 ' CE2' HG12 ' A' ' 126' ' ' ILE . 47.8 m-85 -77.52 -173.91 3.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.884 0.373 . . . . 0.0 110.923 179.958 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -113.06 107.26 15.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.799 179.917 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.546 HD22 ' HA ' ' A' ' 109' ' ' SER . 1.1 mp -45.21 117.08 1.26 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.296 179.842 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.46 HG22 ' N ' ' A' ' 107' ' ' GLY . 47.1 mm -106.25 155.54 7.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.935 -179.512 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.46 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 60.34 37.61 93.38 Favored Glycine 0 CA--C 1.508 -0.396 0 C-N-CA 120.321 -0.942 . . . . 0.0 112.243 179.835 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 51.36 120.3 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.45 -0.875 . . . . 0.0 112.507 179.777 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.721 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.3 p -54.4 -27.64 38.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.307 179.83 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.22 137.16 49.27 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.697 -179.465 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.98 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.9 t -134.87 137.15 51.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.454 0.169 . . . . 0.0 110.621 179.983 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.76 125.78 42.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.878 0.371 . . . . 0.0 111.478 -179.455 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.528 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 34.6 t -90.66 100.67 13.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.662 176.883 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.3 OUTLIER -142.27 159.55 42.0 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.129 -178.495 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.433 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 47.18 32.06 6.52 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.655 -179.912 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.46 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 70.52 6.16 57.7 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.916 -179.759 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -129.8 -178.46 4.72 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.861 0.362 . . . . 0.0 110.498 179.261 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.528 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 92.0 m95 -117.36 122.72 44.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.932 -179.52 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.07 152.65 21.83 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.28 -179.049 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.513 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.5 OUTLIER 67.0 43.27 0.3 Allowed Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.205 179.27 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 56.4 Cg_endo -69.75 141.42 45.22 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.158 1.905 . . . . 0.0 111.261 178.117 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.51 ' HB2' HD23 ' A' ' 105' ' ' LEU . 87.4 Cg_endo -92.25 -169.8 0.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.554 2.169 . . . . 0.0 113.636 -177.594 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.28 -168.03 2.37 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.151 178.853 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 124' ' ' CYS . . . . . 0.424 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 6.7 m -145.84 94.81 2.54 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.006 0.431 . . . . 0.0 110.962 179.95 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -118.93 157.9 26.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.85 -179.772 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.499 HG12 ' CE2' ' A' ' 103' ' ' TYR . 22.9 mm . . . . . 0 C--N 1.324 -0.533 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.229 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.433 ' HB3' HG23 ' A' ' 25' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.446 -0.628 0 CA-C-O 121.166 0.508 . . . . 0.0 111.809 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.47 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 25.7 m -103.6 163.32 17.65 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.647 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 38.1 Cg_endo -67.53 171.8 11.32 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.253 1.969 . . . . 0.0 112.052 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.77 104.38 0.42 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.226 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.557 ' HB3' HD11 ' A' ' 31' ' ' ILE . 2.5 Cg_endo -49.95 156.92 3.05 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.201 1.934 . . . . 0.0 112.058 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.753 ' O ' HD11 ' A' ' 20' ' ' LEU . 6.5 mtt180 -76.23 164.39 26.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.305 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.44 -172.62 2.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.198 0.523 . . . . 0.0 111.633 -178.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.661 HD12 ' HD2' ' A' ' 64' ' ' PRO . 17.1 tt -145.47 143.26 22.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.891 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.458 ' HB2' ' ND2' ' A' ' 17' ' ' ASN . 2.8 p30 -76.65 160.97 28.92 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.032 0.444 . . . . 0.0 110.352 177.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.466 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 0.7 OUTLIER 39.01 29.8 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.224 -178.324 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 16' ' ' ASP . . . -151.42 170.54 31.01 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.638 -178.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.36 137.59 39.03 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.769 0.319 . . . . 0.0 110.674 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.953 HD21 ' CE2' ' A' ' 33' ' ' TYR . 13.1 mt -82.86 159.68 22.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.041 0.448 . . . . 0.0 111.429 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -126.37 71.32 1.27 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.596 177.657 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.918 ' HA ' HG23 ' A' ' 31' ' ' ILE . 1.2 mt -69.81 93.44 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.855 -177.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.6 17.85 57.69 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.712 176.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.27 133.78 1.77 Allowed Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.055 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.433 HG23 ' HB3' ' A' ' 8' ' ' ARG . 17.1 m -119.73 25.9 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.86 0.362 . . . . 0.0 111.055 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 1.4 p-10 -87.11 152.43 22.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.235 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.464 ' CZ ' ' HB3' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -49.98 97.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.746 179.469 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 115.76 6.21 17.23 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.725 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.03 -167.13 1.54 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.833 0.316 . . . . 0.0 110.552 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 47' ' ' SER . 5.5 p -160.28 138.79 10.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.004 0.431 . . . . 0.0 111.675 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.918 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.7 OUTLIER -103.09 150.23 6.81 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.302 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.966 178.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.427 ' O ' ' N ' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -109.38 115.18 29.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.84 0.352 . . . . 0.0 111.144 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.953 ' CE2' HD21 ' A' ' 20' ' ' LEU . 13.7 m-85 -88.23 144.24 26.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.627 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -153.55 160.41 42.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.753 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.436 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 9.1 m -82.21 169.36 16.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.092 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -68.25 -84.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.117 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.37 133.25 12.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.821 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.48 ' O ' HG22 ' A' ' 69' ' ' VAL . . . 67.28 22.21 72.66 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.151 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.518 ' CD2' ' HA ' ' A' ' 68' ' ' SER . 2.4 m-85 -113.94 179.0 4.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.754 0.311 . . . . 0.0 110.785 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.922 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -140.98 112.34 7.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.053 0.454 . . . . 0.0 110.678 178.72 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.933 HD11 ' HG2' ' A' ' 64' ' ' PRO . 5.1 tt -79.7 126.28 30.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.656 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.922 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.1 mm -104.09 163.97 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.992 0.425 . . . . 0.0 111.08 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.434 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 73.15 -133.98 19.15 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.362 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.795 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.9 OUTLIER -84.93 -176.19 6.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.957 0.408 . . . . 0.0 110.956 179.657 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.2 p -157.38 18.78 0.28 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.698 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 0.5 OUTLIER -145.85 131.31 18.7 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -178.375 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.438 ' OG ' ' CB ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -96.28 147.09 24.14 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.698 176.788 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.499 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 2.2 m-85 -124.85 120.25 31.17 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 119.151 -1.02 . . . . 0.0 112.05 178.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 20.2 t -71.44 107.47 4.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.521 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.38 -174.51 3.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.116 0.484 . . . . 0.0 111.333 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.542 HD13 ' H ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.091 -178.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.416 ' HB2' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.148 0 CA-C-O 120.825 0.345 . . . . 0.0 110.267 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.4 m -151.99 174.69 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.08 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.537 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 65.0 m95 -129.09 125.75 37.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.3 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.499 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -68.91 165.19 39.95 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.928 178.442 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.44 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 98.5 Cg_exo -17.21 96.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.804 1 C-N-CA 125.408 4.072 . . . . 0.0 114.695 -178.454 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.473 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -93.94 -77.32 0.46 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.212 -178.228 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.468 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -85.16 108.89 17.33 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -175.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.933 ' HG2' HD11 ' A' ' 41' ' ' LEU . 1.4 Cg_endo -86.01 -154.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.296 2.664 . . . . 0.0 110.989 176.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.478 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 4.3 mm -86.05 164.15 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.852 0.358 . . . . 0.0 110.766 178.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.458 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.8 OUTLIER -168.41 129.81 1.33 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.773 179.446 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.58 168.49 26.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.023 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.518 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 53.3 p -83.69 122.76 29.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.17 0.509 . . . . 0.0 110.537 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.619 ' O ' HG23 ' A' ' 69' ' ' VAL . 22.5 m -45.79 100.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.052 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -94.12 99.03 11.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.321 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.425 ' N ' ' O ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -92.91 116.25 28.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.071 0.462 . . . . 0.0 110.326 179.775 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.22 -163.83 0.07 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.678 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.437 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -41.64 131.84 2.31 Favored Pre-proline 0 N--CA 1.436 -1.139 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.58 179.369 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.49 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 50.0 Cg_exo -54.69 165.71 2.36 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.423 2.082 . . . . 0.0 112.365 -178.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.512 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 80.9 Cg_exo -39.71 161.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.926 2.418 . . . . 0.0 113.021 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.2 t -109.3 88.75 2.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.443 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.683 HG23 ' HE2' ' A' ' 97' ' ' TYR . 19.3 pt -69.32 173.27 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.271 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.6 m -92.96 141.81 27.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.732 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.515 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 7.5 m-80 57.22 30.85 19.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.814 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.447 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . -170.52 -166.06 28.84 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.979 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.404 ' N ' ' O ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -169.63 -175.43 2.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.979 0.418 . . . . 0.0 110.781 -179.378 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 11.3 p80 -105.81 171.85 7.12 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.969 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.758 179.86 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.81 0.338 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.425 ' O ' ' N ' ' A' ' 71' ' ' CYS . 69.3 m-85 -152.34 164.27 37.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.936 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.469 HG22 ' O ' ' A' ' 69' ' ' VAL . 7.2 p -145.76 -175.81 4.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.061 0.458 . . . . 0.0 111.709 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 6.8 p-10 -50.51 94.36 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.63 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.49 24.64 1.91 Allowed Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.49 176.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.41 152.76 24.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 117.165 0.482 . . . . 0.0 111.132 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.433 HG22 ' N ' ' A' ' 95' ' ' VAL . 33.2 m -133.47 154.94 39.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.068 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.547 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 13.6 t -148.94 146.54 17.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.094 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.967 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -100.29 136.76 39.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.625 179.343 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.963 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.4 m-85 -97.32 159.1 15.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.039 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 81' ' ' ARG . 17.9 p -157.26 143.05 17.58 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.378 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.447 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 56.9 m -72.55 167.83 19.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.772 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -98.3 -85.89 0.36 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.894 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.4 t -47.26 -29.9 2.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.339 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.06 45.35 0.2 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.508 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.515 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 32.9 m-85 -82.83 -172.66 4.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.72 0.295 . . . . 0.0 110.684 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 m -108.4 105.46 15.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.937 0.399 . . . . 0.0 111.307 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.626 HD23 ' HB2' ' A' ' 122' ' ' PRO . 3.1 tp -46.22 113.22 0.59 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.996 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.511 HD11 ' HB2' ' A' ' 125' ' ' GLN . 33.0 mm -85.97 156.25 3.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.464 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.438 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 57.0 -130.43 50.95 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.364 -0.922 . . . . 0.0 111.478 -178.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 41.1 p-10 -116.09 136.28 53.17 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.087 0.47 . . . . 0.0 111.208 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.967 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.2 p -66.78 -26.25 66.87 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.476 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.18 142.67 31.97 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.712 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.963 HG21 ' CE1' ' A' ' 97' ' ' TYR . 3.3 t -138.66 120.88 17.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.609 0.242 . . . . 0.0 110.909 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.936 HD22 ' N ' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -79.14 135.93 36.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.931 0.396 . . . . 0.0 111.408 -179.417 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.936 ' N ' HD22 ' A' ' 112' ' ' LEU . 35.0 t -107.93 107.93 18.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.866 176.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.613 ' OG ' HD21 ' A' ' 112' ' ' LEU . 12.0 m -161.74 123.9 2.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.883 0.373 . . . . 0.0 111.729 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.501 ' H ' HG21 ' A' ' 69' ' ' VAL . . . 91.35 27.33 18.35 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.493 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.499 ' N ' ' HB ' ' A' ' 69' ' ' VAL . . . 71.46 18.02 76.69 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.173 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -147.89 179.28 7.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.222 0.534 . . . . 0.0 111.421 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.547 ' CZ3' HG23 ' A' ' 95' ' ' VAL . 93.2 m95 -121.06 144.77 48.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.483 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.435 ' OG ' HD12 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -127.25 149.49 49.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.029 0.442 . . . . 0.0 111.465 -179.279 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.489 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.5 OUTLIER 70.67 46.65 0.27 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.956 179.011 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 93.7 Cg_endo -77.6 138.53 17.29 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.509 2.139 . . . . 0.0 111.795 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.626 ' HB2' HD23 ' A' ' 105' ' ' LEU . 57.2 Cg_endo -89.82 -173.96 0.79 Allowed 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.634 2.223 . . . . 0.0 113.328 -179.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.467 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -135.01 -173.51 3.34 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.019 178.036 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . 0.42 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 17.2 m -144.38 94.74 2.61 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.968 0.413 . . . . 0.0 111.147 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.511 ' HB2' HD11 ' A' ' 106' ' ' ILE . 20.3 mt-30 -117.14 163.23 16.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.777 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.618 HG22 ' O ' ' A' ' 126' ' ' ILE . 35.5 mm . . . . . 0 C--N 1.324 -0.527 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.514 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.452 ' CB ' ' HA ' ' A' ' 26' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 121.113 0.483 . . . . 0.0 111.164 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.544 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 99.2 m -80.83 175.87 4.39 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.768 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.563 ' HD2' ' CD1' ' A' ' 59' ' ' TRP . 34.0 Cg_endo -89.56 179.46 2.19 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 122.734 2.289 . . . . 0.0 112.0 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.9 t -48.59 104.3 0.41 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.723 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.488 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 31.2 Cg_exo -43.09 167.37 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.176 1.917 . . . . 0.0 112.542 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.54 -175.62 1.36 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.743 177.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.661 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 1.6 t0 -139.05 -178.43 5.33 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.329 0.585 . . . . 0.0 111.7 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.558 HG22 ' CD2' ' A' ' 20' ' ' LEU . 13.4 tt -147.11 144.23 19.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.496 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -76.21 -64.02 1.19 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.723 -178.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -90.52 45.47 1.26 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.952 0.406 . . . . 0.0 111.026 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.427 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -164.64 170.63 39.83 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.032 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -131.24 131.13 43.7 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.829 HD21 ' CE2' ' A' ' 33' ' ' TYR . 25.7 mt -82.02 160.34 23.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.16 0.505 . . . . 0.0 111.685 -178.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -130.5 79.72 1.91 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.1 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.899 ' HA ' HG23 ' A' ' 31' ' ' ILE . 52.9 mt -69.72 118.01 13.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.661 -178.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.71 16.99 6.9 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.828 177.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 29' ' ' SER . . . 161.48 120.87 0.55 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.149 -0.548 . . . . 0.0 111.985 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.4 m -109.83 -6.98 11.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.452 ' HA ' ' CB ' ' A' ' 8' ' ' ARG . 1.6 m-20 -70.19 157.77 37.03 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.751 0.31 . . . . 0.0 110.9 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.556 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 7.2 t80 -50.47 116.04 1.73 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.866 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.14 0.87 48.02 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.83 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' A' ' 24' ' ' GLY . 12.9 m -84.48 166.5 17.22 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-N 116.994 0.397 . . . . 0.0 110.496 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.2 p -139.19 146.95 41.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.952 0.406 . . . . 0.0 111.061 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.899 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -108.09 171.2 2.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.599 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.473 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -129.82 116.3 18.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.048 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.829 ' CE2' HD21 ' A' ' 20' ' ' LEU . 11.9 m-85 -94.66 145.49 24.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.489 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.427 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 91.3 p -147.82 161.54 41.05 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.479 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.445 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 1.2 m -82.26 170.91 14.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.941 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.7 -81.51 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.285 -178.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.1 m -163.6 117.47 1.55 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.899 0.381 . . . . 0.0 110.699 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.427 ' HA3' ' HB2' ' A' ' 91' ' ' ASP . . . 86.04 -10.21 66.63 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.189 -177.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.506 ' CZ ' ' HB3' ' A' ' 68' ' ' SER . 2.6 m-85 -78.5 -173.63 3.44 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.758 0.313 . . . . 0.0 110.706 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.792 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -143.01 110.43 5.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.012 0.434 . . . . 0.0 110.075 177.409 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.969 HD21 ' O ' ' A' ' 44' ' ' GLU . 2.6 tt -74.76 121.87 22.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.682 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.792 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.1 mm -104.29 147.56 10.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.013 0.435 . . . . 0.0 110.674 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.29 -133.95 12.13 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.52 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.969 ' O ' HD21 ' A' ' 41' ' ' LEU . 1.0 OUTLIER -74.85 -177.63 3.37 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.177 0.513 . . . . 0.0 112.083 -178.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.6 p -163.15 23.81 0.09 Allowed 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.295 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.473 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 2.5 mtmt -161.54 130.15 4.4 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -177.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.463 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 0.1 OUTLIER -98.06 136.04 38.88 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 176.741 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.497 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.9 m-85 -112.97 118.28 34.41 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 119.182 -1.007 . . . . 0.0 112.292 -178.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.407 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 33.1 t -71.15 71.34 0.58 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.066 177.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.5 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 3.0 tt0 -93.22 172.55 8.23 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.781 -178.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.556 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.61 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.13 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.907 0.385 . . . . 0.0 110.197 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -142.84 169.13 12.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.798 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.563 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 75.5 m95 -117.76 116.4 26.93 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.878 -178.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.497 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -69.89 167.92 21.17 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.949 177.372 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.46 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 76.8 Cg_exo -16.21 101.57 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.816 1 C-N-CA 125.421 4.08 . . . . 0.0 114.847 -178.398 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.504 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.3 OUTLIER -97.88 -69.4 0.76 Allowed 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 115.021 -0.99 . . . . 0.0 113.144 -175.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.661 ' HB2' ' O ' ' A' ' 14' ' ' ASP . . . -102.85 76.02 0.21 Allowed Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -174.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.493 ' HG2' HD11 ' A' ' 41' ' ' LEU . 37.0 Cg_endo -56.9 -152.4 0.0 OUTLIER 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.225 2.617 . . . . 0.0 111.13 175.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.475 HG22 ' N ' ' A' ' 66' ' ' CYS . 5.4 mm -90.74 164.07 2.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.223 0.535 . . . . 0.0 111.927 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.475 ' N ' HG22 ' A' ' 65' ' ' ILE . 0.8 OUTLIER -167.89 120.85 0.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.098 179.338 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.476 ' O ' ' CD2' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -131.86 174.96 9.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.248 -179.048 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.506 ' HB3' ' CZ ' ' A' ' 39' ' ' TYR . 1.5 p -98.23 123.24 42.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.608 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.639 ' O ' HG23 ' A' ' 69' ' ' VAL . 30.6 m -47.9 101.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.177 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -95.41 99.39 11.31 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.73 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 3.2 m -78.55 130.7 36.27 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 175.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.405 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -68.61 -174.94 0.61 Allowed 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.5 -179.544 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 t -68.04 109.0 3.23 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.954 -178.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.71 ' HG3' ' CE2' ' A' ' 118' ' ' TRP 0.287 0.6 OUTLIER -37.48 -178.62 0.0 OUTLIER 'Trans proline' 0 CA--C 1.469 -2.745 0 C-N-CA 123.317 2.678 . . . . 0.0 113.389 174.467 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.562 ' CB ' ' CE2' ' A' ' 97' ' ' TYR . 44.0 Cg_endo -68.47 -166.43 2.84 Favored 'Cis proline' 0 C--N 1.316 -1.171 0 N-CA-C 114.094 0.767 . . . . 0.0 114.094 -18.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 38.2 t -134.87 18.6 3.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 113.95 -1.477 . . . . 0.0 108.907 172.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.666 HD11 ' HA3' ' A' ' 80' ' ' GLY . 16.2 pt -107.75 -159.05 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.295 -177.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.443 ' N ' HG13 ' A' ' 77' ' ' ILE . 0.9 OUTLIER -132.42 134.92 45.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.664 178.36 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.467 ' ND2' ' N ' ' A' ' 79' ' ' ASN . 0.2 OUTLIER 70.08 28.84 3.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.77 -179.49 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.666 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -145.02 -177.68 20.02 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.167 -1.016 . . . . 0.0 113.0 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.443 ' HG2' ' O ' ' A' ' 80' ' ' GLY . 47.3 mtp180 -152.5 -167.81 2.86 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.498 0.666 . . . . 0.0 112.213 -177.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.553 ' CG ' ' HB2' ' A' ' 74' ' ' PRO . 35.5 p-80 -137.87 -178.95 5.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.887 -1.052 . . . . 0.0 111.346 -178.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.574 ' OD1' HG12 ' A' ' 95' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.605 175.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.428 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 6.7 m-85 . . . . . 0 N--CA 1.456 -0.171 0 CA-C-O 120.672 0.272 . . . . 0.0 110.402 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.443 ' CD2' ' HZ2' ' A' ' 118' ' ' TRP . 45.6 m-85 -144.31 178.59 7.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.358 -178.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 25.4 p -139.15 -179.03 5.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.216 0.531 . . . . 0.0 111.794 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.622 ' HB3' HG22 ' A' ' 69' ' ' VAL . 0.7 OUTLIER -57.54 95.53 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.716 -179.179 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 113.94 38.3 1.17 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.709 -0.757 . . . . 0.0 113.493 177.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.484 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -105.66 155.02 19.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.917 0.359 . . . . 0.0 110.658 178.539 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 29.9 m -134.79 146.37 30.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.002 0.429 . . . . 0.0 111.238 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.579 HG23 ' CH2' ' A' ' 118' ' ' TRP . 1.6 t -149.99 137.0 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.334 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.816 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -88.15 132.24 34.41 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 177.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.775 ' CZ ' HG21 ' A' ' 111' ' ' VAL . 3.1 m-30 -99.82 149.69 23.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.302 0.572 . . . . 0.0 112.533 -175.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.421 ' O ' ' N ' ' A' ' 81' ' ' ARG . 88.3 p -129.54 139.8 51.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.139 177.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.492 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 87.9 m -69.53 141.63 53.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.153 0.501 . . . . 0.0 111.992 -177.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -56.24 -85.47 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.386 -178.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.93 -16.94 62.7 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -175.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.26 29.63 0.77 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.269 -0.967 . . . . 0.0 113.131 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.469 ' CE1' HG12 ' A' ' 126' ' ' ILE . 32.1 m-85 -68.57 -171.69 0.29 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 125' ' ' GLN . 3.4 p -107.93 108.45 19.61 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.935 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.488 ' HA ' HD12 ' A' ' 105' ' ' LEU . 1.8 tp -49.03 102.99 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.191 178.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.47 ' HB ' ' CB ' ' A' ' 123' ' ' THR . 39.1 mm -81.98 155.84 4.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.814 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.462 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 54.59 -130.07 45.16 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.782 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -107.83 132.06 53.82 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.145 0.497 . . . . 0.0 112.177 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.816 ' HB2' HG22 ' A' ' 96' ' ' THR . 0.1 OUTLIER -68.64 -30.5 69.22 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 174.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -65.5 123.73 25.72 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.282 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.775 HG21 ' CZ ' ' A' ' 97' ' ' TYR . 43.8 t -126.11 124.67 66.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 110.645 -0.131 . . . . 0.0 110.645 -177.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.69 135.28 35.06 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.064 0.459 . . . . 0.0 112.229 -177.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.525 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 12.0 t -97.09 105.89 18.13 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 175.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.78 166.7 23.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.309 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 60.3 14.74 35.01 Favored Glycine 0 CA--C 1.519 0.318 0 CA-C-N 115.524 -0.762 . . . . 0.0 113.294 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.402 ' O ' ' HG2' ' A' ' 117' ' ' GLU . . . 87.68 8.45 73.46 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.449 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 116' ' ' GLY . 25.8 mt-10 -156.91 -176.08 5.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.87 0.367 . . . . 0.0 110.476 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.71 ' CE2' ' HG3' ' A' ' 74' ' ' PRO . 96.8 m95 -95.78 130.83 42.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.905 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.79 156.09 21.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.251 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.5 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER 55.47 44.39 1.6 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.037 179.834 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 98.5 Cg_endo -78.16 153.45 28.26 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.401 2.067 . . . . 0.0 111.933 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.587 ' HD3' HG22 ' A' ' 111' ' ' VAL . 74.0 Cg_endo -88.84 -170.01 0.45 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.635 2.223 . . . . 0.0 113.298 -178.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.47 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -131.64 176.91 7.93 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.537 176.841 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . 0.444 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 2.9 m -139.17 97.63 3.34 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.976 0.417 . . . . 0.0 110.87 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.424 ' O ' ' CB ' ' A' ' 104' ' ' SER . 17.1 mt-30 -125.36 163.56 22.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.04 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.469 HG12 ' CE1' ' A' ' 103' ' ' TYR . 17.4 mm . . . . . 0 C--N 1.324 -0.515 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.064 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.475 ' HD3' HG23 ' A' ' 25' ' ' VAL . 5.7 mtt180 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.984 0.421 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.471 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 51.7 m -90.35 160.64 39.19 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.974 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 56.0 Cg_endo -70.13 177.54 5.73 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.51 2.14 . . . . 0.0 112.122 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.412 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -53.25 112.79 3.94 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.985 -179.84 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.642 ' HG3' HD13 ' A' ' 22' ' ' ILE . 20.0 Cg_endo -60.34 149.55 85.26 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.353 2.035 . . . . 0.0 112.003 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.778 ' O ' HD11 ' A' ' 20' ' ' LEU . 6.6 mtt180 -57.88 173.45 0.32 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -129.89 -174.82 3.42 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.097 0.475 . . . . 0.0 111.623 -178.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.445 HG23 ' O ' ' A' ' 18' ' ' GLY . 4.5 tt -141.53 148.62 20.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.866 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.49 -58.25 2.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.245 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.438 ' N ' ' ND2' ' A' ' 17' ' ' ASN . 0.5 OUTLIER -93.65 40.78 1.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.864 -179.503 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.445 ' O ' HG23 ' A' ' 15' ' ' ILE . . . -164.27 -179.93 38.74 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.703 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.25 134.51 32.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.745 0.307 . . . . 0.0 110.524 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.909 HD21 ' CE2' ' A' ' 33' ' ' TYR . 13.7 mt -77.83 155.93 30.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.098 0.475 . . . . 0.0 111.687 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.459 ' HB3' ' CB ' ' A' ' 32' ' ' THR . 29.6 t70 -129.3 74.06 1.56 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.114 176.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.915 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.8 OUTLIER -76.97 101.83 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.954 -176.447 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.73 16.82 58.26 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.753 -0.736 . . . . 0.0 111.732 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 162.53 132.35 1.33 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.251 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.475 HG23 ' HD3' ' A' ' 8' ' ' ARG . 34.0 m -113.62 -8.07 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.44 ' HA ' ' CB ' ' A' ' 8' ' ' ARG . 32.8 t0 -70.18 163.48 26.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.968 0.413 . . . . 0.0 111.074 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.518 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 11.0 t80 -54.44 113.82 1.42 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.684 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.87 -7.11 33.21 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.664 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.2 m -78.89 158.85 28.0 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.956 0.378 . . . . 0.0 110.647 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.2 p -134.44 136.41 43.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.041 0.448 . . . . 0.0 111.029 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.915 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -96.95 169.7 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.66 178.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.459 ' CB ' ' HB3' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -132.7 109.83 9.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.942 0.401 . . . . 0.0 111.148 179.515 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.909 ' CE2' HD21 ' A' ' 20' ' ' LEU . 21.5 m-85 -83.59 139.08 33.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.025 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.431 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 41.4 m -144.99 160.31 41.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.711 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.443 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 36.4 m -84.02 167.31 16.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.863 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -65.3 -84.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.129 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.0 t -152.92 137.61 16.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.702 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 59.11 25.89 60.44 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.843 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.512 ' CE1' ' HB3' ' A' ' 68' ' ' SER . 2.4 m-85 -115.85 172.66 7.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.721 0.296 . . . . 0.0 110.91 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.87 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.9 OUTLIER -132.49 122.73 25.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.043 0.449 . . . . 0.0 110.674 178.299 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.87 HD11 ' HG2' ' A' ' 64' ' ' PRO . 10.1 tt -84.77 127.54 34.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.782 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.87 HD11 ' CE1' ' A' ' 40' ' ' HIS . 1.5 mm -108.49 152.27 10.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.086 0.47 . . . . 0.0 111.023 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.22 -137.24 16.76 Favored Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.31 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.828 ' O ' HD21 ' A' ' 41' ' ' LEU . 4.1 pm0 -76.59 178.05 6.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.877 0.37 . . . . 0.0 110.654 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.9 p -156.4 19.11 0.35 Allowed 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.502 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.435 ' HG3' ' HA ' ' A' ' 32' ' ' THR . 21.1 mtpt -159.37 121.46 3.43 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.863 0.319 . . . . 0.0 111.863 -177.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.46 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 0.5 OUTLIER -88.51 131.26 34.98 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 177.092 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.496 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 2.0 m-85 -107.14 115.7 30.63 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 119.246 -0.982 . . . . 0.0 111.555 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.455 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 23.5 t -68.72 80.84 0.28 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.104 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.464 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -97.12 -164.59 1.16 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.626 -179.162 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.518 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.457 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.924 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.245 0 CA-C-O 120.931 0.396 . . . . 0.0 110.399 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.461 HG23 ' HG2' ' A' ' 50' ' ' GLU . 1.3 m -153.72 -177.72 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.527 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.542 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 87.6 m95 -125.14 121.13 33.32 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.104 0.478 . . . . 0.0 112.037 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.496 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 2.4 m120 -72.63 167.05 36.77 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.437 177.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.446 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 83.3 Cg_exo -18.0 104.29 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 125.142 3.894 . . . . 0.0 114.412 -178.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.48 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -106.92 -81.52 0.55 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.186 -177.235 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.471 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -76.13 107.45 4.49 Favored Pre-proline 0 N--CA 1.463 0.191 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -175.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.87 ' HG2' HD11 ' A' ' 41' ' ' LEU . 3.9 Cg_endo -91.52 -155.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 123.459 2.772 . . . . 0.0 111.23 177.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.565 HG22 ' H ' ' A' ' 66' ' ' CYS . 2.2 mm -96.65 168.82 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.873 0.368 . . . . 0.0 110.58 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.565 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.1 m -167.34 136.59 2.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.206 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.43 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.6 OUTLIER -156.29 175.33 14.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.957 179.703 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.512 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 3.1 p -93.88 108.76 20.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.94 0.4 . . . . 0.0 111.121 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.494 ' O ' HG13 ' A' ' 69' ' ' VAL . 2.7 p -48.58 97.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.263 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.13 121.13 25.18 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.289 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.431 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -103.24 116.79 33.14 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.284 178.798 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -70.81 -157.68 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.616 179.537 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.478 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 1.6 t -47.47 139.01 8.44 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.191 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.495 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 34.5 Cg_exo -58.41 160.93 15.37 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.319 2.013 . . . . 0.0 111.811 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.516 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 88.8 Cg_exo -44.03 157.32 0.15 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.584 2.189 . . . . 0.0 112.784 -178.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 87.7 p -107.32 89.3 2.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.633 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.663 HG21 ' O ' ' A' ' 122' ' ' PRO . 14.6 pt -69.46 176.55 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.169 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.6 m -92.97 142.4 27.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.84 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 54.99 29.92 13.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.874 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.467 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -163.37 -176.69 35.62 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.294 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -156.43 -174.61 5.02 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.478 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 2.5 p-80 -122.19 161.82 22.49 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.511 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 23.9 m-20 . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.523 179.568 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.421 ' HA ' ' HA ' ' A' ' 72' ' ' GLN . 12.8 m-85 . . . . . 0 N--CA 1.446 -0.668 0 CA-C-O 121.138 0.494 . . . . 0.0 111.331 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.431 ' N ' ' O ' ' A' ' 71' ' ' CYS . 9.5 m-85 -141.09 167.64 21.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.038 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.3 p -135.06 -177.45 4.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.153 0.502 . . . . 0.0 111.922 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -62.98 95.05 0.07 Allowed 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.93 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 128.53 12.67 2.71 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.35 -0.841 . . . . 0.0 113.362 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.419 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.5 OUTLIER -90.41 154.51 19.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 117.1 0.45 . . . . 0.0 110.403 179.268 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 26.9 m -133.93 148.23 30.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.075 0.464 . . . . 0.0 110.892 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.513 HG23 ' CH2' ' A' ' 118' ' ' TRP . 46.3 t -146.9 151.98 13.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.596 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.781 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -109.04 135.01 50.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.595 179.712 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.973 ' CE1' HG21 ' A' ' 111' ' ' VAL . 5.2 m-85 -93.73 157.55 16.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.196 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.93 149.66 29.9 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.955 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.411 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 72.7 m -85.76 155.14 21.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.899 0.38 . . . . 0.0 111.186 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.467 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 56.1 m-20 -92.31 -72.96 0.57 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.336 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.4 t -51.98 -24.35 6.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.882 0.373 . . . . 0.0 110.805 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.03 29.66 1.46 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.535 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.509 ' CE2' HG12 ' A' ' 126' ' ' ILE . 41.1 m-85 -74.41 -175.83 2.48 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 120.998 0.427 . . . . 0.0 110.55 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 34.3 m -122.34 98.61 6.01 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.63 ' HA ' ' HA ' ' A' ' 124' ' ' CYS . 0.0 OUTLIER -51.93 152.02 3.27 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-O 122.305 1.05 . . . . 0.0 112.504 -175.625 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.472 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 45.1 mm -121.98 145.98 27.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 113.085 -1.87 . . . . 0.0 111.244 -174.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.43 ' O ' ' ND2' ' A' ' 108' ' ' ASN . . . 77.32 39.05 27.56 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.271 -0.966 . . . . 0.0 111.859 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.43 ' ND2' ' O ' ' A' ' 107' ' ' GLY . 8.3 p30 53.5 138.71 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 124.346 1.058 . . . . 0.0 113.117 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.781 ' HB2' HG22 ' A' ' 96' ' ' THR . 0.6 OUTLIER -69.4 -24.61 63.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.583 -179.712 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -64.73 134.06 37.93 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.59 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.973 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.7 t -132.94 121.76 44.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.657 0.265 . . . . 0.0 110.517 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.12 119.68 27.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.909 0.385 . . . . 0.0 111.388 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.501 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 14.6 t -86.7 102.62 14.39 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 176.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.1 t -156.14 148.1 23.17 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.039 0.447 . . . . 0.0 111.328 -178.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 69.55 24.94 75.98 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.54 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.474 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 74.71 5.74 75.13 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.873 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -137.84 174.42 10.59 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.88 0.372 . . . . 0.0 110.328 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.516 ' CD1' ' HD3' ' A' ' 75' ' ' PRO . 86.4 m95 -107.51 128.93 54.95 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.778 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.454 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -100.27 160.37 14.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.536 -178.479 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.449 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 2.2 p-10 46.94 48.35 5.57 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.71 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 91.8 Cg_endo -77.26 135.19 14.88 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.431 2.087 . . . . 0.0 110.512 175.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.663 ' O ' HG21 ' A' ' 77' ' ' ILE . 73.6 Cg_endo -93.67 -176.49 0.54 Allowed 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.09 1.86 . . . . 0.0 114.526 -175.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' A' ' 105' ' ' LEU . 0.2 OUTLIER -118.43 -155.45 0.6 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.407 179.039 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . 0.63 ' HA ' ' HA ' ' A' ' 105' ' ' LEU . 1.8 m -153.8 88.31 1.26 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.928 0.394 . . . . 0.0 110.753 177.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -115.41 162.48 17.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.756 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.509 HG12 ' CE2' ' A' ' 103' ' ' TYR . 26.5 mm . . . . . 0 C--N 1.325 -0.488 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.167 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.493 ' HB3' HG23 ' A' ' 25' ' ' VAL . 9.0 mtm180 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.883 0.373 . . . . 0.0 110.977 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.457 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 19.6 m -93.2 162.32 28.59 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.855 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 36.4 Cg_endo -66.95 171.97 10.42 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.417 2.078 . . . . 0.0 111.997 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.414 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -55.12 112.63 4.33 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.371 179.67 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 11' ' ' SER . 11.0 Cg_endo -55.12 151.13 36.19 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.143 1.895 . . . . 0.0 111.933 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.862 ' O ' HD11 ' A' ' 20' ' ' LEU . 12.1 mtt180 -65.12 152.83 42.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.622 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -99.41 -178.07 3.79 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.953 -176.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.495 HG22 ' CD2' ' A' ' 20' ' ' LEU . 14.2 tt -152.44 141.49 14.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.129 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.41 ' HB2' ' ND2' ' A' ' 17' ' ' ASN . 7.3 p30 -80.45 174.64 11.41 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.718 178.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.496 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 0.7 OUTLIER 37.32 31.05 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.809 179.694 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.447 ' HA2' ' N ' ' A' ' 36' ' ' ASN . . . -167.26 -166.89 27.11 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.62 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.96 146.42 21.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.665 0.269 . . . . 0.0 110.932 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.862 HD11 ' O ' ' A' ' 13' ' ' ARG . 14.5 mt -84.77 157.94 20.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.991 0.424 . . . . 0.0 111.556 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.439 ' HB3' ' CB ' ' A' ' 32' ' ' THR . 1.2 t70 -125.68 76.39 1.57 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.717 177.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.901 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.9 OUTLIER -74.85 101.06 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.117 -176.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.47 18.58 50.6 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.631 176.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 160.43 134.94 1.74 Allowed Glycine 0 C--N 1.334 0.444 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.834 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.493 HG23 ' HB3' ' A' ' 8' ' ' ARG . 33.7 m -128.42 33.16 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -105.39 163.79 12.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.16 0.505 . . . . 0.0 111.243 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.55 ' CE1' ' HE3' ' A' ' 57' ' ' MET . 0.0 OUTLIER -47.97 95.6 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.349 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.77 -4.74 22.72 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.539 -0.839 . . . . 0.0 113.206 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.3 m -70.23 173.9 6.18 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 117.014 0.407 . . . . 0.0 110.289 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.3 p -145.16 144.22 30.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.002 0.429 . . . . 0.0 111.245 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.901 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -105.97 171.84 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.516 -179.662 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.439 ' CB ' ' HB3' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -133.1 115.17 14.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.876 0.37 . . . . 0.0 110.953 179.633 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.831 ' CE2' HD21 ' A' ' 20' ' ' LEU . 15.3 m-85 -88.77 149.0 23.65 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.218 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 83.4 p -154.78 147.85 24.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.196 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.418 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 8.6 m -76.12 168.44 20.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.816 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.447 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 40.9 m-20 -71.24 -84.86 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.37 -178.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.4 t -151.32 135.18 16.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.897 0.379 . . . . 0.0 110.874 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.744 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 65.77 25.35 71.75 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.066 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.498 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.1 m-85 -118.46 170.13 9.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 0.0 111.083 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.939 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -136.1 112.31 9.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.08 0.467 . . . . 0.0 110.557 177.903 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.897 HD21 ' O ' ' A' ' 44' ' ' GLU . 4.2 tt -80.57 119.48 23.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.8 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.939 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.5 mm -94.11 161.96 2.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.186 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.68 -138.01 22.45 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.269 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.897 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -82.74 -174.65 5.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.84 0.352 . . . . 0.0 110.838 179.508 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.7 p -156.16 22.26 0.37 Allowed 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.241 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.438 ' HG3' ' HA ' ' A' ' 32' ' ' THR . 2.9 mtpt -150.76 131.05 13.64 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -177.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.458 ' OG ' ' CB ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -93.42 146.82 23.47 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.286 176.248 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.547 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.9 m-85 -120.78 117.12 26.63 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 119.014 -1.074 . . . . 0.0 111.738 178.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 48.8 t -62.86 115.2 4.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.999 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.27 -170.85 3.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.214 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.514 HD22 ' C ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.594 0 CA-C-O 120.929 0.395 . . . . 0.0 110.874 -178.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.55 ' HE3' ' CE1' ' A' ' 27' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.454 -0.252 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.658 HG23 ' N ' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -118.46 -176.52 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.607 0.717 . . . . 0.0 111.589 -176.834 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.658 ' N ' HG23 ' A' ' 58' ' ' VAL . 69.6 m95 -130.87 133.36 45.82 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.636 -1.166 . . . . 0.0 111.448 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.547 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.6 OUTLIER -75.67 166.46 45.03 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.944 177.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.474 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 97.3 Cg_exo -17.93 96.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 125.251 3.968 . . . . 0.0 114.494 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.479 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.3 OUTLIER -92.87 -76.84 0.46 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.498 -0.773 . . . . 0.0 112.457 -177.374 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.45 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -88.36 109.3 27.68 Favored Pre-proline 0 C--N 1.331 -0.21 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -175.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.88 ' HG2' HD11 ' A' ' 41' ' ' LEU . 1.8 Cg_endo -84.01 -154.96 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.092 2.528 . . . . 0.0 111.073 176.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.499 HG22 ' H ' ' A' ' 66' ' ' CYS . 4.0 mm -90.4 165.65 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.897 0.379 . . . . 0.0 110.895 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.499 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.2 m -163.41 139.32 6.77 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.063 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -159.94 170.86 20.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.823 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.498 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 13.4 p -82.31 117.07 22.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.954 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.744 HG12 ' O ' ' A' ' 38' ' ' GLY . 0.8 OUTLIER -46.67 93.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.291 179.677 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.495 ' HE2' HG23 ' A' ' 90' ' ' THR . 0.3 OUTLIER -72.6 118.51 15.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.061 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -98.69 117.22 32.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.287 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.76 -159.05 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.713 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.47 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 2.1 t -49.86 139.9 16.25 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.925 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.491 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 26.1 Cg_exo -60.52 160.6 23.46 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.433 2.089 . . . . 0.0 112.062 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.527 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 86.2 Cg_exo -42.18 156.51 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.822 2.348 . . . . 0.0 112.842 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.9 m -109.36 90.68 3.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.438 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.575 HG23 ' HE2' ' A' ' 97' ' ' TYR . 21.6 pt -69.37 171.0 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.418 -178.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.5 m -89.92 139.99 30.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.618 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.515 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 2.9 m-80 60.42 29.27 18.88 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.829 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -165.43 -165.89 23.5 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.986 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -168.1 -175.89 2.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.896 0.379 . . . . 0.0 110.805 -179.537 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.47 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 13.3 p80 -115.24 168.81 9.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.123 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.73 179.542 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.406 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 10.4 m-85 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.828 0.347 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.406 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 41.1 m-85 -147.03 168.1 22.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.603 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.495 HG23 ' HE2' ' A' ' 70' ' ' LYS . 17.7 p -138.06 -175.6 4.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.993 0.425 . . . . 0.0 111.496 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.426 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 10.9 m-20 -63.76 96.22 0.13 Allowed 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.304 0.573 . . . . 0.0 111.049 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.93 26.66 1.35 Allowed Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.254 -0.884 . . . . 0.0 113.075 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.425 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.6 OUTLIER -108.26 157.3 18.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.878 0.339 . . . . 0.0 110.494 179.044 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 35.5 m -135.49 151.65 30.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.156 0.503 . . . . 0.0 111.411 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.526 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 18.0 t -147.85 148.06 16.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.404 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.939 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -107.52 125.84 51.78 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.067 0.461 . . . . 0.0 110.851 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 1.004 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.0 m-85 -84.21 164.59 19.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.249 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.52 ' HA ' HD13 ' A' ' 105' ' ' LEU . 51.7 m -156.71 143.33 18.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.504 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.452 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 64.2 m -73.88 157.55 36.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.662 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.417 ' CG ' ' N ' ' A' ' 101' ' ' SER . 1.3 p30 -95.12 -55.5 3.05 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.363 0.602 . . . . 0.0 111.342 -178.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.417 ' N ' ' CG ' ' A' ' 100' ' ' ASN . 6.5 t -75.37 -20.62 58.88 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.4 -178.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 117.96 28.05 2.34 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.446 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.515 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 17.9 m-85 -69.65 -179.83 1.89 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.123 0.487 . . . . 0.0 110.853 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -105.98 96.51 6.54 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.936 178.007 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.52 HD13 ' HA ' ' A' ' 98' ' ' SER . 0.3 OUTLIER -47.74 128.86 13.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.588 0.709 . . . . 0.0 111.965 -177.526 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.48 HG22 ' N ' ' A' ' 107' ' ' GLY . 36.0 mm -112.51 158.98 12.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.55 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.48 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 66.46 31.85 80.01 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.462 -0.875 . . . . 0.0 113.002 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.43 ' O ' ' O ' ' A' ' 107' ' ' GLY . 8.8 p30 52.03 130.85 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 123.983 0.913 . . . . 0.0 113.052 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.939 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.6 p -63.01 -25.39 68.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.388 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -64.14 127.76 35.78 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.466 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 1.004 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.6 t -131.35 123.14 52.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.588 0.233 . . . . 0.0 110.724 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.62 124.06 32.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.946 0.403 . . . . 0.0 111.579 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.506 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 18.4 t -87.23 108.81 19.1 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 176.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.6 OUTLIER -155.77 165.13 37.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.102 0.477 . . . . 0.0 111.508 -178.639 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.67 31.11 7.05 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.604 -0.726 . . . . 0.0 112.889 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.45 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 68.63 12.52 64.35 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.711 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -143.14 176.39 9.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.768 0.318 . . . . 0.0 110.523 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.527 ' CD1' ' HD3' ' A' ' 75' ' ' PRO . 89.3 m95 -110.71 127.54 55.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.824 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.91 148.98 27.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.057 0.456 . . . . 0.0 111.478 -178.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.493 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER 68.08 44.85 0.31 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.121 178.888 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 55.1 Cg_endo -69.63 139.18 40.02 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.175 1.917 . . . . 0.0 111.418 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.538 ' O ' HG21 ' A' ' 77' ' ' ILE . 55.6 Cg_endo -88.28 -174.8 1.19 Allowed 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.569 2.179 . . . . 0.0 113.35 -178.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.41 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -135.13 -157.48 0.8 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.884 179.002 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 1.8 m -156.28 90.21 1.17 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.124 0.488 . . . . 0.0 111.134 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.409 ' O ' ' CB ' ' A' ' 104' ' ' SER . 11.7 mt-30 -115.07 158.97 21.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.6 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.542 HG22 ' O ' ' A' ' 126' ' ' ILE . 29.4 mm . . . . . 0 C--N 1.323 -0.566 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.987 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.449 ' CB ' ' HA ' ' A' ' 26' ' ' ASP . 5.1 ptt180 . . . . . 0 N--CA 1.457 -0.11 0 CA-C-O 120.973 0.416 . . . . 0.0 111.173 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.483 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 12.3 m -93.12 162.68 27.73 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.999 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 51.2 Cg_endo -70.24 178.08 5.24 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.443 2.095 . . . . 0.0 112.172 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 42.2 t -58.5 107.94 1.13 Allowed Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.072 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.486 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 2.6 Cg_endo -50.29 146.96 17.18 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.147 1.898 . . . . 0.0 112.206 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.927 ' O ' HD11 ' A' ' 20' ' ' LEU . 4.4 ttp180 -59.76 151.56 25.02 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.275 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -98.5 -177.82 3.81 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.177 -176.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.608 HG22 ' CD2' ' A' ' 20' ' ' LEU . 8.2 tt -141.38 152.99 19.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.458 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -88.38 -66.98 0.86 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.57 -178.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -91.1 40.33 1.02 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.344 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.44 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -160.37 -179.22 35.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.881 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -137.75 125.18 21.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.743 0.306 . . . . 0.0 110.618 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.927 HD11 ' O ' ' A' ' 13' ' ' ARG . 14.9 mt -66.8 154.21 41.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.99 0.424 . . . . 0.0 111.231 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 32' ' ' THR . 3.9 t0 -127.35 74.67 1.53 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.852 178.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.865 ' HA ' HG23 ' A' ' 31' ' ' ILE . 67.8 mt -70.31 96.28 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.22 -177.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.96 21.48 44.78 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.435 176.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 154.87 140.61 3.05 Favored Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.437 HG23 ' HD2' ' A' ' 8' ' ' ARG . 26.5 m -125.64 -9.21 5.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.449 ' HA ' ' CB ' ' A' ' 8' ' ' ARG . 27.5 t70 -69.68 164.92 22.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.03 0.443 . . . . 0.0 110.95 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.452 ' CZ ' HD12 ' A' ' 51' ' ' LEU . 17.2 t80 -51.9 118.47 3.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.707 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 49' ' ' CYS . . . 100.27 -10.86 59.99 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.659 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.425 ' N ' ' HB3' ' A' ' 49' ' ' CYS . 3.6 m -58.53 179.92 0.07 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.825 0.345 . . . . 0.0 110.964 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.1 p -153.58 133.41 13.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.083 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.865 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.6 OUTLIER -100.97 174.25 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.724 179.584 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.47 ' H ' HG22 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -140.88 106.53 5.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.715 178.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.701 ' CE2' HD21 ' A' ' 20' ' ' LEU . 33.5 m-85 -78.37 138.1 38.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.39 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.0 m -139.46 167.02 23.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.69 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.44 ' HA ' ' HA2' ' A' ' 18' ' ' GLY . 1.3 m -91.8 164.62 13.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.943 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -62.01 -84.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.078 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.63 132.91 9.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.637 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.814 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 64.92 25.94 71.0 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.732 -178.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.525 ' CE1' ' CB ' ' A' ' 68' ' ' SER . 2.6 m-85 -118.34 -179.93 3.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.9 0.381 . . . . 0.0 110.931 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.5 ' CE1' ' HA ' ' A' ' 69' ' ' VAL . 0.0 OUTLIER -136.16 140.47 43.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.841 174.738 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.836 HD21 ' O ' ' A' ' 44' ' ' GLU . 9.6 tt -94.11 138.69 31.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.472 -178.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.577 HD13 ' C ' ' A' ' 41' ' ' LEU . 1.9 mm -110.73 150.5 13.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.077 0.465 . . . . 0.0 111.275 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.27 -147.14 43.75 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.256 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.836 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -62.14 177.74 0.44 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.592 0.234 . . . . 0.0 110.679 179.419 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.6 p -152.3 26.73 0.6 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.955 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.421 ' CG ' ' O ' ' A' ' 31' ' ' ILE . 0.4 OUTLIER -147.02 -171.11 3.7 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.066 -178.541 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.471 ' O ' HG13 ' A' ' 31' ' ' ILE . 1.1 m -167.07 98.92 0.53 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.168 179.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.424 ' CD1' ' N ' ' A' ' 48' ' ' TYR . 1.5 m-85 -80.51 115.85 20.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.134 0.492 . . . . 0.0 111.781 -177.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.482 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 34.8 t -65.91 102.96 0.84 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.031 178.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.498 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 3.7 tt0 -134.06 171.63 13.94 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.315 0.579 . . . . 0.0 110.695 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.498 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.744 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.763 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.24 0 CA-C-O 120.996 0.426 . . . . 0.0 110.385 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -148.67 -174.57 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.612 -178.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.532 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 88.5 m95 -128.06 123.2 34.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.805 0.336 . . . . 0.0 111.194 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -140.01 122.01 9.82 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.979 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.29 -166.89 5.25 Favored 'Cis proline' 0 C--N 1.352 0.725 0 C-N-CA 123.858 -1.309 . . . . 0.0 112.375 -0.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -110.34 -152.72 0.5 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.496 ' CB ' ' CE2' ' A' ' 33' ' ' TYR . . . -79.18 112.82 31.09 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.982 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.434 ' CG ' ' O ' ' A' ' 44' ' ' GLU . 16.6 Cg_exo -69.24 -150.54 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.738 2.292 . . . . 0.0 112.318 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.601 HG22 ' H ' ' A' ' 66' ' ' CYS . 0.5 OUTLIER -106.66 178.37 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.957 0.408 . . . . 0.0 111.251 -179.245 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.601 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.5 OUTLIER -170.69 127.38 0.76 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.747 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.476 ' O ' ' CD2' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -135.48 175.32 9.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.863 179.724 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.525 ' CB ' ' CE1' ' A' ' 39' ' ' TYR . 1.7 p -98.17 124.26 42.64 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.052 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.814 HG12 ' O ' ' A' ' 38' ' ' GLY . 6.7 p -49.58 92.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.982 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.434 ' CD ' ' HB3' ' A' ' 88' ' ' PHE . 0.8 OUTLIER -81.33 128.77 34.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.807 -178.635 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.433 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -110.62 120.44 42.43 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.867 177.625 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.443 ' HA ' ' HA ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -69.8 -160.19 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.964 -179.242 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.576 ' HG ' ' CE1' ' A' ' 82' ' ' HIS . 2.2 t -47.25 136.09 9.0 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.081 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.476 ' HD2' ' CD2' ' A' ' 82' ' ' HIS . 31.6 Cg_exo -56.81 161.81 9.71 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.347 2.031 . . . . 0.0 111.981 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.5 ' HD3' ' CG ' ' A' ' 118' ' ' TRP . 99.3 Cg_exo -42.75 158.15 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.694 2.262 . . . . 0.0 112.735 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.5 m -110.35 88.61 2.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.852 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.667 HG23 ' HE1' ' A' ' 97' ' ' TYR . 19.4 pt -69.65 -179.0 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.364 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.5 m -98.56 146.47 25.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.619 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.484 ' HB3' ' CD2' ' A' ' 103' ' ' TYR . 8.5 m-80 53.53 30.55 10.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.929 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -174.61 -172.29 39.55 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.874 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -170.72 -174.3 1.56 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.904 0.383 . . . . 0.0 110.673 -179.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.576 ' CE1' ' HG ' ' A' ' 73' ' ' SER . 11.5 p-80 -92.45 174.45 7.28 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.264 178.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.436 ' OD1' ' CG1' ' A' ' 95' ' ' VAL . 17.5 p-10 . . . . . 0 C--N 1.332 -0.183 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 72' ' ' GLN . 18.1 m-85 . . . . . 0 N--CA 1.449 -0.493 0 CA-C-O 121.131 0.491 . . . . 0.0 111.612 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.439 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 23.7 m-85 -144.66 169.63 17.63 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.049 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 17.0 p -133.62 178.39 6.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.987 0.423 . . . . 0.0 111.674 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -62.47 100.81 0.2 Allowed 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.539 0.685 . . . . 0.0 110.849 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 122.56 16.71 3.7 Favored Glycine 0 C--N 1.312 -0.792 0 CA-C-N 114.718 -1.128 . . . . 0.0 113.003 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.411 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -99.2 157.7 16.2 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.898 0.349 . . . . 0.0 110.533 179.115 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 34.6 m -136.17 152.01 29.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.164 0.507 . . . . 0.0 111.249 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.47 HG23 ' CH2' ' A' ' 118' ' ' TRP . 43.8 t -146.82 150.1 15.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.6 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.809 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -110.46 126.36 54.25 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.882 -179.537 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.977 ' CE2' HG21 ' A' ' 111' ' ' VAL . 3.8 m-85 -83.75 154.61 23.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.465 -178.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 59.9 p -153.58 147.85 25.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.283 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.454 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 8.4 m -69.81 160.77 31.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.954 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 21.6 m-20 -85.46 -68.99 0.69 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.249 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 66.9 m -77.56 -45.2 26.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.639 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 154.74 41.84 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.766 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.528 ' CE1' HG12 ' A' ' 126' ' ' ILE . 13.4 m-85 -78.15 -166.19 0.78 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' A' ' 124' ' ' CYS . 3.5 m -117.17 104.99 11.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.703 0.287 . . . . 0.0 111.567 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.472 ' HA ' HD12 ' A' ' 105' ' ' LEU . 2.6 tp -47.15 118.26 2.06 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.168 0.509 . . . . 0.0 110.534 178.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.523 HG22 ' N ' ' A' ' 107' ' ' GLY . 19.1 mm -94.27 160.71 2.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.917 -178.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.523 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 59.43 -124.18 35.66 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.852 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.28 122.85 38.09 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.79 0.329 . . . . 0.0 110.93 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.809 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.4 t -58.15 -27.7 64.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.068 0.461 . . . . 0.0 110.474 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.64 135.38 26.79 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.817 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.977 HG21 ' CE2' ' A' ' 97' ' ' TYR . 2.7 t -131.07 119.22 44.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.712 0.291 . . . . 0.0 110.594 178.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.0 118.76 24.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.991 0.424 . . . . 0.0 111.588 -178.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.496 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 14.1 t -85.37 100.54 11.91 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.467 176.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.6 t -136.63 161.39 36.04 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.063 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.99 25.58 3.9 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.756 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.434 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 77.16 7.38 86.78 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.655 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -133.53 -176.56 4.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.825 0.345 . . . . 0.0 110.571 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.5 ' CG ' ' HD3' ' A' ' 75' ' ' PRO . 94.3 m95 -114.61 145.05 42.45 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.171 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.1 147.39 51.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.286 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.495 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.5 t0 71.0 44.56 0.23 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.289 178.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 62.0 Cg_endo -73.23 137.12 25.5 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.191 1.927 . . . . 0.0 111.254 177.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.484 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 73.0 Cg_endo -89.42 -175.42 1.09 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.467 2.112 . . . . 0.0 113.752 -177.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.468 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -124.93 -162.54 1.11 Allowed 'General case' 0 CA--C 1.501 -0.92 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.509 175.34 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . 0.411 ' SG ' ' CB ' ' A' ' 103' ' ' TYR . 5.2 t -170.69 92.76 0.18 Allowed 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.323 -176.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -118.88 175.93 5.52 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.92 -1.037 . . . . 0.0 111.012 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.618 HG22 ' O ' ' A' ' 126' ' ' ILE . 16.9 mm . . . . . 0 C--N 1.324 -0.531 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.579 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.445 ' HB3' HG23 ' A' ' 25' ' ' VAL . 2.4 mtt85 . . . . . 0 N--CA 1.454 -0.238 0 CA-C-O 121.023 0.439 . . . . 0.0 111.92 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.457 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 15.1 m -111.51 161.56 24.86 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.638 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.408 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 55.8 Cg_endo -66.92 171.54 11.0 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.179 1.919 . . . . 0.0 110.471 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.408 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 5.7 p -51.11 120.47 14.1 Favored Pre-proline 0 N--CA 1.45 -0.45 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.719 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.509 ' HB3' HD13 ' A' ' 31' ' ' ILE . 6.3 Cg_endo -47.82 144.59 11.15 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.67 2.247 . . . . 0.0 112.395 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.454 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -52.59 -175.88 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.904 177.615 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -144.55 -179.95 6.89 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.46 0.648 . . . . 0.0 111.994 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.752 HD12 ' O ' ' A' ' 64' ' ' PRO . 7.0 tt -139.77 154.5 24.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.305 -179.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -79.08 -68.72 0.63 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.541 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.496 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 1.2 m120 -93.41 39.08 1.05 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.976 0.417 . . . . 0.0 110.876 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -148.29 178.92 25.55 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.025 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -141.51 134.16 28.53 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.953 HD21 ' CE2' ' A' ' 33' ' ' TYR . 10.5 mt -86.69 152.25 22.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.318 0.58 . . . . 0.0 111.953 -178.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -123.34 80.77 1.81 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.578 177.727 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.819 ' HA ' HG23 ' A' ' 31' ' ' ILE . 6.3 mt -75.5 116.66 18.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.561 -176.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -108.3 19.36 32.0 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.356 175.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.499 ' H ' HG22 ' A' ' 22' ' ' ILE . . . 156.58 164.48 13.51 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -179.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.445 HG23 ' HB3' ' A' ' 8' ' ' ARG . 22.5 m -143.82 22.7 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.861 0.33 . . . . 0.0 111.439 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.4 OUTLIER -93.57 159.27 15.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.805 179.762 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.641 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 2.9 t80 -56.03 87.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.683 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 134.1 -14.56 4.59 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.417 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.01 -170.94 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.612 0.244 . . . . 0.0 110.348 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 47' ' ' SER . 27.7 p -159.28 139.19 11.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.237 0.541 . . . . 0.0 111.819 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.819 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -103.66 176.27 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.866 178.755 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.545 HG23 ' HG2' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -138.24 113.2 9.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.696 0.284 . . . . 0.0 110.828 179.809 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.953 ' CE2' HD21 ' A' ' 20' ' ' LEU . 8.3 m-85 -87.34 149.21 24.65 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.318 0.58 . . . . 0.0 111.751 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.409 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.6 OUTLIER -156.62 164.11 38.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.675 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.467 ' HA ' ' HA2' ' A' ' 18' ' ' GLY . 20.2 m -87.7 165.48 15.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.19 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -66.57 -70.94 0.22 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.92 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.41 141.63 9.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.84 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.797 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 52.46 29.82 32.16 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.171 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.512 ' CZ ' ' HB3' ' A' ' 68' ' ' SER . 2.4 m-85 -117.09 175.84 5.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.799 0.333 . . . . 0.0 111.147 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.525 ' CE1' ' HA ' ' A' ' 69' ' ' VAL . 0.1 OUTLIER -131.76 140.5 49.24 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 174.566 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.972 HD21 ' O ' ' A' ' 44' ' ' GLU . 0.6 OUTLIER -90.16 138.67 31.33 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.256 -176.501 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.86 HD13 ' C ' ' A' ' 41' ' ' LEU . 0.3 OUTLIER -116.38 131.96 67.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 CA-C-O 121.67 0.748 . . . . 0.0 110.552 178.442 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.16 -137.42 13.25 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 114.183 -1.371 . . . . 0.0 111.165 -176.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.972 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.6 OUTLIER -87.32 -172.55 3.98 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.843 0.354 . . . . 0.0 110.687 178.333 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.0 p -144.77 25.54 1.45 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.979 0.419 . . . . 0.0 110.817 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.545 ' HG2' HG23 ' A' ' 32' ' ' THR . 0.2 OUTLIER -160.86 125.92 3.71 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.841 -179.117 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' A' ' 30' ' ' SER . 1.6 m -95.74 149.54 21.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.008 178.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.512 ' CE2' ' HD3' ' A' ' 61' ' ' PRO . 4.0 m-85 -123.08 126.85 47.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.028 0.442 . . . . 0.0 111.278 -178.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.477 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 10.5 t -76.21 91.95 3.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.118 179.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -116.4 178.17 4.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.63 -178.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.641 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 4.8 mt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.606 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.934 0.397 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.5 m -132.84 -175.78 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.91 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.631 ' CE3' HD11 ' A' ' 31' ' ' ILE . 88.3 m95 -120.76 139.32 53.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.877 0.37 . . . . 0.0 110.996 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.424 ' O ' ' N ' ' A' ' 48' ' ' TYR . 3.1 m-20 -148.78 140.2 14.16 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.956 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.512 ' HD3' ' CE2' ' A' ' 48' ' ' TYR . 7.3 Cg_exo -75.93 -151.89 0.72 Allowed 'Cis proline' 0 C--N 1.348 0.512 0 C-N-CA 124.163 -1.182 . . . . 0.0 112.738 1.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -65.2 -130.7 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.908 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.642 ' HB3' ' CA ' ' A' ' 64' ' ' PRO . . . -72.26 -82.53 0.04 OUTLIER Pre-proline 0 CA--C 1.48 -1.733 0 CA-C-O 118.503 -0.76 . . . . 0.0 112.132 -178.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.752 ' O ' HD12 ' A' ' 15' ' ' ILE . 41.2 Cg_endo -102.92 -144.89 0.03 OUTLIER 'Cis proline' 0 C--N 1.317 -1.095 0 CA-C-N 120.73 1.296 . . . . 0.0 114.285 12.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.451 HG13 ' HB ' ' A' ' 42' ' ' ILE . 2.2 pt -91.22 177.0 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -174.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.631 ' HB2' HD11 ' A' ' 15' ' ' ILE . 1.2 m -158.83 112.12 2.33 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 114.282 -1.327 . . . . 0.0 109.513 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.473 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 1.9 mt-10 -102.13 176.8 5.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.006 0.432 . . . . 0.0 111.335 -178.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.512 ' HB3' ' CZ ' ' A' ' 39' ' ' TYR . 2.4 p -97.34 123.02 41.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.802 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.797 HG12 ' O ' ' A' ' 38' ' ' GLY . 3.3 p -45.75 97.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.318 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.619 ' HE2' HG23 ' A' ' 90' ' ' THR . 0.3 OUTLIER -84.78 115.58 22.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.435 -179.139 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -96.38 119.25 34.52 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 177.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -69.81 -157.41 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.577 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.413 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 2.2 t -50.98 138.9 23.92 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.57 0.224 . . . . 0.0 110.736 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.935 ' HG2' HG11 ' A' ' 95' ' ' VAL . 33.9 Cg_exo -58.36 156.36 31.14 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.383 2.055 . . . . 0.0 112.05 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.533 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 76.1 Cg_exo -48.92 156.24 2.2 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.63 2.22 . . . . 0.0 112.921 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 75.4 m -101.63 92.4 4.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.111 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.539 HG23 ' HE1' ' A' ' 97' ' ' TYR . 6.4 pt -68.97 165.51 2.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.298 -178.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.8 m -77.32 140.09 39.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.871 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.503 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 7.0 m-80 52.72 27.21 5.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.051 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.458 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -161.63 -166.62 20.73 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.757 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.438 ' N ' ' O ' ' A' ' 98' ' ' SER . 9.5 ptt180 -170.32 -174.64 1.74 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.984 0.421 . . . . 0.0 110.918 -178.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.429 ' HB3' ' CE2' ' A' ' 97' ' ' TYR . 13.6 p80 -102.14 179.43 4.32 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.549 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.469 ' CB ' ' O ' ' A' ' 96' ' ' THR . 50.2 t30 . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.794 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.438 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 11.1 m-85 . . . . . 0 N--CA 1.453 -0.289 0 CA-C-O 120.637 0.256 . . . . 0.0 110.73 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.451 ' CE2' ' CG2' ' A' ' 95' ' ' VAL . 19.8 m-85 -145.31 164.95 29.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.818 0.342 . . . . 0.0 111.117 -178.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.619 HG23 ' HE2' ' A' ' 70' ' ' LYS . 11.1 p -147.42 -175.21 4.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.766 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 7.6 p-10 -54.78 94.02 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.676 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.39 25.99 1.24 Allowed Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.543 -0.837 . . . . 0.0 113.512 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.32 152.29 26.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 117.36 0.58 . . . . 0.0 111.176 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 27.3 m -144.34 136.2 22.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.118 0.485 . . . . 0.0 110.949 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.935 HG11 ' HG2' ' A' ' 74' ' ' PRO . 3.8 p -134.8 149.75 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.283 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.917 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.2 OUTLIER -91.31 149.72 21.62 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.992 0.425 . . . . 0.0 110.836 -179.658 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.876 ' CE2' HG21 ' A' ' 111' ' ' VAL . 2.8 m-85 -107.79 157.39 18.18 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.81 0.338 . . . . 0.0 111.105 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.438 ' O ' ' N ' ' A' ' 81' ' ' ARG . 10.1 p -144.71 146.16 32.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.257 -0.429 . . . . 0.0 112.086 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.551 ' HB3' ' HB2' ' A' ' 103' ' ' TYR . 91.0 m -69.15 161.11 29.81 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.671 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.458 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 0.9 OUTLIER -53.4 -79.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.86 -178.716 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.1 t -110.81 -30.24 7.64 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.706 -176.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 175.45 31.9 0.04 OUTLIER Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.514 -0.85 . . . . 0.0 113.169 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.555 ' CZ ' HD11 ' A' ' 126' ' ' ILE . 0.2 OUTLIER -69.78 -168.05 0.17 Allowed 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 116.596 0.198 . . . . 0.0 110.681 178.726 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 125' ' ' GLN . 0.2 OUTLIER -125.51 113.95 18.15 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 176.254 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.78 HD12 ' SG ' ' A' ' 124' ' ' CYS . 0.1 OUTLIER -69.62 143.41 53.26 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.762 0.791 . . . . 0.0 112.17 -176.09 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.445 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 33.8 mm -123.09 156.96 28.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 114.281 -1.327 . . . . 0.0 111.266 -178.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.438 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 62.56 32.02 81.81 Favored Glycine 0 CA--C 1.512 -0.137 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.415 178.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.45 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.4 OUTLIER 60.44 135.55 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.313 0.578 . . . . 0.0 111.545 179.218 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.917 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.0 OUTLIER -74.43 -29.96 61.7 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.221 -0.9 . . . . 0.0 112.506 -177.506 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.4 141.45 47.92 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.35 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.876 HG21 ' CE2' ' A' ' 97' ' ' TYR . 13.9 t -134.86 119.17 26.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.644 0.259 . . . . 0.0 111.303 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.92 HD11 ' HB2' ' A' ' 114' ' ' SER . 1.0 OUTLIER -80.18 134.51 36.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.908 0.385 . . . . 0.0 111.194 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.896 ' N ' HD22 ' A' ' 112' ' ' LEU . 35.9 t -106.17 104.96 14.77 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.122 177.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.92 ' HB2' HD11 ' A' ' 112' ' ' LEU . 1.7 t -149.14 131.9 16.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.941 0.401 . . . . 0.0 111.564 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.59 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 80.89 24.28 58.24 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.32 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.458 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 75.7 1.53 66.89 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.312 -178.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -124.52 178.73 5.26 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.03 0.443 . . . . 0.0 110.711 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.608 ' HE3' HG12 ' A' ' 111' ' ' VAL . 92.9 m95 -120.13 133.52 55.49 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.125 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.401 ' O ' ' HB3' ' A' ' 120' ' ' ASP . 0.8 OUTLIER -109.23 160.36 16.18 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.304 178.41 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.574 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 49.7 t0 67.16 33.39 0.1 OUTLIER Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 32.9 Cg_endo -66.92 124.99 12.97 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 121.993 1.796 . . . . 0.0 110.943 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.509 ' HD2' ' CD1' ' A' ' 97' ' ' TYR . 72.3 Cg_endo -91.38 -174.09 0.6 Allowed 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.603 2.202 . . . . 0.0 114.505 -175.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.522 HG22 ' H ' ' A' ' 124' ' ' CYS . 2.5 m -135.81 176.34 8.78 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 113.924 -1.489 . . . . 0.0 108.639 177.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . 0.78 ' SG ' HD12 ' A' ' 105' ' ' LEU . 1.2 m -133.3 103.94 6.22 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.106 -0.638 . . . . 0.0 111.16 177.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.437 ' O ' ' CB ' ' A' ' 104' ' ' SER . 10.2 mt-30 -106.85 153.12 22.96 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.686 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.568 HG22 ' O ' ' A' ' 126' ' ' ILE . 49.2 mm . . . . . 0 C--N 1.315 -0.919 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.839 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.659 ' HD2' HG23 ' A' ' 25' ' ' VAL . 14.4 mtm180 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.888 0.375 . . . . 0.0 111.174 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.454 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 16.7 m -69.67 162.01 70.46 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.725 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' A' ' 57' ' ' MET . 57.5 Cg_endo -70.53 169.32 20.18 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.528 2.152 . . . . 0.0 112.218 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -50.29 105.9 0.57 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.939 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.513 ' HG3' ' CZ2' ' A' ' 59' ' ' TRP . 76.5 Cg_exo -46.63 160.96 0.2 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.429 2.086 . . . . 0.0 112.594 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.859 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -66.16 166.38 11.94 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.178 178.532 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -117.03 -178.6 3.48 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.187 0.517 . . . . 0.0 112.187 -176.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.482 HG22 ' CD2' ' A' ' 20' ' ' LEU . 4.1 tt -144.58 146.74 19.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.378 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -85.81 -61.05 1.84 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.523 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.435 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 0.7 OUTLIER -94.6 34.31 1.34 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.92 -179.142 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.435 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -149.57 -179.18 25.2 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.76 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -138.8 127.99 24.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.769 0.319 . . . . 0.0 110.644 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.859 HD11 ' O ' ' A' ' 13' ' ' ARG . 16.1 mt -76.54 153.74 35.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.096 0.475 . . . . 0.0 111.632 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.454 ' HB3' ' CB ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -127.38 78.82 1.84 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.744 177.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.848 ' HA ' HG23 ' A' ' 31' ' ' ILE . 3.6 mm -68.85 100.32 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.861 -177.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -103.63 22.86 34.47 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.648 177.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 146.57 133.56 2.48 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 111.741 -0.544 . . . . 0.0 111.741 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.659 HG23 ' HD2' ' A' ' 8' ' ' ARG . 6.7 m -121.22 22.32 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.697 0.284 . . . . 0.0 111.489 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.12 149.59 26.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.552 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.594 ' CE2' HD13 ' A' ' 51' ' ' LEU . 3.7 t80 -48.41 113.7 0.81 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.894 0.378 . . . . 0.0 110.853 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.42 6.74 23.39 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.618 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.86 -163.19 0.97 Allowed 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.8 0.3 . . . . 0.0 110.571 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.7 p -168.94 144.02 3.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.935 0.398 . . . . 0.0 111.143 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.848 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -102.6 170.31 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.278 179.413 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.569 HG23 ' HD2' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -130.67 114.42 15.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.0 0.429 . . . . 0.0 111.126 179.885 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.779 ' CE1' HD21 ' A' ' 20' ' ' LEU . 17.2 m-85 -92.84 137.14 32.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.504 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.435 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 3.5 m -143.86 166.25 25.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.44 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.428 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 3.9 m -82.89 170.44 14.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.784 0.326 . . . . 0.0 110.879 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -70.19 -83.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.851 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.6 m -156.44 132.44 9.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.743 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.51 22.75 73.42 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.067 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.494 ' CE1' ' HB3' ' A' ' 68' ' ' SER . 2.7 m-85 -114.65 -174.78 2.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.795 0.331 . . . . 0.0 110.913 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.89 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -145.35 112.41 6.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.435 178.203 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.95 HD11 ' HG2' ' A' ' 64' ' ' PRO . 7.9 tt -77.35 124.17 27.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.768 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.89 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.3 mm -100.16 152.23 4.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.994 0.426 . . . . 0.0 110.931 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.71 -137.34 16.58 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.202 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.902 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.3 OUTLIER -86.67 -175.84 5.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.02 0.438 . . . . 0.0 110.855 179.432 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.5 p -155.86 24.16 0.38 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.23 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.569 ' HD2' HG23 ' A' ' 32' ' ' THR . 0.0 OUTLIER -149.51 130.03 13.94 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.104 0.478 . . . . 0.0 112.221 -178.598 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.447 ' HB3' ' CB ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -101.15 152.8 20.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.34 178.656 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.494 ' CD2' ' HB3' ' A' ' 60' ' ' ASN . 1.3 m-85 -126.23 120.68 30.66 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 119.7 -0.8 . . . . 0.0 111.902 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.487 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 32.2 t -70.21 116.73 10.9 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.095 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -153.6 -177.43 6.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.789 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.594 HD13 ' CE2' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.988 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.403 ' HB2' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.873 0.368 . . . . 0.0 110.555 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.6 m -150.64 176.54 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.917 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.523 ' CE3' HD11 ' A' ' 31' ' ' ILE . 60.0 m95 -128.16 127.98 43.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.944 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.494 ' HB3' ' CD2' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -69.37 163.24 60.19 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.178 179.311 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.432 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 80.1 Cg_exo -16.58 94.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.899 1 C-N-CA 125.574 4.182 . . . . 0.0 114.429 -178.456 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.447 ' CB ' ' HB3' ' A' ' 47' ' ' SER . 0.0 OUTLIER -101.28 -81.98 0.47 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.958 -177.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.462 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -72.95 106.46 2.26 Favored Pre-proline 0 C--N 1.331 -0.212 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -176.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.95 ' HG2' HD11 ' A' ' 41' ' ' LEU . 1.8 Cg_endo -90.05 -156.01 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.469 2.779 . . . . 0.0 111.14 177.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.49 HG22 ' H ' ' A' ' 66' ' ' CYS . 3.8 mm -92.43 165.3 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.877 0.37 . . . . 0.0 110.884 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.49 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.8 OUTLIER -170.21 136.3 1.39 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.002 179.666 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.4 ' C ' ' CD2' ' A' ' 39' ' ' TYR . 1.6 tt0 -159.78 172.37 17.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.909 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.494 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 4.1 p -89.77 107.88 19.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.447 ' O ' HG13 ' A' ' 69' ' ' VAL . 2.4 p -43.06 94.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.524 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.432 ' HG2' ' CG2' ' A' ' 90' ' ' THR . 2.0 mmtp -75.16 127.23 32.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.375 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.92 113.92 27.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.056 178.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.3 -159.74 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.538 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.482 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 1.4 t -44.52 135.2 4.5 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.234 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.489 ' HG2' HG11 ' A' ' 95' ' ' VAL . 31.6 Cg_exo -57.78 161.78 12.03 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.398 2.065 . . . . 0.0 112.116 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.53 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 79.8 Cg_exo -43.14 156.64 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.772 2.314 . . . . 0.0 112.904 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.5 t -104.81 90.56 3.52 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.372 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.66 HG23 ' HE2' ' A' ' 97' ' ' TYR . 10.1 pt -69.28 175.32 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.395 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.4 p -93.79 141.04 28.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.609 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 58.4 28.58 17.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.036 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.467 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -167.05 -171.32 33.0 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.215 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -158.55 -173.58 4.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.078 0.466 . . . . 0.0 110.614 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.482 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 8.4 p80 -117.5 172.19 7.5 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.173 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.952 178.24 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.432 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 7.4 m-85 . . . . . 0 N--CA 1.456 -0.169 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.432 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 65.6 m-85 -155.64 164.87 38.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.642 0.258 . . . . 0.0 110.9 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.432 ' CG2' ' HG2' ' A' ' 70' ' ' LYS . 19.7 p -148.18 -175.29 4.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.005 0.431 . . . . 0.0 111.567 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.441 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 28.8 p-10 -52.92 95.65 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.348 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.04 20.35 2.52 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.231 -0.895 . . . . 0.0 113.261 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.24 147.35 33.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 117.051 0.425 . . . . 0.0 110.965 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.494 HG22 ' N ' ' A' ' 95' ' ' VAL . 33.7 m -128.45 158.44 40.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.005 0.431 . . . . 0.0 111.185 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.533 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 14.0 t -151.67 147.34 15.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.709 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.874 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -106.96 131.41 54.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.852 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 1.001 ' CE1' HG21 ' A' ' 111' ' ' VAL . 5.0 m-85 -88.95 159.08 17.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.516 -178.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 49.7 m -151.97 138.89 19.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.947 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.436 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 84.1 m -73.43 156.25 38.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.499 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.467 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 40.8 m-20 -91.35 -71.97 0.61 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.313 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.6 t -53.51 -23.32 10.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.968 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.2 29.03 1.7 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.557 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.497 ' CE1' HG12 ' A' ' 126' ' ' ILE . 24.0 m-85 -73.98 -174.82 1.97 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.021 0.439 . . . . 0.0 110.365 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -123.35 99.19 6.21 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 176.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.666 HD21 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -52.57 152.95 3.33 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 122.277 1.036 . . . . 0.0 112.387 -175.285 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.479 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 40.6 mm -119.01 150.3 21.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 113.149 -1.841 . . . . 0.0 111.138 -175.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.416 ' O ' ' ND2' ' A' ' 108' ' ' ASN . . . 72.52 33.99 60.59 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.032 -1.08 . . . . 0.0 111.746 -178.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.416 ' ND2' ' O ' ' A' ' 107' ' ' GLY . 8.6 p30 54.05 145.86 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 124.357 1.063 . . . . 0.0 112.997 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.874 ' HB2' HG22 ' A' ' 96' ' ' THR . 0.7 OUTLIER -71.91 -23.48 61.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.764 -178.756 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -62.14 128.24 41.69 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.764 -0.732 . . . . 0.0 113.009 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 1.001 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.5 t -128.9 125.38 62.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.885 HD22 ' N ' ' A' ' 113' ' ' CYS . 1.2 tm? -85.82 135.53 33.68 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.884 0.373 . . . . 0.0 111.456 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.885 ' N ' HD22 ' A' ' 112' ' ' LEU . 39.1 t -108.01 104.8 14.32 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.232 177.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.689 ' OG ' HD11 ' A' ' 112' ' ' LEU . 0.9 OUTLIER -164.83 124.04 1.82 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.923 0.392 . . . . 0.0 111.349 179.865 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.23 26.17 11.57 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.409 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.44 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 68.43 13.51 65.4 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.6 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -145.8 172.3 13.52 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.875 0.369 . . . . 0.0 110.702 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.54 ' CZ3' ' HB2' ' A' ' 113' ' ' CYS . 92.5 m95 -111.27 141.67 44.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.876 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.18 163.81 16.09 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.427 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.448 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 3.7 p-10 46.58 48.66 5.79 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.332 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.47 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 91.0 Cg_endo -78.5 146.58 21.82 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.496 2.131 . . . . 0.0 110.572 176.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.567 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 56.6 Cg_endo -97.65 -177.44 0.29 Allowed 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 122.048 1.832 . . . . 0.0 114.357 -176.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -118.21 -156.25 0.63 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.273 -1.331 . . . . 0.0 109.018 177.788 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 105' ' ' LEU . 2.0 m -152.65 89.1 1.38 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.061 0.458 . . . . 0.0 110.788 177.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -121.45 160.13 24.79 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.658 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.511 HG22 ' O ' ' A' ' 126' ' ' ILE . 16.8 mm . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.053 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.512 ' HD2' HG23 ' A' ' 25' ' ' VAL . 18.6 mtm180 . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 121.11 0.481 . . . . 0.0 111.541 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.554 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 55.6 m -69.42 179.09 0.79 Allowed Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.5 178.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.554 ' CD ' ' HB3' ' A' ' 9' ' ' CYS . 17.9 Cg_endo -88.84 -171.71 0.61 Allowed 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.637 2.225 . . . . 0.0 111.598 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.433 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 2.6 t -57.23 106.22 0.65 Allowed Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.452 ' HG3' ' CD1' ' A' ' 22' ' ' ILE . 9.6 Cg_endo -52.44 162.75 2.05 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.107 1.872 . . . . 0.0 112.029 -178.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.427 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -62.27 -175.94 0.09 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.025 179.159 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -143.09 -175.36 4.49 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.165 0.507 . . . . 0.0 111.268 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.451 HG22 ' CD2' ' A' ' 20' ' ' LEU . 13.7 tt -145.23 158.45 13.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.735 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -93.91 -55.2 3.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.446 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.91 45.79 1.24 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.981 0.419 . . . . 0.0 110.858 -179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 34' ' ' SER . . . -177.18 -179.14 47.38 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.996 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -136.74 137.6 40.07 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.8 0.333 . . . . 0.0 110.392 179.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.887 HD21 ' CE2' ' A' ' 33' ' ' TYR . 19.3 mt -82.74 154.87 24.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.033 0.444 . . . . 0.0 111.537 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -124.45 84.06 2.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.089 178.515 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.873 ' HA ' HG23 ' A' ' 31' ' ' ILE . 3.8 mm -68.68 108.94 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.676 -177.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -112.51 19.99 21.2 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.002 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 147.31 127.14 1.73 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.309 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.512 HG23 ' HD2' ' A' ' 8' ' ' ARG . 35.9 m -116.52 21.09 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.643 0.258 . . . . 0.0 111.47 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -91.01 151.91 20.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.819 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.509 ' CZ ' HD12 ' A' ' 51' ' ' LEU . 9.2 t80 -52.27 96.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.832 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 122.6 13.01 4.83 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.957 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.6 m -101.23 -162.64 0.95 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.862 0.331 . . . . 0.0 110.427 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 47' ' ' SER . 0.9 OUTLIER -166.01 146.62 6.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.05 0.452 . . . . 0.0 111.347 179.12 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.873 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -104.05 172.91 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.364 179.614 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.468 ' H ' HG22 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -134.52 115.14 13.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.922 0.392 . . . . 0.0 111.038 179.722 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.887 ' CE2' HD21 ' A' ' 20' ' ' LEU . 19.2 m-85 -88.16 149.45 23.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.034 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.42 ' O ' ' N ' ' A' ' 19' ' ' GLN . 81.4 p -151.24 154.17 36.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.651 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.442 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 6.3 m -78.04 167.87 20.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.787 0.327 . . . . 0.0 110.868 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -69.01 -83.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.407 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.04 132.08 11.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.889 0.376 . . . . 0.0 110.982 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.48 22.58 76.54 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.98 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.603 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.2 m-85 -117.43 -179.93 3.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.972 0.415 . . . . 0.0 110.908 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.752 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.7 OUTLIER -144.79 114.73 7.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.25 178.338 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.923 HD21 ' O ' ' A' ' 44' ' ' GLU . 7.5 tt -73.91 126.14 29.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.594 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.752 HD11 ' CE1' ' A' ' 40' ' ' HIS . 1.7 mm -101.99 156.06 4.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.004 0.43 . . . . 0.0 110.945 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.29 -147.32 39.02 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.271 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.923 ' O ' HD21 ' A' ' 41' ' ' LEU . 3.4 pt-20 -65.98 -176.22 0.38 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.928 0.394 . . . . 0.0 110.633 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.2 t -163.91 25.9 0.08 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.945 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.402 ' HG3' ' HA ' ' A' ' 32' ' ' THR . 10.7 mtpt -152.88 128.16 9.85 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.966 0.412 . . . . 0.0 112.02 -178.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.478 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 1.0 OUTLIER -92.16 142.09 27.88 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 176.572 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.548 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.2 m-85 -117.22 120.28 37.79 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 119.099 -1.04 . . . . 0.0 112.255 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 34.8 t -71.57 100.78 2.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.753 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.46 -173.4 2.67 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.014 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.509 HD12 ' CZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.873 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.523 -0.077 0 CA-C-O 120.833 0.349 . . . . 0.0 110.186 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.1 m -151.97 173.99 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.975 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.533 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 72.8 m95 -126.82 123.21 36.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.357 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.548 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 1.0 OUTLIER -69.99 166.32 34.12 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.363 178.578 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.459 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 76.7 Cg_exo -21.57 97.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 125.044 3.829 . . . . 0.0 114.163 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.448 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -94.85 -78.34 0.45 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.05 -177.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.463 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -78.07 108.25 7.15 Favored Pre-proline 0 C--N 1.331 -0.216 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -176.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.91 ' HG2' HD11 ' A' ' 41' ' ' LEU . 2.4 Cg_endo -87.3 -156.19 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.115 2.543 . . . . 0.0 111.016 177.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.554 HG22 ' H ' ' A' ' 66' ' ' CYS . 2.9 mm -88.89 169.25 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.967 0.413 . . . . 0.0 110.67 178.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.554 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.0 OUTLIER -169.97 134.29 1.28 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.734 179.273 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.467 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 1.4 tt0 -155.06 -177.84 6.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.54 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.603 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 2.7 p -75.02 147.59 40.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.646 0.736 . . . . 0.0 111.336 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.646 HG23 ' N ' ' A' ' 116' ' ' GLY . 0.0 OUTLIER -61.86 100.72 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 114.504 -1.226 . . . . 0.0 110.312 -179.371 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 89' ' ' TYR . 0.3 OUTLIER -105.62 119.42 39.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.3 -178.222 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.27 119.26 38.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.467 176.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -69.28 -157.93 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.412 -179.513 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.405 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 2.4 t -51.66 136.66 34.04 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.625 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.756 ' CG ' HG21 ' A' ' 95' ' ' VAL . 52.2 Cg_exo -55.05 159.17 10.12 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.411 2.074 . . . . 0.0 112.302 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.419 ' N ' ' OH ' ' A' ' 97' ' ' TYR . 89.5 Cg_exo -44.39 156.44 0.21 Allowed 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.632 2.221 . . . . 0.0 112.597 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 95.6 p -102.94 89.87 3.59 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.775 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.567 HG23 ' HE2' ' A' ' 97' ' ' TYR . 10.3 pt -69.61 176.29 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.127 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.79 143.54 26.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.974 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.465 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 12.5 m-80 52.86 29.5 7.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.148 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.461 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -162.15 -169.16 25.11 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.275 -0.964 . . . . 0.0 113.353 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.72 -173.98 3.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.872 0.368 . . . . 0.0 110.489 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.484 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 7.3 p-80 -113.28 167.17 10.78 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.558 -179.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 96' ' ' THR . 16.2 m-20 . . . . . 0 CA--C 1.518 -0.268 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.832 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.433 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 7.3 m-85 . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 120.821 0.343 . . . . 0.0 110.761 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.472 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 22.4 m-85 -141.8 162.33 35.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.13 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.4 p -122.25 174.91 6.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.173 0.511 . . . . 0.0 112.123 -177.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.436 ' HB3' ' HB ' ' A' ' 69' ' ' VAL . 10.2 p-10 -60.29 95.53 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.163 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 122.46 18.19 3.4 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.291 -0.868 . . . . 0.0 113.075 178.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.09 157.02 16.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.739 0.304 . . . . 0.0 110.595 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 28.6 m -143.52 141.87 25.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.225 0.536 . . . . 0.0 111.152 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.83 HG22 ' CH2' ' A' ' 118' ' ' TRP . 40.2 t -142.48 142.1 27.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.941 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.512 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -89.01 149.54 23.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.646 -177.079 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.756 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.1 m-85 -105.16 159.63 15.71 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.986 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.691 ' HA ' HD13 ' A' ' 105' ' ' LEU . 58.0 m -157.17 153.65 28.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.039 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.414 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 59.5 m -80.02 160.9 25.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.816 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.461 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 60.2 m-20 -87.59 -70.93 0.59 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.418 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.42 -27.62 67.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.24 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.57 35.53 0.49 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.791 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.502 ' CE2' HG12 ' A' ' 126' ' ' ILE . 15.8 m-85 -70.78 -174.68 0.95 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.914 0.387 . . . . 0.0 110.587 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.4 98.16 7.61 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.162 178.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.691 HD13 ' HA ' ' A' ' 98' ' ' SER . 0.3 OUTLIER -46.47 122.53 4.17 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.507 0.67 . . . . 0.0 112.268 -177.747 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.843 HD11 ' HB2' ' A' ' 125' ' ' GLN . 5.1 mm -85.06 154.73 3.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.938 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.85 -126.1 33.94 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.209 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -123.48 140.99 52.45 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.936 0.398 . . . . 0.0 111.024 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.618 ' HB2' HD22 ' A' ' 105' ' ' LEU . 1.8 t -73.05 -29.41 62.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.948 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -78.23 127.83 8.4 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.002 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.756 HG21 ' CE1' ' A' ' 97' ' ' TYR . 3.1 t -118.41 139.97 43.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 178.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.81 131.51 43.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.146 0.498 . . . . 0.0 111.567 -178.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.494 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 12.0 t -97.45 95.16 7.47 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.446 176.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.9 t -151.07 153.14 34.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.455 -178.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.12 -0.56 62.64 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.645 -0.707 . . . . 0.0 113.491 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.646 ' N ' HG23 ' A' ' 69' ' ' VAL . . . 100.24 1.54 55.79 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.902 -177.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -146.3 177.12 9.25 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.821 0.343 . . . . 0.0 110.708 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.83 ' CH2' HG22 ' A' ' 95' ' ' VAL . 95.2 m95 -99.01 155.61 17.34 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.717 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.585 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -143.09 155.28 44.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.031 0.444 . . . . 0.0 111.19 -179.844 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.481 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.7 OUTLIER 66.22 47.0 0.49 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.798 179.599 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 87.0 Cg_endo -79.4 139.3 14.5 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.476 2.117 . . . . 0.0 111.698 178.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.513 ' CG ' HD21 ' A' ' 105' ' ' LEU . 50.3 Cg_endo -90.61 -174.72 0.76 Allowed 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.5 2.133 . . . . 0.0 113.2 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.449 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -128.4 -157.79 0.84 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.499 177.576 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . 0.483 ' SG ' HD12 ' A' ' 105' ' ' LEU . 3.5 m -157.6 89.56 1.04 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.13 0.491 . . . . 0.0 111.133 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.843 ' HB2' HD11 ' A' ' 106' ' ' ILE . 16.4 mt-30 -114.5 170.87 7.99 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.783 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.502 HG12 ' CE2' ' A' ' 103' ' ' TYR . 49.1 mm . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.792 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.448 ' CD ' HG23 ' A' ' 25' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.095 0 CA-C-O 120.851 0.358 . . . . 0.0 111.394 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.486 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 15.1 m -78.67 161.62 68.58 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.448 178.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.02 167.32 25.13 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.338 2.025 . . . . 0.0 111.703 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 t -51.02 105.44 0.52 Allowed Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.936 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.68 ' HG2' HD13 ' A' ' 22' ' ' ILE . 51.3 Cg_exo -50.76 151.07 11.46 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.151 1.901 . . . . 0.0 111.731 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.933 ' O ' HD11 ' A' ' 20' ' ' LEU . 7.1 mpt_? -55.7 159.24 3.11 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.82 -173.85 2.33 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.2 0.524 . . . . 0.0 111.615 -177.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.2 tt -152.57 138.92 12.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.539 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -82.2 -57.31 3.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.676 -177.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.504 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 1.2 m120 -91.2 45.84 1.27 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.055 0.455 . . . . 0.0 111.069 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -176.65 -179.46 47.09 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.39 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.64 137.36 41.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.815 0.341 . . . . 0.0 110.773 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.933 HD11 ' O ' ' A' ' 13' ' ' ARG . 14.5 mt -75.9 152.15 37.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.215 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.462 ' HB3' ' CB ' ' A' ' 32' ' ' THR . 19.4 t0 -120.92 69.64 0.89 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.447 177.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.821 ' HA ' HG23 ' A' ' 31' ' ' ILE . 1.1 mt -80.84 90.95 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.883 -176.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.85 16.13 59.07 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.81 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 29' ' ' SER . . . 165.83 133.21 1.48 Allowed Glycine 0 C--N 1.334 0.435 0 C-N-CA 121.176 -0.535 . . . . 0.0 111.765 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.448 HG23 ' CD ' ' A' ' 8' ' ' ARG . 1.7 m -119.43 -2.54 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -178.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -75.88 164.13 26.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.986 0.422 . . . . 0.0 110.814 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.54 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 13.1 t80 -52.03 115.81 1.88 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.09 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.73 -4.59 46.57 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.764 -0.731 . . . . 0.0 113.066 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 24' ' ' GLY . 57.9 m -74.99 176.83 6.81 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 117.029 0.415 . . . . 0.0 110.602 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 47' ' ' SER . 2.5 p -144.47 149.99 36.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.952 0.406 . . . . 0.0 111.464 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.821 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -118.74 165.83 13.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.468 179.353 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.462 ' CB ' ' HB3' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -135.9 111.75 9.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.896 178.547 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.697 ' CE2' HD21 ' A' ' 20' ' ' LEU . 31.6 m-85 -84.06 135.78 34.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.062 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 84.4 p -141.05 146.86 37.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.154 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.479 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 1.7 m -73.38 174.31 8.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.794 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.68 -82.42 0.06 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.39 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.2 m -155.14 120.16 4.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.476 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.579 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 77.42 -0.58 68.69 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.475 -177.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.517 ' CZ ' ' CB ' ' A' ' 68' ' ' SER . 5.9 m-85 -89.48 166.43 13.69 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 120.782 0.325 . . . . 0.0 110.832 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.806 ' CE1' HG22 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -121.46 127.68 51.34 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 176.578 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.849 HD21 ' O ' ' A' ' 44' ' ' GLU . 6.0 tt -86.02 117.2 24.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.135 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.448 ' HB ' ' HB ' ' A' ' 65' ' ' ILE . 2.1 mm -92.41 153.83 3.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.475 -177.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.82 -151.29 50.27 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.26 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.849 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -55.28 178.92 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.534 0.206 . . . . 0.0 110.536 179.504 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.447 ' HB3' HD22 ' A' ' 41' ' ' LEU . 6.6 p -152.14 18.8 0.66 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.608 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.411 ' HG3' ' HA ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -154.77 175.72 13.36 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.923 0.392 . . . . 0.0 110.958 -178.648 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.469 ' HB2' ' CG1' ' A' ' 31' ' ' ILE . 2.6 m -149.63 123.03 9.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.297 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.408 ' CE1' ' HD3' ' A' ' 61' ' ' PRO . 4.9 m-85 -103.0 114.16 28.23 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.973 0.416 . . . . 0.0 111.452 -178.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.471 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 42.2 t -64.97 77.44 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.374 0.607 . . . . 0.0 110.076 178.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.5 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 1.9 tt0 -97.33 175.13 6.37 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.907 -177.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.54 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.514 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.106 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.442 ' HA ' ' HA ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.961 0.41 . . . . 0.0 110.71 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.1 m -126.03 -176.79 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.383 -178.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.668 ' CE3' HD11 ' A' ' 31' ' ' ILE . 97.5 m95 -116.38 125.6 52.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.126 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -150.08 118.73 3.68 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.771 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.408 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 8.9 Cg_exo -73.21 -172.16 9.47 Favored 'Cis proline' 0 C--N 1.35 0.633 0 C-N-CA 124.221 -1.158 . . . . 0.0 112.413 1.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -111.11 -152.5 0.5 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.891 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.524 ' CB ' ' CE2' ' A' ' 33' ' ' TYR . . . -79.38 111.27 19.31 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.651 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.439 ' CG ' ' O ' ' A' ' 44' ' ' GLU . 15.3 Cg_exo -69.07 -150.76 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.662 2.241 . . . . 0.0 112.296 -179.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.569 HG22 ' H ' ' A' ' 66' ' ' CYS . 0.4 OUTLIER -108.36 -179.69 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.117 0.484 . . . . 0.0 111.222 -179.324 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.569 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.0 OUTLIER -167.43 118.52 0.87 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.524 179.454 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.469 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 0.1 OUTLIER -113.4 166.74 11.2 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.689 179.888 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.517 ' CB ' ' CZ ' ' A' ' 39' ' ' TYR . 1.1 p -107.53 120.42 42.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.993 0.425 . . . . 0.0 111.047 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.806 HG22 ' CE1' ' A' ' 40' ' ' HIS . 3.1 p -46.4 94.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.439 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.44 ' HE2' HG23 ' A' ' 90' ' ' THR . 0.2 OUTLIER -76.8 125.44 29.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.276 -179.581 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.432 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -104.33 126.06 51.1 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.326 178.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -73.62 -169.12 0.65 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.472 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -42.42 135.05 2.59 Favored Pre-proline 0 N--CA 1.438 -1.065 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.436 178.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.513 ' HG2' HG11 ' A' ' 95' ' ' VAL . 34.5 Cg_exo -56.05 159.88 11.45 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.188 1.925 . . . . 0.0 111.923 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.516 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 96.1 Cg_exo -40.85 156.6 0.05 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.757 2.305 . . . . 0.0 112.855 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.3 m -108.5 90.12 3.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.647 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.647 HG21 ' O ' ' A' ' 122' ' ' PRO . 16.5 pt -69.41 170.85 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.298 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.39 133.78 35.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.777 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.508 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 0.2 OUTLIER 67.9 26.41 7.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.602 -179.643 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -171.44 -170.83 35.96 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.732 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.15 -175.47 2.0 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.958 0.409 . . . . 0.0 110.801 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.442 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 12.3 p80 -95.04 176.11 6.37 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.891 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.423 ' ND2' ' O ' ' A' ' 96' ' ' THR . 2.7 m-20 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.169 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.414 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 6.0 m-85 . . . . . 0 N--CA 1.457 -0.121 0 CA-C-O 120.976 0.417 . . . . 0.0 111.154 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.432 ' N ' ' O ' ' A' ' 71' ' ' CYS . 33.0 m-85 -145.05 170.32 16.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.613 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.44 HG23 ' HE2' ' A' ' 70' ' ' LYS . 14.4 p -133.25 175.38 9.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.913 0.387 . . . . 0.0 111.18 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 23.1 p-10 -60.19 94.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.307 0.575 . . . . 0.0 111.038 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 128.31 28.1 0.86 Allowed Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.294 -0.866 . . . . 0.0 113.18 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.405 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -110.11 164.88 12.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.791 0.295 . . . . 0.0 110.661 179.24 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.429 HG22 ' N ' ' A' ' 95' ' ' VAL . 33.5 m -138.47 154.81 27.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.067 0.461 . . . . 0.0 111.274 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.513 HG11 ' HG2' ' A' ' 74' ' ' PRO . 21.7 t -152.42 148.5 14.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.021 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.706 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -104.99 142.94 33.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.306 179.007 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.972 ' CE2' HG21 ' A' ' 111' ' ' VAL . 4.6 m-85 -101.43 155.4 18.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.946 0.403 . . . . 0.0 111.279 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.416 ' HA ' HD13 ' A' ' 105' ' ' LEU . 45.9 m -148.57 141.93 25.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.165 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.431 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 73.5 m -72.75 162.35 29.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.759 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.4 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 39.7 m-20 -92.74 -70.59 0.69 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.347 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.5 m -63.79 -23.37 67.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.198 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 122.21 33.0 0.93 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.495 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.508 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 22.6 m-85 -69.9 -176.95 1.19 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.022 0.439 . . . . 0.0 110.725 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.2 m -108.11 101.73 10.94 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.185 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.649 HD22 ' HB2' ' A' ' 109' ' ' SER . 0.2 OUTLIER -46.32 125.18 6.44 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.426 0.631 . . . . 0.0 111.771 -178.255 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.44 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 34.6 mm -90.79 152.1 3.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.931 -1.032 . . . . 0.0 110.282 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 68.86 -127.49 22.33 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.257 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.59 132.48 52.51 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.712 0.291 . . . . 0.0 110.946 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.706 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.9 t -62.87 -33.16 74.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.773 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -66.03 139.42 38.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.781 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.972 HG21 ' CE2' ' A' ' 97' ' ' TYR . 3.0 t -136.44 119.91 23.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.571 0.224 . . . . 0.0 110.705 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.93 128.72 33.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.965 0.412 . . . . 0.0 111.47 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.52 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 17.7 t -92.8 102.29 14.68 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 176.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 3.1 p -144.54 162.86 35.51 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.074 0.464 . . . . 0.0 111.401 -177.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.2 29.0 4.66 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.778 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.436 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 70.15 16.15 72.78 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.4 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -141.51 -177.76 5.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.869 0.366 . . . . 0.0 110.659 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.52 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 95.1 m95 -117.04 142.19 47.29 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.082 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.18 149.92 47.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.247 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.488 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 2.0 t0 70.14 46.01 0.27 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.036 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 84.1 Cg_endo -78.18 134.43 12.9 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.442 2.095 . . . . 0.0 111.831 178.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.647 ' O ' HG21 ' A' ' 77' ' ' ILE . 73.9 Cg_endo -89.05 -173.06 0.74 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.62 2.214 . . . . 0.0 113.432 -178.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.401 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -131.39 -160.76 1.07 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.96 178.468 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 8.2 m -153.28 91.19 1.49 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.141 0.496 . . . . 0.0 110.957 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -122.39 157.74 31.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.616 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.551 HG22 ' O ' ' A' ' 126' ' ' ILE . 24.0 mm . . . . . 0 C--N 1.323 -0.584 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.932 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 26' ' ' ASP . 3.1 mtm180 . . . . . 0 N--CA 1.455 -0.184 0 CA-C-O 121.167 0.508 . . . . 0.0 112.363 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.462 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 4.2 m -122.58 164.65 25.24 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.339 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 44.3 Cg_endo -66.13 168.05 16.7 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.145 1.897 . . . . 0.0 111.465 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.5 t -52.84 105.95 0.6 Allowed Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.047 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.76 ' HG2' HD13 ' A' ' 22' ' ' ILE . 17.2 Cg_exo -42.15 158.1 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.212 1.941 . . . . 0.0 112.164 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.452 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -74.87 166.93 22.84 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.155 178.411 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.735 ' HA ' HD11 ' A' ' 20' ' ' LEU . 12.0 p-10 -121.48 -175.21 3.03 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 121.079 0.466 . . . . 0.0 112.022 -176.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.848 HD12 ' O ' ' A' ' 64' ' ' PRO . 16.9 tt -151.52 147.21 15.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.715 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.409 ' HB3' ' ND2' ' A' ' 17' ' ' ASN . 4.7 t0 -87.2 156.72 19.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.219 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.523 ' CB ' ' CE1' ' A' ' 39' ' ' TYR . 0.5 OUTLIER 45.44 27.02 0.34 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.096 -179.611 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -147.38 176.96 25.97 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.207 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.54 136.23 34.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.787 0.327 . . . . 0.0 110.812 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.783 HD22 ' CE2' ' A' ' 33' ' ' TYR . 3.5 mt -87.7 159.26 18.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.62 178.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.424 ' CB ' ' HB ' ' A' ' 32' ' ' THR . 5.3 t0 -124.76 71.23 1.16 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.049 177.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.941 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.8 OUTLIER -74.19 95.38 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.776 -177.748 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.77 19.14 55.71 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.722 177.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 158.93 132.16 1.34 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.227 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.0 m -118.63 33.35 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.543 0.211 . . . . 0.0 111.521 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.443 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 43.9 t0 -105.0 162.87 12.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.043 0.449 . . . . 0.0 111.513 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.655 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 5.2 t80 -59.96 91.73 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.619 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.15 3.56 6.79 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.638 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.77 -165.84 1.39 Allowed 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.843 0.321 . . . . 0.0 110.312 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 67.4 p -162.84 146.81 11.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.298 0.57 . . . . 0.0 111.593 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.941 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -114.17 160.45 13.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.871 179.57 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.43 ' HA ' ' HG3' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -123.3 120.48 33.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.919 0.39 . . . . 0.0 110.899 179.184 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.783 ' CE2' HD22 ' A' ' 20' ' ' LEU . 2.2 m-85 -91.98 142.32 27.66 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.533 -178.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.91 164.82 37.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.669 -179.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.429 ' HA ' ' HA2' ' A' ' 18' ' ' GLY . 64.6 m -90.17 172.55 8.72 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.867 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.4 m-20 -78.17 -83.35 0.08 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.205 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.79 135.53 17.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.665 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.784 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 63.31 26.35 69.34 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.867 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.523 ' CE1' ' CB ' ' A' ' 17' ' ' ASN . 2.4 m-85 -120.11 171.28 8.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.807 0.337 . . . . 0.0 111.171 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.791 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -133.86 127.86 33.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.289 178.275 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.816 HD21 ' HG2' ' A' ' 64' ' ' PRO . 1.7 tt -87.72 124.6 33.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.671 -178.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.791 HD11 ' CE1' ' A' ' 40' ' ' HIS . 0.9 OUTLIER -108.06 131.34 58.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.312 0.577 . . . . 0.0 111.038 -179.432 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 112.86 -146.37 18.34 Favored Glycine 0 C--N 1.321 -0.261 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.204 -177.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.752 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -74.31 -135.59 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 176.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.42 ' HB2' ' O ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER 174.02 26.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 117.965 0.348 . . . . 0.0 110.784 177.71 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.493 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 4.3 mttt -160.22 134.49 7.4 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.786 -178.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.504 ' HB3' HD12 ' A' ' 31' ' ' ILE . 32.1 t -107.69 144.38 34.88 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.908 177.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.516 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 3.4 m-85 -126.41 120.27 29.36 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 119.41 -0.916 . . . . 0.0 112.461 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 32.5 t -64.01 99.28 0.25 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.538 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -124.2 -173.7 2.83 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.112 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.655 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.02 -179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.5 mmt . . . . . 0 N--CA 1.455 -0.186 0 CA-C-O 120.868 0.366 . . . . 0.0 110.433 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.7 m -137.04 179.91 3.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.936 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.669 ' CZ3' HD11 ' A' ' 31' ' ' ILE . 66.5 m95 -124.74 127.18 46.84 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.289 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.516 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -69.53 168.97 13.75 Favored Pre-proline 0 CA--C 1.513 -0.449 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.487 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 1.0 OUTLIER -4.97 85.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.282 1 C-N-CA 125.326 4.017 . . . . 0.0 113.816 -179.107 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.634 ' O ' ' CZ ' ' A' ' 33' ' ' TYR . 15.3 mt-10 -69.09 -53.07 22.21 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-N 113.052 -1.885 . . . . 0.0 111.649 -174.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.649 ' CB ' ' HA ' ' A' ' 64' ' ' PRO . . . -65.31 -148.51 0.0 OUTLIER Pre-proline 0 CA--C 1.487 -1.454 0 CA-C-O 116.708 -1.615 . . . . 0.0 108.043 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.848 ' O ' HD12 ' A' ' 15' ' ' ILE . 3.9 Cg_exo -85.91 -157.44 1.25 Allowed 'Cis proline' 0 N--CA 1.484 0.934 0 CA-C-N 123.772 2.383 . . . . 0.0 115.013 16.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.601 ' N ' HD13 ' A' ' 65' ' ' ILE . 1.2 mm -95.68 175.01 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.0 -178.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.588 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.6 m -147.67 135.11 20.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.185 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.484 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 3.0 tt0 -140.55 174.06 10.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.755 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.472 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 37.4 p -89.03 118.87 29.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.984 0.421 . . . . 0.0 111.235 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.784 HG12 ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -40.59 98.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.728 179.773 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.415 ' HG2' HG22 ' A' ' 90' ' ' THR . 1.3 mmtp -67.71 137.04 55.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.389 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.03 124.77 50.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.13 178.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -69.26 -156.31 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.319 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.555 ' HG ' ' CE1' ' A' ' 82' ' ' HIS . 1.4 t -53.45 145.6 27.15 Favored Pre-proline 0 N--CA 1.45 -0.463 0 CA-C-O 120.59 0.234 . . . . 0.0 110.542 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.57 ' HG2' HG11 ' A' ' 95' ' ' VAL . 18.8 Cg_exo -65.29 160.63 41.4 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.53 2.154 . . . . 0.0 112.031 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.52 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 86.8 Cg_exo -40.54 156.68 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.801 2.334 . . . . 0.0 112.892 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.15 91.85 3.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.528 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.694 HG23 ' HE1' ' A' ' 97' ' ' TYR . 15.6 pt -68.98 175.91 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.07 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.9 m -94.49 140.91 29.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.912 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.5 ' HB3' ' CE1' ' A' ' 103' ' ' TYR . 7.0 m-80 57.47 29.25 16.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.989 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.46 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -163.57 -168.03 24.94 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.392 -0.909 . . . . 0.0 112.86 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 7.7 ptt85 -162.48 -175.91 4.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.007 0.432 . . . . 0.0 110.903 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.555 ' CE1' ' HG ' ' A' ' 73' ' ' SER . 4.6 p80 -111.18 172.12 7.07 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.625 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.507 179.426 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.432 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 7.0 m-85 . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.939 0.4 . . . . 0.0 111.333 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.432 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 62.8 m-85 -151.24 164.72 35.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.546 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.415 HG22 ' HG2' ' A' ' 70' ' ' LYS . 19.0 p -128.84 178.47 6.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.912 0.387 . . . . 0.0 111.114 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 14.5 t0 -64.55 101.5 0.46 Allowed 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 121.814 0.816 . . . . 0.0 111.01 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 121.55 21.39 3.01 Favored Glycine 0 C--N 1.311 -0.811 0 CA-C-N 114.312 -1.313 . . . . 0.0 112.993 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.39 160.79 14.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.845 0.322 . . . . 0.0 110.641 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 33.7 m -134.37 152.9 34.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.156 0.503 . . . . 0.0 111.515 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.57 HG11 ' HG2' ' A' ' 74' ' ' PRO . 27.7 t -146.49 148.71 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.688 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.734 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -105.51 132.87 51.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.96 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 1.005 ' CE2' HG21 ' A' ' 111' ' ' VAL . 5.2 m-85 -93.29 159.07 15.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.005 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 56.3 p -156.11 143.67 19.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.204 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.415 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 62.3 m -72.35 160.49 32.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.305 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.46 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 8.1 m-20 -94.45 -71.01 0.68 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.408 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.95 -21.77 66.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.455 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.65 30.88 1.2 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.694 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.505 ' CE2' HG12 ' A' ' 126' ' ' ILE . 51.1 m-85 -71.27 -172.72 0.76 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.658 0.266 . . . . 0.0 110.469 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -109.62 109.3 20.01 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.011 0.434 . . . . 0.0 111.146 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.564 HD23 ' HB2' ' A' ' 122' ' ' PRO . 2.7 tp -47.56 113.56 0.72 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.662 178.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.453 ' HB ' ' CB ' ' A' ' 123' ' ' THR . 39.0 mm -84.86 149.73 4.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.495 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 59.93 -132.43 50.92 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.385 -0.912 . . . . 0.0 111.794 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -112.29 133.45 54.4 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.826 0.346 . . . . 0.0 111.477 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.734 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.3 t -64.92 -27.31 68.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.44 178.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.34 138.95 31.37 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.836 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 1.005 HG21 ' CE2' ' A' ' 97' ' ' TYR . 3.1 t -134.98 123.83 41.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.462 0.173 . . . . 0.0 110.576 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.5 126.94 32.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.964 0.411 . . . . 0.0 111.976 -178.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.516 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 16.4 t -92.4 104.8 17.09 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 176.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 83.1 p -151.79 165.68 33.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.947 -177.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.99 30.71 5.27 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.865 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.434 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 67.9 8.79 54.69 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.51 -179.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -136.98 179.51 6.34 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.817 0.341 . . . . 0.0 110.771 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.52 ' CD1' ' HD3' ' A' ' 75' ' ' PRO . 94.2 m95 -113.5 136.58 52.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.901 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.77 155.86 37.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.134 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.522 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 34.6 t0 67.99 41.94 0.25 Allowed Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 81.4 Cg_endo -78.52 143.21 19.04 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.431 2.087 . . . . 0.0 112.03 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.564 ' HB2' HD23 ' A' ' 105' ' ' LEU . 57.4 Cg_endo -91.19 -172.66 0.49 Allowed 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.895 2.397 . . . . 0.0 113.353 -179.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.453 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -133.47 -177.19 4.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.274 178.097 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 6.4 m -142.13 96.68 3.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.972 0.415 . . . . 0.0 110.908 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -121.23 170.1 9.91 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.81 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.565 HG22 ' O ' ' A' ' 126' ' ' ILE . 36.5 mm . . . . . 0 C--N 1.324 -0.515 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.823 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.423 ' CD ' HG23 ' A' ' 25' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.177 0 CA-C-O 120.838 0.352 . . . . 0.0 111.549 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.433 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 6.9 m -87.56 162.29 42.69 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.638 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.29 169.26 20.0 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.275 1.983 . . . . 0.0 111.532 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -50.47 111.81 2.43 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.021 -179.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.53 157.42 58.42 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.495 2.13 . . . . 0.0 112.002 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.779 ' O ' HD11 ' A' ' 20' ' ' LEU . 10.4 ttt180 -53.85 -179.74 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.956 178.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.74 ' O ' HG22 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -141.3 -3.26 1.2 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -177.662 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.74 HG22 ' O ' ' A' ' 14' ' ' ASP . 15.6 tt 56.03 156.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 122.599 0.36 . . . . 0.0 111.114 -177.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -88.37 -63.34 1.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -176.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.437 ' HA ' ' ND2' ' A' ' 36' ' ' ASN . 0.4 OUTLIER -92.42 26.04 2.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.442 -177.797 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.425 ' HA2' ' N ' ' A' ' 36' ' ' ASN . . . -147.8 177.69 25.9 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.955 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 34' ' ' SER . 1.2 mt-30 -137.61 139.08 40.15 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.815 HD13 ' CZ ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -94.6 174.37 7.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.311 0.577 . . . . 0.0 111.532 -178.395 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 32' ' ' THR . 10.0 t0 -133.12 88.34 2.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.562 177.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.902 ' HA ' HG23 ' A' ' 31' ' ' ILE . 59.9 mt -71.58 115.79 12.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.091 -177.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -122.44 19.06 8.15 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.666 177.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 159.83 131.94 1.3 Allowed Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.423 HG23 ' CD ' ' A' ' 8' ' ' ARG . 6.6 m -124.24 5.36 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -77.33 164.46 25.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.036 0.446 . . . . 0.0 110.983 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.635 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 4.8 t80 -57.1 101.83 0.07 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.201 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 115.45 7.7 15.73 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.958 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.2 p -88.76 -169.11 2.41 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.924 0.362 . . . . 0.0 110.62 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.4 p -160.16 151.3 19.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.953 0.406 . . . . 0.0 111.391 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.902 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.8 OUTLIER -115.78 169.84 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.477 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -123.27 113.1 18.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.956 0.408 . . . . 0.0 111.186 179.259 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.815 ' CZ ' HD13 ' A' ' 20' ' ' LEU . 17.3 m-85 -88.86 140.92 28.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.218 0.533 . . . . 0.0 111.718 -179.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 19' ' ' GLN . 0.4 OUTLIER -144.92 170.69 15.66 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.231 179.151 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.429 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 1.7 m -89.19 166.14 14.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.716 0.293 . . . . 0.0 110.903 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.437 ' ND2' ' HA ' ' A' ' 17' ' ' ASN . 22.9 m-20 -64.42 -84.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.029 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.86 134.02 13.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.81 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.731 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 63.89 23.62 67.66 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.093 -179.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.496 ' CE2' ' HB2' ' A' ' 68' ' ' SER . 2.5 m-85 -115.88 174.27 6.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.81 0.338 . . . . 0.0 111.007 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.886 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -137.21 112.57 9.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.46 178.142 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.917 HD21 ' O ' ' A' ' 44' ' ' GLU . 4.5 tt -77.51 130.63 37.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.772 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.886 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.6 mm -105.52 154.17 6.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.851 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.07 -137.9 17.83 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.273 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.917 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -79.83 -174.21 4.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.948 0.404 . . . . 0.0 110.931 179.599 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.1 p -160.55 25.48 0.15 Allowed 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.067 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.41 ' HG3' ' HA ' ' A' ' 32' ' ' THR . 6.3 mtpt -152.29 132.11 13.27 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.021 0.438 . . . . 0.0 112.179 -178.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.452 ' HB2' ' HA ' ' A' ' 62' ' ' GLU . 26.4 t -96.83 153.12 18.07 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.766 177.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.5 ' CD1' ' HB3' ' A' ' 60' ' ' ASN . 1.4 m-85 -128.68 114.53 16.75 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 119.248 -0.981 . . . . 0.0 111.895 178.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 29.8 t -63.07 109.29 1.45 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.663 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.97 -176.49 4.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.045 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.635 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 5.0 mt . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.199 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.6 mmt . . . . . 0 N--CA 1.456 -0.131 0 CA-C-O 120.835 0.35 . . . . 0.0 110.615 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.519 HG22 ' C ' ' A' ' 51' ' ' LEU . 31.0 m -138.68 -175.17 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.968 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.519 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 68.0 m95 -131.06 134.85 47.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.059 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.5 ' HB3' ' CD1' ' A' ' 48' ' ' TYR . 1.2 m-80 -75.06 166.6 44.13 Favored Pre-proline 0 CA--C 1.517 -0.297 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 177.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.467 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 23.2 Cg_exo -8.96 92.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 0.986 1 C-N-CA 125.568 4.178 . . . . 0.0 114.546 -179.559 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.469 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 3.6 mm-40 -82.91 -87.4 0.1 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.936 -175.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.506 ' HB1' HG13 ' A' ' 15' ' ' ILE . . . -96.32 108.18 40.18 Favored Pre-proline 0 C--N 1.332 -0.169 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -176.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.811 ' HG2' HD11 ' A' ' 41' ' ' LEU . 5.7 Cg_exo -74.71 -151.5 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.797 2.331 . . . . 0.0 111.334 177.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.507 HG22 ' H ' ' A' ' 66' ' ' CYS . 4.8 mm -88.8 166.24 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 0.0 110.712 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.507 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.8 OUTLIER -165.54 137.17 4.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.884 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.06 169.94 23.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.928 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.496 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 1.1 t -80.59 123.75 28.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.146 0.498 . . . . 0.0 111.008 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.731 HG12 ' O ' ' A' ' 38' ' ' GLY . 1.9 p -50.74 104.09 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.984 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.446 ' HD2' ' HB3' ' A' ' 88' ' ' PHE . 46.3 mmtt -71.43 121.65 18.97 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.128 -178.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.418 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -109.2 121.58 45.47 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 176.435 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -69.77 -162.02 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.513 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.599 ' HG ' ' CE1' ' A' ' 82' ' ' HIS . 1.1 t -53.32 141.58 41.63 Favored Pre-proline 0 N--CA 1.449 -0.487 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.328 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.474 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 24.9 Cg_exo -58.3 159.74 18.38 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.204 1.936 . . . . 0.0 111.515 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.426 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 78.1 Cg_exo -39.21 154.56 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.707 2.271 . . . . 0.0 112.799 -178.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.2 t -107.3 89.53 3.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.885 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.621 HG23 ' HE2' ' A' ' 97' ' ' TYR . 22.7 pt -70.12 -177.92 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.327 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.7 m -104.33 142.32 34.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.583 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.514 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 5.4 m-80 61.9 29.79 17.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.814 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.466 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . -175.78 -168.92 36.78 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.771 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -170.55 -174.66 1.68 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.907 0.384 . . . . 0.0 110.535 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.599 ' CE1' ' HG ' ' A' ' 73' ' ' SER . 2.1 p80 -103.15 170.94 7.66 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.152 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.322 -179.561 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.446 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 10.5 m-85 . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.882 0.372 . . . . 0.0 111.094 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.435 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 59.1 m-85 -148.82 152.74 37.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.665 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.4 p -102.0 175.18 5.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.099 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.9 103.12 2.13 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.652 0.739 . . . . 0.0 110.65 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 120.55 24.66 2.56 Favored Glycine 0 C--N 1.312 -0.778 0 CA-C-N 114.588 -1.187 . . . . 0.0 112.751 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.54 163.57 12.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.711 0.291 . . . . 0.0 110.627 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.507 HG22 ' N ' ' A' ' 95' ' ' VAL . 32.6 m -136.27 158.48 38.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.17 0.51 . . . . 0.0 111.333 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.507 ' N ' HG22 ' A' ' 94' ' ' VAL . 22.1 t -153.07 150.4 12.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.769 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.941 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -108.4 136.36 48.16 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.355 178.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.875 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.9 m-85 -93.81 155.57 17.13 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.938 0.399 . . . . 0.0 110.987 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -154.81 144.78 21.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.408 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.466 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 9.5 m -69.95 169.14 13.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.843 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -99.33 -83.81 0.42 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.531 178.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.9 t -54.01 -36.78 63.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.247 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 136.19 47.38 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.548 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.55 ' CE2' HG12 ' A' ' 126' ' ' ILE . 12.4 m-85 -83.77 -170.18 2.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.672 0.272 . . . . 0.0 110.653 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.4 m -116.92 102.3 9.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.726 0.298 . . . . 0.0 110.821 179.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.529 HD11 ' HB3' ' A' ' 97' ' ' TYR . 0.2 OUTLIER -48.38 136.95 11.88 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.632 0.729 . . . . 0.0 111.193 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.481 HG22 ' N ' ' A' ' 107' ' ' GLY . 33.2 mm -103.43 158.86 4.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.304 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.481 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 62.38 -126.1 37.17 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.309 -0.948 . . . . 0.0 112.021 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -124.12 131.72 53.57 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.981 0.42 . . . . 0.0 111.121 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.941 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.2 p -62.77 -26.52 68.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.857 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.2 142.29 31.38 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.821 -0.627 . . . . 0.0 113.014 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.875 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.8 t -140.05 127.02 23.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.98 122.25 32.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.873 0.368 . . . . 0.0 111.807 -178.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.521 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 15.5 t -85.16 101.26 12.33 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 176.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.45 167.19 25.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.047 0.451 . . . . 0.0 111.527 -178.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.24 25.11 2.61 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.665 -0.698 . . . . 0.0 113.033 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.82 19.7 79.48 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.222 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -151.31 -179.3 7.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.772 0.32 . . . . 0.0 110.297 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.521 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 90.1 m95 -113.23 138.53 49.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.898 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.41 146.63 46.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.236 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.48 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER 69.89 45.98 0.28 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.17 178.819 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 71.7 Cg_endo -76.95 136.77 16.89 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.313 2.009 . . . . 0.0 111.383 177.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.527 ' O ' HG21 ' A' ' 77' ' ' ILE . 56.6 Cg_endo -89.7 179.41 2.15 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.383 2.055 . . . . 0.0 113.582 -178.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.45 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -120.13 -159.99 0.81 Allowed 'General case' 0 CA--C 1.503 -0.858 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.955 176.707 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . 0.437 ' SG ' ' HB2' ' A' ' 103' ' ' TYR . 5.5 t -170.7 91.48 0.16 Allowed 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.376 -176.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -118.92 176.57 5.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.812 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.595 HG22 ' O ' ' A' ' 126' ' ' ILE . 39.1 mm . . . . . 0 C--N 1.322 -0.601 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.846 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.459 ' HB2' ' HA ' ' A' ' 26' ' ' ASP . 7.7 ptt180 . . . . . 0 C--O 1.23 0.078 0 CA-C-O 121.071 0.463 . . . . 0.0 111.121 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.558 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 72.4 m -83.89 177.12 3.17 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.693 178.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.558 ' CD ' ' HB3' ' A' ' 9' ' ' CYS . 38.4 Cg_endo -90.78 -165.93 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.701 2.267 . . . . 0.0 112.025 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.39 108.22 1.35 Allowed Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.273 179.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.469 ' HB3' HD11 ' A' ' 31' ' ' ILE . 14.0 Cg_endo -56.67 149.31 59.71 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.153 1.902 . . . . 0.0 111.975 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.82 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.8 OUTLIER -59.25 173.43 0.49 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.28 179.645 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.62 -171.71 2.53 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.147 0.498 . . . . 0.0 111.506 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.582 HD12 ' O ' ' A' ' 64' ' ' PRO . 4.1 tt -151.82 147.23 15.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.004 -178.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.451 ' N ' HG12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -87.72 154.6 20.44 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 177.3 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.477 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 0.3 OUTLIER 48.52 25.44 0.94 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.885 0.374 . . . . 0.0 110.285 -178.521 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -146.3 170.46 27.4 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.658 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -136.46 138.56 41.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.927 0.394 . . . . 0.0 110.689 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.911 HD21 ' CZ ' ' A' ' 33' ' ' TYR . 8.2 mt -84.62 155.1 22.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.061 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.441 ' CB ' ' HB ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -125.45 71.22 1.2 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.776 177.857 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.888 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.8 OUTLIER -70.78 95.69 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.041 -177.024 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.8 19.22 52.91 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.591 176.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.4 ' O ' ' HB3' ' A' ' 29' ' ' SER . . . 155.46 141.47 3.22 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.206 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.42 ' O ' ' HB2' ' A' ' 8' ' ' ARG . 3.1 m -114.6 -12.54 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.459 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 0.8 OUTLIER -69.82 160.3 32.01 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.852 0.358 . . . . 0.0 111.738 -179.033 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.672 ' CE2' HD23 ' A' ' 51' ' ' LEU . 24.1 t80 -50.42 127.21 17.0 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.126 178.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.97 -11.06 71.43 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.065 -178.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.4 ' HB3' ' O ' ' A' ' 24' ' ' GLY . 74.5 m -65.31 -173.4 0.13 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.955 0.378 . . . . 0.0 110.065 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 48' ' ' TYR . 11.0 p -162.12 146.49 12.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.135 0.493 . . . . 0.0 111.808 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.888 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -118.94 151.22 21.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.83 179.157 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.444 ' HA ' ' HG3' ' A' ' 46' ' ' LYS . 3.1 m -115.52 114.61 25.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.037 0.446 . . . . 0.0 111.428 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.911 ' CZ ' HD21 ' A' ' 20' ' ' LEU . 2.1 m-85 -80.83 135.9 36.02 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.252 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.467 ' HA ' HD13 ' A' ' 41' ' ' LEU . 3.7 p -148.24 177.65 9.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.146 -177.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.466 ' HA ' ' HA2' ' A' ' 18' ' ' GLY . 71.9 m -94.16 170.17 9.71 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.634 -178.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.26 -77.82 0.17 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.856 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.03 139.23 17.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.593 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.487 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 54.35 29.68 46.99 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.725 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.5 ' CE2' ' HA ' ' A' ' 67' ' ' GLU . 2.0 m-85 -121.14 163.12 18.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.948 0.404 . . . . 0.0 111.161 -179.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.508 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 1.4 p80 -127.68 134.65 49.59 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 176.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.837 HD21 ' HG2' ' A' ' 64' ' ' PRO . 0.9 OUTLIER -82.72 137.62 34.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.959 -174.572 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.531 HD13 ' C ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -114.88 125.26 72.15 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-O 121.344 0.592 . . . . 0.0 110.995 178.827 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 104.69 -145.43 15.97 Favored Glycine 0 C--N 1.318 -0.452 0 CA-C-N 114.539 -1.21 . . . . 0.0 112.378 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.46 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 11.0 mt-10 -60.97 -134.87 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 178.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.507 ' HB3' HD22 ' A' ' 41' ' ' LEU . 6.4 p 165.32 23.6 0.0 OUTLIER 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 123.712 0.805 . . . . 0.0 111.086 177.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.533 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 1.6 mttt -162.93 146.6 11.08 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -177.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.489 ' HA ' ' O ' ' A' ' 61' ' ' PRO . 32.9 t -119.85 152.62 37.05 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.75 176.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.546 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 3.4 m-85 -134.2 119.54 18.93 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 118.825 -1.15 . . . . 0.0 113.184 -178.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.51 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 36.6 t -65.96 120.87 13.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.902 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.486 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 8.4 tt0 -160.68 168.85 24.02 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.565 0.697 . . . . 0.0 110.845 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.672 HD23 ' CE2' ' A' ' 27' ' ' PHE . 2.8 pp . . . . . 0 C--N 1.317 -0.847 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.074 -179.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.565 ' O ' HG13 ' A' ' 58' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.522 -0.099 0 CA-C-O 120.821 0.343 . . . . 0.0 110.341 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.565 HG13 ' O ' ' A' ' 57' ' ' MET . 8.2 m -159.98 -177.65 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.099 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.53 ' CE3' HD11 ' A' ' 31' ' ' ILE . 75.6 m95 -126.2 135.2 51.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.972 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.546 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.3 OUTLIER -69.58 168.57 16.2 Favored Pre-proline 0 CA--C 1.506 -0.722 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 175.208 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.49 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 0.9 OUTLIER -4.28 120.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.949 1 C-N-CA 125.527 4.151 . . . . 0.0 114.873 -177.209 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.619 ' O ' ' CZ ' ' A' ' 33' ' ' TYR . 13.1 mt-10 -89.18 -62.3 1.51 Allowed 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 114.35 -1.295 . . . . 0.0 111.739 -173.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.677 ' HB1' ' CA ' ' A' ' 64' ' ' PRO . . . -65.45 -153.12 0.0 OUTLIER Pre-proline 0 CA--C 1.484 -1.57 0 CA-C-O 116.704 -1.617 . . . . 0.0 108.691 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.837 ' HG2' HD21 ' A' ' 41' ' ' LEU . 4.0 Cg_exo -89.51 -155.14 0.78 Allowed 'Cis proline' 0 N--CA 1.483 0.879 0 CA-C-N 123.037 2.12 . . . . 0.0 114.804 19.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.545 HG22 ' H ' ' A' ' 66' ' ' CYS . 0.4 OUTLIER -103.15 -167.98 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.072 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.921 -177.905 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.649 ' SG ' HD12 ' A' ' 41' ' ' LEU . 1.7 m -164.19 137.42 5.19 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.822 0.344 . . . . 0.0 111.257 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.5 ' HA ' ' CE2' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -141.24 150.89 43.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.524 -179.431 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.486 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 5.0 t -48.3 139.62 8.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.301 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.487 HG12 ' O ' ' A' ' 38' ' ' GLY . 0.9 OUTLIER -67.38 108.2 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.261 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.427 ' HA ' HG22 ' A' ' 90' ' ' THR . 0.0 OUTLIER -77.18 127.92 33.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.761 -179.391 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.41 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -107.1 119.34 39.1 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.681 177.532 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.65 -157.09 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.791 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.5 t -49.18 139.61 13.07 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.08 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.807 ' HG2' HG11 ' A' ' 95' ' ' VAL . 25.6 Cg_exo -60.23 159.79 25.33 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.474 2.116 . . . . 0.0 111.9 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.51 ' HD3' ' CG ' ' A' ' 118' ' ' TRP . 86.2 Cg_exo -45.81 153.67 0.8 Allowed 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.433 2.089 . . . . 0.0 112.4 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.4 t -106.62 91.81 3.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.635 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.534 HG21 ' O ' ' A' ' 122' ' ' PRO . 14.1 pt -69.27 167.02 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.091 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.4 p -84.87 139.97 31.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.897 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.455 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 7.2 m-80 58.63 27.9 16.43 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.139 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.455 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -163.05 -163.08 14.86 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.422 -0.894 . . . . 0.0 113.054 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.415 ' N ' ' O ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -170.44 -174.61 1.7 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.874 0.369 . . . . 0.0 110.859 -179.475 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.526 ' HB3' ' CE1' ' A' ' 97' ' ' TYR . 2.3 p80 -111.24 167.3 10.39 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.893 -178.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 96' ' ' THR . 10.4 m-20 . . . . . 0 CA--C 1.515 -0.377 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.452 177.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.427 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 7.3 m-85 . . . . . 0 N--CA 1.454 -0.273 0 CA-C-O 120.833 0.349 . . . . 0.0 110.87 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.427 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 6.5 m-85 -142.54 173.18 11.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.79 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.427 HG22 ' HA ' ' A' ' 70' ' ' LYS . 16.7 p -154.02 -175.73 5.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.039 0.447 . . . . 0.0 112.012 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.467 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 4.6 m-20 -57.5 96.53 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.358 0.599 . . . . 0.0 111.062 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 128.46 15.54 2.21 Favored Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 115.081 -0.963 . . . . 0.0 113.281 178.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.431 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.4 OUTLIER -104.52 150.61 24.45 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 117.244 0.522 . . . . 0.0 110.698 179.184 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.484 HG12 ' HA ' ' A' ' 112' ' ' LEU . 18.8 m -146.89 132.83 12.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.084 0.469 . . . . 0.0 110.886 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.807 HG11 ' HG2' ' A' ' 74' ' ' PRO . 2.2 p -132.35 148.7 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.009 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.574 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -92.1 148.91 21.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.077 0.465 . . . . 0.0 110.732 179.85 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.883 ' CE1' HG21 ' A' ' 111' ' ' VAL . 3.0 m-85 -107.17 159.78 16.07 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.846 0.355 . . . . 0.0 110.845 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.415 ' O ' ' N ' ' A' ' 81' ' ' ARG . 50.4 m -155.79 151.44 27.25 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.56 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.452 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 78.4 m -78.38 162.01 26.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.252 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.455 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 17.0 m-20 -91.77 -71.28 0.65 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.488 -179.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.68 -20.96 66.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.434 -179.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.32 31.42 1.17 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.532 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.484 ' CE2' HG12 ' A' ' 126' ' ' ILE . 26.5 m-85 -69.83 -173.47 0.63 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 120.782 0.325 . . . . 0.0 110.539 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.56 103.56 12.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.072 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.591 HD23 ' HB2' ' A' ' 122' ' ' PRO . 3.0 tp -42.62 113.45 0.46 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.135 179.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.734 HD11 ' HB2' ' A' ' 125' ' ' GLN . 39.0 mm -86.75 155.86 3.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.735 -179.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.439 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 57.18 -128.62 47.86 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.351 -0.928 . . . . 0.0 111.766 -178.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -115.04 134.67 54.98 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.029 0.442 . . . . 0.0 111.573 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.574 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.1 t -70.27 -29.83 66.7 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.362 178.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.82 137.28 23.05 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.536 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.883 HG21 ' CE1' ' A' ' 97' ' ' TYR . 9.9 t -128.75 120.11 51.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.483 0.182 . . . . 0.0 110.527 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.883 HD22 ' N ' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -80.0 133.21 36.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.903 0.382 . . . . 0.0 111.442 -178.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.883 ' N ' HD22 ' A' ' 112' ' ' LEU . 25.5 t -104.68 106.48 16.99 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.851 176.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.645 ' HB2' HD11 ' A' ' 112' ' ' LEU . 0.2 OUTLIER -167.29 122.02 1.04 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.981 0.42 . . . . 0.0 111.174 179.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.27 26.79 7.19 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.144 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.438 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 69.24 10.09 61.87 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.521 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -148.69 -177.64 5.9 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.981 0.419 . . . . 0.0 110.665 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.579 ' HE3' HG12 ' A' ' 111' ' ' VAL . 92.9 m95 -116.27 151.19 36.31 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.85 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.68 155.63 49.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.073 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.535 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.2 t0 69.49 42.07 0.22 Allowed Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 74.2 Cg_endo -76.7 137.32 17.94 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.48 2.12 . . . . 0.0 111.941 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.591 ' HB2' HD23 ' A' ' 105' ' ' LEU . 57.2 Cg_endo -90.83 -172.97 0.55 Allowed 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.853 2.369 . . . . 0.0 113.408 -178.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.453 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.3 OUTLIER -132.36 -163.27 1.32 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.021 177.893 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 7.6 m -151.87 92.2 1.71 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.147 0.498 . . . . 0.0 111.164 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.734 ' HB2' HD11 ' A' ' 106' ' ' ILE . 10.1 mt-30 -118.06 164.74 14.67 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.514 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.557 HG22 ' O ' ' A' ' 126' ' ' ILE . 50.0 mm . . . . . 0 C--N 1.324 -0.523 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.946 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.84 ' HD2' HG23 ' A' ' 25' ' ' VAL . 13.1 mtm180 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.934 0.397 . . . . 0.0 110.755 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.463 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 19.6 m -89.35 162.06 38.13 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.826 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.41 170.18 16.75 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.413 2.075 . . . . 0.0 111.985 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.429 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 12.8 t -54.33 106.33 0.65 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.226 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.468 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 3.4 Cg_exo -46.76 153.26 1.37 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.118 1.879 . . . . 0.0 112.045 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.703 ' O ' HD11 ' A' ' 20' ' ' LEU . 2.4 mtt85 -68.52 163.59 23.12 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.14 178.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.454 ' HA ' HD11 ' A' ' 20' ' ' LEU . 2.0 p30 -112.35 179.76 3.9 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.18 0.514 . . . . 0.0 112.129 -176.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.461 HG23 ' C ' ' A' ' 18' ' ' GLY . 7.3 tt -131.63 152.56 37.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.418 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -80.27 -62.34 1.71 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -177.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -94.57 31.07 1.85 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.867 -178.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.461 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -151.03 -179.98 27.22 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.197 -1.002 . . . . 0.0 113.498 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -139.34 135.22 33.52 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.146 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.703 HD11 ' O ' ' A' ' 13' ' ' ARG . 2.6 mt -79.42 163.29 24.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.218 0.533 . . . . 0.0 111.799 -178.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -131.33 77.75 1.79 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.595 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.921 ' HA ' HG23 ' A' ' 31' ' ' ILE . 69.1 mt -69.63 104.51 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.018 -177.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -110.2 22.63 22.53 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.519 177.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 153.66 129.78 1.39 Allowed Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -179.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.84 HG23 ' HD2' ' A' ' 8' ' ' ARG . 0.5 OUTLIER -121.33 0.97 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.665 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 27' ' ' PHE . 34.0 t0 -74.22 162.24 29.13 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.844 0.354 . . . . 0.0 110.952 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.88 ' CZ ' HD13 ' A' ' 51' ' ' LEU . 11.0 t80 -52.56 106.19 0.15 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.843 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.57 -0.08 27.7 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.765 -0.731 . . . . 0.0 113.046 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 82.9 p -77.24 178.99 6.64 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.971 0.385 . . . . 0.0 110.964 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 47' ' ' SER . 3.3 p -149.1 144.03 26.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.998 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.921 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -110.64 170.46 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.618 179.819 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.441 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -129.42 113.12 14.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.905 0.383 . . . . 0.0 111.31 179.482 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.673 ' CE2' HD22 ' A' ' 20' ' ' LEU . 15.8 m-85 -87.77 140.99 28.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.06 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.433 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 16.6 m -146.36 157.52 43.79 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.677 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.437 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 62.7 m -80.34 170.01 16.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.748 0.308 . . . . 0.0 110.647 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.09 -75.65 0.11 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.941 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.8 t -160.01 139.69 11.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.835 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 56.97 25.13 52.79 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.063 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.531 ' CD2' ' HA ' ' A' ' 68' ' ' SER . 2.3 m-85 -116.57 171.05 8.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.871 0.367 . . . . 0.0 111.051 -179.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.866 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -131.86 123.25 27.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.426 178.387 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.941 HD21 ' O ' ' A' ' 44' ' ' GLU . 4.7 tt -86.47 134.27 33.69 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.502 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.866 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.0 mm -112.97 156.98 13.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.02 0.438 . . . . 0.0 111.164 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.4 -128.27 8.36 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.289 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.941 ' O ' HD21 ' A' ' 41' ' ' LEU . 1.5 pm0 -83.78 -173.7 4.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.792 0.329 . . . . 0.0 110.648 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.2 p -162.31 24.27 0.11 Allowed 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.159 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.441 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 13.2 mtpt -164.45 126.45 2.28 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.578 -177.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.455 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 1.9 t -94.06 137.85 32.8 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 176.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.552 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 2.6 m-85 -114.92 118.57 33.85 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.589 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 35.4 t -66.3 92.57 0.19 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.625 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.489 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 1.7 tt0 -123.86 172.12 9.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.518 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.88 HD13 ' CZ ' ' A' ' 27' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--N 1.32 -0.682 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.521 179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.203 0 CA-C-O 121.261 0.553 . . . . 0.0 110.4 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.442 ' N ' ' O ' ' A' ' 50' ' ' GLU . 0.9 OUTLIER -111.99 -175.23 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.432 -179.281 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.536 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 70.7 m95 -125.31 123.73 40.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.916 0.389 . . . . 0.0 111.263 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.552 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 2.7 m-20 -69.04 167.68 19.36 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.49 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 10.4 Cg_exo -7.39 89.86 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.008 1 C-N-CA 125.41 4.073 . . . . 0.0 114.796 -179.054 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.479 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 10.7 mt-10 -84.24 -92.58 0.08 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 114.779 -1.101 . . . . 0.0 112.386 -177.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.48 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -91.63 109.01 33.62 Favored Pre-proline 0 C--O 1.231 0.1 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -176.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.893 ' HG2' HD11 ' A' ' 41' ' ' LEU . 6.1 Cg_exo -79.39 -153.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.892 2.395 . . . . 0.0 111.113 177.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.515 HG22 ' H ' ' A' ' 66' ' ' CYS . 1.5 mm -93.95 168.94 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.859 0.361 . . . . 0.0 110.669 178.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.515 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.8 OUTLIER -170.35 138.69 1.6 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.945 179.759 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -162.44 173.86 13.51 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.625 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.531 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 54.1 p -79.07 113.64 17.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.301 0.572 . . . . 0.0 110.83 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.684 HG21 ' H ' ' A' ' 115' ' ' GLY . 30.9 m -39.2 100.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.425 -179.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 89' ' ' TYR . 0.3 OUTLIER -96.45 103.57 15.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.862 0.363 . . . . 0.0 110.719 178.027 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.94 121.91 35.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.049 179.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.459 ' CG ' ' N ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -69.15 -155.4 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.975 179.402 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.459 ' N ' ' CG ' ' A' ' 72' ' ' GLN . 1.2 t -50.77 142.21 16.79 Favored Pre-proline 0 N--CA 1.449 -0.511 0 CA-C-O 120.642 0.258 . . . . 0.0 110.823 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.496 ' HG2' HG11 ' A' ' 95' ' ' VAL . 26.8 Cg_exo -59.35 164.1 11.38 Favored 'Trans proline' 0 CA--C 1.528 0.198 0 C-N-CA 122.531 2.154 . . . . 0.0 111.936 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.521 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 89.6 Cg_exo -41.75 158.76 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.56 2.174 . . . . 0.0 112.572 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 83.5 p -109.24 88.6 2.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.528 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.645 HG23 ' HE2' ' A' ' 97' ' ' TYR . 15.9 pt -69.79 170.55 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.305 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.7 m -90.09 142.59 27.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.675 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.506 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 7.7 m-80 56.26 29.51 15.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.973 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.477 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -161.75 -171.18 27.48 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.27 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.413 ' N ' ' O ' ' A' ' 98' ' ' SER . 9.5 ptt180 -163.75 -175.33 4.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.971 0.415 . . . . 0.0 110.78 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 1.7 p-80 -117.9 169.22 9.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.053 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.691 179.989 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.434 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 7.0 m-85 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.761 0.315 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.434 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 72.5 m-85 -156.39 160.56 39.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.845 -179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 69' ' ' VAL . 6.7 p -142.63 -177.42 5.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.287 0.565 . . . . 0.0 112.324 -179.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 6.9 p-10 -50.03 94.62 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.489 -179.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 121.96 24.29 2.31 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.373 -0.83 . . . . 0.0 113.37 177.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -110.1 147.4 33.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 117.075 0.437 . . . . 0.0 110.782 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.517 HG22 ' N ' ' A' ' 95' ' ' VAL . 35.2 m -128.68 160.0 39.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.1 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.517 ' N ' HG22 ' A' ' 94' ' ' VAL . 21.5 t -151.8 148.6 14.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.479 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.9 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -108.01 126.02 52.22 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.228 0.537 . . . . 0.0 111.06 -179.608 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.955 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.6 m-85 -83.87 161.6 20.82 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.657 -178.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.432 ' HA ' HD13 ' A' ' 105' ' ' LEU . 14.8 p -155.24 138.66 15.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.348 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.453 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 73.9 m -69.98 158.39 35.71 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.794 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.477 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 26.8 m-20 -92.0 -70.69 0.68 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.429 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.24 -22.83 67.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.323 -179.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 122.0 31.15 1.13 Allowed Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.63 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.506 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 19.9 m-85 -69.61 -175.55 0.87 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.038 0.447 . . . . 0.0 110.898 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.2 m -110.07 98.1 7.45 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.098 178.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.527 HD11 ' HB3' ' A' ' 97' ' ' TYR . 0.2 OUTLIER -48.77 132.48 17.97 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.555 0.693 . . . . 0.0 111.727 -177.834 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.445 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 38.2 mm -114.23 155.52 15.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.092 -178.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.41 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 68.59 23.88 75.32 Favored Glycine 0 C--N 1.328 0.103 0 C-N-CA 120.56 -0.828 . . . . 0.0 113.053 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.41 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.3 OUTLIER 60.37 136.66 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.295 0.569 . . . . 0.0 111.531 179.759 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.9 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.1 p -69.7 -24.13 63.53 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.765 -178.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -63.84 121.72 24.21 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.787 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.955 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.7 t -122.14 141.8 41.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 178.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.895 HD22 ' N ' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -102.92 132.43 49.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.841 0.353 . . . . 0.0 111.505 -178.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.895 ' N ' HD22 ' A' ' 112' ' ' LEU . 41.4 t -104.6 104.59 14.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.034 177.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.798 ' OG ' HD11 ' A' ' 112' ' ' LEU . 12.4 p -165.93 119.27 1.13 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.922 0.391 . . . . 0.0 111.707 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.684 ' H ' HG21 ' A' ' 69' ' ' VAL . . . 102.33 20.98 11.18 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.686 179.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.489 ' N ' ' HB ' ' A' ' 69' ' ' VAL . . . 80.88 2.08 90.02 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.498 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -145.51 170.52 16.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.14 0.495 . . . . 0.0 111.317 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.521 ' CZ3' ' HB2' ' A' ' 113' ' ' CYS . 88.5 m95 -104.37 144.98 30.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.355 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.1 149.77 43.1 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.074 0.464 . . . . 0.0 111.491 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.499 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER 65.66 44.7 0.41 Allowed Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.196 178.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 56.3 Cg_endo -69.82 142.91 48.93 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.22 1.946 . . . . 0.0 111.467 178.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.508 ' HG2' ' CD2' ' A' ' 97' ' ' TYR . 71.1 Cg_endo -90.23 -172.84 0.6 Allowed 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.641 2.227 . . . . 0.0 113.768 -177.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.37 -158.44 0.87 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.652 178.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 2.3 m -155.76 89.16 1.15 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.089 0.471 . . . . 0.0 110.925 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -113.34 161.11 17.65 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.684 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.582 HG22 ' O ' ' A' ' 126' ' ' ILE . 21.9 mm . . . . . 0 C--N 1.323 -0.569 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.935 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.426 ' CB ' HG23 ' A' ' 25' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 120.946 0.403 . . . . 0.0 111.752 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.481 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 3.5 m -93.24 163.04 26.47 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.672 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -67.62 169.83 15.07 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.205 1.937 . . . . 0.0 111.407 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.03 105.1 0.46 Allowed Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.088 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.6 ' HB3' HD13 ' A' ' 31' ' ' ILE . 83.1 Cg_exo -38.42 146.35 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.657 2.238 . . . . 0.0 112.739 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.3 152.98 43.83 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.644 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.415 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -101.18 -167.98 1.5 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.118 -178.701 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 19.1 tt -167.88 144.52 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.568 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.421 ' HB2' ' ND2' ' A' ' 17' ' ' ASN . 0.6 OUTLIER -94.28 160.43 14.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.743 177.566 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.421 ' ND2' ' HB2' ' A' ' 16' ' ' ASP . 0.3 OUTLIER 48.1 25.58 0.84 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.879 0.371 . . . . 0.0 110.638 -179.108 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -158.81 -173.91 27.83 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.615 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -132.14 -171.88 2.74 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.313 0.578 . . . . 0.0 111.787 -177.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.3 mt -140.25 139.28 35.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.465 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.422 ' CB ' ' HB ' ' A' ' 32' ' ' THR . 0.3 OUTLIER -118.07 73.56 0.91 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.851 179.109 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.763 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -82.75 94.21 3.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.947 -176.046 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.38 12.05 63.94 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.048 177.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 29' ' ' SER . . . 156.51 148.12 4.97 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.11 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.426 HG23 ' CB ' ' A' ' 8' ' ' ARG . 29.7 m -120.37 -1.01 8.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.424 ' HA ' ' HB3' ' A' ' 8' ' ' ARG . 0.7 OUTLIER -69.64 153.78 42.93 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.931 0.395 . . . . 0.0 111.224 -179.292 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.46 110.38 0.37 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.855 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 113.79 -9.16 23.61 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.423 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 24' ' ' GLY . 0.4 OUTLIER -72.73 178.44 4.17 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.845 0.323 . . . . 0.0 110.83 179.777 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 47' ' ' SER . 11.4 p -153.82 138.77 17.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.223 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.763 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -103.1 165.78 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.601 179.063 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.423 ' HA ' ' HG3' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -130.35 110.5 11.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.633 178.561 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.491 ' CE2' ' HA ' ' A' ' 63' ' ' ALA . 22.9 m-85 -83.2 146.95 28.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.132 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.47 172.2 14.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.926 0.394 . . . . 0.0 111.425 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.444 ' HA ' ' HA2' ' A' ' 18' ' ' GLY . 1.7 m -96.13 156.7 16.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.497 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.423 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 3.6 m-20 -56.1 -85.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.15 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.5 t -152.19 135.67 16.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.934 0.397 . . . . 0.0 110.719 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.439 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 61.51 24.29 63.74 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.865 -179.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.471 ' CG ' ' O ' ' A' ' 67' ' ' GLU . 2.3 m-85 -116.24 174.69 5.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.805 0.336 . . . . 0.0 110.802 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.806 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.6 OUTLIER -136.94 116.17 12.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.036 0.446 . . . . 0.0 110.478 178.241 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.917 HD21 ' O ' ' A' ' 44' ' ' GLU . 4.7 tt -77.37 124.62 28.11 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.638 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.806 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.7 mm -96.8 152.55 3.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.247 -179.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.09 -149.74 38.04 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.218 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.917 ' O ' HD21 ' A' ' 41' ' ' LEU . 4.3 pm0 -61.63 178.65 0.3 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.609 0.242 . . . . 0.0 110.582 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.0 p -152.38 21.44 0.64 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.374 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.423 ' HG3' ' HA ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -142.97 -174.6 4.23 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.226 0.536 . . . . 0.0 111.934 -178.299 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.456 ' O ' HG13 ' A' ' 31' ' ' ILE . 1.7 m -160.96 108.88 1.54 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.831 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -92.15 117.75 30.16 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.229 0.538 . . . . 0.0 111.839 -177.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.499 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 8.7 t -64.33 90.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.226 179.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.503 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -116.43 175.75 5.42 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.428 -179.51 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.503 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.646 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.235 -178.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.866 0.365 . . . . 0.0 110.11 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.9 m -152.04 -177.66 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.083 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.526 ' CE3' HD11 ' A' ' 31' ' ' ILE . 93.2 m95 -130.51 124.6 32.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.932 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -143.49 126.51 8.92 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.193 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.78 -162.28 2.13 Favored 'Cis proline' 0 C--N 1.351 0.703 0 C-N-CA 124.06 -1.225 . . . . 0.0 111.928 -0.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.488 ' O ' ' CZ ' ' A' ' 33' ' ' TYR . 4.3 pt-20 -112.25 -113.97 0.33 Allowed 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.401 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.491 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -118.92 86.84 32.06 Favored Pre-proline 0 N--CA 1.45 -0.472 0 C-N-CA 122.658 0.383 . . . . 0.0 110.462 -179.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.549 ' HG2' HD11 ' A' ' 41' ' ' LEU . 10.3 Cg_endo -48.58 -158.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.475 0.395 0 C-N-CA 123.863 3.042 . . . . 0.0 113.995 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.487 HG22 ' N ' ' A' ' 66' ' ' CYS . 5.0 mm -93.49 165.28 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.109 -177.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.487 ' N ' HG22 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -161.42 138.22 8.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.268 179.074 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.471 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 1.0 OUTLIER -162.22 -177.1 5.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.898 0.38 . . . . 0.0 111.168 -179.719 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.8 t -83.8 132.27 34.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.108 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -46.21 101.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.553 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.526 ' HE2' HG23 ' A' ' 90' ' ' THR . 0.2 OUTLIER -72.15 123.19 22.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.352 179.951 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.51 122.91 46.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.921 178.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -69.31 -156.28 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.373 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.544 ' HG ' ' CE1' ' A' ' 82' ' ' HIS . 1.8 t -52.95 145.6 22.28 Favored Pre-proline 0 N--CA 1.45 -0.426 0 CA-C-O 120.633 0.254 . . . . 0.0 110.377 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.464 ' HG2' HG11 ' A' ' 95' ' ' VAL . 23.4 Cg_exo -62.62 165.33 16.01 Favored 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 122.48 2.12 . . . . 0.0 112.155 -179.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.518 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 81.2 Cg_exo -43.65 160.6 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.713 2.275 . . . . 0.0 112.87 -179.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 86.7 p -108.29 90.16 3.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.497 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.692 HG23 ' HE2' ' A' ' 97' ' ' TYR . 14.1 pt -69.24 175.22 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.243 -178.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.4 p -96.21 143.41 27.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.717 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.514 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 5.3 m-80 55.42 30.23 14.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.925 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.439 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -167.41 -170.26 32.01 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.53 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.97 -176.71 4.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.035 0.445 . . . . 0.0 111.091 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.544 ' CE1' ' HG ' ' A' ' 73' ' ' SER . 3.4 p80 -108.37 173.26 6.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.117 -179.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.66 179.408 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.434 ' HB3' ' HD3' ' A' ' 70' ' ' LYS . 6.4 m-85 . . . . . 0 N--CA 1.455 -0.196 0 CA-C-O 120.866 0.365 . . . . 0.0 111.521 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.425 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 69.2 m-85 -156.77 165.85 35.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.809 -179.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.526 HG23 ' HE2' ' A' ' 70' ' ' LYS . 19.1 p -149.37 -175.78 5.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.029 0.442 . . . . 0.0 111.62 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 3.8 p30 -52.86 94.42 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.444 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.14 22.63 2.34 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.273 -0.876 . . . . 0.0 113.13 178.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.401 ' HB2' ' HB3' ' A' ' 89' ' ' TYR . 0.9 OUTLIER -110.21 145.83 36.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.951 0.375 . . . . 0.0 110.789 179.104 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 32.7 m -128.58 155.61 40.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.067 0.461 . . . . 0.0 111.249 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.509 HG23 ' CH2' ' A' ' 118' ' ' TRP . 20.7 t -146.54 146.57 18.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.11 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.802 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -101.4 134.22 44.82 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.827 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.911 ' CE1' HG21 ' A' ' 111' ' ' VAL . 5.0 m-85 -95.39 158.83 15.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.915 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 77.1 p -153.0 140.33 19.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.376 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.431 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 68.8 m -71.04 152.46 43.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.891 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.411 ' CG ' ' N ' ' A' ' 101' ' ' SER . 1.5 p30 -92.54 -55.14 3.5 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.419 0.628 . . . . 0.0 111.434 -178.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.411 ' N ' ' CG ' ' A' ' 100' ' ' ASN . 22.4 t -73.98 -14.75 61.08 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.757 -178.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 111.24 24.68 5.32 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.005 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.514 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 30.8 m-85 -69.46 -172.95 0.51 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.855 0.36 . . . . 0.0 110.817 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.1 105.78 15.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.156 -179.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.639 HD23 ' HB2' ' A' ' 122' ' ' PRO . 3.1 tp -44.85 113.52 0.57 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.07 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.453 ' HB ' ' CB ' ' A' ' 123' ' ' THR . 30.6 mm -87.13 157.07 3.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.471 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.438 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 58.69 -131.17 51.92 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.767 -178.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.27 126.28 52.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.771 0.32 . . . . 0.0 110.746 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.802 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.4 t -57.63 -28.45 63.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.045 0.45 . . . . 0.0 110.242 178.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.9 132.2 15.13 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.558 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.911 HG21 ' CE1' ' A' ' 97' ' ' TYR . 6.0 t -125.52 126.83 71.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 110.422 -0.214 . . . . 0.0 110.422 178.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.93 HD22 ' N ' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -81.14 135.52 35.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.889 0.376 . . . . 0.0 111.48 -178.567 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.93 ' N ' HD22 ' A' ' 112' ' ' LEU . 39.3 t -108.28 108.04 18.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.051 177.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.711 ' HB2' HD11 ' A' ' 112' ' ' LEU . 0.2 OUTLIER -164.01 129.67 2.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.868 0.366 . . . . 0.0 111.259 -179.806 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.38 31.04 20.45 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.076 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.16 19.88 62.17 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.018 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -145.53 178.2 8.3 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.104 0.478 . . . . 0.0 111.15 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.528 ' CZ3' ' HB2' ' A' ' 113' ' ' CYS . 92.7 m95 -121.7 145.29 48.17 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.795 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.578 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -125.52 167.02 15.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.991 0.424 . . . . 0.0 111.658 -179.095 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.44 ' N ' ' HD3' ' A' ' 121' ' ' PRO . 6.6 p-10 46.69 52.56 12.06 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.171 179.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.44 ' HD3' ' N ' ' A' ' 120' ' ' ASP . 93.2 Cg_endo -81.28 143.94 14.26 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.666 2.244 . . . . 0.0 111.634 177.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.639 ' HB2' HD23 ' A' ' 105' ' ' LEU . 73.5 Cg_endo -91.23 -172.29 0.46 Allowed 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.877 2.385 . . . . 0.0 113.856 -177.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.453 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -138.66 -174.7 3.9 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.101 178.321 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . 0.424 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 11.9 m -141.11 96.98 3.08 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.026 0.441 . . . . 0.0 111.097 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.429 ' HB2' HD11 ' A' ' 106' ' ' ILE . 20.6 mt-30 -122.54 167.51 13.28 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.863 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.497 HG12 ' CE2' ' A' ' 103' ' ' TYR . 13.0 mm . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.935 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.543 ' HD2' HG23 ' A' ' 25' ' ' VAL . 17.4 mtm180 . . . . . 0 N--CA 1.457 -0.125 0 CA-C-O 120.791 0.329 . . . . 0.0 110.758 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.528 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 69.6 m -77.31 175.86 4.09 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.545 ' HD2' ' CD1' ' A' ' 59' ' ' TRP . 37.9 Cg_endo -91.24 176.29 2.2 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.427 2.084 . . . . 0.0 111.932 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.0 t -53.41 105.6 0.55 Allowed Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.294 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.49 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 51.5 Cg_exo -52.94 142.2 53.66 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.037 1.825 . . . . 0.0 111.804 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.945 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -49.03 120.8 4.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.925 0.869 . . . . 0.0 111.512 -178.852 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.747 ' O ' HG22 ' A' ' 15' ' ' ILE . 6.1 p-10 -59.16 -32.09 69.56 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 113.509 -1.678 . . . . 0.0 112.694 -177.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.747 HG22 ' O ' ' A' ' 14' ' ' ASP . 8.6 tt 58.36 142.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 114.271 -1.331 . . . . 0.0 111.208 -175.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.98 160.41 14.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.0 178.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.494 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 0.3 OUTLIER 50.47 24.07 1.48 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.017 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -154.06 177.61 31.4 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.659 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.43 142.26 39.52 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.74 0.305 . . . . 0.0 110.506 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.945 HD11 ' O ' ' A' ' 13' ' ' ARG . 72.2 mt -89.51 155.67 19.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.167 0.508 . . . . 0.0 111.718 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.412 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 11.1 t0 -124.73 72.91 1.24 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.38 177.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.879 ' HA ' HG23 ' A' ' 31' ' ' ILE . 1.2 mt -76.1 105.71 5.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.992 -176.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.62 13.56 57.99 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.734 176.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 157.19 133.29 1.58 Allowed Glycine 0 C--N 1.335 0.5 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.021 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.543 HG23 ' HD2' ' A' ' 8' ' ' ARG . 15.0 m -112.41 9.01 8.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -72.82 156.25 39.09 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.836 0.351 . . . . 0.0 111.331 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.598 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 8.4 t80 -54.94 91.45 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.867 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 49' ' ' CYS . . . 130.57 -18.25 5.19 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.456 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.5 p -57.24 -173.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.73 0.3 . . . . 0.0 110.863 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 47' ' ' SER . 81.2 p -150.94 150.85 31.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.25 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.879 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -121.44 167.0 15.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.766 179.493 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.412 ' HB ' ' HB3' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -129.85 108.45 10.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.618 178.243 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.436 ' CE1' ' HA ' ' A' ' 63' ' ' ALA . 33.4 m-85 -84.59 143.12 29.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.154 -179.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -152.04 157.08 41.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.198 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 21.3 m -83.8 161.56 20.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.851 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.465 ' ND2' ' HA ' ' A' ' 17' ' ' ASN . 1.2 p30 -55.7 -89.43 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.238 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.8 t -152.08 136.34 16.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.815 0.34 . . . . 0.0 110.524 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.73 17.76 63.09 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.233 -178.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.494 ' CE2' ' HB3' ' A' ' 17' ' ' ASN . 2.1 m-85 -106.87 -173.34 2.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.729 0.299 . . . . 0.0 110.782 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.896 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -147.05 112.46 5.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.983 0.42 . . . . 0.0 110.808 178.86 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.954 HD21 ' O ' ' A' ' 44' ' ' GLU . 2.1 tt -78.72 125.47 29.41 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.363 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.896 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.9 mm -98.47 167.55 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.049 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.532 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 67.03 -130.02 29.84 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.477 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.954 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.8 OUTLIER -83.47 -179.23 7.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.798 0.332 . . . . 0.0 110.925 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.438 ' HA ' ' HG2' ' A' ' 64' ' ' PRO . 3.0 t -154.98 25.44 0.43 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.924 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -150.14 168.72 23.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.245 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.444 ' O ' HG13 ' A' ' 31' ' ' ILE . 2.6 m -149.56 120.27 7.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.374 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -103.46 116.2 31.96 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.16 0.505 . . . . 0.0 111.193 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.411 ' O ' ' N ' ' A' ' 28' ' ' GLY . 53.6 t -59.16 100.87 0.08 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.098 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.28 -170.96 2.07 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.37 -178.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.598 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.848 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.772 0.32 . . . . 0.0 110.601 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.1 m -144.19 -178.45 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.98 0.419 . . . . 0.0 111.333 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.668 ' CE3' HD11 ' A' ' 31' ' ' ILE . 94.1 m95 -121.03 122.97 41.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.527 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -138.67 118.73 9.71 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.426 -178.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.14 -170.53 7.7 Favored 'Cis proline' 0 C--N 1.351 0.663 0 C-N-CA 124.094 -1.211 . . . . 0.0 112.003 -0.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -110.89 -154.66 0.54 Allowed 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.708 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.454 ' HB2' ' HB3' ' A' ' 13' ' ' ARG . . . -72.62 111.84 12.73 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.582 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.438 ' HG2' ' HA ' ' A' ' 45' ' ' SER . 15.2 Cg_exo -69.78 -150.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.628 2.219 . . . . 0.0 112.452 -178.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.501 HG22 ' H ' ' A' ' 66' ' ' CYS . 5.1 mm -100.39 165.73 2.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.6 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.501 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.3 m -161.62 137.12 7.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.589 179.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.473 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.2 OUTLIER -163.33 176.62 9.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.931 0.396 . . . . 0.0 110.965 179.784 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.49 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 12.2 p -94.4 117.37 30.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.917 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.419 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 2.3 p -41.14 93.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.609 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 68' ' ' SER . 0.1 OUTLIER -70.47 121.49 17.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.66 -178.758 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.402 ' N ' ' O ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -104.75 115.49 30.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.695 177.487 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.409 ' CG ' ' N ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -69.95 -157.99 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.792 -179.504 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.437 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 1.6 t -47.33 136.68 9.07 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.237 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.477 ' HG2' HG11 ' A' ' 95' ' ' VAL . 35.3 Cg_exo -58.85 162.03 14.11 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.39 2.06 . . . . 0.0 111.797 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.509 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 80.5 Cg_exo -39.96 156.89 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.764 2.31 . . . . 0.0 112.834 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.9 t -108.15 89.19 2.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.641 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.651 HG23 ' HE2' ' A' ' 97' ' ' TYR . 26.3 pt -69.81 174.59 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.413 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.8 p -97.67 138.79 34.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.912 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.465 ' HB3' ' CE1' ' A' ' 103' ' ' TYR . 0.1 OUTLIER 66.7 27.07 9.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.79 179.458 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.438 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . -172.71 -165.48 29.8 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.897 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 11.1 ptt180 -167.37 -175.26 2.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.873 0.368 . . . . 0.0 110.593 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.437 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 6.1 p80 -105.12 173.46 6.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.082 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.45 179.277 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.433 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 6.5 m-85 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.596 0.236 . . . . 0.0 110.722 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.433 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 60.9 m-85 -151.4 164.04 37.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.866 0.365 . . . . 0.0 111.041 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.443 HG22 ' OG ' ' A' ' 68' ' ' SER . 8.4 p -130.45 168.56 16.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.119 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 0.9 OUTLIER -54.72 94.76 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.289 0.566 . . . . 0.0 110.886 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 129.88 26.76 0.83 Allowed Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.258 -0.883 . . . . 0.0 113.216 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -110.08 162.27 14.72 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.915 0.358 . . . . 0.0 110.697 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 33.9 m -135.58 154.99 35.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.099 0.476 . . . . 0.0 111.301 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.546 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 20.8 t -150.85 147.49 15.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.823 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.98 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -105.5 133.05 50.89 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.74 179.436 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.977 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.9 m-85 -91.53 159.29 16.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.169 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.546 ' HA ' HD13 ' A' ' 105' ' ' LEU . 62.8 m -157.72 149.62 22.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.052 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.438 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 58.0 m -79.09 159.37 27.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.13 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -83.1 -68.52 0.7 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.632 -178.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.5 -26.17 61.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.383 -178.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.2 37.7 0.45 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.521 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.465 ' CE1' ' HB3' ' A' ' 79' ' ' ASN . 11.2 m-85 -69.78 -173.67 0.64 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.852 0.358 . . . . 0.0 110.35 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.3 m -107.95 98.89 8.4 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.079 178.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.546 HD13 ' HA ' ' A' ' 98' ' ' SER . 0.3 OUTLIER -47.94 126.92 11.36 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.623 0.725 . . . . 0.0 111.697 -177.881 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.455 ' HB ' ' CB ' ' A' ' 123' ' ' THR . 31.4 mm -90.6 152.02 3.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.079 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 61.11 -136.53 48.28 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.016 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -112.14 137.59 50.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.945 0.403 . . . . 0.0 111.348 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.98 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.6 p -68.06 -26.53 65.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.78 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -72.39 139.46 27.93 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.968 -0.634 . . . . 0.0 113.014 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.977 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.5 t -135.21 127.89 48.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.533 0.206 . . . . 0.0 110.56 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.06 126.2 34.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.968 0.414 . . . . 0.0 111.804 -178.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.504 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 13.4 t -90.41 101.2 13.94 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 176.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.1 OUTLIER -143.67 160.83 39.99 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.065 0.459 . . . . 0.0 111.411 -178.181 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.0 30.53 5.19 Favored Glycine 0 N--CA 1.453 -0.232 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.665 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.419 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 68.72 19.19 72.96 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.199 -179.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -144.47 179.51 7.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.777 0.322 . . . . 0.0 110.512 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.546 ' CZ3' HG23 ' A' ' 95' ' ' VAL . 92.7 m95 -115.84 152.24 33.73 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.978 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.41 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -133.67 156.34 48.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.234 -179.413 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.489 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER 61.83 46.5 0.96 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.881 179.109 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 96.0 Cg_endo -78.36 137.16 14.72 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.421 2.081 . . . . 0.0 111.577 178.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.54 ' O ' HG21 ' A' ' 77' ' ' ILE . 73.4 Cg_endo -91.94 -173.91 0.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.587 2.191 . . . . 0.0 113.545 -178.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.611 HG22 HE22 ' A' ' 125' ' ' GLN . 0.3 OUTLIER -129.17 -171.6 2.53 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.29 177.405 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 5.0 m -144.74 88.37 1.91 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.069 0.461 . . . . 0.0 110.325 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.611 HE22 HG22 ' A' ' 123' ' ' THR . 2.0 mp0 -118.11 -179.04 3.65 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.519 -178.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 32.3 mm . . . . . 0 C--N 1.321 -0.657 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.92 -179.612 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.1 mtm180 . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.899 0.381 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.479 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 28.9 m -91.09 159.85 38.86 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.077 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.0 168.65 23.38 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.661 2.241 . . . . 0.0 111.992 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.0 t -49.39 103.79 0.39 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.733 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.58 157.76 49.52 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.276 1.984 . . . . 0.0 112.051 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.752 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -51.23 -179.55 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.319 179.23 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.745 ' O ' HG22 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -140.62 -7.58 1.12 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -178.057 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 14' ' ' ASP . 15.1 tt 56.87 142.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 121.223 0.535 . . . . 0.0 111.603 -177.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -81.33 -52.61 7.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.602 -178.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.46 ' N ' ' ND2' ' A' ' 17' ' ' ASN . 0.4 OUTLIER -93.07 45.55 1.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.892 0.377 . . . . 0.0 110.922 -178.419 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 176.48 179.99 47.21 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.51 -0.853 . . . . 0.0 113.249 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -138.44 143.08 39.52 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.826 HD13 ' CZ ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -93.63 168.93 10.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.08 0.467 . . . . 0.0 111.125 -179.019 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -126.1 91.73 3.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.843 178.021 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.865 ' HA ' HG23 ' A' ' 31' ' ' ILE . 5.4 mm -68.46 107.08 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.829 -176.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -114.24 22.76 13.37 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.602 177.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 149.67 124.35 1.28 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.068 -0.587 . . . . 0.0 111.945 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.8 m -120.54 38.24 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.871 0.367 . . . . 0.0 111.261 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.4 OUTLIER -111.25 150.36 29.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.6 179.302 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.561 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 8.0 t80 -49.05 91.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.896 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 130.27 -0.36 5.59 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.764 -0.732 . . . . 0.0 113.021 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -92.17 -168.41 1.99 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 117.038 0.419 . . . . 0.0 110.54 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.6 p -160.63 146.88 15.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.064 0.459 . . . . 0.0 111.27 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.865 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.6 OUTLIER -105.02 170.42 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.34 179.625 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -124.36 112.61 17.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.902 0.382 . . . . 0.0 111.09 179.073 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.826 ' CZ ' HD13 ' A' ' 20' ' ' LEU . 12.3 m-85 -87.04 142.5 27.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.602 -179.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.7 m -149.78 159.22 44.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.525 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 16.5 m -77.79 172.9 12.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.814 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -75.4 -83.87 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.262 -179.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.2 t -150.11 137.56 19.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.628 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.461 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 59.34 25.57 60.55 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.909 -179.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.515 ' CE1' ' HB3' ' A' ' 68' ' ' SER . 2.4 m-85 -116.16 168.74 9.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.805 0.336 . . . . 0.0 110.875 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.816 ' CE1' HD11 ' A' ' 42' ' ' ILE . 1.2 p80 -133.74 113.66 12.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.057 177.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.939 HD11 ' HG2' ' A' ' 64' ' ' PRO . 8.3 tt -76.11 135.48 39.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.773 -178.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.816 HD11 ' CE1' ' A' ' 40' ' ' HIS . 1.9 mm -113.89 153.44 15.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.099 0.476 . . . . 0.0 111.16 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.17 -137.48 18.52 Favored Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.135 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.782 ' O ' HD21 ' A' ' 41' ' ' LEU . 2.0 pt-20 -80.61 -178.04 6.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.044 0.449 . . . . 0.0 110.879 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.6 p -158.46 24.79 0.24 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.891 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.416 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 1.6 mtmt -150.73 124.87 9.35 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -177.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.443 ' HB3' HG13 ' A' ' 31' ' ' ILE . 1.7 t -92.51 146.95 23.28 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.593 177.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.525 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.1 m-85 -120.74 113.51 20.3 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 119.139 -1.024 . . . . 0.0 111.683 178.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.409 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 18.7 t -63.74 95.19 0.1 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.154 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -118.47 -171.28 2.05 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.381 -178.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.561 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.031 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 120.901 0.382 . . . . 0.0 110.55 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -148.15 -179.35 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.036 -179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.539 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 78.9 m95 -128.42 122.11 30.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.388 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.525 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -69.11 167.02 23.02 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.82 178.466 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.451 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 84.9 Cg_exo -18.7 93.01 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 125.096 3.864 . . . . 0.0 114.198 -179.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.411 ' CB ' ' OG ' ' A' ' 47' ' ' SER . 0.0 OUTLIER -97.32 -78.79 0.47 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.879 -177.672 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.471 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -75.05 108.4 5.41 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -176.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.939 ' HG2' HD11 ' A' ' 41' ' ' LEU . 3.5 Cg_endo -87.95 -156.73 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.307 2.671 . . . . 0.0 111.028 177.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.662 HD12 ' HB ' ' A' ' 42' ' ' ILE . 1.1 mt -89.2 174.99 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.844 0.354 . . . . 0.0 110.662 178.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.621 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.7 OUTLIER -171.16 145.91 2.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.891 179.45 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.401 ' HB3' ' CD2' ' A' ' 40' ' ' HIS . 31.2 tt0 -160.44 163.15 33.25 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.924 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.515 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 1.4 p -92.82 118.9 31.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.229 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.52 HG13 ' OD2' ' A' ' 91' ' ' ASP . 1.0 OUTLIER -55.14 93.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.861 179.194 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.401 ' CG ' ' O ' ' A' ' 89' ' ' TYR . 1.3 tttt -77.77 135.91 38.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.897 0.38 . . . . 0.0 111.26 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.431 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -106.64 121.78 45.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.143 178.458 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -69.41 -161.41 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.608 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.418 ' OG ' ' NE2' ' A' ' 82' ' ' HIS . 2.7 t -50.07 137.9 19.96 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.653 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.435 ' HA ' ' CD1' ' A' ' 118' ' ' TRP . 39.6 Cg_exo -57.61 159.13 17.64 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.242 1.961 . . . . 0.0 111.908 -179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.504 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 93.7 Cg_exo -42.54 156.88 0.09 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.653 2.235 . . . . 0.0 112.712 -178.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 75.8 p -106.9 89.13 2.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.789 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.603 HG23 ' HE2' ' A' ' 97' ' ' TYR . 33.8 pt -69.72 169.91 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.179 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -92.44 137.44 32.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.731 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.495 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 0.4 OUTLIER 65.05 29.18 12.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.71 -179.788 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -169.43 -167.4 29.94 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.959 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.2 ptt85 -170.18 -174.49 1.75 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.016 0.436 . . . . 0.0 110.462 -179.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 7.5 p80 -108.09 172.43 6.84 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.056 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' A' ' 96' ' ' THR . 63.1 m-20 . . . . . 0 C--N 1.331 -0.222 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.539 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.416 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 12.2 m-85 . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 121.066 0.46 . . . . 0.0 111.308 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.431 ' N ' ' O ' ' A' ' 71' ' ' CYS . 37.7 m-85 -147.03 169.59 18.9 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.761 179.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.1 p -134.21 175.11 9.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.998 0.428 . . . . 0.0 111.647 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.52 ' OD2' HG13 ' A' ' 69' ' ' VAL . 1.3 m-20 -60.25 99.13 0.07 Allowed 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.445 0.641 . . . . 0.0 111.021 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.45 23.36 1.93 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 114.917 -1.038 . . . . 0.0 113.005 178.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.416 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -108.35 161.56 14.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.81 0.338 . . . . 0.0 110.583 179.066 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.489 HG22 ' N ' ' A' ' 95' ' ' VAL . 32.7 m -138.57 157.62 30.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.079 0.466 . . . . 0.0 111.313 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.493 HG23 ' CH2' ' A' ' 118' ' ' TRP . 18.8 t -151.13 148.61 14.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.555 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.776 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -105.3 131.91 52.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.397 179.203 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.958 ' CE1' HG21 ' A' ' 111' ' ' VAL . 3.6 m-85 -89.25 159.31 17.49 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.052 -178.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.7 m -150.22 133.35 16.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.954 0.407 . . . . 0.0 111.567 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.444 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 74.7 m -69.81 162.67 27.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.745 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -96.81 -84.51 0.36 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.928 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -45.31 -27.38 0.65 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.529 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 124.9 36.0 0.61 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.465 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.495 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 18.9 m-85 -75.52 -173.74 2.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.939 0.399 . . . . 0.0 110.915 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.44 107.45 16.23 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.962 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.514 HD22 ' HA ' ' A' ' 109' ' ' SER . 1.1 tp -46.44 118.74 2.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.163 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.526 HG22 ' N ' ' A' ' 107' ' ' GLY . 45.2 mm -104.59 160.8 4.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.883 -179.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.526 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 52.07 38.44 47.66 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.416 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.419 ' ND2' ' O ' ' A' ' 107' ' ' GLY . 8.1 p30 51.58 124.18 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 123.9 0.88 . . . . 0.0 112.693 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.776 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.3 p -56.03 -27.45 53.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.402 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.59 136.06 49.29 Favored Glycine 0 CA--C 1.518 0.239 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.843 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.958 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.2 t -136.61 130.2 46.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.27 125.37 37.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.92 0.391 . . . . 0.0 111.826 -178.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.498 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 16.7 t -87.32 107.88 18.71 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 175.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 7.0 t -154.95 166.98 31.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.988 -178.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 45.54 33.16 4.38 Favored Glycine 0 CA--C 1.516 0.146 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.692 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.453 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 64.83 19.41 65.36 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.565 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -149.32 -177.77 6.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.933 0.397 . . . . 0.0 110.989 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.504 ' CD1' ' HD3' ' A' ' 75' ' ' PRO . 94.8 m95 -113.27 126.26 55.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.87 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.19 145.84 33.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.261 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.495 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.9 OUTLIER 69.3 44.84 0.26 Allowed Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.123 178.84 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 57.0 Cg_endo -70.14 140.27 40.85 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.166 1.911 . . . . 0.0 111.243 178.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.504 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 94.7 Cg_endo -89.53 -170.58 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.624 2.216 . . . . 0.0 113.798 -177.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -140.58 -172.07 3.36 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.001 178.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . 0.403 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 11.8 m -142.37 95.72 2.84 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.007 0.432 . . . . 0.0 110.907 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -128.52 156.85 42.63 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.973 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.494 HG12 ' CE2' ' A' ' 103' ' ' TYR . 25.6 mm . . . . . 0 C--N 1.323 -0.544 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.011 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.446 ' CB ' ' HA ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.163 0 CA-C-O 120.736 0.303 . . . . 0.0 110.435 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.449 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 98.3 m -78.6 156.97 77.74 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.203 -179.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.444 ' HD3' ' HB2' ' A' ' 57' ' ' MET . 60.4 Cg_endo -71.77 177.44 6.94 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.81 2.34 . . . . 0.0 112.533 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 p -48.91 104.67 0.43 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.896 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.459 ' HG2' ' CD1' ' A' ' 22' ' ' ILE . 71.6 Cg_exo -42.71 143.78 1.56 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.396 2.064 . . . . 0.0 112.323 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.569 ' O ' HD11 ' A' ' 20' ' ' LEU . 10.1 mtt180 -58.9 152.37 19.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.056 178.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.539 ' HA ' HD11 ' A' ' 20' ' ' LEU . 1.7 p30 -105.96 178.76 4.47 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 121.338 0.59 . . . . 0.0 112.542 -175.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.0 tt -138.86 147.79 24.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.033 178.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -82.58 -56.2 4.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.779 -177.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.411 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 0.4 OUTLIER -94.48 27.11 3.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.198 -178.303 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.412 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -149.34 -178.65 24.53 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.383 -0.913 . . . . 0.0 113.297 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -139.13 132.16 29.54 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.569 HD11 ' O ' ' A' ' 13' ' ' ARG . 3.6 mt -76.89 160.78 28.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.203 0.525 . . . . 0.0 111.897 -178.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.437 ' HB3' ' CB ' ' A' ' 32' ' ' THR . 17.3 t70 -130.44 74.29 1.59 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.515 177.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.857 ' HA ' HG23 ' A' ' 31' ' ' ILE . 73.2 mt -72.96 101.45 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.017 -177.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.54 20.72 48.45 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.543 176.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.02 145.42 4.16 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 -179.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.42 ' O ' ' HB2' ' A' ' 8' ' ' ARG . 16.6 m -124.83 -6.79 6.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.446 ' HA ' ' CB ' ' A' ' 8' ' ' ARG . 9.1 m-20 -69.8 156.03 39.65 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.931 0.396 . . . . 0.0 111.698 -178.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.74 ' HZ ' HD13 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -48.17 101.48 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.514 178.923 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 119.05 -15.5 11.01 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.441 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.4 m -63.47 166.87 6.07 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.794 0.297 . . . . 0.0 110.293 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 47' ' ' SER . 12.4 p -137.05 147.1 45.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.082 0.467 . . . . 0.0 111.682 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.857 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.4 OUTLIER -113.07 173.77 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.793 -179.807 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.505 HG23 ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -141.99 106.77 4.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.016 178.645 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.557 ' CE1' HD22 ' A' ' 20' ' ' LEU . 20.9 m-85 -76.59 142.37 40.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.043 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.412 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 1.5 m -141.05 165.38 27.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.543 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.445 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 2.3 m -88.56 165.4 14.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.766 0.317 . . . . 0.0 110.768 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -64.78 -84.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.06 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.6 m -153.93 133.45 12.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.728 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.4 ' HA3' ' CB ' ' A' ' 91' ' ' ASP . . . 63.28 24.59 67.52 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.937 -178.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.509 ' CE1' ' HB3' ' A' ' 68' ' ' SER . 2.6 m-85 -116.72 171.48 7.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.859 0.361 . . . . 0.0 110.906 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.81 ' CE1' HD11 ' A' ' 42' ' ' ILE . 1.0 OUTLIER -134.57 116.17 14.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.624 178.173 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.954 HD21 ' O ' ' A' ' 44' ' ' GLU . 4.6 tt -74.24 127.64 33.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.606 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.81 HD11 ' CE1' ' A' ' 40' ' ' HIS . 3.1 mm -100.94 151.24 5.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.836 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.45 -140.03 23.9 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.691 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.954 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -70.68 175.38 4.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.948 0.404 . . . . 0.0 110.997 179.857 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.431 ' HA ' ' HG2' ' A' ' 64' ' ' PRO . 0.4 OUTLIER -157.77 26.84 0.27 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.296 179.289 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.505 ' HG2' HG23 ' A' ' 32' ' ' THR . 6.6 mtpt -149.97 151.84 33.99 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.998 -179.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.417 ' OG ' ' HB ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -132.25 143.12 49.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.125 179.51 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.511 ' CE2' ' HD3' ' A' ' 61' ' ' PRO . 2.7 m-85 -117.0 125.8 51.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.176 0.512 . . . . 0.0 111.892 -178.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.515 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 24.4 t -73.91 117.13 15.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.695 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.495 ' HA ' ' CE2' ' A' ' 27' ' ' PHE . 12.9 tt0 -160.38 167.58 27.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.424 0.631 . . . . 0.0 111.016 178.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.74 HD13 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.807 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.433 -178.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.592 ' O ' HG13 ' A' ' 58' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.354 0 CA-C-O 121.029 0.442 . . . . 0.0 110.48 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.592 HG13 ' O ' ' A' ' 57' ' ' MET . 2.4 m -160.44 -176.83 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.28 -178.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.82 ' CE3' HD11 ' A' ' 31' ' ' ILE . 92.2 m95 -133.56 126.01 30.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.137 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -149.61 123.68 4.62 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.589 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.511 ' HD3' ' CE2' ' A' ' 48' ' ' TYR . 23.2 Cg_exo -68.65 -174.69 8.68 Favored 'Cis proline' 0 C--N 1.35 0.633 0 C-N-CA 124.287 -1.13 . . . . 0.0 113.055 2.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.1 -143.05 0.39 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.861 -178.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.532 ' CB ' ' CE1' ' A' ' 33' ' ' TYR . . . -86.4 116.51 66.14 Favored Pre-proline 0 CA--C 1.53 0.187 0 CA-C-O 120.407 0.146 . . . . 0.0 111.008 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.545 ' HG2' HD11 ' A' ' 41' ' ' LEU . 11.5 Cg_exo -72.95 -151.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.645 2.23 . . . . 0.0 112.582 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.488 HG22 ' H ' ' A' ' 66' ' ' CYS . 4.5 mm -101.45 166.34 2.47 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-O 121.02 0.438 . . . . 0.0 111.486 -178.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.488 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.3 m -163.61 120.3 1.75 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.379 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.32 171.04 15.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.992 0.425 . . . . 0.0 111.318 -178.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.509 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 8.9 p -93.22 103.18 15.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.848 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.791 HG22 ' HA3' ' A' ' 116' ' ' GLY . 2.7 p -59.46 89.3 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.478 179.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 89' ' ' TYR . 5.4 tttt -63.8 154.22 34.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.558 -0.747 . . . . 0.0 112.184 -177.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.416 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -118.88 127.01 53.1 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.77 177.559 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.413 ' CG ' ' N ' ' A' ' 73' ' ' SER . 0.1 OUTLIER -73.93 -160.48 0.09 Allowed 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.488 179.89 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.413 ' N ' ' CG ' ' A' ' 72' ' ' GLN . 2.7 t -50.21 137.49 21.33 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.505 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.493 ' HD2' ' CD2' ' A' ' 82' ' ' HIS . 37.9 Cg_exo -56.33 162.57 7.64 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.167 1.911 . . . . 0.0 111.574 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.507 ' HD3' ' CG ' ' A' ' 118' ' ' TRP . 82.2 Cg_exo -39.92 156.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.726 2.284 . . . . 0.0 112.571 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.7 m -107.89 89.05 2.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.894 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.571 HG21 ' O ' ' A' ' 122' ' ' PRO . 13.5 pt -69.7 173.92 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.002 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.0 m -95.77 138.76 32.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.878 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.506 ' HB3' ' CD2' ' A' ' 103' ' ' TYR . 3.9 m-80 60.16 28.97 18.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.989 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.498 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -160.26 -170.75 25.25 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.149 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.26 -175.15 3.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.046 0.45 . . . . 0.0 110.858 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.493 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 34.8 p-80 -112.92 169.03 9.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.889 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.417 ' ND2' ' HB ' ' A' ' 96' ' ' THR . 1.2 m-20 . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.793 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.419 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 10.7 m-85 . . . . . 0 N--CA 1.456 -0.165 0 CA-C-O 120.911 0.386 . . . . 0.0 110.938 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.423 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 40.6 m-85 -147.0 165.11 30.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.444 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 17.0 p -129.22 172.09 11.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.005 0.431 . . . . 0.0 111.55 -179.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 0.9 OUTLIER -58.74 97.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.889 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.69 14.87 2.75 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.195 -0.911 . . . . 0.0 113.093 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.98 158.31 15.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.909 0.355 . . . . 0.0 110.393 179.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.419 HG22 ' N ' ' A' ' 95' ' ' VAL . 27.0 m -133.77 156.11 40.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.072 0.463 . . . . 0.0 111.231 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.474 HG23 ' CH2' ' A' ' 118' ' ' TRP . 38.7 t -149.72 150.86 13.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.615 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.983 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -108.22 133.6 52.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.963 0.411 . . . . 0.0 110.53 179.112 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.944 ' CE1' HG21 ' A' ' 111' ' ' VAL . 5.9 m-85 -93.28 155.84 17.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.044 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 20.0 p -152.83 144.32 23.37 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.147 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.459 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 68.5 m -72.95 158.87 34.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.251 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 -86.91 -71.09 0.57 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.692 -178.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 40.5 t -68.39 -21.72 64.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.612 -178.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 123.85 32.42 0.87 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.66 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.506 ' CD2' ' HB3' ' A' ' 79' ' ' ASN . 30.6 m-85 -69.6 -171.85 0.42 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.768 0.318 . . . . 0.0 110.277 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.7 p -107.35 106.06 16.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.975 0.417 . . . . 0.0 111.168 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.598 HD23 ' HB2' ' A' ' 122' ' ' PRO . 3.0 tp -46.92 108.85 0.16 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.702 178.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.488 HG22 ' N ' ' A' ' 107' ' ' GLY . 31.8 mm -84.1 158.35 3.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.651 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.488 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 59.81 -123.16 32.36 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.258 -0.973 . . . . 0.0 111.795 -178.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -125.82 132.91 52.15 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.796 0.331 . . . . 0.0 110.766 178.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.983 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.2 p -66.37 -31.54 72.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.401 179.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.64 136.92 22.69 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.526 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.944 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.9 t -126.54 153.37 35.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 179.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.39 118.36 35.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.903 0.382 . . . . 0.0 111.597 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.508 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 15.1 t -85.55 97.75 10.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.615 176.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 1.0 OUTLIER -132.54 151.1 52.03 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.556 -177.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 48.01 29.77 6.77 Favored Glycine 0 C--N 1.329 0.187 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.745 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.791 ' HA3' HG22 ' A' ' 69' ' ' VAL . . . 79.95 -5.06 63.4 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.936 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -121.17 175.11 6.27 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.93 0.395 . . . . 0.0 110.866 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.508 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 87.2 m95 -112.5 152.27 28.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.895 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.27 147.12 49.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.021 0.438 . . . . 0.0 111.466 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.492 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER 70.07 46.11 0.27 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.161 178.546 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.492 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 74.1 Cg_endo -75.37 139.49 23.42 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.382 2.055 . . . . 0.0 111.623 178.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.598 ' HB2' HD23 ' A' ' 105' ' ' LEU . 57.3 Cg_endo -89.22 -174.52 0.96 Allowed 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.574 2.182 . . . . 0.0 113.559 -178.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.469 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -132.27 -171.75 2.72 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.845 -1.071 . . . . 0.0 109.834 177.829 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 10.4 m -146.3 93.93 2.38 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.0 0.428 . . . . 0.0 111.214 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -119.54 169.54 9.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.878 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.479 HG12 ' CE1' ' A' ' 103' ' ' TYR . 28.3 mm . . . . . 0 C--N 1.323 -0.547 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.944 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.419 ' HD3' HG23 ' A' ' 25' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.785 0.326 . . . . 0.0 110.507 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.477 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 53.6 m -77.85 159.61 75.94 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.664 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.15 169.86 17.17 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.504 2.136 . . . . 0.0 112.305 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 p -50.55 106.38 0.63 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.832 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.47 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 52.2 Cg_exo -43.23 152.92 0.22 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.262 1.974 . . . . 0.0 112.249 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.905 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -70.05 154.75 41.54 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.056 0.455 . . . . 0.0 110.424 178.685 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -97.59 -176.47 3.49 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.889 -176.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.591 HG22 ' CD2' ' A' ' 20' ' ' LEU . 18.6 tt -151.45 144.75 16.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.961 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.418 ' HB3' ' ND2' ' A' ' 17' ' ' ASN . 7.4 t0 -86.57 159.25 19.31 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.108 -0.497 . . . . 0.0 109.974 178.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.499 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 0.1 OUTLIER 43.15 29.63 0.22 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.89 0.376 . . . . 0.0 111.051 -179.445 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -155.02 173.42 33.34 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.629 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -137.53 135.18 36.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.763 0.316 . . . . 0.0 110.589 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.905 HD11 ' O ' ' A' ' 13' ' ' ARG . 14.0 mt -79.27 159.91 27.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.445 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.42 ' HB3' ' CB ' ' A' ' 32' ' ' THR . 34.9 t0 -131.31 75.48 1.66 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.366 178.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.876 ' HA ' HG23 ' A' ' 31' ' ' ILE . 58.3 mt -70.98 118.38 15.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.134 0.492 . . . . 0.0 111.994 -178.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -128.47 19.83 5.6 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.696 177.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 160.12 117.84 0.48 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.175 -0.536 . . . . 0.0 111.94 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.419 HG23 ' HD3' ' A' ' 8' ' ' ARG . 17.4 m -114.47 24.85 4.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.692 0.282 . . . . 0.0 111.554 -178.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -100.97 146.47 27.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.703 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.539 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 5.7 t80 -48.23 97.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.062 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.18 5.58 5.59 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.074 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.58 -158.69 0.69 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 117.037 0.419 . . . . 0.0 110.79 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.2 p -168.62 146.63 4.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.048 0.451 . . . . 0.0 111.413 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.876 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.7 OUTLIER -105.89 167.58 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.225 179.51 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.42 ' CB ' ' HB3' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -127.85 121.31 29.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.802 0.334 . . . . 0.0 110.738 179.001 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.693 ' CE1' HD21 ' A' ' 20' ' ' LEU . 14.1 m-85 -95.51 149.09 21.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.519 -179.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.19 155.82 39.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.771 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.432 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 2.9 m -81.99 169.53 16.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.819 0.342 . . . . 0.0 110.867 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -70.56 -84.97 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.157 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.6 m -153.14 131.91 12.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.933 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.71 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 68.19 21.22 73.74 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.15 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.499 ' CE2' ' HB3' ' A' ' 17' ' ' ASN . 2.5 m-85 -113.46 175.97 5.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.793 0.33 . . . . 0.0 110.868 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.929 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.5 OUTLIER -140.15 113.59 8.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.516 178.662 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.936 HD21 ' O ' ' A' ' 44' ' ' GLU . 6.7 tt -79.5 121.33 25.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.829 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.929 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.2 mm -99.23 168.43 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.129 -179.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.544 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 69.13 -134.1 26.84 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.374 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.936 ' O ' HD21 ' A' ' 41' ' ' LEU . 2.2 pm0 -79.75 -173.05 3.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.766 0.317 . . . . 0.0 110.603 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.2 t -166.66 28.84 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.605 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.409 ' HG3' ' HA ' ' A' ' 32' ' ' THR . 1.1 mtpt -159.76 127.65 4.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.327 -178.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.436 ' OG ' ' CB ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -93.0 143.67 26.01 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.906 178.323 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.534 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.6 m-85 -118.69 114.5 22.82 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.507 178.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.463 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 21.8 t -69.86 99.4 1.38 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.565 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -120.38 -172.17 2.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.098 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.539 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.953 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.412 ' O ' HG13 ' A' ' 58' ' ' VAL . 4.6 mmt . . . . . 0 N--CA 1.455 -0.201 0 CA-C-O 120.96 0.41 . . . . 0.0 110.7 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 57' ' ' MET . 1.4 m -155.52 175.34 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.823 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.549 ' CE3' HD11 ' A' ' 31' ' ' ILE . 79.2 m95 -128.51 121.86 29.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.598 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.534 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -69.52 167.34 23.17 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.342 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.489 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 68.4 Cg_exo -14.58 92.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.872 1 C-N-CA 125.339 4.026 . . . . 0.0 114.622 -178.656 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.479 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -90.81 -75.78 0.46 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.338 -177.4 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.419 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . . . -91.8 108.17 27.87 Favored Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -175.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.897 ' HG2' HD11 ' A' ' 41' ' ' LEU . 4.7 Cg_exo -81.47 -154.15 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.083 2.522 . . . . 0.0 111.123 177.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.504 HG22 ' H ' ' A' ' 66' ' ' CYS . 3.8 mm -88.81 166.03 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.782 0.325 . . . . 0.0 110.438 177.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.504 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.8 OUTLIER -169.32 129.82 1.08 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.605 179.783 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -155.74 173.5 16.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.135 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.493 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 5.2 p -85.4 117.25 24.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.627 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.71 HG12 ' O ' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -42.44 94.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.344 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.489 ' CD ' ' HB3' ' A' ' 88' ' ' PHE . 4.3 ttpt -80.15 131.72 35.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.285 -178.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.432 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -107.08 130.0 54.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.901 -179.285 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.3 -158.48 0.06 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.443 178.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.567 ' HG ' ' CE1' ' A' ' 82' ' ' HIS . 2.0 t -49.98 135.89 21.1 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.842 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.499 ' HG2' HG11 ' A' ' 95' ' ' VAL . 31.8 Cg_exo -56.69 162.92 7.79 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.393 2.062 . . . . 0.0 112.053 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.516 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 87.8 Cg_exo -42.44 156.68 0.09 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.715 2.277 . . . . 0.0 112.776 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 65.1 p -106.01 90.09 3.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.406 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.688 HG23 ' HE1' ' A' ' 97' ' ' TYR . 25.0 pt -69.32 172.54 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.37 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 124' ' ' CYS . 3.0 p -94.98 143.9 26.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.509 179.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.501 ' HB3' ' CE1' ' A' ' 103' ' ' TYR . 2.7 m-80 58.58 28.59 17.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.86 0.362 . . . . 0.0 111.084 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -171.82 -167.54 32.11 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.498 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 10.2 ptt85 -166.54 -176.6 3.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.966 0.413 . . . . 0.0 111.168 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.567 ' CE1' ' HG ' ' A' ' 73' ' ' SER . 25.3 p-80 -103.08 175.16 5.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.038 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.31 179.047 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.489 ' HB3' ' CD ' ' A' ' 70' ' ' LYS . 19.2 m-85 . . . . . 0 N--CA 1.456 -0.175 0 CA-C-O 120.664 0.269 . . . . 0.0 111.077 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.462 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 84.5 m-85 -157.41 169.95 23.56 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.734 -178.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 11.4 p -134.0 178.59 6.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.909 0.385 . . . . 0.0 111.407 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.409 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 28.5 p-10 -62.74 94.77 0.07 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.298 0.571 . . . . 0.0 111.026 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.56 29.53 0.9 Allowed Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.983 179.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.11 163.88 13.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.691 0.282 . . . . 0.0 110.57 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 33.9 m -138.76 150.73 23.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.103 0.478 . . . . 0.0 111.307 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.51 HG23 ' CH2' ' A' ' 118' ' ' TRP . 20.1 t -145.81 147.06 18.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.635 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.963 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -105.76 130.59 53.73 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.893 179.956 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.94 ' CE2' HG21 ' A' ' 111' ' ' VAL . 5.0 m-85 -89.77 160.55 16.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.069 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 82.4 p -156.47 139.26 15.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.078 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.426 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 62.8 m -70.94 160.11 33.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.076 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 -80.85 -81.96 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.299 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.14 -30.99 70.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.214 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 132.57 39.81 0.22 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.645 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.523 ' HE2' HD11 ' A' ' 126' ' ' ILE . 49.7 m-85 -69.51 -174.27 0.67 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.807 0.337 . . . . 0.0 110.545 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 67.3 m -104.97 101.2 10.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.699 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.494 HD21 ' HA ' ' A' ' 109' ' ' SER . 0.2 OUTLIER -50.69 122.18 6.89 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.475 0.655 . . . . 0.0 111.428 -178.713 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.43 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 30.9 mm -91.3 155.43 3.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.943 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.76 -127.53 36.51 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.922 -178.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -126.19 138.59 53.66 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.799 0.333 . . . . 0.0 111.065 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.963 ' OG ' HG22 ' A' ' 96' ' ' THR . 5.7 p -64.79 -32.25 73.85 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.656 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -71.49 138.34 27.37 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.929 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.94 HG21 ' CE2' ' A' ' 97' ' ' TYR . 2.7 t -133.31 119.66 36.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.543 0.211 . . . . 0.0 110.591 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.5 125.79 30.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.889 0.376 . . . . 0.0 111.554 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.504 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 34.7 t -90.22 102.81 15.53 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 176.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 9.0 t -144.22 161.0 40.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.111 0.482 . . . . 0.0 111.308 -178.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.433 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 45.23 33.37 4.0 Favored Glycine 0 CA--C 1.518 0.252 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.912 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.463 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 66.39 16.99 65.83 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.538 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -139.98 178.05 7.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.781 0.324 . . . . 0.0 110.608 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.516 ' CD1' ' HD3' ' A' ' 75' ' ' PRO . 94.5 m95 -116.01 138.18 51.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.926 -179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.72 146.68 46.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.214 -179.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.475 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 3.2 t0 71.02 46.05 0.25 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.074 178.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 97.2 Cg_endo -78.63 134.69 12.43 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.322 2.015 . . . . 0.0 111.379 177.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.459 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 53.7 Cg_endo -87.05 -177.65 2.26 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.374 2.05 . . . . 0.0 113.412 -178.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 105' ' ' LEU . 0.2 OUTLIER -134.2 177.85 7.42 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.542 178.312 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 78' ' ' SER . 12.5 m -132.93 106.68 7.83 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.312 0.577 . . . . 0.0 110.95 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.497 ' C ' HD12 ' A' ' 126' ' ' ILE . 13.7 mt-30 -114.79 -175.87 2.78 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.437 -178.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.791 ' N ' HD12 ' A' ' 126' ' ' ILE . 1.6 mp . . . . . 0 C--N 1.32 -0.68 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.618 -177.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.402 ' HA ' ' HA ' ' A' ' 26' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.78 0.324 . . . . 0.0 110.736 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.449 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 60.6 m -104.78 158.74 31.36 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.9 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.444 ' HD3' ' HB2' ' A' ' 57' ' ' MET . 57.8 Cg_endo -68.91 170.98 14.32 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.362 2.041 . . . . 0.0 110.883 178.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.1 p -53.2 123.53 35.04 Favored Pre-proline 0 N--CA 1.448 -0.525 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.633 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -58.61 158.24 24.48 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.737 2.291 . . . . 0.0 112.338 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.809 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -70.81 142.96 51.29 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.474 178.779 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.417 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 0.7 OUTLIER -83.62 -171.06 3.38 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.417 -177.624 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.671 HG22 ' CD2' ' A' ' 20' ' ' LEU . 20.2 tt -155.97 143.89 11.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.394 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -90.93 158.77 16.55 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.764 177.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.498 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 0.4 OUTLIER 48.27 26.02 0.99 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.825 0.345 . . . . 0.0 110.656 -179.463 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.413 ' HA2' ' N ' ' A' ' 36' ' ' ASN . . . -157.56 -178.6 31.76 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.589 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -146.06 134.43 21.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.672 0.273 . . . . 0.0 110.887 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.809 HD11 ' O ' ' A' ' 13' ' ' ARG . 20.1 mt -78.61 155.18 29.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.986 0.422 . . . . 0.0 111.353 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.44 ' CB ' ' HB ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -124.01 72.65 1.17 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.444 177.203 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.889 ' HA ' HG23 ' A' ' 31' ' ' ILE . 1.1 mt -69.93 101.17 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.008 -176.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.9 17.25 57.55 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.718 176.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 154.96 151.5 5.86 Favored Glycine 0 C--N 1.333 0.382 0 N-CA-C 111.659 -0.576 . . . . 0.0 111.659 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.402 ' O ' ' HB2' ' A' ' 8' ' ' ARG . 23.3 m -133.76 13.61 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 1.8 p-10 -85.5 157.18 20.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.849 0.356 . . . . 0.0 111.094 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.485 ' CZ ' ' HG ' ' A' ' 51' ' ' LEU . 5.9 t80 -51.38 103.34 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.785 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 115.28 -1.51 22.35 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.888 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 94.4 p -78.94 -176.72 5.17 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 116.984 0.392 . . . . 0.0 110.435 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.3 p -151.91 156.36 39.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.936 0.398 . . . . 0.0 111.376 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.889 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.8 OUTLIER -122.37 166.55 16.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.827 -179.713 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.44 ' HB ' ' CB ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -128.89 114.48 16.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.782 179.13 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.474 ' CE2' HD21 ' A' ' 20' ' ' LEU . 31.3 m-85 -88.58 145.01 25.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.979 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -148.41 166.17 28.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.113 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.414 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 1.3 m -89.64 158.79 17.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.716 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.424 ' ND2' ' HA ' ' A' ' 17' ' ' ASN . 15.5 m-20 -58.02 -88.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.31 -178.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.9 t -151.86 133.39 14.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.882 0.372 . . . . 0.0 110.822 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.41 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 69.01 18.49 72.81 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.233 -179.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.498 ' CE1' ' HB3' ' A' ' 17' ' ' ASN . 2.7 m-30 -112.6 -177.93 3.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.911 0.386 . . . . 0.0 110.786 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.818 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -142.08 110.85 6.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.008 177.041 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.941 HD21 ' O ' ' A' ' 44' ' ' GLU . 2.9 tt -72.57 125.19 26.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.336 -178.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.818 HD11 ' CE1' ' A' ' 40' ' ' HIS . 1.7 mm -106.2 165.7 3.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.111 0.482 . . . . 0.0 111.274 -178.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.487 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 70.31 -123.16 11.75 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.305 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.941 ' O ' HD21 ' A' ' 41' ' ' LEU . 1.3 mt-10 -80.77 174.58 11.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.194 0.521 . . . . 0.0 112.019 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.2 p -156.37 19.03 0.35 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.474 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.412 ' HG2' ' O ' ' A' ' 31' ' ' ILE . 8.8 mtpt -159.97 152.05 20.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.059 0.457 . . . . 0.0 112.075 -177.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -121.25 152.73 38.54 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.031 177.986 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.502 ' CB ' ' HB2' ' A' ' 60' ' ' ASN . 1.4 m-85 -131.36 115.13 15.84 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 119.135 -1.026 . . . . 0.0 112.173 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 28.0 t -66.12 109.02 2.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.763 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -133.27 -173.3 3.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.173 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.485 ' HG ' ' CZ ' ' A' ' 27' ' ' PHE . 7.4 mt . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.242 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.444 ' HB2' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.752 0.311 . . . . 0.0 110.801 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.1 -176.95 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.861 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.644 ' CE3' HD11 ' A' ' 31' ' ' ILE . 65.8 m95 -132.01 131.95 42.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.744 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.502 ' HB2' ' CB ' ' A' ' 48' ' ' TYR . 1.0 OUTLIER -69.92 162.62 67.17 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.08 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.474 ' O ' ' HA ' ' A' ' 47' ' ' SER . 21.4 Cg_exo -7.8 109.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.755 1 C-N-CA 125.888 4.392 . . . . 0.0 115.267 -178.189 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.424 ' HA ' ' OG ' ' A' ' 47' ' ' SER . 3.9 mt-10 -98.09 -113.73 0.15 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 114.901 -1.045 . . . . 0.0 112.513 -176.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.449 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -69.25 107.71 2.41 Favored Pre-proline 0 C--N 1.34 0.168 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -176.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.577 ' HG2' HD11 ' A' ' 41' ' ' LEU . 2.2 Cg_endo -81.53 -153.98 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.924 2.416 . . . . 0.0 110.298 176.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.661 HD12 ' HB ' ' A' ' 42' ' ' ILE . 0.3 OUTLIER -86.04 170.73 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.327 0.584 . . . . 0.0 111.573 -179.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.568 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.5 OUTLIER -172.24 141.47 1.25 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.042 179.805 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -169.7 167.8 9.33 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.801 0.334 . . . . 0.0 111.202 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.496 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 2.8 p -77.54 121.85 24.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.247 178.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.702 HG13 ' OD2' ' A' ' 91' ' ' ASP . 1.4 p -40.52 96.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.139 0.495 . . . . 0.0 111.582 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.521 ' HG2' ' CD2' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -92.37 127.53 37.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.172 -178.013 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.43 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -100.29 132.02 45.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.998 -179.001 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -75.81 -159.55 0.11 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.599 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.433 ' HG ' ' CE1' ' A' ' 82' ' ' HIS . 1.9 t -48.44 136.83 12.29 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.04 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.487 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 25.7 Cg_exo -60.59 159.02 29.6 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.351 2.034 . . . . 0.0 112.225 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.427 ' HG2' ' HD3' ' A' ' 121' ' ' PRO . 81.1 Cg_exo -44.78 159.69 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.982 2.455 . . . . 0.0 113.275 -178.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.6 m -108.8 93.11 4.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.516 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.493 HG23 ' CE1' ' A' ' 97' ' ' TYR . 22.4 pt -68.5 175.2 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.249 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.2 p -94.32 137.36 33.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.877 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.503 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 0.1 OUTLIER 68.47 26.87 6.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.879 179.521 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.454 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . -171.84 -164.78 27.99 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.263 -0.97 . . . . 0.0 113.216 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.422 ' N ' ' O ' ' A' ' 98' ' ' SER . 4.9 ptt85 -162.06 -175.1 4.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.044 0.45 . . . . 0.0 110.705 -179.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.433 ' CE1' ' HG ' ' A' ' 73' ' ' SER . 19.6 p-80 -111.14 169.53 8.72 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.71 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.709 179.82 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.521 ' CD2' ' HG2' ' A' ' 70' ' ' LYS . 24.8 m-85 . . . . . 0 N--CA 1.455 -0.217 0 CA-C-O 120.719 0.295 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.468 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 89.2 m-85 -157.17 165.57 35.6 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.419 -178.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.0 p -136.56 -176.4 4.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.072 0.463 . . . . 0.0 111.717 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.702 ' OD2' HG13 ' A' ' 69' ' ' VAL . 2.1 m-20 -63.03 96.64 0.1 Allowed 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.255 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.94 26.54 1.36 Allowed Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.288 -0.869 . . . . 0.0 113.035 178.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.408 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -110.17 162.92 14.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.817 0.341 . . . . 0.0 110.801 179.374 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 36.0 m -144.29 149.44 17.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.135 0.493 . . . . 0.0 111.125 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.514 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 18.1 t -141.1 146.97 22.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.559 179.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.99 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -102.08 136.78 41.32 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.816 -179.764 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.883 ' CE2' HG21 ' A' ' 111' ' ' VAL . 5.8 m-85 -98.81 156.17 17.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.147 -179.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.422 ' O ' ' N ' ' A' ' 81' ' ' ARG . 1.3 p -148.07 141.42 25.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.57 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.454 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 12.1 m -69.38 162.43 27.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.281 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -97.02 -69.07 0.77 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.092 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.75 -28.81 69.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.01 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.36 36.79 0.48 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.548 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.519 ' CE2' HG12 ' A' ' 126' ' ' ILE . 18.2 m-85 -74.27 -171.77 1.26 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.756 0.312 . . . . 0.0 110.664 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.6 m -117.54 101.05 8.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.759 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.691 HD21 ' HG2' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -49.0 132.79 18.7 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.594 0.711 . . . . 0.0 111.155 -179.739 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.449 ' HB ' ' CB ' ' A' ' 123' ' ' THR . 36.1 mm -101.82 156.98 4.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.59 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.434 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 67.35 -126.47 25.37 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.958 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -125.79 127.06 45.54 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.054 0.454 . . . . 0.0 110.931 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.99 ' OG ' HG22 ' A' ' 96' ' ' THR . 3.6 p -59.34 -27.93 66.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.728 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -72.47 121.39 8.08 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.75 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.883 HG21 ' CE2' ' A' ' 97' ' ' TYR . 11.6 t -113.99 116.03 51.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.5 126.61 31.18 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -177.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.5 ' HB2' ' CZ3' ' A' ' 118' ' ' TRP . 41.8 t -91.07 104.12 16.74 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 19.3 t -141.1 150.72 43.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.078 0.466 . . . . 0.0 111.406 -178.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.598 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 46.68 43.24 15.58 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.767 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.468 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 62.32 14.14 46.7 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.647 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -135.11 173.25 11.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.023 0.44 . . . . 0.0 110.679 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.514 ' CZ3' HG23 ' A' ' 95' ' ' VAL . 95.8 m95 -115.48 128.1 55.78 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.527 -178.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.488 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 0.3 OUTLIER -91.81 130.39 37.6 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.663 175.04 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.626 ' HB2' HG13 ' A' ' 111' ' ' VAL . 2.8 m-20 108.92 -132.1 0.0 OUTLIER Pre-proline 0 CA--C 1.475 -1.907 0 N-CA-C 100.41 -3.922 . . . . 0.0 100.41 -167.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.553 ' HA ' ' CB ' ' A' ' 120' ' ' ASP . 60.4 Cg_endo -63.52 -179.53 7.77 Favored 'Cis proline' 0 C--N 1.309 -1.54 0 CA-C-N 125.157 2.878 . . . . 0.0 112.717 -17.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.691 ' HG2' HD21 ' A' ' 105' ' ' LEU . 18.0 Cg_endo -87.94 -179.51 2.53 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 123.023 2.482 . . . . 0.0 111.32 176.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.449 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -109.12 -162.6 0.82 Allowed 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.13 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . 0.427 ' SG ' ' HB2' ' A' ' 103' ' ' TYR . 5.0 t -170.25 85.83 0.12 Allowed 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.904 -176.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -114.61 176.74 4.92 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.909 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.66 HG22 ' O ' ' A' ' 126' ' ' ILE . 26.4 mm . . . . . 0 C--N 1.322 -0.615 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.718 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.874 0.368 . . . . 0.0 110.731 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.467 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 37.9 m -81.33 160.06 66.02 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.874 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.89 174.44 9.62 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.454 2.103 . . . . 0.0 111.961 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -51.11 109.57 1.41 Allowed Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.794 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.41 162.38 14.85 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.258 1.972 . . . . 0.0 111.977 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.575 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -52.11 -175.02 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.447 179.318 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.422 ' O ' HG13 ' A' ' 15' ' ' ILE . 0.4 OUTLIER -140.05 6.53 2.18 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.041 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.936 HD13 ' CD2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER 57.8 -165.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.067 -177.635 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -125.79 -70.88 0.72 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.929 0.395 . . . . 0.0 110.613 178.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.482 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -99.2 29.02 4.11 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.941 178.605 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.43 ' HA2' ' N ' ' A' ' 36' ' ' ASN . . . -137.93 -175.66 14.03 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.214 -178.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -133.75 145.35 49.74 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.672 0.272 . . . . 0.0 110.747 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.789 HD22 HD11 ' A' ' 15' ' ' ILE . 4.9 mt -82.67 155.55 24.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.207 0.527 . . . . 0.0 111.797 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.416 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 4.5 t0 -129.91 68.5 1.44 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.92 175.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.879 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.9 OUTLIER -74.95 116.95 18.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.49 -175.796 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -116.05 19.57 13.5 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.227 175.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 161.0 125.99 0.8 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.007 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.6 m -112.44 5.79 8.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 15.8 t70 -88.46 165.42 14.91 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.871 0.367 . . . . 0.0 110.871 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -57.76 116.71 3.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.635 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.45 5.9 36.42 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.833 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 89.7 p -94.14 -169.59 2.1 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.856 0.328 . . . . 0.0 110.307 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.9 p -165.88 141.66 5.0 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.125 0.488 . . . . 0.0 111.1 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.879 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.6 OUTLIER -106.14 164.38 4.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.209 -179.898 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.424 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -121.86 118.18 28.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.952 0.406 . . . . 0.0 110.671 179.034 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.936 ' CD2' HD13 ' A' ' 15' ' ' ILE . 6.1 m-85 -90.97 135.63 33.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.784 -178.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.9 m -146.97 157.55 43.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.694 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.42 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 1.9 m -79.58 167.56 20.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.846 0.355 . . . . 0.0 110.869 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.43 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 11.1 m-20 -67.15 -84.13 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.971 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.96 134.52 11.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.699 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.29 24.27 73.47 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.897 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.53 ' CE2' ' CB ' ' A' ' 68' ' ' SER . 2.7 m-30 -119.73 174.52 6.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.887 0.375 . . . . 0.0 110.908 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.904 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.6 OUTLIER -134.53 117.12 15.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.364 177.78 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.84 HD21 ' O ' ' A' ' 44' ' ' GLU . 5.7 tt -81.75 127.47 32.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.337 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.904 HD11 ' CE1' ' A' ' 40' ' ' HIS . 1.9 mm -106.09 149.49 9.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.275 -178.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.71 -141.4 19.5 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.369 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.84 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.9 OUTLIER -74.04 -172.94 1.47 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.903 0.383 . . . . 0.0 110.79 179.53 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.8 p -161.69 22.73 0.12 Allowed 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.392 -179.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.424 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 1.1 mtpt -153.31 125.47 7.98 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -177.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.453 ' CB ' ' HA ' ' A' ' 62' ' ' GLU . 0.3 OUTLIER -94.61 145.43 24.84 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.092 178.111 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.537 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.8 m-85 -120.89 120.5 35.7 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 119.315 -0.954 . . . . 0.0 111.797 178.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 26.5 t -68.74 117.66 10.73 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.156 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -156.61 -179.45 8.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.992 179.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.5 ' C ' HD12 ' A' ' 51' ' ' LEU . 4.6 pp . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.656 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.217 0 CA-C-O 121.088 0.47 . . . . 0.0 110.87 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.1 m -149.28 -176.09 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.541 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.56 ' CZ3' HD11 ' A' ' 31' ' ' ILE . 69.7 m95 -131.48 124.96 31.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.988 0.423 . . . . 0.0 111.261 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.537 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 4.8 m-20 -68.4 166.61 24.03 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.439 178.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.47 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 49.3 Cg_exo -12.63 86.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.008 1 C-N-CA 125.361 4.041 . . . . 0.0 114.211 -178.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.496 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.5 OUTLIER -90.26 -76.58 0.42 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.723 -176.236 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.464 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -94.22 108.23 34.51 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -173.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.787 ' HG2' HD11 ' A' ' 41' ' ' LEU . 2.3 Cg_endo -81.41 -154.34 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.189 2.592 . . . . 0.0 110.368 175.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.677 HD12 ' HB ' ' A' ' 42' ' ' ILE . 1.0 OUTLIER -93.19 175.2 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.602 177.767 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.61 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.8 OUTLIER -171.46 144.31 1.92 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.609 179.718 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.417 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 1.3 tt0 -166.73 175.08 8.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.86 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.53 ' CB ' ' CE2' ' A' ' 39' ' ' TYR . 0.2 OUTLIER -99.41 123.4 43.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.658 178.944 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.438 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 1.4 p -45.27 92.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.093 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 68' ' ' SER . 2.4 mmtp -63.99 131.95 49.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.199 -177.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.12 121.0 40.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.62 177.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.3 -159.5 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.655 -179.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.465 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 2.7 t -51.33 139.67 25.9 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.589 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.466 ' HG2' HG11 ' A' ' 95' ' ' VAL . 26.4 Cg_exo -59.22 159.67 21.81 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.201 1.934 . . . . 0.0 111.918 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.492 ' HD3' ' CG ' ' A' ' 118' ' ' TRP . 88.9 Cg_exo -39.79 156.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.934 2.422 . . . . 0.0 113.04 -178.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.1 t -107.97 90.81 3.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.796 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.597 HG23 ' HE2' ' A' ' 97' ' ' TYR . 21.4 pt -69.51 -176.68 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.287 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.6 m -105.25 145.74 30.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.662 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.47 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 7.4 m-80 55.56 28.35 11.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.929 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.471 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -167.52 -163.2 20.99 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.563 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 9.5 ptt180 -170.15 -175.72 2.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.039 0.447 . . . . 0.0 110.971 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.465 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 1.6 p-80 -110.46 168.2 9.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.868 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.636 179.9 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.421 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 7.8 m-85 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.86 0.362 . . . . 0.0 111.106 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.421 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 48.6 m-85 -148.11 165.01 32.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.828 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.415 ' CG2' ' HE3' ' A' ' 70' ' ' LYS . 12.1 p -134.5 -175.19 3.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.905 0.383 . . . . 0.0 111.462 -178.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.42 ' OD1' ' CG1' ' A' ' 69' ' ' VAL . 0.7 OUTLIER -64.5 98.45 0.25 Allowed 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.31 0.576 . . . . 0.0 111.069 -179.876 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.86 22.29 2.23 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.164 -0.925 . . . . 0.0 113.13 178.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.438 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.6 OUTLIER -103.18 157.25 17.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.908 0.354 . . . . 0.0 110.631 179.167 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 28.6 m -136.39 149.06 27.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.079 0.466 . . . . 0.0 111.173 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.475 HG23 ' CH2' ' A' ' 118' ' ' TRP . 21.4 t -144.19 147.39 19.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.747 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.694 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -106.31 129.49 54.32 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.778 -179.984 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.955 ' CE1' HG21 ' A' ' 111' ' ' VAL . 5.5 m-85 -88.56 157.07 18.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.115 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.4 ' HA ' HD13 ' A' ' 105' ' ' LEU . 50.2 m -151.3 141.31 22.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.334 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.425 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 74.0 m -71.89 163.12 28.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.979 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.471 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 18.0 m-20 -96.73 -71.46 0.68 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.513 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.0 t -61.58 -22.57 65.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.23 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 122.37 31.29 1.08 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.534 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.494 ' CD2' HG12 ' A' ' 126' ' ' ILE . 24.8 m-85 -69.96 -174.02 0.72 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 120.959 0.409 . . . . 0.0 110.495 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.0 105.87 14.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.359 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.674 HD22 ' HB3' ' A' ' 109' ' ' SER . 0.2 OUTLIER -46.44 123.41 4.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.385 0.612 . . . . 0.0 111.419 -178.809 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.458 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 42.6 mm -91.13 152.61 3.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.457 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.67 -130.44 36.91 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.104 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -114.67 138.8 50.25 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.839 0.352 . . . . 0.0 110.774 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.694 ' HB2' HG22 ' A' ' 96' ' ' THR . 0.0 OUTLIER -77.23 -30.08 54.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.756 179.906 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.04 127.41 11.02 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.18 178.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.955 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.8 t -120.22 121.86 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.65 0.262 . . . . 0.0 110.642 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.75 122.85 27.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.705 -178.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.496 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 25.6 t -88.85 104.13 16.64 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.6 t -145.39 163.81 33.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.163 -178.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 44.9 30.57 2.44 Favored Glycine 0 CA--C 1.518 0.258 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.928 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.438 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 67.14 19.89 70.55 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.42 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -143.56 175.56 9.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.766 0.317 . . . . 0.0 110.561 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.496 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 95.7 m95 -112.33 142.86 44.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.005 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.9 148.08 50.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.257 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.478 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 26.6 t0 71.74 46.72 0.24 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.082 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 95.4 Cg_endo -78.18 134.03 12.6 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.343 2.029 . . . . 0.0 111.4 177.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.495 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 74.0 Cg_endo -88.66 -173.75 0.92 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.525 2.15 . . . . 0.0 113.532 -177.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.448 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -129.75 -163.42 1.3 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.781 177.756 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 5.1 m -151.97 92.06 1.69 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.047 0.451 . . . . 0.0 110.94 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -122.07 158.11 29.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.852 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.494 HG12 ' CD2' ' A' ' 103' ' ' TYR . 13.6 mm . . . . . 0 C--N 1.324 -0.518 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.859 179.576 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.785 ' HD3' HG23 ' A' ' 25' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.969 0.414 . . . . 0.0 110.834 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.482 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 4.2 m -93.84 162.94 25.6 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.705 179.506 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.42 ' O ' ' HD3' ' A' ' 12' ' ' PRO . 15.5 Cg_endo -60.1 -163.28 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.316 2.011 . . . . 0.0 111.452 -179.883 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.44 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 0.9 OUTLIER -78.46 104.94 2.34 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.718 -0.219 . . . . 0.0 110.805 179.92 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.498 ' CG ' ' CD1' ' A' ' 22' ' ' ILE . 13.2 Cg_endo -55.97 142.84 84.47 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.123 1.882 . . . . 0.0 111.677 179.461 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.42 ' HB3' ' OH ' ' A' ' 33' ' ' TYR . 0.5 OUTLIER -52.19 169.34 0.08 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.467 -179.556 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.747 ' C ' HD21 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -130.02 -5.27 4.47 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -177.149 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.692 HG22 ' O ' ' A' ' 14' ' ' ASP . 3.0 tt 55.45 157.42 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 122.864 0.466 . . . . 0.0 111.798 -178.264 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -101.78 -47.33 4.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.432 -178.349 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -94.04 38.71 1.08 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.878 -179.633 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.464 ' HA2' ' N ' ' A' ' 36' ' ' ASN . . . 177.84 -166.07 36.07 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.969 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.893 ' C ' HD23 ' A' ' 20' ' ' LEU . 0.9 OUTLIER -136.47 177.21 8.03 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.334 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.893 HD23 ' C ' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -126.59 151.5 47.89 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.301 0.572 . . . . 0.0 111.411 -179.836 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 32' ' ' THR . 4.2 t70 -116.25 82.67 1.82 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.528 177.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.806 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.7 OUTLIER -77.39 103.12 4.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.392 -176.908 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.67 19.79 52.95 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.756 177.177 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.07 142.09 3.37 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.06 -0.591 . . . . 0.0 111.955 -179.374 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.785 HG23 ' HD3' ' A' ' 8' ' ' ARG . 11.0 m -128.6 29.64 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.66 0.266 . . . . 0.0 111.492 -178.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -105.69 164.97 11.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.929 0.395 . . . . 0.0 110.838 179.309 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.763 ' HZ ' HD13 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -59.93 90.59 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.925 -179.738 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 136.31 -2.88 3.58 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.32 179.63 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.39 -174.56 3.38 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 117.157 0.479 . . . . 0.0 110.771 179.86 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.427 ' HB2' ' HE2' ' A' ' 46' ' ' LYS . 1.4 p -156.58 145.22 19.99 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.016 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.806 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.4 OUTLIER -100.79 166.15 2.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.234 179.525 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.456 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -127.48 114.95 18.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.827 0.346 . . . . 0.0 110.864 179.654 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.789 ' CE1' HD22 ' A' ' 20' ' ' LEU . 15.4 m-85 -91.92 149.2 21.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.258 0.551 . . . . 0.0 112.061 -178.386 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.406 ' O ' ' HA3' ' A' ' 18' ' ' GLY . 46.0 m -151.44 147.02 26.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.188 178.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.417 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 6.3 m -69.15 167.66 15.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.848 0.356 . . . . 0.0 110.829 -179.351 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.464 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 25.4 m-20 -68.69 -85.76 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.239 -178.317 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.73 134.98 15.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.524 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.535 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 65.92 26.42 72.25 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.771 -178.79 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.499 ' CE2' ' HB3' ' A' ' 68' ' ' SER . 2.1 m-85 -121.41 171.89 8.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.997 0.427 . . . . 0.0 111.179 -179.45 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.864 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -138.26 112.79 8.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.066 177.647 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.932 HD21 ' O ' ' A' ' 44' ' ' GLU . 7.0 tt -75.4 129.93 38.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.856 -178.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.864 HD11 ' CE1' ' A' ' 40' ' ' HIS . 3.0 mm -104.94 157.4 5.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.994 0.426 . . . . 0.0 111.098 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.6 -142.45 31.16 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.05 -179.094 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.932 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -73.0 -172.54 1.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.85 0.357 . . . . 0.0 110.569 179.222 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.417 ' HA ' ' HG3' ' A' ' 64' ' ' PRO . 0.3 OUTLIER -168.21 30.21 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.534 179.682 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.456 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 25.8 mtpt -151.8 126.02 9.29 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.426 -178.534 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.428 ' OG ' ' CB ' ' A' ' 62' ' ' GLU . 0.3 OUTLIER -93.04 137.47 32.37 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.876 178.819 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.515 ' CD1' ' HB3' ' A' ' 60' ' ' ASN . 1.1 m-85 -114.73 121.77 44.37 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.79 -179.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 23.0 t -72.01 117.56 13.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.936 -179.58 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.497 ' HA ' ' CE2' ' A' ' 27' ' ' PHE . 4.6 mt-10 -146.16 -179.47 6.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.034 179.476 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.763 HD13 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.424 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.912 -179.673 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.684 ' O ' HG13 ' A' ' 58' ' ' VAL . 3.2 mmt . . . . . 0 N--CA 1.455 -0.22 0 CA-C-O 120.839 0.352 . . . . 0.0 110.6 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.684 HG13 ' O ' ' A' ' 57' ' ' MET . 2.7 m -163.38 173.95 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.204 -179.484 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.529 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 74.1 m95 -129.25 125.22 36.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.138 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.515 ' HB3' ' CD1' ' A' ' 48' ' ' TYR . 0.7 OUTLIER -69.33 166.06 33.47 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.761 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.47 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 65.7 Cg_exo -11.49 101.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.003 1 C-N-CA 125.647 4.231 . . . . 0.0 114.634 -179.187 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.507 ' O ' ' CG ' ' A' ' 33' ' ' TYR . 0.7 OUTLIER -101.71 -71.1 0.72 Allowed 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 115.159 -0.928 . . . . 0.0 113.159 -175.416 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.438 ' HA ' HD12 ' A' ' 15' ' ' ILE . . . -102.98 76.93 0.23 Allowed Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -174.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.795 ' HG2' HD11 ' A' ' 41' ' ' LEU . 33.3 Cg_endo -55.39 -154.42 0.0 OUTLIER 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 123.249 2.633 . . . . 0.0 111.766 176.015 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.51 HG22 ' H ' ' A' ' 66' ' ' CYS . 6.8 mm -86.97 166.42 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.964 0.412 . . . . 0.0 111.282 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.51 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.1 m -165.34 125.86 1.89 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.762 178.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.16 171.74 13.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.918 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.499 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 96.4 p -84.89 118.53 24.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.552 -179.568 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.559 HG23 ' HB3' ' A' ' 40' ' ' HIS . 0.2 OUTLIER -49.98 99.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.036 178.876 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -62.85 138.95 58.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.188 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.419 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -123.18 126.59 47.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.636 179.588 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -74.57 -168.59 0.71 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.841 179.498 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -41.25 133.38 1.98 Allowed Pre-proline 0 N--CA 1.438 -1.056 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.684 179.364 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.492 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 31.8 Cg_exo -57.82 162.9 10.08 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.378 2.052 . . . . 0.0 112.391 -178.704 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.52 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 85.6 Cg_exo -41.32 160.5 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.879 2.386 . . . . 0.0 113.135 -179.469 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.81 89.61 3.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.642 179.399 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.565 HG23 ' HE1' ' A' ' 97' ' ' TYR . 22.5 pt -69.35 171.99 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.407 -179.025 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.404 ' O ' ' HB2' ' A' ' 124' ' ' CYS . 3.7 m -88.44 141.36 28.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.705 179.645 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.438 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 6.2 m-80 57.22 29.46 16.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.926 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.465 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -169.71 -172.52 36.36 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.81 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 9.4 ptt180 -166.69 -175.61 3.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.92 0.39 . . . . 0.0 110.59 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 16.1 p80 -109.36 167.86 9.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.637 -179.053 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 41.7 p-10 . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.072 178.435 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.42 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 5.1 m-85 . . . . . 0 N--CA 1.455 -0.182 0 CA-C-O 120.769 0.319 . . . . 0.0 110.452 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.42 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 85.9 m-85 -153.62 169.02 24.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.825 -179.232 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.5 p -131.1 179.67 5.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.932 0.396 . . . . 0.0 111.524 -179.059 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.403 ' OD1' ' HB2' ' A' ' 68' ' ' SER . 44.6 p-10 -63.67 95.06 0.1 Allowed 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.354 0.597 . . . . 0.0 111.09 -179.865 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.61 27.95 1.37 Allowed Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.21 -0.905 . . . . 0.0 112.865 179.084 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.412 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -107.52 160.79 15.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.672 0.273 . . . . 0.0 110.458 179.047 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.442 HG22 ' N ' ' A' ' 95' ' ' VAL . 34.4 m -134.16 155.89 40.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.153 0.501 . . . . 0.0 111.389 -179.657 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.553 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 19.5 t -148.71 148.59 15.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.367 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.824 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -108.29 119.67 40.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.178 0.513 . . . . 0.0 111.12 -179.331 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.951 ' CE2' HG21 ' A' ' 111' ' ' VAL . 3.5 m-85 -77.06 164.55 25.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.766 -178.477 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.448 ' HA ' ' CD1' ' A' ' 105' ' ' LEU . 0.7 OUTLIER -155.35 135.35 12.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.671 -179.259 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.414 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 61.1 m -69.78 157.52 37.19 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.765 178.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.465 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 78.1 m-20 -85.82 -76.74 0.32 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.426 -179.349 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.7 t -59.02 -26.53 64.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.831 0.348 . . . . 0.0 111.184 -179.345 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 124.39 35.85 0.64 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.402 -179.724 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.438 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 14.3 m-85 -69.58 -174.0 0.65 Allowed 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 120.876 0.37 . . . . 0.0 110.618 179.853 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.5 m -111.9 99.68 8.31 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.181 179.122 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.588 HD23 ' HB2' ' A' ' 122' ' ' PRO . 0.0 OUTLIER -48.02 144.35 3.7 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.736 0.779 . . . . 0.0 111.682 -177.615 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.475 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 40.5 mm -117.73 159.91 17.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.913 -177.534 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.464 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 51.49 24.69 11.88 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.171 -1.014 . . . . 0.0 112.581 179.728 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.409 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.5 OUTLIER 61.04 135.04 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.191 0.52 . . . . 0.0 111.79 178.898 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.824 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.1 p -62.14 -28.68 69.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.885 -178.776 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -53.44 127.4 36.66 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.883 -179.259 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.951 HG21 ' CE2' ' A' ' 97' ' ' TYR . 3.1 t -128.11 150.38 33.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 178.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 118' ' ' TRP . 0.3 OUTLIER -107.1 129.52 54.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.854 0.359 . . . . 0.0 111.539 -179.201 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.508 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 44.3 t -92.63 106.01 18.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.526 176.228 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.6 t -153.74 164.32 38.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.011 0.434 . . . . 0.0 111.206 -178.425 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 45.25 33.21 3.96 Favored Glycine 0 CA--C 1.518 0.254 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.858 179.604 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 65.42 19.0 66.17 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.42 -179.641 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -146.89 -176.85 5.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.877 0.37 . . . . 0.0 110.778 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.553 ' CZ3' HG23 ' A' ' 95' ' ' VAL . 88.8 m95 -118.49 122.96 43.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.95 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.46 147.12 28.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.111 -179.366 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.514 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER 71.85 41.95 0.18 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.489 179.192 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 53.3 Cg_endo -68.69 145.98 65.32 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 121.993 1.796 . . . . 0.0 111.014 177.88 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.588 ' HB2' HD23 ' A' ' 105' ' ' LEU . 73.3 Cg_endo -96.49 -173.58 0.23 Allowed 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.521 2.147 . . . . 0.0 113.938 -177.096 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.655 HG22 HE22 ' A' ' 125' ' ' GLN . 0.2 OUTLIER -132.9 172.2 12.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.446 -1.252 . . . . 0.0 109.195 177.868 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 78' ' ' SER . 1.9 m -130.18 91.77 3.17 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.095 0.474 . . . . 0.0 110.433 178.659 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.655 HE22 HG22 ' A' ' 123' ' ' THR . 1.3 mp0 -117.11 -179.39 3.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.369 -178.351 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.48 HG22 ' O ' ' A' ' 126' ' ' ILE . 43.6 mm . . . . . 0 C--N 1.321 -0.645 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.02 -179.462 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.472 ' CB ' ' HA ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 121.022 0.439 . . . . 0.0 111.22 . . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.551 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 76.6 m -78.47 176.77 3.31 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.645 178.861 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.555 ' HD2' ' CD1' ' A' ' 59' ' ' TRP . 36.8 Cg_endo -92.21 178.71 1.46 Allowed 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 122.75 2.3 . . . . 0.0 112.21 -179.281 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.7 t -48.57 103.82 0.38 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.442 179.12 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.514 ' HG3' ' CZ2' ' A' ' 59' ' ' TRP . 51.2 Cg_exo -48.75 159.65 0.83 Allowed 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.319 2.013 . . . . 0.0 112.751 -178.518 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.654 ' O ' HD11 ' A' ' 20' ' ' LEU . 6.2 mtm180 -65.22 -178.43 0.48 Allowed 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.54 177.073 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.489 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 2.7 t70 -141.64 167.2 22.72 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.288 0.566 . . . . 0.0 111.217 -176.865 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.404 HG23 ' C ' ' A' ' 18' ' ' GLY . 7.4 tt -119.29 147.94 22.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.438 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -76.53 -58.82 3.06 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -177.671 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.407 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 0.0 OUTLIER -93.87 32.81 1.39 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.191 -177.945 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.404 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -156.86 -171.94 23.55 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.364 -179.579 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -145.56 141.86 28.62 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.291 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.876 HD22 ' CE2' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -88.06 166.35 14.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.28 0.562 . . . . 0.0 111.775 -179.153 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.3 OUTLIER -133.05 85.3 2.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.726 177.263 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.861 ' HA ' HG23 ' A' ' 31' ' ' ILE . 53.6 mt -72.83 105.25 2.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -177.174 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.13 20.96 39.11 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.496 176.414 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 29' ' ' SER . . . 154.39 139.27 2.78 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 -179.135 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.401 ' O ' ' HB2' ' A' ' 8' ' ' ARG . 15.7 m -120.52 -8.06 10.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.9 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.472 ' HA ' ' CB ' ' A' ' 8' ' ' ARG . 25.5 t0 -69.28 164.67 22.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.169 0.509 . . . . 0.0 111.402 -178.816 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.465 ' CZ ' ' HB3' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -53.39 119.09 4.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.512 179.751 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.65 -3.9 61.31 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.507 -178.628 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 24' ' ' GLY . 22.7 m -70.44 174.21 6.01 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 116.951 0.376 . . . . 0.0 110.592 179.553 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.7 p -148.02 149.22 31.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.108 -179.717 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.861 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -115.6 171.31 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.628 -179.92 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 21' ' ' ASP . 1.4 m -130.83 118.35 20.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.914 0.388 . . . . 0.0 111.091 179.733 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.876 ' CE2' HD22 ' A' ' 20' ' ' LEU . 10.0 m-85 -95.76 138.92 32.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.579 -179.212 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.403 ' O ' ' HA3' ' A' ' 18' ' ' GLY . 22.6 m -142.73 157.23 44.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.757 179.416 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.4 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 1.5 m -76.94 170.15 17.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.706 0.289 . . . . 0.0 110.748 179.742 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -65.47 -84.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.968 -179.538 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.0 t -157.32 133.5 9.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.728 179.713 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.6 ' O ' HG22 ' A' ' 69' ' ' VAL . . . 66.93 23.71 72.8 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.054 -179.095 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.507 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.5 m-85 -115.27 -178.25 3.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.933 0.397 . . . . 0.0 110.96 -179.803 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.91 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -141.98 111.63 6.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.882 177.511 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.951 HD21 ' O ' ' A' ' 44' ' ' GLU . 5.3 tt -78.14 127.2 31.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.713 -178.722 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.91 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.4 mm -103.72 149.7 7.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.041 0.448 . . . . 0.0 110.975 -179.592 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.66 -131.72 10.88 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.304 -179.15 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.951 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -89.61 -176.55 5.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.771 0.32 . . . . 0.0 110.71 179.686 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.3 p -161.26 25.22 0.13 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.049 -179.245 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.413 ' HG3' ' HA ' ' A' ' 32' ' ' THR . 1.4 mtpt -153.24 129.65 10.61 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.113 0.483 . . . . 0.0 111.218 -179.171 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -103.38 150.71 23.55 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.0 179.654 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.492 ' CB ' ' HB2' ' A' ' 60' ' ' ASN . 1.9 m-85 -127.04 121.55 31.89 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 119.191 -1.004 . . . . 0.0 113.094 -177.806 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.432 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 25.4 t -70.16 97.63 1.23 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.258 177.65 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.499 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 2.1 tt0 -131.13 171.92 12.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.448 0.642 . . . . 0.0 111.091 -178.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.499 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.632 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.347 -179.237 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.804 0.335 . . . . 0.0 110.295 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.2 m -153.65 -176.94 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.047 -179.422 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.555 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 75.4 m95 -128.83 126.14 39.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.664 -179.285 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.492 ' HB2' ' CB ' ' A' ' 48' ' ' TYR . 2.1 m120 -69.46 164.45 49.54 Favored Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.772 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.493 ' O ' ' HA ' ' A' ' 47' ' ' SER . 67.3 Cg_exo -11.88 121.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 1.003 1 C-N-CA 125.8 4.333 . . . . 0.0 115.309 -175.948 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.512 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 4.9 mm-40 -110.25 -79.78 0.58 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.77 -1.105 . . . . 0.0 113.791 -174.35 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' A' ' 14' ' ' ASP . . . -101.95 79.24 0.25 Allowed Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -174.477 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.589 ' HG2' HD11 ' A' ' 41' ' ' LEU . 30.7 Cg_endo -54.67 -154.35 0.0 OUTLIER 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.335 2.69 . . . . 0.0 111.811 175.822 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.501 HG22 ' H ' ' A' ' 66' ' ' CYS . 5.4 mm -91.15 166.34 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.944 0.402 . . . . 0.0 111.259 -179.879 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.501 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -168.98 134.96 1.69 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.451 179.404 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -152.96 171.24 18.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.883 0.373 . . . . 0.0 111.02 -179.828 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.507 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 1.6 p -83.97 130.92 34.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.156 0.503 . . . . 0.0 111.364 -179.37 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 38' ' ' GLY . 4.3 m -46.68 100.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.545 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.488 ' HE2' HG23 ' A' ' 90' ' ' THR . 1.4 mmtt -86.91 100.2 12.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.229 179.621 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.421 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -87.57 121.32 29.84 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 177.652 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.454 ' CG ' ' N ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -68.85 -154.13 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -179.848 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.454 ' N ' ' CG ' ' A' ' 72' ' ' GLN . 1.8 t -51.49 148.11 9.74 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-O 120.676 0.274 . . . . 0.0 111.119 -179.318 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.483 ' CG ' HG11 ' A' ' 95' ' ' VAL . 12.2 Cg_exo -68.74 157.19 62.87 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.737 2.291 . . . . 0.0 111.909 179.538 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.524 ' HD3' ' CG ' ' A' ' 118' ' ' TRP . 83.0 Cg_exo -44.53 162.03 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.687 2.258 . . . . 0.0 112.741 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 69.4 m -116.63 89.21 3.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.658 179.463 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.628 HG23 ' HE2' ' A' ' 97' ' ' TYR . 17.6 pt -69.17 176.89 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.274 -179.255 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.3 t -89.81 150.93 22.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.659 179.037 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.514 ' HB3' ' CD2' ' A' ' 103' ' ' TYR . 1.2 m-80 48.74 27.47 1.55 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.277 178.111 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.467 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -166.23 -164.95 22.76 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.776 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.7 ptt180 -170.23 -174.68 1.78 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.923 0.392 . . . . 0.0 110.667 -179.414 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.532 ' HB3' ' CE1' ' A' ' 97' ' ' TYR . 8.9 p80 -107.16 165.96 10.98 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.705 -178.844 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.4 ' HB2' ' O ' ' A' ' 96' ' ' THR . 27.1 m-20 . . . . . 0 C--O 1.223 -0.314 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.857 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.442 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 11.8 m-85 . . . . . 0 N--CA 1.448 -0.564 0 CA-C-O 120.816 0.341 . . . . 0.0 110.817 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.442 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 6.8 m-85 -140.62 166.42 24.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.101 -179.445 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.488 HG23 ' HE2' ' A' ' 70' ' ' LYS . 16.6 p -130.79 175.59 8.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.015 0.436 . . . . 0.0 111.829 -178.46 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.584 ' OD2' HG21 ' A' ' 69' ' ' VAL . 0.7 OUTLIER -62.88 99.69 0.17 Allowed 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.619 0.724 . . . . 0.0 110.659 179.68 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 125.24 12.86 3.72 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 114.601 -1.181 . . . . 0.0 113.055 179.007 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -89.04 161.02 16.79 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 117.179 0.49 . . . . 0.0 110.017 178.501 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 20.7 m -150.54 131.16 4.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.11 0.481 . . . . 0.0 110.982 -179.295 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.483 HG11 ' CG ' ' A' ' 74' ' ' PRO . 2.0 p -130.74 143.73 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.698 -179.186 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.795 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -94.56 128.61 41.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.365 0.602 . . . . 0.0 111.376 -178.869 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.911 ' CE1' HG21 ' A' ' 111' ' ' VAL . 3.1 m-85 -84.36 163.81 19.33 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.298 -179.456 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 89.4 p -153.75 133.42 12.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.768 -178.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.445 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 81.9 m -69.84 159.36 33.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.544 178.629 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.467 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 74.0 m-80 -93.65 -79.1 0.42 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.653 -178.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.55 -31.64 25.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.847 0.356 . . . . 0.0 111.277 -179.106 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 130.65 38.87 0.28 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.446 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.514 ' CD2' ' HB3' ' A' ' 79' ' ' ASN . 23.9 m-85 -78.66 -172.77 3.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.836 0.35 . . . . 0.0 110.757 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 125' ' ' GLN . 0.3 OUTLIER -111.66 113.97 26.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.494 179.344 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.535 HD22 ' HA ' ' A' ' 109' ' ' SER . 1.1 mp -53.51 115.17 1.8 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.006 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.543 HG22 ' N ' ' A' ' 107' ' ' GLY . 34.5 mm -99.85 162.11 3.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.856 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.543 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 52.64 28.59 30.39 Favored Glycine 0 CA--C 1.508 -0.357 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.541 179.245 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.403 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.7 OUTLIER 60.31 128.8 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.935 -0.633 . . . . 0.0 111.465 179.44 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.795 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.3 p -60.28 -29.45 68.82 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.81 -178.747 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.76 136.88 49.98 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.908 -178.753 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.911 HG21 ' CE1' ' A' ' 97' ' ' TYR . 4.0 t -133.31 119.36 35.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 110.439 -0.208 . . . . 0.0 110.439 179.369 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.07 124.09 29.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.952 0.406 . . . . 0.0 111.474 -178.714 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 93' ' ' SER . 10.3 t -88.55 108.09 19.24 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.722 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 52.7 p -155.89 166.41 33.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.189 0.519 . . . . 0.0 111.524 -178.157 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.87 31.99 5.8 Favored Glycine 0 CA--C 1.518 0.279 0 CA-C-N 115.594 -0.73 . . . . 0.0 113.199 179.133 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.46 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 68.61 14.23 66.91 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.569 -179.881 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -147.15 171.63 15.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.016 0.436 . . . . 0.0 110.812 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.524 ' CG ' ' HD3' ' A' ' 75' ' ' PRO . 90.7 m95 -103.61 127.22 51.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.56 179.599 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.98 150.9 28.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.312 -179.037 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.492 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER 69.32 44.2 0.25 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.151 178.919 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.492 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 59.2 Cg_endo -72.64 140.62 32.95 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.154 1.903 . . . . 0.0 111.373 178.372 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.505 ' HG2' ' CD2' ' A' ' 97' ' ' TYR . 96.4 Cg_endo -91.73 -169.73 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.643 2.228 . . . . 0.0 113.98 -177.281 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.41 -159.91 1.0 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.391 -1.277 . . . . 0.0 109.743 178.22 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . 0.422 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 10.2 m -156.5 89.63 1.12 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.068 0.461 . . . . 0.0 110.709 179.033 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.414 ' O ' ' HB2' ' A' ' 104' ' ' SER . 15.6 mt-30 -122.69 158.4 30.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.034 -178.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.499 HG12 ' CE1' ' A' ' 103' ' ' TYR . 18.5 mm . . . . . 0 C--N 1.324 -0.536 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.958 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 25' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.909 0.385 . . . . 0.0 110.801 . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.481 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 14.7 m -94.75 162.09 26.56 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.04 -179.576 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 40.2 Cg_endo -67.77 -168.71 0.2 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.605 2.203 . . . . 0.0 112.261 -179.487 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 3.1 t -67.47 110.83 5.91 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.019 -179.54 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 11' ' ' SER . 1.5 Cg_endo -52.29 132.36 43.85 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.182 1.921 . . . . 0.0 112.161 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.942 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -53.47 161.71 0.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.515 179.248 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -108.37 -176.71 3.12 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.528 -178.138 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.477 HG22 ' CD2' ' A' ' 20' ' ' LEU . 14.1 tt -146.69 147.96 17.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.942 -179.624 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.43 160.43 15.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.379 -0.373 . . . . 0.0 109.998 178.535 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.486 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 0.2 OUTLIER 47.21 26.6 0.7 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.766 -179.743 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.45 ' HA2' ' N ' ' A' ' 36' ' ' ASN . . . -153.83 -168.07 16.95 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.846 -179.152 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.64 135.42 15.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.806 0.336 . . . . 0.0 111.071 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.942 HD11 ' O ' ' A' ' 13' ' ' ARG . 8.6 mt -75.17 160.22 30.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.595 -179.746 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.449 ' HB3' ' CB ' ' A' ' 32' ' ' THR . 1.1 t0 -135.39 71.96 1.44 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.774 177.847 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.895 ' HA ' HG23 ' A' ' 31' ' ' ILE . 18.4 mt -75.09 112.97 13.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.224 -177.437 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -107.48 16.15 37.97 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.628 176.383 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 153.94 136.93 2.37 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.823 -179.31 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.412 ' O ' ' HB2' ' A' ' 8' ' ' ARG . 28.3 m -120.39 29.94 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -178.341 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.83 154.59 18.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.828 0.347 . . . . 0.0 111.002 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.478 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 10.0 t80 -48.67 108.87 0.2 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.96 -4.98 34.13 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.663 -178.76 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.9 p -69.63 -164.49 0.07 Allowed 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.738 0.304 . . . . 0.0 110.681 179.762 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.3 p -167.02 143.26 4.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.022 0.439 . . . . 0.0 111.225 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.895 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -112.0 174.17 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.497 179.959 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.573 HG23 ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -135.5 113.11 10.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.948 0.404 . . . . 0.0 110.79 179.319 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.77 ' CE1' HD21 ' A' ' 20' ' ' LEU . 26.2 m-85 -88.92 137.09 32.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.935 -179.558 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.6 m -144.19 156.76 44.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.373 -179.085 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 59.4 m -84.05 166.23 17.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.948 179.74 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.45 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 3.3 m-20 -66.14 -86.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.23 -178.826 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.4 t -151.9 134.67 15.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.871 0.367 . . . . 0.0 110.873 -179.743 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.42 21.99 70.93 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.233 -179.468 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.497 ' CE1' ' HB3' ' A' ' 68' ' ' SER . 2.5 m-30 -114.22 -176.96 3.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.824 0.345 . . . . 0.0 110.832 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.732 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -147.92 112.87 5.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.632 178.876 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.957 HD21 ' O ' ' A' ' 44' ' ' GLU . 3.1 tt -73.84 131.85 41.94 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.494 -179.782 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.732 HD11 ' CE1' ' A' ' 40' ' ' HIS . 3.9 mm -103.35 153.83 5.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.975 -179.637 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.72 -133.59 13.3 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.385 -179.514 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.957 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -80.57 174.94 11.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.712 0.292 . . . . 0.0 110.65 179.408 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.537 ' OG ' HD13 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -155.29 27.0 0.41 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.408 178.987 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.573 ' HG2' HG23 ' A' ' 32' ' ' THR . 0.0 OUTLIER -159.98 121.42 3.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.669 -178.968 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.426 ' HA ' ' HD2' ' A' ' 61' ' ' PRO . 47.9 t -92.84 157.21 16.5 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.513 179.322 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.52 ' CE1' ' HD3' ' A' ' 61' ' ' PRO . 4.0 m-85 -129.48 110.97 12.3 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.202 0.525 . . . . 0.0 111.648 -179.789 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.502 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 23.9 t -60.58 84.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.259 178.934 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -97.94 -171.64 2.21 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.995 -178.814 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.478 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.392 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.242 -179.234 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.815 0.34 . . . . 0.0 110.329 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.5 m -153.64 179.69 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.302 -179.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.672 ' CE3' HD11 ' A' ' 31' ' ' ILE . 95.7 m95 -123.58 123.7 41.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.817 -179.847 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.5 m-20 -148.23 126.82 6.08 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.32 -179.485 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.52 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 2.9 Cg_exo -76.09 -167.45 5.84 Favored 'Cis proline' 0 C--N 1.35 0.656 0 C-N-CA 124.226 -1.156 . . . . 0.0 112.057 -0.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -110.74 -154.2 0.53 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.945 -179.434 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.482 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -69.61 111.21 8.13 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.911 179.863 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.533 ' HG2' HD11 ' A' ' 41' ' ' LEU . 15.3 Cg_exo -69.78 -150.55 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.627 2.218 . . . . 0.0 112.372 -179.165 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.506 HG22 ' H ' ' A' ' 66' ' ' CYS . 6.3 mm -98.45 166.44 2.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.371 -179.07 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.506 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.1 m -164.54 126.66 2.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.476 179.296 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.472 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -153.18 178.24 9.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.913 0.387 . . . . 0.0 111.267 -179.081 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.497 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 27.5 p -90.6 116.12 28.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.746 179.317 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.458 HG11 ' HA2' ' A' ' 115' ' ' GLY . 2.1 p -43.38 96.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.553 -179.804 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.421 ' HD3' ' HB3' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -78.01 120.64 23.14 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.615 -178.928 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.91 125.33 50.24 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.98 178.245 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -69.47 -158.87 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.429 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.406 ' HG ' ' HE2' ' A' ' 82' ' ' HIS . 1.3 t -54.1 143.39 43.52 Favored Pre-proline 0 N--CA 1.45 -0.442 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 179.612 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.459 ' HD2' ' CD2' ' A' ' 82' ' ' HIS . 25.2 Cg_exo -59.97 159.74 24.5 Favored 'Trans proline' 0 CA--C 1.528 0.207 0 C-N-CA 122.429 2.086 . . . . 0.0 112.092 -179.254 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.521 ' HD3' ' CG ' ' A' ' 118' ' ' TRP . 87.3 Cg_exo -46.56 156.44 0.6 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.762 2.308 . . . . 0.0 113.0 -178.856 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 12.8 t -108.06 91.5 3.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.301 178.89 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.748 HG23 ' HE2' ' A' ' 97' ' ' TYR . 22.2 pt -69.03 171.48 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.267 -178.905 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.9 p -89.13 135.17 33.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.021 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.471 ' ND2' ' N ' ' A' ' 79' ' ' ASN . 0.1 OUTLIER 67.41 26.49 8.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.688 179.503 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -166.67 -163.39 20.32 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.106 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.3 ptt85 -170.29 -175.51 1.96 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.992 0.425 . . . . 0.0 110.982 -179.16 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.459 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 9.0 p-80 -115.99 168.02 10.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.854 179.661 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.895 -179.984 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.432 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 6.4 m-85 . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.792 0.33 . . . . 0.0 111.162 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.432 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 24.6 m-85 -144.32 165.57 27.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.95 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 17.0 p -125.01 -179.66 4.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.128 -179.569 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 5.4 p-10 -67.06 95.36 0.39 Allowed 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.389 0.614 . . . . 0.0 110.933 -179.826 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 128.2 31.23 0.69 Allowed Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.132 -0.94 . . . . 0.0 112.93 179.177 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.415 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -110.27 164.16 12.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.689 0.28 . . . . 0.0 110.686 179.476 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 32.5 m -140.55 148.16 22.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.1 0.476 . . . . 0.0 111.276 -179.795 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.529 HG23 ' CH2' ' A' ' 118' ' ' TRP . 21.7 t -145.08 147.87 18.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.676 179.191 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.991 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -101.49 137.05 40.33 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 -179.756 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.95 ' CE1' HG21 ' A' ' 111' ' ' VAL . 3.8 m-85 -97.58 157.3 16.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.169 -179.313 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 84.5 p -149.44 140.9 23.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.397 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.433 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 73.0 m -70.78 159.02 35.31 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.415 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 17.7 m-20 -92.58 -70.88 0.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.54 -178.808 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.13 -22.1 66.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.368 -179.191 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.29 30.92 1.23 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.604 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.496 ' CE2' HG12 ' A' ' 126' ' ' ILE . 21.9 m-85 -69.71 -175.6 0.9 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.973 0.416 . . . . 0.0 110.754 179.634 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 125' ' ' GLN . 0.8 OUTLIER -111.2 104.35 12.85 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.787 177.617 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.55 HD21 ' CG ' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -47.77 129.62 14.17 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.531 0.681 . . . . 0.0 111.799 -177.422 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.438 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 38.1 mm -93.33 158.86 2.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.888 178.726 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.429 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 63.02 -125.83 35.4 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.306 -0.95 . . . . 0.0 111.977 -178.959 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -129.5 134.89 48.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.812 0.339 . . . . 0.0 111.063 179.526 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.991 ' OG ' HG22 ' A' ' 96' ' ' THR . 10.2 p -60.63 -32.26 71.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.115 0.483 . . . . 0.0 110.655 179.286 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -70.63 127.68 16.66 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.795 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.95 HG21 ' CE1' ' A' ' 97' ' ' TYR . 8.8 t -121.29 124.05 71.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 178.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.38 126.16 31.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.007 0.432 . . . . 0.0 111.879 -177.747 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.495 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 30.3 t -94.83 91.72 6.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.739 177.452 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.2 OUTLIER -129.46 156.84 43.47 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.036 0.446 . . . . 0.0 111.687 -177.892 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.458 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 46.98 27.7 3.57 Favored Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.856 179.477 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.456 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 77.81 -1.22 68.67 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.811 -179.524 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -123.8 157.45 34.06 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.895 0.379 . . . . 0.0 110.553 179.602 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.529 ' CH2' HG23 ' A' ' 95' ' ' VAL . 94.4 m95 -96.41 137.98 34.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.027 -179.654 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.633 ' O ' HG13 ' A' ' 111' ' ' VAL . 34.0 t -121.82 177.87 5.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.525 0.678 . . . . 0.0 111.478 179.292 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.457 ' N ' ' HD3' ' A' ' 121' ' ' PRO . 1.3 p-10 42.74 50.57 5.69 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.951 -179.521 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.457 ' HD3' ' N ' ' A' ' 120' ' ' ASP . 84.6 Cg_endo -83.25 141.7 10.39 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.642 2.228 . . . . 0.0 112.05 178.975 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.55 ' CG ' HD21 ' A' ' 105' ' ' LEU . 94.7 Cg_endo -91.56 -171.17 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.781 2.321 . . . . 0.0 113.554 -178.733 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.433 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -135.68 -157.94 0.83 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.616 -1.174 . . . . 0.0 109.884 178.601 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 8.6 m -156.6 89.92 1.13 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.077 0.465 . . . . 0.0 110.967 179.065 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.406 ' O ' ' HB2' ' A' ' 104' ' ' SER . 15.6 mt-30 -121.39 160.53 23.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.935 -179.767 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.496 HG12 ' CE2' ' A' ' 103' ' ' TYR . 18.4 mm . . . . . 0 C--N 1.324 -0.518 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.911 179.494 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.55 ' HB3' HG23 ' A' ' 25' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.237 0 CA-C-O 120.999 0.428 . . . . 0.0 111.957 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.46 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 18.9 m -114.68 159.53 36.8 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.76 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.64 168.59 19.55 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.393 2.062 . . . . 0.0 111.516 179.317 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.1 p -52.59 119.73 16.35 Favored Pre-proline 0 C--N 1.326 -0.447 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.887 -179.204 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.442 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 18.4 Cg_endo -57.79 150.3 63.49 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.55 2.167 . . . . 0.0 112.013 179.739 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.02 136.81 50.76 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.296 0.57 . . . . 0.0 110.701 179.489 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.474 ' HA ' HD11 ' A' ' 20' ' ' LEU . 2.9 p-10 -78.4 -177.38 5.21 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.104 -176.948 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.702 HG22 ' CD2' ' A' ' 20' ' ' LEU . 18.4 tt -145.75 148.49 17.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.095 -179.637 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.82 162.27 14.17 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.335 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.44 ' N ' ' ND2' ' A' ' 17' ' ' ASN . 0.4 OUTLIER 47.26 27.65 0.89 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.947 0.403 . . . . 0.0 110.586 -179.404 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -175.45 173.79 46.44 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.921 -0.582 . . . . 0.0 112.287 -179.355 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.412 ' N ' ' O ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -136.77 156.94 47.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.729 0.3 . . . . 0.0 110.694 -179.856 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.931 HD22 ' CE1' ' A' ' 33' ' ' TYR . 0.2 OUTLIER -91.11 166.6 12.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.044 0.449 . . . . 0.0 110.976 179.188 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 32' ' ' THR . 15.2 t70 -129.97 78.83 1.87 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.052 178.196 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.887 ' HA ' HG23 ' A' ' 31' ' ' ILE . 42.5 mt -69.2 118.31 13.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.206 0.527 . . . . 0.0 112.056 -177.237 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -131.66 19.7 4.71 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.747 177.57 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 161.23 114.69 0.34 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 121.148 -0.549 . . . . 0.0 111.963 -179.475 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.55 HG23 ' HB3' ' A' ' 8' ' ' ARG . 18.7 m -113.58 30.4 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.683 0.278 . . . . 0.0 111.557 -178.837 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.423 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 15.0 t70 -101.55 163.5 12.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.959 0.409 . . . . 0.0 111.158 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.603 ' CZ ' HD12 ' A' ' 51' ' ' LEU . 7.8 t80 -60.83 89.45 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.852 -179.892 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.67 10.92 3.44 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.159 179.47 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.1 m -95.43 -160.47 0.79 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 117.039 0.419 . . . . 0.0 110.453 179.258 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 47' ' ' SER . 3.9 p -168.74 141.08 2.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.054 0.454 . . . . 0.0 111.367 179.488 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.887 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -100.87 170.58 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.317 179.444 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.494 ' HA ' ' HG3' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -132.87 110.33 10.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.931 0.396 . . . . 0.0 111.153 179.65 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.931 ' CE1' HD22 ' A' ' 20' ' ' LEU . 10.6 m-85 -86.03 156.91 20.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.779 -178.886 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 19' ' ' GLN . 66.5 m -156.02 150.94 26.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.94 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 14.3 m -76.42 171.08 15.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.974 179.88 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 17' ' ' ASN . 1.4 t-20 -65.35 -76.95 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.061 -179.656 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.93 136.28 5.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.942 -179.704 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 60.39 23.48 60.27 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.063 -179.428 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.504 ' CE1' ' HB3' ' A' ' 68' ' ' SER . 2.4 m-85 -111.35 -176.62 2.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.802 0.334 . . . . 0.0 110.72 -179.539 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.95 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -142.44 113.24 7.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.544 178.45 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.908 HD21 ' O ' ' A' ' 44' ' ' GLU . 7.0 tt -79.21 120.7 24.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.68 -179.293 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.95 HD11 ' CE1' ' A' ' 40' ' ' HIS . 3.0 mm -98.22 162.17 2.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.216 -179.093 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.4 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 72.76 -140.28 28.77 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.339 -179.762 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.908 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -72.26 -173.53 1.11 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.837 0.351 . . . . 0.0 110.473 179.015 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.1 t -169.66 29.61 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.457 178.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.494 ' HG3' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -163.13 117.26 1.65 Allowed 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.066 -177.801 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.466 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 0.6 OUTLIER -84.58 133.53 34.43 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.293 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.53 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.9 m-85 -110.45 117.71 34.32 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 119.547 -0.861 . . . . 0.0 111.455 179.527 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 33.0 t -72.6 102.36 3.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.753 -179.984 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.54 -174.3 2.88 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.145 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.603 HD12 ' CZ ' ' A' ' 27' ' ' PHE . 5.1 mt . . . . . 0 C--N 1.327 -0.401 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.296 -179.449 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.717 ' O ' HG13 ' A' ' 58' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.938 0.399 . . . . 0.0 110.554 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.717 HG13 ' O ' ' A' ' 57' ' ' MET . 2.4 m -165.87 173.6 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.705 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.53 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 75.8 m95 -128.88 122.48 30.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.695 -179.267 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.53 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.5 OUTLIER -70.66 167.8 24.78 Favored Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.98 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.476 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 71.6 Cg_exo -17.0 95.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 125.113 3.875 . . . . 0.0 114.387 -179.189 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.422 ' CB ' ' OH ' ' A' ' 33' ' ' TYR . 0.2 OUTLIER -96.84 -79.02 0.46 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.179 -177.14 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.482 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . . . -87.94 107.32 15.31 Favored Pre-proline 0 C--N 1.332 -0.189 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -176.506 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.87 ' HG2' HD11 ' A' ' 41' ' ' LEU . 1.8 Cg_endo -86.15 -155.88 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.27 2.646 . . . . 0.0 111.444 178.509 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.489 HG22 ' H ' ' A' ' 66' ' ' CYS . 5.2 mm -89.75 165.57 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.894 0.378 . . . . 0.0 110.711 178.502 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.489 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.1 m -163.05 128.7 3.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.826 179.855 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.478 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -152.81 178.43 9.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.083 -179.652 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.504 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 89.8 p -89.57 117.66 28.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.88 179.591 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.439 ' CG2' ' HB3' ' A' ' 40' ' ' HIS . 2.6 p -44.52 101.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.22 179.754 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.418 ' HD2' ' HB3' ' A' ' 88' ' ' PHE . 38.9 mmtt -81.76 125.52 30.74 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.518 -0.764 . . . . 0.0 112.257 -177.623 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -106.86 120.62 42.53 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.733 176.656 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.89 -159.25 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.36 -179.845 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.479 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 2.0 t -54.08 137.81 56.78 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.81 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.805 ' CG ' HG21 ' A' ' 95' ' ' VAL . 52.1 Cg_exo -56.17 162.54 7.37 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.675 2.25 . . . . 0.0 112.211 -179.579 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -43.79 157.05 0.15 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.59 2.193 . . . . 0.0 112.528 -179.454 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.1 t -103.32 90.11 3.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.617 179.585 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.672 HG23 ' HE1' ' A' ' 97' ' ' TYR . 24.5 pt -69.42 168.49 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.188 -179.253 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.96 132.86 39.34 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.882 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.496 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 0.3 OUTLIER 71.18 27.3 3.27 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.76 179.988 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -168.36 -168.27 30.21 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.219 179.443 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.84 -175.24 3.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.859 0.361 . . . . 0.0 110.739 -179.231 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.479 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 3.0 p-80 -115.53 166.12 12.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.031 -179.569 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.332 -0.186 0 CA-C-O 120.789 0.328 . . . . 0.0 110.22 179.47 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.436 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 6.2 m-85 . . . . . 0 N--CA 1.455 -0.208 0 CA-C-O 120.701 0.286 . . . . 0.0 110.643 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.436 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 43.8 m-85 -146.85 162.47 38.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.204 -178.69 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.3 p -137.08 -177.86 4.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.476 -179.149 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 0.4 OUTLIER -59.43 92.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.252 0.549 . . . . 0.0 111.121 -179.625 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.56 26.8 1.55 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.367 -0.833 . . . . 0.0 113.086 178.571 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.426 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -105.83 154.21 20.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.89 0.345 . . . . 0.0 110.634 179.106 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 17.4 m -139.49 138.07 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.261 0.553 . . . . 0.0 111.472 -179.694 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.805 HG21 ' CG ' ' A' ' 74' ' ' PRO . 21.5 t -137.94 142.22 36.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.812 179.007 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.77 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -93.2 141.67 28.17 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.553 -178.033 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.82 ' CE2' HG21 ' A' ' 111' ' ' VAL . 4.7 m-85 -96.57 161.5 13.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.592 179.234 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.1 m -160.27 139.08 10.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.247 -179.752 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.459 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 59.6 m -69.58 164.87 22.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.037 -179.914 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.404 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 0.3 OUTLIER -97.27 -85.66 0.35 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.12 -179.921 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 41.9 t -47.34 -26.4 1.26 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.351 -179.399 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.27 54.25 0.23 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.088 -179.482 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.496 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 15.0 m-85 -93.1 -173.26 3.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.806 0.336 . . . . 0.0 111.286 -178.696 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -109.58 103.63 12.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.113 179.637 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.456 HD21 ' HA ' ' A' ' 109' ' ' SER . 0.2 OUTLIER -49.99 129.18 20.18 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.515 0.674 . . . . 0.0 111.556 -178.056 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.678 HD11 ' HG3' ' A' ' 125' ' ' GLN . 36.9 mm -95.2 157.68 3.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.294 179.431 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.473 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 60.87 -128.91 45.84 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.319 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -120.04 132.47 55.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.791 0.329 . . . . 0.0 111.086 179.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.77 ' OG ' HG22 ' A' ' 96' ' ' THR . 3.8 p -68.05 -33.09 73.91 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.904 179.597 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -78.3 119.88 5.27 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.784 -179.721 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.82 HG21 ' CE2' ' A' ' 97' ' ' TYR . 2.7 t -108.3 141.97 22.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.145 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.35 128.14 46.49 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.939 0.4 . . . . 0.0 111.302 -179.18 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.492 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 20.4 t -90.34 106.04 18.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.392 176.717 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 9.0 p -143.1 146.28 33.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.41 -178.379 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.402 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 54.05 34.86 53.06 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.746 179.532 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.436 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 67.75 12.44 62.0 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.848 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -138.58 170.17 16.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.918 0.39 . . . . 0.0 110.778 179.659 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.792 ' CH2' HG22 ' A' ' 95' ' ' VAL . 95.7 m95 -107.98 151.86 25.25 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.406 -178.802 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.94 148.92 44.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.158 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.471 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.7 OUTLIER 70.94 47.25 0.26 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.994 178.851 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 96.1 Cg_endo -78.83 136.57 13.47 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.433 2.089 . . . . 0.0 111.647 178.403 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.454 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 73.6 Cg_endo -87.16 -174.3 1.29 Allowed 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.533 2.155 . . . . 0.0 113.589 -178.243 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.481 HG22 ' H ' ' A' ' 124' ' ' CYS . 0.6 OUTLIER -134.02 176.79 8.27 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.272 177.305 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . 0.481 ' H ' HG22 ' A' ' 123' ' ' THR . 10.9 m -137.67 107.04 6.1 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.511 0.672 . . . . 0.0 111.848 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.678 ' HG3' HD11 ' A' ' 106' ' ' ILE . 2.9 pt20 -148.31 -179.0 6.62 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.117 -179.105 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 22.5 mm . . . . . 0 C--N 1.315 -0.905 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.334 -178.014 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.457 ' HD2' HG23 ' A' ' 25' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.449 -0.492 0 CA-C-O 121.196 0.522 . . . . 0.0 111.745 . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 1.226 ' SG ' ' SG ' ' A' ' 49' ' ' CYS . 0.0 OUTLIER -98.57 163.1 19.68 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.684 179.406 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.47 ' HD3' ' CB ' ' A' ' 57' ' ' MET . 37.7 Cg_endo -67.02 170.49 12.92 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.065 1.843 . . . . 0.0 111.851 179.759 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.4 t -51.26 104.56 0.44 Allowed Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.895 -179.332 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.742 ' HB3' HD11 ' A' ' 31' ' ' ILE . 12.1 Cg_endo -56.75 147.29 72.8 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.058 1.839 . . . . 0.0 111.76 179.823 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -55.92 174.01 0.13 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.37 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.745 ' HA ' HD11 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -132.57 -171.2 2.6 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.989 0.423 . . . . 0.0 111.305 -179.61 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.432 HG23 ' C ' ' A' ' 18' ' ' GLY . 5.2 tt -144.1 145.16 22.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.61 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -80.75 -58.68 2.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.256 -178.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.412 ' N ' ' ND2' ' A' ' 17' ' ' ASN . 0.6 OUTLIER -94.0 38.29 1.08 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.852 -179.538 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.432 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -158.37 -177.84 31.84 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.965 -179.804 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.41 ' N ' ' O ' ' A' ' 34' ' ' SER . 0.7 OUTLIER -137.71 140.79 40.93 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 179.59 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.745 HD11 ' HA ' ' A' ' 14' ' ' ASP . 10.2 mt -86.67 154.75 20.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.081 0.467 . . . . 0.0 111.759 -178.862 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.461 ' HB3' ' CB ' ' A' ' 32' ' ' THR . 15.6 t0 -124.39 71.22 1.13 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.631 177.457 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.86 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.9 OUTLIER -76.58 104.59 4.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.774 -177.836 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -110.6 -15.71 10.89 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.077 178.436 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.416 ' O ' ' CB ' ' A' ' 29' ' ' SER . . . -157.69 110.44 0.44 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.118 179.562 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.555 HG13 ' CG2' ' A' ' 22' ' ' ILE . 27.3 m -112.12 51.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.534 0.207 . . . . 0.0 111.534 -179.322 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 25.8 t0 -111.18 163.8 13.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.932 0.396 . . . . 0.0 110.84 178.063 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.456 ' CZ ' ' HB3' ' A' ' 51' ' ' LEU . 1.4 t80 -53.14 95.39 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.904 -179.18 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.17 31.37 5.05 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.148 -179.658 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 24' ' ' GLY . 14.8 m -99.67 -158.42 0.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.285 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 47' ' ' SER . 7.7 p -165.17 139.95 5.08 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 120.273 -0.571 . . . . 0.0 112.288 179.708 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.86 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.8 OUTLIER -105.2 170.68 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.267 178.568 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.463 ' HA ' ' HG3' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -128.48 111.75 13.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.005 0.431 . . . . 0.0 111.11 178.591 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.531 ' CE2' ' CD2' ' A' ' 20' ' ' LEU . 13.6 m-85 -85.13 149.28 25.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.255 -179.604 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.411 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 9.6 p -152.79 165.72 34.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.713 179.475 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.415 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 9.8 m -85.2 168.43 14.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.768 0.318 . . . . 0.0 110.92 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -66.02 -83.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.995 -179.437 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.86 136.23 13.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.476 179.703 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.464 ' HA3' ' CB ' ' A' ' 91' ' ' ASP . . . 59.97 28.84 66.77 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.387 -0.911 . . . . 0.0 111.671 -178.688 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.526 ' CE1' ' CB ' ' A' ' 68' ' ' SER . 2.7 m-85 -120.15 173.07 7.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.816 0.341 . . . . 0.0 110.939 -179.12 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.76 ' CE1' HG22 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -129.85 133.45 46.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.106 175.271 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.933 HD21 ' O ' ' A' ' 44' ' ' GLU . 6.7 tt -97.33 120.95 38.63 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.641 -179.333 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.591 ' N ' HD13 ' A' ' 42' ' ' ILE . 1.2 mm -99.13 149.68 5.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.088 -179.302 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.06 -136.01 13.64 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.275 -179.62 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.933 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -84.55 -173.87 4.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.894 0.378 . . . . 0.0 110.653 179.612 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.9 p -159.51 22.15 0.18 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.462 -178.899 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.463 ' HG3' ' HA ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -154.44 125.89 7.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.945 0.402 . . . . 0.0 112.062 -177.796 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' A' ' 30' ' ' SER . 0.7 OUTLIER -92.4 141.68 28.27 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.673 177.201 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.441 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.4 m-85 -122.69 113.41 19.18 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 119.611 -0.836 . . . . 0.0 111.407 179.129 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 1.226 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 1.6 p -79.89 118.54 21.75 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 119.152 -1.019 . . . . 0.0 111.397 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.97 -170.72 2.57 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.842 -179.837 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.487 HD13 ' H ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.406 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.04 -179.476 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.47 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.336 0 CA-C-O 121.15 0.5 . . . . 0.0 110.734 . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 49' ' ' CYS . 1.7 m -157.21 171.31 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.688 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.555 ' CD2' ' HB3' ' A' ' 49' ' ' CYS . 70.7 m95 -131.15 121.01 24.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.042 0.448 . . . . 0.0 111.6 -179.491 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.495 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 6.3 m-20 -69.68 168.03 19.77 Favored Pre-proline 0 C--O 1.223 -0.298 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.148 178.788 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.495 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 76.3 Cg_exo -20.16 96.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 125.081 3.854 . . . . 0.0 114.412 -178.37 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.465 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -96.01 -78.09 0.47 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.817 -178.421 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.506 ' HB2' ' O ' ' A' ' 14' ' ' ASP . . . -82.13 108.07 10.48 Favored Pre-proline 0 C--N 1.331 -0.2 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -176.565 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.88 ' HG2' HD11 ' A' ' 41' ' ' LEU . 1.0 OUTLIER -85.17 -155.1 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.113 2.542 . . . . 0.0 110.754 176.99 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.461 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 1.5 mm -95.85 159.18 2.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.969 0.414 . . . . 0.0 110.402 177.782 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.2 m -157.92 138.27 12.69 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.775 179.834 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.47 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -150.01 177.03 10.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.55 179.991 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.526 ' CB ' ' CE1' ' A' ' 39' ' ' TYR . 1.2 p -104.49 141.32 36.58 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.575 179.088 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.76 HG22 ' CE1' ' A' ' 40' ' ' HIS . 2.3 p -67.6 66.84 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.287 0.565 . . . . 0.0 110.384 179.154 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.559 ' HE2' HG23 ' A' ' 90' ' ' THR . 1.5 mmpt? -47.75 112.71 0.59 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.159 -178.184 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -97.28 125.79 42.07 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.268 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.04 -166.14 0.97 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.96 -179.342 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 1.5 t -42.24 134.21 2.54 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.329 -179.129 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.495 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 37.4 Cg_exo -58.54 161.52 14.42 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.331 2.021 . . . . 0.0 112.158 -179.245 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.462 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 88.2 Cg_exo -40.56 154.61 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.779 2.319 . . . . 0.0 112.867 -179.477 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.0 p -106.38 91.02 3.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.997 -179.641 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.549 HG21 ' O ' ' A' ' 122' ' ' PRO . 19.9 pt -69.65 175.9 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.066 179.917 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.5 t -93.54 149.07 21.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.635 178.869 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.47 ' HB3' ' CE1' ' A' ' 103' ' ' TYR . 1.1 m-80 50.12 28.45 3.04 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.127 177.927 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.47 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -158.34 -163.61 13.07 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.899 179.872 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 98' ' ' SER . 13.2 ptt180 -170.12 -175.65 2.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.095 0.474 . . . . 0.0 110.931 -179.214 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 4.9 p80 -123.04 166.52 14.98 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.801 179.756 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.434 ' OD1' HG13 ' A' ' 95' ' ' VAL . 46.2 p30 . . . . . 0 C--N 1.327 -0.397 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.422 178.962 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.425 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 13.9 m-85 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.796 0.332 . . . . 0.0 110.542 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.425 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 65.9 m-85 -152.71 167.84 27.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.713 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.559 HG23 ' HE2' ' A' ' 70' ' ' LYS . 24.9 p -141.05 -175.85 4.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.937 0.398 . . . . 0.0 111.361 -179.339 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.464 ' CB ' ' HA3' ' A' ' 38' ' ' GLY . 1.0 OUTLIER -61.55 96.6 0.06 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.295 0.569 . . . . 0.0 110.967 179.879 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 125.34 19.4 2.36 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.16 -0.927 . . . . 0.0 113.222 178.483 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.441 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.7 OUTLIER -100.64 154.16 18.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 117.049 0.424 . . . . 0.0 110.565 178.989 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.18 148.99 31.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.04 0.448 . . . . 0.0 110.918 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.473 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 17.9 t -145.52 147.45 18.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.651 179.852 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.794 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -107.13 126.58 52.55 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.962 -179.624 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.977 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.6 m-85 -85.51 156.5 20.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.932 -179.742 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.432 ' HA ' HD13 ' A' ' 105' ' ' LEU . 72.5 m -149.92 145.55 26.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.17 -179.503 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.457 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 66.7 m -75.16 156.04 36.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.028 179.887 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.47 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 78.9 m-20 -85.06 -78.13 0.26 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.592 -179.03 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.5 m -59.89 -23.49 63.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.378 -178.806 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 123.97 33.73 0.78 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.541 -179.811 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.503 ' CE2' HG12 ' A' ' 126' ' ' ILE . 40.4 m-85 -69.7 -175.52 0.89 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.967 0.413 . . . . 0.0 110.757 179.697 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.1 m -107.84 101.61 10.88 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.387 179.012 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.512 HD21 ' HA ' ' A' ' 109' ' ' SER . 0.3 OUTLIER -47.29 127.05 10.31 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 121.367 0.603 . . . . 0.0 111.514 -178.991 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.438 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 40.7 mm -95.76 154.64 3.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.427 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 66.49 -125.42 26.23 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.93 -178.891 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -127.28 134.24 50.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.878 0.37 . . . . 0.0 110.943 179.167 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.794 ' HB2' HG22 ' A' ' 96' ' ' THR . 0.4 OUTLIER -67.65 -30.39 69.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.804 179.621 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -70.11 132.8 23.88 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.554 179.388 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.977 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.4 t -127.41 121.64 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.675 0.274 . . . . 0.0 110.453 179.329 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.29 117.31 22.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.005 0.431 . . . . 0.0 111.802 -178.463 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.534 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 17.9 t -82.59 104.33 12.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.438 176.559 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 2.2 p -146.42 163.08 36.77 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.364 -178.17 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.33 30.0 4.03 Favored Glycine 0 N--CA 1.453 -0.219 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.767 179.898 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.3 16.14 70.9 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.52 -179.464 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -141.45 -177.4 5.13 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.887 0.375 . . . . 0.0 110.599 179.515 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.534 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 93.7 m95 -117.74 144.99 44.78 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.103 -179.391 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.91 147.02 51.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.298 -179.285 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.489 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER 73.38 46.13 0.21 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.163 178.676 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 73.3 Cg_endo -75.84 136.02 18.25 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.361 2.041 . . . . 0.0 111.331 177.951 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.549 ' O ' HG21 ' A' ' 77' ' ' ILE . 64.8 Cg_endo -91.12 -173.68 0.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.505 2.137 . . . . 0.0 113.496 -178.135 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.436 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -129.37 -162.7 1.22 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.746 177.833 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 4.9 m -156.43 90.82 1.2 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.069 0.462 . . . . 0.0 110.856 179.378 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -118.12 160.7 21.09 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.932 -179.626 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.563 HG22 ' O ' ' A' ' 126' ' ' ILE . 15.9 mm . . . . . 0 C--N 1.323 -0.546 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.997 179.912 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.844 ' HD2' HG23 ' A' ' 25' ' ' VAL . 32.9 mtm-85 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.915 0.388 . . . . 0.0 110.957 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.432 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 8.5 m -91.08 163.0 31.06 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.625 179.55 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -73.62 167.88 26.15 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.281 1.988 . . . . 0.0 111.719 179.87 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.2 p -52.37 108.97 1.21 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.927 -179.275 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.592 ' HG2' HD13 ' A' ' 22' ' ' ILE . 49.2 Cg_exo -49.34 158.05 1.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.314 2.009 . . . . 0.0 112.335 179.906 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.876 ' O ' HD11 ' A' ' 20' ' ' LEU . 4.3 mtt180 -54.11 177.25 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.735 177.354 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.427 ' O ' ' CB ' ' A' ' 63' ' ' ALA . 0.1 OUTLIER -124.9 -177.01 3.7 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.182 0.515 . . . . 0.0 111.678 -178.676 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.501 HG22 ' CD2' ' A' ' 20' ' ' LEU . 5.2 tt -139.47 151.69 22.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.837 -179.397 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -90.34 -64.48 1.13 Allowed 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -177.46 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -92.52 26.92 2.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.775 0.321 . . . . 0.0 111.09 -178.894 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -144.15 -160.4 8.45 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.851 179.708 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.85 133.52 10.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.753 0.311 . . . . 0.0 110.489 179.434 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.876 HD11 ' O ' ' A' ' 13' ' ' ARG . 18.7 mt -72.27 150.72 43.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.178 0.513 . . . . 0.0 111.899 -178.37 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.412 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 5.5 t0 -123.36 69.62 1.02 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.266 177.419 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.894 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.9 OUTLIER -79.4 100.75 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.069 -176.492 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.36 19.26 54.58 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.575 176.696 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 163.32 141.07 3.02 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 121.192 -0.528 . . . . 0.0 111.87 -179.376 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.844 HG23 ' HD2' ' A' ' 8' ' ' ARG . 6.2 m -127.01 -3.77 4.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.898 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.421 ' HA ' ' CB ' ' A' ' 8' ' ' ARG . 1.3 p-10 -69.57 156.58 38.69 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.792 0.33 . . . . 0.0 110.669 179.868 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.451 ' CZ ' ' HG ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -49.26 116.72 1.82 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.021 0.439 . . . . 0.0 111.02 -179.25 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.07 -6.64 47.34 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.585 -178.77 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 m -66.98 -174.29 0.32 Allowed 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.884 0.342 . . . . 0.0 110.762 179.711 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 47' ' ' SER . 0.3 OUTLIER -159.74 139.16 11.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.964 -179.978 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.894 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -108.2 167.63 3.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.921 0.391 . . . . 0.0 110.854 179.681 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.423 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -132.92 110.6 10.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.695 178.554 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.713 ' CE2' HD21 ' A' ' 20' ' ' LEU . 23.8 m-85 -82.76 132.19 35.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.162 -179.272 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.22 159.98 40.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.446 -179.898 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.449 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 56.4 m -84.69 176.13 8.76 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.625 -179.996 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -84.98 -83.22 0.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.911 0.386 . . . . 0.0 110.769 -179.346 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.23 129.4 9.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.344 179.267 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.905 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 74.67 28.77 62.52 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.434 -0.888 . . . . 0.0 111.596 -177.842 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.508 ' CE2' ' HB3' ' A' ' 68' ' ' SER . 29.7 m-85 -134.08 157.77 45.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.003 0.43 . . . . 0.0 111.173 -179.734 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.843 ' CE1' HG22 ' A' ' 69' ' ' VAL . 6.3 m-70 -115.13 134.03 55.51 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 173.63 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.848 HD21 ' O ' ' A' ' 44' ' ' GLU . 6.3 tt -81.65 107.67 14.58 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.023 -179.613 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.431 HG12 ' HA ' ' A' ' 66' ' ' CYS . 1.3 mm -92.72 146.1 6.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.97 -178.229 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.76 -151.97 32.86 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.011 -178.441 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.848 ' O ' HD21 ' A' ' 41' ' ' LEU . 1.3 pm0 -53.22 173.21 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.72 0.26 . . . . 0.0 110.406 179.232 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.519 ' HB3' HD22 ' A' ' 41' ' ' LEU . 8.3 p -153.61 24.07 0.52 Allowed 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.869 0.366 . . . . 0.0 111.522 -178.542 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.423 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 0.8 OUTLIER -157.53 -170.91 3.37 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.947 -178.357 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.447 ' O ' HG13 ' A' ' 31' ' ' ILE . 1.8 m -164.67 98.87 0.79 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.632 179.182 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.487 ' N ' ' CD2' ' A' ' 48' ' ' TYR . 1.2 m-30 -84.95 118.86 24.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.038 0.447 . . . . 0.0 111.21 -179.303 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 16.2 t -70.2 115.62 9.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.298 179.043 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.503 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 2.8 tt0 -144.56 172.35 13.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.449 0.643 . . . . 0.0 111.214 -178.715 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.503 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 1.0 OUTLIER . . . . . 0 C--N 1.323 -0.584 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.303 -179.683 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.421 ' SD ' ' CE1' ' A' ' 27' ' ' PHE . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.922 0.391 . . . . 0.0 110.576 . . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.3 m -146.77 -175.65 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.811 -179.891 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.542 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 88.1 m95 -128.51 137.14 51.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.008 -179.454 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -151.86 122.51 3.64 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.016 -179.697 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.4 ' HG2' ' O ' ' A' ' 46' ' ' LYS . 58.2 Cg_endo -72.65 -167.2 4.8 Favored 'Cis proline' 0 C--N 1.352 0.746 0 C-N-CA 123.744 -1.357 . . . . 0.0 112.259 -0.313 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -110.64 -155.88 0.57 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 -179.306 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.493 ' CB ' ' CE2' ' A' ' 33' ' ' TYR . . . -76.01 112.82 22.46 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.653 179.226 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.474 ' HD2' ' CG ' ' A' ' 33' ' ' TYR . 18.3 Cg_exo -68.26 -150.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.511 2.141 . . . . 0.0 112.192 -179.1 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.5 pt -136.21 -177.95 2.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.841 -179.814 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.431 ' HA ' HG12 ' A' ' 42' ' ' ILE . 78.7 m -149.99 157.32 43.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.353 0.597 . . . . 0.0 111.781 179.452 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -129.63 109.18 10.79 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.41 177.659 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.508 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 11.2 p -49.81 131.78 22.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.232 -178.668 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.905 HG12 ' O ' ' A' ' 38' ' ' GLY . 4.3 p -53.68 104.83 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.26 -178.479 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.467 ' CE ' HG23 ' A' ' 90' ' ' THR . 2.4 mmtp -89.45 114.21 25.66 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.582 177.867 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.11 125.39 38.72 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.103 0.478 . . . . 0.0 110.266 179.125 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.57 -155.64 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.924 178.777 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.408 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 1.1 t -53.15 143.77 31.86 Favored Pre-proline 0 N--CA 1.447 -0.584 0 CA-C-O 120.561 0.22 . . . . 0.0 110.536 179.483 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.488 ' HD2' ' CD2' ' A' ' 82' ' ' HIS . 32.4 Cg_exo -60.14 166.28 9.26 Favored 'Trans proline' 0 CA--C 1.53 0.311 0 C-N-CA 122.633 2.222 . . . . 0.0 112.277 -179.263 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.526 ' HD3' ' CG ' ' A' ' 118' ' ' TRP . 97.7 Cg_exo -40.97 165.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.795 2.33 . . . . 0.0 112.927 -179.517 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 73.1 m -115.32 87.34 2.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.704 179.551 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.632 HG23 ' HE2' ' A' ' 97' ' ' TYR . 7.3 pt -69.48 -173.59 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.071 -179.547 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 t -100.8 148.88 24.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.955 179.679 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.497 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 0.9 OUTLIER 47.22 29.4 1.19 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.112 177.937 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.494 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -161.51 -171.62 27.79 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.056 179.778 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -170.36 -174.87 1.78 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.992 0.425 . . . . 0.0 111.028 -178.723 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.488 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 2.1 p-80 -117.59 171.95 7.67 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.621 -179.962 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.119 179.625 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.439 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 7.3 m-85 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.81 0.338 . . . . 0.0 110.897 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.439 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 49.8 m-85 -152.23 164.32 37.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.0 -179.381 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.467 HG23 ' CE ' ' A' ' 70' ' ' LYS . 16.5 p -148.9 -174.93 4.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.004 0.431 . . . . 0.0 111.427 -179.605 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 7.3 p-10 -52.92 93.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.238 0.542 . . . . 0.0 111.566 -179.155 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.09 26.88 1.61 Allowed Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.474 -0.785 . . . . 0.0 113.628 177.549 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.34 152.5 26.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.191 0.495 . . . . 0.0 110.848 178.994 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.41 HG22 ' N ' ' A' ' 95' ' ' VAL . 34.3 m -134.85 153.62 35.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.156 0.503 . . . . 0.0 111.24 -179.703 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.517 HG23 ' CH2' ' A' ' 118' ' ' TRP . 25.1 t -147.59 148.14 16.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.636 179.263 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.488 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -105.14 134.09 48.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.698 179.876 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.953 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.5 m-85 -92.4 152.17 19.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.037 -179.754 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 59.0 m -146.52 140.29 26.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.754 179.749 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.494 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 82.0 m -69.75 159.03 34.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.033 -179.666 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -93.03 -87.36 0.23 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.222 -179.821 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.7 t -44.52 -33.2 1.65 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.637 -179.071 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 133.22 40.45 0.19 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.563 179.867 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.498 ' CE2' HG12 ' A' ' 126' ' ' ILE . 37.6 m-85 -82.2 -173.07 4.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.845 0.355 . . . . 0.0 110.781 179.794 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.0 m -112.2 109.98 19.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.016 -179.821 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.51 HD23 ' HB2' ' A' ' 122' ' ' PRO . 2.5 tp -45.43 113.5 0.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.903 179.05 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.432 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 35.2 mm -92.07 154.64 3.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.143 179.83 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 65.69 -125.27 28.11 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.362 -0.923 . . . . 0.0 111.811 -178.299 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -123.3 132.84 54.14 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.795 0.331 . . . . 0.0 110.651 179.052 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.488 ' OG ' HG22 ' A' ' 96' ' ' THR . 2.6 t -69.36 -29.94 67.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.49 179.438 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -70.98 135.52 24.48 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.794 179.771 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.953 HG21 ' CE1' ' A' ' 97' ' ' TYR . 3.1 t -129.44 120.78 51.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.596 0.236 . . . . 0.0 110.717 179.266 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.859 HD22 ' N ' ' A' ' 113' ' ' CYS . 1.0 OUTLIER -80.33 130.49 35.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.903 0.382 . . . . 0.0 111.434 -179.232 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.859 ' N ' HD22 ' A' ' 112' ' ' LEU . 37.4 t -102.68 104.18 14.5 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.075 177.461 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.727 ' HB3' HD11 ' A' ' 112' ' ' LEU . 5.3 p -152.93 123.01 7.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.898 0.38 . . . . 0.0 111.714 -179.352 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.42 ' CA ' HG11 ' A' ' 69' ' ' VAL . . . 93.17 19.79 34.95 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.696 179.148 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.449 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 82.14 -1.27 87.41 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.622 -179.173 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -131.51 -177.42 4.4 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.859 0.361 . . . . 0.0 110.432 179.373 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.526 ' CG ' ' HD3' ' A' ' 75' ' ' PRO . 86.5 m95 -120.08 157.43 28.96 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.035 -178.998 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.72 152.34 47.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.054 0.454 . . . . 0.0 111.298 -179.844 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.498 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.7 OUTLIER 69.52 45.57 0.28 Allowed Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.119 179.241 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.498 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 76.9 Cg_endo -77.45 138.32 17.4 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.384 2.056 . . . . 0.0 111.755 178.564 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.51 ' HB2' HD23 ' A' ' 105' ' ' LEU . 74.3 Cg_endo -91.25 -171.64 0.42 Allowed 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.786 2.324 . . . . 0.0 113.482 -178.542 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.88 -167.16 1.83 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.819 177.947 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 7.4 m -148.67 92.82 2.04 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.051 0.453 . . . . 0.0 110.801 179.328 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -118.02 163.93 15.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.551 -179.853 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.551 HG22 ' O ' ' A' ' 126' ' ' ILE . 15.4 mm . . . . . 0 C--N 1.322 -0.594 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.956 -179.789 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.499 ' CD ' HG22 ' A' ' 25' ' ' VAL . 3.4 ptp180 . . . . . 0 N--CA 1.456 -0.148 0 CA-C-O 120.529 0.204 . . . . 0.0 110.979 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.45 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 20.5 m -116.38 161.58 30.84 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.845 0.355 . . . . 0.0 111.575 -178.454 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 57.4 Cg_endo -71.12 174.62 10.39 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.485 2.123 . . . . 0.0 112.02 179.689 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.0 t -54.55 108.25 1.09 Allowed Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.925 -179.683 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.519 ' HG3' ' CZ2' ' A' ' 59' ' ' TRP . 53.3 Cg_exo -46.4 164.56 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.351 2.034 . . . . 0.0 112.123 179.867 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.849 ' O ' HD11 ' A' ' 20' ' ' LEU . 14.7 ttt180 -74.07 158.56 34.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.707 178.103 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.9 -175.42 2.76 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.202 0.525 . . . . 0.0 111.516 -178.301 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.452 HG22 ' CD2' ' A' ' 20' ' ' LEU . 19.7 tt -151.05 146.02 16.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.203 -179.492 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -85.03 158.97 20.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.34 -0.391 . . . . 0.0 109.999 177.844 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.483 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 0.4 OUTLIER 46.66 30.77 1.21 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.887 179.974 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -157.93 175.88 35.09 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.705 -179.413 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -141.84 137.82 31.73 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.658 0.266 . . . . 0.0 110.515 -179.869 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.849 HD11 ' O ' ' A' ' 13' ' ' ARG . 25.9 mt -83.71 157.88 22.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.11 0.481 . . . . 0.0 111.604 -179.558 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -125.45 75.49 1.48 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.625 177.709 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.918 ' HA ' HG23 ' A' ' 31' ' ' ILE . 1.1 mt -71.4 104.01 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.105 -177.156 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.39 15.36 56.21 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.789 176.855 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 156.08 130.99 1.34 Allowed Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.077 -179.591 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.781 HG12 ' HZ2' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -113.24 5.7 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-O 120.768 0.318 . . . . 0.0 110.438 -178.763 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 0.5 OUTLIER -69.37 155.66 40.07 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.907 0.384 . . . . 0.0 111.663 -178.851 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.599 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 5.8 t80 -53.56 90.09 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.711 179.29 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 127.39 -6.92 7.11 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.767 -179.478 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.8 p -72.99 170.89 13.89 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.958 0.379 . . . . 0.0 110.653 179.798 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.2 p -137.13 152.03 49.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.937 179.79 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.918 HG23 ' HA ' ' A' ' 22' ' ' ILE . 1.1 mt -114.87 170.35 5.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.665 -179.306 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.448 ' H ' HG22 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -133.55 115.29 14.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.876 0.369 . . . . 0.0 110.654 179.357 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.578 ' CE2' HD21 ' A' ' 20' ' ' LEU . 14.3 m-85 -89.71 154.0 20.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.629 -178.67 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.29 155.98 34.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.536 179.426 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.437 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 4.0 m -82.11 167.67 18.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.819 0.343 . . . . 0.0 110.958 -179.933 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -68.43 -85.4 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.204 -179.247 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.5 m -153.17 132.61 12.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.832 0.348 . . . . 0.0 111.008 -179.784 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.622 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 68.05 21.84 73.83 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.124 -179.198 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.5 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.6 m-85 -115.16 174.33 6.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.82 0.343 . . . . 0.0 110.86 -179.672 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.875 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -137.82 114.85 10.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.496 177.976 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.927 HD21 ' O ' ' A' ' 44' ' ' GLU . 6.5 tt -78.19 125.36 29.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.502 -179.698 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.875 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.2 mm -102.17 160.82 4.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.053 0.454 . . . . 0.0 111.113 -179.398 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.81 -135.24 22.95 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.485 -179.639 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.927 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -79.96 -173.58 3.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.966 0.413 . . . . 0.0 111.064 -179.952 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -167.31 29.18 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.384 179.389 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.425 ' HG3' ' HA ' ' A' ' 32' ' ' THR . 15.8 mtpt -155.08 127.52 7.87 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.962 0.411 . . . . 0.0 111.641 -178.666 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.454 ' OG ' ' CB ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -94.05 148.05 22.54 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.024 178.403 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.501 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.6 m-85 -124.45 114.95 20.14 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.603 177.922 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 52.8 t -65.67 98.22 0.37 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.468 179.677 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.503 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 0.6 OUTLIER -122.09 175.01 6.58 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.711 -178.501 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.599 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.595 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.171 -179.292 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.884 0.373 . . . . 0.0 110.359 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -145.34 -175.55 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.491 -179.669 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.781 ' HZ2' HG12 ' A' ' 25' ' ' VAL . 76.6 m95 -129.9 121.43 26.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.068 0.461 . . . . 0.0 111.905 -179.031 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.501 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 2.8 m120 -68.91 165.87 33.33 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.35 177.443 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.435 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 81.2 Cg_exo -17.09 94.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 125.289 3.993 . . . . 0.0 114.586 -178.475 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.475 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -91.67 -76.13 0.46 Allowed 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.329 -177.871 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.477 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -88.02 109.02 24.49 Favored Pre-proline 0 C--N 1.331 -0.201 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -175.711 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.92 ' HG2' HD11 ' A' ' 41' ' ' LEU . 2.3 Cg_endo -83.61 -154.59 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.053 2.502 . . . . 0.0 111.28 177.196 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.476 HG22 ' H ' ' A' ' 66' ' ' CYS . 3.0 mm -87.65 165.41 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.917 0.389 . . . . 0.0 110.791 178.64 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.476 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -165.83 131.25 2.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.502 179.455 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -154.82 168.32 27.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.184 -179.009 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.5 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 8.6 p -88.1 111.71 21.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.936 179.744 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.622 HG12 ' O ' ' A' ' 38' ' ' GLY . 4.9 p -45.08 103.9 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.884 179.253 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.492 ' HD2' ' CD1' ' A' ' 88' ' ' PHE . 2.2 ttpp -104.43 134.63 47.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.957 -176.035 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 1.5 m -90.18 136.87 32.78 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.668 177.791 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.54 -169.85 0.25 Allowed 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.817 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.6 t -74.99 111.57 14.03 Favored Pre-proline 0 C--N 1.314 -0.954 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.744 -179.021 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.642 ' HG3' ' CE2' ' A' ' 118' ' ' TRP 0.321 0.0 OUTLIER -34.23 -175.27 0.0 OUTLIER 'Trans proline' 0 CA--C 1.468 -2.796 0 C-N-CA 123.722 2.948 . . . . 0.0 114.102 173.589 . . . . . . . . 4 4 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.545 ' CB ' ' CE1' ' A' ' 97' ' ' TYR . 23.3 Cg_endo -73.3 -164.0 3.12 Favored 'Cis proline' 0 C--N 1.323 -0.814 0 N-CA-C 113.847 0.672 . . . . 0.0 113.847 -18.854 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.2 t -135.55 21.11 3.36 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.54 172.257 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.612 HD12 ' HB2' ' A' ' 124' ' ' CYS . 3.3 pt -111.16 -160.03 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.274 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.213 -177.45 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.472 ' N ' HG13 ' A' ' 77' ' ' ILE . 86.2 p -134.24 151.03 51.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.788 177.61 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 55.6 32.46 19.23 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.578 179.327 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.573 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -151.08 -160.81 9.64 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.127 -1.035 . . . . 0.0 113.731 179.764 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.42 ' N ' ' O ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -161.95 -172.75 3.39 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.801 0.334 . . . . 0.0 111.121 -178.196 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.563 ' CG ' ' HB2' ' A' ' 74' ' ' PRO . 31.3 p80 -124.52 173.41 8.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.157 0.503 . . . . 0.0 112.257 -175.723 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.474 ' H ' HG12 ' A' ' 95' ' ' VAL . 80.8 m-20 . . . . . 0 CA--C 1.534 0.357 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.169 174.021 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.492 ' CD1' ' HD2' ' A' ' 70' ' ' LYS . 9.4 m-85 . . . . . 0 N--CA 1.451 -0.423 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.494 ' CE1' ' HD2' ' A' ' 74' ' ' PRO . 17.6 m-85 -147.24 175.53 10.68 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.624 0.249 . . . . 0.0 110.862 -177.661 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.424 HG22 ' HB2' ' A' ' 70' ' ' LYS . 14.7 p -144.6 169.82 17.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.132 0.492 . . . . 0.0 112.029 -179.28 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.27 94.25 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.307 -179.323 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.53 28.45 0.98 Allowed Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.327 -0.852 . . . . 0.0 113.161 178.376 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.469 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.7 OUTLIER -110.14 157.45 19.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.965 0.383 . . . . 0.0 110.879 179.013 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 35.8 m -138.76 146.08 26.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.759 179.627 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.629 HG23 ' CH2' ' A' ' 118' ' ' TRP . 4.2 t -147.16 142.8 20.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.026 -178.681 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.846 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -98.55 127.39 44.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.174 0.512 . . . . 0.0 110.132 178.692 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.731 ' CZ ' HG21 ' A' ' 111' ' ' VAL . 2.8 m-30 -95.49 166.23 11.96 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.496 0.665 . . . . 0.0 112.756 -174.794 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.42 ' O ' ' N ' ' A' ' 81' ' ' ARG . 67.6 m -152.87 145.54 24.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.542 178.75 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.542 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 76.1 m -69.43 155.67 40.08 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.863 0.363 . . . . 0.0 111.538 -178.881 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.6 -86.47 0.19 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.967 178.934 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -47.03 -27.04 1.18 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.511 -179.385 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 125.25 32.26 0.8 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.877 179.866 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.502 ' CE1' HG12 ' A' ' 126' ' ' ILE . 18.5 m-85 -72.54 -170.85 0.72 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.903 0.383 . . . . 0.0 111.25 179.952 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.9 m -118.04 96.81 5.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.205 177.882 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.439 ' CD2' ' HA ' ' A' ' 109' ' ' SER . 0.2 OUTLIER -47.92 139.53 7.7 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.563 0.697 . . . . 0.0 111.81 -178.226 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.555 HG22 ' N ' ' A' ' 107' ' ' GLY . 16.8 mm -125.5 160.96 30.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.328 -178.71 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.555 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 64.77 25.18 70.34 Favored Glycine 0 N--CA 1.457 0.082 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.453 177.718 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.455 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.3 OUTLIER 67.05 130.84 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.532 0.682 . . . . 0.0 112.355 178.452 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.846 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.1 p -64.54 -24.68 67.68 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.427 -1.26 . . . . 0.0 111.329 178.906 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.55 130.31 48.24 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.856 179.134 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.731 HG21 ' CZ ' ' A' ' 97' ' ' TYR . 16.4 t -135.31 123.71 39.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.492 0.187 . . . . 0.0 110.855 -177.819 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.0 127.98 35.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.967 0.413 . . . . 0.0 111.804 -177.932 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.506 ' HB2' ' CZ3' ' A' ' 118' ' ' TRP . 44.7 t -89.52 98.08 11.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.521 176.386 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 24.0 p -136.76 159.96 40.28 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.672 -179.119 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.498 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 50.67 29.04 17.53 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.835 -179.074 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.487 ' N ' ' HB ' ' A' ' 69' ' ' VAL . . . 68.39 14.51 66.8 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.085 -0.578 . . . . 0.0 112.575 -179.555 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -141.95 177.02 8.49 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 178.665 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.642 ' CE2' ' HG3' ' A' ' 74' ' ' PRO . 99.4 m95 -98.39 126.5 43.94 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.149 0.5 . . . . 0.0 111.158 -179.586 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.9 150.45 24.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.254 -178.829 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.513 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.9 OUTLIER 53.51 42.46 1.18 Allowed Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.101 -179.987 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 37.7 Cg_endo -64.55 151.5 85.34 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.039 1.826 . . . . 0.0 111.098 177.65 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.664 ' HD3' HG22 ' A' ' 111' ' ' VAL . 44.4 Cg_endo -80.27 -173.59 1.92 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 121.922 1.748 . . . . 0.0 113.035 -179.06 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.461 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -122.75 -161.57 0.96 Allowed 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 173.765 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . 0.612 ' HB2' HD12 ' A' ' 77' ' ' ILE . 2.4 t -170.65 83.6 0.1 Allowed 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.25 -175.61 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -115.01 169.04 9.39 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.583 -1.19 . . . . 0.0 111.676 -175.838 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.502 HG12 ' CE1' ' A' ' 103' ' ' TYR . 37.5 mm . . . . . 0 C--N 1.326 -0.442 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.78 179.342 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.75 ' HD2' HG23 ' A' ' 25' ' ' VAL . 7.7 mtm180 . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.821 0.344 . . . . 0.0 110.738 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.45 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 60.8 m -105.33 160.66 25.27 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 -178.956 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.45 ' HD3' ' HB2' ' A' ' 57' ' ' MET . 32.2 Cg_endo -65.86 173.62 6.72 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.59 2.193 . . . . 0.0 112.192 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.7 t -54.37 108.1 1.05 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.578 179.53 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.678 ' HG2' HD13 ' A' ' 22' ' ' ILE . 72.7 Cg_exo -46.98 160.25 0.27 Allowed 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.302 2.001 . . . . 0.0 112.401 -179.468 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.525 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -75.31 174.01 10.1 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.96 178.325 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.582 ' HA ' HD11 ' A' ' 20' ' ' LEU . 1.7 t0 -127.33 -177.0 3.9 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.224 0.535 . . . . 0.0 111.691 -178.866 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.484 HG22 HD21 ' A' ' 20' ' ' LEU . 17.9 tt -146.47 143.06 20.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.785 -179.339 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -81.86 156.8 24.65 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 177.394 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.496 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 0.5 OUTLIER 49.28 26.14 1.46 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.839 0.352 . . . . 0.0 110.554 -179.239 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -153.21 170.59 32.14 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.698 -179.01 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 34' ' ' SER . 0.2 OUTLIER -138.36 144.01 40.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.699 0.285 . . . . 0.0 110.34 179.526 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.781 HD22 ' CE1' ' A' ' 33' ' ' TYR . 0.5 OUTLIER -92.49 163.21 13.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.207 0.527 . . . . 0.0 111.769 -179.312 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 32' ' ' THR . 8.1 t0 -127.47 72.34 1.38 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.875 177.175 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.891 ' HA ' HG23 ' A' ' 31' ' ' ILE . 1.2 mt -72.76 97.8 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.809 -177.789 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.12 16.7 60.77 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.786 176.979 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 160.26 153.46 6.93 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 -179.278 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.75 HG23 ' HD2' ' A' ' 8' ' ' ARG . 17.0 m -134.87 11.58 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.8 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 40.3 t0 -90.02 163.08 15.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.972 0.415 . . . . 0.0 111.377 179.93 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.518 ' CE2' ' HB3' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -50.01 90.27 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.802 -179.599 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 131.99 -9.52 5.43 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.627 -0.796 . . . . 0.0 112.784 -179.566 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.8 m -76.43 157.45 32.23 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 117.107 0.454 . . . . 0.0 110.503 179.536 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.4 p -133.52 142.2 48.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.019 0.437 . . . . 0.0 110.917 179.603 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.891 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -106.81 154.08 7.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.435 -179.789 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.411 ' O ' ' N ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -115.97 119.45 35.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.023 0.44 . . . . 0.0 110.75 179.361 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.781 ' CE1' HD22 ' A' ' 20' ' ' LEU . 11.5 m-85 -95.03 137.95 33.4 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.263 -178.927 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 19' ' ' GLN . 4.4 m -146.77 159.59 43.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.079 179.793 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.414 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 11.1 m -81.97 173.52 12.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.6 179.452 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.415 ' N ' ' O ' ' A' ' 17' ' ' ASN . 0.6 OUTLIER -75.41 -79.88 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.107 -179.447 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.35 134.62 10.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.904 -179.651 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.24 23.52 71.61 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.809 -178.972 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.498 ' CE2' ' HB3' ' A' ' 68' ' ' SER . 2.3 m-85 -118.01 167.88 11.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.842 0.353 . . . . 0.0 110.868 -179.338 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.735 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -132.97 121.82 23.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.337 177.635 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.932 HD21 ' O ' ' A' ' 44' ' ' GLU . 8.7 tt -83.3 127.91 34.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.849 -178.401 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.735 HD11 ' CE1' ' A' ' 40' ' ' HIS . 1.4 mm -106.57 149.46 9.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.051 -179.651 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.08 -142.56 20.71 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.07 -179.102 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.932 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -72.15 -175.8 1.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.869 0.366 . . . . 0.0 110.316 178.469 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -168.1 28.79 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.511 179.431 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -157.08 127.42 6.45 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.973 -179.929 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.432 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -102.59 152.36 21.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.74 -179.663 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.499 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.2 m-85 -128.04 124.89 38.22 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.488 0.661 . . . . 0.0 111.672 -179.971 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.491 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 42.7 t -73.23 118.2 15.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.157 -179.429 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.487 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 9.5 tt0 -159.25 168.45 26.43 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.074 179.018 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.518 ' HB3' ' CE2' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.311 -1.072 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.553 179.729 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.45 ' HB2' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 . . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.661 HG23 ' N ' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -137.22 -175.97 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 121.823 0.82 . . . . 0.0 112.171 -176.054 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.672 ' CE3' HD11 ' A' ' 31' ' ' ILE . 59.9 m95 -133.0 134.86 45.02 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.413 179.281 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.499 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 5.5 m-80 -78.41 163.34 62.22 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.888 178.319 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.42 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 31.6 Cg_exo -11.04 90.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.864 1 C-N-CA 125.758 4.305 . . . . 0.0 114.873 -179.392 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.48 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 39.4 mt-10 -91.27 -93.94 0.13 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.146 -178.284 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.479 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . . . -81.15 108.86 11.54 Favored Pre-proline 0 C--O 1.231 0.131 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -176.124 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.878 ' HG2' HD11 ' A' ' 41' ' ' LEU . 2.1 Cg_endo -82.93 -154.6 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.003 2.469 . . . . 0.0 110.756 176.681 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.446 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 2.0 mm -92.88 158.17 2.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.927 0.394 . . . . 0.0 110.508 178.271 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.2 m -164.34 143.37 7.37 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.957 179.905 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -169.88 170.2 7.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.463 179.954 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.498 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 30.2 p -73.92 99.02 3.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.045 0.45 . . . . 0.0 110.219 178.534 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.548 ' O ' HG13 ' A' ' 69' ' ' VAL . 5.6 p -44.2 93.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.29 179.619 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.468 ' CD ' HG23 ' A' ' 90' ' ' THR . 9.0 mttt -69.73 165.05 22.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.0 -177.467 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.416 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -120.88 131.58 54.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.179 179.079 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -69.19 -157.21 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.08 179.205 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.432 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 1.5 t -52.82 142.65 33.2 Favored Pre-proline 0 N--CA 1.45 -0.446 0 CA-C-O 120.682 0.277 . . . . 0.0 110.276 179.495 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 73' ' ' SER . 37.6 Cg_exo -57.31 162.79 9.22 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.397 2.065 . . . . 0.0 112.036 -179.083 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.507 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 82.4 Cg_exo -39.99 159.06 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.746 2.297 . . . . 0.0 112.947 -179.003 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 86.7 p -109.11 88.45 2.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.635 179.446 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.632 HG23 ' HE1' ' A' ' 97' ' ' TYR . 18.0 pt -69.85 174.12 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.33 -179.347 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.6 m -97.07 140.64 31.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.532 179.295 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.513 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 4.9 m-80 59.56 29.62 19.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.746 -179.913 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -172.83 -170.28 36.36 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.516 179.614 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -170.24 -175.7 2.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.888 0.375 . . . . 0.0 111.095 -179.371 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 0.7 OUTLIER -99.47 178.24 4.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.022 -179.987 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 96' ' ' THR . 3.4 m-20 . . . . . 0 C--N 1.331 -0.235 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.392 -179.645 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.462 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 2.2 m-85 . . . . . 0 N--CA 1.455 -0.224 0 CA-C-O 120.996 0.427 . . . . 0.0 111.971 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.436 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 71.6 m-85 -151.27 154.51 36.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.028 -179.216 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.468 HG23 ' CD ' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -111.4 -174.15 2.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.138 0.494 . . . . 0.0 112.011 -178.617 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.452 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 8.7 m-20 -69.97 96.28 1.02 Allowed 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.033 -179.895 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.46 22.77 2.02 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.956 179.074 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -96.73 156.47 16.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.764 0.316 . . . . 0.0 110.635 179.44 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 34.3 m -135.64 151.13 29.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.17 0.51 . . . . 0.0 111.185 -179.816 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.457 HG23 ' CH2' ' A' ' 118' ' ' TRP . 15.1 t -149.2 146.81 17.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.812 179.783 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.974 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -100.93 142.0 33.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.261 179.03 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.895 ' CE2' HG21 ' A' ' 111' ' ' VAL . 4.0 m-85 -100.4 156.41 17.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.997 0.427 . . . . 0.0 111.202 -179.532 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.434 ' HA ' HD13 ' A' ' 105' ' ' LEU . 36.7 m -150.26 141.61 23.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.133 -179.508 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.419 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 63.2 m -71.96 165.55 23.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.881 179.718 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.32 -86.52 0.34 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.982 179.791 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -46.76 -29.29 1.85 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.403 -179.515 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.19 41.03 0.29 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.539 179.895 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.513 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 43.5 m-85 -80.6 -174.83 4.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.864 0.364 . . . . 0.0 110.817 179.877 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.3 m -112.59 106.99 15.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.173 178.828 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.474 HD11 ' HB3' ' A' ' 97' ' ' TYR . 0.2 OUTLIER -48.26 131.33 16.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.501 0.667 . . . . 0.0 111.683 -178.252 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.445 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 35.4 mm -97.62 155.93 3.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.199 179.16 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.91 -129.32 35.36 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.324 -179.534 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -121.12 129.74 53.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.804 0.335 . . . . 0.0 111.21 -179.771 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.974 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.5 p -61.33 -32.13 72.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.82 179.455 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -71.4 135.01 23.29 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.842 -179.592 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.895 HG21 ' CE2' ' A' ' 97' ' ' TYR . 3.8 t -130.72 120.0 46.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.632 0.253 . . . . 0.0 110.706 179.2 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.878 HD22 ' N ' ' A' ' 113' ' ' CYS . 1.1 tm? -82.18 134.32 35.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.86 0.362 . . . . 0.0 111.284 -179.374 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.878 ' N ' HD22 ' A' ' 112' ' ' LEU . 43.1 t -105.09 102.5 11.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.105 177.999 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.693 ' CB ' HD11 ' A' ' 112' ' ' LEU . 4.3 m -135.57 113.12 10.78 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.488 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 81.66 45.21 7.41 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.009 178.06 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.432 ' HA3' HG22 ' A' ' 69' ' ' VAL . . . 63.32 12.78 46.77 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.778 179.471 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -134.66 173.74 11.33 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.04 0.447 . . . . 0.0 110.663 179.687 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.52 ' CZ3' ' HB2' ' A' ' 113' ' ' CYS . 94.6 m95 -121.4 156.52 32.49 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.905 -179.41 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.74 149.91 46.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.051 0.453 . . . . 0.0 111.368 -179.767 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.477 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER 67.1 47.07 0.42 Allowed Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.786 179.136 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 84.8 Cg_endo -77.7 133.92 13.17 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.396 2.064 . . . . 0.0 111.642 178.701 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.509 ' O ' HG21 ' A' ' 77' ' ' ILE . 63.8 Cg_endo -88.49 -174.27 1.05 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.581 2.187 . . . . 0.0 113.468 -178.301 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.406 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -130.34 -159.39 0.96 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.031 178.431 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 7.6 m -158.62 91.11 1.05 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.087 0.47 . . . . 0.0 110.988 179.255 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -121.24 158.64 27.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.908 -179.922 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.498 HG12 ' CE2' ' A' ' 103' ' ' TYR . 21.0 mm . . . . . 0 C--N 1.324 -0.533 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.111 179.995 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.454 ' HA ' ' HA ' ' A' ' 26' ' ' ASP . 8.2 mtm-85 . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 120.68 0.276 . . . . 0.0 110.925 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.452 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 18.3 m -109.27 160.37 27.87 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.084 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -67.94 170.48 14.15 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.318 2.012 . . . . 0.0 111.75 179.748 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.415 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 0.8 OUTLIER -51.43 105.61 0.55 Allowed Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.948 -179.524 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 11' ' ' SER . 19.8 Cg_endo -61.93 159.78 32.36 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.211 1.941 . . . . 0.0 111.881 179.731 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.441 ' O ' HD12 ' A' ' 20' ' ' LEU . 4.2 mpt_? -49.34 177.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.513 179.636 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.7 ' O ' HG22 ' A' ' 15' ' ' ILE . 0.2 OUTLIER -142.76 -7.74 0.84 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -178.042 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.7 HG22 ' O ' ' A' ' 14' ' ' ASP . 14.4 tt 53.72 163.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 120.749 0.309 . . . . 0.0 111.105 -177.939 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -104.26 -56.03 2.26 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -177.135 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.486 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 0.2 OUTLIER -94.12 31.01 1.75 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.936 0.398 . . . . 0.0 111.071 -178.412 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 34' ' ' SER . . . -157.47 179.65 33.06 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.517 179.473 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -134.92 139.42 44.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.793 0.33 . . . . 0.0 110.25 179.864 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.832 HD21 ' CE1' ' A' ' 33' ' ' TYR . 34.0 mt -88.04 159.77 18.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.377 0.608 . . . . 0.0 112.142 -178.462 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 32' ' ' THR . 5.3 t0 -124.04 83.37 2.13 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.225 176.646 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.892 ' HA ' HG23 ' A' ' 31' ' ' ILE . 1.8 mt -77.44 107.14 8.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.169 -176.678 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.99 19.52 37.85 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.59 176.679 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 152.86 132.77 1.81 Allowed Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.073 -179.373 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.824 HG12 ' CZ2' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -117.38 5.81 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-O 120.811 0.338 . . . . 0.0 110.591 -178.248 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.454 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 6.6 p-10 -75.68 153.71 36.97 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-O 120.964 0.412 . . . . 0.0 111.489 -179.11 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.59 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 3.7 t80 -52.51 95.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.767 179.334 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.02 8.49 5.08 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.989 -179.825 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 84.9 p -97.35 -174.1 2.84 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 116.992 0.396 . . . . 0.0 110.483 179.359 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.1 p -155.12 146.53 22.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.036 0.446 . . . . 0.0 111.121 178.44 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.892 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.8 OUTLIER -106.63 172.59 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.418 -179.394 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.463 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -129.64 118.34 21.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.925 0.393 . . . . 0.0 111.2 179.551 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.832 ' CE1' HD21 ' A' ' 20' ' ' LEU . 19.8 m-85 -94.77 140.96 29.19 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.234 0.54 . . . . 0.0 111.604 -179.486 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 19' ' ' GLN . 16.8 m -148.82 153.65 38.41 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.458 179.744 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.444 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 1.7 m -75.17 167.35 22.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.99 -179.628 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -76.04 -82.03 0.08 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.824 -179.589 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -153.95 121.38 5.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.656 179.351 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.743 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 77.32 14.19 82.79 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.423 -178.766 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.526 ' CZ ' ' CB ' ' A' ' 68' ' ' SER . 23.1 m-85 -111.7 154.47 24.92 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.586 -0.361 . . . . 0.0 111.0 179.546 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.841 ' CE1' HG22 ' A' ' 69' ' ' VAL . 2.3 m-70 -112.86 119.18 37.1 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 175.155 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.957 HD21 ' O ' ' A' ' 44' ' ' GLU . 4.1 tt -83.74 109.31 17.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.928 0.394 . . . . 0.0 110.022 -179.842 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.572 ' N ' HD13 ' A' ' 42' ' ' ILE . 1.5 mm -91.94 148.28 4.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.301 -178.255 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.15 -134.36 12.12 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.287 -179.288 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.957 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -84.31 -173.15 4.56 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.655 0.264 . . . . 0.0 110.686 179.422 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.2 p -160.46 23.38 0.15 Allowed 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.319 -178.91 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.463 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 8.3 mtpt -159.62 123.13 3.67 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.36 -177.701 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -92.13 145.05 24.82 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.196 178.714 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.556 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 0.4 OUTLIER -119.95 116.03 24.98 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 119.401 -0.919 . . . . 0.0 111.635 178.912 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.413 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 15.6 t -69.46 95.66 0.84 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.631 179.628 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -120.18 -168.18 1.57 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.939 -179.79 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.59 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.366 0 CA-C-O 121.009 0.433 . . . . 0.0 111.198 -179.693 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.625 ' O ' HG13 ' A' ' 58' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.533 0 CA-C-O 120.926 0.393 . . . . 0.0 109.981 . . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.625 HG13 ' O ' ' A' ' 57' ' ' MET . 0.9 OUTLIER -162.09 176.68 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.136 -179.303 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.824 ' CZ2' HG12 ' A' ' 25' ' ' VAL . 70.9 m95 -128.61 120.93 27.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.396 -179.253 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.556 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -69.0 167.72 18.99 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.754 178.189 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.487 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 56.1 Cg_exo -13.66 90.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.964 1 C-N-CA 125.399 4.066 . . . . 0.0 114.374 -179.16 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.509 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -94.46 -76.23 0.49 Allowed 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 115.273 -0.876 . . . . 0.0 113.231 -175.799 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.469 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -96.56 85.09 0.3 Allowed Pre-proline 0 N--CA 1.45 -0.462 0 N-CA-C 112.883 0.698 . . . . 0.0 112.883 -173.431 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.684 ' CG ' HD11 ' A' ' 41' ' ' LEU . 22.2 Cg_endo -51.49 -156.28 0.0 OUTLIER 'Trans proline' 0 N--CA 1.473 0.274 0 C-N-CA 123.586 2.858 . . . . 0.0 112.187 174.504 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.576 HG22 ' H ' ' A' ' 66' ' ' CYS . 0.7 OUTLIER -100.88 177.59 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.972 0.415 . . . . 0.0 110.726 178.876 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.576 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -170.74 133.65 0.98 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.681 179.523 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -137.87 113.18 9.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.078 179.795 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.526 ' CB ' ' CZ ' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -51.65 126.62 18.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.744 179.65 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.841 HG22 ' CE1' ' A' ' 40' ' ' HIS . 2.2 p -40.41 96.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.01 -179.674 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.498 ' HE3' HG23 ' A' ' 90' ' ' THR . 0.1 OUTLIER -73.15 114.04 10.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.163 179.868 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.428 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -92.14 122.4 34.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.944 0.402 . . . . 0.0 110.133 178.521 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.01 -159.72 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.111 179.85 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.477 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 1.2 t -54.41 143.6 45.87 Favored Pre-proline 0 N--CA 1.449 -0.509 0 CA-C-O 120.589 0.233 . . . . 0.0 110.554 -179.829 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.519 ' HG2' HG11 ' A' ' 95' ' ' VAL . 22.4 Cg_exo -62.1 160.77 28.83 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.432 2.088 . . . . 0.0 111.941 -179.855 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.508 ' HD3' ' CG ' ' A' ' 118' ' ' TRP . 74.7 Cg_exo -38.64 156.95 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.885 2.39 . . . . 0.0 112.912 -179.489 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.94 89.97 3.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.749 179.906 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.605 HG23 ' HE2' ' A' ' 97' ' ' TYR . 19.8 pt -69.35 178.65 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.057 -179.816 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.8 m -99.2 142.47 30.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.974 179.941 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.504 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 2.6 m-80 59.02 28.79 18.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.099 179.524 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.458 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -165.95 -167.49 26.66 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.857 179.834 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.427 ' N ' ' O ' ' A' ' 98' ' ' SER . 10.1 ptt180 -161.66 -175.49 4.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.032 0.444 . . . . 0.0 110.923 -179.693 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.477 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 9.5 p-80 -108.68 171.35 7.48 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.881 179.88 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.684 179.146 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.431 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 13.5 m-85 . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 120.816 0.341 . . . . 0.0 110.697 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.431 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 32.2 m-85 -145.05 165.66 27.58 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.698 -179.327 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.498 HG23 ' HE3' ' A' ' 70' ' ' LYS . 13.3 p -128.5 178.16 6.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.108 0.48 . . . . 0.0 111.764 -178.384 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 71.3 m-20 -62.25 95.58 0.07 Allowed 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.042 179.981 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 125.58 20.35 2.16 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.372 -0.831 . . . . 0.0 113.208 178.453 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.449 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -97.5 159.28 15.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 117.015 0.408 . . . . 0.0 110.439 178.91 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 27.1 m -134.92 146.28 30.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.022 0.439 . . . . 0.0 111.056 -179.626 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.519 HG11 ' HG2' ' A' ' 74' ' ' PRO . 27.9 t -141.62 148.35 21.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.946 179.699 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.741 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -107.08 131.12 54.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.776 179.663 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.973 ' CE1' HG21 ' A' ' 111' ' ' VAL . 6.2 m-85 -90.42 155.89 18.61 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.106 -179.414 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.427 ' O ' ' N ' ' A' ' 81' ' ' ARG . 1.3 p -149.86 136.68 19.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.542 -179.482 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.423 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 60.5 m -70.13 159.19 34.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.867 179.27 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.458 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 73.0 m-80 -92.13 -76.49 0.46 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.354 -179.483 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.78 -23.16 28.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.225 -179.351 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.65 32.35 1.03 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.525 -179.932 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.509 ' CE2' HG12 ' A' ' 126' ' ' ILE . 46.2 m-85 -69.99 -171.7 0.46 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 120.64 0.257 . . . . 0.0 110.48 179.709 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.8 m -109.78 108.18 18.44 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.91 0.386 . . . . 0.0 111.349 -178.905 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.447 ' HA ' HD12 ' A' ' 105' ' ' LEU . 0.9 OUTLIER -48.14 106.93 0.11 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.374 178.142 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.506 HG22 ' N ' ' A' ' 107' ' ' GLY . 43.6 mm -85.2 158.95 3.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.168 -178.47 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.506 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 59.66 -127.42 44.48 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.844 -179.248 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -118.18 132.75 56.31 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.87 0.367 . . . . 0.0 110.669 178.974 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.741 ' HB2' HG22 ' A' ' 96' ' ' THR . 0.1 OUTLIER -69.45 -28.9 66.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.119 0.485 . . . . 0.0 110.453 179.549 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.58 131.4 14.44 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.764 -179.927 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.973 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.8 t -123.92 121.71 62.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.583 0.23 . . . . 0.0 110.644 179.217 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.67 121.14 25.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.875 0.369 . . . . 0.0 111.443 -178.818 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.494 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 23.3 t -85.73 106.14 16.77 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 176.465 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.414 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.3 OUTLIER -147.81 160.11 43.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.129 0.49 . . . . 0.0 111.394 -178.333 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.28 34.41 6.22 Favored Glycine 0 CA--C 1.518 0.219 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.775 179.611 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 65.91 12.94 58.56 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.641 -179.448 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -136.58 -178.85 5.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.876 0.37 . . . . 0.0 110.704 179.63 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.508 ' CG ' ' HD3' ' A' ' 75' ' ' PRO . 93.2 m95 -119.08 141.63 48.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.969 -179.416 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.08 150.13 50.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.05 0.452 . . . . 0.0 111.535 -179.029 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.478 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.5 OUTLIER 71.26 46.35 0.25 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.125 178.744 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 85.5 Cg_endo -78.22 142.23 19.0 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.376 2.05 . . . . 0.0 111.729 178.424 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.507 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 61.6 Cg_endo -90.13 -172.3 0.56 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.67 2.246 . . . . 0.0 113.476 -178.589 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.452 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -134.71 -178.48 5.09 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.974 178.215 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . 0.435 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 11.1 m -139.51 97.66 3.32 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.965 0.412 . . . . 0.0 111.027 -179.832 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -123.96 155.35 38.34 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.975 -179.683 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.565 HG22 ' O ' ' A' ' 126' ' ' ILE . 18.1 mm . . . . . 0 C--N 1.324 -0.507 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.99 179.932 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.683 ' HD3' HG23 ' A' ' 25' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.068 0 CA-C-O 120.838 0.351 . . . . 0.0 111.007 . . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.426 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 13.1 m -83.93 161.31 55.88 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.733 179.757 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.74 169.19 19.46 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.396 2.064 . . . . 0.0 111.305 179.121 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.43 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -52.81 116.9 9.86 Favored Pre-proline 0 C--N 1.326 -0.436 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.962 -178.794 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.795 ' HG3' HD13 ' A' ' 22' ' ' ILE . 16.3 Cg_endo -57.27 157.58 21.18 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.62 2.214 . . . . 0.0 112.273 179.987 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.439 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 9.2 mtt-85 -64.55 176.05 1.23 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.201 178.974 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.783 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 1.1 t0 -130.89 -172.39 2.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.108 0.48 . . . . 0.0 111.679 -178.895 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.434 HG22 HD21 ' A' ' 20' ' ' LEU . 3.6 tt -145.71 151.48 14.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.727 -179.684 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -80.35 -70.73 0.5 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.672 -178.583 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.442 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 1.2 m120 -91.2 42.9 1.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.929 0.395 . . . . 0.0 110.946 -179.408 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -153.41 -173.76 22.98 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.956 179.904 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -145.66 135.2 23.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.706 0.289 . . . . 0.0 110.415 179.733 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.863 HD22 ' CE1' ' A' ' 33' ' ' TYR . 0.5 OUTLIER -83.73 156.99 22.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.125 0.488 . . . . 0.0 111.677 -179.23 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.433 ' CB ' ' HB ' ' A' ' 32' ' ' THR . 0.3 OUTLIER -127.73 73.75 1.48 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.31 177.061 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.824 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.5 OUTLIER -80.32 95.58 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.835 -176.674 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.02 16.96 59.24 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.99 177.538 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 164.49 149.67 5.87 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.075 -0.583 . . . . 0.0 111.901 -179.582 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.683 HG23 ' HD3' ' A' ' 8' ' ' ARG . 8.7 m -135.91 32.85 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.699 0.285 . . . . 0.0 111.354 -179.455 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.2 OUTLIER -102.75 155.81 18.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.125 179.933 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.571 ' CZ ' HD12 ' A' ' 51' ' ' LEU . 4.9 t80 -50.71 91.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.771 179.657 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 129.97 -12.2 5.87 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.654 -179.251 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.2 p -70.63 177.04 3.71 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.735 0.302 . . . . 0.0 110.659 179.671 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.8 p -148.51 142.89 26.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.116 179.972 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.824 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.6 OUTLIER -104.64 171.14 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.564 179.858 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.433 ' HB ' ' CB ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -135.73 111.14 9.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.993 0.425 . . . . 0.0 111.337 179.568 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.863 ' CE1' HD22 ' A' ' 20' ' ' LEU . 26.5 m-85 -87.37 143.17 27.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.435 -179.755 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.419 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 5.0 m -147.05 168.47 21.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.725 179.442 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.427 ' HA ' ' HA2' ' A' ' 18' ' ' GLY . 1.3 m -87.64 166.14 14.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.828 179.696 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.408 ' ND2' ' HA ' ' A' ' 17' ' ' ASN . 15.0 m-20 -67.25 -84.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.996 -179.76 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -154.03 130.8 10.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.109 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.02 19.26 71.68 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.433 -179.534 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.506 ' CE1' ' HB3' ' A' ' 68' ' ' SER . 3.3 m-30 -111.72 178.59 4.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.859 0.361 . . . . 0.0 110.966 -179.604 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.873 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -138.31 113.23 9.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.136 0.493 . . . . 0.0 110.472 177.645 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.943 HD21 ' O ' ' A' ' 44' ' ' GLU . 6.8 tt -77.38 120.26 22.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.96 -179.01 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.873 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.6 mm -96.22 153.13 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.734 179.685 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.04 -137.14 15.18 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.975 -178.71 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.943 ' O ' HD21 ' A' ' 41' ' ' LEU . 5.1 mt-10 -88.67 -176.84 5.4 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.507 0.67 . . . . 0.0 111.221 179.175 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.7 p -155.15 24.16 0.42 Allowed 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 114.592 -1.186 . . . . 0.0 110.332 179.045 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -150.55 128.95 12.1 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.173 0.511 . . . . 0.0 112.068 -178.763 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -108.03 151.2 26.16 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.89 178.256 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.503 ' CD1' ' CB ' ' A' ' 60' ' ' ASN . 1.5 m-85 -126.28 122.54 35.8 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 119.456 -0.898 . . . . 0.0 112.598 -177.846 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.47 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 26.0 t -71.26 102.27 2.52 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.398 178.55 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -129.33 -176.19 3.81 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.317 -179.039 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.571 HD12 ' CZ ' ' A' ' 27' ' ' PHE . 6.7 mt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.447 -178.879 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 8.0 mmt . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.863 0.363 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.4 m -143.2 177.94 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.069 -179.909 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.532 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 72.6 m95 -131.84 128.65 39.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.344 -179.429 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.503 ' CB ' ' CD1' ' A' ' 48' ' ' TYR . 0.7 OUTLIER -69.67 164.63 48.86 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.707 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.505 ' O ' ' HA ' ' A' ' 47' ' ' SER . 97.7 Cg_exo -13.78 113.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.826 1 C-N-CA 125.552 4.168 . . . . 0.0 115.08 -176.257 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.474 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 3.7 mt-10 -106.17 -96.56 0.35 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.412 -1.267 . . . . 0.0 112.56 -175.579 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.783 ' HB2' ' O ' ' A' ' 14' ' ' ASP . . . -78.2 108.28 7.31 Favored Pre-proline 0 C--O 1.231 0.11 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -176.457 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.898 ' HG2' HD11 ' A' ' 41' ' ' LEU . 1.8 Cg_endo -86.83 -155.28 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.208 2.605 . . . . 0.0 110.881 177.387 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.457 HG22 ' H ' ' A' ' 66' ' ' CYS . 5.0 mm -88.95 163.96 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.893 0.378 . . . . 0.0 110.882 178.61 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.457 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -170.18 125.46 0.77 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.768 179.589 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -153.6 174.35 14.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.914 -178.873 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.506 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 77.1 p -82.25 94.7 7.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.103 0.478 . . . . 0.0 110.337 178.387 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.705 HG22 ' HA3' ' A' ' 116' ' ' GLY . 6.0 p -47.33 102.43 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.214 -179.891 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.428 ' HD2' ' HB3' ' A' ' 88' ' ' PHE . 6.0 mmtp -70.66 157.0 38.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.516 -177.058 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.409 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -132.02 115.27 15.6 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.882 178.435 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -70.61 -163.59 0.08 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.313 -178.779 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.467 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 1.6 t -46.81 139.92 6.36 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.227 -179.539 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.501 ' HD2' ' CE1' ' A' ' 82' ' ' HIS . 24.2 Cg_exo -62.83 146.36 94.99 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.328 2.019 . . . . 0.0 112.449 -179.125 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.537 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 0.2 OUTLIER -119.71 -159.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 124.742 3.628 . . . . 0.0 114.013 -174.784 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 75' ' ' PRO . 3.4 p 96.0 -66.23 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 171.241 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.83 HG22 ' O ' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -76.13 176.05 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 122.251 1.024 . . . . 0.0 113.51 -172.144 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.494 ' N ' HG13 ' A' ' 77' ' ' ILE . 2.4 m -139.93 143.36 36.57 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 113.307 -1.769 . . . . 0.0 108.551 176.42 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.406 ' ND2' ' N ' ' A' ' 79' ' ' ASN . 0.7 OUTLIER 77.03 23.12 0.96 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.795 0.331 . . . . 0.0 111.076 -178.091 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.705 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -147.9 -161.09 9.31 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.55 178.748 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -161.21 -173.92 4.08 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.92 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.514 ' HB2' HG11 ' A' ' 95' ' ' VAL . 2.1 p80 -135.51 150.38 49.75 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.124 0.488 . . . . 0.0 111.927 -178.032 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.416 ' ND2' ' OG1' ' A' ' 96' ' ' THR . 19.3 m-20 . . . . . 0 CA--C 1.533 0.312 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.154 179.106 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.428 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 9.6 m-85 . . . . . 0 N--CA 1.447 -0.588 0 CA-C-O 120.932 0.396 . . . . 0.0 111.187 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.409 ' N ' ' O ' ' A' ' 71' ' ' CYS . 31.1 m-85 -140.75 159.1 42.93 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.272 179.813 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.1 p -122.04 177.27 5.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.118 0.485 . . . . 0.0 111.992 -177.466 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 1.0 OUTLIER -62.9 96.44 0.09 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.918 -179.998 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 125.96 12.54 3.57 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.227 -0.897 . . . . 0.0 113.082 179.107 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.406 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -92.93 155.54 17.5 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.934 0.367 . . . . 0.0 110.433 179.183 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.46 HG22 ' N ' ' A' ' 95' ' ' VAL . 35.4 m -131.44 157.48 43.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.926 0.393 . . . . 0.0 111.02 -179.946 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.514 HG11 ' HB2' ' A' ' 82' ' ' HIS . 41.9 t -153.59 151.7 11.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.999 179.909 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.933 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -111.33 122.45 47.88 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.786 179.922 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 1.035 ' CE1' HG21 ' A' ' 111' ' ' VAL . 6.2 m-85 -81.06 156.1 26.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.651 -178.717 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 81' ' ' ARG . 1.2 p -147.23 134.81 20.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.397 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.441 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 74.8 m -72.0 149.72 44.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.76 0.314 . . . . 0.0 111.454 -179.875 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -96.1 -82.05 0.4 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.931 178.496 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -39.88 -30.99 0.1 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.901 -179.308 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.07 32.7 0.62 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.915 179.597 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.482 ' CD1' HG12 ' A' ' 126' ' ' ILE . 48.2 m-85 -79.96 -171.56 2.97 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.735 0.302 . . . . 0.0 110.779 179.635 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.4 m -118.97 114.5 22.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.967 0.413 . . . . 0.0 110.712 -179.846 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.634 HD21 ' HB2' ' A' ' 97' ' ' TYR . 0.3 OUTLIER -51.04 102.95 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.001 179.959 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.44 HG13 ' HB2' ' A' ' 125' ' ' GLN . 22.8 mm -95.62 151.6 3.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.554 179.171 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 69.19 24.96 75.81 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.497 -0.859 . . . . 0.0 113.033 179.173 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.429 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.3 OUTLIER 60.33 136.83 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.471 0.653 . . . . 0.0 111.642 179.745 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.933 ' HB2' HG22 ' A' ' 96' ' ' THR . 0.8 OUTLIER -70.21 -20.88 63.07 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.988 -179.179 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -64.65 122.42 24.64 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.695 -179.334 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 1.035 HG21 ' CE1' ' A' ' 97' ' ' TYR . 3.2 t -122.63 147.76 26.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 179.175 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.92 115.51 29.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.022 0.439 . . . . 0.0 111.627 -179.003 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.513 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 30.4 t -82.7 98.34 9.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.747 177.167 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.8 OUTLIER -138.48 160.37 39.72 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.362 -178.252 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.73 25.37 3.42 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.69 179.436 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.705 ' HA3' HG22 ' A' ' 69' ' ' VAL . . . 83.24 -6.76 70.4 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.945 -179.859 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -126.16 179.8 5.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.866 0.365 . . . . 0.0 110.556 179.834 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.537 ' CD1' ' HD3' ' A' ' 75' ' ' PRO . 79.0 m95 -110.38 143.44 40.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.703 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.05 162.43 23.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.029 0.442 . . . . 0.0 111.536 -178.78 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.475 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 4.3 p-10 47.65 47.82 5.07 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.058 179.526 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 72.0 Cg_endo -76.08 163.55 32.77 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.416 2.077 . . . . 0.0 111.949 178.49 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.83 ' O ' HG22 ' A' ' 77' ' ' ILE . 41.3 Cg_endo -94.97 -166.1 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.121 2.547 . . . . 0.0 113.778 -178.133 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.26 170.55 17.64 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.5 177.665 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . 0.433 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 1.6 m -122.97 91.24 3.45 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.971 0.415 . . . . 0.0 111.196 179.846 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.44 ' HB2' HG13 ' A' ' 106' ' ' ILE . 19.2 mt-30 -114.15 159.43 20.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.19 178.96 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.539 HG22 ' O ' ' A' ' 126' ' ' ILE . 16.9 mm . . . . . 0 C--N 1.321 -0.67 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.224 -179.375 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 25' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.96 0.409 . . . . 0.0 110.829 . . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.536 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 71.8 m -69.82 176.4 1.77 Allowed Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.174 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.546 ' HD2' ' CD1' ' A' ' 59' ' ' TRP . 30.6 Cg_endo -83.2 175.01 8.75 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 121.792 1.661 . . . . 0.0 110.58 178.261 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.9 p -51.09 104.57 0.44 Allowed Pre-proline 0 C--N 1.324 -0.501 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.611 -179.634 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.883 ' HG2' HD12 ' A' ' 22' ' ' ILE . 32.3 Cg_exo -38.09 156.02 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.748 2.299 . . . . 0.0 112.723 -178.66 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.44 164.53 20.91 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.379 178.652 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -114.09 -173.54 2.3 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.754 -176.707 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.467 HG23 ' C ' ' A' ' 18' ' ' GLY . 5.8 tt -132.32 150.14 33.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.502 179.217 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -76.52 -68.5 0.59 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.79 -177.992 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.417 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 1.2 m120 -92.45 41.57 1.08 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.916 0.389 . . . . 0.0 111.076 -178.58 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.467 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -162.3 -173.66 31.25 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.999 179.815 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -129.91 168.67 16.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.659 0.266 . . . . 0.0 110.31 179.173 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.728 HD12 ' N ' ' A' ' 20' ' ' LEU . 0.4 OUTLIER -119.85 156.59 30.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.025 0.44 . . . . 0.0 111.38 -179.427 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.42 76.49 1.71 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.979 178.358 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.905 ' HA ' HG23 ' A' ' 31' ' ' ILE . 5.9 mm -69.35 109.81 2.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.72 -177.827 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -112.91 15.72 23.52 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.347 178.465 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 152.58 138.26 2.7 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.994 -179.617 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.437 HG12 ' HG3' ' A' ' 12' ' ' PRO . 30.2 m -124.4 25.66 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -178.705 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -94.58 152.03 18.85 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.994 0.426 . . . . 0.0 111.035 -179.966 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.634 ' CZ ' HD12 ' A' ' 51' ' ' LEU . 2.4 t80 -47.25 92.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.088 -179.682 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 126.1 0.51 7.55 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.853 -179.593 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.17 -178.82 7.18 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 116.978 0.389 . . . . 0.0 110.662 179.696 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.0 p -153.84 145.06 22.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.266 0.555 . . . . 0.0 110.862 179.713 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.905 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -109.98 164.88 5.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.181 -179.169 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.673 HG23 ' HD3' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -124.49 107.83 11.49 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.061 0.458 . . . . 0.0 111.157 179.196 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.571 ' CZ ' HD22 ' A' ' 20' ' ' LEU . 6.5 m-85 -82.24 147.21 29.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.528 -179.461 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.45 168.6 20.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.648 179.471 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.423 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 0.8 OUTLIER -95.36 167.18 11.5 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.645 179.795 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.44 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 25.7 m120 -55.16 -85.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.169 -178.434 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.01 125.59 4.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.258 -179.934 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.542 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 74.02 16.51 79.5 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.284 -0.96 . . . . 0.0 112.12 -178.242 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.532 ' CE1' ' CB ' ' A' ' 68' ' ' SER . 2.2 m-85 -107.21 -173.08 2.21 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.709 0.29 . . . . 0.0 110.503 -179.985 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.737 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -149.65 111.0 4.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.037 0.446 . . . . 0.0 110.762 178.265 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.865 HD11 ' CB ' ' A' ' 45' ' ' SER . 0.0 OUTLIER -79.74 132.05 36.08 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.86 179.761 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.737 HD11 ' CE1' ' A' ' 40' ' ' HIS . 3.2 mm -97.27 163.13 2.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.605 -176.865 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.43 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 63.53 -152.25 47.9 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.531 -178.383 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.412 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -60.23 -171.84 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.199 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.865 ' CB ' HD11 ' A' ' 41' ' ' LEU . 91.0 p -171.28 34.19 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 121.307 0.575 . . . . 0.0 109.968 -179.893 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.673 ' HD3' HG23 ' A' ' 32' ' ' THR . 1.9 mmmt -151.63 129.0 11.3 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.803 -178.966 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.447 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 0.2 OUTLIER -95.86 136.32 36.44 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.55 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.526 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.8 m-85 -115.89 123.69 48.76 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 119.307 -0.957 . . . . 0.0 112.196 -178.465 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.404 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 44.7 t -73.19 107.69 5.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.921 179.562 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -137.43 -175.39 4.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.114 179.929 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.634 HD12 ' CZ ' ' A' ' 27' ' ' PHE . 10.9 mt . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.835 -179.891 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.182 0 CA-C-O 121.017 0.437 . . . . 0.0 110.791 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.511 HG22 ' C ' ' A' ' 51' ' ' LEU . 30.8 m -148.57 165.34 4.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.176 -179.785 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.568 ' CZ3' HD11 ' A' ' 31' ' ' ILE . 58.3 m95 -121.43 127.04 50.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.141 179.976 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.526 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 6.6 m-80 -69.76 165.21 43.92 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.171 178.883 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.442 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 42.1 Cg_exo -13.27 96.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.055 1 C-N-CA 125.63 4.22 . . . . 0.0 114.398 -179.227 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.502 ' O ' ' HD2' ' A' ' 64' ' ' PRO . 0.7 OUTLIER -93.17 -70.92 0.68 Allowed 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 114.985 -1.007 . . . . 0.0 113.245 -175.556 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.504 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -106.6 75.39 0.38 Allowed Pre-proline 0 C--N 1.333 -0.143 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -173.861 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.506 ' HG2' ' CD2' ' A' ' 41' ' ' LEU . 11.5 Cg_endo -54.53 -138.76 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 123.95 3.1 . . . . 0.0 112.417 175.849 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.492 HG22 ' H ' ' A' ' 66' ' ' CYS . 3.0 mm -103.54 166.14 2.98 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.327 0 O-C-N 121.288 -0.883 . . . . 0.0 112.687 -175.244 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.492 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.2 m -158.05 136.01 10.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.779 178.569 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -155.22 167.6 29.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.036 -179.814 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.532 ' CB ' ' CE1' ' A' ' 39' ' ' TYR . 4.9 p -96.27 110.57 22.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.154 179.959 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.693 HG11 ' HA2' ' A' ' 115' ' ' GLY . 0.9 OUTLIER -52.17 101.94 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.122 179.405 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.542 ' HE3' HG23 ' A' ' 90' ' ' THR . 0.0 OUTLIER -80.04 117.83 21.22 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.36 -179.729 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.419 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -98.85 115.83 29.71 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.064 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.5 -163.53 0.05 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.843 -179.048 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.452 ' HG ' ' CE1' ' A' ' 82' ' ' HIS . 2.3 t -44.89 137.76 4.35 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.945 -179.864 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.5 ' HG2' HG11 ' A' ' 95' ' ' VAL . 32.1 Cg_exo -56.24 160.93 9.84 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 122.124 1.883 . . . . 0.0 111.791 -179.402 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.516 ' HD3' ' CG ' ' A' ' 118' ' ' TRP . 98.8 Cg_exo -42.17 155.8 0.09 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.839 2.36 . . . . 0.0 112.928 -178.639 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.5 t -107.14 90.23 3.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.43 179.152 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.666 HG23 ' HE1' ' A' ' 97' ' ' TYR . 17.6 pt -69.47 170.23 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.319 -178.998 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.8 m -89.86 138.44 31.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.727 179.688 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 60.41 28.22 17.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.926 179.782 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -163.44 -165.68 21.0 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.268 -0.968 . . . . 0.0 113.225 179.828 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.3 -175.07 3.12 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.084 0.469 . . . . 0.0 110.603 -178.952 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.452 ' CE1' ' HG ' ' A' ' 73' ' ' SER . 11.5 p-80 -107.63 178.12 4.62 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.909 179.731 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.597 -179.827 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.447 ' CD2' ' HB3' ' A' ' 70' ' ' LYS . 18.5 m-85 . . . . . 0 N--CA 1.453 -0.294 0 CA-C-O 121.037 0.446 . . . . 0.0 111.704 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.419 ' N ' ' O ' ' A' ' 71' ' ' CYS . 22.3 m-85 -145.75 169.62 18.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.095 178.727 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.542 HG23 ' HE3' ' A' ' 70' ' ' LYS . 5.5 p -134.38 -174.41 3.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.981 0.42 . . . . 0.0 111.729 -178.699 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.486 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 0.4 OUTLIER -65.76 103.75 0.95 Allowed 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.6 0.714 . . . . 0.0 111.002 -179.905 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 120.77 17.57 4.19 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.563 179.663 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.46 148.73 25.57 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.825 0.345 . . . . 0.0 110.799 179.746 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 35.5 m -129.06 156.04 41.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.032 -179.522 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.526 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 18.5 t -151.74 148.86 14.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.983 179.918 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.429 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.1 OUTLIER -104.38 138.55 40.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.987 -179.936 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.969 ' CE2' HG21 ' A' ' 111' ' ' VAL . 4.4 m-85 -98.8 155.89 17.13 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.342 -179.157 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.475 ' HA ' HD13 ' A' ' 105' ' ' LEU . 74.3 m -151.34 143.28 23.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.066 -179.908 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.466 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 63.7 m -71.78 159.72 33.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.784 179.626 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.463 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 44.5 m-20 -85.85 -70.84 0.57 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.512 -178.944 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.0 t -68.33 -23.62 64.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.384 -179.008 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 124.26 34.79 0.7 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.568 -179.787 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.49 ' CE2' HG12 ' A' ' 126' ' ' ILE . 14.9 m-85 -69.76 -174.46 0.74 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 120.948 0.404 . . . . 0.0 110.573 179.509 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.88 100.66 10.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.424 178.927 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.629 HD21 ' HA ' ' A' ' 109' ' ' SER . 0.3 OUTLIER -46.64 125.59 7.31 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.376 0.608 . . . . 0.0 111.602 -178.873 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.451 ' HB ' ' CB ' ' A' ' 123' ' ' THR . 36.8 mm -89.59 153.17 3.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.098 179.391 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 60.37 -132.3 50.07 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.773 -178.594 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -116.26 137.58 52.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.981 0.42 . . . . 0.0 111.318 179.509 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.629 ' HA ' HD21 ' A' ' 105' ' ' LEU . 0.7 OUTLIER -66.12 -27.64 68.2 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.408 178.7 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -70.9 138.17 27.92 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.545 179.575 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.969 HG21 ' CE2' ' A' ' 97' ' ' TYR . 2.9 t -131.39 130.46 62.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 179.162 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.916 HD22 ' N ' ' A' ' 113' ' ' CYS . 0.6 OUTLIER -89.85 128.18 36.13 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.957 0.408 . . . . 0.0 111.682 -178.576 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.916 ' N ' HD22 ' A' ' 112' ' ' LEU . 42.6 t -99.21 102.92 14.73 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.678 176.648 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.779 ' HB3' HD11 ' A' ' 112' ' ' LEU . 20.0 p -148.03 111.84 5.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.506 -178.657 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.693 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 94.25 39.84 4.69 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.262 179.645 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.434 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 58.82 20.2 46.91 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.145 -179.339 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -143.97 -178.06 5.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.916 0.388 . . . . 0.0 110.867 -179.976 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.53 ' CZ3' ' HB2' ' A' ' 113' ' ' CYS . 93.5 m95 -125.38 144.07 50.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.184 -179.121 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.426 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.9 OUTLIER -123.48 166.65 15.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.495 -178.984 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.446 ' N ' ' HD3' ' A' ' 121' ' ' PRO . 1.5 p30 45.73 50.35 7.77 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.437 -0.802 . . . . 0.0 112.361 179.065 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.468 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 96.6 Cg_endo -80.05 146.36 18.08 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.558 2.172 . . . . 0.0 111.47 177.572 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.507 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 61.1 Cg_endo -94.6 -173.01 0.29 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.786 2.324 . . . . 0.0 113.489 -178.477 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.451 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -131.69 -161.45 1.13 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.933 177.766 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 6.5 m -154.37 89.07 1.25 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.084 0.468 . . . . 0.0 111.122 179.104 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -118.54 170.86 8.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.436 179.324 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.561 HG22 ' O ' ' A' ' 126' ' ' ILE . 22.1 mm . . . . . 0 C--N 1.323 -0.575 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.825 -179.976 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.658 ' HD3' HG23 ' A' ' 25' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.91 0.386 . . . . 0.0 111.071 . . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.457 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 51.1 m -108.54 160.82 25.78 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.751 179.958 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 38.6 Cg_endo -67.27 172.96 9.3 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.51 2.14 . . . . 0.0 112.255 -179.777 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.425 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 2.4 t -50.97 111.55 2.36 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.969 -179.57 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.546 ' HB3' HD11 ' A' ' 31' ' ' ILE . 9.9 Cg_endo -56.66 144.26 86.57 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.192 1.928 . . . . 0.0 111.944 179.724 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.902 ' O ' HD11 ' A' ' 20' ' ' LEU . 3.0 mtt85 -51.61 159.3 0.78 Allowed 'General case' 0 CA--C 1.517 -0.288 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.071 178.901 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.15 -174.21 2.41 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.179 0.514 . . . . 0.0 111.709 -177.918 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.441 HG23 ' C ' ' A' ' 18' ' ' GLY . 2.7 tt -144.36 139.78 24.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.526 -179.726 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -87.08 -48.07 8.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.667 -178.486 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.442 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 0.7 OUTLIER -94.25 25.96 3.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.055 -178.822 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.441 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -157.42 -170.37 22.22 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.816 -179.625 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -141.45 130.82 23.69 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.661 0.267 . . . . 0.0 110.638 179.882 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.902 HD11 ' O ' ' A' ' 13' ' ' ARG . 10.6 mt -73.2 156.61 38.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.188 0.518 . . . . 0.0 111.719 -179.496 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 32' ' ' THR . 0.8 OUTLIER -132.14 73.01 1.51 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.506 177.517 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.924 ' HA ' HG23 ' A' ' 31' ' ' ILE . 68.5 mt -69.16 101.72 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.722 -177.183 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -103.84 17.11 50.02 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.953 177.735 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 29' ' ' SER . . . 157.43 126.15 0.89 Allowed Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.146 -179.697 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.658 HG23 ' HD3' ' A' ' 8' ' ' ARG . 33.3 m -116.71 19.02 7.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 111.631 0.234 . . . . 0.0 111.631 -179.298 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 14.0 t70 -88.03 164.66 15.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.953 0.406 . . . . 0.0 110.847 179.594 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.653 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 4.0 t80 -61.72 91.75 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.787 179.881 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 124.88 12.25 4.08 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.0 179.909 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 1.2 m -96.0 -172.2 2.51 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.869 0.334 . . . . 0.0 110.479 179.289 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 47' ' ' SER . 19.3 p -155.49 147.27 23.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.054 0.454 . . . . 0.0 111.398 179.852 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.924 HG23 ' HA ' ' A' ' 22' ' ' ILE . 1.0 OUTLIER -106.82 171.42 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.669 179.631 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.489 ' H ' HG22 ' A' ' 31' ' ' ILE . 0.1 OUTLIER -131.9 113.52 13.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.012 0.434 . . . . 0.0 111.261 179.499 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.83 ' CE2' HD21 ' A' ' 20' ' ' LEU . 20.6 m-85 -89.19 136.35 33.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.229 -179.813 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.401 ' O ' ' HA3' ' A' ' 18' ' ' GLY . 6.7 m -139.71 158.05 44.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.796 -179.974 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.462 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 31.3 m -87.75 157.74 18.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.949 0.404 . . . . 0.0 110.984 179.9 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.48 -92.72 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.88 -179.359 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -147.48 131.0 16.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.824 0.345 . . . . 0.0 110.834 -179.648 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.586 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 68.47 23.21 75.19 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.917 -178.831 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.491 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.0 m-85 -116.18 168.36 10.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.797 0.332 . . . . 0.0 110.994 -179.183 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.937 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -130.56 124.32 31.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.55 178.248 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.918 HD21 ' O ' ' A' ' 44' ' ' GLU . 5.4 tt -87.99 124.54 33.83 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.725 -179.622 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.937 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.1 mm -102.62 165.09 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.006 0.432 . . . . 0.0 111.071 -179.893 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.463 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 74.65 -136.15 20.47 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.241 -179.458 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.918 ' O ' HD21 ' A' ' 41' ' ' LEU . 1.9 pt-20 -74.54 -173.22 1.71 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.767 0.318 . . . . 0.0 110.534 179.197 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.8 p -163.42 24.31 0.08 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.219 -179.502 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.471 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -166.98 125.7 1.37 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.524 -177.554 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.456 ' CB ' ' HA ' ' A' ' 62' ' ' GLU . 0.4 OUTLIER -92.13 138.72 31.3 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 177.492 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.552 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 2.1 m-85 -116.46 119.71 36.49 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 119.446 -0.902 . . . . 0.0 111.765 179.88 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 26.8 t -70.01 112.8 6.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.756 179.537 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.418 ' OE2' ' ND2' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -139.76 -171.55 3.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 179.741 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.653 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.034 -179.558 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 6.7 mtt . . . . . 0 N--CA 1.455 -0.178 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.2 m -148.93 176.45 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.188 -178.755 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.535 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 65.7 m95 -132.15 125.73 31.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.02 179.813 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.552 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 3.2 m-20 -68.8 168.38 15.22 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.127 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.494 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 19.0 Cg_exo -10.66 88.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.043 1 C-N-CA 125.342 4.028 . . . . 0.0 114.783 -179.032 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.469 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 1.0 OUTLIER -83.82 -97.97 0.05 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.631 -177.381 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.474 ' HA ' ' CD2' ' A' ' 33' ' ' TYR . . . -84.65 110.29 26.34 Favored Pre-proline 0 C--O 1.231 0.096 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -175.903 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.849 ' HG2' HD11 ' A' ' 41' ' ' LEU . 5.0 Cg_exo -78.53 -153.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.918 2.412 . . . . 0.0 111.086 177.025 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.527 HG22 ' H ' ' A' ' 66' ' ' CYS . 3.8 mm -93.83 167.68 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.672 0.272 . . . . 0.0 110.368 177.929 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.527 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -165.43 135.07 3.5 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.017 -179.968 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -156.38 178.38 10.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.955 -179.794 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.491 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 52.9 p -86.1 113.2 21.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.981 179.982 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.726 HG23 ' HB3' ' A' ' 40' ' ' HIS . 0.1 OUTLIER -43.54 98.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.589 -179.907 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.443 ' HE3' ' CG2' ' A' ' 90' ' ' THR . 1.3 mmtp -72.08 107.93 5.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.1 179.852 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.419 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -93.37 125.26 37.87 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.818 0.342 . . . . 0.0 110.159 178.578 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.88 -156.02 0.06 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.478 179.807 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.426 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 1.7 t -48.8 138.24 12.54 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.084 -179.854 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.512 ' HG2' HG11 ' A' ' 95' ' ' VAL . 25.3 Cg_exo -61.11 163.34 17.02 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.372 2.048 . . . . 0.0 112.035 179.764 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.532 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 82.7 Cg_exo -38.75 156.43 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.895 2.396 . . . . 0.0 112.903 -179.274 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.5 m -109.78 89.76 3.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.484 179.315 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.678 HG23 ' HE2' ' A' ' 97' ' ' TYR . 32.7 pt -69.09 175.22 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.09 -179.318 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.426 ' HB3' ' ND2' ' A' ' 79' ' ' ASN . 0.6 OUTLIER -95.71 145.94 24.9 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.399 178.605 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.533 ' HB3' ' CD2' ' A' ' 103' ' ' TYR . 3.0 m-80 59.46 28.74 18.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.895 0.379 . . . . 0.0 111.104 177.876 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -170.48 -161.68 21.48 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.644 -0.788 . . . . 0.0 113.092 179.634 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' ' 98' ' ' SER . 1.4 ptt85 -170.18 -175.22 1.92 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.972 0.415 . . . . 0.0 110.984 -178.79 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 12.2 p80 -105.05 176.43 5.16 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.982 179.874 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.424 ' ND2' ' HB ' ' A' ' 96' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.239 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.543 179.138 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.414 ' HB3' ' HD3' ' A' ' 70' ' ' LYS . 7.3 m-85 . . . . . 0 N--CA 1.455 -0.212 0 CA-C-O 120.96 0.41 . . . . 0.0 111.251 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.419 ' N ' ' O ' ' A' ' 71' ' ' CYS . 62.5 m-85 -144.09 163.52 33.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.491 179.843 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.443 ' CG2' ' HE3' ' A' ' 70' ' ' LYS . 16.0 p -128.22 179.93 5.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.906 0.384 . . . . 0.0 111.349 -179.228 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.1 p-10 -64.48 94.75 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.267 0.556 . . . . 0.0 110.864 -179.926 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.34 28.05 1.04 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.116 179.085 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.433 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -106.0 161.5 14.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.679 0.276 . . . . 0.0 110.522 179.125 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 35.3 m -134.07 152.24 33.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.215 0.531 . . . . 0.0 111.441 -179.567 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.542 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 21.6 t -150.88 147.27 15.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.618 179.27 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.516 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -103.83 144.72 31.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.114 178.574 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.92 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.7 m-85 -100.5 156.76 17.1 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.596 179.941 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 81' ' ' ARG . 51.8 p -153.18 143.88 22.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.349 -178.82 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.482 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 23.3 m -69.52 164.88 22.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.086 -178.844 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -94.88 -84.78 0.32 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.878 178.913 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.35 -41.07 79.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.495 -179.259 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 147.07 42.56 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.644 -179.978 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.533 ' CD2' ' HB3' ' A' ' 79' ' ' ASN . 23.3 m-85 -80.14 -165.85 0.92 Allowed 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 122.355 0.262 . . . . 0.0 110.601 179.962 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 124' ' ' CYS . 4.3 m -120.64 107.53 12.92 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.798 0.332 . . . . 0.0 111.719 -179.967 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.446 HD23 ' HB2' ' A' ' 122' ' ' PRO . 1.4 tp -48.33 117.12 1.82 Allowed 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.334 177.83 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.469 ' HB ' ' CB ' ' A' ' 123' ' ' THR . 44.9 mm -91.53 154.34 3.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.036 -178.859 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.424 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 60.55 -128.88 46.29 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.082 -179.399 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -114.11 127.23 55.82 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.878 0.37 . . . . 0.0 110.819 179.35 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.516 ' HB2' HG22 ' A' ' 96' ' ' THR . 0.1 OUTLIER -64.01 -28.12 69.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.769 179.741 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.31 144.9 41.72 Favored Glycine 0 N--CA 1.452 -0.256 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.822 -179.919 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.92 HG21 ' CE1' ' A' ' 97' ' ' TYR . 3.4 t -140.52 127.51 22.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.544 0.211 . . . . 0.0 110.989 -179.959 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.45 128.87 34.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.911 0.386 . . . . 0.0 111.524 -179.51 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.511 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 24.7 t -91.98 104.69 17.07 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.513 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.2 t -150.89 163.95 37.47 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.146 0.498 . . . . 0.0 111.596 -177.976 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 45.29 32.21 3.58 Favored Glycine 0 N--CA 1.453 -0.219 0 CA-C-N 115.54 -0.754 . . . . 0.0 113.096 179.557 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.464 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 67.92 13.17 63.65 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.696 -179.994 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -143.17 171.42 14.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.84 0.353 . . . . 0.0 110.267 179.292 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.542 ' CZ3' HG23 ' A' ' 95' ' ' VAL . 87.8 m95 -108.43 131.92 54.29 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.885 -179.364 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.99 149.81 34.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.066 0.46 . . . . 0.0 111.234 -179.154 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.493 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER 70.43 44.88 0.24 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.231 179.057 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 73.6 Cg_endo -76.9 140.56 20.55 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.266 1.977 . . . . 0.0 111.215 177.834 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.509 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 36.4 Cg_endo -91.78 -179.55 1.29 Allowed 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.453 2.102 . . . . 0.0 113.255 -178.679 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.469 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -118.77 -162.34 0.89 Allowed 'General case' 0 CA--C 1.502 -0.885 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.041 176.278 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . 0.44 ' SG ' ' HB2' ' A' ' 103' ' ' TYR . 4.9 t -170.39 91.72 0.18 Allowed 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 119.901 -0.72 . . . . 0.0 111.265 -176.486 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -116.2 174.79 5.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.042 -178.685 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.527 HG12 ' CE1' ' A' ' 103' ' ' TYR . 46.7 mm . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.865 -179.881 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.486 ' HB3' HG23 ' A' ' 25' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.133 0 CA-C-O 121.034 0.445 . . . . 0.0 111.14 . . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.46 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 48.0 m -80.99 161.22 63.95 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.813 179.68 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 54.7 Cg_endo -69.77 172.47 12.59 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.355 2.037 . . . . 0.0 111.337 178.773 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.428 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 3.1 p -50.93 117.66 8.97 Favored Pre-proline 0 C--N 1.328 -0.327 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.913 -179.19 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.552 ' HB3' HD11 ' A' ' 31' ' ' ILE . 17.8 Cg_endo -58.71 161.66 14.55 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.708 2.272 . . . . 0.0 112.348 -179.874 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.562 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -61.92 179.92 0.24 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.105 178.744 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.33 -171.07 2.73 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.015 0.436 . . . . 0.0 111.321 -179.678 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.573 HG22 ' CD2' ' A' ' 20' ' ' LEU . 11.0 tt -152.56 150.15 13.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.798 -179.743 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -95.45 -52.39 4.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.111 -179.519 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.43 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 1.4 m120 -94.17 42.05 1.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.122 0.487 . . . . 0.0 110.819 -179.85 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.409 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -169.67 -169.74 33.29 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.429 179.806 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -148.14 130.09 15.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.667 0.27 . . . . 0.0 110.785 -179.505 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.815 HD21 ' CE1' ' A' ' 33' ' ' TYR . 19.5 mt -78.52 161.35 27.1 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.271 0.558 . . . . 0.0 111.72 -179.674 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -132.09 74.16 1.57 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.269 177.523 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.853 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.7 OUTLIER -80.75 107.55 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.86 -176.794 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.31 14.65 56.75 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.988 177.464 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 158.74 155.23 7.52 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.151 -179.62 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.486 HG23 ' HB3' ' A' ' 8' ' ' ARG . 31.2 m -132.72 8.42 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -179.52 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 0.7 OUTLIER -72.72 154.7 40.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.804 0.335 . . . . 0.0 111.009 -179.9 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.595 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 6.0 t80 -50.44 92.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.874 -179.949 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 128.25 -5.16 6.79 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.784 -179.732 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.39 -175.51 0.65 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.903 0.352 . . . . 0.0 110.787 179.92 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.1 p -157.45 139.59 14.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.093 179.776 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.853 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.4 OUTLIER -107.51 170.15 2.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.478 -179.884 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.702 HG23 ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -134.35 115.92 14.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.893 0.378 . . . . 0.0 110.986 179.58 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.815 ' CE1' HD21 ' A' ' 20' ' ' LEU . 23.0 m-85 -93.09 138.02 31.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.361 -179.067 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.83 170.13 16.27 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.782 179.847 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.429 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 50.9 m -91.03 163.39 14.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.858 0.361 . . . . 0.0 111.188 -179.639 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.405 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 1.5 m-20 -62.69 -82.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.255 -179.655 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.39 136.48 13.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.852 -179.702 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.52 23.05 64.42 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.107 -179.42 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.512 ' CE2' ' HB3' ' A' ' 68' ' ' SER . 2.5 m-30 -116.64 174.25 6.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.95 0.405 . . . . 0.0 111.135 -179.273 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.609 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -134.91 123.67 23.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.995 177.453 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.947 HD11 ' HG2' ' A' ' 64' ' ' PRO . 10.2 tt -80.32 144.23 32.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.838 -178.531 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.709 HD13 ' C ' ' A' ' 41' ' ' LEU . 1.9 mm -124.73 152.12 30.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.942 -179.865 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.62 -127.34 7.99 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.039 -179.165 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.852 ' O ' HD21 ' A' ' 41' ' ' LEU . 7.0 pm0 -85.29 167.85 15.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.82 0.343 . . . . 0.0 110.568 178.887 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.8 p -150.8 21.07 0.79 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.898 179.609 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.702 ' HG2' HG23 ' A' ' 32' ' ' THR . 0.0 OUTLIER -163.95 124.37 2.16 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.278 -179.299 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.45 ' HB3' ' CG ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -102.18 156.37 17.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.635 -179.269 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.462 ' CB ' ' HB2' ' A' ' 60' ' ' ASN . 1.7 m-85 -132.45 123.78 27.33 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 119.937 -0.705 . . . . 0.0 112.508 -178.192 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 35.5 t -70.14 95.68 1.0 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.38 178.305 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.5 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 3.7 tt0 -128.01 171.22 12.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.495 0.664 . . . . 0.0 111.033 -179.071 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.595 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 1.3 mt . . . . . 0 C--N 1.321 -0.655 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.366 -179.784 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.941 0.4 . . . . 0.0 111.091 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.2 m -125.97 -169.22 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.687 179.457 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.52 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 73.2 m95 -130.45 130.49 44.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.953 0.406 . . . . 0.0 111.819 -179.193 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.469 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.9 OUTLIER -76.45 166.98 40.68 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.483 177.227 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.469 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 42.9 Cg_exo -11.91 96.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.774 1 C-N-CA 125.646 4.231 . . . . 0.0 115.242 -178.574 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.45 ' CG ' ' HB3' ' A' ' 47' ' ' SER . 36.6 mt-10 -100.79 -98.65 0.25 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.951 -178.147 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.468 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -70.67 107.04 2.09 Favored Pre-proline 0 N--CA 1.462 0.167 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -176.545 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.947 ' HG2' HD11 ' A' ' 41' ' ' LEU . 2.3 Cg_endo -89.45 -156.94 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.512 2.808 . . . . 0.0 111.223 177.723 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.63 HD12 ' HB ' ' A' ' 42' ' ' ILE . 1.0 OUTLIER -93.08 173.26 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.931 0.396 . . . . 0.0 110.393 177.904 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.591 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -171.36 142.65 1.72 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.013 179.622 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -169.49 172.09 7.27 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.805 179.458 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.512 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 34.0 p -80.41 126.87 31.73 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.646 179.583 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.448 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 1.3 p -41.51 97.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.584 -179.499 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.437 ' HD2' ' HB3' ' A' ' 88' ' ' PHE . 13.7 mmtp -66.72 129.78 40.99 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.945 -178.468 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.8 115.93 26.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.538 177.166 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.32 -163.41 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.957 -178.658 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.432 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 1.6 t -45.15 135.27 5.25 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.324 -179.194 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.595 ' HG2' HG11 ' A' ' 95' ' ' VAL . 31.6 Cg_exo -58.96 160.98 16.71 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.364 2.043 . . . . 0.0 112.006 -179.9 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.43 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 87.0 Cg_exo -40.86 156.76 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.795 2.33 . . . . 0.0 112.975 -179.135 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.72 89.84 3.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.783 179.9 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.67 HG21 ' O ' ' A' ' 122' ' ' PRO . 25.8 pt -69.47 178.75 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.551 -179.201 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.4 m -100.48 145.41 28.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.645 179.411 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.415 ' HB3' ' CD2' ' A' ' 103' ' ' TYR . 3.3 m-80 58.55 26.78 14.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.904 179.776 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.464 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -165.87 -164.47 21.41 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.378 179.933 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 98' ' ' SER . 7.7 ptt85 -167.83 -175.86 2.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.151 0.5 . . . . 0.0 111.102 -179.4 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 14.6 p80 -110.76 166.15 11.25 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.661 178.832 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 . . . . . 0 C--N 1.326 -0.436 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.37 179.247 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.437 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 8.2 m-85 . . . . . 0 N--CA 1.456 -0.168 0 CA-C-O 120.824 0.345 . . . . 0.0 111.194 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.436 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 62.5 m-85 -151.0 160.47 43.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.593 -179.913 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.434 ' CG2' ' OG ' ' A' ' 68' ' ' SER . 36.9 p -126.81 -177.24 3.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.022 0.439 . . . . 0.0 111.518 -179.048 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 20.4 p-10 -65.47 94.07 0.17 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.007 -179.805 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 127.1 30.59 0.79 Allowed Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.336 -0.847 . . . . 0.0 113.074 178.817 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.434 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.5 OUTLIER -109.92 160.32 16.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.773 0.32 . . . . 0.0 110.632 179.324 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 34.7 m -136.26 150.97 28.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.132 0.491 . . . . 0.0 111.216 -179.603 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.595 HG11 ' HG2' ' A' ' 74' ' ' PRO . 21.8 t -145.54 148.52 17.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.753 179.686 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.786 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -110.91 123.38 50.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.012 -179.787 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.972 ' CE2' HG21 ' A' ' 111' ' ' VAL . 5.6 m-85 -79.82 156.68 27.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.752 -179.709 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 81' ' ' ARG . 3.9 p -149.86 148.97 29.8 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.914 0.388 . . . . 0.0 112.03 -177.973 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.538 ' HB3' ' HB2' ' A' ' 103' ' ' TYR . 21.2 m -68.8 154.75 41.43 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.541 179.832 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.464 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 85.4 m-20 -73.94 -87.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.111 -177.992 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.43 -43.77 26.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.64 0.257 . . . . 0.0 111.687 -177.642 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 178.44 32.17 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.352 -0.928 . . . . 0.0 113.112 -177.548 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.546 ' CZ ' HG12 ' A' ' 126' ' ' ILE . 0.8 OUTLIER -72.95 -161.81 0.1 Allowed 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.611 -0.295 . . . . 0.0 110.39 -179.524 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' A' ' 124' ' ' CYS . 3.1 t -141.46 117.56 10.62 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.962 0.411 . . . . 0.0 110.77 177.44 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.745 HD22 ' HB2' ' A' ' 109' ' ' SER . 0.2 OUTLIER -58.9 140.4 55.44 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.836 0.826 . . . . 0.0 112.063 -178.119 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.445 HG22 ' N ' ' A' ' 107' ' ' GLY . 37.4 mm -110.24 158.37 10.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 114.057 -1.429 . . . . 0.0 110.075 179.154 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.445 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 63.96 -125.42 32.43 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.034 -179.158 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -123.33 130.76 53.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.856 0.36 . . . . 0.0 110.837 179.38 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.786 ' OG ' HG22 ' A' ' 96' ' ' THR . 2.7 t -66.18 -31.1 71.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.865 179.879 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.4 138.28 30.38 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.049 -179.407 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.972 HG21 ' CE2' ' A' ' 97' ' ' TYR . 2.9 t -134.4 119.44 30.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.64 0.257 . . . . 0.0 110.744 179.024 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.84 125.71 30.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.923 0.392 . . . . 0.0 111.629 -179.114 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.507 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 14.9 t -91.82 105.76 17.96 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 176.176 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.1 OUTLIER -148.69 163.09 38.34 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.109 0.48 . . . . 0.0 111.36 -178.495 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.2 30.91 4.3 Favored Glycine 0 CA--C 1.517 0.187 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.731 179.865 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.448 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 68.91 16.03 69.93 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.599 -179.525 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -141.28 -179.18 5.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.905 0.383 . . . . 0.0 110.68 179.72 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.536 ' CZ3' HG23 ' A' ' 95' ' ' VAL . 94.9 m95 -116.63 142.71 46.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.919 -179.85 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.74 147.35 49.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.142 -179.762 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.487 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER 70.17 45.66 0.26 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.153 179.122 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 98.0 Cg_endo -77.9 133.68 12.72 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.372 2.048 . . . . 0.0 111.295 177.782 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.67 ' O ' HG21 ' A' ' 77' ' ' ILE . 93.7 Cg_endo -93.22 -173.15 0.37 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.475 2.117 . . . . 0.0 113.714 -177.824 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.43 -170.01 2.21 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-N 114.054 -1.43 . . . . 0.0 108.582 176.359 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 104' ' ' SER . 2.5 t -161.2 105.93 1.34 Allowed 'General case' 0 N--CA 1.424 -1.756 0 CA-C-O 122.127 0.965 . . . . 0.0 110.879 -177.667 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -112.14 152.9 27.77 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 113.491 -1.686 . . . . 0.0 110.329 -179.685 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.682 HG22 ' O ' ' A' ' 126' ' ' ILE . 5.0 mm . . . . . 0 C--N 1.32 -0.712 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.953 179.828 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.415 ' HD2' HG23 ' A' ' 25' ' ' VAL . 35.5 mtm180 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.813 0.34 . . . . 0.0 110.79 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.457 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 29.6 m -84.55 159.82 57.69 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.576 179.56 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.5 169.79 17.75 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.543 2.162 . . . . 0.0 112.527 -179.07 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.425 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 3.4 t -51.38 105.63 0.55 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.836 179.89 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 11' ' ' SER . 12.7 Cg_endo -58.5 144.79 96.54 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.044 1.829 . . . . 0.0 111.768 179.699 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.928 ' O ' HD11 ' A' ' 20' ' ' LEU . 3.0 mtt180 -45.45 122.81 3.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.412 0.625 . . . . 0.0 111.343 -179.341 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.663 ' O ' HG22 ' A' ' 15' ' ' ILE . 0.2 OUTLIER -73.91 -7.4 52.18 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.213 -178.932 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.663 HG22 ' O ' ' A' ' 14' ' ' ASP . 18.2 tt 51.72 159.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 121.353 0.597 . . . . 0.0 112.089 -178.803 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.433 ' N ' HG12 ' A' ' 15' ' ' ILE . 7.0 t0 -100.56 159.07 15.45 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.632 177.484 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.496 ' HB2' ' CD2' ' A' ' 39' ' ' TYR . 0.0 OUTLIER 42.82 29.32 0.17 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.77 0.319 . . . . 0.0 111.222 -179.408 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.425 ' HA2' ' N ' ' A' ' 36' ' ' ASN . . . -152.12 176.72 30.3 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.74 -179.42 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -142.56 140.12 31.63 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.673 0.273 . . . . 0.0 110.696 179.938 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.928 HD11 ' O ' ' A' ' 13' ' ' ARG . 52.0 mt -88.99 155.52 19.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.305 0.574 . . . . 0.0 112.096 -178.888 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -124.11 79.03 1.69 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.268 177.181 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.908 ' HA ' HG23 ' A' ' 31' ' ' ILE . 1.3 mt -75.29 107.71 6.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.36 -176.096 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -109.75 20.8 26.55 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.191 175.869 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 154.63 124.8 0.94 Allowed Glycine 0 C--N 1.334 0.444 0 N-CA-C 111.799 -0.52 . . . . 0.0 111.799 -178.948 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.495 HG13 ' CG2' ' A' ' 22' ' ' ILE . 28.7 m -120.4 32.49 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -178.504 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.3 OUTLIER -100.9 151.05 22.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.843 0.354 . . . . 0.0 110.921 179.372 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.523 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 8.1 t80 -49.57 91.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.938 179.996 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 129.5 1.73 5.53 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.997 -179.807 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.37 -164.27 1.16 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 117.052 0.426 . . . . 0.0 110.669 179.677 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.4 p -160.01 153.19 21.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.958 0.409 . . . . 0.0 111.164 179.475 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.908 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.8 OUTLIER -114.01 175.0 2.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.442 -179.972 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.458 ' H ' HG22 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -130.74 120.31 23.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.79 0.329 . . . . 0.0 110.706 178.638 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.461 ' CE2' HD21 ' A' ' 20' ' ' LEU . 19.4 m-85 -96.69 144.67 26.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.301 0.572 . . . . 0.0 112.215 -177.897 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.02 165.33 31.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.287 179.224 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.416 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 1.3 m -85.17 159.41 20.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.878 0.37 . . . . 0.0 110.928 -179.6 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.429 ' ND2' ' HA ' ' A' ' 17' ' ' ASN . 8.7 m-20 -59.76 -86.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.272 -178.68 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.3 t -153.02 132.22 12.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.896 0.379 . . . . 0.0 110.938 -179.979 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.72 22.6 73.69 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.036 -179.396 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.496 ' CD2' ' HB2' ' A' ' 17' ' ' ASN . 2.5 m-30 -114.81 -174.14 2.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.96 0.409 . . . . 0.0 110.902 -179.649 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.942 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -145.1 113.59 6.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.878 177.635 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.98 HD21 ' O ' ' A' ' 44' ' ' GLU . 6.5 tt -79.4 119.2 22.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.824 -178.631 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.942 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.0 mm -103.89 153.11 6.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.513 179.248 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.11 -127.46 8.21 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.989 179.626 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.98 ' O ' HD21 ' A' ' 41' ' ' LEU . 1.3 mt-10 -79.7 179.53 7.47 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.484 0.659 . . . . 0.0 112.618 -177.899 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.425 ' HA ' ' HB2' ' A' ' 33' ' ' TYR . 4.8 p -165.84 27.52 0.05 OUTLIER 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.005 -179.857 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.416 ' CG ' ' O ' ' A' ' 45' ' ' SER . 3.0 mtpt -166.83 123.73 1.24 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -177.774 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.45 ' HB3' HG13 ' A' ' 31' ' ' ILE . 5.8 t -94.07 152.23 18.93 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.103 177.496 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.547 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.1 m-85 -124.63 105.36 9.27 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.736 177.539 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.464 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 27.6 t -58.59 101.05 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.509 179.677 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.01 -171.08 2.22 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.164 -179.172 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.523 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.385 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.055 -179.375 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.4 mmt . . . . . 0 N--CA 1.456 -0.145 0 CA-C-O 120.804 0.335 . . . . 0.0 110.448 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.4 m -148.4 173.88 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.959 -179.537 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.622 ' CZ3' HD11 ' A' ' 31' ' ' ILE . 74.0 m95 -126.29 124.68 40.88 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.147 -179.907 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.547 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.7 OUTLIER -68.98 166.84 24.06 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 177.368 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.478 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 78.3 Cg_exo -15.07 88.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 125.229 3.953 . . . . 0.0 114.253 -179.408 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.446 ' HA ' ' HB2' ' A' ' 47' ' ' SER . 1.0 OUTLIER -92.73 -93.41 0.15 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.244 -177.43 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.23 106.06 1.32 Allowed Pre-proline 0 C--O 1.231 0.125 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -177.118 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.667 ' HG2' HD11 ' A' ' 41' ' ' LEU . 1.9 Cg_endo -84.43 -153.6 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.993 2.462 . . . . 0.0 110.576 178.059 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.466 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 3.4 mm -86.77 161.32 2.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.994 0.426 . . . . 0.0 111.105 179.911 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.406 ' HB3' ' OD1' ' A' ' 17' ' ' ASN . 0.8 OUTLIER -169.76 130.9 1.05 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.965 179.491 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -154.92 175.61 13.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.665 179.576 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.476 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 1.7 p -87.39 121.75 30.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.295 179.053 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.471 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 1.6 p -41.92 94.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 120.971 0.415 . . . . 0.0 111.299 -179.591 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.427 ' HD2' ' HB3' ' A' ' 88' ' ' PHE . 2.7 mmtt -79.63 140.37 37.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.835 -177.85 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.424 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -116.89 122.34 44.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.977 178.544 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.36 -164.66 0.06 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.935 -178.993 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 2.0 t -49.1 136.16 14.86 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.814 -179.504 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.48 ' HG3' ' CZ2' ' A' ' 118' ' ' TRP . 24.3 Cg_exo -59.48 155.71 40.19 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.119 1.879 . . . . 0.0 111.675 179.905 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.434 ' HG2' ' HD3' ' A' ' 121' ' ' PRO . 95.9 Cg_exo -44.17 164.46 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.984 2.456 . . . . 0.0 113.237 -178.458 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 83.0 p -113.04 90.49 3.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.592 179.697 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.2 pt -68.74 172.88 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.942 -179.623 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.0 133.77 35.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.086 -179.555 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.504 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 0.2 OUTLIER 66.78 28.09 9.01 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.707 179.872 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.421 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -163.64 -177.99 36.93 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.287 -0.959 . . . . 0.0 113.187 -179.833 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.71 -175.76 5.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.815 0.34 . . . . 0.0 110.301 179.757 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.503 ' HB3' ' CE2' ' A' ' 97' ' ' TYR . 4.0 p-80 -120.78 161.6 21.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.07 0.462 . . . . 0.0 111.545 179.993 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.905 -179.904 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.427 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 9.7 m-85 . . . . . 0 N--CA 1.448 -0.559 0 CA-C-O 121.104 0.478 . . . . 0.0 111.239 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.424 ' N ' ' O ' ' A' ' 71' ' ' CYS . 21.1 m-85 -141.43 163.39 33.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.797 179.358 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.7 p -122.77 165.57 16.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.042 0.449 . . . . 0.0 111.901 -177.758 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 5.6 p-10 -56.55 98.32 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.697 179.767 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 128.44 12.47 2.79 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.097 -0.956 . . . . 0.0 113.071 179.555 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.79 161.58 13.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.945 0.372 . . . . 0.0 110.399 179.211 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 30.2 m -141.35 147.39 22.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.113 0.482 . . . . 0.0 110.782 -179.913 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.55 HG23 ' CH2' ' A' ' 118' ' ' TRP . 43.7 t -136.94 151.32 27.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.56 179.561 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.972 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -108.2 129.29 55.2 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.977 -179.565 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.977 ' CE2' HG21 ' A' ' 111' ' ' VAL . 6.0 m-85 -92.97 155.65 17.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.081 -179.525 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.1 p -149.16 139.33 22.21 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.443 -179.308 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 52.0 m -69.67 152.87 44.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.676 179.178 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.421 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 26.9 m-20 -92.67 -70.41 0.7 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.237 -179.383 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 36.8 m -55.5 -23.36 25.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.151 -179.683 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 118.77 30.7 1.59 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.344 -179.752 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.504 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 18.8 m-85 -71.39 -173.13 0.84 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.882 0.372 . . . . 0.0 110.774 179.986 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.69 103.89 11.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.296 -179.386 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.637 HD21 ' HG2' ' A' ' 122' ' ' PRO . 2.1 tp -42.62 115.89 0.78 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.419 179.21 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.456 ' HB ' ' CB ' ' A' ' 123' ' ' THR . 46.7 mm -91.01 153.58 3.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.277 179.555 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 65.41 -121.83 21.52 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.084 -1.055 . . . . 0.0 111.502 -178.09 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -136.91 120.81 17.55 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.059 0.457 . . . . 0.0 111.207 178.759 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.972 ' OG ' HG22 ' A' ' 96' ' ' THR . 2.0 p -51.21 -26.6 7.29 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.95 179.326 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.46 119.13 10.86 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.849 -179.376 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.977 HG21 ' CE2' ' A' ' 97' ' ' TYR . 2.5 t -113.53 116.19 51.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 178.796 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.25 120.1 23.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.006 0.432 . . . . 0.0 111.828 -177.382 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.469 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 16.1 t -89.35 94.86 10.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.502 176.591 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.4 OUTLIER -136.17 159.43 41.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.33 -178.123 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.449 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 46.68 29.51 4.2 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.702 179.85 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.471 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 70.09 20.94 76.81 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.267 -179.42 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -142.85 170.85 14.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.833 0.349 . . . . 0.0 110.376 179.299 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.55 ' CH2' HG23 ' A' ' 95' ' ' VAL . 97.4 m95 -112.34 126.64 55.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.35 -179.192 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.48 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -92.97 131.62 37.81 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.489 174.804 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.604 ' HB2' HG13 ' A' ' 111' ' ' VAL . 2.3 m-20 109.42 -135.87 0.0 OUTLIER Pre-proline 0 CA--C 1.474 -1.945 0 N-CA-C 100.432 -3.914 . . . . 0.0 100.432 -166.987 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.566 ' CA ' ' HB3' ' A' ' 120' ' ' ASP . 64.4 Cg_endo -65.41 179.23 12.83 Favored 'Cis proline' 0 C--N 1.308 -1.566 0 CA-C-N 125.258 2.914 . . . . 0.0 113.36 -14.08 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.637 ' HG2' HD21 ' A' ' 105' ' ' LEU . 10.4 Cg_endo -89.56 -174.9 0.97 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.692 2.928 . . . . 0.0 111.463 176.75 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.456 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -121.61 -179.51 4.12 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.83 179.045 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . 0.42 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 4.9 m -139.95 94.59 2.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.743 179.947 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -123.33 163.69 20.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.971 -179.474 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.48 HG12 ' CE2' ' A' ' 103' ' ' TYR . 41.1 mm . . . . . 0 C--N 1.325 -0.478 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.927 -179.917 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 80.2 mtm180 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.915 0.388 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.46 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 48.7 m -92.4 159.86 36.09 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.839 179.864 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 36.9 Cg_endo -66.45 173.85 7.1 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.491 2.127 . . . . 0.0 112.156 -179.695 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.404 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -49.28 107.64 0.82 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.126 -179.47 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.487 ' CG ' ' CD1' ' A' ' 22' ' ' ILE . 9.4 Cg_endo -52.64 154.98 11.06 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.282 1.988 . . . . 0.0 111.824 179.728 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 18.8 mtt180 -80.24 164.91 22.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.257 0.551 . . . . 0.0 111.502 -178.794 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -118.88 -166.71 1.27 Allowed 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.042 -178.023 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.531 HD12 ' HD2' ' A' ' 64' ' ' PRO . 8.5 tt -142.8 155.51 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.566 179.113 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -85.81 -55.45 3.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -176.882 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.415 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 0.2 OUTLIER -92.71 28.3 2.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.632 0.254 . . . . 0.0 111.551 -177.352 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.429 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -167.16 -165.23 24.21 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.784 179.482 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.894 ' C ' HD23 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -132.91 175.36 9.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.621 0.248 . . . . 0.0 110.345 179.031 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.894 HD23 ' C ' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -122.46 157.83 31.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.153 0.501 . . . . 0.0 111.224 -179.964 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -126.94 84.77 2.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.926 178.805 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.854 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -82.98 97.1 4.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.992 -177.01 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.2 11.73 70.08 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.033 177.436 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 165.27 148.69 5.58 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.297 -179.72 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.0 m -129.88 13.87 2.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.948 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -93.52 151.06 19.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.694 0.283 . . . . 0.0 110.578 179.534 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -49.28 100.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.952 0.406 . . . . 0.0 110.758 179.96 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.26 0.41 6.89 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.603 -178.885 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.1 p -99.56 169.54 9.22 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.877 0.339 . . . . 0.0 110.481 179.443 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 47' ' ' SER . 4.4 p -143.27 138.74 29.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.078 0.466 . . . . 0.0 111.015 179.948 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.854 HG23 ' HA ' ' A' ' 22' ' ' ILE . 1.0 OUTLIER -92.84 173.67 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.634 178.949 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.45 ' H ' HG22 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -135.92 113.2 10.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.982 0.42 . . . . 0.0 111.331 -179.667 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.585 ' CE1' HD22 ' A' ' 20' ' ' LEU . 22.2 m-85 -89.27 140.87 29.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.883 179.696 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -147.14 146.31 29.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.731 -179.918 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.441 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 23.1 m -69.81 167.98 16.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.89 0.376 . . . . 0.0 111.001 -179.682 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -66.48 -78.5 0.06 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.006 -179.776 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -158.84 139.13 12.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.607 179.867 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.543 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 58.11 28.39 61.18 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.883 -179.002 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.491 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.1 m-85 -119.37 168.13 11.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.828 0.347 . . . . 0.0 111.09 -179.28 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.924 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -127.39 117.08 21.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.404 177.806 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.919 HD21 ' O ' ' A' ' 44' ' ' GLU . 8.5 tt -81.97 126.03 31.47 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.778 -179.349 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.924 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.1 mm -105.62 164.46 4.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.116 -179.434 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.447 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 72.92 -132.26 16.94 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.507 179.986 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.919 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -81.92 -175.41 5.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.966 0.412 . . . . 0.0 110.759 179.575 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.419 ' O ' ' CG ' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -169.83 30.73 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.43 179.327 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.419 ' CG ' ' O ' ' A' ' 45' ' ' SER . 10.9 mtpt -166.91 114.47 0.82 Allowed 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.021 -178.315 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.486 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 0.4 OUTLIER -84.67 132.31 34.49 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 178.643 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.517 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.6 m-85 -107.1 120.74 42.91 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 119.514 -0.875 . . . . 0.0 111.516 -179.484 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.6 t -67.72 116.94 8.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.318 -179.035 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -158.5 179.66 8.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.371 179.413 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.633 ' C ' HD12 ' A' ' 51' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.326 -0.432 0 CA-C-O 120.746 0.308 . . . . 0.0 110.818 179.6 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.42 ' HA ' ' HA ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.451 -0.397 0 CA-C-O 121.318 0.58 . . . . 0.0 111.529 . . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.2 m -135.16 -175.47 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.458 179.868 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.522 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 59.5 m95 -128.41 128.18 43.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.837 0.351 . . . . 0.0 110.975 179.61 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.517 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.7 OUTLIER -69.69 164.93 46.23 Favored Pre-proline 0 C--O 1.224 -0.271 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.971 178.515 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.447 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 79.2 Cg_exo -16.73 100.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.741 1 C-N-CA 125.32 4.014 . . . . 0.0 114.498 -178.932 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.471 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -104.22 -82.15 0.51 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.753 -177.916 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.476 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -77.08 107.13 4.37 Favored Pre-proline 0 N--CA 1.463 0.185 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -176.355 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.893 ' HG2' HD11 ' A' ' 41' ' ' LEU . 3.1 Cg_endo -90.52 -155.54 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.345 2.697 . . . . 0.0 111.172 178.257 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.512 HG22 ' H ' ' A' ' 66' ' ' CYS . 3.9 mm -97.23 165.82 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.872 0.367 . . . . 0.0 110.847 178.803 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.512 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.2 m -162.32 136.92 6.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.944 179.904 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.22 173.23 16.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.758 179.793 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.491 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 80.8 p -81.42 112.63 18.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.999 179.954 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.756 HG22 ' HB3' ' A' ' 40' ' ' HIS . 6.3 p -44.62 97.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.429 179.844 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -79.76 127.59 32.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.617 -179.024 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.441 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -113.48 119.86 39.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.917 178.336 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.57 -159.63 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.775 0.322 . . . . 0.0 110.597 -179.067 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.463 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 2.3 t -49.06 137.75 13.76 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.818 -179.864 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.449 ' HA ' ' CD1' ' A' ' 118' ' ' TRP . 37.0 Cg_exo -56.77 161.64 9.88 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.168 1.912 . . . . 0.0 111.589 -179.874 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.507 ' HD3' ' CG ' ' A' ' 118' ' ' TRP . 79.7 Cg_exo -39.55 156.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.701 2.267 . . . . 0.0 112.785 -179.231 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.7 m -108.38 88.21 2.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.645 179.756 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.571 HG21 ' O ' ' A' ' 122' ' ' PRO . 13.5 pt -70.08 -177.68 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.299 -179.357 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.6 m -103.43 147.34 27.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.781 179.657 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.43 ' HB3' ' CD2' ' A' ' 103' ' ' TYR . 24.8 m-80 51.43 29.83 5.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.161 179.698 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.465 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -160.36 -165.27 16.87 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.395 -0.907 . . . . 0.0 113.098 179.798 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -164.18 -175.34 3.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.857 0.36 . . . . 0.0 110.463 -179.463 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.463 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 1.8 p-80 -120.37 166.14 13.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.617 -178.999 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.592 179.945 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.428 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 11.3 m-85 . . . . . 0 N--CA 1.449 -0.519 0 CA-C-O 121.091 0.472 . . . . 0.0 110.995 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.441 ' N ' ' O ' ' A' ' 71' ' ' CYS . 16.5 m-85 -141.69 166.89 23.5 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.922 179.569 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.2 p -131.29 179.64 5.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.127 0.489 . . . . 0.0 112.013 -177.97 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 5.4 p-10 -63.26 96.22 0.1 Allowed 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.904 179.888 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.49 14.49 2.9 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.297 -0.865 . . . . 0.0 113.152 179.157 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.67 156.58 16.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.906 0.353 . . . . 0.0 110.349 179.005 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.9 m -135.38 151.51 30.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.174 0.511 . . . . 0.0 111.095 -179.475 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.529 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 14.4 t -148.79 145.43 18.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.028 179.937 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.769 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -105.69 128.44 53.66 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.637 179.341 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.978 ' CE1' HG21 ' A' ' 111' ' ' VAL . 5.4 m-85 -89.0 157.83 18.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.154 -179.242 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.435 ' HA ' HD13 ' A' ' 105' ' ' LEU . 39.6 m -153.57 148.12 26.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.226 179.974 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.444 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 63.0 m -74.03 162.04 29.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.91 179.686 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.465 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 65.3 m-20 -84.9 -72.57 0.47 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.587 -179.055 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.0 m -70.84 -28.21 64.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.344 -178.67 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 132.08 36.78 0.3 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.712 179.854 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.501 ' CE1' HG12 ' A' ' 126' ' ' ILE . 33.8 m-85 -69.97 -174.82 0.82 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.893 0.378 . . . . 0.0 110.586 179.266 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.6 m -106.31 101.32 10.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.291 178.677 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.447 HD22 ' HB2' ' A' ' 109' ' ' SER . 0.3 OUTLIER -48.81 128.04 14.91 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.438 0.637 . . . . 0.0 111.508 -178.466 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.446 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 35.7 mm -91.56 153.31 3.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.955 179.078 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.47 -128.13 38.15 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.994 -178.926 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -123.79 143.86 50.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.828 0.347 . . . . 0.0 110.982 179.432 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.769 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.4 t -72.19 -32.57 66.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.703 179.638 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.13 137.42 29.66 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.747 -179.701 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.978 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.5 t -132.32 118.62 36.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.648 0.261 . . . . 0.0 110.554 179.247 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.71 114.95 21.94 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.916 0.389 . . . . 0.0 111.538 -178.848 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.504 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 26.3 t -82.5 100.93 10.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.659 176.881 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 1.8 t -138.61 154.58 48.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.113 0.482 . . . . 0.0 111.473 -178.2 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.519 ' CA ' HG11 ' A' ' 69' ' ' VAL . . . 53.09 21.02 9.84 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.934 179.489 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.452 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 82.8 8.05 86.46 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.8 -179.917 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.95 176.56 8.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.98 0.419 . . . . 0.0 110.692 179.737 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.529 ' CZ3' HG23 ' A' ' 95' ' ' VAL . 96.3 m95 -113.58 134.97 54.41 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.847 -179.763 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.3 147.22 44.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.343 -179.232 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.473 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER 71.23 46.08 0.24 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.123 178.843 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 98.0 Cg_endo -78.49 133.23 11.63 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.364 2.043 . . . . 0.0 111.453 178.179 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.571 ' O ' HG21 ' A' ' 77' ' ' ILE . 74.2 Cg_endo -91.25 -173.88 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.664 2.243 . . . . 0.0 113.513 -178.04 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.438 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -131.33 -161.23 1.11 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.878 177.689 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 6.6 m -157.4 92.03 1.21 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.199 0.523 . . . . 0.0 110.879 179.074 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.416 ' NE2' HG13 ' A' ' 106' ' ' ILE . 7.9 mt-30 -122.94 160.15 26.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.927 -179.652 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.501 HG12 ' CE1' ' A' ' 103' ' ' TYR . 46.5 mm . . . . . 0 C--N 1.324 -0.529 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.816 179.693 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.473 ' HD2' HG23 ' A' ' 25' ' ' VAL . 32.4 mtm180 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.851 0.358 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.468 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 32.7 m -86.62 160.93 49.48 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.908 -179.965 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.12 169.14 18.77 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.496 2.131 . . . . 0.0 112.02 179.92 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.3 t -50.59 104.52 0.43 Allowed Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.982 -179.351 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.469 ' HG2' HD11 ' A' ' 22' ' ' ILE . 2.7 Cg_exo -45.41 166.32 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.197 1.932 . . . . 0.0 111.919 -179.67 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.623 ' NH1' ' HB3' ' A' ' 63' ' ' ALA . 2.5 ttt-85 -73.84 170.03 16.18 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.0 178.321 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.648 ' HA ' HD11 ' A' ' 20' ' ' LEU . 2.9 p30 -125.4 -177.95 4.06 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.161 0.505 . . . . 0.0 112.055 -176.347 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.628 HG22 HD21 ' A' ' 20' ' ' LEU . 4.3 tt -148.54 142.73 18.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.338 179.372 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -79.89 -60.68 2.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.54 -178.33 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.437 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 1.5 m120 -91.03 45.37 1.24 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.961 0.41 . . . . 0.0 110.911 -179.251 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -167.01 -179.73 40.24 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.92 179.957 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -138.86 137.77 36.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.671 0.272 . . . . 0.0 110.525 179.641 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.856 HD22 ' CE2' ' A' ' 33' ' ' TYR . 0.5 OUTLIER -87.17 154.2 20.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.006 0.431 . . . . 0.0 111.443 -179.653 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -123.97 82.1 1.99 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.902 177.574 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.81 ' HA ' HG23 ' A' ' 31' ' ' ILE . 4.0 mm -68.93 105.08 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.495 -177.529 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.3 15.03 47.28 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.165 178.079 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.424 ' O ' ' CB ' ' A' ' 29' ' ' SER . . . 154.12 121.43 0.8 Allowed Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.206 -179.765 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.473 HG23 ' HD2' ' A' ' 8' ' ' ARG . 31.2 m -108.96 22.24 4.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.754 0.312 . . . . 0.0 111.442 -179.599 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -99.0 158.69 15.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.923 0.392 . . . . 0.0 110.855 179.502 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.562 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 8.3 t80 -56.27 92.1 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.899 -179.957 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 130.93 -0.22 5.3 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.77 -0.728 . . . . 0.0 113.072 -179.859 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 24' ' ' GLY . 58.2 m -89.87 -174.04 4.12 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.969 0.384 . . . . 0.0 110.75 179.848 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 48' ' ' TYR . 7.4 p -155.71 145.4 21.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.068 0.461 . . . . 0.0 111.456 -179.561 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.81 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.4 OUTLIER -104.68 167.57 2.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.444 179.445 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.553 HG23 ' HG3' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -132.81 108.83 9.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.948 0.404 . . . . 0.0 110.701 179.147 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.856 ' CE2' HD22 ' A' ' 20' ' ' LEU . 20.4 m-85 -81.5 149.5 28.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.177 -179.323 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.418 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 5.5 m -153.48 168.28 26.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.801 -179.61 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 1.6 m -88.08 171.99 9.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.833 179.912 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -70.23 -84.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.084 -179.4 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.44 130.5 10.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.524 179.858 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.712 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 64.8 23.63 69.29 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.864 -178.618 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.521 ' CZ ' ' HB3' ' A' ' 68' ' ' SER . 3.4 m-85 -113.85 175.34 5.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.681 0.277 . . . . 0.0 110.842 -179.085 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.791 ' CE1' HG22 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -131.16 132.57 44.85 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 175.731 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.927 HD21 ' O ' ' A' ' 44' ' ' GLU . 7.8 tt -95.35 118.43 32.08 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.886 -178.914 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.579 ' N ' HD13 ' A' ' 42' ' ' ILE . 1.1 mm -97.67 147.26 6.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.666 179.841 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.15 -149.5 23.04 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.21 -179.047 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.927 ' O ' HD21 ' A' ' 41' ' ' LEU . 1.2 pt-20 -67.14 -177.12 0.61 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.071 0.463 . . . . 0.0 110.786 179.361 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.45 30.09 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.336 179.846 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.553 ' HG3' HG23 ' A' ' 32' ' ' THR . 0.0 OUTLIER -162.31 123.37 2.59 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.773 -179.725 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.453 ' HB3' ' CG ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -105.47 155.04 19.54 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.536 -179.384 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.51 ' CD2' ' HB3' ' A' ' 60' ' ' ASN . 1.4 m-85 -130.86 125.06 32.61 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 119.686 -0.806 . . . . 0.0 112.283 -179.46 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.447 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 20.5 t -75.75 98.19 4.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.386 178.786 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.65 -173.33 2.62 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.107 -179.689 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.562 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.815 -179.68 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.496 ' O ' HG13 ' A' ' 58' ' ' VAL . 13.2 mtt . . . . . 0 N--CA 1.455 -0.202 0 CA-C-O 120.872 0.368 . . . . 0.0 110.548 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.496 HG13 ' O ' ' A' ' 57' ' ' MET . 3.4 m -157.76 163.52 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.94 -179.41 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.517 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 69.4 m95 -124.06 123.13 39.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.342 -179.489 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.51 ' HB3' ' CD2' ' A' ' 48' ' ' TYR . 3.2 m-20 -69.7 165.99 36.0 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.911 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 48.7 Cg_exo -9.61 95.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.029 1 C-N-CA 125.74 4.293 . . . . 0.0 115.074 -178.57 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.473 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 42.7 mt-10 -98.08 -99.27 0.21 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.482 -177.772 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.623 ' HB3' ' NH1' ' A' ' 13' ' ' ARG . . . -74.9 108.66 5.73 Favored Pre-proline 0 C--O 1.232 0.135 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -175.343 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.887 ' HG2' HD11 ' A' ' 41' ' ' LEU . 2.5 Cg_endo -87.01 -155.31 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.216 2.61 . . . . 0.0 110.757 176.668 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.466 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 2.1 mm -99.73 161.1 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.87 0.367 . . . . 0.0 110.786 178.685 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.437 ' HB3' ' HB2' ' A' ' 17' ' ' ASN . 1.1 m -155.65 137.53 14.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 -179.908 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.479 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -141.42 172.88 12.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.644 179.896 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.521 ' HB3' ' CZ ' ' A' ' 39' ' ' TYR . 1.1 p -108.38 123.72 49.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.283 -179.813 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.791 HG22 ' CE1' ' A' ' 40' ' ' HIS . 5.1 p -52.12 90.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.596 178.494 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 68' ' ' SER . 0.6 OUTLIER -68.8 132.62 47.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.893 -178.129 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.422 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -112.75 118.56 35.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.585 177.164 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.471 ' CG ' ' N ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -69.29 -157.97 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.358 -179.532 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.585 ' HG ' ' CE1' ' A' ' 82' ' ' HIS . 0.8 OUTLIER -52.38 142.36 30.08 Favored Pre-proline 0 N--CA 1.447 -0.593 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.781 179.919 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.493 ' HA ' ' CD1' ' A' ' 118' ' ' TRP . 23.8 Cg_exo -60.67 157.87 35.34 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.326 2.017 . . . . 0.0 111.813 179.741 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.492 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 81.0 Cg_exo -43.79 156.19 0.17 Allowed 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.62 2.214 . . . . 0.0 112.594 -179.429 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.7 t -105.79 90.27 3.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.771 179.905 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.586 HG23 ' HE1' ' A' ' 97' ' ' TYR . 22.2 pt -69.56 176.32 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.297 -179.477 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.8 m -94.01 143.39 26.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.416 178.898 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.506 ' HB3' ' CD2' ' A' ' 103' ' ' TYR . 4.3 m-80 57.34 30.01 17.81 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.758 -179.829 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.44 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . 178.88 -175.79 47.56 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.689 179.953 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.25 -175.06 1.86 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.765 0.316 . . . . 0.0 110.348 -179.893 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.585 ' CE1' ' HG ' ' A' ' 73' ' ' SER . 12.3 p80 -85.83 174.78 9.07 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.855 179.8 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.417 ' OD1' ' CG1' ' A' ' 95' ' ' VAL . 21.0 p-10 . . . . . 0 C--N 1.332 -0.186 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -178.254 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.425 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 12.7 m-85 . . . . . 0 N--CA 1.446 -0.651 0 CA-C-O 121.186 0.517 . . . . 0.0 111.614 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.425 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 12.3 m-85 -142.28 166.91 23.39 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.017 179.661 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.4 p -127.16 169.56 13.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.969 0.414 . . . . 0.0 111.573 -178.783 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.418 ' OD1' ' CG1' ' A' ' 69' ' ' VAL . 0.1 OUTLIER -58.55 100.79 0.07 Allowed 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.49 0.662 . . . . 0.0 110.689 179.461 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.76 14.28 3.9 Favored Glycine 0 C--N 1.313 -0.745 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.916 179.287 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.424 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.7 OUTLIER -95.97 158.63 15.36 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.957 0.379 . . . . 0.0 110.327 178.808 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.431 HG22 ' N ' ' A' ' 95' ' ' VAL . 35.0 m -134.37 156.17 40.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.055 0.455 . . . . 0.0 111.043 -179.355 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.533 HG23 ' CH2' ' A' ' 118' ' ' TRP . 40.1 t -148.94 152.14 12.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.646 179.95 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.771 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -112.25 121.02 43.72 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.097 0.475 . . . . 0.0 111.01 -179.673 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 1.005 ' CE2' HG21 ' A' ' 111' ' ' VAL . 4.9 m-85 -80.74 155.36 26.75 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.568 -178.986 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.431 ' HA ' ' CD1' ' A' ' 105' ' ' LEU . 90.3 p -153.42 143.97 22.53 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.378 -179.729 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.44 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 6.3 m -69.54 164.86 22.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.442 -179.886 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -93.25 -67.44 0.86 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.883 179.268 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.68 -34.47 72.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.247 -179.716 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 133.63 43.94 0.13 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.491 -179.952 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.524 ' CE1' HG12 ' A' ' 126' ' ' ILE . 6.4 m-85 -78.46 -171.05 2.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.832 0.348 . . . . 0.0 110.644 179.809 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -113.57 98.86 7.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.489 179.051 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.482 HD23 ' HB2' ' A' ' 122' ' ' PRO . 0.1 OUTLIER -49.83 144.67 6.14 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.534 0.683 . . . . 0.0 111.254 -179.091 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.553 HG22 ' N ' ' A' ' 107' ' ' GLY . 23.8 mm -121.67 162.12 21.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.999 -178.096 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.553 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 47.7 45.82 24.3 Favored Glycine 0 C--O 1.226 -0.402 0 C-N-CA 120.574 -0.822 . . . . 0.0 113.237 178.619 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.453 ' ND2' ' O ' ' A' ' 107' ' ' GLY . 0.7 OUTLIER 46.51 128.39 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 124.577 1.151 . . . . 0.0 114.09 177.556 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.771 ' OG ' HG22 ' A' ' 96' ' ' THR . 0.1 OUTLIER -55.07 -33.16 62.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.769 179.207 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -55.43 130.1 47.38 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.2 -178.534 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 1.005 HG21 ' CE2' ' A' ' 97' ' ' TYR . 2.4 t -127.31 150.19 32.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.024 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.28 122.23 47.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.951 0.405 . . . . 0.0 111.668 -179.149 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.504 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 15.3 t -87.76 100.88 13.17 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 176.733 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.6 OUTLIER -150.66 171.22 17.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.984 -178.654 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.418 ' N ' ' OD1' ' A' ' 91' ' ' ASP . . . 46.61 26.16 2.48 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.871 -179.935 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.12 18.82 76.82 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.281 -179.331 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -152.78 -176.68 5.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.895 0.379 . . . . 0.0 110.536 179.889 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.533 ' CH2' HG23 ' A' ' 95' ' ' VAL . 91.6 m95 -111.39 126.32 54.8 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.069 -179.425 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.8 161.09 14.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.263 -179.273 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.478 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 3.6 p30 48.46 46.04 3.33 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.434 179.161 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 57.5 Cg_endo -69.99 150.21 66.5 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.221 1.947 . . . . 0.0 110.691 176.51 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.566 ' O ' HG21 ' A' ' 77' ' ' ILE . 57.0 Cg_endo -95.99 177.51 0.7 Allowed 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.223 1.948 . . . . 0.0 114.089 -176.856 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.451 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -119.46 -160.8 0.83 Allowed 'General case' 0 CA--C 1.505 -0.784 0 CA-C-N 114.343 -1.298 . . . . 0.0 109.044 176.566 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . 0.425 ' SG ' ' HB2' ' A' ' 103' ' ' TYR . 5.0 t -170.32 91.02 0.18 Allowed 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.891 -175.98 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -122.16 175.76 6.19 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.355 -177.415 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.524 HG12 ' CE1' ' A' ' 103' ' ' TYR . 46.3 mm . . . . . 0 C--N 1.326 -0.437 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.677 179.37 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.445 ' HD2' HG23 ' A' ' 25' ' ' VAL . 6.4 mtm180 . . . . . 0 N--CA 1.455 -0.211 0 CA-C-O 120.986 0.422 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.524 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 65.9 m -69.82 175.91 2.04 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.596 178.565 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.553 ' HD2' ' CD1' ' A' ' 59' ' ' TRP . 35.6 Cg_endo -88.66 177.96 2.97 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.532 2.155 . . . . 0.0 111.452 179.047 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.8 t -51.31 105.54 0.54 Allowed Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.427 179.551 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.498 ' HG3' ' CZ2' ' A' ' 59' ' ' TRP . 53.5 Cg_exo -46.55 161.38 0.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.137 1.891 . . . . 0.0 112.366 -179.049 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.421 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -62.15 -173.42 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.849 177.673 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.508 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 0.4 OUTLIER -144.22 -175.95 4.82 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.288 179.524 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.412 HG23 ' C ' ' A' ' 18' ' ' GLY . 9.2 tt -146.71 142.98 20.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.571 179.739 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -73.94 -60.82 2.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.014 -177.63 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.409 ' O ' ' N ' ' A' ' 36' ' ' ASN . 0.1 OUTLIER -94.09 30.47 1.88 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.188 -178.133 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.412 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -147.17 177.43 25.47 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.896 -179.932 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -135.9 130.66 34.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.689 0.281 . . . . 0.0 110.365 179.01 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.868 HD21 ' CE2' ' A' ' 33' ' ' TYR . 24.6 mt -82.91 157.45 23.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.056 0.455 . . . . 0.0 111.726 -178.75 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.03 78.75 1.85 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.163 178.823 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.931 ' HA ' HG23 ' A' ' 31' ' ' ILE . 67.8 mt -69.93 100.27 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.843 -177.993 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.69 17.19 59.71 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.792 177.073 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 150.46 139.73 3.08 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.218 -179.601 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.445 HG23 ' HD2' ' A' ' 8' ' ' ARG . 35.8 m -124.1 31.15 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.915 0.388 . . . . 0.0 111.253 -179.477 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.41 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.4 OUTLIER -101.06 148.93 24.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.574 179.335 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.667 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 4.7 t80 -49.99 92.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.92 0.39 . . . . 0.0 110.79 179.909 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 131.44 -2.28 5.35 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.78 -179.094 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 65.6 p -89.15 -173.14 3.93 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 117.003 0.402 . . . . 0.0 110.444 179.468 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.3 p -155.11 154.36 32.26 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.002 0.43 . . . . 0.0 111.064 179.872 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.931 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.8 OUTLIER -115.65 164.6 11.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.491 -179.987 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -124.19 120.41 32.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.954 0.406 . . . . 0.0 111.253 -179.867 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.868 ' CE2' HD21 ' A' ' 20' ' ' LEU . 16.2 m-85 -97.77 135.28 39.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.182 -179.882 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.406 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -143.65 158.54 43.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.682 179.67 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.435 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 3.0 m -76.45 167.95 20.94 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.737 179.841 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 17' ' ' ASN . 0.6 OUTLIER -63.93 -81.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.898 -179.764 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -158.27 133.68 8.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.81 179.851 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.833 ' O ' HG22 ' A' ' 69' ' ' VAL . . . 64.43 23.61 68.61 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.107 -179.374 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.537 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.6 m-85 -114.58 179.84 3.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.793 0.33 . . . . 0.0 110.862 -179.622 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.882 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.5 OUTLIER -136.17 112.54 9.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.006 0.431 . . . . 0.0 110.55 178.135 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.934 HD11 ' HG2' ' A' ' 64' ' ' PRO . 4.6 tt -78.58 123.93 27.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.251 -179.981 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.882 HD11 ' CE1' ' A' ' 40' ' ' HIS . 1.9 mm -100.17 152.33 4.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.072 0.463 . . . . 0.0 111.059 -179.207 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.77 -137.92 17.4 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.117 -179.211 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.897 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -82.75 -175.86 5.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.943 0.402 . . . . 0.0 110.806 179.439 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.7 p -156.55 21.41 0.34 Allowed 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.458 -178.995 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -148.13 139.16 23.25 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.246 0.546 . . . . 0.0 112.304 -178.377 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.444 ' HB3' HG13 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -107.96 145.23 34.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.875 178.212 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.492 ' CB ' ' HB2' ' A' ' 60' ' ' ASN . 1.6 m-85 -123.61 119.99 31.5 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 119.179 -1.008 . . . . 0.0 112.405 -179.928 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.419 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 19.0 t -71.4 96.83 1.52 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.517 178.935 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.7 -173.96 2.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.167 -179.463 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.667 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.998 -179.851 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.528 ' O ' HG13 ' A' ' 58' ' ' VAL . 4.1 mmt . . . . . 0 N--CA 1.455 -0.194 0 CA-C-O 120.882 0.372 . . . . 0.0 110.513 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.528 HG13 ' O ' ' A' ' 57' ' ' MET . 2.4 m -158.78 172.91 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.1 -179.822 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.627 ' CE3' HD11 ' A' ' 31' ' ' ILE . 69.9 m95 -123.24 124.66 43.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.1 -179.976 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.492 ' HB2' ' CB ' ' A' ' 48' ' ' TYR . 3.1 m120 -69.28 163.98 52.98 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.333 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.439 ' O ' ' HA ' ' A' ' 47' ' ' SER . 38.9 Cg_exo -10.86 99.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.944 1 C-N-CA 125.735 4.29 . . . . 0.0 114.925 -178.618 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.476 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 7.9 mt-10 -91.62 -92.62 0.15 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.167 -0.924 . . . . 0.0 113.146 -176.43 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.508 ' HB2' ' O ' ' A' ' 14' ' ' ASP . . . -81.93 110.47 20.41 Favored Pre-proline 0 CA--C 1.528 0.109 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -174.953 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.934 ' HG2' HD11 ' A' ' 41' ' ' LEU . 5.1 Cg_exo -80.05 -153.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.942 2.428 . . . . 0.0 110.95 176.395 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.522 HG22 ' H ' ' A' ' 66' ' ' CYS . 3.5 mm -94.57 167.38 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.825 0.345 . . . . 0.0 110.919 178.833 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.522 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.2 m -166.44 132.9 2.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.171 179.24 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.9 164.56 35.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.761 -178.909 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.537 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 1.7 p -88.86 120.09 29.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.362 0.601 . . . . 0.0 111.248 -179.906 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.833 HG22 ' O ' ' A' ' 38' ' ' GLY . 0.6 OUTLIER -39.55 91.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.39 179.478 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.659 ' HZ1' ' HA ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -101.4 151.38 21.99 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.85 178.016 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.413 ' C ' ' HE3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -125.61 136.06 52.86 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.412 -177.63 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.659 ' HA ' ' HZ1' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -67.23 -173.18 0.26 Allowed 'General case' 0 N--CA 1.432 -1.354 0 CA-C-O 121.904 0.859 . . . . 0.0 113.115 -178.12 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -48.19 124.4 11.07 Favored Pre-proline 0 N--CA 1.441 -0.894 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.09 175.051 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.528 ' HG2' HG11 ' A' ' 95' ' ' VAL . 31.7 Cg_exo -46.09 153.33 1.01 Allowed 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.593 1.529 . . . . 0.0 111.88 -175.702 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.487 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 86.3 Cg_exo -45.59 154.34 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.741 2.294 . . . . 0.0 112.679 -177.492 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 12.8 t -103.1 91.02 3.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.666 -179.881 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.524 HG21 ' O ' ' A' ' 122' ' ' PRO . 18.9 pt -69.16 172.37 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.808 -179.962 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -93.29 134.04 35.9 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.892 -179.86 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.517 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 0.1 OUTLIER 66.95 27.76 8.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.543 -179.945 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -170.56 176.46 44.1 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.78 179.746 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 80' ' ' GLY . 3.5 mtp85 -148.49 -167.37 2.8 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.505 0.669 . . . . 0.0 111.706 -178.512 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 10.3 p-80 -127.37 160.28 31.87 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.843 178.993 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.611 -179.926 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.517 ' CD2' ' CD ' ' A' ' 70' ' ' LYS . 6.5 m-30 . . . . . 0 N--CA 1.448 -0.568 0 CA-C-O 121.096 0.474 . . . . 0.0 111.149 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.519 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 54.4 m-85 -152.61 166.45 32.04 Favored 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.647 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 12.2 p -147.47 -177.46 5.71 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.53 -0.868 . . . . 0.0 112.927 -178.416 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 7.9 p-10 -49.94 95.53 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.391 -179.575 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.01 10.04 5.9 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.43 -0.891 . . . . 0.0 113.269 177.467 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.422 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -95.16 143.77 26.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 117.253 0.526 . . . . 0.0 110.652 179.61 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 27.2 m -130.31 150.48 34.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.586 -179.736 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.528 HG11 ' HG2' ' A' ' 74' ' ' PRO . 24.3 t -142.96 147.07 21.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.039 179.877 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.714 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -103.68 130.59 51.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.929 -179.64 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.875 ' CE1' HG21 ' A' ' 111' ' ' VAL . 6.8 m-85 -91.68 154.78 18.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.153 -179.575 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.39 134.95 22.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.494 -179.471 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.444 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 81.1 m -69.34 158.39 35.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.908 179.864 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.91 -86.77 0.3 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.31 -179.702 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.0 t -43.6 -28.11 0.36 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.825 -178.944 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.05 38.45 0.43 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.361 -179.872 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.517 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 54.6 m-85 -81.6 -172.95 4.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.759 0.314 . . . . 0.0 110.852 -179.87 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 125' ' ' GLN . 0.3 OUTLIER -112.45 113.68 25.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.11 0.481 . . . . 0.0 110.985 -179.801 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.47 ' HA ' HD12 ' A' ' 105' ' ' LEU . 0.6 OUTLIER -47.51 109.78 0.25 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.509 178.554 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.46 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 47.5 mm -84.31 156.58 3.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.917 -178.947 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.445 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 59.06 -127.52 45.43 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.677 -178.736 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -117.18 133.68 55.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.012 0.434 . . . . 0.0 110.574 178.446 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.714 ' HB2' HG22 ' A' ' 96' ' ' THR . 0.1 OUTLIER -67.79 -29.56 68.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.376 179.6 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -77.0 125.61 7.5 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.673 179.622 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.875 HG21 ' CE1' ' A' ' 97' ' ' TYR . 10.9 t -115.86 124.94 72.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 178.771 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.864 HD22 ' N ' ' A' ' 113' ' ' CYS . 1.3 tm? -80.75 136.04 36.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.041 0.448 . . . . 0.0 111.527 -178.621 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.864 ' N ' HD22 ' A' ' 112' ' ' LEU . 18.4 t -108.95 107.2 17.48 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.702 177.116 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.606 ' CB ' HD11 ' A' ' 112' ' ' LEU . 2.8 t -164.34 134.13 3.94 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.992 0.425 . . . . 0.0 111.349 -179.717 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.49 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 89.76 16.4 56.57 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.477 -179.863 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.488 ' N ' ' HB ' ' A' ' 69' ' ' VAL . . . 86.33 1.83 85.81 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.064 -179.062 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -138.28 -170.66 2.86 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.755 0.788 . . . . 0.0 111.768 -178.809 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.507 ' CH2' ' HG3' ' A' ' 74' ' ' PRO . 97.0 m95 -117.5 159.67 22.46 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.381 179.055 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.544 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.2 OUTLIER -141.15 161.16 38.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.075 0.464 . . . . 0.0 111.785 -179.506 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.4 p30 46.87 53.67 13.99 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.423 179.069 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.448 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 87.3 Cg_endo -80.5 147.29 17.7 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.633 2.222 . . . . 0.0 111.37 177.227 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.524 ' O ' HG21 ' A' ' 77' ' ' ILE . 72.6 Cg_endo -92.05 -172.32 0.41 Allowed 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.71 2.273 . . . . 0.0 114.068 -177.339 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.444 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -136.63 -170.12 2.61 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.878 178.063 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 15.6 m -145.46 95.71 2.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.111 0.481 . . . . 0.0 111.211 -179.85 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.411 ' O ' ' HB2' ' A' ' 104' ' ' SER . 17.4 mt-30 -124.66 155.76 38.66 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.708 179.706 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.496 HG12 ' CE2' ' A' ' 103' ' ' TYR . 27.9 mm . . . . . 0 C--N 1.323 -0.572 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.914 179.961 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.662 ' HD2' HG23 ' A' ' 25' ' ' VAL . 70.0 mtm180 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.874 0.369 . . . . 0.0 111.012 . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.448 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 52.1 m -94.23 159.92 33.07 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.353 179.15 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.406 ' O ' ' HD3' ' A' ' 12' ' ' PRO . 57.4 Cg_endo -68.31 166.38 25.55 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.271 1.981 . . . . 0.0 111.333 178.919 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.4 p -51.71 104.95 0.46 Allowed Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.178 -178.738 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.67 ' HG2' HD13 ' A' ' 22' ' ' ILE . 12.7 Cg_exo -40.62 160.97 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.493 2.129 . . . . 0.0 112.517 -179.429 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.527 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -68.61 169.42 11.12 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.068 178.737 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.52 ' HA ' HD11 ' A' ' 20' ' ' LEU . 1.4 t0 -114.49 -173.98 2.4 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.253 0.549 . . . . 0.0 111.759 -178.192 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.552 HG22 ' CD2' ' A' ' 20' ' ' LEU . 13.9 tt -148.22 149.79 14.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.855 -179.435 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.401 ' O ' HG12 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -90.19 159.82 16.54 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.643 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.433 ' N ' ' ND2' ' A' ' 17' ' ' ASN . 0.3 OUTLIER 46.45 27.51 0.62 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.86 0.362 . . . . 0.0 110.508 -179.138 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.74 170.25 39.76 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.024 -0.607 . . . . 0.0 112.471 -178.974 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -136.57 155.56 49.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.882 0.372 . . . . 0.0 110.41 179.831 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.807 HD22 ' CE2' ' A' ' 33' ' ' TYR . 0.3 OUTLIER -93.05 162.43 14.04 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.256 -179.638 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 32' ' ' THR . 12.8 t0 -128.9 74.61 1.59 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.538 177.962 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.898 ' HA ' HG23 ' A' ' 31' ' ' ILE . 1.5 mt -75.02 102.95 2.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.394 -176.086 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.3 13.1 58.61 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.612 175.893 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 166.46 138.05 2.35 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 -179.495 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.662 HG23 ' HD2' ' A' ' 8' ' ' ARG . 13.7 m -125.52 1.96 4.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.49 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.443 ' HA ' ' CB ' ' A' ' 8' ' ' ARG . 37.3 t70 -71.79 165.12 24.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.879 0.371 . . . . 0.0 110.816 179.943 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.588 ' CZ ' HD12 ' A' ' 51' ' ' LEU . 6.7 t80 -57.68 90.59 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.967 -179.501 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.81 -2.59 6.01 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.007 179.819 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.7 m -82.04 162.32 22.63 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 117.004 0.402 . . . . 0.0 110.485 179.561 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.5 p -131.55 148.92 52.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.94 0.4 . . . . 0.0 110.973 179.785 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.898 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -108.67 170.64 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.668 -179.598 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.463 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -133.15 111.55 11.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.984 0.421 . . . . 0.0 110.874 179.015 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.807 ' CE2' HD22 ' A' ' 20' ' ' LEU . 12.1 m-85 -85.83 149.66 25.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.677 -178.475 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.1 m -149.52 160.64 43.3 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.134 179.821 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.403 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 3.5 m -84.27 169.18 14.97 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.068 179.939 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -67.76 -85.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.247 -178.972 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.23 132.67 12.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.742 -179.833 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.755 ' O ' HG22 ' A' ' 69' ' ' VAL . . . 68.36 21.22 74.07 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.912 -178.718 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.545 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.7 m-85 -116.72 176.12 5.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.719 0.295 . . . . 0.0 110.598 -179.903 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.863 ' CE1' HD11 ' A' ' 42' ' ' ILE . 1.3 p80 -139.93 118.1 11.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.082 0.468 . . . . 0.0 110.243 177.754 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.886 HD21 ' O ' ' A' ' 44' ' ' GLU . 7.9 tt -78.22 123.31 26.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.736 -178.877 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.863 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.0 mm -102.04 165.51 2.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.038 0.447 . . . . 0.0 111.052 -179.343 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.481 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 67.69 -142.56 40.51 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.163 -179.198 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.886 ' O ' HD21 ' A' ' 41' ' ' LEU . 1.0 OUTLIER -66.96 -175.56 0.43 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.006 0.431 . . . . 0.0 110.767 179.414 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.2 t -171.44 31.38 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.409 179.362 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.463 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -160.41 126.79 4.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.468 -178.153 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.458 ' CB ' HD12 ' A' ' 31' ' ' ILE . 0.1 OUTLIER -93.5 145.81 24.24 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.063 178.265 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.545 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.6 m-85 -122.18 115.29 22.14 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 119.414 -0.914 . . . . 0.0 111.583 178.579 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 39.1 t -68.04 100.18 0.96 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.845 -179.89 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.498 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -126.46 175.47 7.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.447 -179.686 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.588 HD12 ' CZ ' ' A' ' 27' ' ' PHE . 7.8 mt . . . . . 0 C--N 1.324 -0.535 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.127 -179.345 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.918 0.389 . . . . 0.0 110.79 . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.4 m -113.31 -169.39 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.767 179.808 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.516 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 73.6 m95 -130.7 146.58 52.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.977 0.418 . . . . 0.0 111.423 -179.543 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.545 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.6 OUTLIER -92.1 166.64 16.95 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.632 177.427 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.482 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 93.6 Cg_exo -16.22 97.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.811 1 C-N-CA 125.387 4.058 . . . . 0.0 114.639 -178.802 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.481 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -93.92 -76.54 0.48 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.088 -178.054 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.488 ' HA ' ' CD2' ' A' ' 33' ' ' TYR . . . -85.53 108.38 16.02 Favored Pre-proline 0 N--CA 1.463 0.176 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -175.896 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.884 ' HG2' HD11 ' A' ' 41' ' ' LEU . 3.5 Cg_exo -82.82 -153.88 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.148 2.565 . . . . 0.0 111.038 177.078 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.538 HG22 ' H ' ' A' ' 66' ' ' CYS . 4.2 mm -90.29 167.38 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.771 0.319 . . . . 0.0 110.541 178.064 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.538 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.1 m -167.53 127.93 1.44 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.037 179.462 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -148.45 173.25 13.29 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.579 179.618 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.545 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 67.6 p -77.41 130.55 37.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.441 0.639 . . . . 0.0 111.368 -179.495 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.755 HG22 ' O ' ' A' ' 38' ' ' GLY . 2.7 m -36.39 104.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 114.934 -1.03 . . . . 0.0 112.95 -178.985 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.57 ' CE ' HG23 ' A' ' 90' ' ' THR . 0.1 OUTLIER -86.77 97.06 10.4 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.271 177.132 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.447 ' N ' ' O ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -83.15 128.35 34.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.991 0.424 . . . . 0.0 110.246 179.264 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.44 -158.24 0.07 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.253 178.993 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.479 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 1.8 t -48.92 137.79 13.15 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.035 -179.997 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.495 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 35.5 Cg_exo -59.71 165.58 9.61 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.43 2.086 . . . . 0.0 112.348 -179.662 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.529 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 84.0 Cg_exo -45.77 157.38 0.34 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.769 2.312 . . . . 0.0 112.781 -179.669 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.7 t -109.87 90.21 3.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.461 179.047 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.727 HG23 ' HE1' ' A' ' 97' ' ' TYR . 17.1 pt -69.26 167.84 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.286 -179.0 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.8 m -81.29 139.45 35.41 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.717 179.684 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.411 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 5.4 m-80 56.5 28.84 14.39 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 -179.821 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.464 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -157.09 -170.29 21.87 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.344 -0.932 . . . . 0.0 113.268 -179.851 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -170.16 -175.32 1.95 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.068 0.461 . . . . 0.0 110.976 -179.307 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.479 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 9.3 p80 -115.84 170.64 8.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.971 -179.74 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 120.948 0.404 . . . . 0.0 111.035 179.012 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.435 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 11.6 m-85 . . . . . 0 N--CA 1.457 -0.103 0 CA-C-O 120.784 0.326 . . . . 0.0 110.817 . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.447 ' O ' ' N ' ' A' ' 71' ' ' CYS . 72.7 m-85 -156.62 164.14 38.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.67 -179.126 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.57 HG23 ' CE ' ' A' ' 70' ' ' LYS . 17.3 p -148.49 -177.04 5.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.087 0.47 . . . . 0.0 112.017 -179.242 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.441 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 56.4 m-20 -52.19 94.01 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.249 -179.503 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 122.43 20.5 2.94 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.184 -0.916 . . . . 0.0 113.044 178.455 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.417 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -106.11 150.02 26.19 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 117.087 0.443 . . . . 0.0 110.554 178.994 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.415 HG22 ' N ' ' A' ' 95' ' ' VAL . 31.1 m -131.36 153.67 39.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.158 0.504 . . . . 0.0 111.359 -179.245 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.521 HG23 ' CH2' ' A' ' 118' ' ' TRP . 23.0 t -145.78 149.17 16.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.374 179.132 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.871 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -105.31 130.41 53.44 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.09 0.471 . . . . 0.0 110.796 -179.966 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.967 ' CE2' HG21 ' A' ' 111' ' ' VAL . 3.2 m-85 -87.52 157.41 19.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.252 -179.115 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 61.0 p -144.29 131.42 20.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.524 -179.746 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.46 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 87.8 m -69.26 151.88 45.72 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.019 179.761 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.464 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 6.4 m-20 -90.62 -71.69 0.61 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.706 -178.384 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.7 t -58.39 -17.95 24.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.512 -179.279 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 115.3 27.23 3.19 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.082 -179.298 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.487 ' CE2' HG12 ' A' ' 126' ' ' ILE . 31.3 m-85 -69.61 -173.72 0.62 Allowed 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 120.886 0.374 . . . . 0.0 110.923 -179.676 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.57 112.4 23.9 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.396 179.126 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.492 HD22 ' HA ' ' A' ' 109' ' ' SER . 1.1 tp -50.1 112.49 0.68 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.074 -179.737 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.448 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 47.5 mm -99.34 155.88 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.729 179.957 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.434 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 60.53 28.13 67.1 Favored Glycine 0 CA--C 1.508 -0.363 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.437 179.497 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 60.22 129.11 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.001 -0.599 . . . . 0.0 111.495 179.65 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.871 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.2 p -61.47 -26.64 68.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.452 -179.059 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -58.66 136.83 50.81 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.788 -179.356 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.967 HG21 ' CE2' ' A' ' 97' ' ' TYR . 3.2 t -136.81 123.48 29.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.613 0.244 . . . . 0.0 110.936 179.734 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.954 HD22 ' N ' ' A' ' 113' ' ' CYS . 0.7 OUTLIER -81.72 136.16 35.47 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.886 0.374 . . . . 0.0 111.226 -179.73 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.954 ' N ' HD22 ' A' ' 112' ' ' LEU . 36.5 t -107.11 108.46 19.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.991 176.835 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.579 ' OG ' HD11 ' A' ' 112' ' ' LEU . 10.2 p -162.0 129.23 3.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.043 0.449 . . . . 0.0 111.848 -179.932 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.519 ' H ' HG21 ' A' ' 69' ' ' VAL . . . 86.58 30.22 22.08 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.508 179.309 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.453 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 68.75 14.15 67.12 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.212 -178.923 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -143.08 -178.15 5.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.181 0.515 . . . . 0.0 111.365 -179.552 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.529 ' CD1' ' HD3' ' A' ' 75' ' ' PRO . 90.4 m95 -123.73 133.05 53.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.525 179.989 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.455 ' OG ' HD12 ' A' ' 112' ' ' LEU . 0.4 OUTLIER -111.89 157.21 20.9 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.085 0.469 . . . . 0.0 111.356 -179.428 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.495 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER 62.63 44.22 0.6 Allowed Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.256 179.21 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 55.2 Cg_endo -69.13 137.24 36.79 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.174 1.916 . . . . 0.0 111.273 178.008 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.513 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 71.0 Cg_endo -86.43 -173.99 1.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.404 2.069 . . . . 0.0 113.772 -177.631 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.58 -175.5 3.97 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.549 178.123 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . 0.415 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 3.8 m -139.29 94.87 2.85 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.972 0.415 . . . . 0.0 110.897 179.688 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -123.26 159.17 29.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.86 -179.666 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.487 HG12 ' CE2' ' A' ' 103' ' ' TYR . 27.3 mm . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.993 179.935 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.47 ' HD2' HG23 ' A' ' 25' ' ' VAL . 66.0 mtm-85 . . . . . 0 C--O 1.232 0.154 0 CA-C-O 121.039 0.447 . . . . 0.0 111.243 . . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.527 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 36.2 m -73.53 175.83 3.23 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.808 178.592 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.56 ' HD2' ' CD1' ' A' ' 59' ' ' TRP . 18.6 Cg_endo -87.2 -174.83 1.41 Allowed 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.791 2.327 . . . . 0.0 111.406 178.882 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.435 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 2.9 t -58.18 106.53 0.71 Allowed Pre-proline 0 C--N 1.325 -0.479 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.402 179.242 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.471 ' HG2' HD11 ' A' ' 22' ' ' ILE . 1.8 Cg_endo -49.91 148.11 13.41 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.09 1.86 . . . . 0.0 111.849 -179.203 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.906 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -58.16 159.47 5.87 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.126 178.981 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -108.33 -178.96 3.75 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.149 0.5 . . . . 0.0 112.021 -176.29 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.5 tt -138.85 144.23 30.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.71 179.585 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.02 -68.95 0.58 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.557 -178.483 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.432 ' HA ' ' ND2' ' A' ' 36' ' ' ASN . 66.5 m-80 -90.02 43.4 1.14 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.222 -179.134 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -160.5 -174.81 30.78 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.093 179.981 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -143.53 128.62 18.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.742 0.306 . . . . 0.0 110.624 -179.598 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.906 HD11 ' O ' ' A' ' 13' ' ' ARG . 13.8 mt -73.11 157.88 36.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.072 0.463 . . . . 0.0 111.497 -179.571 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.98 75.37 1.65 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.643 177.657 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.931 ' HA ' HG23 ' A' ' 31' ' ' ILE . 68.0 mt -69.25 106.32 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.65 -177.643 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -115.87 21.05 12.69 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.66 177.557 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 158.31 119.91 0.58 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.136 -179.512 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.47 HG23 ' HD2' ' A' ' 8' ' ' ARG . 32.8 m -117.84 28.92 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.774 0.321 . . . . 0.0 111.295 -179.596 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -104.89 147.85 27.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.852 179.86 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.482 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 8.4 t80 -47.34 96.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.088 -179.693 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 122.33 16.68 3.8 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.83 -179.951 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.16 -161.0 0.75 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.696 0.284 . . . . 0.0 110.749 179.632 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.4 p -167.68 148.82 5.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.986 0.422 . . . . 0.0 111.318 179.42 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.931 HG23 ' HA ' ' A' ' 22' ' ' ILE . 1.0 OUTLIER -106.94 173.33 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.591 -179.977 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.492 ' H ' HG22 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -130.92 116.35 17.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.99 0.424 . . . . 0.0 111.384 179.375 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.833 ' CE2' HD21 ' A' ' 20' ' ' LEU . 18.7 m-85 -92.29 138.83 31.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.968 179.758 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.418 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 85.3 p -144.01 166.41 25.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.981 -179.74 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.448 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 3.9 m -90.2 165.72 13.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.728 179.915 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.432 ' ND2' ' HA ' ' A' ' 17' ' ' ASN . 34.6 m-80 -64.28 -83.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.851 0.358 . . . . 0.0 111.015 -179.612 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.18 136.81 15.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.624 179.906 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.627 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 60.77 26.92 65.75 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.862 -178.913 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.491 ' CD2' ' HA ' ' A' ' 68' ' ' SER . 2.3 m-85 -119.26 171.41 8.32 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.725 0.298 . . . . 0.0 110.811 -179.328 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.891 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.5 OUTLIER -132.3 120.37 22.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.955 0.407 . . . . 0.0 110.516 177.865 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.902 HD11 ' HG2' ' A' ' 64' ' ' PRO . 6.7 tt -83.46 124.07 30.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.765 -179.294 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.891 HD11 ' CE1' ' A' ' 40' ' ' HIS . 1.9 mm -103.8 167.79 2.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.984 -179.625 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.519 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 73.59 -134.37 19.06 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.097 -179.16 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.894 ' O ' HD21 ' A' ' 41' ' ' LEU . 1.2 pt-20 -80.71 -175.69 5.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.868 0.366 . . . . 0.0 110.688 178.978 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.9 p -160.19 22.31 0.16 Allowed 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.423 -179.258 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.464 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -163.2 124.29 2.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.85 0.357 . . . . 0.0 111.691 -177.984 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 30' ' ' SER . 1.4 t -91.89 138.77 31.28 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 177.233 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.517 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.7 m-85 -113.38 121.53 44.61 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 119.146 -1.022 . . . . 0.0 112.17 -179.473 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 33.9 t -73.28 102.78 3.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.576 179.174 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.01 -172.33 2.43 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.311 -179.543 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.482 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.387 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.03 -179.353 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.446 ' O ' HG13 ' A' ' 58' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.966 0.412 . . . . 0.0 110.628 . . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 57' ' ' MET . 2.2 m -156.46 163.48 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.879 179.692 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.56 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 78.4 m95 -124.75 120.42 31.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.937 0.399 . . . . 0.0 111.528 -179.325 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.517 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -69.9 165.9 37.84 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.14 178.155 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.445 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 89.3 Cg_exo -19.35 98.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 125.216 3.944 . . . . 0.0 114.164 -179.004 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.474 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -100.48 -78.76 0.51 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.344 -177.096 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.478 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -76.55 108.3 6.16 Favored Pre-proline 0 N--CA 1.463 0.19 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -175.032 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.902 ' HG2' HD11 ' A' ' 41' ' ' LEU . 1.0 OUTLIER -88.22 -153.99 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.388 2.725 . . . . 0.0 110.993 176.814 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.573 HG22 ' H ' ' A' ' 66' ' ' CYS . 3.0 mm -98.76 169.57 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.875 0.369 . . . . 0.0 110.76 178.629 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.573 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.1 m -160.51 145.77 14.7 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 179.556 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.471 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.3 OUTLIER -164.56 172.38 13.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.039 -179.951 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.491 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 12.1 p -90.22 112.61 24.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.086 0.469 . . . . 0.0 111.078 179.967 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.627 HG12 ' O ' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -47.79 99.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.344 179.863 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.492 ' HE2' HG23 ' A' ' 90' ' ' THR . 0.1 OUTLIER -81.88 116.13 21.39 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.075 179.923 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.407 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -97.68 129.75 44.72 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.308 179.283 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.85 -156.33 0.12 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.362 179.306 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.443 ' HG ' ' CE1' ' A' ' 82' ' ' HIS . 2.1 t -49.26 137.58 15.14 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.854 179.933 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.52 ' HG2' HG11 ' A' ' 95' ' ' VAL . 27.4 Cg_exo -59.9 163.79 13.15 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.405 2.07 . . . . 0.0 112.062 -179.989 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.517 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 86.1 Cg_exo -39.38 156.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.812 2.341 . . . . 0.0 112.894 -179.605 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.6 t -108.8 90.49 3.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.551 179.449 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.721 HG23 ' HE2' ' A' ' 97' ' ' TYR . 35.7 pt -69.43 175.22 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.326 -179.182 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.36 138.18 39.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.622 179.309 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.498 ' HB3' ' CD2' ' A' ' 103' ' ' TYR . 0.3 OUTLIER 68.65 28.07 5.8 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.676 -179.958 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.452 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . -170.21 -159.99 17.47 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.76 179.694 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.417 ' N ' ' O ' ' A' ' 98' ' ' SER . 1.4 ptt85 -170.13 -176.2 2.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.091 0.472 . . . . 0.0 111.022 -179.226 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.457 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 21.4 p-80 -110.25 170.9 7.78 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.918 179.795 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.775 179.88 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.42 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 5.3 m-85 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.889 0.376 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.42 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 66.4 m-85 -152.77 161.6 42.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.928 -179.689 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.492 HG23 ' HE2' ' A' ' 70' ' ' LYS . 8.1 p -128.36 -175.92 3.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.214 -179.252 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -64.85 94.83 0.14 Allowed 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.271 0.558 . . . . 0.0 110.988 -179.843 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.55 18.72 2.18 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.317 178.656 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.4 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -95.34 162.86 13.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.934 0.367 . . . . 0.0 110.573 179.246 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 35.6 m -138.27 149.64 24.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.13 0.49 . . . . 0.0 111.335 -179.608 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.525 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 23.6 t -146.09 148.68 16.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.743 179.526 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.968 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -106.97 130.89 54.55 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.987 -179.973 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.972 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.9 m-85 -89.88 160.74 16.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.985 -179.67 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.417 ' O ' ' N ' ' A' ' 81' ' ' ARG . 21.3 p -157.37 138.86 13.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.557 -179.941 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.452 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 68.5 m -70.27 164.5 24.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.815 179.4 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -101.68 -85.24 0.43 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.84 0.352 . . . . 0.0 111.207 179.636 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -45.01 -31.36 1.28 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.522 -179.198 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 130.29 45.12 0.17 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.681 179.777 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.504 ' CE1' HG12 ' A' ' 126' ' ' ILE . 29.7 m-85 -87.04 -173.54 4.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.833 0.349 . . . . 0.0 110.836 179.972 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 41.2 m -111.49 108.17 17.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.108 -179.519 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.648 HD23 ' HB2' ' A' ' 122' ' ' PRO . 2.9 tp -44.94 113.16 0.52 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.146 178.935 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.592 HD11 ' HB2' ' A' ' 125' ' ' GLN . 40.0 mm -85.93 156.33 3.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.465 179.79 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.438 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 60.44 -125.62 39.09 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.558 -178.333 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -124.2 135.37 53.4 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.849 0.357 . . . . 0.0 110.584 178.55 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.968 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.2 p -65.94 -29.8 70.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.701 -180.0 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -71.91 137.08 24.97 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.578 179.892 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.972 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.7 t -131.08 119.16 43.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.757 0.313 . . . . 0.0 110.837 179.712 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.03 119.57 23.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.522 -179.006 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.523 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 31.7 t -85.57 101.88 13.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.623 176.996 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.9 t -139.31 153.85 47.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.193 0.52 . . . . 0.0 111.568 -178.143 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.448 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 47.15 33.94 7.71 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.911 179.482 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.461 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 69.94 11.07 65.97 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.746 -179.999 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -131.15 175.15 9.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.899 0.381 . . . . 0.0 110.391 179.225 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.525 ' CZ3' HG23 ' A' ' 95' ' ' VAL . 93.3 m95 -117.12 128.62 55.32 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.787 -179.43 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.38 146.63 35.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.4 -178.852 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.486 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.5 t0 71.53 46.46 0.24 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.207 178.646 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 74.0 Cg_endo -75.32 130.66 13.15 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.319 2.013 . . . . 0.0 111.324 177.934 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.648 ' HB2' HD23 ' A' ' 105' ' ' LEU . 58.0 Cg_endo -86.15 -174.7 1.58 Allowed 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.448 2.099 . . . . 0.0 113.387 -178.229 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.458 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.3 OUTLIER -135.81 -173.62 3.42 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.071 178.392 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . 0.435 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 16.5 m -141.61 94.62 2.71 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.94 0.4 . . . . 0.0 111.108 -179.5 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.592 ' HB2' HD11 ' A' ' 106' ' ' ILE . 20.6 mt-30 -118.83 169.42 9.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.713 179.921 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.504 HG12 ' CE1' ' A' ' 103' ' ' TYR . 19.5 mm . . . . . 0 C--N 1.325 -0.491 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.806 -179.796 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.701 ' HD2' HG23 ' A' ' 25' ' ' VAL . 4.3 mtm180 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.812 0.339 . . . . 0.0 110.798 . . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.473 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 69.4 m -77.67 159.24 77.19 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.577 179.606 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 51.1 Cg_endo -68.85 169.98 16.49 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.345 2.03 . . . . 0.0 111.964 -179.718 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.17 105.91 0.58 Allowed Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.777 -179.745 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.522 ' HG3' ' CZ2' ' A' ' 59' ' ' TRP . 53.0 Cg_exo -53.67 160.16 5.8 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.278 1.985 . . . . 0.0 112.517 -179.759 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.571 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -52.86 -174.58 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.156 177.811 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.767 ' O ' HG22 ' A' ' 15' ' ' ILE . 11.8 p-10 -135.66 -40.88 0.7 Allowed 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -176.314 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.767 HG22 ' O ' ' A' ' 14' ' ' ASP . 5.1 tt 66.08 139.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.777 -177.084 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -94.47 -40.03 10.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.855 -177.736 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.445 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 0.7 OUTLIER -93.83 24.71 4.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.8 0.333 . . . . 0.0 111.116 -179.016 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.08 176.29 40.08 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.544 179.838 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.424 ' N ' ' O ' ' A' ' 34' ' ' SER . 2.2 mt-30 -129.49 129.7 44.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.702 0.287 . . . . 0.0 110.564 179.718 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.699 HD21 ' CE1' ' A' ' 33' ' ' TYR . 49.1 mt -82.63 162.51 21.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.151 0.5 . . . . 0.0 111.632 -179.14 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -130.71 80.59 1.95 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.166 179.259 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.876 ' HA ' HG23 ' A' ' 31' ' ' ILE . 56.3 mt -71.33 103.33 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.441 -178.583 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.31 15.22 50.7 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.303 178.451 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.402 ' O ' ' HB3' ' A' ' 29' ' ' SER . . . 157.11 127.86 1.01 Allowed Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.772 -179.538 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.701 HG23 ' HD2' ' A' ' 8' ' ' ARG . 30.1 m -115.32 26.22 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -178.213 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -101.18 162.09 13.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.986 0.422 . . . . 0.0 110.996 179.08 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.439 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 2.5 t80 -57.18 92.01 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.986 -179.31 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 132.51 -11.87 5.21 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.884 179.87 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.402 ' HB3' ' O ' ' A' ' 24' ' ' GLY . 9.3 m -75.37 -175.74 2.87 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.819 0.309 . . . . 0.0 110.805 179.87 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 47' ' ' SER . 0.3 OUTLIER -154.07 143.45 21.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.493 -179.717 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.876 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -104.51 171.25 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.938 179.222 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.426 ' O ' ' N ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -132.25 120.19 21.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.891 178.933 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.699 ' CE1' HD21 ' A' ' 20' ' ' LEU . 28.5 m-85 -99.65 135.22 41.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.197 -179.624 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.424 ' O ' ' N ' ' A' ' 19' ' ' GLN . 64.3 m -143.33 159.38 42.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.765 179.628 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.438 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 57.0 m -83.87 166.02 18.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.002 -179.947 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.85 -83.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.082 -179.705 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 t -155.44 136.48 13.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.787 -179.895 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.01 23.25 65.7 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.124 -179.294 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.503 ' CE1' ' HB3' ' A' ' 68' ' ' SER . 2.3 m-85 -113.63 -179.02 3.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.918 0.389 . . . . 0.0 110.98 -179.386 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.724 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -143.98 114.56 7.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.393 178.095 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.969 HD21 ' O ' ' A' ' 44' ' ' GLU . 2.3 tt -75.25 136.47 40.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.675 -179.105 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.724 HD11 ' CE1' ' A' ' 40' ' ' HIS . 3.1 mm -108.39 153.94 9.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.199 -179.01 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.64 -135.95 19.1 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.554 -179.948 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.969 ' O ' HD21 ' A' ' 41' ' ' LEU . 4.3 pm0 -75.47 -179.14 4.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.624 0.25 . . . . 0.0 110.691 179.733 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.1 p -152.23 21.04 0.65 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.181 -179.784 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.415 ' CE ' ' O ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -151.91 163.06 40.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.896 -178.882 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.472 ' O ' HG13 ' A' ' 31' ' ' ILE . 2.8 m -137.44 112.05 8.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.643 179.99 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.419 ' CD1' ' N ' ' A' ' 48' ' ' TYR . 2.0 m-30 -90.01 121.2 31.87 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.897 0.38 . . . . 0.0 111.334 -179.258 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.502 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 35.1 t -71.56 97.49 1.7 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.55 179.396 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -124.58 -176.49 3.54 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.128 -179.514 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.599 HD13 ' H ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.01 -179.314 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 4.0 mmt . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.679 0.276 . . . . 0.0 110.443 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.0 m -149.7 -178.13 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.87 0.367 . . . . 0.0 111.275 -179.296 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.564 ' CE3' HD11 ' A' ' 31' ' ' ILE . 95.2 m95 -128.77 123.86 34.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.774 -179.733 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -148.45 119.71 4.34 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.769 -179.459 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -67.72 -176.28 9.64 Favored 'Cis proline' 0 C--N 1.351 0.7 0 C-N-CA 124.135 -1.194 . . . . 0.0 112.718 1.787 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.435 ' O ' ' CD ' ' A' ' 64' ' ' PRO . 0.6 OUTLIER -111.6 -140.77 0.38 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.102 -178.654 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.534 ' CB ' ' CE1' ' A' ' 33' ' ' TYR . . . -95.6 86.17 0.32 Allowed Pre-proline 0 N--CA 1.448 -0.567 0 C-N-CA 122.878 0.471 . . . . 0.0 110.759 179.464 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.713 ' HG2' HD11 ' A' ' 41' ' ' LEU . 9.8 Cg_endo -45.68 -159.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.476 0.451 0 C-N-CA 124.313 3.342 . . . . 0.0 114.53 178.703 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.495 HG22 ' H ' ' A' ' 66' ' ' CYS . 5.5 mm -97.59 165.76 2.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.854 -178.267 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.495 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.2 m -164.83 117.35 1.24 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.342 179.017 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.19 177.68 7.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.893 0.377 . . . . 0.0 111.353 -179.417 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.503 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 49.7 p -88.71 99.35 12.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.22 -179.965 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.765 HG22 ' HA3' ' A' ' 116' ' ' GLY . 6.8 p -60.99 103.89 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.302 178.489 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.5 ' HG2' HG22 ' A' ' 90' ' ' THR . 2.7 mttp -82.21 167.44 18.66 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -176.297 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.421 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -125.96 122.69 36.67 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.525 177.3 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.444 ' CG ' ' N ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -69.43 -155.48 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.988 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.444 ' N ' ' CG ' ' A' ' 72' ' ' GLN . 1.4 t -52.8 144.52 25.6 Favored Pre-proline 0 N--CA 1.448 -0.556 0 C-N-CA 121.081 -0.248 . . . . 0.0 110.373 179.091 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.775 ' HG3' HG21 ' A' ' 95' ' ' VAL . 39.0 Cg_exo -60.78 160.36 25.31 Favored 'Trans proline' 0 C--O 1.231 0.129 0 C-N-CA 122.561 2.174 . . . . 0.0 112.159 -179.327 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -42.39 155.89 0.1 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.568 2.179 . . . . 0.0 112.41 -179.315 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.3 t -103.94 86.39 2.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.828 -179.793 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.642 HD11 ' HA3' ' A' ' 80' ' ' GLY . 8.2 pt -69.85 169.98 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.953 -179.959 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.5 m -91.59 137.91 31.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.81 179.651 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.506 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 4.8 m-80 57.62 29.84 17.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.725 -179.901 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.642 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -165.5 169.36 39.91 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.531 -0.843 . . . . 0.0 112.807 179.685 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 80' ' ' GLY . 19.8 mtt180 -147.19 -166.38 2.5 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.483 0.659 . . . . 0.0 111.622 -178.082 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 1.9 p-80 -130.6 157.24 43.25 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.442 179.911 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.745 ' O ' HG13 ' A' ' 95' ' ' VAL . 1.8 p30 . . . . . 0 CA--C 1.511 -0.524 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.109 177.867 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.407 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 4.2 m-85 . . . . . 0 N--CA 1.455 -0.204 0 CA-C-O 120.725 0.297 . . . . 0.0 110.535 . . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.421 ' N ' ' O ' ' A' ' 71' ' ' CYS . 26.2 m-85 -140.22 158.45 44.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.034 -179.746 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.5 HG22 ' HG2' ' A' ' 70' ' ' LYS . 5.5 p -122.71 176.34 6.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.572 -178.32 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 7.5 p-10 -60.85 93.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.76 179.495 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 125.56 19.1 2.35 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.126 179.134 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -98.82 158.85 15.36 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.868 0.334 . . . . 0.0 110.33 178.865 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 27.8 m -145.57 142.27 22.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.421 0.629 . . . . 0.0 111.972 -179.491 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.853 HG22 ' CH2' ' A' ' 118' ' ' TRP . 40.7 t -144.46 148.12 18.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.488 178.167 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.461 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -95.68 159.92 14.75 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.083 0.468 . . . . 0.0 111.796 -177.5 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.827 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.9 m-85 -110.7 155.66 22.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.997 179.223 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.1 p -150.25 140.18 21.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.339 -178.958 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.442 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 83.9 m -75.24 146.92 40.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.222 -179.951 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -78.78 -83.2 0.09 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.622 -179.057 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.2 t -52.47 -22.96 5.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.538 -178.647 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 123.1 30.55 1.09 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.808 179.971 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.506 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 48.9 m-85 -69.32 -172.19 0.42 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.724 0.297 . . . . 0.0 110.51 179.413 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.2 m -110.45 107.32 16.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.999 0.428 . . . . 0.0 111.302 -179.257 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.539 HD23 ' HB2' ' A' ' 122' ' ' PRO . 1.9 tp -45.52 112.96 0.52 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.944 178.734 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.534 HG22 ' N ' ' A' ' 107' ' ' GLY . 20.1 mm -90.6 160.85 2.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.051 -178.874 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.534 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 56.5 -129.29 48.25 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.148 -179.641 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -110.4 125.0 52.77 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.8 0.333 . . . . 0.0 110.932 179.873 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.511 ' HA ' HD21 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -67.67 -34.57 77.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.203 178.661 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -79.08 130.83 10.17 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.982 178.479 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.827 HG21 ' CE1' ' A' ' 97' ' ' TYR . 3.2 t -117.63 141.33 36.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 179.786 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.07 122.73 44.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.99 0.424 . . . . 0.0 111.712 -178.469 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.428 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 10.9 t -85.88 105.99 16.77 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.055 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.6 OUTLIER -145.34 154.6 42.49 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.183 0.516 . . . . 0.0 111.349 -178.422 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 54.36 22.09 21.89 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.73 179.548 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.765 ' HA3' HG22 ' A' ' 69' ' ' VAL . . . 87.55 -6.44 83.4 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.533 -0.842 . . . . 0.0 113.005 179.996 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -128.66 -176.81 3.95 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.09 0.472 . . . . 0.0 110.932 -179.698 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.853 ' CH2' HG22 ' A' ' 95' ' ' VAL . 95.3 m95 -108.92 157.62 18.46 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.831 -179.71 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.47 149.11 42.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.061 0.458 . . . . 0.0 111.324 -179.369 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.471 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.7 OUTLIER 68.21 47.67 0.39 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.786 178.69 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 74.0 Cg_endo -75.31 137.68 21.34 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.314 2.009 . . . . 0.0 111.534 178.422 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.539 ' HB2' HD23 ' A' ' 105' ' ' LEU . 59.5 Cg_endo -89.29 -174.13 0.89 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.543 2.162 . . . . 0.0 113.561 -178.212 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.45 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -133.6 -174.06 3.41 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.913 177.997 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 8.3 m -143.3 96.5 2.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.143 0.497 . . . . 0.0 111.146 -179.811 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.495 ' HB2' HD11 ' A' ' 106' ' ' ILE . 13.2 mt-30 -121.62 157.72 30.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.775 -179.998 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.549 HG22 ' O ' ' A' ' 126' ' ' ILE . 37.3 mm . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.93 179.918 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.428 ' HD2' HG23 ' A' ' 25' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 121.004 0.43 . . . . 0.0 111.085 . . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.47 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 55.6 m -93.01 160.17 34.21 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.202 -179.126 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.04 176.56 7.56 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.714 2.276 . . . . 0.0 112.531 -179.338 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -50.14 106.58 0.65 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.701 179.662 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.514 ' HG3' ' CZ2' ' A' ' 59' ' ' TRP . 76.2 Cg_exo -48.68 144.22 14.97 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.466 2.111 . . . . 0.0 112.676 -179.323 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.508 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -54.94 164.74 0.75 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.882 178.651 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.569 ' HA ' HD11 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -116.6 -174.17 2.52 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.322 0.582 . . . . 0.0 112.025 -177.785 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.436 HG23 ' C ' ' A' ' 18' ' ' GLY . 2.7 tt -142.06 145.07 24.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.263 -179.768 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -74.9 -66.84 0.7 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -177.106 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.419 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 0.4 OUTLIER -91.74 26.62 2.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.336 -177.998 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.436 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -142.47 -175.5 15.78 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.241 -0.981 . . . . 0.0 113.279 -179.399 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -140.45 137.54 34.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.691 0.282 . . . . 0.0 110.357 179.294 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.569 HD11 ' HA ' ' A' ' 14' ' ' ASP . 3.7 mt -80.45 163.85 23.48 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.154 0.502 . . . . 0.0 111.794 -179.009 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -135.69 71.06 1.42 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.536 177.283 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.846 ' HA ' HG23 ' A' ' 31' ' ' ILE . 62.2 mt -69.9 103.56 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.84 -177.758 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.18 18.21 42.78 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.985 177.843 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 156.02 131.74 1.44 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 121.14 -0.552 . . . . 0.0 111.936 -179.586 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.428 HG23 ' HD2' ' A' ' 8' ' ' ARG . 32.3 m -116.43 25.97 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.686 0.279 . . . . 0.0 111.683 -178.822 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.2 152.23 19.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.042 179.792 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.412 ' CZ ' ' HB3' ' A' ' 51' ' ' LEU . 2.2 t80 -55.51 91.31 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.979 0.419 . . . . 0.0 110.441 179.327 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 131.92 -10.09 5.43 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.515 -178.825 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 92.2 p -75.11 -167.73 0.66 Allowed 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 179.326 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.1 p -157.7 152.05 24.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.073 0.463 . . . . 0.0 111.668 179.857 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.846 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -113.84 169.36 5.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.327 179.332 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.42 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -133.31 112.81 11.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.9 0.381 . . . . 0.0 111.062 178.621 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.535 ' CE1' HD22 ' A' ' 20' ' ' LEU . 17.0 m-85 -85.3 138.53 32.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.946 179.955 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.421 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.2 OUTLIER -138.35 168.75 19.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.668 -179.982 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.458 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 3.8 m -91.65 160.81 15.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.733 179.872 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -60.96 -79.68 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.184 -179.303 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.03 133.65 10.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.724 -179.786 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.599 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 60.72 25.39 63.52 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.79 -178.907 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.488 ' CD2' ' HA ' ' A' ' 68' ' ' SER . 2.3 m-85 -116.53 171.37 7.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.709 0.29 . . . . 0.0 110.78 -179.354 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.642 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -130.66 131.62 44.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.019 0.438 . . . . 0.0 110.718 178.764 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.755 HD21 ' HB2' ' A' ' 64' ' ' PRO . 3.3 tt -87.7 131.01 34.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.816 -179.054 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.642 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.1 mm -105.45 154.23 6.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.982 0.42 . . . . 0.0 111.143 -179.365 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.09 -136.35 23.85 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.61 -178.469 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.421 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 0.8 OUTLIER -81.45 -178.12 6.8 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.33 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.442 ' HA ' ' HG2' ' A' ' 64' ' ' PRO . 6.4 p -155.17 23.6 0.42 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.104 -179.313 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.42 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 3.4 mtpt -147.48 141.57 26.04 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.199 -178.642 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.45 ' HB2' ' CG1' ' A' ' 31' ' ' ILE . 2.5 m -113.01 147.16 37.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.105 178.924 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.452 ' CD1' ' HD3' ' A' ' 61' ' ' PRO . 1.7 m-85 -119.16 121.78 40.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.014 0.435 . . . . 0.0 111.424 -179.597 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.524 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 18.8 t -70.26 77.09 0.53 Allowed 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.03 178.474 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -102.64 179.63 4.24 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.371 -178.491 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.212 -178.821 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.522 -0.113 0 CA-C-O 120.914 0.387 . . . . 0.0 110.457 . . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.6 m -139.8 165.76 21.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.216 -179.199 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.82 ' CE3' HD11 ' A' ' 31' ' ' ILE . 92.2 m95 -102.24 127.62 49.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.17 178.629 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.404 ' HA ' ' C ' ' A' ' 61' ' ' PRO . 14.0 t30 -159.67 127.59 2.81 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.745 -176.873 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.452 ' HD3' ' CD1' ' A' ' 48' ' ' TYR . 21.4 Cg_exo -68.77 -174.38 8.51 Favored 'Cis proline' 0 C--N 1.351 0.677 0 C-N-CA 124.236 -1.152 . . . . 0.0 112.697 1.364 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -110.7 -152.15 0.49 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.128 -178.38 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.457 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -75.27 110.96 11.66 Favored Pre-proline 0 CA--C 1.53 0.181 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.176 -179.717 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.755 ' HB2' HD21 ' A' ' 41' ' ' LEU . 23.6 Cg_exo -66.42 -145.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.832 2.355 . . . . 0.0 112.174 -179.871 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.489 HG22 ' H ' ' A' ' 66' ' ' CYS . 3.4 mm -106.39 165.59 4.01 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 120.762 0.315 . . . . 0.0 111.312 -178.73 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.489 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.8 OUTLIER -164.18 124.46 2.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.92 179.632 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.478 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 3.8 tt0 -143.73 -179.64 6.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.938 179.96 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.488 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 1.3 p -86.43 119.44 26.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.021 0.439 . . . . 0.0 111.125 -179.894 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.612 HG22 ' HB3' ' A' ' 40' ' ' HIS . 3.8 p -49.3 96.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.278 179.778 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 89' ' ' TYR . 1.4 mmtp -71.31 139.87 50.08 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.863 179.752 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.2 128.11 55.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.922 0.391 . . . . 0.0 110.781 179.58 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.412 ' O ' ' NE1' ' A' ' 118' ' ' TRP . 0.0 OUTLIER -67.42 -175.54 0.5 Allowed 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 121.912 0.863 . . . . 0.0 113.176 -177.677 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.558 ' HG ' ' CE1' ' A' ' 82' ' ' HIS . 0.3 OUTLIER -51.82 119.09 12.99 Favored Pre-proline 0 N--CA 1.439 -0.98 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.484 176.388 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.498 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 51.4 Cg_exo -41.71 155.04 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.063 1.842 . . . . 0.0 112.416 -176.564 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.412 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 85.6 Cg_exo -45.31 157.08 0.28 Allowed 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.88 2.387 . . . . 0.0 112.854 -179.015 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.31 90.79 3.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.845 -179.933 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.662 HG21 ' O ' ' A' ' 122' ' ' PRO . 18.4 pt -69.5 171.72 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.361 -179.484 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.7 p -88.12 136.66 32.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.707 179.242 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.497 ' HB3' ' CD2' ' A' ' 103' ' ' TYR . 0.1 OUTLIER 66.34 26.53 10.24 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.52 -179.576 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.446 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . 178.03 -178.66 48.53 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.625 179.978 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.406 ' NE ' ' OD1' ' A' ' 100' ' ' ASN . 0.1 OUTLIER -170.25 -175.84 2.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.784 0.326 . . . . 0.0 110.605 -179.714 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.558 ' CE1' ' HG ' ' A' ' 73' ' ' SER . 42.6 p-80 -95.35 168.91 10.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.038 179.831 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.706 179.392 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.431 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 6.4 m-85 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.767 0.318 . . . . 0.0 110.841 . . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.431 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 39.0 m-85 -145.52 165.01 29.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.972 -179.429 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.8 p -130.32 163.02 27.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.998 0.428 . . . . 0.0 111.47 -178.901 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -50.22 95.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.009 -179.91 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.69 26.53 1.14 Allowed Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.32 -0.855 . . . . 0.0 113.114 178.809 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.407 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -110.28 161.93 15.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.837 0.319 . . . . 0.0 110.6 179.065 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.485 HG22 ' N ' ' A' ' 95' ' ' VAL . 34.1 m -135.2 157.83 40.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.061 0.457 . . . . 0.0 111.058 -179.996 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.496 HG11 ' HB2' ' A' ' 82' ' ' HIS . 25.4 t -148.99 148.24 15.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.299 179.52 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.857 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -109.62 120.93 44.02 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.349 0.595 . . . . 0.0 111.126 -179.372 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.971 ' CE2' HG21 ' A' ' 111' ' ' VAL . 4.4 m-85 -77.26 158.12 30.42 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.69 -178.671 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.0 p -154.37 139.11 17.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.551 -179.929 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.446 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 6.9 m -69.85 164.02 24.61 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.51 179.971 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.406 ' OD1' ' NE ' ' A' ' 81' ' ' ARG . 28.9 m-20 -95.12 -69.93 0.73 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.314 -179.543 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.6 t -68.74 -34.45 75.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.345 -178.928 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 137.14 41.77 0.1 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.574 -179.925 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.518 ' CD1' ' CD1' ' A' ' 126' ' ' ILE . 15.4 m-85 -80.8 -168.14 1.66 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 179.479 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.8 m -117.15 105.42 12.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.804 0.335 . . . . 0.0 111.538 -179.642 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.477 ' CD2' ' HB2' ' A' ' 122' ' ' PRO . 1.6 tp -48.97 121.84 5.17 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.107 0.48 . . . . 0.0 110.615 178.509 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.473 HG22 ' N ' ' A' ' 107' ' ' GLY . 33.7 mm -103.12 159.31 4.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.566 -177.298 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.473 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 52.37 30.32 32.74 Favored Glycine 0 CA--C 1.509 -0.343 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.546 179.468 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.418 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.6 OUTLIER 59.65 127.9 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.984 -0.608 . . . . 0.0 111.394 179.679 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.857 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.2 p -58.56 -29.21 66.2 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.97 -178.332 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -52.69 131.39 39.79 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.706 -0.759 . . . . 0.0 113.154 -178.651 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.971 HG21 ' CE2' ' A' ' 97' ' ' TYR . 2.3 t -130.72 144.28 38.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.39 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.1 tt -104.93 125.24 50.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.963 0.411 . . . . 0.0 112.076 -177.803 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.438 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 11.2 t -88.59 95.47 10.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.436 176.547 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 p -139.06 163.64 31.88 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.208 -178.45 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.2 26.18 2.15 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.773 179.802 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.441 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 76.11 1.51 69.01 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.955 -179.633 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -131.64 179.71 5.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.808 0.337 . . . . 0.0 110.61 179.525 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.498 ' CH2' ' HG3' ' A' ' 74' ' ' PRO . 93.5 m95 -107.79 125.65 51.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 -179.898 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.56 145.07 36.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.145 -179.474 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.486 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 2.0 t70 66.89 44.5 0.35 Allowed Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.256 178.71 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 52.9 Cg_endo -67.44 149.83 80.42 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 121.893 1.728 . . . . 0.0 110.354 176.912 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.662 ' O ' HG21 ' A' ' 77' ' ' ILE . 42.0 Cg_endo -95.71 -178.19 0.45 Allowed 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 122.129 1.886 . . . . 0.0 114.039 -176.925 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.427 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -124.34 -159.81 0.89 Allowed 'General case' 0 CA--C 1.502 -0.867 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.009 176.796 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . 0.579 ' HB2' HD12 ' A' ' 77' ' ' ILE . 3.8 t -170.34 93.8 0.22 Allowed 'General case' 0 N--CA 1.433 -1.288 0 CA-C-O 121.772 0.796 . . . . 0.0 110.87 -175.906 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -106.88 -169.33 1.53 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.303 -1.317 . . . . 0.0 112.096 -176.891 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.662 HG22 ' O ' ' A' ' 126' ' ' ILE . 19.1 mm . . . . . 0 C--N 1.313 -1.012 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.11 179.51 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.68 ' HD3' HG23 ' A' ' 25' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.982 0.42 . . . . 0.0 110.833 . . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.472 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 60.3 m -90.24 161.25 38.01 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.681 179.85 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 37.2 Cg_endo -67.34 176.52 4.71 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.549 2.166 . . . . 0.0 112.393 -179.345 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.3 t -51.78 109.39 1.38 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.06 -179.368 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.409 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 2.3 Cg_endo -52.33 152.97 14.21 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.16 1.907 . . . . 0.0 111.894 179.757 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.825 ' O ' HD11 ' A' ' 20' ' ' LEU . 14.6 mtt180 -66.4 160.2 25.31 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.191 179.24 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -110.86 -178.69 3.54 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-O 121.223 0.535 . . . . 0.0 112.17 -176.129 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.491 HG22 ' CD2' ' A' ' 20' ' ' LEU . 6.0 tt -142.14 145.32 24.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.539 179.673 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -80.36 -65.0 1.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.829 -178.026 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.425 ' ND2' ' N ' ' A' ' 17' ' ' ASN . 0.5 OUTLIER -93.47 36.46 1.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.878 0.371 . . . . 0.0 110.961 -178.909 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.426 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -150.06 176.95 28.48 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.813 179.69 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -136.55 123.66 21.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.779 0.323 . . . . 0.0 110.75 179.595 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.825 HD11 ' O ' ' A' ' 13' ' ' ARG . 14.6 mt -74.41 159.03 32.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.164 0.506 . . . . 0.0 111.92 -179.124 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.453 ' HB3' ' CB ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -130.52 74.3 1.59 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.914 177.608 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.845 ' HA ' HG23 ' A' ' 31' ' ' ILE . 62.6 mt -69.78 93.2 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.735 -178.174 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.73 20.9 47.61 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.932 178.078 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 29' ' ' SER . . . 151.89 133.32 1.96 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.942 -179.455 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.68 HG23 ' HD3' ' A' ' 8' ' ' ARG . 11.9 m -118.37 8.95 6.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.134 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 16.0 t70 -74.46 163.45 27.75 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.011 0.434 . . . . 0.0 110.825 179.481 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.561 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 7.9 t80 -59.79 93.6 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.535 179.987 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.17 -7.73 7.15 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.494 -178.804 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.409 ' OG ' ' N ' ' A' ' 26' ' ' ASP . 1.3 m -71.67 174.32 6.92 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.841 0.32 . . . . 0.0 110.626 179.589 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -143.83 145.3 32.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.018 -179.973 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.845 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -107.34 164.22 4.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.629 179.996 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.453 ' CB ' ' HB3' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -126.48 113.61 17.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.845 179.467 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.824 ' CE1' HD21 ' A' ' 20' ' ' LEU . 21.5 m-85 -91.4 138.56 31.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.556 -179.421 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.426 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.4 OUTLIER -139.87 173.81 11.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.512 179.313 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 1.2 m -92.83 169.92 10.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.347 . . . . 0.0 111.027 -179.915 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.97 -85.45 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.333 -178.844 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.73 116.6 2.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.289 179.917 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.541 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 84.16 -8.08 68.79 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.129 -177.282 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.52 ' CZ ' ' HB3' ' A' ' 68' ' ' SER . 4.0 m-85 -82.25 176.27 9.6 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 120.912 0.387 . . . . 0.0 110.84 179.678 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.733 ' CE1' HG22 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -129.54 129.46 44.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.122 175.983 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.937 HD11 ' HG2' ' A' ' 64' ' ' PRO . 9.2 tt -93.92 112.1 23.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.523 -179.624 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.553 ' N ' HD13 ' A' ' 42' ' ' ILE . 1.2 mm -85.77 149.27 4.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.085 0.469 . . . . 0.0 110.955 -179.009 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.36 -149.77 30.98 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.121 -178.892 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.754 ' O ' HD21 ' A' ' 41' ' ' LEU . 7.4 pt-20 -77.78 176.89 8.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.043 0.449 . . . . 0.0 110.856 179.297 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 33' ' ' TYR . 2.5 p -147.05 28.14 1.03 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.014 -179.306 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.55 138.32 23.4 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.971 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -110.73 159.44 17.62 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.978 178.191 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.492 ' CD1' ' HB3' ' A' ' 60' ' ' ASN . 1.7 m-85 -134.27 119.22 18.47 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 119.509 -0.876 . . . . 0.0 112.38 -179.217 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.412 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 37.2 t -69.75 84.83 0.47 Allowed 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.286 178.81 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.499 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 1.9 tt0 -109.45 173.72 6.19 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.49 -179.178 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.561 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.667 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.095 -179.284 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.0 mmt . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.999 0.428 . . . . 0.0 110.576 . . . . . . . . . 0 0 . 1 . 042 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.1 m -127.05 177.18 5.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.648 -179.982 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.529 ' CE3' HD11 ' A' ' 31' ' ' ILE . 68.7 m95 -118.07 121.13 39.79 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.672 -178.896 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.492 ' HB3' ' CD1' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -70.39 162.98 66.68 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.005 178.011 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.441 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 80.5 Cg_exo -16.64 97.64 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.83 1 C-N-CA 125.534 4.156 . . . . 0.0 114.76 -177.773 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.501 ' HB3' ' CE2' ' A' ' 33' ' ' TYR . 6.1 mt-10 -98.49 -81.71 0.44 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.313 -178.309 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . . . -75.49 108.34 5.59 Favored Pre-proline 0 CA--C 1.529 0.151 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -176.419 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.937 ' HG2' HD11 ' A' ' 41' ' ' LEU . 1.3 Cg_endo -85.5 -154.84 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.222 2.615 . . . . 0.0 110.855 177.071 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.466 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 2.0 mm -97.66 161.17 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.057 0.456 . . . . 0.0 110.756 178.606 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -154.09 138.45 16.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.888 179.988 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.478 ' O ' ' CD2' ' A' ' 39' ' ' TYR . 0.6 OUTLIER -144.54 167.9 21.41 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.354 179.639 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.52 ' HB3' ' CZ ' ' A' ' 39' ' ' TYR . 1.2 p -108.4 118.56 37.09 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.12 0.486 . . . . 0.0 111.511 -179.396 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.733 HG22 ' CE1' ' A' ' 40' ' ' HIS . 2.6 p -46.95 97.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.309 179.364 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.475 ' HA ' HG22 ' A' ' 90' ' ' THR . 0.3 OUTLIER -78.89 131.06 36.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.546 -179.221 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -113.96 117.86 32.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.957 178.527 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -163.75 0.09 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.127 0.489 . . . . 0.0 110.978 -179.493 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -41.09 132.92 1.91 Allowed Pre-proline 0 N--CA 1.436 -1.142 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.926 179.111 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.48 ' HG3' ' CZ2' ' A' ' 118' ' ' TRP . 26.2 Cg_exo -60.78 158.16 34.43 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.321 2.014 . . . . 0.0 112.146 -179.625 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -44.95 156.93 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.905 2.403 . . . . 0.0 113.291 -178.923 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.0 t -104.99 93.41 4.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.464 179.195 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.579 HG23 ' HE2' ' A' ' 97' ' ' TYR . 24.3 pt -68.88 177.16 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.576 -178.556 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.6 m -92.9 144.47 25.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.681 179.478 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.492 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 5.0 m-80 58.25 27.94 15.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.033 179.706 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.457 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . -173.93 -168.14 34.49 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.962 179.69 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.11 -175.23 4.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.971 0.415 . . . . 0.0 110.415 -179.386 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.473 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 12.8 p-80 -108.47 166.0 11.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.907 179.411 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.704 179.912 . . . . . . . . 0 0 . 1 . 042 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.404 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 14.1 m-85 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.851 0.357 . . . . 0.0 111.173 . . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.404 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 69.6 m-85 -154.27 167.0 31.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.677 -179.655 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.475 HG22 ' HA ' ' A' ' 70' ' ' LYS . 21.4 p -151.68 -176.18 5.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.12 0.486 . . . . 0.0 111.845 -179.162 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 25.7 m-20 -50.13 94.56 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.488 -179.554 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.32 20.29 2.46 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.273 177.938 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -110.32 152.83 25.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 117.216 0.508 . . . . 0.0 110.757 179.224 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.457 HG22 ' N ' ' A' ' 95' ' ' VAL . 32.9 m -138.26 156.11 29.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.081 0.467 . . . . 0.0 111.03 -179.718 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.602 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 7.4 t -146.58 145.17 19.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.597 -179.926 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.893 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -104.65 125.6 50.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.134 0.492 . . . . 0.0 110.693 179.938 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.943 ' CE1' HG21 ' A' ' 111' ' ' VAL . 5.2 m-85 -84.27 160.88 20.66 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.498 -178.172 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.1 p -154.05 140.55 18.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.973 0.416 . . . . 0.0 111.775 -178.838 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.457 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 9.9 m -69.29 165.79 19.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.453 179.83 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.451 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 51.1 m-20 -91.03 -68.67 0.78 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.136 179.956 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.74 -38.42 62.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.293 -179.36 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 143.71 41.17 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.842 179.572 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.509 ' CE2' HG12 ' A' ' 126' ' ' ILE . 12.4 m-85 -75.36 -167.63 0.68 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 178.698 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 124' ' ' CYS . 4.3 p -115.39 106.15 13.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.851 0.357 . . . . 0.0 111.369 179.635 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.485 HD22 ' HA ' ' A' ' 109' ' ' SER . 1.6 tp -51.54 119.76 4.47 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.431 178.469 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.547 HG22 ' N ' ' A' ' 107' ' ' GLY . 26.6 mm -100.14 163.01 3.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.349 -177.709 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.547 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 50.54 27.89 13.51 Favored Glycine 0 CA--C 1.508 -0.353 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.679 179.237 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.43 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.3 OUTLIER 60.51 132.64 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.406 0.622 . . . . 0.0 111.293 179.99 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.893 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.3 p -57.61 -25.79 60.59 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.155 -178.441 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -58.77 132.81 52.74 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.78 -177.631 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.943 HG21 ' CE1' ' A' ' 97' ' ' TYR . 3.0 t -133.54 119.56 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 177.807 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.874 HD22 ' N ' ' A' ' 113' ' ' CYS . 1.2 tm? -83.18 136.54 34.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.612 0.244 . . . . 0.0 111.344 -178.709 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.874 ' N ' HD22 ' A' ' 112' ' ' LEU . 42.8 t -106.84 105.86 16.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.455 177.69 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.584 ' CB ' HD11 ' A' ' 112' ' ' LEU . 5.9 t -160.94 135.82 7.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.981 0.419 . . . . 0.0 111.333 179.259 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.424 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 83.32 25.27 48.43 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.07 -179.658 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.444 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 70.85 14.84 73.38 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.231 -178.867 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -142.66 -179.65 6.44 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.05 0.452 . . . . 0.0 111.162 179.958 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.602 ' CZ3' HG23 ' A' ' 95' ' ' VAL . 94.2 m95 -120.65 123.57 43.11 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.253 -179.75 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.559 ' OG ' HD12 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -83.36 128.14 34.26 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.112 175.016 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.663 ' HB2' HG13 ' A' ' 111' ' ' VAL . 70.0 m-20 109.55 -124.65 0.0 OUTLIER Pre-proline 0 CA--C 1.476 -1.878 0 N-CA-C 100.339 -3.948 . . . . 0.0 100.339 -166.533 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.539 ' CA ' ' CB ' ' A' ' 120' ' ' ASP . 67.6 Cg_endo -60.77 178.24 6.14 Favored 'Cis proline' 0 C--N 1.315 -1.235 0 CA-C-N 125.038 2.835 . . . . 0.0 112.553 -21.243 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.599 ' HD3' HG22 ' A' ' 111' ' ' VAL . 43.4 Cg_endo -85.97 179.93 3.53 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.401 2.067 . . . . 0.0 113.006 179.71 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.413 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -114.77 -162.74 0.83 Allowed 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.168 176.157 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . 0.442 ' SG ' ' HB2' ' A' ' 103' ' ' TYR . 4.7 t -170.44 88.91 0.14 Allowed 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 120.109 -0.637 . . . . 0.0 110.828 -175.72 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -117.57 173.64 6.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.27 -177.756 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.651 HG22 ' O ' ' A' ' 126' ' ' ILE . 47.8 mm . . . . . 0 C--N 1.322 -0.602 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.897 -179.751 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.456 ' HD2' HG23 ' A' ' 25' ' ' VAL . 11.6 mtm-85 . . . . . 0 N--CA 1.457 -0.118 0 CA-C-O 120.829 0.347 . . . . 0.0 110.839 . . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.451 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 26.7 m -85.08 160.72 54.43 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.297 -179.165 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.42 171.98 16.59 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.675 2.25 . . . . 0.0 112.237 179.824 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.8 t -51.23 106.45 0.65 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.922 -179.962 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.498 ' HG3' ' CZ2' ' A' ' 59' ' ' TRP . 76.7 Cg_exo -46.92 149.98 2.96 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.331 2.021 . . . . 0.0 112.135 179.643 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.792 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -69.85 143.69 52.78 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.215 0.531 . . . . 0.0 110.321 179.031 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -93.67 -176.86 4.2 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.061 -176.541 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.453 HD12 ' HB1' ' A' ' 63' ' ' ALA . 6.5 tt -135.71 151.04 29.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.599 179.588 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -75.93 -68.83 0.54 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.808 -177.631 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.434 ' N ' ' ND2' ' A' ' 17' ' ' ASN . 0.7 OUTLIER -89.87 44.8 1.23 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.862 0.363 . . . . 0.0 110.985 -179.056 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.437 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -167.36 179.84 40.67 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.957 179.939 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.9 134.54 28.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.823 0.344 . . . . 0.0 110.934 179.645 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.899 HD21 ' CE1' ' A' ' 33' ' ' TYR . 18.6 mt -80.02 158.5 26.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.116 0.484 . . . . 0.0 111.924 -178.855 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 32' ' ' THR . 0.7 OUTLIER -129.1 76.93 1.76 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.866 177.602 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.838 ' HA ' HG23 ' A' ' 31' ' ' ILE . 28.8 mt -70.16 112.6 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.265 -177.607 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -108.47 18.25 32.89 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.926 -0.655 . . . . 0.0 111.693 176.675 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 29' ' ' SER . . . 151.18 136.85 2.56 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 111.759 -0.537 . . . . 0.0 111.759 -179.148 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.456 HG23 ' HD2' ' A' ' 8' ' ' ARG . 18.9 m -118.06 12.21 7.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -178.915 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -69.86 157.48 37.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.8 0.333 . . . . 0.0 110.824 179.415 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.586 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 7.5 t80 -55.62 91.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.628 179.759 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 49' ' ' CYS . . . 127.22 -10.75 6.9 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.677 -179.394 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.407 ' HB3' ' O ' ' A' ' 24' ' ' GLY . 61.1 m -58.71 -174.52 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.748 0.309 . . . . 0.0 110.743 179.898 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 47' ' ' SER . 23.0 p -151.59 140.21 20.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.232 179.736 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.838 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -107.87 166.58 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.551 179.661 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.424 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -129.1 108.6 10.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.885 179.522 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.899 ' CE1' HD21 ' A' ' 20' ' ' LEU . 18.2 m-85 -82.47 149.58 27.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.017 0.436 . . . . 0.0 111.043 -179.814 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.429 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.3 OUTLIER -150.91 164.79 35.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.681 -179.949 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.432 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 3.7 m -87.28 161.57 17.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.855 -179.925 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -57.72 -84.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.078 -179.683 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.74 135.65 14.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.634 179.95 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.779 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 60.16 25.94 62.96 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.522 -0.846 . . . . 0.0 111.732 -178.84 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.481 ' CD2' ' HA ' ' A' ' 68' ' ' SER . 2.1 m-85 -117.0 172.08 7.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.836 0.35 . . . . 0.0 111.088 -179.045 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.591 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -133.27 120.44 21.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.491 178.017 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.972 HD21 ' O ' ' A' ' 44' ' ' GLU . 3.6 tt -81.86 132.76 35.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.245 -179.844 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.591 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.5 mm -101.7 151.54 5.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.219 -178.551 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.39 -147.08 38.48 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.064 -179.044 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.972 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.6 OUTLIER -66.2 -177.92 0.58 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.88 0.371 . . . . 0.0 110.766 179.289 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.57 27.93 0.16 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.289 178.72 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.424 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -147.79 132.45 17.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.324 -179.047 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.403 ' O ' ' HA ' ' A' ' 30' ' ' SER . 2.1 m -104.21 150.04 24.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.152 178.641 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.463 ' CE1' ' HD3' ' A' ' 61' ' ' PRO . 6.8 m-85 -124.18 125.6 44.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.047 0.451 . . . . 0.0 111.51 -178.879 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.502 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 28.3 t -74.58 86.26 2.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.356 179.106 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.498 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 1.1 tt0 -105.13 175.4 5.51 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.425 -179.243 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.586 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.653 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.948 -179.94 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.8 mmt . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 120.825 0.345 . . . . 0.0 110.345 . . . . . . . . . 0 0 . 1 . 043 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.9 m -140.68 -176.81 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.12 -179.076 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.756 ' CE3' HD11 ' A' ' 31' ' ' ILE . 90.9 m95 -123.02 124.81 43.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.289 -179.246 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.427 ' O ' ' CD1' ' A' ' 48' ' ' TYR . 14.5 m-80 -146.88 126.92 6.77 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.886 179.851 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.463 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 71.6 Cg_endo -75.89 -163.64 3.33 Favored 'Cis proline' 0 C--N 1.351 0.685 0 C-N-CA 123.892 -1.295 . . . . 0.0 112.206 -0.34 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.49 ' O ' ' CZ ' ' A' ' 33' ' ' TYR . 28.6 mm-40 -110.13 -107.9 0.35 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.095 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.547 ' HB2' ' HE1' ' A' ' 33' ' ' TYR . . . -122.0 100.0 43.39 Favored Pre-proline 0 N--CA 1.445 -0.714 0 C-N-CA 122.514 0.325 . . . . 0.0 110.722 -177.937 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.78 ' HG2' HD11 ' A' ' 41' ' ' LEU . 20.7 Cg_endo -50.59 -158.02 0.0 OUTLIER 'Trans proline' 0 N--CA 1.476 0.448 0 C-N-CA 123.286 2.657 . . . . 0.0 112.939 177.652 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.64 HG22 ' H ' ' A' ' 66' ' ' CYS . 1.0 OUTLIER -93.0 174.94 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.505 -179.136 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.64 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.7 OUTLIER -170.34 133.32 1.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.695 -179.983 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.472 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -150.65 179.59 8.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.872 -179.94 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.481 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 73.0 p -86.81 120.1 27.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.99 179.862 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.779 HG12 ' O ' ' A' ' 38' ' ' GLY . 1.2 p -48.0 99.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.289 179.876 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -82.69 115.75 21.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.432 -179.344 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.428 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -97.54 123.11 41.3 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.284 -0.416 . . . . 0.0 109.919 178.179 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -74.04 -150.99 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.953 179.694 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.464 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 2.4 t -56.62 144.81 63.46 Favored Pre-proline 0 C--N 1.324 -0.516 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.647 -179.661 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.579 ' HG2' HG11 ' A' ' 95' ' ' VAL . 23.7 Cg_exo -61.87 163.41 19.14 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.544 2.162 . . . . 0.0 111.817 179.732 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.504 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 97.8 Cg_exo -41.11 156.66 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.722 2.281 . . . . 0.0 112.742 -179.315 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 12.3 t -105.96 90.03 3.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.48 179.15 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.661 HG23 ' HE2' ' A' ' 97' ' ' TYR . 20.7 pt -69.48 -178.32 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.21 -179.195 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.1 m -104.02 145.56 29.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.809 179.635 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.508 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 13.2 m-20 56.7 29.57 16.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.214 179.448 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.44 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -166.85 -165.49 24.33 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.794 179.716 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.96 -175.63 4.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.097 0.475 . . . . 0.0 111.005 -179.73 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.464 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 35.1 p-80 -108.51 173.77 6.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.933 179.681 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.493 178.71 . . . . . . . . 0 0 . 1 . 043 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.425 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 8.5 m-85 . . . . . 0 N--CA 1.456 -0.141 0 CA-C-O 120.923 0.392 . . . . 0.0 111.003 . . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.428 ' N ' ' O ' ' A' ' 71' ' ' CYS . 55.0 m-85 -151.76 164.0 37.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.761 -179.523 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.6 p -131.27 -175.89 3.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.231 -179.502 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 5.0 m-20 -65.95 94.47 0.23 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.19 0.519 . . . . 0.0 111.126 -179.767 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.86 31.1 0.77 Allowed Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.973 178.753 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.449 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.6 OUTLIER -110.19 159.0 17.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.74 0.305 . . . . 0.0 110.83 179.418 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 34.6 m -134.72 149.48 29.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.075 0.464 . . . . 0.0 111.191 -179.741 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.579 HG11 ' HG2' ' A' ' 74' ' ' PRO . 26.2 t -144.77 148.0 18.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.841 179.592 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.689 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -108.35 128.5 54.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.033 -179.849 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.961 ' CE1' HG21 ' A' ' 111' ' ' VAL . 7.0 m-85 -89.13 155.77 19.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.953 -179.943 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 77.3 p -149.15 137.84 21.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.086 179.543 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.44 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 83.1 m -69.73 157.87 36.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.057 -179.737 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.3 m-20 -90.03 -71.79 0.6 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.564 -178.898 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.0 t -63.77 -19.68 65.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.555 -178.862 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 119.46 31.04 1.43 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.376 -179.733 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.508 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 35.5 m-85 -69.59 -171.55 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.698 0.285 . . . . 0.0 110.476 179.61 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.72 106.53 16.2 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.907 0.384 . . . . 0.0 111.274 -179.078 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.542 HD23 ' HB2' ' A' ' 122' ' ' PRO . 1.6 tp -45.18 108.95 0.14 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.633 178.476 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.782 HD11 ' HB2' ' A' ' 125' ' ' GLN . 24.3 mm -83.25 160.75 3.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.067 -178.366 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.539 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 54.68 -128.29 42.29 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.902 -179.257 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -115.52 134.39 55.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.975 0.417 . . . . 0.0 110.898 179.018 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.689 ' HB2' HG22 ' A' ' 96' ' ' THR . 0.0 OUTLIER -68.3 -30.6 69.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.377 179.322 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -75.45 133.16 14.21 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.542 179.807 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.961 HG21 ' CE1' ' A' ' 97' ' ' TYR . 3.3 t -125.6 124.2 66.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.506 0.194 . . . . 0.0 110.49 179.393 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.76 123.71 30.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.895 0.379 . . . . 0.0 111.799 -178.269 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.536 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 27.2 t -88.95 104.36 16.89 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 176.354 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 53.3 p -142.99 154.6 44.18 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.042 0.448 . . . . 0.0 111.605 -177.772 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.43 35.49 7.13 Favored Glycine 0 N--CA 1.453 -0.194 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.748 179.519 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.454 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 68.28 11.44 61.66 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.74 -179.439 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -132.87 178.29 6.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.865 0.364 . . . . 0.0 110.558 179.418 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.536 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 93.1 m95 -117.4 148.13 42.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.882 -179.458 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.498 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.1 OUTLIER -128.28 164.06 23.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.111 0.481 . . . . 0.0 111.635 -178.654 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.442 ' N ' ' HD3' ' A' ' 121' ' ' PRO . 1.7 p-10 45.97 52.13 10.71 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.233 179.219 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.442 ' HD3' ' N ' ' A' ' 120' ' ' ASP . 84.0 Cg_endo -82.18 145.64 13.81 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.547 2.164 . . . . 0.0 111.562 177.527 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.542 ' HB2' HD23 ' A' ' 105' ' ' LEU . 90.5 Cg_endo -93.7 -170.1 0.23 Allowed 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.888 2.392 . . . . 0.0 114.177 -177.458 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.452 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -140.54 -170.03 2.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.004 177.806 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . 0.408 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 14.5 m -143.49 95.39 2.74 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.039 0.447 . . . . 0.0 111.11 -179.662 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.782 ' HB2' HD11 ' A' ' 106' ' ' ILE . 23.6 mt-30 -122.78 158.07 31.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.797 179.921 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.503 HG12 ' CE2' ' A' ' 103' ' ' TYR . 28.8 mm . . . . . 0 C--N 1.324 -0.506 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.08 -179.754 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.575 ' HB3' HG23 ' A' ' 25' ' ' VAL . 1.4 mtm180 . . . . . 0 N--CA 1.447 -0.6 0 CA-C-O 121.011 0.434 . . . . 0.0 111.59 . . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.464 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 95.3 m -87.44 158.69 51.44 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.965 -179.824 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 41.0 Cg_endo -68.56 173.49 9.79 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.604 2.203 . . . . 0.0 112.274 -179.971 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -50.65 107.31 0.78 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.783 179.871 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.415 ' HG2' HD11 ' A' ' 22' ' ' ILE . 9.9 Cg_endo -54.8 141.93 75.52 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.202 1.935 . . . . 0.0 112.147 -179.29 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.88 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -52.32 150.83 4.39 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.379 179.259 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.83 -176.06 2.99 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.269 0.556 . . . . 0.0 111.588 -178.038 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.452 HG23 ' C ' ' A' ' 18' ' ' GLY . 11.1 tt -135.58 148.91 28.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.621 -179.585 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -81.02 -62.35 1.69 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.917 -177.635 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.415 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 0.3 OUTLIER -93.15 27.04 2.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.16 -178.549 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.452 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -146.26 -176.58 20.23 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.097 -179.693 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -139.77 127.65 22.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.644 0.259 . . . . 0.0 110.667 179.544 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.88 HD11 ' O ' ' A' ' 13' ' ' ARG . 11.1 mt -72.76 154.14 40.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.11 0.481 . . . . 0.0 111.712 -179.49 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.441 ' CB ' ' HB ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -130.58 76.22 1.71 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.561 177.061 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.917 ' HA ' HG23 ' A' ' 31' ' ' ILE . 54.8 mt -69.97 107.76 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.826 -177.702 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -109.44 15.07 32.7 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.167 178.119 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 29' ' ' SER . . . 162.29 122.9 0.63 Allowed Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.911 -179.639 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.575 HG23 ' HB3' ' A' ' 8' ' ' ARG . 34.9 m -112.94 28.06 2.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.482 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 12.6 t70 -102.45 162.69 12.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.043 0.449 . . . . 0.0 111.271 179.534 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.91 ' CZ ' HD13 ' A' ' 51' ' ' LEU . 7.3 t80 -59.61 93.5 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.911 -179.502 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 123.94 3.27 8.35 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.812 -179.963 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 1.6 m -84.92 -159.0 0.39 Allowed 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 116.892 0.346 . . . . 0.0 110.134 179.161 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 47' ' ' SER . 51.9 p -168.18 153.98 7.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.116 0.484 . . . . 0.0 111.451 179.361 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.917 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.6 OUTLIER -114.82 172.84 3.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.383 179.663 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.441 ' HB ' ' CB ' ' A' ' 21' ' ' ASP . 2.6 m -132.86 109.23 9.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.996 0.427 . . . . 0.0 110.962 178.661 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.869 ' CE2' HD21 ' A' ' 20' ' ' LEU . 22.4 m-85 -84.31 132.12 34.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.828 179.836 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.431 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.7 OUTLIER -135.61 162.71 31.94 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.652 -179.42 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.449 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 5.4 m -84.57 168.01 15.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.789 0.328 . . . . 0.0 110.83 179.875 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -63.66 -78.62 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.013 -179.319 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -156.36 135.76 12.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.743 179.72 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.806 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 55.83 26.49 47.61 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.693 -178.939 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.502 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.1 m-85 -115.15 165.84 12.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.707 0.289 . . . . 0.0 110.805 -179.23 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.974 ' NE2' HG22 ' A' ' 69' ' ' VAL . 95.3 m-70 -117.88 122.01 42.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.457 178.255 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.735 HD21 ' O ' ' A' ' 44' ' ' GLU . 10.1 tt -86.2 110.18 19.42 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.294 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.454 ' HB ' ' HB ' ' A' ' 65' ' ' ILE . 2.2 mm -84.07 155.13 3.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.934 0.397 . . . . 0.0 111.314 -177.801 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.5 -145.64 36.07 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.057 -179.053 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.735 ' O ' HD21 ' A' ' 41' ' ' LEU . 1.0 OUTLIER -74.31 165.92 24.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.628 0.251 . . . . 0.0 110.473 179.009 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.678 ' HB3' HD22 ' A' ' 41' ' ' LEU . 3.2 p -141.66 24.39 2.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.003 -179.883 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.408 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -148.37 135.77 20.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.447 -178.416 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.427 ' C ' ' CD2' ' A' ' 48' ' ' TYR . 1.0 OUTLIER -106.07 161.07 14.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.498 178.605 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.535 ' CE1' ' HD3' ' A' ' 61' ' ' PRO . 3.6 m-85 -134.29 122.14 22.26 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.056 0.455 . . . . 0.0 111.811 -177.569 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.514 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 35.7 t -76.96 94.42 3.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.806 179.484 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -115.19 -172.83 2.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.531 179.641 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.91 HD13 ' CZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.554 179.105 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 120.871 0.367 . . . . 0.0 110.678 . . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.456 HG22 ' C ' ' A' ' 51' ' ' LEU . 8.4 m -152.09 173.87 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.264 -179.128 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.704 ' CE3' HD11 ' A' ' 31' ' ' ILE . 89.9 m95 -129.54 130.99 46.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.06 -179.874 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.471 ' O ' ' CD1' ' A' ' 48' ' ' TYR . 0.9 OUTLIER -160.6 135.14 5.36 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.053 179.897 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.535 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 61.4 Cg_endo -71.33 -165.8 3.5 Favored 'Cis proline' 0 C--N 1.353 0.786 0 C-N-CA 123.984 -1.257 . . . . 0.0 112.691 0.013 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -111.49 -152.3 0.5 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.064 -179.012 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.478 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -73.46 115.24 39.38 Favored Pre-proline 0 C--O 1.231 0.128 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.672 179.213 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.443 ' CG ' ' O ' ' A' ' 44' ' ' GLU . 15.2 Cg_exo -71.22 -150.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.7 2.267 . . . . 0.0 112.54 -178.826 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.585 HG22 ' H ' ' A' ' 66' ' ' CYS . 1.5 mm -103.56 170.64 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.058 -179.162 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.585 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.3 m -159.31 134.69 8.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.109 -179.952 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.73 157.25 44.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.984 179.809 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.502 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 1.4 p -78.67 129.22 34.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.253 0.549 . . . . 0.0 111.553 -179.274 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.974 HG22 ' NE2' ' A' ' 40' ' ' HIS . 3.9 p -50.6 94.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.208 179.458 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.413 ' HE2' HG23 ' A' ' 90' ' ' THR . 0.8 OUTLIER -80.42 116.95 20.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.128 -179.846 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -98.17 119.84 37.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.376 179.074 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -158.63 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.662 179.764 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.432 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 2.2 t -48.64 139.99 10.88 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.96 -179.704 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.509 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 26.5 Cg_exo -60.72 161.93 19.93 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.426 2.084 . . . . 0.0 112.154 -179.862 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.525 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 80.9 Cg_exo -42.88 157.48 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.786 2.324 . . . . 0.0 112.85 -179.692 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.3 m -108.16 89.85 3.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.551 179.094 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.73 HG23 ' HE1' ' A' ' 97' ' ' TYR . 33.8 pt -69.35 173.75 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.242 -179.176 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.1 m -95.31 142.91 27.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.582 179.332 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.418 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 7.0 m-80 60.74 28.44 18.18 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.003 179.815 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.465 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -166.49 -166.99 26.47 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.813 -179.882 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.423 ' N ' ' O ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -166.26 -175.75 3.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.001 0.429 . . . . 0.0 110.798 -179.934 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 3.1 p80 -114.63 167.42 10.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.25 -179.515 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.778 179.812 . . . . . . . . 0 0 . 1 . 044 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.433 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 6.1 m-85 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.786 0.326 . . . . 0.0 110.946 . . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.433 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 31.2 m-85 -147.03 167.62 23.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.04 -179.635 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.413 HG23 ' HE2' ' A' ' 70' ' ' LYS . 21.7 p -139.25 -175.13 4.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.114 -179.78 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.42 ' OD2' ' CG1' ' A' ' 69' ' ' VAL . 0.4 OUTLIER -62.05 95.06 0.06 Allowed 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.197 0.523 . . . . 0.0 110.94 179.937 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.7 26.94 1.34 Allowed Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.496 -0.775 . . . . 0.0 113.151 178.592 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -108.3 152.17 24.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.769 0.285 . . . . 0.0 110.384 178.679 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 35.5 m -130.53 154.41 40.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.02 0.438 . . . . 0.0 111.251 -179.494 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.55 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 43.8 t -148.14 151.15 13.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.763 179.32 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.926 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -109.12 125.62 52.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.172 0.51 . . . . 0.0 110.957 179.905 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.967 ' CE2' HG21 ' A' ' 111' ' ' VAL . 4.5 m-85 -83.35 162.19 21.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.12 -179.043 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 81' ' ' ARG . 2.6 p -150.94 130.39 12.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.853 0.359 . . . . 0.0 111.689 -178.82 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.409 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 71.8 m -69.93 155.28 40.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.699 178.831 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.465 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 12.6 m-20 -92.76 -72.16 0.61 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.594 -178.598 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.5 t -57.2 -20.59 27.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.771 0.32 . . . . 0.0 111.261 -179.365 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 117.81 29.75 1.96 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.29 -179.846 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.472 ' CE2' HG12 ' A' ' 126' ' ' ILE . 43.9 m-85 -70.7 -174.18 0.87 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.876 0.37 . . . . 0.0 110.643 179.898 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 125' ' ' GLN . 0.5 OUTLIER -109.99 110.45 21.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.702 179.56 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.494 ' CD2' ' HB2' ' A' ' 122' ' ' PRO . 1.1 tp -48.08 113.62 0.77 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.936 179.401 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.525 HG22 ' N ' ' A' ' 107' ' ' GLY . 30.1 mm -94.78 161.06 2.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.031 -179.029 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.525 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 51.63 25.8 15.09 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.333 -0.937 . . . . 0.0 112.346 -179.48 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.417 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.3 OUTLIER 60.24 133.42 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.028 -0.586 . . . . 0.0 111.342 -179.567 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.926 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.3 p -60.64 -26.65 67.21 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.485 -179.156 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.84 128.68 47.0 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.115 -178.692 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.967 HG21 ' CE2' ' A' ' 97' ' ' TYR . 2.3 t -123.67 149.79 27.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 178.279 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.8 108.41 17.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.821 0.343 . . . . 0.0 111.441 -179.93 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.512 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 11.6 t -73.68 103.93 4.43 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 176.536 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.5 p -145.9 159.45 43.2 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.212 -178.619 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.67 32.31 8.01 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.739 179.782 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.43 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 71.81 6.41 63.34 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.824 -179.65 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -136.84 173.52 11.62 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.876 0.369 . . . . 0.0 110.624 179.746 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.55 ' CZ3' HG23 ' A' ' 95' ' ' VAL . 83.1 m95 -106.39 124.86 50.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.031 -179.461 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.78 159.05 15.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.517 -178.926 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.472 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 3.6 p-10 49.44 46.58 3.87 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.465 179.076 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 52.9 Cg_endo -68.36 144.44 61.9 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.32 2.013 . . . . 0.0 111.132 177.215 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.505 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 74.1 Cg_endo -89.73 -172.6 0.62 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.528 2.152 . . . . 0.0 114.3 -176.761 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.41 -158.81 0.9 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.363 -1.289 . . . . 0.0 109.822 178.465 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 7.8 m -155.5 90.54 1.25 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.998 0.427 . . . . 0.0 110.894 179.241 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.402 ' O ' ' HB2' ' A' ' 104' ' ' SER . 22.6 mt-30 -117.37 173.34 6.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.779 -179.851 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.472 HG12 ' CE2' ' A' ' 103' ' ' TYR . 29.1 mm . . . . . 0 C--N 1.325 -0.479 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.971 -179.424 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.682 ' HD2' HG23 ' A' ' 25' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.344 0 CA-C-O 121.232 0.539 . . . . 0.0 112.057 . . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.55 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 89.4 m -94.32 177.54 1.86 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.696 179.708 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.55 ' CD ' ' HB3' ' A' ' 9' ' ' CYS . 28.1 Cg_endo -91.33 179.9 1.51 Allowed 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.706 2.27 . . . . 0.0 111.974 -179.538 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.1 t -51.81 105.51 0.53 Allowed Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.567 179.497 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.483 ' HG3' ' CZ2' ' A' ' 59' ' ' TRP . 77.8 Cg_exo -49.47 153.3 5.21 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.304 2.003 . . . . 0.0 112.4 -179.447 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.428 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 1.0 OUTLIER -62.97 168.5 3.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.981 179.124 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.554 ' HA ' HD11 ' A' ' 20' ' ' LEU . 1.0 OUTLIER -118.93 -175.1 2.84 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.303 0.573 . . . . 0.0 111.752 -178.24 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.9 tt -145.19 139.37 22.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.317 -179.692 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -65.34 -72.96 0.14 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.86 -177.568 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.426 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 1.3 m120 -90.02 45.64 1.29 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.933 0.397 . . . . 0.0 110.884 -179.129 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -157.08 171.93 34.54 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.352 -0.928 . . . . 0.0 113.292 179.767 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.403 ' N ' ' O ' ' A' ' 34' ' ' SER . 0.3 OUTLIER -133.55 131.03 39.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.775 0.321 . . . . 0.0 110.36 179.323 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.734 HD22 ' CE1' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -78.54 166.62 22.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.171 0.51 . . . . 0.0 111.748 -178.788 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.452 ' HB3' ' CB ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -135.55 73.39 1.47 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.634 177.127 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.805 ' HA ' HG23 ' A' ' 31' ' ' ILE . 45.4 mt -71.53 92.62 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.582 -178.058 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -97.49 18.42 57.38 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.161 178.212 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 158.51 129.51 1.09 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.109 -0.567 . . . . 0.0 111.887 -179.585 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.682 HG23 ' HD2' ' A' ' 8' ' ' ARG . 32.6 m -115.35 0.91 8.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.553 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -69.6 153.6 43.22 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.923 0.392 . . . . 0.0 111.069 -179.764 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.526 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 12.1 t80 -50.48 106.54 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.935 -179.939 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.18 -7.07 23.23 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.913 179.988 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 99.7 p -71.78 -171.65 0.71 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.791 0.329 . . . . 0.0 110.807 179.971 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 47' ' ' SER . 3.2 p -153.48 156.05 37.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.026 179.727 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.805 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -119.71 168.05 12.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.492 -179.869 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.452 ' CB ' ' HB3' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -128.93 111.1 12.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.918 0.39 . . . . 0.0 110.977 179.054 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.734 ' CE1' HD22 ' A' ' 20' ' ' LEU . 27.8 m-85 -88.84 134.93 33.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.211 -179.645 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.428 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 21.3 p -138.42 167.97 20.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.703 179.908 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.448 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 1.6 m -88.18 162.68 16.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.86 -179.991 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.16 -80.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.849 0.357 . . . . 0.0 111.123 -179.324 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.1 m -158.63 133.72 8.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.773 -179.814 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.727 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 60.06 24.74 61.11 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.789 -178.959 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.477 ' CG ' ' O ' ' A' ' 67' ' ' GLU . 2.0 m-85 -112.47 -179.58 3.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.78 0.324 . . . . 0.0 110.766 -179.662 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.877 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -138.7 113.8 9.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.011 0.434 . . . . 0.0 110.613 178.49 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.713 HD21 ' O ' ' A' ' 44' ' ' GLU . 4.7 tt -78.99 126.36 30.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.514 -179.595 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.877 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.6 mm -100.2 153.51 4.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.401 -178.688 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.9 -145.35 31.05 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.328 -179.711 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.713 ' O ' HD21 ' A' ' 41' ' ' LEU . 3.7 pm0 -70.02 171.56 9.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.576 0.227 . . . . 0.0 110.695 179.477 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.0 p -146.96 18.98 1.26 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.437 -179.599 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.431 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -148.15 134.15 19.2 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.925 0.393 . . . . 0.0 111.495 -178.768 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.45 ' HB2' ' CG1' ' A' ' 31' ' ' ILE . 1.5 m -102.89 152.52 21.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.992 178.51 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.515 ' CE1' ' HD3' ' A' ' 61' ' ' PRO . 4.5 m-85 -125.3 121.05 32.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.135 0.493 . . . . 0.0 111.601 -178.74 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.447 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 41.0 t -72.32 93.77 1.53 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.301 179.216 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.493 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 0.7 OUTLIER -111.93 176.4 5.04 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.372 -178.78 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.526 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.579 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.811 179.79 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.982 0.42 . . . . 0.0 110.397 . . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.0 m -125.62 -176.62 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.074 -179.046 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.698 ' CE3' HD11 ' A' ' 31' ' ' ILE . 86.0 m95 -127.69 127.05 43.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.666 179.976 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -151.87 128.92 5.53 Favored Pre-proline 0 CA--C 1.532 0.285 0 C-N-CA 121.086 -0.246 . . . . 0.0 111.322 -179.416 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.515 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 72.8 Cg_endo -75.7 -165.92 4.63 Favored 'Cis proline' 0 C--N 1.351 0.701 0 C-N-CA 123.864 -1.306 . . . . 0.0 112.335 -0.516 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.79 -153.87 0.53 Allowed 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.014 -179.474 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.475 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -73.63 112.67 17.19 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.819 179.63 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 63' ' ' ALA . 17.3 Cg_exo -68.75 -150.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.669 2.246 . . . . 0.0 112.452 -179.075 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.509 HG22 ' H ' ' A' ' 66' ' ' CYS . 5.7 mm -99.6 166.35 2.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.91 0.386 . . . . 0.0 111.459 -178.842 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.509 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -165.94 123.8 1.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.692 179.381 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.477 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -136.24 176.64 8.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.0 -179.739 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.467 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 4.2 p -94.2 122.48 36.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.15 -179.736 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.727 HG12 ' O ' ' A' ' 38' ' ' GLY . 3.0 p -46.85 99.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.399 179.569 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.408 ' HD2' ' HB3' ' A' ' 88' ' ' PHE . 23.0 mmtt -70.99 114.88 9.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.177 179.958 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.426 ' N ' ' O ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -97.01 121.44 38.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.095 178.73 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -158.74 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.925 -179.643 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.543 ' HG ' ' CE1' ' A' ' 82' ' ' HIS . 2.1 t -48.54 138.08 11.9 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.113 -179.556 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.491 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 24.6 Cg_exo -61.22 162.3 20.38 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.389 2.059 . . . . 0.0 112.001 179.746 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.512 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 91.9 Cg_exo -40.72 158.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.852 2.368 . . . . 0.0 113.01 -179.158 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.7 m -108.91 90.99 3.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.588 179.328 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.719 HG23 ' HE2' ' A' ' 97' ' ' TYR . 23.0 pt -69.14 -177.11 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.23 -179.139 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.0 p -101.37 146.74 27.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.752 179.639 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.512 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 3.3 m-80 53.54 29.62 9.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.12 179.449 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.466 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -171.55 -171.69 36.9 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.543 179.612 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.54 -176.17 4.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.966 0.412 . . . . 0.0 110.914 179.417 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.543 ' CE1' ' HG ' ' A' ' 73' ' ' SER . 8.6 p-80 -100.93 173.03 6.67 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.018 -179.956 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.393 179.223 . . . . . . . . 0 0 . 1 . 045 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.43 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 6.3 m-85 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.827 0.346 . . . . 0.0 111.182 . . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.43 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 70.4 m-85 -151.27 165.15 34.86 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.895 -179.913 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.3 p -127.4 173.57 9.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.97 0.414 . . . . 0.0 111.214 -179.159 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -60.26 95.31 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.303 0.573 . . . . 0.0 110.82 179.744 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 125.81 28.28 1.07 Allowed Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.943 179.34 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.2 158.14 18.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.696 0.284 . . . . 0.0 110.567 179.208 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 32.8 m -131.43 150.43 34.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.066 0.46 . . . . 0.0 111.361 -179.514 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.542 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 33.2 t -143.12 148.67 19.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.563 178.854 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.983 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -104.45 134.42 47.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.936 -179.873 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.962 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.7 m-85 -94.27 158.59 15.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.263 -179.354 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 84.7 p -154.3 139.91 17.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.39 -179.856 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.415 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 66.3 m -70.54 162.73 28.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.224 -179.862 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.466 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 73.6 m-80 -92.05 -78.26 0.41 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.45 -179.232 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.7 m -56.53 -27.33 57.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.855 0.36 . . . . 0.0 110.985 -179.312 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.61 34.09 0.58 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.768 179.679 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.512 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 32.4 m-85 -70.4 -173.06 0.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.763 0.316 . . . . 0.0 110.175 178.939 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.98 109.97 20.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.139 0.495 . . . . 0.0 110.853 179.563 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.644 HD23 ' HB2' ' A' ' 122' ' ' PRO . 2.6 tp -46.65 113.5 0.66 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.936 179.145 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.464 HG22 ' N ' ' A' ' 107' ' ' GLY . 38.7 mm -89.06 157.29 3.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.785 -179.265 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.464 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 62.77 -121.58 25.38 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.462 -0.875 . . . . 0.0 111.587 -178.335 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -127.48 130.52 49.37 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.878 0.37 . . . . 0.0 110.711 178.523 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.983 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.1 p -63.72 -28.48 69.92 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.107 179.123 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -74.33 130.96 12.76 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.594 179.477 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.962 HG21 ' CE1' ' A' ' 97' ' ' TYR . 4.3 t -122.95 134.13 67.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.152 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 118' ' ' TRP . 0.3 OUTLIER -90.02 124.79 35.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.019 0.438 . . . . 0.0 111.785 -178.2 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.521 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 14.5 t -91.02 100.44 13.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.521 176.909 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.9 166.54 27.33 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.098 0.475 . . . . 0.0 111.591 -178.217 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.98 26.93 3.16 Favored Glycine 0 CA--C 1.517 0.214 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.841 179.589 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.421 ' N ' HG11 ' A' ' 69' ' ' VAL . . . 73.83 10.88 80.84 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.597 -179.425 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -142.14 -177.74 5.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.753 0.311 . . . . 0.0 110.459 179.705 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.542 ' CZ3' HG23 ' A' ' 95' ' ' VAL . 85.0 m95 -114.57 149.33 36.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.072 -179.264 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.549 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -130.02 168.87 16.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.444 -179.121 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.456 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 5.0 p-10 46.67 49.62 7.21 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.975 179.801 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 75.5 Cg_endo -77.85 143.01 20.5 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.632 2.221 . . . . 0.0 111.681 178.045 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.644 ' HB2' HD23 ' A' ' 105' ' ' LEU . 70.0 Cg_endo -90.8 -171.54 0.44 Allowed 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.841 2.36 . . . . 0.0 113.819 -178.053 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.424 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -133.96 -161.3 1.13 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.252 178.592 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 10.7 m -153.53 90.14 1.39 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.016 0.436 . . . . 0.0 110.996 179.599 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -118.35 160.84 20.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.651 179.793 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.62 HG22 ' O ' ' A' ' 126' ' ' ILE . 20.5 mm . . . . . 0 C--N 1.322 -0.618 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.103 -179.852 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.622 ' HB3' HG23 ' A' ' 25' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.45 0 CA-C-O 121.078 0.465 . . . . 0.0 111.501 . . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.438 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 18.4 m -72.73 160.82 81.91 Favored Pre-proline 0 N--CA 1.452 -0.346 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.51 179.817 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.45 167.61 16.46 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.171 1.914 . . . . 0.0 111.175 179.517 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.5 p -53.64 107.74 0.93 Allowed Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.152 -178.376 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.564 ' HG2' HD13 ' A' ' 22' ' ' ILE . 50.0 Cg_exo -44.87 167.41 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.312 2.008 . . . . 0.0 112.765 179.724 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.413 ' HB3' ' OH ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -66.36 176.51 1.79 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.593 176.416 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.919 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -130.46 -7.06 4.19 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -177.279 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.698 HD12 ' HD2' ' A' ' 64' ' ' PRO . 17.4 tt 51.67 156.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 123.498 0.719 . . . . 0.0 112.533 -178.685 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.416 ' HB3' ' ND2' ' A' ' 17' ' ' ASN . 3.9 t0 -103.97 157.52 17.04 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.141 178.858 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.416 ' ND2' ' HB3' ' A' ' 16' ' ' ASP . 0.1 OUTLIER 42.97 28.0 0.12 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.293 -179.516 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.447 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -151.25 -163.42 11.38 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.341 -179.781 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.694 ' C ' HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -137.93 175.37 9.64 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.85 0.357 . . . . 0.0 111.132 179.964 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.919 HD11 ' O ' ' A' ' 14' ' ' ASP . 0.8 OUTLIER -125.13 150.65 46.68 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.57 179.514 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.457 ' HB3' ' CB ' ' A' ' 32' ' ' THR . 60.5 t0 -125.97 67.08 1.19 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 177.913 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.94 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -82.33 101.63 7.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.026 -176.613 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.22 7.97 72.48 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.982 176.908 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 175.53 160.36 23.1 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.926 -179.928 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.622 HG23 ' HB3' ' A' ' 8' ' ' ARG . 31.9 m -143.13 33.73 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.873 0.368 . . . . 0.0 111.205 -179.689 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.17 156.9 17.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.081 -179.906 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.518 ' CE2' ' HG ' ' A' ' 51' ' ' LEU . 0.6 OUTLIER -54.23 91.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.723 179.56 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 132.54 -10.47 5.25 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.797 -179.796 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.3 -179.27 5.59 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.804 0.335 . . . . 0.0 110.561 179.565 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 47' ' ' SER . 3.0 p -155.13 141.63 18.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.076 0.465 . . . . 0.0 110.558 179.277 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.94 HG23 ' HA ' ' A' ' 22' ' ' ILE . 1.1 mt -101.95 166.12 2.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.56 -179.239 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.457 ' CB ' ' HB3' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -127.98 104.81 8.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.942 0.401 . . . . 0.0 110.214 178.842 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.529 ' CE2' ' CD2' ' A' ' 20' ' ' LEU . 9.5 m-85 -79.76 157.83 27.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.695 -178.02 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.6 t -162.81 176.59 10.09 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.697 179.99 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.455 ' HB3' ' CB ' ' A' ' 39' ' ' TYR . 45.2 m -98.43 173.78 6.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.876 179.916 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.439 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 30.6 m-20 -72.81 -83.63 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.289 -179.279 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.4 t -149.48 139.04 21.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.631 -179.867 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.877 ' O ' HG22 ' A' ' 69' ' ' VAL . . . 55.89 27.02 49.5 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.811 -179.056 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.555 ' CD2' ' HA ' ' A' ' 68' ' ' SER . 2.4 m-85 -115.82 171.62 7.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.681 0.277 . . . . 0.0 110.763 -179.147 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.878 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -137.5 117.52 13.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.978 0.418 . . . . 0.0 110.608 178.677 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.931 HD21 ' O ' ' A' ' 44' ' ' GLU . 5.9 tt -81.52 125.8 30.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.64 -179.542 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.878 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.0 mm -102.16 153.33 5.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.09 -179.3 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.08 -142.82 26.79 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.452 -179.681 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.931 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -68.43 -172.39 0.33 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.063 0.458 . . . . 0.0 110.882 179.68 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -174.77 32.23 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.202 178.992 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 mtpt -157.34 118.8 3.68 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.033 0.444 . . . . 0.0 111.577 -179.426 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.442 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 0.4 OUTLIER -91.83 139.47 30.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.109 179.214 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.548 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 2.1 m-85 -115.74 118.4 32.95 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 119.43 -0.908 . . . . 0.0 111.439 178.82 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 22.6 t -67.33 116.2 7.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.855 -179.575 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.5 ' HA ' ' CE1' ' A' ' 27' ' ' PHE . 2.7 mt-10 -148.85 177.87 9.16 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.127 0.489 . . . . 0.0 111.338 179.678 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.736 ' O ' HG22 ' A' ' 58' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--N 1.326 -0.421 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.702 -179.065 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.408 ' HB2' ' HA ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 121.227 0.537 . . . . 0.0 111.164 . . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.736 HG22 ' O ' ' A' ' 51' ' ' LEU . 25.8 m -122.23 -172.37 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.645 179.669 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.526 ' CE3' HD11 ' A' ' 31' ' ' ILE . 73.3 m95 -132.66 128.88 37.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.865 0.364 . . . . 0.0 111.439 -179.317 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.548 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 5.3 m-80 -69.18 166.98 23.62 Favored Pre-proline 0 C--O 1.223 -0.323 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.538 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.471 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 57.4 Cg_exo -12.66 90.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 125.228 3.952 . . . . 0.0 114.224 -179.103 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.476 ' O ' ' CG ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -92.8 -72.68 0.59 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.584 -175.826 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.512 ' HA ' ' CD2' ' A' ' 33' ' ' TYR . . . -97.25 106.64 33.28 Favored Pre-proline 0 N--CA 1.463 0.189 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -174.885 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.792 ' HG2' HD11 ' A' ' 41' ' ' LEU . 5.7 Cg_exo -82.64 -152.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.251 2.634 . . . . 0.0 111.335 177.138 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.576 HG22 ' H ' ' A' ' 66' ' ' CYS . 3.2 mm -90.8 169.98 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.825 0.345 . . . . 0.0 110.744 178.648 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.576 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -167.37 139.82 3.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.488 179.313 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -161.09 170.7 19.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.266 -179.098 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.555 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 54.9 p -81.09 120.87 25.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.235 0.541 . . . . 0.0 111.124 179.713 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.877 HG22 ' O ' ' A' ' 38' ' ' GLY . 16.3 m -46.86 107.89 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.829 -179.72 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.53 ' HG2' ' CD1' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -101.7 122.09 43.25 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.313 0.578 . . . . 0.0 110.388 177.409 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.38 128.84 55.12 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.597 -178.759 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.49 -156.17 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.148 179.103 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.444 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.3 OUTLIER -54.97 139.59 62.99 Favored Pre-proline 0 N--CA 1.445 -0.678 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.408 179.212 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.507 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 38.5 Cg_exo -58.27 162.94 10.94 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.558 2.172 . . . . 0.0 112.192 -179.487 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.519 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 94.5 Cg_exo -42.09 155.49 0.09 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.671 2.247 . . . . 0.0 112.647 -179.647 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.4 m -109.57 89.75 3.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.538 179.559 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.626 HG23 ' HE1' ' A' ' 97' ' ' TYR . 16.1 pt -69.38 172.04 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.047 -179.45 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -89.58 131.41 35.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.935 179.99 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.28 26.86 8.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.618 -179.869 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.449 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -158.4 178.46 34.62 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.329 -179.754 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 98' ' ' SER . 5.3 mtm180 -149.27 -166.57 2.59 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.358 0.599 . . . . 0.0 110.991 -179.214 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 4.3 p-80 -132.2 157.42 44.36 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.561 -179.889 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 . . . . . 0 CA--C 1.537 0.465 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.399 -179.887 . . . . . . . . 0 0 . 1 . 046 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.53 ' CD1' ' HG2' ' A' ' 70' ' ' LYS . 45.6 m-85 . . . . . 0 N--CA 1.446 -0.627 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 . . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.474 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 73.5 m-85 -158.94 163.62 36.35 Favored 'General case' 0 C--O 1.223 -0.309 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.896 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.1 p -144.2 -177.3 5.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.365 0.602 . . . . 0.0 112.59 -178.493 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 41.1 p-10 -50.91 95.2 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.373 -179.302 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 121.01 25.4 2.28 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.282 -0.872 . . . . 0.0 113.076 178.15 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.17 145.46 37.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.936 0.368 . . . . 0.0 110.75 179.068 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.488 HG22 ' N ' ' A' ' 95' ' ' VAL . 33.5 m -127.33 158.58 38.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.043 0.449 . . . . 0.0 111.043 -179.777 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.488 ' N ' HG22 ' A' ' 94' ' ' VAL . 15.5 t -151.95 147.77 14.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.641 179.79 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.908 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -108.1 127.59 53.93 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.142 0.496 . . . . 0.0 110.868 -179.899 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.996 ' CE2' HG21 ' A' ' 111' ' ' VAL . 3.9 m-85 -84.81 159.61 20.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.445 -178.963 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 81' ' ' ARG . 19.1 p -147.58 130.28 16.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.84 -179.589 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.455 ' SG ' HD12 ' A' ' 105' ' ' LEU . 93.8 m -69.5 150.11 47.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.907 179.376 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.4 ' OD1' ' HG3' ' A' ' 81' ' ' ARG . 4.9 m-20 -87.11 -72.7 0.5 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.832 -178.383 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.38 -18.49 28.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.557 -178.831 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 116.05 28.5 2.63 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.262 -179.472 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.61 ' HA ' HD13 ' A' ' 126' ' ' ILE . 45.5 m-85 -69.56 -173.45 0.58 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 120.779 0.323 . . . . 0.0 110.555 179.964 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 125' ' ' GLN . 1.4 m -110.44 109.18 19.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 -179.97 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.455 HD12 ' SG ' ' A' ' 99' ' ' CYS . 1.1 mp -46.93 107.91 0.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.96 179.189 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.445 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 43.7 mm -93.8 153.18 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.939 -179.424 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 60.48 25.94 63.71 Favored Glycine 0 CA--C 1.51 -0.228 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.591 -179.916 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.419 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.4 OUTLIER 60.79 135.73 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.288 0.566 . . . . 0.0 111.212 -179.713 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.908 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.2 p -65.52 -24.67 67.18 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.692 -178.678 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -58.93 131.58 52.12 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.022 -179.037 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.996 HG21 ' CE2' ' A' ' 97' ' ' TYR . 2.3 t -133.59 125.49 50.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.626 0.251 . . . . 0.0 110.551 178.927 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.896 HD22 ' N ' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -89.92 130.86 36.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.942 0.401 . . . . 0.0 111.562 -179.234 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.896 ' N ' HD22 ' A' ' 112' ' ' LEU . 48.7 t -100.84 104.81 16.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.665 176.866 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.784 ' HB2' HD11 ' A' ' 112' ' ' LEU . 71.1 m -152.85 126.18 8.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.896 0.379 . . . . 0.0 111.777 -178.907 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.487 ' H ' HG21 ' A' ' 69' ' ' VAL . . . 84.3 22.13 55.09 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.575 178.994 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.509 ' N ' ' HB ' ' A' ' 69' ' ' VAL . . . 84.37 -4.22 84.44 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.43 179.995 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -124.81 173.38 8.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.421 0.629 . . . . 0.0 111.892 -178.669 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.54 ' CZ3' ' HB2' ' A' ' 113' ' ' CYS . 95.2 m95 -115.75 125.93 53.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.008 178.812 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.92 148.34 30.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.232 0.539 . . . . 0.0 111.64 -178.711 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.497 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER 68.8 44.86 0.28 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.299 178.374 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 56.9 Cg_endo -70.59 140.99 40.79 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.078 1.852 . . . . 0.0 111.331 177.859 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.572 ' O ' HG21 ' A' ' 77' ' ' ILE . 67.5 Cg_endo -88.51 -173.82 0.96 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.58 2.186 . . . . 0.0 114.007 -177.25 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.46 -160.82 1.08 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.58 177.661 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . 0.402 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 6.6 m -152.99 90.96 1.49 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.091 0.472 . . . . 0.0 111.028 179.144 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.426 ' O ' ' CB ' ' A' ' 104' ' ' SER . 8.9 mt-30 -121.06 158.4 27.93 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.712 -179.852 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.61 HD13 ' HA ' ' A' ' 103' ' ' TYR . 35.3 mm . . . . . 0 C--N 1.323 -0.568 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.909 179.933 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.425 ' HB3' ' O ' ' A' ' 25' ' ' VAL . 20.6 mtm180 . . . . . 0 N--CA 1.453 -0.319 0 CA-C-O 121.178 0.513 . . . . 0.0 111.834 . . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.547 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 80.7 m -87.8 176.4 3.42 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.839 179.738 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.554 ' HD2' ' CD1' ' A' ' 59' ' ' TRP . 26.4 Cg_endo -88.37 -167.49 0.31 Allowed 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.556 2.171 . . . . 0.0 111.814 179.626 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.448 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 1.1 p -56.79 105.81 0.58 Allowed Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.554 179.603 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.619 ' HB3' HD11 ' A' ' 31' ' ' ILE . 10.1 Cg_endo -52.43 138.99 56.52 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.253 1.969 . . . . 0.0 112.111 -179.194 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.529 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -53.22 160.87 0.99 Allowed 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.581 179.963 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.611 ' HA ' HD11 ' A' ' 20' ' ' LEU . 3.9 p-10 -117.2 -175.1 2.73 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.785 -176.567 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.442 HG23 ' C ' ' A' ' 18' ' ' GLY . 2.7 tt -139.44 145.19 27.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.437 179.395 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -76.14 -65.73 0.88 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.459 -178.463 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.424 ' N ' ' ND2' ' A' ' 17' ' ' ASN . 0.6 OUTLIER -91.77 42.07 1.09 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.861 -179.34 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.442 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -160.88 -179.87 35.91 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.392 -0.908 . . . . 0.0 113.3 -179.89 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -137.95 140.28 40.17 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 179.166 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.611 HD11 ' HA ' ' A' ' 14' ' ' ASP . 10.7 mt -84.38 158.26 21.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.216 0.531 . . . . 0.0 111.875 -179.013 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -131.46 72.76 1.51 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.114 176.741 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.894 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.5 OUTLIER -73.95 106.09 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.238 -176.135 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.1 -5.04 73.77 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.668 175.632 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 172.39 153.03 8.97 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 121.16 -0.543 . . . . 0.0 111.818 -179.95 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.425 ' O ' ' HB3' ' A' ' 8' ' ' ARG . 24.3 m -121.86 3.4 6.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.271 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.414 ' HA ' ' HB3' ' A' ' 8' ' ' ARG . 0.6 OUTLIER -72.54 162.14 29.86 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 121.081 0.467 . . . . 0.0 111.517 -179.349 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.74 ' HZ ' HD13 ' A' ' 51' ' ' LEU . 0.6 OUTLIER -51.91 98.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.202 178.744 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 117.86 -9.24 14.31 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.561 -179.097 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.4 m -75.31 138.23 41.67 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 117.068 0.434 . . . . 0.0 109.985 178.93 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 47' ' ' SER . 2.1 p -115.96 140.54 49.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.251 0.548 . . . . 0.0 111.397 -178.778 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.894 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -98.06 164.32 2.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.946 179.196 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.413 ' HA ' ' HG3' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -124.76 110.4 14.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.957 0.408 . . . . 0.0 110.856 179.574 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.527 ' CE2' ' CD2' ' A' ' 20' ' ' LEU . 13.8 m-85 -83.23 142.64 31.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.231 -179.372 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.439 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 26.5 p -143.61 158.91 43.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.206 179.235 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.2 m -84.62 167.84 15.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.754 0.312 . . . . 0.0 110.936 -179.763 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.49 -82.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.003 -179.597 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -159.61 129.91 5.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.798 179.948 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.402 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 69.92 21.21 76.68 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.078 -179.016 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.482 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.9 m-30 -114.51 178.51 4.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.846 0.355 . . . . 0.0 110.833 -179.637 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.864 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -138.88 119.41 13.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.568 178.244 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.856 HD21 ' O ' ' A' ' 44' ' ' GLU . 7.6 tt -83.25 122.27 28.19 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.647 -179.65 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.864 HD11 ' CE1' ' A' ' 40' ' ' HIS . 1.7 mm -99.65 160.49 3.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.119 0.485 . . . . 0.0 111.313 -178.644 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.89 -145.05 40.97 Favored Glycine 0 N--CA 1.453 -0.191 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.43 -179.758 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.856 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -60.74 -174.38 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.863 0.363 . . . . 0.0 110.538 179.28 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.0 t -172.88 29.96 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.792 178.786 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.413 ' HG3' ' HA ' ' A' ' 32' ' ' THR . 11.9 mtpt -162.21 119.94 2.15 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 120.751 0.31 . . . . 0.0 111.287 -179.329 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.429 ' HB3' HG13 ' A' ' 31' ' ' ILE . 1.0 OUTLIER -87.52 136.79 32.8 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.026 178.919 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.534 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.1 m-85 -111.9 120.71 42.84 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 119.482 -0.887 . . . . 0.0 111.703 179.916 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.421 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 18.5 t -72.45 118.46 15.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.849 -179.973 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.507 ' HA ' ' CE1' ' A' ' 27' ' ' PHE . 10.3 tt0 -156.62 169.21 25.2 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.429 0.633 . . . . 0.0 110.782 179.326 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.74 HD13 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.76 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.039 -178.956 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.803 0.335 . . . . 0.0 110.434 . . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.4 m -153.68 173.45 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.247 -179.493 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.554 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 64.6 m95 -126.4 129.73 49.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.853 179.874 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.534 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 6.1 m-20 -73.69 166.15 46.77 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.489 179.184 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.447 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 90.1 Cg_exo -18.4 96.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 125.247 3.965 . . . . 0.0 114.112 -179.366 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.463 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -97.81 -78.52 0.48 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.268 -176.943 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.469 ' HA ' ' CD2' ' A' ' 33' ' ' TYR . . . -85.46 108.38 15.9 Favored Pre-proline 0 C--N 1.332 -0.168 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -175.726 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.808 ' HG2' HD11 ' A' ' 41' ' ' LEU . 3.5 Cg_exo -84.08 -153.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.201 2.601 . . . . 0.0 111.073 177.211 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.507 HG22 ' H ' ' A' ' 66' ' ' CYS . 3.6 mm -90.79 166.33 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.768 0.318 . . . . 0.0 110.594 178.259 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.507 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -166.66 137.94 3.41 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.947 179.631 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.427 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -161.99 177.0 10.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.047 179.716 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.482 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 6.5 p -89.44 112.16 23.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.118 -179.7 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.497 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 3.2 p -48.43 104.88 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.997 179.602 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.429 ' HD2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -87.54 145.67 26.12 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.021 -177.988 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 1.8 m -105.47 137.16 43.75 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.57 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.407 ' CG ' ' N ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -69.32 -170.56 0.28 Allowed 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 120.469 -0.492 . . . . 0.0 109.849 179.967 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.407 ' N ' ' CG ' ' A' ' 72' ' ' GLN . 2.0 t -72.91 108.94 5.13 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.251 -178.039 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.734 ' HG3' ' CE2' ' A' ' 118' ' ' TRP 0.302 0.2 OUTLIER -35.82 -177.96 0.0 OUTLIER 'Trans proline' 0 CA--C 1.467 -2.864 0 C-N-CA 123.481 2.788 . . . . 0.0 113.553 173.807 . . . . . . . . 4 4 . 1 . 047 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.581 ' CB ' ' CE1' ' A' ' 97' ' ' TYR . 26.7 Cg_endo -71.78 -165.14 3.24 Favored 'Cis proline' 0 C--N 1.315 -1.187 0 N-CA-C 113.994 0.728 . . . . 0.0 113.994 -19.258 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.3 p -132.57 20.28 4.29 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 114.178 -1.374 . . . . 0.0 108.795 172.395 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.835 HD11 ' HA3' ' A' ' 80' ' ' GLY . 17.5 pt -106.43 -159.32 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.265 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.14 -177.952 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.429 ' N ' HG13 ' A' ' 77' ' ' ILE . 0.4 OUTLIER -131.24 148.34 52.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.869 177.199 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.42 ' ND2' ' HB3' ' A' ' 78' ' ' SER . 2.1 m-80 55.46 30.26 14.75 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.882 178.8 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.835 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -144.52 -168.38 12.57 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.417 -0.896 . . . . 0.0 113.039 -179.531 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.419 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 4.2 ptt180 -166.81 -174.49 2.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.069 0.462 . . . . 0.0 111.592 -178.789 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.548 ' CG ' ' HB2' ' A' ' 74' ' ' PRO . 41.1 p-80 -120.31 175.86 5.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.759 -177.858 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.425 ' ND2' ' O ' ' A' ' 96' ' ' THR . 1.2 m-20 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.282 178.216 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.434 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 7.5 m-85 . . . . . 0 N--CA 1.455 -0.184 0 CA-C-O 120.802 0.334 . . . . 0.0 110.885 . . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.515 ' CE2' ' HD2' ' A' ' 74' ' ' PRO . 37.9 m-85 -144.9 159.4 42.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.182 -178.811 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.414 ' CG2' ' HG2' ' A' ' 70' ' ' LYS . 3.2 p -119.11 172.5 7.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.374 -179.055 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 48.8 p-10 -59.81 94.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.14 -179.782 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.94 32.88 0.67 Allowed Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.959 178.681 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.459 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -110.07 160.39 16.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.843 0.354 . . . . 0.0 110.944 179.49 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 29.9 m -139.72 148.21 23.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.044 179.981 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.559 HG23 ' CH2' ' A' ' 118' ' ' TRP . 3.5 t -150.93 144.27 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.365 -179.148 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.425 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -93.67 135.19 35.21 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.146 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.766 ' CZ ' HG21 ' A' ' 111' ' ' VAL . 3.3 m-30 -104.04 158.65 16.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.341 0.591 . . . . 0.0 112.282 -175.21 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.418 ' O ' ' CG ' ' A' ' 81' ' ' ARG . 61.0 m -142.24 144.77 33.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.391 178.766 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.471 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 93.3 m -71.25 148.03 47.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.912 0.387 . . . . 0.0 111.596 -178.893 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.462 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 62.5 m-20 -75.6 -77.42 0.13 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.973 -178.501 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.0 t -62.19 -18.73 61.87 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.641 0.258 . . . . 0.0 111.624 -178.285 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.95 27.46 1.88 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.653 -179.993 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.42 ' CE2' HG12 ' A' ' 126' ' ' ILE . 34.9 m-85 -69.0 -173.35 0.48 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.867 0.365 . . . . 0.0 110.428 179.26 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 125' ' ' GLN . 0.5 OUTLIER -112.06 109.52 19.31 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.855 178.026 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.662 HD22 ' HB3' ' A' ' 109' ' ' SER . 0.2 OUTLIER -52.2 123.42 10.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.457 0.646 . . . . 0.0 111.059 -178.656 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.531 HG22 ' N ' ' A' ' 107' ' ' GLY . 28.3 mm -95.57 162.14 2.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.247 179.783 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.531 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 57.28 -128.66 47.97 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.235 -0.984 . . . . 0.0 112.253 -179.572 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -110.68 135.64 50.98 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.025 0.44 . . . . 0.0 112.118 -178.913 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.662 ' HB3' HD22 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -77.33 -32.52 55.29 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 174.481 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -68.3 117.4 8.38 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 110.536 -1.025 . . . . 0.0 110.536 175.332 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.766 HG21 ' CZ ' ' A' ' 97' ' ' TYR . 32.4 t -117.36 127.01 74.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 C-N-CA 121.977 0.111 . . . . 0.0 110.787 -175.832 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 118' ' ' TRP . 0.6 OUTLIER -84.42 133.32 34.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.43 . . . . 0.0 111.857 -177.744 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.51 ' HB2' ' CZ3' ' A' ' 118' ' ' TRP . 23.0 t -97.0 100.01 11.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.441 176.384 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.33 170.47 16.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.128 -178.45 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.38 26.13 2.28 Favored Glycine 0 CA--C 1.517 0.214 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.727 179.762 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.497 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 71.58 19.47 77.86 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.516 -179.613 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -153.09 179.64 8.52 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.188 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.734 ' CE2' ' HG3' ' A' ' 74' ' ' PRO . 97.1 m95 -100.7 129.47 46.61 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.046 0.45 . . . . 0.0 111.023 -179.703 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.38 156.49 19.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.237 -178.787 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.511 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER 54.53 42.81 1.19 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.13 179.868 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.511 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 72.4 Cg_endo -75.01 154.13 42.21 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.146 1.897 . . . . 0.0 111.748 178.649 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.463 ' CB ' ' O ' ' A' ' 106' ' ' ILE . 57.6 Cg_endo -88.24 -169.73 0.46 Allowed 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.544 2.162 . . . . 0.0 113.191 -179.46 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.459 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -133.32 173.52 11.38 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.962 176.498 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 1.4 m -134.06 97.34 3.84 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.989 179.964 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.4 ' O ' ' HB2' ' A' ' 104' ' ' SER . 22.9 mt-30 -129.35 163.65 25.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.937 -179.228 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.42 HG12 ' CE2' ' A' ' 103' ' ' TYR . 23.2 mm . . . . . 0 C--N 1.324 -0.524 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.07 -179.937 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.946 0.403 . . . . 0.0 111.002 . . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.447 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 34.1 m -79.47 161.41 67.33 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.15 -179.7 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -70.65 172.81 12.78 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.55 2.167 . . . . 0.0 112.18 179.794 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.8 t -54.13 108.73 1.21 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.856 -179.889 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.877 ' HG2' HD13 ' A' ' 22' ' ' ILE . 53.9 Cg_exo -50.55 143.72 27.26 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.321 2.014 . . . . 0.0 112.263 179.905 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -56.91 151.15 15.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.221 179.047 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.602 ' HA ' HD11 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -93.56 -171.75 2.71 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.536 -177.719 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.436 HG22 ' CD2' ' A' ' 20' ' ' LEU . 14.9 tt -147.99 146.39 18.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.914 -179.448 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -86.29 156.43 20.25 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.018 178.446 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.447 ' N ' ' ND2' ' A' ' 17' ' ' ASN . 0.0 OUTLIER 43.28 29.11 0.2 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.964 -179.15 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.436 ' HA2' ' N ' ' A' ' 36' ' ' ASN . . . -157.71 177.91 34.27 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.536 -179.57 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.88 153.97 51.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.768 0.318 . . . . 0.0 110.605 -179.874 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.602 HD11 ' HA ' ' A' ' 14' ' ' ASP . 4.8 mt -91.57 153.15 19.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.002 0.429 . . . . 0.0 111.164 179.76 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.464 ' HB3' ' CB ' ' A' ' 32' ' ' THR . 19.6 t0 -123.96 67.4 1.04 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.337 177.526 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.881 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.9 OUTLIER -79.77 95.82 2.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.77 -176.667 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.11 15.94 61.7 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.025 177.662 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 161.62 128.19 0.93 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.054 -179.6 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.617 HG12 ' CZ2' ' A' ' 59' ' ' TRP . 2.8 m -114.8 15.76 8.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -179.077 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 28' ' ' GLY . 5.2 m-20 -79.59 157.18 27.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.913 0.387 . . . . 0.0 111.312 -179.573 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.596 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 2.0 t80 -54.34 86.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.019 179.705 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 132.79 -5.41 5.12 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.024 179.974 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.9 m -77.87 -178.01 5.23 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.926 0.363 . . . . 0.0 110.787 179.999 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 47' ' ' SER . 5.4 p -146.15 154.09 41.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.871 0.367 . . . . 0.0 111.427 -179.924 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.881 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -115.84 170.89 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.113 179.749 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.489 HG23 ' HG2' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -137.91 106.87 5.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.735 178.41 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.474 ' CE1' ' HA ' ' A' ' 63' ' ' ALA . 34.3 m-85 -79.09 148.25 32.47 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.86 -179.79 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.8 p -152.23 158.3 42.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.222 -179.703 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 6.9 m -84.92 163.88 18.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.958 179.78 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.436 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 5.9 m-20 -64.57 -84.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.295 -179.168 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -153.3 134.48 14.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.85 -179.594 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.691 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 65.12 23.41 69.7 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.945 -178.929 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.492 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.3 m-85 -117.0 175.43 5.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.37 . . . . 0.0 110.906 -179.292 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.739 ' HB3' HG22 ' A' ' 69' ' ' VAL . 0.5 OUTLIER -141.05 115.73 9.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.427 177.549 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.965 HD21 ' O ' ' A' ' 44' ' ' GLU . 2.0 tt -77.33 131.66 38.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.493 -179.448 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.454 ' N ' HD13 ' A' ' 42' ' ' ILE . 2.8 mm -100.15 162.13 3.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.15 -179.218 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.415 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 70.9 -137.25 26.6 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.24 -179.355 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.965 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -76.82 177.47 7.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.729 0.299 . . . . 0.0 110.825 179.621 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.5 p -147.31 22.65 1.18 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.054 179.885 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.489 ' HG2' HG23 ' A' ' 32' ' ' THR . 0.0 OUTLIER -145.92 -177.91 5.84 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.214 0.531 . . . . 0.0 111.527 -178.626 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.421 ' CB ' HG13 ' A' ' 31' ' ' ILE . 0.5 OUTLIER -155.06 147.79 24.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.486 178.567 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.469 ' CD1' ' O ' ' A' ' 60' ' ' ASN . 2.4 m-85 -125.03 118.95 27.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.983 0.42 . . . . 0.0 111.934 -177.652 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.5 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 34.6 t -70.93 112.57 7.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.407 178.417 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.48 -176.77 4.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.15 0.5 . . . . 0.0 111.553 -179.432 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.596 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.853 -179.626 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.1 mmt . . . . . 0 N--CA 1.456 -0.14 0 CA-C-O 120.774 0.321 . . . . 0.0 110.58 . . . . . . . . . 0 0 . 1 . 048 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.1 m -154.01 178.71 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.246 -179.303 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.679 ' CE3' HD11 ' A' ' 31' ' ' ILE . 86.4 m95 -135.1 125.87 27.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.027 -179.427 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.469 ' O ' ' CD1' ' A' ' 48' ' ' TYR . 13.6 m-80 -146.43 127.13 7.13 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.219 -179.636 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.402 ' HG2' ' O ' ' A' ' 46' ' ' LYS . 74.3 Cg_endo -75.36 -165.51 4.28 Favored 'Cis proline' 0 C--N 1.352 0.76 0 C-N-CA 123.849 -1.313 . . . . 0.0 112.394 -0.652 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.8 -151.81 0.49 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.249 -178.819 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.474 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -79.03 116.9 63.59 Favored Pre-proline 0 C--N 1.333 -0.119 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.058 -179.654 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.491 ' HG2' HD11 ' A' ' 41' ' ' LEU . 13.6 Cg_exo -72.21 -151.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.645 2.23 . . . . 0.0 112.499 -179.257 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.519 HG22 ' H ' ' A' ' 66' ' ' CYS . 7.3 mm -99.99 167.22 2.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.403 -178.858 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.519 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.2 m -161.13 128.5 4.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.752 179.219 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.475 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -152.49 178.6 9.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.956 -179.727 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.492 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 87.4 p -80.41 119.62 23.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.185 0.517 . . . . 0.0 111.094 -179.883 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.739 HG22 ' HB3' ' A' ' 40' ' ' HIS . 2.3 p -45.63 96.35 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.526 179.82 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -82.79 118.02 23.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.067 179.888 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.65 117.28 34.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.129 179.047 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.56 -157.01 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.837 -179.605 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.458 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 2.1 t -49.02 138.56 13.01 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.06 -179.656 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.484 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 26.8 Cg_exo -60.32 161.35 20.32 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.349 2.033 . . . . 0.0 111.973 179.807 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.51 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 88.3 Cg_exo -42.39 156.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.675 2.25 . . . . 0.0 112.744 -179.821 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.2 t -108.46 90.91 3.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.552 179.378 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.719 HG23 ' HE2' ' A' ' 97' ' ' TYR . 26.7 pt -69.16 178.33 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.305 -179.163 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -99.23 140.2 33.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.756 179.624 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.502 ' HB3' ' CE2' ' A' ' 103' ' ' TYR . 0.1 OUTLIER 63.92 29.21 14.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.555 -179.992 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.431 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . -169.51 -165.46 26.93 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.814 179.627 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' A' ' 98' ' ' SER . 6.7 ptt180 -168.69 -175.63 2.5 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.85 0.357 . . . . 0.0 110.611 -179.584 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 10.5 p80 -111.61 167.91 9.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.282 -179.651 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.738 179.889 . . . . . . . . 0 0 . 1 . 048 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.416 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 11.0 m-85 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.733 0.302 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.416 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 46.5 m-85 -148.18 162.71 38.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.101 179.924 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 16.5 p -136.3 -174.92 3.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.058 -179.616 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.425 ' OD1' ' CG1' ' A' ' 69' ' ' VAL . 1.6 m-20 -62.25 93.78 0.05 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.193 0.52 . . . . 0.0 111.246 -179.679 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.48 30.42 0.84 Allowed Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.514 -0.766 . . . . 0.0 113.143 178.175 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.436 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.5 OUTLIER -109.83 155.46 21.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.823 0.311 . . . . 0.0 110.62 179.135 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 28.8 m -133.5 150.7 32.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.171 0.51 . . . . 0.0 111.285 -179.719 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.517 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 22.1 t -147.22 149.19 15.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.495 179.612 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.897 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -111.63 123.06 49.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.176 0.512 . . . . 0.0 111.117 -179.991 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 1.013 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.7 m-85 -79.14 161.82 26.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.48 -179.244 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.4 ' O ' ' N ' ' A' ' 81' ' ' ARG . 49.3 m -152.41 133.54 14.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.442 -179.872 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.431 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 73.4 m -69.62 163.92 24.47 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.77 179.415 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.46 -84.93 0.4 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.917 179.514 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.8 t -44.41 -28.68 0.58 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.445 -179.696 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 126.74 35.74 0.54 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.769 179.605 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.507 ' CE1' HG12 ' A' ' 126' ' ' ILE . 52.0 m-85 -76.46 -173.86 2.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.793 0.33 . . . . 0.0 110.467 179.364 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.58 113.67 26.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.079 0.466 . . . . 0.0 111.04 -179.696 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.622 HD21 ' HB2' ' A' ' 97' ' ' TYR . 0.3 OUTLIER -50.63 112.14 0.65 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.74 179.078 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.483 HG22 ' N ' ' A' ' 107' ' ' GLY . 49.9 mm -97.61 158.58 3.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.976 -179.583 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.483 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 52.87 34.55 45.56 Favored Glycine 0 CA--C 1.509 -0.294 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.632 179.3 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.422 ' O ' ' O ' ' A' ' 107' ' ' GLY . 8.6 p30 52.88 138.32 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 124.158 0.983 . . . . 0.0 112.974 179.43 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.897 ' HB2' HG22 ' A' ' 96' ' ' THR . 0.9 OUTLIER -66.9 -23.9 66.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.686 -179.435 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.36 125.37 39.28 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.702 -179.543 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 1.013 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.2 t -129.32 121.56 53.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 179.515 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.98 123.56 32.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.827 0.346 . . . . 0.0 111.525 -178.787 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.506 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 19.8 t -88.83 103.5 16.05 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 176.55 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.37 158.83 43.28 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.048 0.451 . . . . 0.0 111.271 -178.772 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.11 31.39 5.94 Favored Glycine 0 N--CA 1.453 -0.195 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.715 179.824 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.461 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 70.2 12.08 68.36 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.646 -179.369 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -136.04 174.89 10.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.981 0.419 . . . . 0.0 110.67 179.522 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.517 ' CZ3' HG23 ' A' ' 95' ' ' VAL . 91.2 m95 -113.22 129.57 56.48 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.731 -179.732 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.07 145.85 39.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.087 0.47 . . . . 0.0 111.443 -178.822 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.482 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER 69.63 44.63 0.25 Allowed Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.288 178.675 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 55.6 Cg_endo -69.93 143.91 51.5 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.174 1.916 . . . . 0.0 111.27 177.874 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.525 ' HB2' HD23 ' A' ' 105' ' ' LEU . 62.3 Cg_endo -90.91 -173.22 0.56 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.519 2.146 . . . . 0.0 113.719 -177.732 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.55 -159.13 0.93 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.778 178.672 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . 0.417 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 7.6 m -154.82 88.99 1.21 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.949 0.404 . . . . 0.0 110.992 179.337 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -112.57 160.96 17.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.737 179.877 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.507 HG12 ' CE1' ' A' ' 103' ' ' TYR . 15.9 mm . . . . . 0 C--N 1.323 -0.576 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.285 -179.631 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.544 ' HD3' HG23 ' A' ' 25' ' ' VAL . 2.5 mtt180 . . . . . 0 CA--C 1.528 0.134 0 CA-C-O 120.91 0.386 . . . . 0.0 111.827 . . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.455 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 66.4 m -116.0 160.23 36.21 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.697 -179.967 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 40.0 Cg_endo -67.17 172.64 9.69 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.419 2.079 . . . . 0.0 111.928 179.464 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.4 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -49.39 110.62 1.62 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.874 -179.778 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.525 ' HB3' HD11 ' A' ' 31' ' ' ILE . 13.8 Cg_endo -57.32 159.31 16.15 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.209 1.939 . . . . 0.0 112.061 -179.761 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.434 ' O ' HD11 ' A' ' 20' ' ' LEU . 6.2 ttt180 -63.66 174.79 1.25 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.807 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -136.87 -175.69 4.11 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.304 0.573 . . . . 0.0 111.62 -179.534 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.79 HD12 ' O ' ' A' ' 64' ' ' PRO . 10.4 tt -131.68 152.45 37.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.363 179.801 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -77.92 -66.75 0.8 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.391 -178.567 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -93.37 36.72 1.06 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.746 -179.932 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.498 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -149.89 176.88 28.36 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.813 -179.824 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -138.04 134.55 34.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.785 0.326 . . . . 0.0 110.419 179.64 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 1.024 HD21 ' CZ ' ' A' ' 33' ' ' TYR . 11.5 mt -83.71 156.22 22.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.062 0.458 . . . . 0.0 111.486 -179.508 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.83 73.72 0.91 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.679 177.569 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.883 ' HA ' HG23 ' A' ' 31' ' ' ILE . 2.5 mt -70.34 92.76 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.972 -177.395 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.26 10.9 67.1 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.522 -0.846 . . . . 0.0 111.904 176.712 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 150.69 145.65 4.17 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 -179.347 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.544 HG23 ' HD3' ' A' ' 8' ' ' ARG . 35.1 m -119.29 6.15 6.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.489 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.4 ' HA ' ' HB3' ' A' ' 8' ' ' ARG . 2.7 p-10 -69.6 155.58 40.27 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.974 0.416 . . . . 0.0 111.31 -179.417 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.472 ' CZ ' ' HB3' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -49.74 102.47 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.932 179.823 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.27 5.82 24.46 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.516 -179.09 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.96 -178.82 7.05 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.934 0.367 . . . . 0.0 110.448 179.366 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 88.1 p -151.77 147.64 26.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.253 0.549 . . . . 0.0 111.547 -179.551 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.883 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -118.4 150.16 20.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.058 179.466 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.429 ' HA ' ' HG3' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -113.31 119.0 36.18 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.76 0.314 . . . . 0.0 111.182 -179.756 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 1.024 ' CZ ' HD21 ' A' ' 20' ' ' LEU . 3.8 m-85 -85.57 138.56 32.1 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.048 0.452 . . . . 0.0 111.025 179.826 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.43 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.5 OUTLIER -149.58 169.22 21.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.017 -178.933 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.447 ' HA ' ' HA2' ' A' ' 18' ' ' GLY . 92.8 m -90.57 166.71 13.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.505 -179.055 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.71 -75.61 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.893 179.96 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -161.55 139.81 9.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.737 179.784 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.494 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 53.76 26.6 33.25 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.118 -179.327 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.497 ' CE2' ' CB ' ' A' ' 68' ' ' SER . 2.2 m-85 -113.6 -179.81 3.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.07 0.462 . . . . 0.0 111.184 -179.492 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.63 ' HB3' HG23 ' A' ' 69' ' ' VAL . 0.3 OUTLIER -137.12 134.54 36.52 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.208 176.385 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.918 HD21 ' HG2' ' A' ' 64' ' ' PRO . 2.6 tt -88.69 135.13 33.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.542 -175.603 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.676 ' N ' HD13 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -110.57 123.62 66.64 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 CA-C-O 121.424 0.631 . . . . 0.0 111.329 -179.752 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.99 -145.99 16.01 Favored Glycine 0 C--N 1.316 -0.558 0 CA-C-N 114.553 -1.203 . . . . 0.0 112.621 179.527 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.449 ' O ' ' HG2' ' A' ' 64' ' ' PRO . 3.5 mm-40 -61.96 -137.71 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.4 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.8 p 167.56 39.43 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 122.925 0.49 . . . . 0.0 110.806 179.272 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.489 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . 0.7 OUTLIER -168.49 170.18 9.91 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.537 0.685 . . . . 0.0 112.461 -178.013 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.566 ' HA ' ' O ' ' A' ' 61' ' ' PRO . 20.7 m -148.78 139.71 22.95 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.767 178.591 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.546 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -132.42 129.54 39.44 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 117.752 -1.579 . . . . 0.0 113.836 -176.78 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.416 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 30.2 t -74.88 96.68 3.16 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.154 -1.385 . . . . 0.0 110.763 179.171 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.51 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 2.2 tt0 -130.35 173.26 10.98 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.661 -179.967 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.51 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.669 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.435 -178.648 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.521 -0.135 0 CA-C-O 120.844 0.354 . . . . 0.0 110.142 . . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.6 m -142.81 -175.78 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.872 -178.51 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.61 ' CZ3' HD11 ' A' ' 31' ' ' ILE . 73.2 m95 -128.81 125.79 38.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.973 0.416 . . . . 0.0 111.707 -179.69 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.546 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 1.7 m-20 -67.82 171.76 4.98 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 174.729 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.566 ' O ' ' HA ' ' A' ' 47' ' ' SER . 0.3 OUTLIER 4.16 118.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.256 1 C-N-CA 125.467 4.111 . . . . 0.0 115.527 -176.024 . . . . . . . . 4 4 . 1 . 049 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.609 ' O ' ' CZ ' ' A' ' 33' ' ' TYR . 6.1 mm-40 -84.95 -77.6 0.27 Allowed 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 114.536 -1.211 . . . . 0.0 112.05 -174.105 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.629 ' CB ' ' HA ' ' A' ' 64' ' ' PRO . . . -65.54 -139.13 0.0 OUTLIER Pre-proline 0 CA--C 1.499 -1.016 0 CA-C-O 116.477 -1.725 . . . . 0.0 109.48 -177.991 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.918 ' HG2' HD21 ' A' ' 41' ' ' LEU . 4.3 Cg_exo -88.76 -158.7 1.19 Allowed 'Cis proline' 0 N--CA 1.483 0.91 0 CA-C-N 124.213 2.54 . . . . 0.0 114.856 15.441 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.3 pt -97.4 -176.47 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.366 -178.024 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.495 ' SG ' HD12 ' A' ' 41' ' ' LEU . 1.5 m -157.79 116.7 3.2 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.745 -179.052 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -105.46 172.82 6.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.588 178.433 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.497 ' CB ' ' CE2' ' A' ' 39' ' ' TYR . 2.0 p -97.09 113.07 24.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.058 179.896 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.63 HG23 ' HB3' ' A' ' 40' ' ' HIS . 0.6 OUTLIER -49.42 99.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.063 179.523 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.763 ' HE2' HG23 ' A' ' 90' ' ' THR . 0.3 OUTLIER -79.37 124.07 28.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.511 -179.356 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.28 117.58 34.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.924 178.039 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.8 -156.89 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.849 -179.15 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.418 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 1.8 t -47.75 136.56 10.35 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.119 -179.794 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.421 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 30.6 Cg_exo -58.41 161.72 13.71 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.223 1.948 . . . . 0.0 111.461 179.487 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.474 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 93.3 Cg_exo -40.16 156.3 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.57 2.18 . . . . 0.0 112.631 -178.978 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.4 t -106.13 88.62 2.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.855 179.971 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.588 HG21 ' O ' ' A' ' 122' ' ' PRO . 21.4 pt -69.83 174.7 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.121 -179.804 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.4 m -99.22 142.72 30.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.753 179.405 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.504 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 8.9 m-80 60.3 28.51 18.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.193 179.687 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -166.44 -167.45 27.13 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.908 179.848 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.412 ' CD ' ' OD1' ' A' ' 100' ' ' ASN . 9.4 ptt85 -163.92 -175.81 4.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.897 0.379 . . . . 0.0 110.708 -179.534 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 15.7 p80 -114.07 167.17 10.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.984 -179.883 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 . . . . . 0 CA--C 1.534 0.349 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.614 179.785 . . . . . . . . 0 0 . 1 . 049 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.415 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 9.1 m-85 . . . . . 0 N--CA 1.451 -0.378 0 CA-C-O 120.854 0.359 . . . . 0.0 110.872 . . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.415 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 60.6 m-85 -149.26 159.92 43.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.479 179.516 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.763 HG23 ' HE2' ' A' ' 70' ' ' LYS . 9.5 p -122.55 -177.48 3.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.002 0.43 . . . . 0.0 111.64 -178.537 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.433 ' CB ' ' HA3' ' A' ' 38' ' ' GLY . 4.3 p-10 -68.58 96.49 0.71 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.867 179.948 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.67 18.3 2.21 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.286 -0.87 . . . . 0.0 113.182 178.882 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.35 162.06 13.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.871 0.336 . . . . 0.0 110.542 179.121 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 35.3 m -138.08 153.52 27.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.144 0.497 . . . . 0.0 111.198 -179.736 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.466 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 21.3 t -147.93 149.4 15.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.924 179.705 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.855 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -108.41 128.37 54.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.855 179.751 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.971 ' CE2' HG21 ' A' ' 111' ' ' VAL . 5.9 m-85 -88.96 157.58 18.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.201 -179.294 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.434 ' HA ' HD13 ' A' ' 105' ' ' LEU . 22.8 m -154.57 142.11 19.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.458 -179.661 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.43 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 69.0 m -73.51 159.39 33.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.797 179.217 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.421 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 69.8 m-20 -93.04 -70.75 0.69 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.32 -179.404 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.9 t -61.05 -23.48 65.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.224 -179.358 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.56 32.86 1.07 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.452 -179.821 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.504 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 16.0 m-85 -69.92 -175.41 0.91 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.057 0.456 . . . . 0.0 110.934 -179.903 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.75 100.47 9.47 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.206 178.47 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.589 HD22 ' HB2' ' A' ' 109' ' ' SER . 0.2 OUTLIER -44.76 126.21 5.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.442 0.639 . . . . 0.0 111.957 -177.927 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.453 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 35.4 mm -87.72 153.86 3.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.749 178.43 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.03 -129.2 40.89 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.314 -0.946 . . . . 0.0 112.06 -179.04 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -122.62 142.47 50.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.865 0.364 . . . . 0.0 110.874 179.417 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.855 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.6 t -70.19 -29.87 66.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.893 179.985 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -72.57 135.34 21.92 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.818 -179.665 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.971 HG21 ' CE2' ' A' ' 97' ' ' TYR . 2.4 t -131.6 118.51 39.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.703 0.287 . . . . 0.0 110.812 179.44 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.92 122.92 28.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.521 -179.017 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.532 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 16.3 t -89.56 102.09 14.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.569 176.982 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.2 OUTLIER -141.12 157.99 44.53 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.04 -178.608 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.418 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 47.05 33.87 7.28 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.703 -179.965 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.451 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 66.02 10.29 50.86 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.522 -179.115 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -129.8 168.96 15.77 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.894 0.378 . . . . 0.0 110.578 179.407 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.532 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 94.9 m95 -109.98 134.5 52.05 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.929 -179.82 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.7 153.66 32.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.931 179.89 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.55 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 61.2 t0 66.04 37.17 0.2 Allowed Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 179.326 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.55 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 65.1 Cg_endo -75.78 134.89 17.05 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.12 1.88 . . . . 0.0 111.587 179.229 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.588 ' O ' HG21 ' A' ' 77' ' ' ILE . 87.0 Cg_endo -92.11 -172.3 0.4 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.812 2.341 . . . . 0.0 113.889 -177.33 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.446 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -133.11 -158.59 0.9 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.722 178.042 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 8.1 m -153.85 90.49 1.38 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.13 0.491 . . . . 0.0 111.012 179.129 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.429 ' HB2' HD11 ' A' ' 106' ' ' ILE . 10.4 mt-30 -122.33 157.31 32.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.778 179.966 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.576 HG22 ' O ' ' A' ' 126' ' ' ILE . 19.0 mm . . . . . 0 C--N 1.323 -0.564 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.941 -179.87 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.696 ' HD3' HG23 ' A' ' 25' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.162 0 CA-C-O 120.896 0.379 . . . . 0.0 112.01 . . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.475 ' O ' ' O ' ' A' ' 10' ' ' PRO . 1.3 m -100.35 171.35 5.62 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.347 -179.504 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 9' ' ' CYS . 75.5 Cg_exo -51.44 -147.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.262 2.641 . . . . 0.0 113.037 179.298 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.516 ' HG ' ' C ' ' A' ' 12' ' ' PRO . 40.7 t -37.26 -85.25 0.0 OUTLIER Pre-proline 0 CA--C 1.499 -1.011 0 CA-C-O 117.117 -1.42 . . . . 0.0 113.882 -177.216 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.602 ' HG3' HD13 ' A' ' 31' ' ' ILE . 63.7 Cg_endo -77.38 157.58 96.13 Favored 'Cis proline' 0 N--CA 1.481 0.764 0 CA-C-N 123.757 2.378 . . . . 0.0 115.083 -0.969 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.76 ' O ' HD11 ' A' ' 20' ' ' LEU . 17.1 tpp180 -50.64 156.7 0.87 Allowed 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.779 178.883 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.437 ' N ' ' HG3' ' A' ' 13' ' ' ARG . 0.3 OUTLIER -109.57 -175.73 2.83 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.99 -179.779 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.501 HG23 ' C ' ' A' ' 18' ' ' GLY . 6.8 tt -128.01 147.74 32.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.723 179.759 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -83.94 -42.31 16.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.343 -178.521 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . 0.434 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 0.8 OUTLIER -103.07 39.32 1.58 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.849 -179.233 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.501 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -175.5 -172.69 40.59 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.781 179.864 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.428 ' N ' ' O ' ' A' ' 34' ' ' SER . 0.4 OUTLIER -139.17 140.24 37.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.756 0.312 . . . . 0.0 110.407 179.732 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.906 HD21 ' CE1' ' A' ' 33' ' ' TYR . 11.3 mt -85.35 150.91 24.42 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.16 0.505 . . . . 0.0 112.12 -179.091 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.455 ' CB ' ' HB ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -120.51 72.32 0.95 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.23 175.275 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.94 ' HA ' HG23 ' A' ' 31' ' ' ILE . 1.7 mt -69.13 97.84 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.636 -176.974 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -88.94 7.45 82.11 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.282 178.002 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 159.07 136.95 2.14 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.528 179.972 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.696 HG23 ' HD3' ' A' ' 8' ' ' ARG . 15.1 m -113.73 25.23 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.785 0.326 . . . . 0.0 111.189 -179.817 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.407 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.5 OUTLIER -100.88 142.69 31.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.036 179.973 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.535 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 9.4 t80 -47.51 93.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.18 0.514 . . . . 0.0 110.715 179.302 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 134.32 -4.84 4.53 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.556 -178.959 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.91 -162.23 0.91 Allowed 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.975 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -168.41 150.56 5.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.089 0.471 . . . . 0.0 111.046 179.58 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.94 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -104.49 160.16 5.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.908 179.243 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.455 ' HB ' ' CB ' ' A' ' 21' ' ' ASP . 1.7 m -125.3 114.91 19.54 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.803 0.335 . . . . 0.0 110.447 179.307 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.906 ' CE1' HD21 ' A' ' 20' ' ' LEU . 11.2 m-85 -91.53 149.68 21.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.184 0.516 . . . . 0.0 111.962 -178.048 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.428 ' O ' ' N ' ' A' ' 19' ' ' GLN . 0.6 OUTLIER -153.99 145.89 23.51 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.699 179.498 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 10.8 m -70.47 167.45 18.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.714 0.292 . . . . 0.0 110.629 179.816 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -68.97 -84.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.003 -179.44 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.2 m -153.3 134.31 14.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.695 179.716 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.74 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 66.76 26.02 73.03 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.852 -178.93 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.5 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.1 m-85 -118.99 170.25 9.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.868 0.366 . . . . 0.0 111.104 -179.382 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.882 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -134.13 113.52 12.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.376 178.169 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.967 HD21 ' O ' ' A' ' 44' ' ' GLU . 4.8 tt -79.64 122.59 26.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.794 -179.438 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.882 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.3 mm -95.64 157.08 3.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.015 0.436 . . . . 0.0 111.284 -179.179 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.54 -135.23 19.11 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.159 -179.379 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.967 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -85.95 -174.09 4.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.784 0.326 . . . . 0.0 110.822 179.469 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.422 ' HA ' ' HG3' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -160.53 27.27 0.16 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.403 179.616 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 6.5 mtpt -151.32 129.95 12.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.332 -179.467 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.451 ' HB2' ' HA ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -101.28 159.29 15.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.168 179.316 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.488 ' CB ' ' HB2' ' A' ' 60' ' ' ASN . 1.1 m-85 -132.16 121.54 23.89 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.58 -0.848 . . . . 0.0 112.222 -179.642 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 8.4 t -75.23 83.84 2.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.886 178.747 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -103.6 -177.86 3.49 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.622 -178.468 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.535 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.014 -179.262 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.427 ' HB2' ' HA ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.319 0 CA-C-O 121.001 0.429 . . . . 0.0 109.879 . . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.431 HG22 ' C ' ' A' ' 51' ' ' LEU . 1.5 m -127.21 163.48 30.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.869 -178.773 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.497 ' CE2' ' HB3' ' A' ' 12' ' ' PRO . 63.5 m95 -116.01 118.06 31.86 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.647 -178.666 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.488 ' HB2' ' CB ' ' A' ' 48' ' ' TYR . 1.2 m-80 -72.26 165.46 50.53 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.27 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.466 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 87.3 Cg_exo -15.91 98.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.644 1 C-N-CA 125.681 4.254 . . . . 0.0 115.014 -178.39 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.505 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 4.2 mt-10 -99.35 -68.44 0.8 Allowed 'General case' 0 C--O 1.221 -0.426 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -176.487 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.425 ' HA ' ' HD2' ' A' ' 64' ' ' PRO . . . -102.14 77.68 0.22 Allowed Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -174.053 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.57 ' HG2' HD11 ' A' ' 41' ' ' LEU . 36.5 Cg_endo -55.87 -154.37 0.01 OUTLIER 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 123.327 2.684 . . . . 0.0 111.575 175.352 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.489 HG22 ' H ' ' A' ' 66' ' ' CYS . 4.2 mm -93.56 165.32 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.051 0.453 . . . . 0.0 111.42 179.654 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.489 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -165.03 135.25 3.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.662 179.277 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.3 OUTLIER -153.86 176.18 12.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.014 -179.786 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.5 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 26.4 p -85.17 123.48 30.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.16 179.894 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.74 HG12 ' O ' ' A' ' 38' ' ' GLY . 1.3 p -55.82 96.54 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.246 179.973 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.15 124.0 27.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.522 -179.522 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.441 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -104.57 125.94 51.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.957 178.234 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -75.75 -151.38 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.165 -179.962 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.446 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 2.8 t -55.3 138.67 66.96 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-O 120.636 0.255 . . . . 0.0 110.883 -179.568 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.487 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 29.2 Cg_exo -59.51 161.36 17.62 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.373 2.049 . . . . 0.0 112.078 179.969 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.525 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 87.0 Cg_exo -43.07 158.36 0.08 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.725 2.283 . . . . 0.0 112.798 -179.142 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 85.9 p -112.27 89.56 3.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.235 178.548 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.718 HG23 ' HE2' ' A' ' 97' ' ' TYR . 22.3 pt -69.24 167.82 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.206 -178.742 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 p -86.48 134.21 33.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.86 179.811 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.494 ' HB3' ' CE1' ' A' ' 103' ' ' TYR . 0.1 OUTLIER 67.77 28.37 7.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.486 -179.977 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -167.2 -166.04 25.61 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.141 179.661 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 98' ' ' SER . 0.4 OUTLIER -170.19 -174.11 1.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.091 0.472 . . . . 0.0 110.858 -178.829 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 15.3 p80 -104.89 172.37 6.82 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.945 179.537 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 30.1 m-20 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.711 -179.979 . . . . . . . . 0 0 . 1 . 050 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.428 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 5.6 m-85 . . . . . 0 N--CA 1.454 -0.241 0 CA-C-O 121.078 0.466 . . . . 0.0 111.499 . . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.441 ' N ' ' O ' ' A' ' 71' ' ' CYS . 46.5 m-85 -149.08 166.08 29.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.41 -179.551 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.8 p -126.08 -178.62 4.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.967 0.413 . . . . 0.0 111.483 -179.444 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 9.0 p-10 -67.12 96.29 0.45 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.926 -179.867 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.18 23.93 1.52 Allowed Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.236 -0.893 . . . . 0.0 113.061 179.112 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.68 159.22 16.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.645 0.26 . . . . 0.0 110.425 179.254 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.474 HG22 ' N ' ' A' ' 95' ' ' VAL . 33.0 m -132.69 156.27 42.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.29 0.567 . . . . 0.0 111.501 -179.644 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.518 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 22.8 t -151.11 149.38 14.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.341 179.078 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.721 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -103.7 139.47 38.91 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.029 0.442 . . . . 0.0 110.562 179.242 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.98 ' CE1' HG21 ' A' ' 111' ' ' VAL . 3.2 m-85 -95.94 158.57 15.39 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.814 -179.434 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 81' ' ' ARG . 1.2 p -147.78 133.05 18.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.659 -178.681 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 99' ' ' CYS . . . . . 0.466 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 81.9 m -70.19 160.41 32.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.46 178.401 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.58 -85.33 0.36 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.776 0.322 . . . . 0.0 110.987 179.572 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -43.7 -28.82 0.44 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.642 -179.498 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 126.61 36.24 0.53 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.719 179.662 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.499 ' CE2' HG12 ' A' ' 126' ' ' ILE . 47.8 m-85 -77.52 -173.91 3.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.884 0.373 . . . . 0.0 110.923 179.958 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -113.06 107.26 15.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.799 179.917 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.546 HD22 ' HA ' ' A' ' 109' ' ' SER . 1.1 mp -45.21 117.08 1.26 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.296 179.842 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.46 HG22 ' N ' ' A' ' 107' ' ' GLY . 47.1 mm -106.25 155.54 7.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.935 -179.512 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . 0.46 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 60.34 37.61 93.38 Favored Glycine 0 CA--C 1.508 -0.396 0 C-N-CA 120.321 -0.942 . . . . 0.0 112.243 179.835 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 107' ' ' GLY . 8.4 p30 51.36 120.3 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.45 -0.875 . . . . 0.0 112.507 179.777 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.721 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.3 p -54.4 -27.64 38.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.307 179.83 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.22 137.16 49.27 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.697 -179.465 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.98 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.9 t -134.87 137.15 51.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.454 0.169 . . . . 0.0 110.621 179.983 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.76 125.78 42.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.878 0.371 . . . . 0.0 111.478 -179.455 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.528 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 34.6 t -90.66 100.67 13.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.662 176.883 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.3 OUTLIER -142.27 159.55 42.0 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.129 -178.495 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.433 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 47.18 32.06 6.52 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.655 -179.912 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.46 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 70.52 6.16 57.7 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.916 -179.759 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -129.8 -178.46 4.72 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.861 0.362 . . . . 0.0 110.498 179.261 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.528 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 92.0 m95 -117.36 122.72 44.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.932 -179.52 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.07 152.65 21.83 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.28 -179.049 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.513 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.5 OUTLIER 67.0 43.27 0.3 Allowed Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.205 179.27 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 56.4 Cg_endo -69.75 141.42 45.22 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.158 1.905 . . . . 0.0 111.261 178.117 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.51 ' HB2' HD23 ' A' ' 105' ' ' LEU . 87.4 Cg_endo -92.25 -169.8 0.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.554 2.169 . . . . 0.0 113.636 -177.594 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.28 -168.03 2.37 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.151 178.853 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 124' ' ' CYS . . . . . 0.424 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 6.7 m -145.84 94.81 2.54 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.006 0.431 . . . . 0.0 110.962 179.95 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -118.93 157.9 26.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.85 -179.772 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.499 HG12 ' CE2' ' A' ' 103' ' ' TYR . 22.9 mm . . . . . 0 C--N 1.324 -0.533 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.229 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.732 0.301 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.433 ' HB3' HG23 ' A' ' 25' ' ' VAL . 0.2 OUTLIER 54.98 166.7 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 121.166 0.508 . . . . 0.0 111.809 178.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.47 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 25.7 m -103.6 163.32 17.65 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.647 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 38.1 Cg_endo -67.53 171.8 11.32 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.253 1.969 . . . . 0.0 112.052 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.77 104.38 0.42 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.226 -178.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.557 ' HB3' HD11 ' A' ' 31' ' ' ILE . 2.5 Cg_endo -49.95 156.92 3.05 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.201 1.934 . . . . 0.0 112.058 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.753 ' O ' HD11 ' A' ' 20' ' ' LEU . 6.5 mtt180 -76.23 164.39 26.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.305 179.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -114.44 -172.62 2.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.198 0.523 . . . . 0.0 111.633 -178.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.661 HD12 ' HD2' ' A' ' 64' ' ' PRO . 17.1 tt -145.47 143.26 22.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.891 -179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.458 ' HB2' ' ND2' ' A' ' 17' ' ' ASN . 2.8 p30 -76.65 160.97 28.92 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 121.032 0.444 . . . . 0.0 110.352 177.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.466 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 0.7 OUTLIER 39.01 29.8 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.224 -178.324 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 16' ' ' ASP . . . -151.42 170.54 31.01 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.638 -178.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.36 137.59 39.03 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.769 0.319 . . . . 0.0 110.674 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.953 HD21 ' CE2' ' A' ' 33' ' ' TYR . 13.1 mt -82.86 159.68 22.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.041 0.448 . . . . 0.0 111.429 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -126.37 71.32 1.27 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.596 177.657 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.918 ' HA ' HG23 ' A' ' 31' ' ' ILE . 1.2 mt -69.81 93.44 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.855 -177.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.6 17.85 57.69 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.712 176.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.27 133.78 1.77 Allowed Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.055 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.433 HG23 ' HB3' ' A' ' 8' ' ' ARG . 17.1 m -119.73 25.9 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.86 0.362 . . . . 0.0 111.055 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 1.4 p-10 -87.11 152.43 22.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.235 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.464 ' CZ ' ' HB3' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -49.98 97.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.746 179.469 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 115.76 6.21 17.23 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.725 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.03 -167.13 1.54 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.833 0.316 . . . . 0.0 110.552 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 47' ' ' SER . 5.5 p -160.28 138.79 10.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.004 0.431 . . . . 0.0 111.675 179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.918 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.7 OUTLIER -103.09 150.23 6.81 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.302 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.966 178.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.427 ' O ' ' N ' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -109.38 115.18 29.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.84 0.352 . . . . 0.0 111.144 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.953 ' CE2' HD21 ' A' ' 20' ' ' LEU . 13.7 m-85 -88.23 144.24 26.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.627 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -153.55 160.41 42.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.753 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.436 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 9.1 m -82.21 169.36 16.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.092 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -68.25 -84.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.117 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.37 133.25 12.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.821 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.48 ' O ' HG22 ' A' ' 69' ' ' VAL . . . 67.28 22.21 72.66 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.151 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.518 ' CD2' ' HA ' ' A' ' 68' ' ' SER . 2.4 m-85 -113.94 179.0 4.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.754 0.311 . . . . 0.0 110.785 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.922 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -140.98 112.34 7.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.053 0.454 . . . . 0.0 110.678 178.72 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.933 HD11 ' HG2' ' A' ' 64' ' ' PRO . 5.1 tt -79.7 126.28 30.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.656 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.922 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.1 mm -104.09 163.97 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.992 0.425 . . . . 0.0 111.08 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.434 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 73.15 -133.98 19.15 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.362 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.795 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.9 OUTLIER -84.93 -176.19 6.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.957 0.408 . . . . 0.0 110.956 179.657 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.2 p -157.38 18.78 0.28 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.698 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 0.5 OUTLIER -145.85 131.31 18.7 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -178.375 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.438 ' OG ' ' CB ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -96.28 147.09 24.14 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.698 176.788 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.499 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 2.2 m-85 -124.85 120.25 31.17 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 119.151 -1.02 . . . . 0.0 112.05 178.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 20.2 t -71.44 107.47 4.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.521 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.38 -174.51 3.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.116 0.484 . . . . 0.0 111.333 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.542 HD13 ' H ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -95.07 149.59 21.1 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.091 -178.806 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.35 -143.37 0.46 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.563 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.1 t -94.14 -33.83 13.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.815 0.341 . . . . 0.0 110.913 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 81.4 p -103.49 25.45 9.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.778 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.04 21.3 65.77 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.274 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.6 -175.93 6.0 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.017 0.437 . . . . 0.0 111.243 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.416 ' HB2' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -103.83 131.9 50.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.267 179.661 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.4 m -151.99 174.69 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.08 -179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.537 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 65.0 m95 -129.09 125.75 37.87 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.3 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.499 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -68.91 165.19 39.95 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.928 178.442 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.44 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 98.5 Cg_exo -17.21 96.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.804 1 C-N-CA 125.408 4.072 . . . . 0.0 114.695 -178.454 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.473 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -93.94 -77.32 0.46 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.635 -0.711 . . . . 0.0 112.212 -178.228 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.468 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -85.16 108.89 17.33 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -175.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.933 ' HG2' HD11 ' A' ' 41' ' ' LEU . 1.4 Cg_endo -86.01 -154.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.296 2.664 . . . . 0.0 110.989 176.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.478 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 4.3 mm -86.05 164.15 2.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.852 0.358 . . . . 0.0 110.766 178.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.458 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.8 OUTLIER -168.41 129.81 1.33 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.773 179.446 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.58 168.49 26.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.023 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.518 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 53.3 p -83.69 122.76 29.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.17 0.509 . . . . 0.0 110.537 178.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.619 ' O ' HG23 ' A' ' 69' ' ' VAL . 22.5 m -45.79 100.61 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.052 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -94.12 99.03 11.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.321 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.425 ' N ' ' O ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -92.91 116.25 28.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.071 0.462 . . . . 0.0 110.326 179.775 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.22 -163.83 0.07 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.678 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.437 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -41.64 131.84 2.31 Favored Pre-proline 0 N--CA 1.436 -1.139 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.58 179.369 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.49 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 50.0 Cg_exo -54.69 165.71 2.36 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.423 2.082 . . . . 0.0 112.365 -178.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.512 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 80.9 Cg_exo -39.71 161.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.926 2.418 . . . . 0.0 113.021 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.2 t -109.3 88.75 2.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.443 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.683 HG23 ' HE2' ' A' ' 97' ' ' TYR . 19.3 pt -69.32 173.27 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.271 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 13.6 m -92.96 141.81 27.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.732 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.515 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 7.5 m-80 57.22 30.85 19.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.814 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.447 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . -170.52 -166.06 28.84 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.979 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.404 ' N ' ' O ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -169.63 -175.43 2.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.979 0.418 . . . . 0.0 110.781 -179.378 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.429 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 11.3 p80 -105.81 171.85 7.12 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.969 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -104.53 -87.84 0.44 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.758 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.513 ' N ' HG13 ' A' ' 95' ' ' VAL . . . 59.57 153.5 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.814 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.472 ' CD1' ' N ' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -111.03 -33.56 6.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.052 0.453 . . . . 0.0 110.5 179.628 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.43 -172.07 2.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.91 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -106.47 -23.03 12.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.174 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -129.65 170.87 13.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.111 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.425 ' O ' ' N ' ' A' ' 71' ' ' CYS . 69.3 m-85 -152.34 164.27 37.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.936 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.469 HG22 ' O ' ' A' ' 69' ' ' VAL . 7.2 p -145.76 -175.81 4.89 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.061 0.458 . . . . 0.0 111.709 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 6.8 p-10 -50.51 94.36 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.63 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.49 24.64 1.91 Allowed Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.49 176.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.41 152.76 24.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 117.165 0.482 . . . . 0.0 111.132 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.433 HG22 ' N ' ' A' ' 95' ' ' VAL . 33.2 m -133.47 154.94 39.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.068 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.547 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 13.6 t -148.94 146.54 17.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.094 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.967 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -100.29 136.76 39.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.625 179.343 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.963 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.4 m-85 -97.32 159.1 15.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.039 -179.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.404 ' O ' ' N ' ' A' ' 81' ' ' ARG . 17.9 p -157.26 143.05 17.58 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.378 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.447 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 56.9 m -72.55 167.83 19.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.772 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -98.3 -85.89 0.36 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.894 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.4 t -47.26 -29.9 2.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.339 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.06 45.35 0.2 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.508 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.515 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 32.9 m-85 -82.83 -172.66 4.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.72 0.295 . . . . 0.0 110.684 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 m -108.4 105.46 15.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.937 0.399 . . . . 0.0 111.307 -179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.626 HD23 ' HB2' ' A' ' 122' ' ' PRO . 3.1 tp -46.22 113.22 0.59 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.996 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.511 HD11 ' HB2' ' A' ' 125' ' ' GLN . 33.0 mm -85.97 156.25 3.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.464 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.438 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 57.0 -130.43 50.95 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.364 -0.922 . . . . 0.0 111.478 -178.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 41.1 p-10 -116.09 136.28 53.17 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.087 0.47 . . . . 0.0 111.208 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.967 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.2 p -66.78 -26.25 66.87 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.476 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.18 142.67 31.97 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.712 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.963 HG21 ' CE1' ' A' ' 97' ' ' TYR . 3.3 t -138.66 120.88 17.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.609 0.242 . . . . 0.0 110.909 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.936 HD22 ' N ' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -79.14 135.93 36.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.931 0.396 . . . . 0.0 111.408 -179.417 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.936 ' N ' HD22 ' A' ' 112' ' ' LEU . 35.0 t -107.93 107.93 18.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.866 176.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.613 ' OG ' HD21 ' A' ' 112' ' ' LEU . 12.0 m -161.74 123.9 2.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.883 0.373 . . . . 0.0 111.729 -179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.501 ' H ' HG21 ' A' ' 69' ' ' VAL . . . 91.35 27.33 18.35 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.493 179.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.499 ' N ' ' HB ' ' A' ' 69' ' ' VAL . . . 71.46 18.02 76.69 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.173 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -147.89 179.28 7.84 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.222 0.534 . . . . 0.0 111.421 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.547 ' CZ3' HG23 ' A' ' 95' ' ' VAL . 93.2 m95 -121.06 144.77 48.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.483 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.435 ' OG ' HD12 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -127.25 149.49 49.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.029 0.442 . . . . 0.0 111.465 -179.279 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.489 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.5 OUTLIER 70.67 46.65 0.27 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.956 179.011 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 93.7 Cg_endo -77.6 138.53 17.29 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.509 2.139 . . . . 0.0 111.795 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.626 ' HB2' HD23 ' A' ' 105' ' ' LEU . 57.2 Cg_endo -89.82 -173.96 0.79 Allowed 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.634 2.223 . . . . 0.0 113.328 -179.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.467 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -135.01 -173.51 3.34 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.019 178.036 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . 0.42 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 17.2 m -144.38 94.74 2.61 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.968 0.413 . . . . 0.0 111.147 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.511 ' HB2' HD11 ' A' ' 106' ' ' ILE . 20.3 mt-30 -117.14 163.23 16.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.777 179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.618 HG22 ' O ' ' A' ' 126' ' ' ILE . 35.5 mm . . . . . 0 C--N 1.324 -0.527 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.514 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.41 ' HA ' ' CZ ' ' A' ' 7' ' ' ARG . 1.6 mmp_? . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.898 0.38 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.452 ' CB ' ' HA ' ' A' ' 26' ' ' ASP . 0.1 OUTLIER -88.17 171.47 10.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.164 -179.733 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.544 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 99.2 m -80.83 175.87 4.39 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.768 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.563 ' HD2' ' CD1' ' A' ' 59' ' ' TRP . 34.0 Cg_endo -89.56 179.46 2.19 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 122.734 2.289 . . . . 0.0 112.0 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.9 t -48.59 104.3 0.41 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.723 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.488 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 31.2 Cg_exo -43.09 167.37 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.605 0 C-N-CA 122.176 1.917 . . . . 0.0 112.542 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.54 -175.62 1.36 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.743 177.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.661 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 1.6 t0 -139.05 -178.43 5.33 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.329 0.585 . . . . 0.0 111.7 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.558 HG22 ' CD2' ' A' ' 20' ' ' LEU . 13.4 tt -147.11 144.23 19.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.496 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -76.21 -64.02 1.19 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.723 -178.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -90.52 45.47 1.26 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.952 0.406 . . . . 0.0 111.026 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.427 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -164.64 170.63 39.83 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.032 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -131.24 131.13 43.7 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.829 HD21 ' CE2' ' A' ' 33' ' ' TYR . 25.7 mt -82.02 160.34 23.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.16 0.505 . . . . 0.0 111.685 -178.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.9 t0 -130.5 79.72 1.91 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.1 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.899 ' HA ' HG23 ' A' ' 31' ' ' ILE . 52.9 mt -69.72 118.01 13.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.661 -178.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.71 16.99 6.9 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.828 177.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.425 ' O ' ' CB ' ' A' ' 29' ' ' SER . . . 161.48 120.87 0.55 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.149 -0.548 . . . . 0.0 111.985 -179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.4 m -109.83 -6.98 11.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.452 ' HA ' ' CB ' ' A' ' 8' ' ' ARG . 1.6 m-20 -70.19 157.77 37.03 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.751 0.31 . . . . 0.0 110.9 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.556 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 7.2 t80 -50.47 116.04 1.73 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.866 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.14 0.87 48.02 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.83 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' A' ' 24' ' ' GLY . 12.9 m -84.48 166.5 17.22 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-N 116.994 0.397 . . . . 0.0 110.496 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.2 p -139.19 146.95 41.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.952 0.406 . . . . 0.0 111.061 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.899 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -108.09 171.2 2.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.599 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.473 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -129.82 116.3 18.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.048 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.829 ' CE2' HD21 ' A' ' 20' ' ' LEU . 11.9 m-85 -94.66 145.49 24.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.489 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.427 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 91.3 p -147.82 161.54 41.05 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.479 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.445 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 1.2 m -82.26 170.91 14.85 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.941 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.7 -81.51 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.285 -178.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.1 m -163.6 117.47 1.55 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.899 0.381 . . . . 0.0 110.699 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.427 ' HA3' ' HB2' ' A' ' 91' ' ' ASP . . . 86.04 -10.21 66.63 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.189 -177.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.506 ' CZ ' ' HB3' ' A' ' 68' ' ' SER . 2.6 m-85 -78.5 -173.63 3.44 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.758 0.313 . . . . 0.0 110.706 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.792 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -143.01 110.43 5.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.012 0.434 . . . . 0.0 110.075 177.409 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.969 HD21 ' O ' ' A' ' 44' ' ' GLU . 2.6 tt -74.76 121.87 22.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.682 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.792 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.1 mm -104.29 147.56 10.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.013 0.435 . . . . 0.0 110.674 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 88.29 -133.95 12.13 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.52 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.969 ' O ' HD21 ' A' ' 41' ' ' LEU . 1.0 OUTLIER -74.85 -177.63 3.37 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-O 121.177 0.513 . . . . 0.0 112.083 -178.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.6 p -163.15 23.81 0.09 Allowed 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.116 -0.947 . . . . 0.0 111.295 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.473 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 2.5 mtmt -161.54 130.15 4.4 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -177.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.463 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 0.1 OUTLIER -98.06 136.04 38.88 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 176.741 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.497 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.9 m-85 -112.97 118.28 34.41 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 119.182 -1.007 . . . . 0.0 112.292 -178.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.407 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 33.1 t -71.15 71.34 0.58 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.066 177.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.5 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 3.0 tt0 -93.22 172.55 8.23 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.781 -178.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.556 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -82.6 148.46 28.0 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.331 -0.849 . . . . 0.0 111.13 -179.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.65 -123.21 0.11 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.468 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.0 t -114.93 -33.14 5.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.856 0.36 . . . . 0.0 111.019 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 12.4 p -102.54 32.77 3.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.035 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.7 18.75 80.05 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.704 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 1.3 t -83.78 -164.99 1.0 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.873 0.368 . . . . 0.0 111.006 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.28 134.23 55.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.197 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -142.84 169.13 12.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.798 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.563 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 75.5 m95 -117.76 116.4 26.93 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.878 -178.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.497 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -69.89 167.92 21.17 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.949 177.372 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.46 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 76.8 Cg_exo -16.21 101.57 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.816 1 C-N-CA 125.421 4.08 . . . . 0.0 114.847 -178.398 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.504 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.3 OUTLIER -97.88 -69.4 0.76 Allowed 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 115.021 -0.99 . . . . 0.0 113.144 -175.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.661 ' HB2' ' O ' ' A' ' 14' ' ' ASP . . . -102.85 76.02 0.21 Allowed Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 112.416 0.525 . . . . 0.0 112.416 -174.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.493 ' HG2' HD11 ' A' ' 41' ' ' LEU . 37.0 Cg_endo -56.9 -152.4 0.0 OUTLIER 'Trans proline' 0 CA--C 1.534 0.502 0 C-N-CA 123.225 2.617 . . . . 0.0 111.13 175.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.475 HG22 ' N ' ' A' ' 66' ' ' CYS . 5.4 mm -90.74 164.07 2.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.223 0.535 . . . . 0.0 111.927 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.475 ' N ' HG22 ' A' ' 65' ' ' ILE . 0.8 OUTLIER -167.89 120.85 0.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.098 179.338 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.476 ' O ' ' CD2' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -131.86 174.96 9.62 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.248 -179.048 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.506 ' HB3' ' CZ ' ' A' ' 39' ' ' TYR . 1.5 p -98.23 123.24 42.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.608 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.639 ' O ' HG23 ' A' ' 69' ' ' VAL . 30.6 m -47.9 101.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.177 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -95.41 99.39 11.31 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.73 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 3.2 m -78.55 130.7 36.27 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 175.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.405 ' O ' ' HD3' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -68.61 -174.94 0.61 Allowed 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 120.191 -0.604 . . . . 0.0 109.5 -179.544 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 t -68.04 109.0 3.23 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.954 -178.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.71 ' HG3' ' CE2' ' A' ' 118' ' ' TRP 0.287 0.6 OUTLIER -37.48 -178.62 0.0 OUTLIER 'Trans proline' 0 CA--C 1.469 -2.745 0 C-N-CA 123.317 2.678 . . . . 0.0 113.389 174.467 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.562 ' CB ' ' CE2' ' A' ' 97' ' ' TYR . 44.0 Cg_endo -68.47 -166.43 2.84 Favored 'Cis proline' 0 C--N 1.316 -1.171 0 N-CA-C 114.094 0.767 . . . . 0.0 114.094 -18.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 38.2 t -134.87 18.6 3.5 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 113.95 -1.477 . . . . 0.0 108.907 172.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.666 HD11 ' HA3' ' A' ' 80' ' ' GLY . 16.2 pt -107.75 -159.05 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.295 -177.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.443 ' N ' HG13 ' A' ' 77' ' ' ILE . 0.9 OUTLIER -132.42 134.92 45.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.664 178.36 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.467 ' ND2' ' N ' ' A' ' 79' ' ' ASN . 0.2 OUTLIER 70.08 28.84 3.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.77 -179.49 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.666 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -145.02 -177.68 20.02 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.167 -1.016 . . . . 0.0 113.0 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.443 ' HG2' ' O ' ' A' ' 80' ' ' GLY . 47.3 mtp180 -152.5 -167.81 2.86 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 121.498 0.666 . . . . 0.0 112.213 -177.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.553 ' CG ' ' HB2' ' A' ' 74' ' ' PRO . 35.5 p-80 -137.87 -178.95 5.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 114.887 -1.052 . . . . 0.0 111.346 -178.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.574 ' OD1' HG12 ' A' ' 95' ' ' VAL . 0.9 OUTLIER -123.61 -68.7 0.86 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.605 175.591 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 49.93 174.29 0.01 OUTLIER Glycine 0 C--N 1.332 0.317 0 CA-C-N 116.013 -0.539 . . . . 0.0 113.58 177.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.427 ' CD2' ' N ' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -119.57 -30.01 4.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.856 0.36 . . . . 0.0 110.838 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -103.92 -174.47 2.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.399 -178.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.1 -28.83 12.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.27 178.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.428 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 6.7 m-85 -127.55 175.92 7.88 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.402 178.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.443 ' CD2' ' HZ2' ' A' ' 118' ' ' TRP . 45.6 m-85 -144.31 178.59 7.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.358 -178.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 25.4 p -139.15 -179.03 5.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.216 0.531 . . . . 0.0 111.794 -178.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.622 ' HB3' HG22 ' A' ' 69' ' ' VAL . 0.7 OUTLIER -57.54 95.53 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.716 -179.179 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 113.94 38.3 1.17 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.709 -0.757 . . . . 0.0 113.493 177.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.484 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -105.66 155.02 19.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.917 0.359 . . . . 0.0 110.658 178.539 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 29.9 m -134.79 146.37 30.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.002 0.429 . . . . 0.0 111.238 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.579 HG23 ' CH2' ' A' ' 118' ' ' TRP . 1.6 t -149.99 137.0 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.334 -179.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.816 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -88.15 132.24 34.41 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 177.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.775 ' CZ ' HG21 ' A' ' 111' ' ' VAL . 3.1 m-30 -99.82 149.69 23.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.302 0.572 . . . . 0.0 112.533 -175.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.421 ' O ' ' N ' ' A' ' 81' ' ' ARG . 88.3 p -129.54 139.8 51.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.139 177.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.492 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 87.9 m -69.53 141.63 53.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.153 0.501 . . . . 0.0 111.992 -177.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -56.24 -85.47 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.386 -178.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.93 -16.94 62.7 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -175.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.26 29.63 0.77 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.269 -0.967 . . . . 0.0 113.131 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.469 ' CE1' HG12 ' A' ' 126' ' ' ILE . 32.1 m-85 -68.57 -171.69 0.29 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 125' ' ' GLN . 3.4 p -107.93 108.45 19.61 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.935 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.488 ' HA ' HD12 ' A' ' 105' ' ' LEU . 1.8 tp -49.03 102.99 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.191 178.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.47 ' HB ' ' CB ' ' A' ' 123' ' ' THR . 39.1 mm -81.98 155.84 4.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.814 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.462 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 54.59 -130.07 45.16 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.782 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -107.83 132.06 53.82 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.145 0.497 . . . . 0.0 112.177 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.816 ' HB2' HG22 ' A' ' 96' ' ' THR . 0.1 OUTLIER -68.64 -30.5 69.22 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 174.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -65.5 123.73 25.72 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.282 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.775 HG21 ' CZ ' ' A' ' 97' ' ' TYR . 43.8 t -126.11 124.67 66.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 110.645 -0.131 . . . . 0.0 110.645 -177.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.69 135.28 35.06 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.064 0.459 . . . . 0.0 112.229 -177.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.525 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 12.0 t -97.09 105.89 18.13 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 175.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.78 166.7 23.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.309 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 60.3 14.74 35.01 Favored Glycine 0 CA--C 1.519 0.318 0 CA-C-N 115.524 -0.762 . . . . 0.0 113.294 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.402 ' O ' ' HG2' ' A' ' 117' ' ' GLU . . . 87.68 8.45 73.46 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.449 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 116' ' ' GLY . 25.8 mt-10 -156.91 -176.08 5.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.87 0.367 . . . . 0.0 110.476 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.71 ' CE2' ' HG3' ' A' ' 74' ' ' PRO . 96.8 m95 -95.78 130.83 42.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.905 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.79 156.09 21.6 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.251 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.5 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER 55.47 44.39 1.6 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.037 179.834 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.5 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 98.5 Cg_endo -78.16 153.45 28.26 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.401 2.067 . . . . 0.0 111.933 178.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.587 ' HD3' HG22 ' A' ' 111' ' ' VAL . 74.0 Cg_endo -88.84 -170.01 0.45 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.635 2.223 . . . . 0.0 113.298 -178.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.47 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -131.64 176.91 7.93 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.537 176.841 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . 0.444 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 2.9 m -139.17 97.63 3.34 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.976 0.417 . . . . 0.0 110.87 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.424 ' O ' ' CB ' ' A' ' 104' ' ' SER . 17.1 mt-30 -125.36 163.56 22.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.04 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.469 HG12 ' CE1' ' A' ' 103' ' ' TYR . 17.4 mm . . . . . 0 C--N 1.324 -0.515 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.064 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.799 0.333 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.475 ' HD3' HG23 ' A' ' 25' ' ' VAL . 5.7 mtt180 -78.59 -171.45 2.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.102 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.471 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 51.7 m -90.35 160.64 39.19 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.974 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 56.0 Cg_endo -70.13 177.54 5.73 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.51 2.14 . . . . 0.0 112.122 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.412 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -53.25 112.79 3.94 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.985 -179.84 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.642 ' HG3' HD13 ' A' ' 22' ' ' ILE . 20.0 Cg_endo -60.34 149.55 85.26 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.353 2.035 . . . . 0.0 112.003 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.778 ' O ' HD11 ' A' ' 20' ' ' LEU . 6.6 mtt180 -57.88 173.45 0.32 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -129.89 -174.82 3.42 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.097 0.475 . . . . 0.0 111.623 -178.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.445 HG23 ' O ' ' A' ' 18' ' ' GLY . 4.5 tt -141.53 148.62 20.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.866 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.49 -58.25 2.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.245 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.438 ' N ' ' ND2' ' A' ' 17' ' ' ASN . 0.5 OUTLIER -93.65 40.78 1.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.864 -179.503 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.445 ' O ' HG23 ' A' ' 15' ' ' ILE . . . -164.27 -179.93 38.74 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.703 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.25 134.51 32.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.745 0.307 . . . . 0.0 110.524 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.909 HD21 ' CE2' ' A' ' 33' ' ' TYR . 13.7 mt -77.83 155.93 30.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.098 0.475 . . . . 0.0 111.687 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.459 ' HB3' ' CB ' ' A' ' 32' ' ' THR . 29.6 t70 -129.3 74.06 1.56 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.538 -0.756 . . . . 0.0 109.114 176.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.915 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.8 OUTLIER -76.97 101.83 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.954 -176.447 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.73 16.82 58.26 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.753 -0.736 . . . . 0.0 111.732 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 162.53 132.35 1.33 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.251 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.475 HG23 ' HD3' ' A' ' 8' ' ' ARG . 34.0 m -113.62 -8.07 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.44 ' HA ' ' CB ' ' A' ' 8' ' ' ARG . 32.8 t0 -70.18 163.48 26.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.968 0.413 . . . . 0.0 111.074 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.518 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 11.0 t80 -54.44 113.82 1.42 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.684 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.87 -7.11 33.21 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.664 -179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.2 m -78.89 158.85 28.0 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.956 0.378 . . . . 0.0 110.647 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.2 p -134.44 136.41 43.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.041 0.448 . . . . 0.0 111.029 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.915 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -96.95 169.7 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.66 178.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.459 ' CB ' ' HB3' ' A' ' 21' ' ' ASP . 0.1 OUTLIER -132.7 109.83 9.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.942 0.401 . . . . 0.0 111.148 179.515 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.909 ' CE2' HD21 ' A' ' 20' ' ' LEU . 21.5 m-85 -83.59 139.08 33.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.025 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.431 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 41.4 m -144.99 160.31 41.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.711 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.443 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 36.4 m -84.02 167.31 16.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.863 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -65.3 -84.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.129 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.0 t -152.92 137.61 16.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.702 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 59.11 25.89 60.44 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.843 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.512 ' CE1' ' HB3' ' A' ' 68' ' ' SER . 2.4 m-85 -115.85 172.66 7.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.721 0.296 . . . . 0.0 110.91 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.87 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.9 OUTLIER -132.49 122.73 25.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.043 0.449 . . . . 0.0 110.674 178.299 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.87 HD11 ' HG2' ' A' ' 64' ' ' PRO . 10.1 tt -84.77 127.54 34.17 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.782 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.87 HD11 ' CE1' ' A' ' 40' ' ' HIS . 1.5 mm -108.49 152.27 10.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.086 0.47 . . . . 0.0 111.023 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.22 -137.24 16.76 Favored Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.31 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.828 ' O ' HD21 ' A' ' 41' ' ' LEU . 4.1 pm0 -76.59 178.05 6.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.877 0.37 . . . . 0.0 110.654 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.9 p -156.4 19.11 0.35 Allowed 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.502 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.435 ' HG3' ' HA ' ' A' ' 32' ' ' THR . 21.1 mtpt -159.37 121.46 3.43 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.863 0.319 . . . . 0.0 111.863 -177.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.46 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 0.5 OUTLIER -88.51 131.26 34.98 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 177.092 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.496 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 2.0 m-85 -107.14 115.7 30.63 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 119.246 -0.982 . . . . 0.0 111.555 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.455 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 23.5 t -68.72 80.84 0.28 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.272 -0.877 . . . . 0.0 110.104 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.464 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -97.12 -164.59 1.16 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.626 -179.162 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.518 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -105.87 147.98 28.1 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.924 -179.679 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.35 -129.78 0.11 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.564 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.8 t -112.73 -32.03 6.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.78 0.324 . . . . 0.0 110.988 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.07 33.41 2.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.899 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.46 16.76 77.49 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.584 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -86.58 -164.28 1.03 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.692 0.282 . . . . 0.0 110.71 179.646 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.46 148.26 43.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.399 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.461 HG23 ' HG2' ' A' ' 50' ' ' GLU . 1.3 m -153.72 -177.72 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.527 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.542 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 87.6 m95 -125.14 121.13 33.32 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.104 0.478 . . . . 0.0 112.037 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.496 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 2.4 m120 -72.63 167.05 36.77 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.437 177.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.446 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 83.3 Cg_exo -18.0 104.29 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 125.142 3.894 . . . . 0.0 114.412 -178.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.48 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -106.92 -81.52 0.55 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.186 -177.235 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.471 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -76.13 107.45 4.49 Favored Pre-proline 0 N--CA 1.463 0.191 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -175.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.87 ' HG2' HD11 ' A' ' 41' ' ' LEU . 3.9 Cg_endo -91.52 -155.45 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 123.459 2.772 . . . . 0.0 111.23 177.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.565 HG22 ' H ' ' A' ' 66' ' ' CYS . 2.2 mm -96.65 168.82 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.873 0.368 . . . . 0.0 110.58 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.565 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.1 m -167.34 136.59 2.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.206 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.43 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.6 OUTLIER -156.29 175.33 14.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.957 179.703 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.512 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 3.1 p -93.88 108.76 20.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.94 0.4 . . . . 0.0 111.121 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.494 ' O ' HG13 ' A' ' 69' ' ' VAL . 2.7 p -48.58 97.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.263 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.13 121.13 25.18 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.289 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.431 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -103.24 116.79 33.14 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.284 178.798 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -70.81 -157.68 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.616 179.537 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.478 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 1.6 t -47.47 139.01 8.44 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.191 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.495 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 34.5 Cg_exo -58.41 160.93 15.37 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.319 2.013 . . . . 0.0 111.811 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.516 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 88.8 Cg_exo -44.03 157.32 0.15 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.584 2.189 . . . . 0.0 112.784 -178.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 87.7 p -107.32 89.3 2.96 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.633 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.663 HG21 ' O ' ' A' ' 122' ' ' PRO . 14.6 pt -69.46 176.55 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.169 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.6 m -92.97 142.4 27.34 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.84 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 54.99 29.92 13.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.874 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.467 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -163.37 -176.69 35.62 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.294 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -156.43 -174.61 5.02 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.478 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 2.5 p-80 -122.19 161.82 22.49 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.511 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 23.9 m-20 -88.86 -165.1 1.25 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.523 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.453 ' C ' ' CG ' ' A' ' 85' ' ' TYR . . . 72.65 -63.05 1.53 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.374 -0.917 . . . . 0.0 111.684 -178.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.526 ' CD1' ' N ' ' A' ' 85' ' ' TYR . 0.0 OUTLIER 51.62 36.19 16.68 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 122.146 0.974 . . . . 0.0 110.03 -179.832 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.507 ' HB2' ' CZ ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -74.28 -165.92 0.37 Allowed 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 113.572 -1.649 . . . . 0.0 109.897 179.609 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.442 ' O ' ' CD2' ' A' ' 88' ' ' PHE . 1.5 m-20 -110.43 -25.33 10.11 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.712 178.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.442 ' CD2' ' O ' ' A' ' 87' ' ' ASP . 12.8 m-85 -158.62 159.61 35.61 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.331 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.507 ' CZ ' ' HB2' ' A' ' 86' ' ' GLU . 9.5 m-85 -141.09 167.64 21.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.038 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.3 p -135.06 -177.45 4.64 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.153 0.502 . . . . 0.0 111.922 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -62.98 95.05 0.07 Allowed 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.93 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 128.53 12.67 2.71 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.35 -0.841 . . . . 0.0 113.362 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.419 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.5 OUTLIER -90.41 154.51 19.61 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 117.1 0.45 . . . . 0.0 110.403 179.268 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 26.9 m -133.93 148.23 30.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.075 0.464 . . . . 0.0 110.892 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.513 HG23 ' CH2' ' A' ' 118' ' ' TRP . 46.3 t -146.9 151.98 13.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.596 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.781 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -109.04 135.01 50.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.595 179.712 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.973 ' CE1' HG21 ' A' ' 111' ' ' VAL . 5.2 m-85 -93.73 157.55 16.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.196 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.93 149.66 29.9 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.955 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.411 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 72.7 m -85.76 155.14 21.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.899 0.38 . . . . 0.0 111.186 -179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.467 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 56.1 m-20 -92.31 -72.96 0.57 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.336 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.4 t -51.98 -24.35 6.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.882 0.373 . . . . 0.0 110.805 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.03 29.66 1.46 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.535 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.509 ' CE2' HG12 ' A' ' 126' ' ' ILE . 41.1 m-85 -74.41 -175.83 2.48 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 120.998 0.427 . . . . 0.0 110.55 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 34.3 m -122.34 98.61 6.01 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.63 ' HA ' ' HA ' ' A' ' 124' ' ' CYS . 0.0 OUTLIER -51.93 152.02 3.27 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-O 122.305 1.05 . . . . 0.0 112.504 -175.625 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.472 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 45.1 mm -121.98 145.98 27.81 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 113.085 -1.87 . . . . 0.0 111.244 -174.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.43 ' O ' ' ND2' ' A' ' 108' ' ' ASN . . . 77.32 39.05 27.56 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.271 -0.966 . . . . 0.0 111.859 -179.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.43 ' ND2' ' O ' ' A' ' 107' ' ' GLY . 8.3 p30 53.5 138.71 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 124.346 1.058 . . . . 0.0 113.117 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.781 ' HB2' HG22 ' A' ' 96' ' ' THR . 0.6 OUTLIER -69.4 -24.61 63.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.135 -0.939 . . . . 0.0 111.583 -179.712 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -64.73 134.06 37.93 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.59 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.973 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.7 t -132.94 121.76 44.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.657 0.265 . . . . 0.0 110.517 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.12 119.68 27.6 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.909 0.385 . . . . 0.0 111.388 -179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.501 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 14.6 t -86.7 102.62 14.39 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 176.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.1 t -156.14 148.1 23.17 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.039 0.447 . . . . 0.0 111.328 -178.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 69.55 24.94 75.98 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.54 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.474 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 74.71 5.74 75.13 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.873 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -137.84 174.42 10.59 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 120.88 0.372 . . . . 0.0 110.328 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.516 ' CD1' ' HD3' ' A' ' 75' ' ' PRO . 86.4 m95 -107.51 128.93 54.95 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.778 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.454 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -100.27 160.37 14.38 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.536 -178.479 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.449 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 2.2 p-10 46.94 48.35 5.57 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 115.307 -0.86 . . . . 0.0 112.71 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 91.8 Cg_endo -77.26 135.19 14.88 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.431 2.087 . . . . 0.0 110.512 175.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.663 ' O ' HG21 ' A' ' 77' ' ' ILE . 73.6 Cg_endo -93.67 -176.49 0.54 Allowed 'Trans proline' 0 N--CA 1.45 -1.08 0 C-N-CA 122.09 1.86 . . . . 0.0 114.526 -175.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' A' ' 105' ' ' LEU . 0.2 OUTLIER -118.43 -155.45 0.6 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.38 -1.282 . . . . 0.0 109.407 179.039 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . 0.63 ' HA ' ' HA ' ' A' ' 105' ' ' LEU . 1.8 m -153.8 88.31 1.26 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.928 0.394 . . . . 0.0 110.753 177.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -115.41 162.48 17.08 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.756 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.509 HG12 ' CE2' ' A' ' 103' ' ' TYR . 26.5 mm . . . . . 0 C--N 1.325 -0.488 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.167 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.9 mtm180 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.904 0.383 . . . . 0.0 111.032 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.493 ' HB3' HG23 ' A' ' 25' ' ' VAL . 9.0 mtm180 -83.51 174.1 10.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.977 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.457 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 19.6 m -93.2 162.32 28.59 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.855 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 36.4 Cg_endo -66.95 171.97 10.42 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.417 2.078 . . . . 0.0 111.997 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.414 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 0.3 OUTLIER -55.12 112.63 4.33 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.371 179.67 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 11' ' ' SER . 11.0 Cg_endo -55.12 151.13 36.19 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.143 1.895 . . . . 0.0 111.933 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.862 ' O ' HD11 ' A' ' 20' ' ' LEU . 12.1 mtt180 -65.12 152.83 42.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.622 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -99.41 -178.07 3.79 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.953 -176.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.495 HG22 ' CD2' ' A' ' 20' ' ' LEU . 14.2 tt -152.44 141.49 14.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.129 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.41 ' HB2' ' ND2' ' A' ' 17' ' ' ASN . 7.3 p30 -80.45 174.64 11.41 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.718 178.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.496 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 0.7 OUTLIER 37.32 31.05 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.809 179.694 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.447 ' HA2' ' N ' ' A' ' 36' ' ' ASN . . . -167.26 -166.89 27.11 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.62 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.96 146.42 21.78 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.665 0.269 . . . . 0.0 110.932 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.862 HD11 ' O ' ' A' ' 13' ' ' ARG . 14.5 mt -84.77 157.94 20.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.991 0.424 . . . . 0.0 111.556 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.439 ' HB3' ' CB ' ' A' ' 32' ' ' THR . 1.2 t70 -125.68 76.39 1.57 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.717 177.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.901 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.9 OUTLIER -74.85 101.06 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.001 -0.545 . . . . 0.0 112.117 -176.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.47 18.58 50.6 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.631 176.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 160.43 134.94 1.74 Allowed Glycine 0 C--N 1.334 0.444 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.834 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.493 HG23 ' HB3' ' A' ' 8' ' ' ARG . 33.7 m -128.42 33.16 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -178.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -105.39 163.79 12.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.16 0.505 . . . . 0.0 111.243 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.55 ' CE1' ' HE3' ' A' ' 57' ' ' MET . 0.0 OUTLIER -47.97 95.6 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.349 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.77 -4.74 22.72 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.539 -0.839 . . . . 0.0 113.206 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.3 m -70.23 173.9 6.18 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 117.014 0.407 . . . . 0.0 110.289 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.3 p -145.16 144.22 30.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.002 0.429 . . . . 0.0 111.245 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.901 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -105.97 171.84 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.516 -179.662 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.439 ' CB ' ' HB3' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -133.1 115.17 14.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.876 0.37 . . . . 0.0 110.953 179.633 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.831 ' CE2' HD21 ' A' ' 20' ' ' LEU . 15.3 m-85 -88.77 149.0 23.65 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.218 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 83.4 p -154.78 147.85 24.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.196 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.418 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 8.6 m -76.12 168.44 20.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.816 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.447 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 40.9 m-20 -71.24 -84.86 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.37 -178.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.4 t -151.32 135.18 16.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.897 0.379 . . . . 0.0 110.874 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.744 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 65.77 25.35 71.75 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.066 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.498 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.1 m-85 -118.46 170.13 9.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 0.0 111.083 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.939 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -136.1 112.31 9.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.08 0.467 . . . . 0.0 110.557 177.903 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.897 HD21 ' O ' ' A' ' 44' ' ' GLU . 4.2 tt -80.57 119.48 23.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.8 -179.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.939 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.5 mm -94.11 161.96 2.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.186 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.68 -138.01 22.45 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.269 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.897 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -82.74 -174.65 5.36 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.84 0.352 . . . . 0.0 110.838 179.508 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.7 p -156.16 22.26 0.37 Allowed 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.241 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.438 ' HG3' ' HA ' ' A' ' 32' ' ' THR . 2.9 mtpt -150.76 131.05 13.64 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -177.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.458 ' OG ' ' CB ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -93.42 146.82 23.47 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.286 176.248 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.547 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.9 m-85 -120.78 117.12 26.63 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 119.014 -1.074 . . . . 0.0 111.738 178.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 48.8 t -62.86 115.2 4.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.999 -179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.27 -170.85 3.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.214 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.741 HD22 ' N ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -102.59 141.34 35.58 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.929 0.395 . . . . 0.0 110.874 -178.761 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.741 ' N ' HD22 ' A' ' 51' ' ' LEU . . . -61.18 -127.55 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.579 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.3 m -121.51 -39.62 2.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.777 0.322 . . . . 0.0 111.365 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 30.1 p -91.24 43.33 1.14 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.195 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.18 25.21 69.48 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.402 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.65 -158.26 0.62 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.702 0.287 . . . . 0.0 110.404 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.55 ' HE3' ' CE1' ' A' ' 27' ' ' PHE . 0.3 OUTLIER -129.73 116.79 19.29 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.477 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.658 HG23 ' N ' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -118.46 -176.52 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.607 0.717 . . . . 0.0 111.589 -176.834 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.658 ' N ' HG23 ' A' ' 58' ' ' VAL . 69.6 m95 -130.87 133.36 45.82 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.636 -1.166 . . . . 0.0 111.448 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.547 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.6 OUTLIER -75.67 166.46 45.03 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.944 177.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.474 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 97.3 Cg_exo -17.93 96.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 125.251 3.968 . . . . 0.0 114.494 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.479 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.3 OUTLIER -92.87 -76.84 0.46 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.498 -0.773 . . . . 0.0 112.457 -177.374 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.45 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -88.36 109.3 27.68 Favored Pre-proline 0 C--N 1.331 -0.21 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -175.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.88 ' HG2' HD11 ' A' ' 41' ' ' LEU . 1.8 Cg_endo -84.01 -154.96 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 123.092 2.528 . . . . 0.0 111.073 176.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.499 HG22 ' H ' ' A' ' 66' ' ' CYS . 4.0 mm -90.4 165.65 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.897 0.379 . . . . 0.0 110.895 178.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.499 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.2 m -163.41 139.32 6.77 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.063 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -159.94 170.86 20.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.823 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.498 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 13.4 p -82.31 117.07 22.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.954 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.744 HG12 ' O ' ' A' ' 38' ' ' GLY . 0.8 OUTLIER -46.67 93.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.291 179.677 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.495 ' HE2' HG23 ' A' ' 90' ' ' THR . 0.3 OUTLIER -72.6 118.51 15.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.061 -179.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -98.69 117.22 32.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.287 179.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.76 -159.05 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.713 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.47 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 2.1 t -49.86 139.9 16.25 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.925 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.491 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 26.1 Cg_exo -60.52 160.6 23.46 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.433 2.089 . . . . 0.0 112.062 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.527 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 86.2 Cg_exo -42.18 156.51 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.822 2.348 . . . . 0.0 112.842 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.9 m -109.36 90.68 3.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.438 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.575 HG23 ' HE2' ' A' ' 97' ' ' TYR . 21.6 pt -69.37 171.0 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.418 -178.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.5 m -89.92 139.99 30.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.618 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.515 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 2.9 m-80 60.42 29.27 18.88 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.829 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -165.43 -165.89 23.5 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.986 179.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -168.1 -175.89 2.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.896 0.379 . . . . 0.0 110.805 -179.537 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.47 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 13.3 p80 -115.24 168.81 9.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.123 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 -93.92 -85.28 0.29 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.73 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.574 ' H ' HG13 ' A' ' 95' ' ' VAL . . . 61.22 141.46 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.835 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.423 ' N ' ' CD2' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -112.63 -33.87 6.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.055 0.455 . . . . 0.0 110.514 179.864 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.76 -171.86 2.46 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.852 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -103.1 -21.77 13.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.136 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.406 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 10.4 m-85 -134.08 169.72 16.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.16 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.406 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 41.1 m-85 -147.03 168.1 22.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.603 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.495 HG23 ' HE2' ' A' ' 70' ' ' LYS . 17.7 p -138.06 -175.6 4.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.993 0.425 . . . . 0.0 111.496 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.426 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 10.9 m-20 -63.76 96.22 0.13 Allowed 'General case' 0 CA--C 1.516 -0.338 0 CA-C-O 121.304 0.573 . . . . 0.0 111.049 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.93 26.66 1.35 Allowed Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.254 -0.884 . . . . 0.0 113.075 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.425 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.6 OUTLIER -108.26 157.3 18.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.878 0.339 . . . . 0.0 110.494 179.044 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 35.5 m -135.49 151.65 30.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.156 0.503 . . . . 0.0 111.411 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.574 HG13 ' H ' ' A' ' 84' ' ' GLY . 18.0 t -147.85 148.06 16.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.404 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.939 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -107.52 125.84 51.78 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.067 0.461 . . . . 0.0 110.851 -179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 1.004 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.0 m-85 -84.21 164.59 19.01 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.249 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.52 ' HA ' HD13 ' A' ' 105' ' ' LEU . 51.7 m -156.71 143.33 18.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.504 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.452 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 64.2 m -73.88 157.55 36.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.662 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.417 ' CG ' ' N ' ' A' ' 101' ' ' SER . 1.3 p30 -95.12 -55.5 3.05 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.363 0.602 . . . . 0.0 111.342 -178.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.417 ' N ' ' CG ' ' A' ' 100' ' ' ASN . 6.5 t -75.37 -20.62 58.88 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.4 -178.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 117.96 28.05 2.34 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.446 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.515 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 17.9 m-85 -69.65 -179.83 1.89 Allowed 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 121.123 0.487 . . . . 0.0 110.853 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -105.98 96.51 6.54 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.936 178.007 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.52 HD13 ' HA ' ' A' ' 98' ' ' SER . 0.3 OUTLIER -47.74 128.86 13.58 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.588 0.709 . . . . 0.0 111.965 -177.526 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.48 HG22 ' N ' ' A' ' 107' ' ' GLY . 36.0 mm -112.51 158.98 12.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.55 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.48 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 66.46 31.85 80.01 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.462 -0.875 . . . . 0.0 113.002 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.43 ' O ' ' O ' ' A' ' 107' ' ' GLY . 8.8 p30 52.03 130.85 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 123.983 0.913 . . . . 0.0 113.052 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.939 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.6 p -63.01 -25.39 68.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.373 -0.83 . . . . 0.0 111.388 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -64.14 127.76 35.78 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.466 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 1.004 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.6 t -131.35 123.14 52.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.588 0.233 . . . . 0.0 110.724 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.62 124.06 32.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.946 0.403 . . . . 0.0 111.579 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.506 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 18.4 t -87.23 108.81 19.1 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 176.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.6 OUTLIER -155.77 165.13 37.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.102 0.477 . . . . 0.0 111.508 -178.639 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.67 31.11 7.05 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.604 -0.726 . . . . 0.0 112.889 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.45 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 68.63 12.52 64.35 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.711 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -143.14 176.39 9.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.768 0.318 . . . . 0.0 110.523 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.527 ' CD1' ' HD3' ' A' ' 75' ' ' PRO . 89.3 m95 -110.71 127.54 55.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.824 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.91 148.98 27.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.057 0.456 . . . . 0.0 111.478 -178.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.493 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER 68.08 44.85 0.31 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.121 178.888 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 55.1 Cg_endo -69.63 139.18 40.02 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.175 1.917 . . . . 0.0 111.418 178.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.538 ' O ' HG21 ' A' ' 77' ' ' ILE . 55.6 Cg_endo -88.28 -174.8 1.19 Allowed 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.569 2.179 . . . . 0.0 113.35 -178.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.41 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -135.13 -157.48 0.8 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.99 -1.005 . . . . 0.0 109.884 179.002 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 1.8 m -156.28 90.21 1.17 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.124 0.488 . . . . 0.0 111.134 178.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.409 ' O ' ' CB ' ' A' ' 104' ' ' SER . 11.7 mt-30 -115.07 158.97 21.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.6 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.542 HG22 ' O ' ' A' ' 126' ' ' ILE . 29.4 mm . . . . . 0 C--N 1.323 -0.566 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.987 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 27.4 mtm-85 . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.777 0.323 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.449 ' CB ' ' HA ' ' A' ' 26' ' ' ASP . 5.1 ptt180 -85.42 -170.97 3.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.973 0.416 . . . . 0.0 111.173 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.483 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 12.3 m -93.12 162.68 27.73 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.999 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 51.2 Cg_endo -70.24 178.08 5.24 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.443 2.095 . . . . 0.0 112.172 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 42.2 t -58.5 107.94 1.13 Allowed Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.072 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.486 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 2.6 Cg_endo -50.29 146.96 17.18 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.147 1.898 . . . . 0.0 112.206 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.927 ' O ' HD11 ' A' ' 20' ' ' LEU . 4.4 ttp180 -59.76 151.56 25.02 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.275 179.126 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -98.5 -177.82 3.81 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.177 -176.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.608 HG22 ' CD2' ' A' ' 20' ' ' LEU . 8.2 tt -141.38 152.99 19.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.458 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -88.38 -66.98 0.86 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.57 -178.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 67.0 m-80 -91.1 40.33 1.02 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.344 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.44 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -160.37 -179.22 35.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.881 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -137.75 125.18 21.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.743 0.306 . . . . 0.0 110.618 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.927 HD11 ' O ' ' A' ' 13' ' ' ARG . 14.9 mt -66.8 154.21 41.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.99 0.424 . . . . 0.0 111.231 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 32' ' ' THR . 3.9 t0 -127.35 74.67 1.53 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.852 178.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.865 ' HA ' HG23 ' A' ' 31' ' ' ILE . 67.8 mt -70.31 96.28 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.859 -0.61 . . . . 0.0 112.22 -177.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.96 21.48 44.78 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.751 -0.738 . . . . 0.0 111.435 176.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 154.87 140.61 3.05 Favored Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.437 HG23 ' HD2' ' A' ' 8' ' ' ARG . 26.5 m -125.64 -9.21 5.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -178.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.449 ' HA ' ' CB ' ' A' ' 8' ' ' ARG . 27.5 t70 -69.68 164.92 22.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.03 0.443 . . . . 0.0 110.95 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.452 ' CZ ' HD12 ' A' ' 51' ' ' LEU . 17.2 t80 -51.9 118.47 3.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.707 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 49' ' ' CYS . . . 100.27 -10.86 59.99 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.659 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.425 ' N ' ' HB3' ' A' ' 49' ' ' CYS . 3.6 m -58.53 179.92 0.07 Allowed 'General case' 0 C--N 1.333 -0.118 0 CA-C-O 120.825 0.345 . . . . 0.0 110.964 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.1 p -153.58 133.41 13.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.083 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.865 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.6 OUTLIER -100.97 174.25 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.724 179.584 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.47 ' H ' HG22 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -140.88 106.53 5.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.715 178.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.701 ' CE2' HD21 ' A' ' 20' ' ' LEU . 33.5 m-85 -78.37 138.1 38.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.39 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.0 m -139.46 167.02 23.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.69 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.44 ' HA ' ' HA2' ' A' ' 18' ' ' GLY . 1.3 m -91.8 164.62 13.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.943 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -62.01 -84.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.078 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.63 132.91 9.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.637 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.814 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 64.92 25.94 71.0 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.557 -0.83 . . . . 0.0 111.732 -178.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.525 ' CE1' ' CB ' ' A' ' 68' ' ' SER . 2.6 m-85 -118.34 -179.93 3.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.9 0.381 . . . . 0.0 110.931 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.5 ' CE1' ' HA ' ' A' ' 69' ' ' VAL . 0.0 OUTLIER -136.16 140.47 43.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.841 174.738 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.836 HD21 ' O ' ' A' ' 44' ' ' GLU . 9.6 tt -94.11 138.69 31.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.472 -178.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.577 HD13 ' C ' ' A' ' 41' ' ' LEU . 1.9 mm -110.73 150.5 13.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.077 0.465 . . . . 0.0 111.275 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.27 -147.14 43.75 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.256 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.836 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -62.14 177.74 0.44 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.592 0.234 . . . . 0.0 110.679 179.419 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.6 p -152.3 26.73 0.6 Allowed 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.955 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.421 ' CG ' ' O ' ' A' ' 31' ' ' ILE . 0.4 OUTLIER -147.02 -171.11 3.7 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.066 -178.541 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.471 ' O ' HG13 ' A' ' 31' ' ' ILE . 1.1 m -167.07 98.92 0.53 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.168 179.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.424 ' CD1' ' N ' ' A' ' 48' ' ' TYR . 1.5 m-85 -80.51 115.85 20.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.134 0.492 . . . . 0.0 111.781 -177.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.482 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 34.8 t -65.91 102.96 0.84 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.031 178.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.498 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 3.7 tt0 -134.06 171.63 13.94 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.315 0.579 . . . . 0.0 110.695 -179.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.498 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -95.18 141.62 28.58 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.079 -0.964 . . . . 0.0 110.763 179.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 173.99 45.06 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.348 -0.93 . . . . 0.0 113.043 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.448 ' HB3' ' CB ' ' A' ' 56' ' ' SER . 0.2 OUTLIER -140.26 59.22 1.57 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.914 0.388 . . . . 0.0 110.825 179.666 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.3 p 63.15 27.67 15.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.715 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 104.91 27.99 5.77 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.138 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.448 ' CB ' ' HB3' ' A' ' 53' ' ' SER . 0.2 OUTLIER -120.07 -160.42 0.83 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.899 0.38 . . . . 0.0 111.031 -179.302 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.96 147.37 44.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.385 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -148.67 -174.57 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.612 -178.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.532 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 88.5 m95 -128.06 123.2 34.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.805 0.336 . . . . 0.0 111.194 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -140.01 122.01 9.82 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.979 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.29 -166.89 5.25 Favored 'Cis proline' 0 C--N 1.352 0.725 0 C-N-CA 123.858 -1.309 . . . . 0.0 112.375 -0.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -110.34 -152.72 0.5 Allowed 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.496 ' CB ' ' CE2' ' A' ' 33' ' ' TYR . . . -79.18 112.82 31.09 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.982 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.434 ' CG ' ' O ' ' A' ' 44' ' ' GLU . 16.6 Cg_exo -69.24 -150.54 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.738 2.292 . . . . 0.0 112.318 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.601 HG22 ' H ' ' A' ' 66' ' ' CYS . 0.5 OUTLIER -106.66 178.37 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.957 0.408 . . . . 0.0 111.251 -179.245 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.601 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.5 OUTLIER -170.69 127.38 0.76 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.747 179.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.476 ' O ' ' CD2' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -135.48 175.32 9.69 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.863 179.724 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.525 ' CB ' ' CE1' ' A' ' 39' ' ' TYR . 1.7 p -98.17 124.26 42.64 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.052 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.814 HG12 ' O ' ' A' ' 38' ' ' GLY . 6.7 p -49.58 92.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.982 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.434 ' CD ' ' HB3' ' A' ' 88' ' ' PHE . 0.8 OUTLIER -81.33 128.77 34.19 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.807 -178.635 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.433 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -110.62 120.44 42.43 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.867 177.625 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.443 ' HA ' ' HA ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -69.8 -160.19 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.964 -179.242 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.576 ' HG ' ' CE1' ' A' ' 82' ' ' HIS . 2.2 t -47.25 136.09 9.0 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.081 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.476 ' HD2' ' CD2' ' A' ' 82' ' ' HIS . 31.6 Cg_exo -56.81 161.81 9.71 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.347 2.031 . . . . 0.0 111.981 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.5 ' HD3' ' CG ' ' A' ' 118' ' ' TRP . 99.3 Cg_exo -42.75 158.15 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.694 2.262 . . . . 0.0 112.735 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.5 m -110.35 88.61 2.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.852 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.667 HG23 ' HE1' ' A' ' 97' ' ' TYR . 19.4 pt -69.65 -179.0 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.364 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.5 m -98.56 146.47 25.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.619 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.484 ' HB3' ' CD2' ' A' ' 103' ' ' TYR . 8.5 m-80 53.53 30.55 10.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.929 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -174.61 -172.29 39.55 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.874 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -170.72 -174.3 1.56 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.904 0.383 . . . . 0.0 110.673 -179.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.576 ' CE1' ' HG ' ' A' ' 73' ' ' SER . 11.5 p-80 -92.45 174.45 7.28 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.264 178.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.436 ' OD1' ' CG1' ' A' ' 95' ' ' VAL . 17.5 p-10 -106.34 -37.89 6.39 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -178.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' A' ' 85' ' ' TYR . . . -44.42 -71.18 0.49 Allowed Glycine 0 CA--C 1.516 0.136 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.985 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.413 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 3.4 m-85 65.2 28.49 12.08 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 121.264 0.554 . . . . 0.0 110.065 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -69.85 -98.46 0.01 OUTLIER 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.4 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -174.4 -36.72 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.372 0.606 . . . . 0.0 109.642 178.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 72' ' ' GLN . 18.1 m-85 -152.75 159.63 43.12 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.612 -178.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.439 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 23.7 m-85 -144.66 169.63 17.63 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.049 -179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 17.0 p -133.62 178.39 6.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.987 0.423 . . . . 0.0 111.674 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -62.47 100.81 0.2 Allowed 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.539 0.685 . . . . 0.0 110.849 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 122.56 16.71 3.7 Favored Glycine 0 C--N 1.312 -0.792 0 CA-C-N 114.718 -1.128 . . . . 0.0 113.003 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.411 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -99.2 157.7 16.2 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.898 0.349 . . . . 0.0 110.533 179.115 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 34.6 m -136.17 152.01 29.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.164 0.507 . . . . 0.0 111.249 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.47 HG23 ' CH2' ' A' ' 118' ' ' TRP . 43.8 t -146.82 150.1 15.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.6 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.809 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -110.46 126.36 54.25 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.882 -179.537 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.977 ' CE2' HG21 ' A' ' 111' ' ' VAL . 3.8 m-85 -83.75 154.61 23.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.465 -178.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 59.9 p -153.58 147.85 25.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.283 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.454 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 8.4 m -69.81 160.77 31.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.954 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 21.6 m-20 -85.46 -68.99 0.69 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.249 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 66.9 m -77.56 -45.2 26.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.639 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 154.74 41.84 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.766 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.528 ' CE1' HG12 ' A' ' 126' ' ' ILE . 13.4 m-85 -78.15 -166.19 0.78 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' A' ' 124' ' ' CYS . 3.5 m -117.17 104.99 11.76 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.703 0.287 . . . . 0.0 111.567 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.472 ' HA ' HD12 ' A' ' 105' ' ' LEU . 2.6 tp -47.15 118.26 2.06 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.168 0.509 . . . . 0.0 110.534 178.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.523 HG22 ' N ' ' A' ' 107' ' ' GLY . 19.1 mm -94.27 160.71 2.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.917 -178.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.523 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 59.43 -124.18 35.66 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.376 -0.916 . . . . 0.0 111.852 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.28 122.85 38.09 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.79 0.329 . . . . 0.0 110.93 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.809 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.4 t -58.15 -27.7 64.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.068 0.461 . . . . 0.0 110.474 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.64 135.38 26.79 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.692 -0.685 . . . . 0.0 112.817 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.977 HG21 ' CE2' ' A' ' 97' ' ' TYR . 2.7 t -131.07 119.22 44.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.712 0.291 . . . . 0.0 110.594 178.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.0 118.76 24.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.991 0.424 . . . . 0.0 111.588 -178.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.496 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 14.1 t -85.37 100.54 11.91 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.467 176.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.6 t -136.63 161.39 36.04 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.063 -178.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.99 25.58 3.9 Favored Glycine 0 N--CA 1.451 -0.301 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.756 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.434 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 77.16 7.38 86.78 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.655 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -133.53 -176.56 4.19 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.825 0.345 . . . . 0.0 110.571 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.5 ' CG ' ' HD3' ' A' ' 75' ' ' PRO . 94.3 m95 -114.61 145.05 42.45 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.171 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.1 147.39 51.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.286 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.495 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.5 t0 71.0 44.56 0.23 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.289 178.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 62.0 Cg_endo -73.23 137.12 25.5 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.191 1.927 . . . . 0.0 111.254 177.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.484 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 73.0 Cg_endo -89.42 -175.42 1.09 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.467 2.112 . . . . 0.0 113.752 -177.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.468 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -124.93 -162.54 1.11 Allowed 'General case' 0 CA--C 1.501 -0.92 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.509 175.34 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . 0.411 ' SG ' ' CB ' ' A' ' 103' ' ' TYR . 5.2 t -170.69 92.76 0.18 Allowed 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.323 -176.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -118.88 175.93 5.52 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.92 -1.037 . . . . 0.0 111.012 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.618 HG22 ' O ' ' A' ' 126' ' ' ILE . 16.9 mm . . . . . 0 C--N 1.324 -0.531 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.579 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 28.8 mtm-85 . . . . . 0 CA--C 1.529 0.145 0 CA-C-O 120.701 0.286 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.445 ' HB3' HG23 ' A' ' 25' ' ' VAL . 2.4 mtt85 43.34 -167.89 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.023 0.439 . . . . 0.0 111.92 179.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.457 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 15.1 m -111.51 161.56 24.86 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.638 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.408 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 55.8 Cg_endo -66.92 171.54 11.0 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.179 1.919 . . . . 0.0 110.471 178.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.408 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 5.7 p -51.11 120.47 14.1 Favored Pre-proline 0 N--CA 1.45 -0.45 0 C-N-CA 120.437 -0.505 . . . . 0.0 110.719 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.509 ' HB3' HD13 ' A' ' 31' ' ' ILE . 6.3 Cg_endo -47.82 144.59 11.15 Favored 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.67 2.247 . . . . 0.0 112.395 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.454 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -52.59 -175.88 0.0 OUTLIER 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.904 177.615 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -144.55 -179.95 6.89 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.46 0.648 . . . . 0.0 111.994 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.752 HD12 ' O ' ' A' ' 64' ' ' PRO . 7.0 tt -139.77 154.5 24.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.305 -179.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -79.08 -68.72 0.63 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.541 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.496 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 1.2 m120 -93.41 39.08 1.05 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.976 0.417 . . . . 0.0 110.876 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -148.29 178.92 25.55 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.025 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -141.51 134.16 28.53 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.953 HD21 ' CE2' ' A' ' 33' ' ' TYR . 10.5 mt -86.69 152.25 22.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.318 0.58 . . . . 0.0 111.953 -178.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -123.34 80.77 1.81 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.578 177.727 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.819 ' HA ' HG23 ' A' ' 31' ' ' ILE . 6.3 mt -75.5 116.66 18.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.561 -176.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -108.3 19.36 32.0 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.356 175.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.499 ' H ' HG22 ' A' ' 22' ' ' ILE . . . 156.58 164.48 13.51 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -179.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.445 HG23 ' HB3' ' A' ' 8' ' ' ARG . 22.5 m -143.82 22.7 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.861 0.33 . . . . 0.0 111.439 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.4 OUTLIER -93.57 159.27 15.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.805 179.762 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.641 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 2.9 t80 -56.03 87.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.683 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 134.1 -14.56 4.59 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.417 -179.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.01 -170.94 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.612 0.244 . . . . 0.0 110.348 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 47' ' ' SER . 27.7 p -159.28 139.19 11.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.237 0.541 . . . . 0.0 111.819 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.819 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -103.66 176.27 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.866 178.755 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.545 HG23 ' HG2' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -138.24 113.2 9.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.696 0.284 . . . . 0.0 110.828 179.809 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.953 ' CE2' HD21 ' A' ' 20' ' ' LEU . 8.3 m-85 -87.34 149.21 24.65 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.318 0.58 . . . . 0.0 111.751 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.409 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.6 OUTLIER -156.62 164.11 38.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.675 179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.467 ' HA ' ' HA2' ' A' ' 18' ' ' GLY . 20.2 m -87.7 165.48 15.36 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.19 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -66.57 -70.94 0.22 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.92 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.41 141.63 9.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.84 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.797 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 52.46 29.82 32.16 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.171 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.512 ' CZ ' ' HB3' ' A' ' 68' ' ' SER . 2.4 m-85 -117.09 175.84 5.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.799 0.333 . . . . 0.0 111.147 -179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.525 ' CE1' ' HA ' ' A' ' 69' ' ' VAL . 0.1 OUTLIER -131.76 140.5 49.24 Favored 'General case' 0 CA--C 1.516 -0.327 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 174.566 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.972 HD21 ' O ' ' A' ' 44' ' ' GLU . 0.6 OUTLIER -90.16 138.67 31.33 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.256 -176.501 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.86 HD13 ' C ' ' A' ' 41' ' ' LEU . 0.3 OUTLIER -116.38 131.96 67.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 CA-C-O 121.67 0.748 . . . . 0.0 110.552 178.442 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.16 -137.42 13.25 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 114.183 -1.371 . . . . 0.0 111.165 -176.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.972 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.6 OUTLIER -87.32 -172.55 3.98 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.843 0.354 . . . . 0.0 110.687 178.333 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.0 p -144.77 25.54 1.45 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.979 0.419 . . . . 0.0 110.817 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.545 ' HG2' HG23 ' A' ' 32' ' ' THR . 0.2 OUTLIER -160.86 125.92 3.71 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.841 -179.117 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' A' ' 30' ' ' SER . 1.6 m -95.74 149.54 21.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.008 178.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.512 ' CE2' ' HD3' ' A' ' 61' ' ' PRO . 4.0 m-85 -123.08 126.85 47.85 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.028 0.442 . . . . 0.0 111.278 -178.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.477 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 10.5 t -76.21 91.95 3.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.118 179.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -116.4 178.17 4.43 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.63 -178.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.901 HD23 ' O ' ' A' ' 56' ' ' SER . 4.8 mt -80.84 155.91 26.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.606 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 53' ' ' SER . . . 166.18 178.09 38.7 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.465 179.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.524 ' C ' HG23 ' A' ' 54' ' ' THR . 15.8 t 70.81 55.82 0.24 Allowed 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.394 0.616 . . . . 0.0 111.158 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.524 HG23 ' C ' ' A' ' 53' ' ' SER . 1.3 p 71.59 16.99 5.72 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.557 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 105.33 39.79 2.19 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.452 -0.88 . . . . 0.0 112.716 179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.901 ' O ' HD23 ' A' ' 51' ' ' LEU . 33.3 t -121.61 -169.16 1.81 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.734 0.302 . . . . 0.0 110.675 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -96.84 118.38 33.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.934 0.397 . . . . 0.0 110.867 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.5 m -132.84 -175.78 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.91 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.631 ' CE3' HD11 ' A' ' 31' ' ' ILE . 88.3 m95 -120.76 139.32 53.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.877 0.37 . . . . 0.0 110.996 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.424 ' O ' ' N ' ' A' ' 48' ' ' TYR . 3.1 m-20 -148.78 140.2 14.16 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.956 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.512 ' HD3' ' CE2' ' A' ' 48' ' ' TYR . 7.3 Cg_exo -75.93 -151.89 0.72 Allowed 'Cis proline' 0 C--N 1.348 0.512 0 C-N-CA 124.163 -1.182 . . . . 0.0 112.738 1.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -65.2 -130.7 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.908 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.642 ' HB3' ' CA ' ' A' ' 64' ' ' PRO . . . -72.26 -82.53 0.04 OUTLIER Pre-proline 0 CA--C 1.48 -1.733 0 CA-C-O 118.503 -0.76 . . . . 0.0 112.132 -178.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.752 ' O ' HD12 ' A' ' 15' ' ' ILE . 41.2 Cg_endo -102.92 -144.89 0.03 OUTLIER 'Cis proline' 0 C--N 1.317 -1.095 0 CA-C-N 120.73 1.296 . . . . 0.0 114.285 12.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.451 HG13 ' HB ' ' A' ' 42' ' ' ILE . 2.2 pt -91.22 177.0 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -174.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.631 ' HB2' HD11 ' A' ' 15' ' ' ILE . 1.2 m -158.83 112.12 2.33 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 114.282 -1.327 . . . . 0.0 109.513 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.473 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 1.9 mt-10 -102.13 176.8 5.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.006 0.432 . . . . 0.0 111.335 -178.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.512 ' HB3' ' CZ ' ' A' ' 39' ' ' TYR . 2.4 p -97.34 123.02 41.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.802 179.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.797 HG12 ' O ' ' A' ' 38' ' ' GLY . 3.3 p -45.75 97.14 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.318 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.619 ' HE2' HG23 ' A' ' 90' ' ' THR . 0.3 OUTLIER -84.78 115.58 22.8 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.435 -179.139 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -96.38 119.25 34.52 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 177.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.4 pm0 -69.81 -157.41 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.577 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.413 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 2.2 t -50.98 138.9 23.92 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 120.57 0.224 . . . . 0.0 110.736 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.935 ' HG2' HG11 ' A' ' 95' ' ' VAL . 33.9 Cg_exo -58.36 156.36 31.14 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.383 2.055 . . . . 0.0 112.05 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.533 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 76.1 Cg_exo -48.92 156.24 2.2 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.63 2.22 . . . . 0.0 112.921 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 75.4 m -101.63 92.4 4.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.111 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.539 HG23 ' HE1' ' A' ' 97' ' ' TYR . 6.4 pt -68.97 165.51 2.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.298 -178.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 10.8 m -77.32 140.09 39.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.871 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.503 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 7.0 m-80 52.72 27.21 5.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.051 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.458 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -161.63 -166.62 20.73 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.757 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.438 ' N ' ' O ' ' A' ' 98' ' ' SER . 9.5 ptt180 -170.32 -174.64 1.74 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.984 0.421 . . . . 0.0 110.918 -178.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.429 ' HB3' ' CE2' ' A' ' 97' ' ' TYR . 13.6 p80 -102.14 179.43 4.32 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.549 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.469 ' CB ' ' O ' ' A' ' 96' ' ' THR . 50.2 t30 -131.13 24.77 4.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.794 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.448 ' CA ' ' OH ' ' A' ' 89' ' ' TYR . . . -40.39 147.87 0.23 Allowed Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 121.028 -0.606 . . . . 0.0 113.829 -175.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.477 ' CD1' ' N ' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -101.09 -43.31 6.06 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.155 0.502 . . . . 0.0 110.523 -179.549 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.23 -176.42 3.15 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.988 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.72 -26.48 17.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.411 178.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.438 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 11.1 m-85 -132.67 166.32 22.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.73 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.451 ' CE2' ' CG2' ' A' ' 95' ' ' VAL . 19.8 m-85 -145.31 164.95 29.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.818 0.342 . . . . 0.0 111.117 -178.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.619 HG23 ' HE2' ' A' ' 70' ' ' LYS . 11.1 p -147.42 -175.21 4.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.766 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 7.6 p-10 -54.78 94.02 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.676 -179.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.39 25.99 1.24 Allowed Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.543 -0.837 . . . . 0.0 113.512 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.32 152.29 26.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 117.36 0.58 . . . . 0.0 111.176 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 27.3 m -144.34 136.2 22.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.118 0.485 . . . . 0.0 110.949 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.935 HG11 ' HG2' ' A' ' 74' ' ' PRO . 3.8 p -134.8 149.75 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.283 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.917 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.2 OUTLIER -91.31 149.72 21.62 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.992 0.425 . . . . 0.0 110.836 -179.658 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.876 ' CE2' HG21 ' A' ' 111' ' ' VAL . 2.8 m-85 -107.79 157.39 18.18 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 120.81 0.338 . . . . 0.0 111.105 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.438 ' O ' ' N ' ' A' ' 81' ' ' ARG . 10.1 p -144.71 146.16 32.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.257 -0.429 . . . . 0.0 112.086 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.551 ' HB3' ' HB2' ' A' ' 103' ' ' TYR . 91.0 m -69.15 161.11 29.81 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.671 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.458 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 0.9 OUTLIER -53.4 -79.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.86 -178.716 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.1 t -110.81 -30.24 7.64 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.706 -176.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 175.45 31.9 0.04 OUTLIER Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.514 -0.85 . . . . 0.0 113.169 178.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.555 ' CZ ' HD11 ' A' ' 126' ' ' ILE . 0.2 OUTLIER -69.78 -168.05 0.17 Allowed 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 116.596 0.198 . . . . 0.0 110.681 178.726 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 125' ' ' GLN . 0.2 OUTLIER -125.51 113.95 18.15 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 176.254 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.78 HD12 ' SG ' ' A' ' 124' ' ' CYS . 0.1 OUTLIER -69.62 143.41 53.26 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.762 0.791 . . . . 0.0 112.17 -176.09 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.445 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 33.8 mm -123.09 156.96 28.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 114.281 -1.327 . . . . 0.0 111.266 -178.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.438 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 62.56 32.02 81.81 Favored Glycine 0 CA--C 1.512 -0.137 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.415 178.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.45 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.4 OUTLIER 60.44 135.55 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.313 0.578 . . . . 0.0 111.545 179.218 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.917 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.0 OUTLIER -74.43 -29.96 61.7 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.221 -0.9 . . . . 0.0 112.506 -177.506 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.4 141.45 47.92 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.347 -0.93 . . . . 0.0 112.35 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.876 HG21 ' CE2' ' A' ' 97' ' ' TYR . 13.9 t -134.86 119.17 26.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.644 0.259 . . . . 0.0 111.303 -178.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.92 HD11 ' HB2' ' A' ' 114' ' ' SER . 1.0 OUTLIER -80.18 134.51 36.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.908 0.385 . . . . 0.0 111.194 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.896 ' N ' HD22 ' A' ' 112' ' ' LEU . 35.9 t -106.17 104.96 14.77 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.122 177.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.92 ' HB2' HD11 ' A' ' 112' ' ' LEU . 1.7 t -149.14 131.9 16.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.941 0.401 . . . . 0.0 111.564 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.59 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 80.89 24.28 58.24 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.32 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.458 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 75.7 1.53 66.89 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.312 -178.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -124.52 178.73 5.26 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 121.03 0.443 . . . . 0.0 110.711 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.608 ' HE3' HG12 ' A' ' 111' ' ' VAL . 92.9 m95 -120.13 133.52 55.49 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.125 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.401 ' O ' ' HB3' ' A' ' 120' ' ' ASP . 0.8 OUTLIER -109.23 160.36 16.18 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.304 178.41 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.574 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 49.7 t0 67.16 33.39 0.1 OUTLIER Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 32.9 Cg_endo -66.92 124.99 12.97 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 121.993 1.796 . . . . 0.0 110.943 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.509 ' HD2' ' CD1' ' A' ' 97' ' ' TYR . 72.3 Cg_endo -91.38 -174.09 0.6 Allowed 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.603 2.202 . . . . 0.0 114.505 -175.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.522 HG22 ' H ' ' A' ' 124' ' ' CYS . 2.5 m -135.81 176.34 8.78 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 113.924 -1.489 . . . . 0.0 108.639 177.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . 0.78 ' SG ' HD12 ' A' ' 105' ' ' LEU . 1.2 m -133.3 103.94 6.22 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.106 -0.638 . . . . 0.0 111.16 177.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.437 ' O ' ' CB ' ' A' ' 104' ' ' SER . 10.2 mt-30 -106.85 153.12 22.96 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.686 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.568 HG22 ' O ' ' A' ' 126' ' ' ILE . 49.2 mm . . . . . 0 C--N 1.315 -0.919 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.839 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.4 mtt180 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.789 0.328 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.659 ' HD2' HG23 ' A' ' 25' ' ' VAL . 14.4 mtm180 -81.13 156.94 25.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.174 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.454 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 16.7 m -69.67 162.01 70.46 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.725 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' A' ' 57' ' ' MET . 57.5 Cg_endo -70.53 169.32 20.18 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.528 2.152 . . . . 0.0 112.218 -179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -50.29 105.9 0.57 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.939 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.513 ' HG3' ' CZ2' ' A' ' 59' ' ' TRP . 76.5 Cg_exo -46.63 160.96 0.2 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.429 2.086 . . . . 0.0 112.594 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.859 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -66.16 166.38 11.94 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.178 178.532 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -117.03 -178.6 3.48 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-O 121.187 0.517 . . . . 0.0 112.187 -176.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.482 HG22 ' CD2' ' A' ' 20' ' ' LEU . 4.1 tt -144.58 146.74 19.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.378 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -85.81 -61.05 1.84 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.523 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.435 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 0.7 OUTLIER -94.6 34.31 1.34 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.92 -179.142 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.435 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -149.57 -179.18 25.2 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.76 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -138.8 127.99 24.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.769 0.319 . . . . 0.0 110.644 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.859 HD11 ' O ' ' A' ' 13' ' ' ARG . 16.1 mt -76.54 153.74 35.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.096 0.475 . . . . 0.0 111.632 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.454 ' HB3' ' CB ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -127.38 78.82 1.84 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.744 177.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.848 ' HA ' HG23 ' A' ' 31' ' ' ILE . 3.6 mm -68.85 100.32 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.861 -177.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -103.63 22.86 34.47 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.648 177.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 146.57 133.56 2.48 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 111.741 -0.544 . . . . 0.0 111.741 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.659 HG23 ' HD2' ' A' ' 8' ' ' ARG . 6.7 m -121.22 22.32 5.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.697 0.284 . . . . 0.0 111.489 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.12 149.59 26.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.552 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.594 ' CE2' HD13 ' A' ' 51' ' ' LEU . 3.7 t80 -48.41 113.7 0.81 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.894 0.378 . . . . 0.0 110.853 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.42 6.74 23.39 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.618 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.86 -163.19 0.97 Allowed 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.8 0.3 . . . . 0.0 110.571 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.7 p -168.94 144.02 3.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.935 0.398 . . . . 0.0 111.143 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.848 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -102.6 170.31 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.278 179.413 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.569 HG23 ' HD2' ' A' ' 46' ' ' LYS . 0.3 OUTLIER -130.67 114.42 15.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.0 0.429 . . . . 0.0 111.126 179.885 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.779 ' CE1' HD21 ' A' ' 20' ' ' LEU . 17.2 m-85 -92.84 137.14 32.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.504 -179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.435 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 3.5 m -143.86 166.25 25.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.44 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.428 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 3.9 m -82.89 170.44 14.97 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.784 0.326 . . . . 0.0 110.879 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -70.19 -83.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.851 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.6 m -156.44 132.44 9.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.743 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.51 22.75 73.42 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.067 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.494 ' CE1' ' HB3' ' A' ' 68' ' ' SER . 2.7 m-85 -114.65 -174.78 2.55 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.795 0.331 . . . . 0.0 110.913 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.89 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -145.35 112.41 6.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.435 178.203 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.95 HD11 ' HG2' ' A' ' 64' ' ' PRO . 7.9 tt -77.35 124.17 27.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.768 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.89 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.3 mm -100.16 152.23 4.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.994 0.426 . . . . 0.0 110.931 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.71 -137.34 16.58 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.202 -179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.902 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.3 OUTLIER -86.67 -175.84 5.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.02 0.438 . . . . 0.0 110.855 179.432 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.5 p -155.86 24.16 0.38 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.23 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.569 ' HD2' HG23 ' A' ' 32' ' ' THR . 0.0 OUTLIER -149.51 130.03 13.94 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.104 0.478 . . . . 0.0 112.221 -178.598 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.447 ' HB3' ' CB ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -101.15 152.8 20.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.34 178.656 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.494 ' CD2' ' HB3' ' A' ' 60' ' ' ASN . 1.3 m-85 -126.23 120.68 30.66 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 119.7 -0.8 . . . . 0.0 111.902 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.487 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 32.2 t -70.21 116.73 10.9 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.095 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -153.6 -177.43 6.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.789 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.594 HD13 ' CE2' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -95.81 165.6 12.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.988 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.592 ' O ' HD22 ' A' ' 51' ' ' LEU . . . -89.28 -135.52 5.6 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.57 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -93.04 -40.67 10.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.753 0.311 . . . . 0.0 111.011 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.1 p -95.29 44.02 1.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.028 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.13 19.32 30.91 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.654 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.6 t -79.53 -170.21 2.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.763 0.316 . . . . 0.0 110.904 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.403 ' HB2' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -112.66 134.05 54.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.555 -179.572 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.6 m -150.64 176.54 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.917 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.523 ' CE3' HD11 ' A' ' 31' ' ' ILE . 60.0 m95 -128.16 127.98 43.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.944 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.494 ' HB3' ' CD2' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -69.37 163.24 60.19 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.178 179.311 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.432 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 80.1 Cg_exo -16.58 94.13 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.899 1 C-N-CA 125.574 4.182 . . . . 0.0 114.429 -178.456 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.447 ' CB ' ' HB3' ' A' ' 47' ' ' SER . 0.0 OUTLIER -101.28 -81.98 0.47 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.527 -0.76 . . . . 0.0 111.958 -177.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.462 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -72.95 106.46 2.26 Favored Pre-proline 0 C--N 1.331 -0.212 0 N-CA-C 112.654 0.612 . . . . 0.0 112.654 -176.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.95 ' HG2' HD11 ' A' ' 41' ' ' LEU . 1.8 Cg_endo -90.05 -156.01 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.573 0 C-N-CA 123.469 2.779 . . . . 0.0 111.14 177.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.49 HG22 ' H ' ' A' ' 66' ' ' CYS . 3.8 mm -92.43 165.3 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.877 0.37 . . . . 0.0 110.884 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.49 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.8 OUTLIER -170.21 136.3 1.39 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.002 179.666 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.4 ' C ' ' CD2' ' A' ' 39' ' ' TYR . 1.6 tt0 -159.78 172.37 17.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.909 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.494 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 4.1 p -89.77 107.88 19.36 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.447 ' O ' HG13 ' A' ' 69' ' ' VAL . 2.4 p -43.06 94.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.524 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.432 ' HG2' ' CG2' ' A' ' 90' ' ' THR . 2.0 mmtp -75.16 127.23 32.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.375 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.92 113.92 27.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.056 178.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.3 -159.74 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.538 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.482 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 1.4 t -44.52 135.2 4.5 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.234 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.489 ' HG2' HG11 ' A' ' 95' ' ' VAL . 31.6 Cg_exo -57.78 161.78 12.03 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.398 2.065 . . . . 0.0 112.116 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.53 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 79.8 Cg_exo -43.14 156.64 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.772 2.314 . . . . 0.0 112.904 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.5 t -104.81 90.56 3.52 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.372 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.66 HG23 ' HE2' ' A' ' 97' ' ' TYR . 10.1 pt -69.28 175.32 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.395 -178.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.4 p -93.79 141.04 28.95 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.609 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 58.4 28.58 17.02 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.036 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.467 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -167.05 -171.32 33.0 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.215 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -158.55 -173.58 4.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.078 0.466 . . . . 0.0 110.614 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.482 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 8.4 p80 -117.5 172.19 7.5 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.173 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -117.86 -155.75 0.61 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.813 -0.631 . . . . 0.0 109.952 178.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 129.59 162.16 10.76 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.628 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.507 ' CD1' ' N ' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -110.75 -39.54 4.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.138 0.494 . . . . 0.0 110.523 179.752 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -84.61 -177.15 6.53 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.455 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.66 -15.01 15.09 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.585 177.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.432 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 7.4 m-85 -138.88 178.52 7.1 Favored 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.35 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.432 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 65.6 m-85 -155.64 164.87 38.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.642 0.258 . . . . 0.0 110.9 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.432 ' CG2' ' HG2' ' A' ' 70' ' ' LYS . 19.7 p -148.18 -175.29 4.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.005 0.431 . . . . 0.0 111.567 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.441 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 28.8 p-10 -52.92 95.65 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.348 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.04 20.35 2.52 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.231 -0.895 . . . . 0.0 113.261 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.24 147.35 33.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 117.051 0.425 . . . . 0.0 110.965 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.494 HG22 ' N ' ' A' ' 95' ' ' VAL . 33.7 m -128.45 158.44 40.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.005 0.431 . . . . 0.0 111.185 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.533 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 14.0 t -151.67 147.34 15.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.709 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.874 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -106.96 131.41 54.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.852 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 1.001 ' CE1' HG21 ' A' ' 111' ' ' VAL . 5.0 m-85 -88.95 159.08 17.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.516 -178.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 49.7 m -151.97 138.89 19.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.947 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.436 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 84.1 m -73.43 156.25 38.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.499 -179.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.467 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 40.8 m-20 -91.35 -71.97 0.61 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.313 -179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.6 t -53.51 -23.32 10.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.968 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.2 29.03 1.7 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.557 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.497 ' CE1' HG12 ' A' ' 126' ' ' ILE . 24.0 m-85 -73.98 -174.82 1.97 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.021 0.439 . . . . 0.0 110.365 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -123.35 99.19 6.21 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 176.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.666 HD21 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -52.57 152.95 3.33 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 122.277 1.036 . . . . 0.0 112.387 -175.285 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.479 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 40.6 mm -119.01 150.3 21.35 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-N 113.149 -1.841 . . . . 0.0 111.138 -175.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.416 ' O ' ' ND2' ' A' ' 108' ' ' ASN . . . 72.52 33.99 60.59 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.032 -1.08 . . . . 0.0 111.746 -178.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.416 ' ND2' ' O ' ' A' ' 107' ' ' GLY . 8.6 p30 54.05 145.86 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 124.357 1.063 . . . . 0.0 112.997 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.874 ' HB2' HG22 ' A' ' 96' ' ' THR . 0.7 OUTLIER -71.91 -23.48 61.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.764 -178.756 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -62.14 128.24 41.69 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.764 -0.732 . . . . 0.0 113.009 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 1.001 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.5 t -128.9 125.38 62.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.885 HD22 ' N ' ' A' ' 113' ' ' CYS . 1.2 tm? -85.82 135.53 33.68 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.884 0.373 . . . . 0.0 111.456 -178.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.885 ' N ' HD22 ' A' ' 112' ' ' LEU . 39.1 t -108.01 104.8 14.32 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.232 177.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.689 ' OG ' HD11 ' A' ' 112' ' ' LEU . 0.9 OUTLIER -164.83 124.04 1.82 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.923 0.392 . . . . 0.0 111.349 179.865 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 96.23 26.17 11.57 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.409 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.44 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 68.43 13.51 65.4 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.6 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -145.8 172.3 13.52 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.875 0.369 . . . . 0.0 110.702 179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.54 ' CZ3' ' HB2' ' A' ' 113' ' ' CYS . 92.5 m95 -111.27 141.67 44.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.876 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.18 163.81 16.09 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.427 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.448 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 3.7 p-10 46.58 48.66 5.79 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.332 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.47 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 91.0 Cg_endo -78.5 146.58 21.82 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.496 2.131 . . . . 0.0 110.572 176.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.567 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 56.6 Cg_endo -97.65 -177.44 0.29 Allowed 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 122.048 1.832 . . . . 0.0 114.357 -176.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 105' ' ' LEU . 0.3 OUTLIER -118.21 -156.25 0.63 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.273 -1.331 . . . . 0.0 109.018 177.788 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 105' ' ' LEU . 2.0 m -152.65 89.1 1.38 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.061 0.458 . . . . 0.0 110.788 177.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -121.45 160.13 24.79 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.658 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.511 HG22 ' O ' ' A' ' 126' ' ' ILE . 16.8 mm . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.053 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.927 0.394 . . . . 0.0 110.785 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.512 ' HD2' HG23 ' A' ' 25' ' ' VAL . 18.6 mtm180 -61.81 150.51 36.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.541 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.554 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 55.6 m -69.42 179.09 0.79 Allowed Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.5 178.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.554 ' CD ' ' HB3' ' A' ' 9' ' ' CYS . 17.9 Cg_endo -88.84 -171.71 0.61 Allowed 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.637 2.225 . . . . 0.0 111.598 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.433 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 2.6 t -57.23 106.22 0.65 Allowed Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.452 ' HG3' ' CD1' ' A' ' 22' ' ' ILE . 9.6 Cg_endo -52.44 162.75 2.05 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.107 1.872 . . . . 0.0 112.029 -178.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.427 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -62.27 -175.94 0.09 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.025 179.159 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -143.09 -175.36 4.49 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.165 0.507 . . . . 0.0 111.268 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.451 HG22 ' CD2' ' A' ' 20' ' ' LEU . 13.7 tt -145.23 158.45 13.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.735 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -93.91 -55.2 3.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.446 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.91 45.79 1.24 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.981 0.419 . . . . 0.0 110.858 -179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 34' ' ' SER . . . -177.18 -179.14 47.38 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.996 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -136.74 137.6 40.07 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.8 0.333 . . . . 0.0 110.392 179.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.887 HD21 ' CE2' ' A' ' 33' ' ' TYR . 19.3 mt -82.74 154.87 24.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.033 0.444 . . . . 0.0 111.537 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -124.45 84.06 2.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.089 178.515 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.873 ' HA ' HG23 ' A' ' 31' ' ' ILE . 3.8 mm -68.68 108.94 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.676 -177.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -112.51 19.99 21.2 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.002 178.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 147.31 127.14 1.73 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.309 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.512 HG23 ' HD2' ' A' ' 8' ' ' ARG . 35.9 m -116.52 21.09 6.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.643 0.258 . . . . 0.0 111.47 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -91.01 151.91 20.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.819 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.509 ' CZ ' HD12 ' A' ' 51' ' ' LEU . 9.2 t80 -52.27 96.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.832 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 122.6 13.01 4.83 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.957 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.6 m -101.23 -162.64 0.95 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.862 0.331 . . . . 0.0 110.427 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 47' ' ' SER . 0.9 OUTLIER -166.01 146.62 6.57 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.05 0.452 . . . . 0.0 111.347 179.12 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.873 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -104.05 172.91 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.364 179.614 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.468 ' H ' HG22 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -134.52 115.14 13.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.922 0.392 . . . . 0.0 111.038 179.722 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.887 ' CE2' HD21 ' A' ' 20' ' ' LEU . 19.2 m-85 -88.16 149.45 23.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.034 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.42 ' O ' ' N ' ' A' ' 19' ' ' GLN . 81.4 p -151.24 154.17 36.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.651 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.442 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 6.3 m -78.04 167.87 20.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.787 0.327 . . . . 0.0 110.868 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -69.01 -83.81 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.407 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.04 132.08 11.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.889 0.376 . . . . 0.0 110.982 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.48 22.58 76.54 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.98 -179.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.603 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.2 m-85 -117.43 -179.93 3.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.972 0.415 . . . . 0.0 110.908 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.752 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.7 OUTLIER -144.79 114.73 7.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.25 178.338 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.923 HD21 ' O ' ' A' ' 44' ' ' GLU . 7.5 tt -73.91 126.14 29.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.594 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.752 HD11 ' CE1' ' A' ' 40' ' ' HIS . 1.7 mm -101.99 156.06 4.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.004 0.43 . . . . 0.0 110.945 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.29 -147.32 39.02 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.271 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.923 ' O ' HD21 ' A' ' 41' ' ' LEU . 3.4 pt-20 -65.98 -176.22 0.38 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.928 0.394 . . . . 0.0 110.633 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.2 t -163.91 25.9 0.08 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.945 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.402 ' HG3' ' HA ' ' A' ' 32' ' ' THR . 10.7 mtpt -152.88 128.16 9.85 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.966 0.412 . . . . 0.0 112.02 -178.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.478 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 1.0 OUTLIER -92.16 142.09 27.88 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 176.572 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.548 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.2 m-85 -117.22 120.28 37.79 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 119.099 -1.04 . . . . 0.0 112.255 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 34.8 t -71.57 100.78 2.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.753 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.46 -173.4 2.67 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.014 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.509 HD12 ' CZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -100.44 150.6 22.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.873 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -74.19 -147.88 1.32 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.432 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.8 -38.23 13.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.759 0.314 . . . . 0.0 110.948 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 72.7 p -102.33 45.62 0.96 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.983 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 63.22 20.52 63.05 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.647 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.22 -161.73 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.787 0.327 . . . . 0.0 110.886 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.8 140.76 51.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.186 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.1 m -151.97 173.99 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.975 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.533 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 72.8 m95 -126.82 123.21 36.83 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.357 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.548 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 1.0 OUTLIER -69.99 166.32 34.12 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.363 178.578 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.459 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 76.7 Cg_exo -21.57 97.43 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 125.044 3.829 . . . . 0.0 114.163 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.448 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -94.85 -78.34 0.45 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.05 -177.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.463 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -78.07 108.25 7.15 Favored Pre-proline 0 C--N 1.331 -0.216 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -176.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.91 ' HG2' HD11 ' A' ' 41' ' ' LEU . 2.4 Cg_endo -87.3 -156.19 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.115 2.543 . . . . 0.0 111.016 177.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.554 HG22 ' H ' ' A' ' 66' ' ' CYS . 2.9 mm -88.89 169.25 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.967 0.413 . . . . 0.0 110.67 178.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.554 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.0 OUTLIER -169.97 134.29 1.28 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.734 179.273 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.467 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 1.4 tt0 -155.06 -177.84 6.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.54 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.603 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 2.7 p -75.02 147.59 40.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.646 0.736 . . . . 0.0 111.336 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.646 HG23 ' N ' ' A' ' 116' ' ' GLY . 0.0 OUTLIER -61.86 100.72 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 114.504 -1.226 . . . . 0.0 110.312 -179.371 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 89' ' ' TYR . 0.3 OUTLIER -105.62 119.42 39.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.3 -178.222 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.27 119.26 38.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.467 176.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -69.28 -157.93 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.412 -179.513 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.405 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 2.4 t -51.66 136.66 34.04 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.625 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.756 ' CG ' HG21 ' A' ' 95' ' ' VAL . 52.2 Cg_exo -55.05 159.17 10.12 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.411 2.074 . . . . 0.0 112.302 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.419 ' N ' ' OH ' ' A' ' 97' ' ' TYR . 89.5 Cg_exo -44.39 156.44 0.21 Allowed 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.632 2.221 . . . . 0.0 112.597 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 95.6 p -102.94 89.87 3.59 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.775 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.567 HG23 ' HE2' ' A' ' 97' ' ' TYR . 10.3 pt -69.61 176.29 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.127 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.79 143.54 26.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.974 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.465 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 12.5 m-80 52.86 29.5 7.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.148 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.461 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -162.15 -169.16 25.11 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.275 -0.964 . . . . 0.0 113.353 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.72 -173.98 3.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.872 0.368 . . . . 0.0 110.489 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.484 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 7.3 p-80 -113.28 167.17 10.78 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.558 -179.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.444 ' N ' ' O ' ' A' ' 96' ' ' THR . 16.2 m-20 -94.23 17.12 13.27 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.832 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.452 ' HA2' ' OH ' ' A' ' 89' ' ' TYR . . . -48.76 136.41 18.88 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.028 -1.082 . . . . 0.0 112.961 -176.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -108.3 -37.22 6.06 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.964 0.411 . . . . 0.0 111.01 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.87 -175.99 3.32 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.043 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.11 -24.6 16.22 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.78 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.433 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 7.3 m-85 -135.6 169.67 17.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.761 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.472 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 22.4 m-85 -141.8 162.33 35.75 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.13 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 1.4 p -122.25 174.91 6.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.173 0.511 . . . . 0.0 112.123 -177.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.436 ' HB3' ' HB ' ' A' ' 69' ' ' VAL . 10.2 p-10 -60.29 95.53 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.163 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 122.46 18.19 3.4 Favored Glycine 0 N--CA 1.445 -0.735 0 CA-C-N 115.291 -0.868 . . . . 0.0 113.075 178.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.09 157.02 16.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.739 0.304 . . . . 0.0 110.595 179.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 28.6 m -143.52 141.87 25.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.225 0.536 . . . . 0.0 111.152 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.83 HG22 ' CH2' ' A' ' 118' ' ' TRP . 40.2 t -142.48 142.1 27.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.941 179.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.512 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -89.01 149.54 23.21 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.646 -177.079 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.756 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.1 m-85 -105.16 159.63 15.71 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.986 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.691 ' HA ' HD13 ' A' ' 105' ' ' LEU . 58.0 m -157.17 153.65 28.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.039 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.414 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 59.5 m -80.02 160.9 25.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.816 179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.461 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 60.2 m-20 -87.59 -70.93 0.59 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.418 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.42 -27.62 67.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.24 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.57 35.53 0.49 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.791 179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.502 ' CE2' HG12 ' A' ' 126' ' ' ILE . 15.8 m-85 -70.78 -174.68 0.95 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.914 0.387 . . . . 0.0 110.587 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.4 98.16 7.61 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.162 178.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.691 HD13 ' HA ' ' A' ' 98' ' ' SER . 0.3 OUTLIER -46.47 122.53 4.17 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.507 0.67 . . . . 0.0 112.268 -177.747 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.843 HD11 ' HB2' ' A' ' 125' ' ' GLN . 5.1 mm -85.06 154.73 3.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.938 179.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.85 -126.1 33.94 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.209 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -123.48 140.99 52.45 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.936 0.398 . . . . 0.0 111.024 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.618 ' HB2' HD22 ' A' ' 105' ' ' LEU . 1.8 t -73.05 -29.41 62.95 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.948 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -78.23 127.83 8.4 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.002 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.756 HG21 ' CE1' ' A' ' 97' ' ' TYR . 3.1 t -118.41 139.97 43.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 178.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -96.81 131.51 43.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.146 0.498 . . . . 0.0 111.567 -178.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.494 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 12.0 t -97.45 95.16 7.47 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.446 176.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.9 t -151.07 153.14 34.51 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.455 -178.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 76.12 -0.56 62.64 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.645 -0.707 . . . . 0.0 113.491 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.646 ' N ' HG23 ' A' ' 69' ' ' VAL . . . 100.24 1.54 55.79 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.902 -177.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -146.3 177.12 9.25 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 120.821 0.343 . . . . 0.0 110.708 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.83 ' CH2' HG22 ' A' ' 95' ' ' VAL . 95.2 m95 -99.01 155.61 17.34 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.717 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.585 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -143.09 155.28 44.57 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.031 0.444 . . . . 0.0 111.19 -179.844 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.481 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.7 OUTLIER 66.22 47.0 0.49 Allowed Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.798 179.599 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 87.0 Cg_endo -79.4 139.3 14.5 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.476 2.117 . . . . 0.0 111.698 178.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.513 ' CG ' HD21 ' A' ' 105' ' ' LEU . 50.3 Cg_endo -90.61 -174.72 0.76 Allowed 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.5 2.133 . . . . 0.0 113.2 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.449 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -128.4 -157.79 0.84 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.499 177.576 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . 0.483 ' SG ' HD12 ' A' ' 105' ' ' LEU . 3.5 m -157.6 89.56 1.04 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.13 0.491 . . . . 0.0 111.133 178.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.843 ' HB2' HD11 ' A' ' 106' ' ' ILE . 16.4 mt-30 -114.5 170.87 7.99 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.783 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.502 HG12 ' CE2' ' A' ' 103' ' ' TYR . 49.1 mm . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.792 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? . . . . . 0 C--O 1.231 0.13 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.448 ' CD ' HG23 ' A' ' 25' ' ' VAL . 0.0 OUTLIER 42.88 -164.13 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.851 0.358 . . . . 0.0 111.394 178.767 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.486 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 15.1 m -78.67 161.62 68.58 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.448 178.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.02 167.32 25.13 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.338 2.025 . . . . 0.0 111.703 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.6 t -51.02 105.44 0.52 Allowed Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.936 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.68 ' HG2' HD13 ' A' ' 22' ' ' ILE . 51.3 Cg_exo -50.76 151.07 11.46 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.151 1.901 . . . . 0.0 111.731 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.933 ' O ' HD11 ' A' ' 20' ' ' LEU . 7.1 mpt_? -55.7 159.24 3.11 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.82 -173.85 2.33 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.2 0.524 . . . . 0.0 111.615 -177.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 9.2 tt -152.57 138.92 12.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.539 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -82.2 -57.31 3.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.676 -177.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.504 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 1.2 m120 -91.2 45.84 1.27 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.055 0.455 . . . . 0.0 111.069 -178.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -176.65 -179.46 47.09 Favored Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.39 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.64 137.36 41.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.815 0.341 . . . . 0.0 110.773 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.933 HD11 ' O ' ' A' ' 13' ' ' ARG . 14.5 mt -75.9 152.15 37.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.215 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.462 ' HB3' ' CB ' ' A' ' 32' ' ' THR . 19.4 t0 -120.92 69.64 0.89 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.447 177.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.821 ' HA ' HG23 ' A' ' 31' ' ' ILE . 1.1 mt -80.84 90.95 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.883 -176.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.85 16.13 59.07 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.81 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 29' ' ' SER . . . 165.83 133.21 1.48 Allowed Glycine 0 C--N 1.334 0.435 0 C-N-CA 121.176 -0.535 . . . . 0.0 111.765 -179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.448 HG23 ' CD ' ' A' ' 8' ' ' ARG . 1.7 m -119.43 -2.54 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -178.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -75.88 164.13 26.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.986 0.422 . . . . 0.0 110.814 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.54 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 13.1 t80 -52.03 115.81 1.88 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.09 -179.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.73 -4.59 46.57 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.764 -0.731 . . . . 0.0 113.066 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 24' ' ' GLY . 57.9 m -74.99 176.83 6.81 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 117.029 0.415 . . . . 0.0 110.602 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 47' ' ' SER . 2.5 p -144.47 149.99 36.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.952 0.406 . . . . 0.0 111.464 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.821 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -118.74 165.83 13.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.468 179.353 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.462 ' CB ' ' HB3' ' A' ' 21' ' ' ASP . 0.3 OUTLIER -135.9 111.75 9.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.896 178.547 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.697 ' CE2' HD21 ' A' ' 20' ' ' LEU . 31.6 m-85 -84.06 135.78 34.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.062 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 84.4 p -141.05 146.86 37.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.154 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.479 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 1.7 m -73.38 174.31 8.33 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.794 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.68 -82.42 0.06 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.39 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.2 m -155.14 120.16 4.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.476 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.579 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 77.42 -0.58 68.69 Favored Glycine 0 CA--C 1.522 0.475 0 C-N-CA 120.573 -0.823 . . . . 0.0 112.475 -177.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.517 ' CZ ' ' CB ' ' A' ' 68' ' ' SER . 5.9 m-85 -89.48 166.43 13.69 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 120.782 0.325 . . . . 0.0 110.832 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.806 ' CE1' HG22 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -121.46 127.68 51.34 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 176.578 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.849 HD21 ' O ' ' A' ' 44' ' ' GLU . 6.0 tt -86.02 117.2 24.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.135 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.448 ' HB ' ' HB ' ' A' ' 65' ' ' ILE . 2.1 mm -92.41 153.83 3.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.475 -177.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.82 -151.29 50.27 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.26 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.849 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -55.28 178.92 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.534 0.206 . . . . 0.0 110.536 179.504 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.447 ' HB3' HD22 ' A' ' 41' ' ' LEU . 6.6 p -152.14 18.8 0.66 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.608 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.411 ' HG3' ' HA ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -154.77 175.72 13.36 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.923 0.392 . . . . 0.0 110.958 -178.648 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.469 ' HB2' ' CG1' ' A' ' 31' ' ' ILE . 2.6 m -149.63 123.03 9.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.297 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.408 ' CE1' ' HD3' ' A' ' 61' ' ' PRO . 4.9 m-85 -103.0 114.16 28.23 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.973 0.416 . . . . 0.0 111.452 -178.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.471 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 42.2 t -64.97 77.44 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.374 0.607 . . . . 0.0 110.076 178.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.5 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 1.9 tt0 -97.33 175.13 6.37 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.907 -177.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.54 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -88.0 138.57 31.33 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.106 -179.551 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.29 -148.07 0.55 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.754 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -92.04 -38.73 12.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.712 0.292 . . . . 0.0 111.186 -179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.0 p -91.67 40.57 1.04 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.183 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 62.19 19.24 59.19 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.551 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.08 -161.36 0.63 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.702 0.287 . . . . 0.0 110.725 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.442 ' HA ' ' HA ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -134.16 116.99 16.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.71 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.1 m -126.03 -176.79 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.383 -178.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.668 ' CE3' HD11 ' A' ' 31' ' ' ILE . 97.5 m95 -116.38 125.6 52.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.126 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -150.08 118.73 3.68 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.771 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.408 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 8.9 Cg_exo -73.21 -172.16 9.47 Favored 'Cis proline' 0 C--N 1.35 0.633 0 C-N-CA 124.221 -1.158 . . . . 0.0 112.413 1.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -111.11 -152.5 0.5 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.891 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.524 ' CB ' ' CE2' ' A' ' 33' ' ' TYR . . . -79.38 111.27 19.31 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.651 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.439 ' CG ' ' O ' ' A' ' 44' ' ' GLU . 15.3 Cg_exo -69.07 -150.76 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.662 2.241 . . . . 0.0 112.296 -179.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.569 HG22 ' H ' ' A' ' 66' ' ' CYS . 0.4 OUTLIER -108.36 -179.69 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.117 0.484 . . . . 0.0 111.222 -179.324 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.569 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.0 OUTLIER -167.43 118.52 0.87 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.524 179.454 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.469 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 0.1 OUTLIER -113.4 166.74 11.2 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.689 179.888 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.517 ' CB ' ' CZ ' ' A' ' 39' ' ' TYR . 1.1 p -107.53 120.42 42.15 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.993 0.425 . . . . 0.0 111.047 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.806 HG22 ' CE1' ' A' ' 40' ' ' HIS . 3.1 p -46.4 94.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.439 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.44 ' HE2' HG23 ' A' ' 90' ' ' THR . 0.2 OUTLIER -76.8 125.44 29.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.276 -179.581 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.432 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -104.33 126.06 51.1 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.326 178.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -73.62 -169.12 0.65 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.472 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.0 OUTLIER -42.42 135.05 2.59 Favored Pre-proline 0 N--CA 1.438 -1.065 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.436 178.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.513 ' HG2' HG11 ' A' ' 95' ' ' VAL . 34.5 Cg_exo -56.05 159.88 11.45 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.188 1.925 . . . . 0.0 111.923 -178.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.516 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 96.1 Cg_exo -40.85 156.6 0.05 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.757 2.305 . . . . 0.0 112.855 -178.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 20.3 m -108.5 90.12 3.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.647 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.647 HG21 ' O ' ' A' ' 122' ' ' PRO . 16.5 pt -69.41 170.85 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.298 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -91.39 133.78 35.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.777 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.508 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 0.2 OUTLIER 67.9 26.41 7.54 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.602 -179.643 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.431 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -171.44 -170.83 35.96 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.732 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.15 -175.47 2.0 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.958 0.409 . . . . 0.0 110.801 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.442 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 12.3 p80 -95.04 176.11 6.37 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.891 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.423 ' ND2' ' O ' ' A' ' 96' ' ' THR . 2.7 m-20 -121.8 21.75 10.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.169 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.402 ' HA3' ' OH ' ' A' ' 89' ' ' TYR . . . -52.26 150.76 8.27 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.618 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -107.65 -28.65 9.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.067 0.46 . . . . 0.0 110.529 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.57 -172.2 2.83 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.637 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.75 -21.8 12.72 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.125 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.414 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 6.0 m-85 -139.07 168.98 18.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.976 0.417 . . . . 0.0 111.154 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.432 ' N ' ' O ' ' A' ' 71' ' ' CYS . 33.0 m-85 -145.05 170.32 16.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.613 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.44 HG23 ' HE2' ' A' ' 70' ' ' LYS . 14.4 p -133.25 175.38 9.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.913 0.387 . . . . 0.0 111.18 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 23.1 p-10 -60.19 94.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.307 0.575 . . . . 0.0 111.038 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 128.31 28.1 0.86 Allowed Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.294 -0.866 . . . . 0.0 113.18 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.405 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -110.11 164.88 12.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.791 0.295 . . . . 0.0 110.661 179.24 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.429 HG22 ' N ' ' A' ' 95' ' ' VAL . 33.5 m -138.47 154.81 27.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.067 0.461 . . . . 0.0 111.274 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.513 HG11 ' HG2' ' A' ' 74' ' ' PRO . 21.7 t -152.42 148.5 14.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.021 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.706 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -104.99 142.94 33.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.306 179.007 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.972 ' CE2' HG21 ' A' ' 111' ' ' VAL . 4.6 m-85 -101.43 155.4 18.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.946 0.403 . . . . 0.0 111.279 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.416 ' HA ' HD13 ' A' ' 105' ' ' LEU . 45.9 m -148.57 141.93 25.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.165 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.431 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 73.5 m -72.75 162.35 29.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.759 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.4 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 39.7 m-20 -92.74 -70.59 0.69 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.347 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.5 m -63.79 -23.37 67.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.198 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 122.21 33.0 0.93 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.495 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.508 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 22.6 m-85 -69.9 -176.95 1.19 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.022 0.439 . . . . 0.0 110.725 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.2 m -108.11 101.73 10.94 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.185 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.649 HD22 ' HB2' ' A' ' 109' ' ' SER . 0.2 OUTLIER -46.32 125.18 6.44 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.426 0.631 . . . . 0.0 111.771 -178.255 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.44 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 34.6 mm -90.79 152.1 3.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 114.931 -1.032 . . . . 0.0 110.282 179.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 68.86 -127.49 22.33 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.257 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -125.59 132.48 52.51 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.712 0.291 . . . . 0.0 110.946 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.706 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.9 t -62.87 -33.16 74.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.773 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -66.03 139.42 38.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.781 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.972 HG21 ' CE2' ' A' ' 97' ' ' TYR . 3.0 t -136.44 119.91 23.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.571 0.224 . . . . 0.0 110.705 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.93 128.72 33.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.965 0.412 . . . . 0.0 111.47 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.52 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 17.7 t -92.8 102.29 14.68 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 176.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 3.1 p -144.54 162.86 35.51 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.074 0.464 . . . . 0.0 111.401 -177.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.2 29.0 4.66 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.778 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.436 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 70.15 16.15 72.78 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.638 -0.792 . . . . 0.0 112.4 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -141.51 -177.76 5.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.869 0.366 . . . . 0.0 110.659 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.52 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 95.1 m95 -117.04 142.19 47.29 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.082 -179.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.18 149.92 47.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.247 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.488 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 2.0 t0 70.14 46.01 0.27 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.815 -0.629 . . . . 0.0 112.036 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 84.1 Cg_endo -78.18 134.43 12.9 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.442 2.095 . . . . 0.0 111.831 178.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.647 ' O ' HG21 ' A' ' 77' ' ' ILE . 73.9 Cg_endo -89.05 -173.06 0.74 Allowed 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.62 2.214 . . . . 0.0 113.432 -178.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.401 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -131.39 -160.76 1.07 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.784 -1.098 . . . . 0.0 109.96 178.468 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 8.2 m -153.28 91.19 1.49 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.141 0.496 . . . . 0.0 110.957 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -122.39 157.74 31.19 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.616 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.551 HG22 ' O ' ' A' ' 126' ' ' ILE . 24.0 mm . . . . . 0 C--N 1.323 -0.584 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.932 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 29.1 mtt180 . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.969 0.414 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.443 ' HA ' ' HA ' ' A' ' 26' ' ' ASP . 3.1 mtm180 40.04 -163.66 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.363 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.462 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 4.2 m -122.58 164.65 25.24 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.339 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 44.3 Cg_endo -66.13 168.05 16.7 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.145 1.897 . . . . 0.0 111.465 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.5 t -52.84 105.95 0.6 Allowed Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.047 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.76 ' HG2' HD13 ' A' ' 22' ' ' ILE . 17.2 Cg_exo -42.15 158.1 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.212 1.941 . . . . 0.0 112.164 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.452 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -74.87 166.93 22.84 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.155 178.411 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.735 ' HA ' HD11 ' A' ' 20' ' ' LEU . 12.0 p-10 -121.48 -175.21 3.03 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-O 121.079 0.466 . . . . 0.0 112.022 -176.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.848 HD12 ' O ' ' A' ' 64' ' ' PRO . 16.9 tt -151.52 147.21 15.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.715 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.409 ' HB3' ' ND2' ' A' ' 17' ' ' ASN . 4.7 t0 -87.2 156.72 19.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.219 178.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.523 ' CB ' ' CE1' ' A' ' 39' ' ' TYR . 0.5 OUTLIER 45.44 27.02 0.34 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.096 -179.611 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -147.38 176.96 25.97 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.207 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.54 136.23 34.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.787 0.327 . . . . 0.0 110.812 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.783 HD22 ' CE2' ' A' ' 33' ' ' TYR . 3.5 mt -87.7 159.26 18.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.62 178.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.424 ' CB ' ' HB ' ' A' ' 32' ' ' THR . 5.3 t0 -124.76 71.23 1.16 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.049 177.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.941 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.8 OUTLIER -74.19 95.38 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.776 -177.748 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.77 19.14 55.71 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.722 177.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 158.93 132.16 1.34 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.227 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.0 m -118.63 33.35 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.543 0.211 . . . . 0.0 111.521 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.443 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 43.9 t0 -105.0 162.87 12.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.043 0.449 . . . . 0.0 111.513 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.655 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 5.2 t80 -59.96 91.73 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.619 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.15 3.56 6.79 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.638 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -86.77 -165.84 1.39 Allowed 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 116.843 0.321 . . . . 0.0 110.312 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 67.4 p -162.84 146.81 11.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.298 0.57 . . . . 0.0 111.593 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.941 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -114.17 160.45 13.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.871 179.57 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.43 ' HA ' ' HG3' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -123.3 120.48 33.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.919 0.39 . . . . 0.0 110.899 179.184 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.783 ' CE2' HD22 ' A' ' 20' ' ' LEU . 2.2 m-85 -91.98 142.32 27.66 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.533 -178.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.91 164.82 37.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.669 -179.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.429 ' HA ' ' HA2' ' A' ' 18' ' ' GLY . 64.6 m -90.17 172.55 8.72 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.867 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.4 m-20 -78.17 -83.35 0.08 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.205 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -150.79 135.53 17.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.665 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.784 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 63.31 26.35 69.34 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.867 -179.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.523 ' CE1' ' CB ' ' A' ' 17' ' ' ASN . 2.4 m-85 -120.11 171.28 8.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.807 0.337 . . . . 0.0 111.171 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.791 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -133.86 127.86 33.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.289 178.275 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.816 HD21 ' HG2' ' A' ' 64' ' ' PRO . 1.7 tt -87.72 124.6 33.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.671 -178.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.791 HD11 ' CE1' ' A' ' 40' ' ' HIS . 0.9 OUTLIER -108.06 131.34 58.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.312 0.577 . . . . 0.0 111.038 -179.432 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 112.86 -146.37 18.34 Favored Glycine 0 C--N 1.321 -0.261 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.204 -177.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.752 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -74.31 -135.59 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 176.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.42 ' HB2' ' O ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER 174.02 26.6 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 117.965 0.348 . . . . 0.0 110.784 177.71 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.493 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 4.3 mttt -160.22 134.49 7.4 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.786 -178.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.504 ' HB3' HD12 ' A' ' 31' ' ' ILE . 32.1 t -107.69 144.38 34.88 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 116.307 -0.406 . . . . 0.0 109.908 177.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.516 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 3.4 m-85 -126.41 120.27 29.36 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 119.41 -0.916 . . . . 0.0 112.461 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 32.5 t -64.01 99.28 0.25 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.538 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -124.2 -173.7 2.83 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.112 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.655 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -100.44 151.67 21.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.02 -179.348 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -76.41 -125.74 0.23 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.487 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.4 m -110.93 -32.37 6.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.87 0.367 . . . . 0.0 110.884 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 80.8 p -99.21 29.64 3.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.742 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.78 22.38 78.73 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.311 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.3 t -80.48 -161.63 0.39 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.916 0.389 . . . . 0.0 110.994 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.5 mmt -124.58 123.72 40.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.433 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.7 m -137.04 179.91 3.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.936 -179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.669 ' CZ3' HD11 ' A' ' 31' ' ' ILE . 66.5 m95 -124.74 127.18 46.84 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.289 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.516 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -69.53 168.97 13.75 Favored Pre-proline 0 CA--C 1.513 -0.449 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.487 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 1.0 OUTLIER -4.97 85.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.282 1 C-N-CA 125.326 4.017 . . . . 0.0 113.816 -179.107 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.634 ' O ' ' CZ ' ' A' ' 33' ' ' TYR . 15.3 mt-10 -69.09 -53.07 22.21 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-N 113.052 -1.885 . . . . 0.0 111.649 -174.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.649 ' CB ' ' HA ' ' A' ' 64' ' ' PRO . . . -65.31 -148.51 0.0 OUTLIER Pre-proline 0 CA--C 1.487 -1.454 0 CA-C-O 116.708 -1.615 . . . . 0.0 108.043 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.848 ' O ' HD12 ' A' ' 15' ' ' ILE . 3.9 Cg_exo -85.91 -157.44 1.25 Allowed 'Cis proline' 0 N--CA 1.484 0.934 0 CA-C-N 123.772 2.383 . . . . 0.0 115.013 16.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.601 ' N ' HD13 ' A' ' 65' ' ' ILE . 1.2 mm -95.68 175.01 0.8 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-N 115.069 -0.969 . . . . 0.0 111.0 -178.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.588 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.6 m -147.67 135.11 20.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.185 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.484 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 3.0 tt0 -140.55 174.06 10.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.755 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.472 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 37.4 p -89.03 118.87 29.06 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.984 0.421 . . . . 0.0 111.235 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.784 HG12 ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -40.59 98.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.728 179.773 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.415 ' HG2' HG22 ' A' ' 90' ' ' THR . 1.3 mmtp -67.71 137.04 55.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.389 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.03 124.77 50.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.13 178.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -69.26 -156.31 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.319 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.555 ' HG ' ' CE1' ' A' ' 82' ' ' HIS . 1.4 t -53.45 145.6 27.15 Favored Pre-proline 0 N--CA 1.45 -0.463 0 CA-C-O 120.59 0.234 . . . . 0.0 110.542 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.57 ' HG2' HG11 ' A' ' 95' ' ' VAL . 18.8 Cg_exo -65.29 160.63 41.4 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.53 2.154 . . . . 0.0 112.031 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.52 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 86.8 Cg_exo -40.54 156.68 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.801 2.334 . . . . 0.0 112.892 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.15 91.85 3.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.528 179.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.694 HG23 ' HE1' ' A' ' 97' ' ' TYR . 15.6 pt -68.98 175.91 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.07 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.9 m -94.49 140.91 29.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.912 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.5 ' HB3' ' CE1' ' A' ' 103' ' ' TYR . 7.0 m-80 57.47 29.25 16.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.989 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.46 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -163.57 -168.03 24.94 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.392 -0.909 . . . . 0.0 112.86 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 7.7 ptt85 -162.48 -175.91 4.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.007 0.432 . . . . 0.0 110.903 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.555 ' CE1' ' HG ' ' A' ' 73' ' ' SER . 4.6 p80 -111.18 172.12 7.07 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.625 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -96.91 -85.13 0.35 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.507 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.485 ' H ' HG13 ' A' ' 95' ' ' VAL . . . 60.92 142.74 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.959 178.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -113.71 -33.15 5.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.001 0.429 . . . . 0.0 110.724 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.16 -171.93 2.25 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.739 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.26 -22.27 15.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.272 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.432 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 7.0 m-85 -134.34 176.97 8.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.939 0.4 . . . . 0.0 111.333 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.432 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 62.8 m-85 -151.24 164.72 35.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.546 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.415 HG22 ' HG2' ' A' ' 70' ' ' LYS . 19.0 p -128.84 178.47 6.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.912 0.387 . . . . 0.0 111.114 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.43 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 14.5 t0 -64.55 101.5 0.46 Allowed 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 121.814 0.816 . . . . 0.0 111.01 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 121.55 21.39 3.01 Favored Glycine 0 C--N 1.311 -0.811 0 CA-C-N 114.312 -1.313 . . . . 0.0 112.993 179.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.39 160.79 14.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.845 0.322 . . . . 0.0 110.641 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 33.7 m -134.37 152.9 34.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.156 0.503 . . . . 0.0 111.515 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.57 HG11 ' HG2' ' A' ' 74' ' ' PRO . 27.7 t -146.49 148.71 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.688 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.734 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -105.51 132.87 51.14 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.96 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 1.005 ' CE2' HG21 ' A' ' 111' ' ' VAL . 5.2 m-85 -93.29 159.07 15.43 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.005 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 56.3 p -156.11 143.67 19.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.204 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.415 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 62.3 m -72.35 160.49 32.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.305 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.46 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 8.1 m-20 -94.45 -71.01 0.68 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.408 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.95 -21.77 66.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.455 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.65 30.88 1.2 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.694 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.505 ' CE2' HG12 ' A' ' 126' ' ' ILE . 51.1 m-85 -71.27 -172.72 0.76 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 120.658 0.266 . . . . 0.0 110.469 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -109.62 109.3 20.01 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.011 0.434 . . . . 0.0 111.146 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.564 HD23 ' HB2' ' A' ' 122' ' ' PRO . 2.7 tp -47.56 113.56 0.72 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.662 178.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.453 ' HB ' ' CB ' ' A' ' 123' ' ' THR . 39.0 mm -84.86 149.73 4.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.495 -179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 59.93 -132.43 50.92 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.385 -0.912 . . . . 0.0 111.794 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -112.29 133.45 54.4 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.826 0.346 . . . . 0.0 111.477 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.734 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.3 t -64.92 -27.31 68.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.44 178.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.34 138.95 31.37 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.836 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 1.005 HG21 ' CE2' ' A' ' 97' ' ' TYR . 3.1 t -134.98 123.83 41.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.462 0.173 . . . . 0.0 110.576 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.5 126.94 32.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.964 0.411 . . . . 0.0 111.976 -178.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.516 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 16.4 t -92.4 104.8 17.09 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 176.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 83.1 p -151.79 165.68 33.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.947 -177.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.99 30.71 5.27 Favored Glycine 0 N--CA 1.452 -0.235 0 CA-C-N 115.813 -0.63 . . . . 0.0 112.865 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.434 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 67.9 8.79 54.69 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.51 -179.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -136.98 179.51 6.34 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.817 0.341 . . . . 0.0 110.771 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.52 ' CD1' ' HD3' ' A' ' 75' ' ' PRO . 94.2 m95 -113.5 136.58 52.64 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.901 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.77 155.86 37.13 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.134 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.522 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 34.6 t0 67.99 41.94 0.25 Allowed Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.522 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 81.4 Cg_endo -78.52 143.21 19.04 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.431 2.087 . . . . 0.0 112.03 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.564 ' HB2' HD23 ' A' ' 105' ' ' LEU . 57.4 Cg_endo -91.19 -172.66 0.49 Allowed 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 122.895 2.397 . . . . 0.0 113.353 -179.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.453 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -133.47 -177.19 4.42 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.274 178.097 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 6.4 m -142.13 96.68 3.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.972 0.415 . . . . 0.0 110.908 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -121.23 170.1 9.91 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.81 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.565 HG22 ' O ' ' A' ' 126' ' ' ILE . 36.5 mm . . . . . 0 C--N 1.324 -0.515 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.823 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.622 0.248 . . . . 0.0 110.661 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.423 ' CD ' HG23 ' A' ' 25' ' ' VAL . 0.0 OUTLIER 42.11 -162.26 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.549 178.866 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.433 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 6.9 m -87.56 162.29 42.69 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.638 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -70.29 169.26 20.0 Favored 'Trans proline' 0 N--CA 1.462 -0.377 0 C-N-CA 122.275 1.983 . . . . 0.0 111.532 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -50.47 111.81 2.43 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.021 -179.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.53 157.42 58.42 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.495 2.13 . . . . 0.0 112.002 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.779 ' O ' HD11 ' A' ' 20' ' ' LEU . 10.4 ttt180 -53.85 -179.74 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.956 178.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.74 ' O ' HG22 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -141.3 -3.26 1.2 Allowed 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -177.662 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.74 HG22 ' O ' ' A' ' 14' ' ' ASP . 15.6 tt 56.03 156.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 C-N-CA 122.599 0.36 . . . . 0.0 111.114 -177.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -88.37 -63.34 1.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.308 0.484 . . . . 0.0 112.308 -176.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.437 ' HA ' ' ND2' ' A' ' 36' ' ' ASN . 0.4 OUTLIER -92.42 26.04 2.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.442 -177.797 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.425 ' HA2' ' N ' ' A' ' 36' ' ' ASN . . . -147.8 177.69 25.9 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.955 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.419 ' N ' ' O ' ' A' ' 34' ' ' SER . 1.2 mt-30 -137.61 139.08 40.15 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.815 HD13 ' CZ ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -94.6 174.37 7.15 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.311 0.577 . . . . 0.0 111.532 -178.395 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 32' ' ' THR . 10.0 t0 -133.12 88.34 2.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.562 177.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.902 ' HA ' HG23 ' A' ' 31' ' ' ILE . 59.9 mt -71.58 115.79 12.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.091 -177.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -122.44 19.06 8.15 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.666 177.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 159.83 131.94 1.3 Allowed Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.423 HG23 ' CD ' ' A' ' 8' ' ' ARG . 6.6 m -124.24 5.36 4.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -77.33 164.46 25.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.036 0.446 . . . . 0.0 110.983 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.635 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 4.8 t80 -57.1 101.83 0.07 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.201 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 115.45 7.7 15.73 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.958 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.2 p -88.76 -169.11 2.41 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.924 0.362 . . . . 0.0 110.62 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.4 p -160.16 151.3 19.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.953 0.406 . . . . 0.0 111.391 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.902 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.8 OUTLIER -115.78 169.84 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.477 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -123.27 113.1 18.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.956 0.408 . . . . 0.0 111.186 179.259 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.815 ' CZ ' HD13 ' A' ' 20' ' ' LEU . 17.3 m-85 -88.86 140.92 28.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.218 0.533 . . . . 0.0 111.718 -179.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 19' ' ' GLN . 0.4 OUTLIER -144.92 170.69 15.66 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.231 179.151 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.429 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 1.7 m -89.19 166.14 14.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.716 0.293 . . . . 0.0 110.903 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.437 ' ND2' ' HA ' ' A' ' 17' ' ' ASN . 22.9 m-20 -64.42 -84.26 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.029 -179.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.86 134.02 13.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.81 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.731 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 63.89 23.62 67.66 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.093 -179.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.496 ' CE2' ' HB2' ' A' ' 68' ' ' SER . 2.5 m-85 -115.88 174.27 6.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.81 0.338 . . . . 0.0 111.007 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.886 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -137.21 112.57 9.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.46 178.142 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.917 HD21 ' O ' ' A' ' 44' ' ' GLU . 4.5 tt -77.51 130.63 37.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.772 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.886 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.6 mm -105.52 154.17 6.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.851 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.07 -137.9 17.83 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.273 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.917 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -79.83 -174.21 4.26 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.948 0.404 . . . . 0.0 110.931 179.599 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.1 p -160.55 25.48 0.15 Allowed 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.067 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.41 ' HG3' ' HA ' ' A' ' 32' ' ' THR . 6.3 mtpt -152.29 132.11 13.27 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.021 0.438 . . . . 0.0 112.179 -178.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.452 ' HB2' ' HA ' ' A' ' 62' ' ' GLU . 26.4 t -96.83 153.12 18.07 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.766 177.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.5 ' CD1' ' HB3' ' A' ' 60' ' ' ASN . 1.4 m-85 -128.68 114.53 16.75 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 119.248 -0.981 . . . . 0.0 111.895 178.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 29.8 t -63.07 109.29 1.45 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.663 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.97 -176.49 4.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.045 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.904 HD23 ' O ' ' A' ' 56' ' ' SER . 5.0 mt -82.85 167.89 17.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.199 -179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -94.34 -107.31 2.01 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.455 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.0 t -131.67 -44.97 0.97 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.844 0.354 . . . . 0.0 110.923 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 32.3 p -97.11 27.13 4.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.722 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.28 17.66 58.63 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.485 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.904 ' O ' HD23 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -84.53 176.41 8.65 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 120.848 0.356 . . . . 0.0 111.194 -179.416 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.6 mmt -107.09 129.49 54.81 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.615 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.519 HG22 ' C ' ' A' ' 51' ' ' LEU . 31.0 m -138.68 -175.17 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.968 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.519 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 68.0 m95 -131.06 134.85 47.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.059 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.5 ' HB3' ' CD1' ' A' ' 48' ' ' TYR . 1.2 m-80 -75.06 166.6 44.13 Favored Pre-proline 0 CA--C 1.517 -0.297 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 177.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.467 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 23.2 Cg_exo -8.96 92.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 0.986 1 C-N-CA 125.568 4.178 . . . . 0.0 114.546 -179.559 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.469 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 3.6 mm-40 -82.91 -87.4 0.1 Allowed 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 114.448 -1.251 . . . . 0.0 112.936 -175.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.506 ' HB1' HG13 ' A' ' 15' ' ' ILE . . . -96.32 108.18 40.18 Favored Pre-proline 0 C--N 1.332 -0.169 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -176.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.811 ' HG2' HD11 ' A' ' 41' ' ' LEU . 5.7 Cg_exo -74.71 -151.5 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.797 2.331 . . . . 0.0 111.334 177.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.507 HG22 ' H ' ' A' ' 66' ' ' CYS . 4.8 mm -88.8 166.24 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 0.0 110.712 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.507 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.8 OUTLIER -165.54 137.17 4.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.884 179.901 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.06 169.94 23.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.928 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.496 ' HB2' ' CE2' ' A' ' 39' ' ' TYR . 1.1 t -80.59 123.75 28.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.146 0.498 . . . . 0.0 111.008 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.731 HG12 ' O ' ' A' ' 38' ' ' GLY . 1.9 p -50.74 104.09 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.984 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.446 ' HD2' ' HB3' ' A' ' 88' ' ' PHE . 46.3 mmtt -71.43 121.65 18.97 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.128 -178.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.418 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -109.2 121.58 45.47 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 176.435 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -69.77 -162.02 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.513 -179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.599 ' HG ' ' CE1' ' A' ' 82' ' ' HIS . 1.1 t -53.32 141.58 41.63 Favored Pre-proline 0 N--CA 1.449 -0.487 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.328 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.474 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 24.9 Cg_exo -58.3 159.74 18.38 Favored 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 122.204 1.936 . . . . 0.0 111.515 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.426 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 78.1 Cg_exo -39.21 154.56 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.707 2.271 . . . . 0.0 112.799 -178.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 44.2 t -107.3 89.53 3.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.885 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.621 HG23 ' HE2' ' A' ' 97' ' ' TYR . 22.7 pt -70.12 -177.92 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.327 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.7 m -104.33 142.32 34.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.583 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.514 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 5.4 m-80 61.9 29.79 17.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.814 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.466 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . -175.78 -168.92 36.78 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.771 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -170.55 -174.66 1.68 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.907 0.384 . . . . 0.0 110.535 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.599 ' CE1' ' HG ' ' A' ' 73' ' ' SER . 2.1 p80 -103.15 170.94 7.66 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.152 -179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 -103.93 18.86 21.1 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.322 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.42 ' CA ' ' OH ' ' A' ' 89' ' ' TYR . . . -55.07 140.93 38.14 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.232 -0.985 . . . . 0.0 112.498 -179.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -108.31 -27.81 9.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.978 0.418 . . . . 0.0 110.675 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.75 -172.24 2.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.722 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -104.11 -24.79 13.15 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.968 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.446 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 10.5 m-85 -134.65 175.98 9.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.094 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.435 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 59.1 m-85 -148.82 152.74 37.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.665 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 18.4 p -102.0 175.18 5.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.099 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.9 103.12 2.13 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.652 0.739 . . . . 0.0 110.65 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 120.55 24.66 2.56 Favored Glycine 0 C--N 1.312 -0.778 0 CA-C-N 114.588 -1.187 . . . . 0.0 112.751 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -101.54 163.57 12.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.711 0.291 . . . . 0.0 110.627 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.507 HG22 ' N ' ' A' ' 95' ' ' VAL . 32.6 m -136.27 158.48 38.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.17 0.51 . . . . 0.0 111.333 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.507 ' N ' HG22 ' A' ' 94' ' ' VAL . 22.1 t -153.07 150.4 12.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.769 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.941 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -108.4 136.36 48.16 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.355 178.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.875 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.9 m-85 -93.81 155.57 17.13 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.938 0.399 . . . . 0.0 110.987 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -154.81 144.78 21.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.408 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.466 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 9.5 m -69.95 169.14 13.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.843 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -99.33 -83.81 0.42 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.531 178.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.9 t -54.01 -36.78 63.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.247 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 136.19 47.38 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.548 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.55 ' CE2' HG12 ' A' ' 126' ' ' ILE . 12.4 m-85 -83.77 -170.18 2.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.672 0.272 . . . . 0.0 110.653 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 5.4 m -116.92 102.3 9.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.726 0.298 . . . . 0.0 110.821 179.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.529 HD11 ' HB3' ' A' ' 97' ' ' TYR . 0.2 OUTLIER -48.38 136.95 11.88 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-O 121.632 0.729 . . . . 0.0 111.193 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.481 HG22 ' N ' ' A' ' 107' ' ' GLY . 33.2 mm -103.43 158.86 4.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.304 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.481 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 62.38 -126.1 37.17 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.309 -0.948 . . . . 0.0 112.021 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -124.12 131.72 53.57 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.981 0.42 . . . . 0.0 111.121 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.941 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.2 p -62.77 -26.52 68.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.857 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.2 142.29 31.38 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.821 -0.627 . . . . 0.0 113.014 -179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.875 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.8 t -140.05 127.02 23.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.98 122.25 32.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.873 0.368 . . . . 0.0 111.807 -178.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.521 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 15.5 t -85.16 101.26 12.33 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 176.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.45 167.19 25.05 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.047 0.451 . . . . 0.0 111.527 -178.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.24 25.11 2.61 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.665 -0.698 . . . . 0.0 113.033 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.82 19.7 79.48 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.222 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -151.31 -179.3 7.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.772 0.32 . . . . 0.0 110.297 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.521 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 90.1 m95 -113.23 138.53 49.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.898 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.41 146.63 46.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.236 -179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.48 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER 69.89 45.98 0.28 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.17 178.819 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 71.7 Cg_endo -76.95 136.77 16.89 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.313 2.009 . . . . 0.0 111.383 177.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.527 ' O ' HG21 ' A' ' 77' ' ' ILE . 56.6 Cg_endo -89.7 179.41 2.15 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.383 2.055 . . . . 0.0 113.582 -178.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.45 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -120.13 -159.99 0.81 Allowed 'General case' 0 CA--C 1.503 -0.858 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.955 176.707 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . 0.437 ' SG ' ' HB2' ' A' ' 103' ' ' TYR . 5.5 t -170.7 91.48 0.16 Allowed 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 119.643 -0.823 . . . . 0.0 111.376 -176.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -118.92 176.57 5.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.697 -1.138 . . . . 0.0 110.812 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.595 HG22 ' O ' ' A' ' 126' ' ' ILE . 39.1 mm . . . . . 0 C--N 1.322 -0.601 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.846 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.854 0.359 . . . . 0.0 111.002 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.459 ' HB2' ' HA ' ' A' ' 26' ' ' ASP . 7.7 ptt180 -65.8 -172.35 0.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.121 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.558 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 72.4 m -83.89 177.12 3.17 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.693 178.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.558 ' CD ' ' HB3' ' A' ' 9' ' ' CYS . 38.4 Cg_endo -90.78 -165.93 0.18 Allowed 'Trans proline' 0 N--CA 1.451 -1.029 0 C-N-CA 122.701 2.267 . . . . 0.0 112.025 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.39 108.22 1.35 Allowed Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.273 179.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.469 ' HB3' HD11 ' A' ' 31' ' ' ILE . 14.0 Cg_endo -56.67 149.31 59.71 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.153 1.902 . . . . 0.0 111.975 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.82 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.8 OUTLIER -59.25 173.43 0.49 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.28 179.645 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.62 -171.71 2.53 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.147 0.498 . . . . 0.0 111.506 -179.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.582 HD12 ' O ' ' A' ' 64' ' ' PRO . 4.1 tt -151.82 147.23 15.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.004 -178.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.451 ' N ' HG12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -87.72 154.6 20.44 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 177.3 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.477 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 0.3 OUTLIER 48.52 25.44 0.94 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.885 0.374 . . . . 0.0 110.285 -178.521 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -146.3 170.46 27.4 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.658 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -136.46 138.56 41.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.927 0.394 . . . . 0.0 110.689 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.911 HD21 ' CZ ' ' A' ' 33' ' ' TYR . 8.2 mt -84.62 155.1 22.17 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.061 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.441 ' CB ' ' HB ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -125.45 71.22 1.2 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.776 177.857 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.888 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.8 OUTLIER -70.78 95.69 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.041 -177.024 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -92.8 19.22 52.91 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.749 -0.739 . . . . 0.0 111.591 176.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.4 ' O ' ' HB3' ' A' ' 29' ' ' SER . . . 155.46 141.47 3.22 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.206 -179.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.42 ' O ' ' HB2' ' A' ' 8' ' ' ARG . 3.1 m -114.6 -12.54 11.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.459 ' HA ' ' HB2' ' A' ' 8' ' ' ARG . 0.8 OUTLIER -69.82 160.3 32.01 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.852 0.358 . . . . 0.0 111.738 -179.033 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.672 ' CE2' HD23 ' A' ' 51' ' ' LEU . 24.1 t80 -50.42 127.21 17.0 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.126 178.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.97 -11.06 71.43 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.065 -178.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.4 ' HB3' ' O ' ' A' ' 24' ' ' GLY . 74.5 m -65.31 -173.4 0.13 Allowed 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.955 0.378 . . . . 0.0 110.065 179.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 48' ' ' TYR . 11.0 p -162.12 146.49 12.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.135 0.493 . . . . 0.0 111.808 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.888 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -118.94 151.22 21.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.83 179.157 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.444 ' HA ' ' HG3' ' A' ' 46' ' ' LYS . 3.1 m -115.52 114.61 25.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.037 0.446 . . . . 0.0 111.428 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.911 ' CZ ' HD21 ' A' ' 20' ' ' LEU . 2.1 m-85 -80.83 135.9 36.02 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.252 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.467 ' HA ' HD13 ' A' ' 41' ' ' LEU . 3.7 p -148.24 177.65 9.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.463 -0.789 . . . . 0.0 112.146 -177.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.466 ' HA ' ' HA2' ' A' ' 18' ' ' GLY . 71.9 m -94.16 170.17 9.71 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.634 -178.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.26 -77.82 0.17 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.856 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.03 139.23 17.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.593 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.487 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 54.35 29.68 46.99 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.725 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.5 ' CE2' ' HA ' ' A' ' 67' ' ' GLU . 2.0 m-85 -121.14 163.12 18.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.948 0.404 . . . . 0.0 111.161 -179.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.508 ' CE1' ' CD1' ' A' ' 42' ' ' ILE . 1.4 p80 -127.68 134.65 49.59 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 176.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.837 HD21 ' HG2' ' A' ' 64' ' ' PRO . 0.9 OUTLIER -82.72 137.62 34.35 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.959 -174.572 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.531 HD13 ' C ' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -114.88 125.26 72.15 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 CA-C-O 121.344 0.592 . . . . 0.0 110.995 178.827 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 104.69 -145.43 15.97 Favored Glycine 0 C--N 1.318 -0.452 0 CA-C-N 114.539 -1.21 . . . . 0.0 112.378 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.46 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 11.0 mt-10 -60.97 -134.87 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 178.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.507 ' HB3' HD22 ' A' ' 41' ' ' LEU . 6.4 p 165.32 23.6 0.0 OUTLIER 'General case' 0 N--CA 1.439 -1.01 0 C-N-CA 123.712 0.805 . . . . 0.0 111.086 177.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.533 ' HB3' ' CE2' ' A' ' 48' ' ' TYR . 1.6 mttt -162.93 146.6 11.08 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -177.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.489 ' HA ' ' O ' ' A' ' 61' ' ' PRO . 32.9 t -119.85 152.62 37.05 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.75 176.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.546 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 3.4 m-85 -134.2 119.54 18.93 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 118.825 -1.15 . . . . 0.0 113.184 -178.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.51 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 36.6 t -65.96 120.87 13.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.902 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.486 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 8.4 tt0 -160.68 168.85 24.02 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.565 0.697 . . . . 0.0 110.845 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.672 HD23 ' CE2' ' A' ' 27' ' ' PHE . 2.8 pp -75.17 155.99 36.36 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.658 -1.155 . . . . 0.0 111.074 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.523 ' O ' HD12 ' A' ' 51' ' ' LEU . . . -79.05 -125.93 0.47 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.396 179.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 36.3 t -113.15 -33.08 6.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.754 0.312 . . . . 0.0 111.14 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 81.8 p -97.51 33.0 2.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.937 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.27 18.48 78.15 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.587 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.07 -161.33 0.62 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.752 0.31 . . . . 0.0 110.877 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.565 ' O ' HG13 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -125.54 142.6 51.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.341 179.494 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.565 HG13 ' O ' ' A' ' 57' ' ' MET . 8.2 m -159.98 -177.65 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.099 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.53 ' CE3' HD11 ' A' ' 31' ' ' ILE . 75.6 m95 -126.2 135.2 51.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.972 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.546 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.3 OUTLIER -69.58 168.57 16.2 Favored Pre-proline 0 CA--C 1.506 -0.722 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 175.208 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.49 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 0.9 OUTLIER -4.28 120.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.949 1 C-N-CA 125.527 4.151 . . . . 0.0 114.873 -177.209 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.619 ' O ' ' CZ ' ' A' ' 33' ' ' TYR . 13.1 mt-10 -89.18 -62.3 1.51 Allowed 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 114.35 -1.295 . . . . 0.0 111.739 -173.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.677 ' HB1' ' CA ' ' A' ' 64' ' ' PRO . . . -65.45 -153.12 0.0 OUTLIER Pre-proline 0 CA--C 1.484 -1.57 0 CA-C-O 116.704 -1.617 . . . . 0.0 108.691 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.837 ' HG2' HD21 ' A' ' 41' ' ' LEU . 4.0 Cg_exo -89.51 -155.14 0.78 Allowed 'Cis proline' 0 N--CA 1.483 0.879 0 CA-C-N 123.037 2.12 . . . . 0.0 114.804 19.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.545 HG22 ' H ' ' A' ' 66' ' ' CYS . 0.4 OUTLIER -103.15 -167.98 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.072 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.921 -177.905 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.649 ' SG ' HD12 ' A' ' 41' ' ' LEU . 1.7 m -164.19 137.42 5.19 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 120.822 0.344 . . . . 0.0 111.257 -178.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.5 ' HA ' ' CE2' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -141.24 150.89 43.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.524 -179.431 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.486 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 5.0 t -48.3 139.62 8.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.301 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.487 HG12 ' O ' ' A' ' 38' ' ' GLY . 0.9 OUTLIER -67.38 108.2 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.261 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.427 ' HA ' HG22 ' A' ' 90' ' ' THR . 0.0 OUTLIER -77.18 127.92 33.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.761 -179.391 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.41 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -107.1 119.34 39.1 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.681 177.532 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.65 -157.09 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.791 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.5 t -49.18 139.61 13.07 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.08 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.807 ' HG2' HG11 ' A' ' 95' ' ' VAL . 25.6 Cg_exo -60.23 159.79 25.33 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.474 2.116 . . . . 0.0 111.9 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.51 ' HD3' ' CG ' ' A' ' 118' ' ' TRP . 86.2 Cg_exo -45.81 153.67 0.8 Allowed 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.433 2.089 . . . . 0.0 112.4 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.4 t -106.62 91.81 3.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.635 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.534 HG21 ' O ' ' A' ' 122' ' ' PRO . 14.1 pt -69.27 167.02 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.091 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.4 p -84.87 139.97 31.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.897 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.455 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 7.2 m-80 58.63 27.9 16.43 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.139 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.455 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -163.05 -163.08 14.86 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.422 -0.894 . . . . 0.0 113.054 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.415 ' N ' ' O ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -170.44 -174.61 1.7 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.874 0.369 . . . . 0.0 110.859 -179.475 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.526 ' HB3' ' CE1' ' A' ' 97' ' ' TYR . 2.3 p80 -111.24 167.3 10.39 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.893 -178.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 96' ' ' THR . 10.4 m-20 -97.48 19.55 13.18 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.452 177.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.427 ' CA ' ' OH ' ' A' ' 89' ' ' TYR . . . -43.68 127.9 6.03 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.312 -0.947 . . . . 0.0 112.795 -176.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -99.7 -39.08 8.43 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.084 0.468 . . . . 0.0 111.194 -177.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.04 178.11 5.2 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.144 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -90.2 -24.82 20.9 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.346 178.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.427 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 7.3 m-85 -137.56 163.32 31.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.87 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.427 ' OH ' ' CA ' ' A' ' 84' ' ' GLY . 6.5 m-85 -142.54 173.18 11.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.79 -179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.427 HG22 ' HA ' ' A' ' 70' ' ' LYS . 16.7 p -154.02 -175.73 5.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.039 0.447 . . . . 0.0 112.012 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.467 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 4.6 m-20 -57.5 96.53 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.358 0.599 . . . . 0.0 111.062 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 128.46 15.54 2.21 Favored Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 115.081 -0.963 . . . . 0.0 113.281 178.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.431 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.4 OUTLIER -104.52 150.61 24.45 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 117.244 0.522 . . . . 0.0 110.698 179.184 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.484 HG12 ' HA ' ' A' ' 112' ' ' LEU . 18.8 m -146.89 132.83 12.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.084 0.469 . . . . 0.0 110.886 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.807 HG11 ' HG2' ' A' ' 74' ' ' PRO . 2.2 p -132.35 148.7 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.973 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.009 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.574 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -92.1 148.91 21.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.077 0.465 . . . . 0.0 110.732 179.85 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.883 ' CE1' HG21 ' A' ' 111' ' ' VAL . 3.0 m-85 -107.17 159.78 16.07 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.846 0.355 . . . . 0.0 110.845 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.415 ' O ' ' N ' ' A' ' 81' ' ' ARG . 50.4 m -155.79 151.44 27.25 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.56 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.452 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 78.4 m -78.38 162.01 26.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.252 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.455 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 17.0 m-20 -91.77 -71.28 0.65 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.488 -179.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.68 -20.96 66.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.434 -179.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.32 31.42 1.17 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.532 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.484 ' CE2' HG12 ' A' ' 126' ' ' ILE . 26.5 m-85 -69.83 -173.47 0.63 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 120.782 0.325 . . . . 0.0 110.539 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -107.56 103.56 12.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.072 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.591 HD23 ' HB2' ' A' ' 122' ' ' PRO . 3.0 tp -42.62 113.45 0.46 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.135 179.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.734 HD11 ' HB2' ' A' ' 125' ' ' GLN . 39.0 mm -86.75 155.86 3.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.735 -179.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.439 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 57.18 -128.62 47.86 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.351 -0.928 . . . . 0.0 111.766 -178.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -115.04 134.67 54.98 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.029 0.442 . . . . 0.0 111.573 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.574 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.1 t -70.27 -29.83 66.7 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.362 178.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.82 137.28 23.05 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.536 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.883 HG21 ' CE1' ' A' ' 97' ' ' TYR . 9.9 t -128.75 120.11 51.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.483 0.182 . . . . 0.0 110.527 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.883 HD22 ' N ' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -80.0 133.21 36.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.903 0.382 . . . . 0.0 111.442 -178.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.883 ' N ' HD22 ' A' ' 112' ' ' LEU . 25.5 t -104.68 106.48 16.99 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.851 176.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.645 ' HB2' HD11 ' A' ' 112' ' ' LEU . 0.2 OUTLIER -167.29 122.02 1.04 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.981 0.42 . . . . 0.0 111.174 179.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 102.27 26.79 7.19 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.144 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.438 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 69.24 10.09 61.87 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.521 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -148.69 -177.64 5.9 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.981 0.419 . . . . 0.0 110.665 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.579 ' HE3' HG12 ' A' ' 111' ' ' VAL . 92.9 m95 -116.27 151.19 36.31 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.85 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.68 155.63 49.37 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.073 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.535 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.2 t0 69.49 42.07 0.22 Allowed Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 112.496 0.554 . . . . 0.0 112.496 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.535 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 74.2 Cg_endo -76.7 137.32 17.94 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.48 2.12 . . . . 0.0 111.941 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.591 ' HB2' HD23 ' A' ' 105' ' ' LEU . 57.2 Cg_endo -90.83 -172.97 0.55 Allowed 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 122.853 2.369 . . . . 0.0 113.408 -178.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.453 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.3 OUTLIER -132.36 -163.27 1.32 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.021 177.893 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 7.6 m -151.87 92.2 1.71 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.147 0.498 . . . . 0.0 111.164 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.734 ' HB2' HD11 ' A' ' 106' ' ' ILE . 10.1 mt-30 -118.06 164.74 14.67 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.514 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.557 HG22 ' O ' ' A' ' 126' ' ' ILE . 50.0 mm . . . . . 0 C--N 1.324 -0.523 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.946 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.897 0.379 . . . . 0.0 110.859 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.84 ' HD2' HG23 ' A' ' 25' ' ' VAL . 13.1 mtm180 -79.49 -169.01 1.74 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.755 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.463 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 19.6 m -89.35 162.06 38.13 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.826 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.41 170.18 16.75 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.413 2.075 . . . . 0.0 111.985 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.429 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 12.8 t -54.33 106.33 0.65 Allowed Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.226 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.468 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 3.4 Cg_exo -46.76 153.26 1.37 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 122.118 1.879 . . . . 0.0 112.045 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.703 ' O ' HD11 ' A' ' 20' ' ' LEU . 2.4 mtt85 -68.52 163.59 23.12 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.14 178.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.454 ' HA ' HD11 ' A' ' 20' ' ' LEU . 2.0 p30 -112.35 179.76 3.9 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-O 121.18 0.514 . . . . 0.0 112.129 -176.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.461 HG23 ' C ' ' A' ' 18' ' ' GLY . 7.3 tt -131.63 152.56 37.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.418 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -80.27 -62.34 1.71 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -177.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -94.57 31.07 1.85 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.867 -178.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.461 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -151.03 -179.98 27.22 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.197 -1.002 . . . . 0.0 113.498 -179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.411 ' N ' ' O ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -139.34 135.22 33.52 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.146 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.703 HD11 ' O ' ' A' ' 13' ' ' ARG . 2.6 mt -79.42 163.29 24.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.218 0.533 . . . . 0.0 111.799 -178.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -131.33 77.75 1.79 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.595 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.921 ' HA ' HG23 ' A' ' 31' ' ' ILE . 69.1 mt -69.63 104.51 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.018 -177.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -110.2 22.63 22.53 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.519 177.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 153.66 129.78 1.39 Allowed Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 -179.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.84 HG23 ' HD2' ' A' ' 8' ' ' ARG . 0.5 OUTLIER -121.33 0.97 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -178.665 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 27' ' ' PHE . 34.0 t0 -74.22 162.24 29.13 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.844 0.354 . . . . 0.0 110.952 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.88 ' CZ ' HD13 ' A' ' 51' ' ' LEU . 11.0 t80 -52.56 106.19 0.15 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.843 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 111.57 -0.08 27.7 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.765 -0.731 . . . . 0.0 113.046 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 82.9 p -77.24 178.99 6.64 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.971 0.385 . . . . 0.0 110.964 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 47' ' ' SER . 3.3 p -149.1 144.03 26.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.998 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.921 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -110.64 170.46 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.618 179.819 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.441 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -129.42 113.12 14.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.905 0.383 . . . . 0.0 111.31 179.482 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.673 ' CE2' HD22 ' A' ' 20' ' ' LEU . 15.8 m-85 -87.77 140.99 28.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.06 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.433 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 16.6 m -146.36 157.52 43.79 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.677 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.437 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 62.7 m -80.34 170.01 16.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.748 0.308 . . . . 0.0 110.647 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.09 -75.65 0.11 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.941 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.8 t -160.01 139.69 11.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.835 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 56.97 25.13 52.79 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.063 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.531 ' CD2' ' HA ' ' A' ' 68' ' ' SER . 2.3 m-85 -116.57 171.05 8.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.871 0.367 . . . . 0.0 111.051 -179.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.866 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -131.86 123.25 27.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.426 178.387 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.941 HD21 ' O ' ' A' ' 44' ' ' GLU . 4.7 tt -86.47 134.27 33.69 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.502 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.866 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.0 mm -112.97 156.98 13.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.02 0.438 . . . . 0.0 111.164 -179.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.4 -128.27 8.36 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.289 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.941 ' O ' HD21 ' A' ' 41' ' ' LEU . 1.5 pm0 -83.78 -173.7 4.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.792 0.329 . . . . 0.0 110.648 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.2 p -162.31 24.27 0.11 Allowed 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.159 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.441 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 13.2 mtpt -164.45 126.45 2.28 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.578 -177.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.455 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 1.9 t -94.06 137.85 32.8 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 176.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.552 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 2.6 m-85 -114.92 118.57 33.85 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 119.339 -0.944 . . . . 0.0 111.589 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 35.4 t -66.3 92.57 0.19 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.625 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.489 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 1.7 tt0 -123.86 172.12 9.15 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.518 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.88 HD13 ' CZ ' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -102.86 152.0 21.78 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.521 179.474 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.407 ' O ' ' N ' ' A' ' 54' ' ' THR . . . -171.1 -36.6 0.03 OUTLIER Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.279 -0.962 . . . . 0.0 113.237 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.458 ' CB ' ' HB3' ' A' ' 56' ' ' SER . 0.2 OUTLIER -65.73 72.72 0.06 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.034 0.445 . . . . 0.0 111.113 -179.17 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.407 ' N ' ' O ' ' A' ' 52' ' ' GLY . 2.1 p 49.94 28.26 2.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.258 179.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 114.92 2.2 22.31 Favored Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.708 -0.758 . . . . 0.0 113.129 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.458 ' HB3' ' CB ' ' A' ' 53' ' ' SER . 1.9 t -82.9 -159.4 0.33 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.773 0.32 . . . . 0.0 110.75 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.8 113.13 14.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.261 0.553 . . . . 0.0 110.4 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.442 ' N ' ' O ' ' A' ' 50' ' ' GLU . 0.9 OUTLIER -111.99 -175.23 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.432 -179.281 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.536 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 70.7 m95 -125.31 123.73 40.07 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.916 0.389 . . . . 0.0 111.263 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.552 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 2.7 m-20 -69.04 167.68 19.36 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.49 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 10.4 Cg_exo -7.39 89.86 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.008 1 C-N-CA 125.41 4.073 . . . . 0.0 114.796 -179.054 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.479 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 10.7 mt-10 -84.24 -92.58 0.08 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 114.779 -1.101 . . . . 0.0 112.386 -177.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.48 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -91.63 109.01 33.62 Favored Pre-proline 0 C--O 1.231 0.1 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -176.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.893 ' HG2' HD11 ' A' ' 41' ' ' LEU . 6.1 Cg_exo -79.39 -153.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.892 2.395 . . . . 0.0 111.113 177.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.515 HG22 ' H ' ' A' ' 66' ' ' CYS . 1.5 mm -93.95 168.94 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.859 0.361 . . . . 0.0 110.669 178.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.515 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.8 OUTLIER -170.35 138.69 1.6 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.945 179.759 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -162.44 173.86 13.51 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.625 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.531 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 54.1 p -79.07 113.64 17.36 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.301 0.572 . . . . 0.0 110.83 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.684 HG21 ' H ' ' A' ' 115' ' ' GLY . 30.9 m -39.2 100.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.282 -0.872 . . . . 0.0 112.425 -179.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 89' ' ' TYR . 0.3 OUTLIER -96.45 103.57 15.48 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.862 0.363 . . . . 0.0 110.719 178.027 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.94 121.91 35.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.049 179.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.459 ' CG ' ' N ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -69.15 -155.4 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.975 179.402 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.459 ' N ' ' CG ' ' A' ' 72' ' ' GLN . 1.2 t -50.77 142.21 16.79 Favored Pre-proline 0 N--CA 1.449 -0.511 0 CA-C-O 120.642 0.258 . . . . 0.0 110.823 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.496 ' HG2' HG11 ' A' ' 95' ' ' VAL . 26.8 Cg_exo -59.35 164.1 11.38 Favored 'Trans proline' 0 CA--C 1.528 0.198 0 C-N-CA 122.531 2.154 . . . . 0.0 111.936 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.521 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 89.6 Cg_exo -41.75 158.76 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.56 2.174 . . . . 0.0 112.572 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 83.5 p -109.24 88.6 2.77 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.528 179.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.645 HG23 ' HE2' ' A' ' 97' ' ' TYR . 15.9 pt -69.79 170.55 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.305 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.7 m -90.09 142.59 27.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.675 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.506 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 7.7 m-80 56.26 29.51 15.03 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.973 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.477 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -161.75 -171.18 27.48 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.27 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.413 ' N ' ' O ' ' A' ' 98' ' ' SER . 9.5 ptt180 -163.75 -175.33 4.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.971 0.415 . . . . 0.0 110.78 -179.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 1.7 p-80 -117.9 169.22 9.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.053 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -98.54 -84.27 0.4 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.691 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.43 ' HA3' ' OH ' ' A' ' 89' ' ' TYR . . . 63.99 147.54 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.667 -0.777 . . . . 0.0 113.007 178.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -112.02 -35.76 5.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.089 0.471 . . . . 0.0 110.705 179.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -97.05 -172.26 2.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.072 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.7 -23.72 14.57 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.194 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.434 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 7.0 m-85 -131.36 -179.94 5.66 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.434 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 72.5 m-85 -156.39 160.56 39.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.845 -179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 69' ' ' VAL . 6.7 p -142.63 -177.42 5.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.287 0.565 . . . . 0.0 112.324 -179.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 6.9 p-10 -50.03 94.62 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.489 -179.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 121.96 24.29 2.31 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.373 -0.83 . . . . 0.0 113.37 177.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -110.1 147.4 33.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 117.075 0.437 . . . . 0.0 110.782 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.517 HG22 ' N ' ' A' ' 95' ' ' VAL . 35.2 m -128.68 160.0 39.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.1 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.517 ' N ' HG22 ' A' ' 94' ' ' VAL . 21.5 t -151.8 148.6 14.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.479 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.9 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -108.01 126.02 52.22 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.228 0.537 . . . . 0.0 111.06 -179.608 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.955 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.6 m-85 -83.87 161.6 20.82 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.657 -178.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.432 ' HA ' HD13 ' A' ' 105' ' ' LEU . 14.8 p -155.24 138.66 15.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.348 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.453 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 73.9 m -69.98 158.39 35.71 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.794 179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.477 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 26.8 m-20 -92.0 -70.69 0.68 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.429 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.24 -22.83 67.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.323 -179.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 122.0 31.15 1.13 Allowed Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.63 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.506 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 19.9 m-85 -69.61 -175.55 0.87 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.038 0.447 . . . . 0.0 110.898 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.2 m -110.07 98.1 7.45 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.098 178.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.527 HD11 ' HB3' ' A' ' 97' ' ' TYR . 0.2 OUTLIER -48.77 132.48 17.97 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.555 0.693 . . . . 0.0 111.727 -177.834 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.445 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 38.2 mm -114.23 155.52 15.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.092 -178.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.41 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 68.59 23.88 75.32 Favored Glycine 0 C--N 1.328 0.103 0 C-N-CA 120.56 -0.828 . . . . 0.0 113.053 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.41 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.3 OUTLIER 60.37 136.66 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.295 0.569 . . . . 0.0 111.531 179.759 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.9 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.1 p -69.7 -24.13 63.53 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.765 -178.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -63.84 121.72 24.21 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.787 -179.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.955 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.7 t -122.14 141.8 41.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 178.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.895 HD22 ' N ' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -102.92 132.43 49.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.841 0.353 . . . . 0.0 111.505 -178.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.895 ' N ' HD22 ' A' ' 112' ' ' LEU . 41.4 t -104.6 104.59 14.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.034 177.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.798 ' OG ' HD11 ' A' ' 112' ' ' LEU . 12.4 p -165.93 119.27 1.13 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.922 0.391 . . . . 0.0 111.707 -179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.684 ' H ' HG21 ' A' ' 69' ' ' VAL . . . 102.33 20.98 11.18 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.686 179.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.489 ' N ' ' HB ' ' A' ' 69' ' ' VAL . . . 80.88 2.08 90.02 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.498 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -145.51 170.52 16.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.14 0.495 . . . . 0.0 111.317 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.521 ' CZ3' ' HB2' ' A' ' 113' ' ' CYS . 88.5 m95 -104.37 144.98 30.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.355 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.1 149.77 43.1 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.074 0.464 . . . . 0.0 111.491 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.499 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER 65.66 44.7 0.41 Allowed Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.196 178.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 56.3 Cg_endo -69.82 142.91 48.93 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.22 1.946 . . . . 0.0 111.467 178.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.508 ' HG2' ' CD2' ' A' ' 97' ' ' TYR . 71.1 Cg_endo -90.23 -172.84 0.6 Allowed 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.641 2.227 . . . . 0.0 113.768 -177.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.37 -158.44 0.87 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.652 178.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 2.3 m -155.76 89.16 1.15 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.089 0.471 . . . . 0.0 110.925 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -113.34 161.11 17.65 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.684 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.582 HG22 ' O ' ' A' ' 126' ' ' ILE . 21.9 mm . . . . . 0 C--N 1.323 -0.569 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.935 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.603 0.239 . . . . 0.0 110.773 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.426 ' CB ' HG23 ' A' ' 25' ' ' VAL . 0.1 OUTLIER 41.25 -162.08 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.946 0.403 . . . . 0.0 111.752 179.202 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.481 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 3.5 m -93.24 163.04 26.47 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.672 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -67.62 169.83 15.07 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.205 1.937 . . . . 0.0 111.407 179.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -49.03 105.1 0.46 Allowed Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.088 -179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.6 ' HB3' HD13 ' A' ' 31' ' ' ILE . 83.1 Cg_exo -38.42 146.35 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 122.657 2.238 . . . . 0.0 112.739 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.3 152.98 43.83 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.644 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.415 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 0.2 OUTLIER -101.18 -167.98 1.5 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.118 -178.701 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 19.1 tt -167.88 144.52 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.568 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.421 ' HB2' ' ND2' ' A' ' 17' ' ' ASN . 0.6 OUTLIER -94.28 160.43 14.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.743 177.566 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.421 ' ND2' ' HB2' ' A' ' 16' ' ' ASP . 0.3 OUTLIER 48.1 25.58 0.84 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.879 0.371 . . . . 0.0 110.638 -179.108 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -158.81 -173.91 27.83 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.615 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -132.14 -171.88 2.74 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.313 0.578 . . . . 0.0 111.787 -177.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.3 mt -140.25 139.28 35.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.465 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.422 ' CB ' ' HB ' ' A' ' 32' ' ' THR . 0.3 OUTLIER -118.07 73.56 0.91 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.851 179.109 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.763 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -82.75 94.21 3.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.947 -176.046 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.38 12.05 63.94 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.048 177.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 29' ' ' SER . . . 156.51 148.12 4.97 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.11 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.426 HG23 ' CB ' ' A' ' 8' ' ' ARG . 29.7 m -120.37 -1.01 8.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.424 ' HA ' ' HB3' ' A' ' 8' ' ' ARG . 0.7 OUTLIER -69.64 153.78 42.93 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.931 0.395 . . . . 0.0 111.224 -179.292 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -49.46 110.38 0.37 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.855 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 113.79 -9.16 23.61 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.423 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 24' ' ' GLY . 0.4 OUTLIER -72.73 178.44 4.17 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.845 0.323 . . . . 0.0 110.83 179.777 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 47' ' ' SER . 11.4 p -153.82 138.77 17.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.223 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.763 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -103.1 165.78 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.601 179.063 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.423 ' HA ' ' HG3' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -130.35 110.5 11.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.633 178.561 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.491 ' CE2' ' HA ' ' A' ' 63' ' ' ALA . 22.9 m-85 -83.2 146.95 28.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.132 -179.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.47 172.2 14.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.926 0.394 . . . . 0.0 111.425 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.444 ' HA ' ' HA2' ' A' ' 18' ' ' GLY . 1.7 m -96.13 156.7 16.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.497 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.423 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 3.6 m-20 -56.1 -85.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.15 -179.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.5 t -152.19 135.67 16.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.934 0.397 . . . . 0.0 110.719 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.439 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 61.51 24.29 63.74 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.865 -179.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.471 ' CG ' ' O ' ' A' ' 67' ' ' GLU . 2.3 m-85 -116.24 174.69 5.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.805 0.336 . . . . 0.0 110.802 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.806 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.6 OUTLIER -136.94 116.17 12.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.036 0.446 . . . . 0.0 110.478 178.241 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.917 HD21 ' O ' ' A' ' 44' ' ' GLU . 4.7 tt -77.37 124.62 28.11 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.638 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.806 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.7 mm -96.8 152.55 3.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.247 -179.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.09 -149.74 38.04 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.218 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.917 ' O ' HD21 ' A' ' 41' ' ' LEU . 4.3 pm0 -61.63 178.65 0.3 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.609 0.242 . . . . 0.0 110.582 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.0 p -152.38 21.44 0.64 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.374 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.423 ' HG3' ' HA ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -142.97 -174.6 4.23 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.226 0.536 . . . . 0.0 111.934 -178.299 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.456 ' O ' HG13 ' A' ' 31' ' ' ILE . 1.7 m -160.96 108.88 1.54 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.831 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -92.15 117.75 30.16 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.229 0.538 . . . . 0.0 111.839 -177.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.499 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 8.7 t -64.33 90.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.226 179.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.503 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -116.43 175.75 5.42 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.428 -179.51 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.503 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -88.55 145.56 25.65 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.235 -178.326 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -73.2 -112.11 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.475 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.1 t -128.11 -41.58 1.59 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.752 0.31 . . . . 0.0 111.091 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 43.0 p -92.07 49.23 1.5 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.096 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 55.97 33.87 61.04 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.444 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 46.9 t -106.2 -174.37 2.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.851 0.358 . . . . 0.0 111.03 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.29 146.31 41.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.11 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.9 m -152.04 -177.66 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.083 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.526 ' CE3' HD11 ' A' ' 31' ' ' ILE . 93.2 m95 -130.51 124.6 32.3 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.932 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -143.49 126.51 8.92 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.193 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.78 -162.28 2.13 Favored 'Cis proline' 0 C--N 1.351 0.703 0 C-N-CA 124.06 -1.225 . . . . 0.0 111.928 -0.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.488 ' O ' ' CZ ' ' A' ' 33' ' ' TYR . 4.3 pt-20 -112.25 -113.97 0.33 Allowed 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.401 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.491 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -118.92 86.84 32.06 Favored Pre-proline 0 N--CA 1.45 -0.472 0 C-N-CA 122.658 0.383 . . . . 0.0 110.462 -179.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.549 ' HG2' HD11 ' A' ' 41' ' ' LEU . 10.3 Cg_endo -48.58 -158.21 0.0 OUTLIER 'Trans proline' 0 N--CA 1.475 0.395 0 C-N-CA 123.863 3.042 . . . . 0.0 113.995 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.487 HG22 ' N ' ' A' ' 66' ' ' CYS . 5.0 mm -93.49 165.28 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.109 -177.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.487 ' N ' HG22 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -161.42 138.22 8.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.268 179.074 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.471 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 1.0 OUTLIER -162.22 -177.1 5.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.898 0.38 . . . . 0.0 111.168 -179.719 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.8 t -83.8 132.27 34.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.108 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -46.21 101.37 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.553 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.526 ' HE2' HG23 ' A' ' 90' ' ' THR . 0.2 OUTLIER -72.15 123.19 22.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.352 179.951 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.51 122.91 46.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.921 178.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -69.31 -156.28 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.373 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.544 ' HG ' ' CE1' ' A' ' 82' ' ' HIS . 1.8 t -52.95 145.6 22.28 Favored Pre-proline 0 N--CA 1.45 -0.426 0 CA-C-O 120.633 0.254 . . . . 0.0 110.377 179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.464 ' HG2' HG11 ' A' ' 95' ' ' VAL . 23.4 Cg_exo -62.62 165.33 16.01 Favored 'Trans proline' 0 CA--C 1.528 0.222 0 C-N-CA 122.48 2.12 . . . . 0.0 112.155 -179.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.518 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 81.2 Cg_exo -43.65 160.6 0.07 OUTLIER 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.713 2.275 . . . . 0.0 112.87 -179.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 86.7 p -108.29 90.16 3.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.497 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.692 HG23 ' HE2' ' A' ' 97' ' ' TYR . 14.1 pt -69.24 175.22 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.243 -178.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 11.4 p -96.21 143.41 27.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.717 179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.514 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 5.3 m-80 55.42 30.23 14.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.925 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.439 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -167.41 -170.26 32.01 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.53 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.97 -176.71 4.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.035 0.445 . . . . 0.0 111.091 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.544 ' CE1' ' HG ' ' A' ' 73' ' ' SER . 3.4 p80 -108.37 173.26 6.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.117 -179.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -103.99 -85.45 0.46 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.66 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.43 ' H ' HG13 ' A' ' 95' ' ' VAL . . . 60.91 141.58 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.901 179.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -110.82 -31.44 7.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.048 0.451 . . . . 0.0 110.602 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.93 -171.91 2.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.741 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -105.05 -14.98 15.23 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.528 -179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.434 ' HB3' ' HD3' ' A' ' 70' ' ' LYS . 6.4 m-85 -140.58 177.87 7.72 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.866 0.365 . . . . 0.0 111.521 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.425 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 69.2 m-85 -156.77 165.85 35.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.809 -179.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.526 HG23 ' HE2' ' A' ' 70' ' ' LYS . 19.1 p -149.37 -175.78 5.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.029 0.442 . . . . 0.0 111.62 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 3.8 p30 -52.86 94.42 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.444 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.14 22.63 2.34 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.273 -0.876 . . . . 0.0 113.13 178.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.401 ' HB2' ' HB3' ' A' ' 89' ' ' TYR . 0.9 OUTLIER -110.21 145.83 36.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.951 0.375 . . . . 0.0 110.789 179.104 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 32.7 m -128.58 155.61 40.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.067 0.461 . . . . 0.0 111.249 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.509 HG23 ' CH2' ' A' ' 118' ' ' TRP . 20.7 t -146.54 146.57 18.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.11 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.802 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -101.4 134.22 44.82 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.827 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.911 ' CE1' HG21 ' A' ' 111' ' ' VAL . 5.0 m-85 -95.39 158.83 15.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.915 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 77.1 p -153.0 140.33 19.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.376 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.431 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 68.8 m -71.04 152.46 43.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.891 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.411 ' CG ' ' N ' ' A' ' 101' ' ' SER . 1.5 p30 -92.54 -55.14 3.5 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 121.419 0.628 . . . . 0.0 111.434 -178.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.411 ' N ' ' CG ' ' A' ' 100' ' ' ASN . 22.4 t -73.98 -14.75 61.08 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.041 -0.981 . . . . 0.0 111.757 -178.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 111.24 24.68 5.32 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.005 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.514 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 30.8 m-85 -69.46 -172.95 0.51 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.855 0.36 . . . . 0.0 110.817 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.1 105.78 15.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.156 -179.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.639 HD23 ' HB2' ' A' ' 122' ' ' PRO . 3.1 tp -44.85 113.52 0.57 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.07 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.453 ' HB ' ' CB ' ' A' ' 123' ' ' THR . 30.6 mm -87.13 157.07 3.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.471 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.438 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 58.69 -131.17 51.92 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.438 -0.887 . . . . 0.0 111.767 -178.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.27 126.28 52.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.771 0.32 . . . . 0.0 110.746 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.802 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.4 t -57.63 -28.45 63.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.045 0.45 . . . . 0.0 110.242 178.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.9 132.2 15.13 Favored Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.688 -0.687 . . . . 0.0 112.558 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.911 HG21 ' CE1' ' A' ' 97' ' ' TYR . 6.0 t -125.52 126.83 71.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 110.422 -0.214 . . . . 0.0 110.422 178.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.93 HD22 ' N ' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -81.14 135.52 35.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.889 0.376 . . . . 0.0 111.48 -178.567 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.93 ' N ' HD22 ' A' ' 112' ' ' LEU . 39.3 t -108.28 108.04 18.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.051 177.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.711 ' HB2' HD11 ' A' ' 112' ' ' LEU . 0.2 OUTLIER -164.01 129.67 2.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.868 0.366 . . . . 0.0 111.259 -179.806 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 86.38 31.04 20.45 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.076 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 63.16 19.88 62.17 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.018 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -145.53 178.2 8.3 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.104 0.478 . . . . 0.0 111.15 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.528 ' CZ3' ' HB2' ' A' ' 113' ' ' CYS . 92.7 m95 -121.7 145.29 48.17 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.795 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.578 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.6 OUTLIER -125.52 167.02 15.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.991 0.424 . . . . 0.0 111.658 -179.095 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.44 ' N ' ' HD3' ' A' ' 121' ' ' PRO . 6.6 p-10 46.69 52.56 12.06 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.171 179.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.44 ' HD3' ' N ' ' A' ' 120' ' ' ASP . 93.2 Cg_endo -81.28 143.94 14.26 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.666 2.244 . . . . 0.0 111.634 177.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.639 ' HB2' HD23 ' A' ' 105' ' ' LEU . 73.5 Cg_endo -91.23 -172.29 0.46 Allowed 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 122.877 2.385 . . . . 0.0 113.856 -177.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.453 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -138.66 -174.7 3.9 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.101 178.321 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . 0.424 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 11.9 m -141.11 96.98 3.08 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.026 0.441 . . . . 0.0 111.097 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.429 ' HB2' HD11 ' A' ' 106' ' ' ILE . 20.6 mt-30 -122.54 167.51 13.28 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.863 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.497 HG12 ' CE2' ' A' ' 103' ' ' TYR . 13.0 mm . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.935 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.906 0.384 . . . . 0.0 111.23 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.543 ' HD2' HG23 ' A' ' 25' ' ' VAL . 17.4 mtm180 -106.17 -177.74 3.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.758 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.528 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 69.6 m -77.31 175.86 4.09 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.545 ' HD2' ' CD1' ' A' ' 59' ' ' TRP . 37.9 Cg_endo -91.24 176.29 2.2 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.427 2.084 . . . . 0.0 111.932 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.0 t -53.41 105.6 0.55 Allowed Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.294 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.49 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 51.5 Cg_exo -52.94 142.2 53.66 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.037 1.825 . . . . 0.0 111.804 -179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.945 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -49.03 120.8 4.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.925 0.869 . . . . 0.0 111.512 -178.852 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.747 ' O ' HG22 ' A' ' 15' ' ' ILE . 6.1 p-10 -59.16 -32.09 69.56 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 113.509 -1.678 . . . . 0.0 112.694 -177.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.747 HG22 ' O ' ' A' ' 14' ' ' ASP . 8.6 tt 58.36 142.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 114.271 -1.331 . . . . 0.0 111.208 -175.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.98 160.41 14.89 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.0 178.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.494 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 0.3 OUTLIER 50.47 24.07 1.48 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.017 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -154.06 177.61 31.4 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.659 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.43 142.26 39.52 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.74 0.305 . . . . 0.0 110.506 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.945 HD11 ' O ' ' A' ' 13' ' ' ARG . 72.2 mt -89.51 155.67 19.14 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.167 0.508 . . . . 0.0 111.718 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.412 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 11.1 t0 -124.73 72.91 1.24 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.514 -0.767 . . . . 0.0 109.38 177.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.879 ' HA ' HG23 ' A' ' 31' ' ' ILE . 1.2 mt -76.1 105.71 5.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.992 -176.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.62 13.56 57.99 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.734 176.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 157.19 133.29 1.58 Allowed Glycine 0 C--N 1.335 0.5 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.021 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.543 HG23 ' HD2' ' A' ' 8' ' ' ARG . 15.0 m -112.41 9.01 8.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -179.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -72.82 156.25 39.09 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.836 0.351 . . . . 0.0 111.331 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.598 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 8.4 t80 -54.94 91.45 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.867 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 49' ' ' CYS . . . 130.57 -18.25 5.19 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.456 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.5 p -57.24 -173.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.73 0.3 . . . . 0.0 110.863 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 47' ' ' SER . 81.2 p -150.94 150.85 31.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.25 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.879 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -121.44 167.0 15.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.766 179.493 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.412 ' HB ' ' HB3' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -129.85 108.45 10.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.618 178.243 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.436 ' CE1' ' HA ' ' A' ' 63' ' ' ALA . 33.4 m-85 -84.59 143.12 29.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.154 -179.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -152.04 157.08 41.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.198 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 21.3 m -83.8 161.56 20.9 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.851 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.465 ' ND2' ' HA ' ' A' ' 17' ' ' ASN . 1.2 p30 -55.7 -89.43 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.238 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.8 t -152.08 136.34 16.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.815 0.34 . . . . 0.0 110.524 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.73 17.76 63.09 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.233 -178.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.494 ' CE2' ' HB3' ' A' ' 17' ' ' ASN . 2.1 m-85 -106.87 -173.34 2.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.729 0.299 . . . . 0.0 110.782 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.896 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -147.05 112.46 5.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.983 0.42 . . . . 0.0 110.808 178.86 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.954 HD21 ' O ' ' A' ' 44' ' ' GLU . 2.1 tt -78.72 125.47 29.41 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.363 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.896 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.9 mm -98.47 167.55 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.049 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.532 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 67.03 -130.02 29.84 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.477 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.954 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.8 OUTLIER -83.47 -179.23 7.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.798 0.332 . . . . 0.0 110.925 179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.438 ' HA ' ' HG2' ' A' ' 64' ' ' PRO . 3.0 t -154.98 25.44 0.43 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.924 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -150.14 168.72 23.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.245 -179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.444 ' O ' HG13 ' A' ' 31' ' ' ILE . 2.6 m -149.56 120.27 7.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.374 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -103.46 116.2 31.96 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.16 0.505 . . . . 0.0 111.193 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.411 ' O ' ' N ' ' A' ' 28' ' ' GLY . 53.6 t -59.16 100.87 0.08 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.098 179.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.28 -170.96 2.07 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.37 -178.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.598 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -101.92 146.2 28.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.848 -179.716 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.45 ' N ' HG22 ' A' ' 58' ' ' VAL . . . -74.47 -145.21 1.01 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.577 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 6.5 m -93.19 -37.88 11.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.755 0.312 . . . . 0.0 111.049 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.8 p -95.74 41.41 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.275 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 63.71 19.82 63.32 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.825 179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.24 -161.45 0.59 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.763 0.316 . . . . 0.0 110.752 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -123.88 133.8 53.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.601 179.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.45 HG22 ' N ' ' A' ' 52' ' ' GLY . 1.1 m -144.19 -178.45 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.98 0.419 . . . . 0.0 111.333 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.668 ' CE3' HD11 ' A' ' 31' ' ' ILE . 94.1 m95 -121.03 122.97 41.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.527 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -138.67 118.73 9.71 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.426 -178.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -73.14 -170.53 7.7 Favored 'Cis proline' 0 C--N 1.351 0.663 0 C-N-CA 124.094 -1.211 . . . . 0.0 112.003 -0.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -110.89 -154.66 0.54 Allowed 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.708 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.454 ' HB2' ' HB3' ' A' ' 13' ' ' ARG . . . -72.62 111.84 12.73 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.582 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.438 ' HG2' ' HA ' ' A' ' 45' ' ' SER . 15.2 Cg_exo -69.78 -150.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.628 2.219 . . . . 0.0 112.452 -178.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.501 HG22 ' H ' ' A' ' 66' ' ' CYS . 5.1 mm -100.39 165.73 2.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.6 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.501 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.3 m -161.62 137.12 7.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.589 179.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.473 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.2 OUTLIER -163.33 176.62 9.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.931 0.396 . . . . 0.0 110.965 179.784 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.49 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 12.2 p -94.4 117.37 30.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.917 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.419 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 2.3 p -41.14 93.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.609 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 68' ' ' SER . 0.1 OUTLIER -70.47 121.49 17.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.66 -178.758 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.402 ' N ' ' O ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -104.75 115.49 30.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.695 177.487 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.409 ' CG ' ' N ' ' A' ' 73' ' ' SER . 0.7 OUTLIER -69.95 -157.99 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.792 -179.504 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.437 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 1.6 t -47.33 136.68 9.07 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.237 -179.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.477 ' HG2' HG11 ' A' ' 95' ' ' VAL . 35.3 Cg_exo -58.85 162.03 14.11 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.39 2.06 . . . . 0.0 111.797 179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.509 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 80.5 Cg_exo -39.96 156.89 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.764 2.31 . . . . 0.0 112.834 -179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.9 t -108.15 89.19 2.92 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.641 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.651 HG23 ' HE2' ' A' ' 97' ' ' TYR . 26.3 pt -69.81 174.59 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.413 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.8 p -97.67 138.79 34.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.912 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.465 ' HB3' ' CE1' ' A' ' 103' ' ' TYR . 0.1 OUTLIER 66.7 27.07 9.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.79 179.458 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.438 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . -172.71 -165.48 29.8 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.897 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 11.1 ptt180 -167.37 -175.26 2.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.873 0.368 . . . . 0.0 110.593 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.437 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 6.1 p80 -105.12 173.46 6.3 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.082 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -99.91 -84.28 0.42 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.45 179.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.472 ' H ' HG13 ' A' ' 95' ' ' VAL . . . 60.96 150.5 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.779 -0.724 . . . . 0.0 113.068 178.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -112.87 -33.87 5.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.079 0.466 . . . . 0.0 110.634 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.76 -172.47 2.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.991 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -102.95 -23.41 13.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.016 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.433 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 6.5 m-85 -129.96 175.51 8.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.722 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.433 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 60.9 m-85 -151.4 164.04 37.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.866 0.365 . . . . 0.0 111.041 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.443 HG22 ' OG ' ' A' ' 68' ' ' SER . 8.4 p -130.45 168.56 16.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.119 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 0.9 OUTLIER -54.72 94.76 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.289 0.566 . . . . 0.0 110.886 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 129.88 26.76 0.83 Allowed Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.258 -0.883 . . . . 0.0 113.216 178.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -110.08 162.27 14.72 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.915 0.358 . . . . 0.0 110.697 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 33.9 m -135.58 154.99 35.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.099 0.476 . . . . 0.0 111.301 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.546 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 20.8 t -150.85 147.49 15.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.823 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.98 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -105.5 133.05 50.89 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.74 179.436 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.977 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.9 m-85 -91.53 159.29 16.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.169 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.546 ' HA ' HD13 ' A' ' 105' ' ' LEU . 62.8 m -157.72 149.62 22.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.052 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.438 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 58.0 m -79.09 159.37 27.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.13 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -83.1 -68.52 0.7 Allowed 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.632 -178.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.5 -26.17 61.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.383 -178.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.2 37.7 0.45 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.521 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.465 ' CE1' ' HB3' ' A' ' 79' ' ' ASN . 11.2 m-85 -69.78 -173.67 0.64 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.852 0.358 . . . . 0.0 110.35 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.3 m -107.95 98.89 8.4 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.079 178.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.546 HD13 ' HA ' ' A' ' 98' ' ' SER . 0.3 OUTLIER -47.94 126.92 11.36 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 121.623 0.725 . . . . 0.0 111.697 -177.881 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.455 ' HB ' ' CB ' ' A' ' 123' ' ' THR . 31.4 mm -90.6 152.02 3.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.079 179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 61.11 -136.53 48.28 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.016 -179.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -112.14 137.59 50.0 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.945 0.403 . . . . 0.0 111.348 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.98 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.6 p -68.06 -26.53 65.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.78 179.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -72.39 139.46 27.93 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.968 -0.634 . . . . 0.0 113.014 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.977 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.5 t -135.21 127.89 48.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.533 0.206 . . . . 0.0 110.56 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.06 126.2 34.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.968 0.414 . . . . 0.0 111.804 -178.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.504 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 13.4 t -90.41 101.2 13.94 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 176.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.1 OUTLIER -143.67 160.83 39.99 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.065 0.459 . . . . 0.0 111.411 -178.181 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.0 30.53 5.19 Favored Glycine 0 N--CA 1.453 -0.232 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.665 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.419 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 68.72 19.19 72.96 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.199 -179.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -144.47 179.51 7.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.777 0.322 . . . . 0.0 110.512 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.546 ' CZ3' HG23 ' A' ' 95' ' ' VAL . 92.7 m95 -115.84 152.24 33.73 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.978 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.41 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -133.67 156.34 48.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.234 -179.413 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.489 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER 61.83 46.5 0.96 Allowed Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.881 179.109 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 96.0 Cg_endo -78.36 137.16 14.72 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.421 2.081 . . . . 0.0 111.577 178.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.54 ' O ' HG21 ' A' ' 77' ' ' ILE . 73.4 Cg_endo -91.94 -173.91 0.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 122.587 2.191 . . . . 0.0 113.545 -178.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.611 HG22 HE22 ' A' ' 125' ' ' GLN . 0.3 OUTLIER -129.17 -171.6 2.53 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.29 177.405 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 5.0 m -144.74 88.37 1.91 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.069 0.461 . . . . 0.0 110.325 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.611 HE22 HG22 ' A' ' 123' ' ' THR . 2.0 mp0 -118.11 -179.04 3.65 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.519 -178.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 32.3 mm . . . . . 0 C--N 1.321 -0.657 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.92 -179.612 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.865 0.364 . . . . 0.0 110.894 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 8.1 mtm180 -60.29 176.79 0.31 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.004 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.479 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 28.9 m -91.09 159.85 38.86 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.077 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -72.0 168.65 23.38 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.661 2.241 . . . . 0.0 111.992 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 9.0 t -49.39 103.79 0.39 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.733 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -63.58 157.76 49.52 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.276 1.984 . . . . 0.0 112.051 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.752 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -51.23 -179.55 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.319 179.23 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.745 ' O ' HG22 ' A' ' 15' ' ' ILE . 0.1 OUTLIER -140.62 -7.58 1.12 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -178.057 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.745 HG22 ' O ' ' A' ' 14' ' ' ASP . 15.1 tt 56.87 142.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-O 121.223 0.535 . . . . 0.0 111.603 -177.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -81.33 -52.61 7.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.602 -178.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.46 ' N ' ' ND2' ' A' ' 17' ' ' ASN . 0.4 OUTLIER -93.07 45.55 1.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.892 0.377 . . . . 0.0 110.922 -178.419 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 176.48 179.99 47.21 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.51 -0.853 . . . . 0.0 113.249 179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -138.44 143.08 39.52 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.826 HD13 ' CZ ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -93.63 168.93 10.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.08 0.467 . . . . 0.0 111.125 -179.019 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -126.1 91.73 3.44 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.843 178.021 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.865 ' HA ' HG23 ' A' ' 31' ' ' ILE . 5.4 mm -68.46 107.08 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.829 -176.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -114.24 22.76 13.37 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.602 177.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 149.67 124.35 1.28 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 121.068 -0.587 . . . . 0.0 111.945 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.8 m -120.54 38.24 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.871 0.367 . . . . 0.0 111.261 -179.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.428 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.4 OUTLIER -111.25 150.36 29.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.6 179.302 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.561 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 8.0 t80 -49.05 91.91 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.896 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 130.27 -0.36 5.59 Favored Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.764 -0.732 . . . . 0.0 113.021 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -92.17 -168.41 1.99 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 117.038 0.419 . . . . 0.0 110.54 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.6 p -160.63 146.88 15.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.064 0.459 . . . . 0.0 111.27 179.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.865 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.6 OUTLIER -105.02 170.42 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.34 179.625 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -124.36 112.61 17.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.902 0.382 . . . . 0.0 111.09 179.073 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.826 ' CZ ' HD13 ' A' ' 20' ' ' LEU . 12.3 m-85 -87.04 142.5 27.88 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.602 -179.22 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.7 m -149.78 159.22 44.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.525 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 16.5 m -77.79 172.9 12.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.814 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -75.4 -83.87 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.262 -179.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.2 t -150.11 137.56 19.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.628 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.461 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 59.34 25.57 60.55 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.909 -179.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.515 ' CE1' ' HB3' ' A' ' 68' ' ' SER . 2.4 m-85 -116.16 168.74 9.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.805 0.336 . . . . 0.0 110.875 -179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.816 ' CE1' HD11 ' A' ' 42' ' ' ILE . 1.2 p80 -133.74 113.66 12.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.057 177.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.939 HD11 ' HG2' ' A' ' 64' ' ' PRO . 8.3 tt -76.11 135.48 39.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.773 -178.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.816 HD11 ' CE1' ' A' ' 40' ' ' HIS . 1.9 mm -113.89 153.44 15.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.099 0.476 . . . . 0.0 111.16 -179.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.17 -137.48 18.52 Favored Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.658 -0.701 . . . . 0.0 112.135 -179.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.782 ' O ' HD21 ' A' ' 41' ' ' LEU . 2.0 pt-20 -80.61 -178.04 6.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.044 0.449 . . . . 0.0 110.879 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.6 p -158.46 24.79 0.24 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.891 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.416 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 1.6 mtmt -150.73 124.87 9.35 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -177.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.443 ' HB3' HG13 ' A' ' 31' ' ' ILE . 1.7 t -92.51 146.95 23.28 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.593 177.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.525 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.1 m-85 -120.74 113.51 20.3 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 119.139 -1.024 . . . . 0.0 111.683 178.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.409 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 18.7 t -63.74 95.19 0.1 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.154 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -118.47 -171.28 2.05 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.381 -178.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.561 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -97.2 148.19 23.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.031 -179.423 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.415 ' N ' HG22 ' A' ' 58' ' ' VAL . . . -81.35 -144.8 4.41 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.437 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.3 m -85.43 -47.37 10.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.902 0.382 . . . . 0.0 110.905 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.0 p -91.23 47.4 1.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.843 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 51.37 29.14 22.4 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.416 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -89.82 -168.2 2.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.855 0.36 . . . . 0.0 111.007 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.94 133.86 51.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.55 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.415 HG22 ' N ' ' A' ' 52' ' ' GLY . 0.8 OUTLIER -148.15 -179.35 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.036 -179.736 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.539 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 78.9 m95 -128.42 122.11 30.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.388 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.525 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -69.11 167.02 23.02 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.82 178.466 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.451 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 84.9 Cg_exo -18.7 93.01 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 125.096 3.864 . . . . 0.0 114.198 -179.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.411 ' CB ' ' OG ' ' A' ' 47' ' ' SER . 0.0 OUTLIER -97.32 -78.79 0.47 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.879 -177.672 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.471 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -75.05 108.4 5.41 Favored Pre-proline 0 C--N 1.33 -0.243 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -176.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.939 ' HG2' HD11 ' A' ' 41' ' ' LEU . 3.5 Cg_endo -87.95 -156.73 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.307 2.671 . . . . 0.0 111.028 177.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.662 HD12 ' HB ' ' A' ' 42' ' ' ILE . 1.1 mt -89.2 174.99 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.844 0.354 . . . . 0.0 110.662 178.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.621 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.7 OUTLIER -171.16 145.91 2.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.891 179.45 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.401 ' HB3' ' CD2' ' A' ' 40' ' ' HIS . 31.2 tt0 -160.44 163.15 33.25 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.924 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.515 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 1.4 p -92.82 118.9 31.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.229 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.52 HG13 ' OD2' ' A' ' 91' ' ' ASP . 1.0 OUTLIER -55.14 93.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.861 179.194 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.401 ' CG ' ' O ' ' A' ' 89' ' ' TYR . 1.3 tttt -77.77 135.91 38.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.897 0.38 . . . . 0.0 111.26 -179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.431 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -106.64 121.78 45.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.143 178.458 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -69.41 -161.41 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.608 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.418 ' OG ' ' NE2' ' A' ' 82' ' ' HIS . 2.7 t -50.07 137.9 19.96 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.653 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.435 ' HA ' ' CD1' ' A' ' 118' ' ' TRP . 39.6 Cg_exo -57.61 159.13 17.64 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.242 1.961 . . . . 0.0 111.908 -179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.504 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 93.7 Cg_exo -42.54 156.88 0.09 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.653 2.235 . . . . 0.0 112.712 -178.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 75.8 p -106.9 89.13 2.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.789 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.603 HG23 ' HE2' ' A' ' 97' ' ' TYR . 33.8 pt -69.72 169.91 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.179 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -92.44 137.44 32.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.731 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.495 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 0.4 OUTLIER 65.05 29.18 12.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.71 -179.788 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -169.43 -167.4 29.94 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.462 -0.875 . . . . 0.0 112.959 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.2 ptt85 -170.18 -174.49 1.75 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.016 0.436 . . . . 0.0 110.462 -179.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 7.5 p80 -108.09 172.43 6.84 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.056 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.417 ' ND2' ' O ' ' A' ' 96' ' ' THR . 63.1 m-20 -107.75 8.75 29.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.539 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -50.62 134.77 29.82 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.341 -0.933 . . . . 0.0 112.604 -179.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -105.68 -26.93 11.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.057 0.456 . . . . 0.0 110.611 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -86.27 -172.59 4.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.601 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.62 -23.06 11.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.952 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.416 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 12.2 m-85 -137.72 169.95 16.9 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.066 0.46 . . . . 0.0 111.308 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.431 ' N ' ' O ' ' A' ' 71' ' ' CYS . 37.7 m-85 -147.03 169.59 18.9 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.761 179.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.1 p -134.21 175.11 9.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.998 0.428 . . . . 0.0 111.647 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.52 ' OD2' HG13 ' A' ' 69' ' ' VAL . 1.3 m-20 -60.25 99.13 0.07 Allowed 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.445 0.641 . . . . 0.0 111.021 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.45 23.36 1.93 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 114.917 -1.038 . . . . 0.0 113.005 178.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.416 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -108.35 161.56 14.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.81 0.338 . . . . 0.0 110.583 179.066 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.489 HG22 ' N ' ' A' ' 95' ' ' VAL . 32.7 m -138.57 157.62 30.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.079 0.466 . . . . 0.0 111.313 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.493 HG23 ' CH2' ' A' ' 118' ' ' TRP . 18.8 t -151.13 148.61 14.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.555 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.776 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -105.3 131.91 52.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.397 179.203 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.958 ' CE1' HG21 ' A' ' 111' ' ' VAL . 3.6 m-85 -89.25 159.31 17.49 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.052 -178.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.7 m -150.22 133.35 16.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.954 0.407 . . . . 0.0 111.567 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.444 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 74.7 m -69.81 162.67 27.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.745 179.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -96.81 -84.51 0.36 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.928 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -45.31 -27.38 0.65 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.529 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 124.9 36.0 0.61 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.465 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.495 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 18.9 m-85 -75.52 -173.74 2.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.939 0.399 . . . . 0.0 110.915 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.44 107.45 16.23 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.962 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.514 HD22 ' HA ' ' A' ' 109' ' ' SER . 1.1 tp -46.44 118.74 2.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.163 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.526 HG22 ' N ' ' A' ' 107' ' ' GLY . 45.2 mm -104.59 160.8 4.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.883 -179.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.526 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 52.07 38.44 47.66 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.416 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.419 ' ND2' ' O ' ' A' ' 107' ' ' GLY . 8.1 p30 51.58 124.18 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.773 0 C-N-CA 123.9 0.88 . . . . 0.0 112.693 179.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.776 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.3 p -56.03 -27.45 53.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.402 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.59 136.06 49.29 Favored Glycine 0 CA--C 1.518 0.239 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.843 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.958 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.2 t -136.61 130.2 46.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 179.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.27 125.37 37.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.92 0.391 . . . . 0.0 111.826 -178.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.498 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 16.7 t -87.32 107.88 18.71 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 175.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 7.0 t -154.95 166.98 31.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.988 -178.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 45.54 33.16 4.38 Favored Glycine 0 CA--C 1.516 0.146 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.692 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.453 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 64.83 19.41 65.36 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.565 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -149.32 -177.77 6.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.933 0.397 . . . . 0.0 110.989 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.504 ' CD1' ' HD3' ' A' ' 75' ' ' PRO . 94.8 m95 -113.27 126.26 55.2 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.87 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.19 145.84 33.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.261 -179.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.495 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.9 OUTLIER 69.3 44.84 0.26 Allowed Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.123 178.84 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 57.0 Cg_endo -70.14 140.27 40.85 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.166 1.911 . . . . 0.0 111.243 178.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.504 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 94.7 Cg_endo -89.53 -170.58 0.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.624 2.216 . . . . 0.0 113.798 -177.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -140.58 -172.07 3.36 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.511 -1.222 . . . . 0.0 110.001 178.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . 0.403 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 11.8 m -142.37 95.72 2.84 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.007 0.432 . . . . 0.0 110.907 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -128.52 156.85 42.63 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.973 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.494 HG12 ' CE2' ' A' ' 103' ' ' TYR . 25.6 mm . . . . . 0 C--N 1.323 -0.544 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.011 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.0 mtm-85 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.938 0.399 . . . . 0.0 111.73 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.446 ' CB ' ' HA ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -93.29 171.08 9.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.435 178.627 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.449 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 98.3 m -78.6 156.97 77.74 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.203 -179.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.444 ' HD3' ' HB2' ' A' ' 57' ' ' MET . 60.4 Cg_endo -71.77 177.44 6.94 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.81 2.34 . . . . 0.0 112.533 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.3 p -48.91 104.67 0.43 Allowed Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.896 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.459 ' HG2' ' CD1' ' A' ' 22' ' ' ILE . 71.6 Cg_exo -42.71 143.78 1.56 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.396 2.064 . . . . 0.0 112.323 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.569 ' O ' HD11 ' A' ' 20' ' ' LEU . 10.1 mtt180 -58.9 152.37 19.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.056 178.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.539 ' HA ' HD11 ' A' ' 20' ' ' LEU . 1.7 p30 -105.96 178.76 4.47 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-O 121.338 0.59 . . . . 0.0 112.542 -175.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 6.0 tt -138.86 147.79 24.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.033 178.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -82.58 -56.2 4.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.779 -177.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.411 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 0.4 OUTLIER -94.48 27.11 3.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.198 -178.303 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.412 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -149.34 -178.65 24.53 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.383 -0.913 . . . . 0.0 113.297 -179.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -139.13 132.16 29.54 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 110.197 -0.298 . . . . 0.0 110.197 178.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.569 HD11 ' O ' ' A' ' 13' ' ' ARG . 3.6 mt -76.89 160.78 28.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.203 0.525 . . . . 0.0 111.897 -178.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.437 ' HB3' ' CB ' ' A' ' 32' ' ' THR . 17.3 t70 -130.44 74.29 1.59 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.515 177.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.857 ' HA ' HG23 ' A' ' 31' ' ' ILE . 73.2 mt -72.96 101.45 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.975 -0.557 . . . . 0.0 112.017 -177.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.54 20.72 48.45 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.543 176.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.02 145.42 4.16 Favored Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 -179.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.42 ' O ' ' HB2' ' A' ' 8' ' ' ARG . 16.6 m -124.83 -6.79 6.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -178.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.446 ' HA ' ' CB ' ' A' ' 8' ' ' ARG . 9.1 m-20 -69.8 156.03 39.65 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.931 0.396 . . . . 0.0 111.698 -178.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.74 ' HZ ' HD13 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -48.17 101.48 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.514 178.923 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 119.05 -15.5 11.01 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.441 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.4 m -63.47 166.87 6.07 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.794 0.297 . . . . 0.0 110.293 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 47' ' ' SER . 12.4 p -137.05 147.1 45.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.082 0.467 . . . . 0.0 111.682 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.857 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.4 OUTLIER -113.07 173.77 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.793 -179.807 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.505 HG23 ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -141.99 106.77 4.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.016 178.645 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.557 ' CE1' HD22 ' A' ' 20' ' ' LEU . 20.9 m-85 -76.59 142.37 40.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.043 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.412 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 1.5 m -141.05 165.38 27.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.543 179.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.445 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 2.3 m -88.56 165.4 14.86 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.766 0.317 . . . . 0.0 110.768 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -64.78 -84.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.06 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.6 m -153.93 133.45 12.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.728 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.4 ' HA3' ' CB ' ' A' ' 91' ' ' ASP . . . 63.28 24.59 67.52 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.937 -178.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.509 ' CE1' ' HB3' ' A' ' 68' ' ' SER . 2.6 m-85 -116.72 171.48 7.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.859 0.361 . . . . 0.0 110.906 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.81 ' CE1' HD11 ' A' ' 42' ' ' ILE . 1.0 OUTLIER -134.57 116.17 14.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.624 178.173 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.954 HD21 ' O ' ' A' ' 44' ' ' GLU . 4.6 tt -74.24 127.64 33.49 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.606 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.81 HD11 ' CE1' ' A' ' 40' ' ' HIS . 3.1 mm -100.94 151.24 5.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.836 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.45 -140.03 23.9 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.691 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.954 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -70.68 175.38 4.97 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.948 0.404 . . . . 0.0 110.997 179.857 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.431 ' HA ' ' HG2' ' A' ' 64' ' ' PRO . 0.4 OUTLIER -157.77 26.84 0.27 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.296 179.289 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.505 ' HG2' HG23 ' A' ' 32' ' ' THR . 6.6 mtpt -149.97 151.84 33.99 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.998 -179.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.417 ' OG ' ' HB ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -132.25 143.12 49.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.125 179.51 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.511 ' CE2' ' HD3' ' A' ' 61' ' ' PRO . 2.7 m-85 -117.0 125.8 51.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.176 0.512 . . . . 0.0 111.892 -178.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.515 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 24.4 t -73.91 117.13 15.34 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.695 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.495 ' HA ' ' CE2' ' A' ' 27' ' ' PHE . 12.9 tt0 -160.38 167.58 27.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.424 0.631 . . . . 0.0 111.016 178.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.74 HD13 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -82.86 139.95 33.18 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.433 -178.733 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.507 ' N ' HG22 ' A' ' 58' ' ' VAL . . . 177.87 76.29 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.43 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.406 ' HB3' ' HB3' ' A' ' 56' ' ' SER . 23.0 t -176.04 58.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.931 0.396 . . . . 0.0 110.609 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.2 p 63.61 13.97 7.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.131 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 121.01 33.78 0.95 Allowed Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.604 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.406 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 0.2 OUTLIER -132.07 -174.13 3.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.116 0.484 . . . . 0.0 111.335 -179.885 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.592 ' O ' HG13 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -94.77 156.39 16.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.48 179.91 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.592 HG13 ' O ' ' A' ' 57' ' ' MET . 2.4 m -160.44 -176.83 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.28 -178.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.82 ' CE3' HD11 ' A' ' 31' ' ' ILE . 92.2 m95 -133.56 126.01 30.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.137 -179.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -149.61 123.68 4.62 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.589 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.511 ' HD3' ' CE2' ' A' ' 48' ' ' TYR . 23.2 Cg_exo -68.65 -174.69 8.68 Favored 'Cis proline' 0 C--N 1.35 0.633 0 C-N-CA 124.287 -1.13 . . . . 0.0 113.055 2.077 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.1 -143.05 0.39 Allowed 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.861 -178.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.532 ' CB ' ' CE1' ' A' ' 33' ' ' TYR . . . -86.4 116.51 66.14 Favored Pre-proline 0 CA--C 1.53 0.187 0 CA-C-O 120.407 0.146 . . . . 0.0 111.008 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.545 ' HG2' HD11 ' A' ' 41' ' ' LEU . 11.5 Cg_exo -72.95 -151.15 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.645 2.23 . . . . 0.0 112.582 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.488 HG22 ' H ' ' A' ' 66' ' ' CYS . 4.5 mm -101.45 166.34 2.47 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 CA-C-O 121.02 0.438 . . . . 0.0 111.486 -178.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.488 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.3 m -163.61 120.3 1.75 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.379 179.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.32 171.04 15.07 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.992 0.425 . . . . 0.0 111.318 -178.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.509 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 8.9 p -93.22 103.18 15.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.848 179.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.791 HG22 ' HA3' ' A' ' 116' ' ' GLY . 2.7 p -59.46 89.3 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.478 179.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 89' ' ' TYR . 5.4 tttt -63.8 154.22 34.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.558 -0.747 . . . . 0.0 112.184 -177.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.416 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -118.88 127.01 53.1 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.77 177.559 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.413 ' CG ' ' N ' ' A' ' 73' ' ' SER . 0.1 OUTLIER -73.93 -160.48 0.09 Allowed 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.488 179.89 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.413 ' N ' ' CG ' ' A' ' 72' ' ' GLN . 2.7 t -50.21 137.49 21.33 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.505 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.493 ' HD2' ' CD2' ' A' ' 82' ' ' HIS . 37.9 Cg_exo -56.33 162.57 7.64 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.167 1.911 . . . . 0.0 111.574 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.507 ' HD3' ' CG ' ' A' ' 118' ' ' TRP . 82.2 Cg_exo -39.92 156.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.726 2.284 . . . . 0.0 112.571 -179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.7 m -107.89 89.05 2.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.894 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.571 HG21 ' O ' ' A' ' 122' ' ' PRO . 13.5 pt -69.7 173.92 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.002 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.0 m -95.77 138.76 32.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.878 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.506 ' HB3' ' CD2' ' A' ' 103' ' ' TYR . 3.9 m-80 60.16 28.97 18.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.989 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.498 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -160.26 -170.75 25.25 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.149 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.26 -175.15 3.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.046 0.45 . . . . 0.0 110.858 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.493 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 34.8 p-80 -112.92 169.03 9.21 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.889 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.417 ' ND2' ' HB ' ' A' ' 96' ' ' THR . 1.2 m-20 -116.97 63.75 0.72 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.793 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -92.12 151.74 20.9 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.043 -1.075 . . . . 0.0 112.484 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.447 ' CD2' ' N ' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -108.79 -30.31 8.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.16 0.505 . . . . 0.0 110.632 -179.969 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.5 -172.37 2.49 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.845 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -105.33 -24.48 12.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.928 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.419 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 10.7 m-85 -134.08 174.78 10.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.938 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.423 ' O ' ' HG2' ' A' ' 70' ' ' LYS . 40.6 m-85 -147.0 165.11 30.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.444 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 17.0 p -129.22 172.09 11.8 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.005 0.431 . . . . 0.0 111.55 -179.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 0.9 OUTLIER -58.74 97.22 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.889 -179.845 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.69 14.87 2.75 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.195 -0.911 . . . . 0.0 113.093 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.98 158.31 15.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.909 0.355 . . . . 0.0 110.393 179.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.419 HG22 ' N ' ' A' ' 95' ' ' VAL . 27.0 m -133.77 156.11 40.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.072 0.463 . . . . 0.0 111.231 -179.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.474 HG23 ' CH2' ' A' ' 118' ' ' TRP . 38.7 t -149.72 150.86 13.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.615 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.983 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -108.22 133.6 52.24 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.963 0.411 . . . . 0.0 110.53 179.112 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.944 ' CE1' HG21 ' A' ' 111' ' ' VAL . 5.9 m-85 -93.28 155.84 17.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.044 -179.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 20.0 p -152.83 144.32 23.37 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.147 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.459 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 68.5 m -72.95 158.87 34.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.251 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 -86.91 -71.09 0.57 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.692 -178.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 40.5 t -68.39 -21.72 64.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.612 -178.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 123.85 32.42 0.87 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.66 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.506 ' CD2' ' HB3' ' A' ' 79' ' ' ASN . 30.6 m-85 -69.6 -171.85 0.42 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.768 0.318 . . . . 0.0 110.277 179.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 6.7 p -107.35 106.06 16.3 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.975 0.417 . . . . 0.0 111.168 -179.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.598 HD23 ' HB2' ' A' ' 122' ' ' PRO . 3.0 tp -46.92 108.85 0.16 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.702 178.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.488 HG22 ' N ' ' A' ' 107' ' ' GLY . 31.8 mm -84.1 158.35 3.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.651 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.488 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 59.81 -123.16 32.36 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.258 -0.973 . . . . 0.0 111.795 -178.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -125.82 132.91 52.15 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.796 0.331 . . . . 0.0 110.766 178.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.983 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.2 p -66.37 -31.54 72.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.401 179.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.64 136.92 22.69 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.526 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.944 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.9 t -126.54 153.37 35.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 179.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.39 118.36 35.6 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.903 0.382 . . . . 0.0 111.597 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.508 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 15.1 t -85.55 97.75 10.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.615 176.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.44 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 1.0 OUTLIER -132.54 151.1 52.03 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.556 -177.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 48.01 29.77 6.77 Favored Glycine 0 C--N 1.329 0.187 0 CA-C-N 115.791 -0.64 . . . . 0.0 112.745 179.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.791 ' HA3' HG22 ' A' ' 69' ' ' VAL . . . 79.95 -5.06 63.4 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.936 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -121.17 175.11 6.27 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.93 0.395 . . . . 0.0 110.866 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.508 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 87.2 m95 -112.5 152.27 28.98 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.895 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.27 147.12 49.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.021 0.438 . . . . 0.0 111.466 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.492 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER 70.07 46.11 0.27 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.161 178.546 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.492 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 74.1 Cg_endo -75.37 139.49 23.42 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.382 2.055 . . . . 0.0 111.623 178.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.598 ' HB2' HD23 ' A' ' 105' ' ' LEU . 57.3 Cg_endo -89.22 -174.52 0.96 Allowed 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.574 2.182 . . . . 0.0 113.559 -178.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.469 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -132.27 -171.75 2.72 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.845 -1.071 . . . . 0.0 109.834 177.829 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 10.4 m -146.3 93.93 2.38 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.0 0.428 . . . . 0.0 111.214 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -119.54 169.54 9.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.878 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.479 HG12 ' CE1' ' A' ' 103' ' ' TYR . 28.3 mm . . . . . 0 C--N 1.323 -0.547 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.944 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.6 mtt-85 . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.821 0.343 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.419 ' HD3' HG23 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -69.22 171.46 8.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.507 179.488 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.477 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 53.6 m -77.85 159.61 75.94 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.664 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -69.15 169.86 17.17 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.504 2.136 . . . . 0.0 112.305 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 p -50.55 106.38 0.63 Allowed Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.832 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.47 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 52.2 Cg_exo -43.23 152.92 0.22 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.262 1.974 . . . . 0.0 112.249 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.905 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -70.05 154.75 41.54 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 121.056 0.455 . . . . 0.0 110.424 178.685 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -97.59 -176.47 3.49 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.889 -176.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.591 HG22 ' CD2' ' A' ' 20' ' ' LEU . 18.6 tt -151.45 144.75 16.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.961 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.418 ' HB3' ' ND2' ' A' ' 17' ' ' ASN . 7.4 t0 -86.57 159.25 19.31 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.108 -0.497 . . . . 0.0 109.974 178.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.499 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 0.1 OUTLIER 43.15 29.63 0.22 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.89 0.376 . . . . 0.0 111.051 -179.445 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -155.02 173.42 33.34 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.629 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -137.53 135.18 36.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.763 0.316 . . . . 0.0 110.589 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.905 HD11 ' O ' ' A' ' 13' ' ' ARG . 14.0 mt -79.27 159.91 27.05 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.445 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.42 ' HB3' ' CB ' ' A' ' 32' ' ' THR . 34.9 t0 -131.31 75.48 1.66 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.366 178.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.876 ' HA ' HG23 ' A' ' 31' ' ' ILE . 58.3 mt -70.98 118.38 15.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.134 0.492 . . . . 0.0 111.994 -178.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -128.47 19.83 5.6 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.696 177.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 160.12 117.84 0.48 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 121.175 -0.536 . . . . 0.0 111.94 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.419 HG23 ' HD3' ' A' ' 8' ' ' ARG . 17.4 m -114.47 24.85 4.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.692 0.282 . . . . 0.0 111.554 -178.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -100.97 146.47 27.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.703 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.539 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 5.7 t80 -48.23 97.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.062 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.18 5.58 5.59 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.691 -0.766 . . . . 0.0 113.074 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.58 -158.69 0.69 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 117.037 0.419 . . . . 0.0 110.79 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.2 p -168.62 146.63 4.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.048 0.451 . . . . 0.0 111.413 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.876 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.7 OUTLIER -105.89 167.58 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.225 179.51 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.42 ' CB ' ' HB3' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -127.85 121.31 29.76 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.802 0.334 . . . . 0.0 110.738 179.001 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.693 ' CE1' HD21 ' A' ' 20' ' ' LEU . 14.1 m-85 -95.51 149.09 21.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.519 -179.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.19 155.82 39.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.771 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.432 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 2.9 m -81.99 169.53 16.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.819 0.342 . . . . 0.0 110.867 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -70.56 -84.97 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.157 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.6 m -153.14 131.91 12.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.933 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.71 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 68.19 21.22 73.74 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.15 -179.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.499 ' CE2' ' HB3' ' A' ' 17' ' ' ASN . 2.5 m-85 -113.46 175.97 5.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.793 0.33 . . . . 0.0 110.868 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.929 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.5 OUTLIER -140.15 113.59 8.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.516 178.662 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.936 HD21 ' O ' ' A' ' 44' ' ' GLU . 6.7 tt -79.5 121.33 25.08 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.829 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.929 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.2 mm -99.23 168.43 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.129 -179.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.544 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 69.13 -134.1 26.84 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.374 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.936 ' O ' HD21 ' A' ' 41' ' ' LEU . 2.2 pm0 -79.75 -173.05 3.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.766 0.317 . . . . 0.0 110.603 179.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.2 t -166.66 28.84 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.605 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.409 ' HG3' ' HA ' ' A' ' 32' ' ' THR . 1.1 mtpt -159.76 127.65 4.8 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.327 -178.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.436 ' OG ' ' CB ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -93.0 143.67 26.01 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.906 178.323 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.534 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.6 m-85 -118.69 114.5 22.82 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 119.259 -0.976 . . . . 0.0 111.507 178.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.463 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 21.8 t -69.86 99.4 1.38 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.565 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -120.38 -172.17 2.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.098 -179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.539 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -93.18 145.33 24.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.953 -179.608 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -71.71 -137.5 0.2 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.534 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.0 m -92.43 -44.6 8.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.802 0.334 . . . . 0.0 110.959 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 80.4 p -99.57 43.52 1.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.973 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 65.67 19.25 66.96 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.58 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.88 -161.58 0.36 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.849 0.357 . . . . 0.0 110.803 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.412 ' O ' HG13 ' A' ' 58' ' ' VAL . 4.6 mmt -114.87 141.83 47.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.7 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.412 HG13 ' O ' ' A' ' 57' ' ' MET . 1.4 m -155.52 175.34 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.823 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.549 ' CE3' HD11 ' A' ' 31' ' ' ILE . 79.2 m95 -128.51 121.86 29.83 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.598 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.534 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -69.52 167.34 23.17 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 177.342 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.489 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 68.4 Cg_exo -14.58 92.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.872 1 C-N-CA 125.339 4.026 . . . . 0.0 114.622 -178.656 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.479 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -90.81 -75.78 0.46 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.338 -177.4 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.419 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . . . -91.8 108.17 27.87 Favored Pre-proline 0 C--N 1.331 -0.228 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -175.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.897 ' HG2' HD11 ' A' ' 41' ' ' LEU . 4.7 Cg_exo -81.47 -154.15 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.083 2.522 . . . . 0.0 111.123 177.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.504 HG22 ' H ' ' A' ' 66' ' ' CYS . 3.8 mm -88.81 166.03 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.782 0.325 . . . . 0.0 110.438 177.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.504 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.8 OUTLIER -169.32 129.82 1.08 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.605 179.783 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -155.74 173.5 16.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.135 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.493 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 5.2 p -85.4 117.25 24.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.627 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.71 HG12 ' O ' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -42.44 94.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.344 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.489 ' CD ' ' HB3' ' A' ' 88' ' ' PHE . 4.3 ttpt -80.15 131.72 35.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.285 -178.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.432 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -107.08 130.0 54.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.901 -179.285 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.3 -158.48 0.06 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.443 178.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.567 ' HG ' ' CE1' ' A' ' 82' ' ' HIS . 2.0 t -49.98 135.89 21.1 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.842 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.499 ' HG2' HG11 ' A' ' 95' ' ' VAL . 31.8 Cg_exo -56.69 162.92 7.79 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.393 2.062 . . . . 0.0 112.053 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.516 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 87.8 Cg_exo -42.44 156.68 0.09 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.715 2.277 . . . . 0.0 112.776 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 65.1 p -106.01 90.09 3.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.406 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.688 HG23 ' HE1' ' A' ' 97' ' ' TYR . 25.0 pt -69.32 172.54 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.37 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 124' ' ' CYS . 3.0 p -94.98 143.9 26.11 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.509 179.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.501 ' HB3' ' CE1' ' A' ' 103' ' ' TYR . 2.7 m-80 58.58 28.59 17.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.86 0.362 . . . . 0.0 111.084 179.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -171.82 -167.54 32.11 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.498 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 10.2 ptt85 -166.54 -176.6 3.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.966 0.413 . . . . 0.0 111.168 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.567 ' CE1' ' HG ' ' A' ' 73' ' ' SER . 25.3 p-80 -103.08 175.16 5.57 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.038 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -107.18 -86.37 0.5 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.31 179.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.429 ' HA3' ' OH ' ' A' ' 89' ' ' TYR . . . 58.56 154.42 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.117 178.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -114.44 -34.02 5.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.027 0.441 . . . . 0.0 110.793 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -95.12 -171.73 2.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.801 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -102.25 -27.12 13.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.202 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.489 ' HB3' ' CD ' ' A' ' 70' ' ' LYS . 19.2 m-85 -128.86 -176.85 3.98 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.077 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.462 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 84.5 m-85 -157.41 169.95 23.56 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.734 -178.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 11.4 p -134.0 178.59 6.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.909 0.385 . . . . 0.0 111.407 -179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.409 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 28.5 p-10 -62.74 94.77 0.07 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.298 0.571 . . . . 0.0 111.026 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.56 29.53 0.9 Allowed Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.275 -0.875 . . . . 0.0 112.983 179.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.11 163.88 13.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.691 0.282 . . . . 0.0 110.57 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 33.9 m -138.76 150.73 23.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.103 0.478 . . . . 0.0 111.307 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.51 HG23 ' CH2' ' A' ' 118' ' ' TRP . 20.1 t -145.81 147.06 18.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.635 179.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.963 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -105.76 130.59 53.73 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.893 179.956 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.94 ' CE2' HG21 ' A' ' 111' ' ' VAL . 5.0 m-85 -89.77 160.55 16.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.069 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 82.4 p -156.47 139.26 15.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.078 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.426 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 62.8 m -70.94 160.11 33.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.076 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 -80.85 -81.96 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.299 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.14 -30.99 70.72 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.214 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 132.57 39.81 0.22 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.645 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.523 ' HE2' HD11 ' A' ' 126' ' ' ILE . 49.7 m-85 -69.51 -174.27 0.67 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.807 0.337 . . . . 0.0 110.545 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 67.3 m -104.97 101.2 10.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.699 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.494 HD21 ' HA ' ' A' ' 109' ' ' SER . 0.2 OUTLIER -50.69 122.18 6.89 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.475 0.655 . . . . 0.0 111.428 -178.713 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.43 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 30.9 mm -91.3 155.43 3.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 114.935 -1.03 . . . . 0.0 109.943 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.76 -127.53 36.51 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.22 -0.99 . . . . 0.0 111.922 -178.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -126.19 138.59 53.66 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.799 0.333 . . . . 0.0 111.065 179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.963 ' OG ' HG22 ' A' ' 96' ' ' THR . 5.7 p -64.79 -32.25 73.85 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.656 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -71.49 138.34 27.37 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.929 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.94 HG21 ' CE2' ' A' ' 97' ' ' TYR . 2.7 t -133.31 119.66 36.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.543 0.211 . . . . 0.0 110.591 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.5 125.79 30.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.889 0.376 . . . . 0.0 111.554 -179.021 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.504 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 34.7 t -90.22 102.81 15.53 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 176.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 9.0 t -144.22 161.0 40.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.111 0.482 . . . . 0.0 111.308 -178.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.433 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 45.23 33.37 4.0 Favored Glycine 0 CA--C 1.518 0.252 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.912 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.463 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 66.39 16.99 65.83 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.538 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -139.98 178.05 7.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.781 0.324 . . . . 0.0 110.608 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.516 ' CD1' ' HD3' ' A' ' 75' ' ' PRO . 94.5 m95 -116.01 138.18 51.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.926 -179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -121.72 146.68 46.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.214 -179.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.475 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 3.2 t0 71.02 46.05 0.25 Allowed Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.074 178.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 97.2 Cg_endo -78.63 134.69 12.43 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.322 2.015 . . . . 0.0 111.379 177.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.459 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 53.7 Cg_endo -87.05 -177.65 2.26 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.374 2.05 . . . . 0.0 113.412 -178.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 105' ' ' LEU . 0.2 OUTLIER -134.2 177.85 7.42 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.542 178.312 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 78' ' ' SER . 12.5 m -132.93 106.68 7.83 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.312 0.577 . . . . 0.0 110.95 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.497 ' C ' HD12 ' A' ' 126' ' ' ILE . 13.7 mt-30 -114.79 -175.87 2.78 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.437 -178.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.791 ' N ' HD12 ' A' ' 126' ' ' ILE . 1.6 mp . . . . . 0 C--N 1.32 -0.68 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.618 -177.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.782 0.325 . . . . 0.0 111.214 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.402 ' HA ' ' HA ' ' A' ' 26' ' ' ASP . 0.1 OUTLIER -61.94 -174.91 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.736 179.291 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.449 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 60.6 m -104.78 158.74 31.36 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.9 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.444 ' HD3' ' HB2' ' A' ' 57' ' ' MET . 57.8 Cg_endo -68.91 170.98 14.32 Favored 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 122.362 2.041 . . . . 0.0 110.883 178.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 6.1 p -53.2 123.53 35.04 Favored Pre-proline 0 N--CA 1.448 -0.525 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.633 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -58.61 158.24 24.48 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.737 2.291 . . . . 0.0 112.338 -179.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.809 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -70.81 142.96 51.29 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.474 178.779 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.417 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 0.7 OUTLIER -83.62 -171.06 3.38 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.417 -177.624 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.671 HG22 ' CD2' ' A' ' 20' ' ' LEU . 20.2 tt -155.97 143.89 11.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.394 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -90.93 158.77 16.55 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.764 177.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.498 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 0.4 OUTLIER 48.27 26.02 0.99 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.825 0.345 . . . . 0.0 110.656 -179.463 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.413 ' HA2' ' N ' ' A' ' 36' ' ' ASN . . . -157.56 -178.6 31.76 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.589 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -146.06 134.43 21.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.672 0.273 . . . . 0.0 110.887 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.809 HD11 ' O ' ' A' ' 13' ' ' ARG . 20.1 mt -78.61 155.18 29.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.986 0.422 . . . . 0.0 111.353 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.44 ' CB ' ' HB ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -124.01 72.65 1.17 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.444 177.203 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.889 ' HA ' HG23 ' A' ' 31' ' ' ILE . 1.1 mt -69.93 101.17 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.008 -176.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.9 17.25 57.55 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.718 176.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 154.96 151.5 5.86 Favored Glycine 0 C--N 1.333 0.382 0 N-CA-C 111.659 -0.576 . . . . 0.0 111.659 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.402 ' O ' ' HB2' ' A' ' 8' ' ' ARG . 23.3 m -133.76 13.61 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.402 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 1.8 p-10 -85.5 157.18 20.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.849 0.356 . . . . 0.0 111.094 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.485 ' CZ ' ' HG ' ' A' ' 51' ' ' LEU . 5.9 t80 -51.38 103.34 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.785 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 115.28 -1.51 22.35 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.888 -179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 94.4 p -78.94 -176.72 5.17 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-N 116.984 0.392 . . . . 0.0 110.435 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.3 p -151.91 156.36 39.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.936 0.398 . . . . 0.0 111.376 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.889 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.8 OUTLIER -122.37 166.55 16.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.827 -179.713 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.44 ' HB ' ' CB ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -128.89 114.48 16.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.782 179.13 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.474 ' CE2' HD21 ' A' ' 20' ' ' LEU . 31.3 m-85 -88.58 145.01 25.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.979 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -148.41 166.17 28.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.113 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.414 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 1.3 m -89.64 158.79 17.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.716 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.424 ' ND2' ' HA ' ' A' ' 17' ' ' ASN . 15.5 m-20 -58.02 -88.46 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.31 -178.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.9 t -151.86 133.39 14.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.882 0.372 . . . . 0.0 110.822 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.41 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 69.01 18.49 72.81 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.233 -179.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.498 ' CE1' ' HB3' ' A' ' 17' ' ' ASN . 2.7 m-30 -112.6 -177.93 3.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.911 0.386 . . . . 0.0 110.786 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.818 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -142.08 110.85 6.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.008 177.041 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.941 HD21 ' O ' ' A' ' 44' ' ' GLU . 2.9 tt -72.57 125.19 26.85 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.336 -178.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.818 HD11 ' CE1' ' A' ' 40' ' ' HIS . 1.7 mm -106.2 165.7 3.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.111 0.482 . . . . 0.0 111.274 -178.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.487 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 70.31 -123.16 11.75 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.305 -179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.941 ' O ' HD21 ' A' ' 41' ' ' LEU . 1.3 mt-10 -80.77 174.58 11.47 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.194 0.521 . . . . 0.0 112.019 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.2 p -156.37 19.03 0.35 Allowed 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.474 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.412 ' HG2' ' O ' ' A' ' 31' ' ' ILE . 8.8 mtpt -159.97 152.05 20.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.059 0.457 . . . . 0.0 112.075 -177.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 61' ' ' PRO . 0.3 OUTLIER -121.25 152.73 38.54 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.031 177.986 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.502 ' CB ' ' HB2' ' A' ' 60' ' ' ASN . 1.4 m-85 -131.36 115.13 15.84 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 119.135 -1.026 . . . . 0.0 112.173 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 28.0 t -66.12 109.02 2.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.913 -1.039 . . . . 0.0 110.763 179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -133.27 -173.3 3.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.173 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.664 HD23 ' O ' ' A' ' 56' ' ' SER . 7.4 mt -85.63 160.85 19.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.242 -179.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.42 -143.27 3.26 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.532 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.3 t -101.28 -31.41 10.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.792 0.33 . . . . 0.0 110.891 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 26.7 p -113.28 25.56 11.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.852 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.26 32.51 11.99 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.444 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.664 ' O ' HD23 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -102.45 -171.4 1.96 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.988 0.423 . . . . 0.0 111.131 -179.861 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.444 ' HB2' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -109.31 125.61 52.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.801 -179.411 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 17.4 m -141.1 -176.95 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.861 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.644 ' CE3' HD11 ' A' ' 31' ' ' ILE . 65.8 m95 -132.01 131.95 42.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.744 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.502 ' HB2' ' CB ' ' A' ' 48' ' ' TYR . 1.0 OUTLIER -69.92 162.62 67.17 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 176.08 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.474 ' O ' ' HA ' ' A' ' 47' ' ' SER . 21.4 Cg_exo -7.8 109.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.755 1 C-N-CA 125.888 4.392 . . . . 0.0 115.267 -178.189 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.424 ' HA ' ' OG ' ' A' ' 47' ' ' SER . 3.9 mt-10 -98.09 -113.73 0.15 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 114.901 -1.045 . . . . 0.0 112.513 -176.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.449 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -69.25 107.71 2.41 Favored Pre-proline 0 C--N 1.34 0.168 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -176.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.577 ' HG2' HD11 ' A' ' 41' ' ' LEU . 2.2 Cg_endo -81.53 -153.98 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.924 2.416 . . . . 0.0 110.298 176.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.661 HD12 ' HB ' ' A' ' 42' ' ' ILE . 0.3 OUTLIER -86.04 170.73 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.327 0.584 . . . . 0.0 111.573 -179.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.568 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.5 OUTLIER -172.24 141.47 1.25 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.042 179.805 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -169.7 167.8 9.33 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.801 0.334 . . . . 0.0 111.202 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.496 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 2.8 p -77.54 121.85 24.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.247 178.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.702 HG13 ' OD2' ' A' ' 91' ' ' ASP . 1.4 p -40.52 96.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.139 0.495 . . . . 0.0 111.582 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.521 ' HG2' ' CD2' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -92.37 127.53 37.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.172 -178.013 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.43 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -100.29 132.02 45.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.998 -179.001 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.7 pm0 -75.81 -159.55 0.11 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.599 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.433 ' HG ' ' CE1' ' A' ' 82' ' ' HIS . 1.9 t -48.44 136.83 12.29 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.04 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.487 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 25.7 Cg_exo -60.59 159.02 29.6 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.351 2.034 . . . . 0.0 112.225 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.427 ' HG2' ' HD3' ' A' ' 121' ' ' PRO . 81.1 Cg_exo -44.78 159.69 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.982 2.455 . . . . 0.0 113.275 -178.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 9.6 m -108.8 93.11 4.34 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.516 179.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.493 HG23 ' CE1' ' A' ' 97' ' ' TYR . 22.4 pt -68.5 175.2 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.249 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.2 p -94.32 137.36 33.58 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.877 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.503 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 0.1 OUTLIER 68.47 26.87 6.45 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.879 179.521 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.454 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . -171.84 -164.78 27.99 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.263 -0.97 . . . . 0.0 113.216 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.422 ' N ' ' O ' ' A' ' 98' ' ' SER . 4.9 ptt85 -162.06 -175.1 4.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.044 0.45 . . . . 0.0 110.705 -179.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.433 ' CE1' ' HG ' ' A' ' 73' ' ' SER . 19.6 p-80 -111.14 169.53 8.72 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.71 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -100.52 -83.72 0.44 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.709 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.519 ' H ' HG13 ' A' ' 95' ' ' VAL . . . 60.74 148.61 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.617 179.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -115.66 -36.27 4.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.099 0.475 . . . . 0.0 110.613 -179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.79 -171.38 2.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.611 179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -100.89 -25.94 13.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.058 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.521 ' CD2' ' HG2' ' A' ' 70' ' ' LYS . 24.8 m-85 -130.19 -176.67 4.02 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.161 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.468 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 89.2 m-85 -157.17 165.57 35.6 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.419 -178.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.0 p -136.56 -176.4 4.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.072 0.463 . . . . 0.0 111.717 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.702 ' OD2' HG13 ' A' ' 69' ' ' VAL . 2.1 m-20 -63.03 96.64 0.1 Allowed 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.255 -179.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.94 26.54 1.36 Allowed Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 115.288 -0.869 . . . . 0.0 113.035 178.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.408 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -110.17 162.92 14.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.817 0.341 . . . . 0.0 110.801 179.374 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 36.0 m -144.29 149.44 17.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.135 0.493 . . . . 0.0 111.125 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.519 HG13 ' H ' ' A' ' 84' ' ' GLY . 18.1 t -141.1 146.97 22.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.559 179.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.99 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -102.08 136.78 41.32 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.816 -179.764 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.883 ' CE2' HG21 ' A' ' 111' ' ' VAL . 5.8 m-85 -98.81 156.17 17.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.147 -179.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.422 ' O ' ' N ' ' A' ' 81' ' ' ARG . 1.3 p -148.07 141.42 25.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.57 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.454 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 12.1 m -69.38 162.43 27.35 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.281 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -97.02 -69.07 0.77 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.092 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.75 -28.81 69.31 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.01 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.36 36.79 0.48 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.548 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.519 ' CE2' HG12 ' A' ' 126' ' ' ILE . 18.2 m-85 -74.27 -171.77 1.26 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 120.756 0.312 . . . . 0.0 110.664 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.6 m -117.54 101.05 8.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.759 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.691 HD21 ' HG2' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -49.0 132.79 18.7 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.594 0.711 . . . . 0.0 111.155 -179.739 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.449 ' HB ' ' CB ' ' A' ' 123' ' ' THR . 36.1 mm -101.82 156.98 4.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.59 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.434 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 67.35 -126.47 25.37 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.958 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -125.79 127.06 45.54 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.054 0.454 . . . . 0.0 110.931 178.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.99 ' OG ' HG22 ' A' ' 96' ' ' THR . 3.6 p -59.34 -27.93 66.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.728 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -72.47 121.39 8.08 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.75 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.883 HG21 ' CE2' ' A' ' 97' ' ' TYR . 11.6 t -113.99 116.03 51.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.5 126.61 31.18 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -177.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.5 ' HB2' ' CZ3' ' A' ' 118' ' ' TRP . 41.8 t -91.07 104.12 16.74 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 176.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 19.3 t -141.1 150.72 43.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.078 0.466 . . . . 0.0 111.406 -178.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.598 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 46.68 43.24 15.58 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.767 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.468 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 62.32 14.14 46.7 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.647 -179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -135.11 173.25 11.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.023 0.44 . . . . 0.0 110.679 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.514 ' CZ3' HG23 ' A' ' 95' ' ' VAL . 95.8 m95 -115.48 128.1 55.78 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.527 -178.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.488 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 0.3 OUTLIER -91.81 130.39 37.6 Favored 'General case' 0 CA--C 1.511 -0.522 0 C-N-CA 120.05 -0.66 . . . . 0.0 109.663 175.04 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.626 ' HB2' HG13 ' A' ' 111' ' ' VAL . 2.8 m-20 108.92 -132.1 0.0 OUTLIER Pre-proline 0 CA--C 1.475 -1.907 0 N-CA-C 100.41 -3.922 . . . . 0.0 100.41 -167.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.553 ' HA ' ' CB ' ' A' ' 120' ' ' ASP . 60.4 Cg_endo -63.52 -179.53 7.77 Favored 'Cis proline' 0 C--N 1.309 -1.54 0 CA-C-N 125.157 2.878 . . . . 0.0 112.717 -17.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.691 ' HG2' HD21 ' A' ' 105' ' ' LEU . 18.0 Cg_endo -87.94 -179.51 2.53 Favored 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 123.023 2.482 . . . . 0.0 111.32 176.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.449 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -109.12 -162.6 0.82 Allowed 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 176.13 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . 0.427 ' SG ' ' HB2' ' A' ' 103' ' ' TYR . 5.0 t -170.25 85.83 0.12 Allowed 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.904 -176.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -114.61 176.74 4.92 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.909 -178.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.66 HG22 ' O ' ' A' ' 126' ' ' ILE . 26.4 mm . . . . . 0 C--N 1.322 -0.615 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.718 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.816 0.341 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.4 ' HA ' ' HA ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -74.34 175.21 7.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.731 179.594 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.467 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 37.9 m -81.33 160.06 66.02 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.874 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -69.89 174.44 9.62 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.454 2.103 . . . . 0.0 111.961 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -51.11 109.57 1.41 Allowed Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.794 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.41 162.38 14.85 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.258 1.972 . . . . 0.0 111.977 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.575 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -52.11 -175.02 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.447 179.318 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.422 ' O ' HG13 ' A' ' 15' ' ' ILE . 0.4 OUTLIER -140.05 6.53 2.18 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.041 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.936 HD13 ' CD2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER 57.8 -165.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.067 -177.635 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -125.79 -70.88 0.72 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.929 0.395 . . . . 0.0 110.613 178.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.482 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -99.2 29.02 4.11 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.941 178.605 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.43 ' HA2' ' N ' ' A' ' 36' ' ' ASN . . . -137.93 -175.66 14.03 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.656 -0.783 . . . . 0.0 113.214 -178.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -133.75 145.35 49.74 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.672 0.272 . . . . 0.0 110.747 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.789 HD22 HD11 ' A' ' 15' ' ' ILE . 4.9 mt -82.67 155.55 24.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.207 0.527 . . . . 0.0 111.797 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.416 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 4.5 t0 -129.91 68.5 1.44 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.264 -0.88 . . . . 0.0 108.92 175.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.879 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.9 OUTLIER -74.95 116.95 18.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.49 -175.796 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -116.05 19.57 13.5 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.227 175.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 161.0 125.99 0.8 Allowed Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.095 -0.574 . . . . 0.0 112.007 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 6.6 m -112.44 5.79 8.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 15.8 t70 -88.46 165.42 14.91 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.871 0.367 . . . . 0.0 110.871 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -57.76 116.71 3.61 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.635 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.45 5.9 36.42 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.833 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 89.7 p -94.14 -169.59 2.1 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 116.856 0.328 . . . . 0.0 110.307 179.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.9 p -165.88 141.66 5.0 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.125 0.488 . . . . 0.0 111.1 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.879 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.6 OUTLIER -106.14 164.38 4.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.209 -179.898 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.424 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -121.86 118.18 28.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.952 0.406 . . . . 0.0 110.671 179.034 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.936 ' CD2' HD13 ' A' ' 15' ' ' ILE . 6.1 m-85 -90.97 135.63 33.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.784 -178.109 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.9 m -146.97 157.55 43.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.694 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.42 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 1.9 m -79.58 167.56 20.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.846 0.355 . . . . 0.0 110.869 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.43 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 11.1 m-20 -67.15 -84.13 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.971 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -155.96 134.52 11.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.699 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.29 24.27 73.47 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.661 -0.78 . . . . 0.0 111.897 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.53 ' CE2' ' CB ' ' A' ' 68' ' ' SER . 2.7 m-30 -119.73 174.52 6.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.887 0.375 . . . . 0.0 110.908 -179.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.904 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.6 OUTLIER -134.53 117.12 15.85 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.364 177.78 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.84 HD21 ' O ' ' A' ' 44' ' ' GLU . 5.7 tt -81.75 127.47 32.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.337 -179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.904 HD11 ' CE1' ' A' ' 40' ' ' HIS . 1.9 mm -106.09 149.49 9.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.275 -178.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.71 -141.4 19.5 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.369 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.84 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.9 OUTLIER -74.04 -172.94 1.47 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.903 0.383 . . . . 0.0 110.79 179.53 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.8 p -161.69 22.73 0.12 Allowed 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.392 -179.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.424 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 1.1 mtpt -153.31 125.47 7.98 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -177.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.453 ' CB ' ' HA ' ' A' ' 62' ' ' GLU . 0.3 OUTLIER -94.61 145.43 24.84 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.092 178.111 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.537 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.8 m-85 -120.89 120.5 35.7 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 119.315 -0.954 . . . . 0.0 111.797 178.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 26.5 t -68.74 117.66 10.73 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.156 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -156.61 -179.45 8.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.992 179.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.5 ' C ' HD12 ' A' ' 51' ' ' LEU . 4.6 pp -94.09 158.42 15.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.656 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.417 ' O ' ' N ' ' A' ' 54' ' ' THR . . . -155.41 -56.25 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.295 -0.955 . . . . 0.0 113.012 -179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.448 ' HB2' ' HB3' ' A' ' 56' ' ' SER . 0.1 OUTLIER -63.27 77.18 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.99 0.424 . . . . 0.0 111.22 -178.943 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.417 ' N ' ' O ' ' A' ' 52' ' ' GLY . 2.5 p 51.14 27.28 3.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.124 179.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 121.56 -17.8 8.83 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.535 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.448 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 6.6 t -57.49 -159.56 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.916 0.389 . . . . 0.0 110.998 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.87 140.06 49.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.87 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.1 m -149.28 -176.09 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.541 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.56 ' CZ3' HD11 ' A' ' 31' ' ' ILE . 69.7 m95 -131.48 124.96 31.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.988 0.423 . . . . 0.0 111.261 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.537 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 4.8 m-20 -68.4 166.61 24.03 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.439 178.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.47 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 49.3 Cg_exo -12.63 86.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.008 1 C-N-CA 125.361 4.041 . . . . 0.0 114.211 -178.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.496 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.5 OUTLIER -90.26 -76.58 0.42 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.723 -176.236 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.464 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -94.22 108.23 34.51 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -173.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.787 ' HG2' HD11 ' A' ' 41' ' ' LEU . 2.3 Cg_endo -81.41 -154.34 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 123.189 2.592 . . . . 0.0 110.368 175.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.677 HD12 ' HB ' ' A' ' 42' ' ' ILE . 1.0 OUTLIER -93.19 175.2 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.602 177.767 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.61 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.8 OUTLIER -171.46 144.31 1.92 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.609 179.718 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.417 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 1.3 tt0 -166.73 175.08 8.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.86 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.53 ' CB ' ' CE2' ' A' ' 39' ' ' TYR . 0.2 OUTLIER -99.41 123.4 43.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.658 178.944 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.438 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 1.4 p -45.27 92.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.093 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 68' ' ' SER . 2.4 mmtp -63.99 131.95 49.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.199 -177.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.12 121.0 40.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.62 177.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.3 -159.5 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.515 -0.312 . . . . 0.0 110.655 -179.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.465 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 2.7 t -51.33 139.67 25.9 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.589 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.466 ' HG2' HG11 ' A' ' 95' ' ' VAL . 26.4 Cg_exo -59.22 159.67 21.81 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.201 1.934 . . . . 0.0 111.918 -179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.492 ' HD3' ' CG ' ' A' ' 118' ' ' TRP . 88.9 Cg_exo -39.79 156.74 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.934 2.422 . . . . 0.0 113.04 -178.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.1 t -107.97 90.81 3.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.796 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.597 HG23 ' HE2' ' A' ' 97' ' ' TYR . 21.4 pt -69.51 -176.68 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.004 -0.543 . . . . 0.0 111.287 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.6 m -105.25 145.74 30.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.662 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.47 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 7.4 m-80 55.56 28.35 11.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.929 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.471 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -167.52 -163.2 20.99 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.563 179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 9.5 ptt180 -170.15 -175.72 2.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.039 0.447 . . . . 0.0 110.971 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.465 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 1.6 p-80 -110.46 168.2 9.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.868 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -92.95 -87.01 0.24 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.636 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.47 ' H ' HG13 ' A' ' 95' ' ' VAL . . . 60.69 142.96 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.654 -0.784 . . . . 0.0 113.049 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.478 ' CD1' ' N ' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -113.51 -35.74 5.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.091 0.472 . . . . 0.0 110.587 179.423 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.36 -171.53 2.97 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.819 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -103.91 -21.9 13.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.14 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.421 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 7.8 m-85 -134.02 172.48 12.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.106 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.421 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 48.6 m-85 -148.11 165.01 32.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.828 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.415 ' CG2' ' HE3' ' A' ' 70' ' ' LYS . 12.1 p -134.5 -175.19 3.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.905 0.383 . . . . 0.0 111.462 -178.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.42 ' OD1' ' CG1' ' A' ' 69' ' ' VAL . 0.7 OUTLIER -64.5 98.45 0.25 Allowed 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.31 0.576 . . . . 0.0 111.069 -179.876 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.86 22.29 2.23 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.164 -0.925 . . . . 0.0 113.13 178.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.438 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.6 OUTLIER -103.18 157.25 17.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.908 0.354 . . . . 0.0 110.631 179.167 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 28.6 m -136.39 149.06 27.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.079 0.466 . . . . 0.0 111.173 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.475 HG23 ' CH2' ' A' ' 118' ' ' TRP . 21.4 t -144.19 147.39 19.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.747 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.694 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -106.31 129.49 54.32 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.778 -179.984 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.955 ' CE1' HG21 ' A' ' 111' ' ' VAL . 5.5 m-85 -88.56 157.07 18.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.115 -179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.4 ' HA ' HD13 ' A' ' 105' ' ' LEU . 50.2 m -151.3 141.31 22.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.334 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.425 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 74.0 m -71.89 163.12 28.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.979 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.471 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 18.0 m-20 -96.73 -71.46 0.68 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.513 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.0 t -61.58 -22.57 65.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.23 -179.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 122.37 31.29 1.08 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.534 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.494 ' CD2' HG12 ' A' ' 126' ' ' ILE . 24.8 m-85 -69.96 -174.02 0.72 Allowed 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 120.959 0.409 . . . . 0.0 110.495 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.0 105.87 14.01 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.359 179.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.674 HD22 ' HB3' ' A' ' 109' ' ' SER . 0.2 OUTLIER -46.44 123.41 4.85 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.385 0.612 . . . . 0.0 111.419 -178.809 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.458 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 42.6 mm -91.13 152.61 3.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.457 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.67 -130.44 36.91 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.104 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -114.67 138.8 50.25 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.839 0.352 . . . . 0.0 110.774 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.694 ' HB2' HG22 ' A' ' 96' ' ' THR . 0.0 OUTLIER -77.23 -30.08 54.39 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.756 179.906 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.04 127.41 11.02 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.18 178.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.955 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.8 t -120.22 121.86 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.65 0.262 . . . . 0.0 110.642 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.75 122.85 27.66 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.705 -178.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.496 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 25.6 t -88.85 104.13 16.64 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 176.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.6 t -145.39 163.81 33.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.163 -178.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 44.9 30.57 2.44 Favored Glycine 0 CA--C 1.518 0.258 0 CA-C-N 115.959 -0.564 . . . . 0.0 112.928 179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.438 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 67.14 19.89 70.55 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.42 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -143.56 175.56 9.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.766 0.317 . . . . 0.0 110.561 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.496 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 95.7 m95 -112.33 142.86 44.33 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.005 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.9 148.08 50.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.257 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.478 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 26.6 t0 71.74 46.72 0.24 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.082 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 95.4 Cg_endo -78.18 134.03 12.6 Favored 'Trans proline' 0 N--CA 1.462 -0.348 0 C-N-CA 122.343 2.029 . . . . 0.0 111.4 177.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.495 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 74.0 Cg_endo -88.66 -173.75 0.92 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.525 2.15 . . . . 0.0 113.532 -177.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.448 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -129.75 -163.42 1.3 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.781 177.756 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 5.1 m -151.97 92.06 1.69 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.047 0.451 . . . . 0.0 110.94 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -122.07 158.11 29.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.852 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.494 HG12 ' CD2' ' A' ' 103' ' ' TYR . 13.6 mm . . . . . 0 C--N 1.324 -0.518 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.859 179.576 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.907 0.384 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.785 ' HD3' HG23 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -77.34 -175.94 3.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.834 179.754 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.482 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 4.2 m -93.84 162.94 25.6 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.705 179.506 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.42 ' O ' ' HD3' ' A' ' 12' ' ' PRO . 15.5 Cg_endo -60.1 -163.28 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.316 2.011 . . . . 0.0 111.452 -179.883 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.44 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 0.9 OUTLIER -78.46 104.94 2.34 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.718 -0.219 . . . . 0.0 110.805 179.92 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.498 ' CG ' ' CD1' ' A' ' 22' ' ' ILE . 13.2 Cg_endo -55.97 142.84 84.47 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.123 1.882 . . . . 0.0 111.677 179.461 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.42 ' HB3' ' OH ' ' A' ' 33' ' ' TYR . 0.5 OUTLIER -52.19 169.34 0.08 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.467 -179.556 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.747 ' C ' HD21 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -130.02 -5.27 4.47 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -177.149 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.692 HG22 ' O ' ' A' ' 14' ' ' ASP . 3.0 tt 55.45 157.42 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 C-N-CA 122.864 0.466 . . . . 0.0 111.798 -178.264 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -101.78 -47.33 4.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.432 -178.349 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -94.04 38.71 1.08 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.878 -179.633 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.464 ' HA2' ' N ' ' A' ' 36' ' ' ASN . . . 177.84 -166.07 36.07 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.969 179.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.893 ' C ' HD23 ' A' ' 20' ' ' LEU . 0.9 OUTLIER -136.47 177.21 8.03 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.334 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.893 HD23 ' C ' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -126.59 151.5 47.89 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.301 0.572 . . . . 0.0 111.411 -179.836 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 32' ' ' THR . 4.2 t70 -116.25 82.67 1.82 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.528 177.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.806 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.7 OUTLIER -77.39 103.12 4.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.029 -0.532 . . . . 0.0 112.392 -176.908 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.67 19.79 52.95 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.756 177.177 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.07 142.09 3.37 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.06 -0.591 . . . . 0.0 111.955 -179.374 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.785 HG23 ' HD3' ' A' ' 8' ' ' ARG . 11.0 m -128.6 29.64 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.66 0.266 . . . . 0.0 111.492 -178.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -105.69 164.97 11.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.929 0.395 . . . . 0.0 110.838 179.309 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.763 ' HZ ' HD13 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -59.93 90.59 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.925 -179.738 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 136.31 -2.88 3.58 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.32 179.63 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -94.39 -174.56 3.38 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 117.157 0.479 . . . . 0.0 110.771 179.86 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.427 ' HB2' ' HE2' ' A' ' 46' ' ' LYS . 1.4 p -156.58 145.22 19.99 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.016 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.806 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.4 OUTLIER -100.79 166.15 2.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.234 179.525 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.456 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -127.48 114.95 18.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.827 0.346 . . . . 0.0 110.864 179.654 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.789 ' CE1' HD22 ' A' ' 20' ' ' LEU . 15.4 m-85 -91.92 149.2 21.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.258 0.551 . . . . 0.0 112.061 -178.386 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.406 ' O ' ' HA3' ' A' ' 18' ' ' GLY . 46.0 m -151.44 147.02 26.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.188 178.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.417 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 6.3 m -69.15 167.66 15.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.848 0.356 . . . . 0.0 110.829 -179.351 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.464 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 25.4 m-20 -68.69 -85.76 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.239 -178.317 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -151.73 134.98 15.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.524 179.819 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.535 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 65.92 26.42 72.25 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.771 -178.79 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.499 ' CE2' ' HB3' ' A' ' 68' ' ' SER . 2.1 m-85 -121.41 171.89 8.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.997 0.427 . . . . 0.0 111.179 -179.45 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.864 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -138.26 112.79 8.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.066 177.647 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.932 HD21 ' O ' ' A' ' 44' ' ' GLU . 7.0 tt -75.4 129.93 38.14 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.856 -178.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.864 HD11 ' CE1' ' A' ' 40' ' ' HIS . 3.0 mm -104.94 157.4 5.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.994 0.426 . . . . 0.0 111.098 -179.578 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.6 -142.45 31.16 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.05 -179.094 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.932 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -73.0 -172.54 1.07 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.85 0.357 . . . . 0.0 110.569 179.222 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.417 ' HA ' ' HG3' ' A' ' 64' ' ' PRO . 0.3 OUTLIER -168.21 30.21 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.534 179.682 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.456 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 25.8 mtpt -151.8 126.02 9.29 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.426 -178.534 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.428 ' OG ' ' CB ' ' A' ' 62' ' ' GLU . 0.3 OUTLIER -93.04 137.47 32.37 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.876 178.819 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.515 ' CD1' ' HB3' ' A' ' 60' ' ' ASN . 1.1 m-85 -114.73 121.77 44.37 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 119.413 -0.915 . . . . 0.0 111.79 -179.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 23.0 t -72.01 117.56 13.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.936 -179.58 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.497 ' HA ' ' CE2' ' A' ' 27' ' ' PHE . 4.6 mt-10 -146.16 -179.47 6.75 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.034 179.476 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.763 HD13 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -94.46 143.15 26.66 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.912 -179.673 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -63.21 -125.47 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.368 179.722 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.8 t -123.0 -34.22 3.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.767 0.318 . . . . 0.0 111.263 -179.723 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.73 24.77 3.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.242 -179.516 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.56 18.58 61.73 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.679 179.755 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.1 t -95.3 -161.7 0.88 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.785 0.326 . . . . 0.0 111.059 179.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.684 ' O ' HG13 ' A' ' 58' ' ' VAL . 3.2 mmt -119.37 159.33 24.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.6 179.79 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.684 HG13 ' O ' ' A' ' 57' ' ' MET . 2.7 m -163.38 173.95 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.204 -179.484 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.529 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 74.1 m95 -129.25 125.22 36.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.138 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.515 ' HB3' ' CD1' ' A' ' 48' ' ' TYR . 0.7 OUTLIER -69.33 166.06 33.47 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.761 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.47 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 65.7 Cg_exo -11.49 101.29 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 1.003 1 C-N-CA 125.647 4.231 . . . . 0.0 114.634 -179.187 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.507 ' O ' ' CG ' ' A' ' 33' ' ' TYR . 0.7 OUTLIER -101.71 -71.1 0.72 Allowed 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 115.159 -0.928 . . . . 0.0 113.159 -175.416 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.438 ' HA ' HD12 ' A' ' 15' ' ' ILE . . . -102.98 76.93 0.23 Allowed Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -174.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.795 ' HG2' HD11 ' A' ' 41' ' ' LEU . 33.3 Cg_endo -55.39 -154.42 0.0 OUTLIER 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 123.249 2.633 . . . . 0.0 111.766 176.015 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.51 HG22 ' H ' ' A' ' 66' ' ' CYS . 6.8 mm -86.97 166.42 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.964 0.412 . . . . 0.0 111.282 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.51 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.1 m -165.34 125.86 1.89 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.762 178.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.16 171.74 13.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.918 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.499 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 96.4 p -84.89 118.53 24.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.552 -179.568 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.559 HG23 ' HB3' ' A' ' 40' ' ' HIS . 0.2 OUTLIER -49.98 99.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.036 178.876 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.1 mmtp -62.85 138.95 58.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.188 -179.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.419 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -123.18 126.59 47.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.636 179.588 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -74.57 -168.59 0.71 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.841 179.498 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -41.25 133.38 1.98 Allowed Pre-proline 0 N--CA 1.438 -1.056 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.684 179.364 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.492 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 31.8 Cg_exo -57.82 162.9 10.08 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.378 2.052 . . . . 0.0 112.391 -178.704 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.52 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 85.6 Cg_exo -41.32 160.5 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.879 2.386 . . . . 0.0 113.135 -179.469 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.81 89.61 3.06 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.642 179.399 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.565 HG23 ' HE1' ' A' ' 97' ' ' TYR . 22.5 pt -69.35 171.99 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.407 -179.025 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.404 ' O ' ' HB2' ' A' ' 124' ' ' CYS . 3.7 m -88.44 141.36 28.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.705 179.645 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.438 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 6.2 m-80 57.22 29.46 16.74 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.926 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.465 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -169.71 -172.52 36.36 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.81 -179.963 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 9.4 ptt180 -166.69 -175.61 3.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.92 0.39 . . . . 0.0 110.59 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 16.1 p80 -109.36 167.86 9.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.637 -179.053 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 41.7 p-10 -122.66 -157.92 0.76 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.072 178.435 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 134.81 175.33 13.81 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.297 -0.954 . . . . 0.0 112.783 179.453 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -112.08 -27.15 8.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.04 0.448 . . . . 0.0 110.744 179.978 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.74 -175.72 2.89 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.354 -179.024 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -107.55 -25.57 11.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.494 178.654 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.42 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 5.1 m-85 -125.14 178.93 5.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.452 179.112 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.42 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 85.9 m-85 -153.62 169.02 24.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.825 -179.232 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.5 p -131.1 179.67 5.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.932 0.396 . . . . 0.0 111.524 -179.059 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.403 ' OD1' ' HB2' ' A' ' 68' ' ' SER . 44.6 p-10 -63.67 95.06 0.1 Allowed 'General case' 0 CA--C 1.517 -0.307 0 CA-C-O 121.354 0.597 . . . . 0.0 111.09 -179.865 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.61 27.95 1.37 Allowed Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.21 -0.905 . . . . 0.0 112.865 179.084 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.412 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -107.52 160.79 15.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.672 0.273 . . . . 0.0 110.458 179.047 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.442 HG22 ' N ' ' A' ' 95' ' ' VAL . 34.4 m -134.16 155.89 40.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.153 0.501 . . . . 0.0 111.389 -179.657 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.553 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 19.5 t -148.71 148.59 15.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.367 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.824 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -108.29 119.67 40.16 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.178 0.513 . . . . 0.0 111.12 -179.331 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.951 ' CE2' HG21 ' A' ' 111' ' ' VAL . 3.5 m-85 -77.06 164.55 25.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.766 -178.477 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.448 ' HA ' ' CD1' ' A' ' 105' ' ' LEU . 0.7 OUTLIER -155.35 135.35 12.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.671 -179.259 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.414 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 61.1 m -69.78 157.52 37.19 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.765 178.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.465 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 78.1 m-20 -85.82 -76.74 0.32 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.426 -179.349 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.7 t -59.02 -26.53 64.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.831 0.348 . . . . 0.0 111.184 -179.345 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 124.39 35.85 0.64 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.402 -179.724 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.438 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 14.3 m-85 -69.58 -174.0 0.65 Allowed 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 120.876 0.37 . . . . 0.0 110.618 179.853 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.5 m -111.9 99.68 8.31 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.181 179.122 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.588 HD23 ' HB2' ' A' ' 122' ' ' PRO . 0.0 OUTLIER -48.02 144.35 3.7 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.736 0.779 . . . . 0.0 111.682 -177.615 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.475 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 40.5 mm -117.73 159.91 17.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 114.402 -1.272 . . . . 0.0 110.913 -177.534 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.464 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 51.49 24.69 11.88 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.171 -1.014 . . . . 0.0 112.581 179.728 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.409 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.5 OUTLIER 61.04 135.04 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.191 0.52 . . . . 0.0 111.79 178.898 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.824 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.1 p -62.14 -28.68 69.81 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.885 -178.776 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -53.44 127.4 36.66 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.883 -179.259 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.951 HG21 ' CE2' ' A' ' 97' ' ' TYR . 3.1 t -128.11 150.38 33.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 110.24 -0.282 . . . . 0.0 110.24 178.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.416 ' O ' ' HA ' ' A' ' 118' ' ' TRP . 0.3 OUTLIER -107.1 129.52 54.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.854 0.359 . . . . 0.0 111.539 -179.201 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.508 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 44.3 t -92.63 106.01 18.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.526 176.228 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 2.6 t -153.74 164.32 38.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.011 0.434 . . . . 0.0 111.206 -178.425 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 45.25 33.21 3.96 Favored Glycine 0 CA--C 1.518 0.254 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.858 179.604 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 65.42 19.0 66.17 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.42 -179.641 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -146.89 -176.85 5.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.877 0.37 . . . . 0.0 110.778 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.553 ' CZ3' HG23 ' A' ' 95' ' ' VAL . 88.8 m95 -118.49 122.96 43.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.95 -179.755 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.46 147.12 28.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.111 -179.366 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.514 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER 71.85 41.95 0.18 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.489 179.192 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 53.3 Cg_endo -68.69 145.98 65.32 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 121.993 1.796 . . . . 0.0 111.014 177.88 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.588 ' HB2' HD23 ' A' ' 105' ' ' LEU . 73.3 Cg_endo -96.49 -173.58 0.23 Allowed 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.521 2.147 . . . . 0.0 113.938 -177.096 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.655 HG22 HE22 ' A' ' 125' ' ' GLN . 0.2 OUTLIER -132.9 172.2 12.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.446 -1.252 . . . . 0.0 109.195 177.868 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 78' ' ' SER . 1.9 m -130.18 91.77 3.17 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.095 0.474 . . . . 0.0 110.433 178.659 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.655 HE22 HG22 ' A' ' 123' ' ' THR . 1.3 mp0 -117.11 -179.39 3.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.369 -178.351 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.48 HG22 ' O ' ' A' ' 126' ' ' ILE . 43.6 mm . . . . . 0 C--N 1.321 -0.645 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.02 -179.462 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.866 0.365 . . . . 0.0 110.956 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.472 ' CB ' ' HA ' ' A' ' 26' ' ' ASP . 0.0 OUTLIER -93.93 168.98 10.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.22 -179.734 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.551 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 76.6 m -78.47 176.77 3.31 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.645 178.861 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.555 ' HD2' ' CD1' ' A' ' 59' ' ' TRP . 36.8 Cg_endo -92.21 178.71 1.46 Allowed 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 122.75 2.3 . . . . 0.0 112.21 -179.281 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.7 t -48.57 103.82 0.38 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.442 179.12 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.514 ' HG3' ' CZ2' ' A' ' 59' ' ' TRP . 51.2 Cg_exo -48.75 159.65 0.83 Allowed 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.319 2.013 . . . . 0.0 112.751 -178.518 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.654 ' O ' HD11 ' A' ' 20' ' ' LEU . 6.2 mtm180 -65.22 -178.43 0.48 Allowed 'General case' 0 CA--C 1.509 -0.602 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.54 177.073 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.489 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 2.7 t70 -141.64 167.2 22.72 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.288 0.566 . . . . 0.0 111.217 -176.865 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.404 HG23 ' C ' ' A' ' 18' ' ' GLY . 7.4 tt -119.29 147.94 22.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.438 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -76.53 -58.82 3.06 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -177.671 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.407 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 0.0 OUTLIER -93.87 32.81 1.39 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.191 -177.945 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.404 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -156.86 -171.94 23.55 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.364 -179.579 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -145.56 141.86 28.62 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 179.291 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.876 HD22 ' CE2' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -88.06 166.35 14.51 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.28 0.562 . . . . 0.0 111.775 -179.153 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.3 OUTLIER -133.05 85.3 2.2 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.726 177.263 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.861 ' HA ' HG23 ' A' ' 31' ' ' ILE . 53.6 mt -72.83 105.25 2.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -177.174 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.13 20.96 39.11 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.496 176.414 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 29' ' ' SER . . . 154.39 139.27 2.78 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 -179.135 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.401 ' O ' ' HB2' ' A' ' 8' ' ' ARG . 15.7 m -120.52 -8.06 10.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.9 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.472 ' HA ' ' CB ' ' A' ' 8' ' ' ARG . 25.5 t0 -69.28 164.67 22.28 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.169 0.509 . . . . 0.0 111.402 -178.816 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.465 ' CZ ' ' HB3' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -53.39 119.09 4.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.512 179.751 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.65 -3.9 61.31 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.507 -178.628 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 24' ' ' GLY . 22.7 m -70.44 174.21 6.01 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 116.951 0.376 . . . . 0.0 110.592 179.553 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.7 p -148.02 149.22 31.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.108 -179.717 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.861 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -115.6 171.31 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.628 -179.92 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 21' ' ' ASP . 1.4 m -130.83 118.35 20.65 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.914 0.388 . . . . 0.0 111.091 179.733 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.876 ' CE2' HD22 ' A' ' 20' ' ' LEU . 10.0 m-85 -95.76 138.92 32.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.579 -179.212 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.403 ' O ' ' HA3' ' A' ' 18' ' ' GLY . 22.6 m -142.73 157.23 44.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.757 179.416 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.4 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 1.5 m -76.94 170.15 17.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.706 0.289 . . . . 0.0 110.748 179.742 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -65.47 -84.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.968 -179.538 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.0 t -157.32 133.5 9.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.728 179.713 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.6 ' O ' HG22 ' A' ' 69' ' ' VAL . . . 66.93 23.71 72.8 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.054 -179.095 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.507 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.5 m-85 -115.27 -178.25 3.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.933 0.397 . . . . 0.0 110.96 -179.803 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.91 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -141.98 111.63 6.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.882 177.511 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.951 HD21 ' O ' ' A' ' 44' ' ' GLU . 5.3 tt -78.14 127.2 31.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.713 -178.722 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.91 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.4 mm -103.72 149.7 7.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.041 0.448 . . . . 0.0 110.975 -179.592 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 89.66 -131.72 10.88 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.304 -179.15 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.951 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -89.61 -176.55 5.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.771 0.32 . . . . 0.0 110.71 179.686 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.3 p -161.26 25.22 0.13 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.049 -179.245 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.413 ' HG3' ' HA ' ' A' ' 32' ' ' THR . 1.4 mtpt -153.24 129.65 10.61 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.113 0.483 . . . . 0.0 111.218 -179.171 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -103.38 150.71 23.55 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.0 179.654 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.492 ' CB ' ' HB2' ' A' ' 60' ' ' ASN . 1.9 m-85 -127.04 121.55 31.89 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 119.191 -1.004 . . . . 0.0 113.094 -177.806 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.432 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 25.4 t -70.16 97.63 1.23 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.258 177.65 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.499 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 2.1 tt0 -131.13 171.92 12.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.448 0.642 . . . . 0.0 111.091 -178.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.499 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -74.36 153.05 39.45 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.347 -179.237 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.5 -126.97 1.51 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.704 -179.833 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 12.4 t -107.95 -40.81 5.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.73 0.3 . . . . 0.0 111.149 -179.444 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 71.0 p -93.95 36.37 1.12 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.039 -179.742 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.76 19.63 71.52 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.622 179.834 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.35 -161.35 0.69 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.821 0.343 . . . . 0.0 110.782 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.55 143.24 47.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.295 -179.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.2 m -153.65 -176.94 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.047 -179.422 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.555 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 75.4 m95 -128.83 126.14 39.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.664 -179.285 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.492 ' HB2' ' CB ' ' A' ' 48' ' ' TYR . 2.1 m120 -69.46 164.45 49.54 Favored Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 176.772 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.493 ' O ' ' HA ' ' A' ' 47' ' ' SER . 67.3 Cg_exo -11.88 121.07 0.01 OUTLIER 'Trans proline' 0 C--N 1.357 1.003 1 C-N-CA 125.8 4.333 . . . . 0.0 115.309 -175.948 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.512 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 4.9 mm-40 -110.25 -79.78 0.58 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.77 -1.105 . . . . 0.0 113.791 -174.35 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' A' ' 14' ' ' ASP . . . -101.95 79.24 0.25 Allowed Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -174.477 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.589 ' HG2' HD11 ' A' ' 41' ' ' LEU . 30.7 Cg_endo -54.67 -154.35 0.0 OUTLIER 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 123.335 2.69 . . . . 0.0 111.811 175.822 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.501 HG22 ' H ' ' A' ' 66' ' ' CYS . 5.4 mm -91.15 166.34 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.944 0.402 . . . . 0.0 111.259 -179.879 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.501 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -168.98 134.96 1.69 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.451 179.404 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -152.96 171.24 18.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.883 0.373 . . . . 0.0 111.02 -179.828 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.507 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 1.6 p -83.97 130.92 34.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.156 0.503 . . . . 0.0 111.364 -179.37 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 38' ' ' GLY . 4.3 m -46.68 100.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.545 -179.834 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.488 ' HE2' HG23 ' A' ' 90' ' ' THR . 1.4 mmtt -86.91 100.2 12.4 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.229 179.621 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.421 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -87.57 121.32 29.84 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 177.652 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.454 ' CG ' ' N ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -68.85 -154.13 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 -179.848 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.454 ' N ' ' CG ' ' A' ' 72' ' ' GLN . 1.8 t -51.49 148.11 9.74 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-O 120.676 0.274 . . . . 0.0 111.119 -179.318 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.483 ' CG ' HG11 ' A' ' 95' ' ' VAL . 12.2 Cg_exo -68.74 157.19 62.87 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.737 2.291 . . . . 0.0 111.909 179.538 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.524 ' HD3' ' CG ' ' A' ' 118' ' ' TRP . 83.0 Cg_exo -44.53 162.03 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.687 2.258 . . . . 0.0 112.741 -179.765 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 69.4 m -116.63 89.21 3.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.658 179.463 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.628 HG23 ' HE2' ' A' ' 97' ' ' TYR . 17.6 pt -69.17 176.89 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.274 -179.255 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.3 t -89.81 150.93 22.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.659 179.037 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.514 ' HB3' ' CD2' ' A' ' 103' ' ' TYR . 1.2 m-80 48.74 27.47 1.55 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.277 178.111 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.467 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -166.23 -164.95 22.76 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.776 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.7 ptt180 -170.23 -174.68 1.78 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.923 0.392 . . . . 0.0 110.667 -179.414 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.532 ' HB3' ' CE1' ' A' ' 97' ' ' TYR . 8.9 p80 -107.16 165.96 10.98 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.705 -178.844 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.502 ' O ' ' CD1' ' A' ' 85' ' ' TYR . 27.1 m-20 -89.38 -91.04 0.13 Allowed 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.857 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 85' ' ' TYR . . . 37.31 -87.04 0.01 OUTLIER Glycine 0 C--N 1.338 0.671 0 N-CA-C 114.134 0.414 . . . . 0.0 114.134 177.439 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.502 ' CD1' ' O ' ' A' ' 83' ' ' ASN . 22.6 m-85 72.89 29.39 1.87 Allowed 'General case' 0 N--CA 1.437 -1.085 0 C-N-CA 123.745 0.818 . . . . 0.0 110.177 -179.573 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.428 ' HB2' ' CZ ' ' A' ' 89' ' ' TYR . 0.4 OUTLIER -101.28 -171.02 1.92 Allowed 'General case' 0 N--CA 1.435 -1.176 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.069 178.286 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -109.01 -27.32 9.71 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.013 0.435 . . . . 0.0 110.64 178.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.442 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 11.8 m-85 -153.01 162.86 40.82 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.817 179.824 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.442 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 6.8 m-85 -140.62 166.42 24.77 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.101 -179.445 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.488 HG23 ' HE2' ' A' ' 70' ' ' LYS . 16.6 p -130.79 175.59 8.91 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.015 0.436 . . . . 0.0 111.829 -178.46 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.584 ' OD2' HG21 ' A' ' 69' ' ' VAL . 0.7 OUTLIER -62.88 99.69 0.17 Allowed 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.619 0.724 . . . . 0.0 110.659 179.68 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 125.24 12.86 3.72 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 114.601 -1.181 . . . . 0.0 113.055 179.007 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -89.04 161.02 16.79 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 117.179 0.49 . . . . 0.0 110.017 178.501 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 20.7 m -150.54 131.16 4.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.11 0.481 . . . . 0.0 110.982 -179.295 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.483 HG11 ' CG ' ' A' ' 74' ' ' PRO . 2.0 p -130.74 143.73 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.698 -179.186 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.795 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -94.56 128.61 41.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.365 0.602 . . . . 0.0 111.376 -178.869 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.911 ' CE1' HG21 ' A' ' 111' ' ' VAL . 3.1 m-85 -84.36 163.81 19.33 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.298 -179.456 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 89.4 p -153.75 133.42 12.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.768 -178.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.445 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 81.9 m -69.84 159.36 33.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.544 178.629 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.467 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 74.0 m-80 -93.65 -79.1 0.42 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.653 -178.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.55 -31.64 25.08 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.847 0.356 . . . . 0.0 111.277 -179.106 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 130.65 38.87 0.28 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.446 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.514 ' CD2' ' HB3' ' A' ' 79' ' ' ASN . 23.9 m-85 -78.66 -172.77 3.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.836 0.35 . . . . 0.0 110.757 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 125' ' ' GLN . 0.3 OUTLIER -111.66 113.97 26.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.494 179.344 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.535 HD22 ' HA ' ' A' ' 109' ' ' SER . 1.1 mp -53.51 115.17 1.8 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.006 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.543 HG22 ' N ' ' A' ' 107' ' ' GLY . 34.5 mm -99.85 162.11 3.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.856 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.543 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 52.64 28.59 30.39 Favored Glycine 0 CA--C 1.508 -0.357 0 C-N-CA 120.492 -0.861 . . . . 0.0 112.541 179.245 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.403 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.7 OUTLIER 60.31 128.8 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.935 -0.633 . . . . 0.0 111.465 179.44 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.795 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.3 p -60.28 -29.45 68.82 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.81 -178.747 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.76 136.88 49.98 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.908 -178.753 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.911 HG21 ' CE1' ' A' ' 97' ' ' TYR . 4.0 t -133.31 119.36 35.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 110.439 -0.208 . . . . 0.0 110.439 179.369 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.07 124.09 29.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.952 0.406 . . . . 0.0 111.474 -178.714 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 93' ' ' SER . 10.3 t -88.55 108.09 19.24 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 175.722 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 52.7 p -155.89 166.41 33.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.189 0.519 . . . . 0.0 111.524 -178.157 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.87 31.99 5.8 Favored Glycine 0 CA--C 1.518 0.279 0 CA-C-N 115.594 -0.73 . . . . 0.0 113.199 179.133 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.46 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 68.61 14.23 66.91 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.446 -0.883 . . . . 0.0 112.569 -179.881 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -147.15 171.63 15.04 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.016 0.436 . . . . 0.0 110.812 179.815 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.524 ' CG ' ' HD3' ' A' ' 75' ' ' PRO . 90.7 m95 -103.61 127.22 51.07 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.56 179.599 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.98 150.9 28.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.312 -179.037 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.492 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER 69.32 44.2 0.25 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.151 178.919 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.492 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 59.2 Cg_endo -72.64 140.62 32.95 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.154 1.903 . . . . 0.0 111.373 178.372 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.505 ' HG2' ' CD2' ' A' ' 97' ' ' TYR . 96.4 Cg_endo -91.73 -169.73 0.29 Allowed 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.643 2.228 . . . . 0.0 113.98 -177.281 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.41 -159.91 1.0 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.391 -1.277 . . . . 0.0 109.743 178.22 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . 0.422 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 10.2 m -156.5 89.63 1.12 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.068 0.461 . . . . 0.0 110.709 179.033 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.414 ' O ' ' HB2' ' A' ' 104' ' ' SER . 15.6 mt-30 -122.69 158.4 30.17 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.034 -178.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.499 HG12 ' CE1' ' A' ' 103' ' ' TYR . 18.5 mm . . . . . 0 C--N 1.324 -0.536 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.958 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.805 0.336 . . . . 0.0 110.938 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -115.64 -174.84 2.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.801 179.617 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.481 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 14.7 m -94.75 162.09 26.56 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.04 -179.576 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 40.2 Cg_endo -67.77 -168.71 0.2 Allowed 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.605 2.203 . . . . 0.0 112.261 -179.487 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 3.1 t -67.47 110.83 5.91 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.019 -179.54 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 11' ' ' SER . 1.5 Cg_endo -52.29 132.36 43.85 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.182 1.921 . . . . 0.0 112.161 -179.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.942 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -53.47 161.71 0.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.515 179.248 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -108.37 -176.71 3.12 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.528 -178.138 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.477 HG22 ' CD2' ' A' ' 20' ' ' LEU . 14.1 tt -146.69 147.96 17.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.942 -179.624 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -91.43 160.43 15.46 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.379 -0.373 . . . . 0.0 109.998 178.535 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.486 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 0.2 OUTLIER 47.21 26.6 0.7 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.766 -179.743 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.45 ' HA2' ' N ' ' A' ' 36' ' ' ASN . . . -153.83 -168.07 16.95 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.846 -179.152 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.64 135.42 15.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.806 0.336 . . . . 0.0 111.071 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.942 HD11 ' O ' ' A' ' 13' ' ' ARG . 8.6 mt -75.17 160.22 30.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.595 -179.746 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.449 ' HB3' ' CB ' ' A' ' 32' ' ' THR . 1.1 t0 -135.39 71.96 1.44 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.774 177.847 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.895 ' HA ' HG23 ' A' ' 31' ' ' ILE . 18.4 mt -75.09 112.97 13.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.224 -177.437 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -107.48 16.15 37.97 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.628 176.383 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 153.94 136.93 2.37 Favored Glycine 0 C--N 1.335 0.473 0 C-N-CA 121.022 -0.609 . . . . 0.0 111.823 -179.31 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.412 ' O ' ' HB2' ' A' ' 8' ' ' ARG . 28.3 m -120.39 29.94 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -178.341 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -99.83 154.59 18.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.828 0.347 . . . . 0.0 111.002 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.478 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 10.0 t80 -48.67 108.87 0.2 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.866 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.96 -4.98 34.13 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.663 -178.76 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 41.9 p -69.63 -164.49 0.07 Allowed 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.738 0.304 . . . . 0.0 110.681 179.762 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.3 p -167.02 143.26 4.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.022 0.439 . . . . 0.0 111.225 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.895 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -112.0 174.17 2.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.497 179.959 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.573 HG23 ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -135.5 113.11 10.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.948 0.404 . . . . 0.0 110.79 179.319 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.77 ' CE1' HD21 ' A' ' 20' ' ' LEU . 26.2 m-85 -88.92 137.09 32.63 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.935 -179.558 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.6 m -144.19 156.76 44.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.373 -179.085 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 59.4 m -84.05 166.23 17.89 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.948 179.74 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.45 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 3.3 m-20 -66.14 -86.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.23 -178.826 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.4 t -151.9 134.67 15.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.871 0.367 . . . . 0.0 110.873 -179.743 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.42 21.99 70.93 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.233 -179.468 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.497 ' CE1' ' HB3' ' A' ' 68' ' ' SER . 2.5 m-30 -114.22 -176.96 3.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.824 0.345 . . . . 0.0 110.832 -179.798 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.732 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -147.92 112.87 5.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.632 178.876 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.957 HD21 ' O ' ' A' ' 44' ' ' GLU . 3.1 tt -73.84 131.85 41.94 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.494 -179.782 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.732 HD11 ' CE1' ' A' ' 40' ' ' HIS . 3.9 mm -103.35 153.83 5.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.975 -179.637 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.72 -133.59 13.3 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.385 -179.514 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.957 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -80.57 174.94 11.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.712 0.292 . . . . 0.0 110.65 179.408 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.537 ' OG ' HD13 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -155.29 27.0 0.41 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.408 178.987 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.573 ' HG2' HG23 ' A' ' 32' ' ' THR . 0.0 OUTLIER -159.98 121.42 3.18 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.669 -178.968 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.426 ' HA ' ' HD2' ' A' ' 61' ' ' PRO . 47.9 t -92.84 157.21 16.5 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.513 179.322 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.52 ' CE1' ' HD3' ' A' ' 61' ' ' PRO . 4.0 m-85 -129.48 110.97 12.3 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.202 0.525 . . . . 0.0 111.648 -179.789 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.502 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 23.9 t -60.58 84.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.259 178.934 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -97.94 -171.64 2.21 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.995 -178.814 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.478 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -108.17 136.2 48.24 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.242 -179.234 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.476 ' N ' HG22 ' A' ' 58' ' ' VAL . . . -125.38 -172.86 13.53 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.921 -0.657 . . . . 0.0 111.939 179.226 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.604 ' C ' HG23 ' A' ' 54' ' ' THR . 5.9 t 47.52 27.59 1.01 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.969 0.414 . . . . 0.0 111.084 179.854 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.604 HG23 ' C ' ' A' ' 53' ' ' SER . 1.3 p 78.15 -53.55 0.5 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.422 -179.881 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -131.5 41.22 1.54 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.616 -179.591 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.419 ' N ' ' O ' ' A' ' 52' ' ' GLY . 9.1 t -125.69 -168.24 1.81 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.862 0.363 . . . . 0.0 110.991 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.21 144.63 47.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.329 179.574 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.476 HG22 ' N ' ' A' ' 52' ' ' GLY . 1.5 m -153.64 179.69 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.302 -179.809 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.672 ' CE3' HD11 ' A' ' 31' ' ' ILE . 95.7 m95 -123.58 123.7 41.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.817 -179.847 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.5 m-20 -148.23 126.82 6.08 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.32 -179.485 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.52 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 2.9 Cg_exo -76.09 -167.45 5.84 Favored 'Cis proline' 0 C--N 1.35 0.656 0 C-N-CA 124.226 -1.156 . . . . 0.0 112.057 -0.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -110.74 -154.2 0.53 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.945 -179.434 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.482 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -69.61 111.21 8.13 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.911 179.863 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.533 ' HG2' HD11 ' A' ' 41' ' ' LEU . 15.3 Cg_exo -69.78 -150.55 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.627 2.218 . . . . 0.0 112.372 -179.165 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.506 HG22 ' H ' ' A' ' 66' ' ' CYS . 6.3 mm -98.45 166.44 2.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.371 -179.07 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.506 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.1 m -164.54 126.66 2.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.476 179.296 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.472 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -153.18 178.24 9.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.913 0.387 . . . . 0.0 111.267 -179.081 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.497 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 27.5 p -90.6 116.12 28.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.746 179.317 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.458 HG11 ' HA2' ' A' ' 115' ' ' GLY . 2.1 p -43.38 96.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.553 -179.804 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.421 ' HD3' ' HB3' ' A' ' 88' ' ' PHE . 0.1 OUTLIER -78.01 120.64 23.14 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.615 -178.928 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.91 125.33 50.24 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.98 178.245 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -69.47 -158.87 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.429 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.406 ' HG ' ' HE2' ' A' ' 82' ' ' HIS . 1.3 t -54.1 143.39 43.52 Favored Pre-proline 0 N--CA 1.45 -0.442 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 179.612 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.459 ' HD2' ' CD2' ' A' ' 82' ' ' HIS . 25.2 Cg_exo -59.97 159.74 24.5 Favored 'Trans proline' 0 CA--C 1.528 0.207 0 C-N-CA 122.429 2.086 . . . . 0.0 112.092 -179.254 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.521 ' HD3' ' CG ' ' A' ' 118' ' ' TRP . 87.3 Cg_exo -46.56 156.44 0.6 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.762 2.308 . . . . 0.0 113.0 -178.856 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 12.8 t -108.06 91.5 3.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.301 178.89 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.748 HG23 ' HE2' ' A' ' 97' ' ' TYR . 22.2 pt -69.03 171.48 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.267 -178.905 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.9 p -89.13 135.17 33.71 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.021 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.471 ' ND2' ' N ' ' A' ' 79' ' ' ASN . 0.1 OUTLIER 67.41 26.49 8.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.688 179.503 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -166.67 -163.39 20.32 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.106 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 5.3 ptt85 -170.29 -175.51 1.96 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.992 0.425 . . . . 0.0 110.982 -179.16 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.459 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 9.0 p-80 -115.99 168.02 10.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.854 179.661 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -93.07 -88.66 0.21 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.895 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.402 ' HA3' ' OH ' ' A' ' 89' ' ' TYR . . . 61.06 137.04 0.01 OUTLIER Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.903 179.423 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -111.26 -26.52 9.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.957 0.408 . . . . 0.0 110.714 179.384 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -92.91 -171.83 2.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.786 179.785 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -106.09 -22.08 12.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.135 179.764 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.432 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 6.4 m-85 -139.56 170.19 16.37 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.162 -179.449 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.432 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 24.6 m-85 -144.32 165.57 27.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.95 179.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 17.0 p -125.01 -179.66 4.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.128 -179.569 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 5.4 p-10 -67.06 95.36 0.39 Allowed 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.389 0.614 . . . . 0.0 110.933 -179.826 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 128.2 31.23 0.69 Allowed Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.132 -0.94 . . . . 0.0 112.93 179.177 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.415 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -110.27 164.16 12.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.689 0.28 . . . . 0.0 110.686 179.476 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 32.5 m -140.55 148.16 22.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.1 0.476 . . . . 0.0 111.276 -179.795 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.529 HG23 ' CH2' ' A' ' 118' ' ' TRP . 21.7 t -145.08 147.87 18.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.676 179.191 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.991 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -101.49 137.05 40.33 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.924 -179.756 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.95 ' CE1' HG21 ' A' ' 111' ' ' VAL . 3.8 m-85 -97.58 157.3 16.1 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.169 -179.313 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 84.5 p -149.44 140.9 23.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.397 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.433 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 73.0 m -70.78 159.02 35.31 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.415 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 17.7 m-20 -92.58 -70.88 0.67 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.54 -178.808 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.13 -22.1 66.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.368 -179.191 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.29 30.92 1.23 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.604 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.496 ' CE2' HG12 ' A' ' 126' ' ' ILE . 21.9 m-85 -69.71 -175.6 0.9 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.973 0.416 . . . . 0.0 110.754 179.634 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 125' ' ' GLN . 0.8 OUTLIER -111.2 104.35 12.85 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.787 177.617 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.55 HD21 ' CG ' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -47.77 129.62 14.17 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.531 0.681 . . . . 0.0 111.799 -177.422 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.438 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 38.1 mm -93.33 158.86 2.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.888 178.726 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.429 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 63.02 -125.83 35.4 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.306 -0.95 . . . . 0.0 111.977 -178.959 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -129.5 134.89 48.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.812 0.339 . . . . 0.0 111.063 179.526 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.991 ' OG ' HG22 ' A' ' 96' ' ' THR . 10.2 p -60.63 -32.26 71.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.115 0.483 . . . . 0.0 110.655 179.286 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -70.63 127.68 16.66 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.795 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.95 HG21 ' CE1' ' A' ' 97' ' ' TYR . 8.8 t -121.29 124.05 71.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 178.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -82.38 126.16 31.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.007 0.432 . . . . 0.0 111.879 -177.747 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.495 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 30.3 t -94.83 91.72 6.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.739 177.452 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.2 OUTLIER -129.46 156.84 43.47 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.036 0.446 . . . . 0.0 111.687 -177.892 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.458 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 46.98 27.7 3.57 Favored Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.856 179.477 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.456 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 77.81 -1.22 68.67 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.811 -179.524 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -123.8 157.45 34.06 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.895 0.379 . . . . 0.0 110.553 179.602 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.529 ' CH2' HG23 ' A' ' 95' ' ' VAL . 94.4 m95 -96.41 137.98 34.68 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.027 -179.654 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.633 ' O ' HG13 ' A' ' 111' ' ' VAL . 34.0 t -121.82 177.87 5.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.525 0.678 . . . . 0.0 111.478 179.292 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.457 ' N ' ' HD3' ' A' ' 121' ' ' PRO . 1.3 p-10 42.74 50.57 5.69 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.951 -179.521 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.457 ' HD3' ' N ' ' A' ' 120' ' ' ASP . 84.6 Cg_endo -83.25 141.7 10.39 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.642 2.228 . . . . 0.0 112.05 178.975 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.55 ' CG ' HD21 ' A' ' 105' ' ' LEU . 94.7 Cg_endo -91.56 -171.17 0.37 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.781 2.321 . . . . 0.0 113.554 -178.733 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.433 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -135.68 -157.94 0.83 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.616 -1.174 . . . . 0.0 109.884 178.601 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 8.6 m -156.6 89.92 1.13 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.077 0.465 . . . . 0.0 110.967 179.065 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.406 ' O ' ' HB2' ' A' ' 104' ' ' SER . 15.6 mt-30 -121.39 160.53 23.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.935 -179.767 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.496 HG12 ' CE2' ' A' ' 103' ' ' TYR . 18.4 mm . . . . . 0 C--N 1.324 -0.518 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.911 179.494 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.79 0.329 . . . . 0.0 110.979 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.55 ' HB3' HG23 ' A' ' 25' ' ' VAL . 0.1 OUTLIER 41.82 -165.32 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.957 178.981 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.46 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 18.9 m -114.68 159.53 36.8 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.76 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -68.64 168.59 19.55 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.393 2.062 . . . . 0.0 111.516 179.317 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 5.1 p -52.59 119.73 16.35 Favored Pre-proline 0 C--N 1.326 -0.447 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.887 -179.204 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.442 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 18.4 Cg_endo -57.79 150.3 63.49 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.55 2.167 . . . . 0.0 112.013 179.739 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.02 136.81 50.76 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.296 0.57 . . . . 0.0 110.701 179.489 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.474 ' HA ' HD11 ' A' ' 20' ' ' LEU . 2.9 p-10 -78.4 -177.38 5.21 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.104 -176.948 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.702 HG22 ' CD2' ' A' ' 20' ' ' LEU . 18.4 tt -145.75 148.49 17.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.095 -179.637 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -92.82 162.27 14.17 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.335 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.44 ' N ' ' ND2' ' A' ' 17' ' ' ASN . 0.4 OUTLIER 47.26 27.65 0.89 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.947 0.403 . . . . 0.0 110.586 -179.404 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -175.45 173.79 46.44 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.921 -0.582 . . . . 0.0 112.287 -179.355 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.412 ' N ' ' O ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -136.77 156.94 47.84 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.729 0.3 . . . . 0.0 110.694 -179.856 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.931 HD22 ' CE1' ' A' ' 33' ' ' TYR . 0.2 OUTLIER -91.11 166.6 12.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.044 0.449 . . . . 0.0 110.976 179.188 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 32' ' ' THR . 15.2 t70 -129.97 78.83 1.87 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.052 178.196 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.887 ' HA ' HG23 ' A' ' 31' ' ' ILE . 42.5 mt -69.2 118.31 13.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 121.206 0.527 . . . . 0.0 112.056 -177.237 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -131.66 19.7 4.71 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.747 177.57 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 161.23 114.69 0.34 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 121.148 -0.549 . . . . 0.0 111.963 -179.475 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.55 HG23 ' HB3' ' A' ' 8' ' ' ARG . 18.7 m -113.58 30.4 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.683 0.278 . . . . 0.0 111.557 -178.837 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.423 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 15.0 t70 -101.55 163.5 12.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.959 0.409 . . . . 0.0 111.158 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.603 ' CZ ' HD12 ' A' ' 51' ' ' LEU . 7.8 t80 -60.83 89.45 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.852 -179.892 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.67 10.92 3.44 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.159 179.47 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.1 m -95.43 -160.47 0.79 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 117.039 0.419 . . . . 0.0 110.453 179.258 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 47' ' ' SER . 3.9 p -168.74 141.08 2.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.054 0.454 . . . . 0.0 111.367 179.488 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.887 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -100.87 170.58 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.317 179.444 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.494 ' HA ' ' HG3' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -132.87 110.33 10.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.931 0.396 . . . . 0.0 111.153 179.65 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.931 ' CE1' HD22 ' A' ' 20' ' ' LEU . 10.6 m-85 -86.03 156.91 20.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.779 -178.886 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 19' ' ' GLN . 66.5 m -156.02 150.94 26.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.94 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 14.3 m -76.42 171.08 15.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.974 179.88 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 17' ' ' ASN . 1.4 t-20 -65.35 -76.95 0.07 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.061 -179.656 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.93 136.28 5.85 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.942 -179.704 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 60.39 23.48 60.27 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.063 -179.428 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.504 ' CE1' ' HB3' ' A' ' 68' ' ' SER . 2.4 m-85 -111.35 -176.62 2.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.802 0.334 . . . . 0.0 110.72 -179.539 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.95 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -142.44 113.24 7.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.544 178.45 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.908 HD21 ' O ' ' A' ' 44' ' ' GLU . 7.0 tt -79.21 120.7 24.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.68 -179.293 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.95 HD11 ' CE1' ' A' ' 40' ' ' HIS . 3.0 mm -98.22 162.17 2.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.216 -179.093 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.4 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 72.76 -140.28 28.77 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.339 -179.762 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.908 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -72.26 -173.53 1.11 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.837 0.351 . . . . 0.0 110.473 179.015 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.1 t -169.66 29.61 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.457 178.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.494 ' HG3' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -163.13 117.26 1.65 Allowed 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.066 -177.801 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.466 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 0.6 OUTLIER -84.58 133.53 34.43 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.293 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.53 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.9 m-85 -110.45 117.71 34.32 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 119.547 -0.861 . . . . 0.0 111.455 179.527 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 33.0 t -72.6 102.36 3.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.753 -179.984 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -122.54 -174.3 2.88 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.145 -179.779 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.734 HD23 ' O ' ' A' ' 56' ' ' SER . 5.1 mt -80.39 140.49 36.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.296 -179.449 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.01 -102.89 0.5 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.867 -0.683 . . . . 0.0 112.434 179.604 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.605 ' C ' HG23 ' A' ' 54' ' ' THR . 1.8 t -89.1 50.23 1.91 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.694 0.283 . . . . 0.0 110.827 179.672 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.617 ' O ' HD22 ' A' ' 51' ' ' LEU . 1.3 p 79.5 -50.83 0.41 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.332 -179.568 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.92 32.49 5.62 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.587 -0.815 . . . . 0.0 112.715 -179.633 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.734 ' O ' HD23 ' A' ' 51' ' ' LEU . 5.0 t -135.68 -173.22 3.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.876 0.369 . . . . 0.0 110.98 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.717 ' O ' HG13 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -119.36 158.17 26.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.554 -179.751 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.717 HG13 ' O ' ' A' ' 57' ' ' MET . 2.4 m -165.87 173.6 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.705 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.53 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 75.8 m95 -128.88 122.48 30.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.695 -179.267 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.53 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.5 OUTLIER -70.66 167.8 24.78 Favored Pre-proline 0 C--N 1.328 -0.33 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 176.98 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.476 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 71.6 Cg_exo -17.0 95.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 125.113 3.875 . . . . 0.0 114.387 -179.189 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.422 ' CB ' ' OH ' ' A' ' 33' ' ' TYR . 0.2 OUTLIER -96.84 -79.02 0.46 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.179 -177.14 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.482 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . . . -87.94 107.32 15.31 Favored Pre-proline 0 C--N 1.332 -0.189 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -176.506 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.87 ' HG2' HD11 ' A' ' 41' ' ' LEU . 1.8 Cg_endo -86.15 -155.88 0.06 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.27 2.646 . . . . 0.0 111.444 178.509 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.489 HG22 ' H ' ' A' ' 66' ' ' CYS . 5.2 mm -89.75 165.57 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.894 0.378 . . . . 0.0 110.711 178.502 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.489 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.1 m -163.05 128.7 3.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.826 179.855 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.478 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -152.81 178.43 9.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.083 -179.652 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.504 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 89.8 p -89.57 117.66 28.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.88 179.591 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.439 ' CG2' ' HB3' ' A' ' 40' ' ' HIS . 2.6 p -44.52 101.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.22 179.754 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.418 ' HD2' ' HB3' ' A' ' 88' ' ' PHE . 38.9 mmtt -81.76 125.52 30.74 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.518 -0.764 . . . . 0.0 112.257 -177.623 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -106.86 120.62 42.53 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.733 176.656 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.89 -159.25 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.36 -179.845 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.479 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 2.0 t -54.08 137.81 56.78 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.81 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.805 ' CG ' HG21 ' A' ' 95' ' ' VAL . 52.1 Cg_exo -56.17 162.54 7.37 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.675 2.25 . . . . 0.0 112.211 -179.579 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -43.79 157.05 0.15 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.59 2.193 . . . . 0.0 112.528 -179.454 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.1 t -103.32 90.11 3.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.617 179.585 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.672 HG23 ' HE1' ' A' ' 97' ' ' TYR . 24.5 pt -69.42 168.49 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.188 -179.253 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -94.96 132.86 39.34 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.882 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.496 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 0.3 OUTLIER 71.18 27.3 3.27 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.76 179.988 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -168.36 -168.27 30.21 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.363 -0.922 . . . . 0.0 113.219 179.443 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.84 -175.24 3.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.859 0.361 . . . . 0.0 110.739 -179.231 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.479 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 3.0 p-80 -115.53 166.12 12.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.031 -179.569 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -105.3 -71.42 0.74 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.789 0.328 . . . . 0.0 110.22 179.47 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.756 ' N ' HG13 ' A' ' 95' ' ' VAL . . . 70.93 160.82 3.77 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.167 177.718 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -111.63 -39.39 4.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.095 0.474 . . . . 0.0 110.721 179.369 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -106.45 -174.65 2.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.239 -179.462 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.02 -37.46 14.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.696 177.152 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.436 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 6.2 m-85 -119.54 177.48 4.92 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.988 -1.005 . . . . 0.0 110.643 179.07 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.436 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 43.8 m-85 -146.85 162.47 38.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.204 -178.69 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.3 p -137.08 -177.86 4.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.476 -179.149 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 0.4 OUTLIER -59.43 92.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.252 0.549 . . . . 0.0 111.121 -179.625 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.56 26.8 1.55 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.367 -0.833 . . . . 0.0 113.086 178.571 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.426 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -105.83 154.21 20.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.89 0.345 . . . . 0.0 110.634 179.106 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 17.4 m -139.49 138.07 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.261 0.553 . . . . 0.0 111.472 -179.694 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.805 HG21 ' CG ' ' A' ' 74' ' ' PRO . 21.5 t -137.94 142.22 36.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.812 179.007 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.77 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -93.2 141.67 28.17 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.553 -178.033 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.82 ' CE2' HG21 ' A' ' 111' ' ' VAL . 4.7 m-85 -96.57 161.5 13.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.592 179.234 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.1 m -160.27 139.08 10.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.247 -179.752 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.459 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 59.6 m -69.58 164.87 22.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.037 -179.914 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.404 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 0.3 OUTLIER -97.27 -85.66 0.35 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.12 -179.921 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 41.9 t -47.34 -26.4 1.26 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.351 -179.399 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.27 54.25 0.23 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.088 -179.482 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.496 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 15.0 m-85 -93.1 -173.26 3.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.806 0.336 . . . . 0.0 111.286 -178.696 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.4 ' N ' ' O ' ' A' ' 125' ' ' GLN . 0.7 OUTLIER -109.58 103.63 12.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.113 179.637 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.456 HD21 ' HA ' ' A' ' 109' ' ' SER . 0.2 OUTLIER -49.99 129.18 20.18 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.515 0.674 . . . . 0.0 111.556 -178.056 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.678 HD11 ' HG3' ' A' ' 125' ' ' GLN . 36.9 mm -95.2 157.68 3.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.294 179.431 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.473 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 60.87 -128.91 45.84 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.319 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -120.04 132.47 55.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.791 0.329 . . . . 0.0 111.086 179.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.77 ' OG ' HG22 ' A' ' 96' ' ' THR . 3.8 p -68.05 -33.09 73.91 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.904 179.597 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -78.3 119.88 5.27 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.784 -179.721 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.82 HG21 ' CE2' ' A' ' 97' ' ' TYR . 2.7 t -108.3 141.97 22.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 178.145 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.35 128.14 46.49 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.939 0.4 . . . . 0.0 111.302 -179.18 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.492 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 20.4 t -90.34 106.04 18.22 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.392 176.717 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 9.0 p -143.1 146.28 33.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.41 -178.379 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.402 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 54.05 34.86 53.06 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.746 179.532 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.436 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 67.75 12.44 62.0 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.848 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -138.58 170.17 16.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.918 0.39 . . . . 0.0 110.778 179.659 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.792 ' CH2' HG22 ' A' ' 95' ' ' VAL . 95.7 m95 -107.98 151.86 25.25 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.406 -178.802 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.94 148.92 44.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.158 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.471 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.7 OUTLIER 70.94 47.25 0.26 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.994 178.851 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 96.1 Cg_endo -78.83 136.57 13.47 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.433 2.089 . . . . 0.0 111.647 178.403 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.454 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 73.6 Cg_endo -87.16 -174.3 1.29 Allowed 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.533 2.155 . . . . 0.0 113.589 -178.243 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.481 HG22 ' H ' ' A' ' 124' ' ' CYS . 0.6 OUTLIER -134.02 176.79 8.27 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.272 177.305 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . 0.481 ' H ' HG22 ' A' ' 123' ' ' THR . 10.9 m -137.67 107.04 6.1 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.511 0.672 . . . . 0.0 111.848 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.678 ' HG3' HD11 ' A' ' 106' ' ' ILE . 2.9 pt20 -148.31 -179.0 6.62 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.117 -179.105 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 22.5 mm . . . . . 0 C--N 1.315 -0.905 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.334 -178.014 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.3 mtt-85 . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.683 0.278 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.457 ' HD2' HG23 ' A' ' 25' ' ' VAL . 0.2 OUTLIER 48.41 -179.16 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.196 0.522 . . . . 0.0 111.745 178.298 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 1.226 ' SG ' ' SG ' ' A' ' 49' ' ' CYS . 0.0 OUTLIER -98.57 163.1 19.68 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.684 179.406 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.47 ' HD3' ' CB ' ' A' ' 57' ' ' MET . 37.7 Cg_endo -67.02 170.49 12.92 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.065 1.843 . . . . 0.0 111.851 179.759 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.4 t -51.26 104.56 0.44 Allowed Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.895 -179.332 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.742 ' HB3' HD11 ' A' ' 31' ' ' ILE . 12.1 Cg_endo -56.75 147.29 72.8 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.058 1.839 . . . . 0.0 111.76 179.823 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -55.92 174.01 0.13 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.37 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.745 ' HA ' HD11 ' A' ' 20' ' ' LEU . 0.6 OUTLIER -132.57 -171.2 2.6 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.989 0.423 . . . . 0.0 111.305 -179.61 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.432 HG23 ' C ' ' A' ' 18' ' ' GLY . 5.2 tt -144.1 145.16 22.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.61 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -80.75 -58.68 2.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.256 -178.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.412 ' N ' ' ND2' ' A' ' 17' ' ' ASN . 0.6 OUTLIER -94.0 38.29 1.08 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.852 -179.538 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.432 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -158.37 -177.84 31.84 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.965 -179.804 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.41 ' N ' ' O ' ' A' ' 34' ' ' SER . 0.7 OUTLIER -137.71 140.79 40.93 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 179.59 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.745 HD11 ' HA ' ' A' ' 14' ' ' ASP . 10.2 mt -86.67 154.75 20.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.081 0.467 . . . . 0.0 111.759 -178.862 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.461 ' HB3' ' CB ' ' A' ' 32' ' ' THR . 15.6 t0 -124.39 71.22 1.13 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.631 177.457 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.86 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.9 OUTLIER -76.58 104.59 4.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.774 -177.836 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -110.6 -15.71 10.89 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.077 178.436 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.416 ' O ' ' CB ' ' A' ' 29' ' ' SER . . . -157.69 110.44 0.44 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.118 179.562 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.555 HG13 ' CG2' ' A' ' 22' ' ' ILE . 27.3 m -112.12 51.6 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.534 0.207 . . . . 0.0 111.534 -179.322 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 25.8 t0 -111.18 163.8 13.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.932 0.396 . . . . 0.0 110.84 178.063 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.456 ' CZ ' ' HB3' ' A' ' 51' ' ' LEU . 1.4 t80 -53.14 95.39 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.904 -179.18 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.17 31.37 5.05 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.148 -179.658 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' A' ' 24' ' ' GLY . 14.8 m -99.67 -158.42 0.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.285 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 47' ' ' SER . 7.7 p -165.17 139.95 5.08 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 120.273 -0.571 . . . . 0.0 112.288 179.708 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.86 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.8 OUTLIER -105.2 170.68 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.267 178.568 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.463 ' HA ' ' HG3' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -128.48 111.75 13.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.005 0.431 . . . . 0.0 111.11 178.591 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.531 ' CE2' ' CD2' ' A' ' 20' ' ' LEU . 13.6 m-85 -85.13 149.28 25.64 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.255 -179.604 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.411 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 9.6 p -152.79 165.72 34.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.713 179.475 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.415 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 9.8 m -85.2 168.43 14.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.768 0.318 . . . . 0.0 110.92 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -66.02 -83.24 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.995 -179.437 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.86 136.23 13.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.476 179.703 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.464 ' HA3' ' CB ' ' A' ' 91' ' ' ASP . . . 59.97 28.84 66.77 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.387 -0.911 . . . . 0.0 111.671 -178.688 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.526 ' CE1' ' CB ' ' A' ' 68' ' ' SER . 2.7 m-85 -120.15 173.07 7.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.816 0.341 . . . . 0.0 110.939 -179.12 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.76 ' CE1' HG22 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -129.85 133.45 46.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.106 175.271 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.933 HD21 ' O ' ' A' ' 44' ' ' GLU . 6.7 tt -97.33 120.95 38.63 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.641 -179.333 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.591 ' N ' HD13 ' A' ' 42' ' ' ILE . 1.2 mm -99.13 149.68 5.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.088 -179.302 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.06 -136.01 13.64 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.275 -179.62 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.933 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -84.55 -173.87 4.96 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.894 0.378 . . . . 0.0 110.653 179.612 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.9 p -159.51 22.15 0.18 Allowed 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.462 -178.899 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.463 ' HG3' ' HA ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -154.44 125.89 7.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.945 0.402 . . . . 0.0 112.062 -177.796 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.455 ' O ' ' HA ' ' A' ' 30' ' ' SER . 0.7 OUTLIER -92.4 141.68 28.27 Favored 'General case' 0 CA--C 1.518 -0.266 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.673 177.201 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.441 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.4 m-85 -122.69 113.41 19.18 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 119.611 -0.836 . . . . 0.0 111.407 179.129 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 1.226 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 1.6 p -79.89 118.54 21.75 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 119.152 -1.019 . . . . 0.0 111.397 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.97 -170.72 2.57 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.842 -179.837 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.511 HD22 ' HA ' ' A' ' 54' ' ' THR . 0.0 OUTLIER -85.95 126.21 33.94 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.04 -179.476 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.422 ' N ' HG22 ' A' ' 58' ' ' VAL . . . -93.54 -58.87 1.24 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.659 -179.686 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.4 48.01 1.55 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.846 0.355 . . . . 0.0 111.063 -179.683 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.511 ' HA ' HD22 ' A' ' 51' ' ' LEU . 3.9 p 58.31 28.14 16.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.791 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 163.12 -28.73 0.24 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.228 -179.861 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.41 -163.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.738 0.304 . . . . 0.0 110.664 179.514 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.47 ' CB ' ' HD3' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -120.61 144.08 48.32 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.15 0.5 . . . . 0.0 110.734 179.736 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 49' ' ' CYS . 1.7 m -157.21 171.31 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.688 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.555 ' CD2' ' HB3' ' A' ' 49' ' ' CYS . 70.7 m95 -131.15 121.01 24.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.042 0.448 . . . . 0.0 111.6 -179.491 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.495 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 6.3 m-20 -69.68 168.03 19.77 Favored Pre-proline 0 C--O 1.223 -0.298 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.148 178.788 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.495 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 76.3 Cg_exo -20.16 96.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 125.081 3.854 . . . . 0.0 114.412 -178.37 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.465 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -96.01 -78.09 0.47 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.817 -178.421 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.506 ' HB2' ' O ' ' A' ' 14' ' ' ASP . . . -82.13 108.07 10.48 Favored Pre-proline 0 C--N 1.331 -0.2 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -176.565 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.88 ' HG2' HD11 ' A' ' 41' ' ' LEU . 1.0 OUTLIER -85.17 -155.1 0.06 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.113 2.542 . . . . 0.0 110.754 176.99 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.461 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 1.5 mm -95.85 159.18 2.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.969 0.414 . . . . 0.0 110.402 177.782 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.2 m -157.92 138.27 12.69 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.775 179.834 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.47 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -150.01 177.03 10.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.55 179.991 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.526 ' CB ' ' CE1' ' A' ' 39' ' ' TYR . 1.2 p -104.49 141.32 36.58 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.575 179.088 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.76 HG22 ' CE1' ' A' ' 40' ' ' HIS . 2.3 p -67.6 66.84 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.287 0.565 . . . . 0.0 110.384 179.154 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.559 ' HE2' HG23 ' A' ' 90' ' ' THR . 1.5 mmpt? -47.75 112.71 0.59 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.159 -178.184 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -97.28 125.79 42.07 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 176.268 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.04 -166.14 0.97 Allowed 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.96 -179.342 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 1.5 t -42.24 134.21 2.54 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.329 -179.129 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.495 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 37.4 Cg_exo -58.54 161.52 14.42 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.331 2.021 . . . . 0.0 112.158 -179.245 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.462 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 88.2 Cg_exo -40.56 154.61 0.06 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.779 2.319 . . . . 0.0 112.867 -179.477 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.0 p -106.38 91.02 3.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.997 -179.641 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.549 HG21 ' O ' ' A' ' 122' ' ' PRO . 19.9 pt -69.65 175.9 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.066 179.917 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.5 t -93.54 149.07 21.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.635 178.869 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.47 ' HB3' ' CE1' ' A' ' 103' ' ' TYR . 1.1 m-80 50.12 28.45 3.04 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.127 177.927 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.47 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -158.34 -163.61 13.07 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.899 179.872 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.408 ' N ' ' O ' ' A' ' 98' ' ' SER . 13.2 ptt180 -170.12 -175.65 2.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.095 0.474 . . . . 0.0 110.931 -179.214 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 4.9 p80 -123.04 166.52 14.98 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.801 179.756 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.434 ' OD1' HG13 ' A' ' 95' ' ' VAL . 46.2 p30 -116.96 -158.21 0.69 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.422 178.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 138.05 168.2 11.24 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.414 -0.898 . . . . 0.0 112.551 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -113.69 -30.57 6.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.921 0.391 . . . . 0.0 111.122 -179.712 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.54 -173.81 2.56 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.169 -179.541 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.56 -26.64 12.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.667 179.247 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.425 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 13.9 m-85 -125.62 -179.28 4.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.542 179.315 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.425 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 65.9 m-85 -152.71 167.84 27.64 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.713 180.0 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.559 HG23 ' HE2' ' A' ' 70' ' ' LYS . 24.9 p -141.05 -175.85 4.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.937 0.398 . . . . 0.0 111.361 -179.339 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.464 ' CB ' ' HA3' ' A' ' 38' ' ' GLY . 1.0 OUTLIER -61.55 96.6 0.06 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.295 0.569 . . . . 0.0 110.967 179.879 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 125.34 19.4 2.36 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.16 -0.927 . . . . 0.0 113.222 178.483 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.441 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.7 OUTLIER -100.64 154.16 18.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 117.049 0.424 . . . . 0.0 110.565 178.989 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.18 148.99 31.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.04 0.448 . . . . 0.0 110.918 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.473 ' CG2' ' CH2' ' A' ' 118' ' ' TRP . 17.9 t -145.52 147.45 18.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.651 179.852 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.794 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -107.13 126.58 52.55 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.962 -179.624 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.977 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.6 m-85 -85.51 156.5 20.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.932 -179.742 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.432 ' HA ' HD13 ' A' ' 105' ' ' LEU . 72.5 m -149.92 145.55 26.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.17 -179.503 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.457 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 66.7 m -75.16 156.04 36.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.028 179.887 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.47 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 78.9 m-20 -85.06 -78.13 0.26 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.592 -179.03 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 23.5 m -59.89 -23.49 63.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.378 -178.806 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 123.97 33.73 0.78 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.541 -179.811 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.503 ' CE2' HG12 ' A' ' 126' ' ' ILE . 40.4 m-85 -69.7 -175.52 0.89 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.967 0.413 . . . . 0.0 110.757 179.697 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 4.1 m -107.84 101.61 10.88 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.387 179.012 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.512 HD21 ' HA ' ' A' ' 109' ' ' SER . 0.3 OUTLIER -47.29 127.05 10.31 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-O 121.367 0.603 . . . . 0.0 111.514 -178.991 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.438 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 40.7 mm -95.76 154.64 3.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.427 179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 66.49 -125.42 26.23 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.93 -178.891 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -127.28 134.24 50.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.878 0.37 . . . . 0.0 110.943 179.167 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.794 ' HB2' HG22 ' A' ' 96' ' ' THR . 0.4 OUTLIER -67.65 -30.39 69.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.804 179.621 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -70.11 132.8 23.88 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.554 179.388 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.977 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.4 t -127.41 121.64 57.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.675 0.274 . . . . 0.0 110.453 179.329 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.29 117.31 22.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.005 0.431 . . . . 0.0 111.802 -178.463 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.534 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 17.9 t -82.59 104.33 12.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.438 176.559 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 2.2 p -146.42 163.08 36.77 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.364 -178.17 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.33 30.0 4.03 Favored Glycine 0 N--CA 1.453 -0.219 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.767 179.898 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 69.3 16.14 70.9 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.52 -179.464 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -141.45 -177.4 5.13 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.887 0.375 . . . . 0.0 110.599 179.515 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.534 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 93.7 m95 -117.74 144.99 44.78 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.103 -179.391 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.91 147.02 51.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.298 -179.285 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.489 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER 73.38 46.13 0.21 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.163 178.676 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 73.3 Cg_endo -75.84 136.02 18.25 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.361 2.041 . . . . 0.0 111.331 177.951 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.549 ' O ' HG21 ' A' ' 77' ' ' ILE . 64.8 Cg_endo -91.12 -173.68 0.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.505 2.137 . . . . 0.0 113.496 -178.135 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.436 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -129.37 -162.7 1.22 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.746 177.833 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 4.9 m -156.43 90.82 1.2 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.069 0.462 . . . . 0.0 110.856 179.378 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -118.12 160.7 21.09 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.932 -179.626 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.563 HG22 ' O ' ' A' ' 126' ' ' ILE . 15.9 mm . . . . . 0 C--N 1.323 -0.546 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.997 179.912 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.898 0.38 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.844 ' HD2' HG23 ' A' ' 25' ' ' VAL . 32.9 mtm-85 -86.26 -169.01 2.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.957 179.814 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.432 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 8.5 m -91.08 163.0 31.06 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.625 179.55 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -73.62 167.88 26.15 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.281 1.988 . . . . 0.0 111.719 179.87 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.2 p -52.37 108.97 1.21 Allowed Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.927 -179.275 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.592 ' HG2' HD13 ' A' ' 22' ' ' ILE . 49.2 Cg_exo -49.34 158.05 1.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.314 2.009 . . . . 0.0 112.335 179.906 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.876 ' O ' HD11 ' A' ' 20' ' ' LEU . 4.3 mtt180 -54.11 177.25 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.735 177.354 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.427 ' O ' ' CB ' ' A' ' 63' ' ' ALA . 0.1 OUTLIER -124.9 -177.01 3.7 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.182 0.515 . . . . 0.0 111.678 -178.676 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.501 HG22 ' CD2' ' A' ' 20' ' ' LEU . 5.2 tt -139.47 151.69 22.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.837 -179.397 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -90.34 -64.48 1.13 Allowed 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -177.46 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -92.52 26.92 2.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.775 0.321 . . . . 0.0 111.09 -178.894 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.423 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -144.15 -160.4 8.45 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.851 179.708 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.85 133.52 10.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.753 0.311 . . . . 0.0 110.489 179.434 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.876 HD11 ' O ' ' A' ' 13' ' ' ARG . 18.7 mt -72.27 150.72 43.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.178 0.513 . . . . 0.0 111.899 -178.37 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.412 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 5.5 t0 -123.36 69.62 1.02 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.266 177.419 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.894 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.9 OUTLIER -79.4 100.75 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.069 -176.492 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -99.36 19.26 54.58 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.575 176.696 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 163.32 141.07 3.02 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 121.192 -0.528 . . . . 0.0 111.87 -179.376 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.844 HG23 ' HD2' ' A' ' 8' ' ' ARG . 6.2 m -127.01 -3.77 4.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -178.898 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.421 ' HA ' ' CB ' ' A' ' 8' ' ' ARG . 1.3 p-10 -69.57 156.58 38.69 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.792 0.33 . . . . 0.0 110.669 179.868 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.451 ' CZ ' ' HG ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -49.26 116.72 1.82 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.021 0.439 . . . . 0.0 111.02 -179.25 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.07 -6.64 47.34 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.585 -178.77 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 m -66.98 -174.29 0.32 Allowed 'General case' 0 C--O 1.231 0.107 0 CA-C-N 116.884 0.342 . . . . 0.0 110.762 179.711 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 47' ' ' SER . 0.3 OUTLIER -159.74 139.16 11.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.964 -179.978 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.894 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -108.2 167.63 3.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.921 0.391 . . . . 0.0 110.854 179.681 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.423 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -132.92 110.6 10.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.695 178.554 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.713 ' CE2' HD21 ' A' ' 20' ' ' LEU . 23.8 m-85 -82.76 132.19 35.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.162 -179.272 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.22 159.98 40.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.446 -179.898 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.449 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 56.4 m -84.69 176.13 8.76 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.625 -179.996 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -84.98 -83.22 0.16 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.911 0.386 . . . . 0.0 110.769 -179.346 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.23 129.4 9.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.344 179.267 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.905 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 74.67 28.77 62.52 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.434 -0.888 . . . . 0.0 111.596 -177.842 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.508 ' CE2' ' HB3' ' A' ' 68' ' ' SER . 29.7 m-85 -134.08 157.77 45.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.003 0.43 . . . . 0.0 111.173 -179.734 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.843 ' CE1' HG22 ' A' ' 69' ' ' VAL . 6.3 m-70 -115.13 134.03 55.51 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 173.63 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.848 HD21 ' O ' ' A' ' 44' ' ' GLU . 6.3 tt -81.65 107.67 14.58 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.023 -179.613 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.431 HG12 ' HA ' ' A' ' 66' ' ' CYS . 1.3 mm -92.72 146.1 6.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.97 -178.229 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.76 -151.97 32.86 Favored Glycine 0 N--CA 1.452 -0.277 0 CA-C-N 115.595 -0.73 . . . . 0.0 112.011 -178.441 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.848 ' O ' HD21 ' A' ' 41' ' ' LEU . 1.3 pm0 -53.22 173.21 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.72 0.26 . . . . 0.0 110.406 179.232 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.519 ' HB3' HD22 ' A' ' 41' ' ' LEU . 8.3 p -153.61 24.07 0.52 Allowed 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.869 0.366 . . . . 0.0 111.522 -178.542 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.423 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 0.8 OUTLIER -157.53 -170.91 3.37 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.947 -178.357 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.447 ' O ' HG13 ' A' ' 31' ' ' ILE . 1.8 m -164.67 98.87 0.79 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.632 179.182 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.487 ' N ' ' CD2' ' A' ' 48' ' ' TYR . 1.2 m-30 -84.95 118.86 24.8 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.038 0.447 . . . . 0.0 111.21 -179.303 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 16.2 t -70.2 115.62 9.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.298 179.043 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.503 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 2.8 tt0 -144.56 172.35 13.1 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.449 0.643 . . . . 0.0 111.214 -178.715 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.697 HD23 ' O ' ' A' ' 56' ' ' SER . 1.0 OUTLIER -58.76 153.38 16.94 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.303 -179.683 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -94.63 -104.81 1.9 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.503 -179.711 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.3 t -126.43 -61.81 1.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.847 0.356 . . . . 0.0 110.931 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.1 p -89.94 52.6 2.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.922 179.844 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 60.18 39.54 96.04 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.51 -179.994 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.697 ' O ' HD23 ' A' ' 51' ' ' LEU . 10.0 t -108.76 -170.36 1.65 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.78 0.324 . . . . 0.0 110.983 -179.906 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.421 ' SD ' ' CE1' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -116.49 136.2 53.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.576 179.798 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.3 m -146.77 -175.65 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.811 -179.891 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.542 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 88.1 m95 -128.51 137.14 51.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.008 -179.454 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -151.86 122.51 3.64 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.016 -179.697 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.4 ' HG2' ' O ' ' A' ' 46' ' ' LYS . 58.2 Cg_endo -72.65 -167.2 4.8 Favored 'Cis proline' 0 C--N 1.352 0.746 0 C-N-CA 123.744 -1.357 . . . . 0.0 112.259 -0.313 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -110.64 -155.88 0.57 Allowed 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 -179.306 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.493 ' CB ' ' CE2' ' A' ' 33' ' ' TYR . . . -76.01 112.82 22.46 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.653 179.226 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.474 ' HD2' ' CG ' ' A' ' 33' ' ' TYR . 18.3 Cg_exo -68.26 -150.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.511 2.141 . . . . 0.0 112.192 -179.1 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.5 pt -136.21 -177.95 2.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.841 -179.814 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.431 ' HA ' HG12 ' A' ' 42' ' ' ILE . 78.7 m -149.99 157.32 43.04 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.353 0.597 . . . . 0.0 111.781 179.452 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -129.63 109.18 10.79 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.41 177.659 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.508 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 11.2 p -49.81 131.78 22.18 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.232 -178.668 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.905 HG12 ' O ' ' A' ' 38' ' ' GLY . 4.3 p -53.68 104.83 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.298 -0.865 . . . . 0.0 112.26 -178.479 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.467 ' CE ' HG23 ' A' ' 90' ' ' THR . 2.4 mmtp -89.45 114.21 25.66 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.582 177.867 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.11 125.39 38.72 Favored 'General case' 0 CA--C 1.516 -0.353 0 CA-C-O 121.103 0.478 . . . . 0.0 110.266 179.125 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.57 -155.64 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.924 178.777 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.408 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 1.1 t -53.15 143.77 31.86 Favored Pre-proline 0 N--CA 1.447 -0.584 0 CA-C-O 120.561 0.22 . . . . 0.0 110.536 179.483 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.488 ' HD2' ' CD2' ' A' ' 82' ' ' HIS . 32.4 Cg_exo -60.14 166.28 9.26 Favored 'Trans proline' 0 CA--C 1.53 0.311 0 C-N-CA 122.633 2.222 . . . . 0.0 112.277 -179.263 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.526 ' HD3' ' CG ' ' A' ' 118' ' ' TRP . 97.7 Cg_exo -40.97 165.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.795 2.33 . . . . 0.0 112.927 -179.517 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 73.1 m -115.32 87.34 2.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.704 179.551 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.632 HG23 ' HE2' ' A' ' 97' ' ' TYR . 7.3 pt -69.48 -173.59 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.071 -179.547 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 t -100.8 148.88 24.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.955 179.679 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.497 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 0.9 OUTLIER 47.22 29.4 1.19 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.112 177.937 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.494 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -161.51 -171.62 27.79 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.548 -0.834 . . . . 0.0 113.056 179.778 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -170.36 -174.87 1.78 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.992 0.425 . . . . 0.0 111.028 -178.723 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.488 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 2.1 p-80 -117.59 171.95 7.67 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.621 -179.962 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -109.95 -75.88 0.62 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.119 179.625 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.406 ' HA3' ' OH ' ' A' ' 89' ' ' TYR . . . 69.72 154.78 1.05 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.664 179.773 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.461 ' CD1' ' N ' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -110.24 -35.81 5.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.14 0.495 . . . . 0.0 110.63 179.61 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -98.3 -172.71 2.4 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.948 -179.79 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.7 -24.35 14.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.891 179.338 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.439 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 7.3 m-85 -130.27 178.13 6.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.897 179.856 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.439 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 49.8 m-85 -152.23 164.32 37.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.0 -179.381 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.467 HG23 ' CE ' ' A' ' 70' ' ' LYS . 16.5 p -148.9 -174.93 4.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.004 0.431 . . . . 0.0 111.427 -179.605 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 7.3 p-10 -52.92 93.6 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.238 0.542 . . . . 0.0 111.566 -179.155 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.09 26.88 1.61 Allowed Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.474 -0.785 . . . . 0.0 113.628 177.549 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.34 152.5 26.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.191 0.495 . . . . 0.0 110.848 178.994 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.41 HG22 ' N ' ' A' ' 95' ' ' VAL . 34.3 m -134.85 153.62 35.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.156 0.503 . . . . 0.0 111.24 -179.703 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.517 HG23 ' CH2' ' A' ' 118' ' ' TRP . 25.1 t -147.59 148.14 16.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.636 179.263 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.488 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -105.14 134.09 48.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.698 179.876 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.953 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.5 m-85 -92.4 152.17 19.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.037 -179.754 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 59.0 m -146.52 140.29 26.07 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.754 179.749 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.494 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 82.0 m -69.75 159.03 34.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.033 -179.666 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -93.03 -87.36 0.23 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.222 -179.821 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.7 t -44.52 -33.2 1.65 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.637 -179.071 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 133.22 40.45 0.19 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.563 179.867 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.498 ' CE2' HG12 ' A' ' 126' ' ' ILE . 37.6 m-85 -82.2 -173.07 4.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.845 0.355 . . . . 0.0 110.781 179.794 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.0 m -112.2 109.98 19.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.016 -179.821 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.51 HD23 ' HB2' ' A' ' 122' ' ' PRO . 2.5 tp -45.43 113.5 0.6 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.903 179.05 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.432 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 35.2 mm -92.07 154.64 3.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.143 179.83 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 65.69 -125.27 28.11 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.362 -0.923 . . . . 0.0 111.811 -178.299 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -123.3 132.84 54.14 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.795 0.331 . . . . 0.0 110.651 179.052 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.488 ' OG ' HG22 ' A' ' 96' ' ' THR . 2.6 t -69.36 -29.94 67.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.49 179.438 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -70.98 135.52 24.48 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.794 179.771 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.953 HG21 ' CE1' ' A' ' 97' ' ' TYR . 3.1 t -129.44 120.78 51.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.596 0.236 . . . . 0.0 110.717 179.266 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.859 HD22 ' N ' ' A' ' 113' ' ' CYS . 1.0 OUTLIER -80.33 130.49 35.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.903 0.382 . . . . 0.0 111.434 -179.232 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.859 ' N ' HD22 ' A' ' 112' ' ' LEU . 37.4 t -102.68 104.18 14.5 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.075 177.461 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.727 ' HB3' HD11 ' A' ' 112' ' ' LEU . 5.3 p -152.93 123.01 7.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.898 0.38 . . . . 0.0 111.714 -179.352 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.42 ' CA ' HG11 ' A' ' 69' ' ' VAL . . . 93.17 19.79 34.95 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.696 179.148 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.449 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 82.14 -1.27 87.41 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.622 -179.173 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -131.51 -177.42 4.4 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.859 0.361 . . . . 0.0 110.432 179.373 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.526 ' CG ' ' HD3' ' A' ' 75' ' ' PRO . 86.5 m95 -120.08 157.43 28.96 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.035 -178.998 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.72 152.34 47.91 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.054 0.454 . . . . 0.0 111.298 -179.844 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.498 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.7 OUTLIER 69.52 45.57 0.28 Allowed Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.119 179.241 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.498 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 76.9 Cg_endo -77.45 138.32 17.4 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.384 2.056 . . . . 0.0 111.755 178.564 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.51 ' HB2' HD23 ' A' ' 105' ' ' LEU . 74.3 Cg_endo -91.25 -171.64 0.42 Allowed 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.786 2.324 . . . . 0.0 113.482 -178.542 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -131.88 -167.16 1.83 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.819 177.947 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 7.4 m -148.67 92.82 2.04 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.051 0.453 . . . . 0.0 110.801 179.328 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -118.02 163.93 15.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.551 -179.853 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.551 HG22 ' O ' ' A' ' 126' ' ' ILE . 15.4 mm . . . . . 0 C--N 1.322 -0.594 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.956 -179.789 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.716 0.293 . . . . 0.0 110.773 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.499 ' CD ' HG22 ' A' ' 25' ' ' VAL . 3.4 ptp180 -86.55 -158.36 0.41 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.979 -179.78 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.45 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 20.5 m -116.38 161.58 30.84 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.845 0.355 . . . . 0.0 111.575 -178.454 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 57.4 Cg_endo -71.12 174.62 10.39 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.485 2.123 . . . . 0.0 112.02 179.689 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.0 t -54.55 108.25 1.09 Allowed Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.925 -179.683 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.519 ' HG3' ' CZ2' ' A' ' 59' ' ' TRP . 53.3 Cg_exo -46.4 164.56 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.351 2.034 . . . . 0.0 112.123 179.867 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.849 ' O ' HD11 ' A' ' 20' ' ' LEU . 14.7 ttt180 -74.07 158.56 34.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.707 178.103 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.9 -175.42 2.76 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.202 0.525 . . . . 0.0 111.516 -178.301 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.452 HG22 ' CD2' ' A' ' 20' ' ' LEU . 19.7 tt -151.05 146.02 16.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.203 -179.492 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -85.03 158.97 20.31 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.34 -0.391 . . . . 0.0 109.999 177.844 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.483 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 0.4 OUTLIER 46.66 30.77 1.21 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.887 179.974 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -157.93 175.88 35.09 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.705 -179.413 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -141.84 137.82 31.73 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.658 0.266 . . . . 0.0 110.515 -179.869 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.849 HD11 ' O ' ' A' ' 13' ' ' ARG . 25.9 mt -83.71 157.88 22.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.11 0.481 . . . . 0.0 111.604 -179.558 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -125.45 75.49 1.48 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.625 177.709 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.918 ' HA ' HG23 ' A' ' 31' ' ' ILE . 1.1 mt -71.4 104.01 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.105 -177.156 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.39 15.36 56.21 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.789 176.855 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 156.08 130.99 1.34 Allowed Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.077 -179.591 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.781 HG12 ' HZ2' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -113.24 5.7 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-O 120.768 0.318 . . . . 0.0 110.438 -178.763 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 0.5 OUTLIER -69.37 155.66 40.07 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.907 0.384 . . . . 0.0 111.663 -178.851 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.599 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 5.8 t80 -53.56 90.09 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.711 179.29 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 127.39 -6.92 7.11 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.767 -179.478 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.8 p -72.99 170.89 13.89 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.958 0.379 . . . . 0.0 110.653 179.798 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.2 p -137.13 152.03 49.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.937 179.79 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.918 HG23 ' HA ' ' A' ' 22' ' ' ILE . 1.1 mt -114.87 170.35 5.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.665 -179.306 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.448 ' H ' HG22 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -133.55 115.29 14.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.876 0.369 . . . . 0.0 110.654 179.357 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.578 ' CE2' HD21 ' A' ' 20' ' ' LEU . 14.3 m-85 -89.71 154.0 20.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.629 -178.67 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.29 155.98 34.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.536 179.426 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.437 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 4.0 m -82.11 167.67 18.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.819 0.343 . . . . 0.0 110.958 -179.933 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -68.43 -85.4 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.204 -179.247 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.5 m -153.17 132.61 12.89 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.832 0.348 . . . . 0.0 111.008 -179.784 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.622 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 68.05 21.84 73.83 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.124 -179.198 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.5 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.6 m-85 -115.16 174.33 6.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.82 0.343 . . . . 0.0 110.86 -179.672 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.875 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -137.82 114.85 10.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.496 177.976 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.927 HD21 ' O ' ' A' ' 44' ' ' GLU . 6.5 tt -78.19 125.36 29.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.502 -179.698 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.875 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.2 mm -102.17 160.82 4.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.053 0.454 . . . . 0.0 111.113 -179.398 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 71.81 -135.24 22.95 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.485 -179.639 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.927 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -79.96 -173.58 3.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.966 0.413 . . . . 0.0 111.064 -179.952 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -167.31 29.18 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.384 179.389 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.425 ' HG3' ' HA ' ' A' ' 32' ' ' THR . 15.8 mtpt -155.08 127.52 7.87 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.962 0.411 . . . . 0.0 111.641 -178.666 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.454 ' OG ' ' CB ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -94.05 148.05 22.54 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.024 178.403 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.501 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.6 m-85 -124.45 114.95 20.14 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.603 177.922 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 52.8 t -65.67 98.22 0.37 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.468 179.677 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.503 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 0.6 OUTLIER -122.09 175.01 6.58 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.711 -178.501 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.599 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -83.19 147.65 27.9 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.171 -179.292 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.446 ' N ' HG22 ' A' ' 58' ' ' VAL . . . -75.59 -130.63 0.3 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.661 -179.849 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.9 t -109.35 -30.93 7.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.782 0.325 . . . . 0.0 111.014 -179.785 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 68.1 p -102.63 36.67 2.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.972 -179.884 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.83 20.85 72.78 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.452 -179.942 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.04 -162.44 0.86 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.856 0.36 . . . . 0.0 110.913 -179.976 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.0 138.52 52.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.359 179.656 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.446 HG22 ' N ' ' A' ' 52' ' ' GLY . 0.4 OUTLIER -145.34 -175.55 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.491 -179.669 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.781 ' HZ2' HG12 ' A' ' 25' ' ' VAL . 76.6 m95 -129.9 121.43 26.63 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.068 0.461 . . . . 0.0 111.905 -179.031 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.501 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 2.8 m120 -68.91 165.87 33.33 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.35 177.443 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.435 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 81.2 Cg_exo -17.09 94.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 125.289 3.993 . . . . 0.0 114.586 -178.475 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.475 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -91.67 -76.13 0.46 Allowed 'General case' 0 N--CA 1.461 0.103 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.329 -177.871 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.477 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -88.02 109.02 24.49 Favored Pre-proline 0 C--N 1.331 -0.201 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -175.711 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.92 ' HG2' HD11 ' A' ' 41' ' ' LEU . 2.3 Cg_endo -83.61 -154.59 0.05 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 123.053 2.502 . . . . 0.0 111.28 177.196 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.476 HG22 ' H ' ' A' ' 66' ' ' CYS . 3.0 mm -87.65 165.41 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.917 0.389 . . . . 0.0 110.791 178.64 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.476 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -165.83 131.25 2.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.502 179.455 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -154.82 168.32 27.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.184 -179.009 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.5 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 8.6 p -88.1 111.71 21.87 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.936 179.744 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.622 HG12 ' O ' ' A' ' 38' ' ' GLY . 4.9 p -45.08 103.9 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.884 179.253 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.492 ' HD2' ' CD1' ' A' ' 88' ' ' PHE . 2.2 ttpp -104.43 134.63 47.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.957 -176.035 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 116' ' ' GLY . 1.5 m -90.18 136.87 32.78 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.668 177.791 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.54 -169.85 0.25 Allowed 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.817 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.6 t -74.99 111.57 14.03 Favored Pre-proline 0 C--N 1.314 -0.954 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.744 -179.021 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.642 ' HG3' ' CE2' ' A' ' 118' ' ' TRP 0.321 0.0 OUTLIER -34.23 -175.27 0.0 OUTLIER 'Trans proline' 0 CA--C 1.468 -2.796 0 C-N-CA 123.722 2.948 . . . . 0.0 114.102 173.589 . . . . . . . . 4 4 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.545 ' CB ' ' CE1' ' A' ' 97' ' ' TYR . 23.3 Cg_endo -73.3 -164.0 3.12 Favored 'Cis proline' 0 C--N 1.323 -0.814 0 N-CA-C 113.847 0.672 . . . . 0.0 113.847 -18.854 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.2 t -135.55 21.11 3.36 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.54 172.257 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.612 HD12 ' HB2' ' A' ' 124' ' ' CYS . 3.3 pt -111.16 -160.03 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.274 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.213 -177.45 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.472 ' N ' HG13 ' A' ' 77' ' ' ILE . 86.2 p -134.24 151.03 51.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.788 177.61 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 55.6 32.46 19.23 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.578 179.327 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.573 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -151.08 -160.81 9.64 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.127 -1.035 . . . . 0.0 113.731 179.764 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.42 ' N ' ' O ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -161.95 -172.75 3.39 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.801 0.334 . . . . 0.0 111.121 -178.196 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.563 ' CG ' ' HB2' ' A' ' 74' ' ' PRO . 31.3 p80 -124.52 173.41 8.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.157 0.503 . . . . 0.0 112.257 -175.723 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.474 ' H ' HG12 ' A' ' 95' ' ' VAL . 80.8 m-20 -107.65 -98.15 0.37 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.169 174.021 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.758 ' N ' HG13 ' A' ' 95' ' ' VAL . . . 57.14 -80.41 0.01 OUTLIER Glycine 0 C--N 1.342 0.87 0 C-N-CA 121.039 -0.601 . . . . 0.0 113.241 177.826 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.475 ' N ' ' CD2' ' A' ' 85' ' ' TYR . 2.8 m-30 98.42 11.72 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.593 1.557 . . . . 0.0 111.293 179.488 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.87 -173.7 2.36 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.517 178.204 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.26 -24.08 10.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.733 178.651 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.492 ' CD1' ' HD2' ' A' ' 70' ' ' LYS . 9.4 m-85 -147.71 171.41 15.69 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.423 179.413 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.494 ' CE1' ' HD2' ' A' ' 74' ' ' PRO . 17.6 m-85 -147.24 175.53 10.68 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.624 0.249 . . . . 0.0 110.862 -177.661 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.424 HG22 ' HB2' ' A' ' 70' ' ' LYS . 14.7 p -144.6 169.82 17.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.132 0.492 . . . . 0.0 112.029 -179.28 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.27 94.25 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.307 -179.323 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.53 28.45 0.98 Allowed Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.327 -0.852 . . . . 0.0 113.161 178.376 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.469 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.7 OUTLIER -110.14 157.45 19.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.965 0.383 . . . . 0.0 110.879 179.013 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 35.8 m -138.76 146.08 26.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.759 179.627 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.758 HG13 ' N ' ' A' ' 84' ' ' GLY . 4.2 t -147.16 142.8 20.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.026 -178.681 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.846 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -98.55 127.39 44.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.174 0.512 . . . . 0.0 110.132 178.692 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.731 ' CZ ' HG21 ' A' ' 111' ' ' VAL . 2.8 m-30 -95.49 166.23 11.96 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.496 0.665 . . . . 0.0 112.756 -174.794 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.42 ' O ' ' N ' ' A' ' 81' ' ' ARG . 67.6 m -152.87 145.54 24.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.796 -1.093 . . . . 0.0 110.542 178.75 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.542 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 76.1 m -69.43 155.67 40.08 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.863 0.363 . . . . 0.0 111.538 -178.881 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.6 -86.47 0.19 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.967 178.934 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -47.03 -27.04 1.18 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.511 -179.385 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 125.25 32.26 0.8 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.877 179.866 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.502 ' CE1' HG12 ' A' ' 126' ' ' ILE . 18.5 m-85 -72.54 -170.85 0.72 Allowed 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.903 0.383 . . . . 0.0 111.25 179.952 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 2.9 m -118.04 96.81 5.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.205 177.882 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.439 ' CD2' ' HA ' ' A' ' 109' ' ' SER . 0.2 OUTLIER -47.92 139.53 7.7 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.563 0.697 . . . . 0.0 111.81 -178.226 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.555 HG22 ' N ' ' A' ' 107' ' ' GLY . 16.8 mm -125.5 160.96 30.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.727 -1.124 . . . . 0.0 111.328 -178.71 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.555 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 64.77 25.18 70.34 Favored Glycine 0 N--CA 1.457 0.082 0 C-N-CA 120.631 -0.795 . . . . 0.0 113.453 177.718 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.455 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.3 OUTLIER 67.05 130.84 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 121.532 0.682 . . . . 0.0 112.355 178.452 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.846 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.1 p -64.54 -24.68 67.68 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 114.427 -1.26 . . . . 0.0 111.329 178.906 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.55 130.31 48.24 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.339 -0.934 . . . . 0.0 111.856 179.134 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.731 HG21 ' CZ ' ' A' ' 97' ' ' TYR . 16.4 t -135.31 123.71 39.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.492 0.187 . . . . 0.0 110.855 -177.819 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.0 127.98 35.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.967 0.413 . . . . 0.0 111.804 -177.932 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.506 ' HB2' ' CZ3' ' A' ' 118' ' ' TRP . 44.7 t -89.52 98.08 11.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.521 176.386 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 24.0 p -136.76 159.96 40.28 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.672 -179.119 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.498 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 50.67 29.04 17.53 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.534 -0.841 . . . . 0.0 111.835 -179.074 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.487 ' N ' ' HB ' ' A' ' 69' ' ' VAL . . . 68.39 14.51 66.8 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 121.085 -0.578 . . . . 0.0 112.575 -179.555 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -141.95 177.02 8.49 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 178.665 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.642 ' CE2' ' HG3' ' A' ' 74' ' ' PRO . 99.4 m95 -98.39 126.5 43.94 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.149 0.5 . . . . 0.0 111.158 -179.586 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.9 150.45 24.85 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.254 -178.829 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.513 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.9 OUTLIER 53.51 42.46 1.18 Allowed Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.101 -179.987 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 37.7 Cg_endo -64.55 151.5 85.34 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.039 1.826 . . . . 0.0 111.098 177.65 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.664 ' HD3' HG22 ' A' ' 111' ' ' VAL . 44.4 Cg_endo -80.27 -173.59 1.92 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 121.922 1.748 . . . . 0.0 113.035 -179.06 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.461 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -122.75 -161.57 0.96 Allowed 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 173.765 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . 0.612 ' HB2' HD12 ' A' ' 77' ' ' ILE . 2.4 t -170.65 83.6 0.1 Allowed 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.25 -175.61 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -115.01 169.04 9.39 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.583 -1.19 . . . . 0.0 111.676 -175.838 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.502 HG12 ' CE1' ' A' ' 103' ' ' TYR . 37.5 mm . . . . . 0 C--N 1.326 -0.442 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.78 179.342 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.5 mtt180 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.764 0.316 . . . . 0.0 110.829 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.75 ' HD2' HG23 ' A' ' 25' ' ' VAL . 7.7 mtm180 -92.47 -159.92 0.7 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.738 179.953 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.45 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 60.8 m -105.33 160.66 25.27 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 -178.956 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.45 ' HD3' ' HB2' ' A' ' 57' ' ' MET . 32.2 Cg_endo -65.86 173.62 6.72 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.59 2.193 . . . . 0.0 112.192 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.7 t -54.37 108.1 1.05 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.578 179.53 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.678 ' HG2' HD13 ' A' ' 22' ' ' ILE . 72.7 Cg_exo -46.98 160.25 0.27 Allowed 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.302 2.001 . . . . 0.0 112.401 -179.468 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.525 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -75.31 174.01 10.1 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.96 178.325 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.582 ' HA ' HD11 ' A' ' 20' ' ' LEU . 1.7 t0 -127.33 -177.0 3.9 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.224 0.535 . . . . 0.0 111.691 -178.866 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.484 HG22 HD21 ' A' ' 20' ' ' LEU . 17.9 tt -146.47 143.06 20.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.785 -179.339 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -81.86 156.8 24.65 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 177.394 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.496 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 0.5 OUTLIER 49.28 26.14 1.46 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.839 0.352 . . . . 0.0 110.554 -179.239 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -153.21 170.59 32.14 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.698 -179.01 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.414 ' N ' ' O ' ' A' ' 34' ' ' SER . 0.2 OUTLIER -138.36 144.01 40.12 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.699 0.285 . . . . 0.0 110.34 179.526 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.781 HD22 ' CE1' ' A' ' 33' ' ' TYR . 0.5 OUTLIER -92.49 163.21 13.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.207 0.527 . . . . 0.0 111.769 -179.312 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 32' ' ' THR . 8.1 t0 -127.47 72.34 1.38 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.875 177.175 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.891 ' HA ' HG23 ' A' ' 31' ' ' ILE . 1.2 mt -72.76 97.8 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.809 -177.789 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.12 16.7 60.77 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.786 176.979 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 160.26 153.46 6.93 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 111.499 -0.64 . . . . 0.0 111.499 -179.278 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.75 HG23 ' HD2' ' A' ' 8' ' ' ARG . 17.0 m -134.87 11.58 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -178.8 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 40.3 t0 -90.02 163.08 15.06 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.972 0.415 . . . . 0.0 111.377 179.93 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.518 ' CE2' ' HB3' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -50.01 90.27 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.802 -179.599 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 131.99 -9.52 5.43 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.627 -0.796 . . . . 0.0 112.784 -179.566 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.8 m -76.43 157.45 32.23 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 117.107 0.454 . . . . 0.0 110.503 179.536 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.4 p -133.52 142.2 48.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.019 0.437 . . . . 0.0 110.917 179.603 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.891 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -106.81 154.08 7.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.435 -179.789 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.411 ' O ' ' N ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -115.97 119.45 35.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.023 0.44 . . . . 0.0 110.75 179.361 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.781 ' CE1' HD22 ' A' ' 20' ' ' LEU . 11.5 m-85 -95.03 137.95 33.4 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.263 -178.927 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.414 ' O ' ' N ' ' A' ' 19' ' ' GLN . 4.4 m -146.77 159.59 43.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.079 179.793 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.414 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 11.1 m -81.97 173.52 12.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.6 179.452 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.415 ' N ' ' O ' ' A' ' 17' ' ' ASN . 0.6 OUTLIER -75.41 -79.88 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.107 -179.447 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.35 134.62 10.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.904 -179.651 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.24 23.52 71.61 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.809 -178.972 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.498 ' CE2' ' HB3' ' A' ' 68' ' ' SER . 2.3 m-85 -118.01 167.88 11.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.842 0.353 . . . . 0.0 110.868 -179.338 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.735 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -132.97 121.82 23.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.337 177.635 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.932 HD21 ' O ' ' A' ' 44' ' ' GLU . 8.7 tt -83.3 127.91 34.05 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.849 -178.401 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.735 HD11 ' CE1' ' A' ' 40' ' ' HIS . 1.4 mm -106.57 149.46 9.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.051 -179.651 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.08 -142.56 20.71 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.07 -179.102 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.932 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -72.15 -175.8 1.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.869 0.366 . . . . 0.0 110.316 178.469 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -168.1 28.79 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.511 179.431 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -157.08 127.42 6.45 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.973 -179.929 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.432 ' HB3' ' HG2' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -102.59 152.36 21.27 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.74 -179.663 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.499 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.2 m-85 -128.04 124.89 38.22 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.488 0.661 . . . . 0.0 111.672 -179.971 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.491 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 42.7 t -73.23 118.2 15.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.157 -179.429 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.487 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 9.5 tt0 -159.25 168.45 26.43 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.074 179.018 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.518 ' HB3' ' CE2' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -95.76 130.65 42.61 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.553 179.729 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -176.94 93.41 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.013 -179.4 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.444 ' HB3' ' CB ' ' A' ' 56' ' ' SER . 9.6 t -179.09 40.52 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -179.142 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 79.51 29.54 0.31 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.149 -178.89 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 103.7 15.59 22.15 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.115 -179.325 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.461 ' O ' HD23 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -105.31 -159.59 0.71 Allowed 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 178.97 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.45 ' HB2' ' HD3' ' A' ' 10' ' ' PRO . 0.0 OUTLIER -118.24 136.46 53.65 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.538 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.661 HG23 ' N ' ' A' ' 59' ' ' TRP . 0.1 OUTLIER -137.22 -175.97 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 CA-C-O 121.823 0.82 . . . . 0.0 112.171 -176.054 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.672 ' CE3' HD11 ' A' ' 31' ' ' ILE . 59.9 m95 -133.0 134.86 45.02 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.413 179.281 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.499 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 5.5 m-80 -78.41 163.34 62.22 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.888 178.319 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.42 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 31.6 Cg_exo -11.04 90.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.864 1 C-N-CA 125.758 4.305 . . . . 0.0 114.873 -179.392 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.48 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 39.4 mt-10 -91.27 -93.94 0.13 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.004 -0.998 . . . . 0.0 112.146 -178.284 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.479 ' HA ' ' CD1' ' A' ' 33' ' ' TYR . . . -81.15 108.86 11.54 Favored Pre-proline 0 C--O 1.231 0.131 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -176.124 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.878 ' HG2' HD11 ' A' ' 41' ' ' LEU . 2.1 Cg_endo -82.93 -154.6 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.003 2.469 . . . . 0.0 110.756 176.681 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.446 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 2.0 mm -92.88 158.17 2.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.927 0.394 . . . . 0.0 110.508 178.271 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.2 m -164.34 143.37 7.37 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.957 179.905 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -169.88 170.2 7.87 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.463 179.954 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.498 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 30.2 p -73.92 99.02 3.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.045 0.45 . . . . 0.0 110.219 178.534 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.548 ' O ' HG13 ' A' ' 69' ' ' VAL . 5.6 p -44.2 93.95 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.29 179.619 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.468 ' CD ' HG23 ' A' ' 90' ' ' THR . 9.0 mttt -69.73 165.05 22.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.0 -177.467 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.416 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -120.88 131.58 54.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.179 179.079 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -69.19 -157.21 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.08 179.205 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.432 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 1.5 t -52.82 142.65 33.2 Favored Pre-proline 0 N--CA 1.45 -0.446 0 CA-C-O 120.682 0.277 . . . . 0.0 110.276 179.495 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 73' ' ' SER . 37.6 Cg_exo -57.31 162.79 9.22 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.397 2.065 . . . . 0.0 112.036 -179.083 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.507 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 82.4 Cg_exo -39.99 159.06 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.746 2.297 . . . . 0.0 112.947 -179.003 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 86.7 p -109.11 88.45 2.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.635 179.446 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.632 HG23 ' HE1' ' A' ' 97' ' ' TYR . 18.0 pt -69.85 174.12 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.33 -179.347 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.6 m -97.07 140.64 31.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.532 179.295 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.513 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 4.9 m-80 59.56 29.62 19.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.746 -179.913 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -172.83 -170.28 36.36 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.516 179.614 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 1.9 ptt180 -170.24 -175.7 2.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.888 0.375 . . . . 0.0 111.095 -179.371 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.435 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 0.7 OUTLIER -99.47 178.24 4.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.022 -179.987 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 96' ' ' THR . 3.4 m-20 -122.17 18.3 10.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.392 -179.645 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -51.76 153.4 5.39 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.281 -0.961 . . . . 0.0 112.282 -179.878 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.466 ' CD1' ' N ' ' A' ' 85' ' ' TYR . 0.6 OUTLIER -106.53 -30.67 8.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.143 0.497 . . . . 0.0 110.426 179.816 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.18 -173.54 2.45 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.761 179.87 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -107.02 -14.78 14.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.242 179.248 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.462 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 2.2 m-85 -134.74 165.61 24.86 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 120.996 0.427 . . . . 0.0 111.971 -178.351 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.436 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 71.6 m-85 -151.27 154.51 36.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.028 -179.216 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.468 HG23 ' CD ' ' A' ' 70' ' ' LYS . 0.6 OUTLIER -111.4 -174.15 2.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.138 0.494 . . . . 0.0 112.011 -178.617 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.452 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 8.7 m-20 -69.97 96.28 1.02 Allowed 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.033 -179.895 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.46 22.77 2.02 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.956 179.074 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -96.73 156.47 16.33 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.764 0.316 . . . . 0.0 110.635 179.44 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 34.3 m -135.64 151.13 29.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.17 0.51 . . . . 0.0 111.185 -179.816 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.457 HG23 ' CH2' ' A' ' 118' ' ' TRP . 15.1 t -149.2 146.81 17.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.812 179.783 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.974 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -100.93 142.0 33.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.261 179.03 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.895 ' CE2' HG21 ' A' ' 111' ' ' VAL . 4.0 m-85 -100.4 156.41 17.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.997 0.427 . . . . 0.0 111.202 -179.532 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.434 ' HA ' HD13 ' A' ' 105' ' ' LEU . 36.7 m -150.26 141.61 23.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.133 -179.508 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.419 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 63.2 m -71.96 165.55 23.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.881 179.718 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.32 -86.52 0.34 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.982 179.791 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -46.76 -29.29 1.85 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.403 -179.515 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.19 41.03 0.29 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.539 179.895 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.513 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 43.5 m-85 -80.6 -174.83 4.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.864 0.364 . . . . 0.0 110.817 179.877 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.3 m -112.59 106.99 15.54 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.173 178.828 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.474 HD11 ' HB3' ' A' ' 97' ' ' TYR . 0.2 OUTLIER -48.26 131.33 16.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.501 0.667 . . . . 0.0 111.683 -178.252 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.445 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 35.4 mm -97.62 155.93 3.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.199 179.16 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 64.91 -129.32 35.36 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.324 -179.534 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -121.12 129.74 53.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.804 0.335 . . . . 0.0 111.21 -179.771 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.974 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.5 p -61.33 -32.13 72.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.82 179.455 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -71.4 135.01 23.29 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.842 -179.592 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.895 HG21 ' CE2' ' A' ' 97' ' ' TYR . 3.8 t -130.72 120.0 46.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.632 0.253 . . . . 0.0 110.706 179.2 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.878 HD22 ' N ' ' A' ' 113' ' ' CYS . 1.1 tm? -82.18 134.32 35.3 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.86 0.362 . . . . 0.0 111.284 -179.374 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.878 ' N ' HD22 ' A' ' 112' ' ' LEU . 43.1 t -105.09 102.5 11.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.105 177.999 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.693 ' CB ' HD11 ' A' ' 112' ' ' LEU . 4.3 m -135.57 113.12 10.78 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.488 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 81.66 45.21 7.41 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.009 178.06 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.432 ' HA3' HG22 ' A' ' 69' ' ' VAL . . . 63.32 12.78 46.77 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.778 179.471 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -134.66 173.74 11.33 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.04 0.447 . . . . 0.0 110.663 179.687 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.52 ' CZ3' ' HB2' ' A' ' 113' ' ' CYS . 94.6 m95 -121.4 156.52 32.49 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.905 -179.41 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.74 149.91 46.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.051 0.453 . . . . 0.0 111.368 -179.767 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.477 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER 67.1 47.07 0.42 Allowed Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.786 179.136 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 84.8 Cg_endo -77.7 133.92 13.17 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.396 2.064 . . . . 0.0 111.642 178.701 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.509 ' O ' HG21 ' A' ' 77' ' ' ILE . 63.8 Cg_endo -88.49 -174.27 1.05 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.581 2.187 . . . . 0.0 113.468 -178.301 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.406 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -130.34 -159.39 0.96 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.031 178.431 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 7.6 m -158.62 91.11 1.05 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.087 0.47 . . . . 0.0 110.988 179.255 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -121.24 158.64 27.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.908 -179.922 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.498 HG12 ' CE2' ' A' ' 103' ' ' TYR . 21.0 mm . . . . . 0 C--N 1.324 -0.533 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.111 179.995 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.79 0.329 . . . . 0.0 110.998 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.454 ' HA ' ' HA ' ' A' ' 26' ' ' ASP . 8.2 mtm-85 -94.69 -176.68 3.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.925 179.796 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.452 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 18.3 m -109.27 160.37 27.87 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.084 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -67.94 170.48 14.15 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.318 2.012 . . . . 0.0 111.75 179.748 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.415 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 0.8 OUTLIER -51.43 105.61 0.55 Allowed Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.948 -179.524 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 11' ' ' SER . 19.8 Cg_endo -61.93 159.78 32.36 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.211 1.941 . . . . 0.0 111.881 179.731 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.441 ' O ' HD12 ' A' ' 20' ' ' LEU . 4.2 mpt_? -49.34 177.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.513 179.636 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.7 ' O ' HG22 ' A' ' 15' ' ' ILE . 0.2 OUTLIER -142.76 -7.74 0.84 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -178.042 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.7 HG22 ' O ' ' A' ' 14' ' ' ASP . 14.4 tt 53.72 163.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 120.749 0.309 . . . . 0.0 111.105 -177.939 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -104.26 -56.03 2.26 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -177.135 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.486 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 0.2 OUTLIER -94.12 31.01 1.75 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.936 0.398 . . . . 0.0 111.071 -178.412 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 34' ' ' SER . . . -157.47 179.65 33.06 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.517 179.473 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.435 ' N ' ' O ' ' A' ' 34' ' ' SER . 0.0 OUTLIER -134.92 139.42 44.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.793 0.33 . . . . 0.0 110.25 179.864 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.832 HD21 ' CE1' ' A' ' 33' ' ' TYR . 34.0 mt -88.04 159.77 18.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.377 0.608 . . . . 0.0 112.142 -178.462 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.421 ' N ' ' O ' ' A' ' 32' ' ' THR . 5.3 t0 -124.04 83.37 2.13 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.225 176.646 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.892 ' HA ' HG23 ' A' ' 31' ' ' ILE . 1.8 mt -77.44 107.14 8.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.025 -0.534 . . . . 0.0 112.169 -176.678 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.99 19.52 37.85 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.59 176.679 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 152.86 132.77 1.81 Allowed Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.073 -179.373 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.824 HG12 ' CZ2' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -117.38 5.81 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-O 120.811 0.338 . . . . 0.0 110.591 -178.248 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.454 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 6.6 p-10 -75.68 153.71 36.97 Favored 'General case' 0 C--O 1.231 0.095 0 CA-C-O 120.964 0.412 . . . . 0.0 111.489 -179.11 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.59 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 3.7 t80 -52.51 95.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.767 179.334 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 126.02 8.49 5.08 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.989 -179.825 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 84.9 p -97.35 -174.1 2.84 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 116.992 0.396 . . . . 0.0 110.483 179.359 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.1 p -155.12 146.53 22.99 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.036 0.446 . . . . 0.0 111.121 178.44 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.892 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.8 OUTLIER -106.63 172.59 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.418 -179.394 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.463 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -129.64 118.34 21.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.925 0.393 . . . . 0.0 111.2 179.551 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.832 ' CE1' HD21 ' A' ' 20' ' ' LEU . 19.8 m-85 -94.77 140.96 29.19 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.234 0.54 . . . . 0.0 111.604 -179.486 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 19' ' ' GLN . 16.8 m -148.82 153.65 38.41 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.458 179.744 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.444 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 1.7 m -75.17 167.35 22.08 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.99 -179.628 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -76.04 -82.03 0.08 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.824 -179.589 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -153.95 121.38 5.82 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.656 179.351 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.743 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 77.32 14.19 82.79 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.423 -178.766 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.526 ' CZ ' ' CB ' ' A' ' 68' ' ' SER . 23.1 m-85 -111.7 154.47 24.92 Favored 'General case' 0 C--N 1.329 -0.32 0 O-C-N 122.586 -0.361 . . . . 0.0 111.0 179.546 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.841 ' CE1' HG22 ' A' ' 69' ' ' VAL . 2.3 m-70 -112.86 119.18 37.1 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 175.155 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.957 HD21 ' O ' ' A' ' 44' ' ' GLU . 4.1 tt -83.74 109.31 17.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.928 0.394 . . . . 0.0 110.022 -179.842 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.572 ' N ' HD13 ' A' ' 42' ' ' ILE . 1.5 mm -91.94 148.28 4.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.301 -178.255 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 93.15 -134.36 12.12 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.287 -179.288 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.957 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -84.31 -173.15 4.56 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.655 0.264 . . . . 0.0 110.686 179.422 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.2 p -160.46 23.38 0.15 Allowed 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.319 -178.91 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.463 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 8.3 mtpt -159.62 123.13 3.67 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.36 -177.701 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 30' ' ' SER . 0.3 OUTLIER -92.13 145.05 24.82 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.196 178.714 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.556 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 0.4 OUTLIER -119.95 116.03 24.98 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 119.401 -0.919 . . . . 0.0 111.635 178.912 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.413 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 15.6 t -69.46 95.66 0.84 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.631 179.628 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -120.18 -168.18 1.57 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.939 -179.79 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.59 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -105.2 142.02 35.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.009 0.433 . . . . 0.0 111.198 -179.693 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.587 ' N ' HG22 ' A' ' 58' ' ' VAL . . . -125.26 -171.6 13.29 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.681 178.99 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.437 ' C ' HG23 ' A' ' 54' ' ' THR . 3.5 t 44.87 27.26 0.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.899 0.38 . . . . 0.0 111.59 179.41 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.437 HG23 ' C ' ' A' ' 53' ' ' SER . 1.5 p 67.7 19.75 9.65 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.695 179.025 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 169.9 -28.56 0.13 Allowed Glycine 0 CA--C 1.518 0.244 0 C-N-CA 120.124 -1.036 . . . . 0.0 113.384 179.475 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 52' ' ' GLY . 19.7 t -69.49 -176.63 1.02 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.908 0.385 . . . . 0.0 111.064 -179.596 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.625 ' O ' HG13 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -101.58 151.53 21.87 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.981 179.409 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.625 HG13 ' O ' ' A' ' 57' ' ' MET . 0.9 OUTLIER -162.09 176.68 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.136 -179.303 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.824 ' CZ2' HG12 ' A' ' 25' ' ' VAL . 70.9 m95 -128.61 120.93 27.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.396 -179.253 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.556 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -69.0 167.72 18.99 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.754 178.189 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.487 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 56.1 Cg_exo -13.66 90.43 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.964 1 C-N-CA 125.399 4.066 . . . . 0.0 114.374 -179.16 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.509 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -94.46 -76.23 0.49 Allowed 'General case' 0 C--O 1.224 -0.262 0 CA-C-N 115.273 -0.876 . . . . 0.0 113.231 -175.799 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.469 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -96.56 85.09 0.3 Allowed Pre-proline 0 N--CA 1.45 -0.462 0 N-CA-C 112.883 0.698 . . . . 0.0 112.883 -173.431 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.684 ' CG ' HD11 ' A' ' 41' ' ' LEU . 22.2 Cg_endo -51.49 -156.28 0.0 OUTLIER 'Trans proline' 0 N--CA 1.473 0.274 0 C-N-CA 123.586 2.858 . . . . 0.0 112.187 174.504 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.576 HG22 ' H ' ' A' ' 66' ' ' CYS . 0.7 OUTLIER -100.88 177.59 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.972 0.415 . . . . 0.0 110.726 178.876 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.576 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -170.74 133.65 0.98 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.681 179.523 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -137.87 113.18 9.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.078 179.795 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.526 ' CB ' ' CZ ' ' A' ' 39' ' ' TYR . 0.9 OUTLIER -51.65 126.62 18.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.744 179.65 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.841 HG22 ' CE1' ' A' ' 40' ' ' HIS . 2.2 p -40.41 96.59 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.01 -179.674 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.498 ' HE3' HG23 ' A' ' 90' ' ' THR . 0.1 OUTLIER -73.15 114.04 10.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.163 179.868 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.428 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -92.14 122.4 34.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.944 0.402 . . . . 0.0 110.133 178.521 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.01 -159.72 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.111 179.85 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.477 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 1.2 t -54.41 143.6 45.87 Favored Pre-proline 0 N--CA 1.449 -0.509 0 CA-C-O 120.589 0.233 . . . . 0.0 110.554 -179.829 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.519 ' HG2' HG11 ' A' ' 95' ' ' VAL . 22.4 Cg_exo -62.1 160.77 28.83 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.432 2.088 . . . . 0.0 111.941 -179.855 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.508 ' HD3' ' CG ' ' A' ' 118' ' ' TRP . 74.7 Cg_exo -38.64 156.95 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.885 2.39 . . . . 0.0 112.912 -179.489 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.94 89.97 3.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.749 179.906 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.605 HG23 ' HE2' ' A' ' 97' ' ' TYR . 19.8 pt -69.35 178.65 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.057 -179.816 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.8 m -99.2 142.47 30.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.974 179.941 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.504 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 2.6 m-80 59.02 28.79 18.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.099 179.524 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.458 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -165.95 -167.49 26.66 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.857 179.834 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.427 ' N ' ' O ' ' A' ' 98' ' ' SER . 10.1 ptt180 -161.66 -175.49 4.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.032 0.444 . . . . 0.0 110.923 -179.693 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.477 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 9.5 p-80 -108.68 171.35 7.48 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.881 179.88 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.435 ' O ' ' N ' ' A' ' 85' ' ' TYR . 95.5 m-20 -106.97 -96.77 0.36 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.684 179.146 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.641 ' N ' HG13 ' A' ' 95' ' ' VAL . . . 59.93 -81.48 0.01 OUTLIER Glycine 0 C--N 1.337 0.596 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.878 179.34 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.472 ' N ' ' CD2' ' A' ' 85' ' ' TYR . 3.7 m-30 93.66 10.72 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 125.287 1.435 . . . . 0.0 111.374 -179.783 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.53 -174.06 2.45 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.593 178.456 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -110.28 -25.01 10.35 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.631 178.649 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.431 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 13.5 m-85 -145.95 166.93 24.57 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.697 179.847 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.431 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 32.2 m-85 -145.05 165.66 27.58 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.698 -179.327 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.498 HG23 ' HE3' ' A' ' 70' ' ' LYS . 13.3 p -128.5 178.16 6.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.108 0.48 . . . . 0.0 111.764 -178.384 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 71.3 m-20 -62.25 95.58 0.07 Allowed 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.042 179.981 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 125.58 20.35 2.16 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.372 -0.831 . . . . 0.0 113.208 178.453 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.449 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -97.5 159.28 15.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 117.015 0.408 . . . . 0.0 110.439 178.91 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 27.1 m -134.92 146.28 30.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.022 0.439 . . . . 0.0 111.056 -179.626 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.641 HG13 ' N ' ' A' ' 84' ' ' GLY . 27.9 t -141.62 148.35 21.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.946 179.699 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.741 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -107.08 131.12 54.46 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.776 179.663 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.973 ' CE1' HG21 ' A' ' 111' ' ' VAL . 6.2 m-85 -90.42 155.89 18.61 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.106 -179.414 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.427 ' O ' ' N ' ' A' ' 81' ' ' ARG . 1.3 p -149.86 136.68 19.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.542 -179.482 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.423 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 60.5 m -70.13 159.19 34.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.867 179.27 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.458 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 73.0 m-80 -92.13 -76.49 0.46 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.354 -179.483 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.78 -23.16 28.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.225 -179.351 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 121.65 32.35 1.03 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.525 -179.932 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.509 ' CE2' HG12 ' A' ' 126' ' ' ILE . 46.2 m-85 -69.99 -171.7 0.46 Allowed 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 120.64 0.257 . . . . 0.0 110.48 179.709 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.8 m -109.78 108.18 18.44 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.91 0.386 . . . . 0.0 111.349 -178.905 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.447 ' HA ' HD12 ' A' ' 105' ' ' LEU . 0.9 OUTLIER -48.14 106.93 0.11 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.374 178.142 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.506 HG22 ' N ' ' A' ' 107' ' ' GLY . 43.6 mm -85.2 158.95 3.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.168 -178.47 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.506 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 59.66 -127.42 44.48 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.555 -0.831 . . . . 0.0 111.844 -179.248 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -118.18 132.75 56.31 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.87 0.367 . . . . 0.0 110.669 178.974 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.741 ' HB2' HG22 ' A' ' 96' ' ' THR . 0.1 OUTLIER -69.45 -28.9 66.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.119 0.485 . . . . 0.0 110.453 179.549 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -73.58 131.4 14.44 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.764 -179.927 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.973 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.8 t -123.92 121.71 62.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.583 0.23 . . . . 0.0 110.644 179.217 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.67 121.14 25.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.875 0.369 . . . . 0.0 111.443 -178.818 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.494 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 23.3 t -85.73 106.14 16.77 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 176.465 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.414 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.3 OUTLIER -147.81 160.11 43.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.129 0.49 . . . . 0.0 111.394 -178.333 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.28 34.41 6.22 Favored Glycine 0 CA--C 1.518 0.219 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.775 179.611 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 65.91 12.94 58.56 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.641 -179.448 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -136.58 -178.85 5.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.876 0.37 . . . . 0.0 110.704 179.63 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.508 ' CG ' ' HD3' ' A' ' 75' ' ' PRO . 93.2 m95 -119.08 141.63 48.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.969 -179.416 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.08 150.13 50.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.05 0.452 . . . . 0.0 111.535 -179.029 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.478 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.5 OUTLIER 71.26 46.35 0.25 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.125 178.744 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 85.5 Cg_endo -78.22 142.23 19.0 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.376 2.05 . . . . 0.0 111.729 178.424 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.507 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 61.6 Cg_endo -90.13 -172.3 0.56 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.67 2.246 . . . . 0.0 113.476 -178.589 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.452 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -134.71 -178.48 5.09 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.684 -1.144 . . . . 0.0 109.974 178.215 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . 0.435 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 11.1 m -139.51 97.66 3.32 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.965 0.412 . . . . 0.0 111.027 -179.832 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -123.96 155.35 38.34 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.975 -179.683 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.565 HG22 ' O ' ' A' ' 126' ' ' ILE . 18.1 mm . . . . . 0 C--N 1.324 -0.507 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.99 179.932 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 120.975 0.417 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.683 ' HD3' HG23 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -71.73 176.4 4.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.007 -179.788 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.426 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 13.1 m -83.93 161.31 55.88 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.733 179.757 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.74 169.19 19.46 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.396 2.064 . . . . 0.0 111.305 179.121 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.43 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -52.81 116.9 9.86 Favored Pre-proline 0 C--N 1.326 -0.436 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.962 -178.794 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.795 ' HG3' HD13 ' A' ' 22' ' ' ILE . 16.3 Cg_endo -57.27 157.58 21.18 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.62 2.214 . . . . 0.0 112.273 179.987 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.439 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 9.2 mtt-85 -64.55 176.05 1.23 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.201 178.974 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.783 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 1.1 t0 -130.89 -172.39 2.81 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.108 0.48 . . . . 0.0 111.679 -178.895 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.434 HG22 HD21 ' A' ' 20' ' ' LEU . 3.6 tt -145.71 151.48 14.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.727 -179.684 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -80.35 -70.73 0.5 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.672 -178.583 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.442 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 1.2 m120 -91.2 42.9 1.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.929 0.395 . . . . 0.0 110.946 -179.408 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.427 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -153.41 -173.76 22.98 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.956 179.904 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -145.66 135.2 23.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.706 0.289 . . . . 0.0 110.415 179.733 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.863 HD22 ' CE1' ' A' ' 33' ' ' TYR . 0.5 OUTLIER -83.73 156.99 22.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.125 0.488 . . . . 0.0 111.677 -179.23 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.433 ' CB ' ' HB ' ' A' ' 32' ' ' THR . 0.3 OUTLIER -127.73 73.75 1.48 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.31 177.061 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.824 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.5 OUTLIER -80.32 95.58 2.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.835 -176.674 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.02 16.96 59.24 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.99 177.538 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 164.49 149.67 5.87 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.075 -0.583 . . . . 0.0 111.901 -179.582 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.683 HG23 ' HD3' ' A' ' 8' ' ' ARG . 8.7 m -135.91 32.85 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.699 0.285 . . . . 0.0 111.354 -179.455 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.2 OUTLIER -102.75 155.81 18.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.125 179.933 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.571 ' CZ ' HD12 ' A' ' 51' ' ' LEU . 4.9 t80 -50.71 91.0 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.771 179.657 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 129.97 -12.2 5.87 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.654 -179.251 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.2 p -70.63 177.04 3.71 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.735 0.302 . . . . 0.0 110.659 179.671 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.8 p -148.51 142.89 26.28 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.116 179.972 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.824 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.6 OUTLIER -104.64 171.14 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.564 179.858 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.433 ' HB ' ' CB ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -135.73 111.14 9.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.993 0.425 . . . . 0.0 111.337 179.568 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.863 ' CE1' HD22 ' A' ' 20' ' ' LEU . 26.5 m-85 -87.37 143.17 27.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.435 -179.755 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.419 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 5.0 m -147.05 168.47 21.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.725 179.442 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.427 ' HA ' ' HA2' ' A' ' 18' ' ' GLY . 1.3 m -87.64 166.14 14.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.828 179.696 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.408 ' ND2' ' HA ' ' A' ' 17' ' ' ASN . 15.0 m-20 -67.25 -84.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.996 -179.76 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -154.03 130.8 10.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.109 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.02 19.26 71.68 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.433 -179.534 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.506 ' CE1' ' HB3' ' A' ' 68' ' ' SER . 3.3 m-30 -111.72 178.59 4.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.859 0.361 . . . . 0.0 110.966 -179.604 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.873 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -138.31 113.23 9.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.136 0.493 . . . . 0.0 110.472 177.645 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.943 HD21 ' O ' ' A' ' 44' ' ' GLU . 6.8 tt -77.38 120.26 22.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.96 -179.01 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.873 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.6 mm -96.22 153.13 3.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.734 179.685 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.04 -137.14 15.18 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.975 -178.71 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.943 ' O ' HD21 ' A' ' 41' ' ' LEU . 5.1 mt-10 -88.67 -176.84 5.4 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.507 0.67 . . . . 0.0 111.221 179.175 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.7 p -155.15 24.16 0.42 Allowed 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 114.592 -1.186 . . . . 0.0 110.332 179.045 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -150.55 128.95 12.1 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.173 0.511 . . . . 0.0 112.068 -178.763 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -108.03 151.2 26.16 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.89 178.256 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.503 ' CD1' ' CB ' ' A' ' 60' ' ' ASN . 1.5 m-85 -126.28 122.54 35.8 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 119.456 -0.898 . . . . 0.0 112.598 -177.846 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.47 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 26.0 t -71.26 102.27 2.52 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.398 178.55 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -129.33 -176.19 3.81 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.317 -179.039 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.841 HD23 ' O ' ' A' ' 56' ' ' SER . 6.7 mt -83.13 157.84 22.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.447 -178.879 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -83.04 -157.57 23.75 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.618 179.933 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 m -83.83 -32.48 25.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.77 0.319 . . . . 0.0 110.992 -179.874 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.9 p -108.38 24.55 12.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.022 179.985 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 84.2 25.89 42.41 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.569 179.944 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.841 ' O ' HD23 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -93.36 -165.04 1.26 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.832 0.349 . . . . 0.0 110.92 179.962 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 8.0 mmt -109.98 129.82 55.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.768 179.683 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.4 m -143.2 177.94 2.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.069 -179.909 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.532 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 72.6 m95 -131.84 128.65 39.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.344 -179.429 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.503 ' CB ' ' CD1' ' A' ' 48' ' ' TYR . 0.7 OUTLIER -69.67 164.63 48.86 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.707 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.505 ' O ' ' HA ' ' A' ' 47' ' ' SER . 97.7 Cg_exo -13.78 113.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.826 1 C-N-CA 125.552 4.168 . . . . 0.0 115.08 -176.257 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.474 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 3.7 mt-10 -106.17 -96.56 0.35 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.412 -1.267 . . . . 0.0 112.56 -175.579 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.783 ' HB2' ' O ' ' A' ' 14' ' ' ASP . . . -78.2 108.28 7.31 Favored Pre-proline 0 C--O 1.231 0.11 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 -176.457 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.898 ' HG2' HD11 ' A' ' 41' ' ' LEU . 1.8 Cg_endo -86.83 -155.28 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 123.208 2.605 . . . . 0.0 110.881 177.387 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.457 HG22 ' H ' ' A' ' 66' ' ' CYS . 5.0 mm -88.95 163.96 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.893 0.378 . . . . 0.0 110.882 178.61 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.457 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -170.18 125.46 0.77 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.768 179.589 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -153.6 174.35 14.57 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.914 -178.873 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.506 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 77.1 p -82.25 94.7 7.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.103 0.478 . . . . 0.0 110.337 178.387 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.705 HG22 ' HA3' ' A' ' 116' ' ' GLY . 6.0 p -47.33 102.43 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.214 -179.891 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.428 ' HD2' ' HB3' ' A' ' 88' ' ' PHE . 6.0 mmtp -70.66 157.0 38.74 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.516 -177.058 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.409 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -132.02 115.27 15.6 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.882 178.435 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -70.61 -163.59 0.08 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.313 -178.779 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.467 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 1.6 t -46.81 139.92 6.36 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.227 -179.539 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.501 ' HD2' ' CE1' ' A' ' 82' ' ' HIS . 24.2 Cg_exo -62.83 146.36 94.99 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.328 2.019 . . . . 0.0 112.449 -179.125 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.537 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 0.2 OUTLIER -119.71 -159.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 124.742 3.628 . . . . 0.0 114.013 -174.784 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 75' ' ' PRO . 3.4 p 96.0 -66.23 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 171.241 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.83 HG22 ' O ' ' A' ' 122' ' ' PRO . 0.2 OUTLIER -76.13 176.05 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 122.251 1.024 . . . . 0.0 113.51 -172.144 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.494 ' N ' HG13 ' A' ' 77' ' ' ILE . 2.4 m -139.93 143.36 36.57 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 113.307 -1.769 . . . . 0.0 108.551 176.42 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.406 ' ND2' ' N ' ' A' ' 79' ' ' ASN . 0.7 OUTLIER 77.03 23.12 0.96 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.795 0.331 . . . . 0.0 111.076 -178.091 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.705 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -147.9 -161.09 9.31 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.55 178.748 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -161.21 -173.92 4.08 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.92 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.514 ' HB2' HG11 ' A' ' 95' ' ' VAL . 2.1 p80 -135.51 150.38 49.75 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.124 0.488 . . . . 0.0 111.927 -178.032 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.416 ' ND2' ' OG1' ' A' ' 96' ' ' THR . 19.3 m-20 -76.54 -146.15 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.154 179.106 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 85' ' ' TYR . . . 79.4 -66.01 3.55 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.102 -1.046 . . . . 0.0 111.314 -178.352 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.435 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 3.7 m-85 66.18 28.62 10.07 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 121.456 0.646 . . . . 0.0 110.075 179.363 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.91 -173.43 2.61 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.173 178.648 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -109.9 -23.82 11.15 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.897 0.38 . . . . 0.0 110.644 178.553 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.428 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 9.6 m-85 -151.47 163.38 39.12 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.187 -179.652 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.409 ' N ' ' O ' ' A' ' 71' ' ' CYS . 31.1 m-85 -140.75 159.1 42.93 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.272 179.813 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.1 p -122.04 177.27 5.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.118 0.485 . . . . 0.0 111.992 -177.466 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 1.0 OUTLIER -62.9 96.44 0.09 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.918 -179.998 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 125.96 12.54 3.57 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.227 -0.897 . . . . 0.0 113.082 179.107 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.406 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -92.93 155.54 17.5 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.934 0.367 . . . . 0.0 110.433 179.183 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.46 HG22 ' N ' ' A' ' 95' ' ' VAL . 35.4 m -131.44 157.48 43.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.926 0.393 . . . . 0.0 111.02 -179.946 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.514 HG11 ' HB2' ' A' ' 82' ' ' HIS . 41.9 t -153.59 151.7 11.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.999 179.909 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.933 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -111.33 122.45 47.88 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.786 179.922 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 1.035 ' CE1' HG21 ' A' ' 111' ' ' VAL . 6.2 m-85 -81.06 156.1 26.0 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.651 -178.717 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 81' ' ' ARG . 1.2 p -147.23 134.81 20.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.397 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.441 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 74.8 m -72.0 149.72 44.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.76 0.314 . . . . 0.0 111.454 -179.875 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -96.1 -82.05 0.4 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.931 178.496 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -39.88 -30.99 0.1 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.901 -179.308 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 128.07 32.7 0.62 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.915 179.597 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.482 ' CD1' HG12 ' A' ' 126' ' ' ILE . 48.2 m-85 -79.96 -171.56 2.97 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.735 0.302 . . . . 0.0 110.779 179.635 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.4 m -118.97 114.5 22.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.967 0.413 . . . . 0.0 110.712 -179.846 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.634 HD21 ' HB2' ' A' ' 97' ' ' TYR . 0.3 OUTLIER -51.04 102.95 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.001 179.959 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.44 HG13 ' HB2' ' A' ' 125' ' ' GLN . 22.8 mm -95.62 151.6 3.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.554 179.171 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 69.19 24.96 75.81 Favored Glycine 0 C--N 1.331 0.254 0 C-N-CA 120.497 -0.859 . . . . 0.0 113.033 179.173 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.429 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.3 OUTLIER 60.33 136.83 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.471 0.653 . . . . 0.0 111.642 179.745 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.933 ' HB2' HG22 ' A' ' 96' ' ' THR . 0.8 OUTLIER -70.21 -20.88 63.07 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.826 -1.079 . . . . 0.0 111.988 -179.179 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -64.65 122.42 24.64 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.695 -179.334 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 1.035 HG21 ' CE1' ' A' ' 97' ' ' TYR . 3.2 t -122.63 147.76 26.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 179.175 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.92 115.51 29.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.022 0.439 . . . . 0.0 111.627 -179.003 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.513 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 30.4 t -82.7 98.34 9.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.747 177.167 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.429 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.8 OUTLIER -138.48 160.37 39.72 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.362 -178.252 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.73 25.37 3.42 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.69 179.436 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.705 ' HA3' HG22 ' A' ' 69' ' ' VAL . . . 83.24 -6.76 70.4 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.945 -179.859 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -126.16 179.8 5.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.866 0.365 . . . . 0.0 110.556 179.834 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.537 ' CD1' ' HD3' ' A' ' 75' ' ' PRO . 79.0 m95 -110.38 143.44 40.63 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.703 -179.974 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.05 162.43 23.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.029 0.442 . . . . 0.0 111.536 -178.78 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.475 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 4.3 p-10 47.65 47.82 5.07 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.058 179.526 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 72.0 Cg_endo -76.08 163.55 32.77 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.416 2.077 . . . . 0.0 111.949 178.49 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.83 ' O ' HG22 ' A' ' 77' ' ' ILE . 41.3 Cg_endo -94.97 -166.1 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.121 2.547 . . . . 0.0 113.778 -178.133 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.26 170.55 17.64 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.5 177.665 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . 0.433 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 1.6 m -122.97 91.24 3.45 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.971 0.415 . . . . 0.0 111.196 179.846 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.44 ' HB2' HG13 ' A' ' 106' ' ' ILE . 19.2 mt-30 -114.15 159.43 20.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.19 178.96 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.539 HG22 ' O ' ' A' ' 126' ' ' ILE . 16.9 mm . . . . . 0 C--N 1.321 -0.67 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.224 -179.375 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 22.5 mmm-85 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.917 0.389 . . . . 0.0 111.087 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -105.14 164.99 11.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.829 -179.97 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.536 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 71.8 m -69.82 176.4 1.77 Allowed Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.174 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.546 ' HD2' ' CD1' ' A' ' 59' ' ' TRP . 30.6 Cg_endo -83.2 175.01 8.75 Favored 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 121.792 1.661 . . . . 0.0 110.58 178.261 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.9 p -51.09 104.57 0.44 Allowed Pre-proline 0 C--N 1.324 -0.501 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.611 -179.634 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.883 ' HG2' HD12 ' A' ' 22' ' ' ILE . 32.3 Cg_exo -38.09 156.02 0.03 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.748 2.299 . . . . 0.0 112.723 -178.66 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.44 164.53 20.91 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.379 178.652 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -114.09 -173.54 2.3 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.754 -176.707 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.467 HG23 ' C ' ' A' ' 18' ' ' GLY . 5.8 tt -132.32 150.14 33.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.502 179.217 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -76.52 -68.5 0.59 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.79 -177.992 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.417 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 1.2 m120 -92.45 41.57 1.08 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.916 0.389 . . . . 0.0 111.076 -178.58 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.467 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -162.3 -173.66 31.25 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.999 179.815 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -129.91 168.67 16.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.659 0.266 . . . . 0.0 110.31 179.173 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.728 HD12 ' N ' ' A' ' 20' ' ' LEU . 0.4 OUTLIER -119.85 156.59 30.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.025 0.44 . . . . 0.0 111.38 -179.427 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -128.42 76.49 1.71 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.979 178.358 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.905 ' HA ' HG23 ' A' ' 31' ' ' ILE . 5.9 mm -69.35 109.81 2.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.72 -177.827 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -112.91 15.72 23.52 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.347 178.465 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 152.58 138.26 2.7 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.994 -179.617 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.437 HG12 ' HG3' ' A' ' 12' ' ' PRO . 30.2 m -124.4 25.66 3.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -178.705 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -94.58 152.03 18.85 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.994 0.426 . . . . 0.0 111.035 -179.966 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.634 ' CZ ' HD12 ' A' ' 51' ' ' LEU . 2.4 t80 -47.25 92.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.088 -179.682 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 126.1 0.51 7.55 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.853 -179.593 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.17 -178.82 7.18 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 116.978 0.389 . . . . 0.0 110.662 179.696 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.0 p -153.84 145.06 22.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.266 0.555 . . . . 0.0 110.862 179.713 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.905 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -109.98 164.88 5.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.181 -179.169 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.673 HG23 ' HD3' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -124.49 107.83 11.49 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.061 0.458 . . . . 0.0 111.157 179.196 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.571 ' CZ ' HD22 ' A' ' 20' ' ' LEU . 6.5 m-85 -82.24 147.21 29.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.528 -179.461 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -146.45 168.6 20.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.648 179.471 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.423 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 0.8 OUTLIER -95.36 167.18 11.5 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.645 179.795 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.44 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 25.7 m120 -55.16 -85.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.169 -178.434 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.01 125.59 4.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.258 -179.934 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.542 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 74.02 16.51 79.5 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.284 -0.96 . . . . 0.0 112.12 -178.242 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.532 ' CE1' ' CB ' ' A' ' 68' ' ' SER . 2.2 m-85 -107.21 -173.08 2.21 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.709 0.29 . . . . 0.0 110.503 -179.985 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.737 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -149.65 111.0 4.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.037 0.446 . . . . 0.0 110.762 178.265 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.865 HD11 ' CB ' ' A' ' 45' ' ' SER . 0.0 OUTLIER -79.74 132.05 36.08 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.86 179.761 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.737 HD11 ' CE1' ' A' ' 40' ' ' HIS . 3.2 mm -97.27 163.13 2.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.605 -176.865 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.43 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 63.53 -152.25 47.9 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.531 -178.383 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.412 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -60.23 -171.84 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 178.199 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.865 ' CB ' HD11 ' A' ' 41' ' ' LEU . 91.0 p -171.28 34.19 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 121.307 0.575 . . . . 0.0 109.968 -179.893 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.673 ' HD3' HG23 ' A' ' 32' ' ' THR . 1.9 mmmt -151.63 129.0 11.3 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.803 -178.966 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.447 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 0.2 OUTLIER -95.86 136.32 36.44 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.55 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.526 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.8 m-85 -115.89 123.69 48.76 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 119.307 -0.957 . . . . 0.0 112.196 -178.465 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.404 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 44.7 t -73.19 107.69 5.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.921 179.562 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -137.43 -175.39 4.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.114 179.929 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.661 HD23 ' O ' ' A' ' 56' ' ' SER . 10.9 mt -86.71 161.4 18.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.835 -179.891 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -103.35 -87.83 2.02 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.832 -179.566 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.496 ' C ' HG23 ' A' ' 54' ' ' THR . 0.1 OUTLIER -93.71 47.79 1.25 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.826 0.346 . . . . 0.0 111.242 -179.19 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.496 HG23 ' C ' ' A' ' 53' ' ' SER . 1.2 p 68.14 27.38 6.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.905 179.195 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 176.92 -31.87 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.652 -179.697 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.661 ' O ' HD23 ' A' ' 51' ' ' LEU . 18.0 t -78.28 167.34 21.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.885 0.374 . . . . 0.0 110.821 179.882 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.49 135.2 43.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.791 -179.073 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.511 HG22 ' C ' ' A' ' 51' ' ' LEU . 30.8 m -148.57 165.34 4.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.176 -179.785 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.568 ' CZ3' HD11 ' A' ' 31' ' ' ILE . 58.3 m95 -121.43 127.04 50.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.141 179.976 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.526 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 6.6 m-80 -69.76 165.21 43.92 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.171 178.883 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.442 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 42.1 Cg_exo -13.27 96.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.055 1 C-N-CA 125.63 4.22 . . . . 0.0 114.398 -179.227 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.502 ' O ' ' HD2' ' A' ' 64' ' ' PRO . 0.7 OUTLIER -93.17 -70.92 0.68 Allowed 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 114.985 -1.007 . . . . 0.0 113.245 -175.556 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.504 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -106.6 75.39 0.38 Allowed Pre-proline 0 C--N 1.333 -0.143 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -173.861 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.506 ' HG2' ' CD2' ' A' ' 41' ' ' LEU . 11.5 Cg_endo -54.53 -138.76 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 123.95 3.1 . . . . 0.0 112.417 175.849 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.492 HG22 ' H ' ' A' ' 66' ' ' CYS . 3.0 mm -103.54 166.14 2.98 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.327 0 O-C-N 121.288 -0.883 . . . . 0.0 112.687 -175.244 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.492 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.2 m -158.05 136.01 10.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.779 178.569 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -155.22 167.6 29.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.036 -179.814 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.532 ' CB ' ' CE1' ' A' ' 39' ' ' TYR . 4.9 p -96.27 110.57 22.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.154 179.959 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.693 HG11 ' HA2' ' A' ' 115' ' ' GLY . 0.9 OUTLIER -52.17 101.94 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.122 179.405 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.542 ' HE3' HG23 ' A' ' 90' ' ' THR . 0.0 OUTLIER -80.04 117.83 21.22 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.36 -179.729 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.419 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -98.85 115.83 29.71 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.064 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.5 -163.53 0.05 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.843 -179.048 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.452 ' HG ' ' CE1' ' A' ' 82' ' ' HIS . 2.3 t -44.89 137.76 4.35 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.945 -179.864 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.5 ' HG2' HG11 ' A' ' 95' ' ' VAL . 32.1 Cg_exo -56.24 160.93 9.84 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 122.124 1.883 . . . . 0.0 111.791 -179.402 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.516 ' HD3' ' CG ' ' A' ' 118' ' ' TRP . 98.8 Cg_exo -42.17 155.8 0.09 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.297 0 C-N-CA 122.839 2.36 . . . . 0.0 112.928 -178.639 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 2.5 t -107.14 90.23 3.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.43 179.152 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.666 HG23 ' HE1' ' A' ' 97' ' ' TYR . 17.6 pt -69.47 170.23 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.319 -178.998 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.8 m -89.86 138.44 31.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.727 179.688 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 60.41 28.22 17.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.926 179.782 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -163.44 -165.68 21.0 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.268 -0.968 . . . . 0.0 113.225 179.828 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.3 -175.07 3.12 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.084 0.469 . . . . 0.0 110.603 -178.952 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.452 ' CE1' ' HG ' ' A' ' 73' ' ' SER . 11.5 p-80 -107.63 178.12 4.62 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.909 179.731 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -107.4 -14.51 14.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.597 -179.827 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -45.65 138.31 6.63 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.936 -178.741 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -109.76 -25.51 10.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.907 0.385 . . . . 0.0 110.967 -179.743 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.31 -170.81 2.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.678 179.791 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -110.36 -21.17 12.33 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.399 -179.649 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.447 ' CD2' ' HB3' ' A' ' 70' ' ' LYS . 18.5 m-85 -143.6 164.32 30.73 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.037 0.446 . . . . 0.0 111.704 -178.591 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.419 ' N ' ' O ' ' A' ' 71' ' ' CYS . 22.3 m-85 -145.75 169.62 18.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.095 178.727 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.542 HG23 ' HE3' ' A' ' 70' ' ' LYS . 5.5 p -134.38 -174.41 3.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.981 0.42 . . . . 0.0 111.729 -178.699 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.486 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 0.4 OUTLIER -65.76 103.75 0.95 Allowed 'General case' 0 CA--C 1.512 -0.498 0 CA-C-O 121.6 0.714 . . . . 0.0 111.002 -179.905 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 120.77 17.57 4.19 Favored Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.563 179.663 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.46 148.73 25.57 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.825 0.345 . . . . 0.0 110.799 179.746 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 35.5 m -129.06 156.04 41.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.032 -179.522 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.526 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 18.5 t -151.74 148.86 14.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.983 179.918 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.429 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.1 OUTLIER -104.38 138.55 40.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.987 -179.936 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.969 ' CE2' HG21 ' A' ' 111' ' ' VAL . 4.4 m-85 -98.8 155.89 17.13 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.342 -179.157 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.475 ' HA ' HD13 ' A' ' 105' ' ' LEU . 74.3 m -151.34 143.28 23.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.066 -179.908 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.466 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 63.7 m -71.78 159.72 33.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.784 179.626 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.463 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 44.5 m-20 -85.85 -70.84 0.57 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.512 -178.944 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.0 t -68.33 -23.62 64.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.384 -179.008 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 124.26 34.79 0.7 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.568 -179.787 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.49 ' CE2' HG12 ' A' ' 126' ' ' ILE . 14.9 m-85 -69.76 -174.46 0.74 Allowed 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 120.948 0.404 . . . . 0.0 110.573 179.509 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.88 100.66 10.15 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.424 178.927 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.629 HD21 ' HA ' ' A' ' 109' ' ' SER . 0.3 OUTLIER -46.64 125.59 7.31 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.376 0.608 . . . . 0.0 111.602 -178.873 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.451 ' HB ' ' CB ' ' A' ' 123' ' ' THR . 36.8 mm -89.59 153.17 3.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.098 179.391 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 60.37 -132.3 50.07 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.773 -178.594 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -116.26 137.58 52.02 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.981 0.42 . . . . 0.0 111.318 179.509 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.629 ' HA ' HD21 ' A' ' 105' ' ' LEU . 0.7 OUTLIER -66.12 -27.64 68.2 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.408 178.7 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -70.9 138.17 27.92 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.545 179.575 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.969 HG21 ' CE2' ' A' ' 97' ' ' TYR . 2.9 t -131.39 130.46 62.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 179.162 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.916 HD22 ' N ' ' A' ' 113' ' ' CYS . 0.6 OUTLIER -89.85 128.18 36.13 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.957 0.408 . . . . 0.0 111.682 -178.576 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.916 ' N ' HD22 ' A' ' 112' ' ' LEU . 42.6 t -99.21 102.92 14.73 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.678 176.648 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.779 ' HB3' HD11 ' A' ' 112' ' ' LEU . 20.0 p -148.03 111.84 5.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.506 -178.657 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.693 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 94.25 39.84 4.69 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.262 179.645 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.434 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 58.82 20.2 46.91 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.145 -179.339 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -143.97 -178.06 5.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.916 0.388 . . . . 0.0 110.867 -179.976 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.53 ' CZ3' ' HB2' ' A' ' 113' ' ' CYS . 93.5 m95 -125.38 144.07 50.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.184 -179.121 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.426 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.9 OUTLIER -123.48 166.65 15.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.495 -178.984 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.446 ' N ' ' HD3' ' A' ' 121' ' ' PRO . 1.5 p30 45.73 50.35 7.77 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 115.437 -0.802 . . . . 0.0 112.361 179.065 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.468 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 96.6 Cg_endo -80.05 146.36 18.08 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.558 2.172 . . . . 0.0 111.47 177.572 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.507 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 61.1 Cg_endo -94.6 -173.01 0.29 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.786 2.324 . . . . 0.0 113.489 -178.477 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.451 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -131.69 -161.45 1.13 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.869 -1.06 . . . . 0.0 109.933 177.766 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 6.5 m -154.37 89.07 1.25 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.084 0.468 . . . . 0.0 111.122 179.104 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -118.54 170.86 8.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.436 179.324 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.561 HG22 ' O ' ' A' ' 126' ' ' ILE . 22.1 mm . . . . . 0 C--N 1.323 -0.575 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.825 -179.976 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 9.9 mtm180 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.885 0.374 . . . . 0.0 110.772 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.658 ' HD3' HG23 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -70.85 -176.38 1.32 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.071 -179.716 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.457 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 51.1 m -108.54 160.82 25.78 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.751 179.958 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 38.6 Cg_endo -67.27 172.96 9.3 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.51 2.14 . . . . 0.0 112.255 -179.777 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.425 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 2.4 t -50.97 111.55 2.36 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.969 -179.57 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.546 ' HB3' HD11 ' A' ' 31' ' ' ILE . 9.9 Cg_endo -56.66 144.26 86.57 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.192 1.928 . . . . 0.0 111.944 179.724 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.902 ' O ' HD11 ' A' ' 20' ' ' LEU . 3.0 mtt85 -51.61 159.3 0.78 Allowed 'General case' 0 CA--C 1.517 -0.288 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.071 178.901 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.15 -174.21 2.41 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.179 0.514 . . . . 0.0 111.709 -177.918 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.441 HG23 ' C ' ' A' ' 18' ' ' GLY . 2.7 tt -144.36 139.78 24.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.526 -179.726 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -87.08 -48.07 8.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.667 -178.486 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.442 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 0.7 OUTLIER -94.25 25.96 3.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.055 -178.822 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.441 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -157.42 -170.37 22.22 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.816 -179.625 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -141.45 130.82 23.69 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.661 0.267 . . . . 0.0 110.638 179.882 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.902 HD11 ' O ' ' A' ' 13' ' ' ARG . 10.6 mt -73.2 156.61 38.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.188 0.518 . . . . 0.0 111.719 -179.496 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 32' ' ' THR . 0.8 OUTLIER -132.14 73.01 1.51 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.506 177.517 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.924 ' HA ' HG23 ' A' ' 31' ' ' ILE . 68.5 mt -69.16 101.72 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.722 -177.183 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -103.84 17.11 50.02 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.953 177.735 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 29' ' ' SER . . . 157.43 126.15 0.89 Allowed Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.146 -179.697 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.658 HG23 ' HD3' ' A' ' 8' ' ' ARG . 33.3 m -116.71 19.02 7.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 111.631 0.234 . . . . 0.0 111.631 -179.298 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 14.0 t70 -88.03 164.66 15.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.953 0.406 . . . . 0.0 110.847 179.594 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.653 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 4.0 t80 -61.72 91.75 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.787 179.881 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 124.88 12.25 4.08 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.0 179.909 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 1.2 m -96.0 -172.2 2.51 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.869 0.334 . . . . 0.0 110.479 179.289 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 47' ' ' SER . 19.3 p -155.49 147.27 23.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.054 0.454 . . . . 0.0 111.398 179.852 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.924 HG23 ' HA ' ' A' ' 22' ' ' ILE . 1.0 OUTLIER -106.82 171.42 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.669 179.631 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.489 ' H ' HG22 ' A' ' 31' ' ' ILE . 0.1 OUTLIER -131.9 113.52 13.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.012 0.434 . . . . 0.0 111.261 179.499 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.83 ' CE2' HD21 ' A' ' 20' ' ' LEU . 20.6 m-85 -89.19 136.35 33.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.229 -179.813 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.401 ' O ' ' HA3' ' A' ' 18' ' ' GLY . 6.7 m -139.71 158.05 44.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.796 -179.974 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.462 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 31.3 m -87.75 157.74 18.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.949 0.404 . . . . 0.0 110.984 179.9 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.48 -92.72 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.88 -179.359 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -147.48 131.0 16.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.824 0.345 . . . . 0.0 110.834 -179.648 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.586 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 68.47 23.21 75.19 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.917 -178.831 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.491 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.0 m-85 -116.18 168.36 10.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.797 0.332 . . . . 0.0 110.994 -179.183 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.937 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -130.56 124.32 31.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.55 178.248 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.918 HD21 ' O ' ' A' ' 44' ' ' GLU . 5.4 tt -87.99 124.54 33.83 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.725 -179.622 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.937 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.1 mm -102.62 165.09 3.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.006 0.432 . . . . 0.0 111.071 -179.893 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.463 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 74.65 -136.15 20.47 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.241 -179.458 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.918 ' O ' HD21 ' A' ' 41' ' ' LEU . 1.9 pt-20 -74.54 -173.22 1.71 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.767 0.318 . . . . 0.0 110.534 179.197 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.8 p -163.42 24.31 0.08 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.219 -179.502 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.471 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -166.98 125.7 1.37 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.524 -177.554 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.456 ' CB ' ' HA ' ' A' ' 62' ' ' GLU . 0.4 OUTLIER -92.13 138.72 31.3 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 177.492 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.552 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 2.1 m-85 -116.46 119.71 36.49 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 119.446 -0.902 . . . . 0.0 111.765 179.88 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 26.8 t -70.01 112.8 6.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.756 179.537 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.418 ' OE2' ' ND2' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -139.76 -171.55 3.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 179.741 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.653 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -100.78 143.12 31.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.034 -179.558 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -64.9 -148.02 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.421 179.76 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.09 -38.19 12.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.824 0.345 . . . . 0.0 110.861 179.922 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.6 p -97.9 25.28 6.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.835 179.797 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.14 21.95 64.19 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.218 -179.517 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.7 -175.03 5.34 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.063 0.459 . . . . 0.0 111.433 -179.047 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 6.7 mtt -105.68 129.66 53.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.096 178.474 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.2 m -148.93 176.45 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.188 -178.755 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.535 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 65.7 m95 -132.15 125.73 31.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.02 179.813 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.552 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 3.2 m-20 -68.8 168.38 15.22 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.127 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.494 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 19.0 Cg_exo -10.66 88.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.043 1 C-N-CA 125.342 4.028 . . . . 0.0 114.783 -179.032 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.469 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 1.0 OUTLIER -83.82 -97.97 0.05 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.631 -177.381 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.474 ' HA ' ' CD2' ' A' ' 33' ' ' TYR . . . -84.65 110.29 26.34 Favored Pre-proline 0 C--O 1.231 0.096 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -175.903 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.849 ' HG2' HD11 ' A' ' 41' ' ' LEU . 5.0 Cg_exo -78.53 -153.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.918 2.412 . . . . 0.0 111.086 177.025 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.527 HG22 ' H ' ' A' ' 66' ' ' CYS . 3.8 mm -93.83 167.68 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.672 0.272 . . . . 0.0 110.368 177.929 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.527 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -165.43 135.07 3.5 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.017 -179.968 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -156.38 178.38 10.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.955 -179.794 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.491 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 52.9 p -86.1 113.2 21.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.981 179.982 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.726 HG23 ' HB3' ' A' ' 40' ' ' HIS . 0.1 OUTLIER -43.54 98.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.589 -179.907 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.443 ' HE3' ' CG2' ' A' ' 90' ' ' THR . 1.3 mmtp -72.08 107.93 5.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.1 179.852 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.419 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -93.37 125.26 37.87 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.818 0.342 . . . . 0.0 110.159 178.578 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -75.88 -156.02 0.06 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.478 179.807 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.426 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 1.7 t -48.8 138.24 12.54 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.084 -179.854 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.512 ' HG2' HG11 ' A' ' 95' ' ' VAL . 25.3 Cg_exo -61.11 163.34 17.02 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.372 2.048 . . . . 0.0 112.035 179.764 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.532 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 82.7 Cg_exo -38.75 156.43 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.895 2.396 . . . . 0.0 112.903 -179.274 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.5 m -109.78 89.76 3.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.484 179.315 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.678 HG23 ' HE2' ' A' ' 97' ' ' TYR . 32.7 pt -69.09 175.22 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.09 -179.318 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.426 ' HB3' ' ND2' ' A' ' 79' ' ' ASN . 0.6 OUTLIER -95.71 145.94 24.9 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.399 178.605 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.533 ' HB3' ' CD2' ' A' ' 103' ' ' TYR . 3.0 m-80 59.46 28.74 18.19 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.895 0.379 . . . . 0.0 111.104 177.876 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -170.48 -161.68 21.48 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.644 -0.788 . . . . 0.0 113.092 179.634 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.419 ' N ' ' O ' ' A' ' 98' ' ' SER . 1.4 ptt85 -170.18 -175.22 1.92 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.972 0.415 . . . . 0.0 110.984 -178.79 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 12.2 p80 -105.05 176.43 5.16 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.982 179.874 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.424 ' ND2' ' HB ' ' A' ' 96' ' ' THR . 0.2 OUTLIER -131.73 80.62 1.93 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.543 179.138 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -110.88 150.93 17.77 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.189 -1.005 . . . . 0.0 112.53 -179.845 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -106.35 -27.95 10.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.033 0.444 . . . . 0.0 110.546 179.747 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.27 -172.15 2.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.814 179.852 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -111.46 -19.84 12.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.084 179.324 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.414 ' HB3' ' HD3' ' A' ' 70' ' ' LYS . 7.3 m-85 -138.27 167.72 21.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.96 0.41 . . . . 0.0 111.251 -179.557 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.419 ' N ' ' O ' ' A' ' 71' ' ' CYS . 62.5 m-85 -144.09 163.52 33.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.491 179.843 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.443 ' CG2' ' HE3' ' A' ' 70' ' ' LYS . 16.0 p -128.22 179.93 5.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.906 0.384 . . . . 0.0 111.349 -179.228 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 38.1 p-10 -64.48 94.75 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.267 0.556 . . . . 0.0 110.864 -179.926 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.34 28.05 1.04 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.116 179.085 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.433 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -106.0 161.5 14.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.679 0.276 . . . . 0.0 110.522 179.125 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 35.3 m -134.07 152.24 33.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.215 0.531 . . . . 0.0 111.441 -179.567 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.542 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 21.6 t -150.88 147.27 15.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.618 179.27 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.516 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -103.83 144.72 31.11 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.114 178.574 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.92 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.7 m-85 -100.5 156.76 17.1 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.596 179.941 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 81' ' ' ARG . 51.8 p -153.18 143.88 22.72 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.349 -178.82 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.482 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 23.3 m -69.52 164.88 22.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.011 -0.54 . . . . 0.0 112.086 -178.844 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -94.88 -84.78 0.32 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.878 178.913 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.35 -41.07 79.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.495 -179.259 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 147.07 42.56 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.644 -179.978 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.533 ' CD2' ' HB3' ' A' ' 79' ' ' ASN . 23.3 m-85 -80.14 -165.85 0.92 Allowed 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 122.355 0.262 . . . . 0.0 110.601 179.962 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 124' ' ' CYS . 4.3 m -120.64 107.53 12.92 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.798 0.332 . . . . 0.0 111.719 -179.967 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.446 HD23 ' HB2' ' A' ' 122' ' ' PRO . 1.4 tp -48.33 117.12 1.82 Allowed 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.334 177.83 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.469 ' HB ' ' CB ' ' A' ' 123' ' ' THR . 44.9 mm -91.53 154.34 3.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.036 -178.859 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.424 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 60.55 -128.88 46.29 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.082 -179.399 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -114.11 127.23 55.82 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.878 0.37 . . . . 0.0 110.819 179.35 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.516 ' HB2' HG22 ' A' ' 96' ' ' THR . 0.1 OUTLIER -64.01 -28.12 69.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.769 179.741 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.31 144.9 41.72 Favored Glycine 0 N--CA 1.452 -0.256 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.822 -179.919 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.92 HG21 ' CE1' ' A' ' 97' ' ' TYR . 3.4 t -140.52 127.51 22.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.544 0.211 . . . . 0.0 110.989 -179.959 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.45 128.87 34.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.911 0.386 . . . . 0.0 111.524 -179.51 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.511 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 24.7 t -91.98 104.69 17.07 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.513 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.2 t -150.89 163.95 37.47 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.146 0.498 . . . . 0.0 111.596 -177.976 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 45.29 32.21 3.58 Favored Glycine 0 N--CA 1.453 -0.219 0 CA-C-N 115.54 -0.754 . . . . 0.0 113.096 179.557 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.464 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 67.92 13.17 63.65 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.696 -179.994 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -143.17 171.42 14.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.84 0.353 . . . . 0.0 110.267 179.292 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.542 ' CZ3' HG23 ' A' ' 95' ' ' VAL . 87.8 m95 -108.43 131.92 54.29 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.885 -179.364 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.99 149.81 34.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.066 0.46 . . . . 0.0 111.234 -179.154 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.493 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER 70.43 44.88 0.24 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.231 179.057 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.493 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 73.6 Cg_endo -76.9 140.56 20.55 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.266 1.977 . . . . 0.0 111.215 177.834 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.509 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 36.4 Cg_endo -91.78 -179.55 1.29 Allowed 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.453 2.102 . . . . 0.0 113.255 -178.679 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.469 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -118.77 -162.34 0.89 Allowed 'General case' 0 CA--C 1.502 -0.885 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.041 176.278 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . 0.44 ' SG ' ' HB2' ' A' ' 103' ' ' TYR . 4.9 t -170.39 91.72 0.18 Allowed 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 119.901 -0.72 . . . . 0.0 111.265 -176.486 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -116.2 174.79 5.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.042 -178.685 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.527 HG12 ' CE1' ' A' ' 103' ' ' TYR . 46.7 mm . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.865 -179.881 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.81 0.338 . . . . 0.0 110.712 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.486 ' HB3' HG23 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -86.75 170.1 12.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.14 -178.875 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.46 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 48.0 m -80.99 161.22 63.95 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.813 179.68 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 54.7 Cg_endo -69.77 172.47 12.59 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.355 2.037 . . . . 0.0 111.337 178.773 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.428 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 3.1 p -50.93 117.66 8.97 Favored Pre-proline 0 C--N 1.328 -0.327 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.913 -179.19 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.552 ' HB3' HD11 ' A' ' 31' ' ' ILE . 17.8 Cg_endo -58.71 161.66 14.55 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.708 2.272 . . . . 0.0 112.348 -179.874 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.562 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -61.92 179.92 0.24 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.105 178.744 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.33 -171.07 2.73 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.015 0.436 . . . . 0.0 111.321 -179.678 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.573 HG22 ' CD2' ' A' ' 20' ' ' LEU . 11.0 tt -152.56 150.15 13.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.798 -179.743 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -95.45 -52.39 4.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.111 -179.519 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.43 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 1.4 m120 -94.17 42.05 1.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.122 0.487 . . . . 0.0 110.819 -179.85 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.409 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -169.67 -169.74 33.29 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.691 -0.686 . . . . 0.0 112.429 179.806 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -148.14 130.09 15.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.667 0.27 . . . . 0.0 110.785 -179.505 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.815 HD21 ' CE1' ' A' ' 33' ' ' TYR . 19.5 mt -78.52 161.35 27.1 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 121.271 0.558 . . . . 0.0 111.72 -179.674 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -132.09 74.16 1.57 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.269 177.523 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.853 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.7 OUTLIER -80.75 107.55 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.86 -176.794 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -102.31 14.65 56.75 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.988 177.464 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 158.74 155.23 7.52 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.151 -179.62 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.486 HG23 ' HB3' ' A' ' 8' ' ' ARG . 31.2 m -132.72 8.42 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 112.003 0.371 . . . . 0.0 112.003 -179.52 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 0.7 OUTLIER -72.72 154.7 40.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.804 0.335 . . . . 0.0 111.009 -179.9 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.595 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 6.0 t80 -50.44 92.55 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.874 -179.949 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 128.25 -5.16 6.79 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.784 -179.732 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.39 -175.51 0.65 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.903 0.352 . . . . 0.0 110.787 179.92 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.1 p -157.45 139.59 14.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.093 179.776 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.853 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.4 OUTLIER -107.51 170.15 2.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.478 -179.884 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.702 HG23 ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -134.35 115.92 14.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.893 0.378 . . . . 0.0 110.986 179.58 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.815 ' CE1' HD21 ' A' ' 20' ' ' LEU . 23.0 m-85 -93.09 138.02 31.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.361 -179.067 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.83 170.13 16.27 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.782 179.847 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.429 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 50.9 m -91.03 163.39 14.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.858 0.361 . . . . 0.0 111.188 -179.639 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.405 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 1.5 m-20 -62.69 -82.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.255 -179.655 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -155.39 136.48 13.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.852 -179.702 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.52 23.05 64.42 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.107 -179.42 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.512 ' CE2' ' HB3' ' A' ' 68' ' ' SER . 2.5 m-30 -116.64 174.25 6.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.95 0.405 . . . . 0.0 111.135 -179.273 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.609 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -134.91 123.67 23.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.995 177.453 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.947 HD11 ' HG2' ' A' ' 64' ' ' PRO . 10.2 tt -80.32 144.23 32.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.838 -178.531 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.709 HD13 ' C ' ' A' ' 41' ' ' LEU . 1.9 mm -124.73 152.12 30.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.942 -179.865 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 83.62 -127.34 7.99 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.039 -179.165 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.852 ' O ' HD21 ' A' ' 41' ' ' LEU . 7.0 pm0 -85.29 167.85 15.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.82 0.343 . . . . 0.0 110.568 178.887 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.8 p -150.8 21.07 0.79 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.898 179.609 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.702 ' HG2' HG23 ' A' ' 32' ' ' THR . 0.0 OUTLIER -163.95 124.37 2.16 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.278 -179.299 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.45 ' HB3' ' CG ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -102.18 156.37 17.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.635 -179.269 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.462 ' CB ' ' HB2' ' A' ' 60' ' ' ASN . 1.7 m-85 -132.45 123.78 27.33 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 119.937 -0.705 . . . . 0.0 112.508 -178.192 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 35.5 t -70.14 95.68 1.0 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.38 178.305 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.5 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 3.7 tt0 -128.01 171.22 12.05 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.495 0.664 . . . . 0.0 111.033 -179.071 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.745 HD23 ' O ' ' A' ' 56' ' ' SER . 1.3 mt -65.36 161.54 19.48 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.366 -179.784 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 56' ' ' SER . . . -102.23 -116.23 4.1 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.509 179.891 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.6 t -122.56 -46.16 2.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.773 0.32 . . . . 0.0 110.897 179.88 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.8 p -93.34 51.01 1.56 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.842 179.936 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 52.32 39.95 52.35 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.474 -179.952 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.745 ' O ' HD23 ' A' ' 51' ' ' LEU . 25.4 t -117.56 170.81 8.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.791 0.329 . . . . 0.0 110.849 179.855 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -98.53 125.28 43.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.091 -179.307 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.2 m -125.97 -169.22 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.687 179.457 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.52 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 73.2 m95 -130.45 130.49 44.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.953 0.406 . . . . 0.0 111.819 -179.193 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.469 ' CB ' ' HD2' ' A' ' 61' ' ' PRO . 0.9 OUTLIER -76.45 166.98 40.68 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.483 177.227 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.469 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 42.9 Cg_exo -11.91 96.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.774 1 C-N-CA 125.646 4.231 . . . . 0.0 115.242 -178.574 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.45 ' CG ' ' HB3' ' A' ' 47' ' ' SER . 36.6 mt-10 -100.79 -98.65 0.25 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.951 -178.147 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.468 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -70.67 107.04 2.09 Favored Pre-proline 0 N--CA 1.462 0.167 0 N-CA-C 112.657 0.614 . . . . 0.0 112.657 -176.545 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.947 ' HG2' HD11 ' A' ' 41' ' ' LEU . 2.3 Cg_endo -89.45 -156.94 0.06 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.512 2.808 . . . . 0.0 111.223 177.723 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.63 HD12 ' HB ' ' A' ' 42' ' ' ILE . 1.0 OUTLIER -93.08 173.26 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.931 0.396 . . . . 0.0 110.393 177.904 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.591 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -171.36 142.65 1.72 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.013 179.622 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -169.49 172.09 7.27 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.805 179.458 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.512 ' HB3' ' CE2' ' A' ' 39' ' ' TYR . 34.0 p -80.41 126.87 31.73 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.646 179.583 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.448 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 1.3 p -41.51 97.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.584 -179.499 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.437 ' HD2' ' HB3' ' A' ' 88' ' ' PHE . 13.7 mmtp -66.72 129.78 40.99 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.945 -178.468 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -116.8 115.93 26.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.538 177.166 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.32 -163.41 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.957 -178.658 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.432 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 1.6 t -45.15 135.27 5.25 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.324 -179.194 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.595 ' HG2' HG11 ' A' ' 95' ' ' VAL . 31.6 Cg_exo -58.96 160.98 16.71 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.364 2.043 . . . . 0.0 112.006 -179.9 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.43 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 87.0 Cg_exo -40.86 156.76 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.795 2.33 . . . . 0.0 112.975 -179.135 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.72 89.84 3.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.783 179.9 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.67 HG21 ' O ' ' A' ' 122' ' ' PRO . 25.8 pt -69.47 178.75 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.551 -179.201 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.4 m -100.48 145.41 28.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.645 179.411 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.415 ' HB3' ' CD2' ' A' ' 103' ' ' TYR . 3.3 m-80 58.55 26.78 14.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.904 179.776 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.464 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -165.87 -164.47 21.41 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.378 179.933 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.454 ' N ' ' O ' ' A' ' 98' ' ' SER . 7.7 ptt85 -167.83 -175.86 2.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.151 0.5 . . . . 0.0 111.102 -179.4 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.466 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 14.6 p80 -110.76 166.15 11.25 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.661 178.832 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -92.02 -86.48 0.23 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.37 179.247 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.432 ' HA3' ' OH ' ' A' ' 89' ' ' TYR . . . 60.62 139.51 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.761 -0.733 . . . . 0.0 113.261 178.3 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -112.29 -29.78 7.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.1 0.476 . . . . 0.0 110.652 179.137 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.62 -172.26 2.21 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.763 179.682 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -102.45 -20.92 14.35 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.168 179.694 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.437 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 8.2 m-85 -133.84 176.56 8.46 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.194 -179.993 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.436 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 62.5 m-85 -151.0 160.47 43.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.593 -179.913 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.434 ' CG2' ' OG ' ' A' ' 68' ' ' SER . 36.9 p -126.81 -177.24 3.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.022 0.439 . . . . 0.0 111.518 -179.048 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 20.4 p-10 -65.47 94.07 0.17 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.007 -179.805 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 127.1 30.59 0.79 Allowed Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.336 -0.847 . . . . 0.0 113.074 178.817 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.434 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.5 OUTLIER -109.92 160.32 16.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.773 0.32 . . . . 0.0 110.632 179.324 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 34.7 m -136.26 150.97 28.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.132 0.491 . . . . 0.0 111.216 -179.603 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.595 HG11 ' HG2' ' A' ' 74' ' ' PRO . 21.8 t -145.54 148.52 17.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.753 179.686 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.786 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -110.91 123.38 50.04 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.012 -179.787 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.972 ' CE2' HG21 ' A' ' 111' ' ' VAL . 5.6 m-85 -79.82 156.68 27.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.752 -179.709 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 81' ' ' ARG . 3.9 p -149.86 148.97 29.8 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.914 0.388 . . . . 0.0 112.03 -177.973 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.538 ' HB3' ' HB2' ' A' ' 103' ' ' TYR . 21.2 m -68.8 154.75 41.43 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.541 179.832 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.464 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 85.4 m-20 -73.94 -87.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.496 . . . . 0.0 112.111 -177.992 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.43 -43.77 26.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.64 0.257 . . . . 0.0 111.687 -177.642 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 178.44 32.17 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.352 -0.928 . . . . 0.0 113.112 -177.548 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.546 ' CZ ' HG12 ' A' ' 126' ' ' ILE . 0.8 OUTLIER -72.95 -161.81 0.1 Allowed 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.611 -0.295 . . . . 0.0 110.39 -179.524 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' A' ' 124' ' ' CYS . 3.1 t -141.46 117.56 10.62 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.962 0.411 . . . . 0.0 110.77 177.44 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.745 HD22 ' HB2' ' A' ' 109' ' ' SER . 0.2 OUTLIER -58.9 140.4 55.44 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.836 0.826 . . . . 0.0 112.063 -178.119 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.445 HG22 ' N ' ' A' ' 107' ' ' GLY . 37.4 mm -110.24 158.37 10.52 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 114.057 -1.429 . . . . 0.0 110.075 179.154 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.445 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 63.96 -125.42 32.43 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.402 -0.904 . . . . 0.0 112.034 -179.158 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -123.33 130.76 53.17 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.856 0.36 . . . . 0.0 110.837 179.38 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.786 ' OG ' HG22 ' A' ' 96' ' ' THR . 2.7 t -66.18 -31.1 71.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.865 179.879 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.4 138.28 30.38 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.049 -179.407 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.972 HG21 ' CE2' ' A' ' 97' ' ' TYR . 2.9 t -134.4 119.44 30.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.64 0.257 . . . . 0.0 110.744 179.024 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.84 125.71 30.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.923 0.392 . . . . 0.0 111.629 -179.114 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.507 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 14.9 t -91.82 105.76 17.96 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 176.176 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.1 OUTLIER -148.69 163.09 38.34 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.109 0.48 . . . . 0.0 111.36 -178.495 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.2 30.91 4.3 Favored Glycine 0 CA--C 1.517 0.187 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.731 179.865 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.448 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 68.91 16.03 69.93 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.599 -179.525 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -141.28 -179.18 5.97 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.905 0.383 . . . . 0.0 110.68 179.72 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.536 ' CZ3' HG23 ' A' ' 95' ' ' VAL . 94.9 m95 -116.63 142.71 46.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.919 -179.85 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -125.74 147.35 49.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.142 -179.762 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.487 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER 70.17 45.66 0.26 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.153 179.122 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.487 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 98.0 Cg_endo -77.9 133.68 12.72 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.372 2.048 . . . . 0.0 111.295 177.782 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.67 ' O ' HG21 ' A' ' 77' ' ' ILE . 93.7 Cg_endo -93.22 -173.15 0.37 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.475 2.117 . . . . 0.0 113.714 -177.824 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.43 -170.01 2.21 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-N 114.054 -1.43 . . . . 0.0 108.582 176.359 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 104' ' ' SER . 2.5 t -161.2 105.93 1.34 Allowed 'General case' 0 N--CA 1.424 -1.756 0 CA-C-O 122.127 0.965 . . . . 0.0 110.879 -177.667 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 10.8 mt-30 -112.14 152.9 27.77 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 113.491 -1.686 . . . . 0.0 110.329 -179.685 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.682 HG22 ' O ' ' A' ' 126' ' ' ILE . 5.0 mm . . . . . 0 C--N 1.32 -0.712 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.953 179.828 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 121.015 0.436 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.415 ' HD2' HG23 ' A' ' 25' ' ' VAL . 35.5 mtm180 -76.67 171.38 14.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.79 179.705 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.457 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 29.6 m -84.55 159.82 57.69 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.576 179.56 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.5 169.79 17.75 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.543 2.162 . . . . 0.0 112.527 -179.07 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.425 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 3.4 t -51.38 105.63 0.55 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.836 179.89 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 11' ' ' SER . 12.7 Cg_endo -58.5 144.79 96.54 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.044 1.829 . . . . 0.0 111.768 179.699 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.928 ' O ' HD11 ' A' ' 20' ' ' LEU . 3.0 mtt180 -45.45 122.81 3.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.412 0.625 . . . . 0.0 111.343 -179.341 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.663 ' O ' HG22 ' A' ' 15' ' ' ILE . 0.2 OUTLIER -73.91 -7.4 52.18 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.213 -178.932 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.663 HG22 ' O ' ' A' ' 14' ' ' ASP . 18.2 tt 51.72 159.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-O 121.353 0.597 . . . . 0.0 112.089 -178.803 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.433 ' N ' HG12 ' A' ' 15' ' ' ILE . 7.0 t0 -100.56 159.07 15.45 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.632 177.484 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.496 ' HB2' ' CD2' ' A' ' 39' ' ' TYR . 0.0 OUTLIER 42.82 29.32 0.17 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.77 0.319 . . . . 0.0 111.222 -179.408 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.425 ' HA2' ' N ' ' A' ' 36' ' ' ASN . . . -152.12 176.72 30.3 Favored Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.74 -179.42 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -142.56 140.12 31.63 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.673 0.273 . . . . 0.0 110.696 179.938 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.928 HD11 ' O ' ' A' ' 13' ' ' ARG . 52.0 mt -88.99 155.52 19.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.305 0.574 . . . . 0.0 112.096 -178.888 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -124.11 79.03 1.69 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.268 177.181 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.908 ' HA ' HG23 ' A' ' 31' ' ' ILE . 1.3 mt -75.29 107.71 6.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.36 -176.096 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -109.75 20.8 26.55 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.191 175.869 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 154.63 124.8 0.94 Allowed Glycine 0 C--N 1.334 0.444 0 N-CA-C 111.799 -0.52 . . . . 0.0 111.799 -178.948 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.495 HG13 ' CG2' ' A' ' 22' ' ' ILE . 28.7 m -120.4 32.49 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -178.504 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.3 OUTLIER -100.9 151.05 22.2 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.843 0.354 . . . . 0.0 110.921 179.372 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.523 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 8.1 t80 -49.57 91.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.938 179.996 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 129.5 1.73 5.53 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.997 -179.807 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.37 -164.27 1.16 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 117.052 0.426 . . . . 0.0 110.669 179.677 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.4 p -160.01 153.19 21.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.958 0.409 . . . . 0.0 111.164 179.475 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.908 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.8 OUTLIER -114.01 175.0 2.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.442 -179.972 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.458 ' H ' HG22 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -130.74 120.31 23.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.79 0.329 . . . . 0.0 110.706 178.638 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.461 ' CE2' HD21 ' A' ' 20' ' ' LEU . 19.4 m-85 -96.69 144.67 26.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.301 0.572 . . . . 0.0 112.215 -177.897 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -148.02 165.33 31.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.287 179.224 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.416 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 1.3 m -85.17 159.41 20.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.878 0.37 . . . . 0.0 110.928 -179.6 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.429 ' ND2' ' HA ' ' A' ' 17' ' ' ASN . 8.7 m-20 -59.76 -86.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.272 -178.68 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.3 t -153.02 132.22 12.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.896 0.379 . . . . 0.0 110.938 -179.979 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.72 22.6 73.69 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.036 -179.396 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.496 ' CD2' ' HB2' ' A' ' 17' ' ' ASN . 2.5 m-30 -114.81 -174.14 2.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.96 0.409 . . . . 0.0 110.902 -179.649 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.942 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -145.1 113.59 6.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.878 177.635 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.98 HD21 ' O ' ' A' ' 44' ' ' GLU . 6.5 tt -79.4 119.2 22.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.824 -178.631 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.942 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.0 mm -103.89 153.11 6.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.513 179.248 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 85.11 -127.46 8.21 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.989 179.626 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.98 ' O ' HD21 ' A' ' 41' ' ' LEU . 1.3 mt-10 -79.7 179.53 7.47 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.484 0.659 . . . . 0.0 112.618 -177.899 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.425 ' HA ' ' HB2' ' A' ' 33' ' ' TYR . 4.8 p -165.84 27.52 0.05 OUTLIER 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.005 -179.857 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.416 ' CG ' ' O ' ' A' ' 45' ' ' SER . 3.0 mtpt -166.83 123.73 1.24 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -177.774 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.45 ' HB3' HG13 ' A' ' 31' ' ' ILE . 5.8 t -94.07 152.23 18.93 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.103 177.496 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.547 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.1 m-85 -124.63 105.36 9.27 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 119.112 -1.035 . . . . 0.0 111.736 177.539 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.464 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 27.6 t -58.59 101.05 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.509 179.677 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.01 -171.08 2.22 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.164 -179.172 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.523 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -96.21 151.73 19.22 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.055 -179.375 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -75.84 -143.07 1.18 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.437 179.921 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.3 t -95.19 -40.19 9.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.794 0.33 . . . . 0.0 110.924 179.894 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 11.5 p -101.63 36.63 2.0 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.905 179.778 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 71.8 24.39 76.72 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.373 -179.823 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.94 -162.01 0.64 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.848 0.356 . . . . 0.0 110.891 -179.991 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.4 mmt -117.2 134.0 55.32 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.448 179.438 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.4 m -148.4 173.88 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.959 -179.537 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.622 ' CZ3' HD11 ' A' ' 31' ' ' ILE . 74.0 m95 -126.29 124.68 40.88 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.147 -179.907 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.547 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.7 OUTLIER -68.98 166.84 24.06 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 177.368 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.478 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 78.3 Cg_exo -15.07 88.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 125.229 3.953 . . . . 0.0 114.253 -179.408 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.446 ' HA ' ' HB2' ' A' ' 47' ' ' SER . 1.0 OUTLIER -92.73 -93.41 0.15 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.188 -0.914 . . . . 0.0 112.244 -177.43 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.23 106.06 1.32 Allowed Pre-proline 0 C--O 1.231 0.125 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -177.118 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.667 ' HG2' HD11 ' A' ' 41' ' ' LEU . 1.9 Cg_endo -84.43 -153.6 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.993 2.462 . . . . 0.0 110.576 178.059 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.466 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 3.4 mm -86.77 161.32 2.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.994 0.426 . . . . 0.0 111.105 179.911 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.406 ' HB3' ' OD1' ' A' ' 17' ' ' ASN . 0.8 OUTLIER -169.76 130.9 1.05 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.965 179.491 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -154.92 175.61 13.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.665 179.576 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.476 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 1.7 p -87.39 121.75 30.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.295 179.053 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.471 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 1.6 p -41.92 94.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 120.971 0.415 . . . . 0.0 111.299 -179.591 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.427 ' HD2' ' HB3' ' A' ' 88' ' ' PHE . 2.7 mmtt -79.63 140.37 37.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.835 -177.85 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.424 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -116.89 122.34 44.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.977 178.544 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.36 -164.66 0.06 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.935 -178.993 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.43 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 2.0 t -49.1 136.16 14.86 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.814 -179.504 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.48 ' HG3' ' CZ2' ' A' ' 118' ' ' TRP . 24.3 Cg_exo -59.48 155.71 40.19 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.119 1.879 . . . . 0.0 111.675 179.905 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.434 ' HG2' ' HD3' ' A' ' 121' ' ' PRO . 95.9 Cg_exo -44.17 164.46 0.05 OUTLIER 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.984 2.456 . . . . 0.0 113.237 -178.458 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 83.0 p -113.04 90.49 3.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.592 179.697 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.2 pt -68.74 172.88 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.942 -179.623 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.0 133.77 35.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.086 -179.555 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.504 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 0.2 OUTLIER 66.78 28.09 9.01 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.707 179.872 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.421 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -163.64 -177.99 36.93 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.287 -0.959 . . . . 0.0 113.187 -179.833 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.71 -175.76 5.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.815 0.34 . . . . 0.0 110.301 179.757 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.503 ' HB3' ' CE2' ' A' ' 97' ' ' TYR . 4.0 p-80 -120.78 161.6 21.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.07 0.462 . . . . 0.0 111.545 179.993 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 61.9 m-20 -92.37 -171.7 2.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.905 -179.904 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 85' ' ' TYR . . . 88.79 -66.52 3.12 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 120.686 -0.769 . . . . 0.0 111.884 -178.994 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.451 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 4.0 m-85 66.56 30.36 8.49 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-O 121.483 0.658 . . . . 0.0 109.985 179.732 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -87.97 -173.47 4.28 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.014 179.014 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -110.09 -23.27 11.38 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.847 0.356 . . . . 0.0 110.812 178.947 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.427 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 9.7 m-85 -153.74 161.34 42.19 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.239 -179.72 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.443 ' CZ ' ' HB2' ' A' ' 86' ' ' GLU . 21.1 m-85 -141.43 163.39 33.07 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.797 179.358 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 5.7 p -122.77 165.57 16.36 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.042 0.449 . . . . 0.0 111.901 -177.758 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 5.6 p-10 -56.55 98.32 0.03 OUTLIER 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.697 179.767 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 128.44 12.47 2.79 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.097 -0.956 . . . . 0.0 113.071 179.555 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -98.79 161.58 13.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.945 0.372 . . . . 0.0 110.399 179.211 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 30.2 m -141.35 147.39 22.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.113 0.482 . . . . 0.0 110.782 -179.913 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.55 HG23 ' CH2' ' A' ' 118' ' ' TRP . 43.7 t -136.94 151.32 27.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.56 179.561 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.972 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -108.2 129.29 55.2 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.977 -179.565 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.977 ' CE2' HG21 ' A' ' 111' ' ' VAL . 6.0 m-85 -92.97 155.65 17.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.081 -179.525 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.1 p -149.16 139.33 22.21 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.443 -179.308 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 52.0 m -69.67 152.87 44.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.676 179.178 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.421 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 26.9 m-20 -92.67 -70.41 0.7 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.237 -179.383 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 36.8 m -55.5 -23.36 25.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.151 -179.683 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 118.77 30.7 1.59 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.344 -179.752 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.504 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 18.8 m-85 -71.39 -173.13 0.84 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.882 0.372 . . . . 0.0 110.774 179.986 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -112.69 103.89 11.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.296 -179.386 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.637 HD21 ' HG2' ' A' ' 122' ' ' PRO . 2.1 tp -42.62 115.89 0.78 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.419 179.21 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.456 ' HB ' ' CB ' ' A' ' 123' ' ' THR . 46.7 mm -91.01 153.58 3.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.277 179.555 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 65.41 -121.83 21.52 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.084 -1.055 . . . . 0.0 111.502 -178.09 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -136.91 120.81 17.55 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.059 0.457 . . . . 0.0 111.207 178.759 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.972 ' OG ' HG22 ' A' ' 96' ' ' THR . 2.0 p -51.21 -26.6 7.29 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.95 179.326 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.46 119.13 10.86 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.849 -179.376 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.977 HG21 ' CE2' ' A' ' 97' ' ' TYR . 2.5 t -113.53 116.19 51.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 178.796 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.25 120.1 23.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.006 0.432 . . . . 0.0 111.828 -177.382 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.469 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 16.1 t -89.35 94.86 10.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.502 176.591 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.4 OUTLIER -136.17 159.43 41.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.33 -178.123 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.449 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 46.68 29.51 4.2 Favored Glycine 0 CA--C 1.518 0.227 0 C-N-CA 121.051 -0.595 . . . . 0.0 112.702 179.85 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.471 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 70.09 20.94 76.81 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.267 -179.42 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -142.85 170.85 14.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.833 0.349 . . . . 0.0 110.376 179.299 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.55 ' CH2' HG23 ' A' ' 95' ' ' VAL . 97.4 m95 -112.34 126.64 55.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.35 -179.192 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.48 ' O ' ' CB ' ' A' ' 120' ' ' ASP . 0.0 OUTLIER -92.97 131.62 37.81 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.489 174.804 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.604 ' HB2' HG13 ' A' ' 111' ' ' VAL . 2.3 m-20 109.42 -135.87 0.0 OUTLIER Pre-proline 0 CA--C 1.474 -1.945 0 N-CA-C 100.432 -3.914 . . . . 0.0 100.432 -166.987 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.566 ' CA ' ' HB3' ' A' ' 120' ' ' ASP . 64.4 Cg_endo -65.41 179.23 12.83 Favored 'Cis proline' 0 C--N 1.308 -1.566 0 CA-C-N 125.258 2.914 . . . . 0.0 113.36 -14.08 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.637 ' HG2' HD21 ' A' ' 105' ' ' LEU . 10.4 Cg_endo -89.56 -174.9 0.97 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.692 2.928 . . . . 0.0 111.463 176.75 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.456 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -121.61 -179.51 4.12 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.83 179.045 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . 0.42 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 4.9 m -139.95 94.59 2.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.743 179.947 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -123.33 163.69 20.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.971 -179.474 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.48 HG12 ' CE2' ' A' ' 103' ' ' TYR . 41.1 mm . . . . . 0 C--N 1.325 -0.478 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.927 -179.917 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.2 mtt180 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.774 0.321 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 80.2 mtm180 -89.12 168.55 12.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.952 179.826 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.46 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 48.7 m -92.4 159.86 36.09 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.839 179.864 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 36.9 Cg_endo -66.45 173.85 7.1 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.491 2.127 . . . . 0.0 112.156 -179.695 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.404 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 0.0 OUTLIER -49.28 107.64 0.82 Allowed Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.126 -179.47 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.487 ' CG ' ' CD1' ' A' ' 22' ' ' ILE . 9.4 Cg_endo -52.64 154.98 11.06 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.282 1.988 . . . . 0.0 111.824 179.728 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 18.8 mtt180 -80.24 164.91 22.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.257 0.551 . . . . 0.0 111.502 -178.794 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -118.88 -166.71 1.27 Allowed 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.042 -178.023 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.531 HD12 ' HD2' ' A' ' 64' ' ' PRO . 8.5 tt -142.8 155.51 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.566 179.113 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -85.81 -55.45 3.96 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -176.882 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.415 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 0.2 OUTLIER -92.71 28.3 2.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.632 0.254 . . . . 0.0 111.551 -177.352 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.429 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -167.16 -165.23 24.21 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.784 179.482 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.894 ' C ' HD23 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -132.91 175.36 9.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.621 0.248 . . . . 0.0 110.345 179.031 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.894 HD23 ' C ' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -122.46 157.83 31.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.153 0.501 . . . . 0.0 111.224 -179.964 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -126.94 84.77 2.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.926 178.805 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.854 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.4 OUTLIER -82.98 97.1 4.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.992 -177.01 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.2 11.73 70.08 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.033 177.436 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 165.27 148.69 5.58 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.297 -179.72 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 20.0 m -129.88 13.87 2.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -179.948 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -93.52 151.06 19.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.694 0.283 . . . . 0.0 110.578 179.534 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -49.28 100.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.952 0.406 . . . . 0.0 110.758 179.96 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.26 0.41 6.89 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.603 -178.885 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.1 p -99.56 169.54 9.22 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.877 0.339 . . . . 0.0 110.481 179.443 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 47' ' ' SER . 4.4 p -143.27 138.74 29.8 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.078 0.466 . . . . 0.0 111.015 179.948 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.854 HG23 ' HA ' ' A' ' 22' ' ' ILE . 1.0 OUTLIER -92.84 173.67 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.634 178.949 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.45 ' H ' HG22 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -135.92 113.2 10.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.982 0.42 . . . . 0.0 111.331 -179.667 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.585 ' CE1' HD22 ' A' ' 20' ' ' LEU . 22.2 m-85 -89.27 140.87 29.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.883 179.696 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -147.14 146.31 29.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.731 -179.918 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.441 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 23.1 m -69.81 167.98 16.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.89 0.376 . . . . 0.0 111.001 -179.682 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -66.48 -78.5 0.06 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.006 -179.776 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -158.84 139.13 12.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.607 179.867 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.543 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 58.11 28.39 61.18 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.883 -179.002 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.491 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.1 m-85 -119.37 168.13 11.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.828 0.347 . . . . 0.0 111.09 -179.28 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.924 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -127.39 117.08 21.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.404 177.806 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.919 HD21 ' O ' ' A' ' 44' ' ' GLU . 8.5 tt -81.97 126.03 31.47 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.778 -179.349 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.924 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.1 mm -105.62 164.46 4.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.116 -179.434 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.447 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 72.92 -132.26 16.94 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.507 179.986 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.919 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -81.92 -175.41 5.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.966 0.412 . . . . 0.0 110.759 179.575 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.419 ' O ' ' CG ' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -169.83 30.73 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.43 179.327 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.419 ' CG ' ' O ' ' A' ' 45' ' ' SER . 10.9 mtpt -166.91 114.47 0.82 Allowed 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.021 -178.315 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.486 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 0.4 OUTLIER -84.67 132.31 34.49 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 178.643 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.517 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.6 m-85 -107.1 120.74 42.91 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 119.514 -0.875 . . . . 0.0 111.516 -179.484 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 31.6 t -67.72 116.94 8.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.318 -179.035 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -158.5 179.66 8.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.371 179.413 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.633 ' C ' HD12 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -126.56 148.72 49.71 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.746 0.308 . . . . 0.0 110.818 179.6 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.616 ' N ' HD12 ' A' ' 51' ' ' LEU . . . 174.83 33.95 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.306 -0.949 . . . . 0.0 113.313 -179.498 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.42 ' HB3' ' HB3' ' A' ' 56' ' ' SER . 0.1 OUTLIER -120.97 71.41 0.94 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.069 0.461 . . . . 0.0 110.464 179.304 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.3 p 62.14 25.1 15.01 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.455 -178.842 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 104.3 18.44 13.32 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.462 -179.531 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.42 ' HB3' ' HB3' ' A' ' 53' ' ' SER . 15.5 t -115.57 163.24 16.07 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.054 0.454 . . . . 0.0 111.089 179.903 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.42 ' HA ' ' HA ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -87.77 137.83 31.99 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.529 -178.998 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.2 m -135.16 -175.47 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.458 179.868 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.522 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 59.5 m95 -128.41 128.18 43.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.837 0.351 . . . . 0.0 110.975 179.61 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.517 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.7 OUTLIER -69.69 164.93 46.23 Favored Pre-proline 0 C--O 1.224 -0.271 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.971 178.515 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.447 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 79.2 Cg_exo -16.73 100.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.352 0.741 1 C-N-CA 125.32 4.014 . . . . 0.0 114.498 -178.932 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.471 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -104.22 -82.15 0.51 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.753 -177.916 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.476 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -77.08 107.13 4.37 Favored Pre-proline 0 N--CA 1.463 0.185 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -176.355 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.893 ' HG2' HD11 ' A' ' 41' ' ' LEU . 3.1 Cg_endo -90.52 -155.54 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.345 2.697 . . . . 0.0 111.172 178.257 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.512 HG22 ' H ' ' A' ' 66' ' ' CYS . 3.9 mm -97.23 165.82 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.872 0.367 . . . . 0.0 110.847 178.803 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.512 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.2 m -162.32 136.92 6.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.944 179.904 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.22 173.23 16.91 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.758 179.793 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.491 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 80.8 p -81.42 112.63 18.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.999 179.954 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.756 HG22 ' HB3' ' A' ' 40' ' ' HIS . 6.3 p -44.62 97.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.429 179.844 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -79.76 127.59 32.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.617 -179.024 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.441 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -113.48 119.86 39.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.067 -0.515 . . . . 0.0 109.917 178.336 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.57 -159.63 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.775 0.322 . . . . 0.0 110.597 -179.067 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.463 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 2.3 t -49.06 137.75 13.76 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.818 -179.864 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.449 ' HA ' ' CD1' ' A' ' 118' ' ' TRP . 37.0 Cg_exo -56.77 161.64 9.88 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.168 1.912 . . . . 0.0 111.589 -179.874 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.507 ' HD3' ' CG ' ' A' ' 118' ' ' TRP . 79.7 Cg_exo -39.55 156.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.701 2.267 . . . . 0.0 112.785 -179.231 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.7 m -108.38 88.21 2.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.645 179.756 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.571 HG21 ' O ' ' A' ' 122' ' ' PRO . 13.5 pt -70.08 -177.68 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.299 -179.357 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.6 m -103.43 147.34 27.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.781 179.657 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.43 ' HB3' ' CD2' ' A' ' 103' ' ' TYR . 24.8 m-80 51.43 29.83 5.63 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.161 179.698 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.465 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -160.36 -165.27 16.87 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.395 -0.907 . . . . 0.0 113.098 179.798 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -164.18 -175.34 3.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.857 0.36 . . . . 0.0 110.463 -179.463 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.463 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 1.8 p-80 -120.37 166.14 13.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.617 -178.999 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 -98.0 -170.72 2.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.592 179.945 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' A' ' 85' ' ' TYR . . . 90.71 -68.87 2.28 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.533 -0.842 . . . . 0.0 111.72 -178.796 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.424 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 15.0 m-30 71.37 28.52 2.92 Favored 'General case' 0 N--CA 1.435 -1.208 0 C-N-CA 123.542 0.737 . . . . 0.0 110.173 179.308 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.48 ' HB2' ' CZ ' ' A' ' 89' ' ' TYR . 0.2 OUTLIER -87.19 -173.35 4.37 Favored 'General case' 0 N--CA 1.437 -1.088 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.915 178.641 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -111.64 -22.92 10.96 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.802 0.334 . . . . 0.0 110.831 178.97 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.428 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 11.3 m-85 -154.08 160.87 42.16 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.995 -179.776 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.48 ' CZ ' ' HB2' ' A' ' 86' ' ' GLU . 16.5 m-85 -141.69 166.89 23.5 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.922 179.569 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 9.2 p -131.29 179.64 5.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.127 0.489 . . . . 0.0 112.013 -177.97 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 5.4 p-10 -63.26 96.22 0.1 Allowed 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.904 179.888 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.49 14.49 2.9 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.297 -0.865 . . . . 0.0 113.152 179.157 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.67 156.58 16.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.906 0.353 . . . . 0.0 110.349 179.005 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 35.9 m -135.38 151.51 30.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.174 0.511 . . . . 0.0 111.095 -179.475 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.529 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 14.4 t -148.79 145.43 18.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.028 179.937 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.769 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -105.69 128.44 53.66 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.637 179.341 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.978 ' CE1' HG21 ' A' ' 111' ' ' VAL . 5.4 m-85 -89.0 157.83 18.23 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.154 -179.242 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.435 ' HA ' HD13 ' A' ' 105' ' ' LEU . 39.6 m -153.57 148.12 26.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.226 179.974 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.444 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 63.0 m -74.03 162.04 29.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.91 179.686 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.465 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 65.3 m-20 -84.9 -72.57 0.47 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.587 -179.055 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.0 m -70.84 -28.21 64.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.344 -178.67 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 132.08 36.78 0.3 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.712 179.854 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.501 ' CE1' HG12 ' A' ' 126' ' ' ILE . 33.8 m-85 -69.97 -174.82 0.82 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.893 0.378 . . . . 0.0 110.586 179.266 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.6 m -106.31 101.32 10.8 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.291 178.677 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.447 HD22 ' HB2' ' A' ' 109' ' ' SER . 0.3 OUTLIER -48.81 128.04 14.91 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.438 0.637 . . . . 0.0 111.508 -178.466 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.446 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 35.7 mm -91.56 153.31 3.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.955 179.078 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.47 -128.13 38.15 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.267 -0.968 . . . . 0.0 111.994 -178.926 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -123.79 143.86 50.06 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.828 0.347 . . . . 0.0 110.982 179.432 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.769 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.4 t -72.19 -32.57 66.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.703 179.638 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -69.13 137.42 29.66 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.747 -179.701 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.978 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.5 t -132.32 118.62 36.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.648 0.261 . . . . 0.0 110.554 179.247 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.71 114.95 21.94 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.916 0.389 . . . . 0.0 111.538 -178.848 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.504 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 26.3 t -82.5 100.93 10.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.659 176.881 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 1.8 t -138.61 154.58 48.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.113 0.482 . . . . 0.0 111.473 -178.2 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.519 ' CA ' HG11 ' A' ' 69' ' ' VAL . . . 53.09 21.02 9.84 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.934 179.489 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.452 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 82.8 8.05 86.46 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.8 -179.917 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.95 176.56 8.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.98 0.419 . . . . 0.0 110.692 179.737 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.529 ' CZ3' HG23 ' A' ' 95' ' ' VAL . 96.3 m95 -113.58 134.97 54.41 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.847 -179.763 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -119.3 147.22 44.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.343 -179.232 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.473 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER 71.23 46.08 0.24 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.123 178.843 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.473 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 98.0 Cg_endo -78.49 133.23 11.63 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.364 2.043 . . . . 0.0 111.453 178.179 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.571 ' O ' HG21 ' A' ' 77' ' ' ILE . 74.2 Cg_endo -91.25 -173.88 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.664 2.243 . . . . 0.0 113.513 -178.04 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.438 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -131.33 -161.23 1.11 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.878 177.689 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 6.6 m -157.4 92.03 1.21 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.199 0.523 . . . . 0.0 110.879 179.074 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.416 ' NE2' HG13 ' A' ' 106' ' ' ILE . 7.9 mt-30 -122.94 160.15 26.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.927 -179.652 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.501 HG12 ' CE1' ' A' ' 103' ' ' TYR . 46.5 mm . . . . . 0 C--N 1.324 -0.529 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.816 179.693 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 8.9 mtm180 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.826 0.346 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.473 ' HD2' HG23 ' A' ' 25' ' ' VAL . 32.4 mtm180 -49.9 172.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.923 179.827 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.468 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 32.7 m -86.62 160.93 49.48 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.908 -179.965 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.12 169.14 18.77 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.496 2.131 . . . . 0.0 112.02 179.92 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 33.3 t -50.59 104.52 0.43 Allowed Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.982 -179.351 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.469 ' HG2' HD11 ' A' ' 22' ' ' ILE . 2.7 Cg_exo -45.41 166.32 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.197 1.932 . . . . 0.0 111.919 -179.67 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.623 ' NH1' ' HB3' ' A' ' 63' ' ' ALA . 2.5 ttt-85 -73.84 170.03 16.18 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.0 178.321 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.648 ' HA ' HD11 ' A' ' 20' ' ' LEU . 2.9 p30 -125.4 -177.95 4.06 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 121.161 0.505 . . . . 0.0 112.055 -176.347 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.628 HG22 HD21 ' A' ' 20' ' ' LEU . 4.3 tt -148.54 142.73 18.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.338 179.372 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -79.89 -60.68 2.25 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.54 -178.33 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.437 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 1.5 m120 -91.03 45.37 1.24 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.961 0.41 . . . . 0.0 110.911 -179.251 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -167.01 -179.73 40.24 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.92 179.957 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -138.86 137.77 36.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.671 0.272 . . . . 0.0 110.525 179.641 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.856 HD22 ' CE2' ' A' ' 33' ' ' TYR . 0.5 OUTLIER -87.17 154.2 20.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.006 0.431 . . . . 0.0 111.443 -179.653 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -123.97 82.1 1.99 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.902 177.574 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.81 ' HA ' HG23 ' A' ' 31' ' ' ILE . 4.0 mm -68.93 105.08 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.495 -177.529 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.3 15.03 47.28 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.165 178.079 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.424 ' O ' ' CB ' ' A' ' 29' ' ' SER . . . 154.12 121.43 0.8 Allowed Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.206 -179.765 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.473 HG23 ' HD2' ' A' ' 8' ' ' ARG . 31.2 m -108.96 22.24 4.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.754 0.312 . . . . 0.0 111.442 -179.599 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -99.0 158.69 15.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.923 0.392 . . . . 0.0 110.855 179.502 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.562 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 8.3 t80 -56.27 92.1 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.899 -179.957 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 130.93 -0.22 5.3 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.77 -0.728 . . . . 0.0 113.072 -179.859 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 24' ' ' GLY . 58.2 m -89.87 -174.04 4.12 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.969 0.384 . . . . 0.0 110.75 179.848 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 48' ' ' TYR . 7.4 p -155.71 145.4 21.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.068 0.461 . . . . 0.0 111.456 -179.561 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.81 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.4 OUTLIER -104.68 167.57 2.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.444 179.445 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.553 HG23 ' HG3' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -132.81 108.83 9.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.948 0.404 . . . . 0.0 110.701 179.147 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.856 ' CE2' HD22 ' A' ' 20' ' ' LEU . 20.4 m-85 -81.5 149.5 28.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.177 -179.323 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.418 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 5.5 m -153.48 168.28 26.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.801 -179.61 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 1.6 m -88.08 171.99 9.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.833 179.912 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -70.23 -84.14 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.084 -179.4 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -154.44 130.5 10.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.524 179.858 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.712 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 64.8 23.63 69.29 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.422 -0.894 . . . . 0.0 111.864 -178.618 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.521 ' CZ ' ' HB3' ' A' ' 68' ' ' SER . 3.4 m-85 -113.85 175.34 5.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.681 0.277 . . . . 0.0 110.842 -179.085 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.791 ' CE1' HG22 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -131.16 132.57 44.85 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 175.731 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.927 HD21 ' O ' ' A' ' 44' ' ' GLU . 7.8 tt -95.35 118.43 32.08 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.886 -178.914 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.579 ' N ' HD13 ' A' ' 42' ' ' ILE . 1.1 mm -97.67 147.26 6.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.666 179.841 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 86.15 -149.5 23.04 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.21 -179.047 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.927 ' O ' HD21 ' A' ' 41' ' ' LEU . 1.2 pt-20 -67.14 -177.12 0.61 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.071 0.463 . . . . 0.0 110.786 179.361 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.45 30.09 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.336 179.846 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.553 ' HG3' HG23 ' A' ' 32' ' ' THR . 0.0 OUTLIER -162.31 123.37 2.59 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.773 -179.725 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.453 ' HB3' ' CG ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -105.47 155.04 19.54 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.536 -179.384 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.51 ' CD2' ' HB3' ' A' ' 60' ' ' ASN . 1.4 m-85 -130.86 125.06 32.61 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 119.686 -0.806 . . . . 0.0 112.283 -179.46 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.447 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 20.5 t -75.75 98.19 4.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.386 178.786 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.65 -173.33 2.62 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.107 -179.689 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.562 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -93.42 145.09 24.74 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.815 -179.68 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -64.21 -121.68 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.425 179.957 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.32 -32.16 6.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.796 0.332 . . . . 0.0 110.897 -179.962 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 33.6 p -115.71 38.51 3.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.955 179.912 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.5 22.51 69.92 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.386 -179.719 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.5 t -83.9 -161.65 0.56 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.869 0.366 . . . . 0.0 111.068 -179.796 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.496 ' O ' HG13 ' A' ' 58' ' ' VAL . 13.2 mtt -117.29 140.0 50.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.548 179.712 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.496 HG13 ' O ' ' A' ' 57' ' ' MET . 3.4 m -157.76 163.52 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.94 -179.41 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.517 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 69.4 m95 -124.06 123.13 39.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.342 -179.489 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.51 ' HB3' ' CD2' ' A' ' 48' ' ' TYR . 3.2 m-20 -69.7 165.99 36.0 Favored Pre-proline 0 C--N 1.328 -0.336 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.911 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 48.7 Cg_exo -9.61 95.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.358 1.029 1 C-N-CA 125.74 4.293 . . . . 0.0 115.074 -178.57 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.473 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 42.7 mt-10 -98.08 -99.27 0.21 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.482 -177.772 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.623 ' HB3' ' NH1' ' A' ' 13' ' ' ARG . . . -74.9 108.66 5.73 Favored Pre-proline 0 C--O 1.232 0.135 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -175.343 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.887 ' HG2' HD11 ' A' ' 41' ' ' LEU . 2.5 Cg_endo -87.01 -155.31 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.216 2.61 . . . . 0.0 110.757 176.668 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.466 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 2.1 mm -99.73 161.1 3.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.87 0.367 . . . . 0.0 110.786 178.685 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.437 ' HB3' ' HB2' ' A' ' 17' ' ' ASN . 1.1 m -155.65 137.53 14.44 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 -179.908 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.479 ' O ' ' CD1' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -141.42 172.88 12.07 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.644 179.896 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.521 ' HB3' ' CZ ' ' A' ' 39' ' ' TYR . 1.1 p -108.38 123.72 49.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.283 -179.813 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.791 HG22 ' CE1' ' A' ' 40' ' ' HIS . 5.1 p -52.12 90.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.596 178.494 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 68' ' ' SER . 0.6 OUTLIER -68.8 132.62 47.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.893 -178.129 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.422 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -112.75 118.56 35.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.585 177.164 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.471 ' CG ' ' N ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -69.29 -157.97 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.358 -179.532 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.585 ' HG ' ' CE1' ' A' ' 82' ' ' HIS . 0.8 OUTLIER -52.38 142.36 30.08 Favored Pre-proline 0 N--CA 1.447 -0.593 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.781 179.919 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.493 ' HA ' ' CD1' ' A' ' 118' ' ' TRP . 23.8 Cg_exo -60.67 157.87 35.34 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.326 2.017 . . . . 0.0 111.813 179.741 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.492 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 81.0 Cg_exo -43.79 156.19 0.17 Allowed 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.62 2.214 . . . . 0.0 112.594 -179.429 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.7 t -105.79 90.27 3.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.771 179.905 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.586 HG23 ' HE1' ' A' ' 97' ' ' TYR . 22.2 pt -69.56 176.32 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.297 -179.477 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.8 m -94.01 143.39 26.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.416 178.898 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.506 ' HB3' ' CD2' ' A' ' 103' ' ' TYR . 4.3 m-80 57.34 30.01 17.81 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.758 -179.829 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.44 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . 178.88 -175.79 47.56 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.689 179.953 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.25 -175.06 1.86 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.765 0.316 . . . . 0.0 110.348 -179.893 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.585 ' CE1' ' HG ' ' A' ' 73' ' ' SER . 12.3 p80 -85.83 174.78 9.07 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.855 179.8 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.417 ' OD1' ' CG1' ' A' ' 95' ' ' VAL . 21.0 p-10 -109.22 -37.94 5.65 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -178.254 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 85' ' ' TYR . . . -41.06 -62.44 1.75 Allowed Glycine 0 C--N 1.331 0.286 0 C-N-CA 121.044 -0.598 . . . . 0.0 113.302 -178.129 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.448 ' CE1' ' O ' ' A' ' 82' ' ' HIS . 21.2 m-30 66.21 27.39 10.31 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-O 121.319 0.58 . . . . 0.0 110.134 -179.779 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.465 ' HB2' ' CZ ' ' A' ' 89' ' ' TYR . 0.4 OUTLIER -79.36 -167.27 1.14 Allowed 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.317 177.76 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -112.63 -23.06 10.44 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.42 -0.512 . . . . 0.0 111.241 179.487 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.425 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 12.7 m-85 -158.87 159.74 35.35 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.186 0.517 . . . . 0.0 111.614 -179.447 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.465 ' CZ ' ' HB2' ' A' ' 86' ' ' GLU . 12.3 m-85 -142.28 166.91 23.39 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.017 179.661 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.4 p -127.16 169.56 13.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.969 0.414 . . . . 0.0 111.573 -178.783 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.418 ' OD1' ' CG1' ' A' ' 69' ' ' VAL . 0.1 OUTLIER -58.55 100.79 0.07 Allowed 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 121.49 0.662 . . . . 0.0 110.689 179.461 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.76 14.28 3.9 Favored Glycine 0 C--N 1.313 -0.745 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.916 179.287 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.424 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.7 OUTLIER -95.97 158.63 15.36 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.957 0.379 . . . . 0.0 110.327 178.808 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.431 HG22 ' N ' ' A' ' 95' ' ' VAL . 35.0 m -134.37 156.17 40.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.055 0.455 . . . . 0.0 111.043 -179.355 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.533 HG23 ' CH2' ' A' ' 118' ' ' TRP . 40.1 t -148.94 152.14 12.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.646 179.95 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.771 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -112.25 121.02 43.72 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.097 0.475 . . . . 0.0 111.01 -179.673 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 1.005 ' CE2' HG21 ' A' ' 111' ' ' VAL . 4.9 m-85 -80.74 155.36 26.75 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.568 -178.986 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.431 ' HA ' ' CD1' ' A' ' 105' ' ' LEU . 90.3 p -153.42 143.97 22.53 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.378 -179.729 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.44 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 6.3 m -69.54 164.86 22.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.442 -179.886 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.6 m-20 -93.25 -67.44 0.86 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.883 179.268 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.68 -34.47 72.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.247 -179.716 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 133.63 43.94 0.13 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.491 -179.952 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.524 ' CE1' HG12 ' A' ' 126' ' ' ILE . 6.4 m-85 -78.46 -171.05 2.29 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.832 0.348 . . . . 0.0 110.644 179.809 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -113.57 98.86 7.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.489 179.051 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.482 HD23 ' HB2' ' A' ' 122' ' ' PRO . 0.1 OUTLIER -49.83 144.67 6.14 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-O 121.534 0.683 . . . . 0.0 111.254 -179.091 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.553 HG22 ' N ' ' A' ' 107' ' ' GLY . 23.8 mm -121.67 162.12 21.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.945 0 CA-C-N 114.733 -1.121 . . . . 0.0 110.999 -178.096 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.553 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 47.7 45.82 24.3 Favored Glycine 0 C--O 1.226 -0.402 0 C-N-CA 120.574 -0.822 . . . . 0.0 113.237 178.619 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.453 ' ND2' ' O ' ' A' ' 107' ' ' GLY . 0.7 OUTLIER 46.51 128.39 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 124.577 1.151 . . . . 0.0 114.09 177.556 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.771 ' OG ' HG22 ' A' ' 96' ' ' THR . 0.1 OUTLIER -55.07 -33.16 62.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.731 -1.122 . . . . 0.0 111.769 179.207 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -55.43 130.1 47.38 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.2 -178.534 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 1.005 HG21 ' CE2' ' A' ' 97' ' ' TYR . 2.4 t -127.31 150.19 32.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.024 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.28 122.23 47.32 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.951 0.405 . . . . 0.0 111.668 -179.149 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.504 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 15.3 t -87.76 100.88 13.17 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 176.733 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.6 OUTLIER -150.66 171.22 17.48 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.984 -178.654 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.418 ' N ' ' OD1' ' A' ' 91' ' ' ASP . . . 46.61 26.16 2.48 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.871 -179.935 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.12 18.82 76.82 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.281 -179.331 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -152.78 -176.68 5.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.895 0.379 . . . . 0.0 110.536 179.889 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.533 ' CH2' HG23 ' A' ' 95' ' ' VAL . 91.6 m95 -111.39 126.32 54.8 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.069 -179.425 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.8 161.09 14.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.263 -179.273 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.478 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 3.6 p30 48.46 46.04 3.33 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.542 -0.754 . . . . 0.0 112.434 179.161 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 57.5 Cg_endo -69.99 150.21 66.5 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.221 1.947 . . . . 0.0 110.691 176.51 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.566 ' O ' HG21 ' A' ' 77' ' ' ILE . 57.0 Cg_endo -95.99 177.51 0.7 Allowed 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.223 1.948 . . . . 0.0 114.089 -176.856 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.451 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -119.46 -160.8 0.83 Allowed 'General case' 0 CA--C 1.505 -0.784 0 CA-C-N 114.343 -1.298 . . . . 0.0 109.044 176.566 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . 0.425 ' SG ' ' HB2' ' A' ' 103' ' ' TYR . 5.0 t -170.32 91.02 0.18 Allowed 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.891 -175.98 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -122.16 175.76 6.19 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.355 -177.415 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.524 HG12 ' CE1' ' A' ' 103' ' ' TYR . 46.3 mm . . . . . 0 C--N 1.326 -0.437 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.677 179.37 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 15.9 mmt180 . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.896 0.379 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.445 ' HD2' HG23 ' A' ' 25' ' ' VAL . 6.4 mtm180 -97.22 157.25 16.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.183 -179.591 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.524 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 65.9 m -69.82 175.91 2.04 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.596 178.565 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.553 ' HD2' ' CD1' ' A' ' 59' ' ' TRP . 35.6 Cg_endo -88.66 177.96 2.97 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.532 2.155 . . . . 0.0 111.452 179.047 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.8 t -51.31 105.54 0.54 Allowed Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.427 179.551 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.498 ' HG3' ' CZ2' ' A' ' 59' ' ' TRP . 53.5 Cg_exo -46.55 161.38 0.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 122.137 1.891 . . . . 0.0 112.366 -179.049 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.421 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -62.15 -173.42 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.849 177.673 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.508 ' O ' ' HB2' ' A' ' 63' ' ' ALA . 0.4 OUTLIER -144.22 -175.95 4.82 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.288 179.524 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.412 HG23 ' C ' ' A' ' 18' ' ' GLY . 9.2 tt -146.71 142.98 20.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.571 179.739 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -73.94 -60.82 2.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.014 -177.63 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.409 ' O ' ' N ' ' A' ' 36' ' ' ASN . 0.1 OUTLIER -94.09 30.47 1.88 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.188 -178.133 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.412 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -147.17 177.43 25.47 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.443 -0.884 . . . . 0.0 112.896 -179.932 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -135.9 130.66 34.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.689 0.281 . . . . 0.0 110.365 179.01 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.868 HD21 ' CE2' ' A' ' 33' ' ' TYR . 24.6 mt -82.91 157.45 23.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.056 0.455 . . . . 0.0 111.726 -178.75 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.03 78.75 1.85 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.163 178.823 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.931 ' HA ' HG23 ' A' ' 31' ' ' ILE . 67.8 mt -69.93 100.27 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.843 -177.993 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -96.69 17.19 59.71 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.792 177.073 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 150.46 139.73 3.08 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.218 -179.601 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.445 HG23 ' HD2' ' A' ' 8' ' ' ARG . 35.8 m -124.1 31.15 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.915 0.388 . . . . 0.0 111.253 -179.477 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.41 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.4 OUTLIER -101.06 148.93 24.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.574 179.335 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.667 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 4.7 t80 -49.99 92.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.92 0.39 . . . . 0.0 110.79 179.909 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 131.44 -2.28 5.35 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.78 -179.094 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 65.6 p -89.15 -173.14 3.93 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 117.003 0.402 . . . . 0.0 110.444 179.468 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.3 p -155.11 154.36 32.26 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.002 0.43 . . . . 0.0 111.064 179.872 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.931 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.8 OUTLIER -115.65 164.6 11.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.491 -179.987 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -124.19 120.41 32.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.954 0.406 . . . . 0.0 111.253 -179.867 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.868 ' CE2' HD21 ' A' ' 20' ' ' LEU . 16.2 m-85 -97.77 135.28 39.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.182 -179.882 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.406 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.1 OUTLIER -143.65 158.54 43.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.682 179.67 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.435 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 3.0 m -76.45 167.95 20.94 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.737 179.841 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.409 ' N ' ' O ' ' A' ' 17' ' ' ASN . 0.6 OUTLIER -63.93 -81.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.898 -179.764 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -158.27 133.68 8.78 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.81 179.851 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.833 ' O ' HG22 ' A' ' 69' ' ' VAL . . . 64.43 23.61 68.61 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.107 -179.374 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.537 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.6 m-85 -114.58 179.84 3.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.793 0.33 . . . . 0.0 110.862 -179.622 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.882 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.5 OUTLIER -136.17 112.54 9.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.006 0.431 . . . . 0.0 110.55 178.135 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.934 HD11 ' HG2' ' A' ' 64' ' ' PRO . 4.6 tt -78.58 123.93 27.62 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.251 -179.981 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.882 HD11 ' CE1' ' A' ' 40' ' ' HIS . 1.9 mm -100.17 152.33 4.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.072 0.463 . . . . 0.0 111.059 -179.207 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.77 -137.92 17.4 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.117 -179.211 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.897 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -82.75 -175.86 5.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.943 0.402 . . . . 0.0 110.806 179.439 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.7 p -156.55 21.41 0.34 Allowed 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.458 -178.995 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -148.13 139.16 23.25 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.246 0.546 . . . . 0.0 112.304 -178.377 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.444 ' HB3' HG13 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -107.96 145.23 34.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.875 178.212 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.492 ' CB ' ' HB2' ' A' ' 60' ' ' ASN . 1.6 m-85 -123.61 119.99 31.5 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 119.179 -1.008 . . . . 0.0 112.405 -179.928 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.419 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 19.0 t -71.4 96.83 1.52 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.517 178.935 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.7 -173.96 2.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.167 -179.463 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.667 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -95.87 153.61 17.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.998 -179.851 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -73.69 -129.26 0.15 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.517 179.848 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.6 t -114.64 -33.33 5.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.876 0.37 . . . . 0.0 110.953 179.992 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 60.6 p -99.75 33.4 2.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.864 179.91 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 70.7 26.43 74.06 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.427 -179.812 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.7 t -94.04 -161.98 0.9 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.87 0.367 . . . . 0.0 110.901 -179.942 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.528 ' O ' HG13 ' A' ' 58' ' ' VAL . 4.1 mmt -117.44 144.6 44.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.513 179.536 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.528 HG13 ' O ' ' A' ' 57' ' ' MET . 2.4 m -158.78 172.91 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.1 -179.822 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.627 ' CE3' HD11 ' A' ' 31' ' ' ILE . 69.9 m95 -123.24 124.66 43.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.1 -179.976 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.492 ' HB2' ' CB ' ' A' ' 48' ' ' TYR . 3.1 m120 -69.28 163.98 52.98 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 178.333 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.439 ' O ' ' HA ' ' A' ' 47' ' ' SER . 38.9 Cg_exo -10.86 99.49 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.944 1 C-N-CA 125.735 4.29 . . . . 0.0 114.925 -178.618 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.476 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 7.9 mt-10 -91.62 -92.62 0.15 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.167 -0.924 . . . . 0.0 113.146 -176.43 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.508 ' HB2' ' O ' ' A' ' 14' ' ' ASP . . . -81.93 110.47 20.41 Favored Pre-proline 0 CA--C 1.528 0.109 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -174.953 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.934 ' HG2' HD11 ' A' ' 41' ' ' LEU . 5.1 Cg_exo -80.05 -153.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.942 2.428 . . . . 0.0 110.95 176.395 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.522 HG22 ' H ' ' A' ' 66' ' ' CYS . 3.5 mm -94.57 167.38 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.825 0.345 . . . . 0.0 110.919 178.833 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.522 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.2 m -166.44 132.9 2.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.171 179.24 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.9 164.56 35.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.761 -178.909 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.537 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 1.7 p -88.86 120.09 29.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.362 0.601 . . . . 0.0 111.248 -179.906 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.833 HG22 ' O ' ' A' ' 38' ' ' GLY . 0.6 OUTLIER -39.55 91.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.39 179.478 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.659 ' HZ1' ' HA ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -101.4 151.38 21.99 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.85 178.016 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.413 ' C ' ' HE3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -125.61 136.06 52.86 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.412 -177.63 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.659 ' HA ' ' HZ1' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -67.23 -173.18 0.26 Allowed 'General case' 0 N--CA 1.432 -1.354 0 CA-C-O 121.904 0.859 . . . . 0.0 113.115 -178.12 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -48.19 124.4 11.07 Favored Pre-proline 0 N--CA 1.441 -0.894 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.09 175.051 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.528 ' HG2' HG11 ' A' ' 95' ' ' VAL . 31.7 Cg_exo -46.09 153.33 1.01 Allowed 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 121.593 1.529 . . . . 0.0 111.88 -175.702 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.487 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 86.3 Cg_exo -45.59 154.34 0.61 Allowed 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.741 2.294 . . . . 0.0 112.679 -177.492 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 12.8 t -103.1 91.02 3.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.666 -179.881 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.524 HG21 ' O ' ' A' ' 122' ' ' PRO . 18.9 pt -69.16 172.37 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.808 -179.962 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -93.29 134.04 35.9 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.892 -179.86 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.517 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 0.1 OUTLIER 66.95 27.76 8.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.543 -179.945 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -170.56 176.46 44.1 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.78 179.746 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 80' ' ' GLY . 3.5 mtp85 -148.49 -167.37 2.8 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.505 0.669 . . . . 0.0 111.706 -178.512 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 10.3 p-80 -127.37 160.28 31.87 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.843 178.993 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -85.21 -87.66 0.12 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.611 -179.926 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.421 ' HA3' ' OH ' ' A' ' 89' ' ' TYR . . . 59.2 151.39 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.801 179.117 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -116.07 -33.65 4.98 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.982 0.42 . . . . 0.0 110.871 179.824 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.52 -175.94 2.94 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.137 -179.83 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -97.9 -33.07 11.37 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.554 177.157 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.517 ' CD2' ' CD ' ' A' ' 70' ' ' LYS . 6.5 m-30 -103.69 163.75 12.12 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.149 179.585 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.519 ' O ' ' HA ' ' A' ' 70' ' ' LYS . 54.4 m-85 -152.61 166.45 32.04 Favored 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.647 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 70' ' ' LYS . 12.2 p -147.47 -177.46 5.71 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.53 -0.868 . . . . 0.0 112.927 -178.416 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 7.9 p-10 -49.94 95.53 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 115.3 -0.864 . . . . 0.0 111.391 -179.575 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 123.01 10.04 5.9 Favored Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.43 -0.891 . . . . 0.0 113.269 177.467 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.422 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.9 OUTLIER -95.16 143.77 26.32 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 117.253 0.526 . . . . 0.0 110.652 179.61 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 27.2 m -130.31 150.48 34.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.586 -179.736 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.528 HG11 ' HG2' ' A' ' 74' ' ' PRO . 24.3 t -142.96 147.07 21.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.039 179.877 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.714 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -103.68 130.59 51.17 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.929 -179.64 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.875 ' CE1' HG21 ' A' ' 111' ' ' VAL . 6.8 m-85 -91.68 154.78 18.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.153 -179.575 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.39 134.95 22.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.494 -179.471 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.444 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 81.1 m -69.34 158.39 35.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.908 179.864 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.91 -86.77 0.3 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.31 -179.702 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.0 t -43.6 -28.11 0.36 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.825 -178.944 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.05 38.45 0.43 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.361 -179.872 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.517 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 54.6 m-85 -81.6 -172.95 4.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.759 0.314 . . . . 0.0 110.852 -179.87 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 125' ' ' GLN . 0.3 OUTLIER -112.45 113.68 25.98 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.11 0.481 . . . . 0.0 110.985 -179.801 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.47 ' HA ' HD12 ' A' ' 105' ' ' LEU . 0.6 OUTLIER -47.51 109.78 0.25 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.509 178.554 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.46 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 47.5 mm -84.31 156.58 3.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.917 -178.947 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.445 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 59.06 -127.52 45.43 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.677 -178.736 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -117.18 133.68 55.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.012 0.434 . . . . 0.0 110.574 178.446 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.714 ' HB2' HG22 ' A' ' 96' ' ' THR . 0.1 OUTLIER -67.79 -29.56 68.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.376 179.6 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -77.0 125.61 7.5 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.673 179.622 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.875 HG21 ' CE1' ' A' ' 97' ' ' TYR . 10.9 t -115.86 124.94 72.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 178.771 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.864 HD22 ' N ' ' A' ' 113' ' ' CYS . 1.3 tm? -80.75 136.04 36.08 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.041 0.448 . . . . 0.0 111.527 -178.621 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.864 ' N ' HD22 ' A' ' 112' ' ' LEU . 18.4 t -108.95 107.2 17.48 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.702 177.116 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.606 ' CB ' HD11 ' A' ' 112' ' ' LEU . 2.8 t -164.34 134.13 3.94 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.992 0.425 . . . . 0.0 111.349 -179.717 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.49 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 89.76 16.4 56.57 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.477 -179.863 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.488 ' N ' ' HB ' ' A' ' 69' ' ' VAL . . . 86.33 1.83 85.81 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.064 -179.062 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -138.28 -170.66 2.86 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.755 0.788 . . . . 0.0 111.768 -178.809 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.507 ' CH2' ' HG3' ' A' ' 74' ' ' PRO . 97.0 m95 -117.5 159.67 22.46 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.335 -1.302 . . . . 0.0 110.381 179.055 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.544 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.2 OUTLIER -141.15 161.16 38.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.075 0.464 . . . . 0.0 111.785 -179.506 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.4 p30 46.87 53.67 13.99 Favored Pre-proline 0 C--N 1.332 -0.179 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.423 179.069 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.448 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 87.3 Cg_endo -80.5 147.29 17.7 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.633 2.222 . . . . 0.0 111.37 177.227 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.524 ' O ' HG21 ' A' ' 77' ' ' ILE . 72.6 Cg_endo -92.05 -172.32 0.41 Allowed 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.71 2.273 . . . . 0.0 114.068 -177.339 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.444 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -136.63 -170.12 2.61 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.878 178.063 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 15.6 m -145.46 95.71 2.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.111 0.481 . . . . 0.0 111.211 -179.85 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.411 ' O ' ' HB2' ' A' ' 104' ' ' SER . 17.4 mt-30 -124.66 155.76 38.66 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.708 179.706 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.496 HG12 ' CE2' ' A' ' 103' ' ' TYR . 27.9 mm . . . . . 0 C--N 1.323 -0.572 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.914 179.961 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.94 0.4 . . . . 0.0 111.177 . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.662 ' HD2' HG23 ' A' ' 25' ' ' VAL . 70.0 mtm180 -57.11 -171.71 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.012 -179.864 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.448 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 52.1 m -94.23 159.92 33.07 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.353 179.15 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.406 ' O ' ' HD3' ' A' ' 12' ' ' PRO . 57.4 Cg_endo -68.31 166.38 25.55 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.271 1.981 . . . . 0.0 111.333 178.919 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.4 p -51.71 104.95 0.46 Allowed Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.178 -178.738 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.67 ' HG2' HD13 ' A' ' 22' ' ' ILE . 12.7 Cg_exo -40.62 160.97 0.03 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.493 2.129 . . . . 0.0 112.517 -179.429 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.527 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -68.61 169.42 11.12 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.068 178.737 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.52 ' HA ' HD11 ' A' ' 20' ' ' LEU . 1.4 t0 -114.49 -173.98 2.4 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.253 0.549 . . . . 0.0 111.759 -178.192 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.552 HG22 ' CD2' ' A' ' 20' ' ' LEU . 13.9 tt -148.22 149.79 14.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.855 -179.435 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.401 ' O ' HG12 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -90.19 159.82 16.54 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.643 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.433 ' N ' ' ND2' ' A' ' 17' ' ' ASN . 0.3 OUTLIER 46.45 27.51 0.62 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.86 0.362 . . . . 0.0 110.508 -179.138 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.74 170.25 39.76 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.024 -0.607 . . . . 0.0 112.471 -178.974 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -136.57 155.56 49.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.882 0.372 . . . . 0.0 110.41 179.831 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.807 HD22 ' CE2' ' A' ' 33' ' ' TYR . 0.3 OUTLIER -93.05 162.43 14.04 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.256 -179.638 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.427 ' N ' ' O ' ' A' ' 32' ' ' THR . 12.8 t0 -128.9 74.61 1.59 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.538 177.962 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.898 ' HA ' HG23 ' A' ' 31' ' ' ILE . 1.5 mt -75.02 102.95 2.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.802 -0.636 . . . . 0.0 112.394 -176.086 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -101.3 13.1 58.61 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.612 175.893 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 166.46 138.05 2.35 Favored Glycine 0 C--N 1.335 0.5 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 -179.495 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.662 HG23 ' HD2' ' A' ' 8' ' ' ARG . 13.7 m -125.52 1.96 4.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.49 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.443 ' HA ' ' CB ' ' A' ' 8' ' ' ARG . 37.3 t70 -71.79 165.12 24.72 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.879 0.371 . . . . 0.0 110.816 179.943 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.588 ' CZ ' HD12 ' A' ' 51' ' ' LEU . 6.7 t80 -57.68 90.59 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.967 -179.501 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 129.81 -2.59 6.01 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.007 179.819 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 73.7 m -82.04 162.32 22.63 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 117.004 0.402 . . . . 0.0 110.485 179.561 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.5 p -131.55 148.92 52.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.94 0.4 . . . . 0.0 110.973 179.785 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.898 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -108.67 170.64 2.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.668 -179.598 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.463 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -133.15 111.55 11.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.984 0.421 . . . . 0.0 110.874 179.015 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.807 ' CE2' HD22 ' A' ' 20' ' ' LEU . 12.1 m-85 -85.83 149.66 25.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.677 -178.475 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 3.1 m -149.52 160.64 43.3 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.134 179.821 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.403 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 3.5 m -84.27 169.18 14.97 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.068 179.939 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -67.76 -85.48 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.247 -178.972 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.23 132.67 12.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.742 -179.833 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.755 ' O ' HG22 ' A' ' 69' ' ' VAL . . . 68.36 21.22 74.07 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.912 -178.718 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.545 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.7 m-85 -116.72 176.12 5.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.719 0.295 . . . . 0.0 110.598 -179.903 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.863 ' CE1' HD11 ' A' ' 42' ' ' ILE . 1.3 p80 -139.93 118.1 11.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.082 0.468 . . . . 0.0 110.243 177.754 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.886 HD21 ' O ' ' A' ' 44' ' ' GLU . 7.9 tt -78.22 123.31 26.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.736 -178.877 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.863 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.0 mm -102.04 165.51 2.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.038 0.447 . . . . 0.0 111.052 -179.343 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.481 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 67.69 -142.56 40.51 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.163 -179.198 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.886 ' O ' HD21 ' A' ' 41' ' ' LEU . 1.0 OUTLIER -66.96 -175.56 0.43 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.006 0.431 . . . . 0.0 110.767 179.414 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.2 t -171.44 31.38 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.657 -0.702 . . . . 0.0 110.409 179.362 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.463 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -160.41 126.79 4.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.468 -178.153 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.458 ' CB ' HD12 ' A' ' 31' ' ' ILE . 0.1 OUTLIER -93.5 145.81 24.24 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.063 178.265 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.545 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.6 m-85 -122.18 115.29 22.14 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 119.414 -0.914 . . . . 0.0 111.583 178.579 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 39.1 t -68.04 100.18 0.96 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.845 -179.89 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.498 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 0.9 OUTLIER -126.46 175.47 7.86 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.447 -179.686 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.845 HD23 ' O ' ' A' ' 56' ' ' SER . 7.8 mt -79.87 160.06 26.19 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.127 -179.345 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.81 -86.01 0.94 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.55 -179.801 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.0 t -153.26 -45.48 0.09 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.805 0.336 . . . . 0.0 111.023 -179.771 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 81.5 p -95.71 16.25 17.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.435 -179.816 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 103.04 11.28 34.72 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.983 179.671 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.845 ' O ' HD23 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -84.27 159.14 21.01 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.754 0.277 . . . . 0.0 110.649 179.644 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.4 111.14 23.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.918 0.389 . . . . 0.0 110.79 179.984 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.4 m -113.31 -169.39 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.767 179.808 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.516 ' CZ3' ' CG1' ' A' ' 31' ' ' ILE . 73.6 m95 -130.7 146.58 52.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.977 0.418 . . . . 0.0 111.423 -179.543 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.545 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.6 OUTLIER -92.1 166.64 16.95 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.632 177.427 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.482 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 93.6 Cg_exo -16.22 97.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.811 1 C-N-CA 125.387 4.058 . . . . 0.0 114.639 -178.802 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.481 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -93.92 -76.54 0.48 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.088 -178.054 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.488 ' HA ' ' CD2' ' A' ' 33' ' ' TYR . . . -85.53 108.38 16.02 Favored Pre-proline 0 N--CA 1.463 0.176 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -175.896 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.884 ' HG2' HD11 ' A' ' 41' ' ' LEU . 3.5 Cg_exo -82.82 -153.88 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 123.148 2.565 . . . . 0.0 111.038 177.078 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.538 HG22 ' H ' ' A' ' 66' ' ' CYS . 4.2 mm -90.29 167.38 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.771 0.319 . . . . 0.0 110.541 178.064 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.538 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.1 m -167.53 127.93 1.44 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.037 179.462 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -148.45 173.25 13.29 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.579 179.618 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.545 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 67.6 p -77.41 130.55 37.22 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.441 0.639 . . . . 0.0 111.368 -179.495 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.755 HG22 ' O ' ' A' ' 38' ' ' GLY . 2.7 m -36.39 104.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 114.934 -1.03 . . . . 0.0 112.95 -178.985 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.57 ' CE ' HG23 ' A' ' 90' ' ' THR . 0.1 OUTLIER -86.77 97.06 10.4 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.271 177.132 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.447 ' N ' ' O ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -83.15 128.35 34.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.991 0.424 . . . . 0.0 110.246 179.264 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.44 -158.24 0.07 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.253 178.993 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.479 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 1.8 t -48.92 137.79 13.15 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.035 -179.997 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.495 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 35.5 Cg_exo -59.71 165.58 9.61 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.43 2.086 . . . . 0.0 112.348 -179.662 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.529 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 84.0 Cg_exo -45.77 157.38 0.34 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.769 2.312 . . . . 0.0 112.781 -179.669 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.7 t -109.87 90.21 3.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.461 179.047 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.727 HG23 ' HE1' ' A' ' 97' ' ' TYR . 17.1 pt -69.26 167.84 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.286 -179.0 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.8 m -81.29 139.45 35.41 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.717 179.684 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.411 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 5.4 m-80 56.5 28.84 14.39 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 -179.821 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.464 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -157.09 -170.29 21.87 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.344 -0.932 . . . . 0.0 113.268 -179.851 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -170.16 -175.32 1.95 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.068 0.461 . . . . 0.0 110.976 -179.307 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.479 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 9.3 p80 -115.84 170.64 8.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.971 -179.74 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -151.89 103.35 2.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.948 0.404 . . . . 0.0 111.035 179.012 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -122.06 176.91 16.49 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.268 179.568 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.404 ' CD2' ' N ' ' A' ' 85' ' ' TYR . 2.7 m-85 -107.85 -24.57 11.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.973 0.416 . . . . 0.0 110.813 179.643 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.37 -173.15 2.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.928 -179.853 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -109.91 -24.92 10.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.907 179.451 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.435 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 11.6 m-85 -129.13 -179.68 5.26 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.817 179.9 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.447 ' O ' ' N ' ' A' ' 71' ' ' CYS . 72.7 m-85 -156.62 164.14 38.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.67 -179.126 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.57 HG23 ' CE ' ' A' ' 70' ' ' LYS . 17.3 p -148.49 -177.04 5.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.087 0.47 . . . . 0.0 112.017 -179.242 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.441 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 56.4 m-20 -52.19 94.01 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.249 -179.503 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 122.43 20.5 2.94 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.184 -0.916 . . . . 0.0 113.044 178.455 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.417 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -106.11 150.02 26.19 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 117.087 0.443 . . . . 0.0 110.554 178.994 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.415 HG22 ' N ' ' A' ' 95' ' ' VAL . 31.1 m -131.36 153.67 39.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.158 0.504 . . . . 0.0 111.359 -179.245 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.521 HG23 ' CH2' ' A' ' 118' ' ' TRP . 23.0 t -145.78 149.17 16.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.374 179.132 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.871 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -105.31 130.41 53.44 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.09 0.471 . . . . 0.0 110.796 -179.966 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.967 ' CE2' HG21 ' A' ' 111' ' ' VAL . 3.2 m-85 -87.52 157.41 19.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.252 -179.115 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 61.0 p -144.29 131.42 20.59 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.524 -179.746 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.46 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 87.8 m -69.26 151.88 45.72 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.019 179.761 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.464 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 6.4 m-20 -90.62 -71.69 0.61 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.706 -178.384 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.7 t -58.39 -17.95 24.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.512 -179.279 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 115.3 27.23 3.19 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.082 -179.298 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.487 ' CE2' HG12 ' A' ' 126' ' ' ILE . 31.3 m-85 -69.61 -173.72 0.62 Allowed 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 120.886 0.374 . . . . 0.0 110.923 -179.676 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.57 112.4 23.9 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.396 179.126 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.492 HD22 ' HA ' ' A' ' 109' ' ' SER . 1.1 tp -50.1 112.49 0.68 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.074 -179.737 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.448 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 47.5 mm -99.34 155.88 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.729 179.957 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.434 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 60.53 28.13 67.1 Favored Glycine 0 CA--C 1.508 -0.363 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.437 179.497 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 60.22 129.11 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.001 -0.599 . . . . 0.0 111.495 179.65 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.871 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.2 p -61.47 -26.64 68.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.452 -179.059 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -58.66 136.83 50.81 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.788 -179.356 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.967 HG21 ' CE2' ' A' ' 97' ' ' TYR . 3.2 t -136.81 123.48 29.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.613 0.244 . . . . 0.0 110.936 179.734 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.954 HD22 ' N ' ' A' ' 113' ' ' CYS . 0.7 OUTLIER -81.72 136.16 35.47 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.886 0.374 . . . . 0.0 111.226 -179.73 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.954 ' N ' HD22 ' A' ' 112' ' ' LEU . 36.5 t -107.11 108.46 19.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.991 176.835 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.579 ' OG ' HD11 ' A' ' 112' ' ' LEU . 10.2 p -162.0 129.23 3.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.043 0.449 . . . . 0.0 111.848 -179.932 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.519 ' H ' HG21 ' A' ' 69' ' ' VAL . . . 86.58 30.22 22.08 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.508 179.309 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.453 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 68.75 14.15 67.12 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.212 -178.923 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -143.08 -178.15 5.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.181 0.515 . . . . 0.0 111.365 -179.552 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.529 ' CD1' ' HD3' ' A' ' 75' ' ' PRO . 90.4 m95 -123.73 133.05 53.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.525 179.989 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.455 ' OG ' HD12 ' A' ' 112' ' ' LEU . 0.4 OUTLIER -111.89 157.21 20.9 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.085 0.469 . . . . 0.0 111.356 -179.428 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.495 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER 62.63 44.22 0.6 Allowed Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.632 -0.713 . . . . 0.0 112.256 179.21 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 55.2 Cg_endo -69.13 137.24 36.79 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.174 1.916 . . . . 0.0 111.273 178.008 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.513 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 71.0 Cg_endo -86.43 -173.99 1.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.404 2.069 . . . . 0.0 113.772 -177.631 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.58 -175.5 3.97 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.549 178.123 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . 0.415 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 3.8 m -139.29 94.87 2.85 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.972 0.415 . . . . 0.0 110.897 179.688 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -123.26 159.17 29.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.86 -179.666 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.487 HG12 ' CE2' ' A' ' 103' ' ' TYR . 27.3 mm . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.993 179.935 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.0 ttp180 . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.827 0.346 . . . . 0.0 110.811 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.47 ' HD2' HG23 ' A' ' 25' ' ' VAL . 66.0 mtm-85 -48.93 157.7 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.243 -179.803 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.527 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 36.2 m -73.53 175.83 3.23 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.808 178.592 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.56 ' HD2' ' CD1' ' A' ' 59' ' ' TRP . 18.6 Cg_endo -87.2 -174.83 1.41 Allowed 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.791 2.327 . . . . 0.0 111.406 178.882 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.435 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 2.9 t -58.18 106.53 0.71 Allowed Pre-proline 0 C--N 1.325 -0.479 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.402 179.242 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.471 ' HG2' HD11 ' A' ' 22' ' ' ILE . 1.8 Cg_endo -49.91 148.11 13.41 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.09 1.86 . . . . 0.0 111.849 -179.203 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.906 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -58.16 159.47 5.87 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.126 178.981 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -108.33 -178.96 3.75 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-O 121.149 0.5 . . . . 0.0 112.021 -176.29 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 11.5 tt -138.85 144.23 30.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.71 179.585 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.02 -68.95 0.58 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.557 -178.483 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.432 ' HA ' ' ND2' ' A' ' 36' ' ' ASN . 66.5 m-80 -90.02 43.4 1.14 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.222 -179.134 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -160.5 -174.81 30.78 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.093 179.981 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -143.53 128.62 18.63 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.742 0.306 . . . . 0.0 110.624 -179.598 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.906 HD11 ' O ' ' A' ' 13' ' ' ARG . 13.8 mt -73.11 157.88 36.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.072 0.463 . . . . 0.0 111.497 -179.571 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -130.98 75.37 1.65 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.643 177.657 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.931 ' HA ' HG23 ' A' ' 31' ' ' ILE . 68.0 mt -69.25 106.32 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.65 -177.643 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -115.87 21.05 12.69 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.66 177.557 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 158.31 119.91 0.58 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.136 -179.512 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.47 HG23 ' HD2' ' A' ' 8' ' ' ARG . 32.8 m -117.84 28.92 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.774 0.321 . . . . 0.0 111.295 -179.596 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -104.89 147.85 27.31 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.852 179.86 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.482 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 8.4 t80 -47.34 96.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.088 -179.693 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 122.33 16.68 3.8 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.83 -179.951 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.16 -161.0 0.75 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.696 0.284 . . . . 0.0 110.749 179.632 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 47' ' ' SER . 1.4 p -167.68 148.82 5.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.986 0.422 . . . . 0.0 111.318 179.42 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.931 HG23 ' HA ' ' A' ' 22' ' ' ILE . 1.0 OUTLIER -106.94 173.33 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.591 -179.977 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.492 ' H ' HG22 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -130.92 116.35 17.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.99 0.424 . . . . 0.0 111.384 179.375 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.833 ' CE2' HD21 ' A' ' 20' ' ' LEU . 18.7 m-85 -92.29 138.83 31.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.968 179.758 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.418 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 85.3 p -144.01 166.41 25.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.981 -179.74 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.448 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 3.9 m -90.2 165.72 13.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.728 179.915 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.432 ' ND2' ' HA ' ' A' ' 17' ' ' ASN . 34.6 m-80 -64.28 -83.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.851 0.358 . . . . 0.0 111.015 -179.612 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -154.18 136.81 15.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.624 179.906 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.627 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 60.77 26.92 65.75 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.862 -178.913 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.491 ' CD2' ' HA ' ' A' ' 68' ' ' SER . 2.3 m-85 -119.26 171.41 8.32 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.725 0.298 . . . . 0.0 110.811 -179.328 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.891 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.5 OUTLIER -132.3 120.37 22.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.955 0.407 . . . . 0.0 110.516 177.865 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.902 HD11 ' HG2' ' A' ' 64' ' ' PRO . 6.7 tt -83.46 124.07 30.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.765 -179.294 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.891 HD11 ' CE1' ' A' ' 40' ' ' HIS . 1.9 mm -103.8 167.79 2.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.984 -179.625 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.519 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 73.59 -134.37 19.06 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.097 -179.16 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.894 ' O ' HD21 ' A' ' 41' ' ' LEU . 1.2 pt-20 -80.71 -175.69 5.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.868 0.366 . . . . 0.0 110.688 178.978 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.9 p -160.19 22.31 0.16 Allowed 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.423 -179.258 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.464 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -163.2 124.29 2.39 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.85 0.357 . . . . 0.0 111.691 -177.984 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 30' ' ' SER . 1.4 t -91.89 138.77 31.28 Favored 'General case' 0 CA--C 1.517 -0.317 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 177.233 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.517 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.7 m-85 -113.38 121.53 44.61 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 119.146 -1.022 . . . . 0.0 112.17 -179.473 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 33.9 t -73.28 102.78 3.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.576 179.174 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -122.01 -172.33 2.43 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.311 -179.543 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.482 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -92.47 143.58 26.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.03 -179.353 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -93.57 -94.24 1.53 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.672 -179.793 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.22 60.12 1.05 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.957 0.408 . . . . 0.0 111.211 -179.262 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.416 ' HA ' ' CD2' ' A' ' 51' ' ' LEU . 2.9 p 59.57 29.49 19.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.064 179.369 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.0 -25.98 0.24 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.526 -179.95 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.98 -162.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.865 0.364 . . . . 0.0 111.022 -179.849 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.446 ' O ' HG13 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -117.69 139.86 50.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.628 -179.518 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 57' ' ' MET . 2.2 m -156.46 163.48 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.879 179.692 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.56 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 78.4 m95 -124.75 120.42 31.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.937 0.399 . . . . 0.0 111.528 -179.325 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.517 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -69.9 165.9 37.84 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.14 178.155 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.445 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 89.3 Cg_exo -19.35 98.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 125.216 3.944 . . . . 0.0 114.164 -179.004 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.474 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -100.48 -78.76 0.51 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.344 -177.096 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.478 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -76.55 108.3 6.16 Favored Pre-proline 0 N--CA 1.463 0.19 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -175.032 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.902 ' HG2' HD11 ' A' ' 41' ' ' LEU . 1.0 OUTLIER -88.22 -153.99 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.388 2.725 . . . . 0.0 110.993 176.814 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.573 HG22 ' H ' ' A' ' 66' ' ' CYS . 3.0 mm -98.76 169.57 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.875 0.369 . . . . 0.0 110.76 178.629 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.573 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.1 m -160.51 145.77 14.7 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 179.556 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.471 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.3 OUTLIER -164.56 172.38 13.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.039 -179.951 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.491 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 12.1 p -90.22 112.61 24.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.086 0.469 . . . . 0.0 111.078 179.967 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.627 HG12 ' O ' ' A' ' 38' ' ' GLY . 0.4 OUTLIER -47.79 99.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.344 179.863 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.492 ' HE2' HG23 ' A' ' 90' ' ' THR . 0.1 OUTLIER -81.88 116.13 21.39 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.075 179.923 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.407 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -97.68 129.75 44.72 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.308 179.283 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.85 -156.33 0.12 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.362 179.306 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.443 ' HG ' ' CE1' ' A' ' 82' ' ' HIS . 2.1 t -49.26 137.58 15.14 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.854 179.933 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.52 ' HG2' HG11 ' A' ' 95' ' ' VAL . 27.4 Cg_exo -59.9 163.79 13.15 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.405 2.07 . . . . 0.0 112.062 -179.989 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.517 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 86.1 Cg_exo -39.38 156.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.812 2.341 . . . . 0.0 112.894 -179.605 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.6 t -108.8 90.49 3.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.551 179.449 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.721 HG23 ' HE2' ' A' ' 97' ' ' TYR . 35.7 pt -69.43 175.22 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.326 -179.182 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.36 138.18 39.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.622 179.309 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.498 ' HB3' ' CD2' ' A' ' 103' ' ' TYR . 0.3 OUTLIER 68.65 28.07 5.8 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.676 -179.958 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.452 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . -170.21 -159.99 17.47 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.76 179.694 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.417 ' N ' ' O ' ' A' ' 98' ' ' SER . 1.4 ptt85 -170.13 -176.2 2.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.091 0.472 . . . . 0.0 111.022 -179.226 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.457 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 21.4 p-80 -110.25 170.9 7.78 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.918 179.795 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -104.55 -88.09 0.43 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.775 179.88 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.462 ' N ' HG13 ' A' ' 95' ' ' VAL . . . 65.9 153.57 0.19 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.036 178.729 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -114.14 -35.72 4.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.006 0.432 . . . . 0.0 110.813 179.588 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -99.05 -172.76 2.34 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.141 -179.532 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -99.99 -21.13 15.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.295 179.987 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.42 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 5.3 m-85 -133.08 176.72 8.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.205 -179.727 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.421 ' OH ' ' HA3' ' A' ' 84' ' ' GLY . 66.4 m-85 -152.77 161.6 42.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.928 -179.689 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.492 HG23 ' HE2' ' A' ' 70' ' ' LYS . 8.1 p -128.36 -175.92 3.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.214 -179.252 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -64.85 94.83 0.14 Allowed 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.271 0.558 . . . . 0.0 110.988 -179.843 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.55 18.72 2.18 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.317 178.656 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.4 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -95.34 162.86 13.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.934 0.367 . . . . 0.0 110.573 179.246 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 35.6 m -138.27 149.64 24.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.13 0.49 . . . . 0.0 111.335 -179.608 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.525 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 23.6 t -146.09 148.68 16.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.743 179.526 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.968 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -106.97 130.89 54.55 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.987 -179.973 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.972 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.9 m-85 -89.88 160.74 16.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.985 -179.67 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.417 ' O ' ' N ' ' A' ' 81' ' ' ARG . 21.3 p -157.37 138.86 13.87 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.557 -179.941 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.452 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 68.5 m -70.27 164.5 24.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.815 179.4 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -101.68 -85.24 0.43 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.84 0.352 . . . . 0.0 111.207 179.636 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -45.01 -31.36 1.28 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.522 -179.198 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 130.29 45.12 0.17 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.681 179.777 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.504 ' CE1' HG12 ' A' ' 126' ' ' ILE . 29.7 m-85 -87.04 -173.54 4.49 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.833 0.349 . . . . 0.0 110.836 179.972 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 41.2 m -111.49 108.17 17.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.108 -179.519 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.648 HD23 ' HB2' ' A' ' 122' ' ' PRO . 2.9 tp -44.94 113.16 0.52 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.146 178.935 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.592 HD11 ' HB2' ' A' ' 125' ' ' GLN . 40.0 mm -85.93 156.33 3.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.465 179.79 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.438 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 60.44 -125.62 39.09 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.558 -178.333 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -124.2 135.37 53.4 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.849 0.357 . . . . 0.0 110.584 178.55 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.968 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.2 p -65.94 -29.8 70.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.701 -180.0 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -71.91 137.08 24.97 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.578 179.892 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.972 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.7 t -131.08 119.16 43.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.757 0.313 . . . . 0.0 110.837 179.712 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.03 119.57 23.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.522 -179.006 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.523 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 31.7 t -85.57 101.88 13.07 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.623 176.996 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.9 t -139.31 153.85 47.81 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.193 0.52 . . . . 0.0 111.568 -178.143 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.448 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 47.15 33.94 7.71 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.911 179.482 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.461 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 69.94 11.07 65.97 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.746 -179.999 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -131.15 175.15 9.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.899 0.381 . . . . 0.0 110.391 179.225 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.525 ' CZ3' HG23 ' A' ' 95' ' ' VAL . 93.3 m95 -117.12 128.62 55.32 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.787 -179.43 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.38 146.63 35.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.4 -178.852 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.486 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.5 t0 71.53 46.46 0.24 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.207 178.646 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 74.0 Cg_endo -75.32 130.66 13.15 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.319 2.013 . . . . 0.0 111.324 177.934 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.648 ' HB2' HD23 ' A' ' 105' ' ' LEU . 58.0 Cg_endo -86.15 -174.7 1.58 Allowed 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.448 2.099 . . . . 0.0 113.387 -178.229 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.458 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.3 OUTLIER -135.81 -173.62 3.42 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.071 178.392 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . 0.435 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 16.5 m -141.61 94.62 2.71 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.94 0.4 . . . . 0.0 111.108 -179.5 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.592 ' HB2' HD11 ' A' ' 106' ' ' ILE . 20.6 mt-30 -118.83 169.42 9.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.713 179.921 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.504 HG12 ' CE1' ' A' ' 103' ' ' TYR . 19.5 mm . . . . . 0 C--N 1.325 -0.491 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.806 -179.796 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.457 -0.084 0 CA-C-O 120.896 0.379 . . . . 0.0 111.136 . . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.701 ' HD2' HG23 ' A' ' 25' ' ' VAL . 4.3 mtm180 -71.93 157.14 38.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.798 179.394 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.473 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 69.4 m -77.67 159.24 77.19 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.577 179.606 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 51.1 Cg_endo -68.85 169.98 16.49 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.345 2.03 . . . . 0.0 111.964 -179.718 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.17 105.91 0.58 Allowed Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.777 -179.745 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.522 ' HG3' ' CZ2' ' A' ' 59' ' ' TRP . 53.0 Cg_exo -53.67 160.16 5.8 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.278 1.985 . . . . 0.0 112.517 -179.759 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.571 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -52.86 -174.58 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.156 177.811 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.767 ' O ' HG22 ' A' ' 15' ' ' ILE . 11.8 p-10 -135.66 -40.88 0.7 Allowed 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -176.314 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.767 HG22 ' O ' ' A' ' 14' ' ' ASP . 5.1 tt 66.08 139.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.777 -177.084 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -94.47 -40.03 10.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.855 -177.736 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.445 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 0.7 OUTLIER -93.83 24.71 4.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.8 0.333 . . . . 0.0 111.116 -179.016 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.08 176.29 40.08 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.544 179.838 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.424 ' N ' ' O ' ' A' ' 34' ' ' SER . 2.2 mt-30 -129.49 129.7 44.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.702 0.287 . . . . 0.0 110.564 179.718 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.699 HD21 ' CE1' ' A' ' 33' ' ' TYR . 49.1 mt -82.63 162.51 21.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.151 0.5 . . . . 0.0 111.632 -179.14 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -130.71 80.59 1.95 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.166 179.259 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.876 ' HA ' HG23 ' A' ' 31' ' ' ILE . 56.3 mt -71.33 103.33 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.441 -178.583 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -104.31 15.22 50.7 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.303 178.451 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.402 ' O ' ' HB3' ' A' ' 29' ' ' SER . . . 157.11 127.86 1.01 Allowed Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.772 -179.538 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.701 HG23 ' HD2' ' A' ' 8' ' ' ARG . 30.1 m -115.32 26.22 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -178.213 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -101.18 162.09 13.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.986 0.422 . . . . 0.0 110.996 179.08 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.439 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 2.5 t80 -57.18 92.01 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.986 -179.31 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 132.51 -11.87 5.21 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.884 179.87 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.402 ' HB3' ' O ' ' A' ' 24' ' ' GLY . 9.3 m -75.37 -175.74 2.87 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.819 0.309 . . . . 0.0 110.805 179.87 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 47' ' ' SER . 0.3 OUTLIER -154.07 143.45 21.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.493 -179.717 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.876 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -104.51 171.25 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.938 179.222 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.426 ' O ' ' N ' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -132.25 120.19 21.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.891 178.933 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.699 ' CE1' HD21 ' A' ' 20' ' ' LEU . 28.5 m-85 -99.65 135.22 41.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.197 -179.624 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.424 ' O ' ' N ' ' A' ' 19' ' ' GLN . 64.3 m -143.33 159.38 42.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.765 179.628 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.438 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 57.0 m -83.87 166.02 18.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.002 -179.947 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.85 -83.54 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.082 -179.705 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 t -155.44 136.48 13.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.787 -179.895 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.01 23.25 65.7 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.124 -179.294 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.503 ' CE1' ' HB3' ' A' ' 68' ' ' SER . 2.3 m-85 -113.63 -179.02 3.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.918 0.389 . . . . 0.0 110.98 -179.386 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.724 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -143.98 114.56 7.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.393 178.095 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.969 HD21 ' O ' ' A' ' 44' ' ' GLU . 2.3 tt -75.25 136.47 40.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.675 -179.105 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.724 HD11 ' CE1' ' A' ' 40' ' ' HIS . 3.1 mm -108.39 153.94 9.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.199 -179.01 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.64 -135.95 19.1 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.554 -179.948 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.969 ' O ' HD21 ' A' ' 41' ' ' LEU . 4.3 pm0 -75.47 -179.14 4.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.624 0.25 . . . . 0.0 110.691 179.733 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.1 p -152.23 21.04 0.65 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.181 -179.784 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.415 ' CE ' ' O ' ' A' ' 31' ' ' ILE . 0.0 OUTLIER -151.91 163.06 40.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.896 -178.882 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.472 ' O ' HG13 ' A' ' 31' ' ' ILE . 2.8 m -137.44 112.05 8.76 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.643 179.99 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.419 ' CD1' ' N ' ' A' ' 48' ' ' TYR . 2.0 m-30 -90.01 121.2 31.87 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.897 0.38 . . . . 0.0 111.334 -179.258 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.502 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 35.1 t -71.56 97.49 1.7 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.55 179.396 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -124.58 -176.49 3.54 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.128 -179.514 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.599 HD13 ' H ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -90.16 150.26 22.09 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.01 -179.314 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.414 ' HA2' HG21 ' A' ' 58' ' ' VAL . . . -77.24 -118.48 0.18 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.486 -179.889 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.81 -42.04 3.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.859 0.362 . . . . 0.0 110.948 -179.947 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 59.2 p -99.08 56.6 1.04 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.854 -179.888 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 52.84 26.15 25.05 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.373 -179.795 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.85 -165.01 1.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.892 0.377 . . . . 0.0 111.052 -179.851 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 4.0 mmt -124.06 139.08 54.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.443 179.716 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.414 HG21 ' HA2' ' A' ' 52' ' ' GLY . 2.0 m -149.7 -178.13 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.87 0.367 . . . . 0.0 111.275 -179.296 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.564 ' CE3' HD11 ' A' ' 31' ' ' ILE . 95.2 m95 -128.77 123.86 34.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.774 -179.733 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -148.45 119.71 4.34 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.769 -179.459 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -67.72 -176.28 9.64 Favored 'Cis proline' 0 C--N 1.351 0.7 0 C-N-CA 124.135 -1.194 . . . . 0.0 112.718 1.787 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.435 ' O ' ' CD ' ' A' ' 64' ' ' PRO . 0.6 OUTLIER -111.6 -140.77 0.38 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.102 -178.654 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.534 ' CB ' ' CE1' ' A' ' 33' ' ' TYR . . . -95.6 86.17 0.32 Allowed Pre-proline 0 N--CA 1.448 -0.567 0 C-N-CA 122.878 0.471 . . . . 0.0 110.759 179.464 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.713 ' HG2' HD11 ' A' ' 41' ' ' LEU . 9.8 Cg_endo -45.68 -159.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.476 0.451 0 C-N-CA 124.313 3.342 . . . . 0.0 114.53 178.703 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.495 HG22 ' H ' ' A' ' 66' ' ' CYS . 5.5 mm -97.59 165.76 2.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.854 -178.267 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.495 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.2 m -164.83 117.35 1.24 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.342 179.017 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.19 177.68 7.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.893 0.377 . . . . 0.0 111.353 -179.417 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.503 ' HB3' ' CE1' ' A' ' 39' ' ' TYR . 49.7 p -88.71 99.35 12.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.22 -179.965 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.765 HG22 ' HA3' ' A' ' 116' ' ' GLY . 6.8 p -60.99 103.89 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.302 178.489 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.5 ' HG2' HG22 ' A' ' 90' ' ' THR . 2.7 mttp -82.21 167.44 18.66 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -176.297 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.421 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -125.96 122.69 36.67 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.525 177.3 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.444 ' CG ' ' N ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -69.43 -155.48 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 179.988 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.444 ' N ' ' CG ' ' A' ' 72' ' ' GLN . 1.4 t -52.8 144.52 25.6 Favored Pre-proline 0 N--CA 1.448 -0.556 0 C-N-CA 121.081 -0.248 . . . . 0.0 110.373 179.091 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.775 ' HG3' HG21 ' A' ' 95' ' ' VAL . 39.0 Cg_exo -60.78 160.36 25.31 Favored 'Trans proline' 0 C--O 1.231 0.129 0 C-N-CA 122.561 2.174 . . . . 0.0 112.159 -179.327 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_exo -42.39 155.89 0.1 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.568 2.179 . . . . 0.0 112.41 -179.315 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.3 t -103.94 86.39 2.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.828 -179.793 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.642 HD11 ' HA3' ' A' ' 80' ' ' GLY . 8.2 pt -69.85 169.98 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.953 -179.959 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.5 m -91.59 137.91 31.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.81 179.651 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.506 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 4.8 m-80 57.62 29.84 17.87 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.725 -179.901 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.642 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -165.5 169.36 39.91 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.531 -0.843 . . . . 0.0 112.807 179.685 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 80' ' ' GLY . 19.8 mtt180 -147.19 -166.38 2.5 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.483 0.659 . . . . 0.0 111.622 -178.082 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 1.9 p-80 -130.6 157.24 43.25 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.769 -1.105 . . . . 0.0 111.442 179.911 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.745 ' O ' HG13 ' A' ' 95' ' ' VAL . 1.8 p30 -109.36 86.44 2.29 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.109 177.867 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.418 ' HA3' ' OH ' ' A' ' 89' ' ' TYR . . . -90.96 153.49 22.39 Favored Glycine 0 N--CA 1.437 -1.281 0 C-N-CA 119.478 -1.344 . . . . 0.0 112.522 -179.149 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.05 -36.97 8.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.172 0.51 . . . . 0.0 110.377 -179.395 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.76 -176.3 3.0 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.262 -179.482 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.88 -26.49 18.44 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.193 177.809 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.407 ' HB3' ' HD2' ' A' ' 70' ' ' LYS . 4.2 m-85 -134.11 171.85 13.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.535 179.22 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.421 ' N ' ' O ' ' A' ' 71' ' ' CYS . 26.2 m-85 -140.22 158.45 44.01 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.034 -179.746 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.5 HG22 ' HG2' ' A' ' 70' ' ' LYS . 5.5 p -122.71 176.34 6.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.572 -178.32 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 7.5 p-10 -60.85 93.67 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.76 179.495 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 125.56 19.1 2.35 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.289 -0.869 . . . . 0.0 113.126 179.134 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -98.82 158.85 15.36 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.868 0.334 . . . . 0.0 110.33 178.865 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 27.8 m -145.57 142.27 22.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.421 0.629 . . . . 0.0 111.972 -179.491 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.853 HG22 ' CH2' ' A' ' 118' ' ' TRP . 40.7 t -144.46 148.12 18.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.488 178.167 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.461 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -95.68 159.92 14.75 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.083 0.468 . . . . 0.0 111.796 -177.5 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.827 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.9 m-85 -110.7 155.66 22.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.997 179.223 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.1 p -150.25 140.18 21.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.339 -178.958 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.442 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 83.9 m -75.24 146.92 40.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.222 -179.951 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -78.78 -83.2 0.09 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.622 -179.057 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.2 t -52.47 -22.96 5.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.538 -178.647 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 123.1 30.55 1.09 Allowed Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.808 179.971 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.506 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 48.9 m-85 -69.32 -172.19 0.42 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.724 0.297 . . . . 0.0 110.51 179.413 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.2 m -110.45 107.32 16.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.999 0.428 . . . . 0.0 111.302 -179.257 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.539 HD23 ' HB2' ' A' ' 122' ' ' PRO . 1.9 tp -45.52 112.96 0.52 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.944 178.734 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.534 HG22 ' N ' ' A' ' 107' ' ' GLY . 20.1 mm -90.6 160.85 2.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.051 -178.874 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.534 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 56.5 -129.29 48.25 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.148 -179.641 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -110.4 125.0 52.77 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.8 0.333 . . . . 0.0 110.932 179.873 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.511 ' HA ' HD21 ' A' ' 105' ' ' LEU . 0.1 OUTLIER -67.67 -34.57 77.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.203 178.661 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -79.08 130.83 10.17 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.982 178.479 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.827 HG21 ' CE1' ' A' ' 97' ' ' TYR . 3.2 t -117.63 141.33 36.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 179.786 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.07 122.73 44.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.99 0.424 . . . . 0.0 111.712 -178.469 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.428 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 10.9 t -85.88 105.99 16.77 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.055 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.6 OUTLIER -145.34 154.6 42.49 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.183 0.516 . . . . 0.0 111.349 -178.422 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 54.36 22.09 21.89 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.73 179.548 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.765 ' HA3' HG22 ' A' ' 69' ' ' VAL . . . 87.55 -6.44 83.4 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.533 -0.842 . . . . 0.0 113.005 179.996 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -128.66 -176.81 3.95 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.09 0.472 . . . . 0.0 110.932 -179.698 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.853 ' CH2' HG22 ' A' ' 95' ' ' VAL . 95.3 m95 -108.92 157.62 18.46 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.831 -179.71 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.47 149.11 42.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.061 0.458 . . . . 0.0 111.324 -179.369 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.471 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.7 OUTLIER 68.21 47.67 0.39 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.786 178.69 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 74.0 Cg_endo -75.31 137.68 21.34 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.314 2.009 . . . . 0.0 111.534 178.422 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.539 ' HB2' HD23 ' A' ' 105' ' ' LEU . 59.5 Cg_endo -89.29 -174.13 0.89 Allowed 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.543 2.162 . . . . 0.0 113.561 -178.212 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.45 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -133.6 -174.06 3.41 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.913 177.997 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 8.3 m -143.3 96.5 2.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.143 0.497 . . . . 0.0 111.146 -179.811 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.495 ' HB2' HD11 ' A' ' 106' ' ' ILE . 13.2 mt-30 -121.62 157.72 30.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.775 -179.998 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.549 HG22 ' O ' ' A' ' 126' ' ' ILE . 37.3 mm . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.93 179.918 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 23.1 mmt85 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.788 0.327 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.428 ' HD2' HG23 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -118.3 178.3 4.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.085 -179.693 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.47 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 55.6 m -93.01 160.17 34.21 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.202 -179.126 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.04 176.56 7.56 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.714 2.276 . . . . 0.0 112.531 -179.338 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -50.14 106.58 0.65 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.701 179.662 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.514 ' HG3' ' CZ2' ' A' ' 59' ' ' TRP . 76.2 Cg_exo -48.68 144.22 14.97 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.466 2.111 . . . . 0.0 112.676 -179.323 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.508 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -54.94 164.74 0.75 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.882 178.651 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.569 ' HA ' HD11 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -116.6 -174.17 2.52 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.322 0.582 . . . . 0.0 112.025 -177.785 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.436 HG23 ' C ' ' A' ' 18' ' ' GLY . 2.7 tt -142.06 145.07 24.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.263 -179.768 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -74.9 -66.84 0.7 Allowed 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -177.106 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.419 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 0.4 OUTLIER -91.74 26.62 2.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.336 -177.998 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.436 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -142.47 -175.5 15.78 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.241 -0.981 . . . . 0.0 113.279 -179.399 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -140.45 137.54 34.0 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.691 0.282 . . . . 0.0 110.357 179.294 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.569 HD11 ' HA ' ' A' ' 14' ' ' ASP . 3.7 mt -80.45 163.85 23.48 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.154 0.502 . . . . 0.0 111.794 -179.009 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -135.69 71.06 1.42 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.536 177.283 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.846 ' HA ' HG23 ' A' ' 31' ' ' ILE . 62.2 mt -69.9 103.56 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.84 -177.758 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -105.18 18.21 42.78 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.985 177.843 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 156.02 131.74 1.44 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 121.14 -0.552 . . . . 0.0 111.936 -179.586 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.428 HG23 ' HD2' ' A' ' 8' ' ' ARG . 32.3 m -116.43 25.97 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.686 0.279 . . . . 0.0 111.683 -178.822 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.2 152.23 19.34 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.042 179.792 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.412 ' CZ ' ' HB3' ' A' ' 51' ' ' LEU . 2.2 t80 -55.51 91.31 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.979 0.419 . . . . 0.0 110.441 179.327 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 131.92 -10.09 5.43 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.515 -178.825 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 92.2 p -75.11 -167.73 0.66 Allowed 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 179.326 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.1 p -157.7 152.05 24.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.073 0.463 . . . . 0.0 111.668 179.857 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.846 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -113.84 169.36 5.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.327 179.332 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.42 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -133.31 112.81 11.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.9 0.381 . . . . 0.0 111.062 178.621 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.535 ' CE1' HD22 ' A' ' 20' ' ' LEU . 17.0 m-85 -85.3 138.53 32.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.946 179.955 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.421 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.2 OUTLIER -138.35 168.75 19.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.668 -179.982 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.458 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 3.8 m -91.65 160.81 15.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.733 179.872 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -60.96 -79.68 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.184 -179.303 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -157.03 133.65 10.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.724 -179.786 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.599 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 60.72 25.39 63.52 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.79 -178.907 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.488 ' CD2' ' HA ' ' A' ' 68' ' ' SER . 2.3 m-85 -116.53 171.37 7.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.709 0.29 . . . . 0.0 110.78 -179.354 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.642 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -130.66 131.62 44.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.019 0.438 . . . . 0.0 110.718 178.764 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.755 HD21 ' HB2' ' A' ' 64' ' ' PRO . 3.3 tt -87.7 131.01 34.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.816 -179.054 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.642 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.1 mm -105.45 154.23 6.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.982 0.42 . . . . 0.0 111.143 -179.365 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.09 -136.35 23.85 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.61 -178.469 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.421 ' O ' ' CD2' ' A' ' 41' ' ' LEU . 0.8 OUTLIER -81.45 -178.12 6.8 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 178.33 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.442 ' HA ' ' HG2' ' A' ' 64' ' ' PRO . 6.4 p -155.17 23.6 0.42 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.104 -179.313 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.42 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 3.4 mtpt -147.48 141.57 26.04 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.199 -178.642 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.45 ' HB2' ' CG1' ' A' ' 31' ' ' ILE . 2.5 m -113.01 147.16 37.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.105 178.924 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.452 ' CD1' ' HD3' ' A' ' 61' ' ' PRO . 1.7 m-85 -119.16 121.78 40.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.014 0.435 . . . . 0.0 111.424 -179.597 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.524 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 18.8 t -70.26 77.09 0.53 Allowed 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.03 178.474 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -102.64 179.63 4.24 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.371 -178.491 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -88.43 162.12 16.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.212 -178.821 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -89.58 -136.77 6.2 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.552 -179.987 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.1 m -93.87 -40.75 9.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.78 0.324 . . . . 0.0 111.102 -179.74 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 61.8 p -98.65 46.19 1.0 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.16 -179.672 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 61.74 15.62 48.59 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.884 179.507 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.0 t -76.67 -163.35 0.32 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.69 0.281 . . . . 0.0 110.763 179.679 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.97 124.53 37.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.914 0.387 . . . . 0.0 110.457 179.808 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.6 m -139.8 165.76 21.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.216 -179.199 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.82 ' CE3' HD11 ' A' ' 31' ' ' ILE . 92.2 m95 -102.24 127.62 49.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.17 178.629 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.404 ' HA ' ' C ' ' A' ' 61' ' ' PRO . 14.0 t30 -159.67 127.59 2.81 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.745 -176.873 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.452 ' HD3' ' CD1' ' A' ' 48' ' ' TYR . 21.4 Cg_exo -68.77 -174.38 8.51 Favored 'Cis proline' 0 C--N 1.351 0.677 0 C-N-CA 124.236 -1.152 . . . . 0.0 112.697 1.364 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -110.7 -152.15 0.49 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.128 -178.38 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.457 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -75.27 110.96 11.66 Favored Pre-proline 0 CA--C 1.53 0.181 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.176 -179.717 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.755 ' HB2' HD21 ' A' ' 41' ' ' LEU . 23.6 Cg_exo -66.42 -145.74 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.832 2.355 . . . . 0.0 112.174 -179.871 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.489 HG22 ' H ' ' A' ' 66' ' ' CYS . 3.4 mm -106.39 165.59 4.01 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 120.762 0.315 . . . . 0.0 111.312 -178.73 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.489 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.8 OUTLIER -164.18 124.46 2.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.92 179.632 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.478 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 3.8 tt0 -143.73 -179.64 6.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.938 179.96 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.488 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 1.3 p -86.43 119.44 26.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.021 0.439 . . . . 0.0 111.125 -179.894 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.612 HG22 ' HB3' ' A' ' 40' ' ' HIS . 3.8 p -49.3 96.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.278 179.778 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 89' ' ' TYR . 1.4 mmtp -71.31 139.87 50.08 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.863 179.752 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -116.2 128.11 55.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.922 0.391 . . . . 0.0 110.781 179.58 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.412 ' O ' ' NE1' ' A' ' 118' ' ' TRP . 0.0 OUTLIER -67.42 -175.54 0.5 Allowed 'General case' 0 N--CA 1.43 -1.449 0 CA-C-O 121.912 0.863 . . . . 0.0 113.176 -177.677 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.558 ' HG ' ' CE1' ' A' ' 82' ' ' HIS . 0.3 OUTLIER -51.82 119.09 12.99 Favored Pre-proline 0 N--CA 1.439 -0.98 0 CA-C-N 114.124 -1.398 . . . . 0.0 109.484 176.388 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.498 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 51.4 Cg_exo -41.71 155.04 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.063 1.842 . . . . 0.0 112.416 -176.564 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.412 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 85.6 Cg_exo -45.31 157.08 0.28 Allowed 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.88 2.387 . . . . 0.0 112.854 -179.015 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.31 90.79 3.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.845 -179.933 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.662 HG21 ' O ' ' A' ' 122' ' ' PRO . 18.4 pt -69.5 171.72 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.361 -179.484 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.7 p -88.12 136.66 32.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.707 179.242 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.497 ' HB3' ' CD2' ' A' ' 103' ' ' TYR . 0.1 OUTLIER 66.34 26.53 10.24 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.52 -179.576 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.446 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . 178.03 -178.66 48.53 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.625 179.978 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.406 ' NE ' ' OD1' ' A' ' 100' ' ' ASN . 0.1 OUTLIER -170.25 -175.84 2.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.784 0.326 . . . . 0.0 110.605 -179.714 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.558 ' CE1' ' HG ' ' A' ' 73' ' ' SER . 42.6 p-80 -95.35 168.91 10.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.038 179.831 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -105.53 -72.32 0.72 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.706 179.392 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.433 ' HA3' ' OH ' ' A' ' 89' ' ' TYR . . . 59.72 153.36 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.996 178.911 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -112.36 -26.33 8.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.996 0.427 . . . . 0.0 110.863 179.521 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.8 -173.46 2.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.236 -179.315 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.59 -23.46 13.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.854 178.973 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.431 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 6.4 m-85 -135.13 175.07 9.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.841 179.876 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.433 ' OH ' ' HA3' ' A' ' 84' ' ' GLY . 39.0 m-85 -145.52 165.01 29.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.972 -179.429 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.8 p -130.32 163.02 27.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.998 0.428 . . . . 0.0 111.47 -178.901 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -50.22 95.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.009 -179.91 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.69 26.53 1.14 Allowed Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.32 -0.855 . . . . 0.0 113.114 178.809 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.407 ' HB2' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -110.28 161.93 15.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.837 0.319 . . . . 0.0 110.6 179.065 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.485 HG22 ' N ' ' A' ' 95' ' ' VAL . 34.1 m -135.2 157.83 40.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.061 0.457 . . . . 0.0 111.058 -179.996 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.496 HG11 ' HB2' ' A' ' 82' ' ' HIS . 25.4 t -148.99 148.24 15.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.299 179.52 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.857 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -109.62 120.93 44.02 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.349 0.595 . . . . 0.0 111.126 -179.372 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.971 ' CE2' HG21 ' A' ' 111' ' ' VAL . 4.4 m-85 -77.26 158.12 30.42 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.69 -178.671 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.0 p -154.37 139.11 17.05 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.551 -179.929 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.446 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 6.9 m -69.85 164.02 24.61 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.51 179.971 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.406 ' OD1' ' NE ' ' A' ' 81' ' ' ARG . 28.9 m-20 -95.12 -69.93 0.73 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.314 -179.543 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.6 t -68.74 -34.45 75.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.345 -178.928 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 137.14 41.77 0.1 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.574 -179.925 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.518 ' CD1' ' CD1' ' A' ' 126' ' ' ILE . 15.4 m-85 -80.8 -168.14 1.66 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 179.479 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 3.8 m -117.15 105.42 12.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.804 0.335 . . . . 0.0 111.538 -179.642 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.477 ' CD2' ' HB2' ' A' ' 122' ' ' PRO . 1.6 tp -48.97 121.84 5.17 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.107 0.48 . . . . 0.0 110.615 178.509 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.473 HG22 ' N ' ' A' ' 107' ' ' GLY . 33.7 mm -103.12 159.31 4.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.566 -177.298 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.473 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 52.37 30.32 32.74 Favored Glycine 0 CA--C 1.509 -0.343 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.546 179.468 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.418 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.6 OUTLIER 59.65 127.9 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.984 -0.608 . . . . 0.0 111.394 179.679 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.857 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.2 p -58.56 -29.21 66.2 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.97 -178.332 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -52.69 131.39 39.79 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.706 -0.759 . . . . 0.0 113.154 -178.651 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.971 HG21 ' CE2' ' A' ' 97' ' ' TYR . 2.3 t -130.72 144.28 38.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.39 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.1 tt -104.93 125.24 50.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.963 0.411 . . . . 0.0 112.076 -177.803 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.438 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 11.2 t -88.59 95.47 10.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.436 176.547 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 p -139.06 163.64 31.88 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.208 -178.45 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.2 26.18 2.15 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.773 179.802 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.441 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 76.11 1.51 69.01 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.955 -179.633 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -131.64 179.71 5.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.808 0.337 . . . . 0.0 110.61 179.525 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.498 ' CH2' ' HG3' ' A' ' 74' ' ' PRO . 93.5 m95 -107.79 125.65 51.68 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 -179.898 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.56 145.07 36.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.145 -179.474 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.486 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 2.0 t70 66.89 44.5 0.35 Allowed Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.256 178.71 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.486 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 52.9 Cg_endo -67.44 149.83 80.42 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 121.893 1.728 . . . . 0.0 110.354 176.912 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.662 ' O ' HG21 ' A' ' 77' ' ' ILE . 42.0 Cg_endo -95.71 -178.19 0.45 Allowed 'Trans proline' 0 N--CA 1.448 -1.187 0 C-N-CA 122.129 1.886 . . . . 0.0 114.039 -176.925 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.427 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -124.34 -159.81 0.89 Allowed 'General case' 0 CA--C 1.502 -0.867 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.009 176.796 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . 0.579 ' HB2' HD12 ' A' ' 77' ' ' ILE . 3.8 t -170.34 93.8 0.22 Allowed 'General case' 0 N--CA 1.433 -1.288 0 CA-C-O 121.772 0.796 . . . . 0.0 110.87 -175.906 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 18.1 mm-40 -106.88 -169.33 1.53 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.303 -1.317 . . . . 0.0 112.096 -176.891 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.662 HG22 ' O ' ' A' ' 126' ' ' ILE . 19.1 mm . . . . . 0 C--N 1.313 -1.012 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.11 179.51 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.822 0.344 . . . . 0.0 110.938 . . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.68 ' HD3' HG23 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -98.89 176.76 5.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.833 -179.859 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.472 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 60.3 m -90.24 161.25 38.01 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.681 179.85 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 37.2 Cg_endo -67.34 176.52 4.71 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.549 2.166 . . . . 0.0 112.393 -179.345 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 48.3 t -51.78 109.39 1.38 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.06 -179.368 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.409 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 2.3 Cg_endo -52.33 152.97 14.21 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.16 1.907 . . . . 0.0 111.894 179.757 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.825 ' O ' HD11 ' A' ' 20' ' ' LEU . 14.6 mtt180 -66.4 160.2 25.31 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.191 179.24 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -110.86 -178.69 3.54 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-O 121.223 0.535 . . . . 0.0 112.17 -176.129 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.491 HG22 ' CD2' ' A' ' 20' ' ' LEU . 6.0 tt -142.14 145.32 24.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.539 179.673 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -80.36 -65.0 1.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.829 -178.026 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.425 ' ND2' ' N ' ' A' ' 17' ' ' ASN . 0.5 OUTLIER -93.47 36.46 1.07 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.878 0.371 . . . . 0.0 110.961 -178.909 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.426 ' CA ' ' O ' ' A' ' 34' ' ' SER . . . -150.06 176.95 28.48 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.813 179.69 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -136.55 123.66 21.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.779 0.323 . . . . 0.0 110.75 179.595 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.825 HD11 ' O ' ' A' ' 13' ' ' ARG . 14.6 mt -74.41 159.03 32.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.164 0.506 . . . . 0.0 111.92 -179.124 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.453 ' HB3' ' CB ' ' A' ' 32' ' ' THR . 0.9 OUTLIER -130.52 74.3 1.59 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.914 177.608 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.845 ' HA ' HG23 ' A' ' 31' ' ' ILE . 62.6 mt -69.78 93.2 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.735 -178.174 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -95.73 20.9 47.61 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.932 178.078 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 29' ' ' SER . . . 151.89 133.32 1.96 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.028 -0.606 . . . . 0.0 111.942 -179.455 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.68 HG23 ' HD3' ' A' ' 8' ' ' ARG . 11.9 m -118.37 8.95 6.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.134 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 16.0 t70 -74.46 163.45 27.75 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.011 0.434 . . . . 0.0 110.825 179.481 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.561 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 7.9 t80 -59.79 93.6 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.535 179.987 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 127.17 -7.73 7.15 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.494 -178.804 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.409 ' OG ' ' N ' ' A' ' 26' ' ' ASP . 1.3 m -71.67 174.32 6.92 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 116.841 0.32 . . . . 0.0 110.626 179.589 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -143.83 145.3 32.24 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.018 -179.973 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.845 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -107.34 164.22 4.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.629 179.996 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.453 ' CB ' ' HB3' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -126.48 113.61 17.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.845 179.467 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.824 ' CE1' HD21 ' A' ' 20' ' ' LEU . 21.5 m-85 -91.4 138.56 31.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.556 -179.421 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.426 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.4 OUTLIER -139.87 173.81 11.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.512 179.313 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 1.2 m -92.83 169.92 10.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.828 0.347 . . . . 0.0 111.027 -179.915 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -61.97 -85.45 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.333 -178.844 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -158.73 116.6 2.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.289 179.917 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.541 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 84.16 -8.08 68.79 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.129 -177.282 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.52 ' CZ ' ' HB3' ' A' ' 68' ' ' SER . 4.0 m-85 -82.25 176.27 9.6 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 120.912 0.387 . . . . 0.0 110.84 179.678 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.733 ' CE1' HG22 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -129.54 129.46 44.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.122 175.983 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.937 HD11 ' HG2' ' A' ' 64' ' ' PRO . 9.2 tt -93.92 112.1 23.9 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.523 -179.624 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.553 ' N ' HD13 ' A' ' 42' ' ' ILE . 1.2 mm -85.77 149.27 4.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.085 0.469 . . . . 0.0 110.955 -179.009 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 80.36 -149.77 30.98 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.121 -178.892 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.754 ' O ' HD21 ' A' ' 41' ' ' LEU . 7.4 pt-20 -77.78 176.89 8.62 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.043 0.449 . . . . 0.0 110.856 179.297 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 33' ' ' TYR . 2.5 p -147.05 28.14 1.03 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.014 -179.306 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.55 138.32 23.4 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.971 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -110.73 159.44 17.62 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.978 178.191 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.492 ' CD1' ' HB3' ' A' ' 60' ' ' ASN . 1.7 m-85 -134.27 119.22 18.47 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 119.509 -0.876 . . . . 0.0 112.38 -179.217 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.412 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 37.2 t -69.75 84.83 0.47 Allowed 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.224 -0.898 . . . . 0.0 110.286 178.81 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.499 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 1.9 tt0 -109.45 173.72 6.19 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.49 -179.178 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.561 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -86.81 155.85 20.13 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.095 -179.284 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -86.33 -140.01 5.67 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.506 179.844 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.4 m -91.41 -38.06 12.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.765 0.317 . . . . 0.0 111.133 -179.754 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.2 p -97.43 44.28 1.05 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.123 -179.678 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.88 19.61 37.49 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.689 179.705 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.0 t -79.13 -162.6 0.41 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.766 0.317 . . . . 0.0 110.828 179.801 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.0 mmt -128.49 119.6 25.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.576 179.479 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.1 m -127.05 177.18 5.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.648 -179.982 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.529 ' CE3' HD11 ' A' ' 31' ' ' ILE . 68.7 m95 -118.07 121.13 39.79 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.672 -178.896 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.492 ' HB3' ' CD1' ' A' ' 48' ' ' TYR . 0.8 OUTLIER -70.39 162.98 66.68 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.005 178.011 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.441 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 80.5 Cg_exo -16.64 97.64 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.83 1 C-N-CA 125.534 4.156 . . . . 0.0 114.76 -177.773 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.501 ' HB3' ' CE2' ' A' ' 33' ' ' TYR . 6.1 mt-10 -98.49 -81.71 0.44 Allowed 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.313 -178.309 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . . . -75.49 108.34 5.59 Favored Pre-proline 0 CA--C 1.529 0.151 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -176.419 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.937 ' HG2' HD11 ' A' ' 41' ' ' LEU . 1.3 Cg_endo -85.5 -154.84 0.05 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.222 2.615 . . . . 0.0 110.855 177.071 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.466 ' HB ' ' HB ' ' A' ' 42' ' ' ILE . 2.0 mm -97.66 161.17 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.057 0.456 . . . . 0.0 110.756 178.606 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -154.09 138.45 16.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.888 179.988 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.478 ' O ' ' CD2' ' A' ' 39' ' ' TYR . 0.6 OUTLIER -144.54 167.9 21.41 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.354 179.639 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.52 ' HB3' ' CZ ' ' A' ' 39' ' ' TYR . 1.2 p -108.4 118.56 37.09 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.12 0.486 . . . . 0.0 111.511 -179.396 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.733 HG22 ' CE1' ' A' ' 40' ' ' HIS . 2.6 p -46.95 97.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.309 179.364 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.475 ' HA ' HG22 ' A' ' 90' ' ' THR . 0.3 OUTLIER -78.89 131.06 36.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.546 -179.221 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -113.96 117.86 32.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.957 178.527 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -163.75 0.09 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.127 0.489 . . . . 0.0 110.978 -179.493 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -41.09 132.92 1.91 Allowed Pre-proline 0 N--CA 1.436 -1.142 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.926 179.111 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.48 ' HG3' ' CZ2' ' A' ' 118' ' ' TRP . 26.2 Cg_exo -60.78 158.16 34.43 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.321 2.014 . . . . 0.0 112.146 -179.625 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -44.95 156.93 0.22 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.905 2.403 . . . . 0.0 113.291 -178.923 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.0 t -104.99 93.41 4.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.464 179.195 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.579 HG23 ' HE2' ' A' ' 97' ' ' TYR . 24.3 pt -68.88 177.16 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.576 -178.556 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 24.6 m -92.9 144.47 25.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.681 179.478 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.492 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 5.0 m-80 58.25 27.94 15.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.033 179.706 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.457 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . -173.93 -168.14 34.49 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.962 179.69 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.11 -175.23 4.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.971 0.415 . . . . 0.0 110.415 -179.386 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.473 ' CD2' ' HD2' ' A' ' 74' ' ' PRO . 12.8 p-80 -108.47 166.0 11.1 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.907 179.411 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -97.86 -85.14 0.37 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.704 179.912 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.575 ' H ' HG13 ' A' ' 95' ' ' VAL . . . 65.06 148.86 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.699 179.22 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' A' ' 85' ' ' TYR . 0.3 OUTLIER -111.38 -38.4 4.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.14 0.495 . . . . 0.0 110.564 179.724 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -97.13 -172.55 2.46 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.837 179.721 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -100.1 -21.44 15.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.148 179.737 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.404 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 14.1 m-85 -131.26 173.53 10.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.173 -179.83 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.42 ' OH ' ' HA3' ' A' ' 84' ' ' GLY . 69.6 m-85 -154.27 167.0 31.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.677 -179.655 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.475 HG22 ' HA ' ' A' ' 70' ' ' LYS . 21.4 p -151.68 -176.18 5.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.12 0.486 . . . . 0.0 111.845 -179.162 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 25.7 m-20 -50.13 94.56 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.488 -179.554 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.32 20.29 2.46 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.273 177.938 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -110.32 152.83 25.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 117.216 0.508 . . . . 0.0 110.757 179.224 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.457 HG22 ' N ' ' A' ' 95' ' ' VAL . 32.9 m -138.26 156.11 29.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 121.081 0.467 . . . . 0.0 111.03 -179.718 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.602 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 7.4 t -146.58 145.17 19.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.597 -179.926 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.893 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.1 OUTLIER -104.65 125.6 50.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.134 0.492 . . . . 0.0 110.693 179.938 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.943 ' CE1' HG21 ' A' ' 111' ' ' VAL . 5.2 m-85 -84.27 160.88 20.66 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.498 -178.172 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.1 p -154.05 140.55 18.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.973 0.416 . . . . 0.0 111.775 -178.838 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.457 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 9.9 m -69.29 165.79 19.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.453 179.83 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.451 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 51.1 m-20 -91.03 -68.67 0.78 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.136 179.956 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.74 -38.42 62.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.293 -179.36 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 143.71 41.17 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.842 179.572 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.509 ' CE2' HG12 ' A' ' 126' ' ' ILE . 12.4 m-85 -75.36 -167.63 0.68 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 178.698 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 124' ' ' CYS . 4.3 p -115.39 106.15 13.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.851 0.357 . . . . 0.0 111.369 179.635 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.485 HD22 ' HA ' ' A' ' 109' ' ' SER . 1.6 tp -51.54 119.76 4.47 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.431 178.469 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.547 HG22 ' N ' ' A' ' 107' ' ' GLY . 26.6 mm -100.14 163.01 3.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.349 -177.709 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.547 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 50.54 27.89 13.51 Favored Glycine 0 CA--C 1.508 -0.353 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.679 179.237 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.43 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.3 OUTLIER 60.51 132.64 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.406 0.622 . . . . 0.0 111.293 179.99 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.893 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.3 p -57.61 -25.79 60.59 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.155 -178.441 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -58.77 132.81 52.74 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.884 -0.674 . . . . 0.0 113.78 -177.631 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.943 HG21 ' CE1' ' A' ' 97' ' ' TYR . 3.0 t -133.54 119.56 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 177.807 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.874 HD22 ' N ' ' A' ' 113' ' ' CYS . 1.2 tm? -83.18 136.54 34.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.612 0.244 . . . . 0.0 111.344 -178.709 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.874 ' N ' HD22 ' A' ' 112' ' ' LEU . 42.8 t -106.84 105.86 16.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.455 177.69 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.584 ' CB ' HD11 ' A' ' 112' ' ' LEU . 5.9 t -160.94 135.82 7.51 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.981 0.419 . . . . 0.0 111.333 179.259 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.424 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 83.32 25.27 48.43 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.07 -179.658 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.444 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 70.85 14.84 73.38 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.231 -178.867 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -142.66 -179.65 6.44 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.05 0.452 . . . . 0.0 111.162 179.958 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.602 ' CZ3' HG23 ' A' ' 95' ' ' VAL . 94.2 m95 -120.65 123.57 43.11 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.253 -179.75 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.559 ' OG ' HD12 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -83.36 128.14 34.26 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.112 175.016 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.663 ' HB2' HG13 ' A' ' 111' ' ' VAL . 70.0 m-20 109.55 -124.65 0.0 OUTLIER Pre-proline 0 CA--C 1.476 -1.878 0 N-CA-C 100.339 -3.948 . . . . 0.0 100.339 -166.533 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.539 ' CA ' ' CB ' ' A' ' 120' ' ' ASP . 67.6 Cg_endo -60.77 178.24 6.14 Favored 'Cis proline' 0 C--N 1.315 -1.235 0 CA-C-N 125.038 2.835 . . . . 0.0 112.553 -21.243 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.599 ' HD3' HG22 ' A' ' 111' ' ' VAL . 43.4 Cg_endo -85.97 179.93 3.53 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.401 2.067 . . . . 0.0 113.006 179.71 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.413 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -114.77 -162.74 0.83 Allowed 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.168 176.157 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . 0.442 ' SG ' ' HB2' ' A' ' 103' ' ' TYR . 4.7 t -170.44 88.91 0.14 Allowed 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 120.109 -0.637 . . . . 0.0 110.828 -175.72 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -117.57 173.64 6.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.27 -177.756 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.651 HG22 ' O ' ' A' ' 126' ' ' ILE . 47.8 mm . . . . . 0 C--N 1.322 -0.602 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.897 -179.751 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.832 0.348 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.456 ' HD2' HG23 ' A' ' 25' ' ' VAL . 11.6 mtm-85 -87.03 -173.44 4.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.839 179.679 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.451 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 26.7 m -85.08 160.72 54.43 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.297 -179.165 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.42 171.98 16.59 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.675 2.25 . . . . 0.0 112.237 179.824 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.8 t -51.23 106.45 0.65 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.922 -179.962 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.498 ' HG3' ' CZ2' ' A' ' 59' ' ' TRP . 76.7 Cg_exo -46.92 149.98 2.96 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.331 2.021 . . . . 0.0 112.135 179.643 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.792 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -69.85 143.69 52.78 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.215 0.531 . . . . 0.0 110.321 179.031 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -93.67 -176.86 4.2 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.061 -176.541 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.453 HD12 ' HB1' ' A' ' 63' ' ' ALA . 6.5 tt -135.71 151.04 29.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.599 179.588 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -75.93 -68.83 0.54 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.808 -177.631 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.434 ' N ' ' ND2' ' A' ' 17' ' ' ASN . 0.7 OUTLIER -89.87 44.8 1.23 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.862 0.363 . . . . 0.0 110.985 -179.056 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.437 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -167.36 179.84 40.67 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.957 179.939 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.9 134.54 28.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.823 0.344 . . . . 0.0 110.934 179.645 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.899 HD21 ' CE1' ' A' ' 33' ' ' TYR . 18.6 mt -80.02 158.5 26.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.116 0.484 . . . . 0.0 111.924 -178.855 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 32' ' ' THR . 0.7 OUTLIER -129.1 76.93 1.76 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.866 177.602 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.838 ' HA ' HG23 ' A' ' 31' ' ' ILE . 28.8 mt -70.16 112.6 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.265 -177.607 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -108.47 18.25 32.89 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.926 -0.655 . . . . 0.0 111.693 176.675 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 29' ' ' SER . . . 151.18 136.85 2.56 Favored Glycine 0 C--N 1.333 0.399 0 N-CA-C 111.759 -0.537 . . . . 0.0 111.759 -179.148 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.456 HG23 ' HD2' ' A' ' 8' ' ' ARG . 18.9 m -118.06 12.21 7.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -178.915 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -69.86 157.48 37.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.8 0.333 . . . . 0.0 110.824 179.415 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.586 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 7.5 t80 -55.62 91.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.628 179.759 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 49' ' ' CYS . . . 127.22 -10.75 6.9 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.677 -179.394 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.407 ' HB3' ' O ' ' A' ' 24' ' ' GLY . 61.1 m -58.71 -174.52 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.748 0.309 . . . . 0.0 110.743 179.898 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 47' ' ' SER . 23.0 p -151.59 140.21 20.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.232 179.736 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.838 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -107.87 166.58 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.551 179.661 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.424 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -129.1 108.6 10.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.885 179.522 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.899 ' CE1' HD21 ' A' ' 20' ' ' LEU . 18.2 m-85 -82.47 149.58 27.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.017 0.436 . . . . 0.0 111.043 -179.814 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.429 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.3 OUTLIER -150.91 164.79 35.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.681 -179.949 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.432 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 3.7 m -87.28 161.57 17.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.855 -179.925 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -57.72 -84.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.078 -179.683 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.74 135.65 14.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.634 179.95 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.779 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 60.16 25.94 62.96 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.522 -0.846 . . . . 0.0 111.732 -178.84 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.481 ' CD2' ' HA ' ' A' ' 68' ' ' SER . 2.1 m-85 -117.0 172.08 7.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.836 0.35 . . . . 0.0 111.088 -179.045 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.591 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -133.27 120.44 21.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.491 178.017 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.972 HD21 ' O ' ' A' ' 44' ' ' GLU . 3.6 tt -81.86 132.76 35.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.245 -179.844 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.591 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.5 mm -101.7 151.54 5.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.219 -178.551 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.39 -147.08 38.48 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.064 -179.044 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.972 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.6 OUTLIER -66.2 -177.92 0.58 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.88 0.371 . . . . 0.0 110.766 179.289 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.57 27.93 0.16 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.289 178.72 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.424 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -147.79 132.45 17.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.324 -179.047 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.403 ' O ' ' HA ' ' A' ' 30' ' ' SER . 2.1 m -104.21 150.04 24.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.152 178.641 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.463 ' CE1' ' HD3' ' A' ' 61' ' ' PRO . 6.8 m-85 -124.18 125.6 44.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.047 0.451 . . . . 0.0 111.51 -178.879 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.502 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 28.3 t -74.58 86.26 2.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.356 179.106 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.498 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 1.1 tt0 -105.13 175.4 5.51 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.425 -179.243 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.586 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -89.11 154.07 20.47 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.948 -179.94 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -82.22 -141.12 3.63 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.546 -179.961 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.3 m -99.42 -35.78 9.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.82 0.343 . . . . 0.0 111.023 -179.8 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.7 p -94.13 37.6 1.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.928 -179.986 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 63.22 26.13 69.01 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.35 -179.733 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.8 t -91.86 -167.8 1.86 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.897 0.38 . . . . 0.0 111.02 -179.943 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.8 mmt -122.39 129.24 51.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.345 179.364 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.9 m -140.68 -176.81 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.12 -179.076 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.756 ' CE3' HD11 ' A' ' 31' ' ' ILE . 90.9 m95 -123.02 124.81 43.97 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.289 -179.246 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.427 ' O ' ' CD1' ' A' ' 48' ' ' TYR . 14.5 m-80 -146.88 126.92 6.77 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.886 179.851 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.463 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 71.6 Cg_endo -75.89 -163.64 3.33 Favored 'Cis proline' 0 C--N 1.351 0.685 0 C-N-CA 123.892 -1.295 . . . . 0.0 112.206 -0.34 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.49 ' O ' ' CZ ' ' A' ' 33' ' ' TYR . 28.6 mm-40 -110.13 -107.9 0.35 Allowed 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.095 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.547 ' HB2' ' HE1' ' A' ' 33' ' ' TYR . . . -122.0 100.0 43.39 Favored Pre-proline 0 N--CA 1.445 -0.714 0 C-N-CA 122.514 0.325 . . . . 0.0 110.722 -177.937 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.78 ' HG2' HD11 ' A' ' 41' ' ' LEU . 20.7 Cg_endo -50.59 -158.02 0.0 OUTLIER 'Trans proline' 0 N--CA 1.476 0.448 0 C-N-CA 123.286 2.657 . . . . 0.0 112.939 177.652 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.64 HG22 ' H ' ' A' ' 66' ' ' CYS . 1.0 OUTLIER -93.0 174.94 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.505 -179.136 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.64 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.7 OUTLIER -170.34 133.32 1.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.695 -179.983 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.472 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -150.65 179.59 8.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.872 -179.94 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.481 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 73.0 p -86.81 120.1 27.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.99 179.862 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.779 HG12 ' O ' ' A' ' 38' ' ' GLY . 1.2 p -48.0 99.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.289 179.876 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -82.69 115.75 21.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.432 -179.344 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.428 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -97.54 123.11 41.3 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 116.284 -0.416 . . . . 0.0 109.919 178.179 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -74.04 -150.99 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.953 179.694 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.464 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 2.4 t -56.62 144.81 63.46 Favored Pre-proline 0 C--N 1.324 -0.516 0 C-N-CA 121.095 -0.242 . . . . 0.0 110.647 -179.661 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.579 ' HG2' HG11 ' A' ' 95' ' ' VAL . 23.7 Cg_exo -61.87 163.41 19.14 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.544 2.162 . . . . 0.0 111.817 179.732 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.504 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 97.8 Cg_exo -41.11 156.66 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.372 0 C-N-CA 122.722 2.281 . . . . 0.0 112.742 -179.315 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 12.3 t -105.96 90.03 3.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.48 179.15 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.661 HG23 ' HE2' ' A' ' 97' ' ' TYR . 20.7 pt -69.48 -178.32 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.21 -179.195 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.1 m -104.02 145.56 29.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.809 179.635 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.508 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 13.2 m-20 56.7 29.57 16.04 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.214 179.448 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.44 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -166.85 -165.49 24.33 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.794 179.716 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.96 -175.63 4.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.097 0.475 . . . . 0.0 111.005 -179.73 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.464 ' CE1' ' OG ' ' A' ' 73' ' ' SER . 35.1 p-80 -108.51 173.77 6.17 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.933 179.681 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -107.71 -87.28 0.49 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.493 178.71 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.434 ' N ' HG13 ' A' ' 95' ' ' VAL . . . 56.67 159.78 0.01 OUTLIER Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.964 178.996 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -120.67 -35.23 3.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.91 0.386 . . . . 0.0 111.203 -179.757 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.57 -173.04 3.43 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.942 -179.767 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.93 -24.95 13.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.905 179.518 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.425 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 8.5 m-85 -129.49 176.91 7.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.003 179.969 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.428 ' N ' ' O ' ' A' ' 71' ' ' CYS . 55.0 m-85 -151.76 164.0 37.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.761 -179.523 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 7.6 p -131.27 -175.89 3.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.231 -179.502 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 5.0 m-20 -65.95 94.47 0.23 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.19 0.519 . . . . 0.0 111.126 -179.767 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.86 31.1 0.77 Allowed Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.973 178.753 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.449 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.6 OUTLIER -110.19 159.0 17.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.74 0.305 . . . . 0.0 110.83 179.418 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 34.6 m -134.72 149.48 29.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.075 0.464 . . . . 0.0 111.191 -179.741 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.579 HG11 ' HG2' ' A' ' 74' ' ' PRO . 26.2 t -144.77 148.0 18.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.841 179.592 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.689 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -108.35 128.5 54.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.033 -179.849 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.961 ' CE1' HG21 ' A' ' 111' ' ' VAL . 7.0 m-85 -89.13 155.77 19.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.953 -179.943 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 77.3 p -149.15 137.84 21.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.086 179.543 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.44 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 83.1 m -69.73 157.87 36.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.057 -179.737 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.3 m-20 -90.03 -71.79 0.6 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.564 -178.898 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.0 t -63.77 -19.68 65.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.555 -178.862 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 119.46 31.04 1.43 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.376 -179.733 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.508 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 35.5 m-85 -69.59 -171.55 0.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.698 0.285 . . . . 0.0 110.476 179.61 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.72 106.53 16.2 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.907 0.384 . . . . 0.0 111.274 -179.078 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.542 HD23 ' HB2' ' A' ' 122' ' ' PRO . 1.6 tp -45.18 108.95 0.14 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.633 178.476 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.782 HD11 ' HB2' ' A' ' 125' ' ' GLN . 24.3 mm -83.25 160.75 3.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.067 -178.366 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.539 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 54.68 -128.29 42.29 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.902 -179.257 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -115.52 134.39 55.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.975 0.417 . . . . 0.0 110.898 179.018 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.689 ' HB2' HG22 ' A' ' 96' ' ' THR . 0.0 OUTLIER -68.3 -30.6 69.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.377 179.322 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -75.45 133.16 14.21 Favored Glycine 0 N--CA 1.448 -0.551 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.542 179.807 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.961 HG21 ' CE1' ' A' ' 97' ' ' TYR . 3.3 t -125.6 124.2 66.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.506 0.194 . . . . 0.0 110.49 179.393 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.76 123.71 30.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.895 0.379 . . . . 0.0 111.799 -178.269 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.536 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 27.2 t -88.95 104.36 16.89 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 176.354 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 53.3 p -142.99 154.6 44.18 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.042 0.448 . . . . 0.0 111.605 -177.772 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.43 35.49 7.13 Favored Glycine 0 N--CA 1.453 -0.194 0 CA-C-N 115.663 -0.699 . . . . 0.0 112.748 179.519 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.454 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 68.28 11.44 61.66 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.74 -179.439 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -132.87 178.29 6.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.865 0.364 . . . . 0.0 110.558 179.418 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.536 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 93.1 m95 -117.4 148.13 42.04 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.882 -179.458 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.498 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.1 OUTLIER -128.28 164.06 23.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.111 0.481 . . . . 0.0 111.635 -178.654 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.442 ' N ' ' HD3' ' A' ' 121' ' ' PRO . 1.7 p-10 45.97 52.13 10.71 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.233 179.219 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.442 ' HD3' ' N ' ' A' ' 120' ' ' ASP . 84.0 Cg_endo -82.18 145.64 13.81 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.547 2.164 . . . . 0.0 111.562 177.527 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.542 ' HB2' HD23 ' A' ' 105' ' ' LEU . 90.5 Cg_endo -93.7 -170.1 0.23 Allowed 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.888 2.392 . . . . 0.0 114.177 -177.458 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.452 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -140.54 -170.03 2.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.356 -1.293 . . . . 0.0 110.004 177.806 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . 0.408 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 14.5 m -143.49 95.39 2.74 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.039 0.447 . . . . 0.0 111.11 -179.662 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.782 ' HB2' HD11 ' A' ' 106' ' ' ILE . 23.6 mt-30 -122.78 158.07 31.01 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.797 179.921 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.503 HG12 ' CE2' ' A' ' 103' ' ' TYR . 28.8 mm . . . . . 0 C--N 1.324 -0.506 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.08 -179.754 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.531 0.205 . . . . 0.0 110.673 . . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.575 ' HB3' HG23 ' A' ' 25' ' ' VAL . 1.4 mtm180 56.72 162.23 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 121.011 0.434 . . . . 0.0 111.59 178.525 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.464 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 95.3 m -87.44 158.69 51.44 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.965 -179.824 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 41.0 Cg_endo -68.56 173.49 9.79 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.604 2.203 . . . . 0.0 112.274 -179.971 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -50.65 107.31 0.78 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.783 179.871 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.415 ' HG2' HD11 ' A' ' 22' ' ' ILE . 9.9 Cg_endo -54.8 141.93 75.52 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.202 1.935 . . . . 0.0 112.147 -179.29 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.88 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -52.32 150.83 4.39 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.379 179.259 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.83 -176.06 2.99 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.269 0.556 . . . . 0.0 111.588 -178.038 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.452 HG23 ' C ' ' A' ' 18' ' ' GLY . 11.1 tt -135.58 148.91 28.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.621 -179.585 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -81.02 -62.35 1.69 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.917 -177.635 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.415 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 0.3 OUTLIER -93.15 27.04 2.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.16 -178.549 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.452 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -146.26 -176.58 20.23 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.097 -179.693 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -139.77 127.65 22.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.644 0.259 . . . . 0.0 110.667 179.544 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.88 HD11 ' O ' ' A' ' 13' ' ' ARG . 11.1 mt -72.76 154.14 40.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.11 0.481 . . . . 0.0 111.712 -179.49 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.441 ' CB ' ' HB ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -130.58 76.22 1.71 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.561 177.061 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.917 ' HA ' HG23 ' A' ' 31' ' ' ILE . 54.8 mt -69.97 107.76 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.826 -177.702 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -109.44 15.07 32.7 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.167 178.119 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 29' ' ' SER . . . 162.29 122.9 0.63 Allowed Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.911 -179.639 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.575 HG23 ' HB3' ' A' ' 8' ' ' ARG . 34.9 m -112.94 28.06 2.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 111.902 0.334 . . . . 0.0 111.902 -178.482 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 8' ' ' ARG . 12.6 t70 -102.45 162.69 12.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.043 0.449 . . . . 0.0 111.271 179.534 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.91 ' CZ ' HD13 ' A' ' 51' ' ' LEU . 7.3 t80 -59.61 93.5 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.911 -179.502 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 123.94 3.27 8.35 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.812 -179.963 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 1.6 m -84.92 -159.0 0.39 Allowed 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 116.892 0.346 . . . . 0.0 110.134 179.161 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 47' ' ' SER . 51.9 p -168.18 153.98 7.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.116 0.484 . . . . 0.0 111.451 179.361 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.917 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.6 OUTLIER -114.82 172.84 3.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.383 179.663 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.441 ' HB ' ' CB ' ' A' ' 21' ' ' ASP . 2.6 m -132.86 109.23 9.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.996 0.427 . . . . 0.0 110.962 178.661 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.869 ' CE2' HD21 ' A' ' 20' ' ' LEU . 22.4 m-85 -84.31 132.12 34.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.828 179.836 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.431 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.7 OUTLIER -135.61 162.71 31.94 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.652 -179.42 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.449 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 5.4 m -84.57 168.01 15.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.789 0.328 . . . . 0.0 110.83 179.875 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -63.66 -78.62 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.013 -179.319 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -156.36 135.76 12.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.743 179.72 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.806 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 55.83 26.49 47.61 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.459 -0.877 . . . . 0.0 111.693 -178.939 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.502 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.1 m-85 -115.15 165.84 12.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.707 0.289 . . . . 0.0 110.805 -179.23 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.974 ' NE2' HG22 ' A' ' 69' ' ' VAL . 95.3 m-70 -117.88 122.01 42.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.457 178.255 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.735 HD21 ' O ' ' A' ' 44' ' ' GLU . 10.1 tt -86.2 110.18 19.42 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 178.294 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.454 ' HB ' ' HB ' ' A' ' 65' ' ' ILE . 2.2 mm -84.07 155.13 3.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.934 0.397 . . . . 0.0 111.314 -177.801 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.5 -145.64 36.07 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.057 -179.053 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.735 ' O ' HD21 ' A' ' 41' ' ' LEU . 1.0 OUTLIER -74.31 165.92 24.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.628 0.251 . . . . 0.0 110.473 179.009 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.678 ' HB3' HD22 ' A' ' 41' ' ' LEU . 3.2 p -141.66 24.39 2.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.003 -179.883 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.408 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -148.37 135.77 20.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.447 -178.416 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.427 ' C ' ' CD2' ' A' ' 48' ' ' TYR . 1.0 OUTLIER -106.07 161.07 14.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.498 178.605 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.535 ' CE1' ' HD3' ' A' ' 61' ' ' PRO . 3.6 m-85 -134.29 122.14 22.26 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.056 0.455 . . . . 0.0 111.811 -177.569 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.514 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 35.7 t -76.96 94.42 3.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.806 179.484 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -115.19 -172.83 2.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.531 179.641 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.91 HD13 ' CZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -102.45 152.12 21.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.554 179.105 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -110.04 -51.03 0.65 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.751 -179.542 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.3 t -89.61 48.74 1.63 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.82 0.343 . . . . 0.0 110.936 -179.767 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.434 ' CA ' HD23 ' A' ' 51' ' ' LEU . 2.4 p 53.21 28.01 6.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.642 -179.94 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 169.41 -30.81 0.16 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.008 -179.66 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.78 -160.82 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.835 0.35 . . . . 0.0 110.877 179.515 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.66 137.38 51.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.678 179.911 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.456 HG22 ' C ' ' A' ' 51' ' ' LEU . 8.4 m -152.09 173.87 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.264 -179.128 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.704 ' CE3' HD11 ' A' ' 31' ' ' ILE . 89.9 m95 -129.54 130.99 46.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.06 -179.874 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.471 ' O ' ' CD1' ' A' ' 48' ' ' TYR . 0.9 OUTLIER -160.6 135.14 5.36 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.053 179.897 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.535 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 61.4 Cg_endo -71.33 -165.8 3.5 Favored 'Cis proline' 0 C--N 1.353 0.786 0 C-N-CA 123.984 -1.257 . . . . 0.0 112.691 0.013 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -111.49 -152.3 0.5 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.064 -179.012 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.478 ' HA ' ' CE2' ' A' ' 33' ' ' TYR . . . -73.46 115.24 39.38 Favored Pre-proline 0 C--O 1.231 0.128 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.672 179.213 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.443 ' CG ' ' O ' ' A' ' 44' ' ' GLU . 15.2 Cg_exo -71.22 -150.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.7 2.267 . . . . 0.0 112.54 -178.826 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.585 HG22 ' H ' ' A' ' 66' ' ' CYS . 1.5 mm -103.56 170.64 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.058 -179.162 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.585 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.3 m -159.31 134.69 8.39 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.109 -179.952 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -144.73 157.25 44.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.984 179.809 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.502 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 1.4 p -78.67 129.22 34.47 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.253 0.549 . . . . 0.0 111.553 -179.274 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.974 HG22 ' NE2' ' A' ' 40' ' ' HIS . 3.9 p -50.6 94.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.208 179.458 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.413 ' HE2' HG23 ' A' ' 90' ' ' THR . 0.8 OUTLIER -80.42 116.95 20.76 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.128 -179.846 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -98.17 119.84 37.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.376 179.074 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.94 -158.63 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.662 179.764 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.432 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 2.2 t -48.64 139.99 10.88 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.96 -179.704 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.509 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 26.5 Cg_exo -60.72 161.93 19.93 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.426 2.084 . . . . 0.0 112.154 -179.862 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.525 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 80.9 Cg_exo -42.88 157.48 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.786 2.324 . . . . 0.0 112.85 -179.692 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.3 m -108.16 89.85 3.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.551 179.094 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.73 HG23 ' HE1' ' A' ' 97' ' ' TYR . 33.8 pt -69.35 173.75 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.242 -179.176 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.1 m -95.31 142.91 27.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.582 179.332 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.418 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 7.0 m-80 60.74 28.44 18.18 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.003 179.815 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.465 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -166.49 -166.99 26.47 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.813 -179.882 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.423 ' N ' ' O ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -166.26 -175.75 3.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.001 0.429 . . . . 0.0 110.798 -179.934 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 3.1 p80 -114.63 167.42 10.77 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.25 -179.515 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -99.94 -86.77 0.38 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.778 179.812 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.416 ' HA3' ' OH ' ' A' ' 89' ' ' TYR . . . 64.56 144.87 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.836 179.238 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.505 ' CD1' ' N ' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -111.44 -31.22 7.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.997 0.427 . . . . 0.0 110.512 179.448 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.69 -171.53 2.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.027 -179.788 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -104.39 -25.21 12.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.025 179.753 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.433 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 6.1 m-85 -132.53 172.27 12.72 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.946 -179.967 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.433 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 31.2 m-85 -147.03 167.62 23.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.04 -179.635 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.413 HG23 ' HE2' ' A' ' 70' ' ' LYS . 21.7 p -139.25 -175.13 4.06 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.114 -179.78 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.42 ' OD2' ' CG1' ' A' ' 69' ' ' VAL . 0.4 OUTLIER -62.05 95.06 0.06 Allowed 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 121.197 0.523 . . . . 0.0 110.94 179.937 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 124.7 26.94 1.34 Allowed Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.496 -0.775 . . . . 0.0 113.151 178.592 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -108.3 152.17 24.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.769 0.285 . . . . 0.0 110.384 178.679 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 35.5 m -130.53 154.41 40.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.02 0.438 . . . . 0.0 111.251 -179.494 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.55 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 43.8 t -148.14 151.15 13.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.763 179.32 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.926 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -109.12 125.62 52.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.172 0.51 . . . . 0.0 110.957 179.905 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.967 ' CE2' HG21 ' A' ' 111' ' ' VAL . 4.5 m-85 -83.35 162.19 21.16 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.12 -179.043 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 81' ' ' ARG . 2.6 p -150.94 130.39 12.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.853 0.359 . . . . 0.0 111.689 -178.82 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.409 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 71.8 m -69.93 155.28 40.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.699 178.831 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.465 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 12.6 m-20 -92.76 -72.16 0.61 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.594 -178.598 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.5 t -57.2 -20.59 27.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.771 0.32 . . . . 0.0 111.261 -179.365 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 117.81 29.75 1.96 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.29 -179.846 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.472 ' CE2' HG12 ' A' ' 126' ' ' ILE . 43.9 m-85 -70.7 -174.18 0.87 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.876 0.37 . . . . 0.0 110.643 179.898 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.402 ' HB2' ' O ' ' A' ' 125' ' ' GLN . 0.5 OUTLIER -109.99 110.45 21.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.702 179.56 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.494 ' CD2' ' HB2' ' A' ' 122' ' ' PRO . 1.1 tp -48.08 113.62 0.77 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.936 179.401 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.525 HG22 ' N ' ' A' ' 107' ' ' GLY . 30.1 mm -94.78 161.06 2.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.031 -179.029 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.525 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 51.63 25.8 15.09 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.333 -0.937 . . . . 0.0 112.346 -179.48 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.417 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.3 OUTLIER 60.24 133.42 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.028 -0.586 . . . . 0.0 111.342 -179.567 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.926 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.3 p -60.64 -26.65 67.21 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.485 -179.156 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.84 128.68 47.0 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.712 -0.756 . . . . 0.0 113.115 -178.692 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.967 HG21 ' CE2' ' A' ' 97' ' ' TYR . 2.3 t -123.67 149.79 27.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 178.279 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.8 108.41 17.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.821 0.343 . . . . 0.0 111.441 -179.93 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.512 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 11.6 t -73.68 103.93 4.43 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 176.536 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.5 p -145.9 159.45 43.2 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.212 -178.619 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.67 32.31 8.01 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.739 179.782 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.43 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 71.81 6.41 63.34 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.824 -179.65 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -136.84 173.52 11.62 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.876 0.369 . . . . 0.0 110.624 179.746 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.55 ' CZ3' HG23 ' A' ' 95' ' ' VAL . 83.1 m95 -106.39 124.86 50.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.031 -179.461 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.78 159.05 15.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.517 -178.926 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.472 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 3.6 p-10 49.44 46.58 3.87 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.374 -0.83 . . . . 0.0 112.465 179.076 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.472 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 52.9 Cg_endo -68.36 144.44 61.9 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.32 2.013 . . . . 0.0 111.132 177.215 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.505 ' HG3' ' HA ' ' A' ' 109' ' ' SER . 74.1 Cg_endo -89.73 -172.6 0.62 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.528 2.152 . . . . 0.0 114.3 -176.761 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.41 -158.81 0.9 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.363 -1.289 . . . . 0.0 109.822 178.465 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 7.8 m -155.5 90.54 1.25 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.998 0.427 . . . . 0.0 110.894 179.241 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.402 ' O ' ' HB2' ' A' ' 104' ' ' SER . 22.6 mt-30 -117.37 173.34 6.75 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.779 -179.851 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.472 HG12 ' CE2' ' A' ' 103' ' ' TYR . 29.1 mm . . . . . 0 C--N 1.325 -0.479 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.971 -179.424 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.843 0.354 . . . . 0.0 111.256 . . . . . . . . . 0 0 . 1 . 045 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.682 ' HD2' HG23 ' A' ' 25' ' ' VAL . 0.5 OUTLIER 45.16 -171.89 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.982 -0.553 . . . . 0.0 112.057 178.213 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.55 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 89.4 m -94.32 177.54 1.86 Allowed Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.696 179.708 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.55 ' CD ' ' HB3' ' A' ' 9' ' ' CYS . 28.1 Cg_endo -91.33 179.9 1.51 Allowed 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.706 2.27 . . . . 0.0 111.974 -179.538 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.1 t -51.81 105.51 0.53 Allowed Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.567 179.497 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.483 ' HG3' ' CZ2' ' A' ' 59' ' ' TRP . 77.8 Cg_exo -49.47 153.3 5.21 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.304 2.003 . . . . 0.0 112.4 -179.447 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.428 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 1.0 OUTLIER -62.97 168.5 3.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.981 179.124 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.554 ' HA ' HD11 ' A' ' 20' ' ' LEU . 1.0 OUTLIER -118.93 -175.1 2.84 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.303 0.573 . . . . 0.0 111.752 -178.24 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 12.9 tt -145.19 139.37 22.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.317 -179.692 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -65.34 -72.96 0.14 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.86 -177.568 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.426 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 1.3 m120 -90.02 45.64 1.29 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.933 0.397 . . . . 0.0 110.884 -179.129 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -157.08 171.93 34.54 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.352 -0.928 . . . . 0.0 113.292 179.767 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.403 ' N ' ' O ' ' A' ' 34' ' ' SER . 0.3 OUTLIER -133.55 131.03 39.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.775 0.321 . . . . 0.0 110.36 179.323 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.734 HD22 ' CE1' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -78.54 166.62 22.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.171 0.51 . . . . 0.0 111.748 -178.788 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.452 ' HB3' ' CB ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -135.55 73.39 1.47 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.634 177.127 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.805 ' HA ' HG23 ' A' ' 31' ' ' ILE . 45.4 mt -71.53 92.62 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.582 -178.058 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -97.49 18.42 57.38 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.161 178.212 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 158.51 129.51 1.09 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.109 -0.567 . . . . 0.0 111.887 -179.585 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.682 HG23 ' HD2' ' A' ' 8' ' ' ARG . 32.6 m -115.35 0.91 8.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 112.333 0.494 . . . . 0.0 112.333 -178.553 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -69.6 153.6 43.22 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.923 0.392 . . . . 0.0 111.069 -179.764 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.526 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 12.1 t80 -50.48 106.54 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.935 -179.939 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 114.18 -7.07 23.23 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.913 179.988 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 99.7 p -71.78 -171.65 0.71 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.791 0.329 . . . . 0.0 110.807 179.971 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 47' ' ' SER . 3.2 p -153.48 156.05 37.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.026 179.727 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.805 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -119.71 168.05 12.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.492 -179.869 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.452 ' CB ' ' HB3' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -128.93 111.1 12.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.918 0.39 . . . . 0.0 110.977 179.054 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.734 ' CE1' HD22 ' A' ' 20' ' ' LEU . 27.8 m-85 -88.84 134.93 33.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.211 -179.645 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.428 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 21.3 p -138.42 167.97 20.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.703 179.908 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.448 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 1.6 m -88.18 162.68 16.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.86 -179.991 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -59.16 -80.21 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.849 0.357 . . . . 0.0 111.123 -179.324 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.1 m -158.63 133.72 8.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.773 -179.814 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.727 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 60.06 24.74 61.11 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.789 -178.959 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.477 ' CG ' ' O ' ' A' ' 67' ' ' GLU . 2.0 m-85 -112.47 -179.58 3.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.78 0.324 . . . . 0.0 110.766 -179.662 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.877 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -138.7 113.8 9.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.011 0.434 . . . . 0.0 110.613 178.49 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.713 HD21 ' O ' ' A' ' 44' ' ' GLU . 4.7 tt -78.99 126.36 30.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.514 -179.595 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.877 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.6 mm -100.2 153.51 4.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.401 -178.688 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.9 -145.35 31.05 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.328 -179.711 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.713 ' O ' HD21 ' A' ' 41' ' ' LEU . 3.7 pm0 -70.02 171.56 9.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.576 0.227 . . . . 0.0 110.695 179.477 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.0 p -146.96 18.98 1.26 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.437 -179.599 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.431 ' HG2' ' HA ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -148.15 134.15 19.2 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.925 0.393 . . . . 0.0 111.495 -178.768 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.45 ' HB2' ' CG1' ' A' ' 31' ' ' ILE . 1.5 m -102.89 152.52 21.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.992 178.51 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.515 ' CE1' ' HD3' ' A' ' 61' ' ' PRO . 4.5 m-85 -125.3 121.05 32.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.135 0.493 . . . . 0.0 111.601 -178.74 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.447 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 41.0 t -72.32 93.77 1.53 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.301 179.216 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.493 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 0.7 OUTLIER -111.93 176.4 5.04 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.372 -178.78 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.526 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -91.73 157.33 16.98 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.811 179.79 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -87.69 -126.74 2.41 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.592 -179.815 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.02 -40.93 5.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.81 0.338 . . . . 0.0 111.019 -179.8 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 27.8 p -97.9 56.84 1.27 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 179.961 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 50.24 24.86 7.39 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.344 -179.709 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.4 t -84.12 -164.46 0.94 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.894 0.378 . . . . 0.0 111.066 -179.681 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.19 120.83 20.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.397 179.407 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 2.0 m -125.62 -176.62 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.074 -179.046 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.698 ' CE3' HD11 ' A' ' 31' ' ' ILE . 86.0 m95 -127.69 127.05 43.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.666 179.976 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 9.4 m-80 -151.87 128.92 5.53 Favored Pre-proline 0 CA--C 1.532 0.285 0 C-N-CA 121.086 -0.246 . . . . 0.0 111.322 -179.416 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.515 ' HD3' ' CE1' ' A' ' 48' ' ' TYR . 72.8 Cg_endo -75.7 -165.92 4.63 Favored 'Cis proline' 0 C--N 1.351 0.701 0 C-N-CA 123.864 -1.306 . . . . 0.0 112.335 -0.516 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.79 -153.87 0.53 Allowed 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.014 -179.474 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.475 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -73.63 112.67 17.19 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.819 179.63 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 63' ' ' ALA . 17.3 Cg_exo -68.75 -150.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.669 2.246 . . . . 0.0 112.452 -179.075 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.509 HG22 ' H ' ' A' ' 66' ' ' CYS . 5.7 mm -99.6 166.35 2.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.91 0.386 . . . . 0.0 111.459 -178.842 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.509 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -165.94 123.8 1.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.692 179.381 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.477 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -136.24 176.64 8.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.0 -179.739 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.467 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 4.2 p -94.2 122.48 36.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.15 -179.736 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.727 HG12 ' O ' ' A' ' 38' ' ' GLY . 3.0 p -46.85 99.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.399 179.569 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.408 ' HD2' ' HB3' ' A' ' 88' ' ' PHE . 23.0 mmtt -70.99 114.88 9.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.177 179.958 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.426 ' N ' ' O ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -97.01 121.44 38.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.095 178.73 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -158.74 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.925 -179.643 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.543 ' HG ' ' CE1' ' A' ' 82' ' ' HIS . 2.1 t -48.54 138.08 11.9 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.113 -179.556 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.491 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 24.6 Cg_exo -61.22 162.3 20.38 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.389 2.059 . . . . 0.0 112.001 179.746 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.512 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 91.9 Cg_exo -40.72 158.59 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.852 2.368 . . . . 0.0 113.01 -179.158 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.7 m -108.91 90.99 3.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.588 179.328 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.719 HG23 ' HE2' ' A' ' 97' ' ' TYR . 23.0 pt -69.14 -177.11 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.23 -179.139 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.0 p -101.37 146.74 27.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.752 179.639 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.512 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 3.3 m-80 53.54 29.62 9.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.12 179.449 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.466 ' N ' ' ND2' ' A' ' 100' ' ' ASN . . . -171.55 -171.69 36.9 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.543 179.612 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.54 -176.17 4.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.966 0.412 . . . . 0.0 110.914 179.417 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.543 ' CE1' ' HG ' ' A' ' 73' ' ' SER . 8.6 p-80 -100.93 173.03 6.67 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.018 -179.956 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 99.8 m-20 -102.0 -84.11 0.45 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.393 179.223 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.419 ' HA3' ' OH ' ' A' ' 89' ' ' TYR . . . 60.22 147.74 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.098 178.351 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -112.45 -32.83 6.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.141 0.496 . . . . 0.0 110.629 179.104 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.3 -171.61 2.24 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.707 179.629 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -104.64 -19.06 14.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.367 -179.954 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.43 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 6.3 m-85 -134.29 174.93 9.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.827 0.346 . . . . 0.0 111.182 -179.552 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.43 ' CD2' ' C ' ' A' ' 88' ' ' PHE . 70.4 m-85 -151.27 165.15 34.86 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.895 -179.913 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 13.3 p -127.4 173.57 9.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.97 0.414 . . . . 0.0 111.214 -179.159 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -60.26 95.31 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.292 0 CA-C-O 121.303 0.573 . . . . 0.0 110.82 179.744 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 125.81 28.28 1.07 Allowed Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.258 -0.883 . . . . 0.0 112.943 179.34 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.2 158.14 18.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.696 0.284 . . . . 0.0 110.567 179.208 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 32.8 m -131.43 150.43 34.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.066 0.46 . . . . 0.0 111.361 -179.514 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.542 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 33.2 t -143.12 148.67 19.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.563 178.854 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.983 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -104.45 134.42 47.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.936 -179.873 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.962 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.7 m-85 -94.27 158.59 15.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.263 -179.354 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 84.7 p -154.3 139.91 17.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.39 -179.856 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.415 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 66.3 m -70.54 162.73 28.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.224 -179.862 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.466 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 73.6 m-80 -92.05 -78.26 0.41 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.45 -179.232 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.7 m -56.53 -27.33 57.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.855 0.36 . . . . 0.0 110.985 -179.312 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 127.61 34.09 0.58 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.768 179.679 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.512 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 32.4 m-85 -70.4 -173.06 0.66 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.763 0.316 . . . . 0.0 110.175 178.939 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.98 109.97 20.74 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.139 0.495 . . . . 0.0 110.853 179.563 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.644 HD23 ' HB2' ' A' ' 122' ' ' PRO . 2.6 tp -46.65 113.5 0.66 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.936 179.145 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.464 HG22 ' N ' ' A' ' 107' ' ' GLY . 38.7 mm -89.06 157.29 3.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.785 -179.265 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.464 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 62.77 -121.58 25.38 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.462 -0.875 . . . . 0.0 111.587 -178.335 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -127.48 130.52 49.37 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.878 0.37 . . . . 0.0 110.711 178.523 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.983 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.1 p -63.72 -28.48 69.92 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.107 179.123 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -74.33 130.96 12.76 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.594 179.477 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.962 HG21 ' CE1' ' A' ' 97' ' ' TYR . 4.3 t -122.95 134.13 67.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.152 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 118' ' ' TRP . 0.3 OUTLIER -90.02 124.79 35.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.019 0.438 . . . . 0.0 111.785 -178.2 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.521 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 14.5 t -91.02 100.44 13.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.521 176.909 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.9 166.54 27.33 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.098 0.475 . . . . 0.0 111.591 -178.217 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.98 26.93 3.16 Favored Glycine 0 CA--C 1.517 0.214 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.841 179.589 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.421 ' N ' HG11 ' A' ' 69' ' ' VAL . . . 73.83 10.88 80.84 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.597 -179.425 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -142.14 -177.74 5.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.753 0.311 . . . . 0.0 110.459 179.705 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.542 ' CZ3' HG23 ' A' ' 95' ' ' VAL . 85.0 m95 -114.57 149.33 36.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.072 -179.264 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.549 ' O ' HG13 ' A' ' 111' ' ' VAL . 0.0 OUTLIER -130.02 168.87 16.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.444 -179.121 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.456 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 5.0 p-10 46.67 49.62 7.21 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.975 179.801 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.456 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 75.5 Cg_endo -77.85 143.01 20.5 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.632 2.221 . . . . 0.0 111.681 178.045 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.644 ' HB2' HD23 ' A' ' 105' ' ' LEU . 70.0 Cg_endo -90.8 -171.54 0.44 Allowed 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.841 2.36 . . . . 0.0 113.819 -178.053 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.424 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -133.96 -161.3 1.13 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.773 -1.103 . . . . 0.0 110.252 178.592 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 10.7 m -153.53 90.14 1.39 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.016 0.436 . . . . 0.0 110.996 179.599 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 9.3 mt-30 -118.35 160.84 20.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.651 179.793 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.62 HG22 ' O ' ' A' ' 126' ' ' ILE . 20.5 mm . . . . . 0 C--N 1.322 -0.618 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.103 -179.852 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.9 mtm-85 . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.719 0.295 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 046 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.622 ' HB3' HG23 ' A' ' 25' ' ' VAL . 0.0 OUTLIER 53.68 168.54 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.501 178.561 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.438 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 18.4 m -72.73 160.82 81.91 Favored Pre-proline 0 N--CA 1.452 -0.346 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.51 179.817 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -65.45 167.61 16.46 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 122.171 1.914 . . . . 0.0 111.175 179.517 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.5 p -53.64 107.74 0.93 Allowed Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.152 -178.376 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.564 ' HG2' HD13 ' A' ' 22' ' ' ILE . 50.0 Cg_exo -44.87 167.41 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.312 2.008 . . . . 0.0 112.765 179.724 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.413 ' HB3' ' OH ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -66.36 176.51 1.79 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.593 176.416 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.919 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -130.46 -7.06 4.19 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -177.279 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.698 HD12 ' HD2' ' A' ' 64' ' ' PRO . 17.4 tt 51.67 156.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 123.498 0.719 . . . . 0.0 112.533 -178.685 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.416 ' HB3' ' ND2' ' A' ' 17' ' ' ASN . 3.9 t0 -103.97 157.52 17.04 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.141 178.858 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.416 ' ND2' ' HB3' ' A' ' 16' ' ' ASP . 0.1 OUTLIER 42.97 28.0 0.12 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.293 -179.516 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.447 ' HA2' ' HA ' ' A' ' 35' ' ' CYS . . . -151.25 -163.42 11.38 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.341 -179.781 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.694 ' C ' HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -137.93 175.37 9.64 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.85 0.357 . . . . 0.0 111.132 179.964 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.919 HD11 ' O ' ' A' ' 14' ' ' ASP . 0.8 OUTLIER -125.13 150.65 46.68 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.57 179.514 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.457 ' HB3' ' CB ' ' A' ' 32' ' ' THR . 60.5 t0 -125.97 67.08 1.19 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 177.913 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.94 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.2 OUTLIER -82.33 101.63 7.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.026 -176.613 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -94.22 7.97 72.48 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.982 176.908 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 175.53 160.36 23.1 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.926 -179.928 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.622 HG23 ' HB3' ' A' ' 8' ' ' ARG . 31.9 m -143.13 33.73 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.873 0.368 . . . . 0.0 111.205 -179.689 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -104.17 156.9 17.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.081 -179.906 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.518 ' CE2' ' HG ' ' A' ' 51' ' ' LEU . 0.6 OUTLIER -54.23 91.8 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.723 179.56 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 132.54 -10.47 5.25 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.538 -0.839 . . . . 0.0 112.797 -179.796 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.3 -179.27 5.59 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.804 0.335 . . . . 0.0 110.561 179.565 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 47' ' ' SER . 3.0 p -155.13 141.63 18.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.076 0.465 . . . . 0.0 110.558 179.277 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.94 HG23 ' HA ' ' A' ' 22' ' ' ILE . 1.1 mt -101.95 166.12 2.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.56 -179.239 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.457 ' CB ' ' HB3' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -127.98 104.81 8.0 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.942 0.401 . . . . 0.0 110.214 178.842 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.529 ' CE2' ' CD2' ' A' ' 20' ' ' LEU . 9.5 m-85 -79.76 157.83 27.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.695 -178.02 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.6 t -162.81 176.59 10.09 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.697 179.99 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.455 ' HB3' ' CB ' ' A' ' 39' ' ' TYR . 45.2 m -98.43 173.78 6.79 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.876 179.916 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.439 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 30.6 m-20 -72.81 -83.63 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.289 -179.279 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.4 t -149.48 139.04 21.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.631 -179.867 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.877 ' O ' HG22 ' A' ' 69' ' ' VAL . . . 55.89 27.02 49.5 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.647 -0.787 . . . . 0.0 111.811 -179.056 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.555 ' CD2' ' HA ' ' A' ' 68' ' ' SER . 2.4 m-85 -115.82 171.62 7.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.681 0.277 . . . . 0.0 110.763 -179.147 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.878 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -137.5 117.52 13.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.978 0.418 . . . . 0.0 110.608 178.677 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.931 HD21 ' O ' ' A' ' 44' ' ' GLU . 5.9 tt -81.52 125.8 30.93 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.64 -179.542 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.878 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.0 mm -102.16 153.33 5.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.09 -179.3 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 78.08 -142.82 26.79 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.452 -179.681 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.931 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.1 OUTLIER -68.43 -172.39 0.33 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.063 0.458 . . . . 0.0 110.882 179.68 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -174.77 32.23 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.202 178.992 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 5.0 mtpt -157.34 118.8 3.68 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.033 0.444 . . . . 0.0 111.577 -179.426 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.442 ' HB3' ' CD1' ' A' ' 31' ' ' ILE . 0.4 OUTLIER -91.83 139.47 30.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.109 179.214 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.548 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 2.1 m-85 -115.74 118.4 32.95 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 119.43 -0.908 . . . . 0.0 111.439 178.82 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 22.6 t -67.33 116.2 7.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.855 -179.575 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.5 ' HA ' ' CE1' ' A' ' 27' ' ' PHE . 2.7 mt-10 -148.85 177.87 9.16 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.127 0.489 . . . . 0.0 111.338 179.678 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.736 ' O ' HG22 ' A' ' 58' ' ' VAL . 1.0 OUTLIER -65.37 167.38 8.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.702 -179.065 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -115.85 -93.54 1.84 Allowed Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.326 179.739 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.35 -48.54 0.48 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.752 0.311 . . . . 0.0 110.827 179.676 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 57.8 p -113.47 28.25 8.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.046 179.911 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.432 ' HA2' ' CD2' ' A' ' 51' ' ' LEU . . . 75.09 36.02 47.53 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.466 -179.907 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.51 -1.93 46.21 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 179.983 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.408 ' HB2' ' HA ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER 57.47 121.14 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.164 179.653 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.736 HG22 ' O ' ' A' ' 51' ' ' LEU . 25.8 m -122.23 -172.37 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.645 179.669 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.526 ' CE3' HD11 ' A' ' 31' ' ' ILE . 73.3 m95 -132.66 128.88 37.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.865 0.364 . . . . 0.0 111.439 -179.317 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.548 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 5.3 m-80 -69.18 166.98 23.62 Favored Pre-proline 0 C--O 1.223 -0.323 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.538 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.471 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 57.4 Cg_exo -12.66 90.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.356 0.956 0 C-N-CA 125.228 3.952 . . . . 0.0 114.224 -179.103 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.476 ' O ' ' CG ' ' A' ' 33' ' ' TYR . 0.0 OUTLIER -92.8 -72.68 0.59 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.584 -175.826 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.512 ' HA ' ' CD2' ' A' ' 33' ' ' TYR . . . -97.25 106.64 33.28 Favored Pre-proline 0 N--CA 1.463 0.189 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -174.885 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.792 ' HG2' HD11 ' A' ' 41' ' ' LEU . 5.7 Cg_exo -82.64 -152.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.251 2.634 . . . . 0.0 111.335 177.138 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.576 HG22 ' H ' ' A' ' 66' ' ' CYS . 3.2 mm -90.8 169.98 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.825 0.345 . . . . 0.0 110.744 178.648 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.576 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -167.37 139.82 3.33 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.488 179.313 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -161.09 170.7 19.93 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.266 -179.098 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.555 ' HA ' ' CD2' ' A' ' 39' ' ' TYR . 54.9 p -81.09 120.87 25.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.235 0.541 . . . . 0.0 111.124 179.713 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.877 HG22 ' O ' ' A' ' 38' ' ' GLY . 16.3 m -46.86 107.89 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.829 -179.72 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.53 ' HG2' ' CD1' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -101.7 122.09 43.25 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.313 0.578 . . . . 0.0 110.388 177.409 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.38 128.84 55.12 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.597 -178.759 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.49 -156.17 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.148 179.103 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.444 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 0.3 OUTLIER -54.97 139.59 62.99 Favored Pre-proline 0 N--CA 1.445 -0.678 0 CA-C-N 116.661 -0.245 . . . . 0.0 110.408 179.212 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.507 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 38.5 Cg_exo -58.27 162.94 10.94 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.558 2.172 . . . . 0.0 112.192 -179.487 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.519 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 94.5 Cg_exo -42.09 155.49 0.09 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.671 2.247 . . . . 0.0 112.647 -179.647 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.4 m -109.57 89.75 3.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.538 179.559 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.626 HG23 ' HE1' ' A' ' 97' ' ' TYR . 16.1 pt -69.38 172.04 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.047 -179.45 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -89.58 131.41 35.61 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.935 179.99 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 67.28 26.86 8.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.618 -179.869 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.449 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -158.4 178.46 34.62 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.329 -179.754 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.44 ' N ' ' O ' ' A' ' 98' ' ' SER . 5.3 mtm180 -149.27 -166.57 2.59 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 121.358 0.599 . . . . 0.0 110.991 -179.214 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 4.3 p-80 -132.2 157.42 44.36 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.561 -179.889 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 -96.74 -139.74 0.27 Allowed 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.399 -179.887 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 85' ' ' TYR . . . 75.68 -67.96 2.23 Favored Glycine 0 C--N 1.337 0.635 0 C-N-CA 120.112 -1.042 . . . . 0.0 111.311 -178.225 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.432 ' HB2' ' O ' ' A' ' 84' ' ' GLY . 3.3 m-85 66.89 29.45 8.27 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-O 121.439 0.638 . . . . 0.0 110.232 178.697 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.512 ' HB2' ' CZ ' ' A' ' 89' ' ' TYR . 0.1 OUTLIER -89.15 -172.92 3.84 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.743 178.085 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.473 ' O ' ' CD2' ' A' ' 88' ' ' PHE . 6.9 m-20 -102.74 -29.64 11.37 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.122 0.486 . . . . 0.0 110.352 178.648 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.53 ' CD1' ' HG2' ' A' ' 70' ' ' LYS . 45.6 m-85 -155.61 -175.08 5.25 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.401 179.835 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.512 ' CZ ' ' HB2' ' A' ' 86' ' ' GLU . 73.5 m-85 -158.94 163.62 36.35 Favored 'General case' 0 C--O 1.223 -0.309 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -178.896 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 11.1 p -144.2 -177.3 5.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.365 0.602 . . . . 0.0 112.59 -178.493 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 41.1 p-10 -50.91 95.2 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.373 -179.302 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 121.01 25.4 2.28 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 115.282 -0.872 . . . . 0.0 113.076 178.15 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.17 145.46 37.21 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.936 0.368 . . . . 0.0 110.75 179.068 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.488 HG22 ' N ' ' A' ' 95' ' ' VAL . 33.5 m -127.33 158.58 38.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.043 0.449 . . . . 0.0 111.043 -179.777 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.488 ' N ' HG22 ' A' ' 94' ' ' VAL . 15.5 t -151.95 147.77 14.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.641 179.79 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.908 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -108.1 127.59 53.93 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.142 0.496 . . . . 0.0 110.868 -179.899 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.996 ' CE2' HG21 ' A' ' 111' ' ' VAL . 3.9 m-85 -84.81 159.61 20.39 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.445 -178.963 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.44 ' O ' ' N ' ' A' ' 81' ' ' ARG . 19.1 p -147.58 130.28 16.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.84 -179.589 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.455 ' SG ' HD12 ' A' ' 105' ' ' LEU . 93.8 m -69.5 150.11 47.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.907 179.376 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.4 ' OD1' ' HG3' ' A' ' 81' ' ' ARG . 4.9 m-20 -87.11 -72.7 0.5 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.832 -178.383 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.38 -18.49 28.22 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.557 -178.831 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 116.05 28.5 2.63 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.262 -179.472 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.61 ' HA ' HD13 ' A' ' 126' ' ' ILE . 45.5 m-85 -69.56 -173.45 0.58 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 120.779 0.323 . . . . 0.0 110.555 179.964 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 125' ' ' GLN . 1.4 m -110.44 109.18 19.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 -179.97 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.455 HD12 ' SG ' ' A' ' 99' ' ' CYS . 1.1 mp -46.93 107.91 0.13 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.96 179.189 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.445 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 43.7 mm -93.8 153.18 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.939 -179.424 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 60.48 25.94 63.71 Favored Glycine 0 CA--C 1.51 -0.228 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.591 -179.916 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.419 ' O ' ' HB3' ' A' ' 122' ' ' PRO . 0.4 OUTLIER 60.79 135.73 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.288 0.566 . . . . 0.0 111.212 -179.713 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.908 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.2 p -65.52 -24.67 67.18 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.692 -178.678 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -58.93 131.58 52.12 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.022 -179.037 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.996 HG21 ' CE2' ' A' ' 97' ' ' TYR . 2.3 t -133.59 125.49 50.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.626 0.251 . . . . 0.0 110.551 178.927 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.896 HD22 ' N ' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -89.92 130.86 36.08 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.942 0.401 . . . . 0.0 111.562 -179.234 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.896 ' N ' HD22 ' A' ' 112' ' ' LEU . 48.7 t -100.84 104.81 16.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.665 176.866 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.784 ' HB2' HD11 ' A' ' 112' ' ' LEU . 71.1 m -152.85 126.18 8.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.896 0.379 . . . . 0.0 111.777 -178.907 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.487 ' H ' HG21 ' A' ' 69' ' ' VAL . . . 84.3 22.13 55.09 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.575 178.994 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.509 ' N ' ' HB ' ' A' ' 69' ' ' VAL . . . 84.37 -4.22 84.44 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.43 179.995 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -124.81 173.38 8.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.421 0.629 . . . . 0.0 111.892 -178.669 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.54 ' CZ3' ' HB2' ' A' ' 113' ' ' CYS . 95.2 m95 -115.75 125.93 53.4 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.996 -1.002 . . . . 0.0 110.008 178.812 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.92 148.34 30.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.232 0.539 . . . . 0.0 111.64 -178.711 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.497 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER 68.8 44.86 0.28 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.299 178.374 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 56.9 Cg_endo -70.59 140.99 40.79 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.078 1.852 . . . . 0.0 111.331 177.859 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.572 ' O ' HG21 ' A' ' 77' ' ' ILE . 67.5 Cg_endo -88.51 -173.82 0.96 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.58 2.186 . . . . 0.0 114.007 -177.25 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.46 -160.82 1.08 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.58 177.661 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . 0.402 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 6.6 m -152.99 90.96 1.49 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.091 0.472 . . . . 0.0 111.028 179.144 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.426 ' O ' ' CB ' ' A' ' 104' ' ' SER . 8.9 mt-30 -121.06 158.4 27.93 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.712 -179.852 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.61 HD13 ' HA ' ' A' ' 103' ' ' TYR . 35.3 mm . . . . . 0 C--N 1.323 -0.568 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.909 179.933 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.817 0.341 . . . . 0.0 111.198 . . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.425 ' HB3' ' O ' ' A' ' 25' ' ' VAL . 20.6 mtm180 45.06 -171.43 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.178 0.513 . . . . 0.0 111.834 178.437 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.547 ' HB3' ' CD ' ' A' ' 10' ' ' PRO . 80.7 m -87.8 176.4 3.42 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.839 179.738 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.554 ' HD2' ' CD1' ' A' ' 59' ' ' TRP . 26.4 Cg_endo -88.37 -167.49 0.31 Allowed 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.556 2.171 . . . . 0.0 111.814 179.626 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.448 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 1.1 p -56.79 105.81 0.58 Allowed Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.554 179.603 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.619 ' HB3' HD11 ' A' ' 31' ' ' ILE . 10.1 Cg_endo -52.43 138.99 56.52 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.253 1.969 . . . . 0.0 112.111 -179.194 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.529 ' O ' HD11 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -53.22 160.87 0.99 Allowed 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.581 179.963 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.611 ' HA ' HD11 ' A' ' 20' ' ' LEU . 3.9 p-10 -117.2 -175.1 2.73 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.785 -176.567 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.442 HG23 ' C ' ' A' ' 18' ' ' GLY . 2.7 tt -139.44 145.19 27.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.437 179.395 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -76.14 -65.73 0.88 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.459 -178.463 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.424 ' N ' ' ND2' ' A' ' 17' ' ' ASN . 0.6 OUTLIER -91.77 42.07 1.09 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.861 -179.34 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.442 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -160.88 -179.87 35.91 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.392 -0.908 . . . . 0.0 113.3 -179.89 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -137.95 140.28 40.17 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 179.166 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.611 HD11 ' HA ' ' A' ' 14' ' ' ASP . 10.7 mt -84.38 158.26 21.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.216 0.531 . . . . 0.0 111.875 -179.013 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -131.46 72.76 1.51 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.114 176.741 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.894 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.5 OUTLIER -73.95 106.09 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.238 -176.135 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -89.1 -5.04 73.77 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.668 175.632 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 172.39 153.03 8.97 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 121.16 -0.543 . . . . 0.0 111.818 -179.95 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.425 ' O ' ' HB3' ' A' ' 8' ' ' ARG . 24.3 m -121.86 3.4 6.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.271 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.414 ' HA ' ' HB3' ' A' ' 8' ' ' ARG . 0.6 OUTLIER -72.54 162.14 29.86 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 121.081 0.467 . . . . 0.0 111.517 -179.349 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.74 ' HZ ' HD13 ' A' ' 51' ' ' LEU . 0.6 OUTLIER -51.91 98.68 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.202 178.744 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 117.86 -9.24 14.31 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.561 -179.097 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.4 m -75.31 138.23 41.67 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 117.068 0.434 . . . . 0.0 109.985 178.93 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 47' ' ' SER . 2.1 p -115.96 140.54 49.15 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.251 0.548 . . . . 0.0 111.397 -178.778 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.894 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -98.06 164.32 2.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.428 -0.805 . . . . 0.0 109.946 179.196 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.413 ' HA ' ' HG3' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -124.76 110.4 14.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.957 0.408 . . . . 0.0 110.856 179.574 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.527 ' CE2' ' CD2' ' A' ' 20' ' ' LEU . 13.8 m-85 -83.23 142.64 31.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.231 -179.372 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.439 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 26.5 p -143.61 158.91 43.31 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.206 179.235 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.2 m -84.62 167.84 15.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.754 0.312 . . . . 0.0 110.936 -179.763 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.49 -82.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.003 -179.597 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -159.61 129.91 5.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.798 179.948 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.402 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 69.92 21.21 76.68 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.078 -179.016 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.482 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.9 m-30 -114.51 178.51 4.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.846 0.355 . . . . 0.0 110.833 -179.637 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.864 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.3 OUTLIER -138.88 119.41 13.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.568 178.244 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.856 HD21 ' O ' ' A' ' 44' ' ' GLU . 7.6 tt -83.25 122.27 28.19 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.647 -179.65 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.864 HD11 ' CE1' ' A' ' 40' ' ' HIS . 1.7 mm -99.65 160.49 3.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.119 0.485 . . . . 0.0 111.313 -178.644 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.89 -145.05 40.97 Favored Glycine 0 N--CA 1.453 -0.191 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.43 -179.758 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.856 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -60.74 -174.38 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.863 0.363 . . . . 0.0 110.538 179.28 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.0 t -172.88 29.96 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.792 178.786 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.413 ' HG3' ' HA ' ' A' ' 32' ' ' THR . 11.9 mtpt -162.21 119.94 2.15 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 120.751 0.31 . . . . 0.0 111.287 -179.329 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.429 ' HB3' HG13 ' A' ' 31' ' ' ILE . 1.0 OUTLIER -87.52 136.79 32.8 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.026 178.919 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.534 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 1.1 m-85 -111.9 120.71 42.84 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 119.482 -0.887 . . . . 0.0 111.703 179.916 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.421 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 18.5 t -72.45 118.46 15.39 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.849 -179.973 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.507 ' HA ' ' CE1' ' A' ' 27' ' ' PHE . 10.3 tt0 -156.62 169.21 25.2 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.429 0.633 . . . . 0.0 110.782 179.326 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.74 HD13 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -79.82 155.37 27.89 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.039 -178.956 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -73.48 -123.01 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.407 179.907 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.13 -35.25 3.89 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.863 0.364 . . . . 0.0 111.0 -179.964 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 82.4 p -97.8 31.55 2.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.894 179.981 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.735 ' HA2' HD23 ' A' ' 51' ' ' LEU . . . 76.2 20.4 77.36 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.502 -179.777 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.8 t -88.5 -171.32 3.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.851 0.358 . . . . 0.0 110.917 -179.964 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.31 138.69 50.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.434 179.892 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 7.4 m -153.68 173.45 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.247 -179.493 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.554 ' CD1' ' HD2' ' A' ' 10' ' ' PRO . 64.6 m95 -126.4 129.73 49.33 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.853 179.874 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.534 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 6.1 m-20 -73.69 166.15 46.77 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.489 179.184 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.447 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 90.1 Cg_exo -18.4 96.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 125.247 3.965 . . . . 0.0 114.112 -179.366 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.463 ' O ' ' CD1' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -97.81 -78.52 0.48 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.268 -176.943 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.469 ' HA ' ' CD2' ' A' ' 33' ' ' TYR . . . -85.46 108.38 15.9 Favored Pre-proline 0 C--N 1.332 -0.168 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -175.726 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.808 ' HG2' HD11 ' A' ' 41' ' ' LEU . 3.5 Cg_exo -84.08 -153.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 123.201 2.601 . . . . 0.0 111.073 177.211 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.507 HG22 ' H ' ' A' ' 66' ' ' CYS . 3.6 mm -90.79 166.33 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.768 0.318 . . . . 0.0 110.594 178.259 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.507 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -166.66 137.94 3.41 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.947 179.631 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.427 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.5 OUTLIER -161.99 177.0 10.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.047 179.716 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.482 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 6.5 p -89.44 112.16 23.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.118 -179.7 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.497 ' HB ' ' CA ' ' A' ' 116' ' ' GLY . 3.2 p -48.43 104.88 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.997 179.602 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.429 ' HD2' ' HB3' ' A' ' 88' ' ' PHE . 0.0 OUTLIER -87.54 145.67 26.12 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.021 -177.988 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 1.8 m -105.47 137.16 43.75 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.57 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.407 ' CG ' ' N ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -69.32 -170.56 0.28 Allowed 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 120.469 -0.492 . . . . 0.0 109.849 179.967 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.407 ' N ' ' CG ' ' A' ' 72' ' ' GLN . 2.0 t -72.91 108.94 5.13 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 116.087 -0.506 . . . . 0.0 112.251 -178.039 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.734 ' HG3' ' CE2' ' A' ' 118' ' ' TRP 0.302 0.2 OUTLIER -35.82 -177.96 0.0 OUTLIER 'Trans proline' 0 CA--C 1.467 -2.864 0 C-N-CA 123.481 2.788 . . . . 0.0 113.553 173.807 . . . . . . . . 4 4 . 1 . 047 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.581 ' CB ' ' CE1' ' A' ' 97' ' ' TYR . 26.7 Cg_endo -71.78 -165.14 3.24 Favored 'Cis proline' 0 C--N 1.315 -1.187 0 N-CA-C 113.994 0.728 . . . . 0.0 113.994 -19.258 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.3 p -132.57 20.28 4.29 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 114.178 -1.374 . . . . 0.0 108.795 172.395 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.835 HD11 ' HA3' ' A' ' 80' ' ' GLY . 17.5 pt -106.43 -159.32 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.265 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.14 -177.952 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.429 ' N ' HG13 ' A' ' 77' ' ' ILE . 0.4 OUTLIER -131.24 148.34 52.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.869 177.199 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.42 ' ND2' ' HB3' ' A' ' 78' ' ' SER . 2.1 m-80 55.46 30.26 14.75 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.882 178.8 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.835 ' HA3' HD11 ' A' ' 77' ' ' ILE . . . -144.52 -168.38 12.57 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.417 -0.896 . . . . 0.0 113.039 -179.531 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.419 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 4.2 ptt180 -166.81 -174.49 2.75 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.069 0.462 . . . . 0.0 111.592 -178.789 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.548 ' CG ' ' HB2' ' A' ' 74' ' ' PRO . 41.1 p-80 -120.31 175.86 5.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.759 -177.858 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.425 ' ND2' ' O ' ' A' ' 96' ' ' THR . 1.2 m-20 -124.37 9.1 8.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.282 178.216 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -51.16 168.96 0.39 Allowed Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.719 -179.59 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.505 ' N ' ' CD2' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -114.86 -24.3 8.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.751 0.31 . . . . 0.0 111.086 -179.534 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.85 -173.21 3.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.097 -179.35 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.54 -25.1 11.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.932 179.689 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.434 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 7.5 m-85 -134.56 172.43 12.93 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.885 179.962 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.515 ' CE2' ' HD2' ' A' ' 74' ' ' PRO . 37.9 m-85 -144.9 159.4 42.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.182 -178.811 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.414 ' CG2' ' HG2' ' A' ' 70' ' ' LYS . 3.2 p -119.11 172.5 7.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.374 -179.055 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 48.8 p-10 -59.81 94.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.14 -179.782 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.94 32.88 0.67 Allowed Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 115.331 -0.85 . . . . 0.0 112.959 178.681 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.459 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -110.07 160.39 16.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.843 0.354 . . . . 0.0 110.944 179.49 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 29.9 m -139.72 148.21 23.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.044 179.981 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.559 HG23 ' CH2' ' A' ' 118' ' ' TRP . 3.5 t -150.93 144.27 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.365 -179.148 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.425 ' O ' ' ND2' ' A' ' 83' ' ' ASN . 0.0 OUTLIER -93.67 135.19 35.21 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.146 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.766 ' CZ ' HG21 ' A' ' 111' ' ' VAL . 3.3 m-30 -104.04 158.65 16.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.341 0.591 . . . . 0.0 112.282 -175.21 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.418 ' O ' ' CG ' ' A' ' 81' ' ' ARG . 61.0 m -142.24 144.77 33.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.391 178.766 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.471 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 93.3 m -71.25 148.03 47.61 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.912 0.387 . . . . 0.0 111.596 -178.893 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.462 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 62.5 m-20 -75.6 -77.42 0.13 Allowed 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.973 -178.501 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.0 t -62.19 -18.73 61.87 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.641 0.258 . . . . 0.0 111.624 -178.285 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.95 27.46 1.88 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.653 -179.993 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.42 ' CE2' HG12 ' A' ' 126' ' ' ILE . 34.9 m-85 -69.0 -173.35 0.48 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.867 0.365 . . . . 0.0 110.428 179.26 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 125' ' ' GLN . 0.5 OUTLIER -112.06 109.52 19.31 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.855 178.026 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.662 HD22 ' HB3' ' A' ' 109' ' ' SER . 0.2 OUTLIER -52.2 123.42 10.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.457 0.646 . . . . 0.0 111.059 -178.656 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.531 HG22 ' N ' ' A' ' 107' ' ' GLY . 28.3 mm -95.57 162.14 2.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.247 179.783 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.531 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 57.28 -128.66 47.97 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.235 -0.984 . . . . 0.0 112.253 -179.572 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -110.68 135.64 50.98 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.025 0.44 . . . . 0.0 112.118 -178.913 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.662 ' HB3' HD22 ' A' ' 105' ' ' LEU . 0.0 OUTLIER -77.33 -32.52 55.29 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 174.481 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -68.3 117.4 8.38 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 110.536 -1.025 . . . . 0.0 110.536 175.332 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.766 HG21 ' CZ ' ' A' ' 97' ' ' TYR . 32.4 t -117.36 127.01 74.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 C-N-CA 121.977 0.111 . . . . 0.0 110.787 -175.832 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 118' ' ' TRP . 0.6 OUTLIER -84.42 133.32 34.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.002 0.43 . . . . 0.0 111.857 -177.744 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.51 ' HB2' ' CZ3' ' A' ' 118' ' ' TRP . 23.0 t -97.0 100.01 11.52 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.441 176.384 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.33 170.47 16.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.128 -178.45 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 46.38 26.13 2.28 Favored Glycine 0 CA--C 1.517 0.214 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.727 179.762 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.497 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 71.58 19.47 77.86 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.516 -179.613 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -153.09 179.64 8.52 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.188 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.734 ' CE2' ' HG3' ' A' ' 74' ' ' PRO . 97.1 m95 -100.7 129.47 46.61 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.046 0.45 . . . . 0.0 111.023 -179.703 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -109.38 156.49 19.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.237 -178.787 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.511 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER 54.53 42.81 1.19 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.13 179.868 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.511 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 72.4 Cg_endo -75.01 154.13 42.21 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.146 1.897 . . . . 0.0 111.748 178.649 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.463 ' CB ' ' O ' ' A' ' 106' ' ' ILE . 57.6 Cg_endo -88.24 -169.73 0.46 Allowed 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.544 2.162 . . . . 0.0 113.191 -179.46 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.459 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -133.32 173.52 11.38 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.962 176.498 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 1.4 m -134.06 97.34 3.84 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.989 179.964 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.4 ' O ' ' HB2' ' A' ' 104' ' ' SER . 22.9 mt-30 -129.35 163.65 25.29 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.937 -179.228 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.42 HG12 ' CE2' ' A' ' 103' ' ' TYR . 23.2 mm . . . . . 0 C--N 1.324 -0.524 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.07 -179.937 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 88.9 mtt180 . . . . . 0 N--CA 1.457 -0.098 0 CA-C-O 120.912 0.387 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 048 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.82 173.62 11.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.002 -179.86 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.447 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 34.1 m -79.47 161.41 67.33 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.15 -179.7 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -70.65 172.81 12.78 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.55 2.167 . . . . 0.0 112.18 179.794 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.8 t -54.13 108.73 1.21 Allowed Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.856 -179.889 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.877 ' HG2' HD13 ' A' ' 22' ' ' ILE . 53.9 Cg_exo -50.55 143.72 27.26 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.321 2.014 . . . . 0.0 112.263 179.905 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -56.91 151.15 15.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.221 179.047 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.602 ' HA ' HD11 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -93.56 -171.75 2.71 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.536 -177.719 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.436 HG22 ' CD2' ' A' ' 20' ' ' LEU . 14.9 tt -147.99 146.39 18.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.914 -179.448 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -86.29 156.43 20.25 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.018 178.446 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.447 ' N ' ' ND2' ' A' ' 17' ' ' ASN . 0.0 OUTLIER 43.28 29.11 0.2 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.964 -179.15 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.436 ' HA2' ' N ' ' A' ' 36' ' ' ASN . . . -157.71 177.91 34.27 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.536 -179.57 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.88 153.97 51.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.768 0.318 . . . . 0.0 110.605 -179.874 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.602 HD11 ' HA ' ' A' ' 14' ' ' ASP . 4.8 mt -91.57 153.15 19.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.002 0.429 . . . . 0.0 111.164 179.76 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.464 ' HB3' ' CB ' ' A' ' 32' ' ' THR . 19.6 t0 -123.96 67.4 1.04 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.337 177.526 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.881 ' HA ' HG23 ' A' ' 31' ' ' ILE . 0.9 OUTLIER -79.77 95.82 2.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.77 -176.667 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -93.11 15.94 61.7 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.025 177.662 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 161.62 128.19 0.93 Allowed Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.054 -179.6 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.617 HG12 ' CZ2' ' A' ' 59' ' ' TRP . 2.8 m -114.8 15.76 8.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -179.077 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 28' ' ' GLY . 5.2 m-20 -79.59 157.18 27.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.913 0.387 . . . . 0.0 111.312 -179.573 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.596 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 2.0 t80 -54.34 86.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.019 179.705 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 132.79 -5.41 5.12 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.702 -0.761 . . . . 0.0 113.024 179.974 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.9 m -77.87 -178.01 5.23 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.926 0.363 . . . . 0.0 110.787 179.999 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 47' ' ' SER . 5.4 p -146.15 154.09 41.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.871 0.367 . . . . 0.0 111.427 -179.924 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.881 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -115.84 170.89 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.113 179.749 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.489 HG23 ' HG2' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -137.91 106.87 5.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.735 178.41 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.474 ' CE1' ' HA ' ' A' ' 63' ' ' ALA . 34.3 m-85 -79.09 148.25 32.47 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.86 -179.79 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 10.8 p -152.23 158.3 42.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.222 -179.703 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 6.9 m -84.92 163.88 18.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.958 179.78 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.436 ' N ' ' HA2' ' A' ' 18' ' ' GLY . 5.9 m-20 -64.57 -84.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.295 -179.168 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -153.3 134.48 14.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.85 -179.594 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.691 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 65.12 23.41 69.7 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.945 -178.929 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.492 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.3 m-85 -117.0 175.43 5.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.37 . . . . 0.0 110.906 -179.292 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.739 ' HB3' HG22 ' A' ' 69' ' ' VAL . 0.5 OUTLIER -141.05 115.73 9.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.427 177.549 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.965 HD21 ' O ' ' A' ' 44' ' ' GLU . 2.0 tt -77.33 131.66 38.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.493 -179.448 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.454 ' N ' HD13 ' A' ' 42' ' ' ILE . 2.8 mm -100.15 162.13 3.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.15 -179.218 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.415 ' H ' HG22 ' A' ' 42' ' ' ILE . . . 70.9 -137.25 26.6 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.24 -179.355 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.965 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -76.82 177.47 7.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.729 0.299 . . . . 0.0 110.825 179.621 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.5 p -147.31 22.65 1.18 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.054 179.885 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.489 ' HG2' HG23 ' A' ' 32' ' ' THR . 0.0 OUTLIER -145.92 -177.91 5.84 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.214 0.531 . . . . 0.0 111.527 -178.626 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.421 ' CB ' HG13 ' A' ' 31' ' ' ILE . 0.5 OUTLIER -155.06 147.79 24.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.486 178.567 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.469 ' CD1' ' O ' ' A' ' 60' ' ' ASN . 2.4 m-85 -125.03 118.95 27.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.983 0.42 . . . . 0.0 111.934 -177.652 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.5 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 34.6 t -70.93 112.57 7.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.407 178.417 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.48 -176.77 4.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.15 0.5 . . . . 0.0 111.553 -179.432 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.596 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -88.73 139.5 30.41 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.853 -179.626 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.435 ' N ' HG22 ' A' ' 58' ' ' VAL . . . -105.29 -61.01 0.64 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.808 -179.57 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.71 50.14 1.95 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.764 0.316 . . . . 0.0 111.256 -179.397 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.0 p 53.89 30.82 12.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.829 179.65 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 163.19 -27.15 0.23 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.176 -179.693 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.4 t -66.19 -161.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.873 0.368 . . . . 0.0 110.885 179.572 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.1 mmt -125.07 139.74 53.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.58 179.829 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.435 HG22 ' N ' ' A' ' 52' ' ' GLY . 3.1 m -154.01 178.71 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.246 -179.303 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.679 ' CE3' HD11 ' A' ' 31' ' ' ILE . 86.4 m95 -135.1 125.87 27.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.027 -179.427 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.469 ' O ' ' CD1' ' A' ' 48' ' ' TYR . 13.6 m-80 -146.43 127.13 7.13 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.219 -179.636 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.402 ' HG2' ' O ' ' A' ' 46' ' ' LYS . 74.3 Cg_endo -75.36 -165.51 4.28 Favored 'Cis proline' 0 C--N 1.352 0.76 0 C-N-CA 123.849 -1.313 . . . . 0.0 112.394 -0.652 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.8 -151.81 0.49 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.249 -178.819 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.474 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . . . -79.03 116.9 63.59 Favored Pre-proline 0 C--N 1.333 -0.119 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.058 -179.654 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.491 ' HG2' HD11 ' A' ' 41' ' ' LEU . 13.6 Cg_exo -72.21 -151.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.645 2.23 . . . . 0.0 112.499 -179.257 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.519 HG22 ' H ' ' A' ' 66' ' ' CYS . 7.3 mm -99.99 167.22 2.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.403 -178.858 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.519 ' H ' HG22 ' A' ' 65' ' ' ILE . 1.2 m -161.13 128.5 4.17 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.752 179.219 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.475 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.0 OUTLIER -152.49 178.6 9.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.956 -179.727 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.492 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 87.4 p -80.41 119.62 23.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.185 0.517 . . . . 0.0 111.094 -179.883 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.739 HG22 ' HB3' ' A' ' 40' ' ' HIS . 2.3 p -45.63 96.35 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.526 179.82 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -82.79 118.02 23.1 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.067 179.888 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.65 117.28 34.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.129 179.047 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.56 -157.01 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.837 -179.605 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.458 ' OG ' ' CE1' ' A' ' 82' ' ' HIS . 2.1 t -49.02 138.56 13.01 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.06 -179.656 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.484 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 26.8 Cg_exo -60.32 161.35 20.32 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.349 2.033 . . . . 0.0 111.973 179.807 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.51 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 88.3 Cg_exo -42.39 156.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.675 2.25 . . . . 0.0 112.744 -179.821 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.2 t -108.46 90.91 3.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.552 179.378 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.719 HG23 ' HE2' ' A' ' 97' ' ' TYR . 26.7 pt -69.16 178.33 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.305 -179.163 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -99.23 140.2 33.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.756 179.624 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.502 ' HB3' ' CE2' ' A' ' 103' ' ' TYR . 0.1 OUTLIER 63.92 29.21 14.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.555 -179.992 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.431 ' CA ' ' HA ' ' A' ' 99' ' ' CYS . . . -169.51 -165.46 26.93 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.814 179.627 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' A' ' 98' ' ' SER . 6.7 ptt180 -168.69 -175.63 2.5 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.85 0.357 . . . . 0.0 110.611 -179.584 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 10.5 p80 -111.61 167.91 9.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.282 -179.651 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -98.3 -83.95 0.4 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.738 179.889 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.435 ' H ' HG13 ' A' ' 95' ' ' VAL . . . 61.05 145.37 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.823 179.369 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -112.29 -30.37 7.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.063 0.459 . . . . 0.0 110.752 179.632 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -96.28 -171.66 2.35 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.983 -179.768 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.83 -25.81 12.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.069 179.959 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.416 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 11.0 m-85 -131.9 174.5 10.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.889 -179.864 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.422 ' OH ' ' HA3' ' A' ' 84' ' ' GLY . 46.5 m-85 -148.18 162.71 38.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.101 179.924 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 16.5 p -136.3 -174.92 3.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.058 -179.616 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.425 ' OD1' ' CG1' ' A' ' 69' ' ' VAL . 1.6 m-20 -62.25 93.78 0.05 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.193 0.52 . . . . 0.0 111.246 -179.679 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.48 30.42 0.84 Allowed Glycine 0 N--CA 1.447 -0.615 0 CA-C-N 115.514 -0.766 . . . . 0.0 113.143 178.175 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.436 ' CB ' ' HB3' ' A' ' 113' ' ' CYS . 0.5 OUTLIER -109.83 155.46 21.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.823 0.311 . . . . 0.0 110.62 179.135 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 28.8 m -133.5 150.7 32.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.171 0.51 . . . . 0.0 111.285 -179.719 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.517 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 22.1 t -147.22 149.19 15.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.495 179.612 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.897 HG22 ' HB2' ' A' ' 109' ' ' SER . 0.0 OUTLIER -111.63 123.06 49.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.176 0.512 . . . . 0.0 111.117 -179.991 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 1.013 ' CE1' HG21 ' A' ' 111' ' ' VAL . 4.7 m-85 -79.14 161.82 26.21 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.48 -179.244 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.4 ' O ' ' N ' ' A' ' 81' ' ' ARG . 49.3 m -152.41 133.54 14.27 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.442 -179.872 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.431 ' HA ' ' CA ' ' A' ' 80' ' ' GLY . 73.4 m -69.62 163.92 24.47 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.77 179.415 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.46 -84.93 0.4 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.917 179.514 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.8 t -44.41 -28.68 0.58 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.445 -179.696 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 126.74 35.74 0.54 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.769 179.605 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.507 ' CE1' HG12 ' A' ' 126' ' ' ILE . 52.0 m-85 -76.46 -173.86 2.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.793 0.33 . . . . 0.0 110.467 179.364 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.58 113.67 26.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.079 0.466 . . . . 0.0 111.04 -179.696 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.622 HD21 ' HB2' ' A' ' 97' ' ' TYR . 0.3 OUTLIER -50.63 112.14 0.65 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.74 179.078 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.483 HG22 ' N ' ' A' ' 107' ' ' GLY . 49.9 mm -97.61 158.58 3.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.976 -179.583 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.483 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 52.87 34.55 45.56 Favored Glycine 0 CA--C 1.509 -0.294 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.632 179.3 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.422 ' O ' ' O ' ' A' ' 107' ' ' GLY . 8.6 p30 52.88 138.32 0.0 OUTLIER 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 124.158 0.983 . . . . 0.0 112.974 179.43 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.897 ' HB2' HG22 ' A' ' 96' ' ' THR . 0.9 OUTLIER -66.9 -23.9 66.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.686 -179.435 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.36 125.37 39.28 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.702 -179.543 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 1.013 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.2 t -129.32 121.56 53.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 110.387 -0.227 . . . . 0.0 110.387 179.515 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.98 123.56 32.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.827 0.346 . . . . 0.0 111.525 -178.787 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.506 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 19.8 t -88.83 103.5 16.05 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 176.55 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.37 158.83 43.28 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.048 0.451 . . . . 0.0 111.271 -178.772 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 47.11 31.39 5.94 Favored Glycine 0 N--CA 1.453 -0.195 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.715 179.824 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.461 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 70.2 12.08 68.36 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.646 -179.369 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -136.04 174.89 10.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.981 0.419 . . . . 0.0 110.67 179.522 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.517 ' CZ3' HG23 ' A' ' 95' ' ' VAL . 91.2 m95 -113.22 129.57 56.48 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.731 -179.732 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.07 145.85 39.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.087 0.47 . . . . 0.0 111.443 -178.822 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.482 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.6 OUTLIER 69.63 44.63 0.25 Allowed Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.288 178.675 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.482 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 55.6 Cg_endo -69.93 143.91 51.5 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.174 1.916 . . . . 0.0 111.27 177.874 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.525 ' HB2' HD23 ' A' ' 105' ' ' LEU . 62.3 Cg_endo -90.91 -173.22 0.56 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.519 2.146 . . . . 0.0 113.719 -177.732 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.55 -159.13 0.93 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.778 178.672 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . 0.417 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 7.6 m -154.82 88.99 1.21 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.949 0.404 . . . . 0.0 110.992 179.337 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -112.57 160.96 17.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.737 179.877 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.507 HG12 ' CE1' ' A' ' 103' ' ' TYR . 15.9 mm . . . . . 0 C--N 1.323 -0.576 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.285 -179.631 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.647 0.261 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.544 ' HD3' HG23 ' A' ' 25' ' ' VAL . 2.5 mtt180 40.04 -161.05 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.827 179.308 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.455 ' HB3' ' NE1' ' A' ' 59' ' ' TRP . 66.4 m -116.0 160.23 36.21 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.697 -179.967 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 9' ' ' CYS . 40.0 Cg_endo -67.17 172.64 9.69 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.419 2.079 . . . . 0.0 111.928 179.464 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.4 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -49.39 110.62 1.62 Allowed Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.874 -179.778 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.525 ' HB3' HD11 ' A' ' 31' ' ' ILE . 13.8 Cg_endo -57.32 159.31 16.15 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.209 1.939 . . . . 0.0 112.061 -179.761 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.434 ' O ' HD11 ' A' ' 20' ' ' LEU . 6.2 ttt180 -63.66 174.79 1.25 Allowed 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.807 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -136.87 -175.69 4.11 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.304 0.573 . . . . 0.0 111.62 -179.534 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.79 HD12 ' O ' ' A' ' 64' ' ' PRO . 10.4 tt -131.68 152.45 37.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.363 179.801 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -77.92 -66.75 0.8 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.391 -178.567 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -93.37 36.72 1.06 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.746 -179.932 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.498 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -149.89 176.88 28.36 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.813 -179.824 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -138.04 134.55 34.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.785 0.326 . . . . 0.0 110.419 179.64 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 1.024 HD21 ' CZ ' ' A' ' 33' ' ' TYR . 11.5 mt -83.71 156.22 22.71 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.062 0.458 . . . . 0.0 111.486 -179.508 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -117.83 73.72 0.91 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.679 177.569 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.883 ' HA ' HG23 ' A' ' 31' ' ' ILE . 2.5 mt -70.34 92.76 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.972 -177.395 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.26 10.9 67.1 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.522 -0.846 . . . . 0.0 111.904 176.712 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 150.69 145.65 4.17 Favored Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 111.715 -0.554 . . . . 0.0 111.715 -179.347 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.544 HG23 ' HD3' ' A' ' 8' ' ' ARG . 35.1 m -119.29 6.15 6.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -179.489 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.4 ' HA ' ' HB3' ' A' ' 8' ' ' ARG . 2.7 p-10 -69.6 155.58 40.27 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.974 0.416 . . . . 0.0 111.31 -179.417 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.472 ' CZ ' ' HB3' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -49.74 102.47 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.932 179.823 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 112.27 5.82 24.46 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.516 -179.09 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -80.96 -178.82 7.05 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.934 0.367 . . . . 0.0 110.448 179.366 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 88.1 p -151.77 147.64 26.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.253 0.549 . . . . 0.0 111.547 -179.551 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.883 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -118.4 150.16 20.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.058 179.466 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.429 ' HA ' ' HG3' ' A' ' 46' ' ' LYS . 0.2 OUTLIER -113.31 119.0 36.18 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.76 0.314 . . . . 0.0 111.182 -179.756 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 1.024 ' CZ ' HD21 ' A' ' 20' ' ' LEU . 3.8 m-85 -85.57 138.56 32.1 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-O 121.048 0.452 . . . . 0.0 111.025 179.826 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.43 ' O ' ' CA ' ' A' ' 18' ' ' GLY . 0.5 OUTLIER -149.58 169.22 21.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.017 -178.933 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.447 ' HA ' ' HA2' ' A' ' 18' ' ' GLY . 92.8 m -90.57 166.71 13.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.505 -179.055 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.71 -75.61 0.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.893 179.96 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -161.55 139.81 9.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.737 179.784 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.494 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 53.76 26.6 33.25 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.118 -179.327 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.497 ' CE2' ' CB ' ' A' ' 68' ' ' SER . 2.2 m-85 -113.6 -179.81 3.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.07 0.462 . . . . 0.0 111.184 -179.492 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.63 ' HB3' HG23 ' A' ' 69' ' ' VAL . 0.3 OUTLIER -137.12 134.54 36.52 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.208 176.385 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.918 HD21 ' HG2' ' A' ' 64' ' ' PRO . 2.6 tt -88.69 135.13 33.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.542 -175.603 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.676 ' N ' HD13 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -110.57 123.62 66.64 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 CA-C-O 121.424 0.631 . . . . 0.0 111.329 -179.752 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.99 -145.99 16.01 Favored Glycine 0 C--N 1.316 -0.558 0 CA-C-N 114.553 -1.203 . . . . 0.0 112.621 179.527 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.449 ' O ' ' HG2' ' A' ' 64' ' ' PRO . 3.5 mm-40 -61.96 -137.71 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.4 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.8 p 167.56 39.43 0.0 OUTLIER 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 122.925 0.49 . . . . 0.0 110.806 179.272 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.489 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . 0.7 OUTLIER -168.49 170.18 9.91 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.537 0.685 . . . . 0.0 112.461 -178.013 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.566 ' HA ' ' O ' ' A' ' 61' ' ' PRO . 20.7 m -148.78 139.71 22.95 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 114.734 -1.121 . . . . 0.0 108.767 178.591 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.546 ' HB2' ' HB2' ' A' ' 60' ' ' ASN . 0.2 OUTLIER -132.42 129.54 39.44 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 117.752 -1.579 . . . . 0.0 113.836 -176.78 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.416 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 30.2 t -74.88 96.68 3.16 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.154 -1.385 . . . . 0.0 110.763 179.171 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.51 ' CG ' ' N ' ' A' ' 51' ' ' LEU . 2.2 tt0 -130.35 173.26 10.98 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.661 -179.967 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.51 ' N ' ' CG ' ' A' ' 50' ' ' GLU . 0.0 OUTLIER -77.21 157.15 31.04 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.435 -178.648 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.459 ' HA2' HG21 ' A' ' 58' ' ' VAL . . . -88.05 -149.65 18.33 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.802 -0.714 . . . . 0.0 112.644 179.833 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.4 m -84.47 -52.42 6.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.86 0.362 . . . . 0.0 111.033 -179.623 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 34.8 p -71.71 -19.54 62.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.221 -179.921 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 120.7 12.93 5.82 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.665 -179.602 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.409 ' O ' ' HA ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -81.62 -165.93 1.08 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.707 0.289 . . . . 0.0 110.771 179.948 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.16 130.52 55.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.142 179.627 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.459 HG21 ' HA2' ' A' ' 52' ' ' GLY . 1.6 m -142.81 -175.78 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.872 -178.51 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.61 ' CZ3' HD11 ' A' ' 31' ' ' ILE . 73.2 m95 -128.81 125.79 38.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.973 0.416 . . . . 0.0 111.707 -179.69 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.546 ' HB2' ' HB2' ' A' ' 48' ' ' TYR . 1.7 m-20 -67.82 171.76 4.98 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 174.729 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.566 ' O ' ' HA ' ' A' ' 47' ' ' SER . 0.3 OUTLIER 4.16 118.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.256 1 C-N-CA 125.467 4.111 . . . . 0.0 115.527 -176.024 . . . . . . . . 4 4 . 1 . 049 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.609 ' O ' ' CZ ' ' A' ' 33' ' ' TYR . 6.1 mm-40 -84.95 -77.6 0.27 Allowed 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 114.536 -1.211 . . . . 0.0 112.05 -174.105 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.629 ' CB ' ' HA ' ' A' ' 64' ' ' PRO . . . -65.54 -139.13 0.0 OUTLIER Pre-proline 0 CA--C 1.499 -1.016 0 CA-C-O 116.477 -1.725 . . . . 0.0 109.48 -177.991 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.918 ' HG2' HD21 ' A' ' 41' ' ' LEU . 4.3 Cg_exo -88.76 -158.7 1.19 Allowed 'Cis proline' 0 N--CA 1.483 0.91 0 CA-C-N 124.213 2.54 . . . . 0.0 114.856 15.441 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.3 pt -97.4 -176.47 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.366 -178.024 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.495 ' SG ' HD12 ' A' ' 41' ' ' LEU . 1.5 m -157.79 116.7 3.2 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.745 -179.052 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -105.46 172.82 6.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.588 178.433 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.497 ' CB ' ' CE2' ' A' ' 39' ' ' TYR . 2.0 p -97.09 113.07 24.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.058 179.896 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.63 HG23 ' HB3' ' A' ' 40' ' ' HIS . 0.6 OUTLIER -49.42 99.08 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.063 179.523 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.763 ' HE2' HG23 ' A' ' 90' ' ' THR . 0.3 OUTLIER -79.37 124.07 28.08 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.511 -179.356 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.28 117.58 34.45 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.247 -0.433 . . . . 0.0 109.924 178.039 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.8 -156.89 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.849 -179.15 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.418 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 1.8 t -47.75 136.56 10.35 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.119 -179.794 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.421 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 30.6 Cg_exo -58.41 161.72 13.71 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.223 1.948 . . . . 0.0 111.461 179.487 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.474 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 93.3 Cg_exo -40.16 156.3 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.57 2.18 . . . . 0.0 112.631 -178.978 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.4 t -106.13 88.62 2.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.855 179.971 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.588 HG21 ' O ' ' A' ' 122' ' ' PRO . 21.4 pt -69.83 174.7 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.121 -179.804 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.4 m -99.22 142.72 30.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.753 179.405 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.504 ' HB3' ' CD1' ' A' ' 103' ' ' TYR . 8.9 m-80 60.3 28.51 18.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.193 179.687 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -166.44 -167.45 27.13 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.908 179.848 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.412 ' CD ' ' OD1' ' A' ' 100' ' ' ASN . 9.4 ptt85 -163.92 -175.81 4.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.897 0.379 . . . . 0.0 110.708 -179.534 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 15.7 p80 -114.07 167.17 10.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.984 -179.883 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 85' ' ' TYR . 92.5 m-20 -98.21 -97.12 0.22 Allowed 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.614 179.785 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.638 ' N ' HG13 ' A' ' 95' ' ' VAL . . . 58.73 -83.05 0.01 OUTLIER Glycine 0 C--N 1.337 0.588 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.836 179.14 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.448 ' CB ' ' O ' ' A' ' 84' ' ' GLY . 4.1 m-30 93.05 13.32 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 125.2 1.4 . . . . 0.0 111.382 179.819 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -108.07 -174.54 2.55 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.836 179.012 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -110.33 -24.41 10.66 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.605 178.635 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.415 ' C ' ' CD1' ' A' ' 89' ' ' TYR . 9.1 m-85 -143.16 169.69 17.13 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.872 -179.948 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.415 ' CD1' ' C ' ' A' ' 88' ' ' PHE . 60.6 m-85 -149.26 159.92 43.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.479 179.516 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.763 HG23 ' HE2' ' A' ' 70' ' ' LYS . 9.5 p -122.55 -177.48 3.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.002 0.43 . . . . 0.0 111.64 -178.537 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.433 ' CB ' ' HA3' ' A' ' 38' ' ' GLY . 4.3 p-10 -68.58 96.49 0.71 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.867 179.948 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.67 18.3 2.21 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.286 -0.87 . . . . 0.0 113.182 178.882 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.35 162.06 13.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.871 0.336 . . . . 0.0 110.542 179.121 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 35.3 m -138.08 153.52 27.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.144 0.497 . . . . 0.0 111.198 -179.736 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.638 HG13 ' N ' ' A' ' 84' ' ' GLY . 21.3 t -147.93 149.4 15.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.924 179.705 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.855 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -108.41 128.37 54.72 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.855 179.751 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.971 ' CE2' HG21 ' A' ' 111' ' ' VAL . 5.9 m-85 -88.96 157.58 18.34 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.201 -179.294 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.434 ' HA ' HD13 ' A' ' 105' ' ' LEU . 22.8 m -154.57 142.11 19.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.458 -179.661 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.43 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 69.0 m -73.51 159.39 33.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.797 179.217 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.421 ' ND2' ' N ' ' A' ' 80' ' ' GLY . 69.8 m-20 -93.04 -70.75 0.69 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.32 -179.404 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.9 t -61.05 -23.48 65.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.224 -179.358 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 120.56 32.86 1.07 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.452 -179.821 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.504 ' CD1' ' HB3' ' A' ' 79' ' ' ASN . 16.0 m-85 -69.92 -175.41 0.91 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.057 0.456 . . . . 0.0 110.934 -179.903 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -109.75 100.47 9.47 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.206 178.47 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.589 HD22 ' HB2' ' A' ' 109' ' ' SER . 0.2 OUTLIER -44.76 126.21 5.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.442 0.639 . . . . 0.0 111.957 -177.927 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.453 ' O ' ' CB ' ' A' ' 122' ' ' PRO . 35.4 mm -87.72 153.86 3.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.749 178.43 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 63.03 -129.2 40.89 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.314 -0.946 . . . . 0.0 112.06 -179.04 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -122.62 142.47 50.61 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.865 0.364 . . . . 0.0 110.874 179.417 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.855 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.6 t -70.19 -29.87 66.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.893 179.985 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -72.57 135.34 21.92 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.818 -179.665 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.971 HG21 ' CE2' ' A' ' 97' ' ' TYR . 2.4 t -131.6 118.51 39.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.703 0.287 . . . . 0.0 110.812 179.44 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.92 122.92 28.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.521 -179.017 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.532 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 16.3 t -89.56 102.09 14.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.569 176.982 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.421 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.2 OUTLIER -141.12 157.99 44.53 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.04 -178.608 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.418 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 47.05 33.87 7.28 Favored Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.703 -179.965 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.451 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 66.02 10.29 50.86 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.522 -179.115 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -129.8 168.96 15.77 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.894 0.378 . . . . 0.0 110.578 179.407 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.532 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 94.9 m95 -109.98 134.5 52.05 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.929 -179.82 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.7 153.66 32.99 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.931 179.89 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.55 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 61.2 t0 66.04 37.17 0.2 Allowed Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 179.326 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.55 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 65.1 Cg_endo -75.78 134.89 17.05 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.12 1.88 . . . . 0.0 111.587 179.229 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.588 ' O ' HG21 ' A' ' 77' ' ' ILE . 87.0 Cg_endo -92.11 -172.3 0.4 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.812 2.341 . . . . 0.0 113.889 -177.33 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.446 ' CB ' ' HB ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -133.11 -158.59 0.9 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.722 178.042 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . . . . . . . . . 8.1 m -153.85 90.49 1.38 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.13 0.491 . . . . 0.0 111.012 179.129 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.429 ' HB2' HD11 ' A' ' 106' ' ' ILE . 10.4 mt-30 -122.33 157.31 32.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.778 179.966 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.576 HG22 ' O ' ' A' ' 126' ' ' ILE . 19.0 mm . . . . . 0 C--N 1.323 -0.564 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.941 -179.87 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.792 0.33 . . . . 0.0 110.873 . . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.696 ' HD3' HG23 ' A' ' 25' ' ' VAL . 0.0 OUTLIER 40.61 -162.0 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.01 178.648 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.475 ' O ' ' O ' ' A' ' 10' ' ' PRO . 1.3 m -100.35 171.35 5.62 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.347 -179.504 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 9' ' ' CYS . 75.5 Cg_exo -51.44 -147.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.262 2.641 . . . . 0.0 113.037 179.298 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.516 ' HG ' ' C ' ' A' ' 12' ' ' PRO . 40.7 t -37.26 -85.25 0.0 OUTLIER Pre-proline 0 CA--C 1.499 -1.011 0 CA-C-O 117.117 -1.42 . . . . 0.0 113.882 -177.216 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.602 ' HG3' HD13 ' A' ' 31' ' ' ILE . 63.7 Cg_endo -77.38 157.58 96.13 Favored 'Cis proline' 0 N--CA 1.481 0.764 0 CA-C-N 123.757 2.378 . . . . 0.0 115.083 -0.969 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.76 ' O ' HD11 ' A' ' 20' ' ' LEU . 17.1 tpp180 -50.64 156.7 0.87 Allowed 'General case' 0 CA--C 1.512 -0.49 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.779 178.883 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.437 ' N ' ' HG3' ' A' ' 13' ' ' ARG . 0.3 OUTLIER -109.57 -175.73 2.83 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.99 -179.779 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.501 HG23 ' C ' ' A' ' 18' ' ' GLY . 6.8 tt -128.01 147.74 32.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.723 179.759 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -83.94 -42.31 16.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.343 -178.521 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . 0.434 ' HB2' ' HB3' ' A' ' 66' ' ' CYS . 0.8 OUTLIER -103.07 39.32 1.58 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.849 -179.233 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.501 ' C ' HG23 ' A' ' 15' ' ' ILE . . . -175.5 -172.69 40.59 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.781 179.864 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.428 ' N ' ' O ' ' A' ' 34' ' ' SER . 0.4 OUTLIER -139.17 140.24 37.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.756 0.312 . . . . 0.0 110.407 179.732 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.906 HD21 ' CE1' ' A' ' 33' ' ' TYR . 11.3 mt -85.35 150.91 24.42 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.16 0.505 . . . . 0.0 112.12 -179.091 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.455 ' CB ' ' HB ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -120.51 72.32 0.95 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.23 175.275 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.94 ' HA ' HG23 ' A' ' 31' ' ' ILE . 1.7 mt -69.13 97.84 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.636 -176.974 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -88.94 7.45 82.11 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.282 178.002 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 159.07 136.95 2.14 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.528 179.972 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.696 HG23 ' HD3' ' A' ' 8' ' ' ARG . 15.1 m -113.73 25.23 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.785 0.326 . . . . 0.0 111.189 -179.817 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.407 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.5 OUTLIER -100.88 142.69 31.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.036 179.973 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.535 ' HZ ' HD12 ' A' ' 51' ' ' LEU . 9.4 t80 -47.51 93.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.18 0.514 . . . . 0.0 110.715 179.302 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 26' ' ' ASP . . . 134.32 -4.84 4.53 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.556 -178.959 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.91 -162.23 0.91 Allowed 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 178.975 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -168.41 150.56 5.17 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.089 0.471 . . . . 0.0 111.046 179.58 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.94 HG23 ' HA ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -104.49 160.16 5.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.908 179.243 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.455 ' HB ' ' CB ' ' A' ' 21' ' ' ASP . 1.7 m -125.3 114.91 19.54 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.803 0.335 . . . . 0.0 110.447 179.307 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.906 ' CE1' HD21 ' A' ' 20' ' ' LEU . 11.2 m-85 -91.53 149.68 21.56 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.184 0.516 . . . . 0.0 111.962 -178.048 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.428 ' O ' ' N ' ' A' ' 19' ' ' GLN . 0.6 OUTLIER -153.99 145.89 23.51 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.699 179.498 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.426 ' HB3' ' HB2' ' A' ' 39' ' ' TYR . 10.8 m -70.47 167.45 18.29 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.714 0.292 . . . . 0.0 110.629 179.816 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -68.97 -84.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.003 -179.44 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.2 m -153.3 134.31 14.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.695 179.716 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.74 ' O ' HG12 ' A' ' 69' ' ' VAL . . . 66.76 26.02 73.03 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.852 -178.93 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.5 ' CD1' ' HA ' ' A' ' 68' ' ' SER . 2.1 m-85 -118.99 170.25 9.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.868 0.366 . . . . 0.0 111.104 -179.382 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.882 ' CE1' HD11 ' A' ' 42' ' ' ILE . 0.4 OUTLIER -134.13 113.52 12.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.376 178.169 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.967 HD21 ' O ' ' A' ' 44' ' ' GLU . 4.8 tt -79.64 122.59 26.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.794 -179.438 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.882 HD11 ' CE1' ' A' ' 40' ' ' HIS . 2.3 mm -95.64 157.08 3.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.015 0.436 . . . . 0.0 111.284 -179.179 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.54 -135.23 19.11 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.159 -179.379 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.967 ' O ' HD21 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -85.95 -174.09 4.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.784 0.326 . . . . 0.0 110.822 179.469 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.422 ' HA ' ' HG3' ' A' ' 64' ' ' PRO . 0.2 OUTLIER -160.53 27.27 0.16 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.403 179.616 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 31' ' ' ILE . 6.5 mtpt -151.32 129.95 12.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.332 -179.467 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.451 ' HB2' ' HA ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -101.28 159.29 15.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.168 179.316 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.488 ' CB ' ' HB2' ' A' ' 60' ' ' ASN . 1.1 m-85 -132.16 121.54 23.89 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.58 -0.848 . . . . 0.0 112.222 -179.642 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 8.4 t -75.23 83.84 2.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.886 178.747 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -103.6 -177.86 3.49 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.622 -178.468 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.535 HD12 ' HZ ' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -89.11 143.86 26.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.014 -179.262 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -72.87 -120.58 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.389 179.829 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.2 t -105.98 -41.67 5.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.86 0.362 . . . . 0.0 110.894 179.633 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.91 43.39 1.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.852 179.924 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.73 18.76 74.36 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.598 -179.891 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.75 -162.79 0.09 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.795 0.331 . . . . 0.0 110.815 179.668 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.427 ' HB2' ' HA ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER -123.29 117.14 24.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.219 -0.446 . . . . 0.0 109.879 -179.978 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.431 HG22 ' C ' ' A' ' 51' ' ' LEU . 1.5 m -127.21 163.48 30.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.869 -178.773 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.497 ' CE2' ' HB3' ' A' ' 12' ' ' PRO . 63.5 m95 -116.01 118.06 31.86 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.647 -178.666 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.488 ' HB2' ' CB ' ' A' ' 48' ' ' TYR . 1.2 m-80 -72.26 165.46 50.53 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 177.27 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.466 ' HD2' ' CB ' ' A' ' 60' ' ' ASN . 87.3 Cg_exo -15.91 98.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.35 0.644 1 C-N-CA 125.681 4.254 . . . . 0.0 115.014 -178.39 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.505 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 4.2 mt-10 -99.35 -68.44 0.8 Allowed 'General case' 0 C--O 1.221 -0.426 0 N-CA-C 113.666 0.987 . . . . 0.0 113.666 -176.487 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.425 ' HA ' ' HD2' ' A' ' 64' ' ' PRO . . . -102.14 77.68 0.22 Allowed Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -174.053 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.57 ' HG2' HD11 ' A' ' 41' ' ' LEU . 36.5 Cg_endo -55.87 -154.37 0.01 OUTLIER 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 123.327 2.684 . . . . 0.0 111.575 175.352 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.489 HG22 ' H ' ' A' ' 66' ' ' CYS . 4.2 mm -93.56 165.32 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.051 0.453 . . . . 0.0 111.42 179.654 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.489 ' H ' HG22 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -165.03 135.25 3.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.662 179.277 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 39' ' ' TYR . 0.3 OUTLIER -153.86 176.18 12.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.014 -179.786 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.5 ' HA ' ' CD1' ' A' ' 39' ' ' TYR . 26.4 p -85.17 123.48 30.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.16 179.894 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.74 HG12 ' O ' ' A' ' 38' ' ' GLY . 1.3 p -55.82 96.54 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.246 179.973 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.15 124.0 27.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.522 -179.522 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.441 ' O ' ' N ' ' A' ' 89' ' ' TYR . 0.0 OUTLIER -104.57 125.94 51.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.957 178.234 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -75.75 -151.38 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.165 -179.962 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.446 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 2.8 t -55.3 138.67 66.96 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-O 120.636 0.255 . . . . 0.0 110.883 -179.568 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.487 ' HG3' ' CH2' ' A' ' 118' ' ' TRP . 29.2 Cg_exo -59.51 161.36 17.62 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.373 2.049 . . . . 0.0 112.078 179.969 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.525 ' HD3' ' CD1' ' A' ' 118' ' ' TRP . 87.0 Cg_exo -43.07 158.36 0.08 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.725 2.283 . . . . 0.0 112.798 -179.142 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 85.9 p -112.27 89.56 3.1 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.235 178.548 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.718 HG23 ' HE2' ' A' ' 97' ' ' TYR . 22.3 pt -69.24 167.82 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.206 -178.742 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 p -86.48 134.21 33.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.86 179.811 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.494 ' HB3' ' CE1' ' A' ' 103' ' ' TYR . 0.1 OUTLIER 67.77 28.37 7.19 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.486 -179.977 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' A' ' 99' ' ' CYS . . . -167.2 -166.04 25.61 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.141 179.661 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 98' ' ' SER . 0.4 OUTLIER -170.19 -174.11 1.66 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.091 0.472 . . . . 0.0 110.858 -178.829 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 97' ' ' TYR . 15.3 p80 -104.89 172.37 6.82 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.945 179.537 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 30.1 m-20 -112.23 1.03 15.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.711 -179.979 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -48.57 140.26 10.94 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.658 -179.456 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -108.77 -26.46 10.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.949 0.404 . . . . 0.0 110.832 -179.9 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.92 -170.44 2.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.634 179.472 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -112.61 -18.3 12.41 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.437 179.951 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.428 ' C ' ' CD2' ' A' ' 89' ' ' TYR . 5.6 m-85 -145.4 169.88 17.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.078 0.466 . . . . 0.0 111.499 -179.448 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.441 ' N ' ' O ' ' A' ' 71' ' ' CYS . 46.5 m-85 -149.08 166.08 29.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.41 -179.551 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.8 p -126.08 -178.62 4.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.967 0.413 . . . . 0.0 111.483 -179.444 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 114' ' ' SER . 9.0 p-10 -67.12 96.29 0.45 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.926 -179.867 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 126.18 23.93 1.52 Allowed Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.236 -0.893 . . . . 0.0 113.061 179.112 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.68 159.22 16.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.645 0.26 . . . . 0.0 110.425 179.254 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.474 HG22 ' N ' ' A' ' 95' ' ' VAL . 33.0 m -132.69 156.27 42.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.29 0.567 . . . . 0.0 111.501 -179.644 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.518 HG23 ' CZ3' ' A' ' 118' ' ' TRP . 22.8 t -151.11 149.38 14.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.341 179.078 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.721 HG22 ' OG ' ' A' ' 109' ' ' SER . 0.0 OUTLIER -103.7 139.47 38.91 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.029 0.442 . . . . 0.0 110.562 179.242 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.98 ' CE1' HG21 ' A' ' 111' ' ' VAL . 3.2 m-85 -95.94 158.57 15.39 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.814 -179.434 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 81' ' ' ARG . 1.2 p -147.78 133.05 18.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.659 -178.681 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.466 ' HA ' ' HA2' ' A' ' 80' ' ' GLY . 81.9 m -70.19 160.41 32.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.46 178.401 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.58 -85.33 0.36 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.776 0.322 . . . . 0.0 110.987 179.572 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -43.7 -28.82 0.44 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.642 -179.498 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 126.61 36.24 0.53 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.719 179.662 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.499 ' CE2' HG12 ' A' ' 126' ' ' ILE . 47.8 m-85 -77.52 -173.91 3.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.884 0.373 . . . . 0.0 110.923 179.958 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -113.06 107.26 15.71 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.799 179.917 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.546 HD22 ' HA ' ' A' ' 109' ' ' SER . 1.1 mp -45.21 117.08 1.26 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.296 179.842 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.46 HG22 ' N ' ' A' ' 107' ' ' GLY . 47.1 mm -106.25 155.54 7.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.935 -179.512 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.46 ' N ' HG22 ' A' ' 106' ' ' ILE . . . 60.34 37.61 93.38 Favored Glycine 0 CA--C 1.508 -0.396 0 C-N-CA 120.321 -0.942 . . . . 0.0 112.243 179.835 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.415 ' ND2' ' O ' ' A' ' 107' ' ' GLY . 8.4 p30 51.36 120.3 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.45 -0.875 . . . . 0.0 112.507 179.777 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.721 ' OG ' HG22 ' A' ' 96' ' ' THR . 1.3 p -54.4 -27.64 38.07 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.307 179.83 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.22 137.16 49.27 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.697 -179.465 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.98 HG21 ' CE1' ' A' ' 97' ' ' TYR . 2.9 t -134.87 137.15 51.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.454 0.169 . . . . 0.0 110.621 179.983 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.76 125.78 42.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.878 0.371 . . . . 0.0 111.478 -179.455 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.528 ' HB2' ' CH2' ' A' ' 118' ' ' TRP . 34.6 t -90.66 100.67 13.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.662 176.883 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 91' ' ' ASP . 0.3 OUTLIER -142.27 159.55 42.0 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.129 -178.495 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.433 ' HA2' HG11 ' A' ' 69' ' ' VAL . . . 47.18 32.06 6.52 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.655 -179.912 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.46 ' CA ' ' HB ' ' A' ' 69' ' ' VAL . . . 70.52 6.16 57.7 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.916 -179.759 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -129.8 -178.46 4.72 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.861 0.362 . . . . 0.0 110.498 179.261 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.528 ' CH2' ' HB2' ' A' ' 113' ' ' CYS . 92.0 m95 -117.36 122.72 44.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.932 -179.52 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.07 152.65 21.83 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.28 -179.049 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.513 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.5 OUTLIER 67.0 43.27 0.3 Allowed Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.205 179.27 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.513 ' CD ' ' N ' ' A' ' 120' ' ' ASP . 56.4 Cg_endo -69.75 141.42 45.22 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.158 1.905 . . . . 0.0 111.261 178.117 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.51 ' HB2' HD23 ' A' ' 105' ' ' LEU . 87.4 Cg_endo -92.25 -169.8 0.27 Allowed 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.554 2.169 . . . . 0.0 113.636 -177.594 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.28 -168.03 2.37 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.598 -1.183 . . . . 0.0 110.151 178.853 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 124' ' ' CYS . . . . . 0.424 ' HB3' ' CB ' ' A' ' 103' ' ' TYR . 6.7 m -145.84 94.81 2.54 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.006 0.431 . . . . 0.0 110.962 179.95 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -118.93 157.9 26.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.85 -179.772 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.499 HG12 ' CE2' ' A' ' 103' ' ' TYR . 22.9 mm . . . . . 0 C--N 1.324 -0.533 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.229 -179.742 . . . . . . . . 1 1 . 1 stop_ save_